Structure Search

List Search MOL Search Structure Search

 EN

English - EN Chinese - ZH

 Cart 0
Chemistry
Life Science
Catalysts Ligands
Materials Science
Catalysts Ligands
Achiral Nitrogen Ligands
Pyridine and Phenanthroline Ligands (162)
Other Achiral Nitrogen Ligands (53)
Achiral Oxygen Ligands
Achiral Oxygen Ligand (54)
Achiral Phosphine Ligands
Alkyl-phosphine Ligands (17)
Aryl-phosphine Ligands (86)
2-(Diphenylphosphaneyl)Benzaldehyde (5)[1,1'-Biphenyl]-2-Yldi-Tert-Butylphosphane (4)Triphenylphosphine Oxide (7)
Bis-phosphine Ligands (90)
Mono-phosphine Ligands (256)
Multi-phosphine Ligands (5)
Chiral Nitrogen Ligands
Chiral Bis-nitrogen Ligands (133)
Salen Ligands (7)
Other Chiral Nitrogen Ligands (69)
Chiral Oxazoline Ligands
BOX Ligands (510)
Chiral Mono Oxazoline Ligands (363)
Ferrocenyl-oxazoline Ligands (10)
PHOX Ligands (218)
SOX Ligands (34)
TOX Ligands (6)
Other Oxazoline Ligands (14)
Chiral Oxygen Ligands
BINOLs (46)
BIPHENs (2)
Chiral Diphenols (112)
Other Chiral Oxygen Ligands (24)
Chiral Phosphine Ligands
Atropisomeric Bisphosphine Ligands (137)
BIDIME and BIBOP Ligands (78)
BIDIME-BIBOP (7)
2,2',3,3'-Tetrahydro-4,4'-Bibenzo[D][1,3]Oxaphosphole (7)
Chiral Aminophosphine Ligands (50)
Chiral Ferrocenyl Phosphine Ligands (96)
Chiral Phosphoramidite Ligands (98)
Duphos and BPE Ligands (28)
PHOX Ligands (218)
Sadphos Ligands (110)
Other C-Chiral Ligands (76)
Other P-Chiral Ligands (10)
Main-Group Metals
Aluminum (11)
Tin (3)
Metalloids
Metalloid (5)
Organocatalysts
Chiral Hydrogen-Bonding Organocatalysts (79)
Chiral Phosphoric Acids (161)
4-Hydroxy-2,6-Diphenyldinaphtho[2,1-D:1',2'-F][1,3,2]Dioxaphosphepine 4-Oxide (20)
Cinchona Alkaloids (32)
MacMillan Imidazolidinone Organocatalysts (15)
NHTf (59)
Proline-Based Organocatalysts (51)
Other Organocatalysts (45)
Phase-Transfer Catalysts
Achiral Phase-Transfer Catalysts (61)
Chiral Phase-Transfer Catalysts (25)
Photoredox Catalysts
Organic-dye Photoredox Catalysts (86)
Photoredox Acridinium Catalysts (22)
Photoredox Carbazole Catalysts (10)
Photoredox Iridiums Catalysts (104)
Photoredox Rutheniums Catalysts (37)
Other Photoredox Catalysts (13)
Transition Metals
Cadmium (1)
Cobalt (92)
Copper (108)
Gold (70)
Iridium (60)
Iron (101)
Manganese (45)
Molybdenum (11)
Nickel (95)
Osmium (2)
Palladium (240)
Platinum (75)
Rhenium (6)
Rhodium (166)
Ruthenium (199)
Silver (33)
Tantalum (1)
Titanium (10)
Tungsten (6)
Vanadium (6)
Zinc (48)
Other Cheap Metals (6)
Chemistry
Asymmetric Synthesis
Chiral Building Blocks (18939)
Boronic Acids/Esters
1,3,2-Dioxaborinane (394)
Bcat (11)
Boronic Acids (13202)
MIDA Boronates (363)
Pinacol Boronates (16140)
Pinane Boronates (96)
Potassium Organotrifluoroborate Salts (1076)
Other Boronates (132)
Heterocyclic Building Blocks
Acridines (640)
1,2,3,4-Tetrahydroacridine (9)9,10-Diphenylacridin-10-Ium (6)Acridine (18)
Aliphatic Heterocycles (103)
(1R,5S)-3-Azabicyclo[3.1.0]Hexane (11)1,2-Dithiolane (6)1,4-Diazepan-2-One (5)1,4-Diazepan-5-One (9)1,4-Dioxane (17)1,4-Oxazepane (8)10,11-Dihydro-5H-Dibenzo[B,F]Azepine (9)11,12-Didehydro-5,6-Dihydrodibenz[B,F]Azocine (14)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Glycyl)-2,2-Dimethyloxazolidine-4-Carboxylic Acid (8)3H-Diazirine (11)4-Benzyl-1,4-Oxazepane (5)Tetrahydro-2H-Thiopyran 1,1-Dioxide (8)
Aromatic Heterocycles (30)
1,2,4,5-Tetrazine (7)3,4-Dihydronaphthalen-2(1H)-One (23)
Azetidines (2997)
1-(Azetidin-1-Yl)-2-Bromoethan-1-One (3)1-(Azetidin-3-Yl)-1H-Pyrazole (7)1-(Phenylsulfonyl)Azetidine (7)1-Benzhydrylazetidine (13)1-Benzylazetidine (6)1-Methylazetidine (6)1-Phenylazetidine (8)2,7-Diazaspiro[3.5]Nonane (7)2-Azaspiro[3.3]Heptane (11)2-Imino-N-((6R,7R)-8-Oxo-5-Thia-1-Azabicyclo[4.2.0]Oct-2-En-7-Yl)-2-(Thiazol-4-Yl)Acetamide (3)3-Bromoazetidine (3)3-Methylazetidin-3-Ol (3)3-Methyleneazetidine (8)3-Phenylazetidine (5)4-(Azetidin-1-Yl)Piperidine (6)Azetidin-2-One (11)Azetidin-2-Ylmethanol (7)Azetidin-3-Amine (4)Azetidin-3-Ol (11)Azetidin-3-Yl Acetate (3)Azetidin-3-Ylmethanamine (3)Azetidine-2-Carboxylic Acid (6)Azetidine-3-Carboxylic Acid (5)Benzyl Azetidine-1-Carboxylate (9)Methyl Azetidine-2-Carboxylate (3)N-((6R,7R)-8-Oxo-5-Thia-1-Azabicyclo[4.2.0]Oct-2-En-7-Yl)-2-Phenylacetamide (5)Tert-Butyl Azetidine-1-Carboxylate (64)
Benzimidazoles (4428)
Benzimidazole-Carboxylic Acid (43)(1H-Benzo[D]Imidazol-2-Yl)Methanamine (7)(1H-Benzo[D]Imidazol-2-Yl)Methanol (14)1,2-Diphenyl-1H-Benzo[D]Imidazole (7)1-Benzyl-1H-Benzo[D]Imidazole (6)1-Ethyl-1H-Benzo[D]Imidazole (4)1-Methyl-1H-Benzo[D]Imidazole (47)1-Phenyl-1H-Benzo[D]Imidazole (4)1H-Benzo[D]Imidazol-2-Amine (7)1H-Benzo[D]Imidazol-5-Amine (4)1H-Benzo[D]Imidazol-6-Amine (6)1H-Benzo[D]Imidazole-2-Carbaldehyde (5)1H-Benzo[D]Imidazole-2-Carboxylic Acid (7)1H-Benzo[D]Imidazole-2-Thiol (10)1H-Benzo[D]Imidazole-4-Carboxylic Acid (6)1H-Benzo[D]Imidazole-5-Carboxylic Acid (4)2-((Pyridin-2-Ylmethyl)Thio)-1H-Benzo[D]Imidazole (7)2-(1H-Benzo[D]Imidazol-2-Yl)Ethan-1-Amine (6)2-(Chloromethyl)-1H-Benzo[D]Imidazole (9)2-Benzyl-1H-Benzo[D]Imidazole (7)2-Bromo-1H-Benzo[D]Imidazole (4)2-Chloro-1H-Benzo[D]Imidazole (17)2-Methyl-1H-Benzo[D]Imidazole (20)4-Bromo-1H-Benzo[D]Imidazole (14)4-Methyl-1H-Benzo[D]Imidazole (7)5,6-Dichloro-1H-Benzo[D]Imidazole (4)5-Bromo-1H-Benzo[D]Imidazole (13)5-Chloro-1H-Benzo[D]Imidazole (14)5-Methoxy-1H-Benzo[D]Imidazole (2)5-Methyl-1H-Benzo[D]Imidazole (10)6-Chloro-1H-Benzo[D]Imidazole (25)Methyl (1H-Benzo[D]Imidazol-2-Yl)Carbamate (5)Methyl 1H-Benzo[D]Imidazole-2-Carboxylate (3)Tert-Butyl 1H-Benzo[D]Imidazole-1-Carboxylate (5)
Benzisoxazoles (508)
3-Chlorobenzo[D]Isoxazole (7)3-Methylbenzo[D]Isoxazole (8)6-Bromobenzo[D]Isoxazole (5)Benzo[C]Isoxazole (5)Benzo[D]Isoxazol-3-Amine (8)
Benzodioxans (697)
(2,3-Dihydrobenzo[B][1,4]Dioxin-2-Yl)Methanamine (3)2,3-Dihydrobenzo[B][1,4]Dioxine-2-Carboxylic Acid (3)2,3-Dihydrobenzo[B][1,4]Dioxine-6-Carboxylic Acid (3)6-Bromo-2,3-Dihydrobenzo[B][1,4]Dioxine (6)
Benzofurans (3713)
Benzofuran-Carboxylic Acid (67)Dimethoxyisobenzofuran (4)Epoxyisobenzofuran (1)Fluorobenzofuran (19)Fluoroisobenzofuran (5)Methoxyisobenzofuran (4)Methylbenzofuran (25)1-(Benzofuran-2-Yl)Ethan-1-One (3)2,2-Dimethyl-2,3-Dihydrobenzofuran (7)2,3-Dihydrobenzofuran-3-Amine (11)2,3-Dihydrobenzofuran-5-Amine (3)2,3-Dihydrobenzofuran-7-Amine (5)2-(Benzofuran-3-Yl)Acetic Acid (3)2-Bromodibenzo[B,D]Furan (6)2-Ethylbenzofuran (3)2-Methylbenzofuran (5)3-Methylbenzofuran (4)4-Bromobenzofuran (3)4-Phenyldibenzo[B,D]Furan (8)5,7,8-Trimethylchromane (3)5-Bromo-2,3-Dihydrobenzofuran (6)5-Chloro-2,3-Dihydrobenzofuran (5)5-Fluoro-2,3-Dihydrobenzofuran (5)5-Methoxyisobenzofuran-1(3H)-One (5)6-Bromo-2,3-Dihydrobenzofuran (6)6-Fluoro-2,3-Dihydrobenzofuran (6)6-Methoxybenzofuran (4)7-Bromo-2,3-Dihydrobenzofuran (6)7-Bromobenzofuran (6)7-Fluoro-2,3-Dihydrobenzofuran (6)Benzofuran-2(3H)-One (7)Benzofuran-2-Carbaldehyde (5)Benzofuran-2-Carboxylic Acid (21)Benzofuran-2-Ylboronic Acid (8)Benzofuran-3(2H)-One (15)Benzofuran-3-Carboxylic Acid (6)Benzofuran-3-Yl(Phenyl)Methanone (11)Methyl Benzofuran-2-Carboxylate (6)
Benzothiazoles (2422)
Benzothiazole-Carboxylic Acid (27)Bromobenzothiazole (7)Dichlorobenzothiazole (10)Methoxybenzothiazole (4)Methylbenzothiazole (7)2-(Methylthio)Benzo[D]Thiazole (6)2-Bromobenzo[D]Thiazole (28)2-Chlorobenzo[D]Thiazole (21)2-Methylbenzo[D]Thiazole (26)4-Bromobenzo[D]Thiazole (9)4-Chlorobenzo[D]Thiazole (7)4-Fluorobenzo[D]Thiazole (6)4-Methylbenzo[D]Thiazole (10)5-Chlorobenzo[D]Thiazole (5)5-Nitrobenzo[D]Thiazole (3)6-Bromobenzo[D]Thiazole (7)6-Chlorobenzo[D]Thiazole (6)6-Fluorobenzo[D]Thiazole (5)6-Methoxybenzo[D]Thiazole (6)6-Methylbenzo[D]Thiazole (6)6-Nitrobenzo[D]Thiazole (3)7-Bromobenzo[D]Thiazole (8)7-Chlorobenzo[D]Thiazole (6)7-Fluorobenzo[D]Thiazole (9)Benzo[D]Thiazol-2-Amine (29)Benzo[D]Thiazol-5-Amine (3)Benzo[D]Thiazol-6-Amine (3)Benzo[D]Thiazol-6-Ol (2)Benzo[D]Thiazole-2-Carbonitrile (11)Benzo[D]Thiazole-2-Thiol (11)Benzo[D]Thiazole-6-Carboxylic Acid (5)Methyl Benzo[D]Thiazole-6-Carboxylate (5)
Benzothiophenes (1116)
Benzothiophene-Carboxylic Acid (58)2-(Benzo[B]Thiophen-2-Yl)-4,5-Dihydrooxazole (10)2-Methylbenzo[B]Thiophene (4)3-Bromobenzo[B]Thiophene (5)3-Chlorobenzo[B]Thiophene (6)3-Methylbenzo[B]Thiophene (4)4,5,6,7-Tetrahydrobenzo[B]Thiophene (21)5-Bromobenzo[B]Thiophene (3)5-Chlorobenzo[B]Thiophene (4)6-Bromobenzo[B]Thiophene (4)7-Bromobenzo[B]Thiophene (5)Benzo[B]Thiophen-2-Amine (5)Benzo[B]Thiophen-2-Ylboronic Acid (5)Benzo[B]Thiophene-2-Carbaldehyde (7)Benzo[B]Thiophene-2-Carbonitrile (3)Benzo[B]Thiophene-2-Carboxylic Acid (32)Benzo[B]Thiophene-3-Carbaldehyde (6)Ethyl Benzo[B]Thiophene-2-Carboxylate (9)Methyl Benzo[B]Thiophene-2-Carboxylate (27)
Benzoxazoles (2804)
Benzoxazole-Carboxylic Acid (25)2-Chlorobenzo[D]Oxazole (11)2-Methylbenzo[D]Oxazole (26)2-Phenylbenzo[D]Oxazole (22)3-Phenylbenzo[D]Oxazol-3-Ium (8)5-Bromobenzo[D]Oxazole (3)5-Chlorobenzo[D]Oxazole (5)5-Methylbenzo[D]Oxazole (3)6-Chlorobenzo[D]Oxazole (4)Benzo[D]Oxazol-2-Amine (16)Benzo[D]Oxazole-2-Thiol (6)Methyl Benzo[D]Oxazole-2-Carboxylate (3)
Carbazole Series (482)
Carbazolyl-Phenyl-Boronic Acid/Ester (14)1-Methyl-9H-Carbazole (7)2,3,4,9-Tetrahydro-1H-Carbazol-1-One (7)2-Bromo-9H-Carbazole (4)3,9-Diphenyl-9H-Carbazole (7)3-(Tert-Butyl)-9H-Carbazole (3)3-Bromo-9-Phenyl-9H-Carbazole (16)3-Bromo-9H-Carbazole (4)3-Chloro-9H-Carbazole (3)3-Methyl-9H-Carbazole (3)7H-Benzo[C]Carbazole (5)9-([1,1'-Biphenyl]-4-Yl)-9H-Carbazole (9)9-(P-Tolyl)-9H-Carbazole (5)9-Benzyl-9H-Carbazole (7)9-Ethyl-9H-Carbazole (10)
Cinnolines (355)
Cinnoline (11)
Dioxolanes (1580)
(3As,6As)-Tetrahydrofuro[3,4-D][1,3]Dioxole (6)1,3-Dioxolan-2-One (11)2,2-Difluorobenzo[D][1,3]Dioxole (24)2,2-Dimethyl-1,3-Dioxolane (29)2,2-Dimethylbenzo[D][1,3]Dioxole (7)2-Phenyl-1,3-Dioxolane (18)4-Bromobenzo[D][1,3]Dioxole (6)4-Methyl-1,3-Dioxolane (5)5,6-Dihydro-[1,3]Dioxolo[4,5-G]Isoquinolino[3,2-A]Isoquinolin-7-Ium (4)5-Bromobenzo[D][1,3]Dioxole (12)5-Chlorobenzo[D][1,3]Dioxole (5)5-Nitrobenzo[D][1,3]Dioxole (4)9-((3As,4R,6Ar)-Tetrahydrofuro[3,4-D][1,3]Dioxol-4-Yl)-9H-Purine (7)Benzo[D][1,3]Dioxol-5-Amine (3)
Dioxoles (13)
Epoxides (407)
Epoxy (7)Oxirane (64)7-Oxabicyclo[4.1.0]Heptane (7)Ethyl Oxirane-2-Carboxylate (4)Oxiran-2-Ylmethanol (3)
Furans (7000)
Aminodihydrofuran (7)Bromofuran (32)Chlorofuran (2)Chlorofuro (11)Cyanofuran (53)Dibromofuran (5)Dihydrofuran (31)Dihydrofuro (15)Dihydroxydihydrofuran (8)Dimethylfuran (10)Formylfuran (10)Hexahydrofuro (6)Hydroxydihydrofuran (31)Methyldihydrofuran (11)Methylfuran (58)Nitrofuran (10)2,3-Dihydrofuran-3-One (9)2-(Bromomethyl)Furan (3)2-(Chloromethyl)Furan (3)2-(Furan-2-Yl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (6)2-Bromofuran (21)2-Chlorofuran (3)2-Methylfuran (37)2-Nitrofuran (9)3-Bromofuran (13)4-Methylisobenzofuran-1(3H)-One (3)5-Nitro-2,3-Dihydrobenzofuran (3)5-Phenylfuran-2-Carbaldehyde (9)5-Phenylfuran-2-Carboxylic Acid (6)6-Chloro-2,3-Dihydrobenzofuran (3)6-Fluoroisobenzofuran-1(3H)-One (3)7-Chloro-2,3-Dihydrobenzofuran (3)Ethyl Furan-2-Carboxylate (6)Furan-2,5-Dione (8)Furan-2-Carbaldehyde (22)Furan-2-Carbonitrile (8)Furan-2-Carboxylic Acid (31)Furan-2-Ylmethanol (5)Furan-3-Carboxylic Acid (11)Furo[3,2-B]Pyridine (7)Furo[3,2-C]Pyridine (7)Methyl Furan-2-Carboxylate (20)N-(Furan-2-Ylmethyl)Aniline (5)
Imidazoles (833)
Biimidazole (5)Bromoimidazo (102)Dibromoimidazo (8)Dichloroimidazo (9)Dihydroimidazo (25)Imidazol-Amine (1)Methoxyimidazo (13)Methylimidazo (121)Tetrahydroimidazo (40)1,1'-Diphenyl-4,4',5,5'-Tetrahydro-1H,1'H-2,2'-Biimidazole (11)1,2-Dimethyl-1H-Imidazole (6)1,3-Diphenyl-1H-Imidazol-3-Ium (14)1,3-Diphenyl-4,5-Dihydro-1H-Imidazol-3-Ium (5)1-(Imidazo[1,2-A]Pyridin-3-Yl)Ethan-1-One (3)1-(Phenylsulfonyl)-1H-Imidazole (5)1-Benzyl-1H-Imidazole (19)1-Decyl-3-Methyl-1H-Imidazol-3-Ium (14)1-Ethyl-1H-Imidazole (3)1-Isopropyl-1H-Imidazole (5)1-Phenyl-1H-Imidazole-4-Carboxylic Acid (5)1-Trityl-1H-Imidazole (15)1H-Imidazo[4,5-B]Pyridine (14)1H-Imidazo[4,5-C]Pyridine (12)1H-Imidazol-2-Amine (6)1H-Imidazole-2-Carboxylic Acid (7)1H-Imidazole-4-Carbonitrile (2)1H-Imidazole-4-Carboxylic Acid (4)2-(Pyridin-2-Yl)-1H-Benzo[D]Imidazole (5)2-Bromo-1H-Imidazole (13)2-Bromoimidazo[1,2-A]Pyridine (5)2-Ethyl-1H-Imidazole (3)2-Methyl-1-Phenyl-1H-Imidazole (11)2-Methylimidazo[1,2-A]Pyridine (8)2-Phenyl-1H-Benzo[D]Imidazole (26)2-Phenyl-1H-Imidazole (26)2-Phenylimidazo[1,2-A]Pyridine (12)2-Propyl-1H-Imidazole (5)3-Bromoimidazo[1,2-A]Pyrazine (6)3-Bromoimidazo[1,2-A]Pyridine (26)3-Bromoimidazo[1,2-A]Pyrimidine (6)3-Iodoimidazo[1,2-A]Pyridine (10)3-Methylimidazo[1,2-A]Pyridine (3)4,5,6,7-Tetrahydro-3H-Imidazo[4,5-C]Pyridine (5)4-(1H-Imidazol-1-Yl)Benzaldehyde (7)4-Bromo-1-Phenyl-1H-Imidazole (9)4-Methyl-1-Phenyl-1H-Imidazole (7)4-Methyl-1H-Imidazole (6)4-Phenyl-1H-Imidazole (8)5,6,7,8-Tetrahydroimidazo[1,2-A]Pyrazine (15)5,6,7,8-Tetrahydroimidazo[1,2-A]Pyridine (12)5,6,7,8-Tetrahydroimidazo[1,5-A]Pyrazine (11)5-Benzyl-1H-Imidazole (1)5-Bromoimidazo[1,2-A]Pyridine (6)5-Chloro-1H-Imidazole (2)5-Fluoro-1H-Benzo[D]Imidazole (12)5-Iodo-1H-Imidazole (4)5-Methylimidazo[1,2-A]Pyridine (4)5-Phenyl-1H-Imidazole (6)6,7-Dihydro-5H-Pyrrolo[1,2-A]Imidazole (9)6-Bromoimidazo[1,2-A]Pyrazine (11)6-Bromoimidazo[1,2-A]Pyridine (14)6-Bromoimidazo[1,2-A]Pyrimidine (5)6-Chloroimidazo[1,2-A]Pyridine (4)6-Chloroimidazo[1,2-B]Pyridazine (30)7-Methylimidazo[1,2-A]Pyridine (3)8-Bromoimidazo[1,2-A]Pyrazine (7)8-Bromoimidazo[1,2-A]Pyridine (15)8-Chloroimidazo[1,2-A]Pyrazine (8)8-Chloroimidazo[1,2-A]Pyridine (7)8-Fluoroimidazo[1,2-A]Pyridine (3)8-Methylimidazo[1,2-A]Pyridine (9)Ethyl 1H-Imidazole-2-Carboxylate (6)Ethyl 2-(Imidazo[1,2-A]Pyridin-3-Yl)Acetate (3)Ethyl Imidazo[1,2-A]Pyridine-2-Carboxylate (25)Ethyl Imidazo[1,2-A]Pyridine-3-Carboxylate (13)Imidazo[1,2-A]Pyridin-3-Amine (7)Imidazo[1,2-A]Pyridin-8-Amine (7)Imidazo[1,2-A]Pyridin-8-Ol (3)Imidazo[1,2-A]Pyridine-2-Carbaldehyde (8)Imidazo[1,2-A]Pyridine-2-Carboxylic Acid (21)Imidazo[1,2-A]Pyridine-3-Carbaldehyde (9)Imidazo[1,2-A]Pyridine-3-Carboxylic Acid (14)Imidazo[1,2-A]Pyridine-7-Carboxylic Acid (5)Imidazo[1,2-A]Pyridine-8-Carboxylic Acid (6)Imidazo[1,2-A]Pyrimidine-3-Carboxylic Acid (5)Imidazo[1,2-C]Pyrimidine (6)Imidazo[1,5-A]Pyrazine (9)Imidazo[2,1-B]Thiazole (14)Methyl 1H-Imidazole-2-Carboxylate (4)Methyl 1H-Imidazole-5-Carboxylate (8)Methyl Imidazo[1,2-A]Pyridine-8-Carboxylate (3)Tert-Butyl 1H-Imidazole-1-Carboxylate (6)
Imidazolidines (1145)
Methylimidazolidine (3)Oxoimidazolidine (8)Thioxoimidazolidin (9)(3Ar,6As)-Tetrahydro-1H-Thieno[3,4-D]Imidazol-2(3H)-One (18)1-Phenylimidazolidin-2-One (8)3-Phenyl-2-Thioxoimidazolidin-4-One (6)3-Phenylimidazolidine-2,4-Dione (4)Imidazolidin-2-One (16)Imidazolidine-2,4-Dione (17)
Imidazolines (695)
Indazoles (3081)
Indazol-Amide (3)(1H-Indazol-4-Yl)Boronic Acid (3)(1H-Indazol-6-Yl)Boronic Acid (4)1-(1H-Indazol-1-Yl)Ethan-1-One (7)1-(Tetrahydro-2H-Pyran-2-Yl)-1H-Indazole (17)1-Benzyl-1H-Indazole (7)1-Ethyl-1H-Indazole (7)1H-Indazol-3-Amine (23)1H-Indazol-3-Ol (10)1H-Indazol-4-Amine (12)1H-Indazol-4-Ol (4)1H-Indazol-5-Amine (3)1H-Indazol-6-Amine (5)1H-Indazol-6-Ol (6)1H-Indazol-7-Amine (6)1H-Indazole-3-Carbaldehyde (19)1H-Indazole-3-Carbonitrile (9)1H-Indazole-3-Carboxylic Acid (27)1H-Indazole-4-Carboxylic Acid (9)1H-Indazole-5-Carboxylic Acid (4)1H-Indazole-7-Carboxylic Acid (6)2,3-Dimethyl-2H-Indazole (4)2-Methyl-2H-Indazole (34)3-(Piperidin-4-Yl)-1H-Indazole (5)3-Chloro-1H-Indazole (13)4,5,6,7-Tetrahydro-1H-Indazole (12)4-Chloro-1H-Indazole (18)4-Fluoro-1H-Indazole (22)4-Methoxy-1H-Indazole (7)4-Methyl-1H-Indazole (12)4-Nitro-1H-Indazole (10)5-Bromo-1H-Indazole (14)5-Chloro-1H-Indazole (9)5-Methoxy-1H-Indazole (5)5-Nitro-1H-Indazole (5)6-(Trifluoromethyl)-1H-Indazole (6)6-Bromo-1H-Indazole (23)6-Chloro-1H-Indazole (14)6-Fluoro-1H-Indazole (15)6-Methoxy-1H-Indazole (14)6-Methyl-1H-Indazole (9)6-Nitro-1H-Indazole (9)7-Bromo-1H-Indazole (18)7-Chloro-1H-Indazole (7)7-Fluoro-1H-Indazole (12)7-Methoxy-1H-Indazole (5)7-Nitro-1H-Indazole (11)Methyl 1H-Indazole-3-Carboxylate (23)Methyl 1H-Indazole-4-Carboxylate (10)Methyl 1H-Indazole-5-Carboxylate (3)Methyl 1H-Indazole-6-Carboxylate (9)Methyl 1H-Indazole-7-Carboxylate (8)Methyl 2-Methyl-2H-Indazole-3-Carboxylate (3)Tert-Butyl 1H-Indazole-1-Carboxylate (29)
Indoles (7683)
Azaindole (44)Benzyloxyindole (1)Biindolinylidene (1)Bromo-Indole-Carboxylic Acid (28)Cyanoindole (5)Dihydroindolo (14)Fluoroindole (5)Formylindole (44)Hydroxyindole (7)Hydroxyisoindoline (2)Indolecarboxylic (2)Isoindole (26)Methoxyindole (9)Nitroindole (6)(1-(Tert-Butoxycarbonyl)-1H-Indol-2-Yl)Boronic Acid (17)(1H-Indol-2-Yl)Boronic Acid (3)(1H-Indol-2-Yl)Methanol (8)(3As,7As)-Octahydro-1H-Indole (5)(9H-Fluoren-9-Yl)Methyl (2-(1H-Indol-3-Yl)Ethyl)Carbamate (12)1,2,3,4-Tetrahydrocyclopenta[B]Indole (5)1,2-Dimethyl-1H-Indole (4)1-(1H-Indol-1-Yl)Ethan-1-One (9)1-(1H-Indol-3-Yl)Ethan-1-One (6)1-(Phenylsulfonyl)-1H-Indole (26)1-(Triisopropylsilyl)-1H-Pyrrolo[2,3-B]Pyridine (8)1-Benzyl-1H-Indole (10)1-Ethyl-1H-Indole (7)1-Methyl-1H-Indole (85)1-Methyl-1H-Indole-2-Carboxylic Acid (8)1-Methyl-1H-Indole-3-Carbaldehyde (9)1-Methyl-1H-Pyrrolo[2,3-B]Pyridine (14)1-Phenyl-1H-Indole (5)1H-Indol-3-Ol (5)1H-Indol-3-Yl Acetate (4)1H-Indol-4-Amine (10)1H-Indol-4-Ol (7)1H-Indol-5-Ol (4)1H-Indol-6-Amine (21)1H-Indol-6-Ol (6)1H-Indol-7-Amine (10)1H-Indole-2-Carbaldehyde (20)1H-Indole-2-Carbonitrile (9)1H-Indole-3-Carbonitrile (17)1H-Indole-3-Carboxylic Acid (32)1H-Indole-4-Carboxylic Acid (10)1H-Indole-5-Carbonitrile (5)1H-Indole-5-Carboxylic Acid (4)1H-Indole-6-Carbonitrile (4)1H-Indole-6-Carboxylic Acid (5)1H-Indole-7-Carbonitrile (6)1H-Indole-7-Carboxylic Acid (7)1H-Pyrrolo[2,3-B]Pyridine-3-Carbaldehyde (14)1H-Pyrrolo[2,3-B]Pyridine-5-Carbaldehyde (5)2,3,4,5-Tetrahydro-1H-Pyrido[4,3-B]Indole (12)2,3,4,9-Tetrahydro-1H-Pyrido[3,4-B]Indole (12)2,3-Dimethyl-1H-Indole (9)2-(1,3,2-Dioxaborolan-2-Yl)-1-Methyl-1H-Indole (6)2-(1H-Indol-1-Yl)Acetic Acid (5)2-(1H-Indol-3-Yl)Acetic Acid (28)2-(1H-Indol-3-Yl)Ethan-1-Amine (4)2-(1H-Indol-3-Yl)Ethan-1-Ol (10)2-(2-Methyl-1H-Indol-3-Yl)Acetic Acid (5)2-(4-Fluorophenyl)-1H-Indole (4)2-Methyl-1H-Indole-3-Carbaldehyde (3)2-Methyl-1H-Pyrrolo[2,3-B]Pyridine (12)3-(1-Oxoisoindolin-2-Yl)Piperidine-2,6-Dione (21)3-(1H-Indol-3-Yl)Propanoic Acid (4)3-(Piperidin-4-Yl)-1H-Indole (8)3-Iodo-1H-Pyrrolo[2,3-B]Pyridine (11)3-Methyl-1H-Indole (41)3H-Indole (8)4-Bromo-1H-Indole (25)4-Chloro-1H-Indole (21)4-Fluoro-1H-Indole (24)4-Fluoro-1H-Pyrrolo[2,3-B]Pyridine (6)4-Fluoroindoline-2,3-Dione (3)4-Methoxy-1H-Indole (11)4-Methyl-1H-Indole (23)4-Nitro-1H-Indole (6)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-1H-Indole (5)5-(Benzyloxy)-1H-Indole (8)5-Bromo-1-Methyl-1H-Indole (4)5-Chloro-1H-Indole (64)5-Chloro-1H-Indole-2-Carboxylic Acid (6)5-Chloro-1H-Pyrrolo[2,3-B]Pyridine (13)5-Fluoro-1H-Indole (50)5-Fluoro-1H-Pyrrolo[2,3-B]Pyridine (9)5-Fluoroindolin-2-One (4)5-Methoxy-1H-Indole (11)5-Methoxy-2-Methyl-1H-Indole (5)5-Methyl-1H-Indole (33)5-Nitro-1H-Indole (6)6-(Trifluoromethyl)-1H-Indole (5)6-Bromo-1-Methyl-1H-Indole (3)6-Bromo-1H-Indole (15)6-Bromo-1H-Pyrrolo[2,3-B]Pyridine (6)6-Chloro-1H-Indole (19)6-Chloro-1H-Pyrrolo[2,3-B]Pyridine (13)6-Fluoro-1H-Indole (17)6-Methoxy-1H-Indole (12)6-Methyl-1H-Indole (29)6-Methyl-1H-Pyrrolo[2,3-B]Pyridine (8)6-Nitro-1H-Indole (8)7-Bromo-1H-Indole (28)7-Bromoindoline-2,3-Dione (3)7-Chloro-1H-Indole (29)7-Fluoro-1H-Indole (24)7-Fluoro-1H-Indole-2-Carboxylic Acid (5)7-Methoxy-1H-Indole (8)7-Methyl-1H-Indole (34)7-Nitro-1H-Indole (11)9H-Pyrido[3,4-B]Indole (5)Benzo[Cd]Indol-2(1H)-One (5)Ethyl 1H-Indole-3-Carboxylate (6)Ethyl 5-Chloro-1H-Indole-2-Carboxylate (5)Ethyl 5-Fluoro-1H-Indole-2-Carboxylate (5)Ethyl 6-Chloro-1H-Indole-2-Carboxylate (5)Ethyl 7-Chloro-1H-Indole-2-Carboxylate (5)Methyl 1H-Indole-3-Carboxylate (21)Methyl 1H-Indole-4-Carboxylate (9)Methyl 1H-Indole-5-Carboxylate (7)Methyl 1H-Indole-6-Carboxylate (9)Methyl 1H-Indole-7-Carboxylate (7)Methyl 2-(1H-Indol-3-Yl)Acetate (3)N-(2-(1H-Indol-3-Yl)Ethyl)Acetamide (5)Spiro[Indoline-3,4'-Piperidin]-2-One (18)Tert-Butyl 1H-Indole-1-Carboxylate (18)Tert-Butyl 1H-Pyrrolo[2,3-B]Pyridine-1-Carboxylate (9)Tert-Butyl 2-(1,3,2-Dioxaborolan-2-Yl)-1H-Indole-1-Carboxylate (6)Tert-Butyl 3-(Hydroxymethyl)-1H-Indole-1-Carboxylate (10)Tert-Butyl 3-Bromo-1H-Indole-1-Carboxylate (9)Tert-Butyl 3-Iodo-1H-Indole-1-Carboxylate (7)Tert-Butyl 5-Methoxy-1H-Indole-1-Carboxylate (6)Tryptophan (21)
Indolines (4489)
Aminoindoline (10)Bromoindoline (17)Bromoisoindolin (5)Bromoisoindoline (6)Chloroindolin (4)Chloroisoindoline (3)Dibromoindoline (12)Dichloroindoline (16)Difluoroindoline (1)Dimethylindoline (21)Dioxoindoline (8)Dioxoisoindolin (72)Fluoroindolin (9)Fluoroindoline (9)Fluoroisoindoline (10)Hydroxyindolin (5)Indoline-Carboxylate (1)Isoindoline (20)Methoxyindoline (12)Methoxyisoindoline (9)Methylindoline (46)Methylisoindoline (18)Nitroindolin (6)Nitroindoline (11)Nitroisoindoline (8)Oxoindoline (32)Oxoisoindoline (16)Spiro-Indoline-Piperidine (34)(E)-[3,3'-Biindolinylidene]-2,2'-Dione (5)(Z)-3-((1H-Pyrrol-2-Yl)Methylene)Indolin-2-One (8)(Z)-3-(Phenyl(Phenylamino)Methylene)Indolin-2-One (5)(Z)-3-Benzylideneindolin-2-One (7)1-(Indolin-1-Yl)Ethan-1-One (9)1-Benzylindoline-2,3-Dione (5)1-Methylindolin-2-One (14)1-Methylindoline (3)1-Methylindoline-2,3-Dione (8)2-(1,3-Dioxoisoindolin-2-Yl)Propanoic Acid (3)2-Methylindoline (7)2-Methylisoindolin-1-One (7)3,3-Dimethylindolin-2-One (5)3,3-Dimethylindoline (7)4-Bromoindoline (4)4-Chloroindoline-2,3-Dione (6)4-Methylindoline (3)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Indoline (5)5-Bromoindolin-2-One (5)5-Bromoindoline (8)5-Bromoisoindoline-1,3-Dione (3)5-Chloroindolin-2-One (3)5-Fluoroindoline (3)5-Methoxyindoline (4)5-Methylindolin-2-One (3)5-Methylindoline (3)6-Bromoindolin-2-One (8)6-Bromoindoline-2,3-Dione (4)6-Chloroindolin-2-One (5)6-Chloroindoline (3)6-Chloroindoline-2,3-Dione (5)6-Fluoroindolin-2-One (5)6-Fluoroindoline-2,3-Dione (3)7-Bromoindoline (3)7-Fluoroindolin-2-One (3)7-Fluoroindoline-2,3-Dione (6)7-Methylindoline-2,3-Dione (7)Indoline-2-Carboxylic Acid (3)Methyl Indoline-6-Carboxylate (3)Spiro[Cyclopropane-1,3'-Indolin]-2'-One (6)Tert-Butyl Indoline-1-Carboxylate (24)
Isoquinolines (2729)
Bromoisoquinoline (69)Chloroisoquinoline (101)Dibromoisoquinoline (9)Dichloroisoquinoline (14)Dihydroisoquinoline (107)Fluoroisoquinoline (78)Methoxyisoquinoline (59)Methylisoquinoline (59)Nitroisoquinoline (23)1,3-Dichloroisoquinoline (14)1-Bromoisoquinoline (20)1-Chloroisoquinoline (20)1-Methylisoquinoline (9)1H-Benzo[De]Isoquinoline-1,3(2H)-Dione (14)2-Methyl-3,4-Dihydroisoquinolin-1(2H)-One (6)3-Bromoisoquinoline (10)3-Chloroisoquinoline (20)3-Methylisoquinoline (8)4-Bromoisoquinolin-1(2H)-One (3)4-Bromoisoquinoline (33)4-Chloroisoquinoline (11)4-Fluoroisoquinoline (6)5,6-Dihydro-[1,3]Dioxolo[4,5-G]Isoquinolino[3,2-A]Isoquinolin-7-Ium (4)5-Bromoisoquinoline (17)5-Chloroisoquinoline (6)5-Methoxyisoquinoline (6)5-Nitroisoquinoline (7)6-Bromo-3,4-Dihydroisoquinolin-1(2H)-One (6)6-Bromoisoquinoline (9)6-Methoxy-3,4-Dihydroisoquinolin-1(2H)-One (3)7-Bromo-3,4-Dihydroisoquinolin-1(2H)-One (6)7-Bromoisoquinoline (6)7-Chloroisoquinoline (6)7-Fluoroisoquinoline (3)7-Methoxyisoquinoline (5)8-Bromoisoquinoline (17)8-Chloroisoquinoline (7)8-Fluoroisoquinolin-1(2H)-One (3)8-Fluoroisoquinoline (10)8-Methoxyisoquinoline (7)Isoquinolin-1-Amine (18)Isoquinolin-1-Ol (9)Isoquinolin-3-Amine (13)Isoquinolin-3-Ol (6)Isoquinolin-4-Amine (16)Isoquinolin-4-Ol (9)Isoquinolin-4-Ylboronic Acid (3)Isoquinolin-5-Amine (9)Isoquinolin-5-Ol (7)Isoquinolin-8-Amine (6)Isoquinoline-1-Carbonitrile (7)Isoquinoline-1-Carboxylic Acid (10)Isoquinoline-3-Carboxylic Acid (7)Isoquinoline-4-Carboxylic Acid (12)Isoquinoline-5-Carboxylic Acid (5)Isoquinoline-5-Sulfonyl Chloride (3)Isoquinoline-6-Carboxylic Acid (3)Methyl Isoquinoline-3-Carboxylate (3)Methyl Isoquinoline-4-Carboxylate (6)Tert-Butyl 3,4-Dihydroisoquinoline-2(1H)-Carboxylate (19)
Isothiazoles (343)
Methylisothiazole (5)Benzo[D]Isothiazol-3(2H)-One 1,1-Dioxide (10)Benzo[D]Isothiazole (12)Isothiazole (24)
Isoxazoles (3403)
Aminoisoxazole (7)Bromoisoxazole (5)Dihydroisoxazol (2)Dimethylisoxazole (17)Phenylisoxazole (28)(3-Phenylisoxazol-5-Yl)Methanol (7)3-Bromoisoxazole (7)3-Methyl-5-Phenylisoxazole (6)3-Methylisoxazole (30)3-Phenylisoxazol-5-Amine (8)5-(Thiophen-2-Yl)Isoxazole (5)5-Cyclopropylisoxazole (5)5-Methyl-3-Phenylisoxazole (4)5-Methylisoxazole (16)5-Phenylisoxazole-3-Carboxylic Acid (15)Ethyl Isoxazole-3-Carboxylate (8)Ethyl Isoxazole-4-Carboxylate (5)Isoxazol-3-Amine (7)Isoxazol-3-Ylmethanol (3)Isoxazol-5-Amine (15)Isoxazol-5-Ylmethanol (5)Isoxazole-3-Carboxylic Acid (8)Isoxazole-5-Carboxylic Acid (7)Methyl 5-Phenylisoxazole-3-Carboxylate (6)N-((5R,6R)-7-Oxo-4-Thia-1-Azabicyclo[3.2.0]Heptan-6-Yl)-3-Phenylisoxazole-4-Carboxamide (1)
Morpholines (4988)
Benzylmorpholine (25)Cyanomorpholine (6)Dimorpholine (3)Ethylmorpholine (9)Isopropylmorpholine (9)Methylmorpholine (68)Morpholinobenzaldehyde (11)Morpholinobenzo (13)Morpholinobenzoic (8)Morpholinoethanone (5)Morpholinoethoxy (1)Morpholinoethyl (5)Morpholinomethyl (16)Morpholinophenyl (14)Morpholinopropoxy (6)Morpholinopyrimidin (6)Morpholinosulfonyl (7)Oxomorpholine (6)(R)-3-Phenylmorpholine (7)(S)-3-Phenylmorpholine (10)2,2-Dimethylmorpholine (5)2,6-Dimethylmorpholine (5)2-(Methoxymethyl)Morpholine (4)2-(Morpholin-2-Yl)Acetic Acid (5)2-Ethylmorpholine (3)2-Isopropylmorpholine (4)2-Methylmorpholine (7)2-Phenylmorpholine (8)3-(4-Morpholinophenyl)Oxazolidin-2-One (4)3-(Methoxymethyl)Morpholine (4)3-Ethylmorpholine (4)3-Isopropylmorpholine (5)3-Methylmorpholine (13)3-Phenylmorpholine (8)4-(2-Fluorophenyl)Morpholine (8)4-(3-Phenoxypropyl)Morpholine (7)4-(O-Tolyl)Morpholine (6)4-(Pyrazin-2-Yl)Morpholine (5)4-(Pyridin-4-Yl)Morpholine (5)4-(Pyrimidin-2-Yl)Morpholine (9)4-Benzylmorpholin-3-One (6)4-Morpholinoaniline (4)4-Morpholinobenzaldehyde (8)4-Morpholinobenzoic Acid (5)4-Phenylmorpholin-3-One (6)6,6-Dimethylmorpholine-3-Carboxylic Acid (5)Benzyl Morpholine-4-Carboxylate (5)Ethyl Morpholine-2-Carboxylate (4)Methyl 2-(Morpholin-3-Yl)Acetate (3)Methyl Morpholine-2-Carboxylate (4)Methyl Morpholine-3-Carboxylate (10)Morpholin-2-Ylmethanamine (8)Morpholin-2-Ylmethanol (12)Morpholin-3-Ylmethanol (14)Morpholine-2-Carbonitrile (4)Morpholine-2-Carboxylic Acid (12)Morpholine-3-Carboxylic Acid (10)Morpholino(Phenyl)Methanone (11)Tert-Butyl (Morpholin-2-Ylmethyl)Carbamate (3)Tert-Butyl 2-(Bromomethyl)Morpholine-4-Carboxylate (3)Tert-Butyl Morpholine-4-Carboxylate (23)
Naphthyridines (939)
1,5-Naphthyridine-3-Carboxylic Acid (6)1,6-Naphthyridine (22)1,7-Naphthyridine (23)2,7-Naphthyridine (5)3-Bromo-1,5-Naphthyridine (8)4-Bromo-1,5-Naphthyridine (5)4-Chloro-1,5-Naphthyridine (6)5,6,7,8-Tetrahydro-1,6-Naphthyridine (22)5,6,7,8-Tetrahydro-1,7-Naphthyridine (6)
Oxadiazoles (3559)
1,2,4-Oxadiazole (19)1,2,5-Oxadiazole (12)1,3,4-Oxadiazole (25)2,5-Diphenyl-1,3,4-Oxadiazole (6)2-Phenyl-1,3,4-Oxadiazole (26)3-Phenyl-1,2,4-Oxadiazole (23)Benzo[C][1,2,5]Oxadiazole (17)
Oxazines (235)
2,2-Dimethyl-2H-Benzo[B][1,4]Oxazin-3(4H)-One (3)2-Methyl-2H-Benzo[B][1,4]Oxazin-3(4H)-One (3)2H-Pyrido[3,2-B][1,4]Oxazin-3(4H)-One (8)3,4-Dihydro-2H-Pyrido[3,2-B][1,4]Oxazine (5)6-Amino-2H-Benzo[B][1,4]Oxazin-3(4H)-One (3)6-Bromo-2H-Benzo[B][1,4]Oxazin-3(4H)-One (7)6-Bromo-3,4-Dihydro-2H-Benzo[B][1,4]Oxazine (5)6-Chloro-2H-Benzo[B][1,4]Oxazin-3(4H)-One (8)6-Chloro-3,4-Dihydro-2H-Benzo[B][1,4]Oxazine (5)7-Bromo-3,4-Dihydro-2H-Benzo[B][1,4]Oxazine (7)Spiro[Benzo[D][1,3]Oxazine-4,4'-Piperidin]-2(1H)-One (5)
Oxazoles (2026)
Bioxazole (12)2-Bromooxazole (7)2-Chlorooxazole (7)2-Methyloxazole (19)2-Phenyloxazole (16)3,4-Diphenylisoxazole (8)4,5-Diphenyloxazole (7)4-(Oxazol-5-Yl)Aniline (3)4-Methyloxazole (9)5-(4-Nitrophenyl)Oxazole (3)5-Methyloxazole (5)6-Bromobenzo[D]Oxazole (3)Ethyl Oxazole-4-Carboxylate (8)Ethyl Oxazole-5-Carboxylate (3)Methyl Oxazole-4-Carboxylate (9)Oxazol-2-Amine (8)Oxazole-4-Carboxylic Acid (4)Oxazolo[4,5-B]Pyridine (7)Oxazolo[5,4-B]Pyridine (5)
Oxazolidines (1298)
Dimethyloxazolidin (6)Dioxooxazolidin (2)Oxazolidinone (5)Phenyloxazolidin (9)Propionyloxazolidin (5)(R)-4-Benzyloxazolidin-2-One (5)(S)-4-Benzyloxazolidin-2-One (11)3-(4-Morpholinophenyl)Oxazolidin-2-One (4)3-Phenyloxazolidin-2-One (4)4-Isopropyloxazolidine (6)Oxazolidine (21)Oxazolidine-2,5-Dione (9)
Oxazolines (1577)
(3Ar,8As)-2-(Pyridin-2-Yl)-3A,8A-Dihydro-8H-Indeno[1,2-D]Oxazole (6)(3As,8Ar)-2-(Pyridin-2-Yl)-3A,8A-Dihydro-8H-Indeno[1,2-D]Oxazole (7)(4R,5S)-4,5-Diphenyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (5)(R)-4-Benzyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (7)(R)-4-Phenyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (7)(S)-4-Benzyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (8)(S)-4-Phenyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (6)1,3-Bis(4,5-Dihydrooxazol-2-Yl)Benzene (8)2,2'-(1,3-Diphenylpropane-2,2-Diyl)Bis(4,5-Dihydrooxazole) (5)2,2'-(2-Phenylethane-1,1-Diyl)Bis(4,5-Dihydrooxazole) (5)2,3-Dihydropyrazolo[5,1-B]Oxazole (7)2,6-Bis(4,5-Dihydrooxazol-2-Yl)Pyridine (12)2-(6-Benzhydrylpyridin-2-Yl)-4,5-Dihydrooxazole (10)2-(6-Cyclopropylpyridin-2-Yl)-4,5-Dihydrooxazole (10)2-(Benzo[B]Thiophen-2-Yl)-4,5-Dihydrooxazole (10)2-(Pyridin-2-Ylmethyl)-4,5-Dihydrooxazole (14)2-(Quinolin-2-Yl)-4,5-Dihydrooxazole (7)2-Phenyl-4,5-Dihydrooxazole (18)4,4',5,5'-Tetrahydro-2,2'-Bioxazole (10)4-(Tert-Butyl)-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (16)4-Isopropyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (16)Bis((3Ar,8As)-3A,8A-Dihydro-8H-Indeno[1,2-D]Oxazol-2-Yl)Methane (5)Bis((3As,8Ar)-3A,8A-Dihydro-8H-Indeno[1,2-D]Oxazol-2-Yl)Methane (5)Bis(4,5-Dihydrooxazol-2-Yl)Methane (22)
Oxetanes (772)
Methyloxetane (11)
Phthalazines (423)
Dihydrophthalazine (15)Phthalazine (16)
Piperazines (7427)
Isobutylpiperazine (6)Propylpiperazine (10)(9H-Fluoren-9-Yl)Methyl Piperazine-1-Carboxylate (7)(R)-2-Benzylpiperazine (5)1,4-Diphenylpiperazine (7)1-(2-Chlorophenyl)Piperazine (4)1-(2-Fluorophenyl)Piperazine (8)1-(3-Methoxyphenyl)Piperazine (4)1-(4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Phenyl)Piperazine (10)1-(5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridin-2-Yl)Piperazine (6)1-(Methylsulfonyl)Piperazine (5)1-(Phenylsulfonyl)Piperazine (17)1-(Piperidin-4-Yl)Piperazine (6)1-(Pyridin-3-Yl)Piperazine (13)1-(Pyridin-3-Ylmethyl)Piperazine (6)1-Benzhydryl-4-Benzylpiperazine (1)1-Benzhydrylpiperazine (9)1-Benzyl 4-(Tert-Butyl) Piperazine-1,4-Dicarboxylate (10)1-Benzyl-4-Methylpiperazine (10)1-Ethyl-4-Phenylpiperazine (4)1-Ethylpiperazine (5)1-Isopropylpiperazine (4)1-Methyl-4-(Pyridin-2-Yl)Piperazine (5)1-Methyl-4-Phenylpiperazine (22)1-Methylpiperazin-2-One (6)1-Methylpiperazine (21)10-(3-(Piperazin-1-Yl)Propyl)-10H-Phenothiazine (2)2-(4-(Benzyloxy)Phenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (10)2-(Piperazin-1-Yl)Benzonitrile (6)2-(Piperazin-1-Yl)Ethan-1-Amine (8)2-(Piperazin-1-Yl)Ethan-1-Ol (10)2-(Piperazin-1-Yl)Pyrazine (9)2-(Piperazin-1-Yl)Pyrimidine (11)2-Phenylpiperazine (17)3-(Piperazin-1-Yl)Aniline (3)3-(Piperazin-1-Yl)Benzoic Acid (3)3-(Piperazin-1-Yl)Pyridazine (7)3-Methylpiperazin-2-One (7)4-(Piperazin-1-Yl)Benzaldehyde (5)4-(Piperazin-1-Yl)Pyrimidine (13)Benzyl 2-Methylpiperazine-1-Carboxylate (7)Benzyl 3-(Hydroxymethyl)Piperazine-1-Carboxylate (6)Benzyl 3-Methylpiperazine-1-Carboxylate (5)Phenyl(Piperazin-1-Yl)Methanone (20)Piperazine-2,5-Dione (9)Tert-Butyl 3-Oxopiperazine-1-Carboxylate (7)Tert-Butyl 4-(Pyridin-2-Yl)Piperazine-1-Carboxylate (12)Tert-Butyl 4-Benzylpiperazine-1-Carboxylate (13)Tert-Butyl 4-Phenylpiperazine-1-Carboxylate (23)Tert-Butyl Piperazine-1-Carboxylate (30)
Piperidines (21889)
Bipiperidine (12)Chloropiperidine (6)Dimethylpiperidine (46)Ethynylpiperidine (5)Fluoropiperidine (33)Formylpiperidine (9)Isopropylpiperidine (11)Piperidine-Carboxylate (3)Piperidineacetic (5)Piperidinecarboxylic (6)Piperidinyl-Phenyl-Boronic Acid/Ester (32)Propylpiperidine (8)(9H-Fluoren-9-Yl)Methyl Piperidine-1-Carboxylate (16)(E)-N-(3-Oxo-1-Phenyl-3-(Piperidin-1-Yl)Prop-1-En-2-Yl)Benzamide (6)(R)-2-Phenylpiperidine (10)(R)-3-Aminopiperidin-2-One (3)(R)-N-(Piperidin-3-Yl)-7H-Pyrrolo[2,3-D]Pyrimidin-4-Amine (5)(S)-2-Phenylpiperidine (11)(S)-N-Phenylpiperidine-2-Carboxamide (1)1,3-Dihydrospiro[Indene-2,4'-Piperidine] (5)1,4'-Bipiperidine (8)1-((Benzyloxy)Carbonyl)Piperidine-2-Carboxylic Acid (5)1-((Benzyloxy)Carbonyl)Piperidine-3-Carboxylic Acid (3)1-(Methylsulfonyl)Piperidine (6)1-(Phenylsulfonyl)Piperidine (23)1-(Piperidin-1-Yl)Ethan-1-One (13)1-(Piperidin-4-Yl)Piperazine (6)1-Benzyl 3-Methyl Piperidine-1,3-Dicarboxylate (3)1-Benzyl-N-Methylpiperidin-3-Amine (6)1-Benzylpiperidin-3-One (5)1-Benzylpiperidin-4-Amine (8)1-Benzylpiperidin-4-One (8)1-Isopropylpiperidine (5)1-Methyl-4-Phenylpiperidine (4)1-Methylpiperidin-2-One (3)1-Oxa-8-Azaspiro[4.5]Decane (5)1-Phenylpiperidin-2-One (8)2,2-Dimethylpiperidin-4-One (6)2,2-Dimethylpiperidine (21)2,7-Diazaspiro[3.5]Nonane (7)2,8-Diazaspiro[4.5]Decan-3-One (6)2,8-Diazaspiro[4.5]Decane (5)2-(Piperidin-1-Yl)Ethan-1-Amine (8)2-(Piperidin-1-Yl)Ethan-1-Ol (10)2-(Piperidin-1-Yl)Pyridine (11)2-(Piperidin-1-Yl)Pyrimidine (16)2-(Piperidin-2-Yl)Ethan-1-Ol (8)2-(Piperidin-4-Yl)Ethan-1-Ol (5)2-(Piperidin-4-Yl)Pyridine (5)2-Methylpiperidin-4-One (6)2-Methylpiperidine (14)2-Phenylpiperidine (14)3,3-Difluoropiperidin-4-One (3)3,3-Difluoropiperidine (29)3,3-Dimethylpiperidin-4-One (3)3,3-Dimethylpiperidine (5)3-(1-Oxoisoindolin-2-Yl)Piperidine-2,6-Dione (21)3-(Piperidin-1-Yl)Pyridine (5)3-(Piperidin-4-Yl)-1H-Indazole (5)3-(Piperidin-4-Yl)-1H-Indole (8)3-(Piperidin-4-Yl)Pyridine (5)3-Fluoropiperidin-4-One (3)3-Fluoropiperidine (26)3-Methoxypiperidine (7)3-Methylpiperidin-4-One (3)3-Methylpiperidine (10)3-Phenylpiperidine (6)4,4-Difluoropiperidine (5)4-(1H-Pyrazol-1-Yl)Piperidine (11)4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-1,2,3,6-Tetrahydropyridine (11)4-(Azetidin-1-Yl)Piperidine (6)4-(Piperidin-1-Yl)Pyrimidine (8)4-(Pyrrolidin-1-Yl)Piperidine (6)4-Benzylpiperidine (18)4-Hydrazineylpiperidine (5)4-Hydroxypiperidin-2-One (3)4-Methyl-1-Phenylpiperidine (6)4-Methylenepiperidine (14)4-Oxopiperidine-2-Carboxylic Acid (3)4-Phenylpiperidin-4-Ol (10)5-Hydroxypiperidin-2-One (3)6-Azaspiro[2.5]Octane (10)6-Oxopiperidine-2-Carboxylic Acid (3)7-Azaspiro[3.5]Nonane (7)Azepane (25)Benzyl 3-Hydroxypiperidine-1-Carboxylate (7)Benzyl 4-Oxopiperidine-1-Carboxylate (12)Benzyl Piperidin-4-Ylcarbamate (7)Benzyl Piperidine-1-Carboxylate (50)Benzyl-3-Aminopiperidine-1-Carboxylate (6)Ethyl Piperidine-1-Carboxylate (5)Ethyl Piperidine-2-Carboxylate (9)Ethyl Piperidine-3-Carboxylate (14)Ethyl Piperidine-4-Carboxylate (10)Methyl 4-Oxopiperidine-2-Carboxylate (3)Methyl Piperidine-2-Carboxylate (12)Methyl Piperidine-3-Carboxylate (19)N-Benzylpiperidin-4-Amine (3)N-Methylpiperidin-3-Amine (5)N-Phenylpiperidine-2-Carboxamide (2)Phenyl(Piperidin-1-Yl)Methanone (21)Phenyl(Piperidin-4-Yl)Methanone (21)Piperidin-2-Ylmethanamine (6)Piperidin-2-Ylmethanol (11)Piperidin-3-Amine (17)Piperidin-3-Ol (27)Piperidin-3-One (13)Piperidin-3-Ylmethanamine (5)Piperidin-3-Ylmethanol (15)Piperidin-4-Amine (14)Piperidin-4-Ol (44)Piperidin-4-Ylmethanamine (7)Piperidin-4-Ylmethanol (11)Piperidine-2,4-Dione (5)Piperidine-2,6-Dione (13)Piperidine-2-Carboxylic Acid (26)Piperidine-3-Carboxamide (5)Piperidine-3-Carboxylic Acid (14)Piperidine-4-Carboxylic Acid (11)Quinuclidine (5)Spiro[Benzo[D][1,3]Oxazine-4,4'-Piperidin]-2(1H)-One (5)Spiro[Chromane-2,4'-Piperidin]-4-One (6)Spiro[Indene-2,4'-Piperidin]-1(3H)-One (5)Spiro[Indoline-3,4'-Piperidin]-2-One (18)Spiro[Indoline-3,4'-Piperidine] (5)Tert-Butyl (2-Oxopiperidin-3-Yl)Carbamate (4)Tert-Butyl (6-Oxopiperidin-3-Yl)Carbamate (3)Tert-Butyl (Piperidin-3-Ylmethyl)Carbamate (5)Tert-Butyl 2-Oxopiperidine-1-Carboxylate (3)Tert-Butyl 3-Bromopiperidine-1-Carboxylate (4)Tert-Butyl 4-Oxopiperidine-1-Carboxylate (16)Tert-Butyl 4-Phenoxypiperidine-1-Carboxylate (12)Tert-Butyl 4-Phenylpiperidine-1-Carboxylate (16)Tert-Butyl Piperidin-3-Ylcarbamate (9)
Purines (2020)
(R)-N-(9-(Tetrahydrofuran-2-Yl)-9H-Purin-6-Yl)Benzamide (5)2-(Acetoxymethyl)-5-(9H-Purin-9-Yl)Tetrahydrofuran-3,4-Diyl Diacetate (6)2-(Hydroxymethyl)-5-(9H-Purin-9-Yl)Tetrahydrofuran-3,4-Diol (27)2-Chloro-7H-Purine (3)2-Chloro-9H-Purine (5)7H-Purin-2-Amine (6)7H-Purin-6-Amine (9)9-((3As,4R,6Ar)-Tetrahydrofuro[3,4-D][1,3]Dioxol-4-Yl)-9H-Purine (7)9-(Tetrahydrofuran-2-Yl)-9H-Purin-6-Amine (30)9-(Tetrahydrofuran-2-Yl)-9H-Purin-6-Ol (6)9-(Tetrahydrofuran-2-Yl)-9H-Purine (2)9H-Purin-6-Amine (3)
Pyrans (1095)
Chromene-Carboxylic Acid (1)Thioglucopyranoside (4)(S)-2-Phenylchroman-4-One (17)1-(Tetrahydro-2H-Pyran-2-Yl)-1H-Indazole (17)2,2-Dimethylchromane (5)2-(2-Oxo-2H-Chromen-4-Yl)Acetic Acid (4)2-Oxo-2H-Chromene-3-Carbonitrile (4)2-Oxo-2H-Chromene-3-Carboxylic Acid (14)2H-Chromene (16)3,4-Dihydro-2H-Pyran (11)3,6-Dihydro-2H-Pyran (8)3-Acetyl-2H-Chromen-2-One (3)3-Hydroxy-2-Phenyl-4H-Chromen-4-One (21)4-(Trifluoromethyl)-2H-Chromen-2-One (6)4-Hydroxy-2H-Chromen-2-One (10)4-Methyl-2H-Chromen-2-One (27)5-Fluorochroman-4-One (3)5-Fluorochromane (6)5-Hydroxy-2-Phenyl-4H-Chromen-4-One (36)5-Methoxy-2-Phenyl-4H-Chromen-4-One (10)6-Bromochroman-4-One (6)6-Chlorochroman-4-One (6)6-Chlorochromane (6)6-Fluorochroman-4-One (5)6-Fluorochromane (6)6-Methoxychromane (5)7-(Diethylamino)-2H-Chromen-2-One (9)7-Bromochroman-4-One (4)7-Bromochromane (7)7-Chlorochromane (5)7-Fluorochroman-4-One (5)7-Hydroxy-2H-Chromen-2-One (23)7-Methoxy-2H-Chromen-2-One (12)7-Methoxychroman-4-One (3)8-Bromochroman-4-One (4)8-Bromochromane (6)8-Chlorochromane (5)8-Fluorochromane (5)8-Methylchroman-4-One (4)8-Methylchromane (10)Chroman-2-One (5)Chroman-2-Ylmethanamine (3)Chroman-3-Amine (3)Chroman-4-Amine (20)Chroman-4-Ol (4)Chromane-2-Carboxylic Acid (6)Chromane-3-Carboxylic Acid (4)Dihydro-2H-Pyran-2,6(3H)-Dione (5)Ethyl 2-Oxo-2H-Chromene-3-Carboxylate (5)Isochromane (11)Spiro[Chromane-2,4'-Piperidin]-4-One (6)Tetrahydro-2H-Pyran-2-One (15)Tetrahydro-2H-Thiopyran (10)Tetrahydro-4H-Pyran-4-One (12)Thiochroman-4-One (10)
Pyrazines (3359)
Dibromopyrazine (7)Dichloropyrazine (21)Dihydropyrazine (6)Dimethylpyrazine (30)Ethoxypyrazine (5)Ethylpyrazine (7)Fluoropyrazine (6)Hydroxypyrazine (4)Iodopyrazine (17)Methoxypyrazine (36)Phenylpyrazin (5)Pyrazino (5)Pyrazino-Nitrile (50)1,2,3,4-Tetrahydropyrido[2,3-B]Pyrazine (5)1-(Pyrazin-2-Yl)Ethan-1-One (5)1H-Pyrazolo[3,4-B]Pyrazine (5)2,3-Diphenylpyrazine (5)2,5-Dibromopyrazine (4)2,5-Dichloropyrazine (4)2,6-Dibromopyrazine (9)2,6-Dichloropyrazine (14)2-(Piperazin-1-Yl)Pyrazine (9)2-(Trifluoromethyl)Pyrazine (6)2-Bromo-3-Methoxypyrazine (5)2-Bromo-3-Methylpyrazine (5)2-Bromo-5-Chloropyrazine (6)2-Bromo-6-Chloropyrazine (5)2-Bromo-6-Methylpyrazine (5)2-Bromopyrazine (15)2-Chloro-3-Methylpyrazine (7)2-Chloro-6-Methylpyrazine (12)2-Chloropyrazine (24)2-Ethoxypyrazine (3)2-Ethylpyrazine (9)2-Fluoropyrazine (7)2-Iodopyrazine (25)2-Methoxypyrazine (45)2-Methylpyrazine (16)2-Phenylpyrazine (12)3-Chloropyrazin-2-Amine (6)3-Chloropyrazine-2-Carbonitrile (6)4,5,6,7-Tetrahydropyrazolo[1,5-A]Pyrazine (7)4-(Pyrazin-2-Yl)Morpholine (5)5,6,7,8-Tetrahydro-[1,2,4]Triazolo[4,3-A]Pyrazine (11)5,6,7,8-Tetrahydroimidazo[1,2-A]Pyrazine (15)5,6,7,8-Tetrahydroimidazo[1,5-A]Pyrazine (11)5-Bromopyrazin-2-Amine (13)5-Bromopyrazin-2-Ol (5)5-Chloropyrazin-2-Amine (9)5H-Pyrrolo[2,3-B]Pyrazine (14)6-Bromopyrazin-2-Amine (5)6-Chloropyrazin-2-Amine (11)[1,2,4]Triazolo[1,5-A]Pyrazine (9)[1,2,4]Triazolo[4,3-A]Pyrazine (11)Ethyl Pyrazine-2-Carboxylate (10)Imidazo[1,5-A]Pyrazine (9)Methyl 3-Bromopyrazine-2-Carboxylate (5)Methyl 6-Bromopyrazine-2-Carboxylate (7)Methyl 6-Chloropyrazine-2-Carboxylate (5)Methyl Pyrazine-2-Carboxylate (19)Pyrazin-2-Amine (22)Pyrazin-2-Ol (7)Pyrazin-2-Ylmethanamine (12)Pyrazine-2-Carbaldehyde (17)Pyrazine-2-Carbohydrazide (3)Pyrazine-2-Carbonitrile (15)Pyrazine-2-Carboxamide (10)Pyrazine-2-Carboxylic Acid (34)Pyrazolo[1,5-A]Pyrazine (5)Pyrido[2,3-B]Pyrazine (12)Pyrido[3,4-B]Pyrazine (11)Tert-Butyl Pyrazin-2-Ylcarbamate (8)
Pyrazoles (16157)
Bipyrazole (5)Chloropyrazolo (33)Dichloropyrazolo (11)Dihydropyrazolo (28)Dimethylpyrazolo (6)Ethylpyrazole (7)Fluoropyrazolo (9)Hydroxypyrazolo (10)Methoxypyrazolo (16)Methyl-Pyrazole-Carboxylic Acid (147)Methyl-Pyrazolone (87)Methylpyrazolo (32)Pyrazolopyridine-Carboxylic Acid (48)Tetrahydropyrazolo (23)(1-Methyl-1H-Pyrazol-3-Yl)Methanol (7)(1-Phenyl-1H-Pyrazol-4-Yl)Boronic Acid (4)1,3-Dimethyl-1H-Pyrazole (28)1,3-Diphenyl-1H-Pyrazole (6)1,4,5,6-Tetrahydropyrrolo[3,4-C]Pyrazole (6)1,5-Diphenyl-1H-Pyrazole (13)1-(2-Chlorophenyl)-1H-Pyrazole (3)1-(3-Chlorophenyl)-1H-Pyrazole (3)1-(4-Methoxybenzyl)-1H-Pyrazole (5)1-(Azetidin-3-Yl)-1H-Pyrazole (7)1-(Tetrahydro-2H-Pyran-2-Yl)-1H-Pyrazole (9)1-(Tetrahydro-2H-Pyran-4-Yl)-1H-Pyrazole (6)1-Benzyl-1H-Pyrazolo[3,4-B]Pyridine (9)1-Benzyl-4-Bromo-1H-Pyrazole (5)1-Benzyl-4-Iodo-1H-Pyrazole (5)1-Cyclopentyl-1H-Pyrazole (5)1-Cyclopropyl-1H-Pyrazole (9)1-Methyl-1H-Pyrazol-3-Amine (14)1-Methyl-3-Phenyl-1H-Pyrazole (21)1-Methyl-4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-1H-Pyrazole (6)1-Methyl-5-Phenyl-1H-Pyrazole (7)1-Phenyl-1H-Pyrazol-3-Amine (3)1-Phenyl-1H-Pyrazol-3-Ol (3)1-Phenyl-1H-Pyrazol-5-Amine (4)1-Phenyl-1H-Pyrazole-3-Carboxylic Acid (10)1-Phenyl-1H-Pyrazole-4-Carbaldehyde (8)1-Phenyl-1H-Pyrazole-4-Carbonitrile (17)1-Phenyl-1H-Pyrazole-4-Carboxylic Acid (19)1-Phenyl-1H-Pyrazole-5-Carboxylic Acid (3)1-Phenyl-3-(Trifluoromethyl)-1H-Pyrazole (5)1-Trityl-1H-Pyrazole (5)1H-Pyrazol-4-Amine (6)1H-Pyrazol-4-Ol (3)1H-Pyrazol-5-Amine (19)1H-Pyrazole-4-Carbaldehyde (30)1H-Pyrazole-4-Carbonitrile (5)1H-Pyrazole-4-Carboxylic Acid (9)1H-Pyrazole-4-Sulfonyl Chloride (8)1H-Pyrazole-5-Carboxamide (3)1H-Pyrazole-5-Carboxylic Acid (10)1H-Pyrazolo[3,4-B]Pyrazine (5)1H-Pyrazolo[3,4-B]Pyridin-5-Amine (3)1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (5)1H-Pyrazolo[4,3-D]Pyrimidine (5)2,3-Dihydropyrazolo[5,1-B]Oxazole (7)2,4-Dihydro-3H-Pyrazol-3-One (10)2,6-Di(1H-Pyrazol-1-Yl)Pyridine (5)2-(1H-Pyrazol-1-Yl)Pyridine (16)2-(1H-Pyrazol-1-Yl)Pyrimidine (6)2-(1H-Pyrazol-3-Yl)Pyridine (5)2-Phenyl-2,4-Dihydro-3H-Pyrazol-3-One (23)3-(Tert-Butyl)-1-Phenyl-1H-Pyrazole (4)3-Bromo-1-Methyl-1H-Pyrazole (16)3-Bromopyrazolo[1,5-A]Pyridine (6)3-Bromopyrazolo[1,5-A]Pyrimidine (11)3-Chloro-1-Methyl-1H-Pyrazole (7)3-Cyclopropyl-1H-Pyrazole (5)3-Iodo-1-Methyl-1H-Pyrazole (6)3-Iodo-1H-Pyrazolo[3,4-B]Pyridine (4)3-Methyl-1-Phenyl-1H-Pyrazole (23)3-Phenyl-1H-Pyrazol-5-Amine (11)4,5,6,7-Tetrahydro-1H-Pyrazolo[3,4-C]Pyridine (7)4,5,6,7-Tetrahydro-1H-Pyrazolo[4,3-C]Pyridine (14)4,5,6,7-Tetrahydropyrazolo[1,5-A]Pyrazine (7)4,5,6,7-Tetrahydropyrazolo[1,5-A]Pyridine (6)4-(1H-Pyrazol-1-Yl)Benzoic Acid (3)4-(1H-Pyrazol-1-Yl)Piperidine (11)4-Bromo-1-Methyl-1H-Pyrazole (14)4-Bromo-1-Phenyl-1H-Pyrazole (11)4-Bromo-1H-Pyrazolo[3,4-B]Pyridine (4)4-Bromopyrazolo[1,5-A]Pyridine (8)4-Chloro-1H-Pyrazole (10)4-Chloro-1H-Pyrazolo[3,4-B]Pyridine (5)4-Chloro-1H-Pyrazolo[3,4-D]Pyrimidine (5)4-Iodo-1H-Pyrazole (9)4-Methyl-1-Phenyl-1H-Pyrazole (6)4-Methyl-1H-Pyrazole (11)4-Nitro-1H-Pyrazole (8)4-Phenyl-1H-Pyrazole (18)5,6-Dihydro-4H-Pyrrolo[1,2-B]Pyrazole (8)5-(Difluoromethyl)-1H-Pyrazole (6)5-Bromo-1H-Pyrazole (11)5-Bromo-1H-Pyrazolo[3,4-B]Pyridine (11)5-Bromo-1H-Pyrazolo[3,4-C]Pyridine (5)5-Chloro-1H-Pyrazole (8)5-Chloro-1H-Pyrazolo[3,4-B]Pyridine (3)5-Chloropyrazolo[1,5-A]Pyrimidine (24)5-Cyclopropyl-1H-Pyrazole (6)5-Iodo-1H-Pyrazole (4)5-Nitro-1H-Pyrazole (9)5-Nitro-1H-Pyrazolo[3,4-B]Pyridine (3)5-Phenyl-1H-Pyrazole-3-Carboxylic Acid (15)6,7-Dihydro-5H-Pyrazolo[5,1-B][1,3]Oxazine (13)6-Bromopyrazolo[1,5-A]Pyridine (8)6-Bromopyrazolo[1,5-A]Pyrimidine (7)6-Chloro-1H-Pyrazolo[3,4-D]Pyrimidine (12)7-Chloropyrazolo[1,5-A]Pyrimidine (8)Ethyl 1-Phenyl-1H-Pyrazole-3-Carboxylate (4)Ethyl 1-Phenyl-1H-Pyrazole-4-Carboxylate (13)Ethyl 1H-Pyrazole-4-Carboxylate (11)Ethyl Pyrazolo[1,5-A]Pyridine-3-Carboxylate (11)Ethyl Pyrazolo[1,5-A]Pyrimidine-3-Carboxylate (6)Methyl 1H-Pyrazole-4-Carboxylate (10)Methyl 1H-Pyrazolo[3,4-B]Pyridine-5-Carboxylate (3)Methyl Pyrazolo[1,5-A]Pyridine-3-Carboxylate (16)Pyrazolo[1,5-A]Pyrazine (5)Pyrazolo[1,5-A]Pyridine-2-Carboxylic Acid (5)Pyrazolo[1,5-A]Pyridine-3-Carboxylic Acid (13)Pyrazolo[1,5-A]Pyrimidine-3-Carboxylic Acid (7)Tert-Butyl 1H-Pyrazolo[3,4-B]Pyridine-1-Carboxylate (7)Tert-Butyl 4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-1H-Pyrazole-1-Carboxylate (3)
Pyridazines (2753)
Aminopyridazine (12)Dihydropyridazine (26)Dimethylpyridazine (9)Hexahydropyridazines (10)Pyridazinecarboxylic (1)2-Methylpyridazin-3(2H)-One (7)3,6-Dichloropyridazine (20)3-(Piperazin-1-Yl)Pyridazine (7)3-(Trifluoromethyl)Pyridazine (3)3-Bromopyridazine (25)3-Chloro-4-Methylpyridazine (7)3-Chloropyridazine (44)3-Iodopyridazine (5)3-Methoxypyridazine (17)3-Methylpyridazine (6)3-Phenylpyridazine (8)4-Aminopyridazin-3(2H)-One (4)4-Bromopyridazin-3(2H)-One (3)4-Bromopyridazine (5)4-Chloropyridazin-3(2H)-One (4)4-Chloropyridazine (16)4-Methoxypyridazine (8)4-Methylpyridazine (3)6-Chloropyridazin-3(2H)-One (5)6-Chloropyridazin-3-Amine (5)[1,2,4]Triazolo[4,3-B]Pyridazine (10)Ethyl Pyridazine-3-Carboxylate (6)Methyl Pyridazine-3-Carboxylate (7)Pyridazin-3-Amine (18)Pyridazin-3-Ol (3)Pyridazin-4-Amine (10)Pyridazine-3-Carboxylic Acid (7)
Pyridines (70617)
Acetylpyridin (5)Aminopicolinate (8)Benzyloxypyridine (36)Bipyridine (202)Bromopicolinate (19)Bromopicolinic (4)Bromopicolinic Acid (5)Bromopicolinonitrile (6)Bromopyrido (13)Butylpyridine (5)Chloroisonicotinic Acid (5)Chloronicotinaldehyde (23)Chloronicotinamide (11)Chloronicotinate (45)Chloronicotinic (41)Cyanopicolinate (7)Cyanopicolinic (6)Cyanopyridine (34)Cyclopropoxypyridine (6)Cyclopropylpyridine (30)Dibromopicolinate (4)Dibromopicolinic Acid (3)Dibromopyridine (36)Dichloropicolinate (9)Dichloropicolinonitrile (4)Dichloropyridine (120)Difluoropicolinic Acid (3)Difluoropyridine (58)Dihydropyrido (27)Diiodopyridine (13)Dimethoxypicolinic Acid (5)Dimethoxypyridine (33)Dimethylpyridine (143)Diphenylpyridine (6)Dipyridine (28)Ethoxypicolinic Acid (3)Ethoxypyridine (35)Ethylpyridine (36)Ethynylpicolinate (3)Fluoro-Pyridine--Boronate (79)Fluoropicolinaldehyde (8)Fluoropicolinamide (8)Fluoropicolinate (22)Fluoropyridine (288)Fluoropyrido (3)Formylpyridine (23)Hexahydropyrido (7)Hydrazinylpyridine (22)Hydroxymethylpyridine (26)Hydroxypicolinate (13)Hydroxypicolinic (9)Hydroxypicolinonitrile (7)Iodopicolinate (5)Iodopicolinic Acid (4)Iodopyridine (167)Isopropoxypyridine (20)Isopropylpyridine (32)Methoxyisonicotinaldehyde (10)Methoxynicotinaldehyde (18)Methoxypicolinaldehyde (13)Methoxypicolinamide (13)Methoxypicolinate (21)Methoxypicolinic (18)Methoxypicolinic Acid (16)Methoxypicolinimidamide (5)Methoxypicolinonitrile (13)Methoxypyridine (342)Methylisonicotinamide (8)Methylnicotinaldehyde (30)Methylnicotinamide (13)Methylpicolinaldehyde (16)Methylpicolinamide (15)Methylpicolinate (27)Methylpicolinic (23)Methylpicolinonitrile (28)Methylpyrido (13)Nitropyridine (393)Oxopyridin (2)Phenoxypyridin (1)Picolinate (42)Pyridinecarbonitrile (50)Pyridyl-Benzene-Boronic Acid/Ester (16)Pyridyl-Phenyl-Boronate (2)Pyridylmethyl (6)Terpyridine (32)Tetrachloropyridine (5)Tetrafluoropyridine (21)Tetrahydropyridine (49)Tetrahydropyrido (32)Tribromopyridine (9)Trichloropyridine (17)Trifluoropyridine (8)Trimethylpyridine (5)(2-Chloropyridin-4-Yl)Boronic Acid (6)(3-Bromopyridin-2-Yl)Methanol (7)(3-Chloropyridin-2-Yl)Methanamine (6)(3-Fluoropyridin-2-Yl)Methanamine (5)(3-Methylpyridin-2-Yl)Methanamine (5)(3-Methylpyridin-2-Yl)Methanol (10)(3Ar,8As)-2-(Pyridin-2-Yl)-3A,8A-Dihydro-8H-Indeno[1,2-D]Oxazole (6)(3As,8Ar)-2-(Pyridin-2-Yl)-3A,8A-Dihydro-8H-Indeno[1,2-D]Oxazole (7)(4R,5S)-4,5-Diphenyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (5)(5-(Trifluoromethyl)Pyridin-3-Yl)Boronic Acid (4)(5-Bromopyridin-2-Yl)Methanamine (5)(5-Bromopyridin-2-Yl)Methanol (5)(5-Chloropyridin-2-Yl)Methanamine (5)(6-Methylpyridin-2-Yl)Methanamine (6)(6-Methylpyridin-2-Yl)Methanol (5)(6-Phenoxypyridin-3-Yl)Boronic Acid (5)(R)-3-(Pyrrolidin-2-Yl)Pyridine (9)(R)-4-Benzyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (7)(R)-4-Phenyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (7)(S)-4-Benzyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (8)(S)-4-Phenyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (6)1,1'-Diphenyl-[4,4'-Bipyridine]-1,1'-Diium (7)1,10-Phenanthrolin-4-Ol (3)1,2,3,4-Tetrahydropyrido[2,3-B]Pyrazine (5)1,2,3,6-Tetrahydropyridine (22)1,3-Dihydro-2H-Pyrrolo[2,3-B]Pyridin-2-One (19)1,3-Dihydro-2H-Pyrrolo[2,3-C]Pyridin-2-One (5)1,3-Dihydro-2H-Pyrrolo[3,2-B]Pyridin-2-One (11)1,4-Di(Pyridin-4-Yl)Benzene (5)1-(5-Bromopyridin-2-Yl)Piperazine (6)1-(Phenylsulfonyl)-1H-Pyrrolo[2,3-B]Pyridine (30)1-(Pyridin-2-Yl)Ethan-1-Amine (15)1-(Pyridin-2-Yl)Ethan-1-One (36)1-(Pyridin-2-Yl-L2-Azaneyl)Ethan-1-One (12)1-(Pyridin-3-Yl)Ethan-1-Amine (17)1-(Pyridin-3-Yl)Ethan-1-One (29)1-(Pyridin-3-Yl)Piperazine (13)1-(Pyridin-3-Ylmethyl)Piperazine (6)1-(Pyridin-4-Yl)Ethan-1-Amine (23)1-(Pyridin-4-Yl)Ethan-1-One (14)1-Benzyl-1,2,3,6-Tetrahydropyridine (9)1-Benzyl-1H-Pyrazolo[3,4-B]Pyridine (9)1-Methyl-4-(Pyridin-2-Yl)Piperazine (5)1-Methylpyridin-1-Ium Iodide (5)1-Phenyl-3-(4-(Pyridin-4-Yloxy)Phenyl)Urea (8)1H-Imidazo[4,5-B]Pyridine (14)1H-Imidazo[4,5-C]Pyridine (12)1H-Pyrazolo[3,4-B]Pyridin-5-Amine (3)1H-Pyrrolo[2,3-C]Pyridin-7-Ol (3)1H-Pyrrolo[2,3-C]Pyridine-2-Carboxylic Acid (4)1H-Pyrrolo[3,2-B]Pyridine-3-Carboxylic Acid (6)2,2':6',2''-Terpyridine (15)2,2-Dimethyl-1-(Pyridin-2-Yl-L2-Azaneyl)Propan-1-One (7)2,3'-Bipyridine (11)2,3,4,5-Tetrahydro-1H-Pyrido[4,3-B]Indole (12)2,3,4,9-Tetrahydro-1H-Pyrido[3,4-B]Indole (12)2,3,5-Trichloropyridine (13)2,3,6-Trichloropyridine (16)2,3-Dibromopyridine (21)2,3-Dichloropyridine (38)2,3-Difluoropyridine (13)2,3-Dihydro-1H-Pyrrolo[2,3-B]Pyridine (10)2,3-Dihydro-1H-Pyrrolo[2,3-C]Pyridine (5)2,3-Dihydro-1H-Pyrrolo[3,2-C]Pyridine (7)2,3-Dihydro-1H-Pyrrolo[3,4-C]Pyridine (5)2,3-Dihydro-[1,4]Dioxino[2,3-B]Pyridine (5)2,3-Dihydropyridin-2-One (5)2,3-Dimethoxypyridine (7)2,3-Dimethylpyridine (8)2,4,6-Trichloropyridine (5)2,4,6-Triphenylpyridine (7)2,4-Dibromopyridine (5)2,4-Dichloro-6-Methylpyridine (8)2,4-Dichloropyridine (50)2,4-Dimethylpyridine (5)2,5-Dibromopyridine (26)2,5-Dichloropyridine (32)2,5-Difluoropyridine (8)2,6-Bis(4,5-Dihydrooxazol-2-Yl)Pyridine (12)2,6-Di(1H-Pyrazol-1-Yl)Pyridine (5)2,6-Dibromo-3-Fluoropyridine (3)2,6-Dibromopyridin-4-Amine (3)2,6-Dibromopyridine (28)2,6-Dichloro-3-Fluoropyridine (10)2,6-Dichloro-3-Methylpyridine (5)2,6-Dichloro-3-Nitropyridine (6)2,6-Dichloro-4-Iodopyridine (4)2,6-Dichloro-4-Methylpyridine (5)2,6-Dichloronicotinonitrile (8)2,6-Dichloropyridin-3-Amine (11)2,6-Dichloropyridine (49)2,6-Difluoropyridine (29)2,6-Dimethoxypyridine (11)2,6-Dimethylpyridin-4-Ol (4)2,6-Dimethylpyridine (26)2-(1H-Pyrazol-1-Yl)Pyridine (16)2-(1H-Pyrazol-3-Yl)Pyridine (5)2-(2,2,2-Trifluoroethoxy)Pyridine (8)2-(2-Chlorophenyl)Pyridine (3)2-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (6)2-(4-Fluorophenyl)Pyridine (11)2-(6-Benzhydrylpyridin-2-Yl)-4,5-Dihydrooxazole (10)2-(6-Cyclopropylpyridin-2-Yl)-4,5-Dihydrooxazole (10)2-(Benzyloxy)Pyridine (18)2-(Bromomethyl)Pyridine (27)2-(Chloromethyl)-3-Methylpyridine (12)2-(Chloromethyl)Pyridine (12)2-(Chloromethyl)Pyridine 1-Oxide (4)2-(Difluoromethyl)Pyridine (21)2-(Methylsulfonyl)Pyridine (11)2-(Methylthio)Pyridine (5)2-(P-Tolyl)Pyridine (6)2-(Phenoxymethyl)Pyridine (5)2-(Piperidin-1-Yl)Pyridine (11)2-(Piperidin-4-Yl)Pyridine (5)2-(Pyridin-2-Yl)-1H-Benzo[D]Imidazole (5)2-(Pyridin-2-Yl)Acetonitrile (8)2-(Pyridin-2-Yl)Pyrimidine (8)2-(Pyridin-2-Ylmethyl)-4,5-Dihydrooxazole (14)2-(Pyridin-3-Yl)Acetic Acid (14)2-(Pyridin-3-Yl)Acetonitrile (6)2-(Pyrrolidin-2-Yl)Pyridine (5)2-(Thiophen-2-Yl)Pyridine (5)2-(Trifluoromethoxy)Pyridine (6)2-(Trifluoromethyl)Pyridine (6)2-Aminonicotinonitrile (6)2-Benzylpyridine (12)2-Bromo-3-(Trifluoromethyl)Pyridine (4)2-Bromo-3-Chloropyridine (25)2-Bromo-3-Fluoropyridine (26)2-Bromo-3-Iodopyridine (6)2-Bromo-3-Methoxypyridine (7)2-Bromo-3-Methylpyridine (25)2-Bromo-3-Nitropyridine (5)2-Bromo-4-Chloropyridine (7)2-Bromo-4-Methylpyridine (6)2-Bromo-5-(Trifluoromethyl)Pyridine (6)2-Bromo-5-Chloropyridine (22)2-Bromo-5-Fluoropyridine (33)2-Bromo-5-Methoxypyridine (11)2-Bromo-5-Methylpyridine (19)2-Bromo-5-Nitropyridine (11)2-Bromo-6-(Trifluoromethyl)Pyridine (6)2-Bromo-6-Chloropyridine (23)2-Bromo-6-Fluoropyridine (21)2-Bromo-6-Iodopyridine (5)2-Bromo-6-Methoxypyridine (15)2-Bromo-6-Methylpyridine (17)2-Bromo-6-Phenylpyridine (4)2-Bromonicotinic Acid (5)2-Bromopyridin-3-Amine (10)2-Bromopyridin-3-Ol (7)2-Bromopyridine (10)2-Bromopyridine 1-Oxide (6)2-Chloro-3,6-Dimethylpyridine (4)2-Chloro-3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (4)2-Chloro-3-(Trifluoromethyl)Pyridine (12)2-Chloro-3-Fluoropyridin-4-Amine (3)2-Chloro-3-Fluoropyridine (20)2-Chloro-3-Iodopyridin-4-Amine (3)2-Chloro-3-Iodopyridine (13)2-Chloro-3-Methoxypyridine (12)2-Chloro-3-Methylpyridine (17)2-Chloro-3-Nitropyridine (10)2-Chloro-4,6-Dimethylpyridine (7)2-Chloro-4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (14)2-Chloro-4-(Trifluoromethyl)Pyridine (9)2-Chloro-4-Ethoxypyridine (5)2-Chloro-4-Fluoropyridine (10)2-Chloro-4-Iodopyridine (19)2-Chloro-4-Methoxypyridine (22)2-Chloro-4-Methylpyridine (31)2-Chloro-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (6)2-Chloro-5-(Trifluoromethyl)Pyridine (4)2-Chloro-5-Fluoropyridin-4-Amine (3)2-Chloro-5-Fluoropyridine (16)2-Chloro-5-Iodopyridine (18)2-Chloro-5-Methylpyridine (11)2-Chloro-5-Nitropyridine (8)2-Chloro-6-(Trifluoromethyl)Pyridine (16)2-Chloro-6-Fluoropyridine (14)2-Chloro-6-Iodopyridine (9)2-Chloro-6-Methoxypyridine (24)2-Chloro-6-Methyl-3-Nitropyridine (4)2-Chloro-6-Methylnicotinonitrile (10)2-Chloro-6-Methylpyridine (49)2-Chloroisonicotinaldehyde (19)2-Chloroisonicotinic Acid (17)2-Chloroisonicotinonitrile (7)2-Chloronicotinic Acid (7)2-Chloronicotinonitrile (9)2-Chloropyridin-3-Amine (11)2-Chloropyridin-3-Ol (9)2-Chloropyridin-4-Amine (28)2-Chloropyridine 1-Oxide (10)2-Cyclopropyl-4-Phenylquinoline (12)2-Cyclopropylpyridine (20)2-Ethoxypyridine (20)2-Ethylpyridine (9)2-Ethynylpyridine (31)2-Fluoro-3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (7)2-Fluoro-3-Iodopyridine (8)2-Fluoro-3-Methylpyridine (14)2-Fluoro-4-Methylpyridine (6)2-Fluoro-5-Methoxypyridine (4)2-Fluoro-5-Methylpyridine (6)2-Fluoro-6-Methoxypyridine (6)2-Fluoro-6-Methylpyridine (20)2-Fluoropyridine (15)2-Hydrazineylpyridine (32)2-Iodo-6-Methylpyridine (5)2-Iodopyridine (27)2-Isopropoxypyridine (16)2-Isopropylpyridine (14)2-Methoxy-3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (7)2-Methoxy-3-(Trifluoromethyl)Pyridine (6)2-Methoxy-4-Methylpyridine (5)2-Methoxy-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (5)2-Methoxy-5-(Trifluoromethyl)Pyridine (4)2-Methoxy-5-Methylpyridine (5)2-Methoxy-5-Nitropyridine (8)2-Methoxy-6-Methylpyridine (14)2-Methoxyisonicotinic Acid (13)2-Methoxypyridin-3-Amine (6)2-Methoxypyridine (436)2-Methyl-1,10-Phenanthroline (3)2-Methyl-3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (5)2-Methyl-3-Nitropyridine (9)2-Methyl-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (3)2-Methylimidazo[1,2-A]Pyridine (8)2-Methylpyridin-3-Ol (8)2-Methylpyridin-4-Amine (7)2-Methylpyridine 1-Oxide (9)2-Nitropyridine (40)2-Phenoxy-5-(Trifluoromethyl)Pyridine (7)2-Phenylimidazo[1,2-A]Pyridine (12)2-Propoxypyridine (9)2H-Pyrido[3,2-B][1,4]Oxazin-3(4H)-One (8)3,3'-Bipyridine (7)3,4-Dihydro-2H-Pyrido[3,2-B][1,4]Oxazine (5)3,5-Dibromopyridine (12)3,5-Dichloropyridine (16)3,5-Difluoropyridine (12)3,5-Dimethoxypyridine (4)3,5-Dimethylpyridine (8)3,5-Diphenylpyridine (5)3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-5-(Trifluoromethyl)Pyridine (3)3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (74)3-(Benzyloxy)Pyridine (19)3-(Bromomethyl)Pyridine (18)3-(Chloromethyl)Pyridine (22)3-(Cyclopropylmethyl)Pyridine (6)3-(Difluoromethyl)Pyridine (5)3-(Methylsulfonyl)Pyridine (5)3-(Piperidin-1-Yl)Pyridine (5)3-(Piperidin-4-Yl)Pyridine (5)3-(Pyrrolidin-2-Yl)Pyridine (6)3-(Tert-Butyl)Pyridine (5)3-(Trifluoromethyl)-1H-Pyrrolo[2,3-B]Pyridine (3)3-(Trifluoromethyl)Pyridin-2-Ol (5)3-(Trifluoromethyl)Pyridine (52)3-Bromo-1H-Pyrrolo[3,2-B]Pyridine (6)3-Bromo-2-Chloropyridin-4-Amine (3)3-Bromo-2-Chloropyridine (20)3-Bromo-2-Fluoropyridine (21)3-Bromo-2-Methoxypyridine (20)3-Bromo-2-Methylpyridine (27)3-Bromo-4-Methylpyridine (13)3-Bromo-5-Chloropyridine (14)3-Bromo-5-Fluoropyridine (18)3-Bromo-5-Methylpyridine (14)3-Bromo-5-Nitropyridine (10)3-Bromopicolinic Acid (9)3-Bromopicolinonitrile (13)3-Bromopyrazolo[1,5-A]Pyridine (6)3-Bromopyridin-2-Amine (30)3-Bromopyridin-2-Ol (17)3-Bromopyridine 1-Oxide (8)3-Chloro-2-Fluoropyridine (13)3-Chloro-2-Methoxypyridine (16)3-Chloro-2-Methylpyridine (4)3-Chloro-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (5)3-Chloro-5-Fluoropyridine (10)3-Chloro-5-Methylpyridine (7)3-Chloro-5-Nitropyridine (5)3-Chloroimidazo[1,2-A]Pyridine (3)3-Chloropicolinic Acid (9)3-Chloropicolinonitrile (6)3-Chloropyridin-2-Amine (17)3-Chloropyridin-2-Ol (10)3-Cyclopropylpyridine (28)3-Ethoxypyridine (12)3-Ethylpyridine (11)3-Ethynylpyridine (22)3-Fluoro-2-Methoxypyridine (14)3-Fluoro-2-Methylpyridine (15)3-Fluoro-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (7)3-Fluoropicolinic Acid (6)3-Fluoropicolinonitrile (5)3-Fluoropyridin-2-Amine (12)3-Fluoropyridin-4-Amine (4)3-Hydrazineylpyridine (8)3-Iodo-1H-Pyrazolo[3,4-B]Pyridine (4)3-Iodo-1H-Pyrrolo[3,2-B]Pyridine (6)3-Iodo-1H-Pyrrolo[3,2-C]Pyridine (4)3-Iodopyridin-2-Amine (12)3-Iodopyridin-2-Ol (4)3-Iodopyridin-4-Amine (6)3-Iodopyridin-4-Ol (4)3-Iodopyridine (37)3-Methoxypyridin-2-Amine (5)3-Methoxypyridine (52)3-Methyl-1H-Pyrrolo[2,3-B]Pyridine (5)3-Methyl-2-Phenylpyridine (3)3-Methyl-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (6)3-Methyl-5-Nitropyridine (4)3-Methylimidazo[1,2-A]Pyridine (3)3-Methylpicolinic Acid (13)3-Methylpyridin-2-Amine (7)3-Methylpyridine (50)3-Methylpyridine 1-Oxide (7)3-Nitropyridin-2-Ol (11)3-Nitropyridin-4-Amine (5)3-Nitropyridine (54)3-Phenoxypyridine (12)4'-Phenyl-2,2':6',2''-Terpyridine (13)4,4'-Bipyridine (10)4,5,6,7-Tetrahydro-1H-Pyrazolo[3,4-C]Pyridine (7)4,5,6,7-Tetrahydro-1H-Pyrazolo[4,3-C]Pyridine (14)4,5,6,7-Tetrahydro-3H-Imidazo[4,5-C]Pyridine (5)4,5,6,7-Tetrahydrothiazolo[5,4-C]Pyridine (10)4,5,6,7-Tetrahydrothieno[2,3-C]Pyridine (10)4,5,6,7-Tetrahydrothieno[3,2-C]Pyridine (9)4,6-Dichloropyridin-2-Amine (6)4,6-Dichloropyridin-3-Amine (4)4,7-Diphenyl-1,10-Phenanthroline (4)4-(2,4-Diphenyl-1H-Imidazol-5-Yl)Pyridine (5)4-(Benzyloxy)Pyridine (8)4-(Bromomethyl)Pyridine (8)4-(Pyridin-2-Yl)Morpholine (21)4-(Pyridin-3-Yl)Pyrimidine (5)4-(Pyridin-4-Yl)Morpholine (5)4-(Tert-Butyl)-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (16)4-(Tert-Butyl)Pyridine (5)4-(Trifluoromethyl)Nicotinic Acid (3)4-(Trifluoromethyl)Pyridine (14)4-Bromo-2-Chloropyridine (29)4-Bromo-2-Fluoropyridine (4)4-Bromo-2-Methoxypyridine (4)4-Bromo-3-Methylpyridine (5)4-Bromopyrazolo[1,5-A]Pyridine (8)4-Bromopyridine (31)4-Chloro-1H-Pyrazolo[4,3-C]Pyridine (7)4-Chloro-1H-Pyrrolo[2,3-B]Pyridine (13)4-Chloro-1H-Pyrrolo[3,2-C]Pyridine (10)4-Chloro-2,6-Dimethylpyridine (4)4-Chloro-2-Methoxypyridine (6)4-Chloro-3-Methylpyridine (7)4-Chloronicotinic Acid (4)4-Chloropyridin-2-Amine (6)4-Chloropyridine (31)4-Cyclopropylpyridine (7)4-Ethoxypyridine (7)4-Ethynylpyridine (10)4-Iodopyridine (17)4-Isopropyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (16)4-Methoxypyridine (136)4-Methyl-2,2'-Bipyridine (8)4-Methyl-2-Phenylpyridine (3)4-Methyl-3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (5)4-Methyl-3-Nitropyridine (8)4-Methylnicotinic Acid (5)4-Methylpyridine (24)4-Nitropyridine (11)4-Phenoxypyridine (7)4-Phenyl-1,2,3,6-Tetrahydropyridine (7)4-Phenyl-1,4-Dihydropyridine (10)5,6,7,8-Tetrahydroimidazo[1,2-A]Pyridine (12)5,6,7,8-Tetrahydropyrido[3,4-D]Pyrimidine (7)5,6,7,8-Tetrahydropyrido[4,3-D]Pyrimidine (17)5,6-Dichloropyridin-2-Amine (4)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Nicotinonitrile (4)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridin-2-Amine (9)5-(Trifluoromethyl)Pyridin-2-Amine (5)5-(Trifluoromethyl)Pyridin-2-Ol (8)5-Benzyl-4,5,6,7-Tetrahydrothieno[3,2-C]Pyridine (7)5-Bromo-2-Chloro-4-Methylpyridine (5)5-Bromo-2-Chloropyridine (40)5-Bromo-2-Fluoropyridine (22)5-Bromo-2-Iodopyridine (5)5-Bromo-2-Methoxypyridine (29)5-Bromo-2-Methylpyridine (23)5-Bromo-2-Phenylpyridine (3)5-Bromo-4-Methylpyridin-2-Amine (5)5-Bromo-6-Chloropyridin-2-Amine (3)5-Bromonicotinaldehyde (12)5-Bromonicotinic Acid (6)5-Bromonicotinonitrile (6)5-Bromopicolinic Acid (11)5-Bromopicolinonitrile (13)5-Bromopyridin-2-Amine (35)5-Bromopyridin-2-Ol (18)5-Bromopyridin-3-Amine (10)5-Bromopyridin-3-Ol (6)5-Chloro-1H-Pyrazolo[3,4-B]Pyridine (3)5-Chloro-1H-Pyrazolo[4,3-B]Pyridine (6)5-Chloro-1H-Pyrrolo[2,3-C]Pyridine (5)5-Chloro-1H-Pyrrolo[3,2-B]Pyridine (6)5-Chloro-2-Fluoropyridine (13)5-Chloro-2-Methoxypyridine (10)5-Chloro-2-Methylpyridine (10)5-Chloroimidazo[1,2-A]Pyridine (3)5-Chloropicolinic Acid (7)5-Chloropicolinonitrile (6)5-Chloropyridin-2-Amine (26)5-Chloropyridin-2-Ol (15)5-Chloropyridin-3-Amine (7)5-Fluoro-2-Methoxypyridine (15)5-Fluoro-2-Methylpyridine (8)5-Fluoropicolinonitrile (5)5-Fluoropyridin-2-Amine (15)5-Iodopyridin-2-Amine (17)5-Iodopyridin-2-Ol (8)5-Methoxy-1H-Pyrrolo[2,3-C]Pyridine (4)5-Methoxypyridin-3-Amine (4)5-Methylimidazo[1,2-A]Pyridine (4)5-Methylpyridin-2-Amine (7)5-Methylpyridin-3-Amine (4)5-Nitronicotinic Acid (5)5-Nitropyridin-2-Amine (6)5-Phenylpicolinic Acid (4)6,7-Dihydro-5H-Cyclopenta[B]Pyridine (18)6,7-Dihydro-5H-Cyclopenta[C]Pyridine (7)6,7-Dihydro-5H-Pyrrolo[3,4-B]Pyridine (5)6-(Trifluoromethyl)Pyridin-2-Amine (11)6-(Trifluoromethyl)Pyridin-3-Amine (5)6-Bromo-1H-Pyrazolo[4,3-B]Pyridine (4)6-Bromo-1H-Pyrrolo[3,2-B]Pyridine (7)6-Bromo-1H-Pyrrolo[3,2-C]Pyridine (5)6-Bromoimidazo[1,2-A]Pyridine (14)6-Bromonicotinaldehyde (11)6-Bromonicotinic Acid (9)6-Bromonicotinonitrile (7)6-Bromopicolinic Acid (5)6-Bromopyrazolo[1,5-A]Pyridine (8)6-Bromopyridin-2-Amine (8)6-Bromopyridin-3-Amine (12)6-Bromopyridin-3-Ol (13)6-Chloro-1H-Pyrazolo[4,3-C]Pyridine (8)6-Chloro-1H-Pyrrolo[3,2-C]Pyridine (13)6-Chloro-3-Nitropyridin-2-Amine (4)6-Chloro-5-(Trifluoromethyl)Pyridin-2-Amine (3)6-Chloro-5-Iodopyridin-2-Amine (3)6-Chloroimidazo[1,2-A]Pyridine (4)6-Chloronicotinaldehyde (24)6-Chloronicotinic Acid (4)6-Chloropicolinic Acid (12)6-Chloropicolinonitrile (9)6-Chloropyridin-2-Amine (21)6-Chloropyridin-2-Ol (9)6-Chloropyridin-3-Amine (4)6-Chloropyridine-3-Sulfonyl Chloride (5)6-Fluoro-1H-Pyrrolo[2,3-B]Pyridine (3)6-Fluoropyridin-2-Amine (8)6-Fluoropyridin-3-Amine (4)6-Methoxy-1H-Pyrrolo[2,3-B]Pyridine (3)6-Methoxynicotinaldehyde (4)6-Methoxypicolinic Acid (9)6-Methoxypyridin-2-Amine (14)6-Methoxypyridin-3-Amine (8)6-Methylnicotinic Acid (6)6-Methylnicotinonitrile (7)6-Methylpicolinic Acid (12)6-Methylpicolinonitrile (10)6-Methylpyridin-2-Amine (46)6-Methylpyridin-2-Ol (23)6-Methylpyridin-3-Amine (5)6-Methylpyridin-3-Ol (7)6-Phenoxypyridin-3-Amine (5)6-Phenylnicotinic Acid (8)6-Phenylpicolinic Acid (3)7-Bromo-1H-Pyrrolo[2,3-C]Pyridine (4)7-Chloro-1H-Pyrrolo[2,3-C]Pyridine (5)7-Methoxy-1H-Pyrrolo[2,3-C]Pyridine (5)7-Methylimidazo[1,2-A]Pyridine (3)9H-Pyrido[3,4-B]Indole (5)Bis(Pyridin-2-Ylmethyl)Amine (6)Dimethyl Pyridine-2,6-Dicarboxylate (7)Dimethyl(Pyridin-2-Yl)Phosphine Oxide (8)Dimethyl(Pyridin-3-Yl)Phosphine Oxide (7)Ethyl 2-(Pyridin-2-Yl)Acetate (15)Ethyl 2-Methylnicotinate (6)Ethyl 4,6-Dichloronicotinate (4)Ethyl 6-Chloropicolinate (7)Ethyl Isonicotinate (12)Ethyl Nicotinate (25)Ethyl Picolinate (41)Ethyl Pyrazolo[1,5-A]Pyridine-3-Carboxylate (11)Furo[3,2-B]Pyridine (7)Furo[3,2-C]Pyridine (7)Imidazo[1,2-A]Pyridin-2-Ylmethanol (4)Imidazo[1,2-A]Pyridine-5-Carboxylic Acid (3)Imidazo[1,2-A]Pyridine-6-Carbonitrile (3)Isonicotinaldehyde (68)Isonicotinamide (12)Isonicotinic Acid (23)Isonicotinohydrazide (6)Isonicotinonitrile (16)Methyl 1H-Pyrazolo[3,4-B]Pyridine-5-Carboxylate (3)Methyl 1H-Pyrrolo[2,3-B]Pyridine-2-Carboxylate (3)Methyl 2-(Pyridin-2-Yl)Acetate (9)Methyl 2-Chloroisonicotinate (11)Methyl 2-Chloronicotinate (6)Methyl 3-Bromopicolinate (9)Methyl 3-Chloropicolinate (9)Methyl 5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Nicotinate (4)Methyl 5-Hydroxypicolinate (5)Methyl 6-Bromonicotinate (6)Methyl 6-Chloropicolinate (11)Methyl 6-Fluoronicotinate (4)Methyl 6-Methoxynicotinate (4)Methyl Isonicotinate (16)Methyl Nicotinate (52)Methyl Pyrazolo[1,5-A]Pyridine-3-Carboxylate (16)N,N-Dimethylpyridin-2-Amine (10)N,N-Dimethylpyridin-4-Amine (6)N-(Pyridin-2-Yl)Benzamide (9)N-Benzylpyridin-2-Amine (9)N-Methylpicolinamide (10)N-Methylpyridin-2-Amine (47)N-Methylpyridin-3-Amine (15)N-Phenyl-4-(Pyridin-3-Yl)Pyrimidin-2-Amine (5)N-Phenylpicolinamide (8)N-Phenylpyridin-2-Amine (9)Nicotinaldehyde (153)Nicotinamide (64)Nicotinic Acid (53)Nicotinonitrile (82)Oxazolo[4,5-B]Pyridine (7)Oxazolo[5,4-B]Pyridine (5)Phenyl(Pyridin-2-Yl)Methanone (10)Phenyl(Pyridin-3-Yl)Methanone (9)Picolinaldehyde (98)Picolinamide (26)Picolinic Acid (22)Picolinimidamide (11)Picolinohydrazide (5)Pyrazolo[1,5-A]Pyridine-2-Carboxylic Acid (5)Pyrazolo[1,5-A]Pyridine-3-Carboxylic Acid (13)Pyridin-2-Amine (29)Pyridin-2-Ol (170)Pyridin-2-Ylboronic Acid (9)Pyridin-2-Ylmethanamine (38)Pyridin-2-Ylmethanol (65)Pyridin-3-Amine (21)Pyridin-3-Ol (13)Pyridin-3-Ylboronic Acid (49)Pyridin-3-Ylmethanamine (29)Pyridin-3-Ylmethanol (39)Pyridin-4-Amine (22)Pyridin-4-Ol (16)Pyridin-4-Ylboronic Acid (21)Pyridin-4-Ylmethanamine (12)Pyridin-4-Ylmethanol (16)Pyridine 1-Oxide (33)Pyridine-2,3-Diamine (5)Pyridine-2,6-Diamine (12)Pyridine-2,6-Dicarboxylic Acid (9)Pyridine-2,6-Diol (6)Pyridine-2-Sulfonamide (6)Pyridine-2-Sulfonyl Chloride (9)Pyridine-2-Thiol (8)Pyridine-3-Sulfonic Acid (6)Pyridine-3-Sulfonyl Chloride (25)Pyrido[2,3-B]Pyrazine (12)Pyrido[2,3-D]Pyrimidine (8)Pyrido[3,2-D]Pyrimidine (14)Pyrido[3,4-B]Pyrazine (11)Pyrido[3,4-D]Pyrimidine (10)Tert-Butyl (2-Chloropyridin-4-Yl)Carbamate (4)Tert-Butyl 1H-Pyrazolo[3,4-B]Pyridine-1-Carboxylate (7)Tert-Butyl 4-(Pyridin-2-Yl)Piperazine-1-Carboxylate (12)Tert-Butyl Pyridin-2-Ylcarbamate (37)Tert-Butyl Pyridin-3-Ylcarbamate (16)Tert-Butyl Pyridin-4-Ylcarbamate (6)Thiazolo[4,5-B]Pyridine (12)Thiazolo[5,4-B]Pyridine (13)Thiazolo[5,4-C]Pyridine (5)Thieno[2,3-B]Pyridine (22)Thieno[2,3-C]Pyridine (14)Thieno[3,2-B]Pyridine (18)Thieno[3,2-C]Pyridine (13)
Pyrimidines (14557)
Bipyrimidine (4)Dibromopyrimidine (15)Methoxypyrimidine (107)Pyrimidinone (3)Tetraoxatetradecan (10)Trichloropyrimidine (11)(R)-7-(Tetrahydrofuran-2-Yl)-7H-Pyrrolo[2,3-D]Pyrimidine (8)(R)-N-(Piperidin-3-Yl)-7H-Pyrrolo[2,3-D]Pyrimidin-4-Amine (5)1,4,5,6-Tetrahydropyrimidine (4)1-(3-Fluorotetrahydrofuran-2-Yl)Pyrimidin-2(1H)-One (9)1-(5-(Hydroxymethyl)Tetrahydrofuran-2-Yl)Pyrimidine-2,4(1H,3H)-Dione (30)1-(Pyrimidin-2-Yl)Ethan-1-One (5)1-(Pyrimidin-4-Yl)Ethan-1-One (6)1-(Tetrahydrofuran-2-Yl)Pyrimidin-2(1H)-One (46)1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (5)1H-Pyrazolo[4,3-D]Pyrimidine (5)2,4,5-Trichloropyrimidine (6)2,4,6-Trichloropyrimidine (14)2,4,6-Triphenylpyrimidine (9)2,4-Dichloro-6-Methylpyrimidine (7)2,4-Dichloropyrimidin-5-Amine (6)2,4-Dimethoxypyrimidine (13)2,4-Dimethylpyrimidine (7)2-(1H-Pyrazol-1-Yl)Pyrimidine (6)2-(Chloromethyl)Pyrimidine (5)2-(Methylsulfonyl)Pyrimidine (25)2-(Methylthio)Pyrimidin-4-Amine (10)2-(Methylthio)Pyrimidine (19)2-(Piperazin-1-Yl)Pyrimidine (11)2-(Piperidin-1-Yl)Pyrimidine (16)2-(Propylthio)Pyrimidine (5)2-(Pyridin-2-Yl)Pyrimidine (8)2-(Pyrrolidin-1-Yl)Pyrimidine (8)2-(Trifluoromethyl)Pyrimidine (27)2-Aminopyrimidin-4(3H)-One (11)2-Bromopyrimidine (22)2-Chloro-4-(Trifluoromethyl)Pyrimidine (6)2-Chloro-4-Methoxypyrimidine (14)2-Chloro-4-Methylpyrimidine (16)2-Chloro-4-Phenylpyrimidine (7)2-Chloro-5-Fluoropyrimidine (6)2-Chloro-5-Methylpyrimidine (5)2-Chloro-5-Nitropyrimidine (5)2-Chloro-7H-Pyrrolo[2,3-D]Pyrimidine (13)2-Chloropyrimidin-4-Amine (22)2-Cyclopropylpyrimidine (10)2-Ethoxypyrimidine (7)2-Ethylpyrimidine (6)2-Fluoropyrimidine (9)2-Hydrazineylpyrimidine (6)2-Iodopyrimidine (8)2-Methoxypyrimidin-4-Amine (6)2-Methoxypyrimidine (59)2-Methylpyrimidin-4-Amine (22)2-Methylpyrimidin-4-Ol (11)2-Phenoxypyrimidine (8)2-Phenylpyrimidin-5-Amine (5)3-Methylpyrimidin-4(3H)-One (6)4,5-Dichloropyrimidine (7)4,6-Dichloro-2-(Methylthio)Pyrimidine (9)4,6-Dichloro-2-Methylpyrimidine (7)4,6-Dichloropyrimidin-2-Amine (9)4,6-Dichloropyrimidine (14)4,6-Diphenylpyrimidine (7)4-(Dimethoxymethyl)Pyrimidine (5)4-(Piperazin-1-Yl)Pyrimidine (13)4-(Piperidin-1-Yl)Pyrimidine (8)4-(Pyridin-3-Yl)Pyrimidine (5)4-(Pyrimidin-2-Yl)Morpholine (9)4-(Pyrimidin-4-Yl)Morpholine (13)4-(Trifluoromethyl)Pyrimidin-2-Amine (6)4-(Trifluoromethyl)Pyrimidine (12)4-Amino-1-(Tetrahydrofuran-2-Yl)Pyrimidin-2(1H)-One (19)4-Bromopyrimidine (24)4-Chloro-2-(Methylthio)Pyrimidine (29)4-Chloro-2-Methoxypyrimidine (12)4-Chloro-2-Phenylpyrimidine (5)4-Chloro-5-Fluoro-2-Methylpyrimidine (5)4-Chloro-5-Iodopyrimidine (6)4-Chloro-5-Methoxypyrimidine (7)4-Chloro-5-Methylpyrimidine (8)4-Chloro-6-Methoxypyrimidine (5)4-Chloropyrimidin-2-Amine (23)4-Chloropyrimidin-5-Amine (7)4-Chloropyrimidine-5-Carbonitrile (6)4-Ethoxypyrimidine (6)4-Fluoropyrimidine (8)4-Iodopyrimidine (9)4-Methoxy-2-Methylpyrimidine (8)4-Methoxypyrimidin-2-Amine (6)4-Methoxypyrimidine (102)4-Methyl-2-(Methylthio)Pyrimidine (7)4-Methylpyrimidin-2-Amine (9)4-Methylpyrimidine (22)4-Phenoxypyrimidine (5)4-Phenylpyrimidin-2-Amine (15)5,6,7,8-Tetrahydropyrido[3,4-D]Pyrimidine (7)5,6,7,8-Tetrahydropyrido[4,3-D]Pyrimidine (17)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyrimidine (27)5-(Benzyloxy)Pyrimidine (5)5-Benzylpyrimidine (7)5-Bromo-1-(Tetrahydrofuran-2-Yl)Pyrimidine-2,4(1H,3H)-Dione (4)5-Bromo-2-(Methylthio)Pyrimidine (6)5-Bromo-2-Chloropyrimidine (6)5-Bromo-2-Methylpyrimidine (5)5-Bromo-4-Chloropyrimidine (4)5-Bromo-7H-Pyrrolo[2,3-D]Pyrimidine (3)5-Bromopyrimidin-4(3H)-One (3)5-Chloropyrimidin-4(3H)-One (4)5-Chloropyrimidine (8)5-Chloropyrimidine-2,4(1H,3H)-Dione (3)5-Ethylpyrimidine (5)5-Fluoro-1-(Tetrahydrofuran-2-Yl)Pyrimidin-2(1H)-One (7)5-Fluoro-1-(Tetrahydrofuran-2-Yl)Pyrimidine-2,4(1H,3H)-Dione (2)5-Fluoropyrimidin-4(3H)-One (3)5-Fluoropyrimidine (11)5-Fluoropyrimidine-2,4(1H,3H)-Dione (3)5-Iodo-7H-Pyrrolo[2,3-D]Pyrimidine (4)5-Iodopyrimidine (5)5-Methylpyrimidine (3)5-Phenylpyrimidine (16)5H-Pyrrolo[3,2-D]Pyrimidine (16)6,7-Dihydro-5H-Cyclopenta[D]Pyrimidine (5)6,7-Dihydro-5H-Pyrrolo[3,4-D]Pyrimidine (8)6-Chloro-1H-Pyrazolo[3,4-D]Pyrimidine (12)6-Chloropyrimidin-4-Amine (8)7-(Phenylsulfonyl)-7H-Pyrrolo[2,3-D]Pyrimidine (7)7H-Pyrrolo[2,3-D]Pyrimidin-2-Amine (5)7H-Pyrrolo[2,3-D]Pyrimidin-4-Amine (3)[1,2,4]Triazolo[1,5-A]Pyrimidine (14)Ethyl 4-Chloropyrimidine-5-Carboxylate (5)Ethyl Pyrazolo[1,5-A]Pyrimidine-3-Carboxylate (6)Ethyl Pyrimidine-4-Carboxylate (7)Ethyl Pyrimidine-5-Carboxylate (5)Imidazo[1,2-C]Pyrimidine (6)Methyl Pyrimidine-2-Carboxylate (10)Methyl Pyrimidine-4-Carboxylate (11)Methyl Pyrimidine-5-Carboxylate (5)N,N-Dimethylpyrimidin-2-Amine (10)N-(9-((2R,5S)-5-((Trityloxy)Methyl)Tetrahydrofuran-2-Yl)-9H-Purin-6-Yl)Benzamide (5)N-Benzyl-9H-Purin-6-Amine (6)N-Cyclopropylpyrimidin-2-Amine (5)N-Methyl-N-(4-Phenylpyrimidin-2-Yl)Methanesulfonamide (7)N-Methylpyrimidin-2-Amine (10)N-Methylpyrimidin-4-Amine (10)N-Phenyl-4-(Pyridin-3-Yl)Pyrimidin-2-Amine (5)N-Phenylpyrimidin-2-Amine (5)N-Phenylpyrimidin-4-Amine (7)N2,N4-Diphenylpyrimidine-2,4-Diamine (5)Pyrido[2,3-D]Pyrimidine (8)Pyrido[3,2-D]Pyrimidine (14)Pyrido[3,4-D]Pyrimidine (10)Pyrimidin-2-Ol (21)Pyrimidin-2-Ylmethanamine (7)Pyrimidin-2-Ylmethanol (5)Pyrimidin-4-Amine (29)Pyrimidin-4-Ol (25)Pyrimidin-5-Amine (6)Pyrimidin-5-Ol (5)Pyrimidin-5-Ylboronic Acid (9)Pyrimidine-2,4-Diamine (14)Pyrimidine-2-Carbonitrile (14)Pyrimidine-2-Carboxylic Acid (11)Pyrimidine-2-Thiol (6)Pyrimidine-4,6(1H,5H)-Dione (3)Pyrimidine-4-Carbonitrile (9)Pyrimidine-4-Carboxylic Acid (17)Pyrimidine-5-Carbaldehyde (38)Pyrimidine-5-Carbonitrile (6)Pyrimidine-5-Carboxylic Acid (7)Tetrahydropyrimidin-2(1H)-One (6)Thiazolo[5,4-D]Pyrimidine (5)Thieno[2,3-D]Pyrimidine (30)Thieno[3,2-D]Pyrimidine (24)
Pyrroles (4953)
Bromopyrrolo (8)Chloropyrrolo (10)Dihydropyrrolo (15)Octahydropyrrolo (6)Pyrrol-Amine (1)Pyrrolopyridine-Methylamine (6)(9H-Fluoren-9-Yl)Methyl Pyrrolidine-1-Carboxylate (26)(Z)-3-((1H-Pyrrol-2-Yl)Methylene)Indolin-2-One (8)1,3-Dihydro-2H-Pyrrolo[2,3-B]Pyridin-2-One (19)1,3-Dihydro-2H-Pyrrolo[3,2-B]Pyridin-2-One (11)1,4,5,6-Tetrahydropyrrolo[3,4-C]Pyrazole (6)1-(1H-Pyrrolo[2,3-B]Pyridin-3-Yl)Ethan-1-One (4)1-(Phenylsulfonyl)-1H-Pyrrole (24)1-(Phenylsulfonyl)-1H-Pyrrolo[2,3-B]Pyridine (30)1-Benzylpyrrolidin-2-One (18)1-Methyl-1H-Pyrrole (43)1H-Pyrrol-1-Amine (7)1H-Pyrrole-2-Carbaldehyde (21)1H-Pyrrole-2-Carbonitrile (7)1H-Pyrrole-2-Carboxylic Acid (30)1H-Pyrrole-3-Carbaldehyde (9)1H-Pyrrole-3-Carbonitrile (9)1H-Pyrrolo[2,3-B]Pyridin-6-Amine (4)1H-Pyrrolo[2,3-B]Pyridine-3-Carboxylic Acid (5)1H-Pyrrolo[2,3-C]Pyridin-7-Ol (3)2,3-Dihydro-1H-Pyrrolo[2,3-B]Pyridine (10)2,3-Dihydro-1H-Pyrrolo[3,4-C]Pyridine (5)2-Bromo-1H-Pyrrole (11)2-Methyl-1H-Pyrrole (49)2-Nitro-1H-Pyrrole (5)2-Phenyl-1H-Pyrrole (24)3,6-Di(Thiophen-2-Yl)-2,5-Dihydropyrrolo[3,4-C]Pyrrole-1,4-Dione (17)3-Bromo-1H-Pyrrole (16)3-Bromo-1H-Pyrrolo[2,3-B]Pyridine (7)3-Iodo-1H-Pyrrolo[3,2-C]Pyridine (4)3-Methyl-1H-Pyrrolo[2,3-B]Pyridine (5)3-Phenyl-1H-Pyrrole (5)3-Phenylpyrrolidine (26)4-Bromo-1H-Pyrrolo[2,3-B]Pyridine (9)4-Chloro-1H-Pyrrolo[2,3-B]Pyridine (13)4H-Thieno[3,2-B]Pyrrole (6)5-Bromo-1H-Pyrrolo[2,3-B]Pyridine (13)5-Chloro-1H-Pyrrolo[2,3-C]Pyridine (5)5-Methoxy-1H-Pyrrolo[2,3-C]Pyridine (4)5H-Pyrrolo[2,3-B]Pyrazine (14)5H-Pyrrolo[3,2-D]Pyrimidine (16)7-(Phenylsulfonyl)-7H-Pyrrolo[2,3-D]Pyrimidine (7)7-Methoxy-1H-Pyrrolo[2,3-C]Pyridine (5)Ethyl 1H-Pyrrole-2-Carboxylate (24)Ethyl 1H-Pyrrole-3-Carboxylate (8)Methyl 1H-Pyrrole-2-Carboxylate (30)Methyl 1H-Pyrrole-3-Carboxylate (5)Methyl 1H-Pyrrolo[2,3-B]Pyridine-3-Carboxylate (4)Methyl 1H-Pyrrolo[2,3-B]Pyridine-6-Carboxylate (3)Pyrrolo[2,1-F][1,2,4]Triazine (14)Tert-Butyl 1H-Pyrrole-1-Carboxylate (8)Tert-Butyl 1H-Pyrrole-2-Carboxylate (3)
Pyrrolidines (14879)
Acetylpyrrolidine (9)Benzylpyrrolidine (33)Bipyrrolidine (9)Bromopyrrolidine (7)Carbamoylpyrrolidine (5)Difluoropyrrolidine (16)Dimethylpyrrolidine (31)Dioxopyrrolidin (131)Ethylpyrrolidine (9)Fluoropyrrolidine (26)Formylpyrrolidine (10)Mercaptopyrrolidine (4)Methoxypyrrolidine (19)Methylenepyrrolidine (2)Methylpyrrolidine (129)Phenoxypyrrolidine (3)Pyrrolidine-Benzene-Boronic Acid/Ester (20)(3Ar,6As)-Octahydrocyclopenta[C]Pyrrole (5)(9H-Fluoren-9-Yl)Methyl Pyrrolidine-1-Carboxylate (26)(R)-3-(Pyrrolidin-2-Yl)Pyridine (9)(R)-3-Benzylpyrrolidine (6)(R)-3-Phenylpyrrolidine (8)(S)-3-Phenylpyrrolidine (14)(S)-N-(((S)-Tetrahydro-2H-Pyran-2-Yl)Methyl)Pyrrolidine-2-Carboxamide (4)(S)-N-(4-(Thiazol-5-Yl)Benzyl)Pyrrolidine-2-Carboxamide (7)(S)-N-Phenethyl-3-(Pyrrolidin-2-Yl)Propanamide (5)1-((Benzyloxy)Carbonyl)Pyrrolidine-3-Carboxylic Acid (6)1-(3-Chlorophenyl)Pyrrolidine (3)1-(Phenylsulfonyl)Pyrrolidine (15)1-(Pyrrolidin-1-Yl)Ethan-1-One (9)1-Benzyl 2-Methyl Pyrrolidine-1,2-Dicarboxylate (7)1-Benzylpyrrolidin-2-One (18)1-Benzylpyrrolidine (26)1-Methylpyrrolidin-2-One (13)1-Phenylpyrrolidin-2-One (18)2,2-Dimethylpyrrolidine (4)2,5-Dioxopyrrolidin-1-Yl ((Benzyloxy)Carbonyl)Glycinate (8)2,5-Dioxopyrrolidin-1-Yl Benzoate (8)2,8-Diazaspiro[4.5]Decan-3-One (6)2-((3-Phenylpropyl)Amino)-1-(Pyrrolidin-1-Yl)Ethan-1-One (2)2-(2-Chlorophenyl)Pyrrolidine (17)2-(2-Fluorophenyl)Pyrrolidine (16)2-(3-Fluorophenyl)Pyrrolidine (5)2-(Methoxymethyl)Pyrrolidine (6)2-(Pyrrolidin-1-Yl)Benzoic Acid (3)2-(Pyrrolidin-1-Yl)Pyridine (11)2-(Pyrrolidin-1-Yl)Pyrimidine (8)2-(Pyrrolidin-2-Yl)Acetic Acid (8)2-(Pyrrolidin-2-Yl)Pyridine (5)2-(Pyrrolidin-3-Yl)Acetic Acid (6)2-Amino-1-(Pyrrolidin-1-Yl)Ethan-1-One (5)2-Azabicyclo[2.2.1]Heptane (6)2-Methyl-1-Phenyl-1H-Pyrrole (8)2-Methylpyrrolidine (21)3,3-Difluoropyrrolidine (29)3-(Pyrrolidin-2-Yl)Pyridine (6)3-Aminopyrrolidin-2-One (5)3-Bromopyrrolidine (6)3-Hydroxypyrrolidin-2-One (4)3-Phenoxypyrrolidine (5)3-Phenyl-1-(Pyrrolidin-1-Yl)Propan-1-One (5)3-Phenylpyrrolidine (26)4-(Hydroxymethyl)Pyrrolidin-2-One (4)4-(Pyrrolidin-1-Yl)Aniline (3)4-(Pyrrolidin-1-Yl)Piperidine (6)4-Hydroxypyrrolidin-2-One (7)4-Phenylpyrrolidin-2-One (7)4H-Thieno[3,4-C]Pyrrole-4,6(5H)-Dione (7)5-(Aminomethyl)Pyrrolidin-2-One (3)5-(Hydroxymethyl)Pyrrolidin-2-One (7)5-Azaspiro[2.4]Heptane (13)5-Oxopyrrolidine-2-Carboxylic Acid (4)6-Azaspiro[3.4]Octane (4)Benzyl (S)-Pyrrolidin-3-Ylcarbamate (7)Benzyl 3-Hydroxypyrrolidine-1-Carboxylate (5)Benzyl-2-(Hydroxymethyl)Pyrrolidine-1-Carboxylate (9)Benzyl-3-Aminopyrrolidine-1-Carboxylate (7)Ethyl 5-Oxopyrrolidine-2-Carboxylate (3)Hexahydro-1H-Pyrrolizine (12)Methyl 5-Oxopyrrolidine-2-Carboxylate (3)Methyl Prolinate (43)Methyl Pyrrolidine-3-Carboxylate (9)N,N-Dimethylpyrrolidin-3-Amine (7)N-Methylpyrrolidin-3-Amine (6)Octahydrocyclopenta[C]Pyrrole (6)Phenyl(Pyrrolidin-1-Yl)Methanone (12)Proline (13)Pyrrolidin-2-Ylmethanamine (12)Pyrrolidin-2-Ylmethanol (26)Pyrrolidin-3-Ol (59)Pyrrolidin-3-Ylmethanamine (6)Pyrrolidin-3-Ylmethanol (13)Pyrrolidine-2-Carbonitrile (9)Pyrrolidine-2-Carboxamide (12)Pyrrolidine-3-Carbonitrile (6)Pyrrolidine-3-Carboxylic Acid (14)Tert-Butyl (2-Oxopyrrolidin-3-Yl)Carbamate (3)Tert-Butyl (5-Oxopyrrolidin-3-Yl)Carbamate (3)Tert-Butyl 2-Oxopyrrolidine-1-Carboxylate (15)Tert-Butyl 3-((Methylsulfonyl)Oxy)Pyrrolidine-1-Carboxylate (5)Tert-Butyl 3-Hydroxypyrrolidine-1-Carboxylate (20)Tert-Butyl 3-Methoxypyrrolidine-1-Carboxylate (6)Tert-Butyl Pyrrolidin-3-Ylcarbamate (12)Tert-Butyl Pyrrolidine-1-Carboxylate (21)
Pyrrolines (1763)
1,3-Dihydro-2H-Pyrrolo[2,3-C]Pyridin-2-One (5)1-Phenyl-1H-Pyrrole-2,5-Dione (12)2,3-Dihydro-1H-Pyrrolo[2,3-C]Pyridine (5)2,3-Dihydro-1H-Pyrrolo[3,2-C]Pyridine (7)2,5-Dihydro-1H-Pyrrol-2-One (5)2,5-Dihydro-1H-Pyrrole (13)2-Phenyl-2,5,6,7-Tetrahydropyrrolo[2,1-C][1,2,4]Triazol-4-Ium (6)3,4-Dihydro-2H-Pyrrole (5)3-Bromo-1H-Pyrrole-2,5-Dione (3)5,6-Dihydro-4H-Pyrrolo[1,2-B]Pyrazole (8)6,7-Dihydro-5H-Pyrrolo[1,2-A]Imidazole (9)6,7-Dihydro-5H-Pyrrolo[3,4-B]Pyridine (5)6,7-Dihydro-5H-Pyrrolo[3,4-D]Pyrimidine (8)
Quinazolines (3143)
Dichloroquinazoline (14)Iodoquinazoline (10)Methylquinazoline (46)Nitroquinazoline (20)Trichloroquinazoline (5)2,4-Dichloroquinazoline (19)2-(Trifluoromethyl)Quinazoline (4)2-Bromoquinazoline (4)2-Chloroquinazolin-4(3H)-One (4)2-Cyclopropylquinazoline (5)2-Mercaptoquinazolin-4(3H)-One (3)2-Methylquinazoline (20)4-Chloroquinazoline (39)4-Methylquinazoline (4)5,6,7,8-Tetrahydroquinazoline (8)5-Chloroquinazoline (4)6-Bromoquinazoline (7)7-Bromoquinazolin-4(3H)-One (4)7-Fluoroquinazolin-4(3H)-One (4)7-Methoxy-N-Phenylquinazolin-4-Amine (12)8-Bromoquinazoline (8)8-Chloroquinazoline (5)8-Fluoroquinazoline (4)8-Methoxyquinazoline (3)8-Methylquinazoline (3)Ethyl Quinazoline-2-Carboxylate (4)N-(3-Chlorophenyl)Quinazolin-4-Amine (9)Quinazolin-2-Amine (13)Quinazolin-2-Ol (7)Quinazolin-4-Amine (8)Quinazolin-4-Ol (10)
Quinolines (11910)
Iodoquinoline (32)1,2-Dihydroquinoline (5)1-Cyclopropyl-3-(4-(Quinolin-4-Yloxy)Phenyl)Urea (6)2,2'-Biquinoline (3)2,3,6,7-Tetrahydro-1H,5H-Pyrido[3,2,1-Ij]Quinoline (7)2-(Quinolin-2-Yl)-4,5-Dihydrooxazole (7)2-Hydroxyquinolin-4(1H)-One (3)2-Phenylquinoline (18)3,4-Dihydroisoquinoline (11)4-Oxo-1,4-Dihydroquinoline-3-Carboxylic Acid (3)4-Phenoxyquinoline (5)4-Phenylquinoline (9)6-Bromo-3,4-Dihydroquinolin-2(1H)-One (4)7,8-Dihydroquinolin-5(6H)-One (5)7-(Benzyloxy)Quinoline (6)7-Methoxy-3,4-Dihydroquinolin-2(1H)-One (3)N-Phenyl-N-(4-(Quinolin-4-Yloxy)Phenyl)Cyclopropane-1,1-Dicarboxamide (5)N-Phenylquinolin-4-Amine (11)
Quinoxalines (1411)
Dichloroquinoxaline (8)Dihydroquinoxalin (7)1,2,3,4-Tetrahydroquinoxaline (6)2-Chloroquinoxaline (39)2-Methylquinoxaline (5)2-Phenylquinoxaline (5)3,4-Dihydroquinoxalin-2(1H)-One (7)5-Bromoquinoxaline (6)6-Bromoquinoxaline (9)6-Chloroquinoxaline (3)6-Methoxyquinoxaline (6)Quinoxalin-2-Amine (3)Quinoxalin-2-Ol (4)
Quinuclidines (202)
Spiroes (4763)
Aminospiro (4)Azaspiro (246)Bromospiro (11)Diazaspiro (182)Dihydrospiro (18)Dioxaspiro (39)Fluorospiro (4)Oxospiro (22)Triazaspiro (13)1,3-Dihydrospiro[Indene-2,4'-Piperidine] (5)1,4-Dioxaspiro[4.5]Decane (17)2,8-Diazaspiro[4.5]Decane (5)2-Oxa-8-Azaspiro[4.5]Decane (5)3-Phenyloxetane (11)6-Azaspiro[3.4]Octane (4)7-Azaspiro[3.5]Nonane (7)9,9'-Spirobi[Fluorene] (19)Spiro[Cyclopropane-1,3'-Indolin]-2'-One (6)Spiro[Indene-2,4'-Piperidin]-1(3H)-One (5)Spiro[Indoline-3,4'-Piperidine] (5)
Tetrahydrofurans (2265)
Hydroxytetrahydrofuran (16)Iodotetrahydrofuran (3)Methoxytetrahydrofuran (11)Oxotetrahydrofuran (26)(2R,3S)-2-((Benzoyloxy)Methyl)Tetrahydrofuran-3-Yl Benzoate (8)(3Ar,6Ar)-Hexahydrofuro[3,2-B]Furan (5)(3As,6As)-Tetrahydrofuro[3,4-D][1,3]Dioxole (6)(R)-7-(Tetrahydrofuran-2-Yl)-7H-Pyrrolo[2,3-D]Pyrimidine (8)(R)-N-(9-(Tetrahydrofuran-2-Yl)-9H-Purin-6-Yl)Benzamide (5)(Tetrahydrofuran-2-Yl)Methanamine (4)(Tetrahydrofuran-2-Yl)Methanol (6)(Tetrahydrofuran-3-Yl)Methanamine (3)1,3-Dihydrobenzo[C][1,2]Oxaborole (20)1-(3-Fluorotetrahydrofuran-2-Yl)Pyrimidin-2(1H)-One (9)1-(5-(Hydroxymethyl)Tetrahydrofuran-2-Yl)Pyrimidine-2,4(1H,3H)-Dione (30)1-(Tetrahydrofuran-2-Yl)Pyrimidin-2(1H)-One (46)1-Oxa-8-Azaspiro[4.5]Decane (5)2-(Acetoxymethyl)-5-(9H-Purin-9-Yl)Tetrahydrofuran-3,4-Diyl Diacetate (6)2-(Hydroxymethyl)-5-(9H-Purin-9-Yl)Tetrahydrofuran-3,4-Diol (27)2-Oxa-8-Azaspiro[4.5]Decane (5)2-Oxabicyclo[2.1.1]Hexane (6)3-Aminodihydrofuran-2(3H)-One (4)3-Iodotetrahydrofuran (3)4-Amino-1-(Tetrahydrofuran-2-Yl)Pyrimidin-2(1H)-One (19)4-Fluoro-2-(Hydroxymethyl)-5-(9H-Purin-9-Yl)Tetrahydrofuran-3-Ol (4)4-Hydroxydihydrofuran-2(3H)-One (14)5-(Hydroxymethyl)Dihydrofuran-2(3H)-One (7)5-Bromo-1-(Tetrahydrofuran-2-Yl)Pyrimidine-2,4(1H,3H)-Dione (4)5-Fluoro-1-(Tetrahydrofuran-2-Yl)Pyrimidin-2(1H)-One (7)5-Fluoro-1-(Tetrahydrofuran-2-Yl)Pyrimidine-2,4(1H,3H)-Dione (2)5-Oxotetrahydrofuran-2-Carboxylic Acid (4)9-(Tetrahydrofuran-2-Yl)-9H-Purin-6-Amine (30)9-(Tetrahydrofuran-2-Yl)-9H-Purin-6-Ol (6)9-(Tetrahydrofuran-2-Yl)-9H-Purine (2)Dihydrofuran-3(2H)-One (7)Tert-Butyl (Tetrahydrofuran-3-Yl)Carbamate (4)Tetrahydrofuran-2-Carboxylic Acid (4)Tetrahydrofuran-3-Amine (6)Tetrahydrofuran-3-Carboxylic Acid (4)Tetrahydrofuran-3-Ol (7)
Tetrahydroisoquinolines (1291)
Tetrahydroisoquinoline-Carboxylic Acid (48)(9H-Fluoren-9-Yl)Methyl 3,4-Dihydroisoquinoline-2(1H)-Carboxylate (7)1,2,3,4-Tetrahydroisoquinolin-5-Amine (4)1,2,3,4-Tetrahydroisoquinolin-5-Ol (3)1,2,3,4-Tetrahydroisoquinolin-6-Amine (3)1,2,3,4-Tetrahydroisoquinolin-6-Ol (6)1,2,3,4-Tetrahydroisoquinolin-7-Amine (3)1,2,3,4-Tetrahydroisoquinoline-1-Carboxylic Acid (19)1,2,3,4-Tetrahydroisoquinoline-3-Carboxylic Acid (12)1,4-Dihydroisoquinolin-3(2H)-One (5)1-Methyl-1,2,3,4-Tetrahydroisoquinoline (4)2-Methyl-1,2,3,4-Tetrahydroisoquinoline (13)4,4-Dimethyl-1,2,3,4-Tetrahydroisoquinoline (3)5,6,7,8-Tetrahydroisoquinoline (5)5-Bromo-1,2,3,4-Tetrahydroisoquinoline (4)5-Chloro-1,2,3,4-Tetrahydroisoquinoline (3)5-Fluoro-1,2,3,4-Tetrahydroisoquinoline (3)5-Methyl-1,2,3,4-Tetrahydroisoquinoline (4)6-Bromo-1,2,3,4-Tetrahydroisoquinoline (4)6-Chloro-1,2,3,4-Tetrahydroisoquinoline (3)6-Fluoro-1,2,3,4-Tetrahydroisoquinoline (3)6-Methoxy-1,2,3,4-Tetrahydroisoquinoline (3)6-Nitro-1,2,3,4-Tetrahydroisoquinoline (3)7-Bromo-1,2,3,4-Tetrahydroisoquinoline (4)7-Chloro-1,2,3,4-Tetrahydroisoquinoline (5)7-Fluoro-1,2,3,4-Tetrahydroisoquinoline (3)7-Methoxy-1,2,3,4-Tetrahydroisoquinoline (6)7-Nitro-1,2,3,4-Tetrahydroisoquinoline (3)Isoquinoline-1,3(2H,4H)-Dione (7)
Tetrahydropyrans (3359)
Chroman-Amine (1)Difluorochroman (16)(1S,4Ar,7Ar)-1-(((S)-Tetrahydro-2H-Pyran-2-Yl)Oxy)-1,4A,5,7A-Tetrahydrocyclopenta[C]Pyran (4)(6-Phenoxytetrahydro-2H-Pyran-2-Yl)Methanol (17)(R)-2-Phenoxytetrahydro-2H-Pyran (7)(S)-2-(Phenylthio)Tetrahydro-2H-Pyran (5)(S)-7-(((S)-Tetrahydro-2H-Pyran-2-Yl)Oxy)-7,8,9,10-Tetrahydrotetracene-5,12-Dione (5)(S)-N-(((S)-Tetrahydro-2H-Pyran-2-Yl)Methyl)Pyrrolidine-2-Carboxamide (4)1-(Tetrahydro-2H-Pyran-4-Yl)-1H-Pyrazole (6)2-(Phenoxymethyl)Tetrahydro-2H-Pyran (5)2-Phenoxytetrahydro-2H-Pyran (6)2-Phenoxytetrahydro-2H-Pyran-4-Yl Acetate (6)4-Phenoxytetrahydro-2H-Pyran (5)9-Bromoanthracene (5)
Tetrahydroquinolines (1464)
Tetrahydroquinoline-Carboxylic Acid (18)1-Ethyl-1,2,3,4-Tetrahydroquinoline (6)1-Methyl-1,2,3,4-Tetrahydroquinoline (6)2,3-Dihydroquinolin-4(1H)-One (19)2-Methyl-1,2,3,4-Tetrahydroquinoline (3)4,4-Dimethyl-1,2,3,4-Tetrahydroquinoline (3)4-Methyl-1,2,3,4-Tetrahydroquinoline (2)5,6,7,8-Tetrahydroquinoline (17)6-Bromo-1,2,3,4-Tetrahydroquinoline (6)6-Chloro-1,2,3,4-Tetrahydroquinoline (3)6-Fluoro-1,2,3,4-Tetrahydroquinoline (3)7-Fluoro-1,2,3,4-Tetrahydroquinoline (3)Tert-Butyl 3,4-Dihydroquinoline-1(2H)-Carboxylate (11)
Tetrazoles (82)
1-Phenyl-1H-Tetrazole (6)5-Phenyl-1H-Tetrazole (23)5-Phenyl-2H-Tetrazole (9)
Thiadiazoles (2122)
1,2,3-Thiadiazole (8)1,2,4-Thiadiazole (15)1,2,5-Thiadiazole (6)1,3,4-Thiadiazol-2-Amine (9)2-Bromo-1,3,4-Thiadiazole (11)2-Methyl-1,3,4-Thiadiazole (12)2-Phenyl-1,3,4-Thiadiazole (19)4,7-Diphenylbenzo[C][1,2,5]Thiadiazole (6)4-Bromobenzo[C][1,2,5]Thiadiazole (14)Benzo[D][1,2,3]Thiadiazole (7)
Thiazines (62)
Thiazoles (6687)
Acetylthiazole (7)Bromothiazolo (9)Chlorothiazole (32)Chlorothiazolo (18)Cyanothiazole (7)Cyclopropylthiazole (11)Dibromothiazole (7)Dichlorothiazole (8)Dihydrothiazole (16)Dihydrothiazolo (14)Dimethylthiazole (22)Ethylthiazole (8)Formylthiazole (7)Methylthiazole (109)Nitrothiazol (8)Tetrahydrothiazolo (8)1-(Thiazol-2-Yl)Ethan-1-One (9)2,4-Dibromothiazole (5)2,4-Dichlorothiazole (4)2,4-Dimethylthiazole (7)2,5-Dibromothiazole (5)2,5-Dimethylthiazole (4)2-(Chloromethyl)Thiazole (5)2-(Methylthio)Thiazole (5)2-(Thiazol-4-Yl)Acetic Acid (9)2-(Trifluoromethyl)Thiazole (11)2-Bromo-4-Methylthiazole (7)2-Bromo-5-Methylthiazole (7)2-Chloro-4-Methylthiazole (5)2-Chloro-5-Methylthiazole (5)2-Chlorothiazole (32)2-Imino-N-((6R,7R)-8-Oxo-5-Thia-1-Azabicyclo[4.2.0]Oct-2-En-7-Yl)-2-(Thiazol-4-Yl)Acetamide (3)2-Isopropylthiazole (11)2-Methyl-4-Phenylthiazole (6)2-Phenoxythiazole (5)2-Phenylbenzo[D]Thiazole (16)2-Phenylthiazole-4-Carbaldehyde (9)4,5,6,7-Tetrahydrobenzo[D]Thiazole (14)4,5,6,7-Tetrahydrothiazolo[5,4-C]Pyridine (10)4,5-Dihydrothiazole (8)4-(4-Fluorophenyl)Thiazole (9)4-(Trifluoromethyl)Thiazole (7)4-Bromothiazole (10)4-Cyclopropylthiazole (6)4-Methyl-2-Phenylthiazole (6)4-Methylthiazol-2-Amine (7)4-Methylthiazole (5)4-Phenylthiazol-2-Amine (37)5,6-Dihydrobenzo[D]Thiazol-7(4H)-One (5)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Thiazole (7)5-Bromothiazol-2-Amine (6)5-Bromothiazole (8)5-Methyl-4-Phenylthiazole (5)5-Methylthiazol-2-Amine (6)5-Phenylthiazole (20)Ethyl 2-Aminothiazole-4-Carboxylate (6)Ethyl 2-Aminothiazole-5-Carboxylate (5)Ethyl 2-Phenylthiazole-4-Carboxylate (12)Ethyl 2-Phenylthiazole-5-Carboxylate (9)Ethyl Thiazole-2-Carboxylate (7)Ethyl Thiazole-4-Carboxylate (7)Ethyl Thiazole-5-Carboxylate (7)Methyl 2-Aminothiazole-4-Carboxylate (6)Methyl Thiazole-2-Carboxylate (6)Methyl Thiazole-4-Carboxylate (6)N-(Thiazol-2-Yl)Acetamide (9)N-(Thiazol-2-Yl)Benzamide (9)N-Phenylthiazol-2-Amine (9)Tert-Butyl Thiazol-2-Ylcarbamate (22)Thiazol-2-Ylmethanamine (5)Thiazol-2-Ylmethanol (9)Thiazol-5-Amine (6)Thiazole-2-Carbaldehyde (9)Thiazole-2-Carboxylic Acid (9)Thiazole-4-Carboxylic Acid (5)Thiazole-5-Carbaldehyde (19)Thiazole-5-Carbonitrile (7)Thiazole-5-Carboxylic Acid (10)Thiazolo[4,5-B]Pyridine (12)Thiazolo[5,4-B]Pyridine (13)Thiazolo[5,4-C]Pyridine (5)Thiazolo[5,4-D]Pyrimidine (5)
Thiazolidines (1260)
Thioxothiazolidin (23)(E)-5-Benzylidenethiazolidine-2,4-Dione (6)1,2,3-Oxathiazolidine 2,2-Dioxide (14)2-Thioxothiazolidin-4-One (6)Thiazolidine (16)
Thiomorpholines (454)
Thiomorpholine (10)Thiomorpholine 1,1-Dioxide (6)
Thiophenes (960)
Acetylthiophene (5)Aminothiophene (23)Bromothieno (29)Chlorothieno (41)Chlorothiophene (61)Cyanothiophene (5)Dibromothieno (5)Dibromothiophene (17)Dichlorothieno (10)Dichlorothiophene (13)Dihydrothieno (24)Dihydrothiophene (1)Dihydroxythiophene (7)Dimethylthieno (10)Dimethylthiophene (21)Dithiophene (40)Fluorothiophene (18)Formylthiophene (16)Hydroxythiophene (7)Iodothieno (6)Iodothiophene (13)Methylthieno (27)Nitrothiophene (27)Terthiophene (10)Tetrahydrothieno (17)Thiophenecarboxaldehyde (10)Thiphen-Amine-Hydrochloride (58)Trithiophene (5)(9H-Fluoren-9-Yl)Methyl (2-(Thiophen-2-Yl)Ethyl)Carbamate (5)1-(Thiophen-2-Yl)Ethan-1-One (17)2,2'-Bithiophene (25)2,2':5',2''-Terthiophene (9)2,3-Dihydrothieno[3,4-B][1,4]Dioxine (9)2,5-Dibromothiophene (18)2,5-Diphenylthiophene (5)2-(Thiophen-2-Yl)Pyridine (5)2-(Trifluoromethyl)Thiophene (11)2-Chlorothiophene (20)2-Ethynylthiophene (8)2-Iodothiophene (14)2-Methoxythiophene (7)2-Nitrothiophene (20)3-Bromothiophene (6)3-Chlorothiophene (17)3-Fluorothiophene (6)3-Methoxythiophene (9)3-Methylthiophene (14)3-Nitrothiophene (6)3-Phenylthiophene (13)4,4,5,5-Tetramethyl-2-(Thiophen-2-Yl)-1,3,2-Dioxaborolane (23)4,4,5,5-Tetramethyl-2-(Thiophen-3-Yl)-1,3,2-Dioxaborolane (10)4,5,6,7-Tetrahydrothieno[2,3-C]Pyridine (10)4,5,6,7-Tetrahydrothieno[3,2-C]Pyridine (9)4,7-Di(Thiophen-2-Yl)Benzo[C][1,2,5]Thiadiazole (9)4,8-Di(Thiophen-2-Yl)Benzo[1,2-B:4,5-B']Dithiophene (8)4-Phenyl-6H-Thieno[3,2-F][1,2,4]Triazolo[4,3-A][1,4]Diazepine (5)4H-Cyclopenta[2,1-B:3,4-B']Dithiophene (9)4H-Thieno[3,2-B]Pyrrole (6)4H-Thieno[3,4-C]Pyrrole-4,6(5H)-Dione (7)5,6-Dihydro-4H-Cyclopenta[B]Thiophene (7)5-(Thiophen-2-Yl)Isoxazole (5)5-Benzyl-4,5,6,7-Tetrahydrothieno[3,2-C]Pyridine (7)5-Phenylthiophen-2-Amine (5)Benzo[1,2-B:4,5-B']Dithiophene (7)Dibenzo[B,D]Thiophene (22)Dihydrothiophen-3(2H)-One (4)Dithieno[3,2-B:2',3'-D]Thiophene (5)Ethyl Thiophene-2-Carboxylate (19)Ethyl Thiophene-3-Carboxylate (11)Methyl Thiophene-3-Carboxylate (34)N,N-Diphenyl-4-(Thiophen-2-Yl)Aniline (5)Phenyl(Thiophen-2-Yl)Methanone (6)Thieno[2,3-B]Pyridine (22)Thieno[2,3-C]Pyridine (14)Thieno[2,3-D]Pyrimidine (30)Thieno[3,2-B]Pyridine (18)Thieno[3,2-B]Thiophene (19)Thieno[3,2-C]Pyridine (13)Thieno[3,2-D]Pyrimidine (24)Thieno[3,4-B]Thiophene (5)Thiophen-2-Ylboronic Acid (20)Thiophen-2-Ylmethanol (11)Thiophen-3-Amine (18)Thiophen-3-Ol (6)Thiophene-2-Carbaldehyde (43)Thiophene-2-Carbonitrile (23)Thiophene-3-Carbaldehyde (17)Thiophene-3-Carbonitrile (13)Thiophene-3-Carboxamide (5)Thiophene-3-Carboxylic Acid (8)
Triazines (1387)
1,2,4-Triazine (9)1,3,5-Triazin-2-Amine (3)2,4,6-Triphenoxy-1,3,5-Triazine (4)2,4,6-Triphenyl-1,3,5-Triazine (24)2,4-Diphenyl-1,3,5-Triazine (6)2-Chloro-1,3,5-Triazine (10)2-Methoxy-1,3,5-Triazine (10)2-Phenyl-1,3,5-Triazine (6)N2,N4,N6-Triphenyl-1,3,5-Triazine-2,4,6-Triamine (4)Pyrrolo[2,1-F][1,2,4]Triazine (14)
Triazoles (7749)
(5As,10Br)-2-Phenyl-2,5A,6,10B-Tetrahydro-4H-Indeno[2,1-B][1,2,4]Triazolo[4,3-D][1,4]Oxazin-11-Ium (6)1-(Phenylsulfonyl)-1H-1,2,4-Triazole (6)1-Benzyl-1H-1,2,3-Triazole (8)1-Benzyl-1H-1,2,4-Triazole (6)1-Methyl-1H-1,2,3-Triazole (9)1-Methyl-1H-1,2,4-Triazole (17)1-Methyl-1H-Benzo[D][1,2,3]Triazole (10)1-Phenethyl-1H-1,2,4-Triazole (6)1-Phenyl-1H-1,2,3-Triazole (7)1-Phenyl-1H-1,2,4-Triazole (20)1H-1,2,4-Triazol-3-Amine (7)1H-1,2,4-Triazol-5-Amine (6)2-Bromo-[1,2,4]Triazolo[1,5-A]Pyridine (6)2-Phenyl-2,5,6,7-Tetrahydropyrrolo[2,1-C][1,2,4]Triazol-4-Ium (6)2-Phenyl-2H-1,2,3-Triazole (7)2-Phenyl-2H-Benzo[D][1,2,3]Triazole (8)2H-1,2,3-Triazole (7)4-(4-Cyclopropylnaphthalen-1-Yl)-4H-1,2,4-Triazole (7)4-Phenyl-4H-1,2,4-Triazole (6)4-Phenyl-6H-Thieno[3,2-F][1,2,4]Triazolo[4,3-A][1,4]Diazepine (5)4H-1,2,4-Triazole (13)5-Bromo-1H-1,2,4-Triazole (6)5-Bromo-1H-Benzo[D][1,2,3]Triazole (5)5-Fluoro-1H-Benzo[D][1,2,3]Triazole (4)6-Bromo-[1,2,4]Triazolo[1,5-A]Pyridine (12)6-Bromo-[1,2,4]Triazolo[4,3-A]Pyridine (8)8-Bromo-[1,2,4]Triazolo[1,5-A]Pyridine (6)[1,2,4]Triazolo[1,5-A]Pyrazine (9)[1,2,4]Triazolo[1,5-A]Pyridin-2-Amine (17)[1,2,4]Triazolo[4,3-A]Pyridin-3-Ylmethanamine (5)Ethyl 1H-1,2,4-Triazole-3-Carboxylate (3)
Other Aliphatic Heterocycles (6209)
1,3-Dioxane (20)1,4-Diazepane (12)3-Azabicyclo[3.1.0]Hexane (14)
Other Aromatic Heterocycles (37751)
Indolizine (15)Phenazine (8)
NHCs
Achiral NHCs Catalysts (35)
Achiral NHCs Ligands (110)
Chiral NHCs Catalysts (138)
Chiral NHCs Ligands (84)
Organic Building Blocks
Acyl Chlorides (3025)
2-Chlorobenzoyl Chloride (13)2-Phenoxyacetyl Chloride (3)2-Phenylacetyl Chloride (9)
Alcohols (45771)
Amino-Propanol (6)Cyclopropylethanol (6)Diethanol (23)Diethanol (23)Dihydroxybenzylidene (4)Dihydroxynaphthalene (7)Dihydroxypropanoate (7)Dihydroxyterephthalic Acid (3)Hydroxyacetamide (1)Hydroxyacetimidamide (3)Hydroxyadamantan (4)Hydroxyadamantan (4)Hydroxyazetidine (7)Hydroxybenzyl (18)Hydroxybenzylidene (5)Hydroxybicyclo (7)Hydroxybutan (4)Hydroxybutan (4)Hydroxybutanoate (36)Hydroxybutanoic (33)Hydroxycarbamimidoyl (2)Hydroxycinnamic Acid (2)Hydroxycyclobutyl (3)Hydroxycyclohexyl (7)Hydroxycyclopentyl (1)Hydroxydiphenylmethyl (2)Hydroxyethoxy (22)Hydroxyethoxy (22)Hydroxyhexanoate (8)Hydroxyhexanoic (6)Hydroxyimino (11)Hydroxyisonicotinaldehyde (7)Hydroxyisonicotinate (5)Hydroxyisonicotinic (5)Hydroxyisonicotinic (5)Hydroxyisonicotinic Acid (4)Hydroxymethyl-Phenyl-Boronic-Acid (31)Hydroxynaphthalene (29)Hydroxynicotinaldehyde (7)Hydroxynicotinate (13)Hydroxynicotinonitrile (6)Hydroxyoctadec (1)Hydroxyoctadec (1)Hydroxyoctadecanoic (7)Hydroxypentanoate (6)Hydroxypropanoic (35)Pentahydroxyhexanal (9)Phenyl-Methanol (3)Propanediol (9)Propanediol (9)Tetrahydroxy (25)Tetrahydroxy (25)Tetrahydroxyhexanal (9)Tetrahydroxypentanal (5)Trihydroxy (246)Trihydroxy (246)(1-Methyl-1H-Pyrazol-3-Yl)Methanol (7)(1-Phenylcyclopropyl)Methanol (3)(1H-Benzo[D]Imidazol-2-Yl)Methanol (14)(1H-Indol-2-Yl)Methanol (8)(2-(Trifluoromethyl)Phenyl)Methanol (10)(2-Bromo-6-Fluorophenyl)Methanol (4)(2-Bromophenyl)Methanol (39)(2-Chlorophenyl)Methanol (39)(2-Fluorophenyl)Methanol (60)(2-Iodophenyl)Methanol (12)(2-Nitrophenyl)Methanol (29)(3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Phenyl)Methanol (7)(3-(Trifluoromethoxy)Phenyl)Methanol (4)(3-(Trifluoromethyl)Phenyl)Methanol (21)(3-Chlorophenyl)Methanol (38)(3-Fluorophenyl)Methanol (58)(3-Iodophenyl)Methanol (13)(3-Methylpyridin-2-Yl)Methanol (10)(3-Nitrophenyl)Methanol (31)(3-Phenoxyphenyl)Methanol (3)(3-Phenylisoxazol-5-Yl)Methanol (7)(4-Fluorophenyl)Methanol (29)(4-Nitrophenyl)Methanol (17)(6-Methylpyridin-2-Yl)Methanol (5)(Tetrahydrofuran-2-Yl)Methanol (6)1,2-Diphenylethan-1-Ol (8)1-Phenyl-1H-Pyrazol-3-Ol (3)1-Phenylethan-1-Ol (102)2,2,2-Trifluoro-1-Phenylethan-1-Ol (27)2-(1H-Indol-3-Yl)Ethan-1-Ol (10)2-(2-Chlorophenyl)Ethan-1-Ol (8)2-(Piperazin-1-Yl)Ethan-1-Ol (10)2-(Piperidin-1-Yl)Ethan-1-Ol (10)2-(Piperidin-2-Yl)Ethan-1-Ol (8)2-(Piperidin-4-Yl)Ethan-1-Ol (5)2-Amino-2-(2-Fluorophenyl)Ethan-1-Ol (7)2-Amino-2-(Anthracen-9-Yl)Ethan-1-Ol (4)2-Amino-2-Phenylethan-1-Ol (196)2-Hydroxy-1,2-Diphenylethan-1-One (3)2-Hydroxy-1-Phenylethan-1-One (8)2-Hydroxyethyl Benzoate (3)2-Phenoxyethan-1-Ol (14)2-Phenylethan-1-Ol (77)2-Phenylpropan-2-Ol (21)3-Phenylpropan-1-Ol (24)4-Fluoro-2-(Hydroxymethyl)-5-(9H-Purin-9-Yl)Tetrahydrofuran-3-Ol (4)4-Phenylpiperidin-4-Ol (10)Azetidin-2-Ylmethanol (7)Azetidin-3-Ol (11)Benzyl 3-(Hydroxymethyl)Piperazine-1-Carboxylate (6)Benzyl-2-(Hydroxymethyl)Pyrrolidine-1-Carboxylate (9)Bicyclo[1.1.1]Pentan-1-Ylmethanol (3)Cyclobutanol (46)Cyclobutylmethanol (15)Cyclohexanol (72)Cyclohexylmethanol (31)Cyclopentanol (51)Diphenylmethanol (20)Isoxazol-3-Ylmethanol (3)Isoxazol-5-Ylmethanol (5)M-Tolylmethanol (34)Morpholin-2-Ylmethanol (12)Morpholin-3-Ylmethanol (14)Naphthalen-1-Ylmethanol (8)O-Tolylmethanol (35)Oxiran-2-Ylmethanol (3)Piperidin-2-Ylmethanol (11)Piperidin-3-Ol (27)Piperidin-3-Ylmethanol (15)Piperidin-4-Ylmethanol (11)Pyridin-2-Ylmethanol (65)Pyridin-3-Ylmethanol (39)Pyridin-4-Ylmethanol (16)Pyrimidin-2-Ylmethanol (5)Pyrrolidin-2-Ylmethanol (26)Pyrrolidin-3-Ylmethanol (13)Quinazolin-2-Ol (7)Tert-Butyl 3-(Hydroxymethyl)-1H-Indole-1-Carboxylate (10)Thiazol-2-Ylmethanol (9)Thiophen-2-Ylmethanol (11)Triphenylmethanol (13)
Aldehydes (18914)
Aminonicotinaldehyde (5)Aminonicotinaldehyde (5)Carboxyaldehyde (1094)Dicarbaldehyde (37)Dicarbaldehyde (37)Formylisonicotinate (7)Tetracarbaldehyde (8)Tetracarbaldehyde (8)Tricarbaldehyde (10)1-Methyl-1H-Indole-3-Carbaldehyde (9)1-Naphthaldehyde (23)1-Phenyl-1H-Pyrazole-4-Carbaldehyde (8)1H-Benzo[D]Imidazole-2-Carbaldehyde (5)1H-Indazole-3-Carbaldehyde (19)1H-Indole-2-Carbaldehyde (20)1H-Pyrazole-4-Carbaldehyde (30)1H-Pyrrole-2-Carbaldehyde (21)1H-Pyrrole-3-Carbaldehyde (9)1H-Pyrrolo[2,3-B]Pyridine-3-Carbaldehyde (14)1H-Pyrrolo[2,3-B]Pyridine-5-Carbaldehyde (5)2,3-Dichlorobenzaldehyde (7)2,3-Difluorobenzaldehyde (18)2,4-Dichlorobenzaldehyde (8)2,4-Difluorobenzaldehyde (19)2,6-Dibromobenzaldehyde (4)2,6-Difluorobenzaldehyde (25)2-(Benzyloxy)Benzaldehyde (13)2-(Phenylethynyl)Benzaldehyde (9)2-(Trifluoromethoxy)Benzaldehyde (7)2-(Trifluoromethyl)Benzaldehyde (27)2-Bromo-3-Hydroxybenzaldehyde (4)2-Bromo-3-Methoxybenzaldehyde (4)2-Bromo-6-Fluorobenzaldehyde (15)2-Chloro-3-Hydroxybenzaldehyde (4)2-Chloro-3-Methoxybenzaldehyde (7)2-Chloro-4-Fluorobenzaldehyde (10)2-Fluoro-3-Methylbenzaldehyde (8)2-Fluorobenzaldehyde (175)2-Hydroxy-3-Iodobenzaldehyde (3)2-Iodobenzaldehyde (17)2-Methyl-1H-Indole-3-Carbaldehyde (3)2-Naphthaldehyde (12)2-Nitrobenzaldehyde (53)2-Oxo-2-Phenylacetaldehyde (12)2-Phenylacetaldehyde (20)3-(Benzyloxy)Benzaldehyde (13)3-(Trifluoromethoxy)Benzaldehyde (10)3-(Trifluoromethyl)Benzaldehyde (31)3-Bromo-2-Chlorobenzaldehyde (4)3-Bromo-2-Fluorobenzaldehyde (9)3-Bromo-2-Hydroxybenzaldehyde (10)3-Bromo-4-Fluorobenzaldehyde (7)3-Bromo-4-Hydroxybenzaldehyde (9)3-Bromo-4-Methoxybenzaldehyde (9)3-Chloro-2-Fluorobenzaldehyde (9)3-Chloro-2-Hydroxybenzaldehyde (5)3-Chloro-4-Methoxybenzaldehyde (7)3-Chlorobenzaldehyde (106)3-Fluorobenzaldehyde (137)3-Iodobenzaldehyde (28)3-Methoxy-2-Nitrobenzaldehyde (3)3-Nitrobenzaldehyde (49)3-Phenoxybenzaldehyde (7)4-(1H-Imidazol-1-Yl)Benzaldehyde (7)4-(Benzyloxy)Benzaldehyde (23)4-(Piperazin-1-Yl)Benzaldehyde (5)4-Fluorobenzaldehyde (78)4-Hydroxy-3-Nitrobenzaldehyde (5)4-Morpholinobenzaldehyde (8)4-Nitrobenzaldehyde (18)4-Phenoxybenzaldehyde (12)5-Phenylfuran-2-Carbaldehyde (9)6-Methoxynicotinaldehyde (4)[1,1'-Biphenyl]-3-Carbaldehyde (20)[1,1'-Biphenyl]-4-Carbaldehyde (31)Benzo[B]Thiophene-2-Carbaldehyde (7)Benzo[B]Thiophene-3-Carbaldehyde (6)Benzo[D][1,3]Dioxole-5-Carbaldehyde (6)Benzofuran-2-Carbaldehyde (5)Furan-2-Carbaldehyde (22)Imidazo[1,2-A]Pyridine-2-Carbaldehyde (8)Imidazo[1,2-A]Pyridine-3-Carbaldehyde (9)Isonicotinaldehyde (68)Methyl 3-Formylbenzoate (23)Nicotinaldehyde (153)Picolinaldehyde (98)Pyrazine-2-Carbaldehyde (17)Pyrimidine-5-Carbaldehyde (38)Thiazole-2-Carbaldehyde (9)Thiazole-5-Carbaldehyde (19)Thiophene-2-Carbaldehyde (43)Thiophene-3-Carbaldehyde (17)
Aliphatic Chain Hydrocarbons (12579)
Acetylthio (7)Acetylthio (7)Azanonadecan (7)Azanylylidene (1)Azapentadecan (10)Azapentadecan (10)Azatridecan (4)Butyloctyl (4)Butyloctyl (4)Carbonylbis (2)Carbonylbis (2)Diazirine (13)Diazirine (13)Didodecyl (7)Didodecyl (7)Diethyl (73)Diethyl (73)Dihydroxypropan (6)Diisobutyl (2)Diisopropyl (27)Diisopropyl (27)Dimethoxy (306)Dimethyladamantane (14)Dimethyladamantane (14)Dimethylalkanes (7)Dinonyl (1)Dinonyl (1)Dioctyl (1)Dioxide (451)Dioxide (451)Ethoxy (711)Ethoxyethoxy (5)Ethoxyethoxy (5)Ethoxyethyl (16)Ethoxyethyl (16)Ethoxymethyl (11)Ethoxymethylene (1)Ethoxymethylene (1)Isopropylidenebis (2)Isopropylsulfonyl (10)Isopropylsulfonyl (10)Methoxybut (2)Methoxybut (2)Methoxyethoxy (67)Methoxyethoxy (67)Methoxyethyl (69)Methoxyisonicotinic (11)Methoxyisonicotinic (11)Methoxymethoxy (23)Methoxymethoxy (23)Methoxymethyl (117)Methoxynicotinic (26)Methoxynicotinic (26)Methoxynicotinic Acid (20)Methoxypropan (24)Methoxypropan (24)Methoxypropoxy (8)Methoxypropoxy (8)Methoxypropyl (10)Methoxytetrahydro (14)Methoxytetrahydro (14)Methyladamantan (4)Methylisonicotinic (13)Oxoethoxy (1)Oxopropane (10)Oxopropyl (32)Oxopropyl (32)Pentyloxy (7)Tetramethoxy (6)Trimethoxy (15)Trimethoxy (15)Yldisulfanyl (7)
Aliphatic Cyclic Hydrocarbons (11046)
Aminobicyclo (24)Aminocyclobutanol (5)Aminocyclobutyl (5)Aminocyclohexane (55)Aminocyclohexanol (21)Aminocyclopentanol (17)Aminocyclopentyl (6)Aminocyclopropyl (4)Azabicyclo (292)Azabicyclo (292)Azatricyclo (5)Azatricyclo (5)Azetidine (185)Azetidine (185)Benzylazetidin (9)Bicyclo (61)Bicyclohexyl (6)Bromobicyclo (9)Butylcyclohexyl (9)Butylsulfonyl (6)Chlorocyclopropyl (2)Cyanoazetidine (5)Cyanocyclopropyl (4)Cyclobutanecarbonitrile (2)Cyclobutylacetic (4)Cyclobutylmethyl (4)Cyclobutylmethyl (4)Cyclodextrin (1)Cyclodextrin (1)Cyclohexa (176)Cyclohexa (176)Cyclohexane (127)Cyclohexane (127)Cyclohexanecarboxylic (19)Cyclohexanediamine (8)Cyclohexanone (92)Cyclohexylacetic (2)Cyclohexylamino (9)Cyclohexylbutanoic (4)Cyclohexylcarbamoyl (5)Cyclohexylethanamine (12)Cyclohexylmethoxy (4)Cyclohexylmethoxy (4)Cyclohexylmethyl (7)Cyclohexylmethyl (7)Cyclohexyloxy (10)Cyclohexylpropan (94)Cyclohexylpropanoic (9)Cyclopentadienyl (2)Cyclopentane (169)Cyclopentane (169)Cyclopentanecarboxylic (7)Cyclopentyl (56)Cyclopentyl (56)Cyclopentylacetic (3)Cyclopentylamino (1)Cyclopentylmethyl (4)Cyclopentyloxy (16)Cyclopentyloxy (16)Cyclopentylpropanoic (1)Cyclopropanamine (32)Cyclopropanamine (32)Cyclopropanecarbonitrile (14)Cyclopropanecarbonyl (6)Cyclopropanecarbonyl (6)Cyclopropanecarboxamide (14)Cyclopropanol (4)Cyclopropoxyphenyl (7)Cyclopropyl (355)Cyclopropyl (355)Cyclopropylacetate (6)Cyclopropylacetic (3)Cyclopropylamino (24)Cyclopropylcarbamoyl (5)Cyclopropylethan (5)Cyclopropylethan (5)Cyclopropylethynyl (1)Cyclopropylmethoxy (32)Cyclopropylmethoxy (32)Cyclopropylmethyl (22)Cyclopropylmethyl (22)Cyclopropylpropanoic (5)Cyclopropylsulfonyl (6)Cyclopropylsulfonyl (6)Diazabicyclo (77)Diazabicyclo (77)Dicyclohexyl (6)Dicyclohexyl (6)Dicyclohexylphosphino (18)Dicyclohexylphosphino (18)Difluorocyclobutyl (6)Difluorocyclohexyl (7)Dihydroinden (8)Dihydroindeno (5)Dihydroindeno (5)Dihydropteridin (6)Dimethylbicyclo (5)Dimethylbicyclo (5)Dimethylcyclohex (5)Dimethylcyclohexane (16)Dimethylcyclohexanone (7)Dioxathiolane (1)Dioxathiolane (1)Dioxol (175)Dithiolan (1)Dithiolan (1)Ethylcyclohexyl (4)Ethylcyclohexyl (4)Ethylsulfonyl (42)Fluoroazetidine (1)Fluorobicyclo (4)Hexahydrocyclohepta (6)Hexahydrocyclohepta (6)Hexahydrocyclopenta (4)Hydroxycyclobutanecarboxylic (4)Hydroxycyclohexanecarboxylic (6)Methanesulfonyl (314)Methanesulfonyl (314)Methoxycyclohexanamine (6)Methylazetidine (30)Methylbicyclo (6)Methylbicyclo (6)Methylcyclobutanamine (5)Methylcyclobutanecarboxylic (5)Methylcyclohexanamine (12)Methylcyclohexane (8)Methylcyclohexane (8)Methylcyclohexanecarboxylic (5)Methylcyclohexanecarboxylic Acid (4)Methylcyclohexanol (21)Methylcyclohexanone (5)Methylcyclohexyl (33)Methylcyclopentane (2)Methylcyclopropanamine (4)Methylcyclopropanamine (4)Methylcyclopropane (16)Methylsulfinyl (24)Methylsulfonimidoyl (6)Methylsulfonimidoyl (6)Methylsulphonyl (10)Octahydrocyclopenta (14)Oxabicyclo (40)Oxabicyclo (40)Oxazepane (13)Oxetanes (228)Oxoazetidine (8)Oxoazetidine (8)Oxobicyclo (11)Oxobicyclo (11)Oxocyclobutyl (2)Oxocyclohex (3)Oxocyclohexane (4)Oxocyclohexane (4)Oxocyclohexanecarboxylic (6)Oxocyclohexyl (3)Oxocyclohexyl (3)Oxocyclopentane (2)Oxocyclopentyl (5)Pentamethylcyclopentadienyl (11)Pentylcyclohexyl (10)Pentylcyclohexyl (10)Phenylcyclopropanamine (8)Propylcyclohexyl (15)Propylcyclohexyl (15)Tetraazacyclododecane (13)Tetraazacyclododecane (13)Tetraazacyclotetradecane (7)Tetraazacyclotetradecane (7)Tetramethylcyclohexane (4)Tetraoxatridecan (3)Tetraoxatridecan (3)Thiazepine (2)Tricyclohexylphosphine (9)Trimethylbicyclo (21)Trimethylcyclohex (20)Trimethylcyclohexane (1)Trimethylcyclohexane (1)(1-Phenylcyclobutyl)Methanamine (9)(1-Phenylcyclopropyl)Methanamine (12)(1-Phenylcyclopropyl)Methanol (3)(3Ar,E)-4-((Z)-2-(2-Methylenecyclohexylidene)Ethylidene)Octahydro-1H-Indene (7)(4-Cyclohexylphenyl)Boronic Acid (7)(4-Pentylcyclohexyl)Benzene (5)(4-Propylcyclohexyl)Benzene (5)(9H-Fluoren-2-Yl)Boronic Acid (6)(9H-Fluoren-9-Yl)Methyl (4-Methoxybenzyl)Carbamate (7)(Cyclopropylmethoxy)Benzene (18)1,1-Difluorocyclobutane (14)1,1-Difluorocyclohexane (18)1,1-Difluorocyclopentane (5)1-Bromo-2-Cyclopropylbenzene (3)1-Bromo-3-Cyclopropylbenzene (6)1-Chloro-2-Cyclopropylbenzene (7)1-Cyclohexyl-2-Fluorobenzene (4)1-Cyclopropyl-3-Methylbenzene (3)1-Methylcyclohex-1-Ene (26)1-Phenylcyclobutan-1-Amine (5)1-Phenylcyclobutane-1-Carbonitrile (7)1-Phenylcyclobutane-1-Carboxylic Acid (16)1-Phenylcyclohexane-1-Carboxylic Acid (6)1-Phenylcyclopropan-1-Amine (26)1-Phenylcyclopropane-1-Carbonitrile (19)1-Phenylcyclopropane-1-Carboxylic Acid (23)2-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-2-Phenylacetic Acid (5)2-Bromo-9,9-Diphenyl-9H-Fluorene (5)2-Bromo-9H-Fluorene (15)2-Cyclohexylacetic Acid (14)2-Cyclopropyl-4-Phenylquinoline (12)2-Cyclopropylpyridine (20)2-Cyclopropylpyrimidine (10)2-Iodo-9H-Fluorene (8)2-Methylcyclohexan-1-One (3)2-Phenylcyclopropan-1-Amine (19)3,3-Dimethylcyclohexan-1-One (4)3-Cyclopropylpyridine (28)3-Methylcyclohexan-1-One (9)4-Cyclohexylbenzoic Acid (6)4-Cyclohexylbenzonitrile (10)4-Cyclohexylphenol (7)5-Azaspiro[2.4]Heptane (13)6-Azaspiro[2.5]Octane (10)9,9-Dimethyl-9H-Fluorene (16)Bicyclo[1.1.1]Pentan-1-Ylmethanol (3)Bicyclo[1.1.1]Pentane-1-Carboxylic Acid (6)Bicyclo[2.2.1]Hept-2-Ene (18)Bicyclo[2.2.1]Heptane (15)Bromocyclohexane (7)Cyclobutanamine (90)Cyclobutanecarboxylic Acid (23)Cyclobutanol (46)Cyclobutylmethanol (15)Cycloheptane (12)Cyclohex-3-Ene-1-Carboxylic Acid (7)Cyclohexanamine (59)Cyclohexanecarboxylic Acid (83)Cyclohexanol (72)Cyclohexylmethanol (31)Cyclopentanamine (5)Cyclopentanecarboxylic Acid (26)Cyclopentanol (51)Cyclopropoxybenzene (13)Ethyl 1-Phenylcyclopropane-1-Carboxylate (4)Ethyl 2-Phenylcyclopropane-1-Carboxylate (5)Ethyl Cyclohexanecarboxylate (33)Isopropylcyclohexane (19)Methoxycyclohexane (7)Methyl 1-Phenylcyclopropane-1-Carboxylate (10)Methyl 4-Oxocyclohexane-1-Carboxylate (5)Methyl Bicyclo[1.1.1]Pentane-1-Carboxylate (10)Methyl Cyclobutanecarboxylate (24)Methyl Cyclohexanecarboxylate (45)Methyl Cyclopentanecarboxylate (18)N-Methylcyclohexanamine (7)Naphthalene-1,4-Dione (23)Spiro[3.3]Heptane (11)Tert-Butyl (1-Phenylcyclopropyl)Carbamate (6)Tert-Butyl (2-Phenylcyclopropyl)Carbamate (3)Tert-Butyl Bicyclo[1.1.1]Pentan-1-Ylcarbamate (5)Tert-Butyl Cyclobutylcarbamate (17)Tert-Butyl Cyclohexylcarbamate (9)Tert-Butyl Cyclopentylcarbamate (28)
Alkenyls (16078)
Acrylaldehyde (11)Acryloyl (9)Acryloyl (9)Annulene (2)Cyclohexene (88)Cyclooctene (9)Cyclopentene (3)Diacrylamide (6)Diallyl (5)Diazene (21)Divinyl (1)Divinyl (1)Enamide (6)Enamide (6)Enecarbaldehyde (2)Enoyl (9)Methacrylamide (3)Methacrylamide (3)Methoxycinnamaldehyde (3)Nitroethylene (37)Tetrahydrocyclopenta (19)(1E,4E)-1,5-Diphenylpenta-1,4-Dien-3-One (7)(1E,6E)-1,7-Diphenylhepta-1,6-Diene-3,5-Dione (7)(2,2-Dibromovinyl)Benzene (6)(2-(4-Bromophenyl)Ethene-1,1,2-Triyl)Tribenzene (11)(2-Nitrovinyl)Benzene (28)(Allyloxy)Benzene (19)(E)-5-Benzylidenethiazolidine-2,4-Dione (6)(E)-[3,3'-Biindolinylidene]-2,2'-Dione (5)(E)-N-(3-Oxo-1-Phenyl-3-(Piperidin-1-Yl)Prop-1-En-2-Yl)Benzamide (6)(Z)-3-(Phenyl(Phenylamino)Methylene)Indolin-2-One (5)(Z)-3-Benzylideneindolin-2-One (7)1,2-Diphenylethene (5)1,3,3-Trimethylcyclohex-1-Ene (12)1-Bromo-4-Styrylbenzene (5)1-Methylcyclohex-1-Ene (26)2-Benzalacetophenone (36)2-Methoxycyclohexa-2,5-Diene-1,4-Dione (7)2-Methylcyclohexa-2,5-Diene-1,4-Dione (5)3-(2-Fluorophenyl)Acrylic Acid (17)3-(3-Chlorophenyl)Acrylic Acid (10)3-Methylene-2,3-Dihydro-1H-Inden-1-One (5)3-Methyleneazetidine (8)3-Phenylacrylaldehyde (29)3-Styrylphenol (11)4-(1,2,2-Triphenylvinyl)Benzaldehyde (5)4-(Prop-1-En-2-Yl)Cyclohex-1-Ene (5)5H-Dibenzo[B,F]Azepine (4)Allyl Benzoate (5)Cyclohex-1-En-1-Yl Trifluoromethanesulfonate (3)Cyclohex-1-En-1-Ylboronic Acid (4)Cyclohex-1-Ene-1-Carboxylic Acid (4)Cyclohexa-1,3-Diene (5)Cyclopent-2-En-1-Amine (4)Ethyl Cyclohex-1-Ene-1-Carboxylate (5)Methyl Cinnamate (36)Methyl Cyclohex-3-Ene-1-Carboxylate (3)Methylenecyclobutane (8)Methylenecyclohexane (8)N-Phenylacrylamide (7)Styrene (81)Tert-Butyl-Cyclopent-2-En-1-Ylcarbamate (6)Vinylcyclopropane (8)
Alkyls (195)
Isopropyl-Phenyl-Boronic Acid/Ester (26)Methylpentan (11)
Alkynyls (2698)
(Bromoethynyl)Benzene (5)(Prop-2-Yn-1-Yloxy)Benzene (13)1,3,5-Tris(Phenylethynyl)Benzene (6)1,4-Bis(Phenylethynyl)Benzene (7)1,4-Diphenylbuta-1,3-Diyne (9)1-Ethynyl-2-Fluorobenzene (10)1-Methyl-4-(Phenylethynyl)Benzene (7)2-(Phenylethynyl)Benzaldehyde (9)2-Ethynylpyridine (31)2-Ethynylthiophene (8)3-Ethynylpyridine (22)4-(Phenylethynyl)-1,1'-Biphenyl (5)4-(Phenylethynyl)Phenol (7)4-Ethynylpyridine (10)9,10-Bis(Phenylethynyl)Anthracene (5)Ethynylbenzene (145)Trimethyl(Phenylethynyl)Silane (23)
Amides (90371)
Acetamide (651)Acetamide (651)Acetamido (156)Carboxamide (929)Carboxamide (929)Diacetamide (3)Dicarboxamide (19)Diethylacetamide (4)Diethylacetamide (4)Dimethylacetamide (9)Dimethylnicotinamide (7)Dimethylnicotinamide (7)Formamidophenylboronic Acid/Ester (11)Isobutyramide (7)Oxobutanamide (10)Oxobutanamide (10)Pentanamide (18)Pentanamide (18)Propanamide (2)Propanamido (5)Propanamido (5)(3-(Phenylcarbamoyl)Phenyl)Boronic Acid (3)(4-(Phenylcarbamoyl)Phenyl)Boronic Acid (11)(9H-Fluoren-9-Yl)Methyl (3-Phenylpropyl)Carbamate (24)(S)-N-Phenethyl-3-(Pyrrolidin-2-Yl)Propanamide (5)(S)-N-Phenylpiperidine-2-Carboxamide (1)1-(Pyridin-2-Yl-L2-Azaneyl)Ethan-1-One (12)1-Methylindoline-2,3-Dione (8)1-Phenylurea (11)1H-Pyrazole-5-Carboxamide (3)2,2-Dimethyl-1-(Pyridin-2-Yl-L2-Azaneyl)Propan-1-One (7)2-((Tert-Butoxycarbonyl)Amino)Benzoic Acid (11)2-(Trifluoromethyl)Benzamide (6)2-Amino-3-Phenylpropanamide (8)2-Amino-N-Phenylbenzamide (21)2-Aminobenzamide (30)2-Bromo-N-Phenylacetamide (5)2-Chloro-N-Phenylacetamide (26)2-Chloro-N-Phenylbenzamide (4)2-Chlorobenzamide (16)2-Fluoro-N-Methylbenzamide (12)2-Fluorobenzamide (32)2-Hydroxy-N-Phenylbenzamide (3)2-Hydroxybenzamide (14)2-Iodobenzamide (4)2-Methoxybenzamide (9)3-Benzamidopropanoic Acid (3)3-Bromo-4-Fluorobenzamide (3)3-Fluorobenzamide (26)3-Nitrobenzamide (17)3-Oxo-N-Phenylbutanamide (10)4-Amino-N-Phenylbenzamide (7)4-Benzamidobenzoic Acid (3)4-Fluorobenzamide (19)4-Oxo-4-(Phenylamino)Butanoic Acid (7)Benzoylglycine (15)Benzyl Benzylcarbamate (16)Benzyl Cyclohexylcarbamate (9)Benzyl Phenylcarbamate (15)Ethyl 2-Oxo-2-(Phenylamino)Acetate (8)Isonicotinamide (12)N,N-Diethylbenzamide (17)N,N-Dimethylbenzamide (34)N-((5R,6R)-7-Oxo-4-Thia-1-Azabicyclo[3.2.0]Heptan-6-Yl)-3-Phenylisoxazole-4-Carboxamide (1)N-((6R,7R)-8-Oxo-5-Thia-1-Azabicyclo[4.2.0]Oct-2-En-7-Yl)-2-Phenylacetamide (5)N-(2-(1H-Indol-3-Yl)Ethyl)Acetamide (5)N-(2-Benzoylphenyl)-2-Bromoacetamide (3)N-(2-Chlorophenyl)Acetamide (16)N-(2-Iodophenyl)Acetamide (8)N-(2-Nitrophenyl)Acetamide (11)N-(3-Fluorophenyl)Acetamide (14)N-(4-Aminophenyl)Benzamide (2)N-(4-Chlorophenyl)Acetamide (9)N-(4-Chlorophenyl)Benzamide (6)N-(4-Fluorophenyl)Benzamide (3)N-(4-Phenoxyphenyl)Acetamide (4)N-(O-Tolyl)Benzamide (9)N-(P-Tolyl)Benzamide (6)N-(Thiazol-2-Yl)Acetamide (9)N-Isopropylbenzamide (16)N-Methoxy-N-Methylbenzamide (24)N-Methylbenzamide (58)N-Methylpicolinamide (10)N-Phenylacrylamide (7)N-Phenylpivalamide (11)Nicotinamide (64)Phenyl Dimethylcarbamate (5)Phenyl Ethyl(Methyl)Carbamate (5)Picolinamide (26)Piperidine-3-Carboxamide (5)Pyrazine-2-Carboxamide (10)Pyrrolidine-2-Carboxamide (12)Tert-Butyl (1-Phenylethyl)Carbamate (19)Tert-Butyl (4-Fluorophenyl)Carbamate (9)Tert-Butyl Benzylcarbamate (52)Tert-Butyl Methyl(Phenyl)Carbamate (9)Tert-Butyl O-Tolylcarbamate (11)Tert-Butyl Phenethylcarbamate (12)Tert-Butyl-Cyclopent-2-En-1-Ylcarbamate (6)Thiophene-3-Carboxamide (5)
Amidines (1564)
Carbamimidoyl (16)Benzimidamide (50)N'-Hydroxybenzimidamide (13)Picolinimidamide (11)
Amines (139951)
Amino-Carboxylate (2)Amino-Propanol (6)Aminoacetamido (4)Aminoacetyl (2)Aminoadamantan (5)Aminoadamantan (5)Aminoazepane (10)Aminobutane (23)Aminobutane (23)Aminobutyl (15)Aminobutyl (15)Aminoethoxy (18)Aminoethoxy (18)Aminoethyl (157)Aminoethyl (157)Aminohexan (6)Aminohexyl (3)Aminohexyl (3)Aminoisonicotinic Acid (12)Aminomethyl (403)Aminomethyl (403)Aminooxy (6)Aminopentyl (10)Aminopentyl (10)Aminopropanamido (1)Aminopropane (20)Aminopropane (20)Aminopropoxy (2)Aminopropoxy (2)Aminotetrahydro (12)Aminotetrahydro (12)Benzylazetidine (4)Bromobenzylamine (6)Bromobenzylcarbamate (28)Butoxycarbonylamino (8)Butylcarbamoyl (5)Carbamothioyl (2)Carbamoyl (114)Chlorobenzylamine (4)Chroman-Amine (1)Diamino (90)Diamino (90)Diaminopteridin (3)Diaminopteridin (3)Dibutylamino (6)Dibutylamino (6)Dichlorobenzylamine (5)Diethylamino (91)Diethylamino (91)Diisopropylamino (1)Dimethyl-Ethylamine (2)Dimethylamino (490)Dimethylamino (490)Dimethylcarbamoyl (14)Dimethylmethanamine (16)Dipropylamino (1)Dipropylamino (1)Ethylamino (37)Ethylamino (37)Fluindamine (32)Hydroxyamino (3)Hydroxyamino (3)Imidazol-Amine (1)Methoxyethanamine (1)Methoxyethanamine (1)Methoxyimino (2)Methylamino (241)Methylamino (241)Methylcarbamoyl (19)Methylcarbamoyl (19)Propanediamine (6)Propylamino (5)Propylamino (5)Pyrrol-Amine (1)Pyrrolopyridine-Methylamine (6)Silanamine (3)Triamine (25)Triamine (25)(1-Phenylcyclobutyl)Methanamine (9)(1-Phenylcyclopropyl)Methanamine (12)(1H-Benzo[D]Imidazol-2-Yl)Methanamine (7)(2,3-Dihydrobenzo[B][1,4]Dioxin-2-Yl)Methanamine (3)(2-Aminophenyl)(Phenyl)Methanone (30)(2-Bromophenyl)Methanamine (12)(2-Chlorophenyl)Methanamine (28)(2-Fluorophenyl)Methanamine (49)(3-Chlorophenyl)Methanamine (19)(3-Fluoropyridin-2-Yl)Methanamine (5)(3-Methylpyridin-2-Yl)Methanamine (5)(4-Aminophenyl)(Phenyl)Methanone (4)(4-Fluorophenyl)Methanamine (27)(6-Methylpyridin-2-Yl)Methanamine (6)(Tetrahydrofuran-2-Yl)Methanamine (4)(Tetrahydrofuran-3-Yl)Methanamine (3)1,2,3,4-Tetrahydroisoquinolin-5-Amine (4)1,2,3,4-Tetrahydroisoquinolin-6-Amine (3)1,2,3,4-Tetrahydroisoquinolin-7-Amine (3)1,2-Diphenylethan-1-Amine (15)1,3,4-Thiadiazol-2-Amine (9)1,3,5-Triazin-2-Amine (3)1-(2,3-Dihydro-1H-Inden-5-Yl)Ethan-1-Amine (3)1-(2-Aminophenyl)Ethan-1-One (29)1-(2-Bromophenyl)Ethan-1-Amine (10)1-(2-Chlorophenyl)-1H-Pyrazole (3)1-(2-Fluorophenyl)Ethan-1-Amine (80)1-(2-Fluorophenyl)Propan-1-Amine (8)1-(3-(Trifluoromethoxy)Phenyl)Ethan-1-Amine (6)1-(3-(Trifluoromethyl)Phenyl)Ethan-1-Amine (25)1-(3-Aminophenyl)Ethan-1-One (18)1-(3-Chlorophenyl)-N-Methylmethanamine (8)1-(4-(Trifluoromethoxy)Phenyl)Ethan-1-Amine (6)1-(Anthracen-9-Yl)Ethan-1-Amine (3)1-(Pyridin-2-Yl)Ethan-1-Amine (15)1-(Pyridin-3-Yl)Ethan-1-Amine (17)1-(Pyridin-4-Yl)Ethan-1-Amine (23)1-Aminoanthracene-9,10-Dione (8)1-Benzyl-N-Methylpiperidin-3-Amine (6)1-Benzylpiperidin-4-Amine (8)1-Methyl-1H-Pyrazol-3-Amine (14)1-Phenyl-1H-Pyrazol-3-Amine (3)1-Phenyl-1H-Pyrazol-5-Amine (4)1-Phenylcyclobutan-1-Amine (5)1-Phenylcyclopropan-1-Amine (26)1-Phenylethan-1-Amine (436)1H-1,2,4-Triazol-3-Amine (7)1H-1,2,4-Triazol-5-Amine (6)1H-Benzo[D]Imidazol-2-Amine (7)1H-Benzo[D]Imidazol-5-Amine (4)1H-Benzo[D]Imidazol-6-Amine (6)1H-Imidazol-2-Amine (6)1H-Indazol-3-Amine (23)1H-Indazol-4-Amine (12)1H-Indazol-5-Amine (3)1H-Indazol-6-Amine (5)1H-Indazol-7-Amine (6)1H-Indol-4-Amine (10)1H-Indol-6-Amine (21)1H-Indol-7-Amine (10)1H-Pyrazol-4-Amine (6)1H-Pyrazol-5-Amine (19)1H-Pyrrol-1-Amine (7)1H-Pyrrolo[2,3-B]Pyridin-6-Amine (4)2,2,2-Trifluoro-1-Phenylethan-1-Amine (48)2,3-Dichloroaniline (18)2,3-Difluoroaniline (34)2,3-Dihydrobenzofuran-3-Amine (11)2,3-Dihydrobenzofuran-5-Amine (3)2,4-Dibromoaniline (18)2,4-Dichloropyrimidin-5-Amine (6)2,4-Difluoroaniline (44)2,5-Difluoroaniline (34)2,6-Dibromoaniline (17)2,6-Dichloroaniline (27)2,6-Difluoroaniline (23)2,6-Diiodoaniline (8)2-((2-Nitrophenyl)Amino)Ethan-1-Ol (5)2-((3-Phenylpropyl)Amino)-1-(Pyrrolidin-1-Yl)Ethan-1-One (2)2-(1H-Benzo[D]Imidazol-2-Yl)Ethan-1-Amine (6)2-(1H-Indol-3-Yl)Ethan-1-Amine (4)2-(Diethylamino)Ethyl Benzoate (3)2-(Methylsulfonyl)Aniline (3)2-(Phenylamino)Benzoic Acid (11)2-(Piperazin-1-Yl)Ethan-1-Amine (8)2-(Piperidin-1-Yl)Ethan-1-Amine (8)2-(Trifluoromethoxy)Aniline (18)2-(Trifluoromethyl)Aniline (58)2-Amino-2-(2-Fluorophenyl)Ethan-1-Ol (7)2-Amino-2-Phenylethan-1-Ol (196)2-Amino-3,3-Diphenylpropanoic Acid (4)2-Amino-3-Chlorophenol (4)2-Amino-3-Fluorobenzoic Acid (11)2-Amino-6-Bromophenol (3)2-Amino-6-Chlorobenzoic Acid (5)2-Amino-6-Chlorobenzonitrile (3)2-Amino-6-Chlorophenol (5)2-Aminobenzamide (30)2-Aminobenzenesulfonic Acid (9)2-Aminophenol (107)2-Aminopyrimidin-4(3H)-One (11)2-Bromo-3-Chloroaniline (4)2-Bromo-3-Fluoroaniline (13)2-Bromo-3-Methylaniline (6)2-Bromo-4-Methylaniline (14)2-Bromo-6-Methylaniline (11)2-Bromo-N,N-Dimethylaniline (5)2-Bromo-N-Methylaniline (8)2-Chloro-3-Methylaniline (4)2-Chloro-4-Methylaniline (7)2-Chloro-6-Methylaniline (11)2-Chloro-N-Methylaniline (4)2-Chloro-N-Phenylaniline (7)2-Chloroaniline (214)2-Chlorobenzene-1,3-Diamine (3)2-Chlorobenzene-1,4-Diamine (6)2-Chloropyrimidin-4-Amine (22)2-Fluoro-6-Iodoaniline (7)2-Fluoro-N-Phenylaniline (4)2-Fluoroaniline (262)2-Iodo-4-Methylaniline (5)2-Iodo-N,N-Dimethylaniline (3)2-Iodoaniline (87)2-Methoxypyridin-3-Amine (6)2-Methyl-6-Nitroaniline (10)2-Methyl-N-Phenylaniline (6)2-Methylpyridin-4-Amine (7)2-Methylpyrimidin-4-Amine (22)2-Nitro-N-Phenylaniline (3)2-Phenoxyaniline (4)2-Phenylcyclopropan-1-Amine (19)2-Phenylpyrimidin-5-Amine (5)3,4-Dibromoaniline (4)3,4-Dichloroaniline (21)3,4-Difluoroaniline (44)3-(1,3,2-Dioxaborinan-2-Yl)Aniline (3)3-(Benzyloxy)Aniline (12)3-(Methylsulfonyl)Aniline (7)3-(Piperazin-1-Yl)Aniline (3)3-(Trifluoromethoxy)Aniline (22)3-(Trifluoromethyl)Aniline (102)3-Aminobenzenesulfonic Acid (6)3-Aminodihydrofuran-2(3H)-One (4)3-Bromo-2-Fluoroaniline (15)3-Bromo-4-Chloroaniline (13)3-Bromo-4-Fluoroaniline (22)3-Bromo-4-Methoxyaniline (7)3-Bromo-4-Methylaniline (14)3-Bromoaniline (187)3-Bromobenzene-1,2-Diamine (11)3-Chloro-2-Iodoaniline (3)3-Chloro-2-Methylaniline (11)3-Chloro-4-Fluoroaniline (18)3-Chloro-4-Iodoaniline (3)3-Chloro-4-Methoxyaniline (6)3-Chloro-4-Methylaniline (12)3-Chlorobenzene-1,2-Diamine (6)3-Chloropyrazin-2-Amine (6)3-Fluoro-2-Methylaniline (9)3-Fluoroaniline (289)3-Iodo-2-Methylaniline (4)3-Iodoaniline (32)3-Methoxypyridin-2-Amine (5)3-Methyl-N-Phenylaniline (4)3-Methylpyridin-2-Amine (7)3-Nitroaniline (98)3-Phenoxyaniline (2)3-Phenyl-1H-Pyrazol-5-Amine (11)3-Phenylisoxazol-5-Amine (8)4,6-Dichloropyrimidin-2-Amine (9)4-(Benzyloxy)Aniline (8)4-(Oxazol-5-Yl)Aniline (3)4-(Pyrrolidin-1-Yl)Aniline (3)4-(Trifluoromethoxy)Aniline (26)4-Amino-2-Chlorobenzonitrile (8)4-Amino-2-Fluorophenol (9)4-Amino-3-Chlorobenzoic Acid (6)4-Amino-3-Chlorophenol (5)4-Amino-N-Phenylbenzenesulfonamide (3)4-Aminopyridazin-3(2H)-One (4)4-Benzylaniline (7)4-Bromo-3-Chloroaniline (21)4-Bromo-3-Fluoroaniline (29)4-Bromo-3-Methylaniline (19)4-Bromo-3-Nitroaniline (8)4-Bromo-N,N-Diphenylaniline (10)4-Bromo-N-Phenylaniline (6)4-Chloro-2-Iodoaniline (9)4-Chloro-3-Fluoroaniline (17)4-Chloro-3-Iodoaniline (3)4-Chloro-3-Methylaniline (11)4-Chloro-N-Phenylaniline (6)4-Chloropyrimidin-2-Amine (23)4-Chloropyrimidin-5-Amine (7)4-Fluoro-N-Phenylaniline (4)4-Fluoroaniline (225)4-Iodo-N,N-Diphenylaniline (3)4-Methoxy-N-Phenylaniline (5)4-Methyl-3-Nitroaniline (8)4-Methylpyrimidin-2-Amine (9)4-Methylthiazol-2-Amine (7)4-Morpholinoaniline (4)4-Nitroaniline (65)4-Phenoxyaniline (6)4-Phenylpyrimidin-2-Amine (15)4-Phenylthiazol-2-Amine (37)5-Bromopyrazin-2-Amine (13)5-Bromothiazol-2-Amine (6)5-Chloropyrazin-2-Amine (9)5-Methoxypyridin-3-Amine (4)5-Methyl-2-Nitroaniline (6)5-Methylpyridin-2-Amine (7)5-Methylpyridin-3-Amine (4)5-Methylthiazol-2-Amine (6)5-Phenylthiophen-2-Amine (5)5H-Dibenzo[B,F]Azepine (4)6-Amino-2H-Benzo[B][1,4]Oxazin-3(4H)-One (3)6-Bromopyrazin-2-Amine (5)6-Chloropyrazin-2-Amine (11)6-Chloropyridazin-3-Amine (5)6-Chloropyrimidin-4-Amine (8)6-Methoxypyridin-2-Amine (14)6-Methoxypyridin-3-Amine (8)6-Methylpyridin-2-Amine (46)6-Methylpyridin-3-Amine (5)6-Phenoxypyridin-3-Amine (5)7-Methoxy-N-Phenylquinazolin-4-Amine (12)7H-Purin-2-Amine (6)7H-Purin-6-Amine (9)7H-Pyrrolo[2,3-D]Pyrimidin-2-Amine (5)7H-Pyrrolo[2,3-D]Pyrimidin-4-Amine (3)9H-Purin-6-Amine (3)[1,1'-Biphenyl]-2-Amine (8)[1,1'-Biphenyl]-3-Amine (11)[1,2,4]Triazolo[1,5-A]Pyridin-2-Amine (17)[1,2,4]Triazolo[4,3-A]Pyridin-3-Ylmethanamine (5)Azetidin-3-Amine (4)Azetidin-3-Ylmethanamine (3)Aziridine (9)Benzo[B]Thiophen-2-Amine (5)Benzo[D]Oxazol-2-Amine (16)Benzo[D]Thiazol-2-Amine (29)Benzo[D]Thiazol-5-Amine (3)Benzo[D]Thiazol-6-Amine (3)Benzyl-3-Aminopiperidine-1-Carboxylate (6)Benzyl-3-Aminopyrrolidine-1-Carboxylate (7)Bis(Pyridin-2-Ylmethyl)Amine (6)Chroman-2-Ylmethanamine (3)Chroman-3-Amine (3)Chroman-4-Amine (20)Cyclobutanamine (90)Cyclohexanamine (59)Cyclopent-2-En-1-Amine (4)Cyclopentanamine (5)Cyclopropyl(Phenyl)Methanamine (22)Diphenylmethanamine (26)Ethyl 2-Aminobenzoate (23)Ethyl 3-Aminobenzoate (19)Ethyl 4-Aminobenzoate (23)Imidazo[1,2-A]Pyridin-3-Amine (7)Imidazo[1,2-A]Pyridin-8-Amine (7)Isoquinolin-1-Amine (18)Isoquinolin-3-Amine (13)Isoquinolin-4-Amine (16)Isoquinolin-5-Amine (9)Isoquinolin-8-Amine (6)Isoxazol-5-Amine (15)Methyl 2-Amino-2-Phenylacetate (38)Methyl 2-Aminobenzoate (95)Methyl 3-Amino-3-Phenylpropanoate (27)Methyl 3-Aminobenzoate (88)Methyl 4-Aminobenzoate (71)Methyl L-Phenylalaninate (20)Morpholin-2-Ylmethanamine (8)N,N-Diethylaniline (17)N,N-Dimethyl-2-Phenoxyethan-1-Amine (17)N,N-Dimethylaniline (117)N,N-Dimethylnaphthalen-1-Amine (4)N,N-Dimethylpyridin-2-Amine (10)N,N-Dimethylpyridin-4-Amine (6)N,N-Dimethylpyrimidin-2-Amine (10)N,N-Dimethylpyrrolidin-3-Amine (7)N,N-Diphenyl-4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Aniline (6)N,N-Diphenyl-[1,1'-Biphenyl]-4-Amine (8)N-(4-Aminophenyl)Benzamide (2)N-(Furan-2-Ylmethyl)Aniline (5)N-(Prop-2-Yn-1-Yl)-2,3-Dihydro-1H-Inden-1-Amine (3)N-Benzyl-1-Phenylethan-1-Amine (7)N-Benzyl-2-Phenylethan-1-Amine (1)N-Benzylpiperidin-4-Amine (3)N-Cyclopropylpyrimidin-2-Amine (5)N-Methyl-1,2-Diphenylethan-1-Amine (7)N-Methyl-1-Phenylmethanamine (65)N-Methyl-2-Nitroaniline (20)N-Methyl-4-Nitroaniline (6)N-Methylaniline (140)N-Methylcyclohexanamine (7)N-Methylpiperidin-3-Amine (5)N-Methylpyridin-2-Amine (47)N-Methylpyridin-3-Amine (15)N-Methylpyrimidin-2-Amine (10)N-Methylpyrimidin-4-Amine (10)N-Methylpyrrolidin-3-Amine (6)N-Phenyl-3-(Trifluoromethyl)Aniline (3)N-Phenyl-4-(Trifluoromethyl)Aniline (3)N-Phenylnaphthalen-1-Amine (5)N-Phenylpyridin-2-Amine (9)N-Phenylpyrimidin-2-Amine (5)N-Phenylpyrimidin-4-Amine (7)N1,N1-Diphenylbenzene-1,4-Diamine (2)N1-Phenylbenzene-1,4-Diamine (3)N2,N4,N6-Triphenyl-1,3,5-Triazine-2,4,6-Triamine (4)N2,N4-Diphenylpyrimidine-2,4-Diamine (5)Naphthalen-2-Amine (12)O-Benzylhydroxylamine (16)Oxazol-2-Amine (8)Phenylmethanamine (315)Piperidin-2-Ylmethanamine (6)Piperidin-3-Amine (17)Piperidin-3-Ylmethanamine (5)Piperidin-4-Amine (14)Piperidin-4-Ylmethanamine (7)Pyrazin-2-Amine (22)Pyrazin-2-Ylmethanamine (12)Pyridazin-3-Amine (18)Pyridazin-4-Amine (10)Pyridin-2-Amine (29)Pyridin-2-Ylmethanamine (38)Pyridin-3-Amine (21)Pyridin-3-Ylmethanamine (29)Pyridin-4-Amine (22)Pyridin-4-Ylmethanamine (12)Pyridine-2,3-Diamine (5)Pyridine-2,6-Diamine (12)Pyrimidin-2-Ylmethanamine (7)Pyrimidin-4-Amine (29)Pyrimidin-5-Amine (6)Pyrimidine-2,4-Diamine (14)Pyrrolidin-2-Ylmethanamine (12)Pyrrolidin-3-Ylmethanamine (6)Quinazolin-2-Amine (13)Quinazolin-4-Amine (8)Quinoxalin-2-Amine (3)Tetrahydrofuran-3-Amine (6)Thiazol-2-Ylmethanamine (5)Thiazol-5-Amine (6)Thiophen-3-Amine (18)Tri([1,1'-Biphenyl]-4-Yl)Amine (9)
Anhydrides (659)
Dianhydride (3)1H,3H-Benzo[De]Isochromene-1,3-Dione (8)Furan-2,5-Dione (8)
Aryls (187653)
Acetylbenzonitrile (3)Aminobenzyl (7)Benzylamine (21)Benzylamino (47)Benzylhydroxylamine (25)Benzylidene (16)Benzylidene (16)Benzyloxy (1061)Benzylthio (16)Benzylthio (16)Cyanobenzyl (12)Dibenzyl (15)Dibenzylamino (7)Dichlorobenzylidene (8)Difluorobenzyl (17)Dimethoxybenzyl (20)Dimethoxybenzyl (20)Dimethylbenzonitrile (25)Dimethylbenzyl (6)Dimethylbenzyl (6)Dimethylbenzylamine (6)Ethoxybenzyl (8)Ethoxybenzyl (8)Fluorobenzyl (132)Fluorobenzylidene (2)Formylbenzonitrile (35)Iodobenzyl (9)Isopropylbenzonitrile (4)Methoxybenzyl (176)Methoxybenzylamine (7)Methoxybenzylidene (6)Methylbenzonitrile (104)Methylbenzyl (73)Methylbenzyl (73)Methylbenzylamine (8)Methylbenzylidene (1)Methylbenzylidene (1)Nitrobenzyl (33)Nitrobenzylidene (2)Phenoxybenzonitrile (5)Trifluorobenzyl (2)(6-Phenoxytetrahydro-2H-Pyran-2-Yl)Methanol (17)(8S,9S,14R)-1,2,6,7,8,9,10,11,12,13,14,15,16,17-Tetradecahydro-3H-Cyclopenta[A]Phenanthren-3-One (1)(9H-Fluoren-9-Yl)Methyl (2-(Tritylthio)Ethyl)Carbamate (10)(9H-Fluoren-9-Yl)Methyl Cyclohexylcarbamate (8)(Benzylsulfonyl)Benzene (11)(Cyclopentyloxy)Benzene (12)1,1-Dimethylcyclopropane (5)1,3,4,5-Tetrahydro-2H-Benzo[B]Azepin-2-One (15)1,3-Diphenylurea (24)1-(2-Hydroxyphenyl)-2-Phenylethan-1-One (6)1-(2-Hydroxyphenyl)-3-Phenylprop-2-En-1-One (11)1-([1,1'-Biphenyl]-4-Yl)Ethan-1-One (5)1-(Naphthalen-2-Yl)Ethan-1-One (3)1-Benzyl-4-Chlorobenzene (6)1-Benzyl-4-Fluorobenzene (2)1-Bromonaphthalene (4)1-Chloronaphthalene (24)1-Fluoronaphthalene (23)1-Methoxynaphthalene (17)1-Methyl-4-(Phenylethynyl)Benzene (7)1-Methylnaphthalene (10)1-Naphthaldehyde (23)1-Naphthoic Acid (23)1-Nitronaphthalene (3)10H-Phenothiazine (20)2,2',3,3',5,5',6,6'-Octafluoro-1,1'-Biphenyl (4)2,5-Diphenylthiophene (5)2-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Phenol (7)2-(Trifluoromethyl)-1,1'-Biphenyl (8)2-Benzylaniline (5)2-Bromo-1,1'-Biphenyl (12)2-Bromonaphthalene (4)2-Chloro-1,1'-Biphenyl (8)2-Chloronaphthalene (6)2-Ethoxynaphthalene (4)2-Fluorocyclopropane-1-Carboxylic Acid (7)2-Hydroxycyclohexa-2,5-Diene-1,4-Dione (3)2-Iodonaphthalene (5)2-Methoxy-1,1'-Biphenyl (7)2-Methoxynaphthalene (22)2-Methoxytetrahydro-2H-Pyran (9)2-Methyl-1,1'-Biphenyl (26)2-Methylnaphthalene (13)2-Naphthaldehyde (12)2-Naphthoic Acid (14)2-Naphthonitrile (15)2-Nitronaphthalene (4)2-Phenoxytetrahydro-2H-Pyran-4-Yl Acetate (6)2-Phenylnaphthalene (12)3,3'-Diphenyl-5,5',6,6',7,7',8,8'-Octahydro-1,1'-Binaphthalene (13)3,3-Diphenyl-3H-Benzo[C][1,2]Oxathiole 1,1-Dioxide (19)3-Bromo-1,1'-Biphenyl (12)3-Chloro-1,1'-Biphenyl (12)3-Fluoro-1,1'-Biphenyl (16)3-Methyl-1,1'-Biphenyl (10)3-Methyl-1,1':4',1''-Terphenyl (3)3-Phenethylphenol (5)3-Phenyl-1,2,4,5-Tetrazine (9)3-Styrylphenol (11)4-(Bromomethyl)-1,1'-Biphenyl (13)4-(Phenyldiazenyl)Benzoic Acid (4)4-(Phenylsulfonyl)Morpholine (14)4-(Tert-Butyl)-1,1'-Biphenyl (5)4-Cyclohexylphenol (7)4-Iodo-1,1'-Biphenyl (9)4-Methoxy-1,1'-Biphenyl (4)9H-Xanthene (7)[1,1'-Biphenyl]-2-Amine (8)[1,1'-Biphenyl]-2-Carbonitrile (12)[1,1'-Biphenyl]-2-Carboxylic Acid (24)[1,1'-Biphenyl]-2-Ol (16)[1,1'-Biphenyl]-3-Amine (11)[1,1'-Biphenyl]-3-Carbaldehyde (20)[1,1'-Biphenyl]-3-Carboxylic Acid (39)[1,1'-Biphenyl]-3-Ol (9)[1,1'-Biphenyl]-4-Carbaldehyde (31)[1,1'-Biphenyl]-4-Carbonitrile (27)[1,1'-Biphenyl]-4-Ol (28)[1,1'-Biphenyl]-4-Ylboronic Acid (29)Benzyltriphenylphosphonium (14)Cyclopentylbenzene (28)Cyclopropanecarboxylic Acid (11)Cyclopropyl(Phenyl)Methanamine (22)Cyclopropyl(Phenyl)Methanone (13)Diphenyl Phosphonate (11)Diphenylphosphane (25)Diphenylphosphine Oxide (27)Ethane-1,1-Diyldibenzene (3)Ethene-1,1,2-Triyltribenzene (13)Ethyl Cyclopropanecarboxylate (8)Methyl 1-Naphthoate (7)Methyl 2-Naphthoate (11)Methyl [1,1'-Biphenyl]-4-Carboxylate (8)Methyl Cyclopropanecarboxylate (8)N,1-Diphenylmethanimine (15)N,N-Dimethylnaphthalen-1-Amine (4)N-((5R,6R)-7-Oxo-4-Thia-1-Azabicyclo[3.2.0]Heptan-6-Yl)-2-Phenylacetamide (5)N-Benzylbenzamide (21)N-Benzylbenzenesulfonamide (17)N-Cyclopropylbenzamide (14)N-Cyclopropylbenzenesulfonamide (10)N-Phenethylbenzamide (9)N-Phenyl-2-Naphthamide (11)Naphthalen-1-Ol (28)Naphthalen-1-Ylboronic Acid (4)Naphthalen-1-Ylmethanol (8)Naphthalen-2-Amine (12)Naphthalen-2-Ol (25)Naphthalen-2-Ylboronic Acid (8)Naphthalene-1,4-Diol (3)Naphthalene-2-Sulfonic Acid (4)Propane-2,2-Diyldibenzene (17)Tert-Butyl Cyclopropylcarbamate (7)Tetrahydro-2H-Pyran-2-Ol (12)Tetrahydro-2H-Pyran-2-Yl Acetate (12)Tetraphenylmethane (16)Triphenylene (12)Vinylcyclopropane (8)
Azides (42)
Azoes (112)
(E)-1-(Naphthalen-1-Yl)-2-Phenyldiazene (7)1,2-Diphenyldiazene (7)3-(Phenyldiazenyl)Benzoic Acid (7)
Benzene Compounds (19035)
Acetamidophenoxy (1)Acetamidophenyl (5)Acetylbenzoate (7)Acetylphenyl (13)Acetylphenyl (13)Acetylphenylboronic (3)Aminobenzoyl (4)Aminobiphenyl (4)Aminonaphthalene (14)Aminophenoxy (19)Aminophenyl (239)Anisole (4)Anthracenes (142)Benzaldehyde (1601)Benzamidophenyl (1)Benzenedimethanol (4)Benzenethiol (8)Benzhydrylazetidine (10)Benzhydrylazetidine (10)Benzhydryloxy (4)Benzhydryloxy (4)Benziodoxol (2)Benzodioxole (5)Benzoquinone (6)Benzoquinone (6)Benzoylbenzoate (4)Benzoylphenyl (4)Binaphthalene (123)Binaphthalene (123)Biphenyl (1393)Boronophenyl (1)Boronophenyl (1)Bromobenzo (104)Bromobenzoyl (6)Bromodibenzo (9)Bromophenoxy (34)Bromophenyl (989)Butoxyphenyl (8)Butylaniline (7)Butylbenzene (16)Butyldiphenylsilyl (7)Butylphenol (20)Butylphenyl (32)Butylphenyl (32)Carbamoylphenoxy (12)Carbamoylphenyl (8)Carboxyphenyl (17)Carboxyphenyl (17)Chlorobenzenesulfonyl (23)Chlorobenzoyl (9)Chlorodibenzo (18)Chloronaphthalene (36)Chlorophenethyl (7)Chlorophenoxy (44)Chlorophenylacetate (4)Chlorophenylacetate Acid (9)Chlorophenylboronic (5)Cyclopropylaniline (6)Cyclopropylbenzoate (5)Cyclopropylnaphthalen (10)Cyclopropylnaphthalen (10)Cyclopropylphenyl (12)Cyclopropylphenyl (12)Diaminobenzene (7)Dibenzaldehyde (19)Dibenzene (7)Dibenzimidamide (5)Dibenzo (108)Dibenzo (108)Dibenzoate (9)Dibenzonitrile (11)Dibromobenzene (45)Dibromobenzo (14)Dibromodibenzo (8)Dibromonaphthalene (15)Dibromophenanthrene (3)Dibromophenoxy (2)Dibromophenylboronic (3)Dichlorobenzene (38)Dichlorobenzoyl (4)Dichlorophenoxy (16)Dichlorophenyl (345)Dichlorophenylboronic (5)Didehydrodibenz (2)Didehydrodibenz (2)Diethoxyphenyl (10)Diethylaniline (6)Diethylbenzamide (7)Diethylbenzene (6)Diethylbenzene (6)Difluorobenzene (57)Difluorobenzo (12)Difluorobenzoyl (9)Difluorophenoxy (9)Difluorophenyl (403)Difluorophenylboronic (11)Dihydroanthracene (1)Dihydroanthracene (1)Dihydrobenzo (189)Dihydrobenzo (189)Dihydrodibenzo (7)Dihydronaphthalene (104)Dihydronaphthalene (104)Diiodobenzene (12)Diisopropylaniline (5)Diisopropylbenzamide (8)Diisopropylphenyl (40)Diisopropylphenyl (40)Dimesityl (12)Dimesityl (12)Dimethoxyacetophenone (5)Dimethoxyaniline (20)Dimethoxybenzaldehyde (40)Dimethoxybenzamide (6)Dimethoxybenzene (47)Dimethoxybenzo (4)Dimethoxybenzo (4)Dimethoxybenzoate (20)Dimethoxybenzohydrazide (3)Dimethoxybenzonitrile (11)Dimethoxybenzoyl (4)Dimethoxybiphenyl (3)Dimethoxybiphenyl (3)Dimethoxynaphthalene (10)Dimethoxynaphthalene (10)Dimethoxyphenol (22)Dimethoxyphenyl (257)Dimethoxyphenylboronic (17)Dimethoxyphenylboronic (17)Dimethoxystyryl (4)Dimethylaminophenyl (4)Dimethylanthracene (4)Dimethylbenzaldehyde (27)Dimethylbenzamide (37)Dimethylbenzene (334)Dimethylbenzene (334)Dimethylbenzenesulfonamide (16)Dimethylbenzo (21)Dimethylbenzo (21)Dimethylbenzoate (27)Dimethylbenzoyl (3)Dimethylbenzoyl (3)Dimethylnaphthalene (6)Dimethylphenol (36)Dimethylphenoxy (13)Dimethylphenoxy (13)Dimethylphenylboronic (6)Dimethylphenylboronic (6)Dimethylphenylhydrazine (3)Dimethylphenylisothiocyanate (4)Dinaphtho (5)Dinitrobenzene (20)Diphenol (32)Diphenylamino (27)Diphenylaniline (9)Diphenylethane (19)Diphenylethanone (5)Diphenylethene (6)Diphenylethyl (7)Diphenylethyl (7)Diphenylmethyl (8)Diphenylmethyl (8)Diphenylmethylene (6)Diphenylphosphine (204)Diphenylphosphine (204)Diphenylpropane (22)Diphenylsilane (2)Diphenylurea (4)Diphenylurea (4)Ethoxyaniline (10)Ethoxybenzaldehyde (9)Ethoxybenzoate (12)Ethoxybenzonitrile (6)Ethoxyphenoxy (7)Ethoxyphenoxy (7)Ethoxyphenyl (46)Ethoxyphenyl (46)Ethoxyphenylboronic (7)Ethylaniline (8)Ethylaniline (8)Ethylbenzenesulfonamide (338)Ethylbenzo (7)Ethylbenzo (7)Ethylbenzoate (9)Ethylphenol (12)Ethylphenyl (39)Ethylphenyl (39)Ethynylaniline (7)Ethynylbenzaldehyde (17)Ethynylphenyl (35)Fluorobenzeneboronic (24)Fluoronaphthalene (34)Fluorophenoxy (46)Formylbenzoate (39)Formylphenoxy (4)Formylphenoxy (4)Formylphenyl (43)Formylphenyl (43)Formylphenylboronic (9)Formylphenylboronic (9)Hexahydrobenzo (3)Hexahydrobenzo (3)Hexylphenyl (3)Hexylphenyl (3)Homophenylalanine (18)Hydroxybenzenesulfonate (5)Hydroxybenzimidamide (11)Hydroxyisophthalaldehyde (6)Hydroxyphenethyl (2)Hydroxyphenethyl (2)Hydroxyphenyl (461)Hydroxyphenyl (461)Iodobenzo (15)Iodobenzoic (54)Iodobenzoyl (7)Iodobiphenyl (24)Iododibenzo (7)Iodonaphthalene (9)Iodophenoxy (6)Isobutoxyphenyl (15)Isobutoxyphenyl (15)Isobutylbenzene (5)Isobutylbenzene (5)Isobutylphenyl (9)Isophthalate (8)Isophthalonitrile (4)Isopropoxyaniline (10)Isopropoxyaniline (10)Isopropoxybenzaldehyde (7)Isopropoxybenzoate (7)Isopropoxyphenyl (41)Isopropoxyphenyl (41)Isopropylaniline (18)Isopropylbenzaldehyde (6)Isopropylbenzamide (9)Isopropylbenzenesulfonamide (19)Isopropylbenzoate (8)Isopropylphenyl (58)Mercaptobenzo (21)Methanobenzo (15)Methanobenzo (15)Methoxyacetophenone (12)Methoxyaniline (74)Methoxybenzaldehyde (104)Methoxybenzene (1749)Methoxybenzene (1749)Methoxybenzenesulfonamide (6)Methoxybenzenesulfonic (3)Methoxybenzenesulfonyl (13)Methoxybenzenesulfonyl (13)Methoxybenzimidamide (5)Methoxybenzo (52)Methoxybenzo (52)Methoxybenzoate (116)Methoxybenzonitrile (67)Methoxybenzoyl (12)Methoxybenzoyl (12)Methoxycarbonylphenylboronic (5)Methoxynaphthalene (56)Methoxynaphthalene (56)Methoxyphenethyl (1)Methoxyphenethyl (1)Methoxyphenol (72)Methoxyphenoxy (41)Methoxyphenoxy (41)Methoxyphenylacetate (4)Methoxyphenylboronic (24)Methoxyphenylboronic (24)Methoxyphenylhydrazine (4)Methoxystyryl (13)Methylacetophenone (6)Methylaniline (183)Methylanisole (3)Methylanthracene (5)Methylbenzaldehyde (101)Methylbenzamide (90)Methylbenzamido (3)Methylbenzenesulfinamide (4)Methylbenzenesulfonamide (81)Methylbenzenesulfonic (9)Methylbenzenesulfonyl (4)Methylbenzenesulfonyl (4)Methylbenzimidamide (6)Methylbenzoate (193)Methylbenzohydrazide (7)Methylbenzothioamide (6)Methylbenzothioamide (6)Methylbenzotrifluoride (5)Methylbenzoyl (24)Methylbenzoyl (24)Methylnaphthalene (34)Methylnaphthalene (34)Methylphenol (107)Methylphenoxy (18)Methylphenoxy (18)Methylphenyl (529)Methylphenylacetonitrile (45)Methylphenylboronic (24)Methylphenylhydrazine (10)Methylpropiophenone (5)Methylpropiophenone (5)Naphthaldehyde (28)Naphthalene (465)Naphthalene (465)Naphthaleneboronic (15)Naphthalenesulfonic (7)Naphthamide (15)Naphthonitrile (18)Nitrobenzenesulfonyl (8)Nitrobenzo (54)Nitrobenzoyl (13)Nitronaphthalene (24)Nitrophenoxy (43)Nitrophenyl (727)Nitrophenylboronic (14)Nitrotoluene (27)Octylbenzene (11)Octylbenzene (11)Paracyclophane (2)Paracyclophane (2)Pentafluorobenzene (13)Pentylbenzene (5)Pentylbenzene (5)Pentylbenzoate (2)Pentylphenol (4)Pentylphenyl (5)Pentylphenyl (5)Perfluorophenoxy (5)Perfluorophenyl (31)Phenoxyacetate (5)Phenoxyaniline (8)Phenoxybenzaldehyde (5)Phenoxybenzoate (5)Phenoxyethyl (6)Phenoxyethyl (6)Phenoxymethyl (7)Phenoxymethyl (7)Phenoxyphenyl (61)Phenoxyphenyl (61)Phenoxypropan (4)Phenylacetamide (34)Phenylacetonitrile (8)Phenylacetyl (2)Phenylacetyl (2)Phenylacrylamide (3)Phenylalaninol (4)Phenylamino (31)Phenylaniline (19)Phenylanthracene (16)Phenylbenzamide (23)Phenylbenzenesulfonamide (3)Phenylbutanoate (12)Phenylbutoxy (2)Phenylbutoxy (2)Phenylcarbamoyl (4)Phenylcyclohexanone (6)Phenylcyclopropanecarboxylic (6)Phenylcyclopropyl (7)Phenylcyclopropyl (7)Phenyldiazenyl (4)Phenylene (169)Phenylene (169)Phenylenediamine (13)Phenylenedimethanamine (5)Phenylethanamine (12)Phenylethane (14)Phenylethane (14)Phenylethanol (10)Phenylethanone (20)Phenylethoxy (2)Phenylethyl (70)Phenylethyl (70)Phenylethylisocyanate (2)Phenylhex (3)Phenylimino (1)Phenylisocyanate (9)Phenylisoserine (4)Phenylmethanesulfonyl (2)Phenylmethanesulfonyl (2)Phenylmethanone (2)Phenylmethoxy (4)Phenylmethoxy (4)Phenylmethyl (8)Phenylmethyl (8)Phenylnaphthalene (6)Phenylpentan (11)Phenylpentan (11)Phenylpropanamide (15)Phenylpropyl (20)Phenylpyrazolo (8)Phenylsulfinyl (3)Phenylsulfinyl (3)Phenylsulfonyl (88)Phenylsulfonyl (88)Phenylthio (24)Phenylthio (24)Phenylthiophene (23)Phenylthiophene (23)Phenylthiourea (6)Phenylurea (3)Phenylurea (3)Phenylvinyl (9)Phthalate (23)Phthalimide (12)Phthalonitrile (9)Propoxybenzaldehyde (4)Propoxyphenyl (29)Propoxyphenyl (29)Propoxyphenylboronic (79)Propylphenyl (26)Propylphenyl (26)Pyrenes (52)Quaternaphthalene (6)Quaterphenyl (15)Quaterphenyl (15)Styryl (12)Sulfamoylphenyl (3)Sulfophenyl (4)Sulfophenyl (4)Terephthalaldehyde (11)Terephthalate (13)Terphenyl (239)Terphenyl (239)Tetraaniline (6)Tetrabenzaldehyde (7)Tetrafluorobenzene (17)Tetrahydrobenzo (70)Tetrahydrobenzo (70)Tetrahydronaphthalene (149)Tetrahydronaphthalene (149)Tetralone (12)Tetramethylbenzene (9)Tetramethylbenzene (9)Tetramethylbiphenyl (57)Tetramethylbiphenyl (57)Tetraphenyl (11)Tetraphenyl (11)Toluenesulfonyl (68)Tolyl (418)Tolyl (418)Tolylamino (3)Tolylazanediyl (4)Tolylazanediyl (4)Tolylethynyl (3)Tolyloxy (19)Tolyloxy (19)Tolylphosphine (8)Tolylphosphine (8)Tolylthio (3)Tolylthio (3)Trianiline (7)Tribenzaldehyde (5)Tribromobenzene (7)Trichlorobenzene (20)Trichlorophenoxy (3)Trichlorophenylboronic (6)Triethylbenzene (5)Trifluorophenyl (56)Trifluorophenylboronic (154)Triiodobenzene (5)Triisopropylbenzene (9)Triisopropylphenyl (6)Triisopropylphenyl (6)Trimethoxybenzene (43)Trimethoxystyryl (5)Trimethylaniline (18)Trimethylbenzene (28)Trimethylphenol (6)Trimethylphenyl (20)Trimethylphenyl (20)Trimethylpropiophenone (4)Triphenylphosphoranylidene (9)Triphenylphosphoranylidene (9)Triphenylvinyl (11)Trityl (19)Trityl (19)Tritylamino (2)Trityloxy (2)Tritylthio (3)Tritylthio (3)(((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(4-Fluorophenyl)Propanoic Acid (3)(10Ar)-1,2,3,4,4A,9,10,10A-Octahydrophenanthrene (3)(1E,1'E)-N,N'-(Ethane-1,2-Diyl)Bis(1-Phenylmethanimine) (5)(1R,4R)-4-Phenyl-1,1'-Bi(Cyclohexane) (24)(9H-Fluoren-9-Yl)Methyl Benzylcarbamate (22)(9H-Fluoren-9-Yl)Methyl Piperazine-1-Carboxylate (7)(Cyclopentylmethyl)Benzene (5)(R)-3-Benzylpyrrolidine (6)(R)-3-Phenylmorpholine (7)(R)-4-Benzyloxazolidin-2-One (5)(R)-N-(1,2-Diphenylethyl)Benzenesulfonamide (7)(S)-N-(1,2-Diphenylethyl)Benzenesulfonamide (7)1,1':2',1''-Terphenyl (4)1,1':3',1''-Terphenyl (28)1,1':4',1'':4'',1'''-Quaterphenyl (7)1,1,2,2-Tetra([1,1'-Biphenyl]-4-Yl)Ethene (10)1,1-Dimethyl-1,2,3,4-Tetrahydronaphthalene (10)1,2,3,4-Tetrahydronaphthalen-1-Amine (36)1,2,3,4-Tetrahydronaphthalen-1-Ol (5)1,2,3,4-Tetrahydronaphthalene-1-Carboxylic Acid (3)1,2,3,5,6,7-Hexahydro-S-Indacene (23)1,2,4-Trimethylbenzene (41)1,2-Dihydroacenaphthylene (6)1,2-Dinitrobenzene (6)1,3,5-Tris(Phenylethynyl)Benzene (6)1,3,6,8-Tetraphenylpyrene (10)1,3-Bis(Benzyloxy)Benzene (8)1,3-Dihydro-2H-Inden-2-One (6)1,3-Diphenoxypropane (6)1,3-Diphenyl-1H-Pyrazole (6)1,3-Diphenylpropane (7)1,3-Diphenylpropane-1,3-Dione (4)1,4-Bis(Phenylethynyl)Benzene (7)1,4-Diphenylbuta-1,3-Diyne (9)1-(2,3-Dihydro-1H-Inden-5-Yl)Ethan-1-Amine (3)1-(Anthracen-9-Yl)Ethan-1-Amine (3)1-Benzylazetidine (6)1-Bromopyrene (4)1-Cyclohexyl-4-(Phenylethynyl)Benzene (10)1-Cyclopropylnaphthalene (6)1-Phenyl-1H-Tetrazole (6)1-Phenylnaphthalene (12)1-Trityl-1H-Pyrazole (5)1H-Indene (19)1H-Indene-1,3(2H)-Dione (5)2,2 ', 3,3' - Tetrahydro-1,1 '- Spiro [Indene] (5)2,3,4,5-Tetrahydro-1H-Benzo[C]Azepine (7)2,3-Dihydro-1H-Inden-1-Amine (52)2,3-Dihydro-1H-Inden-1-Ol (13)2,3-Dihydro-1H-Inden-4-Amine (6)2,3-Dihydro-1H-Inden-4-Ol (6)2,3-Dihydro-1H-Indene-1-Carboxylic Acid (5)2,3-Dihydro-1H-Indene-4-Carbonitrile (4)2,4-Diphenyl-1,3,5-Triazine (6)2,5-Diphenyl-1,3,4-Oxadiazole (6)2,7-Bis(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-9H-Fluorene (7)2-(2-Chlorophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (24)2-(2-Fluorophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (21)2-(2-Methoxyphenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (29)2-(3-Bromophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (14)2-(3-Fluorophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (19)2-(3-Methoxyphenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (30)2-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Aniline (17)2-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzaldehyde (20)2-(4-Chlorophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (15)2-(4-Fluorophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (16)2-Amino-2-(Anthracen-9-Yl)Ethan-1-Ol (4)2-Methyl-2,3-Dihydro-1H-Inden-1-One (9)2-Phenyl-1,3,5-Triazine (6)2-Phenyl-1,3-Dioxane (7)2-Phenyl-2H-1,2,3-Triazole (7)2-Phenylisoindoline-1,3-Dione (7)2H-Benzo[B][1,4]Thiazin-3(4H)-One (6)3,3-Dimethyl-2,3-Dihydro-1H-Inden-1-One (5)3,4-Dihydro-2H-Benzo[B][1,4]Dioxepine (7)3,5,6,7-Tetrahydro-S-Indacen-1(2H)-One (5)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(2-Bromophenyl)Propanoic Acid (3)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(2-Chlorophenyl)Propanoic Acid (3)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(3-(Trifluoromethyl)Phenyl)Propanoic Acid (3)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(3-Fluorophenyl)Propanoic Acid (3)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(3-Methoxyphenyl)Propanoic Acid (4)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(3-Nitrophenyl)Propanoic Acid (3)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(4-Bromophenyl)Propanoic Acid (3)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(4-Nitrophenyl)Propanoic Acid (3)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(O-Tolyl)Propanoic Acid (3)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(P-Tolyl)Propanoic Acid (3)3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Aniline (25)3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzaldehyde (19)3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzoic Acid (12)3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Phenol (13)3-Methyl-2,3-Dihydro-1H-Inden-1-One (4)3-Phenyl-1H-Pyrrole (5)3-Phenylazetidine (5)3-Phenyloxazolidin-2-One (4)3-Phenylpiperidine (6)4',5'-Diphenyl-1,1':2',1''-Terphenyl (7)4,4,5,5-Tetramethyl-2-(3-(Trifluoromethyl)Phenyl)-1,3,2-Dioxaborolane (19)4,4,5,5-Tetramethyl-2-(3-Nitrophenyl)-1,3,2-Dioxaborolane (24)4,4,5,5-Tetramethyl-2-(M-Tolyl)-1,3,2-Dioxaborolane (21)4,4,5,5-Tetramethyl-2-(O-Tolyl)-1,3,2-Dioxaborolane (24)4,5-Diphenyloxazole (7)4,7-Diphenylbenzo[C][1,2,5]Thiadiazole (6)4-(4-Cyclopropylnaphthalen-1-Yl)-4H-1,2,4-Triazole (7)4-(Phenylethynyl)-1,1'-Biphenyl (5)4-Bromo-2,3-Dihydro-1H-Inden-1-One (5)4-Bromo-2,3-Dihydro-1H-Indene (10)4-Chloro-2,3-Dihydro-1H-Inden-1-One (8)4-Chloro-2,3-Dihydro-1H-Indene (5)4-Cyclohexyl-1,1'-Biphenyl (18)4-Fluoro-2,3-Dihydro-1H-Inden-1-One (6)4-Fluoro-2,3-Dihydro-1H-Indene (14)4-Methoxy-2,3-Dihydro-1H-Inden-1-One (6)4-Methyl-2,3-Dihydro-1H-Inden-1-One (8)4-Methyl-2,3-Dihydro-1H-Indene (3)4-Phenyl-1,1'-Bi(Cyclohexane) (8)4-Phenyl-4H-1,2,4-Triazole (6)5''-([1,1'-Biphenyl]-4-Yl)-1,1':4',1'':3'',1''':4''',1''''-Quinquephenyl (5)5',5''-Diphenyl-1,1':3',1'':3'',1'''-Quaterphenyl (8)5,5',6,6',7,7',8,8'-Octahydro-1,1'-Binaphthalene (6)5,6,7,8-Tetrahydronaphthalen-2-Ol (5)5-Bromo-1,2,3,4-Tetrahydronaphthalene (6)5-Bromo-2,3-Dihydro-1H-Indene (8)5-Fluoro-2,3-Dihydro-1H-Indene (3)5-Methoxy-1,2,3,4-Tetrahydronaphthalene (3)5-Methoxy-2,3-Dihydro-1H-Indene (2)5-Methyl-3,4-Dihydronaphthalen-1(2H)-One (6)5-Phenyl-1H-Imidazole (6)5-Phenylcyclohexane-1,3-Dione (6)6,7,8,9-Tetrahydro-5H-Benzo[7]Annulen-5-One (6)6-Bromo-1,2,3,4-Tetrahydronaphthalene (9)6-Bromo-2,3-Dihydro-1H-Inden-1-One (8)6-Bromo-3,4-Dihydronaphthalen-1(2H)-One (3)6-Chloro-1,2,3,4-Tetrahydronaphthalene (3)6-Chloro-2,3-Dihydro-1H-Inden-1-One (5)6-Fluoro-1,2,3,4-Tetrahydronaphthalene (6)6-Fluoro-2,3-Dihydro-1H-Inden-1-One (4)6-Methoxy-2,3-Dihydro-1H-Inden-1-One (6)6-Methoxy-3,4-Dihydronaphthalen-1(2H)-One (5)6-Methyl-1,2,3,4-Tetrahydronaphthalene (5)6-Methyl-2,3-Dihydro-1H-Inden-1-One (3)6-Methyl-3,4-Dihydronaphthalen-1(2H)-One (2)7-Bromo-2,3-Dihydro-1H-Inden-1-One (13)7-Chloro-2,3-Dihydro-1H-Inden-1-One (9)7-Fluoro-2,3-Dihydro-1H-Inden-1-One (8)7-Hydroxy-2,3-Dihydro-1H-Inden-1-One (6)7-Methoxy-2,3-Dihydro-1H-Inden-1-One (6)7-Methoxy-3,4-Dihydronaphthalen-1(2H)-One (6)7-Methyl-2,3-Dihydro-1H-Inden-1-One (7)9,10-Bis(Phenylethynyl)Anthracene (5)9,10-Diphenylanthracene (16)9-Methylanthracene (4)9-Phenylxanthylium (7)9H-Fluoren-9-One (17)[1,1'-Binaphthalen]-2-Amine (3)[1,1':4',1''-Terphenyl]-4,4''-Dicarbaldehyde (9)Benzenesulfinic Acid (6)Benzil (17)Benzo-18-Crown-6 (7)Benzo[Lmn][3,8]Phenanthroline-1,3,6,8(2H,7H)-Tetraone (10)Benzyl ((Benzyloxy)Carbonyl)Glycinate (8)Benzyl (4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Phenyl)Carbamate (5)Benzyl (S)-Pyrrolidin-3-Ylcarbamate (7)Benzyl 3-Phenylpropanoate (8)Benzyl Piperidin-4-Ylcarbamate (7)Bicyclo[4.2.0]Octa-1,3,5-Triene (13)Cumene (181)Dibenzyl Phosphonate (6)Diphenylmethanimine (9)Ethane-1,1,2-Triyltribenzene (5)Ethylbenzene (198)Mesitylene (71)Methyl 2-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzoate (14)Methyl 3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzoate (11)N,2-Diphenylacetamide (7)N,N,N-Trimethyl-1-Phenylmethanaminium (6)N,N-Diphenyl-[1,1'-Biphenyl]-4-Amine (8)N-Benzyl-2-Phenylethan-1-Amine (1)N-Benzylcyclopropanamine (6)N-Phenylcinnamamide (16)N1,N1,N4,N4-Tetraphenylbenzene-1,4-Diamine (6)N4,N4,N4',N4'-Tetraphenyl-[1,1'-Biphenyl]-4,4'-Diamine (7)Phenanthrene (23)Phenanthrene-9,10-Dione (8)Phenethyldiphenylphosphane (6)Phenothiazin-5-Ium (6)Phenyl (1R,4R)-[1,1'-Bi(Cyclohexane)]-4-Carboxylate (6)Phenyl 4-Cyclohexylbenzoate (8)Tert-Butyl (2,3-Dihydro-1H-Inden-1-Yl)Carbamate (3)Tert-Butylbenzene (251)Triphenyl Phosphate (6)
Benzyl Bromides (1065)
1-(Bromomethyl)-2-(Trifluoromethyl)Benzene (13)1-(Bromomethyl)-2-Chlorobenzene (28)1-(Bromomethyl)-2-Fluorobenzene (50)1-(Bromomethyl)-3-(Trifluoromethyl)Benzene (17)1-(Bromomethyl)-3-Chlorobenzene (27)1-(Bromomethyl)-3-Fluorobenzene (47)1-(Bromomethyl)-3-Methoxybenzene (19)1-Bromo-2-(Bromomethyl)Benzene (34)2-(2-(Bromomethyl)Phenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (9)2-(Bromomethyl)-1,3-Difluorobenzene (12)2-(Bromomethyl)Benzonitrile (15)Methyl 2-(Bromomethyl)Benzoate (33)
Benzyl Chlorides (646)
Dichlorobenzyl (39)1-(Chloromethyl)-2-Fluorobenzene (8)1-(Chloromethyl)-3-Fluorobenzene (11)
Bromides (52859)
Bromoacetyl (14)Bromoaniline (2)Bromoanthracene (5)Bromoanthracene (5)Bromobenzaldehyde (15)Bromobenzamide (7)Bromobenzimidamide (6)Bromobenzyl (36)Bromobut (2)Bromobut (2)Bromobutoxy (4)Bromobutoxy (4)Bromobutyl (6)Bromobutyl (6)Bromochroman (26)Bromochroman (26)Bromocyclopropanecarboxylate (1)Bromoethoxy (22)Bromoethoxy (22)Bromoethyl (86)Bromoethyl (86)Bromoethynyl (6)Bromohexyl (11)Bromohexyl (11)Bromomethyl (760)Bromonicotinaldehyde (5)Bromonicotinamide (5)Bromooctyl (3)Bromopentyl (8)Bromopentyl (8)Bromopropane (10)Bromopropane (10)Bromopropoxy (6)Bromopropoxy (6)Bromopropyl (25)Bromopropyl (25)Bromothiochroman (4)Bromothiochroman (4)Bromovinyl (2)Dibromo (698)Dibromo (698)Dibromoanthracene (3)Dibromoanthracene (3)Dibromobenzaldehyde (8)Dibromobenzonitrile (8)Dibromomethyl (6)Dibromomethyl (6)Dibromopropoxy (1)Dibromopropoxy (1)Tetrabromo (10)Tetrabromo (10)Tribromo (9)Tribromo (9)(1-Bromoethyl)Benzene (11)(2,2-Dibromovinyl)Benzene (6)(2-(4-Bromophenyl)Ethene-1,1,2-Triyl)Tribenzene (11)(2-Bromo-6-Fluorophenyl)Methanol (4)(2-Bromoethyl)Benzene (33)(2-Bromophenyl)(Phenyl)Methanone (3)(2-Bromophenyl)Boronic Acid (39)(2-Bromophenyl)Hydrazine (8)(2-Bromophenyl)Methanamine (12)(2-Bromophenyl)Methanol (39)(3-Bromo-2-Fluorophenyl)Boronic Acid (7)(3-Bromo-2-Methoxyphenyl)Boronic Acid (6)(3-Bromophenyl)Boronic Acid (65)(3-Bromopropyl)Benzene (10)(3-Bromopyridin-2-Yl)Methanol (7)(4-Bromophenyl)(Phenyl)Methanone (9)(5-Bromopyridin-2-Yl)Methanamine (5)(5-Bromopyridin-2-Yl)Methanol (5)(Bromoethynyl)Benzene (5)(Dibromomethyl)Benzene (6)1,2,3-Tribromobenzene (5)1,2,4-Tribromobenzene (13)1,2-Dibromo-3-Chlorobenzene (3)1,2-Dibromo-3-Fluorobenzene (9)1,2-Dibromo-3-Methylbenzene (9)1,2-Dibromo-4-Fluorobenzene (11)1,2-Dibromobenzene (64)1,3-Dibromo-2,4-Difluorobenzene (5)1,3-Dibromo-2,4-Dimethylbenzene (3)1,3-Dibromo-2-Chlorobenzene (8)1,3-Dibromo-2-Fluorobenzene (15)1,3-Dibromo-2-Iodobenzene (4)1,3-Dibromo-2-Methoxybenzene (11)1,3-Dibromo-2-Methylbenzene (14)1,3-Dibromo-2-Nitrobenzene (4)1,4-Dibromo-2-Iodobenzene (3)1-(2-Bromophenyl)Ethan-1-Amine (10)1-(2-Bromophenyl)Ethan-1-One (27)1-(5-Bromopyridin-2-Yl)Piperazine (6)1-(Azetidin-1-Yl)-2-Bromoethan-1-One (3)1-(Benzyloxy)-2-Bromobenzene (12)1-(Benzyloxy)-3-Bromobenzene (12)1-(Benzyloxy)-4-Bromobenzene (8)1-(Bromomethyl)-2-Iodobenzene (9)1-(Bromomethyl)-2-Methoxybenzene (14)1-(Bromomethyl)-2-Methylbenzene (14)1-(Bromomethyl)-2-Nitrobenzene (23)1-(Bromomethyl)-3-Methylbenzene (11)1-Benzyl-3-Bromobenzene (7)1-Benzyl-4-Bromo-1H-Pyrazole (5)1-Bromo-2,3-Dichlorobenzene (18)1-Bromo-2,3-Difluorobenzene (67)1-Bromo-2,3-Dimethoxybenzene (8)1-Bromo-2,3-Dimethylbenzene (23)1-Bromo-2,4-Difluorobenzene (59)1-Bromo-2-(Bromomethyl)Benzene (34)1-Bromo-2-(Difluoromethyl)Benzene (5)1-Bromo-2-(Methylsulfonyl)Benzene (4)1-Bromo-2-(Tert-Butyl)Benzene (7)1-Bromo-2-(Trifluoromethoxy)Benzene (22)1-Bromo-2-Chloro-3-Fluorobenzene (20)1-Bromo-2-Chloro-3-Methoxybenzene (6)1-Bromo-2-Chloro-3-Methylbenzene (9)1-Bromo-2-Chloro-4-Nitrobenzene (5)1-Bromo-2-Cyclopropylbenzene (3)1-Bromo-2-Ethoxybenzene (16)1-Bromo-2-Ethylbenzene (13)1-Bromo-2-Fluoro-3-(Trifluoromethyl)Benzene (4)1-Bromo-2-Fluoro-3-Methoxybenzene (7)1-Bromo-2-Fluoro-3-Methylbenzene (11)1-Bromo-2-Fluoro-3-Nitrobenzene (11)1-Bromo-2-Fluoro-4-Nitrobenzene (13)1-Bromo-2-Iodobenzene (65)1-Bromo-2-Isopropylbenzene (10)1-Bromo-2-Phenoxybenzene (3)1-Bromo-3-(Trifluoromethyl)Benzene (100)1-Bromo-3-Chloro-2-Fluorobenzene (9)1-Bromo-3-Chloro-2-Methylbenzene (6)1-Bromo-3-Cyclopropylbenzene (6)1-Bromo-3-Fluoro-2-Iodobenzene (4)1-Bromo-3-Fluoro-2-Methoxybenzene (12)1-Bromo-3-Fluoro-2-Methylbenzene (17)1-Bromo-3-Fluoro-2-Nitrobenzene (10)1-Bromo-3-Iodobenzene (70)1-Bromo-3-Methoxybenzene (187)1-Bromo-3-Methyl-2-Nitrobenzene (3)1-Bromo-3-Nitrobenzene (235)1-Bromo-3-Phenoxybenzene (8)1-Bromo-4-(Phenylsulfonyl)Benzene (7)1-Bromo-4-Chloro-2-Fluorobenzene (22)1-Bromo-4-Fluoro-2-Methoxybenzene (11)1-Bromo-4-Fluoro-2-Methylbenzene (18)1-Bromo-4-Iodobenzene (67)1-Bromo-4-Phenoxybenzene (8)1-Bromo-4-Styrylbenzene (5)1-Bromobicyclo[1.1.1]Pentane (3)1-Bromoisoquinoline (20)1-Bromonaphthalene (4)2,3-Dibromopyridine (21)2,4-Dibromo-1-Chlorobenzene (8)2,4-Dibromo-1-Fluorobenzene (18)2,4-Dibromo-1-Methoxybenzene (6)2,4-Dibromoaniline (18)2,4-Dibromophenol (16)2,4-Dibromopyridine (5)2,4-Dibromothiazole (5)2,5-Dibromopyrazine (4)2,5-Dibromopyridine (26)2,5-Dibromothiazole (5)2,5-Dibromothiophene (18)2,6-Dibromo-3-Fluoropyridine (3)2,6-Dibromoaniline (17)2,6-Dibromobenzaldehyde (4)2,6-Dibromobenzonitrile (4)2,6-Dibromophenol (21)2,6-Dibromopyrazine (9)2,6-Dibromopyridin-4-Amine (3)2,6-Dibromopyridine (28)2-(2-Bromophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (5)2-(2-Bromophenyl)Acetic Acid (23)2-(2-Bromophenyl)Acetonitrile (10)2-(4-Bromophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (8)2-(Bromomethyl)Furan (3)2-(Bromomethyl)Pyridine (27)2-Amino-3-Bromobenzoic Acid (8)2-Amino-3-Bromobenzonitrile (7)2-Amino-3-Bromophenol (3)2-Amino-6-Bromophenol (3)2-Bromo-1,1'-Biphenyl (12)2-Bromo-1,3,4-Thiadiazole (11)2-Bromo-1,3,4-Trifluorobenzene (16)2-Bromo-1,3,4-Trimethylbenzene (4)2-Bromo-1,3-Dichlorobenzene (12)2-Bromo-1,3-Difluorobenzene (43)2-Bromo-1,3-Dimethoxybenzene (7)2-Bromo-1,3-Dimethylbenzene (35)2-Bromo-1,4-Dichlorobenzene (12)2-Bromo-1,4-Difluorobenzene (64)2-Bromo-1,4-Dimethoxybenzene (11)2-Bromo-1,4-Dimethylbenzene (22)2-Bromo-1-Chloro-3-Fluorobenzene (9)2-Bromo-1-Chloro-4-Fluorobenzene (20)2-Bromo-1-Chloro-4-Methylbenzene (6)2-Bromo-1-Chloro-4-Nitrobenzene (9)2-Bromo-1-Fluoro-3-Nitrobenzene (9)2-Bromo-1-Fluoro-4-(Trifluoromethyl)Benzene (4)2-Bromo-1-Fluoro-4-Methoxybenzene (12)2-Bromo-1-Fluoro-4-Methylbenzene (17)2-Bromo-1-Fluoro-4-Nitrobenzene (23)2-Bromo-1-Methoxy-3-Methylbenzene (3)2-Bromo-1-Methoxy-4-Methylbenzene (7)2-Bromo-1-Methyl-4-Nitrobenzene (12)2-Bromo-1H-Benzo[D]Imidazole (4)2-Bromo-1H-Imidazole (13)2-Bromo-1H-Pyrrole (11)2-Bromo-3-(Trifluoromethyl)Pyridine (4)2-Bromo-3-Chloroaniline (4)2-Bromo-3-Chloropyridine (25)2-Bromo-3-Fluoroaniline (13)2-Bromo-3-Fluoropyridine (26)2-Bromo-3-Hydroxybenzaldehyde (4)2-Bromo-3-Methoxybenzaldehyde (4)2-Bromo-3-Methoxypyridine (7)2-Bromo-3-Methylaniline (6)2-Bromo-3-Methylphenol (4)2-Bromo-3-Methylpyrazine (5)2-Bromo-3-Methylpyridine (25)2-Bromo-3-Nitrobenzoic Acid (4)2-Bromo-3-Nitropyridine (5)2-Bromo-4-(Trifluoromethyl)Aniline (9)2-Bromo-4-Chloro-1-Fluorobenzene (16)2-Bromo-4-Chloro-1-Methoxybenzene (7)2-Bromo-4-Chloro-1-Methylbenzene (11)2-Bromo-4-Chloro-1-Nitrobenzene (5)2-Bromo-4-Chloroaniline (15)2-Bromo-4-Chlorophenol (11)2-Bromo-4-Chloropyridine (7)2-Bromo-4-Fluoro-1-Methoxybenzene (12)2-Bromo-4-Fluoro-1-Methylbenzene (21)2-Bromo-4-Fluoro-1-Nitrobenzene (23)2-Bromo-4-Fluoroaniline (28)2-Bromo-4-Fluorobenzaldehyde (7)2-Bromo-4-Fluorobenzoic Acid (8)2-Bromo-4-Fluorobenzonitrile (7)2-Bromo-4-Fluorophenol (10)2-Bromo-4-Methoxy-1-Nitrobenzene (6)2-Bromo-4-Methoxyaniline (6)2-Bromo-4-Methoxybenzaldehyde (8)2-Bromo-4-Methoxybenzoic Acid (4)2-Bromo-4-Methylaniline (14)2-Bromo-4-Methylbenzoic Acid (5)2-Bromo-4-Methylpyridine (6)2-Bromo-4-Methylthiazole (7)2-Bromo-4-Nitroaniline (12)2-Bromo-5-(Trifluoromethyl)Pyridine (6)2-Bromo-5-Chloropyrazine (6)2-Bromo-5-Chloropyridine (22)2-Bromo-5-Fluoroaniline (18)2-Bromo-5-Fluorobenzaldehyde (7)2-Bromo-5-Fluorobenzoic Acid (11)2-Bromo-5-Fluoropyridine (33)2-Bromo-5-Methoxybenzaldehyde (6)2-Bromo-5-Methoxypyridine (11)2-Bromo-5-Methylpyridine (19)2-Bromo-5-Methylthiazole (7)2-Bromo-5-Nitropyridine (11)2-Bromo-6-(Trifluoromethyl)Aniline (5)2-Bromo-6-(Trifluoromethyl)Pyridine (6)2-Bromo-6-Chloroaniline (10)2-Bromo-6-Chlorophenol (5)2-Bromo-6-Chloropyrazine (5)2-Bromo-6-Chloropyridine (23)2-Bromo-6-Fluoroaniline (14)2-Bromo-6-Fluorobenzaldehyde (15)2-Bromo-6-Fluorobenzoic Acid (11)2-Bromo-6-Fluorobenzonitrile (7)2-Bromo-6-Fluorophenol (9)2-Bromo-6-Fluoropyridine (21)2-Bromo-6-Iodoaniline (4)2-Bromo-6-Methoxyaniline (5)2-Bromo-6-Methoxyphenol (5)2-Bromo-6-Methoxypyridine (15)2-Bromo-6-Methylaniline (11)2-Bromo-6-Methylbenzoic Acid (5)2-Bromo-6-Methylphenol (7)2-Bromo-6-Methylpyrazine (5)2-Bromo-6-Methylpyridine (17)2-Bromo-6-Nitroaniline (14)2-Bromo-6-Nitrophenol (9)2-Bromo-6-Phenylpyridine (4)2-Bromo-9,9-Diphenyl-9H-Fluorene (5)2-Bromo-9H-Fluorene (15)2-Bromo-[1,2,4]Triazolo[1,5-A]Pyridine (6)2-Bromo-N,N-Dimethylaniline (5)2-Bromo-N-Methylaniline (8)2-Bromo-N-Phenylacetamide (5)2-Bromobenzene-1,3-Diol (7)2-Bromobenzene-1,4-Diol (4)2-Bromobenzenesulfonyl Chloride (8)2-Bromobenzo[D]Thiazole (28)2-Bromodibenzo[B,D]Furan (6)2-Bromofuran (21)2-Bromoimidazo[1,2-A]Pyridine (5)2-Bromonaphthalene (4)2-Bromonicotinic Acid (5)2-Bromooxazole (7)2-Bromopyrazine (15)2-Bromopyridin-3-Amine (10)2-Bromopyridin-3-Ol (7)2-Bromopyridine (10)2-Bromopyridine 1-Oxide (6)2-Bromopyrimidine (22)2-Bromoquinazoline (4)3,4-Dibromoaniline (4)3,4-Dibromophenol (3)3,5-Dibromopyridine (12)3-(Bromomethyl)Pyridine (18)3-Bromo-1,1'-Biphenyl (12)3-Bromo-1,5-Naphthyridine (8)3-Bromo-1-Methyl-1H-Pyrazole (16)3-Bromo-1H-Pyrrole (16)3-Bromo-1H-Pyrrolo[2,3-B]Pyridine (7)3-Bromo-1H-Pyrrolo[3,2-B]Pyridine (6)3-Bromo-2-Chlorobenzaldehyde (4)3-Bromo-2-Chlorobenzoic Acid (7)3-Bromo-2-Chloropyridin-4-Amine (3)3-Bromo-2-Chloropyridine (20)3-Bromo-2-Fluoroaniline (15)3-Bromo-2-Fluorobenzaldehyde (9)3-Bromo-2-Fluorobenzoic Acid (10)3-Bromo-2-Fluorobenzonitrile (10)3-Bromo-2-Fluorophenol (5)3-Bromo-2-Fluoropyridine (21)3-Bromo-2-Hydroxybenzaldehyde (10)3-Bromo-2-Hydroxybenzoic Acid (4)3-Bromo-2-Hydroxybenzonitrile (3)3-Bromo-2-Methoxypyridine (20)3-Bromo-2-Methylpyridine (27)3-Bromo-4-Chloroaniline (13)3-Bromo-4-Chlorobenzoic Acid (6)3-Bromo-4-Chlorophenol (5)3-Bromo-4-Fluoroaniline (22)3-Bromo-4-Fluorobenzaldehyde (7)3-Bromo-4-Fluorobenzamide (3)3-Bromo-4-Fluorobenzoic Acid (10)3-Bromo-4-Fluorophenol (11)3-Bromo-4-Hydroxybenzaldehyde (9)3-Bromo-4-Hydroxybenzoic Acid (3)3-Bromo-4-Methoxyaniline (7)3-Bromo-4-Methoxybenzaldehyde (9)3-Bromo-4-Methoxybenzoic Acid (7)3-Bromo-4-Methylaniline (14)3-Bromo-4-Methylbenzoic Acid (9)3-Bromo-4-Methylpyridine (13)3-Bromo-5'-Phenyl-1,1':3',1''-Terphenyl (4)3-Bromo-5-Chloropyridine (14)3-Bromo-5-Fluoropyridine (18)3-Bromo-5-Methylpyridine (14)3-Bromo-5-Nitropyridine (10)3-Bromoaniline (187)3-Bromoazetidine (3)3-Bromobenzene-1,2-Diamine (11)3-Bromobenzene-1,2-Diol (8)3-Bromobenzo[B]Thiophene (5)3-Bromobenzoic Acid (159)3-Bromobenzonitrile (110)3-Bromofuran (13)3-Bromoimidazo[1,2-A]Pyridine (26)3-Bromoimidazo[1,2-A]Pyrimidine (6)3-Bromoisoquinoline (10)3-Bromoisoxazole (7)3-Bromopicolinic Acid (9)3-Bromopicolinonitrile (13)3-Bromopyrazolo[1,5-A]Pyrimidine (11)3-Bromopyridazine (25)3-Bromopyridin-2-Amine (30)3-Bromopyridin-2-Ol (17)3-Bromopyridine 1-Oxide (8)3-Bromopyrrolidine (6)3-Bromothiophene (6)4-(Bromomethyl)-1,1'-Biphenyl (13)4-(Bromomethyl)Pyridine (8)4-Bromo-1,5-Naphthyridine (5)4-Bromo-1-Methyl-1H-Pyrazole (14)4-Bromo-1-Phenyl-1H-Imidazole (9)4-Bromo-1-Phenyl-1H-Pyrazole (11)4-Bromo-1H-Benzo[D]Imidazole (14)4-Bromo-1H-Indole (25)4-Bromo-1H-Pyrazolo[3,4-B]Pyridine (4)4-Bromo-1H-Pyrrolo[2,3-B]Pyridine (9)4-Bromo-2-Chloro-1-Iodobenzene (4)4-Bromo-2-Chloropyridine (29)4-Bromo-2-Fluoro-1-Iodobenzene (8)4-Bromo-2-Fluoropyridine (4)4-Bromo-2-Iodoaniline (8)4-Bromo-2-Methoxypyridine (4)4-Bromo-3-(Trifluoromethyl)Aniline (7)4-Bromo-3-Chloroaniline (21)4-Bromo-3-Fluoroaniline (29)4-Bromo-3-Methylaniline (19)4-Bromo-3-Methylpyridine (5)4-Bromo-3-Nitroaniline (8)4-Bromo-N,N-Diphenylaniline (10)4-Bromo-N-Phenylaniline (6)4-Bromo-N-Phenylbenzenesulfonamide (23)4-Bromobenzo[C][1,2,5]Thiadiazole (14)4-Bromobenzo[D][1,3]Dioxole (6)4-Bromobenzo[D]Thiazole (9)4-Bromobenzofuran (3)4-Bromoindoline (4)4-Bromoisoindolin-1-One (3)4-Bromoisoquinolin-1(2H)-One (3)4-Bromoisoquinoline (33)4-Bromopyridazine (5)4-Bromopyridine (31)4-Bromopyrimidine (24)4-Bromothiazole (10)5-Bromo-1,2,3,4-Tetrahydroisoquinoline (4)5-Bromo-1-Methyl-1H-Indole (4)5-Bromo-1H-1,2,4-Triazole (6)5-Bromo-1H-Benzo[D][1,2,3]Triazole (5)5-Bromo-1H-Benzo[D]Imidazole (13)5-Bromo-1H-Indazole (14)5-Bromo-1H-Pyrazole (11)5-Bromo-1H-Pyrazolo[3,4-B]Pyridine (11)5-Bromo-1H-Pyrazolo[3,4-C]Pyridine (5)5-Bromo-1H-Pyrrolo[2,3-B]Pyridine (13)5-Bromo-2,3-Dihydro-1H-Indene (8)5-Bromo-2,3-Dihydrobenzofuran (6)5-Bromo-2-Chloro-4-Methylpyridine (5)5-Bromo-2-Chloropyridine (40)5-Bromo-2-Chloropyrimidine (6)5-Bromo-2-Fluoropyridine (22)5-Bromo-2-Methoxypyridine (29)5-Bromo-2-Methylpyridine (23)5-Bromo-2-Methylpyrimidine (5)5-Bromo-2-Phenylpyridine (3)5-Bromo-4-Methylpyridin-2-Amine (5)5-Bromo-6-Chloropyridin-2-Amine (3)5-Bromo-7H-Pyrrolo[2,3-D]Pyrimidine (3)5-Bromobenzo[B]Thiophene (3)5-Bromobenzo[D][1,3]Dioxole (12)5-Bromobenzo[D]Oxazole (3)5-Bromoimidazo[1,2-A]Pyridine (6)5-Bromoindoline (8)5-Bromoisoindolin-1-One (8)5-Bromoisoquinoline (17)5-Bromonicotinaldehyde (12)5-Bromonicotinic Acid (6)5-Bromonicotinonitrile (6)5-Bromopicolinic Acid (11)5-Bromopicolinonitrile (13)5-Bromopyrazin-2-Ol (5)5-Bromopyridin-2-Amine (35)5-Bromopyridin-2-Ol (18)5-Bromopyridin-3-Amine (10)5-Bromopyridin-3-Ol (6)5-Bromoquinoxaline (6)5-Bromothiazole (8)6-Bromo-1,2,3,4-Tetrahydroisoquinoline (4)6-Bromo-1,2,3,4-Tetrahydroquinoline (6)6-Bromo-1-Methyl-1H-Indole (3)6-Bromo-1H-Indazole (23)6-Bromo-1H-Indole (15)6-Bromo-1H-Pyrazolo[4,3-B]Pyridine (4)6-Bromo-1H-Pyrrolo[2,3-B]Pyridine (6)6-Bromo-1H-Pyrrolo[3,2-B]Pyridine (7)6-Bromo-1H-Pyrrolo[3,2-C]Pyridine (5)6-Bromo-3,4-Dihydro-2H-Benzo[B][1,4]Oxazine (5)6-Bromo-3,4-Dihydroisoquinolin-1(2H)-One (6)6-Bromo-3,4-Dihydroquinolin-2(1H)-One (4)6-Bromo-[1,2,4]Triazolo[1,5-A]Pyridine (12)6-Bromo-[1,2,4]Triazolo[4,3-A]Pyridine (8)6-Bromobenzo[B]Thiophene (4)6-Bromobenzo[D]Oxazole (3)6-Bromobenzo[D]Thiazole (7)6-Bromochroman-4-One (6)6-Bromoimidazo[1,2-A]Pyrimidine (5)6-Bromoindoline-2,3-Dione (4)6-Bromoisoindolin-1-One (4)6-Bromoisoquinoline (9)6-Bromonicotinaldehyde (11)6-Bromonicotinic Acid (9)6-Bromonicotinonitrile (7)6-Bromopicolinic Acid (5)6-Bromopyrazolo[1,5-A]Pyrimidine (7)6-Bromopyridin-2-Amine (8)6-Bromopyridin-3-Amine (12)6-Bromopyridin-3-Ol (13)6-Bromoquinazoline (7)6-Bromoquinoxaline (9)7-Bromo-1,2,3,4-Tetrahydroisoquinoline (4)7-Bromo-1H-Indazole (18)7-Bromo-1H-Indole (28)7-Bromo-1H-Pyrrolo[2,3-C]Pyridine (4)7-Bromo-2,3-Dihydrobenzofuran (6)7-Bromo-3,4-Dihydro-2H-Benzo[B][1,4]Oxazine (7)7-Bromo-3,4-Dihydroisoquinolin-1(2H)-One (6)7-Bromo-3,4-Dihydronaphthalen-1(2H)-One (8)7-Bromobenzo[B]Thiophene (5)7-Bromobenzo[D]Thiazole (8)7-Bromobenzofuran (6)7-Bromochromane (7)7-Bromoindoline (3)7-Bromoisoquinoline (6)8-Bromo-[1,2,4]Triazolo[1,5-A]Pyridine (6)8-Bromochromane (6)8-Bromoimidazo[1,2-A]Pyridine (15)8-Bromoisoquinoline (17)8-Bromoquinazoline (8)9-Bromoanthracene (5)Bromocyclohexane (7)Ethyl 2-Bromo-2-Phenylacetate (6)Methyl 2-(2-Bromophenyl)Acetate (8)Methyl 2-Bromo-2-Phenylacetate (7)Methyl 2-Bromo-3-Nitrobenzoate (3)Methyl 2-Bromo-5-Fluorobenzoate (8)Methyl 2-Bromo-6-Fluorobenzoate (7)Methyl 2-Bromo-6-Methylbenzoate (8)Methyl 2-Bromobenzoate (69)Methyl 3-(Bromomethyl)Benzoate (16)Methyl 3-Bromo-4-Chlorobenzoate (6)Methyl 3-Bromo-4-Fluorobenzoate (7)Methyl 3-Bromo-4-Methoxybenzoate (10)Methyl 3-Bromo-4-Methylbenzoate (9)Methyl 3-Bromobenzoate (153)Methyl 3-Bromopicolinate (9)Methyl 4-Amino-3-Bromobenzoate (8)Methyl 5-Amino-2-Bromobenzoate (6)Methyl 6-Bromonicotinate (6)N-(2-Benzoylphenyl)-2-Bromoacetamide (3)Tert-Butyl 2-(Bromomethyl)Morpholine-4-Carboxylate (3)Tert-Butyl 3-Bromo-1H-Indole-1-Carboxylate (9)Tert-Butyl 3-Bromopiperidine-1-Carboxylate (4)
Carbamates (7957)
Carboxylic Acid Salts (668)
Carboxylic Acids (58191)
Aceticacid (1249)Acetylbenzoic Acid (3)Acrylic (95)Aminobenzoic (7)Aminobutanoic (8)Aminoheptanoic (6)Aminohexanoic (10)Aminonicotinic Acid (4)Aminopentanoic (8)Aminophenylacetic Acid (22)Aminopropanoic (11)Aminoundecanoic Acid (4)Benzenedicarboxylic (6)Benzenedicarboxylic Acid (6)Benzylpropanoic Acid (75)Benzylsuccinic Acid (6)Boronobenzoic (4)Bromobutanoic (5)Bromododecanoate (3)Bromoisonicotinic Acid (4)Bromonicotinic (8)Bromonicotinic Acid (9)Bromophenylacetic Acid (15)Bromovalerate (4)Butanoic (124)Chlorobenzoic (35)Chloromandelic Acid (3)Chromene-Carboxylic Acid (1)Cyanonicotinic (5)Cyanonicotinic Acid (3)Diacetic (19)Diacetic (19)Diaminobenzoic (7)Diaminobutanoic (5)Diaminohexanoic (4)Dibenzoic (40)Dibromobenzoic (10)Dibromobenzoic Acid (10)Dibromonicotinic Acid (7)Dicarboxylic (183)Dicarboxylic (183)Dichlorobenzoic (21)Dichlorobenzoic Acid (22)Dichloroisonicotinic (6)Dichloroisonicotinic Acid (6)Dichlorophenylacetic Acid (4)Dienoate (14)Dienoic (10)Difluorobenzoic (54)Difluorobutanoic (3)Difluoroisonicotinic Acid (7)Difluorophenylacetic (7)Difluorophenylacetic Acid (7)Diiodobenzoic (5)Diisophthalic (17)Diisophthalic Acid (9)Diisopropylbenzoic Acid (4)Dimethoxybenzoic (33)Dimethoxyphenylacetic Acid (3)Dimethylbenzoic (32)Dimethylbutanoic (13)Dimethylbutanoic (13)Dimethylpropanoic (5)Diphenylpropanoic (8)Diyldimethanol (17)Enedioic (8)Enoic (127)Ethoxybenzoic (9)Ethylbenzoic (11)Ethylbenzoic Acid (12)Ethynylbenzoic (6)Ethynylbenzoic Acid (5)Fluoroisophthalic Acid (4)Fluorophenylacetic (10)Fluorophenylacetic Acid (11)Fluorophthalic (5)Fluorophthalic Acid (3)Fluoropicolinic (12)Formylbenzoic (22)Formylbenzoic Acid (19)Guanidinopentanoic (8)Heptanoic (6)Heptanoic (6)Hexacarboxylic Acid (5)Hexanoic (25)Hexanoic (25)Hydrazinylbenzoic (6)Hydrazinylbenzoic Acid (5)Hydroxynicotinic (15)Indolecarboxylic (2)Isophthalic (29)Isophthalic Acid (15)Isopropoxybenzoic (8)Isopropoxybenzoic Acid (7)Isopropylbenzoic (13)Isopropylnicotinic Acid (4)Malonate (39)Mercaptobenzoic (6)Mercaptobenzoic Acid (4)Mercaptopropanoic (11)Methoxybenzoic (142)Methoxybutanoic (4)Methoxybutanoic (4)Methoxyisophthalic Acid (5)Methoxyphenylacetic (10)Methoxyphenylacetic Acid (11)Methoxypropanoic (7)Methoxypropanoic (7)Methylbenzoic (175)Methylbutanoic (32)Methylbutanoic (32)Methylcinnamic Acid (9)Methylhexanoic (8)Methylhexanoic (8)Methylisophthalic Acid (17)Methylnicotinic (46)Methyloctanoic (6)Methylpentanoic (108)Methylpentanoic (108)Methylpropanoic (57)Naphthoic (64)Nitrobenzoic (161)Nitroisonicotinic Acid (5)Nitroisophthalic Acid (3)Nitronicotinic (10)Nitropicolinic (11)Octanoic (6)Octanoic (6)Oxoacetic (22)Oxobutanoic (57)Oxobutanoic (57)Oxodecanoic (5)Oxodecanoic (5)Oxododecanoic (9)Oxododecanoic (9)Oxoheptanoic (5)Oxoheptanoic (5)Oxoheptanoic Acid (4)Oxohexadecanoic (13)Oxohexadecanoic (13)Oxohexanoic (10)Oxohexanoic (10)Oxooctadecanoic (7)Oxooctadecanoic (7)Oxopentanoic (37)Oxopentanoic (37)Oxopropanoic (8)Pentanedioic (18)Pentanedioic (18)Pentanoic (27)Phenoxybenzoic (5)Phenylacetic (35)Phenylbutanoic (47)Phenylpentanoic (11)Phenylpropanoic (45)Propanoic (1167)Propenoic (6)Pyridazinecarboxylic (1)Succinic (13)Sulfamoylbenzoic (15)Sulfobenzoic (5)Terephthalic (7)Tetraacetic (5)Tetrabenzoic (13)Tetrabenzoic Acid (14)Tetracarboxylic (13)Tribenzoic (15)Tribenzoic Acid (14)Tricarboxylic (18)Trichlorobenzoic (5)Trichlorobenzoic Acid (4)Trifluorobenzoic (12)Trifluorobenzoic Acid (11)Trifluorobutanoic (3)Trifluoromethylbenzoic (5)Trifluoromethylbenzoic Acid (4)Trifluoropentanoic (4)Trifluorophenylacetic Acid (16)Trifluoropropanoic (4)Triiodobenzoic (4)Trimethylbenzoic Acid (4)1,2,3,4-Tetrahydroisoquinoline-1-Carboxylic Acid (19)1,2,3,4-Tetrahydroisoquinoline-3-Carboxylic Acid (12)1,5-Naphthyridine-3-Carboxylic Acid (6)1-((Benzyloxy)Carbonyl)Piperidine-2-Carboxylic Acid (5)1-((Benzyloxy)Carbonyl)Piperidine-3-Carboxylic Acid (3)1-((Benzyloxy)Carbonyl)Pyrrolidine-3-Carboxylic Acid (6)1-Methyl-1H-Indole-2-Carboxylic Acid (8)1-Naphthoic Acid (23)1-Phenyl-1H-Imidazole-4-Carboxylic Acid (5)1-Phenyl-1H-Pyrazole-3-Carboxylic Acid (10)1-Phenyl-1H-Pyrazole-4-Carboxylic Acid (19)1-Phenyl-1H-Pyrazole-5-Carboxylic Acid (3)1-Phenylcyclobutane-1-Carboxylic Acid (16)1-Phenylcyclohexane-1-Carboxylic Acid (6)1-Phenylcyclopropane-1-Carboxylic Acid (23)1H-Benzo[D]Imidazole-2-Carboxylic Acid (7)1H-Benzo[D]Imidazole-4-Carboxylic Acid (6)1H-Benzo[D]Imidazole-5-Carboxylic Acid (4)1H-Imidazole-2-Carboxylic Acid (7)1H-Imidazole-4-Carboxylic Acid (4)1H-Indazole-3-Carboxylic Acid (27)1H-Indazole-4-Carboxylic Acid (9)1H-Indazole-5-Carboxylic Acid (4)1H-Indazole-7-Carboxylic Acid (6)1H-Indole-3-Carboxylic Acid (32)1H-Indole-4-Carboxylic Acid (10)1H-Indole-5-Carboxylic Acid (4)1H-Indole-6-Carboxylic Acid (5)1H-Indole-7-Carboxylic Acid (7)1H-Pyrazole-4-Carboxylic Acid (9)1H-Pyrazole-5-Carboxylic Acid (10)1H-Pyrrole-2-Carboxylic Acid (30)1H-Pyrrolo[2,3-B]Pyridine-3-Carboxylic Acid (5)1H-Pyrrolo[2,3-C]Pyridine-2-Carboxylic Acid (4)1H-Pyrrolo[3,2-B]Pyridine-3-Carboxylic Acid (6)2,3-Difluorobenzoic Acid (35)2,3-Dihydrobenzo[B][1,4]Dioxine-2-Carboxylic Acid (3)2,3-Dihydrobenzo[B][1,4]Dioxine-6-Carboxylic Acid (3)2,4-Difluorobenzoic Acid (29)2,5-Dichlorobenzoic Acid (13)2,5-Difluorobenzoic Acid (32)2,6-Dichlorobenzoic Acid (13)2,6-Difluorobenzoic Acid (33)2-(1,3-Dioxoisoindolin-2-Yl)Propanoic Acid (3)2-(1H-Indol-1-Yl)Acetic Acid (5)2-(1H-Indol-3-Yl)Acetic Acid (28)2-(2-Bromophenyl)Acetic Acid (23)2-(2-Chlorophenyl)Acetic Acid (24)2-(2-Fluorophenyl)Acetic Acid (43)2-(2-Hydroxyphenyl)Acetic Acid (8)2-(2-Methoxyphenyl)Acetic Acid (16)2-(2-Methyl-1H-Indol-3-Yl)Acetic Acid (5)2-(2-Nitrophenyl)Acetic Acid (20)2-(2-Oxo-2H-Chromen-4-Yl)Acetic Acid (4)2-(3-Fluorophenyl)Acetic Acid (50)2-(3-Hydroxyphenyl)Acetic Acid (7)2-(3-Methoxyphenyl)Acetic Acid (23)2-(4-Chlorophenoxy)Acetic Acid (3)2-(4-Fluorophenyl)Acetic Acid (30)2-(4-Methoxyphenyl)Acetic Acid (19)2-(4-Nitrophenyl)Acetic Acid (9)2-(Benzofuran-3-Yl)Acetic Acid (3)2-(M-Tolyl)Acetic Acid (16)2-(Morpholin-2-Yl)Acetic Acid (5)2-(O-Tolyl)Acetic Acid (17)2-(P-Tolyl)Acetic Acid (9)2-(Phenylamino)Benzoic Acid (11)2-(Pyridin-3-Yl)Acetic Acid (14)2-(Pyrrolidin-1-Yl)Benzoic Acid (3)2-(Pyrrolidin-2-Yl)Acetic Acid (8)2-(Pyrrolidin-3-Yl)Acetic Acid (6)2-(Thiazol-4-Yl)Acetic Acid (9)2-(Trifluoromethoxy)Benzoic Acid (8)2-(Trifluoromethyl)Benzoic Acid (33)2-Amino-2-(2-Fluorophenyl)Acetic Acid (11)2-Amino-3,3-Diphenylpropanoic Acid (4)2-Amino-3-(2-Fluorophenyl)Propanoic Acid (16)2-Amino-3-Bromobenzoic Acid (8)2-Amino-3-Chlorobenzoic Acid (7)2-Amino-6-Chlorobenzoic Acid (5)2-Benzoylbenzoic Acid (10)2-Bromo-4-Fluorobenzoic Acid (8)2-Bromo-4-Methylbenzoic Acid (5)2-Bromo-6-Fluorobenzoic Acid (11)2-Bromo-6-Methylbenzoic Acid (5)2-Chloro-3-Methoxybenzoic Acid (6)2-Chloro-3-Methylbenzoic Acid (4)2-Chloro-3-Nitrobenzoic Acid (4)2-Chloro-4-Fluorobenzoic Acid (9)2-Chloro-4-Methylbenzoic Acid (3)2-Chloro-6-Fluorobenzoic Acid (8)2-Chlorobenzoic Acid (130)2-Cyclohexylacetic Acid (14)2-Fluoro-4-Methylbenzoic Acid (7)2-Fluoro-5-Methoxybenzoic Acid (9)2-Fluorobenzoic Acid (220)2-Fluorocyclopropane-1-Carboxylic Acid (7)2-Iodobenzoic Acid (47)2-Methoxyisonicotinic Acid (13)2-Methyl-2-Phenylpropanoic Acid (20)2-Methyl-3-Nitrobenzoic Acid (7)2-Naphthoic Acid (14)2-Nitrobenzoic Acid (65)2-Oxo-2-Phenylacetic Acid (17)2-Oxo-2H-Chromene-3-Carboxylic Acid (14)2-Phenoxypropanoic Acid (13)3-((Tert-Butoxycarbonyl)Amino)-4-(2-Fluorophenyl)Butanoic Acid (9)3-(1H-Indol-3-Yl)Propanoic Acid (4)3-(2-Fluorophenyl)Acrylic Acid (17)3-(3-Chlorophenyl)Acrylic Acid (10)3-(3-Chlorophenyl)Propanoic Acid (11)3-(3-Methoxyphenyl)Propanoic Acid (9)3-(Benzyloxy)Benzoic Acid (5)3-(Chlorosulfonyl)Benzoic Acid (15)3-(Methylsulfonyl)Benzoic Acid (6)3-(Phenyldiazenyl)Benzoic Acid (7)3-(Piperazin-1-Yl)Benzoic Acid (3)3-(Trifluoromethoxy)Benzoic Acid (19)3-(Trifluoromethyl)Benzoic Acid (52)3-Benzamidopropanoic Acid (3)3-Bromo-2-Chlorobenzoic Acid (7)3-Bromo-2-Fluorobenzoic Acid (10)3-Bromo-2-Hydroxybenzoic Acid (4)3-Bromo-4-Chlorobenzoic Acid (6)3-Bromo-4-Fluorobenzoic Acid (10)3-Bromo-4-Hydroxybenzoic Acid (3)3-Bromo-4-Methoxybenzoic Acid (7)3-Bromo-4-Methylbenzoic Acid (9)3-Bromobenzoic Acid (159)3-Chloro-2-Fluorobenzoic Acid (9)3-Chloro-2-Methoxybenzoic Acid (4)3-Chloro-4-Fluorobenzoic Acid (8)3-Chloro-4-Methoxybenzoic Acid (5)3-Chlorobenzoic Acid (144)3-Fluoro-4-Methoxybenzoic Acid (6)3-Fluorobenzoic Acid (206)3-Fluoropicolinic Acid (6)3-Iodobenzoic Acid (55)3-Methoxy-4-Nitrobenzoic Acid (4)3-Methylpicolinic Acid (13)3-Nitrobenzoic Acid (109)3-Phenoxybenzoic Acid (6)3-Phenoxypropanoic Acid (14)4-(1H-Pyrazol-1-Yl)Benzoic Acid (3)4-(Benzyloxy)Benzoic Acid (5)4-(Phenyldiazenyl)Benzoic Acid (4)4-(Trifluoromethyl)Nicotinic Acid (3)4-Amino-3-Chlorobenzoic Acid (6)4-Benzamidobenzoic Acid (3)4-Cyclohexylbenzoic Acid (6)4-Fluoro-3-Iodobenzoic Acid (5)4-Fluorobenzoic Acid (114)4-Methylnicotinic Acid (5)4-Morpholinobenzoic Acid (5)4-Nitrobenzoic Acid (35)4-Oxo-1,4-Dihydroquinoline-3-Carboxylic Acid (3)4-Oxo-4-(Phenylamino)Butanoic Acid (7)4-Oxo-4-Phenylbutanoic Acid (16)4-Oxopiperidine-2-Carboxylic Acid (3)4-Phenoxybenzoic Acid (4)4-Phenylbutanoic Acid (19)5'-(4-Carboxyphenyl)-[1,1':3',1''-Terphenyl]-4,4''-Dicarboxylic Acid (7)5-Oxotetrahydrofuran-2-Carboxylic Acid (4)5-Phenyl-1H-Pyrazole-3-Carboxylic Acid (15)5-Phenylfuran-2-Carboxylic Acid (6)5-Phenylisoxazole-3-Carboxylic Acid (15)6,6-Dimethylmorpholine-3-Carboxylic Acid (5)6-Methoxypicolinic Acid (9)6-Methylnicotinic Acid (6)6-Methylpicolinic Acid (12)6-Oxopiperidine-2-Carboxylic Acid (3)6-Phenylpicolinic Acid (3)7-Fluoro-1H-Indole-2-Carboxylic Acid (5)[1,1'-Biphenyl]-2-Carboxylic Acid (24)[1,1'-Biphenyl]-3-Carboxylic Acid (39)Azetidine-2-Carboxylic Acid (6)Benzo[B]Thiophene-2-Carboxylic Acid (32)Benzo[D]Thiazole-6-Carboxylic Acid (5)Benzofuran-2-Carboxylic Acid (21)Benzofuran-3-Carboxylic Acid (6)Benzoic Acid (3519)Benzoylglycine (15)Bicyclo[1.1.1]Pentane-1-Carboxylic Acid (6)Chromane-2-Carboxylic Acid (6)Chromane-3-Carboxylic Acid (4)Cyclobutanecarboxylic Acid (23)Cyclohex-1-Ene-1-Carboxylic Acid (4)Cyclohex-3-Ene-1-Carboxylic Acid (7)Cyclohexanecarboxylic Acid (83)Cyclopentanecarboxylic Acid (26)Cyclopropanecarboxylic Acid (11)Ethyl 5-Oxopyrrolidine-2-Carboxylate (3)Furan-2-Carboxylic Acid (31)Furan-3-Carboxylic Acid (11)Imidazo[1,2-A]Pyridine-2-Carboxylic Acid (21)Imidazo[1,2-A]Pyridine-3-Carboxylic Acid (14)Imidazo[1,2-A]Pyridine-5-Carboxylic Acid (3)Imidazo[1,2-A]Pyridine-7-Carboxylic Acid (5)Imidazo[1,2-A]Pyridine-8-Carboxylic Acid (6)Imidazo[1,2-A]Pyrimidine-3-Carboxylic Acid (5)Indoline-2-Carboxylic Acid (3)Isonicotinic Acid (23)Isoquinoline-1-Carboxylic Acid (10)Isoquinoline-3-Carboxylic Acid (7)Isoquinoline-4-Carboxylic Acid (12)Isoquinoline-5-Carboxylic Acid (5)Isoquinoline-6-Carboxylic Acid (3)Isoxazole-3-Carboxylic Acid (8)Isoxazole-5-Carboxylic Acid (7)Methyl Benzofuran-2-Carboxylate (6)Methyl Isoquinoline-3-Carboxylate (3)Morpholine-2-Carboxylic Acid (12)Morpholine-3-Carboxylic Acid (10)Nicotinic Acid (53)Oxazole-4-Carboxylic Acid (4)Picolinic Acid (22)Piperidine-2-Carboxylic Acid (26)Piperidine-3-Carboxylic Acid (14)Piperidine-4-Carboxylic Acid (11)Proline (13)Pyrazine-2-Carboxylic Acid (34)Pyrazolo[1,5-A]Pyrimidine-3-Carboxylic Acid (7)Pyridazine-3-Carboxylic Acid (7)Pyridine-2,6-Dicarboxylic Acid (9)Pyrimidine-2-Carboxylic Acid (11)Pyrimidine-4-Carboxylic Acid (17)Pyrimidine-5-Carboxylic Acid (7)Pyrrolidine-3-Carboxylic Acid (14)Tetrahydrofuran-2-Carboxylic Acid (4)Tetrahydrofuran-3-Carboxylic Acid (4)Thiazole-2-Carboxylic Acid (9)Thiazole-4-Carboxylic Acid (5)Thiazole-5-Carboxylic Acid (10)Thiophene-3-Carboxylic Acid (8)Tryptophan (21)
Chlorides (77875)
Chloroacetamide (17)Chloroacetyl (12)Chloroaniline (18)Chlorobenzaldehyde (18)Chlorobenzamide (12)Chlorobutyl (6)Chlorobutyl (6)Chlorocarbonyl (7)Chloroethoxy (10)Chloroethoxy (10)Chloroethyl (89)Chloromethyl (479)Chloropicolinaldehyde (8)Chloropicolinamide (5)Chloropropane (18)Chloropropane (18)Chloropropoxy (2)Chloropropoxy (2)Chloropropyl (23)Dichloride (28)Dichloroaniline (9)Dichloroanthracene (3)Dichlorobenzaldehyde (13)Dichlorobenzamide (8)Dichloroisonicotinaldehyde (4)Dichloromethyl (3)Dichloromethyl (3)Dichloronicotinaldehyde (6)Dichloronicotinic (6)Dichloronicotinic (6)Dichloronicotinic Acid (5)Dichloropalladium (4)Dichloropalladium (4)Tetrachloro (2)Tetrachloro (2)Trichloro (36)Trichloro (36)Trichloroacetimidate (5)Trichloroaniline (6)Trichlorobenzaldehyde (4)Trichloromethyl (11)Trichloromethyl (11)(2,3-Dichlorophenyl)Boronic Acid (11)(2,6-Dichlorophenyl)Boronic Acid (6)(2-Chloroethoxy)Benzene (5)(2-Chlorophenyl)(Phenyl)Methanone (19)(2-Chlorophenyl)Hydrazine (16)(2-Chlorophenyl)Methanamine (28)(2-Chlorophenyl)Methanol (39)(2-Chloropyridin-4-Yl)Boronic Acid (6)(3,4-Dichlorophenyl)Boronic Acid (10)(3-Chloro-4-Fluorophenyl)Boronic Acid (8)(3-Chlorophenyl)(Phenyl)Methanone (19)(3-Chlorophenyl)Boronic Acid (121)(3-Chlorophenyl)Hydrazine (12)(3-Chlorophenyl)Methanamine (19)(3-Chlorophenyl)Methanol (38)(3-Chloropyridin-2-Yl)Methanamine (6)(4-Chlorophenyl)(Phenyl)Methanone (10)(5-Chloropyridin-2-Yl)Methanamine (5)(Chloromethanetriyl)Tribenzene (7)(Chloromethylene)Dibenzene (5)1,2,3,4-Tetrachlorobenzene (8)1,2,4-Trichlorobenzene (26)1,2-Dibromo-3-Chlorobenzene (3)1,2-Dichloro-3-Fluorobenzene (13)1,2-Dichloro-3-Methoxybenzene (7)1,2-Dichloro-3-Methylbenzene (8)1,2-Dichloro-4-Fluorobenzene (15)1,2-Dichloro-4-Methoxybenzene (11)1,2-Dichloro-4-Nitrobenzene (16)1,3-Dibromo-2-Chlorobenzene (8)1,3-Dichloro-2-Fluorobenzene (23)1,3-Dichloro-2-Iodobenzene (5)1,3-Dichloro-2-Methoxybenzene (9)1,3-Dichloro-2-Nitrobenzene (5)1,3-Dichloroisoquinoline (14)1,4-Dichloro-2-Fluorobenzene (11)1,4-Dichloro-2-Methoxybenzene (8)1-(2-Chlorophenyl)Ethan-1-One (40)1-(2-Chlorophenyl)Piperazine (4)1-(3-Chlorophenyl)-1H-Pyrazole (3)1-(3-Chlorophenyl)-N-Methylmethanamine (8)1-(3-Chlorophenyl)Ethan-1-One (38)1-(3-Chlorophenyl)Pyrrolidine (3)1-(Benzyloxy)-2-Chlorobenzene (16)1-(Benzyloxy)-3-Chlorobenzene (6)1-(Bromomethyl)-2-Chlorobenzene (28)1-(Bromomethyl)-3-Chlorobenzene (27)1-(Chloromethyl)-2-Methylbenzene (7)1-Benzyl-2-Chlorobenzene (9)1-Benzyl-3-Chlorobenzene (3)1-Benzyl-4-Chlorobenzene (6)1-Bromo-2,3-Dichlorobenzene (18)1-Bromo-2-Chloro-3-Methylbenzene (9)1-Bromo-3-Chloro-2-Fluorobenzene (9)1-Bromo-3-Chloro-2-Methylbenzene (6)1-Bromo-4-Chloro-2-Fluorobenzene (22)1-Chloro-2,3-Difluorobenzene (27)1-Chloro-2,4-Difluorobenzene (35)1-Chloro-2,4-Dimethoxybenzene (7)1-Chloro-2-(Chloromethyl)Benzene (12)1-Chloro-2-(Trifluoromethoxy)Benzene (20)1-Chloro-2-(Trifluoromethyl)Benzene (81)1-Chloro-2-Cyclopropylbenzene (7)1-Chloro-2-Ethoxybenzene (14)1-Chloro-2-Fluoro-3-Iodobenzene (5)1-Chloro-2-Fluoro-4-Nitrobenzene (9)1-Chloro-2-Iodobenzene (65)1-Chloro-2-Isocyanatobenzene (6)1-Chloro-2-Isothiocyanatobenzene (7)1-Chloro-2-Methyl-3-Nitrobenzene (6)1-Chloro-2-Nitrobenzene (138)1-Chloro-2-Phenoxybenzene (10)1-Chloro-2-Propoxybenzene (5)1-Chloro-3,5-Dimethylbenzene (8)1-Chloro-3-(Chloromethyl)Benzene (7)1-Chloro-3-(Trifluoromethoxy)Benzene (18)1-Chloro-3-(Trifluoromethyl)Benzene (101)1-Chloro-3-Fluoro-2-Methylbenzene (10)1-Chloro-3-Fluoro-2-Nitrobenzene (6)1-Chloro-3-Iodo-2-Methylbenzene (3)1-Chloro-3-Iodobenzene (77)1-Chloro-3-Methoxybenzene (126)1-Chloro-3-Nitrobenzene (161)1-Chloro-3-Phenoxybenzene (5)1-Chloro-4-(Trifluoromethoxy)Benzene (8)1-Chloro-4-Iodobenzene (49)1-Chloro-4-Methoxybenzene (98)1-Chloro-4-Phenoxybenzene (13)1-Chloroanthracene-9,10-Dione (6)1-Chloroisoquinoline (20)1-Chloronaphthalene (24)2,3,5-Trichloropyridine (13)2,3,6-Trichloropyridine (16)2,3-Dichloroaniline (18)2,3-Dichlorobenzaldehyde (7)2,3-Dichlorophenol (9)2,3-Dichloropyridine (38)2,4,5-Trichloropyrimidine (6)2,4,6-Trichloropyridine (5)2,4,6-Trichloropyrimidine (14)2,4-Dibromo-1-Chlorobenzene (8)2,4-Dichloro-1-Fluorobenzene (27)2,4-Dichloro-1-Methoxybenzene (18)2,4-Dichloro-1-Nitrobenzene (19)2,4-Dichloro-6-Methylpyridine (8)2,4-Dichloro-6-Methylpyrimidine (7)2,4-Dichlorobenzaldehyde (8)2,4-Dichlorobenzonitrile (4)2,4-Dichloropyridine (50)2,4-Dichloroquinazoline (19)2,4-Dichlorothiazole (4)2,5-Dichlorophenol (7)2,5-Dichloropyrazine (4)2,5-Dichloropyridine (32)2,6-Dichloro-3-Fluoropyridine (10)2,6-Dichloro-3-Methylpyridine (5)2,6-Dichloro-3-Nitropyridine (6)2,6-Dichloro-4-Methylpyridine (5)2,6-Dichloroaniline (27)2,6-Dichlorobenzoic Acid (13)2,6-Dichlorobenzonitrile (8)2,6-Dichloronicotinonitrile (8)2,6-Dichlorophenol (16)2,6-Dichloropyrazine (14)2,6-Dichloropyridin-3-Amine (11)2,6-Dichloropyridine (49)2-(2-Chlorophenyl)Acetic Acid (24)2-(2-Chlorophenyl)Acetonitrile (16)2-(2-Chlorophenyl)Ethan-1-Ol (8)2-(2-Chlorophenyl)Pyridine (3)2-(2-Chlorophenyl)Pyrrolidine (17)2-(3-Chlorophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (8)2-(3-Chlorophenyl)Acetonitrile (16)2-(4-Chlorophenoxy)Acetic Acid (3)2-(Chloromethyl)-1H-Benzo[D]Imidazole (9)2-(Chloromethyl)-3-Methylpyridine (12)2-(Chloromethyl)Furan (3)2-(Chloromethyl)Pyridine (12)2-(Chloromethyl)Pyridine 1-Oxide (4)2-(Chloromethyl)Pyrimidine (5)2-(Chloromethyl)Thiazole (5)2-Amino-3-Chlorobenzoic Acid (7)2-Amino-3-Chlorobenzonitrile (3)2-Amino-6-Chlorophenol (5)2-Bromo-1,3-Dichlorobenzene (12)2-Bromo-1,4-Dichlorobenzene (12)2-Bromo-1-Chloro-4-Methylbenzene (6)2-Bromo-4-Chloro-1-Iodobenzene (6)2-Bromo-4-Chloro-1-Methoxybenzene (7)2-Bromo-4-Chloro-1-Methylbenzene (11)2-Bromo-4-Chloroaniline (15)2-Bromo-4-Chlorophenol (11)2-Bromo-6-Chloroaniline (10)2-Bromo-6-Chlorophenol (5)2-Chloro-1,1'-Biphenyl (8)2-Chloro-1,3,5-Triazine (10)2-Chloro-1,3-Difluorobenzene (27)2-Chloro-1,3-Dimethoxybenzene (3)2-Chloro-1,3-Dinitrobenzene (2)2-Chloro-1,4-Difluorobenzene (25)2-Chloro-1,4-Dimethoxybenzene (4)2-Chloro-1-Fluoro-4-Nitrobenzene (16)2-Chloro-1-Methyl-3-Nitrobenzene (4)2-Chloro-1-Phenylethan-1-One (20)2-Chloro-1H-Benzo[D]Imidazole (17)2-Chloro-3,6-Dimethylpyridine (4)2-Chloro-3-(Trifluoromethyl)Aniline (3)2-Chloro-3-(Trifluoromethyl)Pyridine (12)2-Chloro-3-Fluoropyridin-4-Amine (3)2-Chloro-3-Hydroxybenzaldehyde (4)2-Chloro-3-Methoxypyridine (12)2-Chloro-3-Methylaniline (4)2-Chloro-3-Methylbenzoic Acid (4)2-Chloro-3-Methylbenzonitrile (5)2-Chloro-3-Methylpyrazine (7)2-Chloro-3-Methylpyridine (17)2-Chloro-3-Nitropyridine (10)2-Chloro-4,6-Dimethylpyridine (7)2-Chloro-4-(Trifluoromethyl)Pyridine (9)2-Chloro-4-Ethoxypyridine (5)2-Chloro-4-Fluoro-1-Nitrobenzene (13)2-Chloro-4-Fluoroaniline (19)2-Chloro-4-Fluoropyridine (10)2-Chloro-4-Methoxypyridine (22)2-Chloro-4-Methyl-1-Nitrobenzene (6)2-Chloro-4-Methylaniline (7)2-Chloro-4-Methylbenzoic Acid (3)2-Chloro-4-Methylpyridine (31)2-Chloro-4-Methylpyrimidine (16)2-Chloro-4-Methylthiazole (5)2-Chloro-4-Phenylpyrimidine (7)2-Chloro-5-(Trifluoromethyl)Pyridine (4)2-Chloro-5-Fluoropyridin-4-Amine (3)2-Chloro-5-Fluoropyridine (16)2-Chloro-5-Methoxyaniline (8)2-Chloro-5-Methylpyridine (11)2-Chloro-5-Methylpyrimidine (5)2-Chloro-5-Methylthiazole (5)2-Chloro-5-Nitropyridine (8)2-Chloro-6-(Trifluoromethyl)Aniline (4)2-Chloro-6-(Trifluoromethyl)Pyridine (16)2-Chloro-6-Fluoroaniline (8)2-Chloro-6-Fluorophenol (5)2-Chloro-6-Fluoropyridine (14)2-Chloro-6-Iodophenol (3)2-Chloro-6-Methoxyaniline (3)2-Chloro-6-Methoxyphenol (4)2-Chloro-6-Methoxypyridine (24)2-Chloro-6-Methyl-3-Nitropyridine (4)2-Chloro-6-Methylaniline (11)2-Chloro-6-Methylnicotinonitrile (10)2-Chloro-6-Methylphenol (5)2-Chloro-6-Methylpyrazine (12)2-Chloro-6-Methylpyridine (49)2-Chloro-6-Nitroaniline (11)2-Chloro-7H-Purine (3)2-Chloro-7H-Pyrrolo[2,3-D]Pyrimidine (13)2-Chloro-9H-Purine (5)2-Chloro-N-Phenylacetamide (26)2-Chloro-N-Phenylaniline (7)2-Chloroaniline (214)2-Chlorobenzamide (16)2-Chlorobenzene-1,3-Diamine (3)2-Chlorobenzene-1,3-Diol (4)2-Chlorobenzene-1,4-Diamine (6)2-Chlorobenzenesulfonyl Chloride (24)2-Chlorobenzenethiol (7)2-Chlorobenzo[D]Oxazole (11)2-Chlorobenzo[D]Thiazole (21)2-Chlorobenzoic Acid (130)2-Chlorobenzonitrile (99)2-Chlorobenzoyl Chloride (13)2-Chlorocyclohexa-2,5-Diene-1,4-Dione (4)2-Chlorofuran (3)2-Chloroisonicotinaldehyde (19)2-Chloroisonicotinic Acid (17)2-Chloroisonicotinonitrile (7)2-Chloronaphthalene (6)2-Chloronicotinic Acid (7)2-Chloronicotinonitrile (9)2-Chlorooxazole (7)2-Chlorophenol (163)2-Chloropyrazine (24)2-Chloropyridin-3-Amine (11)2-Chloropyridin-3-Ol (9)2-Chloropyridin-4-Amine (28)2-Chloropyridine 1-Oxide (10)2-Chloroquinoxaline (39)2-Chlorothiazole (32)2-Chlorothiophene (20)3,4-Dichloroaniline (21)3,5-Dichloropyridine (16)3,6-Dichloropyridazine (20)3-(3-Chlorophenyl)Propanoic Acid (11)3-(Chloromethyl)Pyridine (22)3-Chloro-1,1'-Biphenyl (12)3-Chloro-1-Methyl-1H-Pyrazole (7)3-Chloro-1-Phenylpropan-1-One (10)3-Chloro-1H-Indazole (13)3-Chloro-2-Fluoroaniline (9)3-Chloro-2-Fluorobenzaldehyde (9)3-Chloro-2-Fluorobenzoic Acid (9)3-Chloro-2-Fluorobenzonitrile (7)3-Chloro-2-Fluoropyridine (13)3-Chloro-2-Hydroxybenzaldehyde (5)3-Chloro-2-Methoxypyridine (16)3-Chloro-2-Methylaniline (11)3-Chloro-2-Methylpyridine (4)3-Chloro-2-Nitroaniline (5)3-Chloro-4-(Trifluoromethyl)Aniline (5)3-Chloro-4-Fluoroaniline (18)3-Chloro-4-Fluorobenzoic Acid (8)3-Chloro-4-Hydroxybenzaldehyde (7)3-Chloro-4-Methylaniline (12)3-Chloro-4-Methylpyridazine (7)3-Chloro-4-Nitroaniline (5)3-Chloro-5-Fluoropyridine (10)3-Chloro-5-Methylpyridine (7)3-Chloro-5-Nitropyridine (5)3-Chloro-9H-Carbazole (3)3-Chlorobenzaldehyde (106)3-Chlorobenzene-1,2-Diamine (6)3-Chlorobenzene-1,2-Diol (6)3-Chlorobenzenesulfonyl Chloride (21)3-Chlorobenzo[B]Thiophene (6)3-Chlorobenzoic Acid (144)3-Chlorobenzonitrile (100)3-Chloroimidazo[1,2-A]Pyridine (3)3-Chloroisoquinoline (20)3-Chlorophenol (112)3-Chloropicolinic Acid (9)3-Chloropicolinonitrile (6)3-Chloropyridazine (44)3-Chloropyridin-2-Amine (17)3-Chloropyridin-2-Ol (10)3-Chlorothiophene (17)4,5-Dichloropyrimidine (7)4,6-Dichloro-2-Methylpyrimidine (7)4,6-Dichloropyridin-2-Amine (6)4,6-Dichloropyridin-3-Amine (4)4,6-Dichloropyrimidine (14)4-Chloro-1,5-Naphthyridine (6)4-Chloro-1-Phenylbutan-1-One (8)4-Chloro-1H-Indazole (18)4-Chloro-1H-Indole (21)4-Chloro-1H-Pyrazole (10)4-Chloro-1H-Pyrazolo[3,4-B]Pyridine (5)4-Chloro-1H-Pyrazolo[3,4-D]Pyrimidine (5)4-Chloro-1H-Pyrazolo[4,3-C]Pyridine (7)4-Chloro-1H-Pyrrolo[3,2-C]Pyridine (10)4-Chloro-2,6-Dimethylpyridine (4)4-Chloro-2-Methoxypyridine (6)4-Chloro-2-Phenylpyrimidine (5)4-Chloro-3-Fluoroaniline (17)4-Chloro-3-Methylaniline (11)4-Chloro-3-Methylpyridine (7)4-Chloro-5-Methylpyrimidine (8)4-Chloro-N-Phenylaniline (6)4-Chlorobenzene-1,3-Diol (6)4-Chlorobenzenesulfonic Acid (4)4-Chlorobenzenesulfonyl Chloride (12)4-Chlorobenzo[D]Thiazole (7)4-Chloroindoline-2,3-Dione (6)4-Chloroisoquinoline (11)4-Chloronicotinic Acid (4)4-Chloropyridazine (16)4-Chloropyridin-2-Amine (6)4-Chloropyridine (31)4-Chloroquinazoline (39)5,6-Dichloro-1H-Benzo[D]Imidazole (4)5,6-Dichloropyridin-2-Amine (4)5-Bromo-4-Chloropyrimidine (4)5-Chloro-1,2,3,4-Tetrahydroisoquinoline (3)5-Chloro-1H-Imidazole (2)5-Chloro-1H-Indazole (9)5-Chloro-1H-Indole (64)5-Chloro-1H-Indole-2-Carboxylic Acid (6)5-Chloro-1H-Pyrazole (8)5-Chloro-1H-Pyrazolo[4,3-B]Pyridine (6)5-Chloro-1H-Pyrrolo[2,3-B]Pyridine (13)5-Chloro-1H-Pyrrolo[3,2-B]Pyridine (6)5-Chloro-2,3-Dihydrobenzofuran (5)5-Chloro-2-Fluoropyridine (13)5-Chloro-2-Methoxypyridine (10)5-Chloro-2-Methylpyridine (10)5-Chlorobenzo[B]Thiophene (4)5-Chlorobenzo[D]Oxazole (5)5-Chlorobenzo[D]Thiazole (5)5-Chloroimidazo[1,2-A]Pyridine (3)5-Chloroindolin-2-One (3)5-Chloroisoquinoline (6)5-Chloropicolinic Acid (7)5-Chloropicolinonitrile (6)5-Chloropyrazolo[1,5-A]Pyrimidine (24)5-Chloropyridin-2-Amine (26)5-Chloropyridin-2-Ol (15)5-Chloropyridin-3-Amine (7)5-Chloropyrimidine (8)5-Chloroquinazoline (4)6-Chloro-1,2,3,4-Tetrahydroisoquinoline (3)6-Chloro-1,2,3,4-Tetrahydroquinoline (3)6-Chloro-1H-Benzo[D]Imidazole (25)6-Chloro-1H-Indazole (14)6-Chloro-1H-Indole (19)6-Chloro-1H-Pyrazolo[4,3-C]Pyridine (8)6-Chloro-1H-Pyrrolo[2,3-B]Pyridine (13)6-Chloro-1H-Pyrrolo[3,2-C]Pyridine (13)6-Chloro-2,3-Dihydrobenzofuran (3)6-Chloro-3,4-Dihydro-2H-Benzo[B][1,4]Oxazine (5)6-Chloro-3-Nitropyridin-2-Amine (4)6-Chloro-5-(Trifluoromethyl)Pyridin-2-Amine (3)6-Chlorobenzo[D]Oxazole (4)6-Chlorobenzo[D]Thiazole (6)6-Chlorochroman-4-One (6)6-Chlorochromane (6)6-Chloroindoline (3)6-Chloroindoline-2,3-Dione (5)6-Chloronicotinaldehyde (24)6-Chloronicotinic Acid (4)6-Chloropicolinic Acid (12)6-Chloropicolinonitrile (9)6-Chloropyridazin-3(2H)-One (5)6-Chloropyridin-2-Amine (21)6-Chloropyridin-2-Ol (9)6-Chloropyridin-3-Amine (4)6-Chloropyridine-3-Sulfonyl Chloride (5)6-Chloroquinoxaline (3)7-Chloro-1,2,3,4-Tetrahydroisoquinoline (5)7-Chloro-1H-Indazole (7)7-Chloro-1H-Indole (29)7-Chloro-1H-Pyrrolo[2,3-C]Pyridine (5)7-Chloro-2,3-Dihydrobenzofuran (3)7-Chloro-3,4-Dihydronaphthalen-1(2H)-One (6)7-Chlorobenzo[D]Thiazole (6)7-Chlorochromane (5)7-Chloroisoquinoline (6)7-Chloropyrazolo[1,5-A]Pyrimidine (8)8-Chlorochromane (5)8-Chloroimidazo[1,2-A]Pyridine (7)8-Chloroisoquinoline (7)8-Chloroquinazoline (5)Ethyl 4,6-Dichloronicotinate (4)Ethyl 5-Chloro-1H-Indole-2-Carboxylate (5)Ethyl 6-Chloropicolinate (7)Ethyl 7-Chloro-1H-Indole-2-Carboxylate (5)Methyl 2,6-Dichlorobenzoate (7)Methyl 2-Chloro-4-Fluorobenzoate (5)Methyl 2-Chloro-6-Fluorobenzoate (7)Methyl 2-Chlorobenzoate (79)Methyl 2-Chloroisonicotinate (11)Methyl 2-Chloronicotinate (6)Methyl 3-Chlorobenzoate (88)Methyl 3-Chloropicolinate (9)Methyl 6-Chloropicolinate (11)N-(2-Chlorophenyl)Acetamide (16)N-(3-Chlorophenyl)Benzenesulfonamide (6)N-(3-Chlorophenyl)Quinazolin-4-Amine (9)N-(4-Chlorophenyl)Acetamide (9)Phenyl Carbonochloridate (5)Pyridine-2-Sulfonyl Chloride (9)Pyridine-3-Sulfonyl Chloride (25)Tert-Butyl (2-Chloropyridin-4-Yl)Carbamate (4)
Diazoes (3)
Difluoromethyls (32566)
(Difluoromethyl)Benzene (63)1-(Difluoromethoxy)-2-Fluorobenzene (11)1-(Difluoromethyl)-2-Fluorobenzene (13)1-Bromo-2-(Difluoromethyl)Benzene (5)2-(Difluoromethoxy)Phenol (5)2-(Difluoromethyl)Pyridine (21)3-(Difluoromethyl)Pyridine (5)4-(Difluoromethoxy)Aniline (6)5-(Difluoromethyl)-1H-Pyrazole (6)
Esters (51168)
Acetoxymethyl (85)Acetoxyphenyl (1)Acetyloxy (53)Acrylate (118)Acryloyloxy (3)Adipate (17)Adipate (17)Amino-Carboxylate (2)Aminobenzoate (18)Aminobenzylcarbamate (8)Aminobutanoate (14)Aminocyclobutanecarboxylic Acid (4)Aminocyclohexanecarboxylic (16)Aminocyclohexanecarboxylic Acid (10)Aminocyclopentanecarboxylic (13)Aminoheptanoate (9)Aminohexanoate (6)Aminoisonicotinate (4)Aminoisophthalate (5)Aminonicotinate (7)Aminopentanedioate (15)Aminopentanoate (7)Aminopropanoate (16)Benzoyloxy (14)Benzylcarbamate (8)Bromobenzoate (26)Bromobutanoate (9)Bromocyclopropanecarboxylate (1)Bromodecanoate (20)Bromoisonicotinate (8)Bromoisophthalate (3)Bromonicotinate (13)Bromopropanoate (9)Bromoundecanoate (3)Butoxycarbonyl (1675)Butoxycarbonyl (1675)Carbamate (1539)Chlorobenzoate (49)Chloroformate (4)Chloropicolinate (30)Chloropropanoate (5)Cyanoacrylate (6)Decanedioate (9)Decanedioate (9)Decanoate (7)Decanoate (7)Diacetate (56)Diacetoxy (1)Diacrylate (15)Diaminobenzoate (7)Dibromobenzoate (4)Dicarbamate (14)Dichlorobenzoate (24)Dichloroisonicotinate (9)Dimethacrylate (1)Dimethylbutanoate (14)Dimethylcarbamate (3)Dimethylnicotinate (10)Dimethylnicotinate (10)Dipropanoate (6)Dipropanoate (6)Diyldicarbamate (5)Dodecanoate (11)Enecarboxylate (9)Enoate (116)Ethoxycarbonyl (70)Ethylbutanoate (6)Ethynylbenzoate (7)Ethynylbenzylcarbamate (3)Glutarate (3)Glutarate (3)Hexanoate (14)Hexanoate (14)Indoline-Carboxylate (1)Iodoacrylate (6)Iodobutanoate (4)Iodopropanoate (1)Isobutyrate (18)Isobutyrate (18)Methacrylate (87)Methacryloyloxy (7)Methoxycarbonyl (169)Methoxycarbonyl (169)Methoxyisonicotinate (11)Methoxyisonicotinate (11)Methoxynicotinate (24)Methoxynicotinate (24)Methoxypropanoate (5)Methoxypropanoate (5)Methylacrylate (13)Methylbutanoate (38)Methylmalonate (6)Methylnicotinate (57)Methylpentanoate (17)Methylpropanoate (47)Nitropicolinate (13)Nonanedioate (4)Nonanedioate (4)Oxoacetate (21)Oxoacetate (21)Oxobutanoate (56)Oxobutanoate (56)Oxoheptanoate (8)Oxoheptanoate (8)Oxohexanoate (14)Oxohexanoate (14)Oxopentanoate (31)Oxopropanoate (39)Oxopropanoate (39)Pentanoate (13)Pentanoate (13)Phenylacrylate (5)Phenylpropanoate (42)Propanoate (296)Propylpentanoate (5)Propylpentanoate (5)Succinate (23)Succinate (23)Sulfamoylbenzoate (6)Tetraacetate (7)Tetraacetate (7)Tetradecanoate (10)Tetradecanoate (10)Thiophenecarboxylate (2)Tosylcarbamate (4)Tosyloxy (12)Triacetate (12)Triacetate (12)Vinylbenzoate (3)Vinylcyclopropanecarboxylic Acid (3)(2R,3S)-2-((Benzoyloxy)Methyl)Tetrahydrofuran-3-Yl Benzoate (8)(9H-Fluoren-9-Yl)Methyl (3-Phenylpropyl)Carbamate (24)1,3-Dioxoisoindolin-2-Yl 2-Phenylacetate (5)1-Benzyl 2-Methyl Pyrrolidine-1,2-Dicarboxylate (7)1-Benzyl 3-Methyl Piperidine-1,3-Dicarboxylate (3)1-Benzyl 4-(Tert-Butyl) Piperazine-1,4-Dicarboxylate (10)1H-Indol-3-Yl Acetate (4)2,5-Dioxopyrrolidin-1-Yl Benzoate (8)2-((Tert-Butoxycarbonyl)Amino)Benzoic Acid (11)2-(Diethylamino)Ethyl Benzoate (3)2-Ethylhexyl Benzoate (13)2-Hydroxyethyl Benzoate (3)2-Phenoxyacetyl Chloride (3)4-Cyanophenyl Benzoate (11)Allyl Benzoate (5)Azetidin-3-Yl Acetate (3)Benzoic Anhydride (6)Benzyl Acetate (11)Benzyl Benzoate (12)Benzyl Benzylcarbamate (16)Benzyl Cyclohexylcarbamate (9)Benzyl Morpholine-4-Carboxylate (5)Benzyl Phenylcarbamate (15)Benzyl Piperidine-1-Carboxylate (50)Butyl Benzoate (10)Dimethyl Isophthalate (32)Dimethyl Phthalate (14)Dimethyl Pyridine-2,6-Dicarboxylate (7)Ethane-1,2-Diyl Dibenzoate (11)Ethyl 1-Phenyl-1H-Pyrazole-3-Carboxylate (4)Ethyl 1-Phenyl-1H-Pyrazole-4-Carboxylate (13)Ethyl 1-Phenylcyclopropane-1-Carboxylate (4)Ethyl 1H-1,2,4-Triazole-3-Carboxylate (3)Ethyl 1H-Imidazole-2-Carboxylate (6)Ethyl 1H-Indole-3-Carboxylate (6)Ethyl 1H-Pyrazole-4-Carboxylate (11)Ethyl 1H-Pyrrole-2-Carboxylate (24)Ethyl 1H-Pyrrole-3-Carboxylate (8)Ethyl 2-(Imidazo[1,2-A]Pyridin-3-Yl)Acetate (3)Ethyl 2-(Pyridin-2-Yl)Acetate (15)Ethyl 2-Aminobenzoate (23)Ethyl 2-Aminothiazole-4-Carboxylate (6)Ethyl 2-Aminothiazole-5-Carboxylate (5)Ethyl 2-Bromo-2-Phenylacetate (6)Ethyl 2-Fluorobenzoate (37)Ethyl 2-Hydroxybenzoate (18)Ethyl 2-Iodobenzoate (4)Ethyl 2-Methylbenzoate (26)Ethyl 2-Methylnicotinate (6)Ethyl 2-Nitrobenzoate (9)Ethyl 2-Oxo-2-(Phenylamino)Acetate (8)Ethyl 2-Oxo-2-Phenylacetate (18)Ethyl 2-Oxo-2H-Chromene-3-Carboxylate (5)Ethyl 2-Phenoxyacetate (10)Ethyl 2-Phenylacetate (60)Ethyl 2-Phenylcyclopropane-1-Carboxylate (5)Ethyl 3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzoate (6)Ethyl 3-Aminobenzoate (19)Ethyl 3-Fluorobenzoate (34)Ethyl 3-Hydroxybenzoate (12)Ethyl 3-Iodobenzoate (11)Ethyl 3-Nitrobenzoate (22)Ethyl 3-Oxo-3-Phenylpropanoate (41)Ethyl 3-Phenylpropanoate (17)Ethyl 4-Aminobenzoate (23)Ethyl 4-Chloropyrimidine-5-Carboxylate (5)Ethyl 5-Fluoro-1H-Indole-2-Carboxylate (5)Ethyl 6-Chloro-1H-Indole-2-Carboxylate (5)Ethyl Benzo[B]Thiophene-2-Carboxylate (9)Ethyl Cinnamate (26)Ethyl Cyclohex-1-Ene-1-Carboxylate (5)Ethyl Cyclohexanecarboxylate (33)Ethyl Cyclopropanecarboxylate (8)Ethyl Furan-2-Carboxylate (6)Ethyl Imidazo[1,2-A]Pyridine-2-Carboxylate (25)Ethyl Imidazo[1,2-A]Pyridine-3-Carboxylate (13)Ethyl Isonicotinate (12)Ethyl Isoxazole-3-Carboxylate (8)Ethyl Isoxazole-4-Carboxylate (5)Ethyl Morpholine-2-Carboxylate (4)Ethyl Nicotinate (25)Ethyl Oxazole-4-Carboxylate (8)Ethyl Oxazole-5-Carboxylate (3)Ethyl Oxirane-2-Carboxylate (4)Ethyl Picolinate (41)Ethyl Piperidine-2-Carboxylate (9)Ethyl Piperidine-3-Carboxylate (14)Ethyl Piperidine-4-Carboxylate (10)Ethyl Pyrazine-2-Carboxylate (10)Ethyl Pyridazine-3-Carboxylate (6)Ethyl Pyrimidine-4-Carboxylate (7)Ethyl Pyrimidine-5-Carboxylate (5)Ethyl Quinazoline-2-Carboxylate (4)Ethyl Thiazole-2-Carboxylate (7)Ethyl Thiazole-4-Carboxylate (7)Ethyl Thiazole-5-Carboxylate (7)Ethyl Thiophene-2-Carboxylate (19)Ethyl Thiophene-3-Carboxylate (11)Hexyl Benzoate (5)Isobutyl Benzoate (10)Isopropyl Benzoate (10)Methyl 1-Naphthoate (7)Methyl 1H-Benzo[D]Imidazole-2-Carboxylate (3)Methyl 1H-Imidazole-2-Carboxylate (4)Methyl 1H-Imidazole-5-Carboxylate (8)Methyl 1H-Indazole-3-Carboxylate (23)Methyl 1H-Indazole-4-Carboxylate (10)Methyl 1H-Indazole-5-Carboxylate (3)Methyl 1H-Indazole-6-Carboxylate (9)Methyl 1H-Indazole-7-Carboxylate (8)Methyl 1H-Indole-3-Carboxylate (21)Methyl 1H-Indole-4-Carboxylate (9)Methyl 1H-Indole-5-Carboxylate (7)Methyl 1H-Indole-6-Carboxylate (9)Methyl 1H-Indole-7-Carboxylate (7)Methyl 1H-Pyrazole-4-Carboxylate (10)Methyl 1H-Pyrrole-2-Carboxylate (30)Methyl 1H-Pyrrole-3-Carboxylate (5)Methyl 1H-Pyrrolo[2,3-B]Pyridine-2-Carboxylate (3)Methyl 1H-Pyrrolo[2,3-B]Pyridine-3-Carboxylate (4)Methyl 1H-Pyrrolo[2,3-B]Pyridine-6-Carboxylate (3)Methyl 2,6-Dichlorobenzoate (7)Methyl 2,6-Difluorobenzoate (17)Methyl 2-(1H-Indol-3-Yl)Acetate (3)Methyl 2-(2-Bromophenyl)Acetate (8)Methyl 2-(4-Hydroxyphenyl)Acetate (10)Methyl 2-(Bromomethyl)Benzoate (33)Methyl 2-(Chlorosulfonyl)Benzoate (7)Methyl 2-(Morpholin-3-Yl)Acetate (3)Methyl 2-(Pyridin-2-Yl)Acetate (9)Methyl 2-(Trifluoromethyl)Benzoate (14)Methyl 2-Amino-2-Phenylacetate (38)Methyl 2-Aminobenzoate (95)Methyl 2-Aminothiazole-4-Carboxylate (6)Methyl 2-Bromo-2-Phenylacetate (7)Methyl 2-Bromo-3-Nitrobenzoate (3)Methyl 2-Bromo-5-Fluorobenzoate (8)Methyl 2-Bromo-6-Fluorobenzoate (7)Methyl 2-Bromo-6-Methylbenzoate (8)Methyl 2-Bromobenzoate (69)Methyl 2-Chloro-4-Fluorobenzoate (5)Methyl 2-Chloro-6-Fluorobenzoate (7)Methyl 2-Chlorobenzoate (79)Methyl 2-Cyanobenzoate (22)Methyl 2-Fluorobenzoate (132)Methyl 2-Hydroxybenzoate (74)Methyl 2-Iodobenzoate (28)Methyl 2-Methoxybenzoate (70)Methyl 2-Methyl-2H-Indazole-3-Carboxylate (3)Methyl 2-Methylbenzoate (101)Methyl 2-Naphthoate (11)Methyl 2-Nitrobenzoate (54)Methyl 2-Phenoxyacetate (12)Methyl 2-Phenoxybenzoate (4)Methyl 2-Phenylacetate (114)Methyl 3-(Benzyloxy)Benzoate (5)Methyl 3-(Bromomethyl)Benzoate (16)Methyl 3-(Trifluoromethyl)Benzoate (22)Methyl 3-Amino-3-Phenylpropanoate (27)Methyl 3-Aminobenzoate (88)Methyl 3-Bromo-4-Chlorobenzoate (6)Methyl 3-Bromo-4-Fluorobenzoate (7)Methyl 3-Bromo-4-Methoxybenzoate (10)Methyl 3-Bromo-4-Methylbenzoate (9)Methyl 3-Bromobenzoate (153)Methyl 3-Bromopyrazine-2-Carboxylate (5)Methyl 3-Chlorobenzoate (88)Methyl 3-Cyanobenzoate (29)Methyl 3-Fluorobenzoate (136)Methyl 3-Formylbenzoate (23)Methyl 3-Hydroxybenzoate (58)Methyl 3-Iodo-4-Methylbenzoate (6)Methyl 3-Iodobenzoate (47)Methyl 3-Methoxybenzoate (70)Methyl 3-Methylbenzoate (75)Methyl 3-Nitrobenzoate (109)Methyl 3-Oxo-3-Phenylpropanoate (16)Methyl 3-Phenylpropanoate (28)Methyl 4-Amino-3-Bromobenzoate (8)Methyl 4-Amino-3-Iodobenzoate (7)Methyl 4-Amino-3-Nitrobenzoate (9)Methyl 4-Aminobenzoate (71)Methyl 4-Fluorobenzoate (75)Methyl 4-Nitrobenzoate (29)Methyl 4-Oxocyclohexane-1-Carboxylate (5)Methyl 4-Oxopiperidine-2-Carboxylate (3)Methyl 4-Phenoxybenzoate (3)Methyl 5-Amino-2-Bromobenzoate (6)Methyl 5-Hydroxypicolinate (5)Methyl 5-Oxopyrrolidine-2-Carboxylate (3)Methyl 5-Phenylisoxazole-3-Carboxylate (6)Methyl 6-Bromopyrazine-2-Carboxylate (7)Methyl 6-Chloropyrazine-2-Carboxylate (5)Methyl 6-Methoxynicotinate (4)Methyl [1,1'-Biphenyl]-4-Carboxylate (8)Methyl Azetidine-2-Carboxylate (3)Methyl Benzo[B]Thiophene-2-Carboxylate (27)Methyl Benzo[D]Oxazole-2-Carboxylate (3)Methyl Benzo[D]Thiazole-6-Carboxylate (5)Methyl Bicyclo[1.1.1]Pentane-1-Carboxylate (10)Methyl Cinnamate (36)Methyl Cyclobutanecarboxylate (24)Methyl Cyclohex-3-Ene-1-Carboxylate (3)Methyl Cyclohexanecarboxylate (45)Methyl Cyclopentanecarboxylate (18)Methyl Cyclopropanecarboxylate (8)Methyl Furan-2-Carboxylate (20)Methyl Imidazo[1,2-A]Pyridine-8-Carboxylate (3)Methyl Indoline-6-Carboxylate (3)Methyl Isonicotinate (16)Methyl Isoquinoline-4-Carboxylate (6)Methyl L-Phenylalaninate (20)Methyl Morpholine-2-Carboxylate (4)Methyl Morpholine-3-Carboxylate (10)Methyl Nicotinate (52)Methyl Oxazole-4-Carboxylate (9)Methyl Piperidine-2-Carboxylate (12)Methyl Piperidine-3-Carboxylate (19)Methyl Prolinate (43)Methyl Pyrazine-2-Carboxylate (19)Methyl Pyridazine-3-Carboxylate (7)Methyl Pyrimidine-2-Carboxylate (10)Methyl Pyrimidine-4-Carboxylate (11)Methyl Pyrimidine-5-Carboxylate (5)Methyl Pyrrolidine-3-Carboxylate (9)Methyl Thiazole-2-Carboxylate (6)Methyl Thiazole-4-Carboxylate (6)Methyl Thiophene-3-Carboxylate (34)Phenyl (1R,4R)-[1,1'-Bi(Cyclohexane)]-4-Carboxylate (6)Phenyl Dimethylcarbamate (5)Phenyl Ethyl(Methyl)Carbamate (5)Propyl Benzoate (11)Tert-Butyl (1-Phenylethyl)Carbamate (19)Tert-Butyl (2,3-Dihydro-1H-Inden-1-Yl)Carbamate (3)Tert-Butyl (2-Phenylcyclopropyl)Carbamate (3)Tert-Butyl (3-Oxocyclohexyl)Carbamate (3)Tert-Butyl (Morpholin-2-Ylmethyl)Carbamate (3)Tert-Butyl (Tetrahydrofuran-3-Yl)Carbamate (4)Tert-Butyl 1H-Benzo[D]Imidazole-1-Carboxylate (5)Tert-Butyl 1H-Imidazole-1-Carboxylate (6)Tert-Butyl 1H-Indazole-1-Carboxylate (29)Tert-Butyl 1H-Indole-1-Carboxylate (18)Tert-Butyl 1H-Pyrrole-1-Carboxylate (8)Tert-Butyl 1H-Pyrrole-2-Carboxylate (3)Tert-Butyl 1H-Pyrrolo[2,3-B]Pyridine-1-Carboxylate (9)Tert-Butyl 3,4-Dihydroisoquinoline-2(1H)-Carboxylate (19)Tert-Butyl 3-((Methylsulfonyl)Oxy)Pyrrolidine-1-Carboxylate (5)Tert-Butyl 3-Oxopiperazine-1-Carboxylate (7)Tert-Butyl 4-Phenylpiperazine-1-Carboxylate (23)Tert-Butyl 4-Phenylpiperidine-1-Carboxylate (16)Tert-Butyl Azetidine-1-Carboxylate (64)Tert-Butyl Benzoate (66)Tert-Butyl Benzylcarbamate (52)Tert-Butyl Bicyclo[1.1.1]Pentan-1-Ylcarbamate (5)Tert-Butyl Cyclopentylcarbamate (28)Tert-Butyl Isoindoline-2-Carboxylate (13)Tert-Butyl Methyl(Phenyl)Carbamate (9)Tert-Butyl Morpholine-4-Carboxylate (23)Tert-Butyl O-Tolylcarbamate (11)Tert-Butyl Phenethylcarbamate (12)Tert-Butyl Piperazine-1-Carboxylate (30)Tert-Butyl Pyrrolidine-1-Carboxylate (21)
Ethers (82526)
Butoxy-Phenyl-Boronic Acid/Ester (76)Diethoxy (14)Diethoxy (14)Diethoxyethyl (9)Diethoxyethyl (9)Diethoxymethyl (8)Diethoxymethyl (8)Dimethoxyethyl (8)Dimethoxypropane (11)Dimethoxypropane (11)Dioxane (153)Dioxepine (7)Dioxepine (7)Disulfide (38)Methoxyphenylboronic-Acid (32)(1S,4Ar,7Ar)-1-(((S)-Tetrahydro-2H-Pyran-2-Yl)Oxy)-1,4A,5,7A-Tetrahydrocyclopenta[C]Pyran (4)(2,2,2-Trifluoroethoxy)Benzene (18)(2-(Benzyloxy)Phenyl)Boronic Acid (23)(2-(Phenoxymethyl)Phenyl)Boronic Acid (3)(2-Chloro-3-Methoxyphenyl)Boronic Acid (5)(2-Chloroethoxy)Benzene (5)(2-Methoxyethoxy)Benzene (32)(3-(Benzyloxy)Phenyl)Boronic Acid (9)(3-(Phenoxymethyl)Phenyl)Boronic Acid (3)(3-Chloro-2-Methoxyphenyl)Boronic Acid (4)(3-Phenoxyphenyl)Methanol (3)(4-(Benzyloxy)Phenyl)Boronic Acid (26)(4-(Phenoxymethyl)Phenyl)Boronic Acid (6)(4-Methoxyphenyl)(Phenyl)Methanone (7)(9H-Fluoren-9-Yl)Methyl (2-(Benzyloxy)Ethyl)Carbamate (6)(9H-Fluoren-9-Yl)Methyl (4-Methoxybenzyl)Carbamate (7)(Allyloxy)Benzene (19)(Ethoxymethyl)Benzene (7)(Hexyloxy)Benzene (7)(Methoxymethyl)Benzene (30)(Prop-2-Yn-1-Yloxy)Benzene (13)(R)-2-Phenoxytetrahydro-2H-Pyran (7)(S)-7-(((S)-Tetrahydro-2H-Pyran-2-Yl)Oxy)-7,8,9,10-Tetrahydrotetracene-5,12-Dione (5)1,2-Bis(Benzyloxy)Benzene (11)1,2-Dichloro-3-Methoxybenzene (7)1,2-Dichloro-4-Methoxybenzene (11)1,2-Difluoro-3-Methoxybenzene (28)1,2-Difluoro-4-Methoxybenzene (19)1,2-Dimethoxybenzene (223)1,2-Diphenoxyethane (11)1,3-Bis(Benzyloxy)Benzene (8)1,3-Dibromo-2-Methoxybenzene (11)1,3-Dichloro-2-Methoxybenzene (9)1,3-Diiodo-2-Phenoxybenzene (3)1,3-Dimethoxybenzene (235)1,3-Diphenoxybenzene (8)1,4-Dichloro-2-Methoxybenzene (8)1,4-Dimethoxybenzene (66)1-(2-Methoxyphenyl)Ethan-1-One (33)1-(3-(Benzyloxy)Phenyl)Ethan-1-One (3)1-(3-Methoxyphenyl)Ethan-1-One (38)1-(3-Methoxyphenyl)Piperazine (4)1-(4-(Benzyloxy)Phenyl)Ethan-1-One (4)1-(4-Methoxybenzyl)-1H-Pyrazole (5)1-(Benzyloxy)-2-Bromobenzene (12)1-(Benzyloxy)-2-Chlorobenzene (16)1-(Benzyloxy)-2-Fluorobenzene (10)1-(Benzyloxy)-2-Methoxybenzene (19)1-(Benzyloxy)-2-Methylbenzene (12)1-(Benzyloxy)-2-Nitrobenzene (3)1-(Benzyloxy)-3-Bromobenzene (12)1-(Benzyloxy)-3-Chlorobenzene (6)1-(Benzyloxy)-3-Fluorobenzene (14)1-(Benzyloxy)-3-Methylbenzene (8)1-(Benzyloxy)-3-Nitrobenzene (10)1-(Benzyloxy)-4-Bromobenzene (8)1-(Benzyloxy)-4-Iodobenzene (3)1-(Bromomethyl)-2-Methoxybenzene (14)1-(Bromomethyl)-3-Methoxybenzene (19)1-(Difluoromethoxy)-2-Fluorobenzene (11)1-Benzyl-4-Methoxybenzene (8)1-Bromo-2,3-Dimethoxybenzene (8)1-Bromo-2-Chloro-3-Methoxybenzene (6)1-Bromo-2-Ethoxybenzene (16)1-Bromo-2-Fluoro-3-Methoxybenzene (7)1-Bromo-2-Phenoxybenzene (3)1-Bromo-3-Methoxybenzene (187)1-Bromo-3-Phenoxybenzene (8)1-Bromo-4-Phenoxybenzene (8)1-Chloro-2,4-Dimethoxybenzene (7)1-Chloro-2-Ethoxybenzene (14)1-Chloro-2-Phenoxybenzene (10)1-Chloro-2-Propoxybenzene (5)1-Chloro-3-Fluoro-2-Methoxybenzene (4)1-Chloro-3-Methoxybenzene (126)1-Chloro-3-Phenoxybenzene (5)1-Chloro-4-Methoxybenzene (98)1-Chloro-4-Phenoxybenzene (13)1-Cyclopropyl-3-(4-(Quinolin-4-Yloxy)Phenyl)Urea (6)1-Ethoxy-2,3-Difluorobenzene (9)1-Ethoxy-2-Fluorobenzene (37)1-Ethoxy-3-Nitrobenzene (7)1-Fluoro-2-(Trifluoromethoxy)Benzene (20)1-Fluoro-2-Isopropoxybenzene (18)1-Fluoro-2-Phenoxybenzene (11)1-Fluoro-3-Methoxybenzene (213)1-Fluoro-3-Phenoxybenzene (8)1-Fluoro-4-(Trifluoromethoxy)Benzene (14)1-Fluoro-4-Methoxybenzene (125)1-Fluoro-4-Phenoxybenzene (8)1-Iodo-2-Methoxybenzene (50)1-Iodo-3-Methoxybenzene (48)1-Iodo-4-Methoxybenzene (34)1-Iodo-4-Phenoxybenzene (4)1-Methoxy-2-(Trifluoromethyl)Benzene (21)1-Methoxy-3-(Trifluoromethoxy)Benzene (9)1-Methoxy-3-(Trifluoromethyl)Benzene (40)1-Methoxy-3-Nitrobenzene (108)1-Methoxy-4-(Phenoxymethyl)Benzene (3)1-Methoxy-4-(Trifluoromethyl)Benzene (18)1-Methoxy-4-Nitrobenzene (90)1-Methoxynaphthalene (17)1-Methyl-3-Phenoxybenzene (9)1-Nitro-2-Phenoxybenzene (4)1-Nitro-4-Phenoxybenzene (5)1-Phenoxy-3-(Trifluoromethyl)Benzene (2)1-Phenoxy-4-(Trifluoromethyl)Benzene (2)1-Phenyl-3-(4-(Pyridin-4-Yloxy)Phenyl)Urea (8)2,3,5,6,8,9,11,12-Octahydrobenzo[B][1,4,7,10,13]Pentaoxacyclopentadecine (8)2,3-Dimethoxypyridine (7)2,4,6-Triphenoxy-1,3,5-Triazine (4)2,4-Dibromo-1-Methoxybenzene (6)2,4-Dichloro-1-Methoxybenzene (18)2,4-Difluoro-1-Methoxybenzene (25)2,4-Dimethoxy-1-Nitrobenzene (5)2,4-Dimethoxypyrimidine (13)2,6-Dimethoxypyridine (11)2-(2-Methoxyphenyl)Acetic Acid (16)2-(3-Isopropoxyphenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (5)2-(3-Methoxyphenyl)Acetic Acid (23)2-(4-(Benzyloxy)Phenyl)Acetonitrile (3)2-(4-Methoxyphenyl)Acetic Acid (19)2-(Benzyloxy)Benzaldehyde (13)2-(Benzyloxy)Naphthalene (5)2-(Benzyloxy)Phenol (5)2-(Methoxymethyl)Morpholine (4)2-(Methoxymethyl)Pyrrolidine (6)2-(Phenoxymethyl)Oxirane (13)2-(Phenoxymethyl)Pyridine (5)2-(Phenoxymethyl)Tetrahydro-2H-Pyran (5)2-Bromo-1,3-Dimethoxybenzene (7)2-Bromo-1,4-Dimethoxybenzene (11)2-Bromo-1-Fluoro-4-Methoxybenzene (12)2-Bromo-1-Methoxy-3-Methylbenzene (3)2-Bromo-1-Methoxy-4-Methylbenzene (7)2-Bromo-3-Methoxypyrazine (5)2-Bromo-4-Methoxy-1-Nitrobenzene (6)2-Bromo-4-Methoxyaniline (6)2-Bromo-4-Methoxybenzaldehyde (8)2-Bromo-4-Methoxybenzoic Acid (4)2-Bromo-5-Methoxybenzaldehyde (6)2-Bromo-6-Methoxyaniline (5)2-Bromo-6-Methoxyphenol (5)2-Chloro-1,3-Dimethoxybenzene (3)2-Chloro-1,4-Dimethoxybenzene (4)2-Chloro-3-Methoxybenzaldehyde (7)2-Chloro-3-Methoxybenzoic Acid (6)2-Chloro-4-Fluoro-1-Methoxybenzene (10)2-Chloro-4-Methoxypyrimidine (14)2-Chloro-5-Methoxyaniline (8)2-Chloro-6-Methoxyaniline (3)2-Chloro-6-Methoxyphenol (4)2-Ethoxynaphthalene (4)2-Ethoxypyridine (20)2-Ethoxypyrimidine (7)2-Fluoro-1,3-Dimethoxybenzene (8)2-Fluoro-1-Methoxy-4-Nitrobenzene (8)2-Fluoro-4-Methoxyaniline (6)2-Fluoro-5-Methoxybenzoic Acid (9)2-Fluoro-5-Methoxypyridine (4)2-Fluoro-6-Methoxypyridine (6)2-Isopropoxypyridine (16)2-Methoxy-1,1'-Biphenyl (7)2-Methoxy-1,3,5-Triazine (10)2-Methoxy-4-Methylpyridine (5)2-Methoxy-5-Methylpyridine (5)2-Methoxy-6-Methylpyridine (14)2-Methoxy-6-Nitrophenol (5)2-Methoxybenzamide (9)2-Methoxybenzenesulfonyl Chloride (15)2-Methoxynaphthalene (22)2-Methoxyphenol (197)2-Methoxypyrazine (45)2-Methoxypyridine (436)2-Methoxypyrimidin-4-Amine (6)2-Methoxypyrimidine (59)2-Methoxythiophene (7)2-Methyl-N-Phenylaniline (6)2-Phenoxyacetonitrile (11)2-Phenoxyaniline (4)2-Phenoxybenzonitrile (5)2-Phenoxyethan-1-Ol (14)2-Phenoxypropanoic Acid (13)2-Phenoxypyrimidine (8)2-Phenoxytetrahydro-2H-Pyran (6)2-Phenoxythiazole (5)2-Propoxypyridine (9)3,5-Dimethoxypyridine (4)3-(3-Methoxyphenyl)Propanoic Acid (9)3-(Benzyloxy)Aniline (12)3-(Benzyloxy)Benzaldehyde (13)3-(Benzyloxy)Benzoic Acid (5)3-(Benzyloxy)Phenol (5)3-(Methoxymethyl)Morpholine (4)3-Chloro-2-Methoxybenzoic Acid (4)3-Chloro-4-Methoxyaniline (6)3-Chloro-4-Methoxybenzaldehyde (7)3-Chloro-4-Methoxybenzoic Acid (5)3-Ethoxypyridine (12)3-Fluoro-2-Methoxypyridine (14)3-Fluoro-4-Methoxybenzoic Acid (6)3-Methoxypiperidine (7)3-Methoxypyridazine (17)3-Methoxypyridine (52)3-Methoxythiophene (9)3-Phenoxyaniline (2)3-Phenoxybenzaldehyde (7)3-Phenoxybenzoic Acid (6)3-Phenoxybenzonitrile (5)3-Phenoxypropanoic Acid (14)3-Phenoxypyrrolidine (5)4-(3-Phenoxypropyl)Morpholine (7)4-(Benzyloxy)Aniline (8)4-(Benzyloxy)Benzaldehyde (23)4-(Benzyloxy)Benzoic Acid (5)4-(Benzyloxy)Phenol (2)4-(Difluoromethoxy)Aniline (6)4-(Dimethoxymethyl)Pyrimidine (5)4-(Phenylethynyl)Phenol (7)4-Chloro-2-Methoxypyrimidine (12)4-Chloro-5-Methoxypyrimidine (7)4-Chloro-6-Methoxypyrimidine (5)4-Ethoxypyridine (7)4-Ethoxypyrimidine (6)4-Methoxy-1,1'-Biphenyl (4)4-Methoxy-1H-Indazole (7)4-Methoxy-1H-Indole (11)4-Methoxy-2-Methylpyrimidine (8)4-Methoxy-N-Phenylaniline (5)4-Methoxy-N-Phenylbenzenesulfonamide (3)4-Methoxybenzenesulfonamide (5)4-Methoxypyridazine (8)4-Methoxypyridine (136)4-Methoxypyrimidin-2-Amine (6)4-Methoxypyrimidine (102)4-Phenoxyaniline (6)4-Phenoxybenzaldehyde (12)4-Phenoxybenzoic Acid (4)4-Phenoxypyridine (7)4-Phenoxypyrimidine (5)4-Phenoxyquinoline (5)4-Phenoxytetrahydro-2H-Pyran (5)5-(Benzyloxy)Pyrimidine (5)5-Fluoro-2-Methoxypyridine (15)5-Methoxy-1H-Benzo[D]Imidazole (2)5-Methoxy-1H-Indazole (5)5-Methoxy-1H-Indole (11)5-Methoxy-2-Methyl-1H-Indole (5)5-Methoxy-2-Nitroaniline (7)5-Methoxyindoline (4)5-Methoxyisobenzofuran-1(3H)-One (5)5-Methoxyisoquinoline (6)6-Methoxy-1,2,3,4-Tetrahydroisoquinoline (3)6-Methoxy-1H-Indazole (14)6-Methoxy-1H-Indole (12)6-Methoxy-1H-Pyrrolo[2,3-B]Pyridine (3)6-Methoxy-3,4-Dihydroisoquinolin-1(2H)-One (3)6-Methoxybenzo[D]Thiazole (6)6-Methoxybenzofuran (4)6-Methoxychromane (5)6-Methoxyisoindolin-1-One (3)6-Methoxyquinoxaline (6)7-(Benzyloxy)Quinoline (6)7-Methoxy-1,2,3,4-Tetrahydroisoquinoline (6)7-Methoxy-1H-Indazole (5)7-Methoxy-1H-Indole (8)7-Methoxy-3,4-Dihydroquinolin-2(1H)-One (3)7-Methoxyisoquinoline (5)8-Methoxyisoquinoline (7)8-Methoxyquinazoline (3)Butoxybenzene (51)Ethoxybenzene (285)Ethyl 2-Phenoxyacetate (10)Isobutoxybenzene (22)Isopropoxybenzene (85)Methoxycyclohexane (7)Methyl 2-Methoxybenzoate (70)Methyl 2-Phenoxyacetate (12)Methyl 2-Phenoxybenzoate (4)Methyl 3-(Benzyloxy)Benzoate (5)Methyl 3-Methoxybenzoate (70)Methyl 4-Phenoxybenzoate (3)N,N-Dimethyl-2-Phenoxyethan-1-Amine (17)N-(2-Phenoxyphenyl)Methanesulfonamide (4)N-(4-Phenoxyphenyl)Acetamide (4)N-Phenyl-N-(4-(Quinolin-4-Yloxy)Phenyl)Cyclopropane-1,1-Dicarboxamide (5)Phenethoxybenzene (23)Propoxybenzene (63)Tert-Butoxybenzene (19)Tert-Butyl 3-Methoxypyrrolidine-1-Carboxylate (6)Tert-Butyl 4-Phenoxypiperidine-1-Carboxylate (12)Tert-Butyl 5-Methoxy-1H-Indole-1-Carboxylate (6)
Fluorinated Building Blocks (99063)
Dichlorofluorobenzene (23)Difluoro (901)Difluoroaniline (37)Difluorobenzaldehyde (33)Difluorobenzamide (6)Difluorobenzenesulfonamide (5)Difluorobenzoate (59)Difluoroethyl (27)Difluoroethyl (27)Difluoromethoxy (200)Difluoromethoxy (200)Difluoropropan (7)Difluoropropan (7)Fluindamine (32)Fluoroacetanilide (5)Fluoroacetophenone (8)Fluoroaniline (65)Fluoroanisole (9)Fluorobenzaldehyde (69)Fluorobenzamide (28)Fluorobenzenesulfonamide (7)Fluorobenzenethiol (6)Fluorobenzylamine (10)Fluorobromobenzene (3)Fluorocinnamic (10)Fluorocinnamic (10)Fluorocinnamic Acid (9)Fluorocyclopropanecarboxylic (9)Fluoroethoxy (4)Fluoroethyl (8)Fluoroethyl (8)Fluoroindan (3)Fluoroindan (3)Fluoroisonicotinaldehyde (7)Fluoroisonicotinate (8)Fluoroisonicotinic (13)Fluoroisonicotinic Acid (13)Fluoromethyl (15)Fluoromethyl (15)Fluoronicotinaldehyde (20)Fluoronicotinamide (3)Fluoronicotinic (19)Fluoronicotinic (19)Fluoronicotinic Acid (14)Fluorophenylisocyanate (3)Fluoropropan (15)Fluoropropan (15)Fluorostyryl (7)Fluorosulfonyl (12)Fluorosulfonyl (12)Hexafluoro (9)Hexafluoro (9)Hexafluoropropan (4)Hexafluoropropan (4)Nonafluoro (2)Nonafluoro (2)Octafluoro (2)Octafluoro (2)Pentafluoro (4)Pentafluorobenzoate (4)Tetrafluoro (12)Tetrafluoro (12)Tetrafluoroaniline (7)Tetrafluoroethoxy (3)Tetrafluoroethoxy (3)Trifluoro (271)Trifluoro (271)Trifluoroacetamide (8)Trifluoroacetyl (13)Trifluoroaniline (11)Trifluorobenzaldehyde (9)Trifluorobenzoate (14)Trifluorobut (36)Trifluorobut (36)Trifluoroethan (2)Trifluoroethan (2)Trifluoroethanamine (23)Trifluoroethanol (6)Trifluoroethoxy (60)Trifluoroethoxy (60)Trifluoroethyl (63)Trifluoromethanesulfonamide (4)Trifluoromethanesulfonyl (22)Trifluoromethoxy (480)Trifluoromethoxy (480)Trifluoromethylthio (5)Trifluoromethylthio (5)Trifluoropropane (36)Trifluoropropanoate (5)Trifluoropropyl (9)(2,3-Difluorophenyl)Boronic Acid (33)(2,6-Difluorophenyl)Boronic Acid (28)(2-Chloro-6-Fluorophenyl)Boronic Acid (9)(2-Fluorobenzyl)Hydrazine (6)(2-Fluorophenyl)(Phenyl)Methanone (15)(2-Fluorophenyl)Boronic Acid (229)(2-Fluorophenyl)Hydrazine (22)(2-Fluorophenyl)Methanamine (49)(2-Fluorophenyl)Methanol (60)(3-Fluorophenyl)(Phenyl)Methanone (5)(3-Fluorophenyl)Boronic Acid (169)(3-Fluorophenyl)Methanol (58)(4-Fluorophenyl)(Phenyl)Methanone (8)(4-Fluorophenyl)Boronic Acid (93)(4-Fluorophenyl)Methanamine (27)(4-Fluorophenyl)Methanol (29)1,1-Difluorocyclobutane (14)1,1-Difluorocyclohexane (18)1,2,3,4,5-Pentafluorobenzene (51)1,2,3,4-Tetrafluorobenzene (73)1,2,3-Trifluorobenzene (156)1,2,4-Trifluorobenzene (210)1,2-Dibromo-3-Fluorobenzene (9)1,2-Dibromo-4-Fluorobenzene (11)1,2-Dichloro-3-Fluorobenzene (13)1,2-Dichloro-4-Fluorobenzene (15)1,2-Difluoro-3-Iodobenzene (13)1,2-Difluoro-3-Methoxybenzene (28)1,2-Difluoro-3-Methylbenzene (23)1,2-Difluoro-3-Nitrobenzene (23)1,2-Difluoro-4-Methoxybenzene (19)1,2-Difluoro-4-Nitrobenzene (43)1,2-Difluorobenzene (658)1,3-Dibromo-2,4-Difluorobenzene (5)1,3-Dibromo-2-Fluorobenzene (15)1,3-Dichloro-2-Fluorobenzene (23)1,3-Difluoro-2-Iodobenzene (12)1,3-Difluoro-2-Methylbenzene (18)1,3-Difluoro-2-Nitrobenzene (16)1,4-Dichloro-2-Fluorobenzene (11)1,4-Difluoro-2-Iodobenzene (8)1,4-Difluoro-2-Nitrobenzene (28)1,4-Difluorobenzene (361)1-(2-Fluorophenyl)Ethan-1-Amine (80)1-(2-Fluorophenyl)Ethan-1-One (58)1-(2-Fluorophenyl)Piperazine (8)1-(2-Fluorophenyl)Propan-1-Amine (8)1-(3-Fluorophenyl)Ethan-1-One (63)1-(4-Fluorophenyl)Ethan-1-One (36)1-(Benzyloxy)-2-Fluorobenzene (10)1-(Benzyloxy)-3-Fluorobenzene (14)1-(Bromomethyl)-2-Fluorobenzene (50)1-(Bromomethyl)-3-Fluorobenzene (47)1-(Chloromethyl)-2-Fluorobenzene (8)1-(Chloromethyl)-3-Fluorobenzene (11)1-Benzyl-4-Fluorobenzene (2)1-Bromo-2,3-Difluorobenzene (67)1-Bromo-2,4-Difluorobenzene (59)1-Bromo-2-Chloro-3-Fluorobenzene (20)1-Bromo-2-Fluoro-3-Methylbenzene (11)1-Bromo-3-Fluoro-2-Methoxybenzene (12)1-Bromo-3-Fluoro-2-Methylbenzene (17)1-Bromo-3-Fluoro-2-Nitrobenzene (10)1-Bromo-4-Fluoro-2-Methoxybenzene (11)1-Bromo-4-Fluoro-2-Methylbenzene (18)1-Chloro-2,3-Difluorobenzene (27)1-Chloro-2,4-Difluorobenzene (35)1-Chloro-3-Fluoro-2-Methoxybenzene (4)1-Chloro-3-Fluoro-2-Methylbenzene (10)1-Cyclohexyl-2-Fluorobenzene (4)1-Ethoxy-2,3-Difluorobenzene (9)1-Ethoxy-2-Fluorobenzene (37)1-Ethynyl-2-Fluorobenzene (10)1-Fluoro-2,3-Dimethylbenzene (8)1-Fluoro-2-(Methylsulfonyl)Benzene (5)1-Fluoro-2-Iodo-4-Methylbenzene (3)1-Fluoro-2-Iodobenzene (102)1-Fluoro-2-Isopropoxybenzene (18)1-Fluoro-2-Methylbenzene (255)1-Fluoro-2-Phenoxybenzene (11)1-Fluoro-3,5-Dimethylbenzene (12)1-Fluoro-3-(Methylsulfonyl)Benzene (10)1-Fluoro-3-Iodo-2-Methylbenzene (3)1-Fluoro-3-Iodobenzene (94)1-Fluoro-3-Methoxybenzene (213)1-Fluoro-3-Methylbenzene (255)1-Fluoro-3-Nitrobenzene (216)1-Fluoro-3-Phenoxybenzene (8)1-Fluoro-4-Iodobenzene (65)1-Fluoro-4-Methoxybenzene (125)1-Fluoro-4-Methylbenzene (140)1-Fluoro-4-Phenoxybenzene (8)1-Fluorobicyclo[1.1.1]Pentane (4)1-Fluoronaphthalene (23)2'-Fluoro-1,1':4',1''-Terphenyl (6)2,2',3,3',5,5',6,6'-Octafluoro-1,1'-Biphenyl (4)2,3-Difluoroaniline (34)2,3-Difluorobenzaldehyde (18)2,3-Difluorobenzoic Acid (35)2,3-Difluorobenzonitrile (29)2,3-Difluorophenol (36)2,3-Difluoropyridine (13)2,4-Dibromo-1-Fluorobenzene (18)2,4-Dichloro-1-Fluorobenzene (27)2,4-Difluoro-1-Iodobenzene (14)2,4-Difluoro-1-Methoxybenzene (25)2,4-Difluoro-1-Nitrobenzene (46)2,4-Difluoroaniline (44)2,4-Difluorobenzaldehyde (19)2,4-Difluorobenzoic Acid (29)2,4-Difluorobenzonitrile (21)2,4-Difluorophenol (21)2,5-Difluoroaniline (34)2,5-Difluorobenzoic Acid (32)2,5-Difluoropyridine (8)2,6-Difluoroaniline (23)2,6-Difluorobenzaldehyde (25)2,6-Difluorobenzoic Acid (33)2,6-Difluorobenzonitrile (28)2,6-Difluorophenol (24)2,6-Difluoropyridine (29)2-(2-Fluorophenyl)Acetic Acid (43)2-(2-Fluorophenyl)Acetonitrile (30)2-(2-Fluorophenyl)Pyrrolidine (16)2-(3-Fluorophenyl)Acetic Acid (50)2-(3-Fluorophenyl)Pyrrolidine (5)2-(4-Fluorophenyl)-1H-Indole (4)2-(4-Fluorophenyl)Acetic Acid (30)2-(Bromomethyl)-1,3-Difluorobenzene (12)2-Amino-2-(2-Fluorophenyl)Acetic Acid (11)2-Amino-3-(2-Fluorophenyl)Propanoic Acid (16)2-Amino-3-Fluorobenzoic Acid (11)2-Bromo-1,3,4-Trifluorobenzene (16)2-Bromo-1,3-Difluorobenzene (43)2-Bromo-1,4-Difluorobenzene (64)2-Bromo-1-Chloro-3-Fluorobenzene (9)2-Bromo-1-Chloro-4-Fluorobenzene (20)2-Bromo-1-Fluoro-4-Methylbenzene (17)2-Bromo-4-Chloro-1-Fluorobenzene (16)2-Bromo-4-Fluoro-1-Methoxybenzene (12)2-Bromo-4-Fluoro-1-Methylbenzene (21)2-Bromo-4-Fluoroaniline (28)2-Bromo-4-Fluorobenzaldehyde (7)2-Bromo-4-Fluorobenzonitrile (7)2-Bromo-4-Fluorophenol (10)2-Bromo-5-Fluoroaniline (18)2-Bromo-5-Fluorobenzaldehyde (7)2-Bromo-5-Fluorobenzoic Acid (11)2-Bromo-6-Fluoroaniline (14)2-Bromo-6-Fluorophenol (9)2-Chloro-1,3-Difluorobenzene (27)2-Chloro-1,4-Difluorobenzene (25)2-Chloro-3-Fluoropyridine (20)2-Chloro-4-Fluoro-1-Methoxybenzene (10)2-Chloro-4-Fluoroaniline (19)2-Chloro-4-Fluorobenzaldehyde (10)2-Chloro-4-Fluorobenzoic Acid (9)2-Chloro-4-Fluorobenzonitrile (9)2-Chloro-4-Fluorophenol (9)2-Chloro-5-Fluoropyrimidine (6)2-Chloro-6-Fluoroaniline (8)2-Chloro-6-Fluorobenzoic Acid (8)2-Chloro-6-Fluorobenzonitrile (5)2-Chloro-6-Fluorophenol (5)2-Fluoro-1,3-Dimethoxybenzene (8)2-Fluoro-1,3-Dimethylbenzene (14)2-Fluoro-1-Iodo-4-Methylbenzene (5)2-Fluoro-3-Methylbenzaldehyde (8)2-Fluoro-3-Methylpyridine (14)2-Fluoro-4-Methoxyaniline (6)2-Fluoro-4-Methyl-1-Nitrobenzene (13)2-Fluoro-4-Methylbenzoic Acid (7)2-Fluoro-4-Methylpyridine (6)2-Fluoro-5-Methylpyridine (6)2-Fluoro-6-Methylpyridine (20)2-Fluoro-N-Methylbenzamide (12)2-Fluoro-N-Phenylaniline (4)2-Fluoro-N-Phenylbenzenesulfonamide (6)2-Fluoroaniline (262)2-Fluorobenzaldehyde (175)2-Fluorobenzamide (32)2-Fluorobenzenesulfonamide (12)2-Fluorobenzenesulfonyl Chloride (31)2-Fluorobenzoic Acid (220)2-Fluoropyridine (15)2-Fluoropyrimidine (9)3,3-Difluoropiperidine (29)3,3-Difluoropyrrolidine (29)3,4-Difluoroaniline (44)3,4-Difluorophenol (19)3,5-Difluoropyridine (12)3-((Tert-Butoxycarbonyl)Amino)-4-(2-Fluorophenyl)Butanoic Acid (9)3-Chloro-2-Fluoroaniline (9)3-Fluoro-1,1'-Biphenyl (16)3-Fluoro-2-Iodoaniline (8)3-Fluoro-2-Methylaniline (9)3-Fluoro-2-Methylpyridine (15)3-Fluoro-4-Nitroaniline (7)3-Fluoroaniline (289)3-Fluorobenzaldehyde (137)3-Fluorobenzamide (26)3-Fluorobenzenesulfonyl Chloride (22)3-Fluorobenzoic Acid (206)3-Fluorophenol (180)3-Fluoropiperidine (26)3-Fluoropyridin-2-Amine (12)3-Fluoropyridin-4-Amine (4)3-Fluorothiophene (6)4,4-Difluoropiperidine (5)4-(2-Fluorophenyl)Morpholine (8)4-(4-Fluorophenyl)Thiazole (9)4-Chloro-5-Fluoro-2-Methylpyrimidine (5)4-Fluoro-1-Methyl-2-Nitrobenzene (12)4-Fluoro-1H-Indazole (22)4-Fluoro-1H-Indole (24)4-Fluoro-1H-Pyrrolo[2,3-B]Pyridine (6)4-Fluoro-2-Iodoaniline (7)4-Fluoro-2-Nitroaniline (14)4-Fluoroaniline (225)4-Fluorobenzaldehyde (78)4-Fluorobenzamide (19)4-Fluorobenzenesulfonyl Chloride (26)4-Fluorobenzo[D]Thiazole (6)4-Fluorobenzoic Acid (114)4-Fluorobenzonitrile (89)4-Fluoroisoquinoline (6)4-Fluorophenol (111)4-Fluoropyrimidine (8)5-Fluoro-1,2,3,4-Tetrahydroisoquinoline (3)5-Fluoro-1H-Benzo[D][1,2,3]Triazole (4)5-Fluoro-1H-Benzo[D]Imidazole (12)5-Fluoro-1H-Indole (50)5-Fluoro-1H-Pyrrolo[2,3-B]Pyridine (9)5-Fluoro-2,3-Dihydro-1H-Indene (3)5-Fluoro-2,3-Dihydrobenzofuran (5)5-Fluoro-2-Methylpyridine (8)5-Fluoro-3,4-Dihydronaphthalen-1(2H)-One (5)5-Fluorochromane (6)5-Fluoroindoline (3)5-Fluoroisoindolin-1-One (3)5-Fluoropyridin-2-Amine (15)5-Fluoropyrimidine (11)6-Fluoro-1,2,3,4-Tetrahydroisoquinoline (3)6-Fluoro-1,2,3,4-Tetrahydroquinoline (3)6-Fluoro-1H-Indazole (15)6-Fluoro-1H-Indole (17)6-Fluoro-1H-Pyrrolo[2,3-B]Pyridine (3)6-Fluorobenzo[D]Thiazole (5)6-Fluorochromane (6)6-Fluoropyridin-2-Amine (8)6-Fluoropyridin-3-Amine (4)7-Fluoro-1,2,3,4-Tetrahydroisoquinoline (3)7-Fluoro-1,2,3,4-Tetrahydroquinoline (3)7-Fluoro-1H-Indazole (12)7-Fluoro-1H-Indole (24)7-Fluorobenzo[D]Thiazole (9)7-Fluoroindoline-2,3-Dione (6)7-Fluoroisoquinoline (3)8-Fluoro-3,4-Dihydronaphthalen-1(2H)-One (5)8-Fluorochromane (5)8-Fluoroimidazo[1,2-A]Pyridine (3)8-Fluoroisoquinoline (10)8-Fluoroquinazoline (4)Benzenesulfonyl Fluoride (51)Ethyl 2-Fluorobenzoate (37)Ethyl 3-Fluorobenzoate (34)Fluorobenzene (9967)Methyl 2,6-Difluorobenzoate (17)Methyl 2-Fluorobenzoate (132)Methyl 3-Fluorobenzoate (136)Methyl 4-Fluorobenzoate (75)Methyl 6-Fluoronicotinate (4)N-(3-Fluorophenyl)Acetamide (14)N-(4-Fluorophenyl)Benzamide (3)Pentafluoro(Phenyl)-L6-Sulfane (19)Phenyl Trifluoromethanesulfonate (27)Tert-Butyl (4-Fluorophenyl)Carbamate (9)Trifluoro(Phenyl)Borate (80)
Guanidines (776)
Biguanide (2)Biguanide (2)
Hydrazides (3103)
Acetohydrazide (17)Acetohydrazide (17)Chlorobenzhydrazide (3)Dihydrazide (5)Dihydrazide (5)Fluorobenzohydrazide (6)Pyrazine-2-Carbohydrazide (3)
Hydrazines (6277)
Dichlorophenylhydrazine (3)Hydrazinecarbothioamide (2)Hydrazinecarboxamide (1)Hydrazinylbenzoate (6)(2-Bromophenyl)Hydrazine (8)(2-Chlorophenyl)Hydrazine (16)(2-Fluorobenzyl)Hydrazine (6)(2-Fluorophenyl)Hydrazine (22)(3-Chlorophenyl)Hydrazine (12)2-Hydrazineylpyridine (32)2-Hydrazineylpyrimidine (6)3-Hydrazineylpyridine (8)4-Hydrazineylpiperidine (5)Isonicotinohydrazide (6)Phenylhydrazine (153)Picolinohydrazide (5)
Hydrazones (2042)
1-Benzylidene-2-Phenylhydrazine (4)
Hydroxylamines (623)
N-Hydroxybenzamide (8)
Iodides (14083)
Diiodo (19)Diiodobenzoate (5)Iodoaniline (60)Iodoanisole (5)Iodobenzaldehyde (38)Iodobenzamide (6)Iodobutane (1)Iodobutane (1)Iodoethoxy (6)Iodoethoxy (6)Iodoethyl (5)Iodoethyl (5)Iodomethyl (26)Iodomethyl (26)Iodonicotinaldehyde (6)Iodonicotinic (14)Iodonicotinic (14)Iodopropyl (4)Iodopropyl (4)(2-Iodophenyl)(Phenyl)Methanone (4)(2-Iodophenyl)Methanol (12)(3-Iodophenyl)Boronic Acid (5)(3-Iodophenyl)Methanol (13)1,2-Benziodoxol-3-(1H)-One (6)1,2-Difluoro-3-Iodobenzene (13)1,2-Diiodobenzene (10)1,3-Dibromo-2-Iodobenzene (4)1,3-Dichloro-2-Iodobenzene (5)1,3-Difluoro-2-Iodobenzene (12)1,3-Diiodo-2-Phenoxybenzene (3)1,3-Diiodobenzene (59)1,4-Dibromo-2-Iodobenzene (3)1,4-Difluoro-2-Iodobenzene (8)1-(2-Iodophenyl)Ethan-1-One (4)1-(3-Iodophenyl)Ethan-1-One (7)1-(Benzyloxy)-4-Iodobenzene (3)1-(Bromomethyl)-2-Iodobenzene (9)1-Benzyl-4-Iodo-1H-Pyrazole (5)1-Bromo-2-Iodobenzene (65)1-Bromo-3-Fluoro-2-Iodobenzene (4)1-Bromo-3-Iodobenzene (70)1-Bromo-4-Iodobenzene (67)1-Chloro-2-Fluoro-3-Iodobenzene (5)1-Chloro-2-Iodobenzene (65)1-Chloro-3-Iodo-2-Methylbenzene (3)1-Chloro-3-Iodobenzene (77)1-Chloro-4-Iodobenzene (49)1-Ethyl-2-Iodobenzene (6)1-Fluoro-2-Iodo-4-Methylbenzene (3)1-Fluoro-2-Iodobenzene (102)1-Fluoro-3-Iodo-2-Methylbenzene (3)1-Fluoro-3-Iodobenzene (94)1-Fluoro-4-Iodobenzene (65)1-Iodo-2,3-Dimethylbenzene (8)1-Iodo-2,4-Dimethylbenzene (9)1-Iodo-2-(Trifluoromethoxy)Benzene (6)1-Iodo-2-(Trifluoromethyl)Benzene (13)1-Iodo-2-Isopropylbenzene (4)1-Iodo-2-Methoxybenzene (50)1-Iodo-2-Methylbenzene (91)1-Iodo-2-Nitrobenzene (36)1-Iodo-3-(Trifluoromethoxy)Benzene (6)1-Iodo-3-(Trifluoromethyl)Benzene (30)1-Iodo-3-Methoxybenzene (48)1-Iodo-3-Methylbenzene (60)1-Iodo-3-Nitrobenzene (45)1-Iodo-4-Methoxybenzene (34)1-Iodo-4-Phenoxybenzene (4)2,4-Difluoro-1-Iodobenzene (14)2,6-Dichloro-4-Iodopyridine (4)2,6-Diiodoaniline (8)2,6-Diiodophenol (16)2-Bromo-3-Iodopyridine (6)2-Bromo-4-Chloro-1-Iodobenzene (6)2-Bromo-6-Iodoaniline (4)2-Bromo-6-Iodopyridine (5)2-Chloro-3-Iodopyridin-4-Amine (3)2-Chloro-3-Iodopyridine (13)2-Chloro-4-Iodopyridine (19)2-Chloro-5-Iodopyridine (18)2-Chloro-6-Iodophenol (3)2-Chloro-6-Iodopyridine (9)2-Fluoro-1-Iodo-4-Methylbenzene (5)2-Fluoro-3-Iodopyridine (8)2-Fluoro-6-Iodoaniline (7)2-Hydroxy-3-Iodobenzaldehyde (3)2-Iodo-1,3-Dimethylbenzene (15)2-Iodo-1,4-Dimethylbenzene (5)2-Iodo-1-Methyl-4-Nitrobenzene (3)2-Iodo-4-Methylaniline (5)2-Iodo-6-Methylpyridine (5)2-Iodo-6-Nitroaniline (3)2-Iodo-9H-Fluorene (8)2-Iodo-N,N-Dimethylaniline (3)2-Iodoaniline (87)2-Iodobenzaldehyde (17)2-Iodobenzamide (4)2-Iodobenzene-1,3-Diol (3)2-Iodobenzoic Acid (47)2-Iodobenzonitrile (26)2-Iodonaphthalene (5)2-Iodophenol (63)2-Iodopyrazine (25)2-Iodopyridine (27)2-Iodopyrimidine (8)2-Iodothiophene (14)3-Chloro-2-Iodoaniline (3)3-Chloro-4-Iodoaniline (3)3-Fluoro-2-Iodoaniline (8)3-Iodo-1-Methyl-1H-Pyrazole (6)3-Iodo-1H-Pyrrolo[2,3-B]Pyridine (11)3-Iodo-1H-Pyrrolo[3,2-B]Pyridine (6)3-Iodo-2-Methylaniline (4)3-Iodoaniline (32)3-Iodobenzaldehyde (28)3-Iodobenzoic Acid (55)3-Iodobenzonitrile (27)3-Iodoimidazo[1,2-A]Pyridine (10)3-Iodophenol (21)3-Iodopyridazine (5)3-Iodopyridin-2-Amine (12)3-Iodopyridin-2-Ol (4)3-Iodopyridin-4-Amine (6)3-Iodopyridin-4-Ol (4)3-Iodopyridine (37)3-Iodotetrahydrofuran (3)4-Bromo-2-Chloro-1-Iodobenzene (4)4-Bromo-2-Fluoro-1-Iodobenzene (8)4-Bromo-2-Iodoaniline (8)4-Chloro-2-Iodoaniline (9)4-Chloro-3-Iodoaniline (3)4-Chloro-5-Iodopyrimidine (6)4-Fluoro-2-Iodoaniline (7)4-Fluoro-3-Iodobenzoic Acid (5)4-Iodo-1,1'-Biphenyl (9)4-Iodo-1H-Pyrazole (9)4-Iodo-N,N-Diphenylaniline (3)4-Iodopyridine (17)4-Iodopyrimidine (9)5-Bromo-2-Iodopyridine (5)5-Iodo-1H-Imidazole (4)5-Iodo-1H-Pyrazole (4)5-Iodo-7H-Pyrrolo[2,3-D]Pyrimidine (4)5-Iodopyridin-2-Amine (17)5-Iodopyridin-2-Ol (8)5-Iodopyrimidine (5)6-Chloro-5-Iodopyridin-2-Amine (3)Ethyl 2-Iodobenzoate (4)Ethyl 3-Iodobenzoate (11)Methyl 2-Iodobenzoate (28)Methyl 3-Iodo-4-Methylbenzoate (6)Methyl 3-Iodobenzoate (47)Methyl 4-Amino-3-Iodobenzoate (7)N-(2-Iodophenyl)Acetamide (8)Phenyl(O-Tolyl)Iodonium (14)Tert-Butyl 3-Iodo-1H-Indole-1-Carboxylate (7)
Isocyanates and Isothiocyanates (237)
Isocyanate (4)Isocyanate (4)(Isothiocyanatomethyl)Benzene (6)1-Chloro-2-Isocyanatobenzene (6)1-Chloro-2-Isothiocyanatobenzene (7)Isocyanatobenzene (47)Isothiocyanatobenzene (39)
Isocyanides (69)
Isocyanato (7)Isocyanide (1)Isothiocyanato (5)Isothiocyanato (5)
Ketones (40074)
Acetylacetonate (26)Bromoethanone (4)Butanedione (6)Butanedione (6)Butanone (10)Butanone (10)Carbonyl-Phenyl-Boronic Acid/Ester (184)Chloroethanone (2)Dicarbonyl (2)Dicarbonyl (2)Dichloroacetophenone (5)Dienone (2)Diethanone (5)Diethanone (5)Dione (1793)Dioxobutanoate (2)Enone (21)Ethanone (1026)Heptanedionato (7)Heptanedionato (7)Hydroxyethanone (3)Methyl-Pyrazolone (87)Oxoacetaldehyde (4)Oxoazepane (3)Oxoazepane (3)Oxochroman (5)Oxotetrahydro (11)Pyrimidinone (3)Tetraone (48)Tetraone (48)Trifluoroacetophenone (9)Trifluoroethanone (15)(1E,4E)-1,5-Diphenylpenta-1,4-Dien-3-One (7)(1E,6E)-1,7-Diphenylhepta-1,6-Diene-3,5-Dione (7)(2-Aminophenyl)(Phenyl)Methanone (30)(2-Bromophenyl)(Phenyl)Methanone (3)(2-Chlorophenyl)(Phenyl)Methanone (19)(2-Fluorophenyl)(Phenyl)Methanone (15)(2-Hydroxyphenyl)(Phenyl)Methanone (24)(2-Iodophenyl)(Phenyl)Methanone (4)(3-Chlorophenyl)(Phenyl)Methanone (19)(3-Fluorophenyl)(Phenyl)Methanone (5)(3-Nitrophenyl)(Phenyl)Methanone (5)(4-Aminophenyl)(Phenyl)Methanone (4)(4-Bromophenyl)(Phenyl)Methanone (9)(4-Chlorophenyl)(Phenyl)Methanone (10)(4-Fluorophenyl)(Phenyl)Methanone (8)(4-Hydroxyphenyl)(Phenyl)Methanone (3)(4-Methoxyphenyl)(Phenyl)Methanone (7)(4-Nitrophenyl)(Phenyl)Methanone (3)(R)-5-Thia-1-Azabicyclo[4.2.0]Oct-2-En-8-One (8)1,3-Dioxoisoindolin-2-Yl 2-Phenylacetate (5)1,3-Diphenylpropan-1-One (9)1,4-Diazepan-5-One (9)1,4-Dihydroisoquinolin-3(2H)-One (5)1-(1H-Indazol-1-Yl)Ethan-1-One (7)1-(1H-Indol-1-Yl)Ethan-1-One (9)1-(1H-Indol-3-Yl)Ethan-1-One (6)1-(1H-Pyrrolo[2,3-B]Pyridin-3-Yl)Ethan-1-One (4)1-(2-(Trifluoromethyl)Phenyl)Ethan-1-One (9)1-(2-Aminophenyl)Ethan-1-One (29)1-(2-Bromophenyl)Ethan-1-One (27)1-(2-Chlorophenyl)Ethan-1-One (40)1-(2-Fluorophenyl)Ethan-1-One (58)1-(2-Hydroxyphenyl)-2-Phenylethan-1-One (6)1-(2-Hydroxyphenyl)-3-Phenylprop-2-En-1-One (11)1-(2-Hydroxyphenyl)Ethan-1-One (73)1-(2-Iodophenyl)Ethan-1-One (4)1-(2-Methoxyphenyl)Ethan-1-One (33)1-(2-Nitrophenyl)Ethan-1-One (24)1-(3-(Benzyloxy)Phenyl)Ethan-1-One (3)1-(3-Aminophenyl)Ethan-1-One (18)1-(3-Chlorophenyl)Ethan-1-One (38)1-(3-Fluorophenyl)Ethan-1-One (63)1-(3-Hydroxyphenyl)Ethan-1-One (19)1-(3-Iodophenyl)Ethan-1-One (7)1-(3-Methoxy-2-Nitrophenyl)Ethan-1-One (4)1-(3-Methoxyphenyl)Ethan-1-One (38)1-(3-Nitrophenyl)Ethan-1-One (25)1-(3-Nitrophenyl)Propan-1-One (4)1-(4-(Benzyloxy)Phenyl)Ethan-1-One (4)1-(4-Fluorophenyl)Ethan-1-One (36)1-([1,1'-Biphenyl]-4-Yl)Ethan-1-One (5)1-(Benzofuran-2-Yl)Ethan-1-One (3)1-(Imidazo[1,2-A]Pyridin-3-Yl)Ethan-1-One (3)1-(M-Tolyl)Ethan-1-One (37)1-(Naphthalen-2-Yl)Ethan-1-One (3)1-(O-Tolyl)Ethan-1-One (26)1-(Piperidin-1-Yl)Ethan-1-One (13)1-(Pyrazin-2-Yl)Ethan-1-One (5)1-(Pyridin-2-Yl)Ethan-1-One (36)1-(Pyridin-3-Yl)Ethan-1-One (29)1-(Pyridin-4-Yl)Ethan-1-One (14)1-(Pyrimidin-2-Yl)Ethan-1-One (5)1-(Pyrimidin-4-Yl)Ethan-1-One (6)1-(Pyrrolidin-1-Yl)Ethan-1-One (9)1-(Thiazol-2-Yl)Ethan-1-One (9)1-(Thiophen-2-Yl)Ethan-1-One (17)1-Aminoanthracene-9,10-Dione (8)1-Benzylindoline-2,3-Dione (5)1-Benzylpiperidin-3-One (5)1-Chloroanthracene-9,10-Dione (6)1-Hydroxyanthracene-9,10-Dione (11)1-Methylpiperazin-2-One (6)1-Methylpyrrolidin-2-One (13)1-Phenylbutan-1-One (13)1-Phenylpentan-1-One (12)1-Phenylpiperidin-2-One (8)1-Phenylpropan-2-One (36)2,2,2-Trifluoro-1-Phenylethan-1-One (51)2,2-Dimethyl-1-Phenylpropan-1-One (8)2,2-Dimethyl-2H-Benzo[B][1,4]Oxazin-3(4H)-One (3)2,3,4,9-Tetrahydro-1H-Carbazol-1-One (7)2,3-Dihydrofuran-3-One (9)2,3-Dihydropyridin-2-One (5)2,5-Dichlorobenzoic Acid (13)2-Amino-1-(Pyrrolidin-1-Yl)Ethan-1-One (5)2-Benzalacetophenone (36)2-Benzoylbenzoic Acid (10)2-Chloro-1-Phenylethan-1-One (20)2-Chlorocyclohexa-2,5-Diene-1,4-Dione (4)2-Chloroquinazolin-4(3H)-One (4)2-Hydroxy-1,2-Diphenylethan-1-One (3)2-Hydroxy-1-Phenylethan-1-One (8)2-Hydroxycyclohexa-2,5-Diene-1,4-Dione (3)2-Hydroxyquinolin-4(1H)-One (3)2-Methoxycyclohexa-2,5-Diene-1,4-Dione (7)2-Methyl-1-Phenylpropan-1-One (20)2-Methyl-2H-Benzo[B][1,4]Oxazin-3(4H)-One (3)2-Methyl-3,4-Dihydroisoquinolin-1(2H)-One (6)2-Methylcyclohexa-2,5-Diene-1,4-Dione (5)2-Methylcyclohexan-1-One (3)2-Methylisoindolin-1-One (7)2-Methylisoindoline-1,3-Dione (5)2-Methylpyridazin-3(2H)-One (7)2-Oxo-2-Phenylacetaldehyde (12)2-Oxo-2-Phenylacetic Acid (17)3,3-Difluoropiperidin-4-One (3)3,3-Dimethylcyclohexan-1-One (4)3,3-Dimethylpiperidin-4-One (3)3,4-Dihydroquinoxalin-2(1H)-One (7)3-Acetyl-2H-Chromen-2-One (3)3-Aminopyrrolidin-2-One (5)3-Bromo-1H-Pyrrole-2,5-Dione (3)3-Chloro-1-Phenylpropan-1-One (10)3-Fluoropiperidin-4-One (3)3-Hydroxy-2-Phenyl-4H-Chromen-4-One (21)3-Hydroxypyrrolidin-2-One (4)3-Methylcyclohexan-1-One (9)3-Methylene-2,3-Dihydro-1H-Inden-1-One (5)3-Methylpiperazin-2-One (7)3-Methylpyrimidin-4(3H)-One (6)3-Oxo-3-Phenylpropanenitrile (21)3-Oxo-N-Phenylbutanamide (10)3-Phenyl-1-(Pyrrolidin-1-Yl)Propan-1-One (5)3-Phenyl-2-Thioxoimidazolidin-4-One (6)3-Phenylacrylaldehyde (29)3-Phenylimidazolidine-2,4-Dione (4)4,4,4-Trifluoro-1-Phenylbutane-1,3-Dione (10)4-(1,2,2-Triphenylvinyl)Benzaldehyde (5)4-(Hydroxymethyl)Pyrrolidin-2-One (4)4-Benzylmorpholin-3-One (6)4-Bromoisoindolin-1-One (3)4-Bromopyridazin-3(2H)-One (3)4-Chloro-1-Phenylbutan-1-One (8)4-Chloropyridazin-3(2H)-One (4)4-Fluoroindoline-2,3-Dione (3)4-Hydroxy-2H-Chromen-2-One (10)4-Hydroxydihydrofuran-2(3H)-One (14)4-Hydroxypiperidin-2-One (3)4-Hydroxypyrrolidin-2-One (7)4-Methyl-2H-Chromen-2-One (27)4-Methylisobenzofuran-1(3H)-One (3)4-Oxo-4-Phenylbutanoic Acid (16)4-Phenylbutan-2-One (14)4-Phenylcyclohexan-1-One (11)4-Phenylmorpholin-3-One (6)4-Phenylpyrrolidin-2-One (7)5,6-Dihydrobenzo[D]Thiazol-7(4H)-One (5)5-(Aminomethyl)Pyrrolidin-2-One (3)5-(Hydroxymethyl)Pyrrolidin-2-One (7)5-Bromoisoindolin-1-One (8)5-Bromoisoindoline-1,3-Dione (3)5-Bromopyrimidin-4(3H)-One (3)5-Chloroisoindoline-1,3-Dione (3)5-Chloropyrimidin-4(3H)-One (4)5-Chloropyrimidine-2,4(1H,3H)-Dione (3)5-Fluoro-3,4-Dihydronaphthalen-1(2H)-One (5)5-Fluorochroman-4-One (3)5-Fluoroindolin-2-One (4)5-Fluoroisoindolin-1-One (3)5-Fluoropyrimidin-4(3H)-One (3)5-Fluoropyrimidine-2,4(1H,3H)-Dione (3)5-Hydroxy-2-Phenyl-4H-Chromen-4-One (36)5-Hydroxypiperidin-2-One (3)5-Methoxy-2-Phenyl-4H-Chromen-4-One (10)5-Methyl-3,4-Dihydronaphthalen-1(2H)-One (6)5-Methylindolin-2-One (3)5-Oxopyrrolidine-2-Carboxylic Acid (4)6-Bromoisoindolin-1-One (4)6-Fluorochroman-4-One (5)6-Fluoroindoline-2,3-Dione (3)6-Fluoroisobenzofuran-1(3H)-One (3)6-Hydroxy-2,3-Dihydro-1H-Inden-1-One (3)6-Methoxy-2,3-Dihydro-1H-Inden-1-One (6)6-Methoxy-3,4-Dihydronaphthalen-1(2H)-One (5)6-Methoxyisoindolin-1-One (3)6-Methyl-2,3-Dihydro-1H-Inden-1-One (3)7,8-Dihydroquinolin-5(6H)-One (5)7-(Diethylamino)-2H-Chromen-2-One (9)7-Bromo-3,4-Dihydronaphthalen-1(2H)-One (8)7-Bromochroman-4-One (4)7-Bromoindoline-2,3-Dione (3)7-Bromoquinazolin-4(3H)-One (4)7-Chloro-3,4-Dihydronaphthalen-1(2H)-One (6)7-Fluorochroman-4-One (5)7-Fluoroindolin-2-One (3)7-Fluoroquinazolin-4(3H)-One (4)7-Hydroxy-2H-Chromen-2-One (23)7-Methoxy-2H-Chromen-2-One (12)7-Methoxy-3,4-Dihydronaphthalen-1(2H)-One (6)7-Methoxychroman-4-One (3)7-Methylindoline-2,3-Dione (7)8-Bromochroman-4-One (4)8-Fluoro-3,4-Dihydronaphthalen-1(2H)-One (5)8-Fluoroisoquinolin-1(2H)-One (3)8-Methylchroman-4-One (4)Acetophenone (1120)Azepan-2-One (18)Benzo[Cd]Indol-2(1H)-One (5)Benzofuran-2(3H)-One (7)Chroman-2-One (5)Cyclobutanone (24)Cyclohex-2-En-1-One (27)Cyclohexane-1,3-Dione (12)Cyclopent-2-En-1-One (21)Cyclopentane-1,3-Dione (6)Dihydro-2H-Pyran-2,6(3H)-Dione (5)Dihydrofuran-2,5-Dione (12)Dihydrofuran-3(2H)-One (7)Dihydrothiophen-3(2H)-One (4)Ethene-1,1-Diyldibenzene (10)Ethyl 2-Oxo-2-Phenylacetate (18)Ethyl 3-Oxo-3-Phenylpropanoate (41)Furan-2(5H)-One (26)Isoquinolin-1-Ol (9)Methyl 3-Oxo-3-Phenylpropanoate (16)Morpholin-3-One (11)Phenyl(3-(Trifluoromethyl)Phenyl)Methanone (3)Phenyl(M-Tolyl)Methanone (3)Phenyl(P-Tolyl)Methanone (4)Phenyl(Pyridin-3-Yl)Methanone (9)Phenyl(Thiophen-2-Yl)Methanone (6)Piperidine-2,4-Dione (5)Propiophenone (59)Pyrimidine-4,6(1H,5H)-Dione (3)Tert-Butyl (2-Oxopiperidin-3-Yl)Carbamate (4)Tert-Butyl (2-Oxopyrrolidin-3-Yl)Carbamate (3)Tert-Butyl (3-Oxocyclohexyl)Carbamate (3)Tert-Butyl (5-Oxopyrrolidin-3-Yl)Carbamate (3)Tert-Butyl (6-Oxopiperidin-3-Yl)Carbamate (3)Tert-Butyl 2-Oxopiperidine-1-Carboxylate (3)Tert-Butyl 2-Oxopyrrolidine-1-Carboxylate (15)Tert-Butyl 4-Oxopiperidine-1-Carboxylate (16)Tetrahydropyrimidin-2(1H)-One (6)
Mercaptos (11)
Mercaptopropanoate (10)
Nitrates and Nitrites (1)
Nitriles (28529)
Acetonitrile (255)Acrylonitrile (8)Aminobutanenitrile (5)Aminocyclohexanecarbonitrile (6)Bromobenzonitrile (15)Bromonicotinonitrile (9)Bromophenylacetonitrile (2)Butanenitrile (2)Butanenitrile (2)Chlorobenzonitrile (27)Chloroisonicotinonitrile (4)Chloronicotinonitrile (40)Cyanide (434)Cyanide (434)Cyanoacetamide (4)Cyanoacetate (14)Cyanobenzaldehyde (4)Cyanobenzoate (27)Cyanobenzoic (20)Cyanoethyl (15)Cyanoethyl (15)Cyanoisonicotinate (4)Cyanomethyl (42)Cyanomethyl (42)Cyanonicotinate (8)Cyanophenoxy (8)Cyanophenyl (64)Cyanophenylboronic (5)Cyanopropan (4)Cyanopropan (4)Diacetonitrile (1)Diaminobenzonitrile (8)Dibromoisonicotinonitrile (3)Dicarbonitrile (45)Dicarbonitrile (45)Dichlorobenzonitrile (12)Dichloroisonicotinonitrile (4)Difluorobenzonitrile (41)Fluorobenzonitrile (85)Fluoroisonicotinonitrile (5)Fluoronicotinonitrile (14)Fluorophenylacetonitrile (8)Fluoropicolinonitrile (13)Formylnicotinonitrile (5)Formylnicotinonitrile (5)Hydrazinylbenzonitrile (6)Iodobenzonitrile (44)Iodonicotinonitrile (8)Malononitrile (43)Malononitrile (43)Methoxyisonicotinonitrile (7)Methoxyisonicotinonitrile (7)Methoxynicotinonitrile (18)Methoxynicotinonitrile (18)Methylnicotinonitrile (57)Methylnicotinonitrile (57)Methylpropanenitrile (9)Methylpropanenitrile (9)Nitropicolinonitrile (10)Oxopropanenitrile (8)Phenylacrylonitrile (21)Propanenitrile (41)Propanenitrile (41)Pyrazino-Nitrile (50)Tetrafluorobenzonitrile (5)Thiocyanatoaniline (3)Tricarbonitrile (5)Tricarbonitrile (5)Trifluorobenzonitrile (7)Trifluoromethylbenzonitrile (5)1-Phenyl-1H-Pyrazole-4-Carbonitrile (17)1-Phenylcyclobutane-1-Carbonitrile (7)1-Phenylcyclopropane-1-Carbonitrile (19)1H-Imidazole-4-Carbonitrile (2)1H-Indazole-3-Carbonitrile (9)1H-Indole-2-Carbonitrile (9)1H-Indole-3-Carbonitrile (17)1H-Indole-5-Carbonitrile (5)1H-Indole-6-Carbonitrile (4)1H-Indole-7-Carbonitrile (6)1H-Pyrazole-4-Carbonitrile (5)1H-Pyrrole-2-Carbonitrile (7)1H-Pyrrole-3-Carbonitrile (9)2,3-Difluorobenzonitrile (29)2,4-Dichlorobenzonitrile (4)2,4-Difluorobenzonitrile (21)2,6-Dibromobenzonitrile (4)2,6-Dichlorobenzonitrile (8)2,6-Difluorobenzonitrile (28)2-(1,3,2-Dioxaborinan-2-Yl)Benzonitrile (4)2-(2-Bromophenyl)Acetonitrile (10)2-(2-Chlorophenyl)Acetonitrile (16)2-(2-Fluorophenyl)Acetonitrile (30)2-(3-Chlorophenyl)Acetonitrile (16)2-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzonitrile (14)2-(4-(Benzyloxy)Phenyl)Acetonitrile (3)2-(Bromomethyl)Benzonitrile (15)2-(Piperazin-1-Yl)Benzonitrile (6)2-(Pyridin-2-Yl)Acetonitrile (8)2-(Pyridin-3-Yl)Acetonitrile (6)2-(Trifluoromethoxy)Benzonitrile (7)2-(Trifluoromethyl)Benzonitrile (35)2-Amino-3-Bromobenzonitrile (7)2-Amino-3-Chlorobenzonitrile (3)2-Amino-6-Chlorobenzonitrile (3)2-Aminonicotinonitrile (6)2-Bromo-6-Fluorobenzonitrile (7)2-Chloro-3-Methylbenzonitrile (5)2-Chloro-4-Fluorobenzonitrile (9)2-Chloro-6-Fluorobenzonitrile (5)2-Chloro-N-Methylaniline (4)2-Chlorobenzonitrile (99)2-Hydroxybenzonitrile (45)2-Iodobenzonitrile (26)2-Naphthonitrile (15)2-Nitrobenzonitrile (37)2-Oxo-2H-Chromene-3-Carbonitrile (4)2-Phenoxyacetonitrile (11)2-Phenoxybenzonitrile (5)2-Phenylacetonitrile (172)3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzonitrile (25)3-(Trifluoromethoxy)Benzonitrile (11)3-(Trifluoromethyl)Benzonitrile (47)3-Bromo-2-Fluorobenzonitrile (10)3-Bromo-2-Hydroxybenzonitrile (3)3-Bromobenzonitrile (110)3-Chloro-2-Fluorobenzonitrile (7)3-Chlorobenzonitrile (100)3-Chloropyrazine-2-Carbonitrile (6)3-Fluoropicolinonitrile (5)3-Hydroxybenzonitrile (40)3-Iodobenzonitrile (27)3-Nitrobenzonitrile (59)3-Oxo-3-Phenylpropanenitrile (21)3-Phenoxybenzonitrile (5)4-Amino-2-Chlorobenzonitrile (8)4-Chloropyrimidine-5-Carbonitrile (6)4-Cyanophenyl Benzoate (11)4-Cyclohexylbenzonitrile (10)4-Fluorobenzonitrile (89)4-Nitrobenzonitrile (25)5-Fluoropicolinonitrile (5)6-Methylnicotinonitrile (7)6-Methylpicolinonitrile (10)[1,1'-Biphenyl]-2-Carbonitrile (12)[1,1'-Biphenyl]-4-Carbonitrile (27)Benzo[B]Thiophene-2-Carbonitrile (3)Benzo[D]Thiazole-2-Carbonitrile (11)Benzonitrile (1312)Furan-2-Carbonitrile (8)Imidazo[1,2-A]Pyridine-6-Carbonitrile (3)Isonicotinonitrile (16)Isoquinoline-1-Carbonitrile (7)Methyl 2-Cyanobenzoate (22)Methyl 3-Cyanobenzoate (29)Morpholine-2-Carbonitrile (4)Nicotinonitrile (82)Pyrazine-2-Carbonitrile (15)Pyrimidine-2-Carbonitrile (14)Pyrimidine-4-Carbonitrile (9)Pyrimidine-5-Carbonitrile (6)Pyrrolidine-2-Carbonitrile (9)Pyrrolidine-3-Carbonitrile (6)Thiazole-5-Carbonitrile (7)Thiophene-2-Carbonitrile (23)Thiophene-3-Carbonitrile (13)
Nitroes (23714)
Difluoronitrobenzene (9)Dinitro (7)Dinitroaniline (5)Nitroacetophenone (7)Nitroaniline (211)Nitrobenzaldehyde (100)Nitrobenzamide (35)Nitrobenzenesulfonamide (26)Nitrobenzonitrile (106)Nitrobenzotrifluoride (16)Nitroisophthalate (4)(2-Nitrophenyl)Boronic Acid (13)(2-Nitrophenyl)Methanol (29)(2-Nitrovinyl)Benzene (28)(3-Nitrophenyl)(Phenyl)Methanone (5)(3-Nitrophenyl)Boronic Acid (32)(3-Nitrophenyl)Methanol (31)(4-Nitrophenyl)(Phenyl)Methanone (3)(4-Nitrophenyl)Methanol (17)1,2-Dichloro-4-Nitrobenzene (16)1,2-Difluoro-3-Nitrobenzene (23)1,2-Difluoro-4-Nitrobenzene (43)1,2-Dimethyl-3-Nitrobenzene (6)1,2-Dinitrobenzene (6)1,3-Dibromo-2-Nitrobenzene (4)1,3-Dichloro-2-Nitrobenzene (5)1,3-Difluoro-2-Nitrobenzene (16)1,3-Dimethyl-2-Nitrobenzene (9)1,3-Dinitrobenzene (31)1,4-Difluoro-2-Nitrobenzene (28)1,4-Dimethyl-2-Nitrobenzene (10)1-(2-Nitrophenyl)Ethan-1-One (24)1-(3-Methoxy-2-Nitrophenyl)Ethan-1-One (4)1-(3-Nitrophenyl)Ethan-1-One (25)1-(3-Nitrophenyl)Propan-1-One (4)1-(Benzyloxy)-2-Nitrobenzene (3)1-(Benzyloxy)-3-Nitrobenzene (10)1-(Bromomethyl)-2-Nitrobenzene (23)1-(Methylsulfonyl)-3-Nitrobenzene (7)1-(Tert-Butyl)-2-Nitrobenzene (4)1-(Tert-Butyl)-3-Nitrobenzene (7)1-Bromo-2-Chloro-4-Nitrobenzene (5)1-Bromo-2-Fluoro-3-Nitrobenzene (11)1-Bromo-2-Fluoro-4-Nitrobenzene (13)1-Bromo-3-Methyl-2-Nitrobenzene (3)1-Bromo-3-Nitrobenzene (235)1-Chloro-2-Fluoro-4-Nitrobenzene (9)1-Chloro-2-Methyl-3-Nitrobenzene (6)1-Chloro-2-Nitrobenzene (138)1-Chloro-3-Fluoro-2-Nitrobenzene (6)1-Chloro-3-Nitrobenzene (161)1-Ethoxy-3-Nitrobenzene (7)1-Fluoro-3-Nitrobenzene (216)1-Iodo-2-Nitrobenzene (36)1-Iodo-3-Nitrobenzene (45)1-Methoxy-3-Nitrobenzene (108)1-Methoxy-4-Nitrobenzene (90)1-Methyl-2-Nitrobenzene (176)1-Methyl-3-Nitrobenzene (147)1-Methyl-4-Nitrobenzene (82)1-Nitro-2-(Trifluoromethoxy)Benzene (8)1-Nitro-2-(Trifluoromethyl)Benzene (32)1-Nitro-2-Phenoxybenzene (4)1-Nitro-3-(Trifluoromethoxy)Benzene (9)1-Nitro-3-(Trifluoromethyl)Benzene (82)1-Nitro-4-Phenoxybenzene (5)1-Nitronaphthalene (3)2,4-Dichloro-1-Nitrobenzene (19)2,4-Difluoro-1-Nitrobenzene (46)2,4-Dimethoxy-1-Nitrobenzene (5)2,4-Dimethyl-1-Nitrobenzene (15)2-((2-Nitrophenyl)Amino)Ethan-1-Ol (5)2-(2-Nitrophenyl)Acetic Acid (20)2-(4-Nitrophenyl)Acetic Acid (9)2-Bromo-1-Chloro-4-Nitrobenzene (9)2-Bromo-1-Fluoro-3-Nitrobenzene (9)2-Bromo-1-Fluoro-4-Nitrobenzene (23)2-Bromo-1-Methyl-4-Nitrobenzene (12)2-Bromo-3-Nitrobenzoic Acid (4)2-Bromo-4-Chloro-1-Nitrobenzene (5)2-Bromo-4-Fluoro-1-Nitrobenzene (23)2-Bromo-4-Nitroaniline (12)2-Bromo-6-Nitroaniline (14)2-Bromo-6-Nitrophenol (9)2-Chloro-1,3-Dinitrobenzene (2)2-Chloro-1-Fluoro-4-Nitrobenzene (16)2-Chloro-1-Methyl-3-Nitrobenzene (4)2-Chloro-3-Nitrobenzoic Acid (4)2-Chloro-4-Fluoro-1-Nitrobenzene (13)2-Chloro-4-Methyl-1-Nitrobenzene (6)2-Chloro-4-Nitrophenol (5)2-Chloro-5-Nitropyrimidine (5)2-Chloro-6-Nitroaniline (11)2-Chloro-6-Nitrophenol (7)2-Fluoro-1-Methoxy-4-Nitrobenzene (8)2-Fluoro-4-Methyl-1-Nitrobenzene (13)2-Iodo-1-Methyl-4-Nitrobenzene (3)2-Iodo-6-Nitroaniline (3)2-Methoxy-5-Nitropyridine (8)2-Methoxy-6-Nitrophenol (5)2-Methyl-3-Nitrobenzoic Acid (7)2-Methyl-3-Nitropyridine (9)2-Methyl-6-Nitroaniline (10)2-Nitro-1H-Pyrrole (5)2-Nitro-N-Phenylaniline (3)2-Nitrobenzaldehyde (53)2-Nitrobenzoic Acid (65)2-Nitrobenzonitrile (37)2-Nitrofuran (9)2-Nitronaphthalene (4)2-Nitropyridine (40)2-Nitrothiophene (20)3-Chloro-2-Nitroaniline (5)3-Chloro-4-Nitroaniline (5)3-Fluoro-4-Nitroaniline (7)3-Methoxy-2-Nitrobenzaldehyde (3)3-Methoxy-4-Nitrobenzoic Acid (4)3-Methyl-5-Nitropyridine (4)3-Nitroaniline (98)3-Nitrobenzaldehyde (49)3-Nitrobenzamide (17)3-Nitrobenzene-1,2-Diol (6)3-Nitrobenzenesulfonamide (8)3-Nitrobenzoic Acid (109)3-Nitrobenzonitrile (59)3-Nitrophenol (72)3-Nitropyridin-2-Ol (11)3-Nitropyridin-4-Amine (5)3-Nitropyridine (54)3-Nitrothiophene (6)4,4,5,5-Tetramethyl-2-(2-Nitrophenyl)-1,3,2-Dioxaborolane (5)4-Fluoro-1-Methyl-2-Nitrobenzene (12)4-Fluoro-2-Nitroaniline (14)4-Hydroxy-3-Nitrobenzaldehyde (5)4-Methyl-3-Nitroaniline (8)4-Methyl-3-Nitropyridine (8)4-Nitro-1H-Indazole (10)4-Nitro-1H-Indole (6)4-Nitro-1H-Pyrazole (8)4-Nitroaniline (65)4-Nitrobenzaldehyde (18)4-Nitrobenzene-1,3-Diol (5)4-Nitrobenzoic Acid (35)4-Nitrobenzonitrile (25)4-Nitrophenol (67)4-Nitropyridine (11)5-(4-Nitrophenyl)Oxazole (3)5-Methoxy-2-Nitroaniline (7)5-Methyl-2-Nitroaniline (6)5-Nitro-1H-Indazole (5)5-Nitro-1H-Indole (6)5-Nitro-1H-Pyrazole (9)5-Nitro-1H-Pyrazolo[3,4-B]Pyridine (3)5-Nitro-2,3-Dihydrobenzofuran (3)5-Nitrobenzo[D][1,3]Dioxole (4)5-Nitrobenzo[D]Thiazole (3)5-Nitroisoquinoline (7)5-Nitronicotinic Acid (5)5-Nitropyridin-2-Amine (6)6-Nitro-1,2,3,4-Tetrahydroisoquinoline (3)6-Nitro-1H-Indazole (9)6-Nitro-1H-Indole (8)6-Nitrobenzo[D]Thiazole (3)7-Nitro-1,2,3,4-Tetrahydroisoquinoline (3)7-Nitro-1H-Indazole (11)7-Nitro-1H-Indole (11)Ethyl 2-Nitrobenzoate (9)Ethyl 3-Nitrobenzoate (22)Ethyl Cinnamate (26)Methyl 2-Nitrobenzoate (54)Methyl 3-Nitrobenzoate (109)Methyl 4-Amino-3-Nitrobenzoate (9)Methyl 4-Nitrobenzoate (29)N-(2-Nitrophenyl)Acetamide (11)N-Methyl-2-Nitroaniline (20)N-Methyl-4-Nitroaniline (6)Nitrobenzene (2309)
Oximes (561)
Phenols (1786)
Aminophenol (9)Bromophenol (13)Chlorophenol (28)Dibromophenol (9)Dichlorophenol (17)Difluorophenol (36)Dihydroxybenzaldehyde (16)Dihydroxybenzamide (6)Dihydroxybenzoate (15)Dihydroxybenzoic (17)Dihydroxybenzonitrile (6)Dihydroxyphenyl (98)Dihydroxystyryl (4)Diiodophenol (7)Fluorophenol (73)Hydroxyacetophenone (16)Hydroxybenzaldehyde (88)Hydroxybenzamide (24)Hydroxybenzenesulfonic (4)Hydroxybenzenesulfonic Acid (3)Hydroxybenzoate (113)Hydroxybenzohydrazide (4)Hydroxybenzoic (89)Hydroxybenzonitrile (60)Hydroxybenzoyl (1)Hydroxyphenoxy (7)Hydroxyphenylacetic (7)Hydroxyphenylacetic Acid (7)Hydroxyphenylboronic (8)Hydroxypropiophenone (3)Iodophenol (41)Nitrophenol (134)Tetrafluorophenol (9)Trifluorophenol (5)Trihydroxybenzaldehyde (5)Trihydroxybenzoate (12)Trihydroxybenzoic (5)Trihydroxybenzoic Acid (4)Trihydroxyphenyl (10)1,2,3,4-Tetrahydroisoquinolin-5-Ol (3)1,2,3,4-Tetrahydroisoquinolin-6-Ol (6)1-(2-Hydroxyphenyl)Ethan-1-One (73)1-(3-Hydroxyphenyl)Ethan-1-One (19)1-Hydroxyanthracene-9,10-Dione (11)2,3-Dichlorophenol (9)2,3-Difluorophenol (36)2,4-Dibromophenol (16)2,4-Difluorophenol (21)2,5-Dichlorophenol (7)2,6-Dibromophenol (21)2,6-Dichlorophenol (16)2,6-Difluorophenol (24)2,6-Diiodophenol (16)2,6-Dimethylphenol (19)2-(2-Hydroxyphenyl)Acetic Acid (8)2-(3-Hydroxyphenyl)Acetic Acid (7)2-(Benzyloxy)Phenol (5)2-(Difluoromethoxy)Phenol (5)2-(Tert-Butyl)Phenol (56)2-(Trifluoromethoxy)Phenol (8)2-(Trifluoromethyl)Phenol (23)2-Amino-3-Bromophenol (3)2-Amino-3-Chlorophenol (4)2-Aminophenol (107)2-Benzylphenol (8)2-Bromo-3-Methylphenol (4)2-Bromo-6-Methylphenol (7)2-Bromobenzene-1,3-Diol (7)2-Bromobenzene-1,4-Diol (4)2-Chloro-4-Fluorophenol (9)2-Chloro-4-Nitrophenol (5)2-Chloro-6-Methylphenol (5)2-Chloro-6-Nitrophenol (7)2-Chlorobenzene-1,3-Diol (4)2-Chlorophenol (163)2-Ethylphenol (10)2-Hydroxy-N-Phenylbenzamide (3)2-Hydroxybenzamide (14)2-Hydroxybenzonitrile (45)2-Iodobenzene-1,3-Diol (3)2-Iodophenol (63)2-Isopropylphenol (28)2-Methoxyphenol (197)3,4-Dibromophenol (3)3,4-Difluorophenol (19)3-(Benzyloxy)Phenol (5)3-(Trifluoromethoxy)Phenol (12)3-(Trifluoromethyl)Phenol (43)3-Bromo-2-Fluorophenol (5)3-Bromo-4-Chlorophenol (5)3-Bromo-4-Fluorophenol (11)3-Bromobenzene-1,2-Diol (8)3-Chloro-4-Hydroxybenzaldehyde (7)3-Chlorobenzene-1,2-Diol (6)3-Chlorophenol (112)3-Fluorophenol (180)3-Hydroxybenzonitrile (40)3-Iodophenol (21)3-Nitrobenzene-1,2-Diol (6)3-Nitrophenol (72)4-(Benzyloxy)Phenol (2)4-(Trifluoromethyl)Phenol (18)4-Amino-2-Fluorophenol (9)4-Amino-3-Chlorophenol (5)4-Benzylphenol (14)4-Chlorobenzene-1,3-Diol (6)4-Fluorophenol (111)4-Hydroxybenzenesulfonic Acid (5)4-Nitrobenzene-1,3-Diol (5)4-Nitrophenol (67)6-Hydroxy-2,3-Dihydro-1H-Inden-1-One (3)Ethyl 2-Hydroxybenzoate (18)Ethyl 3-Hydroxybenzoate (12)M-Cresol (147)Methyl 2-(4-Hydroxyphenyl)Acetate (10)Methyl 2-Hydroxybenzoate (74)Methyl 3-Hydroxybenzoate (58)O-Cresol (164)P-Cresol (71)Pyrocatechol (131)Resorcinol (146)
Phosphoruses (827)
Diethoxyphosphoryl (5)Diisopropylphosphoramidite (4)Dimethoxyphosphoryl (4)Dimethoxyphosphoryl (4)Dimethylphosphine (28)Dioxaphosphepine (146)Diphosphonic (9)Phosphorothioate (1)1,1,1-Trifluoro-N-(4-Oxido-2,6-Diphenyldinaphtho[2,1-D:1',2'-F][1,3,2]Dioxaphosphepin-4-Yl)Methanesulfonamide (16)Diethyl Benzylphosphonate (17)Dimethyl(Phenyl)Phosphine Oxide (20)Ethyltriphenylphosphonium (2)Methyltriphenylphosphonium (3)Phenyl Phosphate (3)Phenylphosphonic Acid (6)
Polycyclic Aromatic Hydrocarbons (6)
Protective Groups (23)
Saturated Aliphatic Fused Rings (2)
(8Ar,12Br,14Br)-1,2,3,4,4A,5,6,6A,6B,7,8,8A,9,10,11,12,12A,12B,13,14B-Icosahydropicene (2)
Silicon Compounds (450)
Butyldimethylsilyl (94)Butyldimethylsilyl (94)Butyldimethylsilyloxy (8)Dimethylsilane (16)Dimethylsilane (16)Dimethylsilyl (4)Tetramethyldisiloxane (3)Tetramethyldisiloxane (3)Triethoxysilyl (13)Triethoxysilyl (13)Triisopropylsilyl (22)Triisopropylsilyl (22)Trimethoxysilane (19)Trimethoxysilane (19)Trimethylsilane (155)1-(Triisopropylsilyl)-1H-Pyrrolo[2,3-B]Pyridine (8)Tert-Butyldimethyl(Phenoxy)Silane (17)Tetraphenylsilane (7)Trimethoxy(Phenyl)Silane (6)Trimethyl(Phenyl)Silane (22)Trimethyl(Phenylethynyl)Silane (23)
Sulfamides (10218)
Dimethylsulfamoyl (5)Dimethylsulfamoyl (5)Methanesulfonamide (54)Methanesulfonamide (54)Methylmethanesulfonamide (3)Methylmethanesulfonamide (3)Methylsulfonamido (4)Methylsulfonamido (4)Sulfinamide (55)Sulfinamide (55)2-Fluoro-N-Phenylbenzenesulfonamide (6)2-Fluorobenzenesulfonamide (12)2-Methylbenzenesulfonamide (8)3-Nitrobenzenesulfonamide (8)4-Amino-N-Phenylbenzenesulfonamide (3)4-Bromo-N-Phenylbenzenesulfonamide (23)4-Chloro-N-Phenylbenzenesulfonamide (4)4-Methoxy-N-Phenylbenzenesulfonamide (3)4-Methoxybenzenesulfonamide (5)4-Methyl-N-Phenylbenzenesulfonamide (13)N,N-Diethylbenzenesulfonamide (8)N,N-Dimethylbenzenesulfonamide (23)N-(2-Phenoxyphenyl)Methanesulfonamide (4)N-(3-Chlorophenyl)Benzenesulfonamide (6)N-(O-Tolyl)Benzenesulfonamide (4)N-(Tert-Butyl)Benzenesulfonamide (14)N-Ethylbenzenesulfonamide (8)N-Isopropylbenzenesulfonamide (8)N-Methyl-N-(4-Phenylpyrimidin-2-Yl)Methanesulfonamide (7)N-Methylbenzenesulfonamide (15)N-Phenylbenzenesulfonamide (81)N-Phenylmethanesulfonamide (37)Phenylmethanesulfonamide (13)Pyridine-2-Sulfonamide (6)
Sulfides (10123)
Methylthio (432)(S)-2-(Phenylthio)Tetrahydro-2H-Pyran (5)1,2-Diphenyldisulfane (19)2-((Pyridin-2-Ylmethyl)Thio)-1H-Benzo[D]Imidazole (7)2-(Methylthio)Benzo[D]Thiazole (6)2-(Methylthio)Pyridine (5)2-(Methylthio)Pyrimidin-4-Amine (10)2-(Methylthio)Pyrimidine (19)2-(Methylthio)Thiazole (5)2-(Propylthio)Pyrimidine (5)4,6-Dichloro-2-(Methylthio)Pyrimidine (9)4-Chloro-2-(Methylthio)Pyrimidine (29)4-Methyl-2-(Methylthio)Pyrimidine (7)5-Bromo-2-(Methylthio)Pyrimidine (6)Benzyl(Phenyl)Sulfane (5)Ethyl(Phenyl)Sulfane (8)Pentafluoro(Phenyl)-L6-Sulfane (19)Phenyl(Trifluoromethyl)Sulfane (23)
Sulfonates (1160)
4-Methylbenzenesulfonate (9)
Sulfones (3927)
(4-(Methylsulfonyl)Phenyl)Boronic Acid (6)(Ethylsulfonyl)Benzene (8)1-(Methylsulfonyl)-3-Nitrobenzene (7)1-(Methylsulfonyl)Piperazine (5)1-(Methylsulfonyl)Piperidine (6)1-(Phenylsulfonyl)-1H-1,2,4-Triazole (6)1-(Phenylsulfonyl)-1H-Imidazole (5)1-(Phenylsulfonyl)Azetidine (7)1-Bromo-2-(Methylsulfonyl)Benzene (4)1-Bromo-4-(Phenylsulfonyl)Benzene (7)1-Fluoro-2-(Methylsulfonyl)Benzene (5)1-Fluoro-3-(Methylsulfonyl)Benzene (10)1-Methyl-3-(Methylsulfonyl)Benzene (5)2-(Methylsulfonyl)Aniline (3)2-(Methylsulfonyl)Pyridine (11)2-(Methylsulfonyl)Pyrimidine (25)3-(Methylsulfonyl)Aniline (7)3-(Methylsulfonyl)Benzoic Acid (6)3-(Methylsulfonyl)Pyridine (5)Benzenesulfonyl Fluoride (51)Tetrahydro-2H-Thiopyran 1,1-Dioxide (8)Tetrahydrothiophene 1,1-Dioxide (13)
Sulfonic Acids (1261)
Aminobenzenesulfonic (4)Bromobenzenesulfonic Acid (4)Disulfonic (9)Disulfonic (9)Ethanesulfonic (3)Methanesulfonic (2)Methanesulfonic (2)Methylbenzenesulfonate (144)Propanesulfonic Acid (2)Trifluoromethanesulfonic (4)2-Aminobenzenesulfonic Acid (9)2-Methylbenzenesulfonic Acid (8)3-Aminobenzenesulfonic Acid (6)4-Chlorobenzenesulfonic Acid (4)4-Hydroxybenzenesulfonic Acid (5)Naphthalene-2-Sulfonic Acid (4)Pyridine-3-Sulfonic Acid (6)
Sulfonyl Chlorides (4029)
Fluorobenzenesulfonyl (12)1H-Pyrazole-4-Sulfonyl Chloride (8)2-Bromobenzenesulfonyl Chloride (8)2-Chlorobenzenesulfonyl Chloride (24)2-Fluorobenzenesulfonyl Chloride (31)2-Methoxybenzenesulfonyl Chloride (15)2-Methylbenzenesulfonyl Chloride (22)3-(Chlorosulfonyl)Benzoic Acid (15)3-(Trifluoromethyl)Benzenesulfonyl Chloride (13)3-Chlorobenzenesulfonyl Chloride (21)3-Fluorobenzenesulfonyl Chloride (22)4-Chlorobenzenesulfonyl Chloride (12)4-Fluorobenzenesulfonyl Chloride (26)Isoquinoline-5-Sulfonyl Chloride (3)Methyl 2-(Chlorosulfonyl)Benzoate (7)Phenylmethanesulfonyl Chloride (20)
Sulfonyl Hydrazides (25)
Benzenesulfonohydrazide (12)
Sulfoxides (333)
(Methylsulfinyl)Benzene (7)
Thioesters (625)
Thiols (468)
Dithiole (9)Dithiole (9)Ethanethioate (9)Ethanethioate (9)Methanethiol (6)1H-Benzo[D]Imidazole-2-Thiol (10)2-Chlorobenzenethiol (7)2-Mercaptoquinazolin-4(3H)-One (3)Benzo[D]Oxazole-2-Thiol (6)Benzo[D]Thiazole-2-Thiol (11)Phenylmethanethiol (16)Pyridine-2-Thiol (8)Pyrimidine-2-Thiol (6)
Thiophenols (3045)
Thioureas (1128)
Carbamimidothioate (4)1,3-Diphenylthiourea (8)1-Phenylthiourea (33)
Trifluoromethyls (28951)
Trifluoromethyl-Picolinamide (7)Trifluoromethylaniline (3)(2,2,2-Trifluoroethoxy)Benzene (18)(2-(Trifluoromethoxy)Phenyl)Boronic Acid (5)(2-(Trifluoromethyl)Phenyl)Boronic Acid (20)(2-(Trifluoromethyl)Phenyl)Methanol (10)(2-Fluoro-3-(Trifluoromethyl)Phenyl)Boronic Acid (6)(3-(Trifluoromethoxy)Phenyl)Boronic Acid (9)(3-(Trifluoromethoxy)Phenyl)Methanol (4)(3-(Trifluoromethyl)Phenyl)Boronic Acid (41)(3-(Trifluoromethyl)Phenyl)Methanol (21)(4-(Trifluoromethyl)Phenyl)Boronic Acid (22)(Perfluoropropane-2,2-Diyl)Dibenzene (7)(Trifluoromethyl)Benzene (1336)1,3-Bis(Trifluoromethyl)Benzene (70)1-(2-(Trifluoromethyl)Phenyl)Ethan-1-One (9)1-(3-(Trifluoromethoxy)Phenyl)Ethan-1-Amine (6)1-(3-(Trifluoromethyl)Phenyl)Ethan-1-Amine (25)1-(4-(Trifluoromethoxy)Phenyl)Ethan-1-Amine (6)1-(Bromomethyl)-2-(Trifluoromethyl)Benzene (13)1-(Bromomethyl)-3-(Trifluoromethyl)Benzene (17)1-Bromo-2-(Trifluoromethoxy)Benzene (22)1-Bromo-2-Fluoro-3-(Trifluoromethyl)Benzene (4)1-Bromo-3-(Trifluoromethyl)Benzene (100)1-Chloro-2-(Trifluoromethoxy)Benzene (20)1-Chloro-2-(Trifluoromethyl)Benzene (81)1-Chloro-3-(Trifluoromethoxy)Benzene (18)1-Chloro-3-(Trifluoromethyl)Benzene (101)1-Chloro-4-(Trifluoromethoxy)Benzene (8)1-Fluoro-2-(Trifluoromethoxy)Benzene (20)1-Fluoro-2-(Trifluoromethyl)Benzene (126)1-Fluoro-3-(Trifluoromethyl)Benzene (98)1-Fluoro-4-(Trifluoromethoxy)Benzene (14)1-Fluoro-4-(Trifluoromethyl)Benzene (53)1-Iodo-2-(Trifluoromethyl)Benzene (13)1-Iodo-3-(Trifluoromethyl)Benzene (30)1-Methoxy-2-(Trifluoromethyl)Benzene (21)1-Methoxy-3-(Trifluoromethoxy)Benzene (9)1-Methoxy-3-(Trifluoromethyl)Benzene (40)1-Methoxy-4-(Trifluoromethyl)Benzene (18)1-Methyl-2-(Trifluoromethoxy)Benzene (5)1-Methyl-2-(Trifluoromethyl)Benzene (43)1-Methyl-3-(Trifluoromethyl)Benzene (22)1-Nitro-2-(Trifluoromethoxy)Benzene (8)1-Nitro-2-(Trifluoromethyl)Benzene (32)1-Nitro-3-(Trifluoromethoxy)Benzene (9)1-Nitro-3-(Trifluoromethyl)Benzene (82)1-Phenoxy-3-(Trifluoromethyl)Benzene (2)1-Phenoxy-4-(Trifluoromethyl)Benzene (2)1-Phenyl-3-(Trifluoromethyl)-1H-Pyrazole (5)2,2,2-Trifluoro-1-Phenylethan-1-Amine (48)2,2,2-Trifluoro-1-Phenylethan-1-Ol (27)2,2,2-Trifluoro-1-Phenylethan-1-One (51)2-(2,2,2-Trifluoroethoxy)Pyridine (8)2-(Trifluoromethoxy)Aniline (18)2-(Trifluoromethoxy)Benzaldehyde (7)2-(Trifluoromethoxy)Benzoic Acid (8)2-(Trifluoromethoxy)Benzonitrile (7)2-(Trifluoromethoxy)Phenol (8)2-(Trifluoromethoxy)Pyridine (6)2-(Trifluoromethyl)-1,1'-Biphenyl (8)2-(Trifluoromethyl)Aniline (58)2-(Trifluoromethyl)Benzaldehyde (27)2-(Trifluoromethyl)Benzamide (6)2-(Trifluoromethyl)Benzoic Acid (33)2-(Trifluoromethyl)Benzonitrile (35)2-(Trifluoromethyl)Phenol (23)2-(Trifluoromethyl)Pyrazine (6)2-(Trifluoromethyl)Pyridine (6)2-(Trifluoromethyl)Pyrimidine (27)2-(Trifluoromethyl)Quinazoline (4)2-(Trifluoromethyl)Thiazole (11)2-(Trifluoromethyl)Thiophene (11)2-Bromo-1-Fluoro-4-(Trifluoromethyl)Benzene (4)2-Bromo-4-(Trifluoromethyl)Aniline (9)2-Bromo-6-(Trifluoromethyl)Aniline (5)2-Chloro-3-(Trifluoromethyl)Aniline (3)2-Chloro-4-(Trifluoromethyl)Pyrimidine (6)2-Chloro-6-(Trifluoromethyl)Aniline (4)2-Methoxy-3-(Trifluoromethyl)Pyridine (6)2-Methoxy-5-(Trifluoromethyl)Pyridine (4)2-Phenoxy-5-(Trifluoromethyl)Pyridine (7)3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-5-(Trifluoromethyl)Pyridine (3)3-(Trifluoromethoxy)Aniline (22)3-(Trifluoromethoxy)Benzaldehyde (10)3-(Trifluoromethoxy)Benzoic Acid (19)3-(Trifluoromethoxy)Benzonitrile (11)3-(Trifluoromethoxy)Phenol (12)3-(Trifluoromethyl)-1H-Pyrrolo[2,3-B]Pyridine (3)3-(Trifluoromethyl)Aniline (102)3-(Trifluoromethyl)Benzaldehyde (31)3-(Trifluoromethyl)Benzenesulfonyl Chloride (13)3-(Trifluoromethyl)Benzoic Acid (52)3-(Trifluoromethyl)Benzonitrile (47)3-(Trifluoromethyl)Phenol (43)3-(Trifluoromethyl)Pyridazine (3)3-(Trifluoromethyl)Pyridin-2-Ol (5)3-(Trifluoromethyl)Pyridine (52)3-Chloro-4-(Trifluoromethyl)Aniline (5)4,4,4-Trifluoro-1-Phenylbutane-1,3-Dione (10)4,4,5,5-Tetramethyl-2-(2-(Trifluoromethyl)Phenyl)-1,3,2-Dioxaborolane (5)4,4,5,5-Tetramethyl-2-(3-(Trifluoromethoxy)Phenyl)-1,3,2-Dioxaborolane (5)4-(Trifluoromethoxy)Aniline (26)4-(Trifluoromethyl)-2H-Chromen-2-One (6)4-(Trifluoromethyl)Phenol (18)4-(Trifluoromethyl)Pyridine (14)4-(Trifluoromethyl)Pyrimidin-2-Amine (6)4-(Trifluoromethyl)Pyrimidine (12)4-(Trifluoromethyl)Thiazole (7)4-Bromo-3-(Trifluoromethyl)Aniline (7)5-(Trifluoromethyl)Pyridin-2-Amine (5)5-(Trifluoromethyl)Pyridin-2-Ol (8)6-(Trifluoromethyl)-1H-Indazole (6)6-(Trifluoromethyl)-1H-Indole (5)6-(Trifluoromethyl)Pyridin-2-Amine (11)6-(Trifluoromethyl)Pyridin-3-Amine (5)Methyl 2-(Trifluoromethyl)Benzoate (14)Methyl 3-(Trifluoromethyl)Benzoate (22)N-Phenyl-4-(Trifluoromethyl)Aniline (3)Phenyl(3-(Trifluoromethyl)Phenyl)Methanone (3)Phenyl(Trifluoromethyl)Sulfane (23)
Ureas (1841)
Other Function Groups (5)
Organometallic Reagents
Organoborons (34729)
Fluorene-Phenyl-Boronic Acid/Ester (4)Hydroxymethyl-Phenyl-Boronic-Acid (31)Methoxyphenylboronic-Acid (32)Phenyl-Naphthalene-Boronic Acid/Ester (9)(1-(Tert-Butoxycarbonyl)-1H-Indol-2-Yl)Boronic Acid (17)(1-Phenyl-1H-Pyrazol-4-Yl)Boronic Acid (4)(1H-Indazol-4-Yl)Boronic Acid (3)(1H-Indazol-6-Yl)Boronic Acid (4)(1H-Indol-2-Yl)Boronic Acid (3)(2,3-Dichlorophenyl)Boronic Acid (11)(2,3-Difluorophenyl)Boronic Acid (33)(2,6-Dichlorophenyl)Boronic Acid (6)(2,6-Difluorophenyl)Boronic Acid (28)(2-(Phenoxymethyl)Phenyl)Boronic Acid (3)(2-(Trifluoromethoxy)Phenyl)Boronic Acid (5)(2-(Trifluoromethyl)Phenyl)Boronic Acid (20)(2-Bromophenyl)Boronic Acid (39)(2-Chloro-3-Methoxyphenyl)Boronic Acid (5)(2-Chloro-6-Fluorophenyl)Boronic Acid (9)(2-Fluoro-3-(Trifluoromethyl)Phenyl)Boronic Acid (6)(2-Fluorophenyl)Boronic Acid (229)(2-Nitrophenyl)Boronic Acid (13)(3,4-Dichlorophenyl)Boronic Acid (10)(3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Phenyl)Methanol (7)(3-(Benzyloxy)Phenyl)Boronic Acid (9)(3-(Phenoxymethyl)Phenyl)Boronic Acid (3)(3-(Phenylcarbamoyl)Phenyl)Boronic Acid (3)(3-(Trifluoromethoxy)Phenyl)Boronic Acid (9)(3-(Trifluoromethyl)Phenyl)Boronic Acid (41)(3-Bromo-2-Fluorophenyl)Boronic Acid (7)(3-Bromo-2-Methoxyphenyl)Boronic Acid (6)(3-Bromophenyl)Boronic Acid (65)(3-Chloro-2-Methoxyphenyl)Boronic Acid (4)(3-Chloro-4-Fluorophenyl)Boronic Acid (8)(3-Chlorophenyl)Boronic Acid (121)(3-Fluorophenyl)Boronic Acid (169)(3-Iodophenyl)Boronic Acid (5)(3-Nitrophenyl)Boronic Acid (32)(4-(Benzyloxy)Phenyl)Boronic Acid (26)(4-(Methylsulfonyl)Phenyl)Boronic Acid (6)(4-(Phenoxymethyl)Phenyl)Boronic Acid (6)(4-(Phenylcarbamoyl)Phenyl)Boronic Acid (11)(4-(Trifluoromethyl)Phenyl)Boronic Acid (22)(4-Cyclohexylphenyl)Boronic Acid (7)(4-Fluorophenyl)Boronic Acid (93)(5-(Trifluoromethyl)Pyridin-3-Yl)Boronic Acid (4)(6-Phenoxypyridin-3-Yl)Boronic Acid (5)(9H-Fluoren-2-Yl)Boronic Acid (6)(E)-4,4,5,5-Tetramethyl-2-Styryl-1,3,2-Dioxaborolane (16)1,3,2-Dioxaborinane (6)1-(4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzyl)Piperazine (4)1-(4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Phenyl)Piperazine (10)1-(5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridin-2-Yl)Piperazine (6)1-Methyl-4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-1H-Pyrazole (6)2,7-Bis(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-9H-Fluorene (7)2-(1,3,2-Dioxaborinan-2-Yl)Benzonitrile (4)2-(1,3,2-Dioxaborolan-2-Yl)-1-Methyl-1H-Indole (6)2-(2-(Bromomethyl)Phenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (9)2-(2-Bromophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (5)2-(3-Chlorophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (8)2-(3-Cyclopropylphenyl)-1,3,2-Dioxaborolane (5)2-(3-Isopropoxyphenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (5)2-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzonitrile (14)2-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Phenol (7)2-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (6)2-(4-(Benzyloxy)Phenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (10)2-(4-Bromophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (8)2-(4-Cyclopropylphenyl)-1,3,2-Dioxaborolane (8)2-(4-Fluorophenyl)-1,3,2-Dioxaborinane (5)2-([1,1'-Biphenyl]-4-Yl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (10)2-(Cyclohex-1-En-1-Yl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (16)2-(Furan-2-Yl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (6)2-(M-Tolyl)-1,3,2-Dioxaborinane (4)2-Benzyl-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (12)2-Chloro-3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (4)2-Chloro-4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (14)2-Chloro-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (6)2-Fluoro-3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (7)2-Methoxy-3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (7)2-Methoxy-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (5)2-Methyl-3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (5)2-Methyl-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (3)3-(1,3,2-Dioxaborinan-2-Yl)Aniline (3)3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzonitrile (25)3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (74)3-Chloro-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (5)3-Fluoro-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (7)3-Methyl-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (6)4,4,5,5-Tetramethyl-2-(2-(Trifluoromethyl)Phenyl)-1,3,2-Dioxaborolane (5)4,4,5,5-Tetramethyl-2-(2-Nitrophenyl)-1,3,2-Dioxaborolane (5)4,4,5,5-Tetramethyl-2-(3-(Trifluoromethoxy)Phenyl)-1,3,2-Dioxaborolane (5)4,4,5,5-Tetramethyl-2-(Naphthalen-1-Yl)-1,3,2-Dioxaborolane (19)4,4,5,5-Tetramethyl-2-(Naphthalen-2-Yl)-1,3,2-Dioxaborolane (12)4,4,5,5-Tetramethyl-2-(Thiophen-2-Yl)-1,3,2-Dioxaborolane (23)4,4,5,5-Tetramethyl-2-(Thiophen-3-Yl)-1,3,2-Dioxaborolane (10)4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-1,2,3,6-Tetrahydropyridine (11)4-Methyl-3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (5)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-1H-Indole (5)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Indoline (5)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Nicotinonitrile (4)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridin-2-Amine (9)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyrimidine (27)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Thiazole (7)[1,1'-Biphenyl]-4-Ylboronic Acid (29)Benzo[B]Thiophen-2-Ylboronic Acid (5)Benzofuran-2-Ylboronic Acid (8)Benzyl (4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Phenyl)Carbamate (5)Cyclohex-1-En-1-Ylboronic Acid (4)Ethyl 3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzoate (6)Isoquinolin-4-Ylboronic Acid (3)Methyl 5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Nicotinate (4)N,N-Diphenyl-4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Aniline (6)Naphthalen-1-Ylboronic Acid (4)Naphthalen-2-Ylboronic Acid (8)Phenylboronic Acid (1286)Pyridin-2-Ylboronic Acid (9)Pyridin-3-Ylboronic Acid (49)Pyridin-4-Ylboronic Acid (21)Pyrimidin-5-Ylboronic Acid (9)Tert-Butyl 2-(1,3,2-Dioxaborolan-2-Yl)-1H-Indole-1-Carboxylate (6)Tert-Butyl 4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-1H-Pyrazole-1-Carboxylate (3)Tetraphenylborate (8)Thiophen-2-Ylboronic Acid (20)
Organosilicons (73)
Organotins (5)
Other Organometallic Reagents (1)
Specialty Synthesis
Ionic Liquids (738)
Synthetic Reagents
C-C Bond Formation (62)
Condensation Agents (74)
Fluorination Reagents (20)
Halogenation Reagents (20)
Inorganic Salts (25506)
Phase Transfer Catalysts (29)
Other Synthetic Reagents (106)
Materials Science
Electronic Materials
Contact Printing & Self-Assembly Materials (77)
Liquid Crystal (LC) Materials (413)
Molecular Conductors (80)
Organic Field-Effect Transistors (OFETs) (86)
Organic Light-Emitting Diode (OLED) Materials (22)
4-(Diphenylamino)Benzaldehyde (8)4-Bromo-N,N-Bis(4-Methoxyphenyl)Aniline (3)4-Methoxy-N,N-Diphenylaniline (5)4-Methyl-N,N-Diphenylaniline (6)
Photoresist Materials (249)
Silane Coupling Agents (176)
Energy and Battery Materials
Battery Additives (75)
Battery Electrolytes Materials (16)
Battery Solvent Materials (24)
Electrode Active Materials (4)
Ionic Liquids (738)
Organic Redox Flow Battery Materials (26)
Solution & Vapor Deposition Precursors (31)
Material Building Blocks
Alkyl Chain Building Blocks (93)
Ligands for Functional Metal Complexes (198)
Liquid Crystal (LC) Building Blocks (558)
Phthalocyanine Building Blocks (71)
Small Molecule Semiconductor Building Blocks (1878)
Organic Frameworks and Supramolecular Materials
Covalent Organic Framework (COF) Linkers (1087)
Metal Organic Framework (MOF) Linkers (1693)
Metal Organic Frameworks (MOFs) (85)
Organic Framework Building Blocks (218)
Supramolecular Host Materials  (185)
Polymer Additives
Antioxidants (81)
Crosslinking Agents (75)
Flame Retardants (35)
Light Stabilizers (67)
Plasticizers (84)
Polymerization Catalysts (156)
Polymerization Initiators (141)
Polymerization Reagents (170)
Surfactants (340)
Other Additives (34)
Polymer Reagents
Dendrimer Materials (59)
Ion Exchange Resins (7)
Monomers (3050)
Photopolymer Monomers (180)
Polybenzoxazole and Polyimide Raw Materials (240)
Polymer Semiconductor Monomers (269)
Polymers (375)
Quantum Dots and Micro/Nano Materials
Nanocarbon Materials (45)
Quantum Dots (QD) Capping Agents (178)
Quantum Dots (QD) Synthetic Reagents (13)
Solar Cells and Photonic Materials
Donor Intermediates & Acceptor Intermediates (1029)
Dye-Sensitized Solar Cell (DSSC) Materials (130)
Dyes and Pigments (392)
Organic Non-Linear Optical (NLO) Materials (39)
Organic Phto-Voltaics (OPV) Materials (185)
Perovskite Solar Cell (PSC) Materials (278)
Visible Light Photoredox Catalysts (29)
Other Functional Materials
Aggregation-Induced Emission Materials (169)
Inorganic Compounds and Ceramic Materials (33)
Magnetic Materials (50)
Life Science
Inhibitors/Agonists
ADC (371)
ADC Linker (371)
Angiogenesis (1714)
ALK (86)Bcr-Abl (105)BTK (149)EGFR (403)FAK (56)FGFR (136)FLT3 (134)HER2 (31)HIF (112)JAK (245)PDGFR (127)Src (110)Syk (40)VDA (1)VEGFR (271)
Anti-Infection (4763)
3CLpro (41)Antibacterial (2101)Antifungal (525)Antiparasitic (648)Antiprotozoal (2)Antiviral (48)Arenavirus (5)BVDV (3)CMV (30)Dengue Virus (36)EBV (14)Enterovirus (33)FCoV (3)Filovirus (14)Flavivirus (64)GraR (1)HBV (151)HCV (222)HHV (1)HIV (447)HIV Integrase (39)HIV Protease (68)HPV (10)HRV (3)HSV (75)Influenza Virus (251)LpxC (2)M2 proton channel (2)MERS-CoV (1)Neuraminidase (4)NNRTI (12)NRTI (22)Orthopoxvirus (28)Penicillin-Binding Protein (7)PLP (13)Prion (1)Protein Synthesis (4)Reverse Transcriptase (99)RSV (43)SAMHD1 (1)SARS-CoV (298)SQLE (5)TMV (12)Viral MTase (3)Virus Protease (62)VSV (1)β-lactamase (51)
Antibody-Drug Conjugate/ADC Related (647)
ADC Linker (371)ADC Toxins (123)Payload-Linker Conjugate (165)
Apoptosis (2443)
Apoptosis (2143)Apoptosis Inducer (1407)Bcl-2 (195)Bcl-6 (6)BRK (3)c-Myc (47)c-RET (64)C/EBP (2)Caspase (170)DAPK (12)Ferroptosis (109)FKBP (15)GDNF Receptor (1)IAP (48)IDO (70)MDM2 (143)MRCK (2)Necroptosis (33)p32 (1)p53 (41)PERK (35)PKD (10)Pyroptosis (13)RIP Kinase (84)Survivin (12)Thymidylate Synthase (24)TNF (22)TNF Receptor (117)TNF-alpha (30)
Autophagy (745)
ATG4B (4)ATTECs (3)AUTACs (7)Autophagy (730)Beclin1 (1)FKBP (15)LC3 (1)LRRK2 (32)Lysosome (1)mitoNEET (1)Mitophagy (3)PPT (1)SPHK (27)TFEB (1)ULK (17)
Cell Cycle (4595)
Antifolate (31)APC (6)Aurora Kinase (87)BUB (3)Casein Kinase (101)CDK (475)Chk (46)CRISPR/Cas9 (7)CRM1 (17)DHFR (55)DNA polymerase θ (2)DNA/RNA Synthesis (620)DOCK (3)DYRK (60)E2F (2)eIF (43)Endonuclease (3)FOXM1 (3)G-quadruplex (6)Haspin Kinase (8)HDAC (336)HGF (1)HSF (4)HSP (161)IRE1 (27)Kinesin (35)Lats kinase (1)LIMK (17)Mad2 (1)Microtubule/Tubulin (305)MKLP (1)Mps1 (21)MTH2 (1)Nucleoside Antimetabolite/Analog (1441)p21 (1)PAK (30)PDI (1)PKMYT1 (2)PLK (50)PPAR (193)PTEN (5)RAD51 (18)Rho (14)RNA polymerase 2 (1)RNA polymerase 1 (2)ROCK (90)Separase (1)Sirtuin (129)SRPK (51)STK33 (2)TACC (3)Telomerase (21)TOPK (1)Topoisomerase (271)Wee1 (16)YB-1 (5)
Cytoskeleton (728)
Actin (1)Arp2/3 Complex (6)CYTH (1)Cytoplasmic dynein (1)Dynamin (14)FAK (56)Filamin-A (1)Gap Junction (11)Integrin (134)Kinesin (35)MARK (1)Microtubule/Tubulin (305)MLCK (5)Mps1 (21)Myosin (25)PAK (30)ROCK (90)Spastin (1)
DNA Damage (3023)
ADAR (1)AP endonuclease (1)ATAD5 (1)ATM/ATR (67)Aurora Kinase (87)Casein Kinase (101)ClpP (5)CRISPR/Cas9 (7)DNA Alkylator/Crosslinker (75)DNA-PK (39)DNA/RNA Synthesis (620)HDR (1)HSP (161)MRE11 (1)MTH1 (8)Nucleoside Antimetabolite/Analog (1441)OGG (3)p97 (15)PARP (175)RAD51 (18)RAD52 (3)Telomerase (21)Topoisomerase (271)WRN (5)YB-1 (5)
Endocrinology/Hormones (826)
5 Alpha Reductase (2)ACE (76)Adrenergic Receptor (184)Androgen Receptor (96)Aromatase (8)ERR (218)GHSR (21)Glucocorticoid Receptor (44)GNRH Receptor (19)Mineralocorticoid Receptor (12)Opioid Receptor (54)Progesterone Receptor (9)PTHR (1)Renin (18)Sepiapterin reductase (2)SSTR (28)Taste receptor (3)Thyroid Hormone Receptor (7)TPO (4)TRHR (1)TSH Receptor (17)TTR (7)
Endoplasmic Reticulum Stress (567)
Antioxidant (33)IRE1 (27)JNK (79)PDI (1)PERK (35)ROS (398)
Epigenetics (2366)
AMPK (105)Aurora Kinase (87)DNA Methyltransferase (43)Epigenetic Reader Domain (396)FTO (15)HDAC (336)HIF (112)Histone Acetyltransferase (95)Histone Demethylase (147)Histone Methyltransferase (294)JAK (245)MBD-containing protein (1)METTL3 (10)MicroRNA (16)PAD (24)PARP (175)Pim (58)PKC (157)SF3B1 (3)Sirtuin (129)TET (8)
Ferroptosis Signaling Pathway (78)
ABC Transporter (2)ACC (22)GPx (25)SCD (18)SLC (6)VDAC (6)
GPCR/G Protein (3483)
5-HT Receptor (402)Adenosine Receptor (169)Adenylyl Cyclase (1)Adiponectin Receptor (2)Adrenergic Receptor (184)Amylin receptor (1)Angiotensin Receptor (72)Apelin Receptor (22)Bombesin Receptor (7)Bradykinin Receptor (17)cAMP (34)Cannabinoid Receptor (65)CaSR (23)CCR (89)CGRP Receptor (14)Chemerin Receptor (2)Cholecystokinin Receptor (32)CRF Receptor (19)CXCR (112)Dopamine Receptor (170)Endothelin Receptor (47)Epac (9)G protein (2)GHSR (21)GLP Receptor (25)Glucagon Receptor (50)GNRH Receptor (19)GPCR (203)GPCR19 (2)GPR109A (1)GPR119 (2)GPR139 (3)GPR24 (1)GPR35 (1)GPR40 (7)GPR52 (4)GPR6 (3)GPR68 (2)GPR84 (1)GPR88 (10)Guanylate Cyclase (31)HCAR (2)Histamine Receptor (239)ICMT (61)Kisspeptin Receptor (2)LHCGR (39)LPA Receptor (11)LPL Receptor (118)Melanocortin Receptor (31)mGluR (226)Motilin Receptor (1)MRGPR (13)Neuropeptide Y receptor (8)Neurotensin Receptor (13)NMUR (2)NPFF receptor (3)Opioid Receptor (54)OXTR (10)P2Y Receptor (77)PACAP Receptor (3)PAFR (38)PAR (55)Prostaglandin Receptor (217)Ras (275)RGS (6)RXFP Receptor (14)Sigma Receptor (53)SOS (7)SRPK (51)SSTR (28)SUCNR1 (4)TAAR (8)TSH Receptor (17)Urotensin Receptor (7)Vasopressin Receptor (23)β-arrestin (17)
Hedgehog (Hh) (832)
BMI-1 (3)c-Myc (47)Casein Kinase (101)CDK (475)Cytoplasmic dynein (1)Gli (6)GSK-3 (126)PKA (59)Smo (36)ULK (17)
Hippo (80)
Lats kinase (1)MAP4K (47)MST (2)TEAD (10)YAP (28)
Immunology/Inflammation (2700)
AIM2 (5)AP-1 (14)Arginase (15)Calcineurin (8)CCR (89)CD19 (1)CD20 (2)CD22 (2)CD28 (2)CD28-B7 (1)CD3 (3)CD38 (10)CD47 (6)CD6 (1)CD73 (26)CD80 (1)cGAS (8)Complement System (45)COX (344)CRTH2 (9)CTLA-4 (2)CXCR (112)CYPA (1)FAP (17)FKBP (15)FLAP (17)FPR (17)Galectin (3)Glucocorticoid Receptor (44)Glycoprotein VI (3)GM-CSF (2)Histamine Receptor (239)HMGB (1)IFNAR (24)IL (172)IL Receptor (9)Immunology & Inflammation Related (75)IRAK (71)IRF3 (1)LAG-3 (1)LanC-like protein (1)Legumain (1)LTA4H (3)LTR (71)MALT1 (24)MIF (18)MyD88 (6)NADPH Oxidase (32)NFAT (11)NLR (73)NO Synthesis (6)NOS (186)NOT (1)Nrf2 (99)PD-1/PD-L1 (80)PG Synthase (30)PSMA (13)Pyroptosis (13)ROS (398)Ros1 (18)S100A9 (1)Scavenger receptor (1)SIK (15)SOD (4)SPHK (27)STING (98)TENT (1)Thrombopoietin Receptor (11)Tim3 (4)TLR (163)TSPO (2)VISTA (1)XBP1 (1)
JAK-STAT-Signaling (837)
EGFR (403)JAK (245)Pim (58)STAT (160)
MAPK/ERK Pathway (712)
AP-1 (14)ERK (166)HPK1 (2)JNK (79)KLF (5)MAP3K (24)MAP3K12 (1)MAP4K (47)MAP4K4 (5)MAP4K6 (1)MEK (99)MK2 (11)MLK (14)MNK (11)p38 MAPK (163)Raf (106)RSK (33)TAOK (1)
Membrane Transporter/Ion Channel (1711)
ABC Transporter (2)AKK1 (3)ANT (1)AQP (5)AQP3 (1)ARF (2)ATP synthase (19)ATPase (41)BCRP (23)Calcium Channel (269)CFTR (61)Chloride Channel (30)CRAC Channel (14)CRM1 (17)EAAT (3)Efflux pump (1)ENT (2)Ferroportin (2)GABA Receptor (188)GLUT (32)Glutamate transporter (21)Glycine transporter (23)HCN Channel (2)IBAT (10)ITPKA (2)MAT (24)MCT (17)Na+/Ca2+ Exchanger (15)Na+/K+ ATPase (16)Na/HCO3 cotransporter (1)NKCC (1)Oct (11)OCTN (1)Organic Anion Transporter (1)P-gp (53)P2X Receptor (79)Piezo (4)Potassium Channel (287)Proton Pump (54)SEO1 (1)SGLT (44)SLC (6)Sodium Channel (195)SV2 (2)TRP Channel (182)URAT1 (18)Urea Transporter (2)VDAC (6)VRAC (1)
Metabolic Enzyme (3492)
15-PGDH (2)2OG Oxygenase (1)3-PGDH (2)3MST (1)6PGD (2)ACAT (38)ACC (22)ACMSD (2)Aconitate hydratase (1)ACS (3)Adenosine Deaminase (12)Adenosylhomocysteinase (8)ADP-ribosyltransferase (1)AhR (49)AKR (15)ALDH (30)Aldose Reductase (54)Aminopeptidase (28)Antifolate (31)AO (1)ApoE (1)Arginase (15)Asparagine synthetase (1)ATF/CREB proteins (2)ATP Citrate Lyase (6)ATP synthase (19)BDK (1)Beta-glucuronidase (3)Carbonic Anhydrase (121)Carboxylesterase (23)Carboxypeptidase (7)Cardiolipin Peroxidase (1)Cathepsin (98)Ceramidase (4)CETP (15)Cholesterol Transporter (1)CPA (5)CPSI (2)Creatine kinase (1)Cryptochrome (5)CSE (2)CYP51 (1)D-amino acid oxidase (3)D6D (1)DAPA synthase (1)Decarboxylase (8)Dehydrogenase (156)DGAT (62)DGK (20)Dopamine β-hydroxylase (8)E-NTPDase (1)Elastase (32)Enolase (7)Enteropeptidase (5)ERAP (3)FABP (8)Factor Xa (45)Farnesyl Transferase (4)FAS (35)FBPase (4)Ferroptosis (109)FOXO (3)FPR (17)FTO (15)Fumarate hydratase (2)FVII (2)FXR (71)G0/G1 switch protein 2 (2)Galactosidases (5)GCN (1)GCS (3)GGTase (6)Glucokinase (26)Glucosidase (131)GLUT (32)Glutaminase C (2)Glutathione Reductase (1)Glyoxalase (14)GOAT (1)GPx (25)GSNOR (3)GST (16)Hexokinase (8)HMGCR (45)HPSE (2)Hydrolase (12)Hydroxylase (24)IDH (37)IDO (70)Ketohexokinase (5)LDL (11)LDLR (1)Lipase (93)Lipoxygenase (109)LOX (4)LRH-1 (4)LXR (27)MAGL (2)MASTL (1)MDH (3)MetAP (10)MGAT (7)Mineralocorticoid Receptor (12)Mitochondrial Electron Transport Chain (3)Mitochondrial Metabolism (98)MPC (3)NAMPT (33)Neprilysin (20)NNMT (8)NPP (2)NPR (15)NQO (2)OGT (2)OPA1 (1)P448 (1)P450 (261)PAI-1 (25)PARG (12)PDE (366)PDHK (12)PEPCK (2)PGAM1 (1)PGC-1α (4)PHGDH (5)Phospholipase (108)Phosphorylase (10)PI5P4K (11)PKM1 (2)PKM2 (6)Procollagen C Proteinase (1)Proprotein convertases (5)Pyruvate Kinase (28)QR (2)RAR/RXR (86)RBP (3)REV-ERB (4)ROR (67)SCD (18)sEH (33)SGK (15)SHMT (7)Sialyltransferase (1)Sphingosine acyltransferase (2)SQOR (2)Srx (1)Steroid Sulfatase (8)TDO (3)TGH (1)Thioredoxin (12)Thrombin (43)Thymidylate Synthase (24)Transferase (80)Transketolase (7)TrxR (11)Trypanothione reductase (1)UGT (3)VD/VDR (47)Xanthine Oxidase (49)αKGD (2)
Neuronal Signaling (3852)
5-HT Receptor (402)AAK1 (17)AChE (43)AChR (348)Adenosine Kinase (5)Adrenergic Receptor (184)AMPAR (54)Amylin receptor (1)Amyloid-β (172)Calcium Channel (269)CaMK (54)Cannabinoid Receptor (65)CGRP Receptor (14)Cholecystokinin Receptor (32)Cholinesterase (235)CHT (1)COMT (16)DAT (21)Dopamine Receptor (170)Endorphin (1)Enkephalinase (3)FAAH (45)GABA Receptor (188)Glucosylceramide Synthase (13)GluR (208)GPR119 (2)GPR139 (3)GPR24 (1)Histamine Receptor (239)Huntingtin (3)Imidazoline Receptor (14)Kainate receptor (5)MAO (195)Melanocortin Receptor (31)mGluR (226)MT Receptor (12)NET (3)Neuropeptide Y receptor (8)Neurotensin Receptor (13)NGF (3)NK Receptor (57)NMDA (1)NMDAR (50)Notch (26)Nurr1 (7)OLIG2 (1)Opioid Receptor (54)OX Receptor (50)P2X Receptor (79)Proprotein convertases (5)QC (3)RAGE (3)REST (1)Ryanodine Receptor-1 (1)S100β (1)Secretase (112)SERT (27)Sigma Receptor (53)SMS (4)SSRIs (5)Substance P (2)TAAR (8)Tau Protein (28)TLX (1)Trk Receptor (80)TRP Channel (182)TTR (7)α-synuclein (1)
NF-κB Signaling Pathway (540)
IKK (74)MALT1 (24)NF-κB (419)Nrf2 (99)Pirin (3)RANKL (1)RANKL/RANK (3)RIP Kinase (84)TAK1 (3)
Notch Signaling Pathway (763)
ERK (166)Gli (6)MRCK (2)Notch (26)p53 (41)ROCK (90)TGF-beta/Smad (381)β-catenin (71)
PI3K/AKT/mTOR (1044)
Akt (207)AMPK (105)ATM/ATR (67)DNA-PK (39)FOXO (3)GSK-3 (126)MELK (9)mTOR (187)PDK (22)PDK-1 (3)PI3K (340)PI4K (28)PIKfyve (9)PIN1 (10)PTEN (5)RSK (33)
PPAR Signaling Pathway (2131)
ACS (3)Akt (207)AMPK (105)AQP (5)Bcl-6 (6)FABP (8)FATP (3)IL (172)LXR (27)MMP (179)NF-κB (419)NLR (73)OxPhos (4)PDK-1 (3)PEPCK (2)PPAR (193)RAR/RXR (86)RGS (6)ROS (398)SCD (18)SGK (15)Sirtuin (129)STAT (160)TNF-alpha (30)
Protease (697)
ADAMTS (5)Aspartic Protease (2)Cysteine Protease (24)Dipeptidase 1 (2)DP-IV (2)DPP1 (2)DPP2 (2)DPP4 (72)Glutaminase (25)MMP (179)NEP (4)PE (2)Proteasome (122)Ser/Thr Protease (164)SPP (1)Tyrosinase (100)
Protein Tyrosine Kinase/RTK (2741)
Ack1 (5)ALK (86)Bcr-Abl (105)BMX Kinase (3)BRK (3)BTK (149)c-FMS (60)c-Kit (87)c-Met/HGFR (131)c-RET (64)DDR1/DDR2 Receptor (22)DYRK (60)EGFR (403)Ephrin Receptor (16)ErbB (6)FAK (56)FGF (2)FGFR (136)FLT3 (134)GAK (624)HER2 (31)IGF-1R (28)Insulin Receptor (26)ITK (18)JAK (245)MRCK (2)PDGFR (127)PTK (7)Pyk2 (4)Ros1 (18)SHP2 (48)Src (110)Syk (40)TAM Receptor (50)Tie-2 (16)Trk Receptor (80)VEGFR (271)
Pyroptosis (993)
Caspase (170)Cathepsin (98)IL (172)MyD88 (6)NF-κB (419)TLR (163)
Stem Cells (1527)
BMI-1 (3)Casein Kinase (101)CREB (5)ERK (166)Frizzled (2)Gli (6)GSK-3 (126)Hedgehog (32)JAK (245)LIN28 (4)MST (2)Notch (26)Notum (2)PKA (59)PORCN (10)ROCK (90)sFRP-1 (1)Smo (36)SOD1 (2)STAT (160)TGF-beta/Smad (381)Wnt (104)YAP (28)β-catenin (71)
TGF-beta/Smad (458)
Bcr-Abl (105)PKC (157)ROCK (90)TGF-beta/Smad (381)
Toll-Like Receptor (TLR) (549)
CREB (5)IKK (74)IRAK (71)IRF3 (1)JNK (79)MyD88 (6)p38 MAPK (163)TAK1 (3)TLR (163)
Ubiquitin (370)
DUB (83)E1/E2/E3 Enzyme (142)FBXO (2)NAE (8)p97 (15)Proteasome (122)SUMO (4)
Vitamin D Related/Nuclear Receptor (587)
Androgen Receptor (96)Glucocorticoid Receptor (44)LXR (27)Mineralocorticoid Receptor (12)PPAR (193)Progesterone Receptor (9)RAR/RXR (86)REV-ERB (4)ROR (67)Thyroid Hormone Receptor (7)VD/VDR (47)
Wnt Signaling Pathway (2371)
AP-1 (14)APC (6)ATF/CREB proteins (2)c-Myc (47)Calcineurin (8)CaMK (54)Casein Kinase (101)CDK (475)CREB (5)Frizzled (2)GSK-3 (126)JNK (79)MMP (179)NF-κB (419)NFAT (11)p300/CBP/PROTAC (2)PDE (366)Phospholipase (108)PKC (157)PKG (10)Rho (14)ROCK (90)ROR (67)Wnt (104)β-catenin (71)
Other Inhibitors/Agonists (3218)
20-HETE (2)AIMP2-DX2 (2)Amino Acids and Amino Acid Derivatives (126)Aminoacyl-tRNA Synthetase (18)Anesthetic (3)Anti-inflammation (30)Anti-Thyroid Agent (1)Anti-tumor (7)Anti-ulcer (1)Antioxidant (33)Antispasmodic Agent (3)ASGPR (11)Bcat (11)c-RET (64)Cancer Stem Cells (2)CAR (5)Cardiac transcription factor (2)CBFβ-SMMHC (1)CD20 (2)CD52 (1)CD73 (26)CerK (1)Chelating Agent (15)Choleretic (1)Choline Kinase (3)CNT (1)CRTH2 (9)CSE (2)DCLK (1)DcpS (1)Decarboxylase (8)Dehydrogenase (156)Diabetes (2)Diuretic (1)Drug Metabolite (286)DUE-B (1)E2F (2)ECE (2)Endogenous Metabolite (1247)ERO1 (2)FAP (17)FATP (3)Fer/FerT (1)FPP synthase (1)Fucosyltransferase (4)Fungicide (60)G protein (2)Galectin (3)Galectin-3 (12)GBF1 (1)GCase (4)Glucocorticoid Receptor (44)GRK (21)Herbicide (17)HIPK2 (3)Histidine kinase (1)HNF4α (1)HPPD (3)HRGP (1)Hydroxylase (24)IgE (2)IMP1 (1)Importin β (1)Insecticide (27)ITPKA (2)LAT1 (3)LDL (11)Lipase (93)Lipocalin-2 (1)LYTACs (8)MALAT1 (1)MITF (1)MLKL (4)Molecular Glues (41)MPO (5)MTTP (8)Muscle Relaxant (1)MYOF (1)NAADP (1)Neuroprotection/neurogenic Agent (4)NMD (1)NT (2)Nur77 (8)O-GlcNAcase (9)O-glycosylation (1)OSBP (1)OSBPL (1)OSC (2)Osteoclasts/Bone/Osteogenesis (15)OxPhos (4)PAM complex (1)PANK (2)PAX2 (1)PBR (4)PCA1 (1)PCSK9 (7)PDX1 (1)PEPT (1)PFKFB3 (7)Phosphatase (248)Phosphorylase (10)Photosensitizer (6)PIN1 (10)PKG (10)Platelet (5)PME-1 (2)PMO/MNA (4)PNP (1)PREP (20)Protein Synthesis (4)PXR (3)Quorum Sensing (57)RasGAP (2)Rev-ErbA (3)RUNX (7)SAP (1)SMARC (6)SQS (4)SREBP (5)SRPK (51)Sweetener (3)Tgase (2)Thioredoxin (12)TIR1 (1)TNIK (8)TNK (4)TNNI3K (1)UGT1A1 (1)Urease (5)vanin (4)VDA (1)Vitamin (61)VPS (3)XOR (1)α-amylase (15)Others (2611)
Inhibitory Monoclonal Antibody
Human Inhibitory Monoclonal Antibody (62)
Amyloid-β/monoclonal antibody (2)CA Ⅸ/monoclonal antibody (1)CCR/monoclonal antibody (1)CD19/monoclonal antibody (1)CD20/monoclonal antibody (2)CD22/monoclonal antibody (1)CD25/monoclonal antibody (1)CD3/monoclonal antibody (1)CD38/monoclonal antibody (1)CD4/monoclonal antibody (1)CD40/monoclonal antibody (1)CD47/monoclonal antibody (1)CD52/monoclonal antibody (1)CD6/monoclonal antibody (1)CD62p/monoclonal antibody (1)CD73/monoclonal antibody (1)CGRP Receptor/monoclonal antibody (2)Complement System/monoclonal antibody (1)CTLA-4/monoclonal antibody (1)EGFR/monoclonal antibody (2)HER2/monoclonal antibody (2)IFNAR/monoclonal antibody (1)IgE/monoclonal antibody (2)IGF-1R/monoclonal antibody (1)IL-13/monoclonal antibody (1)IL-17a/monoclonal antibody (1)IL-1β/monoclonal antibody (1)IL-23/monoclonal antibody (2)IL-4Ra/monoclonal antibody (1)IL-5/monoclonal antibody (1)IL-5Rα/monoclonal antibody (1)IL-6/monoclonal antibody (3)Integrin/monoclonal antibody (1)KIR/monoclonal antibody (1)LAG-3/monoclonal antibody (1)PCSK9/monoclonal antibody (2)PD-1/PD-L1/monoclonal antibody (4)RANKL /monoclonal antibody (1)Sclerostin/monoclonal antibody (1)SLAMF7/monoclonal antibody (1)TIGIT/monoclonal antibody (1)Tim3/monoclonal antibody (1)TNF Receptor/monoclonal antibody (3)TNF-alpha/monoclonal antibody (2)TROP2/monoclonal antibody (1)VEGFR/monoclonal antibody (1)
Animal Modeling Reagents
Circulatory System Disease Models (11)
Cardiomyopathy Model (1)Heart Disease Correlation Model (2)Heart Failure Model (1)Hyperlipidemia Model (1)Hypertension Model (3)Thrombolysis Model (2)Vascular Inflammation Model (1)
Digestive System Disease Models (17)
Gallstone Model (1)Gastrointestinal Disease Model (8)Liver Disease Model (5)Pancreatic Disease Model (3)
Endocrine System Disease Models (12)
Aging Model (1)Diabetes Model (4)Hyperuricemia Model (8)
Immune and Inflammatory Disease Models (29)
Arthritis Model (1)Cystitis Model (1)Dermatitis Model (1)Ear Edema Model (1)Encephalomyelitis Model (2)Foot Edema Model (2)Gastrointestinal Inflammation and Ulcer Model (8)Gouty Arthritis Model (1)Liver Inflammation Model (2)Myocarditis Model (2)Nephritis Model (1)Pancreatitis Model (5)Psoriasis Model (3)Systemic Lupus Erythematosus Model (2)
Nervous System Disease Models (10)
Alzheimers Disease Model (3)Epilepsy Model (3)Neuropathic Pain Model (1)Parkinsons Disease Model (3)Schizophrenia Model (1)
Otorhinolaryngological Disease Models (4)
Cataract Model (1)Gingival Hyperplasia Model (2)Optic Neuropathy Model (1)Other Otorhinolaryngological Disease Model (1)
Skin Disease Models (1)
Atopic Dermatitis Model (1)
Tumor Models (9)
Breast Tumor Model (2)Colon Tumor Model (1)Esophageal Tumor Model (1)Kidney Tumor Model (1)Liver Tumor Model (1)Lung Tumor Model (2)Skin Tumor Model (2)Uterine Fibroid Model (1)
Urinary System Disease Models (19)
Aging Model (1)Chronic Kidney Disease Model (2)Diabetes Model (4)Hyperuricemia Model (8)Kidney Stone Model (1)Nephrotoxicity Model (1)Renal Injury Model (5)Other Urinary System Disease Model (3)
Antibiotic and Antivirus
Function (133)
Anti-bacterial Antibiotic (2)Anti-fungal Antibiotic (7)Antivirus (62)Cell Culture Antibiotic (2)Insect Repellent (42)Plant Tissue Culture Antibiotic (2)Preservative and Disinfectant (20)
Structure (8762)
Amino Acid Derivative (3)Aminoglycoside (9)Ansamycin (2)Cephalosporin (7)Chloramphenicol (1)Imidazole (6042)Macrolide (8)Nucleoside (5)Penicillin (3)Pyridine / Pyrimidine (6)Quinolone (19)Sulfonamide (17)Tetracycline (6)β-Lactam (4)Other Antibiotics (35)Others (2611)
Biochemical Reagents
Amino Acids (799)
Amino Acid Amide (17)Biologically Modified Amino Acid (29)C-protective Amino Acid (194)N-protective Amino Acid (438)Non-protein Amino Acid (115)Protein Amino Acid (55)Side Chain Protected Amino Acid (25)
Biological Buffers (2643)
Good's Buffer (19)Other Buffers (13)Others (2611)
Cross-Linking Agents (33)
Amino-amino Crosslinker (7)Amino-sulfhydryl Crosslinker (15)Photoreactive Crosslinker (3)Sulfhydryl-carbonyl Crosslinker (1)Sulfhydryl-sulfhydryl Crosslinker (4)Other Reactive Crosslinkers (3)
Denaturants (2)
Surface Active Agent (2)
Detergents (18)
Amphoteric Surfactant (4)Anionic Surfactant (3)Cationic Surfactant (2)Nonionic Surfactant (6)Sulfonated Betaine (3)
Lipids (219)
Aliphatic Acyl (210)Glycerol Lipid (7)Sphingolipid (2)
Polypeptides (39)
Dipeptide and Tripeptide (36)Oligopeptide (3)
Steroids (2675)
Bile Acid (49)Cholestane (3)Estrogen (1)Plant Sterol (10)Steroidal Glycoside (3)Other Steroids (2)Others (2611)
Sugar and Derivatives (151)
Sugar (137)Sugar Alcohol (15)
Sweeteners (For Research Experiments) (18)
Artificial sweetener (6)Natural sweetener (12)
Cancer
Cancer Stem Cells (2475)
Cathepsin (98)CXCR (112)Hedgehog (32)IL (172)IL Receptor (9)Integrin (134)MIF (18)MMP (179)NF-κB (419)NOS (186)Notch (26)PDGFR (127)PPAR (193)STAT (160)TGF-beta/Smad (381)VEGFR (271)Wnt (104)YAP (28)
Tumor Development and Microenvironment Evolution (1825)
ALK (86)AP-1 (14)CAR (5)CCR (89)Complement System (45)COX (344)DDR1/DDR2 Receptor (22)ErbB (6)GABA Receptor (188)GSK-3 (126)IFNAR (24)IRAK (71)JAK (245)LAG-3 (1)NLR (73)Nrf2 (99)PD-1/PD-L1 (80)STING (98)Syk (40)TLR (163)TNF-alpha (30)TNK (4)
Tumor Epigenetics and Gene Regulation (2861)
Aminoacyl-tRNA Synthetase (18)ATM/ATR (67)DNA Methyltransferase (43)DNA/RNA Synthesis (620)Epigenetic Reader Domain (396)HDAC (336)HIF (112)Histone Acetyltransferase (95)Histone Demethylase (147)Histone Methyltransferase (294)METTL3 (10)MicroRNA (16)PAD (24)PARP (175)Pim (58)PKC (157)RNA polymerase 1 (2)Sirtuin (129)TET (8)Topoisomerase (271)
Tumor Growth, Proliferation and Apoptosis (2213)
Akt (207)Aurora Kinase (87)Bcl-2 (195)c-Met/HGFR (131)c-Myc (47)EGFR (403)ERK (166)HER2 (31)MEK (99)MLKL (4)mTOR (187)p53 (41)PI3K (340)PTEN (5)Raf (106)Ras (275)ROR (67)Telomerase (21)
Tumor Metabolism (1274)
ACC (22)ALDH (30)AMPK (105)Arginase (15)ATP Citrate Lyase (6)Dehydrogenase (156)FBPase (4)FTO (15)GLUT (32)Glutaminase (25)Hexokinase (8)IDH (37)IDO (70)MCT (17)MDH (3)NADPH Oxidase (32)OGT (2)P450 (261)PDHK (12)PHGDH (5)PKM2 (6)ROS (398)SHMT (7)SLC (6)SOD (4)SREBP (5)
Cell Biology
Cell Analysis (2)
Cell Proliferation and Cytotoxicity (2)
Cell Apoptosis/Death Detection (1419)
Apoptosis Inducer (1407)Apoptosis Inhibitor (2)Iron death Inhibitor (10)
Cell Culture (292)
Additive and Auxiliary Reagent (130)Cell Assay Reagents (9)Cell Staining (3)Organoid Culture Additive (90)Stem Cell Induction (83)
Enzymology
Enzyme Inhibitors (206)
Acetaldehyde Dehydrogenase Inhibitor (1)Acyltransferase Inhibitor (4)Alkaline Phosphatase Inhibitor (2)Angiotensin Converting Enzyme Inhibitor (4)ATP Enzyme Inhibitor (7)Calcineurin Inhibitor (1)Carbonic Acid Dehydratase Inhibitor (2)Caspase Inhibitor (2)Cyclooxygenase (COX) Inhibitor (47)DNA Topoisomerase II Inhibitor (11)Hypoxia Inducible Factor (HIF) Inhibitor (3)Inosine Monophosphate (IMP) Dehydrogenase Inhibitor (10)Leukotriene A4 Hydrolase Inhibitor (3)Lipoxygenase Inhibitor (11)Monoamine Oxidase Inhibitor (4)NADH Peroxidase Inhibitor (2)Pancreatic Lipase Inhibitor (2)Phosphodiesterase Inhibitor (20)Protease Inhibitor (20)Reverse Transcriptase Inhibitor (16)Starch Glucosidase Inhibitor (3)Thromboxane Synthase Inhibitor (2)Topoisomerase I Inhibitor (8)Tyrosine / EGF Receptor Protein Kinase Inhibitor (33)
Enzyme Preparation (63)
Cyclooxygenase (COX) (46)E3 Ubiquitin Ligase (2)Hydrolase (12)Nitric Oxide Metabolism (3)
Enzyme Substrates (4)
Peroxidase Substrate (2)β-Glucuronidase Substrate (2)
Fluorescent Probe / Staining
Cell Biology Fluorescent Dyes (61)
Apoptosis Dyes (6)BODIPY (21)Cytoplasm Dyes (5)Cytotoxicity Analysis Dyes (12)Endocytosis and pinocytosis Dyes (5)Endoplasmic Reticulum Dyes (2)Exosome Dyes (4)Lipid Droplet Dyes (3)Lysosome Dyes (4)Membrane Dyes (4)Mitochondrial Dyes (5)NOS Dyes (6)Nucleic Acid Dyes (1)Nucleus Dyes (10)PH Indicators (18)ROS Dyes (27)
Fluorescence Labeling Reagents (2848)
Anthocyanine (1)Boron Dipyrrole Methylene  (2)Coumarin (8)Danacyl (2)Fluoressin (7)Nitrobenzoxadiazole (NBD) (2)Pyrene (6)Other Fluorescence Labeling Reagents (213)Others (2611)
Fluorescent Dyes (2797)
Acridine Dye (8)Blood Dyes (2)Cancer Analysis Dyes (8)Coumarine Dye (57)Cyanine Dye (25)Neuroscience Analysis Dyes (33)Protein (3)Other Fluorescent Dyes (7)Others (2611)
Molecular Biology
Extraction and Analysis Of Nucleic Acid (5)
Hybridization Reagent (3)Probe (2)
Gene Cloning (21)
Buffer (21)
Nucleic Acid Electrophoresis (5)
Electrophoretic Buffer (3)Gelatin (2)
Natural Products
Acanthaceae (20)
Adhatoda (4)Andrographis (9)Justicia (4)Phlogacanthus (2)Strobilanthes (1)
Aceraceae (2)
Acer (2)
Adiantaceae (2)
Adiantum (2)
Alariaceae (76)
Acanthopanax (5)Aralia (8)Diplopanax (3)Eleutherococcus (3)Hedera (3)Oplopanax (1)Panax (53)
Alismataceae (2)
Alisma (2)
Amaranthaceae (5)
Achyranthes (3)Celosia (1)Cyathula (1)
Amaryllidaceae (23)
Agave (4)Allium (5)Curculigo (10)Lycoris (3)Narcissus (1)
Anacardiaceae (15)
Lannea (1)lodes (1)Mangifera (6)Rhus (4)Toxicodendron (3)
Annonaceae (19)
Annona (2)Fissistigma (6)Goniothalamus (4)Guatteria (1)Miliusa (1)Orophea (2)Polyalthia (2)Uvaria (1)
Apocynaceae (45)
Alstonia (3)Apocynum (1)Aspidosperma (1)Catharanthus (5)Cerbera (5)Kopsia (1)Nerium (10)Plumeria (2)Rauvolfia (9)Thevetia (3)Trachelospermum (4)Voacanga (1)
Aquifoliaceae (3)
Ilex (3)
Araceae (14)
Acorus (10)Eminium (2)Pinellia (2)
Aristolochiaceae (15)
Aristolochia (11)Asarum (3)Holostylis (1)
Asclepiadaceae (19)
Cryptolepis (3)Cynanchum (7)Marsdenia (5)Periploca (4)
Asparagaceae (11)
Eucomis (2)Muscari (1)Scilla (8)
Asteraceae (228)
Achillea (3)Ageratum (1)Ambrosia (2)Arctium (2)Arnica (1)Artemisia (25)Aster (2)Atractylodes (9)Aucklandia (5)Bellis (1)Blumea (4)Cacalia (1)Carpesium (1)Carthamus (7)Centaurea (5)Centipeda (4)Chrysactinia (4)Chrysanthemum (6)Cichorium (2)Cirsium (2)Conyza (1)Coreopsis (1)Cosmos (1)Crepis (3)Cynara (1)Dahlia (2)Dittrichia (1)Doronicum (1)Echinacea (2)Eclipta (6)Elephantopus (1)Erigeron (3)Eupatorium (20)Gnaphalium (1)Gynura (2)Helianthus (4)Heterotheca (1)Inula (8)Kalimeris (1)Laggera (13)Laurentia (1)Ligularia (4)Matricaria (2)Petasites (2)Pulicaria (4)Saussurea (3)Scorzonera (2)Senecio (9)Siegesbeckia (2)Silybum (5)Smallanthus (1)Stevia (10)Tagetes (4)Telekia (1)Tessaria (1)Tussilago (2)Verbesina (1)Vernonia (5)Wedelia (2)Xanthium (6)Zinnia (1)
Athyriaceae (1)
Cystopteris (1)
Balsaminaceae (5)
Impatiens (5)
Berberidaceae (37)
Berberis (3)Bongardia (1)Caulophyllum (2)Dysosma (3)Epimedium (26)Sinopodophyllum (2)
Betulaceae (11)
Alnus (6)Betula (1)Carpinus (1)Corylus (3)
Bignoniaceae (16)
Catalpa (8)Crescentia (2)Incarvillea (1)Kigelia (1)Macfadyena (1)Markhamia (1)Oroxylum (2)
Blechnaceae (1)
Woodwardia (1)
Boraginaceae (18)
Arnebia (2)Echium (1)Ehretia (1)Lithospermum (13)Tournefortia (1)
Burseraceae (11)
Boswellia (3)Canarium (5)Commiphora (3)
Buxaceae (3)
Buxus (3)
By Structure (5433)
Alkaloids (149)Coumarins (21)Lignans (36)Phenols (1786)Phenylpropanane (54)Quinones (35)Natural Products-Other Structure (3377)
Calophyllaceae (8)
Pseudostellaria (2)Stellaria (1)Vaccaria (5)
Campanulaceae (14)
Codonopsis (1)Lobelia (2)Platycodon (10)Sphenoclea (1)
Cannabaceae (11)
Cannabis (3)Humulus (8)
Caprifoliaceae (23)
Lonicera (20)Sambucus (1)Viburnum (2)
Celastraceae (16)
Celastrus (3)Euonymus (2)Maytenus (1)Tripterygium (10)
Cephalotaxaceae (10)
Cephalotaxus (10)
Chenopodiaceae (3)
Kochia (1)Spinacia (1)Suaeda (1)
Chloranthaceae (11)
Chloranthus (10)Sarcandra (1)
Clusiaceae (94)
Alliaria (1)Brassica (6)Calophyllum (6)Cratoxylum (2)Descurainia (1)Eruca (1)Garcinia (47)Hypericum (15)Isatis (2)Lepidium (4)Mammea (1)Mesua (1)Raphanus (3)Sinapis (3)Symphonia (1)
Combretaceae (6)
Calycopteris (1)Combretum (2)Terminalia (3)
Convolvulaceae (2)
Erycibe (1)Ipomoea (1)
Coriariaceae (2)
Coriaria (2)
Cornaceae (2)
Cornus (2)
Crassulaceae (12)
Rhodiola (7)Sedum (5)
Cucurbitaceae (44)
Bolbostemma (1)Bryonia (1)Cucumis (1)Cucurbita (1)Echinocystis (1)Gynostemma (4)Hemsleya (2)Herpetospermum (1)Lagenaria (3)Luffa (1)Momordica (9)Siraitia (17)Trichosanthes (2)
Cupressaceae (11)
Chamaecyparis (2)Juniperus (5)Platycladus (4)
Cyperaceae (5)
Carex (2)Cyperus (3)
Daphniphyllaceae (36)
Aquilaria (10)daphne (3)Daphniphyllum (1)Edgeworthia (1)Excoecaria (1)Pieris (2)Stellera (10)Wikstroemia (8)
Dennstaedtiaceae (1)
Dennstaedtia (1)
Dicksoniaceae (4)
Cibotium (4)
Dioscoreaceae (11)
Dioscorea (11)
Dipsacaceae (2)
Dipsacus (2)
Dryopteridaceae (4)
Dryopteris (4)
Elaeagnaceae (7)
Elaeagnus (2)Hippophae (5)
Equisetaceae (3)
Equisetum (3)
Erythroxylaceae (1)
Erythroxylum (1)
Eucommiaceae (12)
Eucommia (12)
Euphorbiaceae (46)
Breynia (1)Croton (7)Endospermum (1)Euphorbia (10)Excoecaria (1)Flueggea (1)Hevea (3)Jatropha (5)Macaranga (1)Mallotus (1)Phyllanthus (11)Suregada (2)Trigonostemon (2)
Fabaceae (348)
Abrus (1)Acacia (9)Adenanthera (1)Albizia (1)Ammothamnus (1)Antheroporum (1)Astragalus (23)Butea (1)Caesalpinia (18)Cajanus (3)Campylotropis (1)Cassia (26)Cicer (1)Crotalaria (5)Cytisus (3)Dalbergia (10)Derris (13)Desmodium (3)Erythrina (13)Flemingia (3)Genista (1)Glycine (22)Glycyrrhiza (41)Griffonia (1)Hedysarum (1)Lespedeza (5)Leucaena (3)Lotus (5)Lupinus (8)Maackia (4)Medicago (1)Millettia (6)Mimosa (1)Mucuna (2)Ononis (2)Parochetus (2)Phyllodium (1)Pisum (1)Pongamia (1)Prosopis (2)Psoralea (18)Pterocarpus (1)Pterolobium (1)Pueraria (25)Robinia (2)Saraca (1)Senna (1)Sophora (36)Spartium (1)Spatholobus (2)Styphnolobium (1)Trifolium (6)Trigonella (2)Vicia (2)Wisteria (2)
Fagaceae (2)
Castanea (1)Lithocarpus (1)
Gentianaceae (28)
Anthocleista (1)Canscora (1)Gentiana (16)Gentianella (1)Halenia (1)Swertia (8)
Geraniaceae (3)
Geranium (2)Pelargonium (1)
Gesneriaceae (1)
Lysionotus (1)
Ginkgoaceae (9)
Ginkgo (9)
Gnetaceae (4)
Gnetum (4)
Hamamelidaceae (2)
Hamamelis (1)Loropetalum (1)
Hernandiaceae (129)
Ammi (2)Angelica (32)Bupleurum (13)Centella (4)Cnidium (9)Cuminum (1)Ferula (3)Heracleum (13)Hernandia (2)Ledebouriella (1)Ligusticopsis (1)Ligusticum (9)Notopterygium (7)Oenanthe (1)Petroselinum (2)Peucedanum (20)Pimpinella (1)Saposhnikovia (7)Seseli (1)
Hippocastanaceae (5)
Aesculus (5)
Illiciaceae (7)
Illicium (7)
Iridaceae (19)
Belamcanda (8)Crocus (6)Eleutherine (3)Iris (2)
Juglandaceae (6)
Diospyros (2)Engelhardtia (1)Juglans (1)Sesamum (2)
Juncaceae (5)
Juncus (5)
Lamiaceae (140)
Ajuga (2)Ballota (1)Clinopodium (3)Coleus (2)Dracocephalum (3)Elsholtzia (1)Isodon (5)Lamiophlomis (1)Leonurus (9)Marrubium (2)Mentha (4)Mosla (2)Perilla (4)Phlomis (1)Plectranthus (1)Pogostemon (1)Rosmarinus (5)Salvia (45)Scutellaria (40)Stachys (2)Tectona (1)Thymus (5)
Lauraceae (22)
Cinnamomum (7)Cryptocarya (3)Endlicheria (1)Laurus (1)Lindera (4)Litsea (1)Nectandra (2)Ocotea (3)
Lepidoziaceae (1)
Lepidozia (1)
Lichenes (1)
Usnea (1)
Liliaceae (78)
Aloe (4)Anemarrhena (9)Asparagus (1)Dracaena (11)Fritillaria (3)Hosta (1)Lilium (3)Liriope (3)Ophiopogon (28)Paris (8)Polygonatum (3)Smilax (1)Trillium (1)Tupistra (1)Veratrum (1)
Linaceae (2)
Linum (2)
Loganiaceae (5)
Buddleja (2)Gelsemium (1)Strychnos (2)
Loranthaceae (1)
Taxillus (1)
Lycopodiaceae (3)
Lycopodium (3)
Lygodiaceae (1)
Lygodium (1)
Lythraceae (11)
Lawsonia (4)Punica (7)
Magnoliaceae (24)
Liriodendron (4)Magnolia (19)Michelia (1)
Malvaceae (5)
Abelmoschus (1)Gossypium (1)Guazuma (2)Hibiscus (1)
Meliaceae (24)
Aglaia (12)Amoora (2)Aphanamixis (3)Melia (4)Walsura (3)
Menispermaceae (13)
Cocculus (2)Diploclisia (1)Menispermum (1)Stephania (5)Tinospora (3)Triclisia (1)
Moraceae (69)
Artocarpus (2)Broussonetia (13)Cudrania (16)Morus (37)Trilepisium (1)
Moringaceae (7)
Moringa (7)
Musaceae (13)
Musa (10)Musella (3)
Myricaceae (6)
Morella (6)
Myristicaceae (7)
Myristica (7)
Myrsinaceae (1)
Ardisia (1)
Myrtaceae (27)
allspice (1)Eucalyptus (16)Psidium (6)Rhodomyrtus (1)Syzygium (3)
Nartheciaceae (4)
Narthecium (1)Philydrum (1)Xanthorrhoea (2)
Nelumbonaceae (3)
Nelumbo (3)
Nyctaginaceae (33)
Atropa (1)Boerhavia (3)Capsicum (5)Datura (7)Lycium (3)Mirabilis (1)Nicotiana (2)Physalis (4)Solanum (6)Withania (1)
Nyssaceae (52)
Camptotheca (6)Gaultheria (1)Pyrola (2)Rhododendron (5)Vaccinium (38)
Oleaceae (37)
Abeliophyllum (1)Forsythia (12)Fraxinus (4)Jasminum (6)Ligustrum (11)Olax (1)Osmanthus (1)Syringa (1)
Orchidaceae (28)
Anoectochilus (1)Bletilla (2)Cremastra (2)Dendrobium (7)Gastrodia (3)Gymnadenia (8)Pholidota (3)Vanda (1)Vanilla (1)
Orobanchaceae (10)
Cistanche (10)
Paeoniaceae (6)
Paeonia (6)
Palmae (6)
Areca (4)Euterpe (1)Trachycarpus (1)
Pandanaceae (3)
Pandanus (3)
Papaveraceae (26)
Chelidonium (10)Corydalis (8)Glaucium (1)Hylomecon (1)Hypecoum (1)Macleaya (2)Papaver (1)Sanguinaria (2)
Parmeliaceae (4)
Parmelia (4)
Passifloraceae (2)
Passiflora (2)
Pentaphylacaceae (1)
Adinandra (1)
Phyllanthaceae (4)
Securinega (3)Uapaca (1)
Phytolaccaceae (6)
Microtea (1)Phytolacca (5)
Pinaceae (35)
Abies (2)Cedrus (4)Larix (1)Pinus (18)Pseudolarix (9)Tsuga (1)
Piperaceae (28)
Piper (28)
Pittosporaceae (1)
Pittosporum (1)
Plantaginaceae (2)
Picrorhiza (1)Plantago (1)
Plumbaginaceae (2)
Limoniastrum (1)Plumbago (1)
Poaceae (14)
Avena (2)Coix (1)Hordeum (2)Leptochloa (1)Oryza (1)Phyllostachys (1)Poa (2)Saccharum (1)Secale (2)Zea (1)
Podocarpaceae (8)
Podocarpus (8)
Polygalaceae (32)
Polygala (31)Securidaca (1)
Polygonaceae (40)
Atraphaxis (2)Fallopia (3)Polygonum (9)Rheum (22)Rumex (4)
Polypodiaceae (2)
Phymatopteris (2)
Pontederiaceae (1)
Monochoria (1)
Portulacaceae (1)
Talinum (1)
Primulaceae (4)
Lysimachia (3)Primula (1)
Proteaceae (4)
Grevillea (1)Helicia (3)
Ranunculaceae (45)
Aconitum (2)Anemone (6)Cimicifuga (9)Clematis (3)Coptis (7)Delphinium (2)Hydrastis (2)Pulsatilla (10)Semiaquilegia (1)Thalictrum (3)
Resedaceae (1)
Reseda (1)
Rhamnaceae (16)
Hovenia (1)Rhamnus (11)Ziziphus (4)
Rhizophoraceae (3)
Cassipourea (1)Kandelia (2)
Rosaceae (31)
Agrimonia (4)Crataegus (4)Exochorda (5)Filipendula (2)Malus (1)Photinia (1)Potentilla (1)Pourthiaea (1)Prunus (3)Rosa (3)Rubus (3)Sanguisorba (1)Sorbus (1)Spiraea (1)
Rubiaceae (69)
Borreria (1)Cinchona (2)Coffea (3)Emmenopterys (1)Galium (5)Gardenia (11)Hedyotis (8)Knoxia (2)Mitragyna (1)Morinda (4)Mussaenda (1)Nauclea (2)Paederia (5)Pausinystalia (2)Pentas (1)Rubia (14)Uncaria (6)
Rutaceae (162)
Aegle (1)Boenninghausenia (2)Cedrelopsis (1)Citrus (38)Clausena (7)Dictamnus (8)Euodia (1)Evodia (13)Flindersia (1)Fortunella (1)Glycosmis (3)Haplophyllum (3)Melicope (1)Micromelum (11)Murraya (21)Phebalium (2)Phellodendron (8)Ptaeroxylon (1)Ruta (3)Skimmia (1)Tetradium (1)Toddalia (14)Zanthoxylum (20)
Salicaceae (2)
Populus (2)
Santalaceae (3)
Thesium (3)
Sapindaceae (10)
Dodonaea (10)
Saururaceae (6)
Houttuynia (1)Saururus (5)
Saxifragaceae (11)
Astilbe (1)Bergenia (1)Dichroa (3)Hydrangea (5)Penthorum (1)
Schisandraceae (18)
Kadsura (5)Schisandra (13)
Scrophulariaceae (33)
Bacopa (6)Euphrasia (1)Limnophila (1)Linaria (2)Melampyrum (1)Paulownia (1)Pedicularis (2)Picria (3)Rehmannia (12)Scrophularia (4)
Selaginellaceae (3)
Selaginella (3)
Simaroubaceae (32)
Ailanthus (8)Brucea (8)Eurycoma (1)Picrasma (14)Quassia (1)
Sinopteridaceae (17)
Onychium (4)Pteridium (3)Pteris (10)
Stemonaceae (1)
Stemona (1)
Sterculiaceae (4)
Casearia (1)Gynocardia (2)Hydnocarpus (1)
Styracaceae (3)
Styrax (3)
Tamaricaceae (1)
Tamarix (1)
Taxaceae (8)
Taxus (7)Torreya (1)
Taxodiaceae (5)
Cryptomeria (2)Sequoia (3)
Theaceae (9)
Camellia (9)
Tiliaceae (2)
Microcos (1)Tilia (1)
Toricelliaceae (3)
Toricellia (3)
Tropaeolaceae (1)
Tropaeolum (1)
Typhaceae (4)
Typha (4)
Ulmaceae (1)
Ulmus (1)
Valerianaceae (19)
Nardostachys (4)Patrinia (5)Valeriana (10)
Verbenaceae (39)
Callicarpa (10)Clerodendrum (7)Duranta (1)Gmelina (1)Lippia (1)Stachytarpheta (1)Verbena (2)Vitex (16)
Violaceae (7)
Viola (7)
Viscaceae (2)
Viscum (2)
Vitaceae (18)
Ampelopsis (4)Turpinia (2)Vitis (12)
Winteraceae (4)
Drimys (4)
Zingiberaceae (79)
Aframomum (1)Alpinia (25)Amomum (1)Boesenbergia (2)Curcuma (33)Kaempferia (1)Zingiber (16)
Zygophyllaceae (6)
Peganum (4)Tribulus (2)
Pharmaceutical Research
Animal Modeling Agents (46)
Cardio-cerebrovascular Disease Model (2)Diabete Model (1)Inflammation Model (21)Lifestyle-related Disease Model (10)Nervous System Model (5)Pain and Pruritus Model (8)Tumor Model (6)Other Modeling Agents (6)
Classical Positive Drugs (61)
Cardiovascular System (20)Diabete (30)Digestive System (11)
Drug Analysis (663)
Drug Standard (208)Plant Standard (457)
Drug Delivery (560)
Cationic Lipids (119)Cholesterol (10)Fluorescent Lipids (1)Pegylated Lipids (11)Phospholipids (175)
Pharmacy Related (27)
Biomaterial (2)Classical Raw Material Drug (2)Cosolvents (12)Medicinal Excipient (14)
Small Molecule Positive Drugs (2843)
Anti-allergy (5)Anti-inflammation (30)Anti-osteoporosis (2)Anti-rheumatoid Arthritis (6)Anti-tumor (7)Antivirus (62)Depressurization (18)Diabete (30)Neurotransmitter (32)Reduce Blood Lipid (6)Other Compounds (66)Others (2611)
PROTACS
E3 Ligand-Linker Conjugate (166)
CRBN Ligand-Linkers (117)VHL Ligand-Linkers (49)
E3 Ligands (72)
CRBN Inactive Ligand (4)CRBN Ligand (56)IAP Ligand (2)MDM2 Ligand (2)VHL Ligand (8)
Molecular Glue (31)
Bcl-6/PROTAC (3)Casein Kinase 1α/PROTAC (2)Cyclin K/PROTAC (5)GSPT1/PROTAC (5)IKZF1/3/PROTAC (7)mHTT/PROTAC (2)PDE6D/PROTAC (2)RBM39/PROTAC (4)β-catenin/PROTAC (1)
Warhead (1)
Bcr-Abl/Warhead Ligand (1)
Vesicle
Exosome (2591)
ApoE (1)ARF (2)Calcium Channel (269)Ceramidase (4)FGF (2)HBV (151)HIV (447)HSP (161)HSV (75)Integrin (134)LPL Receptor (118)MicroRNA (16)mTOR (187)Neurotransmitter (32)p53 (41)PD-1/PD-L1 (80)Phospholipase (108)Ras (275)STAT (160)TGF-beta/Smad (381)
Parkinson'S Disease and Alzheimer'S Disease (5789)
Akt (207)AMPAR (54)Apoptosis (2143)Caspase (170)CDK (475)CREB (5)Dopamine Receptor (170)Dopamine β-hydroxylase (8)ERK (166)Glucagon Receptor (50)GPCR (203)GSK-3 (126)IL (172)JAK (245)JNK (79)LRRK2 (32)MyD88 (6)NF-κB (419)Notch (26)p53 (41)PI3K (340)PKA (59)PTEN (5)RAGE (3)Ras (275)Rho (14)ROCK (90)ROS (398)Secretase (112)STAT (160)STING (98)Tau Protein (28)TLR (163)TNF (22)Tyrosinase (100)Tyrosine / EGF Receptor Protein Kinase Inhibitor (33)Wnt (104)α-synuclein (1)β-catenin (71)
Zoology and Botany
Pesticide Composition (103)
Fungicide (60)Herbicide (17)Insecticide (27)
Home Cart Sign in  
/
Chemistry
/
Organic Building Blocks
/
Alcohols
/
Pentahydroxyhexanal
/
D-Glucose
/
Chemistry
Cell Biology Pharmaceutical Research
/
Organic Building Blocks
Cell Culture Drug Analysis
/
Alcohols
Additive and Auxiliary Reagent Drug Standard
/
Pentahydroxyhexanal
/
Chemical Structure| 50-99-7 Chemical Structure| 50-99-7

Structure of D-Glucose
CAS No.: 50-99-7

Chemical Structure| 50-99-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Dextrose, a simple sugar (monosaccharide), is an important carbohydrate in biology.

Synonyms: Glucose; Dextrose; NSC 287045

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

Quality Control of D-Glucose Purity: 98% SDS Specification
COA

Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.

 NMR

Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.

 CNMR

Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.

 HPLC

Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.

 LC-MS

Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Product Citations

Reynolds, Donald L ; Simpson, E Barry ; Hille, Matthew M ;

DOI:

Abstract: Enterococcus faecalis (E. faecalis) is a ubiquitous microbe occurring in the environment and in the intestinal tract of poultry. E. faecalis has been identified in cases of egg infertility and/or decreased hatchability and can cause amyloid arthropathy in older laying chickens. E. faecalis produces cytolysin, a bacterial exotoxin that can cause lysis of erythrocytes. It has been difficult to demonstrate this virulence trait using conventional culture methods with sheep blood agar. A 96-well microplate hemolysis assay, along with a culture method incorporating glucose and L-arginine into the culture media, is described that demonstrates the production of cytolysin in E. faecalis isolates of avian origin. Additionally, the results show that horse and sheep erythrocytes were susceptible to lysis by the E. faecalis cytolysin, but cow and chicken erythrocytes were less susceptible.

Keywords: Enterococcus faecalis ; hemolysis ; cytolysin ; avian

Purchased from AmBeed: ;

Alternative Products

Product Details of D-Glucose

CAS No. :50-99-7
Formula : C6H12O6
M.W : 180.16
SMILES Code : O=C[C@@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O
Synonyms :
Glucose; Dextrose; NSC 287045
MDL No. :MFCD00148912
InChI Key :GZCGUPFRVQAUEE-SLPGGIOYSA-N
Pubchem ID :107526

Safety of D-Glucose

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

Description
D-Glucose is the naturally occurring form of glucose, and it stands as the most common monosaccharide. It plays a vital role in general metabolism and acts as an essential signaling molecule related to cellular metabolic status and the response to biotic or abiotic stresses[1].[2].[3].

In Vitro:

Cell Line
Concentration Treated Time Description References
RIN-m5F cells 45 mM 36 h High glucose concentration significantly increased the apoptosis rate, and vitamin B12 reduced the apoptosis rate. PMC10607738

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT03253237 - Recruiting October 7, 2017 Croatia ... More >> Association of teachers in general practice / family medicine Recruiting Zagreb, Croatia Contact: Valerija Lang Less <<
NCT01406665 - Completed - Netherlands ... More >> Gelre Ziekenhuis Apeldoorn, Gelderland, Netherlands, 7334 DZ University Medical Center Groningen Groningen, Netherlands, 9700 RB Less <<
NCT02569762 Impaired Glucose Tolerance Not Applicable Active, not recruiting August 2018 Canada, Manitoba ... More >> Richardson Centre for Functional Foods & Nutraceuticals Winnipeg, Manitoba, Canada, R3T 2E1 Less <<
NCT00990184 Impaired Fasting Glucose ... More >> Prediabetes Less << Phase 3 Completed - -
NCT00990184 - Completed - -
NCT01474317 Diabetes Not Applicable Completed - United States, New Jersey ... More >> Consumer Product Testing Co. Fairfield, New Jersey, United States, 07004 United States, New Mexico Southwest Clinical Research Center Santa Fe, New Mexico, United States, 87505 Less <<
NCT01474317 - Completed - -
NCT02645279 Epilepsy Trau... More >>ma Metabolic Disease Less << Phase 4 Unknown February 2016 -
NCT03405415 Subjects Without Diabetes Mell... More >>itus Assessment of Glucose Concentrations Less << Not Applicable Active, not recruiting March 1, 2019 Germany ... More >> Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm Ulm, Baden-Württemberg, Germany, 89081 Less <<
NCT01301274 Hyponatremia Not Applicable Completed - Argentina ... More >> Hospital General de Niños Pedro de Elizalde Buenos Aires, Argentina Less <<
NCT01301274 - Completed - -
NCT01343758 Gastroenteritis ... More >> Dehydration Less << Not Applicable Completed - United States, Massachusetts ... More >> Children's Hospital Boston Boston, Massachusetts, United States, 02115 Less <<
NCT01931020 Pain Not Applicable Completed - India ... More >> Lady Hardinge Medical College New Delhi, Delhi1, India, 110001 Less <<
NCT00841867 - Completed - United States, California ... More >> UCLA General Clinical Research Center (GCRC) Los Angeles, California, United States, 90024 Less <<
NCT00406133 Type 1 Diabetes Phase 3 Completed - United States, California ... More >> University of Southern California Beverly Hills, California, United States, 90211 Kaiser Permanente San Diego, California, United States, 92111 Stanford University Stanford, California, United States, 94305 United States, Colorado University of Colorado Aurora, Colorado, United States, 80010 United States, Connecticut Yale University School of Medicine New Haven, Connecticut, United States, 06520 United States, Florida Nemours Children's Clinic Jacksonville, Florida, United States, 32207 United States, Georgia Atlanta Diabetes Associates Atlanta, Georgia, United States, 30309 United States, Iowa Children's Hospital of Iowa Iowa City, Iowa, United States, 52242 United States, Massachusetts Joslin Diabetes Center - Adults Boston, Massachusetts, United States, 02215 Joslin Diabetes Center - Children Boston, Massachusetts, United States, 02215 United States, Washington University of Washington Seattle, Washington, United States, 98105 Less <<
NCT03650023 Normal Impair... More >>ed Fasting Glucose Impaired Glucose Tolerance Less << Not Applicable Completed - Korea, Republic of ... More >> Laboratory of Clinical Nutrigenetics/Nutrigenomics, Yonsei University. Seoul, Korea, Republic of, 03722 Less <<
NCT00406133 - Completed - -
NCT03545178 - Recruiting December 1, 2018 Switzerland ... More >> Inselspital, Bern University Hospital, University of Bern Recruiting Bern, BE, Switzerland, 3010 Contact: Thomas Züger, MD    +41316324070    thomas.zueger@insel.ch Less <<
NCT03020069 Type 1 Diabetes Not Applicable Enrolling by invitation November 2020 United States, New York ... More >> New York University Medical Center New York, New York, United States, 10016 Less <<
NCT03617757 Progression From Impaired Fast... More >>ing Glucose to Diabetes Mellitus Less << Not Applicable Recruiting June 2019 Hong Kong ... More >> Tsan Yuk Hospital RAMP Clinic Recruiting Hong Kong, Hong Kong, 852 Contact: Yeung KK, Nurse    25892465    ykk600@ha.org.hk    Ap Lei Chau General Out-patient Clinic Recruiting Hong Kong, Hong Kong Contact: YU YT Esther, Doctor    25524640    ytyu@hku.hk    Lek Yuen General Out-patient Clinic Recruiting Hong Kong, Hong Kong Contact: Sit WS Regina, Doctor    25039406    reginasit@cuhk.edu.hk Less <<
NCT03445377 Diabetes Mellitus, Type 1 Not Applicable Enrolling by invitation October 1, 2019 United Kingdom ... More >> Manchester Diabetes Centre, Manchester University NHS Foundation Trust Manchester, United Kingdom, M13 9WL Less <<
NCT03107806 Acute Coronary Syndromes ... More >> Hyperglycemia Hypoglycemia Less << Not Applicable Terminated(Blood withdrawal pr... More >>oblems despite use of different catheters.) Less << January 2018 Sweden ... More >> Karolinska University hospital Stockholm, Sweden, 17176 Less <<
NCT03530189 - Enrolling by invitation December 31, 2022 Croatia ... More >> University Hospital Center Rijeka Rijeka, Croatia, 51000 Less <<
NCT03725033 Impaired Glucose Tolerance Phase 3 Recruiting January 2020 Russian Federation ... More >> Arkhangelsk Regional Clinical Hospital Not yet recruiting Arkhangelsk, Russian Federation, 163045 Contact: Maria Startseva, MD          Principal Investigator: Maria Startseva, MD          Kirov Clinical Hospital № 7 named. V.I. Yurlova Not yet recruiting Kirov, Russian Federation, 610014 Contact: Alexander Sobolev, MD          Principal Investigator: Alexander Sobolev, MD          City Clinical Hospital named after F.I. Inozemtseva Department of Health of Moscow Not yet recruiting Moscow, Russian Federation, 105187 Contact: Tatiana Meleshkevich, MD, PhD          Principal Investigator: Tatiana Meleshkevich, MD, PhD          Moscow Clinical Scientific and Practical Center of the Moscow City Health Department Not yet recruiting Moscow, Russian Federation, 111123 Contact: Ashot Mkrtumyan, MD, PhD, ScD, prof          Principal Investigator: Ashot Mkrtumyan, MD, PhD, ScD, prof          Pirogov Russian National Research Medical University Not yet recruiting Moscow, Russian Federation, 117997 Contact: Ekaterina Dudinskaya, MD, PhD          Principal Investigator: Ekaterina Dudinskaya, MD, PhD          National Medical Research Center for Rehabilitation and Balneology Not yet recruiting Moscow, Russian Federation, 121099 Contact: Larisa Marchenkova, MD, PhD          Principal Investigator: Larisa Marchenkova, MD, PhD          LLC Clinic "Bessalar" Recruiting Moscow, Russian Federation, 123423 Contact: Olga Demicheva, MD          Principal Investigator: Olga Demicheva, MD          Russian Medical Academy of Continuing Vocational Education Not yet recruiting Moscow, Russian Federation, 123995 Contact: Alexander Ametov, MD, PhD, Prof          Principal Investigator: Alexander Ametov, MD, PhD, Prof          Non-governmental private health care institution "Scientific Clinical Center of the Open Joint Stock Company" Russian Railways " Not yet recruiting Moscow, Russian Federation, 125315 Contact: Emma Voychik, MD, PhD          Principal Investigator: Emma Voychik, MD, PhD          Moscow State University of Medicine and Dentistry Not yet recruiting Moscow, Russian Federation, 127473 Contact: Arkady Vertkin, MD, PhD, Prof          Principal Investigator: Arkady Vertkin, MD, PhD, Prof          City Clinical Hospital No. 10 of the Kanavinsky District of Nizhny Novgorod Not yet recruiting Nizhny Novgorod, Russian Federation, 603011 Contact: Galina Varvarina, MD, PhD, professor          Principal Investigator: Galina Varvarina, MD, PhD, professor          Semashko Nizhny Novgorod Regional Clinical Hospital Not yet recruiting Nizhny Novgorod, Russian Federation, 603126 Contact: Olga Zanozina, MD, PhD, Prof          Principal Investigator: Olga Zanozina, MD, PhD, Prof          LLC "Medical Center "Healthy Family" Not yet recruiting Novosibirsk, Russian Federation, 630061 Contact: Lyudmila Ruyutkina, MD, PhD, Prof          Principal Investigator: Lyudmila Ruyutkina, MD, PhD, Prof          Institute of Cytology and Genetics of the Siberian Branch of the Russian Academy of Sciences Not yet recruiting Novosibirsk, Russian Federation, 630090 Contact: Oksana Rymar, MD, PhD          Principal Investigator: Oksana Rymar, MD, PhD          Novosibirsk State Medical University Not yet recruiting Novosibirsk, Russian Federation, 630091 Contact: Irina Bondar, MD, PhD, Prof          Principal Investigator: Irina Bondar, MD, PhD, Prof          Rostov State Medical University Not yet recruiting Rostov-on-Don, Russian Federation, 344022 Contact: Sergey Vorobiev, MD, PhD, ScD, Professor          Principal Investigator: Sergey Vorobiev, MD, PhD, ScD, Professor          Polyclinic Complex JSC Not yet recruiting Saint Petersburg, Russian Federation, 190013 Contact: Elena Arefyeva, MD, PhD          Principal Investigator: Elena Arefyeva, MD, PhD          Saint-Petersburg State Budgetary Healthcare Institution "City Polyclinic No. 6" Not yet recruiting Saint Petersburg, Russian Federation, 192148 Contact: Elena Metkina, MD          Principal Investigator: Elena Metkina, MD          Federal State Budget Military Educational Institution of Higher Education "Military Medical Academy named after S.M. Kirov Defense Ministry of the Russian Federation Not yet recruiting Saint Petersburg, Russian Federation, 194044 Contact: Yuri Khalimov, MD, PhD, Prof          Principal Investigator: Yuri Khalimov, MD, PhD, Prof          Federal State Budget Military Educational Institution of Higher Education "Military Medical Academy named after S.M. Kirov Defense Ministry of the Russian Federation Not yet recruiting Saint Petersburg, Russian Federation, 194044 Contact: Vladimir Salukhov, MD, PhD          Principal Investigator: Vladimir Salukhov, MD, PhD          St. Petersburg State Budgetary Healthcare Institution "City Polyclinic No. 117" Not yet recruiting Saint Petersburg, Russian Federation, 194358 Contact: Diana Alpenidze, MD, PhD          Principal Investigator: Diana Alpenidze, MD, PhD          Pavlov First Saint Petersburg State Medical University Not yet recruiting Saint Petersburg, Russian Federation, 197022 Contact: Anna Volkova, MD, PhD, Prof          Principal Investigator: Anna Volkova, MD, PhD, Prof          LLC Center "Diabetes" Not yet recruiting Samara, Russian Federation, 443067 Contact: Andrey Verbovoy, MD, PhD          Principal Investigator: Andrey Verbovoy, MD, PhD          Samara Regional Clinical Hospital. V.D. Seredavina Not yet recruiting Samara, Russian Federation, 443095 Contact: Galina Seredina, MD          Principal Investigator: Galina Seredina, MD          Volgograd State Medical University Not yet recruiting Volgograd, Russian Federation, 400131 Contact: Sergey Nedogoda, MD, PhD, Prof          Principal Investigator: Sergey Nedogoda, MD, PhD, Prof          Voronezh Regional Clinical Consultative and Diagnostic Center Not yet recruiting Voronezh, Russian Federation, 394018 Contact: Elena Zhdanova, MD, PhD          Principal Investigator: Elena Zhdanova, MD, PhD          The State Budgetary Healthcare Institution of the Yaroslavl Region "Regional Clinical Hospital" Recruiting Yaroslavl, Russian Federation, 150062 Contact: Maria Yanovskaya, MD, PhD, ScD, Professor          Principal Investigator: Maria Yanovskaya, MD, PhD, ScD, Professor Less <<
NCT03447158 Subacromial Bursitis Not Applicable Not yet recruiting March 1, 2020 -
NCT02213276 Glucose Infusion ... More >> Bone Markers Inflammatory Markers Less << Not Applicable Unknown July 2017 Denmark ... More >> Department of Endocrinology and Internal Medicine Aarhus, Aarhus C, Denmark, 8000 Less <<
NCT01162694 Type 2 Diabetes Mellitus Not Applicable Suspended(Study was expanded a... More >>nd included in another study.) Less << - Canada, British Columbia ... More >> St. Paul's Hospital Vancouver, British Columbia, Canada Less <<
NCT01726114 Diabetes Mellitus Not Applicable Completed - United States, California ... More >> C8 MediSensors, Inc. San Jose, California, United States, 95119 Less <<
NCT03273881 Obstetric Labor ... More >> Pregnancy in Diabetics Less << Not Applicable Recruiting October 2018 Israel ... More >> HaEmek medical center Recruiting Afula, Israel, 18101 Contact: galit Garmi, MD    97246494335    galit_ga@clalit.org.il Less <<
NCT03623412 Glucose Tolerance Impaired in ... More >>Pregnancy Less << Not Applicable Not yet recruiting September 30, 2019 -
NCT00761059 Analgesia Not Applicable Unknown December 2010 Germany ... More >> Neonatology, Children's Hospital, University of Cologne Recruiting Cologne, Germany, 50672 Contact: Christoph Huenseler, Dr med    0049-221-478-7190    christoph.huenseler@uni-koeln.de    Contact: Katharina Vezyroglou    0049-221-478-7190    katharina.vezyroglou@uk-koeln.de    Sub-Investigator: Katharina Vezyroglou          Sub-Investigator: Angela Kribs, Dr med          Sub-Investigator: Bernhard Roth, Professor          Sub-Investigator: Lars Welzing, Dr med          Sub-Investigator: Frank Eifinger, Dr med          Sub-Investigator: Anne Vierzig, Dr med Less <<
NCT03650712 Cystic Fibrosis-related Diabet... More >>es Less << Not Applicable Not yet recruiting August 31, 2021 United States, Colorado ... More >> University of Colorado Not yet recruiting Aurora, Colorado, United States, 80045 Contact: Christine L Chan, MD          United States, Iowa University of Iowa Not yet recruiting Iowa City, Iowa, United States, 52242 Contact: Julie Coffey, ARNP          United States, Minnesota University of Minnesota Not yet recruiting Minneapolis, Minnesota, United States, 55455 Contact: Amir Moheet, MD          United States, Missouri Washington University St. Louis Not yet recruiting Saint Louis, Missouri, United States, 63110 Contact: Andrea Granados, MD Less <<
NCT01992965 Hyperglycemia Not Applicable Unknown May 2016 China, Sichuan ... More >> Intensive care unit of West China Hospital Recruiting Chengdu, Sichuan, China, 610000 Contact: Yan Kang, MD    028-85422508    kang_yan_123@163.com    Principal Investigator: Yan Kang, MD          Sub-Investigator: Yan-yan Zuo, MD          Sub-Investigator: Mei-zhu Lu, MD Less <<
NCT00973726 Diabetes Not Applicable Unknown October 2009 Denmark ... More >> Glostrup Hospital Recruiting Glostrup, Denmark, 2600 Contact: Stig Holfort, Medical doctor    +45 43234817       Principal Investigator: Stig Holfort, Medical Doctor Less <<
NCT02074384 Type 1 Diabetes Not Applicable Completed - United States, Connecticut ... More >> Eda Cengiz New Haven, Connecticut, United States, 06511 United States, Florida Larry Deeb Tallahassee, Florida, United States, 32308 United States, Michigan Henry Ford Detroit, Michigan, United States, 48202 United States, Minnesota Park Nicollet International Diabetes Center Minneapolis, Minnesota, United States, 55416 United States, Mississippi The Diabetes Center, PLLC Ocean Springs, Mississippi, United States, 39564 United States, Montana St. Vincent's Billings, Montana, United States, 59101 United States, New York Columbia University New York City, New York, United States, 10032 Less <<
NCT01617356 Temporomandibular Joint Disord... More >>ers Less << Not Applicable Completed - Argentina ... More >> Hospital Italiano de Buenos Aires Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina, 1181 Less <<
NCT02677454 Diabetes Mellitus, Type 1 ... More >> Diabetes Mellitus Less << Not Applicable Completed - Sweden ... More >> NU-Hospital Group Uddevalla, Sweden Less <<
NCT02074384 - Completed - -
NCT01099397 - Completed - -
NCT01291719 Hyperglycemia ... More >> Diabetes Less << Phase 1 Phase 2 Active, not recruiting November 2018 United States, Florida ... More >> 3113 Lawton Road Orlando, Florida, United States, 32803 Less <<
NCT03670017 ICU Dysglycem... More >>ia Less << Not Applicable Recruiting December 31, 2019 United States, Missouri ... More >> Barnes Jewish Hospital Recruiting Saint Louis, Missouri, United States, 63110 Contact: Kelly Bochicchio, MS, RN    314-286-2965    bochicchiok@wustl.edu    Contact: Bryan Sato, RN    314-362-1065    bryansato@wustl.edu    Principal Investigator: Grant Bochicchio, MD, MPH Less <<
NCT01099397 - Completed - United States, Florida ... More >> University of Florida Department of Community Health and Family Medicine Gainesville, Florida, United States, 32610 Less <<
NCT01285713 - Completed - -
NCT01285713 Dehydration Phase 2 Completed - United States, Pennsylvania ... More >> The Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT02283411 - Completed - -
NCT02926118 Glucose Metabolism Disorders Not Applicable Completed - Netherlands ... More >> Maastricht University Maastricht, Netherlands Less <<
NCT02283411 Diabetes Mellitus, Type 1 ... More >> Diabetes Mellitus, Type 2 Less << Not Applicable Completed - United States, California ... More >> William Sansum Diabetes Center Santa Barbara, California, United States, 93105 Diablo Clinical Research Walnut Creek, California, United States, 94598 United States, Georgia Atlanta Diabetes Associates Atlanta, Georgia, United States, 30318 United States, Idaho Rocky Mountain Diabetes & Osteoporosis Center Idaho Falls, Idaho, United States, 83404 United States, Texas Clinical Trials of Texas San Antonio, Texas, United States, 78229 United States, Washington Rainier Clinical Research Center Renton, Washington, United States, 98057 Less <<
NCT03169842 Pancreatic Cyst Not Applicable Recruiting May 2021 United States, Louisiana ... More >> Ochsner Medical Center Recruiting New Orleans, Louisiana, United States, 70121 Contact: Maria Gloth, CCRC    504-842-2417    mgloth@ochsner.org    Contact: Janak N Shah, MD       janak.shah@ochsner.org    Principal Investigator: Janak N Shah, MD Less <<
NCT02583750 Glucose Metabolism Disorders Not Applicable Completed - United States, South Carolina ... More >> Public Health Research Center University of South Carolina Columbia, South Carolina, United States, 29201 Less <<
NCT01289808 Infant Newbor... More >>n Diseases Less << Not Applicable Terminated(changes were made t... More >>o the which needed an entireley new submission) Less << - -
NCT03411811 Ulnar Wrist Pain Not Applicable Not yet recruiting January 2021 -
NCT01061346 Body Weight Changes Not Applicable Completed - United States, Louisiana ... More >> Pennintgon Biomedical Research Center Baton Rouge, Louisiana, United States, 70808 Less <<
NCT03522870 Diabetes Mellitus, Type 1 Not Applicable Recruiting December 30, 2019 China, Guangdong ... More >> The Third Affiliated Hospital of Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510080 Contact: Jianping Weng, PHD,MD    020-85253193    wengjp@vip.163.com    Contact: Jinhua Yan, PHD,MD    020-85253193    yanjh79@163.com Less <<
NCT02142088 Blood Glucose Monitoring in Me... More >>dical ICU Less << Not Applicable Unknown December 2014 -
NCT03460964 Diabetes Mellitus Not Applicable Recruiting June 2019 United States, California ... More >> UCSD Altman Clinical and Translational Research Institute Recruiting San Diego, California, United States, 92161 Contact: Edward C Chao, DO    619-916-8719    ecchao@ucsd.edu    Principal Investigator: Edward C Chao, DO          Sub-Investigator: Joseph Wang, PhD          UCSD Recruiting San Diego, California, United States, 92161 Contact: David Ashley, MPH       dashley@ucsd.edu    Contact: Edward C Chao, DO    619-400-5050    ecchao@ucsd.edu Less <<
NCT02520258 Glucose Metabolism Disorder Not Applicable Recruiting June 2020 United States, New York ... More >> The Rockefeller University Recruiting New York, New York, United States, 10065 Contact: Recruitment Specialist    800-782-2737    rucares@rockefeller.edu    Contact: Thomas Huber, PhD    212 327 8283    hubert@rockefeller.edu    Principal Investigator: Thomas Huber, PhD Less <<
NCT02657252 Varicose Veins ... More >> Telangiectasis Less << Phase 4 Completed - Brazil ... More >> Vascular Lab Botucatu, São Paulo, Brazil, 18618687 Less <<
NCT01514253 Infant, Newborn, Diseases Not Applicable Unknown July 2012 Israel ... More >> NICU Department, The Baruch Padeh medical Center - Poriya Not yet recruiting Tiberias, Israel Contact: Shay Barak, MD    04-6652328    sbarak@poria.health.gov.il    Sub-Investigator: Amir Kushnir, MD          Principal Investigator: Shay Barak, MD          Sub-Investigator: Elena Chulsky, MD          Sub-Investigator: Tatiana Dolgunova, MD          Sub-Investigator: Natali Nikolski, MD          Sub-Investigator: Natali Shaykevich, MD          Sub-Investigator: Orly Benor, RN,BSN.MsN          Sub-Investigator: Gilat Yeganeh, LLB,LLM, RN          Sub-Investigator: Maryanne Nabso, RN,MA          Sub-Investigator: Sijal Hlehel, RN,MA Less <<
NCT03048227 Type1diabetes Phase 2 Not yet recruiting December 31, 2019 France ... More >> Chu de Nancy Not yet recruiting Nancy, Vandoeuvre-les-nancy, France, 54500 Contact: Bruno GUERCI       b.guerci@chu-nancy.fr    CHU de Bordeaux Not yet recruiting Bordeaux, France, 33078 Contact: BOGDAN CATARGI       bogdan.catargi@chu-bordeaux.fr    CH Sud Francilien Not yet recruiting Corbeil-essonnes, France, 91100 Contact: Sylvia FRANC          Contact: sylvia.franc@ch-sud-francilien.fr          CHU de Dijon Not yet recruiting Dijon, France, 77908 Contact: Sabine BAILLOT-RUDONI       sabine.rudoni@chu-dijon.fr    CHRU de Lille Not yet recruiting Lille, France, 59037 Contact: PIERRE FONTAINE       pierre.fontaine@chru-lille.fr    AP - Hôpitaux de Marseille Not yet recruiting Marseille, France, 13005 Contact: Paline SCHAEPELYNCK       pauline.schaepelynck@ap-hm.fr    UHMontpellier Not yet recruiting Montpellier, France, 34295 Contact: Eric RENARD, MD    4 67 33 83 82 ext 33    e-renard@chu-montpellier.fr    AP - Hôpitaux de Paris Not yet recruiting Paris, France, 75014 Contact: Jean Pierre RIVELINE       jeanpierre.riveline@lrb.aphp.fr    CHRU de Strasbourg Not yet recruiting Strasbourg, France, 67091 Contact: Nathalie JEANDIDIER       nathalie.jeandidier@chru-strasbourg.fr    Chu de Toulouse Toulouse, France, 31059 Less <<
NCT03464240 Hyperlipidemias Not Applicable Completed - Canada, Ontario ... More >> Tornto General Hospital, UHN Toronto, Ontario, Canada, M5G 1L7 Kensington Screening Clinic Toronto, Ontario, Canada, M5T 3A9 Less <<
NCT02885909 HYPERGLYCEMIA Phase 4 Recruiting December 2025 Taiwan ... More >> Taichung Veterans General Hospital Recruiting Taichung, Taiwan, 40705 Less <<
NCT03164707 - Not yet recruiting June 1, 2019 -
NCT02054325 Varicose Veins Phase 4 Completed - Brazil ... More >> School of Medicine at Botucatu- Paulista State University- UNESP, São Paulo, Brazil Botucatu, SP, Brazil, 18607030 Less <<
NCT03400631 Osteoarthritis, Knee Not Applicable Not yet recruiting January 2020 -
NCT02657252 - Completed - -
NCT01818557 Gestational Diabetes Not Applicable Completed - United States, Pennsylvania ... More >> Geisinger Health System Danville, Pennsylvania, United States, 17822 United States, Rhode Island Women & Infants Hospital Providence, Rhode Island, United States, 02905 United States, Texas The University of Texas Health Science Center, Houston Houston, Texas, United States, 77030 Less <<
NCT02359617 Type 1 Diabetes Not Applicable Completed - Austria ... More >> Medical University of Graz Graz, Styria, Austria, A-8036 Less <<
NCT02054325 - Completed - -
NCT01694446 Hyperlipidemia Not Applicable Completed - Canada, Ontario ... More >> Toronto General Hopital Toronto, Ontario, Canada, M5G 2C4 Less <<
NCT03719755 Hysterectomy Not Applicable Recruiting May 2019 United States, Arizona ... More >> Mayo Clinic Recruiting Scottsdale, Arizona, United States, 85259 Contact: Heather Crowe    480-342-3987    Crowe.Heather1@mayo.edu    Principal Investigator: Jeffrey Cornella, MD Less <<
NCT01713023 Type 1 Diabetes Not Applicable Completed - Brazil ... More >> University Hospital of Rio de Janeiro, Federal University of Rio de Janeiro Rio de Janeiro, Brazil, 21941-590 Less <<
NCT02969330 Brain Activity ... More >> Glucose Control Less << Not Applicable Unknown - -
NCT00906490 - Completed - United States, District of Col... More >>umbia Washington Hospital Center (WHC) Washington, District of Columbia, United States, 20010 United States, Maryland University of Maryland School of Medicine Baltimore, Maryland, United States, 21201 United States, Minnesota International Diabetes Center (IDC), Methodist Hospital Minneapolis, Minnesota, United States, 55416 United States, Oregon Providence Heart and Vascular Institute Portland, Oregon, United States, 97225 United States, Pennsylvania Thomas Jefferson University Philadelphia, Pennsylvania, United States, 19107 Less <<
NCT01588418 Impaired Glucose Tolerance (IG... More >>T) Diabetes Less << Phase 4 Completed - United States, Texas ... More >> Texas Diabetes Institute and UTHSCSA San Antonio, Texas, United States, 78229 Less <<
NCT03737916 Ulnar Neuropathies Not Applicable Not yet recruiting November 12, 2020 -
NCT02226536 Dysfunction of Vestibular Syst... More >>em Glucose Intolerance Less << Not Applicable Completed - -
NCT03089671 Pelvic Floor Disorders ... More >> Ureter; Kink Less << Not Applicable Recruiting December 2019 Canada, Ontario ... More >> Sunnybrook Health Sciences Centre Recruiting Toronto, Ontario, Canada, M4N 3M5 Contact: Louise-Helene Gagnon, MD, FRCSC    416-480-5845    louise-helene.gagnon@sunnybrook.ca    Mount Sinai Hospital Recruiting Toronto, Ontario, Canada, M5G 1Z5 Contact: Colleen D McDermott, MD    4165864800 ext 6490    colleen.mcdermott@sinaihealthsystem.ca    Contact: Danny Lovatsis, MD    4165864800    danny.lovatsis@sinaihealthsystem.ca Less <<
NCT01835964 Diabetes Mellitus, Type 1 Not Applicable Completed - United States, Virginia ... More >> University of Virginia Charlottesville, Virginia, United States, 22904 Less <<
NCT02796729 Brain Neoplasms, Malignant ... More >> Metastasis Less << Phase 2 Recruiting January 2018 Canada, British Columbia ... More >> BC Cancer Agency- Vancouver Centre Recruiting Vancouver, British Columbia, Canada, V5Z 4E6 Contact: Sonya Lam    604-877-6000 ext 6006       Principal Investigator: Nevin McVicar          Principal Investigator: Michael McKenzie Less <<
NCT01588418 - Completed - -
NCT00976924 Diabetes Not Applicable Completed - China, Tianjin ... More >> Tianjin Medical University general hospital Tianjin, Tianjin, China, 300070 Less <<
NCT03435432 Hyperlipidemias Not Applicable Completed - Canada, Ontario ... More >> Tornto General Hospital, UHN Toronto, Ontario, Canada, M5G 1L7 Less <<
NCT02331069 Superficial Radial Nerve Lesio... More >>n Less << Not Applicable Unknown January 2017 Argentina ... More >> Clinica Scanner Recruiting Rosario, Santa Fe, Argentina, 2000 Contact: Ezequiel Mailand, MD    0054 341 6393318    ezmailand@gmail.com    Contact: Daniel Mailand, MD    0054 341 6393339    dmailand@gmail.com    Instituto Jaime Slullitel Recruiting Rosario, Santa Fe, Argentina, 2000 Contact: MigueL Slullitel, PHD    0054 341 5012223    mslullitel@gmail.com    Contact: Ezequiel Mailand, MD    0054 314 6393318    ezmailand@gmail.com    Principal Investigator: Miguel H Slullitel, Phd          Sub-Investigator: Ezequiel Mailand, MD Less <<
NCT01688674 Once a Preterm Developed Hypog... More >>lycemia, no More Blood Glucose Was Measured During the Study Period. Less << Not Applicable Terminated(There was more bene... More >>fit from the infusion arm compared to the bolus arm.) Less << - Uganda ... More >> Mulago Hospital Kampala, Mulago, Uganda, +256 Less <<
NCT02054585 Dehydration Not Applicable Recruiting August 2019 Israel ... More >> Carmel Medical Center Recruiting Haifa, Israel, 34362 Principal Investigator: Rosana Sh Blejter Palti, MD Less <<
NCT02572856 Diabetes Not Applicable Recruiting May 15, 2019 United States, Washington ... More >> University of Washington Medical Center Recruiting Seattle, Washington, United States, 98195 Contact: Bala G Nair, Ph.D    206-598-4993    nairbg@uw.edu    Contact: Alec G Rooke, MD, PhD    206-598-4260    rooke@uw.edu    Sub-Investigator: E. Patchen Dellinger, MD          Sub-Investigator: Gail A Van Norman, MD          Sub-Investigator: Mayumi Horibe, MD          Sub-Investigator: Veda Tsoi Espina, MD          Sub-Investigator: Irl B Hirsch, MD Less <<
NCT00632775 Hyponatremia Phase 3 Completed - Canada, Ontario ... More >> The Hospital for Sick Children Toronto, Ontario, Canada, M5G 1X8 Less <<
NCT01819844 - Completed - -
NCT02968498 Blood Glucose Not Applicable Completed - Germany ... More >> CRO BioTeSys GmbH Esslingen, Germany, 73728 Less <<
NCT00464386 Burns Trauma Not Applicable Terminated(Study device requir... More >>ed infeasible modifications. No patients received device.) Less << - United States, Texas ... More >> US Army Institute of Surgical Research Fort Sam Houston, Texas, United States, 78234 Less <<
NCT02888795 Osteoarthritis, Knee Not Applicable Completed - Taiwan ... More >> Department of Physical Medicine & Rehabiliation, National Yang-Ming University Hospital I-Lan City, Taiwan Less <<
NCT01819844 Diabetes Mellitus ... More >> Hyperglycemia Less << Not Applicable Completed - United States, Massachusetts ... More >> MGH Diabetes Research Center Boston, Massachusetts, United States, 02114 Less <<
NCT02296372 Glucose Metabolism Disorders ... More >> Diabetic Blood Glucose Monitoring Critical Illness Less << Not Applicable Completed - Germany ... More >> Charite University, Berlin, Germany Berlin, Germany, 13353 Less <<
NCT03454087 Sepsis Not Applicable Recruiting June 30, 2022 United States, Pennsylvania ... More >> University of Pittsburgh Medical Center Recruiting Pittsburgh, Pennsylvania, United States, 15237 Contact: Faraaz A Shah, MD    412-692-2210    shahfa@upmc.edu    Principal Investigator: Faraaz A Shah, MD          Sub-Investigator: Bryan J McVerry, MD          Sub-Investigator: Christopher P O'Donnell, PhD          Sub-Investigator: Alison Morris, MD MS          Sub-Investigator: David T Huang, MD MPH          Sub-Investigator: Sachin Yende, MD MSc          Sub-Investigator: Hyung Kim, MD          Sub-Investigator: Georgios Kitsios, MD PhD Less <<
NCT01839448 - Completed - France ... More >> CH d'Arles - Hôpital Joseph Imbert Arles Cedex, France, 13637 CHU de Montpellier - Hôpital Arnaud de Villeneuve Montpellier Cedex 5, France, 34295 CHU de Montpellier - Hôpital Lapeyronie Montpellier, France, 34295 CHU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 9, France, 30029 Less <<
NCT01210183 Knee Osteoarthritis Phase 2 Phase 3 Completed - Argentina ... More >> Hospital Provincial de Rosario Rosario, Santa Fe, Argentina Less <<
NCT02009514 End-Stage Kidney Disease ... More >> Type 2 Diabetes Mellitus Less << Phase 4 Completed - -
NCT03296995 Systemic Lupus Erythematosus ... More >> Critical Illness Diabetic Blood Glucose Monitoring Less << Not Applicable Recruiting October 1, 2019 China, Shanghai ... More >> Shuang Ye, MD Recruiting Shanghai, Shanghai, China Contact: Shuang Ye, MD    +8613817615871    ye_shuang2000@163.com    Contact: Huijing Wang, postgraduate    +8618267851823    whj30813@163.com Less <<
NCT01453413 - Completed - -
NCT03223129 Type 2 Diabetes Mellitus Not Applicable Completed - -
NCT01453413 Diabetes Not Applicable Completed - United States, California ... More >> TCOYD at San Diego Convention Center San Diego, California, United States, 92101 United States, Florida TCOYD Conference at Tampa Convention Center Tampa, Florida, United States, 33602-5331 Less <<
NCT02569229 - Active, not recruiting November 2018 Switzerland ... More >> University childrens hospital Basel, UKBB Basel, Switzerland, 4056 Less <<
NCT03071159 Flash Glucose Monitoring ... More >> Metabolic Control Less << Not Applicable Recruiting March 10, 2018 Belgium ... More >> Jessa Hospital Recruiting Hasselt, Belgium, 3500 Contact: Guy Massa, MD, PhD Less <<
NCT03000205 Chronic Shoulder Pain Not Applicable Unknown August 2018 Taiwan ... More >> Shuang Ho Hospital Recruiting New taipei city, Zhonghe Dist, Taiwan, 235 Shuang Ho Hospital Recruiting New taipei city, Zhonghe Dist, Taiwan, 235 Contact: ShihWei Huang    +88622490088 ext 1606    13001@s.tmu.edu.tw Less <<
NCT03139383 Postoperative Nausea and Vomit... More >>ing Less << Not Applicable Completed - -
NCT01908530 Diabetes Mellitus Not Applicable Completed - United Kingdom ... More >> Imperial College London London, United Kingdom, W2 1PG Less <<
NCT01912807 Postoperative Vomiting Not Applicable Completed - Canada, Saskatchewan ... More >> Prairieview Surgical Centre Saskatoon, Saskatchewan, Canada Less <<
NCT03238183 Physical Activity ... More >> Functional Disturbance Less << Phase 4 Not yet recruiting July 2019 Taiwan ... More >> Shin Kong Wu Ho-Su Memorial Hospital Taipei, Taiwan, 111-01 Less <<
NCT03276949 - Completed - -
NCT01706172 Temporomandibular Joint Disord... More >>ers Less << Phase 2 Phase 3 Completed - Canada, British Columbia ... More >> Chisel Peak Medical Centre Invermere, British Columbia, Canada, V0A 1K0 Less <<
NCT02984098 Acute Pain PHASE4 COMPLETED 2025-06-15 Department of Pediatrics, Univ... More >>ersity of Medicine and Pharmacy Tirgu Mures, Tirgu Mures, Romania Less <<
NCT02523222 Hypoglycemia ... More >>Infant, Small for Gestational Age Premature Birth of Newborn Fetal Macrosomia Intrauterine Growth Restriction Complication of Prematurity Neonatal Hypoglycemia Less << Not Applicable Completed - United States, Texas ... More >> Ben Taub Harris Health Hospital Houston, Texas, United States, 77030 Less <<
NCT01883037 - Completed - United Kingdom ... More >> Royal Brompton Hospital London, United Kingdom, SW3 6NP Less <<
NCT00186004 - Completed - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT02946411 - Unknown December 2018 Mexico ... More >> Hospital de cardiología Ciudad de mexico, Cdmx, Mexico, 06720 Less <<
NCT01346254 Impaired Glucose Tolerance ... More >> Kidney Transplantation Less << Phase 2 Completed - Austria ... More >> Allgemeines Krankenhaus der Stadt Wien, Universitätskliniken Wien, Austria, 1090 Less <<
NCT01275469 Impaired Glucose Tolerance ... More >> Abdominal Obesity Less << Phase 2 Completed - France ... More >> Site n°31 Angers, France, 49000 Site n°32 Angers, France, 49000 Site n°36 Angers, France, 49000 Site n°37 Angers, France, 49000 Site n°34 Angers, France, 49100 Site n°35 Angers, France, 49100 Site n°39 Angers, France, 49100 Site n°17 Briollay, France, 49125 Site n°16 Cholet, France, 49300 Site n°19 Cholet, France, 49300 Site n°14 le MESNIL en VALLEE, France, 49410 Site n°10 Murs-erigne, France, 49610 Site n°12 Murs-erigne, France, 49610 Site n°2 Nantes, France, 44093 Site n°13 Parcay Les Pins, France, 49390 Site n°1 Paris, France, 75013 Site n°15 Segre, France, 49500 Site n°11 Thouars, France, 79100 Site n°30 Tierce, France, 49125 Site n°18 Vihiers, France, 49310 Less <<
NCT02604069 Free Tissue Flaps Early Phase 1 Unknown - Canada, Ontario ... More >> Juravinski Hospital Not yet recruiting Hamilton, Ontario, Canada, L8V 1C3 Contact: Edward Liu, MD       Edward.Liu@medportal.ca    Sub-Investigator: Edward Liu, MD          Principal Investigator: Ronen Avram, MD          Sub-Investigator: Jiayi Hu, MD          Principal Investigator: Achilleas Thoma, MD          Sub-Investigator: Matthew McRae, MD Less <<
NCT02509429 Type 1 Diabetes Phase 2 Completed - France ... More >> CHU d'Angers Angers, France, 49000 CHU Montpellier - Hôpital Lapeyronie Montpellier, France, 34985 AP-HP, Hôpital Robert Debré Paris, France, 75019 CHU de Tours, Hôpital Clocheville Tours, France, 37000 Less <<
NCT01388192 - Unknown December 2016 Taiwan ... More >> National Taiwan University Hospital Recruiting Taipei, Taiwan, 100 Contact: Yu-Wen Tien, Ph.D.    +886-972651427    kptkptkpt@yahoo.com.tw    Principal Investigator: Yu-Wen Tien, Ph.D. Less <<
NCT00654797 Critically Ill ... More >> Hyperglycemia Less << Phase 2 Unknown December 2018 United States, California ... More >> Childrens Hospital Centeral California Recruiting Madera, California, United States Principal Investigator: Ana Graciano, MD          United States, Minnesota Childrens Hospital of Minnesota - St. Paul Recruiting St. Paul, Minnesota, United States Principal Investigator: Stephen Kurachek, MD          United States, New Hampshire Dartmouth Hitchcock Medical Center Recruiting Lebanon, New Hampshire, United States Principal Investigator: Dan Levin, MD          United States, New York Cornell University Medical College Recruiting New York, New York, United States Principal Investigator: Bruce Greenwald, MD          Mount Sinai Hospital Recruiting New York, New York, United States Principal Investigator: Michelle Gong, MD          United States, North Carolina Wake Forest University Baptist Medical Center Recruiting Winston-Salem, North Carolina, United States Principal Investigator: David Bowton, MD          United States, Ohio Ohio State University Recruiting Columbus, Ohio, United States Principal Investigator: Ali Naeem, MD          United States, Texas University of Texas Medical Branch at Galveston Recruiting Galveston, Texas, United States Principal Investigator: Victor Cardenas, MD          Ben Taub General Hospital Recruiting Houston, Texas, United States Principal Investigator: Kalpalatha Guntupalli, MD          MD Anderson Cancer Center Recruiting Houston, Texas, United States Principal Investigator: Joseph Nates, MD Less <<
NCT00760526 Diabetes Mellitus, Type 1 Phase 3 Completed - United States, California ... More >> Stanford University Medical Center Stanford, California, United States, 94305 United States, Connecticut Yale University, School of Medicine New Haven, Connecticut, United States, 06520 United States, Florida Nemours Children's Clinic Jacksonville, Florida, United States, 32207 United States, Iowa Children's Hospital of Iowa, Department of Pediatrics Iowa City, Iowa, United States, 52242 United States, Missouri Washington University School of Medicine St. Louis, Missouri, United States, 63110 Less <<
NCT01741467 Pre-diabetes ... More >>Impaired Glucose Tolerance Less << Not Applicable Completed - United States, Maryland ... More >> Walter Reed National Military Medical Center Bethesda, Maryland, United States, 20889-5600 Less <<
NCT02590913 Healthy Not Applicable Completed - China, Zhejiang ... More >> Zhejiang university Hangzhou, Zhejiang, China, 310000 Less <<
NCT01068860 Type 2 Diabetes Mellitus ... More >> Impaired Glucose Tolerance Less << Phase 2 Completed - -
NCT03232008 Artificial Sweetener Effects o... More >>n Blood Glucose and Appetite Appetitive Behavior Less << Not Applicable Recruiting February 28, 2018 United Kingdom ... More >> King's College London Recruiting London, United Kingdom, SE1 9NH Contact: Christopher P Corpe    +44 (0) 20 7848 4269    christopher.corpe@kcl.ac.uk Less <<
NCT00760526 - Completed - -
NCT02208895 - Active, not recruiting December 2018 United States, Oklahoma ... More >> VAMC OKC Oklahoma City, Oklahoma, United States, 73104 Less <<
NCT02439177 Diabetes Not Applicable Terminated - Germany ... More >> Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm Ulm, Germany Less <<
NCT01456754 Glucose Intolerance Not Applicable Completed - Netherlands ... More >> University of Maastricht Maastricht, Netherlands Less <<
NCT03295578 Healthy PreDi... More >>abetes Less << Not Applicable Completed - Netherlands ... More >> Jumbo Supermarkten BV. Veghel, Noord-Brabant, Netherlands, 5462 CE Less <<
NCT01068860 - Completed - -
NCT02709707 - Completed - United States, California ... More >> Diablo Clinical Research Walnut Creek, California, United States, 94598 Less <<
NCT00878891 Diabetes Not Applicable Terminated - France ... More >> Service d'endocrinologie-Diabétologie - Hôpital Haut-Lévêque - CHU de Bordeaux Pessac, France, 33604 Less <<
NCT00961363 Impaired Glucose Tolerance Phase 2 Unknown - Taiwan ... More >> National Taiwan University Hospital Recruiting Taipei, Taiwan, 100 Contact: Lee-Ming Chuang, MD, PhD    886-2-23123456 ext 65038    leeming@ntu.edu.tw    Principal Investigator: Lee-Ming Chuang, MD, PhD          Sub-Investigator: Hung-Yuan Li, MD          Sub-Investigator: Hung-Ju Lin, MD          Sub-Investigator: Chia-Hsiung Chang, MD, PhD          Sub-Investigator: Shyang-Rong Shih, MD          Sub-Investigator: Tien-Jyun Chang, MD, PhD          Sub-Investigator: Jaw-Shiun Tsai, MD Less <<
NCT03763240 Blood Glucose, High Not Applicable Recruiting December 1, 2020 Sweden ... More >> Gothia Forum Recruiting Gothenburg, Sweden, 41345 Contact: Helen Svanström, Nurse    031-3439919    rekrytering.ctc.su@vgregion.se Less <<
NCT01093677 Impaired Glucose Tolerance Phase 1 Withdrawn(no subjects enrolled... More >>) Less << July 2010 -
NCT00841503 - Completed - Canada, Manitoba ... More >> I.H. Asper Clinical Research Institute Winnipeg, Manitoba, Canada, R2H 2A6 Less <<
NCT02904512 Diabetes Mellitus Phase 2 Phase 3 Recruiting - United States, Maryland ... More >> Baltimore VA Medical Center Recruiting Baltimore, Maryland, United States, 21201 Contact: Ilias Spanakis, MD    410-605-7000 ext 7394    ispanakis@som.umaryland.edu Less <<
NCT02824757 - Unknown March 2017 China, Beijing ... More >> Peking Union Medical College Hospital Recruiting Beijing, Beijing, China, 100730 Contact: Weigang Zhao, MD    13910054636    xiehezhaoweigang@163.com Less <<
NCT00704795 - Unknown October 2009 Denmark ... More >> Gentofte University Hospital Hellerup, Denmark, 2900 Less <<
NCT00623662 Hepatic Insufficiency ... More >> Liver Failure Less << Not Applicable Recruiting March 2019 Canada, Quebec ... More >> Royal Victoria Hospital, McGill University Health Centre Recruiting Montreal, Quebec, Canada, H3A 1A1 Contact: Ralph Lattermann, MD PhD    514-934-1934 ext 35802    ralph.lattermann@muhc.mcgill.ca    Contact: Thomas Schricker, MD PhD    514-934-1934 ext 36057    thomas.schricker@mcgill.ca    Principal Investigator: Ralph Lattermann, MD PhD          Sub-Investigator: Thomas Schricker, MD PhD          Sub-Investigator: George Carvalho, MD MSc          Sub-Investigator: Peter Metrakos, MD          Sub-Investigator: Linda Wykes, PhD          Sub-Investigator: Mazen Hassanain, MD Less <<
NCT00995670 Hyperglycemia Not Applicable Completed - United States, Wisconsin ... More >> Zablocki VA Medical Center, Milwaukee Milwaukee, Wisconsin, United States, 53295-1000 Less <<
NCT02942069 - Active, not recruiting November 2017 Denmark ... More >> Nordsjællands Hospital Hillerod, Denmark, 3400 Less <<
NCT03293082 - Completed - Slovenia ... More >> UMC - University Children's Hospital Ljubljana Ljubljana, Slovenia, 1000 Less <<
NCT00995670 - Completed - -
NCT01512654 Diabetes Mellitus, ... More >> Diabetes Mellitus, Type 1 Diabetes Mellitus, Type 2 Less << Phase 2 Completed - Czech Republic ... More >> Institute for Clinical and Experimental Medicine Prague, Czech Republic, 14021 France Montpellier University Hospital Montpellier, France, 34000 Italy Universita Degli Studi di Padova Padova, Italy, 35128 Less <<
NCT02933164 Diabetes Mellitus Not Applicable Active, not recruiting - Canada, Ontario ... More >> LMC Clinical Research Inc. Toronto, Ontario, Canada, M4G 3E8 Less <<
NCT00589355 - Unknown October 2008 United States, Connecticut ... More >> Yale Center for Clinical Investigation New Haven, Connecticut, United States, 06520 Less <<
NCT02330341 Glucose Intolerance Phase 2 Completed - Mexico ... More >> Manuel González Ortiz Guadalajara, Jalisco, Mexico, 44140 Less <<
NCT00541515 Diabetes, Type I Not Applicable Completed - Israel ... More >> schneider children medical center of Israel Petach-Tikva, Israel Less <<
NCT01645696 Diabetes Phase 1 Phase 2 Completed - Canada, Ontario ... More >> >LMC Endocrinology Centre, Clinical Research Unit Toronto, Ontario, Canada, M4G 3E8 Less <<
NCT02698878 Local Glucose Uptake ... More >> Glucose Metabolism Disorders Less << Not Applicable Completed - -
NCT01548885 Diabetes Not Applicable Completed - United States, Indiana ... More >> Bayer HealthCare LLC, Diabetes Care Mishawaka, Indiana, United States, 46544 Less <<
NCT01548885 - Completed - -
NCT02072694 Obesity Not Applicable Completed - Brazil ... More >> Clinical Hospital of Ribeirao Preto Ribeirão Preto, Sao Paulo, Brazil, 14091210 Less <<
NCT03154060 Diabetes Mellitus, Type 1 Not Applicable Completed - Belgium ... More >> Onze-Lieve-Vrouwziekenhuis Aalst Aalst, Belgium, 9300 UZ Leuven Leuven, Belgium, 3000 Less <<
NCT01246492 Taste Receptors ... More >> Nutrient Sensing Intestinal Absorption Blood Glucose Appetite Less << Not Applicable Withdrawn May 2011 United Kingdom ... More >> Brain, Performance and Nutrition Research Centre- Northumbria University Newcastle-Upon Tyne, United Kingdom, NE1 8ST Less <<
NCT00301392 Diabetes Mellitus ... More >> Glucose Intolerance Less << Phase 4 Completed - Japan ... More >> The University of Tokyo, Graduate School of Medicine Bunkyo-ku, Tokyo, Japan, 113-8655 Less <<
NCT02117154 - Completed - Malaysia ... More >> University of Malaya Medical Center Kuala Lumpur, Wilayah Persekutuan, Malaysia, 59100 Less <<
NCT03556098 Diabetes Mellitus, Type 1 Not Applicable Recruiting January 1, 2020 Denmark ... More >> Steno Diabetes Center Copenhagen, Clinical Metabolic Physiology Recruiting Hellerup, Denmark, 2900 Contact: Bjørn Hoe, MD    004553634340    bjoern.hoe@regionh.dk    Contact: Filip K Knop, PhD, MD       filip.krag.knop.01@regionh.dk Less <<
NCT01268488 Diabetes Not Applicable Completed - United States, New Jersey ... More >> Consumer Product Testing Company Fairfield, New Jersey, United States, 07004 Less <<
NCT01268488 - Completed - -
NCT01359904 Diabetes Type 2 Not Applicable Completed - Canada, Quebec ... More >> Montreal General Hospital Montreal, Quebec, Canada, H3G 1A4 Less <<
NCT03552315 Postprandial Hyperglycemia ... More >> Metabolic Syndrome Type 2 Diabetes Mellitus Less << Not Applicable Recruiting November 30, 2018 Sweden ... More >> Dept Experimental Medical Science, Lund University Recruiting Lund, Sweden Contact: Kristina E Andersson, PhD    +46 709 307357    kristina_e.andersson@med.lu.se Less <<
NCT01714232 - Completed - -
NCT01359904 - Completed - -
NCT01887691 Diabetes Pred... More >>iabetic Prediabetes Glucose Intolerance Less << Phase 1 Active, not recruiting December 2020 United States, Massachusetts ... More >> Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Less <<
NCT00804596 Diabetes Not Applicable Completed - United States, Minnesota ... More >> International Diabetes Center Minneapolis, Minnesota, United States, 55416 Less <<
NCT01469715 Type 1 Diabetes Mellitus Phase 2 Completed - United States, Virginia ... More >> University of Virginia Charlottesville, Virginia, United States, 22908 Less <<
NCT03734718 Diabetes Mellitus, Type 1 ... More >> Hypoglycemia Less << Not Applicable Recruiting June 1, 2019 Denmark ... More >> Steno Diabetes Center CopenhagenSteno Diabetes Center Copenhagen, Clinical Metabolic Physiology Recruiting Hellerup, Denmark, 2800 Contact: Sebastian M heimbürger, Msc.    +45 38673407    sebastian.moeller.heimbuerger@regionh.dk    Contact: Filip K Knop, Prof, MD          Principal Investigator: Filip K Knop, Prof, MD Less <<
NCT01469715 - Completed - -
NCT00494078 Critical Illness Not Applicable Completed - Austria ... More >> Medical University of Vienna Vienna, Austria, 1090 Less <<
NCT01575080 - Completed - -
NCT01575080 Diabetes Not Applicable Completed - United States, Indiana ... More >> Bayer HealthCare LLC, Diabetes Care Mishawaka, Indiana, United States, 46544 Less <<
NCT00804596 - Completed - -
NCT01268267 Diabetes Not Applicable Completed - United States, California ... More >> AMCR Institute Escondido, California, United States, 92026 Less <<
NCT03591900 Diabetes Pred... More >>iabetes B-Thalassemia Less << Not Applicable Completed - -
NCT01308359 Fetal Movement Perception Not Applicable Unknown January 2012 Israel ... More >> Lis Maternity Hospital, Tel Aviv Sourasky Medical Center Recruiting Tel Aviv, Israel, 64239 Contact: Ariel Many, MD    97236925633       Contact: Nadav Mishan, MD    97236925633       Principal Investigator: Ariel Many, MD          Sub-Investigator: Nadav Mishan, MD Less <<
NCT02734745 Diabetes Type 1 Not Applicable Recruiting December 1, 2017 Italy ... More >> University of Padova Recruiting Padova, Italy Contact: Daniela Bruttomesso, MD, PHD       daniela.bruttomesso@unipd.it Less <<
NCT03487887 - Recruiting March 20, 2019 Croatia ... More >> University Hospital Centre Zagreb Recruiting Zagreb, Croatia, 10 000 Contact: Maja Baretić, MD PhD    0038512376542 Less <<
NCT02374879 Type 1 Diabetes Mellitus Not Applicable Completed - United Kingdom ... More >> BioKinetic Europe Ltd Belfast, Antrim, United Kingdom, BT2 7BA Less <<
NCT01268267 - Completed - -
NCT02607839 Healthy Phase 2 Completed - Canada, Ontario ... More >> Tornto General Hospital, UHN Toronto, Ontario, Canada, M5G 1L7 Less <<
NCT02956642 Diabetes Mellitus Phase 2 Recruiting December 2019 United States, California ... More >> University of California, San Francisco Recruiting San Francisco, California, United States, 94158 Contact: Xochitl Butcher    415-502-3147    xochitl.butcher@ucsf.edu    Principal Investigator: Jenise Wong, MD, PhD Less <<
NCT02821117 Diabetes Mellitus Not Applicable Completed - Germany ... More >> Kinder- und Jugendkrankenhaus Hannover, Germany, 30173 Ireland National Children's Hospital Dublin, Ireland, 24 Temple Street Children's University Hospital Dublin, Ireland, 7 United Kingdom Royal Belfast Hospital for Sick Children Belfast, County Antrim, United Kingdom, BT12 6BE Antrim Area Hospital Antrim, United Kingdom, BT41 2RL Ulster Hospital Belfast, United Kingdom, BT16 St. James University Hospital, Leeds Teaching Hospitals NHS Trust Leeds, United Kingdom, LS9 7TF Altnagelvin Hospital Londonderry, United Kingdom, BT47 6SB Nottingham University Hospitals NHS Trust Nottingham, United Kingdom, NG7 2UH Southampton University Hospital NHS Trust Southampton, United Kingdom, SO16 6YD Less <<
NCT02155023 Diabetes Not Applicable Completed - Austria ... More >> Medical University of Graz Graz, Styria, Austria, 8010 Less <<
NCT03032523 Neonatal Hypoglycemia Not Applicable Completed - United States, California ... More >> Stanford University Stanford, California, United States, 94305 Less <<
NCT02119325 Impaired Fasting Glucose Not Applicable Completed - India ... More >> Lambda Therapeutic Research Ltd Ahmedabad, Gujarat, India, 380 061 Less <<
NCT00707434 Diabetes Not Applicable Terminated - United States, Texas ... More >> The University of Texas Southwestern Medical Center at Dallas Dallas, Texas, United States, 75390 University of Texas Medical Branch at Galveston Galveston, Texas, United States, 77555 University of Texas Health Science Center at Houston Houston, Texas, United States, 77030 University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 University of Texas Health Science Center at San Antonio San Antonio, Texas, United States, 78229 University of Texas Health Science Center at Tyler Tyler, Texas, United States, 75708 Less <<
NCT02119325 - Completed - -
NCT02789553 Obesity Not Applicable Recruiting November 2019 France ... More >> Department of Endocrinology, metabolic diseases and nutrition Recruiting Toulouse, France, 31059 Contact: Patrick Ritz, MD, PhD    0567771638 ext +33    ritz.p@chu-toulouse.fr    Contact: Amandine Pauze    0561778434 ext +33    pauze.a@chu-toulouse.fr Less <<
NCT03353415 Hypoglycemia, Reactive ... More >> Hypoglycemia Less << Not Applicable Not yet recruiting October 2018 United States, Massachusetts ... More >> Joslin Diabetes Center Recruiting Boston, Massachusetts, United States, 02215 Contact: Mary E Patti, MD    617-309-2635    mary.elizabeth.patti@joslin.harvard.edu    Contact: Lauren N Richardson, BS    (617) 309-4463    lauren.richardson@joslin.harvard.edu Less <<
NCT02379299 Type 1 Diabetes Phase 2 Phase 3 Withdrawn - Denmark ... More >> Hvidovre University Hospital Hvidovre, Denmark, 2650 Less <<
NCT01268345 Diabetes Not Applicable Completed - China, Tianjin ... More >> Tianjin Hexi Ruijing metabolism hospital Tianjin, Tianjin, China Less <<
NCT02229487 - Completed - -
NCT02229487 Prediabetes Not Applicable Completed - Thailand ... More >> Faculty of Medicine Ramathibodi Hospital Bangkok, Thailand Less <<
NCT03335501 Type 1 Diabetes Mellitus Phase 2 Withdrawn(The owner of the alg... More >>orithm does not wish that this study be undertaken) Less << December 31, 2018 -
NCT01714895 Type 1 Diabetes ... More >> Continuous Glucose Monitoring Hypoglycemia Less << Not Applicable Completed - Spain ... More >> Servicio de Endocrinología y Nutrición, Hospital Clínico Universitario de Valencia Valencia, Spain, 46010 Less <<
NCT01714232 Diabetes Not Applicable Completed - United States, Indiana ... More >> Bayer HealthCare LLC, Diabetes Care Mishawaka, Indiana, United States, 46544 Less <<
NCT02647905 Diabetes Mellitus Not Applicable Completed - United States, California ... More >> John Muir Physician Network Clinical Research Center Concord, California, United States, 94520 AMCR Institute Escondido, California, United States, 92025 Diablo Clinical Research Walnut Creek, California, United States, 94598 United States, Georgia Atlanta Diabetes Care Atlanta, Georgia, United States, 30318 United States, New York Mount Sinai Diabetes Center New York, New York, United States, 10029 United States, Texas Worldwide Clinical Trials San Antonio, Texas, United States, 78217 Clinical Trials of Texas San Antonio, Texas, United States, 78229 United States, Virginia UVA Diabetes and Endocrine Clinic Charlottesville, Virginia, United States, 22903 United States, Washington Rainier Clinical Research Renton, Washington, United States, 98057 Less <<
NCT02647905 - Completed - -
NCT03246451 Glucose Metabolism Disorders Not Applicable Completed - Denmark ... More >> Center for Diabetes Research Gentofte, Copenhagen, Denmark, 2900 Less <<
NCT03433573 Diabetes Mellitus Not Applicable Completed - United Kingdom ... More >> Leeds Teaching Hospitals NHS Trust Leeds, United Kingdom, LS9 7TF Alder Hey Children's NHS Foundation Trust Liverpool, United Kingdom, L14 5AB Pennine Acute Hospitals NHS Trust Manchester, United Kingdom, M8 5RB Northampton General Hospitals NHS Trust Northampton, United Kingdom, NN1 5BD Nottingham University Hospitals NHS Trust Nottingham, United Kingdom, NG5 1PB Salisbury NHS Foundation Trust Salisbury, United Kingdom, SP2 8BJ Southampton University Hospitals NHS Trust Southampton, United Kingdom, SO16 6YD Great Western Hospitals NHS Foundation Trust Swindon, United Kingdom, SN3 6BB Taunton and Somerset NHS Foundation Trust Taunton, United Kingdom, TA1 5DA St George's Healthcare NHS Trust Tooting, United Kingdom, SW17 0QT Royal Cornwall Hospitals NHS Trust Truro, United Kingdom, TR1 3LQ Less <<
NCT02783612 Gestational Diabetes Not Applicable Unknown July 2018 Israel ... More >> Wolfson medical center Recruiting Holon, Israel Contact: Hadas Miremberg, MD    972526741740    dasile2@gmail.com Less <<
NCT01883440 Common Cold Phase 2 Completed - Sweden ... More >> Öronmottagningen Sunderbyn, Sweden Less <<
NCT01405911 Glucose Intolerance Phase 2 Completed - -
NCT01883440 - Completed - -
NCT02614768 Diabetes Mellitus, Type 1 Not Applicable Completed - -
NCT01668485 Type 1 Diabetes Mellitus Phase 4 Completed - Germany ... More >> Justus Liebig University Giessen, Hessia, Germany, 35392 Less <<
NCT02290067 Diabetes Not Applicable Completed - Germany ... More >> Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft ULM, Germany, 89081 Less <<
NCT02135172 Impaired Glucose Tolerance Not Applicable Completed - United Kingdom ... More >> Leicester Diabetes Centre, Leicester General Hospital Leicester, Leicestershire, United Kingdom, LE5 4PW Less <<
NCT02603237 Obesity Insul... More >>in Resistance Healthy Less << Not Applicable Active, not recruiting June 2020 Germany ... More >> University of Saarland Homburg, Saarland, Germany, 66424 Less <<
NCT01883622 - Completed - Italy ... More >> Department of Gynecology, Perinatology and Human Reproduction, University of Florence Florence, Italy Department of Medicine, University of Padua Padova, Italy Department of Endocrinology and Metabolic Diseases, University of Pisa Pisa, Italy Less <<
NCT03120091 - Completed - China, Sichuan ... More >> Intensive care unit of West China Hospital Chengdu, Sichuan, China, 610000 Less <<
NCT02010827 - Completed - Denmark ... More >> Diabetes Research Division, University Hospital Gentofte Hellerup, Denmark, 2900 Less <<
NCT01547364 Back Pain Lower Back Chronic Phase 2 Completed - United States, Hawaii ... More >> Liza Smigel, M.D. Hilo, Hawaii, United States, 96720 Less <<
NCT03502174 - Recruiting August 2018 United States, California ... More >> Sansum Diabetes Research Institute Recruiting Santa Barbara, California, United States, 93105 Contact: Kristin Castorino, DO    805-682-7638       Diablo Clinical Research Recruiting Walnut Creek, California, United States, 94598 Contact: Mark Christiansen, MD          Principal Investigator: Mark Christiansen, MD          United States, Idaho Rocky Mountain Diabetes & Osteoporosis Center Not yet recruiting Idaho Falls, Idaho, United States, 83404 Contact: David Liljenquist, MD          Principal Investigator: David Liljenquist, MD Less <<
NCT02590016 Gestational Diabetes ... More >> Hypoglycemia, Neonatal Less << Phase 4 Unknown - Finland ... More >> Obstetrics and Gynecology Unit: Tampere University Hospital Recruiting Tampere, Finland, 33521 Contact: Elina Kivekäs, MD    +358331165244    elina.kivekas@pshp.fi Less <<
NCT02388815 Diabetes Mellitus Not Applicable Completed - United Kingdom ... More >> University Hospitals Bristol NHS Foundation Trust Bristol, United Kingdom, BS1 3NU Cambridge University Hospitals NHS Foundation Trust Cambridge, United Kingdom, CB2 0QQ Royal Devon and Exeter NHS Foundation Trust Exeter, United Kingdom, EX2 5DW Harrogate & District NHS Foundation Trust Harrogate, United Kingdom, HG2 7SX St. James University Hospital, Leeds Teaching Hospitals NHS Trust Leeds, United Kingdom, LS9 7TF Northampton General Hospital NHS Trust Northampton, United Kingdom, NNI 5BD Nottingham University Hospitals NHS Trust Nottingham, United Kingdom, NG7 2UH Oxford Radcliffe Hospital NHS Trust Oxford, United Kingdom, OX3 9DU Southampton University Hospital NHS Trust Southampton, United Kingdom, SO16 6YD Less <<
NCT00824148 Diabetes Mellitus, Type 1 Not Applicable Completed - Norway ... More >> Department of Endocrinology, St. Olavs Hospital Trondheim, Norway, N-7006 Less <<
NCT02388815 - Completed - -
NCT03595943 Glucose Intolerance Not Applicable Completed - Canada, Saskatchewan (SK) ... More >> College of Kinesiology, University of Saskatchewan Saskatoon, Saskatchewan (SK), Canada, S7N5B2 Less <<
NCT01699763 - Completed - -
NCT03448367 - Recruiting February 2021 United States, California ... More >> Sansum Diabetes Research Institute Recruiting Santa Barbara, California, United States, 93105 Contact: Kristin Castorino, DO    805-682-7638       United States, Idaho Rocky Mountain Diabetes & Osteoporosis Center Recruiting Idaho Falls, Idaho, United States, 83404 Contact: David Liljenquist, MD          Principal Investigator: David Liljenquist, MD Less <<
NCT00797563 Diabetes Mellitus Not Applicable Completed - United States, New Jersey ... More >> Consumer Product Testing Co., Inc. Fairfield, New Jersey, United States, 07004 Less <<
NCT01699763 Diabetes Not Applicable Completed - United States, Indiana ... More >> Bayer HealthCare LLC, Diabetes Care Mishawaka, Indiana, United States, 46544 Less <<
NCT02336945 - Completed - United States, California ... More >> Unger Primary Care Medical Center & Catalina Research Institute Chino, California, United States, 91710 Dr. Deanna Cheung Long Beach, California, United States, 90807 University of California San Diego Veterns Affairs Medical Center San Diego, California, United States, 92161 United States, Michigan Henry Ford Medical Center Detroit, Michigan, United States, 48202 United States, Missouri St. Luke's Endocrinology and Diabetes Kansas City, Missouri, United States, 64111 United States, North Carolina Duke Southern Regional AHEC Fayetteville, North Carolina, United States, 28304 United States, Texas Diabetes America- Pearland Pearland, Texas, United States, 77584 Less <<
NCT00797563 - Completed - -
NCT02854111 Diabetes Mellitus Not Applicable Completed - Thailand ... More >> Faculty of Medicine Ramathibodi Hospital, Mahidol University Bangkok, Thailand, 10400 Less <<
NCT03339245 Non-Alcoholic Fatty Liver Dise... More >>ase Obesity Less << Not Applicable Recruiting December 1, 2020 United States, New York ... More >> The Rockefeller University Recruiting New York, New York, United States, 10065 Contact: Recruitment Specialist    800-782-2737    rucares@rockefeller.edu Less <<
NCT02390167 Diabetes Not Applicable Completed - United States, California ... More >> AMCR Institute Escondido, California, United States, 92026 Diablo Clinical Research Walnut Creek, California, United States, 94598 Less <<
NCT00884611 Type 1 Diabetes Mellitus Not Applicable Completed - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 United States, Colorado Barbara Davis Center for Childhood Diabetes, University of Colorado Aurora, Colorado, United States, 80045 Less <<
NCT02390167 - Completed - -
NCT03566472 - Not yet recruiting January 31, 2019 -
NCT02291250 Type 2 Diabetes Not Applicable Recruiting September 2018 United Kingdom ... More >> University of Aberdeen Rowett Institute of Nutrition and Health Recruiting Aberdeen, United Kingdom, AB21 9SB Contact: Nigel Hoggard, PhD    01224 716655    N.Hoggard@abdn.ac.uk    Principal Investigator: Nigel Hoggard, PhD Less <<
NCT02440555 - Completed - France ... More >> Chu Saint-Etienne Saint-etienne, France, 42055 Less <<
NCT00884611 - Completed - -
NCT01954771 - Completed - -
NCT02813421 Type 1 Diabetes Mellitus Not Applicable Completed - United States, California ... More >> Children's Hospital Los Angeles Los Angeles, California, United States, 90027 Less <<
NCT03666546 Diabetes Mellitus, Type 2 Phase 4 Recruiting February 2019 Austria ... More >> Clinical Research Center (CRC) Recruiting Graz, Austria, A-8036 Contact: Eva Svehlikova, PhD    +43316385 ext 72835    eva.svehlikova@medunigraz.at    Principal Investigator: Thomas Pieber, Prof. MD Less <<
NCT01680653 Type 1 Diabetes Not Applicable Completed - United States, California ... More >> Stanford University Stanford, California, United States, 94305 Less <<
NCT02789319 Diabetes Phase 4 Completed - United States, California ... More >> Diabetes Technology Society Burlingame, California, United States, 94010 AMCR Institute Escondido, California, United States, 92025 Diablo Clinical Research Walnut Creek, California, United States, 94598 United States, Washington Rainier Clinical Research Center Renton, Washington, United States, 98057 Less <<
NCT01680653 - Completed - -
NCT02423798 - Completed - -
NCT01851616 Obesity Not Applicable Completed - Switzerland ... More >> University Hospital of Basel Basel, Switzerland, CH-4031 Less <<
NCT03715010 Pre-diabetes ... More >>Obese Glucose Intolerance Less << Not Applicable Completed - United States, California ... More >> UCLA Center for Human Nutriiton Los Angeles, California, United States, 90095 Less <<
NCT01954771 Diabetes Mellitus, Type 2 ... More >> Coronary Artery Disease Less << Not Applicable Completed - China, Beijing ... More >> Capital Medical University Affiliated Beijing Anzhen Hospital Beijing, Beijing, China, 100029 Less <<
NCT01820104 Healthy Phase 1 Completed - China, Shaanxi ... More >> Department of pharmacy, Xijing Hospital, Fourth Military Medical University Xi'an, Shaanxi, China Less <<
NCT02530450 - Completed - -
NCT02042768 - Recruiting January 2019 United Kingdom ... More >> University Hospital of North Staffordshire Recruiting Stoke-on-Trent, North Staffordshire, United Kingdom, ST4 6QG Contact: Hayley King       hayley.king@uhns.nhs.uk    Principal Investigator: Simon Davies, MD Less <<
NCT03340311 Gestational Diabetes Mellitus Not Applicable Completed - United States, Virginia ... More >> University of Virginia Maternal Fetal Medicine Clinic Charlottesville, Virginia, United States, 22901 Less <<
NCT03028571 Insulin Resistance Phase 1 Recruiting December 31, 2024 United States, Tennessee ... More >> Vanderbilt University Medical Center Recruiting Nashville, Tennessee, United States, 37232 Contact: Misty Hale, BS    615-322-2318    autonomics@vanderbilt.edu    Sub-Investigator: Italo Biaggioni, MD Less <<
NCT02423798 Diabetes Not Applicable Completed - -
NCT01756274 - Completed - -
NCT01756274 Diabetes Not Applicable Completed - United States, Missouri ... More >> Washington University School of Medicine St. Louis, Missouri, United States, 63110 Less <<
NCT03767790 Type 1 Diabetes Mellitus Not Applicable Not yet recruiting July 1, 2019 United States, California ... More >> Sansum Diabetes Research Institute Not yet recruiting Santa Barbara, California, United States, 93105 Contact: Camille Andre    805-682-7640 ext 217    candre@sansum.org    Principal Investigator: Jordan E Pinsker, MD          Sub-Investigator: Mei Mei Church, NP Less <<
NCT02621060 Impaired Glucose Tolerance Phase 2 Unknown February 2017 Mexico ... More >> Institute of Experimental and Clinical Therapeutics (INTEC), CUCS, University of Guadalajara Recruiting Guadalajara, Jalisco, Mexico, 44340 Less <<
NCT02989675 Hypoglycemia Non Diabetics ... More >> Emergencies Pediatric ALL Critical Illness Less << Not Applicable Recruiting December 2019 Malawi ... More >> Queen Elisabeth Central Hospital Recruiting Blantyre, Malawi Contact: Tim Baker, MD, PhD    +265 991 33 50 15    tim.baker@ki.se    Contact: Queen Dube, MD, PhD    +265 999981454    drdubefirst@yahoo.com    Zomba Central Hospital Recruiting Zomba, Malawi Contact: Helena Hildenwall, PhD    +46737182793    Helena.Hildenwall@ki.se    Contact: Tim Baker, PhD    +265991335015    Tim.Baker@ki.se Less <<
NCT02530450 - Completed - -
NCT03028259 - Completed - -
NCT00809029 Adipose Tissue Not Applicable Unknown December 2012 United Kingdom ... More >> University Hospital Aintree Recruiting Liverpool, United Kingdom, L9 7AL Contact: Christina Daousi, MD FRCP    +44 (0) 151 5295885    cdaousi@liverpool.ac.uk    Contact: Sravan K Thondam, MBBS MRCP    44 (0) 151 5296464    s.thondam@liverpool.ac.uk    Principal Investigator: Christina Daousi, MD FRCP          Sub-Investigator: Sravan K Thondam, MBBS MRCP Less <<
NCT02984514 Type1diabetes Not Applicable Completed - Sweden ... More >> Uppsala University Hospital Uppsala, Sweden, 751 23 Less <<
NCT03471949 Healthy Not Applicable Active, not recruiting December 11, 2018 -
NCT01840982 Healthy People ... More >> Diabetes Mellitus, Type 2 Less << Not Applicable Completed - Korea, Republic of ... More >> Clinical Trial Center for Functional Foods; Chonbuk National University Hospital Jeonju, Jeollabuk-do, Korea, Republic of, 560-822 Less <<
NCT00381186 Impaired Glucose Tolerance ... More >> Type 2 Diabetes Less << Not Applicable Completed - -
NCT02708966 Impaired Glucose Tolerance Phase 2 Recruiting December 2019 Mexico ... More >> Institute of Experimental and Clinical Therapeutics (INTEC), CUCS, University of Guadalajara Recruiting Guadalajara, Jalisco, Mexico, 44340 Contact: Esperanza Martínez-Abundis, PhD    52+ (33) 1058-5200 ext 34211    esperanzamartnezabundi@yahoo.com Less <<
NCT00464529 - Completed - Netherlands ... More >> Isala Clinics, Weezenlanden location Zwolle, Netherlands, 8000 GM Less <<
NCT02342834 Diabetes Mellitus, Type 2 Not Applicable Unknown March 2015 Italy ... More >> Azienda Ospedaliero-Universitaria Pisana Pisa, PI, Italy, 56127 Less <<
NCT01610986 Normal Physiology on Healthy S... More >>ubjects Less << Not Applicable Completed - Switzerland ... More >> University of Lausanne Lausanne, Vaud, Switzerland, 1005 Less <<
NCT02033499 DIABETES MELLITUS, NONINSULIN-... More >>DEPENDENT, 2 (Disorder) Less << Not Applicable Completed - United States, North Carolina ... More >> The University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States, 27599 Less <<
NCT03466697 Obesity Not Applicable Recruiting December 31, 2019 Korea, Republic of ... More >> Pusan National University Hospital Recruiting Busan, Korea, Republic of, 49241 Contact: Kyoungjune Pak, MD, PhD    1071501810 Less <<
NCT02260895 Prediabetes Not Applicable Unknown March 2016 United States, Texas ... More >> Physicians at Sugar Creek - Memorial Family Medicine Residency Program Sugar Land, Texas, United States, 77478 Less <<
NCT01508975 Food Selection Not Applicable Completed - United States, Minnesota ... More >> Department of Food Science and Nutrition St. Paul, Minnesota, United States, 55108 Less <<
NCT01469312 Blood Glucose Concentration ... More >> Type 2 Diabetes Metabolic Syndrome Less << Not Applicable Completed - United States, Minnesota ... More >> Minneapolis VA Health Care System Minneapolis, Minnesota, United States, 55417 Less <<
NCT03504592 Gestational Diabetes ... More >> Pregestational Diabetes Less << Not Applicable Recruiting June 2019 United States, New York ... More >> UR Medicine Obstetrics and Gynecology Recruiting Rochester, New York, United States, 14620 Contact: Heather Link, MD/MPH    585-273-3608    Heather_Link@URMC.rochester.edu    Contact: Lisa Gray, MD    585-275-7408    Lisa_Gray@URMC.rochester.edu Less <<
NCT02763267 - Recruiting August 2021 United States, Massachusetts ... More >> Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02118 Contact: Camille E Powe, MD    617-643-9459    SPRING@partners.org    Contact: Katherine Brock, BS    617-643-9463    kbrock2@mgh.harvard.edu    Sub-Investigator: Camille E Powe, MD          Sub-Investigator: Marie-France Hivert, MD          Principal Investigator: Ravi I Thadhani, MD, MPH Less <<
NCT02498054 Diabetes Mellitus Not Applicable Completed - United Kingdom ... More >> NHS Lothian Edinburgh, United Kingdom, EH16 4SA Less <<
NCT00202033 Type 2 Diabetes Phase 4 Completed - United States, Minnesota ... More >> International Diabetes Center Minneapolis, Minnesota, United States, 55416 Less <<
NCT02033499 - Completed - -
NCT03457779 Triple Negative Breast Cancer Not Applicable Recruiting August 8, 2020 United States, Texas ... More >> Baylor University Medical Center Recruiting Dallas, Texas, United States, 75246 Contact: Brooke Murphy    214-818-8472    cancer.trials@bswhealth.org    Principal Investigator: Joyce O'Shaughnessy, MD Less <<
NCT00945659 Type 1 Diabetes Mellitus Not Applicable Completed - United States, Florida ... More >> Nemours Children's Clinic Jacksonville, Florida, United States, 32207 Less <<
NCT00945659 - Completed - -
NCT02011672 Glucose Regulation ... More >> Low-grade Inflammation Less << Not Applicable Completed - Netherlands ... More >> NIZO food research Ede, Netherlands Less <<
NCT03190148 Bariatric Surgery Candidate ... More >> Pregnancy Complications Pregnancy Related Glucose Metabolism Disorders Less << Not Applicable Completed - -
NCT01799512 Critical Illness Not Applicable Completed - Belgium ... More >> Middelheim General Hospital Antwerp, Belgium, 2020 Antwerp University Hospital Edegem, Belgium, 2650 Less <<
NCT02980588 Sepsis Hyperg... More >>lycemia Critical Illness Less << Not Applicable Unknown September 2017 -
NCT03730727 Diabetes Mellitus, Type 2 ... More >> Hyperglycemia, Postprandial Physical Activity Glucose Intolerance Less << Not Applicable Completed - United Kingdom ... More >> University of Birmingham Edgbaston, West Midlands, United Kingdom, B15 2TT Less <<
NCT01474889 Hypoglycemia Unawareness ... More >> Type 1 Diabetes Healthy Less << Not Applicable Recruiting June 2019 United States, Pennsylvania ... More >> Clinical and Translational Research Center, Hospital of University of Pennsylvania Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Ginger (Cornelia V) Dalton-Bakes    215-746-2085    cornelia.dalton-bakes@uphs.upenn.edu    Contact: Amy Peleckis    215-746-2084    amy.peleckis@uphs.upenn.edu    Principal Investigator: Michael R Rickels, M.D., M.S.          Rodebaugh Diabetes Center, University of Pennsylvania Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Ginger (Cornelia V) Bakes    215-746-2085    cornelia.dalton-bakes@uphs.upenn.edu    Contact: Amy Peleckis    215-746-2084    amy.peleckis@uphs.upenn.edu    Principal Investigator: Michael R. Rickels, M.D., M.S.          Sub-Investigator: Mark H. Schutta, M.D.          University of Pennsylvania - Institute for Diabetes, Obesity and Metabolism Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Ginger (Cornelia V) Bakes, CRC    215-746-2085    cornelia.dalton-bakes@uphs.upenn.edu    Contact: Amy Peleckis, NP    215 746-2084    amy.peleckis@uphs.upenn.edu    Principal Investigator: Michael R Rickels, MD., MS Less <<
NCT03215914 Type1diabetes ... More >> Hypoglycemia Unawareness Nocturnal Hypoglycemia Hypoglycemia Night Hypoglycemia Less << Not Applicable Recruiting December 31, 2022 United States, Pennsylvania ... More >> Clinical and Translational Research Center, Hospital of University of Pennsylvania Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Ginger (Cornelia V) Dalton-Bakes    215-746-2085    cornelia.dalton-bakes@uphs.upenn.edu    Contact: Amy Peleckis    215-746-2084    amy.peleckis@uphs.upenn.edu    Principal Investigator: Michael R Rickels, M.D., M.S.          Rodebaugh Diabetes Center, University of Pennsylvania Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Ginger (Cornelia V) Bakes    215-746-2085    cornelia.dalton-bakes@uphs.upenn.edu    Contact: Amy Peleckis    215-746-2084    amy.peleckis@uphs.upenn.edu    Principal Investigator: Michael R. Rickels, M.D., M.S.          Sub-Investigator: Mark H. Schutta, M.D.          University of Pennsylvania - Institute for Diabetes, Obesity and Metabolism Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Ginger (Cornelia V) Bakes, CRC    215-746-2085    cornelia.dalton-bakes@uphs.upenn.edu    Contact: Amy Peleckis, NP    215 746-2084    amy.peleckis@uphs.upenn.edu    Principal Investigator: Michael R Rickels, MD., MS Less <<
NCT01214824 - Completed - -
NCT02488278 Diabetes Mellitus, Type 1 ... More >> Diabetes Mellitus, Type 2 Less << Not Applicable Unknown October 2015 -
NCT01214824 Diabetes Mellitus Not Applicable Completed - United Kingdom ... More >> Ayr Hospital Ayr, Ayrshire, United Kingdom, KA6 6DX The Royal Liverpool University Hospital Liverpool, Cheshire, United Kingdom, L7 8XP University Hospital Aintree Liverpool, Cheshire, United Kingdom, L9 7AL Glan Clywd Hospital Rhyl, Denbighshire, United Kingdom, LL18 5UJ St. John's Hospital Livingston, Edinburgh, United Kingdom, EH54 6PP Less <<
NCT01845259 Impaired Glucose Tolerance Ass... More >>ociated With Drugs Less << Phase 2 Unknown March 2017 Denmark ... More >> Psychiatric Centre Rigshospitalet Copenhagen, København Ø, Denmark, 2100 Less <<
NCT03330184 Berberine Hydrochloride Phase 3 Completed - China, Shaanxi ... More >> First Affiliated Hospital of Xi'an Jiaotong University Xi'an,, Shaanxi, China, 710061 Second Affiliated Hospital of Xi'an Jiaotong University Xi'an, Shaanxi, China, 710004 Shaanxi Provincial People's Hospital Xi'an, Shaanxi, China, 710068 Less <<
NCT00240604 Glucose Intolerance Phase 3 Unknown October 2015 Israel ... More >> Hadassah Medical Organization Recruiting Jerusalem, Israel, 91120 Contact: Arik Tzukert, DMD    0097226776095    arik@hadassah.org.il    Contact: hadas Lemberg, PhD    0097226777572    lhadas@hadassah.org.il    Principal Investigator: Mordechai Muszkat, MD Less <<
NCT01390610 - Completed - United States, Minnesota ... More >> International Diabetes Center Minneapolis, Minnesota, United States, 55416 Less <<
NCT03378271 Diabetes Mellitus Complication... More >> Renal Impairment Less << Not Applicable Recruiting December 31, 2020 Sweden ... More >> NU-Hospital Group Recruiting Uddevalla, Sweden, 45180 Contact: Arndís Ólafsdóttir Less <<
NCT01123122 Diabetes Mellitus, Type 1 ... More >> Islet Transplantation Less << Not Applicable Withdrawn September 2015 Canada, British Columbia ... More >> Vancouver General Hospital Vancouver, British Columbia, Canada, V5Z 1M9 Less <<
NCT01060917 Diabetes Mellitus Phase 1 Phase 2 Completed - Germany ... More >> Profil Institut für Stoffwechselforschung GmbH Neuss, Germany, 41460 Less <<
NCT03085251 Diabetes Mellitus Not Applicable Completed - Germany ... More >> Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm Ulm, Baden-Württemberg, Germany, 89081 Less <<
NCT03037671 - Recruiting March 2019 United States, Colorado ... More >> Children's Hospital Colorado Recruiting Aurora, Colorado, United States, 80045 Contact: Deirdre Appelhans    720-777-4106    Deirdre.Appelhans@childrenscolorado.org    Principal Investigator: Jenna M Sopfe, MD Less <<
NCT01916694 Gestational Diabetes Mellitus ... More >> Pregnancy Less << Not Applicable Completed - United Kingdom ... More >> John Radcliffe Hospital Oxford, Oxfordshire, United Kingdom, OX3 9DU Less <<
NCT01497938 - Completed - -
NCT01427231 Mental Health ... More >> Cognition Memory Attention Less << Not Applicable Completed - Netherlands ... More >> Wageningen University Wageningen, Gelderland, Netherlands, 6703 HD Less <<
NCT01497938 Type 1 Diabetes Phase 3 Completed - United States, Arkansas ... More >> Arkansas Diabetes Clinic and Research Center Little Rock, Arkansas, United States, 72205 United States, California AMCR Institute, Inc Escondido, California, United States, 92026 Frank Diabetes Research Institute/ Mills-Peninsula Health Center San Mateo, California, United States, 94401 United States, Colorado University of Colorado Denver/ Barbara Davis Center for Childhood Diabetes Aurora, Colorado, United States, 80045 United States, Florida Metabolic Research Institute West Palm Beach, Florida, United States, 33401 United States, Georgia Atlanta Diabetes Associates Atlanta, Georgia, United States, 30309 Physicians Research Associates Lawrenceville, Georgia, United States, 30046 Endocrine Research Solutions Roswell, Georgia, United States, 30046 United States, Idaho Rocky Mountains Diabetes and Osteoporosis Center Idaho Falls, Idaho, United States, 83404 United States, Iowa Iowa Diabetes and Endocrinology Research Center Des Moines, Iowa, United States, 50314 United States, Minnesota International Diabetes Center Minneapolis, Minnesota, United States, 55416 United States, New York Naomie Barrie Diabetes Center New York, New York, United States, 10032 Joslin Diabetes Center Syracuse, New York, United States, 13210 United States, Ohio Ohio University College of Osteopathic Medicine Athens, Ohio, United States, 45701 United States, Texas Texas Diabetes Austin, Texas, United States, 78731 United States, Washington Rainier Clinical Research Center Renton, Washington, United States, 98057 United States, Wisconsin University of Wisconsin - Madison Madison, Wisconsin, United States, 53717 Less <<
NCT03427931 Islet Transplantation ... More >> Type1 Diabetes Mellitus Less << Not Applicable Recruiting December 31, 2018 United States, Virginia ... More >> University of Virginia Center for Diabetes Technology Recruiting Charlottesville, Virginia, United States, 22903 Contact: Sue A Brown, MD    434-982-0602    sab2f@virginia.edu    Contact: Matthew Kime, BS    434-924-5529    mak3mf@virginia.edu    Sub-Investigator: Jose Oberholzer, MD Less <<
NCT02293577 - Completed - United States, Connecticut ... More >> Yale Pediatric Diabetes Research Program New Haven, Connecticut, United States, 06511 Less <<
NCT03626155 Type 2 Diabetes Mellitus Not Applicable Recruiting January 1, 2020 Canada, Alberta ... More >> University of Alberta Recruiting Edmonton, Alberta, Canada, T6G 2E1 Contact: Normand Boule, PhD    7804924695    nboule@ualberta.ca    Contact: Matthew Munan, BSc    784928079    mmunan@ualberta.ca Less <<
NCT03056677 Metabolism Disorder, Glucose Not Applicable Completed - United Kingdom ... More >> University of Aberdeen, The Rowett Institute Aberdeen, United Kingdom, AB25 2ZD Less <<
NCT03012867 Hyperglycemia Stress Phase 4 Completed - Austria ... More >> Medical University of Vienna Vienna, Austria, 1090 Less <<
NCT00663000 - Completed - Germany ... More >> Dept. Internal Medicine, Div. Endocrinology, Charité Campus Mitte, University of Berlin Berlin, Germany, 10117 Endokrinologikum Dresden Dresden, Germany, 01069 Dept. Internal Medicine, Div. Endocrinology, University of Magdeburg Magdeburg, Germany, 39120 Dept. Internal Medicine, Endocrinology, Max Planck Institute for Neuroscience and Psychiatry München, Germany, 80804 Internistische/Endokrinologische Praxis Dr. Droste Oldenburg, Germany, 26122 Dept. Medicine IV Tuebingen, Germany, 72076 Less <<
NCT02981966 Diabetes Mellitus, Type 2 Phase 4 Not yet recruiting January 2021 United States, Texas ... More >> University of Texas Health Science Center San Antonio, Texas, United States, 78229 Less <<
NCT01705639 Diabetes Gluc... More >>ose Tolerance Less << Phase 3 Completed - Finland ... More >> Botniacentret Jakobstad Jakobstad, Finland, 68660 Vasa health care centre Vasa, Finland, 65200 Less <<
NCT01145547 Type 1 Diabetes Mellitus Not Applicable Completed - United States, Oregon ... More >> Legacy Health System--Holladay Park Campus Portland, Oregon, United States, 97232 Less <<
NCT01145547 - Completed - -
NCT00529815 Diabetes Mellitus Type 2 Phase 4 Unknown September 2010 United States, District of Col... More >>umbia Walter Reed Army Hospital Center Washington DC, District of Columbia, United States, 20307 Less <<
NCT03190980 Pain Not Applicable Recruiting June 2018 Lebanon ... More >> Makassed General Hospital Recruiting Beirut, Lebanon Contact: Amal Naous, MD    +9611636000 ext 6941    amalnaous@hotmail.com Less <<
NCT02300285 Hypoglycemia ... More >>Newborn Morbidity Less << Not Applicable Terminated(Insufficient eligib... More >>le participants to meet recruitment goal) Less << - United States, Massachusetts ... More >> Boston Children's Hospital Boston, Massachusetts, United States, 02115 Less <<
NCT03204461 - Completed - Austria ... More >> Medical University of Vienna Vienna, Austria, 1090 Less <<
NCT03343262 Impaired Glucose Tolerance Not Applicable Not yet recruiting December 31, 2020 -
NCT03607448 - Completed - United States, California ... More >> AMCR Escondido, California, United States, 92025 Sansum Diabetes Research Institute Santa Barbara, California, United States, 93105 Diablo Clinical Research Walnut Creek, California, United States, 94598 United States, Idaho Rocky Mountain Diabetes and Osteoporosis Center Idaho Falls, Idaho, United States, 94502 United States, Washington Rainier Clinical Research Center Renton, Washington, United States, 98057 Less <<
NCT01995994 - Completed - Korea, Republic of ... More >> Seoul National University Hospital Seoul, Korea, Republic of, 110-744 Less <<
NCT03141892 - Completed - United States, California ... More >> William Sansum Diabetes Center Santa Barbara, California, United States, 93105 Diablo Clinical Research Walnut Creek, California, United States, 94598 United States, Idaho Rocky Mountain Diabetes & Osteoporosis Center Idaho Falls, Idaho, United States, 83404 United States, Washington Rainier Clinical Research Center Renton, Washington, United States, 98057 Less <<
NCT02185755 Type 2 Diabetes Mellitus Not Applicable Active, not recruiting - Canada, British Columbia ... More >> Dr. Hugh Tildesley Inc. Vancouver, British Columbia, Canada, V6E1M7 Less <<
NCT02713412 Autonomic Nervous System Disea... More >>ses Baroreflex Failure Blood Pressure Hypotension Less << Not Applicable Completed - -
NCT02323542 Blood Glucose Kinetics Not Applicable Completed - Canada, Quebec ... More >> Institut de Recherches Cliniques de Montréal Montréal, Quebec, Canada, H2W1R7 Less <<
NCT03690232 Osteoarthritis, Knee Not Applicable Recruiting June 1, 2020 Taiwan ... More >> Taipei Veterans General Hospital Recruiting Taipei, Taiwan, 241 Contact: Jia chi c Wang, MD    886-2-28757361    jcwang0726@gmail.com Less <<
NCT01187329 Hyperglycemia ... More >> Aortic Valve Replacement Aortic Stenosis Cardiac Surgery Less << Not Applicable Completed - United States, Ohio ... More >> Cleveland Clinic Foundation Cleveland, Ohio, United States, 44195 Less <<
NCT02916576 Diabetes Not Applicable Completed - Germany ... More >> Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm Ulm, Germany, 89081 Less <<
NCT02591927 Myocardial Infarction Phase 3 Not yet recruiting - Switzerland ... More >> Centre Hospitalier Universitaire Vaudois - CHUV Not yet recruiting Lausanne, Vaud, Switzerland, 1011 Contact: PierGiorgio Masci, MD, PhD    79-556-48-63 ext +41    pgmasci@gmail.com Less <<
NCT01187329 - Completed - -
NCT02346149 Hyperglycemia ... More >> Glucose Intolerance Less << Phase 4 Unknown March 2018 Switzerland ... More >> Department of Nephrology, Centre Hospitalier Universitaire Vaudois Recruiting Lausanne, Vaud, Switzerland, 1011 Contact: Menno Pruijm, Dr    0041795565946    menno.pruijm@chuv.ch    Principal Investigator: Michel Burnier, Prof Less <<
NCT01136902 - Completed - Denmark ... More >> Copenhagen University Hospital at Glostrup Copenhagen, Denmark, DK-2600 Less <<
NCT03003936 Non-Diabetic Disorder of Endoc... More >>rine Pancreas Less << Not Applicable Completed - Spain ... More >> University of Murcia Murcia, Spain, 30100 Less <<
NCT01787214 Type-2 Diabetes Not Applicable Terminated(Funding withdrawn) - United States, California ... More >> Loma Linda University, Nichol Hall Loma Linda, California, United States, 92350 Less <<
NCT02292810 Diabetes Mellitus, Type 2 Not Applicable Unknown March 2016 -
NCT02747446 Healthy Not Applicable Completed - Switzerland ... More >> CHUV-clinical research center Lausanne, VD, Switzerland, CH-1011 Less <<
NCT01816997 Diabetes Phase 4 Recruiting December 2022 Taiwan ... More >> Taipei Veterans General Hospital Recruiting Taipei, Taiwan, 11217 Contact: Harn-Shen Chen, MD, PhD    886-2-28757515       Principal Investigator: Harn-Shen Chen, MD, PhD Less <<
NCT03570138 Insulin Treated Type 2 Diabete... More >>s With High Risk of Hypoglycemia Less << Not Applicable Not yet recruiting May 1, 2020 -
NCT01683929 Obesity Not Applicable Completed - Israel ... More >> Meir Medical Center Kfar Saba, Israel Meir Medical Center Kfar-Saba, Israel Less <<
NCT01468376 Impaired Glucose Tolerance Phase 1 Terminated(Sponsor company was... More >> acquired and new owner chose not to proceed with clinical study) Less << - United States, California ... More >> Staywell Research LLC Northridge, California, United States, 91325 Less <<
NCT01410773 - Completed - -
NCT01397279 Newly Diagnosed Type 2 Diabete... More >>s (During the Last 12 Months) Less << Not Applicable Unknown December 2012 Germany ... More >> German Diabetes Center Düsseldorf, Nordrhein-Westfalen, Germany, 40225 Less <<
NCT01410773 Diabetes Not Applicable Completed - United States, Indiana ... More >> Bayer HealthCare LLC, Diabetes Care Mishawaka, Indiana, United States, 46544 Less <<
NCT02041286 Diabetes Not Applicable Completed - United States, California ... More >> AMCR Institute Escondido, California, United States, 92026 United States, Washington Rainier Clinical Research Center Renton, Washington, United States, 98057 Less <<
NCT03193684 Hepatic Glucose Metabolism Phase 4 Recruiting January 31, 2023 United States, Texas ... More >> Diabetes Division, UTHSCSA Recruiting San Antonio, Texas, United States, 78229 Contact: Andrea Hansis-Diarte, MPH    210-617-5300 ext 17822    HansisDiarte@uthscsa.edu Less <<
NCT01016457 Diabetes Mellitus Phase 4 Unknown December 2009 Israel ... More >> Sheba Medical Center Recruiting Ramat Gan, Israel Contact: Kineret Mazor-Aronovitch       kineret@gmail.com Less <<
NCT01236885 Hyperglycemia ... More >> Malignant Neoplasm Less << Not Applicable Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States, 02114 United States, Washington Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT01614262 DIABETES MELLITUS, NONINSULIN-... More >>DEPENDENT, 2 (Disorder) Less << Not Applicable Completed - United States, Georgia ... More >> Atlanta Diabetes Assoicates Atlanta, Georgia, United States, 30309 United States, North Carolina University of North Carolina Chapel Hill, North Carolina, United States, 27599 Less <<
NCT00875290 Diabetes Mellitus, Type I Phase 3 Unknown November 2014 United States, Washington ... More >> Seattle Children's Hospital Recruiting Seattle, Washington, United States, 98105 Less <<
NCT01988987 - Recruiting July 2020 United States, New York ... More >> Winthrop-University Hospital Recruiting Mineola, New York, United States, 11501 Contact: Cheryl Dinglas, D.O.       cdinglas@winthrop.org    Contact: Jolene Muscat, M.D.       jmuscat@winthrop.org    Principal Investigator: Jolene Muscat, M.D.          Sub-Investigator: Cheryl Dinglas, D.O. Less <<
NCT00287807 Diabetes Mellitus, Type 2 Phase 3 Completed - Netherlands ... More >> Isala Clinics Zwolle, Netherlands, 8000 GM Less <<
NCT00906529 Type 2 Diabetes Phase 4 Unknown March 2011 United States, Texas ... More >> Parkland Memorial Hospital Recruiting Dallas, Texas, United States, 75235 Contact: Steve Fordan, MD    214-648-4562    steve.fordan@utsouthwestern.edu    Contact: Valeria Hart, PhD    214-590-8966    VHART@parknet.pmh.org    Principal Investigator: Steve Fordan, MD          Sub-Investigator: John Richard, MD          Sub-Investigator: Chanhaeng Rhee, MD          Principal Investigator: Philip Raskin, MD          Sub-Investigator: Alok Mohan, MD Less <<
NCT02953834 Impaired Glucose Tolerance ... More >> Hypogonadism Less << Phase 1 Recruiting December 2023 United States, Massachusetts ... More >> Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: Margaret Lippincott, MD    617-726-8434    mlippincott@partners.org    Principal Investigator: Margaret Lippincott, MD          Sub-Investigator: Stephanie Seminara, MD Less <<
NCT02322294 Glucose Parameters ... More >> Triglycerides Body Weight Less << Phase 2 Completed - Canada, Ontario ... More >> KGK Synergize Inc. London, Ontario, Canada, N6A 5R8 Less <<
NCT02653027 Diabetes Cyst... More >>ic Fibrosis Less << Not Applicable Withdrawn(We couldn't find any... More >> eligible subjects for the study because most of the study population had already started on the combination therapy.) Less << - -
NCT00820573 Diabetes Phase 4 Completed - United States, Texas ... More >> Texas Diabetes Institute San Antonio, Texas, United States, 78207 Less <<
NCT03766334 Type1 Diabetes Mellitus Not Applicable Enrolling by invitation December 31, 2019 China, Hubei ... More >> Tongji Hospital, Tongji Medical College, Huazhong University of Science and technology Wuhan, Hubei, China Less <<
NCT03665207 Critical Illness ... More >> Hyperglycemia Less << Phase 3 Recruiting September 2025 Belgium ... More >> Department of Intensive Care Medicine, University Hospital Antwerp Not yet recruiting Antwerp, Belgium, 2650 Contact: Philippe Jorens, MD, PhD    +32 3 8213635    Philippe.Jorens@uza.be    Principal Investigator: Philippe Jorens, MD, PhD          Department of Intensive Care Medicine, University Hospital Ghent Not yet recruiting Ghent, Belgium, 9000 Contact: Dominique Benoit, MD, PhD    +32 9 3322775    Dominique.Benoit@UGent.be    Principal Investigator: Dominique Benoit, MD, PhD          Sub-Investigator: Eric Hoste, MD, PhD          Sub-Investigator: Harlinde Peperstraete, MD          Sub-Investigator: Joris Vermassen, MD          Department of Intensive Care Medicine, Jessa Hospital Hasselt Not yet recruiting Hasselt, Belgium, 3500 Contact: Jasperina Dubois, MD    + 32 11 308971    jasperina.dubois@jessazh.be    Principal Investigator: Jasperina Dubois, MD          Department of Intensive Care Medicine, University Hospitals Leuven Recruiting Leuven, Belgium, 3000 Contact: Greet Van den Berghe, MD, PhD    +32 16 344021    greet.vandenberghe@kuleuven.be    Contact: Jan Gunst, MD, PhD    +32 16 344021    jan.gunst@kuleuven.be    Principal Investigator: Greet Van den Berghe, MD, PhD          Principal Investigator: Jan Gunst, MD, PhD          Medical Intensive Care Unit, University Hospitals Leuven Not yet recruiting Leuven, Belgium, 3000 Contact: Greet Hermans, MD, PhD    +32 16 344275    greet.hermans@uzleuven.be    Principal Investigator: Greet Hermans, MD, PhD          Sub-Investigator: Alexander Wilmer, MD, PhD Less <<
NCT02155374 Hyperglycemia Steroid-induced Phase 4 Completed - Netherlands ... More >> Slotervaart Hospital Amsterdam, Netherlands, 1066 EC Antoni van Leeuwenhoek hospital Amsterdam, Netherlands, 1066EC Isala Clinics Zwolle, Netherlands, 8025 AB Less <<
NCT02041286 - Completed - -
NCT01488916 - Unknown December 2012 Taiwan ... More >> Taipei Veterans General Hospital Recruiting Taipei, Taiwan, 112 Contact: Chii-Min Hwu, MD    8862287516    chhwu@vghtpe.gov.tw    Principal Investigator: Chii-Min Hwu, MD Less <<
NCT03540758 Type 2 Diabetes Mellitus ... More >> Glucose Metabolism Disorders Glucose, High Blood Less << Phase 2 Recruiting November 2021 United States, New York ... More >> Albert Einstein College of Medicine Recruiting Bronx, New York, United States, 10461 Contact: Matthew Zhao, B.S.    718-430-2903    matthew.zhao@einstein.yu.edu    Principal Investigator: Meredith Hawkins, M.D., M.S. Less <<
NCT00847899 Hypertension ... More >>Impaired Glucose Tolerance Less << Phase 2 Completed - -
NCT02211742 Fasting Glucose ... More >> Glucose Excursion Glycemic Control Less << Phase 4 Unknown November 2015 Austria ... More >> Medical University Innsbruck, Department of Internal Medicine I Recruiting Innsbruck, Tirol, Austria, 6020 Contact: Markus Laimer, PD MD    0043(0)512504 ext 81411    Markus.Laimer@uki.at    Contact: Christoph Ebenbichler, Prof MD    0043(0)512504 ext 81394    Christoh.Ebenbichler@i-med.ac.at    Principal Investigator: Markus Laimer, PD MD          Sub-Investigator: Christoph Ebenbichler, Prof MD          Sub-Investigator: Andreas Melmer, MD PhD          Sub-Investigator: Pavle Adamovski, MD Less <<
NCT03629704 - Not yet recruiting December 31, 2018 -
NCT03256747 Type2 Diabetes Mellitus Not Applicable Not yet recruiting August 2019 -
NCT00820573 - Completed - -
NCT01883453 Common Cold Phase 2 Completed - Sweden ... More >> Försvarshälsan Boden, Sweden Idrottsmedicin Umeå, Sweden Less <<
NCT00795015 Diabetes Phase 4 Completed - United States, Illinois ... More >> Rush University Medical Center Chicago, Illinois, United States, 60612 Less <<
NCT00569439 Labor Phase 2 Completed - -
NCT01824355 Diabetes Not Applicable Completed - United States, New Jersey ... More >> Consumer Product Testing Co. Fairfield, New Jersey, United States, 07004 Less <<
NCT01824355 - Completed - -
NCT01083433 Type 1 Diabetes Mellitus Not Applicable Completed - United States, Ohio ... More >> UHCMC Cleveland, Ohio, United States, 44106 Less <<
NCT02236598 Borderline Hypokalemia Phase 2 Completed - United States, North Carolina ... More >> Duke University Medical Center Durham, North Carolina, United States, 27710 Less <<
NCT02236598 - Completed - -
NCT01883453 - Completed - -
NCT02492945 Lateral Epicondylitis Phase 4 Completed - Korea, Republic of ... More >> Seoul National University Bundang Hospital SeongNam-Si, Gyeonggi-Do, Korea, Republic of, 463-707 Less <<
NCT03033849 Diabetes Mellitus Not Applicable Completed - Germany ... More >> Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm Ulm, Baden-Württemberg, Germany, 89081 Less <<
NCT00951639 Insulin Resistance ... More >> Impaired Glucose Tolerance Prediabetes Less << Not Applicable Completed - United States, Texas ... More >> Baylor University Department of Health, Human Performance, and Recreation Waco, Texas, United States, 76798 Less <<
NCT00476281 Cystic Fibrosis ... More >> Diabetes Less << Not Applicable Recruiting October 2023 France ... More >> Centre Robert Debré - CHU Angers Recruiting Angers, France Contact: GINIES Jean-Louis, MD    02 41 35 49 87    jlginies@chu-angers.fr    Contact: DUBOIS Séverine, MD       SeDubois@chu-angers.fr    Service d'Endocrinologie et Métabolisme - CHRU de Lille Recruiting Lille, France, 59037 Contact: Marie-christine VANTYGHEM-HAUDIQUET, MD       mc-vantyghem@chru-lille.fr    Contact: Anne PREVOTAT, MD       Anne.PREVOTAT@CHRU-LILLE.FR    Hôpital Laennec - CHU de Nantes Recruiting Nantes, France Contact: HALOUN Alain, MD    02 40 16 52 35    alain.haloun@chu-nantes.fr    Contact: CHAILLOUS Lucy, MD       lucy.chaillous@chu-nantes.fr    Service de Pédiatrie A - CHU de Reims Recruiting Reims, France Contact: ABELY Michel, MD    03 26 78 70 07    mabely@chu-reims.fr    Contact: RAVONINJATOVO Bruno, MD       bravoninjatovo@chu-reims.fr    CRCM Centre de Perharidy Recruiting Roscoff, France, 29684 Contact: RAULT Gilles, MD    02 98 29 39 39    gilles.rault@perharidy.fr    Contact: RAMEL Sophie, MD    02 98 29 39 39    sophie.ramel@perharidy.fr    Service d'Endocrinologie, Diabète et Maladies Métaboliques - Hôpital Civil Recruiting Strasbourg, France, 67091 Contact: Laurence KESSLER, MD    33 3 88 11 65 95    laurence.kessler@chru-strasbourg.fr    Principal Investigator: Laurence KESSLER, MD          Sub-Investigator: François MOREAU, MD          Service de Réanimation Médicale - Hôpital Civil Recruiting Strasbourg, France, 67091 Contact: Michel HASSELMANN, MD    33 3 88 11 50 41    michel.hasselmann@chru-strasbourg.fr    Service de Pneumologie - Hôpital de Hautepierre Recruiting Strasbourg, France, 67098 Contact: Romain KESSLER, MD    33 3 88 12 78 37    romain.kessler@chru-strasbourg.fr    Principal Investigator: Romain KESSLER, MD          Sub-Investigator: Vincent ROSNER, MD          Service de Pédiatrie II Recruiting Strasbourg, France, 67098 Contact: Laurence WEISS, MD    33 3 88 12 83 31    laurence.weiss@chru-strasbourg.fr    Principal Investigator: Laurence WEISS, MD Less <<
NCT03764423 Impaired Glucose Tolerance Not Applicable Recruiting June 30, 2019 Norway ... More >> University of Oslo Recruiting Oslo, Post Box 1046, Blindern, Norway, 0317 Contact: Kirsten Bjørklund Holven, Professor    +47 22851361    kirsten.holven@medisin.uio.no Less <<
NCT02477761 Diabetes Not Applicable Unknown September 2015 Italy ... More >> Azienda Ospedaliero-Universitaria Pisana Pisa, PI, Italy, 56127 Less <<
NCT01440842 Stress Hyperglycaemia Phase 2 Completed - United Kingdom ... More >> Cambridge University Hospitals NHS Foundation Trust, Addenbrookes Hospital Cambridge, Cambridgeshire, United Kingdom, CB2 0QQ Less <<
NCT01341587 Type 1 Diabetes ... More >> Type 2 Diabetes Less << Not Applicable Terminated(participants lost t... More >>o follow-up;) Less << - United States, Maryland ... More >> University of Maryland Baltimore, Maryland, United States, 21201 Less <<
NCT02774876 Type 1 Diabetes Phase 2 Completed - Canada, Quebec ... More >> Institut de recherches cliniques de Montréal Montreal, Quebec, Canada, H2W 1R7 Less <<
NCT01341587 - Terminated(participants lost t... More >>o follow-up;) Less << - -
NCT03769701 Gestational Diabetes Not Applicable Recruiting July 30, 2020 Mexico ... More >> National Institute of Perinatology Recruiting Mexico, Mexico, 11000 Contact: Enrique Reyes-Muñoz, MD    52 (55)55209900 ext 299    dr.enriquereyes@gmail.com    Contact: Carlos Orega-Gonzalez, MD    52 (55) 55209900 ext 307    ortegagonzalez@hotmail.com Less <<
NCT03461068 Ketones Dieta... More >>ry Supplements Less << Phase 1 Recruiting December 2018 Canada, British Columbia ... More >> University of British Columbia, Okanagan. Recruiting Kelowna, British Columbia, Canada, V1V 1V7 Contact: Jonathan P Little, PHD    +12508786893    jonathan.little@ubc.ca    Contact: Étienne Myette-Côté, MSC    250 807 9122    myettect@ualberta.ca Less <<
NCT02506296 Type 2 Diabetes Not Applicable Completed - United Kingdom ... More >> NIHR Exeter Clinical Research Facility Exeter, Devon, United Kingdom, EX1 2TD Less <<
NCT01508065 - Unknown - Israel ... More >> Hadassah Medical Organization Jerusalem, Israel, 91120 Hadassah Medical Organization Jerusalem, Israel Less <<
NCT03181191 Glucose Metabolism Disorders Not Applicable Recruiting December 31, 2018 Denmark ... More >> Center for Diabetes Research Recruiting Hellerup, Denmark, 2900 Contact: Mille Baekdal, MD    +45 26700782    mille.baekdal.nielsen@regionh.dk    Contact: Filip Knop, MD, PhD       filipknop@dadlnet.dk Less <<
NCT00813410 Type 1 Diabetes Not Applicable Completed - Austria ... More >> Medical University of Graz Graz, Styria, Austria, A-8036 Less <<
NCT02189694 Type 1 Diabetes Phase 2 Completed - Canada, Quebec ... More >> Institut de recherches cliniques de Montréal Montreal, Quebec, Canada, H2W 1R7 Less <<
NCT02762370 - Completed - -
NCT02762370 Osteoarthritis of the Knee ... More >> Type 2 Diabetes Mellitus Less << Phase 2 Completed - United States, California ... More >> Anaheim, California, United States, 92801 El Cajon, California, United States, 92020 North Hollywood, California, United States, 91606 United States, Pennsylvania Duncansville, Pennsylvania, United States, 16635 United States, South Carolina Mount Pleasant, South Carolina, United States, 29464 United States, Tennessee Knoxville, Tennessee, United States, 37938 United States, Texas Dallas, Texas, United States, 75231 San Antonio, Texas, United States, 78258 Less <<
NCT02684565 Prediabetic State Not Applicable Completed - United States, California ... More >> University of California, Los Angeles Los Angeles, California, United States, 90095 Less <<
NCT01674972 - Completed - Switzerland ... More >> University Hospital Basel, Division of Gastroenterology and Hepatology Basel, Switzerland Less <<
NCT00717977 Healthy Subjects Without Type ... More >>1 Diabetes Less << Phase 4 Completed - United States, California ... More >> Kaiser Permanente San Diego, California, United States, 92111 Stanford University Stanford, California, United States, 94305 United States, Colorado University of Colorado Aurora, Colorado, United States, 80045 United States, Connecticut Yale University School of Medicine New Haven, Connecticut, United States, 06520 United States, Florida Nemours Children's Clinic Jacksonville, Florida, United States, 32207 United States, Georgia Atlanta Diabetes Associates Atlanta, Georgia, United States, 30309 United States, Iowa Children's Hospital of Iowa Iowa City, Iowa, United States, 52242 United States, Massachusetts Joslin Diabetes Center - Adults Boston, Massachusetts, United States, 02215 Joslin Diabetes Center - Children Boston, Massachusetts, United States, 02215 United States, Washington University of Washington Seattle, Washington, United States, 98105 Less <<
NCT00717977 - Completed - -
NCT01475734 Diabetes Mellitus, Type 2 Phase 2 Completed - United States, California ... More >> GSK Investigational Site Chula Vista, California, United States, 91911 Less <<
NCT01475734 - Completed - -
NCT03072602 Healthy Natri... More >>uretic Peptides Metabolic Syndrome Less << Not Applicable Active, not recruiting December 2022 United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35294 Less <<
NCT01641653 Hernia Phase 4 Completed - United States, New Jersey ... More >> University Hospital Newark, New Jersey, United States, 07101 Less <<
NCT02589613 Exploratory Behavior Not Applicable Completed - -
NCT01641653 - Completed - -
NCT03731065 Exercise Not Applicable Recruiting June 30, 2019 United Kingdom ... More >> Department for Health, University of Bath Recruiting Bath, United Kingdom, BA2 7AY Contact: Javier T Gonzalez, PhD    +44 (0) 1225 38 ext 5125    j.t.gonzalez@bath.ac.uk Less <<
NCT02715934 Diabetes Mellitus Not Applicable Completed - United States, Pennsylvania ... More >> UPMC Community Medicine, Inc. Pittsburgh, Pennsylvania, United States, 15213 Less <<
NCT01805700 Type 1 Diabetes Not Applicable Completed - United Kingdom ... More >> The Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust Bournemouth, Dorset, United Kingdom, BH7 7DW Less <<
NCT01030341 Diabetic Gastroparesis Not Applicable Completed - United States, California ... More >> California Pacific Medical Center San Francisco, California, United States, 94115 Stanford University Stanford, California, United States, 94305-5187 United States, Michigan University of Michigan Medical Center Ann Arbor, Michigan, United States, 48109 United States, Mississippi University of Mississippi Medical Center Jackson, Mississippi, United States, 39216 United States, North Carolina Wake Forest University Health Sciences Winston-Salem, North Carolina, United States, 27157 United States, Pennsylvania Temple University Hospital Philadelphia, Pennsylvania, United States, 19140 United States, Texas Texas Tech University Health Sciences Center El Paso, Texas, United States, 79905 Less <<
NCT00996099 Hyperglycemia ... More >> Cardiac Surgery Less << Not Applicable Completed - Czech Republic ... More >> General University Hospital Prague, Czech Republic, 128 00 Less <<
NCT00444171 Cardiac Surgery Patients ... More >> Blood Glucose Less << Not Applicable Completed - Czech Republic ... More >> General University Hospital Praha, Czech Republic, 12808 Less <<
NCT02902224 Exploratory Behavior Not Applicable Completed - Switzerland ... More >> University Hospital Basel Basel, Switzerland Less <<
NCT01030341 - Completed - -
NCT00645827 - Completed - -
NCT00364377 Pre-diabetes Phase 4 Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT00364377 - Completed - -
NCT00645827 Glucose, Blood Not Applicable Completed - United States, Georgia ... More >> Emory Crawford Long Hospital Atlanta, Georgia, United States, 30308 Less <<
NCT00808054 Pain Phase 4 Completed - Brazil ... More >> Department of Neonatology of Julia Kubitschek Hospital Belo Horizonte, Minas Gerais, Brazil Less <<
NCT02075333 Self-control ... More >>Cognitive Performance Blood Glucose Response Less << Not Applicable Completed - United Kingdom ... More >> Human Appetite Research Unit (University of Leeds) Leeds, United Kingdom, LS29JT Less <<
NCT00811317 Type 1 Diabetes Not Applicable Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT02352298 - Completed - -
NCT00655460 Critically Ill ... More >> Hyperglycemia Less << Phase 2 Unknown December 2018 United States, Connecticut ... More >> Yale University Completed New Haven, Connecticut, United States, 05520 United States, Maryland Johns Hopkins University Recruiting Baltimore, Maryland, United States, 21205 Principal Investigator: Roy Brower, MD          United States, Massachusetts Massachusetts General Hospital Withdrawn Boston, Massachusetts, United States, 02114 Baystate Medical Center Active, not recruiting Springfield, Massachusetts, United States, 01199 United States, North Carolina Wake Forest Medical Center Recruiting Winston-Salem, North Carolina, United States, 27157 Principal Investigator: Robert D Hite, MD          United States, Pennsylvania Pennsylvania State Children's Hospital Completed Hersey, Pennsylvania, United States, 17033 Children's Hospital of Philadelphia Completed Philadelphia, Pennsylvania, United States, 19104 United States, Tennessee Vanderbilt University Completed Nashville, Tennessee, United States, 37232 United States, Utah LDS Hospital Recruiting Salt Lake City, Utah, United States, 84143 Principal Investigator: James Orme, MD          Primary Children's Hospital Completed Salt Lake City, Utah, United States, 84143 United States, Virginia University of Virginia Active, not recruiting Charlottesville, Virginia, United States, 22908 Less <<
NCT01789021 Diabetes Not Applicable Completed - Germany ... More >> Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm Ulm, Germany, 89081 Less <<
NCT02282397 Diabetes Mellitus Not Applicable Completed - -
NCT00811317 - Completed - -
NCT02352298 Diabetes Not Applicable Completed - United States, Colorado ... More >> Barbara Davis Center Aurora, Colorado, United States, 80045 Less <<
NCT01737164 Glucose Metabolism Disorders ... More >> Lipid Metabolism Disorders Metabolic Diseases Less << Not Applicable Completed - United States, Texas ... More >> Texas Diabetes Insitute San Antonio, Texas, United States, 78207 Less <<
NCT03104686 Dietary Modification Not Applicable Completed - Italy ... More >> Department of Food Science, University of Parma Parma, Italy, 43125 Less <<
NCT01894659 Neonatal Procedural Pain Not Applicable Active, not recruiting June 2019 United States, California ... More >> Loma Linda University Medical Center Loma Linda, California, United States, 92354 Less <<
NCT01964703 Prediabetes (Impaired Fasting ... More >>Glucose and/or Impaired Glucose Tolerance) Less << Phase 4 Completed - -
NCT01883024 Type 1 Diabetes Not Applicable Completed - France ... More >> Service d'Endocrinologie-Diabétologie - CHU de Rennes - Hôpital Sud Rennes, France, 35230 Less <<
NCT03098017 Dietary Modification Not Applicable Completed - Italy ... More >> Department of Food Science, University of Parma Parma, Italy, 43125 Less <<
NCT03575000 Schizophrenia ... More >> Glucose Intolerance Less << Phase 4 Not yet recruiting December 1, 2019 -
NCT02235194 Type 2 Diabetes, ... More >> Prediabetes Less << Not Applicable Completed - Germany ... More >> Stoffwechselzentrum Rhein Pfalz Mannheim, Germany, 68163 Less <<
NCT00974831 Overweight Phase 2 Completed - United States, Texas ... More >> University of Texas Austin, Texas, United States, 78712 Less <<
NCT00306826 Glucose Metabolism Disorders Phase 4 Withdrawn(financial support wi... More >>thdrawn) Less << - Germany ... More >> Praxis Antje Horn Gera, Germany, 07548 Praxis Gunter Kässner Leipzig, Germany, 04229 Praxis Heidrun Täschner Leipzig, Germany, 04249 Praxis Martin Schönauer Leipzig, Germany, 04275 University of Leipzig Heart Center Leipzig, Germany, 04289 Praxis Matthias Weissbrodt Leipzig, Germany, 04299 Praxis Matthias Schreiner Leipzig, Germany, 04357 Less <<
NCT02552823 Post-prandial Glucose Response Not Applicable Active, not recruiting March 2019 Canada, Manitoba ... More >> I. H. Asper Clinical Research Institute Winnipeg, Manitoba, Canada, R2H 2A6 Less <<
NCT01300260 - Completed - -
NCT03703544 Diabetes Not Applicable Active, not recruiting January 30, 2019 Singapore ... More >> Clinical Nutrition Research Centre Singapore, Singapore, 117599 Less <<
NCT02022007 Polycystic Ovary Syndrome ... More >> Disorder of Glucose Regulation Less << Phase 3 Completed - United States, Louisiana ... More >> Woman's Hospital Baton Rouge, Louisiana, United States, 70817 Less <<
NCT01300260 Diabetes Mellitus, Type 2 Phase 1 Completed - Germany ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Neuss, Germany, D-41460 Less <<
NCT01328717 Diabetes Not Applicable Completed - United States, Indiana ... More >> Bayer HealthCare LLC, Diabetes Care Mishawaka, Indiana, United States, 46544 Less <<
NCT02022007 - Completed - -
NCT01328717 - Completed - -
NCT01466075 Diabetes Not Applicable Completed - United States, Indiana ... More >> Bayer HealthCare LLC, Diabetes Care Mishawaka, Indiana, United States, 46544 Less <<
NCT01466075 - Completed - -
NCT02064647 Diabetes Mellitus, Type 1 Not Applicable Completed - Canada, Ontario ... More >> Children's Hospital of Eastern Ontario Ottawa, Ontario, Canada, K1H 8L1 Less <<
NCT00796848 Diabetes Mellitus Not Applicable Withdrawn(withdrawn because th... More >>e research efforts at that time followed another path) Less << March 2010 United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT03369899 - Completed - United States, California ... More >> Sansum Diabetes Research Institute Santa Barbara, California, United States, 93105 Less <<
NCT01429467 Type 1 Diabetes Not Applicable Completed - United Kingdom ... More >> University Of Dundee Dundee, Angus, United Kingdom, DD1 9SY Less <<
NCT01402011 Rotator Cuff Tendinitis Not Applicable Completed - Canada, British Columbia ... More >> Dr. Helene Bertrand Inc., 220-1940 Lonsdale Avenue North Vancouver, British Columbia, Canada, V7M 2K2 Active shoulder clinics, West Vancouver sports and orthopedic physiotherapy, 210- 575 16th Street West Vancouver, British Columbia, Canada, V7V 4Y1 Less <<
NCT01402011 - Completed - -
NCT02971202 Type 1 Diabetes Mellitus ... More >> Maturity-Onset Diabetes of the Young, Type 2 MODY2 Insulin Resistance Less << Phase 1 Recruiting June 2019 United States, Tennessee ... More >> Vanderbilt University Medical Center Recruiting Nashville, Tennessee, United States, 37232 Contact: Justin M Gregory, M.D.    615-322-7427    metabolism@vumc.org Less <<
NCT02005224 Insulin Sensitivity ... More >> Weight Less << Not Applicable Completed - Norway ... More >> Norwegian School of Sport Sciences Oslo, Norway, 0806 Less <<
NCT01409993 - Terminated(Aim 1 was stopped b... More >>y DSMB. Aim 2 was stopped due to ending of funding.) Less << - -
NCT01409993 Impaired Glucose Tolerance Phase 4 Terminated(Aim 1 was stopped b... More >>y DSMB. Aim 2 was stopped due to ending of funding.) Less << - United States, Tennessee ... More >> Vanderbilt University Nashville, Tennessee, United States, 37232 Less <<
NCT02590081 End-Stage Kidney Disease ... More >> Hemodialysis Less << Phase 4 Unknown - Malaysia ... More >> Hospital Sultanah Bahiyah, Alor Setar Not yet recruiting Alor Setar, Kedah, Malaysia, 05460 Contact: Chen Hua Ching, MRCP    +60-04-7496898    nchching@yahoo.com    Hospital Tuanku Jaafar Not yet recruiting Seremban, Negeri Sembilan, Malaysia, 70300 Contact: Lily Mushahar, M.Med    +60 6-7684000    lilymushahar@hotmail.com    Hospital Tengku Ampuan Afzan Not yet recruiting Kuantan, Pahang, Malaysia, 25100 Contact: Mohd Ramli Seman, M.Med    +60-09-5572222    mohdramliseman9@gmail.com    Hospital Balik Pulau Not yet recruiting Balik Pulau, Penang, Malaysia, 11000 Contact: Loke Meng Ong          Hospital Bukit Mertajam Not yet recruiting Bukit Mertajam, Penang, Malaysia, 14000 Contact: Anita Bhajan          Penang Hospital Not yet recruiting George Town, Penang, Malaysia, 10990 Contact: Ong Loke Meng, FRCS    00 604 2225333 ext 5767    onglokemeng@gmail.com    Hospital Kepala Batas Not yet recruiting Kepala Batas, Penang, Malaysia, 13200 Contact: Anita Bhajan          Seberang Jaya Hospital Not yet recruiting Seberang Jaya, Penang, Malaysia, 13700 Contact: Anita Bhajan    +60-04-3827496    abmanocha1518@gmail.com    Hospital Sungai Bakap Not yet recruiting Sungai Bakap, Penang, Malaysia, 14200 Contact: Anita Bhajan          Miri Hospital Not yet recruiting Miri, Sarawak, Malaysia, 98000 Contact: Keng Hee Koh, MRCP(UK)    +60-85-420033    kohkenghee@yahoo.com    Selayang Hospital Not yet recruiting Selayang, Selangor, Malaysia, 68100 Contact: Hin Seng Wong, FRCP    +60-03-61367788    hinseng@gmail.com    Hospital Serdang Not yet recruiting Serdang, Selangor, Malaysia, 43400 Contact: Bak Leong Goh, FRCP    +60-03-89475555    bak.leong@gmail.com    UKM Medical Centre Not yet recruiting Cheras, Wilayah persekutuan Kuala lumpur, Malaysia, 56000 Contact: Abdul Halim Abdul Gafor, M.Med    +60-03-91456074    halimgafor@gmail.com    Hospital Kuala Lumpur Not yet recruiting Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia, 50586 Contact: Ghazali Ahmad Kutty, M.Med    +60-03-26155380    ghazaliahmad@moh.gov.my    UM Medical Centre Not yet recruiting Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia, 59100 Contact: Soo Kun Lim    +60-0379492497    sookun_73@yahoo.com Less <<
NCT02176096 Glycogen Storage Disorder Type... More >> 1 Hypoglycemia Cornstarch Glycosade Less << Not Applicable Completed - Canada, Manitoba ... More >> Chrildren's Hospital Research Institute of Manitoba Winnipeg, Manitoba, Canada, R3E 3P4 Less <<
NCT00920881 - Completed - United States, California ... More >> Diablo Clinical Research Walnut Creek, California, United States, 94598 United States, Texas Diabetes & Glandular Disease Clinic San Antonio, Texas, United States, 78229 United States, Washington Ranier Clinical Research Renton, Washington, United States, 98055 Less <<
NCT02150109 Diabetes Not Applicable Completed - United States, California ... More >> AMCR Institute Escondido, California, United States, 92026 United States, Washington Rainier Clinical Research Center Renton, Washington, United States, 98057 Less <<
NCT02748434 Diabetes Mellitus ... More >> Lipohypertrophy Less << Not Applicable Recruiting December 2018 Canada, British Columbia ... More >> Gerontology Research Lab Recruiting Vancouver, British Columbia, Canada, V5Z 1M9 Contact: Boris Feldman    604-875-5115    boris.feldman@vch.ca    Principal Investigator: Graydon S Meneilly, MD          Vancouver General Hospital Diabetes Centre Recruiting Vancouver, British Columbia, Canada, V5Z 1M9 Contact: Boris Feldman    604-875-5115    boris.feldman@vch.ca    Principal Investigator: Graydon S Meneilly, MD Less <<
NCT02150109 - Completed - -
NCT01526044 Hyperglycaemia ... More >> Hypoglycaemia Less << Not Applicable Completed - Netherlands ... More >> Onze Lieve Vrouwe Gasthuis Amsterdam, Netherlands Less <<
NCT02583061 - Recruiting January 2025 Canada, Ontario ... More >> Mount Sinai Hospital Recruiting Toronto, Ontario, Canada, M5G1X5 Contact: Ravi Retnakaran, MD    416-586-4800 ext 3941    rretnakaran@mtsinai.on.ca Less <<
NCT01754792 Type 2 Diabetes ... More >> Impaired Glucose Tolerance Healthy Less << Not Applicable Completed - Spain ... More >> University Hospital Dr Peset Valencia, Spain, 46017 Less <<
NCT03201952 Glucose Intolerance ... More >> Gastric Bypass Surgery Less << Phase 1 Recruiting July 1, 2019 United States, Tennessee ... More >> Vanderbilt University Medical Center Recruiting Nashville, Tennessee, United States, 37232 Contact: Michael Dole, MD    864-616-1389    michael.dole@vanderbilt.edu Less <<
NCT02491346 Hyperglycemia ... More >> Respiratory Failure Critical Illness Less << Phase 4 Unknown September 2015 China, Beijing ... More >> MICU of Peking Union Medical College Hospital Recruiting Beijing, Beijing, China, 100730 Contact: Bin Du, Dr    86-010-69155046    dubin98@gmail.com    Principal Investigator: Bin Du, Doctor Less <<
NCT01048268 Diabetes Mellitus Phase 1 Phase 2 Completed - Denmark ... More >> Department of Internal Medicine F' laboratory Hellerup, Copenhagen County, Denmark, 2900 Less <<
NCT01107431 Pre-diabetes Not Applicable Completed - United States, Texas ... More >> Integrative Health Technologies San Antonio, Texas, United States, 78209 Less <<
NCT02357043 Diabetes Not Applicable Unknown February 2015 United States, Ohio ... More >> Remington-Davis, Inc. Recruiting Columbus, Ohio, United States, 43215 Contact: Hamish Baird    614-487-2560 Less <<
NCT01720381 - Completed - Belgium ... More >> Erasme University Hospital Brussels, Belgium Less <<
NCT03008239 Diabetes Mellitus Not Applicable Recruiting January 2019 Hong Kong ... More >> The Chinese University of Hong Kong Recruiting Sha Tin, Hong Kong Contact: Elaine Chow, Dr.    852 2632 1548    e.chow@cuhk.edu.hk Less <<
NCT03181217 Healthy Not Applicable Completed - Netherlands ... More >> Leids Universitair Medisch Centrum Leiden, Zuid-Holland, Netherlands Less <<
NCT00718575 Liver Transplantation Phase 3 Terminated(too few patients me... More >>eting current eligibility criteria) Less << - Canada, Ontario ... More >> University Health Network (Toronto General Hospital) Toronto, Ontario, Canada, M5G 2N2 Less <<
NCT00998374 - Completed - United States, New York ... More >> Lenox Hill Hospital 186 E76th Street, 1st Floor New York City, New York, United States, 10021 Less <<
NCT00843609 Diabetes Mellitus, Type 1 ... More >> Hypoglycemia Less << Not Applicable Completed - Israel ... More >> Schneider Children's Medical Center of Israel Petah Tikva, Israel, 49202 Slovenia UMC Ljubljana - University Children's Hospital Ljubljana, Slovenia, 1000 Sweden Karolinska Institutet Stockholm, Sweden Less <<
NCT02953587 Obesity Phase 1 Active, not recruiting September 2019 United States, Tennessee ... More >> Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232 Less <<
NCT00998374 - Completed - -
NCT02298803 Diabetes Related Complications Not Applicable Completed - -
NCT02166359 End Stage Renal Disease Not Applicable Recruiting December 2020 Korea, Republic of ... More >> Dong-A University Hospital Recruiting Busan, Korea, Republic of Less <<
NCT00740012 Stress Type 1... More >> Diabetes Less << Not Applicable Completed - Germany ... More >> Diabeteszentrum Bad Lauterberg im Harz Bad Lauterberg, Lower Saxony, Germany, 37431 Less <<
NCT01219231 Impaired Glucose Tolerance Phase 4 Completed - Germany ... More >> Department of Neurology, Charité Universitätsmedizin Berlin, Germany Less <<
NCT03152682 Healthy Phase 1 Completed - Canada, Ontario ... More >> KGK Synergize Inc. London, Ontario, Canada, N6A 5R8 Less <<
NCT01121354 Infection Phase 1 Completed - United States, Maryland ... More >> PAREXEL Early Phase Clinical Unit Baltimore, Maryland, United States, 21225 Less <<
NCT03207269 Type 2 Diabetes Mellitus Not Applicable Completed - Canada, British Columbia ... More >> University of British Columbia, Okanagan. Kelowna, British Columbia, Canada, V1V 1V7 Less <<
NCT01390636 - Terminated(The study was a col... More >>laboration that could not be effectively run.) Less << - United States, Minnesota ... More >> Melrose Institute Minneapolis, Minnesota, United States, 55416 Less <<
NCT01470885 - Completed - China, Shanghai ... More >> Xiaolong Zhao Shanghai, Shanghai, China, 21012 Less <<
NCT02298803 - Completed - -
NCT03424044 Type1diabetes Phase 1 Recruiting June 30, 2019 United States, Oregon ... More >> Oregon Health and Science University Recruiting Portland, Oregon, United States, 97239 Contact: Deborah Branigan, BA CCRP    503-418-9070    branigad@ohsu.edu    Contact: Jessica Castle, MD    503-494-7072    castleje@ohsu.edu    Principal Investigator: Peter Jacobs, PhD          Principal Investigator: Jessica Castle, MD          Sub-Investigator: Kathryn Hanavan, RN MSN ANP-BC BC-ADM          Sub-Investigator: Joseph El Youssef, MBBS          Sub-Investigator: Leah Wilson, MD          Sub-Investigator: Roula Zahr, MD Less <<
NCT00921882 - Completed - Canada, Quebec ... More >> Centre hospitalier universitaire de Sherbrooke Sherbrooke, Quebec, Canada, J1H 5N4 Less <<
NCT03550963 Gestational Diabetes Mellitus ... More >>in Pregnancy Less << Not Applicable Not yet recruiting February 23, 2019 -
NCT03700164 Hyperglycemia Not Applicable Not yet recruiting December 2019 -
NCT00733148 - Completed - Austria ... More >> Medical University Graz Graz, Styria, Austria, A8036 Less <<
NCT00965406 Acute Coronary Syndrome Phase 3 Completed - Tunisia ... More >> Mahdia University Hospital Monastir, Mahdia, Tunisia Monastir University Hospital Monastir, Tunisia, 5000 Sahloul University Hospital Sousse, Tunisia Less <<
NCT02488616 Type 1 Diabetes Phase 2 Withdrawn(Medtronic support te... More >>rminated) Less << November 2018 Canada, Quebec ... More >> Institut de recherches cliniques de Montréal Montreal, Quebec, Canada, H2W 1R7 Less <<
NCT00674986 Diabetes Mellitus, Type 2 Not Applicable Completed - -
NCT03660332 Postprandial Glucose Homeostas... More >>is Less << Not Applicable Completed - Denmark ... More >> Rigshospitalet, Centre of Inflammation and Metabolism (CIM) Centre for Physical Activity Research (CFAS) Copenhagen, Denmark, 2100 Less <<
NCT01795625 - Completed - China ... More >> Shanghai First People's Hospital Shanghai, China Shanghai Jiaotong University, medical school affiliated Third People's Hospital Shanghai, China Less <<
NCT01334658 Cataract Not Applicable Completed - -
NCT00108615 Glucose Metabolism Disorders ... More >> Diabetes Less << Phase 4 Completed - United States, Arkansas ... More >> Central Arkansas Veterans HCS Little Rock, Arkansas, United States, 72205 Less <<
NCT03714594 Glucose, Low Blood Phase 2 Recruiting September 2021 Italy ... More >> Department of Endocrinology and Metabolism, University of Pisa Recruiting Pisa, Italy, 56124 Contact: Stefano Del Prato, MD    +39 050 995103    stefano.delprato@med.unipi.it    Sub-Investigator: Giuseppe Daniele, MD Less <<
NCT02726256 - Not yet recruiting February 2026 -
NCT02006459 - Completed - Denmark ... More >> Diabetes Research Division, University Hospital Gentofte Hellerup, Denmark, 2900 Less <<
NCT01293422 Glucose Metabolism Phase 4 Completed - Finland ... More >> Oulu University Hospital Oulu, Finland, 90029 Less <<
NCT00625781 Impaired Glucose Tolerance ... More >> Fetal Macrosomia Less << Not Applicable Completed - Sweden ... More >> University Hospital Örebro Örebro, Sweden, 70185 Less <<
NCT01227148 Critically Ill Patients Phase 3 Completed - Taiwan ... More >> Kaohsiung Veterans General Hospital Kaohsiung, Taiwan, 813 Less <<
NCT00674986 - Completed - -
NCT03066323 Healthy Not Applicable Completed - Ireland ... More >> Atlantia Food Clinical Trials Cork, Ireland, T12 H2TK Less <<
NCT02105324 Type 1 Diabetes Not Applicable Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT00701051 Type 2 Diabetes Mellitus ... More >> Impaired Glucose Tolerance (Prediabetes) Less << Not Applicable Completed - United States, Maryland ... More >> VA Maryland Health Care System, Baltimore Baltimore, Maryland, United States, 21201 Less <<
NCT01496820 Impaired Fasting Glucose, Newl... More >>y-diagnosed Type 2 Diabetes Less << Phase 2 Phase 3 Completed - Korea, Republic of ... More >> Yonsei University Seoul, Korea, Republic of, 120-749 Less <<
NCT00701051 - Completed - -
NCT03577158 Diabetes Mellitus, Type 1 Not Applicable Recruiting May 31, 2019 Spain ... More >> Hospital Clínic de Barcelona Recruiting Barcelona, Catalonia, Spain, 08036 Contact: Ignacio Conget Donlo, MD    932279846    iconget@clinic.cat    Principal Investigator: Marga Giménez Álvarez, MD          Sub-Investigator: Clara Viñals Domenech, MD Less <<
NCT01873066 Diabetes Mellitus ... More >> Diabetes Mellitus, Type 1 Glucose Metabolism Disorders Endocrine System Diseases Less << Not Applicable Completed - United Kingdom ... More >> University of Cambridge Cambridge, United Kingdom, CB2 0QQ Less <<
NCT02105324 - Completed - -
NCT02671968 Diabetes Not Applicable Completed - Germany ... More >> Gemeinschaftspraxis Dres. Klausmann Aschaffenburg, Germany m&i-Fachklinik Bad Heilbrunn Bad Heilbrunn, Germany Forschungsinstitut Diabetes-Akademie Bad Mergentheim (FIDAM) Bad Mergentheim, Germany Diabetologische Schwerpunktpraxis Bergheim, Germany Medicover Berlin-Mitte Berlin, Germany Diabetologikum Duisburg Duisburg, Germany Diabetes Praxis Essen Essen, Germany Diabetologische Schwerpunktpraxis mit Fußambulanz Essen, Germany Zentrum für Diabetologie Bergedorf Hamburg, Germany Gemeinschaftspraxis Dres. Kaltheuner Leverkusen, Germany Diabetes Schwerpunkt Praxis Zentrum für Hormone und Stoffwechsel Marktredwitz, Germany, 95615 Schwerpunktpraxis für Diabetes und Ernährungsmedizin Münster, Germany, 48153 Less <<
NCT03702465 Pre Diabetes Not Applicable Recruiting March 2020 United Kingdom ... More >> Imperial Clinical Research Facility Recruiting London, United Kingdom, W12 0HS Contact: Karen Mosley, PhD    +44 (0)20 3313 8073    Karen.Mosley@imperial.nhs.uk    Contact: Suzanne Fagerbrink    020 3313 8077    Susanne.Fagerbrink@imperial.nhs.uk    Principal Investigator: Nick Oliver, M. D. Less <<
NCT02065271 Glucose Tolerance ... More >> Lipid Homeostasis Vascular Function Inflammation Less << Not Applicable Completed - Netherlands ... More >> Wageningen university Wageningen, Gelderland, Netherlands, 6703 HD Less <<
NCT01762059 Type 1 Diabetes Not Applicable Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT01762059 - Completed - -
NCT03159546 - Completed - United States, California ... More >> William Sansum Diabetes Center Santa Barbara, California, United States, 93105 Diablo Clinical Research Walnut Creek, California, United States, 94598 United States, Idaho Rocky Mountain Diabetes & Osteoporosis Center Idaho Falls, Idaho, United States, 83404 United States, Washington Rainier Clinical Research Center Renton, Washington, United States, 98057 Less <<
NCT01471509 Type 2 Diabetes ... More >> Metabolic Syndrome Less << Not Applicable Suspended(Lack of funding) November 6, 2017 United States, Minnesota ... More >> Minneapolis VA Health Care System Minneapolis, Minnesota, United States, 55417 Less <<
NCT01359241 Dysglycaemia Not Applicable Completed - United Kingdom ... More >> Wellcome Trust Clinical Research Facility, Addenbrooke's Hospital Cambridge, United Kingdom, CB20QQ Less <<
NCT03252964 Type2 Diabetes Not Applicable Active, not recruiting February 2028 United States, Nevada ... More >> Rogelio Machuca, MD Family Medicine, PLLC Las Vegas, Nevada, United States, 89104 Less <<
NCT03730480 Diabetes Mellitus Phase 3 Recruiting October 31, 2018 United States, California ... More >> AMCR Institute Recruiting Escondido, California, United States, 92025 Contact: Timothy Bailey, MD    760-466-1530    tbailey@amcrinsitiute.com    United States, Washington Ranier Clinical Research Center, Inc. Recruiting Renton, Washington, United States, 98057 Contact: Leslie J Klaff, MD    425-251-1720    ljklaff@ranier-research.com Less <<
NCT03175315 Diabetes Mellitus Not Applicable Completed - Germany ... More >> Diabetes und Stoffwechselpraxis Wetter Wetter, Germany, 58300 Less <<
NCT01440790 Cardiovascular Disease ... More >> Diabetes Less << Not Applicable Completed - -
NCT03290768 Type2 Diabetes Not Applicable Active, not recruiting December 2027 United States, Nevada ... More >> Southwest Medical Associates Las Vegas, Nevada, United States, 89102 Less <<
NCT03092310 Type 1 Diabetes Mellitus Not Applicable Completed - United States, California ... More >> William Sansum Diabetes Center Santa Barbara, California, United States, 93105 Less <<
NCT03239288 Healthy Not Applicable Completed - United States, Illinois ... More >> Biofortis Clinical Research Addison, Illinois, United States, 60101 Less <<
NCT01889576 Glucose Metabolism After Trans... More >>plantation Less << Not Applicable Completed - Belgium ... More >> Ghent University Hospital Ghent, Belgium, 9000 Less <<
NCT02676609 Type 1 Diabetes Not Applicable Completed - France ... More >> Hôpital Lapeyronie Montpellier, Hérault, France, 34000 Less <<
NCT02013583 - Recruiting December 2022 United States, Texas ... More >> UT Southwestern Medical Center Recruiting Dallas, Texas, United States, 75390 Less <<
NCT00688363 Type 2 Diabetes Phase 4 Completed - Germany ... More >> Diabeteszentrum Bad Lauterberg Bad Lauterberg, Niedersachsen, Germany, D-37431 Koch, Peter Bad Harzburg, Germany, 38667 Maxeiner, Stefan Bad Kreuznach, Germany, 55545 Friedrichs, Michael Bad Lauterberg, Germany, 37431 Jödicke, Carmen Bad Lauterberg, Germany, 37431 Mulch-Wiemer, Christa Bad Nauheim, Germany, 61231 Bellmann, Renate Berlin, Germany, 10365 Schoch, Daniela Berlin, Germany, 13055 Warmers, Ulrike Bitburg, Germany, 54634 Leupold, Manfred Borna, Germany, 04552 Kamke, Wolfram Burg/Sreewald, Germany, 03096 Hildebrandt, Rüdiger Clausthal-Zellerfeld, Germany, 38678 Lemmerhirt, Jürgen Cuxhaven, Germany, 27474 Preuß, Uwe Datteln, Germany, 45711 Weller, Ulrich Dorsten, Germany, 46282 Fischer, Harald Düren, Germany, 52351 Krege, Peter Emsdetten, Germany, 48282 Gölz, Stefan Esslingen, Germany, 73728 Wollersen, Karin Freiburg, Germany, 79106 Hendel, Andreas Grassau, Germany, 83224 Pfeiffer, Martha Gronau, Germany, 48559 Jäger, Michael Höchst, Germany, 64739 Müller, Ulrich. A. Jena, Germany, 07740 Niemetz, Ingo Kassel, Germany, 34117 Schmitz, Ulrike Krefeld, Germany, 47805 Kourbanova, Zarema Langenfeld, Germany, 40764 Willms, Gerhard Leverkusen, Germany, 51373 Ley, Heinz-Georg Marl, Germany, 45770 Grossmann, J. Mönchengladbach, Germany, 41061 Füchtenbusch, Martin München, Germany, 80804 Fueting, Frank Nassau, Germany, 56377 Behnke, Thomas Neuwied, Germany, 56564 Böhme, Rainer Nordhausen, Germany, 99734 Fels, Stefan Oldenburg, Germany, 28131 Klein, Frank Schenklengsfeld, Germany, 36277 Naumann, Rainer Schöppenstedt, Germany, 38170 Rieth-Kunert, Anna Stade, Germany, 21684 Nowack, Kirsten Torgau, Germany, 04860 Schmidt-Reinwald, Astrid Waldrach, Germany, 54320 Bödecker, A.-W. Wiehl, Germany, 51674 Oerter, Erika-Maria Würzburg, Germany, 97084 Less <<
NCT01504620 Diabetes Mellitus Phase 4 Completed - Germany ... More >> IKFE - Institute for Clinical Research and Development Mainz, Germany, 55116 Less <<
NCT02846831 Type 1 Diabetes Phase 2 Not yet recruiting December 2018 -
NCT02129868 Diabetes Mellitus ... More >> Diabetes Mellitus, Type 1 Glucose Metabolism Disorders Endocrine System Diseases Autoimmune Diseases Less << Not Applicable Completed - United Kingdom ... More >> University of Cambridge Cambridge, United Kingdom, CB2 0QQ Less <<
NCT01803451 Post-bariatric Surgery Early Phase 1 Recruiting December 2020 United States, Texas ... More >> South Texas Veterans Health Care System Recruiting San Antonio, Texas, United States, 78229 Contact: Marzieh Salehi, MD MS    210-567-6691    salehi@uthscsa.edu    Contact: Andrea Hansis-Diarte    210-567-6691    HansisDiarte@uthscsa.edu    Principal Investigator: Marzieh Salehi, MD Less <<
NCT02258373 Type 1 Diabetes Not Applicable Completed - United States, California ... More >> University of Southern California Beverly Hills, California, United States, 90211 Scripps Health San Diego, California, United States, 92121 United States, Colorado Barbara Davis Center for Diabetes Denver, Colorado, United States, 80045 United States, Florida University of South Florida Tampa, Florida, United States, 33612 United States, Georgia Atlanta Diabetes Atlanta, Georgia, United States, 30318 United States, Illinois Northwestern University Chicago, Illinois, United States, 60611 United States, Iowa Iowa Diabetes and Endocrinology Center Des Moines, Iowa, United States, 50314 United States, Massachusetts Joslin Diabetes Center Boston, Massachusetts, United States, 02215 United States, Michigan University of Michigan Ann Arbor, Michigan, United States, 48109-5456 Henry Ford Health System Detroit, Michigan, United States, 48202 United States, Minnesota International Diabetes Center-Park Nicollet Minneapolis, Minnesota, United States, 55416 United States, Oregon Oregon Health and Science University Portland, Oregon, United States, 97239 United States, Pennsylvania University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104-5160 United States, Washington University of Washington Seattle, Washington, United States, 98105 Less <<
NCT01598610 Diabetes Not Applicable Completed - United States, Indiana ... More >> Midwest Institute For Clinical Research Indianapolis, Indiana, United States, 46260 United States, New Jersey Consumer Product Testing Co. Fairfield, New Jersey, United States, 07004 Less <<
NCT02258373 - Completed - -
NCT01765894 - Completed - Denmark ... More >> XLab, Center for Healthy Aging, Department of Biomedical Sciences, University of Copenhagen Copenhagen, Denmark, 2200 Less <<
NCT01598610 - Completed - -
NCT00939289 - Completed - United States, Colorado ... More >> Barbara Davis Center for Childhood Diabetes Aurora, Colorado, United States, 80045 Less <<
NCT02608372 High Blood Glucose Not Applicable Completed - Denmark ... More >> Department of Nutrition, Exercise and Sports, University of Copenhagen Frederiksberg, Denmark, 1958 Less <<
NCT03685773 Diabetes Mellitus, Type 2 ... More >> Glucose, High Blood Glucose Metabolism Disorders Less << Phase 2 Not yet recruiting December 2021 -
NCT03765008 Glucose Metabolism Disorders ... More >> Dehydration (Physiology) Water Deprivation Less << Not Applicable Not yet recruiting July 29, 2019 -
NCT02068638 Type 1 Diabetes Mellitus ... More >> Exercise Hypoglycemia Carbohydrate Metabolism Less << Not Applicable Completed - Switzerland ... More >> Division of Endocrinology, Diabetes and Clinical Nutrition, Bern University Hospital Bern, Switzerland, 3010 Less <<
NCT00502359 - Completed - Switzerland ... More >> Clinic of obstetrics, University Hospital of Zurich Zurich, Switzerland Less <<
NCT02336438 Hypoglycemia Phase 4 Completed - -
NCT00327210 Type 1 Diabetes Mellitus Not Applicable Completed - United States, Virginia ... More >> University of Viginia Health System Charlottesville, Virginia, United States, 22907 Less <<
NCT02336438 - Completed - -
NCT01883427 Upper Respiratory Tract Infect... More >>ions Less << Phase 2 Completed - Sweden ... More >> Öronmottagningen Piteå, Sweden Öronmottagningen Sunderbyn, Sweden Öronmottagningen Sundsvall, Sweden Öronmottagningen Östersund, Sweden Less <<
NCT01883427 - Completed - -
NCT02877771 Diabetes Mellitus ... More >> Type 1 Diabetes Insulin Pump Less << Phase 1 Completed - United States, California ... More >> Stanford University Palo Alto, California, United States, 94304 United States, Colorado Barbara Davis Center for Childhood Diabetes Aurora, Colorado, United States, 80045 Less <<
NCT03736083 Type1diabetes ... More >> Hypoglycemia Less << Not Applicable Not yet recruiting October 2020 United States, Florida ... More >> UF Health Children's Hospital Gainesville, Florida, United States, 32608 UF Health Pediatrics - Gerold L. Schiebler CMS Center Not yet recruiting Gainesville, Florida, United States, 32608 Contact: Paul Hiers, MD    352-265-7337    phiers88@ufl.edu    Contact: Michael Haller, MD    352-265-7337    hallerms@ufl.edu    Pediatrics Endocrinology/Diabetes at UF Health Medical Plaza and Children's Medical Services Building Not yet recruiting Gainesville, Florida, United States, 32611 Contact: Paul Hiers, MD    352-265-7337    phiers88@ufl.edu    Contact: Michael Haller, MD    352-265-7337    hallerms@ufl.edu Less <<
NCT01058577 Diabetes Mellitus Phase 1 Completed - Germany ... More >> Profil Institut für Stoffwechselforschung GmbH Neuss, Germany, 41460 Less <<
NCT01310556 - Completed - Turkey ... More >> Gulhane School of Medicine Ankara, Turkey, 06100 Less <<
NCT03207893 Diabetes Mellitus, Type 2 Not Applicable Recruiting May 2019 United States, Virginia ... More >> University of Virginia, Dept. of Psychiatry and Neurobehavioral Sciences Recruiting Charlottesville, Virginia, United States, 22908 Contact: Tom A Banton, OD, PhD    434-924-8656    tab2v@hscmail.mcc.virginia.edu    Contact: Daniel J Cox, PhD    434-924-8021    DJC4F@hscmail.mcc.virginia.edu Less <<
NCT02969798 Diabetes Mellitus, Type 2 ... More >> Impaired Glucose Tolerance (IGT) Impaired Fasting Glucose (IFG) Less << Not Applicable Recruiting July 2020 United States, Texas ... More >> The University of Texas Health Science Center at San Antonio Recruiting San Antonio, Texas, United States, 78229 Contact: Ralph A DeFronzo, MD    210-567-6691    defronzo@uthscsa.edu    Contact: Monica Palomo, BS    210-567-6710    palomom@uthscsa.edu    Principal Investigator: Ralph A DeFronzo, MD          Sub-Investigator: Eugenio Cersosimo, MD Less <<
NCT00782418 The Methodology Assessment of ... More >>Glucose Dependent Insulin Secretion Less << Phase 1 Completed - -
NCT03293693 Post Prandial Blood Glucose ... More >> Gut Microbiota Satiety Less << Not Applicable Completed - Norway ... More >> Oslo and Akershus university College Oslo, Norway, 0130 Less <<
NCT03029546 - Recruiting November 2020 United States, Ohio ... More >> Ohio State University Recruiting Columbus, Ohio, United States, 43210 Contact: Megan L Jones, MD    913-961-1915    megan.jones2@osumc.edu    Contact: Catalin Buhimschi, MD    614-293-9217    catalin.buhimschi@osumc.edu Less <<
NCT00782418 - Completed - -
NCT02018315 Glucose Transporter Type 1 Def... More >>iciency Syndrome GLUT1 Deficiency Syndrome Less << Phase 1 Unknown March 2014 United States, Texas ... More >> UT Southwestern Medical Center Dallas, Texas, United States, 75390 Less <<
NCT01034293 Insulin Gluco... More >>se Metabolism Less << Not Applicable Completed - Netherlands ... More >> University of Maastricht Maastricht, Limburg, Netherlands, 6229 ER Less <<
NCT01395602 Body Weight I... More >>mpaired Glucose Tolerance in Obese Less << Phase 1 Phase 2 Completed - United States, New York ... More >> Columbia University New York, New York, United States, 10032 Less <<
NCT01930110 Type 1 Diabetes Phase 2 Completed - Canada, Quebec ... More >> Institut de recherches cliniques de Montréal Montreal, Quebec, Canada, H2W 1R7 Less <<
NCT03602963 - Recruiting March 30, 2019 Belgium ... More >> Jessa Hospital Recruiting Hasselt, Limburg, Belgium, B3500 Contact: Guy G Massa, MD, PhD    +3211309866    guy.massa@jessazh.be    Contact: Renate Zeevaert, MD, PhD       renate.zeevaert@jessazh.be Less <<
NCT03028220 Type 1 Diabetes Mellitus With ... More >>Hypoglycemia Impaired Awareness of Hypoglycemia Type1diabetes Less << Not Applicable Completed - -
NCT03333525 Type 1 Diabetes Mellitus Not Applicable Completed - -
NCT02801916 Glucose Intolerance Not Applicable Completed - -
NCT03400774 Postprandial Hyperglycemia Not Applicable Completed - -
NCT01801540 Glucose Metabolism Not Applicable Completed - -
NCT03686566 Neuroblastoma ... More >> Sarcoma Pediatric Cancer Less << Early Phase 1 Recruiting July 2020 United States, Texas ... More >> UT Southwestern Recruiting Dallas, Texas, United States, 75235 Contact: Kendra Johnston, MD    214-456-7000    kendra.johnston@utsouthwestern.edu    Contact: Tanya Watt, MD    2144567000 Less <<
NCT00636714 Hyperglycemia in Critically Il... More >>l Patients Less << Phase 4 Completed - Canada, Ontario ... More >> St. Michael's Hospital Toronto, Ontario, Canada, M5B1W8 Less <<
NCT01905020 Type 1 Diabetes Phase 2 Completed - Canada, Ontario ... More >> Mount Sinai Hospital Toronto, Ontario, Canada Canada, Quebec Institut de recherches cliniques de Montréal Montreal, Quebec, Canada Montreal Children Hospital Montreal, Quebec, Canada Less <<
NCT01552603 - Completed - -
NCT01552603 Type I Diabetes Mellitus Phase 2 Completed - United States, Oregon ... More >> Legacy Good Samaritan Hospital Portland, Oregon, United States, 97210 Oregon Health and Science University Portland, Oregon, United States, 97239 Less <<
NCT03542487 Diabetes Mellitus Not Applicable Enrolling by invitation November 2018 United States, Virginia ... More >> Inova Heath System Falls Church, Virginia, United States, 22042 Less <<
NCT00582036 Hyperglycemia ... More >> Hematopoietic Stem Cell Transplantation Less << Not Applicable Terminated(study terminated du... More >>e to lack of enrollment) Less << - United States, Oklahoma ... More >> University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma, United States, 73104 Less <<
NCT00582036 - Terminated(study terminated du... More >>e to lack of enrollment) Less << - -
NCT02371239 Type 2 Diabetes Not Applicable Completed - Netherlands ... More >> Human Movement Science, Maastricht University Maastricht, Limburg, Netherlands, 6200 MD Less <<
NCT02092220 Diabetes Mellitus Type 1 Not Applicable Completed - United States, California ... More >> Stanford University Stanford, California, United States, 94305 United States, Massachusetts Massachusetts General Hospital (MGH) Diabetes Research Center Boston, Massachusetts, United States, 02114 UMass Medical Center Worcester, Massachusetts, United States, 01655 United States, North Carolina University of North Carolina Chapel Hill Chapel Hill, North Carolina, United States, 27514 Less <<
NCT03695913 Pre-diabetes Not Applicable Recruiting October 15, 2019 United States, Michigan ... More >> The University of Michigan Recruiting Livonia, Michigan, United States, 48152 Contact: Spring Stonebraker    734-998-7120    sprstone@med.umich.edu Less <<
NCT02092220 - Completed - -
NCT00758069 - Completed - -
NCT01944904 Pre-diabetic Not Applicable Completed - United States, California ... More >> UCLA Center for Human Nutrition Los Angeles, California, United States, 90095 Less <<
NCT00758069 Diabetes Mellitus, Non-Insulin... More >>-Dependent Less << Phase 2 Completed - -
NCT01702311 Diabetes Not Applicable Completed - United States, Georgia ... More >> Grady Memorial Hospital Atlanta, Georgia, United States, 30303 Emory University Hospital Atlanta, Georgia, United States, 30322 Less <<
NCT01909336 Hyponatremia Phase 3 Completed - -
NCT01702311 - Completed - -
NCT01034241 Insulin Gluco... More >>se Metabolism Less << Not Applicable Completed - -
NCT01729546 Diabetes Not Applicable Completed - Germany ... More >> Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm Ulm, Germany, 89081 Less <<
NCT01909336 - Completed - -
NCT01030952 Diabetes Mellitus, Type 2 Phase 4 Completed - China ... More >> Sir Run Run Shaw Hospital, 3 East Qingchun Road Hangzhou, China, 310016 Shanghai Tongji Hospital, 389 Xinchun Road Shanghai, China, 200065 Shanghai Sixth People's Hospital, 600 Xuanshan Road Shanghai, China, 200233 Less <<
NCT01955447 Healthy Subjects Not Applicable Completed - India ... More >> Lambda Therapeutics Research Ltd (LTRL) Ahmedabad, India Less <<
NCT00847028 Pain Not Applicable Unknown April 2009 Belgium ... More >> H Hart ziekenhuis Mol, Antwerp, Belgium, 2400 Less <<
NCT01173042 Cardiovascular Disease Phase 1 Completed - United States, Pennsylvania ... More >> Penn State University University Park, Pennsylvania, United States, 16802 Less <<
NCT01856790 Type 1 Diabetes Early Phase 1 Completed - United States, Connecticut ... More >> Yale University School of Medicine New Haven, Connecticut, United States, 06520 Less <<
NCT01030952 - Completed - -
NCT01984827 Diabetes Phase 1 Not yet recruiting December 2018 United Kingdom ... More >> Richmond Pharmacology Ltd. Croydon University Hospital Thornton Wing, 530, London Road Not yet recruiting London, Croydon, United Kingdom, CR7 7YE Contact: Keith Berelowitz, PhD          Principal Investigator: Ulrike Lorch, MD FRCA FFPM Less <<
NCT02982330 Type2 Diabetes Not Applicable Completed - Canada, British Columbia ... More >> University of British Columbia, Okanagan. Kelowna, British Columbia, Canada, V1V 1V7 Less <<
NCT03382015 Type 2 Diabetes Mellitus Not Applicable Completed - United States, Louisiana ... More >> Pennington Biomedical Research Center Baton Rouge, Louisiana, United States, 70808 Less <<
NCT00439023 Renal Failure, Chronic Phase 4 Completed - Denmark ... More >> Holstebro Hospital Holstebro, Denmark, 7500 Less <<
NCT03097536 Migraine Headache Not Applicable Recruiting January 2021 United States, Massachusetts ... More >> Beth Israel Deaconess Medial Center Recruiting Boston, Massachusetts, United States, 02215 Contact: Shaelah Huntington, BA    617-667-0317    shunting@bidmc.harvard.edu Less <<
NCT02296034 - Withdrawn(Unable to recruit pa... More >>rticipants) Less << - -
NCT00413335 Obesity Impai... More >>red Glucose Tolerance Type 2 Diabetes Mellitus Less << Not Applicable Completed - United States, Connecticut ... More >> Yale School of Medicine New Haven, Connecticut, United States, 06520 Less <<
NCT00413335 - Completed - -
NCT02682056 Diabetes Not Applicable Completed - United States, Georgia ... More >> Children's Healthcare of Atlanta Atlanta, Georgia, United States, 30322 Emory Children's Center Atlanta, Georgia, United States, 30322 Less <<
NCT02846857 Type 1 Diabetes Phase 2 Not yet recruiting February 2019 -
NCT03713060 Hypoglycemia Non-Diabetic ... More >> Gastric Bypass Complicating Pregnancy/Birth/Puerperium Antepartum Condition Less << Not Applicable Not yet recruiting September 30, 2021 -
NCT01460459 Diabetes Mellitus, Type 2 Not Applicable Unknown July 2012 Netherlands ... More >> Diabetes Centre, Isala Clinics Recruiting Zwolle, Netherlands, 8025 BT Principal Investigator: Henk JG Bilo, MD PhD FCRP Less <<
NCT03651895 Chronic Obstructive Pulmonary ... More >>Disease Less << Early Phase 1 Not yet recruiting August 31, 2020 -
NCT02092051 Diabetes Mellitus, Type 1 Not Applicable Completed - Sweden ... More >> Alingsås Hospital Alingsås, Sweden, 44183 Angered Hospital Angered, Sweden, 42422 Helsingborg Hospital Helsingborg, Sweden, 25187 Öbackakliniken Härnösand, Sweden, 871 82 Centralhospital Kristianstad Kristianstad, Sweden, 29185 Halland's Hospital Kungsbacka Kungsbacka, Sweden, 43480 Malmö University Hospital Malmö, Sweden, 205 02 Motala Hospital Motala, Sweden, 591 85 Vrinnevisjukhuset Norrköping, Sweden, 603 82 Södersjukhuset Stockholm, Sweden, 118 81 Trelleborg Hospital Trelleborg, Sweden, 231 85 Uddevalla Hospital Uddevalla, Sweden, 45180 Academic Hospital Uppsala Uppsala, Sweden, 75185 Ängelholm Hospital Ängelholm, Sweden, 262 81 University Hospital Örebro Örebro, Sweden, 70185 Less <<
NCT01615081 Obesity Diabe... More >>tes Less << Not Applicable Completed - Denmark ... More >> Department of Human Nutrition, Faculty of Science, University of Copenhagen Frederiksberg, Denmark, 1958 Less <<
NCT01283126 Hypoglycemia Not Applicable Completed - United States, Massachusetts ... More >> Joslin Diabetes Center Boston, Massachusetts, United States, 02215 Less <<
NCT02490098 Type 1 Diabetes Phase 2 Withdrawn(Funding terminated) July 2018 Canada, Quebec ... More >> Institut de recherches cliniques de Montréal Montreal, Quebec, Canada, H2W 1R7 Less <<
NCT03464084 Glucose Circa... More >>dian Rhythm Melatonin Genes Light Less << Not Applicable Recruiting May 31, 2020 United States, Massachusetts ... More >> Brigham and Women's Hospital Recruiting Boston, Massachusetts, United States, 02115 Contact: Lauren Kelly    617-278-0662    lkelly17@bwh.harvard.edu    Contact: Jingyi Qian    6175257423    jqian@bwh.harvard.edu Less <<
NCT01017263 - Terminated(Due very high scree... More >>n fail rate, pre study feasibility not consistent with screened population.) Less << - -
NCT01112696 Type 1 Diabetes Mellitus ... More >> Type 2 Diabetes Mellitus Less << Not Applicable Completed - United States, California ... More >> AMCR Institute, Inc. Escondido, California, United States, 92026 Sansum Diabetes Research Institute Santa Barbara, California, United States, 93105 United States, Washington Rainier Clinical Research Center, Inc. Renton, Washington, United States, 98057 Less <<
NCT01017263 Attention Deficit Hyperactivit... More >>y Disorder Glucose Intolerance Obesity Less << Phase 4 Terminated(Due very high scree... More >>n fail rate, pre study feasibility not consistent with screened population.) Less << - United States, North Carolina ... More >> Duke Child and Family Study Center Durham, North Carolina, United States, 27705 Less <<
NCT00829062 Type 1 Diabetes Not Applicable Withdrawn(No participants met ... More >>inclusion criteria.) Less << July 2010 United States, Missouri ... More >> Children's Mercy Hospital and Clinics Kansas City, Missouri, United States, 64108 Less <<
NCT01593605 Impaired Glucose Tolerance Not Applicable Completed - United States, Tennessee ... More >> Facility: Vanderbilt University Nashville, Tennessee, United States, 37232 Less <<
NCT03411395 Healthy Not Applicable Completed - -
NCT01021527 Healthy Phase 1 Completed - -
NCT02621307 Hyperglycemia, Postprandial Phase 1 Completed - Canada, Ontario ... More >> St. Michael's Hospital Toronto, Ontario, Canada, M5B 1W8 Less <<
NCT02823665 Post Bariatric Surgery ... More >> Gastric Bypass Sleeve Gastrectomy Hypoglycemia After Gastric Bypass Less << Early Phase 1 Recruiting July 2022 United States, Texas ... More >> South Texas Veterans Health Care System Recruiting San Antonio, Texas, United States, 78229 Contact: Andrea Hansis-Diarte    210-567-6691    hansisdiarte@uthscsa.edu    Principal Investigator: Marzieh Salehi, MD Less <<
NCT01407315 Type 1 Diabetes Phase 1 Completed - Austria ... More >> Medical University of Graz Graz, Austria, 8036 Less <<
NCT01831752 - Completed - United States, California ... More >> Sansum Diabetes Research Institute Santa Barbara, California, United States, 93105 Less <<
NCT03335930 Type 2 Diabetes Mellitus Not Applicable Completed - -
NCT02377531 Gestational Diabetes Not Applicable Recruiting May 2018 United States, Florida ... More >> USF Health South Tampa Center for Advanced Healthcare Recruiting Tampa, Florida, United States, 33606 TGH Health Park Genesis Clinic Recruiting Tampa, Florida, United States, 33610 Contact: Alejandro Rodriguez, MD       arodri24@health.usf.edu Less <<
NCT00889668 Type 1 Diabetes Mellitus ... More >> Type 2 Diabetes Mellitus Less << Phase 1 Phase 2 Unknown October 2012 Israel ... More >> Soroka University Medical Center Recruiting Beer-Sheva, Israel Contact: Adi Gluzberg    +972-52-6401020    adi_g@medicsense.com    Principal Investigator: Ilana Harman-Boehm, MD Less <<
NCT02727231 Type 1 Diabetes Not Applicable Completed - Austria ... More >> Medical University of Graz Graz, Austria, A8036 United Kingdom Cambridge University Hospitals NHS Foundation Trust, Addenbrookes Hospital Cambridge, Cambridgeshire, United Kingdom, CB2 0QQ Less <<
NCT01391702 - Completed - Canada, British Columbia ... More >> BC Women's Hospital Vancouver, British Columbia, Canada, V6H 3N1 British Columbia's Women's Hospital Vancouver, British Columbia, Canada, V6H 3N1 Less <<
NCT01783275 Obesity Type ... More >>2 Diabetes Less << Not Applicable Completed - United States, Tennessee ... More >> Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232 Less <<
NCT02388503 Healthy Not Applicable Completed - Germany ... More >> Charité research organisation Berlin, Charitéplatz 1, Germany, 10117 Less <<
NCT02733991 Type 1 Diabetes Not Applicable Completed - France ... More >> CHU de Besançon Besançon, France CHU Grenoble Grenoble, France APHM - La Conception Marseille, France CHU Montpellier - Hôpital Lapeyronie Montpellier, France Italy Ospedale Papa Giovanni XXIII Bergamo, Italy Ospedale S. Raffaele Milan, Italy Ospedale S. Gionanni di Dio Olbia, Italy Netherlands Groene Hart Ziekenhuis Gouda, Netherlands Maasstad Ziekenhuis Rotterdam, Netherlands UMC Utrecht Utrecht, Netherlands Isala Zwolle, Netherlands United Kingdom Harrogate District Hospital Harrogate, N. Yorkshire, United Kingdom, HG2 7SX King's College London London, United Kingdom, SE5 9NU Manchester Diabetes Center Manchester, United Kingdom Less <<
NCT01444443 Type 1 Diabetes Not Applicable Completed - Denmark ... More >> Hvidovre University Hospital Hvidovre, Denmark, 2650 Less <<
NCT01112696 - Completed - -
NCT00788242 Aortic Stenosis ... More >> Coronary Heart Disease Heart Failure Less << Not Applicable Completed - Switzerland ... More >> Cardiocentro Lugano, Ticino, Switzerland, 6900 Geneva University Hospital Geneva, Switzerland, 1211 Less <<
NCT01364155 Impaired Glucose Tolerance ... More >> Insulin Resistance Less << Phase 2 Unknown August 2011 United States, California ... More >> Profil Institute of Clinical Research, Inc. Recruiting Chula Vista, California, United States, 91911 Contact: Linda Morrow, MD    619-409-1268 Less <<
NCT03344185 Mood Diet Mod... More >>ification Glucose, Low Blood Glucose, High Blood Less << Not Applicable Completed - -
NCT01409434 Drug Induced Hyperglycemia ... More >> Secondary Hyperlipidemia Less << Phase 4 Completed - United States, Florida ... More >> University of Florida College of Pharmacy Gainesville, Florida, United States, 32610 Less <<
NCT01409434 - Completed - -
NCT01022697 Childbirth Not Applicable Completed - France ... More >> Hospital, Avranches Avranches, France Centre Hospitalier Bayeux, France, 14400 Clinique du Parc Caen, France, 14000 University Hospital, Caen Caen, France, 14033 Centre Hospitalier du Rouvray Elbeuf, France, 76350 University Hospital, Lille Lille, France Hospital, Mont Saint Aignan Mont Saint Aignan, France University Hospital, Rouen Rouen, France Centre Hospitalier Mémorial France Etats-Unis Saint-Lô, France, 50000 Less <<
NCT01919788 Diabetes Mellitus Type I. ... More >> Hypoglycemia. Less << Not Applicable Completed - Denmark ... More >> Institute of Clinical Medicine Aarhus, Aarhus C, Denmark, 8000 Less <<
NCT01415544 - Unknown February 2012 United States, New Mexico ... More >> Lovelace Scientific Resources Albuquerque, New Mexico, United States, 87106 Less <<
NCT01307306 Burns Not Applicable Recruiting September 2019 Canada, Ontario ... More >> Ross Tilley Burn Centre, Sunnybrook Health Sciences Centre Recruiting Toronto, Ontario, Canada, M4N 3M5 Contact: Marc G Jeschke, MD PhD    416-480-6703    marc.jeschke@sunnybrook.ca    Contact: Marjorie Burnett, HonsBSc    416-480-6100 ext 88021    marjorie.burnett@sunnybrook.ca    Sub-Investigator: Robert Cartotto, MD          Sub-Investigator: Shahriar Shahrokhi, MD          Sub-Investigator: Alison Cheung, PhD Less <<
NCT03588000 Diabetes Mellitus, Type 2 Not Applicable Active, not recruiting October 2020 China ... More >> Community Health Service Center of Malu Town, Jiading District Shanghai, China, 201801 Community Health Service Center of Nanxiang Town, Jiading District Shanghai, China, 201802 Community Health Service Center of Zhenxin, Jiading District Shanghai, China, 201824 Community Health Service Center of Juyuan New District, Jiading District Shanghai, China, 201899 Less <<
NCT02897570 Feeding Behaviors ... More >> Lack of Satiety Attention Deficit and Disruptive Behavior Disorders Less << Not Applicable Completed - Italy ... More >> San Donato Hospital San Donato Milanese, MI, Italy, 20097 Less <<
NCT01121783 Blood Glucose ... More >> Appetite Therapeutic Uses Hormones Less << Not Applicable Unknown May 2011 United Kingdom ... More >> Salford Royal NHS Foundation Trust Recruiting Manchester, United Kingdom Contact: Nerys M Astbury, Bsc. MMedSci, PhD    0161 206 1447    nerys.astbury@manchester.ac.uk    Contact: Charlotte E Bryant, Bsc, MMedSci    0161 2061447    charlotte.bryant@postgrad.manchester.ac.uk    Principal Investigator: David Thompson, FRCP, fMedSci Less <<
NCT02053584 Diabetes Not Applicable Completed - -
NCT03522181 Liver Transplantation Not Applicable Completed - China, Hunan ... More >> Department of Anesthesiology, The Second Xiangya Hospital Changsha, Hunan, China, 410011 Less <<
NCT00822003 Glucose Homeostasis Phase 1 Phase 2 Completed - Switzerland ... More >> Clinical Research Center, University Hospital Basel Basel, Basel-Stadt, Switzerland, 4031 Less <<
NCT02236364 Diabetes Not Applicable Terminated(No positive results... More >> were detected) Less << - United States, Ohio ... More >> University of Toledo, Health Science Campus Toledo, Ohio, United States, 43614 Less <<
NCT01079624 Physiology Ga... More >>stroenterology Endocrinology Less << Phase 1 Completed - Sweden ... More >> Karolinska University Hospital Stockholm, Sweden, 17176 Less <<
NCT01514435 Major Depressive Disorder Not Applicable Completed - Austria ... More >> Medical University Graz; Department for Psychiatry Graz, Styria, Austria, 8036 Less <<
NCT01921881 Type 2 Diabetes Phase 1 Completed - Denmark ... More >> Department of Clinical Pharmacology, Institute of Public Health, University of Southern Denmark Odense C, Denmark, DK-5000 Less <<
NCT01420302 Critical Illness Phase 2 Phase 3 Completed - Belgium ... More >> Dept Intensive Care Medicine, University Hospitals Leuven Leuven, Belgium, 3000 Less <<
NCT02490085 Type 2 Diabetes Phase 2 Recruiting September 2018 Canada, Quebec ... More >> Institut de recherches cliniques de Montréal Recruiting Montreal, Quebec, Canada, H2W 1R7 Contact: Virginie Messier    514-987-5500 ext 3227    virginie.messier@ircm.qc.ca    Principal Investigator: Rémi Rabasa-Lhoret          Centre hospitalier universitaire de Sherbrooke Not yet recruiting Sherbrooke, Quebec, Canada, J1H 5N4 Contact: André Carpentier    819-564-5241    andre.carpentier@usherbrooke.ca    Principal Investigator: André Carpentier Less <<
NCT03241303 Glucose Metabolism Disorders Not Applicable Recruiting July 1, 2018 Denmark ... More >> Center for Diabetesresearch Recruiting Hellerup, Denmark, 2900 Contact: Filip K Knop, MD, PhD    26830161    Filipknop@dadlnet.dk Less <<
NCT02502344 Insulin Resistance Phase 4 Unknown - China, Beijing ... More >> BEI JING Tsinghua Changguang Hospital Recruiting Beijing, Beijing, China, 102218 Contact: jian Z xiao, doctor    0086-010-56118899 ext 13683685711    xiaojzh858@sina.com Less <<
NCT03094533 Hyperglycemia Stress Not Applicable Recruiting November 30, 2018 Korea, Republic of ... More >> Yeungnam University Hospital Recruiting Daegu, Korea, Republic of, 42415 Contact: Sung Mee Jung, MD, PhD    +82-53-620--3368    applejsm@gmail.com    Principal Investigator: Sung Mee Jung, M.D. Less <<
NCT03166514 Glucose and Insulin Response Not Applicable Completed - -
NCT03255876 Hyperglycemia, Postprandial ... More >> Healthy Less << Not Applicable Recruiting September 1, 2018 United Kingdom ... More >> School of Food Science and Nutrition, University of Leeds Recruiting Leeds, West Yorkshire, United Kingdom, LS2 9JT Contact: Gary Williamson, PhD    +441133438380    G.Williamson@leeds.ac.uk    Contact: Aleksandra Konic Ristic, PhD    +441133432979    a.konicristic@leeds.ac.uk    Principal Investigator: Aleksandra Konic Ristic, PhD          Sub-Investigator: Hilda Nyambe, PhD          Sub-Investigator: Asimina Kerimi, PhD          Sub-Investigator: Sarka Tumova, PhD Less <<
NCT01240837 Healthy Adults Not Applicable Completed - Netherlands ... More >> Wageningen University Wageningen, Gelderland, Netherlands, 6701 BH Less <<
NCT03587441 Post-Dural Puncture Headache Phase 4 Recruiting September 2019 Egypt ... More >> Fayoum University hospital Recruiting Madīnat al Fayyūm, Faiyum Governorate, Egypt, 63514 Contact: Hany M Yassin, MD.    1111363602 ext +20    hmy00@fayoum.edu.eg    Contact: Yasser S Mostafa, M.Sc.    1010509735 ext +20    ysm03@fayoum.edu.eg Less <<
NCT02710617 Diabetes Not Applicable Completed - Germany ... More >> Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm Ulm, Germany, 89081 Less <<
NCT02990962 Carpal Tunnel Syndrome Not Applicable Completed - Taiwan ... More >> Department of Physical Medicine and Rehabilitation, Tri-Service General Hospital Taipei, Neihu District, Taiwan, 886 Less <<
NCT02665455 Diabetes Mellitus Not Applicable Completed - Austria ... More >> VIVIT-Institut am Akad. Lehrkrankenhaus Feldkirch, Innere Medizin und Kardiologie Feldkirch, Austria, 6807 Medizinische Universität Graz Graz, Austria, 8036 Medizinische Universität Wien Vienna, Austria, A-1090 Krankenhaus Hietzing mit Neurologischem Zentrum Rosenhügel Vienna, Austria, A-1130 United Kingdom Royal United Hospital Bath, United Kingdom, BA1 3NG Southmead Hospital Bristol, United Kingdom, BS10 5NB Cambridge University Hospitals NHS Foundation Trust Cambridge, United Kingdom, CB2 0QQ St. James University Hospital, Leeds Teaching Hospitals NHS Trust Leeds, United Kingdom, LS9 7TF Manchester Royal Infirmary Manchester, United Kingdom, M13 9WL James Cook University Hospital Middlesborough, United Kingdom, TS4 3BW John Radcliffe Hospital Oxford, United Kingdom, OX3 9DU Derriford Hospital Plymouth, United Kingdom, PL6 8DH Warwick Hospital Warwick, United Kingdom, CV34 5BW Less <<
NCT02665455 - Completed - -
NCT02996916 Efficacy of Olmesartan on Cere... More >>bral Glucose Metabolism in Essential Hypertension Less << Phase 4 Recruiting December 2020 Japan ... More >> Kurume University Hospital Recruiting Kurume, Japan, 830-0011 Contact: Nobuhiro Tahara, MD, PhD    +81-942-31-7580    ntahara@med.kurume-u.ac.jp    Contact: Akihiro Honda, MD, PhD    +81-942-31-7580    honda_akihiro@med.kurume-u.ac.jp Less <<
NCT01890876 Diabetes Not Applicable Unknown December 2015 Austria ... More >> Department of Sport Science, Medical Section, University of Innsbruck Innsbruck, Austria, 6020 Less <<
NCT02702245 Glucose Intolerance Not Applicable Completed - -
NCT02536066 Blood Glucose ... More >> Blood Glucose Related Variables Less << Not Applicable Completed - Norway ... More >> Lillehammer University College Lillehammer, Norway, 2618 Less <<
NCT02398383 Cystic Fibrosis ... More >> Cystic Fibrosis Related Diabetes Less << Early Phase 1 Unknown January 2018 United States, Connecticut ... More >> Yale New Haven Hospital Recruiting New Haven, Connecticut, United States, 06511 Less <<
NCT02852044 Hyperglycemia ... More >> Insulin Sensitivity Less << Not Applicable Completed - United Kingdom ... More >> Department for Health, University of Bath Bath, United Kingdom, BA2 7AY Less <<
NCT00554112 Aging Glucose... More >> Intolerance Less << Not Applicable Terminated(PI left the VA, per... More >> Central Office) Less << - -
NCT00241423 Type 2 Diabetes Mellitus Phase 2 Completed - United States, District of Col... More >>umbia Research Site Washington, District of Columbia, United States United States, Texas Research Site San Antonio, Texas, United States Less <<
NCT03159065 Postprandial Hyperglycemia Not Applicable Completed - -
NCT02180555 - Unknown - Belgium ... More >> Antwerp University Hospital Recruiting Edegem, Antwerpen, Belgium, 2650 Contact: Philippe G Jorens, MD, PhD    00323821 ext 3635       Sub-Investigator: Walter Verbrugghe, MD          Sub-Investigator: Tom Schepens, MD PhD          Sub-Investigator: Karolien Janssens, MD          Principal Investigator: Christophe De Block, MD, PhD          Sub-Investigator: Sofie Van Ackerbroeck, MD          Sub-Investigator: Philippe G Jorens, MD, PhD Less <<
NCT03202342 Healthy Not Applicable Completed - Netherlands ... More >> Leids Universitair Medisch Centrum Leiden, Zuid-Holland, Netherlands Less <<
NCT00477581 Type 2 Diabetes Mellitus Phase 4 Completed - United States, California ... More >> Research Site Los Angeles, California, United States Research Site Spring Valley, California, United States United States, Florida Research Site Miami, Florida, United States Research Site Pembroke Pines, Florida, United States United States, Illinois Research Site Chicago, Illinois, United States United States, Indiana Research Site Indianapolis, Indiana, United States, 46260 Research Site Indianapolis, Indiana, United States United States, Michigan Research Site Detroit, Michigan, United States United States, Montana Research Site Butte, Montana, United States United States, North Carolina Research Site Winston-Salem, North Carolina, United States United States, Ohio Research Site Cincinatti, Ohio, United States Research Site Marion, Ohio, United States United States, Oregon Research Site Eugene, Oregon, United States Research Site Portland, Oregon, United States United States, South Carolina Research Site Charleston, South Carolina, United States Research Site Greer, South Carolina, United States United States, Texas Research Site Austin, Texas, United States Research Site Corpus Christi, Texas, United States Research Site San Antonio, Texas, United States Less <<
NCT03188263 PreDiabetes C... More >>ircadian Dysregulation Less << Not Applicable Recruiting May 31, 2019 United States, Illinois ... More >> Northwestern Memorial Hospital Recruiting Chicago, Illinois, United States, 60611 Contact: Kristen Knutson, PhD    312-503-1526    kristen.knutson@northwestern.edu    Principal Investigator: Kristen Knutson, PhD Less <<
NCT03252704 Glucose, High Blood ... More >> Glucose, Low Blood Meals Less << Not Applicable Completed - -
NCT01028846 Type 2 Diabetes Phase 2 Recruiting December 2022 United States, New York ... More >> Albert Einstein College of Medicine of Yeshiva University Recruiting Bronx, New York, United States, 10461 Principal Investigator: Meredith Hawkins, MD Less <<
NCT02296593 - Completed - France ... More >> CHU de Caen Caen, Basse Normandie, France, 14000 Less <<
NCT02509988 Hyperglycemia Not Applicable Active, not recruiting March 2022 New Zealand ... More >> The University of Auckland Auckland, New Zealand, 1142 Singapore National University Hospital Singapore, Singapore, 119074 United Kingdom University Hospital Southampton NHS Foundation Trust Southampton, Hampshire, United Kingdom, SO16 6YD Less <<
NCT01474525 Gestational Diabetes Mellitus ... More >> Type 2 Diabetes Mellitus Less << Not Applicable Unknown March 2012 Canada, Ontario ... More >> Mount Sinai Hospital, Leadership Sinai Centre for Diabetes Recruiting Toronto, Ontario, Canada, M5T 3L9 Contact: Alexander G Logan, MD, FRCP(C)    416-586-5187    logan@lunenfeld.ca    Principal Investigator: Alexander G Logan, MD, FRCP(C) Less <<
NCT00685594 Impaired Glucose Tolerance Phase 2 Phase 3 Completed - Norway ... More >> University of Tromso Tromso, Norway, 9037 Less <<
NCT01384656 Acute Coronary Syndrome Phase 4 Completed - Korea, Republic of ... More >> Severance Hospital Seoul, Korea, Republic of, 120-752 Less <<
NCT01050140 Hepatic Fatty Acid Metabolism ... More >> Systemic Insulin Resistance Oxidative Stress Cardiovascular Status Less << Not Applicable Completed - United Kingdom ... More >> School of Biomedical Sciences, University of Nottingham Nottingham, Nottinghamshire, United Kingdom, NG7 2UH Less <<
NCT02367989 Healthy Not Applicable Recruiting August 2019 Canada, Manitoba ... More >> I.H. Asper Clinical Research Institute Recruiting Winnipeg, Manitoba, Canada, R2H2A6 Contact: Heather Blewett, Ph.D    204-237-2954    hblewett@sbrc.ca    Contact: Jay Petkau       jpetkau@sbrc.ca    Sub-Investigator: Nancy Ames, Ph.D          Sub-Investigator: Sora Ludwig, MD Less <<
NCT02258399 Energy Balance ... More >> Blood Glucose Less << Not Applicable Completed - United Kingdom ... More >> Department for Health, University of Bath Bath, United Kingdom, BA2 7AY Less <<
NCT01915849 Type 2 Diabetes Mellitus Phase 1 Phase 2 Completed - United States, California ... More >> Novartis Investigative Site Chula Vista, California, United States, 91910 Less <<
NCT01915849 - Completed - -
NCT02058914 Insulin Sensitivity ... More >> Insulin Tolerance Less << Not Applicable Completed - United States, Missouri ... More >> University of Missouri Columbia, Missouri, United States, 65211 Less <<
NCT03061227 Metabolic Syndrome ... More >> Diabetes Less << Not Applicable Active, not recruiting February 2019 Germany ... More >> University Hospital Tübingen Tübingen, Germany, 72076 Less <<
NCT01072708 Diabetes in Cystic Fibrosis Pa... More >>tients Less << Not Applicable Completed - France ... More >> Service de Médecine Interne - Centre Hospitalier Lyon Sud Pierre Bénite, France, 69495 Less <<
NCT03671915 Closed Loop D... More >>iabetes Mellitus, Type 1 Young Children (6 to 12 Years Old ) Less << Not Applicable Not yet recruiting May 2019 Belgium ... More >> University Hospitals Leuven Not yet recruiting Leuven, Belgium, 3000 Contact: Kristina CASTEELS, MD          Principal Investigator: Kristina Kristina, MD          France Necker Enfants Malades Hospital Not yet recruiting Paris, France, 75015 Contact: Jacques BELTRAND, MD          Sub-Investigator: Cécile GODOT, MD          Principal Investigator: Jacques BELTRAND, MD          Toulouse University Hospital Center Not yet recruiting Toulouse, France, 31059 Contact: Claire LE TALLEC, MD          Principal Investigator: Claire LE TALLEC, MD          Sub-Investigator: Carole MORIN, MD          Sub-Investigator: Maeva TALVARD, MD Less <<
NCT02344992 Diabetes Mellitus Type 1 Phase 1 Completed - Germany ... More >> Profil GmbH Neuss, Germany, 41460 Less <<
NCT00337350 Schizophrenia Phase 4 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Schizophrenia Program Boston, Massachusetts, United States, 02114 Less <<
NCT01728467 Diabetes Phase 2 Completed - Australia, Victoria ... More >> Baker IDI Heart and Diabetes Institute 75 Commercial Road, Melbourne, Victoria, Australia, 3004 Less <<
NCT00994396 Obesity Gluco... More >>se Intolerance Inflammation Less << Not Applicable Completed - United States, Missouri ... More >> University of Missouri Columbia, Missouri, United States, 65211 Less <<
NCT02653274 Healthy Not Applicable Completed - United Kingdom ... More >> Nottingham Digestive Disases Centre Nottingham, Nottinghamshire, United Kingdom, NG7 2UH Less <<
NCT03444922 Environmental Exposure Not Applicable Active, not recruiting April 17, 2019 United States, California ... More >> California Polytechnic State University San Luis Obispo, California, United States, 93405 Less <<
NCT02771093 Type 2 Diabetes Mellitus Phase 4 Completed - Japan ... More >> Naka-city, Ibaragi, Japan Less <<
NCT00337350 - Completed - -
NCT02771093 - Completed - -
NCT01184014 - Completed - -
NCT02157480 Type 2 Diabetes ... More >> Physical Activity Less << Phase 2 Phase 3 Recruiting January 2020 France ... More >> University Hospital Amiens Recruiting Amiens, France Contact: Rachel DESAILLOUD          Clinical Research Center University Hospital Caen Recruiting Caen, France, 14033 Contact: Sylvie BRUCATO, PhD    +33231065227    brucato-s@chu-caen.fr    University Hospital Lille Recruiting Lille, France Contact: Pierre FONTAINE, MD          General Hospital Roubaix Recruiting Roubaix, France Contact: Catherine FERMON          CHU Rouen Recruiting Rouen, France, 76000 Contact: Gaetan prevost, MD Less <<
NCT00207207 Diabetes Mellitus Phase 1 Completed - United States, Massachusetts ... More >> Boston University Medical Center Boston, Massachusetts, United States, 02118 Less <<
NCT00706693 Type 1 Diabetes Mellitus ... More >> Hypoglycemia Less << Not Applicable Completed - Canada, Alberta ... More >> Alberta Children's Hospital Calgary, Alberta, Canada, T3B 6A8 Less <<
NCT00122447 Impaired Glucose Tolerance ... More >> Prediabetic State Less << Not Applicable Completed - United States, Georgia ... More >> Grady Health System Atlanta, Georgia, United States, 30303 Emory University Hospital Atlanta, Georgia, United States, 30322 Less <<
NCT01184014 Hyperglycemia Phase 4 Completed - United States, Minnesota ... More >> Park Nicollet Health Services Methodist Hospital Saint Louis Park, Minnesota, United States, 55416 Less <<
NCT03730610 Obesity Insul... More >>in Resistance Type2 Diabetes Exercise Training Less << Not Applicable Enrolling by invitation December 2020 Finland ... More >> University of Turku Turku, Finland, 20540 Less <<
NCT00122447 - Completed - -
NCT02708875 Insulin Resistance Not Applicable Recruiting June 2018 Australia, Tasmania ... More >> Menzies Institute for Medical Research Recruiting Hobart, Tasmania, Australia, 7000 Contact: Michelle A Keske, PhD    +61362262669    Michelle.Keske@utas.edu.au    Contact: Michelle Keske    +61362262669 Less <<
NCT03328975 Shoulder Injury ... More >> Insulin-dependent Diabetics Less << Not Applicable Withdrawn(PI decided to withdr... More >>aw study) Less << November 1, 2022 -
NCT01549600 Impaired Fasting Glucose Not Applicable Completed - United States, North Carolina ... More >> Duke University Medical Center Durham, North Carolina, United States, 27710 Less <<
NCT03774095 Type 2 Diabetes Mellitus ... More >> Obesity Less << Not Applicable Recruiting December 30, 2018 Denmark ... More >> Odense University Hospital Recruiting Odense, Denmark, 5000 Contact: Karina Sørensen, MSc    26924602       Contact: Kurt Højlund, MD    +45 65413422 Less <<
NCT01371045 - Unknown - United States, California ... More >> Cedars-Sinai Medical Center, Pituitary Center Recruiting Los Angeles, California, United States, 90048 Principal Investigator: John Carmichael, M.D. Less <<
NCT02536950 Diabetes Mellitus, Type 1 Not Applicable Completed - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT00585676 - Unknown - United States, California ... More >> Miller Children's Hospital Recruiting Long Beach, California, United States, 90806 Less <<
NCT00850096 Type 2 Diabetes Phase 2 Completed - United States, Arizona ... More >> Radiant Research Chandler, Arizona, United States, 85225 United States, California AMCR Institute, Inc Escondido, California, United States, 92026 Scripps Whittier Diabetes Clinic LaJolla, California, United States, 92037 Mills-Penninsula Health Services; Dorothy & Frank Diabetes Inst. San Mateo, California, United States, 94401 Diablo Clinical Research Walnut Creek, California, United States, 94598 United States, Colorado Barbara Davis Center Aurora, Colorado, United States, 80045 United States, Florida Clinical Research of West Florida Clearwater, Florida, United States, 33765 University of Miami Diabetes Research Institute Miami, Florida, United States, 33136 Metabolic Research Institute W. Palm Beach, Florida, United States, 33401 United States, Georgia Atlanta Diabetes Associates Atlanta, Georgia, United States, 30309 United States, Hawaii East-West Medical Research Institute Honolulu, Hawaii, United States, 96814 United States, Idaho Rocky Mountain Clinical Research Idaho Falls, Idaho, United States, 83404-7596 United States, Maine Maine Research Associates Auburn, Maine, United States, 04210 United States, Missouri Washington University St. Louis, Missouri, United States, 63110 United States, New York University of Rochester Rochester, New York, United States, 14642 United States, North Carolina Mountain Diabetes and Endocrine Center Asheville, North Carolina, United States, 28803 ECU Diabetes Research Center Greenville, North Carolina, United States, 27834 Physician's East PA Greenville, North Carolina, United States, 27834 United States, Texas Texas Diabetes and Endocrinology Austin, Texas, United States, 78731 University of Texas; Southwestern Medical Center Dallas, Texas, United States, 75390 United States, Washington Rainier Clinical Research Renton, Washington, United States, 98057 Less <<
NCT03300934 Type1 Diabetes Mellitus Not Applicable Completed - Luxembourg ... More >> Clinique des Enfants CHluxembourg Luxembourg, Luxembourg, 1210 Less <<
NCT00850096 - Completed - -
NCT00545727 Type 1 Diabetes ... More >> Type 2 Diabetes Impaired Glucose Metabolism Less << Not Applicable Completed - -
NCT02049034 Type 2 Diabetes Phase 4 Completed - United Kingdom ... More >> University of Surrey FHMS Diabetes and Metabolic Medicine Guildford, Surrey, United Kingdom, GU2 7WG Less <<
NCT01907516 - Completed - -
NCT00978796 Type 1 Diabetes Phase 4 Completed - United States, Colorado ... More >> Barbara Davis Center for Childhood Diabetes Aurora, Colorado, United States, 80010 Less <<
NCT01907516 Diabetes During Pregnancy ... More >> Gestational Diabetes Less << Not Applicable Completed - United States, Hawaii ... More >> Kapiolani Medical Center for Women and Children Honolulu, Hawaii, United States, 96826 Less <<
NCT01894542 Overweight Ob... More >>esity Less << Not Applicable Active, not recruiting December 2018 Norway ... More >> University of Bergen Bergen, Norway Less <<
NCT02531386 Diabetes Not Applicable Completed - Germany ... More >> Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm Ulm, Germany, 89081 Less <<
NCT01510093 Type 2 Diabetes Mellitus Phase 2 Completed - Denmark ... More >> Department of Endocrinology and Internal Diseases Aarhus C, Central Denmark Region, Denmark, 8000 Less <<
NCT03383822 Insulin Resistance Phase 1 Phase 2 Completed - Canada, Ontario ... More >> Tornto General Hospital, UHN Toronto, Ontario, Canada, M5G 1L7 Less <<
NCT01455064 - Completed - -
NCT02669524 Type 2 Diabetes Not Applicable Completed - Denmark ... More >> Center for Diabetes Research, Gentofte Hospital, Copenhagen University Hellerup, Denmark, DK-2900 Less <<
NCT02082028 Diabetes Mellitus Not Applicable Completed - Italy ... More >> Investigational Site Number 016 Andria (BA), Italy Investigational Site Number 011 Avezzano, Italy Investigational Site Number 006 Bergamo, Italy, 24128 Investigational Site Number 002 Brescia, Italy Investigational Site Number 022 Catania, Italy, 95122 Investigational Site Number 001 Cusano Milanino, Italy Investigational Site Number 013 Livorno, Italy Investigational Site Number 015 Lucca, Italy Investigational Site Number 004 Mariano Comense, Italy Investigational Site Number 017 Messina, Italy Investigational Site Number 008 Milano, Italy Investigational Site Number 018 Napoli, Italy Investigational Site Number 021 Potenza, Italy Investigational Site Number 020 Ragusa, Italy Investigational Site Number 014 Ravenna, Italy Investigational Site Number 012 Rimini, Italy, 47900 Investigational Site Number 009 Roma, Italy Investigational Site Number 019 Terlizzi (BA), Italy Investigational Site Number 007 Torino, Italy Investigational Site Number 003 Udine, Italy Less <<
NCT02986906 Ulnar Neuropathy at Elbow Not Applicable Recruiting May 31, 2019 Taiwan ... More >> Department of Physical Medicine and Rehabilitation, Tri-Service General Hospital Not yet recruiting Taipei, Neihu District, Taiwan, 886 Contact: Yung-Tsan Wu, MD    886-2-8792-3311 ext 17068    crwu98@gmail.com    Department of Physical Medicine and Rehabilitation, Tri-Service General Hospital Recruiting Taipei, Neihu District, Taiwan, 886 Contact: Yung-Tsan Wu, MD    886-2-8792-3311 ext 17068    crwu98@gmail.com Less <<
NCT02978001 - Recruiting January 1, 2019 Denmark ... More >> Center for Diabetes Research, Gentofte Hospital, Denmark Recruiting Hellerup, Copenhagen, Denmark, 2100 Less <<
NCT01455064 - Completed - United States, Georgia ... More >> Atlanta Diabetes Associates Atlanta, Georgia, United States, 30309 United States, New Mexico Southwest Clinical Research Center Santa Fe, New Mexico, United States, 87505 Less <<
NCT02608177 Chronic Kidney Diseases ... More >> Type 2 Diabetes Less << Not Applicable Completed - United States, Washington ... More >> University of Washington Seattle, Washington, United States Less <<
NCT00805506 - Completed - United States, Minnesota ... More >> International Diabetes Center Minneapolis, Minnesota, United States, 55416 Less <<
NCT02608177 - Completed - -
NCT02663661 Diabetes Mellitus, Type 1 Not Applicable Recruiting December 2018 United States, Virginia ... More >> University of Virginia, Center for Diabetes Technology Recruiting Charlottesville, Virginia, United States, 22903 Contact: Jennifer Puskaric, RN    434-924-71643    jlw5k@virginia.edu    Contact: Mary Oliveri, MS, CCRP    434-960-6818    mc7m@virginia.edu    Sub-Investigator: Boris Kovatchev, Ph.D.          Sub-Investigator: Marc Breton, Ph.D.          Sub-Investigator: Mark DeBoer, MD, MSc., MCR          Sub-Investigator: Anthony McCall, MD, PhD          Sub-Investigator: Daniel Cherñavvsky, MD, CRC          Sub-Investigator: Stephen Patek, PhD          Sub-Investigator: Christian Wakeman, M.S. Less <<
NCT02416765 Type 1 Diabetes Phase 2 Completed - Canada, Quebec ... More >> Institut de recherches cliniques de Montréal Montreal, Quebec, Canada, H2W1R7 Less <<
NCT03267576 Diabetes Mellitus, Type 2 Phase 4 Completed - Mexico ... More >> Consultorio Privado Guadalajara, Mexico, 44150 Investigación Clínica Especializada Guadalajara, Mexico, 44600 Consultorio Privado en Unidad de Patología Clínica Guadalajara, Mexico, 44650 Instituto Nacional de Ciencias Medicas y Nutrición Salvador Zubirán Mexico City, Mexico, 14080 Hospital Universitario 'Dr. Jose Eleuterio Gonzalez' Monterrey, Mexico, 64460 Less <<
NCT00472342 Impaired Glucose Tolerance ... More >> Diabetes Less << Not Applicable Unknown December 2007 Korea, Republic of ... More >> Mi Young Lee Recruiting Wonju, Kangwon-Do, Korea, Republic of, 220-701 Contact: Mi Young Lee, Dr    82-33-741-0681    domoe46@yonsei.ac.kr Less <<
NCT03135015 Insulin Resistance, Diabetes Phase 1 Completed - Canada, Ontario ... More >> Glycemic Index Laboratories, Inc. Toronto, Ontario, Canada, M5C 2N8 Less <<
NCT03550105 Diabetes Mellitus ... More >> Glucose Metabolism Disorders Physical Activity Less << Not Applicable Enrolling by invitation July 1, 2023 United States, Florida ... More >> CIC Miami Miami, Florida, United States, 33136 Less <<
NCT02288273 - Completed - -
NCT02599740 Healthy Not Applicable Completed - Germany ... More >> Charité Research Organisation GmbH Berlin, Germany Less <<
NCT01726777 Type 2 Diabetes Mellitus ... More >> Vitamin D Deficiency Less << Phase 2 Completed - Canada, Ontario ... More >> University of Guelph Guelph, Ontario, Canada, N1G 2W1 Glycemic Index Laboratories Toronto, Ontario, Canada, M5C 2N8 Canada, Quebec Institut de recherches cliniques de Montréal Montreal, Quebec, Canada, H2W 1R7 Less <<
NCT03426956 Overweight Not Applicable Recruiting May 1, 2019 Denmark ... More >> Dept. of Endocrinology Recruiting Hvidovre, Denmark, 2650 Contact: Christoffer Martinussen, MD    +4538623032    christoffer.martinussen@regionh.dk    Principal Investigator: Christoffer Martinussen, MD Less <<
NCT02994459 - Recruiting January 2021 United States, Missouri ... More >> Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: Stephan van Vliet, PhD    314-362-5001    svanvliet@wustl.edu    Principal Investigator: Bettina Mittendorfer, PhD Less <<
NCT02288273 Type 2 Diabetes Phase 4 Completed - -
NCT02834689 Walking Seate... More >>d Control Less << Not Applicable Active, not recruiting December 2018 Canada, British Columbia ... More >> University of British Columbia, Okanagan. Kelowna, British Columbia, Canada, V1V 1V7 Less <<
NCT01152372 Diabetes Phase 1 Completed - United States, California ... More >> Profil Institute For Clinical Research, Inc. (Picr) Chula Vista, California, United States, 91911 Less <<
NCT02881060 Hypoglycemia ... More >>Diabetes Mellitus, Type 1 Less << Phase 4 Completed - Denmark ... More >> Hvidovre University Hospital Hvidovre, Denmark, 2650 Less <<
NCT01447121 Diabetes Not Applicable Completed - United States, California ... More >> AMCR Institute Escondido, California, United States, 92026 Less <<
NCT00819884 Type II Diabetes Phase 1 Completed - United States, Texas ... More >> Research Site San Antonio, Texas, United States Less <<
NCT01447121 - Completed - -
NCT00114855 Hyperlipidemia ... More >> Glucose Metabolism Disorders Less << Not Applicable Completed - Norway ... More >> Lipidklinikken, Rikshospitalet Oslo, Norway, 0027 Less <<
NCT03748433 Diabetes Mellitus, Type 1 ... More >> Hypoglycemia Unawareness Hypoglycemia Less << Not Applicable Not yet recruiting September 9, 2019 United Kingdom ... More >> Imperial College Clinical Research Facility London, United Kingdom Less <<
NCT02897154 - Completed - United States, California ... More >> Diablo Clinical Research Walnut Creek, California, United States, 94598 United States, Kentucky Kentucky Clinical Trials Laboratory Louisville, Kentucky, United States, 40202 United States, Ohio Cleveland Clinic Cleveland, Ohio, United States, 44195 Less <<
NCT01580176 Other Surgical Procedures Not Applicable Completed - Germany ... More >> University Hospital Heidelberg, Department of Anaesthesiology Heidelberg, Germany, D-69120 Less <<
NCT02509065 Type 1 Diabetes ... More >> Type 2 Diabetes Less << Not Applicable Completed - United States, Massachusetts ... More >> Masscahusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT02321111 Insulin Sensitivity Phase 2 Terminated(Study drug expired) - United States, Texas ... More >> Audie L. Murphy VA Hospital, STVHCS San Antonio, Texas, United States, 78229 Less <<
NCT00994357 Diabetes Preg... More >>nancy Less << Not Applicable Completed - -
NCT02855879 - Unknown - France ... More >> CHU Dijon Bourgogne Recruiting Dijon, France, 21079 Contact: Bruno VERGES    03 80 29 34 53 ext 33    bruno.verges@chu-dijon.fr Less <<
NCT00069602 Diabetes Mellitus Phase 4 Completed - United States, California ... More >> Division of Pediatric Endocrinology and Diabetes, Stanford University Stanford, California, United States, 94305-5208 United States, Colorado Barbara Davis Center for Childhood Diabetes, University of Colorado Denver, Colorado, United States, 80262 United States, Connecticut Department of Pediatrics, Yale University School of Medicine New Haven, Connecticut, United States, 06519 United States, Florida Nemours Children's Clinic Jacksonville,, Florida, United States, 32207 Jaeb Center for Health Research Tampa, Florida, United States, 33647 United States, Iowa Department of Pediatrics, University of Iowa Carver College of Medicine Iowa City, Iowa, United States, 52242 Less <<
NCT01441986 Type 2 Diabetes Mellitus Phase 2 Completed - Germany ... More >> Profil Institute for Metabolic Research Neuss, NRW, Germany, 41460 Less <<
NCT03445065 Diabetes Mellitus Not Applicable Recruiting January 31, 2019 France ... More >> CHU Amiens Picardie Not yet recruiting Amiens, France, 80054 CHU Caen Normandie Recruiting Caen, France, 14033 CHU Grenoble Alpes Recruiting La Tronche, France, 38700 CHRU de Lille Not yet recruiting Lille, France, 59037 APHM - Hopital Sainte-Marguerite Recruiting Marseille, France, 13274 CHU de Montpellier Recruiting Montpellier, France, 34295 Paris Lariboisière Recruiting Paris, France, 75475 APHP Groupe Hospitalier Cochin (Paris) Not yet recruiting Paris, France, 75679 Centre Hospitalier Lyon Sud Recruiting Pierre Benite, France, 69310 CHU de Poitiers Not yet recruiting Poitiers, France, 86021 CHU de Nantes Recruiting St Herblain, France, 44800 CHRU de Strasbourg Recruiting Strasbourg, France, 67091 CHU de Toulouse Recruiting Toulouse, France, 31059 CHU de Nancy Not yet recruiting Vandoeuvre Les Nancy, France, 54511 Institut de diabétologie et Nutrition du Centre Recruiting Vernouillet, France, 28500 Less <<
NCT02253121 Hyperglycemia Steroid-induced Phase 4 Completed - Netherlands ... More >> Slotervaart Hospital Amsterdam, Netherlands, 1066 EC OLVG West Amsterdam, Netherlands Spaarne Ziekenhuis Hoofddorp, Netherlands Isala Zwolle, Netherlands Less <<
NCT02509065 - Completed - -
NCT02099929 Healthy Not Applicable Completed - Brazil ... More >> Laboratório de Bioquímica da Nutrição, Núcleo de Nutrição e Medicina Tropical, Universidade de Brasília Brasília, DF, Brazil, 70910-900 Less <<
NCT02135068 Type 1 Diabetes Early Phase 1 Completed - United States, Connecticut ... More >> Yale University School of Medicine New Haven, Connecticut, United States, 06520 Less <<
NCT01788527 Type 1 Diabetics Who Are Pregn... More >>ant or Planning Pregnancy Less << Not Applicable Completed - -
NCT00709839 Healthy Phase 4 Completed - Austria ... More >> Division of Endocrinology and Metabolism, Department of Medicine III, Medical University of Vienna Vienna, Austria, A-1090 Less <<
NCT00627744 Myocardial Infarction ... More >> Unstable Angina Pectoris Diabetes Mellitus Impaired Glucose Tolerance Less << Phase 4 Completed - Sweden ... More >> Karolinska Institutet Stockholm, Sweden, 171 76 Karolinska University Hospital Solna Stockholm, Sweden Less <<
NCT00621348 Hyponatremia Phase 3 Completed - India ... More >> All India Institute of Medical Sciences New Delhi, Delhi, India, 110029 Less <<
NCT00621348 - Completed - -
NCT00091507 Angina, Unstable ... More >> Cardiovascular Diseases Heart Diseases Coronary Disease Myocardial Infarction Heart Failure, Congestive Less << Phase 3 Completed - United States, Alaska ... More >> Anchorage Site Anchorage, Alaska, United States, 99501 United States, Connecticut New Haven Site New Haven, Connecticut, United States, 06511 United States, Georgia Macon Site Macon, Georgia, United States, 31208 United States, Massachusetts Brockton Site Brockton, Massachusetts, United States, 02301 Concord Site Concord, Massachusetts, United States, 01742 United States, Minnesota St. Paul Site St. Paul, Minnesota, United States, 55128 United States, New Mexico Albuquerque Site Albuquerque, New Mexico, United States, 87131 United States, Pennsylvania Hershey Site Hershey, Pennsylvania, United States, 17033 United States, South Dakota Sioux Falls Site Sioux Falls, South Dakota, United States, 57104 United States, Texas Dallas Site Dallas, Texas, United States, 75201 El Paso Site El Paso, Texas, United States, 79905 United States, Washington Bellingham Site Bellingham, Washington, United States, 98225 United States, Wisconsin Milwaukee Site Milwaukee, Wisconsin, United States, 53226 Less <<
NCT02036372 Diabetes Mellitus Type II Not Applicable Completed - Netherlands ... More >> Academic Medical Center Amsterdam Amsterdam, Please Select, Netherlands, 1105AZ Onze Lieve Vrouwe Gasthuis Amsterdam, Netherlands Diakonessenhuis Utrecht, Netherlands, 3582 KE Less <<
NCT01385995 Impaired Glucose Tolerance ... More >> Obstructive Sleep Apnea Less << Phase 2 Completed - -
NCT01385995 - Completed - -
NCT00091507 - Completed - -
NCT01959984 Diabetes Not Applicable Unknown December 2013 China, Shanghai ... More >> Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai, China, 200021 Less <<
NCT02974478 Healthy Not Applicable Completed - Germany ... More >> Institute of Nutritional Medicine, University of Hohenheim Stuttgart, Germany, 70599 Less <<
NCT01597167 Depression Not Applicable Completed - United States, Florida ... More >> University of Miami Clinical Research Building Miami, Florida, United States, 33136 Less <<
NCT01999543 Healthy Subjects Not Applicable Completed - India ... More >> Lambda Therapeutics Research Ltd (LTRL) Ahemdabad, India Less <<
NCT01548222 - Completed - United States, California ... More >> Diabetes Care Center Salinas, California, United States, 93901 Less <<
NCT01930097 Type 1 Diabetes Phase 2 Completed - Canada, Quebec ... More >> Institut de recherches cliniques de Montréal Montreal, Quebec, Canada, H2W1R7 Less <<
NCT02827318 Hunger Not Applicable Completed - United Kingdom ... More >> Swansea University Swansea, West Glamorgan, United Kingdom, SA2 8PP Less <<
NCT00812539 Diabetes Mellitus, Type 2 Not Applicable Completed - United States, Massachusetts ... More >> Partners HealthCare Hospitals/Clinics (Massachusetts General Hospital, Brigham and Womens Hospital) Boston, Massachusetts, United States, 02114 Less <<
NCT00848822 - Completed - United States, Arizona ... More >> Steele Research Memorial Foundation, Angel Clinic for Children with Diabetes and Endocrine Disorders Tucson, Arizona, United States, 85724 Less <<
NCT00573781 Metabolic Syndrome ... More >> Obesity Impaired Glucose Tolerance Impaired Fasting Glucose Less << Phase 2 Completed - Finland ... More >> University of Kuopio, Department of Clinical Nutrition Kuopio, Finland, 70211 Less <<
NCT02160275 Diabetes Mellitus, Type 1 Not Applicable Completed - Netherlands ... More >> Rijnstate Hospital Arnhem, Gelderland, Netherlands, 6815 AD Academic Medical Center Amsterdam, Noord-Holland, Netherlands, 1105 AZ Less <<
NCT03713190 End Stage Renal Disease Phase 2 Recruiting December 2020 Italy ... More >> Department of Endocrinology and Metabolism, University of Pisa Recruiting Pisa, Italy, 56124 Contact: Stefano Del Prato, MD    +39 050 995103    stefano.delprato@med.unipi.it    Sub-Investigator: Giuseppe Daniele, MD Less <<
NCT02512523 Type 2 Diabetes Mellitus Phase 4 Unknown - Korea, Republic of ... More >> HANDOK Inc. Recruiting Seoul, Korea, Republic of Contact: Sejin Kim, CRM       SeJin.Kim@handok.com    Contact: Sojung Park, CPL       SoJung.Park@handok.com Less <<
NCT02457897 Insulin Resistance ... More >> Diabetes Mellitus Abnormal Glucose Metabolism Less << Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT01720511 Type 2 Diabetic Not Applicable Completed - United States, Louisiana ... More >> Pennington Biomedical Research Center Baton Rouge, Louisiana, United States, 70808 Less <<
NCT03620357 Diabetes Mellitus, Type 2 Not Applicable Recruiting December 31, 2019 United States, California ... More >> Diabetes/Lipid Managment and Research Center Recruiting Huntington Beach, California, United States, 92648 Contact: Ni Yao       niyao@researchca.com    Principal Investigator: Paul D. Rosenblit, M.D., Ph.D.          United States, Georgia Atlanta Diabetes Associates Recruiting Atlanta, Georgia, United States, 30318 Contact: Tracy Lawrence       Tlawrence@atlantadiabetes.com    Principal Investigator: Bruce W. Bode, M.D.          United States, Maryland MODEL Clinical Research (Towson) Recruiting Baltimore, Maryland, United States, 21204 Contact: Karen Klein    443-524-1789    KarenKlein99@hotmail.com    Principal Investigator: Philip Levin, M.D.          United States, Nevada Las Vegas Endocrinology Recruiting Henderson, Nevada, United States, 89052 Contact: Alejandra Martinez       zillah725@gmail.com    Contact: Loida Nguyen       loida.lvendo@gmail.com    Principal Investigator: Quang Nguyen, D.O.          United States, Texas Diabetes and Glandular Disease Clinic Recruiting San Antonio, Texas, United States, 78229 Contact: Terri Ryan       Terri.Ryan@dgdclinic.com    Principal Investigator: Mark Kipnes, M.D. Less <<
NCT02282475 - Enrolling by invitation October 31, 2018 -
NCT02740829 Diabetes Phase 1 Completed - -
NCT02248272 Impaired Glucose Tolerance ... More >> Hyperinsulinism Poor Glycemic Control Hyperglycemia Insulin Sensitivity Less << Not Applicable Completed - -
NCT01711476 Polycystic Ovary Syndrome (PCO... More >>S) Women Less << Not Applicable Unknown January 2013 Venezuela ... More >> Daniela Jakubowicz Recruiting Caracas, San Bernardino, Venezuela, 410 Principal Investigator: Daniela Jakubowicz, MD Less <<
NCT03234491 Post-Prandial Hyperglycemia ... More >> Post-Prandial Hypoglycemia Less << Phase 1 Recruiting February 1, 2022 United States, Connecticut ... More >> Yale Diabetes Research Clinic Recruiting New Haven, Connecticut, United States, 06511 Contact: Lori Carria    203-737-3595    lori.carria@yale.edu    Contact: Kristen Kraemer       kristen.kraemer@yale.edu Less <<
NCT01223690 Sepsis Severe... More >> Sepsis Septic Shock Less << Phase 3 Completed - Greece ... More >> 3rd Department of Critical Care Medicine, National and Kapodistrian University of Athens Athens, Greece, 11528 2nd Department of Critical Care Medicine, National and Kapodistrian University of Athens Athens, Greece, 12462 4th Department of Internal Medicine, National and Kapodistrian University of Athens Athens, Greece, 12462 2nd Department of Medicine, Sismanogleion General Hospital Athens, Greece, 15126 1st Department of Medicine, University of Patras Patras, Greece, 24100 2nd Department of Surgery, University of Thessaloniki Thessaloniki, Greece, 54635 Less <<
NCT03024983 Dietary Modification Not Applicable Completed - Italy ... More >> Department of Food Science, University of Parma Parma, Italy, 43125 Less <<
NCT02056353 Critical Illness ... More >> Hyperglycemia Hypoglycemia Less << Not Applicable Completed - Belgium ... More >> Jessa Hospital Hasselt, Belgium, 3500 Dept Intensive Care Medicine, University Hospitals Leuven Leuven, Belgium, 3000 Medical Intensive Care, University Hospitals Leuven Leuven, Belgium, 3000 Netherlands Academic Medical Center (AMC) Amsterdam, Netherlands, 1105 Less <<
NCT02021526 Glucose Transporter Type 1 Def... More >>iciency Syndrome Glut1 Deficiency Syndrome Less << Phase 1 Phase 2 Not yet recruiting June 2019 United States, Texas ... More >> UT Southwestern Medical Center Not yet recruiting Dallas, Texas, United States, 75390 Less <<
NCT03368209 Diabetes Not Applicable Terminated(Failed to recruit s... More >>ufficient subjects) Less << - Denmark ... More >> Department of Endocrinology M, Odense University Hospital Odense, Denmark, 5000 Less <<
NCT02318693 - Completed - -
NCT01867307 Diabetes Mellitus, Type 2 ... More >> Healthy Less << Phase 2 Completed - United States, Texas ... More >> Boehringer Ingelheim Investigational Site San Antonio, Texas, United States Less <<
NCT01535105 - Unknown April 2017 Israel ... More >> Clalit Health Services Clinic Recruiting Jisr az-Zarqa village, Israel Contact: Nehama Zuckerman-Levin, MD    072524354143    zuckerln@netvision.net.il    Principal Investigator: Nehama Zuckerman-Levin, MD Less <<
NCT02318693 Type 2 Diabetes Mellitus Phase 4 Completed - -
NCT03358121 - Completed - Germany ... More >> Medizinische Klinik, University Hospital Heidelberg, Baden-Wuerttemberg, Germany, 60120 Less <<
NCT01966393 Type 1 Diabetes Phase 2 Completed - Canada, Quebec ... More >> Institut de recherches cliniques de Montréal Montreal, Quebec, Canada, H2W 1R7 Less <<
NCT01889628 Diabetes Impa... More >>ired Glucose Tolerence Less << Not Applicable Completed - Singapore ... More >> Clinical Nutrition Research Centre Singapore, Singapore, 117599 Less <<
NCT01867307 - Completed - -
NCT03023293 - Active, not recruiting December 2019 China, Guangdong ... More >> Weijia, Wu Guangzhou, Guangdong, China Less <<
NCT02146157 Prediabetes Not Applicable Completed - United States, Illinois ... More >> Radiant Research Chicago, Illinois, United States, 60610 United States, Kentucky Central Kentucky Research Associates Lexington, Kentucky, United States, 40509 United States, Michigan Quest Research Institute Bingham Farms, Michigan, United States, 48025 United States, Ohio Radiant Research Cincinnati, Ohio, United States, 45249 Providence Health Partners Center for Clinical Research Dayton, Ohio, United States, 45439 United States, South Carolina Mountain View Clinical Research Greer, South Carolina, United States, 29651 Less <<
NCT02073188 Diabetes Mellitus Phase 3 Completed - Italy ... More >> Sanofi -Aventis Administrative Office Milano, Italy Less <<
NCT00228345 Idiopathic Axonal Polyneuropat... More >>hy Abnormal OGTT Less << Phase 1 Terminated(Study Completed) - United States, Illinois ... More >> University of Chicago Chicago, Illinois, United States, 60637 Less <<
NCT02696252 - Completed - United States, California ... More >> AMCR Institute Escondido, California, United States, 92025 United States, Idaho Rocky Mountain Diabetes and Osteoporosis Center Idaho Falls, Idaho, United States, 83404 United States, Massachusetts Joslin Diabetes Center Boston, Massachusetts, United States, 02215 United States, Texas Clinical Trials of Texas San Antonio, Texas, United States, 78229 Less <<
NCT01378208 Intermittent Fasting ... More >> Meal Frequency Less << Not Applicable Completed - Denmark ... More >> Centre of Inflammation and Metabolism, Rigshospitalet Copenhagen OE, Copenhagen, Denmark, 2100 Less <<
NCT01947855 Diabetes Mellitus, Type 2 Phase 3 Completed - Japan ... More >> 1245.35.002 Boehringer Ingelheim Investigational Site Shinjyuku-ku, Tokyo, Japan 1245.35.001 Boehringer Ingelheim Investigational Site Suita-shi, Osaka, Japan Less <<
NCT02642640 Glucose Circa... More >>dian Rhythm Melatonin Genes Less << Not Applicable Recruiting June 2019 United States, Massachusetts ... More >> Brigham and Women's Hospital Recruiting Boston, Massachusetts, United States, 02115 Contact: Lauren Kelly    617-278-0662    lkelly17@bwh.harvard.edu    Contact: Jingyi Qian, PhD    617-525-7423    jqian@bwh.harvard.edu    Principal Investigator: Frank AJL Scheer, PhD Less <<
NCT03243903 Diabetes Not Applicable Recruiting August 30, 2018 China, Beijing ... More >> Peking University People 's Hospital Recruiting Beijing, Beijing, China, 10000 Contact: Ji Li Nong          Contact: Gao LeiLi Less <<
NCT02154074 Perioperative Blood Glucose an... More >>d Insulin Less << Phase 4 Unknown October 2014 China, Shanxi ... More >> SecondXianJiaotongU Recruiting Xi'an, Shanxi, China Contact: Hongtao Liu    13572225310    lannylouis@163.com Less <<
NCT01825720 Valvular Heart Disease Not Applicable Completed - Korea, Republic of ... More >> Department of Anesthesiology and Pain Medicine, Anesthesia and Pain Research Institute Seoul, Korea, Republic of, 120-752 Less <<
NCT02568384 Diabetes Mellitus Not Applicable Completed - United States, California ... More >> AMCR Institute Escondido, California, United States, 92025 Less <<
NCT01947855 - Completed - -
NCT00740363 Glucose Intolerance Phase 4 Completed - Norway ... More >> Rikshospitalet Medical Center Oslo, Norway, 0027 Less <<
NCT02100488 Diabetes Mellitus, Type 1 Not Applicable Completed - Spain ... More >> Hospital Clínic i Universitari de Barcelona Barcelona, Spain, 08036 Hospital Clínico Universitario de Valencia Valencia, Spain, 46010 Less <<
NCT02568384 - Completed - -
NCT02898428 - Completed - Denmark ... More >> Steno Diabetes Center Copenhagen Gentofte, Denmark, 2820 Less <<
NCT01496768 Effect of Chronic Leucine Supp... More >>lementation on Glucose Homeostasis, Lipid Profile, Body Composition, and Muscle Mass and Strenght Less << Not Applicable Suspended February 2013 Brazil ... More >> University of São Paulo - School of Physical Education and Sports Sao Paulo, SP, Brazil, 05508030 Less <<
NCT00915954 Acromegaly Ty... More >>pe 2 Diabetes Mellitus Less << Phase 4 Unknown - United States, California ... More >> Cedars-Sinai Medical Center Pituitary Center Recruiting Los Angeles, California, United States, 90048 Principal Investigator: John Carmichael, MD Less <<
NCT02003274 Type 1 Diabetes Mellitus Not Applicable Active, not recruiting October 31, 2017 Italy ... More >> Clinical Research Center-University Hospital of Verona c/o Policlinico G.B. Rossi - Piazzale L.A. Scuro, 10, Verona, Italy, 37134 Division of Endocrinology and Metabolic Diseases - University Hospital of Verona Piazzale Stefani 1-Pad. 22, Verona, Italy, 37126 Less <<
NCT01185119 Healthy Phase 2 Phase 3 Completed - Denmark ... More >> Aarhus University, Institute of Pharmacology Aarhus C, Aarhus, Denmark, 8000 Less <<
NCT01987687 Area Under Curve [N06.850.520.... More >>830.200] Less << Not Applicable Suspended(Lack of funding) April 2017 United Kingdom ... More >> Northumbria University Newcastle upon Tyne, Tyne and Wear, United Kingdom, NE1 8ST Less <<
NCT01108640 - Completed - United States, Connecticut ... More >> Yale New Haven Hospital New Haven, Connecticut, United States, 06510 Less <<
NCT03530644 Type1diabetes Not Applicable Active, not recruiting November 30, 2018 Denmark ... More >> Steno Diabetes Center Odense Odense, Denmark, 5000 Less <<
NCT00784745 Insulin Resistance ... More >> Glucose Intolerance Less << Not Applicable Completed - Denmark ... More >> Bispebjerg Hospital Copenhagen, Denmark, 2300 Less <<
NCT01578460 Type 2 Diabetes Mellitus ... More >> Gestational Diabetes Less << Not Applicable Completed - Canada, Ontario ... More >> Western University London, Ontario, Canada, N6G 4X8 Less <<
NCT02862730 - Completed - -
NCT03644004 - Not yet recruiting April 2019 France ... More >> Centre hospitalier Lucien Hussel Not yet recruiting Vienne, France Contact: Arthur PETILLOT    06.37.11.31.21 ext +33    arthur.petillot@etu.univ-lyon1.fr    Contact: Sophie MISSOL    06.46.10.41.49 ext +33    sophie.missol@etu.univ-lyon1.fr    Principal Investigator: Laura BOGENMANN, MD Less <<
NCT03426228 - Recruiting December 31, 2019 United Arab Emirates ... More >> Fakih IVF Recruiting Dubai, United Arab Emirates, 72960 Contact: Ayla Coussa, Dietitian    00971 4 349 7600 ext 162    a.coussa@warwick.ac.uk    Contact: Michael Fakih, MD    00971 4 349 7600 ext 117    mfakih@fakihivf.com Less <<
NCT01550809 Type 1 Diabetes Phase 3 Completed - Spain ... More >> Hospital Clínico Universitario Valencia, Spain, 46010 Less <<
NCT00733174 Impaired Glucose Tolerance Phase 4 Unknown - United States, Colorado ... More >> South Federal Family Practice Recruiting Denver, Colorado, United States, 80219 Contact: Annette Grissett, MA    303-934-2202    annetteg@roydurbin.com    Contact: Stacey Mitchell, BSN, RN    303-399-8020 ext 2059    stacey.mitchell@va.gov Less <<
NCT01781533 Diabetes Not Applicable Completed - Austria ... More >> Medical University of Graz Graz, Styria, Austria, 8010 Less <<
NCT01550809 - Completed - -
NCT02365740 Diabetes Mellitus, Type 1 Not Applicable Unknown November 2016 Italy ... More >> Dept. of "Medicina Clinica e Chirurgia" of Federico II University Recruiting Naples, Italy, 80131 Contact: Brunella Capaldo, MD    0817462311    bcapaldo@unina.it    Contact: Roberta Lupoli, MD    0817462427    sereroby@yahoo.it    Principal Investigator: Brunella Capaldo, MD          Sub-Investigator: Roberta Lupoli, MD          Sub-Investigator: Lutgarda Bozzetto, MD          Sub-Investigator: Giovanni Annuzzi, MD Less <<
NCT02915250 Type 2 Diabetes Mellitus Phase 1 Completed - Germany ... More >> Profil Mainz GmbH & Co.KG Mainz, Germany, 55116 Profil GmbH Neuss, Germany, 41460 Less <<
NCT01754337 Type 1 Diabetes Phase 2 Completed - Canada, Quebec ... More >> Institut de recherches cliniques de Montréal Montreal, Quebec, Canada, H2W 1R7 Less <<
NCT00732160 Diabetes Mellitus Not Applicable Completed - United States, Tennessee ... More >> Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232 Less <<
NCT02862730 Type 1 Diabetes Not Applicable Completed - United States, Oregon ... More >> Oregon Health and Science University Portland, Oregon, United States, 97239 Less <<
NCT00682903 Diabetes Complications Not Applicable Completed - France ... More >> CHU timone Marseille, Bouches du Rhone, France, 13005 Less <<
NCT03138902 Carbohydrate Intolerance Not Applicable Completed - -
NCT03607435 Diabetes Not Applicable Recruiting July 2019 United States, Florida ... More >> Florida Hospital Tampa Recruiting Tampa, Florida, United States, 33613 Contact: Juliet Bala, CCRC    813-610-8110    juliet.bala@ahss.org Less <<
NCT03447301 Type 2 Diabetes Mellitus Not Applicable Not yet recruiting December 25, 2018 Saudi Arabia ... More >> Buraidah Diabetic Center Not yet recruiting Buraidah, Al-Qassim, Saudi Arabia, 52366 Contact: Saddik Zaghoul, MBBS       mohamed_saddik@hotmail.com Less <<
NCT01089569 Type 2 Diabetes Not Applicable Completed - United States, Minnesota ... More >> International Diabetes Center Minneapolis, Minnesota, United States, 55416 Less <<
NCT00732160 - Completed - -
NCT03519841 Diabetes Mellitus Not Applicable Completed - Denmark ... More >> Steno Diabetes Center Odense Odense, Denmark, 5000 Less <<
NCT01168947 Fluid Overload and Hypertensio... More >>n in Hemodialysis Patients Less << Not Applicable Completed - United States, New York ... More >> Yorkville Dialysis Center New York, New York, United States, 10128 Less <<
NCT03350997 Metabolic Disease ... More >> Adipose Tissue Less << Not Applicable Recruiting November 2024 United States, Michigan ... More >> University of Michigan Recruiting Ann Arbor, Michigan, United States, 48109 Principal Investigator: Jeff F Horowitz Less <<
NCT02634164 Hyperglycemia Not Applicable Completed - -
NCT01402362 - Unknown - Israel ... More >> Diabetes and Endocrinology Unit, Hillel Yaffe MC, POB169 Not yet recruiting Hadera, Israel, 38100 Contact: Anat Jaffe, MD PhD    +97246304748    jaffe@hy.health.gov.il    Sub-Investigator: Liana Tripto, MD          Principal Investigator: Anat Jaffe, MD PhD Less <<
NCT01089569 - Completed - -
NCT02988011 Type2 Diabetes ... More >> Weight Loss Insulin Sensitivity Metabolism and Nutrition Disorder Metabolism Disorder, Glucose Bariatric Surgery Candidate Less << Not Applicable Recruiting December 2020 Sweden ... More >> Uppsala univeristy hospital Recruiting Uppsala, Sweden, 75185 Less <<
NCT02509858 Diabetes Mellitus Not Applicable Completed - -
NCT02761434 Insulin Resistance Not Applicable Completed - United States, Arkansas ... More >> University of Arkansas Fayetteville, Arkansas, United States, 72701 Less <<
NCT01993186 Glucose Transporter Type 1 Def... More >>iciency Syndrome (Glut1 DS) Less << Phase 2 Completed - United States, Colorado ... More >> Children's Hospital Colorado - University of Colorado, Denver, School of Medicine Aurora, Colorado, United States, 80045 United States, Florida Miami Children's Hospital Miami, Florida, United States, 33155 Neurology & Epilepsy Research Center Orlando, Florida, United States, 32819 United States, New York Columbia University - Department of Neurology New York, New York, United States, 10032 Columbia University Medical Center New York, New York, United States, 10032 United States, Texas Cook Children's Hospital Fort Worth, Texas, United States, 76104 University of Texas Neurometabolic Clinic Houston, Texas, United States, 77030 United States, Washington Seattle Children's Hospital Seattle, Washington, United States, 98105 Australia, Victoria Melbourne Brain Centre Heidelberg, Victoria, Australia, 3084 France Service de Neurologie Pédiatrique et des Maladies Métaboliques - INSERM U1141 Hôpital Robert Debré - APHP Paris, Cedex 19, France, 75935 Israel Sheba University Medical Center Tel Aviv, Israel Italy Unita' Operativa Neurologia Pediatrica e Malattie Muscolari Istituto "Giannina Gaslini" Genova, Italy Spain Hospital Sant Joan de Deu Barcelona, Spain United Kingdom Newcastle University Newcastle Upon Tyne, United Kingdom Less <<
NCT01488383 Hyperglycemia ... More >> Hypertension Less << Not Applicable Withdrawn(not i) September 2013 Spain ... More >> Basque Public Health Service-Osakidetza (Lakuabizkarra primary care center and Txagorritxu hospital) Vitoria-Gasteiz, Alava, Spain, 01009 Less <<
NCT01272427 Obesity Not Applicable Completed - Canada, Ontario ... More >> Department of Nutritional Sciences Toronto, Ontario, Canada, M5S 3E2 Less <<
NCT03758430 - Not yet recruiting May 17, 2019 United States, Massachusetts ... More >> Joslin Diabetes Center Not yet recruiting Boston, Massachusetts, United States, 02215 Principal Investigator: Elena Toschi Less <<
NCT02461394 Diabetes Not Applicable Completed - Germany ... More >> Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm Ulm, Germany, 89081 Less <<
NCT02133313 - Completed - United States, Alabama ... More >> University of Alabama at Birmingham Home Dialysis Unit (Red Mountain Home Dialysis) Birmingham, Alabama, United States, 35294 Less <<
NCT00282867 - Completed - -
NCT01787318 Type 1 Diabetes Early Phase 1 Completed - United States, Connecticut ... More >> Yale University School of Medicine New Haven, Connecticut, United States, 06520 Less <<
NCT00442884 Type 2 Diabetes Not Applicable Completed - Switzerland ... More >> University Hospital of Zurich, Division of Endocrinology and Diabetes Zurich, Switzerland, 8091 Less <<
NCT00282867 Stroke Hyperg... More >>lycemia Less << Phase 2 Completed - United States, Georgia ... More >> Medical College of Georgia Augusta, Georgia, United States, 30912 United States, Virginia University of Virginia Charlottesville, Virginia, United States, 22908 Less <<
NCT02792400 Type 2 Diabetes Not Applicable Unknown May 2017 Denmark ... More >> Center for Diabetes Research, Gentofte Hospital, Copenhagen University Hellerup, Denmark, DK-2900 Less <<
NCT02337556 Critically Ill Mechanically Ve... More >>ntilated Subjects Less << Not Applicable Completed - United States, Georgia ... More >> Emory University Hospital Atlanta, Georgia, United States, 30322 United States, Illinois University of Chicago Medicine Chicago, Illinois, United States, 60637 United States, Kentucky University of Kentucky Albert B. Chandler Hospital Lexington, Kentucky, United States, 40536 United States, Minnesota Regions Hospital Saint Paul, Minnesota, United States, 55101 United States, North Carolina Wake Forest University Health Sciences Winston-Salem, North Carolina, United States, 27157 United States, Tennessee Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232 Canada, Ontario Queen's University Kingston, Ontario, Canada, K7L 2V7 Less <<
NCT02185872 Hyperglycemia Not Applicable Completed - United States, Kansas ... More >> Kansas State University Manhattan, Kansas, United States, 66506 Less <<
NCT03544684 Type1diabetes Not Applicable Completed - United Kingdom ... More >> Liverpool John Moores University Liverpool, Merseyside, United Kingdom, L3 3AF Less <<
NCT01826409 Impaired Glucose or Type 2 Dia... More >>betes Less << Phase 2 Phase 3 Completed - Korea, Republic of ... More >> Clincial Trial Center for Functional Foods Jeonju, Jeollabok-do, Korea, Republic of, 560-822 Less <<
NCT02533986 Healthy Phase 1 Phase 2 Completed - Sweden ... More >> Food for Health Science Centre (Medicon Village) - Lund University Lund, Skåne, Sweden, 221 00 Less <<
NCT02624609 Hyperglycaemia Not Applicable Completed - United Kingdom ... More >> School of Food Science and Nutrition Leeds, United Kingdom, LS2 9JT Less <<
NCT02180412 Acute Porphyrias Phase 2 Recruiting August 31, 2020 United States, Texas ... More >> University of Texas Medical Branch Recruiting Galveston, Texas, United States, 77555 Contact: Karl E Anderson, MD    409-772-4661    kanderso@utmb.edu    Contact: Csilla Hallberg, MD    409-772-4661    challberg@utmb.edu    Principal Investigator: Karl E Anderson, MD Less <<
NCT03641170 Gestational Diabetes Not Applicable Recruiting April 2021 Denmark ... More >> Department of Obstetrics and Gynecology, Aarhus University Hospital Recruiting Aarhus, Denmark, 8200 Contact: Mette Bisgaard Andersen, MD    +45 30708289    metbisan@rm.dk Less <<
NCT01933529 Diabetes Type 2 ... More >> Impaired Glucose Tolerance Impaired Fasting Glucose Less << Phase 2 Unknown December 2015 Sweden ... More >> Dept of Endocrinology and Diabetes, Karolinska University Hospital Stockholm, Sweden, 17176 Less <<
NCT01324739 Diabetes Mellitus ... More >> Cardiomyopathy Less << Not Applicable Completed - Austria ... More >> Medical University of Vienna Vienna, Austria, 1090 Less <<
NCT02838875 Neonatal Hypoglycemia Phase 3 Not yet recruiting August 2019 -
NCT00441129 - Completed - -
NCT00441129 Type 1 Diabetes Not Applicable Completed - France ... More >> CHU Côte de Nacre Caen, France, 14000 Hôpital Universitaire Debrousse Lyon, France, 69322 Hôpital Sainte Marguerite Marseille, France, 13009 CH La Peyronie Montpellier, France, 34295 American Memorial Hospital Reims, France, 51092 Hôpital Jeanne D'Arc Saint-Mandé, France, 54202 Hôpitaux Universitaires de Strasbourg Strasbourg, France, 67091 CHU Rangueil Toulouse, France, 31054 Less <<
NCT01797042 Obesity Not Applicable Completed - United States, Florida ... More >> Rippe Lifestyle Institute Celebration, Florida, United States, 34747 Less <<
NCT01554020 Prediabetes Phase 2 Withdrawn(Change of CRO) November 2013 United States, California ... More >> SPRIM San Francisco, California, United States, 94109 Less <<
NCT02131948 Insulin Resistance, Diabetes Phase 1 Completed - Canada, Ontario ... More >> Tornto General Hospital, UHN Toronto, Ontario, Canada, M5G 1L7 Less <<
NCT02866435 Hypoglycemia Early Phase 1 Recruiting December 2019 United States, Minnesota ... More >> University of Minnesota Not yet recruiting Minneapolis, Minnesota, United States, 55455 Contact: Anjali F Kumar, PA-C    612-624-0470    kumar045@umn.edu    Sub-Investigator: Elizabeth R Seaquist, MD          Sub-Investigator: Amir A Moheet, MD          Sub-Investigator: Essa Yacoub, PhD          Sub-Investigator: Lynn E Eberly, PhD          University of Minnesota Recruiting Minneapolis, Minnesota, United States, 55455 Less <<
NCT01833559 Gestational Diabetes Not Applicable Recruiting August 2021 China, Guangdong ... More >> Gynecology and obstetrics department of the 1st affiliated hospital of Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510080 Contact: Zilian Wang, Doctor    13602885248 ext +86    zilianwang@gmail.com    Principal Investigator: Zilian Wang, Doctor Less <<
NCT01145534 Diabetes Phase 1 Phase 2 Completed - Brazil ... More >> Centro de Especialidades Odontologicas Patos, Paraiba, Brazil, 58700-020 Less <<
NCT02584907 Hyperglycemia Not Applicable Completed - Iran, Islamic Republic of ... More >> Faculty of Nutrition Sciences and Food Technology Tehran, Iran, Islamic Republic of Less <<
NCT01161862 - Completed - -
NCT01161862 Diabetes Mellitus Not Applicable Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT02358408 Diabetes Not Applicable Completed - Germany ... More >> Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm Ulm, Germany, 89081 Less <<
NCT02345239 Diabetes Mellitus Phase 3 Unknown - -
NCT01114321 Parkinson's Disease Not Applicable Unknown December 2013 France ... More >> CHU Clermont-Ferrand Not yet recruiting Clermont-Ferrand, France, 63003 Contact: Patrick LACARIN    04 73 75 11 95    placarin@chu-clermontferrand.fr    Chu Clermont-Ferrand Recruiting Clermont-Ferrand, France, 63003 Contact: Patrick LACARIN    04 73 75 11 95    placarin@chu-clermontferrand.fr Less <<
NCT01537120 - Completed - -
NCT01537120 Type 2 Diabetes Mellitus Phase 1 Completed - -
NCT03669770 - Completed - United Kingdom ... More >> Florence Nightingale Faculty of Nursing, Midwifery & Palliative Care London, United Kingdom, SE1 8WA Less <<
NCT02004886 Type 2 Diabetes Mellitus Phase 2 Completed - -
NCT03019510 Type2 Diabetes Not Applicable Recruiting September 2021 United States, Missouri ... More >> University of Missouri Recruiting Columbia, Missouri, United States, 65211 Contact: Becky Shafer, MS    573-882-4517    munepkanaleylab@missouri.edu    Contact: Jay Porter, MS       munepkanaleylab@missouri.edu Less <<
NCT00069537 Diabetes Mellitus, Insulin-Dep... More >>endent Less << Phase 4 Completed - United States, California ... More >> Division of Pediatric Endocrinology and Diabetes, Stanford University Stanford, California, United States, 94305-5208 United States, Colorado Barbara Davis Center for Childhood Diabetes, University of Colorado Denver, Colorado, United States, 80262 United States, Connecticut Department of Pediatrics, Yale University School of Medicine New Haven, Connecticut, United States, 06519 United States, Florida Nemours Children's Clinic Jacksonville,, Florida, United States, 32207 Jaeb Center for Health Research Tampa, Florida, United States, 33647 United States, Iowa Department of Pediatrics, University of Iowa Carver College of Medicine Iowa City, Iowa, United States, 52242 Less <<
NCT02963753 - Completed - -
NCT01445990 Postoperative Complications Not Applicable Completed - France ... More >> Department of Plastic reconstructive and Aesthetic Surgery. University Hospital Amiens Amiens, France, 80000 Maxillo-Facial Surgery, Besancon Univestitary Hospital Besancon, France, 25000 Orthopaedic, Traumatologic and Plastic Surgery Unit, Besancon Universitary Hospital Besancon, France, 25000 Maxillo-Facial, Plastic and Reconstructive Surgery Unit, Centre Hospitalier Universitaire Dijon, France, 21000 Less <<
NCT01521312 Impaired Glucose Tolerance Phase 2 Completed - France ... More >> Jean Verdier hospital, Department of Endocrinology-Diabetology-Nutrition Bondy, France, 93140 Less <<
NCT03128073 Ultrafiltration Failure Not Applicable Completed - Sweden ... More >> Kidney Unit Malmö, Skåne, Sweden, 205 02 Less <<
NCT01396330 Diabetes Mellitus ... More >> Mental Stress Less << Not Applicable Completed - Switzerland ... More >> Kantonsspital Frauenfeld Frauenfeld, Switzerland, 8501 Less <<
NCT01841073 Prediabetes Not Applicable Completed - United Kingdom ... More >> Imperial College London London, United Kingdom, W11 0NN Less <<
NCT00818077 - Completed - United States, Minnesota ... More >> International Diabetes Center Minneapolis, Minnesota, United States, 55416 Less <<
NCT01369069 Acute Ischemic Stroke ... More >> Diabetes Hyperglycemia Less << Phase 3 Active, not recruiting December 2018 -
NCT03708419 Obesity Pre-d... More >>iabetic Type 2 Diabetes Mellitus Less << Not Applicable Recruiting July 1, 2020 Netherlands ... More >> Department of Human Biology, Maastricht University Medical Centre Recruiting Maastricht, Netherlands, 6200MD Contact: Ellen Blaak, Prof.    +31(0)43-3881503    e.blaak@maastrichtuniversity.nl    Wageningen University and Research Recruiting Wageningen, Netherlands, 6700AA Contact: Edith JM Feskens, Prof.    +31(0)317482567    edith.feskens@wur.nl Less <<
NCT03191201 Iron-deficiency ... More >> Iron Toxicity Glucose Metabolism Disorders (Including Diabetes Mellitus) Metabolic Side Effects of Drugs Metabolic Disorder, Glucose Safety Issues Less << Phase 4 Recruiting April 20, 2021 Switzerland ... More >> Policlinique Médicale Universitaire Recruiting Lausanne, Vaud, Switzerland, 1011 Contact: Bernard Favrat, MD    21 314 49 06 ext +41    Bernard.Favrat@chuv.ch    Contact: Cornuz Jacques, MD    21 314 05 06 ext +41    Jacques.Cornuz@chuv.ch    Sub-Investigator: Luc Tappy, MD          Sub-Investigator: Favrat Bernard, MD          Sub-Investigator: Evrim Jaccard, MD-PhD          Principal Investigator: Gérard Waeber, MD          Sub-Investigator: Pedro-Manuel Marques-Vidal, MD-PhD          Sub-Investigator: Marc Froissart, MD-PhD          Sub-Investigator: Cédric Gubelmann, Med          Sub-Investigator: Laila Baratali, Med          Sub-Investigator: Kévin Seyssel, PhD Less <<
NCT02691481 Type 2 Diabetes Mellitus ... More >> Obesity Less << Not Applicable Completed - -
NCT03577119 Pre-Diabetes Not Applicable Recruiting June 1, 2021 United States, Vermont ... More >> Clinical Research Center, University of Vermont Medical Center Recruiting Burlington, Vermont, United States, 05401 Contact: Kimberly Luebbers, MSHS    802-656-8990    Kimberly.Luebbers@med.uvm.edu    Contact: Joan Bertolet    (802) 847-4874    joan.bertolet@uvmhealth.org Less <<
NCT01258426 - Completed - -
NCT03552991 Diabetes Mellitus, Type 2 Phase 4 Completed - -
NCT03383627 Diabetes Kidn... More >>ey Diseases Less << Not Applicable Completed - United States, New York ... More >> Northwell Health (Division Endocrinology and Nephrology) Great Neck, New York, United States, 11021 Less <<
NCT02075164 Non-alcoholic Fatty Liver Dise... More >>ase Non-alcoholic Steatohepatitis Less << Not Applicable Recruiting December 2019 Austria ... More >> Medical University of Vienna, General Hospital of Vienna Vienna, Vienna, Austria 1090 Recruiting Vienna, Austria, 1090 Contact: Michael Trauner, Prof. MD.    43140400 ext 4741    michael.trauner@meduniwien.ac.at    Sub-Investigator: Christian Kienbacher, MD, MSc          Sub-Investigator: Stefan Traussnigg, MD          Sub-Investigator: Christian Rechling, MD Less <<
NCT02648685 - Completed - China, Sichuan ... More >> West China Hospital Chengdu, Sichuan, China, 610042 Less <<
NCT02543684 Diabetes Mellitus, Type 2 Not Applicable Completed - Greece ... More >> Harokopio University of Athens Kallithea, Attica, Greece, 17671 Less <<
NCT00524472 - Completed - -
NCT02606617 Type 2 Diabetes Phase 4 Unknown December 2016 -
NCT03196895 Diabetes Mellitus, Type 2 Not Applicable Recruiting August 2021 United States, Virginia ... More >> Dept. of Psychiatry and Neurobehavioral Sciences, University of Virginia Recruiting Charlottesville, Virginia, United States, 22908 Less <<
NCT03612999 Healthy Not Applicable Recruiting December 31, 2018 United States, Minnesota ... More >> Savvysherpa, LLC Recruiting Minnetonka, Minnesota, United States, 55343 Contact: Shane Hoversten, PhD Less <<
NCT00524472 Cardiac Surgery Not Applicable Completed - United States, Ohio ... More >> Cleveland Clinic Cleveland, Ohio, United States, 44195 Canada, Quebec Royal Victoria Hospital Montreal, Quebec, Canada, H3A 1A1 Less <<
NCT01175473 Type 2 Diabetes Mellitus Phase 2 Completed - Germany ... More >> Sanofi-Aventis Investigational Site Number 276006 Berlin, Germany, 14050 Sanofi-Aventis Investigational Site Number 276004 Kiel, Germany, 24105 Sanofi-Aventis Investigational Site Number 276002 Mainz, Germany, 55116 Sanofi-Aventis Investigational Site Number 276003 Mannheim, Germany, 68167 Sanofi-Aventis Investigational Site Number 276005 Mönchengladbach, Germany, 41061 Sanofi-Aventis Investigational Site Number 276007 München, Germany, 80636 Sanofi-Aventis Investigational Site Number 276001 Neuss, Germany, 41460 Less <<
NCT01434901 Type 2 Diabetes Mellitus Phase 1 Completed - United States, Missouri ... More >> Washington University School of Medicine Saint Louis, Missouri, United States, 63131 Less <<
NCT01175473 - Completed - -
NCT00589589 Burns Hypogly... More >>cemia Less << Phase 1 Completed - United States, Texas ... More >> US Army Institute of Surgical Research Fort Sam Houston, Texas, United States, 78234 Less <<
NCT02537912 Obesity Not Applicable Completed - -
NCT01804803 Diabetes Mellitus Phase 3 Unknown July 2014 Italy ... More >> University of Bari Aldo Moro Recruiting Bari, BA, Italy, 70124 Contact: Francesco Giorgino, M.D., Ph.D.       francesco.giorgino@uniba.it    Principal Investigator: Francesco Giorgino, M.D., Ph.D.          IRCSS Casa Sollievo Sofferenza Not yet recruiting San Giovanni Rotondo, FG, Italy Principal Investigator: Salvatore De Cosmo, M.D.          University of Foggia Not yet recruiting Foggia, Italy Contact: Mauro Cignarelli, M.D.       m.cignarelli@unifg.it    Principal Investigator: Mauro Cignarelli, M.D. Less <<
NCT00287066 Diabetes Mellitus Phase 3 Terminated(See termination rea... More >>son in detailed description.) Less << - United States, Pennsylvania ... More >> Pfizer Investigational Site Pittsburgh, Pennsylvania, United States Less <<
NCT00241072 Hypertension ... More >>Impaired Glucose Tolerance Less << Phase 4 Completed - -
NCT03021837 - Completed - -
NCT02324842 Type 2 Diabetes Mellitus Not Applicable Recruiting December 2018 United States, Texas ... More >> University of Texas Health Science Center at San Antonio Recruiting San Antonio, Texas, United States, 78229 Contact: Ralph A DeFronzo, MD    210-567-6691    defronzo@uthscsa.edu    Contact: Monica Palomo, BS    210-567-6710    palomom@uthscsa.edu    Principal Investigator: Ralph A DeFronzo, MD Less <<
NCT00973492 - Unknown December 2009 France ... More >> Service de Diabétologie du Pr Halimi, CHU Grenoble Cedex 9, France, 38043 Less <<
NCT01485679 Tumor Not Applicable Completed - France ... More >> CHU Nord Amiens, France, 80080 Maison de Haut Lévêque CHU Bordeaux, France, 33604 Hôpital Beaujon APHP Clichy, France, 92110 Hôpital C Huriez Lille, France, 59037 Hospices Civils de Lyon Lyon, France, 69437 Institut Paoli Calmettes Marseille, France, 13273 CHU Nord Marseille, France, 13915 CHU Nantes, France, 44093 Hôpital St-Antoine Paris, France, 75012 CHU Hôpital Pontchaillou Rennes, France, 35033 Hôpital de Hautepierre Strasbourg, France, 67098 CHU Rangueil Toulouse, France, 31059 Less <<
NCT00663312 Idiopathic Parkinson's Disease Not Applicable Terminated - France ... More >> CHU Clermont-Ferrand, France, 63000 Less <<
NCT03091673 Diabetes Mellitus, Type 1 Phase 3 Completed - United States, California ... More >> Stanford University Stanford, California, United States, 94305 United States, Colorado Barbara Davis Center for Childhood Diabetes Aurora, Colorado, United States, 80045 United States, Connecticut Yale University New Haven, Connecticut, United States, 06511 United States, Florida University of Florida Gainesville, Florida, United States, 32611 United States, Indiana Indiana University Indianapolis, Indiana, United States, 46202 United States, Iowa University of Iowa Iowa City, Iowa, United States, 52422 United States, New York Women & Children's Hospital of Buffalo Buffalo, New York, United States, 14222 Less <<
NCT03776448 Diabetes Mellitus Not Applicable Not yet recruiting February 2019 Saudi Arabia ... More >> Sulaiman AlRajhi Colleges Not yet recruiting Al Bukairiyah, Qassim, Saudi Arabia, 51941, PO Box 777 Contact: Nazmus Saquib, Phd    966 533445899    a.saquib@sr.edu.sa    Principal Investigator: Nazmus Saquib, Phd          Sub-Investigator: Ahmed Abduljalil Less <<
NCT03648112 Lipid Metabolism ... More >> Glucose Metabolism Satiety Less << Not Applicable Recruiting December 31, 2019 Germany ... More >> Friedrich-Schiller-University Recruiting Jena, Thuringia, Germany, 07743 Contact: Christine Dawczynski, PhD    +49 3641 949656    christine.dawczynski@uni-jena.de    Contact: Stefan Lorkowski, PhD    +49 3641 949711    stefan.lorkowski@uni-jena.de Less <<
NCT00999271 - Completed - Denmark ... More >> Hvidovre Hospital Hvidovre, Denmark, 2650 Less <<
NCT03091673 - Completed - -
NCT00942110 Obstructive Sleep Apnea Not Applicable Completed - Japan ... More >> Kyoto University Graduate School of Medicine Kyoto, Japan, 6068507 Less <<
NCT02726958 - Completed - France ... More >> CHRU Jean Minjoz Besancon Besancon, France, 25000 Less <<
NCT02036853 Glucose Transporter Type-1 Def... More >>iciency Syndrome (Glut1 DS) Less << Phase 2 Recruiting January 2023 United States, Texas ... More >> Cook Childrens Medical Center Recruiting Fort Worth, Texas, United States, 76104 Contact: Dianna Grado, RN, CRC    682-885-2844    Dianna.Grado@cookchildrens.org    Contact: Laurie Bailey, PhD    682-885-2488    Laurie.Bailey@CookChildrens.org    Principal Investigator: Adrian Lacy, MD Less <<
NCT03141398 - Withdrawn(Due to issues with s... More >>tudy design) Less << December 2018 -
NCT03422848 Glucose, High Blood Not Applicable Recruiting September 30, 2021 Sweden ... More >> KFE, Skåne University Hospital in Malmö Recruiting Malmö, Sweden, SE-20502 Contact: Margaretha M Persson, Ph.D.       margaretha.m.persson@skane.se    Contact: Olle Melander, M.D., Prof.    +46 40 391209    olle.melander@med.lu.se    Principal Investigator: Olle Melander, M.D., Professor          Sub-Investigator: Sofia Enhörning, M.D., Ph.D.          Sub-Investigator: Irina Tasevska, M.D., Ph.D. Less <<
NCT01237301 Type 2 Diabetes Not Applicable Completed - United States, Minnesota ... More >> International Diabetes Center Minneapolis, Minnesota, United States, 55416 Less <<
NCT02408705 Type 1 Diabetes Mellitus Phase 2 Completed - Austria ... More >> Medical University Graz Graz, Austria, 8036 Less <<
NCT02782195 - Completed - -
NCT01094418 - Completed - Korea, Republic of ... More >> Catholic University of Medicine, College of Medicine, Bucheon St. Mary's Hospital, Department of Rehabilitation Medicine Bucheon, Kyoungido, Korea, Republic of, 420-717 Less <<
NCT00753181 Diabetes Mellitus, Type 2 Phase 3 Completed - United States, Indiana ... More >> Provident Clinical Research Bloomington, Indiana, United States, 47403 United States, Ohio Radiant Research Cincinnati, Ohio, United States, 45242 Less <<
NCT03263819 - Recruiting December 30, 2019 United States, Tennessee ... More >> Vanderbilt University Medical Center Recruiting Nashville, Tennessee, United States, 37232 Contact: Cyndya Shibao, MD, MSCI       cyndya.shibao@vanderbilt.edu    Contact: Cyndya A Shibao, MD, MSCI    6155120956    cyndya.shibao@vanderbilt.edu    Principal Investigator: Cyndya Shibao, MD, MSCI          Sub-Investigator: Emily Garland, PhD          Sub-Investigator: Amanda Peltier, MD Less <<
NCT01237301 - Completed - -
NCT01641055 Obesity Overw... More >>eight Less << Not Applicable Completed - Norway ... More >> Institute of Medicine, University of Bergen Bergen, Norway, 5021 Less <<
NCT03770052 Type 2 Diabetes Mellitus ... More >> Inadequate Glucose Control Less << Phase 4 Not yet recruiting December 31, 2020 Korea, Republic of ... More >> Pusan National University Hospital Busan, Korea, Republic of Less <<
NCT03725969 Insulin Sensitivity ... More >> Glucose Tolerance Less << Not Applicable Completed - United Arab Emirates ... More >> Imperial College London Diabetes Centre Abu Dhabi, United Arab Emirates, 48338 Less <<
NCT02523131 Diabetes Mellitus ... More >> Diabetes Mellitus, Type 1 Glucose Metabolism Disorders Endocrine System Diseases Autoimmune Diseases Less << Not Applicable Completed - United States, Colorado ... More >> University of Colorado Denver Aurora, Colorado, United States, 80045 United States, Minnesota International Diabetes Center at Park Nicollet Minneapolis, Minnesota, United States, 55416 International Diabetes Centre at Park Nicollet Minneapolis, Minnesota, United States, 55416 United Kingdom University of Cambridge Cambridge, United Kingdom, CB2 0QQ Wellcome Trust-MRC Institute of Metabolic Science Cambridge, United Kingdom, CB2 0QQ Royal Hospital for Sick Children Edinburgh, United Kingdom, EH9 1LF Leeds Teaching Hospitals Leeds, United Kingdom, LS9 7TF Manchester Diabetes Centre, Manchester Royal Infirmary Manchester, United Kingdom Less <<
NCT01176708 Liver Transplantation Not Applicable Unknown December 2012 Denmark ... More >> Department of Internal Medicine F' laboratory Recruiting Hellerup, Copenhagen, Denmark, 2900 Contact: Astrid Plamboeck, M.D.    +45 26208174    astridp@sund.ku.dk    Contact: Tina Vilsbøll, M.D.    +45 39772461    tivi@geh.regionh.dk    Principal Investigator: Astrid Plamboeck, M.D. Less <<
NCT00214578 Schizophrenia Phase 4 Completed - -
NCT02718703 Diabetes Mellitus Not Applicable Completed - United Kingdom ... More >> BioKinetic Europe Ltd Belfast, Antrim, United Kingdom, BT2 7BA Less <<
NCT00418288 Type 2 Diabetes ... More >> Stroke Myocardial Infarction Less << Not Applicable Completed - Denmark ... More >> Department of pharmacology, Aarhus university Aarhus, Denmark, 8000 Less <<
NCT02845557 - Completed - Malaysia ... More >> Penang Medical College Penang, Malaysia, 11450 Less <<
NCT00787839 - Completed - United States, Georgia ... More >> Atlanta VA Medical and Rehab Center, Decatur, GA Decatur, Georgia, United States, 30033 Less <<
NCT00787839 - Completed - -
NCT01233271 Critical Illness Not Applicable Completed - United Kingdom ... More >> Royal Brompton Hospital, Intensive Care Medicine London, United Kingdom, SW3 6NP Less <<
NCT02734667 Type 1 Diabetes Mellitus Not Applicable Active, not recruiting March 2019 United States, California ... More >> Stanford University Stanford, California, United States, 94305 United States, Colorado University of Colorado Aurora, Colorado, United States, 80045 Less <<
NCT01087879 Contraception Not Applicable Completed - Finland ... More >> Department of Obstetrics and Gynaecology, University of Oulu Oulu, Finland, 90014 Less <<
NCT00464854 Diabetes Mellitus Not Applicable Terminated(The study was start... More >>ed before the official request for protocol registration) Less << - Israel ... More >> Assaf Harofe Medical Center Zerifin, Israel, 70300 Less <<
NCT00596427 Diabetes Not Applicable Completed - United States, California ... More >> Diablo Clinical Research, Inc Walnut Creek, California, United States, 94598 United States, Florida Clinical Pharmacology of Miami, Inc Miami, Florida, United States, 33014 United States, Texas Diabetes & Glandular Disease Research Associates San Antonio, Texas, United States, 78229 Less <<
NCT01509157 Type 1 Diabetes Phase 1 Completed - Israel ... More >> Schneider Medical Center Petah-Tikva, Israel, 49202 Less <<
NCT02325622 - Unknown February 2017 Korea, Republic of ... More >> Yonsei University Wonju Severance Cristian Hospital Recruiting Wonju, Kangwon-do, Korea, Republic of, 220-701 Contact: Moon Young Kim, MD,PhD    82-33-741-1225    drkimmy@yonsei.ac.kr    Principal Investigator: Moon Young Kim, MD,PhD Less <<
NCT00596427 - Completed - -
NCT03093753 Hyperglycemia Not Applicable Completed - -
NCT02625350 Healthy Not Applicable Unknown December 2015 -
NCT02758483 Type 1 Diabetes Mellitus Not Applicable Completed - Brazil ... More >> Clementino Fraga Filho University Hospital of Rio de Janeiro Rio de Janeiro, Brazil, 21941-913 Less <<
NCT03059550 - Recruiting December 31, 2020 France ... More >> CHU Dijon Recruiting Dijon, Burgundy, France, 21000 Contact: Vergès Bruno, MD, PhD    +33 380 293453    bruno.verges@chu-dijon.fr Less <<
NCT01034826 - Completed - -
NCT01146847 Critical Illness Not Applicable Completed - Germany ... More >> Klinikum Ludwigshafen am Rhein gGmbH, Klinik für Anästhesiologie und Operative Intensivmedizin Ludwigshafen, Germany, 67063 Less <<
NCT01173549 Healthy Phase 1 Completed - United States, California ... More >> La Jolla, California, United States Less <<
NCT00166673 Diabetes Mellitus, Insulin-Dep... More >>endent Less << Phase 2 Phase 3 Completed - United States, California ... More >> Division of Pediatric Endocrinology and Diabetes, Stanford University Stanford, California, United States, 94305-5208 United States, Colorado Barbara Davis Center for Childhood Diabetes, University of Colorado Aurora, Colorado, United States, 80010 United States, Connecticut Department of Pediatrics, Yale University School of Medicine New Haven, Connecticut, United States, 06519 United States, Florida Nemours Children's Clinic Jacksonville, Florida, United States, 32207 Jaeb Center for Health Research Tampa, Florida, United States, 33647 United States, Iowa Department of Pediatrics, University of Iowa Carver College of Medicine Iowa City, Iowa, United States, 52242 Less <<
NCT03192605 Diabetes Not Applicable Completed - Canada, Prince Edward Island ... More >> University of Prince Edward Island, Health Sciences Charlottetown, Prince Edward Island, Canada, C1A 4P3 Less <<
NCT02977598 - Completed - Turkey ... More >> Erzincan Mengucekgazi Research and Training Hospital Erzincan, Turkey, 00024 Erzincan Mengücekgazi Training and Research Hospital Erzincan, Turkey, 00024 Less <<
NCT01164449 Critical Illness Not Applicable Completed - Switzerland ... More >> University Hospital Zürich Zürich, Switzerland, 8091 Less <<
NCT01752543 Heart Failure Phase 4 Completed - Denmark ... More >> Department of Cardiology, Copenhagen University Hospital, Rigshospital Copenhagen, Denmark, 2100 Less <<
NCT00871871 Hypertension Phase 1 Completed - -
NCT00871871 - Completed - -
NCT00476710 - Completed - United States, Texas ... More >> Diabetes & Glandular Disease Research Associates, Inc. San Antonio, Texas, United States, 78229 Less <<
NCT01864304 - Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT01026675 - Completed - Canada, Quebec ... More >> Centre de recherche clinique Étienne-Le Bel du CHUS Sherbrooke, Quebec, Canada, J1H 5N4 Less <<
NCT02282254 Type 1 Diabetes Phase 2 Completed - Canada, Quebec ... More >> Institut de recherches cliniques de Montréal Montreal, Quebec, Canada, H2W 1R7 Less <<
NCT01164423 Critical Illness Not Applicable Completed - Austria ... More >> Medizinische Universität Graz, Department of Internal Medicine Graz, Austria, 8036 Less <<
NCT01067560 - Completed - Canada, British Columbia ... More >> BC Women's Hospital, Department of Anesthesia Vancouver, British Columbia, Canada, V6H3N1 Less <<
NCT02004886 - Completed - -
NCT00205738 Schizophrenia ... More >> Type 2 Diabetes Mellitus Less << Not Applicable Completed - United States, Missouri ... More >> Washington University School of Medicine, Psychiatry Dept. St. Louis, Missouri, United States, 63110 Less <<
NCT01634035 - Completed - United States, New York ... More >> Staten Island University Hospital Staten Island, New York, United States, 10305 Less <<
NCT01297946 Type 1 Diabetes Phase 1 Phase 2 Completed - Canada, Quebec ... More >> Institut de Recherches Cliniques de Montréal (IRCM) Montreal, Quebec, Canada, H2W 1R7 Less <<
NCT02594865 Disorder of Glucose Regulation Not Applicable Completed - Netherlands ... More >> Onze Lieve Vrouwe Gasthuis Amsterdam, Noord-Holland, Netherlands, 1091 AC Less <<
NCT00803920 - Completed - United States, Minnesota ... More >> International Diabetes Center Minneapolis, Minnesota, United States, 55416 Less <<
NCT02809261 Carpal Tunnel Syndrome Not Applicable Completed - Taiwan ... More >> Department of Physical Medicine and Rehabilitation, Tri-Service General Hospital Taipei, Neihu District, Taiwan, 886 Less <<
NCT01374438 Alzheimer's Disease Phase 2 Completed - United States, Illinois ... More >> Rush Memorial University Medical Center Chicago, Illinois, United States, 60612 Less <<
NCT01374438 - Completed - -
NCT01839344 Diabetes Mellitus, Type 2 Phase 2 Completed - United States, Washington ... More >> Bastyr Center for Natural Health Seattle, Washington, United States, 98103 Less <<
NCT02854709 Sleep Extension ... More >> Glucose Metabolism Less << Not Applicable Completed - Thailand ... More >> Faculty of Medicine Ramathibodi Hospital Bangkok, Thailand, 10400 Less <<
NCT03613935 Healthy Not Applicable Completed - Switzerland ... More >> Nestlé Research Center Lausanne, Switzerland, 1000 Less <<
NCT02693938 Type 1 Diabetes Not Applicable Recruiting January 2020 United States, Connecticut ... More >> Yale University School of Medicine Recruiting New Haven, Connecticut, United States, 06520 Contact: Jennifer Finnegan    203-737-7199    jennifer.finnegan@yale.edu Less <<
NCT01232946 Type 2 Diabetes Not Applicable Completed - United States, Indiana ... More >> Indiana Clinical Research Center Indianapolis, Indiana, United States, 46202 Less <<
NCT00724542 Coronary Heart Disease ... More >> Impaired Glucose Tolerance Less << Not Applicable Unknown December 2010 China, Beijing ... More >> Peking University First Hospital Recruiting Beijing, Beijing, China, 100034 Contact: Wenhui Ding, Professor    86-10-66551122 ext 5001    dwh_rd@126.com Less <<
NCT02583776 Infant, Very Low Birth Weight ... More >> Neonatal Hypoglycemia Less << Phase 4 Completed - United States, Massachusetts ... More >> Boston Children's Hospital Boston, Massachusetts, United States, MA02215 Italy Neonatal Intensive Care Unit - University Hospital of Padua Padua, Italy, 35128 Department of Information Engineering - University of Padua Padua, Italy, 35131 Less <<
NCT01751321 Type 2 Diabetes Not Applicable Unknown October 2013 -
NCT01248364 - Completed - -
NCT01248364 Diabetes Mellitus, Type 2 Phase 2 Completed - Austria ... More >> 1245.39.43001 Boehringer Ingelheim Investigational Site Graz, Austria Germany 1245.39.49002 Boehringer Ingelheim Investigational Site Neuss, Germany Italy 1245.39.39001 Boehringer Ingelheim Investigational Site Pisa, Italy Less <<
NCT01704417 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 1 Completed - Germany ... More >> Novo Nordisk Investigational Site Neuss, Germany, 41460 Less <<
NCT02999321 Oral Glucose Tolerance Not Applicable Completed - United States, Indiana ... More >> Purdue Univeristy West Lafayette, Indiana, United States, 47907 Less <<
NCT01503164 Obstructive Sleep Apnea ... More >> Sleep Apnea Sleep-disordered Breathing Less << Not Applicable Completed - United States, Maryland ... More >> Johns Hopkins Bayview Medical Center Baltimore, Maryland, United States, 21224 Less <<
NCT01854164 Hyperglycemia Not Applicable Completed - Korea, Republic of ... More >> Clinical Trial Center for Functional Foods, Chonbuk National University Hospital Jeonju, Jeollabuk-do, Korea, Republic of, 560-822 Less <<
NCT03615209 Insulin Resistance ... More >> Glucose Intolerance Less << Not Applicable Recruiting April 1, 2019 Germany ... More >> University of Tuebingen, Department of Internal Medicine IV Recruiting Tübingen, Germany, 72076 Contact: Andreas Vosseler    +49 7071 29 80687    andreas.vosseler@med.uni-tuebingen.de    Contact: Martin Heni, MD    +49 7071 29 82714    martin.heni@med.uni-tuebingen.de Less <<
NCT01503164 - Completed - -
NCT03247114 Healthy Not Applicable Completed - Netherlands ... More >> Leids Universitair Medisch Centrum Leiden, Zuid-Holland, Netherlands Less <<
NCT02211235 - Recruiting December 2018 United States, Colorado ... More >> Children's Hospital Colorado, University of Colorado Denver Recruiting Aurora, Colorado, United States, 80045 Contact: Tim Vigers, BA    720-777-4354    tim.vigers@childrenscolorado.org    Principal Investigator: Christine L Chan, MD Less <<
NCT02332603 Osteoarthrosis Phase 3 Completed - Denmark ... More >> Bispebjerg Hospital Copenhagen NV, Denmark, 2400 Less <<
NCT01179945 Overweight Not Applicable Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02101 Children's Hospital Boston, Massachusetts, United States, 02115 Less <<
NCT02727790 Type 2 Diabetes Mellitus Not Applicable Completed - Israel ... More >> Assaf-Harofeh Medical Center Zerifin, Israel, 70300 Less <<
NCT01828970 Diabetes Mellitus Phase 4 Completed - France ... More >> Regional Hospital of Colmar Colmar, France, 68000 Regional Hospital of Mulhouse Mulhouse, France, 68100 Sainte Anne Hospital Strasbourg, France, 67000 University Hospital of Strasbourg Strasbourg, France, 67000 Regional Hospital of Valenciennes Valenciennes, France, 59300 Less <<
NCT03018600 - Completed - -
NCT00432887 Diabetes Mellitus, Type 2 Early Phase 1 Completed - -
NCT02631083 Type 2 Diabetes, Obesity, Pred... More >>iabetes Less << Not Applicable Completed - -
NCT03543423 Healthy Not Applicable Recruiting June 30, 2019 Denmark ... More >> Department of Gastrointestinal Surgery, Righospitalet Recruiting Copenhagen, Capital, Denmark, 2100 Contact: Lars Bo Svendsen, DMSci       lars.bo.svendsen@regionh.dk    Contact: Simon Veedfald, MD    +4541102595    Simon.veedfald@regionh.dk    Principal Investigator: Simon Veedfald, MD          Principal Investigator: Jens J Holst, DMsci          Principal Investigator: Lars Bo Svendsen Less <<
NCT00989898 Type 1 Diabetes Not Applicable Completed - United Kingdom ... More >> Wellcome Trust Clinical Research Facility, Addenbrooke's Hospital Cambridge, Cambridgeshire, United Kingdom, CB20QQ Less <<
NCT03090074 Glucose Metabolism Disorders Not Applicable Recruiting March 19, 2021 Sweden ... More >> University Hospital of Linkoping Recruiting Linkoping, Sweden, 58185 Contact: Fredrik H Nystrom, MD, prof.          Principal Investigator: Fredrik H Nystrom, MD PhD prof Less <<
NCT02589028 Diabetes Mellitus Not Applicable Completed - Korea, Republic of ... More >> Seoul National University Hospital Seoul, Korea, Republic of, 110-744 Less <<
NCT01712594 Type 1 Diabetes Not Applicable Completed - United Kingdom ... More >> King's College London London, United Kingdom, SE5 9PJ Less <<
NCT03478098 Roux-en-Y Gastric Bypass ... More >> Obesity Less << Not Applicable Recruiting June 1, 2019 Denmark ... More >> Department of Endocrinology, Hvidovre Hospital Recruiting Hvidovre, Denmark, DK-2650 Contact: Kirstine N Bojsen-Moller, MD, PHD    +4538626371    kirstine.bojsen-moeller@regionh.dk Less <<
NCT00960973 Diabetes Pred... More >>iabetic State Less << Phase 4 Completed - Korea, Republic of ... More >> Seoul National University Medical School Seoul, Korea, Republic of Less <<
NCT00673543 - Completed - United States, Texas ... More >> Lyndon B. Johnson Hospital Houston, Texas, United States, 77026 Memorial Hermann Hospital Texas Medical Center Houston, Texas, United States, 77030 Less <<
NCT00926133 - Unknown December 2009 Norway ... More >> Oslo University Hospital Ulleval Oslo, Norway, 0407 Less <<
NCT03138174 - Completed - United Kingdom ... More >> Diabetes Centre, Birmingham Heartlands Hospital Birmingham, United Kingdom, B9 5SS Royal Infirmary of Edinburgh Edinburgh, United Kingdom, EH16 4SA Highland Diabetes Institute Inverness, United Kingdom, IV2 3JH Less <<
NCT01381887 Diabetes Mellitus, Type 2 Phase 1 Completed - United States, California ... More >> Chula Vista, California, United States United States, Florida Miramar, Florida, United States United States, Ohio Cincinnati, Ohio, United States United States, Texas Dallas, Texas, United States San Antonio, Texas, United States Less <<
NCT00278057 Hemodialysis Phase 4 Completed - Denmark ... More >> Department of Medicine, Holstebro Hospital Holstebro, Denmark, 7500 Less <<
NCT02714413 Blood Glucose Phase 2 Completed - United States, Florida ... More >> University of Florida Jacksonville, Florida, United States, 32209 Less <<
NCT00237250 Prediabetic State Phase 3 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 Less <<
NCT00722241 - Completed - United States, California ... More >> John Muir Physician Network Clinical Research Center Concord, California, United States, 94520 Advanced Metabolic Care + Research Escondido, California, United States, 92026 Sansum Diabetes Research Institute Santa Barbara, California, United States, 93105 Less <<
NCT01523665 - Completed - Czech Republic ... More >> Investigational Site Hradec Kralove, Czech Republic Investigational Site Plzen, Czech Republic Investigational sites Prague, Czech Republic Denmark Rigshospitalet Copenhagen Copenhagen, Denmark Vejle Sygehus Vejle, Denmark Estonia Tartu University Hospital Tartu, Estonia Germany Klinikum Augsburg, Germany Universitätsklinikum Leipzig Leipzig, Germany Italy Investigational Site Legnano, Italy Investigational site Siena, Italy Poland Wroclaw Medical University Wroclaw, Poland Spain Hospital Sur, Madrid, Spain Sweden Investigational Site Jönköping, Sweden Investigational Site Stockholm, Sweden Investigational Site Södertälje, Sweden United Kingdom West Suffolk Hospital Bury St Edmonds, United Kingdom Royal Cornwall Hospital Truro, United Kingdom Less <<
NCT00065676 Diabetes Mellitus ... More >> Obesity Less << Phase 2 Recruiting December 17, 2025 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)    800-411-1222 ext TTY8664111010    prpl@cc.nih.gov Less <<
NCT03680027 Hyperlipidemias Not Applicable Completed - -
NCT01743313 - Suspended(Primary researcher n... More >>ot able to continue research at the moment.) Less << June 2019 Finland ... More >> Coxa, Hospital for Joint Replacement Tampere, Finland, 33520 Less <<
NCT03297762 Type1diabetes Not Applicable Recruiting June 2019 United States, California ... More >> Stanford Children's Recruiting Stanford, California, United States, 94305 Contact: Maria Chang, MD    650-724-8322    mkchang@stanford.edu Less <<
NCT02855307 Type 1 Diabetes Phase 2 Recruiting January 2019 Canada, Quebec ... More >> Institut de recherches cliniques de Montréal Recruiting Montreal, Quebec, Canada, H2W 1R7 Contact: Corinne Suppere       corinne.suppere@ircm.qc.ca Less <<
NCT01103726 Healthy Phase 1 Completed - United States, Connecticut ... More >> Pfizer Investigational Site New Haven, Connecticut, United States, 06511 Pfizer Investigational Site New Haven, Connecticut, United States, 06519 Pfizer Investigational Site New Haven, Connecticut, United States, 06520 Less <<
NCT03513055 Type2 Diabetes Mellitus Not Applicable Not yet recruiting September 30, 2018 -
NCT00631293 Healthy Phase 1 Phase 2 Completed - Belgium ... More >> University Hospital Ghent Ghent, Belgium, 9000 Less <<
NCT00150085 Tacrolimus-associated Abnormal... More >> Glucose Metabolism in Kidney and Liver Transplant Recipients Less << Phase 4 Terminated - -
NCT02075567 Blood Glucose Decrease During ... More >>and After Defined Individual Exercise in T1DM Less << Not Applicable Completed - -
NCT03419702 Impaired Glucose Tolerance ... More >> Overweight and Obesity Less << Not Applicable Recruiting March 2020 Netherlands ... More >> Maastricht University, Department of Nutrition and Movement Sciences Recruiting Maastricht, Limburg, Netherlands, 6200 MD Contact: Elske Gravesteijn, MSc    0031433881305    e.gravesteijn@maastrichtuniversity.nl    Principal Investigator: Jogchum Plat, PhD          Principal Investigator: Ronald P Mensink, PhD Less <<
NCT02288351 Type 2 Diabetes ... More >> Obesity Less << Not Applicable Withdrawn(The PI decided to wi... More >>thdraw the study. No patient interaction took place.) Less << - -
NCT01562171 Obesity Hyper... More >>cholesterolemia Less << Not Applicable Completed - Canada, Manitoba ... More >> I.H. Asper Clinical Research Institute Winnipeg, Manitoba, Canada, R2H 2A6 Canada, Ontario Glycemic Index Laboratories, Incorporated Toronto, Ontario, Canada, M5C 2N8 Less <<
NCT01209403 Kidney Failure, Chronic Phase 4 Completed - Denmark ... More >> Department of Nephrology, Aarhus University Hospital, Skejby Aarhus, Denmark, 8200 N Less <<
NCT02154126 Diabetes Mellitus Not Applicable Completed - Netherlands ... More >> Academic Medical Centre Amsterdam, Netherlands, 1105AZ Less <<
NCT03262116 Type 1 Diabetes Mellitus Not Applicable Not yet recruiting December 2019 United States, Massachusetts ... More >> Massachusetts General Hospital Not yet recruiting Boston, Massachusetts, United States, 02114 Contact: Courtney A Balliro, BS, RN, CDE    617-726-1242    CBALLIRO@PARTNERS.ORG    Principal Investigator: Steven J Russell, MD, PhD Less <<
NCT03771066 Insulin Sensitivity ... More >> Glucose Metabolism Disorders Microtia Less << Not Applicable Not yet recruiting December 31, 2022 United States, California ... More >> California Polytechnic State University San Luis Obispo, California, United States, 93405 Less <<
NCT00488423 Diabetes Gast... More >>ric Bypass Less << Phase 1 Completed - United States, Ohio ... More >> Cleveland Clinic Cleveland, Ohio, United States, 44195 Less <<
NCT01734590 Healthy Not Applicable Completed - Netherlands ... More >> QPS Groningen, Hanzeplein 1, Netherlands, 9713 GZ Less <<
NCT01432275 - Completed - -
NCT03411460 Insulin-Dependent Diabetes Not Applicable Terminated(logistical difficul... More >>ties) Less << - France ... More >> CHU Nimes Nîmes, France, 30029 Less <<
NCT01956929 Insulin Resistance ... More >> Prediabetic State Less << Phase 1 Completed - United States, Minnesota ... More >> Mayo Clinic in Rochester Rochester, Minnesota, United States, 55905 Less <<
NCT01432275 Diabetes Mellitus Not Applicable Completed - United Kingdom ... More >> Tameside Hospital NHS Foundation Trust Ashton-under-Lyne, United Kingdom, OL6 9RW Ayr Hospital Ayr, United Kingdom, KA6 6DX Royal United Hospital Bath, United Kingdom, BA1 3NG Royal Blackburn Hospital Blackburn, United Kingdom, BB2 7PL North Manchester Diabetes Centre Crumpsall, United Kingdom, M8 5RB Ipswich Hospital NHS Trust Ipswich, United Kingdom, IP4 5PD Greenwood & Sneinton Family Medical Centre Nottingham, United Kingdom, NG3 7DQ Less <<
NCT01677546 Type 1 Diabetes Mellitus Not Applicable Completed - Poland ... More >> Medical University of Warsaw Warsaw, Poland Less <<
NCT02622672 Diabetes Phase 2 Phase 3 Completed - -
NCT00536549 Type 2 Diabetes Not Applicable Completed - Korea, Republic of ... More >> Division of Endocrinology and Metabolism, Department of Internal Medicine,Korea University College of Medicine Seoul, Korea, Republic of, 152-703 Less <<
NCT00607139 - Completed - United States, California ... More >> Division of Pediatric Endocrinology and Diabetes, Stanford University Stanford, California, United States, 94305 United States, Colorado Barbara Davis Center for Childhood Diabetes, University of Colorado Aurora, Colorado, United States, 80010 United States, Connecticut Department of Pediatrics, Yale University School of Medicine New Haven, Connecticut, United States, 06520 United States, Florida Nemours Children's Clinic Jacksonville, Florida, United States, 32207 Jaeb Center for Health Research Tampa, Florida, United States, 33647 United States, Iowa Department of Pediatrics, University of Iowa Iowa City, Iowa, United States, 52242 Less <<
NCT01799850 Diabetes Type 2 Phase 4 Completed - United States, Tennessee ... More >> ETSU Quillen College of Medicine Johnson City, Tennessee, United States, 37614 Less <<
NCT00858676 Diabetes Mellitus ... More >> Impaired Glucose Tolerance Coronary Artery Disease Less << Phase 4 Unknown March 2013 Japan ... More >> Dept. of Intern. Med., School of Dentistry, Aichi Gakuin University Recruiting Nagoya, Japan, 464-8650 Contact: Tatsuaki Matsubara, MD, PhD    +81-52-759-2111       Principal Investigator: Tatsuaki Matsubara, MD, PhD Less <<
NCT00247468 Respiratory Failure ... More >> Cardiovascular Failure Sepsis Trauma Less << Not Applicable Withdrawn(Never received IRB a... More >>pproval) Less << - -
NCT01402037 Type 1 Diabetes Not Applicable Unknown July 2016 Belgium ... More >> UZ Brussels Recruiting Brussels, Belgium, 1090 Contact: Bart Keymeulen, MD PhD    +32 2 477 61 11    bart.keymeulen@uzbrussel.be    Principal Investigator: Katelijn Decochez, MD PhD          UZ Antwerpen Recruiting Edegem, Belgium, 2650 Contact: Christophe Deblock, MD. PhD.          Principal Investigator: Christophe Deblock, MD PhD          UZ Gent Recruiting Gent, Belgium, 9000 Contact: Johannes Ruige, MD PhD       johannes.Ruige@uzgent.be    Principal Investigator: Johannes Ruige, MD PhD Less <<
NCT01530347 Type 1 Diabetes Phase 1 Terminated(Per sponsor decisio... More >>n to stop the development of the study device) Less << - Israel ... More >> Schneider Children's Medical Center Petah- Tikva, Israel, 49202 Less <<
NCT01548651 Impaired Glucose Tolerance Phase 4 Terminated(difficulty with enr... More >>ollment of subjects) Less << - United States, Texas ... More >> Baylor College of Medicine Houston, Texas, United States, 77030 Less <<
NCT00312130 Pre-diabetes Phase 3 Completed - United States, Washington ... More >> University of Washington Seattle, Washington, United States, 98108 Less <<
NCT03138616 Gestational Diabetes Mellitus Phase 4 Enrolling by invitation January 31, 2019 China, Shanghai ... More >> Shanghai First People's Hospital, Shanghai Jiao Tong University 100 Haining Road,Shanghai Shanghai, Shanghai, China, 200080 Less <<
NCT00888238 - Completed - -
NCT00888238 Type 2 Diabetes Mellitus Phase 1 Completed - -
NCT02650947 Healthy Not Applicable Completed - Thailand ... More >> Faculty of Medicine Ramathibodi Hospital, Mahidol University Bangkok, Thailand, 10400 Less <<
NCT01302197 - Active, not recruiting December 2018 United States, Maryland ... More >> University of Maryland Medical System Baltimore, Maryland, United States, 21201 VA Maryland Health Care System, Baltimore Baltimore, Maryland, United States, 21201 Kernan Hospital Baltimore, Maryland, United States, 21207 Less <<
NCT02984644 Type II; Diabetes Phase 3 Recruiting January 31, 2020 United States, Texas ... More >> University of Texas Health Science Center Recruiting San Antonio, Texas, United States, 78229 Contact: Eugenio Cersosimo          Principal Investigator: Ralph A DeFronzo, MD Less <<
NCT01795248 Gestational Diabetes Mellitus Phase 4 Active, not recruiting August 2020 Denmark ... More >> Center for Diabetes Research Hellerup, Denmark, 2900 Less <<
NCT01715649 Diabetes Mellitus, Type 2 Not Applicable Completed - United States, California ... More >> Sutter Health Sacramento, California, United States, 95833 Less <<
NCT02309424 Type 2 Diabetes Not Applicable Completed - -
NCT02000960 Glucose Transporter Type 1 Def... More >>iciency Syndrome Less << Phase 2 Unknown October 2016 Canada, British Columbia ... More >> BC Children's Hospital Vancouver, British Columbia, Canada, V6H 3V4 Less <<
NCT00985270 Glucose Tolerance Phase 4 Completed - Finland ... More >> Oulu University Hospital Oulu, Finland, 90220 Less <<
NCT02518932 Insulin Resistance Phase 1 Unknown March 2016 United States, Texas ... More >> ICON PLC Recruiting San Antonio, Texas, United States, 78209 Contact: Rita Flusche    210-283-4123    Rita.flusche@iconplc.com Less <<
NCT03078491 Type 1 Diabetes Mellitus ... More >> Older Adults Hypoglycemia Less << Not Applicable Recruiting January 1, 2022 United States, Massachusetts ... More >> Joslin Diabetes Center Recruiting Boston, Massachusetts, United States, 02215 Contact: Medha N Munshi, MD    617-632-8676    medha.munshi@joslin.harvard.edu    Contact: Christine Slyne, BS    617-309-4683    Christine.slyne@joslin.harvard.edu    Principal Investigator: Medha N Munshi, MD Less <<
NCT02558491 Type 1 Diabetes Mellitus Not Applicable Completed - United States, Virginia ... More >> University of Virginia Center for Diabetes Technology Charlottesville, Virginia, United States, 22904 Less <<
NCT01176149 Type 2 Diabetes Phase 3 Completed - Italy ... More >> Consorzio Mario Negri Sud Santa Maria Imbaro, Chieti, Italy, 66030 Less <<
NCT01228279 End-stage Renal Disease (ESRD)... More >> Kidney Disease Less << Phase 4 Recruiting December 2018 Canada, Ontario ... More >> Ottawa Hospital Research Institute Recruiting Ottawa, Ontario, Canada Contact: Marcel Ruzicka, MD    613-738-8400 ext 82748    mruzicka@ottawahospital.on.ca    Contact: Brendan McCormick, MD    613-738-8400 ext 82893    bmccormick@ottawahospital.on.ca    Principal Investigator: Marcel Ruzicka, MD, PhD          Sub-Investigator: Brendan McCormick, MD          Sub-Investigator: Frans Leenen, MD          Sub-Investigator: Kathryn Ascah, MD          Sub-Investigator: Greg Knoll, MD Less <<
NCT02087995 Diabetes Mellitus Not Applicable Completed - United States, California ... More >> John Muir Physician Network Clinical Research Concord, California, United States, 94520 AMCR Institute Escondido, California, United States, 92026 Diablo Clinical Research, Inc. Walnut Creek, California, United States, 94598 Less <<
NCT01856946 Insulin Resistance Not Applicable Completed - United States, Missouri ... More >> University of Missouri Adolescent Obesity Clinic Columbia, Missouri, United States, 65201 Less <<
NCT03362528 Diabetes Not Applicable Active, not recruiting July 30, 2020 Denmark ... More >> Department of Endocrinology M Odense, Denmark, 5000 Less <<
NCT01387477 Hypoglycemia Phase 4 Unknown June 2012 France ... More >> Réanimation médico-chirurgicale Recruiting Nice, France Contact: Jean-Christophe Orban, MD       orban.jc@chu-nice.fr Less <<
NCT00231894 Diabetes Schi... More >>zophrenia Insulin Resistance Cognitive Impairment Less << Phase 4 Completed - United States, New York ... More >> Nathan Kline Institute for Psychiatric Research New York, New York, United States, 10035 Less <<
NCT02087995 - Completed - -
NCT02723968 Cystic Fibrosis-related Diabet... More >>es Less << Not Applicable Completed - -
NCT03188835 Type2 Diabetes Not Applicable Recruiting October 2019 Canada, Quebec ... More >> Centre de recherche du CHUS Recruiting Sherbrooke, Quebec, Canada, J1H 5N4 Contact: Frédérique Frisch    8193461110    frederique.frisch@usherbrooke.ca    Principal Investigator: André C. Carpentier Less <<
NCT00231894 - Completed - -
NCT00694473 Critical Illness Not Applicable Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT02444156 Diabetes Mellitus, Type 2 ... More >> Glucose Intolerance Hyperglycemia Less << Not Applicable Completed - United Kingdom ... More >> Leicester Diabetes Centre Leicester, United Kingdom, LE5 4PW Less <<
NCT00812591 Type 1 Diabetes Not Applicable Completed - Austria ... More >> Medical University of Graz Graz, Styria, Austria, A-8036 Less <<
NCT01394887 Glucose Intolerance ... More >> Inflammation Diabetes Less << Phase 2 Phase 3 Completed - Mexico ... More >> Endocrine Outpatient Clinic of the Hospital de Pediatria del CMN "Siglo XXI" Mexico City, DF, Mexico, 06720 Less <<
NCT00694473 - Completed - -
NCT01567254 Diabetes Mellitus, Insulin-Dep... More >>endent Less << Not Applicable Completed - Israel ... More >> Assaf Haroffeh Medical center Zerifin, Israel, 70300 Less <<
NCT02568280 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 1 Completed - Austria ... More >> Novo Nordisk Investigational Site Graz, Austria, 8010 Less <<
NCT02960217 Glucose Transporter Type 1 Def... More >>iciency Syndrome (Glut1 DS) Less << Phase 3 Active, not recruiting April 2019 United States, Colorado ... More >> Children's Hospital Colorado Aurora, Colorado, United States, 80045 United States, Florida Nicklaus Children's Hospital Miami, Florida, United States, 33155 United States, Georgia Center for Rare Neurological Diseases Norcross, Georgia, United States, 30093 United States, New York Columbia Universtiy New York, New York, United States, 10032 France Hopital Robert Debre Paris, France, 75019 Germany University of Essen Essen, Germany, 45122 Klinikum der Universitat München München, Germany, 81377 Universitaetklinikum Tuebingen Tuebingen, Germany, 72076 Italy IRCCS Fondazione Istituto Neurologico Nazionale C. Mondino Pavia Pavia, Italy, 27100 Spain Hospital Universitario Vall d'Hebron Barcelona, Spain, 08035 United Kingdom Leonard Wolfson Experimental Neurology Centre London, United Kingdom, WC1N3BG Sheffield Children's NHS Foundation Trust Sheffield, United Kingdom, S102TH Less <<
NCT02956655 Type 2 Diabetes Mellitus Not Applicable Unknown - China, Guangdong ... More >> The First Affiliated Hospital of Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510080 Contact: Jian Qin, Doctor    020-87330751    himybox@yeah.net Less <<
NCT00814346 Alzheimer's Disease ... More >> Cognitive Impairment Less << Phase 2 Completed - France ... More >> Hôpital Corentin Celton 4 parvis Corentin Celton Issy-Les-Moulineaux, France Hôpital de Juvisy Juvisy sur Orge, France CMPI "Les Rives de Seine" Le Vesinet, France Centre Hospitalier d'Orsay 4 place du Général Leclerc Orsay, France Private practice Paris, France, 75009 Hôpital Broca 54-56 rue Pascal Paris, France, 75013 Observatoire de l'âge Paris, France Hôpital Paul Brousse 12 av Paul-Vaillant-Couturier Villejuif, France Less <<
NCT00634842 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 4 Completed - -
NCT00634842 - Completed - -
NCT02031783 Healthy Not Applicable Completed - New Zealand ... More >> Massey University Wellington, New Zealand Less <<
NCT00814346 - Completed - -
NCT03008044 Healthy Subjects Not Applicable Completed - Hong Kong ... More >> The Chinese University of Hong Kong Sha Tin, Hong Kong Less <<
NCT03545217 Abnormal Glucose Metabolism Not Applicable Recruiting July 2020 Thailand ... More >> Faculty of Medicine Ramathibodi Hospital, Mahidol University Recruiting Bangkok, Thailand, 10400 Contact: Piyamitr Sritara, MD Less <<
NCT00782496 Diabetes Mellitus Not Applicable Completed - United States, Georgia ... More >> Atlanta Diabetes Associates Atlanta, Georgia, United States, 30309 United States, Minnesota International Diabetes Center Minneapolis, Minnesota, United States, 55416 United States, New York Mount Sinai School of Medicine New York City, New York, United States, 10029 United States, Washington University of Washington Medical Center/Diabetes Care Center Seattle, Washington, United States, 98105 Less <<
NCT00319189 Renal Transplant Recipients ... More >> Posttransplant Diabetes Mellitus Posttransplant Impaired Glucose Tolerance Less << Phase 4 Completed - Norway ... More >> Rikshospitalet, Section of Nephrology Oslo, Norway, 0027 Less <<
NCT01649219 Prediabetes Phase 4 Unknown June 2013 Finland ... More >> University of Oulu Oulu, Finland, 90014 Less <<
NCT03509324 Diabetes Mellitus, Type 2 Phase 4 Completed - China, Guangdong ... More >> endocrinology department of the first affiliated hospital of Sun Yat-sen University Guangzhou, Guangdong, China, 510080 Less <<
NCT00782496 - Completed - -
NCT02635139 Healthy Not Applicable Completed - Germany ... More >> Institute of Nutritional Medicine, University of Hohenheim Stuttgart, Germany, 70599 Less <<
NCT03536364 Obesity Pre-D... More >>iabetes Less << Not Applicable Completed - United States, New York ... More >> Comprehensive Weight Control Center New York, New York, United States, 10065 Less <<
NCT00598663 Diabetes Mellitus, Type 1 Phase 4 Completed - Austria ... More >> Hospital Hietzing Vienna, Austria Denmark Steno Diabetes Center Copenhagen, Denmark Glostrup Hospital Glostrup, Denmark Italy Clinica Pediatrica, Policlinico Umberto I Rome, Italy Luxembourg Center Hospitalier de Luxembourg Luxembourg, Luxembourg Netherlands Groene Hart Ziekenhuis Gouda, Netherlands Slovenia University Children's Hospital Ljubljana, Slovenia Spain Hospital Clinic i Universitari Barcelona, Spain Less <<
NCT00322478 Diabetes Mellitus, Type 1 Phase 2 Phase 3 Completed - United States, Texas ... More >> Diabetech Dallas, Texas, United States, 75201 Less <<
NCT00707616 - Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT01173978 Insulin Resistance ... More >> Deteriorated Glucose Homeostasis Inactivity Less << Not Applicable Completed - Denmark ... More >> Department of Clinical Physiology Glostrup, Denmark, DK-2600 Less <<
NCT02267317 Insulin Sensitivity Phase 2 Terminated(Study drug expired) - United States, Texas ... More >> Audie L. Murphy VA Hospital, STVHCS San Antonio, Texas, United States, 78229 Less <<
NCT03406312 - Recruiting January 2019 Belgium ... More >> Endocrinology, UZ Ghent Hospital Recruiting Ghent, Belgium, 9000 Contact: Bruno Lapauw, MD, PhD       bruno.lapauw@uzgent.be    Contact: Frederique Van de Velde       frederique.vandevelde@ugent.be Less <<
NCT03352869 Polycystic Ovary Syndrome ... More >> Overweight and Obesity Disorder of Glucose Regulation Less << Phase 4 Recruiting July 31, 2018 China ... More >> Renji Hospital Department of Endocrinology and Metabolism Recruiting Shanghai, China, 200127 Contact: Wei Liu, MD    +86-18918358342    sue_liuwei@163.com    Contact: Jing Ma, MD    +86-15800983436    cherry1996@live.cn Less <<
NCT02432391 Diabetes Mellitus, Type 2 Not Applicable Completed - United States, Virginia ... More >> University of Virginia Charlottesville, Virginia, United States, 22908 Less <<
NCT03714451 Diabetes Type 2 Not Applicable Recruiting November 30, 2021 United States, Connecticut ... More >> Yale New Haven Hospital Recruiting New Haven, Connecticut, United States, 06510 Contact: Renata Belfort De Aguiar, MD, PhD          Yale University School of Medicine Recruiting New Haven, Connecticut, United States, 06510 Contact: Renata Belfort De Aguiar, MD, PhD          Yale Center for Clinical Investigation Recruiting New Haven, Connecticut, United States, 06519 Contact: Renata Belfort De Aguiar, Md, PhD Less <<
NCT03623139 Type2 Diabetes ... More >> Diabetes Mellitus, Type 2 Glucose Metabolism Disorders Less << Not Applicable Recruiting October 31, 2021 Denmark ... More >> Steno Diabetes Center Copenhagen Recruiting Gentofte, Denmark, DK-2820 Contact: Bettina Ewers, MSc    +45 30912997    bettina.ewers@regionh.dk    Principal Investigator: Bettina Ewers, MSc Less <<
NCT00998855 - Unknown December 2011 United States, Texas ... More >> Baylor College of Medicine Recruiting Houston, Texas, United States, 77030 Contact: Agneta L Sunehag, M.D., Ph.D    713-798-6725    asunehag@bcm.tmc.edu    Principal Investigator: Agneta L Sunehag, M.D., Ph.D Less <<
NCT03249974 - Completed - Belgium ... More >> Jessa Hospital Hasselt, Belgium, 3500 Less <<
NCT02066584 - Unknown April 2016 Israel ... More >> Hillel Yaffe Medical Center Not yet recruiting Hadera, Israel, 38100 Contact: Medeia Michaeli, PhD       medeia_michaeli@yahoo.com    Principal Investigator: Medeia Michaeli, PhD          Sub-Investigator: Adrian Ellenbogen, MD Less <<
NCT01060241 Type 2 Diabetes Mellitus Not Applicable Suspended(Other projects warra... More >>nted more attention) Less << - Canada, British Columbia ... More >> St. Paul's Hospital Vancouver, British Columbia, Canada Less <<
NCT01044368 Type 2 Diabetes Mellitus Not Applicable Suspended(To focus on a simila... More >>r study NCT01175408 prior to recruiting participants.) Less << - Canada, British Columbia ... More >> St. Paul's Hospital Vancouver, British Columbia, Canada Less <<
NCT01261052 Type 1 Diabetes Mellitus Phase 2 Completed - United States, Oregon ... More >> Legacy Good Samaritan Hospital Portland, Oregon, United States, 97210 Less <<
NCT03254082 Blood Glucose Not Applicable Completed - -
NCT00947011 Glucose Homeostasis Phase 2 Terminated(PI left JHU) - United States, Maryland ... More >> Johns Hopkins Bayview Medical Center Baltimore, Maryland, United States, 21224 Less <<
NCT02513641 Type 2 Diabetes Not Applicable Active, not recruiting February 2019 United States, Louisiana ... More >> Pennington Biomedical Research Center Baton Rouge, Louisiana, United States, 70808 Pennington Biomedical Research Center Baton Rouge, Louisiana, United States, 70809 Less <<
NCT02212951 Type 2 Diabetes Mellitus Phase 1 Phase 2 Completed - United States, California ... More >> Profil Institute for Clinical Research Chula Vista, California, United States Less <<
NCT00947011 - Terminated(PI left JHU) - -
NCT01261052 - Completed - -
NCT02225691 Diabetes Mellitus, Type 2 ... More >> Diabetes Mellitus, Type 1 Less << Not Applicable Unknown March 2016 China ... More >> Weiping Jia Not yet recruiting Shanghai, China, 200233 Contact: Weiping Jia, MD,PHD    +8602164369181    wpjia@sjtu.edu.cn    Principal Investigator: Weiping Jia, MD,PHD Less <<
NCT02118142 Insulin Sensitivity Not Applicable Completed - United States, North Carolina ... More >> UNC Nutrition Research Institute Kannapolis, North Carolina, United States, 28081 Less <<
NCT03107208 Diabetic Ketoacidosis ... More >> Type 1 Diabetes Mellitus Less << Phase 4 Recruiting July 2019 United States, Colorado ... More >> Children's Hospital Colorado Recruiting Aurora, Colorado, United States, 80045 Contact: Kathleen Grice    303-724-3285       Contact: Regan Miller    303-724-2592       Principal Investigator: Rebecca A Ohman-Hanson, MD Less <<
NCT00419497 Hyperglycemia ... More >> Coronary Heart Disease Less << Phase 2 Phase 3 Completed - Sweden ... More >> Lund University Hospital Lund, Sweden, 22185 Less <<
NCT01251770 Hyponatremia Phase 3 Completed - Argentina ... More >> Hospital de Niños Pedro de Elizalde Buenos Aires, CF, Argentina, C1270AAN Less <<
NCT00988377 Diabetes Prevention ... More >> Obesity Prevention Less << Not Applicable Completed - Canada, Ontario ... More >> University of Toronto, Department of Nutritional Sciences Toronto, Ontario, Canada, M5S 3E2 Less <<
NCT01385865 Prediabetic State Not Applicable Completed - Korea, Republic of ... More >> Bundang CHA Medical Center Seongnam, Gyeonggi-Do, Korea, Republic of Less <<
NCT01157611 Type 1 Diabetes Not Applicable Completed - Korea, Republic of ... More >> Samsung Medical Center Seoul, Korea, Republic of, 135-710 Less <<
NCT02663544 Insulin Resistance ... More >> Metabolic Syndrome Obesity Diabetes NAFLD Inflammation Less << Not Applicable Active, not recruiting December 2018 United States, Washington ... More >> Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109 Less <<
NCT00542698 Type 2 Diabetes Mellitus Phase 1 Completed - United States, Massachusetts ... More >> Berkshire Health System Pittsfield, Massachusetts, United States, 01201 Baystate Health System Springfield, Massachusetts, United States, 01199 Less <<
NCT03741478 Healthy Controls Phase 1 Not yet recruiting December 2021 Canada, Ontario ... More >> University Health Network - Toronto General Hospital Not yet recruiting Toronto, Ontario, Canada, M5G 2C4 Contact: Satya Dash, MD, PhD    416-340-4800 ext 8094    satya.dash@uhn.ca    Principal Investigator: Satya Dash, MD, PhD          Center for Addiction and Mental Health Not yet recruiting Toronto, Ontario, Canada, M5T 1R8 Contact: Margaret Hahn, MD, PhD    416-535-8501 ext 34368    margaret.hahn@camh.ca    Contact: Mahavir Agarwal, MD, MBBS    416-535-8501 ext 30546    mahavir.agarwal@camh.ca    Principal Investigator: Margaret Hahn, MD, PhD          Sub-Investigator: Mahavir Agarwal, MD, MBBS Less <<
NCT01251770 - Completed - -
NCT02324309 Diabetes Mellitus Phase 1 Phase 2 Completed - United States, California ... More >> Profil Institute for Clinical Research, Inc. (PICR) Chula Vista, California, United States, 91911 Less <<
NCT01311076 Type 1 Diabetes Mellitus Phase 1 Completed - United States, California ... More >> Chula Vista, California, United States Less <<
NCT02773381 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 1 Completed - United Kingdom ... More >> Novo Nordisk Investigational Site Leeds, United Kingdom, LS2 9LH Less <<
NCT03419754 Obesity Metab... More >>olic Syndrome Less << Not Applicable Recruiting January 19, 2021 United States, Missouri ... More >> University of Missouri Recruiting Columbia, Missouri, United States, 65211 Contact: Jill Kanaley, PhD    573-882-2519    kanaleyj@missouri.edu    Principal Investigator: Jill kanaley, PhD Less <<
NCT02429258 - Completed - -
NCT00935350 Blood Glucose, Postprandial Phase 2 Phase 3 Completed - Canada, Ontario ... More >> Glycemic Index Laboratories, Inc. Toronto, Ontario, Canada Less <<
NCT03682237 Diabetes Mellitus, Type 1 Not Applicable Recruiting August 31, 2020 Denmark ... More >> Steno Diabetes Center Copenhagen Recruiting Copenhagen, Denmark Contact: Anna L Secher, MD, PhD Less <<
NCT01676233 Type 1 Diabetes Mellitus Phase 1 Completed - Japan ... More >> Investigational Site Number 392001 Kumamoto-Shi, Japan Less <<
NCT01170858 End Stage Renal Disease Not Applicable Completed - Korea, Republic of ... More >> Severance Hospital Seoul, Korea, Republic of, 120-752 Less <<
NCT02429258 Type II Diabetes Phase 4 Completed - -
NCT03334318 - Recruiting August 31, 2019 United States, Colorado ... More >> Barbara Davis Center / University of Colorado Denver Recruiting Aurora, Colorado, United States, 80045 Contact: Victoria Gage, RN, BSN, CDE    303-724-8369    Victoria.Gage@ucdenver.edu    Principal Investigator: Sarit Polsky, MD          United States, Georgia Emory University - Grady Memorial Hospital Recruiting Atlanta, Georgia, United States, 30303 Contact: Clementina Ramos, MD    404-616-3951    clemenramos@emory.edu    Principal Investigator: Guillermo Umpierrez, MD          Sub-Investigator: Sonya Haw, MD          United States, Illinois Northwestern University Feinberg School of Medicine Recruiting Chicago, Illinois, United States, 60611 Contact: Diane Larsen    312-503-2873    d-larsen@northwestern.edu    Contact: Daphne Adelman    312-908-9002    d-adelman@northwestern.edu    Principal Investigator: Mark Molitch, MD          Sub-Investigator: Amisha Wallia, MD          United States, Massachusetts Joslin Diabetes Center Recruiting Boston, Massachusetts, United States, 02215 Contact: Alessandro Doria, MD PhD MPH    617-309-2406    alessandro.doria@joslin.harvard.edu    Contact: Sara Vecchi    (617) 309-4506    sara.vecchi@joslin.harvard.edu    Principal Investigator: Alessandro Doria, MD PhD MPH          Sub-Investigator: Sylvia Rosas, MD          Sub-Investigator: Robert Stanton, MD          United States, Michigan Brehm Center for Diabetes Research / University of Michigan Recruiting Ann Arbor, Michigan, United States, 48105 Contact: Ginny Leone, MA    734-936-8656    vleone@med.umich.edu    Contact: Cynthia Plunkett, RNC, CCRC       cplunket@med.umich.edu    Principal Investigator: Rodica Pop-Busui, MD, PhD          Henry Ford Health System Recruiting Detroit, Michigan, United States, 48202 Contact: Heather Remtema, MPH, RD, CCRP    (313) 916-3906    hremtem1@hfhs.org    Principal Investigator: Arti Bhan, MD          Sub-Investigator: Davida Kruger, MSN          United States, Minnesota University of Minnesota Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Madeleine Hermans    612-626-3286    herma583@umn.edu    Principal Investigator: Maria Luiza Caramori, MD, PhD          United States, Missouri Washington University Recruiting Saint Louis, Missouri, United States, 63110 Contact: Carol Recklein, RN, MHS, CDE    314-362-8606    crecklein@dom.wustl.edu    Principal Investigator: Janet McGill, MD          United States, New York ICAHN School of Medicine at Mount Sinai Recruiting New York, New York, United States, 10029 Contact: Selassie Ogyaadu    212-241-9089    Selassie.Ogyaadu@mssm.edu    Principal Investigator: Carol Levy, MD          SUNY Upstate Medical University Recruiting Syracuse, New York, United States, 13210 Contact: Suzan Bzdick, RN, CCRC    315-464-9006    bzdicks@upstate.edu    Contact: Jane Bulger, MS, CCRC    (315) 464-9008    bulgerj@upstate.edu    Principal Investigator: Ruth Weinstock, MD          Albert Einstein College of Medicine / Montefiore Medical Center Recruiting The Bronx, New York, United States, 10461 Contact: Danielle Powell, MPH    718-405-8271    PERL@einstein.yu.edu    Principal Investigator: Jill Crandall, MD          United States, Washington Virginia Mason Medical Center Recruiting Seattle, Washington, United States, 98101 Contact: Katherine Wilder    206-223-6169    katherine.wilder@virginiamason.org    Principal Investigator: Grace Lee, MD          University of Washington Recruiting Seattle, Washington, United States, 98105 Contact: Dawn Lum    206-685-4633    PERL-UW@nephrology.washington.edu    Principal Investigator: Ian de Boer, MD          Sub-Investigator: Irl Hirsch, MD          Sub-Investigator: Dace Trance, MD          Providence Sacred Heart Medical Center Recruiting Spokane, Washington, United States, 99204 Contact: Mary Bates, RN    509-474-4962    mary.bates@providence.org    Contact: Joan Milton, RDN    (509) 474-4323    joan.milton@providence.org    Principal Investigator: Katherine R. Tuttle, MD Less <<
NCT03103867 Diabetes Mellitus, Type 1 Not Applicable Completed - Luxembourg ... More >> Clinique des Enfants CHluxembourg Luxembourg, Luxembourg, 1210 Less <<
NCT02200991 Type 2 Diabetes Mellitus Phase 4 Completed - Japan ... More >> Investigational Site Number 392-107 Atsugi-shi, Japan Investigational Site Number 392-125 Chiyoda-ku, Japan Investigational Site Number 392-121 Chuoh-ku, Japan Investigational Site Number 392-102 Ichihara-shi, Japan Investigational Site Number 392-103 Kawaguchi-shi, Japan Investigational Site Number 392-114 Kitamoto-shi, Japan Investigational Site Number 392-122 Kobe-shi, Japan Investigational Site Number 392-126 Kumamoto-shi, Japan Investigational Site Number 392-127 Kumamoto-shi, Japan Investigational Site Number 392-101 Kyoto-shi, Japan Investigational Site Number 392-106 Matsudo-shi, Japan Investigational Site Number 392-124 Mitaka-shi, Japan Investigational Site Number 392-108 Mito-shi, Japan Investigational Site Number 392-119 Nerima-ku, Japan Investigational Site Number 392-117 Okayama-shi, Japan Investigational Site Number 392-111 Sagamihara-shi, Japan Investigational Site Number 392-110 Sapporo-shi, Japan Investigational Site Number 392-116 Satsumasendai-shi, Japan Investigational Site Number 392-105 Shizuoka-shi, Japan Investigational Site Number 392-118 Suita-shi, Japan Less <<
NCT01856907 - Completed - -
NCT01856907 Disorder of Glucose Regulation Phase 4 Completed - United States, Louisiana ... More >> Woman's Hospital Baton Rouge, Louisiana, United States, 70817 Less <<
NCT02158481 Vascular Diseases ... More >> Impaired Glucose Tolerance Less << Not Applicable Completed - United Kingdom ... More >> Aspect Clinical Ledbury, United Kingdom Less <<
NCT03314142 Potential Abnormality of Gluco... More >>se Tolerance Appetitive Behavior Less << Not Applicable Completed - Greece ... More >> Agricultural University of Athens Athens, Greece, 11855 Less <<
NCT00764556 COPD Hypergly... More >>cemia Less << Phase 2 Completed - United Kingdom ... More >> St George's Healthcare NHS Trust London, United Kingdom, SW17 0RE Less <<
NCT03368586 - Completed - -
NCT01262586 Type II Diabetes Mellitus Phase 3 Completed - Germany ... More >> Novartis Investigative Site Mainz, Germany Less <<
NCT03220919 Efficacy, Self ... More >> Adverse Effect Less << Not Applicable Recruiting February 2019 China, Guangdong ... More >> the Second Affiliated Hospital of Guangzhou Medical University Recruiting Guangzhou, Guangdong, China Contact: Wangen Li    86-20-34152032 Less <<
NCT00950898 Type 2 Diabetes Not Applicable Completed - United States, New York ... More >> Brooklyn College of the City University of New York Brooklyn, New York, United States, 11210 Less <<
NCT01586442 Heart Failure ... More >> Type 2 Diabetes Glucose Intolerance Less << Phase 3 Active, not recruiting March 2018 Canada, Quebec ... More >> Montreal Heart Institute Montreal, Quebec, Canada, H1T 1C8 Less <<
NCT01022645 - Completed - United States, Illinois ... More >> Northwestern Medical Faculty Foundation; Northwestern Memorial Hospital Chicago, Illinois, United States, 60611 Less <<
NCT02814357 Healthy Not Applicable Completed - India ... More >> Lambda Therapeutics Research Ltd (LTRL) Ahmedabad, Near Gujrat High Court, SG Highway, Gota, India, 380 061 Gujrat Less <<
NCT01614613 - Completed - -
NCT02486978 Hyperglycaemia Not Applicable Completed - United Kingdom ... More >> School of Food Science and Nutrition Leeds, West Yorkshire, United Kingdom, LS2 9JT Less <<
NCT01092663 Diabetes Mellitus, Type 2 Not Applicable Completed - United States, California ... More >> University of California, San Francisco San Francisco, California, United States, 94110 United States, Florida Clinical Pharmacology of Miami Miami, Florida, United States, 33014 United States, Texas Healthcare Discoveries, LLC d/b/a ICON Development Solutions San Antonio, Texas, United States, 78209 Less <<
NCT01614613 Diabetes Not Applicable Completed - United States, Washington ... More >> Rainier Clinical Research Center Inc Renton, Washington, United States, 98057 Less <<
NCT01092663 - Completed - -
NCT02357550 Ketone Body Metabolism ... More >> Brain Metabolism Less << Not Applicable Completed - Denmark ... More >> Aarhus University Hospital Aarhus, Denmark, 8000 Less <<
NCT03483779 Randomized Controlled Trial ... More >> Ginkgo Biloba Extract Less << Phase 4 Recruiting July 30, 2021 China, Beijing ... More >> Xiyuan Hospital Recruiting Beijing, Beijing, China, 100091 Contact: Yue Liu, PhD    +86 13701167815    liuyueheart@hotmail.com    Principal Investigator: Rui Gao, PhD          Principal Investigator: Yue Liu, PhD Less <<
NCT02776007 Type 1 Diabetes Not Applicable Active, not recruiting March 2019 Israel ... More >> Schneider Children's Medical Center Petach-Tikva, Israel, 49202 Less <<
NCT03755232 Dietary Modification ... More >> Healthy Less << Not Applicable Not yet recruiting December 1, 2019 -
NCT02024321 - Completed - China, Beijing ... More >> Cancer Hospital, Chinese Academy of Medical Sciences Beijing, Beijing, China, 100021 Less <<
NCT01713348 - Completed - -
NCT03708887 Hyperglycaemia (Diabetic) ... More >> Hyperlipidemias Less << Phase 4 Recruiting October 1, 2020 China, Zhejiang ... More >> Lanxi Red Cross Hospital Recruiting Jinhua, Zhejiang, China, 321102 Contact: Weifang Zheng, MD          Sub-Investigator: Yu Zhang, PHD Less <<
NCT00977808 - Completed - -
NCT01713348 Diabetes Mellitus Phase 4 Completed - United Kingdom ... More >> Ayr Hospital Ayr, Ayrshire, United Kingdom, KA6 6DX Tameside Hospital NHS Foundation Trust Ashton-under-Lyne, United Kingdom, OL6 9RW Royal United Hospital Bath, United Kingdom, BA1 3NG Birmingham Heartlands Hospital, Diabetes Clinic City and Borough of Birmingham, United Kingdom, B9 5SS University Hospital of North Durham Durham, United Kingdom, DH1 5TW Ipswich Hospital NHS Trust Ipswich, United Kingdom, IP4 5PD St James Hospital, Leeds, United Kingdom, LS9 7TF Rotherham General Hospital Rotherham, United Kingdom, S60 2UD Diabetes Centre, New Cross Hospital, Wolverhampton,, United Kingdom, WV10 0QP Less <<
NCT03594565 T1DM Hypersen... More >>sitivity Less << Early Phase 1 Completed - -
NCT00918138 Type 2 Diabetes Phase 3 Completed - United States, Arizona ... More >> Dedicated Phase I, Inc. Phoenix, Arizona, United States, 85013 United States, California Pacific Sleep Medicine Services (Avastra Clinical Trials) Redlands, California, United States, 92373 Orange County Research Center Tustin, California, United States, 92780 United States, Florida Clinical Research Of South Florida Coral Gables, Florida, United States, 33134 Palm Springs Research Institute Hialeah, Florida, United States, 33012 Healthcare Clinical Data, Inc. North Miami, Florida, United States, 33161 United States, Georgia River Birch Research Alliance, Llc Blue Ridge, Georgia, United States, 30513 United States, Michigan Jasper Clinic, Inc. Kalamazoo, Michigan, United States, 49007 United States, New York Clinilabs, Inc. New York, New York, United States, 10019 United States, Ohio Medpace Clinical Pharmacology Unit Cincinnati, Ohio, United States, 45212 United States, Texas Clinical Trials Of Texas Inc. San Antonio, Texas, United States, 78229 United States, Utah Advanced Clinical Research West Jordan, Utah, United States, 84088 Argentina Local Institution Capital Federal, Buenos Aires, Argentina, 1429 Local Institution Buenos Aires, Argentina, 1425 Israel Local Institution Beer-Sheva, Israel, 84101 Local Institution Holon, Israel, 58100 Local Institution Kfar-Saba, Israel, 44281 Local Institution Zefat, Israel, 13100 Mexico Local Institution Monterrey, Nuevo Leon, Mexico, 64460 Local Institution Durango, Mexico, 34000 Local Institution Durango, Mexico, 34075 Less <<
NCT00977808 Type 1 Diabetes Not Applicable Completed - United States, Virginia ... More >> University of Virginia Charlottesville, Virginia, United States, 22904 Less <<
NCT02218528 Healthy Not Applicable Completed - India ... More >> Lambda Therapeutics Research Ltd (LTRL) Ahmedabad, India Less <<
NCT02159638 Diabetes Mellitus, Type 1 ... More >> Blood Glucose Less << Not Applicable Completed - Sweden ... More >> NU-hospital Organisation Trollhattan, Sweden, 46173 Uddevalla hospital Uddevalla, Sweden, 45180 Less <<
NCT02256332 Diabetes Mellitus, Type 2 Not Applicable Completed - India ... More >> Ashirwad Hospital and Research Centre, THANE , MAHARASHTRA Thane, Maharashtra, India Lambda Therapeutics Research Ttd (LTRL) Ahemdabad, India Less <<
NCT03708939 Glucose Intolerance ... More >> Glucose, Low Blood Glucose, High Blood Less << Not Applicable Enrolling by invitation January 1, 2021 Israel ... More >> Weizmann Institute of Science Reẖovot, Israel Less <<
NCT00426114 Peritoneal Dialysis Phase 2 Withdrawn - -
NCT03219411 Dysglycemia O... More >>besity Less << Phase 2 Active, not recruiting December 30, 2018 United States, Massachusetts ... More >> Joslin Diabetes Center Boston, Massachusetts, United States, 02215 Less <<
NCT01148862 - Completed - -
NCT02411578 Diabetes Mellitus, Type 1 Phase 2 Completed - United States, Colorado ... More >> University of Colorado/Barbara Davis Center for Diabetes Aurora, Colorado, United States, 80045 United States, Connecticut Yale University of Medicine New Haven, Connecticut, United States, 06510 United States, Massachusetts Joslin Diabetes Center Boston, Massachusetts, United States, 02215 United States, New York SUNY Upstate Medical University Syracuse, New York, United States, 13210 United States, Pennsylvania University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00918138 - Completed - -
NCT00591071 Hyperglycemia ... More >> Critically Ill Patients Less << Phase 3 Unknown September 2010 France ... More >> Medico-surgical ICU Louise Michel Hospital Not yet recruiting Evry, France, 91014 Cedex Contact: Andry Van de Louw, MD       andry.vandelouw@ch-sud-francilien.fr    Principal Investigator: Andry Van de Louw, MD          Medico-surgical ICU Poissy Saint Germain Hospital Recruiting Poissy, France, 78300 Contact: Jean-Claude Lacherade, MD    33 1 39 27 54 55    jclacherade@chi-poissy-st-germain.fr    Principal Investigator: Jean-Claude Lacherade, MD Less <<
NCT02411578 - Completed - -
NCT01148862 Type 1 Diabetes Mellitus Not Applicable Completed - United States, California ... More >> AMCR Institute Escondido, California, United States, 92026 Stanford University Stanford, California, United States, 94305 United States, Colorado Barbara Davis Center of Childhood Diabetes Aurora, Colorado, United States, 80045 Barbara Davis Center for Childhood Diabetes Denver, Colorado, United States, 80045 United States, Washington Rainier Clinical Research Institute Renton, Washington, United States, 98057 Less <<
NCT01476384 Type 2 Diabetes Mellitus Not Applicable Completed - Netherlands ... More >> Maastricht University Medical Center+ Maastricht, Limburg, Netherlands, 6229ER Less <<
NCT00011622 - Completed - United States, Texas ... More >> University of Texas Medical School Houston, Texas, United States, 40202 Less <<
NCT00168519 Diabetes Mellitus, Type 2 Not Applicable Completed - Australia, Victoria ... More >> Baker Heart Research Institute Melbourne, Victoria, Australia, 8008 Less <<
NCT03195400 - Recruiting December 31, 2021 United States, Connecticut ... More >> Yale University Recruiting New Haven, Connecticut, United States, 06510 Contact: Bridget Pierpont, M.A.    203-785-2942    bridget.pierpont@yale.edu    Principal Investigator: Sonia Caprio, M.D. Less <<
NCT03093636 Type1 Diabetes Mellitus Not Applicable Recruiting December 31, 2018 United States, California ... More >> Stanford University Recruiting Stanford, California, United States, 94304 Contact: Bruce Buckingham, MD    650-723-5791    bbendo@stanford.edu    Contact: Ellen Ambers, BSN, RN, PHN, CDE    650-723-8163    eambers@stanford.edu    Principal Investigator: Bruce Buckingham, MD          United States, New York Icahn School of Medicine at Mt. Sinai Recruiting New York, New York, United States, 10029 Contact: Carol Levy, MD, CDE    212-241-9089    Carol.Levy@mssn.edu    Contact: Camilla Levister, ANP-C, MS    212-241-5177    Camilla.Levister@mssm.edu    Principal Investigator: Carol Levy, MD, CDE          United States, Virginia University of Virginia Recruiting Charlottesville, Virginia, United States, 22903 Contact: Stacey M. Anderson, MD    434-982-0945    sg4c@virginia.edu    Contact: Jess Robic    434-982-3459    jlr8yq@virginia.edu    Principal Investigator: Stacey M. Anderson, MD          Sub-Investigator: Sue A. Brown, MD Less <<
NCT01072565 Type 2 Diabetes Not Applicable Completed - United States, Minnesota ... More >> International Diabetes Center Minneapolis, Minnesota, United States, 55416 Less <<
NCT01460446 Diabetes Mellitus, Type 1 ... More >> Diabetes Mellitus, Type 2 Less << Not Applicable Completed - Germany ... More >> Aschaffenburg, Germany, 63739 Augsburg, Germany, 86150 Berlin, Germany, 01627 Berlin, Germany, 12351 Berlin, Germany, 13088 Berlin, Germany, 13597 Duisburg, Germany, 47179 Essen, Germany, 45335 Furth im Wald, Germany, 93437 Köln-Weiden, Germany, 50858 Leipzig, Germany, 04103 München, Germany, 81479 Münster, Germany, 48155 Rostock, Germany, 18057 Simmern, Germany, 55469 Unterhaching, Germany, 82008 Wurzen, Germany, 04808 United Kingdom Blackburn, United Kingdom, BB23HH Bournemouth, United Kingdom, BH7 7DW Bradford, United Kingdom, BD96RJ Chester, United Kingdom, CH21UL Cosham, United Kingdom, PO63LY Coventry, United Kingdom, CV22DX Derby, United Kingdom, DE223NE Exeter, United Kingdom, EX25DW Leicester, United Kingdom, LE15WW Lindley, Huddersfield, United Kingdom, HD33EA Middlesborough, United Kingdom, TS4 3BW Northampton, United Kingdom, NN15BD Nottingham, United Kingdom, NG72UH Rotherham, United Kingdom, S602UD Scunthorpe, United Kingdom, DN157BH Sheffield, United Kingdom, S57AU Less <<
NCT01460446 - Completed - -
NCT01992133 Gestational Diabetes Mellitus ... More >>in Pregnancy Vitamin D Deficiency Less << Not Applicable Completed - Malaysia ... More >> Penang Medical College Penang, Malaysia, 11450 Less <<
NCT00726440 Type 1 Diabetes Not Applicable Completed - Belgium ... More >> CHU Sart Tilman Liège Liege, Belgium, 4000 France CHU Jean Minjoz Besancon, France, 25030 CH SUD Francilien Corbeil Essonnes, France, 91100 University Hospital Grenoble Grenoble, France, 38043 Hopital Edouard Herriot Lyon, France, 69003 CHU Marseille Hôpitaux Sud Marseille, France, 13274 Chu Montpellier Montpellier, France, 34295 CHU Hôpital Jeanne d'Arc Nancy, France, 54201 CHU Nantes Nantes, France, 44093 Hopital Hotel Dieu Paris, France, 75004 CHU La Pitié Salpetrière Paris, France, 75013 CHU Robert Debré Paris, France, 75019 Hopital Haut Leveque Pessac, France, 33604 CHU de Reims-Hôpital Américain Reims, France, 51100 CHU de Reims-Hôpital Robert debré Reims, France, 51100 CHU Rennes Rennes, France, 35056 Hopital Bellevue Saint Etienne, France, 42055 CHU Strasbourg Strasbourg, France, 67091 CHU Toulouse Toulouse, France, 31403 Less <<
NCT00588185 Prostate Cancer Not Applicable Recruiting February 2019 United States, New York ... More >> Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Michael Morris, M.D., Ph,D.    646-422-4469       Principal Investigator: Michael Morris, M.D., Ph.D. Less <<
NCT00986700 Fasting Hyperglycemia Not Applicable Completed - -
NCT03510624 Type 2 Diabetes Mellitus Phase 1 Not yet recruiting June 1, 2019 -
NCT01767441 - Unknown June 2016 Italy ... More >> AOUI Verona Recruiting Verona, Italy, 37126 Contact: Riccardo C Bonadonna, MD, PHD    +390458123115    riccardo.bonadonna@univr.it    Contact: Maria Grazia Zenti, MD    +390458123110    mariagrazia.zenti@univr.it    Principal Investigator: Maria Grazia Zenti, MD Less <<
NCT01074801 Type 1 Diabetes Phase 2 Completed - United Kingdom ... More >> Wellcome Trust Clinical Research Facility, Addenbrooke's Hospital Cambridge, United Kingdom, CB20QQ Less <<
NCT02651597 Normoglycemic ... More >> Normal Body Weight Less << Not Applicable Completed - Canada, Manitoba ... More >> Richardson Centre for Functional Foods and Nutraceuticals, University of Manitoba Winnipeg, Manitoba, Canada, R3T 6C5 Less <<
NCT03155594 Diabete Mellitus Not Applicable Active, not recruiting August 1, 2017 United States, Illinois ... More >> Methodist Medica Center of Illinois Peoria, Illinois, United States, 61602 Less <<
NCT02541344 Prediabetes H... More >>yperglycemia Less << Phase 3 Completed - Germany ... More >> analyze & realize GmbH Berlin, Germany, 10369 Less <<
NCT03458715 Type2 Diabetes Phase 4 Recruiting November 21, 2018 Taiwan ... More >> Division of Endocrinology and Metabolism, Department of Internal Medicine, Mackay Memorial Hospital Recruiting Taipei, Taiwan, 10449 Contact: Yi-Hong Zeng, MD    +886-2-25433535 ext 2174    starrydouchain@yahoo.com.tw    Sub-Investigator: Sung-Chen Liu, MD          Sub-Investigator: Chun-Chuan Lee, MD Less <<
NCT03559621 Gestational Diabetes ... More >> Type 2 Diabetes Mellitus Glucose Intolerance Healthy Lifestyle Less << Not Applicable Not yet recruiting June 6, 2022 Belgium ... More >> OLV Aalst-Asse Not yet recruiting Aalst, Oost-Vlaanderen, Belgium, 9300 Contact: Inge Van Pottelbergh, MD PhD          GZA Not yet recruiting Antwerpen, Belgium, 2018 Contact: Pascale Abrams, MD          Principal Investigator: Wouter Vink, MD          UZA Antwerpen, Belgium, 2560 Imelda Bonheiden Not yet recruiting Bonheiden, Belgium, 2820 Contact: Toon Maes, MD          AZ Klina Not yet recruiting Brasschaat, Belgium, 2930 Contact: Liesbeth Leuridan, MD          UZ Brussel Not yet recruiting Brussel, Belgium, 1090 Contact: Nancy Van Wilder, MD          AZ Groeninge Kortrijk Not yet recruiting Kortrijk, Belgium, 8510 Contact: Nele Myngheer, MD          UZ Leuven Not yet recruiting Leuven, Belgium, 3000 Less <<
NCT02894112 Oral Glucose Tolerance Test ... More >> High Fat Tolerance Test Less << Not Applicable Completed - United States, Texas ... More >> Cardiovascular Aging Research Laboratory Austin, Texas, United States, 78702 Less <<
NCT02660242 - Completed - -
NCT01013402 Hypoglycemia Phase 4 Completed - Turkey ... More >> Gulhane School of Medicine Department of Endocrinology and Metabolism Ankara, Turkey, 06018 Less <<
NCT00145925 Diabetes Mellitus, Type 2 Phase 3 Completed - Australia, Victoria ... More >> The University of Melbourne Melbourne, Victoria, Australia, 3010 Canada, Quebec University of Montreal Montreal, Quebec, Canada, H26 1X2 China, Beijing Cardiovascular Institute & Fu Wai Hospital Xicheng District, Beijing, China, 100037 Netherlands The Julius Center for Health Sciences and Primary Care Utrecht, Netherlands, 3508 BA United Kingdom Imperial College School of Medicine London, United Kingdom, W2 1PG Less <<
NCT00643474 Diabetes Mellitus Type 2 Not Applicable Completed - Italy ... More >> Alessandria, Italy, 15100 Ancona, Italy, 60131 Asti, Italy, 14100 Bari, Italy, 70124 Bassano del Grappa, Italy, 36061 Bergamo, Italy, 24128 Cagliari, Italy, 09042 Catania, Italy, 95122 Catanzaro, Italy, 88100 Fermo, Italy, 60023 Foggia, Italy, 71100 Forlì, Italy, 47034 Genova, Italy, 16149 Lanusei, Italy, 08045 Mariano Comense, Italy, 22066 Messina, Italy, 98126 Milano, Italy, 20121 Milano, Italy, 20132 Milano, Italy, 20150 Monfalcone, Italy, 34074 Napoli, Italy, 80131 Olbia, Italy, 07026 Padova, Italy, 35128 Palermo, Italy, 90047 Perugia, Italy, 06100 Pescara, Italy, 65124 Prato, Italy, 59100 Quartu S. Elena - Cagliari, Italy, 09045 Ravenna, Italy, 48100 Roma, Italy, 00195 Rome, Italy, 00100 Rome, Italy, 00157 Rome, Italy, 0151 Rovigo, Italy, 45100 S. Benedetto del Tronto (AP), Italy, 63039 Salerno, Italy, 84100 Siena, Italy, 53100 Terni, Italy, 05100 Torino, Italy, 10126 Treviso, Italy, 31100 Trieste, Italy, 34148 Udine, Italy, 33100 Vicenza, Italy, 36100 Less <<
NCT01375803 Insulin Resistance Not Applicable Completed - United States, Kentucky ... More >> Louisville Metabolic and Atherosclerosis Research Center Louisvile, Kentucky, United States, 40213 Canada, Ontario KGK Synergize Inc. London, Ontario, Canada, N6A 5R8 Less <<
NCT00313742 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 4 Completed - Germany ... More >> Neuss, Germany, 41460 United Kingdom Newcastle upon Tyne, United Kingdom, NE1 4LP Less <<
NCT00837655 Kidney Failure, Chronic ... More >> End-Stage Renal Disease Insulin Resistance Hyperphosphatemia Less << Not Applicable Withdrawn(PI retired) - Sweden ... More >> Sahlgrenska University Hospital Gothenburg, Sweden, 413 45 Karolinska University Hospital Stockholm, Sweden, 14186 Less <<
NCT01072097 Polycystic Ovary Syndrome Not Applicable Completed - Finland ... More >> Department of Obstetrics and Gynaecology, University of Oulu Oulu, Finland, 90014 Less <<
NCT03412136 Appetitive Behavior ... More >> Pediatric Obesity Less << Not Applicable Completed - Canada, Ontario ... More >> University of Toronto Toronto, Ontario, Canada, M5S 3E2 Less <<
NCT01135771 Diabetes Phase 1 Completed - Germany ... More >> Profil Institut für Stoffwechselforschung Neuss, Germany, 41460 Less <<
NCT02034435 Metabolic Syndrome Not Applicable Recruiting December 2018 United States, Tennessee ... More >> Vanderbilt University Medical Center Recruiting Nashville, Tennessee, United States, 37232-6602 Contact: Loretta Byrne, RN    615-322-2105    loretta.byrne@vanderbilt.edu    Contact: Holly Waldrop       holly.waldrop@vanderbilt.edu    Principal Investigator: James M Luther, MD Less <<
NCT01005342 Hypoglycemia ... More >>Hyperglycemia Less << Not Applicable Completed - Sweden ... More >> Lund University Lund, Sweden, SE-221 00 Less <<
NCT01508923 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 2 Completed - Denmark ... More >> Novo Nordisk Investigational Site Århus C, Denmark, 8000 Less <<
NCT03598322 Carpal Tunnel Syndrome Not Applicable Recruiting June 30, 2023 Taiwan ... More >> Department of Physical Medicine & Rehabilitation , National Taiwan University Hospital Recruiting Taipei, Taiwan, 100 Contact: Chueh-Hung Wu, MD    886-2- 23123456 ext 66473    nojred@gmail.com    Principal Investigator: Chueh-Hung Wu, MD Less <<
NCT02660242 Diabetes Mellitus, Type 1 Phase 2 Completed - United States, Massachusetts ... More >> Joslin Diabetes Center Boston, Massachusetts, United States, 02215 United States, Pennsylvania University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT02413671 Whole Body Glucose and Insulin... More >> Metabolism Less << Not Applicable Completed - -
NCT00551538 Type 2 Diabetes Phase 4 Completed - United States, Indiana ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Indianapolis, Indiana, United States, 46202 Less <<
NCT03090451 Type 1 Diabetes Mellitus ... More >> Hypoglycemia Less << Not Applicable Active, not recruiting June 1, 2019 United States, Oregon ... More >> Oregon Health & Science University Portland, Oregon, United States, 97239 Less <<
NCT02553408 Type 2 Diabetes Not Applicable Completed - Canada, Ontario ... More >> Western University London, Ontario, Canada, N6A 3K7 Less <<
NCT02640118 Diabetes After Total Pancreate... More >>ctomy Less << Not Applicable Completed - -
NCT03638102 Gestational Diabetes Not Applicable Not yet recruiting January 1, 2021 United States, Illinois ... More >> University of Illinois at Chicago Not yet recruiting Chicago, Illinois, United States, 60612 Contact: Sirimon Reutrakul, MD Less <<
NCT02673554 Type 2 Diabetes Phase 1 Completed - -
NCT03566693 Diabetes Mellitus, Type 2 Not Applicable Recruiting May 31, 2022 United States, California ... More >> Scripps Whittier Diabetes Institute Recruiting San Diego, California, United States, 92121 Contact: Cherri Rosario       Rosal.Rosario@scrippshealth.org    Principal Investigator: Athena Philis-Tsimikas, M.D.          United States, Georgia Atlanta Diabetes Associates Recruiting Atlanta, Georgia, United States, 30318 Contact: Nitin Rastogi       Nrastogi@atlantadiabetes.com    Principal Investigator: Bruce W. Bode, M.D.          United States, Idaho Rocky Mountain Diabetes & Osteoporosis Center, P.A. Recruiting Idaho Falls, Idaho, United States, 83404-7596 Contact: Nikki McGraw, MA, CCRC    208-528-9648    nikki.mcgraw@idahomed.com    Principal Investigator: David Liljenquist, M.D.          United States, Iowa Iowa Diabetes and Endocrinology Research Center Recruiting West Des Moines, Iowa, United States, 50265 Contact: Kristie Stifel    515-329-6804    kstifel@iderc.com    Principal Investigator: Anuj Bhargava, M.D.          United States, Maryland MODEL Clinical Research Recruiting Baltimore, Maryland, United States, 21204 Contact: Karen Klein    443-524-1789    karenklein99@hotmail.com    Principal Investigator: Philip Levin, M.D.          United States, Minnesota Park Nicollet International Diabetes Center Recruiting Minneapolis, Minnesota, United States, 55416 Contact: Kathy McCann    952-993-3705    Kathleen.mccann@parknicollet.com    Principal Investigator: Thomas Martens, M.D.          United States, Nevada Las Vegas Endocrinology Recruiting Henderson, Nevada, United States, 89052 Contact: Alejandra Martinez       zillah725@gmail.com    Principal Investigator: Quang Nguyen, D.O.          United States, Texas Texas Diabetes & Endocrinology, P.A. Recruiting Austin, Texas, United States, 78731 Contact: Rachel Barosh    512-334-3505    rbarosh@texasdiabetes.com    Principal Investigator: Thomas Blevins, M.D.          Texas Diabetes & Endocrinology, P.A. Recruiting Austin, Texas, United States, 78749 Contact: Emmanuel Lopez    512-334-3505    elopez@texasdiabetes.com    Principal Investigator: Lindsay Harrison, M.D.          Research Institute of Dallas Recruiting Dallas, Texas, United States, 75231 Contact: Veronica Almanza    214-265-2157    valmanza@researchdallas.com    Principal Investigator: Stephen Aronoff, M.D.          United States, Utah Advanced Research Institute Recruiting Ogden, Utah, United States, 84405 Contact: Hilary Wahlen       hilary@advresearch.org    Principal Investigator: Jack Wahlen, M.D., Ph.D. Less <<
NCT02506582 Prediabetes N... More >>ewly Diagnosed Type 2 Diabetes Less << Not Applicable Completed - -
NCT03258853 Cystic Fibrosis-related Diabet... More >>es Less << Not Applicable Recruiting December 2023 United States, Massachusetts ... More >> Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: Courtney Balliro, RN, CDE    617-726-1242    CBALLIRO@PARTNERS.ORG    Principal Investigator: Steven J Russell, MD, PhD Less <<
NCT01150617 Type 2 Diabetes Mellitus ... More >> Peripheral Vascular Disease Less << Phase 4 Terminated(end-point reached) - Italy ... More >> Cardio-Metabolic and Clinical Trials Unit, San Raffaele Scientific Institute Milan, Italy, 20132 Less <<
NCT01010100 Diabetes Mellitus Phase 3 Completed - Spain ... More >> Agost, Alicante, Spain, 03698 Crevillente, Alicante, Spain Novelda, Alicante, Spain, 03660 San Vicente del Raspeig, Alicante, Spain, 03690 Terrassa, Barcelona, Spain, 08223 Trobajo del Camino, León, Spain, 24010 Begonte, Lugo, Spain, 27373 Villalba, Lugo, Spain, 27800 Camas, Sevilla, Spain, 41900 Constanti, Tarragona, Spain, 43120 Cornudella, Tarragona, Spain, 43360 El Morell, Tarragona, Spain, 43760 Falset, Tarragona, Spain, 43730 Les Borges del Camp, Tarragona, Spain, 43350 Reus, Tarragona, Spain, 43201 Reus, Tarragona, Spain, 43202 Reus, Tarragona, Spain, 43203 Tortosa, Tarragona, Spain, 43500 Vinebre, Tarragona, Spain, 43729 Alicante, Spain, 03007 Madrid, Spain, 28033 Tarragona, Spain, 43005 Tarragona, Spain, 43006 Less <<
NCT01141192 Type 2 Diabetes Not Applicable Completed - United States, Georgia ... More >> Medical College of Georgia Augusta, Georgia, United States, 30912 Less <<
NCT00825383 Non-Insulin-Dependent Diabetes... More >> Mellitus Less << Not Applicable Completed - -
NCT01419535 Endocrine Disease ... More >> Diabetes Less << Phase 1 Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00729326 Type 2 Diabetes Mellitus Phase 4 Completed - United States, Texas ... More >> Research Site San Antonio, Texas, United States Less <<
NCT00523861 Lean Obese Not Applicable Completed - Netherlands ... More >> TNO Quality of Life Zeist, Utrecht, Netherlands, 3700AJ Less <<
NCT00729326 - Completed - -
NCT02052076 Obesity Metab... More >>olic Syndrome Less << Not Applicable Completed - United Kingdom ... More >> David Greenfield Human Physiology Unit, University of Nottingham Medical School Nottingham, Notts, United Kingdom, NG72UH Less <<
NCT01580852 Type 2 Diabetes Mellitus Not Applicable Unknown December 2012 Israel ... More >> Soroka University Medical Cetner Not yet recruiting Beer Sheva, Israel, 84101 Contact: Idit Liberty, MD    972-50-6264572    iliberty@bgu.ac.il    Principal Investigator: Idit Liberty, MD Less <<
NCT02838147 GDM Phase 3 Not yet recruiting July 2019 -
NCT01967849 Obesity Type ... More >>2 Diabetes Less << Not Applicable Recruiting September 2021 United States, Connecticut ... More >> Yale University Recruiting New Haven, Connecticut, United States, 06520 Contact: Sonia Caprio, MD    203-764-9199 Less <<
NCT02558270 Type 2 Diabetes ... More >> Metabolically Healthy Controls Less << Phase 2 Unknown June 2018 Austria ... More >> Medical University Of Vienna, Department of Internal Medicine III Recruiting Vienna, Austria, 1090 Contact: Peter Wolf, MD    004314040043110    peter.wolf@meduniwien.ac.at Less <<
NCT01774565 Diabetes Mellitus Not Applicable Completed - Switzerland ... More >> Inselspital, Bern University Hospital, University of Bern, Department of Diabetes, Endocrinology, Clinical Nutrition and Metabolism Bern, Switzerland, 3010 United Kingdom Cambridge University Hospitals NHS Foundation Trust Cambridge, United Kingdom Less <<
NCT01147861 Diabetes Mellitus, Type 2 Phase 1 Completed - United States, Alabama ... More >> GSK Investigational Site Anniston, Alabama, United States, 36207 United States, Florida GSK Investigational Site Miami Gardens, Florida, United States, 33169 GSK Investigational Site Miami, Florida, United States, 33169 United States, Texas GSK Investigational Site San Antonio, Texas, United States, 78229 Less <<
NCT01607931 Type 2 Diabetes Not Applicable Completed - Denmark ... More >> Rigshospitalet Copenhagen, Denmark Less <<
NCT01833988 Type 1 Diabetes Not Applicable Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT02776696 Type 1 Diabetes Not Applicable Recruiting March 2019 Israel ... More >> Schneider Children's Medical Center Recruiting Petach-Tikva, Israel, 49202 Contact: Moshe Phillip, Prof    972-3-9253747    mosheph@clalit.org.il    Contact: Alona Hamou, Msc    972-3-9253778    alonah@clalit.org.il    Principal Investigator: Moshe Phillip, Prof          Sub-Investigator: Liora Lazar, Prof          Sub-Investigator: Liat De Vreis, Dr.          Sub-Investigator: Shlomit Shalitin, Prof          Sub-Investigator: Yael Lebenthal, Dr          Sub-Investigator: Ariel Tenenbaum, Dr.          Sub-Investigator: Ravital Nimri, Dr.          Sub-Investigator: Tal Oron, Dr          Sub-Investigator: Rachel Bello, Dr          Sub-Investigator: Demol Sharon, Dr          Sub-Investigator: Naama Fish, Dr          Sub-Investigator: Marie Mouler, Dr          Sub-Investigator: Judit Nir, Dr Less <<
NCT01833988 - Completed - -
NCT03067480 T2DM (Type 2 Diabetes Mellitus... More >>) Continuous Glucose Monitoring Less << Not Applicable Recruiting July 1, 2018 United States, Tennessee ... More >> East Tennessee State University Recruiting Johnson City, Tennessee, United States, 37614 Less <<
NCT03180281 Type 2 Diabetes Mellitus Not Applicable Not yet recruiting January 1, 2020 China, Shaanxi ... More >> First Affiliated Hospital of Xi'an Jiao Tong University Not yet recruiting Xi'an, Shaanxi, China, 710061 Contact: Jing Sui, Doctor    0086-18991989230 Less <<
NCT03314272 Diabetes Card... More >>iopulmonary Bypass Less << Not Applicable Recruiting December 2019 Lebanon ... More >> American University of Beirut Medical Center Recruiting Beirut, Lebanon Contact: Roland Kaddoum, MD    00961-1-350000 ext 6380    rk16@aub.edu.lb    Contact: Lama Zahreddine, MS    00961-1-350000 ext 6380    lz08@aub.edu.lb    Principal Investigator: Roland Kaddoum, MD          Sub-Investigator: Sahar Siddik, MPH          Sub-Investigator: Ghassan Kanazi, MD          Sub-Investigator: Marie Aouad, MD          Sub-Investigator: Cynthia Karam, MD          Sub-Investigator: Jean Beresian, MS          Sub-Investigator: Layal Abou Daher, MD          Sub-Investigator: Alain Harb, MD Less <<
NCT01869608 Type 2 Diabetes Not Applicable Active, not recruiting December 2018 Canada, Quebec ... More >> Clinical Research Center Étienne-Le Bel of the Sherbrooke University Hospital Sherbrooke, Quebec, Canada, J1H 5N4 Less <<
NCT02305199 Diabetes Mellitus, Type 2 Not Applicable Withdrawn(impossible to enroll... More >> participants) Less << - Korea, Republic of ... More >> Yeungnam University Hospital Daegu, Korea, Republic of, 705-717 Less <<
NCT02181244 Diabetes Mellitus ... More >> Inflammation Less << Not Applicable Completed - Mexico ... More >> Centro de Investigacion y Desarrollo Hermosillo, Sonora, Mexico Less <<
NCT03067428 Nonalcoholic Fatty Liver Disea... More >>se Glucose Metabolism Disorders Endothelial Dysfunction Less << Not Applicable Recruiting April 1, 2019 Netherlands ... More >> Maastricht University Medical Center Recruiting Maastricht, Limburg, Netherlands, 6200 MD Contact: Nynke Simons, MD    0031433882138    n.simons@maastrichtuniversity.nl Less <<
NCT00305097 Overweight Not Applicable Completed - United States, Massachusetts ... More >> Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Less <<
NCT01763567 - Completed - -
NCT02927015 Glycemic Response Not Applicable Completed - -
NCT02508779 Diabetes Mellitus, Type 1 ... More >> Pregnancy Less << Not Applicable Completed - United States, Virginia ... More >> University of Viginia Center for Behavioral Health & Technology Charlottesville, Virginia, United States, 22903 Less <<
NCT02500979 Type 1 Diabetes Mellitus Phase 1 Completed - United States, California ... More >> Research Site Chula Vista, California, United States, 91911 United States, Oregon Research Site Portland, Oregon, United States, 97239 United States, Tennessee Research Site Chattanooga, Tennessee, United States, 37411 Less <<
NCT01763567 - Completed - United States, Missouri ... More >> St Luke's Hospital Mid America Heart Institute Kansas City, Missouri, United States, 64111 Less <<
NCT02500979 - Completed - -
NCT01842022 Dementia Not Applicable Completed - United Kingdom ... More >> Psychology, Swansea University Swansea, Wales, United Kingdom, sa2 8pp Less <<
NCT02362308 Primary Aldosteronism Not Applicable Recruiting January 2020 United States, Tennessee ... More >> Vanderbilt University Medical Center Recruiting Nashville, Tennessee, United States, 37232 Contact: Loretta Byrne, RN    615-322-2105    loretta.byrne@vanderbilt.edu    Contact: Holly Waldrop    615-343-6161    holly.waldrop@vanderbilt.edu    Principal Investigator: James M Luther, MD, MSCI Less <<
NCT02370212 Healthy Not Applicable Completed - -
NCT01892956 - Unknown April 2016 Israel ... More >> Gastroenterology Institute Recruiting Tel-Aviv, Israel, 64239 Contact: Noya Horowitz, PhD    972-3-6974297    noyah@tlvmc.gov.il    Principal Investigator: Zamir Halpern, MD          Sub-Investigator: Eran Elinav, PhD          Sub-Investigator: Eran Segal, PhD Less <<
NCT01273558 Diabetes Mellitus, Type 2 Phase 1 Completed - Germany ... More >> Neuss, Germany Less <<
NCT03739099 Type 1 Diabetes Mellitus in Pr... More >>epubertal Children Less << Not Applicable Recruiting September 5, 2020 France ... More >> Montpellier University Hospital Recruiting Montpellier, France, 34295 Contact: Sylvine PLAGNOL, Research Assistant    +33467339832    s-plagnol@chu-montpellier.fr    Contact: Lucie CHARRIER, Research Assistant    +3367333050    l-charrier@chu-montpellier.fr    Principal Investigator: Eric M RENARD, MD, PhD Less <<
NCT01398592 Diabetes Mellitus Type 2 Phase 4 Completed - Germany ... More >> Novartis Investigative Site Bad Oeynhausen, Germany, 32549 Novartis Investigative Site Berlin, Germany, 12347 Novartis Investigative Site Berlin, Germany, 13597 Novartis Investigative Site Berlin, Germany, 14089 Novartis Investigative Site Celle, Germany, 29221 Novartis Investigative Site Hannover, Germany, 30165 Novartis Investigative Site Hannover, Germany, 30167 Novartis Investigative Site Kassel, Germany, 34117 Novartis Investigative Site Kirchhain, Germany, 35274 Novartis Investigative Site Lehrte, Germany, 31275 Novartis Investigative Site Mülheim, Germany, 45468 Novartis Investigative Site Oberhausen, Germany, 46049 Novartis Investigative Site Osnabrück, Germany, 49080 Novartis Investigative Site Potsdam, Germany, 14469 Novartis Investigative Site Stuttgart, Germany, 70378 Less <<
NCT01405300 Cardiovascular Disease Phase 1 Completed - United States, Pennsylvania ... More >> Penn State University University Park, Pennsylvania, United States, 16802 Less <<
NCT02417012 Diabetes Mellitus, Type 2 Not Applicable Completed - Denmark ... More >> Center for Physical Activity Research, Copenhagen University Hospital Copenhagen, Denmark, 2100 Less <<
NCT03315988 Diabetes Mellitus, Type 2 ... More >> Heart Diseases Less << Not Applicable Recruiting January 7, 2019 United Kingdom ... More >> Leicester Diabetes Centre Recruiting Leicester, United Kingdom, LE3 4PW Contact: Dr Thomas Yates, Primary Supervisor       ty20@le.ac.uk    Contact: Stavroula Argyridou, Study Co-ordinator       pyhteam@leicester.ac.uk    Principal Investigator: Dr Thomas Yates          Sub-Investigator: Dr Toru Suzuki          Sub-Investigator: Professor Melanie Davies Less <<
NCT03474562 ASCVD Impaire... More >>d Fasting Glucose Hypertension Less << Phase 4 Not yet recruiting October 2019 Korea, Republic of ... More >> Dankook University Hospital Not yet recruiting Cheonan, Korea, Republic of CHA Bundang Medical Center Not yet recruiting Seongnam, Korea, Republic of Gangnam Severance Hospital Not yet recruiting Seoul, Korea, Republic of Severance Hospital Not yet recruiting Seoul, Korea, Republic of Less <<
NCT02596594 Intrauterine Growth Restrictio... More >>n Less << Not Applicable Completed - -
NCT01055340 Obesity Phase 1 Completed - -
NCT01993511 - Unknown June 2014 Denmark ... More >> Hvidovre University Hospital Recruiting Copenhagen, Hvidovre, Denmark, 2650 Contact: Anna Kirstine Bojsen-Møller, MD    +45 30 25 22 06    kirstine.bojsen-moeller@regionh.dk    Principal Investigator: Anna Kirstine Bojsen-Møller, MD Less <<
NCT03024814 Intraventricular Haemorrhage N... More >>eonatal Less << Phase 3 Recruiting October 2018 Saudi Arabia ... More >> Mountasser Al-Mouqdad Recruiting Riyadh, Saudi Arabia, 11196 Contact: Mountasser Al-Mouqdad, MD    00966539095090    m.almouqdad@ksmc.med.sa Less <<
NCT01852448 - Recruiting June 2021 United States, Pennsylvania ... More >> The Children's Hopsital of Philadelphia Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Christina Kubrak    267-426-5135    kubrak@email.chop.edu    Principal Investigator: Andrea Kelly, MD          The University of Pennsylvania Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Christina Kubrak    267-426-5135    kubrak@email.chop.edu    Principal Investigator: Michael Rickels, MD Less <<
NCT02750111 - Recruiting May 8, 2018 Israel ... More >> Sheba_Medical_Center Recruiting Ramat Gan, Israel, 52621 Contact: Orit Hamiel, prof    +97235305015    orit.hamiel@sheba.health.gov.il Less <<
NCT03705260 Type 2 Diabetes Mellitus Not Applicable Enrolling by invitation January 2020 United States, Michigan ... More >> Chelsea Health Center Chelsea, Michigan, United States, 48118 Less <<
NCT02353403 Glycaemia Not Applicable Completed - France ... More >> NutrInvest - Institut Pasteur de Lille Lille, Nord, France, 59019 Less <<
NCT01030978 Impaired Glucose Tolerance Not Applicable Completed - United States, Connecticut ... More >> Yale Center for Clinical Investigation New Haven, Connecticut, United States, 06520 Less <<
NCT03199638 Diabetes Mellitus, Type 1 ... More >> Autoimmune Diseases Diabetes Mellitus Endocrine System Diseases Glucose Metabolism Disorders Immune System Diseases Metabolic Diseases Less << Not Applicable Recruiting June 2017 United States, Florida ... More >> Nemours Children's Clinic Recruiting Jacksonville, Florida, United States, 32207 Contact: Reham Hasan, MD    904-755-3542    rh0023@nemours.org    Principal Investigator: Dominique Darmaun, MD, PhD          Sub-Investigator: Nelly Mauras, MD          Sub-Investigator: Reham Hasan, MD          Nemours Children's Clinic Recruiting Jacksonville, Florida, United States, 32207 Contact: Reham Hasan, MD    904-755-3542    rh0023@nemours.org    Contact: Kaitlin Sikes, ARNP    904-697-3988    ksikes@nemours.org Less <<
NCT02352857 Glycaemia Not Applicable Completed - France ... More >> NutrInvest - Institut Pasteur de Lille Lille, Nord, France, 59019 Less <<
NCT02126605 - Unknown March 2015 United States, Virginia ... More >> University of Virginia Center for Behavioral Medicine Research Not yet recruiting Charlottesville, Virginia, United States, 22908 Contact: Jesse Grabman, B.A.    434-924-5316    JHG5DQ@hscmail.mcc.virginia.edu    Principal Investigator: Linda Gonder-Frederick, Ph.D.          Sub-Investigator: Jaclyn Shepard, Psy.D. Less <<
NCT02160184 Type 1 Diabetes Not Applicable Unknown - Spain ... More >> Parc Tauli University Hospital Not yet recruiting Sabadell, Barcelona, Spain, 08208 Contact: Mercedes Rigla, MD, PhD    +34 93 745 84 12    mrigla@tauli.cat    Principal Investigator: Mercedes Rigla, MD, PhD Less <<
NCT02355509 Glucose Intolerance ... More >> Postprandial Hyperglycemia Cardiovascular Risk Factor Less << Phase 4 Completed - Mexico ... More >> Instituto Nacional de Ciencias Médicas y Nutrición, Salvador Zubirán México City, Distrito Federal, Mexico, 14000 Less <<
NCT00835328 Congenital Hyperinsulinism Phase 1 Phase 2 Recruiting December 2019 United States, Pennsylvania ... More >> The Children's Hospital of Philadelphia Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Stephanie Givler, BS,CCRC    267-426-7622    givler@email.chop.edu    Principal Investigator: Diva D De Leon, MD          Sub-Investigator: Charles A Stanley, MD Less <<
NCT00949221 Type 1 Diabetes Phase 2 Phase 3 Completed - France ... More >> Hôpital Robert Debré Paris, France, 75019 Less <<
NCT02610491 Metabolic Syndrome ... More >> Obesity Less << Phase 2 Completed - Netherlands ... More >> MUMC+ Maastricht, Limburg, Netherlands, 6221EG Less <<
NCT01234727 - Completed - Germany ... More >> Zentrum für Diabetes und Gefäßerkrankungen Münster, Germany, 48145 Diabetes Zentrum Neuwied Neuwied, Germany, 56564 Netherlands Radboud University Nijmegen Centre Nijmegen, Netherlands, 6500 HB Less <<
NCT01569425 Hyperandrogenism ... More >> Insulin Resistance Less << Not Applicable Unknown June 2015 Israel ... More >> Daniela Jakubowicz Holon, Tel Aviv, Israel, 58100 Less <<
NCT01977833 Type 2 Diabetes Not Applicable Unknown January 2014 Israel ... More >> Diabetes Unit E. Wolfson Medical center Recruiting Holon, Tel Aviv, Israel, 58100 Contact: Daniela Jakubowicz, MD    972508105552    daniela.jak@gmail.com    Contact: Julio Wainstein, MD    97254522296    vainstein@wolfson.health.gov.il    Principal Investigator: Daniela Jakubowicz, MD Less <<
NCT01562782 Elevated Triglycerides ... More >> Diabetes Cardiovascular Disease Dyslipidemia Less << Not Applicable Unknown April 2017 United States, New York ... More >> The Rogosin Institute New York, New York, United States, 10065 Weill Cornell Medical College Clinical and Translational Science Center (CTSC) New York, New York, United States, 10065 Less <<
NCT01932086 Healthy Not Applicable Completed - Korea, Republic of ... More >> Clinical Trial Center for Functional Foods; Chonbuk National University Hospital Jeonju, Jeollabuk-do, Korea, Republic of, 560-822 Less <<
NCT02844907 Insulin Secretion Phase 4 Recruiting December 2020 United States, North Carolina ... More >> VA Health Care System Recruiting Durham, North Carolina, United States, 27705 Contact: Leslie S Kelly    910-782-9771    leslie.kelly@va.gov    Contact: Lucy W Piner, MS    919-660-6781    lucy.piner@va.gov    Principal Investigator: David D'Alessio, MD Less <<
NCT01923571 - Unknown - Italy ... More >> Policlinico Umberto I Recruiting Rome, Italy, 00161 Contact: Federico Bilotta, MD, PhD    39 339 33 708 22       Principal Investigator: Federico Bilotta, MD, PhD          Policlinico Umberto I, Rome, Italy Recruiting Rome, Italy Contact: Federico Bilotta, MD, PhD    39 3393370822 Less <<
NCT02940158 Healthy Not Applicable Completed - Canada, Ontario ... More >> Human Nutraceutical Research Unit Guelph, Ontario, Canada, N1G 2W1 Less <<
NCT02933645 Insulin Resistance Not Applicable Completed - Finland ... More >> Turku PET Centre Turku, Finland, 20520 Less <<
NCT01516138 Cardiac Surgery ... More >> Cardiopulmonary Bypass Less << Phase 2 Active, not recruiting February 2022 China, Shaanxi ... More >> Deparment of Cardiovascular surgery,Xijing Hospital, Fourth Military Medical University Xi'an, Shaanxi, China, 710032 Less <<
NCT01375660 Impaired Fasting Glucose ... More >> Impaired Glucose Tolerance Vitamin D Insufficiency Less << Not Applicable Completed - United States, Illinois ... More >> Jesse Brown VA Medical Center, Chicago, IL Chicago, Illinois, United States, 60612 Less <<
NCT00685880 Thumb Carpometacarpal Joint Os... More >>teoarthritis Less << Not Applicable Terminated(Unable to recruit a... More >>dequate numbers of patients) Less << - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55902 Less <<
NCT00607347 Hypertension Not Applicable Completed - United States, Florida ... More >> University of Florida Gainesville, Florida, United States, 32610 Less <<
NCT00685880 - Terminated(Unable to recruit a... More >>dequate numbers of patients) Less << - -
NCT02574793 - Completed - China, Shanghai ... More >> Xiaolong Zhao Jing'an, Shanghai, China, 20041 Less <<
NCT01375660 - Completed - -
NCT01326299 Diabetes Mellitus, Type 2 Phase 2 Phase 3 Completed - United States, Ohio ... More >> Radiant Research Cincinnati, Ohio, United States, 45249 Less <<
NCT01076218 - Completed - United States, California ... More >> Diablo Clinical Research Walnut Creek, California, United States, 94598 United States, Washington Rainier Clinical Research Renton, Washington, United States, 98057 Less <<
NCT00594399 Impaired Glucose Tolerance ... More >> Obesity Diabetes Less << Phase 2 Phase 3 Completed - United States, North Carolina ... More >> Durham VA Medical Center, Durham, NC Durham, North Carolina, United States, 27705 Less <<
NCT02149992 Gestational Diabetes Mellitus ... More >>as Antepartum Condition Less << Not Applicable Unknown August 2016 United States, Oregon ... More >> Oregon Health and Science University Recruiting Portland, Oregon, United States, 97239 Contact: Amy M Valent, DO    503-502-7220    valent@ohsu.edu    Principal Investigator: Amy M Valent, DO Less <<
NCT02217124 Obesity Not Applicable Completed - United States, California ... More >> San Diego State Univeristy San Diego, California, United States, 92182 Less <<
NCT00594399 - Completed - -
NCT03612037 PreDiabetes Not Applicable Active, not recruiting December 30, 2018 -
NCT01911663 Diabetes Phase 4 Completed - Korea, Republic of ... More >> Laboratory of clinical Nutrigenetics/Nutrigenomic Seoul, Korea, Republic of, 120-749 Less <<
NCT03066713 Glycemic Response ... More >> Appetitive Behavior Less << Not Applicable Completed - United States, Indiana ... More >> Purdue University West Lafayette, Indiana, United States, 47906 Less <<
NCT02022176 Resting Metabolic Rate Not Applicable Completed - Sweden ... More >> Karolinska Institutet Stockholm, Sweden, 17177 Less <<
NCT02500186 Diabetes Melltius, Type 2 Not Applicable Completed - -
NCT03439878 Cardiovascular Risk Factor ... More >> Lipemia Less << Not Applicable Completed - United Kingdom ... More >> Department for Health, University of Bath Bath, United Kingdom, BA2 7AY Less <<
NCT01234597 Diabetes Mellitus, Type 2 Phase 4 Completed - Israel ... More >> Investigational Site Number 376003 Beer Sheva, Israel Investigational Site Number 376007 Haifa, Israel Investigational Site Number 376004 Kfar Saba, Israel, 44281 Investigational Site Number 376012 Lod, Israel Investigational Site Number 376013 Nazareth, Israel Investigational Site Number 376006 Netanya, Israel Investigational Site Number 376001 Ramat-Gan, Israel Investigational Site Number 376009 Sachnin, Israel Investigational Site Number 376008 Tel Aviv, Israel Investigational Site Number 376010 Tel-Aviv, Israel Investigational Site Number 376011 Tel-aviv, Israel Less <<
NCT03264001 Insulin Sensitivity ... More >> Glucose Intolerance Insulin Resistance Energy Supply; Deficiency Less << Not Applicable Active, not recruiting December 31, 2018 Singapore ... More >> Clinical Nutrition Research Centre Singapore, Singapore, 117609 Less <<
NCT02981069 Diabetes Mellitus, Type 2 Phase 4 Recruiting January 31, 2020 United States, Texas ... More >> University of Texas Health Science Center Recruiting San Antonio, Texas, United States, 78229 Contact: Eugenio Cersosimo, MD    210-358-7200    cersosimo@uthscsa.edu    Contact: Ralph A DeFronzo, MD    210-567-6691    defronzo@uthscsa.edu    Principal Investigator: Eugenio Cersosimo, MD, PhD Less <<
NCT01161043 - Completed - United States, Alabama ... More >> University of Alabama Birmingham Birmingham, Alabama, United States, 35213 United States, California Sutter Institute for Medical Research Sacramento, California, United States, 95816 United States, Florida Endocrinology/ University of South Florida St. Petersburg, Florida, United States, 33549 United States, Minnesota University of Minnesota Amplatz Children's Hospital Minneapolis, Minnesota, United States, 55455 Less <<
NCT00721552 Diabetes Mellitus ... More >> Steroid Diabetes Glucocorticoid-induced Diabetes Beta-cell Function Less << Not Applicable Completed - Netherlands ... More >> VUmc Diabetes Center Amsterdam, Noord-Holland, Netherlands, 1081 HV Less <<
NCT00044668 Diabetes Mellitus, Type 2 Phase 3 Completed - Hungary ... More >> Diagnostic Units Hungary Kft. Budapest, Hungary, H 1036 Peterfy Teaching Hospital Budapest, Hungary, H 1076 Uzsoki Street Municipal Hospital Budapest, Hungary, H 1145 Less <<
NCT01349166 Overweight/Obesity ... More >> Glucose Intolerance Type 2 Diabetes Sedentarity Less << Not Applicable Unknown February 2012 -
NCT01176760 Vagotomy, Truncal Not Applicable Unknown December 2012 Denmark ... More >> Department of internal medicine F´laboratory, Gentofte Hospital Hellerup, Copenhagen, Denmark, 2900 Less <<
NCT03651713 Endothelial Function ... More >> Hyperglycemia Less << Not Applicable Not yet recruiting September 1, 2019 United States, Iowa ... More >> Medical Education Building Not yet recruiting Iowa City, Iowa, United States, 52242 Contact: Darren P Casey, Ph.D.    319-334-1009    darren-casey@uiowa.edu Less <<
NCT00085722 Osteoarthritis Phase 1 Phase 2 Unknown May 2016 United States, Wisconsin ... More >> Northeast Family Medical Center Madison, Wisconsin, United States, 53704 University of Wisconsin General Clinical Research Center Madison, Wisconsin, United States, 53792 Less <<
NCT03737188 Diabetes Not Applicable Recruiting December 2018 Germany ... More >> Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft an der Universität Ulm Recruiting Ulm, Germany, 89081 Contact: Guido Freckmann, MD          Principal Investigator: Nina Jendrike, MD Less <<
NCT01058525 Nerve Block Phase 4 Completed - France ... More >> Hôpital Privé de l'Ouest Parisien Trappes, France, 78190 Less <<
NCT00337597 Analgesia Phase 3 Completed - France ... More >> Departemental Hospital of la Roche sur Yon La Roche sur Yon, France, 85000 Nantes University Hospital Nantes, France, 44093 Less <<
NCT02065895 Type 1 Diabetes Not Applicable Completed - United States, Massachusetts ... More >> Joslin Diabetes Center Boston, Massachusetts, United States, 02215 Less <<
NCT00330200 Type 2 Diabetes Mellitus Phase 2 Terminated(Due to poor enrollm... More >>ent) Less << May 2008 United States, Connecticut ... More >> Yale - New Haven Hospital New Haven, Connecticut, United States, 06511 Less <<
NCT00703079 - Completed - Italy ... More >> Department of Molecular and Clinical Endocrinology and Oncology, University Federico II of Naples Naples, Italy, 80131 Less <<
NCT02065895 - Completed - -
NCT02542033 Impaired Fasting Glucose Not Applicable Completed - Germany ... More >> Clinical Research Center (CRC) Kiel GmbH Kiel, Schleswig-Holstein, Germany, 24118 Less <<
NCT03091946 Blood Glucose; Subjective Hung... More >>er, Insulin Less << Not Applicable Completed - Canada ... More >> University of Manitoba Winnipeg, Canada Less <<
NCT02599961 Glucose Transporter Type 1 Def... More >>iciency Syndrome Less << Phase 2 Active, not recruiting April 2019 United States, Colorado ... More >> Children's Hospital Colorado - University of Colorado, Denver, School of Medicine Aurora, Colorado, United States, 80045 United States, Florida Miami Children's Hospital Miami, Florida, United States, 33155 United States, New York Columbia University Medical Center New York, New York, United States, 10032 United States, Texas Cook Children's Medical Center Fort Worth, Texas, United States, 76104 United States, Washington Seattle Children's Hospital Seattle, Washington, United States, 98105 Australia, Victoria Melbourne Brain Centre Heidelberg, Victoria, Australia, 3084 Denmark Copenhagen University Hospital Copenhagen, Denmark, 2100 Spain Hospital Sant Joan De Deu Barcelona, Spain, 08950 United Kingdom The Newcastle upon Tyne Hospitals NHS Foundation Trust Newcastle upon Tyne, United Kingdom, NE7 7DN Less <<
NCT00767208 Type 2 Diabetes ... More >> Overweight Less << Not Applicable Completed - France ... More >> Centre de Recherche En Nutrition Humaine Rhone Alpes Lyon, France, 69000 Less <<
NCT02585427 Healthy Not Applicable Completed - Singapore ... More >> Clinical Nutrition Research Centre Singapore, Singapore, 117599 Less <<
NCT00237640 Diabetes Mellitus, Adult Onset Phase 2 Completed - United States, Oklahoma ... More >> General Clinical Research Center Oklahoma City, Oklahoma, United States, 73117 Less <<
NCT02968953 - - - United States, Pennsylvania ... More >> Children's Hospital of Pittsburgh of UPMC Pittsburgh, Pennsylvania, United States, 15224 Less <<
NCT01205750 Obesity Dysli... More >>pidemia Less << Not Applicable Completed - Denmark ... More >> Department of Endocrinology and Internal Medicine, Aarhus University Hospital Aarhus, Denmark, 8000 Less <<
NCT00951912 Type 2 Diabetes Mellitus Not Applicable Completed - China, Guangdong ... More >> The First Affiliated Hospital, Sun Yat-sen University Guangzhou, Guangdong, China, 510080 Less <<
NCT03722251 Appetitive Behavior Not Applicable Completed - Canada, Ontario ... More >> School of Nutrition, Ryerson University Toronto, Ontario, Canada, M5B 2K3 Less <<
NCT02372539 - Recruiting December 2018 United States, Colorado ... More >> University of Colorado Anschutz Medical Campus Recruiting Aurora, Colorado, United States, 80045 Contact: Cindy O'Bryant, PharmD    303-724-2625    cindy.obryant@ucdenver.edu    Contact: Samuel Ellis, PharmD    303-7242616    sam.ellis@ucdenver.edu Less <<
NCT01862263 Type 2 Diabetes Mellitus Phase 4 Completed - Mexico ... More >> Novartis Investigative Site Mexico, Distrito Federal, Mexico, 06700 Novartis Investigative Site Mexico, Distrito Federal, Mexico, 07300 Novartis Investigative Site Mexico, Distrito Federal, Mexico, 14050 Novartis Investigative Site Metepec, Estado de México, Mexico, 52140 Novartis Investigative Site Celaya, Guanajuato, Mexico, 38000 Novartis Investigative Site Guadalajara, Jalisco, Mexico, 44150 Novartis Investigative Site Guadalajara, Jalisco, Mexico, 44600 Novartis Investigative Site Guadalajara, Jalisco, Mexico, 44670 Novartis Investigative Site Monterrey, Nuevo Leon, Mexico, 64710 Novartis Investigative Site Monterrey, Nuevo León, Mexico, 64020 Novartis Investigative Site Cancun, Quintana Roo, Mexico, 77500 Novartis Investigative Site Culiacán, Sinaloa, Mexico, 80000 Novartis Investigative Site Puebla, Mexico, 72190 Less <<
NCT01102452 Diabetes Mellitus Not Applicable Completed - Taiwan ... More >> PingTung Christian Hospital Pingtung, Taiwan Less <<
NCT01479933 Prediabetic State ... More >> Overweight Obese Less << Not Applicable Completed - Finland ... More >> University of Eastern Finland, Kuopio Campus Kuopio, Finland, 70211 Less <<
NCT00993057 Brain Neoplasms ... More >> Intracranial Aneurysm Less << Early Phase 1 Completed - United States, Illinois ... More >> Dhanesh Gupta Chicago, Illinois, United States, 60611 Less <<
NCT00315991 Diabetes Mellitus, Type 1 Not Applicable Completed - United States, Massachusetts ... More >> Joslin Diabetes Center Boston, Massachusetts, United States United States, Virginia University of Virginia Charlottesville, Virginia, United States, 22908 Less <<
NCT02041104 Metabolic Syndrome ... More >> Dyslipidemia Obesity, Abdominal Hyperglycemia Hypertension Less << Not Applicable Enrolling by invitation March 2018 Slovenia ... More >> Community Health Center Ajdovscina Ajdovscina, Slovenia, 5270 Community Healt Center Ljubljana Ljubljana, Slovenia, 1000 Community Health Center Franca Amrozica Postojna Postojna, Slovenia, 6230 Less <<
NCT02938091 Dyslipidemia ... More >>Impaired Glucose Tolerance Less << Not Applicable Completed - -
NCT02720393 Prediabetes Not Applicable Unknown December 2018 United States, Illinois ... More >> University of Illinois at Chicago Recruiting Chicago, Illinois, United States, 60612 Contact: Joanne K. Tobacman, M.D.    312-569-7826    jkt@uic.edu    Principal Investigator: Joanne K. Tobacman, M.D.          Sub-Investigator: Krista Varady, Ph.D. Less <<
NCT00412178 Type 2 Diabetes Mellitus Not Applicable Terminated - Korea, Republic of ... More >> Kangnam St. Mary's Hospital, The Catholic University of Korea Seoul, Korea, Republic of, 137-040 Less <<
NCT01909687 Diabetes Not Applicable Completed - Germany ... More >> Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft an der Universität Ulm Ulm, Germany, 89081 Less <<
NCT00951912 - Completed - -
NCT01175408 Type 2 Diabetes Mellitus Not Applicable Completed - Canada, British Columbia ... More >> St. Paul's Hospital Vancouver, British Columbia, Canada Less <<
NCT01934868 Sciatica Spin... More >>al Stenosis of Lumbar Region Degeneration of Lumbar or Lumbosacral Intervertebral Disc Less << Early Phase 1 Recruiting December 2019 Israel ... More >> Pain Unit, Hadassah Medical Center Recruiting Jerusalem, Israel Contact: Osnat Wende, MD       dowende@gmail.com    Contact: Hadas Lemberg, PhD       lhadas@hadassah.org.il Less <<
NCT01052025 Type 2 Diabetes ... More >> Pre-diabetes Insulin Resistance Cardiovascular Risk Less << Phase 4 Unknown April 2010 Thailand ... More >> HRH Princess Maha Chakri Sirindhorn Medical Center Recruiting Ongkarak, Nakornnayok, Thailand, 26120 Contact: Somlak Chuengsamarn, Medical Doctor    +663739-5085 ext 11001    somlukc@swu.ac.th    Principal Investigator: Somlak Chuengsamarn, Medical Doctor Less <<
NCT02969057 Glucose Response Not Applicable Completed - Singapore ... More >> JeyaKumar Henry Singapore, Singapore Less <<
NCT01093547 End Stage Renal Disease ... More >> Continuous Ambulatory Peritoneal Dialysis Less << Phase 4 Withdrawn December 2011 Colombia ... More >> Bogota, Colombia Less <<
NCT00437918 Diabetes Mellitus ... More >> Type 2 Diabetes Mellitus Less << Phase 4 Completed - Korea, Republic of ... More >> Paik Diabetes Center, Pusan Paik Hospital, College of Medicine, Inje University Busan, Korea, Republic of, 614-735 Endocrinology and Metabolism, Maryknoll General Hospital Busan, Korea, Republic of Less <<
NCT00237588 Hypertension Phase 4 Completed - Norway ... More >> Cardiovascular and Renal Research Center/ Department of Cardiology, Ullevaal University Hospital Oslo, Norway, 0407 Less <<
NCT01525823 Healthy Volunteers Phase 1 Completed - Australia, Victoria ... More >> Local Institution Melbourne, Victoria, Australia, 3004 Less <<
NCT01995773 - Completed - Denmark ... More >> Odense University Hospital Odense, Denmark, 5000 Less <<
NCT01315314 Kidney Failure, Chronic ... More >> Disorders Associated With Peritoneal Dialysis Less << Phase 4 Completed - Korea, Republic of ... More >> Division of Nephrology and Department of Internal Medicine, Kyungpook National University Hospital Daegu, Korea, Republic of, 700-721 Less <<
NCT00467675 - Completed - United States, Minnesota ... More >> International Diabetes Center - Park Nicollet Health Services Minneapolis, Minnesota, United States, 55416 Less <<
NCT01569841 - Completed - -
NCT00382239 Type 2 Diabetes Mellitus Phase 2 Completed - Japan ... More >> Research Site Fukuoka, Japan Research Site Fukushima, Japan Research Site Gunma, Japan Research Site Hiroshima, Japan Research Site Hyogo, Japan Research Site Ibaraki, Japan Research Site Kanagawa, Japan Research Site Kumamoto, Japan Research Site Kyoto, Japan Research Site Nagano, Japan Research Site Oita, Japan Research Site Okayama, Japan Research Site Osaka, Japan Research Site Tokyo, Japan Less <<
NCT01918566 Exploratory Behavior Not Applicable Completed - Switzerland ... More >> University Hospital Basel, Switzerland, CH-4031 Less <<
NCT02923089 Postprandial Glycemia in Healt... More >>hy Adults Less << Not Applicable Completed - Canada, Ontario ... More >> Human Nutraceutical Research Unit Guelph, Ontario, Canada, N1G 2W1 Less <<
NCT00995501 - Terminated(Per interim analysi... More >>s, for futility.) Less << - -
NCT01569841 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 3 Completed - United States, Minnesota ... More >> Novo Nordisk Clinical Trial Call Center Minneapolis, Minnesota, United States, 55416-2699 Less <<
NCT03102424 Type 2 Diabetes Mellitus Not Applicable Recruiting June 30, 2019 Taiwan ... More >> Chia-Yi Christian Hospital Recruiting Chiayi City, Taiwan, 600 Contact: Hsiang-Hsun Chuang          Principal Investigator: Chieh-Hsiang Lu, M.D.          Far Eastern Memorial Hospital Recruiting New Taipei City, Taiwan, 220 Contact: Yi-Chia Lin          Principal Investigator: Ju-Ying Jiang, M.D.          National Cheng Kung University Hospital Recruiting Tainan, Taiwan, 704 Contact: Li-Sheng Chang          Principal Investigator: Horng-Yih Ou, M.D.          Chi Mei Hospital Recruiting Tainan, Taiwan, 710 Contact: Vivi Wu          Principal Investigator: Chewn-Yi Yang, M.D.          National Taiwan University Hospital Recruiting Taipei, Taiwan, 100 Contact: Han-Yu Chen          Principal Investigator: Jin-Ying Lu, M.D. Less <<
NCT01871831 Diabetes Not Applicable Completed - Germany ... More >> Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft an der Universität Ulm Ulm, Germany, 89081 Less <<
NCT03195257 Type 1 Diabetes Mellitus Not Applicable Completed - -
NCT01571622 Type 2 Diabetes Mellitus Not Applicable Completed - Israel ... More >> Diabetes Unit E. Wolfson Hospital Holon, Tel Aviv, Israel, 58100 Less <<
NCT02604524 Type 1 Diabetes Mellitus Not Applicable Completed - United States, Colorado ... More >> University of Colorado, Denver, Barbara Davis Center Aurora, Colorado, United States, 80045 United States, Virginia University of Virginia Charlottesville, Virginia, United States, 22903 Less <<
NCT01074489 - Completed - United States, Ohio ... More >> University of Cincinnati Cincinnati, Ohio, United States, 45267-0526 Less <<
NCT00995501 Inflammation ... More >>Perioperative Morbidity Less << Not Applicable Terminated(Per interim analysi... More >>s, for futility.) Less << - United States, Ohio ... More >> Cleveland Clinic Cleveland, Ohio, United States, 44195 Less <<
NCT01483651 - Completed - -
NCT01538459 Shoulder Pain ... More >> Injury of Shoulder Region Disorder of Shoulder Disorder of Rotator Cuff Disorder of Tendon of Biceps Less << Phase 3 Withdrawn November 2013 United States, Rhode Island ... More >> Newport Hospital Newport, Rhode Island, United States, 02840 Less <<
NCT01745900 - Unknown March 2013 United States, California ... More >> Accelovance Inc. Recruiting San Diego, California, United States, 92108 Principal Investigator: Amber Brassfield, RN Less <<
NCT02092129 - Active, not recruiting December 2017 Denmark ... More >> National University Hospital, Department of Medical Endocrinology Copenhagen, Denmark, DK-2100 Less <<
NCT00501072 Diabetes Mellitus, Type 1 Not Applicable Completed - Netherlands ... More >> Diabetes Outpatient Clinic, Isala clinics Zwolle, Netherlands, 800 GK Less <<
NCT01483651 Type 1 Diabetes Mellitus Not Applicable Completed - United States, Oregon ... More >> Legacy Health System Portland, Oregon, United States, 97210 Less <<
NCT01707784 - Unknown September 2017 Switzerland ... More >> Maternité CHUV, University of Lausanne Lausanne, Switzerland, 1011 Less <<
NCT03165110 Diabetes Mellitus Not Applicable Completed - United States, California ... More >> AMCR Institute Escondido, California, United States, 92026 Less <<
NCT01579981 Type 2 Diabetes Not Applicable Completed - Denmark ... More >> Dept. of Endocrinology, Hvidovre Hospital Hvidovre, Denmark, DK-2650 Less <<
NCT02023489 Type 2 Diabetes Mellitus ... More >> Prediabetes (Insulin Resistance, Impaired Glucose Tolerance) Familiar Hypocalcuric Hypercalcemia Healthy Volunteers Type 1 Diabetes Mellitus Less << Not Applicable Recruiting July 2018 Austria ... More >> Medical University Of Vienna, Department of Internal Medicine III Recruiting Vienna, Austria, 1090 Contact: Michael Krebs, Prof. MD       michael.krebs@meduniwien.ac.at    Principal Investigator: Michael Krebs, Prof. MD          Sub-Investigator: Peter Wolf, MD Less <<
NCT02300181 Prediabetes Not Applicable Completed - Japan ... More >> Hiroshima University Hiroshima, Japan, 734-8551 Less <<
NCT01426737 Type 2 Diabetes Phase 4 Unknown January 2013 Switzerland ... More >> Universitiy Hospital Recruiting Zurich, Switzerland Less <<
NCT00877123 Obesity Phase 4 Completed - Israel ... More >> Clalit Health Services, Haifa and Western Galilee District Haifa, Israel Less <<
NCT02137031 Type 1 Diabetes Mellitus Not Applicable Completed - Canada, Ontario ... More >> Royal Victoria Hospital Barrie, Ontario, Canada, L4M 6M2 Charles H. Best Centre Whitby, Ontario, Canada, L1M 1Z5 Less <<
NCT00612950 Type 2 Diabetes Not Applicable Completed - Denmark ... More >> Dept. of Endocrinology, Hvidovre Hospital Copenhagen, Denmark Less <<
NCT03613688 Glucose Metabolism Disorders Not Applicable Recruiting July 2019 United States, Oregon ... More >> NIS labs Recruiting Klamath Falls, Oregon, United States, 97601 Contact: Gitte Jensen    541-884-0112    gitte@nislabs.com Less <<
NCT03325569 Incretin Hormones in PCOS With... More >> Prediabetes Less << Not Applicable Completed - Slovenia ... More >> UMC Ljubljana Ljubljana, Slovenia, 1000 Less <<
NCT03619031 Type 1 Diabetes Not Applicable Active, not recruiting September 15, 2018 Italy ... More >> Department of Clinical Medicine and Surgery Naples, Italy, 80131 Less <<
NCT02363907 - Completed - -
NCT02363907 - Completed - United States, Idaho ... More >> Rocky Mountain Diabetes and Osteoporosis Center Idaho Falls, Idaho, United States, 83404 Less <<
NCT03257501 - Completed - United States, California ... More >> William Sansum Diabetes Center Santa Barbara, California, United States, 93105 Diablo Clinical Research Walnut Creek, California, United States, 94598 United States, Idaho Rocky Mountain Diabetes & Osteoporosis Center Idaho Falls, Idaho, United States, 83404 United States, Washington Rainier Clinical Research Renton, Washington, United States, 98057 Less <<
NCT00574912 - Completed - -
NCT01929551 Glucose Intolerance Not Applicable Completed - Mexico ... More >> Clinical Nutrition and Obesity Research Center. School of Medicine and Health Sciences, TEC Salud, Tecnológico de Monterrey Monterrey, Nuevo Leon, Mexico, 64710 Less <<
NCT00882427 Critical Illness Not Applicable Completed - United Kingdom ... More >> Royal Brompton Hospital and Harefield NHS Trust London, United Kingdom Less <<
NCT03538834 Physical Activity ... More >> Healthy Less << Not Applicable Active, not recruiting December 2018 Norway ... More >> Oddrun Anita Gudbrandsen Bergen, Norway Less <<
NCT03380988 Type 2 Diabetes Mellitus ... More >> Celiac Disease Less << Not Applicable Completed - Italy ... More >> Department of Clinical Medicine and Surgery Naples, Italy, 80131 Less <<
NCT00775684 Pre-diabetes ... More >>Type 2 Diabetes Less << Not Applicable Completed - United States, Pennsylvania ... More >> Clinical and Translational Research Center, Hospital of University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Rodebaugh Diabetes Center, Hospital of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Pennsylvania Hospital Philadelphia, Pennsylvania, United States, 19107 Less <<
NCT00775684 - Completed - -
NCT01800188 - Completed - Denmark ... More >> Nephrology department, Rigshospitalet Copenhagen, Denmark, 2100 Less <<
NCT01476605 Tennis Elbow Phase 2 Unknown December 2015 United States, Wisconsin ... More >> Northeast Family Medical Center Madison, Wisconsin, United States, 53704 University of Wisconsin General Clinical Research Center Madison, Wisconsin, United States, 53792 Less <<
NCT02487680 Diabetes Not Applicable Completed - -
NCT02130284 Type 1 Diabetes Not Applicable Completed - United States, California ... More >> AMCR Institute, Inc. Escondido, California, United States, 92026 Stanford University Department of Pediatric Endocrinology Stanford, California, United States, 94305 Diablo Clinical Research Walnut Creek, California, United States, 94598 United States, Colorado Barbara Davis Center of Childhood Diabetes Denver, Colorado, United States, 80045 United States, Connecticut Yale University Diabetes Research Program New Haven, Connecticut, United States, 06519 United States, Georgia Atlanta Diabetes Associates Atlanta, Georgia, United States, 30318 United States, Virginia University of Virgina Charlottesville, Virginia, United States, 22903 United States, Washington Rainier Clinical Research Renton, Washington, United States, 98057 Less <<
NCT00574912 Type 2 Diabetes Phase 1 Completed - United States, Tennessee ... More >> Vanderbilt University Nashville, Tennessee, United States, 37232 Less <<
NCT00566592 Type 2 Diabetes, Insulin Requi... More >>ring Less << Not Applicable Completed - United States, New Mexico ... More >> University of New Mexico Clincal and Translational Science Center Albuquerque, New Mexico, United States, 87131 Less <<
NCT02130284 - Completed - -
NCT00820807 Insulin Resistance Not Applicable Terminated(Stopped due to a no... More >>n-safety-related issue with the beverage (test vehicle).) Less << - United States, Kentucky ... More >> Louisville Metabolic and Atherosclerosis Research Center (LMARC) Louisville, Kentucky, United States, 40213 Less <<
NCT03538821 Overweight and Obesity ... More >> Healthy Less << Not Applicable Active, not recruiting December 2020 Norway ... More >> Oddrun Anita Gudbrandsen Bergen, Norway, 5053 Less <<
NCT03489967 Type 1 Diabetes Not Applicable Recruiting May 2020 Canada ... More >> Institut de recherches cliniques de Montréal Recruiting Montréal, Canada Contact: Virginie Messier    1-514-987-5500 ext 3227    virginie.messier@ircm.qc.ca    Principal Investigator: Remi Rabasa-Lhoret Less <<
NCT01027585 - Completed - -
NCT01611883 - Completed - -
NCT03440879 Prostate Cancer ... More >> Resistance Exercise Androgen Deprivation Therapy Less << Not Applicable Recruiting August 2022 Norway ... More >> Norwegian School of Sport Sciences Recruiting Oslo, Norway, 0806 Contact: Tormod S. Nilsen, PhD    95069857 ext 0047    t.s.nilsen@nih.no    Contact: Truls Raastad, Professor    23262328 ext 0047    truls.raastad@nih.no Less <<
NCT00469833 Diabetes Hype... More >>rglycemia Less << Not Applicable Completed - United States, Ohio ... More >> VA Medical Center, Cincinnati Cincinnati, Ohio, United States, 45220 Less <<
NCT00469833 - Completed - -
NCT02616809 Diabetes Hype... More >>rtension Sleep Less << Phase 3 Completed - -
NCT02089438 Type 2 Diabetes Phase 4 Completed - Sweden ... More >> Clinical Research Department Lund, Sweden, 22185 Less <<
NCT02912728 Type 1 Diabetes Mellitus Not Applicable Active, not recruiting December 2019 United States, Indiana ... More >> Indiana Indianapolis, Indiana, United States, 46202 Less <<
NCT01678287 Healthy Volunteers ... More >> Pharmacokinetics of ASP1941 Less << Phase 1 Completed - United States, Florida ... More >> Comprehensive Phase One Miramar, Florida, United States, 33025 Less <<
NCT01611883 Hypercholesterolemia Phase 4 Completed - -
NCT00732147 Type 2 Diabetes Not Applicable Withdrawn(Sponsor could not fu... More >>nd.) Less << - -
NCT03375398 Postprandial Hyperglycemia Not Applicable Completed - -
NCT01738568 Dementia Not Applicable Active, not recruiting December 2019 United States, Minnesota ... More >> Mayo Clinic in Rochester Rochester, Minnesota, United States, 55905 Less <<
NCT00959348 - Completed - Hong Kong ... More >> Kowloon Hospital Hong Kong, Hong Kong Kwong Wah Hospital Hong Kong, Hong Kong Queen Elizabeth Hospital Hong Kong, Hong Kong Queen Mary Hospital Hong Kong, Hong Kong Less <<
NCT00394303 Coronary Artery Bypass Phase 4 Terminated(Trial suspended on ... More >>26 February, following the publication of a trial with negative results (Ann Intern Med 146(4), 2007). Pending ethics committee re-approval.) Less << August 2009 Israel ... More >> Rabin Medical Center, Beilinson Hospital Petah Tikvah, Israel, 49100 Less <<
NCT02248714 Type 2 Diabetes Mellitus Not Applicable Recruiting December 2018 China, Shanghai ... More >> Shanghai Jiao Tong University Affiliated Sixth People's Hospital Recruiting Shanghai, Shanghai, China, 200023 Contact: Yuqian Bao, MD,PHD    +8602164369181    byq522@163.com Less <<
NCT03425578 Healthy Not Applicable Recruiting December 2018 Canada, Ontario ... More >> University of Waterloo Recruiting Waterloo, Ontario, Canada, N2L 3G1 Contact: Kirsten E Bell, PhD Less <<
NCT01193296 Type 2 Diabetes Mellitus Phase 4 Completed - France ... More >> Investigative Site Bondy, France Investigative Site Corbeil, France Investigative Site Marseille, France Investigative Site Nancy, France Investigative Site Paris, France Investigative Site Toulouse, France Investigative Site Venissieux, France Less <<
NCT00561132 Prediabetic State Phase 3 Completed - Mexico ... More >> Unidad de Investigacion Medica en Epidemiologia Clinica, Hospital de Especialidades, UMAE, Centro Medico Nacional de Occidente Guadalajara, Jalisco, Mexico, 44320 Less <<
NCT01783041 Prematurity N... More >>eurodevelopmental Disorder Carnitine Deficiency Less << Phase 2 Phase 3 Recruiting August 2020 United States, New York ... More >> Montefiore Medical Center - Jack D. Weiler Division Recruiting Bronx, New York, United States, 10461 Contact: Mamta Fuloria, MD    718-904-4105 ext 2821    mfuloria@montefiore.org    Contact: Deborah Campbell, MD    718-904-4105 ext 4119    dcampbel@montefiore.org    Sub-Investigator: Deborah Campbell, MD          Sub-Investigator: Marie A Clark, MD, MPH          Sub-Investigator: Nora Esteban-Cruciani, MD, MS          Sub-Investigator: Ruth EK Stein, MD          Sub-Investigator: William Gomes, MD          Montefiore Medical Center - Wakefield Division Recruiting Bronx, New York, United States, 10466 Contact: Mamta Fuloria, MD    718-904-4105 ext 2821    mfuloria@montefiore.org    Contact: Deborah Campbell, MD    718-904-4105 ext 4119    dcampbel@montefiore.org    Principal Investigator: Mamta Fuloria, MD          Sub-Investigator: Elizabeth Hailu, MD          Sub-Investigator: Deborah Campbell, MD          Sub-Investigator: Marie A Clark, MD, MPH          Sub-Investigator: Nora Esteban-Cruciani, MD          Sub-Investigator: Ruth EK Stein, MD          Sub-Investigator: William Gomes, MD Less <<
NCT00220987 Hyperglycemia ... More >> Critical Illness Less << Phase 4 Completed - Australia, New South Wales ... More >> The George Institute for International Health Camperdown, New South Wales, Australia, 2050 Less <<
NCT03367351 Type 1 Diabetes Mellitus ... More >> Continuous Glucose Monitor Less << Not Applicable Completed - United States, Florida ... More >> University of Florida Gainesville, Florida, United States, 32603 Less <<
NCT01396954 - Unknown August 2012 -
NCT00395031 Schizophrenia ... More >> Schizoaffective Disorder Less << Phase 2 Phase 3 Completed - United States, New York ... More >> Manhattan Psychiatric Center New York, New York, United States, 10035 Less <<
NCT00772356 Diabetes Mellitus Type 1 Not Applicable Completed - Germany ... More >> Neuss, Germany, 41460 Less <<
NCT02922296 - Recruiting December 1, 2020 United States, Illinois ... More >> University of Illinois at Chicago Recruiting Chicago, Illinois, United States, 60612 Contact: Victor Gordeuk, MD    312-996-5680    vgordeuk@uic.edu Less <<
NCT01414946 Postoperative Protein Cataboli... More >>sm Less << Not Applicable Completed - Canada, Quebec ... More >> Royal Victoria Hospital, McGill University Health Centre Montreal, Quebec, Canada, H3A 1A1 Less <<
NCT01718093 Type 1 Diabetes Phase 4 Completed - United States, Texas ... More >> Baylor College of Medicine Houston, Texas, United States, 77030 Less <<
NCT00716092 Diabetes Mellitus, Type 2 Phase 2 Completed - Germany ... More >> 1218.37.49003 Boehringer Ingelheim Investigational Site Berlin, Germany 1218.37.49002 Boehringer Ingelheim Investigational Site Mainz, Germany 1218.37.49001 Boehringer Ingelheim Investigational Site Neuss, Germany Less <<
NCT02696161 Carpal Tunnel Syndrome Not Applicable Completed - Taiwan ... More >> Department of Physical Medicine and Rehabilitation, Tri-Service General Hospital Taipei, Neihu District, Taiwan, 886 Less <<
NCT00542009 Weight Management ... More >> Treatment Of Obesity Less << Phase 2 Completed - -
NCT00784511 Type 2 Diabetes Phase 2 Completed - United States, Massachusetts ... More >> Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University Boston, Massachusetts, United States, 02111 Less <<
NCT00716092 - Completed - -
NCT03738293 - Not yet recruiting December 2020 -
NCT02110836 Liver and Muscle Glycogen Use ... More >>During Exercise. Less << Not Applicable Completed - United Kingdom ... More >> Northumbria University Newcastle upon Tyne, Tyne and Wear, United Kingdom, NE1 8ST Less <<
NCT03338829 Diabetes in Pregnancy Not Applicable Recruiting March 2020 United States, Iowa ... More >> University of Iowa Hospital and Clinics Recruiting Iowa City, Iowa, United States, 52246 Contact: Janet Andrews, MD       janet-andrews@uiowa.edu    Contact: Sarah Wernimont, MD PhD       sarah-wernimont@uiowa.edu Less <<
NCT01778348 Diabetes Mellitus ... More >> Diabetes Mellitus, Type 1 Glucose Metabolism Disorders Endocrine System Diseases Autoimmune Diseases Less << Phase 2 Completed - United Kingdom ... More >> University of Cambridge Cambridge, United Kingdom, CB2 0QQ Leeds Teaching Hospitals Leeds, United Kingdom, LS9 7TF University College London Hospital London, United Kingdom, NW1 2BU Less <<
NCT02449603 Type 2 Diabetes Mellitus Phase 4 Completed - China, Shaanxi ... More >> Xijing Hospital, Fourth Military Medical university Xi'an, Shaanxi, China, 710032 Less <<
NCT00220441 Impaired Glucose Tolerance Phase 2 Completed - United States, Washington ... More >> Veterans Affairs Puget Sound Health Care System Seattle, Washington, United States, 98108 Veterans Affairs Puget Sound Health Care System Tacoma, Washington, United States, 98493 Less <<
NCT01072578 Healthy Volunteers Phase 1 Completed - Germany ... More >> Research Site Berlin, Germany Less <<
NCT01330550 Impaired Glucose Tolerance Not Applicable Unknown December 2011 Taiwan ... More >> China Medical University Recruiting Taichung, Taiwan, 404 Contact: Huang Hui-Ying    886-4-22053366 ext 7506    hyhuang@mail.cmu.edu.tw Less <<
NCT01091025 Screening of Cystic Fibrosis R... More >>elated Diabetes Less << Not Applicable Completed - United Kingdom ... More >> Royal Brompton & Harefield NHS Foundation Trust London, United Kingdom, SW3 6NP Less <<
NCT02657083 Type 1 Diabetes Mellitus Not Applicable Completed - Slovenia ... More >> University of Ljubljana, Faculty of Medicine Ljubljana, Slovenia, 1000 Less <<
NCT03341026 Diabetes Mellitus, Type 1 ... More >> Diabetes Mellitus, Type 2 Diabete Mellitus Less << Not Applicable Not yet recruiting August 2019 Austria ... More >> Medical University of Graz Not yet recruiting Graz, Austria Contact: Julia Mader, Ass. Prof.          Denmark Steno diabetes center Not yet recruiting Copenhagen, Denmark Contact: Kirsten Norgaard, Ass. Prof. Less <<
NCT00793741 - Completed - United States, Minnesota ... More >> University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT00596323 - Completed - United States, Alabama ... More >> University of Alabama Children's Hospital Birmingham, Alabama, United States, 35213 Less <<
NCT02974504 Type2 Diabetes Phase 4 Completed - Korea, Republic of ... More >> Division of Endocrinology and Metabolism, Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine Seoul, Korea, Republic of Less <<
NCT01804842 - Completed - -
NCT00438503 Renal Failure, Chronic ... More >> Diabetic Nephropathies Less << Phase 4 Completed - Denmark ... More >> Holstebro Hospital Holstebro, Denmark, 7500 Less <<
NCT01136785 Obstructive Sleep Apnea ... More >> Type 2 Diabetes Less << Not Applicable Completed - United States, Illinois ... More >> The University of Chicago Chicago, Illinois, United States, 60637 Less <<
NCT00795275 Obesity Not Applicable Completed - United States, Colorado ... More >> University of Colorado Denver Aurora, Colorado, United States, 80045 Less <<
NCT01136785 - Completed - -
NCT00433758 Type 1 Diabetes Mellitus ... More >> Type 2 Diabetes Mellitus Gestational Diabetes Less << Not Applicable Unknown December 2008 Israel ... More >> Soroka University Medical Center Beer-Sheva, Israel, 84141 Less <<
NCT00657280 - Completed - -
NCT02426606 Healthy Not Applicable Completed - Canada, Ontario ... More >> Human Nutraceutical Research Unit Guelph, Ontario, Canada, N1G 2W1 Less <<
NCT03352518 Diabetes Mellitus Not Applicable Completed - Denmark ... More >> Department of Endocrinology M, Odense University Hospital Odense, Denmark, 5000 Less <<
NCT01160991 Schizophrenia ... More >> Diabetes Insulin Resistance Less << Not Applicable Completed - Germany ... More >> Central Institute of Mental Health Mannheim, Germany, 68159 Less <<
NCT03583268 Type 1 Diabetes Not Applicable Completed - Canada, Manitoba ... More >> Children's Hospital Research Institute of Manitoba Winnipeg, Manitoba, Canada, R3E 3P4 Less <<
NCT03221517 Healthy Not Applicable Recruiting July 2020 United States, Pennsylvania ... More >> Institute for Translational Medicine and Therapeutics (ITMAT), University of Pennsylvania School of Medicine Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: LaVenia Banas, CRN    215-662-4652    banas@itmat.upenn.edu    Contact: Carsten Skarke, M.D.    215-662-7186    cskarke@upenn.edu    Principal Investigator: Carsten Skarke, M.D.          Principal Investigator: Garret A FitzGerald, M.D. Less <<
NCT00657280 Heart Failure, Congestive Early Phase 1 Completed - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT01685879 Diabetes Treatment (Pilot Stud... More >>y) Less << Not Applicable Completed - United States, Hawaii ... More >> University of Hawaii at Manoa Honolulu, Hawaii, United States, 96822 Less <<
NCT01729078 Impaired Fasting Glucose ... More >> Pre Diabetes Liver Fat Less << Not Applicable Completed - United States, Minnesota ... More >> Mayo clinic Rochester, Minnesota, United States, 55901 Less <<
NCT00271284 Diabetes Mellitus, Type 1 Phase 3 Completed - France ... More >> Sanofi-Aventis Administrative Office Paris, France Less <<
NCT03761251 Diabetes Mellitus, Type 1 ... More >> Adolescent Behavior Less << Not Applicable Enrolling by invitation November 2019 United States, Texas ... More >> University of Texas Southwestern Medical Center Dallas, Texas, United States, 75390 Less <<
NCT01953393 Diabetes Type 2 Not Applicable Completed - Denmark ... More >> 1 The Centre of Inflammation and Metabolism, Department of Infectious Diseases and CMRC, Rigshospitalet, Faculty of Health Sciences, University of Copenhagen Copenhagen N, Denmark, 2200 Less <<
NCT01441518 Gestational Diabetes Mellitus ... More >> Pregestational Diabetes Mellitus Mild Gestational Hyperglycemia Less << Phase 2 Completed - Brazil ... More >> Faculdade de Medicina de Botucatu, Universidade Estadual Paulista Botucatu, Sao Paulo, Brazil, 18618-970 Less <<
NCT02824614 Obesity Not Applicable Recruiting June 2019 Switzerland ... More >> St Claraspital Recruiting Basel, Switzerland, CH-4016 Contact: Bettina K Woelnerhanssen, MD       bettina.woelnerhanssen@usb.ch    Principal Investigator: Bettina Woelnerhanssen, MD Less <<
NCT01804842 Type 2 Diabetes Mellitus Phase 1 Phase 2 Completed - -
NCT03162991 Metabolism Disorder, Glucose ... More >> Physical Activity Sedentary Lifestyle Less << Not Applicable Recruiting May 31, 2019 United States, South Carolina ... More >> Public Health Research Center Recruiting Columbia, South Carolina, United States, 29208 Contact: Joshua R Sparks, MS    803-777-8291    theateamstudy@gmail.com Less <<
NCT03337828 Glucose Metabolism Disorders (... More >>Including Diabetes Mellitus) Overweight and Obesity Less << Not Applicable Active, not recruiting December 2017 Spain ... More >> Fernando Civeira Zaragoza, Spain, 50009 Less <<
NCT03041129 - Recruiting June 1, 2022 United States, Colorado ... More >> University of Colorado Anshutz Medical Campus/Children's Hospital Colorado Recruiting Aurora, Colorado, United States, 80045 Contact: Yesenia Garcia    720-777-6984    yesenia.garciareyes@childrenscolorado.org Less <<
NCT00335465 Diabetes Mellitus, Type 2 Phase 4 Completed - Italy ... More >> Sanofi-Aventis Administrative Office Milan, Italy Less <<
NCT01375270 Type 2 Diabetes Mellitus Not Applicable Completed - Denmark ... More >> Centre of Inflammation and Metabolism, Rigshospitalet Copenhagen, Denmark, 2100 Less <<
NCT00966615 Renal Failure ... More >> ESRD Cardiovascular Disease Less << Phase 4 Completed - Hong Kong ... More >> Department of Medicine & Therapeutics, Prince of Wales Hospital Sha Tin, Hong Kong Less <<
NCT01153438 - Completed - United States, Pennsylvania ... More >> Center for Weight and Eating Disorders, University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT02151461 - Completed - -
NCT01271777 Insulin Resistance ... More >> Abdominal Obesity Less << Phase 2 Completed - France ... More >> Site n°1 Nantes Cedex 1, France, 44093 Site n°2 Pierre Bénite, France, 69310 Less <<
NCT02383823 Menopause Not Applicable Not yet recruiting December 2020 Denmark ... More >> Gynecology Dept. Herning Hospital Herning, Denmark, 7400 Less <<
NCT02935829 Potential Abnormality of Gluco... More >>se Tolerance Appetite; Lack or Loss, Nonorganic Origin Less << Not Applicable Completed - Greece ... More >> Agricultural University of Athens Athens, Greece, 11855 Less <<
NCT03363516 - Recruiting September 2018 Italy ... More >> University Magna Graecia of Catanzaro - Department of Medical and Surgical Sciences - Internal Medicine and Geriatrics Units Recruiting Catanzaro, Italy, 88100 Contact: Maria Perticone, Dr    0039 320 8592076    mariaperticone@hotmail.com    Sub-Investigator: Franco Arturi, Prof Less <<
NCT01021878 - Completed - -
NCT00096707 Lung Cancer B... More >>reast Cancer Pancreatic Cancer Head and Neck Cancer Gastric Cancer Less << Phase 1 Completed - United States, Florida ... More >> University of Miami Sylvester Comprehensive Cancer Center Miami, Florida, United States, 33136 United States, Indiana Indiana University Cancer Center Indianapolis, Indiana, United States, 46202 United States, Texas Institute for Drug Development Cancer Therapy & Research Center San Antonio, Texas, United States, 78229 Less <<
NCT02151461 Type 2 Diabetes Mellitus Phase 2 Completed - United States, California ... More >> Catalina Research Institute Chino, California, United States, 91710 United States, Florida Palm Beach Research Palm Beach, Florida, United States, 33409 Meridien Research Tampa, Florida, United States, 33606 United States, Georgia River Birch Research Alliance Blue Ridge, Georgia, United States, 30513 Meridian Research Savannah, Georgia, United States, 31406 United States, Ohio Streling Research Group Cincinnati, Ohio, United States, 45219 United States, South Carolina Medical Research South Charleston, South Carolina, United States, 29407 United States, Tennessee Meharry Medical College Nashville, Tennessee, United States, 37208 Vanderbilt University Medical Center, Diabetes, Endocrinology, and Metabolism Nashville, Tennessee, United States, 37232 Less <<
NCT02484313 Blood Glucose ... More >> Energy Intake Less << Not Applicable Completed - Canada, Nova Scotia ... More >> Mount Saint Vincent University Halifax, Nova Scotia, Canada, B3M 2J6 Less <<
NCT00362063 Growth Hormone Deficiency Not Applicable Active, not recruiting April 2018 United States, Texas ... More >> Baylor College of Medicine Houston, Texas, United States, 77030 Less <<
NCT01021878 Disorders Associated With Peri... More >>toneal Dialysis Less << Phase 4 Completed - Brazil ... More >> Hospital São João de Deus Divinópolis, MG, Brazil Universidade Federal de Uberlândia Uberlândia, Minas Gerais, Brazil, 38400 089 Instituto do Rim de Curitiba Curitiba, Parana, Brazil, 80250-070 Clinica de Doencas Renais Curitiba, PR, Brazil, 80220901 Nefroclinica de Caxias do Sul Caxias do Sul, Rio Grande do Sul, Brazil, 95010-003 Universidade Estadual Paulista Botucatu, Sao Paulo, Brazil, 18618970 Clinese Aracaju, Sergipe, Brazil, 49075210 Universidade Federal de Sao Paulo Sao Paulo, Brazil, 04023 062 Less <<
NCT01886365 Hyperglycemia Not Applicable Completed - Germany ... More >> University Medical Center Hamburg-Eppendorf Hamburg, Germany, 20246 Less <<
NCT00552500 Insulin Resistance ... More >> Body Composition Less << Not Applicable Completed - United States, Missouri ... More >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Less <<
NCT02183558 Polycystic Ovary Syndrome ... More >> Gestational Diabetes Mellitus Less << Not Applicable Completed - Denmark ... More >> OdenseUH Odense, Denmark, 5230 Less <<
NCT00459511 - Completed - Brazil ... More >> Childrens Institute Sao Paulo, SP, Brazil, 05403000 Less <<
NCT01534442 The Focus of This Study is to ... More >>Evaluete the Significances of the Vagal Cholinerg Nervuos System for the Effect of GLP-1 by Using Atropin Administration. Less << Not Applicable Unknown December 2012 Denmark ... More >> Diabetes research Division, Department of Internal Medicin, Gentofte Hospital Recruiting Hellerup, Denmark, 2900 Contact: Astrid Plamboeck, MD    +45 26208174    astridp@sund.ku.dk    Contact: Tina Vilsbøll, MD, Dr. med    +45 40940825    t.vilsboll@dadlnet.dk    Principal Investigator: Astrid Plamboeck, MD          Diabetes Research Division, Department of Internal Medicine, Gentofte Hospital, Copenhagen Denmark Recruiting Hellerup, Denmark, 2900 Contact: Astrid Plamboeck, MD    +45 26208174    astridp@sund.ku.dk    Principal Investigator: Astrid Plamboeck, MD Less <<
NCT03722225 Diabetes Mellitus, Type 1 Not Applicable Completed - -
NCT03721874 Prediabetic State ... More >> Substrate Oxidation Less << Phase 4 Not yet recruiting January 2020 Netherlands ... More >> Maastricht University and Medical Centre Not yet recruiting Maastricht, Limburg, Netherlands, 6200 MD Less <<
NCT00540488 Diabetes Mellitus Type 2 Phase 3 Completed - United States, Illinois ... More >> Protocare Trials, Chicago Center for Clinical Research Chicago, Illinois, United States, 60610 United States, North Carolina Medical University of South Carolina Charleston, North Carolina, United States, 29425 Less <<
NCT01820169 Diabetes Not Applicable Terminated(Only 2 patients scr... More >>eened but none of them were enrolled.) Less << - Japan ... More >> Kyoto, Japan, 612-8555 Less <<
NCT00392197 Schizophrenia Phase 4 Completed - Japan ... More >> Hokkaido region, Japan Kanto region, Japan Kinki region, Japan Kyushu region, Japan Touhoku region, Japan Less <<
NCT03772600 Type 1 Diabetes Mellitus Not Applicable Enrolling by invitation January 2021 Belgium ... More >> Onze-Lieve-Vrouw Ziekenhuis Aalst Aalst, Belgium, 9300 Imeldaziekenhuis Bonheiden Bonheiden, Belgium, 2820 University Hospital Brussels Jette, Belgium, 1090 AZ Groeninge Kortrijk Kortrijk, Belgium, 8500 University Hospital Leuven Leuven, Belgium, 3000 University Hospital Antwerp Wilrijk, Belgium, 2650 Less <<
NCT01161797 - Completed - Korea, Republic of ... More >> Kyunghee University Medical Center Seoul, Korea, Republic of, 130-702 Less <<
NCT00832481 Type 2 Diabetes Not Applicable Unknown December 2009 China, Beijing ... More >> PLA General Hospital Recruiting Beijing, Beijing, China, 100000 Contact: Dong Cai    +86-10-66939246 Less <<
NCT02856516 Diabetes Not Applicable Completed - United States, California ... More >> Orange County Research Center Tustin, California, United States, 92780 Less <<
NCT00392197 - Completed - -
NCT03510000 Type1diabetes Not Applicable Recruiting August 31, 2019 Canada, Ontario ... More >> Sinai Health System Recruiting Toronto, Ontario, Canada, M5T 3L9 Contact: Andrej Orszag    416-586-4800    class15@lunenfeld.ca    Principal Investigator: Bruce A. Perkins, MD          Canada, Quebec Institut de recherches cliniques de Montréal Recruiting Montréal, Quebec, Canada, H2W 1R7 Contact: Virginie Messier, B.Sc.    514 987-5500    promd@ircm.qc.ca    Principal Investigator: Rémi Rabasa-Lhoret, MD, PhD          McGill University Health Center Recruiting Montréal, Quebec, Canada, H3A 2B4 Contact    514-398-4491    haidarlab.dmc@mcgill.ca    Principal Investigator: Ahmad Haidar Less <<
NCT00132106 Heart Failure, Congestive Not Applicable Unknown - Netherlands ... More >> Radboud University Nijmegen Medical Centre Recruiting Nijmegen, Netherlands, 6500 HB Contact: Marc ER Gomes, MD    31-24-3614533/3616550    m.gomes@cardio.umcn.nl    Sub-Investigator: Marc ER Gomes, MD          Sub-Investigator: Alexandra H Mulder, MD          Sub-Investigator: Freek WA Verheugt, MD, PhD          Sub-Investigator: Paul Smits, MD, PhD          Principal Investigator: Cees J Tack, MD, PhD          Sub-Investigator: Louise Bellersen, MD Less <<
NCT02366481 Obesity Insul... More >>in Resistance Insulin Sensitivity Beta-Cell Dysfunction Prediabetes Less << Phase 1 Phase 2 Recruiting December 30, 2018 United States, Georgia ... More >> Medical College of Georgia; Augusta University Recruiting Augusta, Georgia, United States, 30912 Contact: Norman K Pollock, Ph.D.    706-721-5424    npollock@augusta.edu Less <<
NCT00735163 Critical Illness Not Applicable Completed - Austria ... More >> Medical University Graz Graz, Austria, 8036 Less <<
NCT00786825 Type 1 Diabetes Not Applicable Completed - United States, Minnesota ... More >> University of Minnesota Minneapolis, Minnesota, United States, 55414 Less <<
NCT02198209 Type 2 Diabetes Phase 4 Not yet recruiting December 2020 United States, California ... More >> Cedars Sinai Medical Center Recruiting Los Angeles, California, United States, 90048 Contact: Viorica Ionut, MD PhD       Viorica.Ionut@cshs.org    Principal Investigator: Viorica Ionut, MD PhD          Sub-Investigator: Richard Bergman, PhD          Sub-Investigator: Ruchi Mathur, MD Less <<
NCT00876590 - Completed - Taiwan ... More >> National Taiwan University Hospital Taipei, Taiwan Less <<
NCT00877461 - Completed - Taiwan ... More >> National Taiwan University Hospital Taipei, Taiwan Less <<
NCT00746174 Insulin Sensitivity Phase 4 Completed - United States, Texas ... More >> University of Texas Southwestern Medical Center at Dallas Dallas, Texas, United States, 75390 Less <<
NCT00925080 - Completed - United States, California ... More >> Profil Institute for Clinical Research Chula Vista, California, United States, 91911 Advanced Metabolic Care + Research Escondido, California, United States, 92026 United States, Texas Diabetes and Glandular Disease Research Associates, Inc. San Antonio, Texas, United States, 78229 Less <<
NCT01020955 Diabetes Phase 3 Completed - Sweden ... More >> Department of Endocrinology, karolinska University hospital Solna, Sweden, 171 76 Less <<
NCT00887094 Diabetes Mellitus, Type 2 ... More >> Treatment Exercise Less << Not Applicable Completed - Brazil ... More >> Hospital de Clinicas de Porto Alegre Porto Alegre, RS, Brazil, 90035-003 Less <<
NCT03206593 - Recruiting December 31, 2019 China, Guangdong ... More >> Guangdong General Hospital Recruiting Guangzhou, Guangdong, China, 510080 Contact: Anping Cai, M.D.    860215989267312    caianping1983@hotmail.com Less <<
NCT02671214 Healthy Not Applicable Completed - United Kingdom ... More >> Leatherhead Food Research UK Leatherhead, Randalls Road, Surrey, United Kingdom, KT22 7RY Less <<
NCT02795559 Obesity Diabe... More >>tes Less << Not Applicable Completed - Canada, Ontario ... More >> Glycemic Index Laboratories Toronto, Ontario, Canada, M5C 2X3 Less <<
NCT00442624 - Completed - Switzerland ... More >> University Hospital Basel Basel, Switzerland, 4031 Less <<
NCT01677299 Type 2 Diabetes Mellitus Phase 1 Phase 2 Completed - United States, Arizona ... More >> Celerion, Inc. Tempe, Arizona, United States, 85283 United States, Nebraska Celerion, Inc. Lincoln, Nebraska, United States, 68502 Less <<
NCT01199900 Healthy Phase 1 Completed - United States, Michigan ... More >> Pfizer Investigational Site Kalamazoo, Michigan, United States, 49007 Less <<
NCT01693302 Type 1 Diabetes Not Applicable Completed - United States, Colorado ... More >> Barbara Davis Center Aurora, Colorado, United States, 80045 Less <<
NCT01677299 - Completed - -
NCT03605979 - Completed - France ... More >> Damien JOLLY Reims, France Less <<
NCT00111540 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT03214107 Type 1 Diabetes Mellitus Not Applicable Recruiting December 2018 Canada, Quebec ... More >> Institut de recherches cliniques de Montréal Recruiting Montreal, Quebec, Canada Contact: Virginie Messier    1-514-987-5500 ext 3227    virginie.messier@ircm.qc.ca    Contact: Corinne Suppere    1-514-987-5500 ext 3357    corinne.suppere@ircm.qc.ca    Principal Investigator: Remi Rabasa-Lhoret Less <<
NCT02868177 Prediabetes T... More >>ype 2 Diabetes Hypertriglyceridemia Obesity Disease Insulin Resistance Less << Phase 2 Phase 3 Active, not recruiting August 2019 France ... More >> Institut Pasteur de Lille Lille, France, 59019 Biofortis Mérieux NutriSciences Clinical Investigation Center Saint Herblain, France, 44800 Ireland Atlantia Food Clinical Trials Cork, Ireland, T23 R50R Serbia Clinical center of Kragujevac, / Poseidon CRO Kragujevac, Serbia Clinical Center of Vojvodina / Poseidon CRO Novi Sad, Serbia, 21000 Slovenia University Medical Centre Ljubljana / Poseidon CRO Ljubljana, Slovenia Less <<
NCT02299479 Diabetes Noct... More >>urnal Hypoglycemia Less << Not Applicable Completed - United States, Massachusetts ... More >> Boston Children's Hospital Boston, Massachusetts, United States, 02115 Less <<
NCT00928889 Diabetes Mellitus, Type 2 Phase 4 Completed - China ... More >> People's Liberation Army. The Military General Hospital of BeiJing BeiJing, China, 100020 Peiking University First Hospital BeiJing, China, 100034 Chinese PLA General Hospital Beijing, China, 100853 The First Affiliated Hospital, Zhongshan (Sun Yat-sen) University Guangzhou, China, 510080 The Second Affiliated Hospital, Zhongshan (Sun Yat-sen) University Guangzhou, China, 510120 Nanfang Hospital, the Affiliated South Hospital of the Southern Medical University Guangzhou, China, 510515 Less <<
NCT01623934 - Active, not recruiting May 2019 Canada, Quebec ... More >> Centre de recherche Étienne-Le Bel, Centre hospitalier universitaire de Sherbrooke Sherbrooke, Quebec, Canada, J1H5N4 Less <<
NCT00928889 - Completed - -
NCT01279317 Type 2 Diabetes Mellitus Not Applicable Completed - Netherlands ... More >> Maastricht University Medical Centre Maastricht, Limburg, Netherlands, 6200 MD Less <<
NCT02073058 - Completed - United States, California ... More >> AMCR Institute Escondido, California, United States, 92026 Diablo Clinical Research Walnut Creek, California, United States, 94598 United States, Georgia Atlanta Diabetes Associates Atlanta, Georgia, United States, 30318 United States, Washington Rainier Clinical Research Center Renton, Washington, United States, 98057 Less <<
NCT00712361 Accuracy of the SofTouch Devic... More >>e Measuring Blood Glucose and Other Parameters. Less << Not Applicable Completed - Israel ... More >> Patient's residence Patient's residence city, Patinet's residence Province, Israel Carmel Medical Center Haifa, Israel Lin Medical Center Haifa, Israel CNOGA Medical Ltd. Or Akiva, Israel, 30600 Less <<
NCT02072902 - Completed - Israel ... More >> The Gertner Institute for Epidemiology and Health Policy Research Ramat-Gan, Israel Less <<
NCT01807351 - Completed - -
NCT00886626 Obesity, Morbid Phase 2 Completed - United States, Minnesota ... More >> University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT00886626 - Completed - -
NCT02203240 Prediabetes Not Applicable Completed - United States, Virginia ... More >> Human Integrative Physiology Laboratory Blacksburg, Virginia, United States, 24061 Less <<
NCT01279317 - Completed - -
NCT03369067 Type 1 Diabetes Mellitus Not Applicable Completed - United States, California ... More >> Stanford University Stanford, California, United States, 94304 United States, Colorado Barbara Davis Center, University of Colorado Aurora, Colorado, United States, 80045 United States, Virginia University of Virginia Center for Diabetes Technology Charlottesville, Virginia, United States, 22903 Less <<
NCT01498523 Healthy Not Applicable Completed - Netherlands ... More >> Wageningen University Wageningen, Gelderland, Netherlands, 6703 HA Less <<
NCT03170544 Type 1 Diabetes Mellitus ... More >> Type 2 Diabetes Mellitus Less << Phase 1 Completed - United States, California ... More >> ProSciento Inc. ( Site 0001) Chula Vista, California, United States, 91911 Less <<
NCT01475422 Diabetes Mellitus Not Applicable Unknown March 2012 Brazil ... More >> University of São Paulo Recruiting Ribeirão Preto, São Paulo, Brazil Contact: Vívian Saraiva Veras, Principal Investigator    55 16 88074113    vivianveras@hotmail.com    Principal Investigator: Vívian Saraiva Veras          Sub-Investigator: Maria Lúcia Zanetti, Study Chair Less <<
NCT01472406 Type 1 Diabetes Mellitus Early Phase 1 Unknown March 2014 United States, California ... More >> Sansum Diabetes Research Institute Recruiting Santa Barbara, California, United States, 93105 Contact: Howard Zisser, MD    805-682-7640 ext 255    hzisser@sansum.org    Contact: Wendy Bevier, PhD    805-682-7640 ext 207    wbevier@sansum.org    Sub-Investigator: Lois Jovanovic, MD          Sub-Investigator: Eyal Dassau, PhD          Sub-Investigator: Francis Doyle, Ph.D. Less <<
NCT00529048 - Completed - Denmark ... More >> Endokrinologisk afd. J, Herlev Hospital Herlev, Region Hovedstaden, Denmark, 2730 Less <<
NCT00831389 Type 1 Diabetes Mellitus Not Applicable Completed - United States, Connecticut ... More >> Yale Pediatrics Diabetes Research New Haven, Connecticut, United States, 06519 Less <<
NCT00259727 - Completed - United States, California ... More >> VA Medical Center, San Francisco San Francisco, California, United States, 94121 Less <<
NCT03481530 Type 2 Diabetes Mellitus ... More >> Hypoglycemia Less << Not Applicable Not yet recruiting September 30, 2025 United States, Minnesota ... More >> University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT01129297 - Recruiting January 2025 France ... More >> Lille University Hospital Recruiting Lille, Nord, France Contact: François PATTOU, MD, PhD Less <<
NCT00836329 Diabetes Mellitus ... More >> Cardiovascular Diseases Less << Phase 3 Completed - United States, North Carolina ... More >> Wake Forest Baptist Medical Center Winston-Salem, North Carolina, United States, 27057 Less <<
NCT00831389 - Completed - -
NCT00806520 - Completed - United States, Massachusetts ... More >> Joslin Diabetes Center Boston, Massachusetts, United States, 02215 United States, Minnesota International Diabetes Center Minneapolis, Minnesota, United States, 55416 United States, Nevada Palm Medical Group Las Vegas, Nevada, United States, 89148 United States, North Carolina University of North Carolina Diabetes Care Center Durham, North Carolina, United States, 27713 United States, Washington Rockwood Clinic Spokane, Washington, United States, 99202 Less <<
NCT03609632 Bariatric Surgery Not Applicable Completed - Switzerland ... More >> Division of Endocrinology, Diabetes and Clinical Nutrition, Bern University Hospital Bern, Switzerland, 3010 Less <<
NCT02084095 - Unknown December 2016 Romania ... More >> "C. I. Parhon" Institute of Endocrinology Recruiting Bucharest, Romania, 011863 Less <<
NCT00699322 Type 2 Diabetes Phase 4 Unknown June 2010 Korea, Republic of ... More >> Kangnam St. Mary's hospital Recruiting Seoul, Korea, Republic of, 137-701 Sub-Investigator: Seung-Hwan Lee, M.D.          Sub-Investigator: Eun-Sook Kim, M.D.          Principal Investigator: Kun-Ho Yoon, M.D., Ph.D. Less <<
NCT03305367 Type 2 Diabetes Mellitus Not Applicable Completed - Denmark ... More >> Department of Endocrinology Odense, Denmark, 5000 Less <<
NCT00569907 - Completed - United States, Minnesota ... More >> International Diabetes Center - Park Nicollet Health Services Minneapolis, Minnesota, United States, 55416 Less <<
NCT01104142 - Completed - United States, Colorado ... More >> Barbara Davis Center for Childhood Diabetes Aurora, Colorado, United States, 80045 Less <<
NCT01960231 - Recruiting December 2017 Israel ... More >> Sheba Medical Center Recruiting ramat Gan, Israel, 52621 Contact: Ayana Paster, RD    972-3-5302021 Less <<
NCT01751932 Diabetes Mellitus Not Applicable Completed - Netherlands ... More >> Academic Medical Center Amsterdam, Noord-Holland, Netherlands, 1105AZ Less <<
NCT00846521 - Terminated - -
NCT00846521 Pediatric Obesity ... More >> Insulin Resistance Impaired Glucose Tolerance Cardiovascular Disease Less << Phase 4 Terminated - United States, Connecticut ... More >> Yale School of Medicine New Haven, Connecticut, United States, 06511 Less <<
NCT00944619 Type 1 Diabetes Not Applicable Completed - United Kingdom ... More >> Addenbrooke's Hospital Cambridge, United Kingdom, CB2 0QQ Less <<
NCT01331343 Type 1 Diabetes Mellitus Phase 4 Completed - France ... More >> Hospital Sud Francilien Corbeil-Essonnes Cedex, France CH Robert Debre Paris, France Germany Klinik fur Allgemeine Charite Berlin, Germany Israel Schneider Children Centre Petah Tikva, Israel Italy U.O. Medicina Generale Milano, Italy Slovenia University Children's Hospital Ljubljana, Slovenia Sweden Huddinge University Hospital Huddinge, Sweden United Kingdom Royal Bournemouth Hospital Dorset, United Kingdom Less <<
NCT01576250 Insulin Sensitivity Not Applicable Completed - Netherlands ... More >> Maastricht University Medical Center Maastricht, Netherlands, 6200 MD Less <<
NCT00821067 Fatigue Not Applicable Completed - United States, Colorado ... More >> Aurora Denver Cardiology Association Denver, Colorado, United States, 80218 Less <<
NCT03766308 Type 2 Diabetes Mellitus Not Applicable Active, not recruiting May 31, 2019 China, Hubei ... More >> Tongji Hospital, Tongji Medical College, Huazhong University of Science and technology Wuhan, Hubei, China Less <<
NCT02589002 Glucose Metabolism Disorders Not Applicable Completed - Mexico ... More >> Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran Mexico City, Distrito Federal, Mexico, 14080 Less <<
NCT01629277 Type 1 Diabetes Phase 2 Completed - United Kingdom ... More >> Wellcome Trust Clinical Research Facility, Addenbrooke's Hospital Cambridge, United Kingdom, CB2 0QQ Less <<
NCT00930956 Postprandial Hyperglycemia Not Applicable Completed - United States, Kansas ... More >> Human Metabolism Laboratory (K-State Univ.) Manhattan, Kansas, United States, 66502 Less <<
NCT00542334 - Completed - Canada, Ontario ... More >> Children's Hosiptal of Eastern Ontario Ottawa, Ontario, Canada, K1H 8L1 Less <<
NCT03337477 Hyperkalemia Phase 2 Recruiting December 26, 2018 -
NCT03034798 - Completed - -
NCT02604095 Acanthosis Nigricans ... More >> Obesity Less << Not Applicable Completed - China, Shanghai ... More >> Shanghai Tenth People' Hospital Shanghai, Shanghai, China, 200072 Less <<
NCT02612597 Healthy Overw... More >>eight Less << Not Applicable Unknown April 2016 Switzerland ... More >> Institute of Physiology, University of Zurich Recruiting Zurich, Switzerland, 8057 Contact: Carsten Lundby, Prof. Dr.    +41 44 635 50 52 ext +41    carsten.lundby@access.uzh.ch Less <<
NCT02204813 Bypass, Gastric ... More >> Roux-en-Y Gastric Bypass Vertical Sleeve Gastrectomy Gastric Banding Bariatric Surgery Less << Phase 1 Completed - United States, Missouri ... More >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Less <<
NCT00297635 Diabetes Mellitus, Type 1 ... More >> Diabetes Mellitus, Insulin-Dependent Less << Phase 2 Withdrawn(Decided not to parti... More >>cipate in study per Leslie Padron-Massaro) Less << December 2007 -
NCT00971594 Obesity Gluco... More >>se Intolerance Exercise Capacity Less << Not Applicable Completed - United States, Maryland ... More >> Baltimore VA Medical Center Baltimore, Maryland, United States, 21201 University of Maryland Baltimore, Maryland, United States, 21201 Less <<
NCT02772146 Heart Failure ... More >> Cardio-Renal Syndrome Less << Not Applicable Terminated(After 2 patients it... More >> was concluded that a large change in exclusion criteria and study design was needed to obtain the ojective for the study) Less << - Germany ... More >> Division of Nephrology, Heidelberg University Hospital Heidelberg, Germany, 69120 Less <<
NCT02028078 Type 1 Diabetes Mellitus Phase 2 Completed - Austria ... More >> Medical University of Graz Graz, Styria, Austria, 8036 Less <<
NCT01414647 Metabolic Syndrome ... More >> Impaired Glucose Tolerance Low-grade Inflammation Dyslipidemia Less << Not Applicable Completed - Finland ... More >> University of Eastern Finland, Dpet of Public Health and Clinical Nutrition Kuopio, Finland, FIN-70211 Less <<
NCT01103245 Metabolic Diseases ... More >> Diabetes Mellitus Endocrine System Diseases Glucose Metabolism Disorders Less << Phase 1 Completed - United States, Tennessee ... More >> Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232 Less <<
NCT01198678 Diabetes Phase 1 Completed - Slovenia ... More >> University medical Center Ljubljana Ljubljana, Slovenia, SI-1000 Less <<
NCT01103245 - Completed - -
NCT02154997 - Unknown December 2017 Israel ... More >> Hadassah Ein Kerem Recruiting Jerusalem, Israel, 91120 Contact: Uriel Elchalal, MD       uriel@hadassah.org.il Less <<
NCT03482596 Type 2 Diabetes Mellitus Not Applicable Recruiting September 1, 2019 United Kingdom ... More >> Leicester Diabetes Centre Recruiting Leicester, Leicestershire, United Kingdom, LE5 4PW Contact: Gregory J H Biddle, MSc    01162584874    gjhb1@le.ac.uk    Contact: Charlotte L Edwardson, PhD    01162588577    ce95@le.ac.uk Less <<
NCT03400618 Diabetes Mellitus, Type 1 Not Applicable Recruiting January 2021 Sweden ... More >> NU Hospital Organization Recruiting Uddevalla, Sweden, 45180 Contact: Sofia Isaksson, MSc    00460104350000    sofia.isaksson.2@gu.se Less <<
NCT02258477 - Completed - -
NCT02776098 - Recruiting December 2019 United States, Pennsylvania ... More >> Children's Hospital of Philadelphia Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Saba Sheikh, MD    215-590-3749    sheikhs@email.chop.edu    Contact: Davina Laracuente       LARACUENTD@email.chop.edu    Principal Investigator: Saba Sheikh, MD          University of Pennsylvania Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Davina Laracuente       LARACUENTD@EMAIL.CHOP.EDU    Principal Investigator: Ravinder Reddy, MD Less <<
NCT00005760 - Completed - United States, Maryland ... More >> National Institute of Child Health and Human Development (NICHD) Bethesda, Maryland, United States, 20892 Less <<
NCT02462421 Diabetes Mellitus ... More >> Gout Hyperuricemia Less << Phase 4 Enrolling by invitation September 2019 -
NCT02932592 Acute Coronary Syndrome Phase 4 Unknown October 2017 Italy ... More >> Giuseppe Derosa Recruiting Pavia, Italy, 27100 Contact: Giuseppe Derosa, MD    +39 0382 502614    giuseppe.derosa@unipv.it    Principal Investigator: Giuseppe Derosa, MD, PhD Less <<
NCT02287402 Impaired Glucose Tolerance (IG... More >>T) Less << Phase 4 Completed - -
NCT02258477 Willpower Not Applicable Completed - United States, Colorado ... More >> Anschutz Health and Wellness Center Aurora, Colorado, United States, 80045 Less <<
NCT02287402 - Completed - -
NCT01239004 Dyslipidemia ... More >>Hyperlipidemia Hyperglycemia Less << Phase 4 Completed - United States, Illinois ... More >> Radiant Research Chicago, Illinois, United States United States, Kansas Kansas City, Kansas, United States United States, Minnesota Minneapolis, Minnesota, United States United States, Missouri St Louis, Missouri, United States Less <<
NCT01021969 Healthy Not Applicable Completed - Switzerland ... More >> University Hospital Zurich Zurich, Switzerland, 8091 Less <<
NCT03310099 Heart Failure With Normal Ejec... More >>tion Fraction Obesity Less << Not Applicable Recruiting August 31, 2019 United States, Virginia ... More >> Virginia Commonwealth University Recruiting Richmond, Virginia, United States, 23298 Contact: Antonio Abbate, MD, PhD    804-828-0513    antonio.abbate@vcuhealth.org    Contact: Salvatore Carbone, PhD    (804) 628-3980    salvatore.carbone@vcuhealth.org Less <<
NCT01579656 Cardiovascular Diseases Phase 1 Completed - Canada, Ontario ... More >> St. Michael's Hospital Toronto, Ontario, Canada, L3R 5G4 Less <<
NCT02999607 Depression Not Applicable Completed - Austria ... More >> Department of Psychiatry and Psychotherapy, Medical University of Vienna Vienna, Austria, 1090 Less <<
NCT00888602 Healthy Men Not Applicable Completed - United States, Ohio ... More >> Hill Top Research Miamiville, Ohio, United States, 45147 Less <<
NCT02620670 Obesity Not Applicable Completed - Mexico ... More >> Institute of Experimental and Clinical Therapeutics (INTEC), CUCS, University of Guadalajara Guadalajara, Jalisco, Mexico, 44340 Less <<
NCT00724282 Sleep Insomni... More >>a Insulin Resistance Less << Phase 4 Completed - United States, Illinois ... More >> University of Chicago Chicago, Illinois, United States, 60637 Less <<
NCT00724282 - Completed - -
NCT02909829 Diabetes Mellitus, Type 1 Not Applicable Recruiting September 2018 Canada, Quebec ... More >> McGill University Health Centre Recruiting Montréal, Quebec, Canada Contact: Emilie Palisaitis    514-609-8961    emilie.palisaitis@mail.mcgill.ca    Sub-Investigator: Ahmad Haidar          Principal Investigator: Legault Laurent Less <<
NCT02383316 Child Syndrome Not Applicable Completed - France ... More >> CHU Toulouse - Hôpital des Enfants Toulouse, France, 31052 Less <<
NCT03028506 - Completed - -
NCT02929849 Obesity Not Applicable Active, not recruiting December 2019 United States, New Jersey ... More >> Rutgers University New Brunswick, New Jersey, United States, 08901 Less <<
NCT03641105 - Active, not recruiting March 1, 2019 -
NCT02478190 Hyperglycemia ... More >> Diabetes Mellitus Complications of Diabetes Mellitus Diabetes-Related Complications Diabetes Mellitus, Type 2 Less << Not Applicable Completed - United States, Minnesota ... More >> Hennepin County Medical Center Minneapolis, Minnesota, United States, 55415 Less <<
NCT03284216 Aerobic Exercise ... More >> Hyperglycemia Glucose Metabolism Disorders (Including Diabetes Mellitus) Less << Not Applicable Completed - United Kingdom ... More >> University of Birmingham Birmingham, West Midlands, United Kingdom, B15 2TT Less <<
NCT01591681 - Completed - -
NCT01033916 Blood Glucose ... More >> Coronary Artery Bypass Insulin Coronary Disease Less << Not Applicable Unknown July 2016 United States, Virginia ... More >> Inova Fairfax Hospital Falls Church, Virginia, United States, 22042 Less <<
NCT00845559 Obesity Insul... More >>in Resistance Impaired Glucose Tolerance Cardiovascular Disease Less << Phase 4 Withdrawn - -
NCT00991107 Insulin Resistance Phase 1 Completed - United States, Louisiana ... More >> Clinical Site Baton Rouge, Louisiana, United States, 70808 Less <<
NCT03437330 Type2 Diabetes Mellitus Phase 4 Not yet recruiting March 31, 2019 -
NCT01591681 Type 1 Diabetes Phase 2 Completed - United States, California ... More >> Stanford University Stanford, California, United States, 94305 United States, Colorado Barbara Davis Center for Childhood Diabetes Aurora, Colorado, United States, 80045 Canada, Ontario St. Joseph's Health Care London, Ontario, Canada, N6A4V2 Less <<
NCT03542929 Diabetes Not Applicable Completed - Brazil ... More >> Maíra F Pessoa Recife, Pernambuco, Brazil, 50.741-530 Less <<
NCT00555750 - Completed - -
NCT00555750 Primary Insomnia Not Applicable Completed - United States, Massachusetts ... More >> Brigham and Women's Hospital, Division of Sleep Medicine Boston, Massachusetts, United States, 02115 Less <<
NCT01519466 - Completed - -
NCT02344381 Liver and Muscle Glycogen Repl... More >>enishment Post-exercise Less << Not Applicable Completed - United Kingdom ... More >> Northumbria University Newcastle upon Tyne, North East, United Kingdom, NE1 8ST Less <<
NCT03329651 Impaired Glucose Tolerance ... More >> Diabetes Mellitus, Type 2 Less << Not Applicable Completed - Denmark ... More >> Center for aktiv sundhed Copenhagen, Copenhagen N, Denmark, 2200 Less <<
NCT02562014 Obesity Not Applicable Completed - -
NCT01519466 Type 1 Diabetes Not Applicable Completed - Germany ... More >> Diabetes Zentrum Mergentheim Bad Mergentheim, Germany, 97980 Diabetes-Zentrum für Kinder und Jugendliche Hannover, Germany, 30173 Institut für Diabetes - Technology Forschungs - und Entwicklungsgesellschaft mbH an der Universität Ulm Ulm, Germany, D-89081 Netherlands VU University Medical Centre (VUMC) Amsterdam, Netherlands, 1007 MB Less <<
NCT03486015 Pain Not Applicable Completed - -
NCT00633425 Diabetes Mellitus Phase 4 Completed - France ... More >> Sanofi-Aventis Paris, France Less <<
NCT00655603 Type 2 Diabetes Mellitus Not Applicable Unknown September 2009 -
NCT01879033 Insulin Resistance ... More >> Glucose Intolerance Obesity Atherosclerosis Less << Not Applicable Completed - United States, New York ... More >> Albert Einstein College of Medicine West Campus Clinical Research Center Bronx, New York, United States, 10467 Less <<
NCT01495754 Obesity Infla... More >>mmation Less << Not Applicable Completed - Greece ... More >> Metabolic Unit of the Department of Nutrition and Dietetics, Harokopio University Athens, Greece, 17671 Less <<
NCT03152994 - Recruiting May 1, 2020 China, Guangdong ... More >> Zhujiang Hospital,Southern Medical Universicity Recruiting Guangzhou, Guangdong, China, 510282 Contact: Liqing Wang, Doctor    +86-02062783391    wliqing07@gmail.com Less <<
NCT00350129 - Completed - Switzerland ... More >> University Hospital Basel, Eye Clinic Basel, BS, Switzerland, 4031 Less <<
NCT02866539 Diabetes Mellitus Not Applicable Completed - India ... More >> Narayana Hrudayalaya Limited, Mazumdar Shaw multispecialty Hospital Bangalore, Karnataka, India, 560099 Less <<
NCT02345967 Diabetes Mellitus Not Applicable Completed - United States, California ... More >> Profil Institute for Clinical Research Chula Vista, California, United States, 91911 AMCR Institute Escondido, California, United States, 92025 Less <<
NCT01511861 - Unknown January 2018 Israel ... More >> Edith Wolfson Medical Center Holon, Israel Less <<
NCT01301521 Diabetes Pre-... More >>Diabetes Less << Not Applicable Active, not recruiting April 2019 United States, California ... More >> Travis Air Force Base Travis Air Force Base, California, United States, 94535 United States, Florida Eglin Air Foce Base Eglin Air Force Base, Florida, United States, 32922 United States, Nebraska Offutt Air Force Base Offutt Air Force Base, Nebraska, United States, 68113 United States, Texas Wilford Hall Ambulatory Surgical Center Lackland Air Force Base, Texas, United States, 78236 Less <<
NCT00810589 Diabetes, Type I Phase 1 Completed - Austria ... More >> Medical University Graz Graz, Austria, 8036 Less <<
NCT01030796 Diabetes Mellitus, Type 2 Phase 1 Completed - United States, North Carolina ... More >> Duke University Medical Center Durham, North Carolina, United States, 27710 Less <<
NCT00240149 Hyperglycemia Not Applicable Completed - United States, California ... More >> Lucile Packard Childrens Hospital - PICU Stanford, California, United States, 94305 Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT02767336 Diabetes Mellitus Not Applicable Completed - United Kingdom ... More >> BioKinetic Europe Ltd Belfast, Antrim, United Kingdom, BT2 7BA Diabetes Centre, Heartlands Hospital Birmingham, United Kingdom, B9 5SS NHS Lothian Edinburgh, United Kingdom, EH16 4SA Highland Diabetes Institute Inverness, United Kingdom, IV2 3JH Less <<
NCT01951287 Blood Glucose ... More >> Blood Insulin Less << Not Applicable Completed - United States, Indiana ... More >> Purdue University West lafayette, Indiana, United States, 47906 Less <<
NCT03629639 Psoriasis Vulgaris With Metabo... More >>lic Disorders Less << Phase 4 Not yet recruiting December 1, 2020 -
NCT03185676 Insulin Resistance Not Applicable Completed - Sweden ... More >> Klinisk Prövningsenhet, Kliniska Studier Sverige - Forum Söder Lund, Sweden Less <<
NCT02742701 - Unknown January 2018 -
NCT02241993 - Completed - United States, Oregon ... More >> Oregon Health & Science University Portland, Oregon, United States, 97239 Less <<
NCT01364337 Hypertension Not Applicable Unknown December 2011 Taiwan ... More >> National Health Research Institutes Miaoli County, Taiwan Less <<
NCT03765164 Diabetes Not Applicable Recruiting February 28, 2019 United States, California ... More >> QURE Healthcare Recruiting San Francisco, California, United States, 94109 Contact: John W Peabody, MD    415-321-3388 ext 1    jpeabody@qurehealthcare.com    Contact: Mary T Tran, MS    4153213388 ext 1    mtran@qurehealthcare.com    Principal Investigator: John W Peabody, MD Less <<
NCT03227094 Cystic Fibrosis ... More >> Cystic Fibrosis-related Diabetes Less << Not Applicable Recruiting October 15, 2018 Canada, Quebec ... More >> CHUM Recruiting Montreal, Quebec, Canada, H2W1R7 Contact: Valérie Boudreau    514-987-5500 ext 3238    valerie.boudreau@ircm.qc.ca    Montreal Clinical Research Institute (IRCM) Recruiting Montréal, Quebec, Canada, H2W 1R7 Less <<
NCT00308139 - Completed - -
NCT01709617 Carbohydrate Oxidation and Gly... More >>cogen Utilization During and Following Exercise Less << Not Applicable Unknown January 2014 Netherlands ... More >> Maastricht University Not yet recruiting Maastricht, Limburg, Netherlands, 6200MD Contact       ncermak@gmail.com Less <<
NCT01492283 - Completed - Denmark ... More >> Diabetes Research Division, Gentofte University Hospital, Niels Andersens Vej 65, opgang 4b, 1. sal Hellerup, Denmark, 2900 Less <<
NCT01377961 Metabolic Syndrome ... More >> Diabetes Mellitus, Non-Insulin-Dependent Less << Not Applicable Withdrawn(FDA needs more infor... More >>mation from the manufacturing company of the supplements.) Less << August 2015 United States, Texas ... More >> Internal Medicine Galveston, Texas, United States, 77550 Stark Diabetes Center Clinic Galveston, Texas, United States, 77550 Less <<
NCT00308139 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT01542554 Diabetes Mellitus Not Applicable Unknown December 2012 China, Hong Kong SAR ... More >> Tung Wah Eastern Hospital, Hospital Authority Recruiting Hong Kong SAR, Hong Kong SAR, China Contact: Ace Lee, MBBS    852-21626888    acelee@mac.com    Principal Investigator: Ace Yee Lee, MBBS          Sub-Investigator: Marcus Wing Kai Lai, MSc, RD          Sub-Investigator: Kelvin Chung Sau Chan, MSc,APD Less <<
NCT02589353 Healthy Volunteers Phase 4 Recruiting October 2020 United States, Oregon ... More >> Department of Food Science and Technology Recruiting Corvallis, Oregon, United States, 97331 Contact: Juyun Lim    541-737-6507    juyun.lim@oregonstate.edu Less <<
NCT02896010 Prediabetes H... More >>yperglycemia Postprandial Hyperglycemia Impaired Glucose Tolerance Impaired Fasting Glucose Less << Not Applicable Completed - United States, Maryland ... More >> Johns Hopkins Hospital Baltimore, Maryland, United States, 21287 United States, Pennsylvania Reading Health System Reading, Pennsylvania, United States, 19607 Less <<
NCT02210481 - Completed - France ... More >> Centre Hospitalier Universitaire de Reims Reims, France, 51100 Less <<
NCT01800734 Diabetes Mellitus Type 1 Phase 4 Unknown February 2015 Italy ... More >> Division of Endocrinology and Metabolic Diseases - University Hospital of Verona-Piazzale Stefani 1 Recruiting Verona, Italy, 37126 Less <<
NCT03390179 - Recruiting January 31, 2018 France ... More >> Cuvillon Recruiting Nîmes, Gard, France, 30000 Contact: Philippe cuvillon, MD,PhD    4-66-68-30-50 ext 33    philippe.cuvillon@chu-nimes.fr Less <<
NCT02278042 Conditions: None. Focus: Under... More >>standing the Obesogenic Potential of Fructose Containing Sugars Less << Not Applicable Completed - United States, Florida ... More >> Rippe Lifestyle Institute Celebration, Florida, United States, 34747 Less <<
NCT01727817 Diabetes Mellitus, Type 1 Not Applicable Completed - Italy ... More >> University of Padova Padova, Italy, 35131 Less <<
NCT00236379 Schizophrenia ... More >> Diabetes Mellitus Less << Phase 4 Completed - -
NCT03483129 Pre-Diabetes Not Applicable Active, not recruiting January 2020 United Kingdom ... More >> Carwyn James Building Aberystwyth, Ceredigion, United Kingdom, SY23 3FD Less <<
NCT02412995 Insulin Sensitivity ... More >> Glucose Intolerance Less << Early Phase 1 Completed - Denmark ... More >> Department of Nutrition, Exercise and Sports, University of Copenhagen Frederiksberg C, Denmark, 1958 Less <<
NCT01881009 Type 1 Diabetes Mellitus ... More >> Autoimmune Diabetes Juvenile-Onset Diabetes Diabetes, Mellitus, Type 1 Less << Not Applicable Completed - United States, California ... More >> Stanford University Stanford, California, United States, 94305-5208 Less <<
NCT01121315 - Completed - Sweden ... More >> Research Site Uppsala, Sweden Less <<
NCT00962962 Pre-Diabetes Not Applicable Completed - United States, North Carolina ... More >> Duke Center For Living Durham, North Carolina, United States, 27710 Less <<
NCT01768429 Hyperglycemia Not Applicable Completed - Finland ... More >> University of Eastern Finland Kuopio, Finland Less <<
NCT01035528 Coronary Artery Disease ... More >> Type 2 Diabetes Less << Phase 4 Unknown August 2010 Germany ... More >> Staedt. Klinikum Muenchen Bogenhausen Munich, Bavaria, Germany, 81925 Less <<
NCT03658681 Postprandial Blood Glucose ... More >> Gut Microbiota Satiety Less << Not Applicable Recruiting December 31, 2018 Norway ... More >> Oslo Metropolitan University Recruiting Oslo, Norway, 0130 Contact: Vibeke Telle-Hansen, PhD    47 67 23 68 19    vtelle@oslomet.no    Principal Investigator: Vibeke Telle-Hansen, PhD Less <<
NCT03563885 Obesity Insul... More >>in Resistance Less << Not Applicable Not yet recruiting October 2019 -
NCT03122041 PCOS Phase 4 Completed - -
NCT02617732 Type 2 Diabetes Mellitus Not Applicable Unknown February 2018 China, Beijing ... More >> Peking Union Medical College Hospital traditional Chinese medicine department Not yet recruiting Beijing, Beijing, China, 100730 Contact: Qian Zhang, Doctor    （86+）13810387388    qianqian0409@163.com    Contact: Zhen Tang, Master    （86+）18810941269    1225530172@qq.com Less <<
NCT00135434 HIV Infections Phase 1 Completed - United States, New Jersey ... More >> Clinical Pharmacology Unit, Bristol-Myers Squibb Company Hamilton, New Jersey, United States, 08690 Less <<
NCT00713440 Type 2 Diabetes Mellitus ... More >> Steroids Less << Not Applicable Completed - Denmark ... More >> Clinical Physiology Department; Glostrup Univesity Hospital Glostrup, Region Hovedstaden, Denmark, 2600 Less <<
NCT00486681 - Completed - France ... More >> University Hospital of Grenoble Grenoble, France, 38000 Less <<
NCT03104738 Type2 Diabetes Mellitus Not Applicable Completed - -
NCT03104738 - Completed - -
NCT00468494 - Completed - United States, New Jersey ... More >> University of Medicine & Dentistry of New Jersey Newark, New Jersey, United States, 07101 Less <<
NCT00483769 Cystic Fibrosis ... More >> Glucose Metabolism Disorders Less << Phase 4 Completed - Italy ... More >> Deptm of Pediatrics Regional Cystic Fibrosis Center- University of Naples - Federico II Naples, Italy, 80131 Less <<
NCT03458494 Type2 Diabetes ... More >> Glucose, High Blood Less << Not Applicable Recruiting February 15, 2021 United States, Massachusetts ... More >> JM-USDA Human Nutrition Research Center on Aging at Tufts University Recruiting Boston, Massachusetts, United States, 02111 Contact: Cheryl H Gilhooly, PHD, RD    617-556-3154    Cheryl.Gilhooly@tufts.edu Less <<
NCT01742741 Diabetes Mellitus, Type 1 Not Applicable Completed - France ... More >> Centre d'Investigation Clinique CHU Montipellier Montpellier, France, 34000 Less <<
NCT03701503 PYY Ghrelin ... More >> Appetite Gut Hormones Obesity VAS of Satiety VAS of Hunger GLP - 1 Less << Not Applicable Completed - Indonesia ... More >> Departement of Nutrition, Faculty of Medicine Universitas Indonesia Jakarta, Jakarta Pusat, Indonesia, 10110 Less <<
NCT00874133 Diabetic Gastroparesis Not Applicable Terminated(Completed due to lo... More >>w number of eligible patients) Less << - -
NCT00506298 Type 2 Diabetes Phase 2 Completed - Canada, British Columbia ... More >> Chilliwack, British Columbia, Canada Vancouver, British Columbia, Canada Canada, Manitoba Winnipeg, Manitoba, Canada Canada, Newfoundland and Labrador Bay Roberts, Newfoundland and Labrador, Canada Holyroad, Newfoundland and Labrador, Canada St. Johns, Newfoundland and Labrador, Canada Canada, Ontario Aylmer, Ontario, Canada Burlington, Ontario, Canada Collingwood, Ontario, Canada Corunna, Ontario, Canada Robarts Research Institute London, Ontario, Canada London, Ontario, Canada Newmarket, Ontario, Canada Sarnia, Ontario, Canada Sudbury, Ontario, Canada Toronto, Ontario, Canada Canada, Quebec Montreal, Quebec, Canada Canada, Saskatchewan Saskatoon, Saskatchewan, Canada Less <<
NCT00239707 Type 2 Diabetes Phase 1 Completed - United States, Maryland ... More >> National Institute on Aging, Clinical Research Branch Baltimore, Maryland, United States, 21225 Less <<
NCT00069784 Diabetes Mellitus, Non-Insulin... More >>-Dependent Less << Phase 3 Completed - -
NCT00669864 - Completed - -
NCT00069784 - Completed - -
NCT00669864 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 4 Completed - China, Beijing ... More >> Beijing, Beijing, China, 100034 Less <<
NCT02130505 Atherosclerosis ... More >> Leukocyte Activation Disorder Type 2 Diabetes Mellitus Familial Combined Hyperlipidemia Less << Not Applicable Completed - -
NCT03553524 Type 2 Diabetes ... More >> Insulin Independent Less << Not Applicable Not yet recruiting June 30, 2020 -
NCT01390259 Type 1 Diabetes Mellitus Not Applicable Completed - United States, Virginia ... More >> University of Virginia Health System Charlottesville, Virginia, United States, 22908 Less <<
NCT01390259 - Completed - -
NCT00417950 Diabetes Mellitus ... More >> Impaired Glucose Tolerance Less << Not Applicable Unknown - Taiwan ... More >> Taichung Veterans General Hospital Recruiting Taichung, Taiwan Contact: Wayne H Sheu, MD, PhD    886-4-23592525 ext 3068    whhsheu@vghtc.gov.tw    Principal Investigator: Wayne H Sheu, MD, PhD          Sub-Investigator: I Te Lee, MD, MS Less <<
NCT00687466 Cystic Fibrosis ... More >> Glucose Intolerance Less << Phase 3 Unknown October 2009 Italy ... More >> Pediatric Department, General Hospital,CF Center Cerignola (Foggia), Italy Ospedale Maggiore Policlinico, Adult CF Center Milano, Italy Pediatric Department, Federico II University, Pediatric CF Center Napoli, Italy Pediatric Department G.De Cristina Hospital CF Center Palermo, Italy Bambino Gesù Hospital CF Center Roma, Italy Policlinico Umberto I. CF Center Roma, Italy Less <<
NCT01648985 - Completed - Sweden ... More >> Karolinska Institutet, Daderyd Hospital Stockholm, Sweden, S-182 88 Less <<
NCT02592421 Type II Diabetes Mellitus Phase 3 Recruiting December 30, 2018 United States, Texas ... More >> University of Texas Health Science Center at San Antonio Recruiting San Antonio, Texas, United States, 78229 Contact: Ralph A DeFronzo, MD    210-567-6691    defronzo@uthscsa.edu    Contact: Monica Palomo, BS    210-567-6710    palomom@uthscsa.edu    Principal Investigator: Ralph A DeFronzo, MD Less <<
NCT03659383 Type2 Diabetes Phase 4 Not yet recruiting March 31, 2019 -
NCT02288611 Colon Cancer Not Applicable Completed - -
NCT01514305 - Completed - United States, Idaho ... More >> Rocky Mountain Diabetes and Osteoporosis Center Idaho Falls, Idaho, United States, 83404 Less <<
NCT01439672 - Completed - -
NCT00258128 Insulin Resistance Phase 2 Phase 3 Completed - -
NCT00287820 Schizophrenia ... More >> Diabetes Metabolic Syndrome Hyperglycemia Less << Phase 4 Completed - United States, New York ... More >> Manhattan Psychaitric Center New York, New York, United States, 10035 Less <<
NCT01439672 Type 1 Diabetes Mellitus Not Applicable Completed - United States, Virginia ... More >> University of Virginia, Center for Diabetes Technology Charlottesville, Virginia, United States, 22903 Less <<
NCT01170208 - Completed - -
NCT02392819 Postprandial Blood Glucose Reg... More >>ulation Less << Not Applicable Completed - Sweden ... More >> Food for Health Science Centre, Medicon Village Lund, Sweden, , SE-223 81 LUND Less <<
NCT03529344 Muscle Weakness ... More >> Muscle Loss Blood Sugar; High Inflammation Aging Less << Not Applicable Active, not recruiting December 2020 -
NCT03310476 Overweight and Obesity Not Applicable Recruiting January 2019 United States, Texas ... More >> Texas Woman's University Recruiting Houston, Texas, United States, 77030 Contact: Mindy A Patterson, PhD, RDN    713-794-2375    mmaziarz@twu.edu Less <<
NCT01640223 Type 1 Diabetes Not Applicable Completed - France ... More >> CHU Jean Minjoz Besancon, France, 25030 CHU de Caen Caen, France, 14000 Centre Hospitalier Sud Francilien Corbeil Essonnes, France, 91106 University Hospital Grenoble Grenoble, France, 38043 Chu Montpellier Montpellier, France, 34295 CHU de Nancy Nancy, France, 54500 CHU Toulouse Toulouse, France, 31403 Less <<
NCT03063515 Diabetes Mellitus Phase 1 Recruiting March 30, 2019 United States, Florida ... More >> Diabetes Research Institute Recruiting Miami, Florida, United States, 33136 Contact: Maria Solano    305-243-6145       Principal Investigator: Maria del Pilar Solano, MD Less <<
NCT02147314 - Completed - United States, California ... More >> Profil Institute for Clinical Research Chula Vista, California, United States, 91911 AMCR Institute Escondido, California, United States, 92026 Tri City Endocrinology Oceanside, California, United States, 92056 Less <<
NCT01850199 Gestational Diabetes Not Applicable Completed - Spain ... More >> Parc Tauli Sabadell University Hospital Sabadell, Barcelona, Spain, 08208 Less <<
NCT00044694 Diabetes Mellitus, Non-Insulin... More >>-Dependent Less << Phase 2 Completed - -
NCT01170208 Diabetes Insu... More >>lin Less << Not Applicable Completed - United States, Minnesota ... More >> International Diabetes Center Minneapolis, Minnesota, United States, 55416 Less <<
NCT01803568 Hyperglycemia ... More >> Normoglycemia Myokine Less << Not Applicable Completed - -
NCT02710461 Subjects With Abdominal Obesit... More >>y Less << Not Applicable Completed - Spain ... More >> Institute of Food Science, Technology and Nutrition, National Research Council (ICTAN-CSIC) Madrid, Spain, 28040 Less <<
NCT00835861 Non Insulin Dependent Diabetes... More >> Pregnancy Less << Phase 2 Completed - United States, North Carolina ... More >> University of North Carolina Hospitals Obstetric Clinics Chapel Hill, North Carolina, United States, 27599 Less <<
NCT00835861 - Completed - -
NCT01165268 Type 2 Diabetes Mellitus Phase 1 Completed - United States, California ... More >> Profil Institute For Clinical Research, Inc. Chula Vista, California, United States, 91911 Less <<
NCT02550145 Hypoglycemia Phase 1 Unknown - United States, California ... More >> Stanford University School of Medicine Recruiting Stanford, California, United States, 94305 Contact: Colleen Craig, M.D.    650-350-2153    cmcraig@stanford.edu Less <<
NCT01895179 Prediabetes I... More >>nsulin Resistance Vascular Diseases Less << Not Applicable Completed - United States, Louisiana ... More >> Pennington Biomedical Research Center Baton Rouge, Louisiana, United States, 70808 Less <<
NCT03579615 Diabetes Mellitus, Type 1 Not Applicable Not yet recruiting October 1, 2019 -
NCT00891995 Type 1 Diabetes Phase 2 Phase 3 Terminated(Primary outcome eva... More >>luation determined lack of treatment group difference) Less << - United States, California ... More >> Stanford University Stanford, California, United States, 94305 United States, Colorado Barbara Davis Center for Childhood Diabetes Aurora, Colorado, United States, 80010 United States, Connecticut Yale University New Haven, Connecticut, United States, 06519 United States, Indiana Indiana University Indianapolis, Indiana, United States, 46202 United States, Tennessee Vanderbilt University Nashville, Tennessee, United States, 37232 Less <<
NCT00891995 - Terminated(Primary outcome eva... More >>luation determined lack of treatment group difference) Less << - -
NCT03320993 Diabetes Mellitus, Type 1 Not Applicable Recruiting December 2019 Spain ... More >> Hospital Francesc de Borja Recruiting Gandia, Valencia, Spain, 46072 Contact: Paolo Rossetti, PhD          Sub-Investigator: Agustin Ramos Prol, PhD          Sub-Investigator: Alia García Castells, MD Less <<
NCT02835859 Diabetes Not Applicable Completed - United States, Florida ... More >> Translational Research Institute for Metabolism and Diabetes Orlando, Florida, United States, 32804 Less <<
NCT02834078 Pre Diabetes Not Applicable Completed - -
NCT00221156 Glucose Metabolism Disorders ... More >> Coronary Artery Disease Less << Phase 3 Completed - Japan ... More >> Institute of Biomedical Research and Innovation. Kobe, Hyogo Pref., Japan, 650-0047 Kobe City General Hospital/Institute of Biomedical Research and Innovation Kobe, Hyogo Pref., Japan, 650-0047 Kawasaki Medical School Hospital Kurashiki, Okayama, Japan, 701-0192 Less <<
NCT03046186 - Recruiting June 2017 Denmark ... More >> Hvidovre University Hospital Recruiting Hvidovre, Please Select, Denmark, 2650 Contact: Maria S Svane    38626357    Maria.Saur.Svane@regionh.dk    Principal Investigator: Sten Madsbad, MD, DMSc Less <<
NCT00713986 Pain Analgesi... More >>a Less << Phase 3 Completed - -
NCT01075022 Insulin Resistance ... More >> Glucose Intolerance Less << Not Applicable Unknown July 2010 Brazil ... More >> Hospital de Clínicas de Porto Alegre Porto Alegre, Rio Grande do Sul, Brazil, 90035-903 Less <<
NCT02155855 Type 1 Diabetes Not Applicable Active, not recruiting December 2018 United States, Texas ... More >> TTUHSC Pediatric Clinic Lubbock, Texas, United States, 79410 Less <<
NCT02040025 - Withdrawn October 2016 United States, California ... More >> David Grant USAF Medical Center Travis AFB, California, United States, 94535 Less <<
NCT00895570 Sleep Restriction ... More >> Impaired Glucose Metabolism Less << Not Applicable Completed - United States, Massachusetts ... More >> Brigham & Women's Hospital Boston, Massachusetts, United States, 02115 Less <<
NCT02479334 Healthy Phase 1 Phase 2 Completed - Sweden ... More >> Food for Health Laboratory - Lund University Lund, Skane, Sweden, 223 81 Less <<
NCT01904357 Infections Phase 1 Completed - United States, Arkansas ... More >> Arkansas Children's Hospital Little Rock, Arkansas, United States, 72205 United States, Ohio Toledo Children's Hospital Toledo, Ohio, United States, 43606 Less <<
NCT03385707 Hypoglycemia Not Applicable Not yet recruiting November 2018 -
NCT00546728 Impaired Glucose Tolerance Phase 4 Completed - United States, Minnesota ... More >> International Diabetes Center at Park Nicollet St. Louis Park, Minnesota, United States, 55416 St. Paul Heart Clinic St. Paul, Minnesota, United States, 55102 Less <<
NCT00798915 Diabetes Phase 1 Completed - United States, Missouri ... More >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Less <<
NCT00546728 - Completed - -
NCT03503084 Physiological Effect of TCC on... More >> Glucose Metabolism Less << Not Applicable Completed - Taiwan ... More >> Wan-An Lu Ilan, Taiwan Less <<
NCT00708175 Bone Metabolism Phase 4 Completed - -
NCT01919385 Type 1 Diabetes Phase 1 Completed - United States, California ... More >> Samsum Diabetes Reserach Inst. Santa Barbara, California, United States, 93105 Less <<
NCT00708175 - Completed - -
NCT00949663 Type 2 Diabetes Mellitus Phase 1 Completed - United States, Missouri ... More >> Washington University School of Medicine St. Louis, Missouri, United States, 63110 Less <<
NCT03717935 Polycystic Ovarian Syndrome ... More >> Obesity Hepatic Steatosis Less << Not Applicable Not yet recruiting September 2021 United States, Colorado ... More >> University of Colorado, Anschutz Medical Campus Aurora, Colorado, United States, 80045 Less <<
NCT00106119 Thyroid Diseases Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT02370745 Sarcopenia Not Applicable Completed - United Kingdom ... More >> Division of Medical Sciences and Graduate Entry Medicine - School of Medicine - University of Nottingham Derby, United Kingdom, DE22 3DT Less <<
NCT00004451 Parkinson Disease COMPLETED - University of Virginia, Charlo... More >>ttesville, Virginia, 22908, United States Less <<
NCT02307695 Type 1 Diabetes Phase 4 Unknown March 2017 China, Jiangsu ... More >> First Affiliated Hospital, Nanjing Medical University Recruiting Nanjing, Jiangsu, China, 210029 Contact: Tao Yang, PhD    86-25-83718836 ext 6466    yangt@njmu.edu.cn    Principal Investigator: Tao Yang, PhD Less <<
NCT00106119 - Completed - -
NCT02320526 Diabetes Mellitus, Type 2 Not Applicable Completed - Denmark ... More >> The Centre for Physical Activity Research, Rigshospitalet Copenhagen, Denmark, 2100 Less <<
NCT00878878 Pulmonary Hypertension Phase 4 Completed - United States, Maryland ... More >> ICON Development Solutions Elliott City, Maryland, United States, 21043 Less <<
NCT02545842 Type 2 Diabetes Mellitus Phase 4 Completed - China ... More >> Investigational Site Number 156053 Anshan, China Investigational Site Number 156001 Beijing, China Investigational Site Number 156002 Beijing, China Investigational Site Number 156006 Beijing, China Investigational Site Number 156013 Changchun, China, 130033 Investigational Site Number 156014 Changchun, China, 130033 Investigational Site Number 156022 Changde, China, 415000 Investigational Site Number 156017 Changsha, China Investigational Site Number 156034 Changzhou, China Investigational Site Number 156023 Chenzhou, China Investigational Site Number 156026 Guangzhou, China, 510515 Investigational Site Number 156029 Haikou, China, 570102 Investigational Site Number 156028 Haikou, China Investigational Site Number 156040 Haikou, China Investigational Site Number 156039 Hangzhou, China, 310013 Investigational Site Number 156038 Hangzhou, China Investigational Site Number 156042 Hangzhou, China Investigational Site Number 156044 Hangzhou, China Investigational Site Number 156048 Hefei, China Investigational Site Number 156050 Hefei, China Investigational Site Number 156011 Kunming, China Investigational Site Number 156052 Kunming, China Investigational Site Number 156016 Lanzhou, China Investigational Site Number 156041 Lishui, China Investigational Site Number 156020 Nanchang, China, 330006 Investigational Site Number 156018 Nanchang, China Investigational Site Number 156019 Nanchang, China Investigational Site Number 156031 Nanjing, China Investigational Site Number 156043 Nanjing, China Investigational Site Number 156049 Nanjing, China Investigational Site Number 156035 Shanghai, China Investigational Site Number 156036 Shanghai, China Investigational Site Number 156047 Shanghai, China Investigational Site Number 156027 Shantou, China Investigational Site Number 156015 Shenyang, China Investigational Site Number 156054 Shijiazhuang, China Investigational Site Number 156007 Tangshan, China, 063000 Investigational Site Number 156010 Tianjin, China, 300032 Investigational Site Number 156055 Wuhan, China, 430000 Investigational Site Number 156037 Xuzhou, China Investigational Site Number 156033 Yangzhou, China Investigational Site Number 156030 Yueyang, China Investigational Site Number 156032 Zhenjiang, China, 212001 Investigational Site Number 156025 Zhuzhou, China, 412000 Less <<
NCT02979106 Hereditary Fructose Intoleranc... More >>e Fructose Metabolism, Inborn Errors Glucose Metabolism Disorders Less << Not Applicable Completed - -
NCT02970851 - Recruiting January 2019 Switzerland ... More >> Centre Hospitalier Universitaire Vaudois Recruiting Lausanne, Vaud, Switzerland, 1011 Less <<
NCT02401152 Gastric Distress ... More >> Running Performance Less << Not Applicable Completed - Netherlands ... More >> InnoSportlab Papendal Arnhem, Gelderland, Netherlands, 6816VD Less <<
NCT02306343 Diabetes Mellitus Not Applicable Unknown September 2015 Israel ... More >> InsuLine Medical Recruiting Petach Tikva, Israel, 4900202 Less <<
NCT01715818 Cardiovascular Disease, Diabet... More >>es Mellitus Type 2 Less << Phase 3 Completed - -
NCT00878878 - Completed - -
NCT02102048 HIV Not Applicable Unknown July 2014 Italy ... More >> Department of Public Heath and Infectious Diseases. University of Rome "Sapienza" (Italy) Rome, Italy, 00161 Less <<
NCT00913497 Type 1 Diabetes Mellitus Phase 4 Completed - United States, Michigan ... More >> Helen DeVos Childrens Hospital Grand Rapids, Michigan, United States, 49503 Less <<
NCT02937558 Congenital Hyperinsulinism Phase 2 Completed - United States, California ... More >> UCLA Mattel Children's Hospital Los Angeles, California, United States, 90095 UCSF School of Medicine, Division of Pediatric Endocrinology San Francisco, California, United States, 94143 United States, Missouri Washington University, St. Louis Children's Hospital Saint Louis, Missouri, United States, 63130 United States, Texas Cook Children's Medical Center Fort Worth, Texas, United States, 76104 Baylor College of Medicine, Texas Children's Hospital Houston, Texas, United States, 77030 Less <<
NCT03331757 Potential Abnormality of Gluco... More >>se Tolerance Appetitive Behavior Less << Not Applicable Completed - Greece ... More >> Agricultural University of Athens Athens, Greece, 11855 Less <<
NCT00612625 Diabetes Mellitus Type 2 Not Applicable Completed - Denmark ... More >> Dept. of Endocrinology, Hvidovre Hospital Copenhagen, Denmark Less <<
NCT03181399 GLUT1DS1 Epil... More >>epsy Glut1 Deficiency Syndrome 1, Autosomal Recessive Glucose Metabolism Disorders Glucose Transport Defect Glucose Transporter Type 1 Deficiency Syndrome Glucose Transporter Protein Type 1 Deficiency Syndrome Less << Phase 2 Recruiting May 30, 2023 United States, Texas ... More >> University of Texas Southwestern Medical Center Recruiting Dallas, Texas, United States, 75390 Contact: Juan Pascual, MD    214-648-5155    rare.diseases@utsouthwestern.edu    Contact: Adrian Avila, BS    214-648-5155    rare.diseases@utsouthwestern.edu Less <<
NCT01240252 Type 2 Diabetes Mellitus Phase 1 Completed - United States, Arizona ... More >> Mayo Clinic in Arizona Scottsdale, Arizona, United States, 85259 Less <<
NCT00348972 Hyperglycemia ... More >> Diabetes Mellitus Less << Phase 1 Completed - United States, New Jersey ... More >> Sanofi-Aventis Bridgewater, New Jersey, United States, 08807 Less <<
NCT01960205 Prediabetes Phase 4 Unknown - China, Shandong ... More >> Shandong Provincial Hospital Recruiting Jinan, Shandong, China, 250021 Contact: Xinli Zhou, MD, PhD    15168889976    zhouxinli0301@163.com    Principal Investigator: Xinli Zhou, MD,PhD Less <<
NCT02907190 Impaired Glucose Tolerance Not Applicable Completed - Canada, Ontario ... More >> Glycemic Index Laboratories, Inc Toronto, Ontario, Canada, M5C 2N8 Less <<
NCT00325650 Prediabetic State Phase 3 Terminated(Company decision ta... More >>ken in light of demands by certain national health authorities) Less << - United States, New Jersey ... More >> Sanofi-Aventis Bridgewater, New Jersey, United States, 08807 Less <<
NCT00786175 - Withdrawn December 2018 China ... More >> Hong Kong Institute of Diabetes and Obesity Hong Kong, China Less <<
NCT01168089 - Completed - United States, New Mexico ... More >> InLight Solutions Albuquerque, New Mexico, United States, 87106 Less <<
NCT00107601 Critical Illness Not Applicable Completed - Belgium ... More >> C.H.U. Erasme Bruxelles, Belgium University Hospital Gasthuisberg Leuven, Belgium Centre Hospitalier Universitaire de Liège Liege, Belgium, 4000 France Hopital Raymond Poincare Garches, France Université Joseph Fournier Grenoble, France Institut Gustave Roussy Villejuif, France Germany Universität Ulm Ulm, Germany Israel Rabin Medical Center Patah Tiqwa, Israel Netherlands V.U.Z. Amsterdam Amsterdam, Netherlands Spain Hospital Universitario General Negrin Las Palmas de Gran Canaria, Spain Switzerland C.H.U. Vaudois Lausanne, Switzerland Less <<
NCT02934893 Diabetes Mellitus Not Applicable Unknown November 2016 -
NCT02935985 - Recruiting June 2019 Romania ... More >> Emergency Clinical County Hospital Cluj-Napoca - Emergency Department Recruiting Cluj-Napoca, Cluj, Romania, 400554 Contact: Eugenia M Muresan, MD, PhD stud    0040-748-451-098    muresan.eugenia@umfcluj.ro    Contact: Adela Golea, MD, PhD    0040-745-657-100    adela.golea@umfcluj.ro    Principal Investigator: Adela Golea, MD, PhD          Emergency Clinical County Hospital Cluj-Napoca - Neurology ward Recruiting Cluj-Napoca, Cluj, Romania, 400554 Contact: Nicoleta Tohanean, MD, PhD    0040-726-170-444    nicoleta_alexa@yahoo.com    Principal Investigator: Nicoleta Tohanean, MD, PhD          Spitalul Clinic Judetean de Urgenta Targu Mures Recruiting Targu Mures, Mures, Romania, 540136 Contact: Rodica I Balasa, MD, PhD    0040265216375    rodica.balasa@umftgm.ro    Contact: Zoltan Bajko, MD, PhD    0040745409787    bzoltan2003@yahoo.com    Sub-Investigator: Zoltan Bajko, MD, PhD Less <<
NCT01049152 - Unknown December 2014 Italy ... More >> IRCCS Policlinico San Matteo Recruiting Pavia, Italy, 27100 Contact: Giuseppe Derosa, MD, PhD       giuseppe.derosa@unipv.it    Contact: Pamela Maffioli, MD       pamelamaffioli@hotmail.it    Principal Investigator: Giuseppe Derosa, Md, PhD          Sub-Investigator: Pamela Maffioli, MD Less <<
NCT01972113 Obesity Insul... More >>in Resistance Insulin Sensitivity Prediabetes Dyslipidemia Diabetes Less << Phase 1 Phase 2 Recruiting December 2018 United States, Georgia ... More >> Medical College of Georgia; Augusta University Recruiting Augusta, Georgia, United States, 30909 Principal Investigator: Norman K Pollock, Ph.D. Less <<
NCT02956369 Obesity Not Applicable Recruiting August 2019 Switzerland ... More >> St Claraspital Recruiting Basel, Switzerland, 4016 Contact: Bettina Woelnerhanssen, MD       bettina.woelnerhanssen@usb.ch    Principal Investigator: Bettina Woelnerhanssen, MD Less <<
NCT01193543 Overweight Phase 2 Phase 3 Completed - Norway ... More >> University of Tromso Tromso, Norway, 9037 Less <<
NCT02514954 Type 1 Diabetes Mellitus Phase 1 Completed - Germany ... More >> Profil Institut für Stoffwechselforschung GmbH Neuss, Germany, 41460 Less <<
NCT02037100 - Unknown - Israel ... More >> Sourasky Medical Center Recruiting Tel-Aviv, Israel Less <<
NCT02508844 Pregnancy Obe... More >>sity Gestational Diabetes Mellitus Less << Phase 4 Unknown October 2017 Denmark ... More >> Hvidovre University Hospital Recruiting Hvidovre, Copenhagen, Denmark, 2650 Contact: Andreas M Petersen, MD, PhD       andreas.munk.petersen@regionh.dk    Contact: Sofie I Halkjær, Msc       sofiehalkjaer@gmail.com Less <<
NCT01932944 - Completed - United States, California ... More >> Diablo Clinical Research Walnut Creek, California, United States, 94598 United States, Washington Rainier Clinical Research Center Rainier, Washington, United States, 98057 Less <<
NCT01227460 Type 1 Diabetes Not Applicable Completed - United States, Colorado ... More >> University of Colorado/Barbara Davis Center for Diabetes Aurora, Colorado, United States, 80045 Less <<
NCT03359629 - Completed - Israel ... More >> Tirat Carmel Mental Health Center Tirat Karmel, Haifa, Israel, 30200 Less <<
NCT03704337 Healthy Not Applicable Completed - United States, Texas ... More >> Exercise & Sport Nutrition Lab - Human Clinical Research Facility College Station, Texas, United States, 77845 Less <<
NCT01421225 Type 1 Diabetes Mellitus Not Applicable Completed - United States, Massachusetts ... More >> Children's Hospital Boston Boston, Massachusetts, United States, 02115 Less <<
NCT01073137 - Unknown June 2010 United States, Oregon ... More >> Portland VA Medical Center Recruiting Portland, Oregon, United States, 97239 Contact: Peter G Jacobs, MSEE    503-220-8262 ext 55949    Peter.Jacobs@va.gov    Sub-Investigator: Peter G Jacobs, MSEE Less <<
NCT01421225 - Completed - -
NCT00883415 - Completed - United States, Maryland ... More >> Baltimore VA Medical Center Baltimore, Maryland, United States, 21201 Less <<
NCT02426073 - Recruiting December 2018 Italy ... More >> Catholic University of Sacred Heart Recruiting Rome, Italy, 00168 Contact: Andrea Giaccari, MD, PhD    00390630156664    giaccari@rm.unicatt.it    Sub-Investigator: Andrea Giaccari, MD, PhD          Principal Investigator: Giovambattista Pani, MD, PhD          Ospedale San Giovanni Calibita - Fatebenefratelli Isola Tiberina Not yet recruiting Rome, Italy, 00186 Contact: Simona Frontoni, MD       frontoni@uniroma2.it Less <<
NCT01928329 Type I Diabetes Phase 2 Active, not recruiting August 2018 United States, California ... More >> University of California, San Francisco San Francisco, California, United States United States, Colorado Barbara Davis Center Aurora, Colorado, United States United States, Connecticut Yale University New Haven, Connecticut, United States United States, Florida University of Miami Miami, Florida, United States, 33136 United States, Illinois University of Chicago Chicago, Illinois, United States United States, Massachusetts Joslin Diabetes Center Boston, Massachusetts, United States, 02215 United States, Michigan University of Michigan Ann Arbor, Michigan, United States, 48105 United States, New York SUNY Upstate Medical University Syracuse, New York, United States, 13210 Less <<
NCT01922804 Metabolic Bone Disorder Not Applicable Unknown April 2018 Denmark ... More >> Department of Endocrinology and Internal Medicine THG Aarhus, Denmark, 8000 Less <<
NCT01627210 - Completed - United States, California ... More >> Catalina Research Institute Chino, California, United States, 91710 Diabetes and Endocrine Associate La Mesa, California, United States, 91942 Infosphere West Hills, California, United States, 91307 United States, Nevada Desert Endocrinology Clinical Research Center Henderson, Nevada, United States, 89052 Less <<
NCT02061124 Type 2 Diabetes Not Applicable Completed - Denmark ... More >> Diabetes Research Division, Gentofte Hospital, Copenhagen Hellerup, Denmark, 2900 Less <<
NCT01843855 Type 2 Diabetes Mellitus Early Phase 1 Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905-0001 Less <<
NCT03153930 Sedentary Lifestyle ... More >> Metabolic Disturbance Pediatric Obesity Physical Activity Less << Not Applicable Recruiting June 30, 2020 United States, California ... More >> University of Southern California Keck School of Medicine Recruiting Los Angeles, California, United States, 90032 Contact: Britni R Belcher, PhD, MPH    323-442-8225    bbelcher@usc.edu    Contact: Lissette Ramirez, MPH    323 442 7357    lissettr@usc.edu    Sub-Investigator: Genevieve F Dunton, PhD, MPH          Sub-Investigator: Michael Goran, PhD          Sub-Investigator: Jimi Huh, PhD          Sub-Investigator: Kathleen A Page, MD          Sub-Investigator: Christina Dieli-Conwright, PhD          Sub-Investigator: Megan Herting, PhD Less <<
NCT02315300 Electrocardiography Not Applicable Completed - Germany ... More >> Medizinische Klinik I Aachen, North Rhine Westphalia, Germany, 52074 Less <<
NCT00779298 - Completed - Sweden ... More >> Dept. of Medicine, Malmö University Hospital, Malmö, Skåne, Sweden, 205 02 Less <<
NCT01238224 Type 2 Diabetes Phase 1 Terminated(Durability of study... More >> medications could not be guaranteed after the expire date.) Less << - Sweden ... More >> The Wallenberg Laboratory, Dept of Molecular and Clinical Medicine, Sahlgrenska University Hospital, Bruna stråket 16, Göteborg, Sweden, SE 413 45 Less <<
NCT01477216 Glucose Metabolism Not Applicable Unknown December 2013 -
NCT01168115 - Completed - United States, New Mexico ... More >> InLight Solutions Albuquerque, New Mexico, United States, 87106 Less <<
NCT01085773 Type 2 Diabetes ... More >> Exercise Less << Phase 2 Completed - Denmark ... More >> Department of Endocrinology, Hospital of Southwest Denmark Esbjerg, Syddanmark, Denmark, 6700 Less <<
NCT00566319 Prediabetic State Not Applicable Completed - United Kingdom ... More >> University Hospitals of Leicester Leicester, United Kingdom, LE1 5WW Less <<
NCT01137773 Acute, Non-traumatic Subarachn... More >>oid Hemorrhage Intraparenchymal Hemorrhage Brain Injuries Less << Phase 4 Terminated(Slow enrollment) - United States, Kentucky ... More >> University of Louisville Hospital Louisville, Kentucky, United States, 40202 Less <<
NCT01488279 - Completed - -
NCT02225951 Gestational Diabetes Mellitus ... More >>in Pregnancy Less << Not Applicable Terminated(Current protocol is... More >> not optimal/feasible) Less << - Singapore ... More >> KK Women's and Children's Hospital Singapore, Singapore, 229899 Less <<
NCT01488279 Pre-diabetes ... More >>Impaired Fasting Glucose Impaired Glucose Tolerance Less << Not Applicable Completed - United States, Vermont ... More >> University of Vermont Clinical Research Center South Burlington, Vermont, United States, 05403 Less <<
NCT01137773 - Terminated(Slow enrollment) - -
NCT00948168 Type 2 Diabetes Mellitus Phase 4 Completed - Belgium ... More >> Cliniques universitaires St-Luc Brussels, Brabant, Belgium, 1200 Less <<
NCT01034540 Hypertriglyceridemia Not Applicable Completed - United States, Illinois ... More >> Provident Clinical Research (now Biofortis) Addison, Illinois, United States, 60101 Less <<
NCT01947699 Gestational Diabetes Phase 4 Withdrawn(PI decided to withdr... More >>awal study before recruitment started) Less << - United States, Pennsylvania ... More >> Magee Womens Hospital of UPMC Pittsburgh, Pennsylvania, United States, 15213 Less <<
NCT00910767 Type 1 Diabetes Not Applicable Completed - United Kingdom ... More >> Addenbrooke's Hospital Cambridge, United Kingdom, CB2 0QQ Less <<
NCT00649909 - Completed - Israel ... More >> Hadassah Medical Organization Jerusalem, Israel Less <<
NCT01034540 - Completed - -
NCT03589495 Systemic Inflammatory Response... More >> Syndrome Less << Phase 4 Completed - -
NCT02659995 - Recruiting May 2019 Italy ... More >> University ICU, AOU Ospedali Riuniti Ancona Recruiting Ancona, Marche, Italy, 60126 Contact: Abele Donati, MD    +390715964603    a.donati@univpm.it    Principal Investigator: Abele Donati, MD Less <<
NCT00533559 Diabetes Insu... More >>lin Resistance Less << Phase 4 Completed - Canada, Ontario ... More >> Toronto General Hospital Toronto, Ontario, Canada, M5G 2C4 Less <<
NCT01559896 Arterial Stiffness ... More >> Dietary Modification Impaired Glucose Tolerance Type 2 Diabetes Mellitus Less << Not Applicable Completed - Netherlands ... More >> PreCare Trial & Recruitment Beek, Limburg, Netherlands, 6191 JW Less <<
NCT00810823 - Completed - Denmark ... More >> Hvidovre Hospital Hvidovre, Denmark, 2650 Less <<
NCT01327209 - Completed - United States, California ... More >> University of San Diego San Diego, California, United States, 92161 United States, Florida University of Miami - School of Medicine Miami, Florida, United States, 33136 United States, Minnesota Park Nicollett Institute - International Diabetes Center Minneapolis, Minnesota, United States, 55416 United States, Texas Cetero Research DGD San Antonio, Texas, United States, 78229 Less <<
NCT01180712 Type 2 Diabetes Not Applicable Recruiting September 2018 United Kingdom ... More >> University of Aberdeen Rowett Institute of Nutrition and Health Recruiting Aberdeen, United Kingdom, AB21 9SB Principal Investigator: Nigel Hoggard, PhD Less <<
NCT02146404 Type 1 Diabetes Mellitus ... More >> Hypoglycemia Unawareness Less << Not Applicable Completed - Netherlands ... More >> Radboud umc Nijmegen, Netherlands Less <<
NCT01203111 Diabetes Mellitus, Type 2 Phase 4 Completed - Algeria ... More >> Administrative office Algiers, Algeria Brazil Administrative office Sao Paulo, Brazil Israel Administrative office Natanya, Israel Lebanon Administrative office Beirut, Lebanon Mexico Administrative office Col. Coyoacan, Mexico Morocco Administrative office Casablanca, Morocco Peru Administrative office Lima, Peru Saudi Arabia Administrative office Jeddah, Saudi Arabia United Arab Emirates Administrative office Dubaï, United Arab Emirates Venezuela Administrative office Caracas, Venezuela Less <<
NCT00220961 Impaired Glucose Tolerance ... More >> Type 2 Diabetes Less << Phase 3 Completed - United States, Arizona ... More >> Carl T. Hayden VA Medical Center Phoenix, Arizona, United States, 85012 United States, California USC-Keck School of Medicine Los Angeles, California, United States, 90033 University of California San Diego-San Diego VA Medical Center San Diego, California, United States, 92161 United States, District of Columbia Georgetown University Washington, District of Columbia, United States, 20007 United States, Louisiana Pennington Biomedical Research Center Baton Rouge, Louisiana, United States, 70808 United States, New York SUNY Health Science Center Brooklyn, New York, United States, 11203 United States, Tennessee University of Tennessee Memphis, Tennessee, United States, 38163 United States, Texas Texas Diabetes Institute San Antonio, Texas, United States, 78207 Less <<
NCT00220961 - Completed - -
NCT01933490 Hyperinsulinemic Hypoglycemia Not Applicable Completed - United States, Minnesota ... More >> University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT01017965 - Terminated(intermediary analys... More >>is was performed and significant results were found for the main objective) Less << - France ... More >> Service de Diabétologie du Pr Halimi, CHU Grenoble Cedex 9, France, 38043 Less <<
NCT02438657 Surgery Phase 4 Recruiting November 3, 2018 France ... More >> Centre Hospitalier de la Côte Basque Recruiting Bayonne, France, 64100 Contact: Eric Dufour, MD          Hopital privé de l'Ouest Parisien Recruiting Trappes, France, 78190 Contact: Souhail JAZIRI, MD          Principal Investigator: Souhail JAZIRI, MD Less <<
NCT01569724 Hypertriglyceridemia ... More >> Cutaneous T Cell Lymphoma Less << Phase 4 Completed - France ... More >> Service de dermatologie - Hôpital de Pontchaillou Rennes, France, 35033 Less <<
NCT03538327 Hypertension Phase 4 Completed - -
NCT00870831 - Terminated(PI left University) - -
NCT02413424 Obesity Not Applicable Completed - United States, Illinois ... More >> University of Illinois at Urbana Champaign Urbana, Illinois, United States, 61801 Less <<
NCT02733484 Obesity Not Applicable Recruiting December 2017 China, Shanghai ... More >> Shanghai 10th People's Hospital Recruiting Shanghai, Shanghai, China, 200072 Contact: Cuiling Zhu, MD    18817951953    1263856671@qq.com    Contact: Renyuan Gao, MD       renyuangao@126.com    Principal Investigator: Huanlong Qin, PhD          Principal Investigator: Shen Qu, PhD Less <<
NCT00976261 Diabetes Mellitus, Type 2 Phase 1 Completed - United States, Florida ... More >> GSK Investigational Site Miami, Florida, United States, 33169 United States, Louisiana GSK Investigational Site Baton Rouge, Louisiana, United States, 70808 United States, Ohio GSK Investigational Site Cincinnati, Ohio, United States, 45212 France GSK Investigational Site Gières, France, 38610 GSK Investigational Site Rueil-Malmaison, France, 92502 Germany GSK Investigational Site Neuss, Nordrhein-Westfalen, Germany, 41460 GSK Investigational Site Berlin, Germany, 14050 GSK Investigational Site Hamburg, Germany, 22769 United Kingdom GSK Investigational Site Cambridge, Cambridgeshire, United Kingdom, CB2 2GG Less <<
NCT00333853 Diabetes Not Applicable Completed - United States, California ... More >> Diabetes and Endocrine Associates La Jolla, California, United States, 92037 Children's Hospital, Los Angeles Los Angeles, California, United States, 90027 United States, Florida University of Miami Miller School of Medicine Miami, Florida, United States, 33136 United States, Maryland University of Maryland School of Medicine Baltimore, Maryland, United States, 21201 United States, Massachusetts Joslin Diabetes Center Boston, Massachusetts, United States, 02215 United States, Missouri Washington University School of Medicine St. Louis, Missouri, United States, 63110 United States, Oregon Radiant Research Portland, Oregon, United States, 97239 Less <<
NCT01681173 Diabetes Nutr... More >>ition Disorders Obesity Overweight Metabolic Syndrome x Body Weight Glucose Metabolism Disorders Metabolic Diseases Less << Not Applicable Completed - Germany ... More >> German Instiute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany, 14558 Charite University Berlin, Germany, 12200 Less <<
NCT02438397 Type 2 Diabetes Phase 4 Unknown October 2016 China, Shanghai ... More >> the 6th affliliated hospital of Shanghai Jiaotong university Recruiting Shanghai, Shanghai, China, 200233 Less <<
NCT00678431 Alzheimer's Disease Phase 3 Completed - United States, New York ... More >> James J. Peters VA Medical Center, Bronx, NY Bronx, New York, United States, 10468 Less <<
NCT01464346 Type 1 Diabetes Mellitus ... More >> Type 2 Diabetes Mellitus Less << Not Applicable Completed - United States, California ... More >> Profil Institute for Clinical Research Chula Vista, California, United States, 91911 AMCR Institue Escondido, California, United States, 92026 University of California, San Diego La Jolla, California, United States, 92093 Diablo Clinical Research Walnut Creek, California, United States, 94598 United States, Colorado University of Colorado Denver/Barbara Davis Center for Childhood Diabetes Aurora, Colorado, United States, 80045 United States, Oregon Oregon Health & Science University Portland, Oregon, United States, 97239 United States, Washington Rainier Clinical Research Center Renton, Washington, United States, 98057 Less <<
NCT01464346 - Completed - -
NCT01528189 Surgical Site Infection After ... More >>Major Surgery Less << Not Applicable Recruiting January 2019 Canada, Quebec ... More >> Royal Victoria Hospital, McGill University Health Centre Recruiting Montreal, Quebec, Canada, H3A 1A1 Contact: Ralph Lattermann, MD PhD    514-934-1934 ext 35802    ralph.lattermann@muhc.mcgill.ca    Contact: Thomas Schricker, MD PhD    514-934-1934 ext 36057    thomas.schricker@mcgill.ca    Principal Investigator: Ralph Lattermann, MD PhD          Sub-Investigator: Thomas Schricker, MD PhD          Sub-Investigator: George Carvalho, MD MSc          Sub-Investigator: Peter Metrakos, MD          Sub-Investigator: Linda Wykes, PhD          Sub-Investigator: Mazen Hassanain, MD          Royal Victoria Hospital Not yet recruiting Montreal, Quebec, Canada, H3A1A1 Contact: Ralph Lattermann, MD PhD    514-934-1934 ext 37023    ralph.lattermann@gmail.com    Contact: Thomas Schricker, MD PhD    514-934-1934 ext 36057    thomas.schricker@mcgill.ca    Sub-Investigator: Roupen Hatzakorzian, MD          Sub-Investigator: Peter Metrakos, MD          Sub-Investigator: Prosanto Chaudhury, MD MSc          Sub-Investigator: Charles Frenette, MD          Chile Hospital Clinico Universidad de Chile Not yet recruiting Independencia, Santiago, Chile, 8380456 Contact: Daniela B Advis, M.D.    +5629788211    dbravoadvis@uchile.cl Less <<
NCT02931643 Healthy Not Applicable Completed - Sweden ... More >> Food for Health Science Centre, Lund University Lund, Skåne, Sweden, 22381 Less <<
NCT02241889 Type 1 Diabetes Not Applicable Completed - United States, Oregon ... More >> Oregon Health and Science University Portland, Oregon, United States, 97239 Less <<
NCT01456650 Type 2 Diabetes Phase 4 Completed - Mexico ... More >> Instituto Nacional de Ciencias Medicas y Nutricion Mexico City, DF, Mexico, 14000 Less <<
NCT02488018 Hyperglycemia, Postprandial Early Phase 1 Completed - -
NCT02926079 - Recruiting December 2020 United States, Louisiana ... More >> Pennington Biomedical Research Center Recruiting Baton Rouge, Louisiana, United States, 70808 Contact: Nicholas Broskey, PhD    225-763-3141    nick.broskey@pbrc.edu Less <<
NCT02488018 - Completed - -
NCT02190669 - Completed - United States, California ... More >> Sansum Diabetes Research Institute Santa Barbara, California, United States, 93105 Less <<
NCT00667498 Pediatric Obesity ... More >> Insulin Resistance Hyperinsulinemia Less << Phase 4 Completed - United States, Connecticut ... More >> Yale Center for Clinical Investigation (YCCI) New Haven, Connecticut, United States, 06511 Less <<
NCT02241889 - Completed - -
NCT02095873 Glucose Intolerance ... More >> Aortic Stiffness Vasodilation Less << Phase 1 Phase 2 Completed - United Kingdom ... More >> University Hospitals Coventry & Warwickshire NHS Trust (UHCW) Coventry, Warwickshire, United Kingdom, CV22DX Less <<
NCT00027092 - Completed - United States, California ... More >> Univ of Southern California / LA County USC Med Ctr Los Angeles, California, United States, 900331079 Univ of California San Francisco San Francisco, California, United States, 94110 United States, Hawaii Univ of Hawaii Honolulu, Hawaii, United States, 96816 United States, Illinois Rush Presbyterian - Saint Luke's Med Ctr Chicago, Illinois, United States, 60612 United States, Indiana Indiana Univ Hosp Indianapolis, Indiana, United States, 462025250 Methodist Hosp of Indiana / Life Care Clinic Indianapolis, Indiana, United States, 46202 Wishard Hosp Indianapolis, Indiana, United States, 46202 United States, New York Bellevue Hosp / New York Univ Med Ctr New York, New York, United States, 10016 Less <<
NCT01708044 Type 1 Diabetes Phase 1 Completed - United States, Oregon ... More >> Research Site Portland, Oregon, United States Less <<
NCT02095873 - Completed - -
NCT03414333 Glucose Metabolism Disorders ... More >> Obesity Degenerative Brain Disorder Less << Not Applicable Completed - Italy ... More >> Dept.Clinical and Experimental Medicine.Section of Diabetes. Pisa, Italy Less <<
NCT03241706 Hypoglycemia; Iatrogenic Phase 1 Not yet recruiting May 31, 2022 -
NCT01749163 Extra-pancreatic Incretin Effe... More >>ct Glucose Effectiveness Less << Not Applicable Completed - Denmark ... More >> Rigshospitalet Copenhagen, Capital Region, Denmark, 2100 Less <<
NCT02389127 - Completed - United States, Arkansas ... More >> University of Arkansas for Medical Sciences Little Rock, Arkansas, United States, 72205 Less <<
NCT02313090 Diabetes Mellitus Not Applicable Completed - -
NCT01803724 - Unknown December 2014 Chile ... More >> Department of Gastroenterology, Pontificia Universidad Catolica de Chile Not yet recruiting Santiago, Metropolitan, Chile, 8330024 Contact: Daniel Cisternas, MD    56-2-3543820    dcisterc@gmail.com Less <<
NCT02014207 Obesity Overw... More >>eight Diabetes Metabolic Syndrome Less << Not Applicable Completed - Canada, Ontario ... More >> Department of Nutritional Sciences Toronto, Ontario, Canada, M5S 3E2 Less <<
NCT01889355 Diabetes Mellitus Not Applicable Completed - United States, Georgia ... More >> Atlanta Diabetes Associates Atlanta, Georgia, United States, 30318 Less <<
NCT01910441 Type 2 Diabetes Mellitus Phase 4 Terminated(The study was termi... More >>nated due to the unavailability of Continuous Glucose Monitoring sensors (CGMS) which were required to assess the primary end-point.) Less << - -
NCT01910441 - Terminated(The study was termi... More >>nated due to the unavailability of Continuous Glucose Monitoring sensors (CGMS) which were required to assess the primary end-point.) Less << - -
NCT01890629 Type 2 Diabetes Mellitus Phase 4 Completed - Korea, Republic of ... More >> Severance hospital Seoul, Korea, Republic of, 120-752 Less <<
NCT01339637 - Completed - United States, Alabama ... More >> Radiant Research Birmingham, Alabama, United States United States, Georgia Radiant Research Atlanta, Georgia, United States United States, Illinois Radiant Research Chicago, Illinois, United States United States, Maryland Accelovance Rockville, Maryland, United States United States, Missouri Radiant Research Kansas City, Missouri, United States Less <<
NCT03669796 Healthy Volunteers Not Applicable Completed - Norway ... More >> Haukeland University Hospital Bergen, Norway Ålesund Hospital, Helse Møre og Romsdal HF Ålesund, Norway Less <<
NCT02695810 Prediabetic State ... More >> Obesity Less << Phase 2 Recruiting February 2019 Denmark ... More >> Steno Diabetes Center A/S Recruiting Gentofte, Denmark, 2820 Contact: Kristine Færch, PhD    +4530791461    krif@steno.dk    Contact: Marit E Jørgensen, PhD    +4530756008    maej@steno.dk    Sub-Investigator: Hanan Amadid, MD          Sub-Investigator: Lea B Nielsen, MSc Less <<
NCT02108197 Gestational Diabetes ... More >> Sleep Apnea Less << Not Applicable Completed - Thailand ... More >> Faculty of Medicine Ramathibodi Hospital Bangkok, Thailand, 10400 Less <<
NCT00370643 Hyperglycaemia During Perioper... More >>ative Period Heart Valve Diseases Ventricular Dysfunction Less << Phase 1 Completed - Brazil ... More >> Heart Institute, Hospital of Clinics, São Paulo University Medical School São Paulo, Brazil, 05403-000 Less <<
NCT03222791 Pre Diabetes Not Applicable Recruiting August 2018 Israel ... More >> The Weizmann Institute of Science Recruiting Rehovot, Israel Contact: Orly Ben-Yacov       orlyby@weizmann.ac.il Less <<
NCT01889355 - Completed - -
NCT01667185 - Completed - United States, California ... More >> Advanced Metabolic Care and Research Escondido, California, United States, 92026 CHOC Children's Orange, California, United States, 92868 Stanford University Stanford, California, United States, 94305 United States, Colorado Barbara Davis Center Aurora, Colorado, United States, 80045 United States, Idaho Rocky Mountain Diabetes and Osteoporosis Center, PA Idaho Falls, Idaho, United States, 83404 United States, Massachusetts Joslin Diabetes Center Boston, Massachusetts, United States, 02215 Less <<
NCT02770833 Overweight Not Applicable Completed - Denmark ... More >> Department of Nutrition, Exercise and Sports Copenhagen, Frederiksberg, Denmark, 1958 Less <<
NCT03383068 PCOS Impaired... More >> Glucose Tolerance Less << Phase 4 Not yet recruiting June 30, 2020 China, Shanghai ... More >> Renji Hospital Department of Endocrinology and Metabolism Not yet recruiting Shanghai, Shanghai, China, 200127 Contact: Wei Liu, MD    +86-18918358342    sue_liuwei@163.com Less <<
NCT00897169 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 1 Completed - Denmark ... More >> Novo Nordisk Investigational Site København ø, Denmark, 2100 Japan Novo Nordisk Investigational Site Tokyo, Japan, 113-8655 Less <<
NCT01730885 Diabetes Mellitus Phase 4 Completed - Germany ... More >> Profil Institut für Stoffwechselforschung GmbH Neuss, NRW, Germany, 41460 Less <<
NCT00633282 Nonalcoholic Fatty Liver Disea... More >>se Less << Phase 2 Completed - China, Shanghai ... More >> Endocrinology and Metabolism Department, Zhongshan Hospital, Fudan University, Shanghai, Shanghai, China, 200032 Department of Endocrinology and Metabolism,Shanghai Clinical Center of Diabetes,Shanghai Institute of Diabetes,The sixth people's Hospital Affiliated to Shanghai Jiaotong University Shanghai, Shanghai, China, 200233 Department of Endocrinology and Metabolism,The Fifth People's Hospital，Fudan University Shanghai, Shanghai, China, 200240 Less <<
NCT02465411 Diabetes Mellitus Type 1 Not Applicable Completed - Sweden ... More >> Alingsås Hospital Alingsås, Sweden Angered Hospital Angered, Sweden Helsingborg Hospital Helsingborg, Sweden Öbackakliniken Härnösand, Sweden Central Hospital Kristianstad Kristianstad, Sweden Halland Hospital Kungsbacka Kungsbacka, Sweden Skåne University Hospital Malmö Malmö, Sweden Hospital in Motala Motala, Sweden Vrinnevi Hospital Norrköping, Sweden Södersjukhuset Stockholm, Sweden Hospital Trelleborg Trelleborg, Sweden NU Hospital Group Uddevalla, Sweden Academic Hospital Uppsala Uppsala, Sweden Ängelholm Hospital Ängelholm, Sweden University Hospital Örebro Örebro, Sweden Less <<
NCT02955888 Cystic Fibrosis Phase 2 Terminated(Unsatisfactory rate... More >> of recruitment) Less << - Canada, British Columbia ... More >> St. Paul's Hospital - Pacific Lung Health Centre (PLHC) Vancouver, British Columbia, Canada Canada, Nova Scotia Queen Elizabeth II Health Science Center Halifax, Nova Scotia, Canada Canada, Ontario Ottawa Hospital Research Institute Ottawa, Ontario, Canada St. Michael's Hospital Toronto, Ontario, Canada Canada, Quebec Institut de Recherches Cliniques de Montréal (IRCM) Montreal, Quebec, Canada Centre de Recherche du Centre Hospitalier Universitaire de Sherbrooke Sherbrooke, Quebec, Canada Canada Institut Universitaire de Cardiologie et de Pneumologie de l'Université Laval (IUCPQ) Quebec, Canada Less <<
NCT01630928 Hypertension, Resistant to Con... More >>ventional Therapy Less << Not Applicable Completed - Norway ... More >> University Hospital of North Norway Tromsø, Norway, N-9038 Less <<
NCT02930681 Hyperglycemia, Postprandial Not Applicable Completed - Germany ... More >> analyze & realize GmbH Berlin, Germany, D-13467 Less <<
NCT00230464 Type 2 Diabetes Mellitus Phase 3 Completed - United States, Texas ... More >> Audie L Murphy VA Hospital San Antonio, Texas, United States, 78229 Less <<
NCT00814190 Type 2 Diabetes Mellitus Not Applicable Completed - Canada, British Columbia ... More >> St. Paul's Hospital Vancouver, British Columbia, Canada, V6Z 1Y6 Less <<
NCT02555332 - Completed - -
NCT01241253 Blood Glucose ... More >> Type 2 Diabetes Mellitus Less << Phase 2 Completed - United States, Arizona ... More >> Arizona State University, Nutrition Program Mesa, Arizona, United States, 85212 Less <<
NCT02692144 Peak Rise of Blood Glucose Not Applicable Completed - -
NCT02741687 Hyperglycemia Phase 4 Completed - United States, Georgia ... More >> Grady Memorial Hospital Atlanta, Georgia, United States, 30303 Emory University Hospital Midtown Atlanta, Georgia, United States, 30322 Less <<
NCT02741687 - Completed - -
NCT02723110 - Unknown July 2016 United Kingdom ... More >> OCDEM, University of Oxford Recruiting Oxford, Oxfordshire, United Kingdom, OX3 7LE Contact: Fredrik Karpe    01865 857222    fredrik.karpe@ocdem.ox.ac.uk    Contact: Mahesh M Umapathysivam       mahesh.umapathysivam@spc.ox.ac.uk    Principal Investigator: Fredrik Karpe          Sub-Investigator: Mahesh Umapathysivam          Sub-Investigator: Anna Gloyn          Sub-Investigator: Mark McCarthy          Sub-Investigator: Patrik Rorsman Less <<
NCT02685969 - Recruiting March 1, 2020 Spain ... More >> BarcelonaBeta Brain Research Center Recruiting Barcelona, Catalunya, Spain, 08005 Contact: Karine Fauria, PhD    +34933160990    kfauria@fpmaragall.org    Contact: Carolina Herrero    +34933160990    cherrero@fpmaragall.org    Principal Investigator: Jose Luis Molinuevo, MD, PhD          Sub-Investigator: Juan Domingo Gispert, PhD Less <<
NCT01306955 Behcet's Disease Phase 4 Unknown August 2011 Iran, Islamic Republic of ... More >> Rheumatology Research Center, Tehran University of Medical Science Recruiting Tehran, Iran, Islamic Republic of, 1411713135 Contact: Shahram Farhad, Professor    0098-21-8802-6956    Shahramf@tums.ac.ir    Contact: Mastaneh Mohammadi, MD    0098-21-8802-6956    Mastanehmohammadi88@gmail.com Less <<
NCT03212157 Head and Neck Squamous Cell Ca... More >>rcinoma Lymphoma Glioma Less << Not Applicable Recruiting June 1, 2018 United Kingdom ... More >> University College London Hospital Recruiting London, United Kingdom, NW1 2PG Contact: Sola Adeleke, MBBS       Sola.Adeleke@uclh.nhs.uk Less <<
NCT03711656 Type1diabetes ... More >> Hypoglycemia Less << Not Applicable Recruiting April 30, 2019 Spain ... More >> Hospital Clínic de Barcelona Recruiting Barcelona, Catalonia, Spain, 08036 Contact: Ignacio Conget Donlo, MD    932279846    iconget@clinic.cat    Contact: Clara Viñals Domenech    +342279846    vinals@clinic.cat    Principal Investigator: Ignacio Conget Donlo, MD, PhD          Sub-Investigator: Clara Viñals Domenech, MD          Sub-Investigator: Arthur Bertachi, Msc          Principal Investigator: Josep Vehí, PhD          Sub-Investigator: Marga Giménez Álvarez, MD, PhD Less <<
NCT01296100 Type 2 Diabetes ... More >> Glucose Metabolism Disorders Less << Not Applicable Completed - Colombia ... More >> Camino Bosques de María Barranquilla, Colombia Camino Sur Occidente El Pueblo Barranquilla, Colombia Centro de INvestigacion Sanitaria Barranquilla, Colombia Paso Las Malvinas Barranquilla, Colombia Paso Nueva Era Barranquilla, Colombia Less <<
NCT02796248 - Completed - Canada, Alberta ... More >> Alberta Children's Hospital Calgary, Alberta, Canada, T3B 6A8 Canada, British Columbia British Columbia Children's Hospital Vancouver, British Columbia, Canada, V6H 3V4 Canada, Quebec Centre Hospitalier Universitaire Sainte-Justine Montreal, Quebec, Canada, H3T 1C5 McGill University Health Centre Montreal, Quebec, Canada, H4A 3J1 Less <<
NCT00653510 Type 2 Diabetes Mellitus Not Applicable Completed - Denmark ... More >> Department M (Endocrinology and Diabetes), Aarhus University Hospital Aarhus, Denmark, 8000 Less <<
NCT00039013 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT00039026 Diabetes Mellitus, Non-Insulin... More >>-Dependent Less << Phase 3 Completed - -
NCT00802971 Hypoglycemia Not Applicable Completed - -
NCT00334568 Alzheimer's Disease Phase 2 Terminated(Slow recruitment) - United Kingdom ... More >> GSK Investigational Site Cambridge, Cambridgeshire, United Kingdom, CB2 2EF Less <<
NCT03340285 Cardiovascular Risk Factor Not Applicable Not yet recruiting April 2018 -
NCT00085969 Diabetes Mellitus, Type 2 Phase 2 Completed - -
NCT01686815 - Unknown December 2015 United States, Massachusetts ... More >> Freedom Trail Clinic Recruiting Boston, Massachusetts, United States, 02114 Contact: Liana J Petruzzi, BA    617-912-7882    lpetruzzi@partners.org    Contact: Leah N Briggs, BS    617-912-7848    lbriggs@partners.org    Principal Investigator: David C Henderson, MD Less <<
NCT00776347 Dementia With Lewy Bodies (DLB... More >>) Less << Not Applicable Completed - Japan ... More >> Osaka University Hospital Suita,, Osaka, Japan, 565-0871 Less <<
NCT03173495 Sedentary Lifestyle ... More >> Dyslipidemias Lipid Metabolism Disorders Carbohydrate Inducible Hyperlipemia Less << Not Applicable Completed - -
NCT02497651 Diabetes Mellitus Not Applicable Completed - Denmark ... More >> Center for Diabetes Research, Department of Medicine, Gentofte Hospital Hellerup, Copenhagen, Denmark, 2900 Less <<
NCT03685201 Healthy Not Applicable Active, not recruiting October 13, 2019 United States, Illinois ... More >> Clinical Nutrition Research Center Chicago, Illinois, United States, 60616 Less <<
NCT00013910 Diabetes Mellitus, Non-Insulin... More >>-Dependent Less << Phase 1 Completed - United States, Michigan ... More >> University of Michigan Ann Arbor, Michigan, United States, 48109 Less <<
NCT02164981 Schizophrenia Phase 2 Completed - United States, Massachusetts ... More >> Schizophrenia Clinical Research Program, Massachusetts General Hospital Boston, Massachusetts, United States, 02114 University of Massachusetts Medical School Worcester, Massachusetts, United States, 01605 United States, New York Zucker Hillside Hospital Glen Oaks, New York, United States, 11004 New York University Langone Medical Center/Bellevue Hospital New York, New York, United States, 10016 Less <<
NCT00625040 - Terminated(Not enough patients... More >> in the follow-up period) Less << - Denmark ... More >> Glostrup Hospital Glostrup, Denmark, 2600 Less <<
NCT00502645 Hyperglycemia ... More >> Critically Ill Patients Less << Not Applicable Completed - Austria ... More >> Medical University Graz Graz, Austria, 8036 Less <<
NCT02654938 Prostate Cancer Phase 1 Completed - Russian Federation ... More >> Federal State Budgetary Institution "Russian Oncological Research Center named after N. N. Blokhin" of the Russian Academy of Sciences Moscow, Russian Federation Moscow Scientific Research Institute of Oncology named after P. A. Hertsen of the Ministry of Health of the Russian Federation Moscow, Russian Federation Moscow State Budgetary Healthcare Institution "City Clinical Hospital № 57" of Moscow Healthcare Department Moscow, Russian Federation Moscow State University of Medicine and Dentistry Moscow, Russian Federation Federal State Budgetary Institution "Saint Petersburg Clinical Scientific and Practical Center for Special types of medical care (Oncological)" Saint Petersburg, Russian Federation Federal State Budgetary Institution "Scientific Research Oncology Institute named after N.N. Petrov" of the Ministry of Health of the Russian Federation Saint Petersburg, Russian Federation Less <<
NCT02164981 - Completed - -
NCT00035984 Diabetes Mellitus, Non-Insulin... More >>-Dependent Less << Phase 3 Completed - -
NCT02088424 - Unknown April 2015 Egypt ... More >> Ain shams maternity hospital Not yet recruiting Cairo, Egypt Contact: ABDELLATIF G ELKHOLY, M D          Principal Investigator: ABDELLATIF G ELKHOLY, M D Less <<
NCT02697305 Glucose Metabolism Disorders Not Applicable Completed - Czech Republic ... More >> Centre for Research on Diabetes, Metabolism and Nutrition, 3rd Faculty of Medicine, Charles University in Prague Prague 10, Czech Republic, 100 34 Less <<
NCT01249157 - Terminated(Lack of accrual) - -
NCT00221052 Overweight Ob... More >>esity Inflammation Less << Not Applicable Completed - Netherlands ... More >> TNO Quality of Life Zeist, Netherlands, 3700 AJ Less <<
NCT03263325 - Recruiting August 1, 2019 United States, Massachusetts ... More >> Boston Children's Hospital Recruiting Boston, Massachusetts, United States, 02115 Contact: Douglas Atkinson, MD    617-355-6225    douglas.atkinson@childrens.harvard.edu Less <<
NCT03506932 Post-prandial Glycaemic Respon... More >>se Less << Not Applicable Not yet recruiting March 2020 Canada, Manitoba ... More >> I. H. Asper Clinical Research Institute Winnipeg, Manitoba, Canada, R2H 2A6 Less <<
NCT00726505 Diabetes, NOS Phase 1 Terminated - United States, Texas ... More >> University Of Texas Health Center At San Antonio San Antonio, Texas, United States, 78229 Less <<
NCT02451189 Obesity Overw... More >>eight Less << Not Applicable Completed - United Kingdom ... More >> Glasgow Clinical Research Facility Glasgow, Lanarkshire, United Kingdom, G4 0SF Less <<
NCT01249157 Breast Cancer Not Applicable Terminated(Lack of accrual) - United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00323349 Prediabetic State Not Applicable Completed - United States, Virginia ... More >> Ghent Family Practice Norfolk, Virginia, United States, 23507 Portsmouth Family Medicine Portsmouth, Virginia, United States, 23707 Less <<
NCT01165853 Metabolic Syndrome ... More >> Insulin Resistance Dyslipidemia Less << Not Applicable Completed - United States, California ... More >> Clinical Research Center Sacramento, California, United States, 95655 Less <<
NCT00465751 Metabolic Syndrome ... More >> Familial Hypertriglyceridemia Familial Combined Hyperlipidemia Less << Early Phase 1 Completed - Switzerland ... More >> University Hospital Basel Basel, Switzerland, 4031 Less <<
NCT02625363 Healthy Not Applicable Unknown December 2015 Indonesia ... More >> PT Nutrifood Indonesia Recruiting Jakarta, DKI Jakarta, Indonesia, 13920 Contact: Astri Kurniati, MAppSc       astri@nutrifood.co.id Less <<
NCT01916863 Healthy Subjects Phase 1 Completed - United States, California ... More >> Lexicon Investigational Site Chula Vista, California, United States, 91911 Less <<
NCT03750695 Pregnancy Complications ... More >> Obesity Pre-Eclampsia Gestational Diabetes Less << Not Applicable Recruiting June 30, 2020 United States, Missouri ... More >> Washington University Recruiting Saint Louis, Missouri, United States, 63110 Contact: William T Cade, PhD    314-286-1432    tcade@wustl.edu    Contact: Kay Bohnert    3143622407    bohnertk@wustl.edu Less <<
NCT00753142 - Completed - -
NCT01410851 Metabolic Syndrome Not Applicable Completed - Canada, Ontario ... More >> Department of Nutritional Sciences, University of Toronto Toronto, Ontario, Canada, M5S 3E2 Less <<
NCT00753142 Diabetes Mellitus, Type 2 Not Applicable Completed - United States, Georgia ... More >> Grady Memorial Hospital Atlanta, Georgia, United States, 30303 Less <<
NCT01975883 - Completed - France ... More >> Hopital Beaujon Clichy, Hauts-de-Seine, France, 92110 Less <<
NCT00553488 Diabetes Mellitus, Type 1 Phase 2 Completed - Germany ... More >> Profil Institut fur Stoffwechselforschung GmbH Neuss, Germany, D-41460 Less <<
NCT02980250 Feeding Intolerance ... More >> Premature Birth Domperidone Overdose Gastric Retention Less << Phase 4 Completed - China, Guangdong ... More >> Nanfang Hospital of Southern Medical University Guangzhou, Guangdong, China, 510000 Less <<
NCT03306810 Dysglycemia A... More >>rthroplasty Complications Less << Not Applicable Recruiting December 31, 2025 Finland ... More >> Päijät-Häme Central Hospital Recruiting Lahti, Finland, 15850 Contact: Marianne Ylikoski, MD    +358447195268    marianne.ylikoski@phhyky.fi    Contact: Raine Tiihonen, MD, PhD    +3584406151    raine.tiihonen@phhyky.fi Less <<
NCT01851694 Cystic Fibrosis ... More >> Pancreatic Insufficiency Less << Not Applicable Recruiting September 2019 United States, Pennsylvania ... More >> Children's Hospital of Philadelphia and University of Pennsylvania Recruiting Philadelphia, Pennsylvania, United States, 19060 Contact: Christina Kubrak    267-426-5135    kubrak@email.chop.edu    Principal Investigator: Michael Rickels, M.D., M.S          Principal Investigator: Andrea Kelly, M.D, M.S. Less <<
NCT03204877 Glucose Metabolism Disorders Phase 1 Phase 2 Recruiting March 1, 2020 Denmark ... More >> Aarhus University Hospital Recruiting Aarhus, Denmark, 8000 Contact: Ulla Kampmann          Contact: Julie Stoy          Principal Investigator: Ulla Kampmann, MD, PhD          Sub-Investigator: Julie Stoy, MD, PhD Less <<
NCT02414529 Vitamin D Deficiency Not Applicable Completed - United States, New York ... More >> bellevue hospital CTSI New York, New York, United States, 10016 Less <<
NCT03177096 Type1diabetes Not Applicable Active, not recruiting May 2018 France ... More >> GHRMSA Mulhouse, France, 68100 Less <<
NCT02403427 Type 1 Diabetes Mellitus With ... More >>Hyperglycemia Type 1 Diabetes Mellitus With Hypoglycaemia Less << Not Applicable Unknown December 2015 Poland ... More >> Ewa Pankowska Recruiting Warsaw, Poland, 04-736 Contact: Katarzyna Ruszkowska    +48226164474    ruszkowska.kasia@gmail.com    Principal Investigator: Ewa Pankowska, PhD          Sub-Investigator: Karolina Mazurczak, MD          Sub-Investigator: Piotr Foltynski, PhD Less <<
NCT00264940 - Unknown - -
NCT00451334 - Unknown - Israel ... More >> Assaf-Harofeh Medical Center Not yet recruiting Zrifin, Israel, 70300 Contact: Hanna Levy, PhD    +972-6-388-837    hanna@qsitemed.com    Principal Investigator: Shai Efrati, MD Less <<
NCT01936025 Type 2 Diabetes Mellitus Phase 2 Completed - Germany ... More >> Profil Institut für Stoffwechselforschung GmbH Neuss, Germany, 41460 Less <<
NCT03316690 Impaired Glucose Tolerance ... More >> Diabetes Mellitus, Type 2 Less << Not Applicable Completed - Denmark ... More >> Center for aktiv sundhed Copenhagen, Copenhagen N, Denmark, 2200 Less <<
NCT03117543 - Recruiting - United Kingdom ... More >> Clinical Research Facility, King's College Hospital NHS Foundation Trust Recruiting London, United Kingdom, SE5 9PJ Contact: Elka Giemza       rgiemza@nhs.net Less <<
NCT02739906 Type 1 Diabetes Mellitus Phase 1 Phase 2 Completed - Germany ... More >> Profil Mainz GmbH & Co.KG Mainz, Germany, 44116 Profil GmbH Neuss, Germany, 41460 Less <<
NCT00926094 - Completed - Israel ... More >> Hadassah Medical Organization Jerusalem, Israel Less <<
NCT01621776 Type 1 Diabetes Not Applicable Completed - United States, Florida ... More >> Camp Winona DeLeon Springs, Florida, United States, 32130 Less <<
NCT01128205 - Completed - China ... More >> Peking Univresity People's Hospital Beijing, China Less <<
NCT00282659 Coronary Artery Disease ... More >> Hypertension Dyslipidemia Diabetes Less << Phase 4 Unknown June 2008 United States, Connecticut ... More >> Hartford Hospital Recruiting Hartford, Connecticut, United States, 06102-5037 Contact: Charles M White, PharmD    860-545-2221    Cmwhite@harthosp.org    Contact: Jeffrey Kluger, MD    860-545-2883    Jkluger@harthosp.org    Principal Investigator: Charles M White, PharmD          Sub-Investigator: Jeffrey Kluger, MD          Sub-Investigator: Nickole N Henyan, PharmD          Sub-Investigator: Stephen D Sander, PharmD          Sub-Investigator: Effie L Gillespie, PharmD          Sub-Investigator: Christopher A Clyne, MD          Sub-Investigator: Craig I Coleman, PharmD Less <<
NCT01295788 Type 1 Diabetes Not Applicable Active, not recruiting December 2017 Canada, Ontario ... More >> McMaster Children's Hospital Hamilton, Ontario, Canada, L8S 4J9 Children's Hospital of Western Ontario London, Ontario, Canada, N5Y 3T2 Markham-Stouffville Hospital Markham, Ontario, Canada, L3P 7P3 Children's Hospital of Eastern Ontario Ottawa, Ontario, Canada, K1H 8L1 Hospital for Sick Children Toronto, Ontario, Canada, M5G 1X8 Less <<
NCT03741972 - Not yet recruiting December 2021 Spain ... More >> Germans Trias i Pujol University Hospital Not yet recruiting Badalona, Spain Contact: Antoni Bayés Genís Less <<
NCT02791035 Type 2 Diabetes Mellitus Phase 4 Completed - Korea, Republic of ... More >> Asan Medical Center Seoul, Korea, Republic of Less <<
NCT01117311 Type 2 Diabetes ... More >> Obesity Gastric Emptying Less << Not Applicable Completed - United States, Minnesota ... More >> Mayo Clinic in Rochester Rochester, Minnesota, United States, 55905 Less <<
NCT01621776 - Completed - -
NCT02205996 Type 2 Diabetes Mellitus Not Applicable Completed - United Kingdom ... More >> Hull Royal Infirmary Hull, United Kingdom, HU3 2RW Less <<
NCT03306706 Post-prandial Glycaemic Respon... More >>se Satiety Less << Not Applicable Recruiting August 2019 Canada, Manitoba ... More >> I.H. Asper Clinical Research Institute Recruiting Winnipeg, Manitoba, Canada, R2H2A6 Contact: Heather Blewett, Ph.D    204-237-2954    hblewett@sbrc.ca    Contact: Jay Petkau       jpetkau@sbrc.ca    Sub-Investigator: Dan Ramdath, Ph.D          Sub-Investigator: Sora Ludwig, MD          Sub-Investigator: Michel Aliani, Ph.D Less <<
NCT00256256 Type 2 Diabetes ... More >> Stroke Myocardial Infarction Less << Not Applicable Completed - Denmark ... More >> Department of pharmacology, Aarhus university Aarhus, Denmark, 8000 Less <<
NCT00596063 Diabetes Mellitus Phase 1 Completed - United States, California ... More >> Profil Institute for Clinical Research Inc. Chula Vista, California, United States, 91911 Profil Institute for Clinical Research, Inc. Chula Vista, California, United States, 91911 Less <<
NCT02573662 - Unknown June 2016 Denmark ... More >> Amager University Hospital Recruiting Copenhagen, Denmark, 2300 Contact: Steen B Haugaard, MD, DMSc    +45 53555066    sbhau@dadlnet.dk Less <<
NCT00927524 Type 1 Diabetes Not Applicable Completed - -
NCT00572806 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 4 Completed - France ... More >> Novo Nordisk Investigational Site MONTPELLIER cedex 5, France, 34295 Less <<
NCT01888991 Food Intake Regulation ... More >> Substrate Oxidation Less << Not Applicable Completed - Canada, Ontario ... More >> Department of Nutritional Sciences, University of Toronto Toronto, Ontario, Canada, M5S 3E2 Less <<
NCT01117311 - Completed - -
NCT01439854 Insulin Sensitivity ... More >> Multiple Mitochondrial Dysfunctions Syndrome Less << Not Applicable Completed - United States, Texas ... More >> Diabetes Division, UTHSCSA San Antonio, Texas, United States, 78229 Less <<
NCT03306927 Post-prandial Glycaemic Respon... More >>se Satiety Less << Not Applicable Recruiting August 2019 Canada, Manitoba ... More >> I.H. Asper Clinical Research Institute Recruiting Winnipeg, Manitoba, Canada, R2H2A6 Contact: Heather Blewett, Ph.D    204-237-2954    hblewett@sbrc.ca    Contact: Jay Petkau       jpetkau@sbrc.ca    Sub-Investigator: Dan Ramdath, Ph.D          Sub-Investigator: Sora Ludwig, MD          Sub-Investigator: Michel Aliani, Ph.D Less <<
NCT00001489 - Completed - United States, Maryland ... More >> National Institute of Neurological Disorders and Stroke (NINDS) Bethesda, Maryland, United States, 20892 Less <<
NCT00741390 Diabetes Mellitus, Type 1 ... More >> Diabetes Mellitus, Type 2 Less << Not Applicable Completed - United States, Colorado ... More >> Thomas J. Stephens & Associates Colorado Springs, Colorado, United States, 80915-3540 United States, New Jersey TKL Research, Inc. Carlstadt, New Jersey, United States, 07072 TKL Research, Inc Paramus, New Jersey, United States, 07652 TKL Research, Inc. Ramsey, New Jersey, United States, 07446 Less <<
NCT01586065 Type 1 Diabetes Not Applicable Completed - United States, Florida ... More >> Nemours Children's Clinic Jacksonville, Florida, United States, 32207 Less <<
NCT02929654 Diabetes Mellitus Not Applicable Completed - United Kingdom ... More >> Diabetes Centre, Heartlands Hospital Birmingham, United Kingdom, B9 5SS NHS Lothian Edinburgh, United Kingdom, EH16 4SA Highland Diabetes Institute Inverness, United Kingdom, IV2 3JH Less <<
NCT00302302 Blood Glucose Phase 1 Completed - Denmark ... More >> Institute of Human Nutrition, The Royal Veterinary and Agricultural University Frederiksberg, Denmark, DK-1958 Less <<
NCT02005978 - Unknown December 2017 Denmark ... More >> National University Hospital, Department of Medical Endocrinology Copenhagen, Denmark, DK-2100 Less <<
NCT00741390 - Completed - -
NCT03111953 Obesity, Morbid Not Applicable Completed - Italy ... More >> Catholic University of the Sacred Heart Rome, Italy, 00128 Less <<
NCT03306862 Post-prandial Glycaemia Not Applicable Recruiting August 2019 Canada, Manitoba ... More >> I.H. Asper Clinical Research Institute Recruiting Winnipeg, Manitoba, Canada, R2H2A6 Contact: Heather Blewett, Ph.D    204-237-2954    hblewett@sbrc.ca    Contact: Jay Petkau       jpetkau@sbrc.ca    Sub-Investigator: Dan Ramdath, Ph.D          Sub-Investigator: Sora Ludwig, MD          Sub-Investigator: Michel Aliani, Ph.D Less <<
NCT02923323 Diabetes Mellitus, Type 1 Not Applicable Unknown October 2017 Israel ... More >> Assaf Haroffeh Medical center Recruiting Zerifin, Israel, 70300 Contact: Marianna Rachmiel, MD    972-8-9542007    rmarianna@gmail.com    Sub-Investigator: Renana Gelernter, Md Less <<
NCT02330731 Gastric Varices Not Applicable Completed - -
NCT01871870 Type 1 Diabetes Mellitus Phase 2 Completed - United States, Oregon ... More >> Legacy Research Institute Portland, Oregon, United States, 97232 Less <<
NCT02079870 Diabetes Meta... More >>bolism and Nutrition Disorder Obesity Less << Phase 1 Completed - United Kingdom ... More >> Novo Nordisk Investigational Site Leeds, United Kingdom, LS2 9LH Less <<
NCT02688933 Type 1 Diabetes Mellitus Phase 4 Completed - -
NCT01871870 - Completed - -
NCT02145442 Overweight Ob... More >>esity Less << Phase 2 Phase 3 Completed - Cuba ... More >> National Institute of Endocrinology Plaza de la Revolución, Havana, Cuba, 10400 Less <<
NCT02035241 Healthy Not Applicable Completed - Sweden ... More >> Antidiabetic Food Centre (Medicon Village) - Lund University Lund, Skane, Sweden, 22381 Less <<
NCT02688933 - Completed - -
NCT01839370 Diabetes Mellitus, Type 1 Not Applicable Completed - United States, Virginia ... More >> University of Virginia Charlottesville, Virginia, United States, 22908 Less <<
NCT03387345 Blood Glucose ... More >> Dietary Fiber Hunger Less << Not Applicable Completed - United States, Arizona ... More >> Arizona Biomedical Collaborative Phoenix, Arizona, United States, 85004 Less <<
NCT00675740 Impaired Glucose Tolerance Phase 4 Completed - -
NCT02116075 no Conditions Phase 2 Unknown - United States, California ... More >> Veteran'S Affairs Healthy System Recruiting Long Beach, California, United States Contact: NAVEED NATANZI, DO       NNATANZI@UCI.EDU Less <<
NCT01373216 Coronary Artery Disease ... More >> Decreased Left Ventricular Function Less << Phase 3 Completed - Czech Republic ... More >> General University Hospital Prague, Czech Republic, 128 08 Less <<
NCT01865760 Obesity Hypog... More >>lycemia Surgery Less << Not Applicable Unknown March 2016 Denmark ... More >> Department of Endocrinology, Aarhus University Hospital Recruiting Aarhus C, Denmark, 8000 Contact: Joan Bach Nielsen, Dr    0045+24818454    joanni@rm.dk    Sub-Investigator: Joan Bach Nielsen, MD Less <<
NCT02931578 Healthy Not Applicable Active, not recruiting June 2019 United States, Connecticut ... More >> Yale Center for Clinical Investigation Church Street Research Unit New Haven, Connecticut, United States, 06511 Less <<
NCT00749827 Contrast Induced Nephropathy Phase 4 Withdrawn(No funding received) - Canada, Alberta ... More >> University of Alberta Hospital Edmonton, Alberta, Canada, T6G 2G3 Canada, Newfoundland and Labrador Memorial University of Newfoundland St. John's, Newfoundland and Labrador, Canada, A1S 1B9 Less <<
NCT01364766 - Completed - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT02245906 Healthy Phase 1 Phase 2 Completed - Sweden ... More >> Antidiabetic Food Centre (Medicon Village) - Lund University Lund, Skåne, Sweden, 221 00 Less <<
NCT03182842 Type 1 Diabetes Mellitus ... More >> Hypoglycemia Hyperglycemia Less << Not Applicable Completed - Slovenia ... More >> Medical Faculty - University of Ljubljana Ljubljana, Slovenia, 1000 Less <<
NCT03640026 Kidney Failure, Chronic Phase 4 Not yet recruiting January 2020 France ... More >> Centre Hospitalier Départemental Vendée Not yet recruiting La Roche-sur-Yon, France Principal Investigator: Awena LE FUR          Centre Hospitalier Universitaire Nantes Not yet recruiting Nantes, France Principal Investigator: Jacques DANTAL Less <<
NCT01789307 Focus of Study: Oral Tolerance... More >> Test With Glucose, Lactose, Sucrose Less << Not Applicable Completed - Canada, British Columbia ... More >> Child & Family Research Institute Vancouver, British Columbia, Canada, V5Z4H4 Less <<
NCT01606423 Healthy Volunteers Phase 1 Completed - Singapore ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Singapore, Singapore Less <<
NCT02636192 - Completed - -
NCT00499954 - Completed - Austria ... More >> Medical University Graz - Clinical Research Center Graz, Styria, Austria, 8010 Less <<
NCT02513277 - Completed - United Kingdom ... More >> Diabetes Research Centre, University of Leicester Leicester, United Kingdom, LE5 4PW Less <<
NCT02814123 Diabetes Mellitus, Type 1 Phase 2 Recruiting June 30, 2018 Canada, Quebec ... More >> McGill University Health Centre Recruiting Montréal, Quebec, Canada Contact: Natalia Strauss    514-398-4491    natalia.strauss@mcgill.ca    Contact: Sarah Twardy       sarah.bernier-twardy@mail.mcgill.ca    Sub-Investigator: Ahmad Haidar          Principal Investigator: Laurent Legault Less <<
NCT01440140 Type 1 Diabetes Mellitus Phase 2 Completed - United Kingdom ... More >> Addenbrooke's Hospital Cambridge, United Kingdom, CB2 0QQ King's College London London, United Kingdom, SE5 9RJ Northern General Hospital Sheffield, United Kingdom, S5 7AU Less <<
NCT00515723 Schizophrenia ... More >> Schizoaffective Disorder Type 2 Diabetes Mellitus Hyperglycemia Less << Phase 4 Completed - United States, Missouri ... More >> Washington Univeristy School of Medicine St. Louis, Missouri, United States, 63110 Washington University School of Medicine, Psychiatry Dept. St. Louis, Missouri, United States, 63110 Less <<
NCT01460797 Obesity Not Applicable Completed - Brazil ... More >> School of Health Sciences, University of Brasília Brasília, DF, Brazil, 70910-900 Less <<
NCT01341067 - Completed - United States, Idaho ... More >> Rocky Mountain Diabetes and Osteoporosis Center Idaho Falls, Idaho, United States, 83404 Less <<
NCT01341067 - Completed - -
NCT02829593 Type 1 Diabetes ... More >> Healthy Less << Not Applicable Not yet recruiting July 2020 United States, Minnesota ... More >> University of Minnesota Not yet recruiting Minneapolis, Minnesota, United States, 55455 Contact: Anjali Kumar, PA-C    612-301-7040    studydiabetes@umn.edu    Principal Investigator: Elizabeth Seaquist, MD Less <<
NCT00145392 - Completed - Denmark ... More >> Department of Endocrinology, Odense University Hospital Odense, Funen, Denmark, 5000 Less <<
NCT01293396 Type 2 Diabetes Phase 4 Completed - Austria ... More >> Medical University of Graz, Department for Internal Medicine Graz, Austria, 8036 Less <<
NCT02340507 Type 2 Diabetes ... More >> Obesity Prediabetes Less << Not Applicable Completed - -
NCT01973413 - Completed - -
NCT02074423 Postprandial Glycemia ... More >> Postprandial Insulinemia Less << Not Applicable Completed - France ... More >> Centre de Nutrition Clinique Naturalpha Lilles, France, 59020 Less <<
NCT01973413 Diabetes Mellitus, Type 1 Not Applicable Completed - United States, California ... More >> Stanford University Los Gatos, California, United States, 95032 Less <<
NCT01201460 - Completed - United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35294 United States, Florida University of Florida College of Dentistry Gainesville, Florida, United States, 32610 United States, Minnesota Health Partners Dental Group Minneapolis, Minnesota, United States, 55440-1309 Health Partners Research Foundation Minneapolis, Minnesota, United States, 55440-1524 United States, Oregon Kaiser Permanente Center for Health Research Portland, Oregon, United States, 97227 Permanente Denrtal Associates Portland, Oregon, United States, 97232 Denmark University of Copenhagen Royal Dental College Copenhagen, Denmark Less <<
NCT01369823 - Unknown December 2011 -
NCT00566514 Fibromyalgia Not Applicable Suspended(Protocol Under Revie... More >>w) Less << July 2008 United States, Minnesota ... More >> Bioenergy Life Science, Inc. Minneapolis, Minnesota, United States, 55304 Less <<
NCT02942732 Insulin Resistance Not Applicable Completed - -
NCT01223547 Type 1 Diabetes Not Applicable Completed - Denmark ... More >> Hvidovre University Hospital Hvidovre, Denmark, 2650 Less <<
NCT01222208 Colon Cancer Not Applicable Completed - Canada, Quebec ... More >> Montreal General Hospital Montreal, Quebec, Canada, H3G 1A4 Less <<
NCT02700334 Prediabetes I... More >>mpaired Fasting Glucose Impaired Glucose Tolerance Less << Phase 4 Completed - Mexico ... More >> Intstituto de Terapeútica Experimental y Clínica. Centro Universitario de Ciencias de la Salud. Universidad de Guadalajara Guadalajara, Jalisco, Mexico, 44340 Less <<
NCT01244178 Sepsis Not Applicable Unknown - Canada, Quebec ... More >> Royal Victoria Hospital Montreal, Quebec, Canada, H3A 1A1 Montreal General Hospital Montreal, Quebec, Canada, H3G 1A4 Saudi Arabia King Khalid Univesity Hospital Riyadh, Saudi Arabia, 11421 Less <<
NCT02459535 Pre-diabetes ... More >>Diabetes Less << Not Applicable Unknown December 2016 Germany ... More >> German Institut for Human Nutrition; Department for Clinical Nutrition Recruiting Nuthetal, Brandenburg, Germany, 14458 Contact: Margrit Kemper, Dr. med.    033200 88 2775    margrit.kemper@dife.de    Sub-Investigator: Margrit Kemper, Dr. med. Less <<
NCT02928016 Type 1 Diabetes Not Applicable Completed - -
NCT02722902 Glucose Intolerance Not Applicable Terminated(No effect of carnit... More >>ine on lipid induced insulin resistance after n=8 (p=1.00)) Less << - Netherlands ... More >> Maastricht University Medical Center Maastricht, Limburg, Netherlands, 6229 ER Less <<
NCT02987556 Closed Loop D... More >>iabetes Mellitus, Type 1 Less << Not Applicable Active, not recruiting August 2018 France ... More >> Centre Hospitalier Universitaire Jean Minjoz Besancon, France, 25030 Centre Hospitalier Universitaire Caen, France, 14033 Centre Hospitalier Sud-Francilien Corbeil-Essonnes, France, 91100 Centre Hospitalier Universitaire Grenoble, France, 38700 Centre Hospitalier Universitaire Lyon, France, 69000 Centre Hospitalier Universitaire Marseille, France, 13000 Centre Hospitalier Universitaire Montpellier, France, 34295 Centre Hospitalier Universitaire Nancy, France, 54000 Centre Hospitalier Universitaire Nantes, France, 44000 Centre Hospitalier Universitaire Reims, France, 51100 Centre Hospitalier Universitaire Strasbourg, France, 67000 Centre Hospitalier Universitaire Toulouse, France, 31400 Less <<
NCT00405808 Obesity Phase 3 Terminated(EMEA recommendation... More >> to suspend Acomplia marketing authorisation) Less << - -
NCT03263494 Type 1 Diabetes Mellitus Phase 3 Active, not recruiting July 31, 2019 United States, California ... More >> Children's Hospital Los Angeles Los Angeles, California, United States, 90027 Stanford University Palo Alto, California, United States, 94304 United States, Colorado Barbara Davis Center--University of Colorado Aurora, Colorado, United States, 80045 United States, Connecticut Yale University New Haven, Connecticut, United States, 06511 United States, Idaho Rocky Mountain Diabetes & Osteoporosis Center Idaho Falls, Idaho, United States, 83404 United States, Massachusetts Joslin Diabetes Center Boston, Massachusetts, United States, 02215 United States, Minnesota IDC at Park Nicollet Saint Louis Park, Minnesota, United States, 55416 United States, Missouri Children's Mercy Hospital Kansas City, Missouri, United States, 64111 United States, New York Naomi Berrie Diabetes Center at Columbia University New York, New York, United States, 10032 SUNY Upstate Medical University Syracuse, New York, United States, 13210 United States, North Carolina University of North Carolina Chapel Hill, North Carolina, United States, 27713 United States, Pennsylvania Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 United States, Tennessee Vanderbilt University Nashville, Tennessee, United States, 37212 United States, Texas Baylor College of Medicine Houston, Texas, United States, 77030 Less <<
NCT02645448 Diabetes Mellitus ... More >> Autonomic Diseases Less << Not Applicable Completed - -
NCT01841229 - Unknown May 2013 Canada, Ontario ... More >> The Toronto 3D Knowledge Synthesis and Clinical trials Unit, Clinical Nutrition and Risk Factor Modification Centre, St.Michael's Hospital. Toronto, Ontario, Canada, M5C 2T2 Less <<
NCT00332449 - Unknown December 2008 Israel ... More >> Sheba Medical Center - Neonatal Department Recruiting Ramat Gan, Tel-Hashomer, Israel, 52621 Contact: Ayala Maayan, MD    972-3-530-2451    ayala.maayan@sheba.health.gov.il Less <<
NCT01386645 Impaired Glucose Tolerance ... More >> Oxidative Stress Prediabetes Impaired Fasting Glucose Less << Not Applicable Active, not recruiting May 1, 2019 United States, Washington ... More >> VA Puget Sound Health Care System Seattle, Washington, United States, 98108 Less <<
NCT00502008 Diabetes Not Applicable Completed - India ... More >> St John's Research Institute Bangalore, Karnataka, India, 560034 Less <<
NCT00511979 Healthy Phase 1 Completed - -
NCT03303196 Hyperinsulinism ... More >> Diabetes Pancreatic Diseases Pancreatectomy; Hyperglycemia Less << Not Applicable Recruiting December 2019 United States, Pennsylvania ... More >> Children's Hospital of Philadelphia Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Lauren M Mitteer, MEd, CCRP       MitteerL@email.chop.edu    Principal Investigator: Diva D De Leon, MD, MSCE          Sub-Investigator: Arpana Rayannavar, MD Less <<
NCT00506272 Diabetes Mellitus ... More >> Hyperglycemia Hypoglycemia Less << Not Applicable Unknown - United States, Georgia ... More >> Atlanta VA Medical Center Decatur, Georgia, United States, 30033 Less <<
NCT01205178 Malaria Phase 1 Completed - Thailand ... More >> GSK Investigational Site Bangkok, Thailand, 10700 GSK Investigational Site Tak, Thailand, 63110 Less <<
NCT02111486 Appetite Post... More >>-prandial Glucose Response Less << Not Applicable Withdrawn(Funding withdrawn) - Canada, Manitoba ... More >> I.H. Asper Clinical Research Institute Winnipeg, Manitoba, Canada, R2H 2A6 Richardson Centre for Functional Foods and Nutraceuticals Winnipeg, Manitoba, Canada, R3T 2N2 Less <<
NCT03350984 Type 2 Diabetes Mellitus Phase 4 Completed - Mexico ... More >> Hospital General de León León, Guanajuato, Mexico, 37680 Less <<
NCT03577834 Visceral Obesity ... More >> Tooth Erosion Insulin Resistance Less << Not Applicable Active, not recruiting August 15, 2018 -
NCT01094054 Obesity Diabe... More >>tes Less << Phase 4 Completed - United States, Minnesota ... More >> Mayo Clinic in Rochester Rochester, Minnesota, United States, 55905 Less <<
NCT02532829 - Unknown November 2016 -
NCT02161055 Brain Injuries ... More >> Hyperglycemia Less << Phase 4 Unknown December 2016 China, Jiangsu ... More >> Lianyungang Oriental Hospital Recruiting Lianyungang, Jiangsu, China, 222042 Contact: Wenxue Wang, M.D., Ph.D.    +8615151268106    731545804@qq.com    Principal Investigator: Wenxue Wang, M.D., Ph.D.          The First People's Hospital of Lianyungang Recruiting Lianyungang, Jiangsu, China Contact: Aimin Li, M.D.          Principal Investigator: Aimin Li, M.D. Less <<
NCT02494375 Type 1 Diabetes Not Applicable Active, not recruiting December 2017 France ... More >> Hospices Civils de Lyon Lyon, France, 69000 Less <<
NCT00188773 Insulin Resistance Syndrome X ... More >> Pancreatic Beta Cell Function Less << Phase 4 Completed - Canada, Ontario ... More >> University Health Network Toronto, Ontario, Canada, M5G 2C4 Less <<
NCT02067585 Morbid Obesity Not Applicable Completed - Canada, Alberta ... More >> CAMIS Edmonton, Alberta, Canada, T5H 3V9 Less <<
NCT01083108 Obesity Baria... More >>tric Surgery Morbid Obesity Diabetes Mellitus Type 2 Diet Therapy Less << Phase 2 Completed - United States, Maryland ... More >> University of Maryland, Baltimore Baltimore, Maryland, United States, 21201-1595 National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 United States, Tennessee Vanderbilt University Nashville, Tennessee, United States, 37232 Less <<
NCT00407862 Hypertension ... More >>Impaired Glucose Tolerance Less << Phase 4 Completed - Austria ... More >> Medical University of Graz Graz, Austria, 8036 Less <<
NCT03567837 Adolescent Obesity Not Applicable Recruiting September 2020 United States, New York ... More >> Weill Cornell Medicial College Recruiting New York, New York, United States, 10065 Contact: Lisa Hudgins, MD Less <<
NCT02067585 - Completed - -
NCT01627899 Diabetes Not Applicable Terminated(Business decision t... More >>o terminate trial) Less << - -
NCT03596684 Atorvastatin Not Applicable Not yet recruiting May 1, 2020 France ... More >> Endocrinology and diabetology service, Louis Pradel Hospital Not yet recruiting Bron, France, 69500 Contact: Sybil CHARRIERE, MD    4 27 85 66 66 ext +33    sybil.charriere@chu-lyon.fr    Sub-Investigator: Philippe MOULIN, MD          Principal Investigator: Sybil CHARRIERE, MD          Sub-Investigator: Laure Groisne, MD Less <<
NCT02951130 Congenital Diaphragmatic Herni... More >>a Persistent Pulmonary Hypertension of the Newborn Hypoxemic Respiratory Failure Pulmonary Hypoplasia Less << Phase 2 Recruiting February 2021 United States, Alabama ... More >> University of Alabama at Birmingham Recruiting Birmingham, Alabama, United States, 35233 Contact: Waldemar A Carlo, MD          United States, California Stanford University Not yet recruiting Palo Alto, California, United States, 94304 Contact: Krisa P Van Meurs, MD          United States, Georgia Emory University Recruiting Atlanta, Georgia, United States, 30303 Contact: David P Carlton, MD          United States, Iowa University of Iowa Recruiting Iowa City, Iowa, United States, 52242 Contact: Edward F Bell, MD          United States, New Mexico University of New Mexico Recruiting Albuquerque, New Mexico, United States, 87131 Contact: Kristi L Watterberg, MD          United States, New York University of Rochester Recruiting Rochester, New York, United States, 14642 Contact: Carl T D'Angio, MD          United States, North Carolina RTI International Not yet recruiting Durham, North Carolina, United States, 27709 Contact: Abhik Das, PhD          Duke University Not yet recruiting Durham, North Carolina, United States, 27710 Contact: Michael Cotten, MD          United States, Ohio Cincinnati Children's Medical Center Not yet recruiting Cincinnati, Ohio, United States, 45267 Contact: Brenda Poindexter, MD          Case Western Reserve University, Rainbow Babies and Children's Hospital Recruiting Cleveland, Ohio, United States, 44106 Contact: Michele C Walsh, MD MS          Research Institute at Nationwide Children's Hospital Recruiting Columbus, Ohio, United States, 43205 Contact: Pablo Sanchez          United States, Pennsylvania University of Pennsylvania Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Barbara Schmidt, MD          United States, Rhode Island Brown University, Women & Infants Hospital of Rhode Island Not yet recruiting Providence, Rhode Island, United States, 02905 Contact: Abbot R Laptook, MD          United States, Texas University of Texas Southwestern Medical Center at Dallas Not yet recruiting Dallas, Texas, United States, 75235 Contact: Myra Wyckoff, MD          University of Texas Health Science Center at Houston Not yet recruiting Houston, Texas, United States, 77030 Contact: Kathleen A Kennedy, MD MPH          United States, Utah University of Utah Recruiting Salt Lake City, Utah, United States, 84108 Contact: Bradley Yoder, MD Less <<
NCT01627899 - Terminated(Business decision t... More >>o terminate trial) Less << - -
NCT01130012 Gestational Diabetes Not Applicable Completed - -
NCT01511185 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 1 Completed - United States, Michigan ... More >> Novo Nordisk Investigational Site Ann Arbor, Michigan, United States, 48109-0926 Less <<
NCT02843503 Diabetes Mellitus, Type 1 Not Applicable Completed - Netherlands ... More >> Academic Medical Center Amsterdam, Noord-Holland, Netherlands, 1105AZ Less <<
NCT02956356 Obesity Not Applicable Completed - Switzerland ... More >> St Claraspital Basel, Switzerland, 4016 Less <<
NCT01418703 Type 1 Diabetes Mellitus Not Applicable Completed - United States, Virginia ... More >> University of Virginia Health System Charlottesville, Virginia, United States, 22904 Less <<
NCT01418703 - Completed - -
NCT01373450 Type 2 Diabetes Mellitus Phase 1 Completed - -
NCT02683135 Type 2 Diabetes Not Applicable Completed - Canada, British Columbia ... More >> University of British Columbia, Okanagan. Kelowna, British Columbia, Canada, V1V 1V7 Less <<
NCT00716170 - Completed - Denmark ... More >> Department of Endocrinology J, Herlev Hospital Herlev, Denmark, 2730 Less <<
NCT01029704 Diabetes Mellitus Type 2 Phase 2 Completed - United States, Alabama ... More >> Research Site #10 Birmingham, Alabama, United States United States, California Research Site #04 National City, California, United States United States, Colorado Research Site #12 Denver, Colorado, United States United States, Florida Research Site #07 Miami, Florida, United States Research Site #08 Miami, Florida, United States United States, Pennsylvania Research Site #06 Reading, Pennsylvania, United States United States, Texas Research Site #11 Desoto, Texas, United States Research Site #01 San Antonio, Texas, United States Research Site #15 San Antonio, Texas, United States Canada, Ontario Research Site #03 Brampton, Ontario, Canada Research Site #13 London, Ontario, Canada Research Site #02 Mississauga, Ontario, Canada Less <<
NCT00351000 Schizophrenia Phase 4 Completed - United States, Massachusetts ... More >> Freedom Trail Clinic Boston, Massachusetts, United States, 02114 Less <<
NCT01373450 - Completed - -
NCT00374218 Abdominal Obesity Phase 2 Completed - Canada, Ontario ... More >> Glycemic Index Laboratories Toronto, Ontario, Canada, M5C 2X3 Less <<
NCT01029704 - Completed - -
NCT01027871 Diabetes Mellitus, Type 2 Phase 2 Completed - -
NCT02556554 Diabetes Mellitus, Type I Not Applicable Active, not recruiting December 2018 United States, Colorado ... More >> University of Colorado Aurora, Colorado, United States, 80045 Less <<
NCT02595580 Diabetes Mellitus, Type 1 Not Applicable Terminated(skin irritation cau... More >>sed by device) Less << - Norway ... More >> Sykehuset Østvold Frederikstad, Norway St Olavs Hospital Trondheim, Norway Less <<
NCT01027871 - Completed - -
NCT00943787 - Completed - -
NCT02440217 - Unknown June 2015 Italy ... More >> Azienda Ospedaliero-Universitaria Pisana Pisa, PI, Italy, 56127 Less <<
NCT00351000 - Completed - -
NCT01548963 Perioperative and Postoperativ... More >>e Hyperglycemia Tight Glycemia Control Less << Not Applicable Completed - Czech Republic ... More >> General University Hospital Prague Prague, Czech Republic, 128 51 Less <<
NCT00943787 Diabetes Mellitus, Type 1 Not Applicable Completed - United States, Virginia ... More >> University of Virginia Health System - Behavioral Medicine Center Charlottesville, Virginia, United States, 22908 Less <<
NCT01188083 Non-alcoholic Fatty-liver Dise... More >>ase Less << Not Applicable Completed - United States, Georgia ... More >> Emory Children's Center Atlanta, Georgia, United States, 30322 Less <<
NCT00135915 - Completed - United Kingdom ... More >> Royal Bournemouth Hospital Bournemouth, Dorset, United Kingdom, BH7 7DW Less <<
NCT00544518 Type 2 Diabetes Phase 2 Unknown October 2008 China, Shanxi ... More >> XiJing hospital of Fourth Military Medical University Xi'an, Shanxi, China, 710032 Less <<
NCT02638246 Contingent Versus Noncontingen... More >>t Incentives Less << Not Applicable Completed - -
NCT01172951 Healthy Subjects Not Applicable Completed - Ireland ... More >> Institute for Sport and Health, University College Dublin Dublin, Ireland, 4 St Vincent's University Hospital Dublin, Ireland, 4 Less <<
NCT02706093 Glucose Intolerance Not Applicable Recruiting January 2025 United States, Michigan ... More >> Suzette Howton Recruiting Ann Arbor, Michigan, United States, 48178 Contact: Suzette Howton    734-647-9850    suzetter@med.umich.edu    Principal Investigator: jeff Horowitz Less <<
NCT00328094 Peripheral Vascular Disease ... More >> Abdominal Aortic Aneurysm Less << Not Applicable Terminated(The recruitment rat... More >>e slowed considerably) Less << - United States, Massachusetts ... More >> Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Less <<
NCT00328094 - Terminated(The recruitment rat... More >>e slowed considerably) Less << - -
NCT02400411 Blood Glucose Concentration Not Applicable Unknown - -
NCT00646438 Diabetes Coro... More >>nary Artery Disease Less << Not Applicable Unknown December 2012 United States, Oregon ... More >> Providence St. Vincent Medical Center Recruiting Portland, Oregon, United States, 97225 Contact: Eric M. Johnson, BA/CCRC    503-216-2075    eric.johnson@providence.org    Contact: Tony Furnary, MD    503-297-1419    tfurnary@mac.com    Principal Investigator: Anthony Furnary, MD Less <<
NCT02503527 Aneurysmal Subarachnoid Hemorr... More >>hage Less << Not Applicable Recruiting September 2019 Austria ... More >> Universitätsklinikum Innsbruck Recruiting Innsbruck, Austria, 6020 Contact: R. De Beer, PD Dr. med. Less <<
NCT01324557 Diabetes Poor... More >> Glycemic Control Less << Phase 2 Unknown December 2013 China, Guangdong ... More >> Guangdong General Hospital Recruiting GuangZhou, Guangdong, China, 510080 Contact: Shi Wei, PHD    8602083827812 ext 62027    weishi_gz@126.com    Contact: Liu Shuangxin, PHD    8602083827812 ext 62027    mplsxi@yahoo.com    Principal Investigator: Shi Wei, PHD Less <<
NCT00648687 Retinopathy of Prematurity Not Applicable Completed - Brazil ... More >> Hospital de Clínicas de Porto Alegre Porto Alegre, RS, Brazil Less <<
NCT01003275 - Completed - -
NCT00606073 Fertility Not Applicable Unknown - -
NCT02404870 Diabetes PTH ... More >> Vitamin D Fibroblast Growth Factor (FGF23) Phosphate Less << Phase 1 Recruiting May 1, 2019 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)    800-411-1222 ext TTY8664111010    prpl@cc.nih.gov Less <<
NCT02980406 Irritable Bowel Syndrome Not Applicable Completed - -
NCT01003275 Chronic Kidney Disease Phase 2 Completed - United States, Washington ... More >> University of Washington Seattle, Washington, United States, 98195 Less <<
NCT00153179 - Completed - -
NCT03034226 Hypoglycemia ... More >>Diabetes Mellitus, Type 1 Less << Not Applicable Active, not recruiting October 2019 Denmark ... More >> Department of Clinical Medicine Aarhus, Denmark, 8000 Less <<
NCT02657213 Diabetes, Type 1 Not Applicable Completed - France ... More >> Grenoble University Hospital Grenoble, France, 38000 Montpellier University Hospital Montpellier, France, 34000 Less <<
NCT03423381 Glucose Tolerance Not Applicable Enrolling by invitation October 30, 2019 Sweden ... More >> Food Technology, engineering and Nutrition, LTH, Lund University Lund, Sweden, 22100 Less <<
NCT01218633 Pancreatic Effects of 9,39-Exe... More >>ndin and 9,36-GLP-1 Less << Phase 1 Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT00153179 Type 2 Diabetes Mellitus Phase 1 Phase 2 Completed - United States, Massachusetts ... More >> Brigham & Women's Hospital Boston, Massachusetts, United States, 02115 Less <<
NCT02021903 Parkinsonian Disorders Not Applicable Recruiting June 2019 France ... More >> UHBordeaux Active, not recruiting Bordeaux, France, 33076 UHToulouse Recruiting Toulouse, France, 31059 Contact: Anne Pavy-Le Traon, MD    0561772271 Less <<
NCT00463645 - Completed - Austria ... More >> Medical University Graz Graz, Styria, Austria, 8036 Less <<
NCT02835183 Type 1 Diabetes Phase 1 Unknown October 2017 -
NCT01151176 Acute Coronary Syndrome Phase 4 Suspended(Administrative probl... More >>ems makes changes in hospital staff New clinical research team will restart) Less << December 2013 United States, Georgia ... More >> Emory University School of Medicine Atlanta, Georgia, United States, 30303 Brazil Hospital Cruz Vermelha Brasileira-Filial do Estado do Paraná Curitiba, PR, Brazil, 80420-011 Less <<
NCT03181165 Diet Modification Not Applicable Recruiting July 1, 2020 Canada, British Columbia ... More >> University of British Columbia Recruiting Kelowna, British Columbia, Canada, V1V1V7 Contact: Jonathan Little, PhD    2508079876    jonathan.little@ubc.ca    Contact: Cody Durrer, MSc    2508079122    cdurrer@live.com Less <<
NCT02844699 Prostate Cancer Phase 1 Phase 2 Active, not recruiting January 2018 Russian Federation ... More >> Moscow State Budgetary Healthcare Institution "City Clinical Hospital № 57" of Moscow Healthcare Department Moscow, Russian Federation Moscow State University of Medicine and Dentistry Moscow, Russian Federation Federal State Budgetary Institution "Saint Petersburg Clinical Scientific and Practical Center for Special types of medical care (Oncological)" Saint Petersburg, Russian Federation Federal State Budgetary Institution "Scientific Research Oncology Institute named after N.N. Petrov" of the Ministry of Health of the Russian Federation Saint Petersburg, Russian Federation Less <<
NCT02853916 Blood Glucose Not Applicable Completed - Canada, Manitoba ... More >> Richardson Centre for Functional Foods and Nutraceuticals Winnipeg, Manitoba, Canada, R3T 2N2 Less <<
NCT03477838 Diabetes Mellitus Not Applicable Enrolling by invitation December 31, 2018 United States, Virginia ... More >> Virginia Commonwealth University Richmond, Virginia, United States, 23298 Less <<
NCT02960295 Diabetes, Gestational Not Applicable Completed - United States, California ... More >> Kaiser Permanente Southern California Pasadena, California, United States, 91101 Less <<
NCT01771380 - Completed - Norway ... More >> University of Tromsø Tromsø, Norway, 9037 Less <<
NCT01939834 Type 1 Diabetes Mellitus Not Applicable Terminated(Subjects preferred ... More >>the 5 night overnight system in terms of ease of use.) Less << - United States, Virginia ... More >> University of Virginia Center for Diabetes Technology Charlottesville, Virginia, United States, 22903 Less <<
NCT02594904 Neonatal Hyperbilirubinemia Phase 4 Unknown June 2016 China, Guangdong ... More >> The South Hospital of Southern Medical University Recruiting Guangzhou, Guangdong, China, 510515 Contact: Weimin Huang, Ph.D    13900261113    drhwm2003@hotmail.com Less <<
NCT01199029 Healthy Phase 1 Completed - United States, Michigan ... More >> Pfizer Investigational Site Kalamazoo, Michigan, United States, 49007 Less <<
NCT02330510 - Recruiting February 2020 Canada, Ontario ... More >> Sunnybrook Health Sciences Centre Recruiting Toronto, Ontario, Canada, M4N 3M5 Less <<
NCT01970241 Diabetes Mellitus Phase 4 Completed - United States, Minnesota ... More >> Hennepin County Medical Center Minneapolis, Minnesota, United States, 55415 Less <<
NCT03512496 Nutrition Ped... More >>iatric Obesity Pediatric Caffeine Metabolism Disorder, Glucose Health Behavior Glucose Intolerance Less << Not Applicable Recruiting December 1, 2020 Canada, Alberta ... More >> University of Calgary Recruiting Calgary, Alberta, Canada, T2N 1N4 Contact: Shyamchand Mayengbam, PhD    4032203431    shyamchandsingh.maye@ucalgary.ca Less <<
NCT01937858 - Unknown July 2016 Saudi Arabia ... More >> King Abdulaziz National Guards Hospital Recruiting Al-Ahsa, Saudi Arabia, 31982 Contact: Suzan Aloraibi    +966-13-5910000 ext 36289    OraibiS@NGHA.MED.SA    Contact: Reem Alamoudi    +966-13-8581111 ext 31504    amoudir@ngha.med.sa    Principal Investigator: Reem M Alamoudi Less <<
NCT02505308 Diabetes Mellitus Not Applicable Recruiting January 2019 United Kingdom ... More >> University of Exeter Recruiting Exeter, Devon, United Kingdom, EX2 5DW Contact: Michelle Hudson, BSc    ++44 1392 408183    m.hudson@exeter.ac.uk    Contact: Bridget A Knight, PhD    ++44 1392 408172    B.A.Knight@exeter.ac.uk    Principal Investigator: Timothy M Frayling (Prof), PhD          University of Oxford Not yet recruiting Oxford, Oxfordshire, United Kingdom, OX3 7LE Contact: Mark McCarthy, FRCP       mark.mccarthy@drl.ox.ac.uk    Contact: Fredrik Karpe, FRCP       fredrik.karpe@ocdem.ox.ac.uk    Principal Investigator: Mark I McCarthy, FRCP Less <<
NCT03471585 Healthy Early Phase 1 Completed - United States, Illinois ... More >> University of Chicago Chicago, Illinois, United States, 60637 Less <<
NCT02262208 Type 2 Diabetes Not Applicable Unknown August 2015 Brazil ... More >> Hospital de Clinicas de Porto Alegre Recruiting Porto Alegre, RS, Brazil, 90035-003 Contact: Marcia Raymundo, PhD    +55 51 21 01 8304    mraymundo@hcpa.ufrgs.br    Principal Investigator: Beatriz Schaan, PhD Less <<
NCT01906333 Diabetes Exer... More >>cise Physiology Less << Not Applicable Completed - Netherlands ... More >> Department of Human Biology, Maastricht University Medical Center (MUMC) Maastricht, Netherlands Less <<
NCT02006914 - Completed - United States, New York ... More >> Stony Brook University Hospital GCRC Stony Brook, New York, United States, 11794 Less <<
NCT01750151 Exogenous Obesity Not Applicable Completed - Canada, Nova Scotia ... More >> Department of Applied Human Nutrition Halifax, Nova Scotia, Canada Canada, Ontario School of Nutrition, Ryerson University Toronto, Ontario, Canada Less <<
NCT02139254 - Completed - Switzerland ... More >> Dep. of Obstetrics and Gynecology Bern, Switzerland, 3010 Less <<
NCT02898714 - Active, not recruiting June 12, 2020 Belgium ... More >> UZ Leuven Leuven, Belgium, 3000 Less <<
NCT02547337 - Unknown - Finland ... More >> Turku PET Centre Turku, Finland, 20520 Less <<
NCT01275820 - Completed - United States, South Dakota ... More >> Avera Research Institute Sioux Falls, South Dakota, United States, 57105 Less <<
NCT00774488 Metabolic Syndrome ... More >> Obesity Insulin Sensitivity Less << Not Applicable Completed - -
NCT01116752 Pediatric Patient (1m-21y) ... More >> ICU Admission Hyperglycemia Less << Phase 3 Completed - United States, Georgia ... More >> Children's Healthcare of Atlanta at Egleston Atlanta, Georgia, United States, 30322 Less <<
NCT02636491 Type 1 Diabetes Not Applicable Completed - Germany ... More >> Kinder - und Jugendkrankenhaus AUF DER BULT Hannover, Germany, 30173 Less <<
NCT01582282 Non-Insulin-dependent Diabetes... More >> Mellitus Less << Phase 4 Terminated(due to slow enrollm... More >>ent) Less << - United States, Florida ... More >> University of Miami, Diabetes Unit D-1 Miami, Florida, United States, 33136 United States, Minnesota International Diabetes Center Minneapolis, Minnesota, United States, 55416 Less <<
NCT02926989 Hypokalemia H... More >>yponatremia Hypernatremia Dehydration Less << Phase 4 Recruiting December 2018 Finland ... More >> Oulu University Hospital Recruiting Oulu, Finland, 90029 Contact: Minna Honkila, MD    +35883155863    minna.honkila@ppshp.fi    Contact: Terhi Tapiainen, MD PhD    +35883155185    terhi.tapiainen@oulu.fi    Sub-Investigator: Saara Lehtiranta, MD          Sub-Investigator: Merja Kallio, MD PhD          Sub-Investigator: Niko Paalanne, MD PhD          Sub-Investigator: Outi Peltoniemi, MD PhD          Sub-Investigator: Tytti Pokka, MSc          Sub-Investigator: Hannele Pruikkonen, MD PhD          Sub-Investigator: Marjo Renko, MD PhD          Principal Investigator: Minna Honkila, MD          Principal Investigator: Terhi Tapiainen, MD PhD Less <<
NCT00205725 Schizophrenia ... More >> Type 2 Diabetes Mellitus Less << Not Applicable Completed - United States, Missouri ... More >> Washington University School of Medicine, Psychiatry Dept. St. Louis, Missouri, United States, 63110 Less <<
NCT01582282 - Terminated(due to slow enrollm... More >>ent) Less << - -
NCT01755442 Diabetes Mellitus Phase 1 Terminated(Amgen determined no... More >> further need for this study.) Less << - United States, California ... More >> Research Site San Diego, California, United States, 92161 Less <<
NCT03168295 Diabetes Mellitus, Type 2 Phase 4 Recruiting October 2019 United States, Texas ... More >> The University of Texas Health Science Center at San Antonio Recruiting San Antonio, Texas, United States, 78229 Contact: Ralph A DeFronzo, MD    210-567-6691    defronzo@uthscsa.edu    Principal Investigator: Ralph A DeFronzo, MD Less <<
NCT00116922 Impaired Glucose Tolerance ... More >> Diabetes Less << Phase 3 Completed - Canada, Ontario ... More >> UWO Research Park London, Ontario, Canada, N6G 4X8 Mount Sinai Hospital Toronto, Ontario, Canada, M5G 1X5 Less <<
NCT01065948 Diabetes Phase 1 Completed - United States, Texas ... More >> Practice of Eric Orzeck, MD Houston, Texas, United States, 77025 Less <<
NCT01987206 Type 1 Diabetes Mellitus Early Phase 1 Completed - United States, California ... More >> Sansum Diabetes Research Institute Santa Barbara, California, United States, 93105 Less <<
NCT00438295 Renal Failure, Chronic Phase 4 Completed - Denmark ... More >> Holstebro Hospital Holstebro, Denmark, 7500 Less <<
NCT03415503 Dyslipidemias ... More >> Hyperglycemia Less << Phase 3 Not yet recruiting December 1, 2019 China, Guangdong ... More >> Department of Nutrition and Food Hygiene,School of Public Health, Sun Yat-sen University Not yet recruiting Guangzhou, Guangdong, China Contact: ling w h, professor    87331597 ext 020    lingwh@mail.sysu.edu.cn    Contact: zhang h y    15625084772 ext 86    zhanghy97@mail2.sysu.edu.cn Less <<
NCT01975259 - Completed - United Kingdom ... More >> Liverpool Heart and Chest Hospital Liverpool, United Kingdom, L14 3PE Less <<
NCT01519102 Type-1 Diabetes Phase 2 Completed - Canada, Quebec ... More >> Institut de Recherches Cliniques de Montréal (IRCM) Montreal, Quebec, Canada, H2W 1R7 Less <<
NCT01855490 Type 1 Diabetes Phase 1 Completed - United States, Connecticut ... More >> Yale School of Medicine New Haven, Connecticut, United States, 06519 Less <<
NCT00147745 Type 2 Diabetes Phase 2 Completed - United States, California ... More >> San Diego VMC San Diego, California, United States, 92161 Less <<
NCT01174576 - Completed - -
NCT01140932 Electroretinography Not Applicable Completed - Denmark ... More >> Copenhagen University Hospital at Glostrup Copenhagen, Denmark, DK-2600 Less <<
NCT03233906 Obesity Eatin... More >>g Behavior Mood Glucose Dietary Modification Less << Not Applicable Active, not recruiting August 2018 United States, California ... More >> California State Polytechnic University, Pomona Pomona, California, United States, 91766 Less <<
NCT01581736 Obesity Type ... More >>2 Diabetes Mellitus Less << Phase 1 Terminated(PI job change) - United States, Arizona ... More >> Mayo Clinic in Arizona Scottsdale, Arizona, United States, 85259 Less <<
NCT00813475 Diabetes Not Applicable Unknown July 2011 Israel ... More >> Assaf Harofeh Medical Center Not yet recruiting Zerifin, Israel, 70300 Principal Investigator: Andreas E Buchs, MD Less <<
NCT00347542 Diabetes Mellitus, Non-Insulin... More >>-Dependent Obesity Less << Not Applicable Completed - India ... More >> Sitaram Bhartia Institute of Science and Research New Delhi, Delhi, India, 110016 Less <<
NCT03761290 - Not yet recruiting January 1, 2021 United States, Tennessee ... More >> Vanderbilt University Medical Center Not yet recruiting Nashville, Tennessee, United States, 37212 Contact: Ashley Shoemaker, M.D.    615-343-8116    ashley.h.shoemaker@vumc.org    Principal Investigator: Ashley Shoemaker, M.D. Less <<
NCT03305783 - Recruiting January 1, 2019 Denmark ... More >> Clinical metabolic physiology, Steno Diabetes Center Copenhagen Recruiting Copenhagen, Hellerup, Denmark, 2900 Contact: Christina C Nexøe-Larsen, MD, Ph.D. student Less <<
NCT03654651 Type2 Diabetes ... More >> Cardiovascular Diseases Less << Phase 2 Recruiting December 1, 2019 United States, Pennsylvania ... More >> Pennsylvania State University Recruiting University Park, Pennsylvania, United States, 16802 Contact: Kristina S Petersen, PhD    814-863-8622    kup63@psu.edu Less <<
NCT01291030 Glucose Metabolism ... More >> Renal Transplantation Less << Not Applicable Completed - Belgium ... More >> OLV Aalst Aalst, Belgium University Hospital Ghent Ghent, Belgium, 9000 Less <<
NCT00147745 - Completed - -
NCT02920671 - Recruiting June 2020 United States, Pennsylvania ... More >> University of Pennsylvania Recruiting Philadelphia, Pennsylvania, United States, 19004 Contact: Shana E McCormack, MD       mccormacks1@email.chop.edu    Principal Investigator: Shana E McCormack, MD          Children's Hospital of Philadelphia Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Shana E McCormack, MD       mccormacks1@email.chop.edu Less <<
NCT03029390 Prediabetes I... More >>mpaired Fasting Glucose Impaired Glucose Tolerance Less << Phase 4 Active, not recruiting May 2018 Mexico ... More >> Instituto de Terapeútica Experimental y Clínica. Centro Universitario de Ciencias de la Salud. Universidad de Guadalajara Guadalajara, Jalisco, Mexico, 44340 Less <<
NCT01174576 Health Not Applicable Completed - Greece ... More >> Metabolic Unit of the Department of Nutrition and Dietetics, Harokopio University Athens, Greece, 17671 Less <<
NCT03303729 Muscle Protein Synthesis ... More >> Amino Acid Less << Not Applicable Completed - Denmark ... More >> Bispebjerg Hospital Copenhagen, Copenhagen NV, Denmark, 2400 Less <<
NCT02082301 - Active, not recruiting December 31, 2018 United States, Ohio ... More >> University Hospital Cleveland, Ohio, United States, 44106 MetroHealth Medical Center Cleveland, Ohio, United States, 44109 Less <<
NCT00734448 Gestational Diabetes Mellitus Not Applicable Unknown December 2014 Italy ... More >> University of Messina - Recruiting Messina, Sicilia, Italy, 98100 Contact: francesco corrado, researcher    39-090-2211 ext 2176    francesco.corrado@unime.it    Principal Investigator: rosario d'anna, professor          Sub-Investigator: francesco corrado, researcher Less <<
NCT03323827 - Recruiting August 2018 United States, Arizona ... More >> The University of Arizona Recruiting Tucson, Arizona, United States, 85724 Contact: Oscar Parra, MADM    520-626-6485    oscardp@email.arizona.edu    Principal Investigator: Lawrence Mandarino, PhD Less <<
NCT00725127 Type 2 Diabetes Phase 4 Recruiting June 2021 Spain ... More >> CS Friol Recruiting Friol, Lugo, Spain, 27220 Contact: Esther Gomez, MD    34639512093    Esther.Gomez.Sal@sergas.es    Principal Investigator: Esther Gomez, MD          CS Baiona Recruiting Baiona, Pontevedra, Spain, 36300 Contact: Francisco J Iglesias, MD    34986357239    FranciscoJavier.Iglesias.Mato@sergas.es    Principal Investigator: Francisco J Iglesias, MD          CS Bueu Recruiting Bueu, Pontevedra, Spain, 36930 Contact: Miguel A Aboal, MD    34986323313    miguel.angel.aboal.beato@sergas.es    Principal Investigator: Miguel A Aboal, MD          CS A Estrada Recruiting La Estrada, Pontevedra, Spain, 26680 Contact: Luis Meijide, MD    34986573459    Luis.Meijide.Calvo@sergas.es    Principal Investigator: Luis Meijide, MD          Sub-Investigator: Mariana Carbon, MD          Sub-Investigator: Maria C Garcia, MD          Sub-Investigator: Francisco Romero, MD          Sub-Investigator: Maria P Brea          CS A Guarda Recruiting La Guardia, Pontevedra, Spain, 36780 Contact: Juan J Crespo, MD    34986614450    JuanJose.Crespo.Sabaris@sergas.es    Principal Investigator: Juan J Crespo, MD          Sub-Investigator: Raquel Fernandez, MD          Sub-Investigator: Carmen M Fernandez, MD          Sub-Investigator: Amelia Ferreras, MD          Sub-Investigator: Manuel F Quintans, MD          Sub-Investigator: Javier Rodriguez, MD          Sub-Investigator: Pilar Rua          Sub-Investigator: Aurelio Alvarez          Sub-Investigator: Asuncion Cadilla          Sub-Investigator: Carmen Outeiro          Sub-Investigator: Carmen Soto-Davila          CS Valmiñor Recruiting Nigran, Pontevedra, Spain, 36250 Contact: Susana Hernaiz, MD    34655391498    Susana.Hernaiz.Valero@sergas.es    Principal Investigator: Susana Hernaiz, MD          CS Panxón Recruiting Nigrán, Pontevedra, Spain, 36340 Contact: Jose L Salgado, MD    34986368615    joseluis.salgado.conde@sergas.es    Principal Investigator: Jose L Salgado, MD          Sub-Investigator: Esperanza Parrado          Sub-Investigator: Alfredo Pereira          CS Tomiño Recruiting Tomiño, Pontevedra, Spain, 36200 Contact: Evangelina Filloy, MD    34-986-623411    evangelina.filloy.miguez@sergas.es    Principal Investigator: Evangelina Filloy, MD          Sub-Investigator: Adolfo T Perez, MD          Sub-Investigator: Nieves Turienzo, MD          Sub-Investigator: Dolores Cardalda          Sub-Investigator: Jose C Varela          Sub-Investigator: Francisca Vazquez          Bioengineering & Chronobilogy Labs., University of Vigo Recruiting Vigo, Pontevedra, Spain, 36200 Contact: Ramon C Hermida, PhD    34986812148    rhermida@uvigo.es    Contact: Diana E Ayala, MD, PhD    34986812148    dianaelva@uvigo.es    Principal Investigator: Ramon C Hermida, PhD          Principal Investigator: Diana E Ayala, MD, PhD          Sub-Investigator: Artemio Mojon, PhD          Sub-Investigator: Jose R Fernandez, PhD          Sub-Investigator: Ignacio Alonso, PhD          Sub-Investigator: Maria J Fontao          Sub-Investigator: Rita Soler          Sub-Investigator: Susana Serrano          CS Calle Cuba Recruiting Vigo, Pontevedra, Spain, 36202 Contact: Felisa Dominguez, MD    34986416226    fdominguez@meditex.es    Principal Investigator: Felisa Dominguez, MD          CS A Doblada Recruiting Vigo, Pontevedra, Spain, 36205 Contact: Teresa Rios, MD    34986275121    teresa.rios.rey@sergas.es    Principal Investigator: Teresa Rios, MD          CS Coia Recruiting Vigo, Pontevedra, Spain, 36209 Contact: Peregrina Eiroa, MD    34986209282    pereeiroa@telefonica.net    Principal Investigator: Peregrina Eiroa, MD          Sub-Investigator: Jesus C Nieto, MD          CS Sardoma Recruiting Vigo, Pontevedra, Spain, 36214 Contact: Manuel Dominguez, MD, PhD    34986416324    Manuel.Dominguez.Sardina@sergas.es    Principal Investigator: Manuel Dominguez, MD, PhD          CS Teis Recruiting Vigo, Pontevedra, Spain, 36216 Contact: Pedro A Callejas, MD    34986374229    PedroAntonio.Callejas.Cabanillas@sergas.es    Principal Investigator: Pedro A Callejas, MD          CS Vilaboa Recruiting Vilaboa, Pontevedra, Spain, 36141 Contact: Sonia M Gomara, MD    34986679229    SoniaMaria.Gomara.Villabona@sergas.es    Principal Investigator: Sonia M Gomara, MD          Sub-Investigator: Julio J Alvarez, MD          Sub-Investigator: Margarita Estevez          Sub-Investigator: Maria C Ferreira          CS San Roque Recruiting Vilagarcía De Arousa, Pontevedra, Spain, 36600 Contact: Envira Sineiro, MD    34986507448    Elvira.Sineiro.Galinanes@sergas.es    Principal Investigator: Elvira Sineiro, MD          Sub-Investigator: Margarita Alvariño          Sub-Investigator: Luis M Fontenla          Sub-Investigator: Margarita Fraga, MD          Sub-Investigator: Barbara Llovo          Sub-Investigator: Rita Martinez          Sub-Investigator: Santiago Santidrian, MD          CS Fingoi Recruiting Lugo, Spain, 27002 Contact: Carmen Castiñeira, MD    34982251035    Carmen.Castineira.Perez@sergas.es    Principal Investigator: Carmen Castiñeira, MD          Sub-Investigator: Maria C Aguado          Sub-Investigator: Carmen Costa          Sub-Investigator: Domingo D Garcia, MD          Sub-Investigator: Bernardino Pardo, MD          Sub-Investigator: Enrique J Vazquez, MD          Complexo Hospitalario Universitario de Ourense Recruiting Orense, Spain, 32005 Contact: Alfonso Otero, MD, PhD    34988385625    Alfonso.Santiago.Otero.Gonzalez@sergas.es    Principal Investigator: Alfonso Otero, MD, PhD          CS Lerez Recruiting Pontevedra, Spain, 36156 Contact: Ana Moya, MD    34986871496    ana.moya.alvarez@sergas.es    Principal Investigator: Ana Moya, MD          Sub-Investigator: Andres Ruiz, MD          Sub-Investigator: Aurelia Constenla          Sub-Investigator: Maria I Franco Less <<
NCT03761615 - Recruiting July 31, 2021 United States, California ... More >> Sansum Diabetes Research Institute Recruiting Santa Barbara, California, United States, 93105 Contact: Camille Andre    805-682-7640 ext 217    candre@sansum.org    United States, Minnesota Mayo Clinic Recruiting Rochester, Minnesota, United States, 55905 Contact: Shelly McCrady-Spitzer    507-255-0316    McCradySpitzer.Shelly@mayo.edu    United States, New York Icahn School of Medicine at Mount Sinai Recruiting New York, New York, United States, 10029 Contact: Selassie Ogyaadu    212-241-9089    selassie.ogyaadu@icahn.mssm.edu Less <<
NCT01596504 Type 2 Diabetes Mellitus Phase 2 Completed - Germany ... More >> Investigational Site Number 276008 Berlin, Germany, 10117 Investigational Site Number 276006 Berlin, Germany, 14050 Investigational Site Number 276004 Kiel, Germany, 24105 Investigational Site Number 276002 Mainz, Germany, 55116 Investigational Site Number 276005 Mönchengladbach, Germany, 41061 Investigational Site Number 276007 München, Germany, 80636 Investigational Site Number 276003 Neu-Ulm, Germany, 89231 Investigational Site Number 276001 Neuss, Germany, 41460 Less <<
NCT03356873 Vitamin D Deficiency ... More >> Glucose Intolerance Oxidative Stress Insulin Resistance Less << Not Applicable Recruiting December 1, 2019 Mexico ... More >> Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran Recruiting Mexico City, Mexico, 14080 Contact: Aili L Garcia-Tuomola, MD    525554870900 ext 2405    aililup@gmail.com Less <<
NCT03681054 Diabetes, Gestational ... More >> Dietary Modification Glucose Intolerance During Pregnancy Body Composition Birth Weight Less << Not Applicable Recruiting December 2019 Finland ... More >> Helsinki university central hospital Recruiting Helsinki, Finland Contact: Rhea Paajanen Less <<
NCT03515421 Diabetes Mellitus ... More >> Healthy Volunteers Less << Not Applicable Recruiting June 18, 2018 Germany ... More >> Institut für Diabetes-Technologie Recruiting Ulm, Germany, D-89081 United Kingdom Diabetes Centre Recruiting Birmingham, United Kingdom, B9 5SS Royal Infirmary of Edinburgh Recruiting Edinburgh, United Kingdom, EH16 4SA Centre for Health Science Recruiting Inverness, United Kingdom, IV2 3JH Less <<
NCT03359590 Pharmacological Action Phase 2 Enrolling by invitation July 30, 2019 Germany ... More >> Profil Institut für Stoffwechselforschung GmbH Neuss, Germany Less <<
NCT01596504 - Completed - -
NCT01459406 Healthy Not Applicable Completed - United Kingdom ... More >> NDDC BRU and Sir Peter Mansfield Magnetic Resonance Centre Nottingham, Nottinghamshire, United Kingdom, NG72UH Less <<
NCT01833403 Type 2 Diabetes ... More >> Obesity Less << Not Applicable Completed - United States, Minnesota ... More >> University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT02554669 Hyperglycemia ... More >> Inflammation Less << Not Applicable Completed - -
NCT03687827 Diabetes Mellitus, Type 2 Phase 4 Recruiting December 30, 2019 -
NCT03113110 Posttransplant Diabetes Mellit... More >>us Less << Phase 2 Recruiting December 31, 2019 Austria ... More >> Department of Internal Medicine III, Division of Nephrology and Dialysis, Medical University of Vienna, Austria Recruiting Vienna, Austria, 1090 Contact: Manfred Hecking, MD       manfred.hecking@meduniwien.ac.at    Contact: Elisabeth Schwaiger, MD       elisabeth.schwaiger@meduniwien.ac.at Less <<
NCT00917267 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT01833403 - Completed - -
NCT01162499 - Completed - -
NCT01162499 Postprandial Hypoglycemia Not Applicable Completed - United States, Pennsylvania ... More >> The Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT02047643 Type 1 Diabetes Not Applicable Unknown June 2014 United States, California ... More >> Stanford University Recruiting Stanford, California, United States, 94305 Contact: Matthew Stenerson, MD    650-723-5791    mstenerson@stanford.edu    Contact: Jen Block    650-723-5791    jblock@stanford.edu    Principal Investigator: Bruce A Buckingham, MD          Sub-Investigator: Matthew B Stenerson, MD          Sub-Investigator: Darrell M Wilson, MD Less <<
NCT00917267 - Completed - -
NCT02814474 Healthy Volunteers Early Phase 1 Completed - Denmark ... More >> Department of Nuclear Medicine & PET Center, Aarhus University Hospital Aarhus, Denmark, 8000 Medical Research Laboratories Aarhus, Denmark, 8000 Less <<
NCT01436591 - Terminated - France ... More >> Centre François Baclesse Caen, France, 14076 Less <<
NCT01631929 - Terminated(Monitoring Committe... More >>e found significant & meaningful difference on main outcome) Less << - -
NCT01631929 Diabetes Keto... More >>acidosis Less << Not Applicable Terminated(Monitoring Committe... More >>e found significant & meaningful difference on main outcome) Less << - Argentina ... More >> Hospital General de NIños Pedro de Elizalde Buenos Aires, Argentina, C1270AAN Less <<
NCT01607944 - Completed - Denmark ... More >> Rigshospitalet Copenhagen, Denmark Less <<
NCT01371266 Pre-diabetes Not Applicable Completed - United States, North Dakota ... More >> Grand Forks Human Nutrition Research Center Grand Forks, North Dakota, United States, 58201 Less <<
NCT03330366 PreDiabetes Not Applicable Completed - -
NCT02482675 Prediabetes Not Applicable Active, not recruiting March 2018 United States, Ohio ... More >> The Ohio State University Columbus, Ohio, United States, 43210 Less <<
NCT03013985 Type 2 Diabetes Phase 4 Recruiting December 2018 United States, Georgia ... More >> Grady Memorial Hospital Recruiting Atlanta, Georgia, United States, 30303 Contact: Guillermo Umpierrez, MD    404-778-1665    geumpie@emory.edu    Contact: Saumeth Cardona, MD    404-616-4827    scardon@emory.edu    Emory University Recruiting Atlanta, Georgia, United States, 30322 Contact: Guillermo Umpierrez, MD    404-778-1665    geumpie@emory.edu    Contact: Saumeth Cardona, MD    404-616-4827    scardon@emory.edu    United States, Minnesota Hennepin County Medical Center Recruiting Minneapolis, Minnesota, United States, 55415 Contact: Ameer Khowaja, MD          Principal Investigator: Ameer Khowaja, MD          United States, Ohio Cleveland Clinic Recruiting Cleveland, Ohio, United States, 44195 Contact: M. C Lansang, MD          Principal Investigator: M. C Lansang, MD Less <<
NCT00657306 Cirrhosis With Ascites Phase 2 Unknown May 2009 Italy ... More >> San Giovanni Battista Hospital Turin, Italy, 10126 Less <<
NCT02565979 Pre-diabetes Not Applicable Recruiting December 2018 Netherlands ... More >> Maastricht University and Medical Centre Recruiting Maastricht, Limburg, Netherlands, 6200 MD Contact: Marlies de Ligt, MSc    +31 433 881587    marlies.deligt@maastrcihtuniversity.nl    Contact: Patrick Schrauwen, Prof., Dr.    +31 433 881502    p.schrauwen@maastrichtuniversity.nl Less <<
NCT02857764 - Completed - -
NCT02027571 Prediabetes T... More >>ype 2 Diabetes Obesity Less << Not Applicable Completed - United States, Tennessee ... More >> Clinical Research Center, University of Tennessee Health Scienc Ctr Memphis, Tennessee, United States, 38104 Less <<
NCT02587507 Inflammation Not Applicable Completed - -
NCT01721915 Polycystic Ovary Syndrome ... More >> Healthy Vitamin D Deficiency Less << Phase 4 Completed - Austria ... More >> Medical University of Graz, Department of Internal Medicine, Division of Endocrinology and Metabolism Graz, Austria, 8036 Less <<
NCT01736930 Type 1 Diabetes Phase 2 Completed - United States, California ... More >> Stanford University Stanford, California, United States, 94305 United States, Colorado Barbara Davis Center for Childhood Diabetes Aurora, Colorado, United States, 80045 Less <<
NCT02175459 - Recruiting December 2018 Italy ... More >> Endocrinology - Catholic University Recruiting Rome, RM, Italy, 00168 Principal Investigator: ANDREA GIACCARI, MD, PHD Less <<
NCT03216460 Type1 Diabetes Mellitus Not Applicable Recruiting August 31, 2018 United States, California ... More >> Stanford University Recruiting Palo Alto, California, United States, 94305 Contact: Bruce Buckingham, MD       bbendo@stanford.edu    Contact: Liana Hsu    (650) 725-3939    ljhsu@stanford.edu    United States, Colorado University of Colorado Denver Recruiting Denver, Colorado, United States, 80045 Contact: Gregory Forlenza, MD       gregory.forlenza@ucdenver.edu    Contact: Katelin Thivener    (303) 724-9998    katelin.thivener@ucdenver.com    United States, Connecticut Yale University School of Medicine Not yet recruiting New Haven, Connecticut, United States, 06511 Contact: Jennifer Sherr, MD, PhD       jennifer.sherr@yale.edu    Contact: Lori Carria, MS    (203) 737-3595    lori.carria@yale.edu Less <<
NCT00789191 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT03062592 Type2 Diabetes Mellitus ... More >> Obesity Less << Not Applicable Completed - -
NCT00192621 HIV Infections ... More >> Dyslipidemias Glucose Metabolism Disorders Metabolic Diseases Lipodystrophy Cardiovascular Disease Less << Phase 4 Completed - Australia, New South Wales ... More >> St Vincents Hospital Sydney, New South Wales, Australia, 2010 Less <<
NCT03716479 Diet Modification Not Applicable Recruiting September 1, 2019 United States, Minnesota ... More >> Department of Food Science and Nutrition Recruiting Saint Paul, Minnesota, United States, 55108 Contact: Joanne Slavin, PhD    612-624-7234       Principal Investigator: Joanne Slavin Less <<
NCT03082859 Type 2 Diabetes Not Applicable Recruiting July 2017 United Kingdom ... More >> Ulster University Recruiting Londonderry, United Kingdom Contact: Richard S Metcalfe, PhD    02871675037    r.metcalfe@ulster.ac.uk Less <<
NCT00992901 Post Bariatricsurgery ... More >> Hypoglycemia Less << Early Phase 1 Recruiting July 2020 United States, Texas ... More >> South Texas Veterans Health Care System Recruiting San Antonio, Texas, United States, 78229 Contact: Marzieh Salehi    210-567-6691    salehi@uthscsa.edu    Contact: Andrea Hansis-Diarte    210-567-6691    hansisdiarte@uthscsa.edu    Principal Investigator: Marzieh Salehi, MD, MS Less <<
NCT00626080 Type 1 Diabetes Not Applicable Completed - Netherlands ... More >> VU University Medical Center Amsterdam, Netherlands, 1081 HV Less <<
NCT00741026 Insulin Resistance ... More >> Diabetes Mellitus Less << Not Applicable Completed - United States, Pennsylvania ... More >> Penn State College of Medicine, Penn State Milton S. Hershey Medical Center Hershey, Pennsylvania, United States, 17033 Less <<
NCT00789191 - Completed - -
NCT00741026 - Completed - -
NCT03083587 Obesity Insul... More >>in Resistance Sedentary Lifestyle Less << Not Applicable Recruiting December 31, 2019 Sweden ... More >> Danderyd Hospital Recruiting Stockholm, Sweden, 182 88 Contact: Erik Naslund, MD, PhD       Erik.Naslund@ki.se Less <<
NCT00742456 Hypertension ... More >>Obesity Less << Not Applicable Completed - Netherlands ... More >> University Hospital Maastricht Maastricht, Netherlands, 6202 AZ Less <<
NCT03755479 - Enrolling by invitation December 1, 2019 Qatar ... More >> Sidra Medicine Doha, Qa, Qatar, 26999 Less <<
NCT01961180 Polycystic Ovary Syndrome Phase 4 Completed - Denmark ... More >> Department of Endocrinology, Odense University Hospital Odense, Denmark, 5000 Less <<
NCT01792089 - Completed - Switzerland ... More >> Centre Hospitalier Universitaire Vaudois Lausanne, VD, Switzerland Less <<
NCT01296516 Gestational Diabetes ... More >> Glucose Intolerance Less << Not Applicable Completed - United States, Louisiana ... More >> Pennington Biomedical Research Center Baton Rouge, Louisiana, United States, 70808 Less <<
NCT01736930 - Completed - -
NCT01086189 - Completed - Sweden ... More >> Skane University Hospital Malmo, Skane, Sweden, 205 02 Less <<
NCT03697486 PYY Ghrelin ... More >> Appetite Gut Hormones Obesity Protein Consumption Less << Not Applicable Completed - Indonesia ... More >> Departement of Nutrition, Faculty of Medicine Universitas Indonesia Jakarta, Jakarta Pusat, Indonesia, 10110 Less <<
NCT00616876 Necrotizing Enterocolitis ... More >> Sepsis Less << Phase 2 Completed - Israel ... More >> NICU, Department of Neonatology, Bnai Zion Medical Center Haifa, Israel, 31048 Less <<
NCT02629952 Type 2 Diabetes Not Applicable Recruiting February 2018 Australia, Tasmania ... More >> Menzies Institute for Medical Research Recruiting Hobart, Tasmania, Australia, 7000 Contact: Michelle A Keske, PhD    +61 3 6226 2669    Michelle.Keske@utas.edu.au    Contact: Keske Less <<
NCT00383877 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - China ... More >> Beijing, China Less <<
NCT01698502 - Completed - Denmark ... More >> University of Copenhagen, Faculty of Health Sciences Copenhagen, North, Denmark, 2200 Less <<
NCT02827526 Pain Phase 4 Recruiting December 2018 United States, Illinois ... More >> NorthShore University HealthSystem Recruiting Evanston, Illinois, United States, 60201 Contact: Glenn S Murphy, MD    847-570-2760    dgmurphy2@yahoo.com Less <<
NCT01929798 Type 1 Diabetes Mellitus Early Phase 1 Completed - United States, California ... More >> Sansum Diabetes Research Institutute Santa Barbara, California, United States, 93105 Less <<
NCT01698502 - Completed - -
NCT00500240 - Terminated(Terminated early du... More >>e to futility.) Less << - -
NCT02525705 Oesophageal Atresia ... More >> Dumping Syndrome Less << Not Applicable Recruiting June 2019 France ... More >> Hôpital Pellegrin - Hôpital d'Enfants, Recruiting Bordeaux, France Contact: Thierry Lamireau, MD       thierry.lamireau@chu-bordeaux.fr    Principal Investigator: Thierry Lamireau, MD          CHU Grenoble Recruiting Grenoble, France Contact: Christian Piolat, MD,PhD       cpiolat@chu-grenoble.fr    Principal Investigator: Christian Piolat, MD, PhD          Hôpital Jeanne de Flandre CHRU Recruiting Lille, France Contact: Laurent Michaud, MD       laurent.michaud@chru-lille.fr    Principal Investigator: Laurent Michaud, MD          Hôpital Edouard Herriot,Unité d'Hépatogastroentérologie et Nutrition Pédiatriques Recruiting Lyon, France Contact: Alain Lachaux, MD,PhD       alain.lachaux@chu-lyon.fr    Principal Investigator: Alain Lachaux, MD,PhD          CHU Nantes Recruiting Nantes, France Contact: Huges Piloquet, MD       hugues.piloquet@chu-nantes.fr    Principal Investigator: Huges Piloquet, MD          AP-HP, Hôpital Necker Recruiting Paris, France Contact: Christel Chalouhi, MD          Principal Investigator: Christel Chalouhi, MD          Hôpital Robert Debré ,Service de chirurgie viscérale et urologique Recruiting Paris, France Contact: Marc Bellaiche, MD, Phd       marc.bellaiche@rdb.aphp.fr    Principal Investigator: Marc Bellaiche, MD,PhD          CHU Rouen Recruiting Rouen, France Contact: Frédéric Elbaz, MD       frederic.elbaz@chu-rouen.fr    Principal Investigator: Frédéric Elbaz, MD          CHU Strasbourg Recruiting Strasbourg, France Contact: Anne Schneider, MD       Schneider.an@orange.fr    Principal Investigator: Anne Schneider, MD          CHU Toulouse, Hôpital Enfant Recruiting Toulouse, France Contact: Anne Breton, MD       breton.a@chu-toulouse.fr    Principal Investigator: Anne Breton, MD Less <<
NCT00500240 Leukemia Lymp... More >>homa Less << Phase 3 Terminated(Terminated early du... More >>e to futility.) Less << - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT03034759 Diabetes Mellitus Not Applicable Not yet recruiting December 2018 United States, Connecticut ... More >> Yale Pediatric Diabetes Research Program Not yet recruiting New Haven, Connecticut, United States, 06511 Contact: Michelle Van Name Less <<
NCT01722643 Type 1 Diabetes Not Applicable Completed - United States, New Hampshire ... More >> Dartmouth College Hanover, New Hampshire, United States, 03755 Less <<
NCT00659477 Diabetes Mellitus, Type 2 Phase 4 Completed - Czech Republic ... More >> Sanofi-Aventis Administrative Office Praha, Czech Republic Less <<
NCT02151188 Diabetes Impa... More >>ired Glucose Tolerance Obesity Less << Not Applicable Completed - Singapore ... More >> Clinical Nutrition Research Centre Singapore, Singapore, 117599 Less <<
NCT03235934 - Not yet recruiting October 1, 2021 Canada, Ontario ... More >> Princess Margaret Cancer Centre Toronto, Ontario, Canada, M5G 2M9 Less <<
NCT02747472 Glucose Metabolism Not Applicable Completed - Denmark ... More >> Center for Diabetes Research Copenhagen, Gentofte, Denmark, 2900 Less <<
NCT03627923 - Not yet recruiting August 1, 2021 -
NCT02925299 Diabetes Mellitus ... More >> Diabetes Mellitus, Type 1 Glucose Metabolism Disorders Endocrine System Diseases Autoimmune Diseases Less << Not Applicable Recruiting October 2019 United States, California ... More >> Stanford University Not yet recruiting Palo Alto, California, United States, 95032 Contact: Bruce Buckingham, MD    650-725-6549    buckingham@stanford.edu    Contact: Liana Hsu, RN    650-735-3939    ljhsu@stanford.edu    United States, Colorado University of Colorado Denver School of Medicine Barbara Davis Center Not yet recruiting Aurora, Colorado, United States, 80045 Contact: Paul Wadwa, MD    303-724-6742    Laurel.Messer@ucdenver.edu    Contact: Laurel Messer, RN, MPH, CDE    (303) 724-6742    Laurel.Messer@ucdenver.edu    United States, Connecticut Yale University Not yet recruiting Hartford, Connecticut, United States, 06520 Contact: Stuart Weinzimer    203-785-7924    stuart.weinzimer@yale.edu    Contact: Lori Carria    203-737-3595    lori.carria@yale.edu    United States, Indiana Indiana University Not yet recruiting Indianapolis, Indiana, United States, 43202 Contact: Linda DiMeglio, MD    317-274-3889    dimeglio@iu.edu    Contact: Megan L. Legge    317-274-3889    mlegge@iu.edu    United Kingdom University of Cambridge Recruiting Cambridge, Cambridgeshire County, United Kingdom, CB2 0QQ Contact: Carlo Acerini, MD    +44 (0)1223 336 865    mt641@medschl.cam.ac.uk    Contact: Janet Allen, RN    44 1223 769064    ja305@medschl.cam.au.uk    Principal Investigator: Carlo Acerini, MD          Nottingham Children's Hospital Not yet recruiting Nottingham, England, United Kingdom, NG5 1PB Contact: Tabitha Randell, MD    44 115 924 9924 ext 62336    Tabitha.Randell@nuh.nhs.uk    Southampton Children's Hospital Not yet recruiting Southampton, England, United Kingdom, SO16 6YD Contact: Nicola Trevelyan, MD    44 023 81 20 8518    Nicola.Trevelyan@uhs.nhs.uk    The Leeds Teaching Hospitals NHS Trust Not yet recruiting Leeds, West Yorkshire, United Kingdom, LS9 7TF Contact: Fiona Campbell, MD    44-1132-064-996    Jane.exall@nhs.net    Contact: Jane Exall    44-1132-064-996    Jane.exall@nhs.net Less <<
NCT01722643 - Completed - -
NCT01307904 Diabetes Mellitus Early Phase 1 Completed - United Arab Emirates ... More >> Internal Medicine Department, FMHS, UAE University Al Ain, Abu Dhabi, United Arab Emirates Less <<
NCT03577730 Pain, Postoperative Early Phase 1 Recruiting July 11, 2020 United States, Michigan ... More >> Michigan Medicine Recruiting Ann Arbor, Michigan, United States, 48109 Contact: Phillip E Vlisides, MD    734-936-4280    pvliside@med.umich.edu    Contact: Amy McKinney, MA    734-647-8129    adrongo@med.umich.edu Less <<
NCT01154881 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 1 Completed - Germany ... More >> Novo Nordisk Investigational Site Neuss, Germany, 41460 Less <<
NCT03124134 Obesity Diabe... More >>tes PreDiabetes Less << Not Applicable Completed - Canada ... More >> inVentiv Health Clinique Quebec City, Canada Less <<
NCT02570880 Glycemic Index (MeSH T483740) Not Applicable Unknown December 2015 Switzerland ... More >> ZHAW, Zurich Univeristy of Applied Sciences Wädenswil, Canton Zürich, Switzerland, 8820 Less <<
NCT02978807 - Completed - -
NCT01721811 Healthy Individuals ... More >> Patients With Diabetes. Less << Not Applicable Unknown - Denmark ... More >> Department of Ophthalmology, Glostrup University Hospital Recruiting Glostrup, Denmark, 2600 Contact: Oliver Klefter, MD    +45 38 63 48 18       Contact: Michael Larsen, Professor, DMSci Less <<
NCT00569322 - Completed - United States, Minnesota ... More >> Methodist Hospital - Park Nicollet Health Services Minneapolis, Minnesota, United States, 55416 Less <<
NCT02876029 Poor Glycemic Control Not Applicable Completed - -
NCT02214589 Prevention of Procedural Pain ... More >> Reduction of Procedural Pain Biochemical Effects of Oral Sucrose Less << Not Applicable Recruiting July 2019 United States, California ... More >> Loma Linda University Children's Hospital Recruiting Loma Linda, California, United States, 92354 Contact: Danilyn M Angeles, PhD    909-558-7563    dangeles@llu.edu Less <<
NCT00800085 Type 1 Diabetes Phase 1 Phase 2 Unknown October 2015 Belgium ... More >> Universitair Ziekenhuis Antwerpen Antwerpen, Belgium UZ Brussels Brussels, Belgium, 1090 UZ Gent Gent, Belgium, 9000 UZ Leuven Leuven, Belgium, 3000 Less <<
NCT02738996 Diabetes Not Applicable Unknown April 2017 -
NCT02852759 Insulin Resistance ... More >> Hyperglycemia Hyperinsulinemia Diabetes Obesity Less << Not Applicable Recruiting September 2018 China, Shanxi ... More >> First Affiliated Hospital of Xi'an Jiaotong University Recruiting Xi'an, Shanxi, China, 710061 Contact: Lihong Fan, Ph.D.    0086-13659299821    doc_fanlihong@126.com    Principal Investigator: Li Qiang, Ph.D. Less <<
NCT02468037 Type 2 Diabetes Mellitus ... More >> Prediabetes Less << Not Applicable Completed - -
NCT01572649 Type 2 Diabetes Mellitus Phase 1 Completed - United States, California ... More >> Investigational Site Number 840005 Chula Vista, California, United States, 91911 United States, Kansas Investigational Site Number 840001 Overland Park, Kansas, United States, 66212 United States, Kentucky Investigational Site Number 840003 Louisville, Kentucky, United States, 40202 Mexico Investigational Site Number 484001 Puebla, Mexico, 72190 South Africa Investigational Site Number 710002 Cape Town, South Africa, 7530 United Kingdom Investigational Site Number 826001 Leeds, United Kingdom, LS2 9LH Less <<
NCT00520065 Type 2 Diabetes Mellitus Phase 2 Completed - United States, Indiana ... More >> Provident Clinical Research and Consulting, Inc. Bloomington, Indiana, United States, 47403 Less <<
NCT00803296 - Completed - Denmark ... More >> Gentofte Hospital, University of Copenhagen Hellerup, Copenhagen, Denmark, 2900 Less <<
NCT02827383 Prediabetic State Not Applicable Completed - United States, Georgia ... More >> Clinical and Translational Research Unit, University of Georgia Athens, Georgia, United States, 30602 Less <<
NCT02729064 Ischemic Heart Disease ... More >> Aortic Aneurysm Less << Phase 1 Recruiting September 2019 Canada, Quebec ... More >> Royal Victoria Hospital McGill University Health Centre Recruiting Montreal, Quebec, Canada, H4A 3J1 Contact: Hiroaki Sato, MD., PhD.    5149341934 ext 36717    hiroaki.sato2@mcgill.ca Less <<
NCT01204216 Diabetes Mellitus ... More >> Impaired Fasting Glucose Prediabetes Less << Not Applicable Completed - United States, Ohio ... More >> Cincinnati VA Medical Center, Cincinnati, OH Cincinnati, Ohio, United States, 45220 Less <<
NCT03528174 Type 1 Diabetes Mellitus Not Applicable Completed - United States, Oregon ... More >> Oregon Health and Science University Portland, Oregon, United States, 97239 Less <<
NCT01830686 Insulin Resistance Not Applicable Completed - United States, Louisiana ... More >> Pennington Biomedical Research Center Baton Rouge, Louisiana, United States, 70808 Less <<
NCT02014220 Obesity Overw... More >>eight Diabetes Metabolic Syndrome Less << Not Applicable Completed - Canada, Ontario ... More >> Department of Nutritional Sciences Toronto, Ontario, Canada, M5S 3E2 Less <<
NCT00673790 Hypertension Phase 4 Completed - -
NCT02728414 Diabetes Mellitus, Type 2 Not Applicable Recruiting December 2017 China, Shanghai ... More >> Shanghai 10th People's Hospital Recruiting Shanghai, Shanghai, China, 200072 Contact: Cuiling Zhu, MD    18817951953l    1263856671@qq.com    Principal Investigator: Renyuan Gao, MD Less <<
NCT02482610 Prediabetes Not Applicable Active, not recruiting December 2017 United States, Ohio ... More >> The Ohio State University Columbus, Ohio, United States, 43210 Less <<
NCT00652379 Acromegaly In... More >>sulin Resistance Impaired Glucose Tolerance Less << Not Applicable Completed - Denmark ... More >> Department of Endocrinology, Aarhus University Hospital Aarhus C, Aarhus, Denmark, 8000 Less <<
NCT02094859 - Completed - Austria ... More >> Medical University Graz Graz, Austria, A-8036 Belgium Onze-Lieve-Vrouwziekenhuis Aalst, Belgium, 9300 Less <<
NCT01552213 Diabetes Preg... More >>nancy Less << Not Applicable Active, not recruiting March 2018 United States, California ... More >> Santa Clara Valley Medical Center San Jose, California, United States, 95108 Stanford University School of Medicine/Lucile Packard Childrens Hospital Stanford, California, United States, 94305 Less <<
NCT03167684 Sleep Apnea, Obstructive ... More >> Type 2 Diabetes Mellitus Less << Not Applicable Recruiting March 2020 Canada, Quebec ... More >> McGill University Health Centre - Research Institute Recruiting Montreal, Quebec, Canada, H4A2Y3 Contact: Sushmita Pamidi, MD          Principal Investigator: Sushmita Pamidi, MD Less <<
NCT03659799 Type 1 Diabetes Mellitus Phase 4 Not yet recruiting October 1, 2020 Canada, Quebec ... More >> Institut de recherches cliniques de Montréal Not yet recruiting Montréal, Quebec, Canada, H2W 1R7 Contact: Inès Boukabous       ines.boukabous@ircm.qc.ca Less <<
NCT02830113 Periodontitis ... More >> Prediabetes Less << Not Applicable Completed - -
NCT01267448 Diabetes Mellitus Type 2 ... More >> Severe Hyperglycemia - Blood Glucose Level >300mg/dl. Less << Phase 4 Unknown December 2012 United States, Illinois ... More >> John Stroger Hospital of Cook County Not yet recruiting Chicago, Illinois, United States, 60612 Contact: Ambika Babu, M.D.    312-864-0543    Ambika_Babu@rush.edu    Contact: Leon Fogelfeld, M.D.    312-864-0539    lfogelfe@cchil.org    Principal Investigator: Ambika Babu, M.D.          John Stroger Hospital of Cook County Recruiting Chicago, Illinois, United States, 60612 Contact: Ambika Babu, M.D.    312-864-0543    aamblee@hotmail.com    Contact: Leon Fogelfeld, M.D.    312-864-0539    lfogelfe@cchil.org    Principal Investigator: Ambika Babu, M.D. Less <<
NCT00911625 - Completed - -
NCT02903615 Diabetes Mellitus Not Applicable Recruiting December 2019 Australia, New South Wales ... More >> professor Katherine Samaras Recruiting Sydney, New South Wales, Australia, 2010 Contact: Katherine Samaras, MBBS FRACP PhD       k.samaras@garvan.org.au    Australia Garvan Institute to Medical Research Not yet recruiting Sydney, Australia Contact: Katherine Samaras       k.samaras@garvan.org.au Less <<
NCT02006836 Diabetes Not Applicable Completed - China, Hubei ... More >> Tongji Hospital Wuhan, Hubei, China, 430030 Less <<
NCT02215603 Prolonged Sitting ... More >> Breaking Prolonged Sitting With Physical Activity Less << Not Applicable Unknown December 2016 Denmark ... More >> Centre of Inflammation and Metabolism Recruiting Copenhagen, Denmark, 2100 Contact: Inge Holm          Principal Investigator: Bente Pedersen, PhD          Sub-Investigator: Fabiana Benatti, PhD Less <<
NCT02580110 Healthy Subjects Not Applicable Completed - Sweden ... More >> Food for Health Science Centre, Medicon Village, Lund University Lund, Sweden, , SE-223 81 LUND Less <<
NCT00465881 - Completed - United States, Minnesota ... More >> International Diabetes Center - Park Nicollet Health Services Minneapolis, Minnesota, United States, 55416 Less <<
NCT00747006 - Terminated(Business reasons) - -
NCT00747006 Diabetes Mellitus, Type 2 ... More >> Diabetes Mellitus, Type 1 Less << Phase 2 Terminated(Business reasons) - United States, California ... More >> Sansum Medical Research Institute Santa Barbara, California, United States, 93105 Less <<
NCT02238041 - Withdrawn(Discontinued program... More >>) Less << December 2015 -
NCT00234858 Hypertension ... More >>Metabolic Syndrome Less << Phase 4 Completed - -
NCT02006836 - Completed - -
NCT01580150 Blood Glucose, Postprandial ... More >> Blood Insulin, Postprandial Hyperglycemia Less << Not Applicable Completed - Finland ... More >> University of Eastern Finland Kuopio, Finland, FI-70211 Less <<
NCT02366767 Diabetes Mellitus, Type 1 Not Applicable Completed - United States, California ... More >> Camp Conrad-Chinnock Angelus Oaks, California, United States, 92305 Packard El Camino Hospital Mountain View, California, United States, 94040 Lucile Packard Children's Hospital Palo Alto, California, United States, 94304 Less <<
NCT03451253 Inflammatory Bowel Diseases ... More >> Short Bowel Syndrome Ileostomy - Stoma Less << Not Applicable Recruiting July 2019 United States, Massachusetts ... More >> Brighan and Women's Hospital Recruiting Boston, Massachusetts, United States, 02115 Contact: Alexandra Austin    617-732-5500    aaustin4@bwh.harvard.edu    Contact: Alexandra Austin          Principal Investigator: Joshua Korzenik, MD.          United States, Rhode Island Gastroenterology Associates Recruiting Providence, Rhode Island, United States, 02904 Contact: Alexandra Austin    617-732-5500 ext 6177325500    aaustin4@bwh.harvard.edu    Principal Investigator: Samir Shah, MD. Less <<
NCT01623388 - Withdrawn - United States, California ... More >> Scripps San Diego, California, United States, 92037 Less <<
NCT03650439 - Not yet recruiting October 31, 2019 -
NCT03435198 Volatile Organic Compounds ... More >> Hypoglycemia Type 1 Diabetes Mellitus Less << Not Applicable Active, not recruiting June 30, 2018 United States, Tennessee ... More >> Mountain States Health Alliance Johnson City, Tennessee, United States, 37604 Less <<
NCT01029444 Diabetes Mellitus Phase 3 Terminated(Administrative) - United States, Florida ... More >> Florida Atlantic University Boca Raton, Florida, United States, 33421 Less <<
NCT03731897 Plantar Fascitis Not Applicable Recruiting June 12, 2019 Turkey ... More >> Basak Mansiz-Kaplan Recruiting Ankara, Turkey, 06230 Contact: Basak Mansiz-Kaplan    5358582176    basakmansiz@hotmail.com Less <<
NCT02366767 - Completed - -
NCT02366572 Diabetes Prevention ... More >> Obesity Prevention Less << Not Applicable Active, not recruiting December 2017 -
NCT02510612 Diabetes Phase 4 Unknown December 2016 -
NCT00852982 Type 2 Diabetes ... More >> Impaired Glucose Tolerance Less << Not Applicable Unknown September 2009 Sweden ... More >> Primary health care center Stockholm, Sweden, SE 134 40 Less <<
NCT00805974 Type 1 Diabetes Not Applicable Terminated(difficulties for in... More >>cluding diabetic patients) Less << - France ... More >> University Hospital Grenoble, France Less <<
NCT02159846 - Completed - Malaysia ... More >> Medical Out-Patient Department (M-OPD),Hospital Tengku Ampuan Afzan Kuantan. Kuantan, Pahang, Malaysia, 25200 Less <<
NCT02130401 Type 2 Diabetes Not Applicable Completed - United States, North Carolina ... More >> UNC Highgate Specialty Center - UNC Diabetes Care Center Chapel Hill, North Carolina, United States, 27713 Less <<
NCT00683657 - Completed - -
NCT00683657 Type 2 Diabetes Phase 3 Completed - -
NCT01221467 Type 1 Diabetes Phase 2 Completed - United Kingdom ... More >> Department of Paediatrics, Weston paediatric diabetes centre Cambridge, Cambridgeshire, United Kingdom, CB2 0QQ Less <<
NCT03584607 - Recruiting December 2019 Austria ... More >> Medical University Graz, Division of Pulmonology Recruiting Graz, Steiermark, Austria, 8010 Contact: Horst Olschewski, MD    +43 (316) 385 12183    horst.olschewski@medunigraz.at    Contact: Gabor Kovacs, MD    +43 (316) 385 12183    gabor.kovacs@klinikum-graz.at    Principal Investigator: Bence M. Nagy, PhD Less <<
NCT02110511 Appetite and Glucose Responses Not Applicable Completed - United States, Indiana ... More >> Purdue University West Lafayette, Indiana, United States, 47907 Less <<
NCT00911625 Type 2 Diabetes ... More >> Renal Insufficiency Less << Phase 4 Completed - United States, Illinois ... More >> Northwestern University Medical Center Chicago, Illinois, United States, 60611 Rush University Medical Center Chicago, Illinois, United States, 60612 Loyola University Hospital Maywood, Illinois, United States, 60153 Less <<
NCT02072759 Glucose Intolerance Not Applicable Completed - Netherlands ... More >> Maastricht University Medical Center Maastricht, Limburg, Netherlands, 6229 ER Less <<
NCT03774069 Type 1 Diabetes Mellitus Not Applicable Not yet recruiting January 2020 Israel ... More >> Schnider Children's medical center Not yet recruiting Petach Tikva, Israel, 49202 Contact: Moshe Phillip, Prof    972-3-9253282    mosheph@clalit.org.il    Sub-Investigator: Revital Nimri, Dr.          Sub-Investigator: Shlomit Shalitin, Prof.          Sub-Investigator: Liat De Vries, Prof.          Sub-Investigator: Rachel Bello, Dr.          Sub-Investigator: Tal Oron, Dr.          Sub-Investigator: Michal Nevo Shenker, Dr.          Sub-Investigator: Naama Fish, Dr.          Sub-Investigator: Sari Karpel, Dr.          Sub-Investigator: Ariel Tenennbaum, Dr.          Sub-Investigator: Marie Muler, Dr.          Sub-Investigator: Judit Nir, Dr. Less <<
NCT01357603 Type1 Diabetes Phase 1 Completed - United States, California ... More >> Profil Institute for clinical Research Chula Vista, California, United States, 91911 Less <<
NCT02961179 Insulin Sensitivity ... More >> Type2 Diabetes Less << Not Applicable Recruiting January 2019 Canada ... More >> Research Center CHU de Quebec-Université Laval Recruiting Quebec, Canada, G1V 4G2 Contact: Sarah Chouinard-Castonguay, MSc    418-525-4444 ext 48729    Sarah.Chouinard-Castonguay@crchudequebec.ulaval.ca    Principal Investigator: Iwona Rudkowska, PhD Less <<
NCT00899483 Type 2 Diabetes Not Applicable Unknown - United Kingdom ... More >> University Hospital Birmingham Not yet recruiting Birmingham, West Midlands, United Kingdom, B15 2TH Principal Investigator: Robert S Bonser          Sub-Investigator: Ashvini Menon          Principal Investigator: Michael P Frenneaux Less <<
NCT03014323 Insulin Sensitivity ... More >> Oxidative Stress Less << Phase 1 Withdrawn(No fundings) December 2018 United States, Tennessee ... More >> Cyndya Shibao Nashville, Tennessee, United States, 37027 Less <<
NCT01879059 Insulin Resistance Not Applicable Completed - United States, Missouri ... More >> University of Missouri Columbia, Missouri, United States, 65211 Less <<
NCT02706821 Prediabetes Not Applicable Completed - -
NCT03018496 Insulin Resistance ... More >> Age Problems Less << Not Applicable Recruiting - United Kingdom ... More >> University Of Nottingham Recruiting Derby, United Kingdom, DE22 3NE Contact: Philip Herrod, BMBS       philip.herrod@nottingham.ac.uk    Sub-Investigator: Philip Herrod, BMBS          Principal Investigator: Beth Philips, PhD          Sub-Investigator: Jon Lund, PhD Less <<
NCT00181155 Congestive Heart Failure Phase 2 Completed - United States, Maryland ... More >> Johns Hopkins Hospital Baltimore, Maryland, United States, 21287 Less <<
NCT03667053 Hypoglycemia Phase 3 Recruiting August 1, 2019 United States, California ... More >> AMCR Institute, Inc Recruiting Escondido, California, United States, 92025 Contact: Tim Bailey Less <<
NCT02674906 Intra Operative Bleeding, Bloo... More >>d Salvage Less << Not Applicable Completed - Belgium ... More >> Ziekenhuis Oost-Limburg Genk, Limburg, Belgium, 3600 Less <<
NCT01789593 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 1 Completed - Denmark ... More >> Novo Nordisk Investigational Site Århus C, Denmark, 8000 Less <<
NCT03157414 Diabetes Mellitus ... More >> Renal Insufficiency Safety Issues Less << Phase 4 Active, not recruiting July 2018 Norway ... More >> Oslo University Hospital Rikshospitalet Oslo, Norway, 0424 Less <<
NCT02516150 Type 1 Diabetes Mellitus Phase 4 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Diabetes Research Center Boston, Massachusetts, United States, 02114 Less <<
NCT01879059 - Completed - -
NCT00564395 - Completed - -
NCT02374281 Newborn Neona... More >>tal Screening Less << Phase 3 Completed - France ... More >> CHU de Saint-Etienne Saint-etienne, France, 42000 Less <<
NCT00181155 - Completed - -
NCT02682940 Diabetes Mellitus, Type 1 ... More >> Hypoglycemia Less << Not Applicable Terminated(Insufficient Resour... More >>ces) Less << - United States, Georgia ... More >> Atlanta Diabetes Associates Atlanta, Georgia, United States, 30318 Less <<
NCT00564395 Type 1 Diabetes Mellitus Phase 4 Completed - United States, Texas ... More >> Texas Children's Hospital Endocrine and Diabetes Clinic Houston, Texas, United States, 77030 Less <<
NCT02445781 Hypoglycemia Early Phase 1 Recruiting December 2018 United States, Maryland ... More >> University of Maryland, Baltimore Recruiting Baltimore, Maryland, United States, 21201 Contact: Donna Tate    410-706-5643       Contact: Maka Hedrington, MD    410-706-5623    mhedrington@medicine.umaryland.edu    Principal Investigator: Stephen N Davis, MBBS Less <<
NCT03711682 Type 2 Diabetes Mellitus Phase 2 Completed - El Salvador ... More >> Unidad Comunitaria de Salud Familiar Intermedia de Comasagua (UCSFI-Comasagua) Comasagua, La Libertad, El Salvador, 0504 Less <<
NCT02654301 Postprandial Hyperglycemia Not Applicable Completed - -
NCT03161964 Type 1 Diabetes Mellitus Phase 2 Recruiting July 31, 2019 United States, Utah ... More >> University of Utah Recruiting Salt Lake City, Utah, United States, 84132 Contact: Sally Bradstreet    801-581-4684    Sally.Bradstreet@hsc.utah.edu Less <<
NCT02516150 - Completed - -
NCT01182493 - Completed - -
NCT01507597 Type 2 Diabetes ... More >> Type 1 Diabetes Less << Not Applicable Completed - Denmark ... More >> Gentofte University Hospital Hellerup, Denmark, DK-2900 Less <<
NCT01137695 Type 2 Diabetes Mellitus Phase 3 Unknown April 2012 United States, New Jersey ... More >> North Jersey Endocrine Consultants Denville, New Jersey, United States, 07834 United States, New York University Physicians Group Staten Island, New York, United States, 10301 United States, Pennsylvania St. Mary Medical Center Langhorne, Pennsylvania, United States, 19047 Less <<
NCT02312063 Diabetes Mellitus, Type 2 Phase 4 Completed - Japan ... More >> Saiseikai Noe Hospital Osaka Osaka, Japan, 536-0001 Kansai Electric Power Hospital Osaka, Japan, 553-0003 Less <<
NCT01906970 Diabetes Mellitus Not Applicable Active, not recruiting June 2020 Germany ... More >> Profil Institut für Stoffwechselforschung GmbH Neuss, NRW, Germany, 41460 Less <<
NCT01718522 - Completed - -
NCT01182493 Diabetes Mellitus, Type 2 Not Applicable Completed - -
NCT03522896 Effect of Food on Postprandial... More >> Hyperglycemia Less << Not Applicable Completed - United Kingdom ... More >> University of Leeds Leeds, United Kingdom, LS29JT Less <<
NCT01369979 - Completed - Denmark ... More >> Aarhus University Hospital, PET-centre Aarhus C, Denmark, 8000 Less <<
NCT01386736 Insulin Resistance ... More >> Obesity Vitamin D25 Insufficiency Less << Phase 4 Unknown March 2012 United States, New York ... More >> Weill Cornell Medical College Recruiting New York, New York, United States, 10021 Contact: Sadana Balachandar, MD    212-746-3462    sab9082@nyp.org    Principal Investigator: Maria Vogiatzi, MD Less <<
NCT01698931 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 4 Completed - Italy ... More >> Novo Nordisk Investigational Site Padova, Italy, 35137 Less <<
NCT03674281 Type 1 Diabetes Mellitus ... More >> Cognitive Change Less << Not Applicable Recruiting March 2019 United States, Virginia ... More >> University of Virginia Recruiting Charlottesville, Virginia, United States, 22908 Contact: Ryan McFadden, RN    434-924-7164    rkm2f@virginia.edu    Principal Investigator: Sue Brown, MD          Sub-Investigator: Mark DeBoer, MD          Sub-Investigator: Linda Gonder-Frederick, PhD          Sub-Investigator: Jaclyn Shepard, PsyD          Sub-Investigator: Daniel Chernavvsky, MD Less <<
NCT03646292 NAFLD - Nonalcoholic Fatty Liv... More >>er Disease Type2 Diabetes Less << Phase 4 Not yet recruiting March 2021 Korea, Republic of ... More >> Yonsei University College of Medicine, Department of Internal Medicine, Division of Endocrinology, Severance Hospital, Diabetes Center Not yet recruiting Seoul, Korea, Republic of, 03722 Contact: Bong Soo Cha, MD    +82-2-2228-1932    bscha@yuhs.ac Less <<
NCT02068807 Infant, Newborn, Diseases ... More >> Other Lipid Storage Disorders Less << Phase 1 Phase 2 Completed - Italy ... More >> AOUS Siena, Italy, 53100 Less <<
NCT03288064 Athletic Performance ... More >> Oxidative Stress Inflammation Less << Not Applicable Completed - Greece ... More >> School of Physical Education and Sport Science, University of Thessaly Trikala, Thessaly, Greece, 42100 Less <<
NCT03556605 Diabetes Mellitus Not Applicable Not yet recruiting May 21, 2019 United States, Pennsylvania ... More >> La Comunidad Hispana (LCH) Health Center Not yet recruiting West Chester, Pennsylvania, United States, 19348 Less <<
NCT00643110 Type 1 Diabetes Not Applicable Withdrawn(Not funded) - United States, Nebraska ... More >> Creighton Diabetes Center Omaha, Nebraska, United States, 68131 Less <<
NCT01852968 - Active, not recruiting December 2018 United States, Minnesota ... More >> Clinical and Translational Science Institute and Center for Magnetic Resonance Research, University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT03340467 Diabetes Mellitus Not Applicable Not yet recruiting September 30, 2018 -
NCT01706042 Dietary Prevention Not Applicable Completed - Sweden ... More >> Applied Nutrition and Food Chemistry, Lund University Lund, Sweden, SE-22100 Less <<
NCT00614783 - Completed - United States, Alabama ... More >> Accelovance Huntsville, Alabama, United States, 35802 United States, California Accelovance San Diego, California, United States, 92108 Veteran's Administration Hospital San Diego, California, United States, 92161 United States, District of Columbia MedStar Research Institute Washington, DC, District of Columbia, United States, 20003 United States, Hawaii Kaiser Permanente-Center for Health Research Honolulu, Hawaii, United States, 96813 United States, Illinois Radiant Research Chicago, Illinois, United States, 60610 Accelovance Peoria, Illinois, United States, 61602 United States, Kansas Radiant Research Overland Park, Kansas, United States, 66202 United States, Minnesota Radiant Research Edina, Minnesota, United States, 55435 United States, New Mexico Lovelace Scientific Resources Albuquerque, New Mexico, United States, 87108 United States, New York New York Hospital Queens-Lang Research Center Flushing, New York, United States, 11355 United States, Ohio Radiant Research Cincinnati, Ohio, United States, 45249 United States, Oklahoma Oklahoma Diabetes Center, University of Oklahoma Oklahoma City, Oklahoma, United States, 73104 United States, Pennsylvania Diabetes and Lipid Research, University of Pittsburgh Pittsburgh, Pennsylvania, United States, 15213 United States, Texas Radiant Research San Antonio, Texas, United States, 78229 Less <<
NCT01120444 Diabetes Phase 1 Phase 2 Completed - Germany ... More >> Profil Institute of Clinical Research Neuss, Germany, D41460 Less <<
NCT02040571 Type 1 Diabetes Not Applicable Completed - Australia, Victoria ... More >> St Vincent's Hospital Melbourne Fitzroy, Victoria, Australia, 3065 Less <<
NCT00835939 Achilles Tendinopathy ... More >> Achilles Tendon Enthesopathy Mid-Portion Achilles Tendinopathy Insertional Achilles Tendinopathy Non-Insertional Achilles Tendinopathy Less << Phase 2 Phase 3 Unknown - Canada, Alberta ... More >> University of Calgary Calgary, Alberta, Canada, T2N 1N4 Less <<
NCT03726697 Neonatal Hypoglycemia ... More >> Infant, Small for Gestational Age Macrosomia, Fetal Intrauterine Growth Restriction Premature Infant Neonatal; Hypoglycemia, Diabetes, Maternal Less << Not Applicable Not yet recruiting November 1, 2020 -
NCT02054429 Ischemic Stroke Phase 1 Unknown December 2018 United States, New York ... More >> University of Buffalo Neurosurgery Recruiting Buffalo, New York, United States, 14203 Principal Investigator: Adnan H Siddiqui, M.D, PhD Less <<
NCT00821665 Type 2 Diabetes ... More >> Glycemic Control Less << Not Applicable Completed - Netherlands ... More >> Maastricht University Maastricht, Limbrug, Netherlands, 6200 MD Less <<
NCT02204384 Dietary Modification ... More >> Diabetes Mellitus Type 2 Insulin Tolerance Diabetic Blood Glucose Monitoring Less << Not Applicable Completed - Brazil ... More >> Hospital de Clínicas de Porto Alegre Porto Alegre, Rio Grande do Sul, Brazil, 90035-903 Less <<
NCT02913079 Insulin Sensitivity ... More >> Glucose Tolerance Sedentary Behaviour Physical Activity Less << Not Applicable Completed - Canada, Prince Edward Island ... More >> University of Prince Edward Island Charlottetown, Prince Edward Island, Canada, C1A 4P3 Less <<
NCT01819220 Hypertension Phase 4 Completed - Korea, Republic of ... More >> Yonsei universty medical center Seoul, Korea, Republic of, 120-752 Less <<
NCT02526810 Diabetes Mellitus, Type 2 Phase 4 Unknown September 2016 China, Guangdong ... More >> Endocrinology department of the Third Affiliated Hospital of Sun Yet-san University Recruiting Guangzhou City, Guangdong, China, 510630 Contact: Zeng Longyi, Professor    0086-020-85252160    zssynfmk@163.com    Contact: Lin Shuo, Doctor    0086-020-85253408    littltpig@yeah.net    Principal Investigator: Zeng Longyi, Professor          Sub-Investigator: lin Shuo, Doctor Less <<
NCT01885546 Diabetes Mellitus Not Applicable Completed - United States, Massachusetts ... More >> MassResearch, LLC Waltham, Massachusetts, United States, 02453 Less <<
NCT02282176 Bronchopulmonary Dysplasia Phase 3 Withdrawn January 2018 Belgium ... More >> Centre Hospitalier Chrétien (CHC) Liège, Belgium France Assistance Publique Hôpitaux de Paris (APHP) Paris, France Inserm-Transfert (IT) Paris, France Institut National de la Santé et de la Recherche Médicale (INSERM) Paris, France Only for children pharmaceuticals (04CP) Paris, France Germany Heinrich-Heine-Universität Düsseldorf (UDUS) Dusseldorf, Germany University of Ulm (UUlm) Ulm, Germany Hungary Semmelweis University Budapest, Faculty of Medicine (SOTE) Budapest, Hungary Pandy Kalman County Hospital Gyula, Hungary Italy Mario Negri Institute (IRFMN) Milan, Italy Luxembourg Advanced Biological Laboratories ABL (ABL SA) Luxembourg, Luxembourg Netherlands Erasmus-University Medical Center (ERAMUS) Rotterdam, Netherlands Sweden Karolinska Institutet (KI) Stockholm, Sweden United Kingdom Cardiff University (CU) Cardiff, United Kingdom University of Liverpool (UOL) Liverpool, United Kingdom Simcyp Limited (SimCyp) Sheffield, United Kingdom Less <<
NCT00248625 Acute Liver Failure ... More >> Hepatic Encephalopathy Less << Phase 3 Completed - -
NCT02682342 - Recruiting April 2019 United States, Wisconsin ... More >> Medical College of Wisconsin Recruiting Milwaukee, Wisconsin, United States, 53226 Contact: Michael Widlansky, MD, MPH    414-955-6755    mwidlans@mcw.edu Less <<
NCT00248625 - Completed - -
NCT03075371 Anorexia Nervosa ... More >> Healthy Less << Not Applicable Recruiting February 2018 Germany ... More >> University Hospital Heidelberg Recruiting Heidelberg, Germany Contact: Joe Simon, Dr. Dipl. Psych.       joe.simon@med.uni-heidelberg.de Less <<
NCT01829555 Type 1 Diabetes Not Applicable Completed - United States, Connecticut ... More >> Pediatric Endocrinology, Yale University New Haven, Connecticut, United States, 06519 Less <<
NCT02517307 Very Long-chain Acyl-CoA Dehyd... More >>rogenase Deficiency Trifunctional Protein Deficiency Long-chain 3-hydroxyacyl-CoA Dehydrogenase Deficiency Medium-chain Acyl-CoA Dehydrogenase Deficiency Normal Volunteers Carnitine Palmitoyltransferase II Deficiency, Myopathic Less << Not Applicable Recruiting April 2020 United States, Oregon ... More >> Oregon Health & Science University Recruiting Portland, Oregon, United States, 97239 Contact: Julie Martin, MS    503-494-5313    martijul@ohsu.edu    Contact: Melanie Gillingham, PhD    503-494-1682    gillingm@ohsu.edu Less <<
NCT02526615 Insulin Sensitivity ... More >> Type 2 Diabetes Less << Phase 4 Completed - Finland ... More >> Turku PET Centre Turku, Finland, 20520 Turku university hospital, PET center Turku, Finland, 20520 Turku PET Centre (Turku University Hospital) Turku, Finland, 20521 Less <<
NCT03304158 Type 2 Diabetes Mellitus Not Applicable Active, not recruiting October 2018 Nepal ... More >> A semi-urban area of Pokhara-Lekhnath Metropolitan City of Nepal Pokhara, Nepal Less <<
NCT01353118 Type 2 Diabetes Not Applicable Completed - United Kingdom ... More >> Imperial Weight Centre, Charing Cross Hospital, London, United Kingdom, W6 8FR Charing Cross Hospital London, United Kingdom, W6 8RF Less <<
NCT00450567 - Completed - United States, California ... More >> Jonsson Comprehensive Cancer Center at UCLA Los Angeles, California, United States, 90095-1781 Less <<
NCT02189395 Type 2 Diabetes Mellitus Phase 4 Terminated(difficulty in subje... More >>ct recruitment) Less << - United States, California ... More >> Riverside County Regional Medical Center Moreno Valley, California, United States, 92555 Less <<
NCT02624817 Permanent Neonatal Diabetes Me... More >>llitus Less << Phase 4 Completed - Norway ... More >> Haukeland University Hospital Bergen, Norway, 5021 Less <<
NCT00728065 Post Prandial Blood Glucose Not Applicable Completed - Canada, Ontario ... More >> Clinical Nutrition and Risk Factor Modification Centre Toronto, Ontario, Canada, M5C 2T2 Less <<
NCT01629251 Type 1 Diabetes Phase 2 Completed - United Kingdom ... More >> Wellcome Trust Clinical Research Facility, Addenbrooke's Hospital Cambridge, United Kingdom, CB20QQ Less <<
NCT02624830 Permanent Neonatal Diabetes Me... More >>llitus Less << Phase 4 Unknown February 2016 Norway ... More >> Haukeland University Hospital Bergen, Norway, 5021 Less <<
NCT03690583 Pneumonia Chi... More >>ldren, Only Less << Phase 1 Completed - Mexico ... More >> Hospital Pediatrico de Coyoacan Mexico city, Ciudad De México, Mexico, 04500 Hospital General de Mexico Mexico, Mexico, 06726 Less <<
NCT02009254 Obesity Overw... More >>eight Diabetes Metabolic Syndrome Less << Not Applicable Completed - -
NCT01427998 Diabetes Phase 3 Completed - -
NCT02941874 - Recruiting November 2018 France ... More >> Institut de Biologie - Pathologie Recruiting Grenoble, Isere, France, 38043 Contact: Bottari Serge, MD, PHD    0476637111 ext 33    SBottari@chu-grenoble.fr Less <<
NCT02449577 Alcohol Consumption ... More >> Insulin Resistance Less << Early Phase 1 Completed - Denmark ... More >> Department of Nutrition, Exercise and Sports, University of Copenhagen Frederiksberg C, Denmark, 1958 Less <<
NCT03064321 Insomnia Diab... More >>etes Mellitus, Type 2 Less << Not Applicable Enrolling by invitation March 30, 2020 United States, Pennsylvania ... More >> University of Pittsburgh School of Nursing Pittsburgh, Pennsylvania, United States, 15261 Less <<
NCT02913703 Type 2 Diabetes Phase 1 Active, not recruiting December 2019 United States, North Carolina ... More >> Duke Center For Living Durham, North Carolina, United States, 27705 Less <<
NCT03023891 Glucocorticoids Toxicity ... More >> Glucose Intolerance Less << Phase 1 Recruiting June 2019 United States, Tennessee ... More >> Vanderbilt University Medical Center -CRC Recruiting Nashville, Tennessee, United States, 37203 Contact: Annette Oeser, CCRP    615-322-3778    annette.oeser@vanderbilt.edu Less <<
NCT03415139 - Not yet recruiting April 2025 United States, Tennessee ... More >> Vanderbilt University Medical Center Not yet recruiting Nashville, Tennessee, United States, 37232 Contact: VICC Clinical Trials Information Program    800-811-8480       Contact: Brian G Engelhardt, MD    615-936-0381    brian.engelhardt@vanderbilt.edu Less <<
NCT00675987 - Completed - -
NCT01401127 - Completed - United Kingdom ... More >> Wycombe Hospital High Wycombe, Buckinghamshire, United Kingdom, HP11 2TT Less <<
NCT00675987 Obesity Hyper... More >>tension Hyperglycemia Less << Phase 4 Completed - United States, Arkansas ... More >> CAVS Clinical Research Center Little Rock, Arkansas, United States, 72205 United States, California VA San Diego Health Care System San Diego, California, United States, 92161 United States, Florida University of Miami Diabetes Research Institute Miami, Florida, United States, 33136 United States, Indiana Indiana University School of Medicine Indianapolis, Indiana, United States, 46202 United States, Massachusetts Brigham and Women's Hospital Cardiovascular Division Boston, Massachusetts, United States, 02115 United States, New York St. Lukes Roosevelt Hospital New York, New York, United States, 10025 United States, Pennsylvania University of Pennsylvania School of Medicine Philadelphia, Pennsylvania, United States, 19104 United States, Texas University of Texas SW Medical Center at Dallas Dallas, Texas, United States, 75390 Hypertension Clinical Pharmacology Baylor Clinic Houston, Texas, United States, 77030 Less <<
NCT01128647 - Completed - Switzerland ... More >> Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland, CH-1011 Less <<
NCT03428945 Type1 Diabetes Mellitus Phase 2 Recruiting August 2024 United States, Colorado ... More >> Barbara Davis Center Recruiting Aurora, Colorado, United States, 80045 Contact: Betsy Burke    303-724-6766    Betsy.Burke@ucdenver.edu    Principal Investigator: Andrea Steck, MD          United States, Florida University of Florida Recruiting Gainesville, Florida, United States, 32610 Contact: Jennifer Hosford    352-294-5759    jennifer.hosford@medicine.ufl.edu    Contact: Paula Towe    352-294-5761    pdtowe@peds.ufl.edu    Principal Investigator: Desmond Schatz, MD          University of Miami Recruiting Miami, Florida, United States, 33136 Contact: Della Matheson    305-243-3781    dmatheso@med.miami.edu    Contact: Natalia Sanders-Branca    305-243-6616    n.sanders1@med.miami.edu    Principal Investigator: David Baidal, MD          United States, Pennsylvania University of Pittsburgh Recruiting Pittsburgh, Pennsylvania, United States, 15224 Contact: David Groscost    412-692-7241    david.groscost@chp.edu    Contact: Kelli Delallo    412-692-5210    kelli.delallo@chp.edu    Principal Investigator: Dorothy Becker, MD          United States, Tennessee Vanderbilt Eskind Diabetes Clinic Recruiting Nashville, Tennessee, United States, 37232 Contact: Brenna Dixon    615-337-9597    brenna.dixon@vanderbilt.edu    Contact: Faith Brendle    615-936-8638    faith.brendle@vanderbilt.edu    Principal Investigator: William Russell, MD          United States, Texas University of Texas Southwestern Recruiting Dallas, Texas, United States, 75390 Contact: Lauren Boyles    241-648-4717    lauren.boyles@utsouthwestern.edu    Principal Investigator: Philip Raskin, MD          United States, Washington Benaroya Research Institute Recruiting Seattle, Washington, United States, 98101 Contact: Mary Ramey    206-342-6945    mramey@benaroyaresearch.org    Contact: Marli McCulloch-Olson    206-515-5239    Marli@benaroyaresearch.org    Principal Investigator: Carla Greenbaum, MD Less <<
NCT00457873 Gastroenteritis ... More >> Bronchiolitis Sepsis Urinary Tract Infection Less << Phase 3 Completed - Canada, Quebec ... More >> Montreal Children's Hospital Montreal, Quebec, Canada, H3H 1P3 Less <<
NCT02686996 Insulin Sensitivity Not Applicable Recruiting June 12, 2020 Australia, Victoria ... More >> Monash Centre for Health Research and Implementation Recruiting Melbourne, Victoria, Australia, 3168 Contact: Barbora de Courten, MD,PHD,MPH    +61 3 9594 7086    barbora.decourten@monash.edu    Principal Investigator: Barbora de Courten, MD,PHD,MPH          Sub-Investigator: Helena Teede, MBBS,PhD          Sub-Investigator: James Cameron, MBBS,MD          Sub-Investigator: Alexander Hodge, BSc,MBBS,PHD Less <<
NCT00171496 Kidney Transplant Phase 4 Completed - -
NCT03124043 Diabetes Mellitus, Type 2 Not Applicable Completed - -
NCT03248609 Healthy Not Applicable Active, not recruiting December 31, 2018 United States, California ... More >> University of California Davis (Academic Surge, Ragle Human Nutrition Research Facility) Davis, California, United States, 95616 Less <<
NCT02025296 Diabetes Mellitus With Hypogly... More >>cemia Less << Not Applicable Completed - Korea, Republic of ... More >> SNUBH Seongnam, Gyeonggi, Korea, Republic of, 463-707 Less <<
NCT00580710 - Recruiting August 2020 United States, Connecticut ... More >> Yale University School of Medicine Recruiting New Haven, Connecticut, United States, 06520 Principal Investigator: Robert Sherwin, M.D. Less <<
NCT00857194 - Completed - United States, New Jersey ... More >> Kessler Institute for Rehabilitation West Orange, New Jersey, United States, 07052 United States, New York James J. Peters VA Medical Center, Bronx, NY The Bronx, New York, United States, 10468 Less <<
NCT00315952 Type 1 Diabetes Mellitus Phase 4 Completed - United States, Pennsylvania ... More >> University of Pittsburgh Pittsburgh, Pennsylvania, United States, 15213 Less <<
NCT03330314 Healthy Volunteers Phase 1 Completed - United States, California ... More >> Hanmi Investigative Site Chula Vista, California, United States, 91911 Less <<
NCT01613807 Gestational Diabetes Mellitus Phase 4 Completed - -
NCT01666353 Melanoma Rena... More >>l Cell Carcinoma (RCC) Non-small Cell Lung Cancer (NSCLC) Less << Early Phase 1 Unknown December 2015 United States, Maryland ... More >> Johns Hopkins University Baltimore, Maryland, United States, 21287 Less <<
NCT00897676 - Completed - -
NCT03004612 Prediabetic State ... More >> Insulin Resistance Less << Phase 4 Active, not recruiting August 2018 Mexico ... More >> Universidad de Guanajuato León, Guanajuato, Mexico, 37670 Less <<
NCT01970462 Diabetes Mellitus, Type 2 ... More >> Hyperglycemia Less << Phase 4 Terminated(Recruitment) - United States, Ohio ... More >> The Ohio State University Wexner Medical Center Columbus, Ohio, United States, 43203 Less <<
NCT02687893 Hypoglycemia Not Applicable Unknown January 2017 United States, Oregon ... More >> Oregon Health and Science University Portland, Oregon, United States, 97239 Less <<
NCT02871180 Type 1 Diabetes ... More >> Hypoglycemia Less << Not Applicable Completed - Germany ... More >> Diabeteszentrum Bad Lauterberg Bad Lauterberg, Niedersachsen, Germany, 37431 Less <<
NCT01970462 - Terminated(Recruitment) - -
NCT01692002 Diabetes Mellitus Phase 2 Completed - United Kingdom ... More >> Hammersmith Hospital London, UK, United Kingdom, W12 0NN Imperial College London London, United Kingdom, W12 0NN St John McMichael Centre - Imperial College London London, United Kingdom, W12 0NN Less <<
NCT00897676 Congenital Hyperinsulinism Phase 1 Phase 2 Completed - United States, Pennsylvania ... More >> The Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT03764280 Diabete Mellitus ... More >> Diabetes Mellitus, Type 1 Less << Not Applicable Completed - Canada, Quebec ... More >> Camp Carowanis Sainte-Agathe-des-Monts, Quebec, Canada, J8C 2Z7 Less <<
NCT01611363 Type 2 Diabetes Mellitus Phase 1 Completed - Germany ... More >> Neuss, Germany, 41460 Less <<
NCT02666586 Faba Bean Pos... More >>t-prandial Blood Glucose Appetite Satiety Hormones Insulin Less << Not Applicable Completed - Canada, Manitoba ... More >> Richardson Centre for Functional Foods and Nutraceuticals Winnipeg, Manitoba, Canada, R3T 2N2 Less <<
NCT02148978 Cystic Fibrosis Not Applicable Unknown - Israel ... More >> Hadassah Har Hazofim Recruiting Jerusalem, Israel Contact: Ram Weiss, MD PhD       ramw@ekmd.huji.ac.il Less <<
NCT00313937 Diabetes Mellitus, Type 1 Phase 4 Completed - Germany ... More >> Sanofi-Aventis Berlin, Germany Less <<
NCT03439072 Insulin Hypoglycemia ... More >> Type 1 Diabetes Mellitus Severe Hypoglycemia Less << Phase 3 Completed - United States, California ... More >> ProSciento, Inc. Chula Vista, California, United States, 91911 Diablo Clinical Research, Inc. Walnut Creek, California, United States, 94598 United States, Georgia Atlanta Diabetes Associates Atlanta, Georgia, United States, 30318 United States, Washington Rainier Clinical Research Center, Inc. Renton, Washington, United States, 98057 Canada, Ontario LMC ESD, Inc. Toronto, Ontario, Canada, M4G 3E8 Canada, Quebec Altasciences Algorithme Pharma Montréal, Quebec, Canada, H3P 3P1 Less <<
NCT03520153 - Recruiting August 2021 United States, Connecticut ... More >> Yale New Haven Hospital Recruiting New Haven, Connecticut, United States, 06510 Contact: Cemre Robinson, M.D.    203-785-5809    cemre.robinson@yale.edu Less <<
NCT00319202 Glucose Intolerance ... More >> Obesity Less << Phase 4 Terminated(Difficulties in com... More >>pleting the required sample size) Less << - Colombia ... More >> Fundación Cardiovascular de Colombia Floridablanca, Santander, Colombia, 10000 Less <<
NCT00993824 Type 2 Diabetes Phase 2 Phase 3 Completed - United States, Minnesota ... More >> International Diabetes Center Minneapolis, Minnesota, United States, 55416 Less <<
NCT01635192 the Local Renin-angiotensin Sy... More >>stem (RAS) in Small Intestinal Mucosa in Man Less << Early Phase 1 Completed - Sweden ... More >> Dept of Gastrosurgical R&E, Sahlgrenska Universityhospital Gothenburg, Sweden, SE41345 Less <<
NCT01664624 - Completed - -
NCT01664624 Type 2 Diabetes Phase 1 Completed - United States, California ... More >> Chula Vista, California, United States United States, Florida Orlando, Florida, United States Less <<
NCT00993824 - Completed - -
NCT00930371 Fatty Liver Not Applicable Completed - United States, Washington ... More >> University of Washington Seattle, Washington, United States, 98108 VA Puget Sound Health Care System Seattle, Washington, United States, 98108 Less <<
NCT01514578 Healthy Phase 1 Completed - United States, Nebraska ... More >> ICON Development Solutions Omaha, Nebraska, United States, 68154 Less <<
NCT00700362 - Withdrawn(This study is a part... More >> of the IINDU study) Less << December 2016 Sweden ... More >> Department of Molecular Medicine and Surgery, Rolf Luft Research Center for Diabetes and Endocrinology Stockholm, Sweden, 171 76 Less <<
NCT02537587 Diabetes Mellitus Not Applicable Completed - Canada, Ontario ... More >> Glycemic Index Laboratories, Inc. Toronto, Ontario, Canada, M5C 2N8 Less <<
NCT02709057 Type 2 Diabetes Not Applicable Active, not recruiting December 2021 Finland ... More >> University of Eastern Finland Kuopio, Finland, 70210 Less <<
NCT00614133 Postoperative Protein Cataboli... More >>sm Less << Not Applicable Completed - Canada, Quebec ... More >> Royal Victoria Hospital, McGill University Health Centre Montreal, Quebec, Canada, H3A 1A1 Less <<
NCT00467636 Chronic Obstructive Pulmonary ... More >>Disease Hyperglycemia Less << Not Applicable Terminated(Difficulty recruiti... More >>ng (early discharge scheme initiated)) Less << - United Kingdom ... More >> Royal Bournemouth Hospital Bournemouth, Dorset, United Kingdom, BH7 7DW Less <<
NCT01185496 - Completed - United States, California ... More >> DexCom, Inc San Diego, California, United States, 92121 Less <<
NCT02291458 Adipose Tissue, Brown ... More >> Glucose Intolerance Nitric Oxide Less << Phase 3 Unknown December 2015 Netherlands ... More >> Maastricht University Medical Center + Recruiting Maastricht, Limburg, Netherlands, 6229 ER Contact: Mariette Boon, PhD    +31648126425    m.boon@maastrichtuniversity.nl    Contact: Wouter van Marken Lichtenbelt, PhD    Tel: +31 43 388 1629    markenlichtenbelt@maastrichtuniversity.nl Less <<
NCT00889993 Satiety Not Applicable Completed - United States, Minnesota ... More >> University of Minnesota: General Clinical Research Center Minneapolis, Minnesota, United States, 55455 Less <<
NCT03311516 Type1diabetes Not Applicable Not yet recruiting October 2020 -
NCT02093481 Obesity Metab... More >>olic Syndrome Less << Early Phase 1 Completed - Sweden ... More >> Applied Nutrition and Food Chemistry, Lund Univeristy Lund, SE, Sweden, 221 00 Less <<
NCT00690287 Type 2 Diabetes Phase 1 Completed - Sweden ... More >> Research Site Linköping, Sweden Research Site Luleå, Sweden Research Site Uppsala, Sweden Less <<
NCT02750267 - Completed - -
NCT02848053 - Unknown November 2016 -
NCT00639457 - Completed - -
NCT01083043 - Completed - United States, New York ... More >> Winthrop University Hospital Mineola, New York, United States, 11501 Less <<
NCT00639457 HIV Infections ... More >> Type 2 Diabetes Obesity HIV AIDS Cardiovascular Disease Lipodystrophy Less << Not Applicable Completed - United States, Missouri ... More >> Washington University School of Medicine St. Louis, Missouri, United States, 63110 Less <<
NCT01610154 Insulin Secretion ... More >> Insulin Resistance Less << Phase 4 Completed - China ... More >> Fuwai Hospital Beijing, China Less <<
NCT01610154 - Completed - -
NCT01484457 Diabetes Mellitus, Type 1 Early Phase 1 Completed - United States, California ... More >> Sansum Diabetes Research Institute Santa Barbara, California, United States, 93105 Israel Schneider Children's Medical Center of Israel Petah Tikva, Israel Less <<
NCT02413398 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT02540486 Type 2 Diabetes Mellitus Not Applicable Completed - Canada, Ontario ... More >> LMC Diabetes & Endocrinology Toronto, Ontario, Canada, M4G 3E8 Less <<
NCT01073566 - Completed - -
NCT02750267 Diabetes Mellitus, Type 1 Not Applicable Completed - United States, Virginia ... More >> University of Virginia Center for Diabetes Technology Charlottesville, Virginia, United States, 22903 Less <<
NCT01297049 Diabetes Type 2 ... More >> Obesity Less << Not Applicable Completed - Norway ... More >> Oslo College University Oslo, Arkeshus, Norway, 0130 Less <<
NCT01073566 Diabetes Mellitus Phase 2 Completed - United States, California ... More >> California Pacific Medical Center San Francisco, California, United States, 94110 United States, Illinois Northwestern University Chicago, Illinois, United States, 60611 United States, Michigan Henry Ford Health System Detroit, Michigan, United States, 48202 United States, Minnesota International Diabetes Center at Park Nicollet Minneapolis, Minnesota, United States, 55416 United States, Texas University of Texas Southwestern Medical Center Dallas, Texas, United States, 75390 Less <<
NCT02997319 - Recruiting June 2021 United States, Massachusetts ... More >> Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: Hassan S Dashti, PhD, RD    617-643-7167    SHIFTStudy@partners.org Less <<
NCT01517555 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 1 Completed - Germany ... More >> Novo Nordisk Investigational Site Neuss, Germany, 41460 Less <<
NCT00241956 - Terminated(poor data collectio... More >>n) Less << - Australia, Victoria ... More >> The Royal Melbourne Hospital Melbourne, Victoria, Australia, 3050 Less <<
NCT02413398 - Completed - -
NCT00579904 Polycystic Ovary Syndrome ... More >> Insulin Resistance Less << Not Applicable Completed - United States, California ... More >> Clinical and Translational Science Center Clinical Resources Center (CCRC) Mather, California, United States, 95655 Less <<
NCT01671293 Prediabetic State ... More >> Glucose Intolerance Less << Not Applicable Completed - Chile ... More >> Centro de Salud Santa Amalia Santiago, Región Metropolitana, Chile, 8250403 Centro de Salud Familiar Villa O'Higgins Santiago, Región Metropolitana, Chile, 8260558 Centro de Salud Familiar Fernando Maffioletti-Alvo Santiago, Región Metropolitana, Chile, 8301588 Centro de Salud Familiar Los Quillayes Santiago, Región Metropolitana, Chile, 8310695 Centro de Salud Familiar Los Castaños Santiago, Región Metropolitanta, Chile, 8270041 Less <<
NCT01828671 Healthy Not Applicable Completed - Canada, Manitoba ... More >> St. Boniface General Hospital - Asper Clinical Research Institute Winnipeg, Manitoba, Canada, R2H 2A6 Less <<
NCT01257087 Type 2 Diabetes Mellitus ... More >> Obesity Less << Not Applicable Completed - United Kingdom ... More >> Imperial College Healthcare NHS Trust London, United Kingdom, W6 8RF Less <<
NCT01671293 - Completed - -
NCT02533817 Healthy Not Applicable Completed - -
NCT01101867 Diabetes Admi... More >>tting Hospital Non-critically Ill Less << Phase 4 Completed - United States, Ohio ... More >> The Ohio State University Columbus, Ohio, United States, 43210 Less <<
NCT02836353 Gastrectomy O... More >>esophagectomy Dumping Syndrome Hypoglycaemia Less << Not Applicable Recruiting - United Kingdom ... More >> Cambridge University Hospitals NHS Foundation Trust Recruiting Cambridge, Cambridgeshire, United Kingdom, CB2 0QQ Contact: Geoffrey P Roberts, MA BM BCh    01223 767176    gpr25@cam.ac.uk Less <<
NCT03004079 - Recruiting September 2020 United States, Virginia ... More >> University of Virginia Recruiting Charlottesville, Virginia, United States, 22903 Contact: Rachael Coleman, MPH    434-297-4102    rcoleman@virginia.edu    Principal Investigator: Myla Goldman, MD Less <<
NCT00801814 Blood Glucose, Postprandial Phase 2 Phase 3 Completed - Canada, Ontario ... More >> Glycemic Index Laboratories, Inc. Toronto, Ontario, Canada, M5C 2X3 Less <<
NCT01807910 Obesity NAFLD Early Phase 1 Withdrawn(The study was not fu... More >>nded) Less << April 2018 United States, Tennessee ... More >> Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232 Less <<
NCT01101867 - Completed - -
NCT01462227 Hypoglycemia Not Applicable Completed - United States, Connecticut ... More >> Yale School of Medicine New Haven, Connecticut, United States, 06520 Less <<
NCT01414088 Nephropathy Not Applicable Completed - Denmark ... More >> Medicinsk Forskning, Regionshospitalet i Holstebro Holstebro, Denmark, 7500 Less <<
NCT01462227 - Completed - -
NCT03631134 Type2 Diabetes Phase 4 Not yet recruiting January 30, 2019 -
NCT03131232 - Active, not recruiting December 31, 2017 -
NCT03414892 Hyperglycaemia (Diabetic) ... More >> Type 2 Diabetes Mellitus Less << Phase 1 Recruiting December 1, 2018 China, Jiangsu ... More >> The First Affiliated Hospital of Nanjing Medical University Recruiting Nanjing, Jiangsu, China Contact: Tao Yang Less <<
NCT00941447 Type 2 Diabetes Not Applicable Completed - United States, Tennessee ... More >> University of Tennessee, Healthy Eating and Activity Laboratory (HEAL) Knoxville, Tennessee, United States, 37996 Less <<
NCT03644199 Cystic Fibrosis Not Applicable Withdrawn(Lack of resources) - United Kingdom ... More >> Liverpool Heart and Chest Hospital Liverpool, United Kingdom, L14 3PE Less <<
NCT01509001 Type 2 Diabetes Phase 4 Completed - Brazil ... More >> Clinical Hospital of São Paulo Medical School são Paulo, SP, Brazil Less <<
NCT01242904 End Stage Renal Disease Phase 2 Completed - Canada, Ontario ... More >> London Health Sciences Centre, South Street Hospital, Peritoneal Dialysis Unit London, Ontario, Canada, N6A 5W9 Less <<
NCT00747409 Type 2 Diabetes Mellitus Phase 4 Unknown June 2009 Germany ... More >> Staedt. Klinikum Muenchen Bogenhausen Munich, Bavaria, Germany, 81925 Less <<
NCT02768220 SGLT-2 Inhibitors ... More >> Advanced Glycation End Products Diabetes Less << Phase 4 Withdrawn(no funding) December 2018 -
NCT02274220 Heart Disease ... More >> Dietary Modification Insulin Resistance Less << Not Applicable Completed - Canada, Ontario ... More >> The Hospital for Sick Children Toronto, Ontario, Canada, M5G 1X8 Less <<
NCT00737152 Type II Diabetes Mellitus Phase 2 Unknown April 2014 United States, New Jersey ... More >> MedCenter Not yet recruiting East Brunswick, New Jersey, United States, 08816 Contact: Ratna Grewal, MD    908-941-5480    rgreywal@americanscitech.com    Sub-Investigator: Sarath Babu, MD          Sub-Investigator: Rajiv Patel, MD          Robertwood Johnson Hospital Not yet recruiting New Brunswick, New Jersey, United States, 08901 Contact: Ratna Grewal, MD    908-941-5480    rgreywal@americanscitech.com    Sub-Investigator: Xiangbing Wang, MD          Raritan Bay Medical Center Not yet recruiting Perth Amboy, New Jersey, United States, 08861 Contact: Ratna Grewal, MD    908-941-5480    rgreywal@americanscitech.com    Principal Investigator: Prem Nandiwada, MD          India Sri Ramachandra University Not yet recruiting Porur, Chennai, India Contact: Ratna Grewal, MD    908-941-5480    rgreywal@americanscitech.com    Sub-Investigator: S P Thyagarajan, Ph.D          Dr. JL Rohatagi Hospital Not yet recruiting Sarvoday Nagar, Kanpur, UP, India Contact: Ratna Grewal, MD    908-941-5480    rgreywal@americanscitech.com    Sub-Investigator: S N Agarwal, MD Less <<
NCT00363233 Type 2 Diabetes ... More >> Hypercholesterolemia Less << Phase 2 Phase 3 Completed - China, Shanghai ... More >> Institute for Nutritional Sciences, Chinese Academy of Sciences; Huadong Hospital Shanghai, Shanghai, China, 200031 Less <<
NCT02382237 Head and Neck Cancer ... More >> Oesophageal Cancer Less << Not Applicable Completed - France ... More >> ICM Val d'Aurelle Montpellier, France, 34298 Less <<
NCT00722631 Impaired Glucose Tolerance ... More >> Type 2 Diabetes Mellitus Atherosclerosis Less << Not Applicable Completed - Japan ... More >> Kurume University Hospital Kurume city, Japan, 830-0011 Less <<
NCT01482559 Hypotension L... More >>ow Blood Pressure Intraventricular Hemorrhage of Prematurity Less << Phase 3 Unknown January 2018 Belgium ... More >> University Hospital Antwerp Not yet recruiting Wilrijkstraat 10, Edegem, Belgium, B-2650 Contact: David Van Laere    00 32 3 821 58 07    David.VanLaere@uza.be    Principal Investigator: David Van Laere          Katholieke Universiteit Leuven Not yet recruiting Oude God, Leuven, Belgium, 3000 Contact: Gunnar Naulaers    003216324010    gunnar.naulaers@uzleuven.be    Principal Investigator: Gunnar Naulaers          Canada, Alberta University of Alberta Not yet recruiting Edmonton, Alberta, Canada, T6G 2R3 Contact: Po-Yin Cheung    0017804923111    poyin@ualberta.ca    Principal Investigator: Po-Yin Cheung          Canada, Quebec Centre hospitalier universitaire Sainte-Justine Not yet recruiting Montreal, Quebec, Canada, H1T 1C9 Contact: Keith Barrington    0015143454931    keith.barrington@umontreal.ca    Principal Investigator: Keith Barrington          Czech Republic Univerzita Karlova v Praze Recruiting Ovocný trh 5, Prague, Czech Republic, 11636 Contact: Zbyněk Straňák    00420224491111    z.stranak@seznam.cz    Principal Investigator: Zbyněk Straňák          Ireland Coombe Women and Infants University Hospital Recruiting Dublin 8, Dublin, Ireland, 8 Contact: Jan Miletin    0035314085200    miletinj@yahoo.com    Principal Investigator: Jan Miletin          University College Dublin Not yet recruiting Dun Laoghaire, Rathdown, Dublin, Ireland Contact: Colm O Donnell    0035317167777    codonnell@nmh.ie    Principal Investigator: Colm O Donnell          Cork University Maternity Hospital Recruiting Cork, Ireland Contact: Eugene Dempsey    00 353 21 4920525    gene.dempsey@hse.ie    Contact: Niamh O Shea    00 353 879696229    n.oshea@ucc.ie    Principal Investigator: Peter Filan          Royal College of Surgeons in Ireland Not yet recruiting Dublin, Ireland Contact: David Corcoran    0035314022100    dcorcoran@rotunda.ie    Principal Investigator: David Corcoran          United Kingdom Royal Maternity Hospital Not yet recruiting Belfast, United Kingdom, BT12 6BA Contact: David Millar       david.millar@belfasttrust.hscni.net    Principal Investigator: David Millar Less <<
NCT01196351 Obesity Prevention Not Applicable Completed - Canada, Ontario ... More >> Department of Nutritional Sciences Toronto, Ontario, Canada, M5S 3E2 Less <<
NCT00829660 Coronary Heart Disease ... More >> Acute Coronary Syndrome Impaired Glucose Tolerance Type 2 Diabetes Mellitus (T2DM) Less << Phase 4 Completed - -
NCT01699932 Type 2 Diabetes Mellitus Phase 3 Completed - Lebanon ... More >> Investigational Site Number 422-002 Beirut, Lebanon Investigational Site Number 422-001 Hazmieh, Lebanon Russian Federation Investigational Site Number 643001 Samara, Russian Federation Investigational Site Number 643002 St-Petersburg, Russian Federation Investigational Site Number 643-03 St.-Petersburg, Russian Federation Ukraine Investigational Site Number 804003 Chernivtsi, Ukraine, 58022 Investigational Site Number 804008 Donetsk, Ukraine, 83003 Investigational Site Number 804004 Donetsk, Ukraine, 83059 Investigational Site Number 804001 Donetsk, Ukraine, 83099 Investigational Site Number 804010 Odessa, Ukraine Investigational Site Number 804006 Poltava, Ukraine, 36011 Investigational Site Number 804007 Vinnytsya, Ukraine, 21010 Investigational Site Number 804002 Vinnytsya, Ukraine, 21029 Less <<
NCT01501032 Diabetes Type 1 Phase 1 Withdrawn - Israel ... More >> Schneider children's Medical center Petah-tikva, Israel, 49202 Less <<
NCT00585897 Type 2 Diabetes ... More >> Obesity Less << Not Applicable Completed - United States, North Carolina ... More >> Duke University Medical Center Durham, North Carolina, United States, 27710 Less <<
NCT03418415 Type 2 Diabetes Mellitus ... More >> Renal Denervation Less << Not Applicable Recruiting January 2022 China, Jiangsu ... More >> Zhongda Hospital, Southeast University Recruiting Nanjing, Jiangsu, China, 210009 Contact: Gao-Jun Teng, MD    +86 25 83272121    gjteng@seu.edu.cn    Contact: Tao Pan, PhD    +86-15850651223    15850651223@126.com Less <<
NCT00856700 Metabolic Syndrome Not Applicable Completed - Italy ... More >> Tor Vergata University Rome, Italy, 90100 Less <<
NCT03194100 - Completed - -
NCT00531128 Sitosterolemia Not Applicable Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 United States, Pennsylvania University of Maryland Amish Research Lancaster, Pennsylvania, United States Less <<
NCT02701270 Healthy Volunteers Not Applicable Completed - United Kingdom ... More >> Leatherhead Food Research Leatherhead, United Kingdom, KT22 7RY Less <<
NCT02365285 Obesity Phase 1 Phase 2 Recruiting October 2018 United States, Tennessee ... More >> Vanderbilt University Medical Center Recruiting Nashville, Tennessee, United States, 37232 Contact: Cyndya Shibao, MD       cyndya.shibao@vanderbilt.edu    Contact: Keisha Card, RN       keisha.d.card@vanderbilt.edu Less <<
NCT03662217 Diabetes Type 2 Not Applicable Not yet recruiting March 2020 Israel ... More >> The Edith Wolfson Medical Center Not yet recruiting H̱olon, Israel, 5822012 Contact: Tali Ganz    +972523374030    taliganz@wmc.gov.il    Principal Investigator: Julio Weinstaine, MD          Diabetes Medical Center Not yet recruiting Tel Aviv, Israel, 6937947 Contact: Vered Sason    +97236900333    vered.sason@dmc.org.il Less <<
NCT03739268 Type 2 Diabetes Mellitus Not Applicable Recruiting September 1, 2020 Denmark ... More >> Steno Diabetes Center Copenhagen, Gentofte Hospital Recruiting Hellerup, Denmark, 2900 Contact: Henriette H Nerild, M.D.    +45 3867 4264    henriette.holst.nerild@regionh.dk Less <<
NCT01196364 Healthy Boys With no Emotional... More >>, Behavioral or Learning Problems Within a Normal Body Weight Less << Not Applicable Completed - Canada, Ontario ... More >> Department of Nutritional Sciences Toronto, Ontario, Canada Less <<
NCT02701270 - Completed - -
NCT03154073 PreDiabetes A... More >>ging Less << Not Applicable Recruiting December 2018 United States, Colorado ... More >> University of Colorado Anschutz Medical Campus Recruiting Aurora, Colorado, United States, 80045 Contact: Seth Creasy, PhD    303-724-9115    seth.creasy@ucdenver.edu Less <<
NCT00182026 Diabetes Mellitus, Type 2 Not Applicable Unknown December 2009 Canada, Ontario ... More >> McMaster University Hamilton, Ontario, Canada, L8N 3Z5 Less <<
NCT00846872 Insulin Resistance ... More >> Endothelial Dysfunction Less << Phase 1 Phase 2 Withdrawn(Inadequate subject r... More >>ecruitment) Less << - United States, Louisiana ... More >> Clinical and Translational Research center Tulane Hospital New Orleans, Louisiana, United States, 70112 Clinical and Translational Research Center, University Hospital New Orleans, Louisiana, United States, 70112 Less <<
NCT03340831 - Recruiting May 15, 2020 United States, California ... More >> Scripps Whittier Diabetes Institute Recruiting La Jolla, California, United States, 92037 Contact: Cherrie Rosal    858-336-3414    Rosal.Rosario@scrippshealth.org    Principal Investigator: Athena Philis-Tsimikas, MD          Mills-Peninsula Medical Center Recruiting San Mateo, California, United States, 94401 Contact: Irina Nayberg       NayberI@sutterhealth.org    Principal Investigator: David Klonoff, MD          Sansum Recruiting Santa Barbara, California, United States, 93105 Contact: Donna Frase       dfrase@sansum.org    Principal Investigator: Kristin Castorino, DO          United States, Georgia Atlanta Diabetes Recruiting Atlanta, Georgia, United States, 30318 Contact: Jennifer Boyd, PA-C    404-355-4393 ext 850    jboyd@atlantadiabetes.com    Principal Investigator: Bruce Bode, MD          United States, Idaho Rocky Mountain Diabetes & Osteoporosis Center Recruiting Idaho Falls, Idaho, United States, 83404 Contact: Mark Sulik    208-522-6005    mark@idahomed.com    Principal Investigator: David Liljenquist, MD          United States, Illinois Northshore University Health System Recruiting Skokie, Illinois, United States, 60077 Contact: Allison Monie       AMonie@northshore.org    Principal Investigator: Lianna Billings, MD          United States, Iowa Iowa Diabetes & Endocrinology Research Center Recruiting Des Moines, Iowa, United States, 50314 Contact: Tara Herrold, RN    515-643-5122    therrold@iderc.com    Principal Investigator: Anuj Bhargava, MD          United States, Minnesota International Diabetes Research Center Not yet recruiting Minneapolis, Minnesota, United States, 55416 Contact: Diana Martin       diana.martin@parknicollet.com    Principal Investigator: Amy Criego, MD          Principal Investigator: Anders Carlson, MD          United States, Nebraska Diabetes & Endocrine Associates, PC Recruiting Omaha, Nebraska, United States, 68114 Contact: Jennifer Rahman    402-561-2662    jennifer.rahman@deomaha.com    Principal Investigator: Sarah Konigsberg, MD          United States, North Carolina Mountain Diabetes and Endocrine Center Recruiting Asheville, North Carolina, United States, 28803 Contact: Kaitlin Ramsey    828-684-9588 ext 7    kramsey@mdecresearch.com    Principal Investigator: Wendy Lane, MD          United States, Texas Amarillo Medical Specialists, LLP Recruiting Amarillo, Texas, United States, 79106 Contact: Becky Cota, RN, CDE    806-358-8331    becky.cota@amarillomed.com    Principal Investigator: William Biggs, MD          Texas Diabetes and Endocrine Recruiting Austin, Texas, United States, 78731 Contact: Cory Fields    512-334-3505 ext 2    cfields@texasdiabetes.com    Principal Investigator: Thomas Blevins, MD          Principal Investigator: Lindsay Harrison, MD          Principal Investigator: Kerem Ozer, MD          Research Institute of Dallas Recruiting Dallas, Texas, United States, 75231 Contact: Satanya Brooks    214-265-2137    tbrooks@researchdallas.com    Principal Investigator: Stephen Aronoff, MD          United States, Utah Advanced Research Associates Recruiting Ogden, Utah, United States, 84405 Contact: Hilary Wahlen    801-409-2040    hilary@advresearch.org    Principal Investigator: Jack Wahlen, MD, PhD Less <<
NCT02280863 Type 1 Diabetes Not Applicable Completed - United States, California ... More >> Stanford University Medical Center Stanford, California, United States, 94305 United States, Colorado UC Denver- Barbara Davis Center for Childhood Diabetes Aurora, Colorado, United States, 80045 United States, Connecticut Yale University- Department of Pediatric Endocrinology New Haven, Connecticut, United States, 06520 Less <<
NCT02632630 Malnutrition Phase 2 Completed - Canada, Ontario ... More >> LHSC-University Hospital London, Ontario, Canada, N6A 5A5 Less <<
NCT00552370 Diabetes Mellitus, Type 2 Phase 4 Completed - -
NCT01056497 Type 2 Diabetes ... More >> Prediabetes Less << Phase 4 Completed - Canada, Ontario ... More >> Toronto General Hospital Toronto, Ontario, Canada, M5G 2C4 Less <<
NCT01817595 Type 2 Diabetes Mellitus Not Applicable Completed - Canada, British Columbia ... More >> Endocrine Research Society Vancouver, British Columbia, Canada, V6E1M7 Less <<
NCT00981500 - Completed - United States, Missouri ... More >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Less <<
NCT02423980 Hypoglycemia Phase 2 Completed - United States, California ... More >> Diablo Clinical Research, Inc. Walnut Creek, California, United States, 94598 Less <<
NCT02280863 - Completed - -
NCT01516333 Glucose Blood ... More >> Glycemic Index Less << Phase 1 Completed - United States, Louisiana ... More >> Pennington Biomedical Research Center Baton Rouge, Louisiana, United States, 70808 Less <<
NCT02809365 Type 2 Diabetes Not Applicable Completed - Israel ... More >> E. Wolfson Medical Center Holon, Israel, 58100 Wolfson Medical Center, Bariatric Surgery Clinic Holon, Israel, 58100 Less <<
NCT02423980 - Completed - -
NCT02064205 Body Weight N... More >>on-restrained Eaters Less << Phase 2 Completed - Netherlands ... More >> QPS Groningen, Netherlands, 9713AG Less <<
NCT02064205 - Completed - -
NCT02338817 - Terminated(The device often fa... More >>iled to detect hypoglycemic episodes in glycogen storage disease patients and the rate of false positive alarms was high.) Less << - United States, Florida ... More >> University of Florida Gainesville, Florida, United States, 32610 Less <<
NCT02759289 - Recruiting December 2020 United States, New York ... More >> New York University School of Medicine Recruiting New York, New York, United States, 10016 Contact: Stanley Cobos    646-501-2897    Stanley.Cobos@nyumc.org    Principal Investigator: Jonathan Newman, MD Less <<
NCT01738763 Healthy Insul... More >>in Sensitivity Less << Not Applicable Completed - Spain ... More >> University Hospital Dr Peset Valencia, Spain, 46017 Less <<
NCT00308373 Diabetes Mellitus, Type 2 Not Applicable Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT01282567 Type 1 Diabetes Not Applicable Completed - France ... More >> Rennes University Hospital Rennes, Brittany, France, 35033 Less <<
NCT00966017 - Unknown February 2014 United States, California ... More >> UCLA Recruiting Los Angeles, California, United States, 90024 Contact: Andrea Kaplan    310-825-0545    akaplan@mednet.ucla.edu    Contact: Deborah Dorsey, RN, MN    310-825-0545    ddorsey@mednet.ucla.edu    Principal Investigator: Gary W. Small, MD Less <<
NCT01588093 Type 1 Diabetes Mellitus Not Applicable Completed - Sweden ... More >> Pediatric Endocrinology Unit, Dept of Women's and Children's Health, Karolinska Institute & University Hospital Stockholm, Sweden, SE-17176 Less <<
NCT02894710 Carcinologic Ear, Nose, and Th... More >>roat (ENT) Surgery Less << Phase 3 Recruiting June 2019 France ... More >> Hospices Civils de Lyon / Hôpital de la Croix Rousse Recruiting Lyon, France, 69004 Contact: Christian Bauer       christian.bauer@chu-lyon.fr    Centre Léon Bérard Recruiting Lyon, France, 69008 Contact: Grégoire WALLON       Gregoire.WALLON@lyon.unicancer.fr Less <<
NCT00064727 Congestive Heart Failure Phase 2 Completed - United States, Maryland ... More >> Suburban Hospital Bethesda, Maryland, United States, 20814 National Heart, Lung and Blood Institute (NHLBI), 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT03389789 Analgesia Not Applicable Completed - -
NCT00420511 Type 2 Diabetes Mellitus Phase 2 Completed - Canada, Ontario ... More >> Leadership Sinai Centre for Diabetes Toronto, Ontario, Canada, M5T 3L9 Less <<
NCT00420511 - Completed - -
NCT02556398 Type 1 Diabetes Not Applicable Active, not recruiting August 2018 United States, Massachusetts ... More >> Joslin Diabetes Center Boston, Massachusetts, United States, 02215 Less <<
NCT00712010 Healthy Not Applicable Completed - Switzerland ... More >> Nestec Clinical Development Unit / Metabolic Unit Lausanne, Switzerland, 1000 Less <<
NCT03670641 Type 2 Diabetes Mellitus Phase 4 Not yet recruiting April 1, 2019 United States, Pennsylvania ... More >> UPMC Falk Diabetes Clinic Not yet recruiting Pittsburgh, Pennsylvania, United States, 15213 Contact: Emily Timm, RD, CDE    412-864-0173    timme@upmc.edu    Contact: Sandra Sobel, MD    412-232-9150    sobelsi@upmc.edu    Principal Investigator: Sandra I Sobel, MD          Sub-Investigator: David A Rometo, MD          Sub-Investigator: Linda Siminerio, RN, PhD Less <<
NCT00571324 Congenital Hyperinsulinism Phase 1 Phase 2 Completed - United States, Pennsylvania ... More >> The Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00362011 Type 2 Diabetes Phase 2 Completed - Canada, Ontario ... More >> St. Michael’s Hospital Toronto, Ontario, Canada, M5C2T2 Less <<
NCT02681081 Pain Osteoart... More >>hritis Less << Not Applicable Active, not recruiting September 2019 United States, Florida ... More >> Institute of Aging Gainesville, Florida, United States, 32611 Less <<
NCT00297960 Healthy Male Volunteers Phase 4 Completed - Austria ... More >> Department of Clinical Pharmacology, Medical University Vienna Vienna, Austria, 1090 Less <<
NCT03104712 Dietary Modification Not Applicable Completed - Italy ... More >> Department of Food and Drug, University of Parma Parma, Italy, 43125 Less <<
NCT00712010 - Completed - -
NCT01280695 Diabetes Mellitus, Type 2 Phase 2 Completed - United States, Arizona ... More >> Goodyear, Arizona, United States United States, California Chula Vista, California, United States Los Angeles, California, United States United States, Florida Bradenton, Florida, United States Hialeah, Florida, United States Pembroke Pines, Florida, United States United States, Illinois Chicago, Illinois, United States United States, Montana Butte, Montana, United States United States, North Carolina Greensboro, North Carolina, United States United States, Ohio Cincinnati, Ohio, United States United States, South Carolina Charleston, South Carolina, United States United States, Texas Austin, Texas, United States San Antonio, Texas, United States United States, Utah Salt Lake City, Utah, United States Less <<
NCT01280695 - Completed - -
NCT00413153 - Completed - -
NCT00717288 Diabetes Mellitus Phase 4 Completed - United States, Ohio ... More >> The Ohio State University Columbus, Ohio, United States, 43210 Less <<
NCT00717288 - Completed - -
NCT03407222 Type 2 Diabetes Mellitus ... More >> Physical Activity Less << Not Applicable Not yet recruiting October 30, 2019 Korea, Republic of ... More >> Samsung Medical Center Seoul, Korea, Republic of, 135-710 Less <<
NCT00006162 Glucose Intolerance ... More >> Diabetes Mellitus, Type 2 Less << Not Applicable Completed - United States, Washington ... More >> University of Washington Seattle, Washington, United States, 98195 Less <<
NCT00909480 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 4 Completed - -
NCT00909480 - Completed - -
NCT00527254 Type 2 Diabetes ... More >> Telemedicine Self Monitoring Blood Glucose Primary Care Less << Not Applicable Completed - Spain ... More >> Province of Malaga Health Department Málaga, Spain, 29001 Less <<
NCT02444910 Diabetes Mellitus, Type 2 Phase 2 Completed - United States, Kentucky ... More >> University of Kentucky's Center for Clinical and Translational Science (CCTS) Lexington, Kentucky, United States, 40536-0298 Less <<
NCT00413153 HIV Infections Not Applicable Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT00628524 - Completed - Germany ... More >> University Hospital Homburg / Saar - Cardiology Department Homburg, Saarland, Germany, 66421 Less <<
NCT01252303 Obesity Not Applicable Completed - United States, Kentucky ... More >> University of Kentucky Lexington, Kentucky, United States, 40506-0054 Less <<
NCT00380289 Essential Hypertension Not Applicable Unknown - United Kingdom ... More >> Clinical Pharmacology Unit, Box 110, Level 3 ACCI, Addenbrookes Hospital Recruiting Cambridge, United Kingdom, CB2 2QQ Contact: Mrs M Watts    01223 586865    mw363@medschl.cam.ac.uk    Contact: Dr A Stears, MBBS BSc MRCP    01223 586878    as659@medschl.cam.ac.uk Less <<
NCT01640873 - Completed - -
NCT00546052 - Completed - -
NCT00546052 Hypertension ... More >>Metabolic Disorder Less << Phase 3 Completed - -
NCT03101865 Type 1 Diabetes Mellitus Not Applicable Completed - Austria ... More >> Department of Pediatrics and Adolescent Medicine, Medical University of Graz Graz, Austria, A-8036 Department of Pediatrics I, Medical University of Innsbruck Innsbruck, Austria, A-6020 Deptartment of Pediatrics, Medical University of Vienna Vienna, Austria, A-1090 Germany Division for Paediatric Diabetology, University of Leipzig Leipzig, Germany, D-04103 Luxembourg Clinique Pédiatrique de Luxembourg Luxembourg, Luxembourg, L-1210 United Kingdom University of Cambridge Cambridge, United Kingdom, CB2 0QQ St James's University Hospital Leeds, United Kingdom, LS9 7TF Less <<
NCT01640873 Type 2 Diabetes Phase 1 Completed - -
NCT00851838 End-Stage Renal Disease Phase 2 Completed - Italy ... More >> Division of Nephrology, University of "G. d'Annunzio" Chieti, Italy Less <<
NCT01776853 Irritable Bowel Syndrome Not Applicable Completed - United Kingdom ... More >> NIHR Biomedical Research Unit in Gastrointestinal and Liver Diseases at Nottingham University Hospitals NHS Trust and the University of Nottingham Nottingham, United Kingdom, NG7 2UH Less <<
NCT01406496 Type 1 Diabetes Mellitus Not Applicable Unknown December 2013 Israel ... More >> Pediatric Endocrinology Unit, Kaplan Medical Center Recruiting Rehovot, Israel, 76100 Contact: Amnon Zung, MD    972-8-9441260    amnon_z@clalit.org.il    Principal Investigator: Amnon Zung, MD          Sub-Investigator: Nitza Vazana, RN          Sub-Investigator: Lilach Hofi, R.Nutr Less <<
NCT01791465 - Terminated(This study was term... More >>inated after 6 patients due to loss of funding) Less << - -
NCT01245270 Type 2 Diabetes Not Applicable Completed - United Kingdom ... More >> University of Aberdeen Rowett Institute of Nutrition and Health Aberdeen, United Kingdom, AB21 9SB Less <<
NCT03743025 Stress Hyperglycemia Phase 4 Not yet recruiting October 2022 United States, Georgia ... More >> Grady Memorial Hospital Recruiting Atlanta, Georgia, United States, 30303 Contact: Francisco Pasquel, M.D, M.P.H    404-778-1695    fpasque@emory.edu    Principal Investigator: Francisco Pasquel, M.D, M.P.H          Emory Hospital Midtown Recruiting Atlanta, Georgia, United States, 30308 Contact: Francisco Pasquel, MD, MPH    404-778-1695    fpasque@emory.edu    Principal Investigator: Francisco Pasquel, MD, MPH          Emory University Hospital Recruiting Atlanta, Georgia, United States, 30322 Contact: Guillermo Umpierrez, MD    404-778-1665    GEUMPIE@emory.edu    Contact: , MD          Emory St. Joseph's Hospital Recruiting Atlanta, Georgia, United States, 30342 Contact: Francisco Pasquel, MD, MPH    404-778-1695    fpasque@emory.edu    Principal Investigator: Francisco Pasquel, MD, MPH Less <<
NCT01245270 - Completed - -
NCT02543164 Glycemic Index Not Applicable Completed - -
NCT01482455 Lipid-induced Insulin Resistan... More >>ce Less << Not Applicable Completed - Austria ... More >> Medical University Vienna Vienna, Austria, 1090 Less <<
NCT01791465 Human Immunodeficiency Virus I... More >>nfection Diabetes Mellitus Less << Phase 4 Terminated(This study was term... More >>inated after 6 patients due to loss of funding) Less << - United States, Tennessee ... More >> Vanderbilt University Nashville, Tennessee, United States, 37240 Less <<
NCT00627445 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - China, Beijing ... More >> Beijing, Beijing, China, 100034 Less <<
NCT00657995 Pancreatic Neoplasm Not Applicable Completed - Japan ... More >> Kochi Medical School, Kochi University Nankoku-City, Kohasu-Okocho, Japan, 783-8505 Less <<
NCT01814358 Blood Sugar (Glucose) Control ... More >> Blood Vessel (Vascular) Dysfunction Less << Phase 1 Withdrawn March 2015 United States, California ... More >> UCLA Los Angeles, California, United States, 90095 Less <<
NCT03380546 Gestational Diabetes Mellitus ... More >>in Pregnancy Less << Phase 3 Recruiting March 30, 2022 France ... More >> Jean Verdier Hospital Recruiting Bondy, France, 93140 Contact: Emmanuel COSSON, MD-PhD    01 48 02 65 94 ext +33    emmanuel.cosson@aphp.fr Less <<
NCT03226210 Diabetes Mellitus, Type 2 Phase 4 Completed - China, Jiangsu ... More >> Nanjing First Hostital Nanjing, Jiangsu, China, 210000 Less <<
NCT00814008 Diabetes Mellitus, Type 1 ... More >> Insulin Retina Regional Blood Flow Less << Phase 2 Completed - Austria ... More >> Department of Clinical Pharmacology, Medical University of Vienna Vienna, Austria, 1090 Less <<
NCT00627445 - Completed - -
NCT01424306 Low-grade Chronic Inflammation... More >> Intestinal Permeability Type 2 Diabetes Mellitus Cardiovascular Disease Obesity Less << Not Applicable Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109 Less <<
NCT03041363 Epilepsy GLUT... More >>1DS1 Glut1 Deficiency Syndrome 1, Autosomal Recessive Glucose Metabolism Disorders Glucose Transport Defect Glucose Transporter Type 1 Deficiency Syndrome Glucose Transporter Protein Type 1 Deficiency Syndrome Less << Phase 1 Active, not recruiting March 29, 2025 United States, Texas ... More >> UT Southwestern Medical Center Dallas, Texas, United States, 75390 Less <<
NCT02776488 Brain Injuries, Traumatic Phase 1 Phase 2 Not yet recruiting June 2021 United States, California ... More >> David Geffen School of Medicine at UCLA Not yet recruiting Los Angeles, California, United States, 90095 Contact: Steven Cohen, MHA    310-794-1801    steven.cohen@mednet.ucla.edu Less <<
NCT02082756 Prediabetes Phase 2 Phase 3 Withdrawn(The sponsor have not... More >> enough money to support this trial) Less << April 2018 China, Shaanxi ... More >> First Affiliated Hospital of Xi'an Jiaotong University Xi'an,, Shaanxi, China, 710061 Second Affiliated Hospital of Xi'an Jiaotong University Xi'an, Shaanxi, China, 710004 The 323rd Hospital of People's Liberation Army Xi'an, Shaanxi, China, 710054 Shaanxi Provincial People's Hospital Xi'an, Shaanxi, China, 710068 Less <<
NCT01424306 - Completed - -
NCT03775733 Hyperglycemia Not Applicable Recruiting December 31, 2019 Korea, Republic of ... More >> Clinical Trial Center for Functional Foods Chonbuk National University Hospital Recruiting Jeonju, Jeollabuk-do, Korea, Republic of, 54907 Contact: Soo-Wan Chae, MD., PhD    82-63-259-3040    swchae@jbctc.org Less <<
NCT02214719 Diabetes, Type 1 Not Applicable Unknown December 2016 Canada, Alberta ... More >> University of Alberta Edmonton, Alberta, Canada, T6G 1S2 Less <<
NCT01839864 Metabolic Syndrome Not Applicable Withdrawn(Funding for the stud... More >>y was not received. No recruitment ever occurred.) Less << August 2016 United States, Idaho ... More >> Saint Alphonsus Medical Group Caldwell Clinic Caldwell, Idaho, United States, 83605 Saint Lukes Clinic Jerome Jerome, Idaho, United States, 83338 St Alphonsus Medical Group Nampa Clinic Nampa, Idaho, United States, 83686 Less <<
NCT02169050 - Completed - United States, Illinois ... More >> University of Illinois at Chicago Chicago, Illinois, United States, 60612 Less <<
NCT01869790 Type 1 Diabetes Not Applicable Completed - United States, Massachusetts ... More >> Joslin Diabetes Center Boston, Massachusetts, United States, 02215 Less <<
NCT03299543 - Completed - United States, Washington ... More >> Medamonitor, LLC Seattle, Washington, United States, 98119 Less <<
NCT03290846 Obesity Phase 2 Phase 3 Active, not recruiting February 28, 2018 -
NCT02921906 Neonatal Diabetes Not Applicable Recruiting August 2018 United Kingdom ... More >> Exeter Clinical Research Facility Recruiting Exeter, Devon, United Kingdom, EX25DW Contact: Pamela Bowman, MBBS MA    01392408325    P.Bowman@exeter.ac.uk    Contact: Bea A Knight, PhD    01392408172    B.A.Knight@exeter.ac.uk Less <<
NCT00719108 Diabetes Phase 1 Completed - United States, California ... More >> Profil Institute for Clinical Research Inc. Chula Vista, California, United States, 91911 Less <<
NCT01201590 Insulin Resistance Not Applicable Completed - United Kingdom ... More >> David Greenfield Physiology Laboratories, University of Nottingham Nottingham, Notts, United Kingdom, NG72UH Less <<
NCT02373046 Healthy Phase 1 Completed - United States, Texas ... More >> Lexicon Investigational Site Dallas, Texas, United States, 75247 Less <<
NCT01400659 Type 1 Diabetes Mellitus Phase 4 Completed - -
NCT01575509 Healthy Not Applicable Completed - Finland ... More >> Clinical Life Sciences Ltd Kajaani, Finland, 87100 Less <<
NCT02496156 Type 1 Diabetes Mellitus Not Applicable Completed - United States, Florida ... More >> Nemours Children's Clinic Jacksonville, Florida, United States, 32207 Less <<
NCT01063127 - Completed - Italy ... More >> Department of Internal Medicine, Catholic University Rome, Italy, 00168 Less <<
NCT00858182 End-Stage Renal Disease Phase 2 Withdrawn January 2013 -
NCT01271023 Type 1 Diabetes Phase 1 Completed - United States, California ... More >> Sansum Diabetes Research Institute Santa Barbara, California, United States, 93105 Stanford University Stanford, California, United States, 94305 United States, Colorado University of Colorado Health Sciences Center- Barbara Davis Aurora, Colorado, United States, 80045 United States, Virginia University of Virginia Charlottesville, Virginia, United States, 22908 France Montpellier University Hospital Montpellier, France, 34295 Israel Schneider Children's Medical Center of Israel Petah Tikva, Israel, 49202 Italy University of Padova Padova, Italy, 93106 Less <<
NCT00935805 - Unknown July 2012 Brazil ... More >> Hospital de Clínicas de Porto Alegre Porto Alegre, RS, Brazil, 90035-903 Less <<
NCT00772265 Diabetes Phase 1 Completed - United States, California ... More >> Profil Institute for clinical Research Chula Vista, California, United States, 91911 Less <<
NCT00929422 - Unknown December 2011 Taiwan ... More >> National Taiwan University Hospital Recruiting Taipei, Taiwan, Taiwan, 100 Contact: Yen-Ho Wang, MD    886-2-23123456 ext 67293    lukewang@ntu.edu.tw Less <<
NCT03079921 Type1diabetes ... More >> Hypoglycemia Hypoglycemia Unawareness Less << Early Phase 1 Recruiting December 2020 United States, Pennsylvania ... More >> University of Pennsylvania - Institute for Diabetes, Obesity and Metabolism Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Eileen Markmann    215-350-0364    eileen.markmann@uphs.upenn.edu    Contact: Cornelia Dalton Bakes    2155274490 ext Dalton Bakes    cornelia.dalton-bakes@uphs.upenn.edu    Principal Investigator: Michael R Rickels, MD., MS Less <<
NCT02038517 - Recruiting December 2026 Italy ... More >> Endocrinology and Diabetes Unit, Fondazione IRCCS Cà Granda - Ospedale Maggiore Policlinico Recruiting Milan, MI, Italy, 20122 Contact: Emanuela Orsi, MD    +390255034590    e.orsi@policlinico.mi.it    Sub-Investigator: Elena Lunati, MD          Sub-Investigator: Valeria Grancini, MD          Sub-Investigator: Eva Palmieri, MD          Sub-Investigator: Dario Zimbalatti, MD          Sub-Investigator: Veronica Resi, MD Less <<
NCT02601729 - Active, not recruiting - -
NCT01752348 Systemic Inflammatory Response... More >> Syndrome Less << Not Applicable Completed - Denmark ... More >> Medical Research Laboratory, Department of Internal Medicine and Endocrinology Aarhus C, Denmark, 8000 Less <<
NCT00969592 Diabetes Phase 1 Completed - Germany ... More >> Profil Institut für Stoffwechselforschung GmbH Neuss, Germany, D-41460 Less <<
NCT03444584 Type 2 Diabetes Mellitus Phase 2 Active, not recruiting December 10, 2018 Germany ... More >> Research Site Magdeburg, Germany, 39120 Research Site Mannheim, Germany, 68167 Research Site München, Germany, 81241 Hungary Research Site Balatonfüred, Hungary, 8230 Research Site Miskolc, Hungary, 3529 Research Site Szeged, Hungary, 6720 United Kingdom Research Site Liverpool, United Kingdom, L7 8XP Research Site Manchester, United Kingdom, M13 9NQ Research Site Rotherham, United Kingdom, S65 1DA Research Site Swansea, United Kingdom, SA2 8PP Less <<
NCT01108328 Appetite and Hunger, Suppressi... More >>on Blood Glucose, Postprandial Less << Phase 3 Completed - Canada, British Columbia ... More >> Canadian Centre for Functional Medicine Coquitlam, British Columbia, Canada, V3K6Y2 Canadian Center for Functional Medicine Coquitlam, British Columbia, Canada Less <<
NCT01238406 Type 1 Diabetes Not Applicable Completed - Germany ... More >> Diabetes -Zentrum fuer kinder und jugendliche Hannover, Germany, 30173 Israel Schneider Children's Medical center Petach-Tikva, Israel, 49202 Slovenia University Children's Hospital Ljubljana, Slovenia, SI-1000 Less <<
NCT01176578 Type 2 Diabetes Mellitus Not Applicable Active, not recruiting September 2021 United States, Maryland ... More >> Baltimore VA Medical Center Baltimore, Maryland, United States, 21201 Less <<
NCT01181986 Type 2 Diabetes Mellitus Phase 4 Completed - United States, Arizona ... More >> Phoenix VA Medical Center Phoenix, Arizona, United States, 85012 Less <<
NCT01866215 Healthy Subjects Not Applicable Completed - Switzerland ... More >> Centre Hospitalier Universitaire Vaudois Lausanne, Vaud, Switzerland, CH-1011 Less <<
NCT01116609 Healthy Not Applicable Completed - Denmark ... More >> Medical research laboratories, Aarhus University Hospital Aarhus, Denmark, 8000 Less <<
NCT00631345 Prediabetes O... More >>besity Less << Not Applicable Completed - United States, North Carolina ... More >> Wake Forest University School of Medicine Winston-Salem, North Carolina, United States, 27157 Less <<
NCT00767754 Panic Disorder Phase 4 Completed - Korea, Republic of ... More >> Samsung Medical Center Seoul, Korea, Republic of, 135-710 Less <<
NCT03659461 Type 2 Diabetes Mellitus ... More >> PreDiabetes Less << Not Applicable Recruiting January 2020 Malaysia ... More >> Hospital Sultan Ismail Recruiting Johor Bahru, Johor, Malaysia, 81100 Contact: Chong Shiau Chin, MPHARM    +6073565000    shiauchin83@hotmail.com    Contact    +60361455555 Less <<
NCT02694068 - Recruiting November 2021 United States, Washington ... More >> University of Washington Recruiting Seattle, Washington, United States, 98195 Contact: Rajnish Mehrotra, MD    206-685-0567    rmehrotr@uw.edu    Contact: Anne Goodling, BS    206-685-0777    ag49@uw.edu Less <<
NCT00767871 Panic Disorder Phase 4 Completed - Korea, Republic of ... More >> Samsung Medical Center Seoul, Korea, Republic of, 135-710 Less <<
NCT00922701 End-Stage Renal Disease Phase 2 Completed - Italy ... More >> Division of Nephrology, University of "G. d'Annunzio" Chieti, Italy, 66013 Less <<
NCT01181986 - Completed - -
NCT01600703 Hyperlipidemia Phase 2 Phase 3 Completed - Canada, Ontario ... More >> Toronto General Hospital Toronto, Ontario, Canada, M5G 2C4 Less <<
NCT01600703 - Completed - -
NCT01414556 Type 2 Diabetes Mellitus Early Phase 1 Completed - Denmark ... More >> Gentofte Hospital Hellerup, Denmark, 2900 Less <<
NCT02069236 Glucose-6 Phosphate Dehydrogen... More >>ase Deficiency Less << Not Applicable Completed - Thailand ... More >> Shoklo Malaria Research Unit (SMRU) Mae Sot, Thailand Less <<
NCT03331289 Diabetes Mellitus, Type 2 Phase 4 Recruiting October 30, 2019 United States, Texas ... More >> University Health System Texas Diabetic Institute Recruiting San Antonio, Texas, United States, 78207 Contact: Ralph DeFronzo, MD    210-567-6691    defronzo@uthscsa.edu Less <<
NCT00922701 - Completed - -
NCT00819325 Coronary Artery Disease ... More >> Angina Pectoris Type 2 Diabetes Mellitus Percutaneous Coronary Intervention Less << Phase 4 Completed - Canada, Nova Scotia ... More >> Queen Elizabeth II Health Sciences Centre Halifax, Nova Scotia, Canada, B3H 3A7 Less <<
NCT00475475 Overweight Ob... More >>esity Less << Not Applicable Completed - United States, Washington ... More >> University of Washington General Clinical Research Center Seattle, Washington, United States, 98195 Less <<
NCT02733848 Hypoglycemia Phase 1 Terminated(Lack of funding) - -
NCT00596687 - Completed - -
NCT01415271 Type 2 Diabetes Not Applicable Terminated(Preliminary explora... More >>tion of research concept did not prove to be viable.) Less << - Canada, British Columbia ... More >> Endocrine Research Society Vancouver, British Columbia, Canada, V6E 1M7 Less <<
NCT00596687 Type 2 Diabetes ... More >> Inpatient Hyperglycemia Less << Phase 4 Completed - United States, Georgia ... More >> Grady Memorial Hospital Atlanta, Georgia, United States, 30303 Emory University Hospital Atlanta, Georgia, United States, 30324 Less <<
NCT00979628 Type 2 Diabetes ... More >> Hyperglycemia Less << Phase 4 Completed - United States, Georgia ... More >> Grady Memorial Hospital Atlanta, Georgia, United States, 30303 Emory University Hospital Atlanta, Georgia, United States, 30322 Atlanta VA Medical Center Decatur, Georgia, United States, 30030 United States, South Carolina Medical University of South Carolina Charleston, South Carolina, United States, 29425-6240 United States, Texas Scott & White Memorial Hospital and Clinic Temple, Texas, United States, 76508 Less <<
NCT00979628 - Completed - -
NCT03552523 Type 2 Diabetes Mellitus Not Applicable Recruiting December 2019 United States, Massachusetts ... More >> Diabetes Research Center Recruiting Boston, Massachusetts, United States, 02114 Contact: Mallory Hillard, RN, MSN    617-643-0915    mahillard@partners.org    Contact: Jason Sloane, MD    3154270080    jlsloane@mgh.harvard.edu    Principal Investigator: Steven J Russell, MD, PhD Less <<
NCT02084654 Pre Diabetes ... More >>Insulin Resistance Less << Phase 1 Completed - -
NCT00694122 - Completed - -
NCT00694122 Type 1 Diabetes ... More >> Dawn Phenomenon Less << Phase 3 Completed - United States, Massachusetts ... More >> Massachusettes General Hospital/ Diabetes Research Center Boston, Massachusetts, United States, 02114 Less <<
NCT00401622 - Completed - -
NCT03774186 Type 1 Diabetes Mellitus ... More >> Pregnancy in Diabetes Less << Not Applicable Not yet recruiting June 15, 2020 -
NCT00401622 Diabetes Mellitus, Type 2 Not Applicable Completed - United States, Arizona ... More >> Phoenix, Arizona, United States, 85018 United States, California San Diego, California, United States, 92161 United States, Delaware Wilmington, Delaware, United States, 19805 United States, Florida Hollywood, Florida, United States, 33023 United States, Georgia Dawsonville, Georgia, United States, 30534 United States, New Jersey Whitehouse Station, New Jersey, United States, 08889 United States, New York East Syracuse, New York, United States, 13057 Endwell, New York, United States, 13760 Syracuse, New York, United States, 13210 United States, Texas San Antonio, Texas, United States, 78229 Canada, Ontario Oshawa, Ontario, Canada, L1H1017 Windsor, Ontario, Canada, N8W3P6 United Kingdom Reading, Berkshire, United Kingdom, RG2 7AG Llanishen, Cardiff, United Kingdom, CF145GJ Buckshaw Village, Chorley, United Kingdom, PR7 7NA Lloyd Street North, Manchester, United Kingdom, M15 6SX Glasgow, Scotland, United Kingdom, G20 0XA Claygate, Surrey, United Kingdom, KT10 OSA Less <<
NCT02105792 - Completed - United Kingdom ... More >> University of Exeter Exeter, Devon, United Kingdom, EX2 5DW Oxford University Hospitals NHS Trust Oxford, Oxfordshire, United Kingdom, OX3 7LE University of Newcastle Newcastle upon Tyne, Tyne And Wear, United Kingdom, NE1 7RU University of Glasgow Glasgow, United Kingdom, G12 8TA King's College University of London London, United Kingdom, SE1 9NH Less <<
NCT00686608 Obesity Not Applicable Unknown July 2012 United States, Oregon ... More >> Oregon Health & Science University Recruiting Portland, Oregon, United States, 97239 Contact: Jonathan Q. Purnell, M.D.    503-494-9516    purnellj@ohsu.edu Less <<
NCT02246582 Type 1 Diabetes ... More >> Type 2 Diabetes Less << Not Applicable Completed - United States, California ... More >> AMCR Institute Escondido, California, United States, 92026 Diablo Clinical Research Walnut Creek, California, United States, 94598 United States, Colorado Barbara Davis Center for Childhood Diabetes Aurora, Colorado, United States, 80045 Barbara Davis Center Aurora, Colorado, United States, 80045 United States, Georgia Atlanta Diabetes Associates Atlanta, Georgia, United States, 30318 United States, Washington Rainier Clinical Research Center Renton, Washington, United States, 98057 Less <<
NCT02127957 Cystic Fibrosis ... More >> Cystic Fibrosis Related Diabetes Less << Not Applicable Completed - Canada, Quebec ... More >> CRIMontreal Montréal, Quebec, Canada, H2W 1R7 Less <<
NCT01023945 Type 2 Diabetes Mellitus Phase 1 Completed - Japan ... More >> Kantou, Japan Less <<
NCT02246582 - Completed - -
NCT01585818 Type 2 Diabetes Mellitus Phase 2 Unknown August 2014 Singapore ... More >> National University Hospital Recruiting Singapore, Singapore, 119228 Contact: Eric YH Khoo, MD    67724352    eric_khoo@nuhs.edu.sg Less <<
NCT03330327 Healthy Subjects Phase 1 Completed - United States, California ... More >> Hanmi Investigative Site Chula Vista, California, United States, 91911 Less <<
NCT02518737 - Completed - Denmark ... More >> Department of Biomedical Sciences, University of Copenhagen Copenhagen, Denmark, 2200 Less <<
NCT00248352 Diabetes Mellitus, Type 2 ... More >> Coronary Disease Less << Not Applicable Completed - Canada, Ontario ... More >> University of Ottawa Heart Institute Ottawa, Ontario, Canada, K1Y 4W7 Less <<
NCT02499107 Obesity Diabe... More >>tes Less << Not Applicable Completed - Canada, Ontario ... More >> Department of Nutritional Sciences, FitzGerald Building Toronto, Ontario, Canada, M5S 3E2 Less <<
NCT02014883 Glut1 Deficiency Syndrome Phase 2 Unknown April 2018 France ... More >> Brain and Spine Institute Recruiting Paris, France, 75013 Sub-Investigator: Elodie Hainque, MD          Sub-Investigator: Domitille Gras, MD Less <<
NCT00883558 - Completed - -
NCT00883558 Diabetes Mellitus, Type 1 Phase 2 Completed - United States, Colorado ... More >> Barbara Davis Center for Childhood Diabetes Aurora, Colorado, United States, 80045 United States, Florida Diabetes Research Institute Miami, Florida, United States, 33136 United States, Michigan Henry Ford Health System Detroit, Michigan, United States, 48202 United States, Montana Mercury Street Medical Butte, Montana, United States, 59701 United States, North Carolina UNC Diabetes Care Center/Highgate Specialty Center Durham, North Carolina, United States, 27713 United States, Ohio Cleveland Clinic Cleveland, Ohio, United States, 44195 United States, Texas Texas Diabetes and Endocrinology Austin, Texas, United States, 78731 United States, Washington West Olympia Internal Medicine Olympia, Washington, United States, 98502 Less <<
NCT01819402 To Evaluate the Effect of Piog... More >>litazone on Glucose Metabolism of Fat Tissue by Using FDG-PET/CT Imaging Less << Not Applicable Unknown - Japan ... More >> Kurume University Recruiting Kurume, Japan, 830-0011 Contact: Nobuhiro Tahara, MD, PhD    +81-942-31-7580    ntahara@med.kurume-u.ac.jp Less <<
NCT00824694 Type 2 Diabetes Not Applicable Completed - United States, Arizona ... More >> Carl T. Hayden VAMC Phoenix, Arizona, United States, 85012 Southern Arizona VA Healthcare System Tucson, Arizona, United States, 85723 United States, New Mexico New Mexico VA Health Care System Albuquerque, New Mexico, United States, 87108 Less <<
NCT02438670 Type 1 Diabetes Mellitus Not Applicable Completed - United States, California ... More >> William Sansum Diabetes Center Santa Barbara, California, United States, 93105 Less <<
NCT02903199 Type II Diabetes Mellitus ... More >> Glucose Metabolism Disorders Metabolic Diseases Less << Not Applicable Unknown October 2016 United Kingdom ... More >> Northumbria University Newcastle-upon-Tyne, Tyne & Wear, United Kingdom, NE1 8ST Less <<
NCT02743130 Hyperglycemia, Postprandial Not Applicable Completed - Finland ... More >> University of Eastern Finland Kuopio, Finland, FI-70211 Less <<
NCT01419873 Hyperglycaemia Phase 4 Completed - New Zealand ... More >> Christchurch Womens Hospital, Canterbury District Health Board Christchurch, New Zealand Less <<
NCT02622854 Acute Pancreatitis Not Applicable Recruiting December 2018 Slovenia ... More >> University Medical Centre Ljubljana, Ljubljana, Slovenia Recruiting Ljubljana, Slovenia, 1000 Contact: Jakob Gubensek, MD, PhD       jakob.gubensek@kclj.si Less <<
NCT02465515 Diabetes Mellitus Phase 4 Completed - -
NCT03581968 Diabetes Type... More >> 1 Diabetes Mellitus Less << Not Applicable Completed - Canada, Quebec ... More >> Camp Carowanis Sainte-Agathe-des-Monts, Quebec, Canada Less <<
NCT01518023 - Completed - Brazil ... More >> Hospital das Clinicas- Central Institute ICHC- 9th Floor Rm 9077 Sao Paulo, Brazil, 05403-900 Less <<
NCT03667963 Carbohydrate Intolerance Not Applicable Recruiting March 2019 Canada, Ontario ... More >> Glycemic Index Laboratories Recruiting Toronto, Ontario, Canada, M5C 2X3 Contact: Laura Chiavaroli, PhD    416-861-0506    LChiavaroli@gilabs.com    Principal Investigator: Thomas MS Wolever, MD, PhD Less <<
NCT01886989 Type 2 Diabetes Not Applicable Completed - United States, Oklahoma ... More >> Department of Nutritional Sciences Stillwater, Oklahoma, United States, 74078 Less <<
NCT00571324 - Completed - -
NCT01358435 Diabetes Mellitus Phase 1 Completed - United States, California ... More >> Profil Institute for Clinical Research Chula Vista, California, United States, 91911 Less <<
NCT01719029 Gestational Diabetes Mellitus Not Applicable Completed - United States, Colorado ... More >> University of Colorado, Anschutz Medical Campus Aurora, Colorado, United States, 80045 Less <<
NCT02309138 Gestational Diabetes ... More >> Pregnancy Glucose Intolerance Less << Not Applicable Recruiting July 2019 United States, Pennsylvania ... More >> University of Pittsburgh-Center for Research on Health Care Recruiting Pittsburgh, Pennsylvania, United States, 15213 Contact: Esa M Davis, MD MPH    412-692-4862    davisem@upmc.edu    Contact: Alexandra Illes, MPH    412-586-9859    illesar2@upmc.edu Less <<
NCT01819584 - Unknown December 2015 -
NCT00470262 - Completed - -
NCT00656851 - Completed - -
NCT00656851 HIV Infections ... More >> Cardiovascular Disease Insulin Resistance HIV Lipodystrophy The Metabolic Syndrome Less << Not Applicable Completed - United States, Missouri ... More >> Washington University School of Medicine St. Louis, Missouri, United States, 63110 Less <<
NCT00470262 Metabolic Syndrome X ... More >> Prediabetic State Less << Not Applicable Completed - United States, Colorado ... More >> VA Eastern Colorado Health Care System, Denver Denver, Colorado, United States, 80220 Less <<
NCT02686385 Drug Induced Liver Injury Not Applicable Terminated(Steroids were given... More >> for 2 patients who had biopsy proven Drug induced Liver Injury and both have them developed sepsis.) Less << - India ... More >> Institute of liver and Biliary Sciences New Delhi, Delhi, India, 110070 Less <<
NCT02102243 Hypertension Phase 4 Recruiting December 2018 United States, Texas ... More >> UT Southwestern Medical Center Recruiting Dallas, Texas, United States, 75390 Contact: Debbie Arbique, DNP    214-648-3188    debbie.arbique@utsouthwestern.edu Less <<
NCT01034618 Diabetes Not Applicable Completed - Netherlands ... More >> Maastricht University Medical Center+ Maastricht, Limburg, Netherlands, 6229ER Less <<
NCT01438632 Diabetes Mellitus Phase 4 Completed - Netherlands ... More >> Department of general internal medicine 463, section Diabetes, Radboud University Nijmegen Medical Centre Nijmegen, Gelderland, Netherlands, 6500 HB Less <<
NCT02106975 Acute Lung Injury ... More >> Sepsis Less << Phase 2 Completed - United States, Georgia ... More >> Emory University and Grady Memorial Hospital Atlanta, Georgia, United States, 30322 United States, Kentucky University of Kentucky Lexington, Kentucky, United States, 40506 United States, Ohio The Cleveland Clinic Cleveland, Ohio, United States, 44106 United States, Virginia Virginia Commonwealth University Health System Richmond, Virginia, United States, 23298 United States, Wisconsin Froedtert and The Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 Less <<
NCT01120873 Metabolic Syndrome Phase 3 Completed - Taiwan ... More >> Division of Endocrinology and Metabolism, Department of Internal Medicine, Taichung Veterans General Hospital Taichang, Taiwan, 407 Less <<
NCT02709798 Myocardial Infarction Phase 4 Completed - China ... More >> Beijing Anzhen Hospital, Capital Medical University Beijing, China, 100029 Less <<
NCT03665350 Heart Failure ... More >> Diabetes Mellitus, Type 2 Less << Phase 2 Not yet recruiting October 30, 2020 Italy ... More >> Ospedale Treviglio Not yet recruiting Treviglio, BG, Italy, 24047 Contact: Paolo Sganzerla, MD    0363424269    paolo.sganzerla@asst-bgovest.it    Ospedale di Passirana Not yet recruiting Passirana, MI, Italy, 20017 Contact: Elena Martinoli, MD    02994304471    martinolielena@hotmail.com    Ospedale di Saronno Not yet recruiting Saronno, VA, Italy, 21047 Contact: Daniele Nassiacos, MD    029613459    daniele.nassiacos@asst-valleolona.it Less <<
NCT01044446 Peritonitis Phase 4 Completed - Hong Kong ... More >> Prince of Wales Hospital, Chinese University of Hong Kong Shatin, New Territories, Hong Kong, SAR Less <<
NCT02987595 Metabolic Syndrome ... More >> Overweight Central Obesity Impaired Glucose Tolerance Less << Not Applicable Completed - Sweden ... More >> Paediatric Research Facility; The Children's Hospital at Uppsala University Hospital Uppsala, Sweden, SE-751 85 Less <<
NCT01069926 Glucose Lowering Phase 1 Completed - United States, Florida ... More >> Research Site Orlando, Florida, United States United States, Kansas Research Site Overland Park, Kansas, United States United States, Minnesota Research Site Minneapolis, Minnesota, United States United States, Tennessee Research Site Knoxville, Tennessee, United States Less <<
NCT02906891 Hypoglycemia ... More >>Diabetes Mellitus, Type 1 Less << Not Applicable Terminated(Insufficient resour... More >>ces to complete study) Less << - United States, North Carolina ... More >> East Carolina University Greenville, North Carolina, United States, 27834 Less <<
NCT00738348 Liver Diseases Not Applicable Completed - Japan ... More >> Kochi Medical School Kohasu-Okocho, Nankoku, Japan, 783-8505 Less <<
NCT03242876 Hyperglycemia, Postprandial Not Applicable Completed - United Kingdom ... More >> School of Food Science and Nutrition, University of Leeds Leeds, West Yorkshire, United Kingdom, LS2 9JT Less <<
NCT01991470 - Completed - -
NCT02815150 Gastric Cancer Not Applicable Recruiting December 2018 China, Guangdong ... More >> The First Affiliated Hospital of Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510000 Contact: Dongjie Yang    020-87755766-8211    dongjie.yang@foxmail.com Less <<
NCT01833689 Healthy Not Applicable Recruiting March 2023 United Kingdom ... More >> NIHR/Wellcome Trust Imperial CRF Recruiting London, United Kingdom, W12 0HS Contact: Jeannette Davies    02083838070    Imperial.CRF@imperial.nhs.uk    Principal Investigator: Gary Frost, BSc SRD PhD Less <<
NCT01991470 Insulin Requiring Diabetes Not Applicable Completed - United States, California ... More >> AMCR Institute Escondido, California, United States, 92025 SoCal Diabetes Torrance, California, United States, 90505 Diablo Clinical Research Walnut Creek, California, United States, 94598 United States, Colorado Barbara Davis Center Aurora, Colorado, United States, 80045 United States, Connecticut Yale University, Yale Diabetes Research Program New Haven, Connecticut, United States, 06511 United States, Florida Nemours Children's Clinic Jacksonville, Florida, United States, 32207 United States, Georgia "Atlanta Diabetes Associates Atlanta, Georgia, United States, 30318 United States, Indiana Indiana University, Riley Hospital for Children Indianapolis, Indiana, United States, 46202 United States, Iowa University of Iowa Children Hospital Iowa City, Iowa, United States, 52242 United States, Oklahoma OUHSC Department of Pediatrics Oklahoma City, Oklahoma, United States, 73104 United States, Washington Rainier Clinical Research Center Renton, Washington, United States, 98057 Less <<
NCT03313869 Metabolic Disturbance ... More >> Glucose Intolerance Physical Inactivity Glucose Metabolism Disorders Lipid Metabolism Disorders Oxidative Stress Less << Not Applicable Completed - France ... More >> Medes-Imps Toulouse, France, 31405 Less <<
NCT02147860 Diabetes Mellitus, Type 1 Not Applicable Completed - United States, California ... More >> Stanford University Stanford, California, United States, 93405 United States, Virginia University of Virginia Center for Diabetes Technology Charlottesville, Virginia, United States, 22903 Less <<
NCT01746329 Insulin Resistance ... More >> Obesity Less << Not Applicable Completed - Netherlands ... More >> Radboud University Nijmegen Medical Centre Nijmegen, Gelderland, Netherlands, 6500 HB Less <<
NCT00940797 Diabetes Type 2 Phase 2 Completed - Mexico ... More >> Centro Universitario de Ciencias de la Salud. Universidad de Guadalajara, México Guadalajara, Jalisco, Mexico, 44340 Less <<
NCT02518334 Diabetes Mellitus, Type 2 Not Applicable Completed - United States, Missouri ... More >> University of Missouri Columbia, Missouri, United States, 65202 Less <<
NCT01890954 Diabetes Mellitus, Type 1 Not Applicable Completed - United States, Virginia ... More >> University of Virginia Center for Diabetes Technology Charlottesville, Virginia, United States, 22904 Less <<
NCT01065402 Diabetes Mellitus Not Applicable Unknown April 2010 Taiwan ... More >> PingTung Christian Hospital Recruiting Pingtung, Taiwan, 900 Contact: Chang Daw Ming, Physician    886-8-7368686 ext 2714    dawming@gmail.com    Principal Investigator: Chuang Lee Ming, Physician Less <<
NCT00536250 - Completed - United States, Connecticut ... More >> 47 College Street New Haven, Connecticut, United States, 06520 Less <<
NCT01151488 Breast Cancer Survivorship ... More >> Sarcopenia Less << Not Applicable Completed - United States, Maryland ... More >> Baltimore VAMC Baltimore, Maryland, United States, 21201 Less <<
NCT01722266 - Completed - -
NCT01722266 Type 1 Diabetes Phase 3 Completed - United States, New York ... More >> Diabetes-Endocrinology Center of Western NY Williamsville, New York, United States, 14221 Less <<
NCT01890954 - Completed - -
NCT01755416 - Completed - -
NCT01755416 Type 1 Diabetes Phase 2 Completed - United States, New York ... More >> Albert Einstein College of Medicine West Campus CRC Bronx, New York, United States, 10467 Less <<
NCT01957098 Insulin Resistance Not Applicable Completed - Denmark ... More >> Institute of Human Nutrition, The Royal Veterinary and Agricultural University Frederiksberg, Denmark, DK-1958 Less <<
NCT00154414 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 2 Completed - Japan ... More >> Novo Nordisk Investigational Site Tokyo, Japan, 1000005 Less <<
NCT02135835 Acute Heart Failure Phase 4 Completed - -
NCT02310009 Type 2 Diabetes Mellitus Not Applicable Withdrawn(PI relocated to a di... More >>fferent country and coI moved to a different lab.) Less << - Denmark ... More >> Rigshospitalet Copenhagen, Denmark Less <<
NCT00067626 Obesity Pre-d... More >>iabetes Insulin Resistance Impaired Glucose Tolerance Impaired Fasting Glucose Less << Phase 2 Completed - United States, Connecticut ... More >> Yale-Griffin Prevention Research Center Derby, Connecticut, United States, 06418 Less <<
NCT00154401 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 2 Completed - Denmark ... More >> Novo Nordisk Investigational Site Aalborg, Denmark, 9000 Novo Nordisk Investigational Site Hellerup, Denmark, 2900 Novo Nordisk Investigational Site Hvidovre, Denmark, 2650 Novo Nordisk Investigational Site Kolding, Denmark, 6000 Novo Nordisk Investigational Site København S, Denmark, 2300 Novo Nordisk Investigational Site København, Denmark, 2400 Novo Nordisk Investigational Site Køge, Denmark, 4600 Novo Nordisk Investigational Site Århus C, Denmark, 8000 France Novo Nordisk Investigational Site Antibes, France, 06600 Novo Nordisk Investigational Site DAX, France, 40107 Novo Nordisk Investigational Site LA ROCHELLE cedex, France, 17019 Novo Nordisk Investigational Site Marseille, France, 13009 Novo Nordisk Investigational Site Montpellier, France, 34295 Novo Nordisk Investigational Site Mougins, France, 06250 Novo Nordisk Investigational Site Narbonne, France, 11108 Novo Nordisk Investigational Site NEVERS cedex, France, 58033 Novo Nordisk Investigational Site Nimes, France, 30006 Novo Nordisk Investigational Site Pessac, France, 33600 Novo Nordisk Investigational Site Rennes, France, 35056 Novo Nordisk Investigational Site Venissieux, France, 69200 Netherlands Novo Nordisk Investigational Site Amsterdam, Netherlands, 1105 AZ Novo Nordisk Investigational Site Apeldoorn, Netherlands, 7334 DZ Novo Nordisk Investigational Site Den Bosch, Netherlands, 5223 GV Novo Nordisk Investigational Site Den Haag, Netherlands, 2512 VA Novo Nordisk Investigational Site Groningen, Netherlands, 9713 GZ Novo Nordisk Investigational Site Hengelo, Netherlands, 7555 DL Novo Nordisk Investigational Site Sliedrecht, Netherlands, 3361 XV Slovakia Novo Nordisk Investigational Site Banska Bystrica, Slovakia, 95717 Novo Nordisk Investigational Site Bratislava, Slovakia, 811 08 Novo Nordisk Investigational Site Bratislava, Slovakia, 81526 Novo Nordisk Investigational Site Bratislava, Slovakia, 82102 Novo Nordisk Investigational Site Bratislava, Slovakia, 831 01 Novo Nordisk Investigational Site Kosice, Slovakia, 040 01 Novo Nordisk Investigational Site Kosice, Slovakia, 04011 Novo Nordisk Investigational Site Kosice, Slovakia, 04190 Novo Nordisk Investigational Site Lucenec, Slovakia, 98401 Novo Nordisk Investigational Site Presov, Slovakia, 080 01 Novo Nordisk Investigational Site Sahy, Slovakia, 93601 Novo Nordisk Investigational Site Zilina, Slovakia, 01001 Less <<
NCT01495975 Diabetes Mellitus, Type 2 Not Applicable Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT02089256 Healthy Phase 4 Completed - Estonia ... More >> Tartu University Hospital Tartu, Estonia Less <<
NCT02883842 Coronary Artery Disease ... More >> Diabetes Less << Not Applicable Completed - China, Beijing ... More >> Fuwai hospital Beijing, Beijing, China Less <<
NCT00990444 Diabetes Mellitus Phase 1 Phase 2 Suspended December 2010 Sweden ... More >> Karolinska Trial Alliance, Phase I Unit Stockholm, Solna, Stockholm, Sweden, 17176 Less <<
NCT01136746 Hyperglycemia Phase 3 Terminated(Low enrollment) - United States, Alabama ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Birmingham, Alabama, United States, 35294 United States, Florida For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Jacksonville, Florida, United States, 32209 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Miami, Florida, United States, 33136 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Weston, Florida, United States, 33331 United States, Georgia For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Atlanta, Georgia, United States, 30312 United States, Kansas For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Topeka, Kansas, United States, 66604 United States, Kentucky For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hazard, Kentucky, United States, 41701 United States, Maine For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bangor, Maine, United States, 04401 United States, Missouri For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kansas City, Missouri, United States, 64111 United States, Ohio For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Cleveland, Ohio, United States, 44106 United States, South Carolina For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Charleston, South Carolina, United States, 29425 United States, Tennessee For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Memphis, Tennessee, United States, 38104 Less <<
NCT01495975 - Completed - -
NCT01136746 - Terminated(Low enrollment) - -
NCT01607450 Type 2 Diabetes Mellitus ... More >> Healthy Less << Phase 2 Phase 3 Completed - United States, Indiana ... More >> Indiana Clinical Research Center Indianapolis, Indiana, United States, 46202 Less <<
NCT01607450 - Completed - -
NCT01577095 Type 2 Diabetes Mellitus With ... More >>Features of Insulin Resistance Less << Phase 2 Completed - Taiwan ... More >> Department of Integrative Chinese-Western Clinic, China Medical University Hospital Taichung, Taiwan, 404 Less <<
NCT02458027 Diabetes Prevention ... More >> Obesity Prevention Less << Not Applicable Completed - Canada, Manitoba ... More >> Richardson Centre for Functional Foods and Nutraceuticals Winnipeg, Manitoba, Canada, R3T 2N2 Less <<
NCT03315663 Prediabetes H... More >>yperglycemia Postprandial Hyperglycemia Impaired Glucose Tolerance Impaired Fasting Glucose Less << Not Applicable Recruiting June 30, 2021 United States, Maryland ... More >> Johns Hopkins Medical Institutions Recruiting Baltimore, Maryland, United States, 21287 Contact: Clare J. Lee, MD MHS    443-287-4783    clee158@jhmi.edu    Contact: Aston King    443.287-8498    aking64@jhmi.edu    United States, Pennsylvania Reading Health System Recruiting Reading, Pennsylvania, United States, 19607 Contact: Brian R Kane, MD    610-775-2799    Brian.Kane@readinghealth.org    Contact: Pamela Schearer    484.628-8355    pamela.schearer@readinghealth.org Less <<
NCT02649465 Non-alcoholic Fatty Liver Dise... More >>ase Less << Phase 4 Recruiting September 2020 Japan ... More >> Department of Disease Control and Homeostasis, Kanazawa University Hospital Recruiting Kanazawa, Ishikawa, Japan, 920-8641 Contact: Toshinari Takamura, MD, PhD    +81-76-265-2234    ttakamura@m-kanazawa.jp    Principal Investigator: Yumie Takeshita, MD, PhD Less <<
NCT01530178 Diabetes Mellitus, Type 1 Phase 4 Completed - United States, New York ... More >> Albert Einstein College of Medicine CRC Bronx, New York, United States, 10461 Less <<
NCT02193100 - Withdrawn June 2019 United States, Kentucky ... More >> James Graham Brown Cancer Center-University of Louisville Louisville, Kentucky, United States, 40202 Less <<
NCT01530178 - Completed - -
NCT01033773 Type 2 Diabetes Mellitus Not Applicable Completed - United States, District of Col... More >>umbia Washington Hospital Center Washington, District of Columbia, United States, 20010 Less <<
NCT01828125 Type 1 Diabetes Phase 2 Withdrawn December 2013 Canada, Quebec ... More >> Institut de recherches cliniques de Montréal Montreal, Quebec, Canada, H2W 1R7 Less <<
NCT02094001 Chronic Thromboembolic Pulmona... More >>ry Hypertension Less << Phase 2 Completed - Canada, Ontario ... More >> University of Ottawa Heart Institute Ottawa, Ontario, Canada, K1Y4W7 Less <<
NCT01754181 Type 1 Diabetes Phase 3 Completed - France ... More >> Centre Hospitalier Sud Francilien Evry, France, 91058 University Hospital of Grenoble Grenoble, France, 38043 University Hospital of Toulouse Toulouse, France, 31403 Less <<
NCT03627637 Brain Vascular Function ... More >> Cerebral Blood Flow Glucose Metabolism Cognitive Performance Less << Not Applicable Recruiting December 31, 2019 Netherlands ... More >> Maastricht University Medical Center Recruiting Maastricht, Limburg, Netherlands, 6229 ER Contact: Peter Joris, PhD    +31 43 3881311    p.joris@maastrichtuniversity.nl Less <<
NCT03151239 Glucose Metabolism Disorders Not Applicable Recruiting June 1, 2020 United States, Missouri ... More >> Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: Sally Torbitzky, RN, BSN    314-362-9950    storbitz@wustl.edu    Contact: Mihoko Yoshino, MD    314-362-8228    myoshino@wustl.edu    Principal Investigator: Samuel Klein, MD Less <<
NCT01407900 Heart Failure ... More >> Renal Insufficiency Less << Phase 1 Withdrawn(New technique for ad... More >>ministration of drug, this is the old technique of administration.) Less << - -
NCT02463305 Colitis, Ulcerative Early Phase 1 Recruiting December 2019 United States, Colorado ... More >> University of Colorado Hospital Recruiting Denver, Colorado, United States Less <<
NCT03320031 Type 2 Diabetes Mellitus ... More >> Peritoneal Dialysis Less << Phase 4 Recruiting December 2019 China, Guangdong ... More >> endocrinology department of the first affiliated hospital of Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510080 Contact: Yanbing Li, MD,PhD    8602087334331    easd04lyb@126.com    Principal Investigator: Yanbing Li, MD,PhD Less <<
NCT01786551 Systemic Proinflammatory State Not Applicable Completed - United States, Massachusetts ... More >> Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Less <<
NCT03394352 Type 1 Diabetes Mellitus Not Applicable Completed - United States, Virginia ... More >> University of Virginia Center for Diabetes Technology Charlottesville, Virginia, United States, 22903 Less <<
NCT01786551 - Completed - -
NCT00394524 Diabetes or With New Hyperglyc... More >>emia Less << Not Applicable Completed - United States, Georgia ... More >> Grady Memorial Hospital Atlanta, Georgia, United States, 30303 Piedmont Hopsital Atlanta, Georgia, United States, 30309 United States, Tennessee University of Tennessee Health Science Center, Memphis Memphis, Tennessee, United States, 38103 United States, Washington University of Washington, Seattle Seattle, Washington, United States, 98195 Less <<
NCT03614780 Temperature E... More >>xercise Diabetes Mellitus, Type 2 Less << Not Applicable Completed - United States, Alabama ... More >> Center for the Study of Community Health Birmingham, Alabama, United States, 35294 Less <<
NCT02604927 Spinal Cord Injuries Not Applicable Unknown September 2017 Brazil ... More >> School of Physical Education and Sports, University of Sao Paulo Not yet recruiting São Paulo, Brazil, 05508-030 Contact: Guilherme Artioli, PhD    55 11 3091-3096    artioli@usp.br Less <<
NCT03497260 Type 1 Diabetes Mellitus ... More >> Diabetes Complications Less << Not Applicable Not yet recruiting December 2019 Switzerland ... More >> Division of Endocrinology, Diabetes and Clinical Nutrition, Bern University Hospital Bern, Switzerland, 3010 Less <<
NCT01545700 Postoperative Complications Phase 4 Completed - United States, Illinois ... More >> NorthShore University HealthSystem Evanston, Illinois, United States, 60201 Less <<
NCT02875275 Diabetes Card... More >>iovascular Disease Less << Not Applicable Completed - Singapore ... More >> Clinical Nutrition Reseach Centre Singapore, Singapore, 117599 Less <<
NCT01545700 - Completed - -
NCT00287456 Cystic Fibrosis Related Diabet... More >>es Less << Not Applicable Unknown - United States, Texas ... More >> Children’s Medical Center of Dallas Dallas, Texas, United States, 75390 Less <<
NCT00394524 - Completed - -
NCT00951899 Type 2 Diabetes Phase 4 Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT02408120 Diabetes Mellitus, Type 2 Phase 4 Recruiting January 2019 United States, Georgia ... More >> Grady Memorial Hospital Not yet recruiting Atlanta, Georgia, United States, 30303 Contact: Priyathama Vellanki, MD    404-778-1687    priyathama.vellanki@emory.edu    Emory University Hospital Recruiting Atlanta, Georgia, United States, 30322 Contact: Priyathama Vellanki, MD    404-778-1687    priyathama.vellanki@emory.edu Less <<
NCT00951899 - Completed - -
NCT03333369 Healthy Schiz... More >>otypal Personality Less << Early Phase 1 Completed - Switzerland ... More >> Collegium Helveticum, ETH & Universität Zürich Zürich, Switzerland, 8006 Zürich Less <<
NCT02131766 Diabetes Mellitus Not Applicable Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 United States, New York Mount Sinai Hospital New York, New York, United States, 10029-6574 United States, Virginia University of Virginia Center for Diabetes Technology Charlottesville, Virginia, United States, 22903 Italy University of Padova Padova, Italy, 35131 Less <<
NCT02680054 Type 1 Diabetes Phase 4 Recruiting November 2018 United Kingdom ... More >> Royal Berkshire Hospital Active, not recruiting Reading, Berkshire, United Kingdom Oxford Children's Hospital, John Radcliffe Hospital Recruiting Oxford, Oxon, United Kingdom, OX3 9DU Contact: Annemarie Frohock    01865231674    annemarie.frohock@ouh.nhs.uk    Contact: Loraine Bunton    01865231673    loraine.bunton@ouh.nhs.uk Less <<
NCT01276795 Protein Metabolism ... More >> Colorectal Neoplasms Less << Not Applicable Completed - Canada, Quebec ... More >> Montreal General Hospital Montreal, Quebec, Canada, H3G 1A4 Less <<
NCT01631643 Diabetes Phase 4 Withdrawn(Business decision to... More >> withdraw trial) Less << June 2013 -
NCT01771614 Type 1 Diabetes ... More >> Type 2 Diabetes Less << Not Applicable Withdrawn(PI relocated to a di... More >>fferent country.) Less << January 2017 United Kingdom ... More >> University of Birmingham Birmingham, West Midlands, United Kingdom, B15 2TT Less <<
NCT02402517 Diabetes Obes... More >>ity Less << Not Applicable Active, not recruiting December 2017 Canada, Manitoba ... More >> Richardson Centre for Functional Foods and Nutraceuticals Winnipeg, Manitoba, Canada, R3T 2N2 Less <<
NCT03447028 - Completed - -
NCT03380325 Diabetes Mellitus, Type 2 ... More >> Insulin Sensitivity/Resistance Less << Not Applicable Completed - Netherlands ... More >> VU University Medical Center Amsterdam, Noord-Holland, Netherlands, 1081 HV Less <<
NCT00970528 Diabetes Mellitus, Type 2 Phase 4 Completed - Korea, Republic of ... More >> Wonju-si, Gang''weondo, Korea, Republic of, 220-701 Busan, Korea, Korea, Republic of, 602-714 Gyeonggi-do, Korea, Korea, Republic of, 463-500 Gyeonggi-do, Korea, Korea, Republic of, 471-701 Pusan, Korea, Korea, Republic of, 602-739 Seoul, Korea, Korea, Republic of, 150-713 Daegu, Korea, Republic of, 705-717 Jeonju-si, Korea, Republic of, 456-712 Seongbuk-gu Seoul, Korea, Republic of, 136-705 Seoul, Korea, Republic of, 134-701 Seoul, Korea, Republic of, 135-710 Less <<
NCT03506581 - Completed - -
NCT01063361 Type 2 Diabetes Phase 2 Completed - Canada, Ontario ... More >> St. Michael's Hospital Toronto, Ontario, Canada, M5B 1W8 Less <<
NCT01156116 - Completed - -
NCT00272064 Diabetes Mellitus, Type 2 Phase 3 Completed - Italy ... More >> Sanofi-Aventis Administrative Office Milan, Italy Less <<
NCT02471690 Healthy Phase 1 Completed - United States, Wisconsin ... More >> Spaulding Clinical West Bend, Wisconsin, United States, 53095 Less <<
NCT01156116 Diabetes Slee... More >>p Apnea Less << Not Applicable Completed - United States, Illinois ... More >> The University of Chicago Chicago, Illinois, United States, 60637 Less <<
NCT02370927 Diabetes Prevention ... More >> Obesity Prevention Less << Not Applicable Active, not recruiting December 2017 Canada, Manitoba ... More >> Richardson Centre for Functional Foods and Nutraceuticals Winnipeg, Manitoba, Canada, R3T 2N2 Less <<
NCT00288743 Critically Ill Patients Phase 2 Completed - Belgium ... More >> University Hospital Ghent Ghent, Belgium, 9000 Less <<
NCT02808182 Impaired Glucose Tolerance Not Applicable Recruiting July 2019 Canada, Quebec ... More >> centre de recherche du CHUS Recruiting Sherbrooke, Quebec, Canada, J1H 5N4 Contact: Frederique Frisch    8193461110    frederique.frisch@usherbrooke.ca Less <<
NCT02365363 Diabetes Prevention ... More >> Obesity Prevention Less << Not Applicable Completed - Canada, Manitoba ... More >> Richardson Centre for Functional Foods and Nutraceuticals, University of Manitoba Winnipeg, Manitoba, Canada, R3T 6C5 Less <<
NCT02582606 Insulin Resistance Not Applicable Completed - United Kingdom ... More >> David Greenfield Human Physiology Unit, University of Nottingham Medical School Nottingham, Notts, United Kingdom, NG72UH Less <<
NCT00965991 Gestational Diabetes Not Applicable Completed - United States, New Mexico ... More >> University of New Mexico Diabetes in Pregnancy Clinic Albuquerque, New Mexico, United States, 87131 Less <<
NCT00552786 Hearing Loss Phase 2 Completed - Taiwan ... More >> Environmental and Occupational Medicine, National Taiwan University Hospital Taipei, Taiwan, 100 Less <<
NCT03047486 - Completed - France ... More >> Endocrinology Unit and Clinical Research Center Basse Normandie, University Hospital of Caen Caen, France, 14000 Less <<
NCT02180646 Type 2 Diabetes Not Applicable Completed - -
NCT00596128 Blood Glucose Not Applicable Completed - Germany ... More >> Department of Anaesthesiology and Intensive Care Medicine, UK S-H Campus Kiel Kiel, Schleswig-Holstein, Germany, 24105 Less <<
NCT02416440 - Completed - South Africa ... More >> University of KwaZulu-Natal Durban, KwaZulu-Natal, South Africa, 4013 Less <<
NCT00552786 - Completed - -
NCT03301532 GLUT1DS1 Early Phase 1 Enrolling by invitation July 5, 2023 United States, Texas ... More >> UTexasSouthwestern Dallas, Texas, United States, 75390 Less <<
NCT02180646 - Completed - -
NCT03306316 Preterm Infant ... More >> Development, Infant Nutrition Less << Not Applicable Recruiting June 1, 2020 United States, Ohio ... More >> Nationwide Children's Hospital and affiliated NICUs Recruiting Columbus, Ohio, United States, 43206 Contact: Ethan A Mezoff, MD    614-722-3481    Ethan.Mezoff@nationwidechildrens.org Less <<
NCT00263731 - Unknown December 2018 United States, Kentucky ... More >> James Graham Brown Cancer Center, University of Louisville Recruiting Louisville, Kentucky, United States, 40202 Principal Investigator: Donald M Miller, MD, PhD Less <<
NCT01810952 Hyperglycemia ... More >> Diabetes Mellitus Less << Phase 4 Completed - United States, Texas ... More >> St. Luke's Episcopal Hospital Houston, Texas, United States, 77030 Less <<
NCT01425255 - Withdrawn(Enrollment finished ... More >>and a paper was published.) Less << - Israel ... More >> E. Wolfson Medical Center Holon, Israel, 58100 Less <<
NCT01810952 - Completed - -
NCT00309465 Diabetes Surg... More >>ery Less << Phase 4 Completed - United States, Michigan ... More >> William Beaumont Hospital Royal Oak, Michigan, United States, 48073 William Beaumont Hospital Troy, Michigan, United States, 48085 Less <<
NCT01847144 Type 2 Diabetes Phase 4 Completed - United Kingdom ... More >> NIHR Exeter Clinical Research Facility, Royal Devon & Exeter NHS Foundation Trust Exeter, Devon, United Kingdom, EX2 5DW Less <<
NCT00309465 - Completed - -
NCT02393573 Pre-Diabetes ... More >>Major Lung or Abdominal Surgery Insulin Resistance Less << Not Applicable Terminated(Poor recruitment) - Canada, Quebec ... More >> Montreal General Hospital Montreal, Quebec, Canada, H3G 1A4 Less <<
NCT02234440 NASH Related Cirrhosis Not Applicable Completed - India ... More >> Institute of Liver & Biliary Sciences New Delhi, Delhi, India, 110070 Less <<
NCT00457093 Type 2 Diabetes Not Applicable Completed - United States, California ... More >> Diabetes Care Center Salinas, California, United States, 93901 Less <<
NCT02108301 Chronic Hepatitis C-virus Infe... More >>ction Renal Transplantation Less << Phase 4 Unknown - Austria ... More >> Medical University of Vienna, Department of Internal Medicine III, Division of Nephrology and Dialysis Vienna, Austria, 1090 Less <<
NCT00747968 Type 2 Diabetes Phase 2 Phase 3 Completed - Denmark ... More >> Aarhus University Hospital, Investigational Dept. M of Endocrinology Aarhus, Aarhus C, Denmark, 8000 Aarhus University Hospital, Investigational Dept. M of Endocrinology Aarhus, Denmark, 8000 C Aarhus University Hospital, Investigational Dept. M of Endocrinology Aarhus, Denmark, 8000 Less <<
NCT02237079 Obesity Gluco... More >>se Homeostasis Postmenopausal Symptoms Less << Phase 4 Completed - United States, Louisiana ... More >> Tulane University Clinical Translational Unit New Orleans, Louisiana, United States, 70112 Less <<
NCT00145340 Polycystic Ovary Syndrome Phase 4 Completed - Denmark ... More >> Department of Endocrinology, Odense University Hospital Odense, Funen, Denmark, 5000 Less <<
NCT03732352 EGFR Gene Amplification ... More >> EGFR Gene Mutation Glioblastoma Recurrent Glioblastoma Supratentorial Glioblastoma TP53 wt Allele Less << Phase 2 Not yet recruiting November 1, 2021 United States, California ... More >> UCLA / Jonsson Comprehensive Cancer Center Not yet recruiting Los Angeles, California, United States, 90095 Contact: Timothy F. Cloughesy    310-825-5321    tcloughesy@mednet.ucla.edu    Principal Investigator: Timothy F. Cloughesy Less <<
NCT03173677 Atherosclerosis Not Applicable Completed - -
NCT01049412 Diabetes Mellitus, Type 1 Phase 2 Completed - United States, California ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chula Vista, California, United States, 91911 United States, Georgia For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Atlanta, Georgia, United States, 30309 United States, Idaho For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Idaho Falls, Idaho, United States, 83404 United States, Kansas For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Topeka, Kansas, United States, 66606 United States, Louisiana For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Metairie, Louisiana, United States, 70006 United States, Maryland For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Baltimore, Maryland, United States, 21204 United States, Minnesota For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Minneapolis, Minnesota, United States, 55416 United States, Texas For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Austin, Texas, United States, 78731 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Dallas, Texas, United States, 75230 United States, Washington For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Renton, Washington, United States, 98057 Israel For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Holon, Israel, 22100 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Petah Tiqva, Israel, 49451 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tel Hashomer, Israel, 52661 Less <<
NCT02455076 Type 2 Diabetes Phase 4 Completed - United States, Georgia ... More >> Grady Memorial Hospital Atlanta, Georgia, United States, 30303 Emory University Hospital Atlanta, Georgia, United States, 30322 Less <<
NCT03542071 Diabetes, Gestational ... More >> Dietary Modification Tissue Glucose Body Composition Birth Weight Less << Not Applicable Suspended(The study protocol w... More >>as changed because of too few eligible participants. A registration with revised protocol can be found by ClinicalTrials.gov ID NCT03681054.) Less << July 2019 Finland ... More >> Helsinki university central hospital Helsinki, Finland Less <<
NCT01049412 - Completed - -
NCT02148250 Type 2 Diabetes ... More >> Insulin Resistance High Insulin Requirements Less << Not Applicable Completed - United States, Minnesota ... More >> University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT02052479 Polycystic Ovary Syndrome ... More >> PCOS Less << Early Phase 1 Unknown June 2015 United States, Ohio ... More >> Clinical Research Center at The Ohio University Wexner Medical Center / Nationwide Children's Hospital Recruiting Columbus, Ohio, United States, 43205 Contact: Rachel-Marie A Cazeau, MD    614-722-4935    Rachel-Marie.Cazeau@nationwidechildrens.org    Principal Investigator: Rachel-Marie A Cazeau, MD Less <<
NCT03398902 PreDiabetes Not Applicable Not yet recruiting August 31, 2022 -
NCT01407627 Chronic Kidney Disease Not Applicable Recruiting September 2020 Canada, Alberta ... More >> University of Calgary Recruiting Calgary, Alberta, Canada, T2N 2T9 Contact: Darlene Sola, RN, BScN    (403) 944-2745    dsola@ucalgary.ca Less <<
NCT00973401 - Unknown June 2010 Denmark ... More >> Glostrup Hospital Recruiting Glostrup, Denmark, 2600 Contact: Stig Holfort, medical doctor    +4543234817       Principal Investigator: Stig Holfort, medical doctor Less <<
NCT01857258 Hyperglycemia ... More >> Cardiovascular Disease Less << Not Applicable Completed - United States, Ohio ... More >> The Ohio State University Columbus, Ohio, United States, 43210 Less <<
NCT01643382 Diabetes End ... More >>Stage Renal Disease Less << Not Applicable Completed - United States, California ... More >> University of California San Francisco San Francisco, California, United States, 94123 Less <<
NCT01857258 - Completed - -
NCT02855541 Blood Pressure Not Applicable Completed - United States, Colorado ... More >> University of Colorado Boulder Boulder, Colorado, United States, 80309 Less <<
NCT00525694 Obesity Not Applicable Completed - United States, Delaware ... More >> Christiana Care Health System Newark, Delaware, United States, 19718 Less <<
NCT00709163 Dilated Cardiomyopathy Not Applicable Completed - United States, California ... More >> Mattel Children's Hospital at UCLA Los Angeles, California, United States, 90095 Less <<
NCT00749983 Knee Osteoarthritis ... More >> Fibromyalgia Less << Not Applicable Completed - Brazil ... More >> University of Sao Paulo School of Medicine Sao Paulo, Brazil, 01246903 Less <<
NCT03141710 Diabetes Mellitus, Type 2 Not Applicable Recruiting August 2018 United Kingdom ... More >> The Rowett Institute, Human Nutrition Unit Recruiting Aberdeen, United Kingdom, AB25 2ZD Contact: Alexandra M Johnstone, PhD    00441224438614    alex.johnstone@abdn.ac.uk Less <<
NCT03080831 Thoracic Diseases ... More >> Water-Electrolyte Imbalance Fluid Overload Fluid Retention Sodium Disorder Potassium Disorders Chloride Disorder Less << Phase 4 Completed - Belgium ... More >> University Hospital, Antwerp Edegem, Belgium, 2650 Less <<
NCT01996514 Obesity Prevention Not Applicable Completed - Canada, Ontario ... More >> University of Toronto Toronto, Ontario, Canada, M5S3E2 Less <<
NCT00511108 Type 2 Diabetes Mellitus (T2DM... More >>) Less << Phase 1 Completed - -
NCT02929212 Morbid Obesity Not Applicable Completed - United States, New York ... More >> New York Obesity Nutrition Research Center, St. Luke's-Roosevelt Hospital Center New York, New York, United States, 10025 Less <<
NCT01407003 Type 2 Diabetes Mellitus (T2DM... More >>) Less << Phase 1 Phase 2 Completed - United States, Florida ... More >> Novartis Investigative Site Miami, Florida, United States, 33126 Less <<
NCT00511108 - Completed - -
NCT02855541 - Completed - -
NCT02496000 - Completed - -
NCT02925559 Diabetes Mellitus, Type 2 Phase 4 Unknown December 2017 Brazil ... More >> Centro de Diabetes Curitiba Curitiba, Parana, Brazil, 80810040 Less <<
NCT01158040 - Unknown August 2012 Israel ... More >> Sheba Medical Center Not yet recruiting Ramat Gan, Israel, 52621 Contact: Hagit Shani, MD    972-50-7509442    shani.hagit@gmail.com    Contact: Rakefet Yoeli-Ulman, MD    972-54-6551819    rakefety@bezeqint.net    Principal Investigator: Hagit Shani, MD Less <<
NCT03769389 GI Glycaemic Index Healthy Vol... More >>unteers GL Glycaemic Load Healthy Volunteers Less << Not Applicable Completed - United Kingdom ... More >> NU-Food Research Facility Newcastle upon Tyne, Tyne And Wear, United Kingdom, NE1 7RU Less <<
NCT02371694 Diabetes Mellitus, Type 1 Not Applicable Recruiting December 2018 Ireland ... More >> Cork University Hospital Recruiting Cork, Ireland, T12 DC4A Contact: Susan M O'Connell, MD    +353 21 49 20139    susan.oconnell@hse.ie Less <<
NCT02496000 Diabetes Type 2 Phase 2 Completed - -
NCT02527993 Hypoglycemia ... More >>Obesity Surgery Less << Phase 4 Completed - -
NCT01819272 Type 2 Diabetes Mellitus Phase 2 Completed - -
NCT02623465 Diabetes Mellitus, Type 2 Phase 1 Withdrawn(Change in clinical s... More >>trategy) Less << April 2018 -
NCT01819272 - Completed - -
NCT03032120 Obesity Not Applicable Completed - -
NCT01796184 - Completed - Spain ... More >> Centro de Saúde A-Estrada A Estrada, Pontevedra, Spain, 36680 Less <<
NCT02095808 Lung Cancer Not Applicable Recruiting December 2018 United States, Texas ... More >> University of Texas Southwestern Medical Center Recruiting Dallas, Texas, United States, 75390 Contact: Jessica Saltarski    214-648-7023    Jessica.Saltarski@utsouthwestern.edu Less <<
NCT03165786 Type1diabetes Not Applicable Completed - United States, Illinois ... More >> University of Illinois at Chicago Chicago, Illinois, United States, 60612 Less <<
NCT00173082 - Unknown July 2008 Taiwan ... More >> National Taiwan University Hospital Recruiting Taipei, Taiwan Contact: Vincent Wu, MD    +886-2-23562082    walt-wu@yahoo.com.tw Less <<
NCT03362151 Diabetes Mellitus, Type 1 Not Applicable Completed - United States, California ... More >> Sansum Diabetes Research Institute Santa Barbara, California, United States, 93105 Less <<
NCT02325271 - Completed - Germany ... More >> GWT-TUD GmbH / Studienzentrum Hanefeld Dresden, Germany, 01307 Less <<
NCT02634515 Diabetes Mellitus Phase 1 Completed - Germany ... More >> Profil Institut für Stoffwechselforschung GmbH Neuss, Germany, 41460 Less <<
NCT00361738 Type 2 Diabetes Mellitus Phase 2 Completed - Argentina ... More >> Sanofi-Aventis Administrative Office San Isidro, Argentina Australia, New South Wales Sanofi-Aventis Administrative Office Cove, New South Wales, Australia Belgium Sanofi-Aventis Administrative Office Diegem, Belgium Chile Sanofi-Aventis Administrative Office Santiago, Chile Denmark Sanofi-Aventis Administrative Office Horsholm, Denmark France Sanofi-Aventis Administrative Office Paris, France Germany Sanofi-Aventis Administrative Office Berlin, Germany Italy Sanofi-Aventis Administrative Office Milano, Italy Netherlands Sanofi-Aventis Administrative Office Gouda, Netherlands Poland Sanofi-Aventis Administrative Office Warszawa, Poland South Africa Sanofi-Aventis Administrative Office Midrand, South Africa Less <<
NCT02022813 Critical Illness Not Applicable Completed - Switzerland ... More >> Nutrition Unit, Geneva University Hospital Geneva, GE, Switzerland, 1211 Service of Adult Intensive Care - CHUV Lausanne, VD, Switzerland, 1011 Less <<
NCT02104518 - Completed - Indonesia ... More >> Eijkman Institute for Molecular Biology Jakarta, Indonesia Less <<
NCT03729271 Irritable Bowel Syndrome ... More >> Irritable Bowel Syndrome With Diarrhea Less << Phase 4 Not yet recruiting September 2020 United States, Michigan ... More >> University of Michigan Not yet recruiting Ann Arbor, Michigan, United States, 48109 Contact: Lina Nahlawi, M.P.H    734-936-2761    lnahlawi@med.umich.edu Less <<
NCT00578669 Major Depressive Disorder ... More >> Nicotine Dependence Depression Less << Phase 3 Completed - United States, Rhode Island ... More >> Butler Hospital Providence, Rhode Island, United States, 02906 Less <<
NCT00578669 - Completed - -
NCT00829699 Type 2 Diabetes Early Phase 1 Completed - United States, Maryland ... More >> Univerisity of Maryland, Baltimore Baltimore, Maryland, United States, 21201 Less <<
NCT03231839 Type 2 Diabetes Mellitus ... More >> Nutritional and Metabolic Diseases Liver Fat Insulin Sensitivity Less << Not Applicable Completed - Germany ... More >> University of Tuebingen Tuebingen, Germany, 72074 Less <<
NCT02463682 Diabetes Mellitus, Type 1 Not Applicable Completed - United States, California ... More >> William Sansum Diabetes Center Santa Barbara, California, United States, 93111 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, Virginia University of Virginia Charlottesville, Virginia, United States, 22903 Less <<
NCT00809744 Insulin Sensitivity ... More >> Intraocular Pressure Less << Phase 2 Completed - Norway ... More >> University Hospital of North Norway Tromsø, Norway, 9037 Less <<
NCT02072096 - Terminated(The trial was termi... More >>nated per protocol because of lack of feasibility.) Less << - -
NCT02072096 Diabetes Mellitus, Type 2 Phase 4 Terminated(The trial was termi... More >>nated per protocol because of lack of feasibility.) Less << - -
NCT01772914 - Completed - Switzerland ... More >> University Hospital Basel Basel, Basel-Stadt, Switzerland, 4031 Less <<
NCT01219959 End Stage Renal Disease (ESRD)... More >> Diabetes CAPD Less << Phase 3 Completed - Colombia ... More >> Nefrosalud Ltda Armenia, Colombia RTS Ltda Barranquila Barranquila, Colombia RTS Ltda Soledad Bogota, Colombia Rts Ltda Ag H.U.S Bucaramanga, Colombia RTS Ltda H.U.V Cali, Colombia RTS Ltda STR del Valle Cali, Colombia RTS Ltda Versalles Cali, Colombia Renal Therapy Services (RTS) Ltda Cartagena Cartagena, Colombia RTS Ltda Cucuta Cucuta, Colombia RTS Ltda Girardot Girardot, Colombia Unidad Renal de Tolima Ibague, Colombia RTS Ltda Sucursal Medellin Medellin, Colombia RTS Ltda Valle de Aburra Medellin, Colombia RTS Ltda Sogamoso Sogamoso, Colombia RTS Sucrusal Tulua Tulua, Colombia RTS Ltda Villavicencio Villavicencio, Colombia Less <<
NCT03068039 Healthy Not Applicable Completed - United Kingdom ... More >> Nottingham Digestive Disases Centre , University of Nottingham Nottingham, United Kingdom, NG7 2UH Less <<
NCT00868790 - Terminated(Upon interim analys... More >>is, sufficient data was accrued to assess study hypotheses.) Less << - -
NCT03520569 Vascular Stiffness ... More >> Insulin Sensitivity Less << Early Phase 1 Recruiting December 2022 United States, Virginia ... More >> University of Virginia Recruiting Charlottesville, Virginia, United States, 22908 Contact: Eugene J. Barrett, MD PhD    434-924-1263    ejb8x@virginia.edu    Contact: Zhenqi Liu    434-243-2603    ZL3e@virginia.edu    Principal Investigator: Eugene J. Barrett, MD PhD          Sub-Investigator: Zhenqi Liu, MD          Sub-Investigator: William B Horton, MD Less <<
NCT00868790 Type 2 Diabetes Mellitus Phase 2 Terminated(Upon interim analys... More >>is, sufficient data was accrued to assess study hypotheses.) Less << - -
NCT01121471 Diabetes Mellitus Not Applicable Completed - United States, Ohio ... More >> The Ohio State University Columbus, Ohio, United States, 43210 Less <<
NCT03362554 Insulin Resistance ... More >> Diabetes Mellitus, Type 2 Inflammation Gastrointestinal Microbiome Less << Not Applicable Recruiting January 2019 United Kingdom ... More >> Department for Health, University of Bath Recruiting Bath, United Kingdom, BA2 7AY Contact: Francoise Koumanov, PhD    +441225 384649    F.Koumanov@bath.ac.uk    Contact: Laura Wood, PhD    +441225 384775    L.Wood@bath.ac.uk Less <<
NCT02898766 Diabetes Not Applicable Completed - United States, California ... More >> Orange County Research Center Tustin, California, United States, 92780 Less <<
NCT02115906 - Unknown May 2018 Austria ... More >> Medical University Of Vienna, Department of Internal Medicine III Recruiting Vienna, Austria, 1090 Contact: Peter Wolf, MD    00431404004311    peter.wolf@meduniwien.ac.at    Principal Investigator: Michael Krebs, MD, Prof Less <<
NCT01741103 Diabetes Type I Not Applicable Unknown September 2013 United States, New York ... More >> 115 Flint Road Recruiting Williamsville, New York, United States, 14221 Contact: Paresh Dandona, MD    716-626-7998    pdandona@kaleidahealth.org Less <<
NCT00399724 Diabetes Mellitus, Type 2 Phase 4 Completed - -
NCT01548612 Schizophrenia Phase 2 Completed - Brazil ... More >> University General Hospital of the Ribeirao Preto Medical School Ribeirao Preto, SP, Brazil, 14048-900 Less <<
NCT01441921 Type 2 Diabetes Mellitus Not Applicable Unknown September 2013 Spain ... More >> Human Nutrition Unit, Faculty of Medicine, Rovira i Virgili University Recruiting Reus, Tarragona, Spain, 43201 Less <<
NCT03155867 Diabetes Not Applicable Completed - United States, California ... More >> Orange County Research Center Tustin, California, United States, 92780 Less <<
NCT03620812 Health, Subjective Not Applicable Recruiting June 2019 Germany ... More >> Martin-Luther-University Institute of Agriculture and Nutritional Science Recruiting Halle, Saxony Anhalt, Germany, 06120 Contact: Ulf Schlegelmilch, Dipl.Troph.    (0)-49-345-5522723 Less <<
NCT02400515 Diabetes Mellitus, Type 2 Not Applicable Completed - -
NCT01969149 Stress Hyperglycemia Phase 2 Phase 3 Completed - France ... More >> Post operative intensive care unit of the cardiac surgery department Besançon, France, 25030 Less <<
NCT01119196 End Stage Renal Disease Not Applicable Completed - United States, Tennessee ... More >> Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232 Less <<
NCT02237521 - Completed - Denmark ... More >> Department of Nephrology, Rigshospitalet Copenhagen, Denmark, 2100 Less <<
NCT01518088 Focus of the Study is on Gut H... More >>ealth Less << Not Applicable Completed - United States, California ... More >> USDA, ARS, Western Human Nutrition Research Center Davis, California, United States, 95616 Less <<
NCT02103998 Transient Hypothyroxinemia of ... More >>Prematurity (THOP) Less << Phase 3 Not yet recruiting May 2021 United States, New York ... More >> Maria Fareri Childrens Hospital Not yet recruiting Valhalla, New York, United States, 10595 Contact: Lance Parton, MD    914-493-8558    lance_parton@nymc.edu    Contact: Gad Alpan, MD    914 493 8558    gad_alpan@nymc.edu    Principal Investigator: Lance Parton, MD Less <<
NCT00869414 Type 1 Diabetes ... More >> Hypoglycemia Less << Not Applicable Terminated(PI deceased) - United States, Maryland ... More >> Johns Hopkins Hospital Baltimore, Maryland, United States, 21287 Less <<
NCT03144869 Diabetes Mellitus, Type 1 Not Applicable Completed - United Kingdom ... More >> Sheffield Children's Hospital NHS Foundation Trust Sheffield, United Kingdom Less <<
NCT01454700 Type 1 Diabetes Mellitus Phase 4 Completed - Denmark ... More >> Steno Diabetes Center Gentofte, Copenhagen, Denmark, 2820 Less <<
NCT01978704 Type 1 Diabetes Not Applicable Completed - -
NCT01557634 Type 1 Diabetes Phase 2 Unknown - United Kingdom ... More >> Wellcome Trust Clinical Research Facility, Addenbrooke's hospital Recruiting Cambridge, United Kingdom, CB2 0QQ Contact: Janet Allen, RN    +44 1223 769064    ja385@medschl.cam.ac.uk    Principal Investigator: Roman Hovorka, PhD Less <<
NCT01137058 Diabetes Not Applicable Completed - Korea, Republic of ... More >> Seoul National University Bundang Hospital Seongnam, Korea, Republic of Less <<
NCT01898026 Diabetes Heal... More >>thy Less << Not Applicable Unknown January 2015 Canada, Ontario ... More >> St. Michael's Toronto, Ontario, Canada, M5BW8 Less <<
NCT00869414 - Terminated(PI deceased) - -
NCT03240978 PreDiabetes I... More >>nsulin Sensitivity Less << Not Applicable Completed - -
NCT00134147 Diabetes Mellitus Phase 3 Completed - -
NCT00004992 Diabetes Mellitus, Non-Insulin... More >>-Dependent Glucose Intolerance Less << Phase 3 Completed - United States, Maryland ... More >> George Washington University Biostatistics Center, Suite 750, 6110 Executive Blvd Rockville, Maryland, United States, 20852 Less <<
NCT00330733 Atherosclerosis ... More >> Cardiovascular Disease Inflammation Insulin Resistance Noninsulin-dependent Diabetes Mellitus Less << Phase 2 Phase 3 Completed - United States, Arizona ... More >> Carl T. Hayden VA Medical Center Phoenix, Arizona, United States, 85012 Less <<
NCT00330733 - Completed - -
NCT00349128 Dyslipidemia/Glucose Metabolis... More >>m Disorder Less << Phase 2 Phase 3 Completed - -
NCT01778634 - Active, not recruiting - -
NCT01778634 Ureaplasma Infections Phase 2 Active, not recruiting December 2019 United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35249-7335 United States, Delaware Christiana Care Health Services Newark, Delaware, United States, 19713 United States, Maryland University of Maryland School of Medicine Baltimore, Maryland, United States, 21201 Mercy Medical Center Baltimore, Maryland, United States, 21202 Johns Hopkins University Baltimore, Maryland, United States, 21287 United States, Tennessee Monroe Carell Jr. Children's Hospital at Vanderbilt Nashville, Tennessee, United States, 37232-9544 United States, Virginia University of Virginia Charlottesville, Virginia, United States, 22908-0386 Less <<
NCT00297583 Type 1 Diabetes Mellitus Phase 1 Completed - -
NCT02056847 HbA1c Level Associated With Li... More >>pid Compositions Less << Phase 4 Completed - Korea, Republic of ... More >> JW pharmaceutical Seoul, Korea, Republic of, 137-864 Less <<
NCT01694056 Metabolic Syndrome X Not Applicable Completed - Netherlands ... More >> Wageningen University Wageningen, Netherlands, 6703 HD Less <<
NCT00213759 Neutropenia in Prematures Phase 3 Completed - France ... More >> Xavier Hernandorena Bayonne, France Alain Menget Besancon, France Jean-Louis Demarquez Bordeaux, France Bernard Guillois Caen, France Marie Thieuleux Calais, France André Labbe Clermont-Ferrand, France Jean-Bernard Gouyon Dijon, France Pierre Andrini Grenoble, France Jean Messer Strasbourg, France Less <<
NCT01452958 Inflammation ... More >>Glucose Metabolism Disorders Less << Not Applicable Completed - Denmark ... More >> Medical Department MEA, NBG, Aarhus University Hospital Aarhus, Denmark, 8000 Less <<
NCT02637154 Diabetes Mellitus, Type 1 Not Applicable Active, not recruiting December 2018 Finland ... More >> Helsinki University Central Hospital, Pediatric Diabetes Unit Espoo Espoo, Finland, 00029 Helsinki University Central Hospital, Pediatric Endocrinology Unit Helsinki, Finland, 00029 Oulu University Hospital, Pediatric Endocrinology Unit Oulu, Finland Less <<
NCT00807092 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 4 Completed - China, Beijing ... More >> Beijing, Beijing, China, 100730 Less <<
NCT01820871 Type 2 Diabetes Mellitus Not Applicable Completed - Korea, Republic of ... More >> Haeundae Paik Hospital Busan, Korea, Republic of, 612-030 Less <<
NCT02882737 Type 1 Diabetes Mellitus Not Applicable Completed - Denmark ... More >> Isabelle Steineck Hvidovre, Denmark, 2650 Less <<
NCT01750138 Gut Function Not Applicable Unknown - United Kingdom ... More >> Scarborough District Hospital Recruiting Scarborough, North Yorkshire, United Kingdom, YO12 6QL Contact: Irfan Kabir, MBBS    00-44-1723368111 ext 5123    irfankabir@hotmail.com    Principal Investigator: irfan kabir, MBBS Less <<
NCT02001480 Diabetes Mellitus Type 2 ... More >> End Stage Renal Disease Less << Not Applicable Completed - Germany ... More >> regioMed-Kliniken GmbH Coburg, Bayern, Germany, 96450 University Hospital Würzburg Würzburg, Bayern, Germany, 97080 Department of Internal Medicine I University Hospital RWTH Aachen Aachen, NRW, Germany, 52074 Less <<
NCT01099137 Diabetes Phase 4 Completed - Korea, Republic of ... More >> Seoul National University Bundang Hospital Seongnam, Korea, Republic of Less <<
NCT00807092 - Completed - -
NCT03178006 - Completed - -
NCT01440439 Diabetes Mellitus, Type 1 Phase 4 Unknown June 2012 United Kingdom ... More >> Wycombe Hospital Recruiting High Wycombe, Buckinghamshire, United Kingdom, HP11 2TT Less <<
NCT02328040 Diabetes Mellitus, Type 1 Phase 1 Completed - United States, New York ... More >> Albert Einstein College of Medicine CRC Bronx, New York, United States, 10461 Less <<
NCT01198730 Diabetes Mellitus ... More >> Coronary Artery Disease Less << Not Applicable Recruiting December 2019 Taiwan ... More >> Taichung Veterans General Hospital Recruiting Taichung, Taiwan, 40705 Contact: Wayne H-H Sheu, MD, PHD       whhsheu@vghtc.gov.tw Less <<
NCT02328040 - Completed - -
NCT03122678 Septic Shock ... More >>Shock, Septic Lactic Acidosis Thiamine Deficiency Less << Phase 1 Recruiting April 1, 2018 United States, Florida ... More >> Cleveland Clinic Florida Recruiting Weston, Florida, United States, 33331 Contact: Jinesh Mehta, MD    954-659-5450    mehtaj@ccf.org    Contact: Felix Hernandez, MD    954-659-5450    HernanF@ccf.org Less <<
NCT00544206 Type 2 Diabetes Mellitus Phase 2 Completed - United States, Florida ... More >> Segal Institute for Clinical Research Miami, Florida, United States, 33161 Less <<
NCT03706378 Diabetes Not Applicable Active, not recruiting January 2019 Singapore ... More >> Clinical Nutrition Research Centre Singapore, Singapore, 117599 Less <<
NCT01088841 Appetite and General Nutrition... More >>al Disorders Hormone Replacement Less << Phase 1 Completed - Switzerland ... More >> University Hospital Basel, Clinical Research Center Basel, Switzerland, 4031 Less <<
NCT02362607 Diabetes Not Applicable Completed - Korea, Republic of ... More >> Chungbuk National University Cheongju, Chungcheongbuk-Do, Korea, Republic of, 361-711 Less <<
NCT00352287 Obesity Metab... More >>olic Syndrome Impaired Glucose Tolerance Less << Phase 4 Completed - United States, California ... More >> Veterans Affairs Palo Alto Health Care System Palo Alto, California, United States, 94304 Less <<
NCT03228004 Type 1 Diabetes Mellitus Phase 1 Active, not recruiting June 2019 United States, Florida ... More >> University of Florida Gainesville, Florida, United States, 32611 Less <<
NCT02219295 Disorder of Glucose Regulation Not Applicable Completed - Germany ... More >> Department of Clinical Nutrition Nuthetal, Brandenburg, Germany, D-14558 Less <<
NCT03334045 - Recruiting December 2022 Denmark ... More >> Odense University Hospital Recruiting Odense, Denmark, 5000 Contact: Saga Steinmann Madsen, Engineering    +45 3013 7569    saga.steinmann.madsen@rsyd.dk Less <<
NCT02251301 Type 2 Diabetes Not Applicable Completed - Canada, British Columbia ... More >> University of British Columbia, Okanagan. Kelowna, British Columbia, Canada, V1V 1V7 Less <<
NCT00521690 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 4 Completed - Taiwan ... More >> Taipei, Taiwan, 100 Less <<
NCT01434862 Type 1 Diabetes Mellitus Not Applicable Terminated(Modified study; cre... More >>ated new study as a result of these modifications) Less << - United States, Virginia ... More >> University of Virginia, Center for Diabetes Technology Charlottesville, Virginia, United States, 22903 Less <<
NCT00786604 - Completed - United States, California ... More >> University of California, Irvine Irvine, California, United States, 92630 Less <<
NCT01390688 - Unknown March 2012 Denmark ... More >> Centre of Inflammation and Metabolism Copenhagen, Denmark, 2100 Less <<
NCT00950677 Type 2 Diabetes Phase 4 Completed - United States, Texas ... More >> Baylor College of Medicine Houston, Texas, United States, 77030 Less <<
NCT01714505 Diabetes Mellitus, Type 1 Not Applicable Completed - United States, California ... More >> Sansum Diabetes Research Institute Santa Barbara, California, United States, 93105 United States, Virginia University of Virginia Charlottesville, Virginia, United States, 22908 Less <<
NCT02202876 Diabetes Mellitus, Type 2 ... More >> Cystic Fibrosis Less << Not Applicable Recruiting September 2019 United States, Georgia ... More >> Children's Healthcare of Atlanta and Emory University Recruiting Atlanta, Georgia, United States, 30322 Contact: Joy Dangerfield    404-785-8828    jdanger@emory.edu    Contact: Arlene Stecenko, MD    404-712-8283    astecen@emory.edu    Principal Investigator: Arlene Stecenko, MD Less <<
NCT01149005 Cystic Fibrosis ... More >> Impaired Glucose Tolerance Pulmonary Exacerbation Less << Not Applicable Unknown December 2015 Israel ... More >> Hadassah Hospital Not yet recruiting Jerusalem, Israel Contact: David H Zangen, Dr.    97225844111 ext 74488    ZangenD@hadassah.org.il    Contact: Hila Elyashar-Earon, RD       hilae@hadassah.org.il    Principal Investigator: David H Zangen, Dr. Less <<
NCT02112851 Maximum Observed Plasma Glucos... More >>e Concentration (Cmax) Less << Not Applicable Unknown - United States, Massachusetts ... More >> Tufts University Recruiting Boston, Massachusetts, United States, 02111 Contact: Oliver Chen, PhD    617-556-3128    Oliver.Chen@tufts.edu    Principal Investigator: Jeffrey Blumberg, PhD          Sub-Investigator: Oliver Chen, PhD Less <<
NCT00438698 Type 2 Diabetes ... More >> Cardiovascular Disease Less << Not Applicable Completed - Canada, Ontario ... More >> St. Michael's Hospital Toronto, Ontario, Canada, M5C 2T2 Less <<
NCT01714505 - Completed - -
NCT01658579 Type 1 Diabetes Mellitus Phase 2 Completed - United States, California ... More >> Investigational Site Number 840002 Temecula, California, United States, 92591 United States, Minnesota Investigational Site Number 840001 Minneapolis, Minnesota, United States, 55416 United States, Oregon Investigational Site Number 840003 Portland, Oregon, United States, 97201-3098 Less <<
NCT02592798 Nephrotic Syndrome ... More >> Focal Segmental Glomerulosclerosis Minimal Change Disease Less << Phase 2 Recruiting June 29, 2020 -
NCT01658579 - Completed - -
NCT02366416 Type 2 Diabetes Mellitus Not Applicable Completed - Denmark ... More >> Nordsjællands Hospital Hillerød, Denmark, 3400 Less <<
NCT00850161 Type 1 Diabetes Mellitus Phase 2 Withdrawn(Business purposes.) September 2010 -
NCT02694575 - Recruiting September 1, 2018 United Kingdom ... More >> Leicester Diabetes Centre Recruiting Leicester, Leicestershire, United Kingdom, LE5 4PW Contact: Zin Zin Hitke, MBBS MRCP    0116 258 8602 ext 8602    zin.hitke@uhl-tr.nhs.uk    Principal Investigator: Melanie J Davies, MbChB, MRCP Less <<
NCT02385890 Diabetes Prevention ... More >> Obesity Prevention Less << Not Applicable Completed - Canada, Manitoba ... More >> Richardson Centre for Functional Foods and Nutraceuticals, University of Manitoba Winnipeg, Manitoba, Canada, R3T 6C5 Less <<
NCT02402504 Diabetes Prevention ... More >> Obesity Prevention Less << Not Applicable Active, not recruiting December 2017 Canada, Manitoba ... More >> Richardson Centre for Functional Foods and Nutraceuticals Winnipeg, Manitoba, Canada, R3T 2N2 Less <<
NCT02501616 Endothelial Function ... More >> Type 2 Diabetes Less << Phase 4 Unknown - Korea, Republic of ... More >> Boramae medical center Recruiting Seoul, Korea, Republic of, 156-707 Contact: Bokyung Koo       bokyungkoomd@gmail.com    Principal Investigator: Min Kyong Moon Less <<
NCT01413126 Type 2 Diabetes Mellitus Not Applicable Completed - Brazil ... More >> Federal University of Viçosa Viçosa, Minas Gerais, Brazil, 36570-000 Less <<
NCT01378117 Type 2 Diabetes Mellitus ... More >> Hospitalization Hyperglycemia Less << Phase 4 Completed - United States, Georgia ... More >> Grady Memorial Hospital Atlanta, Georgia, United States, 30303 Emory University Hospital Atlanta, Georgia, United States, 30324 Less <<
NCT02667769 Fasting Not Applicable Unknown - Germany ... More >> Diabeteszentrum Bad Lauterberg Bad Lauterberg, Niedersachsen, Germany, 37431 Less <<
NCT03074630 Diabetes Mellitus, Type 2 ... More >> Hypercholesterolemia Less << Phase 4 Completed - Netherlands ... More >> Academic Medical Center Amsterdam, North Holland, Netherlands, 1105AZ Less <<
NCT02315274 Type 1 Diabetes, Pregnancy Not Applicable Unknown May 2016 United States, Minnesota ... More >> Mayo Clinic Recruiting Rochester, Minnesota, United States, 55905 Contact: Donna M Desjardins, CNP    507-255-6869    desjardins.donna@mayo.edu    Principal Investigator: Yogish C Kudva, MD Less <<
NCT02980276 Gestational Diabetes Phase 3 Recruiting August 2020 Ireland ... More >> Cork University Hospital Not yet recruiting Cork, Ireland Principal Investigator: Prof. Louise Kenny          University Hospital Galway Recruiting Galway, Ireland Principal Investigator: Prof. Fidelma Dunne Less <<
NCT01342939 - Completed - Denmark ... More >> Diabetes Research Division, Gentofte University Hospital, Niels Andersens vej 65, opgang 40, 2. Hellerup, Denmark, 2900 Less <<
NCT03363360 - Recruiting December 31, 2018 China, Jiangxi ... More >> No.1MinDeRoad Recruiting Nanchang, Jiangxi, China, 341000 Contact: Shen YenFeng, professor    18970819455    1359112481@qq.com Less <<
NCT02237053 Hyperglucagonemia ... More >> Obesity Less << Phase 1 Completed - United States, Florida ... More >> Florida Hospital Translational Research Institute for Metabolism and Diabetes Orlando, Florida, United States, 32804 Less <<
NCT01378117 - Completed - -
NCT01167387 Surgery Phase 3 Completed - Italy ... More >> San gerardo hospital Monza, Italy, 20052 Less <<
NCT03318094 Insulin Resistance ... More >> Healthy Obesity Less << Phase 1 Recruiting November 30, 2025 United States, Tennessee ... More >> Autonomic Dysfunction Center Recruiting Nashville, Tennessee, United States, 37232 Contact: Misty D Hale, CCRP    615-343-8649    autonomics@vanderbilt.edu    Contact: Jorge E Celedonio    6153223304    autonomics@vanderbilt.edu Less <<
NCT00069576 Diabetes, Gestational Not Applicable Completed - United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35233 United States, Illinois Northwestern University Chicago, Illinois, United States, 60611 United States, Michigan Wayne State University - Hutzel Hospital Detroit, Michigan, United States, 48201 United States, New York Columbia University-St. Luke's Hospital New York, New York, United States, 10032 United States, North Carolina University of North Carolina-Chapel Hill Chapel Hill, North Carolina, United States, 17599 Wake Forest University School of Medicine Winston-Salem, North Carolina, United States, 27157 United States, Ohio Case Western Reserve University Cleveland, Ohio, United States, 44109 Ohio State University Hospital Columbus, Ohio, United States, 43210 United States, Oregon Oregon Health and Science University Portland, Oregon, United States, 97239 United States, Pennsylvania Drexel University Philadelphia, Pennsylvania, United States, 19107 University of Pittsburgh-Magee Womens Hospital Pittsburgh, Pennsylvania, United States, 15213 United States, Rhode Island Brown University Providence, Rhode Island, United States, 02905 United States, Texas University of Texas Southwestern Medical Center Dallas, Texas, United States, 75235 University of Texas Medical Branch Galveston, Texas, United States, 77555 University of Texas-Houston Houston, Texas, United States, 77030 United States, Utah University of Utah Salt Lake City, Utah, United States, 84132 Less <<
NCT02669693 Diabetes Not Applicable Completed - United Kingdom ... More >> School of Food Science and Nutrition, University of Leeds Leeds, West Yorkshire, United Kingdom, LS2 9JT Less <<
NCT00608179 Type 2 Diabetes Not Applicable Completed - -
NCT02635269 Metabolism, Inborn Errors ... More >> Lipid Metabolism, Inborn Errors Carbohydrate Metabolism, Inborn Errors Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency Glycogenin-1 Deficiency (Glycogen Storage Disease Type XV) Carnitine Palmitoyl Transferase 2 Deficiency VLCAD Deficiency Medium-chain Acyl-CoA Dehydrogenase Deficiency Multiple Acyl-CoA Dehydrogenase Deficiency Carnitine Transporter Deficiency Neutral Lipid Storage Disease Glycogen Storage Disease Type II Glycogen Storage Disease Type III Glycogen Storage Disease Type IV Glycogen Storage Disease Type V Muscle Phosphofructokinase Deficiency Phosphoglucomutase 1 Deficiency Phosphoglycerate Mutase Deficiency Phosphoglycerate Kinase Deficiency Phosphorylase Kinase Deficiency Beta Enolase Deficiency Lactate Dehydrogenase Deficiency Glycogen Synthase Deficiency Less << Not Applicable Recruiting December 2020 Denmark ... More >> Neuromuscular Research Unit, 3342 Recruiting Copenhagen, Denmark, DK-2100 Less <<
NCT02610088 Diabetes Phase 4 Completed - Korea, Republic of ... More >> Seoul National University Bundang Hospital Seongnam, Gyeonggi, Korea, Republic of, 463-707 Less <<
NCT00614094 - Completed - United States, Oklahoma ... More >> Oklahoma State University Center for Health Sciences Tulsa, Oklahoma, United States, 74107 Less <<
NCT01645995 Type 2 Diabetes Mellitus ... More >> Cardiovascular Disease Obesity Less << Not Applicable Completed - United Kingdom ... More >> Department of Food and Nutritional Sciences, University of Reading Reading, Berks, United Kingdom, RG6 6AP Less <<
NCT00747175 Type 2 Diabetes Phase 1 Completed - United States, California ... More >> Research Site Chula Vista, California, United States Less <<
NCT02284230 Kidney Failure, Chronic ... More >> Prediabetic State Less << Phase 2 Withdrawn(Inability to recruit... More >> participants) Less << - Denmark ... More >> Department of Nephrology, Rigshospitalet Copenhagen, Denmark, 2100 Less <<
NCT03272061 Physical Exercise ... More >> Cerebrovascular Function Cerebral Blood Flow Glucose Metabolism Cognitive Performance Less << Not Applicable Recruiting September 1, 2018 Netherlands ... More >> Maastricht University Medical Center Recruiting Maastricht, Netherlands Contact: Peter J Joris, PhD    +31433881311    p.joris@maastrichtuniversity.nl Less <<
NCT01274052 - Completed - Denmark ... More >> Department of Internal Medicine, Glostrup Hospital Glostrup, Denmark, 2600 Less <<
NCT01333176 Type 2 Diabetes Not Applicable Unknown December 2012 Canada, British Columbia ... More >> Vancouver General Hospital Recruiting Vancouver, British Columbia, Canada, V5Z 1M9 Contact: Keith G Dawson, MD    604-351-5565    kdaw@interchange.ubc.ca    Contact: Jessica MacKenzie-Feder, MD    778-847-1466    jessmackfeder@yahoo.com    Sub-Investigator: Sandra Sirrs, MD Less <<
NCT01271153 Septic Shock Not Applicable Completed - Chile ... More >> Hospital Clinico Universidad Catolica de Chile Santiago, RM, Chile, 6510260 Less <<
NCT03532620 Prediabetic State ... More >> Hypertension Dyslipidemias Less << Phase 4 Recruiting September 2020 China, Chongqing ... More >> Fourth People's Hospital of Chongqing Recruiting Chongqing, Chongqing, China, 400014 Contact: Ruihua Yue, MD          Principal Investigator: Ruihua Yue, MD          China, Guangdong First Affiliated Hospital,Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510000 Contact: Jun Tao, MD,PhD    +8613922191609    taojungz123@163.com    Contact: Jianning Zhang    +8615521264372    ningjenny@yeah.net    Principal Investigator: Jun Tao, MD,PhD          Second Affiliated Hospital of Guangzhou Medical University Recruiting Guangzhou, Guangdong, China, 510260 Contact: Wenchao Qu, MD          Principal Investigator: Wenchao Qu, MD          First Affiliated Hospital of Jinan University Recruiting Guangzhou, Guangdong, China, 510630 Contact: Jun Guo, MD          Principal Investigator: Jun Guo, MD          Shenzhen People's Hospital Not yet recruiting Shenzhen, Guangdong, China, 518020 Contact: Xin Jiang, MD          Principal Investigator: Xin Jiang, MD          People's Hospital of Zhongshan City Recruiting Zhongshan, Guangdong, China, 528403 Contact: Li Feng, MD          Principal Investigator: Li Feng, MD          China, Henan First Affiliated Hospital of Zhengzhou University Recruiting Zhengzhou, Henan, China, 450052 Contact: Heping Gu, MD          Principal Investigator: Heping Gu, MD          China, Hubei Yichang Central Hospital Recruiting Yichang, Hubei, China, 443003 Contact: Jiawang Ding, MD          Principal Investigator: Jiawang Ding, MD          China, Jiangsu Taizhou Hospital of TCM Recruiting Taizhou, Jiangsu, China, 214504 Contact: Yongguang Zhang, MD          Principal Investigator: Yongguang Zhang, MD          Wuxi People's Hospital Recruiting Wuxi, Jiangsu, China, 214023 Contact: Ruxing Wang, MD          Principal Investigator: Ruxing Wang, MD          Subei People's Hospital of Jiangsu province Not yet recruiting Yangzhou, Jiangsu, China, 225001 Contact: Shenghu He, MD          Principal Investigator: Shenghu He, MD          China, Qinghai Lanzhou University Second Hospital Recruiting Lanzhou, Qinghai, China, 730030 Contact: Feng Bai, MD          Principal Investigator: Feng Bai, MD          China, Shandong Yantaishan Hospital, Yantai Not yet recruiting Yantai, Shandong, China, 264001 Contact: Lan Zhao, MD          Principal Investigator: Lan Zhao, MD Less <<
NCT01264523 Type-2 Diabetes ... More >> Overweight Less << Not Applicable Completed - Spain ... More >> Department of Nutrition, Food Science, Physiology and Toxicology. University of Navarra Pamplona, Navarra, Spain, 31008 Less <<
NCT00874809 Type 2 Diabetes Mellitus Not Applicable Completed - United States, California ... More >> Diabetes Care Center Salinas, California, United States, 93901 Less <<
NCT02806739 Gestational Diabetes Early Phase 1 Completed - United States, Massachusetts ... More >> Tufts Medical Center Boston, Massachusetts, United States, 02111 Less <<
NCT02137512 Type 1 Diabetes Not Applicable Completed - United States, California ... More >> Sansum Diabetes Research Institute Santa Barbara, California, United States, 93105 Stanford University Stanford, California, United States, 94305 United States, Virginia University of Virginia Charlottesville, Virginia, United States, 22908 France Montpellier University Hospital Montpellier, France, 34295 Israel National Center for Childhood Diabetes- Schneider Children's Medical Center Petah Tikva, Israel, 49202 Italy University of Padova Padova, Italy, 93106 Less <<
NCT01582139 Type 1 Diabetes Mellitus Not Applicable Completed - United States, Virginia ... More >> University of Virginia Charlottesville, Virginia, United States, 22908 Less <<
NCT01582139 - Completed - -
NCT03311802 - Completed - -
NCT02137512 - Completed - -
NCT03287297 - Not yet recruiting December 1, 2019 -
NCT00605475 - Completed - -
NCT00676741 - Completed - Slovakia ... More >> Novo Nordisk Investigational Site Bratislava, Slovakia, 811 05 Less <<
NCT03258229 Hyperglycemia Not Applicable Recruiting December 31, 2017 Korea, Republic of ... More >> Clinical Trial Center for Functional Foods; Chonbuk National University Hospital Recruiting Jeonju, Jeollabuk-do, Korea, Republic of, 560-822 Contact: Soo-Wan Chae, MD., PhD    82-63-250-2539    soowan@jbnu.ac.kr Less <<
NCT02090049 The Focus of the Study is Heal... More >>thy Volunteers Less << Not Applicable Completed - Spain ... More >> Institu of Nutrition and Food Technology "José Mataix" Granada, Spain, 18100 Less <<
NCT00290940 Diabetes Mellitus, Type 2 Phase 2 Completed - -
NCT00560846 Stomach Neoplasms ... More >> Esophageal Neoplasms Less << Not Applicable Terminated(Insufficient recrui... More >>tment over time.) Less << - Switzerland ... More >> Hôpitaux Universitaires Genève Geneva, Switzerland, 1204 Less <<
NCT00535535 Elevated Triglycerides ... More >> Diabetes Cardiovascular Disease Less << Phase 1 Completed - United States, New York ... More >> Rockefeller University New York, New York, United States, 10021 Less <<
NCT03557892 Diabetes Mellitus, Type 1 Not Applicable Recruiting November 2, 2019 Italy ... More >> Diabetologia AOU Careggi Recruiting Firenze, Italy, 50134 Contact: Ilaria Dicembrini, MD    0557946512    idicembrini@gmail.com Less <<
NCT01488136 Type 1 Diabetes Phase 4 Unknown December 2012 United Kingdom ... More >> NHS Tayside Recruiting Dundee, United Kingdom, DD1 9SY Principal Investigator: Priya S George, MRCP Less <<
NCT02135549 Type 2 Diabetes Mellitus Not Applicable Completed - United States, New York ... More >> Accumed Garden City, New York, United States, 11530 Less <<
NCT01694004 The Effect of LCFA on Nutrient... More >> Absorption Less << Phase 1 Enrolling by invitation December 2018 United States, Tennessee ... More >> Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232 Less <<
NCT02954601 Type 2 Diabetes Mellitus Phase 2 Completed - United States, California ... More >> Orange County Research Center Tustin, California, United States, 92780 Less <<
NCT01407289 Diabetes Mellitus, Type 2 Phase 4 Completed - Austria ... More >> Medical University of Graz, Division of Internal Medicine, Department of Endocrinology and Metabolism/ Cardiology Graz, Austria, 8036 Less <<
NCT01493934 Type 2 Diabetes Mellitus Phase 1 Phase 2 Completed - France ... More >> Service de Biophysique et Médecine Nucléaire, CHU de Grenoble Grenoble, France Less <<
NCT02023320 Prediabetes Not Applicable Completed - Japan ... More >> Hiroshima University Hiroshima, Japan, 734-8551 Less <<
NCT03680248 Hepatic Fat Content Not Applicable Recruiting December 2019 Czechia ... More >> Institute for Clinical and Experimental Medicine Recruiting Prague 4, Czechia, 14021 Contact: Jan Kovar, PhD    +420 261363369    jan.kovar@ikem.cz    Contact: Tereza Dusilova, MSc    +420 261362728    tereza.dusilova@ikem.cz Less <<
NCT02069886 Thalassemia (Transfusion Delen... More >>dent) Less << Phase 4 Withdrawn December 2018 -
NCT03474393 Type1diabetes Not Applicable Recruiting December 31, 2021 Sweden ... More >> NU-Hosptial Group Recruiting Uddevalla, Sweden Contact: Arndís Ólafsdóttir    0104350000    finna.olafsdottir@vgregion.se Less <<
NCT02954601 - Completed - -
NCT03526744 Healthy Volunteers Not Applicable Recruiting December 2018 Norway ... More >> Haukeland University Hospital Recruiting Bergen, Norway Contact: Hanna Fjeldheim Dale    +47 98088495    hanna.fjeldheim.dale@helse-bergen.no    Contact: Caroline Jensen    +47 97078964    caroline.jensen@helse-bergen.no    Ålesund Hospital, Helse Møre og Romsdal HF Recruiting Ålesund, Norway Contact: Caroline Jensen    +47 97078964    caroline.jensen@helse-mr.no    Contact: Hanna Fjeldheim Dale    +4798088495    hanna.fjeldheim.dale@helse-mr.no Less <<
NCT02366598 Diabetes Prevention ... More >> Obesity Prevention Less << Not Applicable Active, not recruiting December 2017 Canada, Manitoba ... More >> Richardson Centre for Functional Foods Winnipeg, Manitoba, Canada, R3T2N2 Less <<
NCT02350179 Hemorrhage of Cesarean Section... More >> and/or Perineal Wound Less << Phase 1 Phase 2 Unknown May 2015 Egypt ... More >> Ain Shams University Recruiting Cairo, Egypt Contact: Zarafshan M Raqeeb, MS       zarafzubair@gmail.com Less <<
NCT00605475 Type 2 Diabetes Mellitus Phase 2 Completed - United States, Arkansas ... More >> Arkansas Research Medical Testing Little Rock, Arkansas, United States, 72202 United States, Florida Allied Research International - Cetero Research Miami Miami, Florida, United States, 33169 Elite Research Institute Miami Miami, Florida, United States, 33169 United States, Maryland International Research Center Towson MD, Maryland, United States, 21286 United States, Oregon Covance Clinical Research Unit Inc Portland, Oregon, United States, 97239 United States, Washington Charles River Clinical Services NW Tacoma, Washington, United States, 98418 Germany Novartis Investigator Site Berlin, Germany Novartis Investigator Site Kiel, Germany Novartis Investigator Site Moenchengladbach, Germany Novartis Investigator Site Munich, Germany Novartis Investigative Site Neuss, Germany Russian Federation Novartis Investigative Site Moscow, Russian Federation Novartis Investigative Site St. Petersberg, Russian Federation Less <<
NCT01121835 Diabetes Mellitus, Type 2 Phase 4 Completed - -
NCT02620878 Type 1 Diabetes Not Applicable Completed - -
NCT01226537 it is a Group of Metabolic Dis... More >>eases in Which a Person Has High Blood Sugar, Either Because the Body Does Not Produce Enough Insulin, or Because Cells do Not Respond to the Insulin That is Produced. Less << Phase 1 Phase 2 Unknown December 2014 -
NCT02102737 Diabetes Mellitus ... More >> Insulin Resistance Glucose Metabolism Disorders Metabolic Diseases Endocrine System Diseases Less << Phase 2 Unknown December 2017 France ... More >> Hôpital Michallon . CHU Grenoble Recruiting Grenoble, France, 38043 Less <<
NCT00732485 Burn Phase 2 Phase 3 Withdrawn(Principal Investigat... More >>or Changed) Less << December 2013 -
NCT01130558 Type 2 Diabetes Mellitus Not Applicable Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT03319784 Rotator Cuff Tear ... More >> Rotator Cuff Injury Rotator Cuff Tendinitis Diabetes Mellitus Less << Phase 4 Not yet recruiting October 5, 2020 United States, Pennsylvania ... More >> Penn State College of Medicine Not yet recruiting Hershey, Pennsylvania, United States, 17033 Contact: H. MIke Kim, MD Less <<
NCT00427401 Diabetes Mellitus, Type 2 Phase 2 Terminated(This study was term... More >>inated May 7, 2007. The study stopped due to tablet formulation issues. No safety issues were involved in the termination decision.) Less << - Belgium ... More >> Pfizer Investigational Site Bruxelles, Belgium, 1070 Less <<
NCT01434030 Diabetes Mellitus, Type 1 Not Applicable Completed - United States, Virginia ... More >> University of Virginia - Center for Diabetes Technology Charlottesville, Virginia, United States, 22901 Less <<
NCT00354939 Diabetes Mellitus Type 2 Phase 4 Completed - -
NCT03504046 Type 1 Diabetes Mellitus Phase 2 Phase 3 Completed - United States, California ... More >> Sansum Diabetes Research Institute Santa Barbara, California, United States, 93105 Less <<
NCT03194152 T2D Not Applicable Active, not recruiting December 2018 China ... More >> Liang Sun Shanghai, China, 200040 Less <<
NCT00512265 Pulmonary Morbidity Phase 4 Completed - Switzerland ... More >> University Hospital Basel Basel, Switzerland Department of Surgery, Triemli Hospital, Zurich, Switzerland Zurich, Switzerland Less <<
NCT01792323 Type 1 Diabetes Phase 1 Completed - Austria ... More >> Medical University of Graz Graz, Styria, Austria, A-8036 Less <<
NCT01434030 - Completed - -
NCT03665376 Laparotomy Not Applicable Completed - Uganda ... More >> Mbarara Regional Referral Hospital Mbarara, Uganda, 00256 Less <<
NCT03152890 Hyperglycaemia (Diabetic) ... More >> Liver Transplantation Less << Phase 4 Recruiting March 15, 2019 Korea, Republic of ... More >> Seoul National University Hospital Recruiting Seoul, Korea, Republic of, 110-799 Contact: Jeong-Hwa Hong, MD    82-2-740-8096    jhhong@snu.ac.kr    Principal Investigator: Chul-Woo Jung, MD. PhD Less <<
NCT00576394 Glycemic Control Phase 1 Completed - United States, Massachusetts ... More >> Boston Medical Center Boston, Massachusetts, United States, 02118 Less <<
NCT00670722 - Completed - Czech Republic ... More >> Novo Nordisk Investigational Site Prague, Czech Republic, 16000 Less <<
NCT03186300 Diabetes Mellitus, Type 1 Not Applicable Enrolling by invitation August 2018 Spain ... More >> Institut d'Investigació Biomèdica de Girona (IDIBGI) Girona, Spain, 17007 Less <<
NCT01593215 Type 2 Diabetes Phase 2 Completed - Sweden ... More >> Skanes Universitetssjukhus Malmo, Skane, Sweden, 20502 Less <<
NCT01067092 Diabetes Mellitus, Type 2 Not Applicable Completed - United States, Illinois ... More >> Rush University Medical Center Chicago, Illinois, United States, 60612 Less <<
NCT01593215 - Completed - -
NCT03052595 - Recruiting December 31, 2021 Slovakia ... More >> Biomedical Center, Slovak Academy of Sciences, Institute of clinical and translational reasearch Recruiting Bratislava, Slovakia, 84505 Contact: Adela Penesova, MD. PhD    00421 2 322952245    adela.penesova@savba.sk    Contact: Miroslav Vlcek, MD. PhD    00421 2 322952244    miroslav.vlcek@savba.sk    Sub-Investigator: Richard Imrich, MD. PhD          Sub-Investigator: Zuzana Dean, MD Less <<
NCT01963728 Diabetes Mellitus Phase 4 Terminated(Difficult to enroll... More >>. The blood sugar status of the two enrolled subjects was not evaluable due to multiple hospital admissions.) Less << - United States, Virginia ... More >> Inova Fairfax Hospital Falls Church, Virginia, United States, 22042 Less <<
NCT01013571 Diabetes Mellitus, Type 2 Phase 4 Completed - Canada ... More >> Sanofi-Aventis Administrative Office Laval, Canada Less <<
NCT00882050 Euglycemia Hy... More >>poglycemia Hyperglycemia Less << Phase 1 Phase 2 Completed - United States, Pennsylvania ... More >> University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT03230812 Glucose Intolerance Not Applicable Recruiting October 2019 Netherlands ... More >> Maastricht University Recruiting Maastricht, Limburg, Netherlands, 6229ER Contact: Vera Schrauwen, Dr.    003143874951    v.schrauwen@maastrichtuniversity.nl Less <<
NCT00588172 Type 2 Diabetes Phase 4 Withdrawn(No funding) June 2011 -
NCT02224417 Type 2 Diabetes Mellitus Not Applicable Active, not recruiting March 2020 Singapore ... More >> SingHealth Polyclinics (Geylang) Singapore, Singapore, 389707 SingHealth Polyclinic (Bedok) Singapore, Singapore, 469662 Less <<
NCT00869453 - Completed - Switzerland ... More >> Cardiomet Clinical research Center, CHUV Lausanne, VD, Switzerland, CH-1011 University of Lausanne Lausanne, Switzerland, 1005 Less <<
NCT00885846 - Completed - -
NCT02021591 Diabetes Mellitus Not Applicable Completed - United States, New York ... More >> Clinical Directors Network New York, New York, United States, 10018 Less <<
NCT01709851 - Completed - Austria ... More >> Medical University of Graz, Dept. of Internal Medicine, Endocrinology and Metabolism Graz, Austria, 8036 Less <<
NCT00885846 Diabetes Mellitus, Type 2 Not Applicable Completed - United States, Washington ... More >> Bastyr University Research Center Kenmore, Washington, United States, 98028-4966 Less <<
NCT00763412 Cystic Fibrosis Related Diabet... More >>es Pancreatic Insufficiency Less << Not Applicable Completed - United States, Missouri ... More >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Less <<
NCT02336217 Diabetes Mellitus Not Applicable Recruiting September 2019 United States, West Virginia ... More >> Marshall Health Recruiting Huntington, West Virginia, United States, 25701 Contact: Henry K Driscoll, MD    304-691-1000    endoresearch@marshall.edu    Contact: Prasanna Santhanam, MD    304-691-1000    endoresearch@marshall.edu Less <<
NCT00220766 Immunologic Deficiency Syndrom... More >>e Agammaglobulinemia Severe Combined Immunodeficiency Wiskott-Aldrich Syndrome Common Variable Immunodeficiency Less << Phase 3 Completed - United States, Alabama ... More >> Departments of Medicine and Microbiology Birmingham, Alabama, United States, 35294 United States, Colorado National Jewish Medical and Researach Center Denver, Colorado, United States, 80206 United States, District of Columbia International Center for Interdisciplinary Studies of Immunology Washington, District of Columbia, United States, 20007 United States, Florida Allergy Associates of the Palm Beaches North Palm Beach, Florida, United States, 33408 University of South Florida College of Medicine St. Petersburg, Florida, United States, 33701 United States, Louisiana The Clinical Trials Center, Children's Hospital New Orleans, Louisiana, United States, 70118 United States, Nebraska Allergy, Asthma, and Immunology Omaha, Nebraska, United States, 68124 United States, Ohio University Hospitals of Cleveland Cleveland, Ohio, United States, 44106 Optimed Research, LLC Columbus, Ohio, United States, 43235 Canada, Alberta 3031 Hospital Drive Northwest Calgary, Alberta, Canada, T2N 2T8 Canada, British Columbia St. Paul's Hospital Vancouver, British Columbia, Canada, V6H 3K2 Canada, Ontario Saint Michael's Hospital Toronto, Ontario, Canada, M4V 1R2 The Hospital for Sick Children Toronto, Ontario, Canada, M5G 1X8 Less <<
NCT01780272 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 1 Completed - Denmark ... More >> Novo Nordisk Investigational Site Glostrup, Denmark, 2600 Less <<
NCT01972542 Diabetes Pred... More >>iabetes Less << Not Applicable Completed - Korea, Republic of ... More >> Seoul National University Bundang Hospital Seongnam, Korea, Republic of, 463-707 Less <<
NCT02724566 Diabetes Phase 1 Completed - France ... More >> University Hospitals of Toulouse (Rangueil) Toulouse, Midi-Pyrénées, France, 31059 Less <<
NCT03109951 - Recruiting April 30, 2019 Korea, Republic of ... More >> International St.Mary's Hospital Recruiting Incheon, Korea, Republic of, 22711 Contact: Myong Ki Baeg, MD, PhD Less <<
NCT00279240 Diabetes Phase 1 Completed - India ... More >> Diabetes Research Centre & MV Hospital for Diabetes Chennai, Tamilnadu, India, 600013 Less <<
NCT00917449 Metabolic Syndrome ... More >> Impaired Glucose Tolerance Insulin Resistance Endothelial Dysfunction Less << Phase 3 Completed - Italy ... More >> Scientific Institute San Raffaele Milan, Italy, 20132 Less <<
NCT02336516 Haemolytic and Uremic Syndrome Not Applicable Recruiting October 2021 France ... More >> Arnaud de Villeneuve Hospital Recruiting Montpellier, France, 34295 Montpellier cedex 5 Contact: Marc Fila, MD    +33467336428    m-fila@chu-montpellier.fr    Contact: Georges Deschenes, MD, PhD    +33140031242    georges.deschenes@rdb.aphp.fr Less <<
NCT02333864 - Completed - United States, California ... More >> Diablo Clinical Reasearch Walnut Creek, California, United States, 94598 United States, Minnesota Park Nicollett Institute - International Diabetes Center Minneapolis, Minnesota, United States, 55416 Less <<
NCT03450863 - Enrolling by invitation February 28, 2019 Germany ... More >> Novo Nordisk Investigational Site Schweinfurt, Germany, 97421 Less <<
NCT00460252 Critically Ill Patients ... More >> Mechanical Ventilation Hyperglycemia Less << Not Applicable Completed - Austria ... More >> Medical University Graz Graz, Austria, 8036 Less <<
NCT01976689 - Completed - Turkey ... More >> Baskent University Medical School Ankara, Turkey, 06490 Less <<
NCT03131479 Renal Impairment Phase 2 Completed - United States, Florida ... More >> Novartis Investigative Site Orlando, Florida, United States, 32809 Less <<
NCT03307850 Type 1 Diabetes Mellitus Not Applicable Completed - United States, California ... More >> Sansum Diabetes Research Institute Santa Barbara, California, United States, 93111 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT02278926 - Completed - Italy ... More >> Nigurada Hospital Milano, Italy, 20162 Less <<
NCT03240432 Type 1 Diabetes Mellitus Not Applicable Active, not recruiting October 2019 -
NCT00763412 - Completed - -
NCT00901472 - Completed - United States, Illinois ... More >> The University of Chicago Chicago, Illinois, United States, 60637 Less <<
NCT03661684 Diabetes Hype... More >>rglycemia Steroid-induced Less << Early Phase 1 Completed - -
NCT03017287 Diabetes Mellitus, Type 1 or 2 Not Applicable Not yet recruiting August 2017 Israel ... More >> Diabitic Unit of the Wolfson Medical Center Not yet recruiting Holon, Israel Contact: Michali De Wolf    +972-35028716 Less <<
NCT03630263 Obesity Diabe... More >>tes Mellitus, Type 2 Appetitive Behavior Less << Not Applicable Not yet recruiting February 15, 2019 United States, Indiana ... More >> Purdue University West Lafayette, Indiana, United States, 47907 Less <<
NCT02641743 Diabetes Not Applicable Completed - -
NCT03133741 Glucose Metabolism Disorders Not Applicable Completed - Denmark ... More >> Center for Diabetes Research Gentofte, Copenhagen, Denmark, 2900 Less <<
NCT01843881 Type 2 Diabetes Mellitus Early Phase 1 Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT02478541 Hypertriglyceridaemia Not Applicable Completed - United Kingdom ... More >> Oxford Centre for Diabetes, Endocrinology and Metabolism Oxford, United Kingdom, OX3 7LE Less <<
NCT00691249 Hyperglycemia Not Applicable Completed - United States, Kansas ... More >> Kansas State Univerity: Department of Human Nutrition Manhattan, Kansas, United States, 66506 Less <<
NCT02745730 Pleasure Not Applicable Completed - Netherlands ... More >> Leids Universitair Medisch Centrum Leiden, Zuid-Holland, Netherlands Less <<
NCT02894099 Sedentary Lifestyle Not Applicable Unknown December 2016 Brazil ... More >> Clinics Hospital of the Ribeirao Preto Medical School Recruiting Ribeirão Preto, São Paulo, Brazil, 14048-900 Less <<
NCT01980459 Non-Insulin Dependent Diabetes... More >> Mellitus Less << Phase 1 Completed - Kuwait ... More >> The Dasman Diabetes Institute Kuwait City, Kuwait Less <<
NCT03662984 Myocardial Insulin Sensitivity... More >> Impaired Glucose Metabolism Diastolic Dysfunction Less << Phase 3 Recruiting August 30, 2020 Netherlands ... More >> Nutrition and Movement Sciences Recruiting Maastricht, Limburg, Netherlands, 6200MD Contact: P Schrauwen, Prof    0031433882222    p.schrauwen@maastrichtuniversity.nl Less <<
NCT00431899 Hemodialysis ... More >>End Stage Renal Disease Less << Not Applicable Completed - France ... More >> Laboratoire Régional de Nutrition Humaine Brest, France, F-29200 Less <<
NCT03387787 Type 2 Diabetes Mellitus Phase 2 Phase 3 Not yet recruiting January 1, 2019 Switzerland ... More >> Division of Endocrinology, Diabetes, Clinical Nutrition & Metabolism, University Hospital Berne, Switzerland Not yet recruiting Berne, Switzerland, 3010 Contact: Markus Laimer, PD. Dr.    +41 31 63 2 30 62    Markus.Laimer@insel.ch    Contact: Christoph Stettler, Prof. Dr.    +41 31 63 2 42 21    Christoph.Stettler@insel.ch Less <<
NCT00436475 Glucose Intolerance ... More >> Type 2 Diabetes Mellitus Metabolic Syndrome Less << Phase 1 Phase 2 Completed - United States, Massachusetts ... More >> Tufts-New England Medical Center Boston, Massachusetts, United States, 02111 Less <<
NCT01313156 - Active, not recruiting May 2020 Germany ... More >> Asklepios Klinik St.Georg Hamburg, Germany, 20099 Universitätsklinikum Eppendorf Hamburg, Germany, 20246 Less <<
NCT00337142 - Completed - -
NCT02528019 Effects of the DPP-4 Inhibitor... More >>s or SGLT2 Inhibitors on the Protective Actions for Diabetic Complications Less << Phase 4 Unknown August 2018 Japan ... More >> Kurume University Hospital Recruiting Kurume city, Japan, 830-0011 Contact: Nobuhiro Tahara, MD, PhD    +81-942-31-7580    ntahara@med.kurume-u.ac.jp    Contact: Sho-ichi Yamagishi, MD, PhD    +81-942-31-7562       Principal Investigator: Nobuhiro Tahara, MD, PhD Less <<
NCT02351973 Hypertension Phase 4 Unknown August 2015 United Kingdom ... More >> Clinical Pharmacology Unit, Box 110, Level 3 ACCI, Addenbrookes Hospital Cambridge, United Kingdom, CB2 2QQ Less <<
NCT03015506 Carbohydrate Intolerance Not Applicable Completed - -
NCT01726829 Type 1 Diabetes Not Applicable Completed - Germany ... More >> Diabetes -Zentrum fuer kinder und jugendliche Hannover, Germany Israel Schneider Children's Medical Center Petah-Tikva, Israel, 49202 Slovenia University Children's Hospital Slovenia, Slovenia Less <<
NCT01954082 Retinopathy of Prematurity (RO... More >>P) Less << Phase 3 Terminated(Study terminated du... More >>e to safety concerns; participant follow up will continue until March 2018) Less << - United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35233 United States, California University of California - Los Angeles Los Angeles, California, United States, 90025 Stanford University Palo Alto, California, United States, 94304 United States, Georgia Emory University Atlanta, Georgia, United States, 30303 United States, Indiana Indiana University Indianapolis, Indiana, United States, 46202 United States, Iowa University of Iowa Iowa City, Iowa, United States, 52242 United States, Michigan Wayne State University Detroit, Michigan, United States, 48201 United States, Missouri Children's Mercy Hospital Kansas City, Missouri, United States, 64108 United States, New Mexico University of New Mexico Albuquerque, New Mexico, United States, 87131 United States, New York University of Rochester Rochester, New York, United States, 14642 United States, North Carolina RTI International Durham, North Carolina, United States, 27705 Duke University Durham, North Carolina, United States, 27710 United States, Ohio Cincinnati Children's Medical Center Cincinnati, Ohio, United States, 45267 Case Western Reserve University, Rainbow Babies and Children's Hospital Cleveland, Ohio, United States, 44106 Research Institute at Nationwide Children's Hospital Columbus, Ohio, United States, 43205 United States, Pennsylvania Univeristy of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 United States, Rhode Island Brown University, Women & Infants Hospital of Rhode Island Providence, Rhode Island, United States, 02905 United States, Texas University of Texas Southwestern Medical Center at Dallas Dallas, Texas, United States, 75235 University of Texas Health Science Center at Houston Houston, Texas, United States, 77030 Less <<
NCT01182935 - Completed - Norway ... More >> Univesity of Tromsø Tromsø, Norway, 9037 Less <<
NCT01472159 Type 1 Diabetes Not Applicable Completed - United States, Massachusetts ... More >> Joslin Diabetes Center Boston, Massachusetts, United States, 02215 Less <<
NCT00353431 Hyperglycemias Not Applicable Completed - Switzerland ... More >> Division of Endocrinology, Diabetes & Clinical Nutrition, Dept of Internal Medicine, Basel, Baselstadt, Switzerland, 4031 Less <<
NCT00353431 - Completed - -
NCT01654380 Healthy Volunteers ... More >> Diabetes Mellitus, Type 1 Less << Phase 1 Completed - United States, California ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. San Diego, California, United States Less <<
NCT00720889 - Completed - United States, Illinois ... More >> University of Chicago Chicago, Illinois, United States, 60637 Less <<
NCT01954082 - Terminated(Study terminated du... More >>e to safety concerns; participant follow up will continue until March 2018) Less << - -
NCT00676767 Hyperglycemia Not Applicable Completed - United States, Kansas ... More >> Human Metabolism Laboratory Manhattan, Kansas, United States, 66506 Less <<
NCT03656887 - Not yet recruiting December 2019 France ... More >> Chu Dijon Bourogne Not yet recruiting Dijon, France, 21000 Contact: Benjamin BOUILLET    +33 3 80 29 34 53    benjamin.bouillet@chu-dijon.fr Less <<
NCT02713997 Pancreatitis, Chronic; Diabete... More >>s; Transplant Less << Phase 4 Recruiting January 2024 United States, Minnesota ... More >> University of Minnesota Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Melena D. Bellin, M.D.    612-625-4686    bell0130@umn.edu Less <<
NCT03665636 Glycogen Storage Disease Type ... More >>I Less << Early Phase 1 Not yet recruiting June 2019 United States, Pennsylvania ... More >> UPMC Children's Hospital of Pittsburgh Recruiting Pittsburgh, Pennsylvania, United States, 15210 Contact: Angela Leshinski, MBA, RD, LDN    412-692-5232    angela.leshinski@chp.edu    Contact: Elizabeth McCracken, MS, LCGC    412-692-5662    elizabeth.mccracken@chp.edu    Principal Investigator: Areeg El-Gharbawy, MD Less <<
NCT02932514 Diabetes Mellitus Not Applicable Active, not recruiting - Sweden ... More >> Diabetic Center, Sahlgrenska University Hospital Gothenburg, Sweden, 41345 Skåne University Hospital Lund, Sweden, 22185 Less <<
NCT00322075 Diabetes Mellitus Phase 4 Completed - Czech Republic ... More >> Sanofi-Aventis Prague, Czech Republic Less <<
NCT02940366 Metabolic Syndrome Phase 4 Recruiting November 30, 2019 Korea, Republic of ... More >> Seoul National University Hospital Recruiting Seoul, Korea, Republic of Contact: Hyung-Kwan Kim, MD    82-2-2072-0243    cardiman73@gmail.com    Principal Investigator: Hyung-Kwan Kim, MD Less <<
NCT01128192 Hyperglycemia Phase 2 Completed - United States, California ... More >> CMR Center for Metabolic Research VASDHS San Diego, California, United States, 92161 Less <<
NCT00337337 Diabetes Mellitus Phase 4 Unknown - Taiwan ... More >> National Cheng-Kung University Hospital Recruiting Tainan, Taiwan, 704 Sub-Investigator: H-Y Ou, MD Less <<
NCT03668808 Diabetes Mellitus, Type 1 Phase 4 Not yet recruiting October 2019 United States, California ... More >> Sansum Diabetes Research Institute Not yet recruiting Santa Barbara, California, United States, 93105 Contact: Wendy C Bevier, Ph.D.    805-682-7638 ext 207    wbevier@sansum.org    Contact: Arianna Larez    805-335-0124       United States, Hawaii inControl Diabetes Center Not yet recruiting Honolulu, Hawaii, United States, 96814 Less <<
NCT02714309 Obesity, Abdominal Not Applicable Completed - United Kingdom ... More >> Faculty of Health and Life Sciences, Northumbria University Newcastle upon Tyne, Tyne and Wear, United Kingdom, NE1 8ST Less <<
NCT02532088 Prediabetes Phase 2 Not yet recruiting September 2019 Malaysia ... More >> Seberang Jaya Hospital Not yet recruiting Seberang Jaya, Penang, Malaysia, 13700 Contact: Irene Looi, MRCP, FRCP       irenelooi@yahoo.com    Sub-Investigator: Hock Aun Ang, MRCP, FRCP          Sub-Investigator: Irene Looi, MBBS Less <<
NCT01128192 - Completed - -
NCT02343354 Gestational Diabetes Mellitus ... More >>With Baby Delivered Less << Not Applicable Completed - Canada, Quebec ... More >> McGill University Health Centre - Royal Victoria Hosptial Montreal, Quebec, Canada, H3A 1A1 Less <<
NCT01901055 Type 2 Diabetes ... More >> Obstructive Sleep Apnea Less << Not Applicable Recruiting June 2019 United States, Michigan ... More >> John D. Dingell VAMC Not yet recruiting Detroit, Michigan, United States, 48201 Contact: Safran Badr, MD    313-576-1981    cynthia.marbury@va.gov    United States, Pennsylvania Pittsburgh Veterans Administration Medical Center Recruiting Pittsburgh, Pennsylvania, United States, 15240 Contact: Charles Atwood, MD    412-360-1527    gregory.owens@va.gov    University of Pittsburgh Recruiting Pittsburgh, Pennsylvania, United States, 15261 Contact: Eileen R. Chasens, PhD    412-624-9380    chasense@pitt.edu    Principal Investigator: Eileen R. Chasens, PhD          United States, West Virginia West Virginia University Recruiting Morgantown, West Virginia, United States, 26506 Contact: Robert Stansbury, MD    304-581-1749    lmoore@hsc.wvu.edu Less <<
NCT01740778 - Completed - -
NCT00338104 - Completed - -
NCT00338104 Hyperglycemia ... More >> Diabetes Less << Phase 4 Completed - United States, Illinois ... More >> Northwestern Memorial Hospital Chicago, Illinois, United States, 60611 Less <<
NCT02341924 Hypercholesterolemia Not Applicable Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Canada, Manitoba Richardson Centre for Functional Foods and Nutraceuticals Winnipeg, Manitoba, Canada, R3T 6C5 Less <<
NCT02297074 Healthy Volunteers Not Applicable Completed - -
NCT00402194 Obesity Insul... More >>in Resistance Impaired Glucose Tolerance Pre-diabetes Less << Not Applicable Completed - United States, Indiana ... More >> Indiana University Hospital GCRC Indianapolis, Indiana, United States, 46202 Less <<
NCT00402194 - Completed - -
NCT02199028 Type 1 Diabetes Mellitus Phase 2 Phase 3 Completed - United States, California ... More >> Stanford University Stanford, California, United States, 94305 Less <<
NCT00282971 Diabetes Mellitus Type 2 Phase 3 Terminated(Terminated as marke... More >>ting of this product will be discontinued) Less << - -
NCT01472393 Postmenopausal Women Not Applicable Unknown December 2017 Brazil ... More >> University of Sao Paulo - School of Medicine Recruiting Sao Paulo, Brazil, 01246-903 Contact: Melisa Madureira, PhD    5511 30617158    melisamadureira@usp.br    Principal Investigator: Bruno Gualano, PhD          Principal Investigator: Rosa M' Pereira, PhD Less <<
NCT00282971 - Terminated(Terminated as marke... More >>ting of this product will be discontinued) Less << - -
NCT03244579 Gestational Diabetes Mellitus ... More >>With Baby Delivered Less << Not Applicable Recruiting October 20, 2019 Jordan ... More >> Sabika Allehdan Recruiting Amman, Jordan, 009626 Contact: Sabika Allehdan, MSc    799232789    sabika_1986@Yahoo.com Less <<
NCT00153166 Arterial Occlusive Disease ... More >> Intermittent Claudication Insulin Resistance Less << Phase 2 Phase 3 Completed - United States, Massachusetts ... More >> Brigham & Women's Hospital Boston, Massachusetts, United States, 02115 Less <<
NCT02685241 - Recruiting January 2019 Switzerland ... More >> University Hospital Zurich, Division of Pneumology Recruiting Zurich, ZH, Switzerland, 8091 Contact: Malcolm Kohler, Prof. MD    +41442553828    malcolm.kohler@usz.ch    Contact: Noriane Sievi, MSc    +41442559815    noriane.sievi@usz.ch    Sub-Investigator: Sotiris E Pratsinis, Prof. Dr.          Sub-Investigator: Noriane Sievi, MSc          Sub-Investigator: Andreas Güntner, MSc          Principal Investigator: Malcolm Kohler, Prof. MD Less <<
NCT01153516 - Completed - United States, Texas ... More >> Clinical and Translational Research Center Dallas, Texas, United States, 75390 Less <<
NCT01779362 Prediabetes T... More >>ype 2 Diabetes Less << Phase 3 Active, not recruiting August 2019 United States, Illinois ... More >> Jesse Brown VA Medical Center Chicago, Illinois, United States, 60612 University of Chicago Chicago, Illinois, United States, 60637 United States, Indiana Indiana University Indianapolis, Indiana, United States, 46202 United States, Washington VA Puget Sound Health Care System Seattle, Washington, United States, 98108 Less <<
NCT00153166 - Completed - -
NCT00069628 Diabetes Mellitus, Insulin-Dep... More >>endent Less << Phase 4 Completed - United States, California ... More >> Division of Pediatric Endocrinology and Diabetes, Stanford University Stanford, California, United States, 94305-5208 United States, Colorado Barbara Davis Center for Childhood Diabetes, University of Colorado Denver, Colorado, United States, 80262 United States, Connecticut Department of Pediatrics, Yale University School of Medicine New Haven, Connecticut, United States, 06519 United States, Florida Nemours Children's Clinic Jacksonville,, Florida, United States, 32207 Jaeb Center for Health Research Tampa, Florida, United States, 33647 United States, Iowa Department of Pediatrics, University of Iowa Carver College of Medicine Iowa City, Iowa, United States, 52242 Less <<
NCT01344928 Type 2 Diabetes Mellitus ... More >> Healthy Volunteers Less << Not Applicable Unknown - Finland ... More >> Turku PET Centre Recruiting Turku, Finland, 20521 Contact: Jarna C Hannukainen, PhD    +358-2-3131878    jarna.hannukainen@tyks.fi    Principal Investigator: Jarna C Hannukainen, PhD          Sub-Investigator: Kari K Kalliokoski, PhD          Sub-Investigator: Joonas J Eskelinen, BM          Sub-Investigator: Anna Savolainen, BM          Sub-Investigator: Ilkka Heinonen, PhD          Sub-Investigator: Kirsi A Virtanen, PhD          Sub-Investigator: Jukka Kemppainen, PhD          Sub-Investigator: Juhani Knuuti, Professor          Sub-Investigator: Pirjo Nuutila, Professor          Sub-Investigator: Jussi Pärkkä, MD          Sub-Investigator: Virva Lepomäki, MSc          Sub-Investigator: Riitta Parkkola, MD, PhD Less <<
NCT02842606 Healthy Volunteers Not Applicable Completed - -
NCT01420198 Type 2 Diabetes ... More >> Impaired Glucose Tolerance Obesity Physical Activity Less << Not Applicable Completed - Sweden ... More >> Centre for Primary Health Care Research, Region Skåne and Lund University Malmö, Skåne, Sweden, 20502 Less <<
NCT02686905 Complications of Bariatric Pro... More >>cedures Avitaminosis Less << Not Applicable Unknown June 2017 United States, California ... More >> Oliak Center for Weight Loss Recruiting Brea, California, United States, 92821 Contact: David Oliak, MD    714-582-2530    info@droliak.com    Principal Investigator: Rebecca McDorman, BS          Sub-Investigator: Heather Garcia, BS          Sub-Investigator: Corinne Worland, AA          Sub-Investigator: Jordyn Shubin Less <<
NCT02993614 - Recruiting December 31, 2018 -
NCT01334684 Type 2 Diabetes Not Applicable Unknown September 2013 Italy ... More >> Casa Sollievo Della Sofferenza IRCCS Not yet recruiting San Giovanni Rotondo, Foggia, Italy, 71013 Less <<
NCT01544309 - Completed - -
NCT02099409 Type 1 Diabetes Mellitus Not Applicable Completed - Luxembourg ... More >> DECCP Clinique Pédiatrique de Luxembourg/CHL Luxembourg, Luxembourg, 1210 DECCP Pediatric Clinic , CHLuxembourg Luxembourg, Luxembourg, 1210 Less <<
NCT02962752 Monoamine Oxidase Inhibitor Ac... More >>tivity Prolactin Levels Postprandial Blood Glucose Less << Not Applicable Completed - -
NCT01037647 - Completed - Denmark ... More >> Medical department M (Endocrinology and Diabetes), Aarhus University Hospital Aarhus, DK, Denmark, 8000 Less <<
NCT02550912 Autism Phase 2 Completed - Egypt ... More >> Faculty of Pharmacy AinShams University Cairo, Egypt, 02 Less <<
NCT01217320 Juvenile Systemic Lupus Erythe... More >>matosus Juvenile Dermatomyositis Less << Not Applicable Unknown September 2012 Brazil ... More >> University of Sao Paulo Recruiting Sao Paulo, Brazil, 05508-30 Contact: Bruno Gualano, PhD       gualano@usp.br    Principal Investigator: Bruno Gualano, PhD Less <<
NCT03420040 Type 2 Diabetes Mellitus Not Applicable Enrolling by invitation April 1, 2018 China, Shaanxi ... More >> Xijing Hospital, Fourth Military Medical university Xi'an, Shaanxi, China, 710032 Less <<
NCT01544309 Hypercholesterolemia With Conc... More >>omitant Type 2 Diabetes Less << Not Applicable Completed - -
NCT00549237 Postoperative Complications ... More >> Gastric Bypass Less << Not Applicable Completed - Switzerland ... More >> Hôpitaux Universitaires Genève Geneva, Switzerland, 1211 Less <<
NCT01327378 - Completed - Denmark ... More >> Department of Nephrology P 2131, Rigshospitalet Copenhagen Ø, Denmark, 2100 Less <<
NCT02498340 Glucose-6-Phosphate Dehydrogen... More >>ase Deficiency Less << Phase 2 Phase 3 Unknown - Egypt ... More >> Pediatric Hematology clinic, Ain Shams University Cairo, Egypt Less <<
NCT01627509 - Unknown August 2013 Israel ... More >> The Institute of Endocrinology, Sheba Medical Center Not yet recruiting Tel Hashomer, Gush Dan, Israel, 52621 Contact: Jacob Ilani, DR.    +97235303103    Jacob.Ilany2@sheba.health.gov.il    Contact: Shmuel Levit, DR.    +972508805375    shlevit@gmail.com    Principal Investigator: Jacob Ilani, DR.          Sub-Investigator: Shmuel Levit, DR.          Sheba Medical Center Recruiting Tel Hashomer, Israel, 52621 Less <<
NCT00501592 Diabetes Mellitus, Type II ... More >> Fatty Liver Less << Phase 2 Completed - United States, California ... More >> Profil Institute for Clinical Research, Inc. Chula Vista, California, United States, 91911 UC San Diego VAMC San Diego, California, United States, 92161 United States, Texas Diabetes & Glandular Disease Research Associates, Inc. San Antonio, Texas, United States, 78229 United States, Virginia Virginia Commonwelath University Richmond, Virginia, United States, 23298 Less <<
NCT03150030 - Enrolling by invitation October 1, 2019 Denmark ... More >> Gentofte Hospital Hellerup, Denmark, 2900 Less <<
NCT00991549 Overweight Gl... More >>ucose Intolerance Less << Not Applicable Completed - Canada, Quebec ... More >> Centre de Recherche Clinique (CRC), Centre Hospitalier Universitaire de Sherbrooke Sherbrooke, Quebec, Canada Less <<
NCT01348568 Type 2 Diabetes Phase 2 Completed - Canada, Ontario ... More >> St. Michael's Hospital Toronto, Ontario, Canada, M5C2T2 Less <<
NCT00501592 - Completed - -
NCT03334643 Type2 Diabetes Mellitus Not Applicable Recruiting March 31, 2019 United States, New Jersey ... More >> Institute for Food, Nutrition & Health Recruiting New Brunswick, New Jersey, United States, 08901 Contact: Yan Lam, PhD    848-932-5673    yan.y.lam@rutgers.edu    Principal Investigator: Liping Zhao, PhD          Sub-Investigator: Yan Lam, PhD          Sub-Investigator: Tingting Chen, PhD          Sub-Investigator: Peggy Policastro, PhD          Sub-Investigator: Jeanne Ferrante, MD Less <<
NCT02596477 Chronic Heart Failure Phase 2 Terminated(Terminated for admi... More >>nistrative reasons not related to safety or efficacy) Less << - United States, Michigan ... More >> Research Center Detroit, Michigan, United States, 48202 United States, Mississippi Research Center Tupelo, Mississippi, United States, 38801 Australia, New South Wales Research Center Cardiff, New South Wales, Australia, 2285 Australia, Victoria Research Center Melbourne, Victoria, Australia Less <<
NCT03378908 Gestational Diabetes Mellitus ... More >>in Pregnancy Less << Not Applicable Recruiting January 1, 2019 Spain ... More >> Berta Soldevila Recruiting Badalona, Barcelona, Spain, 08916 Contact: Berta Soldevila, PhD       soldevila.berta@gmail.com    Marta Hernández Recruiting Lleida, Spain, 25196 Contact: Marta Hernández, MD       martahernandezg@gmail.com Less <<
NCT00213122 Type 2 Diabetes Mellitus Phase 3 Completed - Japan ... More >> Ibaraki, Japan Less <<
NCT03562078 Type 2 Diabetes Mellitus Not Applicable Recruiting September 2018 Taiwan ... More >> Linsen Chinese Medicine and Kunming Branch, Taipei City Hospital Recruiting Taipei, Taiwan, 104 Contact: Chien-Jung Huang, Bachelor Less <<
NCT03202563 Type 2 Diabetes Mellitus Phase 4 Active, not recruiting October 30, 2018 Korea, Republic of ... More >> Samsung Medical Center Seoul, Korea, Republic of, 06351 Less <<
NCT00553020 Diabetes Mellitus, Type 2 Phase 4 Completed - -
NCT01343797 Healthy Not Applicable Unknown May 2011 France ... More >> Biofortis Nantes, Pays de La Loire, France, 44000 Less <<
NCT00442767 Type 1 Diabetes Mellitus Phase 4 Completed - United States, New York ... More >> Montefiore Medical Center Bronx, New York, United States, 10467 Less <<
NCT00442767 - Completed - -
NCT01814540 Healthy Not Applicable Completed - United States, California ... More >> University of California, Davis Davis, California, United States, 95616 Less <<
NCT03372824 - Recruiting June 1, 2020 Norway ... More >> Stavanger University hospital Recruiting Stavanger, Rogaland, Norway, 4068 Contact: Johanne H Toft, MD    +4751518000    johanne.holm.toft@sus.no    Principal Investigator: Johanne H Toft, MD Less <<
NCT02665715 Bariatric Surgery (Gastric Byp... More >>ass) Less << Not Applicable Completed - Denmark ... More >> Endocrinology Research Center, Hvidovre University Hospital Hvidovre, Copenhagen, Denmark, 2650 Less <<
NCT02549924 Type 2 Diabetes Mellitus Phase 2 Terminated(no financial suppor... More >>t) Less << - Mexico ... More >> Institute of Experimental and Clinical Therapeutics (INTEC), CUCS, University of Guadalajara Guadalajara, Jalisco, Mexico, 44340 Less <<
NCT02319512 Postoperative Ileus Phase 3 Terminated(Due to a radical ch... More >>ange in postoperative care as well as surgical technique.) Less << - -
NCT01470937 Type 2 Diabetes Mellitus Phase 4 Completed - United States, Indiana ... More >> Indiana University Hospital GCRC Indianapolis, Indiana, United States, 46202 Less <<
NCT00212017 Impaired Glucose Tolerance ... More >> Myocardial Infarction Less << Not Applicable Terminated(We obtained the fin... More >>al results due to the interim analysis.) Less << - Japan ... More >> National Cardiovascular Center Suita, Osaka, Japan, 565-8565 Less <<
NCT02449226 - Completed - France ... More >> Service de REANIMATION, HOPITAL EUROPEEN MARSEILLE Marseille, France Less <<
NCT00284232 Diabetes Mellitus, Type 1 Phase 4 Completed - Norway ... More >> Stavanger University Hospital Stavanger, Norway Less <<
NCT00162487 Hyperkalemia ... More >>Chronic Renal Failure Less << Not Applicable Unknown - Israel ... More >> Hadassah Medical Organization Recruiting Jerusalem, Israel, 91120 Contact: Arik Tzukert, DMD    00 972 2 6776095    arik@hadassah.org.il    Contact: Hadas Lemberg, PhD    00 972 2 6777572    lhadas@hadassah.org.il    Principal Investigator: Yoseph Caraco, MD Less <<
NCT00511472 Type 2 Diabetes Mellitus Phase 1 Completed - -
NCT02035059 - Recruiting June 30, 2019 Switzerland ... More >> Women`s Hospital, University Basel Recruiting Basel, Basel-Stadt, Switzerland, 4031 Contact: Evelyn Huhn, MD    +41615565144    evelyn.huhn@usb.ch    Principal Investigator: Irene Hösli, MD          Principal Investigator: Huhn Evelyn, MD Less <<
NCT00571818 Transplant Di... More >>abetes Less << Not Applicable Completed - United States, Nebraska ... More >> University of Nebraska Medical Center Omaha, Nebraska, United States, 68198 Less <<
NCT02185729 - Completed - -
NCT00511472 - Completed - -
NCT02185729 Diseases, Metabolic ... More >> Insulin Sensitivity Less << Phase 2 Phase 3 Completed - United States, Georgia ... More >> Grady Memorial Hospital Atlanta, Georgia, United States, 30303 Less <<
NCT02161666 - Completed - Denmark ... More >> Hvidovre University Hospital Hvidovre, Danmark, Denmark, 2650 Less <<
NCT01419652 Diabetes Mellitus ... More >> Coronary Artery Disease Less << Phase 4 Completed - United States, New York ... More >> VA New York Harbor New York, New York, United States, 10010 Less <<
NCT03466398 Diabetes Mellitus ... More >> Type 1 Diabetes Mellitus Less << Not Applicable Recruiting April 2020 United States, Texas ... More >> Children's Medical Center Recruiting Dallas, Texas, United States, 75235 Contact: Soumya Adhikari, MD       soumya.adhikari@childrens.com    Principal Investigator: Soumya Adhikari, MD          Sub-Investigator: Huay-Lin Lo, MD          Sub-Investigator: Sneha Patel, APN Less <<
NCT02917252 Acute Ketosis Not Applicable Completed - Denmark ... More >> Aarhus University Hospital Aarhus, Denmark, 8000 Less <<
NCT00564551 Impaired Glucose Tolerance ... More >> Type 2 Diabetes Metabolic Syndrome Less << Not Applicable Completed - Canada, Alberta ... More >> Faculty of Kinesiology, Roger Jackson Centre for Health and Wellness Research Calgary, Alberta, Canada, T2N 1N4 Less <<
NCT00749918 Prediabetes V... More >>itamin D Deficiency Less << Not Applicable Completed - United States, Minnesota ... More >> University of Minnesota, Division of Endocrinology Minneapolis, Minnesota, United States, 55455 Less <<
NCT00704236 Type 2 Diabetes Phase 4 Completed - China, Shanghai ... More >> Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai, China, 200025 Less <<
NCT00211510 - Completed - -
NCT02588729 Gestational Diabetes Mellitus Not Applicable Completed - Norway ... More >> Oslo university hospital Oslo, Norway, 4950 Less <<
NCT00971659 Type 2 Diabetes Phase 1 Completed - Germany ... More >> Profil Institut für Stoffwechselforschung GmbH Neuss, Germany, 41460 Less <<
NCT00211510 Type 1 Diabetes Not Applicable Completed - United States, California ... More >> Children's Hospital of Los Angeles Los Angeles, California, United States, 90027 Stanford University Stanford, California, United States, 94305 United States, Georgia Atlanta Diabetes Associates Atlanta, Georgia, United States, 30309 United States, Massachusetts Joslin Diabetes Center Boston, Massachusetts, United States, 02215 United States, New York The Endocrine Group Albany, New York, United States, 12206 United States, Texas Diabetes and Glandular Diabetes Research Associates San Antonio, Texas, United States, 78229 United States, Washington University of Washington Seattle, Washington, United States, 98195 Less <<
NCT00797823 - Completed - -
NCT02432287 Aging Phase 4 Completed - United States, New York ... More >> Einstein College of Medicine of Yeshiva University Bronx, New York, United States, 10461 Less <<
NCT02432287 - Completed - -
NCT00797823 Type 1 Diabetes Phase 2 Completed - United States, Oregon ... More >> Legacy Research Portland, Oregon, United States, 97232 Less <<
NCT02325206 Type 1 Diabetes Phase 1 Completed - Germany ... More >> Kinder - und Jugendkrankenhaus AUF DER BULT Hannover, Germany, 30173 Less <<
NCT03368807 - Completed - United States, California ... More >> AMCR Institute, Inc. Escondido, California, United States, 92025 Science 37 Inc Los Angeles, California, United States, 90045 Coastal Metabolic Research Ctr Ventura, California, United States, 93003 United States, Idaho Rocky Mountain Diabetes and Osteoporosis Center Idaho Falls, Idaho, United States, 83404 United States, Iowa Iowa Diabetes & Endocrinology Research Center West Des Moines, Iowa, United States, 50265 United States, Utah Advanced Research Institute Ogden, Utah, United States, 84405 Less <<
NCT02933424 Pre-diabetes ... More >>Obesity Less << Not Applicable Completed - Singapore ... More >> Clinical Nutrition Research Centre Singapore, Singapore Less <<
NCT01345435 Type 2 Diabetes Not Applicable Completed - Korea, Republic of ... More >> Kyungpook National University Hospital Daegu, Korea, Republic of Yeungnam University Medical Center Daegu, Korea, Republic of Gangnam Severance Hospital Seoul, Korea, Republic of Yonsei University Health System Seoul, Korea, Republic of Less <<
NCT01096121 Sickle Cell Disease Not Applicable Terminated(Not enough inclusio... More >>ns) Less << - France ... More >> Trousseau Hospital, Nephro-pediatric unit Paris, France, 75012 Less <<
NCT03182985 Weight Loss M... More >>etabolic Syndrome Overweight and Obesity Less << Not Applicable Active, not recruiting June 2019 United States, California ... More >> UCSD La Jolla, California, United States, 92037 Less <<
NCT00213551 Healthy Volunteers Phase 1 Completed - France ... More >> University Hospital of Rouen Rouen, France, 76031 Less <<
NCT00390728 Diabetes Mellitus, Type 1 Phase 4 Completed - -
NCT03694470 - Completed - Russian Federation ... More >> Research site Moscow, Russian Federation Less <<
NCT00206258 Type 1 Diabetes Phase 3 Completed - United States, Texas ... More >> Baylor College of Medicine Houston, Texas, United States, 77030 Less <<
NCT01787617 Insulin Resistance ... More >> Type 2 Diabetes Less << Not Applicable Unknown March 2017 United States, Louisiana ... More >> Pennington Biomedical Research Center Baton Rouge, Louisiana, United States, 70808 Less <<
NCT02517242 Diabetes Phase 4 Unknown - Brazil ... More >> Rafael Vaz Machry Recruiting Porto Alegre, Rio Grande do Sul, Brazil, 90035-903 Contact: Rafael Vaz Machry    (55)5196264337 Less <<
NCT01617577 Alzheimer's Disease Phase 1 Phase 2 Completed - United States, Florida ... More >> USF/Byrd Alzheimer's Center Tampa, Florida, United States, 33612 Less <<
NCT03200795 Diabetes Not Applicable Recruiting February 20, 2019 Nigeria ... More >> Aminu Kano Teaching Hospital Recruiting Kano, Nigeria, 70000 Contact: Badaru Umar, PhD    08028460237    badaruum@gmail.com    Contact: Sammani Jibril, Msc       jsammani.pth@buk.edu.ng Less <<
NCT01571609 Hyperlipidemia ... More >> Diabetes Mellitus Metabolic Syndrome Arterial Hypertension Obesity Less << Not Applicable Completed - Denmark ... More >> Medicinsk forskningslaboratorium, Aarhus Universitet Aarhus, Denmark, 8000 Less <<
NCT02292238 Alzheimer's Disease Phase 2 Recruiting November 2019 United States, New York ... More >> Burke Recruiting White Plains, New York, United States, 10605 Contact: Liz Magier, MPA    914-368-3159    burkegrants@med.cornell.edu Less <<
NCT01895387 Impaired Fasting Glucose ... More >> Newly Diagnosed Type 2 Diabetes Less << Not Applicable Completed - Korea, Republic of ... More >> Yonsei University Seoul, Korea, Republic of Less <<
NCT01211730 Evidence of Liver Transplantat... More >>ion Hyperglycemia Rejection Less << Phase 4 Completed - United States, Illinois ... More >> Northwestern University Feinberg School of Medicine Chicago, Illinois, United States, 60611 Less <<
NCT01211730 - Completed - -
NCT03359824 Physical Activity Not Applicable Completed - -
NCT01617577 - Completed - -
NCT03199716 Diabetes Mellitus, Type 1 Not Applicable Recruiting May 2027 United States, California ... More >> UC Davis Pediatrics Endocrinology Recruiting Sacramento, California, United States, 95817 Contact: Yvonne Lee, MD    916-734-7098    yvonne.lee@ucdmc.ucdavis.edu    Principal Investigator: Dennis Styne, MD          Sub-Investigator: Yvonne Lee, MD Less <<
NCT02157974 Hepatic Steatosis ... More >> Polycystic Ovarian Syndrome Obesity Less << Phase 2 Phase 3 Recruiting December 2018 United States, Colorado ... More >> University of Colorado Anshutz Medical Campus/Children's Hospital Colorado Recruiting Aurora, Colorado, United States, 80045 Contact: Yesenia Garcia    720-777-6984    yesenia.garciareyes@childrenscolorado.org Less <<
NCT03068273 Diabetes Mellitus, Type 1 ... More >> Diabetes Mellitus, Type 2 Less << Not Applicable Recruiting December 31, 2017 United States, California ... More >> Scripps Whittier Diabetes Institute Recruiting La Jolla, California, United States, 92037 Contact: Rosario Rosal    858-626-5628       Principal Investigator: Athena Philis-Tsimikas, MD Less <<
NCT02204670 - Completed - Canada ... More >> The Manitoba Institute of Child Health Winnipeg, Canada Less <<
NCT00389350 Diabetes Phase 2 Phase 3 Completed - United States, New Hampshire ... More >> Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States, 03756 Less <<
NCT01025557 Diabetes Prevention ... More >> Obesity Prevention Less << Phase 1 Phase 2 Completed - Canada, Ontario ... More >> University of Toronto Toronto, Ontario, Canada, M5S 3E2 Less <<
NCT02769884 Type 1 Diabetes Phase 2 Completed - -
NCT02668159 Prediabetes I... More >>nsulin Resistance Less << Not Applicable Completed - Canada ... More >> Institute of Nutrition and Functional Foods (INAF), Laval University Quebec, Canada, G1V 0A6 Less <<
NCT01392534 - Completed - Poland ... More >> Many Locations, Poland Less <<
NCT00811044 - Withdrawn(PI, Dr. K. Polonsky ... More >>has moved to the University of Chicago.) Less << June 2015 -
NCT00790556 - Completed - -
NCT00097786 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT03523143 Pregnancy Complications ... More >> Gestational Diabetes Mellitus in Pregnancy Less << Not Applicable Not yet recruiting December 31, 2020 -
NCT03716336 Insulin Resistance Syndrome Not Applicable Completed - Egypt ... More >> Faculty of physical therapy- Cairo University Giza, Dokki, Egypt, 12613 Less <<
NCT00862589 Hyperglycemia ... More >> Hyperglucagonemia Glucose Intolerance Less << Not Applicable Completed - -
NCT01812122 Diabetes Mellitus, Non-Insulin... More >>-Dependent Less << Phase 4 Completed - Korea, Republic of ... More >> Seoul National University Hospital Seoul, Korea, Republic of, 110-744 Less <<
NCT02822898 Healthy Adult Volunteers Phase 4 Completed - Belgium ... More >> University Hospital, Antwerp Edegem, Belgium, 2650 Less <<
NCT01742130 Contrast Induced Acute Kidney ... More >>Injury Less << Phase 4 Completed - Italy ... More >> Ospedale Misericordia e Dolce Prato, Italy, 59100 Less <<
NCT03165812 Diabetes Mellitus, Type 2 ... More >> Overweight Less << Not Applicable Recruiting April 2019 Malaysia ... More >> Hospital Serdang Recruiting Kajang, Selangor, Malaysia, 43400 Contact: Tikfu Gee, MBBS, MS    +60 18-984 2300    groupesantesoin@gmail.com    Principal Investigator: Tikfu Gee, MBBS, MS          Sub-Investigator: Ng Ooi Chuan, MBBS, MRCP          Sub-Investigator: Ching Siew Mooi, MFamMed          Sub-Investigator: Subashini a/p Chellappah Thambiah, MBBS, Mpath          Sub-Investigator: Intan Nureslyna Samsudin, Mpath          Sub-Investigator: Zubaidah Hanipah, MD, MS          Sub-Investigator: Lim Shu Yu, MS          Hospital Kuala Lumpur Recruiting Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia, 50586 Contact: Tikfu Gee, MBBS, MS    +6018 984 2300    groupesantesoin@gmail.com    Principal Investigator: Tikfu Gee, MBBS, MS          Sub-Investigator: Ng Ooi Chuan, MBBS, MRCP          Sub-Investigator: Ching Siew Mooi, MFamMed          Sub-Investigator: Subashini a/p Chellappah Thambiah, MBBS, Mpath          Sub-Investigator: Intan Nureslyna Samsudin, Mpath          Sub-Investigator: Zubaidah Hanipah, MD, MS          Sub-Investigator: Lim Shu Yu, MS          Sub-Investigator: Raflis Ruzairee Awang, MBChB, MS Less <<
NCT00755404 End Stage Renal Disease ... More >> Diabetes Less << Phase 2 Unknown December 2013 Italy ... More >> Renal, Dialysis and Transplant Unit, University of Bari Active, not recruiting Bari, Italy, 70124 Nephology and Dialysis Unit, "Salvini" Hospital Withdrawn Bollate, Italy, 20021 Division of Nephrology, University of "G. d'Annunzio" Recruiting Chieti, Italy, 66100 Principal Investigator: Mario Bonomini, MD          Nephrology and Dialysis Unit, Desio Hospital Recruiting Desio, Italy, 20100 Principal Investigator: Renzo Scanziani, MD          Sub-Investigator: Marco Pozzi, MD          Nephrology and Dialysis Unit, "Maria SS dello Splendore" Hospital Recruiting Giulianova, Italy, 64021 Principal Investigator: Giancarlo Marinangeli, MD          Division of Nephrology and Dialysis, Ospedale Policlinico Maggiore Active, not recruiting Milano, Italy, 20121 Nephrology and Dialysis Unit, "G. Bernabeo" Hospital Recruiting Ortona, Italy, 66026 Sub-Investigator: Antonio Stingone, MD          Renal Unit, Policlinico MultiMedica Recruiting Sesto San Giovanni, Italy, 20099 Principal Investigator: Silvio V Bertoli, MD          Division of Nephrology and Dialysis, "Mazzini" Hospital Recruiting Teramo, Italy, 64100 Principal Investigator: Goffredo Del Rosso, MD Less <<
NCT00790556 Type 2 Diabetes Phase 1 Completed - -
NCT00700960 - Completed - France ... More >> Novo Nordisk Investigational Site Paris La Défense, France, 92936 Less <<
NCT00755456 End Stage Renal Disease ... More >> Insulin Resistance Less << Phase 2 Unknown December 2013 Italy ... More >> Renal and Dialysis, Bari Policlinic Hospital Recruiting Bari, Italy, 70124 Principal Investigator: Pasquale Coratelli, MD          Renal, Dialysis and Transplant Unit, University of Bari Recruiting Bari, Italy, 70124 Sub-Investigator: Roberto Corciulo, MD          Principal Investigator: Francesco P Schena, MD          Nephology and Dialysis Unit, "Salvini" Hospital Withdrawn Bollate, Italy, 20021 Division of Nephrology, University of "G. d'Annunzio" Recruiting Chieti, Italy, 66100 Sub-Investigator: Lorenzo Di Liberato, MD          Nephrologyand Dialysis Unit, Desio Hospital Not yet recruiting Desio, Italy, 20100 Principal Investigator: Renzo Scanziani, MD          Sub-Investigator: Marco Pozzi, MD          Nephrology and Dialysis Unit, "Maria SS dello Splendore" Hospital Recruiting Giulianova, Italy, 64021 Principal Investigator: Giancarlo Marinangeli, MD          Nephrology and Dialysis Unit, "Renzetti" Hospital Not yet recruiting Lanciano, Italy, 66034 Principal Investigator: Margherita Maccarone, MD          Division of Nephrology and Dialysis, Ospedale Policlinico Maggiore Recruiting Milano, Italy, 20121 Sub-Investigator: Amedeo De Vecchi, MD          Principal Investigator: Piergiorgio Messa, MD          Nephrology and Dialysis Unit, "G. Bernabeo" Hospital Recruiting Ortona, Italy, 66026 Principal Investigator: Antonio Stingone, MD          Renal Unit, Policlinico MultiMedica Recruiting Sesto San Giovanni, Italy, 20099 Principal Investigator: Silvio V Bertoli, MD          Nephrology and Dialysis Unit, "SS Annunziata" Hospital Recruiting Sulmona, Italy, 67039 Principal Investigator: Paolo Cerasoli, MD          Division of Nephrology and Dialysis, "Mazzini" Hospital Recruiting Teramo, Italy, 64100 Principal Investigator: Goffredo Del Rosso, MD          Nephrology and Dialysis Unit, "San Pio da Pietrelcina" Hospital Recruiting Vasto, Italy, 66054 Principal Investigator: Bruno Di Paolo, MD Less <<
NCT00035568 Diabetes Mellitus, Non-Insulin... More >>-Dependent Less << Phase 4 Completed - United States, Arkansas ... More >> Local Institution Little Rock, Arkansas, United States United States, California Local Institution Los Angeles, California, United States United States, Illinois Local Institution Chicago, Illinois, United States United States, Indiana Local Institution Indianapolis, Indiana, United States United States, New York Local Institution Brooklyn, New York, United States Local Institution Rochester, New York, United States United States, Pennsylvania Local Institution Pittsburgh, Pennsylvania, United States United States, Texas Local Institution Dallas, Texas, United States Local Institution San Antonio, Texas, United States Less <<
NCT03500016 Type2 Diabetes ... More >> Insulin Resistance Less << Not Applicable Recruiting November 12, 2020 Denmark ... More >> Department of Endocrinology, Odense University Hospital Recruiting Odense, Denmark, 5000 Contact: Maria H Petersen, MD    +0045 51427331    maria.petersen@rsyd.dk    Contact: Kurt Højlund, Professor, DMSc, PhD, MD       kurt.hoejlund@rsyd.dk    Principal Investigator: Kurt Højlund, Professor, DMSc, PhD, MF          Principal Investigator: Maria H Petersen, MD Less <<
NCT03299205 HIV/AIDS Dysg... More >>lycemia Alcohol Use Disorder Less << Not Applicable Recruiting September 2022 United States, Louisiana ... More >> Louisiana State University Health Sciences Center Recruiting New Orleans, Louisiana, United States, 70112 Contact: Stefany Primeaux, PhD    504-568-2633    sprime@lsuhsc.edu Less <<
NCT02591849 Post-transplant Diabetes Melli... More >>tus Less << Not Applicable Completed - Norway ... More >> Oslo University Hospital, Rikshospitalet Oslo, Norway, N-0424 Less <<
NCT00456885 - Completed - -
NCT00988689 Obesity Prevention ... More >> Diabetes Prevention Less << Not Applicable Completed - Canada, Ontario ... More >> Department of Nutritional Studies, University of Toronto Toronto, Ontario, Canada, M5S 3E2 Less <<
NCT00980941 Obesity Prevention ... More >> Diabetes Prevention Less << Not Applicable Completed - Canada, Ontario ... More >> Department of Nutritional Studies, University of Toronto Toronto, Ontario, Canada, M5S 3E2 Less <<
NCT02364570 Prediabetes C... More >>ardiovascular Disease Less << Not Applicable Active, not recruiting December 2017 United States, Ohio ... More >> The Ohio State University Columbus, Ohio, United States, 43210 Less <<
NCT00097786 - Completed - -
NCT00456885 Obesity Impai... More >>red Glucose Tolerance Less << Phase 4 Completed - United States, Massachusetts ... More >> Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Less <<
NCT00640991 Hyperglycemia ... More >> Cardiovascular Diseases Myocardial Infarction Less << Phase 3 Completed - Argentina ... More >> Instituto Medico Adrogue Adrogue,, Buenos Aires, Argentina Canada, Ontario Hamilton Health Sciences, General Site Hamilton, Ontario, Canada, L8L 2X2 India Assam Medical College Hospital Dt. Dibrugarh, Assam, India, 786002 Lifeworth Super Specialty Hospital Raipur, Chattisgarh, India, 492001 Post Graduate Institute of Medical Rohtak, Haryana, India, 124001 St. Johns Medical College Bangalore, Karnataka, India, 560034 Nanjappa Hospital Shimoga, Karnataka, India, 577201 Baby Memorial Hospital Calicut, Kerala, India, 673004 Caritas Hospital Kottayam, Kerala, India, 686016 KEM Hospital Mumbai, Maharashtra, India, 400012 MGIMS Wardha, Maharashtra, India, 442102 Railway Hospital Chennai, Tamilnadu, India, 600023 Avanti Institute of Cardiology Nagpur, India, 440012 Less <<
NCT02125656 Insulin Resistance ... More >> Sleep Deprivation Less << Not Applicable Unknown May 2015 -
NCT02432781 Total Knee Arthroplasty Not Applicable Completed - Korea, Republic of ... More >> Department of Anesthesiology and Pain Medicine and Anesthesia and Pain Research Institute, Severance Hospital, Yonsei University College of Medicine Seoul, Korea, Republic of Less <<
NCT01167569 Reperfusion Injury Phase 4 Completed - United States, New Jersey ... More >> Robert Wood Johnson University Hospital New Brunswick, New Jersey, United States, 08901 Less <<
NCT00849849 - Completed - United States, Louisiana ... More >> Woman's Hospital Research Institute Baton Rouge, Louisiana, United States, 70815 Less <<
NCT01489163 Gestational Diabetes Not Applicable Active, not recruiting December 2017 United States, California ... More >> Division of Research Northern California Oakland, California, United States, 94612 Less <<
NCT02272153 Food Selection Not Applicable Completed - United States, Minnesota ... More >> Department of Food Science and Nutrition St. Paul, Minnesota, United States, 55108 Less <<
NCT03554486 Diabetes Mellitus, Type 1 Phase 4 Recruiting May 2019 United States, California ... More >> Stanford University Recruiting Palo Alto, California, United States, 94304 Contact: Liana Hsu, BS    650-725-3939    rkingman@stanford.edu    Contact: Ryan Kingman, BS    650-736-4417    rkingman@stanford.edu    Principal Investigator: Bruce Buckingham, MD          Sub-Investigator: Marina Basina, MD          Sub-Investigator: Rayhan Lal, MD Less <<
NCT02042274 - Completed - -
NCT00774124 Diabetes Mellitus ... More >> Pregnancy Less << Not Applicable Completed - United States, Florida ... More >> Tallahassee Memorial Diabetes Center Tallahassee, Florida, United States, 32308 United States, Pennsylvania Temple University Hospital Philadelphia, Pennsylvania, United States, 19140 Less <<
NCT03389269 - Completed - Denmark ... More >> Center for Diabetes Research Hellerup, Denmark, 2900 Less <<
NCT01823341 Type 1 Diabetes Phase 2 Completed - United States, California ... More >> Stanford University Stanford, California, United States, 94305 United States, Colorado Barbara Davis Center for Childhood Diabetes Aurora, Colorado, United States, 80045 Canada, Ontario St. Joseph's Health Care London, Ontario, Canada, N6A4V2 Less <<
NCT02042274 Metabolic Syndrome X Not Applicable Completed - Canada, Ontario ... More >> University of Guelph - Human Nutraceutical Research Unit Guelph, Ontario, Canada, N1G2W1 Less <<
NCT01823341 - Completed - -
NCT02033473 Healthy Phase 1 Completed - France ... More >> University Hospital of Toulouse Toulouse, France, 31059 Less <<
NCT02213549 Prediabetes Not Applicable Completed - Japan ... More >> Hiroshima University Hiroshima, Japan, 734-8551 Less <<
NCT03217175 Type 1 Diabetes Mellitus Not Applicable Suspended(Lack of appropriate ... More >>funds) Less << December 2018 United States, Massachusetts ... More >> MGH Diabetes Research Center Boston, Massachusetts, United States, 02114 Less <<
NCT01085071 Thoracic Surgery ... More >> Cardiac Surgery Critically Ill Less << Phase 4 Completed - Netherlands ... More >> University Medical Center Groningen, University of Groningen Groningen, Netherlands, 9700RB Less <<
NCT01555788 Type 1 Diabetes Mellitus Phase 2 Completed - France ... More >> Montpellier University Hospital Montpellier, France, 34000 Less <<
NCT00188630 Heart Disease ... More >> Acute Renal Failure Less << Phase 3 Completed - Canada, Ontario ... More >> Toronto General Hospital, UHN Toronto, Ontario, Canada, M5G 2C4 Less <<
NCT03557138 Type2 Diabetes Mellitus Not Applicable Recruiting January 2019 Austria ... More >> Medical University of Vienna, Department of Radiology and Nuklear Medicine Recruiting Vienna, Austria, 1090 Contact: Marcus Hacker, Prof., MD       marcus.hacker@meduniwien.ac.at    Principal Investigator: Marcus Hacker, Prof., MD          Sub-Investigator: Sazan Rasul, MD, PhD          Sub-Investigator: Barbara Geist, Dr., Msc. Less <<
NCT00487162 - Terminated(potential harm of i... More >>nsulin infusion outweights the benefit.) Less << - -
NCT02612675 Diabetes Not Applicable Completed - United States, Texas ... More >> Diabetes & Glandular Disease Clinic, PA San Antonio, Texas, United States, 78229-4801 Less <<
NCT00096421 Critical Illness ... More >> Hyperglycemia Insulin Resistance Less << Phase 3 Completed - Colombia ... More >> Hospital Pablo Tobon Uribe Medellin, Antioquia, Colombia Less <<
NCT02914496 Type 1 Diabetes Not Applicable Enrolling by invitation October 2021 Sweden ... More >> Ersta sjukhus Stockholm, Sweden, 11691 Less <<
NCT00487162 Hyperglycemia Not Applicable Terminated(potential harm of i... More >>nsulin infusion outweights the benefit.) Less << - United States, New Jersey ... More >> University Hospital Newark, New Jersey, United States, 07107 Less <<
NCT02775513 - Unknown - -
NCT01926457 Prediabetes G... More >>estational Diabetes Less << Not Applicable Completed - United States, California ... More >> UC San Diego Health System San Diego, California, United States, 92103 Less <<
NCT00998335 - Completed - -
NCT03295695 Breast Cancer ... More >> Breast Cancer, Female Breast Cancer, Male Breast Neoplasms Less << Early Phase 1 Not yet recruiting March 2021 United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Not yet recruiting Tampa, Florida, United States, 33612 Contact: Malesa Pereira    813-745-4090    malesa.pereira@moffitt.orgm    Contact: Jung Choi, M.D.    813-745-2058    jung.choi@moffitt.org    Principal Investigator: Jung Choi, M.D.          Sub-Investigator: Kenneth Gage, M.D., Ph.D.          Sub-Investigator: Roohi Ismail-Khan, M.D.          Sub-Investigator: Daniel Jeong, M.D.          Sub-Investigator: Jaime Montilla-Soler, M.D.          Sub-Investigator: Hatem Soliman, M.D. Less <<
NCT03478475 Deficiency, Vitamin D ... More >> Insulin Resistance Less << Not Applicable Completed - -
NCT00998335 Type 2 Diabetes Phase 4 Completed - United States, Texas ... More >> The University of Texas H.S.C. at San Antonio and the San Antonio Audie L. Murphy VA Hospital San Antonio, Texas, United States, 78229-3900 Less <<
NCT00111228 Diabetes Mellitus Phase 4 Completed - France ... More >> Hôpital Sud Francilien Corbeil Esssonnes, France, 91106 CH Robert Debre Paris, France, 75019 Germany Klinik für Allgemeine Charité, CVK Berlin, Germany, D-13353 Israel Schneider Children Centre Petah Tikva, Israel, 49202 Italy Universita Vita-Salute OspedaleS.Raffaele Milano, Italy, 20132 Slovenia University Children’s Hospital Ljubljana, Slovenia, SI-1525 Sweden Huddinge University Hospital Huddinge, Sweden, SE-141 86 United Kingdom Royal Bournemouth Hospital Bournemouth, United Kingdom, Dorset BH7 7DW Less <<
NCT02885935 Metabolic Syndrome Not Applicable Completed - -
NCT03398356 PreDiabetes I... More >>mpaired Fasting Glucose Impaired Glucose Tolerance Less << Phase 4 Recruiting April 30, 2019 Poland ... More >> NZOZ Nowy Dwór Recruiting Wroclaw, Lower Silesia, Poland, 54-438 Contact: Edyta Sutkowska, PhD    +48/503077016    edytasutkowska@yahoo.com    Contact: Edyta Sutkowska, PhD    +48/503077016    edyta.sutkowska@umed.wroc.pl    Sub-Investigator: Andrzej Gamian, Prof          Sub-Investigator: Jacek Gajek, Prof          Sub-Investigator: Bożena Karolewicz, PhD Less <<
NCT02895750 Renal Insufficiency, Chronic Phase 2 Recruiting August 30, 2020 France ... More >> CHU Amiens Picardie Recruiting Amiens, France, 80054 Contact: Jean-Daniel LALAU, MD, PhD    +33 3 22 45 58 95    lalau.jean-daniel@chu-amiens.fr Less <<
NCT01425905 Depression Im... More >>paired Glucose Tolerance Less << Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT01673321 Healthy Gluco... More >>se Metabolism Less << Not Applicable Completed - Canada, Ontario ... More >> Department of Nutritional Sciences, University of Toronto Toronto, Ontario, Canada, M5S 3E2 Less <<
NCT03455985 Diabetes Mellitus, Type 2 ... More >> Patient Discharge Blood Glucose, Low Blood Glucose, High Less << Not Applicable Recruiting April 30, 2020 United States, Ohio ... More >> The Ohio State University Recruiting Columbus, Ohio, United States, 43210 Contact: Jacob E LaFleur, BA    614-688-6262    jacob.lafleur@osumc.edu    Contact: Angela Howell, LPN    6146883785    angela.howell@osumc.edu    Principal Investigator: Kathleen Dungan, M.D.          Sub-Investigator: Kwame Osei, M.D.          Sub-Investigator: Elizabeth Buscher, M.D.          Sub-Investigator: Cara Harris, NP          Sub-Investigator: David Bradley, M.D. Less <<
NCT02521506 Diabetes Mellitus Not Applicable Completed - Spain ... More >> Complejo Hospitalario Universitario A Coruña A Coruña, Spain, 15006 Hospital Universitario Torrecárdenas Almería, Spain, 04000 Hospital Clínico San Carlos Madrid, Spain, 28000 Hospital Universitario Virgen de la Victoria Málaga, Spain, 29000 Less <<
NCT03179254 Diabetes Type 2 Phase 4 Completed - -
NCT01163721 Diabetes Mellitus, Type 2 Phase 2 Completed - United States, California ... More >> AMCR Institute Escondido, California, United States, 92026 National Research Institute (NRI) Los Angeles, California, United States, 90057 United States, Florida SeaView Research Inc. Miami, Florida, United States, 33126 Orlando Clinical Research Center (OCRC) Orlando, Florida, United States, 32809 United States, Indiana Midwest Institute For Clinical Research Inc. (MICR) Indianapolis, Indiana, United States, 46260 United States, Kansas Vince and Associates Clinical Research Overland Park, Kansas, United States, 66212 United States, Kentucky L-MARC Research Center Louisville, Kentucky, United States, 40213 United States, New York Rochester Clinical Research (RCR) Rochester, New York, United States, 14609 United States, Texas Cetero Research San Antonio, Texas, United States, 78229 Less <<
NCT01163721 - Completed - -
NCT02524249 Bronchopulmonary Dysplasia ... More >> Apnea of Prematurity Less << Not Applicable Unknown - United States, Michigan ... More >> Hutzel Women's Hospital Recruiting Detroit, Michigan, United States, 48202 Contact: Nitin S Chouthai    313-745-5638    nchoutha@med.wayne.edu Less <<
NCT02605148 Prediabetes T... More >>ype 1 Diabetes Less << Not Applicable Enrolling by invitation July 2019 Sweden ... More >> Lund University, Department of Clinical Sciences Malmö Malmö, Sweden, 20502 Less <<
NCT03047824 Metabolic Stress Hyperglycemia Not Applicable Completed - -
NCT01684748 Overweight Ob... More >>ese Prehypertension Hypertension Less << Phase 4 Completed - -
NCT02587780 - Unknown December 2015 -
NCT01111955 Diabetes Mellitus, Type 2 Phase 2 Completed - United States, Florida ... More >> Farid Marquez, Md Hialeah, Florida, United States, 33012 United States, Washington Capital Clinical Reserch Center Olympia, Washington, United States, 98502 United States, Wisconsin Aurora Advanced Healthcare Milwaukee, Wisconsin, United States, 53209 Australia, New South Wales Local Institution Blacktown, New South Wales, Australia, 2148 Australia, Victoria Local Institution Box Hill, Victoria, Australia, 3128 Australia, Western Australia Local Institution Freemantle, Western Australia, Australia, 6959 Canada, British Columbia Local Institution Surrey, British Columbia, Canada, V4A 2H9 Canada, Manitoba Local Institution Winnipeg, Manitoba, Canada, R3E 3P4 Canada, New Brunswick Local Institution Bathurst, New Brunswick, Canada, E2A 4X7 Canada, Newfoundland and Labrador Local Institution St. John'S, Newfoundland and Labrador, Canada, A1A 3R5 Canada, Ontario Local Institution Thornhill, Ontario, Canada, L4J 8L7 Canada, Quebec Local Institution Mirabel, Quebec, Canada, J7J 2K8 Canada, Saskatchewan Local Institution Saskatoon, Saskatchewan, Canada, S7K 7H9 Canada Local Institution Quebec, Canada, G1N 4V3 Less <<
NCT02506920 Hyperlipidemia Not Applicable Completed - -
NCT00006195 Schizophrenia Not Applicable Unknown - United States, Missouri ... More >> Washington University Recruiting St. Louis, Missouri, United States, 63110 Contact: John Newcomer, M.D. Less <<
NCT02231021 Type 2 Diabetes Mellitus Phase 4 Recruiting November 2018 Korea, Republic of ... More >> Seoul St Mary's Hospital, The Catholic University of Korea Recruiting Seoul, Korea, Republic of, 137-701 Principal Investigator: Kun-Ho Yoon, MD, PhD          Sub-Investigator: Yoon-Hee Choi, MD, PhD          Sub-Investigator: Hye-Kyung Yang, MD Less <<
NCT01717716 Childhood Obesity Not Applicable Completed - Canada, Nova Scotia ... More >> Department of Applied Human Nutrition Bedford, Nova Scotia, Canada Less <<
NCT01917669 - Withdrawn(Funding was never av... More >>ailable to conduct the proposed series of experiments.) Less << September 2016 United States, Kentucky ... More >> University of Kentucky Center for Clinical and Translational Science Lexington, Kentucky, United States, 40536 Less <<
NCT03443713 Type 1 Diabetes Mellitus ... More >> MDI CGM Exercise Less << Not Applicable Recruiting May 31, 2019 United States, Oregon ... More >> Oregon Health and Science University Recruiting Portland, Oregon, United States, 97239 Contact: Deborah Branigan, BA CCRP    503-418-9070    branigad@ohsu.edu    Contact: Jessica Castle, MD    503-494-7072    castleje@ohsu.edu Less <<
NCT01684748 - Completed - -
NCT03775057 Diabetes Mellitus, Type 2 Not Applicable Recruiting August 22, 2019 Mexico ... More >> Clínica Nova Recruiting San Nicolás De Los Garza, Nuevo León, Mexico Contact: Hector Eloy Tamez, PhD    5218183483220    hectoreloytp@gmail.com    Principal Investigator: David Soni, MD          Principal Investigator: Oscar Cantu, MD          Sub-Investigator: Rosalinda Gonzalez, BN Less <<
NCT03006510 Hypoglycemia Early Phase 1 Unknown July 2018 -
NCT02169518 - Recruiting December 2018 United Kingdom ... More >> Central Manchester University Hospitals NHS Foundatioon Trust Recruiting Manchester, Lancashire, United Kingdom, M13 9WL Contact: Jonathan Schofield, MRCP    07866529898    jschofield@doctors.org.uk    Contact: See Kwok, MD FRCGP    01612768863    sk7@doctors.org.uk    Principal Investigator: Handrean Soran, MD FRCP Less <<
NCT02013557 Diabetes, Gestational Not Applicable Terminated(Resources allocated... More >> elsewhere.) Less << - United States, Florida ... More >> Tampa General Hospital Tampa, Florida, United States, 33606 Less <<
NCT03591458 Type1 Diabetes Mellitus ... More >> Hypoglycemia Unawareness Less << Phase 2 Recruiting July 2020 United States, Utah ... More >> University of Utah Recruiting Salt Lake City, Utah, United States, 84132 Contact: Sally Bradstreet    801-581-4684    sally.bradstreet@hsc.utah.edu    Principal Investigator: Yu Kuei Lin, M.D. Less <<
NCT02617160 Type 1 Diabetes Not Applicable Recruiting April 2019 Israel ... More >> Schneider Medical Center Recruiting Petach- Tikva, Israel, 49202 Contact: Moshe :Phillip, Prof.    972-3-9253282    mosheph@clalit.org.il    Contact: Alona Hamou, MSc    972-3-9253778    alonah@clalit.org.il    Sub-Investigator: Revital Nimri, Dr.          Sub-Investigator: Tal Oron, Dr.          Sub-Investigator: Sharon Demol, Dr.          Sub-Investigator: Shlomit Shalitin, Dr.          Sub-Investigator: Ariel Tenennbaum, Dr.          Sub-Investigator: Liat De-vries, Dr.          Sub-Investigator: Liora Lazar, Dr.          Sub-Investigator: Avivit Brener, Dr          Sub-Investigator: Rachel Bello, Dr          Sub-Investigator: Marie Mouler, Dr          Sub-Investigator: Naama Fish, Dr          Sub-Investigator: Yael Lebenthal, Dr Less <<
NCT00205699 - Completed - -
NCT01044017 Diabetes Mellitus Type 2 Phase 1 Completed - France ... More >> Strasbourg, France, 67064 Less <<
NCT01637350 - Unknown December 2016 China, Tianjin ... More >> Tianjin Medical University Cancer Institute and Hospital Tianjin, Tianjin, China, 300060 Less <<
NCT03403582 Type 2 Diabetes Mellitus Not Applicable Completed - United States, Oklahoma ... More >> Oklahoma State University Stillwater, Oklahoma, United States, 74078 Less <<
NCT02302963 Type 1 Diabetes Mellitus Not Applicable Completed - United States, California ... More >> Stanford University Stanford, California, United States, 94305 United States, Virginia University of Virginia Center for Diabetes Technology Charlottesville, Virginia, United States, 22903 Less <<
NCT00262145 Diabetes Over... More >>weight Less << Phase 1 Completed - United States, Minnesota ... More >> VA Medical Center Minneapolis, Minnesota, United States, 55417 Less <<
NCT01418573 Glycemic Index of a Meal Not Applicable Completed - United Kingdom ... More >> Leatherhead Food Research Leatherhead, Surrey, United Kingdom, KT22 7RY Less <<
NCT02982551 Healthy Volunteers Early Phase 1 Withdrawn(Principal Investigat... More >>or Departed University) Less << - United States, Pennsylvania ... More >> Western Psychiatric Institute and Clinic Pittsburgh, Pennsylvania, United States, 15213 Less <<
NCT00205699 Aggression At... More >>tention Deficit-Hyperactivity Oppositional Defiant Disorder Pervasive Development Disorders Bipolar Disorder Less << Phase 4 Completed - United States, Missouri ... More >> Washington University School of Medicine, Psychiatry Dept. Saint Louis, Missouri, United States, 63110 Less <<
NCT00004753 - Completed - -
NCT02872415 Great Premature Newborn Not Applicable Recruiting January 18, 2018 France ... More >> Assistance Publique Hôpitaux de Marseille Not yet recruiting Marseille, France, 13354 Contact: Aurelie SAILLE, Coordinator    0491384043    aurelie.saille@ap-hm.fr    Principal Investigator: Isabelle LIGI, PH          Assistance Publique Hôpitaux de Marseille Recruiting Marseille, France, 13354 Contact: Isabelle LIGI, PH    491384043 ext +33    isabelle.ligi@ap-hm.fr    Contact: Aurélie SAILLE, PH    491384043 ext +33    aurelie.saille@ap-hm.fr    Principal Investigator: Isabelle LIGI, PH          Principal Investigator: Gwenn- Marie VERZAT, PH Less <<
NCT01980524 Type 2 Diabetes Phase 2 Phase 3 Completed - Austria ... More >> Division of Endocrinology and Metabolism, Internal Medicine III, Medical University of Vienna Vienna, Austria, 1090 Less <<
NCT01394510 - Completed - -
NCT01080157 - Completed - United States, Alabama ... More >> Accelovance - Huntsville Huntsville, Alabama, United States, 35802 United States, California Accelovance - San Diego, CA San Diego, California, United States, 92108 United States, Illinois Radiant Research, Inc. - Chicago Chicago, Illinois, United States, 60654 Accelovance - Peoria, IL Peoria, Illinois, United States, 61602 United States, Kansas Radiant Research, Inc. - Kansas City Kansas City, Kansas, United States, 66202 United States, Maryland Accelovance - Rockville, MD Rockville, Maryland, United States United States, Minnesota Radiant Research, Inc. - Minneapolis Minneapolis, Minnesota, United States, 55345 United States, New Mexico Lovelace Scientific Resources, Inc. Albuquerque, New Mexico, United States, 87108 United States, Ohio Radiant Research, Inc. - Cincinnati Cincinnati, Ohio, United States, 45249 United States, Texas Juno Research, LLC Houston, Texas, United States, 77036 Dynamed Clinical Research, LP Houston, Texas, United States, 77375 Radiant Research, Inc. - San Antonio San Antonio, Texas, United States, 78229 Less <<
NCT01394510 Type 2 Diabetes ... More >> Oxidative Stress Less << Not Applicable Completed - United States, Washington ... More >> VA Puget Sound Health Care System Seattle, Washington, United States, 98108 Less <<
NCT01884792 Prediabetes Not Applicable Completed - United States, Minnesota ... More >> Department of Human Services St. Paul, Minnesota, United States, 55155 Less <<
NCT03709108 Type 1 Diabetes Mellitus Not Applicable Recruiting March 31, 2019 United States, Virginia ... More >> University of Virginia Recruiting Charlottesville, Virginia, United States, 22908 Contact: Jennifer Pinnata    434-243-6681    jp3te@hscmail.mcc.virginia.edu    Principal Investigator: Chiara Fabris, PhD          Sub-Investigator: Marc Breton, PhD          Sub-Investigator: Daniel Chernavvsky, MD Less <<
NCT01866280 Sleep Meals Not Applicable Completed - United States, New York ... More >> St. Luke's/Roosevelt Hospital New York, New York, United States, 10025 Less <<
NCT01980524 - Completed - -
NCT00629213 Metabolic Syndrome Phase 3 Completed - Germany ... More >> GWT-TUD GmbH Dresden, Saxony, Germany, 01187 Less <<
NCT01772680 Thalassemia Phase 1 Completed - United States, California ... More >> Children's Hospital & Research Center Oakland Oakland, California, United States, 94609 Less <<
NCT02848261 Type 1 Diabetes Mellitus Not Applicable Recruiting August 2019 United States, California ... More >> Stanford University Recruiting Stanford, California, United States, 94305 Contact: Regan C Barley    650-736-1517    rcbarley@stanford.edu    Principal Investigator: Bruce Buckingham, MD          Sub-Investigator: Korey Hood, PhD          United States, Colorado University of Colorado Active, not recruiting Aurora, Colorado, United States, 80045 United States, Indiana Indiana University Active, not recruiting Indianapolis, Indiana, United States, 46202 Less <<
NCT03279107 Pre Diabetes ... More >>Obesity Less << Not Applicable Active, not recruiting June 2019 Singapore ... More >> Clinical Nutrition Research Centre Singapore, Singapore, 117599 Less <<
NCT03020485 Diabetes Mellitus Not Applicable Completed - -
NCT01213719 Healthy Subjects Not Applicable Completed - Brazil ... More >> University of Sao Paulo Sao Paulo, Brazil, 05508-030 Less <<
NCT02271776 Obesity Type ... More >>2 Diabetes Mellitus Less << Not Applicable Completed - Netherlands ... More >> Department of Human Biology, Maastricht University Medical Centre Maastricht, Netherlands, 6200MD Less <<
NCT01674049 Type 2 Diabetes Not Applicable Completed - United States, District of Col... More >>umbia The George Washington University Washington, District of Columbia, United States, 20052 Less <<
NCT02061969 Diabetes Phase 4 Completed - United States, Georgia ... More >> Crestvew Nursing Home Atlanta, Georgia, United States, 30315 Budd Terrace Nursing Home Atlanta, Georgia, United States, 30322 Wesley Woods Nursing Home Atlanta, Georgia, United States, 30322 VA Nursing Home Decatur, Georgia, United States, 30033 Less <<
NCT01298154 Diabetes Prevention ... More >> Obesity Prevention Less << Phase 1 Completed - Canada, Ontario ... More >> University of Toronto Toronto, Ontario, Canada, M5S 3E2 Less <<
NCT02973477 Type2 Diabetes ... More >> Cardiovascular Diseases Less << Phase 4 Recruiting February 2020 United States, Michigan ... More >> University of Michigan Recruiting Ann Arbor, Michigan, United States, 48104 Contact: Jacob E Reiss, B.S.    734-763-0177    jereiss@med.umich.edu    Principal Investigator: Lynn Ang, M.D.          Principal Investigator: Rodica Pop-Busui, M.D., Ph.D. Less <<
NCT03215069 Gestational Diabetes Phase 3 Not yet recruiting September 1, 2021 -
NCT01916733 - Completed - United States, Vermont ... More >> Fletcher Allen Health Care Burlington, Vermont, United States, 05401 Less <<
NCT02459353 Type 2 Diabetes Mellitus Phase 4 Completed - Korea, Republic of ... More >> Seoul St.Mary's Hospital Seoul, Korea, Republic of Less <<
NCT03434691 Septic Shock Not Applicable Recruiting December 31, 2018 Tunisia ... More >> Military hospital of tunis Recruiting Tunis, Mont Fleury, Tunisia, 1008 Contact: zied hajjej, Dr    +21620358907    hajjej_zied@hotmail.com    Principal Investigator: zied hajjej, dr          Military Hopital of Tunis Recruiting Tunis, Tunisia, 1008 Contact: mustapha ferjani    98329256    mustapha.ferjani@planet.tn    Contact: zied hajjej    20358907    hajjej_zied@hotmail.com Less <<
NCT02168296 Healthy Not Applicable Completed - France ... More >> Eurofins OPTIMED Giere, France Less <<
NCT01876992 Diabetes Pre-... More >>diabetes Obesity Less << Not Applicable Terminated(All investigators/c... More >>o-investigators relocating to other institutions.) Less << - United States, Maryland ... More >> Johns Hopkins University Baltimore, Maryland, United States, 21287 Less <<
NCT00721019 Sleep Sleep D... More >>eprivation Insulin Resistance Type 2 Diabetes Less << Not Applicable Completed - United States, Illinois ... More >> University of Chicago Chicago, Illinois, United States, 60637 Less <<
NCT00738088 Diabetes Mellitus, Type 2 Phase 4 Terminated(Following Regulator... More >> inspection in 2009, study terminated as inadequate approvals were in place) Less << - United Kingdom ... More >> NHS Tayside Dundee, United Kingdom, DD1 9SY Less <<
NCT00936663 - Terminated(lack of funding) - -
NCT00936663 Type 2 Diabetes ... More >> End Stage Renal Disease Less << Phase 4 Terminated(lack of funding) - United States, Nebraska ... More >> University of Nebraska Medical Center Omaha, Nebraska, United States, 68198 Less <<
NCT01870713 - Unknown October 2013 China, Henan ... More >> No. 150 Central hospital of Chinese People's Liberation Army Luoyang, Henan, China, 471000 Less <<
NCT00167115 Type 2 Diabetes Mellitus Not Applicable Completed - United States, Minnesota ... More >> University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT03537131 Diabetes Mellitus, Type 1 Phase 2 Recruiting December 22, 2018 United Kingdom ... More >> Clinical Research Unit, OCDEM, Churchill Hospital Recruiting Oxford, Oxfordshire, United Kingdom, OX3 7LE Contact: Lia Anguelova, MD       lia.anguelova@ocdem.ox.ac.uk    Principal Investigator: Ioannis I Spiliotis, MD Less <<
NCT03308773 - Enrolling by invitation September 2027 -
NCT01271140 Hepatitis C Virus Not Applicable Unknown June 2014 Canada, Quebec ... More >> McGill University Helath Centre - (Royal Victoria Hospital) Montreal, Quebec, Canada, H3A 1A1 Less <<
NCT03491436 Pregnancy Diabetic Not Applicable Withdrawn(No patient enrolled) - Belgium ... More >> Ziekenhuis Oost-Limburg Genk, Belgium, 3600 Less <<
NCT03349489 Type 1 Diabetes Mellitus Not Applicable Recruiting January 2019 Canada, Quebec ... More >> McGill University Health Centre Recruiting Montreal, Quebec, Canada, H4A 3J1 Contact: Laurent Legault       laurent.legault@muhc.mcgill.ca    Institut de recherches cliniques de Montréal Recruiting Montréal, Quebec, Canada, H2W 1R7 Contact: Semah Tagougui       semah.tagougui@ircm.qc.ca Less <<
NCT01876992 - Terminated(All investigators/c... More >>o-investigators relocating to other institutions.) Less << - -
NCT02513888 Prediabetes Not Applicable Unknown February 2016 India ... More >> Comprehensive Rural Health Services Project, AIIMS Recruiting Ballabgarh, Haryana, India, 121004 Contact: Puneet Misra, MD       doctormisra@gmail.com Less <<
NCT00972322 Type 2 Diabetes Mellitus Phase 1 Completed - -
NCT01030861 Autoantibody Positive ... More >> Non-diabetic Relatives at Risk for Type 1 Diabetes High Risk Impaired Glucose Tolerance Less << Phase 2 Active, not recruiting January 2019 United States, California ... More >> University of California in San Francisco San Francisco, California, United States, 94143 University of California-San Francisco San Francisco, California, United States, 94143 Stanford University Stanford, California, United States, 94305 United States, Colorado Barbara Davis Center for Childhood Diabetes/ University of Colorado Denver, Colorado, United States, 80045 United States, Connecticut Yale University School of Medicine New Haven, Connecticut, United States, 06519 United States, Florida University of Florida Gainesville, Florida, United States, 32610 University of Miami Miami, Florida, United States, 33136 University of South Florida Tampa, Florida, United States, 33612 United States, Indiana Indiana University Indianapolis, Indiana, United States, 46202 United States, Minnesota University of Minnesota Minneapolis, Minnesota, United States, 55455 United States, Missouri The Children's Mercy Hospital Kansas City, Missouri, United States, 64108 United States, New York Columbia University New York, New York, United States, 10032 United States, Pennsylvania University of Pittsburgh Pittsburgh, Pennsylvania, United States, 15201 United States, Tennessee Vanderbilt University Nashville, Tennessee, United States, 37232 United States, Texas University of Texas Dallas, Texas, United States, 75390-9072 Baylor College of Medicine Houston, Texas, United States, 77030 United States, Washington Benaroya Research Institute Seattle, Washington, United States, 982101 Canada, Ontario The Hospital for Sick Children Toronto, Ontario, Canada, MSG-1X8 Germany Forschergruppe Diabetes Munich, Germany Less <<
NCT00408577 Cardiovascular Disease Phase 3 Completed - Italy ... More >> Scientific Institute San Raffaele Milan, Italy, 20132 Less <<
NCT01889199 Polycystic Ovary Syndrome (PCO... More >>S) Less << Phase 2 Recruiting June 30, 2022 United States, California ... More >> UCaliforniaLA Recruiting Los Angeles, California, United States, 90095-1740 Contact: Daniel A Dumesic, MD    310-794-5542    DDumesic@mednet.ucla.edu    Contact: Rapkin Andrea, MD    (310) 825-6301    ARapkin@mednet.ucla.edu Less <<
NCT01512680 Type 1 Diabetes Phase 2 Completed - France ... More >> Montpellier University Hospital Montpellier, France, 34000 Less <<
NCT00972322 - Completed - -
NCT01058889 Diabetes Mellitus Type 2 ... More >> Insulin Resistance Less << Phase 3 Unknown August 2012 Austria ... More >> Medical University Vienna, Allgemeines Krankenhaus Recruiting Vienna, Austria, 1090 Contact: Karin Schindler, PhD    +43140400 ext 2032    karin.schindler@meduniwien.ac.at    Contact: Bernhard Ludvik, MD    +43140400 ext 4364    bernhard.ludvik@meduniwien.ac.at    Principal Investigator: Bernhard Ludvik, MD Less <<
NCT01398995 Type 1 Diabetes Not Applicable Terminated(Recruitment was ter... More >>minated due to elevated levels of hypoglycaemia) Less << September 2011 United Kingdom ... More >> Wycombe Hospital High Wycombe, Buckinghamshire, United Kingdom, HP11 2TT Less <<
NCT01997021 Metabolic Syndrome ... More >> Diabetes Aging Less << Not Applicable Active, not recruiting November 2019 United States, Colorado ... More >> University of Colorado Denver Anschutz Medical Campus Aurora, Colorado, United States, 80045 Less <<
NCT02891525 Healthy Not Applicable Completed - -
NCT02971098 Reduced Physical Activity Phase 1 Recruiting April 2021 United States, Utah ... More >> University of Utah Recruiting Salt Lake City, Utah, United States, 84108 Contact: Amy Rogers    801-581-5961    amy.rogers@hsc.utah.edu Less <<
NCT03194945 Type 2 Diabetes Mellitus Phase 4 Not yet recruiting December 31, 2020 China, Guangdong ... More >> endocrinology department of the first affiliated hospital of Sun Yat-sen University Guangzhou, Guangdong, China, 510080 Less <<
NCT00967798 - Terminated(Could not achieve t... More >>arget enrollment) Less << - -
NCT01115712 Healthy Overw... More >>eight Obesity Less << Phase 1 Completed - -
NCT01971554 - Completed - -
NCT03013764 Physical Inactivity ... More >> Dietary Protein Less << Not Applicable Completed - United States, Missouri ... More >> University of Missouri Columbia, Missouri, United States, 65211 Less <<
NCT02078128 Burns Not Applicable Completed - Taiwan ... More >> National Taiwan University Hospital Taipei, Taiwan, 100 Less <<
NCT01971554 Type 2 Diabetes Mellitus Phase 1 Completed - -
NCT02061969 - Completed - -
NCT02615327 Healthy Not Applicable Active, not recruiting October 1, 2019 United States, Illinois ... More >> Clinical Nutrition Research Center Chicago, Illinois, United States, 60616 Less <<
NCT00479973 Type 2 Diabetes ... More >> Hypercholesterolemia Less << Phase 2 Unknown May 2008 Canada, Ontario ... More >> Canadian College of Naturopathic Medicine Recruiting Toronto, Ontario, Canada, m2k 1E2 Principal Investigator: Jean-Jacques Dugoua, NDPhD (cand)          UHN - Toronto Western Hospital Recruiting Toronto, Ontario, Canada, M5T 2S8 Principal Investigator: Rowena Ridout, MD Less <<
NCT02244736 - Completed - Greece ... More >> ''Attikon'' University General Hospital Athens, Attiki, Greece, 12462 Less <<
NCT01823406 Type 1 Diabetes Mellitus Not Applicable Completed - United States, Michigan ... More >> University of Michigan Ann Arbor, Michigan, United States, 48109 Less <<
NCT00967798 Cystic Fibrosis ... More >> Prediabetes Less << Phase 3 Terminated(Could not achieve t... More >>arget enrollment) Less << - United States, Georgia ... More >> Emory University and Children's Healthcare of Atlanta at Egleston Atlanta, Georgia, United States, 30322 Children's Healthcare of Atlanta at Scottish Rite Atlanta, Georgia, United States, 30342 United States, Ohio Nationwide Children's Hospital Columbus, Ohio, United States, 43205 Less <<
NCT00001969 - Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT03566511 Diabetes Mellitus, Type 2 ... More >> Glucose, High Blood Glucose Metabolism Disorders (Including Diabetes Mellitus) Less << Phase 2 Recruiting December 2021 United States, New York ... More >> Albert Einstein College of Medicine Recruiting Bronx, New York, United States, 10461 Contact: Matthew Zhao, B.S.    718-430-2903    matthew.zhao@einstein.yu.edu    Principal Investigator: Meredith Hawkins, M.D., M.S. Less <<
NCT02917928 Poor Glycemic Control ... More >> Cardiovascular Risk Factors Cognitive Function 1, Social Less << Phase 2 Recruiting August 2020 Australia, Victoria ... More >> Monash Centre for Health Research and Implementation Recruiting Melbourne, Victoria, Australia, 3168 Contact: Barbora de Courten, MD,PHD,MPH    +61 3 857 22651    barbora.decourten@monash.edu    Principal Investigator: Barbora de Courten, MD,PHD,MPH          Sub-Investigator: Helena Teede, MBBS,PhD          Sub-Investigator: James Cameron, MBBS,MD          Sub-Investigator: Alexander Hodge, BSc,MBBS,PHD          Sub-Investigator: David Scott, BSc,MBBS,PHD Less <<
NCT01241474 Metabolic Syndrome X ... More >> Type 2 Diabetes Mellitus Sarcopenia Less << Not Applicable Completed - United Kingdom ... More >> Rowett Institute of Nutrition and Health, University of Aberdeen Aberdeen, United Kingdom, AB21 9SB Less <<
NCT02689765 Insulin Resistance ... More >> Glucose Metabolism Disorders Type 2 Diabetes Lipid Metabolism Disorders Less << Phase 4 Completed - China, Guangdong ... More >> Baiyun Street Hospital,Yuexiu District Guangzhou, Guangdong, China, 510100 Less <<
NCT02513875 Prediabetes Not Applicable Unknown January 2017 India ... More >> Fortis CDOC center of Excellence for Diabetes Obesity and Endocrinoogy, New Delhi, India Recruiting Delhi, India, 110048 Less <<
NCT00209144 Acute Myocardial Infarction Phase 1 Completed - United States, Georgia ... More >> Emory University Hospital Atlanta, Georgia, United States, 30322 Emory Crawford Long Hospital Atlanta, Georgia, United States, 30329 Less <<
NCT01648218 Post-Transplant Glucocorticoid... More >> Induced Diabetes Less << Phase 4 Terminated(Poor enrollment) - Canada, British Columbia ... More >> Vancouver General Hospital - Jim Pattison Pavilion Vancouver, British Columbia, Canada, V5Z 1M9 Less <<
NCT03030209 - Unknown December 2017 China ... More >> Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China Recruiting Beijing, China, 100730 Contact: Menghua Dai, M.D.       daimh@pumch.cn Less <<
NCT02403648 Hypoglycemia Phase 1 Completed - -
NCT02831738 Healthy Not Applicable Active, not recruiting October 2, 2019 United States, Illinois ... More >> Clinical Nutrition Research Center Chicago, Illinois, United States, 60616 Less <<
NCT00945854 - Completed - -
NCT02197195 Glycemic Control ... More >> Subjective Appetite Less << Not Applicable Completed - Canada, Ontario ... More >> Ryerson University Toronto, Ontario, Canada, KHS344 Less <<
NCT00945854 Metabolic Syndrome Not Applicable Completed - Italy ... More >> Dept. of Clinical and Experimental Medicine, Federico II University Naples, Italy, 80131 Less <<
NCT02578498 Type 1 Diabetes ... More >> Hypoglycemia Less << Phase 4 Completed - Denmark ... More >> Hvidovre University Hospital Hvidovre, Denmark, 2650 Less <<
NCT02301806 Type 2 Diabetes Phase 4 Unknown July 2017 Japan ... More >> Dokkyo Medical University Recruiting Mibu, Tochigo, Japan, 321-0293 Contact: Yoshimasa Aso, MD    81-282-86-1111    yaso@dokkyomed.ac.jp    Principal Investigator: Yoshimasa Aso, MD          Recruiting Mibu, Japan Less <<
NCT01998867 - Unknown August 2018 United States, Virginia ... More >> Health Diagnostic Laboratory, Inc. Richmond, Virginia, United States, 23224 Less <<
NCT00152893 HIV Infections Phase 2 Completed - Canada, Ontario ... More >> University Health Network - Toronto General Hospital Toronto, Ontario, Canada, M5G 2C4 Less <<
NCT02173067 - Completed - Brazil ... More >> Unit of Dentistry, Heart Institute São Paulo, Brazil, 05403-900 Less <<
NCT01275560 Anal Incontinence Phase 3 Completed - France ... More >> Physiology Unit, Hopital Charles Nicolle, 1 rue de Germont Rouen, France, 76031 Less <<
NCT01194479 - Completed - -
NCT02007278 Type 2 Diabetes ... More >> Hypoglycemia Less << Phase 4 Completed - Colombia ... More >> Novartis Investigative Site Medellín, Antioquia, Colombia Novartis Investigative Site Manizales, Caldas, Colombia, 1700 Novartis Investigative Site Bogotá, Cundinamarca, Colombia Novartis Investigative Site Chía, Cundinamarca, Colombia, 11001000 Novartis Investigative Site Cali, Valle del Cauca, Colombia, 760001 Novartis Investigative Site Bogotá, Colombia, 00000 Novartis Investigative Site Cali, Colombia Novartis Investigative Site Monteria, Colombia Less <<
NCT01194479 Type 1 Diabetes Not Applicable Completed - United States, Connecticut ... More >> Yale University School of Medicine New Haven, Connecticut, United States, 06520 Less <<
NCT02007278 - Completed - -
NCT02020798 Glycemic Response Not Applicable Completed - Canada ... More >> Toronto, Canada Less <<
NCT01945138 - Completed - -
NCT03095651 Type 1 Diabetes Mellitus ... More >> Type 2 Diabetes Mellitus Less << Phase 1 Completed - United States, California ... More >> ProSciento Inc. ( Site 0001) Chula Vista, California, United States, 91911 Less <<
NCT01573507 Traumatic Brain Injury ... More >> Subarachnoid Hemorrhage Less << Not Applicable Recruiting December 2018 Switzerland ... More >> CHUV, Lausanne University Hospital Recruiting Lausanne, Switzerland, 1011 Contact: Mauro Oddo, MD    (+41)795561246    mauro.oddo@chuv.ch    Principal Investigator: Mauro Oddo, MD Less <<
NCT02201602 Diabetes Phase 4 Completed - Singapore ... More >> Khoo Teck Puat Hospital Singapore, Singapore, 768828 Less <<
NCT01945138 Chronic Pancreatitis ... More >> Diabetes Mellitus Less << Not Applicable Completed - United States, Minnesota ... More >> University of Minnesota Minneapolis, Minnesota, United States, 55454 Less <<
NCT03050619 - Completed - Germany ... More >> Boehringer Ingelheim Investigational Site Ingelheim, Germany Less <<
NCT02168491 - Completed - -
NCT02168491 Type 2 Diabetes Mellitus Phase 3 Completed - Austria ... More >> Medical University Of Vienna, Department of Internal Medicine III Vienna, Austria, 1090 Less <<
NCT00764712 Hyperglycemia Not Applicable Completed - Czech Republic ... More >> University Hospital in Prague Prague, Czech Republic Less <<
NCT01239992 Hyperlipoproteinemia ... More >> Metabolic Syndrome Less << Phase 4 Terminated(negative endpoint s... More >>tudy resulting in withdrawal of study drug) Less << - Germany ... More >> Medizinische Klinik II, Klinikum der Universitaet Muenchen, Grosshadern Munich, Germany, 81377 Less <<
NCT01239992 - Terminated(negative endpoint s... More >>tudy resulting in withdrawal of study drug) Less << - -
NCT02421107 Adult Intensive Care Patients Not Applicable Unknown August 2015 -
NCT00933114 - Terminated(Funding ceased) - United States, North Carolina ... More >> Duke University Medical Center, Department of Radiation Oncology Durham, North Carolina, United States, 27710 Less <<
NCT03558867 Pre Diabetes ... More >>Type 2 Diabetes Mellitus Less << Not Applicable Recruiting December 23, 2020 Australia, New South Wales ... More >> Garvan Institute of Medical Research Recruiting Sydney, New South Wales, Australia, 2010 Contact: Jerry R Greenfield, MD, PhD    +61292958217    j.greenfield@garvan.org.au    Contact: Dorit Samocha-Bonet, PhD    +61292958309    d.samochabonet@garvan.org.au    Principal Investigator: Dorit Samocha-Bonet, PhD          Principal Investigator: Jerry R Greenfield, MD, PhD Less <<
NCT01070238 Type 2 Diabetes Phase 1 Phase 2 Completed - Germany ... More >> University Hospital Giessen and Marburg Giessen, Hessen, Germany, 35392 Less <<
NCT03300635 Fibromyalgia Not Applicable Recruiting December 31, 2020 Finland ... More >> HelsinkiUCH Recruiting Helsinki, Finland Contact: Ritva Markkula, MD, PhD       ritva.markkula@hus.fi    Contact: Teemu Zetterman, MD       teemu.zetterman@helsinki.fi Less <<
NCT01722227 Type 1 Diabetes Phase 3 Withdrawn(No Funding Received ... More >>from ADA) Less << May 2018 United States, New York ... More >> Diabetes-Endocrinology Center of WNY Williamsville, New York, United States, 14221 Less <<
NCT01994746 Diabetes Mellitus, Type 1 Phase 3 Completed - United States, Colorado ... More >> Barbara Davis Center for Diabetes Aurora, Colorado, United States, 80045 United States, Connecticut Yale University New Haven, Connecticut, United States, 06520 United States, Florida University of Florida Gainesville, Florida, United States, 32605 United States, Indiana Riley Hospital for Children Indiana University Health Indianapolis, Indiana, United States, 46202 United States, Minnesota University of Minnesota Minneapolis, Minnesota, United States, 55454 United States, New York UPA Buffalo Buffalo, New York, United States, 14222 United States, Oregon Oregon Health and Science University Portland, Oregon, United States, 97239 United States, Pennsylvania University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT01994746 - Completed - -
NCT01773486 Obesity Insul... More >>in Resistance Less << Phase 2 Withdrawn(Not funded) - United States, Maryland ... More >> University of Maryland Baltimore, Maryland, United States, 21201 Less <<
NCT02129725 Metabolic Syndrome Phase 4 Completed - United States, Tennessee ... More >> Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232-6602 Less <<
NCT03065790 - Recruiting February 6, 2020 United States, Pennsylvania ... More >> Abramson Cancer Center of the University of Pennsylvania Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Michael Farwell, MD    855-216-0098    PennCancerTrials@emergingmed.com Less <<
NCT02609243 Prediabetes D... More >>iabetes Mellitus Type 2 Obesity NAFLD Dyslipoproteinemia Less << Not Applicable Recruiting December 2020 Germany ... More >> German Institut for Human Nutrition; Department for Clinical Nutrition Recruiting Nuthetal, Brandenburg, Germany, 14458 Contact: Margrit Kemper, Dr. med.    033200 88 2775    margrit.kemper@dife.de    Contact: Silke Hornemann    033200 88 2779    silke.hornemann@dife.de    Sub-Investigator: Margrit Kemper, Dr. med.          Sub-Investigator: Silke Hornemann          Sub-Investigator: Christiana Gerbracht, Dr.          German Institute for Human Nutrition, Department for Clinical Nutrition Recruiting Berlin, Germany, 12203 Contact: Stefan Kabisch, Dr. med.    030 450 514 ext 429    stefan.kabisch@charite.de    Contact: Ulrike Kaiser, M.sc.    030 450 514 ext 428    ulrike.kaiser@charite.de    Sub-Investigator: Stefan Kabisch, Dr. med.          Sub-Investigator: Ulrike Kaiser, M.sc. Less <<
NCT02285231 Pre-diabetes Not Applicable Completed - -
NCT00816608 - Completed - Korea, Republic of ... More >> Seoul National University Bundang Hospital Seongnam, Bundang-gu, Korea, Republic of, 463-707 Less <<
NCT02129725 - Completed - -
NCT00212290 Insulin Resistance ... More >> Type 2 Diabetes Mellitus Less << Phase 4 Completed - United States, Washington ... More >> VA Puget Sound Health Care System (Seattle Campus) Seattle, Washington, United States, 98108 VA Puget Sound Health Care System (American Lake Campus) Tacoma, Washington, United States, 98493 Less <<
NCT02015429 Obesity Diabe... More >>tes Less << Not Applicable Completed - Canada, Ontario ... More >> University of Toronto - Department of Nutritional Sciences Toronto, Ontario, Canada, M5S 3E2 University of Toronto Toronto, Ontario, Canada, M5S 3E2 Less <<
NCT01396564 Type 2 Diabetes Phase 1 Phase 2 Completed - Mexico ... More >> Endocrine Outpatient Clinic of the Hospital de Pediatria del CMN "Siglo XXI" Mexico City, DF, Mexico, 06720 Less <<
NCT00715221 - Completed - United States, Pennsylvania ... More >> University of Pittsburgh Pittsburgh, Pennsylvania, United States, 15213 Less <<
NCT01721382 Cystic Fibrosis Phase 1 Completed - United States, Florida ... More >> Nemours Children's Clinic Jacksonville, Florida, United States, 32207 Less <<
NCT00129233 Hypertension ... More >>Type 2 Diabetes Mellitus Less << Phase 4 Completed - Japan ... More >> Department of Cardiology, Nagoya University Graduate School of Medicine Nagoya, Aichi, Japan, 466-8550 Less <<
NCT02139878 Pre-diabetes Not Applicable Completed - Canada, Prince Edward Island ... More >> University of Prince Edward Island, Health Sciences Charlottetown, Prince Edward Island, Canada, C1A 4P3 Less <<
NCT00823680 Diabetes Mellitus Type 2 Phase 2 Completed - United States, California ... More >> Chula Vista, California, United States, 91911 United States, Florida Miami, Florida, United States, 330014 Austria Graz, Austria, 8036 Germany München, Germany, 80636 Neuss, Germany, 41460 Less <<
NCT02139878 - Completed - -
NCT02885922 - Recruiting December 2020 Taiwan ... More >> outpatient clinic of the Division of Endocrinology and Metabolism in Taichung Veterans General Hospital Recruiting Taichung, Taiwan, 407 Contact: I Te Lee, MD    886-4-23741340    itlee@vghtc.gov.tw    Principal Investigator: I Te Lee, MD Less <<
NCT03415295 - Completed - -
NCT02486341 Diabetes Not Applicable Recruiting March 2019 France ... More >> University Hospital of Bordeaux - Xavier Arnozan Hospital Recruiting Pessac, France, 33600 Contact: Marie DANET-LAMASOU, Dr    +33(5) 57 65 65 71    marie.danet@chu-bordeaux.fr Less <<
NCT01961674 Obesity Diabe... More >>tes Impaired Glucose Tolerance Less << Not Applicable Completed - Singapore ... More >> Clinical Nutrition Research Centre Singapore, Singapore, 117599 Less <<
NCT02635646 - Completed - -
NCT00994149 Infant, Newborn, Diseases ... More >> Pregnancy in Diabetics Infant, Diabetic Mother Hypoglycemia Infant, Large for Gestational Age Less << Phase 2 Phase 3 Unknown October 2011 Canada, Saskatchewan ... More >> Royal University Hospital Not yet recruiting Saskatoon, Saskatchewan, Canada, S7N 0W4 Contact: Koravangattu Sankaran, MD, FRCPC    1-306-966-8118    k.sankaran@usask.ca    Contact: Carmen Dmytryshyn, RN    1-306-966-8138       Principal Investigator: Koravangattu Sankaran, MD, FRCPC Less <<
NCT01867502 Diabetes Mellitus, Type 2 ... More >> Hypoglycemic Agents Diabetic Blood Glucose Monitoring Exercise Less << Phase 4 Unknown August 2015 Brazil ... More >> Hospital de Clínicas de Porto Alegre Porto Alegre Recruiting Porto Alegre, Rio Grande do Sul, Brazil, 90035-903 Contact: Aline Fofonka, MSc    55-5192339191    alinefofonka@hotmail.com    Principal Investigator: Beatriz D Schaan, PhD Less <<
NCT02635646 Prediabetes Not Applicable Completed - Mexico ... More >> Universidad de Guanajuato León, Guanajuato, Mexico, 37670 Less <<
NCT01058733 Diabetes Mellitus Not Applicable Completed - Korea, Republic of ... More >> Seoul St. Mary's Hospital Seoul, Korea, Republic of, 137-701 Less <<
NCT01789957 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT02250066 Prediabetes Not Applicable Completed - -
NCT00489229 Diabetes Impa... More >>ired Glucose Tolerance Less << Phase 3 Completed - Malaysia ... More >> School of Medical Sciences, University Sains Malaysai Kota Bharu, Kelantan, Malaysia, 16150 Less <<
NCT01634997 - Unknown - United Kingdom ... More >> Airedale General Hospital Recruiting Keighley, West Yorkshire, United Kingdom, BD20 6TD Contact: Richard Pope, MD    01535292760 Less <<
NCT03573102 Diabetic Nephropathies Phase 4 Recruiting September 2019 Egypt ... More >> Ain Shams University Hospitals Recruiting Cairo, Egypt, 002 Contact: Nahla H Tohami, MD    1003771280    dr.nahlahussein@gmail.com    Principal Investigator: Magdy Mohamed Saeed El Sharkawy, MD Less <<
NCT01931280 Gestational Diabetes Mellitus ... More >> Pregnancy Less << Not Applicable Completed - United States, North Carolina ... More >> University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States, 27599 Less <<
NCT03064841 - Completed - China ... More >> Peking University Shougang Hospital Beijing, China, 100043 Beijing Hospital Beijing, China Beijing Pinggu Hospital Beijing, China China Meitan General Hospital Beijing, China First Hospital of Jilin University Changchun, China Chinese Traditional Medicine Hospital of Sichuna Provinc Chengdu, China, 610000 West China Hospital Chengdu, China, 610041 First Affiliated Hospital of Dalian Medical University Dalian, China, 116011 Forth Clinical Hospital of Harbin Medical University Harbin, China The First Affiliated Hospital of Anhui Medical University Hefei, China, 230022 The First Affiliated Hospital of Henan University of Science and Technology Luoyang, China Nanjing First Hospital Nanjing, China, 210006 Integrated Chinese and Western Medicine Hospital Nanjing, China, 210029 Affiliated Hospital of Nantong University Nantong, China The affiliated hospital of medicalcollege qingdao university Qingdao, China, 266005 Shengjing Hospital of China Medical University Shenyang, China, 110072 Shenzhen People's Hospital Shenzhen, China, 518020 The First Affiliated Hospital of Soochow University Suzhou, China, 215006 Less <<
NCT00705952 Type 2 Diabetes Not Applicable Completed - -
NCT03212950 Type 1 Diabetes Mellitus Not Applicable Completed - Slovenia ... More >> UMC-University Children's Hospital Ljubljana, Slovenia Less <<
NCT01412554 - Completed - Norway ... More >> Center of Cardiovascular and Renal Research Center Oslo, Norway, 0407 Less <<
NCT02148614 Obesity Phase 1 Phase 2 Recruiting March 2019 Italy ... More >> Pediatric Diabetes and Metabolic Disorders Unit, Department of Life and Reproduction Sciences, University of Verona, 1 Piazzale Stefani Recruiting Verona, Italy, 37126 Contact: Claudio Maffeis, MD    00390458127664    claudio.maffeis@univr.it    Principal Investigator: Claudio Maffeis, MD Less <<
NCT01633762 Diabetes Obes... More >>ity Osteoporosis Inflammation Less << Early Phase 1 Completed - Denmark ... More >> Gentofte University Hospital Hellerup, Denmark, 2900 Less <<
NCT00001651 - Recruiting - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)    800-411-1222 ext TTY8664111010    prpl@cc.nih.gov Less <<
NCT01879228 Cystic Fibrosis ... More >> Pancreatic Insufficiency Less << Not Applicable Recruiting December 2018 United States, Pennsylvania ... More >> Children's Hospital of Philadelphia and University of Pennsylvania Recruiting Philadelphia, Pennsylvania, United States, 19194 Contact: Christina Kubrak, RRT    267-426-5135       Principal Investigator: Michael M Rickels, MD, MS          Principal Investigator: Andrea Kelly, M.D., M.S Less <<
NCT00552890 Obese Type 2 Diabetic Patients Not Applicable Completed - -
NCT02575937 Diabetes Not Applicable Unknown May 2017 China, Guangdong ... More >> Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Department of Nutrition, School of Public Health, Sun Yat-Sen University (Northern Campus) Guangzhou, Guangdong, China, 510080 Less <<
NCT01007266 Obesity Diabe... More >>tes Mellitus, Type 2 Abnormal Glucose Metabolism Type 2 Diabetes Less << Phase 2 Completed - United States, District of Col... More >>umbia Childrens National Medical Center Washington, District of Columbia, United States United States, Maryland National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT01076829 Type II Diabetes Mellitus Not Applicable Completed - United States, California ... More >> David Geffen School of Medicine, UCLA Center for Human Nutrtiion Los Angeles, California, United States, 90095 Less <<
NCT02940873 Type 1 Diabetes Mellitus ... More >> Hypoglycemia Less << Not Applicable Recruiting December 2020 United States, Massachusetts ... More >> Joslin Diabetes Center Recruiting Boston, Massachusetts, United States, 02215 Contact: Astrid Atakov Castillo    617-309-1997    astrid.atakov-castillo@joslin.harvard.edu    Contact: Elena Toschi       elena.toschi@joslin.harvard.edu    United Kingdom Royal Bournemouth Hospital Recruiting Bournemouth, United Kingdom Contact: Augustin Brooks       Augustin.brooks@rbch.nhs.uk    King's College Hospital NHS Foundation Trust and Guy's and St Thomas' NHS Foundation Trust Recruiting London, United Kingdom Contact: Karolina M Bogdanowicz       HARPdoc@kcl.ac.uk    Sheffield Teaching Hospitals NHS Foundation Trust Recruiting Sheffield, United Kingdom Contact: Simon Heller       s.heller@sheffield.ac.uk    Contact: Chloe Husband       Chloe.Husband@sth.nhs.uk Less <<
NCT03205891 Malignant Neoplasms Stated as ... More >>Primary Lymphoid Haematopoietic Classical Hodgkin Lymphoma Anaplastic Large Cell Lymphoma CD30+ Peripheral T-cell Lymphoma Less << Phase 1 Withdrawn(Change in treatment ... More >>priorities for these disease types as well as staffing concerns.) Less << March 2021 -
NCT00728377 Gestational Diabetes Not Applicable Completed - United States, Massachusetts ... More >> Batstate Medical Center Springfield, Massachusetts, United States, 01199 Less <<
NCT01945060 Type 1 Diabetes Mellitus Not Applicable Completed - United States, Virginia ... More >> University of Virginia Center for Diabetes Technology Charlottesville, Virginia, United States, 22903 Virginia Commonwealth University Medical Center Richmond, Virginia, United States, 23298-0140 Less <<
NCT01933672 - Completed - -
NCT01933672 Type 2 Diabetes Mellitus Phase 1 Completed - United States, Florida ... More >> Avail Clinical Research, LLC DeLand, Florida, United States, 32720 Miami Research Associates, Inc. South Miami, Florida, United States, 33143 MRA Clinical Research, LLC South Miami, Florida, United States, 33143 United States, North Carolina High Point Clinical Trials Center, LLC High Point, North Carolina, United States, 27265 United States, Ohio Community Research Cincinnati, Ohio, United States, 45255 United States, Texas Clinical Trials of Texas, Inc San Antonio, Texas, United States, 78229 Diabetes and Glandular Disease Clinic San Antonio, Texas, United States, 78229 United States, Wisconsin Spaulding Clinical Research, LLC West Bend, Wisconsin, United States, 53095 Less <<
NCT02966275 - Completed - -
NCT02349152 Heart Diseases ... More >> Hyperglycemia Less << Phase 4 Completed - United States, Pennsylvania ... More >> UPMC Presbyterian Hospital Pittsburgh, Pennsylvania, United States, 15213 Less <<
NCT03246828 MODY1 MODY3 Not Applicable Recruiting August 2018 United Kingdom ... More >> Clinical Research Unit, OCDEM, Churchill Hospital Recruiting Oxford, Oxfordshire, United Kingdom, OX3 7LE Contact: Ioannis Spiliotis, MD    +44-1865857255    ioannis.spiliotis@ocdem.ox.ac.uk    Principal Investigator: Ioannis Spiliotis, MD Less <<
NCT02287103 Breakfast Not Applicable Unknown November 2015 Israel ... More >> Diabetes Unit E. Wolfson Medical center Recruiting Holon, Tel Aviv, Israel, 58100 Contact: Daniela Jakubowicz, MD    972508105552    daniela.jak@gmail.com    Contact: Julio Wainstein, MD    97254522296    vainstein@wolfson.health.gov.il    Principal Investigator: Daniela Jakubowicz, MD Less <<
NCT02606838 Diabetes Not Applicable Completed - United States, Indiana ... More >> Ascensia Diabetes Care Mishawaka, Indiana, United States, 46544 Less <<
NCT02966275 Hypoglycemia Not Applicable Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT02012608 Breast Cancer Phase 2 Active, not recruiting December 2019 United States, Arkansas ... More >> University of Arkansas for Medical Sciences Little Rock, Arkansas, United States, 72205 Less <<
NCT02349152 - Completed - -
NCT01127997 - Completed - Korea, Republic of ... More >> St. Vincent's hospital Suwon, Kyounggi-do, Korea, Republic of, 442-723 Less <<
NCT02606838 - Completed - -
NCT01982019 Diabetes Obes... More >>ity Less << Not Applicable Recruiting December 2018 France ... More >> University Hospital Rouen Recruiting Rouen, Haute Normandie, France, 76000 Principal Investigator: Gaëtan Prevost, MD          Sub-Investigator: Antoine Gancel, MD          Sub-Investigator: Anne F Cailleux, MD          Sub-Investigator: Michel Scotte, Pr Less <<
NCT00394407 Diabetes Hype... More >>rglycemia Less << Phase 4 Completed - United States, Florida ... More >> University of Miami School of Medicine Coral Gables, Florida, United States, 33124 Less <<
NCT03760640 Type1 Diabetes Mellitus Phase 2 Not yet recruiting August 14, 2019 United States, Georgia ... More >> Atlanta Diabetes Associates Not yet recruiting Atlanta, Georgia, United States, 30318 Principal Investigator: Bruce W Bode Less <<
NCT01834144 Type 1 Diabetes Not Applicable Terminated(Funding for the stu... More >>dy was not renewed) Less << - Canada, Alberta ... More >> University of Calgary Calgary, Alberta, Canada, T2N 1N4 University of Alberta Edmonton, Alberta, Canada, T6G 2R3 Canada, Manitoba Manitoba Institute of Child Health WInnipeg, Manitoba, Canada, R3E 3P4 Canada, Ontario McMaster University Hamilton, Ontario, Canada, L8S 4L8 University of Ottawa Ottawa, Ontario, Canada, K1N 6N5 Less <<
NCT01834144 - Terminated(Funding for the stu... More >>dy was not renewed) Less << - -
NCT01159353 Type 2 Diabetes Mellitus Phase 1 Completed - France ... More >> Sanofi-Aventis Administrative Office Paris, France Less <<
NCT03083145 Obesity Not Applicable Completed - United States, Arkansas ... More >> University of Arkansas Fayetteville, Arkansas, United States, 72704 Less <<
NCT02025920 - Active, not recruiting June 2019 Norway ... More >> University of Bergen Bergen, Norway Less <<
NCT01945099 Type 1 Diabetes Early Phase 1 Completed - United States, Connecticut ... More >> Yale University School of Medicine New Haven, Connecticut, United States, 06520 Less <<
NCT02535715 Type 1 Diabetes Phase 2 Completed - United States, Texas ... More >> The University of Texas Health Science Center at San Antonio San Antonio, Texas, United States, 78229 Less <<
NCT00395746 - Completed - -
NCT02295852 Hypertension ... More >>Body Weight Less << Not Applicable Unknown July 2016 Italy ... More >> Hypertention Outpatient Clinic Dept. of Clinica Medica; Federico 2nd University of Naples Recruiting Naples, Italy, 80131 Contact: Aldo L Ferrara, MD    +390817462302    ferrara@unina.it    Contact: Delia Pacioni, Dietician    +390817463688    pacioni@unina.it    Sub-Investigator: Valentina Di Fronzo, MD          Sub-Investigator: Barbara Russo, MD          Sub-Investigator: Viviana Carlino, MD          Sub-Investigator: Francesco Gargiulo, MD          Sub-Investigator: Enza Speranza, Nutritionist Less <<
NCT00014781 - Completed - United States, Texas ... More >> Southwest Medical Center at Dallas Dallas, Texas, United States, 75390 Less <<
NCT02181127 - Completed - -
NCT02181127 Type 1 Diabetes Not Applicable Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT01972724 Type II Diabetes Mellitus Phase 4 Completed - Korea, Republic of ... More >> Chagwon, Korea, Republic of Daegu, Korea, Republic of Daejeon, Korea, Republic of Gwangju, Korea, Republic of Gyeonggi-do, Korea, Republic of Jeonju, Korea, Republic of Seoul, Korea, Republic of Ulsan, Korea, Republic of Wonju, Korea, Republic of Less <<
NCT00395746 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - Japan ... More >> Novo Nordisk Investigational Site Tokyo, Japan, 1000005 Less <<
NCT01027325 Healthy Cardi... More >>ovascular Disease Atherogenic Dyslipidemia Insulin Resistance Less << Not Applicable Completed - United States, California ... More >> Cholesterol Research Center Berkeley, California, United States, 94705 Children's Hospital Oakland Research Institute Oakland, California, United States, 94609 Less <<
NCT01480843 Diabetes Phase 4 Completed - United States, Massachusetts ... More >> Joslin Diabetes Center Boston, Massachusetts, United States, 02215 Less <<
NCT01972724 - Completed - -
NCT00518882 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT01480843 - Completed - -
NCT01130480 Diabetes Mellitus Type 2 Not Applicable Completed - China ... More >> Beijing, China, 100020 Beijing, China, 100034 Beijing, China, 100044 Beijing, China, 100730 Chengdu, China, 610041 Guangzhou, China, 510080 Guangzhou, China, 510120 Guangzhou, China, 510515 Hangzhou, China, 310003 Nanjing, China, 210008 Nanjing, China, 210029 Shanghai, China, 2000092 Shanghai, China, 200040 Shanghai, China, 200120 Shanghai, China, 200433 Shenyang, China, 110001 Tianjin, China, 300070 Wuhan, China, 430030 Xian, China, 710061 Less <<
NCT01103921 Metabolic Syndrome ... More >> Insulin Resistance Dyslipidemia Less << Not Applicable Completed - United States, California ... More >> Clinical Research Center Sacramento, California, United States, 95655 Less <<
NCT01610778 Type 2 Diabetes on Medication Not Applicable Completed - Japan ... More >> Hiroshima University Hiroshima, Japan, 7320814 Less <<
NCT01599182 - Completed - Canada, Ontario ... More >> University of Waterloo Waterloo, Ontario, Canada, N2L 3G1 Less <<
NCT01559779 - Completed - Denmark ... More >> Dpt. of Endocrinology (215) at Hvidovre Hospital Hvidovre, Copenhagen, Denmark, 2650 Less <<
NCT00518882 - Completed - -
NCT02932423 Overweight and Obesity Not Applicable Completed - France ... More >> Eurofins Optimed Gieres, Auvergne-Rhône-Alpes, France, 38610 Less <<
NCT00946426 - Withdrawn(PI left institution) - United States, Ohio ... More >> Nationwide Children's Hospital Columbus, Ohio, United States, 43205 Less <<
NCT01651117 Type 2 Diabetes Mellitus Not Applicable Completed - United States, Pennsylvania ... More >> Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT02485327 Type 1 Diabetes Mellitus Phase 1 Completed - Germany ... More >> Investigational Site Number 276001 Mainz, Germany, 55116 Less <<
NCT01492062 Type 1 Diabetes Mellitus Not Applicable Withdrawn(Study halted prior t... More >>o enrollment of first participant.) Less << - United States, California ... More >> CTRU located in Blake Wilbur Stanford, California, United States, 94305 Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT01242293 Labor Stage, First ... More >> Labor Stage, Second Less << Not Applicable Completed - Israel ... More >> Dep OB/GYN, HaEmek Medical Center Afula, Israel Less <<
NCT01527981 Depression Ty... More >>pe 1 Diabetes Less << Phase 2 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT03517085 GSD1 Phase 1 Phase 2 Recruiting September 19, 2020 United States, Connecticut ... More >> UCONN Health Recruiting Farmington, Connecticut, United States, 06030-3213 United States, Michigan Michigan Medicine University of Michigan Recruiting Ann Arbor, Michigan, United States, 48109 United States, Texas UT Health - McGovern Medical School Recruiting Houston, Texas, United States, 77030 Less <<
NCT03278392 Pregnancy Related ... More >> Stress, Psychological Glucose Intolerance During Pregnancy Less << Not Applicable Recruiting December 31, 2018 United States, California ... More >> UCI Medical Center, University of California, Irvine Recruiting Orange, California, United States, 92868 Contact: Karen Lindsay, PhD    714-456-8401    kllindsa@uci.edu Less <<
NCT02673762 - Active, not recruiting February 2019 United States, Texas ... More >> San Antonio Endovascular and Heart Institute San Antonio, Texas, United States, 78258 Less <<
NCT01229059 - Active, not recruiting April 2019 Germany ... More >> German Diabetes Center Duesseldorf, NRW, Germany, 40225 Less <<
NCT02546063 Diabetes Mellitus, Type 1 ... More >> Carbohydrates Less << Not Applicable Completed - Switzerland ... More >> Division of Endocrinology, Diabetes and Clinical Nutrition, Bern University Hospital Bern, Switzerland, 3010 Less <<
NCT01053728 Type 1 Diabetes Mellitus Phase 1 Phase 2 Completed - Germany ... More >> Sanofi-Aventis Administrative Office Berlin, Germany Less <<
NCT02299050 Type 2 Diabetes Phase 4 Completed - United States, Texas ... More >> University of Texas Health Science Center San Antonio, Texas, United States, 78229 Less <<
NCT00656864 Diabetes Mellitus, Type 2 Phase 4 Completed - United States, Vermont ... More >> University of Vermont South Burlington, Vermont, United States, 05403 Less <<
NCT00434772 Hypoglycemia Phase 2 Completed - Israel ... More >> Share Zedek Medical Center Jerusalem, Israel, 91031 Less <<
NCT00425009 Type 2 Diabetes Phase 1 Phase 2 Completed - China ... More >> Department of Endocrinology, Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine Shanghai, China, 200092 Less <<
NCT02610179 Gestational Diabetes Mellitus Not Applicable Recruiting March 2021 United States, Texas ... More >> Ben Taub General Hospital Recruiting Houston, Texas, United States, 77030 Contact: Kjersti Aagaard, MD, PhD    713-798-8467    aagaardt@bcm.edu Less <<
NCT02733211 Type 1 Diabetes Not Applicable Active, not recruiting December 2018 Germany ... More >> Diabetes -Zentrum fuer kinder und jugendliche Hannover, Germany, 30173 Israel Schneider Children's Medical Center Petach-Tikva, Israel, 49202 Less <<
NCT01315366 Hypovitaminosis D ... More >> Insulin Resistance Obesity Osteoporosis Less << Phase 3 Completed - Lebanon ... More >> American University of Beirut Beirut, Lebanon, 11-0236 Less <<
NCT03245645 Irritable Bowel Syndrome With ... More >>Diarrhea Irritable Bowel Syndrome With Mixed Bowel Habits Less << Not Applicable Enrolling by invitation July 24, 2019 United States, California ... More >> UCLA Los Angeles, California, United States, 90095 Less <<
NCT02011100 Metabolic Diseases, Type 2 Dia... More >>betes, Cardiovascular Disease Less << Not Applicable Completed - Slovakia ... More >> Univeristy Hospital in Bratislava Bratislava, Slovakia, 81369 Institute of Experimental Endocrinology Slovak Academy of Sciences Bratislava, Slovakia, 83306 Less <<
NCT01207934 - Completed - -
NCT02290106 Obesity Fatty... More >> Liver, Nonalcoholic Less << Not Applicable Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT02194608 Type 2 Diabetes Mellitus Not Applicable Completed - -
NCT01207934 Type Two Diabetes Mellitus Not Applicable Completed - United States, Missouri ... More >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Less <<
NCT01896414 Metabolic Syndrome Not Applicable Completed - United States, Maryland ... More >> University of Maryland Medical Center Baltimore, Maryland, United States, 21201 United States, Pennsylvania Amish Research Center Lancaster, Pennsylvania, United States, 17601 Less <<
NCT01260272 - Completed - -
NCT00666861 - Terminated(Pilot study superse... More >>ded by a larger NHMRC funded trial) Less << - Australia, Victoria ... More >> Alfred Hospital Melbourne, Victoria, Australia, 3004 Less <<
NCT03336528 Type 2 Diabetes Phase 4 Recruiting December 31, 2019 United States, Georgia ... More >> Grady Hospital Recruiting Atlanta, Georgia, United States, 30308 Contact: Guillermo Umpierrez, MD    404-778-1665    geumpie@emory.edu    Emory University Hospital Clinical Research Network Recruiting Atlanta, Georgia, United States, 30322 Contact: Guillermo Umpierrez, MD    404-778-1665    geumpie@emory.edu    United States, New York Mount Sinai Recruiting New York, New York, United States, 10029 Contact: David W Lam, MD       david.w.lam@mssm.edu    Principal Investigator: David W Lam, MD Less <<
NCT01444651 - Completed - -
NCT01260272 Cardiovascular Risk Factors Not Applicable Completed - United States, Kentucky ... More >> Louisville Metabolic and Atherosclerosis Research Center Louisville, Kentucky, United States, 40213 Less <<
NCT00758810 - Completed - France ... More >> CH de Feurs Feurs, France, 42110 CH de Firminy Firminy, France, 42700 Centre Médical de Chavanne Saint-chamond, France, 42400 CHU de Saint-Etienne Saint-etienne, France, 42000 Less <<
NCT03003806 Type1 Diabetes Mellitus Not Applicable Recruiting June 2019 United States, Colorado ... More >> Barbara Davis Center for Childhood Diabetes Recruiting Aurora, Colorado, United States, 80045-6511 Contact: Robert Slover, Prof          Principal Investigator: Robert Slover, Prof          United States, Connecticut Yale University School of Medicine Recruiting New Haven, Connecticut, United States, 06520-8064 Contact: Stuart Weinzimer, Prof          Principal Investigator: Stuart Weinzimer, Prof          United States, Florida University of Florida College of Medicine Recruiting Gainesville, Florida, United States, 32610 Contact: Desmond Schatz, Prof          Principal Investigator: Desmond Schatz, Prof          United States, Massachusetts Joslin Diabetes Center, One Joslin Place Recruiting Boston, Massachusetts, United States, 02215 Contact: Lori Laffel, Prof          Principal Investigator: Lori Laffel, Prof          Germany Diabetes -Zentrum fuer kinder und jugendliche Not yet recruiting Hannover, Germany Contact: Thomas Danne, MD    +49 511 8115 3330       Principal Investigator: Thomas Danne, MD          Israel Schnider children's medical center Recruiting Petach-Tikva, Israel, 49202 Contact: Moshe Phillip, Professor    972-3-9253778    mosheph@clalit.org.il    Principal Investigator: Moshe Phillip, Prof          Sub-Investigator: Revital Nimri, Dr.          Sub-Investigator: Liat De Vries, Dr.          Sub-Investigator: Liora Lazar, Dr.          Sub-Investigator: Tal Oron, Dr.          Sub-Investigator: Ariel Tenennbaum, Dr.          Sub-Investigator: Shlomit Shalitin, Dr.          Sub-Investigator: Alon Farfel, Dr          Sub-Investigator: Judit Nir, Dr          Sub-Investigator: Naama Fish, Dr          Sub-Investigator: Sari Karpel, Dr          Slovenia University Children's Hospital Active, not recruiting Ljubljana, Slovenia Less <<
NCT01444651 Cardiovascular Disease ... More >> Insulin Resistance Glucose Intolerance Obesity Less << Phase 3 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States Less <<
NCT03428295 Glucose, Low Blood ... More >> Glucose, High Blood Less << Phase 1 Phase 2 Suspended(Further software dev... More >>elopment is required.) Less << December 31, 2018 United States, Washington ... More >> Dose Safety Redmond, Washington, United States, 98052 Less <<
NCT01945216 - Completed - -
NCT01945216 - Completed - Japan ... More >> Osaka, Japan Less <<
NCT00744224 Glucocorticoid-induced Glucome... More >>tabolic Abnormalities Glucocorticoid-induced Beta-cell Dysfunction Less << Not Applicable Completed - Netherlands ... More >> VU University Medical Center Amsterdam, Noord-Holland, Netherlands, 1081HV Less <<
NCT01681147 Gestational Diabetes Mellitus Not Applicable Active, not recruiting March 2, 2018 United States, Massachusetts ... More >> Joslin Diabetes Center Boston, Massachusetts, United States, 02215 Less <<
NCT00393718 - Completed - -
NCT01375686 - Completed - United States, Colorado ... More >> Radiant Denver Denver, Colorado, United States, 80239 Less <<
NCT00366379 Diabetes Mellitus Type 2 Phase 2 Completed - United States, Arizona ... More >> Chandler, Arizona, United States, 85225 United States, Florida Oviedo, Florida, United States, 32765 United States, Idaho Nampa, Idaho, United States, 83687 United States, Indiana Evansville, Indiana, United States, 47714 United States, Montana Butte, Montana, United States, 59701 United States, Ohio Canton, Ohio, United States, 44718 United States, Oregon Portland, Oregon, United States, 97239 United States, South Carolina Greer, South Carolina, United States, 29651 United States, Texas Midland, Texas, United States, 79707 United States, Virginia Richmond, Virginia, United States, 23249 Estonia Tallinn, Estonia, 10138 Tartu, Estonia, 50406 Tartu, Estonia, 50708 Tartu, Estonia, 51014 Latvia Jelgava, Latvia, 3001 Riga, Latvia, 1002 Riga, Latvia, 1038 Mexico Chihuahua, Mexico, 31238 Guadalajara, Mexico, 44340 Guadalajara, Mexico, 44650 Pachuca, Mexico, 42086 Less <<
NCT00393718 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - Japan ... More >> Novo Nordisk Investigational Site Tokyo, Japan, 1000005 Less <<
NCT03624803 - Not yet recruiting May 31, 2019 -
NCT03234387 - Not yet recruiting September 2018 -
NCT02289612 Type 2 Diabetes Mellitus Not Applicable Completed - Canada, Ontario ... More >> Human Nutraceutical Research Unit Guelph, Ontario, Canada, N1G 2W1 Less <<
NCT00582309 Hyperglycemia Not Applicable Completed - United States, Illinois ... More >> St. James Hospital and Health Centers Chicago Heights, Illinois, United States, 60411 United States, New Mexico Presbyterian Hospital Albuquerque, New Mexico, United States, 87106 University of New Mexico Hospital Albuquerque, New Mexico, United States, 87131 Less <<
NCT00582309 - Completed - -
NCT00524550 Healthy Not Applicable Completed - Netherlands ... More >> TNO Quality of Life Zeist, Utrecht, Netherlands, 3700AJ Less <<
NCT01463878 Subarachnoid Hemorrhage ... More >> Intracranial Hemorrhage Ischemic Strokes Subdural Hematoma Less << Phase 4 Terminated(Unlikely to show st... More >>atistical significance and slow recruitment.) Less << - United States, Virginia ... More >> Sentara Norfolk General Hospital Norfolk, Virginia, United States, 23507 Less <<
NCT01463878 - Terminated(Unlikely to show st... More >>atistical significance and slow recruitment.) Less << - -
NCT02754375 Depression Not Applicable Recruiting May 2019 France ... More >> CHU de Nice Recruiting Nice, France, 06000 Contact: Vanina OLIVERI, Project manager    0033 4 92 03 42 54    oliveri.v@chu-nice.fr    Principal Investigator: Michel BENOIT, PU-PH          Monaco Hôpital Princesse Grace Recruiting Monaco, Monaco, 98000 Contact: Nicolas Rijo, ARC          Principal Investigator: David SZEKELY, PH Less <<
NCT01296412 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT02902198 Obesity Not Applicable Recruiting July 2019 Switzerland ... More >> University Hopital Basel Recruiting Basel, Switzerland Contact: Bettina Wölnerhanssen, Dr       bettina.woelnerhanssen@usb.ch Less <<
NCT01296412 - Completed - -
NCT00483925 - Unknown - Greece ... More >> Division of Endocrinology, Department of Pathophysiology, Laiko University Hospital, Recruiting Athens, Greece, 11527 Contact: Gregory Kaltsas, MD, FRCP          Principal Investigator: Krystallenia I Alexandraki, MD, MSc, PhD Less <<
NCT00950209 Type 2 Diabetes Not Applicable Completed - France ... More >> Assistance Publique-Hopitaux de Marseille Marseille, France Less <<
NCT02066948 Body Composition, Beneficial ... More >> Paresis Impaired Glucose Tolerance Less << Not Applicable Completed - United States, Indiana ... More >> Purdue University West Lafayette, Indiana, United States, 47907 Less <<
NCT00370305 Metabolic Syndrome ... More >> Impaired Glucose Tolerance Less << Phase 2 Completed - Germany ... More >> Charite, Campus Benjamin Franklin Berlin, Germany, 12200 Less <<
NCT02133729 Gestational Diabetes Not Applicable Completed - France ... More >> Hospices Civils de Lyon - Hôpital Femme-Mère-Enfant - Service de gynécologie obstétrique Bron, France, 69677 CHU Clermont-Ferrand - Hôpital Gabriel Montpied - Service d'endocrinologie Clermont-ferrand, France, 63003 Centre Hospitalier de Givors - Hôpital de Montgelas - Service de médicine 8 Givors, France, 69700 CHU Grenoble - Clinique d'Endocrinologie Diabétologie Nutrition Grenoble, France, 38000 Hospices Civils de Lyon - Groupement Hospitalier Sud - Service d'Endocrinologie, Diabète, Nutrition Pierre Benite, France, 69495 CHU Saint Etienne - Hôpital Nord - Service d'endocrinologie, diabètes, nutrition Saint Etienne, France, 42055 Groupement Hospitalier des Portes du Sud - Service d'Endocrinologie Diabétologie Nutrition Venissieux, France, 69200 Less <<
NCT01435707 Low Back Pain Not Applicable Completed - Korea, Republic of ... More >> Samsung Medical Center Seoul, Korea, Republic of, 135-710 Less <<
NCT00717912 - Completed - -
NCT01271231 Diabetes Ging... More >>ivitis Periodontitis Less << Not Applicable Completed - Colombia ... More >> Universidad de Antioquia, School of dentistry Medellin, Antioquia, Colombia Less <<
NCT01917136 Pulmonary Hypertension Phase 2 Active, not recruiting December 2018 United States, Pennsylvania ... More >> University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00717912 Healthy Volunteers Not Applicable Completed - France ... More >> Biofortis Nantes, France, 44200 Less <<
NCT02688218 Type 1 Diabetes Not Applicable Active, not recruiting September 2018 United States, Oregon ... More >> Oregon Health and Science University Portland, Oregon, United States, 97239 Less <<
NCT01353469 Type 2 Diabetes Mellitus Phase 3 Completed - China ... More >> Investigational Site Number 156024 Beijing, China, 100088 Investigational Site Number 156010 Beijing, China, 100730 Investigational Site Number 156001 Beijing, China, 100853 Investigational Site Number 156033 Changchun, China, 130011 Investigational Site Number 156017 Changchun, China, 130041 Investigational Site Number 156005 Changsha, China, 410008 Investigational Site Number 156021 Chengdu, China, 610072 Investigational Site Number 156006 Chongqing, China, 400016 Investigational Site Number 156032 Hangzhou, China, 310013 Investigational Site Number 156007 Harbin, China, 150001 Investigational Site Number 156020 Hefei, China, 230001 Investigational Site Number 156016 Nanjing, China, 210006 Investigational Site Number 156018 Nanjing, China, 210011 Investigational Site Number 156002 Shanghai, China, 200003 Investigational Site Number 156023 Shanghai, China, 200040 Investigational Site Number 156031 Shanghai, China, 200062 Investigational Site Number 156004 Shanghai, China, 200065 Investigational Site Number 156027 Shenyang, China, 110022 Investigational Site Number 156029 Suzhou, China, 215004 Investigational Site Number 156025 Tianjin, China, 300052 Investigational Site Number 156003 Wuhan, China, 430022 Investigational Site Number 156008 Xi'An, China, 710032 Investigational Site Number 156009 Xi'An, China, 710061 Less <<
NCT00288717 Hypertension Not Applicable Unknown - Japan ... More >> Saitama Medical School Department of Renal Medicine Recruiting Saitama City, Saitama, Japan, 350-0495 Contact: Hidetomo Nakamoto, MD    +81-492-76-1258    nakamo_h@saitama-med.ac.jp    Principal Investigator: Hidetomo Nakamoto, MD Less <<
NCT02094534 - Completed - -
NCT02176681 Haemodialyzed, Type 2 Diabetes Phase 4 Completed - France ... More >> CH d'Amiens Amiens, France, 80054 CH de Besançon Besancon, France, 25030 AURAL Colmar Colmar, France, 68000 Hospices civils de Colmar Colmar, France, 68024 CH de Dijon Dijon, France, 21079 AURAL Mulhouse Mulhouse, France, 68070 CH de Mulhouse Mulhouse, France, 68070 CH de Nancy Nancy, France, 54000 AURAL Clinique Sainte Anne Strasbourg, France, 67000 Clinique Sainte Anne Strasbourg, France, 67000 Hôpitaux Universitaires de Strasbourg Strasbourg, France, 67091 AURAL Strasbourg Strasbourg, France, 67200 CH de Valenciennes Valenciennes, France, 59300 Less <<
NCT00566124 Diabetes Phase 4 Completed - Denmark ... More >> Medical department M (Endocrinology and Diabetes), Aarhus University Hospital Aarhus, DK, Denmark, 8000 Less <<
NCT00988182 Diabetes Prevention ... More >> Obesity Prevention Less << Not Applicable Completed - Canada, Ontario ... More >> University of Toronto, Department of Nutritional Sciences Toronto, Ontario, Canada, M5S 3E2 Less <<
NCT02094534 Diabetes Mellitus Type 1 Phase 2 Completed - United States, California ... More >> Orange County Research Center Tustin, California, United States, 92780 Less <<
NCT00683735 Diabetes Phase 2 Phase 3 Completed - Germany ... More >> Diabeteszentrum Bad Lauterberg Bad Lauterberg, Germany, 37431 Less <<
NCT00804297 Hypoglycemia ... More >>Diabetes Mellitus Less << Phase 3 Completed - United States, Pennsylvania ... More >> Albert Einstein Medical Center Philadelphia, Pennsylvania, United States, 19141 Less <<
NCT02980952 Assessing Muscle Amino Acid Ba... More >>lance Less << Not Applicable Completed - -
NCT00740727 - Completed - -
NCT00398853 Type 2 Diabetes Phase 4 Completed - United States, Louisiana ... More >> Pennington Biomedical Research Center Baton Rouge, Louisiana, United States, 70808 Less <<
NCT01877889 Healthy Phase 1 Completed - Germany ... More >> Neuss, Germany Less <<
NCT01352767 Type 1 Diabetes Mellitus With ... More >>Diabetic Neuralgia Less << Phase 4 Completed - Germany ... More >> Bad Mergentheim Bad Mergentheim, Germany Less <<
NCT00740727 Disaster Medicine ... More >> Difficult Intravenous Access Dehydration Less << Phase 1 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT03463629 Type 2 Diabetes Not Applicable Completed - United States, Texas ... More >> The University of Texas Health Science Center at Houston Houston, Texas, United States, 77030 Less <<
NCT00728143 Type 2 Diabetes Not Applicable Completed - -
NCT00837590 Pre-diabetes ... More >>Obesity Less << Not Applicable Completed - United States, Indiana ... More >> Indiana Clinical Research Center Indianapolis, Indiana, United States, 46202 Less <<
NCT01079364 Diabetes Mellitus, Type 2 Phase 4 Terminated(Slow recruitment) - Netherlands ... More >> Sanofi-Aventis Administrative Office Gouda, Netherlands Less <<
NCT03255902 Diabetes Mellitus, Type 1 Not Applicable Completed - -
NCT01880827 Type 2 Diabetes ... More >> Obesity Less << Phase 1 Unknown January 2016 Finland ... More >> Turku univercity hospital, PET center Recruiting Turku, Finland, 20540 Contact: Jukka P Koffert, MD, PhD student    +35823130000    jukka.koffert@tyks.fi    Sub-Investigator: Jukka P Koffert, MD,PhDstudent Less <<
NCT01994135 Hyperglycaemia Not Applicable Completed - United Kingdom ... More >> School of Food Science and Nutrition Leeds, West Yorkshire, United Kingdom, LS2 9JT Less <<
NCT01497249 Nutritional Intervention Not Applicable Active, not recruiting September 1, 2019 United States, Illinois ... More >> Clinical Nutrition Research Center Chicago, Illinois, United States, 60616 Less <<
NCT00515632 Diabetes Mellitus, Type 2 Phase 3 Completed - Denmark ... More >> Multi-center Copenhagen, Denmark Less <<
NCT02842359 Type 2 Diabetes Mellitus Phase 4 Completed - Korea, Republic of ... More >> Korea Seoul, Korea, Republic of Less <<
NCT03354286 Type 1 Diabetes Mellitus Not Applicable Enrolling by invitation September 30, 2018 United States, California ... More >> Stanford University School of Medicine Palo Alto, California, United States, 94304 Less <<
NCT00941382 Obesity Phase 3 Unknown September 2009 Mexico ... More >> Centro Universitario de Ciencias de la Salud Guadalajara, Jalisco, Mexico, 44340 Less <<
NCT01906359 Type 2 Diabetes Mellitus Not Applicable Completed - Malaysia ... More >> Malaysian Palm Oil Board (MPOB) Kajang, Selangor, Malaysia, 43000 Hulu Langat District Health Office Kajang, Selangor, Malaysia, 43100 Sepang District Health Office Sepang, Selangor, Malaysia, 43900 Universiti Putra Malaysia Serdang, Selangor, Malaysia, 43400 Selangor State Health Office Shah Alam, Selangor, Malaysia, 40100 Less <<
NCT00475345 Type 1 Diabetes Mellitus Not Applicable Completed - Canada, Quebec ... More >> Royal Victoria Hospital Montreal, Quebec, Canada, H3A-1A1 Less <<
NCT01762046 Diabetes Mellitus, Type 2 Phase 1 Active, not recruiting October 2017 United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Brigham and Women's Hospital Boston, Massachusetts, United States, 02116 Joslin Diabetes Center Boston, Massachusetts, United States, 02116 Less <<
NCT01937598 Type 2 Diabetes Phase 3 Completed - Germany ... More >> Diabeteszentrum Bad Lauterberg Bad Lauterberg, Germany, 37431 Less <<
NCT02333851 Type 2 Diabetes Mellitus Phase 4 Terminated(Safety reasons) - -
NCT01937598 - Completed - -
NCT02735889 Glycemic Response ... More >> Gastric Emptying Satiety Less << Not Applicable Completed - Singapore ... More >> Clinical Nutrition Research Centre Singapore, Singapore, 117599 Less <<
NCT02163044 - Recruiting June 2018 Greece ... More >> Onassion Cardiology Hospital Recruiting Athens, Greece Contact: Genovefa Kolovou, MD Less <<
NCT03711084 Obesity Not Applicable Active, not recruiting December 15, 2018 United Kingdom ... More >> University of Manchester Manchester, United Kingdom, M13 9PL Less <<
NCT01322477 - Unknown - Israel ... More >> Hadassah Hebrew University Medical Center Not yet recruiting Jerusalem, Israel Contact: Marina Orevi, MD    0508946211    marinaor@hadassah.org.il    Contact: Roland Chisin, MD       chisin@hadassah.org.il Less <<
NCT01115088 Obesity Type ... More >>2 Diabetes Less << Not Applicable Completed - United States, Louisiana ... More >> Pennington Biomedical Research Center Baton Rouge, Louisiana, United States, 70808 Less <<
NCT01698112 PreDiabetes Not Applicable Completed - United States, Colorado ... More >> University of Colorado Colorado Springs Colorado Springs, Colorado, United States, 80918 United States, Montana University of Montana Missoula, Montana, United States, 59812 Less <<
NCT01582243 - Completed - -
NCT01582243 Diabetes Mellitus, Type 2 Phase 4 Completed - Taiwan ... More >> Novartis Investigative Site Changhua, Taiwan, 500 Less <<
NCT01363622 - Unknown July 2011 Turkey ... More >> Zekai Tahir Burak Maternity Teaching Hospital Recruiting Ankara, Turkey, 06600 Contact: Ahmet Akcay, MD       ahmet1906ak@windowslive.com Less <<
NCT01872533 Insulin Resistance Early Phase 1 Completed - United States, Louisiana ... More >> Pennington Biomedical Research Center Baton Rouge, Louisiana, United States, 70808 Less <<
NCT02987738 Type1diabetes Phase 1 Completed - Germany ... More >> Kinder - und Jugendkrankenhaus AUF DER BULT Hannover, Germany, 30173 Less <<
NCT00776035 - Active, not recruiting February 2019 United States, Missouri ... More >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Less <<
NCT02553213 Bariatric Surgery Candidate Not Applicable Recruiting July 2019 Germany ... More >> University of Hohenheim Recruiting Stuttgart, Germany Contact: Anna Schweinlin    +4971145924880+4970712986584    anna.schweinlin@uni-hohenheim.de Less <<
NCT00888836 Type 2 Diabetes Phase 2 Phase 3 Completed - Italy ... More >> Catholic University, Faculty of Medicine Rome, Italy, 00168 Less <<
NCT01262326 Non-Alcoholic Fatty Liver Dise... More >>ase Less << Not Applicable Completed - United States, Texas ... More >> UT Southwestern Medical Center Dallas, Texas, United States, 75022 Less <<
NCT03026218 Gestational Diabetes Not Applicable Enrolling by invitation August 2020 United States, Maryland ... More >> University of Maryland, Baltimore Baltimore, Maryland, United States, 21201 Less <<
NCT01677936 Diabetes Mellitus Phase 4 Completed - United States, Kentucky ... More >> L-MARC Research Center Louisville, Kentucky, United States, 40213 Less <<
NCT01677936 - Completed - -
NCT00972452 Type 2 Diabetes ... More >> Insulin Resistance Less << Not Applicable Completed - United States, Kansas ... More >> University of Kansas Medical Center Kansas City, Kansas, United States, 66160 Less <<
NCT02036619 - Completed - Belgium ... More >> OLV Aalst Aalst, Belgium, 9300 UZA Antwerpen, Belgium, 2560 OLV Aalst-site Asse Asse, Belgium, 1730 Imelda Bonheiden Bonheiden, Belgium, 2820 AZ St Jan Brugge, Belgium, 8000 Kliniek St Jan Brussel Brussel, Belgium, 1000 UZ Leuven Leuven, Belgium, 3000 Less <<
NCT02162004 Type 1 Diabetes Not Applicable Terminated(Technical problems) - Denmark ... More >> Hvidovre University Hospital Hvidovre, Denmark, 2650 Less <<
NCT01099176 Hyperlipidemia ... More >> Impaired Fasting Glycemia Less << Not Applicable Completed - Poland ... More >> Department of Pharmacology Katowice, Śląskie, Poland, 40-762 Less <<
NCT01600950 Diabetes Mellitus, Type 1 Phase 1 Completed - Germany ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Neuss, Germany, 41460 Less <<
NCT01600950 - Completed - -
NCT00953966 Glucose Metabolism ... More >> Endocrine Metabolism Satiety Less << Not Applicable Unknown December 2009 Germany ... More >> Charité, Dept. of Endocrinology, Diabetes and Nutrition Recruiting Berlin, Germany, 12200 Contact: Joachim Spranger, MD    0049308445 ext 2114    joachim.spranger@charite.de Less <<
NCT00953602 Glucose Metabolism ... More >> Hormonal Changes Satiety Less << Not Applicable Unknown December 2009 Germany ... More >> Charité, Dpt. of Endocrinology, Diabetes and Nutrition Recruiting Berlin, Germany, 12200 Contact: Joachim Spranger, MD    0049308445 ext 2114    joachim.spranger@charite.de Less <<
NCT01444534 Type 1 Diabetes Not Applicable Completed - Netherlands ... More >> Isala Clinics Zwolle, Netherlands, 8025 AB Less <<
NCT00461331 Type 1 Diabetes Mellitus Phase 4 Completed - United States, Louisiana ... More >> General Clinical Research Center New Orleans, Louisiana, United States, 70112 Less <<
NCT02864212 - Unknown December 2018 Mexico ... More >> Unidad de Investigación Médica en Enfermedades Metabólicas IMSS Recruiting Mexico, Mexico City, Mexico, 06720 Contact: Ana Gallardo, Dr.    +525556276900 ext 22154    pancreasartificial@gmail.com Less <<
NCT00461331 - Completed - -
NCT03195062 Test Meal Not Applicable Completed - Switzerland ... More >> University of Lausanne Lausanne, Switzerland, 1005 Less <<
NCT02441842 Perioperative Hypertension Phase 4 Completed - -
NCT03227874 Healthy Individual Not Applicable Completed - United States, California ... More >> San Diego State Univeristy San Diego, California, United States, 92182 Less <<
NCT00789945 Type 1 Diabetes Not Applicable Completed - United States, New Mexico ... More >> University of New Mexico, Health Sciences Center Albuquerque, New Mexico, United States, 87131 Less <<
NCT02763020 Blood Sugar Response Not Applicable Completed - United States, Massachusetts ... More >> USARIEM Natick, Massachusetts, United States, 01760 Less <<
NCT02487537 Diabetes Pre-... More >>diabetes Less << Not Applicable Unknown December 2016 Germany ... More >> German Institut for Human Nutrition; Department for Clinical Nutrition Recruiting Nuthetal, Brandenburg, Germany, 14458 Contact: Margrit Kemper, Dr. med.    033200 88 2775    margrit.kemper@dife.de    Sub-Investigator: Margrit Kemper, Dr. med. Less <<
NCT00574340 - Completed - -
NCT01637675 Pulmonary Hypertension ... More >> Pulmonary Arterial Hypertension Cardiovascular Diseases Lung Diseases Tanshinone IIA Sulfonate Less << Phase 2 Phase 3 Unknown December 2014 China, Guangdong ... More >> The First Affiliated Hospital of Guangzhou Medical University Recruiting Guangzhou, Guangdong, China, 510120 Contact: Jian Wang, MD    +8615013388183    jwang31@jhmi.edu Less <<
NCT02101229 Type 1 Diabetes Phase 2 Phase 3 Completed - France ... More >> Centre Hospitalier du Sud Francillien Evry, France, 91058 University Hospital of Grenoble Grenoble, France, 38043 University Hospital of Montpellier Montpellier, France, 34295 Less <<
NCT03297931 Obesity Diabe... More >>tes Less << Not Applicable Active, not recruiting May 30, 2019 Canada, Ontario ... More >> University of Toronto Toronto, Ontario, Canada, M5S 3E2 Less <<
NCT00207298 Brain Neoplasms ... More >> Lung Neoplasms Lymphoma Melanoma Colorectal Neoplasms Less << Phase 3 Unknown - Canada, British Columbia ... More >> BCCA, Vancouver Centre Recruiting Vancouver, British Columbia, Canada, V5Z 4E6 Contact: Don C Wilson, MD    604-707-5979    dowilson@bccancer.bc.ca Less <<
NCT00574340 Type 2 Diabetes Early Phase 1 Completed - United States, Maryland ... More >> University of Maryland, Baltimore Baltimore, Maryland, United States, 21201 Less <<
NCT01469065 Diabetes Mellitus, Type 2 Phase 1 Completed - United States, California ... More >> Pfizer Investigational Site Chula Vista, California, United States, 91911 United States, Florida Pfizer Investigational Site Miami, Florida, United States, 33169 Japan Pfizer Investigational Site Hachioji-shi, Tokyo, Japan Less <<
NCT01668082 Brain Mass Not Applicable Recruiting February 2022 United States, Texas ... More >> University of Texas Southwestern Recruiting Dallas, Texas, United States, 75390 Contact: Elizabeth Maher, MD, PhD    214-648-7097    elizabeth.maher@utsouthwestern.edu    Sub-Investigator: Craig Malloy, MD          Sub-Investigator: Changho Choi, PhD          Sub-Investigator: Bruce Mickey, MD          Sub-Investigator: Christopher Madden, MD          Sub-Investigator: Robert Bachoo, MD, PhD          Sub-Investigator: Ralph Deberardinis, MD, PhD          Sub-Investigator: Juan Pascual, MD, PhD          Sub-Investigator: Kimmo Hatanpaa, MD, PhD          Sub-Investigator: Jack Raisanen, MD          Sub-Investigator: Daniel Bowers, MD          Sub-Investigator: Laura Klesse, MD, PhD          Sub-Investigator: Bradley Weprin, MD          Sub-Investigator: Kevin Courtney, MD, PhD          Sub-Investigator: Patrick Leavey, MD Less <<
NCT01469065 - Completed - -
NCT01131052 - Completed - -
NCT03491514 Glycemic Response ... More >> Insulinemic Response Subjectvie Hunger Less << Not Applicable Completed - Canada ... More >> Glycemic Index Laboratories Toronto, Canada Less <<
NCT03529396 Vivax Malaria ... More >> G6PD Deficiency Less << Phase 2 Recruiting December 2019 Brazil ... More >> Fundação de Medicina Tropical Doutor Heitor Vieira Dourado Recruiting Manaus, Amazonas, Brazil, 69040-000 Contact: Wuelton M Monteiro, PhD    +55 (92) 2127 3498    wueltonmm@gmail.com Less <<
NCT03493022 Glycemic Response ... More >> Insulinemic Response Subject Hunger Response Less << Not Applicable Completed - Canada ... More >> Glycemic Index Laboratories Toronto, Canada Less <<
NCT02663960 Critical Illness ... More >> Kidney Replacement Disorder Coagulation; Intravascular Less << Phase 4 Unknown February 2016 China, Beijing ... More >> MICU of Peking Union Medical College Hospital Recruiting Beijing, Beijing, China, 100730 Contact: Bin Du, prof.    8610-69155036    dubin@gmail.com    Principal Investigator: Bin Du, prof. Less <<
NCT01131052 Diabetes Hype... More >>rglycemia Less << Phase 4 Completed - United States, Georgia ... More >> Guillermo Umpierrez Atlanta, Georgia, United States, 30303 Less <<
NCT02768818 Gestational Diabetes Mellitus ... More >>in Pregnancy, Diet- Controlled Exercise Addiction High-Risk Pregnancy Dietary Modification Less << Phase 3 Unknown - Italy ... More >> Mother-Infant Department, University of Modena and Reggio Emilia, Italy Recruiting Modena, Italy, 41124 Contact: Fabio Fachhinetti, MD    0039 0594222512    facchi@unimore.it    Sub-Investigator: Elisabetta Petrella, MD          Sub-Investigator: Valeria Tamborrino, MD Less <<
NCT02757443 Cardiac Surgical Procedures ... More >> Heart Valve Prosthesis Implantation Less << Phase 3 Recruiting October 2018 Russian Federation ... More >> Evgeny Fominskiy Recruiting Novosibirsk, Russian Federation, 630055 Contact: Evgeny V. Fominskiy, MD PhD    +79139538754    evfominskiy@gmail.com    Principal Investigator: Vladimir V. Lomivorotov, Prof          Sub-Investigator: Marat Abubakirov, MD          Sub-Investigator: Petr P. Perovsky, MD          Sub-Investigator: Gleb B. Moroz, MD          Sub-Investigator: Valeriy A. Nepomniashchikh, MD PhD          Principal Investigator: Evgeny V. Fominskiy, MD PhD Less <<
NCT00789295 Postprandial Lipemia ... More >> Type 2 Diabetes Less << Not Applicable Completed - Italy ... More >> Department of Clinical and Experimental Medicine, Federico II University Hospital, Naples, Italy, 80100 Less <<
NCT01935362 Blood Pressure ... More >> Endothelial Dysfunction Cardiovascular Disease Risk Reduction Less << Phase 1 Phase 2 Completed - United Kingdom ... More >> School Of Food Science and Nutrition, University Of Leeds Leeds, West Yorkshire, United Kingdom, LS2 9JT Less <<
NCT00407134 Peritoneal Dialysis Not Applicable Completed - Belgium ... More >> University Hospital Ghent Ghent, Belgium, 9000 Less <<
NCT01178476 Type 1 Diabetes Not Applicable Withdrawn March 2011 Denmark ... More >> Hillerød Sygehus Hillerød, Denmark, 3400 Less <<
NCT03569501 Gestational Diabetes Mellitus ... More >>in Pregnancy Less << Not Applicable Recruiting March 1, 2019 China, Shanghai ... More >> Xinhua Hospital Affliated to Shanghai Jiao Tong University School of Medicine; Recruiting Shanghai, Shanghai, China, 200052 Contact: Wenjuan Wang, Master    18621823005 Less <<
NCT00609895 Diabetes Mellitus Phase 4 Completed - Mexico ... More >> Sanofi-Aventis Monterrey, Mexico Less <<
NCT02778269 Diabetes Hypo... More >>glycaemia Chronic Kidney Disease Less << Not Applicable Completed - Germany ... More >> Medizinische Klinik I Aachen, North Rhine Westphalia, Germany, 52074 Less <<
NCT00614120 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT03410277 Diabetes Mellitus, Type 1 Not Applicable Recruiting December 2023 United States, Minnesota ... More >> University of Minnesota Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Elizabeth R Seaquist, MD    612-624-9176    studydiabetes@umn.edu    Principal Investigator: Elizabeth R Seaquist, MD          Sub-Investigator: Gulin Oz, PhD Less <<
NCT00614120 - Completed - -
NCT03049839 Prediabetic State Not Applicable Not yet recruiting October 2019 Colombia ... More >> Universidad Del Norte Not yet recruiting Barranquilla, Colombia Contact: tania Acosta, MD, MPH          Principal Investigator: Tania Acosta, MD, MPH          Sub-Investigator: Edgar Navarro, MD, MSC          Sub-Investigator: Jorge Acosta, MD, MSC          Sub-Investigator: Rafael Tuesca, MD, PhD, MPH          Sub-Investigator: Sandra Rodriguez, PhD          Sub-Investigator: Jesus Arroyabe, PhD          Sub-Investigator: Karen Florez, PhD          Sub-Investigator: Sara Caro, MSC          Sub-Investigator: Mariela Borda, MSC          Asociación Colombiana de Diabetes Not yet recruiting Bogota, Colombia Contact: Pablo Aschner, MD          Principal Investigator: Pablo Aschner, MD          Sub-Investigator: Dilcia Lujan          Sub-Investigator: Margot Latino          Sub-Investigator: Liliana Carvajal          Sub-Investigator: Patricia Barrera          Sub-Investigator: Maria Ronderos Less <<
NCT01234649 Gestational Diabetes Mellitus ... More >> Type 2 Diabetes Mellitus Metabolic Syndrome Impaired Glucose Tolerance Disorder of Glucose Regulation Less << Phase 3 Active, not recruiting August 2019 United States, Louisiana ... More >> Woman's Hospital Baton Rouge, Louisiana, United States, 70815 Less <<
NCT02801448 Diabetes Mellitus, Non-Insulin... More >>-Dependent Less << Phase 2 Active, not recruiting June 2018 -
NCT03165643 - Completed - -
NCT02122874 Diabetes Mellitus Type 2 in Ob... More >>ese Type 2 Diabetes Mellitus With Features of Insulin Resistance Less << Phase 3 Completed - Spain ... More >> General Hospital Elche Elche, Alicante, Spain, 03203 Less <<
NCT00922402 Acute Heart Failure Not Applicable Withdrawn - Italy ... More >> Garibaldi Nesima Hospital Catania, Italy Policlinico S. Matteo Pavia, Italy Less <<
NCT02031497 Glucose Homeostasis Not Applicable Completed - France ... More >> Unit of Clinical Investigation,Centre Hospitalo-Universitaire de Rennes Rennes, France, 35033 Rennes Cedex 9 Less <<
NCT01512797 - Completed - -
NCT03748810 - Recruiting December 31, 2018 Korea, Republic of ... More >> Chungbuk National University Hospital Recruiting Cheonju, Chungcheongbuk-do, Korea, Republic of, 28644 Contact: Eu Jeong Ku, MD    82-10-3462-8863    eujeong.ku@gmail.com Less <<
NCT00846144 Hyperglycemia ... More >> Diabetes Less << Not Applicable Unknown December 2010 Israel ... More >> Diabetes Unit, Hadassah Medical Organization Jerusalem, Israel, 91120 Less <<
NCT03480503 - Not yet recruiting December 2019 -
NCT01512797 Type 2 Diabetes Mellitus Not Applicable Completed - United States, New York ... More >> New York Obesity Nutrition Research Center, Columbia University New York, New York, United States, 10032 Less <<
NCT01027507 - Completed - Sweden ... More >> Departments of Medicine, Malmö University Hospital Malmö, Sweden, 205 02 Less <<
NCT01565941 - Completed - -
NCT01613196 Extrapulmonary Tuberculosis ... More >> Lymph Node Tuberculosis Bone Tuberculosis Less << Not Applicable Completed - France ... More >> BICHAT Claude Bernard Paris, France, 75018 Less <<
NCT03740698 Diabetes Mellitus, Type 1 Not Applicable Recruiting July 2019 United Kingdom ... More >> Imperial College Clinical Research Facility Recruiting London, United Kingdom Contact: Nick Oliver, FRCP    0207 594 2460    nick.oliver@imperial.ac.uk    Principal Investigator: Nick Oliver Less <<
NCT00593307 Glycemic Response ... More >> Hunger Less << Not Applicable Completed - United States, Pennsylvania ... More >> Temple University - Center for Obesity Research and Education Philadelphia, Pennsylvania, United States, 19140 Less <<
NCT01565941 Heart Failure ... More >> Respiratory Failure Less << Phase 3 Completed - -
NCT01653210 - Completed - United States, Virginia ... More >> University of Virginia Center for Diabetes Technology Charlottesville, Virginia, United States, 22904 Less <<
NCT03348020 Glucose Intolerance ... More >> Insulin Resistance Iron Metabolism Less << Not Applicable Recruiting January 30, 2025 United States, Michigan ... More >> Michigan Clincal Research Unit Recruiting Ann Arbor, Michigan, United States, 48109 Contact: Suzette Howton, RDN    734-647-9850    suzetter@med.umich.edu    Principal Investigator: Jeffrey F Horowitz, PhD Less <<
NCT02016846 Glucocorticoid Induced Hypergl... More >>ycemia Less << Phase 3 Unknown - Israel ... More >> Rabin Medical Center, Beilinson Campus Not yet recruiting Petah Tiqva, Israel Contact: Amit Tirosh, MD       tiroshamit@gmail.com Less <<
NCT02097680 Obesity Phase 4 Unknown September 2015 Belgium ... More >> Ghent University Hospital Recruiting Ghent, Belgium, 9000 Sub-Investigator: Yves Van Nieuwenhove, MD, PhD          Principal Investigator: Johannes Ruige, MD, PhD          Sub-Investigator: Peter Smeets, MD          Sub-Investigator: Tine De Backer, MD, PhD          Sub-Investigator: Marlies Bekaert Less <<
NCT01845324 - Unknown June 2014 Israel ... More >> Hillel Yaffe Medical Center Not yet recruiting Hadera, Israel, 38100 Contact: Alon Shrim, MD    +972-4-6188224    alon.shrim@gmail.com Less <<
NCT02112721 Type 2 Diabetes Mellitus Phase 4 Completed - Australia, Victoria ... More >> Monash Centre for Health Research and Implementation Melbourne, Victoria, Australia, 3168 Less <<
NCT01372137 Anemia Chroni... More >>c Diseases Inflammation Less << Phase 1 Completed - United Kingdom ... More >> HMR London, United Kingdom, NW10 7EW Less <<
NCT01443143 Type 2 Diabetes ... More >> Obesity Less << Not Applicable Unknown December 2011 United States, Pennsylvania ... More >> University of Pennsylvania Center for Weight and Eating Disorders Recruiting Philadelphia, Pennsylvania, United States, 190104 Contact: Dana Tioxon    215-573-7520    tida@mail.med.upenn.edu    Contact: Louise Hesson, CRNP    215-898-7314    lhesson@mail.med.upenn.edu    Principal Investigator: Thomas A Wadden, Ph.D.          Sub-Investigator: Marion L Vetter, MD Less <<
NCT00267683 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Terminated(This trial was term... More >>inated due to low recruitment) Less << - -
NCT02556918 Hyperglycemia Phase 4 Recruiting March 2019 United States, Georgia ... More >> Grady Health System Recruiting Atlanta, Georgia, United States, 30303 Contact: Guillermo Umpierrez, MD    404-778-1665    geumpie@emory.edu    Emory Univeristy Hospital Midtown Not yet recruiting Atlanta, Georgia, United States, 30308 Contact: Guillermo Umpierrez, MD    404-778-1665    geumpie@emory.edu    Emory University Hospital Recruiting Atlanta, Georgia, United States, 30322 Contact: Guillermo Umpierrez, MD    404-778-1665 Less <<
NCT01114542 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 1 Completed - Germany ... More >> Novo Nordisk Investigational Site Neuss, Germany, 41460 Less <<
NCT01075984 Fungal Infection Phase 1 Completed - -
NCT02025933 - Terminated(We were unable to r... More >>ecruit a sufficient number of participants) Less << - Norway ... More >> University of Bergen Bergen, Norway, 5021 Less <<
NCT01030575 Infant, Newborn ... More >> Infant, Low Birth Weight Infant, Small for Gestational Age Infant, Premature Retinopathy of Prematurity Bronchopulmonary Dysplasia (BPD) Less << Phase 2 Completed - United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35233 United States, California Stanford University Palo Alto, California, United States, 94304 United States, Connecticut Yale University New Haven, Connecticut, United States, 06504 United States, Georgia Emory University Atlanta, Georgia, United States, 30303 United States, Indiana Indiana University Indianapolis, Indiana, United States, 46202 United States, Iowa University of Iowa Iowa City, Iowa, United States, 52242 United States, Massachusetts Tufts Medical Center Boston, Massachusetts, United States, 02111 United States, Michigan Wayne State University Detroit, Michigan, United States, 48201 United States, New Mexico University of New Mexico Albuquerque, New Mexico, United States, 87131 United States, New York University of Rochester Rochester, New York, United States, 14642 United States, North Carolina RTI International Durham, North Carolina, United States, 27705 Duke University Durham, North Carolina, United States, 27710 United States, Ohio Case Western Reserve University, Rainbow Babies and Children's Hospital Cleveland, Ohio, United States, 44106 United States, Rhode Island Brown University, Women & Infants Hospital of Rhode Island Providence, Rhode Island, United States, 02905 United States, Texas University of Texas Southwestern Medical Center at Dallas Dallas, Texas, United States, 75235 University of Texas Health Science Center at Houston Houston, Texas, United States, 77030 United States, Utah University of Utah Salt Lake City, Utah, United States, 84108 Less <<
NCT03545581 Hereditary Fructose Intoleranc... More >>e Less << Not Applicable Recruiting April 1, 2019 Belgium ... More >> Guillaume Debray Recruiting Liège, Belgium Contact: Guillaume F Debray, MD    +3242249057    fg.debray@chu.ulg.ac.be Less <<
NCT00761540 Diabetes Heal... More >>thy Less << Phase 1 Completed - China, Beijing ... More >> Novo Nordisk Investigational Site Beijing, Beijing, China, 100032 Less <<
NCT01230632 Metabolic Syndrome ... More >> Diabetes Less << Not Applicable Completed - Australia, South Australia ... More >> Leonie Heilbronn Adelaide, South Australia, Australia, 5000 Less <<
NCT01781910 Exercise-induced Delayed Onset... More >> Muscle Soreness Less << Not Applicable Completed - United States, Vermont ... More >> University of Vermont Burlington, Vermont, United States, 05405 Less <<
NCT01075984 - Completed - -
NCT03543644 Healthy Overw... More >>eight and Obesity Metabolic Syndrome PreDiabetes Diabetes Overweight Obesity Dysglycemia Cardiovascular Diseases Cardiovascular Risk Factor Hypertension Less << Not Applicable Recruiting November 2020 Canada, Ontario ... More >> St Michael's Hospital Recruiting Toronto, Ontario, Canada, M5C2T2 Contact: Maxine Seider, MSc, RD    4168677460 ext 8216    seiderm@smh.ca    Principal Investigator: John Sievenpiper, MD, PhD, FRCPC Less <<
NCT01831154 Diabetes Hype... More >>rglycemia Surgical Site Infection Less << Not Applicable Completed - United States, Florida ... More >> James A. Haley VAH Tampa, Florida, United States, 33612 Less <<
NCT02485132 - Terminated(Patients correspond... More >>ing to the inclusion/exclusion criteria not found.) Less << - Canada, Ontario ... More >> University of Toronto Toronto, Ontario, Canada, M5C2T2 Canada, Quebec Institut de recherches cliniques de Montréal Montreal, Quebec, Canada, H2W1R7 Less <<
NCT02180620 Type 2 Diabetes Not Applicable Completed - -
NCT00937755 - Completed - Taiwan ... More >> Taipei Medical University-Municipal Wan-Fang Hospital Taipei, Taiwan, 116 Less <<
NCT01831154 - Completed - -
NCT02568501 Diabetes Type... More >> 1 Diabetes Less << Phase 3 Completed - United States, Pennsylvania ... More >> University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT02971631 Gastric Cancer ... More >> Dumping Syndrome Less << Not Applicable Enrolling by invitation December 2018 United Kingdom ... More >> Cambridge University Hospitals NHS Foundation Trust Cambridge, Cambridgeshire, United Kingdom, CB2 0QQ Less <<
NCT01808846 - Completed - United States, Connecticut ... More >> Yale University New Haven, Connecticut, United States, 06510 Less <<
NCT00584077 - Completed - United States, Texas ... More >> University of Texas Medical Branch Galveston, Texas, United States, 77555 Less <<
NCT00584077 - Completed - -
NCT00412815 Coronary Artery Disease ... More >> Glucose Intolerance Less << Phase 3 Completed - Canada, Ontario ... More >> Hamilton Health Sciences Centre Hamilton, Ontario, Canada, L8L2X2 Less <<
NCT03040414 Type 1 Diabetes Mellitus Not Applicable Not yet recruiting June 29, 2020 United States, Connecticut ... More >> Yale University New Haven, Connecticut, United States, 06510 United States, Florida University of Florida Not yet recruiting Gainesville, Florida, United States, 32611 Contact: Desmond Schatz, MD          Principal Investigator: Desmond Schatz, MD          United States, Massachusetts Joslin Diabetes Center Not yet recruiting Boston, Massachusetts, United States, 02215 Contact: Lori Laffel, MD          Principal Investigator: Lori Laffel, MD          United States, Minnesota International Diabetes Center Not yet recruiting Saint Louis Park, Minnesota, United States, 55416 Contact: Richard Bergenstal, MD          Principal Investigator: Amy Criego, MD          Principal Investigator: Anders Carlson, MD          Germany Hannover Medical School Not yet recruiting Hannover, Germany, 30173 Contact: Thomas Danne, MD          Principal Investigator: Thomas Danne, MD          Israel Schneider Children's Medical Center of Israel Not yet recruiting Petah Tikva, Israel, 4920235 Contact: Moshe Philip, MD          Principal Investigator: Revital Nimri, MD          Slovenia University of Ljubljana Not yet recruiting Ljubljana, Slovenia Contact: Tadej Battelino, MD          Principal Investigator: Tadej Battelino, MD Less <<
NCT03013296 Glucose Metabolism Disorders Not Applicable Completed - Denmark ... More >> Center for Diabetes Research Copenhagen, Gentofte, Denmark, 2900 Less <<
NCT03388697 - Recruiting December 15, 2019 United States, Texas ... More >> Ashley Salazar Recruiting Galveston, Texas, United States, 77555 Contact: Antonio Saad, MD    409-772-0982    afsaad@utmb.edu    Contact: Ashley Salazar    140927720312    assalaza@utmb.edu    Principal Investigator: Antonio Saad, MD          Sub-Investigator: George Saade, MD Less <<
NCT01298518 - Completed - -
NCT02323048 Substance Abuse Not Applicable Completed - -
NCT03624985 Pain, Postoperative ... More >> Opioid Use Less << Phase 4 Recruiting June 9, 2020 United States, Vermont ... More >> University of Vermont Medical Center Recruiting Burlington, Vermont, United States, 05401 Contact: Alexander Friend, MS    802-847-4259    alexander.friend@uvmhealth.org    Principal Investigator: Timothy Dominick, MD          Principal Investigator: David Lunardini, MD Less <<
NCT01298518 Type 2 Diabetes Patients Phase 1 Completed - United States, California ... More >> Pfizer Investigational Site Chula Vista, California, United States, 91911 United States, Florida Pfizer Investigational Site DeLand, Florida, United States, 32720 Pfizer Investigational Site Miami Gardens, Florida, United States, 33169 Less <<
NCT00830297 Hyperglycemia Phase 2 Completed - Austria ... More >> Medical University of Vienna, Department of Internal Medicine III Vienna, Austria, 1090 Less <<
NCT02129946 Type 2 Diabetes Mellitus Not Applicable Completed - Canada, Ontario ... More >> Human Nutraceutical Research Unit Guelph, Ontario, Canada, N1G 2W1 Less <<
NCT02323048 - Completed - -
NCT01759823 Type 2 Diabetes Mellitus Phase 2 Phase 3 Completed - India ... More >> Postgraduate Institute of Medical Education and Research Chandigarh, UT, India, 160012 Less <<
NCT00704314 Hypercholesterolemia ... More >> Diabetes Cardiovascular Disease Less << Not Applicable Completed - Austria ... More >> Medical University of Vienna Vienna, Austria, A-1090 Less <<
NCT02034513 - Completed - -
NCT00511719 Type 2 Diabetes Mellitus Phase 2 Completed - -
NCT01029327 - Completed - Sweden ... More >> Department of Medicine, Malmö University Hospital Malmö, Sweden, 205 02 Less <<
NCT03623113 Type1diabetes ... More >> Type1 Diabetes Mellitus Glucose Metabolism Disorders Less << Not Applicable Recruiting October 31, 2021 Denmark ... More >> Steno Diabetes Center Copenhagen Recruiting Gentofte, Denmark, DK-2820 Contact: Bettina Ewers, MSc    0045 30912997    bettina.ewers@regionh.dk Less <<
NCT01072331 - Completed - -
NCT01072331 Type 2 Diabetes Mellitus Phase 3 Completed - Japan ... More >> Suita, Osaka, Japan Less <<
NCT02034513 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 3 Completed - -
NCT02197520 Diabetes Mellitus, Type 2 Phase 1 Completed - United States, California ... More >> Profil Institute for Clinical Research Inc Chula Vista, California, United States, 91911 Less <<
NCT01261494 Type II Diabetes Mellitus Phase 2 Completed - Bosnia and Herzegovina ... More >> Site n°12 Banja Luka, Bosnia and Herzegovina, 78000 Site n°11 Sarajevo, Bosnia and Herzegovina, 71000 Latvia Site n°22 Riga, Latvia, LV 1002 Site n°21 Riga, Latvia, LV 1004 Site n°23 Valmiera, Latvia, LV4201 Macedonia, The Former Yugoslav Republic of Site n°33 Bitola, Macedonia, The Former Yugoslav Republic of, 7000 Site n°31 Skopje, Macedonia, The Former Yugoslav Republic of, 1000 Site n°32 Skopje, Macedonia, The Former Yugoslav Republic of, 1000 Moldova, Republic of Site n°41 Balti, Moldova, Republic of, 3112 Site n°42 Chisinau, Moldova, Republic of, 2025 Site n°43 Chisinau, Moldova, Republic of, 2068 Romania Site n°72 Oradea, Bihor County, Romania, 410167 Site n°66 Buzau, Buzau County, Romania, 120203 Site n°64 Cluj Napoca, Cluj County, Romania, 400006 Site n°65 Baia Mare, Maramures County, Romania, 430123 Site n°63 Targu Mures, Mures County, Romania, 540098 Site n°62 Targu Mures, Mures County, Romania, 540142 Site n°71 Ploiesti, Prahova County, Romania, 100163 Site n°70 Ploiesti, Prahova County, Romania, 100342 Site n°61 Sibiu, Sibiu County, Romania, 550245 Site n°67 Bucharest, Romania, 020045 Site n°69 Bucharest, Romania, 020045 Site n°68 Bucharest, Romania, 020475 Serbia Site n°52 Belgrade, Serbia, 11000 Site n°53 Belgrade, Serbia, 11000 Site n°56 Belgrade, Serbia, 11000 Site n°54 Kragujevac, Serbia, 34000 Site n°51 Nis, Serbia, 18000 Less <<
NCT02197520 - Completed - -
NCT02678208 Postpartum Hemorrhage Phase 2 Completed - Egypt ... More >> Assiut university Assiut, Egypt, 71111 Less <<
NCT02531750 - Completed - Denmark ... More >> Copenhagen University Hospital Hvidovre Hvidovre, Denmark, 2650 Less <<
NCT02684929 Type 2 Diabetes Mellitus With ... More >>Features of Insulin Resistance Less << Not Applicable Completed - Czech Republic ... More >> Centre fo Research on Diabetes, Metabolism and Nutrition, 3rd Faculty of Medicine, Charles University Prague 10, Czech Republic, 100 00 Less <<
NCT01179360 - Completed - Belgium ... More >> Antwerp University Hospital Edegem, Antwerp, Belgium, 2650 AZ Turnhout Turnhout, Antwerp, Belgium, 2300 Netherlands Academisch Ziekenhuis Vrije Universiteit Amsterdam Amsterdam, Netherlands, 1081HV Less <<
NCT00881972 Insulin Resistance Not Applicable Completed - United States, Missouri ... More >> University of Missouri-Columbia Columbia, Missouri, United States, 65201 Less <<
NCT02432976 Quality of Life Phase 2 Phase 3 Unknown - France ... More >> Post operative intensive care unit of the cardiac surgery department Recruiting Besançon, France, 25030 Contact: Guillaume Besch, MD       gbesch@chu-besancon.fr Less <<
NCT02678390 Prediabetic State Not Applicable Completed - Canada, Quebec ... More >> Research Centre on Aging - CSSS-IUGS - CIUSSS de l'Estrie - CHUS Sherbrooke, Quebec, Canada, J1H 4C4 Less <<
NCT02885961 Idiopathic Pulmonary Fibrosis ... More >> IPF Interstitial Lung Disease Less << Not Applicable Unknown - -
NCT00673465 Type 2 Diabetes Mellitus Phase 1 Completed - -
NCT01065298 - Completed - India ... More >> Post Graduate Institute of Medical Education and Research Chandigarh, Chandigarh UT, India Less <<
NCT03310359 Metabolic Syndrome X Phase 1 Recruiting April 2018 United States, California ... More >> Altman Clinical and Translational Research Institute (ACTRI) Recruiting San Diego, California, United States, 92037 Contact: Adrienne Armstrong, BA    858-646-2884    a3armstrong@ucsd.edu    Sub-Investigator: Sunder Mudaliar, MD          Sub-Investigator: Jeremy Pettus, MD Less <<
NCT00673465 - Completed - -
NCT01234155 Diabetes Mellitus, Type 2 Not Applicable Completed - Denmark ... More >> Rigshospitalet Copenhagen, Denmark, 2100 Less <<
NCT00427154 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Terminated(See termination rea... More >>son in detailed description) Less << - -
NCT01023581 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT01023581 - Completed - -
NCT03227575 Metabolic Syndrome ... More >> Obesity Less << Not Applicable Recruiting July 1, 2018 United States, New Hampshire ... More >> Draper & Maynard Recruiting Plymouth, New Hampshire, United States, 03264 Contact: Michael S Brian, PhD    603-535-3108    msbrian@plymouth.edu    Plymouth State University Not yet recruiting Plymouth, New Hampshire, United States, 03264 Contact: Andrew Ines    603-535-3233    agines@plymouth.edu    Principal Investigator: Michael Brian, PhD Less <<
NCT00443599 Heart Defects, Congenital ... More >> Hyperglycemia Less << Not Applicable Completed - United States, Massachusetts ... More >> Children's Hospital Boston Boston, Massachusetts, United States, 02115 United States, Michigan C.S. Mott Children's Hospital Ann Arbor, Michigan, United States, 48109 Less <<
NCT02556840 Maturity-Onset Diabetes of the... More >> Young Less << Not Applicable Recruiting October 2020 France ... More >> La Pitié Salpêtrière Hospital Recruiting Paris, France, 75651 Contact: Cécile CIANGURA, MD    +33 1 42 17 80 51    cecile.ciangura@aphp.fr    Contact: José TIMSIT, MD, PhD    +33 1 58 41 24 41    jose.timsit@aphp.fr Less <<
NCT00443599 - Completed - -
NCT02667340 Effect of Superstarch on Socce... More >>r Performance Less << Not Applicable Unknown August 2017 -
NCT03688711 Hypoglycemia ... More >>Diabetes Mellitus, Type 1 Less << Phase 3 Recruiting April 18, 2019 United States, California ... More >> ProSciento, Inc. Recruiting Chula Vista, California, United States, 91911 Contact: Julie Willard, MD          AMCR Institute Recruiting Escondido, California, United States, 92025 Contact: Tim Bailey, MD          United States, Washington Rainier Clinical Research, Inc. Recruiting Renton, Washington, United States, 98057 Contact: Leslie Klaff, MD, PhD Less <<
NCT02182895 Diabetes Mellitus Phase 4 Completed - United States, Massachusetts ... More >> Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Less <<
NCT01329744 HIV Lipodystrophy Phase 1 Terminated - United States, Texas ... More >> University of Texas Southwestern Medical Center Dallas, Texas, United States, 75390 Less <<
NCT01468987 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT03738982 Type1 Diabetes Mellitus Not Applicable Recruiting May 10, 2019 United Kingdom ... More >> Imperial College Clinical Research Facility Recruiting London, United Kingdom Contact: Nick Oliver, FRCP    0207 594 2460    nick.oliver@imperial.ac.uk    Principal Investigator: Nick Oliver Less <<
NCT00411892 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Terminated(See termination rea... More >>son in detailed description) Less << - -
NCT03416127 Diabetes Mellitus, Type 2 Phase 2 Not yet recruiting May 1, 2019 Mexico ... More >> Intstituto de Terapeútica Experimental y Clínica. Centro Universitario de Ciencias de la Salud. Universidad de Guadalajara Not yet recruiting Guadalajara, Jalisco, Mexico, 44340 Contact: MANUEL GONZALEZ, PhD    +523310585200 ext 34212    uiec@prodigy.net.mx    Contact: KARINA PEREZ RUBIO, PhD    +523310585200 ext 34212    karina2410@hotmail.com Less <<
NCT03130699 Diabetes Mellitus, Type 2 Not Applicable Recruiting August 2021 United States, California ... More >> Scripps Mercy Chula Vista Recruiting Chula Vista, California, United States, 91910 Contact: Athena Philis-Tsimikas, MD       philis-tsimikas.athena@scrippshealth.org    Contact: Addie Fortmann, PhD       fortmann.addie@scrippshealth.org    Scripps Whittier Diabetes Institute Recruiting La Jolla, California, United States, 92037 Contact: Athena Philis-Tsimikas, MD    858-678-7046    Philis-Tsimikas.Athena@scrippshealth.org    Contact: Addie Fortmann, Ph.D.    (858) 678-7097    fortmann.adelaide@scrippshealth.org    Principal Investigator: Athena Philis-Tsimikas, MD          Sub-Investigator: Addie Fortmann, Ph.D. Less <<
NCT02182895 - Completed - -
NCT03449251 Cardiovascular Diseases ... More >> Type 2 Diabetes Mellitus Less << Phase 2 Recruiting February 2020 United Kingdom ... More >> Addenbrooke's Hospital Recruiting Cambridge, Cambridgeshire, United Kingdom, CB20QQ Contact: Joseph Cheriyan, MBChB, FRCP    01223 926590    jc403@medschl.cam.ac.uk    Principal Investigator: Joseph Cheriyan, MBChB, FRCP Less <<
NCT03315780 Type 2 Diabetes Phase 4 Completed - Japan ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fukuoka, Japan, 812-0025 Less <<
NCT02863276 Diabetes Mellitus Type 2 ... More >> Insulin Resistance Less << Not Applicable Completed - -
NCT03378635 Hypoglycemia ... More >>Diabetes Mellitus, Type 1 Less << Phase 3 Completed - United States, California ... More >> ProSciento Chula Vista, California, United States, 91911 Austria Clinical Research Center, Medizinische Universität Graz Graz, Austria Canada LMC Diabetes & Manna Research Toronto, Canada Germany Profil Mainz, Germany Profil Neuss, Germany Less <<
NCT03224806 Glycemic Response Not Applicable Completed - Canada, Ontario ... More >> Glycemic Index Laboratories, Inc. Toronto, Ontario, Canada, M5C 2X3 Less <<
NCT00657761 HIV Infections Phase 4 Completed - Spain ... More >> Hospital Clinic Barcelona, Spain, 08036 Less <<
NCT03511521 Hyperglycemia Steroid-induced ... More >> Insulin Resistance, Diabetes Less << Phase 4 Recruiting December 31, 2020 United States, Illinois ... More >> Northwestern University Feinberg School of Medicine Recruiting Chicago, Illinois, United States, 60611 Contact: Smita Kumar, MD    312-695-1535    smita.kumar@northwestern.edu    Sub-Investigator: Smita Kumar, MD          Sub-Investigator: Kathleen Schmidt, APRN          Sub-Investigator: Tiffany Grant, APRN          Sub-Investigator: Erica Tayaban, APRN          Sub-Investigator: Diana Johnson Oakes, APRN          Sub-Investigator: Amisha Wallia, MD Less <<
NCT00447239 the Maintenance of Normoglycem... More >>ia the Incidence of Ventilator Associated Pneumonia (VAP) Treatment Period in the Intensive Care Unit Less << Not Applicable Completed - Slovenia ... More >> Clinical Centre Ljubljana Ljubljana, Slovenia, 1000 Less <<
NCT03098654 Human Immunodeficiency Virus ... More >> Diabetes Mellitus, Type 2 Hypertension Less << Not Applicable Recruiting June 30, 2021 Tanzania ... More >> Muhimbili University of Health and Allied Sciences Recruiting Dar Es Salaam, Tanzania Contact: Jessie Mbwambo, MD       jmbwambo@gmail.com Less <<
NCT01468987 - Completed - -
NCT02290860 Diabetes, Gestational Not Applicable Active, not recruiting December 2018 Canada, Quebec ... More >> Centre de recherche clinique du CHUS Sherbrooke, Quebec, Canada, J1H 5N4 Less <<
NCT01967030 - Active, not recruiting September 2023 United States, California ... More >> Kaiser Permanente Northern California, Division of Research Oakland, California, United States, 94612 Less <<
NCT01951729 Pre-diabetes Phase 1 Completed - United States, Missouri ... More >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Less <<
NCT00916357 Diabetes Mellitus, Type 2 Phase 2 Completed - United States, California ... More >> Profil Institute for Clinical Research, Inc. Chula Vista, California, United States, 91911 Less <<
NCT03495284 Type 2 Diabetes Mellitus ... More >> Cardiovascular Diseases Less << Not Applicable Recruiting December 2018 United States, Pennsylvania ... More >> Pennsylvania State University Recruiting University Park, Pennsylvania, United States, 16802 Contact: Kristina S Petersen, PhD    814-863-8622    kup63@psu.edu Less <<
NCT01647542 - Terminated(Due to potential co... More >>ncerns about liver safety (See Detailed Description)) Less << - -
NCT01971047 Type 1 Diabetes ... More >> Type 2 Diabetes Less << Phase 4 Withdrawn September 2018 United States, Georgia ... More >> Emory Healthcare Ambulatory Surgical Center Atlanta, Georgia, United States, 30322 Less <<
NCT02491814 Diabetes Obes... More >>ity Less << Phase 1 Phase 2 Completed - Canada, Ontario ... More >> Department of Nutritional Sciences, FitzGerald Building Toronto, Ontario, Canada, M5S 3E2 Less <<
NCT00916357 - Completed - -
NCT00372814 Diabetes Mellitus, Insulin Dep... More >>endent Less << Not Applicable Completed - United States, Michigan ... More >> Children's Hospital of Michigan Detroit, Michigan, United States, 48201 Less <<
NCT01870141 Type 2 Diabetes ... More >> Psychological Distress Less << Not Applicable Unknown March 2015 Italy ... More >> Division of Endocrinology and Metabolic Diseases Recruiting Verona, Italy, 37126 Contact: Enzo Bonora, MD    00390458123110    enzo.bonora@univr.it    Sub-Investigator: Liliana Indelicato, Psychologist          Sub-Investigator: Carlo Negri, MD Less <<
NCT01647542 Type 2 Diabetes Mellitus Phase 3 Terminated(Due to potential co... More >>ncerns about liver safety (See Detailed Description)) Less << - -
NCT01583270 Metabolic Syndrome Not Applicable Completed - Denmark ... More >> Aarhus University Hospital Aarhus, Denmark, 8000 Less <<
NCT01939782 Type 2 Diabetes Not Applicable Unknown November 2015 Israel ... More >> Daniela Jakubowicz MD Recruiting Holon, N/A = Not Applicable, Israel, 58100 Contact: Daniela Jakubowicz, MD    972508105552    daniela.jak@gmail.com    Contact: Julio Wainstein, MD    972506296940    vainstein@wolfson.health.gov.il Less <<
NCT00874393 Infant, Newborn ... More >> Infant, Low Birth Weight Infant, Small for Gestational Age Infant, Premature Hypotension Blood Pressure Less << Phase 1 Completed - United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35233 United States, California Stanford University Palo Alto, California, United States, 94304 United States, Connecticut Yale University New Haven, Connecticut, United States, 06504 United States, Georgia Emory University Atlanta, Georgia, United States, 30303 United States, Indiana Indiana University Indianapolis, Indiana, United States, 46202 United States, Iowa University of Iowa Iowa City, Iowa, United States, 52242 United States, Massachusetts Tufts Medical Center Boston, Massachusetts, United States, 02111 United States, Michigan Wayne State University Detroit, Michigan, United States, 48201 United States, New Mexico University of New Mexico Albuquerque, New Mexico, United States, 87131 United States, North Carolina RTI International Durham, North Carolina, United States, 27705 Duke University Durham, North Carolina, United States, 27710 United States, Ohio Cincinnati Children's Medical Center Cincinnati, Ohio, United States, 45267 Case Western Reserve University Cleveland, Ohio, United States, 44106 United States, Rhode Island Brown University, Women & Infants Hospital of Rhode Island Providence, Rhode Island, United States, 02905 United States, Texas University of Texas Southwestern Medical Center at Dallas Dallas, Texas, United States, 75235 University of Texas Health Science Center at Houston Houston, Texas, United States, 77030 United States, Utah University of Utah Salt Lake City, Utah, United States, 84108 Less <<
NCT01531283 the Diabetic Process Not Applicable Unknown - United States, Ohio ... More >> Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229 Less <<
NCT02685852 Hyperinsulinemic Hypoglycemia Phase 2 Recruiting November 30, 2018 United States, Minnesota ... More >> University of Minnesota Medical Center Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Jayne Pederson Pederson    612-624-8402    peder059@umn.edu Less <<
NCT03349944 Diabetes Mellitus, Type 2 Not Applicable Recruiting December 2018 Denmark ... More >> August Krogh Building Recruiting Copenhagen, Denmark Contact: Morten Hostrup, PhD    +4524474785    mhostrup@nexs.ku.dk Less <<
NCT02443402 - Completed - -
NCT02733588 Hypoglycemia ... More >>Complications of Bariatric Procedures Less << Phase 2 Completed - United States, Massachusetts ... More >> Joslin Diabetes Center Boston, Massachusetts, United States, 02215 Less <<
NCT02443402 Coronary Artery Disease Phase 4 Completed - United States, Georgia ... More >> Grady Health System Atlanta, Georgia, United States, 30303 Emory University Hospital - Midtown Atlanta, Georgia, United States, 30308 Emory University Hospital Atlanta, Georgia, United States, 30322 Emory Saint Joseph's Hospital Atlanta, Georgia, United States, 30342 Less <<
NCT02733588 - Completed - -
NCT02607007 Diabetes Obes... More >>ity Less << Phase 1 Phase 2 Completed - Canada, Ontario ... More >> Department of Nutritional Sciences, University of Toronto Toronto, Ontario, Canada, M5S 3E2 Less <<
NCT00736229 - Completed - -
NCT00736229 Hyperglycemia ... More >> Acute Coronary Syndromes Myocardial Infarction Less << Phase 4 Completed - United States, Missouri ... More >> Mid America Heart Institute Saint Luke's Health System Kansas City, Missouri, United States, 64111 Less <<
NCT01023646 Diabetes Obes... More >>ity Metabolic Syndrome Cardiovascular Disease Less << Not Applicable Completed - United States, Massachusetts ... More >> Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University Boston, Massachusetts, United States, 02111 Less <<
NCT00916175 Metabolic Syndrome Phase 2 Phase 3 Completed - Mexico ... More >> Fomerrey 19 Community Clinic Guadalupe, Nuevo Leon, Mexico Endocrinology, Outpatient clinic of University Hospital UANL Monterrey, Nuevo Leon, Mexico, 54460 Less <<
NCT01892020 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 4 Completed - China, Beijing ... More >> Beijing, Beijing, China, 100034 Less <<
NCT01766557 Insulin Sensitivity ... More >> Polycystic Ovarian Syndrome Less << Not Applicable Completed - Canada ... More >> Institute Of Nutraceuticals and Functional Foods (INAF), Laval University Quebec, Canada, G1V 0A6 Less <<
NCT01892020 - Completed - -
NCT00962065 Type 2 Diabetes Mellitus Phase 2 Completed - United States, Texas ... More >> Lexicon Investigational Site San Antonio, Texas, United States, 78209 Less <<
NCT00962065 - Completed - -
NCT03357666 Bacterial Vaginosis ... More >> HUDC_VT Haudongchun Less << Phase 2 Recruiting March 30, 2018 Korea, Republic of ... More >> Korea University Guro Hospital Recruiting Seoul, Guro-gu, Korea, Republic of, 08308 Contact: JaeKwan Lee    +82 2-2626-1200    jklee38@korea.ac.kr    Principal Investigator: JaeKwan Lee Less <<
NCT02284334 - Completed - United States, Pennsylvania ... More >> Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT02879955 Overweight Not Applicable Completed - Denmark ... More >> Dept. of Endocrinology Hvidovre, Denmark, 2650 Less <<
NCT00781547 Abdominal Obesity ... More >> Metabolic Syndrome Obesity Less << Phase 3 Completed - Sweden ... More >> Centrum for Endocrinology and Metabolism, Sahlgenska University Hospital Gothenburg, Sweden, 413 45 Less <<
NCT01271062 Diabetes Mellitus, Type 2 ... More >> Bariatric Surgery Candidate Less << Not Applicable Completed - Austria ... More >> Division of Endocrinology and Nuclear Medicine, Department of Internal Medicine, MEdical University of Graz, Austria Graz, Austria, 8036 Switzerland Interdisciplinary Obesity Center, Kantonal Hospital St. Gallen, Switzerland St. Gallen, Switzerland, 9400 Less <<
NCT01178723 Diabetes Mellitus, Type 2 Not Applicable Unknown - Israel ... More >> Diabetes Unit, Wolfson Medical Center Not yet recruiting Holon, Israel, 58100 Diabetes Unit, Wolfson Medical Center Not yet recruiting Holon, Israel, 58100 Contact: Julio Wainstein, M.D    03-5028716    Vainstein@wolfson.health.gov.il Less <<
NCT03495778 Glycemic Insu... More >>linemic Subjective Hunger Responses Less << Not Applicable Completed - Canada ... More >> Glycemic Index Laboratories Toronto, Canada Less <<
NCT02532101 Uncontrolled Insulin-treated T... More >>ype 2 Diabetes Mellitus Less << Not Applicable Terminated(Study was terminate... More >>d due to futility.) Less << - Malaysia ... More >> Seberang Jaya Hospital Seberang Jaya, Penang, Malaysia, 13700 Less <<
NCT02847104 - Completed - -
NCT00567489 ESRD Diabetes... More >> CAPD APD Less << Phase 4 Completed - Hong Kong ... More >> Prince of Wales Hospital Chinese University of Hong Kong Sha Tin, N.t., Hong Kong Alice Ho Miu Ling Nethersole Hospital Tai Po, N.t., Hong Kong Kwong Wah Hospital Kowloon, Hong Kong Korea, Republic of Kyungpook National University Hospital Chung-Gu, Deagu, Korea, Republic of, 700-721 Daegu Fatima Hospital Dong-gu, Deagu, Korea, Republic of, 701-600 Yeungnam University Medical Center Nam-gu, Deagu, Korea, Republic of, 705-717 Seoul National University Hospital Seoul, Korea, Republic of, 110-744 Yonsei University of Medical Center Severance Hospital Seoul, Korea, Republic of, 120-752 Russian Federation Moscow Clinical Hospital # 52 Moscow, Russian Federation Moscow Hospital n a S P Botkin Moscow, Russian Federation Moscow Research n a M F Vladimirsky Moscow, Russian Federation Moscow State Medical Institution: "Municipal Clinical Hospital #7 " Moscow, Russian Federation Samara Hospital n a M I Kalinin Samara, Russian Federation St Petersburg Mariinskaya Hospital St Petersburg, Russian Federation St Petersburg St Elizabeth Hospital St Petersburg, Russian Federation Singapore National University Hospital Singapore, Singapore, 119074 Tan Tock Seng Hospital Singapore, Singapore, 308433 Taiwan China Medical University Hospital Taichung, Taiwan, 404 National Taiwan University Hospital Taipei, Taiwan, 100 Less <<
NCT01944852 Renal Insufficiency Phase 4 Recruiting January 2019 Belgium ... More >> Cliniques Universitaires Saint-Luc Recruiting Brussels, Belgium, 1200 Principal Investigator: Eric Goffin, Professor Less <<
NCT02909803 Hyperglycemia ... More >> Dietary Modification Less << Not Applicable Completed - Canada, Ontario ... More >> Glycemic Index Laboratories, Inc Toronto, Ontario, Canada, M5C 2N8 Less <<
NCT00609154 Type 2 Diabetes Phase 1 Unknown November 2008 United States, New York ... More >> Albert Einstein College of Medicinie Recruiting Bronx, New York, United States, 10461 Contact: Cynthia Rivera, RN    718-430-2446    carivera@aecom.yu.edu    Principal Investigator: Daniel Stein, MD Less <<
NCT01177332 Diabetes Hepa... More >>tic Steatosis Less << Not Applicable Completed - Netherlands ... More >> Department of Human Biology, Maastricht University Maastricht, Netherlands, 6200 MD Less <<
NCT00846391 Type 2 Diabetes Mellitus Phase 2 Terminated(Study was terminate... More >>d due to inability to recruit patients.) Less << - -
NCT02437084 Hyperlipidemia Phase 4 Recruiting December 2019 United States, California ... More >> Stanford University School of Medicine Recruiting Stanford, California, United States, 94305 Less <<
NCT00846391 - Terminated(Study was terminate... More >>d due to inability to recruit patients.) Less << - -
NCT00567398 ESRD Diabetes Phase 3 Completed - Australia, New South Wales ... More >> Royal Prince Alfred Hospital Camperdown, New South Wales, Australia, 2050 Westmead Hospital Sydney, New South Wales, Australia, 2145 Liverpool Hospital Sydney, New South Wales, Australia, 2170 Wollongong Hospital Wollongong, New South Wales, Australia, 2500 Australia, Queensland Princess Alexandra Hospital Wolloongabba, Queensland, Australia, 4102 Australia, South Australia Flinders Medical Centre Adelaide, South Australia, Australia, 5042 Australia, Victoria Monash Medical Centre Clayton, Victoria, Australia, 3168 St. Vincent's Hospital Fitzroy, Victoria, Australia, 3065 Australia Gold Coast Hospital South Port, Australia, 4215 Canada, Manitoba Saint Boniface General Hospital Winnipeg, Manitoba, Canada, R2H 2A6 Canada, New Brunswick Beausejour Hospital Corporation Moncton, New Brunswick, Canada, E1A1J9 Canada, Ontario University Health Network, Toronto General Hospital Toronto, Ontario, Canada, M5G 2C4 Canada, Quebec Montreal General Hospital Montreal, Quebec, Canada, H3G1A4 Royal Victoria Hospital Montreal, Quebec, Canada New Zealand Auckland Hospital Grafton, Auckland, New Zealand Waikato DHB Hamilton, Waikato, New Zealand Less <<
NCT01101204 Diabetes Dysl... More >>ipidemia Inflammation Cytokines Less << Not Applicable Unknown December 2012 Poland ... More >> Department of Clinical Pharmacology Not yet recruiting Katowice, Poland, 40752 Contact: Krzysztof Labuzek, MD, PhD    +48 32 252 39 02    lbuldak@gmail.com    Sub-Investigator: Łukasz Bułdak, MD          Principal Investigator: Bogusław Okopień, MD, PhD          Sub-Investigator: Krzysztof Labuzek, MD, PhD Less <<
NCT00753363 Inflammation ... More >>Insulin Sensitivity Less << Not Applicable Completed - United States, Maryland ... More >> Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD Baltimore, Maryland, United States, 21201 Less <<
NCT00753363 - Completed - -
NCT03646812 Diabetes Not Applicable Recruiting June 2019 Singapore ... More >> Clinical Nutrition Research Centre Recruiting Singapore, Singapore, 117599 Contact: JeyaKumar Christiani Henry, Phd    6407 0793    jeya_henry@sics.a-star.edu.sg    Contact: Winnie Chia, BSc    6407 4049    chia_pei_fen@sics.a-star.edu.sg Less <<
NCT01177709 - Terminated(PI moved to differe... More >>nt institution. Decided to concentrate on different studies.) Less << - -
NCT00965302 Diabetes Mellitus, Type 2 ... More >> Obesity Less << Not Applicable Completed - United States, Texas ... More >> Wilford Hall Medical Center San Antonio, Texas, United States, 78236 Less <<
NCT01177709 Schizophrenia ... More >> Obesity Less << Not Applicable Terminated(PI moved to differe... More >>nt institution. Decided to concentrate on different studies.) Less << - United States, New York ... More >> Manhatan Psychiatric Center New York, New York, United States, 10035 Less <<
NCT01997749 Acute Stroke Phase 1 Completed - Denmark ... More >> Glostrup Hospital Glostrup, Copenhagen, Denmark, 2600 Less <<
NCT02409238 Mild Cognitive Impairment ... More >> Insulin Resistance Diabetes Mellitus, Type 2 Less << Phase 4 Unknown - Singapore ... More >> SingHealth Polyclinics - Marine Parade Polyclinic Recruiting Singapore, Singapore, 440080 Contact: WEE KIEN HAN ANDREW, MCI    (65) 63450049    andrew.wee@singhealth.com.sg    Contact: NG CHIAT ENG    (65)90718977    ng.chiat.eng@singhealth.com.sg Less <<
NCT02240381 Diabetes Mellitus ... More >> Malignant Neoplasm Less << Not Applicable Recruiting December 2020 United States, Tennessee ... More >> Vanderbilt-Ingram Cancer Center Recruiting Nashville, Tennessee, United States, 37232 Contact: VICC Clinical Trials Information Program    800-811-8480       Principal Investigator: Brian G. Engelhardt Less <<
NCT00042458 Diabetes Mellitus, Type 1 Phase 3 Completed - -
NCT01304823 Taste Disorder, Primary, Sweet Phase 1 Completed - Switzerland ... More >> University Hospital Basel, Phase 1 Research Unit Basel, Switzerland, 4031 Less <<
NCT00520182 Diabetes Type 2 Phase 3 Unknown February 2008 Israel ... More >> Clalit HMO Rehovot, Petach Tikva, Ramle, Central region, Israel Less <<
NCT03655535 Type2 Diabetes Mellitus Phase 2 Recruiting August 30, 2019 United States, California ... More >> Coastal Metabolic Research Center, Inc. Recruiting Ventura, California, United States, 93003 Contact: Ronald Chochinov, MD    805-658-8460    rchochinov@yahoo.com    Contact: Sagrario Olmos-Garcia, MD       sagy68@gmail.com    United States, New Mexico Albuquerque Clinical Trials Recruiting Albuquerque, New Mexico, United States, 87102 Contact: Ellen Kim, MD    505-224-7407    ekim@abqct.com    Contact: Jose Atencio       JAtencio@abqct.com    United States, South Carolina Coastal Carolina Research Center Recruiting Mount Pleasant, South Carolina, United States, 29464 Contact: Nathan Morton    843-352-6977    nmorton@coastalcarolinaresearch.com    Contact: Yvonne Davis, MD       ydavis@coastalcarolinaresearch.com    United States, Utah Advanced Research Institute Recruiting Ogden, Utah, United States, 84405 Contact: Jack Wahlen, MD    801-409-2040    jwahlen@advresearch.org    Contact: Jonathan Winkfield, PA-C       jon@advresearch.org Less <<
NCT02885688 Septic Shock Phase 2 Withdrawn - -
NCT02601547 Lymphoma Not Applicable Completed - France ... More >> CHU de Toulouse Toulouse, France, 31000 Less <<
NCT01950039 Obesity Dysgl... More >>ycemia Less << Phase 2 Active, not recruiting June 2018 United States, Massachusetts ... More >> Joslin Diabetes Center and Brigham and Womens Hospital Boston, Massachusetts, United States, 02215 Less <<
NCT01928199 Posttransplant Diabetes Mellit... More >>us Less << Phase 2 Recruiting December 2019 United States, Missouri ... More >> Washington University Recruiting Saint Louis, Missouri, United States, 63110 Contact: Rowena Delos Santos, MD    314-362-4547    delossantos@wustl.edu    Principal Investigator: Rowena Delos Santos, MD          Sub-Investigator: Daniel Brennan, MD          Sub-Investigator: Rebecca Cusanelli, RN, MSN          Sub-Investigator: Timothy Horwedel, PharmD          Sub-Investigator: Jennifer Hagopian, PharmD Less <<
NCT02205983 Healthy Not Applicable Completed - United States, Illinois ... More >> University of Chicago Hospital Chicago, Illinois, United States, 60637 Less <<
NCT02710370 - Enrolling by invitation September 2020 United States, Pennsylvania ... More >> Magee-Womens Hospital of UPMC Pittsburgh, Pennsylvania, United States, 15213 Less <<
NCT03130101 Type 1 Diabetes ... More >> Hypoglycemia Physical Activity Less << Not Applicable Recruiting February 1, 2018 Canada, Ontario ... More >> York University Recruiting Toronto, Ontario, Canada, M3J 1P3 Contact: Michael C Riddell, PhD    416-736-2100 ext 22324    mriddell@yorku.ca    Contact: Dessi P Zaharieva, MSc    416-736-2100 ext 22324    dessi@yorku.ca Less <<
NCT01498367 Diabetes Mellitus, Type 2 Not Applicable Completed - Greece ... More >> Endocrinology and Metabolic Diseases Department - Regional University Hospital of Larisa Larisa, Thessaly, Greece, 41110 Less <<
NCT02771574 Post Bariatric Hypoglycemia Phase 2 Completed - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT02205983 - Completed - -
NCT02701738 Healthy Not Applicable Active, not recruiting January 2022 United States, Michigan ... More >> University of Michigan Ann Arbor, Michigan, United States, 48109 Less <<
NCT01534013 Type 1 Diabetes Mellitus Not Applicable Completed - United Kingdom ... More >> Imperial College London, St Mary's Campus London, United Kingdom, W2 1NY Less <<
NCT02773875 Type 1 Diabetes Not Applicable Unknown December 2016 -
NCT02343380 Diet-induced Thermogenesis Not Applicable Completed - -
NCT00628212 - Completed - -
NCT01035801 Type 1 Diabetes Mellitus Phase 1 Terminated(This study was temp... More >>orarily paused due to an unanticipated bioanalytical issue.) Less << - India ... More >> Care Hospital Hyderabad, Andhra Pradesh, India, 500034 Bharti Research Institute of Diabetes and Endocrinology Karnal, Hariyana, India, 132001 Diacon Hospital,(Diabetes Care and Research Centre) Bangalore, Karnataka, India, 560010 Bangalore Diabetes Hospital Bangalore, Karnataka, India, 560052 Belgaum Diabetic Centre Belgaum, Karnataka, India, 590001 Less <<
NCT00628212 Type 2 Diabetes Phase 2 Completed - Japan ... More >> Takikawa-shi, Hokkaidou, Japan Less <<
NCT01961388 - Withdrawn June 2017 -
NCT00640757 Metabolic Syndrome Phase 2 Completed - -
NCT01294631 Healthy Phase 1 Completed - -
NCT02960659 Type 2 Diabetes Phase 1 Recruiting August 31, 2019 United States, Maryland ... More >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Less <<
NCT03102476 Type1diabetes Not Applicable Completed - United Kingdom ... More >> Hull and East Yorkshire NHS Trust Hull, United Kingdom, HU32RW Less <<
NCT01469104 Type 2 Diabetes Not Applicable Completed - United States, Minnesota ... More >> Minneapolis VA Health Care System Minneapolis, Minnesota, United States, 55417 Less <<
NCT02245659 Pregnancy Sle... More >>ep-disordered Breathing Gestational Diabetes Less << Not Applicable Recruiting March 2019 Canada, Quebec ... More >> McGill University Health Centre Recruiting Montreal, Quebec, Canada, H4A2Y3 Principal Investigator: Sushmita Pamidi, MD Less <<
NCT00851903 Diabetes Mellitus, Type 2 Phase 3 Completed - United States, New Jersey ... More >> Sanofi-Aventis Administrative Office Bridgewater, New Jersey, United States, 08807 Austria Sanofi-Aventis Administrative Office Vienna, Austria Brazil Sanofi-Aventis Administrative Office Sao Paulo, Brazil Colombia Sanofi-Aventis Administrative Office Bogota, Colombia Egypt Sanofi-Aventis Administrative Office Cairo, Egypt Greece Sanofi-Aventis Administrative Office Kallithea, Greece Hong Kong Sanofi-Aventis Administrative Office Hong Kong, Hong Kong India Sanofi-Aventis Administrative Office Mumbai, India Israel Sanofi-Aventis Administrative Office Natanya, Israel Korea, Republic of Sanofi-Aventis Administrative Office Seoul, Korea, Republic of Lebanon Sanofi-Aventis Administrative Office Beirut, Lebanon Mexico Sanofi-Aventis Administrative Office Col. Coyoacan, Mexico Netherlands Sanofi-Aventis Administrative Office Gouda, Netherlands Portugal Sanofi-Aventis Administrative Office Porto Salvo, Portugal Spain Sanofi-Aventis Administrative Office Barcelona, Spain United Kingdom Sanofi-Aventis Administrative Office Guildford Surrey, United Kingdom Less <<
NCT01751360 Diabetes Mellitus Phase 3 Completed - Japan ... More >> Suita-shi, Osaka, Japan Less <<
NCT00851903 - Completed - -
NCT00798590 Critically Ill ... More >> Hypoglycemia Less << Phase 2 Terminated(PI left JHU) - United States, Maryland ... More >> Johns Hopkins Bayview Medical Center Baltimore, Maryland, United States, 21224 Less <<
NCT01729169 - Completed - Denmark ... More >> Aarhus University Hospital Aarhus, Denmark, 8000 Less <<
NCT00798590 - Terminated(PI left JHU) - -
NCT02411682 Type 2 Diabetes Not Applicable Unknown April 2015 -
NCT02623478 Diabetes Mellitus, Type 1 Phase 1 Withdrawn(Change in clinical s... More >>trategy) Less << April 2018 -
NCT03199053 Diabetes Mellitus, Type 2 Phase 3 Recruiting December 20, 2021 -
NCT03150251 Glycemic, Insulinemic, Subject... More >>ive Appetite Responses Less << Not Applicable Completed - Canada ... More >> Glycemic Index Laboratories Toronto, Canada Less <<
NCT00315939 - Completed - -
NCT00537056 Kidney Neoplasms ... More >> Carcinoma, Renal Cell Kidney (Renal Cell) Cancer Less << Not Applicable Completed - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT01719900 Obesity Not Applicable Active, not recruiting December 2018 Canada, Alberta ... More >> University of Calgary Calgary, Alberta, Canada, T2N 1N4 Less <<
NCT03106870 - Completed - -
NCT00315939 Diabetes Mellitus, Type 1 Not Applicable Completed - United States, Virginia ... More >> University of Virginia Charlottesville, Virginia, United States, 22903 Less <<
NCT02538653 Metabolic Disorder; Carbohydra... More >>te, Absorption, Intestine Less << Not Applicable Completed - Australia, New South Wales ... More >> University of Sydney Sydney, New South Wales, Australia, 2006 Less <<
NCT02267005 Juvenile Dermatomyositis Not Applicable Completed - Canada, Ontario ... More >> The Hospital for Sick Children Toronto, Ontario, Canada, M5G 1X8 Less <<
NCT03184064 Postprandial Period Not Applicable Completed - United Kingdom ... More >> Metabolic Research Unit London, England, United Kingdom, SE1 9NH Less <<
NCT01845831 Type 2 Diabetes Phase 4 Completed - United States, Georgia ... More >> Grady Memorial Hospital Atlanta, Georgia, United States, 30303 Emory University Hospital Atlanta, Georgia, United States, 30324 United States, Michigan University of Michigan Ann Arbor, Michigan, United States, 48109 United States, Ohio Ohio State University Columbus, Ohio, United States, 43210 United States, Pennsylvania Temple University Philadelphia, Pennsylvania, United States, 19140 Less <<
NCT00150410 Diabetes Mellitus Phase 3 Completed - -
NCT02615353 Obesity Diabe... More >>tes Less << Early Phase 1 Recruiting December 2021 United States, Arizona ... More >> Arizona State University Recruiting Phoenix, Arizona, United States, 85004 Contact: Allison Williams, MSW    602-496-0147    Allison.nagle@asu.edu    Principal Investigator: Gabriel Q Shaibi, PhD Less <<
NCT01845831 - Completed - -
NCT01515098 Mild Cognitive Decline Phase 2 Completed - United States, North Carolina ... More >> Nutrition Research Institute Kannapolis, North Carolina, United States, 28081 Less <<
NCT03700801 Type 2 Diabetes Mellitus Phase 4 Not yet recruiting March 2019 -
NCT03560323 Heart Failure ... More >> Type 2 Diabetes Mellitus Less << Phase 1 Not yet recruiting December 31, 2022 -
NCT03146286 Insulin Resistance Not Applicable Completed - -
NCT01692327 Obesity Not Applicable Completed - Brazil ... More >> Rio de Janeiro State University Rio de janeiro, Brazil, 20550900 Less <<
NCT03106870 Gestational Diabetes Mellitus ... More >>in Pregnancy Less << Not Applicable Completed - -
NCT01030679 Diabetes Mellitus, Type 2 Phase 2 Completed - Korea, Republic of ... More >> The Inje University Medical Center Busan, Korea, Republic of The Yeungnam University Hospital Daegu, Korea, Republic of The Chtholic University of Korea Uijeongbu St. Mary's Hospital Gyeonggi-do, Korea, Republic of The Seoul National Univertisy Bundang Hospital Gyeonggi-do, Korea, Republic of The Wonju Christian Hospital Kangwon-Do, Korea, Republic of The Inje University Sanggye-Paik Hospital Seoul, Korea, Republic of The Korea University Anam Hospital Seoul, Korea, Republic of The Samsung Medical Center Seoul, Korea, Republic of Less <<
NCT03255629 Post-bariatric Hypoglycemia Phase 1 Phase 2 Completed - United States, Massachusetts ... More >> Joslin Diabetes Center Boston, Massachusetts, United States, 02215 Less <<
NCT01311401 - Unknown - Israel ... More >> Ziv Medical Center Recruiting Safed, Israel, 13110 Contact: Osamah Hussein, MD       osama.h@ziv.health.gov.il    Principal Investigator: Osamah Hussein, MD Less <<
NCT01102881 Healthy Not Applicable Completed - United States, Minnesota ... More >> University of Minnesota St. Paul, Minnesota, United States, 55108 Less <<
NCT00863954 Type II Diabetes Mellitus Phase 1 Completed - United States, Colorado ... More >> pico-tesla Magnetic Therapies Littleton, Colorado, United States, 80120 Less <<
NCT00687960 Hyperglycemia Not Applicable Completed - United States, Kansas ... More >> Kansas State University Manhattan, Kansas, United States, 66506 Less <<
NCT00196989 Diabetes Mellitus, Type 2 Phase 2 Completed - -
NCT01895569 Type 2 Diabetes Mellitus Phase 4 Unknown June 2016 Italy ... More >> IRCCS Policlinico S. Matteo Foundation Recruiting Pavia, Italy, 27100 Contact: Giuseppe Derosa, MD, PhD       giuseppe.derosa@unipv.it    Contact: Pamela Maffioli, MD       pamelamaffioli@hotmail.it    Principal Investigator: Giuseppe Derosa, MD, PhD          Sub-Investigator: Pamela Maffioli, MD Less <<
NCT01268111 - Completed - -
NCT00452296 COPD Hypergly... More >>cemia Less << Not Applicable Unknown December 2012 -
NCT00308451 Diabetes Mellitus, Type 2 Not Applicable Completed - United States, Illinois ... More >> Radiant Research Chicago Chicago, Illinois, United States, 60610 Less <<
NCT01025687 Obesity Prevention Not Applicable Completed - Canada, Ontario ... More >> Department of Nutritional Sciences Toronto, Ontario, Canada Less <<
NCT01268111 Insulin Sensitivity Phase 1 Completed - United States, Texas ... More >> Texas Tech University Health Sciences Center Odessa, Texas, United States, 79763 Less <<
NCT02459834 Type 2 Diabetes Not Applicable Completed - Canada, Ontario ... More >> The Toronto 3D (Diet, Digestive tract and Disease) Knowledge Synthesis and Clinical Trials Unit, Clinical Nutrition and Risk Factor Modification Centre, St. Michael's Hospital Toronto, Ontario, Canada, M5C 2T2 Less <<
NCT00876928 Pre-diabetes Not Applicable Completed - United States, California ... More >> Charles Drew University Los Angeles, California, United States, 90059 Less <<
NCT03556033 Diabetes Mellitus, Type 1 ... More >> Hypoglycemia Hypoglycemia Unawareness Less << Phase 2 Not yet recruiting December 2019 Netherlands ... More >> Radboud university medical center Not yet recruiting Nijmegen, Netherlands, 6500HB Contact: L. van Meijel Less <<
NCT02018302 - - December 2018 United States, Texas ... More >> UT Southwestern Medical Center Dallas, Texas, United States, 75390 Less <<
NCT03021694 Dietary Modification Not Applicable Completed - Canada, Ontario ... More >> Exercise Metabolism Research Laboratory, McMaster Univeristy Hamilton, Ontario, Canada, L8S 4K1 Less <<
NCT02738151 Diabetes Mellitus, Type 2 Phase 4 Completed - -
NCT02738151 - Completed - -
NCT00254085 Type 2 Diabetes Phase 4 Unknown - Denmark ... More >> Gentofte University Hospital Recruiting Hellerup, Denmark, 2900 Contact: Charlotte Gredal, MD    +45 39 77 79 76    chgr@gentoftehosp.kbhamt.dk    Principal Investigator: Charlotte Gredal, MD Less <<
NCT02381119 Diabetes Mellitus, Type 2 Not Applicable Completed - Netherlands ... More >> Diëtistenpraktijk Sylvia van Daalen Arnhem, Gelderland, Netherlands, 6825 AN Netherlands Organisation for Applied Scientific Research (TNO) Zeist, Utrecht, Netherlands, 3704 HE Diëtistenpraktijk Verhoeven & Bac Barendrecht, Zuid-Holland, Netherlands independent practice Willy Gilbert Dordrecht, Zuid-Holland, Netherlands Diëtistenpraktijk Jansen-Sloot Gorinchem, Zuid-Holland, Netherlands Diëtistenpraktijk Care & Cure Hillegom, Zuid-Holland, Netherlands, 2182 CA Diëtistenpraktijk MirjaM - Leefstijl & Dieet Sassenheim, Zuid-Holland, Netherlands, 2172 HC Diëtistenpraktijk Dieetistopsport Zoetermeer, Zuid-Holland, Netherlands, 2717 TK Less <<
NCT01506310 Birth-weight Phase 3 Completed - Italy ... More >> University of Turin Turin, Italy, 10126 Less <<
NCT02418676 Pressure Ulcer ... More >> Wound Less << Phase 1 Phase 2 Completed - -
NCT00597350 - Completed - United States, Louisiana ... More >> Pennington Biomedical Research Center Baton Rouge, Louisiana, United States, 70808 Less <<
NCT00876928 - Completed - -
NCT00929812 Healthy Subjects ... More >> Obesity Diabetes Mellitus, Type 1 Less << Phase 3 Unknown December 2009 Germany ... More >> Charite Campus Benjamin Franklin Berlin, Germany, 12200 Less <<
NCT01414920 Diabetes Mellitus, Type 2 Phase 2 Completed - -
NCT02418676 - Completed - -
NCT02194595 Type 2 Diabetes Phase 3 Recruiting December 2019 Canada, Ontario ... More >> Mount Sinai Hospital Recruiting Toronto, Ontario, Canada, M5G1X5 Contact: Ravi Retnakaran, MD    416-586-4800 ext 3941       Principal Investigator: Ravi Retnakaran, MD Less <<
NCT00942513 Substrate Absorption ... More >> Substrate Oxidation Glucose Regulation Less << Not Applicable Completed - United States, Maryland ... More >> USDA-ARS, Beltsville Human Nutrition Research Center Beltsville, Maryland, United States, 20705 Less <<
NCT03508739 Diabetes Mellitus, Type 2 ... More >> Pre-diabetic Hypertension Elevated Blood Pressure Less << Phase 3 Recruiting June 30, 2020 United States, Pennsylvania ... More >> University of Pennsylvania Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Jessica R Wilson, MD, MSCI Less <<
NCT00774098 Liver Function Not Applicable Completed - Canada, Quebec ... More >> Royal Victoria Hospital Montreal, Quebec, Canada, H3A1A1 Less <<
NCT00551356 Diabetes Mellitus Type 2 Phase 3 Completed - Mexico ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mexico City, Mexico Less <<
NCT02060916 Type 2 Diabetes Treated With I... More >>nsulin Less << Phase 2 Completed - United States, New Hampshire ... More >> Dartmouth-Hitchcock Medical Center Dartmouth, New Hampshire, United States, 03755 Less <<
NCT00607867 - Terminated(The funding ended b... More >>efore the study was completed.) Less << - -
NCT00321321 Diabetes Mellitus, Type 2 Phase 2 Completed - Denmark ... More >> Department of Internal Medicine, Gentofte University Hospital Hellerup, Copenhagen, Denmark, 2900 Less <<
NCT00607867 Diabetes Mellitus ... More >> Diet Less << Not Applicable Terminated(The funding ended b... More >>efore the study was completed.) Less << - United States, Minnesota ... More >> VA Medical Center, Minneapolis Minneapolis, Minnesota, United States, 55417 Less <<
NCT03100227 Healthy Not Applicable Completed - France ... More >> Hospices Civils de Lyon Bron, France, 69500 Less <<
NCT03365180 Diabetes Mellitus, Type 2 Phase 2 Phase 3 Recruiting November 1, 2018 Denmark ... More >> Hvidovre University Hospital Recruiting Hvidovre, Denmark, 2650 Contact: Kirsten Nørgaard, MD, DMSc    27131011 ext 0045    kirsten.noergaard@regionh.dk Less <<
NCT01557296 Diabetic Gastroparesis Phase 2 Completed - Sweden ... More >> Goteborg Universitet, Sahlgrenska Academy, Sahlgrenska University Hospital Goteborg, Sweden, SE 413 45 Less <<
NCT01610518 Type 2 Diabetes Not Applicable Completed - Canada, Ontario ... More >> GILabs Toronto, Ontario, Canada, M5C 2N8 Less <<
NCT00321321 - Completed - -
NCT02892604 Type 1 Diabetes Not Applicable Unknown July 2017 France ... More >> UHMontpellier Recruiting Montpellier, France, 34295 Contact: Eric RENARD, MD PhD    467338382 ext 0033    e-renard@chu-montpellier.fr Less <<
NCT02987751 Type2 Diabetes Phase 4 Active, not recruiting June 2019 India ... More >> Dr.Mallikarjnn Jali Belgaum, Karnataka, India, 590010 Singhvi Health Centre Chennai, Tamil Nadu, India, 600 019 MedWay Hospitals Chennai, Tamil Nadu, India, 600024 Kovai Diabetes Speciality Center and Hospital Coimbatore, Tamil Nadu, India, 641009 Arthur Asirvatham Hospital Madurai, Tamil Nadu, India, 625 020 M.G.Diabetes Speciality and Research Center Salem, Tamil Nadu, India, 636016 Ramana Maharishi Rangammal Hospital Tiruvannamalai, Tamil Nadu, India, 606 603 Trichy Diabetes Speciality Center (P) Ltd Trichy, Tamil Nadu, India, 620018 Less <<
NCT00569582 - Completed - -
NCT00569582 Cushing's Syndrome Phase 3 Completed - United States, Alabama ... More >> University of Alabama at Birmingham School of Medicine Birmingham, Alabama, United States, 35294 United States, California AMCR Institute Inc. Escondido, California, United States, 92026 Stanford University Medical Center Stanford, California, United States, 94305-5826 United States, Florida The Center for Diabetes and Endocrine Care Hollywood, Florida, United States, 33021 United States, Illinois Northwestern University Feinberg Medical; Division of Endocrinology, Metabolism & Molecular Medicine Chicago, Illinois, United States, 60611 The University of Chicago Chicago, Illinois, United States, 60637 United States, Maryland Sinai Hospital of Baltimore Baltimore, Maryland, United States, 21215 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 United States, Michigan University of Michigan Medical Center Ann Arbor, Michigan, United States, 48109 United States, Mississippi University of Mississippi Medical Center Jackson, Mississippi, United States, 39216 United States, New Mexico University of New Mexico HSC Albuquerque, New Mexico, United States, 87131 United States, Ohio Cleveland Clinic Foundation; Dept of Endocrinology, Diabetes & Metabolism Cleveland, Ohio, United States, 44195 United States, Oklahoma Oklahoma University Health Science Center Oklahoma City, Oklahoma, United States, 73104 United States, Oregon Oregon Health Sciences University Portland, Oregon, United States, 97239 United States, Texas University of Texas Southwestern Medical Center Dallas, Texas, United States, 75390 Diabetes and Glandular Disease Clinic San Antonio, Texas, United States, 78229 United States, Wisconsin Endocrinology Center at North Hills, Froedtert and Medical College of Wisconsin Menomonee Falls, Wisconsin, United States, 53051 Less <<
NCT00704132 - Completed - -
NCT01648244 Type II Diabetes Mellitus Not Applicable Completed - United States, Maryland ... More >> Walter Reed National Military Medical Center Bethesda, Maryland, United States, 20889 Less <<
NCT00466713 Dilated Cardiomyopathy Not Applicable Terminated(concern over safety... More >> of rosiglitazone in heart failure) Less << - United States, California ... More >> Stanford University Hospital Stanford, California, United States, 94305 Less <<
NCT01572415 - Completed - Greece ... More >> Greece National Social Insurance Institute (IKA) Athens, Greece Less <<
NCT01987388 Healthy Volunteers Not Applicable Completed - United States, Maryland ... More >> USDA Beltsville Human Nutrition Center Beltsville, Maryland, United States, 20705 Less <<
NCT00704132 Type 2 Diabetes Mellitus (T2DM... More >>) Less << Phase 1 Completed - -
NCT01497535 Diabetes Heal... More >>thy Less << Phase 1 Completed - Germany ... More >> Novo Nordisk Investigational Site Neuss, Germany, 41460 Less <<
NCT01524705 Type 2 Diabetes Phase 4 Completed - United States, California ... More >> So Calif. Permanente Medical Group San Diego, California, United States, 92109 United States, Florida University of Miami Miami, Florida, United States, 33136 United States, Georgia Atlanta Diabetes Associates Atlanta, Georgia, United States, 30309 United States, Massachusetts Joslin Diabetes Center Boston, Massachusetts, United States, 02215 United States, Minnesota International Diabetes Center Minneapolis, Minnesota, United States, 55416 United States, Missouri Washington University St. Louis, Missouri, United States, 63110 United States, New York Kaledia Health of Western New York Buffalo, New York, United States, 14209 United States, North Carolina Diabetes Care Center Durham, North Carolina, United States, 27713 United States, Oregon Oregon Health and Science University Portland, Oregon, United States, 97239 United States, Vermont University of Vermont Colchester, Vermont, United States, 05446 United States, Washington University of Washington Seattle, Washington, United States, 98105 Washington State University Spokane, College of Pharmacy Spokane WA 99202 USA Spokane, Washington, United States, 99202 Less <<
NCT02081001 Hypoglycemia Phase 2 Completed - United States, Oregon ... More >> Oregon Health & Science University Portland, Oregon, United States, 97239 Less <<
NCT00882141 Obesity Insul... More >>in Resistance Sedentary Lifestyle Less << Not Applicable Completed - United States, Maryland ... More >> University of Maryland, VAMC Baltimore, Maryland, United States, 20705 Less <<
NCT03064906 Type 1 Diabetes Mellitus Not Applicable Completed - United States, California ... More >> Stanford University Palo Alto, California, United States, 94305 Diablo Clinical Research Walnut Creek, California, United States, 94598 United States, Colorado University of Colorado Denver Denver, Colorado, United States, 80045 Less <<
NCT03663322 Type2 Diabetes Mellitus ... More >> Osteopathy in Diseases Classified Elsewhere Less << Not Applicable Recruiting February 28, 2021 United States, New York ... More >> NYIT Family Health Care Center Recruiting Central Islip, New York, United States, 11722 Contact: John Lopez, MS    516-686-4944    john.lopes@nyit.edu    Contact: Phyllis Pugliese    516-686-3751    ppuglies@nyit.edu    Principal Investigator: Sonia Rivera-Martinez, DO          Sub-Investigator: Karen Sheflin, DO          NYIT Academic Health Care Center - Riland Bldg. Recruiting Old Westbury, New York, United States, 11568- Contact: John Lopez, MS    516-686-4944    john.lopez@nyit.edu    Contact: Phyllis Pugliese    516-686-3751    ppuglies@nyit.edu    Principal Investigator: Sonia Rivera-Martinez, DO          Sub-Investigator: Karen Sheflin, DO          Sub-Investigator: Bhuma Krischnamachari, PhD          Sub-Investigator: Jayme Mancini, DO          Principal Investigator: Min-Kyung Jung, PhD Less <<
NCT03550378 Diabetes Mellitus, Type II ... More >> Renal Insufficiency Less << Phase 2 Recruiting February 1, 2019 Germany ... More >> Research Site Recruiting Berlin, Germany, 10117 Research Site Withdrawn Dusseldorf, Germany, 40210 Research Site Recruiting Magdeburg, Germany, 39120 Research Site Recruiting Munster, Germany, 48145 Research Site Recruiting München, Germany, 81241 United Kingdom Research Site Withdrawn Airdrie, United Kingdom, ML6 0JS Research Site Recruiting Dundee, United Kingdom, DD1 9SY Research Site Recruiting Edinburgh, United Kingdom, EH16 4SA Research Site Recruiting Edinburgh, United Kingdom, EH4 2XU Research Site Withdrawn Glasgow, United Kingdom, G75 8RG Research Site Withdrawn Kirkaldy, United Kingdom, KY2 5AH Less <<
NCT02710266 Liver Disease Phase 3 Terminated(This study was clos... More >>ed earlier than planned because targeted participant recruitment is not smooth.) Less << - Korea, Republic of ... More >> Severance Hospital Seoul, Korea, Republic of, 03722 Less <<
NCT02081001 - Completed - -
NCT01767831 - Terminated(study team will rev... More >>iew the collected data and make any necessary changes to the educational tool.) Less << - United States, Virginia ... More >> University of Virginia Center for Diabetes Technology Charlottesville, Virginia, United States, 22904 Less <<
NCT00361751 Burns Insulin... More >> Resistance Less << Phase 2 Completed - United States, Texas ... More >> Shriners Hospital for CHildren Galveston, Texas, United States, 77550 Less <<
NCT00537056 - Completed - -
NCT00530881 Type 2 Diabetes Mellitus Phase 2 Completed - United States, California ... More >> Multiple Sites san Diego, California, United States, 92121 Less <<
NCT02853630 TYpe 2 Diabetes Mellitus Phase 4 Active, not recruiting December 2018 India ... More >> Jnana Sanjeevini Medical Centre Bangalore, Karnataka, India, 560 078 Vikas Pai Research Foundation Pune, Maharashtra, India, 411 005 Singhvi Health Centre Chennai, Tamil Nadu, India, 600 019 Dr V.Seshiah Diabetes research Institute, Dr V.Balaji Diabetes care centre Chennai, Tamil Nadu, India, 600029 Arthur Asirvatham Hospital Madurai, Tamil Nadu, India, 625 020 Ramana Maharishi Rangammal Hospital Tiruvannamalai, Tamil Nadu, India, 606 603 Less <<
NCT03078764 Type 2 Diabetes Mellitus Not Applicable Completed - Thailand ... More >> Buengbon Health Promoting Hospital Nong Sua, Pathumthani, Thailand, 12170 Buengkasam 1 Health Promoting Hospital Nong Sua, Pathumthani, Thailand, 12170 Buengkasam 2 Health Promoting Hospital Nong Sua, Pathumthani, Thailand, 12170 Buengshamaor 1 Health Promoting Hospital Nong Sua, Pathumthani, Thailand, 12170 Nongsamwang 1 Health Promoting Hospital Nong Sua, Pathumthani, Thailand, 12170 Salakru Health Promoting Hospital Nong Sua, Pathumthani, Thailand, 12170 Less <<
NCT02869659 Obesity Pre-d... More >>iabetes Less << Not Applicable Recruiting December 2019 United States, North Carolina ... More >> Wake Forest Health Sciences Recruiting Winston-Salem, North Carolina, United States, 27157 Contact: Charlotte Crotts    336-713-8503    chcrotts@wakehealth.edu Less <<
NCT02329626 - Completed - France ... More >> CHRU de Montpellier - Hôpital Gui de Chauliac Montpellier Cedex 5, France, 34295 CHRU de Montpellier - Hôpital Lapeyronie Montpellier, France, 34295 CHRU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 09, France, 30029 Less <<
NCT01683331 Prevention of New Onset Diabet... More >>es Among Kidney Transplant Patients Less << Phase 4 Completed - United States, Michigan ... More >> University of Michigan Ann Arbor, Michigan, United States, 48109 Less <<
NCT03644524 Obesity Polyc... More >>ystic Ovary Syndrome Prehypertension PreDiabetes Cardiovascular Risk Factor Metabolic Syndrome Less << Not Applicable Completed - United States, Oregon ... More >> University of Oregon Eugene, Oregon, United States, 97403 Less <<
NCT01474785 Obesity Phase 1 Completed - United States, Tennessee ... More >> Vanderbilt University Medical Center Nashville, Tennessee, United States, 34232 Less <<
NCT01209312 Type 1 Diabetes Not Applicable Completed - United States, Colorado ... More >> Barbara Davis Center for Childhood Diabetes Aurora, Colorado, United States, 80045 Less <<
NCT01683266 Type 1 Diabetes Mellitus Phase 3 Completed - -
NCT02454153 Sleep Apnea D... More >>iabetes Less << Not Applicable Recruiting December 2018 United States, Maryland ... More >> Johns Hopkins Bayview Medical Center Recruiting Baltimore, Maryland, United States, 21224 Contact: Naresh M Punjabi, MD, PhD    410-550-4891    npunjabi@jhmi.edu    Contact: Nisha Aurora, MD    410-550-4891    raurora2@jhmi.edu    Principal Investigator: Naresh M Punjabi, MD, PhD Less <<
NCT01683266 - Completed - -
NCT02596204 Type 1 Diabetes Mellitus Not Applicable Completed - United States, Minnesota ... More >> Children's Hospitals and Clinics of Minnesota Saint Paul, Minnesota, United States, 55102 Less <<
NCT02276859 Type 1 Diabetes Phase 4 Completed - Poland ... More >> Department of Pediatrics, Medical University of Warsaw, Poland Warsaw, Poland, 01-184 Less <<
NCT02706119 Diabetes Mellitus Phase 4 Completed - Spain ... More >> Hospital Arquitecto Marcide-Naval Ferrol, A Coruña, Spain, 15405 Hospital de Cabueñes Gijón, Asturias, Spain, 33394 Hospital de Mérida Mérida, Badajoz, Spain, 06800 Hospital Son Llátzer Palma de Mallorca, Baleares, Spain, 07198 Hospital General Mancha Centro Alcázar de San Juan, Ciudad Real, Spain, 13600 Hospital Universitario Principe de Asturias Alcalá de Henares, Madrid, Spain, 28805 Hospital Universitario de Fuenlabrada Fuenlabrada, Madrid, Spain, 28942 Hospital Universitario Severo Ochoa Leganés, Madrid, Spain, 28911 Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain, 28222 Hospital Clínico Universitario Virgen de la Arrixaca El Palmar, Murcia, Spain, 30150 Complejo Hospitalario de Navarra Pamplona, Navarra, Spain, 31008 Complejo Hospitalario Universitario de Albacete Albacete, Spain, 02008 Hospital General Universitario de Alicante Alicante, Spain, 03010 Hospital Universitario Infanta Cristina Badajoz, Spain, 06080 Hospital del Mar Barcelona, Spain, 08003 Hospital Universitario Bellvitge Barcelona, Spain, 08907 Hospital de Sant Joan Despi Moisès Broggi (Consorci Sanitari Integral) Barcelona, Spain, 08970 Hospital Universitario Reina Sofía Córdoba, Spain, 14006 Hospital Universitario de Guadalajara Guadalajara, Spain, 19002 Complejo Hospitalario de Jaén Jaén, Spain, 23008 Complejo Asistencial Universitario de León León, Spain, 24008 Hospital Universitario Gregorio Marañón Madrid, Spain, 28007 Fundación Jiménez Díaz Madrid, Spain, 28040 Hospital Clínico San Carlos Madrid, Spain, 28040 Hospital Regional Universitario de Málaga Málaga, Spain, 29009 Hospital Universitario Virgen de la Victoria Málaga, Spain, 29010 Hospital Universitario Virgen del Rocío Sevilla, Spain, 41013 Hospital Universitario Nuestra Señora de la Candelaria Tenerife, Spain, 38010 Hospital Universitario y Politécnico La Fe Valencia, Spain, 46026 Hospital Clínico Universitario de Valladolid Valladolid, Spain, 47003 Hospital Clínico Universitario Lozano Blesa Zaragoza, Spain, 50009 Hospital Universitario Miguel Servet Zaragoza, Spain, 50009 Less <<
NCT00570739 Type 2 Diabetes Mellitus ... More >> Hypercholesterolemia Pre-diabetes Less << Phase 3 Completed - -
NCT01944449 Type 2 Diabetes Not Applicable Completed - Israel ... More >> Daniela Jakubowicz Holon, N/A = Not Applicable, Israel, 58100 Venezuela Daniela Jakubowicz MD Caracas, N/A = Not Applicable, Venezuela, 410 Less <<
NCT00832741 - Completed - Denmark ... More >> Hvidovre University Hospital Hvidovre, Denmark, 2650 Less <<
NCT03604250 Metabolic Syndrome Not Applicable Recruiting May 2019 United States, California ... More >> January, Inc. Recruiting Menlo Park, California, United States, 94025 Contact: Samuel A. Smits, PhD    408-540-4103    sam@january.ai    Principal Investigator: Samuel A Smits, PhD Less <<
NCT01285232 Glucose Intolerance ... More >> Impaired Insulin Secretion Diabetes Mellitus Type 2 Less << Not Applicable Unknown December 2012 Netherlands ... More >> Radboud University Nijmegen Medical Centre Nijmegen, Netherlands, 6500HB Less <<
NCT00506194 Type 2 Diabetes Not Applicable Completed - Taiwan ... More >> Division of Endocrinology and Metabolism, Department of Medicine Taipei, Taiwan, 112 Less <<
NCT01479062 Pre-diabetes ... More >>Diabetes Obesity Less << Not Applicable Completed - United States, California ... More >> Palo Alto Medical Foundation Research Institute Palo Alto, California, United States, 94301 Less <<
NCT00484419 Type 2 Diabetes ... More >> Hyperlipidemia Less << Phase 3 Completed - United States, California ... More >> La Mesa, California, United States Los Angeles, California, United States Los Gatos, California, United States San Antonio, California, United States United States, Florida Chiefland, Florida, United States United States, Indiana Gary, Indiana, United States United States, Maryland Baltimore, Maryland, United States United States, Michigan Dearborn, Michigan, United States W. Bloomfield, Michigan, United States United States, Nevada Las Vegas, Nevada, United States United States, New York Yonkers, New York, United States United States, North Carolina Lexington, North Carolina, United States Winston-Salem, North Carolina, United States United States, Ohio Munroe Falls, Ohio, United States Zaneville, Ohio, United States United States, Oregon Portland, Oregon, United States United States, Pennsylvania Jersey Shore, Pennsylvania, United States United States, South Carolina Clemson, South Carolina, United States United States, Tennessee Harriman, Tennessee, United States United States, Texas Dallas, Texas, United States Less <<
NCT00510705 Severe Coronary Artery Disease... More >> Obesity Impaired Glucose Tolerance Less << Not Applicable Terminated - Germany ... More >> University of Leipzig - Heart Center Leipzig, Germany, 04289 Less <<
NCT00484419 - Completed - -
NCT00510588 Stable Coronary Artery Disease... More >> Obesity Impaired Glucose Tolerance Less << Not Applicable Completed - Germany ... More >> University of Leipzig - heart center Leipzig, Germany, 04289 Less <<
NCT01030744 - Withdrawn(This is quality impr... More >>ovement review and should not have been registered. No participants were enrolled) Less << - United States, Tennessee ... More >> Vanderbilt University : Vanderbilt Diabetes Center (VDC) Nashville, Tennessee, United States, 37237-8148 Less <<
NCT02479113 - Recruiting December 2024 Malaysia ... More >> University of Malaya Recruiting Kuala Lumpur, Malaysia, 50603 Contact: Shireene Vethakkan, MD       shireene.vethakkan@gmail.com    Sub-Investigator: Noor Azmi B Mat Adenan, MBChB          Sub-Investigator: Muhammad Yazid B Jalaludin, MBBS          Sub-Investigator: Lee Ling Lim, MRCP (UK) Less <<
NCT02360878 - Completed - Denmark ... More >> Center for Diabetes Research, Gentofte Hospital, University of Copenhagen Hellerup, Denmark, 2900 Less <<
NCT01319201 - Unknown - China ... More >> Shanghai Jiao-Tong University School of Medicine Shanghai, China, 200025 Less <<
NCT02838693 - Recruiting December 2021 Singapore ... More >> National University Hospital Recruiting Singapore, Singapore, 119074 Contact: Sue-Anne Toh, MBBChir, MSc, MA    +65 67722195    mdcsates@nus.edu.sg    Principal Investigator: Sue-Anne Toh, MBBChir, MSc, MA Less <<
NCT00570739 - Completed - -
NCT02153190 Type 1 Diabetes Mellitus ... More >> Treatement by Insulin Pump Less << Phase 2 Completed - France ... More >> CHU Montpellier Montpellier, France, 34000 Italy University of Padova Padova, Italy Netherlands University of Amsterdam Amsterdam, Netherlands Less <<
NCT01303055 Diabetes Mellitus, Type 2 Not Applicable Unknown December 2014 Japan ... More >> Dept. of Intern. Med., School of Dentistry, Aichi Gakuin University Recruiting Nagoya, Aichi, Japan, 464-8650 Contact: Takahiro Tosaki, MD, PhD    +81-52-759-2111    nrd49075@nifty.com    Principal Investigator: Takahiro Tosaki, MD, PhD          Sub-Investigator: Keiko Naruse, MD, PhD          Tosaki Clinic for Diabetes and Endocrinology Not yet recruiting Nagoya, Aichi, Japan, 468-0009 Contact: Takahiro Tosaki, MD, PhD       nrd49075@nifty.com    Principal Investigator: Takahiro Tosaki, MD, PhD          Diabetes Clinic, Okazaki East Hospital Recruiting Okazaki, Aichi, Japan, 444-0008 Contact: Takahiro Tosaki, MD, PhD    +81-564-22-6616    nrd49075@nifty.com    Sub-Investigator: Chizuko Suzuki, MD, PhD          Sub-Investigator: Maiko Mizutani, MD, PhD          Principal Investigator: Takahiro Tosaki, MD, PhD          Diabetes Center, Yokkaichi Social Insurance Hospital Recruiting Yokkaichi, Mie, Japan, 510-0016 Contact: Takahiro Tosaki, MD, PhD    +81-59-331-2000    nrd49075@nifty.com    Sub-Investigator: Miho Miyoshi, MD          Sub-Investigator: Tomoki Majima, MD          Principal Investigator: Takahiro Tosaki, MD, PhD Less <<
NCT00974090 Type 2 Diabetes Mellitus Phase 3 Completed - Japan ... More >> Sapporo-shi, Hokkaidou, Japan Less <<
NCT00998881 - Completed - -
NCT02966626 - Completed - -
NCT00974090 - Completed - -
NCT01026194 Type 2 Diabetes Mellitus Phase 3 Completed - Japan ... More >> Shinjukuku, Tokyo, Japan Less <<
NCT01318109 Type 2 Diabetes Mellitus Phase 2 Phase 3 Completed - -
NCT01026194 - Completed - -
NCT00998881 Type 2 Diabetes Mellitus Phase 3 Completed - Japan ... More >> Sapporo-shi, Hokkaidou, Japan Less <<
NCT01270789 Type 2 Diabetes Phase 3 Completed - Canada, Ontario ... More >> Mount Sinai Hospital Toronto, Ontario, Canada, M5G1X5 Less <<
NCT02835261 Sleep Cardiov... More >>ascular Disease Obesity Less << Not Applicable Recruiting July 2020 United States, New York ... More >> New York Obesity Nutrition Research Center Recruiting New York, New York, United States, 10032 Contact: Marie-Pierre St-Onge, PhD    212-851-5578    ms2554@cumc.columbia.edu    Contact: Ayanna Campbell, MS    212-851-5583    ac3995@cumc.columbia.edu    Principal Investigator: Marie-Pierre St-Onge, PhD Less <<
NCT01318083 Type 2 Diabetes Mellitus Phase 2 Phase 3 Completed - -
NCT01318109 - Completed - -
NCT01318083 - Completed - -
NCT02167243 Type 1 Diabetes Not Applicable Active, not recruiting April 2019 United States, Connecticut ... More >> Yale University School of Medicine New Haven, Connecticut, United States, 06520 Less <<
NCT00348374 Diabetes Mellitus Phase 3 Completed - -
NCT02233491 Post Transplantation Diabetes ... More >>Mellitus Obesity Transplantation of Kidney Less << Not Applicable Recruiting July 2018 United Kingdom ... More >> University Hospitals Birmingham NHS Foundation Trust Recruiting Birmingham, West Midlands, United Kingdom, B15 2WB Contact: Adnan Sharif, MD       adnan.sharif@uhb.nhs.uk    Principal Investigator: Adnan Sharif, MD Less <<
NCT00348374 - Completed - -
NCT00712426 Huntington's Disease Phase 3 Terminated(Results of an inter... More >>im analysis showed that it was unlikely that creatine was effective in slowing loss of function in early symptomatic Huntington's Disease.) Less << - -
NCT00603031 Type-1 Diabetes Mellitus Not Applicable Completed - Denmark ... More >> Dept. of Endocrinology, Hvidovre Hospital Copenhagen, Denmark, 2650 Less <<
NCT03496597 - Recruiting December 2019 France ... More >> CHU Dijon Bourgogne Recruiting Dijon, France, 21000 Contact: Bruno VERGES, MD    03.80.29.38.54    bruno.verges@chu-dijon.fr Less <<
NCT01117350 - Completed - -
NCT01471600 Upper Gastrointestinal Endosco... More >>py Less << Not Applicable Completed - France ... More >> University Hospital Caen, France, 14033 Less <<
NCT01117350 Diabetes Mellitus, Type 2 Phase 4 Completed - -
NCT00302874 Diabetes Hype... More >>rglycemia Less << Not Applicable Completed - Israel ... More >> Hadassah Medical Organization Jerusalem, Israel, 91120 Less <<
NCT03251846 Diabetes Mellitus, Type 1 Not Applicable Recruiting July 2018 United States, Minnesota ... More >> Children's Hospitals and Clinics of Minnesota Recruiting Saint Paul, Minnesota, United States, 55102 Contact: Laure Gandrud, MD    651-220-6624    laura.gandrud@childrensmn.org    Contact: Krista Mullen, BS    507-581-6000    krista.mullen@childrensmn.org Less <<
NCT00335751 Sarcoma Not Applicable Completed - United States, California ... More >> Jonsson Comprehensive Cancer Center at UCLA Los Angeles, California, United States, 90095-1781 Less <<
NCT02803476 - Unknown August 2016 Egypt ... More >> Ain Shams University Maternity Hospital Recruiting Cairo, Abbasseya district., Egypt, 11566 Less <<
NCT00443755 Type 2 Diabetes ... More >> Insulin Resistance Metabolic Syndrome Less << Phase 2 Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT03703999 - Recruiting March 31, 2019 Italy ... More >> University of Padova Recruiting Padova, Italy Contact: Daniela Bruttomesso, MD, PHD    00390498212183    daniela.bruttomesso@unipd.it Less <<
NCT03510078 Diabetes Mellitus ... More >> Non-critically Ill Patients Less << Not Applicable Recruiting October 1, 2021 Israel ... More >> Rabin Medical Center Recruiting Petah Tikva, Israel Contact: Alon Grossman, Prof    +972504065545    along@clalit.org.il    Contact: Irit Ayalon Dangur, Dr    +972525940042    iritayalon1234@gmail.com Less <<
NCT02717078 Type 2 Diabetes Mellitus Not Applicable Recruiting December 2018 United States, Minnesota ... More >> University of Minnesota Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Anne Bantle    612-625-8673    d-study@umn.edu Less <<
NCT03239119 Type2 Diabetes Mellitus Phase 3 Not yet recruiting January 15, 2019 -
NCT02402985 Diabetes Mellitus, Type 2 ... More >> Nutrition Disorders Obesity Body Weight Metabolic Syndrome x Metabolic Diseases Less << Not Applicable Completed - Germany ... More >> German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany, 14558 Less <<
NCT00443755 - Completed - -
NCT03447080 Diabetes Mellitus, Type 2 Not Applicable Active, not recruiting December 2018 Singapore ... More >> Clinical Nutrition Reseach Centre Singapore, Singapore, 117599 Less <<
NCT00399711 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT01966627 - Completed - United States, Connecticut ... More >> Yale University New Haven, Connecticut, United States, 06510 Less <<
NCT00845182 Type 2 Diabetes ... More >> Healthy Impaired Glucose Tolerance Less << Phase 4 Completed - United States, Texas ... More >> Barter Research Center, ALM VA Hospital San Antonio, Texas, United States, 78229 Less <<
NCT02241421 Obesity Insul... More >>in Resistance Less << Not Applicable Unknown November 2014 Netherlands ... More >> Maastricht University Maastricht, Netherlands Less <<
NCT02735031 Diabetes Mellitus, Type 1 ... More >> Hypoglycemia Less << Phase 2 Phase 3 Completed - Netherlands ... More >> Radboud university medical centre Nijmegen, Netherlands Less <<
NCT01129258 Diabetes Mellitus ... More >> Diabetes Mellitus, Type 2 Glucose Metabolism Disorders Less << Phase 1 Completed - United States, California ... More >> Pfizer Investigational Site Chula Vista, California, United States, 91911 Pfizer Investigational Site Fountain Valley, California, United States, 92708 United States, Florida Pfizer Investigational Site Miami, Florida, United States, 33169 United States, Texas Pfizer Investigational Site San Antonio, Texas, United States, 78229 Less <<
NCT00688974 - Completed - France ... More >> Lille University Hospital Lille, Nord, France, 59037 Less <<
NCT03624010 Hypertension Pulmonary Seconda... More >>ry Heart Failure Right Sided Heart Failure With Normal Ejection Fraction Heart Failure With Normal Ejection Fraction Less << Phase 2 Recruiting December 2021 United States, Arizona ... More >> Banner University Phoenix Lung Institute Recruiting Phoenix, Arizona, United States, 85006 United States, California Stanford Healthcare Recruiting Stanford, California, United States, 94305 United States, Minnesota Mayo Clinic Recruiting Rochester, Minnesota, United States, 55905 United States, New York North Shore University Hospital Active, not recruiting Manhasset, New York, United States, 11030 Less <<
NCT03006289 - Unknown November 2017 -
NCT03494868 Insulin Sensitivity Not Applicable Enrolling by invitation April 20, 2020 United States, Minnesota ... More >> Mayo Clinic in Rochester Rochester, Minnesota, United States, 55905 Less <<
NCT01657032 - Completed - -
NCT02552355 Physical Activity Phase 2 Completed - United States, Colorado ... More >> Colorado State University, Dept. of Health and Exercise Science Fort Collins, Colorado, United States, 80523-1582 Less <<
NCT00969007 Glucose Intolerance ... More >> Obesity Less << Not Applicable Completed - Canada, Quebec ... More >> Universitaire de Sherbrooke Sherbrooke, Quebec, Canada, J1H 5N4 Less <<
NCT01657032 Diarrhea Phase 4 Completed - Poland ... More >> Department of Paediatrics, The Medical University of Warsaw Warsaw, Poland, 01-183 Less <<
NCT03073551 Gestational Diabetes Mellitus Not Applicable Completed - -
NCT02333331 Sarcopenia Phase 2 Completed - -
NCT00261417 Type 2 Diabetes Phase 2 Terminated(The development pro... More >>gram has been terminated) Less << - Japan ... More >> Research Site Ashino, Japan Research Site Fuchu Keijinkai, Japan Research Site Fujimino, Japan Research Site Hijirino Koike, Japan Research Site Houseikai, Japan Research Site Hyuga, Japan Research Site Iriuchijima, Japan Research Site Iwase, Japan Research Site Kato, Japan Research Site Kawamata, Japan Research Site Keishukai Shirakawa, Japan Research Site Koga, Japan Research Site Kouhoku, Japan Research Site Kousei, Japan Research Site Kurosawa, Japan Research Site Nihonmatu, Japan Research Site Oki, Japan Research Site Saiseikai Fukuoka, Japan Research Site Sapporo, Japan Research Site Takamori, Japan Less <<
NCT00377442 Diabetes Mellitus Type 2 Phase 1 Completed - United States, Texas ... More >> San Antonio, Texas, United States, 78229 United States, Washington Tacoma, Washington, United States, 98418 Less <<
NCT01397942 Type 2 Diabetes Not Applicable Completed - Denmark ... More >> Hospital Vendsyssel, Center for Clinical Research Hjørring, Nordjylland, Denmark, 9800 Less <<
NCT01456195 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT02996812 Hyperinsulinemia Hypoglycemia Phase 1 Unknown May 2017 United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT02378675 - Completed - Austria ... More >> Medical University of Vienna Vienna, Austria, 1090 Less <<
NCT01753882 Spinal Cord Injury Phase 1 Unknown July 2017 United States, Illinois ... More >> Rehabilitation Institute of Chicago Chicago, Illinois, United States, 60611 Less <<
NCT00917930 - Completed - -
NCT01788969 Spinal Cord Injury Phase 1 Unknown December 2017 United States, Illinois ... More >> Rehabilitation Institute of Chicago Chicago, Illinois, United States, 60611 Less <<
NCT00597909 Hepatic Encephalopathy Phase 2 Terminated(Study was terminate... More >>d due to lack of enrollment and business decisions.) Less << - United States, California ... More >> UCSF-Fresno University Fresno, California, United States, 93721 Loma Linda University Medical Center Loma Linda, California, United States, 92354 United States, Texas Permian Research Foundation Odessa, Texas, United States, 79761 Less <<
NCT01288898 Healthy Phase 1 Completed - Netherlands ... More >> Groningen, Netherlands, 9470 AE Less <<
NCT00597909 - Terminated(Study was terminate... More >>d due to lack of enrollment and business decisions.) Less << - -
NCT00845182 - Completed - -
NCT00456105 Type 2 Diabetes ... More >> Peripheral Vascular Disease Less << Not Applicable Terminated(The study was stopp... More >>ed due to lack of resources of the study coordinator's time) Less << - Canada, British Columbia ... More >> University of British Columbia Gerontology & Diabetes Research Centre Vancouver, British Columbia, Canada Less <<
NCT00371306 Gestational Diabetes ... More >> Type 2 Diabetes Pregnancy Less << Not Applicable Unknown September 2008 United States, Tennessee ... More >> Regional Obstetrical Consultants Recruiting Chattanooga, Tennessee, United States, 37403 Less <<
NCT01456195 - Completed - -
NCT02871089 Diabetes Mellitus ... More >> Type 1 Diabetes Less << Phase 2 Recruiting October 2021 United Kingdom ... More >> Southampton Children's Hospital Recruiting Southampton, Hampshire, United Kingdom, SO16 6YD Contact: Dr Nicola Trevelyan, MD          Nottingham Children's Hospital Recruiting Nottingham, Nottinghamshire, United Kingdom, NG5 1PB Contact: Dr Tabitha Randell, MD          John Radcliffe Hospital Recruiting Oxford, Oxfordshire, United Kingdom, OX3 9DU Contact: Dr Rachel Besser, MD          Alder Hey Children's NHS Foundation Trust Recruiting Liverpool, West Derby, United Kingdom, L12 2AP Contact: Dr Atrayee Ghatak, MD          St James's University Hospital Recruiting Leeds, West Yorkshire, United Kingdom, LS9 7TF Contact: Dr Fiona Campbell, MD          Cambridge University Hospitals NHS Foundation Trust Recruiting Cambridge, United Kingdom, CB2 0QQ Contact: Martin Tauschmann, MD          Principal Investigator: Carlo Acerini, MD, FRCP          Royal Hospital for Sick Children Recruiting Edinburgh, United Kingdom, EH9 1LF Contact: Dr Daniela Elleri, MD Less <<
NCT02713555 Diabetes Mellitus, Type 2 ... More >> Obesity Less << Not Applicable Recruiting March 2020 Denmark ... More >> Hospital Unit Midt Recruiting Viborg, Region Midt, Denmark, 8800 Contact: katrine brodersen    29411259    katrine.brodersen@rm.dk    Contact: Michael F. Nielsen       michanls@rm.dk Less <<
NCT02845622 Cardiovascular Diseases ... More >> Glucose Metabolism Disorders Less << Not Applicable Completed - Italy ... More >> San Donato Hospital San Donato Milanese, Italy, 20097 Less <<
NCT01201603 Insulin Resistance ... More >> Obesity Less << Not Applicable Completed - United Kingdom ... More >> University of Nottingham Nottingham, Notts, United Kingdom, NG7 2UH Less <<
NCT00856284 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT00006508 Hypoglycemia Not Applicable Completed - United States, Missouri ... More >> Washington University St. Louis, Missouri, United States, 63110 Less <<
NCT00817271 Type 2 Diabetes Phase 1 Completed - United States, California ... More >> Research Site Chula Vista, California, United States Less <<
NCT00856284 - Completed - -
NCT01227473 Prediabetes Phase 1 Phase 2 Completed - United States, North Carolina ... More >> University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States, 27599 Less <<
NCT01134224 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 1 Completed - Germany ... More >> Neuss, Germany, 41460 Less <<
NCT01791088 Unspecified Adult Solid Tumor,... More >> Protocol Specific Unspecified Childhood Solid Tumor, Protocol Specific Less << Phase 1 Active, not recruiting December 2018 United States, Illinois ... More >> University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States, 60637-1470 Less <<
NCT03662334 Type 1 Diabetes Mellitus Phase 4 Completed - United States, California ... More >> Profil Institute for Clinical Research Chula Vista, California, United States, 91911 Less <<
NCT01614496 Type 1 Diabetes Not Applicable Completed - Spain ... More >> Endocrinology and Nutrition Department. Corporació Sanitària i Universitària Parc Taulí Sabadell, Barcelona, Spain, 08208 Less <<
NCT00843232 - Completed - Brazil ... More >> LIMED (Laboratory of Investigation of Metabolism and Diabetes)/GASTROCENTRO/Univeristy of Campinas (UNICAMP) Campinas, SP, Brazil Less <<
NCT02902757 Glioblastoma Not Applicable Recruiting August 25, 2022 United States, California ... More >> UCLA / Jonsson Comprehensive Cancer Center Recruiting Los Angeles, California, United States, 90095 Contact: Ken Herrmann    310-825-7125       Principal Investigator: Ken Herrmann Less <<
NCT01428843 Inflammatory Bowel Disease Phase 3 Terminated(Lack of enrollment) - France ... More >> Chu Amiens Amiens, France, 80054 CHU CAEN Caen, France, 14033 Chu Clermont-Ferrand Clermont-ferrand, France, 63003 Hopital Beaujon Clichy, France, 92110 Hopital Bicetre Le Kremlin Bicetre, France, 94275 CHRU Lille Lille, France Chu Marseille - Hopital Nord Marseille, France, 13915 Chu Nantes Nantes, France, 44093 Hopital Saint Louis Paris, France, 75010 Hopital St Antoine Paris, France, 75012 Hopital Cochin Paris, France, 75014 CHU Bordeaux - Pessac Pessac, France, 33700 CHU LYON Pierre Benite, France, 69495 Chu Rennes Rennes, France, 35033 Chu Rouen Rouen, France, 76031 Chu Saint Etienne St Etienne, France, 42270 Chu Toulouse Toulouse, France, 31403 Chu Tours Tours, France, 37044 Less <<
NCT02394249 Overweight Ob... More >>esity Less << Not Applicable Completed - Netherlands ... More >> Human Movement Science, Maastricht University Maastricht, Netherlands, 6200MD Less <<
NCT01175226 - Completed - -
NCT00863629 Myocardial Infarction ... More >> Oxidative Stress Glycemic Control Less << Phase 4 Completed - Italy ... More >> Second University of Naples Naples, Italy, i-80131 Less <<
NCT01087632 Metabolic Syndrome Not Applicable Completed - Italy ... More >> Federico II University - Department of Internal Medicine Naples, Italy Less <<
NCT01175226 Rhinovirus Phase 2 Completed - -
NCT02631148 Obesity Predi... More >>abetic State Less << Phase 3 Recruiting January 2018 United States, Massachusetts ... More >> Brigham and Women's Hospital Recruiting Boston, Massachusetts, United States, 02215 Contact: Fatima Adigun, MPH    617-264-3071    fadigun-bello@partners.org Less <<
NCT00945165 Diabetes Mellitus, Type 2 ... More >> Hyperglycemia Less << Not Applicable Completed - Netherlands ... More >> Maastricht University Medical Centre Maastricht, Limburg, Netherlands, 6200 MD Less <<
NCT00506662 - Terminated(See termination rea... More >>son in detailed description) Less << - -
NCT00974051 Type 1 Diabetes Not Applicable Completed - United States, Colorado ... More >> Barbara Davis Center Aurora, Colorado, United States, 80045 Less <<
NCT00792935 - Completed - -
NCT01809431 Gestational Diabetes Not Applicable Completed - United States, North Carolina ... More >> UNC-Rex Health Care Raleigh, North Carolina, United States, 27607 WakeMed Raleigh, North Carolina, United States, 27610 Less <<
NCT03460899 Diabetes Mellitus With Hypogly... More >>cemia Diabetes Mellitus, Type 2 Hypoglycemia Hypoglycemic Episode Less << Not Applicable Completed - Austria ... More >> Medical University of Graz, Department for Internal Medicine Graz, Austria, 8036 Less <<
NCT00792935 Type 2 Diabetes Mellitus Phase 2 Completed - -
NCT00974051 - Completed - -
NCT00954109 Insulin Resistance Not Applicable Completed - United States, Missouri ... More >> Harry S. Truman Memorial VA Medical Center Columbia, Missouri, United States, 65201-5297 Less <<
NCT00954109 - Completed - -
NCT00506662 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 4 Terminated(See termination rea... More >>son in detailed description) Less << - France ... More >> Paris La Défense, France, 92936 United Kingdom Cambridge, United Kingdom, CB2 2QQ Less <<
NCT02320721 - Completed - -
NCT03081676 Maturity-Onset Diabetes of the... More >> Young, Type 3 Less << Not Applicable Completed - Denmark ... More >> Center for Diabetes Research, Gentofte Hospital Hellerup, Denmark, 2900 Less <<
NCT01000922 Diabetes Mellitus Phase 2 Completed - United States, California ... More >> Profil Institute for Clinical Research, Inc. (PICR) Chula Vista, California, United States, 91911 Less <<
NCT01356381 Type 2 Diabetes Mellitus Phase 4 Completed - United Kingdom ... More >> Novartis Investigative Site Newcastle Upon Tyne, United Kingdom, NE4 5PL Less <<
NCT01476475 - Completed - -
NCT02320721 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT02979860 Type2 Diabetes ... More >> Sleep Less << Not Applicable Recruiting December 2019 United States, Pennsylvania ... More >> Center for Obesity Research and Education, Temple University Recruiting Philadelphia, Pennsylvania, United States, 19140 Contact: Ashley Greer, MPH    215-707-8650    ashley.greer@temple.edu    Contact: Chantelle Hart, PhD    215-707-8639    chantelle.hart@temple.edu Less <<
NCT01188200 Diabetes Mellitus, Type 2 Phase 3 Completed - Russian Federation ... More >> Kuban State Medical University Krasnodar, Russian Federation, 350043 City Clinical Hospital #68 Moscow, Russian Federation, 109263 City Clinical Hospital #52 Moscow, Russian Federation, 123182 City Hospital #67 Moscow, Russian Federation, 123423 Novosibirsk State Medical University Novosibirsk, Russian Federation, 630047 State Novosibirsk Regional Hospital Novosibirsk, Russian Federation, 630087 Diabetes Centre, LLC Samara, Russian Federation, 443046 Medical Centre Twenty First Century St. Petersburgh, Russian Federation, 190068 City Clinical Hospital #3 St. Petersburg, Russian Federation, 195257 Tyumen State Medical Academy Tyumen, Russian Federation, 625023 Bashkir State Medical University Ufa, Russian Federation, 450071 Less <<
NCT01476475 Type 2 Diabetes Mellitus Phase 2 Completed - -
NCT03414320 Type1 Diabetes Mellitus Not Applicable Completed - Belgium ... More >> UZ Leuven Leuven, Belgium, 3000 Less <<
NCT01102673 Diabetes Mellitus ... More >> Diabetes Mellitus, Type 2 Glucose Metabolism Disorders Less << Phase 1 Completed - United States, Connecticut ... More >> Pfizer Investigational Site New Haven, Connecticut, United States, 06511 Less <<
NCT03770637 Hyperinsulinemic Hypoglycemia Phase 2 Not yet recruiting June 2019 United States, Colorado ... More >> University of Colorado-Denver Not yet recruiting Aurora, Colorado, United States, 80045 Contact: Emma Hulseberg-Dwyer    720-848-5146    EMMA.HULSEBERGDWYER@UCDENVER.EDU    Principal Investigator: Helen Lawler, MD          United States, Maryland Johns Hopkins Hospital Not yet recruiting Baltimore, Maryland, United States, 21287 Contact: Alexis Page    410-502-0993    apage20@jhmi.edu    Principal Investigator: Clare Lee, MD          United States, Massachusetts Joslin Diabetes Center Not yet recruiting Boston, Massachusetts, United States, 02215 Contact: Charlene Coneys    617-732-2400    Charlene.coneys@joslin.harvard.edu    Principal Investigator: Mary-Elizabeth Patti, MD          United States, Minnesota Mayo Clinic- Rochester Not yet recruiting Rochester, Minnesota, United States, 55905 Contact: Paula Giesler    507-255-8345    giesler.paula@mayo.edu    Principal Investigator: Adrian Vella, MD          United States, North Carolina Duke Early Phase Clinical Research Not yet recruiting Durham, North Carolina, United States, 27701 Contact: Jenny Tong, MD    919-684-1672    jenny.tong@duke.edu    Principal Investigator: Jenny Tong, MD Less <<
NCT02601989 Diabetes Mellitus, Type 2 Phase 2 Recruiting December 2018 Sweden ... More >> Sahlgrenska University Hospital Recruiting Gothenburg, Sweden, 41345 Contact: Per-Anders Jansson, Professor    +46(31)3421000    per-anders.jansson@medic.gu.se Less <<
NCT02513615 - Recruiting September 2017 Canada, Ontario ... More >> St. Joseph's Healthcare Recruiting Hamilton, Ontario, Canada, L8N 4a6 Contact: Peter Margetts    9055221155 ext 32299    margetts@mcmaster.ca Less <<
NCT00530023 Type 1 Diabetes Phase 4 Completed - United States, California ... More >> Diabetes Treatment Center, Loma Linda University Loma Linda, California, United States, 92354 United States, Oregon Portland Diabetes & Endocrinology Portland, Oregon, United States, 97210 Less <<
NCT00411411 - Completed - -
NCT00411411 Type 2 Diabetes Phase 3 Completed - Denmark ... More >> Gentofte Hospital Hellerup, Denmark, 2900 Less <<
NCT00530023 - Completed - -
NCT00508599 Type 2 Diabetes ... More >> Insulin Resistance Less << Not Applicable Completed - United States, New Mexico ... More >> University of New Mexico, Clinical Translational Science Center Albuquerque, New Mexico, United States, 87131 Less <<
NCT02514850 Type 2 Diabetes Mellitus Phase 1 Completed - Germany ... More >> Profil Institut für Stoffwechselforschung GmbH Neuss, Germany, 41460 Less <<
NCT03660553 Type 2 Diabetes Mellitus Phase 4 Recruiting June 30, 2020 United States, Florida ... More >> University of Miami Recruiting Miami, Florida, United States, 33136 Contact: Rajesh Garg, MD    305-689-0257    rgarg@miami.edu    Principal Investigator: Rajesh Garg, MD          Sub-Investigator: Daniela Pirela, MD Less <<
NCT01556594 Hypoglycemia Phase 2 Completed - Canada, Quebec ... More >> Algorithme Pharma Montreal, Quebec, Canada, H3P 3P1 Less <<
NCT00289354 Diabetes Mellitus, Type 2 Not Applicable Completed - -
NCT00372762 Heart Failure Phase 3 Withdrawn(Due to changes withi... More >>n the research program this study is not feasible at this time) Less << June 2013 Canada, Ontario ... More >> University Hospital, London Health Sciences Centre London, Ontario, Canada, N6A 5A5 Less <<
NCT01408329 - Completed - -
NCT03687229 - Not yet recruiting February 2022 -
NCT01556594 - Completed - -
NCT01669616 - Completed - United States, Louisiana ... More >> Blue Cross Blue Shield of Louisiana Baton Rouge, Louisiana, United States, 70809 Less <<
NCT01408329 Hypoxia Not Applicable Completed - -
NCT02600845 Diabetes Mellitus, Type 1 Not Applicable Completed - United States, Alabama ... More >> Montgomery, Alabama, United States, 36105 United States, California Huntington Beach, California, United States, 92648 United States, Georgia Atlanta, Georgia, United States, 30318 Macon, Georgia, United States, 31210 United States, Mississippi Ocean Springs, Mississippi, United States, 39564 United States, Nebraska Lincoln, Nebraska, United States, 68521 United States, North Carolina Raleigh, North Carolina, United States, 27609 Wilmington, North Carolina, United States, 28401 United States, Pennsylvania Pottstown, Pennsylvania, United States, 19464 United States, Tennessee Bristol, Tennessee, United States, 37620 United States, Texas Plano, Texas, United States, 75075 Less <<
NCT01230749 Diabetes Mellitus, Type 2 Phase 2 Completed - -
NCT01230749 - Completed - -
NCT03241121 Eating Behavior ... More >> Metabolic Syndrome Obesity Dyslipidemias Glucose Intolerance Steatosis of Liver Less << Not Applicable Recruiting December 2019 Switzerland ... More >> University Hospital of Lausanne (CHUV) Recruiting Lausanne, Switzerland, 1011 Contact: Tinh-Hai Collet, MD       tinh-hai.collet@chuv.ch Less <<
NCT00285896 Type 2 Diabetes Not Applicable Completed - Denmark ... More >> Department of pharmacology, Aarhus university and Medical department M, Aarhus University hospital Aarhus, Denmark, 8000 Less <<
NCT00171717 Maintenance Liver Transplant P... More >>atients With New Onset Diabetes Less << Phase 4 Completed - -
NCT02600845 - Completed - -
NCT03310502 - Recruiting December 31, 2019 Finland ... More >> Turku PET Centre (Turku University Hospital) Recruiting Turku, Finland, 20521 Contact: Pirjo Nuutila, M.D., Ph.D.    +358 2 2611 868    pirnuu@utu.fi Less <<
NCT00362323 Dyslipidemia/Glucose Metabolis... More >>m Disorder Less << Phase 3 Completed - -
NCT02446834 Polycystic Ovary Syndrome Not Applicable Unknown August 2017 China, Shanghai ... More >> Renji Hospital Department of Endocrinology and Metabolism Recruiting Shanghai, Shanghai, China, 200127 Contact: Wei Liu, MD    +86-18918358342    sue_liuwei@163.com    Contact: Jing Ma, MD    +86-15800983436    cherry1996@live.cn Less <<
NCT01263483 - Completed - -
NCT01115205 Type 2 Diabetes Not Applicable Completed - -
NCT03102463 Insulin Resistance Not Applicable Completed - Ireland ... More >> St Vincent's University Hospital Dublin, Ireland, D4 Less <<
NCT00993473 Type 1 Diabetes Mellitus Phase 3 Completed - -
NCT01263483 Type 2 Diabetes Mellitus Phase 2 Phase 3 Completed - -
NCT03151837 Diabetes Mellitus, Type 2 Not Applicable Completed - Taiwan ... More >> Chung Shan Medical University Hospital Taichung, Taiwan, 40201 Less <<
NCT00993473 - Completed - -
NCT01818583 Atrial Fibrillation ... More >> Atrial Flutter Less << Phase 4 Completed - Norway ... More >> Diakonhjemmet Hospital Oslo, Norway, 0370 Less <<
NCT00608348 Diabetes Mellitus Not Applicable Completed - United States, Tennessee ... More >> Vanderbilt University Nashville, Tennessee, United States, 37232 Less <<
NCT01318070 Type 2 Diabetes Mellitus Phase 2 Phase 3 Completed - -
NCT01771926 Obesity Not Applicable Completed - United States, North Dakota ... More >> Grand Forks Human Nutrition Research Center Grand Forks, North Dakota, United States, 58203 Less <<
NCT02811172 - Unknown - Spain ... More >> Universidad de Granada Recruiting Granada, Spain, 18071 Contact: María José Aguilar Cordero, Professor    +34657841751    mariajaguilar@telefonica.net Less <<
NCT01704482 Cardiac Surgery for Rheumatic ... More >>Valvular Heart Disease Renal Dysfunction Less << Phase 2 Completed - Egypt ... More >> Assiut University hospital Assiut, Egypt, 11111 Less <<
NCT00741923 Overweight Ob... More >>esity Metabolic Syndrome Diabetes Hypertension Less << Not Applicable Completed - Canada, Ontario ... More >> Department of Nutritional Sciences, University of Toronto Toronto, Ontario, Canada, M5S 3E2 Less <<
NCT01318070 - Completed - -
NCT03000231 - Recruiting December 2017 United States, Illinois ... More >> The University of Chicago Recruiting Chicago, Illinois, United States, 60637 Contact: Eve Van Cauter, PhD    773-702-0169    evcauter@medicine.bsd.uchicago.edu    Contact: Susan Sam, MD    773-702-5641    ssam@medicine.bsd.uchicago.edu    Principal Investigator: Eve Van Cauter, PhD Less <<
NCT00206401 Type 1 Diabetes Phase 4 Completed - United States, Texas ... More >> Texas Children's Hospital Houston, Texas, United States, 77030 Less <<
NCT00937222 Type 2 Diabetes Not Applicable Completed - United States, California ... More >> Loma Linda University Medical Center Diabetes Treatment Center Loma Linda, California, United States, 92350 Less <<
NCT01779375 Prediabetes T... More >>ype 2 Diabetes Less << Phase 3 Completed - United States, Colorado ... More >> Childrens Hospital Colorado Denver, Colorado, United States, 80045 United States, Connecticut Yale School of Medicine Pediatric Obesity and Type 2 Diabetes Clinic New Haven, Connecticut, United States, 06511 United States, Indiana Indiana University Indianapolis, Indiana, United States, 46202 United States, Pennsylvania Children's Hospital of Pittsburgh of UPMC Pittsburgh, Pennsylvania, United States, 15224 Less <<
NCT01452087 Obesity Not Applicable Completed - United States, Michigan ... More >> Substrate Metabolism Laboratory Ann Arbor, Michigan, United States, 48109 Less <<
NCT01347801 Hypoglycaemia Not Applicable Completed - Denmark ... More >> Centre of Inflammation and Metabolism - Rigshospitalet 7641 Copenhagen, Denmark, 2100 University of Copenhagen Copenhagen, Denmark, 2400 Less <<
NCT01456130 Diabetes Mellitus Phase 3 Completed - Japan ... More >> Nagoya-shi, Aichi, Japan Fukuoka-shi, Fukuoka, Japan Kurume-shi, Fukuoka, Japan Sapporo-shi, Hokkaido, Japan Kobe-shi, Hyogo, Japan Kagoshima-shi, Kagoshima, Japan Kumamoto-shi, Kumamoto, Japan Osaki-shi, Miyagi, Japan Minou-shi, Osaka, Japan Osaka-shi, Osaka, Japan Kamio-shi, Saitama, Japan Koshigaya-shi, Saitama, Japan Adachi-ku, Tokyo, Japan Chuo-ku, Tokyo, Japan Less <<
NCT03685916 Metabolic Disease Not Applicable Recruiting April 2020 Singapore ... More >> Clinical Nutrition Research Centre Recruiting Singapore, Singapore, 117599 Contact: Jeya Christaini Henry, Phd    6407 0793    jeya_henry@sics.a-star.edu.sg    Contact: Sumanto Haldar, Phd    6407 4052    sumanto_haldar@sics.a-star.edu.sg Less <<
NCT02013739 - Completed - Belgium ... More >> Hasselt University Hasselt, Limburg, Belgium, 3500 Less <<
NCT02294474 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT02815943 Type 2 Diabetes ... More >> Obese Less << Not Applicable Recruiting December 2018 Canada, Quebec ... More >> Centre de recherche du CHUS Recruiting Sherbrooke, Quebec, Canada, J1H 5N4 Contact: Frédérique Frisch, MSc    8193461110 ext 12394    frederique.frisch@usherbrooke.ca    Contact: Christophe Noll, PhD    8193461110 ext 15940    christophe.noll@usherbrooke.ca Less <<
NCT02294474 - Completed - -
NCT00896025 Acute Liver Failure ... More >> Fulminant Hepatic Failure Less << Phase 4 Terminated(The low enrollment ... More >>did not provide statistical power for any meaningful results.) Less << - -
NCT01456130 - Completed - -
NCT01779375 - Completed - -
NCT01189890 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT02177604 Insulin Resistance Not Applicable Terminated(Lack of funding) - Australia, South Australia ... More >> South Australian Health & Medical Research Institute Adelaide, South Australia, Australia, 5000 Less <<
NCT00896025 - Terminated(The low enrollment ... More >>did not provide statistical power for any meaningful results.) Less << - -
NCT01189890 - Completed - -
NCT02627911 Closed Loop D... More >>iabetes Mellitus, Type 1 Less << Phase 2 Completed - France ... More >> Hôpital Jean Minjoz Besançon, France, 25030 Centre Hospitalier Universitaire Caen, France, 14033 Centre Hospitalier Sud-Francilien Corbeil-Essonnes, France, 91100 Centre Hospitalier Universitaire Grenoble, France, 38700 Centre Hospitalier Universitaire Marseille, France, 13000 Centre Hospitalier Universitaire Montpellier, France, 34295 Centre Hospitalier Universitaire Nancy, France, 54000 Centre Hospitalier Universitaire Strasbourg, France, 67000 Centre Hospitalier Universitaire Toulouse, France, 31400 Less <<
NCT00885118 Diabetes Mellitus, Type 2 Phase 2 Completed - Japan ... More >> 1245.15.003 Boehringer Ingelheim Investigational Site Hachioji, Tokyo, Japan 1245.15.002 Boehringer Ingelheim Investigational Site Koganei, Tokyo, Japan 1245.15.001 Boehringer Ingelheim Investigational Site Nakano-ku, Tokyo, Japan 1245.15.005 Boehringer Ingelheim Investigational Site Suita, Osaka, Japan 1245.15.004 Boehringer Ingelheim Investigational Site Yokohama, Kanagawa, Japan Less <<
NCT00992537 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 1 Completed - Germany ... More >> Neuss, Germany, 41460 Less <<
NCT01421459 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT00885118 - Completed - -
NCT00135941 Diabetes Mellitus Phase 3 Completed - United States, Wisconsin ... More >> Advanced Healthcare Milwaukee, Wisconsin, United States, 53209 Less <<
NCT00862602 Gestational Diabetes Not Applicable Completed - United States, Michigan ... More >> University of Michigan Health System Ann Arbor, Michigan, United States, 48109 Less <<
NCT00597233 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 4 Completed - Argentina ... More >> Novo Nordisk Investigational Site Junin, Argentina Less <<
NCT02184507 Coronary Artery Disease Phase 2 Completed - -
NCT01421459 - Completed - -
NCT00817440 Healthy Not Applicable Completed - Denmark ... More >> Aarhus sygehus Aarhus, Jylland, Denmark, 8000 Less <<
NCT00014768 - Terminated - United States, Utah ... More >> University of Utah School of Medicine Salt Lake City, Utah, United States, 84132 Less <<
NCT01792284 - Completed - -
NCT03165773 Glycemic and Insulinemic Respo... More >>nse Less << Not Applicable Completed - Canada ... More >> Glycemic Index Laboratories Toronto, Canada Less <<
NCT01792284 Type 1 Diabetes Mellitus Phase 3 Completed - United States, California ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Concord, California, United States, 94520 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Escondido, California, United States, 92026 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fresno, California, United States, 93720 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tustin, California, United States, 92780 United States, Colorado For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Aurora, Colorado, United States, 80045 United States, Georgia For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Roswell, Georgia, United States, 30076 United States, Idaho For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Idaho Falls, Idaho, United States, 83404 United States, Illinois For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Crystal Lake, Illinois, United States, 60012 United States, Iowa For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Des Moines, Iowa, United States, 50314 United States, Kansas For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Topeka, Kansas, United States, 66606 United States, Kentucky For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lexington, Kentucky, United States, 40503 United States, Oklahoma For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Oklahoma City, Oklahoma, United States, 73104 United States, South Carolina For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Greer, South Carolina, United States, 29651 United States, Tennessee For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chattanooga, Tennessee, United States, 37411 United States, Texas For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Austin, Texas, United States, 78731 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Dallas, Texas, United States, 75230 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Round Rock, Texas, United States, 78681 Puerto Rico For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bayamon, Puerto Rico, 00961 Less <<
NCT01637272 - Completed - -
NCT02893072 Diabetes, Gestational Not Applicable Recruiting June 2019 China, Hunan ... More >> the Third Xiangya Hospital of Central South University Recruiting Changsha, Hunan, China, 410013 Contact: Min Liu, M.D.    86-731-88618717    liumin330@hotmail.com    Contact: Meng Wang, M.M.    86-731-88618717    znxywm@163.com    Principal Investigator: Min Liu, M.D. Less <<
NCT00528918 Diabetes Mellitus, Type II Not Applicable Completed - United States, Arizona ... More >> Phoenix VA Health Care System Phoenix, Arizona, United States, 85012 Less <<
NCT00860613 Gestational Diabetes ... More >> Type 2 Diabetes Less << Not Applicable Completed - Mexico ... More >> Instituto Nacional de Perinatologia Isidro Espinosa de los Reyes Mexico, Mexico City, Mexico, 11700 Less <<
NCT01614769 Type 2 Diabetes Mellitus Phase 1 Completed - -
NCT01809288 - Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT02964572 Type2 Diabetes Mellitus Not Applicable Recruiting October 2018 Korea, Republic of ... More >> Yonsei University College of Medicine, Department of Internal Medicine, Division of Endocrinology, Severance Hospital, Diabetes center Recruiting Seoul, Korea, Republic of, 03722 Contact: Yong-ho Lee, M.D., Ph.D.    82-2-2228-1943    yholee@yuhs.ac Less <<
NCT01614769 - Completed - -
NCT01637272 Dumping Syndrome Phase 2 Completed - United States, California ... More >> Ximed Center for Weight Management Ximed Research La Jolla, California, United States, 92037 Stanford University Medical Center SC - SOM230X2203 Stanford, California, United States, 94304 United States, Minnesota Mayo Clinic - Rochester Mayo MN Rochester, Minnesota, United States, 55905 United States, New York Montefiore Medical Center CLCZ696B2320 Bronx, New York, United States, 10467 United States, Texas Texas Tech University Health Science Center El Paso, Texas, United States, 79905 United States, Virginia Virginia Endocrinology Research SC Chesapeake, Virginia, United States, 23321 Belgium Novartis Investigative Site Brugge, Belgium, 8310 Novartis Investigative Site Bruxelles, Belgium, 1200 Novartis Investigative Site Gent, Belgium, 9000 Novartis Investigative Site Leuven, Belgium, 3000 France Novartis Investigative Site Paris Cedex 13, France, 75651 Novartis Investigative Site Pessac Cedex, France, 33604 Novartis Investigative Site Pierre-Benite Cedex, France, 69495 Germany Novartis Investigative Site Hamburg, Germany, 20246 Novartis Investigative Site Würzburg, Germany, 97080 Netherlands Novartis Investigative Site Groningen, Netherlands, 9713 GZ Novartis Investigative Site Utrecht, Netherlands, 3584CX Less <<
NCT01340768 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT01340768 - Completed - -
NCT00472875 Type 1 Diabetes Mellitus Phase 4 Unknown - United Kingdom ... More >> King's College Hospital NHS Foundation Trust Recruiting London, United Kingdom, SE5 9RS Sub-Investigator: David Hopkins, MBBS FRCP Less <<
NCT00999856 Diabetes Care Phase 2 Terminated(Two cohorts success... More >>fully completed; further cohorts not needed; no safety issue!) Less << - Germany ... More >> Diabetes Instiut Heidelberg Heidelberg, Germany, 69115 Less <<
NCT02409784 - Completed - -
NCT03590158 Type2 Diabetes ... More >> Obesity Less << Not Applicable Recruiting June 30, 2020 Australia, South Australia ... More >> University of Adelaide Recruiting Adelaide, South Australia, Australia Contact: Leonie K Heilbronn, PhD    +61 8128 4838    leonie.heilbronn@adelaide.edu.au    Principal Investigator: Leonie K Heilbronn, PhD Less <<
NCT02919839 - Not yet recruiting January 2019 -
NCT02769377 Diabetes Phase 4 Unknown December 2016 Taiwan ... More >> Taichung Veterans General Hospital Recruiting Taichung, Taiwan, 40705 Contact: Wayne H Sheu, MD, PhD    886-4-23592525 ext 3068    whhsheu@vghtc.gov.tw    Sub-Investigator: Jun-Sing Wang, MD Less <<
NCT02409784 Healthy Early Phase 1 Completed - -
NCT02701257 Diabetes Mellitus Type 1 Not Applicable Terminated - United States, Massachusetts ... More >> MGH Diabetes Research Center Boston, Massachusetts, United States, 02114 Less <<
NCT03514576 Hypoglycemia, Reactive Phase 4 Enrolling by invitation November 1, 2018 Denmark ... More >> Zealand University Hospital Køge, Denmark, 4600 Less <<
NCT00639808 Gastroparesis ... More >> Diabetes Mellitus Less << Phase 1 Completed - Denmark ... More >> Aarhus Hospital Aarhus, Denmark Hvidore Hospital Copenhagen, Denmark Sweden Karolinska University Hospital Stockholm, Sweden Less <<
NCT03083600 PreDiabetes Not Applicable Terminated(The Study was not r... More >>ecruiting) Less << - Ireland ... More >> Atlantia Food Clinical Trials, University College Cork Cork, Munster, Ireland, T12 H2TK Less <<
NCT01173926 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 1 Completed - Germany ... More >> Neuss, Germany, 41460 Less <<
NCT02536859 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 1 Completed - Germany ... More >> Novo Nordisk Investigational Site Neuss, Germany, 41460 Less <<
NCT02568904 - Enrolling by invitation January 2020 Austria ... More >> Department of Internal Medicine, Medical University of Graz Graz, Austria, 8010 Less <<
NCT01301287 Diabetes Not Applicable Unknown - Taiwan ... More >> Cardinal Tien Hospital Recruiting New Taipei City, Taiwan, 23137 Contact: Fone-Ching Hsiao, MD       foneching.hsiao@gmail.com Less <<
NCT00536237 Flushing Phase 2 Completed - -
NCT00308737 - Completed - -
NCT00308737 Diabetes, Type 1 ... More >> Diabetes, Type 2 Less << Phase 3 Completed - -
NCT00479466 - Terminated(Sufficient data reg... More >>arding the dose-response to MK-0893 had been obtained from the first cohort of the study to assess the safety and efficacy) Less << - -
NCT00935532 - Completed - -
NCT01433705 Heart Disease Phase 1 Active, not recruiting June 2020 United States, Michigan ... More >> University of Michigan Hospital Ann Arbor, Michigan, United States, 48109 Less <<
NCT00935532 Type 2 Diabetes Mellitus Phase 3 Completed - Japan ... More >> Research Site Aomori, Japan Research Site Chiba, Japan Research Site Ehime, Japan Research Site Fukuoka, Japan Research Site Gunma, Japan Research Site Hiroshima, Japan Research Site Hokkaido, Japan Research Site Hyogo, Japan Research Site Ibaragi, Japan Research Site Kagawa, Japan Research Site Kanagawa, Japan Research Site Kumamoto, Japan Research Site Kyoto, Japan Research Site Nagano, Japan Research Site Nagasaki, Japan Research Site Nara, Japan Research Site Oita, Japan Research Site Osaka, Japan Research Site Saitama, Japan Research Site Shizuoka, Japan Research Site Tokyo, Japan Research Site Toyama, Japan Less <<
NCT03331432 Type 2 Diabetes Mellitus Not Applicable Completed - United States, Missouri ... More >> University of Missouri Columbia, Missouri, United States, 65211 Less <<
NCT00460499 Glycemic Control Phase 1 Completed - United States, Massachusetts ... More >> Boston Medical Center Boston, Massachusetts, United States, 02118 Less <<
NCT00479466 Diabetes Mellitus, Type 2 Phase 2 Terminated(Sufficient data reg... More >>arding the dose-response to MK-0893 had been obtained from the first cohort of the study to assess the safety and efficacy) Less << - -
NCT03076775 Pregnancy Preterm ... More >> Neonatal Hypoglycemia Hyperglycemia Drug Induced Less << Not Applicable Recruiting May 30, 2020 United States, North Carolina ... More >> University of North Carolina - Chapel Hill Recruiting Chapel Hill, North Carolina, United States, 27599 Contact: Ashley N Battarbee, MD Less <<
NCT00738114 - Completed - United States, Georgia ... More >> Emory Universiy Hospital Atlanta, Georgia, United States, 30322 Less <<
NCT01112709 Diabetes Pred... More >>iabetes Less << Phase 2 Completed - United States, Virginia ... More >> Virginia Tech Blacksburg, Virginia, United States, 24061 VT Riverside Roanoke, Virginia, United States, 24016 Less <<
NCT01293669 Type 2 Diabetes Mellitus Phase 2 Completed - United States, Arkansas ... More >> Clopton Clinic Jonesboro, Arkansas, United States, 72401 NCA Medical Center Mountain Home, Arkansas, United States, 72653 United States, California Associated Pharmaceutical Research Center Buena Park, California, United States, 90620 United States, Illinois Cedar Crosse Research Center Chicago, Illinois, United States, 60607 United States, Missouri Medex Healthcare Research, Inc St. Louis, Missouri, United States, 63117 United States, Nevada Om Medical Henderson, Nevada, United States, 89052 United States, New York MEDEX Healthcare Research, Inc New York, New York, United States, 10004 United States, North Carolina PMG Research of WS Winston-Salem, North Carolina, United States, 27103 United States, Ohio Rapid Medical Research, Inc. Cleveland, Ohio, United States, 44122 Providence Health Partners - Center for Research Dayton, Ohio, United States, 45439 United States, Rhode Island Omega Medical Research Warwick, Rhode Island, United States, 02888 United States, South Carolina Ellipsis Research Columbia, South Carolina, United States, 29201 PMG Research of Charleston Mt. Pleasant, South Carolina, United States, 29464 United States, Tennessee New Phase Research and Development Knoxville, Tennessee, United States, 37923 United States, Texas Mercury Clinical Research Houston, Texas, United States, 77093 Quality Research, Inc. San Antonio, Texas, United States, 78209 United States, Utah Highland Clinical Research Salt Lake City, Utah, United States, 84124 United States, Virginia Strelitz Diabetes Center, Eastern Virginia Medical School Norfolk, Virginia, United States, 23510 Less <<
NCT01722578 Cirrhosis of Liver ... More >> Hepatic Encephalopathy Less << Phase 4 Completed - India ... More >> Department of Gastroenterology, D.M.C. and Hospital Ludhiana, Punjab, India, 141001 G.B. Pant Hospital New Delhi, India, 110002 Less <<
NCT00499148 Type 2 Diabetes Phase 2 Phase 3 Completed - United States, Minnesota ... More >> Radiant Research Edina, Minnesota, United States, 55435 United States, Ohio Radiant Research Cincinnati, Ohio, United States, 45249 Less <<
NCT01028391 - Completed - -
NCT00198926 Type 2 Diabetes Mellitus Not Applicable Completed - United States, Maryland ... More >> Johns Hopkins University Baltimore, Maryland, United States, 21093 Less <<
NCT01964963 - Completed - Japan ... More >> Tokyo, Japan Less <<
NCT01028391 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT01990300 - Completed - -
NCT02440061 Type 2 Diabetes Mellitus Phase 1 Withdrawn(This protocol was re... More >>placed with a different one and therefore discontinued.) Less << June 2019 United States, North Carolina ... More >> Duke Center For Living Durham, North Carolina, United States, 27705 Less <<
NCT01777893 Pre-diabetes ... More >>Obesity Less << Not Applicable Active, not recruiting December 2018 Australia ... More >> University of Sydney Sydney, Australia, NSW 2006 Bulgaria Medical University Sofia Sofia, Bulgaria, 1403 Denmark University of Copenhagen Frederiksberg, Denmark, 1958 Finland University of Helsinki Helsinki, Finland, 00014 Netherlands University of Maastricht Maastricht, Netherlands, 6200 New Zealand University of Auckland Auckland, New Zealand, 1024 Spain University of Navarra Pamplona, Spain, 31008 United Kingdom University of Nottingham Medical School Nottingham, United Kingdom, NG7 2UH Swansea University Swansea, United Kingdom, SA1 8EN Less <<
NCT02985853 - Active, not recruiting September 2019 -
NCT02449317 X-ray Contrast Media Adverse R... More >>eaction Less << Not Applicable Completed - -
NCT02280486 Type 2 Diabetes Phase 4 Completed - China, Jiangsu ... More >> at Division of Endocrinology, the Affiliated Drum Tower Hospital of Nanjing University Nanjing, Jiangsu, China, 210008 Less <<
NCT02711059 Hyperparathyroidism ... More >> Diabetes Hypercalcemia Less << Not Applicable Recruiting June 2020 Sweden ... More >> Karolinska University Hospital Recruiting Stockholm, Sweden, SE-17176 Contact: Inga-Lena Nilsson, MD, PhD    +46702167535    inga-lena.nilsson@ki.se    Contact: Rebecka Hallbeck, Res. ass.    +46725836757    rebecka.hallbeck@karolinska.se Less <<
NCT01632046 Chronic Renal Failure ... More >> Peritoneal Membrane Disorder Less << Phase 4 Completed - Austria ... More >> University Children's Hospital Vienna, Austria, 1090 Finland University Children's Hospital Helsinki, Finland, 00029 France University Children's Hospital Strasbourg, France, 67098 Germany University Children's Hospital Essen, Germany, 45122 University Children´s Hospital Hamburg, Germany, 20246 University Children's Hospital Jena, Germany, 07740 Italy University Children`s Hospital Milan, Italy, 20122 Less <<
NCT00991653 - Completed - -
NCT00630825 Diabetes Mellitus Type 2 Phase 2 Completed - -
NCT00868140 - Terminated(Lack of recruitment... More >>) Less << - -
NCT00868140 Polycystic Ovary Syndrome Not Applicable Terminated(Lack of recruitment... More >>) Less << - United States, Virginia ... More >> Virginia Commonwealth University General Clinical Research Center Richmond, Virginia, United States, 23298 Venezuela Hospital de Clinical Caracas Caracas, Venezuela, 1071 Less <<
NCT02165566 Hyperglycemia Phase 4 Completed - Italy ... More >> University of ROme "La Sapienza" Rome Italy Rome, Italy Less <<
NCT01617304 Obesity Type ... More >>2 Diabetes Insulin Resistance Cardiovascular Disease Less << Not Applicable Completed - Denmark ... More >> Department of Human Nutrition, University of Copenhagen Frederiksberg, Denmark Less <<
NCT03226457 Heart Failure ... More >> Type 2 Diabetes Mellitus Less << Phase 4 Active, not recruiting February 2019 United Kingdom ... More >> University of Dundee, Ninewells Hospital and Medical School Dundee, Angus, United Kingdom, DD1 9SY Less <<
NCT01454284 Diabetes Mellitus, Type 1 Phase 3 Completed - -
NCT03039673 Amyotrophic Lateral Sclerosis Phase 2 Recruiting June 2021 France ... More >> CHRU de Lille - Hôpital Roger Salengro Recruiting Lille, France, 59037 Principal Investigator: Dr Véronique Danel, MD, PhD          CHU de Limoges - Hôpital Dupuytren Recruiting Limoges, France, 87042 Principal Investigator: Philippe Couratier, MD, PhD          HCL - Hôpital Neurologique P. Wertheimer Recruiting Lyon, France, 69677 Principal Investigator: Dr Emilien Bernard, MD, PhD          APHM - Hôpital de la Timone Recruiting Marseille, France, 13385 Principal Investigator: P Shahram Attarian, MD, PHD          CHRU de Montpellier - Hôpital Gui de Chauliac Recruiting Montpellier Cedex 5, France, 34295 Principal Investigator: William Camu, MD, PhD          CHU de Nice - Hôpital Pasteur Recruiting Nice, France, 06002 Principal Investigator: Hélène Soriani, MD, PhD          APHP - Groupe Hospitalier Pitié-Salpetrière Recruiting Paris Cedex 13, France, 75651 Principal Investigator: François Salachas, MD          CENTRE HOSPITALIER DE SAINT BRIEUC - Hôpital Yves Le Foll Recruiting Saint Brieuc, France, 22027 Principal Investigator: Kolev Ivan, MD,PhD          CHU de Strasbourg - Hôpital de Hautepierre Recruiting Strasbourg, France, 67098 Principal Investigator: Marie FLEURY-LESAUNIER, MD,PhD          CHRU de Tours - Hôpital Bretonneau Recruiting Tours, France, 37044 Principal Investigator: Philippe Corcia, MD, PhD          United Kingdom Trafford Centre for Biomedical Research Recruiting Brighton, United Kingdom, BN1 9RY Principal Investigator: P Nigel Leigh, MD, PhD          Institute of Neurological Sciences, Queen Elizabeth University Hospital Recruiting Glasgow, United Kingdom, G514TF Principal Investigator: George Gorrie, MD,PhD          North-East London and Essex MND Regional Care Centre Recruiting London, United Kingdom, E1 4NS Principal Investigator: Andrea Malaspina, MD, PhD          King's MND Care and Research Centre Recruiting London, United Kingdom, SE5 8AF Principal Investigator: Ammar Al-Chalabi, MD, PhD          Centre for Neuromuscular Diseases - National Hospital of Neurology Recruiting London, United Kingdom, WC1N 3BG Principal Investigator: Dr Nikhil SHARMA, MD, PhD          Sheffield Care and Research Centre Recruiting Sheffield, United Kingdom, S10 2JF Principal Investigator: Pamela J Shaw, MD, PhD Less <<
NCT02470637 Type 1 Diabetes Mellitus Phase 1 Completed - Germany ... More >> Investigational Site Number 276001 Neuss, Germany, 41460 Less <<
NCT02061488 Type 1 Diabetes Not Applicable Completed - France ... More >> Rennes University Hospital Rennes, France, 35033 Less <<
NCT00630825 - Completed - -
NCT01454284 - Completed - -
NCT03162237 Type 1 Diabetes Not Applicable Enrolling by invitation December 2020 China, Hunan ... More >> Cell Transplantation and Gene Therapy Institute Changsha, Hunan, China, 410013 Less <<
NCT02086396 Obesity Not Applicable Completed - Brazil ... More >> Federal University of Rio de Janeiro Rio de Janeiro, Brazil, 21941-913 Less <<
NCT01755273 Pancreaticoduodenectomy ... More >> Diabetes Less << Not Applicable Unknown - Taiwan ... More >> National taiwan University Hospital Recruiting Taipei, Taiwan, 100 Contact: Jin-Ming Wu, M.D.       kptkptkpt@yahoo.com.tw    Principal Investigator: Yu-Wen Tien, M.D. PhD Less <<
NCT00700154 Diabetes Mellitus ... More >> Insulin Resistance Hyperglycemia Surgery Ulcers Infection Less << Phase 4 Unknown November 2017 Sweden ... More >> Department of Vascular Surgery, Karolinska University Hospital Stockholm, Sweden, SE-171 76 Less <<
NCT01435616 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT02528695 Diabetes Mellitus Type 2 Not Applicable Completed - Netherlands ... More >> RadboudUMC Nijmegen, Gelderland, Netherlands, 6500HB Less <<
NCT01435616 - Completed - -
NCT00222846 Diabetes Mellitus, Type 2 ... More >> Diabetic Nephropathy Less << Not Applicable Completed - United States, Pennsylvania ... More >> University of Pittsburgh School of Medicine Pittsburgh, Pennsylvania, United States, 15213 Less <<
NCT03493984 Polycystic Ovary Syndrome Not Applicable Not yet recruiting May 2019 -
NCT00881543 Diabetes Type 2 Not Applicable Completed - Brazil ... More >> University of São Paulo General Hospital São Paulo, Brazil Less <<
NCT00642915 Diabetes Mellitus Phase 4 Completed - Brazil ... More >> Sanofi-Aventis Sao Paulo, Brazil Less <<
NCT01481779 - Completed - -
NCT00451620 Type 2 Diabetes Phase 2 Completed - Canada, British Columbia ... More >> University of British Columbia Vancouver, British Columbia, Canada Less <<
NCT03143803 Diabetes Mellitus Not Applicable Completed - India ... More >> Mazumdar Shaw Medical Centre Bangalore, Karnataka, India, 560099 Less <<
NCT03738865 Insulin Hypoglycemia ... More >> Type 1 Diabetes Mellitus Severe Hypoglycemia Less << Phase 3 Recruiting April 2019 United States, California ... More >> Diablo Clinical Research Recruiting Walnut Creek, California, United States, 94598 Contact: Erica Bingham, RN    925-930-7267    ebingham@diabloclinical.com    Principal Investigator: Mark Christiansen, MD          United States, Georgia Atlanta Diabetes Associates Recruiting Atlanta, Georgia, United States, 30318 Contact: Betsy Childs, BSN, RN    404-355-4393 ext 864    bchilds@atlantadiabetes.com    Principal Investigator: Bruce Bode, MD          United States, Nevada PPD-Las Vegas Clinical Research Unit Recruiting Las Vegas, Nevada, United States, 89113 Contact: Marjorie Hyderkhan    702-963-1580    Marjorie.Hyderkhan@ppdi.com    Principal Investigator: Samer Nakhle, MD          United States, Washington Rainier Research Center Recruiting Renton, Washington, United States, 98057 Contact: Lisa Aaker    425-251-1720 ext 19    laaker@rainier-research.com    Principal Investigator: Leslie Klaff, MD, PhD          Austria Medizinische Universität Graz-Center for Medical Research Not yet recruiting Graz, Austria, 8010 Contact: Daniela Schwarzenbacher    43-316-385-82383    daniela.schwarzenbacher@medunigraz.at    Principal Investigator: Thomas Pieber, PhD          Canada, Ontario LMC Diabetes & Endocrinology Recruiting Toronto, Ontario, Canada, M4G 3E8 Contact: Nichole McKay    41+-645-2929 ext 9225    nichole.mckay@lmcmanna.com    Principal Investigator: Ronnie Aronson, MD          Germany Profil Institut für Stoffwechselforschung GmbH Not yet recruiting Neuss, Germany, 41460 Contact: Andre Feldmann    49 (0) 2131-4018-450    andre.feldmann@profil.com    Principal Investigator: Oliver Klein, MD          Institut für Diabetes-Technologie Not yet recruiting Ulm, Germany, 89081 Contact: Tobias Naser    0731-50-99-00    tobias.naser@idtulm.De    Principal Investigator: Theodor Rudolf, MD Less <<
NCT02011217 Appetite Regulation Not Applicable Completed - Sweden ... More >> Paediatric Research Facility; The Children's Hospital at Uppsala University Hospital Uppsala, Sweden, SE-751 85 Less <<
NCT01326611 Chronic Lung Disease Phase 4 Completed - Turkey ... More >> Zekai Tahir Burak Maternity Teaching Hospital Neonatology department Ankara, Turkey, 06600 Less <<
NCT01481779 Diabetes Mellitus, Type 1 Phase 3 Completed - -
NCT00593255 Diabetes Diab... More >>etes Mellitus, Type 1 Diabetes Mellitus, Type 2 Less << Phase 4 Completed - China, Beijing ... More >> Novo Nordisk Investigational Site Beijing, Beijing, China, 100034 Novo Nordisk Investigational Site Beijing, Beijing, China, 100101 Novo Nordisk Investigational Site Beijing, Beijing, China, 100853 China, Heilongjiang Novo Nordisk Investigational Site Harbin, Heilongjiang, China, 150001 China, Shanghai Novo Nordisk Investigational Site Shanghai, Shanghai, China, 200433 Less <<
NCT00348725 Dyslipidemia/Glucose Metabolis... More >>m Disorder Less << Phase 3 Completed - France ... More >> Site 24 Anzin, France Site 23 Bachant, France Site 21 Baune, France Site 32 Bersee, France Site 34 Briollay, France Site 27 Denain, France Site 28 Denain, France Site 5 Le Temple de Bretagne, France Site 29 Nantes, France Site 2 Nantes, France Site 8 Nantes, France Site 9 Nantes, France Site 1 Nort sur Erdre, France Site 13 Parcay les Pins, France Site 26 Quarouble, France Site 7 Saint Aignan le Grand, France Site 4 Saint Herblain, France Site 30 Saint-Amand, France Site 11 Sautron, France Site 17 Segre, France Site 10 St Etienne de Montluc, France Site 33 Thiant, France Site 12 Thouars, France Site 25 Vieux Conde, France Site 20 Vihiers, France Less <<
NCT03506022 Diabetes Mellitus, Type 1 Not Applicable Recruiting April 11, 2019 France ... More >> Chu Amiens Picardie Recruiting Amiens, Picardie, France, 80000 Contact: Salha FENDRI    (+33)3 22 45 58 96    Fendri.salha@chu-amiens.fr Less <<
NCT00324584 Type 1 Diabetes Mellitus Phase 3 Completed - France ... More >> University Hospital, Department of Endocrinology Grenoble, France, 38043 University Hospital, Department of Endocrinology Toulouse, France, 31000 Less <<
NCT00109720 Type 2 Diabetes Mellitus Not Applicable Completed - United States, Michigan ... More >> University of Michigan, Department of Family Medicine Clinics Ann Arbor, Michigan, United States, 48109 Detroit Health Department Detroit, Michigan, United States, 48202 Less <<
NCT01357876 Diabetes Mellitus, Type 2 Phase 1 Completed - United Kingdom ... More >> GSK Investigational Site Cambridge, Cambridgeshire, United Kingdom, CB2 2GG Less <<
NCT00929136 Healthy Not Applicable Completed - Denmark ... More >> The Medical Research Laboratories, Dept. M, Aarhus University Hospital Aarhus, Denmark, 8000 Less <<
NCT03487679 Fasting Not Applicable Completed - United States, California ... More >> University of California Davis Davis, California, United States, 95616 Less <<
NCT02587741 Diabetic Retinopathy Early Phase 1 Recruiting July 2025 China, Guangdong ... More >> the third affiliated hospital of Sun yet-san university Recruiting Guangzhou, Guangdong, China, 510000 Contact: Zhu Bilian, master    +8613580364394    bilianzhu@qq.com    Contact: Tang Xixiang, master    +8613570434387    txx_8711@126.com Less <<
NCT01119690 Metabolic Syndrome Not Applicable Completed - Finland ... More >> Finnish Red Cross Blood Transfusion Service Helsinki, Finland, 00310 Linnan Klinikka Hämeenlinna, Finland, 13100 Central Hospital of Kanta-Häme Hämeenlinna, Finland, 13530 MTT Agrifood Research Finland Jokioinen, Finland, 31600 Less <<
NCT00095654 Impaired Glucose Tolerance ... More >> Cardiovascular Disease Glucose Metabolism Disorders Less << Phase 3 Completed - -
NCT01686932 - Completed - -
NCT01686932 Diabetes Mellitus Type 2 Phase 4 Completed - Germany ... More >> Novartis Investigative Site Berlin, Germany, 10115 Novartis Investigative Site Berlin, Germany, 13055 Novartis Investigative Site Dortmund, Germany, 44137 Novartis Investigative Site Dresden, Germany, 01307 Novartis Investigative Site Elsterwerda, Germany, 04910 Novartis Investigative Site Falkensee, Germany, 14612 Novartis Investigative Site Magdeburg, Germany, 39112 Novartis Investigative Site Neuss, Germany, 41460 Novartis Investigative Site Potsdam, Germany, 14469 Novartis Investigative Site Sulzbach-Rosenberg, Germany, 92237 Novartis Investigative Site Wallerfing, Germany, 94574 Less <<
NCT00760578 Type 2 Diabetes Mellitus Phase 2 Completed - United States, California ... More >> Los Angeles, California, United States United States, Florida Miami Gardens, Florida, United States West Palm Beach, Florida, United States United States, Michigan Kalamazoo, Michigan, United States United States, South Carolina Greenville, South Carolina, United States United States, Texas Dallas, Texas, United States San Antonio, Texas, United States United States, Washington Renton, Washington, United States Less <<
NCT03242252 Type 2 Diabetes Mellitus-Chron... More >>ic Kidney Disease Stage 3 Less << Phase 3 Active, not recruiting October 14, 2019 -
NCT02813343 Type 2 Diabetes Not Applicable Completed - Canada, Ontario ... More >> Women's College Hospital Toronto, Ontario, Canada, M5S 1B2 Less <<
NCT01215955 Diabetes Mellitus, Type 2 Phase 4 Completed - -
NCT00760578 - Completed - -
NCT01088451 Diabetes Mellitus, Type 1 Not Applicable Unknown September 2010 Czech Republic ... More >> University Hospital Hradec Králové Hradec Králové, Czech Republic, 50005 Less <<
NCT00873405 Obesity Not Applicable Unknown - Brazil ... More >> Cassiano Antonio Moraes University Hospital, Federal University of Espírito Santo Vitória, Espírito Santo, Brazil, 29040-091 Less <<
NCT01384877 Cancer-related Pain Phase 2 Phase 3 Suspended(Study is suspended p... More >>ending resolution of staffing issues and external review) Less << August 2019 Canada, British Columbia ... More >> BC Cancer Center of the North Prince George, British Columbia, Canada, V2M 7E9 BC Cancer Agency Vancouver, British Columbia, Canada, V5Z 4E6 Less <<
NCT01215955 - Completed - -
NCT00998595 Diabetes, Gestational ... More >> Postpartum Period Less << Not Applicable Completed - United States, California ... More >> Los Angeles County + University of Southern California Medical Center Los Angeles, California, United States, 90033 Less <<
NCT01174303 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 1 Completed - Austria ... More >> Novo Nordisk Investigational Site Graz, Austria, 8036 Less <<
NCT02585674 Type 2 Diabetes Mellitus Phase 3 Completed - Germany ... More >> Investigational Site Number 276002 Berlin, Germany, 10115 Investigational Site Number 276001 Dresden, Germany, 01307 Investigational Site Number 276007 Essen, Germany, 45359 Investigational Site Number 276003 Heidelberg, Germany, 69115 Investigational Site Number 276010 Künzing, Germany, 94550 Investigational Site Number 276005 Neumünster, Germany, 24534 Investigational Site Number 276004 Oldenburg In Holstein, Germany, 23758 Investigational Site Number 276006 Pirna, Germany, 01796 Investigational Site Number 276008 Sulzbach-Rosenberg, Germany, 92237 United Kingdom Investigational Site Number 826003 Airdrie, United Kingdom, ML6 OJS Investigational Site Number 826002 Belfast, United Kingdom, BT12 6BA Investigational Site Number 826011 Bristol, United Kingdom, BS10 5NB Investigational Site Number 826001 Chester, United Kingdom, CH2 1UL Investigational Site Number 826006 Dumfries, United Kingdom, DG1 4AP Investigational Site Number 826008 East Kilbride, United Kingdom, G75 8RG Investigational Site Number 826005 Larbert, United Kingdom, FK5 4WR Investigational Site Number 826010 Londonderry, United Kingdom, BT47 6SB Investigational Site Number 826009 Swansea, United Kingdom, SA6 6NL Investigational Site Number 826007 Taunton, United Kingdom, TA1 5DA Less <<
NCT00392912 Alzheimer's Disease ... More >> Hypogonadism Less << Not Applicable Completed - United States, Texas ... More >> Michael E. DeBakey VA Medical Center Houston, Texas, United States, 77030 Less <<
NCT02798666 Overweight and Obesity Not Applicable Completed - -
NCT02452255 Burn Phase 2 Phase 3 Recruiting December 2022 United States, Texas ... More >> Shriners Hospitals for Children Recruiting Galveston, Texas, United States, 77551 Contact: Cathy Reed, BSN    409-770-6987    ca2reed@utmb.edu    Contact: Deb Benjamin, MSN    409-770-6731    dbenjami@utmb.edu    Principal Investigator: David N Herndon, MD Less <<
NCT03470454 - Recruiting November 30, 2018 Egypt ... More >> Faculty of medicine Fayoum univesity Recruiting Fayoum, Egypt Contact: Ahmed A Hammad, MD          Fayoum University Active, not recruiting Fayoum, Egypt Less <<
NCT00631774 Type 2 Diabetes ... More >> Obesity Less << Not Applicable Completed - Taiwan ... More >> Taipei Veterans General Hospital Taipei, Taiwan Less <<
NCT01376323 Diabetes Mellitus, Type 2 Phase 2 Completed - United States, Alabama ... More >> GSK Investigational Site Anniston, Alabama, United States, 36207 United States, Florida GSK Investigational Site Miami, Florida, United States, 33169 GSK Investigational Site Miramar, Florida, United States, 33025 France GSK Investigational Site Nantes cedex 01, France, 44093 GSK Investigational Site Pierre-Bénite Cedex, France, 69495 GSK Investigational Site Rennes Cedex, France, 35046 GSK Investigational Site Rueil-Malmaison, France, 92502 Spain GSK Investigational Site Alicante, Spain, 03114 GSK Investigational Site Badalona, Spain, 08916 GSK Investigational Site Granada, Spain, 18004 GSK Investigational Site Madrid, Spain, 28046 United Kingdom GSK Investigational Site Edinburgh, Midlothian, United Kingdom, EH4 2XU GSK Investigational Site Cambridge, United Kingdom, CB2 0GG GSK Investigational Site Coventry, United Kingdom, CV2 2DX GSK Investigational Site Newcastle upon Tyne, United Kingdom, NE1 4LP Less <<
NCT00494663 Type 2 Diabetes Phase 2 Terminated(Program Terminated) December 2008 -
NCT02367066 Type 2 Diabetes Mellitus Phase 1 Completed - United States, California ... More >> Research Site Chula Vista, California, United States Less <<
NCT01047813 - Unknown September 2010 United Kingdom ... More >> Institute of Psychological Sciences, University of Leeds, UK Recruiting Leeds, West Yorkshire, United Kingdom, LS2 9JT Contact: Daniel J Lamport    07792362588 ext +44    d.j.lamport02@leeds.ac.uk    Contact: Louise Dye, Professor    01133435753 ext +44    l.dye@leeds.ac.uk    Principal Investigator: Daniel J Lamport Less <<
NCT00771940 Healthy Controls Phase 1 Completed - Denmark ... More >> Aarhus University Hospital Aarhus, Denmark, Dk-8000 Less <<
NCT02367066 - Completed - -
NCT03101228 Metabolic Syndrome ... More >> Physical Activity Insulin Resistance Cardiovascular Diseases Less << Not Applicable Recruiting December 30, 2019 Finland ... More >> Turku PET Centre Recruiting Turku, Finland, 20521 Contact: Ilkka H Heinonen, PhD       ilkka.heinonen@utu.fi Less <<
NCT00605436 Metabolic Syndrome Phase 1 Completed - United States, California ... More >> University of California, San Francisco San Francisco, California, United States, 94115 Less <<
NCT01944124 Metabolic Syndrome X Not Applicable Completed - Canada, Ontario ... More >> Gateway Rural Health Research Institute Seaforth, Ontario, Canada, N0K 1W0 Less <<
NCT02205541 Hemolytic Uremic Syndrome of C... More >>hildhood Less << Phase 3 Completed - France ... More >> University Hospital Amiens, France, 80054 University Hospital Angers, France, 49100 University Hospital Besançon, France, 25030 Pellegrin Hospital Bordeaux, France, 33000 Morvan Hospital Brest, France, 29609 University Hospital Grenoble, France, 60107 Jeanne de Flandre Hospital Lille, France, 59037 Mother and Child Hospital Limoges, France, 87000 Women, Mother and Child Hospital Lyon, France, 69500 La Timone Hospital Marseille, France University Hospital Montpellier, France, 34295 Mother and Child Hospital Nantes, France, 44000 Robert Debré Hospital Paris, France, 75019 Trousseau Hospital Paris, France, 75571 Necker Hospital Paris, France, 75743 Anne de Bretagne University Hospital Rennes, France, 35056 Purpan Children Hospital Toulouse, France, 31059 Clocheville Hospital Tours, France, 37044 Less <<
NCT01376323 - Completed - -
NCT02333734 Type 2 Diabetes Not Applicable Completed - Denmark ... More >> Aarhus Universityhospital, Aarhus University Aarhus C, Denmark, 8000 Less <<
NCT01862939 Type 2 Diabetes Mellitus Phase 1 Completed - United States, Arizona ... More >> Celerion Tempe, Arizona, United States, 85283 Less <<
NCT01566110 Celiac Disease ... More >> Diabetes Mellitus, Type 1 Less << Not Applicable Completed - Canada, Ontario ... More >> McMaster University Hamilton, Ontario, Canada Kingston General Hospital Kingston, Ontario, Canada London Health Sciences London, Ontario, Canada St. Joseph's Healthcare London, Ontario, Canada The Ottawa Hospital Ottawa, Ontario, Canada The Hospital for Sick Children Toronto, Ontario, Canada, M5V1X8 LMC Diabetes and Endocrinology Toronto, Ontario, Canada Less <<
NCT03031886 Type 2 Diabetes ... More >> Obesity PreDiabetes Less << Not Applicable Completed - Singapore ... More >> Clinical Nutrition Research Centre Singapore, Singapore, 117599 Less <<
NCT01951716 Does the Vagus Nerve Mediate t... More >>he Effects of Xenin-25 Less << Phase 1 Withdrawn July 2018 United States, Missouri ... More >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Less <<
NCT02091193 - Completed - United States, Connecticut ... More >> Danbury Hospital Danbury, Connecticut, United States, 06810 Less <<
NCT01062529 Acromegaly Gr... More >>owth Hormone Deficiency Diabetes Less << Not Applicable Completed - Denmark ... More >> Medical department M Aarhus, Denmark, 8000 Less <<
NCT02400450 Pre-Diabetes Not Applicable Withdrawn December 2017 United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Canada, Manitoba St. Boniface General Hospital Winnipeg, Manitoba, Canada, R2H 2A6 Less <<
NCT01605071 Insulin Resistance Not Applicable Completed - United States, Colorado ... More >> University of Colorado Denver Aurora, Colorado, United States, 80045 Less <<
NCT01944098 - Completed - -
NCT01944098 Bariatric Surgical Pain Phase 3 Completed - United States, Florida ... More >> Tampa General Hospital Tampa, Florida, United States, 33606 Less <<
NCT01803776 Overweight Gl... More >>ucose Metabolism Disorders Lipid Metabolism Disorders Blood Pressure Less << Not Applicable Active, not recruiting November 2022 Finland ... More >> University of Eastern Finland Kuopio, Finland, 70211 Less <<
NCT01497132 Diabetes Mellitus, Type 2 ... More >> Glucose Intolerance Vitamin D Deficiency Less << Phase 4 Completed - Sweden ... More >> Dpt of Endocrinology, Karolinska University Hospital Stockholm, Sweden, 17176 Less <<
NCT03288025 Pulmonary Arterial Hypertensio... More >>n Insulin Resistance Less << Not Applicable Recruiting December 28, 2023 United States, Ohio ... More >> Cleveland Clinic Foundation Recruiting Cleveland, Ohio, United States, 44195 Contact: Chazity Bush    216-444-3702    bushc2@ccf.org    Principal Investigator: Raed Dweik          Principal Investigator: Gustavo Heresi          Sub-Investigator: John Kirwan Less <<
NCT01618188 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 1 Completed - Germany ... More >> Novo Nordisk Investigational Site Neuss, Germany, 41460 Less <<
NCT00385203 Gastrointestinal Stromal Tumor... More >>s Soft Tissue Sarcomas Less << Phase 2 Completed - United Kingdom ... More >> Research Site Manchester, United Kingdom Research Site Sutton, United Kingdom Less <<
NCT00385203 - Completed - -
NCT03523741 - Recruiting December 31, 2020 Korea, Republic of ... More >> Seoul National University Bundang Hospital Recruiting Seongnam, Korea, Republic of, 13620 Contact: Seoyoung Kim, MD    031-787-8219    zentiana0@gmail.com Less <<
NCT02917031 Type 2 Diabetes Mellitus ... More >> Heart Failure Less << Phase 4 Recruiting November 13, 2019 -
NCT00821405 - Unknown March 2010 Taiwan ... More >> National Taiwan University Hospital Not yet recruiting Taipei, Taiwan, 100 Contact: Jenq-Wen Huang, MD    +886-2-23123456 ext 63288    007378@ntuh.gov.tw Less <<
NCT03527368 PreDiabetes O... More >>besity Less << Not Applicable Recruiting December 2020 United States, Maryland ... More >> Johns Hopkins ProHealth Recruiting Baltimore, Maryland, United States, 21207 Contact: Letitia Thomas    410-281-1600 Less <<
NCT01249677 Type 2 Diabetes Phase 4 Completed - Germany ... More >> Department of Medicine I; University Hospital St. Josef Hospital Bochum, Germany Less <<
NCT02482662 - Completed - Canada, Quebec ... More >> Centre de recherche clinique du CHUS Sherbrooke, Quebec, Canada, J1H 5N4 Less <<
NCT03156361 Type1 Diabetes Mellitus Phase 2 Completed - United States, Georgia ... More >> Atlanta Diabetes Association Atlanta, Georgia, United States, 30318 Less <<
NCT02360254 - Completed - Italy ... More >> Division of Metabolic Diseases, University Hospital of Padova Padova, Italy, 35128 Less <<
NCT02196350 Type 2 Diabetes Not Applicable Active, not recruiting December 2019 Netherlands ... More >> Netherlands Organisation for Applied Scientific Research (TNO) Zeist, Utrecht, Netherlands, 3704 HE Huisartsenpraktijk Lommelaars Hillegom, Zuid Holland, Netherlands, 2181 EK Huisartspraktijk C.C. Dekker Hillegom, Zuid Holland, Netherlands, 2181 EN Huisartspraktijk Tubbergen Hillegom, Zuid Holland, Netherlands, 2181 EN Huisartsenpraktijk Sixlaan 9 Hillegom, Zuid Holland, Netherlands, 2182 AA Huisartsenpraktijk J.G. van Dusseldorp Hillegom, Zuid Holland, Netherlands, 2182 CA Huisartsenpraktijk van der Kaaden Hillegom, Zuid Holland, Netherlands, 2182 GP Huisartsenpraktijk Elsbroek Hillegom, Zuid Holland, Netherlands, 2182 LN Huisartsenpraktijk Mulders Hillegom, Zuid Holland, Netherlands, 2182 VT Less <<
NCT00859079 Diabetes Mellitus Type 2 ... More >> Hyperglycemia Less << Phase 4 Completed - Austria ... More >> Medical University of Graz, Department for Internal Medicine Graz, Austria, 8036 Less <<
NCT00574834 Metabolic Syndrome Early Phase 1 Terminated(Lack of funding) - United States, Maryland ... More >> University of Maryland, Baltimore Baltimore, Maryland, United States, 21201 Less <<
NCT02729246 Type 2 Diabetes Mellitus ... More >> Obesity Less << Not Applicable Active, not recruiting February 2020 Sweden ... More >> Uppsala University, Department of Medical Sciences, Clinical diabetology and metabolism Uppsala, Sweden Less <<
NCT00574834 - Terminated(Lack of funding) - -
NCT00367926 Hyperglycemia Phase 3 Completed - Canada, Ontario ... More >> Risk Factor Modification Centre Toronto, Ontario, Canada, M5C 2T2 Less <<
NCT02433262 Gestational Diabetes Mellitus Not Applicable Recruiting March 2018 Malaysia ... More >> Obstetrics & Gynaecology Department, National University of Malaysia Recruiting Cheras, Kuala Lumpur, Malaysia, 56000 Contact: Nurul Iftida Basri, MBCHB    +60133452294    nurul.basri@yahoo.co.uk Less <<
NCT01844375 Bowel; Disease, Carbohydrate A... More >>bsorption Difficulty Walking Colorectal Neoplasms Less << Not Applicable Unknown June 2017 Thailand ... More >> Siriraj hospital Recruiting Bangkoknoi, Bangkok, Thailand, 10700 Contact: Mingkwan Wongyingsinn, MD, MSc    (02)-419-7995    minkcheerful@hotmail.com    Principal Investigator: Mingkwan Wongyingsinn, MD, MSc Less <<
NCT00069615 Diabetes Mellitus, Insulin-Dep... More >>endent Less << Phase 4 Completed - United States, California ... More >> Division of Pediatric Endocrinology and Diabetes, Stanford University Stanford, California, United States, 94305-5208 United States, Colorado Barbara Davis Center for Childhood Diabetes, University of Colorado Denver, Colorado, United States, 80262 United States, Connecticut Department of Pediatrics, Yale University School of Medicine New Haven, Connecticut, United States, 06519 United States, Florida Nemours Children's Clinic Jacksonville,, Florida, United States, 32207 Jaeb Center for Health Research Tampa, Florida, United States, 33647 United States, Iowa Department of Pediatrics, University of Iowa Carver College of Medicine Iowa City, Iowa, United States, 52242 Less <<
NCT01106651 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT02962700 Septic Shock Not Applicable Unknown December 2018 Tunisia ... More >> Military Hopital of Tunis Recruiting Tunis, Tunisia, 1008 Contact: mustapha ferjani    98329256    mustapha.ferjani@planet.tn    Contact: zied hajjej    20358907    hajjej_zied@hotmail.com Less <<
NCT02977000 Retinopathy of Prematurity Not Applicable Unknown May 2018 China, Henan ... More >> Propranolol Recruiting Zhengzhou, Henan, China, 450000 Contact: Huiqing Sun, PhD    13838112692    s_huiqing@sina.com Less <<
NCT02340039 Postprandial Hyperglycemia Not Applicable Completed - United Kingdom ... More >> Metabolic Research Unit at King's College London. Franklin-Wilkins Buiding. Waterloo Campus London, England, United Kingdom, W3 7LR Less <<
NCT00941161 Type 2 Diabetes Mellitus Phase 4 Completed - Mexico ... More >> Centro Universitario de Ciencias de la Salud. Universidad de Guadalajara Guadalajara, Jalisco, Mexico Less <<
NCT00900146 Diabetes Mellitus, Type 2 Phase 2 Phase 3 Terminated(Numerically modest ... More >>lowering of HbA1c with canakinumab in combination with metformin was inadequate to continue patients with T2DM into Period IV of this study.) Less << - -
NCT00551590 Type 2 Diabetes Mellitus Phase 1 Completed - Germany ... More >> Clinical Research unit, Dept. of Internal Medicine II - Großhadern, University of Munich Munich, Germany, 81377 Less <<
NCT02438189 Type 1 Diabetes Phase 2 Completed - United States, California ... More >> Stanford University Stanford, California, United States, 94305 United States, Colorado Barbara Davis Center for Childhood Diabetes Aurora, Colorado, United States, 80045 Canada, Ontario St. Joseph's Health Care London, Ontario, Canada, N6A4V2 Less <<
NCT02714972 Type 1 Diabetes ... More >> Hypoglycemia Hyperglycemia Artificial Pancreas Less << Phase 2 Completed - United States, California ... More >> Stanford University Stanford, California, United States, 94305 United States, Colorado Barbara Davis Center for Childhood Diabetes Aurora, Colorado, United States, 80045 Less <<
NCT00625170 Insulin Resistance ... More >> Dyslipidemia Less << Not Applicable Completed - Netherlands ... More >> Leiden University Medical Center Leiden, Netherlands, 2300 RC Less <<
NCT01053793 Diabetes Insu... More >>lin Resistance Less << Not Applicable Completed - Canada, Ontario ... More >> Nutrasource Diagnostic Inc Guelph, Ontario, Canada, N1G 0B4 Less <<
NCT00900146 - Terminated(Numerically modest ... More >>lowering of HbA1c with canakinumab in combination with metformin was inadequate to continue patients with T2DM into Period IV of this study.) Less << - -
NCT01106313 - Completed - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT00606957 Obesity Not Applicable Completed - United States, New York ... More >> Rockefeller University New York, New York, United States, 10021 Less <<
NCT01999504 Insulin Resistance ... More >> Satiety Less << Not Applicable Completed - United Kingdom ... More >> Leatherhead Food Research Leatherhead, Surrey, United Kingdom, KT22 7RY Less <<
NCT01522157 Type 2 Diabetes Mellitus Not Applicable Completed - Sweden ... More >> Department of Medical and Health Sciences, Linköping University Linköping, Sweden, S-59183 Less <<
NCT00635544 Overweight Hy... More >>perlipidemia Less << Not Applicable Completed - Greece ... More >> Department of Nutrition and Dietetics, Harokopio University Athens, Greece, 17671 Hungary Pécsi Tudományegyetem Anyagcseregondozó Pecs, Hungary, 7623 Italy Dipartimento di Pediatria Università di Napoli "Federico II" Napoli, Italy, 80131 Spain Instituto del Frio. Departamento de Metabolismo y Nutrición Madrid, Spain, 28040 Less <<
NCT01569893 Diabetes Mellitus, Type 2 Not Applicable Completed - Italy ... More >> "De Lellis" Hospital - Diabetology-Endocrinology Department Schio, Vicenza, Italy, 36015 Less <<
NCT02187913 Hyperglycemia, Diabetes, and O... More >>besity Less << Not Applicable Unknown - United States, Indiana ... More >> Purdue University Recruiting West Lafayette, Indiana, United States, 47907 Contact: Jan K Green    765-494-6342    jkgreen@purdue.edu Less <<
NCT01106651 - Completed - -
NCT01260883 - Completed - -
NCT02868320 Diabetes Mellitus Not Applicable Completed - Egypt ... More >> Misr University for Science & Technology (MUST) hospital Giza, Cairo, Egypt, 12566 Less <<
NCT01733524 Type 1 Diabetes Mellitus Not Applicable Completed - United States, Texas ... More >> University of Texas Southwestern Medical Center Dallas, Texas, United States, 75390 Less <<
NCT03204799 - Recruiting December 16, 2018 Korea, Republic of ... More >> Yonsei University College of Medicine, Department of Internal Medicine, Division of Endocrinology, Severance Hospital, Diabetes center Recruiting Seoul, Korea, Republic of, 03722 Contact: Yong-ho Lee, M.D., Ph.D.    82-2-2228-1943    yholee@yuhs.ac Less <<
NCT01260883 Postoperative Pain in Infants Phase 3 Completed - United States, Washington ... More >> Seattle Children's Hospital Seattle, Washington, United States, 98105 Less <<
NCT01637584 Non PTSD PTSD Not Applicable Completed - United States, Pennsylvania ... More >> Western Psychiatric Institute and Clinic Pittsburgh, Pennsylvania, United States, 15213 Less <<
NCT02871882 Type 2 Diabetes Mellitus ... More >> Obese Overweight Less << Phase 2 Completed - United States, Minnesota ... More >> Mayo Clinic in Rochester Rochester, Minnesota, United States, 55905 Less <<
NCT01350284 Gastric Emptying ... More >> Diabetes Mellitus Less << Not Applicable Completed - Ireland ... More >> Department of Physical Education & Sport Sciences, University of Limerick Limerick, Ireland Less <<
NCT03244241 Type 2 Diabetes Mellitus Phase 4 Recruiting April 1, 2018 Denmark ... More >> Hvidovre University Hospital Recruiting Hvidovre, Denmark, 2650 Contact: Merete B. Christensen, MD    +4538623389    merete.bechmann.christensen.01@regionh.dk Less <<
NCT02746432 Colon Cancer Phase 4 Not yet recruiting March 2021 Saudi Arabia ... More >> King Saud University Medical City Recruiting Riyadh, Saudi Arabia, 7805 Contact: Weam S Husseim    +966541480459    wshussain@ksu.edu.sa    Contact: Sara Aloudah    +96654602288    oudahsara@gmail.com    Principal Investigator: Dr. Mazen M Hassanain, MBBS FRCSC FACS PhD          Sub-Investigator: Dr. Ahmad M Zubaidi, MBBS MSc FRCSc          Sub-Investigator: Dr. Khayal A Al-Khayal, MBBS FRCSC          Sub-Investigator: Dr. Faisal A Alalem, MBBS SBGS Less <<
NCT02210845 Diabetes Not Applicable Not yet recruiting December 2021 Canada, British Columbia ... More >> Vancouver General Hospital Not yet recruiting Vancouver, British Columbia, Canada, V5Z1M9 Principal Investigator: Tom Elliott, MD Less <<
NCT00585299 Fatty Liver I... More >>nsulin Resistance Less << Not Applicable Completed - United States, Connecticut ... More >> Yale University School of Medicine New Haven, Connecticut, United States, 06520 Less <<
NCT00748566 Schizophrenia and Disorders Wi... More >>th Psychotic Features Less << Phase 4 Terminated(See Detailed Descri... More >>ption) Less << - Canada, Alberta ... More >> Pfizer Investigational Site Calgary, Alberta, Canada, T2N 2T9 Pfizer Investigational Site Calgary, Alberta, Canada, T2N 4Z6 Pfizer Investigational Site Medicine Hat, Alberta, Canada, T1A 4C2 Pfizer Investigational Site Medicine Hat, Alberta, Canada, T1B 4E7 Pfizer Investigational Site Red Deer, Alberta, Canada, T4N 1T6 Canada, British Columbia Pfizer Investigational Site Penticton, British Columbia, Canada, V2A 4M4 Pfizer Investigational Site Victoria, British Columbia, Canada, V8R 4Z3 Canada, Manitoba Pfizer Investigational Site Winnipeg, Manitoba, Canada, R3A 1R9 Pfizer Investigational Site Winnipeg, Manitoba, Canada, R3E 3N4 Pfizer Investigational Site Winnipeg, Manitoba, Canada, R3K 2E2 Pfizer Investigational Site Winnipeg, Manitoba, Canada, R3P 0N5 Canada, New Brunswick Pfizer Investigational Site Bathurst, New Brunswick, Canada, E2A 2Z6 Canada, Newfoundland and Labrador Pfizer Investigational Site St. John's, Newfoundland and Labrador, Canada, A1E 4J8 Canada, Nova Scotia Pfizer Investigational Site Halifax, Nova Scotia, Canada, B3H 2E2 Pfizer Investigational Site Sydney, Nova Scotia, Canada, B1P 1C6 Pfizer Investigational Site Sydney, Nova Scotia, Canada, B1P 1E1 Canada, Ontario Pfizer Investigational Site Burlington, Ontario, Canada, L7R 4E2 Pfizer Investigational Site Chatham, Ontario, Canada, N7L 1B7 Pfizer Investigational Site Kingston, Ontario, Canada, K7L 4X3 Pfizer Investigational Site London, Ontario, Canada, N6A 4G5 Pfizer Investigational Site Markham, Ontario, Canada, L6B 1A1 Pfizer Investigational Site Mississauga, Ontario, Canada, L5M 4N4 Pfizer Investigational Site Ottawa, Ontario, Canada, K1H 8K7 Pfizer Investigational Site Sudbury, Ontario, Canada, P3E 1X3 Pfizer Investigational Site Toronto, Ontario, Canada, M5T 1R8 Pfizer Investigational Site Toronto, Ontario, Canada, M6J 1H4 Pfizer Investigational Site Windsor, Ontario, Canada, N9C 3Z4 Canada, Quebec Pfizer Investigational Site Montreal, Quebec, Canada, H1N 3M5 Pfizer Investigational Site Montreal, Quebec, Canada, H1N 3V2 Pfizer Investigational Site Montreal, Quebec, Canada, H3A 1A1 Pfizer Investigational Site Verdun, Quebec, Canada, H4H 1R3 Canada, Saskatchewan Pfizer Investigational Site Saskatoon, Saskatchewan, Canada, S7K 3H3 Less <<
NCT02633150 Obesity Insul... More >>in Resistance Menopause Less << Not Applicable Unknown June 2017 France ... More >> CHU Montpellier - Lapeyronie hospital Recruiting Montpellier, France, 34295 Contact: Ariane SULTAN, Pr, MD-PHD    +33467338402 ext 0033    a-sultan@chu-montpellier.fr Less <<
NCT01637584 - Completed - -
NCT02358668 Pre-Diabetes Phase 2 Completed - Hong Kong ... More >> The Chinese University of Hong Kong Shatin, Hong Kong Less <<
NCT01281761 Metastatic Colorectal Cancer Phase 2 Completed - Korea, Republic of ... More >> Samsung Medical Center Seoul, Korea, Republic of, 135-710 Less <<
NCT01101503 Endothelial Dysfunction Phase 2 Recruiting December 2020 China, Hubei ... More >> Department of Endocrinology Recruiting Wuhan City, Hubei, China, 430070 Contact: Xiang Guangda, MD, Ph D    +862768878410    Guangda64@hotmail.com    Principal Investigator: Xiang Guangda, MD, Ph D Less <<
NCT01982253 Type 2 Diabetes Mellitus Phase 2 Terminated(Due to potential co... More >>ncerns about liver safety (See Detailed Description)) Less << - -
NCT00625014 Insulin Resistance ... More >> Dyslipidemia Less << Not Applicable Completed - Netherlands ... More >> Leiden University Medical Center Leiden, Netherlands, 2300 RC Less <<
NCT02865278 Healthy Not Applicable Unknown - -
NCT00748566 - Terminated(See Detailed Descri... More >>ption) Less << - -
NCT01354977 Type 2 Diabetes Mellitus ... More >> Insulin Resistance Less << Phase 2 Completed - United States, New York ... More >> Albert Einstein College of Medicine Bronx, New York, United States, 10461 Less <<
NCT03439917 Non-Alcoholic Fatty Liver Dise... More >>ase Insulin Resistance Less << Not Applicable Recruiting December 31, 2020 United Kingdom ... More >> David Greenfield Human Physiology Unit Recruiting Nottingham, Notts, United Kingdom, NG72UH Contact: Sara Brown    +44(0)115 8230434    sara.brown@nottingham.ac.uk    Contact: Liz Simpson, PhD    +44(0)1158230128    liz.simpson@nottingham.ac.uk    Sub-Investigator: Paul L Greenhaff, PhD          Sub-Investigator: Ian A macdonald, PhD Less <<
NCT02358668 - Completed - -
NCT03697109 Cushing Syndrome Phase 3 Recruiting January 2021 United States, Louisiana ... More >> Site 2 Recruiting Metairie, Louisiana, United States, 70006 United States, Mississippi Site 4 Recruiting Jackson, Mississippi, United States, 39202 United States, North Carolina Site 1 Recruiting Wilmington, North Carolina, United States, 28401 United States, South Carolina Site 5 Recruiting Summerville, South Carolina, United States, 29485 United States, Texas Site 3 Recruiting El Paso, Texas, United States, 79935 Less <<
NCT01652716 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT01982253 - Terminated(Due to potential co... More >>ncerns about liver safety (See Detailed Description)) Less << - -
NCT00879801 - Completed - Italy ... More >> Department of Endocrinology and Metabolism, University of Pisa Pisa, Italy Less <<
NCT01652716 - Completed - -
NCT02611232 Type 1 Diabetes Phase 2 Enrolling by invitation June 2019 Finland ... More >> University of Oulu and Oulu University Hospital Oulu, Finland, 90029 University of Tampere and Tampere University Hospital Tampere, Finland, 33521 University of Turku and Turku University Hospital Turku, Finland, 20520 Less <<
NCT02257190 Diabetes Mellitus, Type 2 Not Applicable Completed - Denmark ... More >> Center for Physical Activity Research (CFAS) Copenhagen, Denmark, 2100 Less <<
NCT00955071 Obesity Metab... More >>olic Syndrome Cardiovascular Disease Less << Not Applicable Completed - Canada, Ontario ... More >> School of Kinesiology and Health Studies, Queen's University Kingston, Ontario, Canada, K7L 3N6 Less <<
NCT00331851 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT00333151 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT01211184 - Completed - -
NCT03289494 Type2 Diabetes Not Applicable Recruiting November 2018 France ... More >> Centre de Recherche en Nutrition Humaine Rhone-Alpe Recruiting Pierre-Bénite, France, 69310 Less <<
NCT01211184 Hip Surgery Corrective Not Applicable Completed - Sweden ... More >> Södertälje Hospital Södertälje, Sweden, 15286 Less <<
NCT01722240 Type 1 Diabetes Phase 3 Recruiting November 2019 United States, New York ... More >> Diabetes-Endocrinology Center of WNY Recruiting Buffalo, New York, United States, 14215 Contact: Jeanne Hejna, LPN    716-898-1950    jeannehe@buffalo.edu    Principal Investigator: Paresh Dandona, MBBS,PhD Less <<
NCT00753740 Cancer Ovaria... More >>n Cancer Solid Tumor Less << Phase 2 Withdrawn(Poor trial recruitme... More >>nt) Less << - United States, Illinois ... More >> Decatur Memorial Hospital, Clinical Research Department/ Cancer Care Specialists of Illinois Decatur, Illinois, United States, 62526 United States, Minnesota University of Minnesota Medical Center Minneapolis, Minnesota, United States, 55455 United States, New York Schwartz Gynecologic Onclology, PLLC Brightwaters, New York, United States, 11718 United States, Ohio Gabrail Cancer Center Canton, Ohio, United States, 44718 United States, Tennessee Chattanooga GYN Oncology Chattanooga, Tennessee, United States, 97403 United States, Texas The Methodist Hospital Houston, Texas, United States, 77030 United States, Virginia Riverside Gynecology & Oncology Newport News, Virginia, United States, 23601 Less <<
NCT00617981 Hepatocellular Carcinoma Phase 3 Completed - -
NCT02738879 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT02048358 Healthy Volunteers ... More >> Multiple Sclerosis Less << Phase 1 Terminated - Netherlands ... More >> VUmc, PET and neurology clinical research unit Amsterdam, Noord-Holland, Netherlands, 1081 HV Centre for Human Drug Research (CHDR) Leiden, Netherlands, 2333 CH Less <<
NCT01555164 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT03680274 Sepsis Vitami... More >>n C Intensive Care Unit Less << Phase 3 Recruiting December 31, 2022 Canada, Quebec ... More >> Research Center of the CHUS Recruiting Sherbrooke, Quebec, Canada, J1H 5N4 Contact: Marie-Helene Masse    819-346-1110 ext 14173    marie-helene.masse3@usherbrooke.ca    Contact: Marie-Claude Battista, PhD    819-346-1110 ext 12480    marie-claude.battista@usherbrooke.ca Less <<
NCT01555164 - Completed - -
NCT02457702 Hepatic Insufficiency ... More >> Hypoalbuminemia Less << Not Applicable Recruiting February 2019 United States, Texas ... More >> UT Southwestern Medical Center - Advanced Imaging Research Center Recruiting Dallas, Texas, United States, 75390 Contact: Jeannie Baxter, RN    214-645-2726    jeannie.baxter@utsouthwestern.edu    Principal Investigator: Jeffrey Browning, MD          Sub-Investigator: Eunsook Jin, PhD Less <<
NCT01588873 Adverse Effect of Oral Contrac... More >>eptives, Sequela Less << Phase 4 Recruiting December 2019 Finland ... More >> Department of Obstetrics and Gynaecology, University Hospital of Oulu Recruiting Oulu, Finland, 90029 Contact: Laure C Morin-Papunen, PhD    +358 8 3154109    lmp@cc.oulu.fi    Contact: Juha S Tapanainen, PhD    +358 8 3153172    juha.tapanainen@oulu.fi    Principal Investigator: Anni S Rantala, med student          Sub-Investigator: Johanna Puurunen, MD Less <<
NCT00617981 - Completed - -
NCT03522792 Physiology - Regulation of App... More >>etite and Food Intake Less << Not Applicable Recruiting July 1, 2019 Denmark ... More >> Hvidovre University Hospital Recruiting Hvidovre, Capital, Denmark, 2650 Contact: Simon Veedfald, MD    +45 41 10 25 95    veedfald@sund.ku.dk    Contact: Steen Madsbad, Dr.Med.Sci       sten.madsbad@regionh.dk Less <<
NCT01357850 Heart Failure, Congestive Phase 2 Completed - United States, Georgia ... More >> GSK Investigational Site Savannah, Georgia, United States, 31405 United States, Louisiana GSK Investigational Site Metairie, Louisiana, United States, 70006 United States, Maine GSK Investigational Site Auburn, Maine, United States, 04210 United States, Maryland GSK Investigational Site Baltimore, Maryland, United States, 21287 United States, Michigan GSK Investigational Site Detroit, Michigan, United States, 48202 United States, Minnesota GSK Investigational Site Minneapolis, Minnesota, United States, 55407 United States, Missouri GSK Investigational Site Saint Louis, Missouri, United States, 63110 United States, New Jersey GSK Investigational Site Newark, New Jersey, United States, 7103 United States, New York GSK Investigational Site Stony Brook, New York, United States, 11794 United States, Ohio GSK Investigational Site Columbus, Ohio, United States, 43210 United States, Pennsylvania GSK Investigational Site New York, Pennsylvania, United States, 10032 GSK Investigational Site Philadelphia, Pennsylvania, United States, 19104 United Kingdom GSK Investigational Site Cambridge, Cambridgeshire, United Kingdom, CB2 0QQ GSK Investigational Site London, United Kingdom, W12 0HS GSK Investigational Site Oxford, United Kingdom, OX3 9DU Less <<
NCT02152124 - Unknown August 2017 Belgium ... More >> Ghent University Hospital, Department of Endocrinology, 9K12IE Ghent, Belgium, 9000 Less <<
NCT01357850 - Completed - -
NCT01585792 Diabetic Patients Phase 3 Completed - Japan ... More >> Fukuoka-shi, Fukuoka, Japan Sumida-ku, Tokyo, Japan Less <<
NCT03089437 Metabolic Syndrome ... More >> Atherosclerosis Less << Not Applicable Completed - United States, Texas ... More >> University of Texas at Austin Human Performance Laboratory Austin, Texas, United States, 78712 Less <<
NCT01660009 Type 2 Diabetes Not Applicable Terminated(Insufficient Fundin... More >>g) Less << - United States, Wisconsin ... More >> Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 Less <<
NCT02660073 Spinal Cord Injuries Not Applicable Recruiting September 2019 United States, New York ... More >> James J. Peters VA Medical Center Active, not recruiting Bronx, New York, United States United States, Virginia Hunter Holmes McGuire VA Medical Center Recruiting Richmond, Virginia, United States, 23249 Contact: Ashraf S Gorgey, MPT,PhD, FACSM    804-675-5000 ext 3386    ashraf.gorgey@va.gov    Contact: Lance Goetz, MD    804-675-5000 ext 2475    lance.Goetz@va.gov    Principal Investigator: Ashraf S Gorgey, MPT, PhD, FACSM          Sub-Investigator: Lance Goetz, MD          Sub-Investigator: Robert A Adler, MD          Virginia Commonwealth Unviersity Recruiting Richmond, Virginia, United States Contact: William Carter, MD       wcarter@mcvh-vcu.edu    Contact: Justin O Alicea, CCRP    804-628-1355    joalicea@vcu.edu    Principal Investigator: William Carter, MD          Sub-Investigator: Ashraf Gorgey, MPT, PhD, FACSM          Sub-Investigator: David Cifu Less <<
NCT00964418 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 1 Completed - Austria ... More >> Novo Nordisk Investigational Site Graz, Austria, 8036 Less <<
NCT00288678 Diabetes Mellitus Phase 3 Completed - Taiwan ... More >> Kaohsiung Medical University Hospital Kaohsiung, Taiwan, 80708 China Medical University Hospital Taichung, Taiwan, 40447 National Cheng Kung University Hospital Tainan, Taiwan, 70403 Tri-Services General Hospital Taipei, Taiwan, 11490 Min-Shen General Hospital Taoyuan, Taiwan, 33044 Less <<
NCT00607087 Diabetes Mellitus, Type 1 Phase 4 Completed - United States, New Jersey ... More >> Sanofi-Aventis Administrative Office Bridgewater, New Jersey, United States Australia Sanofi-Aventis Administrative Office Macquarie Park, Australia Austria Sanofi-Aventis Administrative Office Vienna, Austria France Sanofi-Aventis Administrative Office Paris, France Hungary Sanofi-Aventis Administrative Office Budapest, Hungary Israel Sanofi-Aventis Administrative Office Natanya, Israel Italy Sanofi-Aventis Administrative Office Milan, Italy Korea, Republic of Sanofi-Aventis Administrative Office Seoul, Korea, Republic of Netherlands Sanofi-Aventis Administrative Office PE Gouda, Netherlands Spain Sanofi-Aventis Administrative Office Barcelona, Spain Sweden Sanofi-Aventis Administrative Office Bromma, Sweden United Kingdom Sanofi-Aventis Administrative Office Guildford Surrey, United Kingdom Less <<
NCT01690481 - Completed - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT01865318 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 1 Completed - Germany ... More >> Neuss, Germany, 41460 Less <<
NCT01642485 - Completed - -
NCT03377946 Type 2 Diabetes Mellitus Not Applicable Recruiting August 31, 2019 China, Chongqing ... More >> health management center,Southwest hospital Recruiting Chongqing, Chongqing, China, 400030 Contact: Ya lan zhang, MD    13594348611    281072454@qq.com    Contact: xiao lan zhao, MD    13608303976    zhaoxiaolan65@126.com Less <<
NCT02598986 Diabetes Not Applicable Completed - -
NCT02091336 Gestational Diabetes Phase 4 Unknown December 2016 Brazil ... More >> Hospital de Clínicas de Porto Alegre Recruiting Porto Alegre, RS, Brazil, 90035-903 Less <<
NCT00627380 HIV Infections ... More >> HIV Metabolic Cardiovascular Syndrome HIV Lipodystrophy HIV Metabolic Syndromes Hypertension Less << Phase 4 Completed - United States, Missouri ... More >> Washington University School of Medicine St. Louis, Missouri, United States, 63110 Less <<
NCT02779452 - Completed - -
NCT00082381 - Completed - -
NCT01386099 Type 2 Diabetes Mellitus Phase 2 Completed - South Africa ... More >> Synexus Clinical Research SA (Pty) Ltd Pretoria, Gauteng, South Africa Parexel Bloemfontein Bloemfontein, South Africa, 9301 Parexel George George, South Africa, 6529 Parexel Port Elizabeth Port Elizabeth, South Africa, 6045 Less <<
NCT00082381 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT00203996 - Terminated(Did not meet target... More >> patient accrual goals) Less << - -
NCT01768559 Type 2 Diabetes Phase 3 Completed - -
NCT00203996 Polycystic Ovary Syndrome ... More >> Obstructive Sleep Apnea Less << Phase 4 Terminated(Did not meet target... More >> patient accrual goals) Less << - United States, Illinois ... More >> University of Chicago Chicago, Illinois, United States, 60637 Less <<
NCT02653677 Hyperglycemia ... More >> Insulin Sensitivity Less << Not Applicable Completed - -
NCT01164020 Cognition Agi... More >>ng Less << Not Applicable Completed - Brazil ... More >> School of Medicine - Division of Rheumatology São Paulo, Brazil, 05508-030 Less <<
NCT00082407 - Completed - -
NCT00082407 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT01642485 Effects of Different Meals on ... More >>the QT/QTc Interval Insulin and Oral Hypoglycemic [Antidiabetic] Drugs Causing Adverse Effects in Therapeutic Use C-Peptide Effects on the QT/QTc Interval Moxifloxacin ECG Profile in Fed and Fasted State Japanese vs. Caucasian TQT Comparison Less << Phase 1 Completed - United Kingdom ... More >> Richmond Pharmacology Ltd London, Tooting, United Kingdom, SW17 0RE Less <<
NCT02535169 Obesity Predi... More >>abetic State Type 2 Diabetes Less << Not Applicable Recruiting May 2020 United States, Indiana ... More >> Indiana University School of Medicine Recruiting Indianapolis, Indiana, United States, 46202 Contact: Tamara Hannon    317-278-5608    tshannon@iu.edu    Principal Investigator: Tamara S Hannon, MD Less <<
NCT03474666 Liver Transplantation ... More >> Surgical Wound Infection Less << Not Applicable Recruiting June 30, 2020 Brazil ... More >> Hospital Santa Casa de São José dos Campos Recruiting São José Dos Campos, São Paulo, Brazil, 12210110 Contact: Jorge M Padilla, MSc    +551238761999    jpadilla_doc@hotmail.com    Contact: Ramon A Oliveira, MSc    +5511987001434    ramon.oliveira@usp.br Less <<
NCT02426541 Type 2 Diabetes Mellitus Phase 4 Completed - Finland ... More >> Research Site Turku, Finland Less <<
NCT01768559 - Completed - -
NCT02426541 - Completed - -
NCT03481894 Malnutrition Phase 4 Recruiting March 2021 United States, Illinois ... More >> The University of Chicago Medical Center Not yet recruiting Chicago, Illinois, United States, 60637 Contact: Timothy Sentongo, MD          United States, Missouri Children's Mercy Hospital Recruiting Kansas City, Missouri, United States, 64108 Contact: Joel D Lim, MD Less <<
NCT01931527 Obesity Metab... More >>olic Syndrome Hyperuricemia Less << Not Applicable Completed - United States, Missouri ... More >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Less <<
NCT02303470 Polycystic Ovary Syndrome ... More >> Insulin Resistance Less << Not Applicable Unknown July 2016 United States, California ... More >> UCSF Center for Reproductive Health Recruiting San Francisco, California, United States, 94158 Contact: Nik Lenhart    415-885-3598    Nik.Lenhart@ucsf.edu Less <<
NCT02964923 - Unknown December 2017 China, Shaanxi ... More >> Department of psychiatry，Xijing Hospital Xi'an, Shaanxi, China, 710000 Less <<
NCT01826162 Type 2 Diabetes Mellitus ... More >> Obesity Less << Not Applicable Completed - Netherlands ... More >> Maastricht University Maastricht, Limburg, Netherlands, 6200 MD Maastricht University Maastricht, Netherlands, 6200 Less <<
NCT02359552 Alzheimer's Disease Phase 2 Active, not recruiting February 15, 2019 United States, Nevada ... More >> Cleveland Clinic Lou Ruvo Center for Brain Health Las Vegas, Nevada, United States, 89106 United States, Ohio Cleveland Clinic Main Campus Cleveland, Ohio, United States, 44195 Cleveland Clinic Lakewood Hospital Lakewood, Ohio, United States, 44107 Less <<
NCT01841359 Hypoglycemia ... More >>Evidence of Previous Gastric Surgery Less << Phase 4 Active, not recruiting October 2018 United States, Massachusetts ... More >> Joslin Diabetes Center Boston, Massachusetts, United States, 02215 Less <<
NCT03240757 Metabolism and Nutrition Disor... More >>der Less << Not Applicable Completed - -
NCT03252080 Type 2 Diabetes Mellitus Not Applicable Not yet recruiting July 2018 -
NCT02660593 Diabetes Mellitus Not Applicable Unknown July 2017 China, Beijing ... More >> Jiuhua Hospital Recruiting Beijing, Beijing, China, 100001 Contact: Chi Shizhan, Master          Xuanwu Hospital Recruiting Beijing, Beijing, China, 100001 Contact: Chi Shizhan, Master Less <<
NCT01931527 - Completed - -
NCT03376685 Pre-diabetes ... More >>Obesity Cardiovascular Diseases Less << Not Applicable Recruiting August 2019 Canada, Ontario ... More >> University of Guelph Recruiting Guelph, Ontario, Canada, N1G 2W1 Contact: Jamie Burr, PhD Less <<
NCT01879579 Diabetes Mellitus Not Applicable Completed - United States, New York ... More >> Adult Primary Care Clinic, Bellevue Hospital Center New York, New York, United States, 10016 Less <<
NCT03342599 Metabolic Syndrome ... More >> Obesity Less << Not Applicable Completed - United States, California ... More >> University of La Verne Kinesiology Laboratory La Verne, California, United States, 91750 Less <<
NCT01981031 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 1 Completed - Germany ... More >> Neuss, Germany, 41460 Less <<
NCT00993187 Type 2 Diabetes Mellitus Phase 4 Completed - -
NCT01879579 - Completed - -
NCT00993187 - Completed - -
NCT02451813 Orthopedic Disorders Not Applicable Completed - United States, New York ... More >> St. Luke's-Roosevelt Hospital Center New York, New York, United States, 10025 Less <<
NCT00993603 Type 2 Diabetes ... More >> Obesity Less << Not Applicable Completed - United Kingdom ... More >> Royal Bournemouth Hospital Bournemouth, Dorset, United Kingdom, BH7 7DW Less <<
NCT02195856 Type 2 Diabetes ... More >> Ageing Less << Not Applicable Completed - United Kingdom ... More >> Exeter Magnetic Resonance Research Centre, St Luke's Campus Exeter, Devon, United Kingdom, EX1 2LU NIHR Exeter Clinical Research Facility Exeter, Devon, United Kingdom, EX2 5DW Less <<
NCT01268995 New Onset Diabetes Mellitus Af... More >>ter Renal Transplantation Less << Phase 2 Terminated(It was impossible t... More >>o recruit the scheduled number of patients) Less << - Austria ... More >> Medical University of Vienna/General Hospital Vienna, Austria, A-1090 Less <<
NCT02656069 Hypoglycemia ... More >>Diabetes Mellitus, Type 1 Less << Phase 3 Completed - United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35294 United States, California ProSciento, Inc. Chula Vista, California, United States, 91911 AMCR Institute Escondido, California, United States, 92025 Diablo Clinical Research Walnut Creek, California, United States, 94598 United States, Texas Clinical Trials of Texas, Inc. San Antonio, Texas, United States, 78229 United States, Washington Rainier Research Renton, Washington, United States, 98057 Canada, Ontario LMC Diabetes & Endocrinology Toronto, Ontario, Canada, M4G 3E8 Less <<
NCT02656069 - Completed - -
NCT03266978 - Not yet recruiting July 2019 Egypt ... More >> Assiut University Not yet recruiting Assiut, Egypt, 71111 Contact: Heba Elnaggar, MD    01001963100    heba_m_elnaggar@yahoo.com Less <<
NCT01113541 Bipolar Disorder Phase 3 Terminated(See termination rea... More >>son in detailed description.) Less << - Canada, Alberta ... More >> Foothills Medical Centre, Department of Psychiatry Calgary, Alberta, Canada, T2N 2T9 Mental Health Centre for Research and Education Calgary, Alberta, Canada, T2N 2T9 Canada, British Columbia Dr. Alexander McIntyre Inc. Penticton, British Columbia, Canada, V2A 4M4 Canada, Manitoba Country Club Plaza Winnipeg, Manitoba, Canada, R3K 2E2 Edgeland Medical, Dr. Alla Kirshner Medical Corporation Winnipeg, Manitoba, Canada, R3P 0N5 Canada, Nova Scotia Capital, Health Authority, QE II Health Sciences Centre, Mood Disorder Clinic Halifax, Nova Scotia, Canada, B3H 2E2 Office of Dr. A. K. Munshi Sydney, Nova Scotia, Canada, B1S 2E8 Canada, Quebec Centre de recherche Fernand-Seguin de l'hopital Louis H. Lafontaine Montreal, Quebec, Canada, H1N 3V2 Clinique St-Leonard Montreal, Quebec, Canada, H1P 3K2 Diex Research Sherbrooke Inc. Sherbrooke, Quebec, Canada, J1H 1Z1 Less <<
NCT03741218 Obesity Not Applicable Recruiting March 2020 Spain ... More >> Institute of Food Science, Technology and Nutrition, National Research Council (ICTAN-CSIC) Recruiting Madrid, Spain, 28040 Contact: Jara Pérez-Jiménez, PhD    +34915492300 ext 231406    jara.perez@ictan.csic.es Less <<
NCT03259685 Gut Microbiota ... More >> Metabolic Syndrome Less << Not Applicable Recruiting December 2020 Canada ... More >> Laval University Recruiting Québec, Canada, G1V0A6 Contact: Marie-Claude Vohl    418-656-2131 ext 4676    marie-claude.vohl@ulaval.ca Less <<
NCT03631121 Type2 Diabetes Phase 4 Not yet recruiting January 30, 2019 -
NCT00393705 Diabetes Mellitus, Type 2 Phase 4 Completed - Croatia ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Zagreb, Croatia, HR-10000 Poland For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bialystok, Poland, 15-276 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Rzeszow, Poland, 35-0723 Romania For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bucharest, Romania, 020475 South Africa For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kempton Park, South Africa, 1619 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kenilworth, South Africa, 7708 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kuilsriver, South Africa, 7580 Turkey For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Istanbul, Turkey, 34662 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Konya, Turkey, 42075 Less <<
NCT00393705 - Completed - -
NCT01623648 Type 2 Diabetes Not Applicable Unknown October 2016 Israel ... More >> Daniela Jakubowicz Holon, N/A = Not Applicable, Israel, 58100 Venezuela Daniela Jakubowicz Caracas, San Bernardino, Venezuela, 410 Less <<
NCT02216123 - Completed - -
NCT01113541 - Terminated(See termination rea... More >>son in detailed description.) Less << - -
NCT02216123 Malaria, Vivax Phase 3 Completed - Brazil ... More >> GSK Investigational Site Manaus, Amazonas, Brazil, 69040-000 Colombia GSK Investigational Site Cali, Colombia GSK Investigational Site Monteria, Colombia Ethiopia GSK Investigational Site Gondar, Ethiopia GSK Investigational Site Jimma, Ethiopia Peru GSK Investigational Site Iquitos, Loreto, Peru, Iqui 01 Thailand GSK Investigational Site Bangkok, Thailand, 10400 GSK Investigational Site Mae Sot, Thailand, 63110 GSK Investigational Site Tak, Thailand, 63170 Vietnam GSK Investigational Site Ho Chi Minh, Vietnam Less <<
NCT02441296 Infant Metabo... More >>lism Less << Not Applicable Completed - -
NCT00591227 Type 2 Diabetes Mellitus Phase 4 Completed - United States, Illinois ... More >> Rush University Medical Center Chicago, Illinois, United States, 60612 Less <<
NCT00591227 - Completed - -
NCT02204839 Type 1 Diabetes Mellitus Not Applicable Completed - United Kingdom ... More >> Clinical Research Facility, Royal Victoria Infirmary Newcastle upon Tyne, Tyne and Wear, United Kingdom, NE1 4LP Less <<
NCT03139864 Type 1 Diabetes Not Applicable Not yet recruiting December 2018 France ... More >> CHU Clermont-Ferrand Not yet recruiting Clermont-Ferrand, France, 63003 Contact: Patrick LACARIN    04 73 75 11 95    placarin@chu-clermontferrand.fr    Principal Investigator: Daniel TERRAL Less <<
NCT01576848 Sarcopenia Not Applicable Completed - Netherlands ... More >> Maastricht University Maastricht, Limburg, Netherlands, 6200 MD Less <<
NCT01766570 Diabetes Card... More >>iovascular Disease Less << Not Applicable Completed - Canada ... More >> Institute of Nutraceuticals and Functional Foods (INAF), Laval University Quebec, Canada, G1V 0A6 Less <<
NCT00494884 Diabetes Mellitus, Type 2 Phase 3 Completed - Germany ... More >> Novartis Investigative Site Bochum, Germany Less <<
NCT00411554 Diabetes Mellitus, Non-Insulin... More >>-Dependent Less << Phase 3 Completed - -
NCT01045525 Liver Cirrhosis ... More >> Iron Overload Less << Phase 3 Completed - France ... More >> Clermont-Ferrand University Hospital Clermont-Ferrand, France, 63058 La Roche Sur Yon Hospital La Roche Sur Yon, France, 85925 Lorient Hospital Lorient, France, 56100 Service des maladies du foie - Hôpital Pontchaillou Rennes, France, 35000 Saint-Malo Hospital Saint-Malo, France, 35400 Less <<
NCT00411554 - Completed - -
NCT01536860 Glycemic Index ... More >> Glycemic Response Less << Not Applicable Completed - United Kingdom ... More >> Reading Scientific Services Limited (RSSL) Reading, Berkshire, United Kingdom, RG6 6BZ Less <<
NCT00469287 - Completed - Netherlands ... More >> Metabolic ward of TNO Quality of Life Zeist, Utrecht, Netherlands, 3700AJ Less <<
NCT00995787 Type II Diabetes Mellitus Phase 1 Completed - United States, California ... More >> Research Site San Diego, California, United States Less <<
NCT02217826 Healthy Phase 1 Completed - -
NCT01698385 Gestational Diabetes Phase 2 Completed - Finland ... More >> Hospital District of Helsinki and Uusimaa Helsinki, Finland Less <<
NCT02571114 Healthy Not Applicable Completed - Canada, Manitoba ... More >> St. Boniface Hospital, Asper Clinical Research Institute Winnipeg, Manitoba, Canada, R2H 2A6 Less <<
NCT00846248 Insulin Resistance Not Applicable Completed - United States, California ... More >> UCSF San Francisco, California, United States, 94143 Less <<
NCT00929461 Gastric Surgery Not Applicable Completed - Turkey ... More >> Ege University General Surgery Dep Izmir, Turkey, 35100 Less <<
NCT02325193 - Completed - Germany ... More >> Kinder - und Jugendkrankenhaus AUF DER BULT Hannover, Germany, 30173 Less <<
NCT01536860 - Completed - -
NCT00570687 Diabetes Mellitus, Type 2 Phase 2 Completed - Germany ... More >> Profil Institute for Metabolic Research Neuss, GER, Germany Less <<
NCT02562326 Type 2 Diabetes Mellitus Phase 1 Completed - Germany ... More >> Profil Mainz GmbH & Co.KG Mainz, Germany, 44116 Profil GmbH Neuss, Germany, 41460 Less <<
NCT00570687 - Completed - -
NCT02782208 Hypopituitarism ... More >> Insulin Resistance Endocrine System Diseases Glucose Metabolism Disorders Metabolic Diseases Pituitary Diseases Brain Diseases Less << Not Applicable Unknown November 2018 Denmark ... More >> University Hospital of Aarhus Recruiting Aarhus, Denmark, 8000 Contact: Astrid J Hjelholt, MD    +4524800664    ajh@clin.au.dk Less <<
NCT02685449 Diabetes type1 Phase 4 Unknown August 2018 Poland ... More >> Medical University Recruiting Warsaw, Poland, 02- 091 Contact: Agnieszka Szypowska, MD, PhD    +48223179421       Sub-Investigator: Kamila Indulska          Principal Investigator: Katarzyna Dżygało Less <<
NCT01554631 Diabetes Mellitus, Type 2 Phase 1 Completed - Germany ... More >> Mönchengladbach, Nordrhein-Westfalen, Germany, 41061 Less <<
NCT01755468 Type 2 Diabetes Phase 3 Completed - Canada, Ontario ... More >> Mount Sinai Hospital Toronto, Ontario, Canada, M5G1X5 Less <<
NCT01398826 - Unknown August 2011 -
NCT01997411 Diabetes Mellitus, Type 1 Phase 2 Phase 3 Completed - United States, Colorado ... More >> Barbara Davis Center for Diabetes Aurora, Colorado, United States, 80045 United States, Connecticut Yale University New Haven, Connecticut, United States, 06520 United States, Florida University of Florida Gainesville, Florida, United States, 32605 Nemours Children's Clinic Jacksonville, Florida, United States, 32207 United States, Indiana Riley Hospital for Children Indiana University Health Indianapolis, Indiana, United States, 46202 United States, Minnesota University of Minnesota Minneapolis, Minnesota, United States, 55454 United States, New York UPA Buffalo Buffalo, New York, United States, 14222 Less <<
NCT01997411 - Completed - -
NCT02354222 Type 2 Diabetes Mellitus Phase 3 Completed - Japan ... More >> Reserch site Kanto, Japan Reserch site Kinki, Japan Reserch site Tohoku, Japan Less <<
NCT01432093 Hospital Hyperglycemia ... More >> Post-transplant Hyperglycemia Less << Not Applicable Completed - United States, Florida ... More >> Mayo Clinic Jacksonville, Florida, United States, 32224 Less <<
NCT02354235 Type 2 Diabetes Mellitus Phase 3 Completed - Japan ... More >> Reserch site Kanto, Japan Reserch site Kinki, Japan Reserch site Tohoku, Japan Less <<
NCT02354235 - Completed - -
NCT02354222 - Completed - -
NCT03703141 Healthy Not Applicable Completed - -
NCT02762708 Type 2 Diabetes Mellitus ... More >> Obesity Less << Not Applicable Recruiting December 2019 United States, Minnesota ... More >> Mayo Clinic in Rochester Recruiting Rochester, Minnesota, United States, 55905 Contact: Paula D Giesler, RN, BSN, CDE    507-255-8345    giesler.paula@mayo.edu    Sub-Investigator: Adrian Vella, MD Less <<
NCT02192424 Type 2 Diabetes Phase 3 Recruiting September 2020 Canada, Ontario ... More >> Mount Sinai Hospital Recruiting Toronto, Ontario, Canada, M5G1X5 Principal Investigator: Ravi Retnakaran, MD Less <<
NCT01954147 Type 2 Diabetes Phase 1 Phase 2 Unknown October 2015 China, Fujian ... More >> Diabetes Care Center of Nanjing Military Command Fuzhou, Fujian, China, 350025 Less <<
NCT03224533 - Completed - United States, California ... More >> University of California Los Angeles Los Angeles, California, United States, 90095 Less <<
NCT01968148 - Completed - Finland ... More >> Helsinki Emergency Medical Services Helsinki, Finland Helsinki Area Helicopter Emergency Medical Services Vantaa, Finland Less <<
NCT00552734 - Completed - United States, Colorado ... More >> University of Colorado Health Sciences Center, Barbara Davis Center for Diabetes Aurora, Colorado, United States, 80045 Less <<
NCT01095653 Type 2 Diabetes Phase 3 Completed - -
NCT00740948 Sjogren's Disease Phase 2 Phase 3 Completed - France ... More >> CHU de Brest Brest, France, 29200 CHU Clermont-Ferrand Clermont-ferrand, France, 63003 GH Le Havre Le Havre, France, 76 083 AP-HP Bicêtre Le KREMLIN-BICETRE, France, 94275 Ch Le Mans Le Mans, France, 72 037 CHRU de LILLE Lille, France, 59 037 CHU de Marseille Marseille, France Hopital LAPEYRONIE Montpellier, France, 34 295 CHU de Nantes Nantes, France, 44 093 Hôpital Cochin APHP Paris, France, 75 679 CHU Bichat Paris, France, 75018 Hôpital SUD CHU Rennes Rennes, France, 35 203 CHU Rouen Rouen, France, 76 031 CHU de Strasbourg Strasbourg, France, 67 200 Less <<
NCT01340300 Colorectal Cancer ... More >> Breast Cancer Less << Phase 2 Completed - United States, Connecticut ... More >> Yale School of Medicine New Haven, Connecticut, United States, 06520 United States, Massachusetts Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 Less <<
NCT00167934 Schizophrenia Not Applicable Unknown December 2008 United States, Missouri ... More >> Washington University School of Medicine Recruiting St. Louis, Missouri, United States, 63110 Contact: Elizabeth T Westerhaus, MA    314-747-1134    westerhe@psychiatry.wustl.edu    Contact: Julie Schweiger    314-362-3153    schweigj@psychiatry.wustl.eddu    Principal Investigator: Dan W. Haupt, MD Less <<
NCT02274272 Type 2 Diabetes Phase 2 Completed - Taiwan ... More >> Genmont Tainan, Taiwan Less <<
NCT00313001 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - United States, New Jersey ... More >> Novo Nordisk Investigational Site Plainsboro, New Jersey, United States, 08536 Less <<
NCT01302145 Type 2 Diabetes Mellitus Phase 1 Completed - Hungary ... More >> Balatonfured, Hungary, 8230 Budapest, Hungary, 1083 Netherlands Groningen, Netherlands, 9470 AE Poland Warsaw, Poland, 02-097 Slovakia Bratislava, Slovakia, 83305 Less <<
NCT01340300 - Completed - -
NCT03215043 Pre Diabetes Not Applicable Recruiting June 28, 2019 Brazil ... More >> Sao Paulo State University "Julio de Mesquita Filho", Faculdade de Ciências Farmacêuticas Recruiting Araraquara, Sao Paulo, Brazil, 14800-903 Contact: Thais B Cesar, Ph.D.    +55 16 3301-6927    tcesar@fcfar.unesp.br Less <<
NCT01095653 - Completed - -
NCT00468754 Diabetes Mellitus Type 1 Not Applicable Completed - Italy ... More >> Bergamo, Italy, 24128 Brescia, Italy, 25123 Padova, Italy, 35128 Pisa, Italy, 56124 Less <<
NCT01089309 Arterial Stiffness ... More >> Arterial Elasticity Less << Phase 4 Completed - Israel ... More >> Wolfson Medical Center Holon, Israel, 58100 Less <<
NCT00939718 Major Depressive Disorder Not Applicable Unknown September 2010 Pakistan ... More >> Aga Khan University Karachi, Sindh, Pakistan, 74800 Less <<
NCT01978990 - Withdrawn(financial issues) October 2019 -
NCT02352090 Contraception Phase 4 Completed - Finland ... More >> Helsinki University Central Hospital, Kätilöopisto Maternity Hospital Helsinki, Finland Oulu University Hospital, Department of Gynecology and Obstetrics Oulu, Finland Less <<
NCT02273180 - Completed - -
NCT01237314 - Completed - United States, Minnesota ... More >> International Diabetes Center Minneapolis, Minnesota, United States, 55416 Less <<
NCT01401751 Type 1 Diabetes Mellitus Not Applicable Completed - United States, California ... More >> Sansum Diabetes Research Institute Santa Barbara, California, United States, 93105 Less <<
NCT01240200 - Completed - -
NCT02435693 DIABETES MELLITUS, TYPE 2 Not Applicable Completed - India ... More >> Tabrej Aj Mujawar Dhule, Maharashtra, India, 424001 Less <<
NCT01240200 Diabetes Mellitus Phase 4 Completed - United States, Georgia ... More >> Grady Memorial Hospital Atlanta, Georgia, United States, 30303 Less <<
NCT02273180 Type 1 Diabetes Mellitus Phase 3 Completed - -
NCT03588104 Type1 Diabetes Mellitus ... More >> Type2 Diabetes Mellitus Diabetes Mellitus Health Behavior Self Efficacy Less << Not Applicable Not yet recruiting August 2019 Netherlands ... More >> Leiden University Medical Centre Not yet recruiting Leiden, Zuid-Holland, Netherlands, 2333 ZA Contact: Bas Uitbeijerse, MD    +31 71 5297263    b.s.uitbeijerse@lumc.nl    Contact: Merel Ruissen, MD       m.m.ruissen@lumc.nl    Sub-Investigator: Bas Uitbeijerse, MD          Sub-Investigator: Eelco de Koning, MD Ph.D.          Principal Investigator: Jacob Sont, Ph.D.          Sub-Investigator: Merel Ruissen, MD          Spain Reina Sofia University Hospital Not yet recruiting Córdoba, Spain, 14004 Contact: Javier Delgado-Lista, MD Ph.D.       delgadolista@gmail.com    Principal Investigator: Javier Delgado-Lista, MD, Ph.D.          Sub-Investigator: José López-Miranda, MD, Ph.D.          Sub-Investigator: Pablo Pérez-Martínez, MD, Ph.D.          Sub-Investigator: Antonio García-Ríos, MD, Ph.D.          Sub-Investigator: Juan F Alcalá-Diaz, MD, Ph.D.          Sub-Investigator: Francisco Gómez-Delgado, MD, Ph.D.          Sub-Investigator: Ana León-Acuña, MD, Ph.D.          Sub-Investigator: Francisco Fuentes-Jiménez, MD, Ph.D.          Sub-Investigator: Antonio P Arenas-de Larriva, MD          Sub-Investigator: José D Torres-Peña, MD          Sub-Investigator: Oriol A Rangel-Zúñiga, Ph.D.          Sub-Investigator: Elena M Yubero-Serrano, Ph.D.          Sub-Investigator: Antonio Camargo-García, Ph.D.          Sub-Investigator: Rafael Molina-Eslava Less <<
NCT02758522 Diabetes Mellitus ... More >> Hyperglycemia Less << Phase 4 Completed - -
NCT00607087 - Completed - -
NCT01121276 Diabetes Diab... More >>etes Mellitus, Type 1 Diabetes Mellitus, Type 2 Less << Phase 1 Completed - United States, California ... More >> Novo Nordisk Investigational Site Chula Vista, California, United States, 91911 Less <<
NCT01847053 Healthy Males Phase 1 Phase 2 Completed - United States, Illinois ... More >> Biofortis Clinical Research Addison, Illinois, United States, 60101 Less <<
NCT01105455 Diabetes, Gestational Not Applicable Completed - Canada, Ontario ... More >> Mt Sinai Hospital Toronto, Ontario, Canada, M5G 1X5 Less <<
NCT00961324 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 1 Completed - Germany ... More >> Novo Nordisk Investigational Site Neuss, Germany, 41460 Less <<
NCT02409914 - Completed - -
NCT01966419 Acute Episode of Overt Hepatic... More >> Encephalopathy Hepatic Encephalopathy Less << Phase 2 Completed - -
NCT01494909 Cystic Fibrosis Not Applicable Active, not recruiting February 2019 United States, Arkansas ... More >> University of Arkansas for Medical Sciences Little Rock, Arkansas, United States, 72205 Less <<
NCT02910076 Diabetes Type Two Phase 1 Phase 2 Unknown - -
NCT01819688 Insulin Resistance Not Applicable Completed - China, Zhejiang ... More >> Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University Hangzhou, Zhejiang, China, 310016 Less <<
NCT00265148 Alzheimer's Disease Phase 2 Completed - United States, Arizona ... More >> GSK Investigational Site Litchfield Park, Arizona, United States, 85340 GSK Investigational Site Phoenix, Arizona, United States, 85006 GSK Investigational Site Scottsdale, Arizona, United States, 85259 GSK Investigational Site Sun City, Arizona, United States, 85351 GSK Investigational Site Tucson, Arizona, United States, 85724 United States, California GSK Investigational Site Los Angeles, California, United States, 90024 United States, Massachusetts GSK Investigational Site Belmont, Massachusetts, United States, 02478 United States, Michigan GSK Investigational Site Ann Arbor, Michigan, United States, 48109 United States, North Carolina GSK Investigational Site Durham, North Carolina, United States, 27705 Canada, Quebec GSK Investigational Site Montreal, Quebec, Canada, H3T 1E2 GSK Investigational Site Montreal, Quebec, Canada, H4H 1R3 United Kingdom GSK Investigational Site Liverpool, United Kingdom, L9 7LJ GSK Investigational Site Manchester, United Kingdom, M20 3LJ GSK Investigational Site Swindon, United Kingdom, SN1 4HZ GSK Investigational Site West End, Southampton, United Kingdom, SO30 3JB Less <<
NCT01197963 Type 2 Diabetes Mellitus Not Applicable Terminated(IRB temporarily hal... More >>ted enrollment) Less << - United States, Texas ... More >> The University of Texas Bellaire, Texas, United States, 77494 Less <<
NCT03242018 Type 2 Diabetes Mellitus-Chron... More >>ic Kidney Disease Stage 4 Less << Phase 3 Active, not recruiting December 2019 -
NCT01446120 Healthy Volunteers Phase 1 Unknown - -
NCT03367663 Atherosclerosis ... More >> Dyslipidemias Diabetes Less << Early Phase 1 Not yet recruiting December 2018 -
NCT01219582 - Completed - India ... More >> Many Locations, India Less <<
NCT02974309 Type 1 Diabetes Not Applicable Recruiting June 2021 United States, Arizona ... More >> Angel Wing Clinic for Diabetes Recruiting Tucson, Arizona, United States, 85719 Principal Investigator: Michelle M Perfect, Ph.D.          Sub-Investigator: Mark Wheeler, MD Less <<
NCT01995643 Polyphenolic Compounds and Met... More >>abolism Less << Not Applicable Active, not recruiting December 1, 2019 United States, Illinois ... More >> Clinical Nutrition Research Center Chicago, Illinois, United States, 60616 Less <<
NCT00146289 Obesity Insul... More >>in Resistance Less << Phase 2 Completed - United States, California ... More >> UCLA School of Medicine- Divison of Endocrinology Los Angeles, California, United States University of CA at SanDiego- Department of Endocrinology San Diego, California, United States Boehringer Ingelheim Investigational Site Westlake Village, California, United States United States, Illinois Boehringer Ingelheim Investigational Site Chicago, Illinois, United States United States, New York University of Rochester Medical Center Rochester, New York, United States United States, Ohio Boehringer Ingelheim Investigational Site Cincinnati, Ohio, United States United States, Tennessee Boehringer Ingelheim Investigational Site Nashville, Tennessee, United States United States, Texas Boehringer Ingelheim Investigational Site Harker Heights, Texas, United States Canada, Manitoba University of Manitoba, Diabetes Research Group Winnipeg, Manitoba, Canada Canada, Ontario St. Joseph's Health Care London London, Ontario, Canada The Ottawa Hospital - Riverside Campus Ottawa, Ontario, Canada Denmark Århus Sygehus Aarhus C, Denmark Germany Universitätsmedizin Berlin Berlin, Germany Boehringer Ingelheim Investigational Site Künzing, Germany Boehringer Ingelheim Investigational Site Unterschneidheim, Germany Italy Policlinico Monteluce Perugia, Italy Azienda Ospedale Università di Pisa Pisa, Italy Less <<
NCT01513746 - Completed - United States, North Carolina ... More >> Duke University Health System Durham, North Carolina, United States, 27710 Less <<
NCT01790438 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT01326533 Pre-diabetes Phase 4 Completed - United States, Pennsylvania ... More >> University of Pittsburgh, Montefiore Hospital Pittsburgh, Pennsylvania, United States, 15213 Less <<
NCT00930202 Severe Traumatic Brain Injury Phase 1 Completed - United States, Washington ... More >> Harborview Medical Center Seattle, Washington, United States, 98104 Less <<
NCT01790438 - Completed - -
NCT01326533 - Completed - -
NCT01549964 Glycemic Control Phase 3 Terminated(Due to concerns abo... More >>ut potential liver safety (See Detailed Description)) Less << - -
NCT01549964 - Terminated(Due to concerns abo... More >>ut potential liver safety (See Detailed Description)) Less << - -
NCT03051243 DM2 Phase 3 Not yet recruiting November 1, 2019 -
NCT02824510 Type 1 Diabetes Not Applicable Unknown - Belgium ... More >> Pediatric Endocrinology Recruiting Brussels, Belgium, 1200 Contact: Philippe Lysy, MD PhD    +32-2-7641370 Less <<
NCT02633722 Type 2 Diabetes ... More >> Insulin Resistance Less << Not Applicable Completed - Australia, South Australia ... More >> University of Adelaide Adelaide, South Australia, Australia Less <<
NCT01661127 - Unknown December 2015 Korea, Republic of ... More >> Department of dermatology, Pusan National University Hospital Recruiting Busan, Korea, Republic of Contact: Byung-Soo Kim, Ph D.    82-51-240-7338    dockbs@pusan.ac.kr Less <<
NCT01703221 - Completed - -
NCT00802204 Obesity Not Applicable Completed - United States, Tennessee ... More >> Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232 Less <<
NCT00145093 Diabetes Mellitus, Type 2 Phase 3 Completed - Netherlands ... More >> General Practice Heerde, Netherlands Less <<
NCT01703221 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT01704261 - Completed - -
NCT03312712 - Recruiting November 2020 United Kingdom ... More >> Cambridge University Hospitals NHS Foundation Trust Recruiting Cambridge, United Kingdom, CB2 0QQ Contact: Laurence Vass, MSc          Principal Investigator: Joseph Cheriyan, MBCHB, MA, FRCP          Sub-Investigator: Omar Mukhtar, MB, ChB, BSc, MRCP          Sub-Investigator: Laurence Vass, MSc          Royal Papworth Hospital NHS Foundation Trust Recruiting Papworth Everard, United Kingdom, CB23 3RE Contact: Muhunthan Thillai, BA, PhD, MRCP          Principal Investigator: Muhunthan Thillai, BA, PhD, MRCP Less <<
NCT00233142 Diabetes Mellitus ... More >> Stress Depression Less << Phase 2 Completed - United States, New York ... More >> State University of New York Medical University Syracuse, New York, United States, 13244 Syracuse University Syracuse, New York, United States, 13244 United States, Pennsylvania Pennsylvania State University University Park, Pennsylvania, United States, 16802 United States, Tennessee Vanderbilt University Nashville, Tennessee, United States, 37235 Less <<
NCT01704261 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT01436916 Prediabetes V... More >>itamin D Deficiency Less << Phase 4 Completed - India ... More >> PGIMER Chandigarh, Chandigarh(UT), India, 160012 Less <<
NCT03287076 Acute Ischemic Stroke Phase 2 Recruiting December 31, 2020 Australia, Victoria ... More >> Box Hill Hospital Recruiting Melbourne, Victoria, Australia, 3128 Contact: Christopher Bladin    +61 3 9035 7338    chris.bladin@unimelb.edu.au    Principal Investigator: Christopher Bladin Less <<
NCT00802204 - Completed - -
NCT02068300 - Completed - Korea, Republic of ... More >> Seoul National University Hospital Seoul, Korea, Republic of, 110-744 Less <<
NCT00752960 - Unknown December 2009 United States, Connecticut ... More >> Hartford Hospital Institute of Living Recruiting Hartford, Connecticut, United States, 06106 Contact: Steven Woolley, PhD    860-545-7329    Swoolle@harthosp.org    Contact: John D. Goethe, MD    860-545-7118    jgoethe@harthosp.org    Principal Investigator: John W Goethe, MD          United States, Kentucky University of Kentucky Recruiting Lexington, Kentucky, United States, 40508 Contact: Jose de Leon, MD    859-246-7563    jdeleon@uky.edu    Principal Investigator: Jose de Leon, MD Less <<
NCT01874392 Type 1 Diabetes Mellitus Not Applicable Completed - United States, California ... More >> Sansum Diabetes Research Institute Santa Barbara, California, United States, 93105 Less <<
NCT01163370 Osteopenia Os... More >>teoporosis Less << Not Applicable Completed - Brazil ... More >> School of Medicine - Division of Rheumatology Sao Paulo, Brazil, 01246-903 Less <<
NCT03395262 Weight Loss Not Applicable Active, not recruiting December 31, 2018 United States, Texas ... More >> Exercise & Sport Nutrition Lab - Human Clinical Research Facility College Station, Texas, United States, 77845 Less <<
NCT01571310 Type 2 Diabetes Not Applicable Completed - Israel ... More >> Daniela Jakubowicz Holon, N/A = Not Applicable, Israel, 58100 Venezuela Daniela Jakubowicz Caracas, Venezuela, 410 Less <<
NCT00143624 Atherosclerosis ... More >> HIV Infections Less << Not Applicable Completed - Canada, British Columbia ... More >> St. Paul's Hospital Vancouver, British Columbia, Canada, V6Z 1Y6 Less <<
NCT01361594 - Completed - -
NCT03063580 Diabetes Mellitus Phase 1 Completed - France ... More >> Investigational Site Number 250001 Gieres, France, 38610 Less <<
NCT01202526 - Completed - Denmark ... More >> Hvidovre University Hospital Copenhagen, Hvidovre, Denmark, DK-2650 Less <<
NCT01377662 Methamphetamine Dependence ... More >> Cocaine Dependence Less << Phase 2 Completed - United States, North Carolina ... More >> Duke Addictions Clinic Durham, North Carolina, United States, 27705 Duke Clinical Research Unit Durham, North Carolina, United States, 27710 SouthLight Raleigh, North Carolina, United States, 27610 Less <<
NCT01361594 Diabetes Phase 3 Completed - United States, Georgia ... More >> Emory University Hospital Atlanta, Georgia, United States, 30326 Less <<
NCT00140647 Atherosclerosis ... More >> Impaired Glucose Tolerance Isolated Impaired Fasting Glucose Cardiovascular Disease Less << Phase 3 Completed - -
NCT00854503 Type 2 Diabetes ... More >> Diabetic Dyslipidemia Less << Phase 3 Completed - Italy ... More >> University of Rome Tor Vergata Rome, Italy, 00133 Less <<
NCT03207607 Satiety Food ... More >>Intake Less << Not Applicable Completed - Canada, Ontario ... More >> School of Nutrition, Ryerson University Toronto, Ontario, Canada, M5B 2K3 Less <<
NCT03179332 Type1 Diabetes Mellitus Phase 1 Completed - Germany ... More >> Profil Institut für Stoffwechselforschung GmbH Neuss, Germany, 41460 Less <<
NCT03249896 Gestational Diabetes ... More >> Pregnancy Complications Weight Gain Less << Not Applicable Recruiting April 2019 Singapore ... More >> National University Hospital Recruiting Singapore, Singapore, 119228 Contact: E Shyong Tai, PhD    +65 67724371    e_shyong_tai@nuhs.edu.sg    Contact: Tong Wei Yew, MRCP    +65 67723943    tong_wei_yew@nuhs.edu.sg Less <<
NCT02708758 Gestational Diabetes Not Applicable Recruiting December 2019 Mexico ... More >> Instituto Nacional de Perinatología Isidro Espinosa de los Reyes Recruiting Mexico City, Mexico, 11000 Contact: Nayeli Martínez-Cruz, MD    +525555209900 ext 299    nayemc_21@hotmail.com    Contact: Enrique Reyes-Muñoz, MD, PhD.    +525555209900 ext 299    dr.enriquereyes@gmail.com Less <<
NCT03541005 Overweight and Obesity Phase 3 Recruiting December 1, 2019 Cuba ... More >> National Institute of Endocrinology Recruiting Havana, La Habana, Cuba, 10400 Contact: Eduardo Cabrera Rode, Dr.       diabetes@infomed.sld.cu    Sub-Investigator: Ileana Cubas Dueñas, Dr.          Sub-Investigator: Ana I. Conesa González, Dr.          Sub-Investigator: José Hernández, Dr.          Principal Investigator: Judith Parlá Sardiñas, Dr.          Sub-Investigator: Silvia Marín Julia, Dr.          Sub-Investigator: Yuri Arnold Domínguez, Dr.          Sub-Investigator: Antonio D. Reyes Rodríguez, PD          Sub-Investigator: Aimee Álvarez Álvarez, MD          Sub-Investigator: Ragmila Echevarría Valdés, BSc          Sub-Investigator: Janet Rodríguez Acosta, BSc          Sub-Investigator: Liudmila Jorge Espinosa, CPhT          Sub-Investigator: Kenia Enrique Lugo, BNurs          Sub-Investigator: Masiel Peña Roque, BNurs          Sub-Investigator: Rocío Montes de Oca Somoano, Dr. Less <<
NCT00184600 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT00957060 Diabetes Mellitus, Type 2 Phase 4 Completed - Guatemala ... More >> Sanofi-Aventis Administrative Office Guatemala City, Guatemala Mexico Sanofi-Aventis Administrative Office Col. Coyoacan, Mexico Less <<
NCT01254084 Type 2 Diabetes Phase 1 Phase 2 Completed - Vietnam ... More >> National Institute of Gerontology, HMU Hanoi, Vietnam National Institute of Gerontology Hanoi, Vietnam Less <<
NCT00304538 Type 1 Diabetes Phase 1 Completed - United States, California ... More >> University Of California, San Diego San Diego, California, United States, 92103-8765 Less <<
NCT03071016 - Completed - India ... More >> Research Site Hyderabad, Andhra Pradesh, India Research Site Nellor, Andhra Pradesh, India Research Site Vijayawada, Andhra Pradesh, India Research Site Raipur, Chhattisgarh, India Research Site New Delhi, Delhi, India Research Site Ahmedabad, Gujrat, India Research Site Rajkot, Gujrat, India Research Site Surat, Gujrat, India Research Site Bangalore, Karnataka, India Research Site Aurangabad, Maharashtra, India Research Site Mumbai, Maharashtra, India Research Site Nagpur, Maharashtra, India Research Site Pune, Maharashtra, India Research Site Amritsar, Punjab, India Research Site Bhathinda, Punjab, India Research Site Chandigarh, Punjab, India Research Site Ludhiana, Punjab, India Research Site Patiala, Punjab, India Research Site Jaipur, Rajasthan, India Research Site Chennai, Tamil Nadu, India Research Site Coimbatore, Tamil Nadu, India Research Site Madurai, Tamil Nadu, India Research Site Pudhucherry, Tamil Nadu, India Research Site Salem, Tamil Nadu, India Research Site Hyderabad, Telangana, India Research Site Kanpur, UP, India Research Site Lucknow, UP, India Research Site Jalpaiguri, West Bengal, India Research Site Kolkata, West Bengal, India Less <<
NCT01021826 - Completed - Finland ... More >> Coxa, Hospital for Joint Replacement Tampere, Finland, 33580 Less <<
NCT01046422 Diabetes Type 2 Phase 2 Completed - United States, California ... More >> Marina Raikhel, Md Lomita, California, United States, 90717 United States, Nevada Nevada Alliance Against Diabetes Las Vegas, Nevada, United States, 89101 Australia, Queensland Local Institution Caboolture, Queensland, Australia, 4510 Local Institution Meadowbrook, Queensland, Australia, 4131 Australia, South Australia Local Institution Daw Park, South Australia, Australia, 5041 Australia, Victoria Local Institution Geelong, Victoria, Australia, 3220 Australia, Western Australia Local Institution Nedlands, Western Australia, Australia, 6009 Canada, Manitoba Local Institution Winnipeg, Manitoba, Canada, R3P 1R9 Canada, Newfoundland and Labrador Local Institution Mount Pearl, Newfoundland and Labrador, Canada, A1N 1W7 Canada, Ontario Local Institution Brampton, Ontario, Canada, L6T 3J1 Local Institution Toronto, Ontario, Canada, M4G 3E8 Canada, Prince Edward Island Local Institution Charlottetown, Prince Edward Island, Canada, C1A 5Y9 Canada, Quebec Local Institution Drummondville, Quebec, Canada, J2B 7T1 Local Institution Lachine, Quebec, Canada, H8S 2E4 Local Institution Laval, Quebec, Canada, H7T 2P5 Local Institution Montreal, Quebec, Canada, H3J 2V5 Korea, Republic of Local Institution Incheon, Korea, Republic of, 405-760 Local Institution Suwon, Korea, Republic of, 443-721 Less <<
NCT00417729 Diabetes Mellitus Phase 4 Completed - Taiwan ... More >> Taichung Veterans General Hospital Taichung, Taiwan Less <<
NCT00184600 - Completed - -
NCT02624401 Anesthesia Un... More >>consciousness Less << Phase 4 Completed - Finland ... More >> Turku PET Centre Turku, Finland, FI-20521 Less <<
NCT00882063 Relapsed and/or Refractory Mul... More >>tiple Myeloma Less << Phase 1 Phase 2 Completed - India ... More >> Jaslok Hospital & Research Centre Mumbai, Maharashtra, India, 400 026 Shatabdi Superspeciality Hospital Nasik, Maharashtra, India, 422002 Netaji Subhash Chandra Bose Cancer Research Institute Kolkata, West Bengal, India, 700016 Rajiv Gandhi Cancer Institute And Research Centre Delhi, India, 110085 Institute Rotary Cancer Hospital,All India Institute Of Medical Sciences(AIIMS) New Delhi, India, 110029 Less <<
NCT02150356 Glucose and Lipid Metabolism ... More >> Incretin Hormones Plasma Levels Inflammation, Oxidative Stress and Endothelial Function Less << Not Applicable Completed - Italy ... More >> Dept. Clinical Medicine and Surgery, Federico II University Naples, Italy, 80131 Less <<
NCT01917760 - Completed - China, Shanghai ... More >> Department of Endocrinology and Metabolism，Huashan hospital Shanghai, Shanghai, China, 200040 Less <<
NCT03642184 New Onset Diabetes After Trans... More >>plant Kidney Transplant; Complications Less << Phase 4 Recruiting December 31, 2020 China, Shanghai ... More >> Department of nephrology, endocrinology and kidney transplantation , Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine Recruiting Shanghai, Shanghai, China, 200127 Contact: Shan Mou, Dr.    +8613918221242    shan_mou@126.com Less <<
NCT02269098 - Completed - -
NCT01341769 Study Focus 1:Glycaemic Index ... More >> Study Focus 2:Glycaemic Response Study Focus 3:Insulinemic Response Less << Not Applicable Withdrawn(Test ingredient prod... More >>uction did not meet specification) Less << July 2011 United Kingdom ... More >> Reading Scientific Services Limited Reading, Berkshire, United Kingdom, RG6 6BZ Less <<
NCT03283813 Obesity, Childhood ... More >> Insulin Resistance Zinc Deficiency Inositol Less << Phase 4 Recruiting December 31, 2019 Italy ... More >> AOU Maggiore della Carità - Clinica Pediatrica - Ambulatorio di Auxologia ed Endocrinologia Pediatrica Recruiting Novara, Italy, 28100 Contact: Simonetta Bellone, Professor    0390321660693    simonetta.bellone@med.uniupo.it Less <<
NCT02626936 Type 1 Diabetes Phase 2 Completed - Canada, Quebec ... More >> Institut de recherches cliniques de Montréal Montreal, Quebec, Canada, H2W 1R7 Less <<
NCT02269098 Diabetes Mellitus, Type 2 ... More >> Medication Adherence HYPERGLYCEMIA Less << Not Applicable Completed - United States, District of Col... More >>umbia MedStar Washington Hospital Center Washington, District of Columbia, United States, 20010 Less <<
NCT02291874 Type 2 Diabetes Mellitus Phase 4 Completed - Japan ... More >> Chubu, Japan Chugoku, Japan Hokkaido, Japan Kansai, Japan Kanto, Japan Kyushu, Japan Less <<
NCT00400036 Insulin Resistance ... More >> Type 2 Diabetes Less << Phase 2 Completed - Canada, Quebec ... More >> Laval University Quebec city, Quebec, Canada, G1K 7P4 Less <<
NCT02157506 Heart Failure ... More >> Decompensated Heart Failure Acute Heart Failure Less << Phase 2 Completed - -
NCT00206206 Hyperglycemia Not Applicable Terminated - United States, New Jersey ... More >> Morristown Memorial hospital Morristown, New Jersey, United States, 07960 Less <<
NCT00943371 Type 2 Diabetes Mellitus Phase 1 Terminated - -
NCT02350595 Overweight Ob... More >>esity Less << Not Applicable Completed - Norway ... More >> Haukeland University Hospital Bergen, Norway, 5021 Less <<
NCT02820805 Cognitive Ability, General Not Applicable Completed - Canada, Ontario ... More >> School of Nutrition, Ryerson University Toronto, Ontario, Canada Less <<
NCT02356224 Type 2 Diabetes Phase 1 Completed - China, Shanghai ... More >> Shanghai Xuhui Central Hospital Shanghai, Shanghai, China, 200031 Less <<
NCT02849899 Disorder Related to Renal Tran... More >>splantation Diabetes Less << Phase 3 Not yet recruiting January 2020 -
NCT00929799 Growth Hormone Deficiency Phase 4 Completed - Germany ... More >> Charite Campus Benjamin Franklin Berlin, Germany, 12200 Less <<
NCT00295256 Type 2 Diabetes ... More >> Gestational Diabetes Hypertension Preterm Delivery Less << Not Applicable Completed - United States, Maryland ... More >> Johns Hopkins Medical Institutions Baltimore, Maryland, United States, 21287 Less <<
NCT01361581 - Unknown - Czech Republic ... More >> Dept of Anaesthesia and Intensive Care, General University Hospital, 1st Medical Faculty, Charles University Recruiting Prague 2, Czech Republic, 120 00 Contact: Martin Balik, A/Prof       martin.balik@post.cz    Principal Investigator: Martin Balik, MD, PhD Less <<
NCT01144728 Diabetes Mellitus, Type 2 Phase 4 Completed - Kazakhstan ... More >> Sanofi-Aventis Administrative Office Almaty, Kazakhstan Less <<
NCT00617565 Diabetes Diab... More >>etes Mellitus, Type 1 Diabetes Mellitus, Type 2 Less << Phase 3 Completed - China, Beijing ... More >> Novo Nordisk Investigational Site Beijing, Beijing, China, 100034 Novo Nordisk Investigational Site Beijing, Beijing, China, 100730 Novo Nordisk Investigational Site Beijing, Beijing, China, 100853 China, Shanghai Novo Nordisk Investigational Site Shanghai, Shanghai, China, 200032 Novo Nordisk Investigational Site Shanghai, Shanghai, China, 200433 China Novo Nordisk Investigational Site Beijing, China, 100029 Less <<
NCT01746979 Metastatic or Locally Advanced... More >> Unresectable Pancreatic Adenocarcinoma Less << Phase 3 Completed - United States, Massachusetts ... More >> Please Contact U.S. Medical Information Rockland, Massachusetts, United States Germany Please Contact Merck Communication Center Darmstadt, Germany Less <<
NCT01746979 - Completed - -
NCT03135041 Obesity Not Applicable Completed - Denmark ... More >> Department of Nutrition, Exercise and Sports Frederiksberg, Frederiksberg C, Denmark, 1958 Less <<
NCT01531855 Type 1 Diabetes Not Applicable Completed - United Kingdom ... More >> Clinical Research Facility Newcaslte upon Tyne, Tyne and Wear, United Kingdom, NE1 4LP Less <<
NCT00243347 Carcinoma Non... More >>-Small-Cell Lung Carcinoma Head and Neck Neoplasms Less << Phase 1 Completed - United States, Texas ... More >> Research Site Houston, Texas, United States Spain Research Site Barcelona, Spain Less <<
NCT00843050 Mantle Cell Lymphoma Phase 2 Terminated(The study was termi... More >>nated based on interim results and all subjects were off study at that time. No major safety or tolerability concerns) Less << August 2012 United States, Arizona ... More >> Division of Hematology/Oncology, Department of Internal Medicine, Mayo Clinic, Phoenix, Arizona Phoenix, Arizona, United States, 85054 Division of Hematology/Oncology, Department of Internal Medicine, Mayo Clinic, Arizona Scottsdale, Arizona, United States, 85259 United States, Minnesota College of Medicine, Mayo Clinic Rochester, Minnesota, United States, 55905 United States, New Jersey Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 United States, Ohio Gabrail Cancer Center Research Canton, Ohio, United States, 44718 Gabrail Cancer Center Research Dover, Ohio, United States, 44622 United States, Tennessee Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232-5505 United States, Texas Cancer Care Centers of South Texas New Braunfels, Texas, United States, 78130 Cancer Care Centers of South Texas San Antonio, Texas, United States, 78229 United States, Utah Huntsman Cancer Institute, 2000 Circle of Hope, Room 2145 Salt Lake City, Utah, United States, 84112 United States, Washington Seattle Cancer Care Alliance Seattle, Washington, United States, 98109 Department of Medicine, University of Washington Seattle, Washington, United States, 98195 United States, Wisconsin Dept of Hematology/Oncology, University of Wisconsin- Madison Madison, Wisconsin, United States, 53792-5156 India Institute Rotary Cancer Hospital, All India Institute of Medical Sciences New Delhi, Delhi, India, 10029 St. Johns Medical College & Hospital Bangalore, Karnataka, India, 34 Malabar Institute of Medical Sciences Calicut, Kerala, India, 16 Jaslok Hospital and Research Centre Mumbai, Maharashtra, India, 400 026 Tata Memorial Hospital Mumbai, Maharashtra, India, 400012 Cancer Care Clinic and Hospital Nagpur, Maharashtra, India, 440012 Meenakshi mission hospital and research centre Madurai, Tamil nadu, India, 625107 Less <<
NCT00553995 Insulin Resistance Phase 1 Completed - United States, Massachusetts ... More >> Boston University School of Medicine Boston, Massachusetts, United States, 02119 Less <<
NCT00843050 - Terminated(The study was termi... More >>nated based on interim results and all subjects were off study at that time. No major safety or tolerability concerns) Less << - -
NCT01657058 Healthy Phase 1 Phase 2 Unknown October 2014 Canada, Ontario ... More >> St.Michael's Hospital Toronto, Ontario, Canada Less <<
NCT02798250 Type 1 Diabetes Phase 2 Completed - Canada, Quebec ... More >> Institut de recherches cliniques de Montréal Montreal, Quebec, Canada, H2W 1R7 Less <<
NCT02150824 Diabetes Mellitus, Type 2 Phase 2 Completed - Germany ... More >> 1307.4.49003 Boehringer Ingelheim Investigational Site Berlin, Germany 1307.4.49002 Boehringer Ingelheim Investigational Site Mainz, Germany 1307.4.49001 Boehringer Ingelheim Investigational Site Neuss, Germany Less <<
NCT01945983 Septic Shock ... More >>Severe Sepsis Less << Not Applicable Completed - Thailand ... More >> Siriraj Hospital Bangkok, Thailand, 10700 Less <<
NCT02830048 Diabetes Mellitus, Type 2 Phase 2 Completed - United Kingdom ... More >> Clinical Research Unit, OCDEM, Churchill Hospital Oxford, Oxfordshire, United Kingdom, OX3 7LE Less <<
NCT00099320 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT02343757 Dementia Alzh... More >>eimer Disease Less << Not Applicable Unknown December 2016 United States, Ohio ... More >> University Hospital Case Medical Center Recruiting Cleveland, Ohio, United States, 44106 Contact: James K O'Donnell, MD    216-844-3319 Less <<
NCT01467063 Type I Diabetes Mellitus Not Applicable Unknown July 2013 United States, Florida ... More >> Nemours Children's Clinic Jacksonville, Florida, United States, 32207 Less <<
NCT01236365 - Completed - -
NCT00243347 - Completed - -
NCT00750308 Metabolic Syndrome Not Applicable Completed - -
NCT01169779 - Completed - -
NCT00750308 - Completed - -
NCT01169779 Type 2 Diabetes Mellitus Phase 3 Completed - China ... More >> Investigational Site Number 156011 Beijing, China, 100034 Investigational Site Number 156012 Beijing, China, 100101 Investigational Site Number 156019 Beijing, China, 100191 Investigational Site Number 156002 Beijing, China, 100700 Investigational Site Number 156003 Beijing, China, 100730 Investigational Site Number 156009 Beijing, China, 100730 Investigational Site Number 156001 Beijing, China, 100853 Investigational Site Number 156036 Changchun, China, 130041 Investigational Site Number 156016 Changsha, China, 410008 Investigational Site Number 156015 Changsha, China, 410011 Investigational Site Number 156006 Chengdu, China, 610041 Investigational Site Number 156032 Chengdu, China, 610072 Investigational Site Number 156010 Dalian, China, 116027 Investigational Site Number 156004 Guangzhou, China, 510080 Investigational Site Number 156008 Guangzhou, China, 510080 Investigational Site Number 156025 Guangzhou, China, 510630 Investigational Site Number 156031 Haikou, China, 57028 Investigational Site Number 156014 Harbin, China, 150001 Investigational Site Number 156029 Hefei, China, 230022 Investigational Site Number 156013 Qingdao, China, 266003 Investigational Site Number 156007 Shanghai, China, 200003 Investigational Site Number 156030 Shanghai, China, 200065 Investigational Site Number 156020 Shenyang, China, 110004 Investigational Site Number 156035 Suzhou, China, 215004 Investigational Site Number 156033 Taiyuan, China, 030001 Investigational Site Number 156037 Tianjin, China, 300052 Investigational Site Number 156022 Xi'An, China, 710032 Investigational Site Number 156023 Xi'An, China, 710061 Hong Kong Investigational Site Number 344001 Hong Kong, Hong Kong Investigational Site Number 344003 Hong Kong, Hong Kong Investigational Site Number 344002 Shatin, Nt, Hong Kong Malaysia Investigational Site Number 458001 Kelantan, Malaysia, 16150 Investigational Site Number 458003 Kuala Lumpur, Malaysia, 59100 Investigational Site Number 458002 Putrajaya, Malaysia, 62250 Thailand Investigational Site Number 764002 Bangkok, Thailand, 10400 Less <<
NCT02161250 Hyperglycemia, Diabetes, and O... More >>besity Less << Not Applicable Completed - United States, Indiana ... More >> Purdue University West Lafayette, Indiana, United States, 47905 Less <<
NCT02459756 Vascular Stiffness ... More >> Inflammation Less << Not Applicable Completed - United Kingdom ... More >> University of Reading Reading, United Kingdom, RG6 6AP Less <<
NCT01794650 Type 1 Diabetes Mellitus Not Applicable Completed - United Kingdom ... More >> Clinical Research Facility, Royal Victoria Infirmary Newcastle upon Tyne, Tyne and Wear, United Kingdom, NE10 9PY Less <<
NCT01236365 Diabetes Mellitus, Insulin-Dep... More >>endent Hypercholesterolemia Less << Phase 3 Completed - United States, Delaware ... More >> Alfred I duPont Hospital Wilmington, Delaware, United States United States, Florida Nemours Children's Clinic Jacksonville, Florida, United States, 32207 Nemours Children's Clinic Orlando, Florida, United States Nemours Children's Clinic Pensacola, Florida, United States, 32504 United States, Pennsylvania Nemours Children's Clinic-Jefferson Philadelphia, Pennsylvania, United States, 19107 Less <<
NCT03675919 Diabetes Mellitus, Type 2 Not Applicable Not yet recruiting September 2022 Germany ... More >> West German Centre of Diabetes and Health Düsseldorf, Germany, 40591 Less <<
NCT00931619 - Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT01373489 Diabetes Not Applicable Completed - United States, South Carolina ... More >> Franklin C. Fetter Family Health Center, Inc. Charleston, South Carolina, United States, 29403 Less <<
NCT01373489 - Completed - -
NCT02169245 Brain Activity ... More >> Appetite Ingestive Behavior Glucose Control Cholesterol Less << Not Applicable Completed - United States, Indiana ... More >> InnerVision West/Purdue MRI Facility West Lafayete, Indiana, United States, 47906 Purdue University West Lafayette, Indiana, United States, 47907 Less <<
NCT01034111 - Completed - -
NCT02962375 Healthy Not Applicable Active, not recruiting November 2019 United States, Illinois ... More >> Clinical Nutrition Research Center Chicago, Illinois, United States, 60616 Less <<
NCT03664726 PreDiabetes Not Applicable Completed - United States, New York ... More >> University at Buffalo, Department of Pediatrics, Division of Behavioral Medicine Buffalo, New York, United States, 14214 Less <<
NCT01034111 Type 2 Diabetes Phase 3 Completed - -
NCT00978263 Diabetes Not Applicable Completed - China, Chongqing ... More >> the First Affiliated Hospital of Chongqing Medical University Chongqing, Chongqing, China, 400016 Less <<
NCT03101215 Energy Expenditure Not Applicable Recruiting March 24, 2018 Lebanon ... More >> American University of Beirut Recruiting Beirut, Lebanon Contact: Omar Obeid, PhD Less <<
NCT02255812 Exploratory Behavior Not Applicable Completed - Switzerland ... More >> University Hospital Basel, Switzerland, CH-4031 Less <<
NCT02317783 Breast Cancer Not Applicable Recruiting January 2019 United States, Utah ... More >> Huntsman Cancer Institute Recruiting Salt Lake City, Utah, United States, 84112 Contact: Paige Nielsen    801-585-5942    Paige.Nielsen@hci.utah.edu    Principal Investigator: John Hoffman, MD Less <<
NCT01379170 Diabetes Hypo... More >>thyroidism Less << Phase 4 Unknown December 2014 Netherlands ... More >> Maastricht University Medical Centre Recruiting Maastricht, Limburg, Netherlands, 6200MD Contact: Evie Broeders, MD    +31 43 3884254    e.broeders@maastrichtuniversity.nl Less <<
NCT01565421 Cancer Ovaria... More >>n Cancer Solid Tumor Less << Phase 2 Withdrawn(By previous sponsor) - United States, Illinois ... More >> Decatur Memorial Hospital, Clinical Research Department/ Cancer Care Specialists of Illinois Decatur, Illinois, United States, 62526 United States, Minnesota University of Minnesota Medical Center Minneapolis, Minnesota, United States, 55455 United States, New York Schwartz Gynecologic Onclology, PLLC Brightwaters, New York, United States, 11718 United States, Ohio Gabrail Cancer Center Canton, Ohio, United States, 44718 United States, Tennessee Chattanooga GYN Oncology Chattanooga, Tennessee, United States, 97403 United States, Texas The Methodist Hospital Houston, Texas, United States, 77030 United States, Virginia Riverside Gynecology & Oncology Newport News, Virginia, United States, 23601 Less <<
NCT01464437 Diabetes Mellitus Phase 2 Completed - -
NCT03136133 Reconstitution After Bicycle I... More >>ntervention Less << Not Applicable Recruiting December 31, 2018 Norway ... More >> Haukeland University Hospital Recruiting Bergen, Norway, 5021 Contact: Trygve Hausken, MD Less <<
NCT02512575 Safety Tolera... More >>bility Pharmacokinetics Pharmacodynamics Healthy Subjects Rheumatoid Arthritis Less << Phase 1 Completed - Germany ... More >> Research Site Berlin, Germany, 14050 Less <<
NCT02512575 - Completed - -
NCT00850798 Type 2 Diabetes Not Applicable Recruiting December 2020 Taiwan ... More >> Chen-Hsen Lee Recruiting Taipei, Taiwan, 11217 Contact: Harn-Shen Chen, MD, PhD Less <<
NCT01005069 Diabetes Mellitus, Type 2 Phase 2 Completed - Indonesia ... More >> Sanglah Hospital Denpasar Denpasar, Bali, Indonesia RSUD Tarakan Jakarta Pusat, DKI Jakarta, Indonesia Less <<
NCT02705053 Type 1 Diabetes Mellitus Phase 3 Completed - United States, California ... More >> William Sansum Diabetes Center Santa Barbara, California, United States, 93111 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, Virginia University of Virginia Charlottesville, Virginia, United States, 22903 Less <<
NCT02622490 Metabolic Rate ... More >> Plasma Glucose Serum Insulin Serum Triglycerides Sense of Satiety Less << Not Applicable Active, not recruiting December 2018 Sweden ... More >> University Hospital of Linkoping Linkoping, Sweden, 58185 Less <<
NCT01530685 Hyperglycemia Phase 3 Unknown August 2012 France ... More >> CHU Pitié Salpetriere Recruiting Paris, France, 75013 Contact: Salwa Rizkalla, Dr    +33 1 42 17 79 81    salwa.rizkalla@psl.aphp.fr Less <<
NCT02420392 Diabetes Mellitus, Type 2 Not Applicable Completed - Korea, Republic of ... More >> Seoul National University Hospital Seoul, Korea, Republic of, 110-744 Less <<
NCT01044602 Obesity Type ... More >>2 Diabetes Mellitus Less << Not Applicable Completed - United States, Ohio ... More >> The Ohio State University Medical Center Columbus, Ohio, United States, 43210 Less <<
NCT02335294 Pain Phase 2 Completed - United States, California ... More >> Pasadena, California, United States, 91105 United States, Texas Houston, Texas, United States, 77024 Less <<
NCT02059161 Type 1 Diabetes Mellitus Phase 3 Completed - -
NCT00608023 Lipodystrophy ... More >> HIV Infections Less << Phase 3 Completed - -
NCT01927900 Gut Microbiota ... More >> Gastrointestinal Symptoms Less << Not Applicable Completed - Denmark ... More >> Department of Medicine, Køge Hospital Køge, Denmark, 4600 Less <<
NCT01018017 Diabetes Mellitus, Type 2 Phase 2 Completed - Germany ... More >> GSK Investigational Site Neuss, Nordrhein-Westfalen, Germany, 41460 Less <<
NCT00994435 - Completed - Italy ... More >> Department of Metabolic Diseases, Institute of Internal Medicine - Catholic University Rome, Italy, 00168 Less <<
NCT01476345 Diabetes Mellitus Phase 1 Completed - South Africa ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bloemfontein, South Africa, 9301 Less <<
NCT03285217 Sarcopenia Ci... More >>rrhosis Malnutrition Less << Not Applicable Recruiting December 31, 2018 Spain ... More >> Hospital Universitario Miguel Servet Recruiting Zaragoza, Spain, 50009 Contact: Jose M Arbones-Mainar, PhD    +34 976 769 565 Less <<
NCT02468999 Insulin Resistance Not Applicable Completed - Germany ... More >> University of Tuebingen, Department of Internal Medicine IV Tübingen, Germany, 72076 Less <<
NCT02059161 - Completed - -
NCT01919476 Diabetes, Gestational Not Applicable Completed - United States, California ... More >> Children's Hospital Oakland Research Institute Oakland, California, United States, 94609 Less <<
NCT00608023 - Completed - -
NCT00971724 Insulin Resistance ... More >> Hyperglycemia Glucose Intolerance Less << Not Applicable Completed - -
NCT00558883 Type 2 Diabetes Mellitus ... More >> Subclinical Inflammation Less << Phase 3 Completed - Germany ... More >> GWT-TUD GmbH; Centre for Clinical Studies Dresden, Germany, 01187 Less <<
NCT00541879 Type 2 Diabetes ... More >> Obesity Less << Not Applicable Completed - United States, Colorado ... More >> Putnam, Tavelli, Bennett and Dunn Elementary Schools Fort Collins, Colorado, United States, 80524 Less <<
NCT01215903 Insulin Resistance ... More >> Type 2 Diabetes Less << Phase 2 Completed - Canada ... More >> Laval University Quebec, Canada, G1V 0A6 Less <<
NCT01112007 - Completed - Taiwan ... More >> Taipei Veterans General Hospital Taipei, Taiwan, 112 Less <<
NCT00615381 Intracranial Aneurysm Not Applicable Withdrawn(Study was not initia... More >>ted and has been withdrawn due to lack of appropriate cases) Less << - United States, Illinois ... More >> Northwestern Memorial Hospital Chicago, Illinois, United States, 60611 Less <<
NCT00472381 Acute Stroke ... More >>Acute Cerebral Ischemia Less << Phase 2 Phase 3 Completed - France ... More >> AP-HP Urgences cerebro vasculaires La Pitié Salpétrière Poissy, France, 75013 Less <<
NCT00063232 Hepatitis Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT02384993 Alzheimer's Disease ... More >> Aging Less << Not Applicable Completed - United States, Wisconsin ... More >> University of Wisconsin School of Medicine and Public Health Madison, Wisconsin, United States, 53792 Less <<
NCT01247870 Chronic Obstructive Pulmonary ... More >>Disease Less << Phase 4 Completed - United Kingdom ... More >> North Tees and Hartlepool NHS Trust Hartlepool, Cleveland, United Kingdom, TS24 9AH University Hospitals of Morecambe Bay NHS Trust Lancaster, Cumbria, United Kingdom, LA9 7RG East Sussex Healthcare NHS Trust Hastings, East Sussex, United Kingdom, TN37 7PT Blackpool Teaching Hospitals NHS Trust Blackpool, Lancashire, United Kingdom, FY3 8NR Lancashire Teaching Hospitals NHS Trust Preston, Lancashire, United Kingdom, PR2 9HT Sherwood Forest Hospitals NHS Trust Sutton-in-Ashfield, Nottinghamshire, United Kingdom, NG17 4JL Chelsea and Westminster Hospital London, United Kingdom, SW10 9NH St George's Hospital London, United Kingdom, SW17 0QT Freeman Hospital Newcastle, United Kingdom, NE7 7DN Less <<
NCT00063232 - Completed - -
NCT03387293 Pediatric Obesity Not Applicable Completed - -
NCT02166684 Self-monitoring of Health ... More >> Health Behaviour Change Less << Not Applicable Completed - Netherlands ... More >> Netherlands Organisation for Applied Scientific Research (TNO) Zeist, Utrecht, Netherlands, 3704 HE Less <<
NCT01709123 Diabetes Mellitus, Type 1 Not Applicable Unknown September 2013 United States, Louisiana ... More >> Louisiana State University Health Sciences Center in Shreveport Recruiting Shreveport, Louisiana, United States, 71130 Contact: Sushil K Jain, Ph.D.    318-675-6086    sjain@lsuhsc.edu    Sub-Investigator: Robert McVie, M.D.          Sub-Investigator: Tommie Stapleton, RN, CCRC          Sub-Investigator: Cynthia Brewer, RN          Sub-Investigator: John Rowell, RN, MSN          Sub-Investigator: Henry R McKnight, RPH          Sub-Investigator: Pat F Bass, M.D.          Sub-Investigator: Shikha Mane, M.D.          Sub-Investigator: David Micinski, BS          Sub-Investigator: Neslihan Gungor, M.D. Less <<
NCT02414061 Healthy Not Applicable Completed - United Kingdom ... More >> Faculty of Health and Life Sciences, Northumbria University Newcastle upon Tyne, Tyne and Wear, United Kingdom, NE1 8ST Less <<
NCT00791076 Diabetes Mellitus, Type 1 Phase 2 Terminated(PI left JHU) - United States, Maryland ... More >> Johns Hopkins Bayview Medical Center Baltimore, Maryland, United States, 21224 Less <<
NCT01961401 Diabetes, Gestational Not Applicable Terminated(Due to recruitment ... More >>problems) Less << - Norway ... More >> Department of circulation and medical imaging Trondheim, Norway Less <<
NCT00791076 - Terminated(PI left JHU) - -
NCT01045447 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT01045447 - Completed - -
NCT00237471 Myocardial Infarct ... More >> Hyperglycemia Less << Phase 4 Terminated(difficulty recruiti... More >>ng patients) Less << - Australia, Victoria ... More >> The Royal Melbourne Hospital Melbourne, Victoria, Australia, 3050 Less <<
NCT00734669 - Completed - -
NCT02658110 Obesity, Abdominal Not Applicable Completed - United Kingdom ... More >> Faculty of Health and Life Sciences, Northumbria University Newcastle upon Tyne, Tyne and Wear, United Kingdom, NE1 8ST Less <<
NCT03236116 Glucose Intolerance ... More >> Appetite Disorders Glucose Metabolism Disorders (Including Diabetes Mellitus) Lipid Metabolism Disorder Less << Not Applicable Recruiting July 31, 2019 United States, Indiana ... More >> Purdue University Recruiting West Lafayette, Indiana, United States, 47907 Contact: Richard D Mattes, PhD, RD, MPH    765-494-0662    mattes@purdue.edu    Principal Investigator: Richard D Mattes, PhD, RD, MPH          Purdue University Recruiting West Lafayette, Indiana, United States, 47909 Contact: Richard D Mattes, Phd    765-494-0662    mattes@purdue.edu    Contact: Stephanie R Hunter    765-496-3607    hunter99@purdue.edu Less <<
NCT02708485 Alzheimer's Disease Not Applicable Completed - Canada, Quebec ... More >> Research Centre on Aging (CSSS-IUGS - CIUSSS de l'Estrie - CHUS) Sherbrooke, Quebec, Canada, J1H4C4 Less <<
NCT02651051 Healthy Not Applicable Completed - United Kingdom ... More >> Faculty of Health and Life Sciences, Northumbria University Newcastle upon Tyne, Tyne and Wear, United Kingdom, NE1 8ST Less <<
NCT02708485 - Completed - -
NCT00604877 Stroke Cerebr... More >>ovascular Disorders Less << Not Applicable Unknown May 2008 United States, Maryland ... More >> Baltimore VA Medical Center/ University of Maryland School of Medicine Baltimore, Maryland, United States, 21201 Less <<
NCT03665974 - Completed - -
NCT01087567 Type 2 Diabetes Phase 4 Completed - United States, Ohio ... More >> Ohio University Athens, Ohio, United States, 45701 Less <<
NCT02199054 Metabolic Syndrome ... More >> Overweight Less << Not Applicable Active, not recruiting December 2020 United States, Ohio ... More >> The Ohio State University Wexner Medical Center Clinical Research Center Columbus, Ohio, United States, 43210 Less <<
NCT03222284 Diabetes Mellitus, Type 2 Not Applicable Recruiting November 30, 2017 United States, New York ... More >> Healthcare Innovation and Technology Lab Recruiting New York, New York, United States, 10032 Contact: Claire Gutermuth    917-349-2528    C4C@hitlab.org Less <<
NCT00361946 - Completed - United States, Texas ... More >> Baylor College of Medicine Houston, Texas, United States, 77030 Less <<
NCT02098486 Cholangitis Phase 2 Completed - Korea, Republic of ... More >> Sungkyunkwan University Kangbuk Samsung Hospital Seoul, Korea, Republic of, 110-746 Less <<
NCT00191581 Diabetes Mellitus, Type 1 ... More >> Diabetes Mellitus, Type 2 Less << Phase 3 Completed - China ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Beijing, China For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Guangzhou, China Less <<
NCT01191320 Type 2 Diabetes Mellitus ... More >> Secondary Hypogonadism Less << Phase 2 Completed - United States, California ... More >> Paradigm Clinical Research Garden Grove, California, United States, 92844 Northern California Research Corp Sacramento, California, United States, 95821 LABioMed Torrance, California, United States, 90502 United States, Massachusetts Lahey Clinic Peabody, Massachusetts, United States, 01960 United States, Nevada Affiliated Clinical Research Las Vegas, Nevada, United States, 89109 Affiliated Clinical Research Las Vegas, Nevada, United States, 89144 United States, New York Dr. Bruce Gilbert Great Neck, New York, United States, 11021 University Urology New York, New York, United States, 10016 Mount Sinai School of Medicine New York, New York, United States, 10029 Dr. Michael Werner Purchase, New York, United States, 10577 United States, Texas Discovery Clinical Trials Austin, Texas, United States, 78758 Research Across America Carrollton, Texas, United States, 75010 TX Urology Associate Houston, Texas, United States, 77024 Centex Research Houston, Texas, United States, 77062 Dr. Rakesh Patel Houston, Texas, United States, 77095 Protenium Clinical Research Hurst, Texas, United States, 76054 R/D Clinical Research Lake Jackson, Texas, United States, 77566 Cetero Research San Antonio, Texas, United States, 78229 Less <<
NCT03174080 - Not yet recruiting July 2018 -
NCT01191320 - Completed - -
NCT02764021 Type 2 Diabetes Mellitus Not Applicable Completed - Denmark ... More >> Bispebjerg Hospital Copenhagen, Copenhagen NV, Denmark, 2400 Less <<
NCT00590044 Diabetic Ketoacidosis Phase 4 Completed - United States, Georgia ... More >> Grady Memorial Hospital Atlanta, Georgia, United States, 30303 United States, Minnesota University of Minnesota School of Medicine Minneapolis, Minnesota, United States, 55455 Less <<
NCT03163953 Physical Activity ... More >> Sedentary Lifestyle Less << Not Applicable Recruiting February 28, 2018 Thailand ... More >> Mahidol University Recruiting Salaya, Nakon Prothom, Thailand, 73170 Contact: Chutima Jalayondeja, Dr. P.H.    (66)24415450 ext 20801    chutimajala@gmail.com Less <<
NCT00525239 HIV Infections Not Applicable Unknown December 2010 United States, California ... More >> Department of Veterans Affairs Medical Center Recruiting San Francisco, California, United States, 94121 Contact: Mae Pang, RN, MSN    415-750-2005    miyin.pang@ucsf.edu    Contact: Lyda Galvez    415-750-2005    lyda.galvez@va.gov Less <<
NCT01184768 - Completed - Norway ... More >> University Hospital of North Norway Tromsø, Norway, 9038 Less <<
NCT00916604 Type 2 Diabetes Phase 1 Completed - Japan ... More >> Research Site Fukuoka, Japan Research Site Tokyo, Japan Less <<
NCT00590044 - Completed - -
NCT00609245 Photosensitive Epilepsy Phase 4 Completed - United States, Missouri ... More >> The Comprehensive Epilepsy Care Center for Children & Adults Chesterfield, Missouri, United States, 63017 United States, Tennessee Vanderbilt University Nashville, Tennessee, United States, 37232 Less <<
NCT00609245 - Completed - -
NCT02688283 Glycemic Response; Satiety Not Applicable Completed - -
NCT00471614 HIV Infections ... More >> Insulin Resistance Hyperlactatemia Less << Phase 2 Completed - United States, California ... More >> University of California San Francisco San Francisco, California, United States, 94110 Less <<
NCT00808860 Type 2 Diabetes Phase 1 Phase 2 Completed - Vietnam ... More >> National Institute of Gerontology, HMU Hanoi, Vietnam Less <<
NCT01588106 - Completed - Germany ... More >> Diabetespraxis Prenzlauer Allee Berlin, Germany, 10409 Praxis Dr. Fießelmann Berlin, Germany, 13597 Praxis Dr. Stephan Berlin, Germany, 13597 Gemeinschaftspraxis Lorra/Bonnermann Bochum, Germany, 44869 Praxis Dr. Holderied Brand-Erbisdorf, Germany, 09618 Spreewaldklinik Burg, Germany, 03096 Diabeteszentrum DO Dortmund, Germany, 44137 Studienzentrum Prof. Hanefeld Dresden, Germany, 01307 Universitätsklinikum Dresden, Medizinische Klinik III Dresden, Germany, 01307 Gemeinschaftspraxis Schaden Düsseldorf, Germany, 40211 Praxis Dr. Stier Freital, Germany, 01705 SMO.MD GmbH Magdeburg, Germany, 39112 Praxis Dr. Ruhland München, Germany, 80331 Metabolicum München, Germany, 80687 Praxis Dr. Engelmayer München, Germany, 81241 Diabeteszentrum Oschatz Oschatz, Germany, 04758 Less <<
NCT00992641 Abdominal Obesity ... More >> Insulin Resistance Impaired Glucose Tolerance Type 2 Diabetes Cardiovascular Diseases Less << Not Applicable Completed - Denmark ... More >> Aarhus University Aarhus, Denmark University of Copenhagen Copenhagen, Denmark Finland University of Kuopio Kuopio, Finland, FIN-70211 University of Oulu Oulu, Finland Iceland University of Iceland Reykjavik, Iceland Norway Akershus University College Akershus, Norway Sweden Lund University Lund, Sweden Uppsala University Uppsala, Sweden Less <<
NCT01588106 - Completed - -
NCT00690755 - Completed - United States, Florida ... More >> VA Medical Center Tampa, Florida, United States, 33612 Less <<
NCT00668954 Type 2 Diabetes Mellitus Not Applicable Completed - United States, Colorado ... More >> University of Colorado Denver Center for Human Nutrition Denver, Colorado, United States, 80220 Less <<
NCT01402388 Type 2 Diabetes Not Applicable Completed - -
NCT03156478 Type2 Diabetes ... More >> Life Style Diet Habit Physical Activity Empowerment Less << Not Applicable Recruiting December 2037 Finland ... More >> University of Eastern Finland Recruiting Kuopio, Finland Contact: Jussi Pihlajamäki, MD, PhD    +358 50 344 0187    jussi.pihlajamaki@uef.fi Less <<
NCT00361868 Dyslipidemia ... More >>Glucose Metabolism Disorder Less << Phase 3 Terminated(The study was disco... More >>ntinued prematurely at the end of March 2007 due to slow enrolment.) Less << - -
NCT00690755 - Completed - -
NCT01800760 Healthy Not Applicable Active, not recruiting December 2019 United States, Arkansas ... More >> Arkansas Children's Nutrition Center Little Rock, Arkansas, United States, 72202 Less <<
NCT02806999 Hyperglycemia Phase 4 Unknown July 2017 China, Guangdong ... More >> Guangdong Cardiovascular Insititution, Guangdong General Hospital, Guangdong Academy of Medical Science Not yet recruiting Guangzhou, Guangdong, China, 510085 Contact: Jian Zhuang, M.D.    86-13602884548    drzhuangjian5413@163.com    Contact: Chengbin Zhou, M.D.    86-13822182178    zcbwwww@163.com    Principal Investigator: Haiyun Yuan, M.D. Less <<
NCT03523377 Childhood Cancer Survivors Not Applicable Recruiting April 2020 United States, New York ... More >> Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Emily Tonorezos, MD,MPH    646-888-8080       Contact: Danielle Friedman, MD, MS    212-639-7376       Principal Investigator: Emily Tonorezos, MD, MPH Less <<
NCT03070678 Diabetes Mellitus Phase 1 Completed - France ... More >> Investigational site 250001 Gières, France Less <<
NCT02530866 Gestational Diabetes Not Applicable Active, not recruiting December 2018 United States, Oklahoma ... More >> University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma, United States, 73117 Less <<
NCT01289639 Fatty Liver Not Applicable Terminated(Low recruitment in ... More >>intervention study. Baseline data published.) Less << - United States, Washington ... More >> VA Puget Sound Health Care System, Seattle Seattle, Washington, United States, 98108 Less <<
NCT03196362 Type 2 Diabetes Mellitus Phase 4 Recruiting December 31, 2018 China, Guangdong ... More >> endocrinology department of the first affiliated hospital of Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510080 Contact: Yanbing Li, MD,PhD    8602087334331    easd04lyb@126.com    Principal Investigator: Yanbing Li, MD,PhD Less <<
NCT02544321 Type 1 Diabetes Phase 2 Recruiting December 2018 United States, Colorado ... More >> University of Colorado-Denver, Anshutz Medical Campus Recruiting Aurora, Colorado, United States, 80045 Contact: Ellen Lyon, MS    720-848-6690    ellen.lyon@ucdenver.edu    Contact: Amy Baumgartner, MS    720-777-5774    amy.baumgartner@childrenscolorado.org Less <<
NCT02470039 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 2 Completed - Germany ... More >> Novo Nordisk Investigational Site Mainz, Germany, 55116 Novo Nordisk Investigational Site Neuss, Germany, 41460 Less <<
NCT01289639 - Terminated(Low recruitment in ... More >>intervention study. Baseline data published.) Less << - -
NCT01001273 Postoperative Complications Not Applicable Unknown June 2012 Canada, Quebec ... More >> Hospital Royal Victoria Recruiting Montreal, Quebec, Canada, H3A1A1 Contact: Jeanne M Bouteaud    514.934.1934 ext 36237    jeanne.bouteaud@muhc.mcgill.ca    Principal Investigator: Steven Paraskevas, MD, PhD          Principal Investigator: Mazen Hassanain, MD          Sub-Investigator: Peter Metrakos, MD          Sub-Investigator: Prosanto K Chaudhury, MD, Msc          Sub-Investigator: Jean Tchervenkov, MD          Sub-Investigator: Marcelo Cantarovitch, MD          Sub-Investigator: George Carvalho, MD          Sub-Investigator: Ralph Lattermann, MD          Sub-Investigator: Thomas Schricker, MD Less <<
NCT03014011 Diabetes Mellitus, Type II ... More >> Hypoglycemia Cognitive Change Less << Phase 1 Completed - Denmark ... More >> Department of Research in Endocrinology, Bispebjerg University Hospital Copenhagen, Denmark Less <<
NCT01430221 Prediabetes D... More >>epressive Symptoms Mild to Moderate in Severity Less << Not Applicable Completed - United States, North Carolina ... More >> Duke University Medical Center Durham, North Carolina, United States, 27710 Less <<
NCT01708681 Hyperlipidemias ... More >> Nutritional and Metabolic Diseases Nutrition Disorders Metabolic Diseases Glucose Metabolism Disorders Less << Not Applicable Completed - Norway ... More >> National Institute of Nutrition and Seafood Research Bergen, Norway, 5005 Less <<
NCT01938755 This Study Was Focused on Sele... More >>ctive Spinal Anesthesia for Lower Extremity Surgery in Order to Achieve Early Mobilization and to Shorten Hospital Stay Less << Phase 4 Completed - Turkey ... More >> Anestesia and Reanimation Dept.; Ordu University Education and Research Hospital Ordu, Turkey, 52100 Less <<
NCT01001689 Pregnancy Obe... More >>sity Diabetes Less << Not Applicable Completed - Norway ... More >> Sorlandet Hospital Kristiansand, Vest Agder, Norway, 4604 Less <<
NCT02119572 Glucose Metabolism Disorders ... More >> Metabolic Diseases Endocrine System Diseases Diabetes Less << Not Applicable Unknown - China, Jiangsu ... More >> Liuhe Recruiting Nanjing, Jiangsu, China, 210009 Contact: Xiu li Ye, Master    86-25-83272532    yexiuli0703@163.com    Principal Investigator: Zilin Sun, Dr. Less <<
NCT00257257 Type 2 Diabetes Mellitus Phase 3 Completed - United States, New Jersey ... More >> Sanofi-Aventis Administrative Office Bridgewater, New Jersey, United States, 08807 Argentina Sanofi-Aventis Administrative Office Buenos Aires, Argentina Chile Sanofi-Aventis Administrative Office Santiago, Chile Germany Sanofi-Aventis Administrative Office Berlin, Germany Hungary Sanofi-Aventis Administrative Office Budapest, Hungary Netherlands Sanofi-Aventis Administrative Office Gouda, Netherlands Poland Sanofi-Aventis Administrative Office Warszawa, Poland Less <<
NCT01775878 Diabetes Not Applicable Completed - -
NCT02809963 Diabetes Type 2 Phase 4 Completed - Denmark ... More >> Herlev and Gentofte Hospital, Department of Endocrinology and Metabolism, Department of internal medicine, Herlev, Denmark, 2730 Less <<
NCT02004561 - Recruiting January 2019 United States, Connecticut ... More >> Yale Pediatric Endocrinology Clinic Recruiting New Haven, Connecticut, United States, 06520 Contact: Melissa Shaw    203-785-6459 Less <<
NCT02122666 - Active, not recruiting December 2019 United States, Missouri ... More >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Less <<
NCT02250794 Type 2 Diabetes Mellitus Phase 4 Unknown December 2015 -
NCT01182844 Metabolic Syndrome Not Applicable Completed - Austria ... More >> Dept. of Internal Medicine, Medical University of Graz Graz, Austria, 8036 Less <<
NCT01103414 Type 2 Diabetes Phase 2 Completed - United States, Alabama ... More >> Huntsville, Alabama, United States Muscle Shoals, Alabama, United States United States, California Chino, California, United States Los Angeles, California, United States Spring Valley, California, United States Walnut Creek, California, United States United States, Florida Miami, Florida, United States New Port Richley, Florida, United States Palm Harbor, Florida, United States Pembroke Pines, Florida, United States United States, Georgia Marietta, Georgia, United States United States, Illinois Chicago, Illinois, United States United States, Indiana Indianapolis, Indiana, United States United States, Michigan Grand Rapids, Michigan, United States United States, Ohio Cincinnati, Ohio, United States Kettering, Ohio, United States Tiffin, Ohio, United States United States, Oklahoma Oklahoma City, Oklahoma, United States United States, Oregon Eugene, Oregon, United States Portland, Oregon, United States United States, South Carolina Greer, South Carolina, United States United States, Texas Corpus Christi, Texas, United States Houston, Texas, United States San Antonio, Texas, United States Less <<
NCT01103414 - Completed - -
NCT02537314 Obesity Phase 1 Enrolling by invitation April 2019 United States, Tennessee ... More >> Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232 Less <<
NCT01573806 Septic Shock ... More >>Inflammation Glucose Homeostasis Organ Dysfunction Health-related Quality of Life Less << Phase 1 Phase 2 Withdrawn(No funding) October 2014 United States, Washington ... More >> Seattle Children's Hospital Seattle, Washington, United States, 98105 Less <<
NCT00487006 Critical Illness ... More >> Hyperglycemia Less << Not Applicable Completed - United States, Georgia ... More >> Children's Healthcare of Atlanta Atlanta, Georgia, United States Less <<
NCT02305069 Obesity Sarco... More >>penia Less << Not Applicable Completed - United Kingdom ... More >> David Greenfield Physiology Laboratories Nottingham, Nottinghamshire, United Kingdom, NG7 2UH Less <<
NCT03210896 Type2 Diabetes Not Applicable Recruiting December 2018 United Kingdom ... More >> University Hospitals Coventry & Warwickshire NHS Trust Recruiting Coventry, West Midlands, United Kingdom, CV2 2DX Contact: Shivam Joshi       BreathStudyOffice@uhcw.nhs.uk Less <<
NCT00288236 Type 2 Diabetes Mellitus Phase 3 Completed - United States, New Jersey ... More >> Sanofi-Aventis Bridgewater, New Jersey, United States, 08807 Argentina Sanofi-Aventis Buenos Aires, Argentina Australia Sanofi-Aventis Lane Cove, Australia Canada Sanofi-Aventis Laval, Canada Chile Sanofi-Aventis Providencia, Chile France Sanofi-Aventis Paris, France Germany Sanofi-Aventis Berlin, Germany Italy Sanofi-Aventis Milano, Italy Netherlands Sanofi-Aventis Gouda, Netherlands Russian Federation Sanofi-Aventis Moscow, Russian Federation South Africa Sanofi-Aventis Midrand, South Africa United Kingdom Sanofi-Aventis Guildford, United Kingdom Less <<
NCT00274001 HIV Infections ... More >> Quality of Life Less << Phase 4 Completed - Italy ... More >> Ospedale Regionale Ancona, Italy, 60020 Ospedale Santa Maria Annunziata Antella (fi), Italy, 50011 Clinica di Malattie Infettive Bari, Italy, 70124 Ospedali Riuniti di Bergamo Bergamo, Italy, 24128 Ospedale degli Infermi di Biella Biella, Italy, 13900 Istituto di Malattie Infettive Bologna, Italy, 40138 Ospedale Civile Brescia, Italy, 25123 Spedali Civili di Brescia Brescia, Italy, 25123 Ospedale di Circolo di Busto Busto Arsizio (va), Italy, 21052 Ospedale SS. Trinità Cagliari, Italy, 09100 Azienda Ospedaliera Arcispedale S. Anna Ferrara, Italy, 44100 Ospedale San Martino Genova, Italy, 16132 Presidio Ospedaliero "A. Manzoni" Lecco, Italy, 23900 Azienda Ospedaliera Carlo Poma Mantova, Italy, 46100 Ospedale Luigi Sacco Milano, Italy, 20100 Fondazione Centro S. Raffaele del Monte Tabor Milano, Italy, 20127 Azienda Ospedaliera "Luigi Sacco" Milano, Italy, 20157 Ospedale Luigi Sacco Milano, Italy, 20157 Policlinico Universitario Modena, Italy, 41100 Ospedale A. Cotugno Napoli, Italy, 80131 Azienda Ospedaliera di Padova Padova, Italy, 35128 IRCCS Policlinico San Matteo Pavia, Italy, 27100 Ospedale Civile Piacenza, Italy, 29100 Ospedale Cisanello Pisa, Italy, 35128 Less <<
NCT03576677 Heart Failure Phase 4 Not yet recruiting July 30, 2020 Denmark ... More >> Department of Cardiology, The Heart Center, Copenhagen University Hospital, Rigshospitalet Not yet recruiting Copenhagen, Denmark, DK-2100 Contact: Finn Gustafsson, MD, professor, PhD, DMSci    +45 35459743    finng@dadlnet.dk    Contact: Lærke Nelson, MD    +45 35459549    laerke.marie.nelson@regionh.dk    Principal Investigator: Finn Gustafsson, MD, professor, PhD, DMSci          Sub-Investigator: Lærke Nelson, MD          Department of Cardiology, Copenhagen University Hospital, Herlev and Gentofte Hospital, Herlev, Denmark Not yet recruiting Herlev, Denmark, DK-2730 Contact: Morten Schou, MD, PhD    +45 40523920    schou@dadlnet.dk    Principal Investigator: Morten Schou, MD, PhD          Department of Cardiology, Odense University Hospital, Odense, Denmark Not yet recruiting Odense, Denmark, DK-5000 Contact: Jacob E Møller, MD, professor, PhD, DMSci    +45 51439630    jem@dadlnet.do    Contact: Mikael K Poulsen, MD, PhD    +45 24798402    mikael.kjaer.poulsen1@rsyd.dk    Principal Investigator: Jacob E Møller, MD, professor, PhD, DMSci          Sub-Investigator: Mikael K Poulsen, PhD Less <<
NCT03389490 Diabetes Mellitus, Type 2 Phase 4 Not yet recruiting December 31, 2019 -
NCT01973374 Diabetes in Pregnancy ... More >> Gestational Diabetes Texting Interventions Less << Not Applicable Completed - United States, Pennsylvania ... More >> Hospital of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT01836575 Non Small Cell Lung Carcinoma Phase 3 Completed - United States, Florida ... More >> The Mount Sinai Comprehensive Cancer Center Miami Beach, Florida, United States, 33140 Brazil Instituto do Câncer do Ceará - ICC Fortaleza, Ceará, Brazil Hospital Lifecenter Belo Horizonte, Minas Gerais, Brazil Hospital Caridade de Ijuí - CACON Ijuí, RS, Brazil Hospital São Lucas Porto Alegre, RS, Brazil Centro de Pesquisas Oncológicas - CEPON Florianópolis, Santa Catarina, Brazil Hospital Amaral Carvalho Jaú, São Paulo, Brazil INCA Rio de Janeiro, Brazil Instituto do Câncer Arnaldo Vieira de Carvalho São Paulo, Brazil Less <<
NCT01932775 Type 2 Diabetes Phase 3 Completed - Austria ... More >> Medical University of Graz Graz, Austria, 8036 Less <<
NCT03332836 Type 2 Diabetes Mellitus Phase 1 Recruiting June 30, 2019 United States, California ... More >> Hanmi Investigative Site Recruiting Chula Vista, California, United States, 91911 Contact: Hanmi Pharmaceuticals       clinical4@hanmi.co.kr Less <<
NCT00568620 Insulin Resistance and Type 2 ... More >>Diabetes Less << Not Applicable Completed - -
NCT03542682 Type1diabetes Not Applicable Recruiting December 31, 2019 United States, Connecticut ... More >> Yale University Recruiting New Haven, Connecticut, United States, 06520 Contact: Lori Carria, MS    203-737-3595 Less <<
NCT02501343 Dysglycemia T... More >>ype 2 Diabetes Mellitus Less << Not Applicable Completed - Australia, New South Wales ... More >> Garvan Institute of Medical Research Darlinghurst, New South Wales, Australia, 2010 Less <<
NCT01366794 Type 2 Diabetes Not Applicable Completed - Sweden ... More >> Department of Clinical Sciences Lund, Lund University Lund, Sweden, 221 84 Lund University Lund, Sweden, 22184 Less <<
NCT01582451 - Completed - -
NCT01400191 Pharmacogenetics of Metformin Phase 4 Completed - Denmark ... More >> Clinical pharmacology, Institute og public health, University of Southern Denmark Odense, Denmark, 5000 Less <<
NCT03025919 - Recruiting - China, Jiangsu ... More >> Department of Endocrinology, Zhongda Hospital, Institute of Diabetes, Southeast University Recruiting Nanjing, Jiangsu, China Contact: Zilin Sun    +82-025-83262818    sunzilin1963@126.com    Principal Investigator: Zilin Sun          Sub-Investigator: Yang Yuan Less <<
NCT03710200 Dietary Modification Not Applicable Recruiting November 30, 2018 Italy ... More >> Department of Food and Drugs, University of Parma Recruiting Parma, Italy, 43125 Contact: Francesca Scazzina, PhD    +39 0521 906203    francesca.scazzina@unipr.it    Sub-Investigator: Margherita Dall'Asta, PhD Less <<
NCT03467503 Gestational Diabetes ... More >> Obesity Less << Not Applicable Recruiting December 31, 2020 United States, Nevada ... More >> University of Nevada at Las Vegas Recruiting Las Vegas, Nevada, United States, 89154 Contact: Arpita Basu, PhD    702-895-4328    arpita.basu@unlv.edu Less <<
NCT01582451 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT03244800 Type 2 Diabetes Mellitus Phase 2 Completed - Germany ... More >> Research Site Berlin, Germany, 10117 Research Site Magdeburg, Germany, 39120 Research Site Mainz, Germany, 55116 Research Site Neu-Ulm, Germany, 89231 Research Site Neuss, Germany, 41460 Less <<
NCT01499524 - Recruiting April 2021 United Kingdom ... More >> Guy's & St Thomas' NHS Foundation Trust Recruiting London, United Kingdom, SE1 7EH Contact: Jenny Chambers    0208 3835285    jenny.chambers@imperial.ac.uk    Imperial College Healthcare NHS Trust Hammersmith Recruiting London, United Kingdom Contact: Jenny Chambers    0208 3835285 Less <<
NCT02290925 Type 2 Diabetes Mellitus Phase 3 Completed - Sri Lanka ... More >> Teaching Hospital Perdeniya Peradeniya, Central, Sri Lanka, 20400 Teaching Hospital Anuradhapura Anuradhapura, North Central Province, Sri Lanka, 50000 Less <<
NCT03092206 Insulin Resistance Phase 1 Completed - Germany ... More >> Klinikum rechts der Isar (IZAR) Munich, Germany, 81675 Less <<
NCT01476345 - Completed - -
NCT00947427 Type 1 Diabetes ... More >> Preservation of Insulin Secretion Newly Diagnosed Type 1 Diabetes Canakinumab in Type 1 Diabetes Less << Phase 2 Completed - United States, California ... More >> University of California-San Francisco San Francisco, California, United States, 94143 Stanford University Stanford, California, United States, 94305 United States, Connecticut Yale Medical School New Haven, Connecticut, United States United States, Florida University of Florida Gainesville, Florida, United States, 32610- University of Miami School of Medicine Miami, Florida, United States, 33136 United States, Indiana Indiana University-Riley Hospital for Children Indianapolis, Indiana, United States, 46202 United States, Minnesota University of Minnesota Minneapolis, Minnesota, United States, 57931 United States, New York Columbia University New York, New York, United States United States, Pennsylvania University of Pittsburgh Pittsburgh, Pennsylvania, United States, 15213 United States, Texas University of Texas-Southwestern Medical School Dallas, Texas, United States, 75235 United States, Washington Benaroya Research Institute Seattle, Washington, United States, 98101 Canada, Ontario Hospital for Sick Children Toronto, Ontario, Canada, M5G 1X8 Less <<
NCT03659890 Healthy Not Applicable Recruiting September 2019 United Kingdom ... More >> University of Exeter - St Luke's Campus Recruiting Exeter, Devon, United Kingdom, EX2 4TH Contact: Mariana Coelho    07521759471    m.coelho@exeter.ac.uk Less <<
NCT02860429 Gastrointestinal Neoplasms Phase 4 Unknown - China, Liaoning ... More >> The First Affiliated Hospital of Dalian Medical University Not yet recruiting Dalian, Liaoning, China, 116000 Contact: Xiaonan Cui    +8618098876725    cxn23@sina.com    Liaoning Cancer Hospital Not yet recruiting Shenyang, Liaoning, China, 110000 Contact: Rui Zhang    +8613898872185    zzzrrr1234@sina.com Less <<
NCT02468713 Healthy Phase 4 Completed - Korea, Republic of ... More >> Chonbuk National University Hospital Jeonju, Jeonbuk, Korea, Republic of, 561712 Less <<
NCT01753037 Hyperandrogenism Not Applicable Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT00947427 - Completed - -
NCT03088475 Type2 Diabetes Mellitus Not Applicable Not yet recruiting December 30, 2019 -
NCT03507829 Hyperglycemia Phase 3 Completed - -
NCT01761955 Hyperlipidemia ... More >> Obesity Less << Phase 1 Completed - Canada, Manitoba ... More >> Richardson Centre for Functional Foods and Nutraceuticals Winnipeg, Manitoba, Canada, R3T 2N2 Less <<
NCT00771693 Type 2 Diabetes Mellitus ... More >> Postprandial Hyperglycemia Less << Phase 4 Completed - Sweden ... More >> Department of Medicine, Clinical pharmacology Unit, Karolinska University Hospital, Solna. Stockholm, Sweden, SE 171 76 Less <<
NCT00971815 Insulin Resistance ... More >> Low Birth Weight Type 2 Diabetes Cardiovascular Disease Melancholic Depression Anxiety Disorders Less << Not Applicable Completed - Denmark ... More >> Medical Dep M, Diabetes and Endocrinology Aarhus University Hospital, Aarhus Sygehus Aarhus, Denmark, 8000 Less <<
NCT02757560 Insulin Resistance Not Applicable Active, not recruiting July 2019 United States, Arizona ... More >> Carl T. Hayden VA Medical Center Phoenix, Arizona, United States, 85012 Less <<
NCT01423968 Sepsis Not Applicable Completed - United Kingdom ... More >> Queens Medical Centre Nottingham, Nottinghamshire, United Kingdom, NG7 2UH Less <<
NCT02435277 Type 2 Diabetes Mellitus Phase 2 Completed - United States, California ... More >> Catalina Research Institute Chino, California, United States, 91710 United States, Florida Palm Beach Research Palm Beach, Florida, United States, 33409 Meridien Research Tampa, Florida, United States, 33606 United States, Georgia River Birch Research Alliance Blue Ridge, Georgia, United States, 3051313 Meridian Research Savannah, Georgia, United States, 31406 United States, Ohio Streling Research Group Cincinnati, Ohio, United States, 45219 United States, South Carolina Medical Research South Charleston, South Carolina, United States, 29407 United States, Tennessee Meharry Medical College Nashville, Tennessee, United States, 37208 Vanderbilt University Medical Center, Diabetes, Endocrinology, and Metabolism Nashville, Tennessee, United States, 37232 Less <<
NCT02147496 Diabetes Prevention ... More >> Obesity Prevention Less << Phase 1 Phase 2 Completed - Canada, Ontario ... More >> University of Toronto Toronto, Ontario, Canada, M5S 3E2 Less <<
NCT03743285 Type 1 Diabetes Mellitus Not Applicable Recruiting January 28, 2019 United States, Washington ... More >> Rainier Clinical Research Center Recruiting Renton, Washington, United States, 98057 Principal Investigator: Ronald L. Brazg Less <<
NCT01540396 Gestational Diabetes Not Applicable Completed - United States, Pennsylvania ... More >> Magee-Womens Hospital Pittsburgh, Pennsylvania, United States, 15213 Less <<
NCT00106366 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT03160261 Healthy Phase 4 Completed - Estonia ... More >> Tartu University Hospital Tartu, Estonia Less <<
NCT00222768 - Completed - United States, Pennsylvania ... More >> University of Pittsburgh Pittsburgh, Pennsylvania, United States, 15213 Less <<
NCT02003417 - Completed - United States, District of Col... More >>umbia Medstar Georgetown University Hospital Washington, District of Columbia, United States, 20007 United States, North Carolina University of North Carolina at Chapel Hill Cancer Hospital Chapel Hill, North Carolina, United States, 27599 High Point Regional UNC Health Care High Point, North Carolina, United States, 27262 Rex Healthcare, Inc Raleigh, North Carolina, United States, 27607 Rex Healthcare of Wakefield Raleigh, North Carolina, United States, 27614 Marion L. Shepard Cancer Center Washington, North Carolina, United States, 27889 Coastal Carolina Radiation Oncology Wilmington, North Carolina, United States, 28401 United States, Virginia University of Virginia Charlottesville, Virginia, United States, 22908 Less <<
NCT01580475 Type 2 Diabetes Not Applicable Completed - Greece ... More >> Savvas P. Tokmakidis Komotini, Greece, 691 00 Less <<
NCT00438568 Mild Cognitive Impairment ... More >> Alzheimer's Disease Less << Phase 2 Completed - United States, Washington ... More >> Veterans Administration Puget Sound Health Care System Seattle, Washington, United States, 98108 Less <<
NCT03617770 Short Sleep Phenotype ... More >> Type1diabetes Less << Not Applicable Not yet recruiting October 1, 2020 -
NCT02232971 Diabetes Mellitus, Type 1 Phase 4 Unknown July 2015 Denmark ... More >> Hvidovre University Hospital Hvidovre, Denmark, 2650 Less <<
NCT00453362 Non-Small Cell Lung Cancer Phase 1 Phase 2 Completed - -
NCT00453362 - Completed - -
NCT00735228 Pancreatic Disease ... More >> Cardiovascular Diseases Less << Not Applicable Unknown August 2012 Japan ... More >> Kochi Medical School Recruiting Nankoku, Japan, 783-8505 Contact: Takehiro Okabayashi, MD, PhD    +81-88-880-2370    tokabaya@kochi-u.ac.jp    Contact: Kazuhiro Hanazaki, Prof    +81-88-880-2370    im31@kochi-u.ac.jp    Principal Investigator: Takehiro Okabayashi, MD, PhD Less <<
NCT01154621 Tolerability ... More >>Healthy Elderly Less << Phase 1 Completed - United States, Missouri ... More >> Research Site Springfield, Missouri, United States Less <<
NCT01204593 Diabetes Mellitus, Type 1 Phase 4 Completed - -
NCT03201068 Metabolic Syndrome ... More >> Microbiome Immune Function Inflammation Less << Not Applicable Recruiting November 30, 2018 United States, California ... More >> Stanford University Recruiting Stanford, California, United States, 94305 Contact: Jennifer Robinson, PhD    650-736-8577    jlmorris@stanford.edu Less <<
NCT02802215 Polycystic Ovary Syndrome ... More >> Diabetes, Gestational Less << Phase 2 Phase 3 Unknown September 2016 Egypt ... More >> Ain Shams maternity hospital Recruiting Cairo, Egypt Principal Investigator: Ahmed E Elbohoty, Ph.D. Less <<
NCT02298725 Insulin Resistance ... More >> Metabolic Syndrome X Obesity Less << Not Applicable Completed - United States, California ... More >> Western Human Nutrition Research Center Davis, California, United States, 95616 Clinical Translational Science Center Sacramento, California, United States, 95817 Less <<
NCT03038373 - Unknown December 2018 -
NCT00259168 Insulin Resistance ... More >> Impaired Fasting Glucose Less << Phase 4 Completed - Denmark ... More >> Endothelial laboratory, Cardiology clinic Y-research, H:S Bispebjerg Hospital Bispebjerg Bakke, Copenhagen, Copenhagen NV, Denmark, 2400 Less <<
NCT01062815 Cholestasis P... More >>rematurity Gastroschisis Intestinal Atresia Necrotizing Enterocolitis Less << Not Applicable Terminated(Difficulty in recru... More >>iting patients) Less << - United States, Florida ... More >> Holtz's Children's Hospital- University of Miami/Jackson Memorial Hospital Miami, Florida, United States, 33136 Less <<
NCT03301545 Type2 Diabetes Mellitus ... More >> Obesity Bariatric Surgery Candidate Less << Not Applicable Not yet recruiting March 2020 -
NCT01486966 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 4 Terminated(Trial terminated pr... More >>ematurely due to slow recruitment.) Less << - China, Beijing ... More >> Novo Nordisk Investigational Site Beijing, Beijing, China, 100034 China, Chongqing Novo Nordisk Investigational Site Chongqing, Chongqing, China, 400016 China, Jiangsu Novo Nordisk Investigational Site Wuxi, Jiangsu, China, 214023 China, Jiangxi Novo Nordisk Investigational Site Nanchang, Jiangxi, China, 330006 China, Shanghai Novo Nordisk Investigational Site Shanghai, Shanghai, China, 200003 Novo Nordisk Investigational Site Shanghai, Shanghai, China, 200072 Less <<
NCT00465036 Obesity Not Applicable Completed - Denmark ... More >> Institute of Human Nutrition Frederiksberg C, Denmark, 1958 Less <<
NCT03461510 Type 2 Diabetes Mellitus ... More >> Obesity Pediatric Obesity Insulin Resistance Dysglycemia Hyperglycemia Less << Not Applicable Recruiting December 31, 2018 United States, Florida ... More >> Nemours Children's Health System Recruiting Jacksonville, Florida, United States, 32207 Contact: Kaitlin M Sikes, ARNP    904-697-3988    ksikes@nemours.org    Principal Investigator: Lydia Snyder, MD Less <<
NCT03479866 Diabetes Hear... More >>t Diseases Diet Habit Diet Modification Microbial Colonization Healthy Healthy Obesity, Metabolically Less << Not Applicable Recruiting April 1, 2023 United Kingdom ... More >> King's College London Recruiting London, England, United Kingdom, SE1 7EH Contact: Sarah Berry    020 7848 4088    sarah.berry@kcl.ac.uk Less <<
NCT02040727 Musculoskeletal and Metabolic ... More >>Crosstalk Less << Not Applicable Completed - United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35294 Less <<
NCT01486966 - Terminated(Trial terminated pr... More >>ematurely due to slow recruitment.) Less << - -
NCT00561704 Obese Type 2 ... More >>Diabetes Diabetic Nephropathy Glucose Metabolism Angiotensin II Type 1 Receptor Blockers Less << Not Applicable Completed - -
NCT03409497 Glycemic Response ... More >> Appetitive Behavior Less << Not Applicable Not yet recruiting September 2019 United States, Indiana ... More >> Purdue University Not yet recruiting West Lafayette, Indiana, United States, 47909 Contact: Richard D Mattes, PhD    765-494-0662    mattes@purdue.edu    Contact: Judy C George    765-494-6192    georgej@purdue.edu Less <<
NCT02658591 Obesity Diabe... More >>tes Less << Not Applicable Active, not recruiting July 30, 2019 Canada, Ontario ... More >> University of Toronto Toronto, Ontario, Canada, M5S 3E2 Less <<
NCT00437606 Diabetes Mellitus, Type 2 Phase 1 Terminated(poor recruitment) - Germany ... More >> Berlin, Germany Kiel, Germany Slovakia Bratislava, Slovakia Less <<
NCT03409484 Glycemic Response ... More >> Appetitive Behavior Less << Not Applicable Not yet recruiting December 2019 United States, Indiana ... More >> Purdue University Not yet recruiting West Lafayette, Indiana, United States, 47909 Contact: Richard D Mattes, PhD    765-494-0662    mattes@purdue.edu    Contact: Judy C George    765-494-6192    georgej@purdue.edu Less <<
NCT02493309 Diabetes Not Applicable Completed - United Kingdom ... More >> Leicester Diabetes Centre, Leicester General Hospital Leicester, Leicestershire, United Kingdom, LE5 4PW Less <<
NCT01409564 - Completed - -
NCT03283566 Chronic Pancreatitis ... More >> Insulin Dependent Diabetes Less << Phase 2 Recruiting October 3, 2019 United States, Ohio ... More >> Cleveland Clinic Recruiting Cleveland, Ohio, United States, 44195 Contact: Mario Scarcipino    216-444-3599    mascar@ccf.org    Principal Investigator: Betul Hatipoglu, MD Less <<
NCT02988999 Obesity Not Applicable Unknown November 2017 Thailand ... More >> Faculty of Medicine, Chiang Mai University Recruiting Muang Chiang Mai, Chiang Mai, Thailand, 50200 Contact: Supawan Buranapin, MD Less <<
NCT01490099 Diabetes Heal... More >>thy Less << Phase 1 Completed - United Kingdom ... More >> Manchester, United Kingdom, M15 6SH Less <<
NCT02680457 Type 2 Diabetes Mellitus Phase 4 Completed - -
NCT03292224 - Not yet recruiting October 15, 2019 -
NCT00353275 Necrotizing Fasciitis Not Applicable Terminated(Difficulty in enrol... More >>ling eligible patients) Less << - United States, Texas ... More >> LBJ General Hospital/ UT health Science Center-Houston Houston, Texas, United States, 77026/ 77030 Brooke Army Medical Center San Antonio, Texas, United States, 78234 Less <<
NCT01615588 Healthy Not Applicable Completed - New Zealand ... More >> Waiariki Institute of Technology Rotorua, BOP, New Zealand, 3046 Less <<
NCT00353275 - Terminated(Difficulty in enrol... More >>ling eligible patients) Less << - -
NCT02351466 - Active, not recruiting - United States, California ... More >> Stanford University Palo Alto, California, United States, 94305 United States, Connecticut Yale University New Haven, Connecticut, United States, 06511 United States, Florida Nemours Childrens Clinic Jacksonville, Florida, United States, 32207 United States, Iowa University of Iowa Hospitals & Clinics Iowa City, Iowa, United States, 52242 United States, Missouri Washington University Saint Louis, Missouri, United States, 63126 Less <<
NCT01498185 Type 1 Diabetes Mellitus Phase 2 Completed - United States, California ... More >> Profil Institute For Clinical Research, Inc. Chula Vista, California, United States, 91911 Va San Diego Healthcare System San Diego, California, United States, 92161 La Biomed Research Inst. At Harbor Ucla Med Ctr. Torrance, California, United States, 90502 United States, Florida Compass Research Phase 1, Llc Orlando, Florida, United States, 32806 Progressive Medical Research Port Orange, Florida, United States, 32127 United States, Kansas Vince And Associates Clinical Research Overland Park, Kansas, United States, 66212 United States, Kentucky Central Kentucky Research Associates, Inc. Lexington, Kentucky, United States, 40509 United States, Louisiana Louisiana Research Associates, Inc. New Orleans, Louisiana, United States, 70114 United States, Michigan Jasper Clinic, Inc. Kalamazoo, Michigan, United States, 49007 United States, Missouri Kansas City University Of Medicine And Biosciences Kansas City, Missouri, United States, 64106 United States, South Dakota Regional Medical Clinic-Endocrinology Rapid City, South Dakota, United States, 57701 United States, Texas Dallas Diabetes & Endocrine Center Dallas, Texas, United States, 75230 Less <<
NCT01409564 Alzheimer's Dementia Phase 4 Completed - Korea, Republic of ... More >> SMG-SNU Boramae Medical Center Seoul, Korea, Republic of, 156-707 Less <<
NCT01498185 - Completed - -
NCT01975935 - Completed - -
NCT00328627 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT03130894 - Completed - -
NCT02909894 Diabetes Not Applicable Completed - United Kingdom ... More >> Leicester Diabetes Centre, Leicester General Hospital Leicester, Leicestershire, United Kingdom, LE5 4PW Less <<
NCT02285764 Maternal Glycemia Not Applicable Completed - Germany ... More >> Ludwig-Maximilians-University of Munich, Dr. von Hauner Children's Hospital München, Germany, 80337 Spain University of Granda Granada, Spain, 11 18071 University Clinical Hospital San Cecilio Granada, Spain, 16 18012 Less <<
NCT00752180 Diabetes Phase 1 Completed - United States, California ... More >> Profil Institute for Clinical Research Chula Vista, California, United States, 91911 Less <<
NCT01498926 Diabetes Heal... More >>thy Less << Phase 1 Completed - United Kingdom ... More >> Manchester, United Kingdom, M15 6SH Less <<
NCT01485315 Septic Shock Phase 3 Completed - Denmark ... More >> Aarhus University Hospital, NBG Aarhus, Denmark Aarhus University Hospital, Skejby Aarhus, Denmark Bispebjerg Hospital Copenhagen, Denmark Glostrup Hospital Copenhagen, Denmark Hvidovre Hospital Copenhagen, Denmark Rigshospitalet Copenhagen, Denmark Gentofte Hospital Gentofte, Denmark Herning Hospital Herning, Denmark Hjørring Hospital Hjørring, Denmark Holbæk Hospital Holbæk, Denmark Horsens Hospital Horsens, Denmark Kolding Hospital Kolding, Denmark Køge Hospital Køge, Denmark Næstved Hospital Næstved, Denmark Randers Hospital Randers, Denmark Slagelse Hospital Slagelse, Denmark Sønderborg Hospital Sønderborg, Denmark Vejle Hospital Vejle, Denmark Ålborg University Hospital Ålborg, Denmark Finland Helsinki University Hospital Helsinki, Finland Joensuu Hospital Joensuu, Finland Tampere University Hospital Tampere, Finland Norway Haukeland University Hospital Bergen, Norway Akershus University Hospital Oslo, Norway Stavanger University Hospital Stavanger, Norway Ålesund Hospital Ålesund, Norway Sweden Halmstad Hospital Halmstad, Sweden Helsingborg Hospital Helsingborg, Sweden Karolinska Hospital, Huddinge Stockholm, Sweden Karolinska Institutet Solna Stockholm, Sweden Södersjukhuset Stockholm, Sweden Växjö Hospital Växjö, Sweden Less <<
NCT02176044 Schizophrenia Phase 1 Completed - United Kingdom ... More >> Clinical Research Facility, King's College Hospital London, United Kingdom, SE5 Less <<
NCT00328627 - Completed - -
NCT02872961 - Active, not recruiting October 2018 United States, Texas ... More >> The University of Texas of Health Science Center at Houston Houston, Texas, United States, 77030 Less <<
NCT02037854 Glycemic Response Not Applicable Unknown - Canada, Ontario ... More >> GI Labs Recruiting Toronto, Ontario, Canada, M5C 2N8 Contact: Janice Campbell       JCampbell@gilabs.com Less <<
NCT00931372 Diabetes Mellitus, Type 2 Phase 1 Completed - Germany ... More >> Sanofi-Aventis Administrative Office Berlin, Germany Less <<
NCT00551213 Colorectal Cancer Phase 2 Completed - -
NCT02673138 - Completed - -
NCT01975935 Diabetes Mellitus Type 2 ... More >> Non-alcoholic Fatty Liver Disease Obesity Less << Phase 2 Completed - United States, Michigan ... More >> University of Michigan Ann Arbor, Michigan, United States, 48109 Less <<
NCT00747942 Overweight Not Applicable Unknown April 2010 Sweden ... More >> Center for Family and Community Medicine Huddinge, Stockholm, Sweden, 14183 Less <<
NCT00551213 - Completed - -
NCT00263276 Type 2 Diabetes Phase 2 Completed - -
NCT00688701 Diabetes Mellitus, Type 2 Phase 3 Completed - United States, New Jersey ... More >> Sanofi-Aventis Administrative Office Bridgewater, New Jersey, United States, 08807 Belgium Sanofi-Aventis Administrative Office Diegem, Belgium India Sanofi-Aventis Administrative Office Mumbai, India Israel Sanofi-Aventis Administrative Office Natanya, Israel Japan Sanofi-Aventis Administrative Office Tokyo, Japan Korea, Republic of Sanofi-Aventis Administrative Office Seoul, Korea, Republic of Mexico Sanofi-Aventis Administrative Office Mexico, Mexico Poland Sanofi-Aventis Administrative Office Warszawa, Poland Romania Sanofi-Aventis Administrative Office Bucuresti, Romania Russian Federation Sanofi-Aventis Administrative Office Moscow, Russian Federation Tunisia Sanofi-Aventis Administrative Office Megrine, Tunisia Ukraine Sanofi-Aventis Administrative Office Kiev, Ukraine Less <<
NCT00837408 - Completed - China ... More >> HuBei Suizhou Central Hospital Suizhou, China Less <<
NCT00688701 - Completed - -
NCT01512849 - Completed - -
NCT02673138 Type 1 Diabetes Not Applicable Completed - United States, Connecticut ... More >> Yale University School of Medicine New Haven, Connecticut, United States, 06520 Less <<
NCT01682759 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT03202277 Diabetes Mellitus, Type 2 Not Applicable Not yet recruiting August 15, 2019 -
NCT01512849 Type 2 Diabetes Mellitus Phase 1 Completed - Japan ... More >> Reserch site Kanto, Japan Less <<
NCT01682759 - Completed - -
NCT01465789 - Terminated(Loss of participant... More >>s to follow-up) Less << - United States, West Virginia ... More >> West Virginia School of Osteopathic Medicine Lewisburg, West Virginia, United States, 24901 Less <<
NCT02752113 Diabetes Mellitus Type 2 Phase 3 Recruiting January 2019 Germany ... More >> Clinical Research Center, Dept of Nephrology and Hypertenison, University of Erlangen/Nürnberg Recruiting Erlangen, Bavaria, Germany, 91054 Contact: Christian Ott, MD    +49-9131-85 ext 36245    christian.ott@uk-erlangen.de    Contact: Roland Schmieder, Prof. MD    +49 9131 85 ext 36245    roland.schmieder@uk-erlangen.de    Principal Investigator: Roland Schmieder, Prof. MD          Sub-Investigator: Christian Ott, MD Less <<
NCT02709915 Type 2 Diabetes Not Applicable Active, not recruiting January 2018 Israel ... More >> Daniela Jakubowicz Holon, Wolfson Medical Center, Israel, 58100 Less <<
NCT01342484 Diabetes Mellitus, Type 2 Phase 2 Completed - United States, Texas ... More >> 1218.56.01006 Boehringer Ingelheim Investigational Site San Antonio, Texas, United States United States, Virginia 1218.56.01004 Boehringer Ingelheim Investigational Site Norfolk, Virginia, United States Canada, Quebec 1218.56.11001 Boehringer Ingelheim Investigational Site Montreal, Quebec, Canada France 1218.56.33003 Boehringer Ingelheim Investigational Site Fort de France cedex, France 1218.56.33006 Boehringer Ingelheim Investigational Site Rouen, France Guatemala 1218.56.50202 Boehringer Ingelheim Investigational Site Guatemala, Guatemala 1218.56.50203 Boehringer Ingelheim Investigational Site Guatemala, Guatemala Italy 1218.56.39005 Boehringer Ingelheim Investigational Site Firenze, Italy Korea, Republic of 1218.56.82005 Boehringer Ingelheim Investigational Site Busan, Korea, Republic of 1218.56.82001 Boehringer Ingelheim Investigational Site Seoul, Korea, Republic of 1218.56.82002 Boehringer Ingelheim Investigational Site Seoul, Korea, Republic of 1218.56.82003 Boehringer Ingelheim Investigational Site Suwon, Korea, Republic of Mexico 1218.56.52008 Boehringer Ingelheim Investigational Site Chihuahua, Mexico 1218.56.52002 Boehringer Ingelheim Investigational Site Guadalajara, Mexico 1218.56.52001 Boehringer Ingelheim Investigational Site León, Mexico 1218.56.52003 Boehringer Ingelheim Investigational Site Monterrey, Mexico 1218.56.52004 Boehringer Ingelheim Investigational Site Oaxaca, Mexico Poland 1218.56.48002 Boehringer Ingelheim Investigational Site Gdansk, Poland 1218.56.48001 Boehringer Ingelheim Investigational Site Gliwice, Poland 1218.56.48004 Boehringer Ingelheim Investigational Site Warszawa, Poland 1218.56.48003 Boehringer Ingelheim Investigational Site Wroclaw, Poland Russian Federation 1218.56.70001 Boehringer Ingelheim Investigational Site Moscow, Russian Federation 1218.56.70003 Boehringer Ingelheim Investigational Site Saratov, Russian Federation 1218.56.70004 Boehringer Ingelheim Investigational Site Ufa, Russian Federation 1218.56.70006 Boehringer Ingelheim Investigational Site Yekaterinburg, Russian Federation Less <<
NCT01753362 Type 1 Diabetes Phase 3 Recruiting February 2018 United States, New York ... More >> diabetes endocrinology center of WNY Recruiting Buffalo, New York, United States, 14215 Contact: Paresh Dandona, MD    716-898-1940    pdandona@kaleidahealth.org    Principal Investigator: Paresh Dandona, MD          Diabetes Endocrinology Research Center of WNY Recruiting Buffalo, New York, United States, 14215 Contact: Paresh Dandona, MD    716-898-1940    pdandona@kaleidahealth.org    Principal Investigator: paresh dandona, mbbs Less <<
NCT01342484 - Completed - -
NCT02528396 Type 1 Diabetes Mellitus Phase 1 Completed - Germany ... More >> Profil GmbH Neuss, Germany, 41460 Less <<
NCT03038282 Alzheimer Disease Not Applicable Not yet recruiting October 20, 2019 -
NCT03358745 Metabolic Syndrome X ... More >> Insulin Resistance Hyperinsulinism Glucose Metabolism Disorders Metabolic Diseases Less << Not Applicable Active, not recruiting January 30, 2019 Sweden ... More >> Antidiabetic Food Centre, Chemical Centre. Lund University Lund, Skane, Sweden, 221 00 Food for Health Science Centre. Lund University Medicon Village Lund, Sweden, SE 223 81 Less <<
NCT00963768 Diabetes Mellitus, Type 2 Phase 1 Completed - United States, California ... More >> Chula Vista, California, United States Germany Neuss, Germany Korea, Republic of Seoul, Korea, Republic of Less <<
NCT01409382 Hyperinsulinemia ... More >> Miscarriages Pregnancy Sedentary Lifestyle Hypoglycemia Less << Not Applicable Completed - Brazil ... More >> Hospital Federal dos Servidores do Estado Rio de Janeiro, RJ, Brazil, 20221-903 Less <<
NCT01409382 - Completed - -
NCT00353834 Type 2 Diabetes Mellitus Phase 4 Completed - United States, Massachusetts ... More >> Joslin Diabetes Center Boston, Massachusetts, United States, 02215 Less <<
NCT00353834 - Completed - -
NCT01490151 Diabetes Mellitus ... More >> Type 1 Diabetes Metabolic and Nutritional Disorders Less << Not Applicable Completed - United States, California ... More >> Stanford University and Stanford Hospital & Clinics Stanford, California, United States, 94305 Less <<
NCT01363141 Metabolic Syndrome Not Applicable Completed - United States, New York ... More >> Icahn School of Medicine at Mount Sinai New York, New York, United States, 10029 Less <<
NCT01490151 - Completed - -
NCT01536665 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 1 Completed - Austria ... More >> Novo Nordisk Investigational Site Graz, Austria, 8036 Less <<
NCT03565666 Type1diabetes Phase 2 Phase 3 Completed - United States, California ... More >> Stanford University Palo Alto, California, United States, 94305 United States, Colorado Barbara Davis Center for Childhood Diabetes Aurora, Colorado, United States, 80045 United States, Florida Nemours Children's Specialty Care Jacksonville, Florida, United States, 32207 Less <<
NCT00283777 Type 2 Diabetes Phase 4 Completed - United States, Vermont ... More >> University of Vermont Burlington, Vermont, United States, 05410 Less <<
NCT00974272 Type 2 Diabetes Mellitus ... More >> Impaired Glucose Tolerance Less << Phase 4 Completed - United States, Arizona ... More >> Phoenix VA Medical Center Phoenix, Arizona, United States, 85012 Less <<
NCT02894762 - Unknown - Taiwan ... More >> National Taiwan University Hospital Recruiting Taipei, Taiwan, 100 Contact: YUE E Wu    886-913-772-512    duck1038@gmail.com    Principal Investigator: HUNG-YUAN LI, MD Less <<
NCT00497198 Type 2 Diabetes Phase 2 Completed - -
NCT00497198 - Completed - -
NCT01520753 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - Denmark ... More >> Novo Nordisk Investigational Site Århus C, Denmark, 8000 Less <<
NCT01706211 Diabetes Mellitus Non Insulin ... More >>Dependent Oral Agent Therapy Less << Phase 3 Completed - Taiwan ... More >> National Taiwan University Hospital Taipei, Taiwan, 10002 Less <<
NCT00605787 Type 2 Diabetes Mellitus ... More >> Dyslipidemia Less << Phase 2 Completed - Norway ... More >> Haukeland University Hospital Bergen, Norway, 5021 Less <<
NCT02130908 Metabolic Disorders ... More >> Obesity Less << Not Applicable Completed - Norway ... More >> Haukeland University Hospital Bergen, Norway, 5021 Less <<
NCT02631421 - Enrolling by invitation June 2019 United States, Tennessee ... More >> Vanderbilt Univeristy Nashville, Tennessee, United States, 37203 Less <<
NCT02547597 Stable Angina Pectoris Phase 4 Completed - Korea, Republic of ... More >> Gachon University Gil Medical Center Incheon, Korea, Republic of, 405-760 Less <<
NCT00585494 - Completed - -
NCT00585494 - Completed - United States, Wisconsin ... More >> University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States, 53792 Less <<
NCT03707379 Diabetes Mellitus, Type 2 Not Applicable Recruiting March 31, 2021 China, Beijing ... More >> Beijing Ruijing Diabetes Hospital Recruiting Beijing, Beijing, China Contact: Guojing Zhuo    86-10-86393989 Less <<
NCT01142050 Type 2 Diabetes Mellitus Phase 1 Unknown December 2011 China ... More >> Armed Police General Hospital, P.R. China Not yet recruiting Beijing, China, 100085 Principal Investigator: Shi X Y, M.D. Less <<
NCT00501397 Type 2 Diabetes Mellitus ... More >> Diabetes Mellitus, Type 2 Less << Phase 1 Completed - United States, Ohio ... More >> GSK Investigational Site Columbus, Ohio, United States, 43212 Less <<
NCT00815399 Type 2 Diabetes Phase 4 Completed - Italy ... More >> Department of Geriatrics and Metabolic Diseases Naples, Italy, 80138 Less <<
NCT00815789 Cardiovascular Disease ... More >> Diabetes Less << Not Applicable Completed - United States, North Carolina ... More >> Duke University Health Care System Durham, North Carolina, United States, 27705 Less <<
NCT00393445 Hyperglycemia Phase 1 Completed - Germany ... More >> Ludwig Maximilians University, Clinical Research Unit Munich, Germany, D-81377 Less <<
NCT01467414 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 1 Terminated(This trial was term... More >>inated due to low recruitment) Less << - Germany ... More >> Neuss, Germany, 41460 Less <<
NCT00340132 - Recruiting - United States, Arizona ... More >> NIDDK, Phoenix Recruiting Phoenix, Arizona, United States, 85014 Contact: Clifton Bogardus, M.D.    602-200-5311    cbogardus@phx.niddk.nih.gov Less <<
NCT01684332 Postprandial ... More >>Hyperglycemia, Postprandial Feeding Behaviors Antioxidant Lipid Profile Less << Not Applicable Completed - Spain ... More >> Department of Nutrition, Food Science and Physiology Pamplona, Navarra, Spain, 31008 Less <<
NCT01791114 Insulin Sensitivity ... More >> Obesity Less << Not Applicable Unknown January 2017 United States, Texas ... More >> University of Texas Medical Branch at Galveston Recruiting Galveston, Texas, United States, 77555 Contact: Labros Sidossis, PhD    409-266-9690    lasidoss@utmb.edu    Principal Investigator: Labros S Sidossis, PhD Less <<
NCT03511885 - Recruiting December 31, 2018 United Kingdom ... More >> Imperial College London Recruiting London, United Kingdom, SW3 6LR Contact: Kornelia Kotseva, MD,PhD,FESC    +44 (0) 2075943439    k.kotseva@imperial.ac.uk    Contact: David Wood    +44 (0) 2075943439    d.wood@imperial.ac.uk Less <<
NCT02302716 - Completed - -
NCT02302716 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT01947556 Diabetes Mellitus Not Applicable Completed - Netherlands ... More >> Radboud University Nijmegen Medical Centre Nijmegen, Netherlands, 6500HB Less <<
NCT01324921 Diabetes Mellitus, Type 2 Phase 2 Phase 3 Completed - United States, Illinois ... More >> Provident Clinical Research and Consulting LLC Glen Ellyn, Illinois, United States, 60137 United States, Ohio Radiant Research Cincinnati, Ohio, United States, 45249 Less <<
NCT00527397 - Terminated(See termination rea... More >>son in detailed description.) Less << - -
NCT00652288 Diabetes Mellitus, Type I Phase 1 Completed - -
NCT02435277 - Completed - -
NCT03566992 Glucose Metabolism Disorders ... More >> Critical Illness Less << Not Applicable Recruiting September 1, 2018 United States, Virginia ... More >> Winchester Medical Center Recruiting Winchester, Virginia, United States, 22602 Contact: Brett Baney, MS, RD Less <<
NCT00970541 Polycystic Ovary Syndrome ... More >> Insulin Resistance Less << Phase 1 Terminated(Recruitment) - United States, Louisiana ... More >> Pennington Biomedical Research Center Baton Rouge, Louisiana, United States, 70808 Less <<
NCT01828229 Inactivity Ob... More >>esity Type 2 Diabetes Less << Not Applicable Completed - Denmark ... More >> Center og inflammation and metabolism, Rigshospitalet Copenhagen, Denmark Less <<
NCT03080337 Pregnancy Dia... More >>betes Less << Not Applicable Terminated(This study is being... More >> closed prematurely due to resource availability and agreement constraints with the collaborating research site.) Less << - United States, Wisconsin ... More >> UnityPoint Health- Meriter Hospital Madison, Wisconsin, United States, 53715 Less <<
NCT00527397 Diabetes Mellitus, Type 2 ... More >> Diabetes Mellitus, Type 1 Less << Phase 3 Terminated(See termination rea... More >>son in detailed description.) Less << - Japan ... More >> Pfizer Investigational Site Nagoya-shi, Aichi, Japan Pfizer Investigational Site Yokohama-shi, Kanagawa, Japan Pfizer Investigational Site Tenri-shi, Nara, Japan Pfizer Investigational Site Takatsuki-shi, Oosaka, Japan Pfizer Investigational Site Bunkyo-ku, Tokyo, Japan Pfizer Investigational Site Meguro-ku, Tokyo, Japan Pfizer Investigational Site Toyama-shi, Toyama, Japan Pfizer Investigational Site Kyoto, Japan Pfizer Investigational Site Osaka, Japan Pfizer Investigational Site Tokyo, Japan Less <<
NCT03738852 Type1 Diabetes Mellitus Early Phase 1 Not yet recruiting November 30, 2023 -
NCT03076463 Subjects at Cardiometabolic Ri... More >>sk Less << Not Applicable Completed - Spain ... More >> Institute of Food Science, Technology and Nutrition (ICTAN-CSIC) Madrid, Spain, 28040 Less <<
NCT00786500 Type 2 Diabetes Phase 1 Phase 2 Completed - Vietnam ... More >> National Institute of Gerontology, HMU Hanoi, Vietnam Less <<
NCT01186393 Obesity Not Applicable Completed - United States, California ... More >> University of California Davis (Academic Surge, Ragle Human Nutrition Research Facility) Davis, California, United States, 95616 VA Hospital, Mather Mather, California, United States, 95655 Less <<
NCT00345033 Schizophrenia ... More >> Insulin Resistance Less << Phase 4 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Schizophrenia Program Boston, Massachusetts, United States, 02114 Less <<
NCT01425424 Prediabetes P... More >>rehypertension Less << Not Applicable Terminated(The PI was leaving ... More >>Pennington) Less << - United States, Louisiana ... More >> Physicians Care Center Baton Rouge, Louisiana, United States, 70806 Bradley L. Meek, MD, Internal Medicine at Hennessy Baton Rouge, Louisiana, United States, 70808 Pennington Biomedical Research Center Baton Rouge, Louisiana, United States, 70808 Metabolic Clinic Women's Hospital Baton Rouge, Louisiana, United States, 70809 Egan Wellness Clinic/AntiAging & Skin Care Spa Covington, Louisiana, United States, 70433 United States, North Carolina Amarica Family Practice Office (Second Location) Durham, North Carolina, United States, 27704 Amarica Family Practice Office (First Location) Roxboro, North Carolina, United States, 27573 Less <<
NCT01912170 Gestational Diabetes Not Applicable Unknown - China, Zhejiang ... More >> Jiaxing Women's and Children's Hospital Not yet recruiting Jiaxing, Zhejiang, China Contact: Huijuan Liu          Principal Investigator: Duo Li, Ph.D. Less <<
NCT03638349 - Recruiting August 10, 2018 United Kingdom ... More >> Birmingham Heartlands Hospital Recruiting Birmingham, United Kingdom Royal Infirmary of Edinburgh Recruiting Edinburgh, United Kingdom Highland Clinical Research Facility Recruiting Inverness, United Kingdom Less <<
NCT00819741 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 4 Completed - China, Fujian ... More >> Novo Nordisk Investigational Site Fuzhou, Fujian, China, 350001 China, Jiangsu Novo Nordisk Investigational Site Nanjing, Jiangsu, China, 210009 Novo Nordisk Investigational Site Nanjing, Jiangsu, China, 210012 Novo Nordisk Investigational Site Nanjing, Jiangsu, China, 210029 Novo Nordisk Investigational Site Suzhou, Jiangsu, China, 215004 Novo Nordisk Investigational Site Wuxi, Jiangsu, China, 214023 China, Jiangxi Novo Nordisk Investigational Site Nanchang, Jiangxi, China, 330006 China, Shanghai Novo Nordisk Investigational Site Shanghai, Shanghai, China, 200001 Novo Nordisk Investigational Site Shanghai, Shanghai, China, 200025 Novo Nordisk Investigational Site Shanghai, Shanghai, China, 200072 Novo Nordisk Investigational Site Shanghai, Shanghai, China, 200092 Novo Nordisk Investigational Site Shanghai, Shanghai, China, 200120 China, Zhejiang Novo Nordisk Investigational Site Hangzhou, Zhejiang, China, 310003 Novo Nordisk Investigational Site Wenzhou, Zhejiang, China, 325000 China Novo Nordisk Investigational Site Hangzhou, China, 310016 Novo Nordisk Investigational Site Nantong, China, 226001 Novo Nordisk Investigational Site Shanghai, China, 200040 Less <<
NCT02040246 Diabetes Mellitus, Type 2 Phase 4 Completed - China, Shanghai ... More >> Renji Hospital Shanghai, Shanghai, China, 200127 China Renji Hospital Shanghai, China, 200127 Less <<
NCT00060931 Hypertension Phase 4 Completed - -
NCT00345033 - Completed - -
NCT02336659 Severe Obesity Not Applicable Completed - Denmark ... More >> Hvidovre University Hospital Hvidovre, Denmark, DK-2650 Less <<
NCT02954692 Type 2 Diabetes Mellitus Phase 4 Completed - Turkey ... More >> Turkey, Turkey Less <<
NCT01792830 - Completed - -
NCT03574688 Low Water Intake ... More >> High Vasopressin Less << Not Applicable Completed - Sweden ... More >> KFE, Skåne University Hospital in Malmö Malmö, Sweden, 20502 Less <<
NCT01462864 Polycystic Ovary Syndrome Not Applicable Completed - United Kingdom ... More >> University Hospitals of Licester Leicester, Leicestershire, United Kingdom, LE1 5WW Less <<
NCT00518596 Sepsis Phase 2 Completed - India ... More >> Capital Hospital Bhubaneswar, Orissa, India Kalinga Hospital Bhubaneswar, Orissa, India Ispat General Hospital Rourkela, Orissa, India Less <<
NCT01891474 Diabetes Not Applicable Completed - Korea, Republic of ... More >> Seoul National University Bundang Hospital Seongnam, Korea, Republic of, 463-707 Less <<
NCT02161276 Accidental Exposure While Prep... More >>aring Drug for Administration Less << Phase 1 Phase 2 Completed - China, Guizhou ... More >> Tianyuan Hospital of Guiyang City Guiyang, Guizhou, China, 550007 Less <<
NCT02059564 Diabetes Mellitus Phase 1 Unknown December 2014 United States, California ... More >> Hanmi Recruiting California, California, United States Contact: Hanmi Clinical       clinical4@hanmi.co.kr    Principal Investigator: Hanmi Clinical Less <<
NCT00843791 Obesity Insul... More >>in Resistance Less << Not Applicable Completed - United States, Oregon ... More >> Oregon Health & Science University Portland, Oregon, United States, 97239 Less <<
NCT01792830 Poor Glycemic Control Phase 3 Completed - United States, Georgia ... More >> Grady Memorial Hospital Atlanta, Georgia, United States, 30303 Emory Midtown Hospital Atlanta, Georgia, United States, 30308 Emory University Hospital Atlanta, Georgia, United States, 30326 Less <<
NCT00270855 Diabetes Mellitus ... More >> Obesity Paraplegia Quadriplegia Spinal Cord Injury Less << Not Applicable Completed - United States, Virginia ... More >> Hunter Holmes McGuire VA Medical Center Richmond, Virginia, United States, 23249 Less <<
NCT02235298 Type 2 Diabetes Phase 4 Recruiting December 2019 United States, Florida ... More >> University of Miami Recruiting Miami, Florida, United States, 33136 Contact: Gianluca Iacobellis, MD PhD       giacobellis@med.miami.edu    Principal Investigator: Gianluca Iacobellis, MD PhD          University of Miami Recruiting Miami, Florida, United States, 33136 Contact: Gianluca Iacobellis, MD PhD       giacobellis@med.miami.edu Less <<
NCT00928759 - Recruiting December 2018 United States, Virginia ... More >> University of Virginia Recruiting Charlottesville, Virginia, United States, 22908 Contact: Melissa Gilrain    434-243-6911    pcos@virginia.edu    Principal Investigator: Christopher McCartney, MD Less <<
NCT03545841 Type1diabetes Not Applicable Completed - United Kingdom ... More >> Liverpool John Moores University Liverpool, Merseyside, United Kingdom, L3 3AF Less <<
NCT02662400 Diabetes Mellitus, Non-Insulin... More >>-Dependent Less << Phase 2 Phase 3 Completed - -
NCT02498990 Diabetes Mellitus Type 2 ... More >> Dyslipidemia Non-alcoholic Fatty Liver Disease Obesity Less << Not Applicable Enrolling by invitation August 2019 Sweden ... More >> Karolinska University Hospital Stockholm, Sweden, 14186 Less <<
NCT02479048 Glycemic Response Not Applicable Active, not recruiting October 1, 2019 United States, Illinois ... More >> Clinical Nutrition Research Center Chicago, Illinois, United States, 60616 Less <<
NCT03111810 Iatrogenic Cushing's Disease Phase 2 Recruiting January 2019 United Kingdom ... More >> University of Oxford Recruiting Oxford, United Kingdom Contact: Jeremy W Tomlinson, MD PhD    44(0)1865 857359    jeremy.tomlinson@ocdem.ox.ac.uk    Contact: Nadia Othonos, MD       Nantia.Othonos@ocdem.ox.ac.uk Less <<
NCT02630706 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT00001178 - Terminated - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT03748251 Diabetes Mellitus, Type 1 Not Applicable Completed - Italy ... More >> Centro di Diabetologia Pediatrica "G.Stoppoloni" Naples, Italy, 80100 Less <<
NCT00590395 Cholecystitis Not Applicable Completed - United States, California ... More >> Cedars-Sinai Medical Center, S. Mark Taper Foundation Imaging Center Los Angeles, California, United States, 90048 Less <<
NCT01247376 Knee Arthroscopy ... More >> Meniscus Inflammation Hydrops Cooling Less << Not Applicable Completed - Sweden ... More >> Karolinska University Hospital Stockholm, Sweden, 141 86 Less <<
NCT02630706 - Completed - -
NCT03064347 Diabetes Mellitus, Type 2 Not Applicable Completed - United States, California ... More >> USC Diabetes & Obesity Research Institute (DORI) Los Angeles, California, United States, 90033 Less <<
NCT01631370 Treatment Resistant Essential ... More >>Hypertension Insulin Resistance Less << Not Applicable Completed - Denmark ... More >> Medical Research Laboratories, Aarhus University Hospital Aarhus, Denmark, 8000 Less <<
NCT02963454 Septic Shock Not Applicable Recruiting February 2018 Tunisia ... More >> Military Hopital of Tunis Recruiting Tunis, Tunisia, 1008 Contact: zied hajjej    20358907 ext 00216    hajjej_zied@hotmail.com    Contact: mustapha ferjani    98329256 ext 00216    mustapha.ferjani@planet.tn Less <<
NCT03207516 Dyspepsia Not Applicable Completed - -
NCT00270855 - Completed - -
NCT02910518 Type1 Diabetes Mellitus Phase 1 Completed - Germany ... More >> Investigational Site Number 276001 Neuss, Germany, 41460 Less <<
NCT00211536 - Completed - -
NCT03019796 Exercise Therapy ... More >> Metabolic Syndrome X Cardiorespiratory Fitness Less << Not Applicable Recruiting August 2018 Spain ... More >> University of Castilla-La Mancha (Exercise Physiology Lab) Recruiting Toledo, Spain, 45071 Contact: Ricardo Mora-Rodriguez, PhD    92526800 ext 5515    ricardo.mora@uclm.es    Contact: Juan F Ortega, MD, PhD    +3492526800 ext 5515    juanfernando.ortega@uclm.es    Sub-Investigator: Juan F Ortega, MD, PhD          Principal Investigator: Ricardo Mora-Rodriguez, PhD Less <<
NCT03003988 Dietary Supplementation Not Applicable Completed - -
NCT00211536 Type 1 Diabetes Phase 3 Completed - United States, California ... More >> Sansum Medical Research Institute Santa Barbara, California, United States, 93105 United States, Colorado University of Colorado Health Sciences Center Aurora, Colorado, United States, 80010 United States, Missouri Hellman & Rosen Endocrine Associates North Kansas City, Missouri, United States, 64116 United States, Ohio Cleveland Clinic Wooser, Ohio, United States, 44195 United States, Texas Diabetes & Glandular Disease Clinic San Antonio, Texas, United States, 78229 Less <<
NCT01570660 Type 2 Diabetes Mellitus Not Applicable Completed - Austria ... More >> Medical University of Vienna Vienna, Austria Less <<
NCT01933256 Type 2 Diabetes Mellitus Phase 1 Completed - United States, California ... More >> Profil Institute for Clinical Research, Inc. Chula Vista, California, United States, 91911 Less <<
NCT00562133 Diabetes Mellitus Phase 3 Completed - Germany ... More >> Ikfe Mainz, Rhineland-Palatinate, Germany, 55116 Less <<
NCT00729560 - Terminated(Lack of recruitment... More >>) Less << - -
NCT01688635 Healthy Phase 1 Completed - Singapore ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Singapore, Singapore, 117597 Less <<
NCT00729560 Polycystic Ovary Syndrome Not Applicable Terminated(Lack of recruitment... More >>) Less << - United States, Virginia ... More >> Virginia Commonwealth University General Clinical Research Center Richmond, Virginia, United States, 23298 Less <<
NCT01688635 - Completed - -
NCT01025999 - Completed - United States, Washington ... More >> University of Washington Medical Center Seattle, Washington, United States, 98195 Less <<
NCT01459809 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT02380846 Metabolic Diseases Not Applicable Active, not recruiting January 26, 2018 -
NCT01588470 Type 2 Diabetes ... More >> Coronary Heart Disease Less << Phase 4 Completed - -
NCT03118479 Hypogonadotropic Hypogonadism ... More >> Kallmann Syndrome Less << Phase 1 Terminated(Because the PI left... More >> the institution.) Less << - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT01542216 Breast Cancer Not Applicable Withdrawn(Recruitment challeng... More >>es) Less << September 2015 Canada, Ontario ... More >> University of Waterloo Waterloo, Ontario, Canada, N2L 3G1 Less <<
NCT00751114 Diabetes Mellitus, Type 2 Phase 4 Completed - -
NCT01855386 - Terminated(Expired with the IR... More >>B) Less << - United States, Florida ... More >> Shands Medical Plaza Gainesville, Florida, United States, 32608 Less <<
NCT00747383 Type 2 Diabetes Mellitus Not Applicable Completed - United Kingdom ... More >> Royal Bournemouth Hospital Bournemouth, Dorset, United Kingdom, BH7 7DW Less <<
NCT01588470 - Completed - -
NCT03405545 Obese, Pre-diabetics Not Applicable Recruiting February 1, 2020 Netherlands ... More >> University Maastricht Recruiting Maastricht, Limburg, Netherlands, 6229ER Contact: Maaike Bergman, MSc    0433881441    maaike.bergman@maastrichtuniversity.nl    Contact: Rodrigo Mancilla, MSc    0433881493    rodrigo.mancilla@maastrichtuniversity.nl Less <<
NCT01353638 End Stage Renal Disease Phase 1 Phase 2 Terminated(Primary endpoint (H... More >>SP) could not be analyzed with the specified method in the planned interim analysis; a method of increased sensitivity had to be established.) Less << - Austria ... More >> Department of Internal Medicine III; Clinical Division of Nephrology and Dialysis; Medical University of Vienna Vienna, Austria, 1090 Less <<
NCT01299311 Overweight Not Applicable Completed - Netherlands ... More >> Maastricht University Medical Center/ University of Maastricht Maastricht, Netherlands, 6202 AZ Less <<
NCT03533023 Shift Workers' Health ... More >> First Responder Less << Not Applicable Recruiting May 2021 United States, California ... More >> University of California, San Diego Recruiting La Jolla, California, United States, 92093 Contact: Hannah Lo, BS    858-246-2510    hclo@ucsd.edu    Contact: Adena Zadourian, BS    858-246-2510    azadourian@ucsd.edu    Principal Investigator: Pam Taub, MD Less <<
NCT03244449 - Completed - -
NCT01932866 Pre-diabetes ... More >>Diabetes Risk Score Motivation Less << Not Applicable Completed - United States, California ... More >> David Grant Medical Center Travis AFB, California, United States, 94535 United States, Maryland Andrews Military Medical Center Andrews AFB, Maryland, United States, 20762 United States, Nevada Nellis Family Medicine Nellis AFB, Nevada, United States, 89191 United States, Ohio Wright Patterson Medical Center Wright Patterson AFB, Ohio, United States, 45324 United States, Texas Wilford Hall Ambulatory Surgical Center Lackland AFB, Texas, United States, 78236 Less <<
NCT02476448 Injury of Ureter Not Applicable Completed - United States, Florida ... More >> Cleveland Clinic Florida Weston, Florida, United States, 33331 Less <<
NCT00732602 Diabetes Mellitus Not Applicable Completed - Denmark ... More >> University Hospital, Gentofte Hellerup, Capital Region, Denmark, 2900 Less <<
NCT00715624 Diabetes Mellitus, Type 2 Phase 3 Completed - United States, New Jersey ... More >> Sanofi-Aventis Administrative Office Bridgewater, New Jersey, United States, 08807 Brazil Sanofi-Aventis Administrative Office Sao Paulo, Brazil Canada Sanofi-Aventis Administrative Office Laval, Canada Chile Sanofi-Aventis Administrative Office Santiago, Chile Egypt Sanofi-Aventis Administrative Office Cairo, Egypt France Sanofi-Aventis Administrative Office Paris, France Germany Sanofi-Aventis Administrative Office Berlin, Germany India Sanofi-Aventis Administrative Office Mumbai, India Italy Sanofi-Aventis Administrative Office Milano, Italy Korea, Republic of Sanofi-Aventis Administrative Office Seoul, Korea, Republic of Mexico Sanofi-Aventis Administrative Office Mexico, Mexico Puerto Rico Sanofi-Aventis Administrative Office Puerto Rico, Puerto Rico Russian Federation Sanofi-Aventis Administrative Office Moscow, Russian Federation Turkey Sanofi-Aventis Administrative Office Istanbul, Turkey United Kingdom Sanofi-Aventis Administrative Office Guildford Surrey, United Kingdom Less <<
NCT02317211 Diabetes Mellitus，Type 2 Early Phase 1 Completed - -
NCT00715624 - Completed - -
NCT02033239 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 1 Completed - Germany ... More >> Novo Nordisk Investigational Site Neuss, Germany, 41460 Less <<
NCT02544568 Diabetes Mellitus Not Applicable Completed - Sweden ... More >> Karolinska University Hospital Stockholm, Sweden, 17176 Less <<
NCT00910988 - Completed - -
NCT00509262 Diabetes Mellitus, Type 2 ... More >> Renal Insufficiency, Chronic Less << Phase 3 Completed - -
NCT00751114 - Completed - -
NCT00509262 - Completed - -
NCT00910988 Hyperglycemia ... More >> Hyperlipidemia Less << Not Applicable Completed - United States, Missouri ... More >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Less <<
NCT01600534 Gestational Diabetes Mellitus ... More >> Pregnancy Less << Not Applicable Completed - United States, North Carolina ... More >> University of North Carolina clinics Chapel Hill, North Carolina, United States, 27599 Less <<
NCT01620125 Type 2 Diabetes ... More >> Insulin Resistance Less << Early Phase 1 Unknown December 2012 Sweden ... More >> Gothia Forum, CTC, Gröna Stråket 12, Sahlgrenska University Hospital Recruiting Gothenburg, Sweden, S-413 45 Contact: Kaj Stenlöf, Director    46 708 76 01 30    kaj.stenlof@vgregion.se    Sub-Investigator: Niklas Rydberg, MD Less <<
NCT03301519 - Completed - -
NCT00279045 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT03139344 Spinal Cord Injuries Not Applicable Recruiting April 2020 United States, Iowa ... More >> University of Iowa Recruiting Iowa City, Iowa, United States, 52242 Less <<
NCT00866658 - Completed - -
NCT00850239 Type 2 Diabetes Mellitus Phase 3 Terminated December 2010 -
NCT03515720 Chondromalacia Patellae Not Applicable Not yet recruiting March 1, 2020 -
NCT00866658 Diabetes Mellitus, Type 2 Phase 3 Completed - Japan ... More >> Sanofi-Aventis Administrative Office Tokyo, Japan Korea, Republic of Sanofi-Aventis Administrative Office Seoul, Korea, Republic of Philippines Sanofi-Aventis Administrative Office Makati City, Philippines Taiwan Sanofi-Aventis Administrative Office Taipei, Taiwan Less <<
NCT02728037 Pelvic Pain Phase 3 Recruiting December 2018 Canada, Ontario ... More >> Department of Obstetrics & Gynecology, Queen's Unviersity Recruiting Kingston, Ontario, Canada, K7L 2V7 Principal Investigator: Romy Nitsch, MD, MHSc Less <<
NCT01213563 Diabetes Mellitus, Type 2 Not Applicable Completed - United Kingdom ... More >> Imperial College London, Charing Cross Hospital London, United Kingdom, W68NA Less <<
NCT00258115 Obesity Phase 2 Completed - United States, Massachusetts ... More >> Joslin Diabetes Center Boston, Massachusetts, United States, 02215 Less <<
NCT02269735 Type 1 Diabetes Mellitus Phase 1 Completed - -
NCT01420497 Diabetes Heal... More >>thy Less << Not Applicable Completed - Switzerland ... More >> CHUV Lausanne, VD, Switzerland, 1001 Less <<
NCT03309254 Pre Diabetes Not Applicable Completed - Singapore ... More >> Clinical Nutrition Research Centre Singapore, Singapore, 117599 Less <<
NCT02577874 - Unknown January 2016 United Kingdom ... More >> Sheffield Hallam Univeristy Food and Nutrition laboratory Recruiting Sheffield, South Yorkshire, United Kingdom, S1 1WB Contact: Trevor Simper, Dprof    0114 225 3978 ext 3978    t.simper@shu.ac.uk Less <<
NCT01283425 Diabetes Mellitus, Type 1 Phase 4 Completed - United States, California ... More >> Mills-Peninsula Health Services San Mateo, California, United States, 94401 Israel Soroka Medical Center Beer Sheva, Israel Hillel Yaffe Hadera, Israel Rambam Medical Center Haifa, Israel Wolfson Medical Center Holon, Israel Haddasah Medical Organization Jerusalem, Israel Schneider Children's hospital Petah Tikva, Israel Sheba Medical Center Ramat Gan, Israel Less <<
NCT00179062 Schizophrenia ... More >> Schizoaffective Disorder Depressive Disorder, Major Bipolar Disorder Less << Not Applicable Completed - United States, Tennessee ... More >> Psychiatric Hospital at Vanderbilt Nashville, Tennessee, United States, 37212 Less <<
NCT03610178 Gestational Diabetes Mellitus Not Applicable Recruiting July 2020 Russian Federation ... More >> Almazov NMRC Recruiting Saint Petersburg, Russian Federation, 197341 Contact: Polina Popova, MD, PhD    +78127025595    pvpopova@yandex.ru Less <<
NCT03091517 Type 2 Diabetes Mellitus Not Applicable Completed - Singapore ... More >> SingHealth Polyclinics - Tampines Singapore, Singapore, 529203 Less <<
NCT02184832 Metformin Response ... More >> Fasting Glucose Tryptophan Concentration Metformin Concentration Diet Tolerability Less << Early Phase 1 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT02227511 Healthy Subjects Not Applicable Completed - Sweden ... More >> Fredrik H Nystrom Linköping, Sweden, 58185 Less <<
NCT02520050 Type 2 Diabetes ... More >> Obesity Less << Not Applicable Completed - United States, Massachusetts ... More >> Joslin Diabetes Center Boston, Massachusetts, United States, 02215 Less <<
NCT03112343 Diabetes Mellitus ... More >> Insulin Hypoglycemia Insulin-dependent Diabetes Mellitus Less << Not Applicable Recruiting December 30, 2018 Korea, Republic of ... More >> Samsung Medical Center Recruiting Seoul, Korea, Republic of, 135-710 Contact: Sang-Man Jin, MD PhD    +82-2-3410-0271    sangman.jin@samsung.com    Principal Investigator: Sang-Man Jin, MD PhD Less <<
NCT01858012 - Active, not recruiting July 31, 2020 United States, California ... More >> University of california San Francisco San Francisco, California, United States, 94110 Less <<
NCT01733563 Metabolism Not Applicable Completed - Switzerland ... More >> University Hospital Zurich, Endocrinology and Diabetology Zurich, ZH, Switzerland, 8091 Less <<
NCT02051504 - Completed - France ... More >> CHRU Lille Lille, France, 59037 Less <<
NCT02285270 Healthy Not Applicable Completed - United States, Pennsylvania ... More >> University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT02308254 Diabetes Mellitus ... More >> Gastroparesis Less << Phase 1 Phase 2 Unknown April 2016 Australia, South Australia ... More >> Discipline of Medicine, Royal Adelaide Hospital Recruiting Adelaide, South Australia, Australia, 5000 Contact: Karen L Jones, PhD    +61 8 8222 5394 ext 25394    karen.jones@adelaide.edu.au    Contact: Michael Horowitz, PhD, FRACP    +61 8 8222 4327 ext 24327    michael.horowitz@adelaide.edu.au    Principal Investigator: Karen L Jones, PhD          Sub-Investigator: Laurence G Trahair, BHlthSci Hon          Sub-Investigator: Rachael S Tippett, BSc Honours          Sub-Investigator: Chris Rayner, PhD, FRACP          Sub-Investigator: Michael Horowitz, PhD, FRACP Less <<
NCT03565653 Blood Pressure ... More >> Post-Exercise Hypotension Less << Not Applicable Recruiting May 1, 2019 United States, Delaware ... More >> Department of Kinesiology and Applied Physiology, University of Delaware Recruiting Newark, Delaware, United States, 19713 Contact: William B Farquhar, PhD    302-831-6178    wbf@udel.edu    Principal Investigator: Matthew C Babcock, MS          Principal Investigator: William B Farquhar, PhD Less <<
NCT00639912 Contrast Induced Nephropathy Phase 4 Completed - Italy ... More >> Azienda Ospedaliera Universitaria S. Anna Ferrara, Emilia-romagna, Italy Nuovo Ospedale Civile di Baggiovara Modena, Emilia-Romagna, Italy, 41100 Arcispedale S. Maria Nuova Reggio Emilia, Emilia-Romagna, Italy, 42100 Dipartimento di Cardiologia, Ospedale di Lavagna Lavagna, Genova, Italy, 16033 Dipartimento di Cardiologia, Ospedale Maggiore Parma, Italy, 43100 Less <<
NCT00855244 Metabolic Syndrome Not Applicable Terminated(Principal Investiga... More >>tor left the institution) Less << - United States, Ohio ... More >> Nationwide Children's Hospital Columbus, Ohio, United States, 43205 Less <<
NCT01840189 Addison Disease ... More >> Type 1 Diabetes Less << Phase 2 Completed - Norway ... More >> Haukeland University Hospiatl Bergen, Norway, 5021 Less <<
NCT02053935 Hyperglycemia ... More >> Sepsis Less << Phase 1 Completed - United States, New York ... More >> Montefiore Medical Center of Albert Einstein College of Medicine Bronx, New York, United States, 10467 Less <<
NCT02285270 - Completed - -
NCT01586156 - Completed - -
NCT00678483 Obesity Weigh... More >>t Loss Less << Phase 3 Terminated(Company decision ta... More >>ken in light of demands by certain national health authorities) Less << - Croatia ... More >> Sanofi-Aventis Administrative Office Zagreb, Croatia Finland Sanofi-Aventis Administrative Office Helsinki, Finland Hungary Sanofi- Aventis Administrative Office Budapest, Hungary Netherlands Sanofi-Aventis Administrative Office Gouda, Netherlands Romania Sanofi-Aventis Administrative Office Bucuresti, Romania Less <<
NCT00564070 Diabetes Mellitus ... More >> Depression Less << Not Applicable Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT01586156 Pulmonary Hypertension Not Applicable Completed - United States, Ohio ... More >> Cleveland Clinic Cleveland, Ohio, United States, 44195 Less <<
NCT03223649 Healthy Obesi... More >>ty Overweight Less << Phase 2 Recruiting June 28, 2020 United States, Maryland ... More >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)    800-411-1222 ext TTY8664111010    prpl@cc.nih.gov Less <<
NCT02033889 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT00564070 - Completed - -
NCT00819741 - Completed - -
NCT01682902 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 1 Completed - United States, Georgia ... More >> Novo Nordisk Investigational Site Atlanta, Georgia, United States, 30318 Less <<
NCT01110005 Ketosis Not Applicable Completed - United States, Pennsylvania ... More >> Lehigh Valley Hospital Allentown, Pennsylvania, United States, 17901 St. Luke Hospital Bethlehem, Pennsylvania, United States, 18015 The Penn State University Hershey, Pennsylvania, United States, 17033 The Reading Hospital and Medical Center Reading, Pennsylvania, United States, 19611 Less <<
NCT01110005 - Completed - -
NCT01341028 Morbid Obesity Not Applicable Completed - Greece ... More >> University Hospital of Patras Rion, Achaia, Greece, 26500 Less <<
NCT02033889 - Completed - -
NCT02764957 Metabolic Syndrome Phase 2 Phase 3 Completed - Iran, Islamic Republic of ... More >> NNFTRI clinic Tehran, Iran, Islamic Republic of, 19435 Less <<
NCT00179777 Diabetes Mellitus, Type 1 Not Applicable Active, not recruiting September 2017 United States, Pennsylvania ... More >> University of Pittsburgh Pittsburgh, Pennsylvania, United States, 15213-2583 Australia, New South Wales Children's Hospital at Westmead Westmead, New South Wales, Australia, 2145 Canada Robarts Research Institute London, Canada, N6A 5K8 Czechia 3rd Faculty of Medicine, Charles University, University Hospital Vinohrady Prague, Czechia, 10 Estonia Tartu University Children's Hospital Tartu, Estonia, 51014 Finland University of Helsinki Helsinki, Finland, 00029HUS Germany Kinderkrankenhaus auf der Bult Hannover, Germany, 30173 Hungary Semmelweis Medical University Budapest, Hungary, 1083 Italy St. Michele Hospital Cagliari, Sardinia, Italy, 09134 University Campus Bio-Medico of Rome Rome, Italy, 00155 Luxembourg Centre Hospitalier de Luxembourg Luxembourg, Luxembourg, 1210 Netherlands Sophia Children's Hospital Rotterdam, Netherlands, 3015 GJ Poland Medical University of Wroclaw Wroclaw, Poland, 50-376 Spain Hospital de Cruces Barakaldo, Vizcaya, Spain, 48903 Hospital Clinico San Carlos Madrid, Spain, 28040 Sweden University of Linkoping Linkoping, Sweden, S-58185 Switzerland University Children's Hospital Zurich, Switzerland, CH-8032 Less <<
NCT02412774 Type 2 Diabetes ... More >> Overweight Obese Less << Not Applicable Completed - Iran, Islamic Republic of ... More >> NovinDiet Clinic Tehran, Iran, Islamic Republic of, 1913635136 Less <<
NCT02466165 Multiple Sclerosis ... More >> Healthy Controls Less << Not Applicable Completed - Belgium ... More >> REVAL Diepenbeek, Belgium, 3590 Jessa hospital Hasselt, Belgium, 3500 Less <<
NCT01564485 Diabetes Meta... More >>bolic Syndrome Less << Not Applicable Completed - United States, California ... More >> University of California, Irvine Medical Center Orange, California, United States, 92868 Less <<
NCT00425919 Diabetes Mellitus Phase 2 Terminated(Study terminated as... More >> a result of interim analysis not meeting predetermined criteria.) Less << - -
NCT03576534 Congenital Heart Disease Not Applicable Not yet recruiting December 2019 -
NCT03556410 Obesity Not Applicable Recruiting December 2019 United States, Missouri ... More >> University of Missouri Recruiting Columbia, Missouri, United States, 65211 Contact: Jill Kanaley, PhD    573-882-2519    kanaleyj@missouri.edu    Principal Investigator: Jill kanaley, PhD Less <<
NCT00280046 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - Russian Federation ... More >> Novo Nordisk Investigational Site Arkhangelsk, Russian Federation, 163045 Novo Nordisk Investigational Site Belgorod, Russian Federation, 308007 Novo Nordisk Investigational Site Ekaterinburg, Russian Federation, 620102 Novo Nordisk Investigational Site Kazan, Russian Federation, 420064 Novo Nordisk Investigational Site Khabarovsk, Russian Federation, 680067 Novo Nordisk Investigational Site Nizhniy Novgorod, Russian Federation, 603126 Novo Nordisk Investigational Site Novosibirsk, Russian Federation, 630090 Novo Nordisk Investigational Site Omsk, Russian Federation, 644070 Novo Nordisk Investigational Site Saint-Petersburg, Russian Federation, 194291 Novo Nordisk Investigational Site Vladivostok, Russian Federation, 690105 Novo Nordisk Investigational Site Voronezh, Russian Federation, 394053 Less <<
NCT01984567 Oxidative Stress Not Applicable Unknown January 2014 Netherlands ... More >> Maastricht University Medical Centre Maastricht, Limburg, Netherlands, 6229 ER Less <<
NCT03572296 Postprandial Period Not Applicable Recruiting April 2019 United Kingdom ... More >> Metabolic Research Unit Recruiting London, United Kingdom, SE1 9NH Contact: Wendy L Hall, PhD    +44 20 7848 ext 4197    wendy.hall@kcl.ac.uk    Contact: Ana M Pinto, PhD    +44 20 7848 ext 4345    ana_margarida.pinto@kcl.ac.uk Less <<
NCT03272074 Diabetes Mellitus, Type 2 ... More >> Obesity Pre Diabetes Less << Not Applicable Completed - United States, Florida ... More >> Florida State University Tallahassee, Florida, United States, 32306 Less <<
NCT01133730 Upper Limb Surgery ... More >> Iliac Crest Bone Harvest Less << Not Applicable Completed - Canada, Ontario ... More >> Toronto Western Hospital Toronto, Ontario, Canada, M5T 2S8 Less <<
NCT03547960 Gestational Diabetes Not Applicable Recruiting August 2019 United Kingdom ... More >> Imperial College NHS Trust Recruiting London, United Kingdom, W12 0NN Contact: Anne Dornhorst, PhD    020 3313 3380    a.dornhorst@imperial.ac.uk    Contact: Lilian Mendoza, MD    07483212333    l.mendoza-mathison@imperial.ac.uk Less <<
NCT00060918 Hypertension Phase 4 Completed - -
NCT01269034 Type 1 Diabetes Phase 4 Recruiting June 2019 United States, New York ... More >> Albert Einstein CRC- West Campus Recruiting Bronx, New York, United States, 10467 Sub-Investigator: Mariam Gangat, MD          Principal Investigator: Rubina A Heptulla, MD Less <<
NCT02637570 Healthy Not Applicable Completed - Iran, Islamic Republic of ... More >> male sports club members of Isfahan university of medical sciences Isfahan, Iran, Islamic Republic of Less <<
NCT00462046 Diabetes Mellitus, Type 2 ... More >> Metabolic Syndrome Less << Phase 3 Completed - -
NCT02637115 Metabolic Syndrome x ... More >> Glucose Metabolism Disorders Dyslipidemias Obesity Less << Not Applicable Completed - Belgium ... More >> Cliniques universitaires Saint-Luc Brussels, Belgium, 1200 Less <<
NCT02443532 Diabetes Mellitus, Type 1 Not Applicable Terminated(Insufficient recrui... More >>tment) Less << - -
NCT02915211 Intractable Epilepsy ... More >> Glucose Transporter Type 1 Deficiency Syndrome Ketogenic Dieting Less << Not Applicable Completed - United Kingdom ... More >> Central Manchester University Hospitals NHS Foundation Trust Manchester, Greater Manchester, United Kingdom, M13 9WL Leeds Teaching Hospitals NHS Trust Leeds, West Yorkshire, United Kingdom, LS1 3EX Less <<
NCT03658512 - Recruiting February 1, 2028 Germany ... More >> University of Tuebingen, Internal medicine IV Recruiting Tuebingen, Germany, 72074 Contact: Andreas Fritsch, Prof, MD    +49 7071 29 ext 82711    andreas.fritsche@med.uni-tuebingen.de    Principal Investigator: Andreas Fritsche, MD Less <<
NCT03656250 - Recruiting November 2018 United States, New York ... More >> New York University School of Medicine Recruiting New York, New York, United States, 10016 Contact: Nadia Maknoun    212-263-2717    nadia.maknoun@nyumc.org    Principal Investigator: Sungheon Kim, MD Less <<
NCT02056249 - Completed - United States, Connecticut ... More >> PET Center, YCCI Hospital Research Unit (HRU) New Haven, Connecticut, United States, 06519 Less <<
NCT02653092 Obesity Infer... More >>tility Hypogonadotropic Hypogonadotropism Hyperinsulinemia Less << Not Applicable Recruiting March 2020 United States, Colorado ... More >> University of Colorado Denver Recruiting Aurora, Colorado, United States, 80045 Contact: Chanel Mansfield    303-724-6501    chanel.mansfield@ucdenver.edu    Principal Investigator: Nanette Santoro, MD Less <<
NCT01718418 Obesity Metab... More >>olic Syndrome Less << Early Phase 1 Completed - Sweden ... More >> Applied Nutrition and Food Chemistry, Lund University Lund, Sweden, SE-221 00 Less <<
NCT02634216 Type I Diabetes Not Applicable Active, not recruiting November 2019 United States, Ohio ... More >> Carepoint East 543 Taylor Ave. Columbus, Ohio, United States, 43203 Martha Morehouse Medical Plaza 2050 Kenny Road Columbus, Ohio, United States, 43210 Davis Heart and Lung Research Institute Columbus, Ohio, United States, 43212 Less <<
NCT03039829 Nutritional Supplements Not Applicable Completed - -
NCT03237975 Diabetes Mellitus, Type 2 ... More >> Sense of Coherence Self Care Strengths-based Intervention Less << Not Applicable Active, not recruiting October 2017 China, Hunan ... More >> He Xinyuan Community Health Care Center Changsha, Hunan, China, 410000 Yannong Neighborhood Health Care Clinics Changsha, Hunan, China, 410000 Less <<
NCT01811732 Skin and Subcutaneous Tissue B... More >>acterial Infections Less << Phase 3 Completed - -
NCT01842282 Diabetes Mellitus Type 2 ... More >> Non Alcoholic Fatty Liver Disease Obesity Less << Phase 2 Active, not recruiting December 2019 United States, Michigan ... More >> University of Michigan Ann Arbor, Michigan, United States, 48109 Less <<
NCT01811732 - Completed - -
NCT01045707 - Completed - -
NCT03227484 PreDiabetes B... More >>ody Weight Less << Phase 2 Recruiting October 2019 Germany ... More >> University of Tuebingen, Department of Internal Medicine IV Recruiting Tübingen, Germany, 72076 Contact: Martin Heni, MD    +49 7071 29 82714    martin.heni@med.uni-tuebingen.de    Contact: Andreas Fritsche, MD    +49 7071 29 82714    andreas.fritsche@med.uni-tuebingen.de Less <<
NCT00975286 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT01045707 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT02957721 Type 2 Diabetes (T2D) Not Applicable Completed - United States, Virginia ... More >> Virginia Commonwealth University Richmond, Virginia, United States, 23298 Less <<
NCT01724060 - Unknown October 2018 United Kingdom ... More >> Royal Surrey County Hospital Active, not recruiting Guildford, United Kingdom Imperial Weight Centre Recruiting London, United Kingdom Contact: Alexander Miras, MRCP BSc       a.miras@nhs.net Less <<
NCT00166491 Critical Illness ... More >> Hyperglycemia Less << Not Applicable Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT02164032 Healthy Subjects Phase 2 Unknown December 2016 Austria ... More >> Medical University Of Vienna, Department of Internal Medicine III Vienna, Austria, 1090 Less <<
NCT00975286 - Completed - -
NCT03396302 Obesity Hyper... More >>tension Less << Not Applicable Enrolling by invitation March 22, 2019 Spain ... More >> JF Lisón Alfara del Patriarca, Valencia, Spain, 46113 Less <<
NCT00494767 Diabetes Mellitus, Type 2 ... More >> Obesity Less << Phase 1 Completed - United Kingdom ... More >> GSK Investigational Site Cambridge, Cambridgeshire, United Kingdom, CB2 2GG Less <<
NCT03527537 Gestational Diabetes Phase 4 Not yet recruiting June 1, 2028 United States, Wisconsin ... More >> Medical College of Wisconsin Not yet recruiting Milwaukee, Wisconsin, United States, 53226 Less <<
NCT00187681 - Completed - -
NCT02389114 Obesity Satie... More >>ty Diabetes Less << Not Applicable Completed - -
NCT00276497 Diabetes Phase 1 Completed - -
NCT03286751 Diabetes Mellitus, Type 2 Phase 1 Completed - Germany ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician. Mainz, Germany, 55116 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician. Neuss, Germany, 41460 Less <<
NCT00743301 Cardiovascular Disease ... More >> Metabolic Syndrome Less << Not Applicable Unknown December 2009 Denmark ... More >> Department of Human Nutrition Recruiting Frederiksberg, Denmark, 1958 Contact: Marianne Raff, PhD    +4535332533    mrf@life.ku.dk Less <<
NCT00187681 Other Conditions That May Be A... More >> Focus of Clinical Attention Less << Phase 4 Completed - United States, California ... More >> San Francisco General Hospital San Francsico, California, United States, 94143 Less <<
NCT03049306 Obstructive Sleep Apnea Phase 2 Enrolling by invitation January 1, 2023 United States, Maryland ... More >> Johns Hopkins Bayview Medical Center Baltimore, Maryland, United States, 21224 Less <<
NCT00984737 Diabetes Mellitus ... More >> Hyperglycemia Blood Glucose Myocardial Ischemia Less << Not Applicable Completed - Turkey ... More >> Baskent University Faculty of Medicine, Adana Medical Center Adana, Turkey, 01250 Less <<
NCT03594994 Insulin Resistance ... More >> Obesity Less << Not Applicable Not yet recruiting July 2023 -
NCT02858648 Diabetes Not Applicable Completed - United States, Texas ... More >> The University of Texas Health Science Center at Houston Houston, Texas, United States, 77030 Less <<
NCT01877265 - Completed - -
NCT00942318 Type 2 Diabetes Mellitus Phase 4 Completed - France ... More >> University Hospital Toulouse Toulouse, France, 31059 Less <<
NCT02604446 Joint Diseases Phase 3 Recruiting January 2021 Norway ... More >> Anestesiavdelingen, St Olavs Hospital Recruiting Trondheim, Norway Contact: Thorbjørn Rian, md       Torbjorn.Rian@stolav.no Less <<
NCT01877265 Healthy Volunteers Phase 1 Completed - United States, Texas ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Dallas, Texas, United States, 75247 Less <<
NCT02542722 Diabetes Mellitus, Type 2 Not Applicable Completed - -
NCT00638313 Diabetes Mellitus, Type 2 Phase 1 Completed - United States, Arizona ... More >> Pfizer Investigational Site Phoenix, Arizona, United States, 85013 United States, Texas Pfizer Investigational Site San Antonio, Texas, United States, 78229 Less <<
NCT00928876 Diabetes Mellitus, Type 2 ... More >> Insulin Resistance Less << Phase 2 Unknown July 2010 Netherlands ... More >> Rabdoud University Nijmegen Medical Centre Nijmegen, Netherlands, 6500 HB Less <<
NCT01388153 Diabetes Mellitus, Type 2 Phase 1 Completed - Germany ... More >> Mönchengladbach, Nordrhein-Westfalen, Germany, 41061 Less <<
NCT01474083 Type 2 Diabetes Mellitus Phase 1 Phase 2 Completed - United States, Arkansas ... More >> Forest Investigative Site 009 Little Rock, Arkansas, United States, 72211 United States, California Forest Investigative Site 006 Chula Vista, California, United States, 91911 United States, Florida Forest Investigative Site 002 Deland, Florida, United States, 32720 Forest Investigative Site 001 Miami, Florida, United States, 33014 United States, Kansas Forest Investigative Site 010 Overland Park, Kansas, United States, 66212 United States, Minnesota Forest Investigative site 011 St. Paul, Minnesota, United States, 55114 United States, Missouri Forest Investigative Site 005 Springfield, Missouri, United States, 65802 United States, New Jersey Forest Investigative Site 003 Neptune, New Jersey, United States, 07753 Forest Investigative Site 008 Willingboro, New Jersey, United States, 08046 United States, New York Forest Investigative Site 007 New York, New York, United States, 10029 United States, Texas Forest Investigative Site 004 San Antonio,, Texas, United States, 78209 Less <<
NCT01526980 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 2 Completed - United Kingdom ... More >> Novo Nordisk Investigational Site Newcastle, United Kingdom Less <<
NCT03754036 Sleep Not Applicable Not yet recruiting June 2020 Canada, Ontario ... More >> Children's Hospital of Eastern Ontario Research Institute Ottawa, Ontario, Canada, K1H 8L1 Less <<
NCT02796950 Diabetes Mellitus Type 2 Not Applicable Completed - Denmark ... More >> University Hospital of Aarhus Aarhus, Denmark, 8000 Less <<
NCT01256970 - Completed - Taiwan ... More >> Taipei Medical University-WanFang Hospital Taipei, Taiwan Less <<
NCT00286455 Diabetes Mellitus Phase 3 Completed - -
NCT00236626 Obesity Diabe... More >>tes Mellitus, Type 2 Diabetes Mellitus, Adult-Onset Less << Phase 2 Completed - -
NCT00205504 - Completed - -
NCT00205504 Metabolic Syndrome X ... More >> Insulin Resistance Obesity Cardiovascular Diseases Less << Phase 4 Completed - United States, Virginia ... More >> Virginia Commonwealth University General Clinical Research Center Richmond, Virginia, United States, 23298 Less <<
NCT01285791 - Completed - Israel ... More >> Hadassah Medical Organization Jerusalem, Israel, 91120 Less <<
NCT01285791 - Completed - -
NCT00781534 Diabetes Early Phase 1 Completed - United States, Missouri ... More >> Washington University School of Medicine St. Louis, Missouri, United States, 63110 Less <<
NCT03039933 Type1diabetes ... More >> Fear of Hypoglycemia Less << Not Applicable Recruiting July 2019 United States, Colorado ... More >> University of Colorado, Denver Recruiting Aurora, Colorado, United States, 80045 Contact: Kimberly Driscoll, PhD    303-724-9910    kimberly.driscoll@ucdenver.edu Less <<
NCT00286455 - Completed - -
NCT01774149 Diabetes Mellitus, Type 1 Not Applicable Completed - Norway ... More >> University Hopital of North Norway Tromsø, Norway, 9038 Less <<
NCT00493935 - Completed - United States, California ... More >> Division of Pediatric Endocrinology and Diabetes, Stanford University Stanford, California, United States, 94305-5208 United States, Colorado Barbara Davis Center for Childhood Diabetes, University of Colorado Aurora, Colorado, United States, 80010 United States, Connecticut Department of Pediatrics, Yale University School of Medicine New Haven, Connecticut, United States, 06519 United States, Florida Nemours Children's Clinic Jacksonville, Florida, United States, 32207 Jaeb Center for Health Research Tampa, Florida, United States, 33647 United States, Iowa Department of Pediatrics, University of Iowa Carver College of Medicine Iowa City, Iowa, United States, 52242 Less <<
NCT01398722 Cardiac Surgery Phase 2 Unknown July 2012 China, Shaanxi ... More >> Xijing Hospital Not yet recruiting Xi'an, Shaanxi, China, 710032 Contact: Chunhu Gu, MD       guchunhu@fmmu.edu.cn    Principal Investigator: Chunhu Gu, MD          Principal Investigator: Yukun Cao, MD Less <<
NCT01774149 - Completed - -
NCT01637727 - Unknown - Israel ... More >> Shaare Zedek Medical Center Not yet recruiting Jerusalem, Israel Sub-Investigator: ORIT LAMM, MD Less <<
NCT03119597 Depression Not Applicable Active, not recruiting December 22, 2018 United Kingdom ... More >> University of Reading Reading, Berkshire, United Kingdom, RG6 6AL Less <<
NCT02403284 Insulin Resistance Phase 4 Active, not recruiting December 2018 United States, Arizona ... More >> Carl T. Hayden VA Medical Hospital Phoenix, Arizona, United States, 85012 Less <<
NCT01223196 Type 2 Diabetes Phase 4 Completed - United States, Texas ... More >> Bartter Research Unit , ALM VA Hospital San Antonio, Texas, United States, 78229 Less <<
NCT00099515 Diabetes Mellitus, Type 2 Phase 2 Completed - United States, Florida ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Clearwater, Florida, United States United States, New York For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Buffalo, New York, United States For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. New Hyde Park, New York, United States Argentina For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sante Fe, Rosario, Argentina Portugal For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Norway, Portugal South Africa For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. George, South Africa Less <<
NCT01076075 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT00813930 Diabetes Mellitus, Type 2 Not Applicable Unknown July 2010 Canada, Ontario ... More >> St. Michael's Hospital Toronto, Ontario, Canada, M5B 1W8 University Health Network, Toronto Western Hospital Toronto, Ontario, Canada, M5T 2S8 St. Joseph's Health Centre Toronto, Ontario, Canada, M6R 1B5 Less <<
NCT02088827 Sedentary Lifestyle ... More >> Type 2 Diabetes Less << Not Applicable Recruiting September 2019 Canada, British Columbia ... More >> Gerontology Research Lab Recruiting Vancouver, British Columbia, Canada, V5Z 1M9 Contact: Boris Feldman    604-875-5115    boris.feldman@vch.ca    Principal Investigator: Kenneth M Madden, MSc, MD          Sub-Investigator: Marisa Wan, MD Less <<
NCT01223196 - Completed - -
NCT01076075 - Completed - -
NCT03550365 Intestinal Disorder ... More >> Glucose Metabolism Disorders Inflammation Less << Not Applicable Completed - -
NCT02439684 - Completed - Hong Kong ... More >> Tsan Yuk Hospital RAMP Clinic Hong Kong, Hong Kong, 852 Ap Lei Chau General Out-patient Clinic Hong Kong, Hong Kong Lek Yuen General Out-patient Clinic Hong Kong, Hong Kong Less <<
NCT03229044 - Completed - -
NCT01566266 Hypercholesterolemia Not Applicable Completed - Netherlands ... More >> Maastricht University Medical Center Maastricht, Limburg, Netherlands Less <<
NCT01170468 Type 2 Diabetes Mellitus Phase 3 Terminated(inadequate enrollem... More >>ent) Less << - Saudi Arabia ... More >> King Faisal Specialist Hospital & Research Center Riyadh, Saudi Arabia, 11211 Less <<
NCT03248219 - Completed - United States, Colorado ... More >> University of Colorado Anschutz Medical Campus Aurora, Colorado, United States, 80045 Less <<
NCT00351234 - Completed - United States, Missouri ... More >> The Children's Mercy Hospital Kansas City, Missouri, United States, 64108 Less <<
NCT00886366 Type 2 Diabetes Phase 1 Terminated(Part A reached a pr... More >>edefined stopping criteria. Relevant doses for part B could not be established based on A and subsequently study was stopped.) Less << - Sweden ... More >> Research Site Goteborg, Sweden Less <<
NCT03053284 Congenital Hyperinsulinism ... More >> Insulinoma Hyperinsulinism Less << Phase 2 Withdrawn(Funding was withdraw... More >>n by Sponsor prior to start of study) Less << April 2018 -
NCT01511016 HIV Lipodystrophy Not Applicable Completed - United States, Texas ... More >> Baylor College of Medicine Houston, Texas, United States, 77030 Less <<
NCT01798706 Type 2 Diabetes Phase 3 Completed - -
NCT01798706 - Completed - -
NCT00410722 Type 2 Diabetes ... More >> Cardiovascular Disease Diet Therapy Less << Phase 2 Unknown - Canada, Ontario ... More >> St. Michael's Hospital Toronto, Ontario, Canada, M5C 2T2 Less <<
NCT02616159 Glycemic Response Not Applicable Completed - Canada ... More >> Glycemic Index Laboratories Toronto, Canada Less <<
NCT01511016 - Completed - -
NCT03232983 Diabetes Mellitus, Type 2 Phase 1 Completed - Singapore ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician. Singapore, Singapore, 117597 Less <<
NCT03346746 Cognitive Performance ... More >> Glucose, Low Blood Glucose, High Blood Mood Less << Not Applicable Completed - United Kingdom ... More >> University of Reading Reading, Berkshire, United Kingdom, RG6 6AL Less <<
NCT02385149 Healthy Metab... More >>olism Less << Not Applicable Completed - Netherlands ... More >> Wageningen Universiteit Division of Human Nutrition Wageningen, Gelderland, Netherlands, 6703HD Less <<
NCT03249506 - Completed - United States, Pennsylvania ... More >> Health ResearchTx, LLC Trevose, Pennsylvania, United States, 19053 Less <<
NCT02569060 Diabetes Mellitus Not Applicable Completed - United States, California ... More >> Alameda County Community Food Bank Oakland, California, United States, 94614 University of California San Francisco San Francisco, California, United States, 94143 United States, Michigan Gleaners Community Food Bank of Southeastern Michigan Detroit, Michigan, United States, 48207 United States, Texas Houston Food Bank Houston, Texas, United States, 77029 Less <<
NCT02613897 Diabetes Mellitus, Type 2 Not Applicable Completed - United States, Texas ... More >> The University of Texas Health Science Center at San Antonio San Antonio, Texas, United States, 78229 Less <<
NCT00957008 Body Weight Changes ... More >> Overweight Less << Not Applicable Completed - United States, South Carolina ... More >> University of South Carolina Department of Exercise Science Columbia, South Carolina, United States, 29208 Less <<
NCT00957008 - Completed - -
NCT01595789 Coronary Artery Disease ... More >> Diabetes Mellitus, Type 2 Less << Phase 4 Completed - Denmark ... More >> Copenhagen University Hospital, Bispebjerg Copenhagen, Bispebjerg, Denmark, 2400 Less <<
NCT03189407 Type 2 Diabetes Mellitus Not Applicable Completed - -
NCT01002768 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 1 Completed - Austria ... More >> Novo Nordisk Investigational Site Graz, Austria, 8010 Less <<
NCT02303405 Diabetes Mellitus Type 2 With ... More >>Hyperglycemia Less << Phase 2 Terminated(Investigator decisi... More >>on) Less << - United States, California ... More >> Charles Drew University of Medicine and Science Los Angeles, California, United States, 90059 Less <<
NCT01800253 Sleep Deprivation ... More >> Sleep Less << Not Applicable Completed - Sweden ... More >> Department of Neuroscience, Uppsala University Uppsala, Sweden, 75324 Less <<
NCT03436875 - Recruiting December 30, 2020 United States, Texas ... More >> University of Texas Rio Grande Valley - Cardiometabolic Exercise Lab Recruiting Brownsville, Texas, United States, 78520 Contact: Ryan D Russell, PhD    956-882-6509    ryan.russell@utrgv.edu Less <<
NCT03229408 Polycystic Ovary Syndrome Phase 2 Not yet recruiting August 31, 2022 -
NCT01887964 Metabolic Syndrome Not Applicable Completed - United States, South Dakota ... More >> South Dakota State University Brookings, South Dakota, United States, 57007 Less <<
NCT03410719 Insulin Sensitivity Not Applicable Recruiting June 30, 2019 United States, Indiana ... More >> Purdue University Recruiting West Lafayette, Indiana, United States, 47907 Contact: Wayne Campbell    765-494-8236    campbellw@purdue.edu    Contact: Janet Green    765-496-6342    jkgreen@purdue.edu    Principal Investigator: Gabriele Riccardi (Federico II University, Naples, Italy), M.D.          Principal Investigator: Rikard Landberg (University of Agriculture Science, Uppsala, Sweden ), Ph.D Less <<
NCT03044639 Liver Failure Phase 4 Completed - Poland ... More >> Stanley Dudrick's Memorial Hospital Skawina, Poland, 32-050 Less <<
NCT03032640 Obesity Not Applicable Active, not recruiting December 2019 United States, Florida ... More >> Florida Hospital Translational Research Institute for Metabolism and Diabetes Orlando, Florida, United States, 32804 Less <<
NCT02810691 Cystic Fibrosis-related Diabet... More >>es Cystic Fibrosis Less << Not Applicable Completed - Canada, Quebec ... More >> Institut de recherches cliniques de Montréal Montréal, Quebec, Canada, H2W 1R7 Less <<
NCT01165944 Diabetes Mellitus Phase 1 Phase 2 Withdrawn August 2011 United States, Colorado ... More >> University of Colorado Denver Aurora, Colorado, United States, 80045 Less <<
NCT03524469 - Recruiting November 1, 2021 United States, New York ... More >> Clinical Research Center of the University of Rochester Medical Center Recruiting Rochester, New York, United States, 14642 Contact: Ann Miller    585-275-2907    ann_miller@urmc.rochester.edu Less <<
NCT00279305 Type 1 Diabetes Mellitus Phase 2 Completed - United States, California ... More >> Childrens Hospital of Los Angeles Los Angeles, California, United States, 90027 University of California-San Francisco San Francisco, California, United States, 94143 Stanford University Stanford, California, United States, 94305 United States, Colorado Barbara Davis Center for Childhood Diabetes Aurora, Colorado, United States, 80010 United States, Florida University of Florida Gainesville, Florida, United States, 32610-0296 University of Miami Miami, Florida, United States, 33136 United States, Indiana Indiana University-Riley Hospital for Children Indianapolis, Indiana, United States, 46202 United States, Massachusetts Joslin Boston, Massachusetts, United States, 02215 United States, Minnesota University of Minnesota Minneapolis, Minnesota, United States, 55455 United States, New York Columbia University New York, New York, United States, 10032 United States, Pennsylvania University of Pittsburgh Pittsburgh, Pennsylvania, United States, 15213 United States, Texas University of Texas Dallas, Texas, United States, 75235-8858 United States, Washington Benaroya Research Institute Seattle, Washington, United States, 98101 Australia Walter and Eliza Hall Institute of Medical Research Victoria, Australia Canada, Ontario The Hospital for Sick Children Toronto, Ontario, Canada, M5G 1X8 Italy San Raffaele Hospital Milan, Italy Less <<
NCT03574064 Healthy Not Applicable Recruiting December 1, 2018 Denmark ... More >> Hvidovre University Hospital Recruiting Hvidovre, Denmark, 2650 Contact: Kirsa Skov-Jeppesen       kirsa@sund.ku.dk    Contact: Sten Madsbad Less <<
NCT01516320 Type 2 Diabetes Not Applicable Completed - United States, New York ... More >> New York Obesity Nutrition Research Center, St. Luke's-Roosevelt Hospital Center New York, New York, United States, 10025 Less <<
NCT00893451 Chronic Kidney Disease ... More >> Insulin Resistance Vitamin D Deficiency Less << Not Applicable Completed - Sweden ... More >> Department of Kidney diseases, Sahlgrenska University Hospital Gothenburg, Sweden, 41345 Less <<
NCT01720524 Pulmonary Hypertension, Famili... More >>al Persistent, of the Newborn Less << Phase 3 Recruiting December 31, 2020 -
NCT03660748 Obesity Early Phase 1 Recruiting September 1, 2019 Canada, Ontario ... More >> GI Labs Recruiting Toronto, Ontario, Canada, M5C2N8 Contact: Adish Ezatagha, MSc    416 861-9782 ext 208    aezatagha@gilabs.com    Contact: Alexandra L Jenkins, PhD / RN    416 861-9782 ext 200    alexandrajenkins@gilabs.com Less <<
NCT03187951 Other Disorders of Glucose Reg... More >>ulation and Pancreatic Internal Secretion Pancreatic Cancer Less << Not Applicable Recruiting December 31, 2022 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Clinical Research Operations       CR_Study_Registration@mdanderson.org Less <<
NCT03182907 Clostridium Difficile Infectio... More >>n Less << Phase 3 Recruiting May 9, 2022 -
NCT02222623 Diabetes, Type 2 Not Applicable Withdrawn(No participants enro... More >>lled) Less << - United States, Virginia ... More >> Inova Fairfax Hospital Falls Church, Virginia, United States, 22042 Less <<
NCT02122380 Polycystic Ovary Syndrome Phase 4 Active, not recruiting July 1, 2019 United States, Tennessee ... More >> Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232 Less <<
NCT01494987 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT01784289 - Completed - France ... More >> Amiens University Hospital Amiens, France, 80054 Caen University Hospital Caen, France, 14032 Lille University Hospital Lille, France, 59037 Reims University Hospital Reims, France, 51092 Rouen University Hospital Rouen, France, 76031 Less <<
NCT01494987 - Completed - -
NCT01058681 Neuroendocrine Reproductive St... More >>atus Less << Not Applicable Completed - Switzerland ... More >> CHUVaudois Lausanne, Switzerland, 1011 Less <<
NCT03663738 Type 2 Diabetes Mellitus Not Applicable Active, not recruiting December 2018 Spain ... More >> Servicio de Evaluación. Servicio Canario de Salud Santa Cruz de Tenerife, Spain, 38004 Less <<
NCT01002339 Diabetes Mellitus, Adult-Onset Phase 4 Terminated(Terminated higher r... More >>ate of acute rejection in the Cyclosporin A group) Less << - Spain ... More >> Antonio Osuna Granada, Andalucía, Spain, 18014 Domingo Hernández Málaga, Andalucía, Spain, 29010 Carmen Díaz Corte Oviedo, Asturias, Spain, 33006 Carlos Gómez Alamillo Santander, Cantabria, Spain, 39008 Juan Manuel Díaz Barcelona, Cataluña, Spain, 08025 Francisco Moreso Barcelona, Cataluña, Spain, 08035 Francisco Valdés La Coruña, Galicia, Spain, 15006 Armando Torres Ramírez La Laguna, S/C de Tenerife, Spain, 38320 Roberto Gallego Las Palmas de Gran Canaria, Spain, 35010 Luis Pallardo Valencia, Spain, 46017 Less <<
NCT00279305 - Completed - -
NCT00511732 Type 2 Diabetes Mellitus Phase 2 Completed - -
NCT01002339 - Terminated(Terminated higher r... More >>ate of acute rejection in the Cyclosporin A group) Less << - -
NCT00110851 Type 2 Diabetes Mellitus Phase 2 Completed - United States, Connecticut ... More >> Phoenix Internal Medicine Associates Waterbury, Connecticut, United States, 06708 United States, Florida University Clinical Research-DeLand DeLand, Florida, United States, 32720 Center for Diabetes and Endocrine Care Hollywood, Florida, United States, 33021 Genesis Research International Longwood, Florida, United States, 32779 Baptist Diabetes Associates Miami, Florida, United States, 33156 Andres Patron, DO PA Pembroke Pines, Florida, United States, 33028 CLIRECO, Inc. Tamarac, Florida, United States, 33321 Endocrine Clinical Research Winter Park, Florida, United States, 32789, United States, Kansas PRN of Kansas Wichita, Kansas, United States, 67203 United States, North Carolina Medical Research Associates of Charlotte Charlotte, North Carolina, United States, 28211 Neem Research Group of Charlotte Charlotte, North Carolina, United States, 28262 Unifour Medical Research Associates Hickory, North Carolina, United States, 28601 Neem Research Group of Raleigh Raleigh, North Carolina, United States, 27609 Piedmont Medical Research Associates Winston-Salem, North Carolina, United States, 27103 United States, Oklahoma COR Clinical Research, LLC Oklahoma City, Oklahoma, United States, 73103 United States, Oregon Clinical Research Institute of Southern Oregon, PC Medford, Oregon, United States, 97504 United States, Pennsylvania Camp Hill Clinical Research Center Camp Hill, Pennsylvania, United States, 17011 United States, South Carolina Neem Research Group Columbia, South Carolina, United States, 29201 Palmetto Medical Research Associates Mt. Pleasant, South Carolina, United States, 29464 United States, Texas Oaks Medical Center Spring, Texas, United States, 77386 Less <<
NCT02174042 General Disorders and Administ... More >>ration Site Conditions Less << Phase 2 Completed - China, Guizhou ... More >> Nanmeng Tianyuan hospital; Dongfang Hospital; China-Japanese Friendship Hospital Beijing Shi, Guizhou, China, 510000 Less <<
NCT01404676 Type 2 Diabetes Mellitus Phase 4 Completed - Korea, Republic of ... More >> Division of Endocrinology and Metabolism, Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine Seoul, Korea, Republic of, 135-710 Less <<
NCT02134522 Non Alcoholic Fatty Liver Dise... More >>ase Less << Not Applicable Terminated(We were not able to... More >> recruit participants.) Less << - United States, Connecticut ... More >> Yale University New Haven, Connecticut, United States, 06520 Less <<
NCT02134522 - Terminated(We were not able to... More >> recruit participants.) Less << - -
NCT00108329 Metabolic Syndrome X Not Applicable Completed - United States, Maryland ... More >> VA Maryland Health Care System Baltimore, Maryland, United States, 21201 Less <<
NCT02222350 Type 2 Diabetes Mellitus Phase 2 Completed - Japan ... More >> Heishinkai Medical Group Incorporated OCROM Clinic Kasuga, Osaka, Japan, 565-0853 Less <<
NCT01784965 Pre-diabetes ... More >>Older Adults Less << Phase 3 Completed - -
NCT01077960 Human Immunodeficiency Virus-A... More >>ssociated Adipose Redistribution Syndrome Less << Phase 3 Completed - -
NCT00160485 Gestational Diabetes Phase 4 Withdrawn(Active Duty principl... More >>e investigator currently deployed) Less << June 2010 United States, Hawaii ... More >> Tripler Army Medical Center Honolulu, Hawaii, United States, 97859 Less <<
NCT02448667 Glycogen Storage Disease Type ... More >>III Less << Not Applicable Recruiting February 2018 Denmark ... More >> Copenhagen Neuromuscular Center, department 3342, Rigshospitalet Recruiting Copenhagen, Region hovedstaden, Denmark, 2100 Contact: Astrid E Buch, MD    +45 35 45 61 35    astrid.emilie.buch.02@regionh.dk    Contact: Nicolai Preisler, MD    +45 35 45 61 26    nicolai.preisler@regionh.dk Less <<
NCT03103126 Diabetes Mellitus, Type 2 Not Applicable Not yet recruiting August 2019 United Kingdom ... More >> Andrew Scott Portsmouth, Hampshire, United Kingdom, PO1 2ER Less <<
NCT01784965 - Completed - -
NCT02230488 Diabetes Not Applicable Terminated(Unable to enroll du... More >>e to protocol exclusion criteria and participant population pool) Less << - United States, Missouri ... More >> Barnes-Jewish Hospital St. Louis, Missouri, United States, 63110 Less <<
NCT01292590 Type 1 Diabetes Not Applicable Completed - United States, Massachusetts ... More >> Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Less <<
NCT01077960 - Completed - -
NCT01679210 Diabetes Not Applicable Completed - United States, Massachusetts ... More >> Baystate Medical Center Springfield, Massachusetts, United States, 01199 Univeristy of Massachesetts Medical School Worcester, Massachusetts, United States, 01655 Less <<
NCT01157923 Type 1 Diabetes ... More >> Insulin Pump Therapy Less << Not Applicable Completed - Israel ... More >> Schneider Children's Medical center Petaach-Tikva, Israel, 49202 Slovenia University Children's Hospital Ljubljana, Slovenia Less <<
NCT03254979 Interprofessional Relations ... More >> Primary Health Care/Organization & Administration Diabetes Mellitus, Type 2/Prevention & Control Primary Prevention/Methods Risk Reduction Behavior Randomized Controlled Trial Life Style Less << Not Applicable Active, not recruiting December 30, 2019 Spain ... More >> Primary Care Research Unit of Bizkaia, OSAKIDETZA Bilbao, Spain Less <<
NCT01240785 - Completed - -
NCT00813280 - Completed - United States, Minnesota ... More >> Park Nicollet Methodist Hospital Minneapolis, Minnesota, United States, 55416 Less <<
NCT01535612 Type 2 Diabetes Mellitus Not Applicable Completed - Austria ... More >> Medical University of Graz Graz, Austria, A-8036 Less <<
NCT01739283 Hypoglycemia Not Applicable Completed - Denmark ... More >> Gentofte Hospital Hellerup, Denmark, 2900 Less <<
NCT01511172 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 2 Completed - -
NCT01240785 Gestational Diabetes Phase 4 Completed - -
NCT01413217 - Completed - United States, Louisiana ... More >> Pennington Biomedical Research Center Baton Rouge, Louisiana, United States, 70808 Less <<
NCT02010541 - Unknown May 2014 Slovenia ... More >> Dept. of Pediatric Endocrinology, Diabetes & Metabolism, University Children's Hospital, UMCL Ljubljana, Slovenia, 1000 Less <<
NCT03529123 Type 2 Diabetes Mellitus Phase 3 Recruiting August 30, 2019 India ... More >> Investigational Site Number 01 Recruiting Bangalore, India, 560092 Investigational Site Number 012 Recruiting Belgaum, India, 590010 Investigational Site Number 017 Recruiting Coimbatore, India, 641009 Investigational Site Number 06 Recruiting Hyderabad, India, 500063 Investigational Site Number 07 Recruiting Hyderabad, India, 500072 Investigational Site Number 08 Recruiting Jaipur, India Investigational Site Number 04 Recruiting Kolkata, India, 700107 Investigational Site Number 018 Recruiting Lucknow, India Investigational Site Number 014 Recruiting Madurai, India, 625020 Investigational Site Number 05 Recruiting Nasik, India, 422002 Investigational Site Number 010 Recruiting New Delhi, India, 110029 Investigational Site Number 016 Recruiting Pune, India, 411040 Less <<
NCT02185638 Obesity Not Applicable Completed - Denmark ... More >> Department Of Human Nutrition, Faculty of Science, University of Copenhagen Frederiksberg, Denmark, 1958 Less <<
NCT02962921 Diabetes Mellitus ... More >> Ventricular Dysfunction Less << Phase 4 Completed - Israel ... More >> Rambam Medical Center Haifa, Israel Less <<
NCT00554450 Diabetes Mellitus, Type 2 Phase 1 Completed - United States, California ... More >> Advanced Clinical Research Institute Anaheim, California, United States, 92801 United States, Florida Elite Research Institute Miami, Florida, United States, 33169 United States, Minnesota Prism Research St. Paul, Minnesota, United States, 55114 United States, Texas Dgd Research, Inc. San Antonio, Texas, United States, 78229 Less <<
NCT00948545 - Completed - United States, Delaware ... More >> Christiana Care Health Services Newark, Delaware, United States, 19713 Less <<
NCT00763451 Diabetes Mellitus, Type 2 Phase 3 Completed - United States, New Jersey ... More >> Sanofi-Aventis Administrative Office Bridgewater, New Jersey, United States, 08807 Brazil Sanofi-Aventis Administrative Office Sao Paulo, Brazil Chile Sanofi-Aventis Administrative Office Santiago, Chile Colombia Sanofi-Aventis Administrative Office Santafe de Bogota, Colombia Estonia Sanofi-Aventis Administrative Office Tallinn, Estonia Germany Sanofi-Aventis Administrative Office Berlin, Germany Italy Sanofi-Aventis Administrative Office Milano, Italy Lithuania Sanofi-Aventis Administrative Office Vilnius, Lithuania Malaysia Sanofi-Aventis Administrative Office Kuala Lumpur, Malaysia Mexico Sanofi-Aventis Administrative Office Mexico, Mexico Philippines Sanofi-Aventis Administrative Office Makati City, Philippines Poland Sanofi-Aventis Administrative Office Warszawa, Poland Romania Sanofi-Aventis Administrative Office Bucuresti, Romania Slovakia Sanofi-Aventis Administrative Office Brastislava, Slovakia Ukraine Sanofi-Aventis Administrative Office Kiev, Ukraine Less <<
NCT01782105 Excessive Weight Gain During P... More >>regnancy Gestational Diabetes Less << Not Applicable Completed - Canada, Quebec ... More >> Centre Hospitalier Universitaire de Sherbrooke Sherbrooke, Quebec, Canada, J1H5N4 Less <<
NCT02160717 - Completed - United States, Ohio ... More >> Children's Hospital Medical Center, Cincinnati Cincinnati, Ohio, United States, 45229 Less <<
NCT03613805 Diabetes Mellitus, Type 1 Not Applicable Enrolling by invitation December 31, 2018 Italy ... More >> University of Padova Padova, Italy Less <<
NCT00306072 Diabetes Mellitus Phase 1 Phase 2 Completed - United States, Minnesota ... More >> Radiant Research Edina, Minnesota, United States, 55435 United States, Ohio Radiant Research Cincinnati, Ohio, United States, 45236 Less <<
NCT00286429 Diabetes Mellitus Phase 3 Completed - -
NCT00763451 - Completed - -
NCT00600366 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 4 Completed - Former Serbia and Montenegro ... More >> Novo Nordisk Investigational Site Belgrade, Former Serbia and Montenegro, 11000 Novo Nordisk Investigational Site Kragujevac, Former Serbia and Montenegro, 34000 Novo Nordisk Investigational Site Nis, Former Serbia and Montenegro, 18000 Novo Nordisk Investigational Site Novi Sad, Former Serbia and Montenegro, 21000 Less <<
NCT02012166 Type 2 Diabetes Mellitus Phase 1 Completed - -
NCT00286442 Diabetes Mellitus Phase 3 Completed - -
NCT00286468 Diabetes Mellitus Phase 3 Completed - -
NCT00286494 Diabetes Mellitus Phase 3 Completed - -
NCT00286442 - Completed - -
NCT00286468 - Completed - -
NCT02276131 Diabetes Mellitus Not Applicable Completed - -
NCT02597049 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT00286429 - Completed - -
NCT01369043 Exercise and Non-exercise Effe... More >>ct Upon Vitamins E and C Less << Not Applicable Terminated(Lack of successful ... More >>recruiting, budget cuts, and potential study flaws.) Less << - United States, North Dakota ... More >> Grand Forks Human Nutrition Research Center Grand Forks, North Dakota, United States, 58201 Less <<
NCT03024944 Diabetes Mellitus ... More >> Alzheimer Dementia Less << Phase 2 Withdrawn(18F-THK5351 was repo... More >>rted non-specific binding of MAO receptors.) Less << January 2020 United States, New York ... More >> Columbia University Medical Center New York, New York, United States, 10032 Less <<
NCT02597049 - Completed - -
NCT00286494 - Completed - -
NCT00348920 Aortic Stenosis Not Applicable Completed - Canada, Manitoba ... More >> St. Boniface General Hospital Winnipeg, Manitoba, Canada, R2H 2A6 Less <<
NCT01705626 - Recruiting July 1, 2019 Germany ... More >> Albrecht-Kossel-Institute for Neuroregeneration (AKos) Centre for Mental Health Disease University of Rostock Recruiting Rostock, Germany, 18147 Contact: Arndt Rolfs, Prof.    +49 381 494 ext 9540    arndt.rolfs@med.uni-rostock.de    Contact: Sabine Roesner    +49 381 494 ext 4749    sabine.roesner@med.uni-rostock.de Less <<
NCT02798588 Coma Not Applicable Recruiting August 16, 2020 France ... More >> Réanimation polyvalente neurologique Hôpital Neurologique HCL Recruiting Bron, France, 69500 Contact: Florent GOBERT, MD    04 72 68 12 96 ext +33    florent.gobert01@chu-lyon.fr    Sub-Investigator: Frédéric DAILLER, MD          Sub-Investigator: Jacques LUAUTE, MD          Sub-Investigator: Nathalie ANDRE-OBADIA, MD          Principal Investigator: Florent GOBERT, MD Less <<
NCT00971503 Type 1 Diabetes Mellitus Phase 2 Withdrawn(Principal Investigat... More >>or moved to Chile from Argentina) Less << February 2012 Chile ... More >> School of Medicine, Pontificia Universidad Catolica de Chile Santiago de Chile, Chile Less <<
NCT00577174 - Unknown October 2012 United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT02043457 - Recruiting December 2025 United States, Michigan ... More >> University of Michigan Recruiting Ann Arbor, Michigan, United States, 48106 Contact: Amy E Rothberg, MD, PhD    734-647-5871    arothber@med.umich.edu    Contact: Nicole Miller, MPH, RD    734-232-3587    npiazza@med.umich.edu    Principal Investigator: Amy E Rothberg, MD, PhD Less <<
NCT01805245 Emotional Distress ... More >> Type 2 Diabetes Stress Less << Not Applicable Completed - United States, North Carolina ... More >> University of North Carolina Chapel Hill, North Carolina, United States, 27599 Less <<
NCT01865162 Glioblastoma Multiforme Phase 1 Recruiting May 2019 United States, Maryland ... More >> MidAtlantic Epilepsy and Sleep Center Recruiting Bethesda, Maryland, United States, 20817 Contact: Ivana Tyrlikova    301-530-9744    tyrlikovai@epilepsydc.com    Contact: Pavel Klein, MD    301-704-4925    kleinp@epilepsydc.com    Principal Investigator: Pavel Klein, MD Less <<
NCT01408862 - Completed - -
NCT02969863 Type1diabetes Not Applicable Completed - United States, Massachusetts ... More >> MGH Diabetes Research Center Boston, Massachusetts, United States, 02114 Less <<
NCT00713830 Diabetes Mellitus, Type 2 Phase 3 Completed - United States, New Jersey ... More >> Sanofi-Aventis Administrative Office Bridgewater, New Jersey, United States, 08807 Bulgaria Sanofi-Aventis Administrative Office Sofia, Bulgaria Czech Republic Sanofi-Aventis Administrative Office Praha, Czech Republic Egypt Sanofi-Aventis Administrative Office Cairo, Egypt Germany Sanofi-Aventis Administrative Office Berlin, Germany India Sanofi-Aventis Administrative Office Mumbai, India Israel Sanofi-Aventis Administrative Office Natanya, Israel Japan Sanofi-Aventis Administrative Office Tokyo, Japan Korea, Republic of Sanofi-Aventis Administrative Office Seoul, Korea, Republic of Netherlands Sanofi-Aventis Administrative Office Gouda, Netherlands Romania Sanofi-Aventis Administrative Office Bucuresti, Romania Russian Federation Sanofi-Aventis Administrative Office Moscow, Russian Federation Taiwan Sanofi-Aventis Administrative Office Taipei, Taiwan Thailand Sanofi-Aventis Administrative Office Bangkok, Thailand Tunisia Sanofi-Aventis Administrative Office Megrine, Tunisia Turkey Sanofi-Aventis Administrative Office Istanbul, Turkey Less <<
NCT02969863 - Completed - -
NCT01055093 - Recruiting September 2035 Germany ... More >> German Diabetes Center Recruiting Düsseldorf, North-Rhine Westphalia, Germany, 40225 Contact: Clinical Study Center    +49-211-3382-0 ext -209    studienzentrum@ddz.uni-duesseldorf.de    Principal Investigator: Michael Roden, Prof., MD          Sub-Investigator: Dan Ziegler, Prof., MD          Sub-Investigator: Christian Herder, PhD, M.Sci.          Sub-Investigator: Wolfgang Rathmann, MD, MSPH          Sub-Investigator: Andrea Icks, MD          Sub-Investigator: Joachim Rosenbauer, Ph.D.          Sub-Investigator: Jörg Kotzka, Ph.D. Less <<
NCT00572767 Stroke Phase 4 Terminated(Intended length of ... More >>study ended) Less << - Switzerland ... More >> Reha Rheinfelden Rheinfelden, AG, Switzerland, 4310 Less <<
NCT01408862 - Completed - -
NCT00994682 Nonalcoholic Steatohepatitis ... More >> Nonalcoholic Fatty Liver Disease Type 2 Diabetes Mellitus Less << Phase 4 Completed - United States, Texas ... More >> Bartter Research Unit, Audie L Murphy VA Hospital San Antonio, Texas, United States, 78248 Less <<
NCT03549104 Type 1 Diabetes Mellitus Not Applicable Not yet recruiting March 2019 United States, Illinois ... More >> University of Illinois at Chicago Chicago, Illinois, United States, 60612 Less <<
NCT02389374 Malaria Phase 4 Completed - -
NCT02389374 - Completed - -
NCT01180751 Tumors Phase 3 Unknown December 2013 Canada, Manitoba ... More >> Great West Life PET/CT Centre Winnipeg, Manitoba, Canada, R3E 3P4 Less <<
NCT01969409 Ambulatory IPF Phase 2 Completed - United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35233 United States, Massachusetts Brigham and Women's Hospital Boston, Massachusetts, United States United States, Minnesota University of Minnestoa Minneapolis, Minnesota, United States United States, Pennsylvania Geisinger Medical Center Danville, Pennsylvania, United States Temple University Philadelphia, Pennsylvania, United States University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States, 15213 United States, South Carolina Medical University of South Carolina Charleston, South Carolina, United States Less <<
NCT02460445 Hyperandrogenism ... More >> Metabolic Cardiovascular Syndrome Less << Not Applicable Recruiting December 2018 Spain ... More >> Diabetes, Obesity and Human Reproduction Research Group, Department of Endocrinology and Nutrition, Hospital Universitario Ramón y Cajal, Universidad de Alcalá, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS) Recruiting Madrid, Spain, 28034 Contact: Manuel Luque Ramírez, M.D., Ph.D.    0034913369029    manuel.luque@salud.madrid.org    Contact: Héctor F Escobar-Morreale, M.D., Ph.D.    0034913369029    hectorfrancisco.escobar@salud.madrid.org Less <<
NCT00994682 - Completed - -
NCT00067587 - Completed - United States, California ... More >> Children's Hopsital of Los Angeles Los Angeles, California, United States, 90027 University of California at San Diego San Diego, California, United States, 92093 United States, District of Columbia Children's National Medical Center Washington, District of Columbia, United States, 20010 United States, Florida Children's Diagnostic and Treatment Center Fort Lauderdale, Florida, United States, 33316 University of Miami Miami, Florida, United States, 33124 University of South Florida Tampa, Florida, United States, 33606 United States, Illinois Stoger Hospital of Cook County Chicago, Illinois, United States, 60612 United States, Louisiana Tulane University New Orleans, Louisiana, United States, 70112 United States, New York Montefiore Medical Center Bronx, New York, United States, 10467 Mt. Sinai Hospital New York City, New York, United States, 10128 United States, Pennsylvania Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT01727349 Type 2 Diabetes Not Applicable Recruiting December 2020 Belgium ... More >> CHU Sart Tilman Liège Recruiting Liege, Belgium, 4000 Contact: Andre Scheen, MD PHD          Sub-Investigator: Régis RADERMECKER, MD          Principal Investigator: Andre Scheen, MD PHD          France CHU Jean Minjoz Recruiting Besancon, France, 25030 Contact: Alfred PENFORNIS, MD PHD          Principal Investigator: Alfred PENFORNIS, MD PHD          Sub-Investigator: Annie CLERGEOT, MD          CHU de Bondy Recruiting Bondy, France Contact: Emmanuel Cosson, MD PHD          Principal Investigator: Emmanuel Cosson, MD PHD          CHU de BREST Recruiting Brest, France Contact: Emmanuel SONNET, MD          Contact: Natahlie ROUDAUT, MD          Principal Investigator: Emmanuel SONNET, MD          Sub-Investigator: Nathalie ROUDAUT, MD          Sub-Investigator: Veronique KERLAN, MD          Sub-Investigator: Geneviève CROUZEIX, MD          Sub-Investigator: Sandra LESVEN, MD          Sub-Investigator: Alizee LOUBOUTIN, MD          Sub-Investigator: Philippe THUILLIER, MD          CHU de Caen Recruiting Caen, France, 14000 Contact: Yves REZNIK, MD          Principal Investigator: Yves REZNIK, MD PHD          Sub-Investigator: Michael JOUBERT, MD          Sub-Investigator: Anne ROD, MD          Sub-Investigator: Julia MORERA, MD          CH Sud Francilien Recruiting Evry, France, 91000 Contact: Guillaume Charpentier, MD          Principal Investigator: Guillaume CHARPENTIER, MD          University Hospital Grenoble Recruiting Grenoble, France, 38043 Contact: Pierre Yves Benhamou, MD PhD          Principal Investigator: Pierre Yves Benhamou, MD PhD          CHRU Lille Recruiting Lille, France, 59037 Contact: Pierre Fontaine, MD PHD          Principal Investigator: Anne WAMBERGUE, MD          Principal Investigator: Pierre FONTAINE, MD PHD          CHU Marseille Hôpitaux Sud Recruiting Marseille, France, 13274 Contact: Catherine Zevaco Mattei, MD          Sub-Investigator: Pauline SCHAEPELYNCK-BELICAR, MD          Principal Investigator: Catherine ZEVACO MATTEI, MD          CHU de Nancy Recruiting Nancy, France, 54500 Contact: Bruno GUERCI, MD PHD          Principal Investigator: Bruno GUERCI, MD PHD          CHU de REIMS Recruiting Reims, France Contact: Celine Lukas-Croisier, MD          Principal Investigator: Celine Lukas-Croisier, MD          Centre Hospitalier Strasbourg Recruiting Strasbourg, France, 67000 Contact: Nathalie Jeandidier, MD PHD          Sub-Investigator: Nathalie JEANDIDIER, MD PHD          CHU Toulouse Recruiting Toulouse, France, 31403 Contact: Hélène Hanaire, MD PHD          Principal Investigator: Hélène HANAIRE, MD Less <<
NCT01729299 Diabetes Not Applicable Unknown April 2014 United States, Ohio ... More >> University of Cincinnati Recruiting Cincinnati, Ohio, United States, 45267 Contact: Jenny Tong, MD, MPH    513-558-4446    jenny.tong@uc.edu    Contact: Ahrar Haque, MD    513-558-3923    haqueau@uc.edu    Principal Investigator: Jenny Tong, MD, MPH          Cincinnati Children's Hospital and Medical Center Recruiting Cincinnati, Ohio, United States Contact: Ahrar Haque, MD    513-558-3923 Less <<
NCT02097342 Type 2 Diabetes Mellitus ... More >> Insulin Sensitivity/Resistance Less << Phase 4 Unknown January 2015 India ... More >> Postgraduate Institute of Medical Education & Research Recruiting Chandigarh, India, 160012 Contact: Anil Bhansali, MD DM       anilbhansaliendocrine@gmail.com Less <<
NCT03342313 Mastication Not Applicable Completed - Thailand ... More >> Suwimol Sapwarobol Bangkok, Thailand, 10330 Less <<
NCT03298529 Glycemic Response ... More >> Insulinemic Response Healthy Subjects Less << Not Applicable Completed - Italy ... More >> Azienda ospedaliera Specializzata in Gastroenterologia Saverio de Bellis Castellana, Bari, Italy, 70013 Less <<
NCT02524639 Hyperinsulinism Phase 1 Phase 2 Withdrawn(Due to strict inclus... More >>ion and exclusion criteria no subjects were enrolled) Less << - United States, Pennsylvania ... More >> The Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00713830 - Completed - -
NCT00707993 Diabetes Mellitus Phase 3 Completed - -
NCT01423877 - Completed - United States, New York ... More >> Bellevue Hospital Center New York, New York, United States, 10016 Less <<
NCT03073330 Gestational Diabetes Not Applicable Recruiting June 2017 United States, Pennsylvania ... More >> Thomas Jefferson University Hospital Recruiting Philadelphia, Pennsylvania, United States, 19107 Contact: Adeeb Khalifeh, MD       adeeb.khalifeh@jefferson.edu Less <<
NCT00707993 - Completed - -
NCT01926938 - Completed - United States, Massachusetts ... More >> Joslin Diabetes Center Boston, Massachusetts, United States, 02215 Less <<
NCT03684499 Bilirubinemia Not Applicable Not yet recruiting June 30, 2020 -
NCT01762267 Nutritional and Metabolic Dise... More >>ase Less << Phase 3 Completed - Iran, Islamic Republic of ... More >> 1. Department of Community Nutrition, School of Nutrition & Food Science, Isfahan University of Medical Science Isfahan, Iran, Islamic Republic of Less <<
NCT00958815 - Completed - United States, Missouri ... More >> Washington University School of Medicine St.Louis, Missouri, United States, 63110 Less <<
NCT03046147 - Recruiting September 2017 Denmark ... More >> Copenhagen University hospital Hvidovre Recruiting Copenhagen, Denmark, 2820 Contact: Kirstine N Bojsen-Møller, MD, PhD    4538626371    Kirstine.bojsen-moeller@regionh.dk Less <<
NCT00603720 Cardiovascular Diseases Not Applicable Completed - United States, Missouri ... More >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Less <<
NCT00830076 Type 2 Diabetes Mellitus Phase 1 Completed - -
NCT00603720 - Completed - -
NCT02475070 Type 2 Diabetes Phase 4 Completed - Sweden ... More >> Lund University Lund, Sweden, 22184 Less <<
NCT03280758 Type 2 Diabetes Mellitus Not Applicable Not yet recruiting August 30, 2019 -
NCT03724526 Type 2 Diabetes Mellitus Not Applicable Recruiting December 2020 China, Guangdong ... More >> Nanfang Hospital of Southern Medical University Recruiting Guangzhou, Guangdong, China, 510515 Contact: Huijie Zhang, MD,PhD    +86-020-61641635    Huijiezhang2005@126.com    Contact: Peizhen Zhang    +86-18320143528    959305003@qq.com Less <<
NCT00830076 - Completed - -
NCT00898287 Pancreatic Cancer Phase 1 Phase 2 Completed - India ... More >> Central India Cancer Research Institute Nagpur, Ajayonco@hotmail.com, India, 440 010 Global Hospital Hyderabaad, Andhra Pradesh, India, 500004 Curie Manavata Cancer Centre Nashik, Maharashtra, India, 422 004 Deenanath Mangeshkar Hospital & Research Centre Pune, Maharashtra, India, 411004 Sri RamaChandra Medical Centre Chennai, Tamil Nadu, India, 600 116 Lifeline Mutispecilaity Hospital Chennai, Tamil Nadu, India, 600096 Meenakshi Mission Hospital & Reasearch Centre Madurai, Tamil Nadu, India, 625107 Less <<
NCT00546702 Diabetes Mellitus, Type 1 Phase 3 Completed - Russian Federation ... More >> Sanofi-aventis Moscow, Russian Federation Less <<
NCT00774800 - Completed - -
NCT02157298 - Completed - -
NCT02003586 Healthy Not Applicable Completed - France ... More >> Eurofins Optimed Clinical research Gieres, France Less <<
NCT02157298 Type 2 Diabetes Mellitus Phase 4 Completed - Japan ... More >> Research Site Adachi-ku, Japan Research Site Chitose-shi, Japan Research Site Chiyoda-ku, Japan Research Site Chuo-ku, Japan Research Site Fukuoka-shi, Japan Research Site Hirosaki-shi, Japan Research Site Kamakura-shi, Japan Research Site Koriyama-shi, Japan Research Site Mitaka-shi, Japan Research Site Oita-Shi, Japan Research Site Osaka-shi, Japan Research Site Sendai-shi, Japan Research Site Shizuoka-shi, Japan Research Site Yokohama-shi, Japan Less <<
NCT00774800 Type 1 Diabetes Mellitus Phase 2 Completed - United States, California ... More >> Profil Institute for Clinical Research, Inc. Chula Vista, California, United States, 91911 Less <<
NCT01726764 Type 2 Diabetes ... More >> Depression Less << Phase 1 Completed - Denmark ... More >> Department of Clinical Pharmacology, Institute of Public Health, University of Southern Denmark Odense, Denmark, DK-5000 Less <<
NCT01936935 Diabetes Not Applicable Unknown September 2013 United States, Illinois ... More >> Provident Clinical Research (now Biofortis) Addison, Illinois, United States, 60101 Less <<
NCT02702934 Hyperglycemia Not Applicable Completed - Italy ... More >> Department of Clinical Medicine and Surgery Naples, Italy, 80131 Less <<
NCT02402933 - Completed - -
NCT03503942 Pre-diabetes Not Applicable Recruiting December 31, 2022 Singapore ... More >> Singapore General Hospital Recruiting Singapore, Singapore, 169608 Contact: Yong Mong Bee    6321 3753 ext +65    bee.yong.mong@singhealth.com.sg Less <<
NCT02212067 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 1 Completed - Germany ... More >> Novo Nordisk Investigational Site Neuss, Germany, 41460 Less <<
NCT03121261 Inguinal Hernia ... More >> Spinal Anesthesia Less << Phase 4 Active, not recruiting July 2019 Croatia ... More >> Clinical Hospital Dubrava Zagreb, Croatia, 10000 Less <<
NCT00985712 Diabetes Mellitus, Type 1 Phase 4 Completed - Germany ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Aschaffenburg, Germany, 63739 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Asslar, Germany, 35614 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bad Mergentheim, Germany, 97980 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Berlin, Germany, 14089 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bosenheim, Germany, 55545 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Diez, Germany, 65582 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Dresden, Germany, 01307 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Erlangen, Germany, 91054 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Essen, Germany, 45355 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Falkensee, Germany, 14612 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Flensburg, Germany, D-24939 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Frankfurt, Germany, 60388 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fulda, Germany, 36037 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Giessen, Germany, 35385 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hamburg, Germany, 21073 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hannover, Germany, 30173 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Herdecke, Germany, 58313 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Leipzig, Germany, 04103 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mainz, Germany, 55116 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Münster, Germany, 48153 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Neuwied, Germany, 56564 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Rehlingen-Siersburg, Germany, 66780 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Rotenburg-Fulda, Germany, 36199 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Saarbrücken, Germany, 66121 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Schkeuditz, Germany, 04435 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Schwedt/Oder, Germany, 16303 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tuebingen, Germany, 72076 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Warburg, Germany, 34414 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Wuppertal, Germany, 42283 Less <<
NCT03006471 PreDiabetes P... More >>rehypertension Less << Phase 4 Active, not recruiting December 2018 Mexico ... More >> Instituto de Terapeútica Experimental y Clínica. Centro Universitario de Ciencias de la Salud. Universidad de Guadalajara Guadalajara, Jalisco, Mexico, 44340 Less <<
NCT03563638 - Completed - -
NCT00985712 - Completed - -
NCT00850564 - Completed - -
NCT01865305 Diabetes Diab... More >>etes Mellitus, Type 1 Diabetes Mellitus, Type 2 Less << Phase 1 Completed - Germany ... More >> Neuss, Germany, 41460 Less <<
NCT02402933 Hypoglycemia ... More >>Diabetes Mellitus Less << Phase 3 Completed - United States, Florida ... More >> Private Clinic Tallahassee, Florida, United States, 32308 United States, Maryland Private Clinic Baltimore, Maryland, United States, 21229 United States, Massachusetts New England Diabetes and Endocrinology Center (NEDEC) Waltham, Massachusetts, United States, 02451-1136 Less <<
NCT01293773 Coronary Artery Disease ... More >> Diabetes Mellitus Less << Phase 4 Withdrawn - Italy ... More >> Azienda Policlinico-Universitaria di Modena Modena, Italy, 41100 Policlinico Casilino Rome, Italy, 00100 Less <<
NCT00655798 Overweight Di... More >>abetes Cardiovascular Disease Less << Not Applicable Completed - Netherlands ... More >> TNO Quality of Life Zeist, Utrecht, Netherlands, 3704 HE Less <<
NCT00850564 Healthy Volunteers Not Applicable Completed - United States, Massachusetts ... More >> MGH Boston, Massachusetts, United States, 02114 Less <<
NCT02034136 Metabolic Syndrome Not Applicable Unknown December 2014 Korea, Republic of ... More >> Bundang CHA Hospital Not yet recruiting Seoul, Kyeonggi-do, Korea, Republic of Contact: HG Park, PhD       irb@chamc.co.kr    Principal Investigator: DH Jung, MPH Less <<
NCT02199769 Diabetes Pred... More >>iabetes Less << Not Applicable Completed - United States, Texas ... More >> UT Southwestern Medical Center Dallas, Texas, United States, 75390 Less <<
NCT02288572 Metabolic Syndrome X Phase 2 Completed - -
NCT02023918 - Completed - -
NCT01925248 Type 2 Diabetes Mellitus ... More >> Hyperglycemia Less << Not Applicable Completed - United States, California ... More >> Clinical and Translational Science Center Clinical Resources Center (CCRC) Sacramento, California, United States, 95655 Less <<
NCT01218256 Type 2 Diabetes Mellitus Phase 1 Completed - Austria ... More >> Institute of Sports Medicine, Prevention and Rehabilitation, Paracelsus Medical University Salzburg, Austria, 5020 Less <<
NCT02790060 - Completed - France ... More >> Angers University Hospital Angers, France, 49100 Brest University Hospital Brest, France, 29200 La Roche sur Yon Hospital La Roche sur Yon, France, 85925 La Rochelle Hospital La Rochelle, France, 17019 CH Bretagne sud Lorient, France Chu de Nantes Nantes, France, 44035 Poitiers University Hospital Poitiers, France, 86021 Chu de Rennes Rennes, France, 35033 University Hospital of Tours Tours, France, 37170 Less <<
NCT02550808 - Unknown December 2017 Slovenia ... More >> General Hospital Celje Recruiting Celje, Slovenia, SI-3000 Contact: Mitja Lainscak, MD, PhD       mitja.lainscak@guest.arnes.si Less <<
NCT02023918 Diabetes Meta... More >>bolic Syndrome Insulin Resistance Less << Phase 2 Completed - United States, California ... More >> San Francisco General Hospital San Francisco, California, United States, 94110 Less <<
NCT00742742 Metabolic Syndrome X Phase 2 Phase 3 Completed - China ... More >> Institute for Nutritional Sciecnes, Chinese Acadamy of Sciences Shanghai, China, 200031 Less <<
NCT01753674 Metabolic Syndrome ... More >> Insulin Resistance Less << Phase 1 Terminated(non-compliance issu... More >>es) Less << - United States, Connecticut ... More >> University of Connecticut Storrs, Connecticut, United States, 06269 Less <<
NCT02706288 Obesity Insul... More >>in Resistance Less << Not Applicable Recruiting December 2019 United States, Missouri ... More >> Washington University in St. Louis School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: George Schweitzer, PhD    314-362-4884    george.schweitzer@wustl.edu Less <<
NCT01855321 Type 2 Diabetes Phase 1 Completed - United States, Florida ... More >> Shands Medical Plaza Gainesville, Florida, United States, 32608 Less <<
NCT00605774 Type 1 Diabetes Not Applicable Withdrawn - -
NCT01033435 - Completed - Israel ... More >> Western Galilee Hospital Nahariya, Western Galilee, Israel, 25100 Less <<
NCT00672386 Diabetes Mellitus, Type 2 ... More >> Diabetes Mellitus Endocrine System Diseases Nutritional and Metabolic Diseases Less << Phase 2 Completed - -
NCT02562313 Type 1 Diabetes Mellitus Phase 1 Completed - Germany ... More >> Profil GmbH Neuss, Germany, 41460 Less <<
NCT00467376 Diabetes Mellitus Phase 3 Completed - China ... More >> Sanofi-Aventis Beijing, China Less <<
NCT02795910 Diabetes Mellitus ... More >> Hypertension Heart Failure Ischemic Heart Disease Cerebrovascular Disease Less << Not Applicable Active, not recruiting March 31, 2019 Brazil ... More >> Florianopolis City Health Department Florianopolis, Santa Catarina, Brazil, 88.040-400 Less <<
NCT00479791 Type 2 Diabetes Mellitus Not Applicable Completed - United States, Texas ... More >> UT Southwestern Medical Center at Dallas Dallas, Texas, United States, 75235-9052 Less <<
NCT02008188 Type 1 Diabetes Mellitus Not Applicable Unknown May 2015 Italy ... More >> Azienda Ospedaliera di Padova (Padua Hospital) Padova, Italy Less <<
NCT01773668 Type 1 Diabetes ... More >> Type 2 Diabetes Less << Not Applicable Completed - Sweden ... More >> Skåne University Hospital, Department of Endokrinology Malmö, Sweden, 205 02 Less <<
NCT03049462 Healthy Volunteers Phase 1 Recruiting October 1, 2021 United States, Maryland ... More >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)    800-411-1222 ext TTY8664111010    prpl@cc.nih.gov Less <<
NCT00842075 - Completed - -
NCT00082238 Cystic Fibrosis ... More >> Diabetes Mellitus Less << Not Applicable Completed - United States, Texas ... More >> University of Texas Southwestern Dallas, Texas, United States, 75390-9063 Less <<
NCT03204344 Gastrointestinal Surgery Not Applicable Completed - China, Beijing ... More >> Peking University First Hospital Beijing, Beijing, China, 100034 Less <<
NCT01247740 Parenteral Nutrition for Patie... More >>nts With Proven Insufficient Enteral Resorption Less << Phase 3 Completed - China ... More >> Peking Union Medical College Hospital,Department of Gastrointestinal Surgery Beijing, China Less <<
NCT01648582 Type 2 Diabetes Mellitus Phase 3 Completed - China ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Beijing, China, 100730 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Changsha, China, 410011 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chengdu, China, 610041 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chongqing, China, 400030 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Dalian, China, 116011 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Guang Zhou, China, 510120 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Guiyang, China, 550004 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hangzhou, China, 310009 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Harbin, China, 150001 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hefei, China, 230022 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nanchang, China, 330006 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nanjing, China, 210006 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nanning, China, 530021 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Shanghai, China, 200080 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Shenyang, China, 110004 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Shijiazhuang, China, 050051 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Wu Han, China, 430022 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Xi'An, China, 710032 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Yangzhou, China, 225001 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Zhenjiang, China, 212000 Korea, Republic of For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bucheon,, Korea, Republic of, 420-717 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kyunggi-Do, Korea, Republic of, 425-020 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Seoul, Korea, Republic of, 137-701 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Wonju-Si, Korea, Republic of, 220-701 Mexico For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chihuahua, Mexico, 31238 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Monterrey, Mexico, 64460 Russian Federation For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chelyabinsk, Russian Federation, 454047 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Moscow, Russian Federation, 127018 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Saint Petersburg, Russian Federation, 192012 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sankt-Petersburg, Russian Federation, 190000 Less <<
NCT00842075 Type 1 Diabetes Not Applicable Completed - United States, Colorado ... More >> Barbara Davis Center Aurora, Colorado, United States, 80010 Less <<
NCT01180608 Diabetic Neuropathies ... More >> Pain Less << Not Applicable Unknown September 2012 Belgium ... More >> UZ Brussel Not yet recruiting Brussel, Belgium, 1090 Contact: Maarten Moens, MD          Principal Investigator: Maarten Moens, MD Less <<
NCT01710371 Type 2 Diabetes Phase 1 Completed - United States, Connecticut ... More >> Research Site New Haven, Connecticut, United States, 06511 Less <<
NCT01354964 Insulin Resistance Phase 2 Completed - United States, New York ... More >> Albert Einstein College of Medicine of Yeshiva University Bronx, New York, United States, 10461 Less <<
NCT00513643 Diabetes Mellitus Phase 1 Completed - Germany ... More >> Profil Institut für Stoffwechselforschung GmbH Neuss, Germany, 41460 Less <<
NCT02912325 Metabolic Syndrome Not Applicable Recruiting June 2018 Romania ... More >> Opera Contract Research Organization SRL Recruiting Timisoara, Timis, Romania, 300209 Contact: Barattini Dionisio, MD    +393355437574    barattini@operacro.com    Scm Dr Rosu Recruiting Timişoara, Timis, Romania, 300209 Contact: Doina Rosu, MD       dr_doinarosu@yahoo.com Less <<
NCT01834274 Diabetes Mellitus, Type 2 Phase 3 Terminated(Due to potential co... More >>ncerns about liver safety (See Detailed Description)) Less << - -
NCT01648582 - Completed - -
NCT00551954 Type 2 Diabetes Phase 3 Completed - -
NCT00707031 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT01834274 - Terminated(Due to potential co... More >>ncerns about liver safety (See Detailed Description)) Less << - -
NCT01143168 Type 1 Diabetes Mellitus Phase 1 Unknown December 2011 China ... More >> Armed Police General Hospital, P. R. China Not yet recruiting Beijing, China, 100085 Less <<
NCT02255682 Cardiovascular Disease ... More >> Diabetes Mellitus Less << Phase 4 Completed - Denmark ... More >> University of Copenhagen Copenhagen, Denmark, 2200 Less <<
NCT00707031 - Completed - -
NCT01486901 Diabetes Heal... More >>thy Less << Phase 1 Completed - Germany ... More >> Neuss, Germany, 41460 Less <<
NCT01739205 Type 2 Diabetes and Depression Not Applicable Completed - -
NCT01041144 Type 2 Diabetes ... More >> Lifestyle Intervention Glucose Control Internet Communication Less << Not Applicable Completed - Korea, Republic of ... More >> Seoul St. Mary's Hospital Seoul, Korea, Republic of, 137-041 Less <<
NCT01421953 Lung Cancer N... More >>on-small-cell Lung Carcinoma Less << Not Applicable Completed - France ... More >> CHU Bordeaux - hôpital Pellegrin Bordeaux, France, 33000 Less <<
NCT01247753 Diabetes Gest... More >>ational Diabetes Mellitus Less << Not Applicable Completed - Australia, Queensland ... More >> Mater Mothers Hospital South Brisbane, Queensland, Australia, 4101 Less <<
NCT00002981 Prostate Cancer Not Applicable Active, not recruiting April 2020 United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT01198561 - Unknown December 2016 Korea, Republic of ... More >> Samsung Medical Center Recruiting Seoul, Kangnam-Ku, Korea, Republic of, 135-710 Contact: Doh Kwan Kim, M.D., Ph.D.    82-2-3410-3582    paulkim@skku.edu    Principal Investigator: Doh Kwan Kim, M.D., Ph.D. Less <<
NCT00184639 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 3 Completed - Germany ... More >> Novo Nordisk Investigational Site Berlin, Germany, 13353 Novo Nordisk Investigational Site Hannover, Germany, 30173 Less <<
NCT01231295 - Completed - France ... More >> CHU d'Amiens - Hôpital Sud Amiens Cedex 1, France, 80054 CHU d'Angers - Hôtel-Dieu Angers, France, 49933 CHU de Besançon - Hôpital Jean Minjoz Besançon, France, 25030 CHU de Bordeaux - Groupe Hospitalier Pellegrin Bordeaux, France, 33076 APHP - Hôpital Albert Chenevier Creteil Cedex, France, 94010 APHP - Hôpital Charles Foix Ivry Sur Seine Cedex, France, 94205 CHRU de Lille - Hôpital Claude Huriez Lille, France, 59037 CHRU de Lille - Hôpital Roger Salengro Lille, France, 59037 APHP - Hôpital Emile Roux Limeil Brevannes Cedex, France, 94456 APHM - Hôpital La Timone Adultes Marseille cedex 5, France, 13385 CHU de Montpellier - Hôpital Gui de Chauliac Montpellier Cedex 5, France, 34295 CHU de Nancy - Hôpital Central Nancy, France, 54035 CHU de Nice - Hôpitaux L'Archet 1 et 2 Nice, France, 06202 CHU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 09, France, 30029 APHP - Groupe Hospitalier Pitié-Salpetrière Paris cedex 13, France, 75651 APHP - Hôpital Lariboisière Paris, France, 75010 APHP - Hôpital Broca Paris, France, 75013 Groupe Hospitalier Paris Saint-Joseph Paris, France, 75014 CHU de Poitiers Poitiers, France, 86021 CHU de Reims - Hôpital Maison Blanche Reims, France, 51092 CHU de Rouen - Hôpital Charles Nicolle Rouen, France, 76031 CHRU de Strasbourg - Hôpital de Hautepierre Strasbourg, France, 67098 CHRU de Toulouse - Hôpital Garonne Toulouse cedex 9, France, 31059 CHRU de Toulouse - Hôpital Purpan Toulouse Cedex 9, France, 31059 CHRU de Tours - Hôpital Bretonneau Tours, France, 37044 Less <<
NCT01145092 Type 2 Diabetes Mellitus ... More >> Insulin Resistance Less << Not Applicable Completed - Austria ... More >> Landsteiner Institute Vienna, Austria, 1140 Less <<
NCT01403545 Drug Safety Phase 1 Completed - Austria ... More >> Medical University of Vienna, Department of Clinical Pharmacology Vienna, Austria, 1090 Less <<
NCT03167918 Type 2 Diabetes Mellitus ... More >> Pulmonary Function Less << Phase 2 Phase 3 Completed - -
NCT02660047 Diabetes Mellitus Type 2 ... More >> Metabolic Syndrome Cardiovascular Disease Diastolic Dysfunction Fatty Liver Less << Phase 4 Completed - Netherlands ... More >> Leiden University Medical Center Leiden, Albinusdreef 2, Netherlands, 2333 ZA Less <<
NCT03751657 Diabetes Mellitus, Type 2 Phase 2 Recruiting November 7, 2019 -
NCT00664534 - Completed - -
NCT02733315 Diabetes Not Applicable Completed - -
NCT01689844 High Blood Pressure Not Applicable Completed - United States, Maryland ... More >> Johns Hopkins Community Physicians, East Baltimore Medical Center Baltimore, Maryland, United States, 21202 Less <<
NCT00664534 Diabetes Mellitus, Type 2 Phase 4 Completed - Canada, Ontario ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Smiths Falls, Ontario, Canada, K7A 4W8 Egypt For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Alexandria, Egypt For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bab El Louk, Egypt For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Cairo, Egypt, 11562 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Heliopolis, Egypt India For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ahmedabad, India, 380006 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hyderabaad, India, 500033 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Indore, India, 452001 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mumbai, India, 400053 Mexico For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Coatzacoalcos, Mexico, 96400 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mexico City, Mexico, 06700 Portugal For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Aveiro, Portugal, 3814-501 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Barreiro, Portugal, 2830 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lisbon, Portugal, 1250-203 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Porto, Portugal, 4099-001 Romania For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bucharest, Romania, 020359 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Craiova, Romania, 200000 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Galati, Romania, 6200 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Iasi, Romania, 70057 Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Alicante, Spain, 03114 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Badalona, Spain, 08915 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Madrid, Spain, 28040 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Palma De Mallorca, Spain, 07198 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Santa Cruz De Tenerife, Spain, 38320 Turkey For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ankara, Turkey, 06510 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Antalya, Turkey, 07070 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Konya, Turkey, 42075 Less <<
NCT01382420 Cushing Syndrome Not Applicable Unknown May 2018 Korea, Republic of ... More >> Samsung Medical Center Recruiting Seoul, Korea, Republic of Less <<
NCT03600116 Type 1 Diabetes Mellitus Phase 2 Active, not recruiting January 2020 United States, Massachusetts ... More >> Massachusetts General Hospital (MGH) Diabetes Research Center Boston, Massachusetts, United States, 02114 Less <<
NCT02387164 Diabetes Mellitus, Type 1 ... More >> Prediabetic State Less << Phase 2 Enrolling by invitation March 2022 Sweden ... More >> Clinical Research Center, Pediatric Endocrinology, Jan Waldenströms gata 35, 60:11 Malmö, Sweden, 205 02 Less <<
NCT01517412 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT03259724 - Active, not recruiting August 30, 2017 Canada, Ontario ... More >> The Toronto 3D Knowledge Synthesis and Clinical Trials Unit, Clinical Nutrition and Risk Factor Modification Centre Toronto, Ontario, Canada, M5C 2T2 Less <<
NCT01517412 - Completed - -
NCT02746627 Type 1 Diabetes Mellitus Not Applicable Completed - United States, Tennessee ... More >> Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232 Less <<
NCT01995981 - Completed - Netherlands ... More >> Radboud University Nijmegen Medical Centre Nijmegen, Netherlands, 6525 GA United Kingdom Royal Marsden Hospital London, United Kingdom Less <<
NCT03734510 Non Alcoholic Steatohepatitis Not Applicable Recruiting February 1, 2019 Iran, Islamic Republic of ... More >> National Nutrition and Food Technology Research Institute Recruiting Tehran, Iran (the Islamic Republic Of), Iran, Islamic Republic of, 1981619573 Contact: Azits Hekmatdoost, MD,PhD    +982122357484 Less <<
NCT02469922 Malignant Neoplasm of Head and... More >> Neck Locally Advanced Malignant Neoplasm Less << Not Applicable Recruiting January 2019 France ... More >> CHU Brest Recruiting Brest, France Contact: Ulrike Schick          Centre jean Bernard - Rue Victor Hugo Recruiting Le Mans, France, 72015 Contact: Pointreau Yoann       pointr_y@yahoo.fr    Principal Investigator: Pointreau yoann          Hôpital du Scorff Recruiting Lorient, France Contact: Guillaume BERA          Centre Eugene Marquis Recruiting Rennes, France, 35042 Contact: Joël Castelli, MD    + 33 2 99 25 29 68    j.castelli@rennes.unicancer.fr    Principal Investigator: Joël Castelli, MD          Centre d'Oncologie St Vincent - Boulevard de la Boutière Recruiting Saint Grégoire, France, 35460 Contact: Chamois Jérôme       jchamois@vivalto-sante.com    Principal Investigator: Chamois Jérôme Less <<
NCT01277965 Type 1 Diabetes With a Subcuta... More >>neous Insulin Pump Adjustment of the Recommended Basal Insulin Flow Rate in the Event of Physical Activity Adjustment of the Recommended Prandial Insulin in the Event of Physical Activity Less << Not Applicable Completed - France ... More >> Centre Hospitalier Sud Francilien Corbeil Essonnes, Essonne, France, 91100 Less <<
NCT03277742 Pulmonary Tuberculosis ... More >> Diabetes Mellitus, Type 2 Less << Not Applicable Recruiting December 2020 Mexico ... More >> Centro de Salud Camerino Mendoza Recruiting Orizaba, Veracruz, Mexico Contact: Guadalupe Delgado Sanchez       gpe.delgado.s@gmail.com Less <<
NCT01571037 End Stage Heart Disease ... More >> Right Ventricular Dysfunction Less << Phase 1 Completed - United States, Nebraska ... More >> University of Nebraska Medical Center Omaha, Nebraska, United States, 68198-2265 Less <<
NCT02174900 Malaria Phase 2 Phase 3 Completed - Burkina Faso ... More >> Centre National de Recherche et de Formation sur le Paludisme Ouagadougou, Burkina Faso Less <<
NCT00522756 Kidney Failure, Acute Phase 3 Unknown March 2013 Canada, Quebec ... More >> McGill University Health Centre - Royal Victoria Hospital Recruiting Montreal, Quebec, Canada, H3A1A1 Principal Investigator: Benoit de Varennes, MD          Principal Investigator: Ahsan Alam, MD          Sub-Investigator: Danny Del Duca, MD          Sub-Investigator: Sameena Iqbal, MD          Sub-Investigator: Peter Goldberg, MD          Sub-Investigator: Navdeep Tangri Less <<
NCT02032953 Colorectal Cancer Phase 4 Active, not recruiting April 2019 Canada, Quebec ... More >> McGill University Health Centre (MUHC) - Royal Victoria Hospital Montreal, Quebec, Canada, H8A1A1 Less <<
NCT02208544 Thyroid Nodule ... More >> Thyroid Neoplasms Less << Not Applicable Recruiting January 2020 Netherlands ... More >> Radboudumc Recruiting Nijmegen, Gelderland, Netherlands Contact: Lioe-Fee de Geus-Oei, MD, PhD    +31243614048    Lioe-Fee.deGeus-Oei@radboudumc.nl    Contact: R.T. Netea-Maier, MD, PhD    +31243611111    Romana.Netea-Maier@radboudumc.nl    Principal Investigator: Lioe-Fee de Geus-Oei, MD, PhD          Sub-Investigator: E.J. de Koster, MD          MUMC Recruiting Maastricht, Limburg, Netherlands Contact: S.A. Vöö, MD, PhD       stefan.voo@mumc.nl    Contact: B. Havekes, MD, PhD       bas.havekes@mumc.nl    Principal Investigator: S.A. Vöö, MD, PhD          AMC Recruiting Amsterdam, Noord-Holland, Netherlands Contact: E. Fliers, MD, PhD       E.Fliers@amc.uva.nl    Contact: J Booij, MD, PhD       j.booij@amc.uva.nl    Principal Investigator: E. Fliers, MD, PhD          VUmc Recruiting Amsterdam, Noord-Holland, Netherlands Contact: E.W.C.M. van Dam, MD, PhD       EW.vanDam@vumc.nl    Contact: P.G.H.M. Raijmakers, MD, PhD       p.raijmakers@vumc.nl    Principal Investigator: E.W.C.M. van Dam, MD, PhD          MeanderMC Recruiting Amersfoort, Utrecht, Netherlands Contact: L.T. Dijkhorst-Oei, MD, PhD       L.Dijkhorst-oei@meandermc.nl    Contact: J.M.H. de Klerk, MD, PhD       jmh.de.klerk@meandermc.nl    Principal Investigator: L.T. Dijkhorst-Oei, MD, PhD          LUMC Recruiting Leiden, Zuid-Holland, Netherlands Contact: A.M. Pereira Arias, MD, PhD       a.m.pereira@lumc.nl    Contact: L.F. de Geus-Oei, MD, PhD       L.F.de_Geus-Oei@lumc.nl    Principal Investigator: A.M. Pereira Arias, MD, PhD          ErasmusMC Recruiting Rotterdam, Zuid-Holland, Netherlands Contact: R.P. Peeters, MD, PhD       r.peeters@erasmusmc.nl    Contact: J. Verzijlbergen, MD, PhD       j.verzijlbergen@erasmusmc.nl    Principal Investigator: R.P. Peeters, MD, PhD          Onze Lieve Vrouwe Gasthuis Recruiting Amsterdam, Netherlands, 1091AC Contact: P.S. van Dam, MD, PhD    +31205999111    p.s.vandam@olvg.nl    Contact: F. Sivro, MD, PhD    +31205999111    f.sivro@nki.nl    Principal Investigator: P.S. van Dam, MD, PhD          Rijnstate Recruiting Arnhem, Netherlands, 6800TA Contact: V.J.R. Schelfhout, MD, PhD    +31880058888    vschelfhout@rijnstate.nl    Contact: G.S. Bleumink, MD, PhD    +31880058888    gbleumink@rijnstate.nl    Principal Investigator: V.J.R. Schelfhout, MD, PhD          Reinier de Graaf Ziekenhuis Recruiting Delft, Netherlands, 2625 AD Contact: E.T. te Beek, MD, PhD    015-2603060    E.teBeek@rdgg.nl    Contact: M.C.W. Jebbink, MD, PhD       m.jebbink@rdgg.nl    Principal Investigator: E.T. te Beek, MD, PhD          UMCG Recruiting Groningen, Netherlands Contact: T.P. Links, MD, PhD       t.p.links@umcg.nl    Contact: A.H. Brouwers, MD, PhD       a.h.brouwers@umcg.nl    Principal Investigator: T.P. Links, MD, PhD          Principal Investigator: A.H. Brouwers, MD, PhD          St. Antonius Recruiting Nieuwegein, Netherlands, 3430EM Contact: R.G.M. Keijsers, MD, PhD    +310883203000    r.keijsers@antoniusziekenhuis.nl    Contact: I.M. Wakelkamp, MD, PhD    +310883203000    i.wakelkamp@antoniusziekenhuis.nl    Principal Investigator: R.G.M. Keijsers, MD, PhD          HagaZiekenhuis Recruiting The Hague, Netherlands, 2566MJ Contact: M.O. van Aken, MD, PhD    +31702100000    m.vanaken@hagaziekenhuis.nl    Principal Investigator: M.O. van Aken, MD, PhD          UMCU Recruiting Utrecht, Netherlands Contact: B de Keizer, MD, PhD       B.deKeizer@umcutrecht.nl    Contact: K.M.A. Dreijerink, MD, PhD       K.M.A.Dreijerink@umcutrecht.nl    Principal Investigator: B. de Keizer, MD, PhD          Isala Klinieken Recruiting Zwolle, Netherlands, 8025AB Contact: P.L. Jager, MD, PhD    038-4245000    p.l.jager@isala.nl    Contact: G.S. Mijnhout, MD, PhD    038-4245000    g.s.mijnhout@isala.nl    Principal Investigator: P.L. Jager, MD, PhD Less <<
NCT00325546 Obesity Phase 3 Completed - China ... More >> Sanofi-Aventis Shangai, China, 200040 Korea, Republic of Sanofi-Aventis Seoul, Korea, Republic of, 135-755 Taiwan Sanofi-Aventis Taipei, Taiwan, 105 Less <<
NCT01497600 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 1 Completed - United States, California ... More >> Novo Nordisk Investigational Site Chula Vista, California, United States, 91911 Less <<
NCT03275948 Metabolic Disorders and Cognit... More >>ive Decline Less << Not Applicable Completed - -
NCT01552018 Coronary Artery Disease ... More >> Diabetes Mellitus Type 2 Less << Phase 4 Completed - Norway ... More >> Center for Clinical Heart Research, Dept. of Cardiology, Oslo University Hospital Ullevaal Oslo, Norway, N-0424 Less <<
NCT00349726 Infant, Newborn ... More >> Infant, Low Birth Weight Infant, Small for Gestational Age Infant, Premature Retinopathy of Prematurity Bronchopulmonary Dysplasia (BPD) Less << Phase 2 Completed - United States, Connecticut ... More >> Yale University New Haven, Connecticut, United States, 06504 United States, Indiana Indiana University Indianapolis, Indiana, United States, 46202 United States, Michigan Wayne State University Detroit, Michigan, United States, 48201 United States, New Mexico University of New Mexico Albuquerque, New Mexico, United States, 87131 United States, New York University of Rochester Rochester, New York, United States, 14642 United States, North Carolina RTI International Durham, North Carolina, United States, 27705 Duke University Durham, North Carolina, United States, 27710 United States, Ohio Case Western Reserve University, Rainbow Babies and Children's Hospital Cleveland, Ohio, United States, 44106 United States, Rhode Island Brown University, Women & Infants Hospital of Rhode Island Providence, Rhode Island, United States, 02905 United States, Texas University of Texas Southwestern Medical Center at Dallas Dallas, Texas, United States, 75235 United States, Utah University of Utah Salt Lake City, Utah, United States, 84108 Less <<
NCT02379897 Cardiovascular Diseases ... More >> Obesity Less << Not Applicable Completed - -
NCT02623452 Diabetes Mellitus, Type 1 Phase 1 Withdrawn(Change in clinical s... More >>trategy) Less << April 2018 -
NCT00258804 Diabetes Mellitus, Type 2 Phase 4 Completed - -
NCT03341312 Diabetes Mellitus, Type 2 Phase 1 Completed - Germany ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician. Mainz, Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician. Neuss, Germany Less <<
NCT03377153 Non Alcoholic Steatohepatitis Not Applicable Recruiting March 20, 2018 Iran, Islamic Republic of ... More >> National Nutrition and Food Technology Research Institute Recruiting Tehran, Iran, Islamic Republic of Contact: Azits Hekmatdoost Less <<
NCT02531035 Type 1 Diabetes Mellitus (T1DM... More >>) High Level of Sugar (Glucose) in the Blood Less << Phase 3 Completed - -
NCT00395512 Diabetes Mellitus Phase 3 Completed - -
NCT00395512 - Completed - -
NCT01299753 Burns Not Applicable Recruiting August 2020 Canada, Ontario ... More >> Ross Tilley Burn Centre - Sunnybrook HSC Recruiting Toronto, Ontario, Canada, M4N 3M5 Contact: Marc G Jeschke, MD PhD    416-480-6703    marc.jeschke@sunnybrook.ca    Contact: Marjorie Burnett, Hons.BSc    416-480-6100 ext 88021    marjorie.burnett@sunnybrook.ca    Sub-Investigator: Gordon Rubenfeld, MD Less <<
NCT01303042 Diabetes Mellitus, Type 2 Not Applicable Unknown December 2014 Japan ... More >> Dept. of Intern. Med., School of Dentistry, Aichi Gakuin University Recruiting Nagoya, Aichi, Japan, 464-8650 Contact: Takahiro Tosaki, MD, PhD    +81-52-759-2111    nrd49075@nifty.com    Principal Investigator: Takahiro Tosaki, MD, PhD          Sub-Investigator: Keiko Naruse, MD, PhD          Tosaki Clinic for Diabetes and Endocrinology Not yet recruiting Nagoya, Aichi, Japan, 468-0009 Contact: Takahiro Tosaki, MD, PhD       nrd49075@nifty.com    Principal Investigator: Takahiro Tosaki, MD, PhD          Diabetes Clinic, Okazaki East Hospital Recruiting Okazaki, Aichi, Japan, 444-0008 Contact: Takahiro Tosaki, MD, PhD    +81-564-22-6616    nrd49075@nifty.com    Sub-Investigator: Chizuko Suzuki, MD, PhD          Sub-Investigator: Maiko Mizutani, MD, PhD          Principal Investigator: Takahiro Tosaki, MD, PhD          Diabetes Center, Yokkaichi Social Insurance Hospital Recruiting Yokkaichi, Mie, Japan, 510-0016 Contact: Takahiro Tosaki, MD, PhD    +81-59-331-2000    nrd49075@nifty.com    Sub-Investigator: Miho Miyoshi, MD          Sub-Investigator: Tomoki Majima, MD          Principal Investigator: Takahiro Tosaki, MD, PhD Less <<
NCT03772067 Type2 Diabetes ... More >> Healthy Obesity, Metabolically Less << Not Applicable Not yet recruiting October 20, 2019 Israel ... More >> Diabetes Unit E. Wolfson Hospital Holon, Tel Aviv, Israel, 58100 Daniela Jakubowicz Holon, Wolfson Medical Center, Israel, 58100 Less <<
NCT01497561 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 1 Completed - Germany ... More >> Novo Nordisk Investigational Site Graz, Germany, 8036 Less <<
NCT03159494 Diabetes Mellitus ... More >> High-Intensity Interval Training Self Care Less << Not Applicable Completed - -
NCT02941367 Diabetes Mellitus, Type 2 Phase 4 Completed - India ... More >> Investigational Site Number 356005 Ahmedabad, India, 380007 Investigational Site Number 356002 Bangalore, India, 560043 Investigational Site Number 356015 Bangalore, India, 560055 Investigational Site Number 356008 Bangalore, India, 560060 Investigational Site Number 356009 Hyderabad, India, 500001 Investigational Site Number 356018 Hyderabad, India, 500004 Investigational Site Number 356010 Hyderabad, India, 500072 Investigational Site Number 356003 Hyderabad, India, 500095 Investigational Site Number 356007 Jaipur, India Investigational Site Number 356019 Madurai, India, 625020 Investigational Site Number 356014 Mumbai, India, 400007 Investigational Site Number 356022 Nagpur, India, 440010 Israel Investigational Site Number 376001 Haifa, Israel, 31096 Investigational Site Number 376002 Safed, Israel, 13100 Kuwait Investigational Site Number 414001 Kuwait, Kuwait Turkey Investigational Site Number 792002 Zonguldak, Turkey Less <<
NCT00390520 Diabetes Mellitus, Type 2 Phase 3 Completed - Switzerland ... More >> Novartis Basel, Switzerland Less <<
NCT01571661 Diabetes Mellitus, Type 2 Phase 1 Completed - -
NCT01375738 Gastric Cancer ... More >> Diabetes Less << Not Applicable Unknown May 2014 Korea, Republic of ... More >> Severance Hospital Recruiting Seoul, Korea, Republic of, 120-752 Contact: Ji Yeong An, MD    82-2-2228-2100    jar319@yuhs.ac    Contact: Yoo-Min Kim, MD       AUG79@yuhs.ac Less <<
NCT03033667 Metabolism Disorder Not Applicable Completed - -
NCT03479671 Diabetes Mellitus, Type 2 ... More >> Insulin Resistance Insulin Sensitivity Less << Early Phase 1 Not yet recruiting January 2020 -
NCT01649466 Type 2 Diabetes Mellitus Phase 4 Completed - -
NCT03377140 Non Alcoholic Steatohepatitis Not Applicable Recruiting March 20, 2018 Iran, Islamic Republic of ... More >> National Nutrition and Food Technology Research Institute Recruiting Tehran, Iran, Islamic Republic of Contact: Azits Hekmatdoost Less <<
NCT00986973 Phenylketonuria Not Applicable Completed - United States, Pennsylvania ... More >> Children's Hospital of Philadelphia, Section of Metabolism,PKU program Philadelphia, Pennsylvania, United States, 19106 Less <<
NCT01246869 - Recruiting December 2021 United States, Utah ... More >> Huntsman Cancer Institute Recruiting Salt Lake City, Utah, United States, 84112 Principal Investigator: John M Hoffman, MD Less <<
NCT02196571 Gestational Diabetes Mellitus Not Applicable Completed - Croatia ... More >> Association for functional rehabilitation, recreation and applied kinesiology Impuls Zagreb, Croatia, 10000 Less <<
NCT03685357 - Recruiting January 2020 Egypt ... More >> AinShams University Recruiting Cairo, Egypt Principal Investigator: Afnan Elgnainy Less <<
NCT00986973 - Completed - -
NCT00062972 Multiple Sclerosis Phase 3 Withdrawn(Study terminated/wit... More >>hdrawn) Less << - United States, New York ... More >> University Hospital and Medical Center Stony Brook, New York, United States, 11794-8121 Less <<
NCT01791647 Polycystic Ovary Syndrome Not Applicable Unknown - Italy ... More >> Catholic University of Sacred Heart Recruiting Rome, Italy, 00168 Contact: Maurizio Guido, Medical Doctor    063057794       Principal Investigator: Maurizio Guido, Medical Doctor Less <<
NCT01119846 Diabetes Mellitus, Type 2 Phase 2 Completed - United States, Arizona ... More >> GSK Investigational Site Phoenix, Arizona, United States, 85013 United States, California GSK Investigational Site Chula Vista, California, United States, 91910 United States, Florida GSK Investigational Site Miami, Florida, United States, 33169 United States, North Carolina GSK Investigational Site Durham, North Carolina, United States, 27705 United States, Ohio GSK Investigational Site Columbus, Ohio, United States, 43212 United States, Texas GSK Investigational Site San Antonio, Texas, United States, 78209 United States, Washington GSK Investigational Site Tacoma, Washington, United States, 98418 Less <<
NCT03645408 Alcohol Use Disorder Phase 1 Not yet recruiting August 2021 United States, Massachusetts ... More >> Boston University Psychiatry Research Center, Clinical Studies Unit Boston, Massachusetts, United States, 02118 Less <<
NCT03429543 Diabetes Mellitus, Type 2 Phase 3 Recruiting January 31, 2022 -
NCT03519217 - Not yet recruiting December 2020 -
NCT01286103 Healthy Phase 1 Completed - -
NCT02280837 - Unknown September 2018 Japan ... More >> Sapporo Medical University, School of Medicine Recruiting Sappro, Hokkaido, Japan, 0608556 Contact: Michiaki Yamakage, M.D.,PhD    +81116112111 ext 3568    yamakage@sapmed.ac.jp    Principal Investigator: Michiaki Yamakage, M.D.,PhD Less <<
NCT03534193 Type 1 Diabetes Mellitus Not Applicable Recruiting June 2020 United States, New Jersey ... More >> Joseph M. Sanzari Children's Hospital Recruiting Hackensack, New Jersey, United States, 07601 Contact: Susan Mathus, BSN    551-996-8178    susan.mathus@hackensackmeridian.org Less <<
NCT00109434 - Completed - United States, California ... More >> Division of Pediatric Endocrinology and Diabetes, Stanford University Stanford, California, United States, 94305-5208 United States, Colorado Barbara Davis Center for Childhood Diabetes, University of Colorado Denver, Colorado, United States, 80262 United States, Connecticut Department of Pediatrics, Yale University School of Medicine New Haven, Connecticut, United States, 06519 United States, Florida Nemours Children's Clinic Jacksonville, Florida, United States, 32207 United States, Iowa Department of Pediatrics, University of Iowa Carver College of Medicine Iowa City, Iowa, United States, 52242 Less <<
NCT01805414 Diabetes, Type 1 ... More >> Diabetes, Type 2 Cardiovascular Disease Hyperglycemia Less << Not Applicable Completed - United States, North Carolina ... More >> Duke Medical Center Durham, North Carolina, United States, 27710 Less <<
NCT01119846 - Completed - -
NCT01610934 Maturity-onset Diabetes of the... More >> Young Less << Phase 2 Phase 3 Completed - Denmark ... More >> Diabetes research Division, University Hospital Gentofte Hellerup, Denmark, 2900 Less <<
NCT00327626 Type 2 Diabetes Mellitus Phase 2 Withdrawn(study was never star... More >>ted due to regional geopolitical conflict) Less << - Israel ... More >> Soroka Medical Center BeEr-Sheva, Israel, 84101 Rambam Medical Center Haifa, Israel, 31096 Western Galilee Medical Center - Nahariya Nahariya, Israel, 22100 Kaplan Medical Center Rehovot, Israel, 76100 ZIV Hospital Safed, Israel, 13100 Less <<
NCT02212327 - Recruiting December 2019 United States, Tennessee ... More >> Vanderbilt University Medical Center Recruiting Nashville, Tennessee, United States, 37232 Contact: Aseel Alsouqi, MD    615-343-6225    aseel.alsouqi@vanderbilt.edu    Principal Investigator: Alp Ikizler, MD Less <<
NCT03496233 Chronic HCV Hepatitis Phase 3 Not yet recruiting December 2018 Italy ... More >> Policlinico Paolo Giaccone Not yet recruiting Palermo, Italy, 90127 Contact: Vincenza Calvaruso, MD, PHD       vincenza.calvaruso@unipa.it Less <<
NCT03230123 Diabetes Mellitus ... More >> Pre-diabetes Less << Not Applicable Recruiting June 2018 Brazil ... More >> Federal University of Sao Paulo Recruiting Sao Paulo, SP, Brazil, 04039030 Contact: Maria C Izar, M.D.; Ph.D.    55-11-55499395    mcoizar@terra.com.br    Contact: Francisco A Fonseca, M.D.; Ph.D.    55-11-55499395    fahfonseca@terra.com.br    Principal Investigator: Maria C Izar, M.D.; Ph.D.          Sub-Investigator: Edna S Costa, N.D.; M.Sc.          Sub-Investigator: Francisco A Fonseca, M.D.; Ph.D.          Sub-Investigator: Henrique T Bianco, M.D., Ph.D.          Sub-Investigator: Juliana T Kato, N.D., M.Sc.          Sub-Investigator: Thiago T Freitas, N.D., M.Sc.          Sub-Investigator: Carolina N Franca, Ph.D.          Sub-Investigator: Henrique A Fonseca, Ph.D. Less <<
NCT02773368 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT02522390 - Active, not recruiting January 2025 Austria ... More >> Medizinische Universität Graz Graz, Austria, A-8036 Belgium University of Leuven (KU Leuven) Leuven, Belgium Czechia Charles University Prague Prague, Czechia Denmark University of Copenhagen Copenhagen, Denmark Finland University of Eastern Finland Kuopio, Finland, FI-70210 France INRA - L'Institut Nationel de la Recherche Agronomique Clermont, France Ireland University College Dublin Dublin, Ireland Italy CRA-NUT - Centro di Ricerca per gli Alimenti e la Nutrizione Rome, Italy, 00178 Netherlands TNO Zeist, Gelderland, Netherlands Spain University of Barcelona Barcelona, Spain Switzerland Agroscope, Institute for Food Sciences Berne, Switzerland United Kingdom Newcastle University Newcastle, United Kingdom Less <<
NCT02773368 - Completed - -
NCT02844517 Diabetes Mellitus, Type 1 Not Applicable Completed - United States, California ... More >> William Sansum Diabetes Center Santa Barbara, California, United States, 93105 Stanford University Stanford, California, United States, 94304 United States, Colorado Barbara Davis Center, University of Colorado Aurora, Colorado, United States, 80045 United States, Massachusetts Harvard University (Joslin Diabetes Center) Boston, Massachusetts, United States, 02215 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55902 United States, New York Mt. Sinai New York, New York, United States, 10029 United States, Virginia University of Virginia Center for Diabetes Technology Charlottesville, Virginia, United States, 22903 France University of Montpellier Montpellier, France Italy University of Padova Padova, Italy Netherlands Academic Medical Center Amsterdam, Netherlands Less <<
NCT00413400 - Completed - -
NCT01224860 Renal Transplant Phase 2 Completed - Italy ... More >> Mario negri Institute - Clinical Research Center for Rare Diseases Ranica, Bergamo, Italy, 24020 Less <<
NCT00413400 Metabolic Syndrome Not Applicable Completed - United States, Massachusetts ... More >> MGH Boston, Massachusetts, United States, 02114 Less <<
NCT00517465 Diabetes Mellitus Type 2 Phase 1 Completed - Germany ... More >> Berlin, Germany, 14050 Neuss, Germany, 41460 Hungary Balatonfuered, Hungary, 8230 Budapest, Hungary, 1027 Slovakia Bratislava, Slovakia, 82108 Bratislava, Slovakia, 833 05 United Kingdom Slough, United Kingdom, SL1 4AA Welwyn Garden City, United Kingdom, AL7 1TW Less <<
NCT02235584 Type 2 Diabetes Not Applicable Completed - Denmark ... More >> Bispebjerg University Hospital Copenhagen NV, Denmark, 2400 Less <<
NCT00871507 Diabetes Mellitus, Type 2 Phase 1 Completed - United States, Florida ... More >> Fort Myers, Florida, United States United States, Texas San Antonio, Texas, United States Less <<
NCT02967354 Type2 Diabetes Not Applicable Completed - -
NCT02100748 Acute Pain Phase 2 Completed - United States, Arizona ... More >> Premier Research Phoenix, Arizona, United States, 85027 United States, Maryland Chesapeake Research Group Pasadena, Maryland, United States, 21122 United States, Texas Premier Research Austin, Texas, United States, 78705 United States, Utah Jean Brown Research Salt Lake City, Utah, United States, 84124 Less <<
NCT03541096 Adipose Tissue, Brown ... More >> Brown Adipose Tissue Uncoupling Protein 1 Cold Exposure Obesity Type 2 Diabetes Mellitus Winter Swimming Less << Not Applicable Recruiting June 1, 2019 Denmark ... More >> Center for Inflammation and Metabolism/ Center for Physical Activity Research Recruiting Copenhagen, Denmark, 2100 Contact: Susanna Søberg, MSc.    0045 93565234    susanna@sund.ku.dk Less <<
NCT00353587 Type 2 Diabetes Phase 2 Phase 3 Completed - -
NCT00936156 Metastatic, Cerebral Primitive... More >> Neuroectodermal Tumors Less << Phase 2 Completed - France ... More >> Institut Gustave Roussy Villejuif, France, 94800 Less <<
NCT01931540 Maternal-Fetal Relations ... More >> Muscle Weakness Insulin Resistance Less << Not Applicable Completed - Finland ... More >> University of Helsinki, Department of General Practice and Primary Health Care Helsinki, Finland, 00014 Turku PET Centre (Turku University Hospital) Turku, Finland, 20521 Less <<
NCT00758680 Type 2 Diabetes Phase 1 Terminated - -
NCT02967354 - Completed - -
NCT01574820 Prediabetes C... More >>oronary Artery Disease Insulin Resistance Glucose Intolerance Less << Phase 3 Completed - -
NCT00758680 - Terminated - -
NCT02053077 - Completed - Austria ... More >> Medical University of Graz Graz, Styria, Austria, 8010 Less <<
NCT03343366 Chronic Periodontitis ... More >> Type 2 Diabetes Mellitus Less << Phase 2 Phase 3 Recruiting April 30, 2020 Pakistan ... More >> Dow University of Health Sciences Recruiting Karachi, Sind, Pakistan, 00000 Contact: Ambrina Qureshi, PhD Scholar    +922199232660 ext 4063    ambrina.qureshi@duhs.edu.pk    Contact: Zeba Haque, PhD    +922199232660 ext 4035    z.haque@duhs.edu.pk    Principal Investigator: Ambrina Qureshi, M.Phil          Sub-Investigator: Zeba Haque, PhD          Sub-Investigator: Syed Akhtar Hussain Bukhari, PhD          Sub-Investigator: Akhtar Ali Baloch, FRCP Less <<
NCT02685345 Type 2 Diabetes Mellitus Phase 2 Completed - Japan ... More >> Yodogawaku, Osaka, Japan, 565-0853 Less <<
NCT03481101 Non Small Cell Lung Cancer ... More >> Circulating Tumor Cell Circulating Tumor DNA Less << Not Applicable Recruiting February 28, 2021 Denmark ... More >> University Copenhagen Not yet recruiting Copenhagen, Denmark, 2200 Contact: heidi ryssel    +4528727532       University of Copenhagen Recruiting Copenhagen, Denmark Less <<
NCT03251716 Metabolic Syndrome ... More >> Female Schizophrenia Less << Not Applicable Completed - China, Tianjin ... More >> Tianjin Anding Hospital Tianjin, Tianjin, China, 300222 Less <<
NCT02503865 Metabolic Syndrome Phase 1 Phase 2 Completed - Kazakhstan ... More >> Republican Scientific Center for Emergency Medicine Astana, Kazakhstan, 010000 Less <<
NCT02503865 - Completed - -
NCT02679235 Frontal Lobe Hypometabolism Phase 1 Phase 2 Completed - Canada, Quebec ... More >> Research Centre on Aging (CSSS-IUGS - CIUSSS de l'Estrie - CHUS) Sherbrooke, Quebec, Canada, J1H4C4 Less <<
NCT00029926 - Completed - United States, Maryland ... More >> National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Bethesda, Maryland, United States, 20892 Less <<
NCT03485170 Hemophilia Ar... More >>thropathy Inflammation Less << Not Applicable Recruiting December 31, 2018 Taiwan ... More >> Hemophilia care and research center Recruiting Taipei, Taiwan, 114 Contact: Tsung-Ying Li, MD    886-87927166 Less <<
NCT02548494 Diabetes Mellitus, Type 1 ... More >> Diabetic Ketoacidosis Less << Not Applicable Recruiting December 2019 United States, Tennessee ... More >> Children's @ Erlanger Recruiting Chattanooga, Tennessee, United States, 37403 Contact: Rita K Shridharani, MD    423-778-7000    Rita.Shridharani@Erlanger.org    Sub-Investigator: Gregory Talbott, MD          Sub-Investigator: Alissa Guarneri, MD          Sub-Investigator: Amy Gerwin, PharmD Less <<
NCT02548585 Type 2 Diabetes Mellitus Phase 1 Phase 2 Completed - Germany ... More >> Research Site Berlin, Germany, 10117 Research Site Erfurt, Germany, 99084 Research Site Kiel, Germany, 24105 Research Site Leipzig, Germany, 04103 Research Site Lübeck, Germany, 23538 Research Site Magdeburg, Germany, 39120 Research Site Mainz, Germany, 55116 Research Site Mannheim, Germany, 68167 Research Site München, Germany, 81241 Research Site Neu-Ulm, Germany, 89231 Research Site Neuss, Germany, 41460 Less <<
NCT02824263 Obstructive Sleep Apnea Not Applicable Recruiting January 2023 United States, Maryland ... More >> Johns Hopkins Bayview Medical Center Recruiting Baltimore, Maryland, United States, 21224 Contact: Chenjuan Gu    410-550-1816    cgu14@jhmi.edu    Contact: Tracy Klopfer    4105502380    tracy.klopfer@jhmi.edu    Principal Investigator: Jonathan C Jun, MD          Sub-Investigator: Vsevolod Y Polotsky, MD, Ph.D          Sub-Investigator: Alan R Schwartz, MD          Sub-Investigator: Philip L Smith, MD          Sub-Investigator: Susheel Patil, MD, Ph.D          Sub-Investigator: Jason Kirkness, Ph.D          Sub-Investigator: Hartmut Schneider, MD, Ph.D Less <<
NCT02594787 Imbalance of Constituents of F... More >>ood Intake Healthy Less << Not Applicable Completed - -
NCT03246295 - Active, not recruiting October 1, 2017 -
NCT00872846 Type 2 Diabetes ... More >> Obesity Less << Phase 1 Completed - Germany ... More >> University Clinic Hamburg-Eppendorf (UKE) Hamburg, Germany Less <<
NCT01159249 Type 2 Diabetes Phase 3 Completed - Japan ... More >> Novartis Investigative Site Hunabashi, Chiba, Japan, 274-0805 Novartis Investigative Site Chikushino, Fukuoka, Japan, 818-0036 Novartis Investigative Site Itoshima-shi, Fukuoka, Japan, 819-1102 Novartis Investigative Site Koriyama, Fukushima, Japan, 963-8851 Novartis Investigative Site Kobe, Hyogo, Japan, 658-0064 Novartis Investigative Site Kawasaki, Kanagawa, Japan, 210-0852 Novartis Investigative Site Kawasaki, Kanagawa, Japan, 212-0024 Novartis Investigative Site Yokohama-city, Kanagawa, Japan, 221-0077 Novartis Investigative Site Yokohama, Kanagawa, Japan, 221-0065 Novartis Investigative Site Izumisano, Osaka, Japan, 598-0048 Novartis Investigative Site Hannou, Saitama, Japan, 357-0024 Novartis Investigative Site Hiki-Gun, Saitama, Japan, 355-0328 Novartis Investigative Site Kawaguchi, Saitama, Japan, 332-0012 Novartis Investigative Site Koshigaya city, Saitama, Japan, 343-0826 Novartis Investigative Site Tokorozawa, Saitama, Japan, 359-1161 Novartis Investigative Site Edogawa-ku, Tokyo, Japan, 134-0084 Novartis Investigative Site Hachioji, Tokyo, Japan, 192-0046 Novartis Investigative Site Katsushika-ku, Tokyo, Japan, 125-0041 Novartis Investigative Site Minato-ku, Tokyo, Japan, 108-0075 Novartis Investigative Site Shinagawa-ku, Tokyo, Japan, 141-0032 Novartis Investigative Site Toshima-ku, Tokyo, Japan, 171-0021 Novartis Investigative Site Fukuoka, Japan, 807-0857 Novartis Investigative Site Fukuoka, Japan, 816-0094 Novartis Investigative Site Fukuoka, Japan, 819-0168 Less <<
NCT03249259 Diabetes Mellitus, Type 2 Phase 3 Recruiting April 30, 2019 Korea, Republic of ... More >> Seoul National University Bundang Hospital Recruiting Seongnam, Gyeonggi, Korea, Republic of, 463-707 Contact: Soo Lim, MD, PHD    82-31-787-7035    limsoo@snu.ac.kr    Contact: Tae Jung Oh, MD, PHD    82-31-787-7078    ohtjmd@gmail.com    Principal Investigator: Soo Lim, MD, PHD Less <<
NCT01690936 Obesity Not Applicable Completed - United States, Indiana ... More >> Purdue University West Lafayette, Indiana, United States, 47907 Less <<
NCT01367106 21-hydroxylase; Defect Not Applicable Active, not recruiting June 2018 France ... More >> Hôpital saint Louis Paris, France, 75010 Professor GAUTIER Paris, France Less <<
NCT01612741 - Completed - India ... More >> Many Locations, India Less <<
NCT02631265 Type 1 Diabetes Not Applicable Completed - Canada, Quebec ... More >> Institut de recherches cliniques de Montréal Montreal, Quebec, Canada, H2W 1R7 Less <<
NCT02833415 Obesity, Visceral Phase 4 Completed - United States, Texas ... More >> University of Texas Southwestern Medical Center Dallas, Texas, United States, 75390 Less <<
NCT00683813 Cardiovascular Disease Not Applicable Completed - Canada, British Columbia ... More >> St. Paul's Hospital Vancouver, British Columbia, Canada, V6Z 1Y6 Less <<
NCT03310203 Iron Absorption Not Applicable Recruiting March 30, 2019 Lebanon ... More >> American University of Beirut Recruiting Beirut, Lebanon Contact: Omar Obeid, PhD    +9611350000 ext 4440    omar.obeid@aub.edu.lb Less <<
NCT03052582 Atherosclerosis Not Applicable Completed - Denmark ... More >> Department of Nutrition, Exercise and Sports, University of Copenhagen Copenhagen, Denmark, 1958 Less <<
NCT02145559 Breast Neoplasms ... More >> Lung Neoplasms Cancer of Liver Lymphoma Cancer of Kidney Less << Phase 1 Active, not recruiting July 2019 United States, Illinois ... More >> University of Chicago Chicago, Illinois, United States, 60637 Less <<
NCT02948673 Type 2 Diabetes ... More >> Oxidative Stress Mitochondrial Reactive Oxygen Species Production Less << Not Applicable Completed - Denmark ... More >> Xlab, Department of Biomedical Sciences, Faculty Of Health Sciences, University of Copenhagen Copenhagen, Nørrebro, Denmark, 2200 Less <<
NCT01076842 Diabetes Type 2 Phase 4 Completed - United States, District of Col... More >>umbia MedStar Research Institute Washington, District of Columbia, United States, 20003 Walter Reed Army Medical Center Washington, District of Columbia, United States, 20306 Less <<
NCT03305939 Gestational Diabetes Mellitus ... More >>in Pregnancy Less << Not Applicable Recruiting July 31, 2020 Bangladesh ... More >> Icddr,B Recruiting Dhaka, Bangladesh, 1212 Contact: Aliya Naheed, Dr    01709651476 ext 2521    anaheed@icddrb.org    Contact: Sabrina Ahmed, Dr    01674750046 ext 2540    sabrina.ahmed@icddrb.org Less <<
NCT00727857 Diabetes Mellitus Phase 3 Completed - -
NCT00895986 Type 2 Diabetes Not Applicable Completed - United States, Massachusetts ... More >> Joslin Diabetes Center Boston, Massachusetts, United States, 02215 Less <<
NCT00109785 Breast Cancer Phase 1 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00727857 - Completed - -
NCT00097279 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT02044835 Atherosclerotic Renal Artery S... More >>tenosis Less << Phase 2 Phase 3 Unknown - China, Beijing ... More >> Guang anmen Hospital,China Academy of Chinese Medical Sciences Recruiting Beijing, Beijing, China, 100053 Contact: Shen Li    +86-13681116668    lishen58173@163.com    Principal Investigator: Shen Li          Sub-Investigator: Xiangrong Rao          Sub-Investigator: Huichai Pan          Sub-Investigator: Lee Wang          Sub-Investigator: Yu Zhao          Sub-Investigator: Ming Ye          Sub-Investigator: Haitao Lu          Sub-Investigator: Xiujuan Wang          Sub-Investigator: Fengmei Lian Less <<
NCT01858233 Gestational Diabetes ... More >> Weight Gain During Pregnancy Weight Loss After Pregnancy Less << Not Applicable Completed - United States, Pennsylvania ... More >> University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT01835678 Type 2-diabetes Phase 3 Completed - Germany ... More >> Clinical Research Unit, Department of Nephrology and Hypertension, University of Erlangen-Nürnberg Erlangen, Germany, 91054 Clinical Research Unit, Department of Nephrology and Hypertension, University of Erlangen-Nürnberg Nuremberg, Germany, 90471 Less <<
NCT03094767 Diabetes Mellitus, Type 2 ... More >> Rehabilitation Respiratory Therapy Less << Not Applicable Recruiting November 2017 Brazil ... More >> União Educacional do Norte Recruiting Rio Branco, Acre, Brazil, 69915-497 Contact: Natália da Silva Freitas Marques, Master    015 55 68 999726363    nataliafreitas2@hotmail.com Less <<
NCT02065544 Type 2 Diabetes Mellitus Not Applicable Completed - -
NCT01294423 - Completed - -
NCT01294423 Type 2 Diabetes ... More >> High Blood Sugar Less << Phase 3 Completed - Japan ... More >> Research Site Noda, Chiba, Japan Research Site Yukuhashi, Fukuoka, Japan Research Site Hiroshima-shi, Hiroshima, Japan Research Site Chitose-shi, Hokkaido, Japan Research Site Sapporo, Hokkaido, Japan Research Site Takasago-shi, Hyogo, Japan Research Site Hakusan-shi, Ishikawa, Japan Research Site Sanuki-shi, Kagawa, Japan Research Site Takamatsu-shi, Kagawa, Japan Research Site Ebina-shi, Kanagawa, Japan Research Site Kamakura-shi, Kanagawa, Japan Research Site Sendai-shi, Miyagi, Japan Research Site Sendai, Miyagi, Japan Research Site Matsumoto-shi, Nagano, Japan Research Site Osaka-shi, Osaka, Japan Research Site Suita, Osaka, Japan Research Site Otsu-shi, Shiga, Japan Research Site Shizuoka-shi, Shizuoka, Japan Research Site Chuo-ku, Tokyo, Japan Research Site Chuo, Tokyo, Japan Research Site Meguro-ku,, Tokyo, Japan Research Site Ota-ku, Tokyo, Japan Research Site Takaoka-shi, Toyama, Japan Research Site Toyama-shi, Toyama, Japan Research Site Fukuoka, Japan Research Site Okayama, Japan Research Site Tokyo, Japan Less <<
NCT03189225 Diabetes Mellitus Not Applicable Completed - United Kingdom ... More >> Diabetes Centre, Heartlands Hospital Birmingham, United Kingdom, B9 5SS NHS Lothian Edinburgh, United Kingdom, EH16 4SA Highland Diabetes Institute Inverness, United Kingdom, IV2 3JH Less <<
NCT00201942 Breast Cancer Phase 3 Completed - Canada, Ontario ... More >> St. Joseph's Hamilton, Ontario, Canada, L8N 4A6 Juravinski Cancer Centre Hamilton, Ontario, Canada, L8V 1C3 Kingston Regional Cancer Centre Kingston, Ontario, Canada, K7L 5P9 London Regional Cancer Centre London, Ontario, Canada, N6A 4L6 Ottawa Regional Cancer Centre Ottawa, Ontario, Canada, K1Y 4K7 North York Toronto, Ontario, Canada, M2J 1V1 Sunnybrook Regional Cancer Centre and Women's College Toronto, Ontario, Canada, M4N 3M5 St. Michael's Toronto, Ontario, Canada, M5B 1W8 Mount Sinai Hospital Toronto, Ontario, Canada, M5G 1X5 Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Less <<
NCT00972244 Type 2 Diabetes Mellitus Phase 2 Completed - Japan ... More >> Research Site Anjyo, Japan Research Site Bunkyo-ku, Japan Research Site Chuo-ku, Japan Research Site Daito, Japan Research Site Kamagaya, Japan Research Site Kashiwara, Japan Research Site Matsuyama, Japan Research Site Nagoya, Japan Research Site Nakano-ku, Japan Research Site Naka, Japan Research Site Nerima-ku, Japan Research Site Okinawa, Japan Research Site Osaka, Japan Research Site Sapporo, Japan Research Site Shibuya-ku, Japan Research Site Shinjyuku-ku, Japan Research Site Suita, Japan Research Site Uji, Japan Research Site Wakayama, Japan Research Site Yamato, Japan Less <<
NCT00743002 Diabetes Mellitus, Type 2 Phase 2 Completed - United States, California ... More >> Artesia, California, United States Los Angeles, California, United States Santa Ana, California, United States Torrence, California, United States Walnut Creek, California, United States United States, Florida Deland, Florida, United States United States, Illinois Bloomingdale, Illinois, United States United States, Michigan Grand Rapids, Michigan, United States United States, Missouri St. Louis, Missouri, United States United States, Nevada Las Vegas, Nevada, United States United States, New Jersey Clifton, New Jersey, United States United States, North Carolina Asheboro, North Carolina, United States Wilmington, North Carolina, United States United States, Pennsylvania Bensalem, Pennsylvania, United States United States, Tennessee Athens, Tennessee, United States United States, Texas Corpus Christi, Texas, United States Dallas, Texas, United States Houston, Texas, United States Richmond, Texas, United States San Antonio, Texas, United States Less <<
NCT01136798 Type 2 Diabetes ... More >> Sleep Disordered Breathing Less << Not Applicable Completed - United States, Illinois ... More >> The University of Chicago Chicago, Illinois, United States, 60637 University of Chicago Chicago, Illinois, United States, 60637 Less <<
NCT00972244 - Completed - -
NCT03490448 Obesity, Childhood ... More >> Vitamin D Deficiency Less << Not Applicable Completed - China, Shanghai ... More >> Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai, China, 200092 Less <<
NCT01776476 Stress Hyperglycemia ... More >> Insulin Resistance Trauma Critical Illness Less << Phase 2 Unknown February 2014 United States, Tennessee ... More >> Vanderbilt University Medical Center Not yet recruiting Nashville, Tennessee, United States, 37232 Contact: Addison K May, MD FACS FCCM    615-936-7188    addison.may@vanderbilt.edu    Contact: Kaushik Mukherjee, MD MSCI    615-936-2953    kaushik.mukherjee@vanderbilt.edu Less <<
NCT02321553 Metabolic Syndrome Not Applicable Completed - United States, Massachusetts ... More >> Clinical and Translation Research Center, Tufts Medical Center Boston, Massachusetts, United States, 02111 Less <<
NCT03002545 Effect of Magnesium in Diabete... More >>s Less << Not Applicable Recruiting March 2019 Germany ... More >> St. Anna Hospital Recruiting Herne, Germany, 44649 Contact: Klaus Kisters, Prof. Dr.    004923259862100    klaus.kisters@elisabethgruppe.de    Sub-Investigator: Martin Kolisek, Dr. Dr.          Sub-Investigator: Juergen Vormann, Prof. Dr. Less <<
NCT00300287 Diabetes Mellitus, Type 2 Phase 3 Completed - Germany ... More >> Investigative Sites, Germany Less <<
NCT01136798 - Completed - -
NCT03627559 - Completed - -
NCT00661947 - Completed - United States, Florida ... More >> University of Florida, Department of Pharmacy Practice, Center for Pharmacogenomics Gainesville, Florida, United States, 32610 Less <<
NCT00214916 Critical Illness Phase 2 Active, not recruiting June 2021 Belgium ... More >> Dep Intensive Care Medicine University Hospital Leuven Leuven, Belgium, 3000 Less <<
NCT03249610 Diabetes Mellitus, Type 2 ... More >> Metabolic Syndrome Lifestyle Risk Reduction Less << Not Applicable Completed - -
NCT00978640 Healthy Not Applicable Unknown June 2012 Denmark ... More >> mikkel Holm Vendelbo Århus, Jylland, Denmark, 8000 Less <<
NCT01053195 Type 2 Diabetes Not Applicable Completed - China, Shandong ... More >> Qingdao Municipal Center for Disease Control & Prevention Qingdao, Shandong, China, 266033 Less <<
NCT02409927 Healthy Not Applicable Completed - -
NCT00976937 - Completed - -
NCT01425866 Type 2 Diabetes Not Applicable Completed - France ... More >> Groupe Hopitalier Est Réunion Saint Benoît, La Réunion, France, 97470 Centre Hospitalier Gabriel Martin Saint Paul, La Réunion, France, 97863 Diabetolgy - UNiversity Hospital Sud Réunion Saint Pierre, La Réunion, France, 97448 Department of endocrinology, University Hospital Reunion Island - Felix Guyon Site Saint Denis de La Réunion, France, 97405 Less <<
NCT02192255 Diabetes Not Applicable Completed - United States, Minnesota ... More >> HealthPartners Institute for Education and Research Minneapolis, Minnesota, United States, 55425 Less <<
NCT00697333 Non-small Cell Lung Cancer Phase 2 Unknown May 2017 Germany ... More >> Universitätsklinikum Freiburg Recruiting Freiburg i.Br., Baden-Wuerttemberg, Germany, D-79106 Contact: T. Schimek-Jasch, MD    49-761-270 ext 95201    tanja.schimek-jasch@uniklinik-freiburg.de    Contact: S. Adebahr, MD    49-761-270 ext 95371    sonja.adebahr@uniklinik-freiburg.de    Principal Investigator: Ursula Nestle, Prof.          Universitätsklinikum Freiburg Recruiting Freiburg i. Br., Baden-Württemberg, Germany, D-79106 Contact: Ursula Nestle, Prof.    49-761-270 ext 95390    ursula.nestle@uniklinik-freiburg.de    Contact: A.-L. Grosu, Prof.    49-761-270 ext 94610    anca.grosu@uniklinik-freiburg.de Less <<
NCT00976937 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT03689608 PreDiabetes Not Applicable Recruiting December 31, 2022 Australia, South Australia ... More >> University of Adelaide Recruiting Adelaide, South Australia, Australia Contact: Leonie K Heilbronn, PhD    +61 8128 4838    leonie.heilbronn@adelaide.edu.au    Principal Investigator: Leonie K Heilbronn, PhD Less <<
NCT03312764 PreDiabetes Not Applicable Enrolling by invitation January 1, 2020 United States, Nebraska ... More >> University of Nebraska Medical Center Omaha, Nebraska, United States, 68198-4365 Less <<
NCT02409927 - Completed - -
NCT00528372 Type 2 Diabetes Phase 3 Completed - -
NCT00528372 - Completed - -
NCT00519935 Type 1 Diabetes Not Applicable Completed - United States, Michigan ... More >> Children's Hospital of Michigan Detroit, Michigan, United States, 48201 Less <<
NCT01630759 Gestational Diabetes Not Applicable Completed - Ireland ... More >> Letterkenny General Hospital Letterkenny, Donegal, Ireland United Kingdom Altnagelvin Hospital Londonderry, United Kingdom, BT47 6SB Less <<
NCT00661648 Pancreatic Diseases Phase 4 Unknown June 2009 Japan ... More >> Kochi Medical School Recruiting Nankoku-City, Kochi, Japan, 783-8505 Contact: Takehiro Okabayashi, MD    81-88-880-2370    tokabaya@kochi-u.ac.jp    Contact: Kazuhiro Hanazaki, Prof    81-88-880-2370    im31@kochi-u.ac.jp Less <<
NCT00948402 Polycystic Ovarian Syndrome ... More >> Insulin Sensitivity Less << Phase 3 Completed - -
NCT01281579 Healthy Phase 1 Completed - -
NCT01628445 Type 2 Diabetes Phase 3 Terminated(Error made by local... More >> pharmacy caused mixed randomization of 20 participants) Less << - Canada, Manitoba ... More >> Winnipeg Regional Health Authority Health Sciences Centre Winnipeg Diabetes Research Group Winnipeg, Manitoba, Canada, R3E3P4 Less <<
NCT03455816 Diabetes Mellitus, Type 1 Not Applicable Recruiting December 2018 Spain ... More >> Regional University Hospital of Málaga Recruiting Málaga, Spain Contact: Maria Soledad Ruiz de Adana, MD PhD    +34 629221089    solruizdeadana@gmail.com    Principal Investigator: Virginia Morillas Jiménez, MD PhD Less <<
NCT00442988 - Completed - Belgium ... More >> Dpt of Nephrology and Renal Transplantation Leuven, Belgium, B-3000 Less <<
NCT01921322 Type 2 Diabetes Not Applicable Completed - China, Jilin ... More >> The Second Hospital of Jilin University Changchun, Jilin, China China Chinese PLA General Hospital Beijing, China Less <<
NCT01314586 Hypercholesterolemia Not Applicable Completed - United States, Iowa ... More >> Nutrition & Wellness Research Center Ames, Iowa, United States, 50011 Less <<
NCT00612599 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - Denmark ... More >> Novo Nordisk Investigational Site Århus C, Denmark, 8000 Less <<
NCT00826904 - Active, not recruiting December 2018 United States, Colorado ... More >> University of Colorado Denver Aurora, Colorado, United States, 80045 Less <<
NCT01921322 - Completed - -
NCT02818452 Glycemic Responses Not Applicable Completed - Canada ... More >> GI Labs Toronto, Canada Less <<
NCT01868581 Diabetes Heal... More >>thy Less << Phase 1 Completed - Germany ... More >> Neuss, Germany, 41460 Less <<
NCT00657943 Type 2 Diabetes ... More >> Atherosclerosis Arteriosclerosis Less << Phase 4 Completed - Denmark ... More >> Rigshospitalet Copenhagen, Denmark, 2100 Bispebjerg Hospital Copenhagen, Denmark, 2400 Frederiksberg Hospital Frederiksberg, Denmark, 2000 Gentofte Sygehus Gentofte, Denmark, 2820 Steno Diabetes Center Gentofte, Denmark, 2820 Herlev Hospital Herlev, Denmark, 2830 Hillerod Sygehus Hillerod, Denmark, 3400 Hvidovre Hospital Hvidovre, Denmark, 2650 Køge Sygehus Koge, Denmark, 4600 Less <<
NCT00151684 Obesity Hyper... More >>insulinism Less << Phase 2 Completed - Netherlands ... More >> Rijnstate Hospital Arnhem, Netherlands Less <<
NCT02796378 Cardiovascular Disease ... More >> Diabetes Mellitus Less << Phase 4 Recruiting December 2017 Denmark ... More >> University of Copenhagen Recruiting Copenhagen, Denmark, 2200 Contact: Anja B Kuhlman, MD       anjabk@sund.ku.dk    Principal Investigator: Flemming Dela, MD, DMSci Less <<
NCT01887067 Hypertension, Resistant ... More >> Diabetes Mellitus Renal Denervation Therapy Less << Not Applicable Recruiting June 2020 Hong Kong ... More >> Pamela Youde Nethersole Eastern Hospital Recruiting Hong Kong, Hong Kong Contact: Kin Lam Tsui, FRCP (Edin, Glasg)    +852 25956412    tsuikl1@ha.org.hk Less <<
NCT01580904 - Completed - -
NCT03495128 Muscle Atrophy ... More >> Insulin Sensitivity Less << Not Applicable Active, not recruiting March 31, 2019 United Kingdom ... More >> David Greenfield Human Physiology Laboratories Nottingham, Notts, United Kingdom, NG72UH Less <<
NCT03009279 - Not yet recruiting December 2017 -
NCT01580904 Diabetes Mellitus Type 2 Not Applicable Completed - Brazil ... More >> Universidade Estadual da Paraíba João Pessoa, Paraíba, Brazil Less <<
NCT02793297 Appetite Not Applicable Completed - -
NCT02770092 Pulmonary Disease, Chronic Obs... More >>tructive Congestive Heart Failure Less << Not Applicable Recruiting February 2020 United States, Texas ... More >> Texas A&M University-CTRAL Recruiting College Station, Texas, United States, 77843 Contact: Marielle Engelen    979-220-2282    mpkj.engelen@ctral.org    Contact: Agata McNew    979-583-5800    a.wierzchowska@ctral.org Less <<
NCT01691040 Anemia of Chronic Disease Phase 2 Completed - Austria ... More >> University Hospital Graz, Austria, 8036 AKH Vienna Vienna, Austria, 1090 Wilhelminenspital Vienna, Austria, 1160 Bulgaria University Hospital Plovdiv, Bulgaria, 4000 Tokuda Hospital Sofia, Bulgaria, 1407 University Hospital Varna, Bulgaria, 9010 Romania Spitalul Judetean Brasov, Romania, 500326 Institutul Oncologic Cluj-Napoca, Romania, 400124 Spitalul Municipal Craiova, Romania, 208028 Spitalul Judetean Targu-Mures, Romania, 540136 Oncomed Timisoara, Romania, 300239 Less <<
NCT00300976 Cardiovascular Diseases ... More >> Diabetes Mellitus, Type 2 Less << Not Applicable Active, not recruiting June 2021 Japan ... More >> The University of Tokyo Tokyo, Japan, 113-8655 Less <<
NCT03557151 Type 1 Diabetes Mellitus Not Applicable Enrolling by invitation April 1, 2021 United States, Delaware ... More >> Alfred I. duPont Hospital for Children Wilmington, Delaware, United States, 16803 United States, Florida Nemours Children's Clinic Jacksonville, Florida, United States, 32207 Nemours Children's Hospital Orlando, Florida, United States, 33827 Less <<
NCT01068535 - Unknown July 2013 United States, Washington ... More >> Harborview/University of Washington Seattle, Washington, United States, 98104 Less <<
NCT02506647 Diabetes Mellitus, Type 1 Phase 1 Completed - United States, California ... More >> Profil Institute for Clinical Research San Diego, California, United States, 91911 Less <<
NCT00968747 Fasting Non-a... More >>lcoholic Fatty Liver Disease (NAFLD) Less << Not Applicable Active, not recruiting April 30, 2019 United States, Massachusetts ... More >> Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Less <<
NCT02109094 - Completed - United States, Connecticut ... More >> Yale University New Haven, Connecticut, United States Less <<
NCT00252499 Fatty Liver I... More >>nsulin Resistance Less << Not Applicable Terminated(Protocol drug chang... More >>e required new clinicaltrails.gov entry) Less << - United States, Washington ... More >> VA Puget Sound Health Care System, Seattle Seattle, Washington, United States, 98108 Less <<
NCT00252499 - Terminated(Protocol drug chang... More >>e required new clinicaltrails.gov entry) Less << - -
NCT01975428 Diabetes Hype... More >>rtension Cardiac Arrhythmia Less << Not Applicable Completed - United States, California ... More >> Scripps Translational Science Institute La Jolla, California, United States, 92037 Less <<
NCT01838317 Cancer of the Pancreas Phase 2 Completed - United States, Texas ... More >> UT Southwestern Medical Center Dallas, Texas, United States, 75390 Less <<
NCT01779141 - Completed - Poland ... More >> Uniwersytecki Szpital Kliniczny w Białymstoku Białystok, Poland, 15-276 NZOZ Specjalistyczny Ośrodek Internistyczno-Diabetologiczny Białystok, Poland, 15-435 Szpital Wojewódzki w Bielsku Białej Bielsko-Biala, Poland, 43-316 Szpital Uniwersytecki nr 2 im. dr Jana Biziela w Bydgoszczy Bydgoszcz, Poland, 85-168 Szpital Specjalistyczny w Jaśle Jaslo, Poland, 38-200 NZOZ WITAMED Outpatient Diabetes Clinic Kielce, Poland, 25-035 Szpital Uniwersytecki w Krakowie Krakow, Poland, 31-501 Samodzielny Publiczny Szpital Kliniczny nr 4 Uniwersytetu Medycznego w Lublinie Lublin, Poland, 20-090 Wojewódzki Szpital Specjalistyczny w Olsztynie Olsztyn, Poland, 10-561 PSZOZ Wojewódzkie Centrum Medyczne w Opolu Opole, Poland, 45-418 Zakład Opieki Zdrowotnej Poznań-Jeżyce Poznan, Poland, 60-834 Clinic of Gynecology and Obstetrics of Marcinkowski Medical University Poznań, Poland, 60-535 Szpital Wojewódzki nr 2 im. Św. Jadwigi Królowej Rzeszow, Poland, 35-301 Samodzielny Publiczny Wojewódzki Szpital Zespolony w Szczecinie im. Marii Skłodowskiej-Curie Szczecin, Poland, 71-455 Wojewódzki Szpital Zespolony im. L. Rydygiera Torun, Poland, 87-100 Szpital Kliniczny im. ks. Anny Mazowieckiej Warszawskiego Uniwersytetu Medycznego Warszawa, Poland, 00-315 Samodzielny Publiczny Centralny Szpital Kliniczny w Warszawie Warszawa, Poland, 02-097 Mazowiecki Szpital Wojewódzki Sp. z o.o. Warszawa, Poland, 03-242 Wojewódzki Zespół Specjalistycznej Opieki Zdrowotnej Wroclaw, Poland, 50-403 Samodzielny Publiczny Szpital Kliniczny nr 1 im prof. Stanisława Szyszko Zabrze, Poland, 41-800 Zespół Wojewódzkich Przychodni Specjalistycznych w Katowicach Zabrze, Poland, 41-800 NZOZ MED-ART Poradnie Specjalistyczne Sp. z o.o. Zory, Poland, 44-240 Uniwersytecki Szpital Kliniczny nr 1 im. Norberta Barlickiego Uniwersytetu Medycznego w Łodzi Łódź, Poland, 90-153 Uniwersytet Medyczny w Łodzi, Klinika Diabetologii Łódź, Poland, 93-338 Less <<
NCT00908921 Diabetes Mellitus, Type 2 Phase 4 Completed - China ... More >> Sanofi-Aventis Administrative Office Shanghai, China Less <<
NCT03646318 Critical Illness Phase 4 Not yet recruiting May 1, 2019 -
NCT00138554 Diabetes Mellitus, Type 2 Phase 3 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 Less <<
NCT01486888 Diabetes Heal... More >>thy Less << Phase 1 Completed - Germany ... More >> Neuss, Germany, 41460 Less <<
NCT00205660 Schizophrenia ... More >> Type 2 Diabetes Mellitus Less << Phase 4 Completed - United States, Missouri ... More >> Washington University School of Medicine St. Louis, Missouri, United States, 63110 Less <<
NCT02176642 Urinary Urge Incontinence Phase 4 Terminated - United States, North Carolina ... More >> Duke Urogynecology Durham, North Carolina, United States, 27707 Duke OB/GYN Consultants of Raleigh Raleigh, North Carolina, United States, 27607 Less <<
NCT00138515 Diabetes Mellitus, Type 2 Phase 3 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 Less <<
NCT01760447 Type 2 Diabetes Mellitus Phase 3 Active, not recruiting September 13, 2019 -
NCT00138606 Diabetes Mellitus, Type 2 Phase 3 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 Germany Novartis Investigative Site Investigative Centers, Germany Less <<
NCT03650088 Diabetes Mellitus, Type 2 ... More >> Overweight and Obesity Less << Not Applicable Not yet recruiting April 2019 -
NCT02243072 Type 1 Diabetes Not Applicable Completed - United States, Michigan ... More >> Children's Hospital of Michigan Detroit, Michigan, United States, 48201 Less <<
NCT03313856 Type 2 Diabetes Mellitus Phase 2 Phase 3 Completed - -
NCT01589757 Gestational Diabetes Mellitus Phase 2 Phase 3 Completed - Canada, Ontario ... More >> MAIN STUDY ONLY: St Joseph's Heathcare Hamilton, 50 Charlton Avenue East Hamilton, Ontario, Canada, L8N 4A6 St. Michael's Hospital Toronto, Ontario, Canada, M5B 1W8 Mt Sinai Hospital Toronto, Ontario, Canada, M5G 1X5 Sunnybrook Health Sciences Centre Toronto, Ontario, Canada, Room H145, 2075 Bayview Avenue Less <<
NCT02489604 Neuroendocrine Tumors Phase 2 Recruiting December 2020 Italy ... More >> Irst Irccs Recruiting Meldola, FC, Italy, 47014 Contact: Maddalena Sansovini, MD    +390543739100    maddalena.sansovini@irst.emr.it Less <<
NCT00138580 Diabetes Mellitus, Type 2 Phase 3 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 Less <<
NCT02053103 Type 2 Diabetes Mellitus Phase 2 Terminated(On 25April2014, stu... More >>dy was terminated before any dosing due to an AE of safety concern that occurred in protocol B1731003 with the same drug.) Less << - United States, Florida ... More >> Pfizer Investigational Site Orlando, Florida, United States, 32809 Less <<
NCT00386061 Obesity Phase 3 Completed - United States, New Jersey ... More >> Sanofi-Aventis Bridgewater, New Jersey, United States, 08807 Belgium Sanofi-Aventis Brussels, Belgium Finland Sanofi-Aventis Helsinki, Finland France Sanofi-Aventis Paris, France Germany Sanofi-Aventis Berlin, Germany Netherlands Sanofi-Aventis Gouda, Netherlands Sweden Sanofi-Aventis Bromma, Sweden Less <<
NCT00720590 Endothelial Dysfunction Not Applicable Completed - United States, Indiana ... More >> Indiana University School of Medicine Indianapolis, Indiana, United States, 46202 Less <<
NCT02176642 - Terminated - -
NCT02053116 Type 2 Diabetes Mellitus Phase 2 Terminated(On 25April2014, stu... More >>dy was terminated before any dosing due to an AE of safety concern that occurred in protocol B1731003 with the same drug.) Less << - United States, Florida ... More >> Pfizer Investigational Site DeLand, Florida, United States, 32720 Less <<
NCT01761318 Diabetes Mellitus Type 2 ... More >> Metabolic Syndrome Cardiovascular Disease Diastolic Dysfunction Fatty Liver Less << Phase 4 Completed - Netherlands ... More >> Leiden University Medical Center Leiden, Netherlands, 2333 ZA Less <<
NCT01681693 Healthy Type ... More >>2 Diabetes Mellitus Less << Phase 1 Completed - United States, California ... More >> San Francisco General Hospital San Francisco, California, United States, 94110 Less <<
NCT03526445 Non-Alcoholic Fatty Liver Dise... More >>ase Total Pancreatectomy Diabetes Mellitus Less << Not Applicable Recruiting May 2019 Denmark ... More >> Steno Diabetes Center Copenhagen Recruiting Hellerup, Denmark, 2900 Contact: Iben Rix Petersen, MD    +45 24917125    iben.rix.petersen@regionh.dk Less <<
NCT03325179 Weight Loss S... More >>imple Obesity Less << Not Applicable Recruiting March 31, 2018 China, Shanghai ... More >> Institute of Digestive Diseases of Longhua Hospital affiliate to Shanghai University of Traditional Chinese Medicine Recruiting Shanghai, Shanghai, China, 200032 Contact: Guang Ji    +86-64385700 ext 9503    jiliver@vip.sina.com Less <<
NCT02608905 Type 2 Diabetes Mellitus Phase 4 Recruiting May 2019 United States, Texas ... More >> Baylor College of Medicine Recruiting Houston, Texas, United States, 77030 Contact: Mandeep Bajaj, MD    713-798-1712    bajaj@bcm.edu Less <<
NCT01555008 Type 2 Diabetes Mellitus ... More >> Renal Impairment Less << Phase 1 Completed - United States, Alabama ... More >> Lexicon Investigational Site Anniston, Alabama, United States, 36207 United States, California Lexicon Investigational Site Chula Vista, California, United States, 91911 United States, Florida Lexicon Investigational Site Edgewater, Florida, United States, 32132 United States, Minnesota Lexicon Investigational Site Minneapolis, Minnesota, United States, 55404 United States, Texas Lexicon Investigational Site San Antonio, Texas, United States, 78209 United States, Washington Lexicon Investigational Site Renton, Washington, United States, 98057 Less <<
NCT01382264 Diabetes Type 2 Not Applicable Unknown October 2012 United States, District of Col... More >>umbia Walter Reed Army Medical Center Not yet recruiting Washington, District of Columbia, United States, 20307 Principal Investigator: Robert A Vigersky, MD Less <<
NCT02765204 Diabetes Mellitus, Type 2 Phase 4 Completed - Sweden ... More >> Dept of Medical Sciences Uppsala University Hospital Uppsala, Sweden, 75185 Less <<
NCT02421510 Type 1 Diabetes Mellitus Phase 3 Completed - -
NCT01369147 Critical Illness Phase 2 Suspended(The study has been h... More >>alted pending additional funding.) Less << October 2019 United States, Georgia ... More >> Emory University Hospital Atlanta, Georgia, United States, 30322 Less <<
NCT00422201 Cushing's Syndrome Phase 2 Terminated - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 France CHU de Bordeaux Hopital Haut Leveque Bordeaux, France C.H.U Albert Michallon Grenoble, France C.H.U. de Bicetre Kremlin-Bicetre, France CHRU de Lille Lille, France Hopital de la Timone Marseille, France AP-HP, Hopital Cochin Pavillon CORNIL Paris, France CHU de Toulouse Toulouse, France Germany University of Wuerzburg Wuerzbug, Germany Italy Universita Degli Studi Napoli, Italy University of Turin Orbassano, Italy University of Padova Padova, Italy Netherlands Internal Medicine Endocrinology Eindhoven, Netherlands University Hosiptal of Groningen Groningen, Netherlands Erasmus Medical Center Rotterdam, Netherlands Less <<
NCT00422201 - Terminated - -
NCT01480895 Gestational Diabetes Mellitus Not Applicable Completed - -
NCT01125969 Diabetes Mellitus Not Applicable Completed - United States, Pennsylvania ... More >> University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT03705195 Type 2 Diabetes Mellitus Not Applicable Recruiting June 20, 2019 United Kingdom ... More >> Ninewells Hospital and Medical School Recruiting Dundee, United Kingdom, DD1 9SY Contact: Ruth LM Cordiner, MBChB, MRCP    0044 1382 386 715 ext 00441382386715    r.cordiner@dundee.ac.uk    Principal Investigator: Ruth LM Cordiner Less <<
NCT01916265 Diabetes Mellitus Type 1 Phase 1 Completed - Germany ... More >> Profil Institut für Stoffwechselforschung GmbH Neuss, NRW, Germany, 41460 Less <<
NCT00109746 Insulin Resistance ... More >> HIV Infections Less << Phase 1 Phase 2 Completed - United States, New York ... More >> State University of New York/General Clinical Research Center Stony Brook, New York, United States, 11794 Less <<
NCT00590876 - Completed - United States, Connecticut ... More >> Yale University School of Medicine New Haven, Connecticut, United States, 06520 United States, Minnesota University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT02122926 Type II Diabetes ... More >> Cardiovascular Disease Less << Not Applicable Completed - United States, Massachusetts ... More >> Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Less <<
NCT03511352 Sedentary Lifestyle Not Applicable Recruiting May 31, 2022 United States, California ... More >> UC San Diego Recruiting La Jolla, California, United States, 92093 Contact: Brittany Lewars, MPH    858-534-9333    blewars@ucsd.edu    Contact: Lindsay Dillon, MPH    8585349329    ldillon@ucsd.edu Less <<
NCT01938521 Type 2 Diabetes Not Applicable Completed - Israel ... More >> Daniela Jakubowicz MD Holon,, Tel Aviv, Israel, 58100 Less <<
NCT01632163 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT01891617 Endocrine and Metabolic Respon... More >>ses to Exercise and Diets Less << Not Applicable Completed - United States, Michigan ... More >> Michigan Clinical Research Unit Ann Arbor, Michigan, United States, 48109 Less <<
NCT02077348 Diabetes Mellitus Type I ... More >> Ketoacidosis Less << Not Applicable Completed - Denmark ... More >> Institute of Clinical Medicine Aarhus, Aarhus C, Denmark, 8000 Less <<
NCT03130426 Type 2 Diabetes Mellitus Phase 3 Recruiting December 2019 Canada, Alberta ... More >> University of Calgary Recruiting Calgary, Alberta, Canada, T2T 5C7 Contact: Ron Sigal, MD    403-955-8107    rsigal@ucalgary.ca    Canada, Ontario LMC Recruiting Burlington, Ontario, Canada, M4G 3E8 Contact: Mohammed Azharuddin, MD          Joanne Liutkus Recruiting Cambridge, Ontario, Canada, N1R 7L6 Contact: Danielle Gelinas    519-624-8977       McMaster University Recruiting Hamilton, Ontario, Canada, L8N 3Z5 Contact: Natalia McInnes, MD    905-521-2100 ext 73794    natalia.mcinnes@mcmaster.ca    Contact: Ada Smith    905-521-2100 ext 22205    smithad@mcmaster.ca    St. Joseph's Hospital Recruiting London, Ontario, Canada, N6A 4V2 Contact: Irene Hramiak, MD    519-646-6353    Irene.Hramiak@sjhc.london.on.ca    Western University Recruiting London, Ontario, Canada, N6G 2M1 Contact: Stewart Harris, MD    519-661-2111    Stewart.Harris@schulich.uwo.ca    The Ottawa Hospital Recruiting Ottawa, Ontario, Canada, K1Y 4E9 Contact: Heather Lochnan, MD       hlochnan@toh.ca    Canada, Quebec McGill University Recruiting Montreal, Quebec, Canada, H4A 3J1 Contact: Angie Lombardo    514-934-1934 ext 36492    angie.lombardo@muhc.mcgill.ca Less <<
NCT01145742 Type 2 Diabetes ... More >> Hypertension Hyperlipidemia Less << Not Applicable Completed - United States, New York ... More >> Albert Einstein College of Medicine Bronx, New York, United States, 10705 Less <<
NCT01447979 Type 1 Diabetes Mellitus Early Phase 1 Completed - France ... More >> Centre d'Investigation Clinique CHU Montpellier Montpellier, France, 34000 Less <<
NCT01447992 Type 1 Diabetes Mellitus Early Phase 1 Completed - Italy ... More >> Azienda Ospedaliera E Universita Degli Study Di Padova Padova, Veneto, Italy, 35128 Less <<
NCT00666458 - Completed - -
NCT00666458 Type 2 Diabetes Phase 3 Completed - -
NCT03145649 - Completed - -
NCT01100125 Diabetes Phase 4 Completed - Korea, Republic of ... More >> Seoul National University Bundang Hospital Seongnam, Gyeonggi, Korea, Republic of, 463-707 Seoul National University Bundang Hospital Seongnam, Korea, Republic of Less <<
NCT01837680 Diabetes, Gestational ... More >> Diabetes, Type 2 Less << Not Applicable Completed - United States, New York ... More >> St. Luke's-Roosevelt Hospital Center New York, New York, United States, 10019 Less <<
NCT03367390 Type1 Diabetes Mellitus Phase 1 Completed - United States, Washington ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician. Renton, Washington, United States, 98057 Less <<
NCT02854202 Type 2 Diabetes Not Applicable Unknown October 2016 -
NCT03257228 - Completed - -
NCT01472185 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT02985866 Type1 Diabetes Mellitus Not Applicable Recruiting June 1, 2018 United States, California ... More >> William Sansum Diabetes Center Recruiting Santa Barbara, California, United States, 93105 Contact: Jordan Pinsker, MD          Contact: Camille Andre    805-682-7640 ext 217    candre@sansum.org    Principal Investigator: Jordan Pinsker, MD          Sub-Investigator: Mei Mei Church, NP          Stanford University Recruiting Stanford, California, United States, 94304 Contact: Bruce Buckingham, MD    650-723-5791    bbendo@stanford.edu    Contact: Liana Hsu    650-725-3939    ljhsu@stanford.edu    Principal Investigator: Bruce Buckingham, MD          United States, Colorado Barbara Davis Center, University of Colorado Recruiting Aurora, Colorado, United States, 80045 Contact: R. Paul Wadwa, MD    303-724-2323    paul.wadwa@ucdenver.edu    Contact: Emily Jost, MPH RD CDE    (303) 724-7313    emily.jost@ucdenver.edu    Principal Investigator: R. Paul Wadwa, MD          United States, Massachusetts Harvard University (Joslin Diabetes Center) Recruiting Boston, Massachusetts, United States, 02215 Contact: Lori Laffel, MD, MPH    617-732-2603    lori.laffel@joslin.harvard.edu    Contact: Louise Ambler-Osborn, CPNP    617-732-2603    louise.ambler-osborn@joslin.harvard.edu    Principal Investigator: Francis Doyle, PhD          Principal Investigator: Lori Laffel, MD, MPH          United States, Minnesota Mayo Clinic Recruiting Rochester, Minnesota, United States, 55905 Contact: Shelly McCrady-Spitzer    507-255-5916    McCradySpitzer.Shelly@mayo.edu    Contact: Yogish C. Kudva, MBBS, MD       kudva.yogish@mayo.edu    Principal Investigator: Yogish Kudva, MBBS, MD          United States, New York Icahn School of Medicine at Mount Sinai Recruiting New York, New York, United States, 10029 Contact: Carol Levy, MD, CDE    212-241-9089    selassie.ogyaadu@mssm.edu    Contact: Camilla Levister, ANP-C, MS    212-241-5177    Camilla.Levister@mssm.edu    Principal Investigator: Carol Levy, MD, CDE          Sub-Investigator: David Lam, MD          United States, Virginia University of Virginia Center for Diabetes Technology Recruiting Charlottesville, Virginia, United States, 22903 Contact: Stacey M. Anderson, MD    434-982-0945    sg4c@virginia.edu    Contact: Emma Emory, RN    434-243-3992    ee9m@virginia.edu    Sub-Investigator: Sue A. Brown, MD          Sub-Investigator: Linda Gonder-Fredrick, PhD Less <<
NCT01837680 - Completed - -
NCT00626041 Cardiovascular Diseases ... More >> Hypertension Hyperlipidemia Hyperglycemia Less << Not Applicable Unknown June 2011 Canada, Alberta ... More >> Calgary Safeway Pharmacy - Crowfoot Location Recruiting Calgary, Alberta, Canada, T3G 2L4 Contact: Rita Bowron, BScPharm    403-831-6987       Principal Investigator: Charlotte A Jones, PhD MD          Coop Pharmacy - Crowfoot Location Terminated Calgary, Alberta, Canada, T3G 2L5 Less <<
NCT01472185 - Completed - -
NCT00286676 HIV Infection Phase 2 Phase 3 Unknown - United States, Texas ... More >> Aston Ambulatory Care Center Dallas, Texas, United States, 75390 Parkland Health & Hospital System Dallas, Texas, United States, 75390 Veteran’s Affairs Medical Center Dallas, Texas, United States Less <<
NCT00102466 Diabetes Mellitus, Type 2 Phase 3 Completed - Germany ... More >> Investigative Centers Nurnberg, Germany Switzerland Novartis Pharmaceuticals Basel, Switzerland Less <<
NCT00361023 Type 2 Diabetes ... More >> Diabetic Nephropathy Less << Not Applicable Completed - -
NCT02683902 Prediabetes O... More >>besity Weight Loss Diabetes Overweight Less << Not Applicable Recruiting August 2018 Brazil ... More >> Hospital de Clínicas de Porto Alegre Recruiting Porto Alegre, Rio Grande Do Sul, Brazil Contact: Fernando Gerchman, MD    +55 51 33598127    fgerchman@gmail.com    Contact: Carina de Araujo, RND    +55 51 33598127    carinanutr@hotmail.com Less <<
NCT00676819 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 4 Completed - Germany ... More >> Novo Nordisk Investigational Site Köln, Germany, 50825 Less <<
NCT00631007 - Completed - -
NCT03630744 - Not yet recruiting February 2019 Spain ... More >> Hospital Universitario Bellvitge Not yet recruiting Hospitalet de Llobregat, Barcelona, Spain, 08907 Contact: Maria J Colomina, MD, PhD    0034 629993697    mjcolomina@bellvithehospital.cat    Principal Investigator: Maria J Colomina, MD, PhD          Sub-Investigator: Patricia Guilabert, MD          Principal Investigator: Javier Ripollés, MD          Principal Investigator: Jose L Jover, MD          Principal Investigator: Misericordia Basora, MD, PhD          Principal Investigator: Concepción Cassinello, MD          Sub-Investigator: Raquel Ferrandis, MD          Principal Investigator: Juan V LLau, MD, PhD Less <<
NCT00624364 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 4 Completed - South Africa ... More >> Novo Nordisk Investigational Site Bloemfontein, Free State, South Africa, 9301 Novo Nordisk Investigational Site Johannesburg, Gauteng, South Africa, 1827 Novo Nordisk Investigational Site Johannesburg, Gauteng, South Africa, 1829 Novo Nordisk Investigational Site Johannesburg, Gauteng, South Africa, 2001 Novo Nordisk Investigational Site Pretoria, Gauteng, South Africa, 0116 Novo Nordisk Investigational Site Durban, KwaZulu-Natal, South Africa, 4001 Novo Nordisk Investigational Site Durban, KwaZulu-Natal, South Africa, 4091 Novo Nordisk Investigational Site Pietermaritzburg, KwaZulu-Natal, South Africa, 3235 Novo Nordisk Investigational Site Brits, North West, South Africa, 0250 Novo Nordisk Investigational Site Cape Town, Western Cape, South Africa, 7708 Novo Nordisk Investigational Site Cape Town, Western Cape, South Africa, 7800 Novo Nordisk Investigational Site Benoni, South Africa, 1500 Novo Nordisk Investigational Site Bloemfontein, South Africa, 27 51 Novo Nordisk Investigational Site Kimberley, South Africa, 8301 Novo Nordisk Investigational Site Richards Bay, South Africa, 3900 Less <<
NCT02086227 Hypoglycemia Phase 1 Completed - United States, Texas ... More >> West Houston Clinical Research Services, 2026 Wirt Road Houston, Texas, United States, 77055 Less <<
NCT02325960 Type 2 Diabetes Phase 4 Completed - China, Jiangsu ... More >> at Division of Endocrinology, the Affiliated Drum Tower Hospital of Nanjing University Nanjing, Jiangsu, China, 210008 Less <<
NCT01336322 Pre-diabetes Phase 2 Recruiting December 2018 Italy ... More >> Department of Endocrinology and Metabolism, University of Pisa Recruiting Pisa, Italy, 56124 Contact: Stefano Del Prato, MD    +39 050 995103    stefano.delprato@med.unipi.it    Sub-Investigator: Graziano Di Cianni, MD Less <<
NCT00540176 Malignant Gliomas, Glioblastom... More >>a Multiforme Less << Phase 2 Completed - Canada, Alberta ... More >> University of Alberta Hospital Edmonton, Alberta, Canada, T6G 2B7 Less <<
NCT03710928 Type1diabetes Not Applicable Not yet recruiting September 1, 2020 United States, Massachusetts ... More >> Boston Children's Hospital Not yet recruiting Boston, Massachusetts, United States, 02446 Contact: Belinda Lennerz, MD PhD    857-218-3896    belinda.lennerz@childrens.harvard.edu    Contact: David Ludwig    617 355 4878    david.ludwig@childrens.harvard.edu    Sub-Investigator: David Ludwig, MD PhD          Principal Investigator: Belinda Lennerz Less <<
NCT02376088 - Completed - -
NCT00479609 Metabolic Syndrome Phase 3 Unknown April 2009 Sweden ... More >> Karolinska University Hospital Recruiting Stockholm, Sweden, SE14186 Sub-Investigator: Åke Pousette, MD, PhD Less <<
NCT00631007 Type 2 Diabetes Mellitus Phase 2 Completed - -
NCT00918879 Type 2 Diabetes Phase 3 Completed - India ... More >> Research Site Gujarat, Ahmedabad, India Research Site Karnataka, Bangalore, India Research Site Tamil Nadu, Chennai, India Research Site Tamil Nadu, Coimbatore, India Research Site Andhra Pradesh, Hyderabad, India Research Site Madhya Pradesh, Indore, India Research Site Haryana, Karnal, India Research Site Kerala, Kochi, India Research Site Maharashtra, Pune, India Less <<
NCT01934842 Diabetes Anem... More >>ia Less << Not Applicable Withdrawn - United States, Massachusetts ... More >> Seventh Sense Biosytems Cambridge, Massachusetts, United States, 02141 Less <<
NCT00918879 - Completed - -
NCT01636596 Alzheimer's Disease ... More >> Mild Cognitive Impairment Less << Not Applicable Withdrawn January 2015 United States, Louisiana ... More >> LSUHSC Shrevport Psychopharmacology Research Clinic Shreveport, Louisiana, United States, 71130 Less <<
NCT02142309 Type 2 Diabetes Phase 4 Unknown January 2017 Italy ... More >> Department of Geriatrics and Metabolic Diseases Active, not recruiting Naples, Italy, 80138 Katherine Esposito Recruiting Naples, Italy, 80138 Contact: Maria Ida Maiorino, MD       mariaida.maiorino@unina2.it    Sub-Investigator: Giuseppe Bellastella, MD Less <<
NCT00627484 - Active, not recruiting September 1, 2018 United States, New York ... More >> Columbia University Medical Center New York, New York, United States, 10032 Less <<
NCT00410852 Intensive Care Not Applicable Completed - Brazil ... More >> Complexo Hospitalar UNIMED Joinville, Santa Catarina, Brazil Hospital Dona Helena Joinville, Santa Catarina, Brazil Hospital Regional Sao Jose Joinville, Santa Catarina, Brazil Hospital Estadual Mario Covas Santo Andre, Sao Paulo, Brazil Hospital Israelita Albert Einstein Sao Paulo, Brazil, 05651-901 Less <<
NCT03281616 Diabetes Mellitus Not Applicable Completed - -
NCT00287443 Cystic Fibrosis Not Applicable Unknown - United States, Texas ... More >> Children’s Medical Center of Dallas Dallas, Texas, United States, 75390 Less <<
NCT02109978 - Completed - United Kingdom ... More >> University of Exeter Exeter, Devon, United Kingdom, EX2 5DW University of Oxford Oxford, Oxfordshire, United Kingdom, OX1 2JD University of Dundee Dundee, United Kingdom, DD1 9SY Less <<
NCT02121483 - Completed - -
NCT00604253 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - Japan ... More >> Novo Nordisk Investigational Site Tokyo, Japan, 1000005 Less <<
NCT03465878 Type 1 Diabetes Mellitus Phase 1 Recruiting March 18, 2019 Canada, Ontario ... More >> LMC Endocrinology Centres Ltd. Recruiting Toronto, Ontario, Canada, M4G 3E8 Contact    4166452929       Principal Investigator: Ronnie Aronson          Germany Kinderkrankenhaus auf der Bult Recruiting Hannover, Niedersachsen, Germany, 30173 Contact    495118115340       Principal Investigator: Thomas Danne Less <<
NCT02121483 Diabetes Mellitus, Type 2 Phase 1 Completed - United States, Connecticut ... More >> 1245.87.01013 Boehringer Ingelheim Investigational Site New Haven, Connecticut, United States United States, Massachusetts 1245.87.01004 Boehringer Ingelheim Investigational Site Boston, Massachusetts, United States United States, Ohio 1245.87.01002 Boehringer Ingelheim Investigational Site Toledo, Ohio, United States United States, Pennsylvania 1245.87.01012 Boehringer Ingelheim Investigational Site Philadelphia, Pennsylvania, United States 1245.87.01001 Boehringer Ingelheim Investigational Site Pittsburgh, Pennsylvania, United States France 1245.87.33001 Boehringer Ingelheim Investigational Site Lyon, France Israel 1245.87.97202 Boehringer Ingelheim Investigational Site Beer Sheva, Israel 1245.87.97203 Boehringer Ingelheim Investigational Site Tel Hashomer, Israel Mexico 1245.87.52001 Boehringer Ingelheim Investigational Site Chihuahua, Mexico South Africa 1245.87.27003 Boehringer Ingelheim Investigational Site Bellville, South Africa 1245.87.27002 Boehringer Ingelheim Investigational Site Pretoria, South Africa Less <<
NCT00851396 - Completed - United States, Alabama ... More >> Children's Hospital , University of Alabama Birmingham, Alabama, United States, 35233 Less <<
NCT01202474 Diabetes Mellitus, Type 1 Phase 4 Completed - Russian Federation ... More >> Administrative office Moscow, Russian Federation Less <<
NCT01670422 - Completed - China, Sichuan ... More >> West China Hospital of Stomatology Chengdu, Sichuan, China, 610041 Less <<
NCT01470807 Type 1 Diabetes Mellitus Not Applicable Completed - Italy ... More >> University of Padova Padova, Italy Less <<
NCT02731066 Weight Loss O... More >>ther Effects of High Altitude Less << Not Applicable Completed - United States, Massachusetts ... More >> US Army Research Institute of Environmental Medicine Natick, Massachusetts, United States, 01760 Less <<
NCT01590836 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 1 Completed - Germany ... More >> Novo Nordisk Investigational Site Neuss, Germany, 41460 Less <<
NCT01935804 Diabetes Mellitus ... More >> Diabetes Mellitus, Type 2 Glucose Metabolism Disorders Less << Phase 2 Completed - Saudi Arabia ... More >> Center of Excellence for Osteoporosis Research, King Abdulaziz University Jeddah, Makkah, Saudi Arabia, 21589 Less <<
NCT00502138 IDDM Phase 4 Completed - United States, Tennessee ... More >> University Diabetes & Endocrine Consultants Chattanooga, Tennessee, United States, 37403 Less <<
NCT00615004 - Completed - Italy ... More >> Department of Molecular and Clinical Endocrinology and Oncology, University Federico II of Naples Naples, Italy, 80131 Less <<
NCT00937326 Diabetes Mellitus, Type 2 Phase 2 Completed - -
NCT02760355 Insulin Resistance Not Applicable Active, not recruiting June 2018 Switzerland ... More >> Division of Gastroenterology and hepatology, University Hospital Geneva, GE, Switzerland, 1211 Less <<
NCT03371355 NAFLD Diabete... More >>s Mellitus, Type 2 Hypertriglyceridemia Fatty Liver, Nonalcoholic Less << Phase 2 Recruiting May 31, 2019 -
NCT00823108 Septic Shock Phase 1 Completed - United States, North Carolina ... More >> Carolinas Medical Center Charlotte, North Carolina, United States, 28203 Less <<
NCT03292055 - Completed - China, Shandong ... More >> Qilu Hospital Jinan, Shandong, China, 250012 Jinan Central Hospital Jinan, Shandong, China, 250013 Less <<
NCT00937326 - Completed - -
NCT00858273 Diabetes Mellitus, Type 1 Not Applicable Completed - United States, Florida ... More >> Nemours Children's Clinic Jacksonville, Florida, United States, 32207 Less <<
NCT03170921 Physical Activity ... More >> Affective; Reaction Physiological Stress Less << Not Applicable Completed - -
NCT01868542 - Completed - -
NCT03112538 Type 2 Diabetes Mellitus Phase 4 Recruiting December 2018 Malaysia ... More >> Hospital Putrajaya Recruiting Putrajaya, Wilayah Persekutuan, Malaysia, 62250 Contact: Zanariah Hussein, MBBS,MRCP    0122907136    ppzana@hpj.gov.my    Contact: Nurain Mohd Noor, MBBS,MMed    0122051570    ppnurain@hpj.gov.my    Principal Investigator: Noor Rafhati Adyani Abdullah, MBBS,MRCP Less <<
NCT01868542 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 4 Completed - Korea, Republic of ... More >> Novo Nordisk Investigational Site Daejeon, Korea, Republic of, 301-721 Novo Nordisk Investigational Site Daejeon, Korea, Republic of, 301-723 Novo Nordisk Investigational Site Daejeon, Korea, Republic of, 302-120 Novo Nordisk Investigational Site Daejeon, Korea, Republic of, 302-718 Novo Nordisk Investigational Site Daejeon, Korea, Republic of, 330-721 Novo Nordisk Investigational Site Daejeon, Korea, Republic of, 361-711 Less <<
NCT01206712 - Completed - Germany ... More >> IKFE Institute for Clinical Research and Development Mainz, Germany, 55116 Less <<
NCT00592969 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 4 Completed - Argentina ... More >> Novo Nordisk Investigational Site Mariano Acosta s/n, Argentina, 5016 Brazil Novo Nordisk Investigational Site Santa Efigenia, Brazil, 30150-320 Less <<
NCT02917226 Diabetes Mellitus Not Applicable Unknown - -
NCT02372526 - Active, not recruiting June 2017 Denmark ... More >> Endocrinology Research Center, Hvidovre University Hospital Hvidovre, Copenhagen, Denmark, 2650 Less <<
NCT03143816 Diabetes Mellitus, Type 1 Phase 4 Active, not recruiting December 31, 2017 United States, Colorado ... More >> Barbara Davis Center Aurora, Colorado, United States, 80045 Less <<
NCT02923960 Diabetes Not Applicable Completed - United States, Illinois ... More >> Great Lakes Clinical Trials Chicago, Illinois, United States, 60640 United States, Ohio Radiant Research, Inc. Cincinnati, Ohio, United States, 45236 Less <<
NCT03679689 Overweight and Obesity Not Applicable Recruiting January 2019 Mexico ... More >> Universidad Veracruzana Recruiting Xalapa, Veracruz, Mexico, 91190 Contact: Paulina E Viveros-Watty, Master    2281235277    pauwatty@gmail.com    Contact: Mónica Flores-Muñoz, PhD    01 228 841 8925    moflores@uv.mx Less <<
NCT01855087 - Completed - Japan ... More >> Takai Naika Clinic Kamakura, Kanagawa, Japan, 247-0056 Less <<
NCT02506218 Dietary Modification Not Applicable Completed - United States, Indiana ... More >> Purdue University West Lafayette, Indiana, United States, 47907 Less <<
NCT00812487 Congestive Heart Failure ... More >> Diabetes Mellitus Less << Phase 1 Phase 2 Completed - United States, Ohio ... More >> The Ohio State University Columbus, Ohio, United States, 43210 Less <<
NCT00812487 - Completed - -
NCT01839110 Pulmonary Hypertension Not Applicable Active, not recruiting December 2018 United States, Maryland ... More >> University of Maryland Baltimore, Maryland, United States, 21201 United States, Massachusetts Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 United States, Missouri Washington University Saint Louis, Missouri, United States, 63130 United States, Pennsylvania University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT02320110 - Completed - Mexico ... More >> Clinical Nutrition and Obesity Research Center. School of Medicine, TEC Salud, Tecnológico de Monterrey Monterrey, Nuevo León, Mexico, 64710 Less <<
NCT03458858 Healthy Volunteers Not Applicable Active, not recruiting May 2018 United States, Maryland ... More >> USDA-ARS Beltsville Human Nutrition Research Center Beltsville, Maryland, United States, 20705 Less <<
NCT00858897 Diabetes Mellitus, Type 1 Not Applicable Completed - United States, Florida ... More >> Nemours Children's Clinic Jacksonville, Florida, United States, 32207 Less <<
NCT03683368 Diabetes Mellitus, Type 1 Not Applicable Not yet recruiting March 2019 -
NCT00674622 Lateral Epicondylitis ... More >> Tennis Elbow Less << Phase 2 Phase 3 Completed - United States, Pennsylvania ... More >> Center for Integrative Medicine at UPMC Shadyside Pittsburgh, Pennsylvania, United States, 15232 Less <<
NCT02998346 - Completed - -
NCT02254291 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - Japan ... More >> Novo Nordisk Investigational Site Asahikawa-shi, Hokkaido, Japan, 070 0002 Novo Nordisk Investigational Site Chitose, Hokkaido, Japan, 066-0032 Novo Nordisk Investigational Site Chuo-ku Tokyo, Japan, 103-0027 Novo Nordisk Investigational Site Chuo-ku Tokyo, Japan, 104-0031 Novo Nordisk Investigational Site Chuo-ku, Tokyo, Japan, 103 0027 Novo Nordisk Investigational Site Ebina-shi, Japan, 243 0432 Novo Nordisk Investigational Site Izumisano-shi, Japan, 598 0048 Novo Nordisk Investigational Site Kashiwara-shi, Osaka, Japan, 582 0005 Novo Nordisk Investigational Site Katsushika-ku, Tokyo, Japan, 125 0054 Novo Nordisk Investigational Site Kumamoto-shi,Kumamoto, Japan, 862 0976 Novo Nordisk Investigational Site Naka-shi, Ibaraki, Japan, 311 0113 Novo Nordisk Investigational Site Nishinomiya-shi, Hygo, Japan, 662 0971 Novo Nordisk Investigational Site Oita-shi, Japan, 870 0039 Novo Nordisk Investigational Site Osaka-shi, Osaka, Japan, 553 0003 Novo Nordisk Investigational Site Ota-ku, Tokyo, Japan, 144 0035 Novo Nordisk Investigational Site Ota-ku, Tokyo, Japan Novo Nordisk Investigational Site Sapporo-shi, Hokkaido, Japan, 060 0062 Novo Nordisk Investigational Site Sapporo-shi, Hokkaido, Japan, 060-0001 Novo Nordisk Investigational Site Shimotsuke-shi, Tochigi, Japan, 329 0433 Novo Nordisk Investigational Site Shinjuku-ku, Tokyo, Japan, 160-0008 Novo Nordisk Investigational Site Suita-shi, Osaka, Japan, 565-0853 Novo Nordisk Investigational Site Takatsuki-shi, Osaka, Japan, 569 1096 Novo Nordisk Investigational Site Tokyo, Japan, 181-0013 Novo Nordisk Investigational Site Yokohama, Kanagawa, Japan, 236-0004 Novo Nordisk Investigational Site Yokohama-shi, Japan, 235 0045 Less <<
NCT02254291 - Completed - -
NCT02916680 Type 1 Diabetes Mellitus Not Applicable Recruiting April 2020 Switzerland ... More >> University Hospital Basel Recruiting Basel, Switzerland, 4031 Contact: Marc Y Donath, Prof.    0041 61 265 50 78    marc.donath@usb.ch Less <<
NCT00674622 - Completed - -
NCT02561546 HCC Diabetes Phase 2 Unknown December 2017 China, Liaoning ... More >> first affiliated hospital in Dalian University Not yet recruiting Dalian, Liaoning, China Contact: Yuewei Zhang, MD, Ph D       zhangyuewei1121@sina.com Less <<
NCT01013766 Diabetes Mellitus, Type 2 Phase 1 Completed - United States, Arizona ... More >> GSK Investigational Site Phoenix, Arizona, United States, 85013 United States, Minnesota GSK Investigational Site Saint Paul, Minnesota, United States, 55114-1067 Less <<
NCT01421147 Diabetes Mellitus, Type 1 Phase 3 Completed - -
NCT03207841 Spinal Cord M... More >>etabolic Syndrome Diabetes Less << Not Applicable Recruiting October 1, 2021 United States, Alabama ... More >> UAB Recruiting Birmingham, Alabama, United States, 35294 Contact: Jia Li, PhD    205-975-0618    jiali@uab.edu    Contact: Ceren Yarar-Fisher    205-996-6896    cyarar@uab.edu Less <<
NCT01595373 Healthy Early Phase 1 Completed - Denmark ... More >> Aarhus University Hospital Aarhus, Denmark, 8000 Less <<
NCT01422590 Type 2 Diabetes Mellitus Phase 1 Completed - Korea, Republic of ... More >> Samsung Medical Center Seoul, Korea, Republic of Less <<
NCT02999620 Healthy Volunteers Not Applicable Completed - Australia, New South Wales ... More >> Mayo Clinic Rochester, New South Wales, Australia, 55905 Less <<
NCT01421147 - Completed - -
NCT01828060 Anemia Phase 1 Phase 2 Completed - United States, Oregon ... More >> NIS Labs Klamath Falls, Oregon, United States, 97601 Less <<
NCT01656850 Type 2 Diabetes Not Applicable Completed - Taiwan ... More >> Taipei Medical University Taipei City, Taiwan Less <<
NCT02198846 Type 2 Diabetes Mellitus Not Applicable Unknown March 2015 Korea, Republic of ... More >> Konkuk University Chungju Hospital Recruiting Chungju, Korea, Republic of Contact: Soo Bong Choi, MD.PhD    +82-10-4949-9504    mellitus@empal.com    Principal Investigator: Soo Bong Choi, MD.PhD Less <<
NCT03585829 Corticotropin Deficiency ... More >> Fasting Less << Phase 4 Enrolling by invitation July 30, 2018 Tunisia ... More >> University Tunis El Manar Tunis, Tunisia, 1068 Less <<
NCT00862875 Type 2 Diabetes Phase 4 Completed - Canada, Quebec ... More >> Institut de Recherches Cliniques de Montréal Montréal, Quebec, Canada, H2W 1R7 Less <<
NCT01155518 Hypogonadotropic Hypogonadism ... More >> Type 2 Diabetes Less << Phase 2 Terminated(lack of funding) - United States, New York ... More >> Millard Fillmore Gates Hospital Buffalo, New York, United States, 14209 Less <<
NCT03374501 Postprandial Hyperglycemia Not Applicable Completed - -
NCT03487029 Diabetes Not Applicable Recruiting December 20, 2018 Turkey ... More >> Hacettepe University Recruiting Ankara, State, Turkey, 06100 Contact: cemile bozdemir özel    0905352138084    cemilebozdemir@hotmail.com Less <<
NCT00923975 - Completed - -
NCT00923975 Diabetes Not Applicable Completed - United States, California ... More >> AMCR Institute Escondido, California, United States, 92026 Less <<
NCT01656850 - Completed - -
NCT03675464 - Not yet recruiting December 31, 2023 -
NCT00921518 Kidney Injury Phase 2 Completed - United States, Pennsylvania ... More >> Community Medical Center Scranton, Pennsylvania, United States, 18510 Less <<
NCT00921518 - Completed - -
NCT02701894 - Unknown March 2016 -
NCT02124941 Cocaine Dependence ... More >> Healthy Less << Phase 1 Recruiting November 2023 United States, Connecticut ... More >> Connecticut Mental Health Center Recruiting New Haven, Connecticut, United States, 06519 Principal Investigator: Robert Malison, MD Less <<
NCT03356457 Hyperglycaemia (Diabetic) Early Phase 1 Recruiting November 30, 2020 United States, Connecticut ... More >> Yale New Haven Hospital Recruiting New Haven, Connecticut, United States, 06510 Less <<
NCT00135070 Diabetes Mellitus, Type 2 Phase 4 Terminated(No documentation wi... More >>th MHRA to support clinical trial of a medicinal product.) Less << - United Kingdom ... More >> The Royal Bournemouth Hospital Bournemouth, Dorset, United Kingdom, BH7 7DW Less <<
NCT02620553 Type 1 Diabetes Phase 1 Phase 2 Completed - United States, Colorado ... More >> Barbara Davis Center for Childhood Diabetes Aurora, Colorado, United States, 80045 Less <<
NCT02037295 Obesity Phase 1 Recruiting September 30, 2019 United States, Arizona ... More >> NIDDK, Phoenix Recruiting Phoenix, Arizona, United States, 85014 Contact: Jonathan Krakoff, M.D.    602-200-5217    jkrakoff@mail.nih.gov Less <<
NCT00786890 - Unknown December 2018 China ... More >> Hong Kong Institute of Diabetes and Obesity Hong Kong, China, HK Less <<
NCT01456806 Type 2 Diabetes Not Applicable Completed - Argentina ... More >> CENEXA (UNLP-CONICET La PLata) La Plata, Buenos Aires, Argentina, 1900 Less <<
NCT01804738 Hyperglycemia ... More >> Insulin Sensitivity Less << Not Applicable Completed - Singapore ... More >> Clinical Nutrition Research Centre Singapore, Singapore, 117599 Less <<
NCT02970344 Diabetes Not Applicable Recruiting April 2021 United States, North Carolina ... More >> Duke University Medical Center Recruiting Durham, North Carolina, United States, 27710 Contact: Rebecca A Shelby, PhD    919-416-3410    rebecca.shelby@duke.edu Less <<
NCT03429920 Cardiovascular Risk Factor ... More >> Heart Diseases Inflammation Less << Not Applicable Recruiting March 31, 2020 United States, California ... More >> Loma Linda University Recruiting Loma Linda, California, United States, 92350 Contact: Amandeep Kaur, MPH    909-558-4300 ext 47169    akaur1@llu.edu    Contact: Ella Haddad, DrPH    909-558-4300 ext 47150    ehaddad@llu.edu    Principal Investigator: Joan Sabate, DrPH          Sub-Investigator: Ella Haddad, DrPH Less <<
NCT00763815 - Completed - -
NCT03233178 - Completed - Canada, Ontario ... More >> LMC Brampton Brampton, Ontario, Canada, L6S 0C9 Less <<
NCT01774968 Diabetes Mellitus, Type 2 Phase 4 Completed - -
NCT00763815 Diabetes Mellitus Type 2 Phase 3 Completed - -
NCT03481829 - Recruiting September 1, 2029 United States, Arizona ... More >> Phoenix Indian Medical Center Recruiting Phoenix, Arizona, United States, 85016 Less <<
NCT00106340 Diabetes Mellitus, Type 2 Phase 3 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 Germany Investigative Centers Nurnberg, Germany Less <<
NCT02537873 Cocaine Use Disorder Phase 1 Completed - United States, Virginia ... More >> Virginia Commonwealth University, Institute for Drug and Alcohol Studies Richmond, Virginia, United States, 23219 Less <<
NCT01774968 - Completed - -
NCT01705899 Type 1 Diabetes Phase 1 Enrolling by invitation May 2017 United States, Ohio ... More >> The Ohio State University Medical Center Columbus, Ohio, United States, 43210 Less <<
NCT03010969 - Recruiting December 2018 Denmark ... More >> Department of Surgery, Zealand University Hospital, Koge Recruiting Køge, Denmark, 4600 Contact: Sarah Ekeloef, MD          Contact: Ismail Gögenur, Professor          Sub-Investigator: Jakob Oreskov, Stud.med          Principal Investigator: Jakob Burcharth, MD, Phd Less <<
NCT02029989 Hyperlipidemia ... More >> Diabetes Hypertension Less << Not Applicable Completed - United States, Minnesota ... More >> Family Life Mental Health Center Coon Rapids, Minnesota, United States, 55433 Human Development Center Duluth, Minnesota, United States, 55805 Range Mental Health Center Hibbing, Minnesota, United States, 55746 Less <<
NCT02029989 - Completed - -
NCT02909725 Sedentary Lifestyle ... More >> Diabetes Mellitus, Gestational Less << Not Applicable Unknown December 2016 United States, Iowa ... More >> Iowa State University Recruiting Ames, Iowa, United States, 50011 Contact: Caroline McKinney, BS    515-202-5569    clmck@iastate.edu    Contact: Christina Campbell, PhD    515-294-4260    ccampbel@iastate.edu    Principal Investigator: Christina Campbell, PhD Less <<
NCT01447251 Obstructive Sleep Apnea ... More >> Diabetes Mellitus Less << Not Applicable Completed - United States, Nevada ... More >> Mike O'Callaghan Federal Hospital/Nellis AFB Las Vegas, Nevada, United States, 89191 Less <<
NCT01940965 Type 2 Diabetes Mellitus Phase 3 Completed - Japan ... More >> Investigational Site Number 392335 Adachi-Ku, Japan Investigational Site Number 392325 Chiba-Shi, Japan Investigational Site Number 392328 Chiyoda-Ku, Japan Investigational Site Number 392326 Chuo-Ku, Japan Investigational Site Number 392327 Chuo-Ku, Japan Investigational Site Number 392310 Chuoh-Ku, Japan Investigational Site Number 392336 Kagoshima-Shi, Japan Investigational Site Number 392314 Kamakura-Shi, Japan Investigational Site Number 392334 Kashiwara-Shi, Japan Investigational Site Number 392304 Kawagoe-Shi, Japan Investigational Site Number 392306 Kawaguchi-Shi, Japan Investigational Site Number 392307 Kisarazu-Shi, Japan Investigational Site Number 392301 Koriyama-Shi, Japan Investigational Site Number 392312 Mitaka-Shi, Japan Investigational Site Number 392302 Mito-Shi, Japan Investigational Site Number 392324 Mito-Shi, Japan Investigational Site Number 392331 Nagoya-Shi, Japan Investigational Site Number 392332 Nagoya-Shi, Japan Investigational Site Number 392329 Ohta-Ku, Japan Investigational Site Number 392322 Okawa-Shi, Japan Investigational Site Number 392333 Osaka-Shi, Japan Investigational Site Number 392330 Sagamihara-Shi, Japan Investigational Site Number 392320 Saijo-Shi, Japan Investigational Site Number 392303 Sakado-Shi, Japan Investigational Site Number 392311 Shinjuku-Ku, Japan Investigational Site Number 392316 Shizuoka-Shi, Japan Investigational Site Number 392319 Suita-Shi, Japan Less <<
NCT00780195 Diabetes Not Applicable Completed - -
NCT00951392 Insulin Sensitivity ... More >> Aging Less << Not Applicable Completed - France ... More >> Centre de recherche en nutrition humaine Rhône-Alpes Pierre-Bénite, France, 69495 Less <<
NCT03076112 Type 2 Diabetes Mellitus Phase 3 Recruiting December 30, 2019 Korea, Republic of ... More >> Seoul National University Bundang Hospital Recruiting Seongnam, Gyeonggi, Korea, Republic of, 463-707 Contact: Soo Lim, MD, PHD    82-31-787-7035    limsoo@snu.ac.kr    Contact: Kyoung Min Kim, MD, PHD    82-31-787-7047    kyoungmin02@gmail.com    Principal Investigator: Soo Lim, MD, PHD Less <<
NCT01112852 Esophageal Varices ... More >> Bleeding Less << Phase 4 Completed - -
NCT01247363 - Completed - -
NCT01247363 Diabetes Mellitus, Type 2 Phase 1 Completed - United States, Florida ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Miramar, Florida, United States, 33025 Singapore For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Singapore, Singapore, 117597 Less <<
NCT01060540 Diabetes Mellitus Not Applicable Completed - United States, North Carolina ... More >> Durham VA Medical Center, Durham, NC Durham, North Carolina, United States, 27705 Less <<
NCT01060540 - Completed - -
NCT01697150 Type 1 Diabetes Mellitus Not Applicable Completed - United States, California ... More >> Sansum Diabetes Research Institute Santa Barbara, California, United States, 93105 Less <<
NCT00432276 Diabetes Mellitus Phase 3 Completed - -
NCT02076932 Menopause Ins... More >>ulin Resistance Body Composition, Beneficial Less << Not Applicable Completed - Denmark ... More >> Department og Biomedical Sciences Copenhagen N, Denmark, 2200 Less <<
NCT01499082 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT01499082 - Completed - -
NCT03378167 Crohn Disease ... More >> Pediatric Crohns Disease Inflammatory Bowel Diseases Colitis Less << Phase 1 Recruiting March 31, 2020 Canada, Ontario ... More >> McMaster Children's Hospital Recruiting Hamilton, Ontario, Canada, M8V1A4 Contact: Lee Hill, BSc, PhD (c)    905-521-2100 ext 73587    hill.lee.devlin@gmail.com    Contact: Nikhil Pai, BSc, MD    905-521-2100 ext 73587    pain@mcmaster.ca Less <<
NCT03204240 Spinal Cord Injuries ... More >> Skeletal Muscle Atrophy Metabolic Disease Less << Not Applicable Recruiting January 2022 United States, Alabama ... More >> UAB Recruiting Birmingham, Alabama, United States, 35294 Contact: Ceren Yarar-Fisher, PT, PhD    205-500-8180    cyarar@uab.edu    Contact: Mualla Eraslan    205-975-0618    mualla@uab.edu Less <<
NCT00432276 - Completed - -
NCT03120871 - Recruiting December 2018 United States, Colorado ... More >> Children's Hospital Colorado Recruiting Aurora, Colorado, United States, 80045 Principal Investigator: Megan M Kelsey, MD, MS Less <<
NCT00489333 Metabolic Syndrome X Not Applicable Completed - Cameroon ... More >> Laboratory of Nutrition and Nutritional Biochemistry (LNNB), Department of Biochemistry, University of Yaounde I Yaounde, Cameroon Less <<
NCT01428934 - Completed - Spain ... More >> Unidad de Investigación en Atención Primaria de Girona, IDIAP Jordi Gol, Institut Català de la Salut Girona, Spain, 17003 Less <<
NCT01085682 Type 2 Diabetes Phase 4 Completed - Korea, Republic of ... More >> Chung-ju health care center Chung-ju, Chungchungbook-do, Korea, Republic of Less <<
NCT02812927 Critical Illness ... More >> Anesthesia Less << Not Applicable Completed - -
NCT02101151 Type 2 Diabetes Mellitus ... More >> Obesity Hypovitaminosis D Less << Not Applicable Completed - United Arab Emirates ... More >> Rashid Centre for Diabetes and Research Ajman, United Arab Emirates Less <<
NCT00609986 Kidney Transplantation ... More >> Diabetes Hyperglycemia Less << Not Applicable Completed - United States, South Carolina ... More >> Medical University of South Carolina Charleston, South Carolina, United States, 29464 Less <<
NCT00609986 - Completed - -
NCT03455049 Increased Insulin Not Applicable Recruiting May 30, 2018 Indonesia ... More >> Faculty of Medicine, Universitas Indonesia Recruiting Jakarta Pusat, DKI Jakarta, Indonesia, 10430 Contact: Tri Juli Edi Tarigan, MD    +62 813 15 483 293    tje_tar@yahoo.com    Contact: Nida Amalina, PH    +62 856 9703 6895    amalinanida@gmail.com Less <<
NCT03132181 Diabetes Mellitus Type 2 (T2DM... More >>) Less << Phase 2 Recruiting June 30, 2019 Germany ... More >> Department of Internal Medicine I RWTH Aachen University Hospital Recruiting Aachen, NRW, Germany, 52074 Contact: Michael Lehrke, PD Dr. med.    +49 241 80 85152    mlehrke@ukaachen.de    Principal Investigator: Michael Lehrke, PD Dr. med.          Sub-Investigator: Nikolaus Marx, Univ.-Prof. Dr. med. Less <<
NCT00272090 Diabetes Mellitus, Type 1 Phase 3 Completed - -
NCT02148224 - Unknown May 2014 Indonesia ... More >> Nutrifood Research Center Propinsi DKI Jakarta, DKI Jakarta, Indonesia, 13920 Less <<
NCT01085682 - Completed - -
NCT02410161 Healthy Phase 4 Completed - -
NCT01942694 Prediabetes T... More >>ype 2 Diabetes Less << Not Applicable Active, not recruiting December 2018 -
NCT02849288 Type 1 Diabetes Mellitus Phase 1 Completed - United States, California ... More >> William Sansum Diabetes Research Institute Santa Barbara, California, United States, 93111 Stanford University Stanford, California, United States, 94305 United States, Colorado Barbara Davis Center for Childhood Diabetes Aurora, Colorado, United States, 80045 Less <<
NCT03121807 Metastatic Gastric Cancer Not Applicable Recruiting December 1, 2019 Taiwan ... More >> Chung-Ho Memorial Hospital, Kaohsiung Medical University: Recruiting Kaohsiung, Taiwan, 807 Contact: Jaw-Yuan Wang, PhD       cy614112@ms14.hinet.net    Contact: Cheng-Jen Ma, MD       kmu880402@gmail.com    Principal Investigator: Jaw-Yuan Wang, Ph.D.          Sub-Investigator: Cheng-Jen Ma, MD Less <<
NCT00707213 Cancer Not Applicable Terminated(Funding from the NI... More >>H ended and not all patients had been accrued) Less << - United States, Utah ... More >> Huntsman Cancer Institute Salt Lake City, Utah, United States, 84112 Less <<
NCT01210001 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT01454219 Healthy Not Applicable Completed - Finland ... More >> Clinical Life Sciences Ltd Kajaani, Finland, 87100 Less <<
NCT03582956 Type1 Diabetes Mellitus ... More >> Adiposity Less << Not Applicable Not yet recruiting June 15, 2022 -
NCT00535483 - Completed - Austria ... More >> Medical University Graz - Clinical Research Center Graz, Styria, Austria, 8036 Less <<
NCT03185884 Carbohydrate Metabolism Not Applicable Completed - United States, Nebraska ... More >> University of Nebraska-Lincoln Lincoln, Nebraska, United States, 68583-0806 Less <<
NCT00571636 Pain Infant, ... More >>Premature, Diseases Respiration; Insufficient or Poor, Newborn Less << Phase 3 Completed - Italy ... More >> St'Orsola-Malpighi General Hospital Bologna, BO, Italy, 40138 Less <<
NCT00949442 Diabetes Mellitus, Type 2 Phase 4 Completed - -
NCT03552367 Obesity Exerc... More >>ise Cardiovascular Risk Factor Liver Diseases Metabolic Syndrome Childhood Obesity Less << Not Applicable Recruiting July 31, 2020 Mexico ... More >> Hospital General de Mexico Eduardo Liceaga Recruiting Mexico City, Del. Cuauhtemoc, Mexico, 06720 Contact: Nayely Garibay iIeto, MD MSc    2789 2000    gngaribay@hotmail.com Less <<
NCT00887406 Pulmonary Disease, Chronic Obs... More >>tructive Less << Phase 1 Completed - United Kingdom ... More >> GSK Investigational Site London, United Kingdom Less <<
NCT01946347 Insulin Resistance ... More >> Type 2 Diabetes Less << Not Applicable Completed - Czech Republic ... More >> Diabetes Center, Institute of Clinical and Experimental Medicine Prague, Czech Republic, 140 21 Less <<
NCT01210001 - Completed - -
NCT02162407 Diabetes Heal... More >>thy Less << Phase 1 Completed - Austria ... More >> Graz, Austria, 8036 Less <<
NCT03200782 Postprandial Hypoglycemia ... More >> Bariatric Surgery Late Dumping Syndrome Less << Not Applicable Completed - Switzerland ... More >> University Hospital Basel, Department of Endocrinology, Diabetes and Metabolism Basel, Switzerland, 4056 Basel Less <<
NCT03086330 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT02653209 Type 2 Diabetes Phase 4 Recruiting December 2019 United Kingdom ... More >> Exeter Clinical Research Facility Recruiting Exeter, United Kingdom, EX2 5DW Contact: Catherine Angwin    01392408185    C.Angwin@exeter.ac.uk    Contact: Andrew Hattersley    +441392 408231    A.T.Hattersley@exeter.ac.uk    Principal Investigator: Andrew Hattersley Less <<
NCT02365987 Healthy Men Not Applicable Completed - United Kingdom ... More >> Diabetes and Nutritional Sciences Division, School of Medicine, Kings College London London, United Kingdom, SE1 9NH Less <<
NCT01883700 Healthy Phase 2 Unknown September 2013 Canada, Ontario ... More >> Risk Factor Modification Centre, St. Michael's Hospital Toronto, Ontario, Canada, M5B 1W8 Less <<
NCT00488527 Diabetes Mellitus, Type 2 Phase 4 Completed - Mexico ... More >> Sanofi-Aventis Mexico, Mexico Less <<
NCT01771042 Obesity Type ... More >>2 Diabetes Metabolic Syndrome Less << Not Applicable Unknown April 2017 Australia, Victoria ... More >> Baker IDI Heart & Diabetes Institute Not yet recruiting Melbourne, Victoria, Australia, 8008 Contact: Nora E Straznicky, PhD MPH    61 3 8532 1371    nora.straznicky@bakeridi.edu.au    Principal Investigator: Nora E Straznicky, PhD MPH Less <<
NCT00857870 Type 2 Diabetes Phase 4 Completed - Germany ... More >> GWT -TUD, Center for Clinical Studies Dresden, Germany, 01307 Less <<
NCT01128829 - Completed - -
NCT01226043 Diabetes Mellitus, Type 2 Phase 4 Completed - United States, New Jersey ... More >> Sanofi-Aventis Administrative Office Bridgewater, New Jersey, United States, 08807 Less <<
NCT03157817 - Completed - United Kingdom ... More >> Respiratory Biomedical Research Centre Leicester, Leicestershire, United Kingdom, LE3 9QP Loughborough Universtiy Loughborough, Leicestershire, United Kingdom, LE11 3TU Less <<
NCT03164005 - Recruiting March 1, 2018 China, Hubei ... More >> Department of Endocrinology, Union Hospital,Tongji Medical College, Huazhong University of Science and Technology Recruiting Wuhan, Hubei, China Contact: Ye Xiaofeng    +86 18086482871    yexf2016@163.com    Contact: Kong Wen    +86 027-85726798    wenly-kong@163.com    Sub-Investigator: Mohammad Ishraq Zafar          Principal Investigator: Chen Lulu Less <<
NCT01226043 - Completed - -
NCT01701570 Type 2 Diabetes Not Applicable Completed - United States, Colorado ... More >> University of Colorado, Anschutz Medical Campus Aurora, Colorado, United States, 80045 Less <<
NCT00600626 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT03076424 - Completed - United States, North Dakota ... More >> Neuropsychiatric Research Institute (NRI) Fargo, North Dakota, United States, 58103 Less <<
NCT03470857 - Recruiting December 31, 2019 Poland ... More >> Department of Positron Emission Tomography and Molecular Diagnostics, Collegium Medicum of Nicolaus Copernicus University Recruiting Bydgoszcz, Kujawsko Pomorskie, Poland, 85-796 Contact: Bogdan Małkowski, PhD, MD    +48523743430    petidm@cm.umk.pl    The Chair of Medical Biology, Collegium Medicum of Nicolaus Copernicus University Recruiting Bydgoszcz, Kujawsko-Pomorskie, Poland, 85-092 Contact: Paweł Sutkowy, PhD    +48525853822    p.sutkowy@cm.umk.pl    Department of Nuclear Medicine of Center Oncology in Bydgoszcz Recruiting Bydgoszcz, Kujawsko-Pomorskie, Poland, 85-796 Contact: Jolanta Czuczejko, PhD    +48523743430    joczu@wp.pl Less <<
NCT02030600 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT00592527 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - India ... More >> Novo Nordisk Investigational Site Kochi, Kerala, India, 682041 Novo Nordisk Investigational Site Ahmedabad, India, 390009 Novo Nordisk Investigational Site Chennai, India, 600-013 Novo Nordisk Investigational Site Chennai, India, 600010 Novo Nordisk Investigational Site Nagpur, India, 440012 Less <<
NCT02030600 - Completed - -
NCT01526941 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 1 Completed - Germany ... More >> Novo Nordisk Investigational Site Neuss, Germany, 41460 Less <<
NCT01849705 - Completed - Denmark ... More >> Department of Nutrition, Exercise and Sports, University of Copenhagen Frederiksberg, Frederiksberg C, Denmark, 1958 Less <<
NCT03610412 Diabetes Mellitus, Type 2 Phase 2 Not yet recruiting December 2018 -
NCT03000582 Dietary Modification Not Applicable Completed - -
NCT02757183 - Unknown March 2017 United States, California ... More >> Cedars-Sinai Medical Center Recruiting Los Angeles, California, United States, 90048 Less <<
NCT01325987 Type 2 Diabetes ... More >> Vitamin D Deficiency Less << Not Applicable Completed - United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35233 Less <<
NCT01554293 Diabetes Mellitus Phase 1 Unknown September 2013 India ... More >> Fortis Clinical Research Ltd Recruiting Faridabad, Haryana, India, 121 002 Contact: Dr Deepak C Chilkoti    +91-129-4090 900    Deepak.chilkoti@fortis-cro.com    Principal Investigator: Dr Deepak C Chilkoti Less <<
NCT01200771 Fever Not Applicable Completed - France ... More >> Médecine Interne - CHU Amiens, France, 80080 Médecine Nucléaire - CHU Amiens, France, 80080 Médecine Interne - CHU Lille, France, 59037 Médecine Nucléaire et Imagerie Fonctionnelle - CHU Lille, France, 59037 Médecine Interne - CHU Limoges, France, 87042 Médecine Nucléaire - CHU Limoges, France, 87042 Médecine Interne - AP-HP - Hôpital Hôtel Dieu Paris, France, 75004 Médecine Nucléaire - AP-HP - Hôpital Hôtel Dieu Paris, France, 75004 Médecine Interne - AP-HP - La Pitié Salpétrière Paris, France, 75013 Médecine Nucléaire - AP-HP - La Pitié Salpétrière Paris, France, 75013 Médecine Interne - AP-HP - Hôpital Cochin Paris, France, 75014 Médecine Interne - AP-HP - Hôpital Bichat Paris, France, 75018 Médecine Nucléaire - AP-HP - Hôpital Bichat Paris, France, 75018 Service des Isotopes - CRLCC Centre Eugène Marquis Rennes, France, 35042 Département de Médecine pour adulte - CHU Rennes, France, 35056 Médecine Interne - CH Rodez, France, 12000 Médecine Nucléaire - CH Rodez, France, 12000 Médecine Interne - CHU Toulouse, France, 31059 Médecine Nucléaire - CHU Toulouse, France, 31059 Less <<
NCT00148304 - Completed - United States, Arizona ... More >> Phoenix VA Health Care System, Phoenix, AZ Phoenix, Arizona, United States, 85012 Southern Arizona VA Health Care System, Tucson, AZ Tucson, Arizona, United States, 85723 United States, New Mexico New Mexico VA Health Care System, Albuquerque, NM Albuquerque, New Mexico, United States, 87108-5153 Less <<
NCT01159938 Diabetes Mellitus, Type 2 Phase 4 Completed - Finland ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Helsinki, Finland, 00014 Less <<
NCT00101712 Diabetes Mellitus, Type 2 Phase 3 Completed - Germany ... More >> Novartis Investigative Site Investigative Site, Germany Switzerland Novartis Investigative Site Basel, Switzerland Less <<
NCT01128829 Obesity Not Applicable Completed - United States, Missouri ... More >> Washington University School of Medicine St. Louis, Missouri, United States, 63110 Less <<
NCT02250222 Type 2 Diabetes Mellitus Phase 1 Completed - United States, Arizona ... More >> Celerion, Inc Tempe, Arizona, United States, 85283 United States, Florida Clinical Pharmacology of Miami, Inc Miami, Florida, United States, 33014 United States, Ohio Medpace Clinical Pharmacology Cincinnati, Ohio, United States, 45227 Less <<
NCT00222885 - Completed - United States, Pennsylvania ... More >> University of Pittsburgh Pittsburgh, Pennsylvania, United States, 15213 Less <<
NCT01159938 - Completed - -
NCT03158363 Immobilization, Tonic ... More >> Fasting Endotoxemia Metabolism Less << Not Applicable Completed - Denmark ... More >> Institute for Clinical MEdicine Aarhus, Denmark, 8000 Less <<
NCT01711320 Healthy Phase 1 Completed - China, Shaanxi ... More >> Department of pharmacy, Xijing Hospital, Fourth Military Medical University Xi'an, Shaanxi, China Less <<
NCT01464593 Colon Cancer Liver Metastasis Phase 2 Terminated(trial design contin... More >>gent on RFA optimization) Less << - United States, California ... More >> UCLA Los Angeles, California, United States, 90095 United States, New York Montefiore Medical Center Bronx, New York, United States, 10467 United States, Ohio Cleveland Clinic Hospital Cleveland, Ohio, United States, 44195 United States, Rhode Island Rhode Island Hospital Providence, Rhode Island, United States, 02903 Less <<
NCT03693287 Infant,Premature ... More >> Parenteral Nutrition Growth Less << Phase 3 Not yet recruiting May 30, 2021 -
NCT03138447 Diabetes Mellitus, Type 2 Not Applicable Recruiting November 2017 United States, Maryland ... More >> MODEL Clinical Research Recruiting Towson, Maryland, United States, 21204 Contact: Karen Klein    443-524-1789    karenklein99@hotmail.com    Principal Investigator: Philip A Levin, MD Less <<
NCT02561130 Type 2 Diabetes Mellitus Phase 4 Active, not recruiting October 2018 Canada, Alberta ... More >> University of Calgary Calgary, Alberta, Canada, T2T 5C7 Canada, Manitoba Health Science Centre Winnipeg, Manitoba, Canada, R3E 3P4 Canada, Ontario McMaster University Hamilton, Ontario, Canada, L8N 3Z5 St. Joseph's Hospital London, Ontario, Canada, N6A 4V2 Western University London, Ontario, Canada, N6G 2M1 LMC Toronto, Ontario, Canada, M4G 3E8 St. Michaels's Hospital Toronto, Ontario, Canada, M5C 2T2 Less <<
NCT03278847 - Not yet recruiting March 2019 United Kingdom ... More >> Imperial College London, Chelsea and Westminster Hospital campus Active, not recruiting London, United Kingdom, SW10 9NH Less <<
NCT01316367 Type 2 Diabetes Mellitus ... More >> Cardiovascular Risk Factor Less << Phase 4 Completed - Spain ... More >> Hospital Carlos III, Madrid Madrid, Spain, 28029 Less <<
NCT03010904 Unidentified Gastrointestinal ... More >>Discomfort Following Dairy Consumption Less << Not Applicable Completed - Finland ... More >> Department of Biochemistry, University of Turku Turku, Finland, 20014 Food Chemistry, Department of Biochemistry, University of Turku Turku, Finland, 20500 Less <<
NCT01160887 - Completed - Norway ... More >> Haukeland University Hospital Bergen, Norway, 5021 Less <<
NCT00602953 - Completed - United States, Texas ... More >> UT Southwestern Medical Center Dallas, Texas, United States, 75390 Less <<
NCT01978691 Obesity Hyper... More >>glycemia Insulin Resistance Less << Phase 2 Completed - Finland ... More >> VL-Medi Helsinki, Finland, 00101 Kerava healthcare center Kerava, Finland, 04200 FinnMedi Oy Tampere, Finland, 33520 CRST - Clinical Research Services Turku Turku, Finland, 20521 Less <<
NCT03544411 Diabetes Mellitus, Type 2 ... More >> Oxidative Stress Glucose, High Blood Lipid Disorder Less << Phase 1 Completed - Indonesia ... More >> Fkui-Kdk Kiara Jakarta Pusat, DKI Jakarta, Indonesia, 10430 Less <<
NCT00298740 Type 1 Diabetes Not Applicable Completed - United States, Maryland ... More >> Johns Hopkins University Baltimore, Maryland, United States, 21287 Less <<
NCT00298740 - Completed - -
NCT03188848 Healthy Subject Phase 1 Not yet recruiting December 2019 -
NCT03132090 Malignant Melanoma Stage IV Not Applicable Recruiting June 2018 Germany ... More >> Dept. of Radiology, University of Tuebingen Recruiting Tuebingen, Germany, 72076 Contact: Christina Pfannenberg, MD    +49 7071 2982756    christina.pfannenberg@med.uni-tuebingen.de    Contact: Brigitte Gueckel    +49 7071 2981212    brigitte.gueckel@med.uni-tuebingen.de Less <<
NCT02132637 - Completed - -
NCT01162993 Diabetic Neuropathies ... More >> Pain Electric Stimulation Therapy Less << Not Applicable Unknown January 2018 Netherlands ... More >> UMC St. Radboud Nijmegen, Gelderland, Netherlands Maastricht University Medical Center Maastricht, Limburg, Netherlands Less <<
NCT03056456 Type1 Diabetes Mellitus Phase 1 Completed - Germany ... More >> For additional information regarding investigative sites for this trial, contact 1-888-545-5972 Mon - Fri, 9 AM to 4 PM or 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time or speak with your personal physician. Neuss, Germany, 41460 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician. Neuss, Germany Less <<
NCT03053518 Type2 Diabetes Not Applicable Recruiting December 2019 United States, New York ... More >> New York University School of Medicine Recruiting New York, New York, United States, 10016 Contact: Ram Jagannathan       Ram.Jagannathan@nyumc.org    Principal Investigator: Mary Sevick, MD Less <<
NCT02132637 Type 2 Diabetes Mellitus Phase 3 Completed - United States, California ... More >> Profil Institute for Clinical Research Inc Chula Vista, California, United States, 91911 Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mainz, Germany, 55116 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Neuss, Germany, 41460 Less <<
NCT00378820 Metabolic Syndrome ... More >> Obesity Less << Not Applicable Unknown - Denmark ... More >> Institute of Human Nutrition, Rolighedsvej 30 Frederiksberg C, Denmark, 1958 Less <<
NCT00654004 - Completed - -
NCT00602953 - Completed - -
NCT02790489 Overweight Phase 1 Completed - France ... More >> Centre d'Investigation Clinique Clermont-Ferrand, France, 63000 Less <<
NCT01481116 Diabetes Mellitus, Type 2 Phase 3 Terminated(Due to potential co... More >>ncerns about liver safety (See Detailed Description)) Less << - -
NCT00654004 - Completed - United States, Oregon ... More >> Oregon Health & Science University Portland, Oregon, United States, 97239 Less <<
NCT02719756 Diabetes Mellitus ... More >> Hypoglycemic Episodes Less << Phase 4 Unknown December 2016 Russian Federation ... More >> Research Clinical Centre of the Russian Railways, JSC Not yet recruiting Moscow, Russian Federation, 125993 Contact: Alexander Ametov, prof., MD    (499)1510951 ext 8107    alexander.ametov@gmail.ru    Contact: Viktoria Blagova, PhD cand.    (499)6130363 ext 8107    vika-blagova@mail.ru Less <<
NCT02521675 Diabetes Mellitus, Type I ... More >> Adjustment of Basal Insulin Flow Rate During Physical Activity Adjustment of Prandial Insulin in Case of Physical Activity Less << Not Applicable Recruiting January 2020 France ... More >> Hôpital Universitaire Recruiting Angers, France, 49933 Principal Investigator: Séverine Dubois, MD          Sub-Investigator: Ingrid Allix, MD          Hôpital Henri Duffaut Not yet recruiting Avignon, France, 84902 Principal Investigator: Eric Benamo, MD          Sub-Investigator: Françoise Plat, MD          Hôpital Jean Minjoz Withdrawn Besançon, France, 25030 Centre Hospitalier Withdrawn Boulogne sur Mer, France, 62321 Hôpital Universitaire Recruiting Brest, France, 29609 Principal Investigator: Véronique Kerlan, MD          Sub-Investigator: Emmanuel Sonnet, MD          Centre Hospitalier Alpes-Léman Withdrawn Contamine sur Arve, France, 74130 Centre Hospitalier Sud-Francilien Recruiting Corbeil-Essonnes, France, 91100 Principal Investigator: Sylvia Franc, MD          Sub-Investigator: Alfred Penfornis, MD PHD          Sub-Investigator: Guillaume Charpentier, MD          Sub-Investigator: Ahmed Daoudi, MD          Centre Hospitalier Louis Pasteur Recruiting Dole, France, 39108 Principal Investigator: Muriel Tschudnowski, MD          Centre Hospitalier Not yet recruiting Douai, France, 59507 Principal Investigator: Régis Bresson, MD          Hôpital Pierre Zobda-Quitman Withdrawn Fort De France, France, 97261 Hôpital Universitaire Recruiting Grenoble, France, 38043 Principal Investigator: Pierre-Yves Benhamou, MD PHD          Sub-Investigator: Sandrine Lablanche-Cornali, MD PHD          Fondation Hôtel Dieu du Creusot Not yet recruiting Le Creusot, France, 71200 Principal Investigator: Sylvaine Clavel, MD          Centre Hospitalier Régional Universitaire Recruiting Lille, France, 59037 Principal Investigator: Anne Vambergue, MD PHD          Sub-Investigator: Florence Baudoux, MD          Centre Hospitalier Universitaire Recruiting Lyon, France, 69310 Principal Investigator: Charles Thivolet, MD PHD          Hôpital de la Conception Recruiting Marseille, France, 13005 Principal Investigator: Pauline Schaepelynck, MD          Sub-Investigator: Marie-Françoise Jannot-Lamotte, MD          Sub-Investigator: Clémence Treglia, MD          Recruiting Merignac, France, 33700 Contact: Anne Navaranne Roumec, MD          Principal Investigator: Anne Navaranne Roumec, MD          Withdrawn Noisy le Grand, France, 93160 Hôpital Cochin Withdrawn Paris, France, 75014 Hôpital Lariboisière Withdrawn Paris, France, 75475 Centre Hospitalier Universitaire Not yet recruiting Rennes, France, 35056 Principal Investigator: Anne-Marie Leguerrier, MD          Centre Hospitalier Not yet recruiting Saint Dié des Vosges, France, 88187 Principal Investigator: Pascal Mattei, MD          Centre Hospitalier Régional Universitaire Recruiting Strasbourg, France, 67000 Principal Investigator: Nathalie Jeandidier, MD PHD          Sub-Investigator: Dominique Paris, MD          Sub-Investigator: François Moreau, MD          Hôpital Jean Bernard Completed Valenciennes, France, 59322 Centre Hospitalier Les Portes du Sud Withdrawn Venissieux, France, 69200 Less <<
NCT03707171 Type 2 Diabetes Mellitus Phase 3 Not yet recruiting May 1, 2019 China, Chongqing ... More >> The third hospital affiliated to the Third Military Medical University Chongqing, Chongqing, China, 400042 Less <<
NCT00814294 Diabetes Phase 2 Phase 3 Unknown October 2009 -
NCT01922492 Partial Pancreatectomy Due to ... More >>Benign Pancreatic Neoplasm Less << Not Applicable Unknown December 2017 Korea, Republic of ... More >> Seoul National University Hospital Seoul, Korea, Republic of Less <<
NCT02039986 - Completed - United States, Pennsylvania ... More >> The Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00365794 Aging Obesity... More >> Insulin Resistance Hypogonadism Less << Phase 2 Completed - United States, California ... More >> LAC-USC Medical Center GCRC Los Angeles, California, United States, 90033 Less <<
NCT03341299 Diabetes Mellitus, Type 1 Phase 1 Completed - Germany ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician. Mainz, Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician. Neuss, Germany Less <<
NCT01481116 - Terminated(Due to potential co... More >>ncerns about liver safety (See Detailed Description)) Less << - -
NCT00767000 Diabetes Mellitus, Type 2 Phase 2 Terminated - -
NCT03343782 Type 2 Diabetes Mellitus Phase 2 Recruiting December 31, 2018 Vietnam ... More >> Vinmec Research Institute of Stem Cell and Gene Technology Recruiting Hanoi, Vietnam, 10000 Contact: Liem T Nguyen, MD, PhD    (+84 4) 3 974 3556 ext 1420    v.liemnt@vinmec.com Less <<
NCT01943045 Diabetes Mellitus Phase 2 Completed - Australia, Victoria ... More >> NGM Clinical Study Site 6103 Melbourne, Victoria, Australia NGM Clinical Study Site 6104 Melbourne, Victoria, Australia Australia, Western Australia NGM Clinical Study Site 6101 Perth, Western Australia, Australia New Zealand NGM Clinical Study Site 6403 Auckland, New Zealand NGM Clinical Study Site 6405 Auckland, New Zealand NGM Clinical Study Site 6401 Christchurch, New Zealand NGM Clinical Study Site 6406 Dunedin, New Zealand NGM Clinical Study Site 6404 Tauranga, New Zealand NGM Clinical Study Site 6402 Wellington, New Zealand Less <<
NCT00641056 - Completed - -
NCT00641056 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT02986490 Schizophrenia ... More >> Schizoaffective Disorder Bipolar Disorder Less << Not Applicable Unknown December 2017 France ... More >> Recruiting Montpellier, France, 34295 Contact: Jean-Luc FAILLIE, MD PhD    +33 4 67 33 67 52    jl-faillie@chu-montpellier.fr Less <<
NCT02481141 Diabetes Mellitus, Type 2 Not Applicable Completed - -
NCT03615339 Healthy Not Applicable Completed - United Kingdom ... More >> The Rowett Institute, Human Nutrition Unit Aberdeen, United Kingdom, AB25 2ZD Less <<
NCT00767000 - Terminated - -
NCT00290732 Breast Cancer Phase 1 Completed - United States, Indiana ... More >> Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States, 46202-5289 United States, Maryland Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 Less <<
NCT00290732 - Completed - -
NCT01333137 Breast Cancer Phase 1 Terminated - United States, California ... More >> Disney Cancer Center Burbank, California, United States 3855 Health Sciences Drive La Jolla, California, United States, 92093 UC Davis Cancer Center Sacramento, California, United States, 95817 United States, Missouri Washington University St. Louis, Missouri, United States Less <<
NCT02481141 - Completed - -
NCT01435330 Insulin Resistance Phase 1 Completed - United States, California ... More >> Novartis Investigative Site Chula Vista, California, United States, 91910 United States, Washington Novartis Investigative Site Tacoma, Washington, United States, 98418 Less <<
NCT00523562 Metabolic Syndrome X ... More >> Liver Diseases Less << Not Applicable Completed - Switzerland ... More >> Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland, CH-1011 Less <<
NCT03102892 Diabetes Mellitus, Type 1 ... More >> Periodontal Diseases Periodontal Pocket Less << Not Applicable Recruiting December 10, 2018 Brazil ... More >> Bauru School of Dentistry Recruiting Bauru, Sao Paulo, Brazil, 17012-901 Contact: Carla Damante, PhD    55 14 32358278    cdamante@usp.br Less <<
NCT03023137 Recurrent Miscarriage Not Applicable Completed - Brazil ... More >> Hospital Federal dos Servidores do Estado, Ministry of Health Rio de Janeiro, RJ, Brazil, 20221-903 Less <<
NCT00101803 Diabetes Mellitus, Type 2 Phase 3 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 Less <<
NCT01960179 Type 2 Diabetes Mellitus Phase 3 Completed - Japan ... More >> Investigational Site Number 392006 Adachi-Ku, Japan Investigational Site Number 392005 Chiba-Shi, Japan Investigational Site Number 392010 Chiyoda-Ku, Japan Investigational Site Number 392004 Chuo-Ku, Japan Investigational Site Number 392015 Chuo-Ku, Japan Investigational Site Number 392003 Chuoh-Ku, Japan Investigational Site Number 392012 Ebina-Shi, Japan Investigational Site Number 392024 Higashiosaka-Shi, Japan Investigational Site Number 392023 Kashiwara-Shi, Japan Investigational Site Number 392008 Kawagoe-Shi, Japan Investigational Site Number 392009 Kisarazu-Shi, Japan Investigational Site Number 392002 Koganei-Shi, Japan Investigational Site Number 392007 Koriyama-Shi, Japan Investigational Site Number 392011 Mitaka-Shi, Japan Investigational Site Number 392025 Nagoya-Shi, Japan Investigational Site Number 392026 Nagoya-Shi, Japan Investigational Site Number 392013 Ogawa-Machi, Hikigun, Japan Investigational Site Number 392014 Ohta-Ku, Japan Investigational Site Number 392022 Okawa-Shi, Japan Investigational Site Number 392021 Osaka-Shi, Japan Investigational Site Number 392028 Osaka-Shi, Japan Investigational Site Number 392029 Osaka-Shi, Japan Investigational Site Number 392030 Sapporo-Shi, Japan Investigational Site Number 392018 Sendai-Shi, Japan Investigational Site Number 392001 Shinjuku-Ku, Japan Investigational Site Number 392020 Suita-Shi, Japan Investigational Site Number 392017 Toshima-Ku, Japan Investigational Site Number 392027 Toyonaka-Shi, Japan Investigational Site Number 392016 Yokohama-Shi, Japan Investigational Site Number 392019 Yokohama-Shi, Japan Less <<
NCT03023137 - Completed - -
NCT00237237 Diabetes Mellitus, Type 2 Phase 3 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 Germany Investigative Centers Nurnberg, Germany Less <<
NCT00734474 Diabetes Mellitus, Type 2 Phase 2 Phase 3 Completed - -
NCT02313363 Type 2 Diabetes Mellitus Early Phase 1 Completed - -
NCT02480673 Metabolic Syndrome X Not Applicable Unknown May 2016 Mexico ... More >> Instituto Mexicano Del Seguro Social Hospital de Especialidades, Centro Medico Nacional de Occidente Lic. Ignacio Garcia Tellez Unidad Medica de Alta Especialidad Recruiting Guadalajara, Jalisco, Mexico, 44340 Contact: Ana E Pérez Verdin, MD    011523336170060 ext 31465    verdinmd@hotmail.com    Contact: Blanca M Torres Mendoza, PhD    011523336170060 ext 31950    bltorres1@hotmail.com Less <<
NCT00734474 - Completed - -
NCT01515059 - Terminated(Slow recruitment an... More >>d sufficient data available to analyse) Less << - United Kingdom ... More >> Leicester Diabetes Centre Leicester, Leicestershire, United Kingdom, LE5 4PW Less <<
NCT03449433 Diabetes Mellitus, Type 1 Phase 1 Completed - Germany ... More >> Profil Institut für Stoffwechselforschung Neuss, Nordrhein-Westfalen, Germany, 41460 Less <<
NCT00099853 Diabetes Mellitus, Type 2 Phase 3 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 Less <<
NCT01738399 Insulin Resistance Not Applicable Completed - Singapore ... More >> Saw Swee Hock School of Public Health Singapore, Singapore, 117597 Less <<
NCT00099944 Diabetes Mellitus, Type 2 Phase 3 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 Less <<
NCT02381145 Healthy Not Applicable Completed - Netherlands ... More >> Maastricht University Maastricht, Netherlands, 6229 ER Less <<
NCT02931656 Diabetes, Gestational Not Applicable Completed - Brazil ... More >> José Roberto da Silva Junior Recife, Pernambuco, Brazil, 50070-550 Less <<
NCT02559479 Weight Loss O... More >>besity Diabetes Diet, Reducing Carbohydrates Protein Less << Not Applicable Unknown June 2017 Spain ... More >> Fernando Civeira Recruiting Zaragoza, Spain, 50009 Contact: Rocio Mateo-Gallego, RD, PhD    +34 976765500 ext 2895    rmateo.iacs@aragon.es    Contact: Victoria Marco-Benedí, RD    +34 976765500 ext 2895    vito2911@hotmail.com Less <<
NCT01861392 Diabetes Mellitus ... More >> Quality of Life Exercise Therapy Postural Balance Less << Not Applicable Unknown December 2016 Brazil ... More >> Rinaldo Roberto de Jesus Guirro Not yet recruiting Ribeirão Preto, São Paulo, Brazil Contact: Rinaldo Jesus Guirro, PHD    +551636024584    rguirro@fmrp.usp.br    Contact: Ariane H M Pletsch, PHD student    +551636020462    ariane_mansano@usp.br    Sub-Investigator: Ariane H M Pletsch, PHD Student Less <<
NCT01057628 Type 2 Diabetes Mellitus Phase 3 Completed - Japan ... More >> Hokkaido, Japan Kansai, Japan Kantou, Japan Kyushu, Japan Touhoku, Japan Less <<
NCT00474045 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 3 Completed - -
NCT00396071 Diabetes Mellitus, Type 2 Phase 3 Completed - Germany ... More >> Diabetes Zentrum Bad Lauterberg Bad Lauterberg, Germany, 37431 Switzerland Novartis Pharmaceuticals Basel, Switzerland Less <<
NCT03202667 SIAD - Syndrome of Inappropria... More >>te Antidiuresis Hyponatremia Less << Phase 2 Phase 3 Recruiting December 2018 Switzerland ... More >> University Hospital Basel Recruiting Basel, Switzerland, 4031 Contact: Julie Refardt, Dr.    +41(0)61 2652525 Zentrale    julie.refardt@usb.ch    Contact: Mirjam Christ-Crain, Prof       mirjam.christ@usb.ch Less <<
NCT00382096 Diabetes Mellitus, Type 2 Phase 3 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 Germany Investigative Centers, Germany Less <<
NCT00474045 - Completed - -
NCT01906099 Diabetes Mellitus, Type 2 Not Applicable Completed - Iran, Islamic Republic of ... More >> Isfahan University of Medical Sciences Isfahan, Iran, Islamic Republic of Less <<
NCT02635243 Type 1 Diabetes Mellitus Phase 1 Withdrawn November 2016 -
NCT01316354 Metabolic Syndrome Not Applicable Completed - Denmark ... More >> Aarhus University Hospital Aarhus, Denmark, 8000 Less <<
NCT02149459 Brain Neoplasms Phase 1 Recruiting July 2018 Israel ... More >> Sheba Medical Center Recruiting Ramat Gan, Israel, 52621 Less <<
NCT03761693 Mcad Deficiency Not Applicable Not yet recruiting January 2024 -
NCT01720784 Obesity Not Applicable Completed - Denmark ... More >> Department of Nutrition, Exercise and Sports, University of Copenhagen Frederiksberg C, Denmark, 1958 Less <<
NCT00219440 Diabetes Mellitus Phase 4 Completed - United States, Louisiana ... More >> Pennington Center Baton Rouge, Louisiana, United States, 70808 Less <<
NCT03068065 Non-Alcoholic Fatty Liver Dise... More >>ase Type2 Diabetes Less << Phase 4 Completed - China, Jiangsu ... More >> at Division of Endocrinology, the Affiliated Drum Tower Hospital of Nanjing University Nanjing, Jiangsu, China, 210008 Less <<
NCT02621008 Diabetes Hype... More >>rtension Pre-diabetes Overweight Obese Weight Adherence Less << Not Applicable Unknown October 2016 United States, New York ... More >> Mt Sinai Medical Center Recruiting New York, New York, United States, 10029 Contact: steven kaplan, md    646-652-6531    drprostate@aol.com    Contact: oren fuerst, phd    6466526531    oren@eco-fusion.com Less <<
NCT02922426 Healthy Volunteers Phase 1 Completed - United States, California ... More >> Alkermes Investigational Site Chula Vista, California, United States, 91911 Less <<
NCT01581658 Diabetes Mellitus, Type 2 Phase 1 Completed - Japan ... More >> 1245.53.001 Boehringer Ingelheim Investigational Site Kurume, Fukuoka, Japan Less <<
NCT02938546 Non-small-cell Lung Cancer Phase 3 Not yet recruiting January 2023 -
NCT00138619 Diabetes Mellitus, Type 2 Phase 3 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 Germany Investigative Centers, Germany Less <<
NCT02057848 Hypoglycaemia Not Applicable Completed - Germany ... More >> Diabeteszentrum Bad Lauterberg, Germany, 37431 Less <<
NCT01581658 - Completed - -
NCT02143440 Type 2 Diabetes. Not Applicable Unknown May 2014 China, Shanghai ... More >> Renji Hospital Shanghai, Shanghai, China, 200127 Less <<
NCT01109706 - Unknown April 2013 France ... More >> Nantes University hospital Recruiting Nantes, France, 44000 Contact: Bertrand Cariou, MD    02 53 48 27 10    bertrand.cariou@univ-nantes.fr    Principal Investigator: Bertrand Cariou, MD          Sub-Investigator: Vicent Probst, MD          Sub-Investigator: Jean-Noel Trochu, MD          Sub-Investigator: Vincent Letocart, MD          Sub-Investigator: Patrice Guerin, MD          Sub-Investigator: Krempf Michel, MD          Sub-Investigator: Delphine Drui, MD          Sub-Investigator: Lucie Chaillous, MD          Nantes University Hospital Recruiting Nantes, France, 44093 Contact: Bertrand Cariou, MD    02 53 48 27 10    bertrand.cariou@chu-nantes.fr Less <<
NCT03093103 Nephropathy Phase 2 Recruiting December 31, 2018 Switzerland ... More >> Service de Néphrologie Recruiting Lausanne, Vaud, Switzerland, 1011 Contact: Guler Gok-sogut, Ass-med    41 79 556 20 05    guler-gok-sogut@chuv.ch    Contact: Marie-Eve Muller, MD    41 79 556 59 46    Marie-Eve.Muller@chuv.ch    Sub-Investigator: Anne Zanchi, MD          Principal Investigator: Michel Burnier, Prof Less <<
NCT02844803 Diabetes Mellitus Early Phase 1 Unknown - Korea, Republic of ... More >> Dongguk University Ilsan Hospital Recruiting Goyang, Gyeonggi, Korea, Republic of, 410-773 Contact: Namyi Gu, MD, PhD    +82-31-961-8440    namyi.gu@gmail.com Less <<
NCT00280085 Diabetes Mellitus Not Applicable Terminated(Explanation provide... More >>d in detailed descriptiong section of record.) Less << - United States, Connecticut ... More >> Pfizer Investigational Site New Haven, Connecticut, United States, 06510 Less <<
NCT01926041 Diabetes Mellitus ... More >> Cigarette Smoking Prediabetes Less << Not Applicable Recruiting July 2020 Taiwan ... More >> National Taiwan University Hospital Yun-Lin branch Recruiting Yunlin, Taiwan, 640 Contact: Chien-Hsieh Chiang, MD, MPH    +886-9-20511256    jiansie@ntu.edu.tw    Contact: Kuo-Chin Huang, MD, PhD          Principal Investigator: Chien-Hsieh Chiang, MD, MPH          Sub-Investigator: Kuo-Chin Huang, MD, PhD Less <<
NCT00402012 Diabetes Mellitus, Type 2 Phase 4 Completed - United States, Louisiana ... More >> Pennington Biomedical Research Center Baton Rouge, Louisiana, United States, 70808 Less <<
NCT03407599 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 1 Completed - Germany ... More >> Novo Nordisk Investigational Site Hannover, Germany, 30173 Less <<
NCT01098032 Chronic Kidney Disease Phase 3 Completed - Italy ... More >> Unversity of Ferrara, Department of Cardiology Ferrara, Italy IRCCS Multimedica Milan, Italy Unversity School of Medicine of Modena, Deparment of Cardiology Modena, Italy Clinica Mediterranea Naples, Italy, 80121 Less <<
NCT00099866 Diabetes Mellitus, Type 2 Phase 3 Completed - Germany ... More >> Novartis investigative Site Investigative Sites, Germany Less <<
NCT01777282 Diabetes Mellitus Phase 3 Completed - -
NCT02647320 Type 2 Diabetes Mellitus Phase 2 Completed - -
NCT02647320 - Completed - -
NCT00782795 Chronic Pancreatitis ... More >> Insulin Resistance Normal or Mildly Abnormal Stool Fat Levels Less << Phase 2 Completed - United States, Michigan ... More >> University of Michigan Health System Ann Arbor, Michigan, United States, 48109 Less <<
NCT01717911 Type 2 Diabetes Phase 4 Unknown December 2018 Taiwan ... More >> Taipei Veterans General Hospital Recruiting Taipei, Taiwan, 11217 Contact: Harn-Shen Chen, MD, PhD    886-2-28757515    chenhs@vghtpe.gov.tw    Principal Investigator: Harn-Shen Chen, MD, PhD Less <<
NCT00782795 - Completed - -
NCT01777282 - Completed - -
NCT01022762 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 4 Completed - China, Shanghai ... More >> Shanghai, Shanghai, China, 200025 Less <<
NCT01022762 - Completed - -
NCT00754689 Diabetes Mellitus, Type 2 Phase 3 Withdrawn(Company decision tak... More >>en in light of demands by certain national health authorities) Less << - United States, New Jersey ... More >> Sanofi-Aventis Administrative Office Bridgewater, New Jersey, United States, 08807 Less <<
NCT02242864 - Completed - -
NCT02180334 Diabetes Mellitus, Type 2 Phase 4 Completed - Korea, Republic of ... More >> Seoul National University Hospital Seoul, Korea, Republic of, 110-744 Less <<
NCT02605889 Diabetes Mellitus Not Applicable Unknown January 2016 Brazil ... More >> Claudia Dayube Pereira Recruiting Rio de Janeiro, Brazil, 24900000 Contact: Claudia d pereira    552198587536257 Less <<
NCT00617136 Hypothermia Not Applicable Completed - Netherlands ... More >> VU University Medical Center Amsterdam, Netherlands, 1081 HV Spaarne Ziekenhuis Hoofddorp, Netherlands, 2134 TM Isala Klinieken Zwolle, Netherlands Less <<
NCT02926950 Type 2 Diabetes Mellitus Phase 3 Active, not recruiting March 2019 -
NCT03710538 Cystic Fibrosis Not Applicable Not yet recruiting July 15, 2019 Canada, Quebec ... More >> Institut de Recherches Cliniques de Montréal (IRCM) Montreal, Quebec, Canada, H2W 1R7 Less <<
NCT01586780 Diabetes Mellitus, Type 2 ... More >> Satiety Response Less << Not Applicable Completed - Sweden ... More >> Applied Nutrition and Food Chemistry, Lund University Lund, Sweden, SE-221 00 Less <<
NCT00378859 Growth Disorders ... More >> Metabolic Syndrome Less << Not Applicable Completed - Denmark ... More >> Institute of Human Nutrition, Rolighedsvej 30 Frederiksberg C, Denmark, 1958 Less <<
NCT02623608 Metabolic Syndrome Not Applicable Completed - Sweden ... More >> Food for Health Science Centre. Lund University Medicon Village Lund, Sweden, SE 223 81 Less <<
NCT01997281 Diabetes Mellitus Not Applicable Unknown July 2014 Korea, Republic of ... More >> Seoul National University Hospital Seoul, Korea, Republic of, 110-744 Less <<
NCT01302756 Gestational Diabetes ... More >> Gestational Hypertension Less << Not Applicable Withdrawn - -
NCT00755846 Diabetes Mellitus Phase 2 Completed - -
NCT02951624 Sedentary Lifestyle ... More >> Overweight and Obesity Metabolic Disease Less << Not Applicable Completed - Denmark ... More >> Center for Physical Activity Research, Copenhagen University Hospital Copenhagen, Denmark, 2100 Less <<
NCT01139827 - Completed - Korea, Republic of ... More >> Korea university guro hospital Seoul, Korea, Republic of Less <<
NCT01841645 Dietary Modification ... More >> Inflammation Body Composition, Beneficial Less << Not Applicable Completed - Brazil ... More >> Federal University of Rio de Janeiro Rio de Janeiro, Brazil, 21941-909 Less <<
NCT01736748 Obese Not Applicable Recruiting December 2020 Canada, Quebec ... More >> CHU Sainte-Justine Recruiting Montreal, Quebec, Canada, H3T 1C5 Contact: Melanie Henderson    514-345-4735       Principal Investigator: Melanie Henderson Less <<
NCT02874807 SIADH Phase 2 Phase 3 Enrolling by invitation April 2019 Switzerland ... More >> University Hospital Basel Basel, Switzerland, 4031 Less <<
NCT02337933 Metabolic Syndrome X Phase 2 Completed - Mexico ... More >> Instituto de Terapéutica Experimental y Clínica Guadalajara, Jalisco, Mexico, 44140 Less <<
NCT03261466 Obesity, Childhood Phase 4 Completed - Italy ... More >> AOU Maggiore della Carità - Clinica Pediatrica - Ambulatorio di Auxologia ed Endocrinologia Pediatrica Novara, Italy, 28100 Less <<
NCT00004983 Diabetes Mellitus, Non-Insulin... More >>-Dependent Less << Not Applicable Completed - United States, Texas ... More >> The University of Texas at Austin Austin, Texas, United States, 78701 Less <<
NCT03292315 Spinal Cord Injuries ... More >> Insulin Resistance Pre Diabetes Obesity Less << Phase 4 Not yet recruiting December 2021 United States, New Jersey ... More >> Kessler Institute for Rehabilitation Not yet recruiting West Orange, New Jersey, United States, 07052 Contact: Christopher M Cirnigliaro, M.S.    973-731-3900 ext 2755    christopher.cirnigliaro@gmail.com    Sub-Investigator: Christopher M Cirniliaro, M.S. Less <<
NCT00969566 Diabetes Phase 4 Completed - Korea, Republic of ... More >> Seoul National University Bundang Hospital Seongnam, Gyeonggi, Korea, Republic of, 463-707 Less <<
NCT00254371 Aging Low DHE... More >>A for Women Low Testosterone and DHEA for Men Less << Not Applicable Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT00401778 Lung Cancer Phase 1 Completed - United States, Georgia ... More >> Emory University Winship Cancer Institute Atlanta, Georgia, United States, 30322 Less <<
NCT00619697 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 4 Completed - -
NCT02770118 Sleep Deprivation ... More >> Obesity Less << Not Applicable Completed - United States, New York ... More >> New York Nutrition Obesity Research Center New York, New York, United States, 10032 Less <<
NCT00401778 - Completed - -
NCT02220907 - Completed - -
NCT02220907 Type 2 Diabetes Mellitus Phase 3 Completed - Japan ... More >> Research site Chubu, Japan Research site Chugoku, Japan Research site Hokkaido, Japan Research site Kanto, Japan Research site Kyushu, Japan Research site Tohoku, Japan Less <<
NCT01786408 Diabetes Anem... More >>ia Less << Not Applicable Withdrawn - United States, Massachusetts ... More >> Seventh Sense BIosystems Cambridge, Massachusetts, United States, 02141 Less <<
NCT02984358 Healthy Not Applicable Completed - -
NCT00379769 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT00755846 - Completed - -
NCT01401790 Diabetes Mellitus, Type 1 Not Applicable Completed - Canada, Quebec ... More >> Centre Hospitalier Universitaire Sainte-Justine Montreal, Quebec, Canada, H3T 1C5 Less <<
NCT02313519 Postoperative Complications Phase 4 Completed - -
NCT01017523 Type 2 Diabetes Phase 3 Completed - United States, California ... More >> University of California, San Francisco San Francisco, California, United States, 94143 United States, New York SUNY Upstate Medical University, Dept. of Psychiatry Syracuse, New York, United States, 13210 Less <<
NCT03091725 Obesity Not Applicable Recruiting May 2019 United States, Missouri ... More >> Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: Johanna Sonnenschein, BA    314-747-2627    j.sonnenschein@wustl.edu    Contact: Rick Stein, PhD    314-286-0077    rstein@wustl.edu Less <<
NCT01006603 - Completed - -
NCT02152384 Diabetes Mellitus, Type 1 Phase 1 Completed - Germany ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Neuss, Germany, 41460 Less <<
NCT02993549 - Not yet recruiting October 2022 United Kingdom ... More >> Cambridge University Hospital NHS Trust Not yet recruiting Cambridge, Cambridgeshire, United Kingdom, CB2 0QQ Less <<
NCT01506869 - Unknown June 2015 China ... More >> Shanghai Jiao-Tong University School of Medicine Recruiting Shanghai, China, 200025 Contact: Guang Ning, MD,PHD    008621 64370045 ext 663340    guangning@medmail.com.cn Less <<
NCT01613495 Prader Willis Syndrome Not Applicable Completed - -
NCT00379769 - Completed - -
NCT01879098 Healthy Phase 1 Completed - United States, Florida ... More >> University of Florida Gainesville, Florida, United States, 32611 Less <<
NCT03314246 Diabetes Mellitus, Type 2 Not Applicable Recruiting December 2018 Singapore ... More >> Tan Tock Seng Hospital Recruiting Singapore, Singapore, 308433 Contact: Lim    65-97271584    e0002171@u.nus.edu    National Healthcare Group Polyclinic (Bukit Batok) Recruiting Singapore, Singapore, 659164 Contact: Lim    65-97271584    e0002171@u.nus.edu Less <<
NCT00272012 Diabetes Mellitus Type 2 Phase 3 Completed - Germany ... More >> Sanofi-Aventis Berlin, Germany Less <<
NCT01006603 Type 2 Diabetes Mellitus Phase 4 Completed - -
NCT01181674 Type 2 Diabetes Mellitus Phase 4 Completed - Canada, Ontario ... More >> McMaster University Medical Centre, Diabetes Care and Research Program Hamilton, Ontario, Canada, L8N 3Z5 Less <<
NCT00001870 Diabetes Mellitus, Non-Insulin... More >> Dependent Non-Insulin Dependent Less << Phase 2 Completed - United States, Maryland ... More >> National Center for Complementary and Alternative Medicine (NCCAM) Bethesda, Maryland, United States, 20892 Less <<
NCT03206827 Colorectal Cancer ... More >> Type2 Diabetes Less << Not Applicable Active, not recruiting June 30, 2019 -
NCT02242825 - Completed - -
NCT01771978 Ischaemia-reperfusion Injury Phase 3 Unknown - France ... More >> Department of Anaesthesiology Strasbourg, France, 67091 Less <<
NCT01192711 Type 1 Diabetes Phase 3 Unknown - Italy ... More >> Ospedale G.B. Morgagni - L. Pierantoni Not yet recruiting Forlì, Italy, 47100 Contact: Silvia Acquati, MD    +39 0543 731199    s.acquati@ausl.fo.it    Principal Investigator: Silvia Acquati, MD          P.O. di Grosseto - Stabilimento Misericordia Recruiting Grosseto, Italy, 58100 Contact: Mauro Rossi, MD    +39 0564 485272    m.rossi@usl9.toscana.it    Principal Investigator: Mauro Rossi, MD          Az. Osp. S. Anna - Presidio Ospedaliero Cantù - Mariano Comense Recruiting Mariano Comense, Italy, 22066 Contact: Luigi Sciangula, MD    +39 031 755357    luigi.sciangula@hsacomo.org    Principal Investigator: Luigi Sciangula, MD          Istituto Scientifico San Raffaele Recruiting Milan, Italy, 20132 Contact: Andrea Laurenzi, MD    +39 02 2643 ext 2894    laurenzi.andrea@hsr.it    Principal Investigator: Gabriella Galimberti, MD          Ospedale Niguarda Cà Granda Recruiting Milan, Italy, 20162 Contact: Andrea M Bonomo, MD    +39 02 64443912    matteo.bonomo@ospedaleniguarda.it    Principal Investigator: Andrea M Bonomo, MD          II Università di Napoli Centro Regionale di Diabetologia Pediatrica "G. Stoppoloni" Recruiting Naples, Italy, 80138 Contact: Dario Iafusco, MD    +39 081 5665434    dario.iafusco@unina2.it    Principal Investigator: Francesco Prisco, MD          Università degli Studi di Padova Dipartimento di Medicina Clinica e Sperimentale Recruiting Padua, Italy, 35128 Contact: Alberto Maran, MD    +39 049 8212097    alberto.maran@unipd.it    Principal Investigator: Alberto Maran, MD          Ospedale Cisanello Recruiting Pisa, Italy, 56124 Contact: Stefano Del Prato, MD    +39 050 995100    delprato@immr.med.unipi.it    Principal Investigator: Stefano Del Prato, MD          U.O. di Diabetologia, Dip. di Malattie Digestive & Metaboliche Recruiting Ravenna, Italy, 48100 Contact: Paolo Di Bartolo, MD    +39 0544 286326    p.dibartolo@ausl.ra.it    Principal Investigator: Paolo Di Bartolo, MD          Ospedale Infermi Not yet recruiting Rimini, Italy, 47900 Contact: Cinzia Trojani, MD    +39 0541 705370    ctrojani@auslrn.net    Principal Investigator: Cinzia Trojani, MD          Ospedale Sandro Pertini Recruiting Rome, Italy, 00157 Contact: Concetta Suraci, MD    +39 06 41433513    tsuraci@tiscali.it    Principal Investigator: Concetta Suraci, MD          Ospedale Magati Not yet recruiting Scandiano, Italy, 42019 Contact: Valerio Miselli, MD    +39 0522 850247    miselliv@ausl.re.it    Principal Investigator: Valerio Miselli, MD          Azienda Ospedaliera-Universitaria S. Giovanni Battista Recruiting Turin, Italy, 10126 Contact: Giorgio Grassi, MD    +39 011 6335605    giorgio.grassi@gmail.com    Principal Investigator: Giorgio Grassi, MD Less <<
NCT01109316 Diabetes Mellitus, Type 1 Phase 3 Completed - United States, California ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Concord, California, United States, 94520 United States, Colorado For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Aurora, Colorado, United States, 80045 United States, Florida For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hollywood, Florida, United States, 33021 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. West Palm Beach, Florida, United States, 33401 United States, Idaho For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Idaho Falls, Idaho, United States, 83404 United States, Kansas For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Topeka, Kansas, United States, 66606 United States, New Hampshire For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nashua, New Hampshire, United States, 03063 United States, New York For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Albany, New York, United States, 12206 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Syracuse, New York, United States, 13210 United States, North Carolina For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Asheville, North Carolina, United States, 28803 United States, Texas For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Austin, Texas, United States, 78731 Less <<
NCT01098032 - Completed - -
NCT03005951 Insulin Resistance Not Applicable Recruiting March 2019 United States, New York ... More >> Montefiore Medical Center of Albert Einstein College of Medicine Recruiting Bronx, New York, United States, 10467 Contact: Rubina Heptulla, MD    718-920-4664    rheptull@montefiore.org    Sub-Investigator: Sophie Molholm, Ph.D          Principal Investigator: Rubina Heptulla, MD          Sub-Investigator: John Foxe, MD Less <<
NCT01235026 Obesity Diabe... More >>tes Mellitus Type-2 Insulin Resistance Metabolic Syndrome Less << Not Applicable Unknown January 2011 Chile ... More >> Institute of Nutrition and Food Technology (INTA), University of Chile Recruiting Santiago, Chile Principal Investigator: Martin Gotteland, PhD Less <<
NCT00246623 Diabetes Mellitus, Type 2 Phase 3 Completed - United States, Alabama ... More >> Pfizer Investigational Site Birmingham, Alabama, United States United States, California Pfizer Investigational Site Los Angeles, California, United States United States, Connecticut Pfizer Investigational Site New Britain, Connecticut, United States Pfizer Investigational Site Norwalk, Connecticut, United States United States, Florida Pfizer Investigational Site Hollywood, Florida, United States United States, Georgia Pfizer Investigational Site Atlanta, Georgia, United States United States, Idaho Pfizer Investigational Site Boise, Idaho, United States Pfizer Investigational Site Hayden, Idaho, United States United States, Louisiana Pfizer Investigational Site Baton Rouge, Louisiana, United States United States, Massachusetts Pfizer Investigational Site Boston, Massachusetts, United States United States, New York Pfizer Investigational Site Albany, New York, United States Pfizer Investigational Site Syracuse, New York, United States United States, Texas Pfizer Investigational Site Dallas, Texas, United States Pfizer Investigational Site El Paso, Texas, United States Pfizer Investigational Site San Antonio, Texas, United States United States, Vermont Pfizer Investigational Site Bennington, Vermont, United States Less <<
NCT01107015 - Completed - -
NCT01919489 Type 2 Diabetes Phase 4 Recruiting June 2019 United States, Florida ... More >> University of Miami Recruiting Miami, Florida, United States Contact: Gianluca Iacobellis, MD       GIacobellis@med.miami.edu    Principal Investigator: Gianluca Iacobellis, MD          United States, Georgia Grady Memorial Hospital Recruiting Atlanta, Georgia, United States, 30303 Contact: Guillermo E Umpierrez, MD    404-778-1665    geumpie@emory.edu    Contact: Francisco J Pasquel, MD    404 778 1697    fpasque@emory.edu    Principal Investigator: Guillermo Umpierrez, MD          Sub-Investigator: Francisco J Pasquel, MD          Sub-Investigator: Priya Vellanki, MD          Emory University Hospital Recruiting Atlanta, Georgia, United States, 30324 Contact: Francisco Pasquel, MD       fpasque@emory.edu    Sub-Investigator: Francisco Pasquel, MD          Emory Universtiy Hospital at MIdtown Recruiting Atlanta, Georgia, United States Contact: Francisco Pasquel, MD          Sub-Investigator: Rodolfo J Galindo, MD          United States, New York State University of NY at Buffalo Recruiting New York, New York, United States Contact: Ajay Chaudhuri, MD       AChaudhuri@KaleidaHealth.Org    Principal Investigator: Ajay Chaudhuri, MD Less <<
NCT03663803 Pre Diabetes Not Applicable Completed - -
NCT01109316 - Completed - -
NCT02315495 Type 2 Diabetes Phase 3 Completed - China, Jiangsu ... More >> Department of Endocrinology, Zhongda Hospital. Institute of Diabetes, Southeast University Nanjing, Jiangsu, China Less <<
NCT01107015 Diabetes Not Applicable Completed - United States, Maryland ... More >> University of Maryland, Baltimore Baltimore, Maryland, United States, 21201 Less <<
NCT02326129 - Recruiting June 2020 United States, North Carolina ... More >> Duke University Recruiting Durham, North Carolina, United States, 27710 Contact: Pinar Gumus Balikcioglu, M.D.    919-668-4002    pinar.gumus@duke.edu Less <<
NCT01352390 In Need of a Pap Smear (Cervic... More >>al Cancer Screening) In Need of a Blood Pressure Check (Hypertension Screening) In Need of a Cholesterol Test (Lipid Disorder Screening) In Need of a Fasting Plasma Glucose Test (Diabetes) Less << Not Applicable Completed - United States, Pennsylvania ... More >> University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00405418 Diabetes Mellitus, Type 2 Phase 4 Completed - -
NCT03239717 Diabetes Obes... More >>ity Insulin Resistance Less << Not Applicable Recruiting July 5, 2019 United States, Wisconsin ... More >> University of Wisconsin Hospitals, ICTR Clinical Research Unit Recruiting Madison, Wisconsin, United States, 53705 Contact: Protocol Manager    608-262-3005 Less <<
NCT01152242 Diabetes Phase 1 Completed - -
NCT03400501 Type 1 Diabetes Mellitus Early Phase 1 Recruiting February 2020 United States, Connecticut ... More >> Yale University Recruiting New Haven, Connecticut, United States, 06511 Contact: Amy Steffen, RN    203-737-8852    amy.steffen@yale.edu Less <<
NCT01519401 Polycystic Ovary Syndrome ... More >> Estro-progestin Drugs Less << Not Applicable Completed - Italy ... More >> Catholic University of Sacred Heart Rome, Italy, 00168 Less <<
NCT02629705 Diabetes Mellitus, Type 2 ... More >> Insulin Resistance Less << Not Applicable Completed - Germany ... More >> University Hospital Tübingen, Department of Internal Medicine Tübingen, Germany, 72076 Less <<
NCT00370565 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT01405391 Major Advanced Solid Tumors Ot... More >>her Than Colorectal Less << Phase 1 Completed - United States, Colorado ... More >> University of Colorado Cancer Center Aurora, Colorado, United States, 80045 United States, Illinois Cancer Research Center. University of Chicago Hospitals Chicago, Illinois, United States, 60637 Less <<
NCT00425269 Metabolic Syndrome ... More >> Type 2 Diabetes Less << Not Applicable Completed - Norway ... More >> Primary Health Care Health Center Oslo, Holmlia, Oslo, Norway, 1255 Less <<
NCT00468039 Diabetes Mellitus, Type 2 Phase 3 Completed - United States, Texas ... More >> Diabetes and Glandular Disease Research Associates San Antonio, Texas, United States, 78229 Less <<
NCT02655666 - Terminated - China, Shandong ... More >> The Affiliated Hospital of Qingdao University Qingdao, Shandong, China Less <<
NCT02655666 - Terminated - -
NCT00425269 - Completed - -
NCT01436500 Hepatorenal Syndrome Phase 2 Completed - United States, Arizona ... More >> Mayo Clinic - Arizona Phoenix, Arizona, United States, 85054 United States, California UCSD, Hillcrest Medical Center Hospital La Jolla, California, United States, 92093 UCSF (University of California-San Francisco) San Francisco, California, United States, 94143 United States, Georgia Emory University Hospital Atlanta, Georgia, United States, 30322 United States, Indiana Indiana University (Division of Gastroenterology/Hepatology) Indianapolis, Indiana, United States, 46202 United States, Michigan University of Michigan Hospital Ann Arbor, Michigan, United States, 48109 United States, New York NYU Langone Medical Center New York, New York, United States, 10016 United States, Ohio The Ohio State University Columbus, Ohio, United States, 43210 United States, Texas Baylor All Saints Medical Center Fort Worth, Texas, United States, 76104 United States, Utah University of Utah Health Sciences Center Salt Lake City, Utah, United States, 84132 United States, Virginia Virginia Commonwealth University Richmond, Virginia, United States, 23298 India MIDAS Multispeciality Hospital PVT LTD Nagpur, Maharashtra, India, 440010 Less <<
NCT03469492 Hyperglycaemia (Diabetic) Early Phase 1 Recruiting January 2020 United States, Connecticut ... More >> The Anylan Center Recruiting New Haven, Connecticut, United States, 06511 Contact: Janice Hwang, MD          Principal Investigator: Janice Hwang, MD Less <<
NCT01436500 - Completed - -
NCT02374996 - Completed - United States, Michigan ... More >> Wayne State University Clinical Research Center Detroit, Michigan, United States, 48202 Less <<
NCT03576703 Inflammation ... More >>Insulin Sensitivity Less << Not Applicable Completed - -
NCT00882492 Hyperglycemia ... More >> Hypoglycemia Less << Phase 1 Completed - United States, Pennsylvania ... More >> University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT02186353 Insulin Resistance ... More >> Cardiovascular Disease Diabetes Less << Not Applicable Withdrawn(Lack of adequate fun... More >>ding) Less << September 2015 United States, Massachusetts ... More >> Children's Hospital Boston Boston, Massachusetts, United States, 02115 Less <<
NCT03307512 Safety and Tolerability Phase 2 Recruiting August 30, 2018 United States, California ... More >> WCCT Recruiting Cypress, California, United States, 90630 Contact: Emely Nguyen, MS,CCRP    714-252-0700 ext 1047    emely.nguyen@wcct.com    Contact: Neil Patel, MBA    (714) 252-0700 ext 1111    neil.patel@wcct.com Less <<
NCT02713477 Type 2 Diabetes Mellitus Phase 1 Completed - Japan ... More >> Investigational Site Number 392001 Fukuoka-Shi, Japan Less <<
NCT02303730 Diabetes Mellitus, Type 2 ... More >> Non-alcoholic Fatty Liver Disease Less << Phase 4 Unknown May 2017 China, Shanghai ... More >> Department of Endocrinology and Metabolism, Zhongshan Hospital, Fudan University Recruiting Shanghai, Shanghai, China, 200032 Contact: Xin Gao, doctor    862164041990 ext 8021    gao.xin@zs-hospital.sh.cn    Contact: Hua Bian, doctor    13681976102    bian.hua@zs-hospital.sh.cn    Principal Investigator: Xin Gao, doctor          Sub-Investigator: Hua Bian, doctor          Sub-Investigator: Lin Liu, master          Department of Endocrinology and Metabolism, Shanghai Minhang Central Hospital Recruiting Shanghai, Shanghai, China Contact: Jia Lin Yang, doctor    18918169025    Jialinyang2002@163.com    Department of Endocrinology and Metabolism,Huadong Hospital Recruiting Shanghai, Shanghai, China Contact: Jiao Sun, Bachelor    18621831253    sunjiao6972@aliyun.com    Department of Endocrinology and Metabolism,Shanghai 6th People's Hospital Recruiting Shanghai, Shanghai, China Contact: Yu Qian Bao, Bachelor    13788971763    byq522@163.com    Department of Endocrinology and Metabolism,Shanghai Changzheng Hospital Not yet recruiting Shanghai, Shanghai, China Contact: Yong Quan Shi, master    13701794075    young.stone@163.com Less <<
NCT02287285 Type 2 Diabetes Mellitus Early Phase 1 Active, not recruiting October 2018 United States, New York ... More >> New York Obesity Research Center, Columbia University New York, New York, United States, 10032 Less <<
NCT00138567 Diabetes Mellitus, Type 2 Phase 3 Completed - United States, New Jersey ... More >> Novartis Investigative Site East Hanover, New Jersey, United States, 07936 Germany Novartis Investigative site Investigative Centers, Germany Less <<
NCT01693406 - Recruiting September 2020 United States, Colorado ... More >> University of Colorado Anschutz Medical Campus Recruiting Aurora, Colorado, United States, 80045 Contact: Nichole Hirsch, MS    303-724-8966    NICOLE.HIRSCH@UCDENVER.EDU    Principal Investigator: Nancy F Krebs, MD, MS          Principal Investigator: Linda A Barbour, MD, MSPH Less <<
NCT01923090 Healthy Volunteers Phase 2 Unknown October 2013 United Kingdom ... More >> Wellcome Trust Clinical Research Facility, Queen Elizabeth Hospital Recruiting Birmingham, West Midlands, United Kingdom, B15 2TT Contact: Jeremy w Tomlinson, MD PhD    44(0)121 4158715    J.W.Tomlinson@bham.ac.uk    Principal Investigator: Jeremy W Tomlinson, MD PhD Less <<
NCT02776722 - Active, not recruiting January 2018 Canada, Ontario ... More >> The Toronto 3D (Diet, Digestive tract and Disease) Knowledge Synthesis and Clinical Trials Unit, Clinical Nutrition and Risk Factor Modification Centre, St. Michael's Hospital Toronto, Ontario, Canada, M5C 2T2 Less <<
NCT01344161 Overweight Ob... More >>esity Less << Phase 3 Completed - Iran, Islamic Republic of ... More >> Tehran University of Medical Sciences Tehran, Iran, Islamic Republic of, 1416783913 Less <<
NCT03703869 - Recruiting January 2020 -
NCT02317484 - Completed - Japan ... More >> Osaka Saiseikai Nakatsu Hospital Osaka, Japan, 530-0012 Less <<
NCT01344161 - Completed - -
NCT00138541 Diabetes Mellitus, Type 2 Phase 3 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 Less <<
NCT01483118 - Completed - -
NCT02033876 Type 2 Diabetes Mellitus Phase 2 Completed - United States, Minnesota ... More >> Mayo Clinic in Rochester Rochester, Minnesota, United States, 55905 Less <<
NCT01483118 Polycystic Ovary Syndrome Phase 3 Completed - United States, New York ... More >> Columbia University Medical Center New York, New York, United States, 10032 Less <<
NCT01236404 Diabetes Mellitus, Type 2 Phase 1 Phase 2 Completed - United States, California ... More >> Diablo Clinical Research Walnut Creek, California, United States, 94598 United States, Minnesota Prism Research Saint Paul, Minnesota, United States, 55114 United States, Washington Rainier Clinical Research Center, Inc. Renton, Washington, United States, 98057 Less <<
NCT02127047 Diabetes Mellitus Type 1 Phase 2 Completed - Switzerland ... More >> University Hospital Basel Basel, Switzerland, 4031 Less <<
NCT01252082 Metabolic Control Phase 2 Completed - Iran, Islamic Republic of ... More >> Mashhad Dental School, Mashhad University of Medical Sciences Mashhad, Khorasan Razavi, Iran, Islamic Republic of, 91735-984 Less <<
NCT02009995 Type 2 Diabetes Not Applicable Recruiting December 2019 Canada, Alberta ... More >> Richmond Road Diagnostic and Treatment Centre Recruiting Calgary, Alberta, Canada, T2T 5C7 Contact: Samantha McGinley, BSc, MSc    403-955-8117    skmcginl@ucalgary.ca    Principal Investigator: Ronald Sigal, MPH, MD Less <<
NCT00740519 - Completed - United Kingdom ... More >> Novo Nordisk Investigational Site Crawley, United Kingdom, RH11 9RT Less <<
NCT01301456 Diabetes Mellitus ... More >> Diabetes Mellitus, Type 2 Glucose Metabolism Disorders Metabolic Diseases Endocrine System Diseases Less << Phase 1 Completed - United States, California ... More >> Profil Institute for Clinical Research, Inc. Chula Vista, California, United States, 91911 United States, Florida Elite Research Institute Miami, Florida, United States, 33169 Comprehensive Phase One (A Division of Comprehensive NeuroScience, Inc.) Miramar, Florida, United States, 33025 United States, Georgia Atlanta Center for Medical Research Atlanta, Georgia, United States, 30308 United States, Nebraska ICON Clinical Pharmacology, LLC Omaha, Nebraska, United States, 68154 United States, Pennsylvania CRI Worldwide, LLC Philadelphia, Pennsylvania, United States, 19139 United States, Texas Healthcare Discoveries LLC d/b/a ICON Development Solutions San Antonio, Texas, United States, 78209 Less <<
NCT01296620 Gastrointestinal Dysmotility Phase 3 Completed - -
NCT02621502 Overweight Not Applicable Completed - Spain ... More >> Hospital Universitairo La Paz Madrid, Spain, 28046 Less <<
NCT01175824 Diabetes Mellitus, Type 2 Phase 4 Completed - Argentina ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mar Del Plata, Argentina, B7600FZN For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ramos Mejia, Argentina, B1704ETD Brazil For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Porto Alegre, Brazil, 90035-170 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. São Paulo, Brazil, 01244-030 China For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Changzhou, China, 213003 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Harbin, China, 150086 Egypt For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Alexandria, Egypt For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Cairo, Egypt, 11562 India For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Jaipur, India, 302018 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Vishakhapatnam, India, 530002 Korea, Republic of For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Daegu, Korea, Republic of, 700-712 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Goyang-Si, Korea, Republic of, 410-719 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kyunggi-Do, Korea, Republic of, 425-020 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Seoul, Korea, Republic of, 134-090 Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Málaga, Spain, 29010 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. San Boi De Llobregat, Spain, 08830 Turkey For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Antalya, Turkey, 07070 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Istanbul, Turkey, 34865 Less <<
NCT01766778 Type-2 Diabetes Mellitus Phase 4 Completed - Hong Kong ... More >> Novartis Investigative Site Hong Kong SAR, Hong Kong Novartis Investigative Site HongKong, Hong Kong Novartis Investigative Site Tuen Mun, Hong Kong Less <<
NCT01175824 - Completed - -
NCT01301456 - Completed - -
NCT00901979 Type 2 Diabetes Mellitus Phase 2 Completed - -
NCT01163773 Cardiovascular Disease Not Applicable Completed - Canada ... More >> Institute of Nutraceutical and Functional Foods (INAF), Laval University Quebec, Canada, G1V 0A6 Less <<
NCT00380380 Diabetes Mellitus, Type 2 Phase 3 Completed - Germany ... More >> Munich, 81377, Germany Munich, Germany Less <<
NCT03468283 Diabetes Mellitus, Type 2 Not Applicable Completed - -
NCT01335763 Type 2 Diabetes Not Applicable Completed - Canada, Alberta ... More >> EPICORE Centre Edmonton, Alberta, Canada, T6G 2C8 Less <<
NCT01285570 Gastrointestinal Dysmotility Phase 3 Completed - -
NCT02012465 Lymphoma Diab... More >>etes Mellitus, Type 2 Hyperglycemia Less << Early Phase 1 Completed - United States, Missouri ... More >> Washington University in St. Louis Saint Louis, Missouri, United States, 63108 Less <<
NCT00097084 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT02588313 Disorder of Circulatory System... More >> Metabolic Disease Less << Not Applicable Completed - Germany ... More >> BioTeSys GmbH Esslingen, Germany, 73728 Less <<
NCT02616276 Healthy Not Applicable Completed - Spain ... More >> Primary Care Research Unit - The Alamedilla Center for Health Salamanca, Spain, 37003 Less <<
NCT00478595 Obesity Diabe... More >>tes Mellitus Type 2 Less << Phase 3 Terminated(Company decision ta... More >>ken in light of demands by certain national health authorities) Less << - Japan ... More >> Sanofi-Aventis Administrative Office Tokyo, Japan Less <<
NCT01334229 - Completed - -
NCT02940249 Prevention of Hyperglycaemia Not Applicable Completed - United Kingdom ... More >> Metabolic Research Unit at King's College London Waterloo Campus, London, United Kingdom, SE1 9NH Less <<
NCT01334229 Type 2 Diabetes Mellitus Phase 3 Completed - Canada ... More >> Laval University Quebec, Canada, G1V 0A6 Less <<
NCT00115479 Critical Illness Phase 2 Completed - Belgium ... More >> Catholic University of Leuven, University Hospital Gasthuisberg Leuven, Belgium, B-3000 Less <<
NCT02124512 Obese Insulin... More >> Resistance Metabolic Syndrome Less << Phase 2 Recruiting June 2018 United States, Kentucky ... More >> University of Kentucky Center for Clinical and Translational Science Recruiting Lexington, Kentucky, United States, 40536 Contact: Stacie BeBout    859-323-9987    stacybebout@uky.edu    Principal Investigator: Philip Kern, MD Less <<
NCT01542450 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 1 Completed - Japan ... More >> Novo Nordisk Investigational Site Tokyo, Japan, 1000005 Less <<
NCT00811122 Alzheimer's Disease Early Phase 1 Active, not recruiting April 2018 United States, Utah ... More >> University of Utah Salt Lake City, Utah, United States, 84112 Less <<
NCT03739255 Corneal Erosion Not Applicable Not yet recruiting July 31, 2020 -
NCT03078478 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Active, not recruiting March 7, 2019 -
NCT03063229 Type 1 Diabetes Not Applicable Active, not recruiting September 2019 United Kingdom ... More >> Royal Infirmary Edinburgh Edinburgh, Midlothian, United Kingdom, EH16 4SA Less <<
NCT02434315 Diabetes Mellitus Not Applicable Completed - United Kingdom ... More >> Atherstone Surgery Atherstone, United Kingdom Westongrove Partnership Aylesbury, United Kingdom Pebsham Surgery Bexhill, United Kingdom Omnia Practice Birmingham, United Kingdom Hathaway Surgery Chippenham, United Kingdom Rowden Surgery Chippenham, United Kingdom Pound Hill Medical Group Crawley, United Kingdom Claremont Medical Practice Exmouth, United Kingdom White Horse Medical Practice Faringdon, United Kingdom Parkwood Surgery Hemel Hempstead, United Kingdom St James Hospital, Leeds, United Kingdom, LS9 7TF Kings College Hospital London, United Kingdom James Cook Hospital Middlesborough, United Kingdom Milton Keynes Hospital Milton Keynes, United Kingdom Greenwood and Sneinton Centre Nottingham, United Kingdom Mortimer Surgery Reading, United Kingdom Clifton Medical Centre Rotherham, United Kingdom Salford Royal Hospital Salford, United Kingdom Ashfields Primary Care Centre Sandbach, United Kingdom The Kiltearn Medical Centre Sandbach, United Kingdom Albany House Surgery Wellingborough, United Kingdom Rothwell Surgery Wellingborough, United Kingdom Friarsgate Practice Winchester, United Kingdom Less <<
NCT00982254 Type 2 Diabetes Phase 1 Completed - Germany ... More >> Profil Institut für Stoffwechselforschung GmbH Neuss, Germany, 41460 Less <<
NCT00948324 Type 2 Diabetes Mellitus Phase 4 Suspended December 2021 -
NCT00179400 Type 2 Diabetes Mellitus Not Applicable Completed - United States, New York ... More >> Albert Einstein College of Medicine The Bronx, New York, United States, 10461 Less <<
NCT00478972 Obesity Diabe... More >>tes Mellitus Type 2 Less << Phase 3 Terminated(Company decision ta... More >>ken in light of demands by certain national health authorities) Less << - Japan ... More >> Sanofi-Aventis Administrative Office Tokyo, Japan Less <<
NCT03580057 Cardiovascular Risk Factor Not Applicable Recruiting January 2022 Norway ... More >> University of Oslo Recruiting Oslo, Norway, 0317 Contact: Hilde K Brekke, PhD Less <<
NCT01248143 Assess the Effect of Green Tea... More >> on Diabetes Assess the Effect of Fermented Papaya Pretration on Diabetes Effects of Green Tea and FPP on C-reactive Proteins Effects of Green Tea and FPP of Lipid Profiles in Diabetes Effect of Green Tea and FPP on Atheroma Formation Less << Phase 2 Phase 3 Completed - United States, New York ... More >> Touro College of Pharmacy New York, New York, United States, 10027 Austria University of Vienna Vienna, Austria Mauritius University of Mauritius Reduit, Mauritius Less <<
NCT01798030 - Active, not recruiting December 2018 United States, Maryland ... More >> Baltimore VAMC Baltimore, Maryland, United States, 21201 Less <<
NCT00271700 Diabetes Mellitus Not Applicable Unknown March 2011 United States, Massachusetts ... More >> Brigham and Women's Hospital Not yet recruiting Boston, Massachusetts, United States, 02120 Less <<
NCT00457665 HIV Infections Phase 4 Completed - United States, Texas ... More >> University of Texas Southwestern Medical Center Dallas, Texas, United States, 75390 Less <<
NCT02682563 Diabetes Mellitus, Type 2 ... More >> Diabetic Nephropathies Less << Phase 4 Completed - Netherlands ... More >> VU University Medical Center Amsterdam, Noord-Holland, Netherlands, 1081 HV Less <<
NCT03579667 Cardiovascular Risk Factor ... More >> Body Weight Less << Not Applicable Recruiting August 15, 2021 Norway ... More >> University of Oslo Recruiting Oslo, Norway, 0317 Less <<
NCT00997152 Type II Diabetes Mellitus Phase 2 Terminated - -
NCT01022411 Metabolic Syndrome X Phase 2 Phase 3 Completed - China ... More >> Institute for Nutritional Sciences, Chinese Academy of Sciences Shanghai, China Less <<
NCT02389140 Myofascial Pain ... More >> Tension-type Headache Less << Not Applicable Completed - United States, Colorado ... More >> University of Colorado Hospital Aurora, Colorado, United States, 80045 Less <<
NCT03319173 Mild Cognitive Impairment ... More >> Metabolic Syndrome Less << Not Applicable Recruiting May 15, 2018 United States, Minnesota ... More >> Bristlecone Health, Inc. Recruiting Maple Grove, Minnesota, United States, 55311 Contact: Julie A Gomer, Doctorate    763-913-4600    julie@bristleconefitness.com Less <<
NCT01757756 Diabetes Mellitus ... More >> Diabetes Mellitus, Type 2 Glucose Metabolism Disorders Less << Phase 1 Completed - United States, Florida ... More >> Pfizer Investigational Site South Miami, Florida, United States, 33143 Less <<
NCT01814735 Diabetes Mellitus Not Applicable Completed - India ... More >> Madras Diabetes Research Foundation Chennai, India Less <<
NCT02123732 Type 2 Diabetes Mellitus Phase 1 Phase 2 Active, not recruiting - Israel ... More >> Laniado Hospital, Diabetes Unit Netanya, Israel, 42150 Less <<
NCT02620332 Type 1 Diabetes Phase 1 Unknown February 2017 United Kingdom ... More >> Guy's Hospital Recruiting London, United Kingdom, SE1 9RT Contact: Rhanya Chaabane    00 44 7188 7188 ext 88472    multipeptide@gstt.nhs.uk Less <<
NCT02125305 Healthy Elderly Phase 1 Completed - Korea, Republic of ... More >> Seoul National University Bundang Hospital Seoul, Korea, Republic of Less <<
NCT02711839 Type 2 Diabetes Phase 2 Phase 3 Unknown May 2017 -
NCT01744769 - Unknown May 2013 Korea, Republic of ... More >> Konkuk University Medical Center Recruiting Seoul, Korea, Republic of, 143-729 Contact: Jee Hyun An    82-10-9089-4655    jeehyunan@gmail.com    Principal Investigator: Suk Kyoung Kim, MD, PhD          Sub-Investigator: Jee Hyun An, MD, PhD          Sub-Investigator: Ki Ho Song, MD, PhD          Sub-Investigator: Dong Lim Kim, MD, PhD Less <<
NCT02450500 Pre-diabetes Not Applicable Completed - United Kingdom ... More >> University of Plymouth Plymouth, United Kingdom, PL6 8BH Less <<
NCT01114061 Diabetes Not Applicable Suspended - -
NCT00511602 Type 2 Diabetes Mellitus Phase 2 Completed - -
NCT00191178 Type 2 Diabetes Phase 4 Completed - United States, Virginia ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician Charlottesville, Virginia, United States Less <<
NCT00483392 Insulin Resistance Not Applicable Completed - Slovenia ... More >> Department of Endocrinology, Diabetes and Metabolic diseases Ljubljana, Slovenia, 1525 Less <<
NCT01806532 - Recruiting March 2019 United States, Massachusetts ... More >> Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: Marcos Vidal Melo, MD, PhD    617-726-8980    VidalMelo.Marcos@mgh.harvard.edu Less <<
NCT00331604 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Terminated(See termination rea... More >>son in detailed description) Less << - -
NCT02560753 Alzheimer's Disease Phase 1 Phase 2 Completed - United States, Florida ... More >> Brain Matters Research Delray Beach, Florida, United States, 33445 Miami Jewish Health Systems Miami, Florida, United States, 33137 United States, North Carolina New Hope Clinical Research Charlotte, North Carolina, United States, 28204 Less <<
NCT03557697 Type2 Diabetes Phase 2 Not yet recruiting December 2020 -
NCT02115555 Type 1 Diabetes Not Applicable Completed - United States, Indiana ... More >> Riley Children's Specialties Carmel, Indiana, United States, 46032 Riley Children's Hospital Indianapolis, Indiana, United States, 46202 Less <<
NCT02560753 - Completed - -
NCT01973933 Healthy Phase 1 Completed - Korea, Republic of ... More >> Seoul National University Bundang Hospital Seoul, Korea, Republic of Less <<
NCT01857609 Healthy Phase 1 Completed - Korea, Republic of ... More >> Seoul National University Bundang Hospital Seoul,, Korea, Republic of Less <<
NCT02451631 Type 2 Diabetes Not Applicable Unknown March 2016 Korea, Republic of ... More >> Seoul National University Bundang Hospital Not yet recruiting Kyunggi-do, Korea, Republic of Contact: Soo Lim, MD.PhD       limsoo@snu.ac.kr    Principal Investigator: Soo Lim, MD.PhD.          Seoul National University Boramae Medical Center Recruiting Seoul, Korea, Republic of Contact: Min Kyong Moon, MD.PhD.       mkmoon@snu.ac.kr    Principal Investigator: Min Kyong Moon, MD.PhD          Seoul National University Hospital Recruiting Seoul, Korea, Republic of Contact: Young Min Cho, MD. PhD.       ymchomd@snu.ac.kr    Principal Investigator: Yong Min Cho, MD. PhD Less <<
NCT02759107 Healthy Type ... More >>2 Diabetes Mellitus (T2DM) Less << Phase 1 Completed - United States, Florida ... More >> Miami Research Associates South Miami, Florida, United States, 33143 Singapore For additional information regarding investigative sites for this trial, contact 1‐877‐CTLILLY (1‐877‐285‐4559, 1‐317‐615‐4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT ‐ 5 hours, EST) or speak with your personal physician. Singapore, Singapore, 117597 Less <<
NCT01223131 Type 1 Diabetes Mellitus Phase 3 Completed - China ... More >> Investigational Site Number 156006 Beijing, China, 100020 Investigational Site Number 156001 Beijing, China, 100045 Investigational Site Number 156007 Beijing, China, 100730 Investigational Site Number 156009 Changsha, China, 410011 Investigational Site Number 156008 Guangzhou, China, 510630 Investigational Site Number 156004 Hangzhou, China, 310003 Investigational Site Number 156016 Shanghai, China, 200040 Investigational Site Number 156005 Shanghai, China, 201102 Investigational Site Number 156019 Taiyuan, China, 030013 Investigational Site Number 156002 Wuhan, China, 430030 Less <<
NCT00305604 - Completed - -
NCT02066350 Diabetes Type 1 ... More >> Endothelial Dysfunction Less << Not Applicable Completed - Norway ... More >> Oslo University Hospital, Rikshospitalet Oslo, Norway, N-0424 Less <<
NCT00260234 Diabetes Mellitus, Type 1 Phase 1 Phase 2 Terminated(Stopped in December... More >> 2007) Less << - United States, Texas ... More >> CHRISTUS Santa Rosa Transplant Institute San Antonio, Texas, United States, 78229 Diabetes & Glandular Disease Research Associates, P.A. San Antonio, Texas, United States, 78229 Less <<
NCT00305604 Type 2 Diabetes Phase 3 Completed - -
NCT00882986 - Completed - United States, Kansas ... More >> University of Kansas Medical Center Kansas City, Kansas, United States, 66160 Less <<
NCT02346838 Prediabetes Not Applicable Active, not recruiting March 2019 United States, Virginia ... More >> Virginia Polytechnic and State University Blacksburg, Virginia, United States, 24061 Less <<
NCT03043235 - Completed - United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35294 Less <<
NCT01415973 Healthy Not Applicable Completed - United States, Arkansas ... More >> UAMS Center on Aging Little Rock, Arkansas, United States, 72205 Less <<
NCT03573258 Bariatric Surgery Candidate Early Phase 1 Recruiting December 2022 Switzerland ... More >> University Hospital Zurich Recruiting Zürich, Zurich, Switzerland, 8091 Contact: Marco Bueter, MD, PhD    +41 44 255 8895    marco.bueter@usz.ch Less <<
NCT00320099 Septic Shock Phase 3 Completed - France ... More >> Hôpital Avicenne Bobigny, France Hôpital Jean Verdier Bondy, France CHU Grenoble Grenoble, France Hôpital central Nancy, France Hôpital Saint Louis Paris, France, 75 Hôpital Bichat Claude Bernard Paris, France hôpital Cochin Paris, France Hôpital Delafontaine Saint Denis, France, 93 Less <<
NCT01152385 - Completed - -
NCT01152385 Type 2 Diabetes Mellitus Phase 2 Completed - Japan ... More >> Research Site Osaka, Japan Research Site Suita, Japan Research Site Tokyo, Japan Less <<
NCT01503008 Type 2 Diabetes Mellitus Not Applicable Withdrawn August 2012 United States, Illinois ... More >> Northwestern University Chicago, Illinois, United States, 60611 United States, Massachusetts Center for Connected Health, Partners Healthcare Boston, Massachusetts, United States, 02114 Less <<
NCT03333512 Sleep Sleep R... More >>estriction Less << Not Applicable Completed - Singapore ... More >> Duke-NUS Medical School Singapore, Singapore, 169857 Less <<
NCT03261856 - Not yet recruiting December 2017 -
NCT03566524 Ketosis Prone Diabetes Not Applicable Not yet recruiting June 2020 -
NCT01336023 - Completed - -
NCT02779985 Overweight Not Applicable Completed - Netherlands ... More >> Maastricht University Medical Center Maastricht, Limburg, Netherlands, 6229 ER Less <<
NCT01096940 Type 2 Diabetes Mellitus Phase 1 Completed - United States, Texas ... More >> Research Site San Antonio, Texas, United States Less <<
NCT01336023 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT00915980 - Completed - Denmark ... More >> Hvidovre hospital Hvidovre, Denmark, 2650 Less <<
NCT00941954 Diabetes Not Applicable Completed - United Kingdom ... More >> University Hospitals of Leicester (UHL) Leicester, United Kingdom, LE5 4PW Less <<
NCT00742326 HIV Hepatitis... More >> C Liver Disease Fatty Liver Steatosis Less << Phase 4 Terminated(Enrollment stopped ... More >>prior to complete enrollment due to slow accrual) Less << - United States, District of Col... More >>umbia VA Medical Center Washington, District of Columbia, United States, 20422 United States, Maryland National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT02891954 Diabetes Mellitus, Type 2 Phase 1 Enrolling by invitation June 30, 2023 -
NCT00742326 - Terminated(Enrollment stopped ... More >>prior to complete enrollment due to slow accrual) Less << - -
NCT03682640 Diabetes Mellitus, Type 1 ... More >> Diabetes Mellitus Metabolic Disease Glucose Metabolism Disorders Endocrine System Diseases Juvenile Diabetes Insulin Dependent Diabetes Type 1 Diabetes Mellitus Inflammation Diet Modification Less << Phase 2 Recruiting December 31, 2021 Sweden ... More >> The Queen Silvia Children's Hospital / Sahlgrenska University Hospital Recruiting Gothenburg, Sweden Contact: Gun Forsander Less <<
NCT02034331 Spinal Cord Injury ... More >> Insulin Resistance Less << Not Applicable Completed - United States, New York ... More >> James J. Peters VA Medical Center Bronx, New York, United States, 10468 Less <<
NCT00952991 Diabetes Mellitus, Non-Insulin... More >>-Dependent Less << Phase 3 Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT01327079 Premature Birth of Newborn ... More >> Critically Ill Less << Phase 1 Phase 2 Completed - United States, District of Col... More >>umbia Childrens Research Institute Washington, District of Columbia, United States, 20010 Childrens's Research Institute Washington, District of Columbia, United States, 20010 Less <<
NCT01106157 Diabetes Mellitus, Type 1 Phase 1 Phase 2 Active, not recruiting September 2019 United States, California ... More >> University of California, San Francisco San Francisco, California, United States, 94143-0748 United States, Colorado Barbara Davis Center for Childhood Diabetes Aurora, Colorado, United States, 80045-6511 United States, Florida University of Florida Gainesville, Florida, United States, 32610-0296 Less <<
NCT01106157 - Active, not recruiting - -
NCT03651531 Gestational Diabetes Phase 3 Not yet recruiting July 2020 -
NCT00212641 Diabetes Mellitus, Type 2 Phase 2 Completed - -
NCT02226003 - Completed - -
NCT02911753 Obesity Hyper... More >>cholesterolemia Hyperglycemia Hypertriglyceridemia Less << Not Applicable Completed - United States, Arizona ... More >> University of Arizona Collaboratory for Metabolic Disease Prevention and Treatment Tucson, Arizona, United States, 85714 Less <<
NCT01493115 Type 1 Diabetes Mellitus Phase 1 Completed - Japan ... More >> Investigational Site Number 392001 Fukuoka-Shi, Japan, 812-0025 Less <<
NCT01845064 Diabetes Type 2 Phase 1 Phase 2 Completed - Netherlands ... More >> PRA Zuidlaren, Netherlands, 9471 GP Less <<
NCT02116829 Atherosclerosis Not Applicable Completed - Denmark ... More >> Department of Nutrition, Exercise and Sports Copenhagen, Frederiksberg, Denmark, 1958 Less <<
NCT01849185 Hypercholesterolemia Phase 4 Unknown March 2014 Israel ... More >> Division of Cardiology Meir MC Kfar Saba, Israel, 44281 Less <<
NCT00120536 Diabetes Mellitus, Type 2 Phase 3 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 Less <<
NCT00000112 - Unknown - United States, Connecticut ... More >> Yale University School of Medicine, Pediatric Endocrinology Recruiting New Haven, Connecticut, United States, 06520-8064 Less <<
NCT00099905 Diabetes Mellitus, Type 2 Phase 3 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 Less <<
NCT00994825 Low Cardiac Output Syndrome Phase 4 Completed - Brazil ... More >> Santa Casa de Misericórdia de Juiz de Fora Juiz de Fora, Minas Gerais, Brazil, 36.021- 630 Italy Azienda Ospedaliera Ospedali Riuniti Papardo - Piemonte Messina, ME, Italy, 98158 A.O.U. Citta della Salute e della Scienza Torino, TO, Italy, 10126 A. O. Ordine Mauriziano di Torino Torino, TO, Italy Ospedale San Bortolo Vicenza, VI, Italy Policlinico S.Orsola-Malpighi Bologna, Italy, 40138 Azienda Ospedaliera Universitaria "Mater Domini" Catanzaro, Italy Azienda Ospedaliera Universitaria San Martino Genova, Italy, 16132 Ospedale San Raffaele di Milano, Italy Milano, Italy, 20132 Ospedale San Gerardo di Monza Monza, Italy Azienda Ospedaliera Specialistica dei Colli Napoli, Italy Azienda Ospedaliera Universitaria Pisana Pisa, Italy Azienda Ospedaliera Regionale San Carlo Potenza, Italy, 85100 Ospedale Civile SS Annunziata Sassari, Italy Russian Federation Astrakhan Federal Centre for Cardiac Surgery Astrakhan, Russia, Russian Federation, 414000 Scientific Research Institute for Complex Issues of Cardiovascular Diseases Kemerovo, Russia, Russian Federation, 650002 Moscow Regional Clinical & Research Institute Moscow, Russia, Russian Federation, 129110 Research Institute of Circulation Pathology Novosibirsk, Russia, Russian Federation, 630055 Less <<
NCT01190592 Body Composition ... More >> Cardiovascular Risk Factors Less << Not Applicable Completed - United States, Kansas ... More >> University of Kansas Medical Center Kansas City, Kansas, United States, 66160 Less <<
NCT00335712 Type 2 Diabetes Mellitus Phase 2 Completed - Japan ... More >> Kanto Region Kanto, Japan Kyusyu Region Kyusyu, Japan Less <<
NCT00099918 Diabetes Mellitus, Type 2 Phase 3 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 Germany Novartis Investigative Sites Investigative Centers, Germany Less <<
NCT01756404 Healthy Phase 1 Completed - United States, Florida ... More >> Miramar, Florida, United States Less <<
NCT03021746 Diabetes Mellitus Not Applicable Recruiting June 2021 United States, Michigan ... More >> University of Michigan Recruiting Ann Arbor, Michigan, United States, 48109 Contact: Diana Hall, MPH    734-764-3807    halldz@umich.edu    Principal Investigator: Gretchen Piatt, MPH, PhD Less <<
NCT01766778 - Completed - -
NCT00520962 - Completed - Italy ... More >> Medicine Division, Diabetology, Endocrinology and Metabolic Disease Unit, IRCCS San Raffaele Milan, Italy, 20132 Less <<
NCT02477865 Type 2 Diabetes Mellitus Phase 3 Unknown February 2017 -
NCT00379379 Diabetes Mellitus, Type 2 ... More >> Insulin Resistance Less << Not Applicable Completed - Taiwan ... More >> Graduate Insititude of Integration Chinese And Western Medicine, China Medical University Taichung, Taiwan, 40402 Less <<
NCT02226003 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT00151697 Diabetes Mellitus Type II Phase 3 Completed - Netherlands ... More >> Rijnstate Hospital Arnhem, Netherlands, 6800 TA Less <<
NCT00568984 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 4 Completed - China, Beijing ... More >> Novo Nordisk Investigational Site Beijing, Beijing, China, 100034 Novo Nordisk Investigational Site Beijing, Beijing, China, 100044 Novo Nordisk Investigational Site Beijing, Beijing, China, 100730 China, Tianjin Novo Nordisk Investigational Site Tianjin, Tianjin, China, 300052 Malaysia Novo Nordisk Investigational Site Cheras, Malaysia, 56000 Novo Nordisk Investigational Site Ipoh, Malaysia, 30450 Novo Nordisk Investigational Site Kota Bharu, Kelantan, Malaysia, 16150 Philippines Novo Nordisk Investigational Site Cebu City, Philippines, 6000 Novo Nordisk Investigational Site Manila, Philippines, 1003 Novo Nordisk Investigational Site Marikina City, Philippines, 1800 Novo Nordisk Investigational Site Pampanga, Philippines, 2000 Novo Nordisk Investigational Site Quezon City, Philippines, 1100 Novo Nordisk Investigational Site Quezon, Philippines, 4301 Thailand Novo Nordisk Investigational Site Bangkok, Thailand, 10300 Novo Nordisk Investigational Site Bangkok, Thailand, 10330 Less <<
NCT00372060 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT01225159 Nosocomial Infection ... More >> External Causes of Morbidity and Mortality Hypoglycemia Less << Not Applicable Terminated(Hypoglycaemia is si... More >>gnificantly higher in TGC) Less << - Thailand ... More >> Songklanagarind Hospital, Faculty of Medicine, PSU Hat Yai, Songkhla, Thailand, 90110 Less <<
NCT01795833 Prediabetes Not Applicable Completed - United Kingdom ... More >> Imperial college Healthcare NHS Trust London, United Kingdom, W2 1NY Less <<
NCT01585051 Diabetes Mellitus Type 2 Phase 3 Completed - Switzerland ... More >> Department of medicine, Kantonsspital Bruderholz Bruderholz/Basel, Basel-Landschaft, Switzerland, CH-4101 Less <<
NCT01225159 - Terminated(Hypoglycaemia is si... More >>gnificantly higher in TGC) Less << - -
NCT00024518 Insulin-Dependent Diabetes Mel... More >>litus Less << Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 United States, Minnesota Children's Hospital - St. Paul St. Paul, Minnesota, United States United States, Missouri Children's Hospital - Kansas City Kansas City, Missouri, United States United States, Texas University of Texas, Dallas Dallas, Texas, United States, 75216 University of Texas, Houston Houston, Texas, United States, 77030 Less <<
NCT01499095 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT00372060 - Completed - -
NCT03209258 Cerebral Hemorrhage ... More >> Stroke Hypertension Diabetes Anticoagulant-induced Bleeding Cerebral Vascular Disorder Brain Disorder Hemorrhage Intracranial Hemorrhages Cardiovascular Diseases Central Nervous System Diseases Less << Not Applicable Recruiting June 30, 2020 China, Sichuang ... More >> West China Hospital Recruiting Chengdu, Sichuang, China Contact: Lu Ma, PhD    +86 18613228772    alex80350305@163.com Less <<
NCT01939041 Subacute Stroke Not Applicable Withdrawn(Difficult to recruit... More >> participant) Less << - Taiwan ... More >> Chang Gung Memorial Hospital Kwei-Shan, Tao-Yuan, Taiwan, 333 Less <<
NCT00993460 - Active, not recruiting November 2019 United States, Tennessee ... More >> Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232 Less <<
NCT02344186 Type 2 Diabetes Phase 4 Unknown June 2016 United States, Pennsylvania ... More >> Temple University Hospital Philadelphia, Pennsylvania, United States, 19140 Less <<
NCT01648153 Diabetes Mellitus Phase 2 Completed - Spain ... More >> GSK Investigational Site Alicante, Spain, 03004 GSK Investigational Site Alzira/Valencia, Spain, 46600 GSK Investigational Site Granada, Spain, 18012 GSK Investigational Site La Roca del Valles (Barcelona), Spain, 08430 GSK Investigational Site Lleida, Spain, 25198 GSK Investigational Site Madrid, Spain, 28034 GSK Investigational Site Madrid, Spain, 28046 GSK Investigational Site Malaga, Spain, 29010 GSK Investigational Site Málaga, Spain, 29010 GSK Investigational Site Petrer, Alicante, Spain, 03610 GSK Investigational Site Santander, Spain, 39008 United Kingdom GSK Investigational Site Birmingham, Warwickshire, United Kingdom, B15 2TT GSK Investigational Site Cambridge, United Kingdom, CB2 2GG GSK Investigational Site Dundee, United Kingdom, DD1 9SY Less <<
NCT03675659 Temporomandibular Joint Disord... More >>ers Temporomandibular Sprain Less << Early Phase 1 Recruiting November 2019 Egypt ... More >> Atef Recruiting Giza, Egypt, 12111 Contact: atef fouda, prof    01224316042 Less <<
NCT03767543 Type 2 Diabetes Mellitus Phase 3 Not yet recruiting April 2020 -
NCT02445508 Diabetes Mellitus, Type 2 Not Applicable Completed - Denmark ... More >> Center for Diabetes Research Hellerup, Denmark, 2900 Less <<
NCT02919176 Obese Metabol... More >>ic Syndrome Less << Early Phase 1 Recruiting December 1, 2020 United States, Kentucky ... More >> Center for Clinical and Translational Science Recruiting Lexington, Kentucky, United States, 40536 Contact: Zachary Johnson       zrjo223@uky.edu    Contact: Terri Spear       terri.spear@uky.edu    Principal Investigator: Philip Kern, MD Less <<
NCT03444142 Diabetes Mellitus, Type 2 Phase 4 Recruiting December 30, 2018 Mexico ... More >> Instituto de terapeutica Experimental y Clinica. Centro universitario de Ciencias de la Salud. Universidad de Guadalajara Recruiting Guadalajara, Jalisco, Mexico, 44340 Less <<
NCT02156271 Insomnia Phase 4 Completed - -
NCT01680133 - Completed - Netherlands ... More >> Department of Human Biology, Maastricht University Medical Centre Maastricht, Netherlands, 6200MD Less <<
NCT02294084 Neoplasms, Adipose Tissue Phase 4 Completed - Netherlands ... More >> Leiden University Medical Center Leiden, Zuid-Holland, Netherlands, 2333 ZA Less <<
NCT01642719 Sleep Disturbance ... More >> Aging Less << Phase 1 Active, not recruiting December 2018 United States, Arizona ... More >> University of Arizona Tucson, Arizona, United States, 85721-0000 United States, California UCLA Cousins Center for Psychoneuroimmunology Los Angeles, California, United States, 90095 United States, New York SUNY Downstate Medical Center Brooklyn, New York, United States, 12201-0009 United States, South Carolina University of South Carolina Columbia, South Carolina, United States, 29208-0000 Less <<
NCT00297180 Obesity Phase 2 Completed - United States, Florida ... More >> GSK Investigational Site Daytona Beach, Florida, United States, 32114 United States, Louisiana GSK Investigational Site Baton Rouge, Louisiana, United States, 70808 United States, Oregon GSK Investigational Site Portland, Oregon, United States, 97239 Less <<
NCT01024543 Insulin Sensitivity ... More >> Microcirculation Less << Not Applicable Completed - Netherlands ... More >> Maastricht University Medical Centre Maastricht, P.o. Box 5800, Netherlands, Netherlands, 6202 AZ Less <<
NCT01306396 Non-alcoholic Fatty Liver Dise... More >>ase Less << Not Applicable Unknown December 2012 Germany ... More >> University of Hohenheim, Dept. of Nutritional Medicine (180 a) Recruiting Stuttgart, Baden-Württemberg, Germany, 70599 Contact: Ina Bergheim, Ph.D.    ++49/711/4592-4102    ina.bergheim@uni-hohenheim.de    Principal Investigator: Ina Bergheim, Ph.D. Less <<
NCT01776294 - Completed - India ... More >> Andhra Medical College Visakhapatnam, Andhra Pradesh, India, 530002 Less <<
NCT03237819 Thrombotic Thrombocytopenic Pu... More >>rpura Less << Phase 3 Not yet recruiting June 2020 France ... More >> Saint Louis hospital Not yet recruiting Paris, France, 75010 Contact: Lara ZAFRANI, MD PhD Less <<
NCT02156271 - Completed - -
NCT03102801 Type 2 Diabetes Mellitus With ... More >>Hypoglycemia Less << Not Applicable Completed - United Kingdom ... More >> Hull and east Yorkshire Hospitals NHS Trust Hull, United Kingdom, HU32RW Less <<
NCT00682084 - Terminated(Recruitment problem... More >>s) Less << - Denmark ... More >> Department of Endocrinology Aarhus C, Aarhus, Denmark, 8000 Less <<
NCT01894074 Subfertility ... More >>Anovulatory Obese Less << Not Applicable Completed - United States, Michigan ... More >> UMichigan Ann Arbor, Michigan, United States, 48109 Less <<
NCT02317302 Cervical Cancer ... More >> Uterine Cervical Cancer Uterine Cervical Neoplasms Less << Phase 1 Active, not recruiting February 6, 2021 United States, Missouri ... More >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Less <<
NCT01115608 Coronary Heart Disease Not Applicable Unknown June 2011 Norway ... More >> Hospital Pharmacy of North Norway Trust Tromsø, Norway, 9020 Less <<
NCT01475513 Insulin Sensitivity ... More >> Cardiovascular Risk Perimenopausal Disorder Less << Phase 4 Completed - United States, Virginia ... More >> Virginia Commonwealth University Medical Center Richmond, Virginia, United States, 23298-0111 Less <<
NCT01475513 - Completed - -
NCT02390180 - Completed - United States, Indiana ... More >> Purdue University West Lafayette, Indiana, United States, 47907 Less <<
NCT01300637 Obesity Metab... More >>olic Syndrome Schizophrenia Less << Not Applicable Unknown July 2011 Taiwan ... More >> Taipei Medical University-WanFang Hospital Recruiting Taipei, Taiwan, 116 Contact: Chun-Hsin Chen, MD    886-2-29307930 ext 53961    chunhsin57@yahoo.com.tw    Contact: Mong-Liang Lu, MD    886-2-29307930 ext 53961    mongliang@hotmail.com Less <<
NCT00609271 Obesity Body ... More >>Composition Blood Pressure Cardiovascular Diseases Less << Not Applicable Completed - United States, Louisiana ... More >> Tulane University, Office of Health Research New Orleans, Louisiana, United States, 70112 Less <<
NCT02111083 Healthy Volunteers Phase 1 Completed - Singapore ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Singapore, Singapore, 117597 Less <<
NCT02455778 Metabolic Syndrome Not Applicable Completed - India ... More >> Fortis-C-DOC Centre of Excellence for Diabetes, Metabolic Diseases and Endocrinology Delhi, India Less <<
NCT00451568 Polycystic Ovary Syndrome Phase 4 Completed - Denmark ... More >> Odense University Hospital Odense, Denmark Less <<
NCT00609271 - Completed - -
NCT03247322 Medication Compliance Not Applicable Recruiting April 30, 2020 United States, South Carolina ... More >> Medical University of South Carolina Recruiting Charleston, South Carolina, United States, 29425 Contact: Caitlin Schaffner, MPH    843-792-7558       Principal Investigator: David Taber, PharmD, MS Less <<
NCT01779908 Vitamin D-deficient ... More >> Insulin-resistant Less << Not Applicable Active, not recruiting December 2018 Canada, Quebec ... More >> CHU de Québec, Laval University Research Center Quebec city, Quebec, Canada, G1V 4G2 Less <<
NCT03018444 Diabetes Mellitus, Type 2 ... More >> Hydroxymethylglutaryl-CoA Reductase Inhibitors Less << Not Applicable Completed - Denmark ... More >> University Hospital, Gentofte, Copenhagen Hellerup, Region Hovedstaden, Denmark, 2900 Less <<
NCT01572818 Insulin Resistance ... More >> Iron Overload Less << Not Applicable Completed - France ... More >> CHU Nantes, France, F-44000 CHU Rennes, France, F-35203 Less <<
NCT01787682 Chronic Heart Failure ... More >> Chronic Obstructive Pulmonary Disorder Less << Not Applicable Recruiting February 2020 United States, Texas ... More >> Texas A&M University Recruiting College Station, Texas, United States, 77843 Contact: Marielle PKJ Engelen, PhD    9792202282    mpkj.engelen@ctral.org Less <<
NCT03022604 Exercise Ergogenics Not Applicable Completed - -
NCT02604485 Congenital Hyperinsulinism Phase 2 Completed - United States, Pennsylvania ... More >> Philadelphia, Pennsylvania, United States United Kingdom London, United Kingdom Less <<
NCT01790308 Diabetes Mellitus, Type 2 Phase 4 Unknown December 2015 -
NCT01134107 Diabetes Mellitus, Type 1 Phase 3 Completed - France ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Caen, France, 14033 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Corbeil-Essonnes, France, 91106 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. La Rochelle, France, 17019 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Marseille, France, 13009 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Montpellier, France, 34295 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Narbonne, France, 11108 Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ludwigshafen, Germany, 67059 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mainz, Germany, 55116 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Münster, Germany, 48145 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Neuwied, Germany, 56564 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Potsdam, Germany, 14469 Hungary For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bekescsaba, Hungary, 5600 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Budapest, Hungary, 1023 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nyiregyhaza, Hungary, 4400 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Zalaegerszeg, Hungary, 8900 Less <<
NCT02111083 - Completed - -
NCT02773927 Metabolic Syndrome Phase 3 Completed - Mexico ... More >> Universidad de Guadalajara Guadalajara, Jalisco, México, Mexico, 44100 Less <<
NCT01134107 - Completed - -
NCT01269047 Type 1 Diabetes Phase 4 Completed - United States, New York ... More >> Albert Einstein College of Medicine West Campus Clinical Research Center Bronx, New York, United States, 10467 Less <<
NCT01432509 Prediabetes Not Applicable Completed - France ... More >> Clinical Nutrition Center Naturalpha (CNCN) Lille, France, 59020 Less <<
NCT03737240 Diabetes Mellitus Phase 3 Not yet recruiting December 2021 United States, Georgia ... More >> Grady Health System Not yet recruiting Atlanta, Georgia, United States, 30303 Contact: Rodolfo Galindo, MD    404-251-8961    rodolfo.galindo@emory.edu    Emory Clinic Not yet recruiting Atlanta, Georgia, United States, 30322 Contact: Rodolfo Galindo, MD    404-251-8961    rodolfo.galindo@emory.edu Less <<
NCT01269047 - Completed - -
NCT00541775 - Completed - -
NCT00268645 Diabetes Mellitus, Type 2 Phase 4 Completed - Turkey ... More >> Sanofi-Aventis Istanbul, Turkey Less <<
NCT00543621 Diabetes Mellitus, Type 2 Phase 4 Completed - China ... More >> Huandong Hospital Shanghai, China Less <<
NCT00541775 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT03011775 Adverse Effect ... More >> Atherosclerosis, Coronary Insulin Resistance Syndrome Less << Phase 4 Completed - Ukraine ... More >> Ukrainian Medical Stomatological Academy Poltava, Ukraine, 36011 Less <<
NCT02130804 Diabetes Risk Phase 1 Completed - United States, California ... More >> University of Southern California Diabetes Obesity Research Institute (DORI) Los Angeles, California, United States, 90089 University of Southern California, Clinical Trials Unit (CTU) Los Angeles, California, United States, 90089 Less <<
NCT02653599 Type 2 Diabetes Mellitus Phase 2 Completed - -
NCT01031108 Diabetes Mellitus, Type 2 Phase 1 Completed - United Kingdom ... More >> GSK Investigational Site Edinburgh, United Kingdom, EH16 4SB Less <<
NCT01006291 - Completed - -
NCT02744313 - Completed - Canada, Ontario ... More >> Centre For Addiction and Mental Health Toronto, Ontario, Canada, M5T1R8 Less <<
NCT01006291 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT03636217 Appetitive Behavior Not Applicable Completed - Turkey ... More >> Erciyes University Faculty of Health Sciences Kayseri, Turkey, 38039 Less <<
NCT01009580 - Completed - -
NCT01009580 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT00703755 Patients With Metabolic Syndro... More >>me Less << Phase 2 Completed - -
NCT00696475 Hypertriglyceridemia Phase 2 Completed - United States, California ... More >> National Research Institute Los Angeles, California, United States, 90057 United States, Florida Jacksonville Center for Clinical Research Jacksonville, Florida, United States, 32216 Allied Research International/Cetero Research Miami Gardens, Florida, United States, 33169 Meridien Research Tampa, Florida, United States, 33606 United States, Indiana Midwest Institute for Clinical Research Indianapolis, Indiana, United States, 46260 United States, Kentucky L-MARC Research Center Louisville, Kentucky, United States, 40213 United States, Missouri St. Luke's Lipid and Diabetes Research Center Kansas City, Missouri, United States, 64111 United States, North Carolina Piedmont Medical Research Associates Winston Salem, North Carolina, United States, 27103 United States, Ohio Metabolic and Atherosclerosis Research Center (MARC) Cincinnati, Ohio, United States, 45212 Sterling Research Group, Ltd Cincinnati, Ohio, United States, 45219 Frederick C. Smith Clinic Marion, Ohio, United States, 43302 United States, Tennessee TriCities Medical Research Bristol, Tennessee, United States, 37620 Less <<
NCT02847091 Type 2 Diabetes Mellitus Phase 4 Completed - Japan ... More >> Site JP00007 Gunma, Japan Site JP00008 Hiroshima, Japan Site JP00009 Hyogo, Japan Site JP00010 Kanagawa, Japan Site JP00003 Mie, Japan Site JP00004 Osaka, Japan Site JP00015 Shiga, Japan Site JP00002 Tochigi, Japan Site JP00005 Tochigi, Japan Site JP00013 Tochigi, Japan Site JP00001 Tokyo, Japan Site JP00006 Tokyo, Japan Site JP00011 Tokyo, Japan Site JP00012 Tokyo, Japan Site JP00014 Tokyo, Japan Less <<
NCT00686712 Type 2 Diabetes Mellitus Phase 4 Completed - United States, California ... More >> Charles Drew University of Medicine and Science Los Angeles, California, United States, 90059 Less <<
NCT03360604 Diabetes Mellitus, Type 2 ... More >> Cognitive Impairment Less << Not Applicable Recruiting December 2018 United Kingdom ... More >> Hugh Sinclair Unit, University of Reading Recruiting Reading, Berkshire, United Kingdom, RG6 6AL Contact: Julie A Lovegrove, PhD       j.a.lovegrove@reading.ac.uk    Sub-Investigator: Daniel J Lamport, PhD          Sub-Investigator: Matthew J Grout, PhD          Principal Investigator: Julie A Lovegrove, PhD Less <<
NCT00686712 - Completed - -
NCT01809808 - Recruiting June 2020 United States, New York ... More >> Neuroendocrine Unit; Columbia University Medical Center, 180 Fort Washington Avenue 9-970 Recruiting New York, New York, United States, 10032 Contact: Carlos Reyes-Vidal, MD    212-305-4921       Contact: Krystal Hernandez, MD    212-305-4921       Principal Investigator: Pamela U Freda, M.D. Less <<
NCT02068443 Type 2 Diabetes Mellitus Phase 3 Completed - Japan ... More >> Nagoya-shi, Aichi, Japan Chiba-shi, Chiba, Japan Fukuoka-shi, Fukuoka, Japan Kitakyushu-shi, Fukuoka, Japan Kurume-shi, Fukuoka, Japan Aki-gun, Hiroshima, Japan Hiroshima-shi, Hiroshima, Japan Koga-shi, Ibaraki, Japan Mito-shi, Ibaraki, Japan Tushiura-shi, Ibaraki, Japan Ushiku-shi, Ibaraki, Japan Kanazawa-shi, Ishikawa, Japan Takamatsu-chi, Kagawa, Japan Sendai-shi, Miyagi, Japan Ohita-shi, Ohita, Japan Okinawa-shi, Okinawa, Japan Shimajiri-gun, Okinawa, Japan Kashiwara-shi, Osaka, Japan Osaka-shi, Osaka, Japan Hiki-gun, Saitama, Japan Oyama-shi, Tochigi, Japan Shimotsuke-shi, Tochigi, Japan Koutoh-ku, Tokyo, Japan Meguro-ku, Tokyo, Japan Sagae-shi, Yamagata, Japan Yamagata-shi, Yamagata, Japan Yamaguchi-shi, Yamaguchi, Japan Less <<
NCT01801254 Obesity Type ... More >>II Diabetes Cardiovascular Disease Health Behavior Less << Phase 1 Completed - United States, New York ... More >> University of Rochester Rochester, New York, United States, 14627 Less <<
NCT02649010 Type 1 Diabetes Not Applicable Withdrawn(Business Decision) - United States, California ... More >> Diablo Clinical Research Walnut Creek, California, United States, 94598 United States, Washington Rainier Clinical Research Center Renton, Washington, United States, 98057 Less <<
NCT00396734 Opioid-Related Disorders ... More >> Cocaine-Related Disorders Less << Not Applicable Suspended(Grant was not renewe... More >>d) Less << April 2011 Israel ... More >> Hadassah Medical Organization Jerusalem, Israel, 91120 Less <<
NCT01781754 - Unknown January 2014 Israel ... More >> Tel Aviv Sourasky Medical Center Recruiting Tel-Aviv, Israel, 64239 Contact: Nachum Vaisman, MD    972-3-6974807    vaisman@tasmc.health.gov.il    Principal Investigator: Nachum Vaisman, MD Less <<
NCT00605020 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT02068443 - Completed - -
NCT01875224 New Onset Diabetes After Trans... More >>plant Kidney Transplantation Less << Phase 4 Unknown August 2016 United States, Arizona ... More >> University of Arizona Not yet recruiting Tucson, Arizona, United States, 85724 Contact: Rochelle Byrne, RN    520-626-9603    rbyrne@deptofmed.arizona.edu    Principal Investigator: Bruce Kaplan, MD Less <<
NCT01295372 Schizophrenia Phase 3 Completed - Czech Republic ... More >> CZ004 Brno, Czech Republic, 602 00 CZ001 Brno, Czech Republic, 625 00 CZ007 Kladno, Czech Republic, 27201 CZ003 Liberec, Czech Republic, 460 63 CZ002 Olomouc, Czech Republic, 771 11 CZ008 Praha, Czech Republic, 100 00 CZ006 Praha, Czech Republic, 110 00 CZ005 Sternberk, Czech Republic, 785 17 Estonia EE003 Pärnu, Estonia, 80012 EE001 Tallinn, Estonia, 10614 EE002 Tallinn, Estonia, 10617 EE004 Tartu, Estonia, 50406 Finland FI001 Helsinki, Finland, 00250 FI002 Kellokoski, Finland, 04500 France FR001 Clermont Ferrand, France, 63003 FR002 Nimes, France, 30900 FR004 Strasbourg, France, 67091 FR003 Toulon, France, 83000 Poland PL004 Bełchatów, Poland, 97-400 PL002 Gdańsk, Poland, 80-542 PL003 Kielce, Poland, 25-317 PL001 Lublin, Poland, 20-109 PL006 Łódź, Poland, 91-229 PL005 Żuromin, Poland, 93-00 Less <<
NCT03653468 Obesity Cardi... More >>ovascular Risk Factor Physical Activity Less << Not Applicable Completed - Chile ... More >> Cristian Alvarez Los Lagos, Osorno, Chile, 000000000 Less <<
NCT02307591 Ebola Virus Disease Phase 2 Phase 3 Withdrawn(The Study could not ... More >>be started due to an insufficient number of new EVD cases.) Less << - -
NCT03236597 Sedentary Lifestyle ... More >> Risk Factor, Cardiovascular Less << Not Applicable Not yet recruiting April 1, 2019 United States, Minnesota ... More >> University of Minnesota West Bank Office Building Minneapolis, Minnesota, United States, 55454 Less <<
NCT03367377 Diabetes Mellitus, Type 2 Phase 1 Completed - United States, Florida ... More >> Miami Research Associates South Miami, Florida, United States, 33143 United States, North Carolina High Point Clinical Trials Center High Point, North Carolina, United States, 27265 Canada, Ontario LMC Endocrinology Centres Ltd. Toronto, Ontario, Canada, M4G 3E8 Less <<
NCT01799005 Vascular Health Not Applicable Completed - Germany ... More >> Division of Cardiology, Pulmonology and Vascular Medicine Duesseldorf, NRW, Germany, 40225 Less <<
NCT01043510 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 1 Completed - United States, California ... More >> Novo Nordisk Investigational Site Chula Vista, California, United States, 91911 Less <<
NCT01866098 Schizophrenia ... More >> Schizoaffective Disorder Schizophreniform Disorder Bipolar Disorder Severe Major Depression With Psychotic Features Less << Not Applicable Active, not recruiting April 7, 2018 United States, Connecticut ... More >> Connecticut Mental Health Center New Haven, Connecticut, United States, 06519 Less <<
NCT02690792 Healthy NAFLD... More >> (Non-Alcoholic Fatty Liver Disease) NASH (Non-Alcoholic Steatohepatitis) Less << Not Applicable Completed - United States, Texas ... More >> University of Texas Southwestern Medical Center Dallas, Texas, United States, 75390-8568 Less <<
NCT02470260 - Recruiting December 2020 United States, New York ... More >> Columbia University Medical Center Recruiting New York, New York, United States, 10032 Principal Investigator: Jose A Luchsinger, MD Less <<
NCT00097500 Type 2 Diabetes Mellitus Phase 3 Completed - Finland ... More >> Research Site Helsinki, Finland Netherlands Research Site Amsterdam, Netherlands Sweden Research Site Goteborg, Sweden Less <<
NCT01579292 Sedentary Lifestyle ... More >> Physical Activity Pre-Diabetic Less << Not Applicable Completed - United States, California ... More >> University of California San Francisco San Francisco, California, United States, 94118 Less <<
NCT03528317 Obesity Not Applicable Active, not recruiting February 1, 2019 United States, Illinois ... More >> University of Illinois, Chicago Chicago, Illinois, United States, 60622 Less <<
NCT02361138 Type 2 Diabetes Phase 1 Completed - China, Shanghai ... More >> Shanghai Xuhui Central Hospital Shanghai, Shanghai, China, 200030 Less <<
NCT01658501 Type 2 Diabetes Mellitus Phase 2 Completed - -
NCT02445911 Diabetes Mellitus, Type 2 Phase 1 Completed - United States, Arizona ... More >> Celerion Tempe, Arizona, United States, 85283 United States, Florida Clinical Pharmacology of Miami, Inc. Miami, Florida, United States, 33014 Orlando Clinical Research Center Orlando, Florida, United States, 32809 United States, Nebraska Celerion Lincoln, Nebraska, United States, 68502 Less <<
NCT00367445 Diabetes Mellitus, Type 2 Phase 4 Completed - United States, California ... More >> Pfizer Investigational Site Chula Vista, California, United States Less <<
NCT00606034 Type 2 Diabetes ... More >> Insulin Resistance Less << Phase 4 Completed - United States, North Carolina ... More >> Mountain Diabetes and Endocrine Center Asheville, North Carolina, United States, 28803 Less <<
NCT00703612 Type 2 Diabetes Mellitus Phase 1 Phase 2 Unknown January 2009 Philippines ... More >> Beverly Hills Medical Group Makati City, Manila, Philippines, 1223 Veterens Memorial Medical Centre Quezon City, Manila, Philippines, 1229 Less <<
NCT02368704 - Unknown November 2016 France ... More >> Saint-Louis Hospital Paris, France, 75010 Less <<
NCT01140139 HIV-1 Phase 1 Completed - Sweden ... More >> South Hospital Stockholm, Sweden, 1188 Less <<
NCT01812967 Glycemic Control ... More >> Gastrointestinal Hormone Response Healthy Young Men Less << Not Applicable Completed - Canada, Ontario ... More >> University of Toronto Toronto, Ontario, Canada, M5S 3E2 Less <<
NCT00606034 - Completed - -
NCT00290043 Diabetes Mellitus Type 1 Phase 1 Completed - -
NCT01004757 Type 2 Diabetes Mellitus ... More >> Overweight Less << Not Applicable Unknown February 2010 Germany ... More >> Staedt. Klinikum Muenchen-Bogenhausen Munich, Bavaria, Germany, 81925 Less <<
NCT00831285 Healthy Not Applicable Completed - Canada, Manitoba ... More >> St. Boniface General Hospital Research Centre Winnipeg, Manitoba, Canada, R2H 2A6 Less <<
NCT01019356 Polycystic Ovary Syndrome Not Applicable Active, not recruiting October 2021 Canada, Quebec ... More >> Université de Sherbrooke Sherbrooke, Quebec, Canada, J1H 5N4 Less <<
NCT01809184 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 1 Completed - Germany ... More >> Novo Nordisk Investigational Site Neuss, Germany, 41460 Less <<
NCT00732524 Type 2 Diabetes Phase 4 Completed - United States, Illinois ... More >> John H Stroger Hospital Of Cook County Chicago, Illinois, United States, 60612 Less <<
NCT00895531 Arthroplasty, Replacement, Kne... More >>e Less << Phase 4 Terminated(Investigator left i... More >>nstitution) Less << - United States, Kentucky ... More >> University of Louisville Hospital Louisville, Kentucky, United States, 40202 Less <<
NCT00895531 - Terminated(Investigator left i... More >>nstitution) Less << - -
NCT01901913 Type 1 Diabetes Not Applicable Completed - Israel ... More >> Schneider Children's Medical Center Petah-Tikva, Israel, 49202 Less <<
NCT00097500 - Completed - -
NCT00598793 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT00642538 Diabetes Mellitus, Type 2 Phase 1 Completed - Netherlands ... More >> University Medical Centre Groningen Zuidlaren, Netherlands, 9470 AE Less <<
NCT03609255 General Population Not Applicable Completed - United States, Texas ... More >> Texas Tech University - Department of Nutritional Sciences Lubbock, Texas, United States, 79409 Less <<
NCT03324776 Type2 Diabetes Phase 3 Recruiting September 15, 2018 United States, Maryland ... More >> MODEL Clinical Research Recruiting Baltimore, Maryland, United States, 21204 Contact: Karen Klein    443-524-1789    karenklein99@hotmail.com    Contact: Lee Bromberger    410-279-0036    lee-model@hotmail.com Less <<
NCT01195454 Type 1 Diabetes Mellitus Phase 1 Completed - Germany ... More >> Sanofi-Aventis Administrative Office Berlin, Germany Less <<
NCT02081989 Diabetes Phase 4 Withdrawn(Unable to commence s... More >>tudy due to closure of hospital department.) Less << - Australia, Victoria ... More >> Alfred Hospital Melbourne, Victoria, Australia, 3004 Less <<
NCT01263470 - Completed - -
NCT02234349 Pancreas-kidney Transplantatio... More >>n Kidney Transplantation Less << Not Applicable Completed - France ... More >> Hôpital Edourad Herriot - Pavillon P LYON cedex 03, France, 69437 Less <<
NCT01263470 Diabetes Mellitus, Type 2 Phase 2 Completed - Japan ... More >> Okayama, Japan, 701-0192 Less <<
NCT01369277 Diabetes Mellitus ... More >> Diabetes Mellitus, Type 2 Glucose Metabolism Disorders Less << Phase 1 Completed - United States, Connecticut ... More >> Pfizer Investigational Site New Haven, Connecticut, United States, 06511 Less <<
NCT03189121 - Recruiting February 28, 2020 United States, Maryland ... More >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)    800-411-1222 ext TTY8664111010    prpl@cc.nih.gov Less <<
NCT02390050 Diabetes Mellitus, Type 2 Phase 2 Phase 3 Completed - -
NCT00850694 - Completed - United States, Alabama ... More >> Children's Hospital, Universiy of Alabama at Birmingham Birmingham, Alabama, United States, 35233 Less <<
NCT01499095 - Completed - -
NCT01526720 - Recruiting December 2020 Italy ... More >> Division of Endocrinology and Metabolic Diseases - University Hospital of Verona Recruiting Verona, Italy, 37126 Less <<
NCT02075788 Hyperglycemia ... More >> Lack of Satiety Less << Not Applicable Completed - Canada, Ontario ... More >> Human Nutraceutical Research Unit, University of Guelph Guelph, Ontario, Canada, N1G2W1 Less <<
NCT02087826 Genetics Meta... More >>bolism Type 2 Diabetes Less << Not Applicable Recruiting January 2020 United States, Massachusetts ... More >> Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: Varinderpal Kaur    617-643-5423    sigma2mgh@partners.org    Principal Investigator: Jose C Florez, MD, PhD          Sub-Investigator: Jennifer Todd, MD          Sub-Investigator: Jamie L Garry, MS, RD Less <<
NCT01890928 - Completed - United States, Texas ... More >> UT Southwestern Medical Center Dallas, Texas, United States, 75390 Less <<
NCT01901367 Childhood Acute Lymphoblastic ... More >>Leukemia in Remission Less << Not Applicable Completed - United States, Tennessee ... More >> Vanderbilt University Nashville, Tennessee, United States, 37232 Less <<
NCT00315718 Diabetes Mellitus, Type 2 Phase 3 Completed - Slovakia ... More >> Hospital of Trencin Trencin, Slovakia, SK-91171 Less <<
NCT00131664 Type 2 Diabetes Mellitus Phase 3 Completed - Canada, Ontario ... More >> Canadian Heart Research Centre Toronto, Ontario, Canada, m5b 2p9 Less <<
NCT01503112 - Completed - United Kingdom ... More >> Cornwall and Isles of Scilly NHS Primary Care Trust Truro, Cornwall, United Kingdom, TR13HD North Devon NHS Trust Barnstaple, Devon, United Kingdom, EX314JB Royal Devon and Exeter NHS Foundation Trust Exeter, Devon, United Kingdom, EX25DW Plymouth Hospitals NHS Trust Plymouth, Devon, United Kingdom, PL68DH South Devon Healthcare NHS Foundation Trust Torbay, Devon, United Kingdom, TQ27AA Taunton and Somerset NHS Foundation Trust. Taunton, Somerset, United Kingdom, BA228HR Yeovil Disctrict Hospital NHS Foundation Trust Yeovil, Somerset, United Kingdom, BA21 4AT The Royal Bournmouth and Christchurch Hospitals NHS Trust Bournmouth, United Kingdom, BH7 7DW North Bristol NHS Trust Bristol, United Kingdom, BS10 5NB Ipswich Hospital NHS Trust Ipswich, United Kingdom, IP4 5PD Northampton General Hospital NHS Trust Northampton, United Kingdom, NN15BD Oxford Radcliffe Hospitals NHS Trust Oxford, United Kingdom, OX3 9DU Portsmouth Hospitals NHS Trust Portsmouth, United Kingdom, PO6 3LY Surrey and Sussex Healthcare NHS trust Redhill, United Kingdom, RH1 5RH East Sussex Healthcare NHS Trust St Leonards-on-Sea, United Kingdom, TN37 7RD University Hospitls North Staffordshire NHS Trust Stoke on Trent, United Kingdom, ST4 7LN South Warwickshire NHS Foundation Trust Warwick, United Kingdom, CV34 5BW West Hertfordshire Hospitals NHS Trust Watford, United Kingdom, WD18 0HB Less <<
NCT03003897 - Completed - United States, Illinois ... More >> University of Illinois, Urbana-Champaign Urbana, Illinois, United States, 61801 Less <<
NCT01245010 Metabolic Syndrome Not Applicable Completed - Mexico ... More >> National Institute of Public Health Cuernavaca, Morelos, Mexico, 62100 Less <<
NCT02397265 Type 1 Diabetes Not Applicable Suspended(Awaiting further fun... More >>ding) Less << December 2016 United Kingdom ... More >> Imperial College London, United Kingdom Less <<
NCT00131664 - Completed - -
NCT02411825 Type 2 Diabetes Mellitus Phase 1 Completed - Germany ... More >> Investigational Site Number 276001 Berlin, Germany, 10117 Less <<
NCT02053532 - Completed - United States, New York ... More >> NYU School of Medicine New York, New York, United States, 10016 Less <<
NCT01733758 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT02202902 Endocrine System Disease ... More >> Cardiovascular Imaging Less << Not Applicable Unknown December 2017 France ... More >> AP-HP, Bicêtre Hospital Recruiting Le Kremlin-Bicêtre, France, 94275 Contact: Peter KAMENICKY, MD    +33 (0)1 45 21 37 06    peter.kamenicky@bct.aphp.fr Less <<
NCT01733758 - Completed - -
NCT01008163 Diabetes Phase 2 Completed - Korea, Republic of ... More >> Seoul National University Bundang Hospital Seongnam, 300 Gumi-Dong, Bungdang-Gu, Korea, Republic of, 463-707 Less <<
NCT01046110 - Completed - -
NCT01068665 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT03388723 - Recruiting January 31, 2019 India ... More >> KEM Hospital Recruiting Pune, Maharashtra, India, 411011 Contact: Chittaranjan Yajnik, MD FRCP    0091-020-26061958    csyajnik@gmail.com Less <<
NCT01046110 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT01068665 - Completed - -
NCT02981927 Metabolic Responses to Inactiv... More >>ity Less << Not Applicable Completed - United Kingdom ... More >> Sport & Health Sciences Exeter, Devon, United Kingdom, EX1 2LU Less <<
NCT02099110 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT01064414 Diabetes Mellitus, Type 2 ... More >> Renal Insufficiency Less << Phase 3 Completed - -
NCT02099110 - Completed - -
NCT03659695 Cardiovascular Risk Factor Not Applicable Not yet recruiting August 1, 2020 -
NCT03474939 Preanesthetic Medication ... More >> Copeptin Less << Phase 4 Recruiting May 31, 2018 Poland ... More >> I Department of Anesthesiology and Intensive Care Medical University of Warsaw Recruiting Warsaw, Mazowieckie, Poland, 02-005 Contact: Marek Janiak, MD    0048225021724    klinanest1@wum.edu.pl    Principal Investigator: Maryla Śmietanowska, MD          Sub-Investigator: Rafał Kowalczyk, MD          Sub-Investigator: Marek Janiak, MD Less <<
NCT01064414 - Completed - -
NCT01627184 - Completed - United States, Georgia ... More >> Atlanta Diabetes Association Atlanta, Georgia, United States, 30309 Less <<
NCT02282423 Diabetes Obes... More >>ity Less << Not Applicable Terminated(PI job change) - United States, Arizona ... More >> Mayo Clinic Scottsdale, Arizona, United States, 85259 Less <<
NCT00885352 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT00885352 - Completed - -
NCT01644500 Type 2 Diabetes Mellitus Phase 3 Completed - China ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Beijing, China, 100088 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Changsha, China, 410011 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chengdu, China, 610041 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chongqing, China For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Guang Zhou, China, 510120 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Guiyang, China, 550004 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hangzhou, China, 310009 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Harbin, China, 150001 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hefei, China, 230022 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Huai'An, China, 223300 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Jinan, China, 250001 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nanjing, China, 210029 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nanning, China, 530007 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Qingdao, China, 266003 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Shanghai, China, 200040 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Shenyang, China, 110004 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Shijiazhuang, China, 050000 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Wu Han, China, 430022 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Wuxi, China, 214023 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Xi'An, China, 710032 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Xiamen, China, 361003 Korea, Republic of For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Gangwon-Do, Korea, Republic of, 200-722 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Jeju Special Self-Governing Pr, Korea, Republic of, 690-767 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Seoul, Korea, Republic of, 134-090 Taiwan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Changhua, Taiwan, 500 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Jhonghe City, Taiwan, 235 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kaohsiung, Taiwan, 824 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Niao Sung Hsiang, Taiwan, 833 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sindian City, Taiwan, 23148 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Yong Kung City, Taiwan, 71004 Less <<
NCT00545584 Diabetes Mellitus, Non-Insulin... More >>-Dependent Less << Phase 3 Completed - -
NCT00545584 - Completed - -
NCT00837577 - Completed - -
NCT00970593 Diabetes Mellitus Phase 1 Completed - United States, California ... More >> Pfizer Investigational Site Chula Vista, California, United States, 91911 United States, Florida Pfizer Investigational Site Miami Gardens, Florida, United States, 33169 Less <<
NCT03596788 Anomalies Gastrointestinal Not Applicable Not yet recruiting May 2019 -
NCT03075943 PreDiabetes I... More >>nsulin Resistance Less << Not Applicable Recruiting December 2019 Canada ... More >> Institute of Nutrition and Functional Foods (INAF), Laval University Recruiting Quebec, Canada, G1V 0A6 Contact: Julie Marois    418-656-2131 ext 5467    julie.marois@fsaa.ulaval.ca    Principal Investigator: Helene Jacques, Ph.D Dt.P. Less <<
NCT03490851 Satiety Not Applicable Completed - Canada ... More >> Glycemic Index Laboratories Toronto, Canada Less <<
NCT03563794 T2DM Phase 4 Recruiting December 10, 2019 China, Fujian ... More >> The first afilliated hospital of Xiamen university Recruiting Xiamen, Fujian, China, 361003 Contact: Xue-jun Li, MD,PHD    13860451316    lixuejue99@yahoo.com.cn    Principal Investigator: Xue-jun Li, MD,PhD Less <<
NCT03607799 Diabetes, Gestational Not Applicable Not yet recruiting December 31, 2022 Canada, Ontario ... More >> McMaster University Hamilton, Ontario, Canada, L8S4K1 Less <<
NCT03473145 Sedentary Lifestyle Not Applicable Recruiting May 31, 2022 United States, California ... More >> UC San Diego Recruiting La Jolla, California, United States, 92093 Contact: Brittany Lewars    858-534-9333    blewars@ucsd.edu    Contact: Lindsay Dillon    8585349333    ldillon@ucsd.edu Less <<
NCT00837577 Diabetes Mellitus, Non-Insulin... More >>-Dependent Less << Phase 3 Completed - -
NCT01076088 - Completed - -
NCT01985711 Diabetes Mellitus, Type 2 ... More >> Depression Less << Not Applicable Unknown April 2017 China, Beijing ... More >> Beijing Anzhen Hospital Not yet recruiting Beijing, Beijing, China, 010 Sub-Investigator: Huang Zhenru Less <<
NCT01076088 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT03490942 Hypoglycemia Unawareness ... More >> Diabetes Mellitus, Type 1 Less << Phase 2 Recruiting September 30, 2019 United States, Alabama ... More >> University of Alabama, Birmingham Recruiting Birmingham, Alabama, United States, 35294 Contact: Tammy Perkins    205-934-4112    tlperkins@uabmc.edu    Contact: Fernando Ovalle, MD       fovalle@uabmc.edu    Principal Investigator: Fernando Ovalle, MD          United States, California University of California, San Diego Recruiting San Diego, California, United States, 92037 Contact: Adrienne Armstrong    858-246-2151    a3armstrong@ucsd.edu    Principal Investigator: Robert Henry, MD          VA San Diego Healthcare System Recruiting San Diego, California, United States, 92161 Contact: Debra Armstrong    858-646-7329    debra.armstrong@va.gov    Principal Investigator: Robert Henry, MD          United States, Georgia Emory University - Grady Memorial Hospital Recruiting Atlanta, Georgia, United States, 30303 Contact: Saumeth Cardona    404-251-8957    emily.k.tamponi@emory.edu    Principal Investigator: Guillermo Umpierrez, MD          Atlanta Diabetes Associates Recruiting Atlanta, Georgia, United States, 30318 Contact: Betsy Childs       BChilds@atlantadiabetes.com    Principal Investigator: Bruce Bode, MD          United States, Pennsylvania University of Pennsylvania Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Cornelia Dalton-Bakes    215-746-2085    Cornelia.dalton-bakes@uphs.upenn.edu    Principal Investigator: Michael Rickels, MD Less <<
NCT01649297 Diabetes Mellitus, Type 2 Phase 2 Completed - -
NCT00097292 - Recruiting July 2019 -
NCT01644500 - Completed - -
NCT02433873 Microbiota Not Applicable Completed - United States, Virginia ... More >> George Mason University Fairfax, Virginia, United States, 22030 Less <<
NCT02602301 Neonatal Hyperbilirubinemia Phase 4 Unknown March 2016 -
NCT00576368 Diabetes Mellitus Phase 4 Completed - Belgium ... More >> Sanofi-Aventis Brussels, Belgium Less <<
NCT02302599 Type II Diabetes Phase 1 Unknown December 2015 China, Beijing ... More >> Chinese PLA General Hospital Recruiting Beijing, Beijing, China, 100039 Contact: Haojie HAO    +86(10)937516    haojieh@163.com Less <<
NCT01778049 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT01778049 - Completed - -
NCT01649297 - Completed - -
NCT02561078 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT01340924 - Active, not recruiting December 2017 Canada ... More >> Laval University, Institute of Nutraceuticals and Functional Foods Quebec, Canada, G1V 0A6 Less <<
NCT00136916 Diabetes Mellitus Phase 3 Terminated(See termination rea... More >>son in detailed description.) Less << - -
NCT02901860 - Completed - -
NCT02772718 Hypoglycemia Phase 2 Recruiting October 2017 United States, Colorado ... More >> Recruiting Aurora, Colorado, United States United States, Illinois Not yet recruiting Chicago, Illinois, United States United States, Maryland Recruiting Baltimore, Maryland, United States United States, Massachusetts Recruiting Boston, Massachusetts, United States United States, Minnesota Recruiting Rochester, Minnesota, United States Less <<
NCT02639130 Type 2 Diabetes Phase 4 Completed - Germany ... More >> Diabeteszentrum Bad Lauterberg Bad Lauterberg, Niedersachsen, Germany, 37431 Less <<
NCT02219126 Unidentified Stomach Discomfor... More >>t Following Dairy Consumption Less << Not Applicable Completed - Finland ... More >> Department of Biochemistry University of Turku Turku, Finland, 20014 Less <<
NCT03286205 Anemia, Iron Deficiency Phase 4 Recruiting April 14, 2019 United States, California ... More >> Sutter Gould Medical Foundation Recruiting Modesto, California, United States, 95355 Contact: Kristen Moorman, BA    209-521-6097    MoormaK@sutterhealth.org Less <<
NCT00223574 Type 2 Diabetes Not Applicable Completed - Canada, Alberta ... More >> Clinical Trials Centre Edmonton, Alberta, Canada, T6G 2C8 Canada, Ontario St. Joseph's Health Centre London, Ontario, Canada, N6G 2M3 St. Michael's Hosptial Toronto, Ontario, Canada, M5B 1W8 Canada, Quebec Hotel Dieu Montreal, Quebec, Canada, H2W 1T8 Centre Universitaire de Sante de l'estrie Sherbrooke, Quebec, Canada, J1H 5N4 Less <<
NCT03612336 Smoking Cessation ... More >> Cardiovascular Diseases Less << Not Applicable Recruiting June 2020 Switzerland ... More >> Policlinique Médicale Universitaire, Université de Lausanne Not yet recruiting Lausanne, Vaud, Switzerland, 1011 Contact: Jacques Cornuz, Prof.Dr.med       Jacques.Cornuz@chuv.ch    University Clinic for General Internal Medicine, Bern University Hospital Recruiting Bern, Switzerland, 3010 Contact: Nicolas Rodondi, Prof.Dr.med       Nicolas.Rodondi@insel.ch    Département de médecine interne, Hôpitaux universitaires de Genève Not yet recruiting Geneva, Switzerland, 1211 Contact: Jean-Paul Humair, PD Dr.med.       Jean-Paul.Humair@hcuge.ch Less <<
NCT00136916 - Terminated(See termination rea... More >>son in detailed description.) Less << - -
NCT00277732 Diabetes Mellitus Not Applicable Completed - Belgium ... More >> University Hospital Ghent Ghent, Belgium, 9000 Less <<
NCT02610738 Type 1 Diabetes Not Applicable Unknown November 2015 United Kingdom ... More >> Sheffield Children's NHS Foundation Trust Sheffield, Sheffield (South Yorkshire district), United Kingdom, S10 2TH Less <<
NCT03549390 Type 2 Diabetes Mellitus Not Applicable Not yet recruiting September 2019 United Kingdom ... More >> Leicester Diabetes Centre Not yet recruiting Leicester, Leicestershire, United Kingdom, LE5 4PW Contact: Thomas Yates, PhD          Contact: Cameron Razieh, MSc Less <<
NCT00101673 Diabetes Mellitus, Type 2 Phase 3 Completed - Switzerland ... More >> Novartis Pharmaceuticals Basel, Switzerland Less <<
NCT01047735 Type 2 Diabetes Mellitus ... More >> Obesity Less << Not Applicable Active, not recruiting February 2019 United States, Pennsylvania ... More >> Magee-Womens Hospital of UPMC Pittsburgh, Pennsylvania, United States, 15213 Less <<
NCT03330730 Neoplasms Not Applicable Recruiting December 15, 2019 France ... More >> Centre Léon Bérard Recruiting Lyon, Rhône-Alpes, France, 69008 Contact: Isabelle RAY-COQUARD, MD       isabelle.ray-coquard@lyon.unicancer.fr    Institut Daniel Hollard Recruiting Grenoble, France Contact: Claire GARNIER-TIXIDRE, MD       c.garnier-tixidre@ghm-grenoble.fr Less <<
NCT00174642 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT02472561 Peripheral Artery Disease Not Applicable Completed - United States, North Carolina ... More >> Duke University Medical Center Durham, North Carolina, United States, 27705 Less <<
NCT03521362 Type1diabetes Phase 1 Not yet recruiting December 2022 -
NCT02650674 Metabolic Disorder Not Applicable Completed - Australia, New South Wales ... More >> University of Sydney Sydney, New South Wales, Australia, 2006 Less <<
NCT00986349 - Completed - -
NCT03573063 PCOS Disease Not Applicable Recruiting May 31, 2019 Switzerland ... More >> Benjamin P. Magyar Recruiting Aarau, Switzerland, 500 Contact: Benjamin Magyar    0798460923    benjamin.magyar@students.unibe.ch Less <<
NCT00525330 Type 2 Diabetes Phase 2 Completed - United States, California ... More >> San Diego, California, United States Less <<
NCT00753766 Diabetes Mellitus ... More >> Surgical Procedure, Unspecified Less << Not Applicable Completed - -
NCT02031341 - Completed - Netherlands ... More >> Kennemer Gasthuis Haarlem, Netherlands, 2023 KT Less <<
NCT00753766 - Completed - -
NCT01128894 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT00986349 Type 2 Diabetes Not Applicable Completed - Brazil ... More >> Hospital Alemão Oswaldo Cruz Sao Paulo, Brazil, CEP 01323-903 Less <<
NCT00330330 Type 2 Diabetes Mellitus Phase 2 Completed - Poland ... More >> NZOZ Specjalistyczny Osrodek Internistyczno Diabetologiczny Bialystok, Poland, 15-435 Prywatna Praktyka Lekarska Radom, Poland, 26-600 Oddzial Chorob Wewnetrznych ze Stacja Dializ Szpital w Wolominie Wolomin, Poland, 05-200 Russian Federation Chair of Endocrinology and Diabetology of the Faculty of Advenced Training for Physicians Moscow, Russian Federation, 109125 Endocrinology Scientific Centre of RAMS Moscow, Russian Federation, 117036 Medical Institution "Polyclinic OAOA Gazprom" Moscow, Russian Federation, 117420 Close Corporation "MEDSI" Moscow, Russian Federation, 123056 Chair of Endocrinology and Diabetology Central Clinical Hospital of the Ministry of Communications of RF Moscow, Russian Federation, 125315 Moscow Regional Scientific-Research Clinical Institute named after I.F. Vladimirsky Moscow, Russian Federation, 129110 Clinic of Therapy of Postgraduate Education named after N.S. Molchanov St. Petersburg, Russian Federation, 198013 Less <<
NCT02693392 Type-2 Diabetes Mellitus Not Applicable Completed - India ... More >> Department of Medicine and Department of Pharmacology, AIIMS Bhubaneswar, Odisha, India, 751019 Less <<
NCT00110240 Diabetes Mellitus, Type 2 Phase 3 Completed - Switzerland ... More >> Novartis Pharmaceuticals Basel, Switzerland Less <<
NCT00225277 Diabetes Mellitus Phase 3 Completed - -
NCT01128894 - Completed - -
NCT00225277 - Completed - -
NCT00929838 Diabetes Mellitus, Type 2 ... More >> Diabetes Mellitus, Adult-Onset Diabetes Mellitus, Non-Insulin-Dependent Diabetes Mellitus, Noninsulin Dependent Diabetes Mellitus, Type II Less << Not Applicable Unknown June 2016 United States, South Carolina ... More >> Medical University of South Carolina Charleston, South Carolina, United States, 29425 Less <<
NCT02497313 Diabetes Mellitus, Type 2 Not Applicable Completed - Denmark ... More >> Center for Diabetes Research, Herlev-Gentofte Hospital Hellerup, Denmark, 2900 Less <<
NCT02826525 T2DM With NAFLD Phase 1 Phase 2 Active, not recruiting December 28, 2020 -
NCT02059187 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT02905760 Acute Myocardial Infarction Wi... More >>th Right Ventricular Extension Less << Phase 3 Not yet recruiting January 2019 France ... More >> Henri Mondor Hospital Not yet recruiting Creteil, France, 94010 Less <<
NCT01855399 Diabetes Not Applicable Completed - United States, Michigan ... More >> VA Ann Arbor Healthcare System, Ann Arbor, MI Ann Arbor, Michigan, United States, 48105 John D. Dingell VA Medical Center, Detroit, MI Detroit, Michigan, United States, 48201 Less <<
NCT00681161 Obstructive Sleep Apnea Not Applicable Completed - United States, Tennessee ... More >> Vanderbilt University Nashville, Tennessee, United States, 37232 Less <<
NCT02053051 Type 1 Diabetes Not Applicable Suspended August 2019 United Kingdom ... More >> Imperial College London, Imperial College Healthcare NHS Trust London, United Kingdom, W2 1PG Less <<
NCT01989637 Cardiovascular Disease Not Applicable Completed - United States, Pennsylvania ... More >> Penn State University University Park, Pennsylvania, United States, 16801 Less <<
NCT02059187 - Completed - -
NCT01514838 Type II Diabetes Mellitus Phase 3 Terminated(Discontinued due to... More >> company's strategic reason) Less << - Korea, Republic of ... More >> Busan, Korea, Republic of Daegu, Korea, Republic of Daejeon, Korea, Republic of Gwangju, Korea, Republic of Incheon, Korea, Republic of Seongnam, Korea, Republic of Seoul, Korea, Republic of Wonju, Korea, Republic of Taiwan Changha, Taiwan Chiayi, Taiwan Kaohsiung, Taiwan Taichung, Taiwan Tainan, Taiwan Taipei, Taiwan Taoyuan, Taiwan Less <<
NCT02152371 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT02152371 - Completed - -
NCT00663260 Diabetes Mellitus, Type 2 Phase 2 Phase 3 Completed - -
NCT01059799 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT00663260 - Completed - -
NCT00971997 Diabetes Mellitus, Type 2 Phase 4 Completed - Japan ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Aichi, Japan, 455-8530 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chiba, Japan, 277-0832 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fukuoka, Japan, 807-0856 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hiroshima, Japan, 738-8503 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hokkaido, Japan, 051-8501 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hyogo, Japan, 658-0064 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ibaraki, Japan, 300-1207 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kanagawa, Japan, 236-0016 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kumamoto, Japan, 862-0976 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Osaka, Japan, 590-0079 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Saitama, Japan, 340-0203 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sendai, Japan, 983-0835 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tokyo, Japan, 166-0004 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Yamanashi, Japan, 405-0072 Less <<
NCT03060824 - Completed - Sweden ... More >> Heart Centre, Umeå University Hospital Umeå, Sweden, SE 901 85 Less <<
NCT00387972 Type 2 Diabetes Mellitus Phase 2 Phase 3 Withdrawn(Study cancelled befo... More >>re enrollment) Less << October 2007 -
NCT01059799 - Completed - -
NCT02622295 Spinal Cord Injuries Not Applicable Recruiting January 2020 United States, Iowa ... More >> University of Iowa Recruiting Iowa City, Iowa, United States, 52242 Less <<
NCT02017366 Esophageal Cancer Not Applicable Unknown December 2017 Belgium ... More >> University hospital Leuven Enrolling by invitation Leuven, Vl-Brabant, Belgium, 3000 Less <<
NCT00102388 Diabetes Mellitus, Type 2 Phase 3 Completed - Germany ... More >> Novartis Investigative Site Investigative Centers, Germany Switzerland Novartis Pharmaceuticals Basel, Switzerland Less <<
NCT01350518 Obesity Not Applicable Completed - United States, North Carolina ... More >> Wake Forest University Clinical Research Unit Winston-Salem, North Carolina, United States, 27157 Less <<
NCT00971997 - Completed - -
NCT01336738 Diabetes, Type 2 Phase 2 Completed - -
NCT01804413 Adults Growth Hormone Deficien... More >>cy. Less << Not Applicable Unknown December 2013 United States, Oregon ... More >> Oregon Health & Science University Recruiting Portland, Oregon, United States, 97239 Contact: Kevin C.J. Yuen, MRCP(UK),MD    503 4940175    yuenk@ohsu.edu    Contact: Sharon A. Rhoads, RN    503 4949197    rhoadss@ohsu.edu    Sub-Investigator: David M. Cook, MD Less <<
NCT01336738 - Completed - -
NCT02330939 Type 1 Diabetes Not Applicable Unknown - Italy ... More >> Department of Clinical Medicine and Surgery Naples, Italy, 80131 Less <<
NCT03047655 Metabolic Syndrome ... More >> NAFLD Obesity Hypertension Less << Not Applicable Recruiting December 2017 Germany ... More >> German Institut for Human Nutrition; Department for Clinical Nutrition Not yet recruiting Nuthetal, Brandenburg, Germany, 14458 Contact: Margrit Kemper, Dr. med.    033200 88 2775    margrit.kemper@dife.de    Contact: Silke Hornemann    033200 88 2779    silke.hornemann@dife.de    Sub-Investigator: Margrit Kemper, Dr. med.          Sub-Investigator: Silke Hornemann          Sub-Investigator: Christiana Gerbracht, Dr.          DIfE (German Institute for Human Nutrition) Recruiting Berlin, Germany, 12203 Contact: Stefan Kabisch, Dr. med.    030 450 514 429    stefan.kabisch@dife.de Less <<
NCT02388672 Blood Pressure Not Applicable Withdrawn(Personnel changes) - -
NCT01338870 Diabetes Mellitus, Type 2 Phase 2 Completed - -
NCT01338870 - Completed - -
NCT02131246 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 1 Completed - Austria ... More >> Novo Nordisk Investigational Site Graz, Austria, 8010 Less <<
NCT01371643 - Completed - -
NCT01371643 Pituitary Adenoma Phase 4 Completed - United States, New York ... More >> New York University School of Medicine New York, New York, United States, 10016 Less <<
NCT01380873 Diabetes Mellitus Phase 1 Completed - -
NCT00677937 Type 2 Diabetes Mellitus Not Applicable Completed - United Kingdom ... More >> University Hospitals of Leicester Leicester, Leicestershire, United Kingdom, LE1 5WW Less <<
NCT02751866 Overweight, Obesity and Other ... More >>Hyperalimentation (E65-E68) Less << Not Applicable Recruiting January 2020 United States, Ohio ... More >> Dept of Psychiatry & Behavioral Neuroscience, UC Academic Health Center Recruiting Cincinnati, Ohio, United States, 45267-0559 Contact: Marcelle Shidler, MA    513-558-2455    marcelle.shidler@uc.edu Less <<
NCT01676220 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT01676220 - Completed - -
NCT02477969 Type 2 Diabetes Mellitus Phase 3 Unknown June 2017 China, Shanghai ... More >> Shanghai sixth People's Hospital Shanghai, Shanghai, China, 200233 Less <<
NCT00888732 Diabetes Mellitus, Type 1 Phase 3 Completed - Denmark ... More >> Dept of Medicine M, Aarhus University Hospital Aarhus, Denmark, 8000 Less <<
NCT00437398 - Terminated(The study was termi... More >>nated early due to difficulty in recruiting subjects, and ran short of funds.) Less << - -
NCT00437398 Type 1 Diabetes Mellitus Phase 1 Phase 2 Terminated(The study was termi... More >>nated early due to difficulty in recruiting subjects, and ran short of funds.) Less << - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT02113995 To Evaluate Clinical Results, ... More >>Insulin Resistance and Inflammatory Response to Trauma in Morbidly Obese Patients Less << Not Applicable Completed - Brazil ... More >> ACERTO protocol Cuiaba, MT, Brazil, 78000000 Less <<
NCT01698008 - Completed - -
NCT01698008 Diabetes Mellitus Not Applicable Completed - United States, Nebraska ... More >> The University of Nebraska Medical Center Omaha, Nebraska, United States, 68198 Less <<
NCT02472717 Psoriatic Arthritis ... More >> Psoriasis Impaired Glucose Tolerance Type 2 Diabetes Less << Phase 2 Withdrawn - Canada, Ontario ... More >> Toronto Western Hospital, The Centre for Prognosis Studies in the Rheumatic Diseases (CPSRD), University of Toronto Toronto, Ontario, Canada, M5T 2S8 Less <<
NCT01191268 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT02941172 Obesity Not Applicable Active, not recruiting December 30, 2017 Finland ... More >> Turku PET Centre (Turku University Hospital) Turku, Finland, 20521 Less <<
NCT02240680 - Completed - -
NCT00849017 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT03257059 Glycemic Response Not Applicable Recruiting July 2020 Singapore ... More >> Clinical Nutrition Research Centre Recruiting Singapore, Singapore, 117599 Contact: JeyaKumar Christiani Henry, Phd    6407 0793    jeya_henry@sics.a-star.edu.sg    Contact: Phei Ching Siow, Bsc    6407 4380    Siow_Phei_Ching@sics.a-star.edu.sg Less <<
NCT01191268 - Completed - -
NCT01238380 - Completed - United Kingdom ... More >> Peninsula NIHR Clinical Research Facility, Peninsula Medical School, Barrack Rd, Exeter, Devon, United Kingdom, EX2 5DW Peninsula College of Medicine & Dentistry, University of Plymouth, John Bull Building, Tamar Science Park, Plymouth, Devon, United Kingdom, PL6 8BU Biomedical Research Institute, University of Dundee, Dundee, United Kingdom, DD1 9SY Less <<
NCT01373060 Healthy Pharm... More >>acokinetics of ASP1941 Less << Phase 1 Completed - Taiwan ... More >> Taipei, Taiwan Less <<
NCT02240680 Diabetes Mellitus, Type 2 Phase 4 Completed - -
NCT00654667 Insulin Resistance Phase 2 Withdrawn(no participant enrol... More >>lment) Less << - United States, California ... More >> University of California San Francisco, California, United States, 94143-0608 Less <<
NCT01858506 Type 2 Diabetes Mellitus Not Applicable Completed - Israel ... More >> Clalit Health Services, Shomron administration Hadera, Israel Less <<
NCT02582567 Pregnancy Not Applicable Unknown July 2017 Spain ... More >> Pilar Cabello-Turmo Granada, Spain, 18071 Less <<
NCT01162772 - Unknown - Austria ... More >> Medical University of Viemma Recruiting Vienna, Austria, 1090 Contact: Jeanette Strametz-Juranek, MD    0043140400 ext 4618    jeanette.strametz-juranek@meduniwien.ac.at    Contact: Alexandra Kautzky-Willer, MD    0140400 ext 4316    alexandra.kautzky-willer@meduniwien.ac.at    Principal Investigator: Jeanette Strametz-Juranek, MD          Principal Investigator: Alexandra Kautzky-Willer, MD          Sub-Investigator: Alia Sabri, MD          Sub-Investigator: Lana Kosi, MD Less <<
NCT02605655 Metabolic Syndrome X Early Phase 1 Completed - -
NCT00537303 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 4 Completed - -
NCT01591525 - Unknown January 2013 United States, Massachusetts ... More >> Lower Mills Not yet recruiting Dorchester, Massachusetts, United States, 02124 Contact: Kelly Lamb, MA    617-947-9095       Principal Investigator: James Morgan, MD          Sub-Investigator: Jean Bonnet, MD Less <<
NCT00537303 - Completed - -
NCT02744131 Polycystic Ovary Syndrome Not Applicable Recruiting December 2019 India ... More >> KAR clinic and hospital pvt ltd Recruiting Bhubaneswar, Odisha, India, 751001 Contact: Sujata Kar, M.D    +919437824163    suju2463@gmail.com    Contact: Suneeta Panigrahi, B.A       womenwing@karhospitals.com Less <<
NCT02973100 - Completed - -
NCT01222845 Postprandial Glycaemia, ... More >> Postprandial Insulinaemia Appetite Less << Not Applicable Completed - United Kingdom ... More >> Brain, Performance and Nutrition Centre, Northumbria University Newcastle Upon Tyne, Tyne and Wear, United Kingdom, NE1 8ST Less <<
NCT03098446 Atherosclerosis ... More >> Metabolic Syndrome Less << Not Applicable Completed - United States, Texas ... More >> University of Texas at Austin Human Performance Laboratory Austin, Texas, United States, 78712 Less <<
NCT01396941 Insulin Resistance Not Applicable Unknown December 2014 United States, California ... More >> UCSF San Francisco General Hospital Recruiting San Francisco, California, United States, 94110 Contact: Madhu N. Rao, MD    415-206-6381    madhu.rao@ucsf.edu    Principal Investigator: Madhu N. Rao, MD Less <<
NCT00940472 Diabetes Type 2 Phase 2 Phase 3 Completed - Mexico ... More >> Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara Guadalajara, Jal, Mexico, 44340 Less <<
NCT02114892 Metabolic Syndrome X Phase 2 Completed - Mexico ... More >> Intstituto de Terapeútica Experimental y Clínica. Centro Universitario de Ciencias de la Salud. Universidad de Guadalajara Guadalajara, Jalisco, Mexico, 45037 Less <<
NCT02049814 Type 2 Diabetes Mellitus Phase 4 Completed - China, Anhui ... More >> Hefei, Anhui, China Maanshan, Anhui, China China, Beijing Beijing, Beijing, China China, Guangdong Guangzhou, Guangdong, China Shenzhen, Guangdong, China Taishan, Guangdong, China China, Hunan Zhuzhou, Hunan, China China, Jiangsu Nanjing, Jiangsu, China Xuzhou, Jiangsu, China China, Jilin Changchun, Jilin, China Jilin, Jilin, China China, Liaoning Shenyang, Liaoning, China China, Shandong Qingdao, Shandong, China China, Shanghai Shanghai, Shanghai, China China, Shanxi Yan An, Shanxi, China Yanan, Shanxi, China China, Tianjin Tianjin, Tianjin, China China, Zhejiang Wenzhou, Zhejiang, China Less <<
NCT02855684 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT02973100 Type 2 Diabetes Phase 2 Completed - -
NCT02977884 Cardiovascular Diseases ... More >> Diabetes Mellitus Hypertension Dyslipidemias Overweight and Obesity Less << Not Applicable Recruiting December 2020 United States, Ohio ... More >> Ohio University Recruiting Athens, Ohio, United States, 45701 Contact: David S Drozek, DO    678-447-2509    drozek@ohio.edu    Contact: Laura Jensen, MPH    740-593-1136    jensenl@ohio.edu    Principal Investigator: David S Drozek, DO Less <<
NCT01473446 Postoperative Complications Not Applicable Terminated(High exclusion rate... More >>) Less << - Finland ... More >> Oulu University Hospital, Department of Anesthesia and Intensive Care Oulu, Finland, 90029 Norway Haukeland University Hospital Bergen, Norway, 5021 Stavanger Universityhospital, Division for medical service, anesthesia and intensive care Stavanger, Norway, 4011 Less <<
NCT02816411 Skeletal Muscle Damage ... More >> Exercise-induced Aseptic Inflammation Skeletal Muscle Performance Intracellular Signaling in Skeletal Muscle Proteasome Activation Less << Not Applicable Completed - Greece ... More >> Exercise Biochemistry Laboratory, School of Physical Education & Sports Sciences, University of Thessaly Karies, Trikala, Greece, 42100 Less <<
NCT03352063 Atherosclerosis ... More >> Metabolic Syndrome Less << Not Applicable Recruiting December 30, 2018 United States, Texas ... More >> University of Texas at Austin Human Performance Laboratory Recruiting Austin, Texas, United States, 78712 Contact: Ed Coyle, PhD    512-471-8596    coyle@austin.utexas.edu Less <<
NCT03469869 Obesity Insul... More >>in Resistance Inflammation Blood Glucose, High Less << Not Applicable Recruiting October 31, 2018 Indonesia ... More >> University of Indonesia Recruiting Depok, West Java, Indonesia, 16424 Contact: Melyarna Putri, MD    +6281949322771    melyarna.putri@gmail.com    Contact: Meriza Martineta, MD    +628192002120    merizamartineta@gmail.com Less <<
NCT00755833 - Completed - Slovenia ... More >> Novo Nordisk Investigational Site Ljubljana, Slovenia, SI-1000 Less <<
NCT00909051 - Completed - Algeria ... More >> Many Locations, Algeria Bosnia and Herzegovina Many Locations, Bosnia and Herzegovina Cambodia Many Locations, Cambodia China Many Locations, China Hong Kong Many Locations, Hong Kong India Many Locations, India Indonesia Many Locations, Indonesia Korea, Republic of Many Locations, Korea, Republic of Malaysia Many Locations, Malaysia Moldova, Republic of Many Locations, Moldova, Republic of Pakistan Many Locations, Pakistan Philippines Many Locations, Philippines Russian Federation Many Locations, Russian Federation Singapore Many Locations, Singapore Thailand Many Locations, Thailand Vietnam Many Locations, Vietnam Less <<
NCT02617654 Type 1 Diabetes Phase 2 Recruiting September 2019 Sweden ... More >> Uppsala University Hospital Recruiting Uppsala, Sweden, SE-75185 Contact: Tomas Skommevik, MD    +46 18 611 0000    tomas.skommevik@akademiska.se Less <<
NCT01011062 Insulin Resistance ... More >> Type 2 Diabetes Less << Not Applicable Completed - Czech Republic ... More >> Diabetes Center, Institute of Clinical and Experimental Medicine Prague, Czech Republic, 14021 Less <<
NCT00139659 Asthma Diabet... More >>es Mellitus Less << Phase 3 Completed - -
NCT02114892 - Completed - -
NCT01523457 Metastatic Pancreatic Cancer ... More >> Pancreatic Cancer Less << Phase 2 Completed - United States, Connecticut ... More >> Smilow Cancer Center New Haven, Connecticut, United States, 06510 Less <<
NCT03418974 Dyslipidemias Phase 4 Active, not recruiting December 31, 2021 China, Beijing ... More >> Heart Center of Peking University People's Hospital Beijing, Beijing, China, 100044 China, Shanghai School of Public Health, Fudan University Shanghai, Shanghai, China, 200032 Less <<
NCT01890811 Chronic Kidney Failure Not Applicable Withdrawn(Recruitment challeng... More >>es) Less << December 2016 United States, Texas ... More >> Texas A&M University College Station, Texas, United States, 77843 Less <<
NCT02554877 Type 2 Diabetes Mellitus Phase 2 Completed - -
NCT03049228 - Enrolling by invitation April 2, 2019 Netherlands ... More >> Human Biology Maastricht, Limburg, Netherlands, 6200MD Less <<
NCT01523457 - Completed - -
NCT01472614 Type-2 Diabetes Mellitus Phase 3 Completed - Indonesia ... More >> Private Clinic at Jl. Prof. Dr. Moestopo 164 Surabaya, East Java, Indonesia Surabaya Diabetes and Nutrition Centre, Dr. Soetomo Hospital Surabaya, East Java, Indonesia Less <<
NCT00139659 - Completed - -
NCT02052037 Type 2 Diabetes Not Applicable Completed - United States, Connecticut ... More >> Yale-Griffin Prevention Research Center Derby, Connecticut, United States, 06418 Less <<
NCT02133118 - Completed - Netherlands ... More >> Isala Zwolle, Overijssel, Netherlands, 8000 AB Less <<
NCT03191227 - Completed - -
NCT01144975 Type 2 Diabetes Mellitus Phase 2 Completed - Mexico ... More >> Mexico City, Mexico Less <<
NCT02140203 Metabolic Syndrome Not Applicable Completed - China ... More >> The Hong Kong Polytechnic University Hong Kong, China, 852 Less <<
NCT02039141 Obesity Insul... More >>in Resistance Diabetes Less << Not Applicable Unknown July 2017 United States, Arizona ... More >> Arizona State University Phoenix, Arizona, United States, 85003 Less <<
NCT01530035 Adaptation Reaction Not Applicable Completed - Denmark ... More >> Institute of exercise and sports sciences, university of Copenhagen Copenhagen, Denmark, 2100 Less <<
NCT00579813 Metabolic Syndrome ... More >> Insulin Resistance Prediabetes Less << Phase 4 Completed - United States, Arkansas ... More >> University of Arkansas for Medical Sciences Little Rock, Arkansas, United States, 72205 United States, Kentucky University of Kentucky Lexington, Kentucky, United States, 40536 Less <<
NCT02554877 - Completed - -
NCT00579813 - Completed - -
NCT02882685 Morbid Obesity Not Applicable Recruiting December 2026 Finland ... More >> Helsinki University Central Hospital Recruiting Helsinki, Finland, 00029 Contact: Tuure T Saarinen, MD    +358503631709    tuure.saarinen@hus.fi    Contact: Anne T Juuti, MD PhD    +358 9 4711    anne.juuti@hus.fi    Oulu University Hospital Recruiting Oulu, Finland Contact: Sanna Meriläinen, M.D.       sanna.merilainen@ppshp.fi    Contact: Vesa Koivukangas, M.D.       vesa.koivukangas@ppshp.fi    Principal Investigator: Sanna Meriläinen, M.D.          Principal Investigator: Vesa Koivukangas, M.D. Less <<
NCT01035879 Diabetes Phase 2 Completed - United States, California ... More >> Impact Clinical Trials Los Angeles, California, United States, 90036 United States, Nevada Nevada Alliance Against Diabetes Las Vegas, Nevada, United States, 89101 United States, New York United Medical Associates Binghamton, New York, United States, 13901 United States, Texas dgd Research, Inc., a Cetero Research Co. San Antonio, Texas, United States, 78229 Georgia Healthy Life Clinical Diagnostic Center Tbilisi, Georgia, 0144 Georgian Diabetes Center Tbilisi, Georgia, 0159 Medulla Chemotherapy and Immunotherapy Clinic Tbilisi, Georgia, 0186 India Bharti Research Institute of Diabetes and Endocrinology Karnal, Haryana, India, 132001 Diabetes Thyroid Hormone Research Institute Pvt Ltd Indore, M.p., India, 452001 Gandhi Endocrinology & Diabetes Centre Ramdaspeth, Nagpur, India, 10 Gokula Metropolis Research, MS Ramaiah Memorial Hospital Bangalore, India, 560 054 Medisys Clinisearch India Pvt Ltd Bangalore, India, 560043 Hormone Care Research Centre Ghaziabad, India, 201002 Bangalore Endocrinology & Diabetes Research Centre Malleshwaram, India, 560 003 Less <<
NCT03635567 Cervical Cancer Phase 3 Recruiting November 23, 2022 -
NCT00038727 - Active, not recruiting - -
NCT00569959 Diabetes Mellitus ... More >> Normal Glucose Metabolism Hyperlipidemia Less << Not Applicable Completed - United States, Minnesota ... More >> Park Nicollet Internal and Family Medicine Clinics Minneapolis, Minnesota, United States, 55416 Less <<
NCT03007329 Steatosis, Liver ... More >> Type2 Diabetes Less << Phase 4 Recruiting January 2019 Austria ... More >> Abt. für Endokrinologie & Stoffwechsel, Univ. Klin f. Innere Medizin III Recruiting Wien, Austria, 1090 Contact: Magdalena Bastian, BSc          Contact: Jürgen Harreiter, MD       juergen.harreiter@meduniwien.ac.at Less <<
NCT00086515 Diabetes Mellitus, Type II Phase 3 Completed - -
NCT01580319 Obesity Hyper... More >>cholesterolemia High Blood Pressure Sedentary Lifestyle Less << Not Applicable Terminated(Difficulty in selec... More >>ting the sample and follow-up lost.) Less << - Brazil ... More >> Instituto de Cardiologia / Fundação Universitária de Cardiologia Porto Alegre, Rio Grande do Sul, Brazil, 90620-001 Less <<
NCT00283218 Type 1 Diabetes Not Applicable Completed - Denmark ... More >> Dept of Medicine M, Aarhus University Hospital, Nørrebrogade 44 Aarhus, C, Denmark, 8000 Less <<
NCT00086515 - Completed - -
NCT01383889 Blood Pressure ... More >> Heart Rate and Rhythm Disorders Hypoglycemia Lactate Nitrate Cholesterol (Total and HDL) Abnormality in Fetal Heart Rate or Rhythm, Unspecified as to Episode of Care Less << Not Applicable Completed - Brazil ... More >> Instituto Paraibano de Pesquisa Prof. Joaquim Amorim Neto Campina Grande, Paraíba, Brazil, 58406120 Less <<
NCT00822367 Diabetes Mellitus Type 2 Not Applicable Completed - -
NCT03197220 Cardiovascular Risk Factor Not Applicable Completed - -
NCT00038727 Diabetes Mellitus ... More >> Cancer CVD Less << Phase 3 Active, not recruiting January 2025 United States, Maryland ... More >> George Washington University Rockville, Maryland, United States, 20852 Less <<
NCT02045290 Type 1 Diabetes Phase 3 Completed - United States, Florida ... More >> Jaeb Center for Health Research Tampa, Florida, United States, 33647 Less <<
NCT02015377 Overweight Ob... More >>esity Less << Not Applicable Completed - United States, California ... More >> University of Southern California Health Science Campus Los Angeles, California, United States, 90032 Less <<
NCT01235039 Diabetes Mellitus Phase 1 Phase 2 Completed - Germany ... More >> Profil Institut für Stoffwechselforschung GmbH Neuss, Germany, 41460 Less <<
NCT00138593 Diabetes Mellitus, Type 2 Phase 3 Completed - Switzerland ... More >> Novartis Pharmaceuticals Basel, Switzerland Less <<
NCT01188902 Healthy Not Applicable Completed - Germany ... More >> Med Dept. 2 Grosshadern Munich, Germany, 81377 Less <<
NCT01870570 Glycaemia Ins... More >>ulinemia Less << Not Applicable Completed - Australia ... More >> Human Nutrition Unit, The University of Sydney Sydney, Australia, 2006 Canada, Ontario Glycemic Index Laboratories Toronto, Ontario, Canada, M5C 2N8 France Biofortis Saint Herblain, France Less <<
NCT02563834 Type 2 Diabetes Mellitus Not Applicable Completed - United States, Indiana ... More >> Indiana University Hospital GCRC Indianapolis, Indiana, United States, 46202 Less <<
NCT02563834 - Completed - -
NCT02729766 Inappropriate ADH Syndrome Phase 2 Phase 3 Completed - Switzerland ... More >> Department Endocrinology University Hospital Basel Basel, Switzerland, 4031 Less <<
NCT01811511 Metabolic Syndrome Phase 2 Phase 3 Completed - Korea, Republic of ... More >> Obesity Research Center of Chonbuk National University Jeonju, Jeollabuk-do, Korea, Republic of, 560-822 Less <<
NCT01584856 - Unknown January 2013 Switzerland ... More >> University Hospital Zurich, Endocrinology and Diabetology Zurich, ZH, Switzerland, 8091 Less <<
NCT01079234 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 3 Completed - -
NCT00689208 Insulin Resistance Early Phase 1 Completed - Sweden ... More >> Research Site Göteborg, Sweden Less <<
NCT03732690 Type 2 Diabetes Not Applicable Not yet recruiting December 30, 2020 France ... More >> Hôpital PITIE SALPETRIERE - APHP Not yet recruiting Paris, France, 75013 Contact: Karine CLEMENT, MD, PhD Less <<
NCT01073020 Type 2 Diabetes Mellitus ... More >> Obesity Less << Not Applicable Active, not recruiting March 2018 United States, Massachusetts ... More >> Brigham and Women's Hospital Boston, Massachusetts, United States, 02215 Joslin Diabetes Center Boston, Massachusetts, United States, 02215 Less <<
NCT03057470 Diabetes Mellitus, Type 1 Phase 4 Recruiting March 2017 Canada, Ontario ... More >> LMC Bayview Recruiting Toronto, Ontario, Canada Contact: Ronnie Aronson, MD    416-645-2929    torontoresearch@lmc.ca Less <<
NCT03727854 Patients With Type 2 Diabetes Not Applicable Recruiting August 2020 Korea, Republic of ... More >> Seoul National University Hospital Recruiting Seoul, Korea, Republic of, 110-744 Contact: Young Min Cho, MD, PHD    82-2-2072-1965    ymchomd@snu.ac.kr Less <<
NCT01079234 - Completed - -
NCT01856595 Diabetes Mellitus, Type 2 Phase 1 Completed - United States, California ... More >> Anaheim Clinical Trials Anaheim, California, United States, 92801 Profil Institute for Clinical Research, Inc. Chula Vista, California, United States, 91911 United States, Florida MRA Clinical Research, LLC South Miami, Florida, United States, 33143 Less <<
NCT01974544 Type 2 Diabetes Not Applicable Unknown December 2016 Chile ... More >> Pontificia Universidad Católica de Chile Recruiting Santiago, Región Metropolitana, Chile, 8330033 Contact: Castillo Alejandra, Nurse    56223543527    macastia@uc.cl    Contact: Vega Andrea, Nurse    56223543879    abvega@uc.cl    Principal Investigator: Boza Camilo, MD surgeon          Sub-Investigator: Valderas Juan Patricio, MD          Sub-Investigator: Arrese Marco, MD Internist          Sub-Investigator: Muñoz Rodrigo, MD Less <<
NCT00838916 - Completed - -
NCT00699530 - Withdrawn - Denmark ... More >> Department of Endocrinology Aarhus C, Aarhus, Denmark, 8000 Less <<
NCT01856595 - Completed - -
NCT00289848 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT00849017 - Completed - -
NCT00094991 Diabetes Mellitus, Type 2 Phase 3 Completed - United States, Texas ... More >> Local Institution San Antonio, Texas, United States, 78229-3900 Italy Local Institution Pisa, Italy Less <<
NCT00289848 - Completed - -
NCT00838916 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT01857167 Type 2 Diabetes ... More >> Insulin Resistance Less << Not Applicable Completed - China, Zhejiang ... More >> Zhejiang University Hangzhou, Zhejiang, China, 310058 Less <<
NCT01472497 Hypertension ... More >>Insulin Resistance Less << Phase 4 Completed - Japan ... More >> Tottori University Hospital Yonago, Japan, 683-8504 Less <<
NCT02926937 Type 2 Diabetes Mellitus Phase 3 Active, not recruiting May 2019 -
NCT02312843 Mild Cognitive Impairment ... More >> Prediabetes Less << Not Applicable Completed - United States, North Carolina ... More >> Wake Forest Baptist Health Winston-Salem, North Carolina, United States, 27157 Less <<
NCT00094913 - Unknown - United States, New York ... More >> Center for Brain Health, Silberstein Institute, New York University New York City, New York, United States, 10016 Less <<
NCT00397631 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT03211858 Type 1 Diabetes Mellitus-Type ... More >>2 Diabetes Mellitus Less << Phase 3 Active, not recruiting January 2019 -
NCT00666718 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT03155412 - Recruiting December 2018 Czechia ... More >> Third Faculty of Medicine, Charles University Recruiting Prague, Czechia, 100 00 Contact: Michaela Siklova, PhD    +420 267 102 211    michaela.siklova@lf3.cuni.cz    Principal Investigator: Vladimir Stich, prof Less <<
NCT00397631 - Completed - -
NCT00467649 Type 2 Diabetes Mellitus Phase 4 Completed - -
NCT02981121 PreDiabetes Phase 4 Recruiting November 2020 Korea, Republic of ... More >> Kyunghee University Medical Center Recruiting Seoul, Korea, Republic of, 02447 Contact: Jeong-taek Woo, MD, PhD    +82-2-958-8128    jtwoomd@khmc.or.kr    Contact: Sang Youl Rhee, MD, PhD    +82-2-958-8220    bard95@hanmail.net    Principal Investigator: Jeong-taek Woo, MD, PhD          Sub-Investigator: Suk Chon, MD, PhD          Sub-Investigator: Sang Youl Rhee, MD, PhD Less <<
NCT00467649 - Completed - -
NCT00870077 Non-alcoholic Fatty Liver Dise... More >>ase Obesity Less << Not Applicable Completed - Switzerland ... More >> Centre d'investigations cliniques "cardiomet"/ CHUV Lausanne, VD, Switzerland, CH-1011 Less <<
NCT03353207 - Recruiting September 30, 2019 Hong Kong ... More >> Shatin Hospital Recruiting Shatin, Hong Kong Contact: Mandy Yu, MPH    852-26367593    mandyyu@cuhk.edu.hk Less <<
NCT02354339 Metabolic Syndrome X Phase 2 Completed - Mexico ... More >> Instituto de Terapéutica Experimental y Clínica Guadalajara, Jalisco, Mexico, 44340 Less <<
NCT02174016 Acute Brain Injuries Phase 1 Recruiting December 2020 United States, California ... More >> Ronald Reagan UCLA Medical Center Recruiting Los Angeles, California, United States, 90095 Contact: Joyce Matsumoto, MD    310-825-6196       Principal Investigator: Joyce H Matsumoto, MD          Principal Investigator: Christopher C Giza, MD Less <<
NCT00666718 - Completed - -
NCT03697369 - Completed - -
NCT01370005 - Completed - -
NCT00604396 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT01409213 - Completed - -
NCT01035671 Friedreich's Ataxia Phase 2 Completed - United States, Pennsylvania ... More >> The Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT01370005 Diabetes Mellitus, Type 2 ... More >> Hypertension Less << Phase 3 Completed - -
NCT03522974 Cardiovascular Risk Factor Not Applicable Recruiting December 2020 United States, Arizona ... More >> University of Arizona Recruiting Tucson, Arizona, United States, 85721 Contact: Ann Skulas-Ray Less <<
NCT01680341 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT02133144 NAFLD Not Applicable Unknown June 2015 Finland ... More >> Clinical studies: Biomedicum 2U, Tukholmankatu 8, 00290 Helsinki, Rooms 106b and 105b Recruiting Helsinki, Finland, 00290 Contact: Anne Salo, Study nurse       anne.salo@hus.fi    Principal Investigator: Sanja Sadevirta, MD Less <<
NCT03404700 Diabetes Mellitus, Type 2 ... More >> Insulin Resistance Less << Not Applicable Recruiting January 2019 United States, Texas ... More >> Texas Tech University - Department of Nutritional Sciences Recruiting Lubbock, Texas, United States, 79409 Contact: Nikhil V Dhurandhar, PhD    806-834-6446    nikhil.dhurandhar@ttu.edu Less <<
NCT01680341 - Completed - -
NCT01790711 Efficiency Me... More >>thodology Less << Phase 2 Phase 3 Unknown June 2015 China, Jiangsu ... More >> Medical Center for Digestive Diseases, The Second Affiliated Hospital of Nanjing Medical University Nanjing, Jiangsu, China, 210011 Less <<
NCT00905255 - Completed - -
NCT01409213 - Completed - -
NCT01852838 - Unknown April 2015 Israel ... More >> Sheba Medical Center Recruiting Ramat Gan, Israel, 52621 Contact: Eve Keret    972-3-530-3207    eve.keret@sheba.health.gov.il    Principal Investigator: Dr. Nir Peled, PhD,MD, FCCP Less <<
NCT00802152 Hypertension ... More >>Diabetes Less << Not Applicable Completed - United States, Missouri ... More >> University of Missouri, Dept. of Family and Community Medicine Columbia, Missouri, United States, 65211 Less <<
NCT00905255 Diabetes Mellitus, Type 2 Phase 3 Completed - Japan ... More >> Sanofi-Aventis Administrative Office Tokyo, Japan Less <<
NCT01610661 Dyslipidemia Not Applicable Completed - United States, Massachusetts ... More >> Jean Mayer Human Nutrition Research Center on Aging Boston, Massachusetts, United States, 02111 Less <<
NCT01159600 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT02202863 Metabolic Syndrome X ... More >> Oxidative Stress Less << Not Applicable Completed - Chile ... More >> Centro de Nutricion Molecular y Enfermedades Cronicas, Pontificia Universidad Catolica de Chile Santiago, Centro, Chile Less <<
NCT01825382 Type 1 Diabetes Phase 4 Completed - United States, Colorado ... More >> Barbara Davis Center Aurora, Colorado, United States, 80045 Less <<
NCT03484741 Type 1 Diabetes Mellitus Phase 1 Phase 2 Recruiting November 2018 Vietnam ... More >> Van Hanh Geral Hospital Recruiting Ho Chi Minh City, Ho Chi Minh, Vietnam, 700000 Contact: Phuong Le, MSc-MD    (+84)902742732    drbphuong@gmail.com Less <<
NCT01289119 - Completed - -
NCT00768105 Type 2 Diabetes Phase 1 Completed - United States, California ... More >> Research Site Chula Vista, California, United States Less <<
NCT01594060 Diabetes Mellitus Type 2 Phase 4 Completed - -
NCT01289119 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT00774553 Type 2 Diabetes Phase 1 Completed - United States, Texas ... More >> Research Site San Antonio, Texas, United States India Research site Ahmedabad, India Less <<
NCT00360984 Type 1 Diabetes Mellitus Phase 4 Completed - United Kingdom ... More >> Newcastle Diabetes Centre Newcastle, Tyne and Wear, United Kingdom, NE4 6BE Less <<
NCT02011581 - Completed - United States, Missouri ... More >> Washington University School of Medicine St. Louis, Missouri, United States, 63110 Less <<
NCT02582814 Type 1 Diabetes Mellitus Phase 3 Completed - Japan ... More >> Research Site Aizu Wakamatsu-shi, Japan Research Site Chuo-ku, Japan Research Site Fukuoka-shi, Japan Research Site Fukuyama-shi, Japan Research Site Funabashi-shi, Japan Research Site Hamamatsu-shi, Japan Research Site Hirosaki-shi, Japan Research Site Ise-shi, Japan Research Site Kagoshima-shi, Japan Research Site Koriyama-shi, Japan Research Site Kumamoto-shi, Japan Research Site Kunitachi-shi, Japan Research Site Minato-ku, Japan Research Site Nagoya-shi, Japan Research Site Oita-shi, Japan Research Site Otsu-shi, Japan Research Site Oyama-shi, Japan Research Site Sapporo-shi, Japan Research Site Sendai-shi, Japan Research Site Shinjyuku-ku, Japan Research Site Suita-shi, Japan Research Site Tama-shi, Japan Research Site Tsukuba-shi, Japan Research Site Yokohama-shi, Japan Less <<
NCT00618072 Hyperinsulinemia ... More >> Insulin Resistance Obesity Less << Phase 2 Completed - United States, New York ... More >> Albert Einstein College of Medicine Bronx, New York, United States, 10461 Less <<
NCT01217840 Obesity Not Applicable Completed - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT00618072 - Completed - -
NCT00981526 Schizophrenia ... More >> Schizoaffective Disorder Less << Phase 4 Completed - United States, Massachusetts ... More >> University of Massachusetts Medical School Worcester, Massachusetts, United States, 01605 Less <<
NCT01855282 Overweight and Obesity Not Applicable Completed - United States, California ... More >> Reiter Affiliated Companies Oxnard, California, United States, 93030 Reiter Affiliated Companies Watsonville, California, United States, 95076 Less <<
NCT00805922 - Completed - Thailand ... More >> Novo Nordisk Investigational Site Bangkok, Thailand, 10500 Less <<
NCT00981526 - Completed - -
NCT03020264 Type2 Diabetes ... More >> Elderly Hypoglycemia Less << Not Applicable Recruiting December 2018 France ... More >> CHU de Nantes Recruiting Nantes, Loire Atlantique, France, 44000 Contact: Bertrand CARIOU, Pr          Principal Investigator: Bertrand CARIOU, Pr          Sub-Investigator: Laure DE DECKER, Pr          CH d'Ancenis Not yet recruiting Ancenis, France, 44150 Principal Investigator: Xavier ROUTON, Dr          Sub-Investigator: Pascale MAHOT-MOREAU, Dr          CHU d'Angers Not yet recruiting Angers, France, 49100 Principal Investigator: Cédric ANWEILLER, Pr          Sub-Investigator: Séverine DUBOIS, Dr          Hôpital Sud Francilien Not yet recruiting Corbeil-Essonnes, France, 91106 Principal Investigator: Nathalie CERVANTES, Dr          Sub-Investigator: Alfred PENFORNIS, Pr          CHU de Poitiers Not yet recruiting Poitiers, France, 86021 Principal Investigator: Marc PACCALIN, Pr          Sub-Investigator: Samy HADJADJ, Pr          Centre Hospitalier de Saint Nazaire Not yet recruiting Saint Nazaire, France, 44600 Principal Investigator: Sylvie HILY, Dr Less <<
NCT01584232 Type 2 Diabetes Mellitus Phase 3 Completed - Japan ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Aichi, Japan, 448-0852 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chiba, Japan, 286-0048 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ehime, Japan, 790-0024 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fukuoka, Japan, 819-0168 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hokkaido, Japan, 0530018 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kagoshima, Japan, 8910401 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kanagawa, Japan, 247-0055 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kumamoto, Japan, 860-0811 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kyoto, Japan, 606-8397 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nagano, Japan, 385-0022 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nagasaki, Japan, 857-1195 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ooita, Japan, 8700039 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Osaka, Japan, 598-0048 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tokyo, Japan, 103-0028 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Yamaguchi, Japan, 754-0002 Less <<
NCT02681094 - Completed - -
NCT01584232 - Completed - -
NCT03508154 Glycemic Index Not Applicable Completed - Canada, Ontario ... More >> Glycemic Index Laboratories Inc. Toronto, Ontario, Canada, M5C 2N8 Less <<
NCT02012478 Type II Diabetes Mellitus Not Applicable Completed - United States, Pennsylvania ... More >> University of Pennsylvania Hospital Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT01217840 - Completed - -
NCT01929863 Diabetes Mellitus, Type 2 Phase 2 Completed - United States, Florida ... More >> GSK Investigational Site Miami, Florida, United States, 33169 Less <<
NCT02681094 Type 2 Diabetes Mellitus ... More >> Inadequate Glycaemic Control Less << Phase 3 Completed - -
NCT01929863 - Completed - -
NCT00968786 Hypertension ... More >>Type 2 Diabetes Mellitus Less << Not Applicable Unknown September 2009 -
NCT02794506 Diabetes Mellitus ... More >> Periodontitis Less << Phase 4 Completed - Egypt ... More >> Faculty of Dentistry Mansoura, Dakahlia, Egypt Less <<
NCT02500069 Ileal Brake S... More >>atiety Overweight Obesity Overeating Less << Not Applicable Completed - Netherlands ... More >> Maastricht University Medical Center Maastricht, Limburg, Netherlands, 6003 Less <<
NCT03689530 PreDiabetes Not Applicable Enrolling by invitation June 30, 2022 United States, California ... More >> Kaiser Permanente Northern California Oakland, California, United States, 94611 United States, Michigan University of Michigan Ann Arbor, Michigan, United States, 48109-2800 Less <<
NCT01161030 Type 2 Diabetes Not Applicable Completed - -
NCT02938572 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 1 Completed - Austria ... More >> Novo Nordisk Investigational Site Graz, Austria, 8010 Less <<
NCT03593746 Diabetes Mellitus, Type 2 ... More >> High-Intensity Interval Training Exercise Training Hyperglycaemia Due to Type 2 Diabetes Mellitus Less << Not Applicable Recruiting August 2022 Brazil ... More >> UNINOVE Recruiting Sao Paulo, SP, Brazil, 03332010 Contact: Luciana Sampaio, PhD Less <<
NCT01773473 Type 2 Diabetes Mellitus Phase 4 Completed - China ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Beijing, China, 100029 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Changsha, China, 410013 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chengdu, China, 610041 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chongqing, China, 404000 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nanjing, China, 210028 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Shanghai, China, 200092 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Wulumuqi, China, 830000 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Zhengzhou, China, 450052 Japan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ibaraki, Japan, 302-0118 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kagoshima, Japan, 895-0052 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kanagawa, Japan, 242-0004 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Miyagi, Japan, 985-0835 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nagano, Japan, 399-0006 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Okayama, Japan, 700-0013 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Osaka, Japan, 530-0001 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Saitama, Japan, 350-1305 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tochigi, Japan, 329-0433 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tokyo, Japan, 206-0633 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Yamaguchi, Japan, 751-0815 Korea, Republic of For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Daejeon, Korea, Republic of, 302-799 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Incheon, Korea, Republic of, 403-720 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Jeju Special Self-Governing Pr, Korea, Republic of, 690-767 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Seoul, Korea, Republic of, 137-701 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Suwon, Korea, Republic of, 442-723 Turkey For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ankara, Turkey, 06500 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Antalya, Turkey, 07070 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Gaziantep, Turkey, 27070 Less <<
NCT01773473 - Completed - -
NCT02798718 Lactose Malabsorption ... More >> Cardiovascular Disease Less << Not Applicable Unknown - China, Hubei ... More >> Huazhong University of Science and Technology Recruiting Wuhan, Hubei, China, 430030 Contact: Liegang Liu, PhD    +86-27-83650522    liegangliu@gmail.com    Principal Investigator: Xiaoqin Li, PhD          Principal Investigator: Zhilei Shan, PhD          Principal Investigator: Jiawei Yin, PhD Less <<
NCT01253278 Diabetes Mellitus, Type 2 Phase 1 Completed - Germany ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Neuss, Germany, D-41460 Less <<
NCT00982644 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT02137434 Obesity Not Applicable Unknown December 2015 Brazil ... More >> Discipline of Clinical and Experimental Pathophysiology, Rio de Janeiro State University Recruiting Rio de Janeiro, Brazil, 20551-030 Contact: Márcia G Torres, PhD.    55 21 23342063    marciarsimas@gmail.com    Sub-Investigator: Thaís S Ferreira, MSc.          Sub-Investigator: Márcia G Torres, PhD.          Principal Investigator: Antonio F Sanjuliani, PhD.          Sub-Investigator: Vanessa P Antunes          Sub-Investigator: Priscila M Leal Less <<
NCT02803918 Type 2 Diabetes Mellitus Phase 1 Recruiting January 27, 2020 United States, Louisiana ... More >> Investigational Site Number 840002 Recruiting Baton Rouge, Louisiana, United States, 70808 Investigational Site Number 840006 Recruiting New Orleans, Louisiana, United States, 70115-6969 United States, Pennsylvania Investigational Site Number 840009 Recruiting Philadelphia, Pennsylvania, United States, 19104 United States, Texas Investigational Site Number 840007 Recruiting Lufkin, Texas, United States, 75904 Mauritius Investigational Site Number 480001 Recruiting Phoenix, Mauritius Mexico Investigational Site Number 484001 Recruiting Monterrey, Mexico, 64460 Investigational Site Number 484002 Recruiting Puebla, Mexico, 72190 South Africa Investigational Site Number 710001 Recruiting Cape Town, South Africa, 7530 Spain Investigational Site Number 724002 Recruiting Barcelona, Spain, 08009 Investigational Site Number 724001 Recruiting Vitoria, Spain, 01009 Less <<
NCT00982644 - Completed - -
NCT00849056 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT02553382 Type 2 Diabetes Phase 3 Completed - Canada, Ontario ... More >> St. Michael's Hopsital Toronto, Ontario, Canada, M5B 1M4 Croatia Clinical Centre Vuk Vrhovac, Merkur Hospital Zagreb, Croatia, 10000 Less <<
NCT00849056 - Completed - -
NCT01405456 HIV Not Applicable Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT00065377 Obesity Insul... More >>in Resistance Less << Phase 1 Completed - United States, Maryland ... More >> National Center for Complementary and Alternative Medicine (NCCAM) Bethesda, Maryland, United States, 20892 Less <<
NCT01836796 Type 2 Diabetes Not Applicable Completed - Sweden ... More >> Clinical Trial Centre, Gröna Stråket 12, Sahlgrenska University Hospital Gothenburg, Sweden, S-413 45 Less <<
NCT01135927 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 1 Completed - Japan ... More >> Novo Nordisk Investigational Site Tokyo, Japan, 130-0004 Less <<
NCT01212913 Diabetes Mellitus, Type 2 Phase 4 Completed - Korea, Republic of ... More >> Administrative Office Seoul, Korea, Republic of Less <<
NCT00121966 Type 2 Diabetes Mellitus Phase 4 Completed - Denmark ... More >> Diabetes Research Center Odense, Denmark, 5000 Less <<
NCT01508481 - Completed - Korea, Republic of ... More >> Seoul National University Bundang Hospital Seongnam, Korea, Republic of, 463-707 Less <<
NCT02524795 Systemic Lupus Erythematosus Not Applicable Completed - -
NCT03116009 Gestational Diabetes Phase 3 Recruiting October 2019 United States, Illinois ... More >> University of Illinois at Chicago Recruiting Chicago, Illinois, United States, 60612 Contact: Christopher A Enakpene, MD    347-217-5127    cenakpene@gmail.com    Contact: Micaela Della Torre, MD MS    312 543 8813    micaela@uic.edu Less <<
NCT02745327 - Active, not recruiting December 2018 Bangladesh ... More >> The International Centre for Diarrhoeal Disease Research, Bangladesh Dhaka, Bangladesh Less <<
NCT02562300 Postpartum Haemorrhage Phase 2 Completed - -
NCT01281605 Type 2 Diabetes Not Applicable Completed - Taiwan ... More >> Division of Endocrinology and Metabolism, Department of Internal Medicine, Mackay Memorial Hospital Hsinchu branch Hsinchu, Taiwan, 30067 Mackay Memorial Hospital Taipei, Taiwan, 10449 Division of Endocrinology and Metabolism, Department of Internal Medicine, Mackay Memorial Hospital Taitung branch Taitung, Taiwan, 95054 Less <<
NCT00867555 Obesity Type ... More >>2 Diabetes Mellitus Less << Not Applicable Completed - Netherlands ... More >> Dept Human Biology, Maastricht University Maastricht, Netherlands, 6200 MD Less <<
NCT00523393 Type 2 Diabetes Phase 4 Unknown May 2010 Germany ... More >> University Clinics Heidelberg, Dept. Medicine1 Recruiting Heidelberg, Germany, 69120 Contact: Dimitrios Oikonomou    +49 6221 56 ext 37944    dimitrios.oikonomou@med.uni-heidelberg.de Less <<
NCT02079805 Essential Hypertension Complic... More >>ated by Type 2 Diabetes Mellitus Less << Phase 4 Completed - Japan ... More >> Kyoto-Shi, Kyoto, Japan Less <<
NCT00178633 - Completed - United States, Texas ... More >> University of Texas, Health Sciences Center Houston Houston, Texas, United States, 77030 Less <<
NCT00178633 - Completed - -
NCT02414217 Diabetes Not Applicable Completed - -
NCT01405456 - Completed - -
NCT01517490 - Unknown - Denmark ... More >> Department of Ophthalmology, Glostrup Hospital Recruiting Glostrup, Denmark, 2600 Contact: Oliver Klefter, MD    +45 38 63 48 18    oliver.niels@gmail.com    Contact: Michael Larsen, Professor, DMSci    +45 38 63 48 34       Principal Investigator: Oliver Klefter, MD          Principal Investigator: Michael Larsen, Professor, DMSci Less <<
NCT01252030 Ischemic Heart Disease Phase 2 Completed - Belgium ... More >> Jessa Hospital Hasselt, Belgium, 3500 Less <<
NCT02079805 - Completed - -
NCT02409017 Diabetes Preg... More >>nancy Less << Not Applicable Unknown - United States, Pennsylvania ... More >> WellSpan York Hospital Recruiting York, Pennsylvania, United States, 17403 Contact: Jennifer K Caruso, DO    248-217-2405    jenniferkcaruso@gmail.com Less <<
NCT00993096 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 1 Completed - Germany ... More >> Novo Nordisk Investigational Site Neuss, Germany, 41460 Less <<
NCT03525717 Healthy Not Applicable Active, not recruiting May 8, 2023 United States, Maryland ... More >> Johns Hopkins Bayview Medical Center Baltimore, Maryland, United States, 21224 Less <<
NCT03066830 Type 2 Diabetes Mellitus Phase 3 Active, not recruiting May 2019 -
NCT00976391 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT01718080 - Completed - United States, Texas ... More >> Baylor College of Medicine Houston, Texas, United States, 77030 Less <<
NCT00972283 - Completed - -
NCT00972283 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT03322410 Fluid Overload ... More >> Peritoneal Hyperpermeability Peritoneal Dialysis Chronic Kidney Disease Less << Not Applicable Not yet recruiting November 1, 2020 France ... More >> Damien JOLLY Not yet recruiting Reims, France Contact: Fatouma TOURE       ftoure@chu-reims.fr Less <<
NCT00995930 Diabetes Mellitus, Type 2 ... More >> Atherosclerosis Prediabetic State Less << Phase 2 Completed - United States, New York ... More >> Novartis Investigative Site New York, New York, United States, 10029 United States, Ohio Novartis Investigative Site Cincinnati, Ohio, United States, 45219 Canada, Quebec Novartis Investigative Site Montreal, Quebec, Canada, H1T 1C8 Germany Novartis Investigative Site Mainz, Germany, 55116 Novartis Investigative Site Neuss, Germany, 41460 Novartis Investigative Site Ulm, Germany, 89081 Israel Novartis Investigative Site Jerusalem, Israel, 91120 United Kingdom Novartis Investigative Site Oxford, UK, United Kingdom, OX2 6HE Novartis Investigative Site London, United Kingdom, EC1M 6BQ Less <<
NCT01304927 Male Infertility Phase 2 Phase 3 Completed - Denmark ... More >> Rigshospitalet Copenhagen, Denmark, 2100 Less <<
NCT00976391 - Completed - -
NCT00995930 - Completed - -
NCT01985204 Iodine Deficiency ... More >> Subclinical Hypothyroidism Less << Not Applicable Completed - Morocco ... More >> Universite Caddi Ayad, Faculte de Medecine et de Pharmacie Marrakech, Morocco University Cadi Ayyad, Faculte des Sciences Marrakech, Morocco Less <<
NCT01453049 Diabetes Mellitus, Type 2 Phase 3 Terminated(US FDA/EMA/SFDA dec... More >>isions to rosiglitazone-containing medicines, ethic) Less << - China, Hubei ... More >> GSK Investigational Site Wuhan, Hubei, China, 430030 China, Jiangsu GSK Investigational Site Suzhou, Jiangsu, China, 215004 China, Liaoning GSK Investigational Site Dalian, Liaoning, China, 116027 China, Zhejiang GSK Investigational Site Hangzhou, Zhejiang, China, 310003 GSK Investigational Site Hangzhou, Zhejiang, China, 310009 China GSK Investigational Site Beijing, China, 100029 GSK Investigational Site Beijing, China, 100730 GSK Investigational Site Chongqing, China, 400016 GSK Investigational Site Shanghai, China, 200080 GSK Investigational Site Shenyang, China, 110003 GSK Investigational Site Tianjin, China, 300052 GSK Investigational Site Wuhan, China, 430022 Less <<
NCT00247455 Obesity Diabe... More >>tes Less << Not Applicable Completed - Canada, Ontario ... More >> St. Michael's Hospital Toronto, Ontario, Canada, M5B 1W8 Less <<
NCT01051102 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 1 Completed - Japan ... More >> Novo Nordisk Investigational Site Tokyo, Japan, 130-0004 Less <<
NCT01453049 - Terminated(US FDA/EMA/SFDA dec... More >>isions to rosiglitazone-containing medicines, ethic) Less << - -
NCT02637479 Any Cancer With Multiple Bone ... More >>Metastases Less << Not Applicable Unknown December 2018 France ... More >> Assistance Publique Hôpitaux de Marseille Recruiting Marseille, France, 13354 Contact: DESALBRES Urielle, Director    0491382747    drci@ap-hm.fr    Principal Investigator: REGIS Jean, PUPH Less <<
NCT03078725 Gestational Diabetes Mellitus,... More >> Class A2 Less << Phase 4 Withdrawn(Research was competi... More >>ng with other projects in the department, and no patients were recruited.) Less << May 10, 2018 -
NCT02601482 Diabetes Mellitus, Type 2 Not Applicable Unknown October 2016 Denmark ... More >> Center for Physical Activity Research (CFAS) Copenhagen, Denmark, 2100 Less <<
NCT02582840 Type 1 Diabetes Mellitus Phase 1 Completed - Japan ... More >> Fukuoka-shi, Japan Less <<
NCT01472367 Diabetes Mellitus, Type 2 Phase 3 Active, not recruiting October 1, 2019 -
NCT00605306 Asthma Phase 2 Completed - France ... More >> Novartis Investigator Site Neuil, France Novartis Investigator Site Paris, France Novartis Investigator Site Poitiers, France Less <<
NCT03660189 Diabetic Ketoacidosis Not Applicable Recruiting July 30, 2019 United States, Ohio ... More >> MetroHealth Medical Center Recruiting Cleveland, Ohio, United States, 44109 Contact: Vidya Krishnan, MD MHS    216-778-3441    vkrishnan@metrohealth.org Less <<
NCT00539396 Diabetes Mellitus, Type 1 Phase 2 Completed - -
NCT02967224 Diabetes Mellitus, Type 2 Phase 4 Completed - -
NCT01087086 Metabolic Syndrome ... More >> Obesity Diabetes Cardiovascular Disease Less << Not Applicable Completed - Spain ... More >> University of Navarra Pamplona, Navarra, Spain, 31008 Less <<
NCT00605306 - Completed - -
NCT03421262 Gestational Diabetes Not Applicable Recruiting December 2019 Spain ... More >> Hospital Universitari Mutua Terrassa Recruiting Terrassa, Barcelona, Spain, 08221 Contact: Verónica Perea, MD    0034937365050 ext 11330    vperea@mutuaterrassa.cat Less <<
NCT02967211 Diabetes Mellitus, Type 2 Phase 4 Completed - -
NCT01826279 Obesity Not Applicable Unknown August 2014 Denmark ... More >> Department of Endocrinology and Internal Medicine Aarhus C, Denmark, 8000 Less <<
NCT00095082 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 3 Completed - -
NCT03299153 Type 2 Diabetes Phase 4 Completed - -
NCT00847080 Reactive Hypoglycemia Phase 4 Completed - Mexico ... More >> Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran Mexico, DF, Mexico, 14000 Less <<
NCT01938469 Gastric Bypass Surgery ... More >> Obesity Less << Not Applicable Completed - United States, New York ... More >> St. Lukes- Roosevelt Hospital- New York Obesity Research Center New York, New York, United States, 10025 Less <<
NCT01618214 - Completed - -
NCT01892124 Cardiovascular Diseases ... More >> Diabetes Mellitus, Type 2 Depression Dysthymic Disorder Less << Not Applicable Completed - United States, Washington ... More >> University of Washington, Indigenous Wellness Research Institute Seattle, Washington, United States, 98105 Less <<
NCT02167620 Diabetes Mellitus, Type 2 ... More >> Schizophrenia Less << Phase 4 Completed - Canada, Ontario ... More >> Center for Addiction and Mental Health Toronto, Ontario, Canada Less <<
NCT01299012 - Completed - -
NCT01618214 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 4 Completed - China, Anhui ... More >> Novo Nordisk Investigational Site Hefei, Anhui, China, 230001 Novo Nordisk Investigational Site Hefei, Anhui, China, 230022 China, Beijing Novo Nordisk Investigational Site Beijing, Beijing, China, 100029 Novo Nordisk Investigational Site Beijing, Beijing, China, 100088 Novo Nordisk Investigational Site Beijing, Beijing, China, 100700 Novo Nordisk Investigational Site Beijing, Beijing, China, 100730 China, Chongqing Novo Nordisk Investigational Site Chongqing, Chongqing, China, 400010 Novo Nordisk Investigational Site ChongQing, Chongqing, China, 404000 China, Guangdong Novo Nordisk Investigational Site Guangzhou, Guangdong, China, 510080 China, Hebei Novo Nordisk Investigational Site Shijiazhuang, Hebei, China, 050051 Novo Nordisk Investigational Site Shijiazhuang, Hebei, China, 050082 China, Hubei Novo Nordisk Investigational Site Wuhan, Hubei, China, 430034 China, Inner Mongolia Novo Nordisk Investigational Site Tongliao, Inner Mongolia, China, 028007 China, Jiangsu Novo Nordisk Investigational Site Nanjing, Jiangsu, China, 210011 Novo Nordisk Investigational Site Yangzhou, Jiangsu, China, 225001 China, Jiangxi Novo Nordisk Investigational Site Nanchang, Jiangxi, China, 330006 China, Jilin Novo Nordisk Investigational Site Changchun, Jilin, China, 130041 Novo Nordisk Investigational Site Siping, Jilin, China, 136000 China, Shaanxi Novo Nordisk Investigational Site Xi'an, Shaanxi, China, 710032 China, Shandong Novo Nordisk Investigational Site Jinan, Shandong, China, 250013 China, Shanghai Novo Nordisk Investigational Site Shanghai, Shanghai, China, 200072 China, Zhejiang Novo Nordisk Investigational Site Hangzhou, Zhejiang, China, 310003 Less <<
NCT00206297 Type 1 Diabetes Phase 3 Completed - United States, Texas ... More >> Baylor College of Medicine Houston, Texas, United States, 77030 Less <<
NCT00341406 - Completed - United States, Maryland ... More >> National Institute of Diabetes and Digestive and Kidney Disorders (NIDDK), 9000 Bethesda, Maryland, United States, 20892 Less <<
NCT01689142 Type 2 Diabetes Mellitus Phase 3 Completed - Japan ... More >> Investigational Site Number 392226 Amagasaki-Shi, Japan Investigational Site Number 392218 Chigasaki-Shi, Japan Investigational Site Number 392212 Chiyoda-Ku, Japan Investigational Site Number 392209 Chuo-Ku, Japan Investigational Site Number 392210 Chuo-Ku, Japan Investigational Site Number 392208 Chuoh-Ku, Japan Investigational Site Number 392217 Ebina-Shi, Japan Investigational Site Number 392216 Fujisawa-Shi, Japan Investigational Site Number 392222 Higashiosaka-Shi, Japan Investigational Site Number 392223 Izumisano-Shi, Japan Investigational Site Number 392215 Kamakura-Shi, Japan Investigational Site Number 392225 Kashiwara-Shi, Japan Investigational Site Number 392205 Kawagoe-Shi, Japan Investigational Site Number 392204 Kawaguchi-Shi, Japan Investigational Site Number 392206 Kisarazu-Shi, Japan Investigational Site Number 392201 Koriyama-Shi, Japan Investigational Site Number 392228 Kurashiki-Shi, Japan Investigational Site Number 392229 Matsuyama-Shi, Japan Investigational Site Number 392230 Matsuyama-Shi, Japan Investigational Site Number 392211 Mitaka-Shi, Japan Investigational Site Number 392220 Nagoya-Shi, Japan Investigational Site Number 392227 Nishinomiya-Shi, Japan Investigational Site Number 392203 Ogawa-Machi, Hikigun, Japan Investigational Site Number 392231 Okawa-Shi, Japan Investigational Site Number 392224 Osaka-Shi, Japan Investigational Site Number 392207 Shinjuku-Ku, Japan Investigational Site Number 392219 Shizuoka-Shi, Japan Investigational Site Number 392221 Takatsuki-Shi, Japan Investigational Site Number 392202 Ushiku-Shi, Japan Investigational Site Number 392213 Yokohama-Shi, Japan Investigational Site Number 392214 Yokohama-Shi, Japan Less <<
NCT02201004 Type 2 Diabetes Mellitus Phase 4 Completed - Japan ... More >> Investigational Site Number 392-028 Adachi-ku, Japan Investigational Site Number 392-007 Atsugi-shi, Japan Investigational Site Number 392-026 Chuoh-ku, Japan Investigational Site Number 392-021 Fukuoka-shi, Japan Investigational Site Number 392-002 Ichihara-shi, Japan Investigational Site Number 392-012 Iruma-shi, Japan Investigational Site Number 392-003 Kawaguchi-shi, Japan Investigational Site Number 392-014 Kitakyusyu-shi, Japan Investigational Site Number 392-027 Kobe-shi, Japan Investigational Site Number 392-004 Koga-shi, Japan Investigational Site Number 392-022 Kunitachi-shi, Japan Investigational Site Number 392-019 Kurume-shi, Japan Investigational Site Number 392-001 Kyoto-shi, Japan Investigational Site Number 392-024 Kyoto-shi, Japan Investigational Site Number 392-006 Matsudo-shi, Japan Investigational Site Number 392-008 Mito-shi, Japan Investigational Site Number 392-030 Musashino-shi, Japan Investigational Site Number 392-029 Okayama-shi, Japan Investigational Site Number 392-017 Otsu-shi, Japan Investigational Site Number 392-011 Sagamihara-shi, Japan Investigational Site Number 392-020 Sakai-shi, Japan Investigational Site Number 392-010 Sapporo-shi, Japan Investigational Site Number 392-016 Sendai-shi, Japan Investigational Site Number 392-018 Shinjuku-ku, Japan Investigational Site Number 392-005 Shizuoka-shi, Japan Investigational Site Number 392-031 Suita-shi, Japan Investigational Site Number 392-015 Sumida-ku, Japan Investigational Site Number 392-023 Sunto-gun, Japan Investigational Site Number 392-013 Tokorozawa-shi, Japan Investigational Site Number 392-025 Yokohama-shi, Japan Less <<
NCT01898351 Healthy Not Applicable Completed - United Kingdom ... More >> Rowett Institute of Nutrition and Health, University of Aberdeen Aberdeen, Scotland, United Kingdom, AB21 9SB Less <<
NCT01945671 - Unknown May 2015 -
NCT01606397 Diabetes Mellitus, Type 2 Phase 1 Completed - Singapore ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Singapore, Singapore United Kingdom For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Plymouth, United Kingdom Less <<
NCT01876394 Healthy Not Applicable Unknown June 2016 Canada, Ontario ... More >> Risk Factor Modification Centre, St. Michael's Hospital Recruiting Toronto, Ontario, Canada, M5B 1W8 Less <<
NCT00983775 Diabetes Mellitus, Type 1 Not Applicable Completed - Netherlands ... More >> Radboud University Nijmegen Medical Centre Nijmegen, P.O. Box 9101, Netherlands, 6500 HB Less <<
NCT02744976 Coronary Artery Disease ... More >> Atherosclerosis Prediabetic State Less << Phase 4 Recruiting December 2020 Latvia ... More >> Pauls Stradins Clinical University hospital Recruiting Riga, Latvia Less <<
NCT00339833 Type 2 Diabetes ... More >> Diabetes Less << Phase 4 Completed - United States, Arizona ... More >> NIDDK, Phoenix Phoenix, Arizona, United States, 85014 Less <<
NCT00570154 - Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00434499 Hypertension ... More >>Obesity Type 2 Diabetes Insulin Resistance Less << Phase 2 Withdrawn(Not funded) - United States, Maryland ... More >> University of Maryland Baltimore, Maryland, United States, 21201 Less <<
NCT01657630 - Completed - Israel ... More >> Schneider Children's Medical Center Petah-Tikva, Israel, 49202 Less <<
NCT03489317 - Recruiting December 2021 Hong Kong ... More >> Department of Microbiology, Chinese University of Hong Kong Recruiting Sha Tin, Hong Kong Contact: Yun Kit Yeoh    85235053333    yeohyunkit@cuhk.edu.hk    Lek Yuen Health Centre Recruiting Sha Tin, Hong Kong Contact: Martin Wong    85222528782    wong_martin@cuhk.edu.hk Less <<
NCT02124681 Insulin Resistance Phase 1 Completed - United States, Pennsylvania ... More >> UPMC Montefiore Hospital Pittsburgh, Pennsylvania, United States, 15234 Less <<
NCT02472951 Type 2 Diabetes Not Applicable Completed - Denmark ... More >> Endocrinological Dept. Bispebjerg University Hospital Copenhagen, Zealand, Denmark, 2400 Less <<
NCT02046187 Glioblastoma (GBM) Phase 1 Phase 2 Terminated(excessive protocol ... More >>deviations due to strict nature of diet requirements) Less << - United States, Arizona ... More >> Barrow Neurological Institute at St. Joseph's Hospital and Medical Center Phoenix, Arizona, United States, 85013 Less <<
NCT00351650 - Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00705536 Diabetes Mellitus Phase 1 Completed - United States, Texas ... More >> Diabetes and Glandular Disease Research, Inc. San Antonio, Texas, United States, 78229 Less <<
NCT02084550 Ulcerative Colitis Not Applicable Active, not recruiting September 2017 Denmark ... More >> Department of Surgery P, Aarhus University Hospital Aarhus C, Denmark, 8000 Less <<
NCT02195934 Cardiovascular Disease Not Applicable Completed - United Kingdom ... More >> Institute of Food Research Norwich, Norfolk, United Kingdom, NR4 7UA Less <<
NCT00984750 Diabetes Type 2 ... More >> Hypertension Less << Phase 3 Completed - Italy ... More >> Hospital "Azienda Ospedaliera di Treviglio e Caravaggio" Ambulatory of Diabetology Ponte San Pietro, Bergamo, Italy, 24036 Clinical Research Center for Rare Diseases "Aldo and Cele Daccò" Ranica, Bergamo, Italy, 24020 Hospital "Azienda Ospedaliera di Treviglio-Caravaggio"Unit of Diabetology and Metabolic Diseases Romano di Lombardia, Bergamo, Italy Hospital "Azienda Ospedaliera di Treviglio-Caravaggio" Unit of Diabetology and Metabolic Disease Treviglio, Bergamo, Italy Hospital "Azienda Ospedaliera Ospedali Riunitidi Bergamo" Unit of Diabetology Bergamo, Italy, 24100 Less <<
NCT00360698 Diabetes Mellitus, Type 2 Phase 4 Completed - United States, New Jersey ... More >> Sanofi-aventis Bridgewater, New Jersey, United States, 08807 Russian Federation Sanofi-Aventis Moscow, Russian Federation United Kingdom Sanofi-aventis Guildford, United Kingdom Less <<
NCT00705536 - Completed - -
NCT00360698 - Completed - -
NCT00339833 - Completed - -
NCT01765270 Type 2 Diabetes Mellitus ... More >> Cardiovascular Disease Less << Phase 4 Terminated(The study was stopp... More >>ed due to poor enrollment.) Less << - United States, Alabama ... More >> Cardiology, PC Birmingham, Alabama, United States, 35211 Cardio-Thoracic Surgeons PC Birmingham, Alabama, United States, 35243 Heart Center Research, LLC Huntsville, Alabama, United States, 35801 United States, Arkansas Sparks Regional Medical Center Fort Smith, Arkansas, United States, 72901 Arkansas Cardiology, PA Little Rock, Arkansas, United States, 72205 United States, California Stanford University Medical Center Palo Alto, California, United States, 94304 United States, Georgia Emory University Hospital Midtown Atlanta, Georgia, United States, 30308 United States, North Carolina Duke University Medical Center (DUMC) Durham, North Carolina, United States, 27710 United States, Virginia Chippenham Medical Center Richmond, Virginia, United States, 23225 United States, West Virginia Charleston Area Medical Center (CAMC) Charleston, West Virginia, United States, 25304 Less <<
NCT03634566 Liver Transplant; Complication... More >>s Less << Phase 1 Phase 2 Recruiting October 1, 2018 Egypt ... More >> Faculty of medicine Recruiting Cairo, Egypt Contact: Fathy Tash, MD    01006236620    mona_3mmar@Hotmail.com Less <<
NCT00086502 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT01765270 - Terminated(The study was stopp... More >>ed due to poor enrollment.) Less << - -
NCT03441412 Healthy Volunteers Phase 1 Completed - Sweden ... More >> gothia Forum CTC Gothenburg, Sweden, 41345 Less <<
NCT00711230 HIV Infection Phase 2 Unknown January 2015 Germany ... More >> ifi-Medizin GmbH at the Asklepios Klinik St. Georg Hamburg, Germany, 20099 ICH Grindel Hamburg, Germany, 20146 University Medical Center Hamburg-Eppendorf Hamburg, Germany, 20249 Less <<
NCT00393770 Type 2 Diabetes Mellitus Phase 2 Completed - Italy ... More >> Clinical Research Center for Rare Diseases Ranica, Bergamo, Italy, 24020 Less <<
NCT03613740 Metabolic Syndrome Phase 2 Not yet recruiting September 2020 Mexico ... More >> Instituto de Terapeútica Experimental y Clínica. Centro Universitario de Ciencias de la Salud. Universidad de Guadalajara Guadalajara, Jalisco, Mexico, 44340 Less <<
NCT02020616 Type 2 Diabetes Mellitus Phase 1 Phase 2 Terminated(Lack of Efficacy) - United States, California ... More >> Orange County Research Center Orange, California, United States, 92868 United States, Florida Miami Research Associates Miami, Florida, United States, 33143 Compass Research Orlando, Florida, United States, 32806 United States, New York Clinilabs, Inc (New York) New York, New York, United States, 10019 United States, Texas Dallas Diabetes Endocrine Center Dallas, Texas, United States, 75230 Less <<
NCT00086502 - Completed - -
NCT02020616 - Terminated(Lack of Efficacy) - -
NCT02629263 - Active, not recruiting December 2017 Canada, Ontario ... More >> The Toronto 3D Knowledge Synthesis and Clinical Trials Unit, Clinical Nutrition and Risk Factor Modification Centre Toronto, Ontario, Canada, M5C 2T2 Less <<
NCT00871650 - Completed - United States, Pennsylvania ... More >> University of Pittsburgh Pittsburgh, Pennsylvania, United States, 15213 Less <<
NCT03392961 Type 2 Diabetes Mellitus Phase 1 Completed - -
NCT01110746 Type 1 Diabetes Mellitus Phase 3 Completed - United States, Oregon ... More >> Oregon Health and Science University/Legacy Health System Portland, Oregon, United States, 97232 Less <<
NCT00291356 Diabetes Mellitus, Type 2 ... More >> Non-Insulin-Dependent Diabetes Mellitus Less << Phase 2 Completed - United States, California ... More >> GSK Investigational Site Chula Vista, California, United States, 91910 Germany GSK Investigational Site Neuss, Nordrhein-Westfalen, Germany, 41460 GSK Investigational Site Berlin, Germany, 14050 Less <<
NCT01145703 Vitamin D Deficiency ... More >> Metabolic Syndrome Less << Not Applicable Terminated(Investigator termin... More >>ated study due to low enrollment of eligible subjects) Less << - United States, Maryland ... More >> Baltimore VAMC Baltimore, Maryland, United States, 21201 Less <<
NCT01736865 Type 2 Diabetes Phase 2 Phase 3 Completed - United States, Massachusetts ... More >> Tufts Medical Center Boston, Massachusetts, United States, 02111 United States, Ohio Cincinnati VA Medical Center Cincinnati, Ohio, United States Less <<
NCT02756832 - Completed - -
NCT01763346 Prediabetes T... More >>ype 2 Diabetes Obesity Less << Not Applicable Completed - United States, California ... More >> University of Southern California Los Angeles, California, United States, 91011 Less <<
NCT02542774 - Unknown November 2016 United Kingdom ... More >> The George Institute for Global Health, Nuffield Department for Population Health, University of Oxford Oxford, United Kingdom, OX1 3BD Less <<
NCT00562393 Insulin Resistance Not Applicable Completed - Australia, New South Wales ... More >> Garvan Institute of Medical Research Darlinghurst, New South Wales, Australia, 2010 Less <<
NCT02511275 Nephrectomy K... More >>idney Cancer Microdialysis Less << Not Applicable Terminated(this type of surger... More >>y is now performed with a surgical robot that no longer allows the realization of microdialysis) Less << - France ... More >> Chu de Saint Etienne Saint Etienne, France, 42055 Less <<
NCT02559843 Diabetes Type 2 Phase 4 Completed - Iran, Islamic Republic of ... More >> NNFTRI clinic Tehran, Iran, Islamic Republic of, 19435 Less <<
NCT02673502 Laparoscopic Abdominal Surgery Not Applicable Recruiting May 2018 Canada, Quebec ... More >> Montreal General Hospital Recruiting Montreal, Quebec, Canada, H3G 1A4 Contact: Liane Feldamn, MD    514 934 1934 ext 44337    liane.feldman@mcgill.ca    Contact: Negar Negar, MD    514 934 1934 ext 48475    negar.karimian@mail.mcgill.ca    Principal Investigator: Liane Feldman, MD          Principal Investigator: Francesco Carli, MD          Principal Investigator: Negar Karimian, MD          Principal Investigator: Francesco Donatelli, MD          Principal Investigator: Julio Fiore, PhD          Principal Investigator: Patrick Charlebois, MD          Principal Investigator: Sender Liberman, MD          Principal Investigator: Barry Stein, Md Less <<
NCT00560430 Hypertension ... More >>Metabolic Syndrome Hypertriglyceridemia Less << Phase 3 Completed - Germany ... More >> Center for Cardiovascular Research, University Berlin Berlin, Germany, 10115 Med. Dept. 2, University Munich Munich, Germany, 81377 Less <<
NCT00198913 Type 2 Diabetes Mellitus ... More >> Obesity Less << Not Applicable Completed - United States, Maryland ... More >> Johns Hopkins University Lutherville, Maryland, United States, 21093 Less <<
NCT00138671 Diabetes Mellitus ... More >> Chronic Obstructive Pulmonary Disease Less << Phase 3 Terminated(See termination rea... More >>son in detailed description.) Less << - -
NCT00138671 - Terminated(See termination rea... More >>son in detailed description.) Less << - -
NCT03254849 Type 2 Diabetes Mellitus Phase 4 Recruiting September 15, 2019 Germany ... More >> Profil Institut für Stoffwechselforschung GmbH Recruiting Neuss, North Rhine-Westphalia, Germany, 41460 Contact: Maren Lübkert    +49 2131 4018 146    maren.luebkert@profil.com    Principal Investigator: Tim Heise, MD Less <<
NCT01652729 - Completed - -
NCT01652729 Diabetes Type 2 Phase 3 Completed - -
NCT00373386 Growth Hormone Deficiency ... More >> Panhypopituitarism Short Stature Less << Phase 4 Completed - United States, Ohio ... More >> Ohio State University Columbus, Ohio, United States, 43210 Less <<
NCT03486964 - Recruiting September 30, 2018 Italy ... More >> IRCCS Policlinico San Matteo Foundation Recruiting Pavia, Lombardy, Italy, 27100 Contact: Giuseppe Derosa, MD, PhD, FESC    + 39 0382 502614    giuseppe.derosa@unipv.it    Sub-Investigator: Pamela Maffioli, MD, PhD Less <<
NCT01504321 Polycystic Ovary Syndrome Phase 4 Completed - Australia, Victoria ... More >> Heart Centre, Alfred Hospital Prahran, Victoria, Australia, 3004 Less <<
NCT00745186 Hypoglycemia Phase 1 Completed - United Kingdom ... More >> Charles River Laboratories Edinburgh, United Kingdom, EH14 4AP Less <<
NCT00722397 - Completed - -
NCT00373386 - Completed - -
NCT00657852 Bone Disease, Metabolic Phase 4 Completed - Spain ... More >> Hospital Clinic i Provincial of Barcelona Barcelona, Spain, 08036 Less <<
NCT01474538 Type 2 Diabetes Mellitus Phase 3 Completed - United States, Arkansas ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Little Rock, Arkansas, United States, 72205 United States, Florida For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Jacksonville, Florida, United States, 32216 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. West Palm Beach, Florida, United States, 33401 United States, Georgia For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Atlanta, Georgia, United States, 30309 United States, Idaho For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Idaho Falls, Idaho, United States, 83404 United States, Iowa For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Des Moines, Iowa, United States, 50314 United States, Kansas For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Topeka, Kansas, United States, 66606 United States, Louisiana For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Metairie, Louisiana, United States, 70006 United States, North Carolina For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Asheville, North Carolina, United States, 28803 United States, Tennessee For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chattanooga, Tennessee, United States, 37411 United States, Texas For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Austin, Texas, United States, 78731 United States, Utah For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Salt Lake City, Utah, United States, 84102 Less <<
NCT00673894 Type 2 Diabetes Phase 1 Unknown June 2010 Australia, New South Wales ... More >> Clinical Research Facility Recruiting Sydney, New South Wales, Australia, 2010 Contact: Dr J Greenfield, FRACP    612-9295-8100 ext 8217    j.greenfield@garvan.org.au    Principal Investigator: Jerry Greenfield, FRACP Less <<
NCT02536248 Type 2 Diabetes Mellitus Phase 3 Active, not recruiting March 31, 2018 Canada, Quebec ... More >> Laval University Quebec City, Quebec, Canada, G1V 0A6 Less <<
NCT02676648 Diabetes Mellitus, Type 2 Not Applicable Completed - United States, Michigan ... More >> University of Michigan Ann Arbor, Michigan, United States, 48109 Less <<
NCT03142568 Bronchopulmonary Dysplasia Phase 2 Recruiting August 2019 United States, Arkansas ... More >> University of Arkansas for Medical Sciences Recruiting Little Rock, Arkansas, United States, 72205 Principal Investigator: Sherry Courtney, MD          United States, Indiana Riley Hospital for Children at IU Health Recruiting Indianapolis, Indiana, United States, 46202 Principal Investigator: Gregory Sokol, MD          United States, Kansas Wesley Medical Center Recruiting Wichita, Kansas, United States, 67214 Principal Investigator: Barry Bloom, MD          United States, Louisiana Ochsner Baptist Medical Center Recruiting New Orleans, Louisiana, United States, 70115 Principal Investigator: Amanda England, MD          United States, Nevada Children's Hospital of Nevada at UMC Recruiting Las Vegas, Nevada, United States, 89106 Contact: Ronald Roemer    702-207-8345    Ronald.Roemer@umcsn.com    Principal Investigator: Alaa Eldemerdash, MD          United States, New York Kings County Hospital Center Recruiting Brooklyn, New York, United States, 11203 Principal Investigator: Gratias Mundakel, MD          Cohen Children's Medical Center of NY Recruiting New Hyde Park, New York, United States, 11040 Principal Investigator: Mohamed N Ahmed, MD          Golisano Children's Hospital - University of Rochester Medical Center Recruiting Rochester, New York, United States, 14642 Principal Investigator: Gloria Pryhuber, MD          United States, North Carolina WakeMed Health and Hospitals Recruiting Raleigh, North Carolina, United States, 27610 Principal Investigator: Stephen Kicklighter, MD          United States, Ohio Cincinnati Childrens Hospital Medical Center Recruiting Cincinnati, Ohio, United States, 45229 Principal Investigator: Brenda Poindexter, MD          United States, Oklahoma University of Oklahoma Recruiting Oklahoma City, Oklahoma, United States, 73104 Principal Investigator: Kimberly Ernst, MD Less <<
NCT00497133 - Completed - Denmark ... More >> Gentofte Hostital, Dep. og Internal Medicin F Gentofte, Hellerup, Denmark, DK-2900 Less <<
NCT00928057 Diabetes Mellitus, Type 1 ... More >> Diabetes Mellitus, Type 2 Less << Not Applicable Completed - United States, Alabama ... More >> Radiant Research Birmingham, Alabama, United States, 35209 United States, California AMCR Institute, Inc. Escondido, California, United States, 92026 United States, Georgia Atlanta Diabetes Associates Atlanta, Georgia, United States, 30309 United States, Washington Rainier Clinical Research Center, Inc. Renton, Washington, United States, 98057 Less <<
NCT02564679 Morbid Obesity ... More >> NAFLD Less << Not Applicable Completed - -
NCT02923453 Type II Diabetes Control Phase 2 Completed - Canada, Ontario ... More >> : Clinical Nutrition and Risk Factor Modification Centre, St. Michael's Hospital Toronto, Ontario, Canada, M5B 1W8 Less <<
NCT01474538 - Completed - -
NCT02869750 - Completed - Egypt ... More >> Ahmed Kotb Cairo, Al Qahirah, Egypt Less <<
NCT01413204 Type 2 Diabetes Mellitus Phase 3 Completed - Japan ... More >> Reserch site Chubu, Japan Reserch site Kanto, Japan Reserch site Kinki, Japan Reserch site Shikoku, Japan Reserch site Tohoku, Japan Less <<
NCT00558740 - Completed - Switzerland ... More >> Centre Hospitalier Universitaire Vaudois Lausanne, Vaud, Switzerland, CH-1011 Less <<
NCT00708981 Diabetic Nephropathy Phase 4 Completed - United States, Illinois ... More >> John H. Stroger Jr. Hospital of Cook County Chicago, Illinois, United States, 60612 Less <<
NCT00291772 Type 1 Diabetes Phase 4 Completed - United States, Texas ... More >> Texas Children's Hospital Houston, Texas, United States, 77030 Less <<
NCT00928057 - Completed - -
NCT01413204 - Completed - -
NCT01686568 - Completed - -
NCT00843479 - Completed - Brazil ... More >> LIMED (Laboratory of Investigation of Metabolism and Diabetes)/GASTROCENTRO/Univeristy of Campinas (UNICAMP) Campinas, SP, Brazil Less <<
NCT01686568 Insulin Resistance Phase 3 Completed - United States, Minnesota ... More >> Mayo Clinic in Rochester Rochester, Minnesota, United States, 55905 Less <<
NCT02607345 Diabetes Mellitus Not Applicable Completed - -
NCT03608163 Diabetes Mellitus, Type 1 ... More >> Hypoglycemia Hypoglycemia Unawareness Less << Phase 4 Recruiting July 2020 United States, New York ... More >> Albert Einstein College of Medicine Recruiting Bronx, New York, United States, 10461 Contact: Matthew Zhao    718-839-4903    matthew.zhao@einstein.yu.edu Less <<
NCT01858597 - Completed - China, Guangdong ... More >> Obstetrics and Gynechology Department of the 1st affiliated hospital of Sun Yat-sen University Guangzhou, Guangdong, China, 510080 Less <<
NCT03037528 Diabetes Mellitus, Type 2 Not Applicable Recruiting May 1, 2021 United States, Michigan ... More >> University of Michigan Recruiting Ann Arbor, Michigan, United States, 48109 Contact: Laura Saslow, PhD       info@succeedstudy.org Less <<
NCT02971722 Healthy Phase 1 Unknown March 2018 -
NCT00377117 - Completed - Canada, Ontario ... More >> Regional Mental Health Care London London, Ontario, Canada, N6A 4H1 Less <<
NCT00960791 Type II Diabetes Mellitus Phase 1 Completed - United States, California ... More >> Research Site San Diego, California, United States United States, Texas Research Site San Antonio, Texas, United States Less <<
NCT02125045 Health Subjects With Cardiovas... More >>cular Risk Factors Less << Phase 3 Completed - Italy ... More >> Oberdan Parodi, MD Milan, Italy, 20162 Less <<
NCT01218061 Pre-diabetes Not Applicable Active, not recruiting June 2023 France ... More >> Nantes University Hospital Nantes, France Less <<
NCT00843479 - Completed - -
NCT03421119 Diabetes Mellitus, Type 2 Phase 3 Not yet recruiting December 1, 2019 -
NCT01999452 Type 2 Diabetes Not Applicable Withdrawn(Recruitment problems... More >>) Less << December 2022 Sweden ... More >> Center for Primary Health Care Research, Clinical Research Centre (CRC), hus 28, plan 11, Jan Waldenströms gata 35 Malmö, Skåne, Sweden, 205 02 Less <<
NCT02124590 Elderly Pre-d... More >>iabetic Less << Not Applicable Completed - United States, North Carolina ... More >> Duke Center for Living Durham, North Carolina, United States, 27710 Less <<
NCT00456300 Type 1 Diabetes Phase 4 Completed - United States, Texas ... More >> Texas Children's Hospital/ Baylor College of Medicine Houston, Texas, United States, 77030 Less <<
NCT03222245 - Recruiting May 1, 2020 United Kingdom ... More >> Portsmouth Hospital NHS Trust Recruiting Portsmouth, UK, United Kingdom, PO6 3LY Contact: Alice Mortlock    02392 286236 ext 7700    alice.mortlock@porthosp.nhs.uk    Principal Investigator: Sharon Allard Less <<
NCT00363519 Type 2 Diabetes Mellitus Phase 3 Completed - Japan ... More >> Chubu Region Chubu, Japan Chugoku Region Chugoku, Japan Hokkaido Region Hokkaido, Japan Kanto Region Kanto, Japan Kinki Region Kinki, Japan Kyushu Region Kyushu, Japan Shikoku Region Shikoku, Japan Tohoku Region Tohoku, Japan Less <<
NCT01889667 Diabetes Mellitus Type 2 Phase 2 Completed - United States, California ... More >> Orange County Research Center Tustin, California, United States, 92780 Less <<
NCT01889667 - Completed - -
NCT00371007 Type 2 Diabetes Mellitus Phase 2 Completed - -
NCT03105011 Diabetes Not Applicable Completed - United States, Missouri ... More >> University of Missouri Columbia, Missouri, United States, 65212 Less <<
NCT01465724 Insulin Resistance ... More >> Blood Pressure Less << Phase 3 Completed - Netherlands ... More >> UMC Utrecht Utrecht, Netherlands Less <<
NCT01147627 Diabetes Mellitus, Type 2 ... More >> Newly Diagnosed Less << Not Applicable Completed - -
NCT00856986 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT00975169 - Unknown - Taiwan ... More >> Department of Internal Medicine, National Taiwan University Hospital Recruiting Taipei, Taiwan Contact: Linda Huang    886 9 67670020    linda590203@gmail.com    Principal Investigator: Tien-Jyun Chang, Ph D Less <<
NCT02989649 - Terminated(Business Decision; ... More >>No Safety Or Efficacy Concerns) Less << - China, Beijing ... More >> Beijing, Beijing, China China, Hubei Wuhan, Hubei, China China, Liaoning Dalian, Liaoning, China Shenyang, Liaoning, China China, Shandong Jinan, Shandong, China Qingdao, Shandong, China Tai'an, Shandong, China Taian, Shandong, China China, Tianjin Tianjin, Tianjin, China Hong Kong Sai Ying Pun, Hong Kong Sha Tin, Hong Kong Less <<
NCT00363948 Type 2 Diabetes Mellitus Phase 3 Completed - Japan ... More >> Chubu Region Chubu, Japan Chugoku Region Chugoku, Japan Hokkaido Region Hokkaido, Japan Hokuriku Region Hokuriku, Japan Kanto Region Kanto, Japan Kinki Region Kinki, Japan Kyushu Region Kyushu, Japan Tohoku Region Tohoku, Japan Less <<
NCT01147627 - Completed - -
NCT01312090 Obesity Not Applicable Completed - -
NCT00326573 Diabetes Mellitus Phase 1 Phase 2 Terminated - United Kingdom ... More >> Dept of Child Health, UHW Cardiff, South Glamorgan, United Kingdom, CF14 4XN Less <<
NCT03285594 Type 2 Diabetes Mellitus Phase 3 Active, not recruiting August 24, 2019 -
NCT02520518 - Terminated(Designed a new modi... More >>fied/simplified protocol see NCT 03180489) Less << - -
NCT01595919 Obesity Hyper... More >>glycemia Less << Not Applicable Completed - Canada, Ontario ... More >> University of Toronto, Department of Nutritional Sciences Toronto, Ontario, Canada, M5S 3E2 Less <<
NCT00647595 Obesity Pregn... More >>ancy Diabetes Mellitus Less << Phase 3 Completed - United States, Washington ... More >> Madigan Army Medical Center Ft Lewis, Washington, United States, 98431 Less <<
NCT03376802 Type 2 Diabetes Mellitus Phase 1 Recruiting January 2019 United States, Florida ... More >> Investigational Site Number 8400001 Recruiting Orlando, Florida, United States, 32804 United States, Louisiana Investigational Site Number 8400002 Recruiting Baton Rouge, Louisiana, United States, 70808 Less <<
NCT02520518 Weight Loss Phase 2 Terminated(Designed a new modi... More >>fied/simplified protocol see NCT 03180489) Less << - United States, Colorado ... More >> Colorado State University, Dept. of Health and Exercise Science Fort Collins, Colorado, United States, 80523-1582 Less <<
NCT00856986 - Completed - -
NCT01387737 - Completed - -
NCT01828242 Glycemic Control for Diabetes ... More >>Mellitus Less << Phase 2 Completed - Indonesia ... More >> Telecommunication Company Jakarta, Indonesia Less <<
NCT03117829 PreDiabetes Not Applicable Recruiting October 1, 2018 United States, Wisconsin ... More >> University of Wisconsin-Madison Recruiting Madison, Wisconsin, United States, 53705 Contact: Randall Gretebeck    608-263-0927    rgretebeck@wisc.edu Less <<
NCT01387737 Type 2 Diabetes Mellitus Phase 3 Completed - Japan ... More >> Research site Chugoku, Japan Research site Hokkaido, Japan Research site Kanto, Japan Research site Kinki, Japan Research site Kyushu, Japan Research site Shikoku, Japan Research site Tohoku, Japan Less <<
NCT02609633 Diabetes Mellitus, Type 1 Not Applicable Completed - United States, Arizona ... More >> Pediatric Endocrinology of Phoenix Phoenix, Arizona, United States, 85053 United States, California Center of Excellence in Diabetes and Endocrinology Sacramento, California, United States, 95821 United States, Colorado Barbara Davis Center for Childhood Diabetes Aurora, Colorado, United States, 80045 United States, Florida Nemours Childrens Hospital Pensacola, Florida, United States, 32504 Tallahassee Memorial Hospital Tallahassee, Florida, United States, 32308 University of South Florida College of Medicine Tampa, Florida, United States, 33612 United States, Georgia Pediatric Endocrine Associates Atlanta, Georgia, United States, 30342 United States, Idaho Rocky Mountain Diabetes & Osteoporosis Center Idaho Falls, Idaho, United States, 83404 United States, Illinois Advocate Center for Pediatric Research Oak Lawn, Illinois, United States, 60453 United States, Indiana Indiana University Riley Carmel, Indiana, United States, 46032 United States, Minnesota Childrens Hospital and Clinics of Minnesota Saint Paul, Minnesota, United States, 55102 United States, New York Women and Children's Hospital of Buffalo Buffalo, New York, United States, 14222 United States, North Carolina East Caroline University - Pediatric specialty Care Greenville, North Carolina, United States, 27834 Less <<
NCT00590226 - Completed - -
NCT03011632 Sinusitis Ast... More >>hma Less << Phase 4 Recruiting March 2019 Poland ... More >> Department of Internal Medicine, Asthma and Allergy, Barlicki University Hospital, Medical University of Lodz, Lodz, Poland Recruiting Lodz, Poland, 90-153 Contact: Pawel Majak, MD, PhD Less <<
NCT03424395 Healthy Metab... More >>olism Less << Not Applicable Active, not recruiting December 1, 2018 United States, New Jersey ... More >> Campbell Soup Company Camden, New Jersey, United States, 08103 Less <<
NCT01660074 Healthy Not Applicable Completed - Taiwan ... More >> Food Science Department Pingtung, Taiwan Less <<
NCT02609633 - Completed - -
NCT01392391 Stroke Phase 2 Unknown April 2018 United States, Maryland ... More >> University of Maryland Active, not recruiting Baltimore, Maryland, United States, 21201 Jamaica University of West Indies Recruiting Kingston, Mona 7, Jamaica Contact: Terrence Forrester, MD    876-7024687    terrence.forrester@uwimona.edu.jm    Contact: Sandra Boynes    876-927-1884    sandra.boyne@uwimona.edu.jm    Principal Investigator: Terrence Forrester, MD          Sub-Investigator: Sandra Boynes Less <<
NCT02093858 - Unknown December 2017 China, Hunan ... More >> Mental Health Institute Recruiting Changsha, Hunan, China, 410011 Contact: Renrong Wu, PhD    86-15874179855    wurenrong2013@163.com.cn    Principal Investigator: Renrong Wu, Doctor Less <<
NCT02589756 Obesity Metab... More >>olic Syndrome Diabetes Less << Not Applicable Active, not recruiting September 2018 Norway ... More >> Oslo University Hospital, Ullevål Oslo, Norway Less <<
NCT02929459 Gut Microbiota Phase 2 Recruiting December 2018 Netherlands ... More >> Medical Microbiology, UMCG Groningen Recruiting Groningen, Netherlands, 9713 Contact: Mehdi Sadaghian Sadabad, D.V.M PhD    +31-50-36 15 186    m.sadaghian@umcg.nl Less <<
NCT01039662 Healthy Not Applicable Completed - Japan ... More >> Hiroshima University Hiroshima, Japan, 734-8551 Less <<
NCT02403713 Asthma Phase 1 Completed - United Kingdom ... More >> Belfast, United Kingdom Less <<
NCT01417897 Type 2 Diabetes Mellitus Phase 4 Unknown May 2012 Germany ... More >> ife GmbH, Clinic Mainz, Rhineland-Palatinate, Germany, 55116 Less <<
NCT01536028 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 1 Completed - Germany ... More >> Novo Nordisk Investigational Site Neuss, Germany, 41460 Less <<
NCT02940080 Postprandial Glycemia Not Applicable Active, not recruiting December 2018 Finland ... More >> Department of Biochemistry, University of Turku University of Turku, Turku, Finland, 20014 Less <<
NCT02093676 Type 1 Diabetes Not Applicable Completed - Israel ... More >> Sheba Medical Center Ramat Gan, Israel Less <<
NCT00590226 Type 2 Diabetes Phase 4 Completed - United States, Georgia ... More >> Grady Memorial Hospital Atlanta, Georgia, United States, 30303 United States, Illinois Rush University Medical Center Chicago, Illinois, United States, 60612 Less <<
NCT00682448 Metabolic Complications Phase 4 Completed - United States, Illinois ... More >> Rush University Medical Center Chicago, Illinois, United States, 60612 Less <<
NCT03766438 Type2 Diabetes Not Applicable Not yet recruiting June 1, 2021 United States, Arizona ... More >> Mountain Park Health Center Not yet recruiting Phoenix, Arizona, United States, 85012 Contact: Valentina Hernandez    602-323-3158    vhernandez@mphc-az.org    Principal Investigator: Davinder Singh, MD          United States, Minnesota Hennepin Healthcare Not yet recruiting Minneapolis, Minnesota, United States, 55404 Contact: Latasha Jennings, MPH    612-873-3034    Latasha.Jennings@hcmed.org    Principal Investigator: Katherine Vickery, md          Mayo Clinic in Rochester Rochester, Minnesota, United States, 55905 Less <<
NCT01619332 Type II Diabetes Phase 1 Phase 2 Completed - United States, California ... More >> Novartis Investigative Site Chula Vista, California, United States, 91910 United States, Florida Novartis Investigative Site Miami, Florida, United States, 33126 Novartis Investigative Site Orlando, Florida, United States, 32809 United States, Ohio Novartis Investigative Site Cincinnati, Ohio, United States, 45227 United States, Tennessee Novartis Investigative Site Knoxville, Tennessee, United States, 37920 United States, Texas Novartis Investigative Site San Antonio, Texas, United States, 78209 Less <<
NCT03151005 Polycystic Ovary Syndrome (PCO... More >>S) Overweight Obesity Less << Phase 4 Recruiting December 31, 2018 China, Chongqing ... More >> The Second Affiliated Hospital, Third Military Medical University Recruiting Chongqing, Chongqing, China, 400037 Principal Investigator: Min Long, MD Less <<
NCT01270191 Type 2 Diabetes Phase 4 Unknown December 2015 Taiwan ... More >> Taipei Veterans General Hospital Recruiting Taipei, Taiwan, 11217 Contact: Harn-Shen Chen, MD, PhD    886-2-28757515    chenhs@vghtpe.gov.tw    Principal Investigator: Harn-Shen Chen, MD, PhD Less <<
NCT00622765 Obesity Nutri... More >>tional and Metabolic Diseases Metabolic Diseases Nutrition Disorders Overweight Less << Phase 2 Completed - Belgium ... More >> Edegem, Belgium Liege, Belgium Denmark Frederiksberg C N/A, Denmark Hellerup N/A, Denmark Vipperroed, Denmark Finland Helsinki, Finland Kuopio, Finland Germany Berlin, Germany Dresden, Germany Heidelberg, Germany Netherlands Amsterdam, Netherlands Hilversum, Netherlands Rotterdam, Netherlands Sweden Göteborg, Sweden Huddinge, Sweden United Kingdom Liverpool, United Kingdom London, United Kingdom Luton, United Kingdom Less <<
NCT00970567 Type 1 Diabetes Not Applicable Completed - Germany ... More >> Charité-Universitätsmedizin Berlin, Department of Endocrinology, Diabetes and Nutrition Berlin, Germany, 12200 Less <<
NCT01621178 Type 2 Diabetes ... More >> Chronic Kidney Disease Less << Phase 3 Completed - -
NCT03334266 Obesity Infan... More >>t Obesity Mother-Child Relations Dietary Habits Breast Feeding Physical Activity Childhood Obesity Feeding Behavior Less << Not Applicable Recruiting December 31, 2021 United States, Arizona ... More >> Johns Hopkins Center for American Indian Health Recruiting Fort Defiance, Arizona, United States, 86504 Contact: Allison Barlow, PhD    410-955-6931    abarlow@jhu.edu    Contact: Nicole Neault, MPH    5057973309    nneault@jhu.edu    Johns Hopkins Center for American Indian Health Recruiting Whiteriver, Arizona, United States, 85941 Contact: Allison Barlow, PhD    410-955-6931    abarlow@jhu.edu    Contact: Nicole Neault, MPH    5057973309    nneault@jhu.edu    United States, New Mexico Johns Hopkins Center for American Indian Health Recruiting Shiprock, New Mexico, United States, 87420 Contact: Allison Barlow, PhD    410-955-6931    abarlow@jhu.edu    Contact: Nicole Neault, MPH    5057973309    nneault@jhu.edu Less <<
NCT01076634 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 1 Completed - Austria ... More >> Novo Nordisk Investigational Site Graz, Austria, 8010 Less <<
NCT01358149 Motor Activity Not Applicable Completed - United Kingdom ... More >> Hull York Medical School Hull, United Kingdom Less <<
NCT01098045 - Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT01054092 Type 2 Diabetes Mellitus Phase 3 Completed - Japan ... More >> Chubu, Japan Chugoku, Japan Hokkaido, Japan Kansai, Japan Kantou, Japan Kyushu, Japan Touhoku, Japan Less <<
NCT01642108 Type 2 Diabetes Not Applicable Unknown June 2013 Japan ... More >> Nobumasa Ohara Recruiting Niigata, Japan, 951-8510 Contact: Nobumasa Ohara, Medical Doctor       oharan@med.niigata-u.ac.jp Less <<
NCT01638260 Type 2 Diabetes Mellitus Phase 4 Terminated(Terminated because ... More >>of insufficient number of subjects included.) Less << - Netherlands ... More >> Maastricht University Medical Center Maastricht, Netherlands, 6229HX Less <<
NCT03761134 Type 2 Diabetes Mellitus Phase 3 Recruiting September 2020 China ... More >> Investigational Site Number 1560013 Recruiting Shanghai, China Less <<
NCT03278951 Obesity Weigh... More >>t Loss Telemedicine Less << Not Applicable Completed - -
NCT01621178 - Completed - -
NCT00042042 Diabetes Mellitus Not Applicable Unknown - United States, North Carolina ... More >> Duke University Recruiting Durham, North Carolina, United States, 27710 Contact: Susan Spratt, MD    919-684-4090    sprat002@mc.duke.edu    Contact: Diana McNeill, MD    919-684-6841 Less <<
NCT03485989 Nutrition Poor ... More >> Micronutrient Deficiency Aging Less << Not Applicable Completed - United States, Oregon ... More >> Linus Pauling Science Center Corvallis, Oregon, United States, 97331 Less <<
NCT00254800 Type 2 Diabetes Mellitus Phase 1 Completed - United Kingdom ... More >> Research Site Plymouth, United Kingdom Less <<
NCT00100698 AIDS HIV Infe... More >>ctions Less << Not Applicable Completed - United States, Massachusetts ... More >> MGH Boston, Massachusetts, United States, 02114 Less <<
NCT00100698 - Completed - -
NCT02610322 Metabolic Syndrome Not Applicable Unknown December 2018 -
NCT03760965 Type 2 Diabetes Mellitus Phase 3 Recruiting August 2021 China ... More >> Investigational Site Number 1560002 Recruiting Beijing, China, 101200 Investigational Site Number 1560019 Recruiting Huzhou, China Less <<
NCT03686722 Diabetes Mellitus, Type 2 ... More >> Hepatitis C Drug Interactions Less << Phase 1 Completed - Egypt ... More >> Drug research centre Cairo, Egypt Less <<
NCT00622089 Type 2 Diabetes Phase 2 Phase 3 Terminated(Program terminated) December 2008 -
NCT02740283 Gestational Diabetes Mellitus Not Applicable Unknown December 2017 -
NCT01070758 Congenital Hyperinsulinism Phase 4 Unknown February 2015 Israel ... More >> Pediatric Endocrinology Unit, Sheba Medical Center Recruiting Tel-Hashomer, Ramat-Gan, Israel, 52653 Contact: Dalit Modan, M.D.    +972-3-5345410    dmodan@sheba.health.gov.il    Principal Investigator: Dalit Modan, M.D. Less <<
NCT03773029 Peritoneal Dialysis Patients Not Applicable Not yet recruiting May 2019 Iran, Islamic Republic of ... More >> National Nutrition and Food Technology Research Institute Not yet recruiting Tehran, Iran (the Islamic Republic Of), Iran, Islamic Republic of, 1981619573 Contact: Zahra Yari    +982122357484    zahrayari_nut@yahoo.com Less <<
NCT02863887 Obesity Diabe... More >>tes Less << Not Applicable Completed - United States, Louisiana ... More >> Pennington Biomedical Research Center Baton Rouge, Louisiana, United States, 70808 Less <<
NCT03208686 Type2 Diabetes Not Applicable Not yet recruiting August 2019 -
NCT00952445 Diabetes Mellitus, Type II Phase 2 Completed - United States, California ... More >> Whittier Diabetes Institute La Jolla, California, United States Charles R. Drew University Los Angeles, California, United States National Research Institute Los Angeles, California, United States Lovelace Research Institute Santa Ana, California, United States United States, Florida University of Miami Miami, Florida, United States United States, Indiana GFI Research Center Evansville, Indiana, United States United States, Massachusetts Joslin Diabetes Center Boston, Massachusetts, United States United States, Minnesota Radiant Research Edina, Minnesota, United States United States, Missouri Radiant Research St. Louis, Missouri, United States St Louis Center for Clinical Research St. Louis, Missouri, United States United States, New York Kaleida Health Diabetes Center Buffalo, New York, United States Rochester Clinical Research Rochester, New York, United States United States, North Carolina Duke University Medical Center Durham, North Carolina, United States United States, Oregon Radiant Research Portland, Oregon, United States United States, South Carolina Radiant Research Anderson, South Carolina, United States United States, Texas Baylor University Endocrine Center Dallas, Texas, United States Dallas Diabetes and Endocrine Research Center Dallas, Texas, United States Endocrine Associates of Dallas Dallas, Texas, United States Diabetes and Grandular Disease Clinic and Reseach Center San Antonio, Texas, United States United States, Utah Endocrine Research Specialists Ogden, Utah, United States United States, Virginia Salem VA Medical Center Salem, Virginia, United States Less <<
NCT01494610 Asthma Phase 2 Completed - Australia, New South Wales ... More >> GSK Investigational Site Randwick, New South Wales, Australia, 2031 New Zealand GSK Investigational Site Wellington, New Zealand, 6021 Less <<
NCT03777722 Alzheimer Disease ... More >> Diabetes Mellitus, Type 2 Less << Not Applicable Recruiting October 31, 2023 United States, New York ... More >> Rensselaer Polytechnic Institute Recruiting Troy, New York, United States, 12180 Contact: Barbara Plitnick, RN    518-687-7166    plitnb@rpi.edu Less <<
NCT00359879 Type 2 Diabetes Phase 3 Completed - Brazil ... More >> Research Site Campinas, Brazil Research Site Curitiba, Brazil Research Site Fortaleza, Brazil Research Site Goiania, Brazil Research Site Porto Alegre, Brazil Research Site Rio de Janeiro, Brazil Research Site Salvador, Brazil Research Site Sao Jose Do Rio Preto, Brazil Research Site Sao Paulo, Brazil Mexico Research Site Guadalajara, Jalisco, Mexico Research Site Monterrey, Nuevo Leon, Mexico Research Site Merida, Yucatan, Mexico Research Site Aguascalientes, Mexico Research Site Mexico City, Mexico Research Site San Luis Potosi, Mexico Less <<
NCT02721602 Type 2 Diabetes ... More >> Pediatric Obesity Less << Not Applicable Completed - United States, Minnesota ... More >> University of Minnesota, School of Nursing Minneapolis, Minnesota, United States, 55455 Less <<
NCT00548782 Type 2 Diabetes Mellitus Not Applicable Completed - United States, California ... More >> University of California San Francisco San Franciscco, California, United States, 94143 Less <<
NCT02726425 Diabetes Mellitus Not Applicable Recruiting June 2020 United States, Massachusetts ... More >> Boston Medical Center Recruiting Boston, Massachusetts, United States, 02118 Contact: Suzanne E Mitchell, MD, MS       suzanne.mitchell@bmc.org Less <<
NCT01494610 - Completed - -
NCT01106131 Type 2 Diabetes Mellitus Phase 3 Completed - Korea, Republic of ... More >> Kangbuk Samsung Hospital Seoul, Korea, Republic of Less <<
NCT02183935 Obesity Diabe... More >>tes Metabolic Syndrome Less << Phase 3 Unknown December 2016 Slovenia ... More >> UMC Ljubljana Recruiting Ljubljana, Slovenia Contact: Tadej Battelino, PhD    00386 01 522 9235    tadej.battelino@mf.uni-lj.si    Principal Investigator: Tadej Battelino, MD, PhD          Sub-Investigator: Rok Orel, MD, PhD          Sub-Investigator: Matjaž Homan, MD, PhD          Sub-Investigator: Primož Kotnik, MD, PhD Less <<
NCT00800033 Metabolic Syndrome Phase 3 Completed - Canada, Saskatchewan ... More >> College of Kinesiology, University of Saskatchewan Saskatoon, Saskatchewan, Canada, S7N 5B2 Less <<
NCT02983188 Schizophrenia ... More >> Schizophrenia Spectrum and Other Psychotic Disorders Metabolic Syndrome x Less << Phase 2 Phase 3 Recruiting October 2020 Hong Kong ... More >> Castle Peak Hospital - The Department of General Adult Psychiatry Recruiting Tuen Mun, Hong Kong Contact: Wing-Him, Elvis LAI, MBBS    +852 2456 7272    lwh041@ha.org.hk    Sub-Investigator: Wing-Him, Elvis LAI, MBBS Less <<
NCT02575131 Obesity Phase 2 Completed - Netherlands ... More >> TNO Quality of Life Zeist, Utrecht, Netherlands, 3704HE Less <<
NCT01796847 - Completed - Italy ... More >> University of Rome La Sapienza, University Hospital Rome, Italy, 00185 Less <<
NCT02128932 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT00207389 - Terminated(Insufficient fundin... More >>g) Less << - United States, Massachusetts ... More >> Boston University Medical Center Boston, Massachusetts, United States, 02118 Less <<
NCT02128932 - Completed - -
NCT02274740 Type II Diabetes Mellitus Phase 2 Terminated(Sponsor decision no... More >>t related to safety reasons) Less << - -
NCT02113241 Metabolic Syndrome X Phase 4 Completed - Mexico ... More >> Intstituto de Terapeútica Experimental y Clínica. Centro Universitario de Ciencias de la Salud. Universidad de Guadalajara Guadalajara, Jalisco, Mexico, 44340 Less <<
NCT01286389 Mild Cognitive Impairment ... More >> Obesity Less << Not Applicable Completed - Brazil ... More >> Hospital das Clínicas - Faculdade de Medicina da USP Sao Paulo, Brazil, 05403010 Less <<
NCT01388361 - Completed - -
NCT01388361 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT00480350 HIV Infections Phase 2 Unknown January 2009 Israel ... More >> Hadassah Medical Organization Not yet recruiting Jerusalem, Israel, 91120 Contact: Arik Tzukert, DMD    00 972 26776095    arik@hadassah.org.il    Contact: Hadas Lemberg, PhD    00 972 2 6777572    Lhadas@hadassah.org.il Less <<
NCT01038648 Type 2 Diabetes Phase 3 Withdrawn December 2014 India ... More >> Dr.Ambady Ramachandran Chennai, Tamil nadu, India, 600 008 Less <<
NCT00391209 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT01697592 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT01697592 - Completed - -
NCT01399892 Type 1 Diabetes Not Applicable Completed - -
NCT00510315 - Active, not recruiting January 2020 United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00784966 Type 1 Diabetes Mellitus Phase 1 Phase 2 Withdrawn(University decision.... More >>) Less << September 2017 United States, Virginia ... More >> Virginia Commonwealth University Health System Richmond, Virginia, United States, 23298 Less <<
NCT03668951 Heart Diseases Phase 1 Recruiting August 30, 2020 United States, Ohio ... More >> Cincinnati Children's Hospital Medical Center Recruiting Cincinnati, Ohio, United States, 45229 Contact: Jayant Pratap, MA, MB BChir, MRCPCH, FRCA    513-803-3793    jayant.pratap@cchmc.org Less <<
NCT00647179 - Completed - Denmark ... More >> Department of Endocrinology, Aarhus University Hospital Aarhus C, Aarhus, Denmark, DK-8000 Less <<
NCT03386344 Type 2 Diabetes Mellitus Phase 3 Active, not recruiting December 2020 -
NCT00396851 Type 2 Diabetes Mellitus Not Applicable Unknown - India ... More >> PGIMER Not yet recruiting Chandigarh, India, 160012 Contact: Samir Malhotra       samirmalhotra345@yahoo.com    Sub-Investigator: Promila Pandhi, MD,DM Less <<
NCT03304041 Irritable Bowel Syndrome ... More >> Diet Modification Less << Not Applicable Recruiting September 1, 2018 China, Zhe Jiang ... More >> Sir Run Run Shaw Hospital , College of Medicine, Zhejiang University Recruiting Hangzhou, Zhe Jiang, China, 310016 Contact: ning dai, md    0086-13867457664    2267454962@qq.com Less <<
NCT03385265 Type1diabetes Not Applicable Recruiting September 19, 2019 United States, Kansas ... More >> University of Kansas Medical Center Recruiting Kansas City, Kansas, United States, 66160 United States, Missouri The Children's Mercy Hospital Recruiting Kansas City, Missouri, United States, 64108 Principal Investigator: Mark Clements, MD          Principal Investigator: Kathy Goggin, PhD Less <<
NCT02429024 Diabetes Mellitus Phase 4 Completed - United Kingdom ... More >> BioKinetic Europe Ltd Belfast, Antrim, United Kingdom, BT2 7BA Diabetes Centre, Heartlands Hospital Birmingham, United Kingdom, B9 5SS NHS Lothian Edinburgh, United Kingdom, EH16 4SA Highland Diabetes Institute Inverness, United Kingdom, IV2 3JH Less <<
NCT01729949 Nutritional and Metabolic Dise... More >>ase Overweight Less << Not Applicable Active, not recruiting December 1, 2019 United States, Illinois ... More >> Clinical Nutrition Research Center Chicago, Illinois, United States, 60616 Less <<
NCT03157960 Chronic Kidney Diseases ... More >> Diabetes Mellitus, Type 2 Less << Not Applicable Recruiting November 30, 2019 Sweden ... More >> Karolinska University Hospital Recruiting Stockholm, Sweden, 17176 Contact: Neda R Ekberg, M.D./Ph.D.    +46-51770000    neda.ekberg@ki.se Less <<
NCT03464045 - Active, not recruiting December 1, 2020 Sweden ... More >> The Swedish prescribed drug register Stockholm, Sweden United Kingdom United Kingdom Clinical Practice Research Datalink (CPRD) London, United Kingdom Less <<
NCT03555565 - Active, not recruiting October 31, 2019 Japan ... More >> Takeda Selected Site Tokyo, Japan Less <<
NCT03278158 Diabetes Mellitus, Type 2 Phase 2 Recruiting December 2018 Denmark ... More >> Odense University Hospital Recruiting Odense, Denmark, 5000 Contact: Henning Beck-Nielsen, Dr       henning.beck-nielsen@rsyd.dk Less <<
NCT00978900 Healthy Phase 1 Completed - -
NCT02235896 Cardiovascular Disease Risk Fa... More >>ctors Less << Not Applicable Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT02105597 Diabetes Mellitus Not Applicable Withdrawn(Poor patient recruit... More >>ment) Less << - Singapore ... More >> Singapore General Hospital Singapore, Singapore, 169608 Less <<
NCT01557907 Diabetes Phase 1 Phase 2 Completed - Germany ... More >> Profil Institut fur Stoffwechselfforschung GmbH Neuss, Germany, D-41460 Less <<
NCT03645421 Type 2 Diabetes Phase 2 Recruiting December 6, 2018 Japan ... More >> Research Site Recruiting Chuo-ku, Japan, 103-0027 Research Site Recruiting Shinjuku-ku, Japan, 160-0008 Research Site Recruiting Shinjuku-ku, Japan, 162-0053 Research Site Recruiting Suita-shi, Japan, 565-0853 Less <<
NCT01177384 - Completed - -
NCT01177384 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT02974816 Diabetes Mellitus, Type 2 Not Applicable Recruiting March 1, 2019 United States, California ... More >> John Muir Physician Network Clinical Research Center Recruiting Concord, California, United States, 94520 Contact: Hetal Vellanki, RN    925-687-8860    Hetal.Vellanki@johnmuirhealth.com    Contact: Vicki Potts, RN    925-687-8860    vicki.potts@johnmuirhealth.com    Principal Investigator: Anna Chang, MD          Sub-Investigator: Yeran Bao, MD          Sub-Investigator: Sirintorn Mann, PA          Sutter Health Terminated Elk Grove, California, United States, 95758 United States, Montana Billings Clinic Recruiting Billings, Montana, United States, 59101 Contact: Becky Kiesow    406-435-8473    bkiesow@billingsclinic.org    Principal Investigator: Jeanne Pereles-Ortiz, MD Less <<
NCT01326442 Type 2 Diabetes Mellitus ... More >> Hypertension Hyperlipidemia Obesity Less << Phase 3 Completed - Canada, Ontario ... More >> University of Guelph Guelph, Ontario, Canada, N1G2W1 Less <<
NCT01394380 Obesity Dysli... More >>pidemia Metabolic Syndrome Less << Not Applicable Completed - Switzerland ... More >> Clinical Research Center, CHUV Lausanne, VD, Switzerland, CH-1011 Less <<
NCT02936414 Schizophrenia Not Applicable Completed - China, Tianjin ... More >> Tianjin Anding Hospital Tianjin, Tianjin, China, 300222 Less <<
NCT01305226 Acute Myocardial Infarction Phase 3 Completed - India ... More >> Sri Jayadeva Institute of Cardiology. Bangalore, Karnataka, India, 560 069 Narayana Hrudayalaya Bangalore, Karnataka, India, 560 099 Lotus Super speciality Hospita Agra, Uttar Pradesh, India, 282 002 Institute of Post Graduate Medical Education and Research (IPGMER) Kolkatta, West Bengal, India, 700 020 Less <<
NCT03697382 Atherosclerosis ... More >> Metabolic Syndrome Less << Not Applicable Recruiting August 31, 2019 United States, Texas ... More >> University of Texas at Austin Human Performance Laboratory Recruiting Austin, Texas, United States, 78712 Contact: Edward F Coyle, Ph.D.    512-471-8596    coyle@austin.utexas.edu    Contact: Heath M Burton, M.S.    8649404103    heath.burton@utexas.edu Less <<
NCT03362398 Diabetes Mellitus, Type 2 Not Applicable Completed - Egypt ... More >> The British University in Egypt Cairo, Egypt Less <<
NCT03598400 Type1diabetes Not Applicable Not yet recruiting August 1, 2019 United Kingdom ... More >> Liverpool John Moores University Not yet recruiting Liverpool, United Kingdom, L33AF Contact: Matthew Cocks, PhD    07540191292    m.s.cocks@ljmu.ac.uk Less <<
NCT00854035 Type 2 Diabetes Mellitus Phase 3 Completed - Japan ... More >> Chubu Region Chubu, Japan Chugoku Region Chugoku, Japan Hokuriku Region Hokuriku, Japan Kanto Region Kanto, Japan Kinki Region Kinki, Japan Kyushu Region Kyushu, Japan Tohoku Region Tohoku, Japan Less <<
NCT00174681 Diabetes Mellitus, Type 2 Phase 4 Completed - Croatia ... More >> Sanofi-Aventis Zagreb, Croatia Czech Republic Sanofi-Aventis Prague, Czech Republic France Sanofi-Aventis Paris, France Romania Sanofi-Aventis Bucharest, Romania Russian Federation Sanofi-Aventis Moscow, Russian Federation Slovenia Sanofi-Aventis Ljubljana, Slovenia Less <<
NCT02944110 Diabetes After Total Pancreate... More >>ctomy Less << Not Applicable Enrolling by invitation December 2017 -
NCT02024971 - Completed - -
NCT00218998 Impaired Glucose Tolerance ... More >> Overweight Hypertension Dyslipidemia Less << Not Applicable Completed - Norway ... More >> The medical faculty at norwegian university of science and technology Trondheim, Norway, 7489 Less <<
NCT02084004 Type 2 Diabetes Mellitus Phase 2 Phase 3 Withdrawn(The sponsor have not... More >> enough money to support this trial) Less << April 2018 China, Shaanxi ... More >> Second Affiliated Hospital of Xi'an Jiaotong University Xi'an, Shaanxi, China, 710004 The 323rd Hospital of People's Liberation Army Xi'an, Shaanxi, China, 710054 First Affiliated Hospital of Xi'an Jiaotong University Xi'an, Shaanxi, China, 710061 Shaanxi Provincial People's Hospital Xi'an, Shaanxi, China, 710068 Less <<
NCT01204580 Diabetes Mellitus, Type 2 Phase 4 Completed - Indonesia ... More >> Sanofi-Aventis Administrative Office Jakarta, Indonesia Less <<
NCT01008306 - Unknown - Norway ... More >> Oslo University Hospital Rikshospitalet HF, Division of Pediatrics Oslo, Norway, 0027 Less <<
NCT02124759 Insulin Sensitivity Phase 2 Recruiting December 2019 United States, Texas ... More >> Audie L. Murphy VA Hospital, STVHCS Recruiting San Antonio, Texas, United States, 78229 Contact: Nicolas Musi, MD.    210-617-5300 ext 15197    Musi@uthscsa.edu    Contact: Lauri Che Kelly, RN    210-617-5300 ext 14731    che@uthscsa.edu    Principal Investigator: Nicolas Musi, MD Less <<
NCT02706522 Insulin Resistance ... More >> Inflammation Delirium Less << Not Applicable Completed - -
NCT03611140 Metabolic Syndrome Not Applicable Completed - Mexico ... More >> Nimbe Torres y Torres Mexico City, Please Select An Option Below, Mexico, 14080 Less <<
NCT02215200 Diabetes Mellitus, Type 1 Phase 2 Active, not recruiting October 2018 United States, California ... More >> University of California - San Francisco San Francisco, California, United States, 94158-2549 Stanford University Stanford, California, United States, 94305 United States, Colorado Barbara Davis Center Aurora, Colorado, United States, 80045 United States, Connecticut Yale University New Haven, Connecticut, United States, 06519 United States, Florida University of Florida Gainesville, Florida, United States, 32610 University of Miami Miami, Florida, United States, 33136 University of South Florida Diabetes Center Tampa, Florida, United States, 33612 United States, Indiana Indiana University-Riley Hospital for Children Indianapolis, Indiana, United States, 46202 United States, Minnesota University of Minnesota Minneapolis, Minnesota, United States, 55455 United States, New York Columbia University-Naomi Berrie Diabetes Center New York, New York, United States, 10032 United States, Pennsylvania University of Pittsburgh Pittsburgh, Pennsylvania, United States, 15224 United States, Tennessee Vanderbilt Eskind Diabetes Clinic Nashville, Tennessee, United States, 37232 United States, Washington Benaroya Research Institute Seattle, Washington, United States, 98101 Less <<
NCT00137046 Diabetes Mellitus, Type 1 Phase 3 Terminated(See termination rea... More >>son in detailed description.) Less << - -
NCT01403571 Diabetes Mellitus ... More >> Overweight Obesity Less << Phase 2 Completed - Canada, Ontario ... More >> Risk Factor Modification Centre, St. Michael's Toronto, Ontario, Canada, M5B1W8 Less <<
NCT00027456 Syndrome Phase 2 Completed - United States, Maryland ... More >> National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Bethesda, Maryland, United States, 20892 Less <<
NCT02024971 - Completed - -
NCT00014911 Diabetes Mellitus, Insulin-Dep... More >>endent Less << Phase 2 Completed - United States, Florida ... More >> University of Miami Miami, Florida, United States, 33136 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 United States, Minnesota University of Minnesota Minneapolis, Minnesota, United States, 55455 United States, Missouri Washington University St. Louis, Missouri, United States, 63110 United States, Washington Benaroya Research Institute at Virginia Mason Research Center Seattle, Washington, United States, 98101 Canada, Alberta University of Alberta Edmonton, Alberta, Canada Germany Justus-Leibig University Giessen, Germany, 35385 Italy University of Milan Milan, Italy Switzerland University of Geneva Geneva, Switzerland Less <<
NCT00014911 - Completed - -
NCT02606357 Diabetes Mellitus, Type 2 Phase 4 Completed - Jordan ... More >> JORDAN Jordan, Jordan Less <<
NCT03654521 Gestational Diabetes Not Applicable Recruiting December 31, 2020 Israel ... More >> Rambam health care campus Recruiting Haifa, Israel Contact: Yaniv Zipori, MD    0587966963    y_zipori@rambam.health.gov.il Less <<
NCT02934425 Pre-diabetes Not Applicable Completed - United States, Illinois ... More >> Illinois Institute of Technology - Institute for Food Safety and Health Chicago, Illinois, United States, 60616 Less <<
NCT02692313 Diabetes Complications Early Phase 1 Recruiting December 2018 United States, Maryland ... More >> University of Maryland, Baltimore Recruiting Baltimore, Maryland, United States, 21201 Contact: Donna Tate    410-706-5643       Contact: Maka Hedrington, MD    410-706-5636       Principal Investigator: Stephen N Davis, MBBS Less <<
NCT01545388 - Completed - -
NCT02229097 Type 1 Diabetes Phase 4 Completed - France ... More >> University Hospital Toulouse Rangueil Toulouse, Haute Garonne, France, 31059 Saint-André Hospital Bordeaux, France, 33000 Lapeyronie Hospital Montpellier, France, 34295 Less <<
NCT01140165 Cardiovascular Disease Not Applicable Unknown December 2011 Denmark ... More >> Department of Human Nutrition Frederiksberg, Denmark Less <<
NCT01754467 - Completed - -
NCT01287299 Obesity Insul... More >>in Resistance Less << Not Applicable Completed - United States, California ... More >> San Francisco General Hospital San Francisco, California, United States, 94110 Less <<
NCT03301792 Pregnancy Ges... More >>tational Diabetes Type 2 Diabetes Less << Not Applicable Recruiting September 10, 2020 United States, Missouri ... More >> Washington University in St. Louis Recruiting Saint Louis, Missouri, United States, 63110 Contact: Ebony B Carter, MD, MPH    314-362-8280    cartere@wudosis.wustl.edu Less <<
NCT00314717 Gestational Diabetes Phase 2 Completed - Canada, Ontario ... More >> St. Michael's Hospital Toronto, Ontario, Canada, M5B 1W8 Less <<
NCT01545388 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT00137046 - Terminated(See termination rea... More >>son in detailed description.) Less << - -
NCT03576430 Diabetes Mellitus, Type 2, Str... More >>ess Less << Not Applicable Recruiting December 31, 2019 Denmark ... More >> Department of Medicine, Herlev Hospital Recruiting Herlev, Denmark, 2730 Contact: jens faber, professor    004523235134    jens.faber@regionh.dk Less <<
NCT01224132 Atopic Dermatitis, Probiotics Phase 3 Completed - -
NCT01754467 Diabetes Mellitus Not Applicable Completed - United States, Illinois ... More >> Northwestern University Chicago, Illinois, United States, 60611 Less <<
NCT03050645 - Completed - Denmark ... More >> University of Southern Denmark Odense, Denmark, 5000 Less <<
NCT01216618 Diabetes Mellitus, Insulin-Dep... More >>endent Less << Phase 3 Completed - United States, California ... More >> Mills-Peninsula Health Services San Mateo, California, United States, 94401 Israel Wolfson Medical Center Holon, Israel Haddasah Medical Organization Jerusalem, Israel Less <<
NCT00124553 Type 2 Diabetes Mellitus Not Applicable Unknown June 2008 New Zealand ... More >> Edgar National Centre for Diabetes Research Recruiting Dunedin, Otago, New Zealand, 9001 Contact: Chris S Booker, BSc(Hons)    64-3-474-7775    chris.booker@stonebow.otago.ac.nz    Contact: Kirsten Coppell, FAFPHM    64-3-474-7774    kirsten.coppell@stonebow.otago.ac.nz    Principal Investigator: Jim I Mann, FRACP Less <<
NCT02666430 Type 1 Diabetes Mellitus Phase 3 Unknown March 2017 -
NCT02897557 Type 1 Diabetes Not Applicable Completed - United States, California ... More >> Stanford University Palo Alto, California, United States, 94305 William Sansum Diabetes Center Santa Barbara, California, United States, 93105 Diablo Clinical Research Walnut Creek, California, United States, 94598 United States, Colorado University of Colorado Denver Denver, Colorado, United States, 80045 Less <<
NCT01308164 Type 1 Diabetes Not Applicable Completed - Israel ... More >> Schneider Children's Medical center Petach-Tikva, Israel, 49202 Slovenia University Children's Hospital Ljubljana, Slovenia Less <<
NCT01754350 Recurrent Glioblastoma Not Applicable Active, not recruiting June 2018 Germany ... More >> Dr. Senckenberg Institute of Neurooncology Frankfurt, Germany University of Tuebingen Tuebingen, Germany Less <<
NCT02623998 Type 2 Diabetes Mellitus Phase 3 Active, not recruiting December 2018 Canada, Alberta ... More >> University of Calgary Calgary, Alberta, Canada, T2T 5C7 Canada, Manitoba Health Science Centre Winnipeg, Manitoba, Canada, R3E 3P4 Canada, Ontario McMaster University Hamilton, Ontario, Canada St. Joseph's Hospital London, Ontario, Canada, N6A 4V2 LMC Markham, Ontario, Canada Canada, Quebec Univeristy of Montreal Montreal, Quebec, Canada Less <<
NCT02298192 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT02298192 - Completed - -
NCT00465478 Diabetes Mellitus, Type 1 ... More >> Diabetes Mellitus, Type 2 Less << Phase 1 Phase 2 Unknown March 2014 China, Shandong ... More >> Qilu Hospital of Shandong University Recruiting Jinan, Shandong, China, 250012 Contact: Li Chen, MD    0086-531-82169408    chenli3@medmai.com.cn    Contact: Xingli Wang, MD,PhD    832-355-9939    xlwang@bcm.tmc.edu    Principal Investigator: Li Chen, MD          Principal Investigator: Xingli Wang, MD,PhD          Principal Investigator: Weikai Hou, MD          Principal Investigator: Jianjun Dong, MD          Principal Investigator: Kuanxiao Tang, MD,PhD          Principal Investigator: Xinguo Hou, MD          Principal Investigator: Lei Sun, MD Less <<
NCT03312478 Type 1 Diabetes Phase 4 Completed - Pakistan ... More >> National Institute of Child Health Karachi, Sind, Pakistan, 75510 Less <<
NCT00589459 - Unknown December 2008 United States, Connecticut ... More >> Bridgeport Hospital Bridgeport, Connecticut, United States, 06610 Yale Center for Clinical Investigation New Haven, Connecticut, United States, 06520 Less <<
NCT00428571 Type 2 Diabetes Not Applicable Terminated - Canada, Ontario ... More >> St. Joseph's Healthcare Hamilton, Ontario, Canada, L8N 4A6 Less <<
NCT01729403 Diabetes Mellitus Type 2 Phase 2 Completed - Germany ... More >> Neuss, Germany, 41460 Less <<
NCT03074552 Ventilator Associated Pneumoni... More >>a Infection Trauma Less << Not Applicable Recruiting December 22, 2018 Greece ... More >> AHEPA University Hospital Recruiting Thessaloníki, Greece, 56346 Contact: Katerina Kotzampassi, PhD    +302310994862    kakothe@yahoo.com    Contact: Georgia Tsaousi, Professor    +302310994855    tsaousig@otenet.gr Less <<
NCT00553852 Obesity GHD Phase 3 Completed - Italy ... More >> Department of Molecular and Clinical Endocrinology and Oncology Federico II University Naples, Italy, 80131 Less <<
NCT02960373 PreDiabetes D... More >>iabetes Mellitus Dysglycemia Less << Not Applicable Unknown - Canada, Ontario ... More >> GI Labs Toronto, Ontario, Canada, M5C 2N8 Less <<
NCT03612973 Chronic Hepatitis c Not Applicable Not yet recruiting December 31, 2021 -
NCT01771562 - Completed - Senegal ... More >> Hôpital d'enfant Albert Royer Dakar, Senegal Hôpital Roi Baudoin Guédiawaye, Senegal Less <<
NCT00572689 Gestational Diabetes Phase 4 Withdrawn - United States, District of Col... More >>umbia Georgetown University Medical Center Washington, District of Columbia, United States, 20007 Washington Hospital Center Washington, District of Columbia, United States, 20010 Less <<
NCT03544892 Diabetes Mellitus, Type 1 Not Applicable Recruiting May 1, 2019 United States, Oklahoma ... More >> University of Oklahoma Harold Hamm Diabetes Center Recruiting Tulsa, Oklahoma, United States, 74135 Contact: Julie Crawford, MS AHIP    918-619-4812    Julia-Crawford@ouhsc.edu Less <<
NCT02015780 Type 2 Diabetes Mellitus ... More >> Chronic Kidney Disease Less << Phase 3 Withdrawn(Due to potential con... More >>cerns about liver safety (See Detailed Description)) Less << January 2016 -
NCT01515930 Diabetes Not Applicable Completed - United States, Michigan ... More >> Wayne State University Detroit, Michigan, United States, 48201 Less <<
NCT03421379 Diabetes Mellitus Phase 3 Completed - Japan ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fukuoka, Japan, 812-0025 For additional information regarding investigative sites for this trial, contact 1-888-545-5972 Mon - Fri, 9 AM to 4 PM or 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time or speak with your personal physician. Shinjuku-Ku, Japan, 162-0053 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sumida, Japan, 130-0004 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tokyo, Japan, 169-0073 Less <<
NCT02379624 Nutrition Disorders ... More >> Critical Illness Less << Phase 1 Phase 2 Completed - -
NCT01462266 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT03313752 Type2 Diabetes Mellitus ... More >> Stable Coronary Artery Disease Less << Phase 3 Recruiting June 2019 Italy ... More >> Center For Endocrine and Metabolic Diseases - Catholic University Recruiting Rome, RM, Italy, 00168 Contact: ANDREA GIACCARI, MD, PhD    +390630156664    andrea.giaccari@unicatt.it    Contact: SERENA ROTUNNO    +390630158272    serenarotunno@guest.policlinicogemelli.it    Principal Investigator: ANDREA GIACCARI, MD, PHD Less <<
NCT01462266 - Completed - -
NCT01555190 Polycystic Ovary Syndrome ... More >> Hirsutism Menstrual Irregularity Less << Not Applicable Unknown - Italy ... More >> Catholic University of Sacred Heart Recruiting Rome, Italy, 00168 Contact: Maurizio Guido, Medical Doctor    00390630156013    maurizioguido@libero.it    Principal Investigator: Maurizio Guido, doctor Less <<
NCT01582061 Cushing's Disease Phase 3 Completed - -
NCT01468181 Type 2 Diabetes Mellitus Phase 3 Completed - Japan ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Aichi, Japan, 466-0815 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chiba, Japan, 277-0825 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hokkaido, Japan, 050-0073 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hyogo, Japan, 662-0971 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ibaraki, Japan, 300-0053 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kanagawa, Japan, 231-0023 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kyoto, Japan, 615-8125 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nagano, Japan, 390-1401 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Okayama, Japan, 700-8558 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Osaka, Japan, 560-0082 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Saitama, Japan, 3438577 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tokyo, Japan, 1030002 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Toyama, Japan, 930-0859 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Wakayama, Japan, 644-0011 Less <<
NCT01582061 - Completed - -
NCT01122979 Diabetes Mellitus, Type 2 Phase 4 Completed - Brazil ... More >> Investigational Site Number 076-007 Curitiba, Brazil, 80060-900 Investigational Site Number 076-010 Fortaleza, Brazil, 60015-052 Investigational Site Number 076-001 Fortaleza, Brazil, 60115-282 Investigational Site Number 076-003 Porto Alegre, Brazil, 91350-250 Investigational Site Number 076-005 São Paulo, Brazil, 01244-030 Investigational Site Number 076-013 São Paulo, Brazil, 01308-050 Investigational Site Number 076-004 São Paulo, Brazil, 01323-001 Investigational Site Number 076-002 São Paulo, Brazil, 04024-002 Investigational Site Number 076-009 São Paulo, Brazil, o4039-000 Investigational Site Number 076-006 Taguatinga, Brazil, 72155000 Less <<
NCT01817673 Healthy Persons Not Applicable Completed - Brazil ... More >> Univsersity of Sao Paulo Sao Paulo, Brazil, 05508-030 Less <<
NCT01468181 - Completed - -
NCT00959894 - Completed - -
NCT03365531 NAFLD Obesity... More >> Diabetes Mellitus, Type 2 Less << Not Applicable Recruiting May 31, 2019 United States, Florida ... More >> University of Florida Recruiting Gainesville, Florida, United States, 32610 Less <<
NCT00837122 - Recruiting - Ghana ... More >> University of Ghana Recruiting Accra, Ghana Contact: Albert Amoah    23330250038    agbamoah@hotmail.com    University of Science and Tech Recruiting Kumasi, Ghana Contact: Benjamin Eghan, M.D.    233322060021    eghanben@yahoo.com    Nigeria University of Nigeria Recruiting Enugu, Nigeria Contact: Johnnie Oli    08069332648    johnieoli@hotmail.com    University of Ibadan Recruiting Ibadan, Nigeria Contact: Clement Adebamowo    (410) 706-6116    cadebamo@yahoo.com    University of Lagos Recruiting Lagos, Nigeria Contact: Olufemi Fasanmadea    234805769990    ofasanmade@yahoo.com Less <<
NCT00959894 HIV Infections Phase 2 Completed - United States, North Carolina ... More >> The University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States, 27599-7215 Carolinas Medical Center Charlotte, North Carolina, United States, 28207 Wake Forest University Health Sciences Winston-Salem, North Carolina, United States, 27157 Less <<
NCT01631747 Pregnancy Wei... More >>ght Gain Less << Not Applicable Completed - United States, Illinois ... More >> Northwestern Memorial Hospital; Prentice Women's Chicago, Illinois, United States, 60611 Northwestern University: Dept of Preventive Medicine Chicago, Illinois, United States, 60611 Less <<
NCT01631747 - Completed - -
NCT02971228 Diabetes Mellitus, Type 1 Phase 2 Completed - United States, Massachusetts ... More >> MGH Diabetes Center Boston, Massachusetts, United States, 02114 Less <<
NCT02098746 - Completed - -
NCT02098746 - Completed - -
NCT03414736 Type 2 Diabetes Mellitus Phase 1 Completed - United States, Minnesota ... More >> Investigational Site Number 8400002 Saint Paul, Minnesota, United States, 55144 United States, Tennessee Investigational Site Number 8400003 Knoxville, Tennessee, United States, 37920 United States, Texas Investigational Site Number 8400001 Austin, Texas, United States, 78744 Less <<
NCT00501657 Gastroparesis ... More >> Diabetes Mellitus Less << Phase 1 Completed - Australia, South Australia ... More >> Discipline of Medicine, Royal Adelaide Hospital Adelaide, South Australia, Australia, 5000 Less <<
NCT00891514 Stroke Insuli... More >>n Resistance Sedentary Lifestyle Less << Not Applicable Completed - United States, Maryland ... More >> University of Maryland, VAMC Baltimore, Maryland, United States, 20705 Less <<
NCT03622424 Overweight and Obesity ... More >> PreDiabetes Type2 Diabetes Less << Not Applicable Recruiting November 2018 Denmark ... More >> University of Copenhagan Recruiting Frederiksberg, Denmark, DK-1958 Contact: Anders M Sjodin, MD    45 35 33 24 70    amsj@nexs.ku.dk Less <<
NCT01270061 Diabetes Hype... More >>rtension HIV Less << Not Applicable Withdrawn(We did not receive p... More >>roper funding to complete this study) Less << June 2015 United States, New York ... More >> Community Bronx Bronx, New York, United States, 10467 Less <<
NCT02097316 Type 1 Diabetes Phase 3 Completed - France ... More >> Centre Hospitalier Sud Francilien Evry, France, 91000 CHU Marseille-Hôpital Nord Marseille, France, 13000 CHU Strasbourg Strasbourg, France, 67091 Less <<
NCT03533738 Diabetes Mellitus ... More >> Obesity Less << Not Applicable Active, not recruiting December 2018 Singapore ... More >> Clinical Nutrition Research Centre Singapore, Singapore, 117599 Less <<
NCT02735044 Type 1 Diabetes Mellitus Phase 3 Active, not recruiting December 24, 2018 -
NCT03430284 Diabetes Mellitus, Type 2 Phase 4 Recruiting December 31, 2020 China, Shandong ... More >> Shandong Provincial Hospital Not yet recruiting Jinan, Shandong, China, 250021 Contact: Shanshan Shao    +8653168776094    shaoshanshan11@126.com    Shandong Provincial Hospital Recruiting Jinan, Shandong, China Less <<
NCT01801033 - Withdrawn - -
NCT01329367 Obesity Not Applicable Active, not recruiting December 2019 Spain ... More >> UNavarre Pamplona, Navarra, Spain, 31008 University of Navarre Pamplona, Navarra, Spain, 31008 Less <<
NCT00911404 Gestational Diabetes Mellitus ... More >>(GDM) Less << Not Applicable Completed - Spain ... More >> Hospital Universitari Arnau de Vilanova Lleida, Spain, 25198 Less <<
NCT00686192 Obesity Not Applicable Completed - United States, California ... More >> San Francisco General Hospital San Francisco, California, United States, 94110 Less <<
NCT01955031 Type 2 Diabetes Not Applicable Active, not recruiting August 2018 France ... More >> University Hospitals of Toulouse (Rangueil and Salies-Du-Salat) Toulouse, Midi-Pyrénées, France, 31059 Less <<
NCT03075228 - Terminated(Low recruitment rat... More >>e; high proportion of screening failures.) Less << - Netherlands ... More >> NIZO food research BV Ede, Netherlands, 6710 BA Less <<
NCT01681810 Metabolic Syndrome ... More >> Hypertension Less << Phase 2 Completed - United States, Pennsylvania ... More >> Montefiore Hospital of UPMC Pittsburgh, Pennsylvania, United States, 15213 Less <<
NCT00574639 Type 1 Diabetes Early Phase 1 Completed - United States, Maryland ... More >> University of Maryland, Baltimore Baltimore, Maryland, United States, 21201 Less <<
NCT02908555 - Completed - United States, Connecticut ... More >> Yale School of Nursing West Haven, Connecticut, United States, 06516-0972 Less <<
NCT02655263 Healthy Not Applicable Completed - Denmark ... More >> Aarhus University Hospital Aarhus, Denmark, 8000 Less <<
NCT00980083 Healthy Subjects ... More >> Gastric Emptying Less << Phase 1 Completed - Germany ... More >> Department of Internal Medicine II, University of Munich Munich, Germany, 81377 Less <<
NCT01263717 HIV HIV Lipod... More >>ystrophy Less << Not Applicable Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT01238289 Diabetes Mellitus, Type 2 Not Applicable Completed - United States, California ... More >> Scripps Whittier Diabetes Institute La Jolla, California, United States, 92037 Less <<
NCT02846233 Type 2 Diabetes Mellitus Not Applicable Recruiting December 2018 United States, California ... More >> UCSF Fresno Recruiting Fresno, California, United States, 93701 Contact: SOE NAING       snaing@fresno.ucsf.edu Less <<
NCT00824616 - Completed - -
NCT01263717 - Completed - -
NCT00341614 Cardiovascular Diseases ... More >> Diabetes Mellitus, Type 2 Less << Phase 1 Completed - United States, California ... More >> University of California, San Francisco San Francisco, California, United States, 94143 Less <<
NCT00824616 Type 2 Diabetes Mellitus Phase 2 Completed - -
NCT01250106 Obesity Type ... More >>2 Diabetes Less << Phase 1 Phase 2 Unknown December 2011 Germany ... More >> German Diabetes Center Recruiting Düsseldorf, Duesseldorf, Germany, 40225 Contact: Nanette C Schloot, MD    +49 211 3382 ext 665    schloot@ddz.uni-duesseldorf.de    Contact: Marie-Christine Simon, Dipl. Oecotroph    +49 211 3382 ext 229    marie-christine.simon@ddz.uni-duesseldorf.de    Principal Investigator: Nanette C. Schloot, MD Less <<
NCT01163006 Type 2 Diabetes Mellitus ... More >> Obesity Less << Not Applicable Completed - Netherlands ... More >> Maastricht University Maastricht, Netherlands, 6200 MD Less <<
NCT02209025 Cardiovascular Disease Not Applicable Completed - Netherlands ... More >> Maastricht University Hospital Maastricht, Netherlands, 6200 MD Less <<
NCT02131896 Type 1 Diabetes Not Applicable Terminated(Recruitment difficu... More >>lties) Less << - Israel ... More >> Schneider Children's Medical Center Petah-Tikva, Israel, 49202 Less <<
NCT01354015 - Completed - -
NCT01751100 HIV Infections Not Applicable Withdrawn(We did not receive p... More >>roper funding to complete this study.) Less << July 2016 United States, New York ... More >> Albert Einstein College of Medicine Bronx, New York, United States, 10461 Less <<
NCT00958399 Healthy Not Applicable Completed - United States, Minnesota ... More >> University of Minnesota - General Clinical Research Center Minneapolis, Minnesota, United States, 55455 Less <<
NCT00272077 Diabetes Mellitus, Type 2 Phase 4 Completed - -
NCT01654341 Type 2 Diabetes Mellitus Not Applicable Unknown March 2017 Spain ... More >> Hospital Universitario de Getafe Madrid, Getafe, Spain, 28905 Less <<
NCT01354015 Diabetes Not Applicable Completed - United States, Louisiana ... More >> Tulane University New Orleans, Louisiana, United States, 70112 Less <<
NCT00468364 - Completed - Germany ... More >> Clinical Research Unit Giessen, Germany, 35392 Less <<
NCT00755313 - Completed - United States, California ... More >> UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States, 94115 Less <<
NCT01563120 Gestational Diabetes Mellitus Phase 4 Completed - Israel ... More >> Dep. OB/GYN, Emek Medical Center Afula, Israel Less <<
NCT00401453 Diabetes Mellitus Type 2 ... More >> Insulin Resistance Less << Phase 3 Completed - Germany ... More >> Fifth Medical Clinic Mannheim, Baden-Wuerttemberg, Germany, 68167 Less <<
NCT01457911 Type 2 Diabetes Mellitus Phase 3 Completed - China ... More >> Investigational Site Number 156001 Beijing, China, 100044 Investigational Site Number 156016 Beijing, China, 100088 Investigational Site Number 156003 Beijing, China, 100730 Investigational Site Number 156018 Beijing, China, 100730 Investigational Site Number 156002 Beijing, China, 100853 Investigational Site Number 156019 Changchun, China, 130041 Investigational Site Number 156017 Chengdu, China, 610083 Investigational Site Number 156014 Guangzhou, China, 510080 Investigational Site Number 156022 Guangzhou, China, 510150 Investigational Site Number 156011 Hangzhou, China, 310003 Investigational Site Number 156012 Hefei, China, 230001 Investigational Site Number 156020 Jinan, China, 250012 Investigational Site Number 156023 Jinan, China, 250021 Investigational Site Number 156010 Shanghai, China, 200040 Investigational Site Number 156006 Shanghai, China, 200072 Investigational Site Number 156009 Shanghai, China, 200080 Investigational Site Number 156021 Shenyang, China, 110022 Investigational Site Number 156005 Shijiazhuang, China, 050051 Investigational Site Number 156004 Taiyuan, China, 030001 Investigational Site Number 156024 Tianjin, China, 300052 Investigational Site Number 156008 Wuhan, China, 430022 Investigational Site Number 156015 Xiamen, China, 361003 Less <<
NCT02232087 Healthy Phase 1 Completed - United Kingdom ... More >> Quotient Clinical Ltd Ruddington, Nottingham, United Kingdom, NG11 6JS Less <<
NCT00638573 - Completed - Denmark ... More >> Gentofte University Hospital Hellerup, Copenhagen County, Denmark, 2900 Less <<
NCT01792986 - Completed - -
NCT02189005 Diabetes Mellitus ... More >> Pre-Diabetes Hyperglycemia Metabolic Syndrome Less << Phase 3 Completed - India ... More >> Dia Care- Diabetes Care and Hormone Clinic Ahmedabad, Gujarat, India, 380015 St. Johns College and Hospital Bangalore, Karnataka, India, 560034 Totall Diabetes and Hormone Institution Indore, Madhya Pradesh, India, 452010 Bhatia Hospital Mumbai, Maharashtra, India, 411007 Inamdar Multispeciality Hospital Pune, Maharashtra, India, 411040 Diabetes Care Centre Jaipur, Rajasthan, India, 302018 Less <<
NCT01995539 - Completed - -
NCT01792986 Diabetes Meta... More >>bolic Diseases Less << Not Applicable Completed - United States, Utah ... More >> Intermountain Medical Center Murray, Utah, United States, 84107 Intermountain Medical Center Salt Lake City, Utah, United States, 84107 Less <<
NCT01995539 Diabetes Mellitus, Type 2 Not Applicable Completed - India ... More >> Madras Diabetes Research Foundation Gopalapuram, Chennai, India, 600086 DIA Care Ahmedabad, Gujarat, India, 380015 Medanta Gurgaon, Haryana, India, 122 001 Jothydev's Diabetes and Research Centre Trivandrum, Kerala, India, 695032 TOTALL Diabetes Hormone Institute Indore, Madhya Pradesh, India, 452010 K.G.N Diabetes and Endocrine Centre Mumbai, Maharashtra, India, 400008 Lina Diabetes Care Centre Mumbai, Maharashtra, India, 400053 Dr.Kovil's Diabetes Care centre Mumbai, Maharashtra, India, 400058 Diab Care Center Mumbai, Maharashtra, India, 400080 Diabetes Care & Research Center Pune, Maharashtra, India, 411011 M.V Hospital for Diabetes Research centre Chennai, Tamil Nadu, India, 600013 Less <<
NCT02574156 Hyperglycemia Phase 3 Recruiting December 20, 2018 Brazil ... More >> Eduesley Santana Santos Recruiting São Paulo, Brazil, 01307-000 Contact: Eduesley Santana-Santos, Ph.D Less <<
NCT03361098 Type 2 Diabetes Mellitus ... More >> Obesity Less << Phase 4 Recruiting January 31, 2020 Netherlands ... More >> VU Medical Center Recruiting Amsterdam, Noord-Holland, Netherlands, 1081 HV Contact: Charlotte C van Ruiten, MD    +31204443287    c.ruiten@vumc.nl Less <<
NCT00896610 - Recruiting - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)    800-411-1222 ext TTY8664111010    prpl@cc.nih.gov Less <<
NCT02024477 Type 2 Diabetes Phase 4 Active, not recruiting January 2018 United States, District of Col... More >>umbia Medical Faculty Associates Inc Washington, District of Columbia, United States, 20037 Less <<
NCT00543361 Diabetes Mellitus, Type 2 Phase 3 Terminated - -
NCT02093572 Skipping Breakfast ... More >> Circadian Rhythms Less << Not Applicable Recruiting March 2020 United States, Missouri ... More >> Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: Kyleigh Kirbach, RDN    314-362-8250    kkirbach@wustl.edu    Contact: Rick Stein, PhD    314-286-0077    rstein@wustl.edu    Principal Investigator: Jun Yoshino, MD, PhD          Sub-Investigator: Samuel Klein, MD Less <<
NCT00479258 Diabetes Mellitus, Type 1 Phase 3 Terminated(See termination rea... More >>son in detailed description.) Less << - United States, New York ... More >> Pfizer Investigational Site Buffalo, New York, United States, 14222 Less <<
NCT02027753 Diabetes Mellitus, Type 2 Phase 4 Completed - Korea, Republic of ... More >> Sanofi-Aventis Administrative Office Seoul, Korea, Republic of Less <<
NCT00362765 Type 2 Diabetes ... More >> Dyslipidemia Less << Phase 2 Phase 3 Terminated(The study was prema... More >>turely terminated, due to difficulties in the recruitment of T2DM patients who are not under statin therapy at inclusion.) Less << - Finland ... More >> Site 2 Turku, Finland Ireland Site 3 Dublin, Ireland Italy Site 1 Pisa, Italy Less <<
NCT02978547 Resectable Pancreatic Ductal A... More >>denocarcinoma Less << Phase 2 Not yet recruiting January 2021 Canada, British Columbia ... More >> BC Cancer Agency - Vancouver Cancer Centre Vancouver, British Columbia, Canada, V5Z 4E6 Less <<
NCT00923962 Type 2 Diabetes Mellitus Not Applicable Completed - Denmark ... More >> University Hospital Gentofte, Department of Cardiology Gentofte, Denmark, 2900 Less <<
NCT00479258 - Terminated(See termination rea... More >>son in detailed description.) Less << - -
NCT03029702 Gestational Diabetes ... More >> Diabetes, Gestational Pregnancy in Diabetes Less << Phase 4 Recruiting March 30, 2021 United States, Pennsylvania ... More >> Magee Womens Hospital of UPMC Recruiting Pittsburgh, Pennsylvania, United States, 15213 Contact: Maisa Feghali, MD    412-641-4874    feghalim@upmc.edu    Principal Investigator: Maisa Feghali, MD Less <<
NCT03146975 Periodontitis ... More >> Diabetes Mellitus Less << Not Applicable Completed - Brazil ... More >> Federal university of minas gerais Belo Horizonte, Minas Gerais, Brazil Less <<
NCT01185236 Type 2 Diabetes Mellitus Witho... More >>ut Insulin Treatment Less << Phase 4 Unknown August 2011 Korea, Republic of ... More >> Seoul national university hospital Not yet recruiting Seoul, Korea, Republic of, 110744 Principal Investigator: Hyun-Jae Kang Less <<
NCT01724645 Diabetes Mellitus, Type 2 Not Applicable Completed - Korea, Republic of ... More >> Clinical Trial Center for Functional Foods; Chonbuk National University Hospital Jeonju, Jeollabuk-do, Korea, Republic of, 560-822 Less <<
NCT00766909 Complications of Transplanted ... More >>Organs and Tissue Diabetes Mellitus Nos New Onset Less << Phase 4 Completed - Denmark ... More >> Department of Nephrology, Aarhus University Hospital, Skejby Aarhus, Jutland, Denmark, 8200 Less <<
NCT02517697 Metabolic Syndrome ... More >> Hypertension Less << Phase 2 Not yet recruiting June 2020 United States, Pennsylvania ... More >> Montefiore Hospital of UPMC Recruiting Pittsburgh, Pennsylvania, United States, 15213 Less <<
NCT01393210 Obesity Not Applicable Completed - Poland ... More >> Institute of Animal Reproduction and Food Research, Polish Academy of Sciences Olsztyn, Poland, 10-748 Less <<
NCT01803633 Metabolic Syndrome ... More >> Obesity Less << Not Applicable Completed - United States, California ... More >> USDA Western Human Nutrition Research Center Davis, California, United States, 95616 Less <<
NCT00676923 - Completed - United States, Oregon ... More >> Legacy Good Samaritan Hospital Portland, Oregon, United States Oregon Health and Science University Portland, Oregon, United States United States, Pennsylvania University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States, 15213 United States, Washington University of Washington Seattle, Washington, United States, 98195 Virginia Mason Medical Center Seattle, Washington, United States, 98195 Less <<
NCT00410800 - Completed - United States, Arizona ... More >> NIDDK, Phoenix Phoenix, Arizona, United States, 85014 Less <<
NCT00895921 Diabetes Phase 4 Completed - United States, California ... More >> VA San Diego Healthcare System San Diego, California, United States, 92161 Less <<
NCT01735253 Non Insulin Dependent Diabetes... More >> Mellitus Less << Not Applicable Completed - Korea, Republic of ... More >> Yoonseok Heo Incheon, Korea, Republic of, 400-712 Less <<
NCT01475565 - Terminated(Only 2 participants... More >> were enrolled) Less << - United States, Virginia ... More >> Virginia Commonwealth University Medical Center Richmond, Virginia, United States, 23298-5051 Less <<
NCT02058160 Type 2 Diabetes Phase 3 Completed - -
NCT02026310 Diabetes Mellitus, Type 2 Not Applicable Completed - China, Chongqing ... More >> The First Affiliated Hospital of Chongqing Medical University Chongqing,, Chongqing, China, 400016 Less <<
NCT00640224 Polycystic Ovary Syndrome Phase 4 Completed - United States, Pennsylvania ... More >> Children's Hospital of Pittsburgh Pittsburgh, Pennsylvania, United States, 15224 Less <<
NCT02197299 Type 2 Diabetes Phase 2 Unknown - United Kingdom ... More >> David Greenfield Human Physiology Unit, School of Life Sciences, The University of Nottingham Recruiting Nottingham, United Kingdom, NG72UH Contact: Sara Brown       sara.brown@nottingham.ac.uk    Principal Investigator: Francis B Stephens, PhD Less <<
NCT00640224 - Completed - -
NCT01060605 Diabetes Mellitus, Type 1 Phase 3 Completed - Italy ... More >> Transplant Unit, IRCCS San Raffaele Milano, Italy, 20131 Less <<
NCT02783703 Metabolic Syndrome X Not Applicable Completed - United States, Massachusetts ... More >> Boston Medical Center Boston, Massachusetts, United States, 02118 Less <<
NCT03126981 PreDiabetes Not Applicable Active, not recruiting April 30, 2019 United States, Florida ... More >> MB Clinical Research Boca Raton, Florida, United States, 33487 United States, Illinois Illinois Institute for Food Safety and Health (IFSH) at Illinois Instiute of Technology (IIT) Chicago, Illinois, United States, 60616 Less <<
NCT00670228 - Terminated(Due to Negative fea... More >>sibility assessment of recruiting the planned number of subjects within the study timelines) Less << - -
NCT00670228 AMI Phase 3 Terminated(Due to Negative fea... More >>sibility assessment of recruiting the planned number of subjects within the study timelines) Less << - United States, New Jersey ... More >> Sanofi-Aventis Administrative Office Bridgewater, New Jersey, United States Argentina Sanofi-Aventis Administrative Office Buenos Aires, Argentina Brazil Sanofi-Aventis Administrative Office Sao Paulo, Brazil Canada Sanofi-Aventis Administrative Office Laval, Canada Mexico Sanofi-Aventis Administrative Office Col. Coyoacan, Mexico Less <<
NCT00854347 - Completed - -
NCT02577016 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT02058160 - Completed - -
NCT02577016 - Completed - -
NCT03351478 Type 2 Diabetes Mellitus Phase 3 Active, not recruiting May 2019 -
NCT00460018 Gestational Diabetes Mellitus Phase 2 Completed - United States, California ... More >> Kaiser Permanente Oakland Oakland, California, United States, 94611 Kaiser Permanente Division of Research Oakland, California, United States, 94612 Kaiser Permanente San Francisco San Francisco, California, United States, 94115 Kaiser Permanente Santa Clara/Santa Teresa Santa Clara, California, United States, 95051 Kaiser Permanente Walnut Creek Walnut Creek, California, United States, 94596 Less <<
NCT00982293 Type 2 Diabetes Phase 2 Terminated(Difficulty in Recru... More >>itment) Less << - United States, Colorado ... More >> pico-tesla Magnetic Therapies Littleton, Colorado, United States, 80120 Less <<
NCT00360334 Type 2 Diabetes Phase 3 Completed - United Kingdom ... More >> Research Site Aberdeen, United Kingdom Research Site Bath, United Kingdom Research Site Blackburn, United Kingdom Research Site Bolton, United Kingdom Research Site Bournemouth, United Kingdom Research Site Bristol, United Kingdom Research Site Chippenham, United Kingdom Research Site Edinburgh, United Kingdom Research Site Glasgow, United Kingdom Research Site Haywards Heath, United Kingdom Research Site High Wycombe, United Kingdom Research Site Hull, United Kingdom Research Site Ipswich, United Kingdom Research Site Kent, United Kingdom Research Site Leicester, United Kingdom Research Site Liverpool, United Kingdom Research Site Livingstone, United Kingdom Research Site London, United Kingdom Research Site Manchester, United Kingdom Research Site Middlesborough, United Kingdom Research Site Norwich, United Kingdom Research Site Nottingham, United Kingdom Research Site Oldham, United Kingdom Research Site Oxford, United Kingdom Research Site Plymouth, United Kingdom Research Site Rochdale, United Kingdom Research Site Salford, United Kingdom Research Site Swansea, United Kingdom Research Site Torquay, United Kingdom Research Site Wakefield, United Kingdom Research Site Wirral, United Kingdom Less <<
NCT02256865 Insulin Resistance Early Phase 1 Active, not recruiting October 2019 United States, California ... More >> Los Angeles Biomedical Research Institute Torrance, California, United States, 90509 Less <<
NCT00360334 - Completed - -
NCT00729196 Type 2 Diabetes Mellitus ... More >> Obesity Less << Not Applicable Completed - United States, Pennsylvania ... More >> University of Pennsylvania, Center for Weight and Eating Disorders Philadelphia, Pennsylvania, United States, 19104-3309 Less <<
NCT03293706 Gastro-Intestinal Tolerance Not Applicable Completed - Canada, Ontario ... More >> Glycemic Index Laboratories, Inc. Toronto, Ontario, Canada, M5C 2N8 Less <<
NCT00795691 Type 2 Diabetes Not Applicable Unknown December 2008 United States, New York ... More >> Albert Einstein College of Medicine, General Clinical Research Center Bronx, New York, United States, 10461 Less <<
NCT01339143 Diabetes Mellitus ... More >> Oxidative Stress Less << Phase 4 Unknown May 2013 Korea, Republic of ... More >> Korea University Anam Hospital Recruiting Seoul, Korea, Republic of Less <<
NCT02929472 Physical Activity ... More >> Metabolic Diseases Less << Not Applicable Completed - -
NCT00989378 - Completed - United States, Illinois ... More >> University of Chicago Chicago, Illinois, United States, 60637 Less <<
NCT01319357 Diabetes Mellitus Type 2 Phase 3 Completed - Germany ... More >> Clinical Research Center, Department of Nephrology and Hypertension, University of Erlangen-Nuremberg Erlangen, Germany, 91054 Less <<
NCT00871572 Diabetes Mellitus, Type 2 Phase 2 Completed - United States, California ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Buena Park, California, United States, 90620 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Huntington Park, California, United States, 90255 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Westlake Village, California, United States, 91361 United States, Florida For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fort Lauderdale, Florida, United States, 33306 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Jupiter, Florida, United States, 33458 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. New Port Richey, Florida, United States, 34652 United States, Idaho For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Idaho Falls, Idaho, United States, 83404 United States, Kansas For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Topeka, Kansas, United States, 66606 United States, Kentucky For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Madisonville, Kentucky, United States, 42431 United States, Nevada For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Las Vegas, Nevada, United States, 89101 United States, South Dakota For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Rapid City, South Dakota, United States, 57702 United States, Texas For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. San Antonio, Texas, United States, 78229 United States, Virginia For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Norfolk, Virginia, United States, 23502 Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Aschaffenburg, Germany, 63739 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mainz, Germany, 55116 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Munchen, Germany, 80336 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Saarlouis, Germany, 66740 Lithuania For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kaunas, Lithuania, LT-51270 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Vilnius, Lithuania, LT-08661 Less <<
NCT00241605 Diabetes Mellitus, Type 2 Phase 4 Completed - -
NCT00417170 High Blood Pressure ... More >> Metabolic Syndrome Insulin Resistance Endothelial Dysfunction Less << Phase 2 Completed - United States, California ... More >> Novartis Investigative Site Santa Monica, California, United States, 90404 Less <<
NCT00004699 Hyperinsulinism Not Applicable Completed - -
NCT02918591 Type 2 Diabetes Not Applicable Not yet recruiting December 2018 -
NCT00871572 - Completed - -
NCT01336751 Diabetes Mellitus, Type 2 Phase 3 Completed - United States, New Jersey ... More >> Sanofi-Aventis Administrative Office Bridgewater, New Jersey, United States Less <<
NCT01691547 Pulmonary Disease, Chronic Obs... More >>tructive Less << Phase 1 Completed - United States, Maryland ... More >> GSK Investigational Site Baltimore, Maryland, United States, 21225 Less <<
NCT00727779 Metabolic Syndrome Not Applicable Completed - United States, Tennessee ... More >> East Tennessee State Univ Johnson City, Tennessee, United States, 37614 Less <<
NCT00417170 - Completed - -
NCT01283854 Gestational Diabetes Mellitus Not Applicable Completed - Australia, Western Australia ... More >> King Edward Memorial Hospital Perth, Western Australia, Australia, 6008 Less <<
NCT01770561 Diabetes Type 1 Not Applicable Completed - Denmark ... More >> Hvidovre Hospital Hvidovre, Denmark, 2650 Less <<
NCT01144078 Type 2 Diabetes Mellitus Not Applicable Completed - Canada, Alberta ... More >> University of Alberta Edmonton, Alberta, Canada, T6G 2H9 Less <<
NCT02850874 Pancreatic Neoplasms ... More >> Pancreatic Adenocarcinoma Less << Phase 2 Withdrawn(no accrual rate) - United States, North Carolina ... More >> Carolinas Medical Center Charlotte, North Carolina, United States, 28204 Less <<
NCT03494010 - Not yet recruiting April 30, 2021 -
NCT02830126 Health Information Technology Not Applicable Recruiting December 2019 United States, Missouri ... More >> Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: Sherry McKinnon, BS    314-286-1768    mckinnos@anest.wustl.edu    Principal Investigator: Michael S. Avidan, MBBCh, FCASA Less <<
NCT01924637 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 1 Completed - Austria ... More >> Novo Nordisk Investigational Site Graz, Austria, 8010 Less <<
NCT01773798 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 1 Completed - Austria ... More >> Graz, Austria, 8010 Less <<
NCT02106039 Diabetes Mellitus ... More >> Pulmonary Tuberculosis Less << Not Applicable Active, not recruiting December 31, 2018 Indonesia ... More >> Faculty of Medicine, Universitas Padjadjaran Bandung, West Java, Indonesia, 40161 Peru Universidad Peruana Cayetano Heredia Lima, San Martin De Porres, Peru, 31 Romania University of Medicine and Pharmacy Craiova Bucharest, Romania Less <<
NCT01666223 Type 2 Diabetes ... More >> Obesity Less << Not Applicable Completed - Denmark ... More >> Diabetes Research Division, Department of Internal Medicine, Gentofte Hospital, University of Copenhagen Hellerup, Copenhagen, Denmark Less <<
NCT00770614 Contrast Induced Nephropathy Phase 4 Completed - Italy ... More >> Ospedale Misericordia e Dolce Prato, Italy, 59100 Less <<
NCT02783196 Type 2 Diabetes Not Applicable Unknown June 2017 Israel ... More >> Diabetes Unit E. Wolfson Hospital Holon, Tel Aviv, Israel, 58100 Less <<
NCT02942056 Diabetes Mellitus Phase 2 Not yet recruiting January 2020 -
NCT01240980 Diabetes Phase 1 Completed - United States, Florida ... More >> Comprehensive Phase One Miramar, Florida, United States, 33025 United States, Texas Ppd Development, Lp Austin, Texas, United States, 78744 Less <<
NCT02058940 Brain Injuries Phase 4 Completed - United States, North Carolina ... More >> University of North Carolina; UNC Medical Center Chapel Hill, North Carolina, United States, 27599 Less <<
NCT01865292 Diabetes Diab... More >>etes Mellitus, Type 1 Diabetes Mellitus, Type 2 Less << Phase 1 Completed - Germany ... More >> Neuss, Germany, 41460 Less <<
NCT02058940 - Completed - -
NCT02029846 - Terminated(No sufficient numbe... More >>rs of eligible participants) Less << - -
NCT01048606 Overweight Phase 4 Completed - Canada, Quebec ... More >> Centre de recherche sur le vieillissement du CSSS-IUGS Sherbrooke, Quebec, Canada, J1H 4C4 Less <<
NCT01868529 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 1 Completed - Germany ... More >> Neuss, Germany, 41460 Less <<
NCT02020694 Obesity Overw... More >>eight Insulin Resistance Less << Phase 4 Completed - Italy ... More >> Catholic University of Sacred Heart Rome, Italy, 00168 Less <<
NCT01844050 Type 2 Diabetes Mellitus Not Applicable Completed - China, Shanghai ... More >> Shanghai University of Traditional Chinese Medicine Shanghai, Shanghai, China, 201108 Less <<
NCT02029846 Type 2 Diabetes Mellitus Phase 4 Terminated(No sufficient numbe... More >>rs of eligible participants) Less << - United States, Maryland ... More >> Bay West Endocrinology Associates Baltimore, Maryland, United States, 21204 Less <<
NCT03766854 Diabetes Mellitus, Type 1 Phase 1 Not yet recruiting December 13, 2019 Japan ... More >> Novo Nordisk Investigational Site Not yet recruiting Fukuoka, Japan, 812-0025 Less <<
NCT01771185 Type 2 Diabetes Not Applicable Unknown December 2013 -
NCT02681887 Obesity Predi... More >>abetic State Less << Phase 3 Recruiting December 2021 United States, Massachusetts ... More >> Brigham and Women's Hospital Recruiting Boston, Massachusetts, United States, 02115 Contact: Fatima Adigun, MPH    617-264-3071    fadigun-bello@partners.org    Principal Investigator: John P Forman, MD, MSc Less <<
NCT02948647 NAFLD Not Applicable Recruiting November 2019 United States, California ... More >> Diabetes & Obesity Research Institute Recruiting Los Angeles, California, United States, 90033-9073 Contact: Christina Ayala, MPH    323-442-2500    trujillc@usc.edu    Principal Investigator: Michael I Goran, PhD Less <<
NCT03536650 NASH - Nonalcoholic Steatohepa... More >>titis Less << Not Applicable Recruiting December 31, 2019 Belgium ... More >> Erasme Hospital Recruiting Brussels, Belgium, 1070 Contact: Mona Hammam    +32 2 555 47 64    mona.hammam@erasme.ulb.ac.be    Principal Investigator: Jacques Deviere, MD,PhD          Sub-Investigator: Christophe Moreno, MD, PhD Less <<
NCT03696797 Iron Diabetes... More >> Nonalcoholic Fatty Liver Less << Not Applicable Not yet recruiting November 2023 United States, North Carolina ... More >> University of North Carolina at Chapel Hill (UNC) Not yet recruiting Chapel Hill, North Carolina, United States, 27599-2100 Contact: John Buse, MD, Ph.D       John_buse@med.unc.edu    Contact: Laura Young, MD       Laura_Young@med.unc.edu    Wake Forest University Health Sciences Not yet recruiting Winston-Salem, North Carolina, United States, 27157 Contact: Donald A McClain, MD    336-716-7782    dmcclain@wakehealth.edu    Contact: Audrey Bell-Farrow, MBA, MHA    336-713-0370    abellfa@wakehealth.edu Less <<
NCT01310452 Type 2 Diabetes Mellitus Not Applicable Unknown - China ... More >> Zhong Shan Hospital, Fudan University Shang hai, China Less <<
NCT02778776 Metabolic Syndrome Phase 3 Completed - Mexico ... More >> Universidad de Guadalajara Guadalajara, Jalisco, México, Mexico, 44100 Less <<
NCT00755547 Type 2 Diabetes Mellitus ... More >> Adolescent Obesity Less << Phase 4 Completed - Canada, Manitoba ... More >> Manitoba Institute of Child Health Winnipeg, Manitoba, Canada, R3E3P4 Less <<
NCT02586168 Insulin Sensitivity Phase 2 Completed - -
NCT00562172 Type 2 Diabetes Mellitus Phase 4 Completed - Korea, Republic of ... More >> Sanofi-aventis Seoul, Korea, Republic of Less <<
NCT00675493 - Completed - Romania ... More >> Bucharest, Romania, 010031 Less <<
NCT01985685 Critically Ill ... More >> Respiratory Failure Less << Phase 2 Completed - United States, Massachusetts ... More >> Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Less <<
NCT01985685 - Completed - -
NCT01500850 Insulin-requiring Type 2 Diabe... More >>tes Mellitus Less << Phase 4 Unknown October 2012 Germany ... More >> ikfe GmbH Recruiting Mainz, Rheinland-Pfalz, Germany, 55116 Contact: Thomas Forst, MD    +49(0) 6131-576 36 -40 ext 16    thomasf@ikfe.de    Contact: Daniela Sachsenheimer, MD    +49(0) 6131-576 36 40 ext 46    danielas@ikfe.de    Sub-Investigator: Daniela Sachsenheimer, MD          Sub-Investigator: Stephanie Helleberg, MD          Sub-Investigator: Stephan Diessel Less <<
NCT02088658 Diabetes Mellitus, Type 2 ... More >> Diabetes Mellitus, Adult-Onset Diabetes Mellitus, Non-Insulin-Dependent Diabetes Mellitus, Noninsulin Dependent Diabetes Mellitus, Type II Less << Not Applicable Active, not recruiting April 2019 United States, South Carolina ... More >> Medical University of South Carolina Charleston, South Carolina, United States, 29425 Less <<
NCT01447524 Morbid Obesity ... More >> Type 2 Diabetes Mellitus Less << Not Applicable Completed - Italy ... More >> San Giovanni Calibita Fatebenefratelli Hospital Rome, Italy, 00186 Less <<
NCT00373178 Type 2 Diabetes Mellitus Phase 4 Completed - Greece ... More >> AHEPA University Hospital of Thessaloniki Thessaloniki, Greece Aristotle University of Thessaloniki Thessaloniki, Greece Less <<
NCT00303134 Diabetes Mellitus, Type 1 Phase 1 Suspended - United States, New York ... More >> New York Presbyterian Hospital - Weill Cornell Medical Center New York, New York, United States, 10021 Less <<
NCT02293772 Hypoxia Not Applicable Completed - -
NCT01752803 Type 2 Diabetes Mellitus ... More >> Obesity Hypertension Hyperlipidemia Less << Not Applicable Unknown July 2015 Malaysia ... More >> Universiti Kebangsaan Malaysia Medical Center Recruiting Kuala Lumpur, WP, Malaysia, 56000 Principal Investigator: Somayyeh Firouzi, Master Less <<
NCT00546325 Diabetes Mellitus, Type 2 Phase 3 Completed - Australia ... More >> Sanofi-Aventis Administrative Office North Ryde, Australia Less <<
NCT00682097 Diabetes Mellitus Type 2 Phase 1 Completed - United States, California ... More >> Chula Vista, California, United States, 91911 United States, Texas San Antonio, Texas, United States, 78229 Germany Neuss, Germany, 41460 Less <<
NCT00867932 Hemoglobinuria, Paroxysmal Phase 4 Completed - United States, California ... More >> Orange, California, United States, 92868 United States, Florida Pensacola, Florida, United States, 32504 United States, Tennessee Memphis, Tennessee, United States, 38105 Less <<
NCT00867932 - Completed - -
NCT03330470 Subjective Cognitive Impairmen... More >>t Mild Cognitive Impairment Parkinson Disease Healthy Volunteers Less << Not Applicable Recruiting December 31, 2020 Slovakia ... More >> University Hospital Bratislava, Comenius University Active, not recruiting Bratislava, Slovakia, 81369 Biomedical Research Center, Slovak Academy of Sciences Recruiting Bratislava, Slovakia, 84505 Contact: Barbara Ukropcová, Assoc. Prof., MD, PhD    +421 2 32295 2261    barbara.ukropcova@savba.sk    Principal Investigator: Jozef Ukropec, DrSC., PhD          Sub-Investigator: Lucia Slobodová, Mgr.          Sub-Investigator: Martin Schon, MD          Taiwan Laboratory of Cognitive Neurophysiology, Institute of Physical Education, Health & Leisure Studies, National Cheng Kung University Active, not recruiting Tainan City, Tainan, Taiwan, 701 Less <<
NCT01169818 Diabetes Mellitus, Type 2 Phase 4 Completed - China ... More >> Administrative office Shanghai, China India Administrative office Mumbai, India Japan Administrative office Tokyo, Japan Pakistan Administrative office Karachi, Pakistan Philippines Administrative office Makati City, Philippines Russian Federation Administrative office Moscow, Russian Federation Less <<
NCT01848795 Type 2 Diabetes ... More >> Obesity Less << Phase 4 Recruiting May 2019 Italy ... More >> ISMETT Recruiting Palermo, Italy, 90127 Contact: Anna Casu, MD    +390912192111    acasu@ismett.edu    Contact: Mario Traina, MD    +390912192111    mtraina@ismett.edu    Principal Investigator: Anna Casu, MD          Sub-Investigator: Mario Traina, MD Less <<
NCT01667900 - Completed - -
NCT01667900 Diabetes Mellitus, Type 2 ... More >> Healthy Volunteers Less << Phase 1 Completed - China ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Beijing, China, 100034 Less <<
NCT01298817 Abdominal Obesity Not Applicable Completed - United States, North Carolina ... More >> Wake Forest University Winston-Salem, North Carolina, United States, 27157 Less <<
NCT00456027 Latent Autoimmune Diabetes in ... More >>Adult (LADA) Less << Phase 2 Completed - Sweden ... More >> Alingsås Hospital Alingsås, Sweden Falu Hospital Falun, Sweden Capio Lundby Hospital Göteborg, Sweden Helsingborg Hospital Helsingborg, Sweden Härnösand Hospital Härnösand, Sweden Karlstad Central Hospital Karlstad, Sweden Central Hospital, Kristianstad Kristianstad, Sweden Sunderby Hospital Luleå, Sweden University Hospital MAS Malmö, Sweden Vrinnevi Hospital Norrköping, Sweden Skellefteå Hospital Skellefteå, Sweden S:t Göran Hospital Stockholm, Sweden Stockholm South General Hospital Stockholm, Sweden Norrlands University Hospital Umeå, Sweden Uppsala University Hospital Uppsala, Sweden Växjö Central Hospital Växjö, Sweden Odensala Health Clinic Östersund, Sweden Less <<
NCT03045354 Childhood Obesity ... More >> Breakfast Less << Not Applicable Completed - Canada, Ontario ... More >> School of Nutrition, Ryerson University Toronto, Ontario, Canada, M5B 2K3 Less <<
NCT03371368 Insulin Resistance ... More >> Obesity Less << Not Applicable Recruiting June 30, 2023 United States, New York ... More >> Columbia University Medical Center Recruiting New York, New York, United States, 10032 Contact: Judith Korner, M.D, PhD    212-305-3725    jk181@cumc.columbia.edu Less <<
NCT03258268 Type 2 Diabetes Mellitus Not Applicable Recruiting October 7, 2018 Sweden ... More >> Region Skåne Recruiting Skåne, Sweden Contact: Ulf Malmqvist, MD       Ulf.Malmqvist@skane.se Less <<
NCT00071409 Diabetes Mellitus, Insulin-Dep... More >>endent Less << Phase 2 Completed - United States, California ... More >> Radiant Research Irvine, California, United States, 92618 VA Hospital UCSD San Diego, California, United States, 92161 Diablo Clinical Research Walnut Creek, California, United States, 94598 United States, District of Columbia MedStar Clinical Research Center Washington, District of Columbia, United States, 20003 United States, Illinois Springfield Diabetes and Endocrine Center Springfield, Illinois, United States, 62704 United States, Montana Mercury Street Medical Butte, Montana, United States, 59701 United States, North Carolina UNC Diabetes Care Center Durham, North Carolina, United States, 27713 United States, Oregon Clinical Research Institute of Southern Oregon Medford, Oregon, United States, 97504 United States, Texas University of Texas Health Science Center - Texas Diabetes Institute San Antonio, Texas, United States, 78207 DGD Research Associates San Antonio, Texas, United States, 78229 Less <<
NCT00695825 Metabolic Syndrome X Not Applicable Completed - Netherlands ... More >> University Maastricht Maastricht, Netherlands, 6229 ER Less <<
NCT03002311 General Medicine ... More >> Maternal Health Pediatric Health Neurology Psychiatry Emergency Medicine Internal Medicine Nephrology Wellness Mobile Health Surgery Mental Health Chronic Obstructive Pulmonary Disease Diabetes Mellitus CHF Depression Breast Feeding PostPartum Depression Perinatal Mood and Anxiety Disorder Less << Phase 1 Phase 2 Enrolling by invitation - United States, Missouri ... More >> St. Louis Children's Hospital Saint Louis, Missouri, United States, 63110 Washington University School of Medicine - Barnes Jewish Hospital Saint Louis, Missouri, United States, 63110 Less <<
NCT01406717 Type 2 Diabetes Mellitus Phase 3 Completed - India ... More >> SPIL Site 22 Hyderabad, Andhra Pradesh, India SPIL Site 25 Hyderabad, Andhra Pradesh, India SPIL Site 26 Hyderabad, Andhra Pradesh, India SPIL Site 23 Visakhapatnam, Andhra Pradesh, India SPIL Site 1 Ahmedabad, Gujrat, India SPIL Site 2 Ahmedabad, Gujrat, India SPIL Site 3 Ahmedabad, Gujrat, India SPIL Site 5 Rajkot, Gujrat, India SPIL Site 6 Surat, Gujrat, India SPIL Site 7 Surat, Gujrat, India SPIL Site 8 Surat, Gujrat, India SPIL Site 9 Surat, Gujrat, India SPIL Site 10 Vadodara, Gujrat, India SPIL Site 19 Bangalore, kARNATAKA, India SPIL Site 30 Bangalore, Karnataka, India SPIL Site 31 Bangalore, Karnataka, India SPIL Site 33 Bangalore, Karnataka, India SPIL Site 29 Manipal, Karnataka, India SPIL Site 35 Indore, Madhya Pradesh, India SPIL Site 21 Nagpur, Maharashtra, India SPIL Site 24 Nagpur, Maharashtra, India SPIL Site 32 Nashik, Maharashtra, India SPIL Site 11 Pune, Maharashtra, India SPIL Site 12 Pune, Maharashtra, India SPIL Site 13 Bhubaneshwar, Orrissa, India SPIL Site 14 Jaipur, Rajasthan, India SPIL Site 15 Jaipur, Rajasthan, India SPIL Site 34 Vellore, Tamil Nadu, India SPIL Site 16 Chennai, Tamilnadu, India SPIL Site 17 Coimbatore, Tamilnadu, India SPIL Site 20 Coimbatore, Tamilnadu, India SPIL Site 18 Madurai, Tamilnadu, India, 625020 SPIL Site 27 Lucknow, Uttar Pradesh, India SPIL Site 28 Lucknow, Uttar Pradesh, India Less <<
NCT01428960 Healthy Not Applicable Completed - Malaysia ... More >> Malaysian Palm Oil Board Kajang, Selangor, Kajang, Selangor,, Malaysia, 43000 Less <<
NCT03596008 Healthy Not Applicable Active, not recruiting October 12, 2020 United States, Illinois ... More >> Clinical Nutrition Research Center Chicago, Illinois, United States, 60616 Less <<
NCT01408667 Metabolic Cardiovascular Syndr... More >>ome Less << Phase 1 Phase 2 Completed - Netherlands ... More >> Academic Medical Centre, Amsterdam, Netherlands, 1100 DD Less <<
NCT02958579 - Recruiting January 2020 Iran, Islamic Republic of ... More >> Tehran University of Medical Sciences Recruiting Tehran, Iran, Islamic Republic of, 13145-784 Contact: Alireza Esteghamati, M.D.       esteghamati@tums.ac.ir    Contact: Zahra Aryan, MD, MPH       aryanzahra@yahoo.com    Principal Investigator: Mohsen Afarideh, M.D.          Principal Investigator: Alireza Ghajar, MD Less <<
NCT00562029 Type 2 Diabetes Mellitus Not Applicable Completed - United States, New York ... More >> Sound Shore Medical Center of Westchester New Rochelle, New York, United States, 10802 Less <<
NCT00367055 Type 2 Diabetes Mellitus Phase 4 Completed - -
NCT00785499 Obesity Metab... More >>olic Syndrome Less << Not Applicable Completed - Denmark ... More >> Department of Human Nutrition Frederiksberg, Denmark, 1958 Less <<
NCT00367055 - Completed - -
NCT02134938 Obesity Phase 1 Unknown - Canada, Ontario ... More >> Clinical Risk Factor and Modification Centre Recruiting Toronto, Ontario, Canada, M5C 2T2 Less <<
NCT01148576 Chronic Hepatitis B ... More >> Hepatic Steatosis Less << Phase 4 Unknown February 2012 China, Zhejaing ... More >> The first affiliated hospital, college of medicine, zhejiang university Recruiting Hangzhou, Zhejaing, China, 310003 Sub-Investigator: Yi da Yang, PhD Less <<
NCT02734277 - Recruiting March 2027 United States, California ... More >> UCSF School of Medicine Recruiting San Francisco, California, United States, 94143 Contact: Rebecca Wesch    415-476-5984    rebecca.wesch@ucsf.edu    Principal Investigator: Stephen Gitelman, MD          Stanford University Recruiting Stanford, California, United States, 94305 Contact: Trudy Esrey    650-498-4450    tesrey@stanford.edu    Principal Investigator: Darrell Wilson, MD          United States, Colorado University of Colorado School of Medicine: Barbara Davis Center for Diabetes Recruiting Aurora, Colorado, United States, 80045 Contact: Mara Kinney    303-724-8272    MARA.KINNEY@ucdenver.edu    Principal Investigator: Peter Gottlieb, MD          United States, Connecticut Yale University Recruiting New Haven, Connecticut, United States, 06519 Contact: Linda Ryall    203-737-4510    linda.ryall@yale.edu    Contact: Mikhail Smolgovsky    203-785-6248    mikhail.smolgovsky@yale.edu    Principal Investigator: Kevan Herold, MD          United States, Georgia Emory University Withdrawn Atlanta, Georgia, United States, 30322 United States, Indiana Indiana University Riley Hospital for Children Recruiting Indianapolis, Indiana, United States, 46202 Contact: American Newnum    317-278-7052    anewnum@iu.edu    Contact: Robin Hufferd    317-278-0528    rhufferd@iu.edu    Principal Investigator: Linda DiMeglio, MD, MPH          United States, Iowa University of Iowa Health Care Division of Pediatric Endocrinology Not yet recruiting Iowa City, Iowa, United States, 52242 Contact: Joanne Cabbage    319-356-4035    joanne-cabbage@uiowa.edu    Principal Investigator: Eva Tsalikian, MD          United States, Massachusetts Joslin Diabetes Center Recruiting Boston, Massachusetts, United States, 02215 Contact: Suzanne Krishfield    617-309-4493    Suzanne.Krishfield@joslin.harvard.edu    Principal Investigator: Jason Gaglia, MD          United States, Minnesota University of Minnesota Recruiting Minneapolis, Minnesota, United States, 55454 Contact: Anne Street    612-625-9709    stree065@umn.edu    Principal Investigator: Antoinette Moran, MD          United States, Missouri Children's Mercy Hospital Recruiting Kansas City, Missouri, United States, 64108 Contact: Marissa Beidelschies    816-760-5918    mkbeidelschies@cmh.edu    Contact: Jennifer Dolan    (816) 760-8876    jldolan@cmh.edu    Principal Investigator: Wayne Moore, MD, PhD          United States, South Dakota Sanford Research Recruiting Sioux Falls, South Dakota, United States, 57104 Contact: Christina Huber    605-328-8741    christina.huber@sanfordhealth.org    Principal Investigator: Kurt Griffin, MD          United States, Washington Benaroya Research Institute Recruiting Seattle, Washington, United States, 98101 Contact: Marli M Olson    206-342-6943    marli@benaroyaresearch.org    Principal Investigator: Carla Greenbaum, MD Less <<
NCT00330473 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT03216486 Osteogenesis Imperfecta Phase 2 Withdrawn(Administrative Reaso... More >>n) Less << November 1, 2018 United States, New Mexico ... More >> Mereo Investigator Site Albuquerque, New Mexico, United States, 87106 United States, Texas Mereo Investigator Site Houston, Texas, United States, 77030 Less <<
NCT01530165 Prediabetic State & High Risk ... More >>Individuals Less << Not Applicable Unknown October 2015 Pakistan ... More >> The Aga Khan University Hospital Karachi, Sindh, Pakistan, 74800 Less <<
NCT02651636 Polycystic Ovary Syndrome ... More >> Menstrual Pattern Hyperandrogenism Metabolic Features Less << Not Applicable Completed - -
NCT01497522 Diabetes Mellitus, Type 2 Phase 3 Completed - Japan ... More >> Novartis Investigative Site Kitakyushu, Fukuoka, Japan, 800-0296 Novartis Investigative Site Kurume, Fukuoka, Japan, 830-8543 Novartis Investigative Site Ohkawa-city, Fukuoka, Japan, 831-0016 Novartis Investigative Site Kawasaki-city, Kanagawa, Japan, 210-0014 Novartis Investigative Site Yokohama, Kanagawa, Japan, 221-0802 Novartis Investigative Site Kyoto-city, Kyoto, Japan, 615-0035 Novartis Investigative Site Takatsuki, Osaka, Japan, 569-1096 Novartis Investigative Site Ageo-city, Saitama, Japan, 362-8588 Novartis Investigative Site Bunkyo-ku, Tokyo, Japan, 113-0031 Novartis Investigative Site Edogawa-ku, Tokyo, Japan, 134-0084 Novartis Investigative Site Hachioji, Tokyo, Japan, 192-0046 Novartis Investigative Site Kiyose, Tokyo, Japan, 204-0021 Novartis Investigative Site Minato-ku, Tokyo, Japan, 105-7390 Novartis Investigative Site Minato-ku, Tokyo, Japan, 108-0075 Novartis Investigative Site Nerima-ku, Tokyo, Japan, 177-0051 Novartis Investigative Site Shinagawa-ku, Tokyo, Japan, 141-0032 Novartis Investigative Site Toshima-ku, Tokyo, Japan, 171-0021 Novartis Investigative Site Fukuoka, Japan, 810-0001 Novartis Investigative Site Fukuoka, Japan, 819-0168 Novartis Investigative Site Kyoto, Japan, 607-8062 Less <<
NCT03330951 - Active, not recruiting December 2021 Norway ... More >> Stavanger University Hospital Stavanger, Rogaland, Norway, 4068 Less <<
NCT00541606 Diabetes Mellitus, Type 2 Not Applicable Completed - United States, Massachusetts ... More >> Lahey Clinic Burlington, Massachusetts, United States, 01805 Less <<
NCT01855373 Blood Sugar E... More >>ndothelial Function Less << Not Applicable Completed - United States, Florida ... More >> Life Extension Clinical Research Inc. Fort Lauderdale, Florida, United States, 33308 Less <<
NCT02295176 Metabolic Syndrome ... More >> Insulin-resistance Left Ventricular Hypertrophy Less << Not Applicable Completed - Italy ... More >> Domenico Bonaduce Naples, Italy, 80131 Ferruccio Galletti Naples, Italy Giuseppe Schillaci Terni, Italy Less <<
NCT01786941 Branched-chain Amino Acid Meta... More >>bolism Insulin Sensitivity Less << Not Applicable Completed - United States, North Carolina ... More >> Duke University Medical Center Durham, North Carolina, United States, 27710 Less <<
NCT00839527 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT00839527 - Completed - -
NCT00356187 - Terminated(Slow enrollment, en... More >>d of funding) Less << - -
NCT02697253 Obesity Phase 2 Active, not recruiting December 2020 United States, New York ... More >> Columbia University Medical Center - Russ Berrie Building New York, New York, United States, 10032 Less <<
NCT00838903 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT02768558 Non-Small Cell Lung Cancer Phase 3 Active, not recruiting October 2024 United States, California ... More >> UC San Diego Moores Cancer Center La Jolla, California, United States, 92093 Stanford University Stanford, California, United States, 94305 United States, Florida University of Florida Gainesville, Florida, United States, 32610 Mount Sinai Cancer Research Center Miami Beach, Florida, United States, 33140 United States, Georgia Nancy N. & J.C. Lewis Cancer & Research Pavilion at St. Joseph's/Candler Hospital Savannah, Georgia, United States, 31405 United States, Kentucky University of Kentucky Lexington, Kentucky, United States, 40536 United States, Maryland Mercy Medical Cancer Center Baltimore, Maryland, United States, 21202 United States, Michigan Henry Ford Health System Detroit, Michigan, United States, 48202 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 University of Rochester Rochester, New York, United States, 14642 United States, Ohio Metro Health Medical Center Cleveland, Ohio, United States, 44109 United States, Pennsylvania Reading Hospital/McGlinn Cancer Institute West Reading, Pennsylvania, United States, 19611 United States, Texas University of Texas Southwestern Medical Center Dallas, Texas, United States, 75390 United States, Virginia Inova Fairfax Hospital Falls Church, Virginia, United States, 22042 United States, Washington Virginia Mason Seattle, Washington, United States, 98101 United States, Wisconsin University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States, 53792 Less <<
NCT02346175 Type 2 Diabetes Mellitus Phase 1 Completed - -
NCT01257464 Cystic Fibrosis Phase 2 Terminated(Lack of recruitment... More >>) Less << - Canada, British Columbia ... More >> University of British Columbia Gerontology & Diabetes Reserach Centre (ViTALITY) Vancouver, British Columbia, Canada, V5Z 1L8 Less <<
NCT00542633 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT01264497 Type 2 Diabetes Phase 2 Completed - -
NCT00838903 - Completed - -
NCT00184665 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 3 Completed - -
NCT01427413 - Recruiting December 2018 Italy ... More >> Cervesi Hospital Recruiting Cattolica, Rimini, Italy, 47841 Contact: Silvia De Stefani, Biotecnology    +39 320 1111937    silvia.destefani83@libero.it    Contact: Simone Palini, biology    +39 339 4572101    simonepalini@yahoo.it Less <<
NCT00322257 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 3 Terminated(See termination rea... More >>son in detailed description) Less << - -
NCT00117780 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 4 Completed - Belgium ... More >> Novo Nordisk Investigational Site Aalst, Belgium, 9300 France Novo Nordisk Investigational Site Lille, France, 59037 Luxembourg Novo Nordisk Investigational Site Luxembourg, Luxembourg, 2763 Less <<
NCT00171509 Liver Transplant Phase 4 Completed - -
NCT02338193 Diabetes Prevention in Women A... More >>fter GDM Who Are at High-risk Less << Phase 3 Active, not recruiting March 2019 United States, Louisiana ... More >> Woman's Hospital Baton Rouge, Louisiana, United States, 70815 Less <<
NCT00569764 - Unknown October 2009 Korea, Republic of ... More >> Seoul National Hospital Recruiting Seoul, Korea, Republic of, 039-757 Contact: Shi Hyun Kang, M.D.    82-2-2204-0326    drshe@hanmail.net    Principal Investigator: Jong il Lee, M.D.          Seoul National Hospital Recruiting Seoul, Korea, Republic of, 139-757 Contact: Jong-il Lee, M.D., Ph.D.    82-2-2204-0104    lji7542@hanmail.net Less <<
NCT02665117 Hypertension Not Applicable Recruiting January 2019 United States, Texas ... More >> University of Texas Southwestern Medical Center at Dallas Recruiting Dallas, Texas, United States, 75390 Contact: Debbie Arbique, RN    214-648-2968    debbie.arbique@utsouthwestern.edu    Principal Investigator: Wanpen Vongpatanasin, MD          University of Texas Southwestern Medical Center Recruiting Dallas, Texas, United States, 75390 Contact: Wanpen Vongpatanasin, MD    214-648-2103    Wanpen.Vongpatanasin@UTSouthwestern.edu    Principal Investigator: Wanpen Vongpatanasin, MD          UT Southwestern Medical Center Recruiting Dallas, Texas, United States, 75390 Contact: Debbie Arbique, DNP    214-648-3188    debbie.arbique@utsouthwestern.edu Less <<
NCT01748305 Gestational Diabetes Mellitus ... More >> Exercise Less << Not Applicable Terminated(Recruitment issues.... More >>) Less << - United States, Oregon ... More >> Oregon Health & Science University Portland, Oregon, United States, 97239 Less <<
NCT01363609 Obesity Type ... More >>2 Diabetes Less << Not Applicable Completed - Netherlands ... More >> VU University Medical Center Amsterdam, Netherlands, 1081 HV Less <<
NCT01216956 Insulin Sensitivity ... More >> Lipoproteins Metabolism Non Esterified Fatty Acid Kinetics Lipid Profile Less << Not Applicable Completed - France ... More >> Centre de Recherche en Nutrition Humaine Nantes, France Less <<
NCT00948584 Diabetes Mellitus, Type 2 Not Applicable Completed - -
NCT02206607 Type 2 Diabetes Mellitus Phase 1 Completed - United States, North Carolina ... More >> High Point Clinical Trials Center High Point, North Carolina, United States, 27265 United States, Texas Clinical Trials of Texas, Inc. San Antonio, Texas, United States, 78229 Less <<
NCT03513042 - Not yet recruiting December 2022 -
NCT00737776 - Completed - Korea, Republic of ... More >> Novo Nordisk Investigational Site Seoul, Korea, Republic of, 137-920 Less <<
NCT01877512 Growth Hormone Deficiency ... More >> Cardiovascular Diseases Metabolic Syndrome Cognition Physical Activity Less << Phase 4 Completed - Netherlands ... More >> VU University Medical Center Amsterdam, PO Box 7057, Netherlands, 1007 MB Less <<
NCT02206607 - Completed - -
NCT00434954 - Completed - -
NCT00760448 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 1 Completed - United Kingdom ... More >> Novo Nordisk Investigational Site Guildford, United Kingdom, GU2 7XX Less <<
NCT00434954 Type 2 Diabetes Mellitus Phase 3 Completed - Germany ... More >> Research Site Bad Mergentheim, Germany Research Site Berlin, Germany Research Site Bosenheim, Germany Research Site Burghausen, Germany Research Site Datteln, Germany Research Site Dresden, Germany Research Site Essen, Germany Research Site Friedrichsthal, Germany Research Site Hildesheim, Germany Research Site Hirschhorn, Germany Research Site Hohenmolsen, Germany Research Site Jena, Germany Research Site Lehrte, Germany Research Site Leipzig, Germany Research Site Ludwigsburg, Germany Research Site Mannheim, Germany Research Site Marburg, Germany Research Site Marktheidenfeld, Germany Research Site Meissen, Germany Research Site Munchen, Germany Research Site Offenbach, Germany Research Site Oschatz, Germany Research Site Pohlheim, Germany Research Site Regensburg, Germany Research Site Riesa, Germany Research Site Rodgau, Germany Research Site Roding, Germany Research Site Rosenheim, Germany Research Site Schluchtern, Germany Research Site Schwedt/Oder, Germany Research Site Sinsheim, Germany Research Site Speyer, Germany Research Site Unterhaching, Germany Research Site Volklingen, Germany Research Site Wallerfing, Germany Research Site Wangen, Germany Research Site Warburg, Germany Research Site Wiesbaden, Germany Research Site Wolfsburg, Germany Less <<
NCT01645332 Type-2-diabetes Mellitus ... More >> New Onset Less << Phase 3 Completed - Indonesia ... More >> Division of Endocrinology, Department of Internal Medicine, Dr. Kariadi Hospital Semarang, Jawa Tengah, Indonesia, 50231 Less <<
NCT02727608 Diabetes Mellitus Phase 2 Completed - Sweden ... More >> Dept of Surgical Sciences, Section of Transplantation Surgery, University Hospital Uppsala, Sweden, 752 37 Less <<
NCT00356187 Trauma Phase 2 Terminated(Slow enrollment, en... More >>d of funding) Less << - United States, Colorado ... More >> Denver Health Medical Center Denver, Colorado, United States, 80204 Less <<
NCT02115711 Hypertension ... More >>Diabetes Smoking Cardiovascular Diseases Less << Not Applicable Completed - India ... More >> Dalkhola Dalkhola, West Bengal, India, 733201 Less <<
NCT02521025 Atrophy, Disuse ... More >> Insulin Resistance Less << Not Applicable Completed - Netherlands ... More >> Maastricht University Medical Center+ Maastricht, Limburg, Netherlands, 6229ER Less <<
NCT02773823 Cardiovascular Diseases Not Applicable Completed - China, Hubei ... More >> Wuhan university Wuhan, Hubei, China, 430071 Less <<
NCT01245166 The Objectives of the Study is... More >> to Evaluate the Efficacy and Safety of Acarmet (Metformin HCl 500 mg Plus Acarbose 50 mg Tablets) Thrice Daily Versus Acarbose 50 mg Thrice Daily Over 16 Weeks in Subjects With Type 2 Diabetes Mellitus. Less << Phase 3 Unknown December 2011 Taiwan ... More >> Taichung Veterans General Hospital Recruiting Taichung, Taiwan, 40705 Contact: Elaine Liu, Bachelor    886-2-2778-5188 ext 335    elaine@lotuspharm.com Less <<
NCT02087683 Heart Failure ... More >> Vitamin D Deficiency Less << Not Applicable Recruiting December 2018 Mexico ... More >> Clinical Nutrition and Obesity Research Center. School of Medicine and Health Sciences, TEC Salud, Tecnológico de Monterrey Recruiting Monterrey, Nuevo León, Mexico, 64710 Contact: Leticia Elizondo-Montemayor, MD    (01)+52 8188882192    lelizond@itesm.mx    Contact: Beatriz Astudillo, MD    (01)+52 8188882192    beatriz.astudillor@gmail.com    Principal Investigator: Leticia Elizondo-Montemayor, MD Less <<
NCT01601574 Type 2 Diabetes ... More >> Overweight Obesity Less << Phase 3 Completed - United States, Alabama ... More >> Diabetes Research and Training Center, University of Alabama at Birmingham Birmingham, Alabama, United States, 35294 United States, California Scripps Clinical Research La Jolla, California, United States, 92037 United States, Georgia CSRA Partners in Health Augusta, Georgia, United States, 30909-6599 United States, Illinois Northwestern University Feinberg School Chicago, Illinois, United States, 60611 United States, New York Obesity Research Center St. Luke's Roosevelt Hospital Center New York, New York, United States, 10025 Weill Medical College of Cornell University New York, New York, United States, 10065 United States, North Carolina Center for Nutrition and Preventive Medicine Charlotte, North Carolina, United States, 28277 Obesity Clinical Trials Program Duke University Medical Center Durham, North Carolina, United States, 27710 United States, Ohio Your Diabetes Endocrine Nutrition Group Inc. Mentor, Ohio, United States, 44060 United States, Oregon Oregon Weight Loss Surgery, LLC Portland, Oregon, United States, 97210 United States, Pennsylvania The University of Pennsylvania Center for Weight and Eating Disorders Philadelphia, Pennsylvania, United States, 19104 United States, South Carolina Medical University of South Carolina Charleston, South Carolina, United States, 29425 United States, Texas Baylor Endocrine Center Dallas, Texas, United States, 75246-1906 Oakwell Clinical Research San Antonio, Texas, United States, 78218 United States, Virginia Washington Center for Weight Management & Research, Inc The Navy League Building Arlington, Virginia, United States, 22201 Less <<
NCT02879409 Diabetes Mellitus Type 2 Not Applicable Recruiting August 2019 Qatar ... More >> Hamad Medical Corporation Recruiting Doha, Qatar, 3050 Contact: Ibrahim Janahi, MD    4439-2434 ext 00974    Imohd@hamad.qa    Principal Investigator: Ibrahim Janahi, MD          Sub-Investigator: Mashhood Siddique, MD          Sub-Investigator: Hamda Ali, MD Less <<
NCT02391779 Hypertension Phase 2 Completed - Canada, Saskatchewan ... More >> College of Pharmacy, University of Saskatchewan Saskatoon, Saskatchewan, Canada, S7N 5E5 Less <<
NCT00347087 Chronic Heart Failure Phase 4 Completed - Germany ... More >> Applied Cachexia Research, Cardiology Dept. Charite Medical School, Virchow Klinikum Berlin, Germany Less <<
NCT02606812 Metabolic Syndrome X Not Applicable Unknown April 2018 -
NCT02099838 - Completed - -
NCT02843724 Diabetes Mellitus, Type 2 Phase 1 Phase 2 Not yet recruiting July 2019 Canada, Ontario ... More >> Wise Elephant Family Health Team Not yet recruiting Brampton, Ontario, Canada, L6V 4H4 Contact: Sanjeev Goel, MD    (289) 323-0660       The Canadian College of Naturopathic Medicine Toronto, Ontario, Canada, M2K 1E2 Less <<
NCT02099838 Diabetes Mellitus, Type 2 Phase 4 Completed - China, Hubei ... More >> Tongji Hospital Wuhan, Hubei, China, 430030 Less <<
NCT01048606 - Completed - -
NCT03526653 Physical Activity ... More >> Elderly Less << Not Applicable Recruiting July 1, 2018 Belgium ... More >> WZC Begralim (Campus Sint-Elisabeth) Recruiting Hasselt, Belgium, 3500 Contact: Nastasia Marinus, drs.    +32 11 26 93 05    nastasia.marinus@uhasselt.be    Contact: Bart Vossen    +32 498 32 58 63    bbohasselt@begralim.be    Principal Investigator: Dominique Hansen, prof. dr.          Sub-Investigator: Nastasia Marinus, drs. Less <<
NCT02888691 Type 1 Diabetes Not Applicable Completed - Denmark ... More >> Hvidovre University Hospital Hvidovre, Denmark, 2650 Less <<
NCT00257218 Diabetes Mellitus Not Applicable Unknown - Taiwan ... More >> Chia Nan University of Pharmacy and Science Not yet recruiting Tainan, Taiwan, 717 Less <<
NCT00085982 Insulin Resistance Phase 2 Recruiting January 1, 2030 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)    800-411-1222 ext TTY8664111010    prpl@cc.nih.gov Less <<
NCT00960661 - Completed - -
NCT02967237 Diabetes Mellitus, Type 2 Phase 4 Completed - -
NCT00960661 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT01298245 - Unknown December 2012 Taiwan ... More >> Taipei Veterans General Hospital Recruiting Taipei, Taiwan, 112 Contact: Chii-Min Hwu, MD    8862287516    chhwu@vghtpe.gov.tw Less <<
NCT00904592 Diabetic Retinopathy Not Applicable Completed - China, Sichuan ... More >> Chengdu University of TCM Chengdu, Sichuan, China, 610075 Less <<
NCT02034578 - Completed - -
NCT02003677 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 1 Completed - Germany ... More >> Novo Nordisk Investigational Site Neuss, Germany, 41460 Less <<
NCT02034578 Healthy Volunteers Phase 1 Completed - United States, Maryland ... More >> Parexel Baltimore Early Phase Clinical Unit Baltimore, Maryland, United States, 21225 Less <<
NCT02291146 Pediatric Obesity Not Applicable Completed - United States, California ... More >> University of Southern California Los Angeles, California, United States, 90089 Less <<
NCT00595374 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 3 Completed - Netherlands ... More >> Novo Nordisk Investigational Site Amersfoort, Netherlands, 3818 ES Novo Nordisk Investigational Site Apeldoorn, Netherlands, 7334 DZ Novo Nordisk Investigational Site Den Haag, Netherlands, 2566 MJ Novo Nordisk Investigational Site Den Haag, Netherlands, 2597 AX Novo Nordisk Investigational Site Den Helder, Netherlands, 1782 GZ Novo Nordisk Investigational Site Deventer, Netherlands, 7415 CM Novo Nordisk Investigational Site Enschede, Netherlands, 7511 JX Novo Nordisk Investigational Site Gouda, Netherlands, 2805 AH Novo Nordisk Investigational Site Hoogeveen, Netherlands, 7909 AA Novo Nordisk Investigational Site Leidschendam, Netherlands, 2262 BA Novo Nordisk Investigational Site Meppel, Netherlands, 7943 KA Novo Nordisk Investigational Site Rotterdam, Netherlands, 3083 AN Novo Nordisk Investigational Site Stadskanaal, Netherlands, 9501 EH Novo Nordisk Investigational Site Utrecht, Netherlands, 3563 AZ Novo Nordisk Investigational Site Waalwijk, Netherlands, 5141 BM Novo Nordisk Investigational Site Weert, Netherlands, 6001 BE Novo Nordisk Investigational Site Zevenaar, Netherlands, 6903 ZN Novo Nordisk Investigational Site Zwolle, Netherlands, 8025 AB Less <<
NCT01890122 Diabetes Mellitus Phase 3 Completed - -
NCT01890122 - Completed - -
NCT00469092 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 4 Completed - -
NCT01140893 Type 2 Diabetes Phase 2 Phase 3 Unknown - France ... More >> Endocrinology Unit and Clinical Research Center Basse Normandie, University Hospital of Caen Recruiting Caen, France, 14000 Contact    +33 2 31 06 45 75       Principal Investigator: Michael JOUBERT, MD          Principal Investigator: Yves REZNIK, MD          CERIDT Recruiting Corbeil-Essonne, France Contact: Guillaume Charpentier, MD          Endocrinology Unit Not yet recruiting Strasbourg, France Contact: Nathalie Jeandidier, MD, PhD Less <<
NCT02528994 Serine Not Applicable Withdrawn(The PI will be leavi... More >>ng the institution and not continuing the study) Less << - -
NCT00469092 - Completed - -
NCT00120497 - Unknown December 2011 United States, Massachusetts ... More >> Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: David B Rhoads, PhD    617-724-2707    rhoads@helix.mgh.harvard.edu    Sub-Investigator: Martin Torriani, MD          Sub-Investigator: Bijoy J Thomas, MBBS          Sub-Investigator: Miriam Bredella, M.D.          Sub-Investigator: Paul A Boepple, M.D.          Sub-Investigator: David B Rhoads, Ph.D. Less <<
NCT01689129 Type 1 Diabetes Mellitus Phase 3 Completed - Japan ... More >> Investigational Site Number 392119 Amagasaki-Shi, Japan Investigational Site Number 392106 Chuo-Ku, Japan Investigational Site Number 392107 Chuo-Ku, Japan Investigational Site Number 392110 Ebina-Shi, Japan Investigational Site Number 392115 Higashiosaka-Shi, Japan Investigational Site Number 392117 Izumisano-Shi, Japan Investigational Site Number 392109 Kamakura-Shi, Japan Investigational Site Number 392101 Koriyama-Shi, Japan Investigational Site Number 392121 Kurashiki-Shi, Japan Investigational Site Number 392112 Nagoya-Shi, Japan Investigational Site Number 392120 Nishinomiya-Shi, Japan Investigational Site Number 392113 Osaka-Shi, Japan Investigational Site Number 392116 Osaka-Shi, Japan Investigational Site Number 392118 Osaka-Shi, Japan Investigational Site Number 392104 Shinjuku-Ku, Japan Investigational Site Number 392105 Shinjuku-Ku, Japan Investigational Site Number 392111 Shizuoka-Shi, Japan Investigational Site Number 392114 Takatsuki-Shi, Japan Investigational Site Number 392122 Tokushima-Shi, Japan Investigational Site Number 392103 Tomioka-Shi, Japan Investigational Site Number 392102 Ushiku-Shi, Japan Investigational Site Number 392108 Yokohama-Shi, Japan Less <<
NCT03723486 - Recruiting September 2020 Canada, Ontario ... More >> University Health Network, Toronto General Hospital Recruiting Toronto, Ontario, Canada, M5G 1Z5 Contact: Katherine Schwenger, BASc, MAN, RD, PhD    416-340-4104 ext 4104    kschweng@uhnresearch.ca    Principal Investigator: Johane P Allard, MD, FRCPC Less <<
NCT01646320 Type 2 Diabetes Phase 3 Completed - -
NCT01762644 Type 1 Diabetes Phase 3 Withdrawn(This study was withd... More >>rawn prior to enrollment.) Less << August 2016 -
NCT03709147 Advanced LKB1-inactive Lung Ad... More >>enocarcinoma Less << Phase 2 Not yet recruiting September 10, 2023 Italy ... More >> Marina Chiara Garassino Not yet recruiting Milan, Italy, 20133 Contact: MARINA CHIARA GARASSINO, MD    0223903813 ext +39    marina.garassino@istitutotumori.mi.it Less <<
NCT02423993 Diabetes Mellitus, Type 1 Not Applicable Completed - -
NCT02423993 - Completed - -
NCT01931631 Diabetes Mellitus, Type 2 Not Applicable Suspended(Erroneously duplicat... More >>ed study) Less << January 2019 United States, District of Col... More >>umbia Physicians Committee for Responsible Medicine Washington, District of Columbia, United States, 20016 Less <<
NCT03017352 Diabetes Mellitus, Type 1 Phase 2 Recruiting July 2018 Denmark ... More >> Steno Diabetes Center Recruiting Gentofte, Capital Region, Denmark, 2820 Sub-Investigator: Nicklas J Johansen, MD          Sub-Investigator: Thomas F Dejgaard, MD          Sub-Investigator: Asger Lund, MD, PhD          Principal Investigator: Henrik U Andersen, MD, Dmsc          Principal Investigator: Filip K Knop, Professor, MD, PhD Less <<
NCT00543959 Diabetes Mellitus Type 2 Phase 2 Terminated(This study is being... More >> discontinued based on data suggesting that none of the doses tested demonstrated both glycemic & body fluid benefits vs. the comparitor) Less << - -
NCT01646320 - Completed - -
NCT03029429 Pseudohypoparathyroidism ... More >> Albright Hereditary Osteodystrophy Less << Phase 2 Recruiting November 1, 2021 United States, Tennessee ... More >> Ashley Shoemaker Recruiting Nashville, Tennessee, United States, 37212 Contact: Ashley Shoemaker, MD    615-343-8116    ashley.h.shoemaker@vanderbilt.edu    Principal Investigator: Ashley Shoemaker, MD, MSCI Less <<
NCT00678145 Diabetes Mellitus ... More >> Hypoglycemia Autonomic Failure Less << Phase 2 Recruiting August 2022 United States, New York ... More >> Albert Einstein College of Medicine / General Clinical Research Center Recruiting Bronx, New York, United States, 10461 Less <<
NCT03547427 Type 1 Diabetes Mellitus Not Applicable Recruiting November 30, 2018 United States, Virginia ... More >> University of Virginia Center for Diabetes Technology Recruiting Charlottesville, Virginia, United States, 22903 Contact: Leon S. Farhy, PhD    434-924-2496    lsf8n@virginia.edu    Sub-Investigator: Stacey M. Anderson, MD          Sub-Investigator: Andy Basu, MD          Sub-Investigator: Marc D. Breton, PhD Less <<
NCT01525784 - Unknown June 2014 Israel ... More >> Soroka University Medical Center Not yet recruiting Beer Sheva, Israel Contact: Nta Lebental          Wolfson Medical Center Not yet recruiting Holon, Israel Contact: Zohar Landau, MD          Sheba Medical Center Not yet recruiting TEl Aviv, Israel Contact: Orit Hamiel, MD          Assaf harofeh Medical Center Not yet recruiting Zerifin, Israel, 70300 Contact: Marianna Rachmiel, MD       mariannar@asaf.health.gov.il    Principal Investigator: Marianna rachmiel, MD Less <<
NCT01662193 Nutritional and Metabolic Dise... More >>ase Less << Not Applicable Unknown - Iran, Islamic Republic of ... More >> Medical School of Isfahan Recruiting Isfahan, Iran, Islamic Republic of Contact: esmaillzadeh, PhD       esmaillzadeh@hlth.mui.ac.ir    Principal Investigator: marjan tabesh, MS Less <<
NCT01354925 Diabetes Type 2 ... More >> Treatment During Ramadan Less << Phase 4 Completed - Israel ... More >> Clalit HMO Haifa, Israel Less <<
NCT03176043 Dehydration (Physiology) ... More >> Thirst; Due to Deprivation of Water Plasma Osmolality Increased Hypovolemia Less << Early Phase 1 Recruiting August 2017 United Kingdom ... More >> Institute of Sport Exercise & Health Recruiting London, United Kingdom, W1T7HA Contact: Hugh Montgomery, MB BS Less <<
NCT02726438 Bone Diseases, Infectious Phase 1 Completed - United States, California ... More >> eStudySite La Mesa, California, United States, 91941 United States, Montana Mercury St Medical Group, PLLC Butte, Montana, United States, 59701 Less <<
NCT01194856 HIV Infection ... More >> Mitochondrial Dysfunction Less << Phase 4 Terminated(Closed due to low e... More >>nrollment) Less << - United States, Ohio ... More >> Cleveland Clinic Cleveland, Ohio, United States, 44195 Less <<
NCT01194856 - Terminated(Closed due to low e... More >>nrollment) Less << - -
NCT02813668 Diabetes Hear... More >>t Disease Obesity Less << Not Applicable Recruiting June 2020 India ... More >> Madras Diabetes Research Foundation Recruiting Chennai, India Contact: Ranjani Harish, PhD    044 43968888    ranjani@mdrf.org    Public Health Foundation of India Recruiting New Delhi, India Contact: Panniyamamkal Jeemon, PhD    01244781400    jeemon.p@phfi.org Less <<
NCT02974699 Type II Diabetes Early Phase 1 Recruiting - United States, Michigan ... More >> Wayne State University Recruiting Detroit, Michigan, United States, 48202 Contact: Paul Burghardt    313-577-0107    paul.burghardt@wayne.edu Less <<
NCT02228291 Obesity Overw... More >>eight Less << Not Applicable Completed - Netherlands ... More >> Maastricht University Medical Center Maastricht, Limburg, Netherlands, 6229HX Less <<
NCT00121875 - Terminated(Enrollment was too ... More >>low.) Less << - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT00519142 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT03159052 Type 2 Diabetes Mellitus Phase 3 Not yet recruiting June 2019 China ... More >> Chinese PLA General Hospital Not yet recruiting Beijing, China Contact: Juming Lu, PhD    010-66937166    lujuming301@126.com Less <<
NCT02248779 - Active, not recruiting September 2019 United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00999375 Type I Diabetes Phase 2 Completed - United States, Massachusetts ... More >> Joslin Diabetes Center Boston, Massachusetts, United States Less <<
NCT01690312 Cardiovascular Disease Not Applicable Completed - Canada, Ontario ... More >> Nutrasource Diagnostics Inc. Guelph, Ontario, Canada, N1G 0B4 Less <<
NCT02404025 Cytopaenia Phase 2 Completed - Japan ... More >> Novartis Investigative Site Aichi, Japan, 453-8511 Novartis Investigative Site Aichi, Japan, 460-0001 Novartis Investigative Site Ibaraki, Japan, 305-8576 Novartis Investigative Site Ishikawa, Japan, 920-8641 Novartis Investigative Site Miyagi, Japan, 981-1293 Novartis Investigative Site Okayama, Japan, 700-0962 Novartis Investigative Site Osaka, Japan, 530-0012 Novartis Investigative Site Osaka, Japan, 543-8555 Novartis Investigative Site Osaka, Japan, 565-0871 Novartis Investigative Site Tochigi, Japan, 329-0498 Novartis Investigative Site Tokyo, Japan, 141-8625 Less <<
NCT03309982 Anthocyanins Not Applicable Completed - United States, California ... More >> UC Davis Nutrition Department Davis, California, United States, 95616 Less <<
NCT00660374 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 2 Completed - Brazil ... More >> Salvador, Brazil, 40420-000 Less <<
NCT00841919 Diabetes Mellitus, Type 2 Phase 4 Completed - United States, Illinois ... More >> John H Stroger Jr. Hospital Chicago, Illinois, United States, 60612 Less <<
NCT00970424 Diabetes Mellitus, Type II Phase 3 Terminated - -
NCT00753896 Type 2 Diabetes Phase 3 Completed - United States, Arizona ... More >> Research Site Mesa, Arizona, United States Research Site Tempe, Arizona, United States United States, California Research Site Concord, California, United States Research Site Fresno, California, United States Research Site La Mesa, California, United States United States, Georgia Research Site Atlanta, Georgia, United States United States, Idaho Research Site Idaho Falls, Idaho, United States United States, Kentucky Research Site Bowling Green, Kentucky, United States United States, Oregon Research Site Corvallis, Oregon, United States United States, Tennessee Research Site Chattanooga, Tennessee, United States Research Site Memphis, Tennessee, United States Canada, British Columbia Research Site New Westminister, British Columbia, Canada Canada, Ontario Research Site Ajax, Ontario, Canada Research Site Cambridge, Ontario, Canada Research Site Windsor, Ontario, Canada Mexico Research Site Chihuahua, Chiuahua, Mexico Research Site Monterrey, Nuevo Leon, Mexico Research Site Distrito Federal, Mexico Romania Research Site Baia Mare, Romania Research Site Brasov, Romania Research Site Bucharesti, Romania Research Site Craiova, Romania Research Site Iasi, Romania Research Site Suceava, Romania South Africa Research Site Johannesburg, South Africa Research Site Pretoria, South Africa Less <<
NCT01095822 Diabetes Mellitus Phase 4 Unknown March 2011 United States, Maryland ... More >> Dr. Pokov's Polyclinic. 6821 Reisterstown Road Suite 206 Baltimore, Maryland, United States, 21215 Less <<
NCT02035943 Critical Ill Patient Undergone... More >> Parenteral Nutrition Less << Not Applicable Completed - Italy ... More >> Policlinico Hospital Milano, MI, Italy, 20122 Less <<
NCT03386864 - Recruiting April 2018 Germany ... More >> German Diabetes Center Recruiting Düsseldorf, NRW, Germany, 40223 Contact: Julia Szendroedi, PD Dr. med., PhD    +492113382203    Julia.szendroedi@ddz.uni-duesseldorf.de    Sub-Investigator: Daniel Scheiber, Dr. med Less <<
NCT03037918 Insulin Sensitivity ... More >> Insulin Resistance Type 2 Diabetes Mellitus Less << Not Applicable Completed - United Kingdom ... More >> Loughborough University Loughborough, Leicestershire, United Kingdom, LE11 3TU Less <<
NCT03095846 Adipose Tissue ... More >> Brown Adipose Tissue Brown Fat Uncoupling Protein 1 Adipokines Proteomics Infra-red Thermography BAT Winter Swimmers Type2 Diabetes Proteins Less << Not Applicable Completed - Denmark ... More >> Center for Inflammation and Metabolism/ Center for Physical Activity Research Copenhagen, Denmark, 2100 Less <<
NCT02354807 Brown Fat Phase 2 Recruiting March 2018 United States, Michigan ... More >> Children's Hospital of Michigan Recruiting Detroit, Michigan, United States, 48201 Contact: Otto Muzik, PhD    313-993-2616    otto@pet.wayne.edu    Contact: Cynthia Burnett, MS,CJ    313-993-3848    cgburnet@med.wayne.edu Less <<
NCT02189135 Diabetes Mellitus, Non-Insulin... More >>-Dependent Less << Phase 4 Completed - Malaysia ... More >> Klinik Kesihatan Pandamaran Klang, Selangor, Malaysia, 42000 Less <<
NCT00717509 - Unknown October 2009 Korea, Republic of ... More >> Seoul National Hospital Recruiting Seoul, Korea, Republic of, 139-757 Contact: Shi Hyun Kang, M.D.    82-2-2204-0326    drshe@hanmail.net Less <<
NCT02084498 Type 1 Diabetes Not Applicable Completed - Denmark ... More >> Steno Diabetes Center Gentofte, Denmark, 2820 Less <<
NCT00753896 - Completed - -
NCT02657018 Overweight Ob... More >>esity Diabetes Mellitus, Type 2 Less << Not Applicable Completed - Switzerland ... More >> Division of Sports and Exercise Medicine, Department of Sport, Exercise and Health, University of Basel Basel, BS, Switzerland, 4052 Less <<
NCT01098461 Diabetes Mellitus, Type 2 Phase 2 Completed - Japan ... More >> GSK Investigational Site Aichi, Japan, 466-0815 GSK Investigational Site Ehime, Japan, 790-0067 GSK Investigational Site Fukuoka, Japan, 810-0001 GSK Investigational Site Fukuoka, Japan, 811-1346 GSK Investigational Site Fukuoka, Japan, 815-8555 GSK Investigational Site Fukuoka, Japan, 819-0168 GSK Investigational Site Hiroshima, Japan, 731-0103 GSK Investigational Site Hokkaido, Japan, 003-0023 GSK Investigational Site Hokkaido, Japan, 044-0053 GSK Investigational Site Hokkaido, Japan, 061-1395 GSK Investigational Site Hokkaido, Japan, 080-0010 GSK Investigational Site Hokkaido, Japan, 080-0016 GSK Investigational Site Ibaraki, Japan, 310-0826 GSK Investigational Site Ibaraki, Japan, 311-0113 GSK Investigational Site Kagoshima, Japan, 891-0401 GSK Investigational Site Kanagawa, Japan, 210-0852 GSK Investigational Site Kanagawa, Japan, 235-0045 GSK Investigational Site Kumamoto, Japan, 862-0976 GSK Investigational Site Kumamoto, Japan, 866-0862 GSK Investigational Site Miyagi, Japan, 980-0021 GSK Investigational Site Miyagi, Japan, 985-0852 GSK Investigational Site Nagasaki, Japan, 856-0831 GSK Investigational Site Saitama, Japan, 355-0321 GSK Investigational Site Saitama, Japan, 362-0021 GSK Investigational Site Tochigi, Japan, 329-0101 GSK Investigational Site Tochigi, Japan, 329-0433 GSK Investigational Site Tokyo, Japan, 125-0054 GSK Investigational Site Tokyo, Japan, 154-0015 GSK Investigational Site Tokyo, Japan, 177-0041 GSK Investigational Site Yamagata, Japan, 990-0885 Less <<
NCT01880476 Diabetes Mellitus, Type 2 Not Applicable Completed - Canada, Ontario ... More >> McMaster University Hamilton, Ontario, Canada, L8S 4K1 Less <<
NCT00668174 Breast Cancer Prevention Phase 2 Phase 3 Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98102 Less <<
NCT02847806 Hypogonadism Phase 3 Completed - France ... More >> Endocrinology Unit and Clinical Research Center Basse Normandie, University Hospital of Caen Caen, France, 14000 Less <<
NCT00509236 Diabetes Mellitus, Type 2 ... More >> End-Stage Kidney Disease Less << Phase 3 Completed - -
NCT00826007 - Completed - United States, Michigan ... More >> William Beaumont Hospital Royal Oak, Michigan, United States, 48073 Less <<
NCT02313220 Obesity Phase 2 Completed - Sweden ... More >> Dept of Medical Sciences, Clinical Diabetes and Metabolism, Uppsala University and Section for Diabetes and Endocrinology at the Uppsala University Hospital Uppsala, Sweden, 75185 Less <<
NCT01387633 Diabetes Mellitus Not Applicable Unknown - Brazil ... More >> Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo Recruiting Ribeirão Preto, São Paulo, Brazil, 14048-900 Contact: Ana Emilia Pace, Principal Investigator    (55) 16 3602-3401    aepace@eerp.usp.br    Principal Investigator: Ana Emilia Pace, Principal Investigator Less <<
NCT01098461 - Completed - -
NCT00698802 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 2 Completed - India ... More >> Vijayawada, India, 520002 South Africa Johannesburg, Gauteng, South Africa, 2193 United Arab Emirates Abu Dhabi, United Arab Emirates, 51900 Less <<
NCT00348231 Diabetes Mellitus, Type 2 Not Applicable Unknown - Japan ... More >> The Jikei university school of medicine division of diabetes and endoclinology dept. of internal medicine Recruiting Tokyo, Japan, 1058461 Contact: Yumi Miyawshita, MD    +081334331111 ext 3249    yumi-m@jikei.ac.jp Less <<
NCT00727220 - Completed - -
NCT00509236 - Completed - -
NCT02898506 Type 1 Diabetes Phase 2 Enrolling by invitation July 2019 Finland ... More >> University of Oulu and Oulu University Hospital, Dept of Children and Adolescents Oulu, Finland, 90029 University of Tampere and Tampere University Hospital Tampere, Finland, 33520 University of Turku and Turku University Hospital Turku, Finland, 20520 Sweden Lund University and Skåne University Hospital Malmö, Sweden, 205 02 Less <<
NCT00826007 - Completed - -
NCT00099476 Hypertension Phase 1 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00727220 - Completed - United States, Indiana ... More >> Riley Hospital for Children Indianapolis, Indiana, United States, 46202 Less <<
NCT02703337 Diabetes Mellitus, Type 2 Phase 1 Completed - Germany ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician. Neuss, Germany Less <<
NCT03030300 Type2 Diabetes Phase 4 Completed - China, Shandong ... More >> Shandong Provincial Hospital Jinan, Shandong, China, 250001 Qianfoshan Hospital Jinan, Shandong, China, 250012 Qilu Hospital Jinan, Shandong, China, 250014 Less <<
NCT01045590 Diabetes Mellitus, Type 2 Phase 4 Completed - Korea, Republic of ... More >> GSK Investigational Site Seoul, Korea, Republic of, 110-744 GSK Investigational Site Seoul, Korea, Republic of, 120-752 GSK Investigational Site Seoul, Korea, Republic of, 135-710 GSK Investigational Site Seoul, Korea, Republic of, 137-701 Less <<
NCT03706612 - Recruiting June 2021 United States, California ... More >> University of California, San Francisco Recruiting San Francisco, California, United States, 94143 Contact: Andrea Garber, PhD    415-514-2180    andrea.garber@ucsf.edu    United States, Hawaii University of Hawaii Cancer Center Recruiting Honolulu, Hawaii, United States, 96813 Contact: Nisa Kelly    808-440-5234    nnkelly@hawaii.edu    United States, Louisiana Pennington Biomedical Research Center Recruiting Baton Rouge, Louisiana, United States, 70808 Contact: Steven Heymsfield, MD    225-763-2541    steven.heymsfield@pbrc.edu Less <<
NCT01792635 Diabetes Mellitus, Type 2 Phase 2 Terminated(The study was termi... More >>nated prematurely on 16 May 2014 due to a safety concern.) Less << - United States, California ... More >> Profil Institute for Clinical Research, Inc. Chula Vista, California, United States, 91911 Less <<
NCT03433677 Diabetes Type 1 Phase 3 Completed - United States, California ... More >> Valley Research Fresno, California, United States, 93720 United States, Colorado Barbara Davis Center for Childhood Diabetes Aurora, Colorado, United States, 80045 United States, Georgia Atlanta Diabetes Associates Atlanta, Georgia, United States, 30318 Spain For additional information regarding investigative sites for this trial, contact 1-888-545-5972 Mon - Fri, 9 AM to 4 PM or 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time or speak with your personal physician. Sevilla, Spain, 41009 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Seville, Spain, 41003 Less <<
NCT01205672 Endometrial Cancer Early Phase 1 Completed - United States, Texas ... More >> Lyndon B. Johnson General Hospital Houston, Texas, United States, 77026 University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00604448 Obesity Overw... More >>eight Less << Not Applicable Completed - Canada, Ontario ... More >> Leadership Sinai Centre for Diabetes, Mt. Sinai Hospital Toronto, Ontario, Canada, M5G 1X5 Less <<
NCT02748018 Type 1 Diabetes Not Applicable Recruiting December 2021 -
NCT01547156 Diabetes Mellitus Type 2 ... More >> Hypertension Less << Not Applicable Completed - Finland ... More >> Sipoo Health Care Centre Sipoo, Finland Less <<
NCT00001953 - Completed - United States, Maryland ... More >> National Institute of Dental And Craniofacial Research (NIDCR) Bethesda, Maryland, United States, 20892 Less <<
NCT00644241 Type 2 Diabetes Mellitus Phase 2 Completed - India ... More >> Pgimer Chandigarh, India Less <<
NCT01689051 Type 2 Diabetes ... More >> Blod Pressure Glucagon-like Peptide-1 Human Physiology Blood Flow Less << Not Applicable Completed - Denmark ... More >> Gentofte Hospital, Department of Cardiology Hellerup, Denmark, 2900 Less <<
NCT03339453 Hypoglycemia ... More >>Diabetes Mellitus, Type 1 Less << Phase 1 Completed - Germany ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician. Mainz, Germany, 55116 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician. Neuss, Germany Less <<
NCT01461577 Type 2 Diabetes Mellitus Phase 4 Completed - Japan ... More >> Administrative office Tokyo, Japan Less <<
NCT00276393 Type 1 Diabetes Phase 4 Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT01792635 - Terminated(The study was termi... More >>nated prematurely on 16 May 2014 due to a safety concern.) Less << - -
NCT02279732 Lung Cancer (NSCLC) Phase 3 Completed - -
NCT02403024 Colorectal Cancer Not Applicable Completed - Denmark ... More >> Rigshospitalet Copenhagen, Denmark, 2100 Hvidovre Hospital Hvidovre, Denmark, 2650 Less <<
NCT00137709 Epilepsy Phase 4 Unknown July 2008 Hong Kong ... More >> United Christian Hospital Recruiting Kowloon, Hong Kong Contact: Ping Wing Ng, FHKAM          Principal Investigator: Ping Wing Ng, FHKAM          Prince of Wales Hospital Recruiting Shatin, Hong Kong Contact: Patrick Kwan, FHKAM    852-2632-2211    patrickkwan@cuhk.edu.hk    Contact: Evelyn Yu, MSc    852-2632-3856    evelyn.yu@cuhk.edu.hk    Principal Investigator: Patrick Kwan, FHKAM          Sub-Investigator: Howan Leung, MRCP Less <<
NCT00943709 Hyperglycemia ... More >> Leukemia Less << Phase 3 Withdrawn(lack of accrual) - United States, New Jersey ... More >> Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School New Brunswick, New Jersey, United States, 08903 Less <<
NCT00947557 Diabetes Mellitus, Type II Phase 3 Terminated - -
NCT01459601 Diabetes Type 2 Not Applicable Unknown February 2012 -
NCT03637855 - Recruiting September 2020 United States, Hawaii ... More >> University of Hawaii Cancer Center Recruiting Honolulu, Hawaii, United States, 96813 Contact: Nisa Kelly       nnkelly@hawaii.edu Less <<
NCT02343471 Healthy Type ... More >>2 Diabetes Less << Not Applicable Completed - -
NCT00873639 - Completed - Romania ... More >> Novo Nordisk Investigational Site Bucharest, Romania, 010031 Less <<
NCT01890330 Metabolic Syndrome Not Applicable Completed - Canada, Manitoba ... More >> St. Boniface General Hospital - I.H. Asper Clinical Research Institute Winnipeg, Manitoba, Canada, R2H 2A6 Less <<
NCT01432405 - Completed - -
NCT02330276 Pre-diabetes Phase 1 Completed - United States, California ... More >> VA San Diego Healthcare System San Diego, California, United States, 92161 Less <<
NCT02330276 - Completed - -
NCT00618761 Kidney Transplantation ... More >> Pancreas Transplantation Less << Not Applicable Unknown January 2014 Belgium ... More >> Department of Endocrinology, Leuven, UZ-Gasthuisberg Recruiting Leuven, Belgium, 3000 Contact: Pieter Gillard, M.D.    003216346994    pieter.gillard@uz.kuleuven.ac.be    Sub-Investigator: Pieter Gillard, M.D. Less <<
NCT01734447 Foetal Growth Problem ... More >> Small for Gestational Age Less << Phase 4 Completed - France ... More >> Novo Nordisk Investigational Site Paris, France Less <<
NCT01432405 Type 2 Diabetes Mellitus Phase 4 Completed - United States, Texas ... More >> Baylor College of Medicine Houston, Texas, United States, 77030 Less <<
NCT02419027 Irritable Bowel Syndrome Not Applicable Unknown December 2016 -
NCT00428090 Alzheimer's Disease Phase 3 Completed - -
NCT00949416 - Unknown September 2009 -
NCT03005600 - Recruiting January 2019 India ... More >> Madras Diabetes Research Foundation Recruiting Chennai, Tamil Nadu, India, 600086 Contact: Deepa Mohan, PhD    00914443968888    deepa.mohan1@gamil.com    Contact: Bhavadharini Balaji, PhD    00914443968888    bhavadharini.balaji@gmail.com    Principal Investigator: V Mohan, PhD          Sub-Investigator: Uma Ram, FRCOG          Sub-Investigator: Ranjit M Anjana, PhD          Sub-Investigator: Deepa Mohan, PhD          Kenya Moi University School of Medicine & Teaching and Referral Hospital Recruiting Eldoret, Kenya Contact: Sonak Pastakia, DPharm MPH    00254729027569    spastaki@gmail.com    Contact: Wycliffe Kosgei, MBBS, MMed    00254723758638    wycliffe.kosgei@gmail.com    Principal Investigator: Sonak Pastakia, DPharm MPH          Sub-Investigator: Astrid Christoffersen-Deb, MRCOG PhD          Sub-Investigator: Wycliffe Kosgei, MBBS, MMed          Sub-Investigator: Beryl Onyango, BPharm Less <<
NCT00428090 - Completed - -
NCT03180489 Weight Loss Phase 2 Recruiting May 2019 United States, Colorado ... More >> Colorado State University, Dept. of Health and Exercise Science Recruiting Fort Collins, Colorado, United States, 80523-1582 Contact: Christopher Bell, PhD    970-491-7522    Christopher.Bell@colostate.edu    Contact: Laurie M Biela, BS    970-491-2242    Laurie.Biela@colostate.edu    Principal Investigator: Christopher Bell, PhD          Principal Investigator: Christopher Melby, Dr.P.H. Less <<
NCT00871832 - Completed - United States, New York ... More >> Staten Island University Hospital Staten Island, New York, United States, 10305 Less <<
NCT02380339 Hypoglycemia ... More >>Type One Diabetes Less << Not Applicable Recruiting September 2019 Israel ... More >> Hadassah Medical Organization, Jerusalem, Israel Recruiting Jerusalem, Israel Contact: Hadas Lemberg, PhD    972-6777111 Less <<
NCT01095666 Type 2 Diabetes Phase 3 Completed - -
NCT01095666 - Completed - -
NCT01304836 Kidney Transplantation Phase 4 Completed - -
NCT02667977 Hyponatremia Not Applicable Withdrawn(Difficulty getting l... More >>abs in this setting. After pilot study, this study was not continued.) Less << June 2016 United States, Illinois ... More >> Ann and Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States, 60611 Less <<
NCT01165125 Asthma Phase 1 Completed - United Kingdom ... More >> GSK Investigational Site London, United Kingdom, NW10 7EW Less <<
NCT03347305 Renal Failure Not Applicable Recruiting February 20, 2018 France ... More >> CHU Clermont-Ferrand Recruiting Clermont-Ferrand, France, 63003 Contact: Patrick LACARIN    0473751195    placarin@chu-clermontferrand.fr    Principal Investigator: Julien ANIORT          Sub-Investigator: Marc BOUILLER          Sub-Investigator: Myriam ISNARD          Sub-Investigator: Didier AGUILERA Less <<
NCT02932475 Diabetes Preg... More >>nancy Less << Phase 3 Recruiting June 30, 2021 United States, Alabama ... More >> University of Alabama Not yet recruiting Birmingham, Alabama, United States, 35294 Contact: Lori Harper, MD    205-934-5611    lmharper@uabmc.edu    United States, California University of California - San Diego Not yet recruiting San Diego, California, United States, 92093 Contact: Gladys Ramos, MD    619-543-6906    gramos@ucsd.edu    United States, Mississippi University of Mississippi Not yet recruiting Jackson, Mississippi, United States, 38677 Contact: Kedra Wallace, MD    601-984-5396    kwallace2@umc.edu    United States, New York Columbia University Not yet recruiting New York, New York, United States, 10027 Contact: Ronald Wapner, MD    212-305-1521    rw2191@columbia.edu    United States, North Carolina University of North Carolina Recruiting Chapel Hill, North Carolina, United States, 27599 Contact: Kim Boggess, MD    919-966-1601    kboggess@med.unc.edu    Contact: Karen Dorman    984-974-9012    kdorman@med.unc.edu    United States, Ohio Ohio State University Not yet recruiting Columbus, Ohio, United States, 43210 Contact: Mark Landon, MD    614-293-8513    mark.landon@osumc.edu    United States, Pennsylvania University of Pennsylvania Not yet recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Celeste Durswald, MD    215-615-3817    celeste.durnwald@uphs.upenn.edu    United States, Texas University of Texas Medical Branch Not yet recruiting Galveston, Texas, United States, 77555 Contact: Gayle Olson, MD    409-747-4905    golson@utmb.edu    University of Texas - Houston Not yet recruiting Houston, Texas, United States, 77030 Contact: Jeffie Refuerzo    713-500-6416    jerrie.s.refuerzo@uth.tmc.edu    United States, Utah University of Utah Not yet recruiting Salt Lake City, Utah, United States, 84112 Contact: Michael Varner    801-581-4173    michael.varner@hsc.utah.edu Less <<
NCT01044355 Resistant Hypertension ... More >> Obstructive Sleep Apnea Less << Not Applicable Active, not recruiting January 2020 Canada, Quebec ... More >> Royal Victoria Hospital Montreal, Quebec, Canada, H3A 1A1 Montreal General Hospital Montreal, Quebec, Canada, H3G 1A4 Less <<
NCT03526536 End-Stage Renal Disease ... More >> Diabetes Mellitus Less << Phase 4 Recruiting December 31, 2018 United States, New York ... More >> SUNY Downstate Medical Center Recruiting Brooklyn, New York, United States, 11203 Contact: Ketan Shevde, MD    718-613-8742    ketan.shevde@downstate.edu    Contact: Joanna Serafin, PhD    718-613-8742    joanna.serafin@downstate.edu Less <<
NCT01707316 Healthy Phase 1 Completed - China ... More >> Beijing, China Less <<
NCT01520454 Obesity Lepti... More >>n Resistance Less << Not Applicable Completed - United States, Massachusetts ... More >> Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Less <<
NCT00714233 Polycystic Ovary Syndrome Phase 3 Completed - -
NCT00714233 - Completed - -
NCT00447382 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 3 Completed - Former Serbia and Montenegro ... More >> Belgrade, Former Serbia and Montenegro, 11000 Germany Frankfurt, Germany, 60590 Macedonia, The Former Yugoslav Republic of Skopje, Macedonia, The Former Yugoslav Republic of, 1000 Russian Federation Moscow, Russian Federation, 119034 South Africa Cape Town, Western Cape, South Africa, 7925 Less <<
NCT01520454 - Completed - -
NCT01403194 - Terminated(Analysis was not do... More >>ne because only 1 subject was able to come back for the 3 month follow up visit.) Less << - -
NCT00447382 - Completed - -
NCT00604344 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 3 Completed - Japan ... More >> Novo Nordisk Investigational Site Tokyo, Japan, 1000005 Less <<
NCT01403194 Sleep Disordered Breathing Not Applicable Terminated(Analysis was not do... More >>ne because only 1 subject was able to come back for the 3 month follow up visit.) Less << - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT02278939 - Completed - -
NCT00755742 Obesity Insul... More >>in Resistance Metabolic Syndrome Hepatitis C Less << Not Applicable Completed - Canada, Ontario ... More >> Toronto Western Hospital, University Health Network Toronto, Ontario, Canada, M5T2S8 Less <<
NCT02278939 Pre-diabetes ... More >>Overweight Obese Less << Not Applicable Completed - United States, California ... More >> San Francisco / Daly City Communities San Francisco, California, United States, 94118 Less <<
NCT02671656 - Unknown April 2016 France ... More >> Service de Rhumatologie, Hôpital Lariboisière Not yet recruiting Paris, France, 75010 Contact: Thomas BARDIN, MD, PhD    33 1 49 95 62 90    thomas.bardin@lrb.aphp.fr Less <<
NCT00543517 Diabetes Mellitus, Type 2 Phase 3 Terminated - -
NCT00978627 - Completed - -
NCT01307410 - Unknown December 2014 -
NCT03305822 Diabetes Mellitus, Type 2 Phase 1 Completed - Germany ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician. Neuss, Nordrhein-Westfalen, Germany Less <<
NCT00801346 - Completed - United States, Tennessee ... More >> Vanderbilt-Ingram Cancer Center - Cool Springs Nashville, Tennessee, United States, 37064 Vanderbilt-Ingram Cancer Center at Franklin Nashville, Tennessee, United States, 37064 Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232-6838 Less <<
NCT02734394 Cancer Not Applicable Recruiting December 2025 Canada, Ontario ... More >> University of Waterloo Recruiting Waterloo, Ontario, Canada, N2L 3G1 Contact: Caryl Russell, MSc    519-888-4567 ext 36379    crussell@uwaterloo.ca    Contact: Marina Mourtzakis, PhD    519-888-4567 ext 38459    mmourtzakis@uwaterloo.ca Less <<
NCT03353792 Type1 Diabetes Mellitus Not Applicable Recruiting November 2022 United States, Connecticut ... More >> Yale New Haven Hospital Recruiting New Haven, Connecticut, United States, 06510 Less <<
NCT01618045 - Active, not recruiting December 2019 United States, Ohio ... More >> OSU CarePoint East Columbus, Ohio, United States, 43203 University Hospital East (Wound Center) Columbus, Ohio, United States, 43205 University Hospital East, OSUWMC Diabetes Clinic Columbus, Ohio, United States, 43205 The Ohio State University/Ohio State University Wexner Medical Center Columbus, Ohio, United States, 43210 OSUWMC Comprehensive Wound Care Center, Martha Morehouse Medical Plaza Columbus, Ohio, United States, 43221 Less <<
NCT00924053 - Completed - -
NCT02138188 - Unknown April 2016 Italy ... More >> Division of Endocrinology, Diabetes and Metabolism-Department of Medicine-AOUI Verona Recruiting Verona, Italy, 37126 Contact: Maddalena Trombetta, MD Phd    +39 045 8123110    maddalena.trombetta@univr.it    Principal Investigator: Maddalena Trombetta, MD Phd          Sub-Investigator: Liliana Indelicato, Psychologist Less <<
NCT00924053 Diabetes Mellitus Type 2 Phase 1 Completed - United States, Texas ... More >> dgd Research Inc., a Cetero Research Company San Antonio, Texas, United States, 78229 Less <<
NCT00978627 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 3 Completed - -
NCT02421029 Heavy Metal Toxicity Phase 4 Withdrawn(it was logistically ... More >>difficult to obtain the drug needed to conduct the study) Less << December 2018 United States, Florida ... More >> Mount Sinai Medical Center Miami Beach, Florida, United States, 33140 Less <<
NCT01187849 Patients With Glucocorticoid T... More >>reatment Less << Phase 4 Completed - Switzerland ... More >> University Hospital Basel Basel, Basel-Stadt, Switzerland, 4031 Less <<
NCT00481117 Type 2 Diabetes Phase 1 Completed - India ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ambawadi, India, 380015 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bangalore, India, 560 078 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Belgaum, India, 590 010 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hyderabaad, India, 500004 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Maharashtra, India, 422 002 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Rabale, India, 400 7001 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Siddhapudur, India, 641 044 Mexico For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mexico City, Mexico, 14050 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Morelia, Mexico, CP 58249 New Zealand For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Wellington, New Zealand South Africa For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. George, South Africa, 6529 Less <<
NCT00909701 Starvation Not Applicable Completed - United Kingdom ... More >> Nottingham Digestive Diseases Centre Biomedical Research Unit Nottingham, Nottinghamshire, United Kingdom, NG7 2UH Less <<
NCT02694289 Type 2 Diabetes Mellitus Not Applicable Withdrawn(failure to enroll pa... More >>rticipants) Less << - -
NCT00292890 Diabetes Mellitus Not Applicable Completed - Netherlands ... More >> University Medical Centre Groningen Groningen, Netherlands, 9700RB Less <<
NCT03657537 Type2 Diabetes ... More >> Ketonemia Cognitive Change Less << Phase 1 Recruiting April 1, 2019 Denmark ... More >> Department of Research in Endocrinology, Bispebjerg University Hospital Recruiting Copenhagen, Denmark Contact: Nicole J Jensen    +4530914667    nicole.jacqueline.jensen@regionh.dk    Principal Investigator: Jørgen Rungby, Professor Less <<
NCT02175784 Type 2 Diabetes Mellitus Phase 4 Completed - Japan ... More >> Chubu, Japan Chugoku, Japan Hokkaido, Japan Kansai, Japan Kanto, Japan Kyushu, Japan Shikoku, Japan Touhoku, Japan Less <<
NCT00907153 - Completed - -
NCT02584075 Coronary Endothelial Function Phase 4 Unknown January 2018 -
NCT02876770 Motor Activity Early Phase 1 Terminated - -
NCT00907153 Polycystic Ovary Syndrome Phase 1 Phase 2 Completed - United States, Pennsylvania ... More >> Penn State College of Medicine, Penn State Milton S Hershey Medical Center Hershey, Pennsylvania, United States, 17033 Less <<
NCT02397447 Diabetes Mellitus Type 2 Phase 2 Completed - Mexico ... More >> Institute of Experimental and Clinical Therapeutics (INTEC), CUCS, University of Guadalajara Guadalajara, Jalisco, Mexico, 44340 Less <<
NCT01832298 Advanced Solid Tumor Phase 1 Completed - China, Beijing ... More >> Cancer Institute and Hospital, Chinese Academy of Medical Sciences Beijing, Beijing, China, 100021 China, Heilongjiang The tumor hospital affiliated to Harbin medical university Harbin, Heilongjiang, China, 150000 China, Sichuan West China Hospital, Sichuan University Chengdu, Sichuan, China, 610000 Less <<
NCT00949286 - Completed - -
NCT02346994 Obesity Overw... More >>eight Pediatric Obesity Less << Not Applicable Completed - United States, New York ... More >> New York Nutrition Obesity Research Center New York, New York, United States, 10032 Less <<
NCT00543556 Type 2 Diabetes Mellitus Phase 2 Terminated - -
NCT00737815 Diabetes Mellitus, Type 2 ... More >> Inflammation Less << Not Applicable Completed - United States, California ... More >> UCLA General Clinical Research Center Los Angeles, California, United States, 90095 Less <<
NCT00812253 Congestive Heart Failure ... More >> Diabetes Mellitus Less << Phase 2 Completed - United States, Ohio ... More >> The Ohio State University Columbus, Ohio, United States, 43210 Less <<
NCT00845468 - Completed - Denmark ... More >> Hospital of Fünen Svendborg Svendborg, Denmark, 5700 Less <<
NCT01071785 Metabolic Syndrome ... More >> Albuminuria Less << Not Applicable Completed - Brazil ... More >> HCPA Porto Alegre, RS, Brazil, 90630040 Less <<
NCT00422487 Type 2 Diabetes Mellitus Phase 2 Completed - United States, Texas ... More >> Diabetes and Glandular Disease Research Associates San Antonio, Texas, United States, 78229-4801 Less <<
NCT01570946 Prediabetic State Not Applicable Completed - India ... More >> India Diabetes Research Foundation Chennai, Tamil Nadu, India, 600 008 United Kingdom Imperial College London, United Kingdom, SW1P 3NE Less <<
NCT00454597 Obesity Diabe... More >>tes Mellitus Type 2 Less << Early Phase 1 Completed - Mexico ... More >> Hospital General Regional de León, Universidad de Guanajuato, Facultad de Medicina de León Leon, Guanajuato, Mexico, 37320 Less <<
NCT00518115 - Completed - -
NCT01022177 Diabetes Mellitus, Type 2 Phase 2 Unknown May 2012 Germany ... More >> University Carl Gustav Carus Recruiting Dresden, Saxonia, Germany, 01307 Sub-Investigator: Kathleen - Wozniak, - Less <<
NCT01922817 Type 1 Diabetes ... More >> Hypoglycaemia Less << Phase 3 Completed - United Kingdom ... More >> Clinical research centre, Ninewells Hospital and Medical School Dundee, United Kingdom, DD1 9SY Less <<
NCT00812253 - Completed - -
NCT02286206 Psychotic Disorders ... More >> Schizophrenia Less << Phase 4 Active, not recruiting December 2017 Canada, British Columbia ... More >> UBC Hospital - Detwiller Pavilion Vancouver, British Columbia, Canada, V6T 2A1 Less <<
NCT02258698 - Completed - Switzerland ... More >> Andrea Kopp Lugli Basel, BS, Switzerland, 4031 Less <<
NCT00518115 Diabetes Mellitus, Type 2 Phase 2 Completed - -
NCT02700607 Cerebral Aneurysm Not Applicable Unknown January 2017 -
NCT00793273 - Completed - Switzerland ... More >> Zurich, Oerlikon, Switzerland, CH-8050 Less <<
NCT01739712 Diabetes Not Applicable Completed - United States, Arizona ... More >> Angel Wing Clinic for Diabetes Tucson, Arizona, United States, 85719 Less <<
NCT02739698 Peritoneal Carcinomatosis Phase 2 Completed - -
NCT01098539 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT01832935 Type 2 Diabetes Mellitus Phase 4 Completed - Iran, Islamic Republic of ... More >> Tehran University of Medical Sciences Tehran, Iran, Islamic Republic of, 13145-784 Less <<
NCT01098539 - Completed - -
NCT01306214 Diabetes Mellitus, Type 2 ... More >> Obesity Less << Phase 3 Completed - -
NCT02568605 Non-alcoholic Fatty Liver Dise... More >>ase Less << Not Applicable Recruiting August 2020 Canada, Alberta ... More >> University of Calgary Recruiting Calgary, Alberta, Canada, T2N 1N4 Contact: Raylene A Reimer, PhD, RD    403-220-8218    reimer@ucalgary.ca Less <<
NCT00131287 Diabetes Mellitus, Type II Phase 3 Completed - Taiwan ... More >> Chung-Hua Hsu Taipei, Taiwan, 886 Less <<
NCT01306214 - Completed - -
NCT02739698 - Completed - -
NCT00534105 - Completed - -
NCT01729156 Type 2 Diabetes ... More >> Dyslipidemia Less << Phase 4 Completed - -
NCT00455741 Postmenopause ... More >> Aging Less << Phase 1 Phase 2 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT02757118 Cardiac Surgery Not Applicable Unknown January 2017 -
NCT00455741 - Completed - -
NCT01307137 Diabetes Pre-... More >>diabetes Less << Not Applicable Unknown September 2013 United States, Florida ... More >> Miami VAMC Not yet recruiting Miami, Florida, United States, 33125 Contact: Lisset Oropesa, MD, MS    305-794-2669    lisset.oropesa@va.gov    Principal Investigator: Hermes J Florez, MD, MPH, PhD          University of Miami Miami, Florida, United States, 33125 Less <<
NCT02771873 Coronary Heart Disease Not Applicable Active, not recruiting May 2020 India ... More >> Sree Chitra Tirunal Institute for Medical Sciences and Technology Trivandrum, Kerala, India, 695011 Less <<
NCT01272804 Diabetes Mellitus, Type 2 ... More >> NIDDM Less << Phase 1 Completed - United States, Florida ... More >> Elite Research Institute Miami, Florida, United States, 33169 Miami Research Associates South Miami, Florida, United States, 33143 MRA Clinical Research South Miami, Florida, United States, 33143 United States, Ohio Medpace Clinical Pharmacology Unit Cincinnati, Ohio, United States, 45212 Less <<
NCT01231984 Diabetes Mellitus, Type 1 ... More >> Diabetes Mellitus, Type 2 Less << Not Applicable Completed - United States, California ... More >> AMCR Institute, Inc. Escondido, California, United States, 92026 United States, Georgia Atlanta Diabetes Associates Atlanta, Georgia, United States, 30309 United States, Illinois Springfield Diabetes and Endocrine Center Springfield, Illinois, United States, 62704 United States, Minnesota International Diabetes Center (IDC) Minneapolis, Minnesota, United States, 55416 United States, Nebraska Diabetes and Endocrine Associates Omaha, Nebraska, United States, 68131 United States, New Jersey The Molly Diabetes Center for Adults and Children at Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 United States, North Carolina Mountain Diabetes and Endocrine Center Asheville, North Carolina, United States, 28803 United States, Tennessee University Diabetes and Endocrine Consultants Chattanooga, Tennessee, United States, 37403 United States, Texas Clinical Trials of Texas, Inc San Antonio, Texas, United States, 78229 United States, Virginia Corporate Lane Internal Medicine and Research Center Virgina Beach, Virginia, United States, 23462 Less <<
NCT01272804 - Completed - -
NCT00286234 Metabolic Syndrome ... More >> Hypertriglyceridemia Less << Phase 4 Completed - United States, South Dakota ... More >> Sanford Clinic Clinical Research Services Sioux Falls, South Dakota, United States, 57105 Less <<
NCT01231984 - Completed - -
NCT03604419 Type 2 Diabetes Mellitus (T2DM... More >>) Less << Phase 2 Recruiting June 1, 2019 United States, Florida ... More >> Clinical Pharmacology of Miami Recruiting Miami, Florida, United States, 33014 Contact: KENNETH Lasseter, MD Less <<
NCT01628341 - Completed - France ... More >> Novo Nordisk Investigational Site Paris La défense cedex, France, 92932 Less <<
NCT01661426 Obesity Insul... More >>in Resistance Less << Not Applicable Completed - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT03202108 Ketogenic Dieting ... More >> Epilepsy Glucose Transporter Type 1 Deficiency Syndrome Less << Not Applicable Not yet recruiting September 30, 2017 United Kingdom ... More >> National Hospital for Neurology and Neurosurgery Not yet recruiting London, Greater London, United Kingdom, WC1N 3BG Contact: Kit Kaalund Hanssen    0203 448 3454    Kit.KaalundHansen@UCLH.NHS.UK    Leeds Children's Hospital Not yet recruiting Leeds, West Yorkshire, United Kingdom, LS1 3EX Contact: Rachel Meskell    0113 392 3507    R.Meskell@NHS.Net Less <<
NCT00534105 - Completed - United States, Massachusetts ... More >> Baystate Medical Center Springfield, Massachusetts, United States, 01199 Less <<
NCT02725593 Type 2 Diabetes Phase 3 Recruiting April 24, 2020 -
NCT02901496 Adiposity Not Applicable Recruiting November 2017 Denmark ... More >> Rigshospitalet, Centre of Inflammation and Metabolism (CIM) Centre for Physical Activity Research (CFAS) Recruiting Copenhagen, Denmark, 2100 Contact: Louise L Lehrskov, MD    +45 35457190    louise.lang.lehrskov@regionh.dk    Principal Investigator: Louise L Lehrskov, MD          Principal Investigator: Regitse H Christensen, MD          Principal Investigator: Anne-Sophie Wedel-Neergard, MD Less <<
NCT01252238 Insulin Sensitivity ... More >> Aortic Compliance Diastolic Function Less << Not Applicable Terminated(Study sponsor termi... More >>nated study due to AE's reported with valsartan and aliskiren) Less << - United States, Massachusetts ... More >> Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Less <<
NCT01028963 Type 2 Diabetes Mellitus Phase 2 Completed - Australia, Queensland ... More >> Auchenflower, Queensland, Australia Kippa-Ring, Queensland, Australia Czech Republic Beroun, Czech Republic Hlucin, Czech Republic Neratovice, Czech Republic Novy Jicin, Czech Republic Ostrava, Czech Republic Pardubice, Czech Republic Prague, Czech Republic Prelouc, Czech Republic Slany, Czech Republic Uhersky Brod, Czech Republic Unicov, Czech Republic Usti nad Labem, Czech Republic Germany Basenheim, Germany Berlin, Germany Cologne, Germany Dresden, Germany Heidelberg, Germany Mannheim, Germany Nuremberg, Germany Saarlouis, Germany Hungary Balatonfuered, Hungary Budapest, Hungary Satoraljaujhely, Hungary Szikszo, Hungary New Zealand Christchurch, New Zealand Wellington, New Zealand Less <<
NCT00310297 Type 2 Diabetes Mellitus Phase 1 Completed - -
NCT00736879 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT01497041 Carcinoma, Non-Small-Cell Lung... More >> Carcinoma, Squamous Carcinoma, Large Cell Less << Phase 2 Unknown December 2013 Korea, Republic of ... More >> Soonchunhyang University Cheonan Hospital Recruiting Cheonan, Korea, Republic of Contact: Sang Byung Bae, M.D.    +82-41-570-3667    baesan@schmc.ac.kr    Principal Investigator: Sang Byung Bae, M.D.          Sub-Investigator: Han Jo Kim, M.D.          Sub-Investigator: Kyu Taek Lee, M.D.          Chungbuk National University Hospital Recruiting Cheongju, Korea, Republic of Contact: Ki Hyeong Lee    +82-43-269-6015    kihlee@chungbuk.ac.kr    Sub-Investigator: Hye Suk Han          Principal Investigator: Ki Hyeong Lee          Chungnam National University Hospital Recruiting Daejeon, Korea, Republic of Contact: Hwan Jung Yun    +82-42-280-7157    hjyun@cnuh.co.kr    Principal Investigator: Hwan Jung Yun          Sub-Investigator: Sam Yong Kim          Sub-Investigator: Hyo Jin Lee          The Catholic University of Korea Daejeon ST. Mary's Hospital Recruiting Daejeon, Korea, Republic of Contact: Suk Young Park    +82-42-220-9832    sypark1011@hotmail.com    Principal Investigator: Suk Young Park          Sub-Investigator: Young Joon Yang          Sub-Investigator: Ji Chan Park          Chonbuk National University Hospital Recruiting Jeonju, Korea, Republic of Contact: Eun-Kee Song    +82-63-254-1609    eksong@jbnu.ac.kr    Principal Investigator: Eun-Kee Song          Sub-Investigator: Chang-Yeol Yim          Sub-Investigator: Na-Ri Lee Less <<
NCT00736879 - Completed - -
NCT01252238 - Terminated(Study sponsor termi... More >>nated study due to AE's reported with valsartan and aliskiren) Less << - -
NCT01596244 Diabetes Mellitus, Type II Not Applicable Completed - Jordan ... More >> Ein El-Basha Ministry of Health Center Amman, Jordan Jabl Nasr Ministry of Health Center Amman, Jordan Less <<
NCT01042977 Type 2 Diabetes Mellitus ... More >> Cardiovascular Disease Inadequate Glycaemic Control Less << Phase 3 Completed - -
NCT00950534 Diabetes Mellitus, Type 2 Phase 4 Terminated(due to poor recruit... More >>ment) Less << - Australia ... More >> Sanofi-Aventis Administrative Office Macquarie Park, Australia Less <<
NCT01042977 - Completed - -
NCT02777034 Crohn's Disease Not Applicable Unknown December 2017 China, Zhejiang ... More >> Sir Run Run Shaw Hospital Recruiting Hangzhou, Zhejiang, China Contact: Jianjian Xiang, doctor    008615168326849    ybxjj1990@126.com Less <<
NCT00997659 Insulin Resistance ... More >> Obesity Less << Not Applicable Completed - United States, New York ... More >> Stony Brook University GCRC Stony Brook, New York, United States, 11794 Less <<
NCT02757027 CABG Surgery Not Applicable Unknown January 2017 -
NCT00845988 Bipolar Disorders ... More >> Metabolic Complication Less << Phase 4 Completed - Korea, Republic of ... More >> Seoul National University Bundang Hospital Seongnam-si, Gyeonggi-do, Korea, Republic of, 463-707 Less <<
NCT01824043 Diabetic Retinopathy ... More >> Vitreous Hemorrhage Less << Phase 4 Unknown December 2013 Brazil ... More >> Marcelo Novello Recruiting Sao Jose, SC, Brazil, 88103-901 Contact: MARCELO NOVELLO       mbnovell@yahoo.com Less <<
NCT01050868 Diabetes Mellitus Type 1 Not Applicable Completed - Germany ... More >> Ulm, Germany, 89081 Less <<
NCT01472666 Metabolic Syndrome ... More >> Type 2 Diabetes Cardiovascular Disease Abdominal Obesity Less << Not Applicable Completed - Denmark ... More >> Aarhus University Hospital Aarhus, Aarhus C, Denmark, 8000 Less <<
NCT01217892 Type 2 Diabetes Phase 3 Completed - -
NCT00826761 Obesity Appet... More >>ite Regulation Less << Not Applicable Completed - Denmark ... More >> Department of Human Nutrition Frederiksberg, Denmark Less <<
NCT01217892 - Completed - -
NCT00806975 Diabetes Complications ... More >> Diabetes Mellitus, Type 2 Less << Not Applicable Unknown June 2009 Japan ... More >> Nagaoka Red Cross Hospital Not yet recruiting 2-291 Nagaoka, Niigata, Japan, 940-2085 Contact: Kyuzi Kamoi, MD    +81-0258-28-3600    kkam-int@echigo.ne.jp    Sub-Investigator: Shinichi Minagawa, MD          Sub-Investigator: Keita Kimura, MD          Sub-Investigator: Takako Ito, MD          Sub-Investigator: Akane Kobayashi, MD Less <<
NCT03092063 Type2 Diabetes Not Applicable Recruiting March 31, 2021 United States, California ... More >> Olive View-UCLA Medical Center Recruiting Sylmar, California, United States, 91342 Contact: alex kopelowicz    818-364-4823    akopel@ucla.edu Less <<
NCT03440450 Advanced Solid Tumors Phase 1 Recruiting March 2021 United States, Arizona ... More >> Honor Health Research Institute Recruiting Scottsdale, Arizona, United States, 85258 Contact: Joyce Schaffer, RN    480-323-1791    joyce.schaffer@honorhealth.com    Principal Investigator: Erkut Borazanci, MD Less <<
NCT02770027 Colon Surgery Not Applicable Unknown January 2017 -
NCT00543751 Diabetes Mellitus, Type 2 Phase 3 Terminated - -
NCT00329225 Diabetes Mellitus, Type 2 Phase 4 Completed - -
NCT01128621 - Completed - -
NCT00961974 Type 1 Diabetes Not Applicable Completed - United States, Massachusetts ... More >> Joslin Diabetes Center Boston, Massachusetts, United States, 02215 Less <<
NCT01710592 Gastro Oesophageal Cancer Phase 2 Completed - Ireland ... More >> Mercy University Hospital Cork, Ireland Beaumont Hospital Dublin, Ireland Mater Misericordiae University hospital & Mater Private Hospital Dublin, Ireland St James's Hospital Dublin, Ireland The Adelaide and Meath Hospital Dublin, Ireland Waterford Regional Hospital Waterford, Ireland Less <<
NCT03740165 Ovarian Cancer ... More >> Fallopian Tube Cancer Peritoneal Neoplasms Less << Phase 3 Not yet recruiting August 8, 2025 -
NCT01128621 Diabetes Mellitus, Type 2 Phase 2 Completed - United States, California ... More >> GSK Investigational Site Chula Vista, California, United States, 91910 United States, Florida GSK Investigational Site Miami, Florida, United States, 33169 Less <<
NCT01086956 Prostatic Cancer Not Applicable Completed - Korea, Republic of ... More >> Severance Hospital Seoul, Korea, Republic of Less <<
NCT01241695 Diabetes Not Applicable Completed - Germany ... More >> Medical Practice Stockach, Baden-Württemberg, Germany, 78333 Less <<
NCT02347020 Obesity Diabe... More >>tes Mellitus, Type II Cardiovascular Disease Less << Not Applicable Completed - United States, New York ... More >> New York Nutrition Obesity Research Center New York, New York, United States, 10032 Less <<
NCT00162799 Insulin Resistance Phase 2 Completed - Spain ... More >> Unitat de Diabetologia, Endocrinologia y Nutrición Hosp Josep Trueta Girona, Spain, 17007 Less <<
NCT03168633 Diabetes Mellitus, Type 2 Not Applicable Completed - -
NCT01240018 Obesity Appet... More >>ite Regulation Less << Not Applicable Completed - Denmark ... More >> University of Copenhagen, Department of Human Nutrition Frederiksberg, DK, Denmark, 1958 Less <<
NCT03541603 Hypertension Pulmonary Seconda... More >>ry Heart Failure, Right Sided Heart Failure With Normal Ejection Fraction Less << Phase 2 Recruiting December 2019 United States, Arizona ... More >> Banner University Medical Center Phoenix Lung Institute Recruiting Phoenix, Arizona, United States, 85006 United States, California Stanford Healthcare Recruiting Stanford, California, United States, 94305 United States, New York Mayo Clinic Recruiting Rochester, New York, United States, 55905 Less <<
NCT02067026 Overweight He... More >>althy Subjects Less << Not Applicable Completed - Italy ... More >> Fondazione Edmund Mach -Centro Ricerca ed Innovazione San Michele all'Adige, TN, Italy, 38010 Unità di Dietetica e Nutrizione Clinica, Ospedale S. Chiara, Via Orsi 1 Trento, TN, Italy, 38100 Less <<
NCT01097681 Type 2 Diabetes Mellitus Phase 1 Completed - Japan ... More >> Kansai, Japan Kantou, Japan Less <<
NCT01159600 - Completed - -
NCT01001104 - Completed - -
NCT00795210 - Completed - -
NCT00280865 Type 2 Diabetes Phase 2 Completed - -
NCT02736331 Healthy Not Applicable Active, not recruiting July 30, 2019 United States, Illinois ... More >> Clinical Nutrition Research Center Chicago, Illinois, United States, 60616 Less <<
NCT01001104 Diabetes Mellitus, Type 2 Phase 2 Completed - Japan ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chiba, Japan, 276-0049 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kanagawa, Japan, 359-1161 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kochi, Japan, 781-8555 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kyoto, Japan, 604-8151 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Osaka, Japan, 530-0047 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tokyo, Japan, 171-0021 Less <<
NCT01739868 Pre-diabetes Not Applicable Unknown April 2018 France ... More >> Nantes University Hospital Nantes, France Less <<
NCT00795210 HIV Lipodystrophy Not Applicable Completed - United States, Massachusetts ... More >> MGH Boston, Massachusetts, United States, 02114 Less <<
NCT03171506 Ovarian Cancer ... More >> Endometrial Cancer Less << Not Applicable Completed - -
NCT01022112 Type 2 Diabetes Mellitus Phase 2 Completed - Japan ... More >> Research site Chugoku, Japan Research site Kanto, Japan Research site Kinki, Japan Research site Kyushu, Japan Research site Shikoku, Japan Research site Tohoku, Japan Less <<
NCT01931995 Major Depressive Disorder, Rec... More >>urrent Less << Not Applicable Active, not recruiting July 2018 United States, Massachusetts ... More >> Martinos Center for Biomedical Imaging/Massachusetts General Hospital Charlestown, Massachusetts, United States, 02129 Less <<
NCT00732121 Type 2 Diabetes Phase 4 Unknown August 2010 United States, Vermont ... More >> University of Vermont South Burlington, Vermont, United States, 05403 Less <<
NCT00277342 Wildtype Poly... More >>morphism Liver FABP Less << Not Applicable Completed - Germany ... More >> German Institute of Human Nutrition DIfE, Dpt. of Clinical Nutrition, Potsdam-Rehbrücke Nuthetal, Germany, 14558 Less <<
NCT00873821 Diabetes Mellitus, Type 2 Phase 1 Completed - -
NCT03700346 Septic Shock Not Applicable Recruiting December 31, 2018 Tunisia ... More >> Military hospital of tunis Recruiting Tunis, Mont Fleury, Tunisia, 1008 Contact: zied hajjej, Dr    +21620358907    hajjej_zied@hotmail.com    Principal Investigator: zied hajjej, dr          Military Hopital of Tunis Recruiting Tunis, Tunisia, 1008 Contact: mustapha ferjani    98329256    mustapha.ferjani@planet.tn    Contact: zied hajjej    20358907    hajjej_zied@hotmail.com Less <<
NCT02271594 Insulin Injections and Lipohyp... More >>ertrophy Less << Not Applicable Completed - United Kingdom ... More >> Ealing Hospital Middlesex, London, United Kingdom, UB1 3HW Less <<
NCT01022112 - Completed - -
NCT02836704 Diabetes Mellitus, Type 2 Phase 4 Completed - China ... More >> China, China Less <<
NCT03758651 - Recruiting June 30, 2021 United States, Massachusetts ... More >> Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: Takara Stanley, MD          Principal Investigator: Barbara Pober, MD Less <<
NCT00099931 Diabetes Mellitus, Type 2 Phase 3 Completed - Germany ... More >> Novartis Investigative Site Investigative Sites, Germany Less <<
NCT02441205 Aging Disease Not Applicable Completed - United States, North Carolina ... More >> Duke Center for Living Durham, North Carolina, United States, 27705 Less <<
NCT01087242 Type 2 Diabetes Phase 3 Unknown June 2010 China, Jiang Su ... More >> TCM school of Jiang Su province Nan Jing, Jiang Su, China, 210029 China, Liao Ning Liaoning University of Traditional Chinese Medicine Shen Yang, Liao Ning, China, 116600 China, Shang Hai Shanghai University of Traditional Chinese Medicine Shang Hai, Shang Hai, China, 200032 China, Tian Jin Tian Jin traditional chinese medicine university Tian Jin, Tian Jin, China, 300193 Less <<
NCT00611546 Preterm Infants Not Applicable Completed - -
NCT01814748 Diabetes Mellitus Phase 3 Completed - -
NCT00318786 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - Japan ... More >> Novo Nordisk Investigational Site Tokyo, Japan, 1000005 Less <<
NCT01814748 - Completed - -
NCT00512408 - Terminated - Italy ... More >> IRCCS San Raffaele Rome, Italy, 00163 Less <<
NCT01283308 Diabetes Mellitus, Type 2 Not Applicable Completed - India ... More >> Madras Diabetes Research Foundation Chennai, Tamil Nadu, India, 600 086 Less <<
NCT01938365 - Unknown December 2016 China, Shanghai ... More >> Ruijin hospital, Shanghai Jiao-Tong University School of Medicine Recruiting Shanghai, Shanghai, China, 200025 Contact: Guang Ning, Professor    8621-64370045 ext 665344    feifei1116@hotmail.com    Principal Investigator: Guang Ning, Professor Less <<
NCT03350191 Type 2 Diabetes Mellitus Phase 1 Completed - Sweden ... More >> Investigational Site Number 7520001 Uppsala, Sweden, 75237 Less <<
NCT01153100 Diabetes Not Applicable Completed - United States, Colorado ... More >> University of Colorado Denver Aurora, Colorado, United States, 80045 Less <<
NCT03174340 Gestational Diabetes Not Applicable Completed - -
NCT02542059 - Recruiting May 2019 Netherlands ... More >> Rijnstate Hospital Recruiting Arnhem, Gelderland, Netherlands, 6815 AD Contact: Laura Deden, Msc       ldeden@rijnstate.nl    Contact: Edo Aarts, Dr    088 - 005 8888    eaarts@rijnstate.nl    Principal Investigator: Edo Aarts, Dr.          Sub-Investigator: Laura Deden, Msc          RadboudUMC Recruiting Nijmegen, Gelderland, Netherlands, 6500HB Contact: Marti Boss, Msc    +31-24-36 ext 67243    marti.boss@radboudumc.nl    Contact: Martin Gotthardt, Prof. Dr.    +31-24-36 ext 14048    martin.gotthardt@radboudumc.nl    Sub-Investigator: Marti Boss, Msc          Principal Investigator: Martin Gotthardt, Prof. Dr.          Sub-Investigator: Mijke Buitinga, Msc Less <<
NCT01186003 Diabetes Not Applicable Completed - United States, Colorado ... More >> University of Colorado Denver Aurora, Colorado, United States, 80045 Less <<
NCT00101751 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 4 Completed - United States, New Jersey ... More >> Novo Nordisk Clinical Trial Call Center Princeton, New Jersey, United States, 08540 Less <<
NCT02370121 Metabolic Syndrome Phase 2 Completed - -
NCT00873821 - Completed - -
NCT02459561 Overweight and Obesity ... More >> Diabetes Less << Not Applicable Active, not recruiting April 2019 United Kingdom ... More >> Imperial Clinical Trials Unit London, United Kingdom, W2 1PG Less <<
NCT02015130 Type 2 Diabetes ... More >> Hypertension Less << Not Applicable Enrolling by invitation October 2025 Denmark ... More >> Hospital of south west Denmark Esbjerg, Denmark, 6700 Medicinsk afdeling.Holbæk Sygehus. Holbæk, Denmark, 4300 Næstved Lægecenter Næstved, Denmark, 4700 Odense University Hospital Odense, Denmark, 5000 Less <<
NCT03587727 - Not yet recruiting September 30, 2021 United States, Colorado ... More >> University of Colorado Anshutz Medical Campus/Children's Hospital Colorado Not yet recruiting Aurora, Colorado, United States, 80045 Contact: Yesenia Garcia Reyes    720-777-6984    yesenia.garciareyes@childrenscolorado.org Less <<
NCT00757939 Alzheimer's Disease Phase 1 Completed - -
NCT02551835 - Unknown August 2016 -
NCT00276939 Diabetes Mellitus, Type 2 Not Applicable Completed - United States, District of Col... More >>umbia Physicians Committee for Responsible Medicine Washington, District of Columbia, United States, 20016 Less <<
NCT02370121 - Completed - -
NCT00004381 Glucosephosphate Dehydrogenase... More >> Deficiency Hyperbilirubinemia Hemolytic Disease of Newborn Less << Phase 2 Completed - United States, Massachusetts ... More >> New England Medical Center Hospital Boston, Massachusetts, United States, 02111 United States, New York Rockefeller University Hospital New York, New York, United States, 10021-6399 Less <<
NCT01565564 - Completed - -
NCT00910923 Diabetes Mellitus, Type 2 Phase 1 Completed - -
NCT01565564 Gestational Diabetes Mellitus Not Applicable Completed - China, Tianjin ... More >> Tianjin Women and Children's Health Center Tianjin, Tianjin, China Less <<
NCT01556880 Pre-diabetes ... More >>Diabetes Less << Not Applicable Completed - Hong Kong ... More >> Department of Family Medicine and Primary Care, The University of Hong Kong Hong Kong Island, Hong Kong Diabetes Centre, Department of Medicine and Rehabilitation, Tung Wah Eastern Hospital Hong Kong Island, Hong Kong School of Nursing, The University of Hong Kong Hong Kong Island, Hong Kong Less <<
NCT01079845 Polycystic Ovary Syndrome Not Applicable Terminated(For this pilot, we ... More >>constructed conditional power curves and noted that we would not substantially enhance power by enrolling additional participants.) Less << - United States, Massachusetts ... More >> Children's Hospital Boston Boston, Massachusetts, United States, 02115 Less <<
NCT01721980 Healthy Phase 1 Completed - Belgium ... More >> SGS LSS Clinical Pharmacology Unit Antwerp Antwerp, Belgium Less <<
NCT03421314 HIV ART ... More >> Zinc Deficiency Selenium Deficiency Metabolic Complication Inflammation Less << Not Applicable Recruiting January 1, 2019 Mexico ... More >> Centro de Investigaciones en Enfermedades Infecciosas Recruiting Mexico city, DF, Mexico, 14080 Contact: Ivan Osuna Padilla, MD    56667085 ext 109    ivan.osuna@cieni.org.mx    Principal Investigator: Gustavo Reyes-Terán, MD          Sub-Investigator: Ivan Osuna Padilla, MD          Sub-Investigator: Olivia Briceño Cárdenas, PhD          Sub-Investigator: Nadia Rodriguez Moguel, MD          Sub-Investigator: Adriana Aguilar Vargas, MD Less <<
NCT00574665 Type 2 Diabetes Not Applicable Completed - United States, Tennessee ... More >> Vanderbilt University Nashville, Tennessee, United States, 37232 Less <<
NCT00674466 Type 2 Diabetes Mellitus Phase 2 Completed - Canada, Quebec ... More >> Maggie Wang Montreal, Quebec, Canada, H2X 3Y8 Less <<
NCT01167231 - Completed - Poland ... More >> Many Locations, Poland Less <<
NCT00674466 - Completed - -
NCT00067951 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT01206166 Critical Illness ... More >> Acute Respiratory Failure Less << Phase 3 Terminated(Low enrollment rate... More >>s.) Less << - United States, Colorado ... More >> University of Colorado DHSC Boulder, Colorado, United States, 80045 United States, Missouri Washington University School of Medicine in St. Louis St. Louis, Missouri, United States, 63110-1093 Mercy Hospital St. Louis St. Louis, Missouri, United States, 63141 United States, Ohio Cleveland Clinic Lerner College of Medicine Cleveland, Ohio, United States, 44195 The Ohio State Univsersity Medical Center Columbus, Ohio, United States, 43221 United States, Oregon Oregon Health & Science University Portland, Oregon, United States, 97239-3098 United States, Texas University of Texas Health Science Center Houston, Texas, United States, 77030 Belgium Erasme University Hospital Brussels, Belgium, B - 1070 Canada, Alberta Royal Alexandra Hospital Edmonton, Alberta, Canada, T5H 3V9 University of Alberta Edmonton, Alberta, Canada, T5H 3V9 Grey Nuns Hospital Edmonton, Alberta, Canada, T6L 5X8 France Nouvel Hôpital Civil Strasbourg, France, F - 67091 Less <<
NCT01455142 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 1 Completed - Austria ... More >> Graz, Austria, 8010 Less <<
NCT01961076 Glycogen Storage Disease Type ... More >>1 (GSD 1) Less << Not Applicable Completed - Switzerland ... More >> University Hospital Zurich, Division of Endocrinology, Diabetes and Clinical Nutrition Zurich, ZH, Switzerland, 8091 Less <<
NCT00901043 DIABETES MELLITUS TYPE 2 Not Applicable Completed - United States, Connecticut ... More >> Griffin Hospital Derby, Connecticut, United States, 06418 Less <<
NCT02314637 Type 2 Diabetes Mellitus Phase 3 Completed - Japan ... More >> Reserch site Shikoku, Japan Less <<
NCT03704818 Type1 Diabetes Mellitus Phase 1 Recruiting December 31, 2020 United States, California ... More >> UC San Diego Altman Clinical & Translational Research Institute Recruiting La Jolla, California, United States, 92037 Contact: Todd May, MS       tmay@ucsd.edu Less <<
NCT02482922 Pre-Diabetic ... More >>Overweight Obesity Less << Not Applicable Completed - United States, North Carolina ... More >> University of North Carolina Family Medicine Center Chapel Hill, North Carolina, United States Less <<
NCT02124408 Diabetes Mellitus Not Applicable Unknown - China, Zhejiang ... More >> Ningbo Beilun District Traditional Chinese Medicine Hospital Recruiting Ningbo, Zhejiang, China, 315800 Contact: Manhong Zhao, MD    +86-574-86784207    maohongzhao12@126.com Less <<
NCT01309698 Type 2 Diabetes Phase 4 Completed - Japan ... More >> Novartis Investigative Site Tokyo, Japan Less <<
NCT02314637 - Completed - -
NCT02458586 NAFLD Obesity... More >> Prediabetes Dyslipoproteinemia Less << Not Applicable Unknown November 2017 Germany ... More >> German Institut for Human Nutrition; Department for Clinical Nutrition Recruiting Nuthetal, Brandenburg, Germany, 14458 Contact: Margrit Kemper, Dr. med.    033200 88 2775    margrit.kemper@dife.de    Contact: Silke Hornemann    033200 88 2779    silke.hornemann@dife.de    Sub-Investigator: Margrit Kemper, Dr. med.          Sub-Investigator: Silke Hornemann          Sub-Investigator: Christiana Gerbracht, Dr. Less <<
NCT02905448 Hyperlipidemia ... More >> Metabolic Syndrome X Less << Not Applicable Unknown March 2017 -
NCT00299871 Type 2 Diabetes Phase 2 Completed - United States, New Jersey ... More >> Sanofi-Aventis Administrative Office Bridgewater, New Jersey, United States, 08807 Brazil Sanofi-Aventis Administrative Office Sao Paulo, Brazil Canada Sanofi-Aventis Administrative Office Laval, Canada Poland Sanofi-Aventis Administrative Office Warszawa, Poland Romania Sanofi-Aventis Administrative Office Bucuresti, Romania Russian Federation Sanofi-Aventis Administrative Office Moscow, Russian Federation Ukraine Sanofi-Aventis Administrative Office Kiev, Ukraine Less <<
NCT02856113 Diabetes Mellitus, Type 2 Phase 3 Recruiting June 11, 2021 -
NCT02068989 - Terminated - United States, Connecticut ... More >> Yale New Haven Hospital St. Raphael Campus New Haven, Connecticut, United States, 06511 Norwalk Hospital Norwalk, Connecticut, United States, 06850 Less <<
NCT01411930 Diabetes Phase 4 Completed - United States, California ... More >> VA San Diego Healthcare System San Diego, California, United States, 92161 Less <<
NCT02863185 Chronic Kidney Disease Phase 4 Recruiting December 2019 Korea, Republic of ... More >> Won Suk An Recruiting Busan, Korea, Republic of, 602-715 Contact: Won Suk An, M.D., Ph.D.    +82-51-240-2811    anws@dau.ac.kr    Dong-A University Not yet recruiting Busan, Korea, Republic of, 602715 Contact: Su Mi Lee, MD    +822405549    promise131@hanmail.net Less <<
NCT02036554 Kidney; Complications, Allogra... More >>ft Less << Phase 4 Unknown December 2015 Korea, Republic of ... More >> division of nephrology;Seoul St Mary's Hospital Recruiting Seoul, Korea, Republic of Contact: Chul Woo Yang    82-2-2258-6851    yangch@catholic.ac.kr Less <<
NCT00283049 - Terminated(Due to technical is... More >>sues relating to the Electronic diary data.) Less << - -
NCT00651001 - Completed - Spain ... More >> Renal Unit of Mateo Orfila Hospital, Balearic Islands - Spain Menorca, Balearic Islands, Spain, 07703 Less <<
NCT02010242 Type 2 Diabetes Mellitus With ... More >>Diabetic Nephropathy Less << Phase 2 Completed - -
NCT00283049 Diabetes Mellitus, Type 2 Phase 4 Terminated(Due to technical is... More >>sues relating to the Electronic diary data.) Less << - United States, New Jersey ... More >> sanofi-aventis, US Bridgewater, New Jersey, United States, 08807 Less <<
NCT02699203 Insulin Resistance Not Applicable Completed - Canada, British Columbia ... More >> University of British Columbia, Okanagan. Kelowna, British Columbia, Canada, V1V 1V7 Less <<
NCT01918865 Type 2 Diabetes Mellitus ... More >> Obese Less << Phase 2 Completed - Argentina ... More >> Isis Investigative Site Mar del Plata, Buenos Aires, Argentina, B7600FZN Isis Investigative Site Rosario, Santa Fe, Argentina, S2000CVD Canada, Alberta Isis Investigational Site Edmonton, Alberta, Canada, T6G 2E1 Canada, British Columbia Isis Investigational Site Kelowna, British Columbia, Canada, V1Y 3G8 Isis Investigational Site Vancouver, British Columbia, Canada, V6J 1S3 Canada, Ontario Isis Investigational Site Etobicoke, Ontario, Canada, M9R 4E1 Isis Investigational Site Toronto, Ontario, Canada, M4G 3E8 Isis Investigative Site Toronto, Ontario, Canada, M9V 4B4 Canada, Saskatchewan Isis Investigational Site Saskatoon, Saskatchewan, Canada, S7K 3H3 South Africa Isis Investigational Site Centurion, Gauteng, South Africa, 0154 Isis Investigational Site Mamelodi, Gauteng, South Africa, 0122 Isis Investigational Site Pretoria, Gauteng, South Africa, 0001 Isis Investigational Site Port Elizabeth, Korsten, South Africa Isis Investigational Site Durban, KwaZulu-Natal, South Africa Isis Investigational Site Middelburg, Mpumalanga, South Africa Isis Investigational Site Limpopo, Thabazimbi, South Africa, 0380 Isis Investigational Site Cape Town, Western Cape, South Africa, 7570 Isis Investigational Site Cape Town, Western Cape, South Africa Isis Investigational Site Benoni, South Africa, 1500 Isis Investigational Site Bloemfontein, South Africa, 9301 Isis Investigational Site Pretoria, South Africa, 0184 Less <<
NCT01741428 Cardiovascular Disease Not Applicable Active, not recruiting December 2021 Norway ... More >> LHL-Hospital Gardermoen Jessheim, Norway, N-2051 Less <<
NCT00371800 Type 1 Diabetes Mellitus Phase 2 Phase 3 Completed - United States, New Hampshire ... More >> Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States, 03756 Less <<
NCT03627039 - Not yet recruiting August 1, 2020 -
NCT02660294 Infertility Phase 1 Phase 2 Unknown April 2017 Egypt ... More >> Rasha Recruiting Cairo, Al Qahirah, Egypt Contact: Rasha M Abdul-hady, MD    1224448449 ext 0020    rashamedhat30@gmail.com    Contact: ahmed M kotb, MD    1004711414 ext 0020    ahmedmkotp@hotmail.com Less <<
NCT00422266 Dyslipidemia Phase 3 Completed - India ... More >> National Thermal Power Corporation Delhi, Badarpur, India Less <<
NCT01100892 Cystic Fibrosis ... More >> Diabetes Less << Phase 3 Recruiting June 2019 Australia, New South Wales ... More >> John Hunter Children's Hospital Recruiting New Lambton, New South Wales, Australia, 2310 Contact: Jodi Hilton          Contact: Patricia Crock          Sydney Children's Hospital Recruiting Randwick, New South Wales, Australia, 2031 Contact: Charles Verge    93821456    c.verge@UNSW.edu.au    Contact: Shihab Hameed    93821456    s.hameed@UNSW.edu.au    Children's Hospital at Westmead Recruiting Westmead, New South Wales, Australia, 2145 Contact: Hiran Selvadurai          Contact: Peter Cooper          Australia, Queensland Lady Cilento Children's Hospital Recruiting Brisbane, Queensland, Australia, 4101 Contact: Claire Wainwright          Contact: Joyce Cheney          Australia, South Australia Women's and Children's Hospital Recruiting Adelaide, South Australia, Australia, 5006 Contact: Andrew Tai          Contact: Alexia Pena Less <<
NCT03194204 - Not yet recruiting October 2020 Egypt ... More >> Assiut University Not yet recruiting Assiut, Egypt, 71000515 Less <<
NCT03568630 - Recruiting July 2023 United States, Nebraska ... More >> Nebraska Medical Center Recruiting Omaha, Nebraska, United States, 68198 Contact: Christina Hoy, DNP    402-559-1577    christina.hoy@unmc.edu Less <<
NCT02047071 Obstructive Sleep Apnea Not Applicable Completed - Spain ... More >> Hospital Universitario Valme Seville, Spain, 41014 Less <<
NCT01324414 - Completed - United States, Arizona ... More >> Mayo Clinic Phoenix, Arizona, United States, 85054 Less <<
NCT02498483 Pain Circumci... More >>sion Less << Phase 4 Recruiting June 2017 United States, New York ... More >> Well Baby Nursery Recruiting New York, New York, United States, 10032 Contact: Roya Oneal, MD    212-305-7623 Less <<
NCT03761186 Type1diabetes Not Applicable Not yet recruiting December 2021 -
NCT00790088 - Unknown March 2012 -
NCT02772861 Intestinal Diseases Not Applicable Completed - United Kingdom ... More >> University College, London London, United Kingdom, NW1 2BU Less <<
NCT00845156 Insulin Resistance Not Applicable Completed - United States, California ... More >> University of California at San Francisco San Francisco, California, United States, 94143 Less <<
NCT02725502 Type 1 Diabetes Mellitus Not Applicable Unknown May 2016 India ... More >> Department of Endocrinology, PGIMER Recruiting Chandigarh, India, 160012 Contact: Snajay Kr Bhadada, MD, DM       bhadadask@rediffmail.com    Contact: Soham Mukherjee, MD    9914743222    drsoham.mukherjee@gmail.com    Principal Investigator: sanjay Kr Bhadada, MD, DM Less <<
NCT00402909 Type 2 Diabetes Phase 4 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07974 Less <<
NCT01734785 - Completed - -
NCT01734785 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT01799720 Overweight Not Applicable Completed - Spain ... More >> Pharmacy Iborra Campos Elche, Alicante, Spain, 03202 Less <<
NCT03173391 Diabetes Mellitus, Type 2 Phase 3 Recruiting December 31, 2019 China, Shanghai ... More >> Hua Medicine Limited Recruiting Shanghai, Shanghai, China, 201203 Contact: YI ZHANG, PhD    +86-021-58863005    yzhang@huamedicine.com    Principal Investigator: Dalong Zhu, PhD Less <<
NCT02949037 Diabetes Mellitus, Type 2 Not Applicable Active, not recruiting December 31, 2018 United States, Nevada ... More >> Mike O'Callaghan Federal Medical Center Nellis Air Force Base, Nevada, United States, 89191 United States, Washington Madigan Army Medicall Center Tacoma, Washington, United States, 98431 Less <<
NCT03192228 - Completed - -
NCT03184376 Non-Alcoholic Fatty Liver Dise... More >>ase Less << Not Applicable Completed - -
NCT00493519 Anorexia Nervosa ... More >> Bulimia Nervosa Less << Not Applicable Unknown December 2007 Israel ... More >> TASMC Recruiting Tel Aviv, Israel, 64239 Contact: Nachum Vaisman, Prof.    +972-524-266596    vaisman@tasmc.health.gov.il Less <<
NCT01153048 Type 2 Diabetes Phase 1 Unknown September 2011 Mali ... More >> ONG Santé Diabète Mali Bamako, Mali, BP2736 Less <<
NCT01799720 - Completed - -
NCT01678469 Gestational Diabetes Mellitus Not Applicable Unknown May 2016 France ... More >> Assitance Publique Hôpitaux de Marseille Recruiting Marseille, France, 13005 Contact: Patrice Darmon          Principal Investigator: patrice Darmon Less <<
NCT01719003 - Completed - -
NCT00806936 - Completed - China, Beijing ... More >> Novo Nordisk Investigational Site Beijing, Beijing, China, 100004 Less <<
NCT00493740 Cephalic Phase, Oncology Patie... More >>nts Less << Not Applicable Unknown December 2007 Israel ... More >> Tel Aviv Sourasky Medical Center Recruiting Tel Aviv, Israel Contact: Nachum Vaisman, Prof.    +972-524-266596    vaisman@tasmc.health.gov.il    Principal Investigator: Nachum Vaisman, Prof. Less <<
NCT02474719 End-stage Renal Disease Not Applicable Unknown July 2016 France ... More >> Besançon University Hospital, Nephrology Department Recruiting Besançon, Franche-Comté, France, 25000 Contact: Cécile Courivaud, MCU/PH    +33381219218    ccourivaud@chu-besancon.fr    Contact: Stéphanie Py, PhD    +33381218999    s1py@chu-besancon.fr Less <<
NCT00225225 Diabetes Mellitus, Type 2 Not Applicable Terminated(due to published da... More >>ta on Rosiglitazone) Less << - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT01719003 Diabetes Mellitus, Type 2 ... More >> Hyperglycemia Less << Phase 3 Completed - -
NCT00663624 Diabetes Phase 4 Withdrawn(Lack of funding for ... More >>the study at the Emory site) Less << - -
NCT03345992 Sepsis Pneumo... More >>nia Gram-Negative Bacteria Infection Multiple Organ Failure Respiratory Distress Syndrome Mortality Biomarkers Less << Phase 3 Recruiting November 2019 Belgium ... More >> Intensive Care Unit, Saint-Pierre University Hospital Not yet recruiting Brussels, Belgium, 1000 Contact: Stéphan De Wit, MD, PhD    003225354130    Stephane_DEWIT@stpierre-bru.be    Intensive Care Unit, Brugmann University Hospital Not yet recruiting Brussels, Belgium, 1020 Contact: Jacques Devriendt, MD, PhD    003224773645    Jacques.Devriendt@chu-brugmann.be    Contact: David De Bels, MD    003224779120    David.Debels@chu-brugmann.be    Intensive Care Unit, Erasme University Hospital Not yet recruiting Brussels, Belgium, 1070 Contact: David Grimaldi, MD, PhD    003225553395    David.Grimaldi@erasme.ulb.ac.be    Greece Intensive Care Unit, Korgialeneio-Benakeio General Hospital Not yet recruiting Athens, Greece, 11526 Contact: Konstantinos Mandragos, MD, PhD    00302132068844    mandragk@otenet.gr    Intensive Care Unit, Laikon General Hospital Not yet recruiting Athens, Greece, 11527 Contact: Ioannis Floros, MD    00302132061156    jfloros@otenet.gr    2nd Department of Intensive Care Medicine, Attikon University Hospital Not yet recruiting Athens, Greece, 12462 Contact: Apostolos Armaganidis, MD, PhD    0030 210 5832183    aarmag@med.uoa.gr    4th Department of Internal Medicine, Attikon University Hospital Recruiting Athens, Greece, 12462 Contact: Anastasia Antoniadou, MD, PhD    00302105831990    ananto@med.uoa.gr    2nd Department of Internal Medicine, Sismanogleio General Hospital Not yet recruiting Athens, Greece, 15126 Contact: Malvina Lada, MD    00302132058360    malvinalada@gmail.com    Intensive Care Unit, Agios Dimitrios General Hospital Not yet recruiting Thessaloniki, Greece, 54 634 Contact: Glykeria Vlachogianni, MD    0030 2313 322173    glykav@otenet.gr    Intensive Care Unit, G. Gennimatas General Hospital Not yet recruiting Thessaloniki, Greece, 546 35 Contact: Eleni Antoniadou, MD    0030 2310 963321    eleni.antoniadou@gmail.com    Intensive Care Unit, Theageneio Oncological Hospital Not yet recruiting Thessaloniki, Greece, 546 39 Contact: Souzana Anisoglou, MD    0030 213 898200    souzanis@freemail.gr    Intensive Care Unit, Ippokrateion General Hospital Not yet recruiting Thessaloniki, Greece, 546 42 Contact: Eleni Mouloudi, MD    0030 2310 892000    elmoulou@yahoo.gr Less <<
NCT03053115 Hypothyroidism Phase 2 Phase 3 Recruiting December 31, 2019 Italy ... More >> AziendaUSLModena Recruiting Modena, Italy, 41126 Contact: Manuela Simoni, MD, PhD    00390593961806    manuela.simoni@unimore.it    Principal Investigator: Manuela Simoni, MD, PhD Less <<
NCT00575471 Type 2 Diabetes Phase 2 Completed - Japan ... More >> Fukuoka, Japan Osaka, Japan Tokyo, Japan Less <<
NCT03713437 - Not yet recruiting June 2020 -
NCT03720080 - Not yet recruiting June 30, 2019 -
NCT02936687 Metabolic Syndrome X Phase 1 Recruiting December 2019 United States, Wisconsin ... More >> University of Wisconsin, Madison Recruiting Madison, Wisconsin, United States, 53706 Contact: William G. Schrage, Ph.D.    608-263-6308    william.schrage@wisc.edu Less <<
NCT02068508 - Completed - -
NCT03239782 Glucose Metabolism Disorders ... More >> Obesity, Visceral Obesity; Endocrine Insulin Sensitivity/Resistance Less << Not Applicable Completed - -
NCT00966862 Healthy People Phase 1 Phase 2 Unknown - Israel ... More >> Suorasky Medical Center Not yet recruiting Tel Aviv, Israel Contact: Nachum Vaisman, Prof'    +972-3-6974807    vaisman@tasmc.health.gov.il    Principal Investigator: Nachum Vaisman, Prof' Less <<
NCT00412347 - Completed - United States, Georgia ... More >> University Hospital Atlanta, Georgia, United States, 30324 Less <<
NCT00632879 - Unknown March 2008 Taiwan ... More >> Far Eastern Memorial Hospital Recruiting PanChiao, Taipei, Taiwan, 220 Contact: Shao-Yu Yang, MD    886-2-89667000 ext 1164    yangshaoyo@yahoo.com.tw Less <<
NCT00851201 Obesity Diabe... More >>tes Less << Not Applicable Completed - United States, New York ... More >> North Bronx Health Network The Bronx, New York, United States, 10461 Less <<
NCT00094796 Diabetes Mellitus, Type II ... More >> Insulin Resistance Less << Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 United States, Virginia Medical College of Virginia Richmond, Virginia, United States Less <<
NCT02561663 Metabolic Syndrome Not Applicable Completed - Netherlands ... More >> Maastricht University Medical Centre+ Maastricht, Limburg, Netherlands, 6229ER Less <<
NCT00687999 Chronic Hepatitis C ... More >> Insulin Resistance Less << Not Applicable Completed - Taiwan ... More >> Kaohsiung Medical University Hospital Kaohsiung, Taiwan, 807 Less <<
NCT00417989 Type 1 Diabetes Not Applicable Completed - -
NCT02836808 Type 2 Diabetes Not Applicable Recruiting December 31, 2028 Mexico ... More >> Instituto Nacional de Ciencias Medicas y Nutricion Recruiting Mexico City, DF, Mexico, 14000 Contact: Carlos A Aguilar-Salinas, MD    52-55-56554523    caguilarsalinas@yahoo.com    Principal Investigator: Sergio Hernández, MD Less <<
NCT00417989 - Completed - -
NCT03734107 Type 1 Diabetes Mellitus Not Applicable Enrolling by invitation December 2022 United States, District of Col... More >>umbia Children's National Health System Washington, District of Columbia, United States, 20010 Less <<
NCT02293837 Type 1 Diabetes Mellitus ... More >> New-onset Type 1 Diabetes Mellitus T1DM T1D Less << Phase 2 Active, not recruiting July 2020 -
NCT02651181 Type 1 Diabetes Not Applicable Active, not recruiting September 2018 Israel ... More >> Schneider Medical Center Petach- Tikva, Israel, 49202 Less <<
NCT02228252 Metabolic Syndrome Not Applicable Completed - Denmark ... More >> Aarhus University Hospital Aarhus, Aarhus C, Denmark, 8000 Less <<
NCT01493050 Diabetic Nephropathy Phase 2 Completed - United States, New York ... More >> Beth Israel Medical Center New York, New York, United States, 10003 Icahn School of Medicine at Mount Sinai New York, New York, United States, 10029 Less <<
NCT03313960 Diabetes Mellitus, Type 2 Phase 4 Active, not recruiting September 30, 2019 United States, New York ... More >> One Drop New York, New York, United States, 10002 Less <<
NCT00360815 Type 1 Diabetes Mellitus Not Applicable Completed - -
NCT02087124 Metabolic Syndrome Not Applicable Completed - Denmark ... More >> Aarhus University Hospital Aarhus, Aarhus C., Denmark, 8000 Less <<
NCT02427555 Healthy Subjects Not Applicable Completed - Sweden ... More >> Food for Health Science Centre, Medicon Village, Lund University Lund, Sweden, , SE-223 81 LUND Less <<
NCT01234051 Biliary Tract Cancer Phase 2 Unknown December 2013 Korea, Republic of ... More >> Eun Ki Song Recruiting Chonbuk, Korea, Republic of Contact: Eun Ki Song       eksong@jbnu.ac.kr    Contact: Hwan Jung Yun       hjyun@cnu.ac.kr Less <<
NCT03061266 Type 2 Diabetes Mellitus Not Applicable Recruiting March 8, 2017 Taiwan ... More >> Puli Christian Hospital Recruiting Nantou, Taiwan, 54510 Contact: Chen Mei-Chih    +886--49291-2151    pch@mail.pch.org.tw Less <<
NCT01168076 - Completed - United States, New Mexico ... More >> InLight Solutions Albuquerque, New Mexico, United States, 87106 Less <<
NCT01520831 Diabetes Heal... More >>thy Less << Phase 1 Completed - Germany ... More >> Novo Nordisk Investigational Site Neuss, Germany, 41460 Less <<
NCT00768651 Type 1 Diabetes Phase 2 Completed - Canada, Alberta ... More >> University of Alberta - Clinical Islet Transplant Program Edmonton, Alberta, Canada, T6G2C8 Less <<
NCT01264796 Type 2 Diabetes Not Applicable Completed - United States, Maryland ... More >> Johns Hopkins University Baltimore, Maryland, United States, 21205 Less <<
NCT00768651 - Completed - -
NCT02513381 Polycystic Ovary Syndrome Not Applicable Completed - United Kingdom ... More >> Michael White Centre for Diabetes and Endocrinology Hull, East Yorkshire, United Kingdom, HU3 2RW Less <<
NCT01046318 Type 2 Diabetes Phase 3 Completed - Japan ... More >> Chubu Region, Japan Kanto Region, Japan Tohoku Region, Japan Less <<
NCT01875107 Hyperglycemia in Pregnant Diab... More >>etic Patients Less << Phase 4 Withdrawn(Time constraints of ... More >>primary investigator.) Less << August 2014 United States, Minnesota ... More >> University of Minnesota Medical Center Minneapolis, Minnesota, United States, 55454 Less <<
NCT02744300 Gestational Diabetes Mellitus Not Applicable Recruiting October 2018 United States, Colorado ... More >> University of Colorado Denver Recruiting Denver, Colorado, United States, 80202 Contact: Danielle Cook    303-724-8998    danielle.cook@ucdenver.edu    Contact: Jacinda Nicklas, MD, MPH, MA       jacinda.nicklas@ucdenver.edu    Principal Investigator: Jacinda Nicklas, MD, MPH, MA Less <<
NCT00998686 Type 2 Diabetes Mellitus Phase 3 Terminated November 2011 -
NCT01623284 PPA Primary P... More >>rogressive Aphasia Aphasia Non-fluent Aphasia Semantic Dementia Apraxia of Speech Primary Progressive Nonfluent Aphasia Progressive Aphasia Less << Phase 1 Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT01186250 Cardiac Allograft Vasculopathy Phase 2 Completed - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT01186250 - Completed - -
NCT02551419 Mild Cognitive Impairment Not Applicable Recruiting December 2019 Canada, Quebec ... More >> Research Center on Aging Recruiting Sherbrooke, Quebec, Canada, J1H 4C4 Contact: Mélanie Fortier, M.Sc.    819-780-2220 ext 45252    melanie.fortier2@usherbrooke.ca    Contact: Alexandre Castellano, Ph.D.    819-780-2220 ext 45623    Alexandre.Castellano@USherbrooke.ca    Principal Investigator: Stephen Cunnane, Ph.D. Less <<
NCT01930318 Gastrointestinal Cancer Phase 4 Unknown September 2015 China, Jiangsu ... More >> Jinling Hospital Recruiting Nanjing, Jiangsu, China, 200002 Contact: Wencheng Kong, MD    15850722032    wenchengkong@gmail.com    Contact: Yousheng Li, MD       liys@medmail.com.cn    Principal Investigator: Wencheng Kong, MD          Sub-Investigator: Danhua Yao, MD          Sub-Investigator: lele Ren, PhD Less <<
NCT01089790 Diabetes Mellitus, Type 2 Phase 3 Terminated - -
NCT00875108 Diabetes Mellitus Phase 3 Completed - -
NCT01951651 - Completed - -
NCT03308487 Maternal Vitamin D Status Not Applicable Recruiting September 2018 Iran, Islamic Republic of ... More >> National Nutrition and Food Technology Research Institute Recruiting Tehran, Iran, Islamic Republic of, 19395-4741 Contact: Tirang R Neyestani, PhD    00989123507663    neytr@yahoo.com Less <<
NCT03640221 Hypertension ... More >>Diabetes Mellitus, Type 2 Less << Phase 4 Not yet recruiting August 31, 2020 United States, California ... More >> Cedars-Sinai Medical Center Los Angeles, California, United States, 90048 Less <<
NCT00980356 Diabetes Mellitus Phase 2 Completed - Austria ... More >> Medical University of Vienna Vienna, Austria, 1090 Less <<
NCT00902161 - Completed - -
NCT01951651 Type 2 Diabetes Mellitus Phase 4 Completed - United States, Texas ... More >> Baylor College of Medicine Houston, Texas, United States, 77030 Less <<
NCT01526759 Healthy Not Applicable Completed - Netherlands ... More >> Wageningen University Wageningen, Netherlands, 7002HD Less <<
NCT03369548 Healthy Not Applicable Recruiting December 23, 2019 United Kingdom ... More >> Hugh Sinclair Unit of Human Nutrition, Department of Food and Nutritional Sciences, University of Reading Recruiting Reading, Berkshire, United Kingdom, RG6 6AP Contact: Julie A Lovegrove, Professor    0044(0)1183786418 ext 6418    j.a.lovegrove@reading.ac.uk    Contact: Camilla Pedersen, PhD    +44 (0)797 617 6090    C.Pedersen@reading.ac.uk    Principal Investigator: Julie A Lovegrove, Professor          Sub-Investigator: Camilla Pedersen, PhD          Sub-Investigator: Kim Jackson, PhD          Sub-Investigator: Jeremy Spencer, Professor Less <<
NCT00902161 Type 2 Diabetes Mellitus Phase 1 Completed - -
NCT03467737 Malnutrition, Child Not Applicable Completed - -
NCT01107171 Diabetes Mellitus, Type 2 Phase 2 Completed - China ... More >> The Affiliated Hospital to Changchun University of Chinese Medicine Changchun, China, 130041 Jilin Hospital of Integrated Traditional and Western Medicine Changchun, China, 132001 Shanghai Shuguang Hospital Affiliated with Shanghai University of Traditional Chinese Medicine Shanghai, China The Affiliated Hospital to Liaoning University of Traditional Chinese Medicine Shenyang, China The Second Affiliated Hospital to Liaoning University of TCM Shenyang, China First Teaching Hospital of Tianjin University of TCM Tianjin, China Less <<
NCT00728403 Diabetes Mellitus Type 2 Phase 2 Unknown August 2015 Canada, Ontario ... More >> Clinical Nutrition and Risk Factor Modification Centre Toronto, Ontario, Canada, M5C 1N8 Less <<
NCT01778309 Skeletal Muscle Damage ... More >> Skeletal Muscle Performance Intgracellular Signaling in Skeletal Muscle Inflammatory Status Less << Not Applicable Completed - Greece ... More >> Laboratory of Physical Education & Sport Performance Komotini, Thrace, Greece, 69100 Less <<
NCT00633763 - Completed - United States, California ... More >> University of California Irvine Medical Center Orange, California, United States, 92868 Less <<
NCT03203811 Diabetes Phase 1 Completed - United States, Ohio ... More >> Medpace Cincinnati, Ohio, United States, 45227 Less <<
NCT00451399 Weight Gain Phase 4 Completed - China, Hunan ... More >> Institute of Mental Health of The Second Xiangya Hospital, Central South University Changsha, Hunan, China, 410011 Less <<
NCT01319344 Metabolic Syndrome ... More >> Endothelial Dysfunction Less << Phase 3 Completed - Germany ... More >> Clinical Research Unit, Department of Nephrology and Hypertension, University of Erlangen-Nurnberg Erlangen, Germany, 91054 Clinical Research Unit, Department of Nephrology and Hypertension, University of Erlangen-Nürnberg Nürnberg, Germany, 90471 Less <<
NCT03322631 Type 2 Diabetes Mellitus Phase 1 Active, not recruiting May 29, 2019 Japan ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician. Hachioji, Tokyo, Japan, 192-0071 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician. Shinjuku-Ku, Tokyo, Japan, 169-0073 Less <<
NCT03010683 Type 2 Diabetes Mellitus ... More >> Coronary Artery Disease Less << Not Applicable Recruiting December 2017 Greece ... More >> ''Attikon'' University General Hospital Recruiting Haidari, Athens, Attiki, Greece, 12462 Principal Investigator: Ignatios Ikonomidis, MD Less <<
NCT03341650 Diet Therapy Not Applicable Completed - Italy ... More >> Department of Food and Drug, University of Parma Parma, Italy, 43125 Less <<
NCT02422082 Osteopenia Not Applicable Completed - Sweden ... More >> Geriatric Medicine, Mölndal Hospital Mölndal, Västra Götaland, Sweden, 43180 Less <<
NCT00221208 Diabetes Phase 1 Completed - Canada, Alberta ... More >> University of Alberta Edmonton, Alberta, Canada, T6G 2H9 Less <<
NCT00706680 Diabetes Graf... More >>t Rejection Less << Phase 4 Unknown June 2009 Canada, British Columbia ... More >> St Paul's Hospital Not yet recruiting Vancouver, British Columbia, Canada, V6Z 2E8 Contact: John Gill    604-681-7191       Principal Investigator: John Gill          Sub-Investigator: David Landsberg          Canada, Ontario St Michael's Hospital Not yet recruiting Toronto, Ontario, Canada, M5C 2T2 Contact: Ramesh Prasad    (416) 867-3722    Ramesh.Prasad@utoronto.ca    Principal Investigator: Ramesh Prasad          Sub-Investigator: Jeffrey Zaltzman          University health Network Recruiting Toronto, Ontario, Canada, M5G 2N2 Contact: Bricio Rodriguez    416-340-4800 ext 5921    bricio.rodriguez@uhn.on.ca    Sub-Investigator: Carl Cardella          Principal Investigator: Edward Cole Less <<
NCT02013843 Pediatric Obesity ... More >> Dyslipidemia Hypertension Diabetes Quality of Life Less << Not Applicable Completed - Denmark ... More >> Pediatric department Holbaek, Denmark, 4300 Less <<
NCT00780715 - Completed - -
NCT00529919 Overweight Not Applicable Completed - United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35294 Less <<
NCT00780715 Diabetes Mellitus, Type 2 Phase 4 Completed - United Kingdom ... More >> Ninewells Hospital & Medical School Dundee, United Kingdom, DD1 9SY Less <<
NCT00799630 Nutrition Processes Not Applicable Completed - France ... More >> Service de Physiologie Clinique et de l'Exercice, CHU Saint-Etienne Saint-Etienne, France, 42055 Less <<
NCT01448109 Septic Shock Phase 4 Completed - -
NCT03702959 - Not yet recruiting March 1, 2020 Israel ... More >> Rambam health care campus Haifa, Israel Less <<
NCT02235038 Obesity Not Applicable Completed - United States, Massachusetts ... More >> Boston Children's Hospital Boston, Massachusetts, United States, 02115 Brigham & Women's Hospital Boston, Massachusetts, United States, 02115 Boston Medical Center Boston, Massachusetts, United States, 02118 Framingham State University Framingham, Massachusetts, United States, 01702 Less <<
NCT00651105 Type-2 Diabetes ... More >> Healthy Less << Phase 3 Completed - Germany ... More >> Novartis Investigator Site Bad Lauterberg im Harz, Germany Novartis Investigator Site Berlin, Germany Less <<
NCT00433173 Metabolic Syndrome Not Applicable Suspended(Primary investigator... More >> is taking a leave of absence) Less << March 2011 United States, Maryland ... More >> Johns Hopkins Bayview Medical Center Baltimore, Maryland, United States, 21224 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT03444064 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 1 Recruiting March 2021 Canada, Alberta ... More >> University of Alberta Recruiting Edmonton, Alberta, Canada, T6G 2C8 Contact: Andrew Malcolm, PhD    (780) 407-6952    andrew.malcolm@ualberta.ca    Contact: Parastoo Dinyari, BSc    (780) 407-3904    parastoo@islet.ca    Principal Investigator: James Shapiro, MD PhD Less <<
NCT00605839 Type 1 Diabetes Not Applicable Completed - United States, Indiana ... More >> Riley Hospital Diabetes Clinics Indianapolis, Indiana, United States, 46202 Less <<
NCT00824668 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 1 Completed - Germany ... More >> Novo Nordisk Investigational Site Neuss, Germany, 41460 Less <<
NCT01655901 Active Video Games and Appetit... More >>e Control Less << Not Applicable Completed - Canada, Ontario ... More >> Children's Hospital of Eastern Ontario Research Institute Ottawa, Ontario, Canada, K1H 8L1 Less <<
NCT01482481 - Completed - Spain ... More >> Gerencia Atención Primaria Madrid, Spain, 28029 Less <<
NCT00482768 Type 2 Diabetes Not Applicable Completed - United States, Texas ... More >> University of Texas Health Sciences Center San Antonio, Texas, United States, 78229-4404 Less <<
NCT00605839 - Completed - -
NCT02197910 Pre-hypertension Not Applicable Unknown March 2016 Italy ... More >> S. Orsola-Malpighi University Hospital Recruiting Bologna, BO, Italy, 40138 Contact: Arrigo FG Cicero, MD, PhD    ++39516362224    arrigo.cicero@unibo.it    Sub-Investigator: Arrigo FG Cicero, MD, PhD          Principal Investigator: Claudio Borghi, MD, PhD          Sub-Investigator: Maddalena Veronesi, MD          Sub-Investigator: Sergio D'Addato, MD, PhD Less <<
NCT02693782 Hypercholesterolemia ... More >> Flatulence Intestinal Diseases Less << Not Applicable Completed - United Kingdom ... More >> Rowett Institute of Nutrition and Health, University of Aberdeen Aberdeen, United Kingdom, AB21 9SB Less <<
NCT00238576 - Completed - United States, California ... More >> Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine Stanford, California, United States, 94305 Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT00932412 Acute Myeloid Leukemia Phase 2 Completed - France ... More >> Hôpital Sud - CHU Amiens Amiens, France, 80054 Centre Hospitalier Regional et Universitaire d'Angers Angers, France, 49033 Hôpital Victor Dupouy Argenteuil, France, 95107 Hôpital Avicenne - bobigny Bobigny, France, 93009 Centre Hospitalier Boulogne/Mer Boulogne / Mer, France, 62280 Hôpital Clemenceau - chu Caen Caen, France, 14033 Centre Hospitalier René Dubos Cergy Pontoise, France, 95303 HIA Percy Clamart, France, 92141 Hôpital de Corbeil Corbeil, France, 91100 Hôpital Mondor Créteil, France, 94010 Hôpital Dubocage Dijon, France, 21000 Centre Hospitalier Dunkerque Dunkerque, France, 59395 Hôpital Michallon Grenoble, France, 38043 Centre Hospitalier Versailles Le Chesnay, France, 78150 Centre Hospitalier Schaffner Lens, France, 62307 Hôpital Huriez Lille, France, 59037 CHU Dupuytren Limoges, France, 87042 Institut Paoli-Calmette Marseille, France, 13273 Centre Hospitalier Meaux Meaux, France, 77104 CHU - Hôtel Dieu Nantes, France, 44093 Centre A. Lacassagne Nice, France, 06100 Hôpital Archet 1 Nice, France, 06202 Hôpital St Louis Paris, France, 75010 Pitié-Salpetrière Paris, France, 75013 Paris Necker Paris, France, 75743 Hôpital Haut Lévêque Pessac, France, 33604 Hospices Civils de Lyon - Centre Hospitalier Lyon Sud Pierre-benite, France, 69495 Hôpital V. Provo Roubaix, France, 59056 Centre Henri Becquerel - CHRU ROUEN Rouen, France, 76038 Centre Hospitalier Huguenin Saint Cloud, France, 92210 Hôpital Purpan Toulouse, France, 31059 Centre Hospitalier Valenciennes Valenciennes, France, 59322 CHU de Brabois Vandoeuvre Les Nancy, France, 54511 Institut Gustave Roussy Villejuif, France, 94800 Less <<
NCT02048215 Obesity Phase 3 Completed - Italy ... More >> Istituto Auxologico Italiano -Ospedale San Giuseppe Verbania, VB, Italy, 28824 Less <<
NCT03120585 Respiratory Distress Syndrome,... More >> Newborn Less << Not Applicable Recruiting December 2020 United States, New York ... More >> Icahn School of Medicine at Mount Sinai Recruiting New York, New York, United States, 10029-5674 Contact: Annemarie Stroustrup, MD    212-241-6186       United States, Oklahoma Comanche county Memorial hospital Recruiting Lawton, Oklahoma, United States, 73501 Contact: Abhishek Makkar, M.D    717-215-5056    abhishek-makkar@ouhsc.edu Less <<
NCT01974297 Mixed Hyperlipidemia Not Applicable Unknown July 2014 Korea, Republic of ... More >> Severance Hospital, Yonsei University College of Medicine Recruiting Seoul, Korea, Republic of Contact: Sang-Hak Lee, PhD    82-2-2228-8456    SHL1106@hanmail.net    Contact: Jiyeong Jeong, bachelor    82-2-2228-8277    jiyoung112@yuhs.ac    Principal Investigator: Sang-Hak Lee, PhD Less <<
NCT02098980 Insulin Resistance Not Applicable Unknown December 2017 Qatar ... More >> Hamad Medical Corporation Recruiting Doha, Qatar Contact: Amin Jayyousi, M.D.    0097455530236    ajayyousi@hamad.qa    Sub-Investigator: Amin Jayyousi, M.D. Less <<
NCT01059812 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT00736515 Type 2 Diabetes Phase 4 Completed - China, Beijing ... More >> Peking University First Hospital Beijing, Beijing, China, 100034 Beijing Hospital Beijing, Beijing, China, 100730 China, Guangdong Guangdong General Hospital Guangzhou, Guangdong, China, 510080 China, Heilongjiang The 2nd Affiliated Hospital of Harbin Medical University Harbin, Heilongjiang, China, 150086 China, Hubei Tongji Hospital of Tongji Medical College of Huazhong University of Science & Technology Wuhan, Hubei, China, 430030 China, Shanghai Shanghai Sixth People's Hospital Affiliated to Shanghai Jiaotong University School of Medicine Shanghai, Shanghai, China, 200233 China, Sichuan West China Hospital of Sichuan University Chengdu, Sichuan, China, 610041 China, Zhejiang SIR RUN RUN SHAW Hospital Affiliated to Zhejiang University School of Medicine Hangzhou, Zhejiang, China, 310016 Less <<
NCT00099619 Type 2 Diabetes Mellitus Phase 3 Completed - Australia, New South Wales ... More >> Research Site Westmead, New South Wales, Australia Australia, South Australia Research Site Daw Park, South Australia, Australia Research Site Fullarton, South Australia, Australia Australia, Victoria Research Site Box Hill, Victoria, Australia Research Site East Ringwood, Victoria, Australia Greece Research Site Athens, Greece Research Site Piraeus, Greece Research Site Thessaloniki, Greece Hungary Research Site Budapest, Hungary Research Site Gyula, Hungary Research Site Pecs, Hungary Research Site Veszprem, Hungary Research Site Zalaegerszeg, Hungary Italy Research Site Bari, Italy Research Site Bergamo, Italy Research Site Catania, Italy Research Site Milan, Italy Research Site Perugia, Italy Research Site Rome, Italy Mexico Research Site Guadalajara, Jalisco, Mexico Research Site Zapopan, Jalisco, Mexico Research Site Monterrey, N.l., Mexico Research Site Mexico City, Mexico Poland Research Site Bydgoszcz, Poland Research Site Gdansk, Poland Research Site Lublin, Poland Less <<
NCT01204554 Reconstructive Surgery ... More >> Microcirculation Less << Early Phase 1 Unknown December 2010 Norway ... More >> Oslo University Hospital Recruiting Oslo, Norway, 0304 Contact: Haris Mesic, M.D    004722118080    haris.mesic@oslo-universitetssykehus.no    Principal Investigator: Haris Mesic, M.D          Sub-Investigator: Ravi Bains, MD. PhD Less <<
NCT01173432 Obstructive Sleep Apnea ... More >> Insulin Resistance Metabolic Syndrome Inflammation Less << Not Applicable Active, not recruiting June 2018 Hong Kong ... More >> The University of Hong Kong Hong Kong, Hong Kong, 852 Less <<
NCT01698697 Diabetes Heal... More >>thy Less << Phase 1 Completed - South Africa ... More >> Novo Nordisk Investigational Site Bloemfontein, South Africa, 9324 Less <<
NCT00456963 Diabetes Mellitus ... More >> Hypertension Less << Phase 4 Terminated(Because of delay in... More >> approval of the protocol by a number of Ethics Commitees the trial was terminated on March 4, 2010. No patient had received any study drug.) Less << - Italy ... More >> Istituto Auxologico Italiano. Milan, Italy, 20145 Less <<
NCT01608724 Diabetes Mellitus, Non-Insulin... More >>-Dependent Less << Phase 4 Completed - China ... More >> Research Site Baotou, China Research Site Beijing, China Research Site Benxi, China Research Site Changchun, China Research Site Chengdu, China Research Site Chongqing, China Research Site Dalian, China Research Site Dongguan, China Research Site Foshan, China Research Site Fuzhou, China Research Site Guangzhou, China Research Site Guiyang, China Research Site Haikou, China Research Site Hangzhou, China Research Site Hhht, China Research Site Hubei, China Research Site Jimo, China Research Site Jinan, China Research Site Kunming, China Research Site Linyi, China Research Site Nanjing, China Research Site Nantong, China Research Site Qingdao, China Research Site Shanghai, China Research Site Shantou, China Research Site Shenyang, China Research Site Shiyan, China Research Site Suzhou, China Research Site Taiyuan, China Research Site Tianjin, China Research Site Urumqi, China Research Site Wenzhou, China Research Site Wuhan, China Research Site Wuxi, China Research Site Xian, China Research Site Zhanjiang, China Research Site Zhengzhou, China Less <<
NCT01608724 - Completed - -
NCT02168218 Obesity Not Applicable Completed - Switzerland ... More >> CHUV-clinical research center Lausanne, VD, Switzerland, CH-1011 Less <<
NCT00489879 Diabetes Hype... More >>rtension Obesity Less << Not Applicable Completed - Korea, Republic of ... More >> Department of Internal Medicine, Korea University College of Medicine Seoul, VD, Korea, Republic of, 152-703 Less <<
NCT00145379 Type 1 Diabetes Mellitus Phase 4 Completed - Denmark ... More >> Diabetes Research Center Odense, Funen, Denmark, 5000 Less <<
NCT03229980 Cardioplegia Phase 2 Completed - Egypt ... More >> Faculty of Medicine Assiut, Egypt Less <<
NCT01965496 Type 2 Diabetes Phase 1 Completed - China ... More >> People's Liberation Army General Hospital of Chengdu Military Region Chengdu, China Less <<
NCT01133392 Healthy Volunteers Phase 1 Completed - Singapore ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Singapore, Singapore Less <<
NCT03529188 - Recruiting September 9, 2019 France ... More >> CHRU de Brest Recruiting Brest, France, 29609 Contact: Chantal METZ       chantal.metz@chu-brest.fr    Centre Hospitalier de Bretagne Sud Recruiting Lorient, France, 56322 Contact: Raphaël TEISSIER       r.teissier@ch-bretagne-sud.fr Less <<
NCT00672399 Healthy Subjects Phase 1 Completed - United Kingdom ... More >> Reseach Site Derriford, Plymouth, United Kingdom Research Site Leeds, West Yorkshire, United Kingdom Less <<
NCT01965509 Type 2 Diabetes Phase 2 Completed - China ... More >> China-Japan Friendship Hospital Beijing, China Less <<
NCT01412710 - Completed - -
NCT01412710 Type 2 Diabetes Not Applicable Completed - United States, Florida ... More >> Human Nutrition Laboratory, Florida International University Miami, Florida, United States, 33199 Less <<
NCT01059812 - Completed - -
NCT03724682 Chronic Renal Failure Not Applicable Not yet recruiting December 16, 2019 Sweden ... More >> Skånes Universitetssjukhus, Malmö Malmö, Skåne, Sweden, 205 02 Less <<
NCT01075282 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT01133392 - Completed - -
NCT02278068 Diabetes Endo... More >>crine, Nutritional and Metabolic Diseases (E00-E89) Less << Not Applicable Active, not recruiting April 2018 New Zealand ... More >> Auckland City Hospital Auckland, New Zealand Middlemore Hospital Auckland, New Zealand North Shore Hospital Auckland, New Zealand Christchurch Hospital Christchurch, New Zealand Dunedin Hospital Dunedin, New Zealand Wellington Hospital Wellington, New Zealand Less <<
NCT01333774 - Completed - Poland ... More >> Many Locations, Poland Less <<
NCT01315483 Breast Cancer Not Applicable Completed - United States, Colorado ... More >> Rocky Mountain Cancer Center Denver, Colorado, United States, 80220 Less <<
NCT01075282 - Completed - -
NCT03675360 Diabetes PreD... More >>iabetes Metabolic Disease Hyperglycemia Diet Modification Glucose Intolerance Glucose Metabolism Disorders (Including Diabetes Mellitus) Endocrine System Diseases Less << Not Applicable Recruiting October 2020 United States, Louisiana ... More >> Tulane Office of Health Research Recruiting New Orleans, Louisiana, United States, 70112 Contact: Mariel Dronson, MPH    504-988-4331    mdronson@tulane.edu    Contact: Erin Mahone, RN, MPH    (504)988-4361    emahone@tulane.edu Less <<
NCT01753934 - Recruiting May 2020 United States, California ... More >> Stanford University School of Medicine Recruiting Stanford, California, United States, 94305 Contact: Tandy Aye, MD    650-723-5791    taye@stanford.edu    Principal Investigator: Tandy Aye MD Less <<
NCT02700477 Diabetes Phase 4 Completed - -
NCT00580957 Obesity Not Applicable Completed - United States, Tennessee ... More >> Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232 Less <<
NCT00580957 - Completed - -
NCT02660008 Hypoglycemia Phase 2 Completed - Germany ... More >> Profil Institut für Stoffwechselforschung GmbH Neuss, Germany, 41460 Less <<
NCT03587870 Muscle Wasting in Critically I... More >>ll Less << Not Applicable Not yet recruiting April 1, 2020 -
NCT03603704 Diabetes Mellitus, Type 2 Phase 1 Recruiting February 28, 2019 Japan ... More >> P-one clinic Recruiting Hachioji, Tokyo, Japan, 192-0071 Contact    81120360605       Principal Investigator: Kenichi Furihata          Sumida Hospital Recruiting Sumida-ku, Tokyo, Japan, 130-0004 Contact    81120360605       Principal Investigator: Ayumi Mugitani          Hakata Clinic Recruiting Fukuoka, Japan, 812-0025 Contact    81120360605       Principal Investigator: Megumi Inoue Less <<
NCT00998465 - Completed - Denmark ... More >> University Hospital Koege, Department of Clinical Physiology and Nuclear Medicine Koege, Denmark, DK-4600 Less <<
NCT00663377 Heart Failure Phase 4 Completed - -
NCT02694601 Healthy Adults Not Applicable Completed - Canada, Quebec ... More >> Research Centre on Aging (CSSS-IUGS - CIUSSS de l'Estrie - CHUS) Sherbrooke, Quebec, Canada, J1H4C4 Less <<
NCT01966588 - Unknown March 2017 Canada, British Columbia ... More >> BC Mental Health and Addictions Research Institute Recruiting Vancouver, British Columbia, Canada, V5Z 4H4 Contact: Delrae Fawcett, M.Sc.    604-875-2000 ext 6115    delrae.fawcett@ubc.ca    Contact: Heidi N Boyda, Ph.D. (cand)    604-612-5025    hnboyda@gmail.com    Principal Investigator: Alasdair M Barr, Ph.D. Less <<
NCT02694601 - Completed - -
NCT03377335 Type 2 Diabetes Mellitus Phase 4 Active, not recruiting January 2019 Italy ... More >> University Hospital of Palermo Palermo, Italy, 90127 Less <<
NCT02472847 Healthy Participants Phase 4 Completed - -
NCT02552251 Congenital Adrenal Hyperplasia Phase 2 Phase 3 Unknown - France ... More >> Service Endocrinologie et Maladies Métaboliques Recruiting Caen, France, 14000 Contact: Yves REZNIK, MD, PhD    02.31.06.45.86    reznik-y@chu-caen.fr Less <<
NCT00121667 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT02472847 - Completed - -
NCT00956059 Focal Segmental Glomeruloscler... More >>osis Less << Not Applicable Unknown December 2012 China, Shaanxi ... More >> The second affiliated hospital of medical college, Xi'an Jiaotong University Not yet recruiting Xi'an, Shaanxi, China, 710004 Contact: Baosong Gui, MD    86-29-87679917    guibsdoctor@sina.com.cn Less <<
NCT00964262 Type 2 Diabetes Mellitus Phase 1 Completed - Korea, Republic of ... More >> Clinical Trials Center, Seoul National University Hospital Seoul, Korea, Republic of, 110-744 Less <<
NCT02578563 - Active, not recruiting December 31, 2019 Singapore ... More >> Research Site Singapore, Singapore Less <<
NCT00121667 - Completed - -
NCT03722641 Healthy Not Applicable Recruiting December 20, 2019 Sweden ... More >> Aventure AB Recruiting Lund, Sweden Contact: Kristina Andersson, PhD    +46 (0)46 16 39 40    kristina.andersson@aventureab.com    Contact: Linda Ekström, PhD       linda.ekstrom@aventureab.com Less <<
NCT00542399 Type 1 Diabetes Mellitus Phase 4 Completed - Israel ... More >> Schneider Children's Medical Center Petach-Tikva, Israel Less <<
NCT01215435 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 4 Completed - Iran, Islamic Republic of ... More >> Teheran, Iran, Islamic Republic of Less <<
NCT01037842 Type 2 Diabetes Phase 3 Completed - Korea, Republic of ... More >> Pusan National University College of Medicine Busan, Korea, Republic of Kyungpook National University School of Medicine Daegu, Korea, Republic of Chungnam National University College of Medicine Daejeon, Korea, Republic of Chonnam National University College of Medicine Gwangju, Korea, Republic of Chonbuk National University College of Medicine Jeonju, Korea, Republic of Eulji University School of Medicine Seoul, Korea, Republic of Hallym University College of Medicine Seoul, Korea, Republic of Korea University College of Medicine Seoul, Korea, Republic of Seoul St. Mary's Hospital Seoul, Korea, Republic of SungKyunKwan University School of Medicine Seoul, Korea, Republic of The Catholic University of Korea Seoul, Korea, Republic of Yonsei University College of Medicine Seoul, Korea, Republic of Uijeongbu St. Mary Hospital Uijeongbu, Korea, Republic of Less <<
NCT01189045 Stroke Not Applicable Completed - Canada, British Columbia ... More >> GF Strong Rehabilitation Centre Vancouver, British Columbia, Canada Vancouver General Hospital Vancouver, British Columbia, Canada Less <<
NCT01432028 Postmenopause Not Applicable Completed - Brazil ... More >> Hospital de Clínicas de Porto Alegre Porto Alegre, Rio Grande do Sul, Brazil Less <<
NCT03764410 Diabetes Mellitus, Type 2 ... More >> Periodontal Diseases Less << Not Applicable Completed - Brazil ... More >> Caio Vinicius Gonçalves Roman Torres Santos, SP, Brazil, 11015001 Less <<
NCT01215435 - Completed - -
NCT02667964 Physical Activity Not Applicable Unknown June 2017 Germany ... More >> Charité Recruiting Berlin, Germany, 10117 Contact: Thomas Bobbert, Dr.    450514252 ext 030    endokrinologie@charite.de Less <<
NCT00262197 Diabetes Mellitus Not Applicable Completed - -
NCT01462253 Acute Lymphoblastic Leukemia Phase 2 Completed - Italy ... More >> Unità Operativa Ematologia 1 - Università degli Studi di Bari Bari, Italy, 70010 Divisione di Ematologia - Ospedali Riuniti Bergamo, Italy Istituto di Ematologia "Lorenzo e A. Seragnoli" - Università degli Studi di Bologna - Policlinico S. Orsola - Malpighi Bologna, Italy Azienda Sanitaria di Bolzano - Ospedale Centrale - Ematologia e Centro TMO Bolzano, Italy Sezione di Ematologia e Trapianti Spedali Civili Brescia, Italy, 21125 Azienda ASL di Cagliari Cagliari, Italy, 9121 Ospedale Santa Croce Divisione di Ematologia Cuneo Cuneo, Italy Policlinico di Careggi, Università delgi studi di Firenze Firenze, Italy Istituto Scientifico Romagnoli per lo Studio e la Cura dei Tumori- IRST Meldola, Italy U.O. di Ematologia- Ospedale dell'Angelo - Mestre Mestre, Italy U.O. Ematologia e Trapianto di MIdollo - Ist.Scientifico Ospedale San Raffaele Milano, Italy UO Centro Trapianti di Midollo - IRCCS Ospedale Maggiore Policlinico Milano, Italy Centro Oncologico Modenese - Dipartimento di Oncoematologia Modena, Italy N. Osp. divisione di Ematologia "S.Gerardo dei Tintori" Monza, Italy Azienda Ospedaliera di Rilievo Nazionale "A. Cardarelli" Napoli, Italy Azienda Ospedaliera Universitaria - Università degli Studi di Napoli "Federico II" - Facoltà di Medicina e Chirurgia Napoli, Italy Ospedale Cervello Palermo, Italy, 90146 U.O. Ematologia Clinica - Azienda USL di Pescara Pescara, Italy, 65100 Università di Pisa - Azienda Ospedaliera Pisana - Dipartimento di Oncologia, dei Trapianti e delle nuove Tecnologie in Medicina - Divisione di Ematologia Pisa, Italy Dipartimento Oncologico - Ospedale S.Maria delle Croci Ravenna, Italy Calabria Dipartimento Emato-Oncologia A.O."Bianchi-Melacrino-Morelli" Reggio Calabria, Italy Umberto I di Roma - Dipartimento di Biotecnologie Cellulari ed Ematologia Roma, Italy, 00161 Complesso Ospedaliero S. Giovanni Addolorata Roma, Italy Università degli Studi "Sapienza" - Dip Biotecnologie Cellulari ed Ematologia - Divisione di Ematologia Roma, Italy Università degli Studi - Policlinico di Tor Vergata Roma, Italy Istituto di Ematologia - IRCCS Ospedale Casa Sollievo della Sofferenza San Giovanni Rotondo, Italy SCDO Ematologia 2 AOU Giovanni Battista Torino, Italy Less <<
NCT03344133 Overweight and Obesity Not Applicable Recruiting November 30, 2017 United Kingdom ... More >> School of Medicine, University of Glasgow / New Lister Building, Glasgow Royal Infirmary Recruiting Glasgow, United Kingdom, G312ER Contact: Eleni Rizou, BSc MSc       e.rizou.1@research.gla.ac.uk    Contact: Konstantinos Gerasimidis, BSc MSc PhD       Konstantinos.Gerasimidis@glasgow.ac.uk Less <<
NCT01618630 Burn Injury Not Applicable Completed - United States, Texas ... More >> Shriners Hospitals for Children Galveston, Texas, United States, 77550 Less <<
NCT00971243 Type 2 Diabetes Mellitus Phase 2 Completed - -
NCT00777621 Diabetes Not Applicable Completed - United States, Missouri ... More >> Saint Louis University Saint Louis, Missouri, United States, 63104 Less <<
NCT02108353 Sleep Disorders, Circadian Rhy... More >>thm Less << Phase 3 Completed - Germany ... More >> University Medical Center Aachen Aachen, North Rhine-Westphalia, Germany, 52074 CTC North GmbH & Co. KG Hamburg, Germany, 20246 Italy Department of Systems Medicine Rome, Lazio, Italy, 00133 Less <<
NCT01135446 Type 2 Diabetes Phase 1 Completed - United States, Texas ... More >> Ppd Development, Lp Austin, Texas, United States, 78744 Less <<
NCT02538640 Metabolism and Nutrition Disor... More >>ders Less << Not Applicable Completed - Australia ... More >> Human Nutrition Unit, The University of Sydney Sydney, Australia, 2006 Less <<
NCT00123240 Obesity Not Applicable Completed - United States, New York ... More >> Rockefeller University New York, New York, United States, 10021 Less <<
NCT00971243 - Completed - -
NCT00875459 Diabetes Mellitus Phase 3 Completed - -
NCT01101945 Type 2 Diabetes Mellitus Phase 2 Terminated March 2010 -
NCT00825253 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 1 Completed - Germany ... More >> Novo Nordisk Investigational Site Neuss, Germany, 41460 Less <<
NCT01460095 Diabetes Mellitus Not Applicable Completed - Cameroon ... More >> Yaounde Central Hospital Yaounde, Centre, Cameroon Bamenda Regional Hospital Bamenda, North West, Cameroon Garoua Regional Hospital Garoua, North, Cameroon Buea Regional Hospital Buea, South West, Cameroon Bafoussam District Hospital Bafoussam, Cameroon Guinea Boke Regional Hospital Boke, Guinea CHU Donka Conakry, Guinea Kankan Regional Hospital Kankan, Guinea Labe regional Hospital Labe, Guinea Less <<
NCT01889368 Metabolic Syndrome Not Applicable Completed - United States, California ... More >> VA Hospital, Mather Mather, California, United States, 95655 Less <<
NCT03452761 Healthy Young Adults Not Applicable Completed - United States, Georgia ... More >> Augusta University Augusta, Georgia, United States, 30909 Less <<
NCT02403141 - Active, not recruiting March 2017 United Arab Emirates ... More >> Imperial College London Diabetes Centre Abu Dhabi, United Arab Emirates, P.O Box 48338 Less <<
NCT03553849 Morbid Obesity Not Applicable Recruiting August 1, 2019 United States, Delaware ... More >> Christiana Care Health System Recruiting Newark, Delaware, United States, 19713 Contact: Caitlin A Halbert, DO, MS Less <<
NCT00563004 Diabetes Mellitus, Non-insulin... More >> Dependant Diabetes Mellitus Type 2 Diabetes Mellitus, on Oral Hypoglycemic Treatment Adult Type Diabetes Mellitus Less << Not Applicable Completed - Israel ... More >> Meir Medical Center Kfar-saba, Israel, 44281 Less <<
NCT02690350 Advanced Solid Tumors ... More >> Hepatocellular Cancer (HCC) Less << Phase 1 Terminated(Program discontinue... More >>d for business reasons (not safety).) Less << - United Kingdom ... More >> Glasgow, Lanarkshire, United Kingdom, G12 0YN The Royal Marsden Hospital Sutton, Surrey, United Kingdom Guy's Hospital London, United Kingdom The Christie NHS Foundation Trust Manchester, United Kingdom Less <<
NCT01090869 Insulin Sensitivity Not Applicable Completed - Denmark ... More >> University of Copenhagen, Faculty Of Health Sciences, Department of Biomedical Sciences Copenhagen, Denmark, 2200 Less <<
NCT01834378 Type 2 Diabetes Not Applicable Completed - -
NCT03676309 Diabetes Mellitus, Type 2 ... More >> Nutritional and Metabolic Diseases Vascular System Injury Therapy-Related Morphologic Change Less << Phase 2 Completed - Italy ... More >> Capomolla Antonio Monterosso Calabro, VV, Italy, 89819 Less <<
NCT00543491 Diabetes Mellitus, Type 2 Phase 3 Terminated - -
NCT03583983 Health Behavior ... More >> Genetic Information Cardiovascular Risk Factor Less << Not Applicable Active, not recruiting November 30, 2018 Canada, Ontario ... More >> Hamilton Health Sciences (Juravinski Hospital, General Hospital, MUMC) Hamilton, Ontario, Canada, L8L2X2 Less <<
NCT01755962 160 Participants Aged 18-35 Ye... More >>ars and Obese (BMI ≥30) Open to Men and Women of All Ethnicity Less << Not Applicable Unknown December 2015 United States, California ... More >> University of California, Los Angeles Recruiting Los Angeles, California, United States, 90095 Principal Investigator: Christian K Roberts, PhD Less <<
NCT02218268 - Completed - United States, Florida ... More >> University of Florida Gainesville, Florida, United States, 32610 Less <<
NCT00454233 Diabetes Mellitus Type 2 Phase 2 Completed - Russian Federation ... More >> Ekaterinburg, Russian Federation 4 Sites Moscow, Russian Federation N. Novgorod, Russian Federation Petrozavodsk, Russian Federation Samara, Russian Federation 10 Sites St. Petersburg, Russian Federation Less <<
NCT00831129 Pre-diabetes Phase 2 Phase 3 Completed - United States, Illinois ... More >> University of Chicago Chicago, Illinois, United States, 60637 Less <<
NCT01410292 Type 2 Diabetes Mellitus Not Applicable Unknown January 2012 Brazil ... More >> Hospital de Clínicas de Porto Alegre Recruiting Porto Alegre, Rio Grande do Sul, Brazil Contact: Flávia M Silva    93771824    flavia.moraes.silva@hotmail.com    Sub-Investigator: Thais Steemburgo          Sub-Investigator: Caroline Kramer          Sub-Investigator: Giovana Menegotto Less <<
NCT01967888 Pancreatectomy for Chronic Pan... More >>creatitis Less << Phase 2 Phase 3 Completed - United States, California ... More >> University of California. Department of Surgery, Division of Transplantation San Francisco, California, United States, 94143 United States, Illinois The University of Chicago Medical Center Chicago, Illinois, United States, 60637 United States, Minnesota Schulze Diabetes Institute University of Minnesota Medical School Minneapolis, Minnesota, United States, 55455 United States, New Hampshire Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States, 03756 United States, Ohio The University of Cincinnati Medical Center Cincinnati, Ohio, United States, 45219 United States, Pennsylvania Thomas E. Starzl Transplantation Institute University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States, 15213 United States, South Carolina Medical University of South Carolina Charleston, South Carolina, United States, 29425 United States, Texas Baylor University Medical Center Dallas, Texas, United States, 75246 Canada, Alberta University of Alberta, Clinical Islet Transplant Program Edmonton, Alberta, Canada, T6G 2C8 Less <<
NCT00288977 Diabetes Kidn... More >>ey Transplantation Less << Not Applicable Completed - -
NCT02218268 - Completed - -
NCT02726490 Gestational Diabetes Not Applicable Terminated(Lack of Recruitment... More >>) Less << - United States, Texas ... More >> TTUHSC El Paso El Paso, Texas, United States, 79905 Less <<
NCT00941369 Diabetes Mellitus, Type 2 Phase 4 Completed - Germany ... More >> Sanofi-Aventis Administrative Office Berlin, Germany Less <<
NCT00831129 - Completed - -
NCT03288233 - Recruiting August 2018 United States, Ohio ... More >> University of Cincinnati Recruiting Cincinnati, Ohio, United States, 45220 Contact: Colleen Rogge, BSN    513-475-6478    marycolleenrogge@va.gov    Contact: Stephanie Donnelly, MBA    513-558-2639    donnelsi@ucmail.uc.edu    Principal Investigator: Robert Cohen, MD Less <<
NCT01194258 Diabetes Mellitus, Type II Phase 2 Completed - United States, California ... More >> John Muir Physician Network Clinical Research Center Concord, California, United States, 94520 Medical Group of Encino Encino, California, United States, 91436 AMCR Institute, Inc. Escondido, California, United States, 92026 Marin Endocrine Care and Research Greenbrae, California, United States, 94904 Mills-Peninsula Health Services San Mateo, California, United States, 94401 United States, Florida Center for Diabetes and Endocrine Care Hollywood, Florida, United States, 33021 Diabetes Research Institute Miami, Florida, United States, 33136 Baptist Diabetes Associates Miami, Florida, United States, 33156 United States, Idaho Rocky Mountain Diabetes and Osteoporosis Center Idaho Falls, Idaho, United States, 83404 United States, Kansas Mid-America Diabetes Associates Wichita, Kansas, United States, 67211 United States, Louisiana Tulane University Health Sciences Center New Orleans, Louisiana, United States, 70112 United States, Maryland Medstar Research Institute Hyattsville, Maryland, United States, 20782 United States, Michigan Henry Ford Health System Detroit, Michigan, United States, 48202 United States, Minnesota International Diabetes Center Minneapolis, Minnesota, United States, 55416 United States, Montana Mercury Street Medical Butte, Montana, United States, 59701 United States, Nevada Desert Endocrinology Henderson, Nevada, United States, 89052 United States, North Carolina Diabetes and Endocrinology Associates, PC Morehead, North Carolina, United States, 28557 United States, Texas UT Southwestern Medical Center at Dallas Dallas, Texas, United States, 75390 Texas Diabetes and Endocrinology Round Rock, Texas, United States, 78681 Cetero Research-San Antonio San Antonio, Texas, United States, 78229 United States, Washington West Olympia Internal Medicine Olympia, Washington, United States, 98502 University of Washington School of Medicine Seattle, Washington, United States, 98105 Less <<
NCT01578096 Diabetes Mellitus, Type 2 Not Applicable Completed - United States, Connecticut ... More >> Yale University New Haven, Connecticut, United States Less <<
NCT01194258 - Completed - -
NCT00044460 Diabetes Mellitus, Type 2 Phase 4 Completed - -
NCT00324363 Type 2 Diabetes Mellitus Phase 3 Completed - China ... More >> Research Site Beijing, China Research Site Guangzhou, China Research Site Nanjing, China Research Site Shanghai, China Research Site Sichuan, China India Research Site Chennai, India Research Site Mumbai, India Research Site Pune, India Korea, Republic of Research Site Seoul, Korea, Republic of Research Site Sungnam City, Korea, Republic of Taiwan Research Site Chiayi, Taiwan Research Site Taichung, Taiwan Research Site Tainan, Taiwan Research Site Taipei, Taiwan Less <<
NCT02401243 Type 2 Diabetes Mellitus Phase 3 Completed - Canada ... More >> Investigational Site Number 124001 Abbotsford, Canada, V2S3N5 Investigational Site Number 124013 Brampton, Canada, L6T4V3 Investigational Site Number 124008 Burlington, Canada Investigational Site Number 124024 Burnaby, Canada, V5G1T4 Investigational Site Number 124015 Collingwood, Canada, L9Y1W3 Investigational Site Number 124025 Corunna, Canada, N0N 1G0 Investigational Site Number 124019 Etobicoke, Canada, M9V4V4 Investigational Site Number 124021 Hamilton, Canada Investigational Site Number 124011 Laval, Canada, H7T 2P5 Investigational Site Number 124005 Levis, Canada, G6W5M6 Investigational Site Number 124018 London, Canada, N5W 6A2 Investigational Site Number 124003 Oshawa, Canada Investigational Site Number 124010 Quebec, Canada, G1W4R4 Investigational Site Number 124012 Quebec, Canada Investigational Site Number 124007 Sarnia, Canada, N7T 4R9 Investigational Site Number 124002 Saskatoon, Canada, S7K 3H3 Investigational Site Number 124023 Sherbrooke, Canada, J1G5K2 Investigational Site Number 124009 Smiths Falls, Canada, K7A4W8 Investigational Site Number 124017 Strathroy, Canada, N7G1Y7 Investigational Site Number 124020 Toronto,, Canada, M8V3X8 Investigational Site Number 124006 Vancouver, Canada, V5Z1M9 Investigational Site Number 124026 Vancouver, Canada, V6J1S3 Investigational Site Number 124004 Victoria, Canada, V8V4H1 Investigational Site Number 124014 Winnipeg, Canada, R2V4W3 Investigational Site Number 124016 Winnipeg, Canada, R3E 3P4 Less <<
NCT00832624 Diabetes Mellitus Non-insulin-... More >>dependent Less << Phase 4 Terminated(Business Reasons) - -
NCT03630445 Obesity Diabe... More >>tes Mellitus, Type 2 Appetitive Behavior Less << Not Applicable Completed - United States, Indiana ... More >> Purdue University West Lafayette, Indiana, United States, 47907 Less <<
NCT00832624 - Terminated(Business Reasons) - -
NCT01889095 Diabetes Type 2 Phase 4 Completed - Iran, Islamic Republic of ... More >> Tehran University of Medical Sciences Tehran, Iran, Islamic Republic of, 13145-784 Less <<
NCT03393338 Diabetes Not Applicable Recruiting December 31, 2020 United States, Pennsylvania ... More >> Thomas Jefferson University Recruiting Philadelphia, Pennsylvania, United States, 19107 Contact: Robin J Casten, PhD    215-503-1250    Robin.Casten@Jefferson.edu Less <<
NCT03151343 Type2 Diabetes Mellitus Phase 3 Recruiting April 2020 Denmark ... More >> Herlev og Gentofte Hospital Recruiting Herlev, Denmark, 2730 Contact: Mikkel Jürgens, MD    +45 38 68 21 39    mikkel.juergens.01@regionh.dk    Principal Investigator: Caroline M Kistorp, MD, PhD          Sub-Investigator: Mikkel Jürgens, MD Less <<
NCT00693771 Diabetes Mellitus, Type 2 Phase 4 Completed - China ... More >> Sanofi-Aventis Administrative Office Shanghai, China Less <<
NCT01917227 Diabetes Mellitus Not Applicable Completed - Taiwan ... More >> Chang Gung Memorial Hospital Taoyuan, Taiwan, 333 Less <<
NCT01125956 Diabetes Mellitus Phase 2 Completed - United States, Pennsylvania ... More >> Philadelphia Veterans Affairs Medical Center Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00127192 Type 2 Diabetes Mellitus Phase 2 Completed - -
NCT02501850 Diabetes Mellitus Type 2 Phase 4 Unknown October 2015 Spain ... More >> Hospital Universitari Vall d'Hebron Recruiting Barcelona, Spain, 08035 Contact: Andreea Ciudin, PhD    +34932744736    aciudin@vhebron.net    Contact: Cristina Hernandez, MD, PhD    +34 932746591    cristina.hernandez@vhir.org    Principal Investigator: Cristina Hernandez, MD, PhD          Sub-Investigator: Andreea Ciudin, MD          Sub-Investigator: Olga Simó-Servat, MD Less <<
NCT00127192 - Completed - -
NCT03261895 Diabetes Mellitus, Type 2 Not Applicable Completed - China ... More >> The First Affiliated Hospital of Xi'an Jiaotong University Xi'an, China The Second Affiliated Hospital of Xi'an Jiaotong University Xi'an, China The Shaanxi Provincial People's Hospital Xi'an, China Xi'an Central Hospital Xi'an, China Less <<
NCT00575159 Diabetes Mellitus, Type 1 Phase 2 Completed - United States, California ... More >> GSK Investigational Site San Diego, California, United States, 92161 Less <<
NCT02166697 - Completed - -
NCT01664026 Obesity Not Applicable Unknown December 2013 Argentina ... More >> Clinica Bazterrica Buenos Aires, Argentina Less <<
NCT00505960 Diabetes Phase 1 Completed - United States, Maryland ... More >> Korean Resource Center Ellicott City, Maryland, United States, 20143 Less <<
NCT00575159 - Completed - -
NCT01624116 Diabetes, Type 2 Not Applicable Completed - Pakistan ... More >> Endocrinology Unit & Diabetes Management Centre, Services Hospital. Lahore, Pakistan Less <<
NCT00256126 Growth Hormone Deficiency ... More >> Turner Syndrome Less << Phase 4 Completed - Argentina ... More >> Local Medical Information Office Buenos Aires, Argentina Australia Local Medical Information Office Sydney, Australia Austria Local Medical Information Office Vienna, Austria Canada Local Medical Information Office Mississauga, Canada France Local Medical InformationOffice Paris, France Germany Local Medical Information Office Munich, Germany Italy Local Medical Information Office Rome, Italy Norway Local Medical Information Office Oslo, Norway Russian Federation Local Medical Information Office Russia, Russian Federation Singapore Local Medical Information Office Singapore, Singapore Spain Local Medical Information Office Madrid, Spain Sweden Local Medical Information Office Stockholm, Sweden United Kingdom Local Medical Information Office Feltham, United Kingdom Less <<
NCT03376607 Diabetes Mellitus ... More >> Telemedicine Community Health Workers Less << Not Applicable Not yet recruiting May 31, 2020 Rwanda ... More >> Kibuye Referral Hospital Not yet recruiting Kibuye, Karongi, Rwanda Contact: Jean Paul Uwizihiwe, MD, MSc    ‭+250788611186‬    jpaul.uwizihiwe@ph.au.dk    Contact: Charilaos Lygidakis, MD, PgD    +250785922247    charilaos.lygidakis@uni.lu    Ruhengeri Provincial Hospital Not yet recruiting Ruhengeri, Musanze, Rwanda Contact: Jean Paul Uwizihiwe, MD, MSc    +250788611186    jpaul.uwizihiwe@ph.au.dk    Contact: Charilaos Lygidakis, MD, PgD    +250785922247    charilaos.lygidakis@uni.lu    Kibungo Referral Hospital Not yet recruiting Kibungo, Ngoma, Rwanda Contact: Jean Paul Uwizihiwe, MD, MSc    +250788611186‬    jpaul.uwizihiwe@ph.au.dk    Contact: Charilaos Lygidakis, MD, PgD    ‭+250785922247‬    charilaos.lygidakis@uni.lu    Bushenge Provincial Hospital Not yet recruiting Bushenge, Nyamasheke, Rwanda Contact: Jean Paul Uwizihiwe, MD, MSc    +250788611186‬    jpaul.uwizihiwe@ph.au.dk    Contact: Charilaos Lygidakis, MD, PgD    +250785922247    charilaos.lygidakis@uni.lu    Muhima District Hospital Not yet recruiting Kigali, Nyarugenge, Rwanda Contact: Jean Paul Uwizihiwe, MD, MSc    +250788611186    jpaul.uwizihiwe@ph.au.dk    Contact: Charilaos Lygidakis, MD, PgD    ‭+250785922247‬    charilaos.lygidakis@uni.lu    Ruhango Provincial Hospital Not yet recruiting Kinazi, Ruhango, Rwanda Contact: Jean Paul Uwizihiwe, MD, MSc    +250788611186    jpaul.uwizihiwe@ph.au.dk    Contact: Charilaos Lygidakis, MD, PgD    ‭+250785922247‬    charilaos.lygidakis@uni.lu    Kinihira Provincial Hospital Not yet recruiting Kinihira, Rulindo, Rwanda Contact: Jean Paul Uwizihiwe, MD, MSc    +250788611186    jpaul.uwizihiwe@ph.au.dk    Contact: Charilaos Lygidakis, MD, PgD    ‭+250785922247‬    charilaos.lygidakis@uni.lu    Kabutare District Hospital Not yet recruiting Huye, Rwanda Contact: Jean Paul Uwizihiwe, MD, MSc    ‭+250788611186‬    jpaul.uwizihiwe@ph.au.dk    Contact: Charilaos Lygidakis, MD, PgD    +250785922247    charilaos.lygidakis@uni.lu    Rwamagana Provincial Hospital Not yet recruiting Rwamagana, Rwanda Contact: Jean Paul Uwizihiwe, MD, MsC    +250788611186    jpaul.uwizihiwe@ph.au.dk    Contact: Charilaos Lygidakis, MD, PgD    +250785922247    charilaos.lygidakis@uni.lu Less <<
NCT00713960 - Completed - -
NCT01542463 - Completed - Germany ... More >> Mainz, Germany, 55127 Less <<
NCT02166697 - Completed - -
NCT00282451 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 4 Completed - Egypt ... More >> Novo Nordisk Investigational Site Aghakhan, Egypt Novo Nordisk Investigational Site Giza, Egypt Saudi Arabia Novo Nordisk Investigational Site Jeddah, Saudi Arabia, 80215 Novo Nordisk Investigational Site Riyadh, Saudi Arabia, 245 Less <<
NCT00349427 Type 2 Diabetes Mellitus ... More >> Diabetes Mellitus, Type 2 Less << Phase 3 Completed - China, Jiangsu ... More >> GSK Investigational Site Nanjing, Jiangsu, China, 210008 China, Shanxi GSK Investigational Site Xian, Shanxi, China, 710032 China GSK Investigational Site Beijing, China, 100029 GSK Investigational Site Beijing, China, 100034 GSK Investigational Site Beijing, China, 100730 GSK Investigational Site Beijing, China, 100853 GSK Investigational Site Shanghai, China, 200001 GSK Investigational Site Shanghai, China, 200032 GSK Investigational Site Shanghai, China, 200233 GSK Investigational Site Tianjin, China, 300052 Less <<
NCT00854594 - Completed - -
NCT00256126 - Completed - -
NCT03196336 Pharmaceutical Services Not Applicable Active, not recruiting December 2017 Brazil ... More >> Vital Brazil Community Pharmacy Sorocaba, São Paulo, Brazil, 18013004 Less <<
NCT00542724 Type 1 Diabetes Mellitus Phase 3 Completed - -
NCT03771261 Pre Diabetes ... More >>Obesity Less << Not Applicable Recruiting June 2020 United States, North Carolina ... More >> Duke University Medical Center Recruiting Durham, North Carolina, United States, 27710 Contact: Kathryn Starr, RD, PHD    919-660-7571    kathryn.starr@duke.edu    Contact: Dipa Patel, BS    9196607507    dipa.patel@duke.edu Less <<
NCT00854594 Diabetes Mellitus Not Applicable Completed - United States, Ohio ... More >> Louis Stokes VA Medical Center Cleveland, Ohio, United States, 44106-3800 Less <<
NCT02532855 - Completed - -
NCT02029677 - Active, not recruiting January 2019 United States, Oregon ... More >> Oregon Weight Loss Surgery Portland, Oregon, United States, 97210 Less <<
NCT02027103 Type 2 Diabetes Mellitus Not Applicable Completed - Iran, Islamic Republic of ... More >> Diabetes Clinic, Vali-Asr Hospital, Tehran University of Medical Sciences Tehran, Iran, Islamic Republic of, 13145-784 Less <<
NCT02532855 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT01386671 Type 2 Diabetes Phase 3 Completed - Mexico ... More >> Unidad Antidiabética Integral Mexico City, AA, Mexico, 06600 Paracelsus S.A. de C.V. Mexico, city, AA, Mexico, 03800 Unidad de Investigacion en Epidemiologia Clinica. UMAE Hospital de Especialidades Centro Medico Nacional Siglo XXI. Instituto Mexicano del Seguro Social Mexico City, Distrito Federal, Mexico, 06720 Instituto de terapéutica experimental y clínica (INTEC) Guadalajara, Jalisco, Mexico, 44600 Less <<
NCT01811329 Metabolic Syndrome ... More >> Obesity Less << Not Applicable Completed - United States, California ... More >> USDA Western Human Nutrition Research Center Davis, California, United States, 95616 Less <<
NCT02020629 Type 2 Diabetes Phase 4 Completed - Sweden ... More >> Clinical Research Department Malmö, Sweden, 20502 Less <<
NCT03672903 Obesity Phase 1 Phase 2 Recruiting December 2022 Sweden ... More >> Sahlgrenska University Hospital Recruiting Göteborg, Sweden, S-405 30 Contact: John-Olov Jansson, Professor, PhD, MD       joj@neuro.gu.se    Contact: Edwin Gidestrand, MD       edwin.gidestrand@vgregion.se    Principal Investigator: Per-Anders Jansson, Professor, PhD, MD          Sub-Investigator: John-Olov Jansson, Professor, PhD, MD          Sub-Investigator: Edwin Gidestrand, MD Less <<
NCT02886013 - Completed - -
NCT02798172 Diabetes Mellitus, Type 2 Not Applicable Completed - -
NCT03658031 PreDiabetes M... More >>yocardial Infarction T2DM (Type 2 Diabetes Mellitus) CVD Less << Phase 3 Not yet recruiting January 31, 2021 Qatar ... More >> Heart Hospital, Hamad Medical Coorporation Not yet recruiting Doha, Qatar, 3050 Contact: Jassim Al-Suwaidi, MD    55823041    jalsuwaidi@hotmail.com Less <<
NCT02796144 Schizophrenia ... More >> Schizoaffective Disorder Overweight Less << Phase 4 Recruiting March 2020 United States, New York ... More >> New York State Psychiatric Institute (NYSPI), Columbia University Not yet recruiting New York, New York, United States, 11032 Contact: Scott Stroup, MD, MPH    646-774-8435    stroups@nyspi.columbia.edu    United States, North Carolina University of North Carolina at Chapel Hill Recruiting Chapel Hill, North Carolina, United States, 27599 Contact: Lars F Jarskog, MD    919-843-7683    lars_jarskog@med.unc.edu Less <<
NCT00004203 Bladder Cancer ... More >> Transitional Cell Cancer of the Renal Pelvis and Ureter Less << Phase 2 Completed - United States, Illinois ... More >> University of Illinois at Chicago Chicago, Illinois, United States, 60612 University of Chicago Cancer Research Center Chicago, Illinois, United States, 60637-1470 Louis A. Weiss Memorial Hospital Chicago, Illinois, United States, 60640 Cancer Care Specialists of Central Illinois, S.C. Decatur, Illinois, United States, 62526 Evanston Northwestern Health Care Evanston, Illinois, United States, 60201 Division of Hematology/Oncology Park Ridge, Illinois, United States, 60068 Oncology/Hematology Associates of Central Illinois, P.C. Peoria, Illinois, United States, 61602 Central Illinois Hematology Oncology Center Springfield, Illinois, United States, 62701 United States, Indiana Fort Wayne Medical Oncology and Hematology, Inc. Fort Wayne, Indiana, United States, 46885-5099 Michiana Hematology/Oncology P.C. South Bend, Indiana, United States, 46617 United States, Pennsylvania University of Pennsylvania Cancer Center Philadelphia, Pennsylvania, United States, 19104-4283 Canada, Ontario Cancer Care Ontario-Hamilton Regional Cancer Centre Hamilton, Ontario, Canada, L8V 5C2 Cancer Care Ontario-London Regional Cancer Centre London, Ontario, Canada, N6A 4L6 Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Less <<
NCT00992186 Prostate Cancer Phase 2 Completed - United States, Florida ... More >> Orange City, Florida, United States United States, Michigan Ann Arbor, Michigan, United States United States, South Carolina Charleston, South Carolina, United States Belgium Antwerpen, Belgium Bruxelles, Belgium Wilrijk, Belgium Russian Federation Moscow, Russian Federation St Petersburg, Russian Federation St-Petersburg, Russian Federation United Kingdom Birmingham, United Kingdom Guildford, United Kingdom Leeds, United Kingdom Southampton, United Kingdom Sutton, United Kingdom Less <<
NCT03075514 Glioblastoma ... More >>Glioblastoma Multiforme Glioblastoma, Adult Less << Not Applicable Active, not recruiting March 2020 United Kingdom ... More >> Univeristy of Liverpool/ The Walton Centre NHS Foundation Trust Liverpool, Merseyside, United Kingdom, L9 7LJ Less <<
NCT03134170 Diabetes Mellitus, Type 2 Not Applicable Active, not recruiting December 31, 2019 United States, New Jersey ... More >> Henry J Austin Health Clinic Trenton, New Jersey, United States, 08618 Less <<
NCT00992186 - Completed - -
NCT00997178 Chronic Periodontitis ... More >> Type 2 Diabetes Less << Phase 3 Completed - United States, Alabama ... More >> Clinical Site: University of Alabama at Birmingham Birmingham, Alabama, United States, 35294 United States, Minnesota Clinical Site: University of Minnesota Minneapolis, Minnesota, United States, 55455 Core Laboratory: University of Minnesota Minneapolis, Minnesota, United States, 55455 United States, New York Coordinating Center: Stony Brook University- Stony Brook, New York, United States, 11794-8036 Administrative Center/Study Chair's Office: Stony Brook University Stony Brook, New York, United States, 11794 Clinical Site: Stony Brook University Stony Brook, New York, United States, 11794 United States, Texas University of Texas, Health Sciences Center at Houston Houston, Texas, United States, 77030 Clinical Site: University of Texas Health Science Center San Antonio, Texas, United States, 78229 Less <<
NCT00231530 Obesity Diabe... More >>tes Mellitus, Type 2 Diabetes Mellitus, Adult-Onset Less << Phase 3 Completed - -
NCT01677923 Obesity Phase 3 Completed - Lithuania ... More >> Rasa Verkauskiene Kaunas, Eiveniu str. 2, Lithuania, LT50009 Less <<
NCT02065674 - - December 2014 India ... More >> ,Father Muller Homoeopathic Medical College, Prasanth Nivas Ashram Nmpt Hospital Mangalore, Karnataka, India, 575002 Less <<
NCT01392573 - Completed - -
NCT01392573 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT00795704 Type 2 Diabetes Phase 2 Phase 3 Completed - United States, Mississippi ... More >> University of Mississippi Medical Center Jackson, Mississippi, United States, 39216 Less <<
NCT00309608 Diabetes Mellitus, Type 2 Phase 2 Completed - -
NCT02318966 Glycogen Storage Disease Not Applicable Recruiting March 31, 2020 United States, Connecticut ... More >> Connecticut Children's Medical Center Recruiting Hartford, Connecticut, United States, 06106 Contact: David Weinstein          France Hôpital Antoine Béclère Recruiting Clamart, France, 92140 Cedex Contact: Aurélie Hubert    +33 (01) 45 37 42 72    Aurelie.Hubert@Abc.Aphp.Fr    Netherlands Universitair Medisch Centrum Groningen Recruiting Groningen, Netherlands, 9700RB Contact: Terry Derks    +31 (0) 50 361 4156    T.G.J.Derks@UMCG.Nl    United Kingdom National Hospital for Neurology and Neurosurgery Recruiting London, Greater London, United Kingdom, WC1N 3BG Contact: Elaine Murphy    +44 (0) 203 448 4778    Elaine.Murphy@UCLH.NHS.UK    Evelina Children's Hospital Recruiting London, United Kingdom Contact: Helen Mundy    +44 (0) 207 188 0848    Helen.Mundy@GSTT.NHS.UK    Great Ormond Street Hospital for Children Recruiting London, United Kingdom Contact: James Davison    +44 (0) 207 813 8549    James.Davison@GOSH.NHS.UK Less <<
NCT00684827 Asthma Phase 2 Completed - United States, California ... More >> Encinitas, California, United States Los Angeles, California, United States United States, Massachusetts North Dartmouth, Massachusetts, United States United States, Missouri St. Louis, Missouri, United States Less <<
NCT00684866 Asthma Phase 2 Completed - United States, California ... More >> Madera, California, United States San Diego, California, United States United States, Georgia Savannah, Georgia, United States United States, Kentucky Louisville, Kentucky, United States United States, New York Cortland, New York, United States United States, Oregon Medford, Oregon, United States Portland, Oregon, United States United States, Pennsylvania Chester, Pennsylvania, United States United States, Tennessee Knoxville, Tennessee, United States United States, Texas Dallas, Texas, United States Houston, Texas, United States Less <<
NCT03326544 Chronic Knee Joint Osteoarthri... More >>tis Less << Not Applicable Enrolling by invitation September 2018 Egypt ... More >> Mansoura University Hospitals Mansourah, DK, Egypt, 050 Less <<
NCT03341013 Type 2 Diabetes Mellitus Phase 1 Completed - United States, Texas ... More >> Research Site Dallas, Texas, United States, 75247 Less <<
NCT00309608 - Completed - -
NCT00460941 Diabetes Mellitus Type 2 Phase 2 Completed - -
NCT00858013 Type 2 Diabetes Mellitus Phase 4 Completed - Korea, Republic of ... More >> Myongji Hospital Ilsan, Kyounggi, Korea, Republic of Hanyang University Medical Center Guri-si, Kyunggi-do, Korea, Republic of Inha University Hospital Incheon, Korea, Republic of Hallym University Medical Center Seoul, Korea, Republic of Korea University Guro Hospital Seoul, Korea, Republic of Kyung hee University Medical Center Seoul, Korea, Republic of Ajou University Hospital Suwon-si, Korea, Republic of Less <<
NCT00270985 Prediabetes I... More >>nsulin Resistance Metabolic Syndrome Less << Phase 1 Completed - United States, New Jersey ... More >> UMDNJ Newark, New Jersey, United States, 07103 Less <<
NCT03178461 Delivery, Obstetric Not Applicable Recruiting December 30, 2018 Israel ... More >> Meir Medical Center Recruiting Kfar Saba, Israel Contact: Hanoch Schreiber, MD    972-53-332-3248    hanoch.schreiber@clalit.org.il    Contact: Yair Daykan, MD    0542198231    yair.daykan@clalit.org.il    Principal Investigator: Hanoch Schreiber, MD          Meir Medical Center Recruiting Kfar Saba, Israel Contact: Hanoch Schreiber    0533323248    Hanochsc@gmail.com Less <<
NCT00795704 - Completed - -
NCT00222833 Overweight Hy... More >>perlipidemia Cardiovascular Diseases Less << Phase 4 Completed - United States, Pennsylvania ... More >> Western Psychiatric Institute and Clinic of UPMC Pittsburgh, Pennsylvania, United States, 15213 Less <<
NCT00858013 - Completed - -
NCT00477191 Psoriasis Met... More >>abolic Syndrome Hyperlipidemia Obesity Hypertension Less << Not Applicable Terminated(Difficulty in recru... More >>itment.) Less << - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT01768169 - Unknown July 2013 Taiwan ... More >> Taipei Mecical University Hospital Recruiting Taipei, Taiwan, 100 Contact: Wen-Yi Cheng    886223711458    rhoda2891@hotmail.com    Principal Investigator: Shih-Yi Huang, Ph.D.          Sub-Investigator: Hsiu-Yue Su, MSc          Sub-Investigator: Chien-Tien Su, Ph.D Less <<
NCT02363335 Healthy Volunteers Phase 1 Completed - United States, Maryland ... More >> National Institute of Aging, Clinical Research Unit Baltimore, Maryland, United States, 21224 Less <<
NCT00477191 - Terminated(Difficulty in recru... More >>itment.) Less << - -
NCT01334554 Metabolic Syndrome ... More >> Obesity Less << Phase 1 Phase 2 Completed - United States, Tennessee ... More >> Vanderbilt University Nashville, Tennessee, United States, 37232 Less <<
NCT01334554 - Completed - -
NCT00896077 Healthy Type ... More >>1 Diabetes Less << Phase 1 Phase 2 Completed - United States, New Jersey ... More >> Advanced Biomedical Research, Inc. (ABR) Hackensack, New Jersey, United States, 07601 Less <<
NCT00614757 Insulin Resistance ... More >> Metabolic Syndrome x Less << Not Applicable Suspended December 2013 United States, Missouri ... More >> Kansas City VA Medical Center Kansas City, Missouri, United States, 64128 Less <<
NCT00256607 - Completed - United States, Arizona ... More >> Carl T. Hayden VA Medical Center Phoenix, Arizona, United States, 85012 Southern Arizona VA Health Care System, Tucson Tucson, Arizona, United States, 85723 United States, California VA Medical Center, Long Beach Long Beach, California, United States, 90822 VA San Diego Healthcare System, San Diego San Diego, California, United States, 92161 United States, Florida Miami VA Healthcare System, Miami, FL Miami, Florida, United States, 33125 United States, Illinois Edward Hines, Jr. VA Hospital Hines, Illinois, United States, 60141-5000 United States, Pennsylvania VA Pittsburgh Health Care System Pittsburgh, Pennsylvania, United States, 15240 Less <<
NCT01031680 Type 2 Diabetes Mellitus ... More >> Cardiovascular Disease Hypertension Inadequate Glycaemic Control Less << Phase 3 Completed - -
NCT02460380 - Completed - -
NCT02458131 Pre-Diabetes Not Applicable Recruiting December 2018 United States, New York ... More >> Icahn School of Medicine at Mount Sinai Recruiting New York, New York, United States, 10029 Contact: Nita Vangeepuram, MD, MPH       Nita.Vangeepuram@mssm.edu    Principal Investigator: Nita Vangeepuram, MD, MPH Less <<
NCT03512665 Insulin Resistance Not Applicable Completed - Colombia ... More >> University Of Los Andes Columbia Bogotá, Cundinamarca, Colombia, 111711 Less <<
NCT00325936 Hypertension ... More >>Metabolic Syndrome X Less << Phase 4 Completed - Korea, Republic of ... More >> Cheil general hospital Seoul, Korea, Republic of, 100-380 Less <<
NCT02460380 Polycystic Ovary Syndrome ... More >> Vitamin D Deficiency Less << Phase 4 Completed - -
NCT02800668 - Completed - Germany ... More >> Herz- und Diabeteszentrum Bad Oeynhausen, Germany, 32545 Less <<
NCT00435565 - Completed - -
NCT01107808 Insulin Resistance ... More >> Insulin Sensitivity Obesity Vitamin D Deficiency Less << Not Applicable Withdrawn(Poor recruitment to ... More >>the study) Less << March 2011 -
NCT01031680 - Completed - -
NCT03241212 Type 1 Diabetes Mellitus Not Applicable Active, not recruiting October 2018 United States, Colorado ... More >> Barbara Davis Center Aurora, Colorado, United States, 800045 Less <<
NCT02737657 - Completed - Kuwait ... More >> Kuwait City, Kuwait Lebanon Amioun, Lebanon Beirut, Lebanon Nabatieh, Lebanon Saida, Lebanon Taalabya, Lebanon Tripoli, Lebanon United Arab Emirates Al Ain, United Arab Emirates Dubai, United Arab Emirates Less <<
NCT00328172 Diabetes Mellitus, Type 2 Phase 2 Completed - -
NCT03589690 Metabolic Syndrome Not Applicable Not yet recruiting July 25, 2019 -
NCT01882036 Type 2 Diabetes Mellitus ... More >> Insulin Resistance Less << Not Applicable Active, not recruiting December 2022 United States, Minnesota ... More >> University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT00549874 Type 2 Diabetes Not Applicable Completed - United States, Michigan ... More >> University of Michigan Ann Arbor, Michigan, United States, 48109 United States, Ohio University of Toledo - Health Campus Toledo, Ohio, United States, 43606 Less <<
NCT00221234 Type 2 Diabetes Phase 2 Completed - -
NCT01213277 Diabetes Mellitus Not Applicable Suspended(a pilot study of 7 p... More >>atients did not reveal a temperature dependent difference in glycation rates) Less << - -
NCT00328172 - Completed - -
NCT01075997 Diabetes Mellitus Not Applicable Unknown October 2010 United States, District of Col... More >>umbia Walter Reed Army Hospital Center Washington DC, District of Columbia, United States, 20307 Less <<
NCT01890070 Obesity Not Applicable Unknown - Italy ... More >> Clinical Nutrition and Nutrigenomic, School of Medicine University of Rome Torvergata Recruiting Rome, Italy, 00133 Principal Investigator: Laura Di Renzo, Phd Less <<
NCT02835820 HIV Neurocogn... More >>itive Impairment Less << Not Applicable Active, not recruiting March 30, 2019 United States, Alabama ... More >> UAB 1917 Clinic Birmingham, Alabama, United States, 35294 Less <<
NCT01619059 Type 2 Diabetes Phase 3 Completed - -
NCT01619059 - Completed - -
NCT03412552 - Completed - Egypt ... More >> Kasr Alainy medical school Cairo, Egypt, 12151 Less <<
NCT03335293 Pregnancy Ces... More >>arean Section Less << Phase 4 Not yet recruiting May 20, 2019 United States, Florida ... More >> University of Florida Health Science Center Not yet recruiting Jacksonville, Florida, United States, 32209 Less <<
NCT01157052 Neoplasms, Colorectal ... More >> Colorectal Cancer Colorectal Carcinoma Less << Phase 1 Unknown September 2015 Canada, Alberta ... More >> Cross Cancer Institute Not yet recruiting Edmonton, Alberta, Canada, T6G 1Z2 Sub-Investigator: Judith Meza-Junco, MD Less <<
NCT02274571 Menopause Early Phase 1 Completed - United States, Louisiana ... More >> Pennington Biomedical Research Center Baton Rouge, Louisiana, United States, 70808 Less <<
NCT01479075 Diabetes Phase 4 Active, not recruiting June 2018 Germany ... More >> German Diabetic Center Düsseldorf, Nordrhein- Westfalen, Germany, 40225 Less <<
NCT01488409 - Completed - -
NCT01488409 Abdominal Obesity ... More >> Insulin Resistance Hypertriglyceridemia Less << Phase 2 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT02444325 Pregnancy Ges... More >>tational Diabetes Type 2 Diabetes Less << Not Applicable Completed - United States, Colorado ... More >> Denver Health Denver, Colorado, United States, 80204 United States, Missouri Washington University in St. Louis Saint Louis, Missouri, United States, 63110 Less <<
NCT00814372 Type 2 Diabetes Mellitus Phase 2 Terminated(MBX-102 did not mee... More >>t the target efficacy profile of HbA1c change.) Less << - United States, California ... More >> Providence Clinical Research Burbank, California, United States, 91505 American Institute of Research Los Angeles, California, United States, 90017 United States, Nevada Nevada Alliance Against Diabetes Las Vegas, Nevada, United States, 89101 United States, North Carolina Piedmont Medical Research Associates Winston-Salem, North Carolina, United States, 27103 United States, Texas DGD Research, Inc. San Antonio, Texas, United States, 78229 India Kamineni Hospitals Pvt, Ltd. Hyderabad, Andhra Pradesh, India, 50008 Bangalore Diabetes Centre Bangalore, India Diacon Hospital Diabetes & Research Centre Bangalore, India M. S. Ramaiah Memorial Hospital Bangalore, India St. John's Medical College & Hospital Bangalore, India Dr. V. Seshiah Diabetes Care & Research Institute Chennai, India Mediciti Hospital Hyderabad, India Medwin Hospital Hyderabad, India Diabetes Thyroid Hormone Research Institute Pvt. Ltd. Indore, India Fortis Hospital Jaipur, India Bharti Research Institute of Diabetes & Endocrinology Karnal, India Amrita Institute of Medical Sciences Kochi, India Diabetes Action Centre Mumbai, India, 400067 BYL Nair Hospital Mumbai, India PD Hindhuja National Hospital Mumbai, India Gandhi Endocrinology & Diabetes Centre Nagpur, India All India Institute of Medical Sciences New Delhi, India Deenanath Mangeshkar Hospital & Research Centre Pune, India Diabetes Care & Research Centre Pune, India Health & Research Centre Trivendrum, India Christian Medical College Vellore, India Less <<
NCT03363464 - Active, not recruiting November 15, 2021 United States, Massachusetts ... More >> Bringham Women Hospital Boston, Massachusetts, United States, 02120 Less <<
NCT00336674 Type 1 Diabetes Phase 2 Active, not recruiting December 2019 Australia, New South Wales ... More >> The Children's Hospital at Westmead Westmead, New South Wales, Australia, 2145 Australia, Queensland Mater Children's Hospital Brisbane, Queensland, Australia, 4101 Australia, South Australia Womens and Childrens Hospital North Adelaide, South Australia, Australia, 5006 Australia, Victoria Royal Melbourne Hospital Melbourne, Victoria, Australia, 3050 Australia, Western Australia Princess Margaret Hospital Subiaco, Western Australia, Australia, 6840 New Zealand University of Auckland Auckland, New Zealand Less <<
NCT00001625 - Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT01646619 Severe Hypoxic Ischemic Enceph... More >>alopathy Moderate Hypoxic Ischemic Encephalopathy Less << Phase 3 Unknown June 2014 Egypt ... More >> Mansoura University Children's Hospital Recruiting Mansoura, Egypt Contact: Islam A Noor, MD    +20103893026    islamnoor79@yahoo.com    Contact: Prof. Mohammed T Khashaba    +20502317925    khashabamohamed@hotmail.com    Principal Investigator: Mohamed T Khashaba          Malaysia University Malaya Medical Center (UMMC) Recruiting Kuala Lumpur, Malaysia Contact: Lucy CS Lum, Prof    60379492065    lumcs@ummc.edu.my    Contact: Hasimah B Zainol, Nursing    03-79492428/ 016-6217549    hasimah@ummc.edu.my    Principal Investigator: Lucy CS Lum, Professor          Qatar NICU,Women's Hospital, Hamad Medical Corporation Recruiting Doha, Qatar, 00000 Contact: Sarrah A Eltinay, MBBS    +974-44398940    magcoolcoordinator@gmail.com    Contact: Sajjad Ur Rahman, MBBS,DCH,MCPS,FCPS,FRCPCH,FNP    +974-44396123    magcoolstudy@hotmail.com    Sub-Investigator: Samawal Lutfi, MD, CABP, NPM (Dalhousie)          Sub-Investigator: Hussain Parappil, MBBS,MD,DCH,FRCPCH          Saudi Arabia Arrayan Hospital-Dr Sulaiman Al Habib Medical Group Recruiting Riyadh, Saudi Arabia Contact: Jassim Anabrees, MD,MRCPCH    +96614904000 ext 9690    jasim1800@yahoo.com    Principal Investigator: Jassim Anabress, MD          Turkey Zekai Tahir Burak Maternity Teaching Hospital Recruiting Ankara, Turkey Contact: Fuat E Canpolat, MD    +905326315185    femrecan@gmail.com    Contact: Prof. Ugur Dilmen    +903123065267    ugurdilmen@gmail.com    Principal Investigator: Fuat E Canpolat, MD          Diyarbakir Children's Hospital Recruiting Diyarbakir, Turkey Contact: Melek Akar, MD    904122245751507    Melek_akar@yahoo.com.tr    Contact: Heybet Tuzun, Pharm       drheybet@hotmail.com    Principal Investigator: Melek Akar, MD          Sub-Investigator: Heybet Tuzun, Pharm          United Arab Emirates Tawam Hospital Recruiting AlAin, United Arab Emirates Contact: Aiman Rahmani, MD    97137072181    arahmani@tawamhospital.ae    Contact: Fares Chedid, MD    971504474661    fchedid@tawamhospital.ae    Principal Investigator: Aiman Rahmani, MD          Sub-Investigator: Fares Chedid, MD          Sub-Investigator: Moghis Rehman, MD Less <<
NCT03235050 Diabetes Mellitus, Type 2 Phase 2 Active, not recruiting March 9, 2020 -
NCT03504683 PreDiabetes Not Applicable Not yet recruiting February 28, 2023 -
NCT01315756 Type 2 Diabetes Early Phase 1 Completed - Norway ... More >> Norwegian Centre for Integrated Care and Telemedicine (NST ), University Hospital of North- Norway Tromsø, Troms, Norway, 9038 Oslo University College Oslo, Norway, 0167 Less <<
NCT01827826 Diabetes Mellitus, Type 2 Not Applicable Completed - United States, Washington ... More >> Group Health Research Institute Seattle, Washington, United States, 98101 Less <<
NCT02114814 Diabetes Not Applicable Unknown - United States, North Carolina ... More >> UNCG Recruiting Greensboro, North Carolina, United States, 27412 Contact: Jie Hu, PhD    336-334-5217    j_hu2@uncg.edu Less <<
NCT01821508 Complications of Diabetes Mell... More >>itus Less << Not Applicable Active, not recruiting May 2021 Brazil ... More >> Hospital Alemão Oswaldo Cruz São Paulo, Brazil, 01323-020 Less <<
NCT02136654 Type 2 Diabetes Mellitus Not Applicable Recruiting October 2019 Canada, British Columbia ... More >> University of British Columbia Recruiting Vancouver, British Columbia, Canada, V6Z 1Y6 Contact: Gurpreet Oshan, BA    778 387 3100       Contact: Nadia Khan, MD       nakhanubc@gmail.com    Principal Investigator: Nadia Khan, MD          Principal Investigator: Tricia Tang, PhD Less <<
NCT00648817 HIV Infections Phase 4 Completed - United Kingdom ... More >> Chelsea and Westminster Hospital London, United Kingdom, SW10 9NH Less <<
NCT02887677 Diabetes Mellitus Phase 4 Recruiting December 2019 Greece ... More >> Ahepa Hospital Recruiting Thessaloniki, Greece, 54621 Contact: Kalliopi Kotsa    +306932045201    kalli@med.auth.gr    Sub-Investigator: Elena Aggeloudi          Hippokrateio Hospital Recruiting Thessaloniki, Greece, 54642 Contact: Asterios Karagiannis    +306972011271    astkar@med.auth.gr    Sub-Investigator: Eirini Papadopoulou          Sub-Investigator: Athanasios Binas          Sub-Investigator: Alexia Piperidou          Papageorgiou Hospital Recruiting Thessaloniki, Greece, 56429 Contact: Glyceria Tzatzagou    2313323165    tzatzagougl@hotmail.gr    Sub-Investigator: Despoina Kosmidou          Sub-Investigator: Eleonora Kella Less <<
NCT01892969 - Unknown September 2017 -
NCT00973076 Cancer Solid ... More >>Tumors Advanced Solid Malignancies Less << Phase 1 Completed - Japan ... More >> Research Site Tokyo, Japan Less <<
NCT00933972 Diabetes Mellitus Type 2 Phase 1 Completed - United States, Washington ... More >> Renton, Washington, United States, 98055 Russian Federation Moscow, Russian Federation, 115419 Less <<
NCT01621516 - Completed - -
NCT03459079 Nonalcoholic Fatty Liver Disea... More >>se (NAFLD) Type 2 Diabetes (T2DM) Less << Phase 2 Recruiting March 2020 United States, Florida ... More >> University of Florida Recruiting Gainesville, Florida, United States, 32610 Contact: Danielle Poulton    352-294-4895    Danielle.Poulton@medicine.ufl.edu    Contact: Amanda Slater    352-294-4896    amanda.slater@medicine.ufl.edu    Sub-Investigator: Fernando Bril, MD          Sub-Investigator: Diana Barb, MD          Sub-Investigator: Troy Donahoo, MD          Sub-Investigator: Julio Leey, MD Less <<
NCT00934765 - Unknown - Norway ... More >> Oslo University College Recruiting Oslo, Norway, N-0130 Contact: Trine B. Haugen, PhD    +47 45 3023    Trine.B.Haugen@hioa.no    Contact: Oliwia Witczak, PhD    +47 67236277    Oliwia.Witczak@hioa.no    Principal Investigator: Oliwia Witczak, PhD Less <<
NCT03166540 Diet Modification ... More >> Cardiovascular Risk Factor Nutritional and Metabolic Diseases Less << Not Applicable Completed - Italy ... More >> Department of Food and Drug, University of Parma Parma, Italy, 43125 Less <<
NCT03583437 NAFLD - Nonalcoholic Fatty Liv... More >>er Disease Less << Not Applicable Recruiting May 2021 Denmark ... More >> Department of Diabetes and Hormone diseases in Aarhus University Hopital Recruiting Skejby, Aarhus N, Denmark, 8200 Contact: Jeyanthini Risikesan Less <<
NCT02380521 Type 2 Diabetes Mellitus Phase 4 Completed - Italy ... More >> University Hospital of Palermo Palermo, Italy, 90127 Less <<
NCT01067924 Type 2 Diabetes Not Applicable Completed - Canada, Alberta ... More >> University of Calgary Calgary, Alberta, Canada Less <<
NCT03678727 - Not yet recruiting May 1, 2021 -
NCT00481598 Type 1 Diabetes Mellitus Not Applicable Completed - Austria ... More >> Landsteiner Institute for Endocrinology and Metabolic Diseases, Hanusch Hospital Heinrich Collin Straße 30 Vienna, Austria, 1140 Less <<
NCT03025451 Cardiovascular Diseases ... More >> Diabetes Mellitus Hypertension Dyslipidemias Overweight and Obesity Less << Not Applicable Completed - United States, Ohio ... More >> Ohio University Athens, Ohio, United States, 45701 Less <<
NCT00110422 Metabolic Syndrome ... More >> Hypertension Less << Phase 4 Completed - France ... More >> Local Institution Angers, France Local Institution Nantes, France Local Institution Tierce, France Germany Local Institution Hannover, Germany Local Institution Muenchen, Germany Local Institution Ornbau, Germany Local Institution Rotenburg An De Fluda, Germany Local Institution Tuebingen, Germany Local Institution Villingen-Schwenningen, Germany Italy Local Institution Ancona, Italy Local Institution Chieti Scalo, Italy Local Institution Pisa, Italy Local Institution Ravenna, Italy Local Institution Sassari, Italy Norway Local Institution Oslo, Norway Local Institution Snaroya, Norway Russian Federation Local Institution Moscow, Russian Federation Local Institution Saratov, Russian Federation Local Institution St. Petersburg, Russian Federation Local Institution Yaroslavl, Russian Federation Spain Local Institution A Coruna, Spain Local Institution Barcelona, Spain Local Institution Granada, Spain Local Institution Sevilla, Spain Local Institution Zaragoza, Spain Less <<
NCT01619592 Diabetes Not Applicable Completed - Belgium ... More >> Ghent University Hospital Ghent, Belgium, 9000 AZ Nikolaas: Department of Endocrinology Sint-Niklaas, Belgium, 9100 Less <<
NCT01068197 Obesity Type ... More >>2 Diabetes Mellitus Less << Phase 2 Phase 3 Completed - United States, District of Col... More >>umbia Children's National Medical Center Washington, District of Columbia, United States, 20010 Less <<
NCT00065130 Diabetes Gest... More >>ational Diabetes Less << Phase 3 Completed - United States, California ... More >> Novo Nordisk Investigational Site Santa Barbara, California, United States, 93105 Less <<
NCT03729479 Type2 Diabetes Mellitus ... More >> Hypertension PreDiabetes Overweight and Obesity Less << Phase 1 Phase 2 Recruiting March 1, 2020 United States, Michigan ... More >> University of Michigan Recruiting Ann Arbor, Michigan, United States, 48109 Contact: Caitlyn Trussell    734-763-4571    trusselc@umich.edu Less <<
NCT01594489 Acute Kidney Injury Phase 4 Completed - Italy ... More >> Ospedale Misericordia e Dolce Prato, Italy, 59100 Less <<
NCT01964950 - Completed - Japan ... More >> Tokyo, Japan Less <<
NCT00145288 - Unknown - Denmark ... More >> Department of Endocrinology, Odense University Hospital Odense, Funen, Denmark, 5000 Less <<
NCT02664428 Hypercholesterolemia Not Applicable Completed - Italy ... More >> Casa di Cura Eremo Arco, Trento, Italy, 38062 Centro Ricerca Innovazione Fondazione Edmund Mach San Michele all'Adige, Trento, Italy, 38010 Less <<
NCT00241683 - Completed - -
NCT00247403 Intracranial Neoplasms ... More >> Neoplasm Metastasis Less << Phase 1 Withdrawn(Pharmaceutical compa... More >>ny no longer manufactures drug) Less << June 2008 United States, Iowa ... More >> University of Iowa Hospitals and Clinics Iowa City, Iowa, United States, 52242 Less <<
NCT01964950 - Completed - -
NCT00621205 Insulin Resistance ... More >> Metabolic Syndrome Less << Not Applicable Completed - Finland ... More >> University of Kuopio, School of Public Health and Clinical Nutrition, Department of Clinical Nutrition and Food and Health Research Centre Kuopio, Finland, FI-70211 Less <<
NCT03627104 Obesity Insul... More >>in Resistance Less << Not Applicable Recruiting May 1, 2020 Mexico ... More >> Martha Guevara Cruz Recruiting Mexico City, Mexico, 14060 Contact: Martha Guevara Cruz, Dr Less <<
NCT02235519 Hypertension ... More >>Obesity Type 2 Diabetes Mellitus Less << Phase 2 Phase 3 Unknown June 2015 Mexico ... More >> Hospital General de Mexico "Dr. Eduardo Liceaga" Recruiting Mexico, Mexico, D.F., Mexico, 06720 Contact: Juan A Peralta, bachelor Less <<
NCT01617642 - Not yet recruiting December 2021 Norway ... More >> Nordlandssykehuset HF Not yet recruiting Bodø, Nordland, Norway, N-8092 Contact: Ole L Brekke, MD, PhD    +47 75578365    ole.lars.brekke@nlsh.no    Principal Investigator: Ole L Brekke, MD, PhD          Sub-Investigator: Elin Storjord, MD          Sub-Investigator: Tom E Mollnes, MD, PhD Less <<
NCT00262964 Non-alcoholic Fatty Liver Dise... More >>ase Less << Not Applicable Completed - United States, Missouri ... More >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Less <<
NCT01757587 Type 2 Diabetes Phase 4 Completed - France ... More >> CH Sud Francilien Evry, France, 91000 Less <<
NCT02417090 - Enrolling by invitation December 2019 -
NCT01061216 Diabetes Mellitus, Type 1 ... More >> Diabetes Mellitus, Type 2 Less << Phase 1 Phase 2 Completed - Germany ... More >> Profil Institut für Stoffwechselforschung GmbH Neuss, Germany, D-41460 Less <<
NCT00262964 - Completed - -
NCT02250677 - Completed - Denmark ... More >> University of Copenhagen Copenhagen, Denmark, 2200 Less <<
NCT03139890 Dietary Fats ... More >>Carbohydrates Proteins Macronutrients Vascular Function Postprandial Metabolism Less << Not Applicable Completed - Netherlands ... More >> Maastricht University Medical Center Maastricht, Netherlands Less <<
NCT03704103 Type 2 Diabetes Mellitus Not Applicable Recruiting March 2019 United States, Kansas ... More >> University of Kansas Medical Center Recruiting Kansas City, Kansas, United States, 66160 Contact: Teri Lavenbarg, APRN       tlavenbarg@kumc.edu    Contact: Kristin Grdinovac, MD          Principal Investigator: David Robbins, MD Less <<
NCT03640767 Message-based Rehabilitation f... More >>or Peripheral Artery Disease Patients Less << Not Applicable Not yet recruiting June 30, 2020 Hong Kong ... More >> Choy Hau Kim Hong Kong, HK, Hong Kong, HK Less <<
NCT01453842 Type 2 Diabetes Mellitus Early Phase 1 Completed - Denmark ... More >> Department of Clinical Physiology Glostrup, Denmark, 2600 Less <<
NCT02412566 - - - United States, Texas ... More >> Baylor College of Medicine / Texas Children's Hospital Houston, Texas, United States, 77030 Contact: Muralidhar H. Premkumar, MD    832-826-7980    premkuma@bcm.edu    Sub-Investigator: Amy Hair, MD          Principal Investigator: Murali Premkumar, MD Less <<
NCT01105858 - Suspended - United States, Arizona ... More >> NIDDK, Phoenix Phoenix, Arizona, United States, 85014 Less <<
NCT01140542 Diabetes Mellitus Type 2 Phase 2 Completed - -
NCT03369912 HCMV Infection Phase 2 Withdrawn(Company decision to ... More >>withdraw before study started) Less << November 15, 2022 -
NCT00236886 Epilepsy Epil... More >>epsies, Partial Epilepsy, Generalized Seizures Less << Phase 3 Completed - -
NCT01846130 Bed Rest Not Applicable Unknown - United States, Texas ... More >> Unversity of Texas Medical Branch Recruiting Galveston, Texas, United States, 77555 Principal Investigator: Douglas Paddon-Jones, Ph.D. Less <<
NCT01177150 Healthy Phase 1 Completed - -
NCT01815112 Alzheimer Disease ... More >> Mild Cognitive Impairment Vascular Dementia Less << Not Applicable Terminated(Administrative re-o... More >>rganization of the department. Referent physician left the hospital.) Less << - France ... More >> CHU Rouen Rouen, Haute Normandie, France, 76000 CHU Amiens Amiens, Picardie, France, 80054 Less <<
NCT02980627 Type 1 Diabetes Mellitus ... More >> Eating Disorders Less << Not Applicable Active, not recruiting June 2019 United States, North Carolina ... More >> Duke University Health System Durham, North Carolina, United States, 27710 Duke University Medical Center Durham, North Carolina, United States, 27713 Less <<
NCT02703350 Diabetes Mellitus, Type 1 Phase 1 Completed - Germany ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician. Mainz, Germany Less <<
NCT01920802 Healthy Phase 4 Completed - United States, New York ... More >> New York State Psychiatric Institute New York, New York, United States, 10032 Less <<
NCT01795638 Prematurity Phase 4 Terminated(The unit's standard... More >> nutrition practices change which impacted our methodology.) Less << - United States, Ohio ... More >> University of Cincinnati Medical Center Cincinnati, Ohio, United States, 45229 Less <<
NCT00315354 Obesity Insul... More >>in Resistance Less << Not Applicable Completed - United States, Massachusetts ... More >> Children's Hospital Boston Boston, Massachusetts, United States, 02115 Less <<
NCT03126084 Inguinal Hernia ... More >> Postoperative Pain Less << Phase 4 Completed - Turkey ... More >> Izmir Bozyaka Training and Research Hospital Izmir, Turkey, 35170 Less <<
NCT01920802 - Completed - -
NCT02450097 Obesity Diabe... More >>tes Type 2 Less << Not Applicable Completed - Sweden ... More >> Karolinska University Hospital Stockholm, Sweden, 17176 Less <<
NCT00916513 - Completed - -
NCT01203852 Hypertension Phase 4 Completed - United States, Florida ... More >> University of Florida Gainesville, Florida, United States, 32610 United States, Georgia Emory University School of Medicine Atlanta, Georgia, United States, 30322 United States, Minnesota Mayo Clinic, Division of Hypertension Rochester, Minnesota, United States, 55905 Less <<
NCT00237549 Type 2 Diabetes Not Applicable Completed - Denmark ... More >> Institute of Public Health Aarhus, Denmark, 8000 Netherlands Julius Centre for health Sciences and Primary Care, University of Utrecht Utrecht, Netherlands United Kingdom Department of Public Health and general Practice Cambridge, United Kingdom, UK CB2 2SR University Hospital and Department of Health Sciences, University of Leicster Leicester, United Kingdom Less <<
NCT00145353 Type 1 Diabetes Mellitus Phase 4 Unknown - Denmark ... More >> Diabetes Research Center Odense, Funen, Denmark, 5000 Less <<
NCT00898950 Diabetes Type 2 Not Applicable Completed - United Kingdom ... More >> School of Pharmacy and Biomedical Sciences, University of Posrtmouth Portsmouth, Hampshire, United Kingdom, PO1 2DT Diabetes Centre, Queen Alexandra Hospital, Portsmouth Hospitals NHS Trust Portsmouth, Hampshire, United Kingdom, PO6 3LY Less <<
NCT01233726 - Completed - -
NCT00655863 Diabetes Mellitus Phase 3 Completed - Netherlands ... More >> Amsterdam, Netherlands Sweden Gothenburg, Sweden Less <<
NCT01233726 Critical Illness ... More >> Hyperglycemia Dietary Modification Metabolic Stress Hyperglycemia Mechanical Ventilation Complication Less << Not Applicable Completed - Spain ... More >> Intensive Care Unit. Hospital Universitario 12 de Octubre Madrid, Spain Intensive Care Unit. Hospital Clinico Universitario de Valencia Valencia, Spain Less <<
NCT01326026 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT01326026 - Completed - -
NCT02664441 Hypothalamic Obesity Phase 3 Recruiting December 2019 United States, Minnesota ... More >> Children's Hospitals adn Clinics of Minnesota Recruiting Minneapolis, Minnesota, United States, 55404 Contact: Brittany Machus, MA       Brittany.Machus@childrensmn.org    Principal Investigator: Jennifer Abuzzahab, MD          United States, Tennessee Vanderbilt University School of Medicine Recruiting Nashville, Tennessee, United States, 37235 Contact: Jennifer Leshko, RN, BSN    615-875-7803    jenny.leshko@vanderbilt.edu    Principal Investigator: Ashley Shoemaker, MD          United States, Washington Seattle Childrens Recruiting Seattle, Washington, United States, 98105 Contact: Sue Kearns, RN    206-987-1758    sue.kearns@seattlechildrens.org    Principal Investigator: Christian Roth, MD Less <<
NCT02946541 Type 2 Diabetes Mellitus Phase 3 Completed - Korea, Republic of ... More >> Kangdong Sacred Heart Hospital Seoul, Korea, Republic of, 134-701 Less <<
NCT01496339 Type 1 Diabetes Mellitus Phase 1 Phase 2 Unknown May 2014 China, Zhejiang ... More >> The First Affiliated Hospital of Zhejiang University Recruiting Hangzhou, Zhejiang, China, 310003 Contact: Chengjiang Li, MD          Principal Investigator: Charlie Xiang, Professor Less <<
NCT00655863 - Completed - -
NCT01453166 - Completed - -
NCT01785004 Adiposity Not Applicable Enrolling by invitation July 2020 United States, Massachusetts ... More >> Brigham and Women's Hospital Boston, Massachusetts, United States, 02215 Less <<
NCT00594698 Coronary Artery Disease Phase 2 Phase 3 Completed - -
NCT01453166 Cardiovascular Diseases Not Applicable Completed - Brazil ... More >> Hospital do Coracao Sao Paulo, Brazil, 04005000 Less <<
NCT02084251 Type II Diabetes Phase 1 Completed - China, Beijing ... More >> Peking University First Hospital Beijing, Beijing, China, 100000 Less <<
NCT01365507 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT01203852 - Completed - -
NCT01364428 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT01365507 - Completed - -
NCT01364428 - Completed - -
NCT03675529 Prostate Cancer Not Applicable Not yet recruiting December 2019 Denmark ... More >> Center for Physical Activity Research, Copenhagen University Hospital Copenhagen, Denmark, DK-2100 Less <<
NCT02129985 Type 2 Diabetes Phase 4 Unknown September 2015 China, Shanghai ... More >> Xiaolong Zhao Recruiting Jingan, Shanghai, China, 20041 Contact: xiaolong zhao, MD.    86-18918067241    xiaolongzhao@163.com    Principal Investigator: xiaolong zhao, MD. Less <<
NCT00833365 - Terminated(Study drug not avai... More >>lable) Less << - -
NCT03195153 Diabetes Mellitus Type 2 Plate... More >>lets Reactivity Statin Less << Phase 4 Recruiting July 15, 2017 Italy ... More >> Policlinico Umberto I Recruiting Rome, Roma, Italy, 00155 Contact: MARINA MD POLACCO    3333347960    POLAMARI@LIBERO.IT Less <<
NCT01124487 Lipid Profile Not Applicable Completed - Malaysia ... More >> Malaysian Palm Oil Board Kajang, Selangor, Malaysia, 43000 Less <<
NCT03416439 Lifestyle Intervention Phase 3 Completed - -
NCT01473147 Type 2 Diabetes Mellitus Not Applicable Completed - Taiwan ... More >> Chang Gung Memorial Hospital Taoyuan, Taiwan, 333 Less <<
NCT00833365 Patent Ductus Arteriosus ... More >> Prematurity Less << Not Applicable Terminated(Study drug not avai... More >>lable) Less << - United States, Utah ... More >> University of Utah Salt Lake City, Utah, United States, 84132 Less <<
NCT02420470 - Recruiting December 2018 China, Shaanxi ... More >> Tangdu Hospital Recruiting Xi'an, Shaanxi, China, 710032 Contact: Ying Yu, master    029-18191260958    yqlmn@126.com Less <<
NCT01519505 Type 2 Diabetes Mellitus Not Applicable Unknown March 2012 Spain ... More >> IDIAP Jordi Gol Barcelona, Spain Less <<
NCT01888939 Healthy Volunteer Phase 1 Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT01608191 Obesity Weigh... More >>t Loss Less << Not Applicable Completed - Sweden ... More >> Orebro County Council Orebro, Sweden, 70185 Less <<
NCT03117517 Polycystic Ovarian Syndrome Early Phase 1 Completed - Pakistan ... More >> Mardan Medical Complex Mardan, Khyber Pukhtunkhwah, Pakistan, 25000 Less <<
NCT01768611 - Completed - Brazil ... More >> Faculdade de Medicina da USP São Paulo, SP, Brazil, 01246-000 Less <<
NCT00624767 Diabetes Mellitus Phase 2 Completed - United States, Texas ... More >> Diabetes and Glandular Disease Research Associates San Antonio, Texas, United States, 78258 Less <<
NCT01360697 Diabetes Not Applicable Unknown December 2015 China ... More >> Chinese Medicine Hospital of Anhui Province Anhui, China Third People's Hospital of Hefei City Hefei, China HuaiAn Second People's Hospital HuaiAn, China Jiangsu Province Official Hospital Jiangsu, China Rehab Hosp of Zhenjiang, Jiangsu Province Jiangsu, China The Affiliated Hosp of Jiangsu-Nantong U Jiangsu, China First People's Hospital of Kunshan City Kunshan, China Second Affiliated Hospital of Suzhou University Suzhou, China Less <<
NCT01455441 Type 2 Diabetes Phase 4 Completed - Denmark ... More >> Department of Internal Medicine, Gentofte Hospital Hellerup, Denmark, 2900 Less <<
NCT03508635 Healthy Phase 1 Completed - United Kingdom ... More >> Quotient Clinical Nottingham, Nottinghamshire, United Kingdom, NG11 6JS Less <<
NCT01716819 Obesity, Abdominal Not Applicable Completed - France ... More >> CIC-P - INSERM - Institut Lorrain du Cœur et des vaisseaux Vandoeuvre Lès Nancy, Meurthe et Moselle, France, 54500 Less <<
NCT01625026 Obesity Galls... More >>tones Less << Phase 2 Completed - Sweden ... More >> Hanns-Ulrich Marschall Göteborg, Sweden, 411 31 Less <<
NCT03613727 Hodgkin Lymphoma ... More >> Lymphoid Leukemia Multiple Myeloma Myeloid Leukemia Monocytic Leukemia Non Hodgkin Lymphoma Myelodysplasia Less << Phase 2 Recruiting October 31, 2022 United States, Virginia ... More >> Virginia Commonwealth University/ Massey Cancer Center Recruiting Richmond, Virginia, United States, 23298 Contact: Catherine Roberts, PhD    804-828-1292    croberts2@vcu.edu    Contact: Gary L Simmons, DO    804-827-7952    gary.simmons@vcuhealth.org Less <<
NCT01446276 Obesity Nonal... More >>coholic Fatty Liver Disease Less << Not Applicable Completed - Denmark ... More >> Department of Endocrinology and Internal Medicine Aarhus C, Denmark, 8000 Less <<
NCT02745210 Traumatic Brain Injury Not Applicable Enrolling by invitation January 2020 -
NCT00711126 Pulmonary Disease, Chronic Obs... More >>tructive Less << Phase 1 Completed - United Kingdom ... More >> GSK Investigational Site London, United Kingdom, NW10 7NS Less <<
NCT00015626 Insulin Resistance ... More >> Diabetes Mellitus Less << Phase 2 Completed - United States, New York ... More >> Cornell University New York, New York, United States, 10021 Less <<
NCT00611117 Healthy Not Applicable Active, not recruiting June 2020 United States, Louisiana ... More >> Pennington Biomedical Research Center Baton Rouge, Louisiana, United States, 70808 Less <<
NCT02458495 Diabetes Mellitus, Type 2 Not Applicable Completed - United States, Tennessee ... More >> Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232 Less <<
NCT01882257 Obstructive Sleep Apnea ... More >> Hypercapnia Spinal Cord Injury Less << Not Applicable Completed - United States, Michigan ... More >> University of Michigan Health System Ann Arbor, Michigan, United States, 48109 Less <<
NCT01948986 Renal Impairment ... More >> Type 2 Diabetes Mellitus Less << Phase 1 Completed - -
NCT01592279 Uncontrolled Type 1 Diabetic P... More >>atients Less << Phase 4 Unknown - -
NCT00707954 - Completed - -
NCT01882257 - Completed - -
NCT00437554 Diabetes Mellitus, Type 2 Phase 3 Completed - Korea, Republic of ... More >> Handok Seoul, Korea, Republic of Less <<
NCT01902316 - Completed - -
NCT02502253 Mild Cognitive Impairment ... More >> Alzheimer's Disease Less << Phase 1 Recruiting October 2019 United States, Maryland ... More >> Johns Hopkins University Recruiting Baltimore, Maryland, United States, 21224 Contact: Sarah Lawrence, MS    410-550-9020       Contact: Meghan Schultz, MSN    410-550-4258 Less <<
NCT00679679 Polycystic Ovary Syndrome Phase 4 Completed - Argentina ... More >> Hospital Privado de Córdoba Cordoba, Argentina, X5016KEH Less <<
NCT00618007 Diabetes Mellitus, Type 2 Phase 2 Completed - -
NCT00707954 Type 2 Diabetes Mellitus Phase 1 Phase 2 Completed - Japan ... More >> P-One Clinic Hachioji-city, Tokyo-to, Japan Less <<
NCT01164878 - Completed - -
NCT03208309 Complications of Diabetes Mell... More >>itus Diabetes Mellitus Diabetes Mellitus, Type 2 Less << Phase 2 Completed - Brazil ... More >> Universidade Estadual de Feira de Santana Feira de Santana, Bahia, Brazil Centro de Estudos em Diabetes e Hipertensão Fortaleza, Ceará, Brazil Universidade Estadual de Campinas Campinas, São Paulo, Brazil Less <<
NCT01748110 Prostate Cancer ... More >> Erectile Dysfunction Following Radical Prostatectomy Urinary Incontinence Less << Not Applicable Withdrawn(Funding could not be... More >> secured) Less << - United States, Maryland ... More >> Johns Hopkins Hospital Baltimore, Maryland, United States, 21287 Less <<
NCT03561597 Adolescent Obesity Not Applicable Recruiting October 2019 Singapore ... More >> KKWCH Recruiting Singapore, Singapore Contact: Chuan Ping Foo Less <<
NCT03727321 Obesity Metab... More >>olic Syndrome Less << Phase 2 Recruiting March 1, 2021 Canada, Alberta ... More >> Royal Alexandra Hospital Recruiting Edmonton, Alberta, Canada, T5H 3V9 Contact: Valentin Mocanu, MD    7809097109    vmocanu1987@gmail.com    Contact: Karen Madsen, PhD    7804925257    kmadsen@ualberta.ca    University of Alberta Hospital Recruiting Edmonton, Alberta, Canada, T6G 2B7 Contact: Valentin Mocanu, MD    7809097109    vmocanu1987@gmail.com    Contact: Karen Madsen, PhD    7804925257    kmadsen@ualberta.ca    Principal Investigator: Karen Madsen, PhD          Sub-Investigator: Valentin Mocanu, MD Less <<
NCT02371187 Physical Activity Phase 2 Completed - United States, Colorado ... More >> Colorado State University, Dept. of Health and Exercise Science Fort Collins, Colorado, United States, 80523-1582 Less <<
NCT01877603 - Completed - China, Hubei ... More >> Wuhan General Hospital Wuhan, Hubei, China, 430070 Less <<
NCT02229240 Diabetes Mellitus, Type 2 Phase 3 Withdrawn(Study was cancelled ... More >>prior to enrolling any patients) Less << December 2015 -
NCT03736668 Type2 Diabetes Not Applicable Recruiting November 30, 2021 France ... More >> Groupe Hospitalier Paris Saint-Joseph Recruiting Paris, France, 75014 Contact: Helene BEAUSSIER, PhD, PharmD    144127038    crc@hpsj.fr Less <<
NCT02095418 Diabetes Not Applicable Unknown February 2018 Korea, Republic of ... More >> Daegu Catholic University Medical Center Not yet recruiting Daegu, Korea, Republic of Contact: Dongrak Choi, M.D., Ph.D.    82-10-9041-0742    dnchoi@cu.ac.kr    Samsung Medical Center Recruiting Seoul, Korea, Republic of, 135-710 Contact: Jae Won Joh, M.D., Ph.D.    82 2 1599 3114    jw.joh@Samsung.com    National Cancer Center Not yet recruiting Seoul, Korea, Republic of Contact: Seoung Hoon Kim, M.D., Ph.D.    82-10-2907-3766    kshlj@hanmail.net    Seoul National University Not yet recruiting Seoul, Korea, Republic of Contact: Kwang-Woong Lee, M.D., Ph.D.    82-2-2072-2511    kwleegs@gmail.com    Ajou University Hospital Not yet recruiting Suwon, Korea, Republic of Contact: Hee-Jung Wang, M.D., Ph.D.    82-31-219-5204    wanghj@ajou.ac.kr Less <<
NCT02058147 Type 2 Diabetes Phase 3 Completed - -
NCT00064714 Diabetes Mellitus Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00575874 Type 2 Diabetes Phase 2 Completed - China ... More >> Hong Kong, China Less <<
NCT00929890 Obesity Not Applicable Unknown March 2012 Brazil ... More >> Hospital de Clínicas de Porto Alegre Porto Alegre, RS, Brazil, 90035-903 Less <<
NCT00046150 Diabetes, Type I Phase 3 Completed - France ... More >> Hospital de Rangueil Toulouse, France, 31403 Germany Sanofi-aventis Administrative Office Berlin, Germany Netherlands Sanofi-aventis Administrative Office Gouda, Netherlands Less <<
NCT01719406 Gestational Diabetes Not Applicable Completed - United States, Oregon ... More >> Oregon Health & Science University Portland, Oregon, United States, 97239 Less <<
NCT03656367 Lipaemia Not Applicable Recruiting June 2019 Denmark ... More >> Department of Nutrition, Exercise and Sports Recruiting Frederiksberg, Denmark, 1958 Contact: Anne Raben, Professor          Contact: Louise Kjølbæk, postdoc Less <<
NCT01729117 Type 2 Diabetes ... More >> Obesity Less << Not Applicable Completed - United States, California ... More >> Roybal Diabetes Management Clinic Los Angeles, California, United States, 90022 Less <<
NCT03442257 Hypertension ... More >>Cardiovascular Risk Factor Less << Not Applicable Recruiting December 2018 Sweden ... More >> Lomma vårdcentral Recruiting Lomma, Skåne, Sweden, 23434 Contact: Susanna Calling       susanna.calling@med.lu.se    Löddeköpinge vårdcentral Recruiting Löddeköpinge, Skåne, Sweden, 24630 Contact: Moa Wolff       moa.wolff@med.lu.se    Sorgenfri vårdcentral Recruiting Malmö, Skåne, Sweden, 214 33 Contact: Beata B Bolmsjö       beata.borgström_bolmsjo@med.lu.se Less <<
NCT02451137 Diabetes Mellitus, Type 2 Phase 4 Completed - -
NCT02058147 - Completed - -
NCT02000700 Diabetes Mellitus, Type 2 Phase 1 Completed - United States, Arkansas ... More >> Little Rock, Arkansas, United States United States, California Los Angeles, California, United States United States, Colorado Aurora, Colorado, United States United States, Connecticut New Haven, Connecticut, United States United States, Florida Jacksonville, Florida, United States United States, Indiana Indianapolis, Indiana, United States United States, Kansas Lenexa, Kansas, United States United States, Maryland Baltimore, Maryland, United States United States, Missouri Kansas City, Missouri, United States United States, Ohio Toledo, Ohio, United States United States, Pennsylvania Pittsburgh, Pennsylvania, United States United States, Texas Houston, Texas, United States United States, Utah Salt Lake City, Utah, United States Brazil Campinas, Brazil Curitiba, Brazil Ribeirão Preto, Brazil Sao Paulo, Brazil Less <<
NCT01041677 Obesity Nutri... More >>tional and Metabolic Diseases Metabolic Diseases Nutrition Disorders Overweight Less << Phase 2 Completed - Finland ... More >> Helsinki, Finland Netherlands Zuidlaren, Netherlands Sweden Göteborg, Sweden Less <<
NCT02811575 - Recruiting December 2019 France ... More >> CHU de Toulouse Recruiting Toulouse, France, 31059 Contact: Pierre Gourdy Less <<
NCT00556465 Diabetic Nephropathy ... More >> Chronic Kidney Disease Diabetes Type 2 Less << Phase 2 Phase 3 Completed - Iran, Islamic Republic of ... More >> Mohammad mahdi sagheb Shiraz, Fars, Iran, Islamic Republic of, 0098711 Less <<
NCT01070810 Septic Shock Phase 1 Phase 2 Completed - United States, Massachusetts ... More >> Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Less <<
NCT01070810 - Completed - -
NCT01223560 Type 1 Diabetes Not Applicable Completed - Denmark ... More >> Hvidovre University Hospital Hvidovre, Denmark, 2650 Less <<
NCT03390959 Diabetes Mellitus, Type 2 Not Applicable Recruiting March 30, 2018 Brazil ... More >> Maria das Graças Araujo Recruiting Recife, Pernambuco, Brazil, 50670-901 Less <<
NCT01298375 - Unknown March 2013 Netherlands ... More >> Maastricht University Recruiting Maastricht, Limburg, Netherlands, 6200MD Contact: Madeleen Bosma, M.S.    31433884254    m.bosma@maastrichtuniversity.nl    Principal Investigator: Lauren M Sparks, PhD          Principal Investigator: Madeleen Bosma, M.S.          Sub-Investigator: Vera Schrauwen-Hindeling, PhD Less <<
NCT00599365 Chronic Kidney Disease Not Applicable Unknown December 2009 United States, California ... More >> VA Medical Center San Francisco Recruiting San Francisco, California, United States, 94121 Principal Investigator: Nelson Chee, Pharm.D          Sub-Investigator: Jenin Lee, Pharm.D          Sub-Investigator: Audrey Lee, Pharm.D          Sub-Investigator: Kristen Johansen, MD          Sub-Investigator: Philip Chiao, Pharm.D          Sub-Investigator: David Lovett, MD Less <<
NCT02836691 Asthma Not Applicable Unknown December 2017 Spain ... More >> Lorena Soto-Retes Recruiting Barcelona, Spain, 08025 Contact: Lorena Soto-Retes, physician    +34 93 556 59 72    lsoto@santpau.cat    Contact: Vicente Plaza, physician    +34 93 556 59 72    vplaza@santpau.cat    Principal Investigator: Vicente Plaza, physician          Principal Investigator: Lorena Soto-Retes, physician          Sub-Investigator: Jordi Giner, technician          Sub-Investigator: Raquel Bailón, engineer          Sub-Investigator: Jesús Lazaro, engineer          Sub-Investigator: Eduardo Gil, engineer Less <<
NCT02224365 Diabetes Card... More >>iovascular Diseases Prediabetes Less << Phase 2 Completed - United States, Florida ... More >> Department of Nutrition, Food and Exercise Sciences, Center for Advancing Exercise and Nutrition Research on Aging, Florida State University Tallahassee, Florida, United States, 32306 Less <<
NCT02066831 Type 2 Diabetes Mellitus Not Applicable Completed - Germany ... More >> West-German Center of Diabetes and Health Düsseldorf, Germany, 40591 Less <<
NCT01495013 Diabetes Mellitus, Type 2 Phase 3 Completed - Korea, Republic of ... More >> GSK Investigational Site Bucheon, Korea, Republic of, 134 727 GSK Investigational Site Busan, Korea, Republic of, 602-739 GSK Investigational Site Kangwondo, Korea, Republic of, 220-701 GSK Investigational Site Seocho-ku, Seoul, Korea, Republic of, 137-701 GSK Investigational Site Seongnam-si Gyeonggi-do, Korea, Republic of, 463-707 GSK Investigational Site Seoul, Korea, Republic of, 110-744 GSK Investigational Site Seoul, Korea, Republic of, 110-746 GSK Investigational Site Seoul, Korea, Republic of, 135-710 GSK Investigational Site Seoul, Korea, Republic of, 138-736 GSK Investigational Site Seoul, Korea, Republic of, 139-872 GSK Investigational Site Seoul, Korea, Republic of, 152-703 GSK Investigational Site Suwon, Korea, Republic of, 463442 Malaysia GSK Investigational Site Ipoh, Malaysia, 30450 GSK Investigational Site Johor Bahru, Malaysia, 80100 GSK Investigational Site Kuala Lumpur, Malaysia, 59100 GSK Investigational Site Kubang Kerian, Malaysia, 16150 Mexico GSK Investigational Site Cuernavaca, Mexico, 62250 GSK Investigational Site Del. Cuauhtémoc, Mexico, 06700 GSK Investigational Site Gadalajara, Jalisco, Mexico, C.P. 44130 GSK Investigational Site Guadalajara Jalisco, Mexico, C.P. 44210 GSK Investigational Site Mexico City, Mexico, 06700 GSK Investigational Site Mexico, D.F., Mexico, 11650 Philippines GSK Investigational Site Cebu City, Philippines, 6000 GSK Investigational Site Davao City, Philippines, 8000 GSK Investigational Site Manila, Philippines, 1008 GSK Investigational Site Pasig City, Philippines, 1600 GSK Investigational Site Sta. Cruz, Manila, Philippines, 1012 Russian Federation GSK Investigational Site Moscow, Russian Federation, 109240 GSK Investigational Site Saratov, Russian Federation, 410054 GSK Investigational Site St. Petersburg, Russian Federation, 191119 Thailand GSK Investigational Site Chiangrai, Thailand, 57000 GSK Investigational Site Nakhon Ratchasima, Thailand, 30000 GSK Investigational Site Rajathevee, Thailand, 10400 Less <<
NCT03078101 Diabetic Kidney Disease ... More >> Diabetes Mellitus, Type 2 Chronic Kidney Disease stage3 Chronic Kidney Disease stage4 Less << Phase 2 Recruiting August 2019 Austria ... More >> Department of Internal Medicine III, Division of Nephrology and Dialysis, Medical University of Vienna, Austria Recruiting Vienna, Austria, 1090 Contact: Manfred Hecking, MD       manfred.hecking@meduniwien.ac.at    Contact: Marlies Antlanger, MD       marlies.antlanger@meduniwien.ac.at Less <<
NCT02648555 Sterility Pla... More >>centa; Implantation Risk Reduction Behavior Lifestyle Neonatal Hypoglycemia Less << Not Applicable Unknown May 2018 Brazil ... More >> Hospital Federal dos Servidores do Estado, Ministry of Health Not yet recruiting Rio de Janeiro, RJ, Brazil, 20221-903 Contact: Silvia Hoirisch-Clapauch, MD, PhD    +55-21-99973-7500    sclapauch@ig.com.br    Principal Investigator: Silvia Hoirisch-Clapauch, MD Less <<
NCT00960674 Type 2 Diabetes Phase 3 Completed - Sweden ... More >> Center for Family and Community Medicin, KI Huddinge, Sweden, SE-14183 Less <<
NCT01666665 Insulin Resistance ... More >> Hypermetabolism Hyperglycemia Less << Phase 2 Phase 3 Recruiting August 2020 United States, Texas ... More >> Shriners Hospitals for Children Recruiting Galveston, Texas, United States, 77551 Contact: Cathy Reed, BSN    409-770-6987    ca2reed@utmb.edu    Contact: Deb Benjamin, MSN    409-770-6731    dbenjami@utmb.edu    Principal Investigator: David N Herndon, MD          Sub-Investigator: Oscar Suman, PhD Less <<
NCT00708266 Obesity Type ... More >>2 Diabetes Mellitus Less << Not Applicable Completed - Austria ... More >> Medical University Graz - Clinical Research Center Graz, Steiermark, Austria, A-8010 Less <<
NCT00494988 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 4 Completed - China ... More >> Beijing, China, 100029 Less <<
NCT03449654 Diabetes Mellitus, Type 2 Phase 4 Recruiting October 1, 2019 Denmark ... More >> Steno Diabetes Center Copenhagen Recruiting Gentofte, Denmark, 2820 Contact: Peter Rossing, MD       peter.rossing@regionh.dk    Contact: Emilie Zobel, MD       emilie.hein.zobel@regionh.dk    Principal Investigator: Peter Rossing, MD          Sub-Investigator: Emilie Zobel, MD          Sub-Investigator: Tine Willum Hansen, MD          Sub-Investigator: Viktor Rotbain Curovic Less <<
NCT03002675 Obesity Phase 4 Unknown - Netherlands ... More >> Leiden University Medical Center Recruiting Leiden, Zuid-Holland, Netherlands, 2333 ZA Contact: Ingrid Jazet, MD, PhD    +33-715268161    i.m.jazet@lumc.nl    Contact: Mariëtte Boon, PhD    +31-715265462    m.r.boon@lumc.nl Less <<
NCT00572052 Diabetes Diab... More >>etes Mellitus, Type 1 Diabetes Mellitus, Type 2 Delivery Systems Less << Phase 4 Completed - United States, California ... More >> Novo Nordisk Investigational Site Walnut Creek, California, United States, 94598 United States, New Jersey Novo Nordisk Investigational Site Berlin, New Jersey, United States, 08009 Novo Nordisk Investigational Site Lawrenceville, New Jersey, United States, 08648 United States, Ohio Novo Nordisk Investigational Site Kettering, Ohio, United States, 45429 United States, Texas Novo Nordisk Investigational Site San Antonio, Texas, United States, 78229 Less <<
NCT00473733 Diabetes Mellitus Type 2 Phase 4 Unknown - Israel ... More >> Assaf Harofeh Medical Center Not yet recruiting Zerifin, Israel, 70300 Contact: eFRAT Broide, MD    972-8-9779722    efibroide@yahoo.com    Principal Investigator: Efrat Broide, MD Less <<
NCT01800370 Healthy Phase 1 Completed - United States, Minnesota ... More >> Mayo Clinic in Rochester Rochester, Minnesota, United States, 55905 Less <<
NCT01616784 Type 1 Diabetes Phase 3 Completed - United Kingdom ... More >> Addenbrookes Wolfson Diabetes and Endocrine Clinic, Box 281, Addenbrookes Hospital, Hills Road Cambridge, Cambridgeshire, United Kingdom, CB2 0QQ Harrogate District Hospital, Diabetes Centre, Lancaster Park Road, Harrogate, North Yorkshire, United Kingdom, HG2 7SX Dumfries and Galloway Royal Infirmary, Diabetes Centre, Cluden West, Crichton Hall, Dumfries, Scotland, United Kingdom, DG1 4TG Royal Infirmary of Edinburgh, Department of Diabetes, 51 Little France Crescent Edinburgh, Scotland, United Kingdom, EH16 4SA Stobhill ACH, Diabetes Clinic, 133 Balornock Road Glasgow, Scotland, United Kingdom, G21 3UW Sheffield Teaching Hospital, Diabetes Centre, Northern General Hospital, PO Box 1, Herries Road Sheffield, South Yorkshire, United Kingdom, S5 7AU Kings College Hospital, Diabetes Centre, Suite 3, Golden Jubilee Wing, Denmark Hill London, United Kingdom, SE5 9RS Nottingham University Hospitals NHS Trust, Queens Medical Centre Campus, Derby Road Nottingham, United Kingdom, NG7 2UH Less <<
NCT02832999 Type 2 Diabetes Mellitus Phase 4 Completed - Cameroon ... More >> National Obesity Centre Yaounde, Cameroon Less <<
NCT03164187 - Completed - Azerbaijan ... More >> Azerbaijan Republic Ministry of Health Republic Endocrinology Center Baku, Azerbaijan, AZ 1/122 Azer-Turk Med clinic Baku, Azerbaijan, AZ 1025 Hospital of oil workers, polyclinics and private clinics Baku, Azerbaijan, AZ 1025 Medical Clinic of Azerbaijan Medical University Baku, Azerbaijan, AZ-1078 Less <<
NCT02702726 Glycaemic Response and Energy ... More >>Balance Less << Not Applicable Completed - Singapore ... More >> Clinical Nutrition Research Centre Singapore, Singapore, 117599 Less <<
NCT02812888 - Unknown June 2017 China, Jiangsu ... More >> The First People's Hospital of Xuzhou, Recruiting Xuzhou, Jiangsu, China, 221000 Contact: Zhen Zhongli, MD    +86 13952200973    1973324055@qq.com    Contact: Xi Jijiang, MD    +86 13814429263    549932860@qq.com Less <<
NCT00672204 - Terminated(Raptiva was withdra... More >>wn from the market) Less << - -
NCT00672204 Type 1 Diabetes Mellitus ... More >> Hypoglycemia Less << Phase 1 Phase 2 Terminated(Raptiva was withdra... More >>wn from the market) Less << - United States, Minnesota ... More >> Universtiy of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT03407118 Diabetes Mellitus, Type 1 Phase 1 Completed - Japan ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician. Fukuoka, Japan, 812-0025 Less <<
NCT00246987 Diabetes, Type 2 Phase 3 Completed - -
NCT03503019 - Enrolling by invitation December 31, 2018 -
NCT00339885 - Recruiting - Finland ... More >> Natl Inst for Health & Welfare (THL) Recruiting Helsinki, Finland Contact: Heikki Koistinen    358400416    heikki.koistinen@helsinki.fi    Research Ethics Committee of Hospital District of Northern Savo Recruiting Kuopio, Finland Contact: Markku Laasko    35840672       Norway University of Tromso Recruiting Tromso, Norway Contact: Inger Njolstad    Not Listed    Inger.Njolstad@ism.uit.no    Norwegian U of Science & Technology Recruiting Trondheim, Norway Contact: Kristian Hveem    Not Listed    kristian.hveem@ntnu.no Less <<
NCT00212914 Gestational Diabetes Not Applicable Completed - Canada, Ontario ... More >> The Ottawa Hospital, Civic Campus, High Risk Unit Ottawa, Ontario, Canada, K1Y 1J7 Less <<
NCT00368394 Diabetes Mellitus, Type I Phase 1 Completed - Germany ... More >> Sanofi-Aventis Neuss, Germany Less <<
NCT02930044 Diabetic Ketoacidosis Not Applicable Recruiting June 2019 United States, Maryland ... More >> University of Maryland Medical Center Recruiting Baltimore, Maryland, United States, 21217 Contact: George C Willis, MD    410-971-0080    gwillis@em.umaryland.edu    Contact: Linda H Barstow, PharmD    434-806-3162    LindaBarstow@umm.edu Less <<
NCT01325064 - Completed - Spain ... More >> Luis Garcia Ortiz Salamanca, Spain, 37003 Less <<
NCT03507413 Abdominal Aortic Aneurysm Phase 2 Phase 3 Not yet recruiting November 15, 2022 Austria ... More >> Medical University of Vienna, Department of Surgery, Division of Vascular Surgery Not yet recruiting Vienna, Austria, 1090 Contact: Wolf Eilenberg, MD    +43140400 ext 56200    wolf.eilenberg@meduniwien.ac.at Less <<
NCT02786823 Diabetes Mellitus, Type 2 Phase 2 Phase 3 Completed - India ... More >> All India Institute of Medical Sciences, Bhubaneswar Bhubaneswar, Odisha, India, 751019 Less <<
NCT01723748 Acromegaly Me... More >>tabolic Diseases Less << Not Applicable Completed - Denmark ... More >> Aarhus University Hospital Aarhus, Denmark, 8000 Less <<
NCT01789151 - - - Australia, New South Wales ... More >> Westmead Hospital Sydney, New South Wales, Australia, 2145 Less <<
NCT03594097 Healthy Ageing Not Applicable Recruiting December 2019 Australia, Queensland ... More >> University of Southern Queensland Not yet recruiting Toowoomba, Queensland, Australia, 4350 Contact: Sunil Panchal, PhD    +61-7-4631-1012    sunil.panchal@usq.edu.au    Principal Investigator: Sunil Panchal, PhD          Canada, Manitoba Richardson Centre for Functional Foods and Nutraceuticals, University of Manitoba Recruiting Winnipeg, Manitoba, Canada, R3T 6C5 Contact: Stephanie Jew    204-272-1549    stephanie.jew@umanitoba.ca    Principal Investigator: Peter JH Jones, PhD Less <<
NCT03031821 Prostate Cancer ... More >> Metabolic Syndrome Less << Phase 3 Not yet recruiting June 1, 2023 Canada, British Columbia ... More >> BC Cancer Agency - Vancouver Cancer Centre Not yet recruiting Vancouver, British Columbia, Canada, V5Z 4E6 Contact: Bernie Eigl, MD    604-877-6000    bernie.eigl@bccancer.bc.ca    Principal Investigator: Bernie Eigl, MD Less <<
NCT02175121 - Completed - -
NCT02175121 Diabetes Mellitus, Type II Phase 2 Completed - United States, California ... More >> Anaheim Clinical Trials, LLC Anaheim, California, United States, 92801 Profil Institute for Clinical Research, Inc. Chula Vista, California, United States, 91911 Diablo Clinical Research, Inc. Walnut Creek, California, United States, 94598 United States, Florida Avail Clinical Research, LLC DeLand, Florida, United States, 32720 SeaView Research, Inc. Miami, Florida, United States, 33125 SeaView Research, Inc. Miami, Florida, United States, 33126 Compass Research, LLC Orlando, Florida, United States, 32806 Miami Research Associates, Inc. South Miami, Florida, United States, 33143 MRA Clinical Research, LLC South Miami, Florida, United States, 33143 MRA Clinical Research South Miami, Florida, United States, 33143 United States, Kentucky Louisville Metabolic and Atherosclerosis Research Center Louisville, Kentucky, United States, 40213 United States, Minnesota DaVita Clinical Research Minneapolis, Minnesota, United States, 55404 United States, New Jersey Clinilabs, Inc. Eatontown, New Jersey, United States, 07724 PRA International Marlton, New Jersey, United States, 08053 United States, New York Buffalo Clinical Research Center, LLC Buffalo, New York, United States, 14202 United States, North Carolina High Point Clinical Trials Center, LLC High Point, North Carolina, United States, 27265 United States, Ohio Community Research Cincinnati, Ohio, United States, 45255 United States, Texas Clinical Trials of Texas, Inc. San Antonio, Texas, United States, 78229 United States, Washington Rainier Clinical Research Center, Inc. Renton, Washington, United States, 98057 Less <<
NCT00571935 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 4 Completed - Poland ... More >> Novo Nordisk Investigational Site Bialystok, Poland, 15-274 Novo Nordisk Investigational Site Gliwice, Poland, 44-100 Novo Nordisk Investigational Site Kielce, Poland, 25-734 Novo Nordisk Investigational Site Krakow, Poland, 30-663 Novo Nordisk Investigational Site Warszawa, Poland, 01-184 Less <<
NCT03179280 Type1 Diabetes Not Applicable Completed - Greece ... More >> Unit of Pediatric Endocrinology, Diabetes and Metabolism-4th Department of Pediatrics, Medical School of Aristotle University of Thessaloniki Thessaloniki, Greece, 56403 Less <<
NCT00881530 - Completed - -
NCT02518009 - Recruiting December 2021 Sweden ... More >> Karolinska Institutet Recruiting Stockholm, Sweden, 14186 Contact: Anna M Wiik, PhD    +46858586771    anna.wiik@ki.se Less <<
NCT03049631 Healthy Subjects ... More >> Pre-diabetes Less << Not Applicable Active, not recruiting August 30, 2019 United States, Illinois ... More >> Clinical Nutrition Research Center Chicago, Illinois, United States, 60616 Less <<
NCT03088501 Intervention Study Not Applicable Recruiting December 30, 2019 India ... More >> Sri rampura Referral Hospital Recruiting Bengaluru, Karnataka, India, 560021 Contact: Maithili Karthik, M.Sc    9845902376    maithili.k@iiphh.org Less <<
NCT02280564 Type 1 Diabetes Not Applicable Completed - United States, Colorado ... More >> University of Colorado Barbara Davis Center for Childhood Diabetes Aurora, Colorado, United States, 80045 United States, North Carolina WakeMed Hospital Raleigh, North Carolina, United States, 27610 United States, Ohio Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45206 Less <<
NCT00881530 Diabetes Mellitus, Type 2 Phase 2 Completed - -
NCT00868673 Overweight and Obesity ... More >> Metabolic Syndrome Hyperuricemia Less << Not Applicable Completed - Mexico ... More >> Instituto Nacional de Cardiología Igancio Chávez Mexico, Mexico city, Mexico, 14080 Less <<
NCT00621868 Diabetes Mellitus Phase 2 Completed - Japan ... More >> Chubu, Japan Chugoku, Japan Hokkaidou, Japan Kansai, Japan Kantou, Japan Kyushu, Japan Shikoku, Japan Touhoku, Japan Less <<
NCT01170832 - Completed - United States, Michigan ... More >> University Of Michigan Ann Arbor, Michigan, United States, 48106 Less <<
NCT03458741 Glycogen Depletion ... More >> Insulin Sensitivity Less << Not Applicable Completed - Denmark ... More >> Department of Nutrition, Exercise and Sports Copenhagen, Capital Region, Denmark, 2100 Less <<
NCT02537145 - Terminated(Not enough obese su... More >>bjects could be recruited.) Less << - Netherlands ... More >> Spaarne Gasthuis Hoofddorp, Noord Holland, Netherlands, 2134 TM Less <<
NCT00334841 - Unknown - Israel ... More >> Hadassah Medical Organization Recruiting Jerusalem, Israel Contact: Arik Tzukert, DMD    00 972 2 6776095    arik@hadassah.org.il    Contact: Hadas Lemberg, PhD    00 972 2 6777572    lhadas@hadassah.org.il    Principal Investigator: Uriel Elchalal, Dr. Less <<
NCT02715193 Type 1 Diabetes Mellitus ... More >> Diabetes Less << Phase 1 Completed - United States, California ... More >> San Diego, California, United States United States, Missouri St. Louis, Missouri, United States Less <<
NCT00595244 Coronary Artery Disease Phase 3 Completed - United States, Arizona ... More >> Michael Morgan, MD Phoenix, Arizona, United States, 85018 United States, California Long Beach VA Medical Center Cardiology Division Long Beach, California, United States, 90822 University of California San Diego Division of Cardiology San Diego, California, United States, 92103 San Francisco VA Medical Center NCIRE San Francisco, California, United States, 94121 United States, District of Columbia Washington Hospital Center Cardiovascular Research Institute Washington, District of Columbia, United States, 20010 United States, Kansas The Center for Cardiovascular Studies Kramer & Crouse Cardiology Shawnee Mission, Kansas, United States, 66204 United States, Massachusetts New England Medical Center Boston, Massachusetts, United States, 02111 United States, Missouri St. Louis University Medical Center St. Louis, Missouri, United States, 63110 United States, Ohio The Cleveland Clinic Foundation Department of Cardiology Cleveland, Ohio, United States, 44195 United States, Oregon Oregon Health Sciences University Portland, Oregon, United States, 97239 United States, Pennsylvania University of Pittsburgh Cardiovascular Institute Pittsburgh, Pennsylvania, United States, 15213 United States, Texas University of Texas Health Sciences Center at San Antonio San Antonio, Texas, United States, 78229 United States, Washington Virginia Mason Medical Center Seattle, Washington, United States, 98101 Harborview Medical Center Department of Cardiology Seattle, Washington, United States, 98104 Northwest Cardiovascular Research Institute Spokane Cardiology Spokane, Washington, United States, 99204 Less <<
NCT00988078 Polycystic Ovary Syndrome Not Applicable Unknown December 2013 Brazil ... More >> Federal University of Sao Paulo Recruiting Sao Paulo, Brazil Contact: Margareth Iwata       megiwata@yahoo.com Less <<
NCT01237769 Metabolic Syndrome Phase 4 Unknown March 2012 Greece ... More >> Outpatient Lipid Clinic, University Hospital of Ioannina Recruiting Ioannina, Greece, 45 110 Contact: Moses Elisaf, MD    +302651007509    egepi@cc.uoi.gr    Sub-Investigator: Evangelos Liberopoulos, MD          Sub-Investigator: Stefania Makariou, MD          Sub-Investigator: Anna Challa, PhD Less <<
NCT00595673 Coronary Artery Disease Phase 3 Completed - United States, Arizona ... More >> Heartcare, P.C. Scottsdale, Arizona, United States, 85258 Mayo Clinic Scottsdale Scottsdale, Arizona, United States, 85259 United States, California University of California San Francisco San Francisco, California, United States, 94143 Stanford University Medical Center Stanford, California, United States, 94305 United States, Indiana Krannert Institute of Cardiology Indianapolis, Indiana, United States, 46202 United States, Kansas The Center for Cardiovascular Studies Kramer & Crouse Cardiology Shawnee Mission, Kansas, United States, 66204 United States, Maine Androscoggin Cardiovascular Associates Auburn, Maine, United States, 04210 Maine Cardiology Associates South Portland, Maine, United States, 04106 United States, Missouri Cardiovascular Consultants Kansas City, Missouri, United States, 64111 Washington University School of Medicine St. Louis, Missouri, United States, 63110 United States, New York St. Luke's Roosevelt Hospital Echocardiography Lab New York, New York, United States, 10025 Mount Sinai Hospital New York, New York, United States, 10029 United States, Ohio MidWest Cardiologist Research Columbus, Ohio, United States, 43214 United States, Oregon Endovascular Research, LLC Eugene, Oregon, United States, 97401 United States, Texas Austin Heart Austin, Texas, United States, 78705 Presbyterian Hospital of Dallas Dallas, Texas, United States, 75231 Methodist DeBakery Heart Center Cardiovascular Imaging Institute Houston, Texas, United States, 77030 United States, Virginia University of Virginia Health System Charlottesville, Virginia, United States, 22908 United States, Washington Inland Cardiology Spokane, Washington, United States, 99204 Less <<
NCT02010528 - Completed - Slovenia ... More >> Dept. of Pediatric Endocrinology, Diabetes & Metabolism, University Children's Hospital, UMCL Ljubljana, Slovenia, 1000 Less <<
NCT01662557 Obesity Not Applicable Completed - United States, Pennsylvania ... More >> University of Pennsylvania Center for Weight and Eating Disorders Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT02984605 Overweight Ob... More >>esity Type2 Diabetes Less << Not Applicable Not yet recruiting December 2020 -
NCT00173043 - Unknown - Taiwan ... More >> National Taiwan University Hospital Recruiting Taipei, Taiwan, 100 Contact: Chen Mei-Jou, MD    886-2-23123456 ext 3950    metro@ha.mc.ntu.edu.tw Less <<
NCT02474147 Type 2 Diabetes Not Applicable Completed - Czechia ... More >> Institute for Clinical and Experimental Medicine Prague, Czech Republic, Czechia, 14021 Less <<
NCT02761538 Over Weight Not Applicable Recruiting December 2019 France ... More >> Departement Nutrition Diabète Hôpital lapeyronie 371 avenue du Doyen Gaston Giraud Recruiting Montpellier, France, 34295 Contact: Antoine AA Avignon, PU PH    +33(0)467338402    a-avignon@chu-montpellier.fr    Montpellier University Hospital Recruiting Montpellier, France, 34295 Contact: Antoine AVIGNON, MD    04 67 33 84 06    a-avignon@chu-montpellier.fr Less <<
NCT01275040 Diabetes Not Applicable Unknown May 2012 South Africa ... More >> School of Health Systems and Public Health, University of Pretoria Pretoria, Gauteng, South Africa, 0001 Less <<
NCT00344851 Polycystic Ovary Syndrome Phase 2 Completed - United States, Louisiana ... More >> Facility: Metabolic Center of Louisiana Research Foundation Baton Rouge, Louisiana, United States, 70808 Less <<
NCT01990638 - Completed - Taiwan ... More >> National Taiwan University Hospital Taipei, Taiwan, 100 Less <<
NCT01987674 Type 2 Diabetes Mellitus Phase 1 Phase 2 Terminated(Test products expir... More >>ed.) Less << - Sweden ... More >> Lindsdals hälsocentral Kalmar, Sweden, 39365 Less <<
NCT00492661 Renal Transplantion ... More >> Kidney Transplantion Less << Phase 4 Completed - Australia ... More >> Camperdown N/A, Australia Camperdown, Australia Clayton, Australia Perth, Australia Woodville, Australia Less <<
NCT02684513 Dehydration Not Applicable Active, not recruiting December 2018 United States, Florida ... More >> UF Health Gainesville, Florida, United States, 32610-3003 Less <<
NCT01342874 - Completed - Italy ... More >> University of Chieti Chieti, CH, Italy, 66100 Less <<
NCT03093857 - Recruiting December 31, 2018 Germany ... More >> University Hospital RWTH Aachen Recruiting Aachen, NRW, Germany, 52074 Contact: Alexander GOmbert, Dr. med. Less <<
NCT00222781 - Completed - United States, Pennsylvania ... More >> University of Pittsburgh Pittsburgh, Pennsylvania, United States, 15213 Less <<
NCT02945475 - Recruiting November 2020 United States, California ... More >> Esther Jahng Recruiting Los Angeles, California, United States, 90089 Contact: Esther Jahng       ejahng@usc.edu    Contact: Ana Romero, MPH    3234422842    anaromer@usc.edu    Principal Investigator: Kathleen Page, MD Less <<
NCT01918345 Diabetes Not Applicable Recruiting March 2021 Canada, Ontario ... More >> Scarborough and Rouge Hospital Not yet recruiting Scarborough, Ontario, Canada, M1W 3W3 Contact: Cathy Robb    416-495-2400 ext 5323    crobb@tsh.to    Principal Investigator: Afshan Zahedi, BASc, MD          Michael Garron Hospital Not yet recruiting Toronto, Ontario, Canada, M4C 5M5 Contact: Amina Chaudary    416-351-3732 ext 2532    amina.chaudhary@wchospital.ca    Principal Investigator: Rebecca Fine, MD, FRCPC          Sunnybrook Health Sciences Centre Recruiting Toronto, Ontario, Canada, M4N 3M5 Contact: Sapida Adib    416-480-6100 ext 87703    sapida.adib@sunnybrook.ca    Principal Investigator: Ilana Halperin, MD, FRCPC          Saint Michael's Hospital Not yet recruiting Toronto, Ontario, Canada, M5B 1W8 Contact: Susan Jackson    416-351-3732 ext 2321    susan.jackson@wchospital.ca    Principal Investigator: Joel Ray, MD, MSc, FRCPC          Mount Sinai Hospital Not yet recruiting Toronto, Ontario, Canada, M5T 3L9 Contact: Christina Yu    416-351-3732 ext 5117    christina.yu@wchospital.ca    Principal Investigator: Denice Feig, MD, MSc, FRCPC Less <<
NCT01201759 Spinal Cord Injury Not Applicable Completed - United States, Florida ... More >> The Miami Project to Cure Paralysis Miami, Florida, United States, 33136 Less <<
NCT01201759 - Completed - -
NCT02973178 Urinary Tract Infections ... More >> Proteinuria Ketone Urine Hematuria Glucose Intolerance Less << Not Applicable Unknown December 2016 United States, California ... More >> West Coast Research, LLC Recruiting Mountain View, California, United States, 94040 Contact: Tim Davis    925-413-1451       Contact: Jenny Li    650-567-6389       West Coast Research, LLC Completed San Leandro, California, United States, 94577 Less <<
NCT00696748 Metabolic Syndrome ... More >> Hypogonadism Less << Phase 3 Unknown December 2010 Russian Federation ... More >> Scientific Centre for Endocrinology RAMS Recruiting Moscow, Russian Federation, 117136 Contact: Svetlana Kalinchenko, PhD    +7(095)1244301    kalinchenko@list.ru    Contact: Yuliya Tishova, PhDstudent    +79032213276    yulya_tishova@mail.ru    Sub-Investigator: Tishova Yulya, PhD student Less <<
NCT03548480 Prader-Willi Syndrome Not Applicable Enrolling by invitation July 2019 Spain ... More >> Hospital Sant Joan de Deu Barcelona, Spain, 08950 Less <<
NCT00566475 Type 1 Diabetes Not Applicable Completed - United States, New York ... More >> SUNY Upstate Medical University Syracuse, New York, United States, 13210 Less <<
NCT00354224 - Terminated(due to low accrual) - -
NCT00855439 Type 2 Diabetes Mellitus ... More >> Diabetic Peripheral Neuropathy Less << Not Applicable Completed - United States, Michigan ... More >> The University of Michigan Health System Ann Arbor, Michigan, United States, 48109 Less <<
NCT00855439 - Completed - -
NCT01156597 Type 2 Diabetes Mellitus Phase 3 Completed - United States, Florida ... More >> Diabetes Research Institute Miami, Florida, United States, 33136 Less <<
NCT01156597 - Completed - -
NCT00354224 Gastric Cancer Phase 2 Terminated(due to low accrual) - United States, South Carolina ... More >> Hollings Cancer Center at Medical University of South Carolina Charleston, South Carolina, United States, 29425 Less <<
NCT02772926 Type 2 Diabetes Mellitus Not Applicable Completed - Mexico ... More >> Department of Medical Sciences, University of Guanajuato, León Mexico León, Guanajuato, Mexico, 37320 Less <<
NCT00133718 Type 2 Diabetes Mellitus Phase 4 Completed - Norway ... More >> Asker and Baerum Hospital, Medical Department RUD, Norway, 1309 Less <<
NCT01665586 Benign Prostate Hyperplasia ... More >> Bladder Tumor Less << Not Applicable Completed - Korea, Republic of ... More >> Department of Anesthesiology and Pain Medicine, and Anesthesia and Pain Research Institute Seoul, Korea, Republic of, 120-752 Less <<
NCT00912639 Recurrent Breast Cancer Phase 4 Unknown May 2011 Korea, Republic of ... More >> Department of surgery, The Catholoic university of Korea, St. Mary's hospital. Seoul, Korea, Republic of Less <<
NCT01820663 Stroke Ischem... More >>ic Stroke Less << Phase 1 Phase 2 Completed - United States, New York ... More >> Burke Rehabilitation Hospital White Plains, New York, United States, 10605 Less <<
NCT00970099 Insulin Resistance ... More >> Insulin Sensitivity Type 2 Diabetes Less << Phase 1 Completed - United States, California ... More >> Ucsf Gcrc San Francisco, California, United States, 94143 Less <<
NCT03504267 Pregnancy Related ... More >> Obesity Less << Not Applicable Recruiting April 30, 2019 United States, Kentucky ... More >> Graves Gilbert Obstetric Clinic Recruiting Bowling Green, Kentucky, United States, 42101 Contact: Crystal Holland    270-780-0561    hollandc@ggclinic.com Less <<
NCT01452412 Chronic Kidney Disease ... More >> Metabolic Acidosis Less << Phase 2 Phase 3 Completed - United States, New York ... More >> Albert Einstein College of Medicine Bronx, New York, United States, 10461 United States, Ohio Case Western Reserve University Cleveland, Ohio, United States, 44106 Less <<
NCT00194805 Diabetes Agin... More >>g Less << Not Applicable Completed - United States, Washington ... More >> University of Washington Seattle, Washington, United States, 98195 Less <<
NCT01865279 Diabetes Diab... More >>etes Mellitus, Type 1 Diabetes Mellitus, Type 2 Less << Phase 1 Completed - Germany ... More >> Neuss, Germany, 41460 Less <<
NCT00174668 Diabetes Mellitus, Type 2 Phase 3 Completed - Australia ... More >> Sanofi-Aventis North Ryde, Australia Belgium Sanofi-Aventis Brussels, Belgium Czech Republic Sanofi-Aventis Prague, Czech Republic France Sanofi-Aventis Paris, France Germany Sanofi-Aventis Berlin, Germany Italy Sanofi-Aventis Milan, Italy Netherlands Sanofi-Aventis Gouda, Netherlands Poland Sanofi-Aventis Warsaw, Poland Portugal Sanofi-Aventis Porto Salvo, Portugal Romania Sanofi-aventis Bucharest, Romania Slovakia Sanofi-Aventis Bratislava, Slovakia Spain Sanofi-Aventis Barcelona, Spain Sweden Sanofi-Aventis Stockholm, Sweden Switzerland Sanofi-Aventis Meyrin, Switzerland United Kingdom Sanofi-Aventis Guildford, United Kingdom Less <<
NCT02987491 Insulin Sensitivity ... More >> Obesity Sedentary Lifestyle Less << Not Applicable Recruiting December 2018 United States, Oregon ... More >> Oregon State University Recruiting Corvallis, Oregon, United States, 97331 Contact: Matthew Robinson, PhD    541-737-1988    TMR.Lab@oregonstate.edu    Principal Investigator: Matthew Robinson, PhD          Principal Investigator: Sean Newsom, PhD Less <<
NCT01718457 Type 2 Diabetes ... More >> Obesity Less << Phase 4 Unknown January 2018 Israel ... More >> Sheba medical center, Tel-Hashomer Ramat-Gan, Israel, 52621 Less <<
NCT00680706 Heart Failure ... More >> Diabetes Less << Phase 2 Completed - United States, Massachusetts ... More >> Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Baystate Medical Center Springfield, Massachusetts, United States, 01199 Less <<
NCT02146651 Diabetes Mellitus Type 1 Phase 2 Completed - Germany ... More >> Profil Institut für stoffwechselforschung GmbH Neuss, Germany, 41460 Less <<
NCT00065650 Diabetes Mellitus, Type 2 Phase 2 Completed - United States, Oregon ... More >> Kaiser Permanente Center for Health Research Portland, Oregon, United States, 97227 Less <<
NCT02595684 Obesity Phase 4 Completed - Mexico ... More >> Instituto de Terapéutica Experimental y Clínica Guadalajara, Jalisco, Mexico, 44140 Less <<
NCT00680706 - Completed - -
NCT01736202 Insulin Sensitivity Phase 4 Unknown December 2013 Germany ... More >> German Diabetes Center Recruiting Düsseldorf, Nordrhein-Westfalen, Germany, 40225 Contact: Sabine Kahl, M.D.    +492113382740    sabine.kahl@ddz.uni-duesseldorf.de    Contact: Bettina Nowotny, M.D.    +492113382575    bettina.nowotny@ddz.uni-duesseldorf.de    Principal Investigator: Sabine Kahl, M.D. Less <<
NCT03307486 - Enrolling by invitation December 2030 Brazil ... More >> Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo Sao Paulo, Brazil, 05403000 Less <<
NCT03185689 Diabetes Mellitus, Type 2 Not Applicable Completed - -
NCT02841449 Healthy Not Applicable Completed - United Kingdom ... More >> University of Bath Bath, Somerset, United Kingdom, BA2 7AY Less <<
NCT02890693 Gestational Diabetes Mellitus Not Applicable Recruiting September 2020 Switzerland ... More >> University Hospital Lausanne Recruiting Lausanne, Vaud, Switzerland, 1011 Contact: Jardena Puder, MD    +41213140638    jardena.puder@chuv.ch    Contact: Antje Horsch, DClinPsych    +41795560750    antje.horsch@chuv.ch    Principal Investigator: Jardena Puder, MD          Principal Investigator: Antje Horsch, DClinPsych Less <<
NCT02416193 Diabetes Exec... More >>utive Dysfunction Less << Phase 2 Completed - United States, Illinois ... More >> Loyola University Medical Center Maywood, Illinois, United States, 60153 Less <<
NCT00018122 - Unknown - United States, Missouri ... More >> Washington University School of Medicine St. Louis, Missouri, United States, 63110 Less <<
NCT01945242 - Completed - -
NCT01945242 - Completed - -
NCT00846898 Type 2 Diabetes Mellitus Phase 2 Completed - United Kingdom ... More >> Brent teaching Primary Care trust (NHS) Wembley, London, United Kingdom, HA0 4UZ Less <<
NCT02069197 Obesity Diabe... More >>tes Obstructive Sleep Apnea Less << Phase 2 Recruiting September 2020 United States, Maryland ... More >> Mid-Atlantic Epilepsy and Sleep Center, LLC Recruiting Bethesda, Maryland, United States, 20817 Contact: Ivana Tyrlikova, MD    301-530-9744    tyrlikovai@epilepsydc.com    Contact: Arcady Barber, MSCN    301-530-9744    barbera@epilepsydc.com Less <<
NCT01154244 - Completed - Korea, Republic of ... More >> GSK Investigational Site Bucheon, Korea, Republic of, 150-713 GSK Investigational Site Seoul, Korea, Republic of, 110-749 Less <<
NCT01964976 - Completed - -
NCT01964976 - Completed - Japan ... More >> Tokyo, Japan Less <<
NCT01758471 Type 2 Diabetes Phase 4 Unknown June 2014 China, Shanghai ... More >> Shanghai Clinic Center for Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Institute for Endocrine and Metabolic Diseases Recruiting Shanghai, Shanghai, China, 200025 Contact: Guang Ning, M.D.    86-021-64370045 ext 665344 Less <<
NCT00363844 Type 2 Diabetes Mellitus Phase 3 Completed - Japan ... More >> Chubu Region Chubu, Japan Chugoku Region Chugoku, Japan Hokkaido Region Hokkaido, Japan Kanto Region Kanto, Japan Kinki Region Kinki, Japan Kyushu Region Kyushu, Japan Shikoku Region Shikoku, Japan Tohoku Region Tohoku, Japan Less <<
NCT00535600 - Completed - United States, Arizona ... More >> NIDDK, Phoenix Phoenix, Arizona, United States, 85014 Less <<
NCT02162901 Diabetes Prevention Not Applicable Unknown February 2017 United States, Virginia ... More >> Virginia Tech Translational Obesity Research Center Roanoke, Virginia, United States, 24016 Less <<
NCT00739336 - Completed - -
NCT02383784 Type 2 Diabetes Mellitus Not Applicable Completed - Brazil ... More >> Metabolism and body composition laboratory, Federal University of Vicosa Vicosa, Minas Gerais, Brazil, 36570-000 Less <<
NCT01603550 Energy Restriction ... More >> Sleep Deprivation Less << Not Applicable Completed - United States, Massachusetts ... More >> USARIEM Natick, Massachusetts, United States, 01760 Less <<
NCT00739336 Type 2 Diabetes Mellitus Not Applicable Completed - United States, New York ... More >> SUNY Upstate Medical University Syracuse, New York, United States, 13210 Less <<
NCT00441363 Type 2 Diabetes Phase 3 Terminated(Failure to Recruit ... More >>in a Timely manner) Less << - -
NCT00768326 Schizophrenia Phase 2 Completed - Germany ... More >> DE001 Munich, Germany, 80336 Less <<
NCT01600521 Rheumatoid Arthritis Not Applicable Completed - China ... More >> Beijing Friendship Hospital, Affiliated to Capital Medical University Beijing, China, 100050 Institute of Chinese Medical Sciences, University of Macau Taipa, China Less <<
NCT00441363 - Terminated(Failure to Recruit ... More >>in a Timely manner) Less << - -
NCT01181830 Family History of Metabolic Sy... More >>ndrome Family History of Diabetes Less << Phase 4 Completed - Italy ... More >> Azienda Ospedaliera Universitaria Integrata - Division of Internal Medicine C Verona, VR, Italy, 37134 Less <<
NCT01757080 Diabetics Patients ... More >> Hypertensive Patients Less << Not Applicable Completed - Brazil ... More >> Universidade Federal de Pernambuco Recife, Pernambuco, Brazil, 52061-100 Less <<
NCT00231647 Obesity Diabe... More >>tes Mellitus, Type 2 Diabetes Mellitus, Adult-Onset Less << Phase 2 Completed - -
NCT01557166 Metabolism and Nutrition Disor... More >>der Obesity Obstructive Sleep Apnoea Less << Phase 3 Completed - -
NCT02096705 - Completed - -
NCT01557166 - Completed - -
NCT03719911 Diabetes Mellitus Not Applicable Recruiting April 15, 2019 United States, California ... More >> Welkin Health Recruiting San Francisco, California, United States, 94110 Contact: Kristin Neland, BSN, MPH    512-694-7104    kristin@welkinhealth.com    Contact: Gideon Wald    5126947104    gideon@welkinhealth.com    Principal Investigator: Kristin Neland, BSN, MPH          Sub-Investigator: Larry Katz, PhD Less <<
NCT01665196 Autoimmune Disease Early Phase 1 Recruiting December 2017 China, Beijing ... More >> Peking Union Medical College Hospital Recruiting Beijing, Beijing, China, 100730 Contact: Zhaohui Zhu, MD    86-10-69154196    zhuzhh@pumch.cn    Contact: Hua Chen, MD    86-10-69158797    chen77hua@gmail.com Less <<
NCT02096705 Diabetes Phase 3 Completed - -
NCT00833846 - Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00490867 Type 2 Diabetes Phase 2 Completed - -
NCT02973438 Spinal Cord Injuries ... More >> Obesity Insulin Resistance Less << Not Applicable Recruiting December 2018 United States, Florida ... More >> The Miami Project to Cure Paralysis Recruiting Miami, Florida, United States, 33136 Contact: Jennifer L Maher, PhD    305-243-6320    jlmaher@med.miami.edu    Contact: Mark S Nash, PhD    305-243-7122    mnash@med.miami.edu Less <<
NCT01325805 Obese Overwei... More >>ght Miscarriage Recurrent Pregnancy Loss Less << Not Applicable Terminated(Difficult to recrui... More >>t, very poor compliance with interventions) Less << - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT02703324 Diabetes Mellitus, Type 1 Phase 1 Completed - Germany ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician. Neuss, Germany Less <<
NCT02632032 Type 1 Diabetes Not Applicable Completed - -
NCT00657124 Liver Disease Phase 4 Completed - Japan ... More >> Kochi Medical School Nankoku-City, Kohasu-Okocho, Japan, 783-8505 Less <<
NCT03362073 Ketamine Refr... More >>actory Cancer Pain Less << Phase 2 Recruiting December 31, 2019 Korea, Republic of ... More >> Pusan National University Yangsan Hospital Recruiting Yangsan, Gyeongsangnam-do, Korea, Republic of, 50612 Contact: Kwonoh Park, MD, PhD    82+-10-3378-3529    parkkoh@daum.net    Sub-Investigator: So Yeon Oh          Sub-Investigator: Sang-Bo Oh          Sub-Investigator: Eun-Ju Park Less <<
NCT01895296 Postoperative Dumping Syndrome Phase 2 Completed - Belgium ... More >> University Hospitals Leuven Leuven, Vlaams-Brabant, Belgium, 3000 Less <<
NCT00757588 Type 2 Diabetes Phase 3 Completed - -
NCT03084809 Colorectal Cancer ... More >> Cytokine-induced Killer Cells Postoperative Complications Survival Less << Phase 4 Completed - -
NCT00482729 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT00757588 - Completed - -
NCT02144441 Diabetes Mellitus Not Applicable Withdrawn(Very few patients me... More >>t eligibility criteria, none of whom elected to enroll.) Less << - United States, Pennsylvania ... More >> Hospital of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT02060383 Cushing's Disease ... More >> Acromegaly Less << Phase 4 Completed - -
NCT03296800 Type 2 Diabetes Mellitus Phase 1 Completed - United States, Florida ... More >> Covance Clinical Research Unit Daytona Beach, Florida, United States, 32117 Less <<
NCT01803230 Healthy Not Applicable Unknown February 2015 Brazil ... More >> University of Sao Paulo Recruiting Sao Paulo, Brazil Contact: Carlos Merege    5511 30913096    carlosmeregefilho@gmail.com    Principal Investigator: Bruno Gualano, Professor Less <<
NCT01296633 Diabetes Mellitus Not Applicable Completed - United States, Illinois ... More >> Northwestern Medical Faculty Foundation Clinic of Northwestern University Chicago, Illinois, United States, 60611 OSF Medical Group of OSF Saint Francis Medical Center Peoria, Illinois, United States, 61637 Less <<
NCT00453375 Diabetes Hypo... More >>glycemia Less << Phase 1 Completed - United States, Alabama ... More >> University of Alabama at Birmingham School of Medicine Birmingham, Alabama, United States, 35294 United States, California Valley Research Fresno, California, United States, 93720 United States, Colorado Barbara Davis Center for Childhood Diabetes Aurora, Colorado, United States, 80045 Private Practice Denver, Colorado, United States, 80209 United States, District of Columbia MedStar Research Institute Washington, District of Columbia, United States, 20003 United States, Florida University of Miami, Miller School of Medicine, Diabetes Research Institute Miami, Florida, United States, 33136 Private Practice Wellington, Florida, United States, 33414 United States, Nebraska Creighton Diabetes Center Omaha, Nebraska, United States, 68131 United States, Texas Diabetes and Glandular Disease Center San Antonio, Texas, United States, 78229 United States, Washington Benaroya Research Institute at Virginia Mason Seattle, Washington, United States, 98101-2795 Australia, Queensland Peninsula Clinical Research Centre Kippa Ring, Queensland, Australia, 4021 Australia, Victoria Royal Melbourne Hospital Parkville, Victoria, Australia, 3050 Eastern Clinical Research Unit Ringwood East, Victoria, Australia, 3050 Australia, Western Australia Fremantle Hospital Fremantle, Western Australia, Australia, 6160 New Zealand Middlemore Hospital Otahuhu, Auckland, New Zealand, Private Bag 93311 Christchurch Hospital Christchurch, Canterbury, New Zealand, Private Bag 4710 Waikato Regional Diabetes Service Hamilton, Waikato, New Zealand, Private bag 3200 The Diabetes Centre Newtown, Wellington, New Zealand, Private Bag 7902 Less <<
NCT02992093 - Not yet recruiting August 2020 China, Fujian ... More >> Fujian Maternity and Child Health Hosptial Not yet recruiting Fuzhou, Fujian, China, 350000 Contact: Jinbang Xu    13559958096    13559958096@126.com Less <<
NCT02655367 Metabolic Syndrome Not Applicable Completed - United Kingdom ... More >> Institute of Food Research Norwich, Norfolk, United Kingdom, NR4 7UA Less <<
NCT00564746 Pulmonary Disease, Chronic Obs... More >>tructive Less << Phase 1 Completed - United Kingdom ... More >> GSK Investigational Site Tranent, West Lothian, United Kingdom, EH33 2NE Less <<
NCT00482729 - Completed - -
NCT00756613 - Completed - United States, Arizona ... More >> Phoenix VA Health Care System, Phoenix, AZ Phoenix, Arizona, United States, 85012 United States, Florida Miami VA Healthcare System, Miami, FL Miami, Florida, United States, 33125 Less <<
NCT00325624 Hypertension ... More >>Diabetes Mellitus Less << Phase 1 Completed - Canada, Ontario ... More >> Sunnybrook Health Sciences Centre Toronto, Ontario, Canada, M4N 3M5 Canada, Saskatchewan Battleford Tribal Council Indian Health Services North Battleford, Saskatchewan, Canada, S9A 0V0 Less <<
NCT02159378 Pregnancy Ges... More >>tational Diabetes Less << Not Applicable Completed - France ... More >> Centre hospitalier départemental Vendée La Roche sur Yon, France, 85925 Less <<
NCT03555591 - Active, not recruiting October 31, 2021 Japan ... More >> Takeda Selected Site Tokyo, Japan Less <<
NCT01709305 Type 2 Diabetes Mellitus Phase 4 Completed - -
NCT01201278 Type 1 Diabetes Phase 1 Unknown - United States, California ... More >> Profil Institute for Clinical Research Not yet recruiting Chula Vista, California, United States, 91911 Principal Investigator: Marcus Hompesch, MD Less <<
NCT01709305 - Completed - -
NCT00104572 Hypogonadism ... More >>Diabetes Sarcopenia Osteoporosis Depression Less << Phase 2 Completed - United States, Maryland ... More >> National Institute of Aging, Clinical Research Unit Baltimore, Maryland, United States, 21224 Less <<
NCT00560469 - Completed - United States, Vermont ... More >> Fletcher Allen Health Care South Burlington, Vermont, United States, 05403 Less <<
NCT01759576 Renal Insufficiency ... More >> Healthy Less << Phase 1 Completed - United States, Florida ... More >> Orlando, Florida, United States United States, Minnesota Minneapolis, Minnesota, United States United States, Tennessee Knoxville, Tennessee, United States Less <<
NCT00104572 - Completed - -
NCT02372253 Type 1 Diabetes Mellitus Phase 2 Active, not recruiting December 2019 United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35233 Less <<
NCT03698786 - Recruiting July 2019 United Kingdom ... More >> Applied & Human Sciences Human Performance Lab Recruiting Kingston Upon Thames, Surrey, United Kingdom, KT1 2EE Contact: Hannah J Moir, PhD    020 84172876    H.Moir@kingston.ac.uk    Principal Investigator: Simone Benedetti Less <<
NCT01248481 - Completed - Korea, Republic of ... More >> Many Locations, Korea, Republic of Less <<
NCT00131755 Diabetes Mellitus, Type 1 Phase 4 Completed - Norway ... More >> University Hospital of Trondheim Trondheim, Norway, 7006 Less <<
NCT00950716 Diabetes Not Applicable Completed - China ... More >> Asia Diabetes Foundation Hong Kong, China Less <<
NCT02209493 Cardiovascular Disease Not Applicable Completed - United States, Arizona ... More >> Nutrition Laboratory at Arizona State University Phoenix, Arizona, United States, 85004 Less <<
NCT02677857 Breast Cancer ... More >> Sedentary Lifestyle Less << Not Applicable Terminated(Recruitment efforts... More >> were not effective.) Less << - United States, Tennessee ... More >> Healthy Eating and Activity Laboratory Knoxville, Tennessee, United States, 37996 Less <<
NCT03608358 Type 2 Diabetes Mellitus Phase 3 Not yet recruiting March 1, 2021 China ... More >> Research Site Not yet recruiting Baotou, China, 014016 Research Site Not yet recruiting Beijing, China, 100039 Research Site Not yet recruiting Beijing, China, 100044 Research Site Not yet recruiting Beijing, China, 100101 Research Site Not yet recruiting Beijing, China, 100144 Research Site Not yet recruiting Beijing, China, 101199 Research Site Not yet recruiting Beijing, China, 101200 Research Site Not yet recruiting Changchun, China, 130021 Research Site Not yet recruiting Chenzhou, China Research Site Withdrawn Chongqing, China, 400014 Research Site Not yet recruiting Fuzhou, China, 350025 Research Site Withdrawn Guangzhou, China, 510000 Research Site Withdrawn Guangzhou, China, 510080 Research Site Not yet recruiting Guangzhou, China, 510515 Research Site Not yet recruiting Haerbin, China, 150001 Research Site Not yet recruiting Hefei, China, 230001 Research Site Not yet recruiting Hefei, China Research Site Not yet recruiting Hengyang, China, CN-421001 Research Site Not yet recruiting Hohhot, China, 010017 Research Site Not yet recruiting Huizhou, China, 516001 Research Site Not yet recruiting Jinan, China, 250001 Research Site Withdrawn Jinzhou, China, 121004 Research Site Withdrawn Nanchang, China, 330006 Research Site Not yet recruiting Nanjing, China, 210012 Research Site Not yet recruiting Nanjing, China, 210029 Research Site Not yet recruiting Nantong, China, 226001 Research Site Not yet recruiting Qingdao, China, 266003 Research Site Not yet recruiting Shanghai, China, 200240 Research Site Not yet recruiting Shantou, China, 515065 Research Site Not yet recruiting Shengyang, China, 110004 Research Site Not yet recruiting Tangshan, China Research Site Not yet recruiting Tianjin, China, 300211 Research Site Not yet recruiting Wuhan, China, 430033 Research Site Not yet recruiting Wuhan, China, CN-430022 Research Site Not yet recruiting Wulumuqi, China, 830054 Research Site Not yet recruiting Xian, China, 710061 Research Site Withdrawn Xining, China, 810001 Research Site Not yet recruiting Yancheng, China, 224005 Research Site Withdrawn Yinchuan, China, 750004 Research Site Not yet recruiting Yueyang, China, 414000 Research Site Not yet recruiting Zhuzhou, China, 412007 Thailand Research Site Not yet recruiting Bangkok, Thailand, 10400 Vietnam Research Site Not yet recruiting Ho Chi Minh, Vietnam, 10000 Research Site Not yet recruiting Ho Chi Minh, Vietnam Less <<
NCT01910051 - Recruiting August 2020 Germany ... More >> Profil Institut für Stoffwechselforschung GmbH Recruiting Neuss, Germany, 41460 Contact: Elke Gurschke    +4921314018 ext 411    regulatory@profil.com    Principal Investigator: Leona Plum-Mörschel, MD Less <<
NCT00001402 Heart Failure, Congestive Phase 2 Completed - United States, Maryland ... More >> National Heart, Lung and Blood Institute (NHLBI) Bethesda, Maryland, United States, 20892 Less <<
NCT01592539 - Completed - United States, Nebraska ... More >> Creighton University Omaha, Nebraska, United States, 68131 Less <<
NCT02982265 - Recruiting January 2019 Italy ... More >> Asst Papa Giovanni Xxiii Recruiting Bergamo, Italy, 24127 Contact: Chiara Viviani, M.D.    00390352675113    cviviani@asst-pg23.it    Contact: Ferdinando L Lorini, M.D.    00390352675113    llorini@asst-pg23.it Less <<
NCT03728959 Hypoparathyroidism Not Applicable Enrolling by invitation April 12, 2019 Denmark ... More >> Hvidovre University Hospital Hvidovre, Denmark, 2650 Less <<
NCT01053234 Type 2 Diabetes ... More >> Cardiovascular Risk Hemostasis Inflammation Endothelial Function Less << Not Applicable Completed - Denmark ... More >> Hospital of South West Denmark Esbjerg, Denmark, 6700 Less <<
NCT01855243 Diabetes Mellitus (DM) Not Applicable Unknown June 2014 Egypt ... More >> the department of internal medicine, Cairo University teaching hospitals, Cairo, Egypt Less <<
NCT00593476 Type 2 Diabetes Not Applicable Completed - United States, Pennsylvania ... More >> Jeanes Hospital Medical Office Building Philadelphia, Pennsylvania, United States, 19111 Center for Obesity Research and Education Philadelphia, Pennsylvania, United States, 19140 Less <<
NCT00111800 Diabetes Mellitus, Type 2 Phase 2 Completed - -
NCT00818935 Type 2 Diabetes ... More >> Inflammation Cardiovascular Disease Less << Not Applicable Completed - Jamaica ... More >> University of the West Indies Kingston, Jamaica Less <<
NCT00551564 Diabetes Mellitus, Type 2 Phase 1 Completed - United States, California ... More >> GSK Investigational Site Chula Vista, California, United States, 91911 Less <<
NCT00339482 - Completed - United States, Arizona ... More >> NIDDK, Phoenix Phoenix, Arizona, United States, 85014 Less <<
NCT01017133 Non-small Cell Lung Cancer Phase 1 Completed - United States, Pennsylvania ... More >> Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00150163 - Unknown - Denmark ... More >> Department of Endocrinology, Odense University Hospital Odense, Funen, Denmark, 5000 Less <<
NCT00661362 Type 2 Diabetes Phase 3 Completed - -
NCT00698932 - Completed - -
NCT00661362 - Completed - -
NCT02326714 Polycystic Ovary Syndrome Not Applicable Recruiting June 2019 China, Heilongjiang ... More >> First Affiliated Hospital, Heilongjiang University of Chinese Medicine Recruiting Harbin, Heilongjiang, China, 150040 Contact: Lihui Hou, Bachelor    86-451-82111401    houlihui2007@sina.com Less <<
NCT00111800 - Completed - -
NCT01132118 Rheumatoid Arthritis ... More >> Insulin Resistance Less << Phase 3 Completed - United States, Massachusetts ... More >> Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Less <<
NCT01004718 Lymphoma Not Applicable Unknown - United States, Pennsylvania ... More >> Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT01132118 - Completed - -
NCT00698932 Type 2 Diabetes Phase 3 Completed - -
NCT01418638 - Unknown - Israel ... More >> Ziv MC Recruiting Safed, Israel, 13110 Contact: Osamah Hussein, MD          Principal Investigator: Osamah Hussein, MD Less <<
NCT01338376 Type 2 Diabetes Mellitus Phase 4 Unknown May 2012 China, Beijing ... More >> Peking University First Hospital Recruiting Beijing, Beijing, China, 100034 Contact: Peking University First Hospital, 3A grade    +86 10 83572211    dyyy@bddyyy.com.cn Less <<
NCT00770445 Diabetes Mellitus Phase 4 Completed - Germany ... More >> Lichtenfels, Bavaria, Germany Frankfurt, Hessen, Germany Kassel, Hessen, Germany Wiesbaden, Hessen, Germany Bad Oeynhausen, North Rhine-Westphalia, Germany Dinslaken, North Rhine-Westphalia, Germany Duisburg, North Rhine-Westphalia, Germany Essen, North Rhine-Westphalia, Germany Münster, North Rhine-Westphalia, Germany Wuppertal, North Rhine-Westphalia, Germany Mainz, Rheinland-Pfalz, Germany Diez, Rhineland-Palatinate, Germany Landau, Rhineland-Palatinate, Germany Dresden, Saxony, Germany Leipzig, Saxony, Germany Jena, Thüringen, Germany Berlin, Germany Hamburg, Germany Less <<
NCT01680211 Prediabetes H... More >>yperlipidemia Less << Not Applicable Completed - India ... More >> Srinivasa Clinic & Diabetic Care Center Bangalore, Karnataka, India, 560050 Less <<
NCT00071448 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 3 Completed - -
NCT01004848 Pre-diabetes Not Applicable Completed - United States, New York ... More >> Icahn School of Medicine at Mount Sinai New York, New York, United States, 10029 Less <<
NCT03726931 Breast Cancer Not Applicable Recruiting November 13, 2020 Netherlands ... More >> VU University Medical Center Recruiting Amsterdam, Noord- Holland, Netherlands Contact: R Iqbal, MD    +31-20-4444321    trialoffice@vumc.nl Less <<
NCT02650830 - Unknown December 2016 Korea, Republic of ... More >> Yonsei University College of Medicine Recruiting Seoul, Korea, Republic of, 03722 Contact: Jeong-Ho Kim, MD    +82 02-2228-2455 Less <<
NCT01004848 - Completed - -
NCT00441272 HIV Infections ... More >> Hepatic Steatosis Insulin Resistance Less << Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00143013 - Unknown - Denmark ... More >> Department of Clinical Biochemistry and Genetics, KKA Recruiting Odense C, Funen, Denmark, 5000 Contact: Vibe Skov, MSc    +45 6541 2837    vibe.skov@ouh.fyns-amt.dk Less <<
NCT01696266 - Completed - -
NCT02448225 Lung Carcinoma ... More >> Solitary Pulmonary Nodule Cigarette Smoking Behavior Less << Phase 2 Recruiting June 2021 United States, Tennessee ... More >> Vanderbilt-Ingram Cancer Center Recruiting Nashville, Tennessee, United States, 37232 Principal Investigator: Pierre Massion, MD Less <<
NCT03770910 Endocrine - Other Not Applicable Active, not recruiting March 1, 2020 Denmark ... More >> Clinical Metabolic Physiology Gentofte, Copenhagen, Denmark, 2900 Clinical Metabolic Physiology Copenhagen, Gentofte, Denmark, 2900 Less <<
NCT00441272 - Completed - -
NCT01269710 - Completed - -
NCT01269710 - Completed - United States, North Carolina ... More >> University of North Carolina Chapel Hill, North Carolina, United States, 27514 Less <<
NCT00938405 Diabetes Mellitus, Type 1 ... More >> Hyperlipidemias Less << Not Applicable Completed - United States, Colorado ... More >> Barbara Davis Center for Diabetes Aurora, Colorado, United States, 80045 Less <<
NCT03750604 Urologic Diseases ... More >> Overactive Bladder Syndrome Obesity, Abdominal Less << Not Applicable Completed - -
NCT01839227 Elderly Patients Undergoing Sp... More >>inal Surgery Less << Not Applicable Completed - Korea, Republic of ... More >> Department of Anesthesiology and Pain Medicine, Anesthesia and Pain Research Institute, Yonsei University College of Medicine Seoul, Korea, Republic of, 120-752 Less <<
NCT02800538 Healthy Volunteers Not Applicable Completed - Belgium ... More >> University Hospitals Leuven, campus Gasthuisberg Leuven, Belgium, 3000 Less <<
NCT01435486 Bronchiolitis ... More >> Apnea Caffeine Less << Not Applicable Completed - Qatar ... More >> Pediatric emergency center, Hamad Medical Corporation Doha, Qatar, 3050 Less <<
NCT01546545 - Unknown March 2013 United States, Louisiana ... More >> Pennington Biomedical Research Center Recruiting Baton Rouge, Louisiana, United States, 70808 Contact: Jeffrey Gimble, MD, PhD    225-763-3171    jeffrey.gimble@pbrc.edu Less <<
NCT01257412 Type 2 Diabetes Phase 3 Suspended(FSI delayed until 15... More >> January 2013) Less << June 2013 India ... More >> Research Site Hyderabad, Andhra Pradesh, India Research Site Vijaywada, Andhra Pradesh, India Research Site Ahmedabad, Gujarat, India Research Site Bangalore, Karnataka, India Research Site Mysore, Karnataka, India Research Site Trivandrum, Kerala, India Research Site Indore, Madhya Pradesh, India Research Site Mumbai, Maharashtra, India Research Site Nagpur, Maharashtra, India Research Site Pune, Maharashtra, India Research Site Jaipur, Rajasthan, India Research Site Chennai, Tamil Nadu, India Research Site Coimbatore, Tamil Nadu, India Research Site Madurai, Tamil Nadu, India Research Site Ghaziabad, Uttar Pradesh, India Less <<
NCT01783210 Maternal Obesity Complicating ... More >>Pregnancy, Birth,or Puerperium Gestational Diabetes Mellitus in Pregnancy, Diet- Controlled Exercise Addiction High-Risk Pregnancy Dietary Modification Less << Not Applicable Unknown December 2015 Italy ... More >> Mother-Infant Department, University of Modena and Reggio Emilia, Italy Recruiting Modena, Italy, 41124 Contact: Fabio Fachhinetti, MD    0039 0594222512    facchi@unimore.it    Sub-Investigator: Elisabetta Petrella, MD          Sub-Investigator: Valentina Bertarini, PHD Less <<
NCT02236481 Diabetes Mellitus, Type 2 ... More >> Arthritis, Rheumatoid Less << Phase 4 Terminated(Decision of the Spo... More >>nsor for Early Benefits) Less << - Italy ... More >> L'Aquila University L'Aquila, Italy, 67100 Less <<
NCT02127216 Diabetes Not Applicable Active, not recruiting June 2020 United States, Maryland ... More >> Baltimore VA Maryland Health Care System Baltimore, Maryland, United States, 21201 Less <<
NCT00779701 - Completed - -
NCT00021944 - Completed - -
NCT01073969 Healthy Phase 4 Completed - United States, Illinois ... More >> Provident CRC Glen Ellyn, Illinois, United States, 60137 Less <<
NCT01411540 Overweight Ob... More >>esity Pre-diabetic Less << Not Applicable Completed - United States, Ohio ... More >> Cleveland Clinic Cleveland, Ohio, United States, 44195 Less <<
NCT00073268 Diabetes Mellitus, Type 2 Phase 1 Completed - United States, New York ... More >> Russ Berrie Pavilion New York, New York, United States, 10032 New York Presbyterian Hospital New York, New York, United States Less <<
NCT00779701 Hyperglycemia Phase 4 Completed - United States, Pennsylvania ... More >> Temple University Hospital Philadelphia, Pennsylvania, United States, 191440 Less <<
NCT03352596 Fructose Metabolism Disorder Not Applicable Active, not recruiting November 30, 2017 -
NCT02258750 Satiation, Satiety Not Applicable Terminated(End of EU funding f... More >>or the work package under investigation) Less << - United Kingdom ... More >> University of Liverpool Liverpool, Merseyside, United Kingdom, L69 7ZA Less <<
NCT02079181 Malignant Neoplasm Not Applicable Recruiting January 31, 2021 United States, California ... More >> USC Norris Comprehensive Cancer Center Recruiting Los Angeles, California, United States, 90033 Contact: Bhushan S. Desai    323-652-0343    bhushand@usc.edu    Principal Investigator: Peter S. Conti Less <<
NCT01798420 - Completed - Israel ... More >> Department of medicine Nzareth, Nazareth, Israel, 16000 Less <<
NCT00701090 Type 2 Diabetes Mellitus, Non ... More >>Insulin Dependent Diabetes Mellitus, Non-Insulin-Dependent Less << Phase 3 Completed - -
NCT00299325 Metabolic Syndrome Phase 3 Completed - United States, New Jersey ... More >> Sanofi-Aventis Administrative Office Bridgewater, New Jersey, United States, 08807 Canada Sanofi-Aventis Administrative Office Laval, Canada Denmark Sanofi-Aventis Administrative Office Hoersholm, Denmark Finland Sanofi-Aventis Administrative Office Helsinki, Finland France Sanofi-Aventis Administrative Office Paris, France Italy Sanofi-Aventis Administrative Office Milan, Italy Spain Sanofi-Aventis Administrative Office Barcelona, Spain Sweden Sanofi-Aventis Administrative Office Stockholm, Sweden United Kingdom Sanofi-Aventis Administrative Office Guildford, United Kingdom Less <<
NCT02304211 Healthy Early Phase 1 Completed - United States, North Carolina ... More >> Duke University Medical Center Durham, North Carolina, United States, 27710 Less <<
NCT02107976 - Recruiting February 28, 2024 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)    800-411-1222 ext TTY8664111010    prpl@cc.nih.gov Less <<
NCT01120912 Diabetes Phase 1 Completed - Israel ... More >> Assaf Harofe Medical Center Zrifin, Beer-Yaakov, Israel, 70300 Less <<
NCT02384265 Diabetes Mellitus Not Applicable Active, not recruiting December 2018 United States, California ... More >> Holman United Methodist Church Los Angeles, California, United States, 90018 Less <<
NCT00701090 - Completed - -
NCT00941655 Gastric Cancer Phase 3 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00240253 Type 2 Diabetes Mellitus Phase 4 Completed - -
NCT00698789 Type 2 Diabetes Phase 2 Terminated(Study ended after d... More >>iabetes development plan review. .) Less << - United States, Arizona ... More >> Phoenix, Arizona, United States, 85029 Tucson, Arizona, United States, 85705 United States, California Chula Vista, California, United States, 91911 Los Angeles, California, United States Mission Viejo, California, United States, 92691 Orange, California, United States, 92869 Paramount, California, United States, 90723 San Diego, California, United States, 92117 Santa Ana, California, United States, 92701 Tustin, California, United States, 92780 United States, Colorado Colorado Springs, Colorado, United States, 80909 United States, Florida St. Petersburg, Florida, United States, 33709 United States, Kansas Shawnee Mission, Kansas, United States, 66216 United States, Louisiana Shreveport, Louisiana, United States, 71101 United States, Michigan Dearborn, Michigan, United States, 48126 United States, Missouri St. Louis, Missouri, United States, 63110 United States, Nebraska Omaha, Nebraska, United States, 68154 United States, New Jersey Elizabeth, New Jersey, United States, 07202 United States, North Carolina Charlotte, North Carolina, United States, 28211 United States, Oklahoma Oklahoma City, Oklahoma, United States, 73103 United States, Rhode Island East Providence, Rhode Island, United States, 02914 United States, Texas San Antonio, Texas, United States, 78229 Less <<
NCT03430310 Type 2 Diabetes Mellitus Not Applicable Recruiting June 2023 United States, Alabama ... More >> The University of Alabama at Birmingham Recruiting Birmingham, Alabama, United States, 35294 Contact: Laura Lee Goree, MS, RD, LD    205-934-4386    LLG@uab.edu    Principal Investigator: Barbara Gower, PhD Less <<
NCT02272296 Diabetes Mellitus Phase 4 Completed - Netherlands ... More >> Radboud university medical center Nijmegen, Netherlands, 6542 JK Less <<
NCT03627377 Schizophrenia ... More >> Obesity Diabetes Lifestyle Risk Reduction Serious Mental Illness Less << Not Applicable Active, not recruiting August 31, 2022 United States, California ... More >> University of California, San Diego Division of Geriatric Psychiatry La Jolla, California, United States, 92093 Less <<
NCT00941655 - Completed - -
NCT03642860 Tarui Disease ... More >> Debrancher Deficiency GYG1 DEFICIENCY Less << Phase 2 Recruiting December 31, 2019 Denmark ... More >> Copenhagen Neuromuscular Center Recruiting Copenhagen, Denmark, 2200 Contact: Mette Cathrine Ørngreen, MD, DMsc    004535457614    mette.cathrine.oerngreen.01@regionh.dk    Contact: Daniel Emil Raaschou-Pedersen, Medical Student    004535456135    daniel.emil.tadeusz.raaschou-pedersen.01@regionh.dk    Principal Investigator: Mette Cathrine Ørngreen, MD, DMsc Less <<
NCT00592410 Acute Renal Failure Phase 2 Withdrawn(no enrollment) - -
NCT01864655 Alzheimer's Disease Phase 1 Completed - United States, Connecticut ... More >> Yale Alzheimer's Disease Research Unit New Haven, Connecticut, United States, 06510 Less <<
NCT01200940 Healthy Volunteers Phase 1 Phase 2 Recruiting June 30, 2020 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)    800-411-1222 ext TTY8664111010    prpl@cc.nih.gov Less <<
NCT02025673 - Unknown July 2014 -
NCT01275235 - Terminated(We were unable to r... More >>ecruit enough sibling pairs in a timely manner.) Less << - United States, Louisiana ... More >> Pennington Biomedical Research Center Baton Rouge, Louisiana, United States, 70808 Less <<
NCT01122641 Insulin Resistance ... More >> Microvascular Disease Less << Phase 3 Completed - United Kingdom ... More >> Diabetes and Vascular Research Department Exeter, Devon, United Kingdom, EX2 5AX Less <<
NCT02360774 - Completed - -
NCT00139178 HIV Associated Lipodystrophy S... More >>yndrome. HIV Hypercholesterolemia Lipoatrophy Less << Phase 4 Completed - Denmark ... More >> Department of Infectious Diseases, Aarhus University Hospital Aarhus, Denmark, 8200 Department of Infectious Diseases, Rigshospitalet Copenhagen, Denmark, 2100 Department of Infectious Diseases, Hvidovre University Hospital Hvidovre, Denmark, 2650 Department of Infectious diseases, Odense University Hospital Odense, Denmark, 5000 Less <<
NCT02682407 IgAN Lupus Ne... More >>phritis MN C3G Less << Phase 2 Recruiting December 2018 United States, Colorado ... More >> Omeros Investigational Site Recruiting Denver, Colorado, United States, 80230 United States, Georgia Omeros Investigational Site Recruiting Augusta, Georgia, United States, 30909 United States, Illinois Omeros Investigational Site Recruiting Evergreen Park, Illinois, United States, 60805 United States, New Jersey Omeros Investigational Site Recruiting Voorhees, New Jersey, United States, 08043 United States, New York Omeros Investigational Site Recruiting Flushing, New York, United States, 11355 United States, Texas Omeros Investigational Site Recruiting San Antonio, Texas, United States, 78215 United States, Wisconsin Omeros Investigational Site Recruiting Milwaukee, Wisconsin, United States, 53226 Less <<
NCT02360774 Type 2 Diabetes ... More >> Overweight Obesity Less << Phase 4 Completed - United States, Massachusetts ... More >> Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Less <<
NCT03692299 Systemic Sclerosis ... More >> Small Intestinal Bacterial Overgrowth Less << Phase 4 Recruiting June 2019 Mexico ... More >> Maria del Pilar Cruz Dominguez Recruiting Mexico, Mexico City, Mexico, 07800 Contact: Maria del Pilar Cruz-Dominguez, MD    5557245900 ext 23015    maria.cruzdo@live.com.mx    Sub-Investigator: Grettel García Collinot, MD          Sub-Investigator: Pablo Ramírez Mendoza, MD          Sub-Investigator: Margarita Martínez Cruz, Nutrition Less <<
NCT03658655 Type2 Diabetes Early Phase 1 Recruiting September 30, 2019 China, Shanghai ... More >> Changhai hospital Recruiting Shanghai, Shanghai, China Contact: Qin Huang, Doctor    +86 13818333125    qxinyi1220@163.com Less <<
NCT01047410 Post-transplant Weight Gain ... More >> Kidney Transplant Metabolic Syndrome Less << Not Applicable Completed - Netherlands ... More >> Reade Amsterdam, Noord-Holland, Netherlands, 1056 AB Revalidatiecentrum Lindenhof Goes, Zeeland, Netherlands, 4462 RA AMC Amsterdam, Netherlands Isala Kliniek Zwolle, Netherlands Vogellanden Zwolle, Netherlands Less <<
NCT03023228 Diabetes Mellitus ... More >> Hyperglycemia Less << Not Applicable Completed - -
NCT01554358 Gestational Diabetes Mellitus ... More >>(GDM) Less << Not Applicable Unknown - China ... More >> Tianjin Women's and Children's Health Center Recruiting Tianjin, China, 30070 Contact: Huikun Liu, PhD       huikun_liu@sina.com    Principal Investigator: Huiguang Tian, PhD          Principal Investigator: Gang Hu, PhD Less <<
NCT01441245 Acute Heart Failure Phase 4 Completed - Italy ... More >> Department of Internal Medicine, Cardiology Section Center Siena,, Italy, 53100 Less <<
NCT00472082 Kidney Transplantation ... More >> Chronic Kidney Failure Less << Phase 1 Phase 2 Terminated(This study was term... More >>inated at the request of the drug manufacturer.) Less << - United States, Georgia ... More >> Emory University Atlanta, Georgia, United States, 30322 Less <<
NCT03536377 Diabetes Mellitus Type 2 in Ob... More >>ese Less << Not Applicable Not yet recruiting November 2019 Barbados ... More >> Abundant Life Assembly Bridgetown, Bank Hall, Saint Michael, Barbados Ellerton Wesleyan Church Not yet recruiting Bridgetown, Ellerton, Saint George, Barbados Contact: Francine Bowman-Jones, MBBS    1 246-436-3661    franbeejay1205@gmail.com    River Road New Testament Church of God Not yet recruiting Bridgetown, River Road, Saint Michael, Barbados Contact: Natasha Sobers-Grannum, MBBS, MSc    1 246-4266030    Natasha.sobers-grannum@cavehill.uwi.edu    Mount of Praise Wesleyan Church Not yet recruiting Bridgetown, Tudor Bridge, Saint Michael, Barbados Contact: Susan Taitt, RN    1 246-4246929    ggriffith188@gmail.com Less <<
NCT01465620 Peripheral Nervous System Dise... More >>ases Diabetic Polyneuropathy Metabolic Syndrome X Less << Phase 3 Completed - France ... More >> Hôpital Henri Mondor Créteil, France, 94010 Less <<
NCT00794235 Melanoma Stage III or IV ... More >> No Prior Chemotherapy Less << Phase 2 Completed - Switzerland ... More >> Department of Dermatology, University Hospital Zurich Zurich, Switzerland, 8091 Less <<
NCT01780870 - Completed - -
NCT00472082 - Terminated(This study was term... More >>inated at the request of the drug manufacturer.) Less << - -
NCT03763396 Brain Tumor, Recurrent ... More >> Cancer, Advanced Glioma of Brain Less << Early Phase 1 Not yet recruiting December 2020 Canada, Ontario ... More >> Toronto Western Hospital Not yet recruiting Toronto, Ontario, Canada, M5T 2S8 Contact: Clinical Research Analyst          Contact       eric.monsalves@uhnresearch.ca    Principal Investigator: Gelareh Zadeh, MD, PhD          Sub-Investigator: Alireza Mansouri, MD, MSc Less <<
NCT01780870 Obesity Weigh... More >>t Loss Less << Not Applicable Completed - United States, Massachusetts ... More >> Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02115 Less <<
NCT01954706 Breast Cancer ... More >> Sarcopenia Less << Not Applicable Terminated(The study was stopp... More >>ed due to recruitment difficulties) Less << - United States, Maryland ... More >> Baltimore VA Medical Center Baltimore, Maryland, United States, 21201 Less <<
NCT01121172 - Completed - Greece ... More >> Unit of Pediatric Endocrinology, Diabetes and Metabolism-4th Department of Pediatrics, Medical School of Aristotle University of Thessaloniki Thessaloniki, Greece, 56403 Less <<
NCT01848327 Relapsing Remitting MS ... More >> Secondary Progressive MS Primary Progressive MS Less << Not Applicable Completed - United States, Florida ... More >> University of Miami Miller School of Medicine Miami, Florida, United States, 33136 Less <<
NCT01441245 - Completed - -
NCT01616134 Insulin Resistance ... More >> Obesity Less << Not Applicable Completed - Korea, Republic of ... More >> Pusan National University Yangsan Hospital Yangsan, Gyeongsangnam-do, Korea, Republic of, 626-770 Less <<
NCT01858896 Type 2 Diabetes Mellitus Early Phase 1 Active, not recruiting December 2018 United States, Maryland ... More >> University of Maryland, Baltimore Baltimore, Maryland, United States, 21201 Less <<
NCT00686283 Diabetes Phase 1 Completed - United States, Arizona ... More >> University Medical Center Tucson, Arizona, United States, 85721 Less <<
NCT03032549 Dietary Supplements Not Applicable Completed - -
NCT02794701 - Completed - China ... More >> The Nethersole School of Nursing, Chinese University of Hong Kong Hong Kong SAR, China Less <<
NCT00009035 - Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT01121172 - Completed - -
NCT02917057 - Completed - United States, Massachusetts ... More >> Optum Epidemiology Boston, Massachusetts, United States, 02215 Less <<
NCT03000283 Cerebral Hemorrhage ... More >> Cerebral Edema Intracerebral Hemorrhage Stroke Less << Not Applicable Enrolling by invitation January 2020 United States, Minnesota ... More >> United Hospital Saint Paul, Minnesota, United States, 55102 Less <<
NCT03428932 Type 1 Diabetes Mellitus Not Applicable Recruiting June 1, 2019 United States, California ... More >> Stanford University Not yet recruiting Palo Alto, California, United States, 94305 Contact: Tali Jacobson    650-721-8782    talij@stanford.edu    Principal Investigator: Bruce Buckingham, MD          Sub-Investigator: Darrell Wilson, MD          Sub-Investigator: Tandy Aye, MD          United States, Connecticut Yale University Not yet recruiting New Haven, Connecticut, United States, 06511 Contact: Amy Steffen, RN    203-737-8852    amy.steffen@yale.edu    Principal Investigator: Stuart Weinzimer, MD          Sub-Investigator: William Tamborlane, MD          United States, Florida Nemours Childrens Clinic Recruiting Jacksonville, Florida, United States, 32207 Contact: Kaitlin M Sikes, ARNP    904-697-3988    ksikes@nemours.org    Contact: Kim Englert, RN    904-697-3056    kimberly.englert@nemours.org    Principal Investigator: Nelly Mauras, MD          Sub-Investigator: Larry Fox, MD          United States, Missouri Washington University St. Louis Not yet recruiting Saint Louis, Missouri, United States, 63126 Contact: Lucy Levandoski, PA-C    314-454-6025    Levandoski_L@kids.wustl.edu    Principal Investigator: Neil White, MD          Sub-Investigator: Ana Maria Arbelaez, MD Less <<
NCT01280396 - Completed - Hong Kong ... More >> Western Psychiatric Centre Hong Kong, Hong Kong, 00000 Less <<
NCT02076542 Diabetes Mellitus Not Applicable Recruiting December 2018 Germany ... More >> Research Institute of the Diabetes Academy Mergentheim (FIDAM) Recruiting Bad Mergentheim, Germany, D-97980 Contact: Norbert Hermanns, PhD    0049 7931 594 ext 553    hermanns@diabetes-zentrum.de    Principal Investigator: Bernhard Kulzer, PhD          Sub-Investigator: Nikola Bergis-Jurgan, MSc          Sub-Investigator: Dominic Ehrmann, MSc          Zentrum für Diabetologie Bergedorf Recruiting Hamburg, Germany, 21029 Contact: Jens Kröger, M.D.       diabeteszentrumhamburg@t-online.de    Principal Investigator: Jens Kröger, M.D          Diabeteszentrum Ludwigsburg Recruiting Ludwigsburg, Germany, 71634 Contact: Jörg Gloyer, M.D       kontakt@diabeteszentrum-ludwigsburg.de    Principal Investigator: Jörg Gloyer, M.D          Diabetologische Schwerpunktpraxis Neuss Recruiting Neuss, Germany, 41462 Contact: Rainer Betzholz, M.D       info@dr-betzholz.de    Principal Investigator: Rainer Betzholz, M.D Less <<
NCT01364675 Pre-diabetes ... More >>Pre-hypertension Less << Not Applicable Unknown December 2016 Thailand ... More >> Ubon ratchathani Public Health Office Not yet recruiting Muang District, Ubon ratchathani, Thailand, 34000 Principal Investigator: Phisitt Vejakama, M.D. Less <<
NCT00538642 - Completed - -
NCT00490932 Diarrhea Dyse... More >>ntery Less << Phase 4 Completed - India ... More >> ID & BG Hospital, Beliaghata, Kolkata-700 010 Kolkata, West Bengal, India, 700010 Less <<
NCT03273387 Precapillary Pulmonary Hyperte... More >>nsion Less << Phase 2 Phase 3 Recruiting October 1, 2018 Indonesia ... More >> National Cardiovascular Center Harapan Kita Hospital Recruiting Jakarta, Indonesia, 11420 Contact: Hary Sakti Muliawan, MD, PhD    +6281311666626    saqti1@gmail.com    Contact: Bambang Budi Siswanto, MD, PhD    +62816924957    bambbs@gmail.com    Principal Investigator: Hary Sakti Muliawan, MD, PhD Less <<
NCT02017561 Metabolic Syndrome X ... More >> Diastolic Dysfunction Insulin Resistance Less << Phase 2 Active, not recruiting December 2018 Portugal ... More >> Gaia/Espinho Hospital Centre Vila Nova de Gaia, Portugal, 4434-502 Less <<
NCT02467478 Type 2 Diabetes ... More >> Impaired Renal Function Less << Phase 4 Recruiting December 2019 United States, District of Col... More >>umbia The George Washington University Medical Faculty Associates Recruiting Washington, District of Columbia, United States, 20037 Contact: Fiona Dore, BS    202-741-2342    fdore@mfa.gwu.edu Less <<
NCT03498001 Type II Diabetes Not Applicable Recruiting December 2020 France ... More >> Chu Dijon Bourgogne Recruiting Dijon, France, 21000 Contact: Charles GUENANCIA    03.80.29.56.23    charles.guenancia@chu-dijon.fr Less <<
NCT03739762 Sedentary Lifestyle Not Applicable Not yet recruiting March 31, 2023 United States, Washington ... More >> Kaiser Permanente Washington Not yet recruiting Seattle, Washington, United States, 98101 Contact: Julie B Cooper, MPA    206-287-2802    julie.b.cooper@kp.org    Principal Investigator: Dori E Rosenberg, PhD, MPH Less <<
NCT01438086 Heart Failure ... More >> Myocardial Infarction Less << Phase 1 Phase 2 Completed - Ireland ... More >> Cork University Hospital Cork, Ireland Netherlands Leiden University Medical Center Leiden, Netherlands Less <<
NCT01678235 Type 1 Diabetes Mellitus Phase 4 Completed - Poland ... More >> Department of Pediatrics, Medical University of Warsaw, Poland Warsaw, Poland, 01-184 Less <<
NCT00543179 Dumping Syndrome Phase 4 Unknown - Netherlands ... More >> UMC St. Radboud Medical Center Recruiting Nijmegen, Gelderland, Netherlands, 6500 HB Contact: Serena Slavenburg, MD    +31243617272    s.slavenburg@mdl.umcn.nl Less <<
NCT03259737 - Recruiting December 1, 2020 Norway ... More >> Innlandet Hospital Trust Lillehammer Not yet recruiting Lillehammer, Norway, 2609 Contact: Ellen Bøhmer, phD MD    004741907719    ellen.bohmer@sykehuset-innlandet.no    Contact: Ole Jonas Rolstad, MD    004791379093    olejonas.rolstad@sykehuset-innlandet.no    Ellen Bøhmer Recruiting Lillehammer, Norway Contact: Ellen Bøhmer, MD    004748018344    ellen.bohmer@sykehuset-innlandet.no Less <<
NCT01356303 Non-small Cell Lung Cancer Met... More >>astatic Less << Phase 2 Suspended(Difficulty in enroll... More >>ing patients) Less << August 2016 Saudi Arabia ... More >> King Abdul Aziz Medical City for National Guard Health Affairs Riyadh, Saudi Arabia, 11426 Less <<
NCT02200796 Overweight Ob... More >>esity Less << Not Applicable Completed - Canada, Ontario ... More >> Ryerson University, FIRST Labaratory. 350 Victoria Street Toronto, Ontario, Canada, M5B 2K3 Less <<
NCT02616510 - Completed - Netherlands ... More >> University Medical Center Utrecht Utrecht, Netherlands Less <<
NCT02462863 Diabetes Mellitus, Type 2 Phase 1 Unknown July 2017 United States, Ohio ... More >> J. Wesley Alexander, M.D., Sc.D. Recruiting Cincinnati, Ohio, United States, 45229 Contact: J. Wesley Alexander, M.D., Sc.D.    513-640-1268    jwesley.alexander@uc.edu    Contact: Meenakshi Iyer, M.D.    513-267-1558    meenakshi.iyer@thechristhospital.com Less <<
NCT02428946 Insulin Sensitivity Not Applicable Completed - Netherlands ... More >> Academic Medical Center Amsterdam, Netherlands, 1105AZ Less <<
NCT02112162 Rectal Neoplasms Phase 1 Terminated(Loss of funding) - United States, Missouri ... More >> Washington University School of Medicine St. Louis, Missouri, United States, 63110 Less <<
NCT00244777 Diarrhoea Phase 4 Completed - Bangladesh ... More >> International Centre for Diarrhoeal Disease Research, Bangladesh Dhaka, Bangladesh, 1212 Less <<
NCT00538642 Schizophrenia ... More >> Schizoaffective Disorder Bipolar Disorder Less << Not Applicable Completed - United States, Texas ... More >> The University of Texas Health Science Center At San Antonio San Antonio, Texas, United States, 78229 Less <<
NCT00146484 Diabetes Mellitus, Type 1 Phase 2 Completed - Canada, Ontario ... More >> Children's Hospital of Eastern Ontario Ottawa, Ontario, Canada, K1H 8L1 Less <<
NCT01672762 Type 2 Diabetes Mellitus Phase 3 Completed - Japan ... More >> Chubu, Japan Hokkaido, Japan Kansai, Japan Kantou, Japan Kyushu, Japan Shikoku, Japan Touhoku, Japan Less <<
NCT00663611 Healthy Phase 1 Completed - United States, Maryland ... More >> National Institute of Aging, Clinical Research Unit Baltimore, Maryland, United States, 21224 Less <<
NCT01492166 - Completed - Indonesia ... More >> Novo Nordisk Investigational Site Jakarta, Indonesia, 12520 Less <<
NCT03159234 Fetal Distress Not Applicable Completed - Egypt ... More >> Women Health Hospital - Assiut university Assiut, Egypt, 71111 Less <<
NCT02706262 Obesity Insul... More >>in Resistance Less << Not Applicable Recruiting December 2019 United States, Missouri ... More >> Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: Heather Gentile    314-273-1879    hgentile@wustl.edu    Principal Investigator: Samuel Klein, MD Less <<
NCT02005796 Postprandial Glycemia Not Applicable Completed - Finland ... More >> Department of Biochemistry, University of Turku University of Turku, Turku, Finland, 20014 Less <<
NCT01972152 - Completed - -
NCT01590797 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT02334475 Chronic Pain Not Applicable Completed - -
NCT01972152 Hypoglycemia Phase 2 Completed - United States, Texas ... More >> Texas Diabetes Institute, University Health System San Antonio, Texas, United States, 78207 Less <<
NCT01590797 - Completed - -
NCT03390322 Diabetes Mellitus, Type 2 Not Applicable Recruiting March 2019 Czechia ... More >> IKEM Recruiting Prague, Czechia Contact: Gabriela Petranova    +420 261 365 154    Gabriela.Petranova@ikem.cz    Principal Investigator: Marek Benes, MD          Israel Shaarei Tzedek Not yet recruiting Jerusalem, Israel Contact: Yael Lagemi       yaelagemi@szmc.org.il    Principal Investigator: Eran Goldin, Prof, MD          Spain Barcelona Clinical Hospital Not yet recruiting Barcelona, Spain Contact: Joseph Vidal Cortada       jovidal@clinic.cat    Principal Investigator: Joseph Vidal Cortada, MD          Ramón y Cajal Insitute of Health Research Not yet recruiting Madrid, Spain Contact: Chen BotvinMoshe       chenbm@digmamedical.com    Principal Investigator: Enrique Vazques, MD Less <<
NCT00721201 Subclinical Cushing's Phase 1 Phase 2 Completed - United Kingdom ... More >> Sheffield Teaching Hospitals NHS Foundation Trust Sheffield, United Kingdom Less <<
NCT02933853 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 1 Completed - Austria ... More >> Novo Nordisk Investigational Site Graz, Austria, 8010 Less <<
NCT03767270 Ornithine Transcarbamylase Def... More >>iciency Less << Phase 1 Phase 2 Not yet recruiting June 2022 -
NCT00021580 Diabetes Mellitus Phase 1 Unknown - United States, Missouri ... More >> Washington University School of Medicine St. Louis, Missouri, United States, 63110 Less <<
NCT00608049 Overweight Ca... More >>rdiovascular Diseases Less << Not Applicable Completed - United States, Maryland ... More >> Johns Hopkins Medical Institutions Baltimore, Maryland, United States, 21205 United States, Massachusetts Harvard T. H. Chan School of Public Health Boston, Massachusetts, United States, 02215 Less <<
NCT03548155 Schizophrenia ... More >> Therapeutics Less << Phase 4 Completed - -
NCT02021435 Blood Pressure ... More >> Cardiovascular Diseases Death Less << Not Applicable Unknown - China, Tibet ... More >> Not yet recruiting Damxung, Tibet, China, 851500 Not yet recruiting Maizhokunggar, Tibet, China, 850200 Less <<
NCT00108901 Obesity Type ... More >>2 Diabetes Prevention Executive Function (Cognition) Less << Phase 2 Completed - United States, Georgia ... More >> Georgia Prevention Institute, Medical College of Georgia Augusta, Georgia, United States, 30912 Less <<
NCT01589653 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 4 Completed - Egypt ... More >> Novo Nordisk Investigational Site Alexandria, Egypt, 21131 Novo Nordisk Investigational Site Beni-Suef, Egypt, 62511 Novo Nordisk Investigational Site Cairo, Egypt, 11562 Indonesia Novo Nordisk Investigational Site Bandung, Indonesia, 40161 Novo Nordisk Investigational Site Malang, Indonesia, 65111 Morocco Novo Nordisk Investigational Site Casablanca, Morocco, 20100 Novo Nordisk Investigational Site Marrakech, Morocco, 40000 Saudi Arabia Novo Nordisk Investigational Site Jeddah, Saudi Arabia, 80215 Novo Nordisk Investigational Site Riyadh, Saudi Arabia, 11211 Novo Nordisk Investigational Site Riyadh, Saudi Arabia, 11426 Novo Nordisk Investigational Site Taif, Saudi Arabia, 21944 Tunisia Novo Nordisk Investigational Site Tunis, Tunisia, 1007 Novo Nordisk Investigational Site Tunis, Tunisia, 1008 Vietnam Novo Nordisk Investigational Site Ha Noi City, Vietnam Novo Nordisk Investigational Site Ho Chi Minh City, Vietnam Less <<
NCT02478762 Gestational Diabetes Mellitus Phase 3 Terminated(very difficult recr... More >>uitment) Less << - Canada, Quebec ... More >> Centre de recherche du Centre hospitalier universitaire de Sherbrooke Sherbrooke, Quebec, Canada, J1H5N4 Less <<
NCT00006432 Diabetes Mellitus, Non-Insulin... More >>-Dependent Less << Not Applicable Completed - United States, North Carolina ... More >> Duke University Medical Center Durham, North Carolina, United States, 27710 Less <<
NCT02337660 Non-alcoholic Fatty Liver Dise... More >>ase Less << Not Applicable Completed - Denmark ... More >> Center for Diabetes Research Gentofte, Denmark, 2900 Less <<
NCT00647023 Polycystic Ovary Syndrome Not Applicable Terminated - -
NCT02828228 Obesity Not Applicable Recruiting February 2019 Poland ... More >> IUCCGdansk Recruiting Gdansk, Pomorskie, Poland, 80-210 Contact: Agnieszka Szlagatys, MD, PhD    601622894    aga1@gumed.edu.pl Less <<
NCT01589653 - Completed - -
NCT02760017 Diabetes Not Applicable Completed - Brazil ... More >> Universidade do Extremo Sul Catarinense Criciuma, Santa Catarina, Brazil, 88801450 Less <<
NCT00455858 - Completed - -
NCT01410604 Obesity Phase 4 Completed - Mexico ... More >> Hospital Infantil de México Federico Gómez México, Distrito Federal, Mexico, 06720 Hospital Regional de Alta Especialidad del Bajío León, Guanajuato, Mexico, 37670 Less <<
NCT00455858 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 4 Completed - Korea, Republic of ... More >> Seoul, Korea, Republic of Less <<
NCT03033407 Diabetes Mellitus Not Applicable Completed - -
NCT01410604 - Completed - -
NCT01206153 Amenorrhea Phase 4 Completed - China, Hunan ... More >> Institute of Mental Health of The Second Xiangya Hospital, Central South University Changsha, Hunan, China, 410011 Less <<
NCT01509482 Insulin Resistance ... More >> Oligospermia Azoospermia Less << Not Applicable Completed - Egypt ... More >> The Egyptian IVF-ET center Cairo, Egypt, 11431 Less <<
NCT01452893 - Completed - Germany ... More >> Dept. of Endocrinology and Diabetology, Dept. of Medicine I, University Hospital Wuerzburg Wuerzburg, Germany, 97080 Less <<
NCT03280511 Peritoneum Cancer ... More >> Peritoneal Carcinomatosis Peritoneal Metastases Colo-rectal Cancer Less << Phase 2 Recruiting March 1, 2025 Denmark ... More >> Odense PIPAC Center, Department of Surgery, Odense University Hospital Recruiting Odense, Denmark, 5000 Contact: Martin Graversen, MD    +45 30549497    martin.graversen@rsyd.dk    Principal Investigator: Martin Graversen, MD, Ph.D. Less <<
NCT01109927 Diabetes, Autoimmune ... More >> Diabetes Mellitus, Adult-Onset Less << Phase 4 Completed - -
NCT00115973 Diabetes Diab... More >>etes Mellitus, Type 2 Delivery Systems Less << Phase 1 Completed - United States, California ... More >> Novo Nordisk Investigational Site Chula Vista, California, United States, 91911 United States, Florida Novo Nordisk Investigational Site Miami, Florida, United States, 33142 United States, Kansas Novo Nordisk Investigational Site Witchita, Kansas, United States, 67214-4942 United States, New Jersey Novo Nordisk Investigational Site Willingboro, New Jersey, United States, 08046 United States, North Dakota Novo Nordisk Investigational Site Fargo, North Dakota, United States, 58104 United States, Texas Novo Nordisk Investigational Site San Antonio, Texas, United States, 78229 Less <<
NCT01517321 Type 2 Diabetes Phase 3 Completed - Japan ... More >> Chubu Region Clinical Site Chubu, Japan Chugoku Region Clinical Site Chugoku, Japan Kanto Region Clinical Site Kanto, Japan Kinki Region Clinical Site Kinki, Japan Kyusyu Region Clinical Site Kyusyu, Japan Tohoku Region Clinical Site Tohoku, Japan Less <<
NCT00119990 Peritoneal Dialysis Not Applicable Terminated January 2010 Denmark ... More >> Deparment of Renal Medicine, Skejby Hospital Aarhus, Denmark, 8200 Less <<
NCT00706420 Diabetes Mellitus Phase 1 Active, not recruiting April 2019 United States, California ... More >> City of Hope Medical Center Duarte, California, United States, 91010 Less <<
NCT02066155 Type 2 Diabetes Not Applicable Active, not recruiting December 31, 2019 United States, Michigan ... More >> University of Michigan Medical School Ann Arbor, Michigan, United States, 48109 Less <<
NCT00245206 Schizophrenia ... More >> Alzheimer's Disease Dementia Less << Phase 4 Completed - United States, California ... More >> University of California, San Diego San Diego, California, United States, 92037 Less <<
NCT00001325 - Completed - United States, Maryland ... More >> National Institute of Neurological Disorders and Stroke (NINDS) Bethesda, Maryland, United States, 20892 Less <<
NCT02649907 Hormonal Response to Different... More >> Compositions of Macronutrients Less << Not Applicable Unknown October 2017 Germany ... More >> Charite Campus Mitte Recruiting Berlin, Germany, 10117 Contact: Knut Mai, MD       knut.mai@charite.de    Contact: Joachim Spranger, Prof       joachim.spranger@charite.de Less <<
NCT02644954 Psoriasis Phase 3 Unknown - -
NCT02974244 - Completed - United States, Massachusetts ... More >> Optum Epidemiology Boston, Massachusetts, United States, 02215 Less <<
NCT00849576 Type 2 Diabetes Phase 3 Completed - Germany ... More >> IKFE Parcusstrasse 8, Mainz, Germany, 55116 Less <<
NCT02420262 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT02420262 - Completed - -
NCT02463084 Prediabetic State ... More >> Insulin Resistance Middle Age Prehypertension Mild Cognitive Impairment Less << Not Applicable Completed - United States, North Carolina ... More >> Wake Forest Baptist Health Winston-Salem, North Carolina, United States, 27157 Less <<
NCT01046721 Type 2 Diabetes Not Applicable Completed - United Kingdom ... More >> David Greenfield Human Physiology Laboratories Nottingham, Notts, United Kingdom, NG72UH Less <<
NCT01517464 Neoplasm Phase 1 Completed - United States, Texas ... More >> University of Texas, M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT02583438 Type 2 Diabetes ... More >> Obesity Less << Phase 4 Unknown January 2018 -
NCT01112449 Effect of Selenium on Oxidativ... More >>e Stress in Healthy Men Less << Not Applicable Completed - United States, Pennsylvania ... More >> Penn State Milton Hershey Medical Center Hershey, Pennsylvania, United States, 17033 Less <<
NCT01342562 Benign Prostatic Hypertrophy Not Applicable Completed - Korea, Republic of ... More >> Severance Hospital Seoul, Korea, Republic of, 120-752 Less <<
NCT01832233 Chronic Kidney Disease Not Applicable Active, not recruiting December 2017 Canada, Saskatchewan ... More >> Regina Qu'Appelle Health Region Regina, Saskatchewan, Canada Less <<
NCT02132442 Type 2 Diabetes ... More >> Nonalcoholic Fatty Liver Disease Vitamin D Deficiency Less << Phase 3 Completed - United States, Massachusetts ... More >> University of Massachusetts Medical School Worcester, Massachusetts, United States, 01609 Less <<
NCT03652649 Type2 Diabetes Mellitus ... More >> Obesity Less << Not Applicable Recruiting November 1, 2020 United States, Maryland ... More >> Ivana Tyrlikova Recruiting Bethesda, Maryland, United States, 20817 Contact: Ivana Tyrlikova, MD    301-530-9744    tyrlikovai@epilepsydc.com    Contact: Pavel Klein, MD    3015309744    kleinp@epilepsydc.com    Principal Investigator: Pavel Klein, MD Less <<
NCT02398877 Childhood Trauma ... More >> Major Depressive Disorder Less << Not Applicable Completed - Germany ... More >> Charite University Berlin, Germany Less <<
NCT00633087 Prostate Cancer Phase 1 Phase 2 Terminated(Slow accrual) - United States, New Jersey ... More >> The Cancer Institute of New Jersey New Brunswick, New Jersey, United States, 08901 Less <<
NCT03113773 Ischemic Heart Disease Phase 1 Phase 2 Recruiting August 2019 United Kingdom ... More >> Addenbrooke's Hospital Recruiting Cambridge, Cambridgeshire, United Kingdom, CB20QQ Contact: Joseph Cheriyan, MBChB, MA, FRCP       jc403@medschl.cam.ac.uk    Principal Investigator: Joseph Cheriyan, MBChB, MA, FRCP Less <<
NCT00633087 - Terminated(Slow accrual) - -
NCT01384968 Acute Nitrate Ingestion on Ath... More >>letic Performance Less << Not Applicable Completed - Netherlands ... More >> Maastricht University Maastricht, Limburg, Netherlands, 6229ER Less <<
NCT01007656 Healthy Not Applicable Completed - Taiwan ... More >> PingTung Christian Hospital Pingtung, Taiwan Less <<
NCT03592667 Hypertension Phase 4 Enrolling by invitation May 2019 Mexico ... More >> Instituto de Terapeútica Experimental y Clínica. Centro Universitario de Ciencias de la Salud. Universidad de Guadalajara Guadalajara, Jalisco, Mexico, 44340 Less <<
NCT01007656 - Completed - -
NCT03434860 Type2 Diabetes ... More >> Insulin Resistance Probiotic Less << Not Applicable Completed - -
NCT00395343 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT00395343 - Completed - -
NCT00290927 Diabetes Mellitus, Type 2 Phase 3 Completed - Japan ... More >> Sanofi-Aventis Tokyo, Japan Less <<
NCT00295633 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT00295633 - Completed - -
NCT00922376 Diabetes (Insulin-requiring, T... More >>ype 1 or Type 2) Less << Not Applicable Completed - United Kingdom ... More >> University College London (UCL) London, United Kingdom, W1W 7EJ Less <<
NCT00521105 Type 1 Diabetes Mellitus Not Applicable Completed - Canada, Alberta ... More >> Endocrine Clinic, Alberta Children's Hospital Calgary, Alberta, Canada, T3B 6A8 Less <<
NCT03504098 - Recruiting July 31, 2020 Taiwan ... More >> National Taiwan University Hospital Recruiting Taipei, Taiwan, 100 Contact: Jin-Shing Chen    8862-23123456-70918    chenjs@ntu.edu.tw Less <<
NCT03307343 Hypertension ... More >>Prehypertension Less << Not Applicable Recruiting June 2022 United States, Pennsylvania ... More >> University of Pittsburgh Physical Activity and Weight Management Research Center Recruiting Pittsburgh, Pennsylvania, United States, 15216 Contact: Diane Casille    412-310-4020       Principal Investigator: Bethany Barone Gibbs, PhD          Sub-Investigator: John M Jakicic, PhD          Sub-Investigator: Subashan Perera, PhD          Sub-Investigator: Matthew Muldoon, MD          Sub-Investigator: Margaret B Conroy, MD Less <<
NCT01704378 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 4 Completed - Finland ... More >> Novo Nordisk Investigational Site Kotka, Finland, 48210 Novo Nordisk Investigational Site Kuopio, Finland, 70210 Novo Nordisk Investigational Site Lahti, Finland, 15850 Norway Novo Nordisk Investigational Site Gjøvik, Norway, NO-2819 Novo Nordisk Investigational Site Horten, Norway, NO-3188 Novo Nordisk Investigational Site Kirkenær, Norway, 2260 Novo Nordisk Investigational Site Kongsvinger, Norway, 2212 Novo Nordisk Investigational Site Notodden, Norway, NO-3675 Sweden Novo Nordisk Investigational Site Falun, Sweden, 791 82 Novo Nordisk Investigational Site Helsingborg, Sweden, 254 43 Novo Nordisk Investigational Site Motala, Sweden, 591 85 United Kingdom Novo Nordisk Investigational Site Derby, United Kingdom, DE7 1DY Novo Nordisk Investigational Site Edinburgh, United Kingdom, EH16 4SA Novo Nordisk Investigational Site Hull, United Kingdom, HU3 2JZ Novo Nordisk Investigational Site Liverpool, United Kingdom, L7 8XP Novo Nordisk Investigational Site Scarborough, United Kingdom, YO12 6QL Novo Nordisk Investigational Site Wirral, Merseyside, United Kingdom, CH63 4JY Less <<
NCT01962857 Insulin Resistance ... More >> Obesity Metabolic Syndrome Less << Not Applicable Suspended(No member of staff a... More >>vailable for active recruitment at the moment) Less << December 2017 United Kingdom ... More >> University of Glasgow Glasgow, United Kingdom, G12 8QQ Less <<
NCT02368600 Gestational Diabetes Mellitus Not Applicable Completed - China ... More >> Chinese University of Hong Kong Hong Kong, China Less <<
NCT02152111 Obesity Cardi... More >>ovascular Risk Factor Less << Not Applicable Completed - -
NCT00461149 Acromegaly Phase 4 Completed - Italy ... More >> Department of Molecular and Clinical Endocrinology and Oncology University Federico II of Naples Naples, Italy, 80131 Less <<
NCT01920256 Type 2 Diabetes Not Applicable Completed - United States, Michigan ... More >> University of Michigan Health System Ann Arbor, Michigan, United States, 48109 Less <<
NCT03028714 Health Knowledge, Attitudes, P... More >>ractice Less << Not Applicable Completed - United Kingdom ... More >> Kingston University, London & St George's, University of London London, United Kingdom, SW17 0RE Less <<
NCT01818674 Diabetes Mellitus, Type 2 ... More >> Obesity Less << Not Applicable Active, not recruiting December 2017 Jordan ... More >> Abu Nseir Ministry of Health Center Amman, Jordan Kreibet Al Souq Ministry of Health Center Amman, Jordan Naour Ministry of Health Center Amman, Jordan Less <<
NCT00001972 - Completed - United States, Maryland ... More >> National Institute of Neurological Disorders and Stroke (NINDS) Bethesda, Maryland, United States, 20892 Less <<
NCT02413060 Diabetes Not Applicable Unknown March 2016 China, Shanghai ... More >> Cao jia du community health service centre Shanghai, Shanghai, China Less <<
NCT01854463 DIABETES MELLITUS Phase 4 Completed - Korea, Republic of ... More >> Chuncheon Sacred Heart Hospital Chuncheon, Gangwon-do, Korea, Republic of, 200704 Less <<
NCT00186459 Obesity Not Applicable Unknown - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT02987348 - Completed - United Kingdom ... More >> Pharmatelligence Cardiff, United Kingdom, CF14 3QZ Less <<
NCT02255578 Polycystic Ovary Syndrome Phase 3 Unknown September 2018 Israel ... More >> Sheba Medical Center Ramat Gan, Israel, 526210 Less <<
NCT03096002 - Recruiting April 2019 Canada, British Columbia ... More >> YMCA of Okanagan Recruiting Kelowna, British Columbia, Canada, V1X 2M9 Contact: Mary E Jung, PhD    250-807-8419    mary.jung@ubc.ca    Principal Investigator: Mary E Jung, PhD Less <<
NCT02864160 Diabetes Mellitus Not Applicable Recruiting September 2019 United States, Arizona ... More >> University of Arizona College of Nursing Recruiting Tucson, Arizona, United States, 85724 Contact: Usha Menn, PhD    520-626-0828    umenon@email.arizona.edu    Contact: Dianna Candito    520-626-3628    dcandito@email.arizona.edu    United States, Ohio The Ohio State University Recruiting Columbus, Ohio, United States, 43201 Contact: Estephanie Ortiz, BA    614-688-2126    ortiz.115@osu.edu    Contact: Usha Menon, PhD    520-626-0828    umenon@email.arizona.edu    Principal Investigator: Usha Menon, PhD, RN          Principal Investigator: Glenn A Martinez, PhD, MPH          Sub-Investigator: Laura A Szalacha, EdD          Sub-Investigator: Margaret Graham, PhD, CRNP          Sub-Investigator: Jose Pares Avila, PhD Less <<
NCT02924896 Lipidaemia Not Applicable Completed - United Kingdom ... More >> NIHR/Wellcome Trust Imperial Clinical Research Facility London, United Kingdom, W12 0HS Less <<
NCT01635673 Effects of Whole Body Vibratio... More >>n Exercise on Metabolic Systems Less << Not Applicable Completed - United States, California ... More >> USC Biokinesiology and Physical Therapy, Clinical Exercise Research Center Los Angeles, California, United States, 90033 Less <<
NCT02041520 - Completed - -
NCT03714646 Pre Diabetes ... More >>Obesity Less << Not Applicable Recruiting February 2019 Netherlands ... More >> Maastricht University Recruiting Maastricht, Limburg, Netherlands, 5229 ER Contact: Ellen E Blaak, PhD Less <<
NCT03659825 Hypoxia Ketos... More >>is Less << Not Applicable Not yet recruiting November 15, 2018 -
NCT02057224 Insulin Resistance ... More >> Hypertension Less << Phase 4 Suspended(Renal denervation ha... More >>s not been used as clinical method in our hospital the last two years) Less << December 2017 Sweden ... More >> Umeå University Umeå, Sweden, 90187 Less <<
NCT02041520 HIV/AIDS Phase 3 Completed - Mexico ... More >> Instituto Mexicano del Seguro Social Leon, Guanajuato, Mexico, 37320 Less <<
NCT00879957 Infant, Premature ... More >> Anticoagulants Thrombosis Less << Not Applicable Withdrawn(A study was publishe... More >>d regarding the same question this study had.) Less << - United States, Texas ... More >> University Hospital San Antonio, Texas, United States, 78229 Less <<
NCT03287375 Peritoneum; Carcinomatosis ... More >> Peritoneal Neoplasms Peritoneal Metastases Chemotherapy Effect Chemotherapeutic Toxicity Quality of Life Histologic Progression Less << Phase 2 Recruiting December 1, 2020 Denmark ... More >> Department of Surgery, Odense University Hospital Recruiting Odense, Denmark, 5000 Principal Investigator: Michael B Mortensen, MD, Ph.D. Less <<
NCT01417247 Metabolic Syndrome Not Applicable Recruiting June 2020 China, Chongqing ... More >> 2ndChongqingMU Recruiting Chongqing, Chongqing, China, 400010 Contact: Yuehui Yin, MD    0086-23-63693766    yinyh63@163.com    Principal Investigator: Yuehui Yin, MD Less <<
NCT00961740 Childhood Obesity Not Applicable Completed - Norway ... More >> University of Bergen Bergen, Hordaland, Norway, 5020 Less <<
NCT01894945 - Unknown July 2014 Denmark ... More >> Odense University Hospital, Department of hematology Recruiting Odense, Denmark, 5000 Contact: Karen Mylam, MD    0045 6441 3186    karen.mylam@rsyd.dk    Principal Investigator: Karen Juul Mylam, MD          Roskilde Hospital Not yet recruiting Roskilde, Denmark, 4000 Contact: Lars Møller Pedersen, MD       lmpn@regionsjaelland.dk    Sub-Investigator: Lars Møller Pedersen, MD Less <<
NCT03673904 - Completed - -
NCT03072901 - Terminated(GID terminated the ... More >>Registry due to evolving registry requirements) Less << - -
NCT01772251 Diabetes Mellitus, Insulin-Dep... More >>endent, 1 Less << Phase 1 Phase 2 Completed - Israel ... More >> Assaf-Harofeh Medical Center Zerifin, Israel Less <<
NCT00802230 Heart Failure Phase 4 Completed - United States, Utah ... More >> University of Utah Salt Lake City, Utah, United States, 84104 Less <<
NCT02024854 Premature Birth Not Applicable Recruiting January 2021 Norway ... More >> Nyfødt intensiv, Drammen sykehus Recruiting Drammen, Norway Contact: Daniel Øyan, MD          Contact: Kristoffer Hochnowski, MD          Nyfødt intensiv, Sørlandet Sykehus Recruiting Kristiansand, Norway Contact: Helene Engesland, MD          Contact: Kåre Danielsen, MD          NICU St Olavs Hospital Recruiting Trondheim, Norway Contact: Laila M Kristoffersen, MSc Less <<
NCT03620617 Gut Microbiota ... More >> Metabolic Syndrome Less << Not Applicable Recruiting September 2020 Canada ... More >> Laval University Recruiting Québec, Canada, G1V0A6 Contact: Marie-Claude Vohl    418-656-2131 ext 4676    marie-claude.vohl@ulaval.ca Less <<
NCT03254381 Cognitive Impairment Not Applicable Recruiting February 2020 Canada, Ontario ... More >> Community Recruiting London, Ontario, Canada Contact: Lindsay S Nagamatsu, PhD Less <<
NCT03687645 Cancer Cardio... More >>vascular Diseases Less << Not Applicable Recruiting June 30, 2020 United Kingdom ... More >> University College London Recruiting London, United Kingdom Contact: Dr Shonit Punwani          Contact: Dr Arash Latifoljar          Principal Investigator: Dr Shonit Punwani, PhD, FRCR          Sub-Investigator: Dr Arash Latifoltojar, MD, MSc Less <<
NCT02587286 Diabetes Mellitus, Type 2 Not Applicable Completed - -
NCT00123760 Brain Neoplasms ... More >> Lung Neoplasms Thyroid Neoplasms Colorectal Neoplasms Lymphoma Less << Phase 2 Phase 3 Completed - Canada, Alberta ... More >> Cross Cancer Institute Edmonton, Alberta, Canada, T6G 1Z2 Less <<
NCT02980744 Stroke Not Applicable Completed - Canada, Alberta ... More >> University of Alberta Edmonton, Alberta, Canada, T6G 2G4 Less <<
NCT00005905 Lipodystrophy Phase 2 Completed - United States, Maryland ... More >> National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Bethesda, Maryland, United States, 20892 Less <<
NCT00824343 Squamous Cell Carcinoma of Hea... More >>d and Neck Less << Phase 2 Completed - India ... More >> Bharath Hospital & Institute of Oncology, Mysore Mysore, Karnataka, India, 570017 Regional Cancer Centre Trivandrum, Kerala, India, 695011 Kashyap Nursing Home Mumbai, Maharashtra, India, 400014 Jaslok Hospital, Mumbai Mumbai, Maharashtra, India, 400026 Central India Cancer Research Institute, Nagpur, Maharashtra, India, 440010 Deenanath Mangeshkar Hospital & Research Centre Pune, Maharashtra, India, 411004 Bhagwan Mahaveer Cancer Hospital & Research Centre, Dept. Of Medical Oncology, Jaipur Jaipur, Rajasthan, India, 302 017 V. N. Cancer Centre, GKNM Hospital, Coimbatore, Tamilnadu, India, 641037 Dept. Of Surgical Oncology, CSM Medical University, Lucknow Lucknow, UttarPradesh, India, 226003 Less <<
NCT03731598 - Recruiting January 2022 United States, Utah ... More >> University of Utah Recruiting Salt Lake City, Utah, United States, 84108 Contact: Amy Rogers    801-585-5961    amy.rogers@hsc.utah.edu    The University of Utah Recruiting Salt Lake City, Utah, United States, 84112 Contact: Micah Drummond, PhD    801-587-7764       Contact       micah.drummond@hsc.utah.edu    Principal Investigator: Micah Drummond Less <<
NCT01054300 - Completed - -
NCT00491725 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 4 Completed - China, Beijing ... More >> Beijing, Beijing, China, 100034 Less <<
NCT02130492 Radiosensitive Stage IV Solid ... More >>and Hematological Tumors With High FDG Uptake Not Responding to Standard of Care Lung Cancer, Head and Neck Cancer, Breast Cancer, Gastric Cancer, Pancreatic Cancer, Colon Cancer, Lymphomas, Sarcomas, Etc Less << Phase 1 Suspended(The study has moved ... More >>to another institution and will re-open in the near future) Less << July 2021 United States, New York ... More >> Weill Medical College of Cornell University New York, New York, United States, 10024 Less <<
NCT01873690 Urolithiasis Phase 3 Terminated(Due to the low recr... More >>uitment rate and the large number lost to follow-up) Less << - Canada, Ontario ... More >> St. Joseph's Hospital, St. Joseph's Health Care London London, Ontario, Canada, N6A 4V2 Less <<
NCT01883401 Dyslipidemia ... More >>Obesity Less << Not Applicable Completed - United States, Oklahoma ... More >> Oklahoma State University Stillwater, Oklahoma, United States, 74078 Less <<
NCT02551640 Diabetes Mellitus, Type 2 ... More >> Prediabetic State Hypertension Prehypertension Obesity Less << Not Applicable Active, not recruiting December 2018 United States, Massachusetts ... More >> Mass General: Charlestown Healthcare Center Charlestown, Massachusetts, United States, 02129 Mass General Revere HealthCare Center Revere, Massachusetts, United States, 02151 Less <<
NCT02451917 Type 2 Diabetes Mellitus ... More >> Chronic Kidney Disease Less << Phase 4 Completed - Brazil ... More >> University of Sao Paulo Sao Paulo, Brazil, 05410001 Less <<
NCT01054300 Diabetes Mellitus, Type 2 ... More >> Adult Less << Phase 1 Completed - -
NCT02451917 - Completed - -
NCT00678080 - Completed - -
NCT03438162 Diabetes Mellitus, Type 2 ... More >> Education Drug-Related Side Effects and Adverse Reactions Less << Not Applicable Completed - Croatia ... More >> University Hospital Dubrava Zagreb, Croatia, 10000 Less <<
NCT03643315 Obesity Not Applicable Not yet recruiting September 2019 -
NCT00678080 Pregnancy Complications Not Applicable Completed - United States, Texas ... More >> Valley Baptist Hospital Brownsville, Texas, United States, 78520 Lyndon B Johnson Hospital Houston, Texas, United States, 77026 Memorial Hermann Hospital Houston, Texas, United States, 77030 Less <<
NCT02577003 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT02577003 - Completed - -
NCT01377155 Diabetes Mellitus, Type 2 Not Applicable Completed - United States, California ... More >> Diabetes Care Center Salinas, California, United States, 93901 Less <<
NCT02834715 Diabetes Mellitus Not Applicable Completed - Cameroon ... More >> National Obesity Centre Yaounde, Cameroon Less <<
NCT03265002 Irritable Bowel Syndrome Not Applicable Recruiting March 2019 United Kingdom ... More >> University of Nottingham Recruiting Nottingham, Nottinghamshire, United Kingdom, NG7 2UH Contact: David Gunn, BMBS    01159709966    david.gunn@nottingham.ac.uk Less <<
NCT00204230 Immunosuppressive Agents ... More >> Kidney Failure, Chronic Kidney Transplantation Less << Not Applicable Terminated - -
NCT02002221 Type 2 Diabetes Mellitus (T2DM... More >>) Less << Phase 4 Completed - Japan ... More >> Novartis Investigative Site Fukuoka-city, Fukuoka, Japan, 810-8798 Novartis Investigative Site Fukuoka-city, Fukuoka, Japan, 815-0071 Novartis Investigative Site Fukutsu-city, Fukuoka, Japan, 811-3217 Novartis Investigative Site Kitakyushu-city, Fukuoka, Japan, 800-0295 Novartis Investigative Site Koriyama-city, Fukushima, Japan, 963-8851 Novartis Investigative Site Mito-city, Ibaraki, Japan, 311-4153 Novartis Investigative Site Ibusuki-city, Kagoshima, Japan, 891-0401 Novartis Investigative Site Yokohama-city, Kanagawa, Japan, 221-0802 Novartis Investigative Site Kumamoto-city, Kumamoto, Japan, 861-8039 Novartis Investigative Site Kumamoto-city, Kumamoto, Japan, 861-8520 Novartis Investigative Site Yatsushiro-city, Kumamoto, Japan, 866-8533 Novartis Investigative Site Kyoto-city, Kyoto, Japan, 615-0035 Novartis Investigative Site Sendai-city, Miyagi, Japan, 980-0021 Novartis Investigative Site Hirakata-City, Osaka, Japan, 573-0153 Novartis Investigative Site Izumisano-city, Osaka, Japan, 598-8577 Novartis Investigative Site Osaka-city, Osaka, Japan, 530-0001 Novartis Investigative Site Osaka-city, Osaka, Japan, 534-0021 Novartis Investigative Site Takatsuki-city, Osaka, Japan, 569-1096 Novartis Investigative Site Ageo-city, Saitama, Japan, 362-8588 Novartis Investigative Site Saitama-city, Saitama, Japan, 336-0963 Novartis Investigative Site Sayama-city, Saitama, Japan, 350-1305 Novartis Investigative Site Tokorozawa-city, Saitama, Japan, 359-1161 Novartis Investigative Site Adachi-ku, Tokyo, Japan, 123-0845 Novartis Investigative Site Chiyoda-ku, Tokyo, Japan, 101-0024 Novartis Investigative Site Chuo-ku, Tokyo, Japan, 103-0027 Novartis Investigative Site Chuo-ku, Tokyo, Japan, 103-0028 Novartis Investigative Site Chuo-ku, Tokyo, Japan, 104-0061 Novartis Investigative Site Nerima-ku, Tokyo, Japan, 177-0041 Novartis Investigative Site Nerima-ku, Tokyo, Japan, 177-0051 Novartis Investigative Site Ota-ku, Tokyo, Japan, 144-0051 Novartis Investigative Site Suginami-ku, Tokyo, Japan, 166-0004 Less <<
NCT01778738 Type 2 Diabetes ... More >> Morbid Obesity Less << Not Applicable Active, not recruiting March 2023 Norway ... More >> The Morbid Obesity Center, Vestfold Hospital Trust Tønsberg, Vestfold, Norway, 3103 Less <<
NCT02791867 Diabetes Mellitus, Type 2 Phase 1 Phase 2 Terminated(The study drug was ... More >>not provided resulting in termination for unacceptable delays) Less << - Kuwait ... More >> Dasman DIabetes Institute Kuwait, Kuwait Less <<
NCT02366624 - Completed - Chile ... More >> Pontificia Universidad Catolica de Chile Santiago, Region Metropolitana, Chile Less <<
NCT03689374 Diabetes Mellitus, Type 2 Phase 3 Recruiting November 13, 2020 -
NCT02823249 Endocrine System Diseases Not Applicable Completed - Switzerland ... More >> University Hospital Basel Basel, Basel-Stadt, Switzerland, 4031 Less <<
NCT00662714 Cystic Fibrosis ... More >> Diabetes Mellitus Less << Phase 3 Completed - Austria ... More >> Universitätsklinik für Kinder- und Jugendheilkunde Graz, Austria, 8036 Universitätsklinik für Kinder- und Jugendheilkunde Wien, Austria, 1090 France CRCM adultes Lille, France, 59037 CRCM adultes, Centre Hospitalier Lyon Sud Lyon, France, 69495 APHP, CRCM pediatrique, Hopital Necker Paris, France, 75015 APHP, CRCM pediatrique, Hopital Robert Debre Paris, France, 75019 APHP, CRCM pediatrique, Hopital Cochin Paris, France, 75679 CRCM adultes, Hopital Civil Strasbourg, France, 67000 Germany Helios Klinikum Emil von Behring Berlin, Germany, 12200 Heliosklinikum Berlin-Buch Berlin, Germany, 13125 Prof.-Hess-Kinderklinik/ Zentralkrankenhaus Bremen, Germany, 28205 Zentralkrankenhaus "Links der Weser" Bremen, Germany, 28277 Universitätskinderklinik Düsseldorf Düsseldorf, Germany, 40225 Klinik für Kinder und Jugendliche Erlangen Erlangen, Germany, 91054 Universitätsklinikum Essen Essen, Germany, 45147 Ruhrlandklinik Essen Essen, Germany, 45239 Zentrum für Kinderheilkunde Frankfurt Frankfurt, Germany, 60590 Med. Klinik II, Allergologie und Pneumologie Frankfurt, Germany, 60596 Klinik Schillerhöhe Gerlingen, Germany, 70839 Klinik und Poliklinik für Kinder- und Jugendmedizin Greifswald, Germany, 17475 Altona - Klinik Hamburg, Germany, 22763 Medizinische Hochschule Hannover, Abt. Kinderheilkunde Hannover, Germany, 30625 Medizinische Hochschule Hannover, CF-Ambulanz f. Erwachsene Hannover, Germany, 30625 Klikum der Universität Heidelberg, Kinderklinik Heidelberg, Germany, 69120 Universitätsklinik für Kinder- und Jugendmedizin Homburg, Germany, 66421 Kinderkrankenhaus Park Schönfeld Kassel, Germany, 34121 Städtisches Krankenhaus Kiel Kiel, Germany, 24116 Klinik und Poliklinik für allgemeine Kinderheilkunde Köln, Germany, 50937 Universitätsklinik Mainz Mainz, Germany, 55101 Clemenshospital Münster, Germany, 48153 Elisabeth Kinderkrankenhaus Oldenburg, Germany, 26133 Kinderhospital Osnabrück Osnabrück, Germany, 49082 Kinderklinik Dritter Orden, Sozialpädiatrisches Zentrum Passau, Germany, 94032 Universitätsklinik für Kinder- und Jugendmedizin Tübingen, Germany, 72076 Julius-Maximilians Universität, Kinderpoliklinik Würzburg, Germany, 97080 Italy Centro Fibrosi Cistica Verona, Italy, 37100 Less <<
NCT00013598 Fatty Liver N... More >>onalcoholic Steatohepatitis Less << Phase 2 Completed - United States, Maryland ... More >> National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Bethesda, Maryland, United States, 20892 Less <<
NCT00001432 - Completed - United States, Maryland ... More >> National Cancer Institute (NCI) Bethesda, Maryland, United States, 20892 Less <<
NCT01849289 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT03266055 Gut Microbiota ... More >> Metabolic Syndrome Less << Not Applicable Recruiting December 2020 Canada ... More >> Laval University Recruiting Québec, Canada, G1V0A6 Contact: Marie-Claude Vohl    418-656-2131 ext 4676    marie-claude.vohl@ulaval.ca Less <<
NCT02002221 - Completed - -
NCT00123773 Sarcoma Multi... More >>ple Myeloma Testicular Neoplasms Ovarian Neoplasms Kidney Neoplasms Less << Phase 2 Completed - Canada, Alberta ... More >> Cross Cancer Institute Edmonton, Alberta, Canada, T6G 1Z2 Less <<
NCT01849289 - Completed - -
NCT01973920 Diabetes Mellitus ... More >> Insulin-Dependent Type 1 Less << Phase 2 Completed - Israel ... More >> Assaf-Harofeh Medical Center Zerifin, Israel Less <<
NCT02055651 - Completed - Brazil ... More >> Sao Paulo, Brazil Less <<
NCT00001342 - Completed - United States, Maryland ... More >> National Institute of Child Health and Human Development (NICHD) Bethesda, Maryland, United States, 20892 Less <<
NCT02343367 Pediatric Obesity Not Applicable Recruiting September 2020 United States, Texas ... More >> University of Texas Health Science Center San Antonio Recruiting San Antonio, Texas, United States, 78229 Contact: Laura Esparza, MS    210-562-6514    laura.esparza@austin.utexas.edu    Contact: Dorothy Long Parma, MD, MPH    210-562-6524    LongParma@uthscsa.edu Less <<
NCT00482443 Type 1 Diabetes Mellitus Not Applicable Completed - United Kingdom ... More >> Royal Bournemouth Hospital Bournemouth, Dorset, United Kingdom, BH7 7DW Less <<
NCT01720290 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 4 Completed - China, Beijing ... More >> Novo Nordisk Investigational Site Beijing, Beijing, China, 100191 China Novo Nordisk Investigational Site Beijing, China, 100029 Novo Nordisk Investigational Site Shanghai, China Less <<
NCT02017171 Diabetic Nephropathies ... More >> Coronary Artery Disease Less << Phase 3 Active, not recruiting June 2019 -
NCT01426126 Bladder Cancer ... More >> Ureter Cancer Less << Phase 2 Completed - Korea, Republic of ... More >> Asan Medical Center Seoul, Korea, Republic of, 138-736 Less <<
NCT03227107 - Recruiting December 30, 2020 China, Hunan ... More >> Xiangya hospital of Central South University Recruiting Changsha, Hunan, China, 410008 Contact: Li Haitao, Doctor    (+86)18684916132    168101013@csu.edu.cn Less <<
NCT02320448 Peritoneal Carcinomatosis Phase 2 Completed - Denmark ... More >> Odense University Hospital Odense, Denmark, 5000 Less <<
NCT02228837 Metabolic Syndrome Phase 2 Completed - United States, Florida ... More >> Department of Nutrition, Food and Exercise Sciences, Center for Advancing Exercise and Nutrition Research on Aging, Florida State University Tallahassee, Florida, United States, 32306 Less <<
NCT02758691 Human Memory ... More >>Intranasal Insulin Less << Phase 1 Completed - -
NCT00980187 Hypertension ... More >>Type 2 Diabetes Mellitus Less << Phase 4 Completed - Romania ... More >> Cardiology, University and Emergency Hospital Bucharest, Romania, 050098 Less <<
NCT01702298 - Completed - -
NCT01702298 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT00504218 - Terminated - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT03543449 - Active, not recruiting April 2019 Korea, Republic of ... More >> Department of Anesthesiology & Pain Medicine, Yonsei university college of medicine Seoul, Korea, Republic of, 120-752 Less <<
NCT02097069 Gestational Diabetes Mellitus Not Applicable Unknown - Italy ... More >> Hospital "SS Annunziata" Not yet recruiting Chieti, Italy, 66100 Contact: Ester Vitacolonna, Professor    +393398073446    e.vitacolonna@unich.it    Principal Investigator: Ester Vitacolonna, Professor Less <<
NCT00067821 - Recruiting - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office    (888) NCI-1937 Less <<
NCT01516476 Diabetes Mellitus Type 2 Phase 2 Terminated - United States, Ohio ... More >> Cincinnati, Ohio, United States, 45227 Less <<
NCT01729936 Overweight Ob... More >>ese Sedentary Less << Not Applicable Unknown December 2016 Spain ... More >> IDIAP Jordi Gol Recruiting Barcelona, Spain Contact: Carme Martín-Borràs       sedestactiv@gmail.com Less <<
NCT02711306 Metabolic Syndrome Not Applicable Completed - -
NCT02185482 Depression Ty... More >>pe 2 Diabetes Mellitus Less << Not Applicable Completed - India ... More >> NMP Medical Research Institute Kaithal, Haryana, India GyanSanjeevani Jaipur, Rajasthan, India Less <<
NCT03009916 Bileacid Malabsorption Phase 4 Completed - Denmark ... More >> Center for Diabetes Research, Gentofte Hospital Hellerup, Denmark, 2900 Less <<
NCT02683226 Polycystic Ovary Syndrome ... More >> Insulin Resistance Less << Phase 4 Completed - Slovenia ... More >> University Medical Center Ljubljana Ljubljana, Slovenia, 1000 Less <<
NCT00295659 - Completed - Canada, Quebec ... More >> Royal Victoria Hospital, McGill University Health Centre Montreal, Quebec, Canada, H3A 1A1 Less <<
NCT00920725 Diabetic Ketoacidosis Not Applicable Completed - United States, Illinois ... More >> Rush University Medical Center Chicago, Illinois, United States, 60612 Less <<
NCT01932879 Fuel Management Not Applicable Completed - United States, Maryland ... More >> USDA Beltsville Human Nutrition Research Center Beltsville, Maryland, United States, 20705 Less <<
NCT02062788 Insulin Resistance ... More >> Postoperative Complication Less << Phase 3 Terminated(patient enrollment ... More >>was failed.) Less << - Korea, Republic of ... More >> Seoul National University Bundang Hospital SeongNam, GyeongGi, Korea, Republic of, 463-707 Less <<
NCT02588950 Diabetes Mellitus, Type 2 Phase 1 Terminated(Slow enrollment) - United States, California ... More >> Profil Institute for Clinical Research Chula Vista, California, United States, 91911 Less <<
NCT00745303 - Completed - Taiwan ... More >> Taipei Veterans General Hospital Taipei, Taiwan, 112 Less <<
NCT00313313 Diabetes Phase 3 Completed - -
NCT03033433 Type2 Diabetes Phase 1 Completed - Taiwan ... More >> Tri-Service General Hospital Taipei, Taiwan, 114 Less <<
NCT00313313 - Completed - -
NCT02008682 - Completed - -
NCT02008682 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 4 Completed - China, Beijing ... More >> Novo Nordisk Investigational Site Beijing, Beijing, China, 100071 Novo Nordisk Investigational Site Beijing, Beijing, China, 100700 Novo Nordisk Investigational Site Beijing, Beijing, China, 100853 China, Chongqing Novo Nordisk Investigational Site ChongQing, Chongqing, China, 404000 China, Hebei Novo Nordisk Investigational Site Cangzhou, Hebei, China, 061000 Novo Nordisk Investigational Site Hengshui, Hebei, China, 053000 Novo Nordisk Investigational Site Shijiazhuang, Hebei, China, 050000 Novo Nordisk Investigational Site Shijiazhuang, Hebei, China, 050051 China, Jiangsu Novo Nordisk Investigational Site Nanjing, Jiangsu, China, 210011 Novo Nordisk Investigational Site Nanjing, Jiangsu, China, 210012 Novo Nordisk Investigational Site Nanjing, Jiangsu, China, 210029 Novo Nordisk Investigational Site Suzhou, Jiangsu, China, 215004 Novo Nordisk Investigational Site Wuxi, Jiangsu, China, 214023 Novo Nordisk Investigational Site Zhenjiang, Jiangsu, China, 212001 China, Jiangxi Novo Nordisk Investigational Site Nanchang, Jiangxi, China, 330006 China, Jilin Novo Nordisk Investigational Site Changchun, Jilin, China, 130041 China, Liaoning Novo Nordisk Investigational Site Dalian, Liaoning, China, 116033 Novo Nordisk Investigational Site Shenyang, Liaoning, China, 110021 China, Shandong Novo Nordisk Investigational Site Qingdao, Shandong, China, 266003 China, Shanghai Novo Nordisk Investigational Site Shanghai, Shanghai, China, 200080 Novo Nordisk Investigational Site Shanghai, Shanghai, China, 200092 Novo Nordisk Investigational Site Shanghai, Shanghai, China, 200120 Novo Nordisk Investigational Site Shanghai, Shanghai, China, 200240 Novo Nordisk Investigational Site Shanghai, Shanghai, China, 201199 China Novo Nordisk Investigational Site Beijing, China, 101200 Less <<
NCT01630369 Type 2 Diabetes Mellitus Phase 4 Completed - Ukraine ... More >> Sanofi-Aventis Administrative Office Kyiv, Ukraine Less <<
NCT02688530 Shoulder Arthroscopy ... More >> Pain Less << Phase 4 Completed - United States, New York ... More >> Hospital for Special Surgery New York, New York, United States, 10021 Less <<
NCT02069366 Post-Traumatic Stress Disorder Not Applicable Recruiting December 2019 United States, Michigan ... More >> Eugene Applebaum College of Pharmacy and Health Sciences Recruiting Detroit, Michigan, United States, 48201 Contact: Farrah Elrahal    313-577-5404    felrahal@wayne.edu    Principal Investigator: Christine A. Rabinak, PhD Less <<
NCT01889446 Obesity Insul... More >>in Resistance Diabetes Less << Not Applicable Unknown June 2015 United States, Massachusetts ... More >> Brigham and Women's Hospital Recruiting Boston, Massachusetts, United States, 02115 Principal Investigator: Amir Tirosh, MD PhD Less <<
NCT02306005 - Unknown - Poland ... More >> Department of Internal Medicine and Diabetiology Poznan University of Medical Sciences Recruiting Poznan, Poland, 60-834 Contact: Aleksandra Uruska, PhD    607620750 ext +48    aleksandrauruska@gmail.com    Contact: Dorota Zozulinska-Ziolkiewicz, Prof    618474579 ext +48    kldiab@raszeja.poznan.pl Less <<
NCT02654665 Non-alcoholic Fatty Liver Dise... More >>ase (NAFLD) Weight Loss Non-alcoholic Steatohepatitis (NASH) Less << Phase 3 Recruiting December 2018 Singapore ... More >> Changi General Hospital Recruiting Singapore, Singapore, 529889 Contact: Joan Khoo, MRCP    +658503807 Less <<
NCT02460510 Acute Liver Failure Not Applicable Completed - India ... More >> Institute of Liver and Biliary Sciences New Delhi, Delhi, India, 110070 Less <<
NCT02169570 Type 2 Diabetes Mellitus ... More >> Pulmonary Tuberculosis Less << Phase 4 Unknown December 2017 Pakistan ... More >> School of Public Health, Dow university of Health Sciences Not yet recruiting Karachi, Sindh, Pakistan Contact: Nadia Shah, MAS          Contact: Saadiyah Rao, MSc          Principal Investigator: Kashif Shafique, PhD          Sub-Investigator: Saadiyah Rao, MSc          Sub-Investigator: Nadia Shah, MAS Less <<
NCT03593135 Randomized Controlled Trial ... More >> Diabetes Mellitus Less << Not Applicable Completed - Pakistan ... More >> Shaikh Zayed Medical Complex Lahore, Punjab, Pakistan, 54000 Less <<
NCT02454517 Obesity Overw... More >>eight Prostate Adenocarcinoma Stage I Prostate Cancer AJCC V7 Stage IIA Prostate Cancer AJCC v7 Less << Phase 3 Recruiting - United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Jonathan L. Wright    206-667-7987    jlwright@u.washington.edu    Principal Investigator: Jonathan L. Wright Less <<
NCT00982228 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 3 Completed - -
NCT00982228 - Completed - -
NCT01824277 Diabetes Not Applicable Completed - Canada, Manitoba ... More >> Youville Diabetes Center Winnipeg, Manitoba, Canada, R2H 0S8 I.H. AsperInstitute, St. Boniface General Hospital Winnipeg, Manitoba, Canada, R2H 2A6 Less <<
NCT01564121 Giant Cell Tumors of Bone Phase 1 Phase 2 Terminated - France ... More >> CHU de Nantes Nantes, France Less <<
NCT02237352 - Enrolling by invitation July 2019 Ecuador ... More >> UNEMI, Universidad Estatal de Milagro, Facultad de Ciencias de la Salud Milagro, Guayas, Ecuador, 091050 Less <<
NCT03025984 Diabetes Mellitus Not Applicable Suspended(On Internal Hold) June 1, 2019 United States, Missouri ... More >> St. Mary's Health Center Saint Louis, Missouri, United States, 63117 Less <<
NCT02154100 Metabolic Syndrome ... More >> Cardiovascular Diseases Diabetes Less << Phase 2 Completed - United States, Florida ... More >> Department of Nutrition, Food and Exercise Sciences, Center for Advancing Exercise and Nutrition Research on Aging, Florida State University Tallahassee, Florida, United States, 32306 Less <<
NCT03373435 Postbariatric Hypoglycemia Phase 2 Recruiting October 2018 United States, California ... More >> Stanford University Recruiting Palo Alto, California, United States, 94304 Contact: Aileen Muno       munoai@stanford.edu    Contact: Marilyn Tan, MD       mjtan@stanford.edu    Principal Investigator: Marilyn Tan, MD          United States, Colorado University of Colorado, Denver Recruiting Aurora, Colorado, United States, 80045 Contact: Helen Lawler, MD    720-848-5146    Endo.ClinicalTrials@ucdenver.edu    United States, Maryland Johns Hopkins University Recruiting Baltimore, Maryland, United States, 21287 Contact: Dezeray Cephas    443-507-8222    dcephas1@jhu.edu    Principal Investigator: Clare Lee, MD, MHS          United States, North Carolina Duke Early Phase Clinical Research Recruiting Durham, North Carolina, United States, 27710 Contact    919-613-6246    DCRIvolunteer@duke.edu    United States, Wisconsin University of Wisconsin Recruiting Madison, Wisconsin, United States, 53792 Contact: Constance B Trantow    608-265-7814 Less <<
NCT02577159 Diabetes Mellitus, Type 2 Phase 4 Active, not recruiting August 31, 2018 Japan ... More >> Sousei Hospital Kadoma, Osaka, Japan, 5710025 Osaka Central Hospital Osaka city, Osaka, Japan, 5300001 Osaka University Hospital Suita, Osaka, Japan, 5650871 Less <<
NCT01316861 Type 2 Diabetes Mellitus Phase 3 Completed - Brazil ... More >> Marcio Antonio Pereira Clinica Sao Jose Dos Campos, SP, Brazil, 12.245-000 Less <<
NCT02527525 Diabetes Mellitus, Type 1 Not Applicable Enrolling by invitation June 2020 -
NCT00545805 Insulin Resistance ... More >> Obesity Metabolic Syndrome X Less << Phase 2 Phase 3 Completed - Brazil ... More >> LIMED (Laboratory of Investigation of Metabolism and Diabetes)/GASTROCENTRO/Univeristy of Campinas (UNICAMP) Campinas, SP, Brazil Less <<
NCT00453817 Type 1 Diabetes Mellitus Phase 1 Terminated(Feasibility issues) - Switzerland ... More >> Geneva University Hospitals Department of Surgery Geneva, Switzerland, 1211 Less <<
NCT00958997 - Completed - United States, Connecticut ... More >> Yale University School of Medicine, PET Center New Haven, Connecticut, United States, 06520 Less <<
NCT01278160 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 4 Completed - China, Beijing ... More >> Beijing, Beijing, China, 100029 Less <<
NCT01925092 Cushing's Disease Phase 3 Withdrawn(Lack of enrollment) - United States, Maryland ... More >> National Institute of Child Health and Human Development (NICHD) Bethesda, Maryland, United States, 20892-1103 Less <<
NCT01149681 Myelofibrosis Phase 2 Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Italy Azienda Ospedaliero Universitaria Careggi di Firenze Firenze, Italy, 50134 Less <<
NCT02925156 - Active, not recruiting December 2020 United States, Illinois ... More >> Loyola University Medical Center Maywood, Illinois, United States, 60153 Less <<
NCT02510521 Type 2 Diabetes Not Applicable Completed - France ... More >> Endocrinology Unit and Clinical Research Center Basse Normandie, University Hospital of Caen Caen, France, 14000 Less <<
NCT02291666 Type 2 Diabetes Phase 4 Recruiting October 2019 Canada, Quebec ... More >> Centre hospitalier de l'Université de Montréal (CHUM) Recruiting Montreal, Quebec, Canada, H2X0A9 Contact: Veronique Michaud, BPharm, PhD    514-8908000 ext 15812    v.michaud@umontreal.ca    Contact: Jacques Turgeon, BPharm,PhD    514-8908045    jacques.turgeon@umontreal.ca    Principal Investigator: Veronique Michaud, BPharm,PhD          Sub-Investigator: Jean-Louis Chiasson, MD          Sub-Investigator: Jacques Turgeon, BPharm,PhD Less <<
NCT02994316 Diabetic Ketoacidosis Children Not Applicable Recruiting July 2019 France ... More >> University hospital Montpellier Recruiting Montpellier, France, 34295 Contact: JULIE JT TENENBAUM, PH    33(0)467337123    j-tenenbaum@chu-montpellier.fr Less <<
NCT02722499 Diabetes Mellitus ... More >> Type 2 Diabetes Mellitus Adult-Onset Diabetes Mellitus Non-Insulin-Dependent Diabetes Mellitus Noninsulin Dependent Diabetes Mellitus, Type II Less << Not Applicable Active, not recruiting March 2019 United States, South Carolina ... More >> Medical University of South Carolina Charleston, South Carolina, United States, 29425 Less <<
NCT01740921 Type 2 Diabetes Not Applicable Completed - United Kingdom ... More >> Peninsula Clinical Research Facility Exeter, United Kingdom, EX2 5DW Less <<
NCT02017223 Obesity Not Applicable Completed - United States, California ... More >> University of Southern California University Park Campus Los Angeles, California, United States, 90015 University of Southern California Health Science Campus Los Angeles, California, United States, 90033 Less <<
NCT00409786 Obesity Not Applicable Completed - United States, Pennsylvania ... More >> University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States, 15213 Less <<
NCT02682121 Prediabetes Phase 1 Completed - United States, Utah ... More >> University of Utah Salt Lake City, Utah, United States, 84112 Less <<
NCT03231618 Healthy and Overweight/ Obesit... More >>y Males Less << Not Applicable Completed - China, Shanghai ... More >> Institute for Nutritional Sciences, Chinese Academy of Sciences Shanghai, Shanghai, China, 200031 Less <<
NCT02659748 Insulin Sensitivity ... More >> Type 2 Diabetes Less << Not Applicable Unknown December 2016 United States, Vermont ... More >> Clinical Research Center, University of Vermont Medical Center Burlington, Vermont, United States, 05401 Less <<
NCT03040531 Osteoporosis, Steroid Induced Phase 2 Phase 3 Recruiting December 30, 2018 Italy ... More >> University of Messina Recruiting Messina, Italy, 98123 Principal Investigator: Francesco Squadrito, MD          University Hospital Recruiting Messina, Italy, 98125 Contact: Francesco Squadrito, MD    +390902213648    fsquadrito@unime.it    Principal Investigator: Marco Atteritano, MD          Sub-Investigator: Alessandra Bitto, MD/PhD Less <<
NCT01278160 - Completed - -
NCT00830440 - Completed - -
NCT00409786 - Completed - -
NCT03635671 - Recruiting December 31, 2020 Canada, British Columbia ... More >> Eye Care Center Recruiting Vancouver, British Columbia, Canada, V5Z 3N9 Contact: Theresa Wiens, MSc    604-875-4111 ext 62544    twiens@eyecarecentre.org    Sub-Investigator: Sonja Karst, MD Less <<
NCT00682890 - Terminated(Lack of recruitment... More >>) Less << - -
NCT00830440 Obesity Not Applicable Completed - Netherlands ... More >> University Hospital Maastricht Maastricht, Netherlands Less <<
NCT00229658 - Completed - -
NCT00862849 Diabetes Mellitus Phase 1 Completed - United States, California ... More >> Profil Institute for Clinical Research, Inc. Chula Vista, California, United States, 91911 Less <<
NCT00862849 - Completed - -
NCT01702012 Type 2 Diabetes ... More >> Obesity Less << Not Applicable Completed - United States, North Carolina ... More >> Wake Forest University Health Sciences Winston-Salem, North Carolina, United States, 27157 Less <<
NCT02662842 - Completed - United States, California ... More >> AMCR Institute Inc. Escondido, California, United States, 92025 United States, Georgia Atlanta Diabetes Associates Atlanta, Georgia, United States, 30318 United States, Idaho Rocky Mountain Diabetes and Osteoporosis Center Idaho Falls, Idaho, United States, 83404 United States, New Jersey TKL Research Fair Lawn, New Jersey, United States, 07410 Less <<
NCT00682890 Polycystic Ovary Syndrome ... More >> PCOS Insulin Sensitivity Less << Phase 4 Terminated(Lack of recruitment... More >>) Less << - United States, Virginia ... More >> General Clinical Research Center Richmond, Virginia, United States, 23298 Less <<
NCT01457612 Insulin Resistance ... More >> Nutritional Disease Metabolic Disease Less << Not Applicable Active, not recruiting December 1, 2019 United States, Illinois ... More >> Clinical Nutrition Research Center Chicago, Illinois, United States, 60616 Less <<
NCT00437489 - Terminated(This protocol was t... More >>erminated not for safety reasons, but because Pfizer decided to return the worldwide rights for Exubera to Nektar, on 18 October 2007.) Less << - -
NCT01221090 Type 2 Diabetes Phase 4 Completed - United States, Texas ... More >> Scott & White Clinic Temple, Texas, United States, 76504 Less <<
NCT02835664 Obesity Insul... More >>in Resistance Less << Not Applicable Recruiting December 2018 Netherlands ... More >> Maastricht University Medical Centre Recruiting Maastricht, Netherlands Contact: Carlijn Remie, Msc          Contact: Patrick Schrauwen, Prof.Dr. Less <<
NCT01796366 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 1 Completed - Germany ... More >> Novo Nordisk Investigational Site Neuss, Germany, 41460 Less <<
NCT00437489 Diabetes Mellitus, Type 2 Phase 4 Terminated(This protocol was t... More >>erminated not for safety reasons, but because Pfizer decided to return the worldwide rights for Exubera to Nektar, on 18 October 2007.) Less << - Hong Kong ... More >> Pfizer Investigational Site Hong Kong, Hong Kong Pakistan Pfizer Investigational Site Karachi, Sindh, Pakistan, 74600 Philippines Pfizer Investigational Site Makati, Philippines, 1218 Pfizer Investigational Site Marikina City, Philippines, 1810 Pfizer Investigational Site Pasay City, Philippines, 1300 Pfizer Investigational Site Pasig City, Philippines, 1605 Pfizer Investigational Site Quezon City, Philippines, 1102 Singapore Pfizer Investigational Site Singapore, Singapore, 119074 Pfizer Investigational Site Singapore, Singapore, 159964 Less <<
NCT00785005 - Completed - United States, Colorado ... More >> University of Colorado Denver Aurora, Colorado, United States, 80045 Less <<
NCT00699790 Type 2 Diabetes Phase 2 Completed - Russian Federation ... More >> Local Institution Dzerzhnsky, Russian Federation, 140090 Local Institution Moscow, Russian Federation, 105229 Local Institution Moscow, Russian Federation, 117036 Local Institution Moscow, Russian Federation, 125315 Local Institution Nizhny Novgorod, Russian Federation, 603126 Local Institution Saint Petersburg, Russian Federation, 191015 Local Institution Saint Petersburg, Russian Federation, 195271 Local Institution Saint-Petersburg, Russian Federation, 190068 Local Institution Saint-Petersburg, Russian Federation, 194044 Local Institution Tyumen, Russian Federation, 625023 Local Institution Voronezh, Russian Federation, 394066 Local Institution Yaroslavl, Russian Federation, 150023 Less <<
NCT01221090 - Completed - -
NCT01593774 Schizophrenia Phase 2 Completed - Iran, Islamic Republic of ... More >> Shafa Psychiatric Hospital Rasht, Guilan, Iran, Islamic Republic of, 55599-41939 Less <<
NCT02441010 Suboptimal Health Status ... More >> Metabolic Abnormality Less << Not Applicable Completed - China, Beijing ... More >> Chinese PLA General Hospital Beijing, Beijing, China, 100853 China, Liaoning The Second Affiliated Hospital of Dalian Medical University Dalian, Liaoning, China Less <<
NCT00229658 - Completed - -
NCT01647997 Sepsis Not Applicable Completed - Switzerland ... More >> Centre Hospitalier Universitaire Vaudois Lausanne, Vaud, Switzerland, CH-1011 Less <<
NCT00800709 Alzheimer's Disease Phase 4 Completed - China, Shanghai ... More >> Department of Psychogeriatrics，Shanghai Mental Health Center Shanghai, Shanghai, China, 200030 Less <<
NCT01408628 Type 2 Diabetes Not Applicable Completed - United States, Kansas ... More >> The University of Kansas Medical Center Kansas City, Kansas, United States, 66160 Less <<
NCT02609815 Diabetes Not Applicable Recruiting December 31, 2019 Korea, Republic of ... More >> Seoul National University Bundang Hospital Recruiting Seongnam, Gyeonggi, Korea, Republic of, 463-707 Contact: Soo Lim, MD, PHD    82-31-787-7035    limsoo@snu.ac.kr    Contact: Tae Jung Oh, MD, PHD    82-31-787-7078    ohtjmd@gmail.com    Principal Investigator: Soo Lim, MD, PHD Less <<
NCT01408628 - Completed - -
NCT01809327 - Completed - -
NCT00404963 Type 2 Diabetes Mellitus Phase 1 Completed - United States, Indiana ... More >> GSK Investigational Site Evansville, Indiana, United States, 47714 Less <<
NCT01846013 Sit-Stand Workstations Not Applicable Completed - United States, Minnesota ... More >> University of Minnesota Minneapolis, Minnesota, United States, 55454 Fairview Energy Park St. Paul, Minnesota, United States, 55108 MN Department of Human Services St. Paul, Minnesota, United States, 55164 Less <<
NCT03490136 - Active, not recruiting June 2019 India ... More >> Dr.Ambady Ramachandran Chennai, Tamil Nadu, India, 600 008 Less <<
NCT03259321 - Completed - -
NCT00160732 Diabetes Mellitus, Type 1 Phase 1 Phase 2 Active, not recruiting October 2025 United States, Illinois ... More >> The University of Chicago Hospitals Chicago, Illinois, United States, 60637 Less <<
NCT01490372 - Completed - Canada, Quebec ... More >> Centre de recherche clinique Étienne-Le Bel du CHUS Sherbrooke, Quebec, Canada, J1H 5N4 Less <<
NCT01809327 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT01334606 Diabetes Mellitus, Type 2 Not Applicable Terminated(This study was term... More >>inated due to unanticipated recruitment difficulties.) Less << - United States, Minnesota ... More >> International Diabetes Center (IDC) Minneapolis, Minnesota, United States, 55416 United States, New Jersey Comprehensive Clinical Research Berlin, New Jersey, United States, 08009 Canada, Ontario BioPharma Services Inc. Toronto, Ontario, Canada, M9L 3A2 Less <<
NCT00253786 Type 2 Diabetes Mellitus ... More >> Diabetic Nephropathy Less << Not Applicable Completed - Japan ... More >> Okayama University Hospital Okayama, Japan, 700-8558 Less <<
NCT00005769 Menopause Phase 2 Unknown - United States, Vermont ... More >> University of Vermont Burlington, Vermont, United States, 05401 Less <<
NCT01947569 Treatment of Type I Diabetes M... More >>ellitus. Less << Phase 1 Phase 2 Unknown - United States, Pennsylvania ... More >> UPMC Not yet recruiting Pittsburgh, Pennsylvania, United States, 15213 Principal Investigator: Mary Korytokowski, MD Less <<
NCT01334606 - Terminated(This study was term... More >>inated due to unanticipated recruitment difficulties.) Less << - -
NCT00869128 - Completed - -
NCT00869128 Diabetes Mellitus, Type 2 ... More >> Insomnia Less << Phase 2 Completed - -
NCT02752880 Type 2 Diabetes Phase 2 Phase 3 Completed - Taiwan ... More >> Taoyuan, Taiwan Less <<
NCT01071772 Heart Failure ... More >> Type 2 Diabetes Less << Phase 2 Completed - Denmark ... More >> Department ofCardiology, Aarhus University Hospital, Skejby Aarhus, Region Midtjylland, Denmark, 8200 Less <<
NCT02006342 Diabetic Ketoacidosis Not Applicable Completed - United States, Texas ... More >> Lyndon B Johnson Hospital Houston, Texas, United States, 77026 Memorial Herman Hospital-Texas Medical Center Houston, Texas, United States, 77030 Less <<
NCT02550236 - Recruiting December 2020 Germany ... More >> LIFE Leipzig Research Centre for Civilization Diseases, University of Leipzig Recruiting Leipzig, Saxony, Germany, 04103 Contact: Wieland Kiess, Prof. MD       wieland.kiess@medizin.uni-leipzig.de    Contact: LIFE Child       contact@life.uni-leipzig.de    Principal Investigator: Wieland Kiess, Prof., MD          Principal Investigator: Antje Körner, Prof.,MD Less <<
NCT01286350 Type 1 Diabetes Not Applicable Completed - United States, Colorado ... More >> University of Colorado Barbara Davis Center for Childhood Diabetes Aurora, Colorado, United States, 80045 United States, Ohio Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45206 Less <<
NCT01607294 Hyperlipidemia ... More >> Type 2 Diabetes Less << Phase 2 Completed - United States, Florida ... More >> Miramar, Florida, United States Less <<
NCT02006342 - Completed - -
NCT02415556 Type 2 Diabetes Mellitus Phase 2 Phase 3 Recruiting June 2020 United States, Massachusetts ... More >> Beth Israel Deaconess Medical Center Recruiting Boston, Massachusetts, United States, 02215 Contact: Brahyan Galindo, MD    617-632-8859    safelab@bidmc.harvard.edu    Contact: Freddy J Alfaro, MD    6176328883    safelab@bidmc.harvard.edu    Brigham and Women's Hospital Recruiting Boston, Massachusetts, United States, 02215 Contact: Peter Novak, MD PhD    617-424-4101    PNOVAK2@PARTNERS.ORG    Contact: Freddy J Alfaro    617-525-3161    falfarom@bidmc.harvard.edu Less <<
NCT02131701 Family History of Type 2 Diabe... More >>tes Less << Not Applicable Completed - Finland ... More >> Folkhälsan Research Center Helsinki, Finland Less <<
NCT01507012 Healthy Not Applicable Completed - New Zealand ... More >> The New Zealand Institute for Plant & Food Research Ltd Auckland, New Zealand, 1025 Less <<
NCT01178957 - Completed - Denmark ... More >> Department of Endocrinology MEA, Aarhus Hospital Aarhus C, Denmark, 8000 Less <<
NCT03139214 Metabolic Syndrome Not Applicable Completed - -
NCT02366273 - Unknown - Italy ... More >> IRCCS Policlinico San Matteo Foundation Recruiting Pavia, Italy, 27100 Contact: Giuseppe Derosa, MD, PhD, FESC          Contact: Pamela Maffioli, MD          Sub-Investigator: Valeria Brazzelli, MD          Sub-Investigator: Pamela Maffioli, MD Less <<
NCT01720303 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 4 Completed - China, Beijing ... More >> Novo Nordisk Investigational Site Beijing, Beijing, China, 100101 China, Shanghai Novo Nordisk Investigational Site Shanghai, Shanghai, China, 200040 Novo Nordisk Investigational Site Shanghai, Shanghai, China, 200433 Less <<
NCT00206362 - Completed - United States, Texas ... More >> Texas Children's Hospital Houston, Texas, United States, 77030 Less <<
NCT02805361 - Completed - Kuwait ... More >> Research Site Kuwait City, Kuwait United Arab Emirates Research Site Abu Dhabi, United Arab Emirates Research Site Ajman, United Arab Emirates Research Site Dubai, United Arab Emirates Less <<
NCT02524457 - Not yet recruiting September 2020 -
NCT01632007 Diabetes Mellitus Phase 3 Completed - Japan ... More >> Akita-shi, Akita, Japan Matsudo-shi, Chiba, Japan Fukuoka-shi, Fukuoka, Japan Fukuyama-shi, Hiroshima, Japan Ishikari-shi, Hokkaido, Japan Nakagawa-gun, Hokkaido, Japan Sapporo-shi, Hokkaido, Japan Naka-shi, Ibaragi, Japan Sagamihara-shi, Kanagawa, Japan Kumamoto-shi, Kumamoto, Japan Kashiwara-shi, Osaka, Japan Osaka-shi, Osaka, Japan Suita-shi, Osaka, Japan Arakawa-ku, Tokyo, Japan Bunkyo-ku, Tokyo, Japan Chiyoda-ku, Tokyo, Japan Chuo-ku, Tokyo, Japan Itabashi-ku, Tokyo, Japan Katsushika-ku, Tokyo, Japan Mitaka-shi, Tokyo, Japan Shinjuku-ku, Tokyo, Japan Shunan-shi, Yamaguchi, Japan Less <<
NCT00468442 Type 1 Diabetes Mellitus Phase 2 Terminated(Lack of efficacy) - United States, Pennsylvania ... More >> University of Pennsylvania Philadelphia, Pennsylvania, United States Less <<
NCT03725059 Breast Cancer Phase 3 Not yet recruiting January 24, 2031 -
NCT02643771 Chronic Periodontitis ... More >> Diabetes Mellitus, Type 2 Less << Phase 2 Unknown October 2017 Brazil ... More >> Departamento de Odontologia; Universidade Federal do Rio Grande do Norte Recruiting Natal, Rio Grande do Norte, Brazil, 59056-000 Contact: Bruno CV Gurgel, Doctor    +558432154136    bcgurgel@yahoo.com.br    Contact: Eduardo A Figueira, Doctor    +5584999521370    edufigueira@yahoo.com.br Less <<
NCT00282360 Coronary Artery Disease ... More >> Type II Diabetes Mellitus Less << Phase 4 Completed - -
NCT02366377 Type 2 Diabetes Mellitus Phase 1 Unknown - -
NCT02366351 Type 2 Diabetes Mellitus Phase 1 Unknown - China ... More >> Chinese PLA General Hospital Recruiting Beijing, China Contact: Juming Lu, PhD    010-66937166 Less <<
NCT01469351 Alzheimers Disease Not Applicable Completed - Denmark ... More >> Aarhus University Aarhus, Denmark, 8000 Less <<
NCT01686711 Diabetes Mellitus Phase 4 Completed - Japan ... More >> Hirosaki-shi, Aomori, Japan Kisaratsu-shi, Chiba, Japan Matsuyama-shi, Ehime, Japan Fukuoka-shi, Fukuoka, Japan Kitakyushu-shi, Fukuoka, Japan Kurume-shi, Fukuoka, Japan Fukuyama-shi, Hiroshima, Japan Hiroshima-shi, Hiroshima, Japan Sapporo-shi, Hokkaido, Japan Koga-shi, Ibaraki, Japan Yokohama-shi, Kanagawa, Japan Kumamoto-shi, Kumamoto, Japan Miyazaki-shi, Miyazaki, Japan Suita-shi, Osaka, Japan Koshigaya-shi, Saitama, Japan Otsu-shi, Shiga, Japan Chiyoda-ku, Tokyo, Japan Chuo-ku, Tokyo, Japan Itabashi-ku, Tokyo, Japan Meguro-ku, Tokyo, Japan Minato-ku, Tokyo, Japan Ohta-ku, Tokyo, Japan Shinjuku-ku, Tokyo, Japan Toyama-shi, Toyama, Japan Shimonoseki-shi, Yamaguchi, Japan Less <<
NCT02634528 Diabetes Mellitus Phase 1 Active, not recruiting April 30, 2018 Germany ... More >> Profil Neuss GmbH Neuss, Germany, 41460 Less <<
NCT02479022 Diabetes Diab... More >>etes Mellitus, Type 2 Healthy Less << Phase 1 Completed - Germany ... More >> Neuss, Germany, 41460 Less <<
NCT00344266 - Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00332085 Type 2 Diabetes Phase 1 Terminated(Issues w/recruitmen... More >>t) Less << - United States, Washington ... More >> Bastyr University Campus SPR Kenmore, Washington, United States, 98036 Bastyr Center for Natural Health Seattle, Washington, United States Less <<
NCT03777176 Congenital Hyperinsulinism Phase 3 Not yet recruiting February 2020 United States, California ... More >> Rady Children's Hospital San Diego Not yet recruiting San Diego, California, United States, 92093 United States, Colorado Children's Hospital of Colorado Not yet recruiting Aurora, Colorado, United States, 13123 United States, Pennsylvania Children's Hospital of Philadelphia Not yet recruiting Philadelphia, Pennsylvania, United States, 19104 United States, Texas Cook Children's Medical Center Not yet recruiting Fort Worth, Texas, United States, 76104 United Kingdom NHS Greater Glasgow and Clyde Not yet recruiting Glasgow, United Kingdom Great Osmond Street Hospital for Children NHS Foundation Trust Not yet recruiting London, United Kingdom Central Manchester University Hospital NHS Foundation Trust Not yet recruiting Manchester, United Kingdom Less <<
NCT02881528 Prediabetic State Phase 4 Withdrawn(Poor Recruitment pri... More >>or to end of funding timelines.) Less << - United Kingdom ... More >> NHS Ayrshire & Arran Kilmarnock, Ayrshire, United Kingdom, KA2 0BE NHS Grampian Aberdeen, Grampian, United Kingdom, AB25 2ZG NHS Lanarkshire Wishaw, Lanarkshire, United Kingdom, ML2 0DP NHS Tayside Dundee, Tayside, United Kingdom, DD1 9SY NHS Greater Glasgow & Clyde Glasgow, United Kingdom, G3 8SJ Less <<
NCT02525276 Metabolic Syndrome Not Applicable Unknown August 2018 -
NCT00206349 - Completed - United States, Texas ... More >> Texas Children's Hospital Houston, Texas, United States, 77030 Less <<
NCT02626767 High-intensity Interval Traini... More >>ng Less << Not Applicable Completed - -
NCT01675271 Gestational Diabetes ... More >> Cardiovascular Risk Factors Less << Not Applicable Completed - Finland ... More >> Helsinki University Central Hospital / dept of Obstetrics and Gynecology Helsinki, Finland, 00029 Less <<
NCT01140035 Kidney Transplant Not Applicable Completed - United States, California ... More >> U C San Francisco San Francisco, California, United States, 94143 Less <<
NCT01222728 - Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT02759484 Diabetes Mellitus, Type 2 Not Applicable Recruiting March 2019 United States, Illinois ... More >> Rush University Internists Recruiting Chicago, Illinois, United States, 60612 Contact: Kelly Stein, MD    312-563-2875    Kelly_Stein@rush.edu    Contact: Kathleen Fischer, RN    312-563-2875       Erie Family Health Center Recruiting Chicago, Illinois, United States, 60622 Contact: Laura Zimmerman, MD          Cicero Health Center of Cook County Recruiting Cicero, Illinois, United States, 60804 Contact: Araceli Andablo, MD Less <<
NCT00770081 Diabetes Mellitus, Type 2 ... More >> Renal Insufficiency Less << Phase 3 Completed - -
NCT01377844 Diabetes Mellitus Phase 2 Completed - United States, California ... More >> Site 5 Buena Park, California, United States Site 4 Los Angeles, California, United States Site 3 Santa Ana, California, United States United States, Florida Site 1 Hialeah, Florida, United States United States, New Jersey Site 9 Berlin, New Jersey, United States United States, North Carolina Site 7 Cary, North Carolina, United States United States, Ohio Site 6 Marion, Ohio, United States Site 8 Munroe Falls, Ohio, United States United States, Oregon Site 2 Portland, Oregon, United States United States, Texas Site 11 North Richland Hills, Texas, United States Site 7 San Antonio, Texas, United States Less <<
NCT00559624 Leukemia, B-Cell, Chronic Phase 1 Phase 2 Completed - Belgium ... More >> Hematology Department, ZNA Stuivenberg Antwerpen, Belgium Cliniques universitaires Saint-Luc Haematology Dept Brussels, Belgium Hematology Department UZ Gasthuisberg Leuven, Belgium France Hôpital Avicenne Bobigny, France Service des maladies du sang Hôpital HURIEZ, CHRU Lille, France Spain Hematologia Clinica, Institut Catala d'Oncologia Barcelona, Spain, 08907 Hospital Madrid Nortesanchinarro Madrid, Spain, 28050 Hospital Clinico Universitario de Valencia Valencia, Spain, 46010 Less <<
NCT03414151 - Recruiting July 2019 Canada, Ontario ... More >> Centre For Addiction and Mental Health Recruiting Toronto, Ontario, Canada, M5T1R8 Contact: Nicole MacKenzie, M.Ed    416-535-8501 ext 34719    nicole.mackenzie@camh.ca    Principal Investigator: Margaret Hahn, MD, PhD Less <<
NCT01052181 Obesity Insul... More >>in Resistance Less << Phase 4 Unknown June 2012 India ... More >> Sitaram Bhartia Institute of Science and Research New Delhi, Delhi, India, 110016 Less <<
NCT01505426 Type II Diabetes Mellitus Phase 3 Completed - Korea, Republic of ... More >> Busan, Korea, Republic of Daegu, Korea, Republic of Daejeon, Korea, Republic of Gwangju, Korea, Republic of Incheon, Korea, Republic of Jeonju, Korea, Republic of Seoul, Korea, Republic of Wonju, Korea, Republic of Taiwan Kaohsiung, Taiwan Taichung, Taiwan Tainan, Taiwan Taipei, Taiwan Less <<
NCT01574508 Type 2 Diabetes Phase 4 Unknown December 2014 China, Shanghai ... More >> Ruijin hospital, Shanghai Jiao-Tong University School of Medicine Recruiting Shanghai, Shanghai, China, 200025 Contact: Guang Ning, Professor    8621-64370045 ext 665344    feifei1116@hotmail.com    Principal Investigator: Guang Ning, Professor Less <<
NCT02048839 - Completed - Finland ... More >> Helsinki University Helsinki, Finland Less <<
NCT02317575 Healthy Volunteers Phase 1 Completed - Singapore ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Singapore, Singapore, 117597 Less <<
NCT01169870 Breast Cancer Phase 2 Withdrawn(withdrawn studies) - -
NCT02702479 - Unknown June 2016 Canada, Ontario ... More >> The Toronto 3D (Diet, Digestive tract and Disease) Knowledge Synthesis and Clinical Trials Unit, Clinical Nutrition and Risk Factor Modification Centre, St. Michael's Hospital Toronto, Ontario, Canada, M5C 2T2 Less <<
NCT00749047 Diabetes Mellitus, Type 2 Phase 4 Unknown March 2010 New Zealand ... More >> Christchurch Hospital Christchurch, Canterbury, New Zealand, 8001 Less <<
NCT01351207 Healthy Not Applicable Completed - United States, Massachusetts ... More >> Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University Boston, Massachusetts, United States, 02111 Less <<
NCT00339313 - Completed - United States, Arizona ... More >> NIDDK, Phoenix Phoenix, Arizona, United States, 85014 Less <<
NCT02081820 - Completed - Germany ... More >> Department of Neurosurgery, Heinrich-Heine-University Düsseldorf Düsseldorf, NRW, Germany, 40225 Less <<
NCT00242619 Depression Bi... More >>polar Disorder Insulin Resistance Less << Not Applicable Completed - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT00242619 - Completed - -
NCT01600937 Type 2 Diabetes Not Applicable Completed - Italy ... More >> University of Rome La Sapienza, Department of Clinical and Molecular Medicine, Sant'Andrea Hospital, Diabetes Unit Rome, RM, Italy, 00189 Less <<
NCT00336310 Diabetes Mellitus, Type 2 Phase 4 Unknown - Taiwan ... More >> National Cheng-Kung University Hospital Not yet recruiting Tainan, Taiwan, 704 Sub-Investigator: H-Y Ou, MD          National Cheng-Kung University Hospital Not yet recruiting Tainan, Taiwan, 704 Less <<
NCT03404947 Exercise Metabolism Following ... More >>Ethanol Ingestion Less << Not Applicable Recruiting April 2018 United Kingdom ... More >> University of Bath Recruiting Bath, Somerset, United Kingdom, BA2 7AY Contact: James Betts, PhD    01225 383448    j.betts@bath.ac.uk    Sub-Investigator: Harry Smith          Principal Investigator: James Betts, PhD Less <<
NCT01633684 - Completed - United States, Nebraska ... More >> Creighton University Omaha, Nebraska, United States, 68131 Less <<
NCT00341770 - Completed - United States, Arizona ... More >> NIDDK, Phoenix Phoenix, Arizona, United States, 85014 Less <<
NCT00106704 - Completed - -
NCT02201381 Cancer Overal... More >>l Survival Less << Phase 3 Recruiting October 22, 2023 United Kingdom ... More >> Care Oncology Clinic Recruiting London, United Kingdom, W1G 9PP Contact: Gregory Stoloff    +44 207 580 3266    info@careoncologyclinic.com    Contact: Robin Bannister, PhD    +44 207 153 6577    robin.bannister@seekacure.com Less <<
NCT03621358 Overweight Not Applicable Active, not recruiting September 30, 2018 Spain ... More >> La Paz University Hospital Madrid, Spain Less <<
NCT02701751 Healthy Not Applicable Active, not recruiting January 2021 United States, Michigan ... More >> University of Michigan Ann Arbor, Michigan, United States, 48109 Less <<
NCT02024113 - Completed - Belgium ... More >> Ziekenhuis Oost-Limburg Genk, Limburg, Belgium, 3600 Hasselt University Hasselt, Limburg, Belgium, 3500 Less <<
NCT00529165 Diabetes Mellitus Type 2 Not Applicable Completed - Germany ... More >> Friedrich-Schiller-University, department of internal medicine III Jena, Germany, 07740 Less <<
NCT03417466 Diabetes Mellitus Not Applicable Completed - China ... More >> PLA Army General Hospital Beijing, China, 100700 Sir Run Run Shaw Hospital School of Medicine Zhejiang University Hangzhou, China, 310016 Shanghai Sixth People's Hospital Shanghai, China, 200233 Less <<
NCT01095744 - Completed - France ... More >> Pitie Salpêtrière Hospital Paris, Ile de France, France, 75651 Less <<
NCT03088410 HIV Insulin S... More >>ensitivity Diabetes Mellitus Less << Phase 4 Recruiting March 31, 2021 Botswana ... More >> Botswana-Harvard AIDS Institute Partnership Recruiting Gaborone, Botswana Principal Investigator: Jennifer Jao, MD Less <<
NCT00808587 - Active, not recruiting March 2029 United States, California ... More >> Scripps Health San Diego, California, United States, 92037 Less <<
NCT03437551 - Completed - Switzerland ... More >> Vista Diagnostics Zürich, Switzerland Less <<
NCT00997282 Diabetes Type 2 Phase 2 Phase 3 Completed - Japan ... More >> Chubu Region, Japan Chugoku Region, Japan Kansai Region, Japan Kanto Region, Japan Kyushu Region, Japan Shikoku Region, Japan Tohoku Region, Japan Less <<
NCT00106704 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT00660075 Diabetes Mellitus ... More >> Postprandial Lipemia Less << Phase 3 Completed - Canada, Quebec ... More >> Laval University Medical Center Quebec City, Quebec, Canada, G1V 4G2 Less <<
NCT00660075 - Completed - -
NCT01322035 - Completed - United States, Alabama ... More >> Mobile Infirmary Medical Center Mobile, Alabama, United States, 36607 University of South Alabama Mobile, Alabama, United States, 36617 Less <<
NCT01980017 Pre-diabetic ... More >>Diabetic Type II Mellitus Less << Not Applicable Completed - Canada, Ontario ... More >> University of Ottawa Heart Institute Ottawa, Ontario, Canada, K1Y 4W7 Less <<
NCT01157403 Evidence of Liver Transplantat... More >>ion Less << Phase 2 Phase 3 Unknown August 2014 China, Chongqing ... More >> Endocrine Department, the south west Hospital of the Third Military Medical University Recruiting Chongqing, Chongqing, China, 400038 Contact: Chen Bing, doctor       cb@mail.tmmu.com.cn    Contact: Lu Debin, doctor       ldb2005056@yahoo.COM.CN Less <<
NCT01871493 Healthy Volunteers Phase 1 Completed - Singapore ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Singapore, Singapore, 117597 Less <<
NCT01895595 Obesity Insul... More >>in Resistance Metabolic Syndrome Less << Not Applicable Completed - United States, California ... More >> University of Southern California Los Angeles, California, United States, 90033 Less <<
NCT02015442 Healthy Volunteers Not Applicable Completed - United Kingdom ... More >> NIHR/Wellcome Trust Imperial Clinical Research Facility London, United Kingdom Less <<
NCT00260936 - Completed - United States, California ... More >> Childrens Hospital of Los Angeles Los Angeles, California, United States, 90054 University of California at San Diego San Diego, California, United States, 92093 University of California at San Francisco San Francisco, California, United States, 94143 United States, District of Columbia Childrens Hopital National Medical Center Washington, District of Columbia, United States, 20010 United States, Florida Children's Diagnoistic and Treatment Center Fort Lauderdale, Florida, United States, 33301 University of Miami Miami, Florida, United States, 33101 University of South Florida Tampa, Florida, United States, 33606 United States, Illinois Stroger Hospital of Cook County Chicago, Illinois, United States, 60612 United States, Massachusetts Children's Hopsital of Boston Boston, Massachusetts, United States, 02115 United States, New York Montefiore Medical Center Bronx, New York, United States, 10467 Mount Siani Medical Center New York, New York, United States, 10128 United States, Pennsylvania Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 02115 Puerto Rico University Pediatric Hospital San Juan, Puerto Rico, 00936 Less <<
NCT02012855 Hyperlipidemia Not Applicable Completed - Canada, Saskatchewan ... More >> University of Saskatchewan Saskatoon, Saskatchewan, Canada, S7N 5B2 Less <<
NCT02196051 Insulin Resistance Not Applicable Completed - United States, Connecticut ... More >> YCCI/YNNH Hospital Research Unit New Haven, Connecticut, United States, 06520 Less <<
NCT00658164 Nonalcoholic Fatty Liver Disea... More >>se Less << Phase 3 Unknown - Italy ... More >> U.O. Medicina Interna 1/B Recruiting Milan, Italy, 20122 Contact: Silvia Fargion, Prof.    39-02-5503-3301    silvia.fargion@unimi.it    Principal Investigator: Silvia Fargion, Prof.          Sub-Investigator: Luca Valenti, Md Less <<
NCT00608816 Type 1 Diabetes Not Applicable Withdrawn - -
NCT01364350 - Completed - United States, California ... More >> Children's Hospital Los Angeles Los Angeles, California, United States, 90027 United States, Colorado University of Colorado Denver Denver, Colorado, United States, 80262 United States, Connecticut Yale University New Haven, Connecticut, United States, 06519 United States, Maryland George Washington University Biostatistics Center Rockville, Maryland, United States, 20852 United States, Massachusetts Massachusetts General Hospital Diabetes Center Boston, Massachusetts, United States, 02114 Joslin Diabetes Center Boston, Massachusetts, United States, 02215 United States, Missouri Saint Louis University St Louis, Missouri, United States, 63104 Washington University St Louis, Missouri, United States, 63110 United States, New York Columbia University Medical Center New York City, New York, United States, 10032 State University of New York Upstate Medical University Syracuse, New York, United States, 13214 United States, Ohio Case Western Reserve University Cleveland, Ohio, United States, 44106 United States, Oklahoma University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma, United States, 73117 United States, Pennsylvania Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 Children's Hospital of Pittsburgh Pittsburgh, Pennsylvania, United States, 15213 United States, Texas Baylor College of Medicine Houston, Texas, United States, 77030 University of Texas Health Science Center at San Antonio San Antonio, Texas, United States, 78229 Less <<
NCT01565824 Diabetes Type 1 ... More >> Pregnancy Early Motherhood Less << Not Applicable Completed - Sweden ... More >> Sahlgrenska Academy, Institute of Health Care Sciences Gothenburg, Sweden Less <<
NCT02285205 Type 2 Diabetes ... More >> Non-alcoholic Fatty Liver Disease Less << Phase 4 Completed - Korea, Republic of ... More >> Severance Hospital, Department of Internal Medicine, Yonsei University College of Medicine Seoul, Korea, Republic of, 120-752 Less <<
NCT00405925 HIV Infections Phase 3 Completed - Netherlands ... More >> Rijnstate Hospital Arnhem, Gelderland, Netherlands, 6800 TA Less <<
NCT02160379 - Completed - Switzerland ... More >> CHUV-clinical research center Lausanne, VD, Switzerland, CH-1001 Less <<
NCT02964104 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 1 Completed - Germany ... More >> Novo Nordisk Investigational Site Neuss, Germany, 41460 Less <<
NCT03608033 IgA Nephropathy Phase 3 Recruiting April 2023 United States, Alabama ... More >> Omeros Investigational Site Recruiting Florence, Alabama, United States, 35630 Contact: Laura Haas    206-676-0886    lhaas@omeros.com    United States, Arizona Omeros Investigational Site Recruiting Mesa, Arizona, United States, 85210 Contact: Laura Haas    206-676-0886    lhaas@omeros.com    United States, California Omeros Investigational Site Recruiting Los Angeles, California, United States, 90022 Contact: Laura Haas    206-676-0886    lhaas@omeros.com    Omeros Investigational Site Recruiting Northridge, California, United States, 91324 Contact: Laura Haas    206-676-0886    lhaas@omeros.com    Omeros Investigational Site Recruiting Torrance, California, United States, 90502 Contact: Laura Haas    206-676-0886    lhaas@omeros.com    United States, Florida Omeros Investigational Site Recruiting Coral Gables, Florida, United States, 33134 Contact: Laura Haas    206-676-0886    lhaas@omeros.com    Omeros Investigational Site Recruiting Miami Lakes, Florida, United States, 33014 Contact: Laura Haas    206-676-0886    lhaas@omeros.com    United States, Georgia Omeros Investigational Site Recruiting Lawrenceville, Georgia, United States, 30046 Contact: Laura Haas    206-676-0886    lhaas@omeros.com    United States, Iowa Omeros Investigational Site Recruiting Iowa City, Iowa, United States, 52242 Contact: Laura Haas    206-676-0886    lhaas@omeros.com    United States, Massachusetts Omeros Investigational Site Recruiting Boston, Massachusetts, United States, 02111 Contact: Laura Haas    206-676-0886    lhaas@omeros.com    Omeros Investigational Site Recruiting Springfield, Massachusetts, United States, 01107 Contact: Laura Haas    206-676-0886    lhaas@omeros.com    United States, Missouri Omeros Investigational Site Recruiting Kansas City, Missouri, United States, 64111 Contact: Laura Haas    206-676-0886    lhaas@omeros.com    Omeros Investigational Site Recruiting Saint Louis, Missouri, United States, 63110 Contact: Laura Haas    206-676-0886    lhaas@omeros.com    United States, New York Omeros Investigational Site Recruiting Flushing, New York, United States, 11355 Contact: Laura Haas    206-676-0886    lhaas@omeros.com    United States, Texas Omeros Investigational Site Recruiting Fort Worth, Texas, United States, 76104 Contact: Laura Haas    206-676-0886    lhaas@omeros.com    Omeros Investigational Site Recruiting Houston, Texas, United States, 77024 Contact: Laura Haas    206-676-0886    lhaas@omeros.com    Omeros Investigational Site Recruiting San Antonio, Texas, United States, 78215 Contact: Laura Haas    206-676-0886    lhaas@omeros.com    United States, Washington Omeros Investigational Site Recruiting Seattle, Washington, United States, 98104 Contact: Laura Haas    206-676-0886    lhaas@omeros.com Less <<
NCT00458029 Type 2 Diabetes Phase 3 Completed - United States, California ... More >> University of California at Irvine Irvine, California, United States, 92868 United States, Maryland George Washington University Biostatistics Center Rockville, Maryland, United States, 20852 United States, North Carolina University of North Carolina at Chapel Hill Chapell Hill, North Carolina, United States, 27599 United States, Oregon Oregon Health & Science University Portland, Oregon, United States, 97239 United States, Pennsylvania Temple University Philadelphia, Pennsylvania, United States, 19140 University of Pittsburgh Pittsburgh, Pennsylvania, United States, 15213 United States, Texas Baylor College of Medicine Houston, Texas, United States, 77030 University of Texas Health Science Center San Antonio, Texas, United States, 78210 Less <<
NCT02838069 Osteoarthritis Phase 2 Recruiting June 2019 France ... More >> UH Montpellier Recruiting Montpellier, France, 34295 Contact: Christian Jorgensen, MD    0033 467 337798    christian.jorgensen@chu-montpellier.fr    Contact: Yves Marie PERS, MD       rosanna.ferreira@chu-montpellier.fr    Principal Investigator: Christian Jorgensen, MD Less <<
NCT01391884 - Completed - Denmark ... More >> Department of Nephrology P, Copenhagen University Hospital, Rigshospitalet Copenhagen, Denmark, 2100 Less <<
NCT01177163 Diabetes Mellitus, Type 2 Phase 1 Completed - United States, California ... More >> Chula Vista, California, United States United States, Texas San Antonio, Texas, United States Less <<
NCT03406299 Biliary Tract Neoplasms Phase 2 Recruiting December 31, 2020 Taiwan ... More >> Taiwan Cooperative Oncology Group, National Health Research Institutes Recruiting Taipei, Taiwan Contact: Tsang-Wu Liu, MD    +886-2-26534401 ext 25150    walter@nhri.org.tw    Principal Investigator: Li-Tzong Chen, MD PHD          Principal Investigator: Nai-Jung Chiang, MD Less <<
NCT01686828 Insulin Resistance ... More >> Type 2 Diabetes Mellitus Obesity Androgen Deficiency Metabolic Disease Less << Phase 1 Phase 2 Completed - United States, Washington ... More >> University of Washington Seattle, Washington, United States, 98195 Less <<
NCT02139943 Diabetes Mellitus, Type 1 Phase 2 Completed - -
NCT02139943 - Completed - -
NCT00607503 Type 1 Diabetes Phase 1 Completed - United States, California ... More >> Division of Pediatric Endocrinology and Diabetes, Stanford University Stanford, California, United States, 94305 United States, Connecticut Department of Pediatrics, Yale University School of Medicine New Haven, Connecticut, United States, 06519 United States, Florida Nemours Children's Clinic Jacksonville, Florida, United States, 32207 Jaeb Center for Health Research Tampa, Florida, United States, 33647 United States, Iowa Department of Pediatrics, University of Iowa Carver College of Medicine Iowa City, Iowa, United States, 52242 United States, Missouri Washington University St. Louis, Missouri, United States, 63110 Less <<
NCT03478215 Renal Transplantation ... More >> Mesenchymal Stem Cells Less << Phase 2 Recruiting July 2021 United States, Texas ... More >> Houston Methodist Hospital System Recruiting Houston, Texas, United States, 77030 Contact: LaTisha Hargrove    713-441-6013    lmhargrove@tmhs.org    Contact: Darrel Cleere, RN,CCRP    713-441-6232    DWCLEERE@houstonmethodist.org    Principal Investigator: Ahmed O Gaber, MD Less <<
NCT01686828 - Completed - -
NCT02897674 Healthy Volunteers Not Applicable Unknown September 2017 United Kingdom ... More >> NIHR/Wellcome Trust Imperial Clinical Research Facility Recruiting London, United Kingdom, W12 0HS Less <<
NCT03307408 - Recruiting February 2020 France ... More >> CHU de Nice Recruiting Nice, France, 06000 Contact: Sylvie MALERBA    +33492034011    drc@chu-nice.fr    Principal Investigator: Rodolphe ANTY, MD Less <<
NCT02689362 Diabetes Mellitus, Type 2 Phase 2 Completed - Brazil ... More >> Centro de Estudos em Diabetes e Hipertensão Fortaleza, Ceará, Brazil Hospital Universitário João de Barros Barreto - HUJBB Belém, Pará, Brazil CCBR Brasil Centro de Pesquisas e Analises Clinicas Ltda Rio de Janeiro, Brazil Centro de Pesquisa Clínica em Diabetes - UNIFESP São Paulo, Brazil CEPIC - Centro Paulista de Investigação Clínica São Paulo, Brazil Clinica de Endocrinologia e Metabologia LTDA São Paulo, Brazil CPCLIN - Centro de Pesquisas Clinicas LTDA São Paulo, Brazil HCFMUSP São Paulo, Brazil IMA - Instituto de Pesquisa Clínica e Medicina Avançada Ltda São Paulo, Brazil IPEC - Instituto de Pesquisa Clínica Ltda São Paulo, Brazil Less <<
NCT02819830 Rheumatoid Arthritis ... More >> Physical Activity Less << Not Applicable Completed - United Kingdom ... More >> Musgrave Park Hospital, Belfast health and social care trust. Belfast, County Down, United Kingdom, BT9 7JB Less <<
NCT02302677 - Completed - -
NCT03132233 Migraine Epis... More >>odic Migraine Less << Not Applicable Recruiting July 31, 2019 Switzerland ... More >> University Children's Hospital (UKBB) Recruiting Basel, Basel-Stadt, Switzerland, 4031 Contact: Elena C Gross, PhD    +41 704 22 94    elena.gross@ukbb.ch    Contact: Anna-Lena Orsini, MD    +41 61 704 12 12    Anna-Lena.Orsini@ukbb.ch    Sub-Investigator: Elena C Gross, PhD          Sub-Investigator: Simone Schmidt, MD          Principal Investigator: Dirk Fischer, MD          Sub-Investigator: Anna-Lena Orsini, MD          Principal Investigator: Peter Sandor, MD Less <<
NCT00365495 Type 2 Diabetes Not Applicable Unknown June 2007 Denmark ... More >> University of Southern Denmark and Odense University Hospital Odense, Denmark, 5000 Less <<
NCT02338921 Type 2 Diabetes Phase 4 Recruiting December 2018 Korea, Republic of ... More >> Soo Lim Recruiting Seongnam, Gyeonggi, Korea, Republic of, 463-707 Contact: Dong Hwa Lee, MD Less <<
NCT00309309 Kidney Transplant Phase 2 Completed - Italy ... More >> Clinical Research Center for Rare Diseases Ranica, Bergamo, Italy, 24020 Less <<
NCT01771445 Type 2 Diabetes Not Applicable Completed - Switzerland ... More >> University Hospital of Basel, Division of Endocrinology Basel, Switzerland Less <<
NCT02661425 - Completed - United States, Connecticut ... More >> Greenwich, Connecticut, United States, 06830 Hamdon, Connecticut, United States, 06518 United States, Florida Coral Springs, Florida, United States, 33065 Maitland, Florida, United States, 32751 Orlando, Florida, United States, 32836 Tampa, Florida, United States, 33626 Winter Park, Florida, United States, 32789 United States, Georgia Smyrna, Georgia, United States, 30080 United States, Maryland Columbia, Maryland, United States, 21045 United States, Missouri St. Louis, Missouri, United States, 63141 United States, New York Lynbrook, New York, United States, 11563 New York, New York, United States, 10065 United States, Tennessee Kingsport, Tennessee, United States, 37663 Knoxville, Tennessee, United States, 37923 Morristown, Tennessee, United States, 37814 United States, Texas Bedford, Texas, United States, 76022 Less <<
NCT01876485 Diabetes Mellitus Not Applicable Completed - United States, Illinois ... More >> Jesse Brown VA Medical Center, Chicago, IL Chicago, Illinois, United States, 60612 Edward Hines Jr. VA Hospital, Hines, IL Hines, Illinois, United States, 60141-5000 United States, Texas Michael E. DeBakey VA Medical Center, Houston, TX Houston, Texas, United States, 77030 Less <<
NCT01622309 Obesity Obesi... More >>ty, Abdominal Less << Not Applicable Completed - Brazil ... More >> Policlínica de Alcantara São Gonçalo, Rio de Janeiro, Brazil Less <<
NCT01277471 Diabetes Mellitus, Type 2 Not Applicable Completed - Czech Republic ... More >> Institute for Clinical and Experimental Medicine Prague, Czech Republic, 140 21 Less <<
NCT00620308 Stable Chronic Heart Failure Phase 1 Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT03774108 PreDiabetes H... More >>IV-1-infection Less << Phase 4 Not yet recruiting March 8, 2019 Mexico ... More >> Hospital Civil de Guadalajara Not yet recruiting Guadalajara, Jalisco, Mexico, 44280 Contact: Juan Luis Soto-Mancilla, MD    +523339422441 ext 41014 Less <<
NCT02207374 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - Japan ... More >> Novo Nordisk Investigational Site Akita-shi, Akita, Japan, 010 8543 Novo Nordisk Investigational Site Annaka-shi, Gunma, Japan, 379 0116 Novo Nordisk Investigational Site Asahikawa-shi, Hokkaido, Japan, 070 0002 Novo Nordisk Investigational Site Asahikawa-shi, Hokkaido, Japan, 078 8510 Novo Nordisk Investigational Site Bunkyo-ku, Tokyo, Japan, 113 8431 Novo Nordisk Investigational Site Chuo-ku Tokyo, Japan, 103-0027 Novo Nordisk Investigational Site Chuo-ku Tokyo, Japan, 104-0031 Novo Nordisk Investigational Site Chuo-ku, Tokyo, Japan, 103 0002 Novo Nordisk Investigational Site Chuo-ku, Tokyo, Japan, 103 0027 Novo Nordisk Investigational Site Chuo-ku, Tokyo, Japan, 104-0061 Novo Nordisk Investigational Site Fukuoka, Japan, 812 0025 Novo Nordisk Investigational Site Higashiosaka-shi, Osaka, Japan Novo Nordisk Investigational Site Izumisano-shi, Japan, 598 0048 Novo Nordisk Investigational Site Kashiwara-shi, Osaka, Japan, 582 0005 Novo Nordisk Investigational Site Katsushika-ku, Tokyo, Japan, 125 0054 Novo Nordisk Investigational Site Kitakyushu-shi, Fukuoka, Japan, 800 0252 Novo Nordisk Investigational Site Koriyama-shi, Fukushima, Japan, 963 8851 Novo Nordisk Investigational Site Kumamoto-shi,Kumamoto, Japan, 862 0976 Novo Nordisk Investigational Site Kyoto-shi, Kyoto, Japan, 615 8125 Novo Nordisk Investigational Site Mito-shi, Ibaraki, Japan Novo Nordisk Investigational Site Miyazaki-shi, Japan, 880 0034 Novo Nordisk Investigational Site Naka-shi, Ibaraki, Japan, 311 0113 Novo Nordisk Investigational Site Nishinomiya-shi, Hygo, Japan, 662 0971 Novo Nordisk Investigational Site Nishinomiya-shi, Hyogo, Japan, 663-8501 Novo Nordisk Investigational Site Okawa-shi, Fukuoka, Japan, 831 0016 Novo Nordisk Investigational Site Okayama-shi, Okayama, Japan, 700 8505 Novo Nordisk Investigational Site Osaka-shi, Osaka, Japan, 532 0003 Novo Nordisk Investigational Site Ota-ku, Tokyo, Japan, 144 0035 Novo Nordisk Investigational Site Ota-ku, Tokyo, Japan Novo Nordisk Investigational Site Oyama-shi, Tochigi, Japan, 323 0022 Novo Nordisk Investigational Site Saga-shi,Saga, Japan, 849 0937 Novo Nordisk Investigational Site Sapporo-shi, Hokkaido, Japan, 060 0062 Novo Nordisk Investigational Site Sapporo-shi, Hokkaido, Japan, 062 0007 Novo Nordisk Investigational Site Sendai-shi, Japan, 980 0021 Novo Nordisk Investigational Site Shimotsuke-shi, Tochigi, Japan, 329 0433 Novo Nordisk Investigational Site Shinjuku-ku, Tokyo, Japan, 160-0008 Novo Nordisk Investigational Site Shizuoka-shi, Japan, 424 0853 Novo Nordisk Investigational Site Suita-shi, Osaka, Japan, 565-0853 Novo Nordisk Investigational Site Takatsuki-shi, Osaka, Japan, 569 1096 Novo Nordisk Investigational Site Tokyo, Japan, 103-0028 Novo Nordisk Investigational Site Tokyo, Japan, 123-0845 Novo Nordisk Investigational Site Ube-shi, Yamaguchi, Japan Novo Nordisk Investigational Site Yokohama-shi, Japan, 235 0045 Less <<
NCT02970656 Diabetes Mellitus, Type 1 Not Applicable Active, not recruiting December 30, 2018 United States, Connecticut ... More >> Yale School of Nursing West Haven, Connecticut, United States, 06516-7399 Less <<
NCT00528879 Type 2 Diabetes Phase 3 Completed - -
NCT02867215 Metabolic Syndrome Not Applicable Completed - -
NCT00528879 - Completed - -
NCT01332877 Obesity Phase 3 Unknown - Israel ... More >> Wolfson Medical Center Recruiting Holon, Israel, 58100 Contact: Daniela Jakubowicz, MD    972-50-810-5552    daniela.jak@gmail.com    Principal Investigator: Daniela Jakubowicz, MD Less <<
NCT01161394 Inflammation Phase 4 Completed - United States, New York ... More >> Millard Fillmore gates Hospital Buffalo, New York, United States, 14226 Less <<
NCT03100708 - Recruiting April 2021 Germany ... More >> Universitätsklinikum Leipzig - AöR Recruiting Leipzig, Sachsen, Germany, 04103 Less <<
NCT00579436 - Completed - -
NCT02179281 Type 1 Diabetes Mellitus Not Applicable Completed - Israel ... More >> Schneider Children's Medical Center of Israel, The Jesse Z and Sara Lea Shafer Institute for Endocrinology and Diabetes Petah Tikva, Israel, 4920235 Slovenia University of Ljubljana, Faculty of Medicine Ljubljana, Slovenia, 1000 Less <<
NCT02900417 Type 2 Diabetes Not Applicable Unknown November 2016 -
NCT00579436 Metabolic Syndrome ... More >> Insulin Resistance Less << Not Applicable Completed - United States, Kentucky ... More >> University of Kentucky Medical Cener Lexington, Kentucky, United States, 40475 Less <<
NCT03578887 Obesity, Gliosis, Weight-Loss Not Applicable Not yet recruiting June 30, 2023 -
NCT00937638 Metabolic Syndrome ... More >> Cardiovascular Disease Less << Not Applicable Completed - United States, Pennsylvania ... More >> Penn State University University Park, Pennsylvania, United States, 16802 Less <<
NCT02171351 Type 2 Diabetes ... More >> Insulin Resistance Less << Not Applicable Not yet recruiting December 2019 France ... More >> Clinical Research Center Caen University Hospital Not yet recruiting Caen, France, 14033 Contact: Sylvie Brucato, PhD    +33231065227    brucato-s@chu-caen.fr    Principal Investigator: michael joubert, MD          Sub-Investigator: yves reznik, MD          Sub-Investigator: julia morera, MD          Sub-Investigator: anne rod, MD          Sub-Investigator: aini haddouche, MD          Sub-Investigator: corinne fourmy, MD          Sub-Investigator: juliette hardouin, MD          Sub-Investigator: herve normand, PhD          Sub-Investigator: pierre denise, PhD Less <<
NCT02677792 Pediatric Obesity Not Applicable Recruiting June 2019 United States, Mississippi ... More >> University of Mississippi Medical Center Recruiting Jackson, Mississippi, United States, 39216 Contact: Crystal S. Lim, Ph.D.    601-815-1021       Contact    601-984-5839 Less <<
NCT02276196 Diabetic Kidney Disease ... More >> Diabetic Nephropathy Diabetes Mellitus Glucagon-Like Peptide 1 Less << Phase 4 Completed - Netherlands ... More >> VU Universtiy Medical Center Amsterdam, Netherlands, 1081 HV Less <<
NCT01743820 Malaria Phase 2 Completed - Mali ... More >> Malaria Research and Training Centre Bamako, Mali Less <<
NCT02284425 Diabetes Mellitus, Type 2 Phase 1 Terminated - United States, Florida ... More >> Miami, Florida, United States United States, Georgia Atlanta, Georgia, United States United States, Tennessee Knoxville, Tennessee, United States Less <<
NCT02907346 Type 1 Diabetes Not Applicable Recruiting December 2018 United States, Connecticut ... More >> Yale University School of Medicine Recruiting New Haven, Connecticut, United States, 06520 Contact: Marcia DeSousa, BA    203-737-6877    DeSousa@uchc.edu    Principal Investigator: William Tamborlane, MD Less <<
NCT00993304 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 1 Completed - Denmark ... More >> Novo Nordisk Investigational Site Aarhus C, Denmark, 8000 Less <<
NCT03344692 Type2 Diabetes Phase 3 Not yet recruiting March 15, 2019 -
NCT02011828 Inflammation ... More >>Insulin Resistance Less << Phase 1 Completed - United States, Utah ... More >> University of Utah Salt Lake City, Utah, United States, 84112 Less <<
NCT01131299 Cardiovascular Disease Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT01131299 - Completed - -
NCT00890331 Type 1 Diabetes Phase 1 Completed - United States, District of Col... More >>umbia Children's National Medical Center Washington, District of Columbia, United States, 20010 United States, Virginia Virginia Commonwealth University Richmond, Virginia, United States, 23284 Less <<
NCT00847262 Hypertension ... More >>Obesity Diabetes Less << Phase 4 Completed - China ... More >> The third hospital affiliated to the Third Military Medical University Chongqing, China, 400042 Less <<
NCT02449213 - Recruiting June 2021 United States, Pennsylvania ... More >> Fox Chase Cancer Center Recruiting Philadelphia, Pennsylvania, United States, 19111 Contact: CAROLYN FANG    215-728-4062    Carolyn.Fang@fccc.edu    Principal Investigator: CAROLYN FANG Less <<
NCT02501772 Diabetic Nephropathy Phase 2 Phase 3 Unknown September 2015 Taiwan ... More >> Mackay Memerial Hospital Recruiting Taipei, Taiwan Contact: Sung-Chen Liu, master    886-975835741 Less <<
NCT00723853 Obesity Type ... More >>2 Diabetes Less << Not Applicable Completed - United States, Illinois ... More >> University of Chicago GCRC (General Clinical Research Center) Chicago, Illinois, United States, 60637 Less <<
NCT02847468 Carcinoma, Hepatocellular Not Applicable Recruiting March 27, 2021 France ... More >> Emilie REDERSTORFF Recruiting Dijon, France, 21000 Contact: Emilie REDERSTORFF, PhD    0033 3 80 73 75 00 ext 3461    ERederstorff@cgfl.fr    Contact: Sandrine TIAGO    0033 3 80 73 75 00    stiago@cgfl.fr    Principal Investigator: Alexandre COCHET, MD Less <<
NCT01527266 Carbohydrate Mouth-rinse on Ti... More >>me Trial Performance Less << Not Applicable Unknown January 2013 Netherlands ... More >> Maastricht University Recruiting Maastricht, Netherlands Less <<
NCT01818245 - Completed - -
NCT03527277 Cardiovascular Risk Factor ... More >> Type2 Diabetes Mellitus Insulin Sensitivity Metabolic Syndrome Less << Not Applicable Recruiting March 31, 2023 United States, California ... More >> University of California, Davis Recruiting Davis, California, United States, 95616 Contact: Kimber Stanhope, Ph.D.    530-752-3720    klstanhope@ucdavis.edu    Contact: Vivien Lee, B.S.    530-752-2714    vilee@ucdavis.edu Less <<
NCT01818245 Healthy Volunteers Phase 1 Completed - United States, Texas ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Dallas, Texas, United States Less <<
NCT00415688 Type 2 Diabetes Mellitus ... More >> Overweight Obesity Less << Phase 4 Completed - United States, North Carolina ... More >> Duke University Health System Durham, North Carolina, United States, 27704 Less <<
NCT01003236 Diabetic Nephropathy Phase 2 Completed - Iran, Islamic Republic of ... More >> Motahari Clinic Shiraz, Fars, Iran, Islamic Republic of, 71345 Less <<
NCT00602914 Intradermal Injections Early Phase 1 Completed - -
NCT03271879 Heart Failure ... More >> Diabetes Mellitus Arrythmia Less << Phase 4 Not yet recruiting June 1, 2020 -
NCT03318055 - Completed - South Africa ... More >> Groote Schuur Hospital Cape Town, Western Cape, South Africa, 7599 Mitchells Plain Hospital Cape Town, Western Cape, South Africa, 7599 Somerset Hospital Cape Town, Western Cape, South Africa, 7599 Victoria Hospital Cape Town, Western Cape, South Africa, 7599 George Hospital George, Western Cape, South Africa, 7599 Paarl Hospital Paarl, Western Cape, South Africa, 7599 Less <<
NCT00422253 Type 2 Diabetes ... More >> Insulin Resistance Obesity Less << Not Applicable Completed - Australia, Victoria ... More >> Baker Heart Research Insitute Melbourne, Victoria, Australia, 3186 Less <<
NCT02148861 Diabetes Type... More >> 2 Diabetes Mellitus Less << Phase 1 Completed - Germany ... More >> Novo Nordisk Investigational Site Neuss, Germany, 41460 Less <<
NCT01212328 Type 2 Diabetes Mellitus ... More >> Hypertension Dyslipidaemia Less << Not Applicable Unknown June 2014 India ... More >> Bangalore Endocrinology and Diabetes Research Centre, Recruiting #35, 5th Cross,Malleswaram Circle,, Bangalore, Karnataka, India, 560 003 Contact: Mala Dharmalingam, MD DM    +919845208163    drmala@bedrc.com    Principal Investigator: Mala Dharamalingam, MD DM          St. John's Medical College & Hospital, Recruiting Sarjapur Road, Koramangala,, Bangalore, India, 560 034 Contact: Ganapathy Bantwal, MD DM    +919448067318    mallyaganapathi@rediffmail.com    Principal Investigator: Ganapathy Bantwal, MD DM          Diabetes Research Centre & MV Hospital for Diabetes, Recruiting No 4 West Madha Church Street, Royapuram, Chennai, India, 600 013 Contact: Vijay Viswanathan, MD DM    +919840055535    dr_vijay@vsnl.com    Principal Investigator: Vijay Vishwanatha, MD DM          Public Health Foundation of India Recruiting New Delhi, Delhi, India, 110016 Contact: Dorairaj Prabhakaran, MD, DM, MSc.    +91-11-26850588    dprabhakaran@ccdcindia.org    Principal Investigator: Nikhil Tandon, MD, PhD          Endocrine Division, Department of Medicine, Goa Medical College, Not yet recruiting Bambolim, Goa, India, 403202 Contact: Ankush Desai, MD DM    +91-9923486199    ankush_desai@rediffmail.com    Principal Investigator: Ankush Desai, MD DM          Department of Endocrinology, CARE Hospital, Recruiting Road No 1, Banjara Hills,, Hyderabad,, India, 500 034 Contact: Bipin Sethi, MD, DM    +919848021482    bipinkumarsethi@yahoo.co.uk    Principal Investigator: Bipin Sethi, MD, DM          Osmania General Hospital, Recruiting 2nd Floor, Golden Jubilee Block, Afzalgunj,, Hyderabad, India, 500012 Contact: Rakesh Sahay, MD DM    +919849597507    sahayrk@gmail.com    Principal Investigator: Rakesh Sahay, MD DM          Amrita Institute of Medical Sciences Recruiting Kochi, Kerala, India, 682041 Contact: A G Unnikrishnan, MD, DM    +91-4844001559    unnikrishnanag@aims.amrita.edu    Principal Investigator: A G Unnikrishnan, Md, DM          Topiwala National Medical College & BYL Nair Ch. Hospital, Recruiting Dr. A. L. Nair Road, Mumbai Central,, Mumbai, India, 400 008 Contact: Premalata Varthakavi, MD, DM    +919224480560    premavar@hotmail.com    Principal Investigator: Premlatha Varthakavi, MD, DM          Pakistan Department of CHS, The Aga Khan, University, Recruiting P.O. BOx. 3500 Stadium, Road,, Karachi, Pakistan, 74800 Contact: Hassan Daudzai, MBBS    +92214930051 ext 4919    hassan.daudzai@aku.edu    Principal Investigator: Abdul Jabbar, MD DM Less <<
NCT02169999 Diabetes Not Applicable Completed - United States, Illinois ... More >> University of Chicago Hospitals Chicago, Illinois, United States, 60637 Less <<
NCT03234751 Diabetes Phase 1 Recruiting January 2019 United States, Florida ... More >> Translational Research Institute for Metabolism and Diabetes Recruiting Orlando, Florida, United States, 32804 Contact: Quianna Stokes-Washington    407-303-7100    tri@flhosp.org Less <<
NCT00988403 Healthy Volunteers Not Applicable Completed - United States, Iowa ... More >> University of Iowa Hospitals and Clinics Iowa City, Iowa, United States, 52242 Less <<
NCT02561000 Arterial Occlusive Diseases ... More >> Coronary Artery Disease Coronary Disease Arteriosclerosis Heart Diseases Myocardial Ischemia Vascular Diseases Acute Coronary Syndrome Less << Phase 2 Suspended(Pending continued fu... More >>nding) Less << June 2019 United States, Massachusetts ... More >> Tufts Medical Center Boston, Massachusetts, United States, 02111 UMass Memorial Medical Center Worcester, Massachusetts, United States, 01605 United States, Virginia Inova Heart and Vascular Institute, Inova Fairfax Hospital Falls Church, Virginia, United States, 22042 Less <<
NCT00203632 Diabetes Mellitus Phase 3 Terminated(Terminated at 50% e... More >>nrollment due to recent concerns about rosiglitazone) Less << - Canada, Alberta ... More >> Foothills Medical Centre Calgary, Alberta, Canada, T2N 2T9 Less <<
NCT01563419 Diabetes Mellitus Not Applicable Completed - Korea, Republic of ... More >> Seoul National University Hospital Seoul, Korea, Republic of, 110-744 Less <<
NCT02979496 Healthy Not Applicable Completed - United States, Florida ... More >> University of Florida Gainesville, Florida, United States, 32611 Less <<
NCT00110864 Type 2 Diabetes Mellitus Phase 2 Completed - United States, Connecticut ... More >> Phoenix Internal Medicine Associates Waterbury, Connecticut, United States, 06708 United States, Florida Center for Diabetes and Endocrine Care Hollywood, Florida, United States, 33021 Genesis Research International Longwood, Florida, United States, 32779 Baptist Diabetes Associates Miami, Florida, United States, 33156 Andres Patron, DO PA Pembroke Pines, Florida, United States, 33028 CLIRECO,Inc. Tamarac, Florida, United States, 33321 Endocrine Clinical Research Winter Park, Florida, United States, 32789 United States, Kansas PRN of Kansas Wichita, Kansas, United States, 67203 United States, North Carolina Medical Research Associates of Charlotte Charlotte, North Carolina, United States, 28211 Neem Research Group of Charlotte Charlotte, North Carolina, United States, 28262 Unifour Medical Research Associates Hickory, North Carolina, United States, 28601 Neem Research Group of Raleigh Raleigh, North Carolina, United States, 27609 Piedmont Medical Research Associates Winston-Salem, North Carolina, United States, 27103 United States, Oklahoma COR Clinical Research, LLC Oklahoma City, Oklahoma, United States, 73103 United States, Oregon Clinical Research Institute of Southern Oregon, PC Medford, Oregon, United States, 97504 United States, Pennsylvania Camp Hill Clinical Research Center Camp Hill, Pennsylvania, United States, 17011 United States, South Carolina Neem Research Group Columbia, South Carolina, United States, 29201 United States, Texas Oaks Medical Center Spring, Texas, United States, 77386 Less <<
NCT01539928 - Unknown March 2015 Denmark ... More >> Department of Pulmonary Medicine Recruiting Odense C, Fünen, Denmark, 5000 Contact: Niels Christian Hansen, MD       niels.christian.hansen@rsyd.dk Less <<
NCT00228865 Diabetes Mellitus Phase 2 Phase 3 Terminated(Administrative) - United States, Florida ... More >> Florida Atlantic University Boca Raton, Florida, United States, 33431 Less <<
NCT03022058 Diabetes Mellitus, Type 1 Not Applicable Completed - Denmark ... More >> Diabetes Research Center Odense, Denmark, 5000 Less <<
NCT01806727 Type 2 Diabetes ... More >> Overweight Obesity Less << Not Applicable Completed - United States, North Carolina ... More >> Wake Forest Baptist Health Winston-Salem, North Carolina, United States, 27157 Less <<
NCT01864564 Gestational Diabetes ... More >> Obesity Less << Not Applicable Completed - United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35233 United States, Louisiana Ochsner Health System New Orleans, Louisiana, United States, 70121 Less <<
NCT03625427 Obesity Chron... More >>ic Inflammation Less << Not Applicable Not yet recruiting November 2020 United States, North Carolina ... More >> University of North Carolina Nutrition Research Institute Not yet recruiting Kannapolis, North Carolina, United States, 28081 Contact: Jomari Torres, MD    704-250-5062    jomari_torres@unc.edu Less <<
NCT02258438 Health Behavior Not Applicable Recruiting December 2019 United States, Colorado ... More >> University of Colorado Hospital Recruiting Aurora, Colorado, United States, 80045 Contact: Audrey Bergouignan    303-724-3036    audrey.bergouignan@ucdenver.edu Less <<
NCT01249963 Acute Pancreatitis ... More >> Enteral Nutrition Less << Not Applicable Unknown March 2013 Spain ... More >> Clinical Nutrition and Dietetic Unit, Hospital Universitario Gregorio Marañón Recruiting Madrid, Spain, 28007 Contact: Cristina Velasco Gimeno, BA    +34 91 586 71 64    cvelasco.hgugm@salud.madrid.org Less <<
NCT00855894 - Completed - -
NCT03066089 Type 2 Diabetes Mellitus Phase 4 Completed - India ... More >> Gian Sagar Medical College & Hospital Rajpura, Punjab, India, 140601 Less <<
NCT00021788 Diabetes Mellitus, Type 1 Phase 2 Completed - United States, Florida ... More >> University of Miami Diabetes Research Institute Miami, Florida, United States, 33136 Less <<
NCT01288144 Gestational Diabetes Mellitus Not Applicable Completed - -
NCT00855894 Non-Small Cell Lung Cancer Phase 2 Completed - United States, California ... More >> Los Angeles, California, United States, 90033 Rancho Mirage, California, United States, 92270 United States, Nebraska Omaha, Nebraska, United States, 68114 United States, Washington Seattle, Washington, United States, 98195 Australia Adelaide, Australia, 5000 Chermside, Australia, 4032 East Melbourne, Australia, 3002 Heidelberg, Australia, 3084 Herston, Australia, 4029 Sydney, Australia, 2065 Less <<
NCT01006018 Prediabetic State Not Applicable Terminated(Unanticipated delay... More >>s due to sterilization/stabilization testing of GLP-1.) Less << - United States, Georgia ... More >> Grady Memorial Hospital Atlanta, Georgia, United States, 30303 Emory University Hospital Atlanta, Georgia, United States, 30322 Less <<
NCT00388986 Diabetes Mellitus Type 2 Phase 1 Completed - United States, California ... More >> Cypress, California, United States, 90630 United States, Hawaii Honolulu, Hawaii, United States, 96813 United States, New York Buffalo, New York, United States, NY 14215 United States, Texas San Antonio, Texas, United States, 78229 Less <<
NCT00306384 Diabetes Mellitus Phase 3 Completed - -
NCT02817360 Heart Diseases ... More >> Diabetes Mellitus, Type 2 Less << Phase 4 Recruiting February 2021 Austria ... More >> Internistische Ordination Recruiting Mödling, Niederösterreich, Austria, 2340 Contact: Christian Feinböck, MD    +43 2236 869 142    office@dr-feinboeck.at    Contact: Christiane Feinböck    +43 2236 869 142    office@dr-feinboeck.at    Sub-Investigator: Egbert Seyfried, MD          Principal Investigator: Christian Feinböck, MD          Klinischen Abteilung für Endokrinologie und Diabetologie MU Graz Recruiting Graz, Steiermark, Austria, 8036 Contact: Harald Sourij    +43-316-385-80363    ha.sourij@medunigraz.at    Contact: Michael Zink    +43-680-128-5120    m.zink@medunigraz.at    Sub-Investigator: Julia Mader, MD Prof          Sub-Investigator: Eva Novak, MD          Sub-Investigator: Caren Sourij, MD          Konventhospital der Barmherzigen Brüder Abteilung für Innere Medizin Recruiting Linz, Upper Austria, Austria, 4021 Contact: Martin Clodi, Prof.Dr.       martin.clodi@bblinz.at    Principal Investigator: Martin Clodi, Prof.Dr.          Sub-Investigator: Michael Resl, Dr.          Krankenanstalt Rudolfstiftung, 1. Medizinische Abteilung Recruiting Vienna, Austria, 1030 Contact: Bernhard Ludvik, Prof.Dr.    +43 1 711 65 ext 2107    bernhard.ludvik@wienkav.at    Principal Investigator: Bernhard Ludvik, Prof.Dr.          Sub-Investigator: Eva-Christina Krzizek, Dr.          Sub-Investigator: Johanna Brix, Dr.          Sub-Investigator: Astrid Feder, Dr.          Sub-Investigator: Florian Hoellerl, Dr.          Medical University of Vienna Univ.Clinic for Internal Medicine II Department of Cardiology Recruiting Vienna, Austria, 1090 Contact: Martin Huelsmann, Doz.Dr.    +43 1 40400 ext 46140    martin.huelsmann@meduniwien.ac.at    Principal Investigator: Martin Huelsmann, Doz.Dr.          Sub-Investigator: Raphael Wurm, Dr.          Univ. Klinik für Innere Medizin III Med. Uni Wien Recruiting Vienna, Austria, 1090 Contact: Anton Luger, Prof.Dr.    00 43 1 40400 ext 43100    anton.luger@meduniwien.ac.at    Principal Investigator: Anton Luger, Prof.Dr.          Sub-Investigator: Michael Krebs, Prof.Dr.          Universitätsklinik für Augenheilkunde und Optometrie Medizinische Universität Wien Recruiting Vienna, Austria, 1090 Contact: Sonja Prager, Dr.    +43 1 40400 ext 79470    sonja.prager@meduniwien.ac.at    Principal Investigator: Sonja Prager, Dr.          Sub-Investigator: Julia Hafner, Dr.          Diabetes & Stoffwechselambulanz Gesundheitszentrum Wien Süd Recruiting Vienna, Austria, 1100 Contact: Helmut Brath, OA Dr.    +43 1 60122 ext 4264    helmut.brath@wgkk.at    Principal Investigator: Helmut Brath, OA Dr.          3. Med. Abtlg., KH Hietzing mit Neurologischem Zentrum Rosenhügel Recruiting Vienna, Austria, 1130 Contact: Rudolf Prager, Prof.Dr.    +43 1 80110 ext 2351    rudolf.prager@wienkav.at    Principal Investigator: Rudolf Prager, Prof.Dr.          Sub-Investigator: Slobodan Peric, Dr.          Zentrum für Klinische Studien Recruiting Wien, Austria, 1060 Contact: Ursula Hanusch, MD    +43 1 266 21 91    dr.hanusch@dieinternistin.com    Contact: Michaela Mauritz    +43 1 266 21 91    office@dieinternistin.com    Sub-Investigator: Marita Spak, MD          Netherlands Maastricht University Medical Center; Dep. Cardiology Recruiting Maastricht, Netherlands, 6202 Contact: Hans-Peter Brunner-La Rocca, MD Prof    +31 43-3877097    hp.brunnerlarocca@mumc.nl    Contact: Mireille Spanjers    +31 43-3877099    m.spanjers@mumc.nl    Sub-Investigator: Nick Marks, MD          Sub-Investigator: Wouter Robaeys, MD          New Zealand Christchurch Heart Institute Recruiting Christchurch, New Zealand, 8140 Contact: Richard Troughton, MD Prof    +64 3 364 1063    Richard.Troughton@cdhb.health.nz    Contact: Lorraine Skelton    +64 3 364 1063    lorraine.skelton@cdhb@health.nz    Principal Investigator: Richard Troughton, MD Prof Less <<
NCT02173990 Metastatic Colorectal Cancer Phase 2 Unknown July 2017 France ... More >> Institut Bergonié Recruiting Bordeaux, France, 33076 Contact: Simone MATHOULIN, MD, PhD    33 556337841    s.mathoulin@unicancer.fr    Principal Investigator: Yves BECOUARN, MD          Centre Georges François Leclerc Recruiting Dijon, France, 21079 Contact: Sandrine TIAGO, CRA    33 345348051    stiago@cgfl.fr    Principal Investigator: François GHIRINGHELLI, MD          Kremlin Bicetre Recruiting Le Kremlin Bicetre, France, 94275 Contact: Anne THIROT-BIDAULT, MD    33 145213720    anne.bidault@bct.aphp.fr    Principal Investigator: Anne THIROT-BIDAULT, MD          Centre Oscar Lambret Recruiting Lille, France, 59020 Contact: Marie VANSEYMORTIER, PharmD    33 320295918    promotion@o-lambret.fr    Principal Investigator: Antoine ADENIS, MD, PhD          CHRU Recruiting Lille, France, 59037 Contact: Mohamed HEBBAR, MD    33 320445461    mohamed.hebbar@chru-lille.fr    Principal Investigator: Mohamed HEBBAR, MD, PhD          Institut Paoli Calmettes Recruiting Marseille, France, 13273 Contact: Dominik VERDIER-PINARD, CRA    33 491223762    verdierd@ipc.unicancer.fr    Principal Investigator: Jean-Luc RAOUL, MD, PhD          Hôpital Universitaire Paul Brousse Recruiting Villejuif, France, 94804 Contact: Reza ETESSAMI, MD    33 145596678    REZA.ETESSAMI@PBR.APHP.FR    Principal Investigator: Mohamed BOUCHAHDA, MD          Gustave Roussy Not yet recruiting Villejuif, France, 94805 Contact: Natacha COLIN-BATAILHOU, CRA    33 142114952    Natacha.Colin@gustaveroussy.fr    Principal Investigator: Michel DUCREUX, MD, PhD Less <<
NCT03495908 Type 2 Diabetes ... More >> Type 2 Diabetes Mellitus Less << Not Applicable Recruiting December 31, 2018 United States, Florida ... More >> East Coast Institute for Research, LLC Recruiting Jacksonville, Florida, United States, 32204 Contact: Rebecca F Goldfaden, PharmD    904-384-2379 ext 1    rebecca.goldfaden@ecirmed.com    United States, Georgia East Coast Institute for Research, LLC Recruiting Macon, Georgia, United States, 31210 Contact: Rebecca F Goldfaden, PharmD    478-746-8626 ext 260    rebecca.goldfaden@ecirmed.com Less <<
NCT00687115 Obesity Diet ... More >>Therapy Weight Loss Weight Gain Nutrition Therapy Less << Phase 2 Recruiting March 31, 2020 United States, Arizona ... More >> NIDDK, Phoenix Recruiting Phoenix, Arizona, United States, 85014 Contact: Susanne Votruba, Ph.D.    602-200-5336    votrubas@mail.nih.gov Less <<
NCT02516956 Regulation, Appetite ... More >> Eating Behavior Cognition Less << Not Applicable Completed - Italy ... More >> University of Parma Parma, PR, Italy, 43125 Less <<
NCT00439387 - Terminated - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00718874 Obesity Type ... More >>2 Diabetes Less << Not Applicable Completed - United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35294 Less <<
NCT03293914 Diabetes Mellitus Not Applicable Active, not recruiting August 31, 2019 United States, California ... More >> LAC+USC Primary Care Adult West Clinic Los Angeles, California, United States, 90033 Less <<
NCT03228732 Type 1 Diabetes Mellitus Early Phase 1 Recruiting December 10, 2020 United States, Maryland ... More >> University of Maryland Recruiting Baltimore, Maryland, United States, 21201 Contact: Maka S Hedrington, MD    410-706-5623    mhedrington@som.umaryland.edu Less <<
NCT00306384 - Completed - -
NCT02835495 Pre-diabetes ... More >>Obesity Less << Not Applicable Recruiting February 2019 United States, North Carolina ... More >> Wake Forest School of Medicine Recruiting Winston-Salem, North Carolina, United States, 27157 Contact: Mariela Arias    336-716-9470    mnarias@wakehealth.edu    Principal Investigator: Mara Z Vitolins, DrPH MPH RDN Less <<
NCT00561626 Metabolic Syndrome X Not Applicable Completed - Netherlands ... More >> Maastricht University, Department of Human Biology Maastricht, Netherlands, 6229 ER Less <<
NCT02573675 - Unknown October 2018 -
NCT00865592 Type 2 Diabetes Mellitus ... More >> Type 2 Diabetes Less << Phase 3 Terminated March 2011 -
NCT03122119 Chronic Low Back Pain ... More >> Sacroiliitis Sacroiliac; Backache Platelet Rich Plasma Platelet Injection Site Ultrasound Therapy; Complications Treatment Less << Phase 4 Enrolling by invitation March 2020 United States, Colorado ... More >> Star Spine and Sport Golden, Colorado, United States, 80401 Less <<
NCT02415114 CoQ10 Blood Levels ... More >> CoQ10 Blood Levels With Statin Use Less << Phase 1 Completed - Canada, Ontario ... More >> KGK Synergize Inc. London, Ontario, Canada, N6A 5R8 Less <<
NCT00154011 Healthy Subjects Not Applicable Completed - Germany ... More >> Institute of Clinical Pharmacology Dresden, Germany, 01307 Less <<
NCT02629627 Metabolic Syndrome Phase 2 Completed - -
NCT01770054 - Completed - Ecuador ... More >> Center of Health Atahualpa, Santa Elena, Ecuador, 0000 Less <<
NCT00001522 - Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00487734 Metabolic Syndrome ... More >> Hypogonadism Less << Phase 4 Completed - United States, Virginia ... More >> Hunter Holmes McGuire VA Medical Center Richmond, Virginia, United States, 23249 Less <<
NCT02597400 Type 2 Diabetes Mellitus Phase 1 Completed - United States, New Jersey ... More >> Frontage Clinical Services Inc. Hackensack, New Jersey, United States, 07601 Less <<
NCT00474838 Type 2 Diabetes Mellitus ... More >> Pancreatic Beta Cell Function Glucotoxicity Less << Phase 4 Completed - Korea, Republic of ... More >> Hanyang University Medical Center Kuri, Kyunggi-do, Korea, Republic of, 471-020 The Catholic University of Korea Bucheon St.Mary's Hospital Bucheon, Korea, Republic of Inha University Hospital In Cheon, Korea, Republic of, 400-711 Jeju National University Hospital Jeju-do, Korea, Republic of Kyunghee University Medical Center Seoul, Korea, Republic of, 130-702 Korea University Guro Hospital Seoul, Korea, Republic of, 152-730 Kyung Hee University East Weast Neo Medicalcenter Seoul, Korea, Republic of Ajou University Medical Center Suwon, Korea, Republic of, 443-721 Less <<
NCT00683826 Overweight Ob... More >>esity Less << Not Applicable Completed - United States, New York ... More >> Columbia University Medical Center New York, New York, United States, 10032 Less <<
NCT00683826 - Completed - -
NCT01011868 Diabetes Mellitus, Type 2 Phase 2 Completed - -
NCT03703115 Infertility P... More >>olycystic Ovary Syndrome Less << Not Applicable Recruiting September 1, 2019 Egypt ... More >> KasrELAiniH Recruiting Cairo, Egypt Contact: Abdelmaguid Ramzy, MD    00223682030    amramzy@gmail.com    Contact: Amira Dieb    00223682030    amirasaied2026@cu.edu.gov    Principal Investigator: Ramzy, MD Less <<
NCT03711383 Obesity Pre D... More >>iabetes Less << Not Applicable Recruiting November 2018 Netherlands ... More >> Maastricht University Medical Centre Recruiting Maastricht, Netherlands Contact: Emanuel E Canfora, PhD    +31 43 3881 669    emanuel.canfora@maastrichtuniversity.nl Less <<
NCT03008005 PostTraumatic Stress Disorder Phase 4 Recruiting December 31, 2019 United States, Michigan ... More >> Eugene Applebaum College of Pharmacy and Health Sciences Recruiting Detroit, Michigan, United States, 48201 Contact: Farrah Elrahal    313-577-5404    felrahal@wayne.edu    Principal Investigator: Christine A. Rabinak, PhD Less <<
NCT03619421 Zinc Deficiency ... More >> Dyslipidemias Zinc Excess Inflammation Less << Not Applicable Recruiting December 31, 2018 United States, California ... More >> UCSF Benioff Children's Hospital Oakland Research Institute Recruiting Oakland, California, United States, 94609 Contact: Janet C King, PhD    510-450-7939    jking@chori.org Less <<
NCT01709474 Systemic Lupus Erythematosus Phase 2 Terminated(Due to slow enrollm... More >>ent) Less << - United States, California ... More >> Children's Hospital Los Angeles Los Angeles, California, United States, 90027 Lucile Packard Children's Hospital, Stanford University Palo Alto, California, United States, 94304 UCSF School of Medicine San Francisco, California, United States, 94143 United States, Illinois Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States, 60611 University of Chicago Chicago, Illinois, United States, 60637 United States, Indiana Riley Hospital for Children Indianapolis, Indiana, United States, 46202 United States, New York Montefiore Medical Center Bronx, New York, United States, 10467 Columbia University New York, New York, United States, 10032 University of Rochester Rochester, New York, United States, 14642 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 United States, Pennsylvania The Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 United States, Texas Children's Medical Center of Dallas Dallas, Texas, United States, 75235 United States, Washington Seattle Children's Hospital Seattle, Washington, United States, 98101 Less <<
NCT02988427 - Withdrawn - -
NCT01709474 - Terminated(Due to slow enrollm... More >>ent) Less << - -
NCT02040012 Type 2 Diabetes Mellitus Phase 1 Unknown October 2015 United Kingdom ... More >> Quintiles Drug Research Unit at Guy's Hospital London, United Kingdom, SE1 1YR Less <<
NCT01811160 Second Generation Antipsychoti... More >>c Induced Metabolic Adverse Effects Less << Phase 4 Completed - Mexico ... More >> Instituto Nacional de Psiquiatría "Dr. Ramón de la Fuente" Mexico City, México City, Mexico, 14370 Less <<
NCT02561377 Prediabetic State Not Applicable Unknown September 2016 China, Guangxi ... More >> The first Affiliated hospital of Guangxi medical university Recruiting Nanning, Guangxi, China, 530021 Contact: Xia Dai, director    8613977166323    daixia333@aliyun.com    China, Jiangsu Southeast University, China Recruiting Nanjing, Jiangsu, China, 210096 Contact: Hong Ji    8613511681180    1059653855@qq.com Less <<
NCT03668470 Adult Subjects With Type1Diabe... More >>tes and Insulin Microsecretion Less << Phase 2 Not yet recruiting June 2020 France ... More >> Service d'Endocrinologie, Maladies Métaboliques et Nutrition, CHU Grenoble, Hopital de la Tronche Not yet recruiting La Tronche, France, 38700 Contact: Pierre-Yves BENHAMOU    +33 4 76 76 55 09    PYBenhamou@chu-grenoble.fr    Principal Investigator: Pierre-Yves BENHAMOU          Sub-Investigator: Sandrine LABLANCHE          Département d''Endocrinologie, Diabétologie, Nutrition ; CHU Montpellier ; Hôpital Lapeyronie, Avenue du Doyen Giraud Not yet recruiting Montpellier 5, France, 34295 Contact: Eric RENARD    +33 4 67 33 83 82    e-renard@chu-montpellier.fr    Principal Investigator: Eric RENARD          Sub-Investigator: Anne WOJTUSCISZYN          Service d'Endocrinologie, Maladies Métaboliques et Nutrition,CHU Nantes,Hôpital Nord Laennec,Bd Jacques-Monod,Saint-Herblain Not yet recruiting NANTES cedex 1, France, 44093 Contact: Bertrand CARIOU    +33 2 53 48 27 01    bertrand.cariou@univ-nantes.fr    Principal Investigator: Bertrand CARIOU          Sub-Investigator: Lucy CHAILLOUS          Service de Diabétologie et Maladies Métaboliques, Assistance Publique des Hôpitaux de Paris ;Hôpital Cochin, 27 rue du Faubourg Saint-Jacques Not yet recruiting Paris, France, 75014 Contact: Etienne LARGER    +33 1 58 41 19 19    etienne.larger@cch.aphp.fr    Principal Investigator: Etienne LARGER          Service d'Endocrinologie, Diabétologie, Maladies de la Nutrition, Hospices Civils de Lyon, Centre hospitalier Lyon-Sud Not yet recruiting Pierre-Bénite, France, 69495 Contact: Charles THIVOLET    +33 4 78 86 14 87    charles.thivolet@chu-lyon.fr    Principal Investigator: Charles THIVOLET          Sub-Investigator: Lucien MARCHAND          Service de Diabétologie Maladies Métaboliques et Nutrition ; CHU Toulouse, Pôle cardiovasculaire et métabolique, Hôpital Rangueil ; 1, avenue du Professeur Jean Poulhès - TSA 50032 Not yet recruiting TOULOUSE cedex 9, France, 31059 Contact: Hélène HANAIRE    : +33 5 61 32 30 18    hanaire.h@chu-toulouse.fr    Principal Investigator: Hélène HANAIRE          Service de Diabétologie, Maladies Métaboliques, Nutrition ; CHU Nancy ; Technopôle Nancy-Brabois ; Rue du Morvan, Not yet recruiting Vandœuvre-lès-Nancy, France, 54500 Contact: Bruno GUERCI    +33 3 83 65 65 28    b.guerci@chu-nancy.fr    Principal Investigator: Bruno GUERCI Less <<
NCT02991209 Metabolic Syndrome ... More >> Testicular Cancer Leydig Cell Failure in Adult Less << Phase 2 Phase 3 Recruiting December 2019 Denmark ... More >> Rigshospitalet Recruiting Copenhagen, Denmark, 2100 Contact: Mikkel Bandak, MD    +45 35456354    mikkel.bandak@regionh.dk    Contact: Niels Jørgensen, MD, ph.D    +45 3545 0633    niels.joergensen@regionh.dk Less <<
NCT01011868 - Completed - -
NCT02505958 Obesity Not Applicable Unknown July 2016 United States, Pennsylvania ... More >> Temple University Hospital Philadelphia, Pennsylvania, United States, 19140 Less <<
NCT00694057 Type 2 Diabetes Mellitus Phase 2 Completed - United States, California ... More >> Anaheim, California, United States, 92801 Anaheim, California, United States, 92805 Beverly Hills, California, United States, 90211 Buena Park, California, United States, 90620 Burbank, California, United States, 91505 Carmichael, California, United States, 95608 Escondido, California, United States, 92025 Fresno, California, United States, 93726 Huntington Park, California, United States, 90255 Long Beach,, California, United States, 90806 Los Angeles, California, United States, 90057 National City, California, United States, 91950 Roseville, California, United States, 95661 United States, Illinois Chicago, Illinois, United States, 60616 United States, Louisiana Baton Rouge, Louisiana, United States, 70808 United States, Missouri St. Louis, Missouri, United States, 63141 United States, Nevada Las Vegas, Nevada, United States, 89106 Las Vegas, Nevada, United States, 89148 United States, Texas El Paso, Texas, United States, 79905 San Antonio, Texas, United States, 78229 United States, Utah Salt Lake City, Utah, United States, 84107 United States, Wisconsin Kenosha, Wisconsin, United States, 53142 Less <<
NCT02307110 Insulin-Dependent Diabetes Mel... More >>litus 1 Less << Not Applicable Completed - Switzerland ... More >> Vista Klinik Binningen, Switzerland, 4102 Less <<
NCT00468117 Type 1 Diabetes Mellitus Phase 3 Completed - United States, California ... More >> University of California, San Francisco San Francisco, California, United States, 94143 United States, Florida University of Miami Miami, Florida, United States, 33124 United States, Georgia Emory Universtiy Atlanta, Georgia, United States, 30322 United States, Illinois Northwestern University Chicago, Illinois, United States, 60208 University of Illinois at Chicago Chicago, Illinois, United States, 60607 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 United States, Minnesota University of Minnesota Minneapolis, Minnesota, United States, 55455 United States, Pennsylvania University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 United States, Wisconsin University of Wisconsin Madison, Wisconsin, United States, 53792 Canada, Alberta University of Alberta Edmonton, Alberta, Canada, T6G 2C8 Less <<
NCT02182830 - Completed - -
NCT00264667 Metabolic Syndrome X Phase 2 Completed - -
NCT00961909 Diabetes Mellitus Type 2 Phase 1 Completed - United States, California ... More >> Anaheim, California, United States, 92801 Chula Vista, California, United States, 91911 United States, Florida Ft. Myers, Florida, United States, 33901 Miramar, Florida, United States, 33025 United States, Texas San Antonio, Texas, United States, 78209 San Antonio, Texas, United States, 78229-4801 Less <<
NCT03563313 Type 1 Diabetes Mellitus Not Applicable Active, not recruiting April 2019 United States, California ... More >> Sansum Diabetes Research Institute Santa Barbara, California, United States, 93105 Stanford University Stanford, California, United States, 94304 United States, Colorado Barbara Davis Center, University of Colorado Aurora, Colorado, United States, 80045 United States, Massachusetts Harvard University (Joslin Diabetes Center) Boston, Massachusetts, United States, 02215 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55902 United States, New York Icahn School of Medicine at Mount Sinai New York, New York, United States, 10029 United States, Virginia University of Virginia Center for Diabetes Technology Charlottesville, Virginia, United States, 22903 Less <<
NCT03591354 Type 1 Diabetes Mellitus Not Applicable Not yet recruiting May 2019 United States, California ... More >> William Sansum Diabetes Center Santa Barbara, California, United States, 93105 Stanford University Stanford, California, United States, 94304 United States, Colorado Barbara Davis Center, University of Colorado Aurora, Colorado, United States, 80045 United States, Massachusetts Harvard University (Joslin Diabetes Center) Boston, Massachusetts, United States, 02215 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, New York Mount Sinai Hospital New York, New York, United States, 10029-6574 Icahn School of Medicine at Mount Sinai New York, New York, United States, 10029 United States, Virginia University of Virginia Center for Diabetes Technology Not yet recruiting Charlottesville, Virginia, United States, 22903 Contact: Sue Brown, MD    434-982-0602    sab2f@virginia.edu    Sub-Investigator: Stacey M. Anderson, MD Less <<
NCT00001932 - Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT02182830 Diabetes Mellitus, Type 2 ... More >> Hypertension Less << Phase 3 Completed - -
NCT01857973 Type 1 Diabetes Not Applicable Completed - United States, California ... More >> AMCR Institute, Inc. 700 West El Norte Parkway, Suite 201 Escondido, California, United States, 92026 United States, Colorado Barbara Davis Center, 1775 Aurora Court, A140 Aurora, Colorado, United States, 80045 United States, Connecticut Yale University School of Medicine, 2 Church Street South, Suite 404 New Haven, Connecticut, United States, 06519 United States, Idaho Rocky Mountain Diabetes and Osteoporosis Center Idaho Falls, Idaho, United States, 83404 United States, Virginia University of Virginia, 617 West Main Street, 4th Floor Charlottesville, Virginia, United States, 22903 United States, Washington Rainier Clinical Research, 723 SW 10th Street, Suite 100 Renton, Washington, United States, 98057 Less <<
NCT01420133 Autoimmune Diseases ... More >> Asthma Less << Not Applicable Completed - France ... More >> Cochin Hospital Paris, France, 75014 Less <<
NCT01726465 Ischemic Reperfusion Injury ... More >> Insufficiency; Hepatic, Postoperative Liver Tumour Less << Phase 2 Terminated(The first phase was... More >> completed) Less << - Italy ... More >> Istituto Clinico Humanitas IRCCS Rozzano, Milano, Italy, 20089 Less <<
NCT01403831 Diabetes Not Applicable Completed - United States, California ... More >> University of Southern California Los Angeles, California, United States, 90033 Less <<
NCT00111358 HIV Metabolic... More >> Diseases Less << Not Applicable Completed - United States, Massachusetts ... More >> Mass General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT02156349 Type II Diabetes Mellitus Not Applicable Completed - -
NCT02268929 Diabetes Mellitus, Type 2 Not Applicable Completed - -
NCT01517542 Stroke Cardio... More >>vascular Diseases Less << Not Applicable Unknown December 2015 Brazil ... More >> Hospital de Clínicas de Porto Alegre Recruiting Porto Alegre, RS, Brazil, 90035903 Contact: Vanessa A Piper, SI    555199828748    vanalves001@gmail.com    Contact: Sheila Martins, PI    5199628467    smartins@portoweb.com.br Less <<
NCT00778804 Hypertension ... More >>Diabetes Mellitus Hyperlipidemia Less << Not Applicable Completed - United States, Pennsylvania ... More >> Geisinger Medical Center Danville, Pennsylvania, United States, 17822 Temple University Hospital Philadelphia, Pennsylvania, United States, 19140 Temple University Hosptial Philadelphia, Pennsylvania, United States, 19140 Less <<
NCT03115814 - Recruiting June 2019 China ... More >> Chinese PLA General Hospital Recruiting Beijing, China, 100853 Contact: Zhiqi Mao, Ph.D    8618910155994    markmaoqi@126.com    Principal Investigator: Zhiqi Mao, Ph.D Less <<
NCT02695082 - Recruiting November 30, 2019 United States, Delaware ... More >> Research Site Recruiting Wilmington, Delaware, United States United States, District of Columbia Research Site Recruiting Washington, District of Columbia, United States United Kingdom Research Site Recruiting London, United Kingdom Less <<
NCT02695095 - Recruiting November 30, 2019 United States, Delaware ... More >> Research Site Recruiting Wilmington, Delaware, United States United States, District of Columbia Research Site Recruiting Washington, District of Columbia, United States United Kingdom Research Site Recruiting London, United Kingdom Less <<
NCT00943501 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 1 Completed - United States, California ... More >> Novo Nordisk Investigational Site Cypress, California, United States, 90630 Novo Nordisk Investigational Site Los Angeles, California, United States, 90036 Novo Nordisk Investigational Site Los Angeles, California, United States, 90048-1869 United States, Colorado Novo Nordisk Investigational Site Aurora, Colorado, United States, 80045 United States, Iowa Novo Nordisk Investigational Site Iowa City, Iowa, United States, 52242 United States, Kentucky Novo Nordisk Investigational Site Louisville, Kentucky, United States, 40202 United States, Missouri Novo Nordisk Investigational Site Kansas City, Missouri, United States, 64108-4619 United States, Ohio Novo Nordisk Investigational Site Cincinnati, Ohio, United States, 45229 Novo Nordisk Investigational Site Cleveland, Ohio, United States, 44106 Novo Nordisk Investigational Site Toledo, Ohio, United States, 43606 United States, Pennsylvania Novo Nordisk Investigational Site Philadelphia, Pennsylvania, United States, 19104 Novo Nordisk Investigational Site Pittsburgh, Pennsylvania, United States, 15224 United States, Tennessee Novo Nordisk Investigational Site Memphis, Tennessee, United States, 38103-2800 United States, Texas Novo Nordisk Investigational Site Dallas, Texas, United States, 75235 Belgium Novo Nordisk Investigational Site Brussels, Belgium, 1090 Slovenia Novo Nordisk Investigational Site Ljubljana, Slovenia, 1525 United Kingdom Novo Nordisk Investigational Site Birmingham, United Kingdom, B4 6NH Novo Nordisk Investigational Site Manchester, United Kingdom, M13 9WL Novo Nordisk Investigational Site Nottingham, United Kingdom, NG7 2UH Novo Nordisk Investigational Site Sheffield, United Kingdom, S102TH Less <<
NCT00724009 - Completed - -
NCT02695433 Pre-diabetes ... More >>Metabolic Syndrome Less << Not Applicable Recruiting October 15, 2019 United States, Illinois ... More >> Clinical Nutrition Research Center Recruiting Chicago, Illinois, United States, 60616 Contact: Eunyoung Park, MS, RD    312-567-5307    epark4@iit.edu    Contact: Indika Edirisinghe, Ph.D    708-308-0178    iedirisi@iit.edu Less <<
NCT02605200 Complications of Transplanted ... More >>Organs and Tissue Less << Not Applicable Enrolling by invitation December 2025 United States, Georgia ... More >> Children's Healthcare of Atlanta-Egleston Atlanta, Georgia, United States, 30322 Emory Children's Center Atlanta, Georgia, United States, 30322 Less <<
NCT00738023 Type 2 Diabetes ... More >> Hypertension Less << Phase 4 Completed - United States, Georgia ... More >> Grady Memorial Hospital Atlanta, Georgia, United States, 30303 Less <<
NCT00738023 - Completed - -
NCT01237093 - Recruiting - United States, Arizona ... More >> NIDDK, Phoenix Recruiting Phoenix, Arizona, United States, 85014 Contact: Susanne Votruba, Ph.D.    602-200-5336    votrubas@mail.nih.gov Less <<
NCT00711503 Type 1 Diabetes Phase 2 Phase 3 Completed - Denmark ... More >> Aalborg Hospital Aalborg, Denmark, 9100 Aarhus Universitetshospital Aarhus, Denmark, 8000 C Bispebjerg Universitetshospital Copenhagen, Denmark, 2400 NV Steno Diabetes Center Gentofte, Denmark, 2820 Nordsjællands Hospital, Hillerød Hillerød, Denmark, 3400 Germany Ulm University, Dept. of Internal Medicine Ulm, Donau, Germany, 89081 Leibniz Center for Diabetes research, Heinrich-Heine University Duesseldorf, Germany, 40225 University of Frankfurt am Main Frankfurt am Main, Germany, 60590 Institut für Diabetesforschung, Munich University of Technology Munich, Germany, 80804 Italy University Campus Bio-Medico Rome, Italy, 00128 Netherlands Leiden University Medical Center Leiden, Netherlands, 2300 RC Poland Medical University of Bialystok Bialystok, Poland, 15-269 Spain Hospital de Cruces, Diabetes Research Group Barakaldo, Bizkaia, Spain, 48903 Hospital Unversitario Insular de Gran Canaria Las Palmas, Gran Canaria, Spain, 35016 Hospital Santa Creu i Sant Pau Barcelona, Spain, 08025 Hospital Arnua de Vilanova Lleida, Spain, 25198 Switzerland University Hospital Zürich Zürich, Switzerland, CH-8091 Less <<
NCT01664650 Metabolic Syndrome Phase 2 Phase 3 Completed - Italy ... More >> University of Magnia Graecia Catanzaro, Italy University of Messina Messina, Italy, 98123 University of Palermo Palermo, Italy, 90129 Less <<
NCT00906503 Pulmonary Nodule Phase 1 Completed - United States, Michigan ... More >> Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201-1379 Sinai-Grace Hospital Detroit, Michigan, United States, 48235 Less <<
NCT00906503 - Completed - -
NCT00724009 Leukemia Phase 2 Completed - United States, Illinois ... More >> The University of Chicago hospitals Chicago, Illinois, United States, 60637 Less <<
NCT00250731 Diabetes Phase 1 Completed - United States, New York ... More >> State University of New York Upstate Medical University Syracuse, New York, United States, 13210 Less <<
NCT01486342 - Completed - United States, Missouri ... More >> Washington University in St. Louis School of Medicine St. Louis, Missouri, United States, 63110 Less <<
NCT00593489 Diabetes Mellitus Not Applicable Unknown March 2010 Canada, Ontario ... More >> Lawson Health Research Institute London, Ontario, Canada, N6A 4G5 Less <<
NCT01409239 Type 2 Diabetes ... More >> Inpatient Less << Phase 4 Completed - United States, Ohio ... More >> The Ohio State University Columbus, Ohio, United States, 43210 Less <<
NCT01409239 - Completed - -
NCT00779363 Type 2 Diabetes ... More >> Obesity Less << Not Applicable Completed - United States, California ... More >> Cedars Sinai Los Angeles, California, United States, 90048 United States, Texas Diabetes and Glandular Disease Clinic (DGD) San Antonio, Texas, United States, 78229 Less <<
NCT01013246 Obesity Not Applicable Completed - Denmark ... More >> University of Copenhagen Copenhagen, Denmark, DK-1958 Less <<
NCT01497301 Diabetes Mellitus, Type 2 Not Applicable Unknown February 2013 United States, Oregon ... More >> Oregon Health and Science University Not yet recruiting Portland, Oregon, United States, 97239 Contact: Holly M Milne, MD    503-494-8573    milne@ohsu.edu    Sub-Investigator: Holly M Milne, MD Less <<
NCT00801892 - Completed - -
NCT03266133 Gestational Diabetes Mellitus ... More >>in Pregnancy Less << Not Applicable Enrolling by invitation July 2019 United States, Pennsylvania ... More >> Magee-Womens Hospital of UPMC Pittsburgh, Pennsylvania, United States, 15213 Less <<
NCT03622762 Diabetic Nephropathy Type 2 Phase 2 Recruiting June 20, 2019 Mexico ... More >> Institute of Experimental and Clinical Therapeutics (INTEC), CUCS, University of Guadalajara Recruiting Guadalajara, Jalisco, Mexico, 44340 Contact: Fernando Grover Paez, PhD    (33) 10585200 ext 34215    fgroverp@hotmail.com Less <<
NCT00801892 Sleep Apnea, Obstructive ... More >> Diabetes Mellitus, Type 2 Less << Phase 3 Completed - United States, Pennsylvania ... More >> University of Pittsburgh Pittsburgh, Pennsylvania, United States, 15261 Less <<
NCT01729650 Schizophrenic Disorders ... More >> Schizoaffective Disorders Bipolar Disorders Less << Not Applicable Completed - Spain ... More >> Jordi Gol i Gurina Foundation Barcelona, Spain, 08007 Less <<
NCT01337141 Diabetes Mellitus, Type 1 ... More >> Metabolic Disorder Less << Not Applicable Completed - Spain ... More >> Hospital de Cruces Barakaldo, Spain, 48903 Hospital Clínic de Barcelona Barcelona, Spain, 08036 Hospital Clínico de Madrid Madrid, Spain, 28040 Hospital Carlos Haya Malaga, Spain, 29010 Hospital Clínico de Valencia Valencia, Spain, 46010 Less <<
NCT01069965 Diabetes Mellitus Phase 2 Terminated(Funding support wit... More >>hdrawn.) Less << - -
NCT02489942 - Active, not recruiting May 31, 2020 Japan ... More >> Multiple Locations, Japan Less <<
NCT03352245 Lung Neoplasm Malignant Not Applicable Recruiting April 2019 United States, Connecticut ... More >> Yale University Recruiting New Haven, Connecticut, United States, 06510 Contact: Brett Bade, MD    203-785-6670    brett.bade@yale.edu Less <<
NCT03352674 Diabetes Mellitus Phase 2 Recruiting June 1, 2018 Indonesia ... More >> Department of Internal Medicine Cipto Mangunkusumo Hospital, Faculty of Medicine Universitas Indonesia Recruiting Jakarta Pusat, Jakarta, Indonesia, 10520 Contact: Tri Juli Edi Tarigan, MD       tje_tar@yahoo.com Less <<
NCT01370707 Diabetes Mellitus Phase 3 Completed - Korea, Republic of ... More >> Bucheon St. Mary's Hospital Bucheon, Korea, Republic of Seoul National University Bundang Hospital Bundang, Korea, Republic of Chonbuk National University Hospital Chonju, Korea, Republic of Kyungpook University Hospital Daegu, Korea, Republic of Yeungnam University Medical Center Daegu, Korea, Republic of National Health Insurance Coporation Ilsan Hospital Ilsan, Korea, Republic of Inha University Hospital Incheon, Korea, Republic of Inje University Pusan Baik Hospital Pusan, Korea, Republic of Pusan National University Hospital Pusan, Korea, Republic of Asan Medical Center Seoul, Korea, Republic of Eulji Medical Center Seoul, Korea, Republic of Hallym University Medical Center(Gangdong) Seoul, Korea, Republic of Hallym University Medical Center(Gangnam) Seoul, Korea, Republic of Kangbuk Samsung Hospital Seoul, Korea, Republic of Korea University Guro Hospital Seoul, Korea, Republic of Kyung Hee University Hospital Seoul, Korea, Republic of Samsung Medical Center Seoul, Korea, Republic of Seoul St. Mary's hospital Seoul, Korea, Republic of Severance Hospital Seoul, Korea, Republic of Ajou University Hospital Suwon, Korea, Republic of Uijeongbu St. Mary's Hospital Uijeongbu, Korea, Republic of Less <<
NCT03174821 Insulin Pump Therapy in Treati... More >>ng Diabetic Nephropathy Less << Not Applicable Completed - -
NCT02460874 Cerebral Edema ... More >> Brain Metastases Less << Phase 1 Phase 2 Recruiting October 2020 United States, Alabama ... More >> University of Alabama at Birmingham (UAB) Department of Radiation Oncology Recruiting Birmingham, Alabama, United States, 35249 Contact: Kristin Webb       kkwebb@uabmc.edu    Contact: Valerie Powell       vpowell@uabmc.edu    Principal Investigator: Drexell H Boggs, MD Less <<
NCT02659150 Rheumatoid Arthritis Phase 4 Enrolling by invitation March 30, 2019 -
NCT00592735 - Completed - Australia, New South Wales ... More >> St Vincent's Hospital Sydney, New South Wales, Australia, 2010 Less <<
NCT01749683 - Unknown - United States, New York ... More >> SUNY Upstate Medical University Recruiting Syracuse, New York, United States, 13210 Contact: Annie Pennella, MS    315-464-9574       Principal Investigator: Kan Liu, MD Less <<
NCT00664729 Abdominal Obesity ... More >> Metabolic Syndrome Less << Not Applicable Completed - United States, North Carolina ... More >> Wake Forest University Health Sciences Winston-Salem, North Carolina, United States, 27157 Less <<
NCT00844194 Diabetic Neuropathies ... More >> Depressive Disorder, Major Less << Phase 4 Completed - Germany ... More >> 1208.34.49008 Boehringer Ingelheim Investigational Site Achim bei Bremen, Germany 1208.34.49025 Boehringer Ingelheim Investigational Site Aschaffenburg, Germany 1208.34.49001 Boehringer Ingelheim Investigational Site Bad Mergentheim, Germany 1208.34.49018 Boehringer Ingelheim Investigational Site Baesweiler, Germany 1208.34.49007 Boehringer Ingelheim Investigational Site Berlin-Steglitz, Germany 1208.34.49002 Boehringer Ingelheim Investigational Site Berlin, Germany 1208.34.49005 Boehringer Ingelheim Investigational Site Berlin, Germany 1208.34.49009 Boehringer Ingelheim Investigational Site Berlin, Germany 1208.34.49021 Boehringer Ingelheim Investigational Site Bremen, Germany 1208.34.49028 Boehringer Ingelheim Investigational Site Frankfurt am Main, Germany 1208.34.49012 Boehringer Ingelheim Investigational Site Gera, Germany 1208.34.49004 Boehringer Ingelheim Investigational Site Hamburg, Germany 1208.34.49020 Boehringer Ingelheim Investigational Site Hamburg, Germany 1208.34.49023 Boehringer Ingelheim Investigational Site Hamburg, Germany 1208.34.49015 Boehringer Ingelheim Investigational Site Hattingen, Germany 1208.34.49027 Boehringer Ingelheim Investigational Site Heidenheim, Germany 1208.34.49016 Boehringer Ingelheim Investigational Site Kelkheim, Germany 1208.34.49006 Boehringer Ingelheim Investigational Site Limburgerhof, Germany 1208.34.49022 Boehringer Ingelheim Investigational Site Münster, Germany 1208.34.49019 Boehringer Ingelheim Investigational Site Neuwied, Germany 1208.34.49024 Boehringer Ingelheim Investigational Site St. Ingberg, Germany 1208.34.49010 Boehringer Ingelheim Investigational Site Stuhr, Germany 1208.34.49013 Boehringer Ingelheim Investigational Site Unterhaching, Germany 1208.34.49029 Boehringer Ingelheim Investigational Site Wiesbaden, Germany 1208.34.49026 Boehringer Ingelheim Investigational Site Wuppertal, Germany Less <<
NCT02942914 Diabetes Mellitus, Type 2 Phase 1 Completed - Germany ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician. Neuss, Germany, 41460 Less <<
NCT00844194 - Completed - -
NCT03734627 - Enrolling by invitation July 1, 2019 Ireland ... More >> Department of Surgery, St. James's Hospital Dublin, Ireland, D4 Wellcome Trust-Health Research Board Clinical Research Facility, St. James's Hospital Dublin, Ireland, D8 Less <<
NCT02074215 Alzheimer's Disease Not Applicable Completed - Taiwan ... More >> National Taiwan University Hospital Taipei, Taiwan, 100 Less <<
NCT01236794 Diabetes Mellitus, Type 2 Not Applicable Completed - United States, Arizona ... More >> Arizona State University Tempe, Arizona, United States, 85287 Less <<
NCT02103855 Nephrotoxicity Phase 4 Completed - United States, Indiana ... More >> Indiana University Health, University Hospital Indianapolis, Indiana, United States, 46202 Less <<
NCT01074762 Diabetes Mellitus ... More >> Quality of Health Care Health Services Research Less << Not Applicable Completed - Denmark ... More >> The Research Unit for General Practice in Copenhagen, Centre for Health and Community, Øster Farimagsgade 5 Copenhagen, Denmark, DK-1014 Less <<
NCT00000532 Cardiovascular Diseases ... More >> Diabetes Mellitus Heart Diseases Hypercholesterolemia Hypertension Obesity Menopause Postmenopause Less << Phase 3 Completed - -
NCT02103855 - Completed - -
NCT00869102 Diabetes Meta... More >>bolic Syndrome Less << Not Applicable Withdrawn December 2011 Germany ... More >> University of Tübingen Tübingen, Germany, 72076 Less <<
NCT01006018 - Terminated(Unanticipated delay... More >>s due to sterilization/stabilization testing of GLP-1.) Less << - -
NCT01956357 Diabetes Mellitus, Type 2 Not Applicable Completed - Brazil ... More >> Physical Education School of Federal University of Rio Grande do Sul Porto Alegre, Rio Grande do Sil, Brazil, 90690-200 Less <<
NCT00989781 Polycystic Ovary Syndrome Not Applicable Completed - United States, California ... More >> UCSD Medical Center San Diego, California, United States, 92103 Less <<
NCT02328183 Hospital Infection Phase 4 Unknown November 2015 Thailand ... More >> Siriraj hospital Recruiting Bangkok, Thailand, 10700 Contact: Thundon Ngamprasertchai, MD    66850887736    thundon_ngamprasertchai@hotmail.com    Contact: Visanu Thamlikitkul, MD    66818206271    visanu.tha@mahidol.ac.th    Sub-Investigator: Adhiratha Boonyasiri, MD Less <<
NCT01999322 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 3 Completed - United States, Georgia ... More >> Novo Nordisk Investigational Site Atlanta, Georgia, United States, 30318 Germany Novo Nordisk Investigational Site Neuss, Germany, 41460 Less <<
NCT00989781 - Completed - -
NCT01864174 Type 2 Diabetes Mellitus Phase 4 Completed - -
NCT03166124 Diabetes Mellitus, Type 1 Phase 1 Completed - Germany ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician. Mainz, Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician. Neuss, Germany Less <<
NCT01864174 - Completed - -
NCT00227110 Nonalcoholic Steatohepatitis Phase 4 Completed - United States, Texas ... More >> Audie L Murphy VA Hospital San Antonio, Texas, United States, 78229 Less <<
NCT03359837 Type 2 Diabetes Mellitus Phase 4 Recruiting November 7, 2019 China ... More >> Recruiting Not Listed, China Less <<
NCT01999322 - Completed - -
NCT02959762 Obesity Insul... More >>in Resistance Obesity in Diabetes Nutritional and Metabolic Diseases Hyperlipidemia Hyperglycemia Cardiovascular Diseases Less << Phase 1 Phase 2 Recruiting December 30, 2018 United States, Georgia ... More >> Medical College of Georgia; Augusta University Recruiting Augusta, Georgia, United States, 30912 Contact: Norman K Pollock, Ph.D.    706-721-5424    npollock@augusta.edu Less <<
NCT03234946 Metabolic Syndrome Not Applicable Recruiting June 19, 2021 Mexico ... More >> Instituto Nacional de Salud Pública Recruiting Cuernavaca, Morelos, Mexico, 62100 Contact: Gabriela Torres Mejía, MD    3293000 ext 3287    gtorres@insp.mx    Sub-Investigator: Gabriela Torres Mejía, MD          Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán Recruiting Mexico City, Mexico, 14000 Contact: Carlos A Aguilar Salinas, MD    55737378    caguilarsalinas@yahoo.com.mx    Contact: Ana C García Ulloa, MD    55737378    dra_ulloa@yahoo.com.mx    Principal Investigator: Ana C García Ulloa, MD          Sub-Investigator: Sergio C Hernández Jiménez, MD          Sub-Investigator: Carlos A Aguilar Salinas, MD          Sub-Investigator: Christa N Ovalle Escalera, MD Less <<
NCT00184613 Diabetes Diab... More >>etes Mellitus, Type 2 Delivery Systems Less << Phase 1 Completed - Denmark ... More >> Novo Nordisk Investigational Site Århus C, Denmark, 8000 Less <<
NCT00722709 Colon Surgery Phase 1 Completed - New Zealand ... More >> Manukau Surgery Centre-Middlemore Hospital Auckland, New Zealand, 2240 University of Auckland Auckland, New Zealand Less <<
NCT02057913 Locally-advanced or Metastatic... More >> Penile Neoplasms Less << Phase 2 Active, not recruiting September 2018 United Kingdom ... More >> Velindre NHS Trust Whitchurch, Cardiff, United Kingdom, CF14 2TL Royal Cornwall Hospitals NHS Trust Truro, Cornwall, United Kingdom, TR1 3LJ University College London Hospitals NHS Foundation Trust London, Greater London, United Kingdom, NW1 2PG The Christie NHS Foundation Trust Manchester, Greater Manchester, United Kingdom, M20 4BX St George's Healthcare NHS Trust Tooting, London, United Kingdom, SW17 0QT Clatterbridge Centre for Oncology NHS Foundation Trust Wirral, Merseyside, United Kingdom, CH63 4JY Beatson West of Scotland Cancer Centre Glasgow, United Kingdom, G12 0YN St James's University Hospital Leeds, United Kingdom, LS79 7TF Leicester Royal Infirmary Leicester, United Kingdom, LE1 5WW Less <<
NCT02144454 Cardiovascular Disease Not Applicable Completed - United Kingdom ... More >> University of Reading Reading, Berkshire, United Kingdom, RG6 6AP Less <<
NCT01486680 Type 2 Diabetes Mellitus ... More >> Obesity Less << Not Applicable Active, not recruiting October 2019 New Zealand ... More >> North Shore Hospital Auckland, New Zealand, 0622 University of Auckland Auckland, New Zealand Less <<
NCT01715428 - Completed - Italy ... More >> University Hospital of Palermo Palermo, Italy, 90127 Less <<
NCT03374462 Diabetes Mellitus, Type 1 Not Applicable Active, not recruiting October 31, 2019 United States, California ... More >> University of California-Davis Sacramento, California, United States, 95817 Less <<
NCT00666029 Metabolic Syndrome Phase 2 Completed - -
NCT02305914 - Unknown May 2016 China, Jiangxi ... More >> the First Affiliated Hospital of Nanchang University Recruiting Nanchang, Jiangxi, China, 330006 Contact: Nonghua Lv, MD    13707086809    lunonghua@163.com    Contact: Kunhe Zhang, MD    13007202818    393467260@qq.com    Principal Investigator: Nonghua Lv, MD Less <<
NCT02077179 Metabolic Cardiovascular Syndr... More >>ome Less << Not Applicable Terminated(Poor retention and ... More >>recruitment,changes need to be made to the program) Less << - Canada, Ontario ... More >> Queen's Unviersity Kingston, Ontario, Canada, K7L 2V7 Less <<
NCT00666029 - Completed - -
NCT00541567 Obesity and Type 2 Diabetes Phase 2 Phase 3 Withdrawn June 2010 -
NCT02625649 - Completed - Denmark ... More >> Department of Enodocrinology and Internal Medicine, Aarhus University Hospital Aarhus, Denmark, 8000 Less <<
NCT00172796 - Unknown - Taiwan ... More >> Department of Internal Medicine, Yun-Lin Branch, National Taiwan University Hospital Recruiting Yun-Lin, Taiwan, 640 Contact: Hung-Yuan Li, MD    886-5-5323911 Less <<
NCT02962986 Hypotension Not Applicable Completed - Canada, Ontario ... More >> Mount Sinai Hospital Toronto, Ontario, Canada, M5G1X5 Less <<
NCT02068144 Insulin Resistance ... More >> Atherosclerosis Less << Not Applicable Completed - United States, Louisiana ... More >> Pennington Biomedical Research Center Baton Rouge, Louisiana, United States, 70808 Less <<
NCT00484861 - Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT03094260 Binge-Eating Disorder Not Applicable Recruiting October 29, 2019 France ... More >> HCL Centre REférent pour l'Anorexie et les Troubles du Comportement Alimentaire de Lyon (CREATyon) Recruiting Bron, France, 69500 Contact: Sylvain ICETA, MD    4.27.85.60.11 ext +33    sylvain.iceta@chu-lyon.fr    Contact: Dominique DELAUNAY    4.72.11.00.64 ext +33    Dominique.delaunay@chu-lyon.fr    Principal Investigator: Sylvain ICETA, MD          Sub-Investigator: Bérénice SEGRESTIN, MD Less <<
NCT01996631 - Unknown June 2014 -
NCT01187550 - Completed - -
NCT01122316 Heart Failure ... More >> Diabetes Less << Not Applicable Completed - United States, California ... More >> Ahmanson-UCLA Cardiomyopathy Center Los Angeles, California, United States, 90095-7368 Less <<
NCT00326482 - Recruiting - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)    800-411-1222 ext TTY8664111010    prpl@cc.nih.gov Less <<
NCT00916838 - Completed - -
NCT01481623 Diabetes Not Applicable Unknown September 2015 France ... More >> Lariboisiere hospital Recruiting Paris, France, 75010 Principal Investigator: Pierre-Jean Guillausseau Less <<
NCT00842361 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 2 Completed - Japan ... More >> Novo Nordisk Investigational Site Chuo-ku, Tokyo, Japan, 103 0002 Novo Nordisk Investigational Site Miyazaki-shi, Japan, 880 0034 Novo Nordisk Investigational Site Naka-shi, Ibaraki, Japan, 311 0113 Novo Nordisk Investigational Site Ota-ku, Tokyo, Japan, 144 0035 Novo Nordisk Investigational Site Oyama-shi, Tochigi, Japan, 323 0022 Novo Nordisk Investigational Site Sendai-shi, Japan, 980 0021 Novo Nordisk Investigational Site Shizuoka-shi, Japan, 424 0853 Novo Nordisk Investigational Site Tagajo-shi, Japan, 985 0852 Less <<
NCT00803660 - Completed - Vietnam ... More >> Research Site Qui Nhon, Binh Dinh, Vietnam Research Site Buon Me Thuoc, Dak Lak, Vietnam Research Site Bien Hoa, Dong Nai, Vietnam Research Site Thong Nhat, Dong Nai, Vietnam Research Site Nha Trang, Khanh Hoa, Vietnam Research Site Hue, Thua Thien, Vietnam Research Site An Giang, Vietnam Research Site Bac Lieu, Vietnam Research Site Ca Mau, Vietnam Research Site Can Tho, Vietnam Research Site Da Nang, Vietnam Research Site Dong Thap, Vietnam Research Site Hai Phong, Vietnam Research Site Hanoi, Vietnam Research Site Ho Chi Minh, Vietnam Research Site Kien Giang, Vietnam Research Site Nam Dinh, Vietnam Research Site Thai Binh, Vietnam Research Site Tien Giang, Vietnam Less <<
NCT00842361 - Completed - -
NCT00173056 - Unknown - Taiwan ... More >> National Taiwan University Hospital Recruiting Taipei, Taiwan, 100 Contact: Jenq-Wen Huang, MD    886-2-23123456 ext 3924    jenqwen@ha.mc.ntu.edu.tw Less <<
NCT01550315 Postural Tachycardia Syndrome ... More >>(POTS) Less << Not Applicable Active, not recruiting March 2019 United States, Tennessee ... More >> Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232 Less <<
NCT03036254 Diabetes Mellitus Not Applicable Recruiting July 2023 United States, New York ... More >> Icahn School of Medicine at Mount Sinai Recruiting New York, New York, United States, 10029 Contact: Rebecca West, PhD    212-659-5603    rebecca.west@mssm.edu    Contact: Michal Schnaider-Beeri, PhD    212-659-8807    michal.beeri@mssm.edu    Principal Investigator: Michal Schnaider-Beeri, PhD          United States, Wisconsin University of Wisconsin Not yet recruiting Madison, Wisconsin, United States, 53076 Contact: Barbara Bendlin, PhD    608-265-2483    bbb@medicine.wisc.edu    Contact: Jennifer Oh, M.A.    (608)265-9161    jmoh@medicine.wisc.edu    Principal Investigator: Barbara Bendlin, PhD          Israel Sheba Medical Center Not yet recruiting Ramat Gan, Israel Contact: Ramit Ravona, PhD    972-3-5303825    ramitrs@hotmail.com    Contact: Keren Koifman, BA       Keren.Koifman@sheba.health.gov.il    Principal Investigator: Ramit Ravona, PhD          Assaf HaRofeh Medical Center Not yet recruiting Tzrifin, Israel, 70300 Contact: Shai Efrati, MD    972-(0)8-977-9393/5    efratishai@013.net    Contact: Osha Meir, BA    972-8-9779393       Principal Investigator: Shai Efrati, MD Less <<
NCT02594228 Physical Performance Not Applicable Completed - -
NCT01047982 Gestational Diabetes Not Applicable Completed - Italy ... More >> Obstetrics and Gynecology Unit, University of Messina and Obstetrics and Gynecology Unit of Modena University Messina and Modena, Italy Less <<
NCT01187550 Dwarfism, Pituitary Phase 4 Completed - -
NCT02864914 - Active, not recruiting January 1, 2020 United Kingdom ... More >> RTI health solutions One Or Multiple Sites, United Kingdom Less <<
NCT00546455 Obesity Insul... More >>in Resistance Less << Phase 2 Unknown April 2015 United States, California ... More >> University of California at San Diego Hospitals Recruiting San Diego, California, United States, 92161 Contact: Monique Gagnon, BA    858-552-8585 ext 7216    monique.gagnon@va.gov Less <<
NCT00184782 Colorectal Neoplasms Not Applicable Unknown December 2008 Netherlands ... More >> Radboud University Nijmegen Medical Centre Recruiting Nijmegen, Gelderland, Netherlands, 6500 HB Contact: Charlotte Peeters, MD    +31-24-3611111 ext 17365    C.Peeters@chir.umcn.nl    Contact: Theo Ruers, PhD    +31-24-3611111 ext 17365    T.Ruers@chir.umcn.nl Less <<
NCT00755287 Diabetes Mellitus Type 2 Phase 3 Completed - -
NCT01991054 Diabetes Mellitus ... More >> Vitamin D Deficiency Less << Phase 4 Completed - Israel ... More >> Haemek medical center, endocrone clinic Afula, Israel, 1834111 Less <<
NCT02041143 Protein Synthesis Overnight Phase 1 Completed - Switzerland ... More >> Metabolic Unit Lausanne, Vaud, Switzerland, 1000 Less <<
NCT01717313 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT03032354 Diabetes Mellitus, Type 1 Phase 4 Not yet recruiting December 2018 -
NCT01717313 - Completed - -
NCT00007124 - Completed - United States, Maryland ... More >> National Institute of Neurological Disorders and Stroke (NINDS) Bethesda, Maryland, United States, 20892 Less <<
NCT00217828 Cardiovascular Diseases ... More >> Heart Diseases Less << Not Applicable Completed - -
NCT00497653 Polycystic Ovary Syndrome Phase 2 Phase 3 Terminated - United States, Virginia ... More >> General Clinical Research Center Richmond, Virginia, United States, 23298 Less <<
NCT02853253 Preterm Neonates Phase 4 Not yet recruiting May 2019 France ... More >> Hopital Femme Mère Enfant Not yet recruiting Bron, France Contact: Olivier Claris, Pr       olivier.claris@chu-lyon.fr Less <<
NCT02695173 - Recruiting November 30, 2019 United States, Delaware ... More >> Research Site Recruiting Wilmington, Delaware, United States United States, District of Columbia Research Site Recruiting Washington, District of Columbia, United States United Kingdom Research Site Recruiting London, United Kingdom Less <<
NCT03388762 Prediabetic State Not Applicable Recruiting September 2019 United States, Maryland ... More >> University of Maryland Center for Diabetes and Endocrinology Recruiting Baltimore, Maryland, United States, 21201 Contact: Kashif Munir, MD    443-682-6800    kmunir@medicine.umaryland.edu    University of Maryland Family Medicine Associates Recruiting Baltimore, Maryland, United States, 21201 Contact: Mary Bahr-Robertson    410-706-6155    mbahr@som.umaryland.edu    University of Maryland School of Medicine, Department of Family and Community Medicine, East Hall Not yet recruiting Baltimore, Maryland, United States, 21201 Contact: Mary Bahr-Robertson    410-706-6155    mbahr@som.umaryland.edu    United States, Ohio Alliance Integrative Medicine Recruiting Cincinnati, Ohio, United States, 45236 Contact: Lisa Gallagher, ND    513-791-5521    lisa.gallagher@myhealingpartner.com Less <<
NCT01128985 Diabetes Mellitus, Type 2 Phase 1 Completed - United States, Florida ... More >> Fort Myers, Florida, United States Miramar, Florida, United States Less <<
NCT02456922 Type 1 Diabetes ... More >> Type 2 Diabetes Less << Not Applicable Withdrawn(For administraive re... More >>asons) Less << December 2018 -
NCT01860599 Prediabetes Not Applicable Completed - United States, Massachusetts ... More >> Baystate Medical Center Springfield, Massachusetts, United States, 01199 Less <<
NCT02088203 Diabetes Prevention Phase 1 Completed - United States, Louisiana ... More >> Pennington Biomedical Research Center Baton Rouge, Louisiana, United States, 70808 Less <<
NCT03629301 Obesity or Overweight Not Applicable Active, not recruiting October 30, 2019 Mexico ... More >> Centro de Promoción de Salud Nutricional (CPSN) Hermosillo, Sonora, Mexico, 83000 Less <<
NCT02465021 Obesity Diabe... More >>tes Less << Not Applicable Completed - Canada, Ontario ... More >> Department of Nutritional Sciences, University of Toronto Toronto, Ontario, Canada, M5S3E2 Less <<
NCT00428688 - Unknown August 2014 Israel ... More >> The Endothelaial function lab, The Heart Institute, Sheba Medical Center, Israel Ramat-Gan, Israel, 52621 Less <<
NCT01922791 Pregnancy Obe... More >>sity Gestational Diabetes Mellitus Less << Not Applicable Active, not recruiting January 2020 Finland ... More >> University of Turku Turku, Finland, 20014 Turku University Hospital Turku, Finland, 20521 Less <<
NCT00188253 - Active, not recruiting February 2019 Canada, Ontario ... More >> Princess Margaret Hospital, University Health Network Toronto, Ontario, Canada, M5G 2M9 Less <<
NCT03587415 - Completed - Turkey ... More >> Recep Tayyip Erdogan University Rize, Turkey, 53000 Less <<
NCT01303562 Healthy Not Applicable Completed - United States, Massachusetts ... More >> Tufts Clinical and Translational Research Center Boston, Massachusetts, United States, 02111 Less <<
NCT02488057 Pre-Diabetes Phase 4 Recruiting September 2020 United States, California ... More >> Cedars-Sinai Medical Center Recruiting Los Angeles, California, United States, 90048 Contact: Mark Goodarzi, MD, PhD    310-423-1424    mark.goodarzi@cshs.org    L.A. Biomedical Research Institute Recruiting Torrance, California, United States, 90502 Contact: Jerome Rotter, MD       jrotter@labiomed.org    United States, Texas Magnolia Multiservice Center Recruiting Houston, Texas, United States, 77011 Contact: Maria Montes    832-395-0912    maria.montes2@houstontx.gov    Contact: Roy Villarreal    832-393-4052    roy.villarreal@houstontx.gov    Denver Harbor Multi-service Center Recruiting Houston, Texas, United States, 77020 Contact: Jesse Rodriquez, BA    832-395-0909    jesus.rodriquez@houstontx.gov    Contact: Maria Montes, MSHS    832-395-0912    maria.montes2@houstontx.gov    Sub-Investigator: Evangelina T Villagomez, RN, PhD          Principal Investigator: David Bradley, MD Less <<
NCT02017704 Rectal Cancer Phase 2 Active, not recruiting October 2021 United States, Florida ... More >> Moffitt Cancer Center Tampa, Florida, United States, 33607 United States, Georgia Winship Cancer Institute, Emory University Atlanta, Georgia, United States, 30322 United States, Maryland The SKCCC at Johns Hopkins Baltimore, Maryland, United States, 21287 United States, New York Beth Israel Hospital New York, New York, United States, 10003 Less <<
NCT03730662 Type 2 Diabetes Mellitus Phase 3 Recruiting June 15, 2021 -
NCT00972686 Solid Tumours Phase 1 Completed - United States, California ... More >> GSK Investigational Site San Francisco, California, United States, 94115 United States, New Jersey GSK Investigational Site New Brunswick, New Jersey, United States, 08901 United States, North Carolina GSK Investigational Site Chapel Hill, North Carolina, United States, 27599-7600 United States, Texas GSK Investigational Site Dallas, Texas, United States, 75246 GSK Investigational Site Houston, Texas, United States, 77030 United States, Utah GSK Investigational Site Salt Lake City, Utah, United States, 84112-5550 United States, Washington GSK Investigational Site Seattle, Washington, United States, 98109 Netherlands GSK Investigational Site Amsterdam, Netherlands, 1066 CX GSK Investigational Site Utrecht, Netherlands, 3584 CX Less <<
NCT01548300 - Completed - United States, Michigan ... More >> University of Michigan Ann Arbor, Michigan, United States, 48103 United States, Ohio The Ohio State University Columbus, Ohio, United States, 43210 China, Beijing Peking Union Medical College Peking, Beijing, China, 81657 Less <<
NCT03012113 Obesity Phase 4 Recruiting September 2017 Netherlands ... More >> Leiden University Medical Center Recruiting Leiden, Zuid-Holland, Netherlands, 2333 ZA Contact: Ingrid Jazet, MD, PhD    +33-715268161    i.m.jazet@lumc.nl    Contact: Mariëtte Boon, PhD    +31-715265462    m.r.boon@lumc.nl Less <<
NCT00872092 - Completed - Germany ... More >> University of Bonn Bonn, Germany, 53105 Less <<
NCT03500003 Nutrition Not Applicable Recruiting April 2019 France ... More >> Centre de Recherche en Nutrition Humaine d'Auvergne Recruiting Clermont-Ferrand, France, 63000 Contact: Ruddy Richard, Prof    +33473608250    ruddy.richard@udamail.fr    Contact: Adeline Blot    +33473608253    ablot@chu-clermontferrand.fr    Principal Investigator: Ruddy Richard, Prof          Sub-Investigator: Prulière Amandine          Sub-Investigator: Laporte Françoise Less <<
NCT02999867 Type2 Diabetes Mellitus Not Applicable Completed - China, Beijing ... More >> Peking Union Medical College Hospital, Chinese Academy of Medical Sciences Beijing, Beijing, China, 100730 Less <<
NCT00541710 Metabolic Syndrome Phase 2 Phase 3 Completed - Italy ... More >> University of Magnia Graecia Catanzaro, Italy Azienda Policlinico Universitario, G. Martino Messina, Italy, 090 University of Palermo Palermo, Italy, 90129 Less <<
NCT02716610 Type 2 Diabetes Mellitus Phase 1 Phase 2 Completed - -
NCT02843139 - Completed - China, Jiangsu ... More >> Nanjing Maternal and Child Health Care Hospital Affiliated to Nanjing Medical University Nanjing, Jiangsu, China, 210004 Less <<
NCT01892254 Polycystic Ovary Syndrome Phase 4 Completed - Denmark ... More >> Copenhagen University Hospital Gentofte Hellerup, Select A State, Denmark, 2900 Less <<
NCT02939768 Diabetes Mellitus, Type 1 Not Applicable Completed - Brazil ... More >> Universidade Federal do Rio Grande do Sul Porto Alegre, Rio Grande Do Sul, Brazil Less <<
NCT02884388 Arthropathy of Hip Not Applicable Unknown December 2017 China, Qinghai ... More >> Qinghai University Affiliated Hospital Recruiting Xining, Qinghai, China, 810001 Contact: Liangde A, Master    8618009782881    liangdea_qu@sina.com Less <<
NCT02916251 Diabetes Mellitus Type 1 Phase 2 Completed - Germany ... More >> Profil Institut für Stoffwechselforschung GmbH Neuss, North Rhine-Westphalia, Germany, 41460 Less <<
NCT00491465 Type 1 Diabetes Not Applicable Unknown July 2009 Israel ... More >> Schnider children's medical center Not yet recruiting Petach-Tikva, Israel Principal Investigator: Ravital Nimri, MD          Principal Investigator: Moshe Phillip, Prof.          Sub-Investigator: Rachel Frumkin, MD          Sub-Investigator: Neomi Weintrob, MD          Sub-Investigator: Shlomit Shalitin, MD          Sub-Investigator: Nesia Nagelberg, MA Less <<
NCT02702011 Diabetes Mellitus, Type 1 Phase 2 Completed - Japan ... More >> Souseikai Hakata Clinic Fukuoka, Fukuoka, Japan, 812-0025 Nishikumamoto Hospital Kumamoto, Kumamoto, Japan, 861-4157 Shinjuku Research Park Clinic Tokyo, Shinjyuku-ku, Japan, 169-0073 SOUSEIKAI Sumida Hospital Tokyo, Sumida-ku, Japan, 130-0004 Less <<
NCT02702011 - Completed - -
NCT01825473 Gastroesophageal Reflux ... More >> Apnea Bradycardia Less << Not Applicable Unknown June 2014 United States, Virginia ... More >> University of Virginia Children's Hospital Recruiting Charlottesville, Virginia, United States, 22903 Principal Investigator: Fara Davalian, MD          Sub-Investigator: David A Kaufman, MD Less <<
NCT02371668 H1N1 Influenza Healthy Volunte... More >>ers Less << Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT03034850 - Completed - -
NCT01787916 - Completed - -
NCT03314727 Hypertension ... More >>Sodium Excess Oxidative Stress Inflammation Less << Not Applicable Completed - Turkey ... More >> Koc University Hospital Istanbul, Turkey, 34010 Less <<
NCT00154037 Healthy Subjects Not Applicable Completed - Germany ... More >> Institute of Clinical Pharmacology, Medical Faculty, University of Technology Dresden, Germany, 01307 Less <<
NCT00239109 Schizophrenia Phase 4 Completed - Spain ... More >> Pfizer Investigational Site Bilbao, Vizcaya, Spain Pfizer Investigational Site Badajoz, Spain Pfizer Investigational Site Barcelona, Spain Pfizer Investigational Site Madrid, Spain Pfizer Investigational Site Salamanca, Spain Pfizer Investigational Site Sevilla, Spain Pfizer Investigational Site Zamora, Spain Less <<
NCT01787916 Type 1 Diabetes Phase 4 Completed - Canada ... More >> CHU de Québec Quebec, Canada, G1V 4G2 Less <<
NCT02421198 Pediatric Obesity Not Applicable Completed - -
NCT03608176 Overweight and Obesity Not Applicable Recruiting August 1, 2019 Mexico ... More >> Centro de Promoción de Salud Nutricional (CPSN) Recruiting Hermosillo, Sonora, Mexico, 83000 Contact: Rolando Giovanni Díaz Zavala, Ph.D.    6622893793 ext 4632    giovanni.diaz@unison.mx    Principal Investigator: Rolando Giovanni Díaz Zavala, Ph.D. Less <<
NCT01595776 Critical Limb Ischemia Phase 1 Phase 2 Completed - Italy ... More >> Fondazione IRCCS Policlinico San Matteo Pavia, Italy, 27100 Less <<
NCT01006395 Prostate Cancer Phase 2 Phase 3 Recruiting April 2019 Australia, Victoria ... More >> Austin Health Recruiting Heidelberg, Victoria, Australia, 3084 Contact: Grossmann    61394965000       Principal Investigator: Mathis Grossmann, MD PhD FRACP Less <<
NCT03731858 - Not yet recruiting July 15, 2019 Egypt ... More >> Algazeerah and Kasralainy hospital Not yet recruiting Giza, Egypt Contact: Mahmoud Alalfy, master    +201002611058    mahmoudalalfy@ymail.com    Contact: Ahmed Elgazzar, M.D    +201014005959       Principal Investigator: Mahmoud Alalfy, master Less <<
NCT00673231 Type 2 Diabetes Phase 3 Completed - -
NCT02537704 Obesity Overw... More >>eight Less << Not Applicable Unknown April 2017 Mexico ... More >> Centro de Promoción de Salud Nutricional (CPSN) Hermosillo, Sonora, Mexico, 83000 Centro de Salud Urbano Dr. Domingo Olivares Hermosillo, Sonora, Mexico, 83000 Hospital General del Estado de Sonora Hermosillo, Sonora, Mexico, 83000 Hospital Ignacio Chávez Hermosillo, Sonora, Mexico, 83000 Centro Avanzado de Atención a la Salud (CAAPS) Hermosillo, Sonora, Mexico, 83180 Less <<
NCT00348309 Alzheimer's Disease Not Applicable Completed - -
NCT01004120 Metabolic Syndrome X Phase 1 Phase 2 Completed - United Kingdom ... More >> School of Chemistry, Food Biosciences and Pharmacy, The University of Reading Reading, Berkshire, United Kingdom, RG6 6AU Less <<
NCT02694614 Overweight Ob... More >>esity Less << Not Applicable Active, not recruiting April 2018 Switzerland ... More >> Zentrum für Adipositas und Stoffwechselmedizin Winterthur GmbH Winterthur, Zürich, Switzerland, 8400 Less <<
NCT00348309 - Completed - -
NCT01498913 - Completed - Korea, Republic of ... More >> Novo Nordisk Investigational Site Seoul, Korea, Republic of, 137-920 Less <<
NCT02294526 Type 2 Diabetes Not Applicable Completed - -
NCT00614640 HIV Infections Phase 1 Phase 2 Withdrawn - -
NCT01747005 - Unknown December 2015 Russian Federation ... More >> Samoilova maternity home Recruiting Arkhangelsk, Arkhangelskya oblast, Russian Federation, 163000 Contact: Eduard Ed Antypin, MD    0079600114083    vard67@mail.ru    Principal Investigator: Eduard Ed Antypin, MD Less <<
NCT01634165 Healthy Volunteers Phase 1 Completed - Singapore ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Singapore, Singapore, 117597 Less <<
NCT00635674 Obstructive Sleep Apnea ... More >> Metabolic Syndrome Less << Not Applicable Completed - Slovakia ... More >> Medical Faculty, PJ Safarik University Kosice, Slovakia, 041 90 Less <<
NCT00572858 - Recruiting December 2018 United States, California ... More >> Cedars-Sinai Women's Heart Center Recruiting Los Angeles, California, United States, 90048 Contact: Ying Mou, PhD    310-248-7669    Ying.Mou@cshs.org    Contact: Sophie yoo, MS    424-315-4306    Jihye.Yoo@cshs.org    Principal Investigator: C.Noel Bairey-Merz, MD Less <<
NCT00673231 - Completed - -
NCT01208649 Nonalcoholic Fatty Liver Disea... More >>se Less << Phase 4 Completed - Germany ... More >> Department of Medicine I; University Hospital St. Josef-Hospital Bochum, Germany, 44791 Less <<
NCT01634165 - Completed - -
NCT00340613 Type 1 Diabetes Phase 4 Completed - United States, Texas ... More >> Texas Children's Diabetes Center Houston, Texas, United States, 77030 Less <<
NCT02148458 Overweight Pr... More >>e-hypertension Hypertension Hypercholesterolemia Glucose Intolerance Less << Not Applicable Completed - United States, Missouri ... More >> Washington University school of Medicine Saint Louis, Missouri, United States, 63110 Less <<
NCT02020967 - Completed - Russian Federation ... More >> Moscow Board of Health Endocrinology Dispensary Moscow, Russian Federation, 119034 Endocrinology Hospital at First Moscow State Medical University Moscow, Russian Federation, 119435 Less <<
NCT00548808 Type 2 Diabetes Mellitus Phase 4 Completed - -
NCT02656212 Pre-diabetes Phase 1 Completed - United States, California ... More >> CMR Center for Metabolic Research VASDHS San Diego, California, United States, 92161 VA San Diego Healthcare System San Diego, California, United States, 92161 Less <<
NCT03237767 Cystic Fibrosis ... More >> Cystic Fibrosis-related Diabetes Less << Not Applicable Not yet recruiting September 2018 -
NCT00659698 Liver Diseases Phase 4 Completed - Japan ... More >> Kochi Medical School Nankoku-City, Kochi, Japan, 783-8505 Less <<
NCT03190018 Peritoneal Dialysis Not Applicable Completed - Sweden ... More >> Sahlgrenska University Hospital Gothenburg, Västra Götalands Regionen, Sweden, 413 45 Less <<
NCT00788489 - Completed - Canada, Ontario ... More >> Juravinski Cancer Centre Hamilton, Ontario, Canada, L8V 5C2 Less <<
NCT00099892 Diabetes Mellitus, Type 2 Phase 3 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 Less <<
NCT01269008 Type 1 Diabetes Phase 1 Completed - United States, New York ... More >> Albert Einstein College of Medicine CRC Bronx, New York, United States, 10461 Less <<
NCT01812590 Type 2 Diabetes Not Applicable Completed - Denmark ... More >> Rigshospitalet Copenhagen, Denmark Less <<
NCT00548808 - Completed - -
NCT03412617 - Completed - -
NCT00589888 Endothelial Dysfunction ... More >> Hypertension Less << Not Applicable Completed - United States, Georgia ... More >> Grady Memorial Hospital Atlanta, Georgia, United States, 30303 Less <<
NCT01261598 Lung Cancer N... More >>SCLC Less << Not Applicable Completed - France ... More >> Centre Henri Becquerel Rouen, France, 76000 Less <<
NCT01481675 - Completed - Greece ... More >> University Hospital of Patras Rion, Achaia, Greece, 26500 University Hospital of Patras Rion, Achaia, Greece, 26504 Less <<
NCT00589888 - Completed - -
NCT00925119 Diabetes Mellitus, Type 2 Phase 4 Terminated - United States, Maryland ... More >> University of Maryland Baltimore, Maryland, United States, 21201 Less <<
NCT01141894 Femoral Fracture Not Applicable Terminated(slow recruitment) - Sweden ... More >> Karolinska University Hospital Huddinge, Sweden, 14186 Less <<
NCT00313547 Hypertension Phase 4 Terminated(Very difficult to r... More >>ecruit patients/slow recruitment(2 patients in nearly 2 years).) Less << - Canada, Quebec ... More >> Montreal Heart Institute Montreal, Quebec, Canada, H1T 1C8 Less <<
NCT02099955 Spinal Cord Injury ... More >> Vitamin D Deficiency Less << Phase 1 Phase 2 Completed - United States, New York ... More >> James J Peters VA Medical Center Bronx, New York, United States, 10468 Less <<
NCT00368368 Diabetes Mellitus Type 2 Phase 1 Completed - United States, California ... More >> Cypress, California, United States, 90630 United States, Texas Austin, Texas, United States, 78758 Dallas, Texas, United States, 75247 San Antonio, Texas, United States, 78229 Slovakia Bratislava, Slovakia, 833 01 Less <<
NCT02487576 Metabolic Response to Dietary ... More >>Modification Less << Not Applicable Completed - Germany ... More >> German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany, 14558 Less <<
NCT01979614 Coronary Artery Disease Phase 2 Completed - United Kingdom ... More >> Novartis Investigative Site Clydebank, West Dumbartonshire, United Kingdom, G81 4HX Novartis Investigative Site Edinburgh, United Kingdom, EHN 2XU Novartis Investigative Site Leicester, United Kingdom, LE3 9QP Less <<
NCT01042106 Type 2 Diabetes Mellitus Phase 1 Completed - United States, Texas ... More >> Cetero Research San Antonio, Texas, United States, 78229 Less <<
NCT00541450 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT00541450 - Completed - -
NCT03616977 Healthy Phase 1 Completed - Singapore ... More >> Lilly Centre for Clinical Pharmacology Singapore, Singapore, 138623 Less <<
NCT01459120 HIV/AIDS Tube... More >>rculosis Diabetes Mellitus Arterial Hypertension Less << Not Applicable Completed - Lesotho ... More >> Seboche Hospital Seboche, Botha-Bothe, Lesotho, P.O. 304 Paray Hospital Thaba-Tseka, Lesotho Less <<
NCT00674271 - Unknown May 2018 Denmark ... More >> Medical Department M, Aarhus University Hospital Aarhus C, Denmark, 8000 Less <<
NCT00480168 - Completed - Canada, Ontario ... More >> London Health Science Centre London, Ontario, Canada Windsor Regional Hospital Windsor, Ontario, Canada, N8W 1L9 Less <<
NCT03777839 - Recruiting December 2021 Canada, Quebec ... More >> Matthieu Pelletier-Galarneau Recruiting Montreal, Quebec, Canada, H3L3C1 Contact: Matthieu Pelletier-Galarneau, MD MSc FRCPC    5143763330 ext 4418    matthieu.pelletier-galarneau@icm-mhi.org Less <<
NCT02103764 Dysfunctional Uterine Bleeding Phase 3 Active, not recruiting December 2018 Thailand ... More >> Faculty of Medicine Siriraj Hospital, Mahidol University Bangkok, Thailand, 10700 Less <<
NCT01574131 Second or Third Degree Burns Phase 4 Terminated(lost funding) - United States, Texas ... More >> University of Texas Medical Branch Galveston, Texas, United States, 77551 Less <<
NCT00224822 Schizophrenia ... More >> Schizoaffective Disorder Bipolar Disorder Metabolic Syndrome X Less << Phase 4 Completed - United States, New Mexico ... More >> New Mexico VA Healthcare System Albuquerque, New Mexico, United States, 87108 Less <<
NCT01116674 - Completed - United States, Georgia ... More >> Children's Healthcare of Atlanta at Egleston - Pediatric Cardiac Intensive Care Unit Atlanta, Georgia, United States, 30308 Children's Healthcare of Atlanta at Egleston - Pediatric Intensive Care Unit Atlanta, Georgia, United States, 30308 Medical Center of Central Georgia - Pediatric Intensive Care Unit Macon, Georgia, United States, 31201 Less <<
NCT01024816 Metabolic Syndrome Not Applicable Completed - United States, California ... More >> University of California, San Diego San Diego, California, United States, 92037 Unversity of California, San Francisco San Francisco, California, United States, 94115 Less <<
NCT03599388 Sleep Metabol... More >>ic Syndrome Less << Not Applicable Not yet recruiting March 31, 2019 United States, New York ... More >> New York University School of Medicine Not yet recruiting New York, New York, United States, 10016 Contact: Shannique Richards    646-501-2672    Shannique.Richards@nyumc.org    Principal Investigator: Susan Malone, MD Less <<
NCT00148538 Diabetes Mellitus, Type 1 Phase 2 Phase 3 Completed - Canada, Ontario ... More >> Ottawa Health Research Institute Ottawa, Ontario, Canada, K1Y 4E9 Less <<
NCT02377076 Type 2 Diabetes Mellitus ... More >> Overweight Less << Not Applicable Completed - Brazil ... More >> Metabolism and body composition laboratory, Federal University of Vicosa Viçosa, Minas Gerais, Brazil, 36570-000 Less <<
NCT01952535 Type II Diabetes Mellitus Phase 1 Completed - China, Shanghai ... More >> Hua Medicine Limited Shanghai, Shanghai, China, 201203 Less <<
NCT00534014 Atherosclerosis ... More >> Type 2 Diabetes Less << Not Applicable Completed - United States, New Mexico ... More >> University of New Mexico , Clinical Translational Science Center Albuquerque, New Mexico, United States, 87131 Less <<
NCT02490176 Heart Failure Not Applicable Unknown July 2016 China, Beijing ... More >> PLA General Hospital Recruiting Beijing, Beijing, China, 100853 Contact: Wei Ren Chen, M.D.    +8610-66939709    chen_weiren@sina.com    Principal Investigator: Yun Dai Chen, M.D. Less <<
NCT02549443 Coronary Artery Disease Not Applicable Completed - Canada, Quebec ... More >> McGill University Health Center Montreal, Quebec, Canada, H3A 1A1 Less <<
NCT02542735 - Unknown December 2018 Spain ... More >> Hospital Regional Universitario Recruiting Málaga, Malaga, Spain, 29009 Contact: Gemma Rojo-Martínez, PhD    951290226    gemma.rojo.m@gmail.com Less <<
NCT03246321 Colorectal Neoplasms ... More >> Cecal Neoplasms Peritoneal Metastases Peritoneal Carcinomatosis Less << Phase 1 Phase 2 Completed - Netherlands ... More >> Catharina Hospital Eindhoven, Netherlands, 5623 EJ Less <<
NCT01448070 Diabetes Heal... More >>thy Less << Phase 1 Completed - United Kingdom ... More >> Novo Nordisk Investigational Site Manchester, United Kingdom, M15 6SH Less <<
NCT01221545 Type 2 Diabetes Mellitus Phase 1 Completed - United States, California ... More >> Research Site Chula Vista, California, United States Less <<
NCT00108069 - Completed - -
NCT02461589 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 2 Completed - -
NCT00108069 Glioma Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00599807 Knee Osteoarthritis Phase 4 Completed - Switzerland ... More >> University Hospital Zurich, Centre on Aging and Mobility Zurich, ZH, Switzerland, 8091 Less <<
NCT00733772 Metabolic Syndrome X Phase 2 Phase 3 Completed - China, Shanghai ... More >> Institute for Nutritional Sciences, Chinese Academy of Sciences Shanghai, Shanghai, China, 200031 Less <<
NCT02471040 Type 1 Diabetes ... More >> Hypoglycemia Less << Not Applicable Recruiting December 2019 United States, Connecticut ... More >> Yale New Haven Hospital Recruiting New Haven, Connecticut, United States, 06510 Less <<
NCT03151590 Non-Responder Not Applicable Recruiting - Germany ... More >> Institute for Diabetes research and Metabolic Diseases of the Helmholtz Center Munich at the University of Tübingen Recruiting Tübingen, Germany, 72076 Contact: Anja Böhm, Dr. med.       anja.boehm@med.uni-tuebingen.de Less <<
NCT02461589 - Completed - -
NCT02177331 Hypertension Phase 3 Completed - -
NCT00388518 Diabetes Mellitus Type 2 Phase 2 Completed - -
NCT00610558 Epilepsy Not Applicable Completed - United States, California ... More >> Center for Functional Onco-Imaging, University of California Irvine, California, United States, 92697 Less <<
NCT00744367 Diabetes Mellitus Type 2 Phase 3 Completed - -
NCT02136329 Acute Kidney Injury Phase 1 Completed - United Kingdom ... More >> Department of Cardiovascular Sciences. Leicester, Leicestershire, United Kingdom, LE3 9QP Less <<
NCT00324285 Diarrhoea Sev... More >>ere Malnutrition Less << Phase 3 Completed - Bangladesh ... More >> ICDDR,B Dhaka, Bangladesh, 1000 Less <<
NCT00992043 Diabetes Rena... More >>l Function Less << Not Applicable Completed - Brazil ... More >> General Hospital - School of Medicine - University of Sao Paulo Sao Paulo, Brazil, 05508-030 Less <<
NCT01989039 - Unknown July 2014 Taiwan ... More >> WanFang Medical Center at Taipei Medical University Recruiting Taipei City, Taiwan, 116 Contact: Ming I Hsu, MD    886-2-2930-7930 ext 2508    hsumingi@yahoo.com.tw Less <<
NCT01843114 Type I Diabetes Not Applicable Completed - Austria ... More >> Department of Clinical Pharmacology Vienna, Austria, 1090 Less <<
NCT00005272 - Completed - -
NCT00730964 - Completed - -
NCT00376181 Type 2 Diabetes Phase 3 Terminated(Combination formula... More >>tion concerns) Less << - -
NCT00730964 Echocardiography Phase 4 Completed - United States, New Jersey ... More >> GE Healthcare Princeton, New Jersey, United States, 08540 Less <<
NCT01980914 - Recruiting December 2018 Canada, British Columbia ... More >> Vancouver Coastal Health Research Institute (VCHRI/VCHA) site -Vancouver General Hospital Recruiting Vancouver, British Columbia, Canada, V6M 1N7 Contact: Boris Feldman    604-875-5115    boris.feldman@vch.ca    Principal Investigator: Graydon S Meneilly, MD          Sub-Investigator: Kenneth M Madden, MD, MSc          Sub-Investigator: Andrew D Krahn, MD Less <<
NCT02637388 Obesity Not Applicable Unknown December 2016 United Kingdom ... More >> Queen Margaret University, Edinburgh Musselburgh, East Lothain, United Kingdom, EH21 6UU Less <<
NCT01479088 Secondary Hyperparathyroidism Phase 2 Phase 3 Unknown December 2013 Italy ... More >> U.O. Nefrologia e Dialisi- Ospedale Giovanni XXIII Active, not recruiting Bari, Italy, 70100 U.O. Nefrologia e Dialisi - Istituto di Ricovero e Cura a Carattere Scientifico Giannina Gaslini Recruiting Genoa, Italy, 16147 Contact: Enrico E Verrina, MD    +390105636276    enricoverrina@ospedale-gaslini.ge.it    Contact: Ornella Della Casa Alberighi, MD PhD    +390105636461    ornelladellacasa@ospedale-gaslini.ge.it    Principal Investigator: Enrico E. Verrina, MD          U.O. Nefrologia e Dialisi Pediatrica - Clinica De Marchi Active, not recruiting Milan, Italy, 20100 U.O. Nefrologia e Dialisi - Ospedale Santobono Active, not recruiting Naples, Italy, 80100 U.O. Nefrologia e Dialisi - Ospedale Bambino Gesù Active, not recruiting Rome, Italy, 00100 Less <<
NCT01173159 Cholestasis Not Applicable Recruiting July 2025 United States, Ohio ... More >> Cincinnati Children's Hospital Medical Center Recruiting Cincinnati, Ohio, United States, 45229 Contact: Crystal Slaughter, BA    513-636-0137    crystal.slaughter@cchmc.org    Principal Investigator: Samuel A Kocoshis, MD Less <<
NCT02273258 Type 1 Diabetes Phase 1 Completed - Germany ... More >> Sanofi Administrative Office Frankfurt, Germany Less <<
NCT03089632 Diabetes Mellitus, Type 1 ... More >> Gastroparesis Dyspepsia Gluten Sensitivity Less << Not Applicable Recruiting June 30, 2018 Canada, Ontario ... More >> McMaster Health Sciences Centre Recruiting Hamilton, Ontario, Canada, L8N3Z5 Contact: Natalia Causada Calo, MD    9059020215    causadan@mcmaster.ca    Sub-Investigator: María Inés Pinto-Sánchez, MD          Sub-Investigator: Suzanne Hansen, Dietician          Sub-Investigator: Natalia Causada Calo, MD          Principal Investigator: Premysl Bercik, MD, PhD Less <<
NCT01974674 Patients With Type 1 Diabetes Phase 2 Recruiting January 2022 France ... More >> Saint Louis hospital Recruiting Paris, Ile de France, France, 75010 Contact: Pierre CATTAN, MD PhD    33 1 42494786    pierre.cattan@sls.aphp.fr Less <<
NCT01949714 - Recruiting January 2022 Denmark ... More >> Department of Endocrinology MEA, Aarhus Hospital Recruiting Aarhus C, Please Select, Denmark, 8000 Contact    4578461631       Principal Investigator: Esben Søndergaard, MD, PhD Less <<
NCT02821923 Obesity Not Applicable Recruiting October 2019 Switzerland ... More >> University Hospital Recruiting Basel, Switzerland, CH-4031 Contact: Bettina K Woelnerhanssen, MD       bettina.woelnerhanssen@usb.ch    Principal Investigator: Christoph Beglinger, MD Less <<
NCT01922830 NAFLD Not Applicable Active, not recruiting January 2019 Israel ... More >> Tel Aviv Sourasky Medical Center Tel Aviv, Israel, 64239 Less <<
NCT00502710 Diabetes Mellitus Type 2 Phase 2 Completed - -
NCT02969070 Hypercholesterolemia ... More >> Endothelial Dysfunction Less << Phase 3 Unknown March 2017 Italy ... More >> University of Naples "Federico II" Recruiting Naples, Italy, 80131 Contact: Giuseppe Giugliano, MD, PhD    +390817462240    giuseppe.giugliano@unina.it    Sub-Investigator: Raffaele Izzo, MD          Sub-Investigator: Maurizio Galderisi, MD          Sub-Investigator: Giuseppe Giugliano, MD, PhD Less <<
NCT02954588 Abdominal Obesity Metabolic Sy... More >>ndrome Less << Not Applicable Recruiting February 2019 Netherlands ... More >> Maastricht University Medical Center Recruiting Maastricht, Netherlands, 6200MD Contact: Mathias Van den Eynde    +31 (0) 433884250    m.vandeneynde@maastrichtuniversity.nl Less <<
NCT00497003 Endothelial Function ... More >> Beta Blocker Less << Phase 4 Completed - Denmark ... More >> Department of Cardiology, University Hospital of Copenhagen, Bispebjerg Copenhagen, Denmark, 2400 Less <<
NCT00005548 - Completed - -
NCT03753997 Type1diabetes ... More >> Psychology Functional Behavior Less << Not Applicable Not yet recruiting December 31, 2022 -
NCT01500356 Cardiovascular Disease ... More >> Obesity Less << Not Applicable Completed - United States, Pennsylvania ... More >> University of Pittsburgh Pittsburgh, Pennsylvania, United States, 15260 Less <<
NCT00681460 Diabetes, Gestational ... More >> Insulin Resistance Less << Not Applicable Completed - Poland ... More >> Div of Obstetrics and Women's Diseases, Dept of Obstetrics and Gynecology, K Marcinkowski Univ of Med Sciences Poznan, Poland, 60-535 Less <<
NCT00021801 Type 1 Diabetes Mellitus Phase 2 Completed - United States, Florida ... More >> University of Miami Diabetes Research Institute Miami, Florida, United States, 33136 Less <<
NCT00769717 Obesity Phase 2 Phase 3 Unknown May 2011 United States, Pennsylvania ... More >> The Reading Hospital and Medical Center West Reading, Pennsylvania, United States, 19611 Less <<
NCT00025883 Lipodystrophy Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT01398059 Feasibility I... More >>nsulin Glucose Lipids Eating Less << Not Applicable Completed - Canada, Ontario ... More >> Behavioural Metabolic Research Unit, University of Ottawa Ottawa, Ontario, Canada, K1N 6N5 Less <<
NCT00025883 - Completed - -
NCT02983942 Primary Central Nervous System... More >> Lymphoma Less << Phase 1 Phase 2 Not yet recruiting December 2019 China, Beijing ... More >> Beijing Tiantan Hospital Not yet recruiting Beijing, Beijing, China, 100050 Contact: Song Lin, M.D.    861067096509    linsong2005@126.com    Contact: Chun Zeng, M.D.    861067096509    zengchun79@aliyun.com Less <<
NCT02058823 Hypoxia Sleep... More >> Apnea Obstructive Sleep Apnea Less << Phase 4 Unknown December 2017 France ... More >> Laboratoire EFCR - Functional Cardio-respiratory Exploration Laboratory La Tronche, Isère, France, 38700 Less <<
NCT00103935 Type 2 Diabetes Mellitus Phase 2 Completed - United States, California ... More >> Research Site Walnut Creek, California, United States United States, Hawaii Research Site Honolulu, Hawaii, United States United States, Missouri Research Site St. Louis, Missouri, United States United States, Montana Research Site Butte, Montana, United States United States, Oregon Research Site Portland, Oregon, United States United States, Texas Research Site San Antonio, Texas, United States United States, Washington Research Site Olympia, Washington, United States Less <<
NCT01248286 Diabetes Pred... More >>iabetes Less << Not Applicable Completed - United States, New York ... More >> Icahn School of Medicine at Mount Sinai New York, New York, United States, 10029 Less <<
NCT03123432 Gastric Cancer Not Applicable Completed - Taiwan ... More >> Chung-Ho Memorial Hospital, Kaohsiung Medical University: Kaohsiung, Taiwan, 807 Less <<
NCT01796561 Hypertension Not Applicable Completed - New Zealand ... More >> Institute of Food, Nutrition and Human Health, Massey University Albany, North Shore, Auckland, New Zealand, 0745 Less <<
NCT03726008 Gestational Diabetes Not Applicable Enrolling by invitation July 31, 2020 Taiwan ... More >> Kaohsiung Medical University Chung-Ho Memorial Hospital Kaohsiung City, Sanmin Dist, Taiwan, 807 Less <<
NCT01016509 Restenosis Ti... More >>ght Glycemic Control Less << Not Applicable Completed - Italy ... More >> Dept Geriatric and Metabolic diseases SUN Naples, Italy, 80138 Less <<
NCT02388113 Diabetes Mellitus, Type 2 Not Applicable Completed - Norway ... More >> Department of Circulation and Diagnostic Imaging Trondheim, Norway Less <<
NCT02756442 Respiratory Disorder in Patien... More >>t With Gestational Diabetes Less << Not Applicable Active, not recruiting April 2019 France ... More >> Assistance Publique Hopitaux de Marseille Marseille, France, 13354 Less <<
NCT01194245 Diabetes Mellitus, Type 1 Phase 2 Completed - United States, California ... More >> AMCR Institute, Inc. Escondido, California, United States, 92026 Scripps Whittier Diabetes Institute La Jolla, California, United States, 92037 Mills-Peninsula Health Services San Mateo, California, United States, 94401 United States, Colorado Barbara Davis Center for Childhood Diabetes Aurora, Colorado, United States, 80045 United States, Florida Center for Diabetes and Endocrine Care Hollywood, Florida, United States, 33021 Diabetes Research Institute Miami, Florida, United States, 33136 United States, Idaho Rocky Mountain Diabetes and Osteoporosis Center Idaho Falls, Idaho, United States, 83404 United States, Kansas Mid-America Diabetes Associates Wichita, Kansas, United States, 67211 United States, Louisiana Tulane University Health Sciences Center New Orleans, Louisiana, United States, 70112 United States, Maryland Medstar Research Institute Hyattsville, Maryland, United States, 20782 United States, Michigan Henry Ford Health System Detroit, Michigan, United States, 48202 United States, Minnesota International Diabetes Center Minneapolis, Minnesota, United States, 55416 United States, Montana Mercury Street Medical Butte, Montana, United States, 59701 United States, Nevada Desert Endocrinology Henderson, Nevada, United States, 89052 United States, Texas UT Southwestern Medical Center at Dallas Dallas, Texas, United States, 75390 Texas Diabetes and Endocrinology Round Rock, Texas, United States, 78681 Cetero Research-San Antonio San Antonio, Texas, United States, 78229 United States, Washington West Olympia Internal Medicine Olympia, Washington, United States, 98502 University of Washington School of Medicine Seattle, Washington, United States, 98105 Less <<
NCT03626792 Physical Activity ... More >> Blood Pressure Less << Not Applicable Completed - Brazil ... More >> Jaqueline Pontes Batista Uberlândia, Minas Gerais, Brazil, 38400-678 Less <<
NCT01194245 - Completed - -
NCT01575483 - Completed - Korea, Republic of ... More >> Research Site Seoul, Korea, Republic of Less <<
NCT02914691 Type 2 Diabetes ... More >> Diabetic Nephropathy Less << Phase 4 Completed - Denmark ... More >> Steno Diabetes Center Gentofte, Denmark, 2820 Less <<
NCT01862757 - Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT02714712 - Completed - -
NCT01713127 Preterm Infants ... More >> Mechanical Ventilator Care Less << Phase 1 Phase 2 Terminated(declined enrollment... More >>) Less << - Korea, Republic of ... More >> Seoul National University Children's Hospital Seoul, Korea, Republic of, 110-744 Less <<
NCT00744926 Diabetes Mellitus Type 2 Phase 3 Completed - -
NCT01750502 - Completed - China, Zhejiang ... More >> Second Hispital of Wenzhou Medical College Wenzhou, Zhejiang, China, 325000 Less <<
NCT02971306 Alcoholic Hepatitis Phase 4 Recruiting December 2017 India ... More >> Dept of Hepatology, PGIMER Recruiting Chandigarh, India, 160012 Contact: Virendra Singh, MD, DM    +911722756338    virendrasingh100@hotmail.com Less <<
NCT02650206 Diabetes Mellitus, Type 2 ... More >> Diabetes Mellitus, Type II Diabetes Mellitus, Adult-Onset Inflammation Less << Phase 4 Recruiting August 2018 United States, California ... More >> Freidenrich Center for Translational Research (FCTR) Recruiting Stanford, California, United States, 94305 Contact: Elizabeth Colbert    650-736-2056    ecolbert@stanford.edu    Contact: Dalia Perelman    6507362056    daliap@stanford.edu; Less <<
NCT02838472 Glucocorticoids Deficiency Not Applicable Unknown December 2017 Israel ... More >> Hadassah medical center Jerusalem, Israel, 99305 Less <<
NCT02164474 Physical Activity Not Applicable Completed - Canada, British Columbia ... More >> Health and Exercise Psychology Laboratory Kelowna, British Columbia, Canada, V1V 1V7 Less <<
NCT01750502 - Completed - -
NCT00504257 Fallopian Tube Cancer ... More >> Ovarian Cancer Malignant Tumor of Peritoneum Less << Phase 2 Completed - United States, Florida ... More >> Broward General Medical Center Cancer Center Fort Lauderdale, Florida, United States, 33316 Women's Cancer Associates Saint Petersburg, Florida, United States, 33701 H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612-9497 United States, North Carolina Duke Cancer Institute Durham, North Carolina, United States, 27710 Less <<
NCT00128154 Metabolic Syndrome X ... More >> Prediabetic State Insulin Resistance Obesity Metabolic Diseases Less << Not Applicable Completed - United States, Pennsylvania ... More >> University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00638287 - Withdrawn January 2011 -
NCT03196687 - Not yet recruiting June 1, 2018 -
NCT02094391 In-transit Metastases Melanoma... More >> Stage IIIB and IIIC Less << Phase 2 Completed - France ... More >> Gustave Roussy Cancer Campus Grand Paris Villejuif, Val de Marne, France, 94805 Less <<
NCT01315171 Hypo-unawareness ... More >> Type 1 Diabetes Mellitus Less << Not Applicable Completed - United States, Connecticut ... More >> Yale University School of Medicine New Haven, Connecticut, United States, 06511 Less <<
NCT00504257 - Completed - -
NCT03573739 Critical Illness ... More >> Shock Mechanical Ventilation Critical Illness Myopathy Nosocomial Infection Less << Not Applicable Not yet recruiting December 2021 France ... More >> Centre Hospitalier Not yet recruiting Angoulême, France, 16959 Contact: Christophe Cracco          Ch Annecy-Genevois Not yet recruiting Annecy, France, 74374 Contact: Michel Sirodot          Centre Hospitalier D'Argenteuil Not yet recruiting Argenteuil, France, 95100 Contact: Gaetan Plantefeve          Chu Jean Minjoz Not yet recruiting Besançon, France, 25030 Contact: Gael Piton          Hopital Pellegrin Chu Not yet recruiting Bordeaux, France, 33000 Contact: Hoang-Nam BUI          CHU Cavale Blanche Not yet recruiting Brest, France, 29609 Contact: Anne Renault          Hôpital de Béthune Béthune, France, 62408 Ch Chartres Louis Pasteur Not yet recruiting Chartres, France, 28630 Contact: Christophe Gontier          Chu Gabriel Montpied Not yet recruiting Clermont-Ferrand, France, 63003 Contact: Bertrand Souweine          Nantes University Hospital Not yet recruiting Nantes, France, 44000 Contact: Jean Reignier          Nantes University Hospital Not yet recruiting Nantes, France, 44000 Contact: Karim Asehnoune Less <<
NCT00372125 Prader-Willi Syndrome Not Applicable Completed - Denmark ... More >> Center for rare Diseases, Department of Pediatrics, Skejby University Hospital Aarhus N, Denmark, 8200 Norway Endokrinologisk seksjon, Med Avd, Rikshospitalet Oslo, Norway Sweden Department of Endocrinology and Diabetology, Karolinska Hospital Stockholm, Sweden, 171 76 Less <<
NCT02093221 - Terminated(Wk 52 primary endpo... More >>int results would be unaffected by follow-up data so trial was discontinued prior to wk 104. No safety data was collected after wk 52.) Less << - -
NCT02477345 - - - United States, New York ... More >> Staten Island University Hospital Staten Island, New York, United States, 10305 Less <<
NCT02093221 Type 1 Diabetes Mellitus Phase 2 Terminated(Wk 52 primary endpo... More >>int results would be unaffected by follow-up data so trial was discontinued prior to wk 104. No safety data was collected after wk 52.) Less << - -
NCT03599817 Overweight Ob... More >>esity Less << Not Applicable Recruiting July 2020 Mexico ... More >> Dispensario médico Recruiting Cd. Obregon, Loma De Guamúchil, Mexico Contact: Claudia Valencia          Dispensario médico Not yet recruiting Guaymas, Pótam, Mexico Dispensario médico Not yet recruiting Guaymas, Tórim, Mexico Dispensario médico Not yet recruiting Guaymas, Vícam, Mexico Less <<
NCT01831908 Cardiovascular Risk Factors ... More >> Stroke Ischemic Heart Disease Less << Not Applicable Active, not recruiting August 2020 Ecuador ... More >> Community Center Atahualpa, Santa Elena, Ecuador Less <<
NCT00925119 - Terminated - -
NCT00544102 - Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT01017783 Obesity Not Applicable Completed - United States, North Carolina ... More >> University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States, 27599-7294 Less <<
NCT02001766 Type 2 Diabetes Phase 1 Phase 2 Unknown August 2016 Denmark ... More >> Centre of Inflammation and Metabolism (CIM), Rigshospitalet, Tagensvej 20, section M7641 Recruiting Copenhagen, Denmark, 2100 Contact: Kamilla Winding, MSc PhD    +45 35459574    kamilla.winding@regionh.dk Less <<
NCT00039715 - Completed - United States, Maryland ... More >> National Institute of Mental Health (NIMH) Bethesda, Maryland, United States, 20892 Less <<
NCT00364767 Diabetes Mellitus, Type 2 ... More >> Cardiovascular Disease Less << Not Applicable Completed - -
NCT01268644 Type 1 Diabetes Phase 1 Terminated(Sponsor request) - United States, Texas ... More >> UT Southwestern Medical Center Dallas, Texas, United States, 75390 Less <<
NCT01665352 Type 2 Diabetes Mellitus Phase 2 Completed - United States, California ... More >> Site 18 Chula Vista, California, United States, 91911 Site 1 Los Angeles, California, United States, 90057 United States, Colorado Site 13 Denver, Colorado, United States, 80220 United States, Florida Site 4 Coral Gables, Florida, United States, 33134 Site 5 Port Orange, Florida, United States, 32127 United States, Hawaii Site 3 Honolulu, Hawaii, United States, 96814 United States, Indiana Site 17 Indianapolis, Indiana, United States, 46254 United States, Kentucky Site 7 Louisville, Kentucky, United States, 40213 United States, Maine Site 8 Auburn, Maine, United States, 04210 United States, Nevada Site 9 Las Vegas, Nevada, United States, 89101 United States, New Jersey Site 26 Trenton, New Jersey, United States, 08611 United States, New York Site 12 Rochester, New York, United States, 14609 United States, Ohio Site 14 Cincinnati, Ohio, United States, 45219 United States, South Carolina Site 6 Mount Pleasant, South Carolina, United States, 29464 United States, Texas Site 16 Dallas, Texas, United States, 75230 Site 10 Houston, Texas, United States, 77072 Site 2 Houston, Texas, United States, 77074 Site 11 Katy, Texas, United States, 77450 United States, Virginia Site 15 Richmond, Virginia, United States, 23294 Less <<
NCT02654392 Effect of Essential Fatty Acid... More >>s on Exercise Performance Less << Not Applicable Unknown February 2017 Canada, Ontario ... More >> Exercise Nutrition Research Laboratory, Western University London, Ontario, Canada, N6A 3K7 Less <<
NCT01529216 Type 2 Diabetes Mellitus Not Applicable Completed - France ... More >> Hospital Georges Pompidou Paris, France Netherlands Atrium Medisch Centrum Heerlen, Netherlands Less <<
NCT01638429 Diabetes Obes... More >>ity Less << Not Applicable Completed - United States, California ... More >> Cedars-Sinai Medical Center Los Angeles, California, United States, 90048 Less <<
NCT00816218 Type 2 Diabetes Mellitus Phase 4 Completed - United States, Texas ... More >> The University of Texas Health Science Center at San Antonio San Antonio, Texas, United States, 78229 Less <<
NCT03592784 Gestational Diabetes Not Applicable Recruiting July 31, 2019 United States, New York ... More >> Materal-Fetal Medicine of Weill Cornell Medicine Recruiting New York, New York, United States, 10065 Contact: Wanda Truong, MS    646-962-2423    wat7003@med.cornell.edu    Sub-Investigator: Nancy E Addison, RD          Sub-Investigator: Louis J Aronne, MD          Sub-Investigator: Joshua B Cadwell          Sub-Investigator: Anthony J Casper          Sub-Investigator: Shari Gelber, MD/PhD          Sub-Investigator: Ampadi Karan          Sub-Investigator: Karen Lin          Sub-Investigator: Brienne C Lubor          Sub-Investigator: Kathy Matthews, MD          Sub-Investigator: Felicia A Mendelsohn Curanaj          Sub-Investigator: Wanda Truong, MS Less <<
NCT02367131 - Completed - Japan ... More >> NISND Center One Or Multiple Investigational Sites, Japan Less <<
NCT02367131 - Completed - -
NCT02029924 Diabetes Mellitus Type 1 Phase 1 Completed - Germany ... More >> Neuss, Germany, 41460 Less <<
NCT02752087 Healthy Phase 1 Completed - Singapore ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician. Singapore, Singapore, 117597 Less <<
NCT01613105 - Completed - India ... More >> Many Locations, India Less <<
NCT01897259 Tennis Elbow ... More >>Lateral Epicondylitis Less << Phase 2 Recruiting June 2019 United States, Kentucky ... More >> Christine M. Kleinert Institute of Hand and Microsurgery Recruiting Louisville, Kentucky, United States, 40202 Contact: Christina L Kaufman, PhD    502-562-0390    ckaufman@cmki.org    Contact: Millicent L Horn, BS    502-562-0307    mhorn@cmki.org    Principal Investigator: Tuna Ozyurekoglu, MD Less <<
NCT01278628 Metabolic Syndrome Phase 1 Completed - Japan ... More >> SUMCO corporation Imari, Saga, Japan, 849-4271 Less <<
NCT00867425 Obesity Diabe... More >>tes Cardiovascular Disease Less << Not Applicable Completed - United States, Texas ... More >> Wilford Hall Medical Center Lackland AFB, Texas, United States, 78236 Less <<
NCT03652389 Type2 Diabetes Not Applicable Not yet recruiting February 2023 United States, New York ... More >> New York University School of Medicine Not yet recruiting New York, New York, United States, 10016 Contact: Devin Mann    212-263-4205    devin.mann@nyumc.org    Principal Investigator: Antoinette Schoenthaler, MD Less <<
NCT02140424 - Recruiting January 2019 United States, Massachusetts ... More >> Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: Deborah M Mitchell, MD    617-724-2034    dmmitchell@partners.org Less <<
NCT01138930 Polycystic Ovary Syndrome ... More >> Obesity Less << Not Applicable Unknown June 2013 China, Guangdong ... More >> Affiliated Hospital of Guangzhou Medical University Recruiting Guangzhou, Guangdong, China Contact: Hongxia Ma, MD          Principal Investigator: Hongxia Ma, MD          China, Heilongjiang First Affliated Hospital of Harbin Medical University Recruiting Harbin, Heilongjiang, China, 150001 Contact: Zhuoran Wang, MD          Principal Investigator: Zhuoran Wang, MD          Forth Affiliated Hospital of Harbin Medcal University Recruiting Harbin, Heilongjiang, China, 150001 Contact: Shiyu Han, MD          Principal Investigator: Shiyu Han, MD          Department of Obstetrics and Gynecology,First Affliated Hospital,Heilongjiang University of Chinese Medicine . Recruiting Harbin, Heilongjiang, China, 150040 Contact: Xiaoke Wu, MD.PhD.    86-451-8213 0094    xiaokewu2002@vip.sina.com Less <<
NCT01617603 Diabetes Type 2 Not Applicable Completed - United Kingdom ... More >> Endocrinology, Diabetes & Metabolism, Hull York Medical School, Michael White Diabetes Centre, 220-236, Anlaby Road Hull, United Kingdom, HU3 2RW Less <<
NCT01617603 - Completed - -
NCT03004664 - Recruiting March 30, 2020 United States, New Mexico ... More >> One Hope Centro de Vida Health Center Recruiting Albuquerque, New Mexico, United States, 87108 Contact: Blanca Pedigo    505-266-3590    blanca@eastcentralministries.com    University of New Mexico Hospital Recruiting Albuquerque, New Mexico, United States, 87131 Contact: Mary Lynn Johnston    505-272-8062    MLJohnston@salud.unm.edu Less <<
NCT01422668 Diabetes Mellitus Phase 3 Completed - United Arab Emirates ... More >> Faculty of Medicine and Health Sciences UAE University Al Ain, AB, United Arab Emirates Less <<
NCT00348140 Alzheimer's Disease Phase 3 Completed - -
NCT00642278 Diabetes Mellitus, Type II ... More >> Diabetes Mellitus, Non Insulin Dependent Less << Phase 2 Completed - -
NCT02407548 Dyslipidemia Phase 3 Completed - China, Guangdong ... More >> Hongshan Street community health service centre Guangzhou, Guangdong, China, 510000 Less <<
NCT00642278 - Completed - -
NCT01122446 Prediabetes T... More >>ype 1 Diabetes Less << Phase 2 Completed - Sweden ... More >> Clinical Research Center, Pediatric Endocrinology, Jan Waldenströms gata 35, 60:11 Malmö, Sweden, 205 02 Less <<
NCT00348140 - Completed - -
NCT01550133 Obese Overwei... More >>ght Less << Not Applicable Unknown December 2016 United States, Indiana ... More >> Purdue University West Lafayette, Indiana, United States, 47907 Less <<
NCT03659162 - Not yet recruiting July 24, 2019 -
NCT00486863 Schistosomiasis Phase 2 Completed - Philippines ... More >> Research Institute for Tropical Medicine - Health Compound Muntinlupa City, National Capital Region, Philippines, 1781 Less <<
NCT02064881 Type 2 Diabetes Phase 2 Phase 3 Recruiting August 2020 Mexico ... More >> Instituto Nacional de Ciencias Médicas Y Nutrición Salvador Zubirán Recruiting México, Distrito Federal, Mexico, 14000 Contact: Francisco Gómez, Doctor    55133891    gomezperezfco@gmail.com    Contact: Paloma Almeda, Doctor    56554523    palomaalmeda@yahoo.com    Principal Investigator: Francisco J Gómez, Doctor Less <<
NCT03408678 - Recruiting December 31, 2018 South Africa ... More >> SAMRC/WITS Developmental Pathways of Health Research Unit, University of Witwatersrand Recruiting Johannesburg, Gauteng, South Africa, 2013 Contact: Tinashe Chikowore, :PhD       tinashe.chikowore1@wits.ac.za    Contact: Nomses Baloyi       Vukosi.Baloyi@wits.ac.za    Sub-Investigator: Clement Kufe, MSc          Sub-Investigator: Maphoko Masemola, MSc          Sub-Investigator: Tinashe Chikowore, PhD          Sub-Investigator: Tshifhiwa Ratshikombo, Hons          Sub-Investigator: Melikhaya Soboyisi, Hons Less <<
NCT01573377 Polycystic Ovary Syndrome ... More >> Insulin Resistance Less << Not Applicable Completed - China, Chongqing ... More >> The First Affiliated Hospital of Chongqing Medical University Chongqing, Chongqing, China, 400016 Less <<
NCT00613782 Type 2 Diabetes ... More >> Hypogonadism Less << Phase 2 Phase 3 Completed - Australia, Victoria ... More >> Austin Health Melbourne, Victoria, Australia, 3084 Less <<
NCT01878721 - Active, not recruiting December 2019 Finland ... More >> Turku University Hospital Turku, Finland, FI-20521 Less <<
NCT00859898 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT00229255 Obesity Insul... More >>in Resistance Fatty Liver Less << Not Applicable Completed - United States, New York ... More >> Rockefeller University Hospital New York, New York, United States, 10021 Less <<
NCT02551874 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT00486863 - Completed - -
NCT02551874 - Completed - -
NCT00445627 - Recruiting - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)    800-411-1222 ext TTY8664111010    prpl@cc.nih.gov Less <<
NCT01290250 Overweight Ob... More >>esity Less << Not Applicable Completed - Spain ... More >> Department of Biochemistry and Molecular Biology II, Institute of Nutrition and Food Technology, Center for Biomedical Research, University of Granada, Spain, 18071 Less <<
NCT03141073 Diabetes Mellitus, Type 2 Phase 3 Recruiting December 2019 China ... More >> Hua Medicine Limited Recruiting Shanghai, China Contact: YI ZHANG, MD,PhD    +86-021-58869997    yzhang@huamedicine.com Less <<
NCT00250029 Colonic Diseases ... More >> Cancer Less << Not Applicable Completed - United States, New Mexico ... More >> Hematology Oncology Associates Albuquerque, New Mexico, United States, 87102-3661 Lovelace Sandia Health Systems Dept of Hematology Albuquerque, New Mexico, United States, 87108 University of New Mexico Cancer Center Albuquerque, New Mexico, United States, 87131 New Mexico Veterans Administration Health Care System Albuquerque, New Mexico, United States Less <<
NCT01739413 Colorectal Surgery Not Applicable Completed - Canada, Quebec ... More >> Montreal General Hospital Montreal, Quebec, Canada, H3G 1A4 Less <<
NCT02189200 Dietary Modification Not Applicable Completed - Brazil ... More >> Instituto Estadual de Cardiologia Aloysio de Castro - IECAC Rio de Janeiro, Brazil, 22261-010 Less <<
NCT01811550 - Active, not recruiting November 2019 -
NCT01753973 - Completed - Brazil ... More >> Hospital das Clinicas - Faculdade de Medicina da Universidade de São Paulo Sao Paulo, Brazil, 05403-900 Less <<
NCT00005399 - Completed - -
NCT01479595 - Completed - -
NCT03626909 - Recruiting January 13, 2021 Guatemala ... More >> Hospital Obras Sociales Recruiting San Lucas Tolimán, Solala, Guatemala Contact: Sean Duffy, MD    +502 4607-0561    Sean.Duffy@fammed.wisc.edu    Contact: , MD Less <<
NCT01479595 Asthma Phase 2 Completed - United States, California ... More >> Novartis Investigative Site Anaheim, California, United States, 92801 Novartis Investigative Site Riverside, California, United States, 92506 Novartis Investigative Site Rolling Hills Estates, California, United States, 90274 Novartis Investigative Site San Marino, California, United States, 91108 United States, Colorado Novartis Investigative Site Denver, Colorado, United States, 80206 Novartis Investigative Site Denver, Colorado, United States, 80230 United States, Florida Novartis Investigative Site Aventura, Florida, United States, 33180 United States, Massachusetts Novartis Investigative Site Boston, Massachusetts, United States, 02115 United States, Minnesota Novartis Investigative Site Minneapolis, Minnesota, United States, 55402 United States, Missouri Novartis Investigative Site St. Louis, Missouri, United States, 63110 United States, North Carolina Novartis Investigative Site Raleigh, North Carolina, United States, 27607 Novartis Investigative Site Winston-Salem, North Carolina, United States, 27157 United States, Oklahoma Novartis Investigative Site Oklahoma City, Oklahoma, United States, 73120 United States, Oregon Novartis Investigative Site Medford, Oregon, United States, 97504-8741 United States, South Carolina Novartis Investigative Site Spartanburg, South Carolina, United States, 29303 Germany Novartis Investigative Site Berlin, Germany, 10117 Novartis Investigative Site Frankfurt, Germany, 60596 Novartis Investigative Site Wiesbaden, Germany, 65187 United Kingdom Novartis Investigative Site London, United Kingdom, SE11YR Novartis Investigative Site Manchester, United Kingdom, M23 9QZ Less <<
NCT03202875 Type 1 Diabetes Phase 1 Completed - Germany ... More >> Investigational Site 276001 Neuss, Germany Less <<
NCT00396474 - Withdrawn(Study design no long... More >>er relevant and no patients were recruited.) Less << January 2012 -
NCT02770872 - Completed - United States, Kentucky ... More >> VA Medical Center Lexington, Kentucky, United States, 40515 Less <<
NCT01065766 - Completed - -
NCT01065766 - Completed - -
NCT01525693 - Unknown January 2014 China ... More >> People's Hospital of Peking University Beijing, China Xijing Hospital Xian, China Less <<
NCT03316989 - Completed - -
NCT01197742 - Completed - Germany ... More >> Städ Krankenhaus münchen Schwabing München, Germany, 80804 Klinikum Nürnberg Süd /Cardiology Nürnberg, Germany, 90471 Less <<
NCT01429506 Diabetes Mellitus ... More >> Obesity Less << Not Applicable Completed - India ... More >> PGIMER Chandigarh, India, 160012 Less <<
NCT00935922 Body Weight L... More >>ipids Blood Glucose Insulin Less << Not Applicable Completed - United States, California ... More >> CCRC Mather, California, United States, 95655 Less <<
NCT02525744 Healthy Phase 1 Completed - Singapore ... More >> For additional information regarding investigative sites for this trial, contact 1‐877‐CTLILLY (1‐877‐285‐4559, 1‐317‐615‐4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT ‐ 5 hours, EST) or speak with your personal physician. Singapore, Singapore Less <<
NCT03191435 Diabetes Mellitus, Type 2 Not Applicable Recruiting January 31, 2019 Brazil ... More >> Hospital de Clínicas de Porto Alegre Recruiting Porto Alegre, Rio grande do sul, Brazil, 90.035-903 Contact: Beatriz D'agord Schaan, PhD       bschaan@hcpa.edu.br Less <<
NCT00859898 - Completed - -
NCT01005121 Diabetic Nephropathy Phase 2 Unknown December 2015 Israel ... More >> Sheba medical center, Tel hashomer Recruiting Ramat gan, Israel, 52621 Contact: Shaye Kivity, MD    03-5302436    kivitys@gmail.com    Sub-Investigator: Shaye Kivity, MD Less <<
NCT02890108 Insulin Sensitivity Not Applicable Unknown October 2016 Chile ... More >> Institute of Nutrition and Tecnology of Food, University of Chile Recruiting Santiago, Metropolitan region, Chile Contact: Verónica Cornejo Espinoza, Director    +56229781 410    vcornejo@inta.uchile.cl    Contact: Sandra Hirsch Birn, Academic    +56229781495 ext +56229781499    shirsch@inta.uchile.cl    Principal Investigator: Romina A Goza Ferreira, Magister c          Principal Investigator: Sandra Hirsch Birn, Magister          Sub-Investigator: Gladys Barrera Acevedo, Magister Less <<
NCT01790412 Pregnancy Not Applicable Completed - Spain ... More >> Technical University of Madrid Madrid, Spain, 28040 Less <<
NCT02636361 Healthy Phase 1 Completed - Singapore ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician. Singapore, Singapore, 117597 Less <<
NCT01870557 - Completed - Denmark ... More >> Department of Endocrinology, Aalborg University Hospital Aalborg, Denmark, 9000 Department of Endocrinology and Internal Medicine, Aarhus University Hospital Aarhus, Denmark, 8000 Less <<
NCT02308605 - Completed - United Kingdom ... More >> University Hospitals Coventry & Warwickshire NHS Trust Coventry, United Kingdom, CV2 2DX University of Keele Stoke-on-Trent, United Kingdom, ST4 7QB Less <<
NCT03676296 Cardiovascular Disease Risk Fa... More >>ctors Less << Phase 2 Recruiting November 2019 China ... More >> The University of Hong Kong Recruiting Hong Kong, China Contact: Man Ki Kwok, Ph.D.    852+39176750    maggiek@hku.hk Less <<
NCT03705923 Obesity Not Applicable Not yet recruiting October 2023 Germany ... More >> University of Tuebingen, Department of Internal Medicine IV Not yet recruiting Tübingen, Germany, 72076 Contact: Martin Heni, MD    +49 7071 29 82714    martin.heni@med.uni-tuebingen.de    Contact: Markus Quante, MD    +49 7071 29 86619    markus.quante@med.uni-tuebingen.de    Sub-Investigator: Stephanie Kullmann, PhD Less <<
NCT01733108 Healthy Phase 1 Completed - -
NCT01171716 Low Protein Dietary Intake ... More >> High Protein Dietary Intake Less << Not Applicable Completed - United States, Indiana ... More >> Purdue University, Dept of Foods and Nutrition West Lafayette, Indiana, United States, 47906 Less <<
NCT03643146 Cardiovascular Diseases Not Applicable Not yet recruiting January 15, 2019 United States, New York ... More >> New York University School of Medicine Not yet recruiting New York, New York, United States, 10016 Contact: Azizi Seixas    646-501-2672    azizi.seixas@nyumc.org    Principal Investigator: Azizi Seixas, MD Less <<
NCT02282592 - Completed - -
NCT03084913 Prostate Cancer Not Applicable Completed - -
NCT02432950 Obesity Stage... More >> IA Breast Cancer Stage IB Breast Cancer Stage IIA Breast Cancer Stage IIB Breast Cancer Stage IIIA Breast Cancer Stage IIIB Breast Cancer Stage IIIC Breast Cancer Less << Not Applicable Active, not recruiting April 2019 United States, California ... More >> City of Hope Medical Center Duarte, California, United States, 91010 Less <<
NCT00720616 Metabolic Syndrome Not Applicable Withdrawn December 2012 United States, Oregon ... More >> Oregon Health and Science University Portland, Oregon, United States, 97239 Less <<
NCT01616433 Arthritis Dia... More >>betes Hypertension Preventive Behaviors Less << Phase 2 Completed - United States, Pennsylvania ... More >> Community sites Allegheny County primarily, Pennsylvania, United States Less <<
NCT03190798 Type2 Diabetes Mellitus ... More >> Cardiovascular Diseases Less << Phase 4 Withdrawn(Study has been withd... More >>rawn from IRB review pending IND revision) Less << August 1, 2018 United States, Texas ... More >> The University of Texas Health Science Center at San Antonio San Antonio, Texas, United States, 78229 Less <<
NCT00525577 Diabetes Phase 2 Phase 3 Unknown September 2008 -
NCT03334448 Healthy Phase 1 Completed - Singapore ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician. Singapore, Singapore Less <<
NCT00404950 - Completed - United States, New York ... More >> The New York Presbyterian Hospital - Weill Medical College of Cornell University New York, New York, United States, 10021 Less <<
NCT00076323 Glucosephosphate Dehydrogenase... More >> Deficiency Favism Less << Not Applicable Completed - United States, Maryland ... More >> Walter Reed Army Institute of Research Silver Spring, Maryland, United States, 20910 Less <<
NCT00969098 - Unknown September 2015 Italy ... More >> Istituto Clinico Humanitas Rozzano, Milano, Italy, 20089 Less <<
NCT01088165 Psoriasis Car... More >>diovascular Diseases Diabetes Mellitus, Type 2 Less << Phase 4 Unknown May 2014 Austria ... More >> Medical University Vienna Dpt. of Dermatology Recruiting Vienna, Austria, 1090 Contact: Gregor Holzer, Dr    40400 7702    gregor.holzer@meduniwien.ac.at    Contact: Adrian Tanew, ao Univ. Prof.    40400 7701    adrian.tanew@meduniwien.ac.at    Principal Investigator: Gregor Holzer, Dr Less <<
NCT02003014 - Completed - -
NCT02003014 - Completed - -
NCT01992861 Cervical Adenocarcinoma ... More >> Cervical Adenosquamous Carcinoma Cervical Squamous Cell Carcinoma, Not Otherwise Specified Cervical Undifferentiated Carcinoma Recurrent Cervical Carcinoma Stage IB2 Cervical Cancer Stage II Cervical Cancer Stage IIA Cervical Cancer Stage IIB Cervical Cancer Stage III Cervical Cancer Stage IIIA Cervical Cancer Stage IIIB Cervical Cancer Stage IVA Cervical Cancer Less << Not Applicable Recruiting - United States, Florida ... More >> University of Miami Miller School of Medicine-Sylvester Cancer Center Recruiting Miami, Florida, United States, 33136 Contact: Aaron H. Wolfson    305-243-4210    awolfson@med.miami.edu    Principal Investigator: Aaron H. Wolfson          United States, Georgia Augusta University Medical Center Withdrawn Augusta, Georgia, United States, 30912 United States, Illinois Loyola University Medical Center Recruiting Maywood, Illinois, United States, 60153 Contact: Matthew M. Harkenrider    708-216-2575    mharkenrider@lumc.edu    Principal Investigator: Matthew M. Harkenrider          United States, Ohio Ohio State University Comprehensive Cancer Center Recruiting Columbus, Ohio, United States, 43210 Contact: Michael V. Knopp    614-293-8315    Michael.Knopp@osumc.edu    Principal Investigator: Michael V. Knopp          United States, Washington Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Nina A. Mayr    206-598-4110    ninamayr@uw.edu    Principal Investigator: Nina A. Mayr          Canada, Ontario University of Toronto Recruiting Toronto, Ontario, Canada, M5S 1A1 Contact: Eric Leung    416-480-5000    eric.leung@sunnybrook.ca    Principal Investigator: Eric Leung          Hong Kong University of Hong Kong Not yet recruiting Hong Kong, Hong Kong Contact: Elaine Y. Lee    852 2255 3307    eyplee77@hku.hk    Principal Investigator: Elaine Y. Lee Less <<
NCT01798264 Type 2 Diabetes Phase 1 Completed - United States, Florida ... More >> Miami Gardens, Florida, United States, 33169 United States, Ohio Medpace Clinical Pharmacology Unit Cincinnati, Ohio, United States, 45212 United States, Texas dGd Research San Antonio, Texas, United States, 78229 Less <<
NCT03272867 Healthy Volunteers ... More >> Age Group: 60-70 Overweight Less << Not Applicable Completed - Netherlands ... More >> UMCG Groningen, Netherlands, 9700RB Less <<
NCT02935868 - Completed - Brazil ... More >> Bauru School of Dentistry Bauru, Sao Paulo, Brazil, 17012-901 Less <<
NCT02666170 Polycystic Ovary Syndrome Not Applicable Unknown - -
NCT02683148 Synovial Sarcoma ... More >> Sarcoma, Synovial Less << Phase 1 Phase 2 Recruiting June 30, 2025 United States, Missouri ... More >> Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: Brian A Van Tine, M.D., Ph.D.    314-362-5737    bvantine@wustl.edu    Principal Investigator: Brian A Van Tine, M.D, Ph.D. Less <<
NCT01798264 - Completed - -
NCT01587521 - Completed - Thailand ... More >> Chiang Mai University Chiang Mai, Thailand, 50200 Less <<
NCT01987258 Type 2 Diabetes Mellitus Not Applicable Completed - Denmark ... More >> Centre of Inflammation and Metabolism (CIM), Rigshospitalet, Tagensvej 20, section M7641 Copenhagen, Denmark, 2100 Less <<
NCT01464398 Polycystic Ovary Syndrome ... More >> Overweight Obesity Stress, Physiological Stress, Psychological Less << Not Applicable Completed - United States, Pennsylvania ... More >> Penn State College of Medicine, Penn State Milton S. Hershey Medical Center Hershey, Pennsylvania, United States, 17033 Less <<
NCT01620684 Metabolic Syndrome ... More >> Obesity Insulin Resistance Less << Phase 4 Unknown - Australia, Victoria ... More >> Heart Centre, Alfred Hospital Recruiting Prahran, Melbourne, Victoria, Australia, 3181 Contact: Nora E Straznicky, BPharm PhD MPH    61 3 8532 1371    nora.straznicky@bakeridi.edu.au    Principal Investigator: Nora E Straznicky, PhD MPH Less <<
NCT01521806 Focus of the Study is Insulin ... More >>Sensitivity Less << Not Applicable Unknown September 2013 United States, Alabama ... More >> Clinical Research Unit Not yet recruiting Birmingham, Alabama, United States, 35249 Contact: Brandon Kane    205-975-9629    kane003@uab.edu    Principal Investigator: Barbara Gower, PhD Less <<
NCT02244814 Gestational Diabetes Mellitus Not Applicable Recruiting December 2019 United States, Colorado ... More >> University of Colorado/Anschutz Medical Campus Recruiting Aurora, Colorado, United States, 80045 Contact: Kristin M Garcia    303-724-0110    kristin.garcia@ucdenver.edu    Sub-Investigator: Linda A Barbour, MD, MSPH          Sub-Investigator: Jacob E Friedman, PhD          Sub-Investigator: David Brumbaugh, MD          Sub-Investigator: Daniel N Frank, PhD          Sub-Investigator: Nancy F Krebs, MD, MS          Sub-Investigator: Regina M Reynolds, MD          Sub-Investigator: Rachael E Van Pelt, PhD Less <<
NCT01272193 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT00814476 Type 1 Diabetes Phase 4 Completed - Israel ... More >> Schnider children medical center Petach-Tikva, Israel Less <<
NCT01272193 - Completed - -
NCT01340664 Diabetes Mellitus, Type 2 Phase 2 Completed - -
NCT00593099 Bipolar Disorder Phase 1 Phase 2 Completed - United States, Connecticut ... More >> Connecticut Mental Health Center New Haven, Connecticut, United States, 06519 Less <<
NCT01340664 - Completed - -
NCT01135394 Type 2 Diabetes Not Applicable Completed - United States, Maryland ... More >> University of Maryland School of Medicine Baltimore, Maryland, United States, 21201 Less <<
NCT03247608 Diabetes Mellitus ... More >> Coronary Artery Disease Heart Failure Less << Not Applicable Recruiting March 2018 United States, Maryland ... More >> Sinai Hospital of Baltimore Recruiting Baltimore, Maryland, United States, 21215 Contact: Alexander Yabut    410-601-5559    ayabut@lifebridgehealth.org    Contact: Tonja Howell    410-601-8461    tjhowell@lifebridgehealth.org    Principal Investigator: Mauro Moscucci, MD Less <<
NCT03426085 Autonomic Nervous System Disea... More >>ses Sweat Gland Diseases Diabetic Neuropathy With Neurologic Complication Less << Phase 2 Recruiting January 2019 United States, Virginia ... More >> Strelitz Diabetes Center Recruiting Norfolk, Virginia, United States, 23510 Contact: Henri K Parson, PhD    757-446-7976    parsonhk@evms.edu    Contact: Joshua F Edwards, MPH    7574460335    edwardj@evms.edu    Principal Investigator: Aaron I Vinik, MD, PhD Less <<
NCT02284893 Type 2 Diabetes Phase 3 Completed - -
NCT00372086 Type 1 Diabetes ... More >> Puberty: >Tanner 2 Breast Development or Testis >4ml Less << Phase 4 Completed - Australia, New South Wales ... More >> Sydney Children's Hospital Sydney, New South Wales, Australia, 2038 Less <<
NCT01451372 - Completed - Sweden ... More >> Medtronic AB Stockholm, Kista, Sweden, 164 21 Less <<
NCT00592670 Type 1 Diabetes Not Applicable Completed - United States, Tennessee ... More >> Vanderbilt University Nashville, Tennessee, United States, 37232-0475 Less <<
NCT01276288 Diabetes Mellitus, Type 2 Phase 1 Completed - Germany ... More >> 1245.42.1 Boehringer Ingelheim Investigational Site Neuss, Germany Less <<
NCT02284893 - Completed - -
NCT00205296 Obesity Low F... More >>itness Less << Not Applicable Completed - United States, Wisconsin ... More >> University of Wisconsin Madison, Wisconsin, United States, 53792 Less <<
NCT01331642 - Terminated(the Albrecht Kossel... More >> Institute of University Rostock terminated participation in the study conduct; Study Sponsorship is moved to Centogene AG) Less << - Algeria ... More >> Pediatric practice Oran, Algeria, 31000 Brazil Health Technology Assessment in Clinical Genetics Research Group Porto Alegre -RS, Brazil, 90035-003 Clinics Hospital of Ribeirao Preto- University of Sao Paulo Sao Paulo, Brazil, 14048-900 Germany University of Rostock, Albrecht-Kossel Institute Rostock, Germany, 18147 Greece Aristotle University of Thessaloniki-Ippokration General Hospital Thessaloniki, Greece, 54642 India NIRMAN, University of Mumbai Mumbai, India, 400705 Serbia Mother and Child Health Institute of Serbia Novi-Beograd, Serbia, 11070 Less <<
NCT00229229 Obesity Cardi... More >>ovascular Disease Metabolic Syndrome Less << Phase 4 Terminated(Lack of funding) - Canada, Ontario ... More >> Vascular Disease Prevention and Research Centre Kingston, Ontario, Canada, K7L 5G2 Less <<
NCT01276288 - Completed - -
NCT02669875 Liver Cirrhosis ... More >> Hypertension, Portal Less << Phase 2 Completed - United Kingdom ... More >> Liver Unit, Royal Infirmary of Edinburgh Edinburgh, United Kingdom, EH164TJ Less <<
NCT01559857 Major Depressive Disorder ... More >> Insulin Resistance Less << Phase 4 Completed - United States, California ... More >> Stanford University Department of Psychiatry & Behavioral Sciences Palo Alto, California, United States, 94305 Less <<
NCT01128153 - Completed - -
NCT00989079 Type 2 Diabetes Mellitus Phase 1 Completed - -
NCT01128153 Type 2 Diabetes Phase 3 Completed - -
NCT03555305 Healthy Phase 1 Recruiting September 27, 2019 China, Sichuan ... More >> West China Hospital of Sichuan University Recruiting Chengdu, Sichuan, China, 610041 Contact    8618980601304       Principal Investigator: Yerong Yu Less <<
NCT01559857 - Completed - -
NCT00745953 Metabolic Syndrome ... More >> Lipotoxicity Less << Phase 4 Unknown August 2009 United States, Texas ... More >> University of Texas Southwestern Medical Center Recruiting Dallas, Texas, United States, 75390 Less <<
NCT03436498 Type 1 Diabetes Mellitus Phase 1 Completed - United States, Arkansas ... More >> Investigational Site Number 8400001 Little Rock, Arkansas, United States, 72211 United States, Colorado Investigational Site Number 8400002 Denver, Colorado, United States, 80262 United States, Iowa Investigational Site Number 8400003 West Des Moines, Iowa, United States, 50265 Less <<
NCT03113279 - Completed - -
NCT00001507 Breast Neoplasm ... More >> Neoplasm Metastasis Less << Phase 1 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT01748851 Gastric Carcinoma Stage IV Phase 3 Terminated(Poor enrollment of ... More >>patients) Less << - Korea, Republic of ... More >> Dong-A University Hospital Busan, Korea, Republic of, 602-715 Less <<
NCT03348267 Skeletal Muscle Damage ... More >> Muscle Inflammation Muscle Recovery Soccer Performance Less << Not Applicable Completed - Greece ... More >> Exercise Biochemistry Laboratory, School of Physical Education & Sports Sciences, University of Thessaly Tríkala, Greece, 42100 Less <<
NCT01356394 Obesity Metab... More >>olic Syndrome Chronic Kidney Disease Less << Phase 4 Completed - Brazil ... More >> NIEPEN Juiz de Fora, Minas Gerais, Brazil, 36036-330 Less <<
NCT01969747 Diabetes Mellitus, Type 1 Phase 2 Completed - Austria ... More >> 1245.78.43001 Boehringer Ingelheim Investigational Site Graz, Austria Germany 1245.78.49001 Boehringer Ingelheim Investigational Site Neuss, Germany Less <<
NCT01358591 Exercise Fat Oxidation Not Applicable Completed - United Kingdom ... More >> Northumbria University Newcastle Upon Tyne, Tyne and Wear, United Kingdom, NE1 8ST Less <<
NCT00100178 Diabetes Mellitus, Type 1 Phase 2 Completed - United States, California ... More >> Childrens Hospital Los Angeles Los Angeles, California, United States, 90027 University of California-San Francisco San Francisco, California, United States, 94143 Stanford University Stanford, California, United States, 94305-5208 United States, Colorado Barbara Davis Center for Childhood Diabetes, University of Colorado Denver, Colorado, United States, 80262 United States, Florida University of Florida Gainesville, Florida, United States, 32610 United States, Indiana Indiana University Indianapolis, Indiana, United States, 46202 United States, Massachusetts Joslin Diabetes Center Boston, Massachusetts, United States, 02215 United States, Minnesota University of Minnesota Minneapolis, Minnesota, United States, 55455 United States, New York Columbia University New York, New York, United States, 10032 United States, Washington Benaroya Research Institute Seattle, Washington, United States, 98101 Canada, Ontario Hospital for Sick Children Toronto, Ontario, Canada, M5G 1X8 Less <<
NCT00747279 Acute Ischemic Stroke Phase 4 Unknown - Brazil ... More >> Hospital Sao Domingos Recruiting Sao Luis, MA, Brazil, 65060-642 Contact: JOSE R AZEVEDO, MD    55 98 32275735    jrazevedo@elo.com.br    Principal Investigator: JOSE R AZEVEDO, MD Less <<
NCT00100178 - Completed - -
NCT03183752 Thyroid Nodule ... More >> Insulin Resistance Less << Not Applicable Recruiting July 10, 2018 Brazil ... More >> Patricia Santos Recruiting Rio de Janeiro, Brazil, 21941913 Contact: Patricia Santos    55 21 981669799    patriciaborges.endocrino@gmail.com Less <<
NCT02708576 Obesity Phase 1 Completed - Australia, Victoria ... More >> NGM Clinical Study Site Melbourne, Victoria, Australia Less <<
NCT00006331 - Unknown - United States, Michigan ... More >> 3914 Taubman Center Recruiting Ann Arbor, Michigan, United States, 48109-0364 Contact: Akinlolu O. Ojo, M.D.    734-763-9041    aojo@umich.edu Less <<
NCT01258075 Type 2 Diabetes Mellitus Phase 4 Recruiting June 2019 -
NCT01172886 - Unknown - Italy ... More >> Dept. of Senology - National Cancer Institute of Naples Recruiting Naples, Italy, 80131 Contact: immacolata capasso, MD    00393381829067    icapasso@tiscali.it    Principal Investigator: immacolata capasso, MD Less <<
NCT01969747 - Completed - -
NCT00873925 Type 1 Diabetes Phase 1 Completed - United States, Florida ... More >> University of Florida Gainesville, Florida, United States, 32608 Less <<
NCT01284608 - Completed - Spain ... More >> Research Site El Ejido, Almeria, Spain Research Site Huercal Overa, Almeria, Spain Research Site Merida, Badajoz, Spain Research Site El Hospitalet de Llobregat, Barcelona, Spain Research Site Sabadell, Barcelona, Spain Research Site Aranda de Duero, Burgos, Spain Research Site Miranda de Ebro, Burgos, Spain Research Site Ferrol, Coru?a, Spain Research Site San Sebastian, Guipuzcoa, Spain Research Site Palma de Mallorca, Illes Balears, Spain Research Site Logrono, La Rioja, Spain Research Site Monforte (casco Urbano), Lugo, Spain Research Site Alcala de Henares, Madrid, Spain Research Site Coslada, Madrid, Spain Research Site Majadahonda, Madrid, Spain Research Site San Sebastian de Los Reyes, Madrid, Spain Research Site Antequera, Malaga, Spain Research Site Vigo, Pontevedra, Spain Research Site Osuna, Sevilla, Spain Research Site Reus, Tarragona, Spain Research Site Baracaldo, Vizcaya, Spain Research Site Bilbao, Vizcaya, Spain Research Site Galdakao, Vizcaya, Spain Research Site Calatayud, Zaragoza, Spain Research Site Albacete, Spain Research Site Barcelona, Spain Research Site Cordoba, Spain Research Site Granada, Spain Research Site Guadalajara, Spain Research Site Jaen, Spain Research Site Madrid, Spain Research Site Toledo, Spain Research Site Zaragoza, Spain Less <<
NCT02854696 Type 1 Diabetes Phase 3 Recruiting December 2023 France ... More >> University Hospital of Besançon Recruiting Besancon, France Contact: Sophie BOROT, MD, PhD    +33 3 81 66 82 29    sophie.borot@univ-fcomte.fr    Principal Investigator: Sophie BOROT, MD, PhD          university hospital of Clermont Ferrand Not yet recruiting Clermont Ferrand, France Contact: Igor TAUVERON, MD, PhD    +33 4 73 75 15 29    itauveron@chu-clermontferrand.fr    Principal Investigator: Igor TAUVERON, MD, PhD          Sub-Investigator: Béatrice ROCHE, MD, PhD          Grenoble University Hospital Recruiting Grenoble, France, 38000 Contact: Sandrine LABLANCHE, MD, PhD    +33 4 76 63 54 26    slablanche@chu-grenoble.fr    Contact: Myriam HADDOUCHE       mhaddouche@chu-grenoble.fr    Sub-Investigator: Sandrine LABLANCHE, MD, PhD          Principal Investigator: Pierre-Yves BENHAMOU, MD, PhD          Sub-Investigator: Rachel TETAZ, MD, PhD          University hospital of Lille Recruiting Lille, France, 59000 Contact: Marie-Christine VANTYGHEM, MD, PhD    +33 3.20.44.45.35    Marie-Christine.VANTYGHEM@CHRU-LILLE.FR    Principal Investigator: Marie-Christine VANTYGHEM, MD, PhD          Sub-Investigator: François PATTOU, MD, PhD          Sub-Investigator: Noel NOEL, MD, PhD          Sub-Investigator: Kristell LE MAPIHAN, MD          University Hospital of Lyon Recruiting Lyon, France, 69000 Contact: Charles THIVOLET, MDPHD    +33 4 78 86 14 87    charles.thivolet@chu-lyon.fr    Principal Investigator: Charles THIVOLET, MD, PhD          Sub-Investigator: Emmanuel MORELON, MD, PhD          Sub-Investigator: Lionel BADET, MD, PhD          Sub-Investigator: Fanny BURON, MD          University Hospital of Montpellier Recruiting Montpellier, France, 34000 Contact: Anne WOJTUSCISZYN, MD, PhD    +33 4 67 33 83 86    a-wojtusciszyn@chu-montpellier.fr    Principal Investigator: Anne WOJTUSCISZYN, MD, PhD          Sub-Investigator: Eric RENARD, MD, PhD          University hospital of Nancy Not yet recruiting Nancy, France, 54511 Contact: Sophie GIRERD, MD, PhD    +33 3.83.15.31.69    s.girerd@chu-nancy.fr    Principal Investigator: Luc FRIMAT, MD, PhD          Sub-Investigator: Sophie GIRERD, MD, PhD          Sub-Investigator: Bruno GUERCI, MD, PhD          university hospital of Nantes Recruiting Nantes, France, 44093 Contact: Lucy CHAILLOUS, MD, PhD    +33 2 53 48 27 01    lucy.chaillous@chu-nantes.fr    Principal Investigator: Lucy CHAILLOUS, MD, PhD          Sub-Investigator: Diego CANTAROVICH, MD, PhD          APHP Recruiting Paris, France, 75010 Contact: Jean-Pierre RIVELINE, MD, PhD    +33 1 49 95 83 79    jeanpierre.riveline@lrb.aphp.fr    Contact: Nahima Geblaoui    +33 1 49 95 87 04    nahima.gueblaoui@aphp.fr    Principal Investigator: Jean-Pierre RIVELINE, MD, PhD          Sub-Investigator: Pierre CATTAN, MD, PhD          Sub-Investigator: Marie-Noelle PERALDI, MD, PhD          Sub-Investigator: Antoine DURRBACH, MD, PhD          University hospital of Strasbourg Recruiting Strasbourg, France, 67000 Contact: Laurence KESSLER, MD, PhD    +33 3 88 11 62 67    laurence.kessler@chru-strasbourg.fr    Principal Investigator: Laurence KESSLER, MD, PhD          Switzerland University Hospital of Geneva Active, not recruiting Geneva, Switzerland, CH-1211 Less <<
NCT01850615 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT01850615 - Completed - -
NCT01808690 Type 1 Diabetes Phase 3 Completed - United States, Colorado ... More >> Children's Hospital Colorado and University of Colorado Denver Health Sciences Center Aurora, Colorado, United States, 80045 Less <<
NCT01774084 - Completed - -
NCT01774084 Insulin Sensitivity Phase 4 Completed - Sweden ... More >> Södersjukhuset AB Stockholm, Sweden, 116 48 Södertälje hospital Södertälje, Sweden, 15286 Less <<
NCT03022721 - Recruiting September 2028 Germany ... More >> Department of Medicine, University of Heidelberg Recruiting Heidelberg, Germany, 69120 Contact: Stefan Kopf, MD    +49-6221- ext 37790    stefan.kopf@med.uni-heidelberg.de    Contact: Jan B Groener, MD    +49-6221- ext 37639    jan.groener@med.uni-heidelberg.de    Principal Investigator: Stefan Kopf, MD          Sub-Investigator: Jan B Groener, MD          Sub-Investigator: Peter P Nawroth, Prof. Less <<
NCT00612794 Type 2 Diabetes Phase 1 Completed - Japan ... More >> Research Site Fukuoka, Japan Research Site Kanagawa, Japan Research Site Osaka, Japan Research Site Tokyo, Japan Less <<
NCT03042936 Pre Diabetes Not Applicable Active, not recruiting December 2020 -
NCT01123083 - Completed - -
NCT00735683 Obesity Phase 2 Withdrawn April 2009 -
NCT01169090 Type 2 Diabetes Phase 2 Completed - -
NCT01123083 Diabetes Mellitus, Type 1 Phase 3 Completed - Italy ... More >> GSK Investigational Site Roma, Italy, 00155 Less <<
NCT01439217 - Completed - United States, Maryland ... More >> Johns Hopkins Hospital Baltimore, Maryland, United States, 21287 Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States, 21287 Less <<
NCT00538486 Hypertension ... More >>Obesity Less << Phase 4 Completed - China ... More >> The third hospital affiliated to the Third Military Medical University Chongqing, China, 400042 Less <<
NCT01357642 Asthma Phase 3 Completed - -
NCT01606007 - Completed - -
NCT02173756 Cancer Phase 3 Unknown June 2016 France ... More >> Service d'oncohématologie pédiatrique, Hôpital de Hautepierre Strasbourg, Alsace, France, 67098 Less <<
NCT01606007 Type 2 Diabetes Phase 3 Completed - -
NCT02980978 Diabetes Mellitus, Type 2 Not Applicable Enrolling by invitation December 2020 -
NCT00532935 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT01306994 - Not yet recruiting December 2022 United States, West Virginia ... More >> Freeman-Sheldon Research Group, Inc. Headquarters Not yet recruiting Buckhannon, West Virginia, United States, 26201 Contact: Mikaela I Poling, BA    304-460-9038    poling_mi@fsrgroup.org    Sub-Investigator: Mikaela I Poling, BA Less <<
NCT00532935 - Completed - -
NCT01761994 Acute Kidney Injury Phase 4 Completed - Korea, Republic of ... More >> Severance Hospital Seoul, Korea, Republic of, 120-752 Less <<
NCT02435329 - Unknown March 2016 United Kingdom ... More >> Tameside Hospital NHS Foundation Trust Recruiting Lancashire, United Kingdom, OL6 9RW Contact: Edward Jude, MD    01619223000 ext 6445    edward.jude@tgh.nhs.uk    Principal Investigator: Edward Jude, MD          Sub-Investigator: Janice Mascarenhas Less <<
NCT00309244 Diabetes Type 2 Phase 3 Completed - -
NCT00474227 Obesity Not Applicable Completed - Israel ... More >> Lev Hasharon Mental Health Center Netanya, Israel, 42100 Less <<
NCT00309244 - Completed - -
NCT03437226 Heart Failure Phase 3 Recruiting December 31, 2019 Austria ... More >> Medical University Innsbruck Recruiting Innsbruck, Tirol, Austria, 6020 Contact: Kathrin Becker, PhD    +43512900371 ext 844    leodor@i-med.ac.at    Contact: Sabine Embache-Aichhorn    +43512900370 ext 086    leodor@i-med.ac.at Less <<
NCT01714011 Schizophrenia Phase 4 Completed - Malaysia ... More >> University Malaya Medical Centre Kuala Lumpur, Malaysia, 59100 Less <<
NCT03345004 Diabetes Mellitus, Type 1 ... More >> Diabetes Mellitus Autoimmune Diseases Metabolic Disease Glucose Metabolism Disorders Immune System Diseases Endocrine System Diseases Juvenile Diabetes Insulin Dependent Diabetes Autoimmune Diabetes Vitamin D Physiological Effects of Drugs Less << Phase 2 Recruiting August 2020 Czechia ... More >> Diabetes Centre, Institute of Clinical and Experimental Medicine Recruiting Praha, Czechia, 14021 Department of Paediatrics, University Hospital Motol Recruiting Praha, Czechia, 15006 Spain Adult and Pediatrics Endocrinology and Diabetology, Hospital Universitario Cruces Recruiting Barakaldo, Spain, 48903 Adult Endocrinology and Diabetology, Hospital vall D' Hebrón Recruiting Barcelona, Spain, 08035 Pediatrics Endocrinology and Diabetology, Hospital Vall D'Hebrón Recruiting Barcelona, Spain, 08035 Adult Endocrinology and Diabetology, Hospital Ramón y Cajal Recruiting Madrid, Spain, 28033 Pediatrics Endocrinology and Diabetology, Hospital Ramón y Cajal Recruiting Madrid, Spain, 28033 Adult Endocrinology and Diabetology, Hospital Carlos Haya Recruiting Málaga, Spain, 29009 Pediatrics Endocrinology and Diabetology, Hospital Materno-Ifantil Recruiting Málaga, Spain, 29011 Adult Endocrinology and Diabetology, Hospital Macarena Recruiting Sevilla, Spain, 41009 Pediatrics Endocrinology and Diabetology, Hospital Virgen del Rocío Recruiting Sevilla, Spain, 41013 Adult and Pediatrics Endocrinology and Diabetology, Hospital Miguel Servet Recruiting Zaragoza, Spain, 50009 Sweden Barn- och Ungdomskliniken, Universitetssjukhuset Recruiting Linköping, Sweden, 58185 Endokrinmedicinska kliniken. Universitetssjukhuset Recruiting Linköping, Sweden, 58185 Barn-och Ungdomsmedicinmottagningen and Endokrinmottagningen, Skånes Universitetssjukhus Recruiting Malmö, Sweden, 20502 Barn- och ungdomskliniken, Uddevalla Sjukhus Recruiting Uddevalla, Sweden, 45180 Diabetesmottagningen, Uddevalla Sjukhus Recruiting Uddevalla, Sweden, 45180 Barnmottagningen, Norrlands Universitetssjukhus Recruiting Umeå, Sweden, 901 85 Less <<
NCT00542204 Diabetes Mellitus Not Applicable Completed - United States, California ... More >> PAMF Palo Alto Health Care Division Fremont, California, United States, 94538 PAMF Palo Alto Health Care Division Los Altos, California, United States, 94022 PAMF Camino Region Mountain View, California, United States, 94040 PAMF Palo Alto Health Care Division Palo Alto, California, United States, 94301 PAMF Palo Alto Health Care Division Redwood City, California, United States, 94063 PAMF Santa Cruz Medical Clinic Santa Cruz, California, United States, 95062 Less <<
NCT01638104 Healthy Volunteers Phase 1 Completed - United States, Nebraska ... More >> Celerion Lincoln, Nebraska, United States, 68502 Less <<
NCT02506946 - Recruiting July 2020 United States, New York ... More >> Columbia University Medical Center Recruiting New York, New York, United States, 10032 Contact: Hailey Roumimper, AB    212-305-1518    hr2388@cumc.columbia.edu    Contact: Aviva B Sopher, MD, MS, MS    212-305-9362    ahs32@cumc.columbia.edu    Principal Investigator: Aviva B Sopher, MD, MS, MS          Sub-Investigator: Sharon E Oberfield, MD          Sub-Investigator: Ilene Fennoy, MD, MPH          Sub-Investigator: Abeer Hassoun, MD          Sub-Investigator: Jodi Lerner, MD          Sub-Investigator: Camila Pereira-Eshargi, MD Less <<
NCT01964833 Periodontitis ... More >> Diabetes Mellitus Type 2 Less << Not Applicable Completed - Brazil ... More >> Universidade Nove de Julho São Paulo, SP, Brazil, 01504015 Less <<
NCT00239148 Type 1 Diabetes Phase 1 Completed - United States, Alabama ... More >> Pinnacle Research Group Anniston, Alabama, United States, 36207 United States, California Diablo Clinical Research Walnut Creek, California, United States, 94598 United States, New York Diabetes - Endocrinology Center of West New York Buffalo, New York, United States, 14209 United States, North Carolina Highgate Specialty Center Durham, North Carolina, United States, 27713 United States, Texas Diabetes and Glandular Disease Research Associates San Antonio, Texas, United States, 78229-4801 Less <<
NCT03730909 Type1diabetes ... More >> Hypoglycemia Unawareness Less << Not Applicable Recruiting June 11, 2019 Netherlands ... More >> Radoud university medical center Recruiting Nijmegen, Netherlands Contact: Bastiaan de Galan, PhD Less <<
NCT03169205 - Enrolling by invitation May 1, 2019 Egypt ... More >> Faculty of Medicine Beni-suef, Egypt Beni-suef, Egypt Less <<
NCT03161457 Rheumatoid Arthritis ... More >> Arthritis, Rheumatoid Less << Phase 1 Recruiting December 30, 2018 -
NCT02044861 Cancer Phase 1 Unknown - United States, District of Col... More >>umbia Lombardi Comprehensive Cancer Center, Georgetown University Recruiting Washington, District of Columbia, United States, 20007 Contact: Paula R Pohlmann, MD, PhD    202-444-4655    Paula.R.Pohlmann@gunet.georgetown.edu    Principal Investigator: Paula R Pohlmann, MD PhD          United States, Kentucky James Graham Brown Cancer Center Recruiting Louisville, Kentucky, United States, 40202 Contact: Rebecca Redman, MD    502-562-4673    rebecca.redman@louisville.edu    Principal Investigator: Rebecca Redman, MD          United States, Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77230 Contact: Siqing Fu, MD PhD    713-742-4318    siqingfu@mdanderson.org    Contact: Jing Gong, RN    713-563-8392    jinggong@mdanderson.org    UT Health Science Center at San Antonio Recruiting San Antonio, Texas, United States, 78229 Contact: Devalingam Mahalingam, MD PhD    210-450-5970    Mahalingam@uthscsa.edu    Contact: Patricia O'Rourke, RN    210-450-5976    ORourkeP@uthscsa.edu Less <<
NCT02098733 - Completed - -
NCT01579097 Nutrition Support Phase 3 Completed - China ... More >> Shanghai No. 6 Hospital Shanghai, China Less <<
NCT02098733 - Completed - -
NCT01414803 Hyperlipidemia Phase 4 Completed - Korea, Republic of ... More >> Severance Hospital Seoul, Korea, Republic of, 120-752 Less <<
NCT01346085 - Completed - -
NCT02146339 Cardiometabolic Risk Not Applicable Completed - France ... More >> Centre de recherche en Nutrition Humaine-Auvergne -Unité d'Exploration Nutritionnelle Clermont-ferrand, France, 63000 Centre de Recherche en Nutrition Humaine Rhône-Alpes Lyon, France Less <<
NCT00885638 Healthy Type ... More >>2 Diabetes Less << Phase 4 Completed - Sweden ... More >> Department of Clinical Sciences Lund, Lund University Lund, Sweden, 221 84 Less <<
NCT01605279 Hemodynamic Instability Phase 2 Completed - Spain ... More >> La Paz University Hospital Madrid, Spain, 28046 Less <<
NCT03057444 Diabetes Mellitus, Type 2 ... More >> Pre Diabetes Less << Not Applicable Completed - Germany ... More >> Institute of Clinical Nutrition Stuttgart, Baden-Württemberg, Germany, 70599 Less <<
NCT01829256 Diabetes Hype... More >>rtension Diabetic Kidney Disease Less << Not Applicable Active, not recruiting December 2018 United States, North Carolina ... More >> Duke University Health System Clinics Durham, North Carolina, United States, 27705 Less <<
NCT00885638 - Completed - -
NCT02155582 Non Hodgkin Lymphoma Phase 1 Completed - Belgium ... More >> Bruxelles - Brussel, Belgium, 1000 Bruxelles - Brussel, Belgium, 1200 Gent, Belgium, 9000 France Caen Cedex 5, France, 14076 Lille, France, 59037 Nice Cedex 2, France, 06102 Pierre Benite, France, 69495 United Kingdom Sutton, Surrey, United Kingdom, SM2 5PT London, United Kingdom, W1G 6AD Less <<
NCT00313430 - Completed - Denmark ... More >> Department of Medicine, Holstebro Hospital Holstebro, Ringkjoebing, Denmark, 7500 Less <<
NCT02775747 Previous Incision ... More >> Scar; Previous Cesarean Section Less << Phase 1 Phase 2 Completed - Egypt ... More >> Rasha Cairo, Al Qahirah, Egypt, 002 Less <<
NCT01346085 Type 1 Diabetes Phase 1 Phase 2 Completed - Italy ... More >> IRCCS San Raffaele Scientific Institute Milan, Italy, 20132 Switzerland Universitè de Geneve Geneve, Switzerland, 1211 Less <<
NCT00566813 Diabetes Mellitus, Type 1 Phase 1 Phase 2 Completed - United States, Illinois ... More >> University of Illinois at Chicago Chicago, Illinois, United States, 60612 Less <<
NCT01395290 Infection Phase 3 Completed - Norway ... More >> University Hospital of North Norway Tromsø, Norway, 9038 Less <<
NCT02705248 - Completed - -
NCT00374907 Type 2 Diabetes Phase 3 Completed - United States, California ... More >> Va San Diego Healthcare System San Diego, California, United States, 92161 United States, Louisiana Pennington Biomedical Research Center Baton Rouge, Louisiana, United States, 70808 United States, Texas Diabetes & Glandular Disease Research Assoc,, Inc. San Antonio, Texas, United States, 78229 Less <<
NCT00374907 - Completed - -
NCT03552562 Retinal Blood Flow Not Applicable Not yet recruiting July 1, 2019 -
NCT02909881 Hypoglycemia Not Applicable Unknown September 2017 Canada, Ontario ... More >> Exercise Nutrition Research Laboratory, Western University London, Ontario, Canada, N6A 3K7 Less <<
NCT00184691 Foetal Growth Problem ... More >> Small for Gestational Age Less << Phase 3 Completed - Spain ... More >> Novo Nordisk Investigational Site Baracaldo, Spain, 48903 Novo Nordisk Investigational Site Barcelona, Spain, 08035 Novo Nordisk Investigational Site Cádiz, Spain, 11009 Novo Nordisk Investigational Site Córdoba, Spain, 14004 Novo Nordisk Investigational Site El Palmar, Spain, 30120 Novo Nordisk Investigational Site Esplugues Llobregat, Spain, 08950 Novo Nordisk Investigational Site Granada, Spain, 18012 Novo Nordisk Investigational Site Madrid, Spain, 28009 Novo Nordisk Investigational Site Madrid, Spain, 28046 Novo Nordisk Investigational Site Málaga, Spain, 29011 Novo Nordisk Investigational Site Santa Cruz de Tenerife, Spain, 38010 Novo Nordisk Investigational Site Santiago de Compostela, Spain, 15705 Novo Nordisk Investigational Site Sevilla, Spain, 41013 Less <<
NCT00566813 - Completed - -
NCT02214017 - Completed - -
NCT01328210 Metabolic Syndrome Phase 1 Phase 2 Completed - Germany ... More >> Kliniken Essen-Mitte, University Duisburg-Essen Essen, North-Rhine Westfalia, Germany, 45130 Less <<
NCT02214017 Type 2 Diabetes Mellitus Not Applicable Completed - Denmark ... More >> Endrinology Dept, Kolding Hospital Kolding, Denmark, 6000 Less <<
NCT02491801 Type 2 Diabetes Mellitus ... More >> Obesity Less << Not Applicable Completed - Canada, Ontario ... More >> Department of Nutritional Sciences, FitzGerald Building Toronto, Ontario, Canada, M5S 3E2 Less <<
NCT01672255 Type 1 Diabetes ... More >> Hypoglycemia Associated Autonomic Failure Less << Early Phase 1 Recruiting December 2018 United States, Maryland ... More >> University of Maryland, Baltimore Recruiting Baltimore, Maryland, United States, 21201 Contact: Donna Tate    410-706-5643       Principal Investigator: Stephen N. Davis, MBBS Less <<
NCT00386100 Diabetes Mellitus, Type 2 Phase 4 Completed - -
NCT01690091 Insulin Resistance ... More >> Chronic Heart Failure Less << Phase 2 Phase 3 Completed - Czechia ... More >> Diabetes Center, Institute of Clinical and Experimental Medicine Prague, Czechia Less <<
NCT02841553 - Recruiting December 2020 United States, Missouri ... More >> Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: Fumihiko Urano, MD    314-362-8683       Contact: Cris Brown, BS    +1-314-362-8684    crisbrown@wustl.edu    Principal Investigator: Fumihiko Urano, MD Less <<
NCT01470066 - Unknown May 2012 Korea, Republic of ... More >> Chonnam National University Hwasun Hospital Recruiting Hwasun-gun, Jeollanam-do, Korea, Republic of, 519-809 Contact: So-Young Lee, Nurse    82-61-379-7628    kaosin@naver.com    Principal Investigator: Deok-Hwan Yang, M.D.,Ph.D. Less <<
NCT02334137 - Completed - -
NCT00386100 - Completed - -
NCT00334919 Diabetes Mellitus, Type 2 ... More >> Prediabetes Less << Phase 2 Completed - United States, Oregon ... More >> Oregon Health & Science University General Clinical Research Center Portland, Oregon, United States, 97239 Less <<
NCT00508287 Type 2 Diabetes Phase 1 Completed - United States, Florida ... More >> Elite Research Institute Miami, Florida, United States, 33169 Orlando Clinical Research Center Orlando, Florida, United States, 32809 United States, Tennessee New Orleans Center For Clinical Research Knoxville, Tennessee, United States, 37920 Less <<
NCT00207233 Obesity Type ... More >>2 Diabetes Mellitus Less << Phase 1 Phase 2 Completed - United States, Massachusetts ... More >> Boston University Medical Center Boston, Massachusetts, United States, 02118 Less <<
NCT00525629 Metabolic Syndrome ... More >> Type 2 Diabetes Cardiovascular Disease Less << Not Applicable Completed - United States, Massachusetts ... More >> Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Less <<
NCT01357096 Acute Myocardial Infarction ... More >> Stable Angina Less << Not Applicable Unknown - Taiwan ... More >> Kaohsiung Medical University Hospital Recruiting Kaohsiung, Taiwan, 807 Contact: Tsung-Hsien Lin, MD, PHD    88673121101 ext 7741    lth@kmu.edu.tw    Principal Investigator: Sheng-Hsiung Sheu, MD Less <<
NCT00525629 - Completed - -
NCT02666924 Diabetes Mellitus Type 2 Not Applicable Recruiting July 1, 2018 Canada, British Columbia ... More >> Richmond Diabetes Education Center Recruiting Richmond, British Columbia, Canada, V6X 1A2 Contact: Natalie Choi, RD    604-244-5163    natalie.choy@vch.ca    Contact: David E Harris, MD    778-995-5414    deharrismd@gmail.com Less <<
NCT01043445 Type 2 Diabetes Not Applicable Completed - Denmark ... More >> Department of Clinical Physiology, Glostrup Hospital Glostrup, Denmark, 2600 Less <<
NCT00965783 Apnea Obstruc... More >>tive Sleep Apnea (OSA) Obesity Less << Not Applicable Completed - United States, Illinois ... More >> The University of Chicago Chicago, Illinois, United States, 60637 Less <<
NCT00859989 Breast Cancer ... More >> Obesity Weight Changes Less << Phase 3 Unknown - United States, Illinois ... More >> University of Illinois Cancer Center Chicago, Illinois, United States, 60612-7243 Less <<
NCT00436644 - Completed - -
NCT03035981 Appetitive Behavior Not Applicable Completed - -
NCT01827605 Relapsed Follicular Lymphoma Phase 3 Recruiting April 2019 -
NCT01067118 Diabetes Mellitus Phase 2 Withdrawn(The study was suspen... More >>ded due to lack of study drug) Less << June 2011 United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 United States, Colorado University of Colorado Denver School of Medicine Barbara Davis Center Denver, Colorado, United States, 80045 Less <<
NCT01674946 Echolocation Phase 1 Completed - Switzerland ... More >> University Hospital Basel, Phase 1 Research Unit Basel, Switzerland, 4031 Less <<
NCT00436644 Ovarian Cancer ... More >> Peritoneal Cavity Cancer Less << Phase 2 Completed - United States, Arizona ... More >> Mayo Clinic Arizona Scottsdale, Arizona, United States, 85254 United States, Florida Mayo Clinic in Jacksonville Jacksonville, Florida, United States, 32224 United States, Minnesota Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 Less <<
NCT03308812 Cardiovascular Diseases Not Applicable Recruiting September 30, 2020 United States, Georgia ... More >> Grady Health System Recruiting Atlanta, Georgia, United States, 30303 Contact: Arshed Quyyumi, MD    404-712-2741    aquyyum@emory.edu    Morehouse School of Medicine, Clinical Research Center Recruiting Atlanta, Georgia, United States, 30310 Contact: Arshed Quyyumi, MD    404-712-2741    aquyyum@emory.edu    Emory University Clinical Research Network Recruiting Atlanta, Georgia, United States, 30322 Contact: Arshed Quyyumi, MD    404-712-2741    aquyyum@emory.edu Less <<
NCT02503943 Type 2 Diabetes ... More >> Overweight Obesity Masked Hypertension Less << Phase 4 Unknown September 2016 -
NCT00507520 Hyperlipidemia ... More >> Diet Therapy Cardiovascular Disease Less << Phase 2 Completed - Canada, Ontario ... More >> St. Michael's Hospital Toronto, Ontario, Canada, M5S 2T2 Less <<
NCT00744237 Hypertension ... More >>Type 2 Diabetes Mellitus Less << Phase 4 Completed - -
NCT02769520 Squamous Cell Carcinoma of the... More >> Head and Neck Less << Phase 2 Recruiting June 2020 United States, California ... More >> UCSD Moores Cancer Center Recruiting La Jolla, California, United States, 92093 University of California San Francisco Not yet recruiting San Francisco, California, United States, 94115 Contact: Alain Algazi, MD          University of California Los Angeles Not yet recruiting Torrance, California, United States, 90505 Contact: Deborah Wong, MD    310-325-8252    dewong@mednet.ucla.edu Less <<
NCT00505427 Insulin Resistance ... More >> Oxidative Stress Less << Phase 1 Completed - United States, California ... More >> University of California at San Francisco San Francisco, California, United States, 94143 Less <<
NCT00637338 Diabetes Mellitus, Type 2 Phase 1 Terminated(See termination rea... More >>son in detailed description.) Less << - United States, Arizona ... More >> Pfizer Investigational Site Phoenix, Arizona, United States, 85013 United States, Florida Pfizer Investigational Site Miami, Florida, United States, 33169 United States, Kansas Pfizer Investigational Site Wichita, Kansas, United States, 67214 United States, Oregon Pfizer Investigational Site Portland, Oregon, United States, 97239 Less <<
NCT02930031 Skeletal Muscle Damage ... More >> Aseptic Inflammation Skeletal Muscle Function Less << Not Applicable Completed - Greece ... More >> University of Athens, Medical School, Department of Clinical Therapeutics Athens, Greece, 11527 Less <<
NCT00744237 - Completed - -
NCT02434094 - Completed - United States, Virginia ... More >> University of Virginia Center for Diabetes Technology Charlottesville, Virginia, United States, 22903 Less <<
NCT03211767 Hypertension Not Applicable Completed - Canada, Manitoba ... More >> Richardson Centre for Functional Foods and Nutraceuticals Winnipeg, Manitoba, Canada, R3T 6C5 Less <<
NCT02777853 Insulin Resistance Not Applicable Completed - United Kingdom ... More >> Research Institute for Sport and Exercise Sciences (RISES), Liverpool John Moores University Liverpool, United Kingdom, L3 3AF Less <<
NCT02266433 DeQuervains Tenosynovitis ... More >> Lateral Epicondylitis Tennis Elbow Trigger Finger Tenosynovitis Inflammatory Disease Less << Phase 3 Recruiting December 2018 United States, New York ... More >> New York University School of Medicine Recruiting New York, New York, United States, 10016 Contact: Marina Godina       godinm01@nyumc.org    Contact: Cara-Lee Fontaine       cara-lee.fontaine@nyumc.org    Principal Investigator: Anthony Sapienza, MD          Sub-Investigator: Kenneth Brock, BS          Sub-Investigator: Sergio Glait, MD Less <<
NCT01255085 Obesity Type ... More >>II Diabetes Mellitus Metabolic Syndrome Less << Not Applicable Completed - Canada, Ontario ... More >> University of Toronto - Department of Nutritional Sciences Toronto, Ontario, Canada, M5S 3E2 Less <<
NCT00304694 - Unknown - Taiwan ... More >> National Taiwan University Hospital Recruiting Taipei, Taiwan, 10012 Principal Investigator: Ruoh-Fang Yen, MD, PhD Less <<
NCT01461330 Blood Pressure Not Applicable Terminated - Brazil ... More >> Hospital de Clínicas de Porto Alegre Porto Alegre, Rio Grande do Sul, Brazil Less <<
NCT01982604 Healthy Volunteers Phase 1 Completed - United States, California ... More >> Chula Vista, California, United States, 91911 Less <<
NCT02145247 Polycystic Ovary Syndrome Not Applicable Completed - United States, California ... More >> University of California, San Diego La Jolla, California, United States, 92037 Less <<
NCT01132703 Traumatic Brain Injury ... More >> Stroke Less << Phase 1 Completed - United States, Michigan ... More >> Jasper Clinic Kalamazoo, Michigan, United States, 49007 Less <<
NCT00435240 Diabetes Mellitus, Type 2 Phase 2 Completed - Sweden ... More >> Lund University Hospital Lund, Skåne, Sweden, 22185 Less <<
NCT02750774 Maternal Obesity Complicating ... More >>Pregnancy, Birth,or Puerperium Gestational Diabetes Mellitus Birthweight Large for Gestational Age (LGA) Caloric Restriction Lifestyle Intervention Less << Not Applicable Unknown December 2016 Italy ... More >> Mother-Infant Department, University of Modena and Reggio Emilia, Italy Recruiting Modena, Italy, 41124 Contact: Fabio Fachhinetti, MD    0039 0594222512    facchi@unimore.it    Sub-Investigator: Elisabetta Petrella, MD          Sub-Investigator: Valentina Bertarini, PhD Less <<
NCT01541592 Insulin Resistance Not Applicable Completed - United States, Minnesota ... More >> Mayo Clinic in Rochester Rochester, Minnesota, United States, 55905 Less <<
NCT03042741 Atherosclerosis Phase 3 Recruiting December 18, 2018 Mongolia ... More >> Immunitor LLC Recruiting Ulaanbaatar, CA, Mongolia, 13838 Contact: aldar bourinbaiar    3014760930    aldar@immunitor.com Less <<
NCT01472341 - Completed - -
NCT03398590 Type2 Diabetes ... More >> Obesity Less << Not Applicable Completed - United States, Massachusetts ... More >> Joslin Diabetes Center Boston, Massachusetts, United States, 02215 Less <<
NCT01472341 - Completed - -
NCT02273050 Type 2 Diabetes Mellitus Phase 3 Completed - China ... More >> Research Site Beijing, China Research Site Changchun, China Research Site Chuangchun, China Research Site Fuzhou, China Research Site Guiyang, China Research Site Ha'er bin, China Research Site Hangzhou, China Research Site Hefei, China Research Site Jinan, China Research Site Nanchang, China Research Site Nanjing, China Research Site Shanghai, China Research Site Shijiazhuang, China Research Site Siping, China Research Site Tianjin, China Research Site Wuxi, China Research Site Yueyang, China Less <<
NCT01754142 - Completed - Korea, Republic of ... More >> Research Site Seoul, Korea, Republic of Less <<
NCT03019653 Heart Failure ... More >> Cardiorenal Disease Renal Disfunction Less << Phase 1 Enrolling by invitation July 2023 United States, Minnesota ... More >> Mayo Clinic in Rochester Rochester, Minnesota, United States, 55905 Less <<
NCT02273050 - Completed - -
NCT02488785 Type 2 Diabetes Mellitus Not Applicable Completed - United States, Texas ... More >> Doctors Hospital at Renaissance Edinburg, Texas, United States, 78539 Less <<
NCT00109174 Healthy Not Applicable Recruiting April 23, 2019 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)    800-411-1222 ext TTY8664111010    prpl@cc.nih.gov Less <<
NCT01185171 Head and Neck Cancer Phase 2 Active, not recruiting August 2018 United States, Illinois ... More >> The University of Chicago Medical Center Chicago, Illinois, United States, 60653 Less <<
NCT03221452 Cognitive Function Abnormal ... More >> Diabetes Mellitus, Type 2 Less << Not Applicable Active, not recruiting October 2017 -
NCT01991197 Psoriasis Typ... More >>e 2 Diabetes Mellitus Less << Phase 2 Completed - Ireland ... More >> The Adelaide and Meath Hospital Dublin 24, Ireland UCD Clinical Research Centre, St Vincent's University Hospital, Dublin 4, Ireland Less <<
NCT03205904 Cystic Fibrosis-related Diabet... More >>es Cystic Fibrosis Less << Not Applicable Recruiting March 13, 2020 Brazil ... More >> Ticiana da Costa Rodrigues Recruiting Porto Alegre, Rio Grande Do Sul, Brazil, 90035-903 Contact: Raquel E Prates Freiberg, Student    5551984080375    raqueccel@gmail.com Less <<
NCT01708694 Prediabetes Not Applicable Completed - United States, Louisiana ... More >> Pennington Biomedical Research Center Baton Rouge, Louisiana, United States, 70808 Less <<
NCT02112656 Hepatocellular Carcinoma Phase 3 Completed - -
NCT02220920 Type 2 Diabetes Mellitus Phase 4 Completed - Japan ... More >> Reserch site Chubu, Japan Reserch site Chugoku, Japan Reserch site Hokkaido, Japan Reserch site Kanto, Japan Reserch site Kinki, Japan Reserch site Kyushu, Japan Reserch site Tohoku, Japan Less <<
NCT01072370 Cerebral Palsy Phase 1 Phase 2 Recruiting July 2019 United States, Georgia ... More >> Augusta University Recruiting Augusta, Georgia, United States, 30912 Contact: James E Carroll, M.D.    706-721-3371    jcarroll@augusta.edu    Principal Investigator: James E Carroll, M.D.          Sub-Investigator: Elizabeth Sekul, M.D.          Sub-Investigator: Roni Bollag, M.D., Ph.D.          Sub-Investigator: Afshin Ameri, MD          Sub-Investigator: Theodore Johnson, MD, PhD          Sub-Investigator: Colleen McDonough, MD Less <<
NCT01317264 Healthy Not Applicable Completed - Denmark ... More >> University of Copenhagen Copenhagen, Denmark, 1165 Less <<
NCT01728740 Diabetes Mellitus, Type II Phase 1 Completed - Korea, Republic of ... More >> Seoul, Korea, Republic of, 110-744 Less <<
NCT01926925 - Completed - -
NCT02220920 - Completed - -
NCT00505375 Type 1 Diabetes Mellitus Phase 2 Completed - United States, California ... More >> Childrens Hospital Los Angeles Los Angeles, California, United States, 90027 University of California - San Francisco San Francisco, California, United States, 94143 Stanford University Stanford, California, United States, 94305 United States, Colorado The Barbara Davis Center for Childhood Diabetes Aurora, Colorado, United States, 80045 United States, Florida University of Florida Gainesville, Florida, United States, 32610-0296 University of Miami Miami, Florida, United States, 33136 United States, Massachusetts Joslin Diabetes Center Boston, Massachusetts, United States, 02215 United States, Minnesota University of Minnesota Minneapolis, Minnesota, United States, 55455 United States, New York Columbia University, Naomi Berrie Diabetes Center New York, New York, United States, 10032 United States, Pennsylvania University of Pittsburgh, Children's Hospital of Pittsburgh Pittsburgh, Pennsylvania, United States, 15213 United States, Texas University of Texas, Southwestern Medical School Dallas, Texas, United States, 75235-8858 United States, Washington Benaroya Research Institute Seattle, Washington, United States, 98101 Canada, Ontario The Hospital for Sick Children Toronto, Ontario, Canada, M5G-1X8 Less <<
NCT00505375 - Completed - -
NCT03181737 Diabetes Mellitus Type 2 Not Applicable Recruiting April 1, 2019 Germany ... More >> Department of Psychology, Philipps University Marburg Recruiting Marburg, Hessen, Germany, 35032 Contact: Winfried Rief, Prof. Dr.    +49-6421-28 23657    rief@staff.uni-marburg.de Less <<
NCT02563847 Endocrine System Diseases Not Applicable Completed - Switzerland ... More >> University Hospital Basel, Phase 1 Research Unit Basel, Switzerland Less <<
NCT01376778 Congenital Cytomegalovirus Inf... More >>ection Maternal Cytomegalovirus Infection Less << Phase 3 Active, not recruiting December 2018 United States, Alabama ... More >> University of Alabama - Birmingham Birmingham, Alabama, United States, 35233 United States, California Stanford University Stanford, California, United States, 94305-5317 United States, Colorado University of Colorado Denver Aurora, Colorado, United States, 80045 United States, Illinois Northwestern University Chicago, Illinois, United States, 60611 United States, New York Columbia University New York, New York, United States, 10032 United States, North Carolina University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States, 27599 Duke University Durham, North Carolina, United States, 27710 United States, Ohio Case Western Reserve-Metrohealth Cleveland, Ohio, United States, 44109 Ohio State University Columbus, Ohio, United States, 43210 United States, Pennsylvania Hospital of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Magee Womens Hospital of UPMC Pittsburgh, Pennsylvania, United States, 15213 United States, Rhode Island Brown University Providence, Rhode Island, United States, 02905 United States, Texas University of Texas - Southwestern Medical Center Dallas, Texas, United States, 75235 University of Texas - Galveston Galveston, Texas, United States, 77555 University of Texas - Houston Houston, Texas, United States, 77030 United States, Utah University of Utah Medical Center Salt Lake City, Utah, United States, 84132 Less <<
NCT00271739 Diabetes Mellitus Not Applicable Completed - United States, New York ... More >> Columbia University New York, New York, United States, 10032 SUNY Upstate Medical University Syracuse, New York, United States, 13210 Less <<
NCT01913756 Blood Pressure ... More >> Metabolic Syndrome X Less << Not Applicable Completed - Norway ... More >> Norwegian University of Life Sciences Aas, Norway, 1432 Less <<
NCT02252952 Focus: Understanding the Obeso... More >>genic Potential of Sugars and Non-caloric Sweeteners Less << Not Applicable Unknown - United States, Florida ... More >> Rippe Lifestyle Institute Celebration, Florida, United States, 34747 Less <<
NCT02280993 Hodgkin Lymphoma ... More >> Refractory Relapse Less << Phase 1 Active, not recruiting May 2020 Denmark ... More >> Rigshospitalet Copenhagen, Denmark France Centre Hospitalier Universitaire Lille, France Hospices Civils de Lyon Lyon, France Centre Hospitalier et Universitaire Nantes, France Hôpital Saint Louis Paris, France Institut Gustave Roussy Paris, France Netherlands Academic Medical Center Amsterdam, Netherlands, 1105 AZ Free University Medical Center Amsterdam, Netherlands University Medical Center Groningen Groningen, Netherlands Erasmus Medical Center Rotterdam, Netherlands United Kingdom Cambridge University Hospitals NHS Foundation Trust | Addenbrooke's Hospital Cambridge, United Kingdom King's College Hospital NHS Foundation Trust London, United Kingdom Christie Hospital, Manchester Manchester, United Kingdom Less <<
NCT01537809 Vitamin D Deficiency Not Applicable Completed - United States, Massachusetts ... More >> Tufts University Boston, Massachusetts, United States, 02111 Less <<
NCT00787878 - Completed - Netherlands ... More >> Novo Nordisk Investigational Site Rotterdam, Netherlands, 3015 CN Less <<
NCT00489645 Type 1 Diabetes Not Applicable Completed - -
NCT00685022 Asthma Phase 2 Completed - United States, California ... More >> Encinitas, California, United States United States, Massachusetts N. Dartmouth, Massachusetts, United States United States, Missouri St. Louis, Missouri, United States Less <<
NCT02596373 Advanced Recurrent or Metastat... More >>ic Breast Cancer Less << Phase 2 Recruiting September 2018 China ... More >> Fudan University Cancer Hospital Recruiting Shanghai, China Contact: Xichun Hu, Ph.D    +8613816110335    xchu2009@hotmail.com    Principal Investigator: Xichun Hu, Ph.D Less <<
NCT02127125 Insulin Sensitivity Phase 2 Recruiting December 2019 United States, Texas ... More >> Audie L. Murphy VA Hospital, STVHCS Recruiting San Antonio, Texas, United States, 78229 Contact: Nicolas Musi, MD.    210-617-5300 ext 15197    Musi@uthscsa.edu    Contact: Lauri Che Kelly, RN    210-617-5300 ext 14731    sathavarodom@uthscsa.edu    Principal Investigator: Nicolas Musi, MD Less <<
NCT00801164 Diabetes Type 2 ... More >> Periodontitis Less << Phase 1 Completed - United States, Texas ... More >> The University of Texas Health Science Center at San Antonio, Dental School San Antonio, Texas, United States, 78229 Less <<
NCT00613288 Hypogonadism Not Applicable Completed - Denmark ... More >> Medical department M and Investigational Laboratories Aarhus C, Jutland, Denmark, 8000 Less <<
NCT00130845 Diabetic Retinopathy Phase 3 Completed - United States, New Jersey ... More >> Novartis East Hanover, New Jersey, United States, 07936 Less <<
NCT01206634 Knee Arthrosis Phase 4 Completed - -
NCT03630458 Obesity Diabe... More >>tes Mellitus, Type 2 Appetitive Behavior Less << Not Applicable Active, not recruiting September 20, 2018 United States, Indiana ... More >> Purdue University West Lafayette, Indiana, United States, 47907 Less <<
NCT02278757 Metabolic Syndrome X ... More >> Weight Loss Less << Not Applicable Completed - Mexico ... More >> Mexican National Institute of Public Health Cuernavaca,, Morelos, Mexico, 62100 Less <<
NCT01675310 Pregestational Obesity (BMI > ... More >>27kg/m2) History of Polycystic Ovary Syndrome Less << Phase 4 Completed - Mexico ... More >> National Institute of Perinatology Mexico, Mexico, 11000 Less <<
NCT00131144 Diabetic Retinopathy Phase 3 Completed - United States, New Jersey ... More >> Novartis East Hanover, New Jersey, United States, 07936 Less <<
NCT03635541 - Not yet recruiting August 2020 China, Beijing ... More >> Beijing Friendship Hospital, Capital Medical University Not yet recruiting Beijing, Beijing, China, 100050 Contact: Yiwen Shi, Docor    8601063138665    yiwenshi90@163.com    Principal Investigator: Hong You, Doctor Less <<
NCT02757638 Obesity Surge... More >>ry Less << Not Applicable Recruiting October 2019 United States, Texas ... More >> Texas A&M University-CTRAL Recruiting College Station, Texas, United States, 77843 Contact: Marielle Engelen, PhD    979-220-2282    mpkj.engelen@ctral.org    Contact: Agata Wierzchowska    979-583-5800    a.wierzchowska@ctral.org Less <<
NCT03069300 Alcoholic Hepatitis ... More >> Infection Less << Phase 3 Recruiting June 1, 2018 United Kingdom ... More >> St Mary's Hospital, Imperial College Recruiting London, United Kingdom, W2 1NY Contact: Nikhil Vergis, PhD Less <<
NCT03017703 Endothelial Dysfunction ... More >> Insulin Resistance Less << Not Applicable Recruiting November 2017 Denmark ... More >> Cardiovascular and Renal Research Recruiting Odense, Denmark, 5000 Contact: Stefan P Mortensen, DMSc       smortensen@health.sdu.dk Less <<
NCT03262597 Healthy Not Applicable Completed - United States, California ... More >> Sonoma State Univrsity Rohnert Park, California, United States, 94928 Less <<
NCT00118794 Malaria Phase 3 Completed - Gambia ... More >> Medical Research Council Laboratories Banjul, Gambia, POBOX273 Less <<
NCT03084003 Diet Intervention Not Applicable Completed - United States, California ... More >> University of California, Merced Merced, California, United States, 95343 Less <<
NCT02793531 Cancer Not Applicable Withdrawn(low enrollment poten... More >>tial in local community) Less << May 2019 United States, Texas ... More >> Texas A&M University-CTRAL College Station, Texas, United States, 77845-4253 Less <<
NCT00384384 End Stage Renal Disease Phase 2 Completed - Switzerland ... More >> Department of nephrology and hypertension, University hospital of berne Berne, Switzerland, 3010 Less <<
NCT00185705 Hypertension ... More >>Insulin Resistance Dyslipidemia Less << Not Applicable Unknown - United States, California ... More >> Stanford Medical Center Recruiting Stanford, California, United States, 94305-5401 Contact: Carolyn H Chi, MD    650-723-5791    cchi@stanford.edu    Principal Investigator: Carolyn H Chi, MD Less <<
NCT03140865 - Recruiting June 2021 United States, North Carolina ... More >> Wake Forest Baptist Health Recruiting Winston-Salem, North Carolina, United States, 27157 Contact: Hudaisa Fatima    336-716-6463 ext 5    hfatima@wakehealth.edu Less <<
NCT00718276 Healthy Phase 1 Completed - Switzerland ... More >> University Hospital Zurich, Centre on Aging and Mobility Zurich, ZH, Switzerland, 8091 Less <<
NCT03374215 - Recruiting December 31, 2020 United States, Maryland ... More >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)    800-411-1222 ext TTY8664111010    prpl@cc.nih.gov Less <<
NCT02181842 - Completed - -
NCT02076880 Severe Obesity ... More >> Type 2 Diabetes Less << Not Applicable Unknown November 2017 France ... More >> CHU Montpellier Recruiting Montpellier, France, 34295 Contact: GALTIER Florence       f-galtier@chu-montpellier.fr    Principal Investigator: GALTIER Florence, MD Less <<
NCT02780206 Obesity Very ... More >>Low Calorie Diet Less << Not Applicable Recruiting May 2020 United States, Texas ... More >> Texas A&M University-CTRAL Recruiting College Station, Texas, United States, 77843 Contact: Marielle Engelen    979-220-2282    mpkj.engelen@ctral.org    Contact: Agata McNew    9795835800    a.wierzchowska@ctral.org Less <<
NCT00813995 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT00813995 - Completed - -
NCT03658317 Diabetic Nephropathy Not Applicable Not yet recruiting September 2019 -
NCT00952198 Type 2 Diabetes Phase 1 Completed - United States, California ... More >> Profil Institute for Clinical Research Chula Vista, California, United States, 91911 United States, Texas Cetero San Antonio, Texas, United States, 78229 Less <<
NCT01897883 - Completed - -
NCT01083329 Obesity Phase 2 Completed - France ... More >> Centre d'Investigation Clinique, Purpan University Toulouse Hospital Toulouse, France, 31059 Less <<
NCT01215396 Psychological Phenomena: Centr... More >>al Fatigue Less << Phase 1 Completed - Canada, Ontario ... More >> McMaster University Hamilton, Ontario, Canada, L8S4K1 Less <<
NCT01846273 Age-related Macular Degenerati... More >>on Polypoidal Choroidal Vasculopathy PCV Less << Phase 4 Completed - -
NCT02353104 Blood Pressure Phase 2 Completed - -
NCT03314779 - Recruiting September 28, 2018 Denmark ... More >> Odense University Hospital Recruiting Odense, Denmark, 5000 Less <<
NCT03235804 Dietary Modification Not Applicable Not yet recruiting December 31, 2020 -
NCT02589769 Cardiovascular Disease ... More >> Dietary Modification Cardiovascular Risk Factors Less << Not Applicable Completed - Norway ... More >> Oslo Universitetssykehus, Ullevål Oslo, Norway, 0424 Less <<
NCT00493805 - Terminated(Slow Enrollment) - -
NCT01445951 Type 1 Diabetes Mellitus Phase 3 Completed - -
NCT00493805 Hepatitis C, Chronic ... More >> Insulin Resistance Less << Phase 4 Terminated(Slow Enrollment) - -
NCT00738504 - Completed - Brazil ... More >> Hospital Sao Domingos Sao Luis, MA, Brazil, 65000 Less <<
NCT02381964 Metabolic Processes Not Applicable Completed - United Kingdom ... More >> Brain performance and nutrition research centre, Northumbria university Newcastle upon Tyne, Tyne And Wear, United Kingdom, NE1 8ST Less <<
NCT00954577 - Unknown June 2012 United States, New York ... More >> Maimonides Medical Center Recruiting Brooklyn, New York, United States, 11219 Contact: Deborah DeSantis, Ph.D.    718-283-6814    ddesantis@maimonidesmed.org    Principal Investigator: Deborah DeSantis, Ph.D.          North Shore LIJ Schneider Children's Hospital Recruiting Manhasset, New York, United States, 11030 Contact: Phyllis Speiser, M.D.    718-470-3290    pspeiser@LIJ.edu    Principal Investigator: Phyllis Speiser, M.D.          Winthrop University Hospital Recruiting Mineola, New York, United States, 11501 Contact: Warren Rosenfeld, M.D.    516-663-2288    wrosenfeld@winthrop.org    Principal Investigator: Warren Rosenfeld, M.D.          Mt. Sinai Medical Center Recruiting New York, New York, United States, 10028 Contact: Robert Rapaport, MD    212-241-8487    robert.rapaport@msnyuhealth.org    Principal Investigator: Robert Rapaport, M.D.          Columbia University Medical Center/The New York Presbyterian Hospital Recruiting New York, New York, United States, 10032 Contact: Ilene Fennoy, M.D.. M.P.H.    212-851-5315    if1@columbia.edu    Principal Investigator: Ilene Fennoy, M.D., M.P.H. Less <<
NCT01429818 Endothelial Dysfunction ... More >> Diabetes Mellitus Less << Phase 4 Completed - Mexico ... More >> Unidad PET Ciclotrón. Facultad de Medicina. Universidad Nacional Autónoma de México Mexico city, Distrito Federal, Mexico, 04510 Less <<
NCT01445951 - Completed - -
NCT01326598 - Completed - -
NCT00762684 Diabetes Mellitus Phase 3 Terminated(Hepatic safety sign... More >>al identified.) Less << - -
NCT02304718 Gestational Diabetes Mellitus Not Applicable Completed - China, Beijing ... More >> Peking University First Hospital Beijing, Beijing, China, 100034 Less <<
NCT03728868 Healthy Individuals Not Applicable Recruiting October 1, 2019 Sweden ... More >> Geriatric Medicine, Sahlgrenska University Hospital, Mölndal Recruiting Gothenburg, Västra Götaland, Sweden, 43180 Contact: Maria Falkdal, Nurse    +4631 34 310 67    maria.falkdal@gu.se    Contact: Linda Jonsson, Nurse Less <<
NCT02237378 Pulmonary Hypertension Not Applicable Terminated(Poor enrolment) - Canada, Ontario ... More >> University of OttawaHeart Institute Ottawa, Ontario, Canada, K1Y4W7 Less <<
NCT03485222 Cardiovascular Diseases Phase 4 Recruiting December 2020 United States, New York ... More >> Mount Sinai Heart - Icahn School of Medicine at Mount Sinai Recruiting New York, New York, United States, 10029 Principal Investigator: Juan J Badimon, PhD Less <<
NCT00565799 Patients Who Consented to Unde... More >>rgo Laparoscopic Gastric Banding Surgery for Weight Loss and Consent to Participate in This studyBMI ≥35 kg/m2 Confirmed Type 2 Diabetes Treated With Oral Agents and/or Only Diet Therapy Age 18-64 Years Less << Phase 2 Terminated(Conflicting interim... More >> data) Less << - United States, New York ... More >> NYU School of Medicine NY, New York, United States, 10016 Less <<
NCT01585454 - Withdrawn - -
NCT03560960 Alzheimer Disease ... More >> Mild Cognitive Impairment Less << Early Phase 1 Enrolling by invitation June 2023 United States, Indiana ... More >> Indiana University Alzheimer Disease Center Indianapolis, Indiana, United States, 46202 United States, Massachusetts BU Alzheimer Disease Center Boston, Massachusetts, United States, 02118 Memory Center VA Boston Healthcare Jamaica Plain, Massachusetts, United States, 02130 Less <<
NCT01612468 Diabetes Mellitus, Type 1 ... More >> Overweight Less << Phase 4 Completed - Denmark ... More >> Steno Diabetes Center Gentofte, Denmark, 2820 Less <<
NCT02608983 Healthy Not Applicable Completed - -
NCT03073070 Diabetes Red ... More >>Blood Cell Survival Less << Phase 1 Recruiting September 2022 United States, Iowa ... More >> University of Iowa Recruiting Iowa City, Iowa, United States, 52242 Contact: Guohua An, MD, PhD    319-467-4600    guohua-an@uiowa.edu    Contact: Demet Nalbant, PhD    319-335-8485    demet-nalbant@uiowa.edu Less <<
NCT01696448 Metabolic Syndrome Not Applicable Completed - United States, Georgia ... More >> Atlanta Vascular Research Foundation Atlanta, Georgia, United States, 30342 Less <<
NCT02077530 - Active, not recruiting November 2023 Korea, Republic of ... More >> Korea University Anam Hospital Metabolic Syndrome Research Center Seoul, Korea, Republic of, 136-705 Less <<
NCT02691312 - Active, not recruiting January 2019 United States, Florida ... More >> Florida Diabetes Camps De Leon Springs, Florida, United States, 32130 Pediatrics Endocrinology/Diabetes at UF Health Medical Plaza and Children's Medical Services Building Gainesville, Florida, United States, 32611 Children With Diabetes Friends For Life Conference Orlando, Florida, United States, 32821 Less <<
NCT01375322 Hypertension ... More >>Diabetes Mellitus, Type 2 Albuminuria Less << Phase 4 Completed - Taiwan ... More >> Chang Gung Memorial Hospital-Kaohsiung Kaohsiung, Taiwan, 833 Taichung Veterans General Hospital Taichung, Taiwan, 407 Tri-Service General Hospital Taipei, Taiwan, 114 Far Eastern Memorial Hospital Taipei, Taiwan, 220 Less <<
NCT00776971 Obesity Diet Not Applicable Completed - Denmark ... More >> Department of Internal Medicine/Endocrinology C, Aarhus University Hospital Aarhus, Denmark, 8000 Less <<
NCT01183104 Type 2 Diabetes Not Applicable Completed - Japan ... More >> Japan Association for Diabetes Education and Care Chiyoda-Ku, Tokyo, Japan, 102-0083 Less <<
NCT02099357 Spinal Cord Injuries Not Applicable Completed - Portugal ... More >> Centro de Medicina de Reabilitação da Região Centro - Rovisco Pais Cantanhede, Coimbra, Portugal, 3064-908 Centro de Reabilitação do Norte Vila Nova de Gaia, Porto, Portugal, 4405-565 Less <<
NCT00595140 Acromegaly Phase 4 Completed - Germany ... More >> Medizinische Klinik - Innenstadt of the University of Munich Munich, Germany, 80336 Less <<
NCT03638843 Obesity Obesi... More >>ty, Morbid Obesity; Endocrine Bariatric Surgery Candidate Less << Not Applicable Not yet recruiting September 20, 2020 United States, Maryland ... More >> Johns Hopkins Medical Institutions Not yet recruiting Baltimore, Maryland, United States, 21287 Contact: Vivek Kumbhari, MD    410-933-7495    vkumbha1@jhmi.edu    Contact: Lea Fayad, MD    518-423-5090    lfayad3@jhmi.edu Less <<
NCT01183104 - Completed - -
NCT00410410 Ulcerative Colitis Phase 3 Completed - -
NCT00872456 - Active, not recruiting December 31, 2018 -
NCT00410410 - Completed - -
NCT01285518 Diabetes Mellitus, Type 2 Phase 1 Completed - United States, California ... More >> Profil Institute for Clinical Research, Inc. Chula Vista, California, United States, 91911 United States, Florida Comprehensive Phase One (A Division of Comprehensive NeuroScience, Inc.) Ft. Meyers, Florida, United States, 33901 Elite Research Institute Miami, Florida, United States, 33169 Comprehensive Phase One (A Division of Comprehensive NeuroScience, Inc.) Miramar, Florida, United States, 33025 United States, Texas Cetero Research San Antonio, Texas, United States, 78229 Less <<
NCT01334242 Healthy Phase 1 Completed - United States, Texas ... More >> Lexicon Investigational Site San Antonio, Texas, United States, 78209 Less <<
NCT01883154 - Not yet recruiting September 2023 Israel ... More >> Meir medical center Not yet recruiting Kfar Saba, Israel Contact: Tal Biron Shental, MD          Sub-Investigator: Rivka Sukenik Halevy, MD          Principal Investigator: Tal Biron Shental, MD Less <<
NCT01285518 - Completed - -
NCT00117338 Asthma Phase 3 Completed - -
NCT03526263 Obesity Obesi... More >>ty, Morbid Obesity; Endocrine Bariatric Surgery Candidate Less << Not Applicable Completed - United States, Maryland ... More >> Johns Hopkins Bayview Medical Center Baltimore, Maryland, United States, 21202 Less <<
NCT00117338 - Completed - -
NCT02524782 Type 2 Diabetes Phase 1 Completed - United States, Alabama ... More >> Research Site Anniston, Alabama, United States, 36207 United States, California Research Site Chula Vista, California, United States, 91911 United States, Florida Research Site Jacksonville, Florida, United States, 32216 Research Site Miami, Florida, United States, 33014 Research Site South Miami, Florida, United States, 33143 United States, North Carolina Research Site Durham, North Carolina, United States, 27710 Research Site Raleigh, North Carolina, United States, 27612 United States, Ohio Research Site Cincinnati, Ohio, United States, 45227 United States, Tennessee Research Site Knoxville, Tennessee, United States, 37920 United States, Texas Research Site San Antonio, Texas, United States, 78209 Research Site San Antonio, Texas, United States, 78229 Less <<
NCT00739180 Abdominal Obesity Not Applicable Completed - United States, Pennsylvania ... More >> Children's Hospital of Pittsburgh, University of Pittsburgh School of Medicine Pittsburgh, Pennsylvania, United States, 15213 Less <<
NCT02151227 - Completed - Korea, Republic of ... More >> Sang-Yhun Ju Seoul, Korea, Republic of, 150-713 Less <<
NCT02000479 Chronic Heart Failure Not Applicable Completed - -
NCT02721953 Insulin Resistance ... More >> Obesity Less << Phase 2 Phase 3 Unknown March 2018 Italy ... More >> University of Naples Federico II Recruiting Naples, Italy, 80131 Contact: Roberto Berni Canani, MD, PhD    +390817462680 Less <<
NCT00455793 - Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT01680640 Non-Alcoholic Fatty Liver Dise... More >>ase Less << Not Applicable Recruiting October 2019 United Kingdom ... More >> Southamption General Hospital Recruiting Southampton, Hants, United Kingdom, SO166YD Contact: Christopher D Byrne, MBBCH PHD    44 23 8120 5006    C.D.BYRNE@SOUTHAMPTON.AC.UK    Contact: Lucinda C England    44 23 8120 5006    L.C.ENGLAND@SOUTHAMPTON.AC.UK Less <<
NCT00743756 Obesity Diabe... More >>tes Less << Not Applicable Terminated(slow patient enroll... More >>ment) Less << - United States, Georgia ... More >> Grady Health System Atlanta, Georgia, United States, 30303 Less <<
NCT02471404 Type 2 Diabetes Mellitus ... More >> Inadequate Glycaemic Control Less << Phase 4 Completed - -
NCT00687479 - Completed - United States, Louisiana ... More >> Woman's Hospital Pathology Laboratory Baton Rouge, Louisiana, United States, 70815 Less <<
NCT01135472 Healthy Phase 1 Completed - United States, California ... More >> City of Hope Medical Center Duarte, California, United States, 91010 Less <<
NCT01716468 - Completed - -
NCT01838902 Malaria Phase 3 Completed - Gambia ... More >> Medical Research Council Unit (MRC), The Gambia Fajara, Gambia Less <<
NCT01716468 Cancer Not Applicable Completed - United States, Pennsylvania ... More >> VA Pittsburgh Healthcare System Pittsburgh, Pennsylvania, United States, 15240 Less <<
NCT00771901 Insulin Resistance ... More >> Diabetes Obesity Less << Not Applicable Completed - United States, Missouri ... More >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Less <<
NCT00526682 Obesity Overw... More >>eight Dyslipidemia Less << Not Applicable Completed - -
NCT00771901 - Completed - -
NCT02695121 - Recruiting April 30, 2024 United States, Delaware ... More >> Research Site Recruiting Wilmington, Delaware, United States United States, District of Columbia Research Site Recruiting Washington, District of Columbia, United States Netherlands Research Site Recruiting Utrecht, Netherlands United Kingdom Research Site Recruiting London, United Kingdom Less <<
NCT03584217 Type 2 Diabetes Mellitus ... More >> Obesity Nephropathy Adolescent Obesity Less << Phase 1 Phase 2 Recruiting June 2023 United States, Colorado ... More >> Children's Hospital Colorado Recruiting Aurora, Colorado, United States, 80238 Contact: Petter Bjornstad, M.D.          Principal Investigator: Petter Bjornstad, M.D.          Sub-Investigator: Kristen Nadeau, M.D. Less <<
NCT01585493 Schizophrenia ... More >> Metabolic Syndrome Less << Phase 3 Completed - Denmark ... More >> Mental Health Services in the Capital Region, Denmark Copenhagen, Denmark, 2400 Less <<
NCT02418429 Weight Loss Not Applicable Completed - -
NCT00420654 Turner Syndrome Not Applicable Completed - Denmark ... More >> Medical Department M (Endocrinology and Diabetes), Aarhus University Hospital Aarhus, DK, Denmark, 8000 Less <<
NCT01135992 - Completed - -
NCT01505803 Diabetes Mellitus, Type 2 ... More >> Insulin Resistance Less << Phase 1 Completed - Australia, New South Wales ... More >> University of Sydney Sydney, New South Wales, Australia, 2006 Less <<
NCT01135992 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT03686657 Type 2 Diabetes ... More >> High Blood Pressure Arthritis Obesity Less << Phase 1 Phase 2 Not yet recruiting August 31, 2021 United States, New York ... More >> Albany Medical College Not yet recruiting Albany, New York, United States, 12206 Contact: Kevin Fiesthamel, MS    518-264-4472    feistht@amc.edu    Contact: Spencer Phelps, CCRC    518-264-4474    phelpss2@amc.edu    Principal Investigator: Robert Busch, MD          Sub-Investigator: Grimm Loretta, FNP-C Less <<
NCT00529399 Type 1 Diabetes Mellitus Phase 2 Completed - United States, California ... More >> Childrens Hospital of Los Angeles Los Angeles, California, United States, 90027 Stanford University Palo Alto, California, United States, 94305 University of California-San Francisco San Francisco, California, United States, 94143 United States, Colorado Barbara Davis Center for Childhood Diabetes/University of Colorado Health Sciences Center Aurora, Colorado, United States, 80045 United States, Connecticut Yale University School of Medicine New Haven, Connecticut, United States, 06520 United States, Florida University of Florida Gainesville, Florida, United States University of Miami/ Miller School of Medicine Miami, Florida, United States, 33136 United States, Indiana Indiana University School of Medicine Indianapolis, Indiana, United States, 46202 United States, Massachusetts Joslin Diabetes Center Boston, Massachusetts, United States, 02215 United States, Minnesota University of Minnesota Minneapolis, Minnesota, United States, 55455 United States, New York Columbia University New York, New York, United States, 10032 United States, Pennsylvania Childrens Hospital of Pittsburgh Pittsburgh, Pennsylvania, United States, 15213 United States, Texas University of Texas/Southwestern Medical School Dallas, Texas, United States, 75390-8858 United States, Washington Benaroya Research Institute Seattle, Washington, United States, 98101 Canada, Ontario Hospital for Sick Children Toronto, Ontario, Canada, M5G 1X8 Less <<
NCT00271739 - Completed - -
NCT02343146 Diabetes Mellitus, Type 1 Not Applicable Enrolling by invitation August 2019 United States, District of Col... More >>umbia Children's Research Institute Washington, District of Columbia, United States, 20010 Less <<
NCT02646475 Obesity Insul... More >>in Resistance Hypertension Metabolic Cardiovascular Syndrome Less << Phase 1 Recruiting December 2019 United States, Tennessee ... More >> Vanderbilt University School of Medicine Recruiting Nashville, Tennessee, United States, 37232 Contact: Kaleigh Rae, MPH    615-875-7421    kaleigh.rae@vanderbilt.edu Less <<
NCT02569164 - Unknown December 2015 -
NCT01609725 Cardiovascular Diseases ... More >> Atheroma Coronary Artery Disease Less << Phase 4 Unknown December 2016 Brazil ... More >> Federal University of Rio Grande do Sul, School of Dentistry and University Hospital Recruiting Porto Alegre, RS, Brazil, 90035003 Contact: Alex Haas, PhD    +55 51 33085318    periodontia@ufrgs.br    Principal Investigator: Cassio Kampits, MS          Principal Investigator: Ingrid Sanada, MS          Principal Investigator: Marlon Montenegro, MS Less <<
NCT00529399 - Completed - -
NCT01605123 - Recruiting January 2020 Germany ... More >> LIFE Leipzig Research Centre for Civilization Diseases, University of Leipzig Recruiting Leipzig, Saxony, Germany, 04103 Contact: Wieland Kiess, Prof. MD       wieland.kiess@medizin.uni-leipzig.de    Contact: LIFE Child       contact@life.uni-leipzig.de    Principal Investigator: Wieland Kiess, Prof., MD          Principal Investigator: Antje Körner, Prof.,MD          University Leipzig Medical Center, Department of Women and Child Health, Center for Pediatric Research Recruiting Leipzig, Saxony, Germany, 04103 Contact: Wieland Kiess, MD       Wieland.Kiess@medizin.uni-leipzig.de    Principal Investigator: Körner Antje, MD Less <<
NCT02130180 - Unknown October 2015 United States, Minnesota ... More >> Children's Hospitals and Clinics of Minnesota Recruiting Minneapolis and St Paul, Minnesota, United States Contact: Kelly Bergmann, MS, DO    612-813-6843    kelly.bergmann@childrensmn.org    Principal Investigator: Kelly Bergmann, MS, DO Less <<
NCT03572205 Fatty Acids G... More >>enetics Less << Not Applicable Active, not recruiting December 19, 2018 Finland ... More >> University of Eastern Finland Kuopio, Finland, 70211 Less <<
NCT03482986 Bariatric Surgery ... More >> Sleeve Gastrectomy Obesity Less << Not Applicable Not yet recruiting May 2022 United States, Massachusetts ... More >> Brigham and Women's Hospital Not yet recruiting Boston, Massachusetts, United States, 02115 Contact: Courtney O'Keefe    617-525-7032    cokeefe1@bwh.harvard.edu    Contact: Ivy Mason, PhD    617-732-6256    imason@bwh.harvard.edu    Principal Investigator: Frank Scheer, PhD          Principal Investigator: Ali Tavakkoli, MD Less <<
NCT00896298 Hypoleptinemia ... More >> Generalized Lipodystrophy Partial Lipodystrophy Insulin Resistance Less << Phase 2 Phase 3 Completed - United States, Texas ... More >> UT Southwestern Medical Center Dallas, Texas, United States, 75390 Less <<
NCT00823940 Diabetes Mellitus, Type 2 Phase 1 Completed - United States, Minnesota ... More >> GSK Investigational Site Minneapolis, Minnesota, United States, 55404 Less <<
NCT00388050 Type 2 Diabetes Not Applicable Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT00076414 Healthy Phase 1 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center (CC) Bethesda, Maryland, United States, 20892 Less <<
NCT01940003 Diabetes, Gestational Not Applicable Unknown December 2016 Brazil ... More >> Instituto de Medicina Integral Prof. Fernando Figueira Recruiting Recife, Pernambuco, Brazil, 50070-550 Contact: José Roberto da Silva Junior, Master    55-81-9815-4243    roberto.junior@imip.org.br    Sub-Investigator: Karine Ferreira Agra, Master          Principal Investigator: José Roberto da Silva Junior, Master Less <<
NCT03666065 Type1diabetes Not Applicable Not yet recruiting April 1, 2020 -
NCT02671279 Obesity Not Applicable Recruiting June 2018 Norway ... More >> Haukeland University Hospital Not yet recruiting Bergen, Hordaland, Norway, 5020 Contact: Gunnar Mellgren, M.D., Ph.D.       Gunnar.mellgren@med.uib.no    Principal Investigator: Gunnar Mellgren, M.D., Ph.D.          Sub-Investigator: Silje Kvistad, M.D          Sub-Investigator: Jørn V. Sagen, M.D, Ph. D          Sub-Investigator: Simon Dankel, Ph.D          Sub-Investigator: Oddrun Gudbrandsen, Ph.D          Sub-Investigator: Ellinor Vogt, M.D.          Haugesund Sjukehus, Helse Fonna Recruiting Haugesund, Norway Contact: Bjørn Nedrebø, MD, PhD       bned@helse-fonna.no    Sub-Investigator: Henrik Næss, MD          Sub-Investigator: Andreas Diamantopoulos, MD          Sub-Investigator: Arne-Christian Mohn, MD          Principal Investigator: Bjørn Nedrebø, MD, PhD Less <<
NCT03080181 Cushing Disease Phase 4 Completed - -
NCT02356757 Diabetes Foot... More >> Ulcer Less << Not Applicable Recruiting April 1, 2020 United States, New York ... More >> Manhattan Campus of the VA NY Harbor Healthcare System, New York, NY Recruiting New York, New York, United States, 10010 Contact: John G Hay, MD    212-686-7500 ext 3860    john.hay@va.gov    Contact: David S Goldfarb, MD    (212) 686-7500 ext 3877    David.Goldfarb@va.gov    Principal Investigator: Sundar Natarajan, MD MSc Less <<
NCT01760772 Heart Disease Not Applicable Unknown February 2015 United States, Ohio ... More >> Veteran's Affairs Clinical Research Unit Not yet recruiting Cincinnati, Ohio, United States, 45220 Contact: Michelle R Adams, PhD    513-558-6920    michelle.adams@uc.edu    Principal Investigator: Michelle R Adams, PhD          Principal Investigator: David D'Alessio, MD Less <<
NCT00853151 Diabetes Mellitus, Type 2 Phase 1 Completed - -
NCT01703208 - Terminated(The study was termi... More >>nated for business reasons and not due to any safety or efficacy concerns related to omarigliptin) Less << - -
NCT02386982 Type 2 Diabetes Phase 1 Completed - China ... More >> The 1st Betuhune Hospital of Jilin University Changchun, China Less <<
NCT02446028 Diabetes Mellitus Phase 2 Suspended(IND Withdrawn) May 2016 United States, Florida ... More >> Meridien Research Bradenton, Florida, United States, 34208 United States, Georgia Endocrine Research Solutions Roswell, Georgia, United States, 30076 United States, Illinois Cedar Crosse Research Center Chicago, Illinois, United States, 60607 Springfield Diabetes and Endocrine Center Springfield, Illinois, United States, 62711 United States, North Carolina Diabetes and Endocrinology Consultants Morehead City, North Carolina, United States, 28557 United States, Texas Clinical Trials of Texas San Antonio, Texas, United States, 78229 United States, Washington Ranier Clinical Research Center Renton, Washington, United States, 98057 Less <<
NCT03244059 Chronic Obstructive Pulmonary ... More >>Disease Emphysema Less << Phase 2 Recruiting July 2020 United States, Alabama ... More >> UAB Lung Health Center Recruiting Birmingham, Alabama, United States, 35205 Contact: Elizabeth Westfall    205-934-9282    ewestfall@uabmc.edu Less <<
NCT03212833 - Recruiting December 1, 2018 Egypt ... More >> Assiut University Recruiting Assiut, Egypt Contact: Rasha H Sayed, master    00201093241729    rashrusha@yahoo.com Less <<
NCT01703208 Type 2 Diabetes Mellitus Phase 3 Terminated(The study was termi... More >>nated for business reasons and not due to any safety or efficacy concerns related to omarigliptin) Less << - -
NCT03138746 - Recruiting February 2019 Australia, South Australia ... More >> Hyperbaric Medicine Unit, Royal Adelaide Hospital Recruiting Adelaide, South Australia, Australia, 5000 Contact: David C Wilkinson, FANZCA    61 8 7074 0180    david.wilkinson@sa.gov.au    Principal Investigator: David C Wilkinson, FANZCA          Sub-Investigator: Ian M Chapman, PhD          Sub-Investigator: Leonie K Heilbronn, PhD Less <<
NCT01021865 - Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT00376207 Cerebral Infarction Not Applicable Completed - Denmark ... More >> Bispebjerg Hospital Copenhagen, Denmark, 2400 Less <<
NCT01714622 - Unknown October 2016 Korea, Republic of ... More >> Department of Surgery, Yonsei University Colleage of Medicine, Not yet recruiting Seoul, Korea, Republic of, 120-752 Contact: Ji Yeong An, MD    82-2-2228-2095    ugids@naver.com    Ji Yeong An Not yet recruiting Seoul, Korea, Republic of, 120-752 Contact: Ji Yeong An, MD          Sevrance hospital, Department of General surgery Recruiting Seoul, Korea, Republic of, 120-752 Contact: Ji Young An, MD    82 2 2228 2095    ajy8339@yuhs.ac Less <<
NCT00776191 Endstage Renal Disease Phase 4 Terminated(al study sites stop... More >>ed on 15/05/2012 because of insufficient recrutement.) Less << - Germany ... More >> Pediatric Nephrology, Universiy Children's Hospital Cologne, Germany Dept. of Pediatric Nephrology, University Hospital Erlangen Erlangen, Germany Dept. of Pediatric Nephrology, University of Hannover Hannover, Germany, 30625 Dept. of Nephrology, children´s hospital Memmingen Memmingen, Germany, 87700 Dept. of Nephrology, University of Rostock Rostock, Germany, 18057 Less <<
NCT00674518 Obesity Physi... More >>cal Inactivity Diabetes Less << Not Applicable Unknown March 2009 United States, Oregon ... More >> Oregon Health & Science University Portland, Oregon, United States, 97239 Less <<
NCT00853151 - Completed - -
NCT00722371 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT00472654 Weight Loss V... More >>itamin D or Placebo Less << Not Applicable Completed - United States, New Jersey ... More >> Rutgers University New Brunswick, New Jersey, United States, 08901 Less <<
NCT00722371 - Completed - -
NCT02663570 Polycystic Ovary Syndrome Not Applicable Unknown - Italy ... More >> Catholic university of Sacred Heart Recruiting Rome, Italy, 00168 Contact: Rosanna Apa, MD       krimisa@libero.it    Principal Investigator: Rosanna Apa, MD Less <<
NCT03486223 Diabetes Mellitus ... More >> Endocrine System Diseases Glucose Metabolism Disorders PreDiabetes Obesity Less << Phase 2 Recruiting October 1, 2020 United States, Tennessee ... More >> Vanderbilt University Medical Center Recruiting Nashville, Tennessee, United States, 37232 Contact: Robert Manning, RN    615-322-2105    robert.m.manning@Vanderbilt.edu    Contact: Holly Waldrop       holly.waldrop@Vanderbilt.edu    Principal Investigator: James M Luther, MD Less <<
NCT00975390 Exercise Recovery Not Applicable Completed - Netherlands ... More >> Maastricht University Maastricht, Netherlands Less <<
NCT02535299 GLP-1；Metformin；Telomere-telom... More >>erase System；Par-4 Less << Phase 4 Recruiting December 2019 China, Chongqing ... More >> Southwest Hospital of the Third Military Medical University Recruiting Chongqing, Chongqing, China, 400038 Contact: wu qi nan, doctor    13452867542 ext +86    wqn11@126.com    Contact: chen bing, doctor    68754138 ext +86    chenbing3@medmail.com.cn Less <<
NCT02679183 Prebiotics Ho... More >>ney Premature Infants Intestinal Microbiota Less << Early Phase 1 Completed - -
NCT01581099 - Completed - Brazil ... More >> Heart Institute - University of São Paulo São Paulo, Brazil, 05403-000 Less <<
NCT02204332 Colorectal Cancer Phase 2 Terminated(Interim analysis pe... More >>rformed on the first 10 patients showed no efficacy of cabazitaxel) Less << - Spain ... More >> Hospital German Trias i Pujol Badalona, Spain Hospital Arnau de Vilanova Lérida, Spain Hospital Ramón y Cajal Madrid, Spain Hospital Carlos Haya Málaga, Spain CHU de Orense Orense, Spain Hospital Clinico de Santiago Santiago de Compostela, Spain Hospital General de Valencia Valencia, Spain Hospital Miguel Servet Zaragoza, Spain Less <<
NCT01992016 Adenocarcinoma of the Prostate... More >> Bone Metastases Soft Tissue Metastases Stage IIA Prostate Cancer Stage IIB Prostate Cancer Stage III Prostate Cancer Stage IV Prostate Cancer Less << Not Applicable Completed - United States, Colorado ... More >> University of Colorado Cancer Center Aurora, Colorado, United States, 80045 Less <<
NCT03490370 NASH - Nonalcoholic Steatohepa... More >>titis Insulin Sensitivity Less << Not Applicable Recruiting January 14, 2019 United Kingdom ... More >> NHS Tayside Recruiting Dundee, United Kingdom Contact: Shirley Cleary    01382 383577    shirley.cleary@nhs.net Less <<
NCT01682343 Nutritional and Metabolic Dise... More >>ases Less << Not Applicable Completed - United Kingdom ... More >> Northumbria University Newcastle upon Tyne, Tyne on Wear, United Kingdom, NE1 8ST Less <<
NCT02360982 - Completed - -
NCT01348867 Diabetes Not Applicable Completed - Hong Kong ... More >> Diabetes & Endocrine Centre, Prince of Wales Hospital Shatin, New Territories, Hong Kong Less <<
NCT01316341 Diabetes Mellitus, Type 2 Phase 1 Completed - China ... More >> 1245.44.86001 Boehringer Ingelheim Investigational Site Beijing, China Less <<
NCT01559792 - Unknown - Denmark ... More >> Hvidovre Hospital Recruiting Hvidovre, Denmark, 2650 Contact: Siv H Jacobsen          Principal Investigator: Siv H Jacobsen, MD          Hvidovre hospital Recruiting Hvidovre, Denmark, 2650 Contact: siv H Jacobsen, MD Less <<
NCT00703417 - Completed - United States, California ... More >> China Basin Imaging Center San Francisco, California, United States, 94107 Less <<
NCT03408249 Inflammatory Bowel Diseases Not Applicable Completed - Canada, Alberta ... More >> Division of Gastroenterology, Department of Medicine, Faculty of Medicine University of Alberta, Edmonton, Alberta, Canada, T6G 2R7 Canada, British Columbia GIRI (GI Research Institute) Vancouver, British Columbia, Canada, V6Z 2K5 Canada, Quebec Hôtel-Dieu de Lévis, Lévis, Quebec, Canada Less <<
NCT01316341 - Completed - -
NCT00509223 Diabetes Mellitus Type 2 Not Applicable Completed - United States, California ... More >> Mission Internal Medical Group Mission Viejo, California, United States, 92691 Advanced Metabolic Care and Research Institute Temecula, California, United States, 92951 United States, Florida Clinical Research of South Florida Coral Gables, Florida, United States, 33134 United States, Georgia SleepMed of Central Georgia Macon, Georgia, United States, 31201 United States, Maryland Johns Hopkins University Baltimore, Maryland, United States, 21224 United States, Minnesota International Diabetes Center St Louis Park, Minnesota, United States, 55416 United States, New York Rochester Clinical Research Rochester, New York, United States, 14609 United States, Ohio OSU Sleep Medicine Program Columbus, Ohio, United States, 43210 United States, South Carolina SleepMed of West Ashley Charleston, South Carolina, United States, 29407 SleepMed of South Carolina Columbia, South Carolina, United States, 29201 United States, Texas Cetero Research San Antonio, Texas, United States, 78229 Australia, New South Wales Royal North Shore Hospital Sydney, New South Wales, Australia, 2065 Australia, Victoria Eastern Clinical Research Unit Box Hill, Victoria, Australia, 3128 Baker IDI Heart and Diabetes Institute Melbourne, Victoria, Australia, 3004 Canada, Quebec IUCPQ Quebec City, Quebec, Canada, G1V 4G5 Less <<
NCT01992016 - Completed - -
NCT00509223 - Completed - -
NCT01436734 Hyperglucagonemia Not Applicable Completed - Denmark ... More >> Gentofte Hospital Hellerup, Denmark, 2900 Less <<
NCT00770653 - Completed - -
NCT02485834 Adenocarcinoma of the Gastroes... More >>ophageal Junction Gastric Adenocarcinoma Gastric Cancer Less << Phase 2 Active, not recruiting - -
NCT01939496 Diabetes Mellitus, Type 2 ... More >> Hypertension Less << Phase 4 Completed - -
NCT00770653 Diabetes Mellitus ... More >> Dyslipidemias Less << Phase 3 Completed - -
NCT01939496 - Completed - -
NCT02555020 Evidence of Cholecystectomy Phase 3 Completed - -
NCT01869959 Diabetes Mellitus, Type 2 Phase 1 Completed - United States, California ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Cypress, California, United States, 90630 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tustin, California, United States, 92780 United States, Florida For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Deland, Florida, United States, 32720 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Miramar, Florida, United States, 33025 United States, Ohio For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Cincinnati, Ohio, United States, 45212 United States, Oregon For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Portland, Oregon, United States, 97239 United States, Texas For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. San Antonio, Texas, United States, 78229 Less <<
NCT01869959 - Completed - -
NCT02766322 - Recruiting April 2021 United States, Illinois ... More >> University of Illinois at Urbana Champaign Recruiting Urbana, Illinois, United States, 61801 Contact: Belen Acevedo, PhD    217-300-4709    mba17@illinois.edu    Contact: Christine R Canfield, BS, CCRP    217-326-0095    Christine.Canfield@Carle.com    Principal Investigator: Marta Y Pepino, PhD Less <<
NCT02214641 Diabetes Mellitus, Type 1 ... More >> Diabetes Mellitus, Type 2 Less << Not Applicable Completed - United States, California ... More >> USC Los Angeles, California, United States, 90089 Less <<
NCT03185507 Cryotherapy Effect ... More >> Oxygen Deficiency Less << Phase 1 Completed - United States, Virginia ... More >> University of Virginia Memorial Gymnasium Charlottesville, Virginia, United States, 22904 Less <<
NCT01817777 Diabetes Mellitus, Type 2 Phase 4 Terminated(It's no longer feas... More >>ible to continue to recruit patients into the study as severe recruitment difficulties have been experienced since the study start) Less << - Argentina ... More >> GSK Investigational Site Correintes, Argentina GSK Investigational Site Corrientes, Argentina GSK Investigational Site Mendoza, Argentina, 5515 GSK Investigational Site Mendoza, Argentina, 5539 GSK Investigational Site Mendoza, Argentina GSK Investigational Site Provincia de Buenos Aires, Argentina, 1754 GSK Investigational Site Tucumán, Argentina, T 4000IOE Less <<
NCT02949193 Type 2 Diabetes Mellitus Phase 3 Completed - Korea, Republic of ... More >> Kangbuk Samsung Medical Center Seoul, Korea, Republic of, 110-746 Less <<
NCT02194673 Healthy Not Applicable Completed - Malaysia ... More >> MalaysiaPOB Kajang, Selangor, Malaysia, 43000 Less <<
NCT03278236 Type2 Diabetes ... More >> Insulin Resistance Less << Not Applicable Terminated(Insufficient fundin... More >>g to complete pilot.) Less << - Australia, South Australia ... More >> Adelaide Medical School Adelaide, South Australia, Australia, 5005 Less <<
NCT02075528 Schizophrenia ... More >> Schizoaffective Disorder Less << Phase 4 Completed - Taiwan ... More >> Taipei City Hospital, Songde Branch Taipei, Taiwan, 110 Less <<
NCT03142880 Anesthesia, Spinal Not Applicable Not yet recruiting November 2017 -
NCT01817777 - Terminated(It's no longer feas... More >>ible to continue to recruit patients into the study as severe recruitment difficulties have been experienced since the study start) Less << - -
NCT01869101 - Unknown February 2014 -
NCT00711243 Gastric Cancer ... More >> Unspecified Adult Solid Tumor, Protocol Specific Less << Phase 1 Phase 2 Completed - United States, Illinois ... More >> Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States, 60611-3013 Less <<
NCT00711243 - Completed - -
NCT02770885 Primary Polydipsia Phase 2 Recruiting November 2019 Switzerland ... More >> University Hospital Basel Recruiting Basel, Switzerland Contact: Winzeler F Bettina    061 556 50 75 ext 0041    bettina.winzeler@usb.ch    Contact: Julie Refardt    061 328 76 08    julie.refardt@usb.ch Less <<
NCT01602913 - Completed - -
NCT01462071 - Terminated - United States, New York ... More >> Yorkville Dialysis Center New York, New York, United States, 10128 Less <<
NCT01357382 Metabolic Syndrome Phase 4 Unknown July 2012 Canada, British Columbia ... More >> St. Paul's Hospital Not yet recruiting Vancouver, British Columbia, Canada, V6Z1Y6 Less <<
NCT01318135 Type 2 Diabetes Mellitus Phase 2 Phase 3 Completed - -
NCT01318122 - Completed - -
NCT01318122 Type 2 Diabetes Mellitus Phase 2 Phase 3 Completed - -
NCT01468116 - Unknown December 2013 Denmark ... More >> Hvidovre University Hospital Recruiting Copenhagen, Hvidovre, Denmark, DK-2650 Contact: Kirstine Nyvold Bojsen-Møller, MD    +4538626371    kirstine.bojsen-moeller@hvh.regionh.dk    Principal Investigator: Kirstine Nyvold Bojsen-Møller, MD Less <<
NCT03723941 Adrenocortical Carcinoma Phase 3 Recruiting June 30, 2021 Italy ... More >> ASST Spedali Civili di Brescia Recruiting Brescia, BS, Italy, 25123 Contact: Alfredo Berruti, MD    0039 030 399 5410    alfredo.berruti@gmail.com Less <<
NCT01318135 - Completed - -
NCT02847351 Nutritional and Metabolic Dise... More >>ases Less << Not Applicable Unknown December 2016 Italy ... More >> Internal Medicine Department, Clinica Medica II, IRCCS San Matteo Foundation Pavia, PV, Italy, 27100 IRCCS Policlinico San Matteo Foundation Pavia, Italy, 27100 Less <<
NCT01753154 Chronic Renal Failure Phase 4 Completed - Poland ... More >> Centrum Dializ Fresenius Nephrocare Gdańsk,, Poland Samodzielny Publiczny Szpital Kliniczny nr 4 w Lublinie Lublin, Poland Uniwersytecki Szpital Kliniczny nr 1 Łódź, Poland Spain Complejo hospitalario universitario de Albacete Albacete, Spain Fundación Hospital Alcorcón Madrid, Spain Hospital Universitario Puerta de Hierro Madrid, Spain Hospital Universitario Ramón y Cajal Madrid, Spain Less <<
NCT00722917 Diabetes Mellitus Phase 2 Terminated(Animal Toxicity Fin... More >>dings) Less << - United States, California ... More >> Artesia, California, United States Norwalk, California, United States Santa Ana, California, United States Santa Monica, California, United States United States, Florida Panama City, Florida, United States United States, Rhode Island Cranston, Rhode Island, United States United States, Texas Dallas, Texas, United States Houston, Texas, United States Less <<
NCT00832182 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 3 Completed - Croatia ... More >> Novo Nordisk Investigational Site Zagreb, Croatia, 10 000 Czech Republic Novo Nordisk Investigational Site Praha 10, Czech Republic, 10034 Novo Nordisk Investigational Site Praha 2, Czech Republic, 12821 Israel Novo Nordisk Investigational Site Tel Hashomer, Israel, 52621 Russian Federation Novo Nordisk Investigational Site Moscow, Russian Federation, 117036 Novo Nordisk Investigational Site Moscow, Russian Federation, 119435 Novo Nordisk Investigational Site Moscow, Russian Federation, 125315 Novo Nordisk Investigational Site Moscow, Russian Federation, 129110 Novo Nordisk Investigational Site Saint-Petersburg, Russian Federation, 194354 Slovenia Novo Nordisk Investigational Site Ljubljana, Slovenia, 1000 Less <<
NCT03651661 Obesity Not Applicable Recruiting January 2019 Germany ... More >> University of Tuebingen, Department of Internal Medicine IV Recruiting Tübingen, Germany, 72076 Contact: Caroline Willmann, MD    004970712982711    caroline.willmann@med.uni-tuebingen.de Less <<
NCT03546972 Obesity and Other Hyperaliment... More >>ation Less << Not Applicable Recruiting November 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact       kbasenen@mdanderson.org Less <<
NCT01263509 Type 2 Diabetes Mellitus Phase 2 Phase 3 Completed - -
NCT00006505 Diabetes Mellitus Type 1 Phase 2 Active, not recruiting June 1, 2020 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT01868568 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 1 Completed - Germany ... More >> Neuss, Germany, 41460 Less <<
NCT02167256 Alzheimer's Disease Phase 2 Completed - -
NCT01263496 - Completed - -
NCT01341535 Primary Non-operated Squamous ... More >>Cell Carcinoma of Oral Cavity Primary Non-operated Squamous Cell Carcinoma of Oropharynx Primary Non-operated Squamous Cell Carcinoma of Hypopharynx Primary Non-operated Squamous Cell Carcinoma of Larynx Less << Phase 2 Active, not recruiting December 2018 Belgium ... More >> Department of Radiotherapy, University Hospital Ghent Ghent, Belgium, 9000 Clinique & Materinité Sainte Elisabeth Namur, Belgium Less <<
NCT01263496 Type 2 Diabetes Mellitus Phase 2 Completed - -
NCT03695315 - Not yet recruiting August 2023 United States, California ... More >> University of California San Francisco Not yet recruiting San Francisco, California, United States, 94110 Principal Investigator: Jean-Marc Schwarz, PhD Less <<
NCT02065141 Chronic Heart Failure ... More >> Pulmonary Disorder, Chronic Obstructive Less << Not Applicable Recruiting February 2020 United States, Texas ... More >> Texas A&M University Recruiting College Station, Texas, United States, 77843 Contact: Marielle P Engelen, Ph.D.    979-220-2282    mpkj.engelen@ctral.org    Contact: Agata McNew, M.Sc.Eng    .979.583.5800    a.wierzchowska@ctral.org    Principal Investigator: Marielle Engelen, Ph.D.          Principal Investigator: Nicolaas E Deutz, Ph.D. Less <<
NCT02605772 Type 2 Diabetes Mellitus Phase 4 Unknown March 2017 -
NCT01065753 Metabolic Syndrome Not Applicable Completed - Taiwan ... More >> Taichung Veterans General Hospital Taichung, Taiwan, 407 Less <<
NCT03622957 - Not yet recruiting September 3, 2018 Italy ... More >> University of Pisa Not yet recruiting Pisa, Italy, 56125 Contact: Anna Solini, Associate Professor, MD, PhD    +39 050993482    anna.solini@med.unipi.it    Contact: Alessandro Mengozzi, MD    +39 050993640    alessandro.mengozzi@medmcs.unipi.it    Principal Investigator: Anna Solini, Associate Professor, MD, PhD          Sub-Investigator: Amalia Gastaldelli, Associate Professor, PhD          Sub-Investigator: Alessandro Mengozzi, MD Less <<
NCT03132545 - Completed - -
NCT01562093 Asthma Not Applicable Terminated(Investigational dru... More >>gs no longer available) Less << - Norway ... More >> St Olav University Hospital Trondheim, Norway Less <<
NCT00316082 - Completed - -
NCT01263509 - Completed - -
NCT03538015 Hypoglycemia Unawareness Phase 2 Not yet recruiting June 2020 United States, Utah ... More >> University of Utah Not yet recruiting Salt Lake City, Utah, United States, 84132 Less <<
NCT01683006 Critical Illness ... More >> Cardiac Arrest Less << Not Applicable Completed - Austria ... More >> Medical University Vienna Vienna, Austria, 1090 Less <<
NCT00316082 Diabetes Phase 3 Completed - -
NCT02679287 Diabetes Mellitus, Type 1 Not Applicable Active, not recruiting April 2019 United States, Virginia ... More >> University of Virginia Center for Diabetes Technology Charlottesville, Virginia, United States, 22903 Less <<
NCT01631084 Diabetes Not Applicable Active, not recruiting December 2019 Hong Kong ... More >> Asia Diabetes Foundation Shatin, Hong Kong Less <<
NCT00005383 - Completed - -
NCT03167788 Organ Failure, Multiple ... More >> Inflammation Sepsis Less << Phase 2 Not yet recruiting December 2019 United Kingdom ... More >> Department of Cardiovascular Sciences Not yet recruiting Leicester, Leicestershire, United Kingdom, LE3 9QP Contact: Gavin J Murphy, Prof       gjm19@le.ac.uk    Contact: Hardeep S Aujla       ha200@le.ac.uk Less <<
NCT00419107 - Terminated(Completed) - Denmark ... More >> Medical Department M (Endocrinology and Diabetes), Aarhus University Hospital Aarhus, Aarhus C, Denmark, 8000 Less <<
NCT02783053 Obesity Not Applicable Completed - Netherlands ... More >> Academic Medical Center Amsterdam, Netherlands, 1105AZ Less <<
NCT03764709 Patient Monitoring Not Applicable Not yet recruiting March 31, 2021 Italy ... More >> ASL Roma6 Not yet recruiting Albano Laziale, Roma, Italy, 00040 Contact: Filomena Pietrantonio    3291710748 Less <<
NCT00667030 Inflammation ... More >>Aging Metabolism Exercise Less << Not Applicable Active, not recruiting December 2020 United States, Maryland ... More >> University of Maryland; Baltimore VA Medical Center Baltimore, Maryland, United States, 21044 Less <<
NCT02827669 Type 2 Diabetes Mellitus Not Applicable Completed - United States, California ... More >> Evidation Health San Mateo, California, United States, 94401 Less <<
NCT02101814 Obesity Morbi... More >>d Obesity Metabolic Syndrome Inflammation Energy Balance Less << Not Applicable Unknown - Brazil ... More >> Hospital de Clínicas/Federal University of Paraná Curitiba, Paraná, Brazil, 80060-900 Less <<
NCT00815451 Obesity Phase 2 Unknown December 2009 United Kingdom ... More >> Queen margaret university Musselburgh, East Lothian, United Kingdom, eh21 6uu Less <<
NCT01608334 Adequate Anesthesia With Unimp... More >>aired Motor Strength Less << Not Applicable Completed - Korea, Republic of ... More >> Severance hospital Seoul, Korea, Republic of, 120-752 Less <<
NCT00828620 - Terminated(Lack of recruitment... More >>) Less << - Belgium ... More >> ZNA Middelheim Antwerpen, Belgium AZ Groeninge Kortrijk, Belgium UZLeuven Leuven, Belgium, 3000 H Hart Roeselare Campus menen Menen, Belgium Stedelijk Ziekenhuis Roeselare Roeselare, Belgium Sint Augustinus Ziekenhuis Wilrijk, Belgium Less <<
NCT00638560 Obesity Type ... More >>2 Diabetes Less << Phase 1 Completed - Germany ... More >> University of Leipzig Leipzig, Germany, 04103 Less <<
NCT02612844 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 1 Completed - Austria ... More >> Novo Nordisk Investigational Site Graz, Austria, 8010 Less <<
NCT01831102 - Completed - United States, Colorado ... More >> University of Colorado Anschutz Medical Center Aurora, Colorado, United States, 80045 Less <<
NCT00698230 Type 2 Diabetes Phase 2 Completed - -
NCT01432106 Hypertension ... More >>Metabolic Syndrome Less << Phase 1 Withdrawn(Novartis terminated ... More >>all projects involving aliskiren. Findings of the DMC overseeing the ALTITUDE clinical trial found a higher incidence of adverse events.) Less << - United States, Michigan ... More >> University of Michigan Health System Ann Arbor, Michigan, United States, 48106 Less <<
NCT02872571 Disorder of Endocrine Pancreas Phase 1 Phase 2 Recruiting April 2022 France ... More >> CHRU, Hôpital Claude Huriez Recruiting Lille, France Principal Investigator: François Pattou, MD,PhD Less <<
NCT01274091 Insulin Sensitivity Not Applicable Completed - Finland ... More >> University of Eastern Finland Kuopio, Finland, FIN-70211 Less <<
NCT00989547 Type 1 Diabetes ... More >> Children Less << Phase 1 Unknown - Germany ... More >> Forschergruppe Diabetes der Technischen Universität München, Bavaria, Germany, 80804 Less <<
NCT00816348 Cholestasis T... More >>otal Parenteral Nutrition-induced Cholestasis Less << Phase 2 Terminated - United States, New York ... More >> Cohen Children's Medical Cenetr of New York at North Shore Manhasset, New York, United States, 11030 Cohen Children's Medical Center of New York New Hyde Park, New York, United States, 11040 Less <<
NCT03084302 - Recruiting June 30, 2020 United States, Pennsylvania ... More >> Physical Activity and Weight Management Research Center Recruiting Pittsburgh, Pennsylvania, United States, 15261 Contact: Bethany Barone Gibbs, PhD    412-383-4020       Contact: Diane Casile-Groxx    412-383-4020       Sub-Investigator: Janet Catov, PhD          Sub-Investigator: Arun Jeyebalan, MD          Sub-Investigator: John M Jakicic, PhD Less <<
NCT02292433 Type 2 Diabetes Mellitus Phase 1 Completed - Japan ... More >> P-one Clinic, Keikokai Medical Corporation Hachioji-shi, Tokyo, Japan, 192-0071 Less <<
NCT02292433 - Completed - -
NCT00816348 - Terminated - -
NCT02452567 Weight Loss Not Applicable Active, not recruiting September 2019 United States, Missouri ... More >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Less <<
NCT01048021 - Completed - Canada, Manitoba ... More >> HSC Pain Management Centre Winnipeg, Manitoba, Canada Less <<
NCT01131182 - Completed - -
NCT02327286 Diabetes Mellitus ... More >> Diabetes, Gestational Less << Phase 3 Recruiting December 2019 Brazil ... More >> Centro de Estudos em Diabetes e Hipertensão Recruiting Fortaleza, Ceará, Brazil, 60135-180 Contact: Adriana Costa e Forti, MD, PhD    85 3105 8300    adrianaforti@uol.com.br    Contact: Cristina Façanha, MD, MSc    85 3105 8300    crisffacanha@hotmail.com    Principal Investigator: Adriana Costa e Forti, MD, PhD          Sub-Investigator: Cristina Façanha, MD, MSc          Federal University of Pelotas Recruiting Pelotas, Rio Grande do Sul, Brazil, 96020-220 Contact: Pedro C Hallal, PhD    53 3284 1300    prchallal@gmail.com    Principal Investigator: Pedro C Hallal, PhD          Hospital de Clínicas de Porto Alegre Recruiting Porto Alegre, Rio Grande do Sul, Brazil, 90035-903 Contact: Maria I Schmidt, MD, PhD    51 3359 6302    maria.schmidt@ufrgs.br    Contact: Bruce B Duncan, MD, PhD    51 3359 6301    bbduncan@ufrgs.br    Principal Investigator: Maria I Schmidt, MD, PhD Less <<
NCT00507494 Diabetes Mellitus ... More >> Kidney Transplantation Proteinuria Less << Phase 3 Completed - Germany ... More >> Nephrology, Department of Medicine, university hospital Dresden Dresden, Germany, 01307 Less <<
NCT01131182 Type 2 Diabetes Mellitus (T2DM... More >>) Less << Phase 4 Completed - -
NCT00108225 Diabetes Mellitus, Type 2 Not Applicable Completed - United States, Minnesota ... More >> VA Medical Center, Minneapolis Minneapolis, Minnesota, United States, 55417 Less <<
NCT02213003 Type 1 Diabetes Mellitus ... More >> Hypoglycemia Hypoglycemia Unawareness Less << Phase 1 Phase 2 Recruiting May 2022 United States, Florida ... More >> Diabetes Research Institute, University of Miami Miller School of Medicine Recruiting Miami, Florida, United States, 33136 Contact: Rodolfo Alejandro, MD    305-243-5324    ralejand@med.miami.edu    Contact: David A Baidal, MD    3052437740    dbaidal@med.miami.edu    Principal Investigator: Rodolfo Alejandro, MD Less <<
NCT02955953 Healthy Phase 1 Completed - Singapore ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician. Singapore, Singapore Less <<
NCT03491423 Coronary Artery Disease Withou... More >>t Heart Failure Less << Not Applicable Recruiting December 2020 France ... More >> CHU de DIJON Recruiting Dijon, France, 21079 Contact: Jean-Marie CASILLAS    3.80.29.38.15 ext +33    jean-marie.casillas@chu-dijon.fr Less <<
NCT00480779 Prediabetes M... More >>etabolic Syndrome Less << Not Applicable Completed - United States, Pennsylvania ... More >> University of Pittsburgh Pittsburgh, Pennsylvania, United States, 15213 Less <<
NCT00480779 - Completed - -
NCT03125369 Diabetes Mellitus ... More >> Obesity Bariatric Surgery Candidate Weight Loss Less << Not Applicable Recruiting May 2018 China ... More >> Chinese University of Hong Kong Recruiting Hong Kong, China Contact: Enders Ng, MD    +852 26322956    endersng@surgery.cuhk.edu.hk Less <<
NCT01426802 Type 2 Diabetes Mellitus Phase 4 Completed - Egypt ... More >> Investigative site Cairo, Egypt Less <<
NCT00108056 Glioma Phase 1 Terminated - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00706017 - Completed - Mexico ... More >> Novo Nordisk Investigational Site Mexico City, Mexico Less <<
NCT02942654 Healthy Phase 1 Completed - Singapore ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician. Singapore, Singapore Less <<
NCT00885378 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT01938352 Influenza Phase 2 Completed - United Kingdom ... More >> Retroscreen Virology Ltd London, United Kingdom, E1 2AX Less <<
NCT01062048 - Completed - -
NCT00669500 Obesity Hyper... More >>lipidemia Less << Not Applicable Completed - United States, Oregon ... More >> Oregon Health & Science University Portland, Oregon, United States, 97239 Less <<
NCT03378232 Cardiovascular Disease Not Applicable Completed - -
NCT02974491 Oxidative Stress Not Applicable Completed - -
NCT01608061 Alzheimer Disease Not Applicable Active, not recruiting September 2018 United States, Arizona ... More >> Banner Alzheimer's Institute Phoenix, Arizona, United States, 85006 Banner Research Institute at Sun City Sun City, Arizona, United States, 85351 United States, Florida University of Florida at Gainesville Gainesville, Florida, United States, 32607 United States, Maryland Johns Hopkins Bayview Baltimore, Maryland, United States, 21224 United States, Pennsylvania Hospital of the University of Pennsylvania: Penn Memory Clinic Philadelphia, Pennsylvania, United States, 19104 United States, Rhode Island Brown University Providence, Rhode Island, United States, 02906 Canada, Ontario Toronto Western Hospital Toronto, Ontario, Canada, M5T 2S8 Less <<
NCT00571844 Hypertension Not Applicable Completed - United States, North Carolina ... More >> Duke University Durham, North Carolina, United States, 27710 Less <<
NCT03710811 - Recruiting August 30, 2021 China, Jiangsu ... More >> at Division of Endocrinology, the Affiliated Drum Tower Hospital of Nanjing University Recruiting Nanjing, Jiangsu, China, 210008 Contact: Dalong Zhu, MD,PhD    86-25-83-105302    zhudldr@gmail.com    Contact: Yan Bi, MD,PhD    86-25-83-105302    biyan@nju.edu.cn    Principal Investigator: Dalong Zhu, MD,PhD          Sub-Investigator: Yan Bi, MD,PhD          China, Zhejiang Zhejiang Provincial People'S Hospital Recruiting Hangzhou, Zhejiang, China Contact: xiao ye, MD    86-571-85893937       Principal Investigator: xiao ye, MD Less <<
NCT00885378 - Completed - -
NCT01461616 Diabetes Mellitus, Type 1 Phase 3 Completed - Denmark ... More >> Department of Endocrinology and Internal Medicine, Aarhus University Hospital Aarhus, Denmark, 8000 Less <<
NCT01399814 Surgery Perio... More >>perative Care Immunization Abdominal Neoplasms Less << Phase 3 Completed - -
NCT01261585 - Completed - France ... More >> Centre Henri Becquerel Rouen, Hate Normandie, France, 76000 Less <<
NCT02496728 Cardiovascular Disease Not Applicable Enrolling by invitation February 28, 2019 United States, Illinois ... More >> Northwestern University Chicago, Illinois, United States, 60611 Less <<
NCT02812511 Costello Syndrome Not Applicable Completed - France ... More >> CHU de Bordeaux Bordeaux, Aquitaine, France, 33000 Less <<
NCT00359762 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT01266954 Solid Tumours Phase 1 Completed - United Kingdom ... More >> GSK Investigational Site London, United Kingdom, W12 0HS Less <<
NCT00642720 Quality of Life ... More >> Acromegaly Less << Phase 4 Completed - -
NCT03422185 - Completed - Malawi ... More >> MEIRU Lilongwe, Malawi Less <<
NCT01881087 Disorder of Knee ... More >> Anesthesia Less << Phase 4 Completed - Colombia ... More >> Fundación Valle del Lili Cali, Valle del Cauca, Colombia, 76001000 Less <<
NCT00464035 Obesity Not Applicable Completed - Denmark ... More >> Institute of Human Nutrition Copenhagen, Denmark, 1958 Less <<
NCT01881087 - Completed - -
NCT01170403 - Completed - Korea, Republic of ... More >> Seoul National University Bundang Hospital Seongnam, Bundang-gu, Korea, Republic of, 463-707 Less <<
NCT02725957 Healthy Volunteer Subjects Phase 1 Completed - United States, Maryland ... More >> PAREXEL Baltimore Early Phase Clinical Unit; Harbor Hospital Baltimore, Maryland, United States, 21225 Less <<
NCT00359762 - Completed - -
NCT03129932 Obesity Not Applicable Active, not recruiting December 1, 2018 -
NCT01038102 Obesity Diabe... More >>tes Insulin Resistance Fatty Liver Less << Not Applicable Completed - Sweden ... More >> Uppsala University Hospital, Uppsala Science Park Uppsala, Sweden, 75185 Less <<
NCT01553513 - Unknown December 2014 Germany ... More >> Department of Nuclear Medicine, Departmen of Cardiology, University of Munich Not yet recruiting Munich, Bavaria, Germany, 81377 Contact: Marcus Hacker, MD    +49 (0)89 7095 4646    marcus.hacker@med.uni-muenchen.de    Contact: Sebastian Lehner, MD    +49 (0)89 7095 4646    sebastian.lehner@med.uni-muenchen.de Less <<
NCT01145482 Memory Disorders Not Applicable Completed - United States, Texas ... More >> University of texas at Austin Austin, Texas, United States, 78712 Less <<
NCT00691158 Obesity Not Applicable Unknown July 2012 United States, Oregon ... More >> Oregon Health & Science University Portland, Oregon, United States, 97239 Less <<
NCT03061851 Diabetes Mellitus, Type 2 Not Applicable Recruiting December 2018 China, Shandong ... More >> Qingdao University Hospital Recruiting Qingdao, Shandong, China Contact: Nailong Yang    0086-18661806185    nailongyang@163.com Less <<
NCT02661906 Diabetes Mellitus, Non-Insulin... More >>-Dependent Less << Not Applicable Completed - Kuwait ... More >> Dasman Diabetes Institute Kuwait, Kuwait, 1180 Less <<
NCT03370614 - Enrolling by invitation May 3, 2020 United States, Pennsylvania ... More >> Thomas Jefferson University, Marcus Institute of Integrative Health Centers Philadelphia, Pennsylvania, United States, 19107 Thomas Jefferson University, Marcus Institute of Integrative Health Centers Villanova, Pennsylvania, United States, 19085 Less <<
NCT01028404 Diabetes Diab... More >>etes Mellitus, Type 1 Diabetes Mellitus, Type 2 Healthy Less << Phase 1 Completed - Germany ... More >> Novo Nordisk Investigational Site Neuss, Germany, 41460 Less <<
NCT02751736 Rectal Cancer Not Applicable Enrolling by invitation December 2017 -
NCT00236613 Obesity Phase 2 Completed - -
NCT03776279 Relapsed or Refractory Periphe... More >>ral T-cell and NK/T-cell Lymphoma Less << Phase 2 Recruiting December 30, 2020 China, Guangdong ... More >> Sun Yat-sen University Cancer Center Recruiting Guangzhou, Guangdong, China, 510060 Contact: Huiqiang Huang, Doctor    020-87343350 Less <<
NCT00562796 - Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT00811915 Kidney Transplantation Phase 3 Completed - France ... More >> UHAmiens Amiens, France UHAngers Angers, France, 49933 UHCaen Caen, France, 14000 UHLimoges Limoges, France UHNecker Paris, France, 75015 UHRennes Rennes, France, 35000 UHRouen Rouen, France, 76000 UHTours Tours, France Less <<
NCT00360516 Diet Not Applicable Completed - United States, California ... More >> UCSF 505 Parnassus Ave San Francisco, California, United States, 94143 Less <<
NCT01776788 Diabetes Mellitus, Type 2 Phase 4 Completed - China, Fujian ... More >> The first afilliated hospital of Xiamen university Xiamen, Fujian, China, 361003 Less <<
NCT00776607 Latent Autoimmune Diabetes in ... More >>Adults LADA Less << Not Applicable Unknown April 2011 United Kingdom ... More >> Diabetes Unit Not yet recruiting Cardiff, Wales, United Kingdom, CF64 2XX Contact: Julia Platts    02920 711 711 ext 5149    Julia.Platts@CardiffandVale.wales.nhs.uk    Principal Investigator: Julia Platts          Clinical Research Unit Recruiting Swansea, Wales, United Kingdom, SA6 6NL Contact: Lucy Barlow    +44 (0) 1792 703722 ext 3722    Lucy.Barlow@swansea-tr.wales.nhs.uk    Principal Investigator: Jeffrey Stephens Less <<
NCT00353613 Surgical Wound Infection Not Applicable Completed - United States, Texas ... More >> Lyndon Baines Johnson General Hospital Houston, Texas, United States, 77026 Ben Taub General Hospital Houston, Texas, United States, 77030 Less <<
NCT01185431 Functional Constipation Not Applicable Completed - Korea, Republic of ... More >> Chonbuk National University Hospital Jeonju, Jeollabuk-do, Korea, Republic of, 561-712 Less <<
NCT01292018 - Completed - -
NCT00760344 Diabetes Mellitus Phase 2 Completed - -
NCT02681588 Obesity Not Applicable Completed - -
NCT00270803 Marijuana Dependence Not Applicable Completed - Israel ... More >> Department of Nuclear Medicine Tel Aviv, Israel, 64239 Less <<
NCT01962259 Overweight and Obesity Not Applicable Completed - Denmark ... More >> University of Copenhagen, Department of Biomedical Sciences Copenhagen, Denmark, 2200 Less <<
NCT00570817 Methotrexate Induced Nephrotox... More >>icity Less << Not Applicable Completed - Denmark ... More >> Aarhus University Hospital, Skejby Aarhus, Aarhus N, Denmark, 8200 Less <<
NCT01713530 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT00637520 - Terminated - United States, North Carolina ... More >> Duke University Medical Center Durham, North Carolina, United States, 27710 Less <<
NCT02654171 RESPIRATORY SYNCYTIAL VIRUS IN... More >>FECTIONS Less << Phase 2 Recruiting December 31, 2018 Australia, Queensland ... More >> Lady Cilento Children's Hospital Recruiting South Brisbane, Queensland, Australia, 4101 Contact: Debbie Long    +61-7-3068-1474    Debbie.Long2@health.qld.gov.au    Principal Investigator: Andreas Schibler, MD Less <<
NCT01713530 - Completed - -
NCT00473356 Obesity Post-... More >>gastric Bypass Less << Not Applicable Completed - United States, Alabama ... More >> UAB Kirklin Clinic Birmingham, Alabama, United States, 35294 Less <<
NCT00700817 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT01396187 Diabetes Mellitus, Type 2 Phase 1 Completed - United States, California ... More >> Pfizer Investigational Site Chula Vista, California, United States, 91911 United States, Florida Pfizer Investigational Site Miami, Florida, United States, 33169 Pfizer Investigational Site South Miami, Florida, United States, 33143 United States, Kansas Pfizer Investigational Site Overland Park, Kansas, United States, 66212 United States, Texas Pfizer Investigational Site San Antonio, Texas, United States, 78229 Less <<
NCT03645915 - Completed - -
NCT00945672 Alzheimer's Disease Phase 2 Completed - Sweden ... More >> Pfizer Investigational Site Göteborg, Sweden, 413 45 Pfizer Investigational Site Malmo, Sweden, 205 02 Pfizer Investigational Site Molndal, Sweden, 431 41 Pfizer Investigational Site Stockholm, Sweden, 141 86 Less <<
NCT02126592 - Unknown May 2014 China ... More >> Renji Hospital Recruiting Shanghai, China, 200001 Contact: Jing Ma, Dr.    +86-21-68383083    cherry1996@live.cn Less <<
NCT00912938 Metastatic Breast Cancer Phase 4 Unknown December 2010 Korea, Republic of ... More >> Department of Surgery, Korea University Guro Hospital Seoul, Korea, Republic of Less <<
NCT02832453 Metabolic Syndrome X ... More >> Lifestyle-related Condition Lifestyle Risk Reduction Cardiovascular Risk Factor Less << Not Applicable Active, not recruiting December 2017 Spain ... More >> INEFC-Lleida Lleida, Spain, 25192 Less <<
NCT01124071 Obesity Not Applicable Unknown April 2011 Australia, New South Wales ... More >> The University of Sydney Sydney, New South Wales, Australia, 2006 Less <<
NCT01795235 Healthy Not Applicable Unknown July 2014 United States, Virginia ... More >> University of Virginia Recruiting Charlottesville, Virginia, United States, 22902 Contact: Ralf Nass, MD       rmn9a@virginia.edu    Principal Investigator: Michael O Thorner Less <<
NCT01718431 Metabolic Syndrome Early Phase 1 Completed - Sweden ... More >> Applied Nutrition and Food Chemistry, Lund University Lund, Sweden, SE-221 00 Less <<
NCT01396187 - Completed - -
NCT02687256 Type 1 Diabetes Phase 1 Completed - United States, California ... More >> Stanford University Palo Alto, California, United States, 94304 Less <<
NCT00700817 - Completed - -
NCT02495961 - Completed - Mexico ... More >> Asociación Científica Latina A.C. Toluca, State of Mexico, Mexico, 50120 Less <<
NCT03725137 - Not yet recruiting December 2021 -
NCT01525992 Diabetes Mellitus, Type 2 Not Applicable Completed - Iran, Islamic Republic of ... More >> Taleghani Community Pharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences Tehran, Iran, Islamic Republic of Less <<
NCT02229227 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT00104104 Multiple Myeloma Phase 4 Completed - -
NCT01456065 Ovarian Epithelial Cancer Phase 1 Unknown April 2013 Austria ... More >> Hospital Landeskrankenhaus Innsbruck Innsbruck, Austria, 6020 Hospital Korneuburg Korneuburg, Austria, 2100 Hospital Barmherzigen Schwestern Linz, Austria, 4010 Hungary Semelweis University Budapest, Hungary, 1083 National Oncology Institute Budapest, Hungary, 1122 Less <<
NCT01133093 - Completed - Spain ... More >> Department of Preventive Medicine and Public Health. Universidad Autonoma de Madrid Madrid, Spain, 28029 Less <<
NCT02229227 - Completed - -
NCT00812409 Obesity Not Applicable Completed - United States, Indiana ... More >> Purdue University West Lafayette, Indiana, United States, 47907 Less <<
NCT02734173 Hepatitis C Phase 4 Recruiting December 2018 Canada, Ontario ... More >> The Ottawa Hospital, General Campus Recruiting Ottawa, Ontario, Canada Contact: Curtis Cooper, MD    613-737-8924       Principal Investigator: Curtis Cooper, MD Less <<
NCT00104104 - Completed - -
NCT02406040 Obesity Not Applicable Completed - Canada, Ontario ... More >> Exercise Metabolism Research Laboratory, McMaster Univeristy Hamilton, Ontario, Canada, L8S 4K1 Less <<
NCT01156779 Diabetes Mellitus Phase 1 Completed - Korea, Republic of ... More >> Clinical Trial center, Clinical Research institute, Seoul National University Hospital Seoul, Korea, Republic of Less <<
NCT00289926 Quality of Life ... More >> Menopausal Syndrome Libido Disorder Less << Phase 3 Completed - Australia, Victoria ... More >> Women's Health Research Program, Monash University, The Alfred Hospital Melbourne, Victoria, Australia, 3004 Less <<
NCT03449901 Soft Tissue Sarcoma Phase 2 Recruiting February 9, 2025 United States, California ... More >> Sarcoma Oncology Center Not yet recruiting Santa Monica, California, United States, 90403 Contact: Sant P Chawla, M.D.    310-552-9999       Principal Investigator: Sant P Chawla, M.D.          United States, Missouri Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: Brian A Van Tine, M.D., Ph.D.    314-362-5817    bvantine@wustl.edu    Principal Investigator: Brian A Van Tine, M.D., Ph.D.          Sub-Investigator: Douglas Adkins, M.D.          Sub-Investigator: Angie Hirbe, M.D.          Sub-Investigator: Jingqin (Rosy) Luo, Ph.D. Less <<
NCT02803905 Islets of Langerhans Transplan... More >>tation Diabetes Mellitus, Type 1 Less << Phase 2 Recruiting December 2020 Italy ... More >> IRCCS San Raffaele Scientific Institute Recruiting Milan, Italy, 20132 Contact: Lorenzo Piemonti, MD       piemonti.lorenzo@hsr.it    Contact: Paola Maffi, MD       paola.maffi@hsr.it    Principal Investigator: Paola Maffi, MD          Principal Investigator: Lorenzo Piemonti, MD          Principal Investigator: Carlo Socci, MD Less <<
NCT02913001 Acne Vulgaris Not Applicable Completed - -
NCT03440164 - Completed - -
NCT00930917 Hypothermia, Preterm Infants Phase 3 Completed - -
NCT00006185 HIV Infections ... More >> Lipodystrophy Insulin Resistance Less << Phase 1 Completed - United States, New York ... More >> University Hospital at Stony Brook New York Stony Brook, New York, United States, 11794 Less <<
NCT02863809 Keratolysis Phase 1 Phase 2 Recruiting March 2020 United States, California ... More >> The Jules Stein Eye Institute Recruiting Los Angeles, California, United States, 90095-7003 Contact: Ellen Pascual       pascual@jsei.ucla.edu    Principal Investigator: Anthony Aldave, MD          UC Davis Health System Eye Center Recruiting Sacramento, California, United States, 95817 Contact: Denise Macias    916-734-6303    dcmacias@ucdavis.edu    Principal Investigator: Mark Mannis, MD          Shiley Eye Institute, University of California, San Diego Recruiting San Diego, California, United States, 92093 Contact: Natalie Afshari, MD          Principal Investigator: Natalie Afshari, MD, FACS          United States, Florida Bascom Palmer eye Institute Not yet recruiting Miami, Florida, United States, 33136 Contact: Marisa Braun       mxb1423@med.miami.edu    Principal Investigator: Victor Perez, MD          United States, Illinois Illinois Eye and Ear Infirmary Recruiting Chicago, Illinois, United States, 60612 Contact: Roxy Ng    312-355-4866    rtoh@uic.edu    Principal Investigator: Jose De La Cruz, MD          United States, Kentucky Cincinnati Eye Institute Recruiting Edgewood, Kentucky, United States, 41017 Contact: Rachel Crabtree    859-331-9000 ext x4120    rcrabtree@cincinattieye.com    Principal Investigator: Edward Holland, MD          United States, Maryland Wilmer Eye Institute Recruiting Baltimore, Maryland, United States, 21287 Contact: Shanna Ingrodi    410-955-5214    singrod1@jhmi.edu    Principal Investigator: Esen Akpek, MD          United States, Michigan W.K. Kellogg Eye Center Recruiting Ann Arbor, Michigan, United States, 48105 Contact: Munira Hussain    734-647-8397    hussain@umich.edu    Principal Investigator: Shahzad Mian, MD          United States, Missouri Tauber Eye Center Recruiting Kansas City, Missouri, United States, 64111 Contact: Megan Hefter    816-531-9100    mh@taubereye.com    Principal Investigator: Joseph Tauber, MD          United States, New York David and Ilene Flaum Eye Institute, University of Rochester Recruiting New York, New York, United States, 14642 Contact: Olga Pikul    585-273-3937    olga.pikul@rochester.edu    Principal Investigator: James Aquavella, MD          United States, Ohio University Hospitals Eye Institute Not yet recruiting Cleveland, Ohio, United States, 44106 Contact: Sangeetha Raghupathy       Sangeetha.Raghupathy@UHhospitals.org    Principal Investigator: Pankaj Gupta, MD, MS          United States, Pennsylvania Wills Eye Recruiting Bala-Cynwyd, Pennsylvania, United States, 19007 Contact: Cathy Petrocella    484-434-2706    cpetrocella@oppdoctors.com    Contact: Aditya Kanesa-thasan, MD    484-434-2706    adityakanesa@gmail.com    United States, Texas Wilford Hall Ambulatory Surgical Center (WHASC) Not yet recruiting Lackland Air Force Base, Texas, United States, 78236 Contact: Douglas Apsey    210-292-2554    Douglas.apsey.2.ctr@us.af.mil    Principal Investigator: Richard Townley, MD Less <<
NCT00731809 Crohn's Disease Phase 4 Unknown October 2010 Israel ... More >> Rabin Medical Center Recruiting Petah-tikva, Israel, 49100 Contact: Bernstine, MD       hannab2@clalit.org.il    Principal Investigator: Hanna Bernstine, MD Less <<
NCT01047059 Non-Small-Cell Lung Carcinoma Phase 2 Completed - Germany ... More >> Center for Integrated Oncology (CIO), University Hospital Cologne Cologne, Northrhine-Westphalia, Germany, 50924 Less <<
NCT02692781 Obesity Phase 1 Completed - Israel ... More >> Tel Aviv Sourasky Medical Center Tel Aviv, Israel, 64239 Less <<
NCT02224495 Myocardial Infarction Phase 1 Phase 2 Completed - Portugal ... More >> Cardiology Department Gaia Hospital Center Gaia, Portugal, 4450-189 Less <<
NCT00961701 - Terminated(sample size was not... More >> enrolled) Less << October 2016 Israel ... More >> Endocrine Institute , Haemek Medical Center Afula, Israel, 18101 Less <<
NCT03454152 - Not yet recruiting June 2020 -
NCT01317576 Diabetes Mellitus, Type 2 ... More >> Non-alcoholic Fatty Liver Disease Obesity Less << Not Applicable Completed - Netherlands ... More >> Maastricht University Maastricht, Limburg, Netherlands, 6200MD Less <<
NCT00201292 - Unknown October 2008 Taiwan ... More >> Department of Health-Yuli Hospital Recruiting Yuli, Hu-lien County, Taiwan, 981 Contact: Tsuo Hung Lan, MD, PhD          Principal Investigator: Tsuo Hung Lan, MD, PhD          Song-de Branch, Taipei City Hospital Not yet recruiting Taipei, Taiwan, 110 Contact: Shih-Ku Lin, MD          Principal Investigator: Shih-Ku Lin, MD          Mackay Memorial Hospital Not yet recruiting Taipei, Taiwan Contact: Shen-Ing Liu, MD, PhD          Principal Investigator: Shen-Ing Liu, MD, PhD Less <<
NCT01422759 Obesity Hyper... More >>androgenemia Polycystic Ovary Syndrome Less << Not Applicable Recruiting December 2019 United States, Virginia ... More >> University of Virginia Center for Research in Reproduction Recruiting Charlottesville, Virginia, United States, 22908 Contact: Deborah Sanderson    434-243-6911    pcos@virginia.edu    Principal Investigator: Christine Burt Solorzano, MD          Sub-Investigator: John C. Marshall, MD, PhD Less <<
NCT01997762 Gestational Diabetes Phase 4 Unknown December 2016 Canada, Manitoba ... More >> Manitoba Institute of Child Health Recruiting Winnipeg, Manitoba, Canada, R3E 3P4 Principal Investigator: Shayne P Taback, MD Less <<
NCT02804750 Cushing's Syndrome Phase 2 Completed - -
NCT00279201 Diabetes Mellitus, Type 2 Phase 4 Completed - -
NCT02397421 Heart Failure ... More >> Diabetes Less << Phase 4 Completed - United Kingdom ... More >> Ninewells Hospital and Medical School Dundee, Angus, United Kingdom, DD1 9SY Less <<
NCT03086733 Non Small Cell Lung Cancer ... More >> Lung Cancer Less << Phase 2 Recruiting December 2020 Canada, Ontario ... More >> Toronto General Hospital Recruiting Toronto, Ontario, Canada, M5G 2C4 Contact: Alexandra Salvarrey, MD MSc    1-416-340-4800 ext 6992    alexandra.salvarrey@uhn.on.ca    Contact: Jennifer Lister, BSc    1-416-340-4800 ext 4857    jennifer.lister@uhn.on.ca    Principal Investigator: Thomas Waddell, MD FRCSC          Princess Margaret Hospital Recruiting Toronto, Ontario, Canada, M5G 2M9 Contact: Alexandra Salvarrey, MD MSc    1-416-946-4501 ext 5444    alexandra.salvarrey@uhn.on.ca    Contact: Jennifer Lister, BSc    1-416-340-4800 ext 4857    jennifer.lister@uhn.on.ca    Principal Investigator: Natasha Leighl, MD MSc FRCPC Less <<
NCT00739778 Dental Caries Phase 2 Completed - United States, Massachusetts ... More >> The Forsyth Institute Boston, Massachusetts, United States, 02115 Less <<
NCT01785043 DIABETES Mellitus Type 2 Not W... More >>ell Controlled Less << Phase 4 Completed - Spain ... More >> Hospital Clínic de Barcelona Barcelona, Spain, 08036 Less <<
NCT01323413 - Unknown December 2016 Israel ... More >> Rambam Health Care Campus Recruiting Haifa, Israel Contact: Ahmad Khalaila, MD    =972-502061686       Sub-Investigator: Ahmad Khalaila, MD Less <<
NCT00279201 - Completed - -
NCT01772927 - Unknown July 2013 Belgium ... More >> Department of Neonatology University hospital of Liege Not yet recruiting Liege, Belgium, 4000 Contact: Thibault Senterre, MD PhD    00 32 4 225 6322    thibault.senterre@chu.ulg.ac.be    Contact: Masendu Kalenga, MD PhD    00 32 4 6546    Masendu.kalenga@chrcitadelle.be    Sub-Investigator: Thibault Senterre, MD PhD Less <<
NCT03611972 Healthy Not Applicable Recruiting December 31, 2019 United States, California ... More >> University of California, Davis Recruiting Davis, California, United States, 95616 Contact: Candice Price, PhD    530-752-5379    caaprice@ucdavis.edu    University of California, Davis CTSC Clinical Research Center Recruiting Sacramento, California, United States, 95817 Contact: Christopher Kain, RN, MSN, CNL    916-703-5595 Less <<
NCT01025323 Pre-Hypertension Not Applicable Terminated(The study was termi... More >>nated due to difficult recruitment and retention of subjects, these were attributed by subjects to conflict with their job schedule.) Less << - United States, Florida ... More >> Florida Heart Research Institute Miami, Florida, United States, 33137 Less <<
NCT00515801 Diabetes Mellitus, Type 1 Phase 2 Phase 3 Completed - Switzerland ... More >> University Hospital Basel Basel, Switzerland, 4031 Less <<
NCT01150955 Metabolic Syndrome ... More >> Obesity Less << Not Applicable Completed - Denmark ... More >> Aarhus University Hospital, Department of Endocrinology, MEA Aarhus, Denmark, 8000 Less <<
NCT03499704 Diabetes Mellitus, Type 2 Phase 4 Not yet recruiting December 31, 2020 -
NCT01433120 Obesity Insul... More >>in Resistance Less << Not Applicable Completed - Denmark ... More >> Department of Human Nutrition, Faculty of Life Sciences, University of Copenhagen Frederiksberg C, Denmark, 1958 Less <<
NCT01386853 Hyperlipidemia Phase 3 Unknown July 2012 Taiwan ... More >> Changhua Christian Hospital Not yet recruiting Chang-hua, Taiwan Principal Investigator: Chien-Hsun Hsia, M.D.          Sub-Investigator: Lee-Shin Lin, M.D.          National Cheng Kung University Hospital Not yet recruiting Tainan, Taiwan Principal Investigator: Ping-Yen Liu, M.D. Ph.D.          Sub-Investigator: Po-Sheng Chen, M.D.          Sub-Investigator: Ju-Yi Chen, M.D.          Sub-Investigator: Wei-Ting Li, M.D.          Sub-Investigator: Yen-Wen Liu, M.D.          Sub-Investigator: Cheng-Han Lee, M.D.          Sub-Investigator: Wei-Chuan Tsai, M.D.          Sub-Investigator: Yi-Heng Li, M.D.          Sub-Investigator: Chih-Chan Lin, M.D.          Sub-Investigator: Shih-Hung Chan, M.D.          Sub-Investigator: Ting-Hsing Chao, M.D.          Chang Gung Memorial Hospital-LinKou Not yet recruiting Taipei, Taiwan Principal Investigator: Ming-Shien Wen, M.D. Ph.D.          Sub-Investigator: Kuo-Chun Hung, M.D.          Sub-Investigator: I-Chang Hsieh, M.D.          Sub-Investigator: Chao-Yung Wang, M.D.          Sub-Investigator: Chun-Chi Chen, M.D.          National Taiwan University Hospital Not yet recruiting Taipei, Taiwan Principal Investigator: Kuo-Liong Chien, M.D. Ph.D.          Sub-Investigator: Chia-Lun Chao, M.D.          Sub-Investigator: Ta-Chen Su, M.D. Ph.D.          Sub-Investigator: Hung-Ju Lin, M.D.          Taipei Veterans General Hospital Not yet recruiting Taipei, Taiwan Principal Investigator: Tao-Cheng Wu, M.D. Ph.D.          Sub-Investigator: Chin-Chou Huang, M.D.          Sub-Investigator: Liang-Yu Lin, M.D.          Sub-Investigator: Wen-Chung Yu, M.D.          Tri-Service General Hospital Taipei, Taiwan Less <<
NCT03617393 - Recruiting December 1, 2020 China, Shanghai ... More >> Ruijin Hospital Shanghai Jiao Tong University School of Medicine Recruiting Shanghai, Shanghai, China, 200025 Contact: Jieming QU, Ph.D., M.D.    +86 18317030297    jmqu0906@163.com Less <<
NCT03693612 Neoplasms Phase 1 Phase 2 Recruiting June 16, 2022 United States, Massachusetts ... More >> GSK Investigational Site Not yet recruiting Boston, Massachusetts, United States, 02215 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Centre    877-379-3718    GSKClinicalSupportHD@gsk.com    United States, New York GSK Investigational Site Not yet recruiting New York, New York, United States, 10016- Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Centre    877-379-3718    GSKClinicalSupportHD@gsk.com    GSK Investigational Site Not yet recruiting New York, New York, United States, 10032 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Centre    877-379-3718    GSKClinicalSupportHD@gsk.com    United States, Oklahoma GSK Investigational Site Not yet recruiting Oklahoma City, Oklahoma, United States, 73104 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Centre    877-379-3718    GSKClinicalSupportHD@gsk.com    United States, Pennsylvania GSK Investigational Site Not yet recruiting Pittsburgh, Pennsylvania, United States, 15232 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Centre    877-379-3718    GSKClinicalSupportHD@gsk.com    United States, Texas GSK Investigational Site Recruiting San Antonio, Texas, United States, 78240 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Centre    877-379-3718    GSKClinicalSupportHD@gsk.com    Principal Investigator: Anthony Tolcher          Australia, New South Wales GSK Investigational Site Not yet recruiting Darlinghurst, New South Wales, Australia, 2010 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Centre    877-379-3718    GSKClinicalSupportHD@gsk.com    Australia, Victoria GSK Investigational Site Not yet recruiting Melbourne, Victoria, Australia, 3000 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Centre    877-379-3718    GSKClinicalSupportHD@gsk.com    Canada, Ontario GSK Investigational Site Not yet recruiting Ottawa, Ontario, Canada, K1H 8L Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Centre    877-379-3718    GSKClinicalSupportHD@gsk.com    GSK Investigational Site Not yet recruiting Toronto, Ontario, Canada, M5G 2M Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Centre    877-379-3718    GSKClinicalSupportHD@gsk.com Less <<
NCT03557541 Diabetes Mellitus, Type 2 ... More >> PreDiabetes Diet Habit Diabetes Nutritional and Metabolic Disease Less << Not Applicable Completed - Spain ... More >> Diana A Diaz Rizzolo Barcelona, Spain, 08036 Less <<
NCT01992588 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 1 Completed - Germany ... More >> Novo Nordisk Investigational Site Neuss, Germany, 41460 Less <<
NCT03083327 Hematologic Neoplasms Not Applicable Recruiting May 1, 2022 Australia, New South Wales ... More >> Royal North Shore Hospital Recruiting Sydney, New South Wales, Australia Contact: Site Investigator          Australia, South Australia Royal Adelaide Hospital Recruiting Adelaide, South Australia, Australia Contact: Site Investigator          New Zealand Christchurch Hospital, CDHB Recruiting Christchurch, New Zealand Contact: Site Investigator Less <<
NCT01422746 Obesity Hyper... More >>androgenemia Polycystic Ovary Syndrome Less << Not Applicable Recruiting December 2019 United States, Virginia ... More >> University of Virginia Center for Research in Reproduction Recruiting Charlottesville, Virginia, United States, 22908 Contact: Deborah Sanderson    434-243-6911    pcos@virginia.edu    Principal Investigator: Christine Burt Solorzano, MD          Sub-Investigator: John C. Marshall, MD, PhD Less <<
NCT03325387 Healthy Phase 1 Completed - United Kingdom ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician. Leeds, West Yorkshire, United Kingdom, LS2 9LH Less <<
NCT01457209 Polycystic Ovary Syndrome ... More >> Insulin Resistance Less << Phase 1 Completed - Sweden ... More >> Institute of Neuroscienncec and Physiology Göteborg, Sweden, 43252 Less <<
NCT00194402 Dyslipidemia Phase 4 Completed - United States, Washington ... More >> Northwest Lipid Research Clinic, University of Washington Seattle, Washington, United States, 98104 Less <<
NCT02081261 - Completed - Korea, Republic of ... More >> Samsung Medical Center Seoul, Korea, Republic of, 135-710 Less <<
NCT00500331 Diabetes Mellitus, Type 2 Phase 2 Completed - -
NCT00500331 - Completed - -
NCT02726217 Diabetes Type... More >> 2 Diabetes (T2D) Less << Not Applicable Completed - United States, New York ... More >> New York University School of Medicine New York, New York, United States, 10016 Less <<
NCT03351686 Postpartum Hemorrhage Phase 2 Phase 3 Completed - -
NCT03512236 Type 1 Diabetes Mellitus Phase 1 Recruiting October 31, 2018 Germany ... More >> Profil Institut für Stoffwechselforschung GmbH Recruiting Neuss, Germany Contact: Bianca Schmidt Less <<
NCT00092157 Hypercholesterolemia Phase 3 Completed - -
NCT01498900 - Completed - Turkey ... More >> Novo Nordisk Investigational Site Istanbul, Turkey, 34335 Less <<
NCT01509755 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 2 Completed - Denmark ... More >> Novo Nordisk Investigational Site Hvidovre, Denmark, 2650 Novo Nordisk Investigational Site Kolding, Denmark, 6000 Novo Nordisk Investigational Site København, Denmark, 2400 Novo Nordisk Investigational Site Køge, Denmark, 4600 Novo Nordisk Investigational Site Thisted, Denmark, 7700 Novo Nordisk Investigational Site Århus C, Denmark, 8000 Norway Novo Nordisk Investigational Site Bekkestua, Norway, 1357 Novo Nordisk Investigational Site Elverum, Norway, 2408 Novo Nordisk Investigational Site Harstad, Norway, 9480 Novo Nordisk Investigational Site Oslo, Norway, 0370 Sweden Novo Nordisk Investigational Site Grästorp, Sweden, 467 22 Novo Nordisk Investigational Site Göteborg, Sweden, 413 45 Novo Nordisk Investigational Site Lund, Sweden, 221 85 Novo Nordisk Investigational Site Uppsala, Sweden, 751 85 Novo Nordisk Investigational Site Örebro, Sweden, 701 85 United Kingdom Novo Nordisk Investigational Site Ayrsh, United Kingdom, KA2 0BE Novo Nordisk Investigational Site Church Village, United Kingdom, CF38 1AB Novo Nordisk Investigational Site Edinburgh, United Kingdom, EH16 4SA Novo Nordisk Investigational Site Enfield, United Kingdom, EN2 8JL Novo Nordisk Investigational Site Hull, United Kingdom, HU3 2JZ Novo Nordisk Investigational Site Leicester, United Kingdom, LE5 4PW Novo Nordisk Investigational Site Liverpool, United Kingdom, L7 8XP Novo Nordisk Investigational Site Northampton, United Kingdom, NN1 5BD Novo Nordisk Investigational Site Nottingham, United Kingdom, NG7 2UH Novo Nordisk Investigational Site Oxford, United Kingdom, OX2 6HE Novo Nordisk Investigational Site Plymouth, United Kingdom, PL8 8DQ Novo Nordisk Investigational Site Rugby, United Kingdom, CV22 5PX Novo Nordisk Investigational Site Sheffield, United Kingdom, S5 7AU Novo Nordisk Investigational Site Worksop, United Kingdom, S81 OBD Less <<
NCT00493012 Overweight Ob... More >>esity Less << Not Applicable Completed - Germany ... More >> Heart and Diabetes Center NRW Bad Oeynhausen, North-Rhine Westfalia, Germany, 32545 Less <<
NCT00493012 - Completed - -
NCT00454662 Hypertension ... More >>Cardiovascular Disease Diabetes Less << Phase 4 Completed - Japan ... More >> COLM-Study Data Center Kamiyacho MT Bld.14F, 4-3-20 Toranomon Minato-ku, Tokyo, Japan, 105-0001 Less <<
NCT01889264 - Completed - United States, Ohio ... More >> Cleveland Clinic Cleveland, Ohio, United States, 44195 Less <<
NCT00786487 Healthy Volunteers Not Applicable Completed - United States, Minnesota ... More >> University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT00513032 - Completed - Switzerland ... More >> Service d'Anesthésiologie, Hôpitaux Universitaires de Genève, Rue Micheli-du-Crest Geneva, Switzerland, CH-1211 Less <<
NCT01567007 Physical Activity ... More >> Obesity Less << Not Applicable Unknown August 2012 Brazil ... More >> Hospital das Clínicas da Faculdade de Medicina da USP - HCFMUSP São Paulo, Brazil, 05403-000 Less <<
NCT03382873 PreDiabetes Not Applicable Recruiting December 2023 United States, Ohio ... More >> The Ohio State University Recruiting Columbus, Ohio, United States, 43210 Contact: Carla Miller, Ph.D.    614-292-1391 Less <<
NCT00786487 - Completed - -
NCT00694512 Obesity Not Applicable Completed - United States, Oregon ... More >> Oregon Health & Science University Portland, Oregon, United States, 97239 Less <<
NCT01665092 Septic Shock Phase 2 Active, not recruiting May 2019 United States, Alabama ... More >> University of Alabama Birmingham Birmingham, Alabama, United States United States, California Univeristy of California Davis Sacramento, California, United States United States, Delaware Christiana Care Health Services Wilmington, Delaware, United States United States, Florida University of Florida Jacksonville, Florida, United States United States, Illinois Northwestern University Chicago, Illinois, United States United States, Indiana Indiana University Indianapolis, Indiana, United States United States, Massachusetts BIDMC Boston, Massachusetts, United States BWH Boston, Massachusetts, United States MGH Boston, Massachusetts, United States St. Vincent Hospital Worcester, Massachusetts, United States United States, Michigan Wayne State University Detroit, Michigan, United States United States, Mississippi University of Mississippi Medical Center Jackson, Mississippi, United States, 29316 United States, New Jersey Cooper University Hospital Camden, New Jersey, United States United States, North Carolina Carolinas Medical Center Charlotte, North Carolina, United States Less <<
NCT01674348 Type 2 Diabetes Mellitus Phase 2 Terminated(Due to non-recruitm... More >>ent, the study is being halted. There are no major safety or tolerability concerns in the study conducted so far.) Less << - Canada, Ontario ... More >> LMC Endocrinolgy Centres Ltd Toronto, Ontario, Canada, M4G 3E8 Less <<
NCT02333136 - Unknown June 2017 United States, New York ... More >> University Dialsyis Center Syracuse, New York, United States, 13210 Less <<
NCT01124656 Diabetes Mellitus, Type 2 Phase 3 Terminated(Formulation issues.... More >>) Less << - -
NCT00545337 Diabetes Mellitus, Type 1 Phase 3 Completed - Ukraine ... More >> Sanofi-Aventis Kiev, Ukraine Less <<
NCT03757871 Laser Stimulation Not Applicable Not yet recruiting February 2020 France ... More >> Hôpital Robert Debré Not yet recruiting Paris, France, 75019 Contact: Farnoux Carlone, PhD    01 40 03 20 61    caroline.farnoux@aphp.fr    Contact: Biran Valerie, PHD    01 40 03 41 91    valerie.biran@aphp.fr Less <<
NCT00268619 Myocardial Ischemia Phase 3 Completed - -
NCT01930578 HEALTHY Not Applicable Completed - Canada, Ontario ... More >> The Hospital for Sick Children Toronto, Ontario, Canada Less <<
NCT03300700 - Not yet recruiting March 1, 2020 Egypt ... More >> Assiut University Hospital Not yet recruiting Assiut, Egypt, Assiut,Egypt,Assiut university Less <<
NCT03401515 Traumatic Brain Injury Phase 4 Completed - -
NCT02324738 Healthy Phase 4 Completed - Thailand ... More >> Faculty of Tropical Medicine Bangkok, Thailand, 10400 Less <<
NCT03278249 Glioblastoma Not Applicable Recruiting January 2021 United States, Ohio ... More >> UC Health Recruiting Cincinnati, Ohio, United States, 45219 Contact: University of Cincinnati Cancer Institute    513-584-7698    kastla@ucmail.uc.edu Less <<
NCT00214474 Diabetes Not Applicable Completed - United States, California ... More >> Ucsf Dept of Medicine Box 1364 San Francisco, California, United States, 94143-1364 Less <<
NCT02924558 Hypertriglyceridemia Not Applicable Completed - -
NCT00364273 Pulmonary Disease, Chronic Obs... More >>tructive Less << Phase 1 Completed - United Kingdom ... More >> GSK Investigational Site Manchester, Lancashire, United Kingdom, M23 9LT GSK Investigational Site London, United Kingdom Less <<
NCT03350893 Skin Problems Not Applicable Recruiting October 31, 2018 Taiwan ... More >> Chia Nan University of Pharmacy and Science Recruiting Tainan, Taiwan, 71710 Contact: Ching-Gong Lin, PhD    886-6-2664911 ext 7383    ncglin@mail.cnu.edu.tw    Contact: Ya-Hui Chen, Master    886-6-5052151 ext 326    yahui@genmont.com.tw Less <<
NCT03349840 Type2 Diabetes Phase 4 Not yet recruiting September 1, 2018 Qatar ... More >> Hamad Medical Corporation Doha, Qatar, 3050 Less <<
NCT01033630 Hypertension Phase 2 Completed - Hong Kong ... More >> Alice Ho Miu Ling Nethersole Hospital Hong Kong, Hong Kong Prince of Wales Hospital Hong Kong, Hong Kong Yan Chai Hospital Hong Kong, Hong Kong Less <<
NCT02528461 - Active, not recruiting January 2020 Denmark ... More >> Aarhus University Hospital Aarhus C, Denmark, 8000 Less <<
NCT00648869 Healthy Not Applicable Withdrawn(Drug was not sent) November 2008 Israel ... More >> Diabetes Unit, Hadassah Hebew University Hospital Jerusalem, Israel, 91120 Less <<
NCT00944827 Hypercholesterolemia Phase 2 Completed - Greece ... More >> General Hospital of Trikala Trikala, Thessaly, Greece, 42100 Less <<
NCT02443753 Obesity Type ... More >>2 Diabetes Less << Not Applicable Terminated - Malaysia ... More >> Universiti Malaya Medical Centre, Jalan universiti Kuala Lumpur, Malaysia, 50603 Less <<
NCT01596192 - Unknown June 2013 Israel ... More >> BMT unit, Rabin Medical Center, Beilinson Hospital Not yet recruiting Petah-Tiqva, Israel, 49100 Contact: Ron Ram, M.D.    972-3-9378116    ronra@clalit.org.il    Principal Investigator: Ron Ram, M.D.          Sub-Investigator: Moshe Yeshurun, M.D.          Sub-Investigator: Hanna Bernstine, M.D.          Sub-Investigator: David Groshar, M.D. Less <<
NCT01307514 - Unknown - Israel ... More >> Hadassah Medical Organization, Active, not recruiting Jerusalem, Israel Less <<
NCT00415974 Obesity Overw... More >>eight Weight Loss Less << Not Applicable Completed - United States, California ... More >> UCSD - CALIT2- Atkinson Hall La Jolla, California, United States, 92037 Less <<
NCT01968928 - Unknown December 2016 Taiwan ... More >> Department of Urology, National Taiwan University Hospital Not yet recruiting Taipei, Taiwan, 10002 Contact: Kuo-How Huang, M.D.,Ph.D.    886-2-23123456 ext 65952    khhuang123@ntu.edu.tw    Principal Investigator: Kuo-How Huang, M.D.,Ph.D. Less <<
NCT02608892 Pain Not Applicable Completed - -
NCT00955903 Obesity Diabe... More >>tes Hypertension Hyperlipidemia Less << Phase 3 Completed - United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35294 Less <<
NCT00134199 Obesity Phase 2 Phase 3 Completed - United States, Florida ... More >> Pfizer Investigational Site Clearwater, Florida, United States, 33761 Pfizer Investigational Site Kissimmee, Florida, United States, 34741 Pfizer Investigational Site Orlando, Florida, United States, 32809 United States, Kentucky Pfizer Investigational Site Lexington, Kentucky, United States, 40509 Pfizer Investigational Site Louisville, Kentucky, United States, 40213 United States, Louisiana Pfizer Investigational Site Baton Rouge, Louisiana, United States, 70808 United States, Massachusetts Pfizer Investigational Site Milford, Massachusetts, United States, 01757 United States, New York Pfizer Investigational Site New York, New York, United States, 10021 United States, North Carolina Pfizer Investigational Site Charlotte, North Carolina, United States, 28211 United States, Tennessee Pfizer Investigational Site Nashville, Tennessee, United States, 37203 United States, Texas Pfizer Investigational Site Dallas, Texas, United States, 75231 Pfizer Investigational Site Dallas, Texas, United States, 75247 Pfizer Investigational Site San Antonio, Texas, United States, 78229 United States, Washington Pfizer Investigational Site Tacoma, Washington, United States, 98403 Pfizer Investigational Site Tacoma, Washington, United States, 98418 Less <<
NCT00955903 - Completed - -
NCT00817505 Type 1 Diabetes Phase 1 Completed - United States, Texas ... More >> Research site San Antonio, Texas, United States Less <<
NCT02317718 - Unknown July 2015 United Arab Emirates ... More >> Fakihivf Fertiity Center Recruiting Abudhabi, Abu Dhabi, United Arab Emirates, 31453 Contact: MONIKA CHAWLA, MD    97124444107 Less <<
NCT02755064 Diabetes Mellitus, Type 1 Phase 1 Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT00583323 Lymphoma Phase 3 Completed - -
NCT02050555 Overweight Not Applicable Completed - Japan ... More >> Hiroshima University Hiroshima, Japan, 734-8551 Less <<
NCT01044537 - Completed - -
NCT01868646 Type II Diabetes Mellitus Phase 4 Completed - Russian Federation ... More >> Municipal budgetary authority "Khimki Central Clinical Hospital" Moscow region, Russian Federation, 141400 State Healthcare Institution of Moscow "Central research institute of gastroenterology" of Department of health care of Moscow Moscow, Russian Federation, 111123 State Educational Institution of Higher Professional Education "Moscow State Medical Academy named after I.M. Sechenov" Moscow, Russian Federation, 119991 Nonstate Health Care Institution "Central Clinical Hospital №2 named after N.A. Semashko of Public Limited Company "Russian Railways" Moscow, Russian Federation, 129128 Nizhny Novgorod regional State Budgetary Health Institution " Nizhny Novgorod regional Clinical Hospital named after N.A. Semashko " Nizhny Novgorod Region, Russian Federation, 603126 State Budgetary Educational Institution of High Professional Training "Rostov State Medical University" of Ministry of Health of Russian Federation, Department of Endocrinology Rostov-on-Don, Russian Federation, 344022 Co.Ltd " Diabet Center" Samara, Russian Federation, 443067 The State Budgetary Educational Institution of Higher Professional Education "Smolensk National Research Medical University" Ministry of Health of the Russian Federation Smolensk, Russian Federation, 214019 St. Petersburg State Budgetary Health Care Institution "City Polyclinic №6" St. Petersburg, Russian Federation, 191482 St. Petersburg State Budgetary Health Care Institution "Saint Venerable Martyr Elizaveta Municipal Hospital" St. Petersburg, Russian Federation, 195257 State Budgetary Educational Institution of High Professional Training "St. Petersburg State Medical University named after academician I.P. Pavlov" of Ministry of Health of Russian Federation, Therapy Faculty Board St. Petersburg, Russian Federation, 197022 St. Petersburg Sate Budgetary Institution "Consultative-Diagnostic Polyclinic №1 of Coastal Area" St. Petersburg, Russian Federation, 197183 St. Petersburg State Budgetary Health Care Institution "Consultative-Diagnostic Center № 85", Diabetes Center №2 St. Petersburg, Russian Federation, 198260 St. Petersburg State Budgetary Health Care Institution "City Polyclinic №77 of Nevsky District", The City Diabetes Center №4 St.Petersburg, Russian Federation, 192177 Vladimir region State budgetary institution of health care "Regional clinical hospital" Vladimir, Russian Federation, 600023 Independent Health Care Institution of Voronezh Region "Voronezh Regional Clinical Consultative-Diagnostic Center" Voronezh, Russian Federation, 394018 State Budgetary Health Care Institution of Yaroslavl Region "Regional Сlinical Hospital" Yaroslavl, Russian Federation, 150062 Less <<
NCT03678831 - Not yet recruiting October 2021 -
NCT03468179 Obesity Cardi... More >>ovascular Diseases Less << Not Applicable Recruiting December 2019 United States, Tennessee ... More >> Vanderbilt University Medical Center Recruiting Nashville, Tennessee, United States, 37232 Less <<
NCT02010476 - Completed - Finland ... More >> Department of Neurology and Brain Research Unit, Institute of Clinical Medicine, University of Eastern Finland Kuopio, Finland, FI-70211 Less <<
NCT01044537 Type 2 Diabetes Mellitus Phase 1 Completed - United States, Arizona ... More >> Dedicated Phase 1 Phoenix, Arizona, United States, 85013 United States, California West Coast Clinical Trials, LLC Cypress, California, United States, 90630 United States, Florida Elite Research Institute Miami, Florida, United States, 33169 Less <<
NCT01573988 Volunteers Not Applicable Terminated(Difficulties in rec... More >>ruiting of volunteers with a BMI (Body Mass Index) between 30 and 35 kg/m2) Less << - France ... More >> Centre Hospitalier Lyon Sud - Centre de Recherche en Nutrition Humaine Pierre Bénite, France, 69495 Less <<
NCT00509470 Essential Hypertension Phase 4 Completed - Japan ... More >> Department of Nephrology and Endocrinology, University of Tokyo Graduate School of Medicine Tokyo, Japan, 113-8655 Less <<
NCT00339469 Inflammation ... More >>Prevention and Control Colonic Neoplasms Diet Insulin Less << Early Phase 1 Completed - United States, Pennsylvania ... More >> Pennsylvania State University University Park, Pennsylvania, United States, 16802 Less <<
NCT01389869 Obesity Not Applicable Completed - Korea, Republic of ... More >> Seoul National University Hospital Seoul, Korea, Republic of, 110-744 Less <<
NCT01334151 Diabetes Mellitus Type 1 Phase 1 Completed - United States, California ... More >> Profil Institute for Clinical Research, Inc. (PICR) Chula Vista, California, United States, 91911 Less <<
NCT01256944 - Completed - Taiwan ... More >> Taipei Medical University-WanFang Hospital Taipei, Taiwan Less <<
NCT03305263 Recurrent Pregnancy Loss Phase 3 Recruiting January 2023 Denmark ... More >> Rigshospitalet Recruiting København, Denmark, 2100 Contact: Louise Lunøe, Nurse    +4535458486    anne.louise.lunoee@regionh.dk    Contact: Henriette S Nielsen, MD    +4535457515    henriette.svarre.nielsen@regionh.dk Less <<
NCT00482924 - Recruiting December 2019 Austria ... More >> Clinical Institute for Medical and Chemical Laboratory Diagnosis Recruiting Graz, Styria, Austria, 8036 Contact: Harald Mangge, Prof., MD    +43316 385 ext 83340    harald.mangge@klinikum-graz.at    Principal Investigator: Harald Mangge, Prof., MD Less <<
NCT00260286 Anovulation A... More >>menorrhea Infertility Starvation Less << Not Applicable Completed - United States, Ohio ... More >> Ohio University Athens, Ohio, United States, 45701 Less <<
NCT00538083 Cardioprotection Phase 1 Completed - United States, Connecticut ... More >> Griffin Hospital Derby, Connecticut, United States, 06418 Less <<
NCT00707447 Diabetes Mellitus Phase 4 Completed - Germany ... More >> Research Institute of the Diabetes Academy Mergentheim (FIDAM) Bad Mergentheim, Germany, D-97980 Less <<
NCT01256944 - Completed - -
NCT03150576 Breast Cancer Phase 2 Phase 3 Recruiting January 2032 United Kingdom ... More >> Cambridge University Hospitals NHS Foundation Trust & the University of Cambridge Recruiting Cambridge, Cambridgeshire, United Kingdom, CB2 0QQ Contact: Anne-Laure Vallier    +44(0) 1223 348086    anne-laure.vallier@addenbrookes.nhs.uk    Contact: Louise Grybowicz    +44(0)1223 348447 Less <<
NCT01863576 Chagas Cardiomyopathy Early Phase 1 Completed - Brazil ... More >> Evandro Chagas Institute of Clinical Research RJ, Br, Brazil, 21040-360 Less <<
NCT02150798 Heart Failure Not Applicable Completed - Mexico ... More >> Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán" Mexico City, Mexico, 14000 Less <<
NCT01010009 Cognitive and Cerebral Blood F... More >>low Effects of Resveratrol Less << Not Applicable Completed - United Kingdom ... More >> Northumbria University Newcastle upon Tyne, United Kingdom, NE1 8ST Less <<
NCT01010009 - Completed - -
NCT00707447 - Completed - -
NCT03528707 Type2 Diabetes ... More >> NAFLD Probiotic Omega-3 Fatty Acids Less << Not Applicable Completed - -
NCT00799448 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 4 Terminated(Low recruitment sta... More >>tus) Less << - Greece ... More >> Novo Nordisk Investigational Site Athens, Greece, 15127 Less <<
NCT00488124 Idiopathic Short Stature Phase 2 Completed - Germany ... More >> Kinderklinik, Universitätsklinikum der RWTH Aachen, Pauwelsstraße 30 Aachen, Germany, 52074 Klinik und Poliklinik für Kinder und Jugendliche der Technischen Universität Dresden, Fetscherstr. 74 Dresden, Germany, 01307 Klinik für Kinder und Jugendliche, Schwerpunkt Kinder-Endokrinologie und - Diabetologie, Loschgestr. 15 Erlangen, Germany, 91054 Klinik für Päd. Hämatologie, Onkologie und Endokrinologie, Zentrum für Kinderheilkunde, der Universität Duisburg-Essen, Hufelandstrasse 55 Essen, Germany, 45122 Kinder- und Jugendärztin, Pippinplatz 4 Gauting, Germany, 82131 Endokrinologikum Hamburg, Lornsenstrasse 4 - 6 Hamburg, Germany, 22767 Kinderarztpraxis, Brabeckstrasse 153 Hannover, Germany, 30539 Universitätsklinik für Kinder- und Jugendliche, Abt. Kinderheilkunde, Im Neuenheimer Feld 430 Heidelberg, Germany, 69120 Universitätsklinik für Kinder- und Jugendmedizin, Kirrberger Strasse Homburg/Saar, Germany, 66421 Klinik u. Poliklinik für Kinder und Jugendliche, Med. Einrichtungen der Universität Köln, Joseph-Stelzmann-Strasse 9 Köln, Germany, 50931 Zentrum für Frauen und Kindermedizin, Liebigstrasse 20 a Leipzig, Germany, 04103 Klinik für Allgemeine Pädiatrie und Neonatologie, Otto-von-Guericke-Universität Magdeburg, Leipziger Straße 44 Magdeburg, Germany, 39112 Klinik für Kinderheilkunde und Jugendmedizin, Sektion Pädiatrische Endokrinologie, Hoppe-Seyler-Straße 1 Tübingen, Germany, 72076 Less <<
NCT00575900 Obesity Not Applicable Completed - Israel ... More >> Schnider children medical center Petach-Tikva, I, Israel Less <<
NCT01777061 - - - United States, Kansas ... More >> University of Kansas Medical Center Kansas City, Kansas, United States, 66160 Less <<
NCT00076362 Obesity Phase 4 Completed - United States, Arizona ... More >> Phoenix Children'S Hospital Phoenix, Arizona, United States, 85016 United States, California Children's Hospital of Orange County Orange, California, United States, 92868 University of California at San Francisco San Francisco, California, United States, 94143 United States, Colorado University of Colorado Denver, Colorado, United States, 80218 United States, Florida Miami Children'S Hopital Miami, Florida, United States, 33155 United States, Illinois Childrens Memorial Hospital Chicago, Illinois, United States, 60614 United States, Indiana St. Vincent Children's Center for Cancer and Blood Diseases Indianapolis, Indiana, United States, 46260 United States, Iowa University of Iowa Hospitals and Clinics Iowa City, Iowa, United States, 52242 United States, Missouri Washington University St. Louis, Missouri, United States, 63110 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27705 United States, Pennsylvania Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 Children's Hospital of Pittsburgh Pittsburgh, Pennsylvania, United States, 15213 United States, Tennessee U of Tennessee HELP Center Memphis, Tennessee, United States, 38103 United States, Texas UT Southwestern Children's Medical Center of Dallas Dallas, Texas, United States, 75390 Texas Children's Hospital Houston, Texas, United States, 77030 Less <<
NCT01449747 Type 2 Diabetes Mellitus Phase 4 Completed - Korea, Republic of ... More >> The Catholic University of Korea; St.Paul's Hospital Seoul, Korea, Republic of, 130-709 The Catholic University of Korea; Seoul St. Mary's Hospital Seoul, Korea, Republic of, 137-701 Less <<
NCT01449747 - Completed - -
NCT00130299 Obesity Not Applicable Completed - United States, Massachusetts ... More >> Children's Hospital Boston Boston, Massachusetts, United States, 02115 Less <<
NCT01162876 Diabetes Phase 3 Completed - Japan ... More >> Kyushu Clinical Pharmacology Reserch Clinic Fukuoka, Japan Less <<
NCT02749227 Pituitary Tumor ... More >> ACTH-producing Pituitary Tumour Less << Phase 2 Recruiting May 2018 United States, New York ... More >> Neuroendocrine Unit and Pituitary Center, Columbia University Recruiting New York, New York, United States, 10032 Contact: Pamela U. Freda, MD    212-305-2254       Contact: Carlos M. Reyes-Vidal, MD    212-305-4921    csr52@cumc.columbia.edu Less <<
NCT02042664 Obesity Diabe... More >>tes Less << Phase 3 Completed - France ... More >> Assistance Publique Hopitaux de Marseille Marseille, France, 13354 Less <<
NCT02683616 Obstructive Sleep Apnea ... More >> Fatty Acid Metabolism Continuous Positive Airway Pressure Less << Not Applicable Recruiting December 2019 Czechia ... More >> FN Kralovske Vinohrady Recruiting Prague, Czechia, 10034 Contact: Jan Polak, MD, PhD    +420267162710    jan.polak@lf3.cuni.cz    Contact: Jan Gojda, MD, PhD    +420267168144    jan.gojda@lf3.cuni.cz Less <<
NCT00092872 Obesity Phase 3 Completed - -
NCT00334269 Obesity Not Applicable Completed - Canada, Ontario ... More >> SHARE-AP Office, Six Nations Health Services P.O. Box 5000 Ohsweken, Ontario, Canada, N0A 1M0 Less <<
NCT03146026 Obesity, Adolescent Not Applicable Completed - -
NCT02141880 - Recruiting December 2018 United States, Missouri ... More >> University of Missouri Recruiting Columbia, Missouri, United States, 65212 Principal Investigator: Elizabeth J Parks, PhD Less <<
NCT01307995 - Completed - Poland ... More >> Departament of Diabetology and Metabolic Diseases, Polish Mothers Research Hospital Lodz, Poland, 93-338 Less <<
NCT03685253 Diabetic Neuropathy Peripheral Phase 1 Phase 2 Not yet recruiting October 1, 2023 United States, Maryland ... More >> University of Maryland Not yet recruiting Baltimore, Maryland, United States, 21201 Contact: Neda M Ilieva, B.S.    410-328-6583    inmed@som.umaryland.edu    Contact: James W Russell, MD    (410) 328-3100    jrussell@som.umaryland.edu    Principal Investigator: James W Russell, MD          Sub-Investigator: Lindsay A Zilliox, MD Less <<
NCT01891682 - Completed - United States, Ohio ... More >> Cleveland Clinic Cleveland, Ohio, United States, 44195 Less <<
NCT00770835 Diabetes Mellitus Phase 4 Completed - Italy ... More >> Padova, Italy Pisa, Italy Less <<
NCT02550548 Insulin Secretion Phase 1 Active, not recruiting August 2019 United States, North Carolina ... More >> Duke Center for Living Durham, North Carolina, United States, 27705 Less <<
NCT00620360 Lipid Metabolism Not Applicable Completed - Switzerland ... More >> Centre Hospitalier Universitaire Vaudois Lausanne, Vaud, Switzerland, 1005 Less <<
NCT02250872 Cancer Cispla... More >>tin Adverse Reaction Less << Phase 2 Phase 3 Unknown June 2018 Korea, Republic of ... More >> Seoul National University Bundang Hospital Recruiting Seongnam-si, Gyeonggi-do, Korea, Republic of, 463-707 Contact: Hyunjin Cho    82 31 787 7030       Principal Investigator: Ki Young Na, MD PhD Less <<
NCT00354666 Pulmonary Disease, Chronic Obs... More >>tructive Less << Phase 2 Completed - -
NCT01537094 Obese Disorde... More >>r of Vitamin C Growth Hormone Secretion Abnormality Less << Phase 2 Withdrawn(Unable to obtain fun... More >>ding to initiate the study. No subjects were enrolled.) Less << - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT01186562 Pancreatitis ... More >>Diabetes Less << Phase 4 Completed - United States, Minnesota ... More >> University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT01638611 Healthy Phase 1 Completed - United States, Nebraska ... More >> Celerion Lincoln, Nebraska, United States, 68502 Less <<
NCT02979756 Gestational Diabetes Mellitus ... More >>in Pregnancy Less << Not Applicable Completed - Morocco ... More >> 20 facilities in Marrakech and Al Haouz - Region Marrakech-Safi Marrakech, Morocco, 40000 Less <<
NCT01186562 - Completed - -
NCT03039478 Physiological Satiation Mechan... More >>isms Less << Not Applicable Completed - Switzerland ... More >> University Hospital Basel Basel, Switzerland, 4031 Less <<
NCT00540904 Radiographic Contrast Agent Ne... More >>phropathy Less << Phase 2 Completed - Brazil ... More >> Hospital do Cancer de Barretos - Fundação PIO XII Barretos, São Paulo, Brazil, 14784-400 Less <<
NCT01388478 Alzheimer's Disease Phase 2 Completed - United States, Kansas ... More >> University of Kansas Medical Center Kansas City, Kansas, United States, 66160 Less <<
NCT00558571 Diabetes Mellitus, Type 2 Phase 1 Completed - Germany ... More >> 1245.4.49003 Boehringer Ingelheim Investigational Site Berlin, Germany 1245.4.49002 Boehringer Ingelheim Investigational Site Mainz, Germany 1245.4.49001 Boehringer Ingelheim Investigational Site Neuss, Germany Less <<
NCT03228602 Obesity Diabe... More >>tes Less << Not Applicable Recruiting July 2017 France ... More >> CHU Dijon Bourgogne Recruiting Dijon, France, 21079 Contact: Agnès JACQUIN-PIQUES    3 80 29 37 54 ext +33    agnes.jacquin-piques@chu-dijon.fr Less <<
NCT00558571 - Completed - -
NCT00798668 Elderly Not Applicable Completed - United States, Indiana ... More >> Purdue University West Lafayette, Indiana, United States, 47907 Less <<
NCT03725709 - Recruiting December 31, 2019 Taiwan ... More >> Chang Gung Memorial Hospital Recruiting Taoyuan, Taiwan, 333 Contact: Fu Chao Liu, MD,PHD    +886 975365718    ana5189@cgmh.org.tw Less <<
NCT02642263 Cesarean Delivery Phase 4 Not yet recruiting January 2022 Switzerland ... More >> Dep. of Anesthesiology and Pain Medicine, Bern University Hospital Not yet recruiting Bern, Switzerland, 3010 Contact: Pascal H Vuilleumier, MD    +41 (0)31 632 21 11    pascal.vuilleumier@insel.ch    Contact: Juerg Schliessbach, MD    +41 (0)31 632 21 11 ext 7818    juerg.schliessbach@insel.ch    Principal Investigator: Pascal H Vuilleumier, MD          Sub-Investigator: Juerg Schliessbach, MD          Sub-Investigator: Fabienne Treichel, RN Less <<
NCT00828451 Prematurity N... More >>ecrotizing Enterocolitis Less << Not Applicable Completed - United States, Missouri ... More >> St. Louis Children's Hospital Saint Louis, Missouri, United States, 63110 Less <<
NCT00828451 - Completed - -
NCT03285750 - Completed - Germany ... More >> German Diabetes Center Duesseldorf, Nordrhein-Westfalen, Germany, 40225 Less <<
NCT01505673 - Completed - -
NCT01505673 Type 2 Diabetes Mellitus ... More >> Obesity Less << Phase 4 Completed - United States, Texas ... More >> UT Southwestern Dallas, Texas, United States, 75390 Less <<
NCT02533167 - Completed - -
NCT03376945 - Completed - China, Hubei ... More >> Hepatic Surgery Center of Tongji Hospital Wuhan, Hubei, China, 430030 Less <<
NCT02533167 Skin to Skin Contact in Cesare... More >>an Deliveries Less << Not Applicable Completed - United States, North Carolina ... More >> Novant Health Forsyth Medical Center Winston-Salem, North Carolina, United States, 27103 Less <<
NCT00391027 Diabetes Mellitus, Type 2 Phase 4 Completed - -
NCT02622113 Type 2 Diabetes Mellitus Phase 4 Completed - Japan ... More >> Reserch site Chubu, Japan Reserch site Chugoku, Japan Reserch site Hokkaido, Japan Reserch site Kanto, Japan Reserch site Kinki, Japan Reserch site Kyushu, Japan Reserch site Tohoku, Japan Less <<
NCT03053986 Endothelial Dysfunction Not Applicable Recruiting April 1, 2017 Italy ... More >> S. Orsola-Malpighi University Hospital Recruiting Bologna, Italy, 40038 Contact: Arrigo FG Cicero, MD, PhD    ++39 512142224    arrigo.cicero@unibo.it    Contact: Arrigo FG Cicero, MD, PhD    ++39 3498558017    afgcicero@gmail.com Less <<
NCT03105583 - Enrolling by invitation October 2017 -
NCT01350102 Diabetes, Type 1 ... More >> Diabetes, Type 2 Foot Ulcer, Diabetic Less << Phase 4 Terminated(study closed due to... More >> recruitment problems) Less << - United States, Pennsylvania ... More >> Penn State Milton S. Hershey Medical Center Hershey, Pennsylvania, United States, 17033 Less <<
NCT00391027 - Completed - -
NCT01350102 - Terminated(study closed due to... More >> recruitment problems) Less << - -
NCT01123980 - Completed - -
NCT00798408 Elderly Not Applicable Completed - United States, Indiana ... More >> Purdue University West Lafayette, Indiana, United States, 47907 Less <<
NCT02057172 Type 2 Diabetes Phase 2 Completed - United States, California ... More >> Hanmi pharmaceutical CA, California, United States Less <<
NCT01123980 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 4 Completed - -
NCT00172042 Non-Small-Cell Lung Cancer Phase 3 Completed - -
NCT01264042 Pregnancy Not Applicable Completed - Switzerland ... More >> University Hospital Zurich Zurich, Switzerland, 8091 Less <<
NCT00430430 Hyperlipidemia ... More >> Cardiovascular Diseases Diet Therapy Less << Phase 2 Completed - Canada, Ontario ... More >> Risk Factor Modification Centre, St. Michael's Hospital Toronto, Ontario, Canada, M5C 2T2 Less <<
NCT03245099 - Not yet recruiting April 2019 Egypt ... More >> AssiutU Not yet recruiting Assiut, Egypt Contact: Rewaa Less <<
NCT02068521 Pediatric Growth Hormone Defic... More >>iency Less << Phase 2 Phase 3 Terminated(The primary endpoin... More >>t of non-inferiority to daily therapy in the pediatric Phase 3 study was not achieved) Less << - -
NCT00826033 - Completed - Japan ... More >> Gunma University Graduate School of Medicine Gunma, Japan, 371-8511 Less <<
NCT00172042 - Completed - -
NCT01868594 Type I Diabetes Mellitus Phase 4 Completed - Russian Federation ... More >> Municipal budgetary authority "Khimki Central Clinical Hospital" Moscow region, Russian Federation, 141400 State Healthcare Institution of Moscow "Central research institute of gastroenterology" of Department of health care of Moscow Moscow, Russian Federation, 111123 State Educational Institution of Higher Professional Education "Moscow State Medical Academy named after I.M. Sechenov" Moscow, Russian Federation, 119991 Nonstate Health Care Institution "Central Clinical Hospital №2 named after N.A. Semashko of Public Limited Company "Russian Railways" Moscow, Russian Federation, 129128 The State Budgetary Institution of Health Care of the Nizhny Novgorod Region "City clinical hospital No. 10 " Nizhny Novgorod, Russian Federation, 603011 Nizhny Novgorod regional State Budgetary Health Institution " Nizhny Novgorod regional Clinical Hospital named after N.A. Semashko " Nizhny Novgorod, Russian Federation, 603126 State Budgetary Educational Institution of High Professional Training "Rostov State Medical University" of Ministry of Health of Russian Federation, Department of Endocrinology Rostov-on-Don, Russian Federation, 344022 Co.Ltd " Diabet Center" Samara, Russian Federation, 443067 Private company "Polyclinic Complex" St. Petersburg, Russian Federation, 190013 St. Petersburg State Budgetary Health Care Institution "City Polyclinic №6" St. Petersburg, Russian Federation, 191482 St. Petersburg State Budgetary Health Care Institution "Saint Venerable Martyr Elizaveta Municipal Hospital" St. Petersburg, Russian Federation, 195257 State Budgetary Educational Institution of High Professional Training "St. Petersburg State Medical University named after academician I.P. Pavlov" of Ministry of Health of Russian Federation, Therapy Faculty Board St. Petersburg, Russian Federation, 197022 St. Petersburg Sate Budgetary Institution "Consultative-Diagnostic Polyclinic №1 of Coastal Area" St. Petersburg, Russian Federation, 197183 Independent Health Care Institution of Voronezh Region "Voronezh Regional Clinical Consultative-Diagnostic Center" Voronezh, Russian Federation, 394018 State Budgetary Health Care Institution of Yaroslavl Region "Regional Сlinical Hospital" Yaroslavl, Russian Federation, 150062 Less <<
NCT00722046 Alzheimer's Disease Phase 2 Completed - -
NCT03582254 Primary Central Nervous System... More >> Lymphoma Less << Not Applicable Recruiting May 12, 2020 France ... More >> Pitié Salpêtrière Hospital Recruiting Paris, France, 75013 Contact: Aurélie KAS, Dr Less <<
NCT01408446 Hypertension ... More >>Prehypertension Less << Phase 2 Phase 3 Recruiting October 2018 China, Chongqing ... More >> The Third Military Medical University Recruiting Chongqing, Chongqing, China, 400042 Contact: Hongbo He, M.D.    86-23-68715705    qhehongbo@gmail.com Less <<
NCT00567034 Schizophrenia ... More >> Psychotic Disorders Less << Phase 1 Completed - United States, Massachusetts ... More >> McLean Hospital Belmont, Massachusetts, United States, 02478 Less <<
NCT03027726 Overweight Children With Type ... More >>2 Diabetes Risk Less << Not Applicable Completed - Spain ... More >> Pediatric Endocrinology Unit of the University Hospital of Araba (HUA) Vitoria-Gasteiz, Araba, Spain, 01009 Less <<
NCT01462331 Healthy Phase 1 Completed - Canada, Ontario ... More >> KGK Synergize London, Ontario, Canada, N6A 5R8 Less <<
NCT00261898 Obesity Chron... More >>ic Sleep Deprivation Less << Phase 2 Terminated(This study has been... More >> terminated. (Interim analysis of preliminary results indicated the need for protocol re-design).) Less << - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT02648204 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT00299273 Obesity Not Applicable Terminated(PI left institution... More >>) Less << - United States, New York ... More >> The Rockefeller University Hospital New York, New York, United States, 10021 Less <<
NCT00996658 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT02648204 - Completed - -
NCT00996658 - Completed - -
NCT03334175 PreDiabetes O... More >>verweight and Obesity Less << Phase 1 Phase 2 Recruiting July 2019 United States, California ... More >> University of California, San Francisco Recruiting San Francisco, California, United States, 94143 Contact: Traci Plaut Less <<
NCT02229396 Diabetes Mellitus Phase 3 Completed - -
NCT02229396 - Completed - -
NCT02580591 Diabetes Mellitus, Type 1 Phase 3 Completed - -
NCT01093651 Diabetes Insu... More >>lin Resistance Less << Phase 2 Phase 3 Completed - United States, Missouri ... More >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Less <<
NCT02580591 - Completed - -
NCT01572389 Diabetes Mellitus ... More >> Depression Less << Not Applicable Completed - United States, Texas ... More >> Michael E. DeBakey VA Medical Center, Houston, TX Houston, Texas, United States, 77030 Less <<
NCT00171613 Hypothalamic Obesity Phase 4 Completed - -
NCT01093651 - Completed - -
NCT03672955 - Active, not recruiting January 1, 2020 Norway ... More >> Oslo University Hospital Oslo, Norway, 0424 Less <<
NCT01331967 Diabetic Stable Angina ... More >> Diabetic Unstable Angina Less << Phase 4 Completed - Korea, Republic of ... More >> Korea University Anam Hospital Seoul, Korea, Republic of, 136705 Less <<
NCT01572077 Pulmonary Arterial Hypertensio... More >>n Less << Not Applicable Completed - Canada, Ontario ... More >> University of OttawaHeart Institute Ottawa, Ontario, Canada, K1Y4W7 Less <<
NCT01941238 - Completed - Saudi Arabia ... More >> National Guards Hospital Dammam, Saudi Arabia, 31412 Less <<
NCT01572389 - Completed - -
NCT01718392 Multiple Sclerosis Not Applicable Completed - Belgium ... More >> REVAL Diepenbeek, Belgium, 3590 Less <<
NCT01622634 Metabolic Syndrome Not Applicable Completed - United States, Georgia ... More >> Body Composition and Metabolism Lab, Ramsey Center, University of Georgia Athens, Georgia, United States, 30602 Less <<
NCT03471117 Chronic Kidney Diseases Phase 4 Recruiting June 1, 2020 United States, Texas ... More >> University of Texas at Arlington Recruiting Arlington, Texas, United States, 76010 Contact: Paul J Fadel, PhD    817-272-4653    paul.fadel@uta.edu    UT Southwestern Recruiting Dallas, Texas, United States, 75390 Contact: Robert Toto, MD    214-648-2744    Robert.Toto@UTSouthwestern.edu Less <<
NCT03413202 Acute Ischemic Stroke Phase 4 Recruiting July 2020 China, Jilin ... More >> First Hospital of Jilin University Recruiting Changchun, Jilin, China, 130000 Contact: Yi Yang, MD, PhD       doctor_yangyi@163.com Less <<
NCT01666418 Melanoma Phase 2 Completed - Switzerland ... More >> University Hospital Zurich, Division of Dermatology Zurich, Switzerland Less <<
NCT02356419 Chronic Renal Failure Phase 1 Unknown March 2015 China, Liaoning ... More >> Shengjing Hospital affiliated to China Medical University Recruiting Shenyang, Liaoning, China, 110004 Contact: limei zhao, doctor    8624-96615    zhaolm@sj-hospital.org    Contact: feng qiu, doctor    8624-96615    zhaolm@sj-hospital.org Less <<
NCT01680185 Hyperglycemia Phase 3 Completed - Austria ... More >> Medical University of Vienna Vienna, Austria, 1090 Less <<
NCT00661869 Schizophrenia ... More >> Schizoaffective Disorder Bipolar Disorder Less << Not Applicable Completed - United States, New York ... More >> Manhattan Psychiatric Center New York, New York, United States, 10035 Less <<
NCT00697814 Hypogonadotropic Hypogonadism ... More >> Prolactinoma Less << Phase 2 Completed - Brazil ... More >> Neuroendocrine Unit - Escola Paulista de Medicina (UNIFESP) Sao Paulo, SP, Brazil, 09541-330 Less <<
NCT00847977 Head Trauma Phase 3 Terminated - France ... More >> Service de Réanimation CHU de Nantes Boulevard Jean Monnet Nantes, France, 44093 Less <<
NCT03314844 - Completed - -
NCT01465165 - Terminated(Study procedures we... More >>re not feasible.) Less << - United States, Utah ... More >> University of Utah Dept of Psychiatry Salt Lake City, Utah, United States, 84112 Less <<
NCT02847390 - Active, not recruiting June 30, 2019 -
NCT00761761 - Completed - -
NCT03176056 Type 2 Diabetes Mellitus Not Applicable Completed - -
NCT00190749 Schizophrenia ... More >> Schizoaffective Disorder Less << Phase 4 Completed - United States, California ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. San Diego, California, United States, 92161 Less <<
NCT00190749 - Completed - -
NCT03280654 - Completed - -
NCT01243879 Calorie Restriction ... More >> Aging Less << Not Applicable Completed - -
NCT02813096 Carcinoma, Hepatocellular Not Applicable Unknown July 2018 -
NCT00934505 - Unknown April 2014 France ... More >> CLCC H.Becquerel Recruiting Rouen, Haute Normandie, France, 76000 Contact: THILLAYS Marc, RT    0033232082497    marc.thillays@touen.fnclcc.fr    Contact: GOUEL Pierrick, RT    0033232082497    pierrick.gouel@rouen.fnclcc.fr    Sub-Investigator: BENYOUCEF Ahmed, MD Less <<
NCT01944618 - Terminated() - Australia, Victoria ... More >> Local Institution Clayton, Victoria, Australia, VIC 3168 Less <<
NCT01419743 - Terminated(Low recruitment num... More >>bers) Less << - United States, Illinois ... More >> Northwestern Memorial Faculty Foundation Chicago, Illinois, United States, 60611 Northwestern Memorial Hospital Chicago, Illinois, United States, 60611 Northwestern University Feinberg School of Medicine Chicago, Illinois, United States, 60611 Less <<
NCT01323088 Abdominal Obesity ... More >> Physical Activity Less << Not Applicable Completed - United States, Pennsylvania ... More >> Children's Hospital of Pittsburgh, University of Pittsburgh School of Medicine Pittsburgh, Pennsylvania, United States Less <<
NCT02164552 - Unknown December 2014 Saudi Arabia ... More >> Center of Excellence for Osteoporosis Research, King Abdulaziz University Recruiting Jeddah, Makkah, Saudi Arabia, 21589 Contact: Veronica B Orbacedo, BSc    0096612640000 ext 25574    vorbacedo@yahoo.com    Contact: Ramia Al-sobhi, BSc    0096612640000 ext 25528    ceor@kau.edu.sa    Sub-Investigator: Ahmed Y Ali, MD          Sub-Investigator: Ghazi Y Refai, MD          Sub-Investigator: Mohammed H Qari, FRCPA          Sub-Investigator: Heba S Kary, MD Less <<
NCT00605111 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 4 Completed - Australia, New South Wales ... More >> Novo Nordisk Investigational Site Blacktown, New South Wales, Australia, 2148 Novo Nordisk Investigational Site Broadmeadow, New South Wales, Australia, 2292 Australia Novo Nordisk Investigational Site Fitzroy, Australia, 3065 Novo Nordisk Investigational Site Garran, Australia, 2605 Novo Nordisk Investigational Site Stones Corner, Australia, 4120 Hong Kong Novo Nordisk Investigational Site Hong Kong Island, Hong Kong Novo Nordisk Investigational Site Shatin, New Territories, Hong Kong Malaysia Novo Nordisk Investigational Site Cheras, Malaysia, 56000 Novo Nordisk Investigational Site Georgetown, Penang, Malaysia, 10450 Novo Nordisk Investigational Site Kota Bharu, Kelantan, Malaysia, 16150 Philippines Novo Nordisk Investigational Site Cebu City, Philippines, 6000 Novo Nordisk Investigational Site Quezon City, Philippines, 1100 Singapore Novo Nordisk Investigational Site Singapore, Singapore, 159964 Taiwan Novo Nordisk Investigational Site Changhua, Taiwan, 500 Novo Nordisk Investigational Site Kaoshiung, Taiwan, 807 Thailand Novo Nordisk Investigational Site Bangkok, Thailand, 10300 Novo Nordisk Investigational Site Bangkok, Thailand, 10330 Less <<
NCT01987908 Sickle Cell Disease Phase 2 Terminated(Study was terminate... More >>d early by the Sponsor due to unblinding between study drug and placebo groups at the subject, site and Sponsor levels.) Less << - United Kingdom ... More >> Quintiles Ltd. - Quintiles Drug Research Unit, 6 Newcomen Street London, United Kingdom, SE1 1YR Less <<
NCT01630980 - Completed - Canada, Ontario ... More >> The Toronto 3D (Diet, Digestive tract and Disease) Knowledge Synthesis and Clinical Trials Unit, Clinical Nutrition and Risk Factor Modification Centre, St. Micheal's Hospital Toronto, Ontario, Canada, M5C 2T2 Less <<
NCT02906709 Type 2 Diabetes Mellitus Phase 4 Completed - -
NCT02546401 Diabetes Type 1 Phase 3 Completed - France ... More >> CHRU Brest Brest, France, 29200 Less <<
NCT01725399 Post-operative Vomiting Not Applicable Completed - United States, North Carolina ... More >> UNC Chapel Hill Chapel Hill, North Carolina, United States, 27599 Less <<
NCT01987908 - Terminated(Study was terminate... More >>d early by the Sponsor due to unblinding between study drug and placebo groups at the subject, site and Sponsor levels.) Less << - -
NCT00845936 Drug Induced Weight Gain Phase 4 Unknown May 2010 Israel ... More >> Beer-Yaacov MHC Not yet recruiting Beer Yaacov, Israel, 70350 Contact: Pazit Leibovich, MD    972-9284065    pazit.leib@gmail.com    Sub-Investigator: Pazit Leibovich, MD Less <<
NCT02433691 Memory Impairment Not Applicable Completed - United States, California ... More >> UCLA Longevity Center Los Angeles, California, United States, 90095 Less <<
NCT00659711 Type 2 Diabetes Not Applicable Unknown December 2013 United States, New York ... More >> 115 Flint Road Buffalo, New York, United States, 14221 Less <<
NCT00184626 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 4 Completed - Turkey ... More >> Novo Nordisk Investigational Site Istanbul, Turkey, 111 Less <<
NCT02305953 - Completed - Canada, Ontario ... More >> Lynderm Research Markham, Ontario, Canada, L3P 1X2 Windsor Clinical Research Inc. Windsor, Ontario, Canada, N8W 5L7 Canada, Quebec Clinique Dre Isabelle Delorme Drummondville, Quebec, Canada, J2B 5L4 Innovaderm Research Montreal, Quebec, Canada, H2K 4L5 Less <<
NCT03323580 Fluid Therapy ... More >> Brain Edema Brain Tumor Less << Not Applicable Recruiting November 2019 China, Beijing ... More >> Beijing Tiantan Hospital Recruiting Beijing, Beijing, China, 100050 Contact: Yuming Peng, MD    8610-67096658    florapym766@163.com    Contact: Jia Dong Less <<
NCT02680873 Diabetes Mellitus Type 2 in Ob... More >>ese Less << Not Applicable Completed - -
NCT01797198 Drug-Drug Interaction (DDI) ... More >> Healthy Subjects Less << Phase 1 Completed - United Kingdom ... More >> PAREXEL Early Phase Clinical Unit Harrow, United Kingdom, HA1 3U Less <<
NCT02434952 Malaria, Falciparum ... More >> G6PD Deficiency Less << Phase 4 Completed - Cambodia ... More >> Ratanakiri Provincial Hospital Ratanakiri, Cambodia Less <<
NCT02348762 Aging Erythro... More >>cyte Glutathione Deficiency Muscle Weakness Less << Phase 1 Recruiting December 2018 United States, Texas ... More >> Baylor Metabolic Research Unit (MRU) Recruiting Houston, Texas, United States, 77030 Contact: R V Sekhar, M.D. Less <<
NCT01314690 Obesity Not Applicable Completed - France ... More >> Assistance publique-hopitaux de Paris Paris, France Less <<
NCT00184574 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT01394497 Liver Failure ... More >> Liver Failure, Acute Liver Diseases Carcinoma, Hepatocellular Liver Neoplasms Less << Phase 2 Completed - Italy ... More >> Azienda Ospedaliera di Padova Padova, Italy, 35128 Less <<
NCT00579774 Aging Not Applicable Completed - United States, New York ... More >> Mount Sinai School of Medicine New York, New York, United States, 10029 Less <<
NCT02487615 - Completed - Brazil ... More >> State University Of Campinas Campinas, Sao Paulo, Brazil, 13083-887 Dante Pazzanese Institute of Cardiology São Paulo, Brazil, 04012-909 Less <<
NCT02903433 Cardiovascular Disease Not Applicable Recruiting December 2018 United States, California ... More >> South Bay Latino Research Center Recruiting Chula Vista, California, United States, 91910 Contact: Nicole Villa, MPH    619-205-1931    nvilla@mail.sdsu.edu    Contact: Manuel Lopez    619-240-7775 Less <<
NCT03198325 HIV Seropositivity Not Applicable Recruiting April 2018 Italy ... More >> Ospedale San Raffaele Scientific Institute Recruiting Milan, Italy, 20127 Contact: Elisabetta Carini    0039022643 ext 7934    carini.elisabetta@hsr.it Less <<
NCT01722682 Type 1 Diabetes Phase 1 Phase 2 Completed - Italy ... More >> Ospedale San Raffaele Milan, Italy, 20132 Less <<
NCT01068652 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 4 Completed - Algeria ... More >> Novo Nordisk Investigational Site Ain Témouchent, Algeria, 46000 Novo Nordisk Investigational Site Alger, Algeria, 16000 Novo Nordisk Investigational Site Algiers, Algeria, 16000 Novo Nordisk Investigational Site Constantine, Algeria, 25000 Novo Nordisk Investigational Site Oran, Algeria, 31000 Novo Nordisk Investigational Site Setif, Algeria, 19000 Novo Nordisk Investigational Site Sidi Bel Abbes, Algeria, 22000 Egypt Novo Nordisk Investigational Site Alexandria, Egypt, 21131 Morocco Novo Nordisk Investigational Site Casablanca, Morocco, 20000 South Africa Novo Nordisk Investigational Site Port Elizabeth, Eastern Cape, South Africa, 6014 Novo Nordisk Investigational Site Johannesburg, Gauteng, South Africa, 1812 Novo Nordisk Investigational Site Pretoria, Gauteng, South Africa, 0002 Novo Nordisk Investigational Site Pretoria, Gauteng, South Africa, 0083 Novo Nordisk Investigational Site Vaderbijlpark, Gauteng, South Africa, 1900 Novo Nordisk Investigational Site Durban, KwaZulu-Natal, South Africa, 4170 Novo Nordisk Investigational Site Durban, KwaZulu-Natal, South Africa, 4450 Novo Nordisk Investigational Site Kimberly, Northern Cape, South Africa, 8301 Novo Nordisk Investigational Site Cape Town, Western Cape, South Africa, 7945 Novo Nordisk Investigational Site Sandton, South Africa, 2146 Tunisia Novo Nordisk Investigational Site Tunisia, Tunisia, 1053 Less <<
NCT01068652 - Completed - -
NCT03546595 Polycystic Ovary Syndrome ... More >> Insulin Resistance Less << Not Applicable Recruiting December 31, 2019 China, Heilongjiang ... More >> First Affiliated Hospital, Heilongjiang University of Chinese Medicine Recruiting Harbin, Heilongjiang, China, 150040 Contact: Lihui Hou, Bachelor    86-451-82111401    houlihui2007@sina.com Less <<
NCT01887327 Jaundice, Neonatal ... More >> Hyperbilirubinemia, Neonatal Less << Phase 2 Completed - United States, California ... More >> Arrowhead Regional Medical Center Colton, California, United States, 92324 University of California San Diego Medical Center San Diego, California, United States, 92103 University of CA, San Francisco San Francisco, California, United States, 94145 United States, Florida Univ Florida Hospital Jacksonville, Florida, United States, 32209 United States, Iowa University of Iowa Children's Hospital Iowa City, Iowa, United States, 52242 United States, Kentucky Kosair Children's Hospital Louisville, Kentucky, United States, 40202 University of Louisville Hospital Louisville, Kentucky, United States, 40202 United States, Nevada Univ Med Ctr of Southern Nevada Las Vegas, Nevada, United States, 89102 United States, New Jersey Rutgers University Hospital Newark, New Jersey, United States, 07103 United States, New York Winthrop University Hospital Mineola, New York, United States, 11501 Stoney Brook Univ Hospital Stony Brook, New York, United States, 11794 Stoney Brook Univ Hospital Stony Brook, New York, United States, 22794 United States, North Carolina WakeMed Health and Hospitals Raleigh, North Carolina, United States, 27610 United States, Ohio Toledo Children's Hospital Toledo, Ohio, United States, 43606 United States, Pennsylvania Hahnemann University Hospital/St. Christopher's Hospital for Children Philadelphia, Pennsylvania, United States, 19102 United States, South Carolina Medical Univ of South Carolina Charleston, South Carolina, United States, 29425 United States, Tennessee University of Tennessee Health Science Center Memphis, Tennessee, United States, 38163 United States, Texas JPS Health Network Fort Worth, Texas, United States, 76104 Univ Texas Medical Branch Galveston, Texas, United States, 77555 United States, Virginia Children's Hospital of Richmond at VCU Richmond, Virginia, United States, 23298 Less <<
NCT00005100 - Unknown - United States, New York ... More >> Columbia University College of Physicians and Surgeons Recruiting New York, New York, United States, 10032 Contact: Pamela U. Freda    212-305-3725 Less <<
NCT00384085 Diabetes Mellitus, Type 2 Phase 4 Completed - United States, New Jersey ... More >> Sanofi-Aventis Administrative Office Bridgewater, New Jersey, United States Less <<
NCT01144520 - Active, not recruiting December 2018 United States, Ohio ... More >> Ohio State University Comprehensive Wound Center Columbus, Ohio, United States, 43221 Less <<
NCT00384085 - Completed - -
NCT00311077 Diabetes Mellitus Phase 1 Completed - -
NCT02083159 - Unknown - Korea, Republic of ... More >> Korea Univ. Guro Hospital Recruiting Seoul, Korea, Republic of Contact: Ho Cheol Hong, M.D.    822-2626-3044    naeyo21@naver.com    Contact: Kyung Mook Choi, M.D.    822-2626-3043    medica7@gmail.com Less <<
NCT01680484 Nonreassuring Fetal Status Not Applicable Completed - Turkey ... More >> Dr. Sami Ulus Maternity and Children's Training and Research Hospital Ankara, Turkey, 06080 Less <<
NCT03758742 Diabetes Mellitus, Type 2 Not Applicable Not yet recruiting June 2021 -
NCT01897844 Healthy Phase 1 Completed - Italy ... More >> Centro Ricerche Cliniche Verona, Italy, 37134 Less <<
NCT02690883 Diabetic Nephropathies Phase 4 Unknown October 2017 -
NCT02026232 Type 2 Diabetes Mellitus Not Applicable Recruiting December 2018 United States, Missouri ... More >> Washington University Recruiting Saint Louis, Missouri, United States, 63110 Contact: Stacy Hurst, BSN, RN    314-747-3294    shurst@wustl.edu    Contact: Janet B. McGill, M.D.    (314) 362-8681    jmcgill@wustl.edu    Principal Investigator: Clay F. Semenkovich, M.D.          Sub-Investigator: Janet B. McGill, M.D. Less <<
NCT02857387 Acute Coronary Syndrome Not Applicable Completed - France ... More >> Chu Reims France, Reims, France, 51092 Less <<
NCT02151786 - Completed - -
NCT02118324 Acute Lymphoblastic Leukemia Not Applicable Completed - United States, Minnesota ... More >> University of Minnesota Amplatz Children's Hospital Minneapolis, Minnesota, United States, 55454 Less <<
NCT02082496 Obesity Phase 2 Active, not recruiting April 2019 Denmark ... More >> Department of Biomedical Sciences Copenhagen, Denmark, 2200 Less <<
NCT03275090 Sepsis Newborn Phase 4 Completed - Egypt ... More >> Mansoura University Children Hospital Mansourah, Dakahlia, Egypt, 35516 Less <<
NCT01824771 - Unknown March 2015 China, Guangdong ... More >> The first affiliated hospital, Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510080 Contact: Liu Yong-Jun, PhD    15913111033 ext +8620    yjliu2004@163.com    Principal Investigator: Liu Yong-Jun, PhD Less <<
NCT00791479 Diabetes Mellitus, Type 2 Phase 2 Completed - -
NCT02151786 - Completed - -
NCT01486875 - Completed - Sweden ... More >> Novo Nordisk Investigational Site Lund, Sweden, 221 85 Less <<
NCT01562561 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - Hong Kong ... More >> Novo Nordisk Investigational Site Shatin, New Territories, Hong Kong Malaysia Novo Nordisk Investigational Site Kota Bharu, Kelantan, Malaysia, 16150 Philippines Novo Nordisk Investigational Site Marikina City, Philippines, 1800 Novo Nordisk Investigational Site Pasig City, Philippines, 1605 Novo Nordisk Investigational Site Quezon City, Philippines, 1100 South Africa Novo Nordisk Investigational Site Johannesburg, Gauteng, South Africa, 2193 Novo Nordisk Investigational Site Pretoria, Gauteng, South Africa Novo Nordisk Investigational Site Durban, KwaZulu-Natal, South Africa, 4001 Novo Nordisk Investigational Site Brits, North West, South Africa, 0250 Novo Nordisk Investigational Site Cape Town, Western Cape, South Africa, 7460 Novo Nordisk Investigational Site Alberton, South Africa, 1449 Taiwan Novo Nordisk Investigational Site Tainan city, Taiwan, 710 Less <<
NCT00791479 - Completed - -
NCT00251797 Brain and Nervous System ... More >> Cancer Less << Phase 1 Completed - United States, New Mexico ... More >> University of New Mexico Albuquerque, New Mexico, United States, 87131 Less <<
NCT03347942 Feeding Behavior ... More >> Diet, Reducing Eating Less << Not Applicable Recruiting July 2018 Brazil ... More >> Hospital de Clínicas de Porto Alegre Recruiting Porto Alegre, Rio Grande Do Sul, Brazil, 90035903 Contact: Milena Artifon, Nutricionist    55 54 991661416    milena.artifon@gmail.com    Contact: Thaís R Moreira, Nutricionist    55 51 999161004    thaisr_moreira@hotmail.com Less <<
NCT00675311 Type 1 Diabetes ... More >> Type 2 Diabetes Less << Not Applicable Completed - United States, Georgia ... More >> Marietta, Georgia, United States Less <<
NCT01943604 Neuropsychology Not Applicable Completed - United States, Texas ... More >> Baylor College of Medicine Houston, Texas, United States, 77030 Less <<
NCT03713164 Healthy Phase 1 Phase 2 Completed - United States, California ... More >> UCLA Center for Human Nutrition, 900 Veteran Ave. Los Angeles, California, United States, 90095 Less <<
NCT02757456 Cardiovascular Disease Not Applicable Completed - Canada, Quebec ... More >> Royal Victoria Hospital Montreal, Quebec, Canada, H3A 1A1 Montreal General Hospital Montreal, Quebec, Canada, H3G 1A4 Less <<
NCT01525238 Type 2 Diabetes Mellitus Phase 1 Completed - United States, Alabama ... More >> The Children Hospital Of Alabama Birmingham, Alabama, United States, 35233 United States, California Axis Clinical Trials Los Angeles, California, United States, 90036 United States, Florida Nemours Childrens Hospital Orlando, Florida, United States, 32827 United States, Georgia Emory University Atlanta, Georgia, United States, 30322 United States, Kentucky Kosair Charities Pediatric Clinical Research Unit Louisville, Kentucky, United States, 40202 United States, Louisiana Lsuhsc-Shreveport Shreveport, Louisiana, United States, 71103 United States, Missouri Childrens Mercy Hospital Kansas City, Missouri, United States, 64108 United States, New York Women And Children'S Hopsital Of Buffalo Buffalo, New York, United States, 14222 United States, Ohio Promedica Toledo Children'S Hospital Toledo, Ohio, United States, 43606 Mercy Children'S Hospital Toledo, Ohio, United States, 43608 United States, Pennsylvania Children'S Hospital Of Philadelphia Philadelphia, Pennsylvania, United States, 19104 Children'S Hospital Of Pittsburgh Of Upmc Pittsburgh, Pennsylvania, United States, 15224 United States, Tennessee Methodist Le Bonheur Hlthcare Memphis, Tennessee, United States, 38103 United States, Texas Christus Santa Rosa Childrens Hospital San Antonio, Texas, United States, 78207 Mexico Local Institution Guadalajara, Jalisco, Mexico, 44150 Local Institution Monterrey, Nuevo Leon, Mexico, 64460 Local Institution Veracruz, Mexico, 91910 Less <<
NCT02820298 Type 2 Diabetes Mellitus Phase 1 Completed - United States, Colorado ... More >> Denver Clinical Research Unit Lakewood, Colorado, United States, 80228 Less <<
NCT03774511 Nonalcoholic Fatty Liver Disea... More >>se Obesity Exercise Less << Not Applicable Completed - Egypt ... More >> Dr Sayed Tanatwy Giza, Egypt Less <<
NCT01495949 Coronary Artery Disease ... More >> Valvular Heart Disease Less << Phase 4 Completed - Thailand ... More >> Siriraj Hospital Mahidol University Bangkok, Thailand, 10700 Less <<
NCT00522496 - Unknown August 2009 Canada, Alberta ... More >> Foothills Medical Centre Recruiting Calgary, Alberta, Canada, T2N 2T9 Contact: David A Zygun, MD    403-944-1691    dzygun@ucalgary.ca    Principal Investigator: David A Zygun, MD          Sub-Investigator: John Hurlbert, MD          Sub-Investigator: Ian Parney, MD          Sub-Investigator: Walter Hader, MD          Sub-Investigator: Clare Gallagher, MD          Sub-Investigator: Wee Yong, P.hD          Sub-Investigator: Christopher Doig, MD          Sub-Investigator: Paul Kubes, MD          Sub-Investigator: Andreas Kramer, MD Less <<
NCT02336789 Disorientation as to People, T... More >>ime and Place Less << Not Applicable Unknown December 2016 Israel ... More >> Kaplan Medical Center Recruiting Rehovot, Israel, 76100 Contact: Ali Abdullah, MD    089441370 Less <<
NCT00985010 - Terminated(The authors finishe... More >>d their jobs in the hospitals where the study was begun.) Less << - -
NCT01525238 - Completed - -
NCT01479920 Major Depressive Disorder ... More >> Depression Less << Not Applicable Completed - China ... More >> School of Traditional Chinese Medicine, Southern Medical University Guangzhou, China Department of Psychiatry, Queen Mary Hospital Hong Kong, China Department of Psychiatry, Kowloon Hospital Kowloon, China Hong Kong Department of Diagnostic Radiology, The University of Hong Kong Hong Kong, Hong Kong Less <<
NCT00985010 - Terminated(The authors finishe... More >>d their jobs in the hospitals where the study was begun.) Less << - Mexico ... More >> General Hospital "Dr. Darío Fernández Fierro" Mexico, D.f., Mexico, 03900 Less <<
NCT01107678 Childhood Obesity Not Applicable Completed - United States, Kansas ... More >> Energy Balance Lab, The University of Kansas Lawrence, Kansas, United States, 66045 Less <<
NCT00600106 Myocardial Ischemia Not Applicable Completed - United States, California ... More >> Cedars-Sinai Women's Heart Center, 8631 W. 3rd St, Suite 740 Los Angeles, California, United States, 90048 Less <<
NCT03124485 Endoscopic Sleeve Gastroplasty Not Applicable Not yet recruiting September 2020 China ... More >> Chinese University of Hong Kong Hong Kong, China Less <<
NCT00324532 GERD Phase 3 Completed - Israel ... More >> Shaarei Zedek Medical Center Jerusalem, Israel Less <<
NCT01277614 Metabolic Syndrome ... More >> Triglycerides Blood Pressure Diabetes Less << Not Applicable Completed - Trinidad and Tobago ... More >> Dan Ramdath St. Augustine, Mt. Hope, Trinidad and Tobago, TTO Less <<
NCT01831921 Pre Diabetes ... More >>Obesity Metabolic Syndrome Less << Not Applicable Completed - United States, North Carolina ... More >> Wake Forest School of Medicine Winston-Salem, North Carolina, United States, 27157 Less <<
NCT02461472 - Recruiting December 2018 China, Shanghai ... More >> Huasha Hospital Recruiting Shanghai, Shanghai, China, 200040 Contact: Zihui Tang, M.D and Ph.D    +8615821993541    dr_zhtang@yeah.net Less <<
NCT00761761 Bipolar I Disorder ... More >> Bipolar II Disorder Bipolar Disorder NOS Less << Phase 3 Completed - United States, Pennsylvania ... More >> Western Psychiatric Institute and Clinic University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States, 15213-2593 Western Psychiatric Institute and Clinic Pittsburgh, Pennsylvania, United States, 15213 Less <<
NCT01241448 Diabetes Mellitus, Type 2 Phase 2 Completed - -
NCT01677104 Type 2 Diabetes ... More >> Obesity Less << Not Applicable Completed - United Kingdom ... More >> Diabetes and Vascular Center Exeter, United Kingdom, EX2 5AX Less <<
NCT00600106 - Completed - -
NCT01831921 - Completed - -
NCT01519674 - Completed - -
NCT03200860 Heart Failure Acute ... More >> Heart Failure，Congestive Heart Failure; With Decompensation Less << Phase 2 Recruiting December 2019 Netherlands ... More >> University Medical Center Groningen Recruiting Groningen, Netherlands, 9700RB Contact: Kevin Damman, MD,PhD    0031503616161       Principal Investigator: Kevin Damman, MD,PhD Less <<
NCT00716222 - Unknown May 2009 Belgium ... More >> Cliniques Universitaires Saint Luc Recruiting Brussels, Belgium, 1200 Contact: Veronique VB Beauloye, PhD    +3227641370    Veronique.Beauloye@uclouvain.be Less <<
NCT01519674 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 4 Completed - -
NCT03618862 - Not yet recruiting December 2019 France ... More >> Service des maladies infectieuses et tropicales - Hôpital de la Croix Rousse - GHN Not yet recruiting Lyon, France, 69004 Contact: Tristan FERRY, Pr    04 72 07 11 07 ext +33    tristan.ferry@chu-lyon.fr    Principal Investigator: Tristan FERRY, Pr          Sub-Investigator: Christian CHIDIAC, Pr Less <<
NCT00135330 Diabetes Mellitus, Type 2 Phase 3 Completed - United States, Arizona ... More >> Research Site Phoenix, Arizona, United States United States, California Research Site San Francisco, California, United States United States, Florida Research Site Jacksonville, Florida, United States Research Site Orlando, Florida, United States United States, Georgia Research Site Atlanta, Georgia, United States United States, Hawaii Research Site Honolulu, Hawaii, United States United States, Indiana Research Site Indianapolis, Indiana, United States United States, Massachusetts Research Site Boston, Massachusetts, United States Research Site Pittsfield, Massachusetts, United States United States, Minnesota Research Site Minneapolis, Minnesota, United States Research Site Rochester, Minnesota, United States United States, New York Research Site Bronx, New York, United States Research Site Syracuse, New York, United States United States, Ohio Research Site Cincinatti, Ohio, United States United States, Texas Research Site League City, Texas, United States Research Site New Braunfels, Texas, United States Research Site San Antonio, Texas, United States United States, Washington Research Site Renton, Washington, United States Research Site Spokane, Washington, United States Less <<
NCT02977416 Juvenile Idiopathic Arthritis Not Applicable Recruiting September 2020 France ... More >> CHU Clermon-Ferrand Recruiting Clermont-Ferrand, France, 63003 Contact: Patrick LACARIN    0473751195    placarin@chu-clermontferrand.fr    Principal Investigator: Etienne MERLIN Less <<
NCT01241448 - Completed - -
NCT03390231 Diabetes Mellitus, Type 1 ... More >> Diabetes Mellitus, Type 2 Less << Phase 2 Recruiting December 31, 2020 China ... More >> Department of Endocrinology, Chinese PLA General Hospital Recruiting Beijing, China, 100853 Contact: Yu Cheng, MD,PhD    86 10 55499301    chengyu_301@163.com    Contact: Yiming Mu, MD,PhD    86 10 55499301    muyiming@301hospital.com.cn Less <<
NCT01215370 Metabolic Syndrome Not Applicable Completed - Netherlands ... More >> Wageningen University, Division of Human Nutrition Wageningen, Gelderland, Netherlands Less <<
NCT02583880 - Completed - -
NCT02566317 Obesity Hyper... More >>tension Diabetes Less << Not Applicable Recruiting December 15, 2018 United States, Arizona ... More >> Arizona State University Recruiting Tempe, Arizona, United States, 85281 Contact: Matthew P Buman, PhD    602-827-2289    matthew.buman@asu.edu    United States, Minnesota University of Minnesota Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Mark A Pereira, PhD    612-624-4173    perei004@umn.edu Less <<
NCT03068078 Type2 Diabetes ... More >> Nonalcoholic Steatohepatitis Non-Alcoholic Fatty Liver Disease Atherosclerosis Dyslipidemias Less << Not Applicable Recruiting December 2020 Denmark ... More >> Odense University Hospital Recruiting Odense, Denmark, 5000 Less <<
NCT02854683 Chronic Fatigue Syndrome ... More >> Myalgic Encephalomyelitis Systemic Exertion Intolerance Disease (SEID) Postural Tachycardia Syndrome (POTS) Neurally Mediated Syncope (NMS) Less << Phase 1 Active, not recruiting January 2019 United States, New York ... More >> NewYork Medical College Hawthorne, New York, United States, 10532 Less <<
NCT00841087 - Completed - -
NCT02673281 Obesity Not Applicable Active, not recruiting February 2020 United States, Massachusetts ... More >> Beth Israel Deaconess Medical Center, Clinical Research Center Boston, Massachusetts, United States, 02215 Less <<
NCT02045563 - Unknown - France ... More >> CHU de DIJON Recruiting Dijon, France, 21079 Contact: Jean-Michel PETIT    3 80 29 34 53 ext +33    jean-michel.petit@chu-dijon.fr Less <<
NCT02870361 Insulin Secretion Not Applicable Completed - Germany ... More >> University of Tuebingen, Department of Internal Medicine IV Tübingen, Germany, 72076 Less <<
NCT00135330 - Completed - -
NCT02439879 - Completed - -
NCT00841087 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 2 Completed - Japan ... More >> Novo Nordisk Investigational Site Chuo-ku, Tokyo, Japan, 103 0002 Novo Nordisk Investigational Site Ebina-shi, Japan, 243 0432 Novo Nordisk Investigational Site Koriyama-shi, Fukushima, Japan, 963 8851 Novo Nordisk Investigational Site Kumamoto-shi,Kumamoto, Japan, 862 0976 Novo Nordisk Investigational Site Oita-shi, Japan, 870 0039 Novo Nordisk Investigational Site Sapporo-shi, Hokkaido, Japan, 060 0062 Novo Nordisk Investigational Site Sapporo-shi, Hokkaido, Japan, 062 0007 Novo Nordisk Investigational Site Yokohama-shi, Japan, 235 0045 Less <<
NCT01816698 Prehypertension Phase 3 Completed - China, Chongqing ... More >> The third hospital affiliated to the Third Military Medical University Chongqing, Chongqing, China, 400042 Less <<
NCT02265822 Premedication ... More >> Anaesthesia Less << Phase 4 Completed - -
NCT02439879 Diabetic Neuropathy Phase 4 Completed - -
NCT03411681 Obesity Not Applicable Completed - United States, Illinois ... More >> Freer Hall Urbana, Illinois, United States, 61801 Less <<
NCT00708578 Type 2 Diabetes Mellitus Phase 4 Completed - Korea, Republic of ... More >> Sanofi-Aventis Administrative Office Seoul, Korea, Republic of Less <<
NCT02170207 - Completed - -
NCT02748733 Primary Study Outcome: Sodium ... More >>Clearance in Dialysis Solute Removal Ultrafiltration Less << Not Applicable Completed - Germany ... More >> Center for Pediatric and Adolescent Medicine Heidelberg, BW, Germany, 69120 Less <<
NCT02170207 - Completed - -
NCT02740179 HIV Not Applicable Recruiting - United States, Massachusetts ... More >> Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: Suman Srinivasa, MD, MS    617-724-9109    ssrinivasa@mgh.harvard.edu    Contact: Steven K. Grinspoon, MD    6177249109    sgrinspoon@mgh.harvard.edu Less <<
NCT01935531 Actinic Keratoses Phase 4 Completed - Germany ... More >> University hospital Regensburg Regensburg, Bavaria, Germany, 93053 Less <<
NCT01076205 - Completed - -
NCT00536185 Heart Disease Not Applicable Completed - United States, California ... More >> UC Davis, Western Human Nutrition Research Center Davis, California, United States, 95616 Ethnich Health Institute Oakland, California, United States, 94609 UC Davis (TICON-1) Sacramento, California, United States, 95820 Less <<
NCT01750567 Relapsed Chronic Lymphocytic L... More >>eukemia Less << Phase 2 Recruiting January 2019 United States, Michigan ... More >> University of Michigan Comprehensive Cancer Center Recruiting Ann Arbor, Michigan, United States, 48109 Contact: Sami Malek, MD    734-936-5310    smalek@med.umich.edu    Contact: Erlene Seymour, MD    734-647-2892    ekuizon@med.umich.edu    Principal Investigator: Sami Malek, MD          Sub-Investigator: Daniel Lebovic, MD          Sub-Investigator: Erlene Seymour, MD Less <<
NCT02460094 Progressive Supranuclear Palsy Phase 1 Completed - United States, Alabama ... More >> The University of Alabama at Birmingham Birmingham, Alabama, United States United States, California David Geffen School of Medicine at UCLA Los Angeles, California, United States University of California San Diego San Diego, California, United States University of California, San Francisco, Medical Center at Parnassus San Francisco, California, United States United States, Florida Parkinsons Disease and Movement Disorders Center of Boca Raton Boca Raton, Florida, United States University of Florida College of Medicine Gainesville, Florida, United States University of South Florida Tampa, Florida, United States United States, Illinois The University of Chicago Department of Neurology Chicago, Illinois, United States United States, Minnesota University of Minnesota Medical School Minneapolis, Minnesota, United States United States, New Jersey Robert Wood Johnson Medical School New Brunswick, New Jersey, United States United States, New York Columbia University Medical Center New York, New York, United States United States, Pennsylvania Hospital of the University of Pennsylvania Philadelphia, Pennsylvania, United States United States, Texas The University of Texas Southwestern Medical Center Dallas, Texas, United States Less <<
NCT01889615 - Unknown January 2017 Denmark ... More >> Department of Nuclear Medicine Recruiting Odense C, Fünen, Denmark, 5000 Contact: Mie H Vilstrup, MD    +45 2159 3008    mie.holm.vilstrup@rsyd.dk    Principal Investigator: Mie H Vilstrup, MD Less <<
NCT01903070 Diabetes Mellitus Phase 4 Completed - Germany ... More >> Profil Institut für Stoffwechselforschung GmbH Neuss, NRW, Germany, 41460 Less <<
NCT00942253 Restless Legs Syndrome ... More >> End Stage Renal Disease Hemodialysis Muscle Cachexia Sleep Disorders Less << Phase 2 Completed - Greece ... More >> University Hospital of Larissa, Nephrology Clinic Larissa, Thessaly, Greece, 41110 Less <<
NCT00471172 Obesity Not Applicable Completed - United States, California ... More >> Pfizer Investigational Site Los Angeles, California, United States United States, Florida Pfizer Investigational Site Clearwater, Florida, United States Pfizer Investigational Site Kissimmee, Florida, United States Pfizer Investigational Site Pembroke Pines, Florida, United States United States, Kentucky Pfizer Investigational Site Lexington, Kentucky, United States Pfizer Investigational Site Louisville, Kentucky, United States United States, Massachusetts Pfizer Investigational Site Milford, Massachusetts, United States United States, North Carolina Pfizer Investigational Site Charlotte, North Carolina, United States United States, Pennsylvania Pfizer Investigational Site Harleysville, Pennsylvania, United States United States, Rhode Island Pfizer Investigational Site Warwick, Rhode Island, United States United States, Tennessee Pfizer Investigational Site Nashville, Tennessee, United States United States, Wisconsin Pfizer Investigational Site Milwaukee, Wisconsin, United States Less <<
NCT01165684 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 4 Completed - -
NCT01165684 - Completed - -
NCT01264666 Alcohols Card... More >>iovascular Diseases Less << Phase 1 Completed - China, Zhejiang ... More >> Department of Food Science of Nutrition, Zhejiang University Hangzhou, Zhejiang, China, 310029 Less <<
NCT01771887 Diabetes Mellitus Not Applicable Completed - Lebanon ... More >> Outpatient of hospital of Hotel Dieu de France Beirut, Lebanon, 16-6830 Less <<
NCT03064958 Oxidative Stress Not Applicable Recruiting March 29, 2019 United States, Pennsylvania ... More >> Penn State University Recruiting University Park, Pennsylvania, United States, 16802 Contact: Kristina Petersen, PhD    814-863-8622    kup63@psu.edu    Principal Investigator: Penny Kris-Etherton, PhD          Sub-Investigator: Sheila West, PhD          Sub-Investigator: Connie Rogers, PhD          Sub-Investigator: David Proctor, PhD          Sub-Investigator: Kristina Petersen, PhD Less <<
NCT01541215 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT00571519 Type 2 Diabetes Mellitus Phase 3 Terminated(DSPD focussing on S... More >>tudy 301 to confirm clinical profile before proceeding.) Less << - United States, Alabama ... More >> Huntsville, Alabama, United States, 35801 Huntsville, Alabama, United States, 35802 United States, California San Diego, California, United States, 92128 San Francisco, California, United States, 94115 United States, Connecticut Ridgefield, Connecticut, United States, 06877 United States, Florida Fort Lauderdale, Florida, United States, 33308 Pembroke Pines, Florida, United States, 33026 United States, Mississippi Port Gibson, Mississippi, United States, 39150 United States, Nevada Las Vegas, Nevada, United States, 89119 United States, New Mexico Albuquerque, New Mexico, United States, 87109 United States, Ohio Kettering, Ohio, United States, 45429 United States, Pennsylvania Fleetwood, Pennsylvania, United States, 19522 Harrisburg, Pennsylvania, United States, 17112 United States, South Carolina Simpsonville, South Carolina, United States, 29681 United States, Texas Daingerfield, Texas, United States, 75638 Dallas, Texas, United States, 75216 Plano, Texas, United States, 75093 San Antonio, Texas, United States, 78205 Less <<
NCT00452049 - Unknown - Belgium ... More >> University Hopsital Leuven Recruiting Leuven, Belgium, 3000 Contact: Pieter Evenepoel, MD, PhD    003216344580    pieter.evenepoel@uz.kuleuven.ac.be Less <<
NCT03122925 - Enrolling by invitation July 1, 2019 United States, Minnesota ... More >> CMRR Minneapolis, Minnesota, United States, 55455 Less <<
NCT03241342 Stress Urinary Incontinence Phase 2 Completed - -
NCT02687516 Childhood Obesity Not Applicable Recruiting December 2019 Norway ... More >> Haukeland University Hospital Recruiting Bergen, Norway, 5020 Contact: Petur Juliusson, PhD    97777079 ext 0047       Principal Investigator: Petur Juliusson, PhD, MD          Sub-Investigator: Yngvild Danielsen, PhD Less <<
NCT00461058 Diabetes Mellitus Type 2 Phase 2 Completed - -
NCT00940329 Healthy Phase 1 Completed - Germany ... More >> Nycomed Konstanz, Germany, 78467 Less <<
NCT01213901 Diabetes Not Applicable Completed - Canada, British Columbia ... More >> Vitality Research Centre - Vancouver General Hospital Vancouver, British Columbia, Canada Less <<
NCT01135433 Type 2 Diabetes Mellitus Phase 3 Completed - Japan ... More >> Chubu, Japan Chugoku, Japan Hokkaido, Japan Kansai, Japan Kantou, Japan Kyushu, Japan Touhoku, Japan Less <<
NCT01006889 - Completed - -
NCT01006889 Nonalcoholic Fatty Liver Disea... More >>se Type 2 Diabetes Mellitus Less << Phase 4 Completed - United States, Texas ... More >> The University of Texas H.S.C. at San Antonio and the San Antonio Audie L. Murphy VA Hospital San Antonio, Texas, United States, 78229-3900 Less <<
NCT02175524 - Unknown - Taiwan ... More >> Taichung Verterans General Hospital Recruiting Taichung, Taiwan, 40705 Contact: Ping-Ting Lin, Ph.D.    +886-24730022 ext 12187    apt810@csmu.edu.tw    Contact: Bore-Jen Lee, Ph.D.    +886-23592525 ext 3190    borjen@vghtc.gov.tw Less <<
NCT03015220 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - Japan ... More >> Novo Nordisk Investigational Site Annaka-shi, Gunma, Japan, 379 0116 Novo Nordisk Investigational Site Arakawaku, Tokyo, Japan, 116-0012 Novo Nordisk Investigational Site Chiba-shi, Chiba, Japan, 260-0804 Novo Nordisk Investigational Site Chuo-ku Tokyo, Japan, 103-0027 Novo Nordisk Investigational Site Chuo-ku, Tokyo, Japan, 103 0027 Novo Nordisk Investigational Site Chuo-ku, Tokyo, Japan, 104-0061 Novo Nordisk Investigational Site Iruma-shi, Saitama, Japan, 358 0011 Novo Nordisk Investigational Site Kashiwara-shi, Osaka, Japan, 582 0005 Novo Nordisk Investigational Site Katsushika-ku, Tokyo, Japan, 125 0054 Novo Nordisk Investigational Site Kawagoe-shi, Saitama, Japan, 350 0851 Novo Nordisk Investigational Site Kawaguchi-city Saitama, Japan, 332855 Novo Nordisk Investigational Site Koriyama-shi, Fukushima, Japan, 963 8851 Novo Nordisk Investigational Site Kumamoto-shi,Kumamoto, Japan, 862 0976 Novo Nordisk Investigational Site Kurashiki-shi, Okayama, Japan, 701 0192 Novo Nordisk Investigational Site Kyoto-shi, Kyoto, Japan, 601 1495 Novo Nordisk Investigational Site Mito-shi, Ibaraki, Japan Novo Nordisk Investigational Site Miyazaki-shi, Japan, 880 0034 Novo Nordisk Investigational Site Naka-shi, Ibaraki, Japan, 311 0113 Novo Nordisk Investigational Site Ota-shi, Gunma, Japan, 373-0036 Novo Nordisk Investigational Site Sapporo-shi, Hokkaido, Japan, 004-0004 Novo Nordisk Investigational Site Sapporo-shi, Japan, 062 0007 Novo Nordisk Investigational Site Sendai-shi, Japan, 980 0021 Novo Nordisk Investigational Site Shimotsuke-shi, Tochigi, Japan, 329 0433 Novo Nordisk Investigational Site Shinagawa-ku, tokyo, Japan, 141-0032 Novo Nordisk Investigational Site Shinjuku-ku, Tokyo, Japan, 160-0008 Novo Nordisk Investigational Site Shizuoka-shi, Japan, 424 0853 Novo Nordisk Investigational Site Suita-shi, Osaka, Japan, 565-0853 Novo Nordisk Investigational Site Takatsuki-shi, Osaka, Japan, 569 1096 Novo Nordisk Investigational Site Tokyo, Japan, 123-0845 Novo Nordisk Investigational Site Tokyo, Japan, 144-0051 Novo Nordisk Investigational Site Tokyo, Japan, 181-0013 Novo Nordisk Investigational Site Toshima-ku, Tokyo, Japan, 171-0021 Novo Nordisk Investigational Site Yamato-shi, Kanagawa, Japan, 242-0004 Novo Nordisk Investigational Site Yokohama-shi Kanagawa, Japan, 232-0064 Less <<
NCT03737071 Fatty Liver Not Applicable Recruiting November 2022 Finland ... More >> Biomedicum 2U Recruiting Helsinki, Uusimaa, Finland, 00290 Contact: Aila Karioja-Kallio    +358094711    ext-aila.karioja-kallio@hus.fi Less <<
NCT02037815 Brain Edema Phase 4 Completed - China, Beijing ... More >> Neurosurgical ICU, Beijing Tiantan Hospital, Capital Medical University Beijing, Beijing, China, 100050 Less <<
NCT00526513 Diabetes Mellitus Phase 4 Completed - Egypt ... More >> Sanofi-Aventis Administrative Office Cairo, Egypt Less <<
NCT00583388 - Withdrawn(PI is leaving the In... More >>stitution, IRB will close the protocol.) Less << - -
NCT00441467 Soft Tissue Sarcoma Phase 2 Completed - United States, Arizona ... More >> Premiere Oncology of Arizona Scottsdale, Arizona, United States, 85260 Arizona Cancer Center Tucson, Arizona, United States, 85724 United States, California Stanford Cancer Center Stanford, California, United States, 94305 United States, Florida H. Lee Moffitt Cancer Center Tampa, Florida, United States, 33612 United States, Missouri Washington University School of Medicine, Division of Oncology St. Louis, Missouri, United States, 63110 United States, New Mexico University of New Mexico Cancer Research and Treatment Center Albuquerque, New Mexico, United States, 87131 United States, New York St. Vincent's Comprehensive Cancer Center New York, New York, United States, 10011 Less <<
NCT01225081 Type 2 Diabetes Mellitus Phase 3 Completed - Japan ... More >> Chubu, Japan Chugoku, Japan Hokkaido, Japan Kansai, Japan Kantou, Japan Kyushu, Japan Touhoku, Japan Less <<
NCT01445730 Central Obesity ... More >> Hypertriglyceridemia Less << Not Applicable Completed - Canada ... More >> Université Laval Québec, Canada Finland Helsinki University Central Hospital, Biomedicum Helsinki, Finland, 00290 Italy University of Naples, Federico II, and Faculty of Medicine Naples, Italy Sweden Sahlgrenska Academy at University of Gothenburg and Sahlgrenska University Hospital Gothenburg, Sweden Less <<
NCT01541215 - Completed - -
NCT01374178 Diabetes Mellitus Phase 1 Completed - Singapore ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Singapore, Singapore Less <<
NCT00737334 Internal Carotid Artery Stenos... More >>is Less << Not Applicable Completed - Canada, Manitoba ... More >> Health Sciences Centre Winnipeg, Manitoba, Canada, R3A 1R9 Less <<
NCT00441467 - Completed - -
NCT01374178 - Completed - -
NCT01470222 Overweight Ob... More >>esity Compliance Behavior Less << Not Applicable Completed - -
NCT01242215 Type 2 Diabetes Mellitus Phase 3 Completed - Japan ... More >> Chubu, Japan Chugoku, Japan Hokkaido, Japan Kansai, Japan Kantou, Japan Kyushu, Japan Touhoku, Japan Less <<
NCT01242202 Type 2 Diabetes Mellitus Phase 3 Completed - Japan ... More >> Chubu, Japan Hokkaido, Japan Kansai, Japan Kantou, Japan Kyushu, Japan Touhoku, Japan Less <<
NCT01497106 Insulin Resistance Not Applicable Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT01872845 Coronary Artery Occlusive Dise... More >>ase Less << Not Applicable Unknown May 2018 Korea, Republic of ... More >> Severance Hospital Recruiting Seoul, Korea, Republic of, 120-752 Contact: MyeongKi Hong, MD, PhD    82-2-2228-8460    mkhong61@yuhs.ac Less <<
NCT02333539 Type 1 Diabetes Not Applicable Active, not recruiting January 28, 2019 United States, Florida ... More >> Florida State University Tallahassee, Florida, United States, 32306 Less <<
NCT02799953 Type 2 Diabetes Mellitus ... More >> Hypertension Less << Not Applicable Completed - China, Hong Kong ... More >> Pamela Youde Nethersole Eastern Hospital Hong Kong, Hong Kong, China Less <<
NCT00442598 - Terminated - -
NCT03118336 Type 2 Diabetes Phase 3 Recruiting February 2020 France ... More >> Assistance Publique Hopitaux de Marseille Recruiting Marseille, France Contact: ANNE DUTOUR       anne.dutour@ap-hm.fr Less <<
NCT00442598 Ovarian Cancer Phase 2 Terminated - United States, Arizona ... More >> Premiere Oncology of Arizona Scottsdale, Arizona, United States, 85260 Arizona Cancer Center Tucson, Arizona, United States, 85724 United States, California California Cancer Center Greenbrae, California, United States, 94904 UCI Chao Family Comprehensive Cancer Center Orange, California, United States, 92868 United States, Indiana Indiana University Cancer Center Indianapolis, Indiana, United States, 46202 United States, Kentucky Louisville Oncology Clinical Research Program Louisville, Kentucky, United States, 40202 United States, New Mexico New Mexico Cancer Care Alliance Albuquerque, New Mexico, United States, 87106 United States, Ohio Gabrail Cancer Center Canton, Ohio, United States, 44718 United States, South Carolina Gynecologic Oncology Research & Development, LLC Greenville, South Carolina, United States, 29601 United States, Texas Harrington Cancer Center Amarillo, Texas, United States, 79106 Less <<
NCT02005900 HIV-associated Hypertriglyceri... More >>demia HIV-associated Hypercholesterolemia HIV-associated Inflammatory State Less << Phase 3 Completed - Spain ... More >> Hospital de la Santa Creu i Sant Pau Barcelona, Spain, 08025 Less <<
NCT00097877 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT02492763 Type II Diabetes Mellitus Phase 2 Terminated - -
NCT03165136 Recurrent Miscarriage ... More >> First Trimester Abortion Less << Phase 3 Recruiting February 1, 2023 France ... More >> CHU Besançon Not yet recruiting Besançon, France, 25030 Contact: Aude Bourtembourg-Matras       a1bourtembourg@chu-besancon.fr    CHRU de Brest Recruiting Brest, France, 29609 Contact: Elisabeth PASQUIER       elisabeth.pasquier@chu-brest.fr    Contact: Gisèle MARHIC       gisele.marhic@chu-brest.fr    CHU Estaing Not yet recruiting Clermont-Ferrand, France Contact: Denis Gallot       dgallot@chu-clermontferrand.fr    Hôpital Nord - Unité mère-enfant Not yet recruiting Marseille, France, 13015 Contact: Florence Bretelle       florence.bretelle@ap-hm.fr    CHU de Nantes Not yet recruiting Nantes, France, 44093 Contact: NORBERT WINER       norbert.winer@chu-nantes.fr    Hopital Port Royal Cochin Not yet recruiting Paris 14, France, 75679 Contact: Geneviève Plu-Bureau       genevieve.plu-bureau@aphp.fr    Hopital Saint Antoine Not yet recruiting Paris, France, 75012 Contact: Arsène Mekinian       arsene.mekinian@aphp.fr    CHG François Mitterand Not yet recruiting Pau, France, 64 000 Contact: Caroline Bohec       caroline.bohec@ch-pau.fr    Centre hospitalier de Cornouaille Not yet recruiting Quimper, France, 29000 Contact: Charles Bellot       c.bellot@ch-cornouaille.fr    CHU de Saint Etienne - Hôpital Nord Not yet recruiting Saint Etienne, France, 42 270 Contact: Céline Chauleur       celine.chauleur@chu-st-etienne.fr Less <<
NCT03406377 Type 2 Diabetes Mellitus Phase 2 Recruiting June 2019 United States, California ... More >> National Research Institute - Huntington Park Recruiting Huntington Park, California, United States, 90255 Contact: Stanley Hsin-Wei Hsia          National Research Institute - Wilshire Recruiting Los Angeles, California, United States, 90057 Contact: Juan Pablo Frias          United States, Florida Clinical Pharmacology of Miami, LLC Recruiting Hialeah, Florida, United States, 33014 Contact: Kenneth Lasseter, MD Less <<
NCT01316107 Type 2 Diabetes Mellitus Phase 3 Completed - Japan ... More >> Hokkaido, Japan Kantou, Japan Kyushu, Japan Touhoku, Japan Less <<
NCT03292042 Metabolic Syndrome Not Applicable Recruiting May 1, 2019 Spain ... More >> university hospital Ramón y Cajal Recruiting Madrid, Spain, 28034 Contact: sara Fernández Guijarro, Nurse    686389386    sfguijarro@salud.madrid.org    Principal Investigator: sara Fernández Guijarro, Nurse Less <<
NCT00001366 - Completed - United States, Maryland ... More >> National Institute of Neurological Disorders and Stroke (NINDS) Bethesda, Maryland, United States, 20892 Less <<
NCT02936167 Hyponatremia Not Applicable Unknown February 2017 India ... More >> Post Graduate Institute of Medical Education and Research Recruiting Chandigarh, India, 160012 Contact: Neerja Bhardwaj, MD    9815174439    neerja.bhardwaj@gmail.com    Contact: Preethy Mathew, MD    9417800203 Less <<
NCT03673748 Lupus Nephritis ... More >> Lupus Erythematosus Less << Phase 2 Not yet recruiting December 2021 Spain ... More >> University Hospital Río Hortega Not yet recruiting Valladolid, Spain, 47012 Contact: Julia Barbado, MD, PhD Less <<
NCT00611754 Head and Neck Cancer Phase 2 Completed - France ... More >> Sanofi-Aventis Paris, France Less <<
NCT02492763 - Terminated - -
NCT02419859 Type 2 Diabetes Mellitus Not Applicable Completed - Austria ... More >> Medical University of Graz Graz, Austria, A-8036 Less <<
NCT02554045 Obesity Sexua... More >>l Dysfunction Less << Phase 4 Completed - -
NCT01357252 Type 2 Diabetes Mellitus Phase 3 Completed - China, Beijing ... More >> Novartis Investigative Site Beijing, Beijing, China, 100088 China, Hebei Novartis Investigative Site Shijiazhuang, Hebei, China, 050051 China, Hubei Novartis Investigative Site Wuhan, Hubei, China, 430070 China, Hunan Novartis Investigative Site Changsha, Hunan, China, 410003 China, Jiangsu Novartis Investigative Site Nanjing, Jiangsu, China, 210006 Novartis Investigative Site Nanjing, Jiangsu, China, 210008 Novartis Investigative Site Nanjing, Jiangsu, China, 210029 Novartis Investigative Site Zhenjiang, Jiangsu, China, 212001 China, Liaoning Novartis Investigative Site ShenYang, Liaoning, China, 110003 China, Shanghai Novartis Investigative Site Shanghai, Shanghai, China China, Tianjin Novartis Investigative Site Tianjin, Tianjin, China, 300211 China Novartis Investigative Site Beijing, China, 100029 Novartis Investigative Site Beijing, China, 100034 Novartis Investigative Site Beijing, China, 100730 Novartis Investigative Site Beijing, China Novartis Investigative Site Guang zhou, China, 510080 Novartis Investigative Site Shanghai, China, 200040 Novartis Investigative Site Shanghai, China, 200233 Less <<
NCT01594801 Diabetics Mellitus Type 1 ... More >> Diabetes Mellitus Type 2 Less << Not Applicable Completed - Germany ... More >> Gemeinschaftspraxis Dr. Klausmann/ Dr. Welslau Aschaffenburg, Germany, 63739 Diabeteszentrum Bad Mergentheim Bad Mergentheim, Germany ikfe GmbH, Berlin Berlin, Germany, 10115 GWT-TUD GmbH, Zentrum für Klinische Studien Dresden, Germany, 01307 ikfe GmbH Mainz Mainz, Germany, 55116 Zentrum Für Klinische Studien Neuwied Neuwied, Germany, 56564 ikfe GmbH, Potsdam Potsdam, Germany, 14469 Dr. Notghi Clinical Trials Potsdam, Germany, 14471 Allgemeinärztliche Berufsausübungs-gemeinschaft Waldfischbach-Burgalben Waldfischbach-Burgalben, Germany, 67714 Less <<
NCT01219803 Diabetes Mellitus, Type 2 ... More >> Dose-Response Relationship, Drug Less << Not Applicable Unknown August 2014 China, Beijing ... More >> Beijing Traditional Chinese Medicine Hospital of the Capital University of Medical Sciences Recruiting Beijing, Beijing, China, 100010 Principal Investigator: Bai Chang, Ph.D          China-Japan Friendship Hospital Recruiting Beijing, Beijing, China, 100029 Principal Investigator: Yuan Xu, Ph.D          Ji Shui Tan Hospital of Beijing Recruiting Beijing, Beijing, China, 100035 Principal Investigator: Xia Wang, M.D          Dongzhimen Hospital Attached to Beijing Traditional Chinese Medicine University Recruiting Beijing, Beijing, China, 100700 Principal Investigator: Hongfang Liu, Ph.D Less <<
NCT00547950 Ischemic Stroke Not Applicable Unknown October 2009 China, Guangdong ... More >> Guangdong Province Hospital of Tradtional Chinese Medicine Not yet recruiting Guangzhou, Guangdong, China, 510120 Contact: Lixin Wang, Doctor    (08620)81887233 ext 34530    plawlx@126.com    Principal Investigator: Yan Huang, Doctor Less <<
NCT03653949 Cystic Fibrosis Not Applicable Not yet recruiting December 2019 -
NCT02218931 Pre-eclampsia ... More >> Obesity Raised Lipids High Blood Pressure Insulin Resistance Gestational Diabetes Small for Gestational Age Stillbirth Less << Not Applicable Completed - United Kingdom ... More >> Barts Health NHS Trust London, United Kingdom, E1 1BB Less <<
NCT01242228 Type 2 Diabetes Mellitus Phase 3 Completed - Japan ... More >> Chubu, Japan Hokkaido, Japan Kansai, Japan Kantou, Japan Kyushu, Japan Touhoku, Japan Less <<
NCT00130286 - Completed - -
NCT02795481 - Recruiting June 2019 United Kingdom ... More >> University Hospitals Coventry & Warwickshire NHS Trust Recruiting Coventry, United Kingdom, CV2 2DX Contact: Shivam Joshi    02476 966907    Shivam.Joshi@uhcw.nhs.uk Less <<
NCT00734201 Obesity Phase 1 Completed - United Kingdom ... More >> Hammersmith Medicines Research London, United Kingdom, NW10 7NS Less <<
NCT02308293 Type 1 Diabetes Mellitus ... More >> Hypoglycemia Unawareness Less << Not Applicable Completed - Netherlands ... More >> Radboud umc Nijmegen, Netherlands Less <<
NCT03371446 - Completed - Brazil ... More >> Arthur Belem Novaes Junior Ribeirão Preto, SP, Brazil, 14040-904 Less <<
NCT01610401 Ischemia Reperfusion Injury ... More >> Endothelial Function Less << Phase 4 Completed - Netherlands ... More >> Radboud University Nijmegen Medical Centre Nijmegen, Gelderland, Netherlands, 6500 HB Less <<
NCT00130286 HIV-Associated Lipodystrophy S... More >>yndrome Insulin Resistance HIV Infections Metabolic Syndrome X Body Weight Changes Less << Phase 1 Phase 2 Completed - United States, New York ... More >> AIDS Community Research Initiative of America (ACRIA) New York, New York, United States, 10018 Cornell HIV Clinical Trials Unit, Weill Medical College of Cornell University New York, New York, United States, 10021 St. Luke's-Roosevelt Hospital Center New York, New York, United States, 10025 Columbia University College of Physicians and Surgeons New York, New York, United States, 10032 Less <<
NCT02364583 Plasmodium Vivax Phase 4 Unknown December 2016 Papua New Guinea ... More >> PNG Institute of Medical Research Recruiting Madang, Madang Province, Papua New Guinea Contact: Brioni R Moore, PhD    +61466266334    brioni.moore@uwa.edu.au    Principal Investigator: Inoni Betuela, MD PhD Less <<
NCT03590041 Diabetes Mellitus, Type 2 Not Applicable Not yet recruiting December 2022 -
NCT00479986 Type 2 Diabetes Mellitus ... More >> Cardiovascular Disease Less << Phase 4 Completed - Germany ... More >> Dr. Michael Morcos Heidelberg, Germany IKFE Mainz, Germany, 55116 Less <<
NCT02677363 Quality of Life ... More >> Aging Memory Loss Cardiovascular Diseases Less << Not Applicable Completed - United States, Missouri ... More >> University of Missouri-Columbia Columbia, Missouri, United States, 65211 Less <<
NCT02133755 PCOS Insulin ... More >>Resistance Less << Phase 3 Unknown December 2015 Canada, Nova Scotia ... More >> IWK Health Centre Not yet recruiting Halifax, Nova Scotia, Canada, B3K 6R8 Contact: Renda Bouzayen, MD, FRCSC    902-470-6457    renda.bouzayen@iwk.nshealth.ca    Contact: Cora Fanning, BN    902-470-7158    cora.fanning@iwk.nshealth.ca    Principal Investigator: Renda Bouzayen, MD, FRCSC Less <<
NCT01544881 Type 1 Diabetes Mellitus Phase 1 Completed - United States, California ... More >> Profil Institute for Clinical Research Chula Vista, California, United States, 91911 Less <<
NCT00700830 - Completed - Algeria ... More >> Algiers, Algeria, 16035 Less <<
NCT02305264 Multiple Sclerosis, Relapsing-... More >>Remitting Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Primary Progressive Less << Not Applicable Recruiting February 2018 France ... More >> Saint Antoine Hospital Recruiting Paris, France, 75012 Pitie Salpetriere Hospital Recruiting Paris, France, 75013 Less <<
NCT01451398 Type 2 Diabetes Phase 3 Completed - -
NCT00633958 Tumors of the Central Nervous ... More >>System Less << Not Applicable Terminated(Large phase II open... More >>ed to accue same patients) Less << - United States, Massachusetts ... More >> Children's Hospital Boston Boston, Massachusetts, United States, 02115 Less <<
NCT01451398 - Completed - -
NCT01656915 - Completed - Netherlands ... More >> CHDR Leiden, Zuid-Holland, Netherlands, 2333 CH Less <<
NCT01025609 - Completed - United States, North Carolina ... More >> Carolinas Rehabilitation Charlotte, North Carolina, United States, 28203 Less <<
NCT03712046 Diabetic Foot Infection Not Applicable Not yet recruiting December 2020 -
NCT03592511 Food Selection ... More >> Metabolic Syndrome Less << Not Applicable Completed - -
NCT02991365 Insulin Resistance Not Applicable Recruiting March 2019 Germany ... More >> University of Tuebingen, Department of Internal Medicine IV Recruiting Tübingen, Germany, 72076 Contact: Andreas Fritsche, Prof. Dr.    +49 7071 29 82714    andreas.fritsche@med.uni-tuebingen.de    Contact: Martin Heni, Dr.    +49 7071 29 82714    martin.heni@med.uni-tuebingen.de    Sub-Investigator: Martin Heni, MD Less <<
NCT02376075 Arterial Hypertension ... More >> Albuminuria Less << Phase 3 Completed - Germany ... More >> Profil Mainz GmbH & Co. KG Mainz, Rhineland-Palatinate, Germany, 55116 Less <<
NCT02127996 Angina Pectoris ... More >> Myocardial Infarction Reperfusion Injury Coronary Heart Disease Less << Phase 2 Active, not recruiting July 2021 United Kingdom ... More >> Papworth Hospital Cambridge, Cambridgeshire, United Kingdom, CB23 3RE Less <<
NCT00642434 Diabetes Phase 4 Completed - United States, New Mexico ... More >> UNMHSC Albquerque, New Mexico, United States, 87131 Less <<
NCT03352037 Pancreatic Cystic Neoplasms Not Applicable Recruiting July 31, 2018 Canada, Ontario ... More >> University Health Network Recruiting Toronto, Ontario, Canada, M5G 1Z5 Contact: Maryam Razzaz    4169464501 ext 5734    maryam.razzaz@uhn.ca Less <<
NCT02743195 GI Health Mic... More >>robial Composition Less << Not Applicable Completed - Canada, Ontario ... More >> KGK Synergize Inc. London, Ontario, Canada, N6A 5R8 Less <<
NCT02348775 HIV Infection ... More >> Erythrocyte Glutathione Deficiency Less << Phase 1 Active, not recruiting December 2018 United States, Texas ... More >> Baylor Metabolic Research Unit (MRU) Houston, Texas, United States, 77030 Less <<
NCT03155087 - Completed - -
NCT01548235 - Completed - Denmark ... More >> Novo Nordisk Investigational Site Copenhagen S, Denmark, 2300 Less <<
NCT01512368 Sedentary Lifestyle Not Applicable Completed - Mexico ... More >> INCMNSZ Mexico City, Tlalpan, Mexico, 14000 Less <<
NCT01970228 Adverse Reactions to Metal Deb... More >>ris Infection of Total Hip Joint Prosthesis Mechanical Loosening of Prosthetic Joint Less << Not Applicable Completed - Finland ... More >> Turku University Hospital Turku, Finland, 20521 Less <<
NCT01512368 - Completed - -
NCT01643148 - Completed - -
NCT01880866 Pulmonary Arterial Hypertensio... More >>n Less << Phase 1 Withdrawn January 2014 United States, California ... More >> UCSF San Francisco, California, United States, 94110 Less <<
NCT02585804 Focal Segmental Glomeruloscler... More >>osis Less << Phase 4 Completed - Canada, Ontario ... More >> Renal Physiology Laboratory, University Health Network Toronto, Ontario, Canada, M5G 2N2 Less <<
NCT01825148 - Completed - Netherlands ... More >> Radboud University Nijmegen Medical Center Nijmegen, Gelderland, Netherlands, 6500 HB Less <<
NCT02158741 Type 2 Diabetes Mellitus ... More >> NIDDM Non-insulin Dependent Diabetes Mellitus Less << Not Applicable Completed - Canada, Alberta ... More >> Edmonton Oliver PCN Edmonton, Alberta, Canada Leduc Beaumont Devon PCN Leduc, Alberta, Canada, T9E 6W2 Sherwood Park PCN Sherwood Park, Alberta, Canada Canada, Ontario McMaster University Hamilton, Ontario, Canada, L8S 4K1 Ross Memorial Hospital Lindsay, Ontario, Canada St. Joseph's Health Care London, Ontario, Canada Peterborough Regional Health Centre Peterborough, Ontario, Canada Port Hope Community Health Centre Port Hope, Ontario, Canada Less <<
NCT02192853 Type 2 Diabetes Mellitus Phase 4 Completed - Denmark ... More >> Diabetes Research Division, Department of Endocrinology, Gentofte Hospital Hellerup, Denmark, 2900 Less <<
NCT01951183 Diabetes Mellitus Type 2 Phase 2 Withdrawn(Cancelled due to Spo... More >>nsor's decision) Less << December 2013 -
NCT01952145 - Completed - -
NCT03495310 Obesity, Childhood ... More >> Mindfulness Less << Not Applicable Not yet recruiting December 30, 2018 Mexico ... More >> Unit or research in Medical Nutrition, Pediatric Hospital CMN "Siglo XXI", Instituto Mexicano del Seguro Social Mexico City, Mexico, 06720 Less <<
NCT02259153 Lipid Metabolism Disorders ... More >> Sterols Diet, High-Fat Cholesterol Fatty Acids Hyperlipidemias Less << Not Applicable Completed - -
NCT00696995 - Completed - Finland ... More >> Novo Nordisk Investigational Site Lahti, Finland, 15110 Less <<
NCT01952145 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT01192373 Heart Failure ... More >> Diabetes Less << Phase 2 Completed - Denmark ... More >> Dept. of cardiology, Aarhus University hospital Skejby, Aarhus, Region Midjylland, Denmark, 8200 Less <<
NCT00899054 Squamous Cell Carcinoma of Hea... More >>d and Neck Less << Phase 1 Phase 2 Completed - India ... More >> Government Medical College Aurangabad, Maharashtra, India, 431001 Curie Manavata Cancer Center Nashik, Maharashtra, India, 422 004 Bhagwan Mahawir Cancer Hospital & Research Centre Jaipur, Rajasthan, India, 302017 V. N. Cancer Centre, GKNM Hospital Coimbatore, Tamil Nadu, India, 641037 Meenakshi Mission Hospital & Research Centre Madurai, Tamil Nadu, India, 625107 Christian Medical College Vellore, Tamil Nadu, India, 632 004 Less <<
NCT00983788 Carnitine Palmitoyltransferase... More >> II Deficiency Very Long Chain Acyl Coa Dehydrogenase Deficiency Less << Phase 2 Completed - Denmark ... More >> Neuromusculare Research Unit, Rigshospitalet Copenhagen, Denmark, 2100 Less <<
NCT01632813 - Completed - Belgium ... More >> Dept Intensive Care Medicine Leuven, Vlaams Brabant, Belgium, 3000 Less <<
NCT00995345 Type 2 Diabetes Phase 2 Completed - -
NCT00995345 - Completed - -
NCT02542631 Diabetes Mellitus, Type 2 Not Applicable Completed - -
NCT00854412 Obesity Weigh... More >>t Loss Less << Not Applicable Completed - -
NCT02542631 - Completed - -
NCT00884091 - Completed - Taiwan ... More >> Section of Endocrinology and Metabolism, Department of Medicine, Taipei Veterans General Hospital Taipei, Taiwan, 112 Less <<
NCT02771912 Sedation Phase 4 Completed - France ... More >> Fondation Ophtalmique Adolphe de Rothschild Paris, France, 75019 Less <<
NCT00067886 - Completed - United States, Arkansas ... More >> Arkansas Children's Hospital/University of Arkansas for Medical Sciences Little Rock, Arkansas, United States, 72202 Less <<
NCT03604224 - Recruiting March 29, 2019 India ... More >> Diacon Hospital Recruiting Bangalore, India, 560010 Dr. A. Ramachandran's Diabetes Hospitals Not yet recruiting Chennai, India, 600032 CARE Hospitals Not yet recruiting Hydrabad, India, 500001 Less <<
NCT00004769 - Completed - -
NCT01145482 - Completed - -
NCT01219725 Cardiovascular Disease Phase 2 Unknown December 2011 United Kingdom ... More >> Centre for Sports and Exercise Sciences, University of Leeds Recruiting Leeds, West Yorkshire, United Kingdom, LS2 9JT Principal Investigator: Karen M Birch, BSc, PhD Less <<
NCT00568074 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 4 Completed - China, Shanghai ... More >> Novo Nordisk Investigational Site Shanghai, Shanghai, China, 200025 Novo Nordisk Investigational Site Shanghai, Shanghai, China, 200433 China, Sichuan Novo Nordisk Investigational Site Chengdu, Sichuan, China, 610041 China Novo Nordisk Investigational Site Beijing, China, 100029 Less <<
NCT00001723 - Completed - -
NCT01444248 Type 2 Diabetes Mellitus Phase 4 Completed - Korea, Republic of ... More >> Handok Pharmaceuticals Seoul, Korea, Republic of Less <<
NCT00001723 Diabetes Mellitus ... More >> Hypertension Metabolic Disease Obesity Sleep Apnea Syndrome Less << Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00468091 Digestive Physiology ... More >> Gastrointestinal Motility Gastrointestinal Hormones Glucagon-like Peptide 1 Exendin (9-39) Less << Phase 1 Completed - Germany ... More >> Clinical Research unit, Dept. of Internal Medicine II - Großhadern, University of Munich Munich, Germany, 81377 Less <<
NCT02727166 Functional Gastrointestinal Di... More >>sorders Less << Not Applicable Completed - -
NCT02029144 - Completed - China, Shanghai ... More >> Obstetrics and Gynecology Hospital of Fudan University Shanghai, Shanghai, China, 200011 Less <<
NCT01248442 Healthy Humans Phase 4 Completed - Austria ... More >> Medical University Graz Graz, Austria, 8036 Less <<
NCT00396448 Obesity Phase 3 Terminated(See termination rea... More >>son in detailed description.) Less << - -
NCT02761525 Critical Illness Not Applicable Completed - -
NCT02708316 - Recruiting December 2019 China, Shaanxi ... More >> First Affiliated Hospital of Xian Jiaotong University Recruiting Xi'an, Shaanxi, China, 710061 Contact: Xiancang Ma, MD,PHD    008613002951782    maxiancang@163.com Less <<
NCT00904410 Breast Cancer Phase 4 Completed - France ... More >> Centre Oscar Lambret Lille, France, 59020 Less <<
NCT03500601 Cognitive Function ... More >> Urinary Metabolites Intestinal Microbiota Less << Not Applicable Recruiting December 31, 2018 United Kingdom ... More >> Northumbria University Recruiting Newcastle upon Tyne, Tyne & Wear, United Kingdom, NE1 8ST Contact: Fiona Dodd    0191 2273377 ext 3377    f.dodd@northumbria.ac.uk    Contact: Joanne Forster    01912437252 ext 7252    jo.forster@northumbria.ac.uk Less <<
NCT01924767 Diabetes Mellitus, Type 2 Phase 1 Completed - Germany ... More >> 1245.2.1 Boehringer Ingelheim Investigational Site Neuss, Germany Less <<
NCT01924767 - Completed - -
NCT00916019 Healthy Not Applicable Completed - Japan ... More >> Fukuoka University Fukuoka, Japan, 814-0133 Less <<
NCT03001323 Diabetes Mellitus Not Applicable Recruiting January 2019 United States, Minnesota ... More >> Hennepin County Medical Center Recruiting Minneapolis, Minnesota, United States, 55415 Contact: Lisa Fish, MD    612-873-8760    Lisa.Fish@hcmed.org Less <<
NCT01190527 Non-Small Cell Lung Cancer Not Applicable Completed - United States, Michigan ... More >> University of Michigan Cancer Center Ann Arbor, Michigan, United States, 48109 Less <<
NCT01190527 - Completed - -
NCT00199615 Non-Small Cell Lung Cancer Not Applicable Completed - France ... More >> Pathologie Respiratoire Limoges, France, 87042 Less <<
NCT01884051 - Recruiting July 2022 United States, Tennessee ... More >> Vanderbilt University Medical Center Recruiting Nashville, Tennessee, United States, 37232 Less <<
NCT03041142 Cardiovascular Risk Factor Not Applicable Completed - -
NCT02077920 Ventilator-associated Pneumoni... More >>a Less << Phase 2 Unknown March 2017 China, Liaoning ... More >> The General Hospital of Shenyang Military Region Recruiting Shenyang, Liaoning, China, 110000 Contact: Zhuang Ma          Principal Investigator: Zhuang Ma, PhD Less <<
NCT00312598 - Completed - -
NCT01865500 Chronic Obstructive Pulmonary ... More >>Disease Less << Phase 4 Completed - Turkey ... More >> Ataturk University Faculty of Medicine Pulmonary Disease Department Erzurum, Turkey, 25240 Less <<
NCT02850302 Breast Neoplasms Not Applicable Completed - France ... More >> CGFL Dijon, France, 21079 Less <<
NCT01209884 - Completed - United States, California ... More >> Scripps Translational Science Institute La Jolla, California, United States, 92037 Less <<
NCT03463993 Post Partum Hemorrhage Phase 3 Recruiting February 2019 Zimbabwe ... More >> Harare Central Hospital Recruiting Harare, Zimbabwe Parirenyatwa Group of Hospitals Recruiting Harare, Zimbabwe Less <<
NCT01935882 Malaria Asymp... More >>tomatic Malaria Plasmodium Falciparum Less << Phase 2 Phase 3 Completed - Burkina Faso ... More >> Centre National de Recherche et de Formation sur le Paludisme Ouagadougou, Burkina Faso Less <<
NCT01290185 Arthritis Not Applicable Completed - Canada, Ontario ... More >> Sunnybrook Health Sciences Centres, Holland Orthopedic and Arthritic Centre Toronto, Ontario, Canada, M4N 3M5 Less <<
NCT01319994 Glucocorticoid Treatment Phase 2 Phase 3 Unknown January 2015 United Kingdom ... More >> Barts and the London Recruiting London, United Kingdom Less <<
NCT02916589 Inflammation Phase 1 Phase 2 Completed - Sweden ... More >> University of Kristianstad Kristianstad, Skåne, Sweden, 29188 Less <<
NCT02012582 - Completed - -
NCT02075827 Appetite and General Nutrition... More >>al Disorders Sedentary Lifestyle Less << Not Applicable Unknown - United Kingdom ... More >> UCL Institute of Child Health Recruiting London, United Kingdom, WC1N 1EH Contact: Panos Michael    +44(0)7546842700    panos.michael.11@ucl.ac.uk    Principal Investigator: Jonathan CK Wells, PhD Less <<
NCT00646581 - Completed - -
NCT00646581 Schizophrenia ... More >> Schizoaffective Disorder Less << Phase 4 Completed - United States, Massachusetts ... More >> Freedom Trail Clinic Boston, Massachusetts, United States, 02114 Less <<
NCT02012582 Traumatic Brain Injury Phase 2 Completed - Austria ... More >> Medical University Innsbruck Department of Neurology Innsbruck, Austria, 6020 France HIA Sainte-Anne Boulevard Sainte-Anne Toulon, France, 83800 Spain Vall d'Hebron University Hospital Department of Neurosurgery Barcelona, Spain, 08035 Hospital Clinic University of Barcelona Surgical Intensive Care Unit Barcelona, Spain, 08036 Switzerland University Hospital Zuerich Surgical Intensive Care Zuerich, Switzerland, 8091 United Kingdom Southampton University Hospital Division of Clinical Neurosciences Southampton, United Kingdom, SO16 6YD Less <<
NCT02652884 Transient Hypoparathyroidism Phase 4 Unknown December 2017 Argentina ... More >> Hospital Italiano de Buenos Aires Recruiting Ciudad Autonoma de Buenos Aires, Argentina, C1181ACH Contact: Diego Giunta, MD    (05411)49590200 ext 4419    diego.giunta@hospitalitaliano.org.ar    Principal Investigator: Diego Giunta, MD          Principal Investigator: Veronica Gonzalez, BA Less <<
NCT01995656 Diabetes Mellitus, Type 2 Phase 1 Completed - Singapore ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Singapore, Singapore, 117597 Less <<
NCT03055169 - Completed - France ... More >> CHU Cote de Nâcre Caen, France Hôpital Roger Salengro, CHRU de Lille Lille, France CH Victor Provot Roubaix, France CHU Charles Nicolle Rouen, France CH Tourcoing Tourcoing, France Less <<
NCT00686426 Obesity Weigh... More >>t Gain Less << Not Applicable Completed - United States, Kansas ... More >> University of Kansas Lawrence, Kansas, United States, 66045 United States, Tennessee The University of Tennessee Knoxville, Tennessee, United States, 37996-1920 Less <<
NCT01547832 - Terminated - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT01843959 - Active, not recruiting April 2017 United Arab Emirates ... More >> Imperial College London Diabetes Centre Abu Dhabi, United Arab Emirates, 48338 Less <<
NCT00143962 Obesity Phase 4 Completed - United States, Colorado ... More >> University of Colorado Denver, Colorado, United States United States, Missouri Washington University St. Louis, Missouri, United States United States, Pennsylvania University of Pennsylvania Philadelphia, Pennsylvania, United States Less <<
NCT02096939 - Withdrawn April 2016 -
NCT02912611 Acute Kidney Injury Not Applicable Unknown - Bolivia ... More >> Hospital Obrero #2 Recruiting Cochabamba, Bolivia Contact: Rolando Claure, MD          Malawi Queen Elizabeth Central Hospital (QECH) Recruiting Blantyre, Malawi Contact: Ulla Hemmila          Nepal BP Koirala Institute of Health Sciences Recruiting Dharan, Nepal Contact: Sanjib Sharma, MD Less <<
NCT03324737 Gestational Diabetes ... More >> Weight Loss Diet Habit Less << Not Applicable Not yet recruiting March 31, 2020 -
NCT00765817 - Completed - -
NCT01507038 Diabetes Mellitus Phase 2 Completed - Korea, Republic of ... More >> Yuhan Seoul, Korea, Republic of Less <<
NCT00765817 Type 2 Diabetes Phase 3 Completed - -
NCT00725517 Chronic Kidney Disease ... More >> Peritoneal Dialysis Less << Phase 4 Completed - -
NCT01463644 Chronic Obstructive Pulmonary ... More >>Diseases Chronic Airways Limitation Bronchitis Less << Phase 3 Completed - Canada, Ontario ... More >> Firestone Institute of Respiratory Health, St Joseph's Hospital Hamilton, Ontario, Canada, L8N 4A6 Less <<
NCT00616811 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT03287765 Alzheimer Disease Phase 2 Recruiting November 2021 United States, Missouri ... More >> Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: Kelley Jackson    314-362-6737    jacksonk@wustl.edu Less <<
NCT01974947 - Completed - France ... More >> Jean Verdier Hospital Bondy, France, 93140 Less <<
NCT02243176 Type 2 Diabetes Mellitus Phase 4 Completed - China ... More >> Research Site Shanghai, China Less <<
NCT01117584 Type 2 Diabetes Mellitus Phase 2 Completed - -
NCT03258619 - Recruiting December 2018 France ... More >> Chu Dijon Bourgogne Recruiting Dijon, France, 21000 Contact: Bélaïd BOUHEMAD    0380293528    belaid.bouhemad@chu-dijon.fr Less <<
NCT00877890 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT01713270 Hypertension ... More >>Atrial Fibrillation Less << Not Applicable Unknown July 2015 China, Jiangsu ... More >> First Affiliated Hospital of Nanjing Medical University Recruiting Nanjing,, Jiangsu, China, 210000 Contact: Qijun Shan, professor    0086 025 68136407    qjshan@njmu.edu.cn Less <<
NCT00877890 - Completed - -
NCT03714009 Infertility Not Applicable Recruiting September 1, 2019 Egypt ... More >> KasrELAiniH Recruiting Cairo, Egypt, 11956 Contact: Amira Dieb, MD       amirasaied2026@yahoo.com Less <<
NCT02697669 - Recruiting December 2018 Taiwan ... More >> Far Eastern Memorial Hospital Recruiting New Taipei City, Taiwan, 220 Contact: Yen-Wen Wu, MD, PhD    886-2-8966-7000 ext 1090    wuyw0502@gmail.com    Principal Investigator: Yen-Wen Wu, MD, PhD Less <<
NCT01735799 - Unknown - Israel ... More >> Liver Clinic, ZIv Medical Center Not yet recruiting Safed, Israel, 13100 Contact: Nimer Assy, MD    +972-4-6828445    assy.n@ziv.health.gov.il Less <<
NCT02614365 Mild Cognitive Impairment Not Applicable Recruiting December 2019 United States, District of Col... More >>umbia Howard University Clinical Research Unit Recruiting Washington, District of Columbia, United States, 20060 Contact: Alice Ukaegbu, NP    202-865-4272    aukaegbu@Howard.edu    Contact       aukaegbu@Howard.edu    Principal Investigator: Thomas O. Obisesan, MD, MPH Less <<
NCT02243176 - Completed - -
NCT03384303 Morbid Obesity Not Applicable Completed - -
NCT00152360 Obesity Heart... More >> Diseases Less << Phase 4 Completed - Canada, British Columbia ... More >> Healthy Heart Program/Lipid Clinic, St. Paul's Hospital Vancouver, British Columbia, Canada Less <<
NCT00712842 - Completed - Austria ... More >> Department of Clinical Pharmacology, Medical University of Vienna Vienna, Austria, 1090 Less <<
NCT01007097 Diabetes Mellitus, Type 2 Phase 2 Completed - -
NCT02128945 Untreated B-Chronic Lymphocyti... More >>c Leukemia or Diffuse Large B Cells Lymphoma Patients Less << Phase 1 Completed - France ... More >> University Hospital Caen, France, 14000 Less <<
NCT01071850 Diabetes Mellitus, Type 2 Phase 2 Completed - -
NCT03109301 Neoplasms, Nerve Tissue ... More >> Neurofibromatosis 1 Heredodegenerative Disorders, Nervous System Peripheral Nervous System Diseases Less << Phase 2 Recruiting February 1, 2023 United States, Maryland ... More >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office    888-624-1937 Less <<
NCT03288207 - Recruiting December 31, 2020 United States, Maryland ... More >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)    800-411-1222 ext TTY8664111010    prpl@cc.nih.gov Less <<
NCT01417351 Vitamin D Deficiency Not Applicable Completed - United States, California ... More >> USDA-Western Human Nutrition Research Center Davis, California, United States, 95616 UC Davis Medical Center Obstetrics & Gynecology Sacramento, California, United States, 95817 Less <<
NCT01605773 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 4 Completed - United States, Texas ... More >> Novo Nordisk Investigational Site Houston, Texas, United States, 77030 Less <<
NCT02233088 Metabolic Syndrome Not Applicable Active, not recruiting December 31, 2018 United States, Illinois ... More >> Rush University Medical Center Chicago, Illinois, United States, 60612 Less <<
NCT00690456 Diabetes Mellitus, Type 2 Phase 3 Terminated(Company decision ta... More >>ken in light of demands by certain national health authorities) Less << - United States, New Jersey ... More >> Sanofi-Aventis Administrative Office Bridgewater, New Jersey, United States, 08807 Indonesia Sanofi-Aventis Administrative Office Jakarta, Indonesia Lithuania Sanofi-Aventis Administrative Office Vilnius, Lithuania Malaysia Sanofi-Aventis Administrative Office Kuala Lumpur, Malaysia Mexico Sanofi-Aventis Administrative Office Mexico, Mexico Philippines Sanofi-Aventis Administrative Office Makati City, Philippines Poland Sanofi-Aventis Administrative Office Warszawa, Poland Romania Sanofi-Aventis Administrative Office Bucuresti, Romania Russian Federation Sanofi-Aventis Administrative Office Moscow, Russian Federation Slovakia Sanofi-Aventis Administrative Office Brastislava, Slovakia Taiwan Sanofi-Aventis Administrative Office Taipei, Taiwan Thailand Sanofi-Aventis Administrative Office Bangkok, Thailand Ukraine Sanofi-Aventis Administrative Office Kiev, Ukraine Less <<
NCT02188641 Psoriatic Arthritis Not Applicable Completed - Egypt ... More >> University of Alexandria Alexandria, Egypt, 00203 Less <<
NCT01288820 Vivax Malaria Phase 3 Completed - Indonesia ... More >> Labuhan Batu Utara Regency Tanjung leidong village North Sumatra, North Sumatera, Indonesia Less <<
NCT02531399 Healthy Not Applicable Completed - Austria ... More >> Department of Clinical Pharmacology, Medical University of Vienna, Austria Vienna, Austria, 1090 Less <<
NCT02059174 Type 1 Diabetes Mellitus Phase 1 Completed - -
NCT01372644 Atypical Ductal Breast Hyperpl... More >>asia Lobular Carcinoma in Situ (LCIS) Atypical Lobular Hyperplasia (ALH) of Breast Less << Phase 1 Completed - United States, New York ... More >> NYU School of Medicine New York, New York, United States, 10016 Less <<
NCT02059174 - Completed - -
NCT00940082 - Unknown October 2015 China, Chongqing ... More >> Endocrine Department, the First Affiliated Hospital of the Third Military Medical University Recruiting Chongqing, Chongqing, China, 400038 Contact: qinan wu, master    02368765217 ext 86    wqn11@126.com    Sub-Investigator: qinan wu, master Less <<
NCT03221816 Menopause Dys... More >>lipidemias Homocystinaemia Less << Phase 4 Completed - -
NCT00435578 Carcinoma, Small Cell Lung Phase 2 Terminated - United States, California ... More >> California Cancer Center Greenbrae, California, United States, 94904 United States, Florida H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 United States, Michigan Karmanos Cancer Institute Detroit, Michigan, United States, 48201 Less <<
NCT00766857 Type 2 Diabetes Mellitus ... More >> Congestive Heart Failure Less << Phase 4 Completed - Netherlands ... More >> VU University Medical Center Amsterdam, Noord-Holland, Netherlands, 1081 Less <<
NCT00519480 Diabetes Mellitus, Type 2 Phase 1 Completed - United States, Florida ... More >> GSK Investigational Site Miami, Florida, United States, 33169 United States, Texas GSK Investigational Site San Antonio, Texas, United States, 78209 Argentina GSK Investigational Site Buenos Aires, Argentina, 1425 Germany GSK Investigational Site Berlin, Germany, 14050 Less <<
NCT03465098 Infective Endocarditis Not Applicable Not yet recruiting October 2, 2020 -
NCT03651466 Diabetes Mellitus Phase 1 Completed - Germany ... More >> NUVISAN Neu-Ulm, Germany, 89231 Less <<
NCT00266864 Spinal Cord Injury ... More >> Hypogonadism Less << Phase 2 Phase 3 Completed - United States, New Jersey ... More >> Kessler Institute for Rehabilitation West Orange, New Jersey, United States, 07052 United States, New York James J. Peters VA Medical Center The Bronx, New York, United States, 10468 Less <<
NCT00266864 - Completed - -
NCT00139893 Diabetic Gastroparesis Not Applicable Completed - United States, Wisconsin ... More >> Schwarz Milwaukee, Wisconsin, United States Less <<
NCT01597713 Diabetes Diab... More >>etes Mellitus, Type 2 Healthy Less << Phase 1 Completed - Germany ... More >> Neuss, Germany, 41460 Less <<
NCT00804986 Diabetes Mellitus, Type 2 Phase 2 Completed - -
NCT01017302 Diabetes Mellitus Type 2 Phase 1 Completed - United States, Texas ... More >> San Antonio, Texas, United States, 78229 Less <<
NCT02444377 Obesity, Metabolically Benign Not Applicable Completed - -
NCT01109979 Cardiovascular Diseases Phase 4 Completed - United States, Massachusetts ... More >> Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Less <<
NCT00804986 - Completed - -
NCT01109979 - Completed - -
NCT03060694 - Completed - China ... More >> Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China Shanghai, China Less <<
NCT03063567 Obstructive Sleep Apnea of Adu... More >>lt Less << Not Applicable Completed - -
NCT02418377 - Recruiting August 2018 Singapore ... More >> National University Hospital, Singapore Recruiting Singapore, Singapore, 119074 Contact: Yung Seng Lee, M.D, PhD    +6567724420    paeleeys@nus.edu.sg    Contact: Delicia Ooi, PhD    +6566013316    paeosqd@nus.edu.sg    Principal Investigator: Yung Seng Lee, M.D., PhD          Sub-Investigator: Kah Yin Loke, M.D          Sub-Investigator: Andrew Sng, M.D          Sub-Investigator: Yvonne Lim, M.D          Sub-Investigator: Griva Konstadina, PhD          Sub-Investigator: Delicia Ooi, PhD          Health Promotion Board Recruiting Singapore, Singapore, 168937 Contact: Veronica Tay, M.D    +656435 3703    Veronica_Tay@hpb.gov.sg    Contact: Delicia Ooi, PhD    +6566013316    paeosqd@nus.edu.sg    Principal Investigator: Veronica Tay, M.D          Sub-Investigator: Vijaya Karuppiah, M.D          Sub-Investigator: Andrew Sng, M.D          Sub-Investigator: Yvonne Lim, M.D          Sub-Investigator: Delicia Ooi, PhD Less <<
NCT01728727 Liver Cirrhosis ... More >> End Stage Liver Disease Less << Phase 1 Phase 2 Unknown September 2015 China, Shaanxi ... More >> Xijing Hospital of Digestive Disease Recruiting Xi'an, Shaanxi, China, 710032 Contact: Ying Han    86-29-84771539    hanying@fmmu.edu.cn    Contact: Yongquan Shi    86-29-84771515    shiyquan@fmmu.edu.cn Less <<
NCT03716401 - Recruiting September 1, 2038 Finland ... More >> Turun Yliopisto Recruiting Turku, Finland Contact: Niina Koivuviita, MD       niina.koivuviita@tyks.fi    Principal Investigator: Pirjo Nuutila, MD          France Centre Hospitalier Universitaire de Bordeaux Not yet recruiting Bordeaux, France Contact: Corinne Castermans       corinne.castermans@chu-bordeaux.fr    Principal Investigator: Nicolas Grenier, MD          Italy Università degli Studi di Bari Aldo Moro Not yet recruiting Bari, Puglia, Italy Contact: Massimo Papale, PhD       mpapale78@gmail.com    Principal Investigator: Loreto Gesualdo, MD          Sweden Lund University Diabetes Centre Active, not recruiting Malmö, Sweden, 214 28 Switzerland Swiss Institute of Bioinformatics Active, not recruiting Lausanne, Switzerland, 1015 United Kingdom University of Exeter Not yet recruiting Exeter, United Kingdom Contact: Kim Gooding, PhD       k.m.gooding@exeter.ac.uk    Principal Investigator: Angela Shore, PhD          University of Leeds Recruiting Leeds, United Kingdom Contact: Steven Sourbron, PhD       s.sourbron@leeds.ac.uk    Principal Investigator: Steven Sourbron, PhD Less <<
NCT02111096 Diabetes Mellitus, Type 2 Phase 2 Terminated(The overall benefit... More >>-risk profile did not support continued development of LY2409021 for type 2 diabetes.) Less << - -
NCT03425630 Hypercholesterolemia Not Applicable Completed - -
NCT03570632 Diabetes Mellitus, Type 1 ... More >> Pregnancy in Diabetes Less << Phase 4 Not yet recruiting December 2020 United States, Pennsylvania ... More >> Magee Womens Hospital of UPMC Pittsburgh, Pennsylvania, United States, 15213 Less <<
NCT03099252 Pain Not Applicable Enrolling by invitation September 30, 2019 Canada, Ontario ... More >> Children's Hospital of Eastern Ontario Ottawa, Ontario, Canada, K1H 8L1 Less <<
NCT02111096 - Terminated(The overall benefit... More >>-risk profile did not support continued development of LY2409021 for type 2 diabetes.) Less << - -
NCT01451957 Obesity Not Applicable Completed - United States, Michigan ... More >> Michigan Clincal Research Unit Ann Arbor, Michigan, United States, 48109 Less <<
NCT02378077 Obesity Insul... More >>in Resistance Less << Not Applicable Recruiting March 2018 United States, Arizona ... More >> Mayo Clinic in Arizona Recruiting Scottsdale, Arizona, United States, 85259 Contact: Charlene Robinson    480-301-4626    ARZClinicalStudies@mayo.edu    Principal Investigator: Elena De Filippis, MD PhD Less <<
NCT00473525 Diabetes Mellitus, Type 2 Phase 2 Completed - -
NCT01705093 Childhood Obesity ... More >> Cardiovascular Disease Less << Phase 2 Completed - United States, California ... More >> Ragle Human Nutrition Research Center, Academic Surge, UC Davis Davis, California, United States, 95616 Less <<
NCT01081834 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT01243034 - Unknown October 2011 Taiwan ... More >> Changhua Christian Hospital Changhua, Taiwan, 500 Less <<
NCT03160599 Malignant Tumors Not Applicable Recruiting December 1, 2020 China, Guangdong ... More >> the Second Affiliated Hospital of Guangzhou Medical University Recruiting Guangzhou, Guangdong, China Contact: Qian Chen    86 20 81340031 Less <<
NCT00464555 Type 1 Diabetes Mellitus Phase 2 Completed - United States, Florida ... More >> University of Miami Miami, Florida, United States United States, Illinois University of Illinois at Chicago Chicago, Illinois, United States, 60607 Less <<
NCT01081834 - Completed - -
NCT01579799 Healthy Not Applicable Completed - Switzerland ... More >> University Hospital Zurich, Gastroenterology Zurich, ZH, Switzerland, 8091 Less <<
NCT01176097 Type 2 Diabetes Phase 1 Completed - United States, California ... More >> Research Site Chula Vista, California, United States Less <<
NCT01983046 Obesity Type ... More >>2 Diabetes Less << Not Applicable Completed - Netherlands ... More >> University Maastricht Maastricht, Limburg, Netherlands, 6229 ER Less <<
NCT02683187 Healthy Phase 1 Completed - United States, North Carolina ... More >> Leslie Willis Durham, North Carolina, United States, 27707 Less <<
NCT02194231 Malignant Pleural Mesothelioma Phase 2 Active, not recruiting June 2019 Italy ... More >> Azienda ospedaliera ss. Antonio e Biagio e Cesare Arrigo Alessandria, AL, Italy Cliniche Humanitas Gavazzeni Bergamo, BG, Italy Azienda Ospedaliera Universitaria Policlinico Sant'Orsola Malpighi Bologna, Bo, Italy, 40138 P.O. Spedalli Civili Brescia, BS, Italy, 25125 Azienda Ospedaliera S. Gerardo di Monza Monza, MB, Italy, 20900 Istituto Clinico Humanitas Rozzano, MI, Italy, 20089 Istituto Oncologico Veneto - IOV Padova, PD, Italy, 35128 Azienda Ospedaliro-Universitaria di Parma Parma, Italy, 43126 Less <<
NCT02325375 - Completed - Denmark ... More >> Aarhus University Hospital Aarhus, Denmark, 8000 Less <<
NCT00853164 Prostate Cancer Not Applicable Completed - United States, Missouri ... More >> Washington University School of medicine Saint Louis, Missouri, United States, 63108 Less <<
NCT00821795 Type 2 Diabetes Mellitus Phase 4 Completed - United States, Kentucky ... More >> VA Medical Center - Lexington 596 Lexington, Kentucky, United States, 40502 Less <<
NCT01030354 Weight Reduction ... More >> Obesity Weight Management Less << Phase 2 Phase 3 Completed - United States, California ... More >> University of California, Los Angeles Los Angeles, California, United States, 90095 Less <<
NCT03606694 Type 2 Diabetes Mellitus Phase 2 Not yet recruiting September 30, 2020 Mexico ... More >> Instituto de Terapeútica Experimental y Clínica. Centro Universitario de Ciencias de la Salud. Universidad de Guadalajara Guadalajara, Jalisco, Mexico, 44340 Less <<
NCT00548223 Stroke Phase 4 Completed - -
NCT01253980 Kerosene Pneumonitis Not Applicable Completed - South Africa ... More >> Red Cross War Memorial Children's Hospital Cape Town, Western Cape, South Africa, 7700 Less <<
NCT01253980 - Completed - -
NCT00699855 - Completed - -
NCT00709202 Schizophrenia ... More >> Schizoaffective Disorder Schizophreniform Disorder Bipolar I Disorder Bipolar II Bipolar NOS Psychotic Disorder Not Otherwise Specified Autism Less << Phase 2 Completed - United States, New York ... More >> Nathan Kline Insitute for Psychiatric Research Orangeburg, New York, United States, 10962 Less <<
NCT02686476 Non Alcoholic Fatty Liver Dise... More >>ase Less << Not Applicable Completed - India ... More >> Division Of Endocrinology , Medanta The Medicity Sec 38 Gurgaon, Haryana, India, 122001 Less <<
NCT01811381 Mild Cognitive Impairment Phase 2 Recruiting December 31, 2019 United States, California ... More >> VA Greater Los Angeles Healthcare System, West Los Angeles, CA Recruiting West Los Angeles, California, United States, 90073 Contact: Dean T Yamaguchi, MD    310-268-4437    Dean.Yamaguchi@va.gov    Contact: Sally A Frautschy, PhD    (310) 468-3711 ext 46499    sally.frautschy@va.gov    Sub-Investigator: Cathy Alessi, MD          Sub-Investigator: David Sultzer, MD          Sub-Investigator: Donna Ames, MD          Sub-Investigator: Edmond H Teng, PhD MD          Sub-Investigator: Rebecca J Melrose, PhD          Principal Investigator: Sally A Frautschy, PhD Less <<
NCT02093455 1. Endothelial Dysfunction (En... More >>doPAT Score <=2) Less << Not Applicable Recruiting July 2018 United States, Minnesota ... More >> Mayo Clinic in Rochester Recruiting Rochester, Minnesota, United States, 55905 Contact: Jeremy Smith    507-255-2831    smith.jeremy@mayo.edu    Principal Investigator: Lerman Amir, M.D. Less <<
NCT00680745 Type 2 Diabetes Phase 3 Completed - -
NCT00680745 - Completed - -
NCT01402115 Bone Health in Perimenopausal ... More >>Women Less << Phase 2 Phase 3 Completed - Korea, Republic of ... More >> Healthcare claims and management; Chonbuk National university Jeonju, Jeollabuk-do, Korea, Republic of, 560-822 Less <<
NCT02282488 Healthy Not Applicable Completed - France ... More >> Hôpital de la Croix-Rouse Lyon, France, 69317 Less <<
NCT01511835 Gestational Diabetes Phase 4 Unknown - Italy ... More >> AGUNCO Recruiting Rome, Italy, 00155 Contact: Gianfranco Carlomagno       gianfranco.carlomagno@agunco.it    Principal Investigator: Vittorio Unfer          Principal Investigator: Gianfranco Carlomagno Less <<
NCT02784275 Diabetes Mellitus Type 2 in Ob... More >>ese Less << Phase 2 Completed - United States, California ... More >> Los Angeles, California, United States, 90036 United States, Florida Hialeah, Florida, United States, 33016 United States, Texas Houston, Texas, United States, 77095 Tomball, Texas, United States, 77375 Less <<
NCT00764699 - Terminated(PI left institution... More >>) Less << - -
NCT01402115 - Completed - -
NCT02223234 Obesity Not Applicable Completed - Canada, Ontario ... More >> Univeristy of Guelph Guelph, Ontario, Canada, N1G 2W1 Less <<
NCT02074202 Hepatocellular Carcinoma ... More >> Liver Disease Less << Phase 3 Unknown March 2015 Taiwan ... More >> National Taiwan University Hospital Not yet recruiting Taipei, Taiwan, 10002 Contact: Kai-Yuan Tzen, MD    886-2-23123456 ext 62164    tzenky@ntuh.gov.tw    Contact: Pan-Fu Kao, MD    886-9-88334304    pfkao@csmu.edu.tw Less <<
NCT01660789 Obesity Not Applicable Completed - Denmark ... More >> Centre of Inflammation and Metabolism, Rigshospitalet Copenhagen, Denmark, 2100 Less <<
NCT00764699 Crohn Disease Phase 2 Phase 3 Terminated(PI left institution... More >>) Less << - United States, Ohio ... More >> Nationwide Children's Hospital Columbus, Ohio, United States, 43205 Less <<
NCT00842933 Septic Shock ... More >>Acute Adrenal Insufficiency Less << Phase 4 Terminated(Unable to meet enro... More >>llment goal prior to PI transfer) Less << - United States, Texas ... More >> The Methodist Hospital Houston, Texas, United States, 77030 Less <<
NCT02094768 Obesity Dysli... More >>pidemia Less << Not Applicable Completed - United States, California ... More >> Cholesterol Research Center Berkeley, California, United States, 94705 Less <<
NCT03760770 Keratoconus C... More >>rosslinking Less << Not Applicable Recruiting February 1, 2019 Mexico ... More >> Instituto de oftalmología conde de Valenciana Recruiting Mexico City, Mexico, 06800 Contact: Enrique Graue Hernandez, MD MSc    +52 5554421700 ext 3710    egraueh@gmail.com    Contact: Laura Toro, MD    +52 5554421700 ext 3710    lauratorog@hotmail.com Less <<
NCT03648892 - Recruiting December 31, 2021 United States, Maryland ... More >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)    800-411-1222 ext TTY8664111010    prpl@cc.nih.gov Less <<
NCT01051011 Diabetes Mellitus Type 2 Phase 3 Terminated(high discontinuatio... More >>n rates mainly due to GI tolerability and implementation of risk mitigation plan to address hypersensitivity reactions) Less << - -
NCT01096095 Spinocerebellar Ataxia Type 3 Phase 2 Withdrawn(Regulatory authoriti... More >>es did not allow the entrance of the study drug in the country) Less << July 2011 Brazil ... More >> Hospital de Clínicas de Porto Alegre Porto Alegre, Rio Grande do Sul, Brazil, 90.035-903 Less <<
NCT02506738 Heart Failure Not Applicable Completed - -
NCT00133783 - Unknown - Taiwan ... More >> Chailin Chang Recruiting Kwei-Shan, Tao-Yuan, Taiwan, 333 Contact: Chialin Chang, M.D.    886-968372657    amego@cgmh.org.tw    Principal Investigator: Chialin Chang, M.D. Less <<
NCT01548079 Non-alcoholic Fatty Liver Dise... More >>ase Morbid Obesity Less << Not Applicable Completed - -
NCT02954783 Prostate Cancer Not Applicable Recruiting March 2020 Denmark ... More >> Center for Physical Activity Research, Copenhagen University Hospital Recruiting Copenhagen, Denmark, DK-2100 Contact: Sissal S. Djurhuus, MD    +4525705700    sissaldjurhuus@regionh.dk Less <<
NCT03769883 Type 2 Diabetes Mellitus ... More >> Type2 Diabetes Diabetes Mellitus, Type 2 Type2 Diabetes Mellitus Less << Not Applicable Recruiting August 2021 Denmark ... More >> Center for Physical Activity Research, Copenhagen University Hospital Recruiting Copenhagen, Denmark, 2100 Contact: Mathias Ried-larsen, PhD    0045 35 45 06 99    mathias.ried-larsen@regionh.dk    Contact: Inge Holm    0045 35 45 76 21    inge.holm@regionh.dk Less <<
NCT00525863 Chronic Schizophrenia Phase 3 Unknown December 2009 Israel ... More >> Beersheva Mental Health Center Recruiting Beersheva, Israel Contact: Yuly Bersudsky, MD, PhD    9728-6401602    yuly@bgu.ac.il Less <<
NCT01064687 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT01566370 - Terminated(recruitment infeasi... More >>ble) Less << - -
NCT01155128 Cardiovascular Disease ... More >> Chronic Kidney Disease Chronic Renal Disease Hypertension Less << Phase 4 Unknown December 2012 Brazil ... More >> University Federal of Pelotas Pelotas, RS, Brazil, 96020220 Less <<
NCT02505334 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - Japan ... More >> Novo Nordisk Investigational Site Annaka-shi, Gunma, Japan, 379 0116 Novo Nordisk Investigational Site Chitose, Hokkaido, Japan, 066-0032 Novo Nordisk Investigational Site Chuo-ku Tokyo, Japan, 103-0027 Novo Nordisk Investigational Site Chuo-ku, Tokyo, Japan, 103 0002 Novo Nordisk Investigational Site Chuo-ku, Tokyo, Japan, 103 0027 Novo Nordisk Investigational Site Chuo-ku,, Japan, 104 0061 Novo Nordisk Investigational Site Fukuoka-shi, Fukuoka, Japan Novo Nordisk Investigational Site Higashiosaka-shi, Osaka, Japan Novo Nordisk Investigational Site Hokkaido, Japan, 078-8236 Novo Nordisk Investigational Site Ichikawa-shi, Chiba, Japan Novo Nordisk Investigational Site Iruma-shi, Saitama, Japan, 358 0011 Novo Nordisk Investigational Site Izumisano-shi, Japan, 598 0048 Novo Nordisk Investigational Site Kashiwara-shi, Osaka, Japan, 582 0005 Novo Nordisk Investigational Site Kawagoe-shi, Saitama, Japan, 350 0851 Novo Nordisk Investigational Site Kobe-shi, Hyogo, Japan Novo Nordisk Investigational Site Kumamoto-shi,Kumamoto, Japan, 862 0976 Novo Nordisk Investigational Site Mito-shi, Ibaraki, Japan, 310-0845 Novo Nordisk Investigational Site Mito-shi, Ibaraki, Japan Novo Nordisk Investigational Site Miyazaki-shi, Japan, 880 0034 Novo Nordisk Investigational Site Naka-shi, Ibaraki, Japan, 311 0113 Novo Nordisk Investigational Site Neyagawa-shi, Osaka, Japan Novo Nordisk Investigational Site Nishinomiya-shi, Hygo, Japan, 662 0971 Novo Nordisk Investigational Site Nishinomiya-shi, Hyogo, Japan, 663-8501 Novo Nordisk Investigational Site Oita-shi, Japan, 870 0039 Novo Nordisk Investigational Site Okawa-shi, Fukuoka, Japan, 831 0016 Novo Nordisk Investigational Site Osaka-shi, Osaka, Japan, 553 0003 Novo Nordisk Investigational Site Osaka-shi, Osaka, Japan, 5590012 Novo Nordisk Investigational Site Oyama-shi, Tochigi, Japan, 323 0022 Novo Nordisk Investigational Site Saga-shi,Saga, Japan, 849 0937 Novo Nordisk Investigational Site Sapporo-shi, Hokkaido, Japan, 060 0062 Novo Nordisk Investigational Site Sapporo-shi, Hokkaido, Japan, 060-0001 Novo Nordisk Investigational Site Sapporo-shi, Hokkaido, Japan, 062 0007 Novo Nordisk Investigational Site Sappro-shi, Hokkaido, Japan, 060 8648 Novo Nordisk Investigational Site Shimotsuke-shi, Tochigi, Japan, 329 0433 Novo Nordisk Investigational Site Shinjuku-ku, Tokyo, Japan, 160-0008 Novo Nordisk Investigational Site Shizuoka-shi, Japan, 424 0853 Novo Nordisk Investigational Site Suita-shi, Osaka, Japan, 565-0853 Novo Nordisk Investigational Site Takatsuki-shi, Osaka, Japan, 569 1096 Novo Nordisk Investigational Site Tokyo, Japan, 103-0028 Novo Nordisk Investigational Site Tokyo, Japan, 105-8471 Novo Nordisk Investigational Site Tokyo, Japan, 123-0845 Novo Nordisk Investigational Site Tokyo, Japan, 144-0051 Novo Nordisk Investigational Site Tokyo, Japan, 169-0073 Novo Nordisk Investigational Site Tokyo, Japan, 181-0013 Novo Nordisk Investigational Site Yokohama, Kanagawa, Japan, 236-0004 Novo Nordisk Investigational Site Yokohama-shi Kanagawa, Japan, 232-0064 Novo Nordisk Investigational Site Yokohama-shi, Japan, 235 0045 Less <<
NCT00644267 Hypertension Not Applicable Unknown October 2010 United States, Pennsylvania ... More >> Temple University School of Medicine Philadelphia, Pennsylvania, United States, 19140 Less <<
NCT02505334 - Completed - -
NCT00784615 - Unknown - Argentina ... More >> Hospital Universitario de Maternidad y Neonatología Recruiting Cordoba, Argentina, X5000 Contact: Paula S Mereshian, MD    54 351 433 1053    paula.mereshian@gmail.com    Principal Investigator: Carolina Fux Otta, MD Less <<
NCT02498002 Obesity Type ... More >>2 Diabetes Less << Not Applicable Completed - United Kingdom ... More >> University of Bath Bath, Somerset, United Kingdom, BA2 7AY Less <<
NCT01981525 Li-Fraumeni Syndrome Phase 1 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT01566370 Alcohol Use Disorders ... More >> Bipolar Disorder Less << Phase 2 Terminated(recruitment infeasi... More >>ble) Less << - United States, Connecticut ... More >> VA Connecticut Healthcare System West Haven, Connecticut, United States, 06516 Less <<
NCT00159770 Schizophrenia ... More >> Schizoaffective Disorder Psychotic Disorders Less << Phase 3 Completed - -
NCT00766987 - Recruiting March 2022 Canada, Ontario ... More >> Hamilton Health Sciences Centre Recruiting Hamilton, Ontario, Canada Contact: Karen Gulenchyn, MD          Principal Investigator: Karen Gulenchyn, MD          London Health Sciences Centre Recruiting London, Ontario, Canada Contact: Gerald Wisenberg, MD          Principal Investigator: Gerald Wisenberg, MD          University of Ottawa Heart Institute Recruiting Ottawa, Ontario, Canada, K1Y 4W7 Contact: Linda Garrard, RN, BScN    613-696-7000 ext 14192    lgarrard@ottawaheart.ca    Principal Investigator: Rob S Beanlands, MD, FRCP C          University Health Network Recruiting Toronto, Ontario, Canada Contact: Robert Iwanochko, MD          Principal Investigator: Robert Iwanochko, MD Less <<
NCT00001288 - Completed - United States, Maryland ... More >> National Institute of Neurological Disorders and Stroke (NINDS) Bethesda, Maryland, United States, 20892 Less <<
NCT00498147 - Unknown July 2010 Canada, Ontario ... More >> Group Health Centre Sault Ste. Marie, Ontario, Canada, P6A 1Y7 Less <<
NCT02908789 Dental Caries Not Applicable Recruiting April 2020 Brazil ... More >> Universidade Federal Fluminense Recruiting Nova Friburgo, Rio De Janeiro, Brazil, 28625650 Contact: Livia Antunes, PhD    55219871519191    liviaazeredo@gmail.com    Contact: Leonardo Antunes, PhD    5521988911919    leonardoantunes@id.uff.br Less <<
NCT00351507 Diabetes Mellitus, Type 2 Phase 3 Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT00001385 - Completed - United States, Maryland ... More >> National Cancer Institute (NCI) Bethesda, Maryland, United States, 20892 Less <<
NCT01351753 Obesity Metab... More >>olic Syndrome X Less << Phase 2 Suspended(Change of staff) October 2019 United States, Iowa ... More >> University of Iowa Hospitals and Clinics Iowa City, Iowa, United States, 52241 Less <<
NCT02512107 Inflammation Not Applicable Unknown May 2016 United States, Tennessee ... More >> The University of Memphis Recruiting Memphis, Tennessee, United States, 38152 Contact: Marie van der Merwe, PhD    901-678-3476    mvndrmrw@memphis.edu Less <<
NCT00653666 Carnitine Palmitoyl Transferas... More >>e Type 1A (CPT1A) Deficiency Less << Not Applicable Completed - United States, Oregon ... More >> Oregon Health & Science University Portland, Oregon, United States, 97239 Less <<
NCT00685945 - Completed - -
NCT00326521 - Unknown May 2009 United States, California ... More >> Long Beach Memorial Medical Center Recruiting Long Beach, California, United States, 90806 Contact: Christine Preslicka, RN    562-933-2755    cpreslicka@memorialcare.org    Contact: Michael P Nageotte, MD    562-933-2730    mnageotte@memorialcare.org    Principal Investigator: Michael P Nageotte, MD          Sub-Investigator: Kim C Winovitch, MD          UCI Medical Center Recruiting Orange, California, United States, 92686 Contact: Pam Rumney, RN    714-456-5967    prumney@uci.edu    Contact: Deborah Wing, MD    714-456-5967    dwing@uci.edu    Principal Investigator: Deborah Wing, MD          Sub-Investigator: Kim C Winovitch, MD Less <<
NCT02732795 Pediatric Sleep Apnea ... More >> Obesity Morphine Metabolism Less << Not Applicable Recruiting January 2019 United States, Maryland ... More >> Bloomberg Children's Hospital Recruiting Baltimore, Maryland, United States, 21287 Contact: Nicholas M Dalesio, MD    410-955-7610 Less <<
NCT02226419 Carnitine Transporter, Plasma-... More >>membrane, Deficiency of Less << Not Applicable Completed - -
NCT01263548 - Completed - Canada, Ontario ... More >> Mood Disorders Psychopharmacology Unit Toronto, Ontario, Canada, M5T 2S8 Less <<
NCT02319954 Rhinoplasty E... More >>cchymosis Less << Not Applicable Completed - -
NCT01257451 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT00685945 Obesity Not Applicable Completed - United States, Tennessee ... More >> Vanderbilt University Medical Center-GCRC Nashville, Tennessee, United States, 37232 Less <<
NCT02252965 Diabetes Mellitus, Type 2 Phase 4 Completed - Germany ... More >> Please contact the Merck KGaA Communication Center Darmstadt, Germany Less <<
NCT00994877 - Unknown May 2010 Israel ... More >> Asaf Harofeh Medical Center Recruiting Beer Yaakov, Israel Contact: asaf miller       asafmiller@gmail.com    Principal Investigator: ASAF MILLER, MD Less <<
NCT00789737 - Completed - -
NCT01451918 Dyslipidaemia ... More >> Insulin Resistance Less << Phase 2 Completed - Canada, Ontario ... More >> Toronto General Hospital Toronto, Ontario, Canada Less <<
NCT03168880 Triple Negative Breast Cancer Phase 3 Recruiting November 30, 2024 India ... More >> Tata memorial Centre Recruiting Mumbai, Maharashtra, India, 400012 Contact: Rohini Hawaldar    24168601    rwhawaldar@gmail.com Less <<
NCT00789737 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT01986855 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT00462475 - Completed - Italy ... More >> Department of Molecular and Clinical Endocirnology and Oncology University Federico II of Naples Naples, Italy, 80131 Less <<
NCT02137070 - Active, not recruiting September 2019 United States, Florida ... More >> University of Florida - College of Public Health and Health Professions Gainesville, Florida, United States, 32610 Less <<
NCT02252965 - Completed - -
NCT02164266 Healthy Volunteer, Type 2 Diab... More >>etes Less << Phase 1 Completed - Netherlands ... More >> Leiden, Netherlands, 2333 Less <<
NCT00381342 Type 2 Diabetes Mellitus Phase 3 Completed - United States, Idaho ... More >> Research Site Idaho Falls, Idaho, United States United States, Indiana Research Site Indianapolis, Indiana, United States India Research Site Aligarh, India Research Site Bangalore, India Research Site Chennai, India Research Site Indore, India Research Site Karnal, India Research Site New Delhi, India Research Site Vellore, India Puerto Rico Research Site Manati, Puerto Rico Research Site San Juan, Puerto Rico Romania Research Site Alba Iulia, Romania Research Site Baia Mare, Romania Research Site Bucuresti, Romania Research Site Galati, Romania Research Site Oradea, Romania Research Site Targu Mures, Romania Russian Federation Research Site Moscow, Russian Federation Research Site St. Petersburg, Russian Federation Less <<
NCT01986855 - Completed - -
NCT02317926 Hypothyroidism Not Applicable Unknown - United States, Maryland ... More >> Walter Reed National Military Medical Center Recruiting Besthesda, Maryland, United States, 20889 Contact: Mohamed K Shakir, MD    301-295-5165    mohamed.k.shakir.civ@mail.mil    Contact: Angela Taylor    301-295-5165    angela.l.taylor38.civ@mail.mil@mail.mil Less <<
NCT02585765 Spinal Cord Injury ... More >> Pressure Ulcers Less << Phase 2 Withdrawn(an alternate plan of... More >> investigation was developed.) Less << - United States, New York ... More >> James J. Peters VA Medical Center Bronx, New York, United States, 10468 Less <<
NCT00612495 Endometrial Cancer Phase 2 Completed - France ... More >> Sanofi-Aventis Paris, France Less <<
NCT02100475 - Completed - -
NCT02100475 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT00571220 - Completed - United States, New York ... More >> St Luke's Roosevelt Hospital Center New York, New York, United States, 10025 Less <<
NCT01338883 HIV-1 Infection Phase 2 Completed - -
NCT02219750 Diabetes Phase 4 Completed - Taiwan ... More >> Mackay Memerial Hospital Taipei, Taiwan Less <<
NCT02810483 Prader-Willi Syndrome Phase 3 Terminated - France ... More >> Hôpital La Pitié Salpêtrière Paris, France, 75013 Less <<
NCT02598791 Obesity Adipo... More >>sity Type 2 Diabetes Less << Not Applicable Completed - Denmark ... More >> Center for Diabetesresearch, Gentofte hospital Hellerup, Denmark, 2900 Less <<
NCT02668744 Obesity Not Applicable Recruiting March 2020 United States, Texas ... More >> Barbara Jordan Elementary Recruiting Austin, Texas, United States, 78724 Contact: Adrienne Williams    512-414-2578    adrienne.williams@austinisd.org    Decker Elementary Recruiting Austin, Texas, United States, 78724 Contact: Natalie Long    512-278-4150    Natalie.Long@manorisd.net    Oak Meadows Elementary Recruiting Austin, Texas, United States, 78724 Contact: Salvador Vega    512-278-4175    salvador.vega@manorisd.net    Pleasant Hill Elementary Recruiting Austin, Texas, United States, 78745 Contact: Kristi Cisneros    512-414-4453    kristi.cisneros@austinisd.org    Hart Elementary Recruiting Austin, Texas, United States, 78753 Contact: Sonia Tosh    512-841-2100    sonia.tosh@austinisd.org    Voigt Elementary Recruiting Round Rock, Texas, United States, 78664 Contact: Cheryl Hester    512-428-7500    cheryl_hester@roundrockisd.org Less <<
NCT03237598 - Completed - -
NCT01441154 - Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT02138630 Metabolism Ex... More >>ercise Less << Early Phase 1 Unknown January 2016 Canada, Prince Edward Island ... More >> UPEI Charlottetown, Prince Edward Island, Canada, C1A4P3 Less <<
NCT01355510 - Unknown - Germany ... More >> Hannover Medical School Recruiting Hannover, Germany Contact: Jens Jordan, MD    +495115322821    jordan.jens@mh-hannover.de    Principal Investigator: Jens Jordan, MD          Sub-Investigator: Julia Reuter, MD          Sub-Investigator: Karsten Heusser, MD Less <<
NCT02069418 Non-small Cell Lung Cancer Met... More >>astatic or Non-small Cell Lung Cancer Recurrent No EGFR Activating Mutation Less << Phase 2 Unknown June 2016 France ... More >> University Hospital, Bordeaux Bordeaux, Gironde, France, 33000 Army Hospital, Percy Percy, Haut de Seine, France, 92140 University Hospital, Toulouse Toulouse, Haute Garonne, France, 31000 University Hospital, Tours Tours, Indre et Loire, France, 37000 University Hospital, Angers Angers, Maine et Loire, France, 49933 University Hospital, Nancy Nancy, Meurthe et Moselle, France, 54000 University Hospital, Rouen Rouen, Seine maritime, France, 76000 Hospital, Créteil Créteil, Val de Marne, France, 94000 Less <<
NCT00945217 - Unknown July 2012 Taiwan ... More >> Section of Endocrinology and Metabolism, Department of Medicine, Taipei Veterans General Hospital Recruiting Taipei, Taiwan, 112 Contact: Chii-Min Hwu, MD    88622875716    chhwu@vghtpe.gov.tw    Principal Investigator: Chii-Min Hwu, MD Less <<
NCT01202994 Alzheimer's Disease Phase 2 Active, not recruiting December 2018 United States, Utah ... More >> University of Utah Center for Alzheimer's Care, Imaging and Research Salt Lake City, Utah, United States, 84108 Less <<
NCT00954694 Diabetes Inac... More >>tivity Less << Not Applicable Unknown November 2009 United States, Nebraska ... More >> The Nebraska Medical Center Diabetes Center Not yet recruiting Omaha, Nebraska, United States, 68198-4100 Less <<
NCT03582748 - Not yet recruiting September 1, 2024 -
NCT02147431 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 1 Completed - Austria ... More >> Novo Nordisk Investigational Site Graz, Austria, 8010 Less <<
NCT02182167 Drug-Induced Liver Injury Phase 2 Phase 3 Recruiting August 2019 South Africa ... More >> Groote Schuur Hospital Recruiting Cape Town, Western Province, South Africa, 7925 Sub-Investigator: Farouk M Chughlay          Sub-Investigator: Mashiko Setshedi          Sub-Investigator: Gary Maartens          Sub-Investigator: Mark Sonderup          Sub-Investigator: Wendy Spearman          Principal Investigator: Karen Cohen          Sub-Investigator: Hannah Gunter          New Somerset Hospital Recruiting Cape Town, Western Province, South Africa, 8005 Sub-Investigator: Shiraz Moosa          Sub-Investigator: Dave Stead Less <<
NCT01202994 - Active, not recruiting - -
NCT02557412 Sleep Apnea D... More >>yslipidaemia Less << Phase 4 Recruiting May 2020 Spain ... More >> Hospital Universitario Príncipe de Asturias Recruiting Alcalá de Henares, Madrid, Spain, 28805 Contact: David Barros, MD    +34669356321    barroscasas@hotmail.com Less <<
NCT03174652 - Completed - Thailand ... More >> Shoklo Malaria Research Unit Mae Sot, Tak, Thailand, 63110 Less <<
NCT00358098 - Terminated - Canada, Alberta ... More >> Cross Cancer Institute Edmonton, Alberta, Canada, T6G 1Z2 Less <<
NCT00321204 - Terminated(Terminated We are n... More >>o longer recruiting.) Less << - United States, Georgia ... More >> Emory University Hospital Atlanta, Georgia, United States, 30322 Emory Crawford Long Hospital Atlanta, Georgia, United States, 30365 Veteran Administration Medical Center Decatur, Georgia, United States, 30033 Less <<
NCT00461617 Diabetes Phase 3 Completed - -
NCT01259661 Postmenopausal Women Not Applicable Unknown October 2012 Taiwan ... More >> Taipei Medical University WanFang Hospital Recruiting Taipei, Taiwan Contact: Jen-Chen Tsai    886-2-27361661 ext 6308    jenchent@tmu.edu.tw Less <<
NCT01938950 Childhood Obesity Not Applicable Terminated(PI is leaving the i... More >>nstitution) Less << - United States, Pennsylvania ... More >> Children's Hospital of Pittsburgh of UPMC Pittsburgh, Pennsylvania, United States, 15224 Less <<
NCT03069781 Muscle Atrophy Early Phase 1 Withdrawn(Lack of funding) - Canada, Ontario ... More >> McMaster Univeristy Hamilton, Ontario, Canada Less <<
NCT00123786 Sarcoma Phase 2 Terminated(Lack of Enrollment) - Canada, Alberta ... More >> Cross Cancer Institute Edmonton, Alberta, Canada, T6G 1Z2 Less <<
NCT01792193 - Completed - Germany ... More >> Saarland University Homburg / Saar, Saarland, Germany, 66421 Less <<
NCT00339703 - Unknown - United States, Texas ... More >> Wilford Hall Medical Center San Antonio, Texas, United States, 78236 Less <<
NCT03245723 - Recruiting August 2020 United States, Wisconsin ... More >> UW Madison Recruiting Madison, Wisconsin, United States, 53792 Contact: Jeni A Nestler, BS    608-262-4233    jnestler@medicine.wisc.edu    Contact: Tina M Palas, BS    608-262-4554    tmp@medicine.wisc.edu    Principal Investigator: Kara N Goss, MD Less <<
NCT03254368 Type 2 Diabetes Mellitus ... More >> Overweight and Obesity Less << Phase 2 Recruiting April 2019 Australia, New South Wales ... More >> Coffs Harbour GP SuperClinic Recruiting Coffs Harbour, New South Wales, Australia, 2450 Contact: Melissa Hull-Moody    ‭+61266913573‬    melissah@coffsgpsc.com.au    Northside Health Active, not recruiting Coffs Harbour, New South Wales, Australia, 2450 The Aim Centre Recruiting Merewether, New South Wales, Australia, 2291 Contact: Kate Bone    ‭+61249632323‬    kate@hunterdiabetes.com.au    The Boden Institute Recruiting Sydney, New South Wales, Australia, 2006 Contact: Tegan Picone    +61286270141    tegan.picone@sydney.edu.au    Holdsworth House Medical Practice Recruiting Sydney, New South Wales, Australia, 2010 Contact: Trina Vincent    ‭+61280381044‬    trina.vincent@holdsworthhouse.com.au    Pendlebury Research Recruiting Sydney, New South Wales, Australia, 2289 Contact: Paula Abrego    ‭+61249025162‬    paula@pendleburyresearch.com.au    Australia, Queensland Q-Pharm Active, not recruiting Herston, Queensland, Australia, 4006 Griffith University, Gold Coast Campus Recruiting Southport, Queensland, Australia, 4222 Contact: Danielle O'Reilly    +61755527260    d.oreilly@griffith.edu.au    Australia, South Australia Southern Adelaide Diabetes & Endocrine Services Active, not recruiting Daw Park, South Australia, Australia, 5041 Australia, Victoria Eastern Clinical Research Unit (ECRU) Recruiting Box Hill, Victoria, Australia, 3128 Contact: Joanne Phillips    ‭+61390949509‬    joanne.phillips@monash.edu    Barwon Health Recruiting Geelong, Victoria, Australia, 3218 Contact: Bree Sarah    +61342152875    brees@barwonhealth.org.au    Royal Melbourne Hospital Recruiting Parkville, Victoria, Australia, 3050 Contact: Marika Bjorasen    ‭+61393427344‬    marika.bjorasen@mh.org.au    New Zealand Optimal Clinical Trials Recruiting Auckland, New Zealand, 1021 Contact: Liz Smaill    ‭+6493034987‬    liz@optimalclinicaltrials.com    Middlemore Hospital Recruiting Auckland, New Zealand, 2025 Contact: Ruth Cammell    ‭+6492760044 ext 2976‬    ruth.cammell@mmclintrials.nz    Christchurch Diabetes Centre Active, not recruiting Christchurch, New Zealand, 8011 Southern Clinical Trials Recruiting Christchurch, New Zealand, 8024 Contact: Julia Matheison    ‭+6433371979‬    julia@sctrials.co.nz    Lipid and Diabetes Research Group Recruiting Christchurch, New Zealand, 8140 Contact: Zarnia Morrison    ‭+6433641375‬    zarnia.morrison@cdhb.health.nz    Clinical Trials New Zealand Ltd Recruiting Hamilton, New Zealand, 3206 Contact: Eileen Bisley    +6478430105    eileen@clinicaltrialsnz.com    P3 Research Hawkes Bay Recruiting Hastings, New Zealand, 4130 Contact: Alison Strong    +64 21 335693    alison.strong@p3research.co.nz    P3 Research Wellington Recruiting Newtown, New Zealand, 6021 Contact: Mary McKay    ‭+616448010002‬    mary@p3research.co.nz    Lakeland Clinical Trials Recruiting Rotorua, New Zealand, 3010 Contact: Philippa Williams    +64 (0)7 3477 870    philippa@lakelandtrials.com    P3 Research Tauranga Recruiting Tauranga, New Zealand, 3110 Contact: Katie Kennett    ‭+6475790453‬    katie@p3research.co.nz    Wellington Hospital Recruiting Wellington, New Zealand, 6021 Contact: Cecilia Ross    ‭+6448062371‬    cecilia.ross@ccdhb.org.nz Less <<
NCT00806325 - Completed - United States, Ohio ... More >> The Ohio State University Columbus, Ohio, United States, 43210 Less <<
NCT02158078 - Terminated(Terminated to allow... More >> continued optimization of the product.) Less << - Austria ... More >> Medical University of Graz Graz, Austria, A-8036 Less <<
NCT00357370 Type 2 Diabetes Phase 2 Phase 3 Completed - -
NCT01264536 Sepsis Phase 2 Completed - Peru ... More >> Hospital Nacional Alberto Sabogal Sologuren Callao, Lima, Peru, Callao2 Hospital Guillermo Almnara Irigoyen Lima, Peru, Lima13 Hospital Nacional Cayetano Heredia Lima, Peru, Lima31 Less <<
NCT03552172 - Recruiting March 2019 France ... More >> Chu Dijon Bourogne Recruiting Dijon, France, 21000 Contact: Véronique BONNIAUD    0380293800    veronique.bonniaud@chu-dijon.fr Less <<
NCT00357370 - Completed - -
NCT01064687 - Completed - -
NCT02696941 Non-alcoholic Fatty Liver Dise... More >>ase Less << Phase 1 Completed - United Kingdom ... More >> University of Oxford Oxford, United Kingdom Less <<
NCT00635492 - Completed - -
NCT02123901 Type 2 Diabetes Not Applicable Completed - Thailand ... More >> The Primary Health Promoting Hospital Prapadang, Samut Prakan, Thailand, 10130 Less <<
NCT01522807 Diabetes Mellitus, Type 2 Phase 1 Completed - Singapore ... More >> Pfizer Investigational Site Singapore, Singapore, 188770 Less <<
NCT00635492 - Completed - -
NCT00822211 Type 2 Diabetes Mellitus Phase 3 Completed - China ... More >> China-Japan Friendship Hospital Beijing, China General Hospital of Beijing Military Region of PLA Beijing, China Peking Union Medical College Hospital Beijing, China Peking University First Hospital Beijing, China The General Hospital of the PLA Beijing, China The General Hospital of the Second Artilleryman of PLA Beijing, China The Affiliated Union Hospital of Fujian Medical University Fuzhou, China The Fuzhou General Hospital of the PLA Nanjing Military Area Fuzhou, China Guangdong Provincial People's Hospital Guangzhou, China Second Affiliated Hospital of Nanchang University Nanchang, China The Jiangxi Provincial People's Hospital Nanchang, China Te Affiliated Drum Tower of Nanjing University Medical School Nanjing, China Tongji Hospital of Tongji University Nanjing, China Shanghai Changzheng Hospital Shanghai, China The Second Affiliated Hospital of China Medical University Shenyang, China The Second Affiliated Hospital of Tianjin Medical University Tianjin, China First Affiliated Hospital of 4th Military Medical University Xi'an, China Less <<
NCT03192293 Breast Cancer Phase 2 Recruiting January 20, 2019 Singapore ... More >> National University Hospital Singapore Recruiting Singapore, Singapore, 119228 Less <<
NCT02816762 Diabetic Nephropathy ... More >> Sleep Apnea Less << Phase 4 Recruiting September 2020 Spain ... More >> Hospital Universitari Son Espases Recruiting Palma de Mallorca, Islas Baleares, Spain, 07120 Contact: Alberto Alonso-Fernández          Principal Investigator: Alberto Alonso-Fernández, MD          Sub-Investigator: Sheila Cabello Pelegrín, MD          Hospital Universitario Infanta Sofía Recruiting San Sebastián de los Reyes, Madrid, Spain, 28703 Contact: Mayte Ramirez, MD          Principal Investigator: Mayte Ramirez, MD          Sub-Investigator: Vanesa Lores, MD          Hospital Universitario General de Guadalajara Recruiting Guadalajara, Spain, 19002 Contact: Olga Mediano, MD          Principal Investigator: Olga Mediano, MD          Sub-Investigator: Pilar Resano Barrio, MD          Hosptial Universitario La Paz, IdiPAZ Recruiting Madrid, Spain, 28034 Contact: Francisco Garcia-Rio, MD    +34639911718    fgr01m@gmail.com    Sub-Investigator: Olga Costero, MD          Sub-Investigator: Ester Zamarrón, MD          Sub-Investigator: Elisabet Martínez-Cerón, MD          Fundación Jiménez Díaz Recruiting Madrid, Spain, 28040 Contact: Nicolas González Mangado          Principal Investigator: Nicolás González-Mangado, MD          Sub-Investigator: Paula Rodríguez Rodríguez, MD          Hospital Universitario 12 de Octubre Recruiting Madrid, Spain, 28041 Contact: Trinidad Diaz-Cambriles, MD          Principal Investigator: Trinidad Diaz Cambriles, MD Less <<
NCT02391701 Cardiovascular Disease Not Applicable Unknown May 2015 Spain ... More >> Hospital Clinico Universitario de Santiago Recruiting Santiago de Compostela, Spain, 15706 Contact: Juan Sanchez, MD    +34986573460    juan.jose.sanchez.castro@sergas.es Less <<
NCT00907075 Type 2 Diabetes Mellitus Not Applicable Completed - United States, Illinois ... More >> Provident Clinical Research & Consulting, Inc. Addison, Illinois, United States, 60101 United States, Indiana Provident Clinical Research & Consulting, Inc. Bloomington, Indiana, United States, 47403 Less <<
NCT03267758 Cardiovascular Disease Not Applicable Recruiting December 2019 United States, Wisconsin ... More >> Medical College of Wisconsin Recruiting Milwaukee, Wisconsin, United States, 53226 Principal Investigator: Michael E Widlansky Less <<
NCT00158587 Malaria Vivax... More >> Malaria Less << Phase 3 Completed - -
NCT03169959 Type 2 Diabetes Mellitus Phase 1 Completed - United States, Maryland ... More >> Research Site Baltimore, Maryland, United States, 21225 Less <<
NCT02762578 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT01666938 Diabetes Mellitus Not Applicable Completed - Brazil ... More >> Center for Family Health 03 Ribeirao Preto, Sao Paulo, Brazil, 14051-297 Less <<
NCT00001363 - Completed - United States, Maryland ... More >> National Institute of Neurological Disorders and Stroke (NINDS) Bethesda, Maryland, United States, 20892 Less <<
NCT01427920 - Completed - -
NCT01427920 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 4 Completed - -
NCT01175486 Diabetes Phase 4 Unknown December 2015 Taiwan ... More >> Taipei Veterans General Hospital, Taiwan Recruiting Taipei, Taiwan Principal Investigator: Harn-Shen Chen, MD, PhD Less <<
NCT01016184 Vitamin D Deficiency Phase 4 Completed - Israel ... More >> Rambam health care campus Haifa, Israel Less <<
NCT00600912 Inflammatory Response ... More >> Hepatic Function Less << Phase 4 Completed - Germany ... More >> Klinikum der Stadt Ludwigshafen, Department of Anesthesiology and Intensive Care Medicine Ludwigshafen, Germany, 67063 Less <<
NCT00330941 Pain, Postoperative ... More >> Opioid Consumption, Postoperative Postoperative Fatigue Less << Phase 4 Completed - Belgium ... More >> CHU de Liège, University of Liège Liege, Belgium, B-4000 Less <<
NCT01540123 Cerebral Blood Flow Not Applicable Completed - United Kingdom ... More >> Brain, Performance and Nutrition Research Centre Newcastle Upon-Tyne, United Kingdom, NE18ST Less <<
NCT01525316 Late Onset Neonatal Sepsis Phase 3 Completed - Peru ... More >> Hospital Nacional Alberto Sabogal Sologuren Lima, Peru, 0511 Hospital Nacional Cayetano Heredia Lima, Peru, 0511 Hospital Nacional Guillermo Almenara Irigoyen Lima, Peru, 0511 Less <<
NCT03194009 Diabetes Mellitus, Type 2 ... More >> Prediabetic State Less << Not Applicable Recruiting December 31, 2022 Mexico ... More >> Centros de Salud. Secretaría de Salud Ciudad de México Recruiting Mexico City, Mexico, 06820 Contact: Alberto Gallardo, MD    +52 (55) 50381700 ext 1597    albgallardo@yahoo.com.mx    Contact: Carmen Vanegas, MD    +52(55) 50381700 ext 1067    carmenvanegas_5@hotmail.com Less <<
NCT00777725 - Completed - Australia, Victoria ... More >> Alfred Hospital Melbourne, Victoria, Australia, 3004 Less <<
NCT02939378 Glioblastoma Multiforme Phase 1 Phase 2 Unknown December 2018 China, Beijing ... More >> Beijing Tiantan Hospital Recruiting Beijing, Beijing, China, 100005 Contact: Song Lin, M.D.,    +8601067096509    linsong2005@126.com    Contact: Xiaohui Ren, M.D.,    +8601067096509    xiaohuiren@aliyun.com Less <<
NCT02762578 - Completed - -
NCT00396227 Diabetes Mellitus, Type 2 Phase 3 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 Less <<
NCT03746093 Diabetes Mellitus, Type 2 Not Applicable Recruiting December 2019 Portugal ... More >> NOVA Medical School, NOVA University of Lisbon Recruiting Lisboa, Portugal, 1169-056 Contact: Conceição Calhau    00351918482491    diabeer@nms.unl.pt Less <<
NCT01625325 - Completed - Germany ... More >> Ambulatory Obesity Program, Charité University, Berlin Berlin, Germany, 13353 Vestische Kinderklinik, University of Witten/Herdecke Datteln, Germany University Duisburg-Essen Essen, Germany, 45147 University Hospital Leipzig Leipzig, Germany, 04103 Dept for Pediatrics and Adolescent Medicine, University of Ulm: Interdisciplinary obesity clinic Ulm, Germany, 89075 Less <<
NCT02171403 - Completed - Belgium ... More >> TARGID, KU Leuven Leuven, Vlaams-Brabant, Belgium, 3000 Less <<
NCT01727206 Erdheim-Chester Disease Phase 2 Terminated - Italy ... More >> San Raffaele Hospital Milano, Italy, 20132 Less <<
NCT00351585 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT01984489 Type 2 Diabetes Phase 2 Completed - -
NCT03469102 - Completed - France ... More >> CHRU de Brest Brest, France, 29609 Less <<
NCT01126580 - Completed - -
NCT02202161 - Completed - -
NCT00661518 - Unknown December 2008 Netherlands ... More >> Radboud University Nijmegen Medical Centre Recruiting Nijmegen, Gelderland, Netherlands, 6500HB Contact: Maarten Truijers, MD    +31243613956    M.truijers@chir.umcn.nl    Principal Investigator: Maarten Truijers, MD Less <<
NCT03193554 - Not yet recruiting December 30, 2019 -
NCT02202161 Diabetes Mellitus, Type 2 Phase 2 Completed - United States, California ... More >> GSK Investigational Site Chula Vista, California, United States, 91910 United States, Florida GSK Investigational Site Miami, Florida, United States, 33169 United States, Maryland GSK Investigational Site Baltimore, Maryland, United States, 21225 United States, Texas GSK Investigational Site San Antonio, Texas, United States, 78209 Less <<
NCT01126580 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT03629444 - Not yet recruiting October 1, 2020 -
NCT00603109 Prader-willi Syndrome Phase 3 Unknown August 2008 United States, New York ... More >> New York Presbyterian Hospital-Weill Cornell Medical College Recruiting New york, New York, United States, 10065 Contact: Roja Motaghedi, MD    212-746-3462    rom9027@med.cornell.edu    Contact: Elizabeth G Diaz, CPNP    212-746-3462    egl2002@med.cornell.edu    Principal Investigator: Roja Motaghedi, MD          Sub-Investigator: Elizabeth G Diaz, CPNP Less <<
NCT01932190 Renal Replacement Therapy for ... More >>Acute Kidney Injury in Intensive Care Unit Less << Not Applicable Completed - France ... More >> Hôpital Louis Mourier Colombes, France, 92700 Less <<
NCT01372813 - Terminated(Terminated for insu... More >>fficient accrual.) Less << - -
NCT01372813 Advanced Clear Cell Renal Carc... More >>inoma Less << Phase 2 Terminated(Terminated for insu... More >>fficient accrual.) Less << - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT03142659 - Recruiting July 30, 2026 Israel ... More >> Tel Aviv Medical Center Recruiting Tel Aviv, Israel Contact: Michal Laufer, MD    972-527360430    michalpela@gmail.com Less <<
NCT00505882 Type 1 Diabetes Phase 4 Withdrawn December 2008 United States, Texas ... More >> UT Southwestern at Dallas Dallas, Texas, United States, 75390 Less <<
NCT00921609 - Recruiting December 2019 United States, California ... More >> Cedars-Sinai Medical Center, Pituitary Center Recruiting Los Angeles, California, United States, 90048 Less <<
NCT00197093 Schizophrenia Phase 1 Completed - -
NCT01593800 Lactose Intolerance Not Applicable Completed - -
NCT00577824 - Completed - -
NCT00074945 - Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT02268214 Type 1 Diabetes Mellitus Phase 3 Completed - -
NCT01040468 Type 2 Diabetes Phase 3 Completed - United States, Pennsylvania ... More >> University of Pennsylvania Center for Weight and Eating Disorders Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT02268214 - Completed - -
NCT01204645 - Recruiting January 2024 Sweden ... More >> Danderyd University Hospital Recruiting Stockholm, Sweden, 18288 Contact: Jonas Spaak, MD, PhD    +46 8 6557685    jonas.spaak@ds.se Less <<
NCT00577824 Type 2 Diabetes Phase 3 Completed - Japan ... More >> Research Site Chiba, Japan Research Site Fukuoka, Japan Research Site Fukushima, Japan Research Site Hyogo, Japan Research Site Ibaragi, Japan Research Site Kanagawa, Japan Research Site Kumamoto, Japan Research Site Kyoto, Japan Research Site Nagano, Japan Research Site Oita, Japan Research Site Osaka, Japan Research Site Tokyo, Japan Less <<
NCT00758108 - Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT01025076 Morbid Obesity Phase 2 Completed - Canada, Alberta ... More >> CAMIS, Royal Alexandra Hospital Edmonton, Alberta, Canada, T5H 3V9 Less <<
NCT02759055 Pre-diabetes Not Applicable Enrolling by invitation July 2020 United States, Minnesota ... More >> Essentia Health Duluth, Minnesota, United States, 55805 Less <<
NCT00634777 Head and Neck Squamous Cell Ca... More >>rcinoma Less << Not Applicable Unknown January 2012 Belgium ... More >> Cliniques Universitaires Saint-Luc Recruiting Brussels, Belgium, 1200 Contact: Liza Nguyen Gia, MSc    +3227641274    liza.nguyen-gia@uclouvain.be    Contact: Sandra Schmitz, MD    +3227641976    schmitz_sany@hotmail.com    Principal Investigator: Marc Hamoir, MD          Sub-Investigator: Max Lonneux, MD Less <<
NCT02747108 Prediabetes Not Applicable Active, not recruiting March 30, 2020 United States, Michigan ... More >> VA Ann Arbor Healthcare System, Ann Arbor, MI Ann Arbor, Michigan, United States, 48105 Less <<
NCT00001759 - Completed - United States, Maryland ... More >> National Institute of Allergy and Infectious Diseases (NIAID) Bethesda, Maryland, United States, 20892 Less <<
NCT01346098 Postpancreatectomy Hyperglycem... More >>ia Less << Phase 2 Recruiting April 2019 Italy ... More >> IRCCS San Raffaele Recruiting Milan, Italy, 20132 Contact: Gianpaolo Balzano, MD    390226432664    gianpaolo.balzano@hsr.it    Contact: Lorenzo Piemonti, MD    390226432706    lorenzo.piemonti@hsr.it Less <<
NCT02038348 Metastatic Melanoma Phase 2 Unknown June 2016 France ... More >> Assistance Publique Hopitaux de Marseille Recruiting Marseille, France, 13354 Contact: caroline gaudy       caroline.gaudy@ap-hm.fr    Principal Investigator: caroline gaudy Less <<
NCT01025076 - Completed - -
NCT02767583 Neuropathology Not Applicable Completed - France ... More >> Groupe Hopitalier Paris Saint Joseph Service de neurologie Paris, Ile-de-France, France, 75014 Less <<
NCT00323414 Fatty Liver Phase 2 Completed - United States, Ohio ... More >> MetroHealth Medical Center Cleveland, Ohio, United States, 44109 Cleveland Clinic Foundation Cleveland, Ohio, United States, 44195 Less <<
NCT02692326 Cholestasis in Newborn Not Applicable Completed - Spain ... More >> Nelia Navarro patiño Madrid, Spain, 28007 Less <<
NCT00733577 Diabetes Mellitus, Type 2 Phase 1 Completed - United States, Florida ... More >> GSK Investigational Site Miami, Florida, United States, 33169 GSK Investigational Site Orlando, Florida, United States, 32809 United States, New Jersey GSK Investigational Site Hackensack, New Jersey, United States, 07601 United States, Texas GSK Investigational Site San Antonio, Texas, United States, 78209 Less <<
NCT00323414 - Completed - -
NCT03380338 Type 2 Diabetes Mellitus ... More >> Insulin Sensitivity/Resistance Less << Not Applicable Completed - Netherlands ... More >> VU University Medical Center Amsterdam, Noord-Holland, Netherlands, 1081 HV Less <<
NCT01187576 Motivation for Physical Activi... More >>ty Less << Not Applicable Withdrawn(Never started) - Sweden ... More >> Dalby Vårdcentral Dalby, Sweden Less <<
NCT01289990 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT01103622 Type 2 Diabetes Mellitus Phase 1 Completed - United States, California ... More >> Research Site Chula Vista, California, United States Less <<
NCT01342744 Metabolic Syndrome Phase 4 Unknown March 2012 Thailand ... More >> Siriraj Hospital Recruiting Bangkoknoi, Bangkok, Thailand, 10700 Contact: Suchada Indhavivadhana, M.D.    0-2419-4657    sisto@mahidol.ac.th Less <<
NCT01668433 G6PD Normal G... More >>6PD Deficient Healthy Less << Phase 1 Completed - Thailand ... More >> Hospital for Tropical Diseases Bangkok, Thailand, 10400 Less <<
NCT01289990 - Completed - -
NCT01304394 Infant Nutrition Disorders ... More >> Infant, Premature, Diseases Digestive System Disorders Less << Phase 3 Completed - Belgium ... More >> CHR Citadelle Liege, Belgium CHU Tivoli La Louvière Louviere, Belgium France Hôpital HFME - Groupement Hospitalier Est Bron, France CHU de Nancy- Hôpital d'Enfants Nancy, France Maternité Régionale Adolphe Pinard Nancy, France CHU de Nantes Nantes, France Groupe Hospitalier Cochin-St Vincent de Paul Paris, France Hôpital Necker Paris, France CHU de Poitiers Poitiers, France Hôpital Pontchaillou Rennes, France Hôpital Charles Nicolle Rouen, France Hôpital de Hautepierre Strasbourg, France Hôpital pédiatrique Gatien de Clocheville Tours, France Less <<
NCT01852240 - Unknown - Austria ... More >> Krankenanstalt Rudolfstiftung Recruiting Vienna, Austria, 1030 Contact: Florian Wimpissinger, MD       florianthomas.wimpissinger@wienkav.at Less <<
NCT03222765 PreDiabetes Not Applicable Recruiting December 31, 2019 Spain ... More >> Centro de Salud Jose Marva Recruiting Madrid, Spain, 28030 Contact: Esther Sanchez, MD    +34629       Contact: Ana M Santos Less <<
NCT01238978 Type 2 Diabetes Mellitus ... More >> Elderly Less << Phase 4 Completed - France ... More >> Novartis Investigative Site Armentieres, France, 59208 Novartis Investigative Site Brest, France, 29200 Novartis Investigative Site Caen, France, 14000 Novartis Investigative Site Creil, France, 60100 Novartis Investigative Site #2 Paris, France, 75012 Novartis Investigative Site Paris, France, 75020 Novartis Investigative Site Pau, France, 64000 Novartis Investigative Site St Jean de la Ruelle, France, 45140 Novartis Investigative Site Strasbourg, France, 67000 Novartis Investigative Site Strasbourg, France Novartis Investigative Site Toulouse, France, 31200 Novartis Investigative Site Tours, France, 37000 Novartis Investigative Site Venissieux, France, 69200 Novartis Investigative Site #2 Venissieux, France Novartis Investigative Site Versailles, France, 78000 Less <<
NCT03088670 Diabetes Mellitus, Type 2 Phase 3 Completed - Russian Federation ... More >> Non-state healthcare Organization "Road Clinical Hospital at the station Chelyabinsk Open Joint Stock Company" Russian Railways Chelyabinsk, Russian Federation, 454048 State Budget Healthcare Institution of Moscow "Endocrinology Dispensary" Moscow, Russian Federation, 119034 SEI HPE "First Moscow State Medical University n.a. I.M. Sechenov of Ministry of Health and Social Development of the Russian Federation", Chair of faculty therapy #2 based at SHI of Moscow "City clinical hospital #61" Moscow, Russian Federation, 119048 State Budget Educational Institution higher professional education "1st Moscow State Medical University n.a. I.M. Sechenov of the Ministry of Healthcare of Russian Federation" Moscow, Russian Federation, 119435 Federal State Institution "Clinical Hospital № 1" of the Office of the President of the Russian Federation Moscow, Russian Federation, 121352 State Budget Healthcare Institution of Moscow city "City Clinical Hospital # 71 by the Department of Healthcare in Moscow" Moscow, Russian Federation, 121374 State Budget Educational Institution of higher professional education "1st Moscow State Medical University n.a. I.M. Sechenov of the Ministry of Healthcare of Russian Federation" based on Endocrinology department of Hospital № 67 n.a L A Vorohobova Moscow, Russian Federation, 123423 SEI APE "Russian Medical Academy of Postgraduate Education of Roszdrav", Chair of endocrinology and diabetology with course of endocrine surgery based at FSI "Central Clinical hospital of civil aviation" Moscow, Russian Federation, 125367 State budgetary institution "Nizhny Novgorod Regional Clinical Hospital n.a Semashko Nizhny Novgorod, Russian Federation, 603126 State Health Care Institution "Perm Regional Hospital for War Veterans" Perm, Russian Federation, 614097 State Educational Institution of Higher Professional Education "Perm State Medical Academy n.a. academician EA Wagner's "Ministry of Health of the Russian Federation on the basis of Department of Endocrinology Regional Clinical Hospital Perm, Russian Federation, 614990 SHI "Republic Hospital n.a. V.A. Baranov" Petrozavodsk, Russian Federation, 185019 State budgetary institution of Ryazan region "City Clinical Hospital № 11" Ryazan, Russian Federation, 390037 St. Petersburg State healthcare institution "City Outpatient Clinic #37" Saint Petersburg, Russian Federation, 191119 FSHI "Clinical Hospital #122 n.a. L.G. Sokolov of FMBA of Russia", Internal medicine department Saint Petersburg, Russian Federation, 194291 State Health Care Institution Leningrad Regional Hospital Saint Petersburg, Russian Federation, 194291 Autonomous Noncommercial Organization "Medical Centre "XXI сentury" Saint Petersburg, Russian Federation, 194354 St. Petersburg State healthcare institution "City Hospital of Saint Martyr Elizaveta" Saint Petersburg, Russian Federation, 195257 FSMEI HPE "Military Medical Academy n.a. S.M. Kirov" of the Ministry of Defence of the Russian Federation, 1st Internal medicine Chair of advanced training Saint Petersburg, Russian Federation, 198013 "Diabetes Center "LLC Samara, Russian Federation, 443041 State Budget Educational Institution higher professional education "Saratov State Medical University n.a. V.I. Razumovsky" of the Ministry of Healthcare of Russian Federation based on Clinical Hospital n.a S.R. Mirotvortsev Saratov, Russian Federation, , 410054 Municipal health care institution "City polyclinic №20 Saratov, Russian Federation, 410018 SBEI HPE "Smolensk State Medical Academy" of the Ministry of Health and Social Development of the Russian Federation, Center of clinical research of diagnostic and medicinal products, Chair of clinical pharmacology Smolensk, Russian Federation, 214019 State budget educational institution of higher education "Smolensk State Medical Academy," of Ministry of Health and Social Development of the Russian Federation on the basis of sanatorium SSMA Smolensk, Russian Federation, 214019 State autonomous healthcare institution of Yaroslavl Region "Сlinical hospital for emergency medical care n. a. N.V. Solovyov" Yaroslavl, Russian Federation, 150003 Municipal clinical health institution Health Service Novo-Yaroslavl Oil Refinery Yaroslavl, Russian Federation, 150023 SHI of Yaroslavl region "Regional Clinical Hospital", Endocrinology department Yaroslavl, Russian Federation, 150062 Less <<
NCT02568969 Continuous Lactate Measurement... More >>s Cardiosurgery Less << Not Applicable Completed - Russian Federation ... More >> City hospital # 1 / Northern State Medical University, Arkhangelsk, Russian Federation, 163001 Less <<
NCT01159847 Type 1 Diabetes Phase 1 Phase 2 Completed - China, Hunan ... More >> Diabetes Center, Institute of Metabolism and Endocrinology, Second Xiangya Hospital, Central South University Changsha, Hunan, China, 410011 Less <<
NCT00552188 Acute Coronary Syndrome Phase 2 Completed - United States, California ... More >> VIA Pharmaceuticals San Francisco, California, United States, 94111 United States, New Jersey VIA Pharmaceuticals Princeton, New Jersey, United States, 08540 Less <<
NCT00653185 Diabetes Mellitus Phase 2 Completed - -
NCT00894322 Type 2 Diabetes Mellitus Phase 1 Phase 2 Completed - United States, Nebraska ... More >> Research Site Lincoln, Nebraska, United States Less <<
NCT00599859 Lactose Intolerance Not Applicable Completed - Canada, Quebec ... More >> Sir Mortimer B Davis General Hospital Montreal, Quebec, Canada, H3T 1E2 Less <<
NCT00894322 - Completed - -
NCT00372697 Acromegaly Phase 3 Completed - Italy ... More >> Novartis Investigative Site Brescia, Italy Less <<
NCT00372697 - Completed - -
NCT00552188 - Completed - -
NCT00962806 Pediatric Obesity ... More >> Insulin Resistance Mitochondrial Dysfunction Less << Not Applicable Unknown December 2012 United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT00770952 Diabetes Mellitus Phase 3 Completed - Germany ... More >> Villingen-Schwenningen, Baden-Württemberg, Germany Aschaffenburg, Bayern, Germany Ingolstadt, Bayern, Germany Frankfurt, Hessen, Germany Frielendorf, Hessen, Germany Rotenburg, Hessen, Germany Hannover, Niedersachsen, Germany Dortmund, Nordrhein-Westfalen, Germany Siegen, Nordrhein-Westfalen, Germany Kallstadt, Rheinland-Pfalz, Germany Mainz, Rheinland-Pfalz, Germany Mayen, Rheinland-Pfalz, Germany Neuwied, Rheinland-Pfalz, Germany Rhaunen, Rheinland-Pfalz, Germany Friedrichsthal, Saarland, Germany Meißen, Sachsen, Germany Berlin, Germany Less <<
NCT02500329 Endothelial Function ... More >> Type 2 Diabetes Gemigliptin Acarbose Less << Phase 4 Unknown - Korea, Republic of ... More >> Boramae medical center Recruiting Seoul, Korea, Republic of, 156-707 Contact: Bokyung Koo       bokyungkoomd@gmail.com    Principal Investigator: Min Kyong Moon Less <<
NCT01792115 Fatty Liver Phase 2 Active, not recruiting August 1, 2019 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT02827760 Gut Microbiota Not Applicable Completed - United Kingdom ... More >> Food and Nutritional sciences Reading, Berkshire, United Kingdom, RG6 6UR Less <<
NCT03309007 PreDiabetes A... More >>ging Less << Phase 3 Recruiting July 31, 2018 United States, New Mexico ... More >> University of New Mexico Clincal & Translational Science Center Recruiting Albuquerque, New Mexico, United States, 87131 Contact: Mark R Burge, MD    505-272-4658    mburge@salud.unm.edu Less <<
NCT02006329 NAFLD Accupun... More >>cture Less << Not Applicable Unknown - Israel ... More >> Ziv Medical Center Not yet recruiting Safed, Israel, 13100 Contact: Nimer Assy, MD    972-4-6828442    assy.n@ziv.health.gov.il Less <<
NCT00001722 - Completed - United States, Maryland ... More >> National Institute of Child Health and Human Development (NICHD) Bethesda, Maryland, United States, 20892 Less <<
NCT03258918 PreDiabetes Not Applicable Completed - United States, Michigan ... More >> Michigan Medicine Ann Arbor, Michigan, United States, 48109 Less <<
NCT00759720 Diabetes Mellitus Phase 3 Terminated(Potential hepatic s... More >>afety signal) Less << - -
NCT00461006 Diabetes Mellitus Type 2 Phase 2 Completed - -
NCT03403231 Prediabetes Not Applicable Recruiting January 29, 2020 United States, Michigan ... More >> VA Ann Arbor Healthcare System, Ann Arbor, MI Recruiting Ann Arbor, Michigan, United States, 48105 Contact: Bradley Youles, MPA    734-845-5055    bradley.youles@va.gov    Contact: Kimberly Beers    (734) 845-3653    Kimberly.Beers@va.gov    Principal Investigator: Jeffrey T. Kullgren, MD MPH MS Less <<
NCT01783704 Hip Fracture Not Applicable Completed - United States, Connecticut ... More >> University of Connecticut Health Center Farmington, Connecticut, United States, 06030 United States, Maryland University of Maryland, Baltimore Baltimore, Maryland, United States, 21201 United States, New Hampshire Dartmouth Medical School Lebanon, New Hampshire, United States, 03756 United States, Pennsylvania Arcadia University Glenside, Pennsylvania, United States, 19038-3295 Less <<
NCT00762112 Diabetes Mellitus Phase 3 Terminated(Hepatic safety sign... More >>al identified.) Less << - -
NCT01967797 Overweight and Obesity Not Applicable Completed - Canada, Alberta ... More >> University Of Alberta Edmonton, Alberta, Canada Less <<
NCT00062777 - Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00762957 Diabetes Mellitus Phase 3 Terminated(Hepatic Safety Sign... More >>al Identified.) Less << - -
NCT01862978 Acute Ischemic Stroke Phase 4 Unknown December 2015 Slovakia ... More >> Neurology Clinic Univeristy Hospital in Martin Recruiting Martin, Slovakia, 03659 Contact: Jana Dluha, MD    +421905514377    jana.dluha@gmail.com    Principal Investigator: Vladimir Nosal, MD, PhD          Principal Investigator: Egon Kurca, MD,PhD,prof          Sub-Investigator: Jana Dluha, MD          Sub-Investigator: Stefan Sivak, MD,PhD          Sub-Investigator: Jozef Michalik, MD          Sub-Investigator: Ema Kantorova, MD,PhD          Sub-Investigator: Milan Grofik, MD          Sub-Investigator: Milan Kratky, MD          Sub-Investigator: Peter Kubisz, MD,DSc,prof          Sub-Investigator: Peter Chudy, MD,PhD          Sub-Investigator: Lukas Duraj, Mgr          Sub-Investigator: Jela Ivankova, RNDr Less <<
NCT00763022 Diabetes Mellitus Phase 3 Completed - -
NCT02689479 Type 1 Diabetes Not Applicable Completed - Sweden ... More >> Karolinska University Hospital Stockholm, Sweden Uppsala University Uppsala, Sweden Less <<
NCT00762736 Diabetes Mellitus Phase 2 Completed - -
NCT01231269 Lymphoma Hodg... More >>kin Lymphoma Non-Hodgkin Lymphoma (Follicular, Diffuse B-cel Lymphoma, PTLD and Mantle Cel Lymphoma) Less << Not Applicable Unknown December 2017 Belgium ... More >> University Hospital Leuven Leuven, Vlaams-Brabant, Belgium, 3000 Less <<
NCT02077452 Type 2 Diabetes Mellitus Phase 1 Completed - -
NCT00387595 - Completed - -
NCT00110370 Diabetes Mellitus, Type 2 Phase 4 Completed - -
NCT00739362 Electric Stimulation Therapy ... More >> Obesity Weight Loss Eating Less << Phase 2 Recruiting January 30, 2025 United States, Arizona ... More >> NIDDK, Phoenix Recruiting Phoenix, Arizona, United States, 85014 Contact: Marci Gluck, Ph.D.    602-200-5312    gmarci@mail.nih.gov Less <<
NCT00693082 Polycystic Ovarian Syndrome Phase 2 Terminated(recruitment and pil... More >>ot funding issues) Less << - United States, North Carolina ... More >> Duke Univeristy Medical Center Durham, North Carolina, United States, 27710 Less <<
NCT03153527 Inflammatory Disorder ... More >> Autoimmune Less << Phase 4 Recruiting December 2020 Switzerland ... More >> Departement of Internal Medicine, Kantonsspital Aarau Recruiting Aarau, Switzerland, 5001 Contact: Philip Schuetz, Prof Dr med    +41 62 838 95 24    schuetzph@gmail.com    Endocrinology/Diabetology/Metabolism; University Hospital Basel Recruiting Basel, Switzerland, 4031 Contact: Marc Donath, Prof Dr Med    +41 61 265 50 78    marc.donath@usb.ch    Department of Rheumatology, Immunology, and Allergology, Inselspital Recruiting Bern, Switzerland, 3010 Contact: Peter Villiger, Prof Dr med    +41-31- 632 31 55    peter.villiger@insel.ch    Kantonsspital Baselland/Bruderholz Recruiting Bruderholz, Switzerland, 4101 Contact: Jonas Rutishauser, Prof Dr med    +41-61-436 36 71    j.rutishauser@unibas.ch    Institute for Primary Health Care, Basel University, Kantonsspital Baselland Recruiting Liestal, Switzerland, 4410 Contact: Andreas Zeller, Prof Dr med          Contact    +41-61-925 20 75    andreas.zeller@unibas.ch    Internal Medicine, Kantonsspital Baselland/Liestal Recruiting Liestal, Switzerland, 4410 Contact: Jörg Leuppi, Prof Dr med    +41-61-925 21 80    joerg.leuppi@ksbl.ch    Departement of Internal medicine, Luzerner Kantonsspital Recruiting Luzern 16, Switzerland, 6000 Contact: Christoph Henzen, Prof Dr med    +41-41-205 51 03    christoph.henzen@luks.ch    Department of Internal Medicine, Kantonsspital St. Gallen Recruiting St. Gallen, Switzerland, 9007 Contact: Michael Brändle, Prof Dr med    +41-71-494 61 21    michael.braendle@kssg.ch    GZO Spital Wetzikon Not yet recruiting Wetzikon, Switzerland, 8620 Contact: Urs Eriksson, Prof. Dr. MD Less <<
NCT02124265 Burn Any Degree Involving 20-2... More >>9 Percent of Body Surface Burn Any Degree Involving 30-39 Percent of Body Surface Burn Any Degree Involving 40-49 Percent of Body Surface Burn Any Degree Involving 50-59 Percent of Body Surface Burn Any Degree Involving 60-65 Percent of Body Surface Less << Phase 1 Unknown December 2017 United States, Maryland ... More >> Johns Hopkins Bayview Burn Center Baltimore, Maryland, United States, 21224 Less <<
NCT01237041 Obesity Short... More >> Stature Growth Hormone Deficiency Less << Phase 1 Phase 2 Terminated(Study Medication un... More >>available) Less << - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00469040 Pulmonary Disease, Chronic Obs... More >>tructive Less << Phase 1 Completed - United Kingdom ... More >> GSK Investigational Site London, United Kingdom, NW10 7NS Less <<
NCT00924365 - Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT01237041 - Terminated(Study Medication un... More >>available) Less << - -
NCT01763528 Body Mass Index Quantitative T... More >>rait Locus 8 Disorder Tangier Disease Less << Phase 3 Completed - -
NCT01922934 Obesity Phase 4 Completed - United States, Colorado ... More >> Denver Health and Hospital Authority Denver, Colorado, United States, 80204 Less <<
NCT03553030 - Completed - Italy ... More >> Raffaele Marfella Naples, Italy, 80138 Less <<
NCT01087073 Diabetes Mellitus Not Applicable Unknown December 2017 United States, Illinois ... More >> ACCESS Grand Boulevard Family Health Center Chicago, Illinois, United States, 60609 Friend Family Health Center Chicago, Illinois, United States, 60615 Chicago Family Health Center Chicago, Illinois, United States, 60617 Kovler Diabetes Center Chicago, Illinois, United States, 60637 University of Chicago, Primary Care Group Chicago, Illinois, United States, 60637 ACCESS Booker Family Health Center Chicago, Illinois, United States, 60653 Less <<
NCT00969657 - Completed - Netherlands ... More >> MAASTRO clinic Maastricht, Limburg, Netherlands, 6201BN Less <<
NCT03670602 PreDiabetes Phase 1 Phase 2 Not yet recruiting June 2020 -
NCT01922934 - Completed - -
NCT03616275 Prediabetes A... More >>utonomic Nervous System Imbalance Poor Glycemic Control Psychological Distress Less << Not Applicable Recruiting July 31, 2019 Taiwan ... More >> Tri-Service Medical Center Recruiting Taipei, Taiwan Contact: Yu-Ju Chen, Ph.D.    886-2-87923100 ext 18762    judychen37@gmail.com Less <<
NCT01327846 Atherosclerosis Phase 3 Active, not recruiting April 1, 2020 -
NCT00754403 Diabetes Mellitus Phase 4 Completed - -
NCT01620593 - Completed - -
NCT02068833 - Unknown December 2016 Canada, Quebec ... More >> CRIUCPQ Recruiting Québec, Quebec, Canada, G1V4G5 Contact: Marc Lapointe    4184558221    marc.lapointe@criucpq.ulaval.ca    Principal Investigator: André Tchernof          Principal Investigator: Laurent Biertho Less <<
NCT00620282 - Completed - -
NCT00288873 Vitamin D Deficiency ... More >> Secondary Hyperparathyroidism Obesity Less << Phase 4 Unknown July 2007 United States, New York ... More >> Weill Cornell Medical College New York, New York, United States, 10021 Less <<
NCT03650270 Pediatric Status Epilepticus Phase 3 Completed - South Africa ... More >> Red Cross War Memorial Children's Hospital Cape Town, Western Cape, South Africa, 7700 Less <<
NCT00620282 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - United States, Minnesota ... More >> Novo Nordisk Investigational Site Rochester, Minnesota, United States, 55905 Less <<
NCT00363402 Cystic Fibrosis Not Applicable Completed - Israel ... More >> Hadassah Medical Organization Jerusalem, Israel, 24035 Less <<
NCT02022800 Glioma Cerebr... More >>al Metastases Less << Not Applicable Completed - France ... More >> Centre Antoine Lacassagne Nice, France, 06189 Less <<
NCT01041820 Metabolism Not Applicable Completed - United States, Alabama ... More >> Family Care Center Birmingham, Alabama, United States, 35210 University of Alabama at Birmingham Birmingham, Alabama, United States, 35294 Less <<
NCT01827280 1- Microvascular Function ... More >> 2-oxidative Stress 3-inflammation Less << Phase 4 Completed - Brazil ... More >> Laboratory for Clinical and Experimental Research on Vascular Biology Rio de Janeiro, Brazil, 20550-900 Less <<
NCT01620593 Prostate Cancer Phase 2 Completed - United States, Texas ... More >> Cancer Therapy and Research Center University of Texas Health Science Center San Antonio San Antonio, Texas, United States, 78229 Less <<
NCT02874313 Diabetic Retinopathy ... More >> Sleep Apnea Less << Phase 4 Recruiting October 2020 Spain ... More >> Hospital Universitario La Paz Recruiting Madrid, Spain, 28046 Contact: Francisco Garcia-Rio, MD    +34917277253    fgr01m@gmail.com    Principal Investigator: Francisco Garcia-Rio, MD          Sub-Investigator: Mónica Asencio Durán, MD          Sub-Investigator: Jesús Ramón García Martínez, MD          Sub-Investigator: Aldara García Sánchez, MD Less <<
NCT00607945 Type 2 Diabetes Mellitus Phase 1 Completed - United States, Ohio ... More >> The Ohio State University Clinical Research Center (Davis Medical Research Center) Columbus, Ohio, United States, 43210 Less <<
NCT00001324 - Completed - United States, Maryland ... More >> National Institute of Neurological Disorders and Stroke (NINDS) Bethesda, Maryland, United States, 20892 Less <<
NCT00614055 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 2 Completed - France ... More >> Novo Nordisk Investigational Site Alès, France, 30100 Novo Nordisk Investigational Site Brest, France, 29609 Novo Nordisk Investigational Site LA ROCHELLE cedex, France, 17019 Novo Nordisk Investigational Site Le Creusot, France, 71200 Novo Nordisk Investigational Site Mont de Marsan, France, 40024 Novo Nordisk Investigational Site Venissieux, France, 69200 Germany Novo Nordisk Investigational Site Bad Kreuznach, Germany, 55545 Novo Nordisk Investigational Site Bad Mergentheim, Germany, 97980 Novo Nordisk Investigational Site Dormagen, Germany, 41539 Novo Nordisk Investigational Site Hohenmölsen, Germany, 06679 Novo Nordisk Investigational Site Neuss, Germany, 41460 Novo Nordisk Investigational Site Neuwied, Germany, 56564 Norway Novo Nordisk Investigational Site Elverum, Norway, 2408 Novo Nordisk Investigational Site Hamar, Norway, 2317 Novo Nordisk Investigational Site Kongsvinger, Norway, 2212 Novo Nordisk Investigational Site Oslo, Norway, 0586 Novo Nordisk Investigational Site Stavanger, Norway, 4011 Novo Nordisk Investigational Site Tromsø, Norway, 9038 Romania Novo Nordisk Investigational Site Bucharest, Romania, 011234 Novo Nordisk Investigational Site Bucharest, Romania, 020042 Novo Nordisk Investigational Site Bucharest, Romania, 020475 Novo Nordisk Investigational Site Bucharest, Romania, 020992 Novo Nordisk Investigational Site Bucharest, Romania Spain Novo Nordisk Investigational Site Almería, Spain, 04001 Novo Nordisk Investigational Site Partida de Bacarot, Spain, 03114 Novo Nordisk Investigational Site Sevilla, Spain, 41010 Novo Nordisk Investigational Site Valencia, Spain, 46014 Novo Nordisk Investigational Site Valladolid, Spain, 47011 Less <<
NCT00614055 - Completed - -
NCT03178591 Diabetes Mellitus, Type 2 ... More >> Ischemic Heart Disease Less << Phase 4 Completed - Thailand ... More >> Faculty of Medicine, Chiang Mai University Chiang Mai, Thailand, 50200 Less <<
NCT01037140 Vitamin D Deficiency ... More >> Obesity Less << Phase 4 Completed - Denmark ... More >> Dept. of Endocrinology and Metabolism, Aarhus University Hospital Aarhus, Denmark Less <<
NCT00745433 - Completed - Belgium ... More >> Brussels, Belgium, 1070 Less <<
NCT02193295 Insulin Resistance Not Applicable Recruiting October 2022 United States, Connecticut ... More >> Yale Center for Clinical Investigation HRU Recruiting New Haven, Connecticut, United States, 06520 Contact: Kitt Petersen, MD    203-688-4106       Principal Investigator: Kitt Petersen, MD Less <<
NCT01933269 Cancers of the Head and Neck Early Phase 1 Withdrawn(Change in Principal ... More >>Investigator and protocol revisions delayed study start and ultimately the decision was made to cancel the study.) Less << - -
NCT03156881 Non-Alcoholic Fatty Liver Dise... More >>ase Less << Not Applicable Not yet recruiting May 2018 -
NCT00857558 Diabetes, Type 2 Phase 2 Completed - Japan ... More >> Chubu regin, Japan Chugoku region, Japan Hokkaido region, Japan Kanto region, Japan Kinki region, Japan Kyushu region, Japan Shikoku region, Japan Tohoku region, Japan Less <<
NCT00243542 Acne Vulgaris Phase 4 Completed - -
NCT03282487 Adrenal Insufficiency Phase 4 Enrolling by invitation December 2019 Ireland ... More >> Adelaide and Meath Hospital incorporating the National Childrens Hospital Dublin, Ireland Less <<
NCT02147002 Chronic Kidney Disease ... More >> Cardiovascular Complications Less << Not Applicable Unknown December 2014 Poland ... More >> 1Katedra i Klinika Nefrologii, Nadciśnienia Tętniczego i Chorób Wewnętrznych, Bydgoszcz Recruiting Bydgoszcz, Kujawsko-pomorskie, Poland, 85-094 Contact: Agnieszka Pluta, dr    693716980 ext 0048    agnieszkapluta@poczta.onet.pl    Principal Investigator: Paweł Stróżecki, dr Less <<
NCT02107326 Type 1 Diabetes ... More >> Quality of Life Hypoglycaemia Less << Not Applicable Completed - Switzerland ... More >> University Hospital of Geneva Geneva, GE, Switzerland, 1211 Less <<
NCT02324491 Obesity Type ... More >>2 Diabetes Less << Phase 2 Terminated(Sponsor decision to... More >> analyze available safety and efficacy data) Less << - Australia, New South Wales ... More >> Royal Prince Alfred Hospital Camperdown, New South Wales, Australia, 2050 Pendlebury Research Cardiff, New South Wales, Australia, 2285 Australian Clinical Research Network Maroubra, New South Wales, Australia, 2035 Royal North Shore Hospital St. Leonards, New South Wales, Australia, 2065 Illawara Diabetes Service Wollongong, New South Wales, Australia, 2500 Australia, Queensland Q-Pharm Herston, Queensland, Australia, 4006 Ipswich Research Institute Ipswich, Queensland, Australia, 4305 AusTrials Sherwood, Queensland, Australia, 4075 Australia, South Australia CMAX Adelaide, South Australia, Australia, 5000 Australia, Victoria Box Hill Hospital Box Hill, Victoria, Australia, 3128 St. Vincent's Hospital Fitzroy, Victoria, Australia, 3065 Barwon Health Geelong, Victoria, Australia, 3220 Austin Health Heidelberg West, Victoria, Australia, 3081 Emeritus Research Malvern East, Victoria, Australia, 3145 Baker IDI Heart and Diabetes Institute Melbourne, Victoria, Australia, 3004 Australia, Western Australia Keogh Institute for Medical Research Nedlands, Western Australia, Australia, 6009 Less <<
NCT03679273 Diabetic Foot Not Applicable Recruiting May 15, 2020 Taiwan ... More >> Chang Gung Memorial Hospital Recruiting Taipei, Taiwan, 333 Contact: Yu-Yao Huang    +88633281200 ext 8826    yyh@gmail.com Less <<
NCT02043652 Malaria Not Applicable Completed - Brazil ... More >> Hospital do Jurua Cruzeiro do Sul, Brazil Less <<
NCT01303315 Diabetes Mellitus, Type 2 Not Applicable Terminated(Company strategic d... More >>ecision) Less << - Czech Republic ... More >> Fakultni Nemocnice U SV. Anny V Brne Brno, Czech Republic, 656 91 Klinika gerontologická a metabolická, Hradec Kralove, Czech Republic, 500 05 General University Hospital, Prague, Czech Republic, 128 08 Prednosta OB Kliniky a.s., Prague, Czech Republic, 130 00 Germany Diabetes Zentrum Bad Mergentheim, Germany Asklepios Klinik St. Georg Hamburg, Germany, 20099 Diabetes-Praxis Muenster Münster, Germany, 48153 Romania 'N. Paulescu' National Institute of Diabetes, Nutrition and Metabolic Diseases Bucharest, Romania, 79811 CMI Dr Busegeanu Mihaela Magdalena-Ploiesti Bucharest, Romania, A Fundeni Hospital - Surgical Bucharest, Romania, A Sanatatea Ta Medical Center Bucharest, Romania, A Sf. Ioan Hospital - Surgical Bucharest, Romania, A Spitalul Pelican, Orada Bucharest, Romania, A Less <<
NCT02160496 Weight Loss O... More >>besity Overweight Diet, Reducing Lipids Less << Not Applicable Completed - -
NCT02043652 - Completed - -
NCT01375166 - Recruiting April 2019 Austria ... More >> Department of Clinical Pharmacology Recruiting Vienna, Austria, 1090 Less <<
NCT00396838 - Completed - Israel ... More >> Rambam MC Haifa, Israel Less <<
NCT01848990 Type 1 Diabetes Mellitus Phase 4 Completed - -
NCT00783068 Endotoxemia S... More >>epsis Vagal Activity Less << Not Applicable Completed - Netherlands ... More >> Radboud University Nijmegen Medical Centre Nijmegen, GLD, Netherlands, 6525 GA Less <<
NCT01848990 - Completed - -
NCT03209596 Healthy Athletes Not Applicable Completed - Brazil ... More >> University of São Paulo, School of Physical Education and Sports of Ribeirão Preto. Ribeirão Preto, São Paulo, Brazil, 14049-900 Less <<
NCT03250702 - Completed - -
NCT00981838 Nephrotic Syndrome Phase 3 Completed - Italy ... More >> Hospital "Azienda Ospedaliera Ospedali Riunitidi Bergamo"Unit of Nephrology and Dialysis Bergamo, Italy, 24100 Hospital "Azienda Ospedaliera santobono-Pausilipon" - Unit of Nephrology and Dialysis Napoli, Italy Hospital "Azienda Ospedaliero Universitaria Federico II" - Nephrology Napoli, Italy Hospital "Seconda Università di Napoli" - Policlinico Nuovo Napoli, Italy Hospital "IRCCS Pediatrico Bambino Gesù di Roma" - Department of Nephrology and Pediatric Urology Roma, Italy Hospital "IRCCS Istituto per l'Infanzia Burlo Garofolo" - Pediatric Nephrology Service Trieste, Italy Hospital "Ospedale di Cattinara" - Ambulatory of nephrology Trieste, Italy Less <<
NCT03504735 Metabolic Syndrome Phase 4 Completed - -
NCT01943409 Obstruction C... More >>ancer Ileus Malnutrition Surgery Less << Phase 4 Recruiting June 2019 Canada, Ontario ... More >> University Health Network Recruiting Toronto, Ontario, Canada, M5G 2C4 Contact: Sultan Alenezi, MScAHN    +1-416-340-4413    sultan.alenezi@uhnresearch.ca    Contact: Monica L Ponta, MD    +1-416-340-4413    monica.ponta@uhnresearch.ca    Principal Investigator: Johane P Allard, MD Less <<
NCT03268005 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Active, not recruiting January 29, 2019 -
NCT00428987 - Recruiting - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)    800-411-1222 ext TTY8664111010    prpl@cc.nih.gov Less <<
NCT03275792 Hemolytic-Uremic Syndrome Phase 1 Not yet recruiting April 2020 Canada, Alberta ... More >> Alberta Children's Hospital Not yet recruiting Calgary, Alberta, Canada, T3B 6A8 Contact: Stephen Freedman, MDCM, MSc    403-955-7740    stephen.freedman@ahs.ca Less <<
NCT02687295 Metabolic Syndrome ... More >> Obesity Less << Not Applicable Completed - -
NCT00067132 Trauma Phase 1 Completed - United States, Nevada ... More >> University Medical Trauma Center/UNSOM Las Vegas, Nevada, United States, 89102 Less <<
NCT01662791 Parkinson's Disease Phase 3 Completed - United States, Arizona ... More >> Mayo Clinic in Arizona Scottsdale, Arizona, United States, 85259 Less <<
NCT00523627 - Recruiting - United States, Arizona ... More >> NIDDK, Phoenix Recruiting Phoenix, Arizona, United States, 85014 Contact: Marie Thearle, M.D.    602-200-5304    thearlem@mail.nih.gov Less <<
NCT00414063 - Completed - United States, Arizona ... More >> NIDDK, Phoenix Phoenix, Arizona, United States, 85014 Less <<
NCT02287766 - Completed - United States, Arizona ... More >> EPIC Research and Diagnostics Scottsdale, Arizona, United States, 85255 Integrated Health Institute, LLC Scottsdale, Arizona, United States, 85255 Less <<
NCT01217112 Dyslipidemias ... More >> Diabetes Mellitus, Type 2 Less << Phase 2 Completed - United Kingdom ... More >> Woolpit Health Centre Bury St Edmonds, United Kingdom, IP30 9QU Mount Farm Surgery Bury St Edmonds, United Kingdom, IP32 7EW University of Nottingham, Medical School at Derby, Royal Derby Hospital Derby, United Kingdom, DE22 3DT James Paget University Hospital Gorleston-on-Sea, Norfolk, United Kingdom, NR31 6LA MAC UK Neuroscience Ltd. Manchester, United Kingdom, M32 0UT Less <<
NCT01662791 - Completed - -
NCT01367808 Pharmacokinetics and Pharmacod... More >>ynamics of Sublingual Buprenorphine Less << Phase 1 Completed - Finland ... More >> Department of Anaesthesiology & Intensive Care Turku, Finland, 21500 Less <<
NCT02998489 Feeding Behavior Not Applicable Completed - -
NCT02143232 Total Knee Replacement ... More >> Total Hip Replacement Less << Not Applicable Completed - Canada, Ontario ... More >> The Ottawa Hospital Ottawa, Ontario, Canada, K1Y 4E9 Less <<
NCT00995098 Acute Necrotizing Pancreatitis Phase 4 Completed - China, Sichuan ... More >> Sichuan Academy of Medical Sciences, Sichuan Provincial People's Hospital Chengdu, Sichuan, China, 610072 Less <<
NCT03712592 Muscle Fatigue Not Applicable Completed - France ... More >> CHU Grenoble-Alpes Grenoble, France, 38043 Less <<
NCT01992276 Influenza Phase 2 Withdrawn(Due to preliminary e... More >>fficacy results from an influenza challenge trial) Less << February 2015 -
NCT00001478 - Completed - United States, Maryland ... More >> National Institute of Mental Health (NIMH) Bethesda, Maryland, United States, 20892 Less <<
NCT02297126 Adverse Drug Reaction Not Applicable Completed - United States, Indiana ... More >> Eskenazi Health System Indianapolis, Indiana, United States, 46250 Less <<
NCT00759993 Weight Gain O... More >>besity Less << Phase 2 Terminated(inability to recrui... More >>t and retain) Less << March 2013 -
NCT02036515 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT01217112 - Completed - -
NCT02036515 - Completed - -
NCT01106677 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT02779257 Gastro-enteropancreatic Neuroe... More >>ndocrine Tumor Less << Phase 4 Withdrawn(Subject passed away ... More >>prior to enrollment) Less << - -
NCT00560417 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT02719132 Diabetes Mellitus Type 2 Phase 4 Withdrawn November 2017 -
NCT02388542 Cardiovascular Disease Not Applicable Unknown December 2017 Bangladesh ... More >> Appollo Ispat Complex Ltd Dhaka, Bangladesh Shardharan Bima Coorporation Dhaka, Bangladesh India Bharat Heavy Electrical Limited Bangalore, India TVS Motor company Limited Hosur, India Sri Lanka Department of Census & Statistics Colombo, Sri Lanka Sri Lanka Telecom Colombo, Sri Lanka Less <<
NCT01106677 - Completed - -
NCT02242175 Irritable Bowel Syndrome Not Applicable Unknown September 2016 Korea, Republic of ... More >> Sevrance hospital Not yet recruiting Seoul, Korea, Republic of, 120-752 Contact: Yong Chan Lee, MD    82-2-2228-1960    leeyc@yuhs.ac Less <<
NCT00560417 - Completed - -
NCT01824264 Type 2 Diabetes Mellitus Phase 2 Withdrawn November 2016 -
NCT03610984 - Recruiting September 30, 2021 China, Hunan ... More >> Institute of Metabolism and Endocrinology, Second Xiangya Hospital, Central South University Recruiting Changsha, Hunan, China, 410011 Contact: Zhiguang Zhou, MD/PhD    86-731-85292154    zhouzg@hotmail.com Less <<
NCT03012074 Diabetes Mellitus, Type II Not Applicable Active, not recruiting December 1, 2018 United States, North Carolina ... More >> Duke University School of Nursing Durham, North Carolina, United States, 27710 Less <<
NCT03534687 Diabetes Mellitus, Type 2 Not Applicable Not yet recruiting June 2023 -
NCT00782262 Obesity Phase 2 Phase 3 Unknown - Australia, South Australia ... More >> University of Adelaide, Royal Adelaide Hospital Recruiting Adelaide, South Australia, Australia, 5000 Contact: Gary Wittert, MD, MB Bch, FRACP    +61 8 8222.5502    gary.wittert@adelaide.edu.au    Principal Investigator: Cynthia Piantadosi, PhD Less <<
NCT00495469 Diabetes Mellitus, Type 2 Phase 2 Completed - -
NCT00098254 Non-Small-Cell Lung Carcinoma Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00495469 - Completed - -
NCT01958749 Tympanic Membrane Perforation Not Applicable Unknown - Canada, British Columbia ... More >> Providence Health St Paul's Hospital Not yet recruiting Vancouver, British Columbia, Canada Principal Investigator: Brian Westerberg, MD          Canada, Nova Scotia ENT department, Victoria General Hospital Not yet recruiting Halifax, Nova Scotia, Canada, B3H 2Y9 Principal Investigator: Manohar Bance, MD          Sub-Investigator: James Rainsbury, BMBS FRCS          United Kingdom Derriford Hospital Not yet recruiting Plymouth, Devon, United Kingdom Principal Investigator: James Rainsbury, BMBS FRCS          University Hospital North Staffordshire Not yet recruiting Stoke-on-Trent, United Kingdom Principal Investigator: Sanjiv Kumar, FRCS Less <<
NCT00098254 - Completed - -
NCT02132728 Metabolic Syndrome Not Applicable Completed - Brazil ... More >> Clinical Hospital of Ribeirao Preto Ribeirão Preto, São Paulo, Brazil, 14049-900 Less <<
NCT02708407 Heart Failure ... More >> Chronic Kidney Disease Less << Not Applicable Unknown March 2018 United Kingdom ... More >> Derby Teaching Hospitals NHS Foundation Trust Recruiting Derby, Derbyshire, United Kingdom, DE22 3DT Contact: Samia Hussain          Principal Investigator: Nick Selby Less <<
NCT00227500 HIV Infections ... More >> Lipid Metabolism Glucose Metabolism Metabolic Abnormality Lipodystrophy Cardiovascular Disease Less << Phase 4 Completed - Australia, New South Wales ... More >> St. Vincents Hospital Sydney, New South Wales, Australia, 2010 Less <<
NCT02994277 Diabetes Not Applicable Completed - -
NCT02777541 Enteral Nutritional Support Not Applicable Unknown December 2017 Poland ... More >> Department of Gastroenterology, Hepatology and Feeding Disorders Recruiting Warsaw, Poland, 04-730 Contact: Jaroslaw Kierkus    +48 22 815 73 84    j.kierkus@czd.pl    Principal Investigator: Jaroslaw Kierkus, Md PhD Less <<
NCT01624259 - Completed - -
NCT01381900 Diabetes Mellitus, Type 2 Phase 3 Completed - China ... More >> Baotou, China Beijing, China Changchun, China Changsha, China Chengdu, China Chongqing, China Guangzhou, China Hangzhou, China Harbin, China Nanchang, China Nanjing, China Nanning, China Shanghai, China Shenyang, China Shiyan, China Siping, China Su Zhou, China Tianjin, China Wuxi, China Xi'An, China Malaysia Kota Bharu, Malaysia Pulau Pinang, Malaysia Selangor, Malaysia Vietnam Hanoi, Vietnam Ho Chi Minh, Vietnam Less <<
NCT01624259 Type 2 Diabetes Phase 3 Completed - -
NCT01940666 - Completed - Taiwan ... More >> WanFang Medical Center at Taipei Medical University Taipei, Taiwan, 116 Less <<
NCT01381900 - Completed - -
NCT00092222 Lymphoproliferative Disorder ... More >> HHV-8 Malignancy HIV Less << Phase 2 Recruiting October 1, 2020 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office    (888) NCI-1937 Less <<
NCT01195090 Type 2 Diabetes Phase 4 Completed - Taiwan ... More >> Division of Endocrinology and Metabolism, Department of Internal Medicine, Mackay Memorial Hospital Taipei, Taiwan, 10449 Less <<
NCT02810392 Stroke Phase 2 Recruiting December 2018 United States, North Carolina ... More >> Wake Forest University Health Sciences Recruiting Winston-Salem, North Carolina, United States, 27157-1043 Contact: Nancy C. Buchheimer, BS    336-716-3961    nbuchhe@wfubmc.edu    Principal Investigator: Cheryl Bushnell, MD Less <<
NCT03768245 Obesity Diabe... More >>tes Mellitus, Type 2 Cardiovascular Function Kidney Diseases Liver Diseases Physical Fitness Less << Not Applicable Completed - Mexico ... More >> Hospital Regional Adolfo Lopez Matelos Mexico City, Distrito Federal, Mexico, 01620 Less <<
NCT01195090 - Completed - -
NCT03570294 Premature Birth Not Applicable Active, not recruiting December 30, 2018 Poland ... More >> Department of Obstetrics, Perinatology and Gynecology, Polish Mother's Memorial Hospital-Research Institute Łódź, Poland, 93-338 Less <<
NCT01700894 Cardiovascular Diseases Not Applicable Completed - United States, Illinois ... More >> University of Illinois at Chicago Mile Square Health Center at Back of the Yards Chicago, Illinois, United States, 60609 University of Illinois at Chicago Mile Square Health Center Chicago, Illinois, United States, 60612 Roseland Community Hospital Chicago, Illinois, United States, 60628 Holy Cross Hospital Chicago, Illinois, United States, 60629 Austin Health Center of Cook County Health & Hospitals System Chicago, Illinois, United States, 60651 Westside Health Authority Chicago, Illinois, United States, 60651 Rush Oak Park Hospital Oak Park, Illinois, United States, 60304 Less <<
NCT00748137 Type 1 Diabetes Not Applicable Unknown January 2011 Australia, New South Wales ... More >> Gosford District Hospital Recruiting Gosford, New South Wales, Australia, 2915 Principal Investigator: Monique Stone, MD          John Hunter Children's Hospital Recruiting Newcastle, New South Wales, Australia, 2305 Contact: Donald Anderson, MBBS FRACP    +61 2 49855634    donald.anderson@hnehealth.nsw.gov.au    Contact: Liz Nunn, BHSc    61 2 49213753    liz.nunn@hnehealth.nsw.gov.au    Principal Investigator: Donald G Anderson, MBBS FRACP Grad Dip Biostat          Sub-Investigator: Elizabeth Nunn, BHSc Grad Dip Epid          Sub-Investigator: Dierdre Burgess, BSc          Sydney Children's Hospital Recruiting Sydney, New South Wales, Australia Principal Investigator: Charles Verge, MD          Australia, Queensland Mater Children's Hospital Recruiting Brisbane, Queensland, Australia Principal Investigator: Mark Harris, MD          Sub-Investigator: Bridgid Knight          Royal Children's Hospital Recruiting Brisbane, Queensland, Australia Principal Investigator: Sarah MacMahon, MD Less <<
NCT03561116 Metabolic Syndrome Not Applicable Recruiting October 2018 Portugal ... More >> Medical Faculty of University of Porto Recruiting Porto, Portugal, 4200-319 Contact: Raquel Soares, PhD    (+351)225513624    raqsoa@med.up.pt Less <<
NCT02956044 Type2 Diabetes Mellitus Phase 1 Completed - United States, Indiana ... More >> Clinical Research Site Evansville, Indiana, United States, 47710 Less <<
NCT02075307 Metabolic Syndrome ... More >> Insulin Resistance DNA Damage Less << Not Applicable Enrolling by invitation December 31, 2017 United States, California ... More >> Children's Hospital & Research Center Oakland Oakland, California, United States, 94609 Less <<
NCT01985633 Osteoarthritis, Knee Phase 1 Phase 2 Unknown June 2014 India ... More >> Department of Orthopaedics Postgraduate Institute of Medical Education & Research Recruiting Chandigarh, India, 160012 Contact: Aggarwal       agg_adityadoc@yahoo.co.in    Contact: Sunil       sunilkumartr@gmail.com    Principal Investigator: Aditya K Aggarwal, MS,DNB,DOrth          Sub-Investigator: Sunil K TR, MBBS Less <<
NCT02004678 Type 2 Diabetes Mellitus Phase 1 Completed - United States, Florida ... More >> Clinical Pharmacology of Miami, Inc. Miami, Florida, United States Less <<
NCT03561714 - Completed - -
NCT03167411 Type2 Diabetes Mellitus Phase 1 Completed - United States, Indiana ... More >> Clinical Research Site Evansville, Indiana, United States, 47710 Less <<
NCT02327039 Type 2 Diabetes Phase 4 Completed - Italy ... More >> Division of Metabolic Diseases, University Hospital of Padova Padova, Italy, 35128 Less <<
NCT02025907 Diabetes Mellitus, Type 2 Phase 4 Completed - -
NCT02337894 Liver Steatosis ... More >> Insulin Resistance Whole Body Protein Metabolism Body Composition, Beneficial Less << Not Applicable Not yet recruiting February 2020 -
NCT00250159 - Enrolling by invitation - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00657618 - Completed - -
NCT03638297 Colorectal Cancer Phase 2 Recruiting December 30, 2019 China, Guangdong ... More >> Gastrointestinal Hospital, Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510655 Contact: Yanghong Deng, PhD    008613925106525    dengyanh@mail.sysu.edu.cn    Principal Investigator: Yanhong Deng, PhD          The Sixth Affiliated Hospital of Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510655 Contact: Yanhong Deng, M.D.    008613925106525    dengyanh@mail.sysu.edu.cn Less <<
NCT01648140 Hepatitis C, Chronic Phase 2 Completed - -
NCT02065310 Diabetes Not Applicable Enrolling by invitation October 2018 United States, California ... More >> City of Hope Medical Center Duarte, California, United States, 91010 Less <<
NCT00657618 Leishmaniasis Phase 1 Phase 2 Completed - United States, District of Col... More >>umbia Walter Reed National Military Medical Center Washington, District of Columbia, United States, 20307 Less <<
NCT02025907 - Completed - -
NCT01708902 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT01386541 Type 2 Diabetes Mellitus Phase 1 Completed - Germany ... More >> Nycomed Investigational site Mannheim, Germany, 68167 Less <<
NCT02898571 The Impact of Vitamin c and Ep... More >>icatechin Upon Antioxidant Capactity Less << Not Applicable Unknown - United Kingdom ... More >> NU-Food Research Facility Recruiting Newcastle Upon Tyne, Tyne and Wear, United Kingdom, NE1 7RU Contact: Anthony Watson, PhD    +44 (0) 191 208 6619    anthony.watson@ncl.ac.uk    Contact: Wendy Bal, BSc    +44 (0) 191 208 6619    wendy.bal@ncl.ac.uk Less <<
NCT01253928 ESRD Phase 4 Unknown - Switzerland ... More >> Nephrology Service Department of Medicine CHUV Recruiting Lausanne, Vaud, Switzerland, 1011 Contact: Anne Zanchi, MD    41 21 314 11 54    azanchidel@hotmail.com    Principal Investigator: Anne Zanchi, MD Less <<
NCT01648140 - Completed - -
NCT01384006 - Unknown June 2014 Germany ... More >> Regensburg University Hospital Recruiting Regensburg, Bavaria, Germany, 93053 Contact: Andrea Proneth, MD    +49-941-944 ext 0    andrea.proneth@klinik.uni-r.de    Contact: Susanne Melter    +49-941-944 ext 6770    susanne.melter@klinik.uni-r.de Less <<
NCT03011645 Cardiovascular Diseases Phase 1 Enrolling by invitation November 2022 United States, North Carolina ... More >> Duke University Medical Center Durham, North Carolina, United States, 27710 Less <<
NCT03710083 Diabetes Mellitus Not Applicable Not yet recruiting June 2019 -
NCT00006421 - Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT01708902 - Completed - -
NCT02982408 Type 2 Diabetes Mellitus ... More >> Insulin Resistance Dyslipidemia Less << Not Applicable Unknown August 2018 Denmark ... More >> Rigshospitalet, Denmark Recruiting Copenhagen, Capital Region, Denmark, 2100 Contact: Charlotte Brøns, PhD    +45 3545 7127    charlotte.broens@regionh.dk    Principal Investigator: Charlotte Brøns, Phd Less <<
NCT01034228 Acute Infectious Diarrhoea in ... More >>Children Less << Phase 2 Completed - Bangladesh ... More >> Dhaka Hospital, ICDDR,B Dhaka, Bangladesh, 1212 Less <<
NCT02469337 Insulin Resistance Phase 4 Active, not recruiting June 2017 United Kingdom ... More >> University Hospitals Nottingham Queen's Medical Centre Nottingham, United Kingdom, NG7 2UH Less <<
NCT01041898 - Completed - United States, Alabama ... More >> UAB Birmingham, Alabama, United States, 35294 Less <<
NCT00283894 - Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT02067923 - Completed - United States, Connecticut ... More >> Church Street Research Unit New Haven, Connecticut, United States, 06519 Less <<
NCT01871207 - Completed - Italy ... More >> Spedali Civili di Brescia Brescia, Italy, 25123 Less <<
NCT02578368 Gastric Cancer Phase 3 Recruiting December 2021 Germany ... More >> Krankenhaus Nordwest Recruiting Frankfurt am Main, Germany, 60488 Contact: Salah-Eddin Al-Batran, MD    +496976014420    albatran@aol.com    Contact: Claudia Pauligk, PhD    +496976013906    pauligk.claudia@khnw.de    Principal Investigator: Salah-Eddin Al-Batran, MD Less <<
NCT00954447 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT00463697 Pulmonary Disease, Chronic Obs... More >>tructive Less << Phase 1 Completed - United Kingdom ... More >> GSK Investigational Site Harrow, Middlesex, United Kingdom, HA1 3UJ GSK Investigational Site London, United Kingdom, SE1 1YR GSK Investigational Site Manchester, United Kingdom, M23 9QZ Less <<
NCT01483352 Diabetes Mellitus, Type 1 Not Applicable Completed - Germany ... More >> Bad Heilbrunn, Germany, 83670 Less <<
NCT01483352 - Completed - -
NCT00090831 - Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT01466803 Healthy Phase 1 Completed - Finland ... More >> Turku University Hospital Turku, Finland, 20500 Less <<
NCT00361777 - Active, not recruiting - United States, District of Col... More >>umbia GW University Medical Center GW Hospital Center Washington, District of Columbia, United States, 20037 United States, Maryland National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00001308 - Terminated - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT02433301 - Completed - Denmark ... More >> Rigshospitalet Copenhagen, Denmark, DK-2100 Less <<
NCT00954447 - Completed - -
NCT03545867 Spinal Cord Injuries Not Applicable Completed - United States, Florida ... More >> Lois Pope Life Center Miami, Florida, United States, 33143 Less <<
NCT01553500 Metabolic Syndrome ... More >> Non Alcoholic Fatty Liver Disease Insulin Resistance Less << Phase 2 Completed - Italy ... More >> Bambino Gesù Children's Hospital and Research Institute Rome, Italy, 00165 Less <<
NCT00406445 - Recruiting - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)    800-411-1222 ext TTY8664111010    prpl@cc.nih.gov Less <<
NCT03021187 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT00147342 - Completed - United States, California ... More >> Division of Pediatric Endocrinology and Diabetes, Stanford University Stanford, California, United States, 94305-5208 United States, Colorado Barbara Davis Center for Childhood Diabetes, University of Colorado Aurora, Colorado, United States, 80010 United States, Connecticut Department of Pediatrics, Yale University School of Medicine New Haven, Connecticut, United States, 06519 United States, Florida Nemours Children's Clinic Jacksonville, Florida, United States, 32207 Jaeb Center for Health Research Tampa, Florida, United States, 33647 United States, Iowa Department of Pediatrics, University of Iowa Carver College of Medicine Iowa City, Iowa, United States, 52242 Less <<
NCT00260858 Healthy Not Applicable Completed - -
NCT02272543 Moderate Acute Malnutrition Phase 1 Completed - Bangladesh ... More >> icddr,b Dhaka Hospital Dhaka, Bangladesh, 1212 Less <<
NCT00006073 - Terminated - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00700336 Malignant Pleural Mesothelioma... More >> Solid Tumors Less << Phase 1 Phase 2 Completed - United States, Arizona ... More >> Mayo Clinic Scottsdale, Arizona, United States Arizona Cancer Center Tucson, Arizona, United States United States, California City of Hope Duarte, California, United States United States, Illinois University of Chicago Chicago, Illinois, United States United States, Michigan Karmanos Cancer Institute/Wayne State University Detroit, Michigan, United States United States, Nevada Nevada Cancer Institute Las Vegas, Nevada, United States, 89135 United States, New Mexico University of New Mexico Cancer Center Albuquerque, New Mexico, United States, 87131 United States, New York Memorial-Sloan Kettering Cancer Center New York, New York, United States, 10022 United States, Ohio Cleveland Clinic Cleveland, Ohio, United States United States, Pennsylvania Penn State Milton S. Hershey Medical Ctr. Hershey, Pennsylvania, United States, 17033 United States, Texas Cancer Therapy & Research Center San Antonio, Texas, United States, 78229 United States, Utah Huntsman Cancer Institute Salt Lake City, Utah, United States Less <<
NCT01527526 - Completed - Brazil ... More >> University of Campinas Campinas, São Paulo, Brazil, 13083-888 Less <<
NCT00103987 - Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT02442024 Diabetes Mellitus Not Applicable Unknown December 2015 Italy ... More >> Azienda Ospedaliero-Universitaria Pisana Recruiting Pisa, PI, Italy, 56127 Contact: Andrea Natali, Professor    050992814    andrea.natali@med.unipi.it    Principal Investigator: Andrea Natali, Professor Less <<
NCT00743574 Polycystic Ovarian Syndrome ... More >> Vitamin D Deficiency Less << Not Applicable Completed - United States, Connecticut ... More >> Yale-New Haven Hospital-Women's Center New Haven, Connecticut, United States, 06520-8063 Less <<
NCT01790724 Diabetes Type 2 ... More >> Metabolic Syndrome Less << Not Applicable Completed - United States, Illinois ... More >> University of Illinois at Urbana-Champaign Urbana, Illinois, United States, 61801 Less <<
NCT00743574 - Completed - -
NCT03364868 Diabetes Mellitus, Type 1 Phase 2 Recruiting January 2025 Belgium ... More >> University Hospitals Leuven, Faculty of Medicine, Catholic University of Leuven, Leuven, Belgium Not yet recruiting Leuven, Belgium, 3000 Contact: Kristina Casteels, Prof. Dr.          Germany Forschergruppe Diabetes, Klinikum rechts der Isar, Technische Universität München, Munich, Germany Recruiting Munich, Bavaria, Germany, 80804 Contact: Anette-G. Ziegler, Prof. Dr.    +49-(0)800 - 000 00 18    contact@gppad.org    Contact: Peter Achenbach, Prof. Dr.    +49-(0)800 - 000 00 18    contact@gppad.org    AUF DER BULT, Kinder- und Jugendkrankenhaus, Hanover, Germany Recruiting Hanover, Lower Saxony, Germany, 30173 Contact: Olga Kordonouri, Prof. Dr.          Klinik und Poliklinik f. Kinder und Jugendmedizin, Universitätsklinikum Carl Gustav Carus, Technische Universität Dresden, CRTD/DFG-Forschungszentrum für Regenerative Therapien, Dresden, Germany Recruiting Dresden, Saxony, Germany, 01307 Contact: Reinhard Berner, Prof. Dr.          Poland Medical University of Warsaw, Department of Paediatrics, Warsaw, Poland Recruiting Warsaw, Poland, 00-001 Contact: Agnieszka Szypowska, Prof. Dr.          Sweden Lund University Dep. of Clinical Sciences Malmo, Skane University Hospital SUS, University Hospital MAS, Malmo, Sweden Recruiting Malmö, Sweden, 202 13 Contact: Helena Elding Larsson, Assoc. Prof. Dr.          United Kingdom Department of Paediatrics Clinical Vaccine Research and Immunisation Education, Children's Hospital, Headington, Oxford, UK Not yet recruiting Oxford, United Kingdom, OX3 9DU Contact: Matthew Snape, Dr. Less <<
NCT02529228 Metabolic Disease ... More >> Cardiovascular Disease Less << Not Applicable Completed - -
NCT01829503 Acute Myeloid Leukemia Phase 2 Active, not recruiting October 2017 United States, Pennsylvania ... More >> University of PIttsburgh Cancer Institute Pittsburgh, Pennsylvania, United States, 15232 Less <<
NCT02914002 Child Malnutrition ... More >> Child Overnutrition Malnutrition in Children Malnutrition, Child Nutrition Disorders, Child Malnutrition Less << Not Applicable Completed - Mexico ... More >> Banco de Alimentos de Mexico Mexico, Mexico, 06700 Less <<
NCT02789683 Metabolic Diseases Not Applicable Completed - Singapore ... More >> Clinical Nutrition Research Centre Singapore, Singapore, 117599 Less <<
NCT00918840 - Completed - Italy ... More >> IRCCS Policlinico S. Matteo Pavia, Italy, 27100 Less <<
NCT01829503 - Active, not recruiting - -
NCT01083212 Type 2 Diabetes Mellitus Phase 1 Completed - Sweden ... More >> Reserach Site Linkoping, Sweden Research Site Lulea, Sweden Research Site Uppsala, Sweden Less <<
NCT00605696 Respiratory Distress Syndrome,... More >> Adult Sepsis Hyperglycemia Less << Phase 2 Completed - United States, New York ... More >> Montefiore Medical Center Bronx, New York, United States, 10467 Less <<
NCT01285609 Lung Cancer - Non Small Cell S... More >>quamous Less << Phase 3 Completed - -
NCT00605696 - Completed - -
NCT02851849 Type 2 Diabetes Mellitus Phase 2 Completed - -
NCT01469559 Diabetic Peripheral Neuropathy Phase 2 Completed - Canada, Alberta ... More >> Heritage Medical Research Clinic Calgary, Alberta, Canada, T2N 4Z6 Less <<
NCT00444288 - Completed - United States, North Carolina ... More >> Duke University Medical Center Durham, North Carolina, United States, 27710 Less <<
NCT01285609 - Completed - -
NCT01614379 - Withdrawn June 2013 Denmark ... More >> Department of Endocrinology Aarhus, Denmark, 8000 MR Centre Aarhus, Denmark, 8000 Less <<
NCT01396772 Prediabetes Not Applicable Unknown - Canada, Ontario ... More >> Brescia University College Recruiting London, Ontario, Canada, N6G1H2 Contact: Isabelle T. Giroux, PhD    519-432-8353 ext 28255    igiroux@uwo.ca    Contact: Gillian Mandich, BhSc    519-432-8353 ext 28034    gmandich@uwo.ca    Principal Investigator: Isabelle T. Giroux, PhD, RD Less <<
NCT02414958 Diabetes Mellitus, Type 1 Phase 3 Completed - -
NCT01739127 - Completed - Canada, British Columbia ... More >> BC Mental Health & Addictions Research Institute Vancouver, British Columbia, Canada, V5Z 4H4 Less <<
NCT03769948 - Not yet recruiting July 2020 -
NCT02414958 - Completed - -
NCT00823992 Diabetes Mellitus Type 2 Phase 3 Completed - -
NCT02459496 Type 2 Diabetes ... More >> NAFLD Obesity Dyslipoproteinaemia Hypertension Less << Not Applicable Recruiting December 2020 Germany ... More >> German Institut for Human Nutrition; Department for Clinical Nutrition Not yet recruiting Nuthetal, Brandenburg, Germany, 14458 Contact: Margrit Kemper, Dr. med.    033200 88 2775    margrit.kemper@dife.de    Contact: Silke Hornemann    033200 88 2779    silke.hornemann@dife.de    Sub-Investigator: Margrit Kemper, Dr. med.          Sub-Investigator: Silke Hornemann          Sub-Investigator: Christiana Gerbracht, Dr.          German Institute for Human Nutrition, Department for Clinical Nutrition Recruiting Berlin, Germany, 12203 Contact: Stefan Kabisch, Dr. med.    030 450 514 ext 429    stefan.kabisch@charite.de    Contact: Ulrike Kaiser, M.sc.    030 450 514 ext 428    ulrike.kaiser@charite.de    Sub-Investigator: Stefan Kabisch, Dr. med.          Sub-Investigator: Ulrike Kaiser, M.sc. Less <<
NCT02014740 Type 2 Diabetes ... More >> Overweight Obesity Less << Phase 4 Completed - United States, Florida ... More >> University of Miami Miami, Florida, United States, 33136 Less <<
NCT02134860 Metabolic Syndrome ... More >> Type 2 Diabetes Critical Illness Less << Not Applicable Completed - Denmark ... More >> Rigshospitalet Copenhagen, Denmark Less <<
NCT02014740 - Completed - -
NCT01473654 Prediabetes Not Applicable Completed - United States, New York ... More >> Mount Sinai Medical Center New York, New York, United States, 10029 Less <<
NCT00672308 Cholera Phase 2 Completed - Bangladesh ... More >> ICDDR,B Dhaka, Bangladesh, 1212 Less <<
NCT00999453 Hypercholesterolemia Not Applicable Completed - Korea, Republic of ... More >> Kyungpook National University Hospital, Daegu, Korea, Republic of Severance Hospital Seoul, Korea, Republic of Less <<
NCT00136188 Diabetic Nephropathies Phase 2 Phase 3 Completed - Germany ... More >> CRC, Medizinische Klnik 4 - Nephrology and Hypertension, Uni Erlangen-Nürnberg Erlangen, Germany, 91054 Less <<
NCT01847937 - Completed - Denmark ... More >> Department of Endocrinology and Internal Medicine Aarhus, Denmark, 8000 Department of Neurology Aarhus, Denmark, 8000 Department of Neurophysiology Aarhus, Denmark, 8000 MR Centre Aarhus, Denmark, 8000 Germany Neurologische Universitätsklinik Heidelberg Abteilung für Neuroradiologie Heidelberg, Baden-Württemberg, Germany, 69120 Less <<
NCT02130102 - Completed - Austria ... More >> AIT Austrian Institute of Technology GmbH Wiener Neustadt, Lower Austria, Austria, 2700 Less <<
NCT01059825 Diabetes Mellitus, Type 2 Phase 2 Completed - -
NCT02807649 Mental Fatigue ... More >> Fatigue Chronic Fatigue Syndrome Less << Not Applicable Completed - -
NCT00425490 Diabetes Mellitus Type 2 Phase 3 Completed - Israel ... More >> Sheba_Medical_Center Tel Hashomer, Israel Less <<
NCT02582242 Diabetes Type... More >> 2 Diabetes Mellitus Less << Phase 4 Completed - -
NCT01059825 - Completed - -
NCT02057523 Proteinuria T... More >>ransplant Glomerulopathy Less << Phase 4 Unknown September 2016 United States, Illinois ... More >> University of Illinois at Chicago Recruiting Chicago, Illinois, United States, 60612 Contact: Sanjeev Akkina, MD    312-996-8075    sakkina@uic.edu    Contact: Maya Campara, PharmD    312-996-0897    mcampa4@uic.edu    Principal Investigator: Sanjeev Akkina, MD Less <<
NCT00678886 Diabetes Mellitus, Type 1 Phase 3 Completed - -
NCT02582242 - Completed - -
NCT00799435 Diabetes Mellitus, Type 2 ... More >> Heart Failure, Diastolic Less << Phase 4 Terminated(Inability to recrui... More >>t adequate Sample Size who met the entry criteria) Less << - United States, Texas ... More >> Baylor College of Medicine Houston, Texas, United States, 77030 Less <<
NCT01424150 Abdominal Surgery Phase 4 Completed - Australia, Victoria ... More >> Alfred Hospital Melbourne, Victoria, Australia, 3004 Less <<
NCT03648996 Diabetes Mellitus, Type 2 ... More >> Hyperuricemia Less << Phase 2 Not yet recruiting September 30, 2021 -
NCT00957762 - Unknown October 2012 United States, Virginia ... More >> Hunter Holmes McGuire Spinal Cord Injury Research Lab Recruiting Richmond, Virginia, United States, 23249 Contact: Joshua Miller, MS    804-675-6200    Joshua.Miller@va.gov Less <<
NCT02689661 - Active, not recruiting July 2019 United States, Michigan ... More >> University of Michigan Ann Arbor, Michigan, United States, 48109-2200 Less <<
NCT02958644 Obesity Class III Not Applicable Not yet recruiting July 2018 Brazil ... More >> Hospital Dona Helena Not yet recruiting Joinville, Santa Catarina, Brazil, 89204-250 Contact: Micheli Arruda, R.N.    +554734365500    micheli.c@donahelena.com.br    Hospital Regional Hans Dieter Schmidt Not yet recruiting Joinville, SC, Brazil Contact: Marilyn G Ferreira, PhD    +55 47 91029228    marilyn.ferreira@ielusc.br    Hospital do Coração Not yet recruiting São Paulo, SP, Brazil, 04004-030 Contact: Bernardete Weber, PhD       bweber@hcor.com.br Less <<
NCT00678886 - Completed - -
NCT03726125 Healthy Phase 1 Recruiting March 20, 2019 Singapore ... More >> Lilly Centre for Clinical Pharmacology Recruiting Singapore, Singapore, 138623 Contact    +65-6413 9930       Principal Investigator: Ronan Kelly Less <<
NCT00683878 Type 2 Diabetes Phase 3 Completed - -
NCT00683878 - Completed - -
NCT00799435 - Terminated(Inability to recrui... More >>t adequate Sample Size who met the entry criteria) Less << - -
NCT00048932 Rheumatoid Arthritis Phase 3 Completed - -
NCT00119678 Systemic Lupus Erythematosus Phase 2 Completed - -
NCT01234350 - Completed - -
NCT00119678 - Completed - -
NCT02352181 Liver Transplantation Not Applicable Completed - France ... More >> Hôpital de la Croix Rousse Lyon, France Less <<
NCT00048932 - Completed - -
NCT01074268 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 3 Completed - -
NCT01074268 - Completed - -
NCT02595242 Diffuse Large B Cell Lymphoma Phase 1 Withdrawn June 2017 China ... More >> Tianjin people's Hospital Tianjin, China Less <<
NCT01492465 Diabetes Mellitus Phase 1 Terminated(Decision by Sponsor... More >>) Less << - United States, Nebraska ... More >> Research Site Omaha, Nebraska, United States, 68154 United States, Texas Research Site San Antonio, Texas, United States, 78209 San Antonio, Texas, United States, 78209 Less <<
NCT03254394 Neuropathy, Painful ... More >> Chemotherapy-induced Peripheral Neuropathy Colorectal Cancer Less << Phase 1 Phase 2 Recruiting June 1, 2019 United States, Missouri ... More >> Washington University School of Medicine/Barnes Jewish Hospital Recruiting Saint Louis, Missouri, United States, 63110 Contact: Karen Frey, BS    314-454-5980    freyk@anest.wustl.edu    Principal Investigator: Simon Haroutounian, PhD          Sub-Investigator: Mathias Leinders, PhD Less <<
NCT03061214 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Active, not recruiting April 17, 2019 -
NCT01482702 Overweight Po... More >>stmenopausal Breast Cancer Less << Not Applicable Completed - United States, Vermont ... More >> Vermont Cancer Center Burlington, Vermont, United States, 05405 Less <<
NCT02585336 Metabolic Health Not Applicable Unknown November 2016 United States, California ... More >> University of California, San Francisco San Francisco, California, United States, 94143 Less <<
NCT02460978 - Completed - -
NCT01282281 - Completed - Canada, Ontario ... More >> Sunnybrook Health Sciences Centre Toronto, Ontario, Canada, M4N 3M5 Less <<
NCT02626195 Pancreatic Cancer ... More >> Biliary Cancer Malnutrition Less << Not Applicable Completed - Korea, Republic of ... More >> National Cancer Center Goyang-si, Gyeonggi-do, Korea, Republic of, 410-769 Less <<
NCT02460978 Type 1 Diabetes Mellitus Phase 3 Completed - -
NCT01100398 - Completed - United States, Texas ... More >> Brooke Army Medical Center Fort Sam Houston, Texas, United States, 78234 Less <<
NCT03280914 - Recruiting December 31, 2025 China ... More >> Community of Huanghua Road Recruiting Guangzhou, China, 510000 Contact: Wei Liang, M.D.    +86 13570003053    liang580215@163.com Less <<
NCT02221284 - Completed - Japan ... More >> Osaka, Japan Tokyo, Japan Less <<
NCT02192372 - Completed - Turkey ... More >> Ankara University School Of Medicine, Department of Cardiology Ankara, Turkey, 06230 Less <<
NCT01877551 HIV Related Insulin Resistance... More >> Protease Inhibitor Related Insulin Resistance Endoplasmic Reticulum Stress Less << Not Applicable Completed - United States, Missouri ... More >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Less <<
NCT02060240 Obesity Predi... More >>abetic State Sedentary Lifestyle Less << Not Applicable Unknown April 2017 United States, Oregon ... More >> Oregon Health & Science University Recruiting Portland, Oregon, United States, 97239 Contact: Scott M Chadderdon, MD    503-494-8750    chadderd@ohsu.edu    Principal Investigator: Scott M Chadderdon, MD Less <<
NCT00005775 Infant, Newborn ... More >> Infant, Low Birth Weight Infant, Small for Gestational Age Infant, Premature Sepsis Less << Phase 3 Completed - United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35233 United States, California Stanford University Palo Alto, California, United States, 94304 University of California at San Diego San Diego, California, United States, 92103-8774 United States, Connecticut Yale University New Haven, Connecticut, United States, 06504 United States, Florida University of Miami Miami, Florida, United States, 33136 United States, Georgia Emory University Atlanta, Georgia, United States, 30303 United States, Indiana Indiana University Indianapolis, Indiana, United States, 46202 United States, Michigan Wayne State University Detroit, Michigan, United States, 48201 United States, New Mexico University of New Mexico Albuquerque, New Mexico, United States, 87131 United States, North Carolina RTI International Durham, North Carolina, United States, 27705 United States, Ohio Cincinnati Children's Medical Center Cincinnati, Ohio, United States, 45267 Case Western Reserve University, Rainbow Babies and Children's Hospital Cleveland, Ohio, United States, 44106 United States, Rhode Island Brown University, Women & Infants Hospital of Rhode Island Providence, Rhode Island, United States, 02905 United States, Texas University of Texas Southwestern Medical Center at Dallas Dallas, Texas, United States, 75235 University of Texas Health Science Center at Houston Houston, Texas, United States, 77030 Less <<
NCT00966407 - Completed - United States, District of Col... More >>umbia Children's National Medical Center Washington, District of Columbia, United States, 20010 Less <<
NCT02964247 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT00772174 Diabetes Mellitus Phase 3 Completed - -
NCT03467659 Obesity Diabe... More >>tes Mellitus, Type 2 Appetitive Behavior Less << Not Applicable Completed - United States, Indiana ... More >> Purdue University West Lafayette, Indiana, United States, 47907 Less <<
NCT00903500 Type 2 Diabetes Not Applicable Completed - Belgium ... More >> Univerversity Ghent Ghent, Belgium Less <<
NCT01691196 - Unknown September 2017 United States, Illinois ... More >> University of Illinois at Chicago Recruiting Chicago, Illinois, United States, 60612 Contact: Natalia Litbarg, MD    312-996-6736    nlitbarg@uic.edu    Contact: Giamila Fantuzzi, PhD    312-413-5398    giamila@uic.edu    Principal Investigator: Jerrold S Levine, MD          Principal Investigator: Natalia Litbarg, MD          Principal Investigator: Giamila Fantuzzi, PhD Less <<
NCT01599728 Heart Failure ... More >> Endothelium Less << Not Applicable Completed - United Kingdom ... More >> Wellcome Trust Clinical Research Facility, Royal Infirmary of Edinburgh Edinburgh, United Kingdom, EH16 4SA Less <<
NCT01731366 Metabolic Disease ... More >> Injury of Gastrointestinal Tract Less << Not Applicable Unknown December 2015 Denmark ... More >> Department of Human Nutrition, University of Copenhagen Fredriksberg, Denmark, 1958 Less <<
NCT02241317 - Unknown April 2015 -
NCT01496430 Hypertension ... More >>Diabetes Less << Phase 3 Terminated(Business Decision; ... More >>No Safety Or Efficacy Concerns. (See below)) Less << - -
NCT01496430 - Terminated(Business Decision; ... More >>No Safety Or Efficacy Concerns. (See below)) Less << - -
NCT01274078 Risk Factors Cardiovascular Di... More >>sease Inflammation Exercise Sedentary Life Less << Not Applicable Completed - Sweden ... More >> Linkoeping, Sweden Less <<
NCT00448630 - Completed - Turkey ... More >> Pfizer Investigational Site Kurttepe, Adana, Turkey, 01360 Pfizer Investigational Site Adana, Turkey Pfizer Investigational Site Ankara, Turkey, 06200 Pfizer Investigational Site Ankara, Turkey Pfizer Investigational Site Antakya, Turkey Pfizer Investigational Site Bolu, Turkey Pfizer Investigational Site Denizli, Turkey Pfizer Investigational Site Elazig, Turkey Pfizer Investigational Site Eskisehir, Turkey Pfizer Investigational Site Istanbul, Turkey, 34147 Pfizer Investigational Site Istanbul, Turkey Pfizer Investigational Site Izmir, Turkey Pfizer Investigational Site Kayseri, Turkey Pfizer Investigational Site Konya, Turkey Pfizer Investigational Site Manisa, Turkey Pfizer Investigational Site Samsun, Turkey Pfizer Investigational Site Trabzon, Turkey Pfizer Investigational Site Trakya, Turkey Less <<
NCT02178501 Type 2 Diabetes ... More >> Cardiovascular Diseases Less << Not Applicable Completed - Poland ... More >> Samodzielny Publiczny Szpital Kliniczny nr 7 Śląskiego Uniwersytetu Medycznego w Katowicach Górnośląskie Centrum Medyczne im. prof. Leszka Gieca Katowice, Poland, 40-635 Krakowski Szpital Specjalistyczny im. Jana Pawła II Krakow, Poland, 31-202 Less <<
NCT01168700 Metabolic Syndrome Phase 4 Unknown October 2010 Colombia ... More >> Medicine School, Universidad de Santander Recruiting Bucaramanga, Santander, Colombia, 0000000 Sub-Investigator: Yudy A Rodriguez, Bact          Sub-Investigator: Ronald G García, MD, PhD Less <<
NCT00006334 - Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT01115114 Serious Mental Illness Not Applicable Completed - United States, Texas ... More >> Center for Health Care Services San Antonio, Texas, United States, 78207 University of Texas Health Science Center at San Antonio San Antonio, Texas, United States, 78229 Less <<
NCT01641172 Testicular Cancer Phase 4 Completed - Netherlands ... More >> University Medical Center Groningen Groningen, Netherlands, 9713 GZ Less <<
NCT00006278 - Completed - United States, Maryland ... More >> National Institute of Child Health and Human Development (NICHD) Bethesda, Maryland, United States, 20892 Less <<
NCT01121198 Healthy Volunteer ... More >> Pharmacokinetics of ASP1941 Less << Phase 1 Completed - Japan ... More >> Kantou, Japan Less <<
NCT00166803 Diabetes Mellitus, Atheroscler... More >>osis Less << Not Applicable Suspended(no fund) - Taiwan ... More >> National Taiwan University Hospital Taipei, Taiwan, 10012 Less <<
NCT03235219 Diabetes Mellitus, Type 2 Phase 1 Completed - United States, California ... More >> ProSciento, Inc. Chula Vista, California, United States, 91911 United States, Florida Advanced Pharma CR, LLC Miami, Florida, United States, 33147 Less <<
NCT00448630 - Completed - -
NCT03262363 Chronic Kidney Diseases ... More >> Diabetes Mellitus, Type 2 Polymorphism Less << Phase 2 Phase 3 Not yet recruiting April 30, 2019 Mexico ... More >> Umae Hospital de Especialidades Recruiting Guadalajara, Jalisco, Mexico, 44340 Contact: LAURA CORTES-SANABRIA, PhD    33 3660 3000 ext 32204    cortes_sanabria@yahoo.com.mx    Contact: ERIKA FABIOLA GOMEZ-GARCIA, MsC    33 3660 3000 ext 32204    erikaf.gomezg@yahoo.com.mx Less <<
NCT03096665 - Enrolling by invitation September 30, 2017 Korea, Republic of ... More >> Hanyang university guri hospital, Department of emergency medicine Guri, GyeongGido, Korea, Republic of, 471-701 Less <<
NCT03368937 Type1 Diabetes Mellitus Not Applicable Completed - United States, Virginia ... More >> University of Virginia Center for Diabetes Technology Charlottesville, Virginia, United States, 22903 Less <<
NCT03136484 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT00167817 Schizophrenia Phase 4 Completed - United States, California ... More >> VA San Diego Healthcare System San Diego, California, United States, 92161 Less <<
NCT01444833 Hypertension Not Applicable Unknown December 2012 Slovakia ... More >> Institute of Experimental Endocrinology, SAS Recruiting Bratislava, Slovakia, 833 06 Contact: Stefan Zorad, Dr.    00421 2 54772800 ext 250    stefan.zorad@savba.sk    Contact: Adela Penesova, MD.    00421 2 54772800 ext 260    adela.penesova@savba.sk    Principal Investigator: Richard Imrich, MD.          Principal Investigator: Katarina Krskova, Dr.          Principal Investigator: Miroslav Vlcek, MD.          Sub-Investigator: Adrian Oksa, MD. Less <<
NCT01814137 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT02017470 Cardiovascular Disease Not Applicable Unknown August 2015 Singapore ... More >> National University Heart Centre, Singapore Singapore, Singapore Less <<
NCT01662921 Diabetes During Pregnancy Phase 2 Completed - United States, California ... More >> William Sansum Diabetes Center Santa Barbara, California, United States, 93105 Less <<
NCT01485913 Diabetes Not Applicable Completed - Mali ... More >> Hopital National du Mali Bamako, Mali Less <<
NCT01612013 Acute Renal Failure Not Applicable Completed - Brazil ... More >> Hospital das Forcas Armadas - Fundacao Zerbine - INCOR Brasilia, DF, Brazil Less <<
NCT01814137 - Completed - -
NCT00200148 Pancreaticoduodenectomy ... More >> Hepatectomy Less << Phase 3 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT01811485 - Completed - -
NCT01835431 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 3 Completed - -
NCT03653091 Type 2 Diabetes Not Applicable Recruiting February 2020 United States, Florida ... More >> Florida Hospital / TRANSLATIONAL RESEARCH INSTITUTE FOR METABOLISM AND DIABETES (TRI) Recruiting Orlando, Florida, United States, 32804 Contact: Quianna Stokes-Washington    407-303-7100    TRI@flhosp.org    Principal Investigator: Steven Smith, MD          Sub-Investigator: Robert Hawes, MD          United States, Pennsylvania University of Pennsylvania - Penn Metabolic Medicine Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Anastassia Amaro, MD    215-294-9525    Anastassia.Amaro@uphs.upenn.edu    Contact: Gregory G. Ginsberg, MD    215-349-8222    Gregory.Ginsberg@uphs.upenn.edu    Principal Investigator: Anastassia Amaro, MD          Sub-Investigator: Gregory G. Ginsberg, MD Less <<
NCT01835431 - Completed - -
NCT01452451 Diabetes Mellitus Phase 2 Completed - United States, Ohio ... More >> Ohio, Ohio, United States Less <<
NCT03380273 Surgical Site Infection Not Applicable Not yet recruiting November 2023 -
NCT03374436 Physical Activity ... More >> Diet Modification Less << Not Applicable Recruiting June 30, 2019 Canada, British Columbia ... More >> University of British Columbia Okanagan Recruiting Kelowna, British Columbia, Canada, V1V 3G1 Contact: Hossein Rafiei    2508079122    hossein.rafiei@ubc.ca Less <<
NCT02772783 Diabetes Mellitus, Type 1 Not Applicable Completed - United States, Massachusetts ... More >> Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02115 Less <<
NCT00628277 Obesity Phase 3 Completed - United States, Vermont ... More >> University of Vermont College of Medicine Burlington, Vermont, United States, 05401 Less <<
NCT00013546 Osteoporosis ... More >>Turner's Syndrome Less << Phase 2 Completed - United States, Maryland ... More >> National Institute of Child Health and Human Development (NICHD) Bethesda, Maryland, United States, 20892 Less <<
NCT03163719 - Recruiting November 2018 France ... More >> CHU de Clermont-Ferrand Recruiting Clermont-Ferrand, Auvergne, France, 63003 Contact: Patrick LACARIN    04 73 75 11 95    placarin@chu-clermontferrand.fr    Contact: Farès MOUSTAFA    06 24 36 63 69    fmoustafa@chu-clermontferrand.fr    Sub-Investigator: Arthur RAISON          Sub-Investigator: Jeannot SCHMIDT          Sub-Investigator: Jennifer SAINT-DENIS          Sub-Investigator: Nicolas DUBLANCHET Less <<
NCT01811485 Diabetes Mellitus, Type 2 Phase 3 Completed - Japan ... More >> Novartis Investigative Site Chikushino-city, Fukuoka, Japan, 818-0083 Novartis Investigative Site Fukuoka-city, Fukuoka, Japan, 810-0014 Novartis Investigative Site Fukuoka-city, Fukuoka, Japan, 819-0006 Novartis Investigative Site Iizuka-city, Fukuoka, Japan, 820-8505 Novartis Investigative Site Kitakyushu-city, Fukuoka, Japan, 800-0296 Novartis Investigative Site Kitakyushu-city, Fukuoka, Japan, 807-0857 Novartis Investigative Site Koga-city, Ibaraki, Japan, 306-0232 Novartis Investigative Site Kawasaki-city, Kanagawa, Japan, 210-0852 Novartis Investigative Site Yokohama-city, Kanagawa, Japan, 221-0802 Novartis Investigative Site Yokohama-city, Kanagawa, Japan, 231-0023 Novartis Investigative Site Yatsushiro-city, Kumamoto, Japan, 866-8533 Novartis Investigative Site Yatsushiro-city, Kumamoto, Japan, 866-8660 Novartis Investigative Site Kyoto-city, Kyoto, Japan, 607-8062 Novartis Investigative Site Kyoto-city, Kyoto, Japan, 615-0035 Novartis Investigative Site Sakai-city, Osaka, Japan, 590-0064 Novartis Investigative Site Takatsuki-city, Osaka, Japan, 569-1096 Novartis Investigative Site Ageo-city, Saitama, Japan, 362-8588 Novartis Investigative Site Tokorozawa-city, Saitama, Japan, 359-1161 Novartis Investigative Site Bunkyo-ku, Tokyo, Japan, 113-0031 Novartis Investigative Site Edogawa-ku, Tokyo, Japan, 134-0084 Novartis Investigative Site Hachioji-city, Tokyo, Japan, 192-0918 Novartis Investigative Site Hachioji, Tokyo, Japan, 192-0046 Novartis Investigative Site Katsushika-ku, Tokyo, Japan, 124-0024 Novartis Investigative Site Kiyose-city, Tokyo, Japan, 204-0021 Novartis Investigative Site Minato-ku, Tokyo, Japan, 105-7390 Novartis Investigative Site Minato-ku, Tokyo, Japan, 108-0075 Novartis Investigative Site Nerima-ku, Tokyo, Japan, 177-0051 Novartis Investigative Site Shibuya-ku, Tokyo, Japan, 150-0002 Novartis Investigative Site Shinagawa-ku, Tokyo, Japan, 141-0032 Novartis Investigative Site Toshima-ku, Tokyo, Japan, 171-0021 Less <<
NCT02053272 Diabetes Mellitus, Type 2 Phase 2 Completed - Romania ... More >> Diabol SRL Brasov, Romania, 500365 Nicodiab SRL Bucuresti, Romania, 010507 Spitalul Universitar de Urgenta Militar Central "Dr. Carol Davila" Bucuresti, Romania, 010825 Institutul National de Diabet Bucuresti, Romania, 020475 Centrul Medical 'Sanatatea Ta' SRL Bucuresti, Romania, 020614 ArtMedical Clinic Bucuresti, Romania, 021107 Societatea Civila Medicala dr. Paveliu Bucuresti, Romania, 050538 Consultmed SRL Iasi, Romania, 700547 Cabinet Medical Individual Diabet Nutritie si Boli Metabolice Maramures, Romania, 430123 Grandmed SRL Oradea, Romania, 410159 Spitalul Judetean de Urgente Satu Mare Satu Mare, Romania, 440055 Spitalul Clinic Judetean de Urgenta Sibiu Sibiu, Romania, 550245 Gagiu D. Remus Cabinet Medical Individual Targoviste, Romania, 130083 Mediab SRL Diabet Zaharat Targu Mures, Romania, 540142 United Kingdom Avondale Surgery Chesterfield, Derbyshire, United Kingdom, S40 4TF Hull and East Yorkshire Hospitals NHS Trust Hull, East Yorkshire, United Kingdom, HU3 2JZ Salford Royal NHS Foundation Trust Salford, Greater Manchester, United Kingdom, M6 8HD University Hospitals of Leicester NHS Trust Leicester, Leicestershire, United Kingdom, LE5 4QF Aintree University Hospitals NHS Foundation Trust Liverpool, Merseyside, United Kingdom, L9 7AL Strensall Medical Practice York, North Yorkshire, United Kingdom, YO32 5UA Churchill Hospital Oxford, Oxfordshire, United Kingdom, OX3 9DU Hathaway Surgery Chippenham, Wiltshire, United Kingdom, SN14 6GT Avenue Surgery Warminster, Wiltshire, United Kingdom, BA12 9AA St Chad's Surgery Bath, United Kingdom, BA3 2UH Barts and The London NHS Trust London, United Kingdom, E1 1BB Less <<
NCT01558271 Type 2 Diabetes Mellitus Phase 3 Completed - Japan ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fukuoka, Japan, 819-0168 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hokkaido, Japan, 060-8604 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hyogo, Japan, 663-8501 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ibaraki, Japan, 302-0118 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ishikawa, Japan, 920-8641 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kanagawa, Japan, 235-0045 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kumamoto, Japan, 862-0976 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Miyagi, Japan, 980-0021 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nagano, Japan, 399-0006 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Osaka, Japan, 532-0003 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tokyo, Japan, 160-0022 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Toyama, Japan, 939-0363 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Yamaguchi, Japan, 756-0095 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Yokohama, Japan, 220-0012 Less <<
NCT00009581 Sickle Cell Anemia Phase 2 Completed - United States, Maryland ... More >> Warren G. Magnuson Clinical Center (CC) Bethesda, Maryland, United States, 20892 Less <<
NCT00677313 Lipodystrophy Not Applicable Completed - United States, California ... More >> Research Site Santa Barbara, California, United States United States, Illinois Research Site Chicago, Illinois, United States United States, Michigan Research Site Ann Arbor, Michigan, United States United States, Nevada Local Institution Reno, Nevada, United States, 89502 United States, North Carolina Research Site Greenville, North Carolina, United States Less <<
NCT02694263 Diabetes Mellitus, Type 2 Phase 4 Recruiting September 2018 United Kingdom ... More >> University Hospitals of Leicester NHS Trust Recruiting Leicester, Leicestershire, United Kingdom, LE5 4PW Contact: Emer Brady, PhD    0116248 ext 8959    emer.brady@uhl-tr.nhs.uk    Contact: Natasha Wileman, MSc    0116258 ext 8929    natasha.wileman@uhl-tr.nhs.uk    University Hospitals Birmingham NHS Foundation Trust Recruiting Birmingham, West Midlands, United Kingdom, B15 2TH Contact: Wasim Hanif    0121371 ext 4404    wasim.hanif@uhb.nhs.uk    Contact: Deborah Smith    0121371 ext 4707    deborah.smith@uhb.nhs.uk Less <<
NCT03272269 Type 1 Diabetes Mellitus Phase 1 Active, not recruiting April 2019 Belgium ... More >> Hôpital Erasme Brussels, Belgium UZ Brussel Brussels, Belgium UZ Gent Gent, Belgium Denmark Bispebjerg and Frederiksberg Hospital Copenhagen, Denmark France CHU de Nantes, Hôpital Laennec Nantes, France Germany GWT-TUD GmbH Dresden, Germany Lithuania Klaipeda University Hospital Klaipėda, Lithuania University Hospital Santaros Klinikos Vilnius, Lithuania Sweden Clinical Trial Center, CTC Göteborg, Sweden ProbarE Stockholm Stockholm, Sweden United Kingdom Cambridge University Hospitals NHS Foundation Trust Cambridge, United Kingdom Cardiff University Cardiff, United Kingdom Royal Devon and Exeter NHS Trust Exeter, United Kingdom Guy's and St. Thomas NHS Trust London, United Kingdom St. Bartholomew's Hospital (Barts Health NHS Trust) London, United Kingdom Newcastle University Newcastle upon Tyne, United Kingdom Oxford University Hospitals NHS Foundation Trust Oxford, United Kingdom Less <<
NCT02766478 Prostate Cancer Phase 2 Recruiting October 2019 United States, Georgia ... More >> Emory University Recruiting Atlanta, Georgia, United States, 30322 Contact: Elizabeth Ivie, RD, LD, CDE    404-727-1399    elizabeth.a.ivie@emory.edu Less <<
NCT02131272 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Terminated - -
NCT01459133 Diabetes Not Applicable Withdrawn(Unable to register T... More >>reatment IND with the US Food And Drug Administration's new process of establishing TLS encryption for email correspondence.) Less << October 2014 United States, California ... More >> South Orange County Endocrinology Laguna Hills, California, United States, 92653 Less <<
NCT01301833 Type 2 Diabetes Mellitus Phase 3 Completed - Japan ... More >> Chitose-shi, Hokkaidou, Japan Less <<
NCT01558271 - Completed - -
NCT02131272 - Terminated - -
NCT03163797 - Recruiting July 31, 2018 Taiwan ... More >> Chang Gung Memorial Hospital Recruiting Gueishan, Taoyuan, Taiwan, 333 Contact: Shu-Hang Ng, MD    +886-9-75365741    shuhangng@gmail.com    Principal Investigator: Shu-Hang Ng, MD          Sub-Investigator: Sheung-Fat Ko, MD          Sub-Investigator: Jiun-jie Wang          Sub-Investigator: Chun-Ta Liao, MD          Sub-Investigator: Hung-Ming Wang, PhD          Sub-Investigator: Yu-Chun Lin, MD          Sub-Investigator: Gigin Lin, MD          Sub-Investigator: Kang-Hsing Fan, MD          Sub-Investigator: Tzu-Chen Yen, MD          Sub-Investigator: Chien-Yu Lin, MD          Sub-Investigator: Sheng-Chieh Chan Less <<
NCT03017482 - Active, not recruiting August 30, 2020 United States, California ... More >> Stanford University Stanford, California, United States, 94305 Less <<
NCT01301833 - Completed - -
NCT03353311 - Completed - Italy ... More >> Fondazione Policlinico Unversitario Agostino Gemelli Roma, Italy, 00168 Less <<
NCT00332631 Cardiac Surgery and Cardiopulm... More >>onary Bypass Less << Phase 2 Completed - Australia, Victoria ... More >> Austin Hospital Melbourne, Victoria, Australia, 3084 Less <<
NCT00494208 Hysterectomy ... More >>Ovariectomy Menopause Testosterone Deficiency Less << Not Applicable Completed - United States, Massachusetts ... More >> Boston University Medical Center Boston, Massachusetts, United States, 02118 Less <<
NCT03403127 Lung Cancer N... More >>on-Small Cell Lung Cancer Less << Not Applicable Active, not recruiting January 2020 -
NCT02218138 Type 2 Diabetes ... More >> Depression Obesity Less << Not Applicable Completed - United States, Colorado ... More >> Colorado State University Fort Collins, Colorado, United States, 80523-1570 Less <<
NCT01275131 Type 1 Diabetes Mellitus Phase 1 Completed - United States, California ... More >> Profil Institute for Clinical Research Chula Vista, California, United States, 91911 Less <<
NCT01495052 Diabetes Mellitus Not Applicable Completed - China, Inner Mongolia Autonomo... More >>us Region Arms Industry New Century Hotel Baotou, Inner Mongolia Autonomous Region, China, 014032 Less <<
NCT03191396 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT02083315 Pain, Acute Phase 1 Completed - United States, Utah ... More >> CRI Lifetree Salt Lake City, Utah, United States, 84106 Less <<
NCT01014832 Diabetes Not Applicable Completed - United States, New Jersey ... More >> TKL Research INC. Paramus, New Jersey, United States, 07652 Less <<
NCT01275131 - Completed - -
NCT02104804 Type 2 Diabetes Mellitus Phase 3 Completed - China ... More >> Research Site Beijing, China Research Site Changchun, China Research Site Fuzhou, China Research Site Guangzhou, China Research Site Ha'er bing, China Research Site Hefei, China Research Site Nanchang, China Research Site Nanjing, China Research Site Shanghai, China Research Site ShiJiazhuang, China Research Site Shiyan, China Less <<
NCT00798486 - Completed - -
NCT02373865 Diabetes Mellitus Type 2 Phase 4 Terminated(Premature terminati... More >>on due to insufficient patient recruitement..) Less << - Germany ... More >> GWT-TUD GmbH / Studienzentrum Hanefeld Dresden, Germany, 01307 Less <<
NCT00005666 Carcinoma, Non-Small-Cell Lung Not Applicable Completed - United States, Michigan ... More >> UH B2 C490 Box 0010 E. Medical Center Drive Ann Arbor, Michigan, United States, 48109 Less <<
NCT02562664 Reproductive Endocrinology ... More >> Polycystic Ovarian Syndrome Less << Phase 2 Completed - -
NCT02104804 - Completed - -
NCT01659697 - Unknown July 2015 Israel ... More >> Central district Clalit Health Services Rishon Le Zion, Israel Less <<
NCT02261948 - Completed - -
NCT00798486 Diabetes Not Applicable Completed - United States, California ... More >> John Muir Physician Network Clinical Research Center Concord, California, United States, 94520 United States, New Jersey Consumer Product Testing Co., Inc. Fairfield, New Jersey, United States, 07004 Less <<
NCT00574535 - Completed - United States, California ... More >> Cedars Sinai Medical Center Los Angeles, California, United States, 90048 Less <<
NCT02278185 Adenocarcinoma of the Prostate... More >> Recurrent Prostate Cancer Stage III Prostate Cancer Stage IV Prostate Cancer Less << Phase 2 Recruiting December 2019 United States, Colorado ... More >> University of Colorado Cancer Center - Anschutz Cancer Pavilion Recruiting Aurora, Colorado, United States, 80045 Contact: Michael Wacker    720-848-3427    michael.wacker@ucdenver.edu    Principal Investigator: Elizabeth R. Kessler, MD          Sub-Investigator: Al Barqawi, MD          Sub-Investigator: Thomas W Flaig, MD          Sub-Investigator: Elaine T Lam, MD          Sub-Investigator: Paul Maroni, MD          Sub-Investigator: Shandra Wilson, MD          University of Colorado Health - Poudre Valley Hospital Recruiting Fort Collins, Colorado, United States, 80524 Contact: Joanne O'Malia    970-297-6153    Joanne.omalia@uchealth.org    Principal Investigator: Steven Schuster, MD Less <<
NCT02398318 Obsessive Compulsive Disorder Phase 2 Phase 3 Withdrawn(A pilot study is rec... More >>ruiting) Less << April 2018 China, Guangdong ... More >> Guangzhou psychiatric hospital Guangzhou, Guangdong, China, 510370 China, Shanghai Shanghai Mental Health Center Shanghai, Shanghai, China, 200030 China, Sichuan West China Hospital Chengdu, Sichuan, China, 610041 Less <<
NCT01041794 - Completed - United States, Alabama ... More >> UAB Birmingham, Alabama, United States, 35294 Less <<
NCT00376870 Coronary Atherosclerosis ... More >> Coronary Restenosis Diabetes Less << Phase 3 Unknown April 2011 Italy ... More >> Policlinico di Tor Vergata Not yet recruiting Rome, Italy, 00133 Principal Investigator: Fabrizio Clementi, MD. PhD          Policlinico di Tor Vergata Recruiting Rome, Italy, 00133 Contact: Saverio Muscoli, MD    +390620904009    fabrizio.clementi@me.com    Principal Investigator: Fabrizio Clementi, MD, PhD Less <<
NCT02261948 Heart Failure Phase 4 Completed - Italy ... More >> Centro Cardiologico Monzino Milano, MI, Italy, 20138 Less <<
NCT00909597 Diabetes Mellitus Type 2 Phase 3 Completed - -
NCT00357344 - Completed - United States, Arizona ... More >> NIDDK, Phoenix Phoenix, Arizona, United States, 85014 Good Samaritan Regional Medical Center Phoenix, Arizona, United States Mayo Clinic Scottsdale, Arizona, United States, 85259 Less <<
NCT00745238 Myotonia Not Applicable Unknown December 2012 France ... More >> France.Functional Cardio-Respiratory Exploration Laboratory Recruiting Grenoble., Isere, France, 38000 Contact: Jean -Louis JL PEPIN, professor    0033476765516    JPepin@chu-grenoble.fr Less <<
NCT00001657 - Completed - United States, Maryland ... More >> National Institute of Mental Health (NIMH) Bethesda, Maryland, United States, 20892 Less <<
NCT01021579 Polycystic Ovary Syndrome Phase 4 Completed - Iran, Islamic Republic of ... More >> Zainabieh Hospital Shiraz, Fars, Iran, Islamic Republic of, 7173646199 Less <<
NCT01821586 Malnourished Children With Wat... More >>ery Diarrhoea Less << Phase 2 Completed - Bangladesh ... More >> Dhaka Hospital, icddr,b Dhaka, Bangladesh, 1212 Less <<
NCT02712619 Healthy Phase 1 Completed - -
NCT02857543 Obesity Hyper... More >>cholesterolemia Cardiovascular Disease Less << Not Applicable Active, not recruiting October 2018 United States, Ohio ... More >> Cleveland Clinic Cleveland, Ohio, United States, 44195 Less <<
NCT01695317 Migraine Phase 4 Completed - Norway ... More >> Norwegian National Headache Centre Trondheim, Norway, 7489 Less <<
NCT03462940 Diabetes Mellitus, Type 2 ... More >> Insulin Response Endothelial Dysfunction Less << Not Applicable Enrolling by invitation March 2020 United States, Massachusetts ... More >> Boston Medical Center Boston, Massachusetts, United States, 02118 Less <<
NCT01809769 Knee Osteoarthritis Phase 1 Phase 2 Completed - China, Shanghai ... More >> Department of Rheumatology,Ren Ji Hospital,School of Medicine,Shanghai Jiao Tong University,Shanghai,China Shanghai, Shanghai, China, 200127 Less <<
NCT00706381 Healthy Volunteers Not Applicable Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00537277 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 4 Completed - Turkey ... More >> Istanbul, Turkey, 343662 Less <<
NCT00151762 Type 2 Diabetes Phase 3 Completed - -
NCT02931201 Lymphoma, Large B-Cell, Diffus... More >>e Less << Not Applicable Unknown December 2018 China, Beijing ... More >> Peking University Cancer Hospital Recruiting Beijing, Beijing, China, 100142 Contact: Xuejuan Wang, MD    86 10-88196364    xuejuan_wang@hotmail.com    Contact: Yuewei Zhang       zhang_yue_wei@126.com Less <<
NCT03051542 Lymphoma, Extranodal NK-T-Cell Not Applicable Not yet recruiting December 31, 2020 China, Beijing ... More >> Peking University Cancer Hospital Beijing, Beijing, China, 100142 Less <<
NCT03412253 Metabolic Surgery Not Applicable Suspended(financial causes, an... More >>d the study will be continued within days.) Less << February 4, 2018 -
NCT02928861 Lymphoma, Large B-Cell, Diffus... More >>e Less << Not Applicable Unknown December 2018 China, Beijing ... More >> Peking University Cancer Hospital Recruiting Beijing, Beijing, China, 100142 Contact: Xuejuan Wang, MD    86 10-88196364    xuejuan_wang@hotmail.com    Contact: Yuewei Zhang       zhang_yue_wei@126.com    China Peking University Cancer Hospital Recruiting Beijing, China, 100142 Contact: Xuejuan Wang, MD    86 10-88196364    xuejuan_wang@hotmail.com Less <<
NCT03025659 - Recruiting January 2019 United States, Florida ... More >> University of Florida Shands Children's Hospital Recruiting Gainesville, Florida, United States, 32610 Less <<
NCT02240836 DCIS Grade 3 ... More >>Stage I Breast Cancer Stage II Breast Cancer Less << Not Applicable Recruiting June 2026 Norway ... More >> Oslo University Hospital Recruiting Oslo, Norway Contact: Inger Thune, MD. PhD    +4791372717    inger.thune@uit.no    Principal Investigator: Inger Thune, MD. PhD          Sub-Investigator: Erik A Wist, MD, PhD          Sub-Investigator: Ellen Schlichting, MD, PhD          St. Olavs Hospital Recruiting Trondheim, Norway, 7000 Contact: Gro Bertheussen, MD. PhD    +4791545550    gro.f.bertheussen@ntnu.no    Sub-Investigator: Gro Bertheussen, MD. PhD          Sub-Investigator: Hans Fjosne, MD PhD Less <<
NCT03051555 Lymphoma, Extranodal NK-T-Cell Not Applicable Not yet recruiting December 31, 2020 China, Beijing ... More >> Peking University Cancer Hospital Beijing, Beijing, China, 100142 Less <<
NCT03051568 Lymphoma, T-Cell, Peripheral Not Applicable Not yet recruiting December 31, 2020 China, Beijing ... More >> Peking University Cancer Hospital Beijing, Beijing, China, 100142 Less <<
NCT01092559 Pulmonary Arterial Hypertensio... More >>n Less << Phase 2 Completed - United States, Massachusetts ... More >> Tufts Boston, Massachusetts, United States, 02111 United States, Ohio University Hospital Cleveland, Ohio, United States, 44106 United States, Texas University of Texas Southwestern Medical Center Dallas, Texas, United States, 75390 Less <<
NCT01092559 - Completed - -
NCT03101930 Obesity PreDi... More >>abetes Less << Phase 4 Recruiting September 1, 2021 United States, Tennessee ... More >> Vanderbilt University Medical Center Recruiting Nashville, Tennessee, United States, 37232 Contact: Dustin Mayfield, RN    615-343-8701       Contact: Nancy J Brown, MD    6153438701    nancy.j.brown@vanderbilt.edu Less <<
NCT03317522 - Completed - -
NCT00274729 Overweight Ob... More >>esity Less << Not Applicable Completed - -
NCT01138241 - Completed - Thailand ... More >> HIV-NAT, Thai Red Cross AIDS Research Centre Bangkok, Thailand, 10330 Less <<
NCT01871558 Type 2 Diabetes Mellitus (T2DM... More >>) Less << Phase 3 Completed - France ... More >> Novartis Investigative Site Antibes, France, 06600 Novartis Investigative Site Auxerre, France, 89000 Novartis Investigative Site Bar le Duc, France, 55012 Novartis Investigative Site Bondy, France, 93143 Novartis Investigative Site Brest, France, 29200 Novartis Investigative Site Caen, France, 14000 Novartis Investigative Site Corbeil Essonnes, France, 91100 Novartis Investigative Site Fleury sur Orne, France, 14123 Novartis Investigative Site Maisons Laffitte, France, 78600 Novartis Investigative Site Menton, France, 06500 Novartis Investigative Site Montpellier, France, 34090 Novartis Investigative Site Paris, France, 75010 Novartis Investigative Site Rennes, France, 35203 Novartis Investigative Site Saint Nazaire, France, 44600 Novartis Investigative Site Sanary Sur Mer, France, 83110 Novartis Investigative Site Strsbourg, France, 67000 Novartis Investigative Site Toulouse, France, 31300 Novartis Investigative Site Valence, France, 26000 Novartis Investigative Site Valenciennes, France, 59300 Less <<
NCT01631123 Metabolic Response to Dietary ... More >>Modification Less << Not Applicable Completed - Germany ... More >> German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany, 14558 Less <<
NCT03051581 Lymphoma, T-Cell, Peripheral Not Applicable Not yet recruiting December 31, 2020 China, Beijing ... More >> Peking University Cancer Hospital Beijing, Beijing, China, 100142 Less <<
NCT01188863 Type 2 Diabetes Mellitus Phase 1 Completed - United States, Texas ... More >> Lexicon Investigational Site San Antonio, Texas, United States, 78209 Less <<
NCT03722862 Diet Modification Not Applicable Recruiting September 14, 2019 United States, Minnesota ... More >> Department of Food Science and Nutrition Recruiting Saint Paul, Minnesota, United States, 55108 Contact: Joanne Slavin, PhD    612-624-7234       Principal Investigator: Joanne Slavin Less <<
NCT01907854 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 4 Completed - -
NCT02158143 Vitamin D Deficiency Not Applicable Completed - China, Shanghai ... More >> Institute for Nutrition Sciences, Chinese Academy of Sciences Shanghai, Shanghai, China, 200031 Less <<
NCT01536600 - Completed - Korea, Republic of ... More >> Novo Nordisk Investigational Site Seoul, Korea, Republic of, 137-920 Less <<
NCT00885690 Schizophrenia Not Applicable Terminated(Due to recruitment ... More >>problems) Less << - Denmark ... More >> Aalborg Psychiatric Hospital Aalborg, Denmark, 9000 Sweden Universitets Allmänna Sjukhuset, Malmø UMAS Malmø, Sweden Less <<
NCT02575755 Pregnancy Inf... More >>ections, Plasmodia Drug Kinetics Clinical Efficacy Less << Phase 4 Unknown October 2016 Papua New Guinea ... More >> Papua New Guinea Institute of Medical Research Recruiting Madang, Madang Province, Papua New Guinea, 511 Contact: Brioni R Moore, BSc, PhD    (+61) 0466266334    brioni.moore@uwa.edu.au    Contact: Leanne J Robinson, BSc, PhD, MPH    (+675) 422 2909    robinson@wehi.edu.au Less <<
NCT03434119 Type 2 Diabetes Mellitus Phase 3 Terminated("Trial terminated (... More >>recruitment delays)") Less << - -
NCT01334034 Diabetes Heal... More >>thy Less << Phase 1 Completed - Germany ... More >> Novo Nordisk Investigational Site Neuss, Germany, 41460 Less <<
NCT03581201 - Recruiting July 1, 2019 Austria ... More >> Medical University of Vienna Recruiting Vienna, Austria, 1090 Contact: Alexandra Kautzky-Willer, Univ.Prof.Dr.    +434040021260    alexandra.kautzky-willer@meduniwien.ac.at Less <<
NCT01907854 - Completed - -
NCT03653156 - Recruiting January 1, 2028 -
NCT03380091 PCOS Depressi... More >>on Vitamin D Deficiency Insulin Resistance Less << Phase 4 Recruiting April 2019 United States, California ... More >> UCSF Center for Reproductive Health Recruiting San Francisco, California, United States, 94158 Contact: Nik Lenhart    415-885-3598    Nik.Lenhart@ucsf.edu Less <<
NCT03761446 Type2 Diabetes Not Applicable Not yet recruiting May 2023 -
NCT03249168 Post Laparoscopic Shoulder Pai... More >>n Less << Phase 3 Not yet recruiting December 1, 2020 -
NCT03077282 Healthy Volunteers Phase 1 Recruiting July 15, 2018 Thailand ... More >> Thammasat university Recruiting Khlong Luang, Pathumthani, Thailand, 12120 Contact: Nichamon Mukkasombut, Master Less <<
NCT01755156 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT01871558 - Completed - -
NCT01779024 - Completed - -
NCT01779024 fMRI Alcohol ... More >>Drinking Alcoholism Less << Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT03421301 Type 2 Diabetes Mellitus Not Applicable Completed - -
NCT03520972 Type 2 Diabetes Mellitus Phase 2 Recruiting September 5, 2019 China ... More >> Peking University People's Hospital Recruiting Peking, China, 100000 Contact: Linong Ji, MD,PhD Less <<
NCT00774904 Diabetic Nephropathy Not Applicable Completed - China ... More >> Shanghai No.3 people's hospital Shanghai, China, 201900 Less <<
NCT00887367 Substance Dependence Phase 1 Completed - Netherlands ... More >> GSK Investigational Site Leiden, Netherlands, 2333 CL Less <<
NCT02055547 Type II Diabetes Mellitus Phase 1 Completed - -
NCT01755156 - Completed - -
NCT00695994 Non Small Cell Lung Cancer ... More >> Breast Cancer Less << Phase 2 Completed - Singapore ... More >> National University Hospital Singapore, Singapore Less <<
NCT01565252 Healthy Volunteers Not Applicable Unknown August 2015 Israel ... More >> Rabin Medical Center, Campus Beilinson Not yet recruiting Petach Tikva, Israel, 49100 Contact: Pierre Singer, Professor ,MD    972-39376521    psinger@clalit.org.il    Contact: Milana Grinev, Study Coordinator    972-39376521    milang@clalit.org.il Less <<
NCT01494363 Biliary Tract Cancer Phase 2 Unknown December 2013 Korea, Republic of ... More >> Hyun Jung Kim Recruiting Bucheon, Korea, Republic of Contact: Hyun Jung Kim, M.D.    +82-32-621-5114    khjbless@schmc.ac.kr    Han Jo Kim Recruiting Cheonan, Korea, Republic of Contact: Han Jo Kim, M.D.    +82-41-570-3693    hzmd@schmc.ac.kr    Nam Su Lee Recruiting Seoul, Korea, Republic of Contact: Nam Su Lee, M.D.    +82-2-709-9114    mdnslee@schmc.ac.kr Less <<
NCT03544996 - Completed - United States, Florida ... More >> Langford Research Institute Palm Beach Gardens, Florida, United States, 33410 Less <<
NCT00763139 - Completed - -
NCT02927379 Abdominal Cancer Phase 3 Completed - Egypt ... More >> South Egypt Cancer Instuite Assuit, Egypt, 171516 Less <<
NCT00320008 Type 2 Diabetes Not Applicable Active, not recruiting December 2025 Denmark ... More >> Slagelse Hospital Slagelse, Denmark, 4200 Less <<
NCT03341117 Diabetes Mellitus, Type 2 ... More >> Antioxidant Enzyme System Less << Phase 3 Completed - -
NCT00574405 Diabetes Mellitus Not Applicable Completed - United States, Arkansas ... More >> Arkansas Children's Hospital/Research Institute Little Rock, Arkansas, United States, 72202 Less <<
NCT00574405 - Completed - -
NCT02081014 Hypoglycemia Phase 2 Completed - United States, Texas ... More >> Baylor College of Medicine, Children's Nutritional Research Center, Texas Children's Hospital Houston, Texas, United States, 77030 Less <<
NCT00542620 - Completed - -
NCT00542620 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 4 Completed - France ... More >> Paris, France Less <<
NCT03593694 Diabetes Mellitus, Type 2 Not Applicable Recruiting December 31, 2021 United States, Wisconsin ... More >> Medical College of Wisconsin Recruiting Milwaukee, Wisconsin, United States, 53226 Contact: Jo Bergholte       JBergholte@mcw.edu    Principal Investigator: Leonard E Egede, MD, MS Less <<
NCT02518022 Type 1 Diabetes Mellitus ... More >> Hypoglycemia Less << Not Applicable Withdrawn(unexpected low willi... More >>ngness of patient to participate on the study) Less << - Germany ... More >> Kinder - und Jugendkrankenhaus AUF DER BULT Hannover, Germany, 30173 Less <<
NCT03074019 Healthy Not Applicable Completed - Canada, Ontario ... More >> Nutrasource Diagnostics Inc. Guelph, Ontario, Canada, N1G 0B4 Less <<
NCT00763139 Rheumatoid Arthritis Not Applicable Completed - United States, Tennessee ... More >> Vanderbilt Clinical Research Center Nashville, Tennessee, United States, 37232-2195 Less <<
NCT02644824 Congenital Heart Disease (CHD) Not Applicable Completed - Canada, Ontario ... More >> The Hospital for Sick Children Toronto, Ontario, Canada, M5G 1X8 Less <<
NCT02658539 - Recruiting September 2019 United Kingdom ... More >> Department of Food and Nutritional Sciences, University of Reading Recruiting Reading, Berkshire, United Kingdom, RG6 6AP Contact: Julie A Lovegrove, BSc PhD    0118378 ext 6418    j.a.lovegrove@reading.ac.uk    Contact: Kim G Jackson, BSc PhD    0118378 ext 5361    k.g.jackson@reading.ac.uk    Principal Investigator: Julie A Lovegrove, BSc PhD          Sub-Investigator: Kim G Jackson, BSc PhD          Sub-Investigator: Rada Mihaylova, RN          Sub-Investigator: Karen Jenkins, RN          Sub-Investigator: Sarah Hargreaves Less <<
NCT02081014 - Completed - -
NCT02470455 - Completed - India ... More >> SCB Medical College Cuttack, Odisha, India, 752001 Less <<
NCT01219985 Liver Cancer Not Applicable Completed - France ... More >> centre hospitalier universitaire d'Amiens Amiens, Picardy, France, 80054 Less <<
NCT01475461 Type 2 Diabetes Mellitus Phase 2 Completed - -
NCT01110928 - Active, not recruiting October 31, 2018 Japan ... More >> Novo Nordisk Investigational Site Tokyo, Japan, 1000005 Less <<
NCT02160639 Diabetes Mellitus Type 2 Not Applicable Unknown May 2017 United States, Arizona ... More >> El Rio Community Health Center Tucson, Arizona, United States, 85701 United States, Missouri Cross Trails Medical Center Cape Girardeau, Missouri, United States, 63703 United States, North Carolina Triad Adult and Pediatric Medicine, Inc. High Point, North Carolina, United States, 27262 United States, West Virginia FamilyCare Health Center Scott Depot, West Virginia, United States, 25560 Less <<
NCT01477567 - Completed - -
NCT01477567 Diabetes Mellitus, Type 2 Phase 1 Completed - Singapore ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Singapore, Singapore Less <<
NCT01219985 - Completed - -
NCT03383601 - Recruiting October 2023 Kazakhstan ... More >> Kazakhstan Academy of Preventive Medicine Recruiting Almaty, Kazakhstan, 050008 Contact: Baurzhan Zhussupov, MS    +7 777 482 21 71    Baurzhan.zhussupov@gmail.com Less <<
NCT03407833 - Enrolling by invitation February 2028 United States, Tennessee ... More >> Vanderbilt University Medical Center Nashville, Tennessee, United States, 37212 Less <<
NCT01909479 Adult Growth Hormone Deficienc... More >>y Less << Phase 3 Terminated(Main Study was comp... More >>leted. LT-OLE was discontinued as sufficient safety data has been generated.) Less << - Israel ... More >> Opko Biologics Kiryat Gat, Israel, 8211804 Less <<
NCT01475461 - Completed - -
NCT01255254 Gingival Scaling ... More >> Metabolic Control Less << Phase 1 Unknown August 2011 Israel ... More >> Department of Periodontology, School of Graduate Dentistry Rambam Health care campus Recruiting Haifa, Israel Contact: Dr. Rina Elmaleh, DMD    +97206470740    r_elmaleh@rambam.health.gov.il    Sub-Investigator: Prof Eli Machtei, DMD Less <<
NCT00921336 Solid Tumor Phase 1 Completed - United States, Maryland ... More >> University of Maryland Greenbaum Cancer Center Baltimore, Maryland, United States, 21201-1595 United States, Michigan Karmanos Cancer Institute Detroit, Michigan, United States, 48201 United States, New York Memorial Sloan Kettering New York, New York, United States, 10021 Less <<
NCT01865331 Diabetes Heal... More >>thy Less << Phase 1 Completed - Germany ... More >> Neuss, Germany, 41460 Less <<
NCT01517373 Diabetes Mellitus, Type 2 Phase 2 Completed - -
NCT01660451 Lymphoma, Non-Hodgkin Phase 2 Active, not recruiting March 8, 2019 -
NCT00926406 Anemia Malnut... More >>rition Inflammation Lead Poisoning Less << Not Applicable Unknown December 2011 Taiwan ... More >> Chang Gung Memorial Hospital Recruiting Taoyuan, Taiwan, 33333 Contact: Tsang-Tang Hsieh, MD       tth3388@adm.cgmh.org.tw    Principal Investigator: Ja-Liang Lin, MD Less <<
NCT01517373 - Completed - -
NCT00364988 Type 2 Diabetes ... More >> Diabetic Nephropathy Less << Not Applicable Completed - -
NCT03446898 - Recruiting July 1, 2019 China, Xizang Autonomous Regio... More >>n Tibetan Traditional Medical College Recruiting Lhasa, Xizang Autonomous Region, China Contact: Yingchun He, Master    +86-13880930756    17190782@qq.com    Contact: Tonghua Liu, Professor    +86-13801020306    thliu@vip.163.com Less <<
NCT01578928 Renal Impairment Phase 1 Completed - Germany ... More >> Novartis Investigative Site Berlin, Germany, 14050 South Africa Novartis Investigative Site Bloemfontein, Free State, South Africa, 9300 Less <<
NCT03513874 Type 1 Diabetes Mellitus ... More >> Autoimmune Diabetes Less << Phase 4 Recruiting March 1, 2019 China, Hunan ... More >> Institute of Metabolism and Endocrinology, Second Xiangya Hospital, Central South University Recruiting Changsha, Hunan, China, 410011 Contact: Zhiguang Zhou, MD/PhD    86-731-85292154    zhouzg@hotmail.com Less <<
NCT00422318 Heart Failure ... More >> Hyperuricemia Less << Phase 4 Completed - Japan ... More >> Tottori University Hospital Yonago, Japan, 683-8504 Less <<
NCT03310034 Aging Mitocho... More >>ndrial Function Less << Not Applicable Recruiting December 2019 Netherlands ... More >> Maastricht University Recruiting Maastricht, Limburg, Netherlands, 6229ER Contact: Niels Connell, MSc    +31433881587    n.connell@maastrichtuniversity.nl Less <<
NCT00962442 Alcoholic Hepatitis Phase 3 Completed - Belgium ... More >> Erasme University Hospital Brussels, Belgium, 1070 Less <<
NCT01584063 Pregnancy Pos... More >>tpartum Period Less << Not Applicable Completed - -
NCT01660451 - Active, not recruiting - -
NCT03130036 Alzheimer Disease ... More >> Mild Cognitive Impairment Less << Not Applicable Completed - United States, North Carolina ... More >> Wake Forest School of Medicine Winston-Salem, North Carolina, United States, 27157 Less <<
NCT01526733 Type 1 Diabetes Mellitus Phase 4 Completed - United States, California ... More >> Profil Institute for Clinical Research Chula Vista, California, United States, 91911 Less <<
NCT01856881 Diabetes Mellitus Phase 1 Terminated(This study was term... More >>inated on August 29th, 2014 due to a business decision by the Sponsor. The study was not terminated due to a safety reason.) Less << - United States, California ... More >> Research Site Chula Vista, California, United States, 91911 United States, Florida Research Site Miramar, Florida, United States, 33025 United States, Kansas Research Site Overland Park, Kansas, United States, 66212 United States, Ohio Research Site Cincinnati, Ohio, United States, 45255 United States, Texas Research Site San Antonio, Texas, United States, 78209 United States, Washington Research Site Renton, Washington, United States, 98057 Less <<
NCT00943865 Metabolic Syndrome ... More >> Obesity Less << Not Applicable Completed - Brazil ... More >> Hospital de Clinicas de Porto Alegre Porto Alegre, RS, Brazil, 90035903 Less <<
NCT02214173 Human Immunodeficiency Virus I... More >>nfection Less << Not Applicable Completed - United States, Florida ... More >> University of Miami Miller School of Medicine, Clinical Research Building, Department of Psychiatry & Behavioral Sciences Miami, Florida, United States, 33136 Less <<
NCT01617434 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT01617434 - Completed - -
NCT01372800 - Unknown - China, Shaanxi ... More >> Xijing Hospital Recruiting Xi'an, Shaanxi, China, 710032 Contact: Ling Tao, M.D Ph.D    +86-15002955798    lingtao2006@gmail.com    Principal Investigator: Ling Tao, M.D Ph.D Less <<
NCT01526733 - Completed - -
NCT01840618 - Completed - United States, New York ... More >> Children's Hospital at Montefiore Bronx, New York, United States, 10467 Less <<
NCT01920282 Hypertension Phase 4 Completed - -
NCT03474731 Diabetes Mellitus Not Applicable Recruiting November 2024 United States, Kentucky ... More >> University of Kentucky Recruiting Lexington, Kentucky, United States, 40536 Contact: Nancy Schoenberg, PhD    859-323-8175    nesch@uky.edu    Contact: Tiffany Scott    859 323 5771    tiffany.scott@uky.edu    Principal Investigator: Nancy Schoenberg, PhD          Sub-Investigator: Laura Hieronymus, DNP          Sub-Investigator: Roberto Cardarelli          Sub-Investigator: Brittany Smalls, PhD, MHSA          Sub-Investigator: Frances Feltner, DNP          Sub-Investigator: Glen Mays          Sub-Investigator: Richard Charnigo, PhD Less <<
NCT01767688 Diabetes Mellitus, Type 2 Phase 1 Completed - -
NCT01920282 - Completed - -
NCT00510952 Diabetes Mellitus, Type 2 Phase 3 Completed - United States, Arkansas ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Jonesboro, Arkansas, United States, 72401 United States, California For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Huntington Park, California, United States, 90255 United States, Florida For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Miami, Florida, United States, 33145 United States, Georgia For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Atlanta, Georgia, United States, 30312 United States, Indiana For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Indianapolis, Indiana, United States, 46222 United States, Kansas For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Wichita, Kansas, United States, 67208 United States, Kentucky For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lexington, Kentucky, United States, 40502 United States, Louisiana For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Slidell, Louisiana, United States, 70458 United States, New Jersey For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Toms River, New Jersey, United States, 08755 United States, New York For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Brooklyn, New York, United States, 11203 United States, Washington For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tacoma, Washington, United States, 98405 Brazil For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Brasilia, Brazil, 71625-009 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fortaleza, Brazil, 60430-350 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Joinville, Brazil, 89201-260 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sao Paulo, Brazil, 01244-030 Canada, British Columbia For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Victoria, British Columbia, Canada, V8R 6V4 Puerto Rico For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ponce, Puerto Rico, 00716 Less <<
NCT00510952 - Completed - -
NCT02479035 Insulin Resistant Not Applicable Active, not recruiting June 15, 2019 United States, Illinois ... More >> Clinical Nutrition Research Center Chicago, Illinois, United States, 60616 Less <<
NCT03203694 Type 2 Diabetes Mellitus Not Applicable Recruiting June 1, 2022 United States, Missouri ... More >> University of Missouri Recruiting Columbia, Missouri, United States, 65212 Contact: Jaume Padilla    573-882-7056    padillaja@missouri.edu Less <<
NCT01767688 - Completed - -
NCT01812031 Lung Cancer N... More >>on Small Cell Lung Cancer Chronic Obstructive Pulmonary Disease Less << Not Applicable Completed - France ... More >> CHU Amiens Amiens, Picardie, France, 80054 Less <<
NCT02059889 Recurrent Non-small Cell Lung ... More >>Cancer Stage IIA Non-small Cell Lung Cancer Stage IIB Non-small Cell Lung Cancer Stage IIIA Non-small Cell Lung Cancer Stage IIIB Non-small Cell Lung Cancer Less << Not Applicable Withdrawn(slow accrual) - United States, Virginia ... More >> Virginia Commonwealth University Massey Cancer Center Richmond, Virginia, United States, 23298 Less <<
NCT00537277 - Completed - -
NCT02825251 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 3 Completed - -
NCT02796339 Inflammatory Bowel Diseases Phase 2 Active, not recruiting September 2018 Greece ... More >> Harokopio University Athens, Greece, 17671 Less <<
NCT03503864 Neuroblastoma Phase 2 Recruiting December 30, 2029 China, Guangdong ... More >> Sun Yat-sen Memorial Hospital, Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510120 Contact: Yang Li, Professor    +8602081332456    drliyang@126.com Less <<
NCT00373269 - Completed - -
NCT02825251 - Completed - -
NCT01901666 Chronic Myelogenous Leukemia ... More >> Short Stature Less << Phase 4 Unknown December 2014 India ... More >> Postgraduate Institute of Medical Education and Research Recruiting Chandigarh, UT, India, 160012 Contact: anil bhansali, MBBS,MD,DM    9316977995    anilbhansaliendocrine@rediffmail.com Less <<
NCT00373269 - Completed - -
NCT02459938 Hypoglycemia Phase 1 Completed - Australia, Victoria ... More >> Nucleus Network Melbourne, Victoria, Australia, 3005 Less <<
NCT03197363 - Enrolling by invitation July 2023 Poland ... More >> Medical University of Bialystok Białystok, Poland, 15-089 Less <<
NCT02648217 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - Algeria ... More >> Novo Nordisk Investigational Site Algiers, Algeria Novo Nordisk Investigational Site Oran, Algeria, 31000 Novo Nordisk Investigational Site Setif, Algeria, 19000 Novo Nordisk Investigational Site Sidi Bel abbes, Algeria, 22000 India Novo Nordisk Investigational Site Hyderabad, Andhra Pradesh, India, 500 001 Novo Nordisk Investigational Site Hyderabad, Andhra Pradesh, India, 500058 Novo Nordisk Investigational Site Mysore, Karnataka, India, 570001 Novo Nordisk Investigational Site Kozhikode, Kerala, India, 673017 Novo Nordisk Investigational Site Mumbai, Maharashtra, India, 400010 Novo Nordisk Investigational Site Mumbai, Maharashtra, India, 400058 Novo Nordisk Investigational Site Pune, Maharashtra, India, 411001 Novo Nordisk Investigational Site Kolkatta, West Bengal, India, 700073 Novo Nordisk Investigational Site New Delhi, India, 110001 Lebanon Novo Nordisk Investigational Site Beirut, Lebanon Novo Nordisk Investigational Site Hazmieh, Lebanon Novo Nordisk Investigational Site Lebanon - Beirut, Lebanon, 9611 Malaysia Novo Nordisk Investigational Site Cheras, Malaysia, 56000 Novo Nordisk Investigational Site Kota Bharu, Kelantan, Malaysia, 16150 Novo Nordisk Investigational Site Seremban, Negeri Sembilan, Malaysia, 70400 South Africa Novo Nordisk Investigational Site Benoni, Gauteng, South Africa, 1501 Novo Nordisk Investigational Site Johannesburg, Gauteng, South Africa, 1812 Novo Nordisk Investigational Site Johannesburg, Gauteng, South Africa, 1827 Novo Nordisk Investigational Site Lenasia, Gauteng, South Africa, 1827 Novo Nordisk Investigational Site Pretoria, Gauteng, South Africa, 0181 Novo Nordisk Investigational Site Durban, KwaZulu-Natal, South Africa, 4091 Novo Nordisk Investigational Site Durban, KwaZulu-Natal, South Africa, 4092 Novo Nordisk Investigational Site Durban, KwaZulu-Natal, South Africa, 4450 Novo Nordisk Investigational Site Cape Town, Western Cape, South Africa, 7925 United Arab Emirates Novo Nordisk Investigational Site Ajman, United Arab Emirates, 21499 Novo Nordisk Investigational Site Ajman, United Arab Emirates, 4184 Novo Nordisk Investigational Site Dubai, United Arab Emirates, 7272 Novo Nordisk Investigational Site Umm Al Quwain, United Arab Emirates, 24 Less <<
NCT00604968 Breast Neoplasms Phase 4 Terminated - -
NCT00220740 Polyradiculoneuropathy, Chroni... More >>c Inflammatory Demyelinating Less << Phase 3 Completed - -
NCT02648217 - Completed - -
NCT03567824 Hypomagnesemia in Type 2 Diabe... More >>tic Patients Less << Phase 2 Not yet recruiting April 2019 -
NCT00220740 - Completed - -
NCT01681095 - Completed - -
NCT00604968 - Terminated - -
NCT01681095 Coronary Artery Disease ... More >> Myocardial Ischemia Coronary Disease Heart Diseases Valvular Heart Disease Less << Phase 2 Completed - United States, Michigan ... More >> William Beaumont Hospital Royal Oak, Michigan, United States, 48073 Less <<
NCT02755610 End-Stage Kidney Disease ... More >> Peritonitis Less << Not Applicable Not yet recruiting February 2019 Thailand ... More >> Faculty of Medicine, Chulalongkorn University Not yet recruiting Bangkok, Thailand, 10330 Contact: Krit Pongpirul, MD,MPH,PhD.    +66866055088    doctorkrit@gmail.com    Contact: Talerngsak Kanjanabuch, MD.    +66891144966    golfnephro@hotmail.com Less <<
NCT02076763 - Completed - Spain ... More >> Clinica Universidad de Navarra Pamplona, Navarra, Spain, 31008 12 Octubre Hospital Madrid, Spain, 28041 Less <<
NCT02030249 Pre-diabetes ... More >>Obesity Less << Not Applicable Active, not recruiting May 2018 Australia, New South Wales ... More >> The University of Sydney Camperdown, New South Wales, Australia, 2006 Garvan Institute of Medical Research Darlinghurst, Sydney, New South Wales, Australia, 2010 Prince of Wales Hospital Randwick, Sydney, New South Wales, Australia, 2031 Less <<
NCT01103609 Type 2 Diabetes Mellitus Phase 1 Completed - United Kingdom ... More >> Research Site London, United Kingdom Less <<
NCT03504059 Obesity Cardi... More >>ovascular Diseases Diabetes Mellitus Less << Not Applicable Active, not recruiting June 30, 2025 Spain ... More >> School of Pharmacy. University of Barcelona. Barcelona, Spain, 08028 Fundación SHE Barcelona, Spain, 08037 Less <<
NCT03407053 - Recruiting December 31, 2020 United States, Maryland ... More >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)    800-411-1222 ext TTY8664111010    prpl@cc.nih.gov Less <<
NCT02104739 - Completed - -
NCT02104739 Prediabetes O... More >>besity Less << Phase 4 Completed - United States, Texas ... More >> The University of Texas Health Science Center at Houston Houston, Texas, United States, 77030 Less <<
NCT01188070 Health Promotion Not Applicable Completed - United States, Georgia ... More >> Emory Universtiy Atlanta, Georgia, United States, 30322 Less <<
NCT00153764 Healthy Phase 1 Completed - United States, Texas ... More >> The Cooper Institute Dallas, Texas, United States, 75230 Less <<
NCT01972893 Type 2 Diabetes Mellitus Phase 1 Completed - India ... More >> Zydus Research Centre, Survey No. 396/403, Opp. Sarvotam Hotel, Nr. Nova Petrochemicals, Sarkhej-Bavla N.H. No. 8A, Village : Moraiya, Ahmedabad, Gujarat, India, 382213 Less <<
NCT00614939 Type 2 Diabetes Phase 3 Completed - -
NCT00670800 - Completed - -
NCT00670800 Polycystic Ovary Syndrome Not Applicable Completed - United States, Michigan ... More >> University of Michigan, Michigan Clinical Research Unit Ann Arbor, Michigan, United States, 48109 Less <<
NCT00104182 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT02171130 Hypoglycemia ... More >>Diabetes Mellitus Drug-Specific Antibodies Less << Phase 3 Completed - United States, Massachusetts ... More >> New England Diabetes and Endocrinology Center (NEDEC) Waltham, Massachusetts, United States, 02451-1136 United States, Minnesota University of Minnesota Minneapolis, Minnesota, United States, 55455 United States, New York Albany Medical College Division of Community Endocrinology Albany, New York, United States, 12206 Canada, Manitoba Winnipeg Clinic Winnipeg, Manitoba, Canada, R3C 0N2 Canada, Ontario Diabetes Clinic Smiths Falls, Ontario, Canada, K7A 4W8 Canada, Quebec IRCM Montreal, Quebec, Canada, H2W 1R7 Centre de recherche d'endocrinologie Godin & St-Pierre Sherbrooke, Quebec, Canada, J1G 5K2 Applied Medical Informatics Research Westmount, Quebec, Canada, H3Z 1E5 Canada Centre Hospitalier de l'Université de Québec Quebec, Canada, G1V 4G2 Less <<
NCT02639637 - Completed - -
NCT01492985 HIV-1 Infection Phase 2 Active, not recruiting April 2018 France ... More >> Service d'Immunologie clinique, Centre de vaccination anti-VIH ANRS Mondor Ile-de-France, Hôpital Henri Mondor Créteil, France, 94010 Less <<
NCT02639637 Type 2 Diabetes Mellitus Phase 4 Completed - United States, Tennessee ... More >> Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232 Less <<
NCT01032629 Diabetes Mellitus, Type 2 ... More >> Cardiovascular Diseases Risk Factors Less << Phase 3 Completed - -
NCT00246051 Sleep Disorders ... More >> Sleep Apnea, Obstructive Restless Legs Syndrome Sleep Disorders, Circadian Rhythm Sleep Initiation and Maintenance Disorders Less << Not Applicable Completed - United States, Massachusetts ... More >> Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Less <<
NCT00613951 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 2 Completed - Finland ... More >> Novo Nordisk Investigational Site Helsinki, Finland, 00260 Novo Nordisk Investigational Site Kuopio, Finland, 70210 Novo Nordisk Investigational Site Lahti, Finland, 15110 Novo Nordisk Investigational Site Pori, Finland, FI-28100 France Novo Nordisk Investigational Site Bar-Le-Duc, France, 55000 Novo Nordisk Investigational Site GRENOBLE cedex, France, 38043 Novo Nordisk Investigational Site Hayange, France, 57700 Novo Nordisk Investigational Site LA ROCHELLE cedex, France, 17019 Novo Nordisk Investigational Site Nanterre, France, 92014 Novo Nordisk Investigational Site NEVERS cedex, France, 58033 Novo Nordisk Investigational Site Pointe à Pitre, France, 97159 Germany Novo Nordisk Investigational Site Berlin, Germany, 12163 Novo Nordisk Investigational Site Pirna, Germany, 01796 Novo Nordisk Investigational Site Riesa, Germany, 01587 Novo Nordisk Investigational Site Saarbrücken, Germany, 66121 Novo Nordisk Investigational Site St. Ingbert, Germany, 66386 Novo Nordisk Investigational Site Völklingen, Germany, 66333 Novo Nordisk Investigational Site Wangen, Germany, 88239 Poland Novo Nordisk Investigational Site Bydgoszcz, Poland, 85-822 Novo Nordisk Investigational Site Gniewkowo, Poland, 88-140 Novo Nordisk Investigational Site Nysa, Poland, 48-300 Novo Nordisk Investigational Site Plock, Poland, 09-400 Novo Nordisk Investigational Site Szczecin, Poland, 70-483 Novo Nordisk Investigational Site Tychy, Poland, 43-100 Novo Nordisk Investigational Site Warszawa, Poland, 02-507 Novo Nordisk Investigational Site Wroclaw, Poland, 50-127 Spain Novo Nordisk Investigational Site Almería, Spain, 04001 Novo Nordisk Investigational Site Barcelona, Spain, 08035 Novo Nordisk Investigational Site Granada, Spain, 18012 Novo Nordisk Investigational Site Madrid, Spain, 28034 Novo Nordisk Investigational Site San Juan, Spain, 03550 Less <<
NCT00859755 Type 2 Diabetes Phase 1 Completed - United States, California ... More >> Profil Institute for Clinical Research, Inc. Chula Vista, California, United States, 91911 Less <<
NCT00613951 - Completed - -
NCT03309124 Healthy Not Applicable Recruiting July 1, 2019 Canada, Ontario ... More >> School of Nutrition, Ryerson University Recruiting Toronto, Ontario, Canada, M5B 2K3 Contact: Nick Bellissimo, PhD    416 979 5000 ext 3026    nick.bellissimo@ryerson.ca    Principal Investigator: Nick Bellissimo, PhD Less <<
NCT01032629 - Completed - -
NCT00637273 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT03307681 Healthy Not Applicable Not yet recruiting July 1, 2019 Canada, Ontario ... More >> School of Nutrition, Ryerson University Toronto, Ontario, Canada, M5B 2K3 Less <<
NCT00637273 - Completed - -
NCT00611884 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 2 Completed - -
NCT00707629 - Completed - United States, Indiana ... More >> Riley Hospital for Children Indianapolis, Indiana, United States, 46202 Less <<
NCT02438943 Cardiovascular Disease ... More >> Dyslipidemia Diabetes Melletus Obesity Less << Not Applicable Unknown December 2016 Jamaica ... More >> University of the West Indies, mona Recruiting Kingston, Jamaica Contact: Michelle Harris       michelle.harris06@uwimona.edu.jm Less <<
NCT02363530 Cataract Not Applicable Unknown December 2015 China, Zhejiang ... More >> Eye Center of the Second Affiliated Hospital of Zhejiang University Recruiting Hangzhou, Zhejiang, China, 310003 Contact: Wangshu Yu, MD    008615088733997    yuwangshu@zju.edu.cn    Contact: Xiuming Jin, PhD    008613989455778    lzyjxm@zju.edu.cn Less <<
NCT02554578 Heart Transplant Not Applicable Unknown - -
NCT00611884 - Completed - -
NCT01712282 Acute Ischemic Stroke Not Applicable Unknown August 2013 Denmark ... More >> Hillerød Hospital Recruiting Hillerød, Denmark, 3400 Contact: Anna Maria Strømmen, MD    +4548297353    anna.maria.stroemmen@regionh.dk    Principal Investigator: Anna Maria Strømmen, MD Less <<
NCT01589445 Type 2 Diabetes Mellitus Phase 4 Completed - Bangladesh ... More >> Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders (BIRDEM) Dhaka, Bangladesh, 1000 Less <<
NCT03224234 Diabetes Not Applicable Recruiting December 30, 2019 United States, Georgia ... More >> Emory Clinic, Emory University Hospital (non-CRN), Emory University Hospital Clinical Research Network, Emory University Hospital Midtown, Grady Health System (non-CRN) Recruiting Atlanta, Georgia, United States, 30322 Contact: Guillermo Umpierrez, MD    404-778-1665    geumpie@emory.edu    Contact: Saumeth Cardona Bolivar, MD    404-616-4827    scardon@emory.edu Less <<
NCT01595269 Diabetes Mellitus, Type 2 Not Applicable Completed - Canada, Alberta ... More >> Calgary Health Region's offices across southwestern Alberta Lethbridge, Alberta, Canada Less <<
NCT02229383 - Completed - -
NCT01060059 - Completed - -
NCT02229383 Diabetes Mellitus Phase 3 Completed - -
NCT01589445 - Completed - -
NCT02590822 Diabetes Phase 4 Recruiting August 2019 United Kingdom ... More >> Glenfield Hospital (University Hospitals of Leicester NHS Trust) Recruiting Leicester, United Kingdom, LE3 9QP Contact: Gerry McCann, Prof          Contact: Susan Mackness    0116 258 3285 ext 3285    susan.mackness@uhl-tr.nhs.uk Less <<
NCT01618162 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT02920801 Type 2 Diabetes Mellitus Phase 4 Completed - China, Shanghai ... More >> Fang Li Shanghai, Shanghai, China, 200032 Less <<
NCT02548299 Diabetes Not Applicable Completed - -
NCT01388920 Chronic Obstructive Pulmonary ... More >>Disease (COPD) Less << Phase 2 Terminated(The study was termi... More >>nated based on a non-safety related corporate decision.) Less << - -
NCT01060059 - Completed - -
NCT02521779 Endotoxemia Not Applicable Completed - United States, Iowa ... More >> Nutrition and Wellness Research Center Ames, Iowa, United States, 50010 Less <<
NCT02193425 Functional Connectivity Early Phase 1 Recruiting March 31, 2021 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)    800-411-1222 ext TTY8664111010    prpl@cc.nih.gov Less <<
NCT03459573 Diabetes Mellitus, Type 2 ... More >> Diabetes Mellitus, Type 1 PreDiabetes Less << Not Applicable Active, not recruiting June 1, 2019 United States, New York ... More >> One Drop New York, New York, United States, 10002 Less <<
NCT01388920 - Terminated(The study was termi... More >>nated based on a non-safety related corporate decision.) Less << - -
NCT01274364 Diabetes Not Applicable Completed - Hong Kong ... More >> Asia Diabates Foundation Shatin, Hong Kong Less <<
NCT03609697 Pre-diabetes Not Applicable Recruiting May 31, 2020 Hong Kong ... More >> The University of Hong Kong Recruiting Hong Kong, Hong Kong Contact: Mandy Ho, PhD    (+852) 39176973    mandyho1@hku.hk    Principal Investigator: Mandy Ho, PhD          Sub-Investigator: Pui Hing Chau, PhD          Sub-Investigator: Esther Yee Tak Yu          Sub-Investigator: Cindy Lo Kuen Lam          Principal Investigator: Michael Tin Cheung Ying, PhD Less <<
NCT03716791 Obesity Not Applicable Not yet recruiting December 2019 -
NCT01725126 Obesity Phase 2 Completed - United States, California ... More >> GSK Investigational Site Chula Vista, California, United States, 91910 United States, Florida GSK Investigational Site Miami, Florida, United States, 33169 United States, Kansas GSK Investigational Site Overland Park, Kansas, United States, 66211 Less <<
NCT03018665 Diabetes Mellitus, Type 2 Phase 4 Not yet recruiting - China, Jilin ... More >> First Hospital of Jilin University Not yet recruiting Changchun, Jilin, China, 130021 Contact: Guixia Wang, PhD       gwang168@jlu.edu.cn Less <<
NCT01565733 - Completed - Poland ... More >> Novo Nordisk Investigational Site Warszawa, Poland, PL-02-274 Less <<
NCT01997385 Renal Insufficiency, Chronic Phase 4 Completed - Korea, Republic of ... More >> Samsung Medical Center Seoul, Korea, Republic of Less <<
NCT02264951 Type 2 Diabetes Not Applicable Completed - -
NCT01618162 - Completed - -
NCT03613662 Lumbosacral Radicular Pain Phase 1 Recruiting July 1, 2019 United States, Idaho ... More >> Semnur Research Site 1 Recruiting Boise, Idaho, United States, 83713 Less <<
NCT01467323 Diabetes Diab... More >>etes Mellitus, Type 1 Diabetes Mellitus, Type 2 Less << Phase 3 Completed - Austria ... More >> Novo Nordisk Investigational Site Graz, Austria, 8036 Novo Nordisk Investigational Site Wien, Austria, A 1080 Germany Novo Nordisk Investigational Site Anklam, Germany, 17389 Novo Nordisk Investigational Site Berlin, Germany, 10559 Novo Nordisk Investigational Site Berlin, Germany, 14089 Novo Nordisk Investigational Site Cottbus, Germany, 03048 Novo Nordisk Investigational Site Erkner, Germany, 15537 Novo Nordisk Investigational Site Hamburg, Germany, 20251 Novo Nordisk Investigational Site Jena, Germany, 07743 Novo Nordisk Investigational Site Leipzig, Germany, 04177 Novo Nordisk Investigational Site München, Germany, 80804 Novo Nordisk Investigational Site Neunkirchen, Germany, 66538 Novo Nordisk Investigational Site Quakenbrück, Germany, 49610 Novo Nordisk Investigational Site Rostock, Germany, 18057 Novo Nordisk Investigational Site Saarlouis, Germany, 66740 Novo Nordisk Investigational Site Schwedt, Germany, 16303 Novo Nordisk Investigational Site Ulm, Germany, 89081 Novo Nordisk Investigational Site Würzburg, Germany, 97080 Ireland Novo Nordisk Investigational Site Cork, Ireland Novo Nordisk Investigational Site Dublin 9, Ireland Novo Nordisk Investigational Site Dublin, Ireland, DUBLIN 8 Switzerland Novo Nordisk Investigational Site Bern, Switzerland, 3010 United Kingdom Novo Nordisk Investigational Site Ayr, United Kingdom, KA6 6DX Novo Nordisk Investigational Site Bath, United Kingdom, BA1 3NG Novo Nordisk Investigational Site Birmingham, United Kingdom, B9 5SS Novo Nordisk Investigational Site Blackburn, United Kingdom, BB3 3LR Novo Nordisk Investigational Site Bolton, United Kingdom, BL1 4QS Novo Nordisk Investigational Site Bristol, United Kingdom, BS2 8HW Novo Nordisk Investigational Site Kettering, United Kingdom, NN16 8UZ Novo Nordisk Investigational Site Leicester, United Kingdom, LE1 5WW Novo Nordisk Investigational Site Livingstone, United Kingdom, EH54 6PP Novo Nordisk Investigational Site Newcastle, United Kingdom, NE7 7DN Novo Nordisk Investigational Site Northampton, United Kingdom, NN1 5BD Novo Nordisk Investigational Site Nottingham, United Kingdom, NG7 2UH Novo Nordisk Investigational Site Paisley, United Kingdom, PA2 9PL Novo Nordisk Investigational Site Watford, United Kingdom, WD18 0HB Novo Nordisk Investigational Site Whiston, United Kingdom, L35 5DR Less <<
NCT03746496 - Recruiting September 2019 Finland ... More >> FinnHEMS10, Emergency Medicine and Services, Helsinki University Hospital Recruiting Vantaa, Finland Contact: Jouni Nurmi, MD, PhD    358505951576    jouni.nurmi@hus.fi    Contact: Susanne Ångerman, MD    ‭+358505818015‬    susanne.angerman-haasmaa@hus.fi Less <<
NCT02640768 Diabetes Not Applicable Completed - Italy ... More >> AUSL Ospedale Maggiore Bologna, Italy Azienda Ospedaliero-Universitaria Ferrara, Italy, 44121 AUSL Carpi Modena, Italy Azienda Ospedaliero-Universitaria Parma Parma, Italy, 43126 AUSL Piacenza Piacenza, Italy, 29121 AUSL Montecchio Reggio Emilia, Italy, 42027 Less <<
NCT02940184 Physiology Not Applicable Recruiting October 2018 Denmark ... More >> Department of Surgery C, Rigshospitalet Recruiting Copenhagen, Denmark, 2100 Contact: Simon Veedfald, MD    +45 41 10 25 95       Contact: Lars Bo Svendsen, Dr.Med.Sci    +45 35 45 21 22    Lars.Bo.Svendsen@regionh.dk    Principal Investigator: Simon Veedfald, MD Less <<
NCT03142464 Postoperative Nausea ... More >> Postoperative Vomiting Renal Function Abnormal Hunger Thirst Fluid Electrolyte Disorders Less << Not Applicable Completed - -
NCT03604627 Childhood Cancer Not Applicable Recruiting June 2025 France ... More >> Gustave Roussy Recruiting Villejuif, Val De Marne, France, 94805 Contact: Brice FRESNEAU, MD    0142114211 ext +33    birce.fresneau@gustaveroussy.fr Less <<
NCT01725126 - Completed - -
NCT02500082 - - - United States, Massachusetts ... More >> Department of Neurology, Boston Children's Hospital Boston, Massachusetts, United States, 02115 Less <<
NCT01531907 - Unknown September 2014 United Kingdom ... More >> Academic Unit of Bone Metabolism Sheffield, South Yorkshire, United Kingdom, S5 7AU Less <<
NCT02500706 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 3 Completed - -
NCT01265121 Acromegaly Ob... More >>structive Sleep Apnea Insulin Resistance Less << Not Applicable Unknown June 2011 Brazil ... More >> General Hospital of the University of São Paulo São Paulo, Brazil, 05403-000 Less <<
NCT01029886 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT01029886 - Completed - -
NCT01686620 Type 1 Diabetes Mellitus Phase 2 Completed - -
NCT01342042 Type 2 Diabetes Phase 2 Unknown December 2011 China, Beijing ... More >> Peking University First Hospital Recruiting Peking, Beijing, China, 010 Contact: Cui Yi Min, MD    86-10-88325988       Principal Investigator: Cui Yi Min, MD Less <<
NCT02500706 - Completed - -
NCT00608101 Type 1 Diabetes Not Applicable Withdrawn - -
NCT00508937 Insulin Resistance ... More >> Type 2 Diabetes Metabolic Syndrome Cardiovascular Disease Dyslipidemia Less << Not Applicable Completed - United States, California ... More >> Cholesterol Research Center Berkeley, California, United States, 94705 San Francisco General Hospital San Francisco, California, United States, 94110 Less <<
NCT01441232 Type 2 Diabetes Mellitus Phase 1 Completed - United States, Texas ... More >> Lexicon Investigational Site San Antonio, Texas, United States, 78209 Less <<
NCT02464462 Type 2 Diabetes Mellitus Phase 1 Completed - -
NCT01415713 Metastatic Pancreatic Adenocar... More >>cinoma Less << Phase 1 Phase 2 Completed - Taiwan ... More >> National Taiwan University Hospital Taipei, Taiwan Less <<
NCT03485066 Neuronal Plasticity Not Applicable Recruiting November 1, 2020 Austria ... More >> Department of Psychiatry and Psychotherapy, Medical University of Vienna Recruiting Vienna, Austria Contact: Rupert Lanzenberger, Assoc Prof    +43140400 ext 35760    rupert.lanzenberger@meduniwien.ac.at    Principal Investigator: Andreas Hahn, Ass Prof Less <<
NCT02252224 - Completed - Korea, Republic of ... More >> Research Site Bucheon-si, Korea, Republic of Research Site Busan, Korea, Republic of Research Site Daejeon, Korea, Republic of Research Site Jeonju-si, Korea, Republic of Research Site Seoul, Korea, Republic of Research Site Wonju-si, Korea, Republic of Less <<
NCT01703637 Type 2 Diabetes Mellitus Not Applicable Unknown - China, Shandong ... More >> YuCheng people's hospital Recruiting Dezhou, Shandong, China, 253000 Contact: Pengfei Li       lpf9669@163.com    Hospital of SINOTRUK Recruiting Jinan, Shandong, China, 250010 Contact: Xiling Fu       fxl1936@163.com    Jinan central hospital Recruiting Jinan, Shandong, China, 250010 Contact: Shuguang Pang       shuguangpang@163.com    The jinan military region general hospital Recruiting Jinan, Shandong, China, 250010 Contact: Zhaoshun Jiang       zhaoshunjiang@sohu.com    Qianfoshan Hospital Recruiting Jinan, Shandong, China, 250012 Contact: Lin Liao, MD    8615168888260    liaolin@medmail.com.cn    People's Hospital of Qingdao Chengyang Recruiting Qingdao, Shandong, China, 266100 Contact: Xiaopang Rao       123raoxiaopang@163.com    Zibo central hospital Recruiting Zibo, Shandong, China, 255000 Contact: Xiaodong Zhao       19xiaodong@163.com    Zibo eighth people's hospital Recruiting Zibo, Shandong, China, 255000 Contact: Ling Dai    +86 13853388549 Less <<
NCT00984867 Type 2 Diabetes Phase 3 Completed - -
NCT00984867 - Completed - -
NCT02675972 - Completed - China, Guangdong ... More >> Dongguan Peoples' Hospital Dongguan, Guangdong, China, 523029 Less <<
NCT01552993 Infant, Premature ... More >> Retinopathy Less << Not Applicable Terminated(the chosen interven... More >>tion was obviously ineffective) Less << - Norway ... More >> St.Olavs University Hospital Trondheim, Trondelag, Norway, 7006 Less <<
NCT01879384 Microsurgery ... More >>Head and Neck Reconstructive Surgery Head and Neck Cancer Head and/or Neck Shotgun Trauma Bone Free Flap Less << Not Applicable Completed - France ... More >> Amiens University Hospital Amiens, Picardie, France, 80054 Less <<
NCT02353169 Myocardial Repolarization ... More >> Healthy Less << Phase 4 Completed - Canada, British Columbia ... More >> BC Children's Hospital - Department of Anesthesia Vancouver, British Columbia, Canada, V6H 3V4 Less <<
NCT03180710 Type 2 Diabetes Mellitus Phase 1 Completed - Germany ... More >> Profil Mainz GmbH & Co. KG Mainz, Germany Profil Institut für Stoffwechselforschung GmbH Neuss, Germany Less <<
NCT02527265 Type 1 Diabetes Mellitus Phase 2 Recruiting January 2021 United States, Colorado ... More >> Investigational Site 637 Recruiting Aurora, Colorado, United States, 80045 United States, Connecticut Investigational Site 635 Recruiting New Haven, Connecticut, United States, 06510 United States, Florida Investigational Site 636 Recruiting Gainesville, Florida, United States, 32610 Investigational Site 643 Recruiting Tampa, Florida, United States, 33612 United States, Georgia Investigational Site 002 Recruiting Atlanta, Georgia, United States, 30318 Investigational Site 639 Recruiting Atlanta, Georgia, United States, 30318 Investigational Site 642 Recruiting Atlanta, Georgia, United States, 30322 United States, Maryland Investigational Site 638 Recruiting Baltimore, Maryland, United States, 21229 United States, Nevada Investigational Site 646 Recruiting Las Vegas, Nevada, United States, 89113 United States, Pennsylvania Investigational Site 640 Recruiting Philadelphia, Pennsylvania, United States, 19104 United States, Tennessee Investigational Site 641 Recruiting Memphis, Tennessee, United States, 38105 Less <<
NCT02025881 High-risk Medulloblastoma Phase 1 Phase 2 Recruiting September 2022 France ... More >> Gustave Roussy Recruiting Villejuif, Val de Marne, France, 94805 Contact: Christelle Dufour, MD    0142114247 ext +33    christelle.dufour@gustaveroussy.fr    Contact: Perrine Capolino    0142113590 ext +33    perrine.capolino@gustaveroussy.fr    Principal Investigator: Christelle Dufour, MD Less <<
NCT01490112 - Completed - Korea, Republic of ... More >> Novo Nordisk Investigational Site Seoul, Korea, Republic of, 137-920 Less <<
NCT02540538 - Completed - -
NCT00614939 - Completed - -
NCT00847327 Type 1 Diabetes Not Applicable Completed - United States, District of Col... More >>umbia Children's National Medical Center Washington, District of Columbia, United States, 20010 United States, Virginia Virginia Commonwealth University Richmond, Virginia, United States, 23284 Less <<
NCT02540538 Hepatitis B Phase 1 Completed - Netherlands ... More >> Maastricht UMC Maastricht, Netherlands, 6202 AZ Less <<
NCT02476604 Cardiovascular Diseases Not Applicable Completed - United States, Maryland ... More >> Integrative Cardiac Health Project, Walter Reed National Military Medical Center Bethesda, Maryland, United States, 20889 United States, Pennsylvania Seton Hill University Greensburg, Pennsylvania, United States, 15601 Less <<
NCT02754739 Diabetes Mellitus ... More >> Prediabetic State Less << Phase 4 Completed - Korea, Republic of ... More >> Division of Endocrinology and Metabolism, Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine Seoul, Korea, Republic of, 135-710 Less <<
NCT01142570 Critically Ill Not Applicable Unknown November 2012 -
NCT00643851 - Completed - -
NCT01099306 Metabolic Syndrome Not Applicable Completed - Jordan ... More >> family medicine clinic JUH Amman, Jordan, 13046 Less <<
NCT03537989 Colorectal Surgery ... More >> Postoperative Complications Less << Phase 4 Completed - -
NCT00643851 Type 2 Diabetes Phase 3 Completed - -
NCT02196623 Elderly Persons Not Applicable Active, not recruiting December 2018 Germany ... More >> Hannover Medical School Hannover, Lower Saxony, Germany, 30625 Less <<
NCT01296113 Non-small Cell Lung Cancer ... More >> Hiv-positive Less << Phase 2 Completed - France ... More >> Centre Hospitalier du Pays d'Aix Aix-en-Provence, France Annemasse - CH Ambilly, France, 74100 Annecy - CH Annecy, France, 74374 Avignon - CH Avignon, France CH de la Côte Basque Bayonne, France CHU Besancon - Pneumologie Besancon, France, 25000 Caen - CHU Côte de Nacre Caen, France, 14000 CH Cahors Cahors, France CHU Clermont-Ferrand, France CH Colmar, France CH Compiègne - Pneumologie Compiègne, France Créteil - CHI Créteil, France, 94000 CHU Grenoble - pneumologie Grenoble, France, 38000 Le Mans - Centre Hospitalier Le Mans, France, 72000 CH Longjumeau, France Hôpital de la Croix Rousse Lyon, France Hôpital Louis Pradel Lyon, France APHM - Hôpital Nord Marseille, France, 13000 Montpellier - CHRU Montpellier, France, 34295 Nevers - CH Nevers, France, 58033 Centre Antoine Lacassagne Nice, France CHR d'Orléans La Source Orléans, France APHP - Hopital Tenon - Pneumologie Paris, France, 75020 GH Paris Saint-Joseph Paris, France Hôpital Saint Antoine Paris, France Paris - Pitié-salpêtrière Paris, France Pau - CH Pau, France, 64046 Centre François Magendie - hôpital du Haut-Lévèque Pessac, France HCL - Lyon Sud (Pneumologie) Pierre Bénite, France, 69495 Reims - CHU Reims, France, 51092 Rennes - CHU Rennes, France, 35033 Saint Brieuc - CHG Saint Brieuc, France, 22000 NHC - Pneumologie Strasbourg, France, 63000 Suresnes - Hopital Foch Suresnes, France, 92151 Thonon les bains - CH Thonon les bains, France, 74200 Toulon - CHI Toulon, France, 83000 CHU Toulouse - Pneumologie Toulouse, France Tourcoing - CH Tourcoing, France, 59208 Tours - CHU Tours, France, 37000 CH Valence Valence, France Less <<
NCT03668236 Septic Shock Phase 4 Recruiting November 2021 Czechia ... More >> Medical Intensive Care Unit, Fakultni Nemocnice Not yet recruiting Plzen, Czechia Contact: Marek Nalos, MD          Denmark Dept. of Anaesthesia and Intensive Care, Aalborg University Hospital, Denmark. Not yet recruiting Aalborg, Denmark Contact: Bodil S Rasmussen, MD, PhD          Dept of Intensive Care,Copenhagen University Hospital Rigshospitalet Recruiting Copenhagen, Denmark, 2100 Contact: Tine Sylvest Meyhoff, MD    +45 3545 0606    classic@cric.nu    Dept. of Anaesthesia and Intensive Care, Bispebjerg Hospital Not yet recruiting Copenhagen, Denmark Contact: Søren Hoffmann, MD          Dept. of Intensive Care, Gentofte Hospital Not yet recruiting Gentofte, Denmark Contact: Louise Gyldensted, MD          Dept. of Intensive Care, Copenhagen University Hospital Herlev Not yet recruiting Herlev, Denmark, 2730 Contact: Henrik Christensen, MD       Henrik.Christensen@regionh.dk    Dept. of Anaesthesia and Intensive Care, Herning Hospital Not yet recruiting Herning, Denmark Contact: Rikke Leander Label, MD          Dept. of Intensive Care, Hillerød Hospital Not yet recruiting Hillerød, Denmark, 3400 Contact: Morten Bestle, MD       morten.bestle@regionh.dk    Dept. of Anaesthesia and Intensive Care, Zealand University Hospital Køge Not yet recruiting Køge, Denmark Contact: Lars Nebrich, MD          Dept. of Anaesthesia and Intensive Care, Randers Hospital Not yet recruiting Randers, Denmark Contact: Marianne Vang, MD          Dept. of Anaesthesia and Intensive Care, Zealand University Hospital Roskilde Not yet recruiting Roskilde, Denmark Contact: Lene Russell, MD          Dept. of Anaesthesia and Intensive Care, Slagelse Hospital Not yet recruiting Slagelse, Denmark Contact: Klaus Vennick Marcussen,, MD          Dept. of Anaesthesia and Intensive Care, Viborg Hospital Not yet recruiting Viborg, Denmark Contact: Christoffer Sølling, MD          Finland Dept. of Intensive Care Medicine, Helsinki University Hospital, Helsinki, Finland. Not yet recruiting Helsinki, Finland Contact: Ville Pettilä, MD, PhD          France Department of Intensive Care Medicine, Hôpital St. Louis Not yet recruiting Paris, France Contact: Michael Darmon, MD          Italy Dept. of Intensive Care, Humanitas Research Hospital Not yet recruiting Milan, Italy Contact: Maurizio Cecconi, MD          Netherlands Dept. of Intensive Care, University Medical Center Groningen Not yet recruiting Groningen, Netherlands, 9713 Contact: Iwan van der Horst, MD, PhD       i.c.c.van.der.horst@umcg.nl    Norway Dept. of Intensive Care, Oslo University Hospital Not yet recruiting Oslo, Norway, 0450 Contact: Jon Henrik Laake, MD       jon.henrik.laake@rikshospitalet.no    Spain Dept. of Intensive Care, Hospital Vall d'Hebron Not yet recruiting Barcelona, Spain Contact: Ricardo Ferrer Roca, MD          Sweden Södersjukhuset Not yet recruiting Stockholm, Sweden Contact: Maria Cronhjort, MD          Principal Investigator: Maria Cronhjort, MD          Switzerland Dept. of Intensive Care, University Hospital Bern Not yet recruiting Bern, Switzerland Contact: Stephan M Jakob, MD Less <<
NCT03767699 - Completed - Mexico ... More >> Materno-Perinatal Hospital "Mónica Pretelini" Toluca, Mexico, 50130 Less <<
NCT02140983 Insulin Resistance ... More >> Dementia Less << Phase 1 Completed - United States, California ... More >> Stanford Department of Psychiatry Stanford, California, United States, 94305 Less <<
NCT02432469 Coronary Artery Bypass Graftin... More >>g Medication Adherence Mobile Applications Less << Not Applicable Unknown December 2016 China, Beijing ... More >> China National Center for Cardiovascular Diseases Recruiting Beijing, Beijing, China, 100037 Contact: Zhe Zheng, M.D., Ph.D.    8610-8839-6051    zhengzhefuwai@tom.com    Principal Investigator: Zhe Zheng, M.D., Ph.D. Less <<
NCT01835730 Type 2 Diabetes Mellitus (T2DM... More >>) Less << Phase 1 Completed - United States, Alabama ... More >> Pinnacle Research Group, LLC Anniston, Alabama, United States, 36207 United States, Florida Palm Springs Research Institute Hialeah, Florida, United States, 33012 United States, Washington Rainier Clinical Research Renton, Washington, United States, 98057 Less <<
NCT01769378 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT02521753 Polycystic Ovary Syndrome ... More >> Obesity Less << Not Applicable Recruiting December 2018 Mexico ... More >> Hospital de Gineco Obstetricia Centro Médico "La Raza" Recruiting Mexico City, D.f., Mexico, 2990 Contact: Victor S Vital-Reyes, MD, PhD    52 55 57245900 ext 23719    vitalito23@hotmail.com Less <<
NCT00714441 Diabetes Type 2 Not Applicable Completed - United States, California ... More >> UC San Francisco, Family and Community Medicine Dept. San Francisco, California, United States, 94143 Less <<
NCT01676116 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT01676116 - Completed - -
NCT01779622 Healthy Volunteers Recruited F... More >>rom the General Population Less << Not Applicable Completed - Sweden ... More >> Department of Clinical Sciences, Lund University Lund, Sweden, 22184 Less <<
NCT01240759 Type 2 Diabetes Mellitus Phase 2 Completed - United States, Texas ... More >> Juno Research, LLC Houston, Texas, United States, 77074 Less <<
NCT01769378 - Completed - -
NCT01885416 Inflammation ... More >>Obesity Nutritional Intervention Less << Not Applicable Completed - Switzerland ... More >> University Hospital, Inselspital Berne Bern, Switzerland, 3010 Less <<
NCT02516501 Neoplasms Phase 1 Recruiting December 2020 Germany ... More >> Department of Radiotherapy and Radiation Oncology Recruiting Schweinfurt, Bavaria, Germany, 97421 Contact: Reinhart A Sweeney, MD    +49 9721 7206420    rsweeney@leopoldina.de    Principal Investigator: Rainer J Klement, PhD Less <<
NCT00936130 - Completed - United States, Louisiana ... More >> Pennington Biomedial Research Center Baton Rouge, Louisiana, United States, 70808 Less <<
NCT00519623 - Completed - -
NCT00519623 Type 1 Diabetes Phase 1 Phase 2 Completed - United States, Georgia ... More >> Altea Therapeutics Clinical Research Center 387 Technology Circle, NW, Suite 100, Atlanta, Georgia, United States, 30313 Less <<
NCT01775813 Obesity Insul... More >>in Resistance Gonadal Dysfunction Type 2 Diabetes Less << Phase 4 Completed - United States, Colorado ... More >> Children's Hospital Colorado Aurora, Colorado, United States, 80045 Less <<
NCT01463748 Metabolic Syndrome Phase 2 Phase 3 Completed - Taiwan ... More >> Chung Shan Medical University Taichung, Taiwan, 40201 Less <<
NCT01329016 Gestational Diabetes Mellitus Phase 1 Phase 2 Unknown June 2015 United States, Indiana ... More >> Indiana University School of Medicine Indianapolis, Indiana, United States, 46202 United States, Pennsylvania University of Pittsburgh Pittsburgh, Pennsylvania, United States, 15213 United States, Texas University of Texas Medical Branch Galveston, Texas, United States, 77555 United States, Washington University of Washington Seattle, Washington, United States, 98195 Less <<
NCT02645942 Obstructive Sleep Apnea Not Applicable Unknown May 2017 -
NCT01678742 Diabetes Mellitus ... More >> Obesity Less << Not Applicable Completed - Korea, Republic of ... More >> Jeju National University Hospital Jeju, Korea, Republic of, 690-767 Less <<
NCT00121641 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT01617525 Hypercholesterolemia Not Applicable Completed - United States, Maryland ... More >> USDA Beltsville Human Nutrition Research Center Beltsville, Maryland, United States, 20705 Less <<
NCT02887625 Type 2 Diabetes Not Applicable Unknown May 2017 Qatar ... More >> Hamad General Hospital Recruiting Doha, Qatar Contact: Osama Mujahed, MD    66703172    pvedromigahid@gmail.com    Contact: Ayman Mujahed, MD    44391208    ymndodo20@gmail.com Less <<
NCT01802944 Chronic Multisymptom Illness i... More >>n Gulf War Veterans Less << Phase 2 Recruiting December 2017 United States, Massachusetts ... More >> VA Boston Healthcare System Recruiting Boston, Massachusetts, United States, 02130 Contact: Maxine Krengel, PhD    617-232-9500    Maxine.Krengel@va.gov    Principal Investigator: Maxine Krengel, PhD          United States, New York James J. Peters VA Medical Center Recruiting The Bronx, New York, United States, 10468 Contact: Julia A Golier, MD    718-584-9000 ext 5196    Julia.Golier@va.gov    Principal Investigator: Julia A Golier, MD Less <<
NCT03447340 Dietary Modification ... More >> Diabetes Hypertension Health Behavior Less << Not Applicable Recruiting December 2020 Nepal ... More >> Dhulikhel Hospital Recruiting Dhulikhel, Nepal Contact: Dipesh Tamrakar, MD    9779801002404    bob.dipesh@gmail.com    Contact: Biraj M Karmacharya, PhD, MD    9779808660568    birajmk@gmail.com Less <<
NCT03047109 Spinal Hypotension Phase 2 Phase 3 Recruiting June 30, 2018 Egypt ... More >> Assiut university hospital Recruiting Assiut, Egypt, 71515 Contact: MOHAMED F MOSTAFA, ND    01001123062 ext 002    mo7_fathy@yahoo.com    Contact: HAMDY A YOUSSEF, MD    01090008490 ext 002    hamdyayoussef@yahoo.com Less <<
NCT02728544 Prader Willi Syndrome Not Applicable Unknown March 2017 -
NCT01224704 - Recruiting - United States, Arizona ... More >> NIDDK, Phoenix Recruiting Phoenix, Arizona, United States, 85014 Contact: Jonathan Krakoff, M.D.    602-200-5217    jkrakoff@mail.nih.gov Less <<
NCT00682149 Type 2 Diabetes Not Applicable Unknown October 2008 Turkey ... More >> Sisli Etfal Education and Research Hospital Recruiting Istanbul, Turkey Contact: Tayyibe Saler, Dr    (+90 505) 7734300    taybe1970@hotmail.com    Contact: Aysen Fenercioglu, Assist Prof. Dr.    (+90 537) 9645751    aysenfenerci@hotmail.com    Sub-Investigator: Tayyibe Saler, Dr          Principal Investigator: Aysen Fenercioglu, Assist Prof. Dr. Less <<
NCT00121641 - Completed - -
NCT02188823 Prediabetes Not Applicable Terminated(low recruitment) - United States, California ... More >> University of California, San Francisco San Francisco, California, United States, 94115 Less <<
NCT02206152 Type 1 Diabetes ... More >> Hypoglycemia Unawareness Less << Phase 1 Phase 2 Completed - United States, Minnesota ... More >> University of Minnesota Department of Medicine, Division of Diabetes, Endocrinology and Metabolism Minneapolis, Minnesota, United States, 55455 Less <<
NCT02277236 - Active, not recruiting November 2019 United States, District of Col... More >>umbia Washington DC VA Medical Center Washington, District of Columbia, United States, 20422 Less <<
NCT00721617 - Completed - -
NCT02373150 Type 2 Diabetes Mellitus Phase 1 Completed - United Kingdom ... More >> Hammersmith Medicines Research (HMR) London, United Kingdom Less <<
NCT03451968 Metabolism and Nutrition Disor... More >>der Less << Not Applicable Not yet recruiting January 2019 -
NCT02936362 Dietary Modification ... More >> Bread Gastrointestinal Microbiome Hematologic Tests Body Weight Changes Less << Not Applicable Completed - Israel ... More >> Weizmann Institute of Science Rehovot, Israel Department of Gastroentherology Tel Aviv, Israel, 64239 Less <<
NCT00721617 Diabetes Hype... More >>rtension Obesity Less << Not Applicable Completed - United States, Georgia ... More >> Grady Memorial Hospital Atlanta, Georgia, United States, 30303 Less <<
NCT00501163 - Completed - United States, Missouri ... More >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Less <<
NCT00360373 - Completed - United States, Ohio ... More >> Cincinnati Children's Hospital Medical Center Cincinnati,, Ohio, United States, 45229 Less <<
NCT03441919 - Recruiting January 1, 2020 Netherlands ... More >> Radboud University Nijmegen Medical Centre, Department of Internal Medicine Recruiting Nijmegen, Netherlands, PO BOX 9101, 6500 HB Contact: Cees Tack, PhD, MD          Sub-Investigator: Anna Janssen, MSc Less <<
NCT01699074 Type 2 Diabetes ... More >> Metabolic Syndrome Less << Phase 1 Completed - Canada, Ontario ... More >> : Clinical Nutrition and Risk Factor Modification Centre, St. Michael's Hospital Toronto, Ontario, Canada, M5B 1W8 Less <<
NCT00407472 Healthy Phase 1 Completed - -
NCT01241877 Athletic Performance Not Applicable Unknown - Netherlands ... More >> Maastricht University Recruiting Maastricht, LI, Netherlands, 6229 Contact: Peter Res, MSc    +3143381383    peter.res@maastrichtuniversity.nl Less <<
NCT01185210 Fructose Intolerance Not Applicable Recruiting December 31, 2018 United States, Iowa ... More >> University of Iowa Hospitals and Clinics Recruiting Iowa City, Iowa, United States, 52242 Contact: Satish SC Rao, MD    319-353-6602    satish-rao@uiowa.edu Less <<
NCT02428920 Health Behavior Phase 3 Completed - Grenada ... More >> St. George's University St. George's, Grenada Less <<
NCT01513590 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT01289860 Healthy Adults. Not Applicable Completed - United Kingdom ... More >> University of Reading Reading, Berkshire, United Kingdom, RG6 6AP Less <<
NCT02802501 Malaria, Vivax Phase 3 Recruiting November 29, 2019 Indonesia ... More >> GSK Investigational Site Recruiting Jakarta, Indonesia, 10430 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com Less <<
NCT01513590 - Completed - -
NCT01453296 Asthma Phase 2 Completed - United States, California ... More >> GSK Investigational Site Cypress, California, United States, 90630 GSK Investigational Site Huntington Beach, California, United States, 92647 United States, Colorado GSK Investigational Site Denver, Colorado, United States, 80206 United States, Illinois GSK Investigational Site Normal, Illinois, United States, 61761 United States, Oregon GSK Investigational Site Medford, Oregon, United States, 97504 Less <<
NCT02090725 Muscle Weakness Not Applicable Enrolling by invitation December 2020 United States, New Hampshire ... More >> Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States, 03221 Less <<
NCT01542060 - Completed - Jordan ... More >> Amman, Jordan, 11844 Less <<
NCT01453296 - Completed - -
NCT03532672 Healthy Obese Not Applicable Recruiting May 26, 2019 Brazil ... More >> Hospital das Clínicas Recruiting Belo Horizonte, Minas Gerais, Brazil, 30130-100 Contact: Adaliene VM Ferreira, PhD    +553134093680    adaliene@gmail.com Less <<
NCT02798757 Diabetes Phase 4 Recruiting May 2018 Greece ... More >> University of Ioannina Recruiting Ioánnina, Greece, 45500 Contact: Vasilis Tsimihodimos, Assistant Professor    +306971705609    vtsimi@uoi.gr Less <<
NCT01794182 Ischemic Stroke ... More >> Malignant Edema Less << Phase 2 Unknown April 2016 United States, Arizona ... More >> University of Arizona Medical Center Tucson, Arizona, United States, 85719 United States, California Stanford University Medical Center Stanford, California, United States, 94305 United States, Connecticut Yale University School of Medicine New Haven, Connecticut, United States, 06510 United States, Florida University of Florida, Jacksonville Jacksonville, Florida, United States, 32209 United States, Illinois Northwestern Memorial Hospital Chicago, Illinois, United States, 60611 United States, Kentucky University of Louisville Hospital Louisville, Kentucky, United States, 40202 United States, Maine Maine Medical Center Scarborough, Maine, United States, 04074 United States, Maryland University of Maryland School of Medicine Baltimore, Maryland, United States, 21201 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 UMASS Memorial Medical Center Worcester, Massachusetts, United States, 01655 United States, Ohio Cleveland Clinic Cleveland, Ohio, United States, 44195 Ohio State University Wexner Medical Center Columbus, Ohio, United States, 43210 United States, Oregon Oregon Health & Science University Hospital Portland, Oregon, United States, 97239 United States, Pennsylvania Abington Memorial Hospital Abington, Pennsylvania, United States, 19001 UPMC Presbyterian Hospital Pittsburgh, Pennsylvania, United States, 15213 United States, South Carolina Medical University of South Carolina Charleston, South Carolina, United States, 29425 United States, Utah University of Utah Healthcare Salt Lake City, Utah, United States, 84132 Less <<
NCT01412658 Drug Safety Phase 1 Completed - United States, Texas ... More >> Baylor University Center for Exercise, Nutrition, and Preventive Health Research Waco, Texas, United States, 76706 Less <<
NCT01084967 - Recruiting April 2021 China, Shanghai ... More >> Shanghai Jiao Tong University School of Medicine Recruiting Shanghai, Shanghai, China, 200025 Contact: Guang Ning, MD.PhD    86-21-64370045 ext 665340    guangning@medmail.com.cn    Contact: Jie Hong, PhD    86-21-64370045 ext 665345    hongjie13d@hotmail.com    Principal Investigator: Guang Ning, MD.PhD Less <<
NCT02202486 - Unknown December 2015 Denmark ... More >> Danish Headache Center, Glostrup Hospital Recruiting Glostrup, Copenhagen, Denmark, 2600 Contact: Faisal M Amin, MD    +4538633066    faisal.mohammad.amin.01@regionh.dk Less <<
NCT02227849 Type 2 Diabetes Mellitus Phase 4 Completed - Japan ... More >> Reserch site Chubu, Japan Reserch site Hokkaido, Japan Reserch site Kanto, Japan Reserch site Kinki, Japan Less <<
NCT01814995 Gestational Diabetes Mellitus ... More >>With Baby Delivered Less << Not Applicable Completed - Canada, Quebec ... More >> McGill University Health Centre Montreal, Quebec, Canada, H3A 1A1 Sir Mortimer Davis Jewish General Hospital Montreal, Quebec, Canada, H3T 1E2 Less <<
NCT02670915 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 3 Completed - -
NCT03509571 Spinal Cord Injuries Not Applicable Active, not recruiting March 2021 United States, Alabama ... More >> UAB Hospital Birmingham, Alabama, United States, 35294 Less <<
NCT01182480 - Completed - -
NCT00878605 - Terminated(Unable to reach acc... More >>rual target.) Less << - -
NCT01182480 Diabetes Mellitus Not Applicable Completed - United States, Colorado ... More >> Denver Health and Hospital Authority Denver, Colorado, United States, 80204 Less <<
NCT00762138 Wounds Leg Ul... More >>cers Pressure Ulcers Diabetic Foot Ulcers Less << Not Applicable Terminated(Discontinued due to... More >> favorable results) Less << - United States, Georgia ... More >> Aiyan Diabetes Center Augusta, Georgia, United States, 30809 United States, Texas Providence Wound Institute El Paso, Texas, United States, 79902 Less <<
NCT03431558 Neonatal Sepsis ... More >> Necrotizing Enterocolitis Less << Phase 3 Recruiting April 2019 Pakistan ... More >> Aga Khan University Hospital Recruiting Karachi, Sindh, Pakistan, 74800 Contact: Shabina Associate Professor    +92 21 34864357 ext 4357    Shabina.ariff@aku.edu    Contact: Dr. Saajid B Soofi Soofi, FCPS MBBS    +92 21 99244230 ext 8186    Sajid.soofi@aku.edu    Sub-Investigator: Neeloy A Alam          Sub-Investigator: William T Mordi Less <<
NCT00878605 Diabetes Phase 2 Terminated(Unable to reach acc... More >>rual target.) Less << - United States, California ... More >> VA Greater Los Angeles Healthcare System, West Los Angeles, CA West Los Angeles, California, United States, 90073 Less <<
NCT02198417 Polycystic Ovary Syndrome Not Applicable Active, not recruiting December 2020 -
NCT01003184 - Completed - -
NCT01206413 Obesity Prevention Phase 4 Completed - -
NCT01740817 - Completed - -
NCT00858247 Obesity Phase 2 Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT00858247 - Completed - -
NCT01003184 Type 2 Diabetes Mellitus Phase 3 Completed - Ireland ... More >> Research Site Dublin, Ireland United Kingdom Research Site Addlestone, England, United Kingdom Research Site Bath, England, United Kingdom Research Site Birmingham, England, United Kingdom Research Site Blackburn, England, United Kingdom Research Site Bournemouth, England, United Kingdom Research Site Chippenham, England, United Kingdom Research Site Derby, England, United Kingdom Research Site Exeter, England, United Kingdom Research Site High Wycombe, England, United Kingdom Research Site Hull, England, United Kingdom Research Site Leicester, England, United Kingdom Research Site Liverpool, England, United Kingdom Research Site London, England, United Kingdom Research Site Manchester, England, United Kingdom Research Site Merseyside, England, United Kingdom Research Site Middlesborough, England, United Kingdom Research Site Newcastle, England, United Kingdom Research Site Northampton, England, United Kingdom Research Site Oldham, England, United Kingdom Research Site Plymouth, England, United Kingdom Research Site Portsmouth, England, United Kingdom Research Site Sheffield, England, United Kingdom Research Site Stevenage, England, United Kingdom Research Site Suffolk, England, United Kingdom Research Site Wakefield, England, United Kingdom Research Site Wiltshire, England, United Kingdom Research Site Aberdeen, Scotland, United Kingdom Research Site Dundee, Scotland, United Kingdom Research Site Carmathen, Wales, United Kingdom Research Site Swansea, Wales, United Kingdom Research Site Wrexham, Wales, United Kingdom Research Site Leytonstone, United Kingdom Research Site Livingston, United Kingdom Less <<
NCT01740817 Diabetes Obes... More >>ity Less << Not Applicable Completed - United States, Texas ... More >> Audie L. Murphy VA Hospital San Antonio, Texas, United States, 78229 Less <<
NCT01029795 Diabetes Mellitus, Type 2 Phase 2 Terminated(Terminated due to n... More >>onclinical safety findings) Less << - Australia, South Australia ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Elizabeth Vale, South Australia, Australia, 5112 Australia, Victoria For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. East Ringwood, Victoria, Australia, 3135 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Heidelberg, Victoria, Australia, 3081 Austria For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Vienna, Austria, 1090 Czech Republic For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Holesov, Czech Republic, 769 01 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Prague, Czech Republic, 140 59 Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mainz, Germany, 55116 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Neuss, Germany, D-41460 Israel For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Jerusalem, Israel, 91120 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nahariya, Israel, 22100 Russian Federation For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Rostov-On-Don, Russian Federation, 344022 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Saint Petersburg, Russian Federation, 191126 Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Barcelona, Spain, 08022 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Cordoba, Spain, 14004 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Dos Hermanas, Spain, 41014 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Teruel, Spain, 44002 Less <<
NCT01024244 - Terminated(Terminated due to n... More >>onclinical safety findings) Less << - -
NCT00277771 Obesity Overw... More >>eight Less << Not Applicable Completed - United States, Pennsylvania ... More >> University of Pittsburgh School of Nursing Pittsburgh, Pennsylvania, United States, 15261 Less <<
NCT01720446 - Completed - -
NCT01029795 - Terminated(Terminated due to n... More >>onclinical safety findings) Less << - -
NCT02226822 - Active, not recruiting December 31, 2018 Japan ... More >> Research Site Aichi, Japan Research Site Aomori, Japan Research Site Chiba, Japan Research Site Ehime, Japan Research Site Fukui, Japan Research Site Fukuoka, Japan Research Site Fukushima, Japan Research Site Gifu, Japan Research Site Gunma, Japan Research Site Hiroshima, Japan Research Site Hokkaido, Japan Research Site Hyogo, Japan Research Site Hyougo, Japan Research Site Ibaraki, Japan Research Site Ishikawa, Japan Research Site Kagawa, Japan Research Site Kagoshima, Japan Research Site Kanagawa, Japan Research Site Kochi, Japan Research Site Kumamoto, Japan Research Site Kyoto, Japan Research Site Mie, Japan Research Site Miyagi, Japan Research Site Miyazaki, Japan Research Site Nagano, Japan Research Site Nara, Japan Research Site Nigata, Japan Research Site Oita, Japan Research Site Okayama, Japan Research Site Okinawa, Japan Research Site Osaka, Japan Research Site Saga, Japan Research Site Saitama, Japan Research Site Shiga, Japan Research Site Shizuoka, Japan Research Site Tochigi, Japan Research Site Tokushima, Japan Research Site Tokyo, Japan Research Site Wakayama, Japan Research Site Yamagata, Japan Research Site Yamaguchi, Japan Research Site Yamanashi, Japan Less <<
NCT00715663 - Completed - Indonesia ... More >> Novo Nordisk Investigational Site Jakarta, Indonesia, 12520 Less <<
NCT01720446 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT01168765 Diabetes, Obesity Not Applicable Completed - United States, Texas ... More >> University of Texas School of Public Health-Brownsville Regional Campus Brownsville, Texas, United States, 78520 Less <<
NCT01024244 Diabetes Mellitus, Type 2 Phase 2 Terminated(Terminated due to n... More >>onclinical safety findings) Less << - United States, Kansas ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Topeka, Kansas, United States, 66606 United States, New Jersey For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Toms River, New Jersey, United States, 08753 United States, New York For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Syracuse, New York, United States, 13210 Australia, New South Wales For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. St. Leonards, New South Wales, Australia, 2065 Australia, South Australia For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Daw Park, South Australia, Australia, 5041 Australia, Victoria For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Box Hill, Victoria, Australia, 3128 Puerto Rico For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Manati, Puerto Rico, 00674 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. San Juan, Puerto Rico, 00907 Russian Federation For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Arkhangelsk, Russian Federation, 163045 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Moscow, Russian Federation, 119435 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Rostov-On-Don, Russian Federation, 344022 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Saint Petersburg, Russian Federation, 194354 Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Alcira, Spain, 46600 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Alicante, Spain, 03114 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Dos Hermanas, Spain, 41014 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Santa Cruz De Tenerife, Spain, 38320 Less <<
NCT00729859 - Completed - -
NCT00439972 Contraception Phase 2 Unknown December 2011 United States, Washington ... More >> University of Washington, Northwest Lipid Research Clinic Seattle, Washington, United States, 98104 Less <<
NCT02127541 Endogenous Hyperinsulinaemic H... More >>ypoglycaemia Less << Not Applicable Completed - Switzerland ... More >> University Hospital Basel Basel, Switzerland, 4031 Less <<
NCT02846818 Postoperative; Dysfunction Fol... More >>lowing Cardiac Surgery Less << Not Applicable Completed - Denmark ... More >> Odense University Hospital Odense, Fyn, Denmark, 5000 Less <<
NCT01866462 Type 2 Diabetes Early Phase 1 Completed - United States, Louisiana ... More >> Pennington Biomedical Research Center Baton Rouge, Louisiana, United States, 70808 Less <<
NCT01004354 Obesity Vitam... More >>in D Deficiency Psychosis Schizophrenia Schizoaffective Disorder Less << Not Applicable Completed - United States, Massachusetts ... More >> University of Massachusetts Medical School Worcester, Massachusetts, United States, 01655 Less <<
NCT00729859 Healthy Phase 2 Completed - -
NCT01420874 Colorectal Cancer ... More >> Cancer of Pancreas Pancreatic Neoplasm Malignant Neoplasm of Large Intestine Malignant Tumor of Colon Colon Carcinoma Cancer of Colon Pancreatic Cancer Less << Phase 1 Active, not recruiting June 2019 United States, Michigan ... More >> Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48601 Less <<
NCT01175811 Diabetes Mellitus, Type 2 Phase 4 Completed - China ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Beijing, China, 100730 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Guang Zhou, China, 510515 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kunming, China, 650032 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nanjing, China, 210109 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Shanghai, China, 200080 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Xi'An, China, 710032 Korea, Republic of For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Daegu, Korea, Republic of, 705-718 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Goyang-Si, Korea, Republic of, 410-719 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Seoul, Korea, Republic of, 130-702 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Yeongdeungpo-Gu, Korea, Republic of, 150-950 Taiwan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Changhua, Taiwan, 500 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kuei Shan Hsiang, Taiwan, 33305 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sindian City, Taiwan, 23148 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Yong Kung City, Taiwan, 71004 Less <<
NCT01004354 - Completed - -
NCT02536820 Diabetes Mellitus, Type 2 Phase 3 Unknown - -
NCT02949622 Metabolic Syndrome X Not Applicable Completed - Spain ... More >> Jaqueline Garcia da Silva Granada, Spain, 18009 Less <<
NCT01175811 - Completed - -
NCT01149421 - Completed - -
NCT01489319 Polycystic Ovary Syndrome Phase 1 Terminated(The PI left Indiana... More >> University. The findings served as preliminary data for a recently awarded NIH R01 grant.) Less << - United States, Indiana ... More >> Indiana University Hospital Indianapolis, Indiana, United States, 46202 Less <<
NCT00283751 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT03249597 - Recruiting October 31, 2018 Sweden ... More >> AISAB (Ambulansen i Storstockholm AB) Not yet recruiting Stockholm, Sweden Contact: Åke Östman, CEO    +46 (0)70-484 30 71    ake.ostman@sll.se    Falck ambulans AB Not yet recruiting Stockholm, Sweden Contact: Per Ryding, Director    +46 (0)73-373 29 49    Per.Ryding@se.Falck.com    Samariten Ambulans AB Recruiting Stockholm, Sweden Contact: Ulf Kanfjäll, Manager    +46 (0)70-569 78 00    ulf.kanfjall@samariten.se Less <<
NCT01536613 - Completed - Korea, Republic of ... More >> Seoul, Korea, Republic of, 137-920 Less <<
NCT01149421 Diabetes Mellitus, Type 2 Phase 2 Completed - -
NCT01665742 Overweight Ob... More >>esity Less << Not Applicable Completed - Ireland ... More >> Trinity Centre for Health Sciences, St, James's Hospital Dublin 8, Ireland Adelaide and Meath Hospital, Incorporating the National Children's Hospital Dublin, Dublin, Ireland University College Dublin Dublin, Ireland Less <<
NCT01288885 Healthy Phase 1 Completed - United Kingdom ... More >> Manchester, United Kingdom, M15 6SH Less <<
NCT03495089 Neuropathy, Diabetic ... More >> Diabetes Mellitus, Type 2 Less << Not Applicable Recruiting September 2018 Spain ... More >> Hospital Universitari Mútua Terrassa Recruiting Terrassa, Barcelona, Spain, 08221 Contact: Moya Charo López, MD       rlopez21340@coib.net    Principal Investigator: Moya Charo López, MD          Mútua Terrassa Primary Care Recruiting Terrassa, Barcelona, Spain, 08221 Contact: Teresa Mur, MD       tmm637@gmail.com    Principal Investigator: Teresa Mur, MD          Hospital Universitari Sant Joan de Reus Recruiting Reus, Tarragona, Spain, 43204 Contact: Nicolau Ortiz, MD       nortiz@grupsagessa.com    Principal Investigator: Nicolau Ortiz, MD Less <<
NCT01325454 - Unknown December 2011 Taiwan ... More >> Division of Pulmonary Medicine, Taipei Medical University Hospital Recruiting Taipei, Taiwan, 110 Contact: Chi-Li Chung, MD, PhD    886-2-27372181 ext 3903    d102092009@tmu.edu.tw    Principal Investigator: Chi-Li Chung, MD, PhD          Sub-Investigator: Shih-Hsin Hsiao, MD Less <<
NCT02229708 Pregnancy Bod... More >>y Weight Changes Behavioral Obesity Less << Not Applicable Active, not recruiting July 17, 2019 United States, Pennsylvania ... More >> Temple University Philadelphia, Pennsylvania, United States, 19140 Less <<
NCT00679042 Type 1 Diabetes Mellitus Phase 3 Active, not recruiting July 2027 United States, Illinois ... More >> University of Illinois at Chicago Medical Center Chicago, Illinois, United States, 60612 Less <<
NCT01453023 Asthma Phase 2 Completed - United States, California ... More >> GSK Investigational Site Huntington Beach, California, United States, 92647 Less <<
NCT00238498 Diabetes Mellitus, Type 2 Phase 2 Completed - -
NCT01453023 - Completed - -
NCT01541956 Type 2 Diabetes Phase 4 Completed - China ... More >> Novartis Investigative Site Beijing, China, 100028 Less <<
NCT02244879 Type 2 Diabetes Mellitus ... More >> Inflammation Insulin Resistance Other Disorders of Bone Density and Structure Less << Phase 3 Completed - Italy ... More >> University of Turin Turin, IT, Italy, 10126 Less <<
NCT02931773 - Unknown December 2017 Mexico ... More >> Laboratio de Síncope Recruiting Mexico City, DF, Mexico, 14080 Contact: Manuel A Sierra-Beltrán, MD    00525556557059 ext 1477    manuel.sierra-beltran96@alumni.imperial.ac.uk    Contact: Antonio González-Hermosillo, MD    00525556557059 ext 1477    sincope39@yahoo.com.mx Less <<
NCT00371293 Sleep Apnea Syndromes ... More >> Inflammation Less << Not Applicable Completed - United States, Pennsylvania ... More >> Philadelphia Veterans Affairs Medical Center Philadelphia, Pennsylvania, United States, 19014 University of Pennsylvania Philadelphia, Pennsylvania, United States, 19014 Less <<
NCT00371293 - Completed - -
NCT01697631 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 4 Completed - Poland ... More >> Novo Nordisk Investigational Site Bialystok, Poland, 15-276 Novo Nordisk Investigational Site Bytom, Poland, 41-902 Novo Nordisk Investigational Site Kamieniec Zabkowicki, Poland, 57-230 Novo Nordisk Investigational Site Katowice, Poland, 40-053 Novo Nordisk Investigational Site Krakow, Poland, 31-261 Novo Nordisk Investigational Site Nysa, Poland, 48-300 Novo Nordisk Investigational Site Otwock, Poland, 05-400 Novo Nordisk Investigational Site Radom, Poland, 26-600 Novo Nordisk Investigational Site Ruda Slaska, Poland, 41-700 Novo Nordisk Investigational Site Sosnowiec, Poland, 41-200 Novo Nordisk Investigational Site Warsaw, Poland, 01-877 Novo Nordisk Investigational Site Wroclaw, Poland, 50-306 Less <<
NCT01384279 Obesity Not Applicable Completed - Taiwan ... More >> Beitou Armed Forces Hospital Taipei, Taiwan, 11243 Less <<
NCT01182948 Type 2 Diabetes Not Applicable Completed - -
NCT03018028 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - Japan ... More >> Novo Nordisk Investigational Site Akita-shi, Akita, Japan, 010 8543 Novo Nordisk Investigational Site Arakawaku, Tokyo, Japan, 116-0012 Novo Nordisk Investigational Site Chuo-ku Tokyo, Japan, 103-0027 Novo Nordisk Investigational Site Chuo-ku, Tokyo, Japan, 103 0027 Novo Nordisk Investigational Site Ebina-shi, Japan, 243 0432 Novo Nordisk Investigational Site Minato-ku, Tokyo, Japan, 108-0075 Novo Nordisk Investigational Site Naka-shi, Japan, 311 0113 Novo Nordisk Investigational Site Osaka-shi, Osaka, Japan, 553 0003 Novo Nordisk Investigational Site Ota-shi, Gunma, Japan, 373-0036 Novo Nordisk Investigational Site Saga-shi,Saga, Japan, 849 0937 Novo Nordisk Investigational Site Sendaishi, Miyagi, Japan, 980-8574 Novo Nordisk Investigational Site Shinjuku-ku, Tokyo, Japan, 160-0008 Novo Nordisk Investigational Site Suita-shi, Osaka, Japan, 565-0853 Novo Nordisk Investigational Site Tokyo, Japan, 103-0028 Novo Nordisk Investigational Site Tokyo, Japan, 144-0051 Novo Nordisk Investigational Site Yokohama-shi Kanagawa, Japan, 232-0064 Less <<
NCT01826422 - Completed - -
NCT01956305 Type 2 Diabetes Mellitus Phase 1 Completed - United States, Texas ... More >> Worldwide Clinical Trials San Antonio, Texas, United States, 78217 Less <<
NCT01826422 Muscular Dystrophy, Duchenne Not Applicable Completed - Mexico ... More >> Unit of Medical Researcha in Nutrition, Pediatric Hospital, IMSS. Mexico city, Mexico, 06720 Less <<
NCT01695109 Healthy Human Male Subjects Phase 4 Completed - Austria ... More >> Division of Endocrinology and Metabolism, Medical University of Vienna Vienna, Austria, 1090 Less <<
NCT01826591 Obesity Insul... More >>in Resistance Less << Not Applicable Completed - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT02359292 Asthma Phase 1 Completed - Belgium ... More >> SGS CPU Antwerpen Antwerpen, Belgium Less <<
NCT02396875 Heart Failure Not Applicable Unknown December 2016 United Kingdom ... More >> Guy's and St Thomas Hospital Trust Not yet recruiting London, United Kingdom, Se1 7EH Contact: Simon Claridge, MBBS LLB       simon.claridge@kcl.ac.uk    Contact: Reza Razavi, MBBS MD       reza.razavi@kcl.ac.uk    Principal Investigator: Christopher Rinaldi, MBBS MD Less <<
NCT01492153 - Completed - Indonesia ... More >> Novo Nordisk Investigational Site Jakarta, Indonesia, 12520 Less <<
NCT00336882 Traumatic Brain Injury Phase 3 Terminated - France ... More >> Réanimation Chirurgicale - Hôpital de Pontchaillou Rennes, France, 35033 Less <<
NCT01681680 Healthy Phase 1 Completed - -
NCT03267901 Metabolic Syndrome Not Applicable Completed - Korea, Republic of ... More >> ICAN Nutrition Education and Research Seoul, Korea, Republic of, 07327 Less <<
NCT00791661 Diabetes Mellitus, Non-Insulin... More >>-Dependent Less << Phase 1 Completed - -
NCT00094757 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT00094757 - Completed - -
NCT02686853 Cryptococcal Meningitis Phase 4 Unknown - -
NCT00791661 - Completed - -
NCT00233298 - Completed - United States, Maryland ... More >> National Institute of Aging, Clinical Research Unit Baltimore, Maryland, United States, 21224 Less <<
NCT02087709 Weight Loss I... More >>nsulin Resistance Adipokines Less << Not Applicable Completed - Brazil ... More >> Federal University of Rio de Janeiro Rio de Janeiro, RJ, Brazil, 21941- 902 Less <<
NCT02642523 Obesity Hyper... More >>insulinemia Less << Early Phase 1 Withdrawn(Preliminary data run... More >> on rat samples showed that this study question and design would not produce conclusive results. The PI decided not to carry out the study.) Less << - -
NCT00701935 Diabetes Mellitus Phase 2 Terminated(Enrollment was much... More >> slower than anticipated, leading to a decision to terminate the study early for enrollment futility.) Less << - United States, Arizona ... More >> Research Site Temple, Arizona, United States United States, Colorado Research Site Colorado Springs, Colorado, United States United States, Hawaii Research Site Honolulu, Hawaii, United States United States, Nebraska Research Site Bellevue, Nebraska, United States United States, Nevada Research Site Las Vegas, Nevada, United States Canada, Alberta Research Site Calgary, Alberta, Canada Canada, British Columbia Research Site Vancouver, British Columbia, Canada Research Site Victoria, British Columbia, Canada Canada, Manitoba Research Site Winnipeg, Manitoba, Canada Canada, New Brunswick Research Site Saint John, New Brunswick, Canada Canada, Ontario Research Site Brampton, Ontario, Canada Research Site London, Ontario, Canada Research Site Ottawa, Ontario, Canada Research Site Toronto, Ontario, Canada Canada, Quebec Research Site Chicoutimi, Quebec, Canada Research Site Pointe-Claire, Quebec, Canada Canada Research Site Quebec, Canada Less <<
NCT01745783 Multiple Sclerosis Phase 1 Phase 2 Recruiting December 2019 Spain ... More >> University Hospital Reina Sofia Recruiting Córdoba, Spain, 14004 Contact: Eduardo Agüera, MD    957010482;    doctoredu@gmail.com    Principal Investigator: Eduardo Agüera, MD          University Regional Hospital Carlos Haya Recruiting Málaga, Spain, 29010 Contact: Victoria Fernández, MD    951291135    victoriae.fernandez.sspa@juntadeandalucia.es    Principal Investigator: Victoria Fernández, MD          University Hospital Virgen Macarena Recruiting Sevilla, Spain, 41009 Contact: Guillermo Navarro, MD    955009025    guillermo.navarro.sspa@juntadeandalucia.es    Principal Investigator: Guillermo Navarro, MD Less <<
NCT00701935 - Terminated(Enrollment was much... More >> slower than anticipated, leading to a decision to terminate the study early for enrollment futility.) Less << - -
NCT00383058 Obesity Phase 3 Completed - Taiwan ... More >> Taipei Hospital Taipei, Taiwan, 886 Less <<
NCT03596580 - Recruiting June 2019 Italy ... More >> Fondazione Ca' Granda Ospedale Maggiore Policlinico Recruiting Milan, Italy, 20122 Contact: Ivana Maria Rosi, Dr    +390255035457    ivana.rosi@policlinico.mi.it    Contact: Roberto Milos, Dr    +390255032704    roberto.milos@policlinico.mi.it    Principal Investigator: Ivana Maria Rosi, Dr          Sub-Investigator: Roberto Milos, Dr          Sub-Investigator: Loris Bonetti, Dr Less <<
NCT03575390 Hearing Impairment Not Applicable Recruiting January 31, 2020 Taiwan ... More >> Dalin Tzu Chi Hospital Recruiting Chiayi City, Taiwan, 66247 Contact: Juen-Haur Hwang, MD, PhD.    +886-5-2648000 ext 5239    juenhaur@ms96.url.com.tw Less <<
NCT01586754 - Unknown May 2012 Turkey ... More >> Istanbul Medeniyet University Goztepe Training and Research Hospital Istanbul, Turkey, 34000 Less <<
NCT03142763 Cardiovascular Risk Factor Not Applicable Active, not recruiting December 2018 United States, Connecticut ... More >> University of Connecticut Storrs, Connecticut, United States, 06269 Less <<
NCT02603458 Schizophrenia Phase 2 Withdrawn(The study was withdr... More >>awn by the sponsor.) Less << - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 United States, New York New York University Langone Medical Center/ Bellevue Hospital New York, New York, United States, 10016 Less <<
NCT00696657 - Completed - -
NCT01553968 Diabetes Mellitus, Type 2 Not Applicable Completed - Netherlands ... More >> Maastricht University Medical Center Maastricht, Limburg, Netherlands, 6202 AZ Less <<
NCT01836523 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 3 Completed - -
NCT01836523 - Completed - -
NCT01512979 Diabetes Mellitus, Type 2 Phase 4 Completed - -
NCT01845896 Multiple Sclerosis ... More >> Healthy Controls Less << Not Applicable Completed - Belgium ... More >> Reval Diepenbeek, Belgium, 3590 Less <<
NCT00696657 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 2 Completed - -
NCT03332316 Postoperative Pain ... More >> Nerve Block Less << Phase 4 Recruiting September 2019 Finland ... More >> Tampere University Hospital Recruiting Tampere, Finland, 33521 Contact: Maija-Liisa Kalliomäki, PhD    +358 3 311 69424    maija-liisa.kalliomaki@pshp.fi    Contact: Jenni Kanerva, PhD    +358 3 311 67415    jenni.kanerva@pshp.fi    Principal Investigator: Suvi Kastikainen, PhD          Principal Investigator: Jenni Kanerva, PhD Less <<
NCT02121132 - Recruiting October 2020 -
NCT00529542 Polycystic Ovary Syndrome Phase 2 Completed - United States, Pennsylvania ... More >> Penn State Milton S Hershey Medical Center, College of Medicine Hershey, Pennsylvania, United States, 17033 Less <<
NCT01512979 - Completed - -
NCT02637622 - Unknown June 2016 United States, Maryland ... More >> Johns Hopkins Bloomberg School of Public Health Baltimore, Maryland, United States, 21205 Less <<
NCT02858102 Metabolic Syndrome ... More >> Mental Disorders Less << Not Applicable Recruiting December 2019 Spain ... More >> University Hospital Marqués de Valdecilla Recruiting Santander, Cantabria, Spain, 39008 Less <<
NCT00529542 - Completed - -
NCT03532763 Inflammation ... More >>Cardiovascular Risk Factor Less << Not Applicable Recruiting June 30, 2019 Malaysia ... More >> Malaysian Palm Oil Board Recruiting Kajang, Selangor, Malaysia, 43000 Contact: JU YEN FU, PhD Less <<
NCT03380611 Intestinal Cholesterol Absorpt... More >>ion Less << Not Applicable Completed - Netherlands ... More >> Maastricht University Medical Center Maastricht, Limburg, Netherlands, 6229ER Less <<
NCT02894931 Dietary Habits ... More >> Serum; Disease Macrophage Atherogenicity Atherosclerosis Less << Not Applicable Unknown August 2018 Israel ... More >> Rambam Health care center Recruiting Haifa, Israel, 320000 Contact: Niroz Abu-Saleh, PhD    972504278858    asniroz@gmail.com Less <<
NCT00688714 Antiplatelet Effect Phase 1 Completed - -
NCT03034473 Locally Advanced Rectal Cancer Not Applicable Active, not recruiting October 2020 Germany ... More >> University Medical Center Goettingen Gottingen, Lower Saxony, Germany, 37075 Less <<
NCT01192048 - Recruiting December 2025 United States, Ohio ... More >> Nationwide Children's Hospital Recruiting Columbus, Ohio, United States, 43205 Principal Investigator: Vidu Garg, MD Less <<
NCT02684331 - Recruiting January 2019 Denmark ... More >> The diabetes outpatient clinic, Slagelse Hospital, Denmark Recruiting Slagelse, Denmark, 4200 Contact: Peter H Gaede, DMSc    +45 23959055    phgo@regionsjaelland.dk    Contact: Annemie S Bojer, DM    +45 22857526    asph@regionsjaelland.dk    Principal Investigator: Martin H Soerensen, DM Less <<
NCT02823678 - Enrolling by invitation December 2021 -
NCT03003793 - Active, not recruiting December 2017 Denmark ... More >> Center for Diabetes Research, Gentofte Hospital, University of Copenhagen Hellerup, Denmark, 2900 Less <<
NCT00172198 Critical Ill Patients in SICU Phase 4 Unknown - Taiwan ... More >> National Taiwan University Hospital Recruiting Taipei, Taiwan, 100 Contact: Hong-Shiee Lai, M.D., Ph.D.    886-2-23123456 ext 5112    hslai@ha.mc.ntu.edu.tw Less <<
NCT00334711 Diabetes Mellitus Not Applicable Completed - -
NCT02009488 Diabetes Mellitus, Type 2 Phase 1 Completed - United States, California ... More >> San Diego, La Jolla, California, United States United States, Florida Gainesville, Florida, United States Less <<
NCT01190358 Metabolic Syndrome Not Applicable Completed - United States, California ... More >> University of California Davis (Academic Surge, Ragle Human Nutrition Research Facility) Davis, California, United States, 95616 VA Hospital, Mather Mather, California, United States, 95655 Less <<
NCT03610321 Coronary Artery Disease Phase 2 Phase 3 Recruiting December 31, 2020 China, Heilongjiang ... More >> the first affiliated hospital of Harbin medical university Recruiting Harbin, Heilongjiang, China, 150001 Contact: Jing Shi, MD Less <<
NCT01806493 - Completed - Italy ... More >> Villa delle Querce Rehabilitation Institute Nemi, Italy, 00040 Less <<
NCT02259426 Malaria Asymp... More >>tomatic Malaria Plasmodium Falciparum Less << Phase 3 Completed - Kenya ... More >> ICIPE Mbita, Nyanza, Kenya, 30-40305 Less <<
NCT02528279 Malaria Not Applicable Completed - Gabon ... More >> Centre de Recherches Médicales de Lambaréné, Hôpital Albert Schweitzer Lambaréné, Moyen-Ogooué, Gabon, 118 Centre de Recherches Médicales de Ngounié Fougamou, Ngounié, Gabon, 113 Less <<
NCT01210976 Heart Valve Disease Phase 4 Completed - Finland ... More >> Tampere University Hospital Tampere, Finland Less <<
NCT00933647 Dyslipidemia ... More >>Inflammation Obesity Less << Phase 3 Unknown December 2009 Brazil ... More >> Instituto de Cardiologia / Fundação Universitária de Cardiologia Recruiting Porto Alegre, RS, Brazil, 90620-001 Contact: Bruna Pontin, MD    55 54 9129 1027    brunapontin@hotmail.com Less <<
NCT01880736 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - Japan ... More >> Novo Nordisk Investigational Site Chuo-ku, Tokyo, Japan, 103 0002 Novo Nordisk Investigational Site Chuo-ku, Tokyo, Japan, 103 0027 Novo Nordisk Investigational Site Fukui-shi, Fukui, Japan, 918-8503 Novo Nordisk Investigational Site Fukuoka, Japan, 812 0025 Novo Nordisk Investigational Site Gifu-shi, Gifu, Japan, 501-1194 Novo Nordisk Investigational Site Izumisano-shi, Japan, 598 0048 Novo Nordisk Investigational Site Kagoshima-shi, Kagoshima, Japan, 890-8520 Novo Nordisk Investigational Site Kamakura-shi, Japan, 247 0056 Novo Nordisk Investigational Site Kashiwara-shi, Osaka, Japan, 582 0005 Novo Nordisk Investigational Site Katsushika-ku, Tokyo, Japan, 125 0054 Novo Nordisk Investigational Site Kawasaki-shi, Kanagawa, Japan, 216-8511 Novo Nordisk Investigational Site Kitakyushu-shi, Fukuoka, Japan, 800 0252 Novo Nordisk Investigational Site Kitakyushu-shi, Fukuoka, Japan, 807-8555 Novo Nordisk Investigational Site Kitakyusyu-shi, Fukuoka, Japan, 800-0222 Novo Nordisk Investigational Site Koriyama-shi, Fukushima, Japan, 963 8851 Novo Nordisk Investigational Site Kumamoto-shi,Kumamoto, Japan, 862 0976 Novo Nordisk Investigational Site Mito-shi, Ibaraki, Japan, 310-0845 Novo Nordisk Investigational Site Miyazaki-shi, Japan, 880 0034 Novo Nordisk Investigational Site Naka-shi, Ibaraki, Japan, 311 0113 Novo Nordisk Investigational Site Niigata-shi, Niigata, Japan, 951-8520 Novo Nordisk Investigational Site Nishinomiya-shi, Hyogo, Japan, 663-8501 Novo Nordisk Investigational Site Oita-shi, Japan, 870 0039 Novo Nordisk Investigational Site Okawa-shi, Fukuoka, Japan, 831 0016 Novo Nordisk Investigational Site Osaka-shi, Osaka, Japan, 532 0003 Novo Nordisk Investigational Site Oyama-shi, Tochigi, Japan, 323 0022 Novo Nordisk Investigational Site Sakaide-shi, Kagawa, Japan, 762-0031 Novo Nordisk Investigational Site Sapporo-shi, Hokkaido, Japan, 060 0062 Novo Nordisk Investigational Site Sapporo-shi, Hokkaido, Japan, 060-0001 Novo Nordisk Investigational Site Sapporo-shi, Hokkaido, Japan, 062 0007 Novo Nordisk Investigational Site Sendai-shi, Japan, 980 0021 Novo Nordisk Investigational Site Shimotsuke-shi, Tochigi, Japan, 329 0433 Novo Nordisk Investigational Site Suita-shi, Osaka, Japan, 565-0853 Novo Nordisk Investigational Site Takatsuki-shi, Osaka, Japan, 569 1096 Novo Nordisk Investigational Site Tokyo, Japan, 103-0028 Novo Nordisk Investigational Site Tokyo, Japan, 113-8655 Novo Nordisk Investigational Site Tokyo, Japan, 123-0845 Novo Nordisk Investigational Site Tokyo, Japan, 143-8541 Novo Nordisk Investigational Site Tokyo, Japan, 144-0051 Novo Nordisk Investigational Site Tokyo, Japan, 162-8655 Novo Nordisk Investigational Site Yokkaichi-shi, Mie, Japan, 510-0829 Less <<
NCT00350779 - Completed - -
NCT00350779 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT00903110 - Recruiting December 2023 United Kingdom ... More >> Ipsen Central Contact Recruiting Slough, Berkshire, United Kingdom Contact       clinical.trials@ipsen.com Less <<
NCT00784264 - Completed - Hong Kong ... More >> Research Site Hong Kong, Hong Kong Less <<
NCT03075306 Weight Loss Not Applicable Recruiting June 2021 United States, Maryland ... More >> Johns Hopkins Children's Mental Health Center Recruiting Baltimore, Maryland, United States, 21287 Contact: Joseph Gennusa, PhD       jgennus1@jhmi.edi Less <<
NCT03643094 Hyperlipidemias ... More >> Hyperglycemia Less << Not Applicable Active, not recruiting October 14, 2018 United States, Oregon ... More >> Gitte Jensen Klamath Falls, Oregon, United States, 97601 Less <<
NCT02113696 Morbid Obesity Not Applicable Completed - -
NCT02063074 - Recruiting June 2034 United States, California ... More >> Women's Health and Exercise Laboratory, University of southern California Recruiting Los Angeles, California, United States, 90089 Contact: Christina Dieli-Conwright, PhD    323-442-2905    cdieli@usc.edu    Principal Investigator: Christina M Dieli-Conwright, PhD Less <<
NCT00760929 Non-Squamous Non-Small Cell Lu... More >>ng Cancer Less << Phase 2 Completed - -
NCT01489995 Fabry Disease Phase 1 Completed - United States, Texas ... More >> GSK Investigational Site Austin, Texas, United States, 78744 Less <<
NCT00676338 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT02725775 Healthy Not Applicable Completed - United Kingdom ... More >> Human Appetite Research Unit, University of Leeds Leeds, West Yorkshire, United Kingdom, LS29JT Less <<
NCT01967901 Diabetic Kidney Disease Not Applicable Completed - Switzerland ... More >> University of Lausanne Hospitals Lausanne, Vaud, Switzerland, 1011 Less <<
NCT02121717 Type 2 Diabetes Phase 3 Completed - -
NCT02821481 Physical Endurance Not Applicable Completed - United States, Florida ... More >> Max Orovitz Laboratories Coral Gables, Florida, United States, 33146 Less <<
NCT02919397 Pre-diabetes Not Applicable Completed - -
NCT00676338 - Completed - -
NCT00398060 Obesity Type ... More >>2 Diabetes Less << Phase 3 Completed - Finland ... More >> Päijät-Häme Hospital District Lahti, Finland, 15850 Less <<
NCT02512068 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT01096667 Diabetes Mellitus, Type 2 ... More >> Hypertension Less << Phase 2 Completed - -
NCT02870764 Angina, Stable ... More >> Inflammation Less << Phase 4 Unknown August 2017 China, Jiangsu ... More >> Taizhou Fourth People's Hospital Recruiting Taizhou, Jiangsu, China, 225300 Contact: Bailing Su, MD    0086052380185012    tzsybgs055@sina.com    Contact: Haoshen Wang, MD    008613952613616    billet1116@163.com Less <<
NCT02000817 Diabetes Mellitus, Type 1 Phase 2 Completed - Belgium ... More >> GSK Investigational Site Brussels, Belgium, 1090 GSK Investigational Site Bruxelles, Belgium, 1070 GSK Investigational Site Edegem, Belgium, 2650 GSK Investigational Site Gent, Belgium, 9000 GSK Investigational Site Leuven, Belgium, 3000 GSK Investigational Site Liège, Belgium, 4000 Less <<
NCT01293344 Cardiovascular Diseases Not Applicable Completed - Canada ... More >> Institute of Nutraceuticals and Functional Foods (INAF), Laval University Quebec, Canada, G1V0A6 Less <<
NCT02791490 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT01119911 - Unknown June 2012 Israel ... More >> Meir Medical Center Recruiting Kfar Saba, Israel, 44281 Less <<
NCT03486054 Safety Issues Not Applicable Not yet recruiting December 2018 Uganda ... More >> Uganda Cancer Institute Not yet recruiting Kampala, Uganda, P O Box 3935 Contact: Henry Ddungu, MD    ++256 772426806    hddungu@fredhutch.org Less <<
NCT02173457 Type 2 Diabetes Phase 3 Completed - -
NCT03538990 Heart Failure NYHA Class III Not Applicable Recruiting December 2019 United States, Georgia ... More >> University of Georgia Clinical and Translational Research Unit Recruiting Athens, Georgia, United States, 30606 Contact: Kimberly Schmitz, MS    706-713-2721    schmitzk@uga.edu Less <<
NCT01524731 Postoperative Nausea and Vomit... More >>ing Less << Not Applicable Completed - Canada, Quebec ... More >> McGill University Health Centre-Royal Victoria Hospital Montreal, Quebec, Canada, H3A 1A1 Royal Victoria Hospital Montreal, Quebec, Canada, H3A 1A1 Less <<
NCT01096667 - Completed - -
NCT03660982 - Recruiting September 30, 2020 Hong Kong ... More >> Department of psychiatry, Faculty of Medicine, The Chinese University of Hong Kong Recruiting Hong Kong, Hong Kong Contact: Jihui Zhang, PhD Less <<
NCT03328858 Brain Tumors Not Applicable Recruiting November 30, 2023 United States, Florida ... More >> Nicklaus Children's Hospital Recruiting Miami, Florida, United States, 33155 Contact: Jennifer Caceres, MS, RDN, LDN    786-624-4854    jennifer.caceres@mch.com    Contact: Matthew Bittle, MBA/HSA, RRC    786-624-2838    matthew.bittle@nicklaushealth.org    Principal Investigator: Jennifer Caceres, MS, RDN, LDN          Sub-Investigator: Ziad Khatib, MD          Sub-Investigator: Michael Barbato, MD          Sub-Investigator: Maria Pilar Generao, ARNP, CNRN          Sub-Investigator: Nolan Altman, MD          Sub-Investigator: Sara Rivero-Conil, PsyD          Sub-Investigator: Daria Salyakina, PhD          Sub-Investigator: Weize Wang, Statistician Less <<
NCT03193229 Pre Diabetes ... More >>Obesity Less << Not Applicable Completed - United States, Iowa ... More >> Signal Center Innovation Lab Coralville, Iowa, United States, 52241 Less <<
NCT00289380 - Recruiting January 2020 China, Beijing ... More >> Beijing Friendship Hospital, Capital Medical University Active, not recruiting Beijing, Beijing, China, 100730 Peking Union Medical College Hospital Active, not recruiting Beijing, Beijing, China, 100730 China, Chongqing Chongqing Medical Univ. Hospital Completed Chongqing, Chongqing, China Xin Qiao Hospital Recruiting Chongqing, Chongqing, China Contact: Hua Yang, M.D.    +86 13668057773    hyang@med.umich.edu    Principal Investigator: Hua Yang, M.D.          China, Guangdong The First Affiliated Hospital, Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510080 Contact: Wen-hua Zhan, M.D.    +86 20 87755766    wenhuazhan@medmail.com.cn    Principal Investigator: Wen-hua Zhan, M.D.          Sub-Investigator: Xiao-qing Liu, M.D.          China, Guangxi The First Affiliated Hospial, Guangxi Medical University Recruiting Nanning, Guangxi, China, 530021 Contact: Ning Xia, M.D.    +86 771 5303201       Principal Investigator: Ning Xia, M.D.          China, Hebei The First University Hospital, Hebei Medical University Recruiting Shijiazhuang, Hebei, China, 050031 Contact: Ru-mei Jia, M.D.    +86 311 85917000    jiarm@jyyy.com.cn    Principal Investigator: Ru-mei Jia, M.D.          Nankai Hospital Active, not recruiting Tianjin, Hebei, China, 300100 China, Hubei Tongji Hospital, Huazhong University of Science and Technology Recruiting Wuhan, Hubei, China, 430030 Contact: Yi-ping Wu, M.D.    +86 27 62363420    mail@tjh.tjmu.edu.cn    Principal Investigator: Yi-ping Wu, M.D.          China, Jiangsu Nanjing General Hospital of Nanjing Military Command Recruiting Nanjing, Jiangsu, China, 210002 Contact: Zhi-wei Jiang, M.D.    +86 25 84619727    surgery34@163.com    Principal Investigator: Zhi-wei Jiang, M.D.          China, Shanghai Xin Hua Hospital, Shanghai Jiaotong University Recruiting Shanghai, Shanghai, China, 200029 Contact: Wei Cai, M.D.    +86 21 65790000    caiwei204@yahoo.com.cn    Principal Investigator: Wei Cai, M.D.          Sixth Hospital Recruiting Shanghai, Shanghai, China Contact: Huai-Long Qin, M.D.       hlqin@sjtu.edu.cn    Sub-Investigator: Huai-Long Qin, M.D.          China, Xinjiang The First Affiliated Hospital, Xinjiang Medical University Active, not recruiting Urumqi, Xinjiang, China, 830054 China, Zhejiang Second Affiliated Hospital, Zhejiang University Active, not recruiting Hangzhou, Zhejiang, China, 310006 Less <<
NCT01699490 Major Depressive Disorder Phase 4 Unknown July 2015 Taiwan ... More >> Department of Psychiatry, National Cheng-Kung University Hospital Recruiting Tainan, Taiwan, 701 Contact: Po See Chen, M.D., Ph.D.    +886-6-2353535 ext 5213    chenps@mail.ncku.edu.tw Less <<
NCT03480594 Fatty Liver Early Phase 1 Not yet recruiting December 31, 2020 -
NCT01748552 Diabetes Mellitus, Type 2 Phase 1 Completed - Singapore ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Singapore, Singapore, 117597 Less <<
NCT02405806 Obesity Diet ... More >>Modification Less << Not Applicable Completed - -
NCT03047668 Type 2 Diabetes ... More >> NAFLD Obesity Dyslipidemia Hypertension Metabolic Syndrome Less << Not Applicable Recruiting December 2018 Germany ... More >> DIfE (German Institute for Human Nutrition) Recruiting Berlin, Germany, 12203 Contact: Stefan Kabisch, Dr. med.    030 450 514 429    stefan.kabisch@dife.de Less <<
NCT02041234 Type II Diabetes in Subjects B... More >>MI 27 to 32 Less << Phase 4 Recruiting March 2020 Singapore ... More >> Khoo Teck Puat Hospital Recruiting Singapore, Singapore, 768828 Contact: Bernice Tan    +65 6602 3169    tan.bernice.lt@alexandrahealth.com.sg    Principal Investigator: Anton Cheng, MBBS          Sub-Investigator: Chee Fang Sum, MBBS          Sub-Investigator: Su Chi Lim, MBBS          Sub-Investigator: Tavintharan Subramaniam, MBBS          Sub-Investigator: Nitish Mishra, MBBS          Sub-Investigator: Ester Yeoh, MBBS          Sub-Investigator: Chun Hai Tan, MBBS          Sub-Investigator: Benjamin Chih Chiang Lam, MBBS          Sub-Investigator: Thazin Ma, MBBS          Sub-Investigator: Michael Wong, MBBS Less <<
NCT03199430 EGCG Influence on Catecholamin... More >>e Metabolism Less << Phase 4 Completed - -
NCT03653390 Physical Disability Not Applicable Not yet recruiting December 31, 2020 United States, Washington ... More >> University of Washington Not yet recruiting Seattle, Washington, United States, 98195 Contact: Rana Salem, MA          Principal Investigator: Ivan Molton, PhD Less <<
NCT03281512 - Completed - -
NCT01077570 - Completed - China, Beijing ... More >> Beijing, Beijing, China, 100004 Less <<
NCT01707147 - Completed - Korea, Republic of ... More >> Multiple Locations, Korea, Republic of Less <<
NCT02616471 Metabolic Syndrome Not Applicable Completed - Denmark ... More >> Department of Nutrition, Exercise and Sport Copenhagen, Frederiksberg, Denmark, 1958 Less <<
NCT01054118 Diabetes Mellitus, Type 2 Phase 1 Completed - United States, Nebraska ... More >> Lincoln, Nebraska, United States Less <<
NCT03482284 Dietary Habits ... More >> Endotoxemia Less << Not Applicable Active, not recruiting September 15, 2018 -
NCT00719056 Total Hip and Knee Arthroplast... More >>ies Less << Phase 4 Completed - Greece ... More >> 2nd Department of Orthopedics, KAT Hospital Maroussi, Athens, Greece, 14527 3rd Department of Orthopedics, KAT Hospital Maroussi, Athens, Greece, 14527 4th Department of Orthopedics, KAT Hospital Maroussi, Athens, Greece, 14527 Less <<
NCT00005889 Infant, Low Birth Weight ... More >> Hyperglycemia Less << Not Applicable Unknown - United States, Texas ... More >> Baylor College of Medicine Recruiting Houston, Texas, United States, 77030 Contact: Agneta L. Sunehag    713-798-6725    asunehag@bcm.tmc.edu Less <<
NCT00654381 Diabetes Mellitus, Type 2 Phase 3 Completed - Japan ... More >> 1218.23.05 Boehringer Ingelheim Investigational Site Asahi, Chiba, Japan 1218.23.06 Boehringer Ingelheim Investigational Site Funabashi, Chiba, Japan 1218.23.21 Boehringer Ingelheim Investigational Site Hitachinaka, Ibaraki, Japan 1218.23.44 Boehringer Ingelheim Investigational Site Hitachiota, Ibaraki, Japan 1218.23.09 Boehringer Ingelheim Investigational Site Imizu, Toyama, Japan 1218.23.45 Boehringer Ingelheim Investigational Site Inashiki-gun, Ibaraki, Japan 1218.23.13 Boehringer Ingelheim Investigational Site Izumisano, Osaka, Japan 1218.23.27 Boehringer Ingelheim Investigational Site Kariya, Aichi, Japan 1218.23.47 Boehringer Ingelheim Investigational Site Kitakatsushika-gun, Saitama, Japan 1218.23.39 Boehringer Ingelheim Investigational Site Kitakyuushuu, Fukuoka, Japan 1218.23.02 Boehringer Ingelheim Investigational Site Koriyama, Fukushima, Japan 1218.23.03 Boehringer Ingelheim Investigational Site Koriyama, Fukushima, Japan 1218.23.10 Boehringer Ingelheim Investigational Site Kyoto, Kyoto, Japan 1218.23.37 Boehringer Ingelheim Investigational Site Marugame, Kagawa, Japan 1218.23.38 Boehringer Ingelheim Investigational Site Marugame, Kagawa, Japan 1218.23.23 Boehringer Ingelheim Investigational Site Matsumoto, Nagano, Japan 1218.23.07 Boehringer Ingelheim Investigational Site Meguro-ku, Tokyo, Japan 1218.23.25 Boehringer Ingelheim Investigational Site Nagoya, Aichi, Japan 1218.23.26 Boehringer Ingelheim Investigational Site Nagoya, Aichi, Japan 1218.23.28 Boehringer Ingelheim Investigational Site Nagoya, Aichi, Japan 1218.23.29 Boehringer Ingelheim Investigational Site Nagoya, Aichi, Japan 1218.23.30 Boehringer Ingelheim Investigational Site Nagoya, Aichi, Japan 1218.23.04 Boehringer Ingelheim Investigational Site Naka, Ibaraki, Japan 1218.23.15 Boehringer Ingelheim Investigational Site Nishi-ku, Hiroshima, Hiroshima, Japan 1218.23.34 Boehringer Ingelheim Investigational Site Nishi-ku, Sakai, Osaka, Japan 1218.23.22 Boehringer Ingelheim Investigational Site Nishishinjyuku, Shinjyuku-ku, Tokyo, Japan 1218.23.16 Boehringer Ingelheim Investigational Site Oita, Oita, Japan 1218.23.40 Boehringer Ingelheim Investigational Site Oita, Oita, Japan 1218.23.36 Boehringer Ingelheim Investigational Site Okayama, Okayama, Japan 1218.23.11 Boehringer Ingelheim Investigational Site Osaka, Osaka, Japan 1218.23.12 Boehringer Ingelheim Investigational Site Osaka, Osaka, Japan 1218.23.32 Boehringer Ingelheim Investigational Site Osaka, Osaka, Japan 1218.23.33 Boehringer Ingelheim Investigational Site Osaka, Osaka, Japan 1218.23.35 Boehringer Ingelheim Investigational Site Osaka, Osaka, Japan 1218.23.17 Boehringer Ingelheim Investigational Site Sapporo, Hokkaido, Japan 1218.23.18 Boehringer Ingelheim Investigational Site Sapporo, Hokkaido, Japan 1218.23.19 Boehringer Ingelheim Investigational Site Sapporo, Hokkaido, Japan 1218.23.41 Boehringer Ingelheim Investigational Site Sapporo, Hokkaido, Japan 1218.23.42 Boehringer Ingelheim Investigational Site Sapporo, Hokkaido, Japan 1218.23.43 Boehringer Ingelheim Investigational Site Sapporo, Hokkaido, Japan 1218.23.01 Boehringer Ingelheim Investigational Site Sendai, Miyagi, Japan 1218.23.20 Boehringer Ingelheim Investigational Site Sendai, Miyagi, Japan 1218.23.46 Boehringer Ingelheim Investigational Site Shinjuku-ku, Tokyo, Japan 1218.23.08 Boehringer Ingelheim Investigational Site Shinjyuku-ku,Tokyo, Japan 1218.23.14 Boehringer Ingelheim Investigational Site Suita, Osaka, Japan 1218.23.31 Boehringer Ingelheim Investigational Site Takatsuki, Osaka, Japan 1218.23.48 Boehringer Ingelheim Investigational Site Yokohama, Kanagawa, Japan Less <<
NCT02330432 Sepsis Phase 2 Phase 3 Recruiting January 2019 India ... More >> Department of Pulmonary Medicine Recruiting Chandigarh, UT, India, 160012 Contact: Ritesh Agarwal, MD, DM, FCCP    2756825    riteshpgi@gmail.com    Contact: Ashutosh N Aggarwal, MD, DM, FCCP    2756824    ashutosh@indiachest.org    Principal Investigator: Ritesh Agarwal, MD, DM, FCCP          Principal Investigator: Dhruva Chaudhry, MD, DM          Principal Investigator: Sriram Sampath, MD Less <<
NCT00151749 Type 2 Diabetes Phase 3 Completed - -
NCT01871844 Healthy Male Volunteers Phase 1 Completed - Italy ... More >> Centro Ricerche Cliniche Verona, Italy United Kingdom Quotient Clinical Ruddington, Nottingham, United Kingdom, NG116JS Less <<
NCT02945540 - Unknown April 2017 France ... More >> Caen University Hospital Recruiting Caen, France, 14033 Contact: Lidwine TRONCY, MSc    +33 2 31 06 30 23    troncy-l@chu-caen.fr Less <<
NCT00654381 - Completed - -
NCT01889914 Diabetes Phase 4 Unknown September 2015 France ... More >> CHU Recruiting Dijon, France, 21000 Contact: Sabine RUDONI, MD       sabine.rudoni@chu-dijon.fr    Principal Investigator: Sabine RUDONI, MD Less <<
NCT00450710 Diabetes Phase 4 Completed - Brazil ... More >> Hospital de Especialidades Goiania, Brazil Less <<
NCT01208012 Diabetes Mellitus, Type 2 Phase 4 Completed - Germany ... More >> IKFE Institute for Clinical Research and Development Mainz, Germany, 55116 Less <<
NCT02551900 Type 2 Diabetes Not Applicable Completed - Thailand ... More >> Laemchabang stadium, Sukhumvit Rd Si Racha, Chon Buri, Thailand, 20230 Less <<
NCT03077984 Stroke Not Applicable Enrolling by invitation December 2020 -
NCT01232608 Coronary Artery Disease ... More >> Diabetes Mellitus, Type 2 Atherosclerosis Less << Not Applicable Completed - Norway ... More >> Oslo University Hospital, Ullevål Oslo, Norway, NO-0424 Less <<
NCT01996436 Cerebral Vasospasm Phase 4 Recruiting December 2020 United States, Connecticut ... More >> Yale School of Medicine Recruiting New Haven, Connecticut, United States, 06520 Contact: Nils Petersen, MD       nils.petersen@yale.edu    Principal Investigator: Nils Petersen, MD          United States, Illinois University of Illinois College of Medicine at Chicago Recruiting Chicago, Illinois, United States, 60612 Contact: Ali Alaraj, MD    312-996-4842    alaraj@uic.edu    Principal Investigator: Ali Alaraj, MD          United States, Michigan University of Michigan Not yet recruiting Ann Arbor, Michigan, United States, 48109 Contact: Aditya Pandey, MD    734-615-4486    adityap@med.umich.edu    United States, New York Northwell Health Not yet recruiting Manhasset, New York, United States, 11030 Contact: David Ledoux, MD    516-562-3590       Lenox Hill Not yet recruiting New York, New York, United States, 10065 Contact: David Ledoux, MD          United States, North Carolina Wake Forest University Health Sciences Recruiting Winston-Salem, North Carolina, United States, 27157 Contact: Stacey Wolfe, MD    336-716-3842    sqwolfe@wakehealth.edu    Contact: Wendy Jenkins    336.716.3842    mailto:wejenkin@wakehealth.edu    United States, Pennsylvania Geisinger Clinic Recruiting Danville, Pennsylvania, United States, 17822 Contact: Clemens Schirmer, MD          Contact: Tejal Raichura    570.214.6084    taraichura@geisinger.edu    Thomas Jefferson University Not yet recruiting Philadelphia, Pennsylvania, United States, 19107 Contact: Pascal M Jabbour, MD    215-955-7000    Pascal.Jabbour@jefferson.edu    Principal Investigator: Pascal M Jabbour, MD          Temple University Recruiting Philadelphia, Pennsylvania, United States, 19140 Contact: Kadir Erkmen, MD    617-697-4722    Kadir.Erkmen@tuhs.temple.edu    Contact: Kathleen Hatala       Kathleen.Hatala@tuhs.temple.edu    United States, Texas University of Texas Medical School at Houston Recruiting Houston, Texas, United States, 77030 Contact: Sunil Sheth, MD       Sunil.A.Sheth@uth.tmc.edu    Contact: Aditya A Sanzgiri, MBBS MPH    713-704-7263    Aditya.A.Sanzgiri@uth.tmc.edu    Principal Investigator: Sunil Sheth, MD Less <<
NCT02318121 Prolonged Labor Phase 2 Completed - -
NCT00191113 Turner Syndrome Phase 3 Completed - Canada, Alberta ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 am - 5 pm Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Calgary, Alberta, Canada, T2T 5C7 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 am - 5 pm Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Edmonton, Alberta, Canada, T6G 2B7 Canada, British Columbia For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 am - 5 pm Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Vancouver, British Columbia, Canada, V6H 3V4 Canada, Manitoba For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 am - 5 pm Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Winnipeg, Manitoba, Canada, R3E 0Z2 Canada, Nova Scotia For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 am - 5 pm Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Halifax, Nova Scotia, Canada, B3J 3G9 Canada, Ontario For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 am - 5 pm Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hamilton, Ontario, Canada, L8S 3Z5 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 am - 5 pm Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kingston, Ontario, Canada, K7L 3N6 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 am - 5 pm Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. London, Ontario, Canada, K7L 3N6 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 am - 5 pm Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ottawa, Ontario, Canada, K1H 8L1 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 am - 5 pm Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Toronto, Ontario, Canada, M5G 1X8 Canada, Quebec For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 am - 5 pm Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Montreal, Quebec, Canada, H3H 1P3 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 am - 5 pm Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Montreal, Quebec, Canada, H3T 1C5 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 am - 5 pm Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sainte-Foy, Quebec, Canada, G1V 4G2 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 am - 5 pm Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sherbrooke, Quebec, Canada, J1G 2E8 Less <<
NCT02598544 Obesity Diabe... More >>tes Less << Not Applicable Completed - Belgium ... More >> Hasselt University Diepenbeek, Belgium, B-3590 Ziekenhuis Oost-Limburg Genk, Belgium, B-3600 Jessa Ziekenhuis Hasselt, Belgium, B-3500 Netherlands Maastricht University Maastricht, Netherlands Less <<
NCT01803594 Dyslipidemia Not Applicable Completed - United States, California ... More >> UC Davis, Ragle Human Nutrition Center Davis, California, United States, 95616 Less <<
NCT03557658 Type2 Diabetes Mellitus Phase 1 Recruiting December 20, 2018 United States, Massachusetts ... More >> Clinical Research Site 1 Recruiting Boston, Massachusetts, United States, 02114 United States, Minnesota Clinical Research Site 2 Recruiting Saint Paul, Minnesota, United States, 55114 Less <<
NCT01419483 Pancreatic Neoplasms Not Applicable Terminated(poor accrual) - United States, Iowa ... More >> Holden Comprehensive Cancer Center Iowa City, Iowa, United States, 52242 Less <<
NCT01385345 Vitamin D Deficiency ... More >> Insulin Resistance Less << Not Applicable Terminated(Recommended by DMEC... More >>. Poor recruitment, changes in current clinical management of Vit D deficiency. Research question no longer relevant) Less << - United Kingdom ... More >> Leicester Diabetes Centre, University Hospitals of Leicester Leicester, Leicestershire, United Kingdom, LE5 4PW Less <<
NCT02899416 - Recruiting December 2018 France ... More >> CHRU,Hôpital Jeanne de Flandres Recruiting Lille, France Principal Investigator: Fréderic Gottrand, MD,PhD          Sub-Investigator: Stéphanie Coopman, MD Less <<
NCT01419587 Carcinoma, Non-Small-Cell Lung Not Applicable Terminated(Poor accrual and co... More >>mpliance) Less << - United States, Iowa ... More >> Holden Comprehensive Cancer Center Iowa City, Iowa, United States, 52242 Less <<
NCT01301339 - Completed - United States, Nevada ... More >> Mike O'Callaghan Federal Hospital/Nellis Air Force Base Las Vegas, Nevada, United States, 89191 Less <<
NCT01314807 - Unknown January 2018 Belgium ... More >> University Hospital Leuven Leuven, Belgium, 3000 Less <<
NCT00602433 - Completed - United States, Illinois ... More >> Northwestern University, Northwestern Medical Faculty Foundation Chicago, Illinois, United States, 60611-3013 Less <<
NCT02026414 Obesity Not Applicable Active, not recruiting December 2022 United States, Ohio ... More >> The Ohio State University Wexner Medical Center (Davis Heart and Lung Research Institute) Columbus, Ohio, United States, 43210 Less <<
NCT01168362 - Completed - Korea, Republic of ... More >> Seoul National University Bundang Hospital Seongnam, Korea, Republic of Less <<
NCT01409889 Pre Diabetes ... More >>Diabetes Less << Not Applicable Completed - United States, New York ... More >> Anthony Jordan Health Center Rochester, New York, United States, 14605 Rochester General Medical Associates Rochester, New York, United States, 14605 Unity Health System Rochester, New York, United States, 14606 Westside Health Services Rochester, New York, United States, 14611 Less <<
NCT00191113 - Completed - -
NCT02782897 Intracranial Hemorrhage, Hyper... More >>tensive Less << Phase 2 Unknown April 2018 China, Hubei ... More >> Department of Neurology, Tongji Hospital, Huazhong University of Science and Technology Not yet recruiting Wuhan, Hubei, China, 430030 Contact: Shabei Xu, Doctor    86-13554178768    xushabei@126.com    Contact: Xiang Luo, Doctor    86-15172507950    flydottjh@163.com Less <<
NCT01276912 Pre-diabetes Not Applicable Unknown December 2013 China ... More >> Beijing Tongren Hospital Recruiting Beijing, China, 100730 Contact: Jin-Kui Yang, M.D., Ph.D.    +86-10-58268445    jinkui.yang@gmail.com Less <<
NCT00297219 End-Stage Renal Disease ... More >> Hemodialysis Less << Not Applicable Completed - United States, Kentucky ... More >> University of Kentucky Medical Center Lexington, Kentucky, United States, 40536-0084 Turkey FMC Clinics Bornova, Izmir, Turkey Ege University School of Medicine Bornova-Izmir, Turkey, 35100 Less <<
NCT00497328 Contrast Induced Nephropathy Phase 2 Phase 3 Completed - Singapore ... More >> The Heart Institute Singapore, Singapore, 119074 Less <<
NCT01378585 Healthy Not Applicable Completed - Indonesia ... More >> PT Equilab International Jakarta, Indonesia, 12430 Less <<
NCT00744458 Diabetes Arte... More >>rial Hypertension Less << Not Applicable Completed - Cameroon ... More >> Medical districts of Mfou, Mbankomo Obala and Esse in Central Cameroon Divisions of Mefou and Lékié, Central Province, Cameroon, 4056 Less <<
NCT01866748 Diabetes Diab... More >>etes Mellitus, Type 2 Healthy Less << Phase 1 Completed - Germany ... More >> Berlin, Germany, 14050 Less <<
NCT01266330 Oxidative Stress ... More >> Inflammation Less << Not Applicable Completed - United States, Tennessee ... More >> The University of Tennessee Nutrition and Metabolic Research Laboratory Knoxville, Tennessee, United States, 37996 Less <<
NCT01640834 - Completed - -
NCT01784211 Diabetes Mellitus, Type 1 Phase 1 Completed - Germany ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Neuss, Germany Less <<
NCT00842010 - Completed - United States, Illinois ... More >> John H. Stroger Jr. Hospital Chicago, Illinois, United States, 60612 Less <<
NCT01564797 Diabetes Pre-... More >>diabetes Less << Not Applicable Completed - -
NCT02275845 Gestational Diabetes Mellitus Phase 3 Unknown September 2017 Netherlands ... More >> Maasstad Ziekenhuis Recruiting Rotterdam, Netherlands Contact: Huguette Brink, Drs    +31 10 291 2889    brinkH@maasstadziekenhuis.nl    Contact: Wetenschapsbureau    +31 10 291 3357    wetenschapsbureau@maasstadziekenhuis.nl Less <<
NCT01640834 Diabetes Mellitus, Type 1 Phase 1 Completed - Germany ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Neuss, Germany, 41460 Less <<
NCT03688698 - Completed - -
NCT01509040 - Completed - -
NCT00423215 - Completed - Israel ... More >> Sanofi-Aventis Administrative Office Natanya, Israel Less <<
NCT00932516 Overweight Not Applicable Completed - United States, California ... More >> Medicus Research Northridge, California, United States, 91325 United States, Florida SIBR Research Bradenton, Florida, United States, 34205 Miami Research Associates Miami, Florida, United States, 33143 United States, Virginia Chase Wellness & Research Center Virginia Beach, Virginia, United States, 23455 Less <<
NCT00924534 Type 2 Diabetes Phase 2 Completed - Bulgaria ... More >> Site Reference ID/Investigator# 54183 Dimitrovgrad, Bulgaria, 6400 Site Reference ID/Investigator# 54182 Pleven, Bulgaria, 5800 Site Reference ID/Investigator# 44722 Plovdiv, Bulgaria, 4000 Site Reference ID/Investigator# 44723 Sofia, Bulgaria, 1407 Poland Site Reference ID/Investigator# 44725 Lubin, Poland, 59-301 Site Reference ID/Investigator# 44724 Pulawy, Poland, 24-100 Site Reference ID/Investigator# 54185 Radzymin, Poland, 05-250 Site Reference ID/Investigator# 44727 Ruda Slaska, Poland Site Reference ID/Investigator# 54184 Wroclaw, Poland, 50-349 South Africa Site Reference ID/Investigator# 44728 Cape Town, South Africa, 7130 Site Reference ID/Investigator# 44730 Cape Town, South Africa, 7937 Site Reference ID/Investigator# 44729 Johannesburg, South Africa, 2198 Less <<
NCT00616941 Epithelial Ovarian Cancer ... More >> Fallopian Tube Cancer Primary Peritoneal Cancer Less << Phase 1 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT03406494 Sepsis Not Applicable Not yet recruiting April 30, 2021 -
NCT02090673 - Completed - Korea, Republic of ... More >> Local Institution Seoul, Korea, Republic of, 110-756 Less <<
NCT02170324 Obesity Phase 4 Completed - China, Hubei ... More >> Wuhan General Hospital Wuhan, Hubei, China, 430070 Less <<
NCT01671735 Diabetes Not Applicable Withdrawn(Not considered a cli... More >>nical trial because both treatment protocols have been approved as usual care) Less << August 2013 United States, Michigan ... More >> VA Ann Arbor Healthcare System Ann Arbor, Michigan, United States, 48113-0170 Less <<
NCT03671798 - Recruiting April 2022 Hong Kong ... More >> Department of psychiatry, Faculty of Medicine, The Chinese University of Hong Kong Recruiting Hong Kong, Hong Kong Contact: Jihui Zhang, PhD Less <<
NCT01509040 Cardiac Arrest Phase 1 Phase 2 Completed - United States, Washington ... More >> Harborview Medical Center Seattle, Washington, United States, 98040 Less <<
NCT03263351 Type2 Diabetes ... More >> Type 2 Diabetes Mellitus Insulin Sensitivity Insulin Resistance Depression Adolescent Obesity Less << Not Applicable Recruiting April 1, 2022 United States, Colorado ... More >> Children's Hospital Colorado Recruiting Aurora, Colorado, United States, 80045 Contact: Lauren Shomaker, PhD    720-777-3138    lauren.shomaker@childrenscolorado.org    Contact: Allison Hilkin, BA    (720) 777-6148    allison.hilkin@childrenscolorado.org Less <<
NCT03030534 Health Behavior Not Applicable Active, not recruiting September 2017 -
NCT02631928 Diabetes Mellitus Phase 1 Completed - Germany ... More >> Profil Institut für Stoffwechselforschung GmbH Neuss, Germany, 41460 Less <<
NCT01768546 Pre-diabetes Not Applicable Completed - -
NCT00616941 - Completed - -
NCT02787824 Anemia of Chronic Kidney Disea... More >>se Less << Phase 4 Completed - Greece ... More >> Papageorgiou General Hospital Thessaloniki, Greece, 56403 Less <<
NCT01771133 Obesity Hyper... More >>glycemia Less << Not Applicable Terminated(recruiting or enrol... More >>ling participants has halted prematurely by Life-Moms Consortium and will not resume; participants are no longer being examined or treated.) Less << - Puerto Rico ... More >> University of Puerto Rico Medical Science Campus San Juan, Puerto Rico, 00935 Less <<
NCT00865397 - Completed - Hungary ... More >> Novo Nordisk Investigational Site Budapest, Hungary, 1025 Novo Nordisk Investigational Site Budapest, Hungary, H-1025 Less <<
NCT02545062 Diabetes Mellitus Type 1 ... More >> Diabetes Mellitus Type 2 Mild Cognitive Impairment Less << Not Applicable Unknown August 2016 Israel ... More >> Viviana Ostrovsky Recruiting Nes Tziona, Israel, 7404964 Contact: Viviana VO Ostrovsky, MD    +972503265303    vivianaos@clalit.org.il Less <<
NCT01975766 Head and Neck Neoplasms Not Applicable Terminated(Poor accrual) - United States, Iowa ... More >> Holden Comprehensive Cancer Center Iowa City, Iowa, United States, 52242 Less <<
NCT02324569 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT00042601 Diabetes Mellitus, Type 1 ... More >> Diabetes Mellitus, Type 2 Less << Phase 2 Completed - Australia, South Australia ... More >> Royal Adelaide Hospital Adelaide, South Australia, Australia, 5000 Less <<
NCT03473951 - Recruiting December 2018 Taiwan ... More >> Tri-service General Hospital, songshan branch Recruiting Taipei, Songshan Dist., Taiwan, 105 Contact: Liu, MD    +886-910682383    issac700319@gmail.com    Principal Investigator: Cheng-Wei Liu, MD          Sub-Investigator: Wei-Cheng Chang, MD Less <<
NCT03082729 Psoriasis Car... More >>diovascular Diseases Less << Phase 4 Recruiting January 2021 United States, California ... More >> University of Southern California Recruiting Los Angeles, California, United States, 90033 Contact: Brittany Gibbons, MPH       brittany.gibbons@med.usc.edu    Principal Investigator: April Armstrong, MD, MPH          United States, Maryland Derm Associates, P.C. Recruiting Rockville, Maryland, United States, 20850 Contact: Thomas Blondo       MDiStefano@buffalomedicalgroup.com    Principal Investigator: Benjamin Lockshin, MD FAAD          United States, New York Buffalo Medical Group, P.C. Recruiting Buffalo, New York, United States, 14221 Contact: Mary Anne Hitt       MDiStefano@buffalomedicalgroup.com    Principal Investigator: Robert E Kalb, MD          United States, Oregon Oregon Medical Research Center Recruiting Portland, Oregon, United States, 97223 Contact: Brenda Norton       bnorton@oregonmedicalresearch.com    Principal Investigator: Andrew Blauvelt, MD, MBA          United States, Pennsylvania Dermatology and Skin Surgery Center Recruiting Exton, Pennsylvania, United States, 19341 Contact: Roberta Roth       bobbiroth@aol.com    Principal Investigator: Scott Gottlieb, MD          The University of Pennsylvania Recruiting Philadelphia, Pennsylvania, United States, 19140 Contact: Suzette Baez VanderBeek, MPH    215-662-3515    suzette.baezvanderbeek@uphs.upenn.edu    Principal Investigator: Joel Gelfand, MD MSCE          United States, Texas Center for Clinical Studies Recruiting Houston, Texas, United States, 77004 Contact: Mario Guerrero       mguerrero@ccstexas.com    Principal Investigator: Stephen K Tyring, MD, PhD, MBA Less <<
NCT03424187 Obesity Not Applicable Active, not recruiting April 2019 -
NCT01157936 Systolic and Diastolic Blood P... More >>ressure Levels Uric Acid Levels Metabolic Syndrome Parameters Hepatic Enzymes Less << Phase 2 Completed - Mexico ... More >> Insituto Nacional de Cardiología Ignacio Chávez Mexico, Mexico, 14080 Less <<
NCT01687569 Glycaemic Response Measurement... More >>s Less << Not Applicable Completed - United Kingdom ... More >> Reading Scientific Services Limited (RSSL) Reading,, United Kingdom Less <<
NCT02034591 - Completed - -
NCT02034591 Healthy Subjects Phase 1 Completed - United States, Texas ... More >> Healthcare Discoveries, LLC D/B/A Icon Development Solutions San Antonio, Texas, United States, 78209 Less <<
NCT02355132 - Completed - -
NCT00432809 Diabetes Mellitus, Type 2 ... More >> Obesity Less << Not Applicable Completed - United States, Ohio ... More >> Cleveland Clinic Cleveland, Ohio, United States, 44195 Less <<
NCT02573194 Obesity Not Applicable Completed - Sweden ... More >> Food for Health Science Center Lund, Scania, Sweden, 223 81 Less <<
NCT01358929 Diabetes Mellitus Type 2 Phase 1 Completed - United States, California ... More >> Chula Vista, California, United States, 91911 United States, Ohio Cincinnati, Ohio, United States, 45227 Less <<
NCT03184337 PreDiabetes M... More >>etabolic Syndrome Overweight Less << Not Applicable Completed - United States, California ... More >> University of California, San Francisco San Francisco, California, United States, 94143-0606 Less <<
NCT01927471 - Recruiting December 2018 United States, New York ... More >> Human Metabolic Research Unit, Cornell University Recruiting Ithaca, New York, United States, 14853 Contact: Erica Bender, MSN, CNM    607-255-9417    eb572@cornell.edu    Principal Investigator: Marla E. Lujan, PhD          Strong Fertility Center Recruiting Rochester, New York, United States, 14623 CRC at University of Rochester Medical Center Recruiting Rochester, New York, United States, 14642 Less <<
NCT00254254 Type 2 Diabetes Mellitus Phase 2 Completed - United States, Arkansas ... More >> Research Site Little Rock, Arkansas, United States United States, California Research Site San Diego, California, United States United States, Colorado Research Site Denver, Colorado, United States United States, Kentucky Research Site Louisville, Kentucky, United States United States, Texas Research Site San Antonio, Texas, United States Less <<
NCT01469988 Heart Failure Phase 2 Terminated(Feasibility) - Canada ... More >> Ajax / Pickering Ajax, Canada Brampton (McMaster University) Brampton, Canada Foothills Hospital (University of Calgary) Calgary, Canada The University of Alberta (Mazankowski Alberta Heart Institute): Edmonton, Canada Surrey Memorial Hospital (University of British Columbia) Surrey, Canada Toronto General Hospital (University of Toronto): Toronto, Canada Vancouver General Hospital (University of British Columbia) Vancouver, Canada Less <<
NCT00432809 - Completed - -
NCT00220805 - Completed - -
NCT02750410 Type 2 Diabetes Phase 4 Completed - Japan ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Adachi-ku, Japan, 123-0845 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chiba, Japan, 2610004 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chiyoda, Japan, 102-0082 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chuo-ku, Japan, 103-0027 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Chuo-ku, Japan, 103-0028 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chuou-ku, Japan, 1030002 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fuchu, Japan, 183-8524 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ichikawa, Japan, 272-8516 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Isahaya, Japan, 8548501 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Kamakura, Japan, 247-0056 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Kashihara, Japan, 634-8522 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kumamoto, Japan, 862-0965 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Kumamoto, Japan, 862-0976 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Maebashi-City, Japan, 3710821 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Mito, Japan, 310-0845 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Naka, Japan, 311-0113 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Nishinomiya, Japan, 662-0971 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Ooita, Japan, 870-0039 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Osaka, Japan, 530-0001 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Sasebo, Japan, 857-1195 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Shimotsuke, Japan, 329-0433 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Shizuoka, Japan, 424-0855 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Tama, Japan, 206-0633 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Toda, Japan, 335-0023 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Yokohama, Japan, 241-0821 Less <<
NCT03531398 Nutrition Not Applicable Recruiting September 1, 2018 United Kingdom ... More >> King's College London Recruiting London, UK, United Kingdom, SE1 9NH Contact: Sarah Berry, PhD    020 7848 4088    sarah.e.berry@kcl.ac.uk Less <<
NCT00220805 Macular Degeneration Phase 2 Completed - Germany ... More >> Universitatsklinikum Aachen, Augenklinik Aachen, Germany, 52074 Augenklinik Tausendfensterhaus Duisburg, Germany, 47119 St. Martinus-Krankenhaus, Augenabteilung Düsseldorf, Germany, 40219 Medizinische Eirnrichtungen der Universitat Essen, Klinik fur Erkrankungen des hinteren Augenabschnittes Essen, Germany, 45147 Kliniken und Polikliniken der Albert Ludwigs Universität Freiburg, Germany, 79106 Medizinische Einrichtungen der Universitat zu Koln, Centrum fur Augenheilkunde Koln, Germany, 50931 Klininkum der Eberhard-Karls-Universitat Tubingen, Universitats-Augenklinik Tubingen, Germany, 72076 Less <<
NCT02887898 Type 2 Diabetes Not Applicable Unknown - Denmark ... More >> Hvidovre University Hospital Recruiting Hvidovre, Denmark, 2650 Contact: Merete B. Christensen, MD    +4538623389    merete.bechmann.christensen.01@regionh.dk Less <<
NCT02523001 - Completed - Italy ... More >> Department of Biomedical Sciences Human Oncology - Clinica Medica "A. Murri" Bari, Italy, 70124 Less <<
NCT02413112 Aging Muscle ... More >>Strength Less << Not Applicable Completed - -
NCT00892788 Overweight Ob... More >>esity Less << Phase 2 Completed - United States, Connecticut ... More >> University of Connecticut Health Center Farmington, Connecticut, United States, 06030-3944 Less <<
NCT01422733 Hyperandrogenemia ... More >> Obesity Polycystic Ovary Syndrome Less << Early Phase 1 Withdrawn(The study team decid... More >>ed not to pursue this study.) Less << - United States, Virginia ... More >> University of Virginia Center for Research in Reproduction Charlottesville, Virginia, United States, 22908 Less <<
NCT03146442 Obesity, Adolescent Not Applicable Recruiting July 2021 United States, Indiana ... More >> Purdue University Recruiting West Lafayette, Indiana, United States, 47907 Contact: Heather Leidy, PhD    765-496-0184    hleidy@purdue.edu Less <<
NCT00930384 - Completed - United States, District of Col... More >>umbia George Washington University Department of Dermatology Washington, District of Columbia, United States, 20037 Less <<
NCT02086526 Polycystic Ovary Syndrome Phase 1 Completed - United States, Minnesota ... More >> Mayo Clinic in Rochester Rochester, Minnesota, United States, 55905 Less <<
NCT03342274 Weight Loss Not Applicable Recruiting February 2020 South Africa ... More >> University of the Western Cape Recruiting Cape Town, South Africa Contact: Thandi Puoane, PhD Less <<
NCT00922649 Type 2 Diabetes Not Applicable Completed - United States, California ... More >> The Regents of the University of California on behalf of its San Diego campus La Jolla, California, United States, 92093 AMCR Institute, Inc. San Diego, California, United States, 92026 United States, Georgia Atlanta Diabetes Associates, Inc. Atlanta, Georgia, United States, 30309 United States, Idaho Rocky Mountain Diabetes and Osteoporosis Center, PA Idaho Falls, Idaho, United States, 83404 United States, Kentucky Kentucky Diabetes Endocrinology Center Lexington, Kentucky, United States, 40503 United States, Texas dgd Research, Inc. San Antonio, Texas, United States, 78229 Less <<
NCT03544320 Pre-Diabetes Not Applicable Active, not recruiting May 2019 United States, Pennsylvania ... More >> Penn Medicine Philadelphia, Pennsylvania, United States, 19103 Less <<
NCT02870088 Insulin Sensitivity Not Applicable Completed - -
NCT02862860 Type-1 Diabetes Not Applicable Unknown - France ... More >> CHU Dijon Bourgogne Recruiting Dijon, France, 21079 Contact: Laurence DUVILLARD    3.80.29.36. 46 ext +33    laurence.duvillard@chu-dijon.fr Less <<
NCT01236573 Skin Cancer M... More >>etastatic Melanoma Less << Phase 1 Phase 2 Terminated(Unexpected toxiciti... More >>es, likely due to TIL/IL-12 & low % of durable responses.) Less << - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT03768453 - Recruiting July 1, 2019 China, Shanghai ... More >> Ren Ji Hospital Affliated to School of Medicine, Shanghai Jiao Tong University Recruiting Shanghai, Shanghai, China, 200127 Contact: Jun Pu, Professor    86-21-68383477    pujun310@hotmail.com Less <<
NCT01236573 - Terminated(Unexpected toxiciti... More >>es, likely due to TIL/IL-12 & low % of durable responses.) Less << - -
NCT03527290 Obesity, Abdominal ... More >> Dyslipidemias Insulin Resistance Blood Pressure Weight Loss Less << Not Applicable Completed - United States, California ... More >> Institute for Clinical and Translational Science Irvine, California, United States, 92697 Less <<
NCT02749032 Type 2 Diabetes Phase 1 Completed - Germany ... More >> Diabeteszentrum Bad Lauterberg Bad Lauterberg, Niedersachsen, Germany, 37431 Less <<
NCT02384941 Type 1 Diabetes Mellitus Phase 3 Completed - -
NCT01143493 - Enrolling by invitation - United States, North Carolina ... More >> NIEHS Clinical Research Unit (CRU) Research Triangle Park, North Carolina, United States Less <<
NCT00620191 Amnestic Mild Cognitive Impair... More >>ment Less << Phase 2 Completed - United States, New York ... More >> Columbia University Medical Center New York, New York, United States, 10032 Less <<
NCT01477918 - Unknown - Korea, Republic of ... More >> Asan medical center Not yet recruiting Seoul, Korea, Republic of, 138-736 Contact: Yeon-Ho Joo, Ph. D.    82-2-3010-3412    jooyh@amc.seoul.kr Less <<
NCT00946972 Diabetes Mellitus, Type 2 Phase 1 Terminated(No safety signals w... More >>ere noted. The study completed the main phase, additional potential study cohorts not required.) Less << - -
NCT03336411 Pre-diabetes ... More >>Overweight and Obesity Less << Not Applicable Recruiting September 2020 United States, New York ... More >> New York University School of Medicine Recruiting New York, New York, United States, 10016 Contact: Mary Sevick, ScD    646-501-2606    Personal.diet@nyumc.org    Contact: Lisa Ganguzza       Lisa.Ganguzza@nyumc.org    Principal Investigator: Mary Ann Sevick, MD          Principal Investigator: Eran Segal, PhD Less <<
NCT01572740 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - Japan ... More >> Novo Nordisk Investigational Site Chuo-ku, Tokyo, Japan, 103 0002 Novo Nordisk Investigational Site Ebina-shi, Kanagawa, Japan, 243 0401 Novo Nordisk Investigational Site Ebina-shi, Japan, 243 0432 Novo Nordisk Investigational Site Kashiwara-shi, Osaka, Japan, 582 0005 Novo Nordisk Investigational Site Katsushika-ku, Tokyo, Japan, 125 0054 Novo Nordisk Investigational Site Koriyama-shi, Fukushima, Japan, 963 8851 Novo Nordisk Investigational Site Miyazaki-shi, Japan, 880 0034 Novo Nordisk Investigational Site Naka-shi, Ibaraki, Japan, 311 0113 Novo Nordisk Investigational Site Niigata-shi, Niigata, Japan, 950 1104 Novo Nordisk Investigational Site Nishinomiya-shi, Hygo, Japan, 662 0971 Novo Nordisk Investigational Site Oita-shi, Japan, 870 0039 Novo Nordisk Investigational Site Okawa-shi, Fukuoka, Japan, 831 0016 Novo Nordisk Investigational Site Osaka-shi, Osaka, Japan, 553 0003 Novo Nordisk Investigational Site Ota-ku, Tokyo, Japan, 144 0035 Novo Nordisk Investigational Site Oyama-shi, Tochigi, Japan, 323 0022 Novo Nordisk Investigational Site Sapporo-shi, Hokkaido, Japan, 060 0062 Novo Nordisk Investigational Site Sapporo-shi, Hokkaido, Japan, 062 0007 Novo Nordisk Investigational Site Sendai-shi, Japan, 980 0021 Novo Nordisk Investigational Site Shimotsuke-shi, Tochigi, Japan, 329 0433 Novo Nordisk Investigational Site Shizuoka-shi, Japan, 424 0853 Novo Nordisk Investigational Site Takatsuki-shi, Osaka, Japan, 569 1096 Novo Nordisk Investigational Site Tokyo, Japan, 187 8510 Novo Nordisk Investigational Site Yokohama-shi, Japan, 235 0045 Less <<
NCT00252876 Type 2 Diabetes Phase 3 Terminated(The development pro... More >>gram has been terminated) Less << - -
NCT01572740 - Completed - -
NCT01316016 Obesity Not Applicable Completed - Sweden ... More >> Endocrinology Clinic, Lund University Hospital Lund, Sweden, SE-22185 Less <<
NCT02999048 Hematoma Absorption and Neurol... More >>ogical Function Recovery Less << Phase 4 Completed - -
NCT02939638 Overweight Ob... More >>esity Insulin Resistance Less << Not Applicable Recruiting December 2018 United States, District of Col... More >>umbia Physicians Committee for Responsible Medicine Recruiting Washington, District of Columbia, United States, 20016 Contact: Hana Kahleova, M.D., PhD    202-527-7379    HKahleova@pcrm.org    Contact: Nora Burgess    202-527-7317    nburgess@pcrm.org    Principal Investigator: Neal D Barnard, M.D. Less <<
NCT01265537 Acute Graft Rejection ... More >> Diabetes Less << Not Applicable Unknown December 2017 Canada, British Columbia ... More >> St. Paul's Hospital Recruiting Vancouver, British Columbia, Canada, V6Z 1Y6 Contact: Jesmint Dhillon, BSc    604-862-2344 ext 64708    jdhillon@providencehealth.bc.ca Less <<
NCT00105898 Diabetes Mellitus ... More >> Hypertension Less << Not Applicable Completed - United States, Massachusetts ... More >> VA Boston Healthcare System Brockton Campus, Brockton, MA Brockton, Massachusetts, United States, 02301 Less <<
NCT02653352 Overweight Ch... More >>ildren Less << Not Applicable Completed - -
NCT00511355 Contraception Phase 3 Completed - -
NCT03735316 Vasoplegic Syndrome Phase 2 Recruiting December 31, 2020 United States, Minnesota ... More >> Mayo Clinic Saint Mary's Hospital Recruiting Rochester, Minnesota, United States, 55902 Contact: Midhat Mujic, R.R.T., L.R.T.    507-293-2612    mujic.midhat@mayo.edu    Contact: Brenda Anderson, R.N.    507-255-7157    anderson.brenda@mayo.edu Less <<
NCT02303483 Obese Not Applicable Completed - Denmark ... More >> Medical Research Laboratories, Aarhus University Hospital Aarhus, Denmark, 8000 Less <<
NCT01357889 Diabetes Mellitus, Type 2 Phase 2 Completed - -
NCT00379197 - Terminated(slow accrual) - -
NCT01532765 Epiretinal Membrane Not Applicable Terminated(Resident Project wh... More >>ich was not followed through after graduation) Less << - Canada, Ontario ... More >> Sunnybrook Health Sciences Centre Toronto, Ontario, Canada, M4N 3M5 St. Michael's Hospital Toronto, Ontario, Canada, M5B 1W8 Toronto Western Hospital Toronto, Ontario, Canada, M5T 2S8 Less <<
NCT00511355 - Completed - -
NCT03733743 Diabetes Mellitus, Type 2 ... More >> Insulin Resistance Less << Not Applicable Recruiting March 2019 Netherlands ... More >> Maastricht University Recruiting Maastricht, Limburg, Netherlands, 6229 ER Contact: Jakob Wefers, MSc    +31433884596    jakob.wefers@maastrichtuniversity.nl Less <<
NCT01357889 - Completed - -
NCT00684086 Diabetes Mellitus, Type 2 Not Applicable Completed - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT03388411 - Recruiting October 12, 2018 Korea, Republic of ... More >> Hallym University Kangnam Sacred Heart Hospital Recruiting Seoul, Korea, Republic of, 07440 Contact: Saeam Shin, M.D.    82-2-829-5695    saeam0304@hallym.or.kr Less <<
NCT00379197 Breast Cancer Phase 2 Terminated(slow accrual) - United States, Minnesota ... More >> Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT02884037 - Completed - Egypt ... More >> Nasser H Mousa,MD,mousa_medic@yahoo.com. +201227029213 Mansoura, Egypt Less <<
NCT00727103 Schizophrenia ... More >> Schizoaffective Disorder Alcohol Dependence Nicotine Dependence Less << Phase 4 Terminated(Slow recruitment, h... More >>igh drop-out rate in both arms) Less << - United States, New York ... More >> SUNY Upstate Medical University Syracuse, New York, United States, 13210 Less <<
NCT03392584 - Recruiting December 31, 2018 Norway ... More >> The Norwegian Radium Hospital Oslo University Hospital Recruiting Oslo, Norway, 0379 Contact: Ebbe B Thorgersen, MD PhD    +4722934615    Ebbe.Billmann.Thorgersen@rr-research.no    Contact: Stein G Larsen, MD PhD    +4722934052    STL@ous-hf.no Less <<
NCT00327015 Diabetes Phase 3 Completed - -
NCT03615885 Metabolic Syndrome ... More >> Insulin Resistance Hypertension Less << Not Applicable Completed - United Kingdom ... More >> University of Hertfordshire Hatfield, United Kingdom, AL10 9AB Less <<
NCT02837120 - Unknown July 2016 China, Shandong ... More >> Qilu Hospital of Shandong University Recruiting Jinan, Shandong, China, 250012 Contact: Yuguo Chen, M.D., Ph.D.    86-18678812777    chen919085@126.com Less <<
NCT00327015 - Completed - -
NCT01377558 Type 2 Diabetes Not Applicable Unknown June 2012 Germany ... More >> University of Giessen Giessen, Hessen, Germany, 35394 Sportpark Zwickau, Glauchau, Meerane Zwickau, Sachsen, Germany, 08056 Less <<
NCT01209351 Healthy Volunteers Phase 1 Completed - United States, Texas ... More >> Cetero Clinical Research San Antonio, Texas, United States, 78229 Less <<
NCT01173380 Metabolic Syndrome X Not Applicable Completed - United States, California ... More >> Ragle Human Nutrition Center Davis, California, United States, 95616 Less <<
NCT03544242 Diabetes Phase 2 Recruiting September 7, 2020 United States, Alabama ... More >> University of Alabama at Birmingham Recruiting Birmingham, Alabama, United States, 35294 Contact: Adam Sturdivant, MPH    205-934-4042    Adamsturdivant@uabmc.edu    Principal Investigator: Blair Smith, MD Less <<
NCT00819091 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT02926534 - Completed - Kazakhstan ... More >> Kazakhstan Academy of Preventive Medicine Almaty, Kazakhstan, 050008 Less <<
NCT01516125 - Recruiting July 2020 United States, North Carolina ... More >> Wake Forest Health Sciences Recruiting Winston-Salem, North Carolina, United States, 27157 Contact: Priscilla Ivester, M.A.    336-716-7388    ivester@wakehealth.edu    Contact: Tammy Lee, M.S.    336-716-7388    talee@wakehealth.edu    Principal Investigator: Floyd (Ski) H. Chilton, Ph.D. Less <<
NCT01086800 Cardiovascular Disease ... More >> Obstructive Sleep Apnea Coronary Artery Disease Less << Phase 2 Completed - United States, Maryland ... More >> Johns Hopkins University Baltimore, Maryland, United States, 21224 United States, Massachusetts Partners HealthCare Boston, Massachusetts, United States, 02115 VA Boston Healthcare System Boston, Massachusetts, United States, 02132 United States, Ohio Case Western Reserve University Cleveland, Ohio, United States, 44106 Less <<
NCT03481296 Colorectal Cancer Not Applicable Recruiting June 30, 2022 United States, Maryland ... More >> University of Maryland College Park Recruiting College Park, Maryland, United States, 20742 Contact: Yan Qiao, BS    240-484-3945    yqiao805@umd.edu    Contact: Young S Oh, M.Ed    240-484-6032    ohjoy@umd.edu    Principal Investigator: Sunmin Lee, ScD Less <<
NCT02246400 Obesity Metab... More >>olic Syndrome Pre-diabetes Type 2 Diabetes Cardiovascular Disease Less << Not Applicable Completed - United States, California ... More >> Palo Alto Medical Foundation, Mills Peninsula Division Burlingame, California, United States, 94010 Less <<
NCT00819091 - Completed - -
NCT02205437 - Recruiting December 2018 Spain ... More >> University Hospital Marques de Valdecilla Recruiting Santander, Cantabria, Spain, 39008 Less <<
NCT01562392 Metabolic Syndrome ... More >> Inflammation Aging Fermentation Less << Not Applicable Completed - Sweden ... More >> Applied Nutrition and Food Chemistry, Lund University Lund, Sweden, SE-22100 Less <<
NCT01846117 Oxidative Stress ... More >> Inflammation Aging Pain Less << Phase 1 Phase 2 Completed - Canada, Saskatchewan ... More >> Saskatoon Centre for Patient-Oriented Research Saskatoon, Saskatchewan, Canada, S7K 0M7 Less <<
NCT02372812 Pain Phase 2 Completed - Uganda ... More >> Mulago Hospital National Refferal, surgical wards Kampala, Uganda, +256 Less <<
NCT01062724 Premature Birth Phase 3 Terminated - Mexico ... More >> Intensive Care Unit and Nutrition Parenteral Department, Pediatric Hospital , Instituto Mexicano del Seguro Social Mexico, Distrito Federal, Mexico, 06720 Less <<
NCT01094561 Pancreatic Cancer Not Applicable Completed - United States, New York ... More >> Columbia University Medical Center New York, New York, United States, 10032 Less <<
NCT01094561 - Completed - -
NCT01367223 Inflammatory Response ... More >> Multi-organ Failure Less << Phase 4 Completed - Spain ... More >> Hospital Sant Joan de Déu Esplugues de Llobregat, Barcelona, Spain, 08950 Less <<
NCT01821300 - Active, not recruiting July 1, 2019 United States, District of Col... More >>umbia Children's National Medical Center Washington, District of Columbia, United States, 20010 United States, Pennsylvania The Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT03390881 Fasting Fed Not Applicable Completed - Switzerland ... More >> University of Lausanne Lausanne, Switzerland, 1005 Less <<
NCT02701569 Type 2 Diabetes Not Applicable Completed - -
NCT03192878 - Recruiting July 2019 Italy ... More >> IRCCS Ospedale San Raffaele Recruiting Milano, MI, Italy, 20132 Contact: Elena M Baldissera, MD    +39022643 ext 7254    baldissera.elena@hsr.it    Contact: Giulio Cavalli, MD    +39022643 ext 4683    cavalli.giulio@hsr.it Less <<
NCT01360333 Dehydration H... More >>ydration Less << Not Applicable Completed - Sweden ... More >> Intensive Care Unit, University Hospital Linkoeping, Sweden Less <<
NCT02568982 - Recruiting September 2020 France ... More >> AP-HP, Hôpital Cochin Recruiting Paris, France, 75014 Contact: Jerôme Bertherat, M.D., PhD    + 33 1 58 41 18 95    jerome.bertherat@cch.aphp.fr Less <<
NCT01312467 Adenomatous Polyp ... More >> Colorectal Cancer Obesity Less << Phase 2 Completed - United States, California ... More >> Veterans Administration Long Beach Medical Center Long Beach, California, United States, 90822 University of California Medical Center At Irvine-Orange Campus Orange, California, United States, 92868 Kaiser Permanente - Sacramento Sacramento, California, United States, 95825 Canada, Quebec Jewish General Hospital Montreal, Quebec, Canada, H3T 1E2 Less <<
NCT01849302 Obesity Not Applicable Completed - Sweden ... More >> Department of Applied Nutrition and Food Chemistry Lund, Skane, Sweden, 221 00 Less <<
NCT02789722 Cardiovascular Disease ... More >> Diabetes Less << Not Applicable Completed - Brazil ... More >> Euclides Lara Cardozo Júnior Toledo, Paraná, Brazil, 85.900-000 Less <<
NCT03484858 Glycaemic Response Not Applicable Completed - Singapore ... More >> Clinical Nutrition Research Centre Singapore, Singapore, 117599 Less <<
NCT00939939 Diabetes Mellitus Type 2 Phase 4 Terminated(Recruitment failure... More >>) Less << - Germany ... More >> Medical Dept. 2, Grosshadern, University Munich Munich, Germany, 81377 Less <<
NCT01312467 - Completed - -
NCT01595737 Cardiac Surgery Phase 4 Completed - Spain ... More >> Hospital de la Santa Creu i Sant Pau Barcelona, Spain, 08025 Less <<
NCT00487240 Diabetes Mellitus, Type 1 Phase 3 Completed - -
NCT00487240 - Completed - -
NCT01708096 Diabetes Mellitus Typ 2 and Ob... More >>esity Less << Not Applicable Completed - Sweden ... More >> Karolinska Institutet Stockholm, Stockholm County Council, Sweden, 116 91 Uppsala University Hospital Uppsala, Sweden Less <<
NCT01705678 Metabolic Syndrome Not Applicable Completed - -
NCT03734445 Diabetes Mellitus, Type 2 Not Applicable Not yet recruiting March 26, 2020 -
NCT01526148 Bipolar Disorder Phase 4 Terminated(Ran out of funding) - United States, Ohio ... More >> University Hospitals Cleveland Medical Center - Mood Disorders Program Cleveland, Ohio, United States, 44106 Less <<
NCT02065245 Aging Frailty Phase 1 Phase 2 Active, not recruiting December 2020 United States, Florida ... More >> ISCI/University of Miami Miller School of Medicine Miami, Florida, United States, 33136 Less <<
NCT01663207 - Completed - United States, Texas ... More >> ICON Development Solutions, Gault Lane San Antonio, Texas, United States, 78209 Less <<
NCT01650129 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - Japan ... More >> Novo Nordisk Investigational Site Tokyo, Japan, 1000005 Less <<
NCT01547104 Diabetes Mellitus Type 2 Phase 4 Unknown October 2012 Germany ... More >> ikfe GmbH Recruiting Mainz, Rhineland-Palatinate, Germany, 55116 Contact: Thomas Forst, MD, PhD    + 49 6131 57636 ext 16    ThomasF@ikfe.de    Contact: Daniela Sachsenheimer, MD    + 49 6131 57636 ext 46    DanielaS@ikfe.de    Sub-Investigator: Daniela Sachsenheimer, MD          Sub-Investigator: Stephanie Helleberg, MD          Sub-Investigator: Stefan Diessel          Sub-Investigator: Michael Mitry, MD Less <<
NCT01526148 - Terminated(Ran out of funding) - -
NCT00088374 - Completed - -
NCT00088374 Hippel-Lindau Disease ... More >> Kidney Cancer Less << Phase 2 Completed - United States, Maryland ... More >> National Cancer Institute, National Institutes of Health Bethesda, Maryland, United States, 20892 Less <<
NCT01848353 Insulin Resistance ... More >> Obesity Sedentary Lifestyle Less << Not Applicable Active, not recruiting May 2018 United States, Oklahoma ... More >> Choctaw Nation of Oklahoma Healthcare Hugo, Oklahoma, United States, 74743 Choctaw Nation Diabetes Wellness Center Talihina, Oklahoma, United States, 74571 Less <<
NCT02106182 Nocturia Beni... More >>gn Prostatic Hyperplasia Less << Phase 4 Completed - Korea, Republic of ... More >> Bucheon St.Mary's Hospital Bucheon, Gyeonggi-do, Korea, Republic of, 420-818 Ajou University Hospital Suwon, Gyeonggi-do, Korea, Republic of, 443-380 Pusan Natonal University Hospital Busan, Korea, Republic of, 602-739 Eulji University Hospital Daejeon, Korea, Republic of, 302-799 Hanyang University Hospital Seoul, Korea, Republic of, 133-792 Soon Chun Hyang University Hospital Seoul, Korea, Republic of, 140-887 Less <<
NCT01539070 - Completed - -
NCT03130790 Gastric Cancer Phase 2 Phase 3 Active, not recruiting September 2022 Estonia ... More >> 2 Sites Tallinn, Estonia Hong Kong 1 Site Hong Kong, Hong Kong Korea, Republic of 2 Sites Daegu, Korea, Republic of 1 Site Incheon, Korea, Republic of 1 Site Jeongnam, Korea, Republic of 11 Sites Seoul, Korea, Republic of 2 Sites Suwon, Korea, Republic of Lithuania 2 Sites Kaunas, Lithuania 1 Site Vilnius, Lithuania Malaysia 2 Sites Kuala Lumpur, Malaysia Singapore 1 Site Singapore, Singapore Taiwan 1 Site Kaohsiung, Taiwan 1 Site Taichung, Taiwan 1 Site Taipei, Taiwan Thailand 1 Site Khon Kaen, Thailand 1 Site Pathum Thani, Thailand Less <<
NCT00087516 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT00087516 - Completed - -
NCT01539070 Childhood Obesity Not Applicable Completed - Mexico ... More >> Epidemiology and Health Services Research Unit, Coordination of Health Research. Mexican Institute of Social Security, Mexico, D.F. Mexico, Distrito Federal, Mexico, 06720 Less <<
NCT00783744 Diabetes Mellitus, Type 2 Phase 3 Completed - Austria ... More >> Sanofi aventis administrative office Vienna, Austria Finland Sanofi-aventis administrative office Helsinki, Finland France Sanofi-aventis administrative office Paris, France Germany Sanofi-Aventis Administrative Office Berlin, Germany Italy Sanofi-Aventis Administrative Office Milan, Italy Netherlands Sanofi-Aventis Administrative Office Gouda, Netherlands Spain Sanofi-Aventis Administrative Office Barcelona, Spain Sweden Sanofi-Aventis Administrative Office Bromma, Sweden Switzerland Sanofi-Aventis Administrative Office Geneva, Switzerland United Kingdom Sanofi-Aventis Administrative Office Guildford, United Kingdom Less <<
NCT03325933 Insulin Sensitivity ... More >> Endothelial Dysfunction Blood Pressure Less << Not Applicable Recruiting May 31, 2019 United States, Arizona ... More >> Arizona State University Recruiting Phoenix, Arizona, United States, 85004 Contact: Siddhartha S Angadi, Phd    626-269-9615    sangadi@asu.edu    Contact: Theresa Jorgensen, BS    6028272283    tmjorgen@asu.edu    Principal Investigator: Siddhartha S Angadi, PhD          Sub-Investigator: Robert S Santana, MS          Sub-Investigator: Glenn Gaesser, PhD          Sub-Investigator: Theresa Jorgensen, BS          Sub-Investigator: Corrie Whisner, PhD          Sub-Investigator: Matthew Buman, PhD          Sub-Investigator: Jared Dickinson, PhD          Sub-Investigator: Shannon Wilson, MS Less <<
NCT03480022 Pre Diabetes ... More >>Polycystic Ovary Syndrome Obesity Android Less << Phase 3 Recruiting November 15, 2020 United States, Louisiana ... More >> Woman's Hospital Recruiting Baton Rouge, Louisiana, United States, 70817 Contact: Karen Elkind-Hirsch, PhD.    225-231-5278       Contact: Ericka Seidemann, MS    225-231-5275    ericka.seidemann@womans.org    Principal Investigator: Karen Elkind-Hirsch, Ph.D.          Sub-Investigator: Renee Harris, M.D.          Sub-Investigator: Drake Belanger, MD          Sub-Investigator: Neil Chappell, M.D. Less <<
NCT00280020 Aging Insomni... More >>a Less << Not Applicable Completed - United States, California ... More >> Cousins Center for Psychoneuroimmunology, UCLA Neuropsychiatric Institute Los Angeles, California, United States, 90095 Less <<
NCT01576276 Healthy Controls Not Applicable Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Charlestown, Massachusetts, United States, 02129 Less <<
NCT01293578 Type 2 Diabetes Mellitus Not Applicable Completed - United States, Minnesota ... More >> Albert Lea Medical Center Albert Lea, Minnesota, United States, 56007 Mayo Clinic Kasson Kasson, Minnesota, United States, 55944 Mayo Clinic Health System- Immanual St. Joseph's Mankato, Minnesota, United States, 56002 Hennepin County Medical Center Minneapolis, Minnesota, United States, 55415 Park Nicollet Institute St. Louis Park, Minnesota, United States, 55416 United States, Wisconsin Mayo Clinic Health System-Franciscan Healthcare La Crosse, Wisconsin, United States, 54601 Less <<
NCT03698396 Diabetes Mellitus, Type 1 Phase 1 Phase 2 Not yet recruiting December 1, 2023 -
NCT01768182 Human Immunodeficiency Virus (... More >>HIV) Infection Less << Not Applicable Completed - Brazil ... More >> Hospital de Clínicas de Porto Alegre Porto Alegre, RS, Brazil Less <<
NCT02808013 Lower Urinary Tract Symptoms Phase 2 Unknown - -
NCT01570751 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT01965795 Brain-derived Neurotrophic Fac... More >>tor (BDNF) Cognitive Function Affect Less << Not Applicable Completed - United States, California ... More >> UCLA Semel Institute Los Angeles, California, United States, 90095 Less <<
NCT01576276 - Completed - -
NCT03679910 - Recruiting March 1, 2020 Egypt ... More >> Dina Mohammed Safwat Recruiting Assiut, Egypt Contact: Dina Mohammed, Dr    01017897213    dina_safwat14@yahoo.com Less <<
NCT02941159 Good Health Phase 1 Recruiting February 2018 Zambia ... More >> Tropical Diseases Resaerch Centre Recruiting Ndola, Copperbelt, Zambia, 71769 Contact: Modest Mulenga, MD; PhD    +260-212-620737    mulengam@tdrc.org.zm    Contact: Shepherd Khondowe, MPH    +260-212-620737    khondowes@tdrc.org.zm    Principal Investigator: Ray Handema, PhD          Sub-Investigator: Alasford Ngwengwe, PhD          Sub-Investigator: Victor Mwanakasale, MD; PhD Less <<
NCT01551706 High Oxidation Stress ... More >> Oxidized LDL Level Less << Phase 1 Completed - Canada, Ontario ... More >> KGK Synergize Inc. London, Ontario, Canada, N6A 5R8 Less <<
NCT00576732 Autistic Disorder ... More >> Autism Less << Phase 4 Completed - United States, Alabama ... More >> Dothan, Alabama, United States United States, Arizona Phoenix, Arizona, United States United States, California Sacramento, California, United States Santa Ana, California, United States United States, Florida Boca Raton, Florida, United States Miami, Florida, United States United States, Georgia Smyrna, Georgia, United States United States, Illinois Hoffman Estates, Illinois, United States Naperville, Illinois, United States United States, Louisiana Lake Charles, Louisiana, United States United States, New York Bronx, New York, United States Manhasset, New York, United States New York, New York, United States Staten Island, New York, United States United States, Ohio Columbus, Ohio, United States United States, Oklahoma Oklahoma City, Oklahoma, United States United States, Pennsylvania Philadelphia, Pennsylvania, United States United States, Texas Houston, Texas, United States United States, Virginia Fairfax, Virginia, United States Portsmouth, Virginia, United States Less <<
NCT02367534 Type 1 Diabetes Mellitus Phase 1 Phase 2 Completed - -
NCT01570751 - Completed - -
NCT02740816 - Recruiting January 2021 United States, California ... More >> Stanford University Recruiting Stanford, California, United States, 94305 Contact: Klaira Lerma       familyplanningresearch@stanford.edu    Principal Investigator: Paul D Blumenthal, MD, MPH Less <<
NCT02563704 Malaria Phase 3 Completed - -
NCT01617811 Hepatectomy Not Applicable Completed - China, Zhejiang ... More >> Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University Hangzhou, Zhejiang, China, 310016 Less <<
NCT00225264 Diabetes Mellitus Phase 3 Completed - United States, Illinois ... More >> Chicago, Illinois, United States Less <<
NCT00174993 Diabetes Mellitus Phase 3 Completed - -
NCT01576796 Stage III Non-small-cell Lung ... More >>Cancer Less << Phase 2 Unknown June 2017 France ... More >> Centre Henri Becquerel Rouen, France, 76000 Less <<
NCT02213146 Diabetes Mellitus Type 1 Phase 1 Phase 2 Completed - Germany ... More >> Profil GmbH Neuss, Germany, 41460 Less <<
NCT00576732 - Completed - -
NCT01151917 - Completed - Italy ... More >> Day Hospital of Metabolic Diseases, Catholic University Rome, Italy, 00168 Less <<
NCT01050205 Diabetes Card... More >>iovascular Risk Factor Less << Not Applicable Completed - United States, Pennsylvania ... More >> University of Pittsburgh Pittsburgh, Pennsylvania, United States, 15213 Less <<
NCT02094911 Diabetes Mellitus Type 2 Not Applicable Unknown May 2015 Netherlands ... More >> Wageningen University Wageningen, Netherlands Less <<
NCT01965873 Acute Pancreatitis Phase 4 Completed - -
NCT02990637 Overweight and Obesity ... More >> Elevated Cholesterol Less << Not Applicable Completed - Netherlands ... More >> Maastricht University Medical Center Maastricht, Netherlands Less <<
NCT00529529 Asthma Phase 3 Completed - -
NCT03433248 Type2 Diabetes Phase 4 Recruiting December 1, 2020 Netherlands ... More >> VU University Medical Center Recruiting Amsterdam, Noord-Holland, Netherlands, 1081HV Contact: Michaël JB van Baar, MD    +31 20 444 4709    m.vanbaar@vumc.nl    Contact: Daniël H van Raalte, MD PhD    +31 20 444 0534    d.vanraalte@vumc.nl    Principal Investigator: Mark HH Kramer, MD PhD          Principal Investigator: Daniël H van Raalte, MD PhD Less <<
NCT01513473 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 3 Completed - -
NCT01513473 - Completed - -
NCT01050205 - Completed - -
NCT03221868 Diabetes Mellitus Not Applicable Completed - Brazil ... More >> Physical Education School of the Federal University of Pelotas Pelotas, Rio Grande do Sul, Brazil, 96055-630 Less <<
NCT01068717 - Completed - -
NCT03294915 Prediabetes Not Applicable Not yet recruiting May 2020 -
NCT02644759 Diabetes Mellitus Type 1 ... More >> Autoimmune Diseases Endocrine System Diseases Glucose Metabolism Disorders Immune System Diseases Metabolic Diseases Less << Phase 1 Phase 2 Completed - Jordan ... More >> Stem Cells Arabia Amman, Jordan, 11953 Less <<
NCT00529529 - Completed - -
NCT01068717 Type 2 Diabetes Mellitus Phase 1 Completed - United States, Texas ... More >> Ppd Development, Lp Austin, Texas, United States, 78744 Less <<
NCT01006590 Type 2 Diabetes Mellitus Phase 4 Completed - -
NCT00449553 - Completed - Denmark ... More >> Multiple, Denmark Iceland Multiple, Iceland Norway Multiple, Norway Sweden Multiple, Sweden Less <<
NCT03619941 Metabolic Syndrome ... More >> Insulin Resistance Hypertension Less << Not Applicable Active, not recruiting September 29, 2018 United Kingdom ... More >> University of Hertfordshire Hatfield, Hertfordshire, United Kingdom, AL10 9AB Less <<
NCT01075295 Schizophreniform Disorder ... More >> Bipolar I Disorder Bipolar II Disorder Major Depressive Disorder Substance-Induced Psychoses Psychosis Not Otherwise Specified Schizophrenia Schizoaffective Disorder Less << Not Applicable Completed - Canada, Ontario ... More >> Centre for Addiction and Mental Health Toronto, Ontario, Canada, M5T 1R8 Less <<
NCT00675857 Diabetes Mellitus, Type 2 ... More >> Metabolic Syndrome X Less << Phase 2 Completed - Canada, Alberta ... More >> Calgary, Alberta, Canada, T3B 0M3 Canada, Manitoba Winnipeg, Manitoba, Canada, R3E 3P4 Canada, Ontario Etobicoke, Ontario, Canada, M9R 4E1 London, Ontario, Canada, N6A 4V2 Oakville, Ontario, Canada, L6H 3P1 Ottawa, Ontario, Canada, K1H 1A2 Ottawa, Ontario, Canada, K1K 4L2 Thornhill, Ontario, Canada, L4J 8L7 Toronto, Ontario, Canada, M4R 2G4 Toronto, Ontario, Canada, M5C 2T2 Canada, Quebec Chicoutimi, Quebec, Canada, G7H 5H6 Greenfield Park, Quebec, Canada, J4V 2H1 Laval, Quebec, Canada, H7T 2P5 Montreal, Quebec, Canada, H1T 2M4 Montreal, Quebec, Canada, H2W 1T7 Montréal, Quebec, Canada, H3A 1A1 Montréal, Quebec, Canada, H3H 2L9 Montréal, Quebec, Canada, H3N 1S4 Québec, Quebec, Canada, G1V 4G5 Sherbrooke, Quebec, Canada, J1G 1B8 Sherbrooke, Quebec, Canada, J1H 5N4 Less <<
NCT03215498 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 1 Completed - Germany ... More >> Novo Nordisk Investigational Site Neuss, Germany, 41460 Less <<
NCT03689738 Insulin Sensitivity ... More >> Lipid Metabolism Resistant Starch Potato Less << Not Applicable Recruiting January 1, 2019 United States, Florida ... More >> Melissa Ashe Recruiting Boca Raton, Florida, United States, 33487 Contact: Melissa D Ashe, MS    561-703-5216    mashe@mbclinicalresearch.com    Contact: Cathy Maki, RN, MSN    561-757-5766    cmaki@mbclinicalresearch.com    Principal Investigator: Mary Ann Buggia, MD Less <<
NCT00406653 Crohn's Disease Phase 3 Terminated(Sponsor Decision) - -
NCT01006590 - Completed - -
NCT01285245 Diabetes Mellitus Phase 2 Unknown December 2011 Netherlands ... More >> Radboud University Nijmegen Medical Centre Recruiting Nijmegen, Netherlands, 6500HB Less <<
NCT00879970 Diabetes Mellitus, Type 2 Phase 4 Terminated(FDA has placed the ... More >>trial on full clinical hold.) Less << - -
NCT03374449 Renin Angiotensin System ... More >> Surgery Less << Not Applicable Recruiting April 6, 2021 France ... More >> Hospital Lariboisiere Recruiting Paris, France, 75010 Contact: Etienne Gayat, MD,PhD    01 49 95 55 83 ext +33    etienne.gayat@aphp.fr    Contact: Matthieu Legrand, MD,PhD    Tel. 01 42 49 95 70 ext +33    matthieu.legrand@aphp.fr Less <<
NCT01459770 Chronic Kidney Disease ... More >> End-Stage Renal Disease Less << Not Applicable Completed - United States, Washington ... More >> Providence Sacred Heart Medical Center & Children's Hospital Spokane, Washington, United States, 99204 Less <<
NCT00654485 Metabolic Syndrome Phase 3 Completed - -
NCT00639964 Pregnancy Pre... More >>gnancy in Diabetes Type 1 Diabetes Mellitus Type 2 Diabetes Mellitus Less << Not Applicable Completed - France ... More >> CHRU, Lille Lille, France, 59037 Less <<
NCT03239366 Type2 Diabetes Phase 2 Not yet recruiting October 2018 Canada, Quebec ... More >> Montreal Heart Institute Not yet recruiting Montréal, Quebec, Canada, H1T1C8 Contact: Jean Claude Tardif, MD    514 376 3330    jean-claude.tardif@ICM-mhi.org Less <<
NCT01183013 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT00406653 - Terminated(Sponsor Decision) - -
NCT00879970 - Terminated(FDA has placed the ... More >>trial on full clinical hold.) Less << - -
NCT01183013 - Completed - -
NCT00672919 Diabetes Mellitus Phase 4 Completed - -
NCT02166931 Stress Associated Cognitive In... More >>hibition Essence of Chicken Cognition Immunity Metabolism Less << Phase 4 Unknown October 2014 Taiwan ... More >> Shuang Ho Hospital, Taipei medical University Recruiting New Taipei, Taiwan Contact: Ming-Show Hsieh, R.N.    886-2-22490088 ext 8112    13508@s.tmu.edu.tw    Contact: Chaur-Jong Hu, M.D.    886-2-22490088 ext 8112    chaurjongh@tmu.edu.tw    Principal Investigator: Chaur-Jong Hu, M.D. Less <<
NCT00634751 Pancreatic Neoplasms ... More >> Bile Duct Neoplasms Less << Phase 1 Phase 2 Completed - United States, Wisconsin ... More >> University of Wisconsin Madison, Wisconsin, United States, 53792 Less <<
NCT01597024 Obesity Not Applicable Completed - Greece ... More >> Harokopia Univeristy Athens, Greece Netherlands University Medical Center Utrecht Utrecht, Netherlands, 3584 CX United Kingdom The Rowett Institute of Nutrition and Health, University of Aberdeen Aberdeen, Aberdeenshire, United Kingdom, AB21 9SB Less <<
NCT01863667 Type 2 Diabetes Mellitus Phase 3 Terminated - -
NCT00634751 - Completed - -
NCT00762190 Diabetes Mellitus Phase 3 Terminated(Hepatic safety sign... More >>al identified.) Less << - -
NCT02353845 - Completed - China, Beijing ... More >> Department of Neurolgy,Xuanwu Hospital of Capital Medical University Beijing, Beijing, China, 100053 Less <<
NCT01863667 - Terminated - -
NCT03764267 Breast Diseases Phase 3 Completed - -
NCT02367053 Hypoglycemia Phase 1 Completed - Germany ... More >> Profil GmbH Neuss, Germany, 41460 Less <<
NCT01376557 - Completed - -
NCT01853761 Obesity, Abdominal Not Applicable Completed - Portugal ... More >> Andreia Noites Vila Nova de Gaia, Porto, Portugal, 4400-303 Andreia Noites Vila Nova de Gaia, Porto, Portugal, 4400-330 Less <<
NCT01085331 Metastatic Colorectal Cancer Phase 1 Phase 2 Terminated(Conduct the randomi... More >>zed Phase 2 part not recommended due to the achieved MTD for pimasertib (45mg/day) in combination with FOLFIRI) Less << - Belgium ... More >> Research Site Leuven, Belgium Italy Research Site Napoli, Italy Spain Research Site Barcelona, Spain Less <<
NCT02690168 - Completed - United States, Louisiana ... More >> Pennington Biomedical Research Center Baton Rouge, Louisiana, United States, 70808-4124 Less <<
NCT01376557 Type 2 Diabetes Mellitus Phase 2 Completed - -
NCT01085331 - Terminated(Conduct the randomi... More >>zed Phase 2 part not recommended due to the achieved MTD for pimasertib (45mg/day) in combination with FOLFIRI) Less << - -
NCT00589680 - Unknown July 2008 United States, West Virginia ... More >> St. Mary's Medical Center Huntington, West Virginia, United States, 25702 Less <<
NCT00263887 - Completed - -
NCT03164330 Employee Health and Well-being Not Applicable Active, not recruiting December 2020 United States, Illinois ... More >> University of Chicago Chicago, Illinois, United States, 60605 Less <<
NCT01427556 - Completed - United States, California ... More >> Western Human Nutrition Center, University of California Davis Davis, California, United States, 95616 Less <<
NCT00908284 HIV Acquired ... More >>Immunodeficiency Syndrome Cardiovascular Diseases Less << Not Applicable Completed - United States, Florida ... More >> University of Miami, Department of Pediatrics, Division of Clinical Research, Batchelor Children's Research Institute Miami, Florida, United States, 33136 Less <<
NCT00263887 Alpha 1-Antitrypsin Deficiency Phase 2 Completed - Denmark ... More >> Gentofte Hospital Department of Respiratory Medicine Hellerup, Denmark, 2900 Sweden Department of Pulmonary Medicine, Malmö University Hospital Malmö, Sweden United Kingdom Queen Elizabeth Hospital Birmingham, England, United Kingdom, B15 2TH Less <<
NCT03221673 - Recruiting May 31, 2020 United States, Arkansas ... More >> Arkansas Children's Nutrition Center Recruiting Little Rock, Arkansas, United States, 72202 Contact: Lauren J Ramsey, MS    501-364-3309    acncstudies@uams.edu Less <<
NCT02005939 Cardiovascular Risk Factors Not Applicable Completed - United Kingdom ... More >> Queen Margaret University Edinburgh, Scotland, United Kingdom, EH21 6UU Less <<
NCT01477957 Obesity Diabe... More >>tes Mellitus, Non-Insulin-Dependent Less << Not Applicable Recruiting December 2021 Germany ... More >> DDZ (Deutsches Diabetes Zentrum) Recruiting Düsseldorf, NRW, Germany, 40225 Contact: Michael Roden, Prof. med.    49(0) 2 11-33 82-201    roden@ddz.uni-duesseldorf.de    Contact: Julia Szendrödi, Dr. med Ph.D    0211/3382-203    julia.Szendroedi@ddz.uni-duesseldorf.de Less <<
NCT00308308 Diabetes, Type I Phase 3 Completed - -
NCT02945761 Wound Infection ... More >> Sugar Solution Less << Not Applicable Unknown - -
NCT00308308 - Completed - -
NCT01650181 Liver Disease Phase 4 Completed - Mexico ... More >> Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán Mexico City, Mexico, 14000 Less <<
NCT03715517 Hepatectomy P... More >>ain, Postoperative Liver Neoplasms Less << Not Applicable Recruiting December 2019 Canada, Manitoba ... More >> University of Manitoba Recruiting Winnipeg, Manitoba, Canada, R3E 0Z2 Contact: Alex Grunfeld, MD    204-787-1125    alexander.grunfeld@umanitoba.ca Less <<
NCT00442390 Addison Syndrome Not Applicable Completed - -
NCT03463252 Endometrial Cancer ... More >> Atypical Endometrial Hyperplasia Less << Phase 2 Phase 3 Recruiting December 31, 2020 China, Sichuan ... More >> West China Second University Hospital Recruiting Chengdu, Sichuan, China, 610000 Contact: Zheng Ying, professor    +8613018256012    935398163@qq.com Less <<
NCT01250275 Peripheral Arterial Disease Not Applicable Completed - Canada, Manitoba ... More >> IH Asper Clinical Research Insitute, St. Boniface General Hospital Winnipeg, Manitoba, Canada Less <<
NCT03387709 Overweight and Obesity Not Applicable Recruiting January 2020 United States, California ... More >> University of California, San Diego Recruiting La Jolla, California, United States, 92093 Contact: Elizabeth Quintana, MS, RDN    858-822-6162    elquintana@ucsd.edu Less <<
NCT02863328 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT02180308 Head and Neck Cancer Not Applicable Completed - United States, New York ... More >> NYU Langone Medical Center New York, New York, United States, 10016 Less <<
NCT03557268 - Recruiting May 31, 2020 United States, Colorado ... More >> Children's Hospital Colorado Recruiting Aurora, Colorado, United States, 80045 Contact: Natalie Nokoff, MD    720-777-3607    Natalie.Nokoff@childrenscolorado.org Less <<
NCT01855048 Healthy Volunteers ... More >> Anti-Bacterial Agents Methicillin-Resistant Staphylococcus Aureus Less << Phase 1 Completed - Korea, Republic of ... More >> Seoul National University Hospital Seoul, Korea, Republic of, 110-744 Less <<
NCT01346631 Male Infertility Not Applicable Withdrawn(We didn't start the ... More >>study) Less << May 2012 Israel ... More >> HaEmek Medical Center Afula, Israel Less <<
NCT00455338 Polycystic Ovary Syndrome Not Applicable Completed - -
NCT01410643 Obesity Not Applicable Completed - United States, Alabama ... More >> UAB Birmingham, Alabama, United States, 35294 Less <<
NCT01337440 Type 2 Diabetes Mellitus ... More >> Chronic Liver Disease Less << Phase 4 Unknown March 2013 Japan ... More >> Internal medicine, Kanazawa university hospital Recruiting Kanazawa, Ishikawa, Japan, 920-8641 Contact: Toshinari Takamura, MD, PhD    +81-76-265-2233    ttakamura@m-kanazawa.jp    Sub-Investigator: Kosuke R Shima, MD Less <<
NCT02171273 Aging Sleep R... More >>estriction Circadian Disruption Less << Not Applicable Recruiting May 2019 United States, Massachusetts ... More >> Brigham and Women's Hospital Recruiting Boston, Massachusetts, United States, 02115 Contact: Jacob Medina    617-525-8719    sleepstudy@partners.org    Contact: Jeanne Duffy, PhD    617-732-7995    jduffy@research.bwh.harvard.edu Less <<
NCT00809614 Psoriatic Arthritis Phase 2 Completed - Germany ... More >> Novartis Investigative Site Berlin, Germany, 12203 Novartis Investigative Site Hamburg, Germany, 22081 Novartis Investigative Site Hamburg, Germany, 22415 Novartis Investigative Site Herne, Germany, 44649 Novartis Investigative Site Muenchen, Germany, 80336 Netherlands Novartis Investigative Site Amsterdamn, DE, Netherlands, 1100 Novartis Investigative Site Meerssen, KR, Netherlands, 6231 United Kingdom Novartis Investigative Site Glasgow, United Kingdom, G12 8TA Novartis Investigative Site Leeds, United Kingdom, LS7 4SA Novartis Investigative Site Newcastle upon Tyne, United Kingdom, NE2 4HH Less <<
NCT02777073 Type 1 Diabetes Phase 3 Completed - United States, New York ... More >> ECMC Ambulatory Center, 3rd Floor Buffalo, New York, United States, 14215 Less <<
NCT00809614 - Completed - -
NCT02984709 Type1diabetes Not Applicable Completed - United States, Tennessee ... More >> Vanderbilt University Medical Center Nashville, Tennessee, United States, 37203 Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232 Less <<
NCT01223339 Diabetes Mellitus, Type 2 Phase 1 Completed - -
NCT01607684 Diabetic Polyneuropathy ... More >> Diabetic Gastroparesis Diabetes Mellitus Less << Phase 2 Completed - Germany ... More >> Universitätsklinikum Halle Halle, Germany, 06120 Less <<
NCT02971618 - Completed - Russian Federation ... More >> Research Site Moscow, Russian Federation Research Site Saint Petersburg, Russian Federation Less <<
NCT01349855 Type 1 Diabetes Mellitus Phase 1 Completed - Germany ... More >> Investigational site number 276001 Neuss, Germany Less <<
NCT01397071 Healthy Volunteers Phase 3 Completed - United States, California ... More >> UCLA Center for Human Nutriiton Los Angeles, California, United States, 90095 Less <<
NCT00095056 Diabetes Mellitus, Type 2 ... More >> Chronic Renal Insufficiency Less << Phase 3 Completed - -
NCT00095056 - Completed - -
NCT03241394 - Recruiting September 15, 2017 Greece ... More >> University Hospital of Ioannina Recruiting Ioánnina, Greece Contact: Stelios Tigas, Prof.    0030 6978642944    stigas@cc.uoi.gr Less <<
NCT03315338 Healthy Phase 1 Recruiting August 5, 2018 United Kingdom ... More >> Quotient Clinical Recruiting Nottingham, Nottinghamshire, United Kingdom, NG11 6JS Less <<
NCT00905905 Myocardial Infarction Phase 4 Completed - Brazil ... More >> Hospital de Base do Distrito Federal Brasilia, DF, Brazil, 70673103 Less <<
NCT03144271 Diabetes Diab... More >>etes Mellitus, Type 2 Healthy Less << Phase 1 Completed - Germany ... More >> Novo Nordisk Investigational Site Neuss, Germany, 41460 Less <<
NCT01309477 Nephrotic Syndrome Phase 3 Completed - China, Guangdong ... More >> The First Affiliated Hospital of Sun Yat-sen University Guangzhou, Guangdong, China, 510080 Less <<
NCT01599988 Enteral Feeds Phase 2 Phase 3 Completed - Ireland ... More >> University College Cork Cork, Ireland Less <<
NCT03042325 Diabetes Mellitus, Type 2 Phase 4 Withdrawn(Business decision, n... More >>o safety or efficacy concerns) Less << January 15, 2018 -
NCT02511041 PGM3 Phase 1 Terminated - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT03154294 Advanced Solid Tumor Phase 1 Recruiting July 2021 United States, South Dakota ... More >> Avera Cancer Institute Recruiting Sioux Falls, South Dakota, United States, 57105 Contact: Brian Leyland-Jones    605-322-6900    Brian.LeylandJones@avera.org    Contact: Casey Williams    605-322-6900    Casey.Williams@Avera.org Less <<
NCT03585192 Safety Issues Not Applicable Recruiting June 2019 United States, Ohio ... More >> UH Cleveland Medical Center Recruiting Cleveland, Ohio, United States, 44106 Contact    216-844-1529 Less <<
NCT02296385 Healthy Not Applicable Completed - -
NCT01724424 Sepsis Phase 1 Completed - United Kingdom ... More >> University of Aberdeen Aberdeen, Scoltand, United Kingdom, AB25 2ZD Less <<
NCT03229161 Gestational Diabetes Mellitus ... More >>in Pregnancy Less << Not Applicable Completed - Denmark ... More >> Danish Centre of strategic research of type 2 diabetes Odense, Denmark, 5000 Less <<
NCT00348712 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Terminated(See termination rea... More >>son in detailed description) Less << - -
NCT00343980 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Terminated(See termination rea... More >>son in detailed description) Less << - Australia, New South Wales ... More >> Novo Nordisk Investigational Site St Leonards, New South Wales, Australia, 2065 Novo Nordisk Investigational Site Wollongong, New South Wales, Australia, 2500 Australia Novo Nordisk Investigational Site Garran, Australia, 2605 Novo Nordisk Investigational Site Kingswood, Australia, 2747 Croatia Novo Nordisk Investigational Site Osijek, Croatia, 31 000 Novo Nordisk Investigational Site Zagreb, Croatia, 10 000 India Novo Nordisk Investigational Site Chennai, Tamil Nadu, India, 600086 Novo Nordisk Investigational Site Vellore, Tamil Nadu, India, 632004 Novo Nordisk Investigational Site Bangalore, India, 560010 Novo Nordisk Investigational Site Chennai, India, 600020 Novo Nordisk Investigational Site Coimbatore, India, 641002 Macedonia, The Former Yugoslav Republic of Novo Nordisk Investigational Site Skopje, Macedonia, The Former Yugoslav Republic of, 1000 Philippines Novo Nordisk Investigational Site Cebu City, Philippines, 6000 Novo Nordisk Investigational Site Makati City, Philippines, 1200 Novo Nordisk Investigational Site Manila, Philippines, 1000 Russian Federation Novo Nordisk Investigational Site Moscow, Russian Federation, 119034 Novo Nordisk Investigational Site Moscow, Russian Federation, 121356 Novo Nordisk Investigational Site Moscow, Russian Federation, 127486 Novo Nordisk Investigational Site Moscow, Russian Federation, 127644 Novo Nordisk Investigational Site Saint-Petersburg, Russian Federation, 194354 Novo Nordisk Investigational Site Saint-Petersburg, Russian Federation, 198013 Turkey Novo Nordisk Investigational Site Bornova-IZMIR, Turkey, 35100 Novo Nordisk Investigational Site Bursa, Turkey, 16059 Novo Nordisk Investigational Site Istanbul, Turkey, 34098 Novo Nordisk Investigational Site Istanbul, Turkey, 34390 Novo Nordisk Investigational Site Istanbul, Turkey, 34718 Less <<
NCT01488734 Vitamin D Deficiency ... More >> Metabolic Syndrome Prediabetes Less << Not Applicable Completed - United States, New York ... More >> Icahn School of Medicine at Mount Sinai New York, New York, United States, 10029 Less <<
NCT03230396 Nutrient Pharmacokinetics Not Applicable Completed - -
NCT03608748 - Not yet recruiting May 1, 2019 Israel ... More >> Haemek medical center Afula, Israel, 1834111 Less <<
NCT02139852 Metabolism Phase 1 Unknown January 2016 Canada, Prince Edward Island ... More >> UPEI Charlottetown, Prince Edward Island, Canada, C1A4P3 Less <<
NCT01140295 Colonoscopy Preparation Phase 4 Terminated - United States, Pennsylvania ... More >> The Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT01907399 Obesity Type ... More >>2 Diabetes Healthy Volunteers Less << Not Applicable Unknown - France ... More >> CHU de Dijon Recruiting Dijon, France, 21079 Contact: m CARPENTIER    03.80.29.35.10    maud.carpentier@chu-dijon.fr    Principal Investigator: Bernard BONNOTTE Less <<
NCT01921231 Knee Arthroscopy (for Diagnost... More >>ic or Therapy) Inguinal Hernia Repair (Not Urgent) Less << Phase 4 Completed - Spain ... More >> Vic Hospital Consortium Vic, Catalonia, Spain, 08500 Less <<
NCT01292993 Type 2 Diabetes Mellitus Phase 1 Completed - United States, Texas ... More >> Lexicon Investigational Site San Antonio, Texas, United States, 78209 Less <<
NCT00469586 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Terminated(See termination rea... More >>son in detailed description) Less << - -
NCT02735720 - Recruiting June 2019 United States, Michigan ... More >> Department of Cardiac Surgery, University of Michigan Health System Recruiting Ann Arbor, Michigan, United States, 48109 Contact: Theodorus van Bakel, MD    734-548-1660    vanbakel@med.umich.edu    Contact: Alberto Figueroa, PhD    734-7638680    figueroc@med.umich.edu    Sub-Investigator: Foeke J Nauta, MD          Principal Investigator: Alberto C Figueroa, PhD          Sub-Investigator: Arnoud V Kamman, MD          Sub-Investigator: El-Sayed H Ibrahim, PhD          Sub-Investigator: Prachi P Agarwal, MD          Sub-Investigator: Bo Yang, MD          Sub-Investigator: Karen Kim, MD          Sub-Investigator: David M Williams, MD          Sub-Investigator: Joost A van Herwaarden, MD, PhD          Sub-Investigator: Frans L Moll, MD, PhD          Sub-Investigator: Kim A Eagle, MD          Sub-Investigator: Santi Trimarchi, MD, PhD          Sub-Investigator: Himanshu J Patel, MD          Sub-Investigator: Theodorus MJ van Bakel, MD Less <<
NCT03335878 - Recruiting September 2, 2021 United States, Missouri ... More >> Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: Samantha Ranck, MSW    314-362-6514    rancks@npg.wustl.edu    Contact: Tasha Doty, MA    314-362-7160    dotyt@npg.wustl.edu    Principal Investigator: Tamara G Hershey, PhD Less <<
NCT01217073 Type 2 Diabetes Mellitus Phase 2 Completed - -
NCT02323698 Spinal Cord Injuries Phase 1 Phase 2 Recruiting May 2020 United States, Massachusetts ... More >> Spaulding Rehabilitation Hospital Recruiting Cambridge, Massachusetts, United States, 02138 Contact: Randy D Trumbower, PT, PhD    617-952-6951    randy.trumbower@mgh.harvard.edu    Contact: Lorna Brown, DPT    (617) 952-6950    labtrumbower@gmail.com Less <<
NCT01490229 Coronary Artery Disease Phase 4 Unknown December 2016 Italy ... More >> San Raffaele Pisana Recruiting Rome, Italy, 00100 Contact: Giuseppe Marazzi, MD    +39 335 8381320    giuseppe.marazzi@yahoo.com Less <<
NCT01375153 Healthy Not Applicable Completed - Austria ... More >> Medical University of Vienna Vienna, Austria, 1090 AKH, Medical University of Vienna Vienna, Austria, A-1090 Less <<
NCT01252251 Uveal Melanoma Phase 2 Completed - United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT01068236 Obesity Phase 2 Completed - -
NCT01252251 - Completed - -
NCT01260376 Diabetes Obes... More >>ity Less << Not Applicable Completed - Denmark ... More >> University Hospital of Aarhus, Norrebrogade Aarhus, Denmark, 8000 University Hospital of Aarhus, Norrebrogade Aarhus, Denmark, 8 Less <<
NCT01829906 Obesity, Morbid Not Applicable Terminated(too few candidates ... More >>for enrollment) Less << - Norway ... More >> St. Olavs Hospital Trondheim, Norway Less <<
NCT01640015 Blood Pressure Not Applicable Unknown March 2013 United Kingdom ... More >> Sir John Michael Center - Hammersmith Hospital Not yet recruiting London, United Kingdom, w2 Sub-Investigator: Ghadeer Aljuraiban, Msc Less <<
NCT01140295 - Terminated - -
NCT01217073 - Completed - -
NCT02294123 Diabetes Over... More >>weight Healthy Less << Not Applicable Completed - Mexico ... More >> Mexican National Institute of Public Health Cuernavaca,, Morelos, Mexico, 62100 Less <<
NCT01225744 Metastatic Colorectal Cancer Phase 2 Completed - United Kingdom ... More >> North Wales Cancer Treatment Centre Llansantffraid Glan Conwy, United Kingdom, LL18 5UJ The Royal Marsden London and Surrey, United Kingdom The Christie NHS Foundation Trust Manchester, United Kingdom, M20 4BX Less <<
NCT03332472 Telemedicine Not Applicable Completed - Spain ... More >> Hospital Regional Universitario de Málaga. Unidad de Diabetes Málaga, Spain, 29010 Less <<
NCT01649986 Hyperlipidemia Phase 4 Unknown December 2017 Italy ... More >> Sapienza University Recruiting Rome, Italy, 00166 Contact: Francesco Pelliccia, MD    +39064997 ext 123    f.pelliccia@mclink.it    Principal Investigator: Francesco Pelliccia, MD Less <<
NCT01559181 - Completed - Denmark ... More >> Aarhus Universitetshospital Aarhus, Denmark, 8000 Department of Gynaecology and Obstetrics, Rigshospitalet Copenhagen, Denmark, 2100 Odense University Hospital, Diabetes Research Center Odense, Denmark, 5000 Less <<
NCT01467856 - Completed - United States, Florida ... More >> The Miami Project to Cure Paralysis Miami, Florida, United States, 33136 Less <<
NCT01392677 Type 2 Diabetes Mellitus ... More >> High HbA1c Level Inadequate Glycaemic Control Less << Phase 3 Completed - -
NCT03080207 Lower Extremity Lymphedema Not Applicable Recruiting January 1, 2018 Turkey ... More >> Istanbul University Faculty of Health Science Recruiting Istanbul, Turkey, 34740 Contact: Ahmet Akgul, Prof.Dr.          Contact: Ela Tarakci, Assoc.Prof. Less <<
NCT01917656 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 4 Completed - -
NCT01531933 Prediabetic Phase 3 Completed - Indonesia ... More >> Department of Internal Medicine, dr. M. Djamil Padang Hospital Padang, West Sumatera, Indonesia Less <<
NCT01917656 - Completed - -
NCT00439738 - Completed - -
NCT00439738 Hypertension Phase 4 Completed - United States, Alabama ... More >> Terence T. Hart, MD Muscle Shoals, Alabama, United States, 35662 United States, California Westlake Medical Research Westlake Village, California, United States, 91361 United States, Oklahoma Oklahoma Cardiovascular & Hypertension Oklahoma City, Oklahoma, United States, 73132 United States, Texas Northeast Tarrant Internal Medicine Assoc Euless, Texas, United States, 76040 United States, Washington Frandsen Family Medicine Port Orchard, Washington, United States, 98366 Less <<
NCT02233283 Female Reproductive System Dis... More >>order Less << Not Applicable Completed - Switzerland ... More >> Clinical Research Center, University Hospital Lausanne, Vaud, Switzerland, 1011 Less <<
NCT00228579 - Active, not recruiting December 2020 United States, Indiana ... More >> Purdue University West Lafayette, Indiana, United States, 47906 Less <<
NCT02276430 - Active, not recruiting June 2019 Netherlands ... More >> Antoni van Leeuwenhoek Hospital Amsterdam, Netherlands University Medical Center Groningen Groningen, Netherlands, 9700 RB University Medical Center St. Radboud Nijmegen, Netherlands Less <<
NCT01392677 - Completed - -
NCT00811239 Snake Bite Phase 1 Phase 2 Completed - Vietnam ... More >> Vietnam Poison Control Center, Bach Mai Hospital, HMU Hanoi, Vietnam Less <<
NCT01304095 Coronary Artery Disease ... More >> Angina Metabolic Syndrome Less << Phase 4 Unknown November 2013 United States, Georgia ... More >> Atlanta Heart Specialist, LLC Cumming, Georgia, United States, 30041 Atlanta Heart Specialists, LLC Tucker, Georgia, United States, 30084 Less <<
NCT02261168 Diabetes Mellitus, Type 2 ... More >> Insulin Resistance Less << Not Applicable Completed - Netherlands ... More >> Maastricht University Maastricht, Netherlands Less <<
NCT02272530 - Unknown December 2018 Germany ... More >> University Hospital Duesseldorf Recruiting Duesseldorf, Germany, 40225 Contact: Miriam Cortese-Krott, PhD       Miriam.Cortese@uni-duesseldorf.de    Contact: Georg Wolff       Georg.Wolff@med.uni-duesseldorf.de Less <<
NCT00434850 Diabetes Mellitus, Type 1 Phase 2 Completed - United States, California ... More >> University of Californinia, San Francisco San Francisco, California, United States, 94143 United States, Illinois Northwestern University Chicago, Illinois, United States, 60611 United States, Minnesota University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT01633177 Type 2 Diabetes Not Applicable Unknown October 2017 United States, Massachusetts ... More >> Division of Preventive Medicine, Brigham and Women's Hospital Boston, Massachusetts, United States, 02215 Less <<
NCT01995526 - Completed - -
NCT01995526 Healthy Volunteers Phase 1 Completed - Japan ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fukuoka, Japan, 812-0025 Less <<
NCT01138774 Obesity Body ... More >>Fat Insulin Resistance Less << Not Applicable Completed - Spain ... More >> Department of Nutrition, Food Science, Physiology and Toxicology. University of Navarra Pamplona, Navarra, Spain, 31008 Less <<
NCT01553708 Deep Partial Thickness Burn Phase 2 Phase 3 Completed - Thailand ... More >> Burn Unit, Siriraj Hospital Bangkok, Thailand, 10700 Less <<
NCT01553708 - Completed - -
NCT02374788 Type 2 Diabetes ... More >> Prediabetes Less << Not Applicable Active, not recruiting December 2020 Sweden ... More >> Sophiahemmet University Stockholm, Sweden, 114 86 Less <<
NCT03129776 Uterine Cervical Neoplasms Phase 1 Recruiting October 2019 Canada, Ontario ... More >> Sunnybrook Health Sciences Centre Recruiting Toronto, Ontario, Canada, M4N 3M5 Contact: Julie Green, MSc    416-480-6100 ext 83655    julie.green@sunnybrook.ca    Principal Investigator: Charles Cunningham, PhD Less <<
NCT03108521 Diabetes Mellitus Phase 4 Recruiting March 2019 China, Sichuan ... More >> Sichuan provincial people's hospital Recruiting Chengdu, Sichuan, China, 610000 Contact: Enwu Long, Master    +86 2887393316    dragon984169@126.com Less <<
NCT00422357 Type 2 Diabetes Mellitus Phase 1 Completed - Iran, Islamic Republic of ... More >> Primary Health Care Office Mahmood-Abaad, Mazandaran, Iran, Islamic Republic of Less <<
NCT00960882 Healthy Phase 1 Completed - Mexico ... More >> Pharmacology and toxicology department, UANL Monterrey, Nuevo León, Mexico, 64460 Less <<
NCT01298726 DIABETES MELLITUS, TYPE 2 Not Applicable Completed - Brazil ... More >> Universidade Federal de Ouro Preto Ouro Preto, Minas Gerais, Brazil, 35400-000 Less <<
NCT02081898 Overweight Ob... More >>ese Less << Phase 3 Completed - Korea, Republic of ... More >> Laboratory of Clinical Nutrigenetics/Nutrigenomics Seoul, Korea, Republic of, 120-749 Less <<
NCT01442974 Pancreatic Cancer Not Applicable Completed - Spain ... More >> Centro Integral Oncologico Clara Campal Madrid, Spain, 28050 Less <<
NCT02465346 Acute Stroke Not Applicable Recruiting June 2019 Germany ... More >> Department of Neurology, University Hospital of the Saarland Recruiting Homburg/Saar, Saarland, Germany, 66424 Contact: Klaus C Fassbender, Prof. Dr.    +49-6841-16 ext 24103    klaus.fassbender@uniklinikum-saarland.de    Contact: S          Principal Investigator: Klaus C Fassbender, Prof. Dr.          Sub-Investigator: Andreas Ragoschke-Schumm, MD          Sub-Investigator: Silke Walter, MD Less <<
NCT00941239 Healthy Phase 1 Completed - Mexico ... More >> Pharmacology and toxicology department, UANL Monterrey, Nuevo León, Mexico, 64460 Less <<
NCT03573934 Healthy Not Applicable Completed - Denmark ... More >> Hvidovre University Hospital Hvidovre, Denmark, 2650 Less <<
NCT00958841 Pancreatic Neoplasm ... More >> Pituitary Neoplasm Nelson Syndrome Ectopic ACTH Syndrome Less << Phase 2 Terminated(Slow recruitment ra... More >>te into this study with rare tumors of neuroendocrine origin (enrollment issues)) Less << - -
NCT00958841 - Terminated(Slow recruitment ra... More >>te into this study with rare tumors of neuroendocrine origin (enrollment issues)) Less << - -
NCT02311790 Insulin Sensitivity Not Applicable Completed - United States, Massachusetts ... More >> Jean Mayer Human Nutrition Research Center on Aging Boston, Massachusetts, United States, 02111 Less <<
NCT03699709 Diabetes Mellitus, Type 2 Not Applicable Not yet recruiting November 30, 2021 United States, South Dakota ... More >> Missouri Breaks Industries Research Inc Not yet recruiting Eagle Butte, South Dakota, United States, 57625 Less <<
NCT00574327 - Recruiting January 2024 United States, Missouri ... More >> Department of Veterans Affairs Medical Center Recruiting Kansas City, Missouri, United States, 64128 Principal Investigator: Prateek Sharma, MD          Sub-Investigator: Sharad Mathur, MD          Sub-Investigator: Prashant Pandya, DO Less <<
NCT03089697 Staphylococcus Aureus Bacterem... More >>ia Anti-Bacterial Agents Less << Phase 2 Recruiting April 2020 Korea, Republic of ... More >> Seoul National University Bundang Hospital Recruiting Seongnam-si, Gyeonggi-do, Korea, Republic of, 13620 Contact: Hong Bin Kim, M.D, PhD    +82-31-787-7021    hbkimmd@snu.ac.kr    Seoul National University Hospital Recruiting Seoul, Korea, Republic of, 03080 Contact: Wan Beom Park, M.D, PhD    +82-2-2072-2114    wbpark1@snu.ac.kr Less <<
NCT03237455 Hyperostosis, Diffuse Idiopath... More >>ic Skeletal Metabolic Syndrome Diabetes Mellitus Less << Not Applicable Active, not recruiting December 30, 2019 Israel ... More >> HaEmek MC and Chaim Sheba MC Afula, Israel, 18101 Less <<
NCT01291238 Weight Loss F... More >>ood Habits Mental Retardation Less << Not Applicable Completed - Sweden ... More >> Karolinska Institutet, Department of clinical science, intervention and technology. Division of pediatrics, B62 Stockholm, Sweden, SE-141 86 Less <<
NCT02396888 Angiogenesis Phase 3 Unknown May 2015 Mexico ... More >> Hospital Central Dr. Ignacio Morones Prieto San Luis Potosí, Mexico, 78290 Less <<
NCT01716338 Healthy Volunteers Phase 1 Completed - United States, Missouri ... More >> Washington University in St. Louis Clinical Research Unit (CRU) St. Louis, Missouri, United States, 63110 Less <<
NCT03568864 Healthy Not Applicable Completed - United Kingdom ... More >> St Luke's Campus - University of Exeter Exeter, Devon, United Kingdom, EX1 2LU Less <<
NCT03064542 - Recruiting June 1, 2019 Singapore ... More >> Tan Tock Seng Hospital, Endocrinology Clinic Recruiting Singapore, Singapore, 308433 Contact: Melvin Leow, MD    6407 0105    melvin_leow@sics.a-star.edu.sg    Contact: Yanrong Guo, Msc    83444898    yanrong_GUO@ttsh.com.sg Less <<
NCT00244075 End Stage Renal Disease Phase 2 Completed - United States, Tennessee ... More >> Vanderbilt University Nashville, Tennessee, United States, 37232 Less <<
NCT02908152 Type 2 Diabetes ... More >> Nonalcoholic Fatty Liver Less << Phase 2 Phase 3 Unknown October 2017 Iran, Islamic Republic of ... More >> Not yet recruiting Tehran, Iran, Islamic Republic of Less <<
NCT00874172 Sickle Cell Anemia Not Applicable Completed - France ... More >> Henri Mondor Hospital, Emergency Department Créteil, France, 94000 Less <<
NCT03117998 Type1 Diabetes Mellitus Phase 2 Recruiting June 30, 2019 United States, California ... More >> Altman Clinical and Translational Research Institute Recruiting San Diego, California, United States, 92037 Contact: Todd May    858-657-7039    tmay@ucsd.edu    Diablo Clinical Research Recruiting Walnut Creek, California, United States, 94598 Contact: Caitlin Sheets    925-930-7267    csheets@Diabloclinical.com    Contact: Mark Christiansen, MD          United States, Missouri Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: Karen Flavin    314-747-8592    flavinkarens@wustl.edu Less <<
NCT02615613 Eating Behavior Not Applicable Completed - -
NCT02400203 Overweight Not Applicable Active, not recruiting December 2017 Canada, Manitoba ... More >> Richardson Centre for Functional Foods and Nutraceuticals, University of Manitoba Winnipeg, Manitoba, Canada, R3T 6C5 Less <<
NCT00798161 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT03143933 Stress Phase 2 Phase 3 Recruiting September 2017 Egypt ... More >> Kasr Al Aini Recruiting Cairo, Egypt Contact: Tarek A Radwan    (002) 0122210277    dtradwan@yahoo.com Less <<
NCT00095147 Rheumatoid Arthritis Phase 3 Completed - -
NCT01885208 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT01885208 - Completed - -
NCT00321256 Type 1 Diabetes Mellitus Phase 1 Phase 2 Completed - France ... More >> University Hospital, Department of Endocrinology Besancon, France, 25000 University Hospital, Department of Endocrinology Grenoble, France, 38043 University Hospital, Department of Endocrinology Lyon, France, 69000 University Hospital, Department of Endocrinology Montpellier, France, 34000 University Hospital, Department of Endocrinology Strasbourg, France, 66000 Switzerland University Hospital, Department of Surgery Geneva, Switzerland, 1211 Less <<
NCT00798161 - Completed - -
NCT02621489 Atherosclerosis ... More >> Diabetes Restenosis Less << Phase 4 Recruiting December 2019 Sweden ... More >> Dept of clinical science and education Karolinska Institutet Södersjukhuset Recruiting Stockholm, Other, Sweden, 11883 Contact: Thomas Nyström, MD, PhD    +4686163211    thomas.nystrom@sodersjukhuset.se    Contact: Nils Witt, Md, PhD    +4686161000       Sub-Investigator: Nils Witt, MD, PhD          Sub-Investigator: Irene Santos, MD Less <<
NCT00095147 - Completed - -
NCT00481286 Diabetes Hype... More >>rtension Less << Phase 2 Completed - -
NCT02754037 - Recruiting December 10, 2027 United States, California ... More >> University of California Davis Medical Center Recruiting Sacramento, California, United States, 95817 Contact: Sandeep Dhaliwal    916-734-8696    sandhaliwal@ucdavis.edu    Principal Investigator: Souvik Sarkar, M.D., Ph.D.          Sub-Investigator: Guobao Wang, PhD          Sub-Investigator: Michael Corwin, M.D.          Sub-Investigator: Ramsey Badawi, PhD          Sub-Investigator: Kristin Olson, MD Less <<
NCT02224118 Healthy Diabe... More >>tes Mellitus, Type 2 Less << Phase 1 Completed - Japan ... More >> Fukukoka, Japan Less <<
NCT01038921 - Completed - -
NCT01172093 - Completed - Hong Kong ... More >> Queen Mary Hospital Hong Kong, Hong Kong, 852 Less <<
NCT01846169 Biometrics Not Applicable Completed - United States, Massachusetts ... More >> Boston Medical Center Boston, Massachusetts, United States, 02118 Less <<
NCT01969318 Type 2 Diabetes Phase 2 Completed - China ... More >> Chinese PLA General Hospital Beijing, China Less <<
NCT00654511 - Completed - -
NCT00645099 Schizophrenia Phase 3 Completed - -
NCT01038921 Metabolic Syndrome Phase 2 Completed - United States, Georgia ... More >> Emory Hospital Atlanta, Georgia, United States, 30322 Emory University Atlanta, Georgia, United States, 30322 Less <<
NCT00654511 Tonsillitis Phase 4 Completed - United States, District of Col... More >>umbia Children's National Medical Center Washington, District of Columbia, United States, 20010 Less <<
NCT00922194 Obesity Type ... More >>2 Diabetes Mellitus Less << Not Applicable Completed - India ... More >> Sircar Diabetes Clinic Lucknow, UP, India, 226006 Less <<
NCT00922194 - Completed - -
NCT01970046 Type 2 Diabetes Phase 3 Unknown January 2015 China ... More >> Chinese PLA General Hospital Recruiting Beijing, China Contact: Changyu Pan, M.D.       panchy301@aliyun.com    Principal Investigator: Changyu Pan, M.D. Less <<
NCT00645099 - Completed - -
NCT02043054 Type 2 Diabetes Mellitus ... More >> Cardiovascular Disease Less << Phase 3 Completed - United Kingdom ... More >> University Hospitals of Leicester NHS Trust, Diabetes Research Centre Leicester, Leicestershire, United Kingdom, LE5 4PW Less <<
NCT02158676 Obesity Not Applicable Completed - Brazil ... More >> Hospital Universitário Polydoro Ernani de São Thiago Florianópolis, Santa Catarina, Brazil, 88040-900 Less <<
NCT01142596 - Completed - -
NCT00843765 Stroke Not Applicable Completed - China, Beijing ... More >> China Academy of Chinese Medical Sciences Beijing, Beijing, China, 100700 Less <<
NCT01588639 - Completed - China ... More >> Many Locations, China Less <<
NCT01142596 Schizophrenia Phase 3 Completed - -
NCT01345149 Obesity Not Applicable Completed - Denmark ... More >> Department of Obstetrics and Gynecology, Hvidovre University Hospital Copenhagen, Denmark, DK-2650 Less <<
NCT01969357 Type 2 Diabetes Phase 2 Completed - China ... More >> Chinese PLA General Hospital Beijing, China Less <<
NCT03171623 Hyperglycaemia (Diabetic) ... More >> Healthy Volunteers Less << Phase 1 Completed - China, Jiangsu ... More >> The First Affiliated Hospital of Nanjing Medical University Nanjing, Jiangsu, China Less <<
NCT00828542 Breastfeeding ... More >> Contraception Less << Not Applicable Completed - Brazil ... More >> University of Sao Paulo Ribeirao Preto, Sao Paulo, Brazil, 14049-900 Less <<
NCT00828542 - Completed - -
NCT03560375 Diabetes Mellitus, Type 2 ... More >> Sarcopenia Weight Loss Frailty Less << Phase 4 Recruiting November 2020 Israel ... More >> The Institute of Endocrinology Metabolism and Hypertension Recruiting Tel Aviv, Israel, 64239 Contact: Naftali Stern, Professor    +972-3-6973732    naftalis@tlvmc.gov.il    Principal Investigator: Naftali Stern, Professor          Sub-Investigator: Roy Eldor, PhD Less <<
NCT01528254 Type 2 Diabetes Mellitus Phase 4 Active, not recruiting April 18, 2019 -
NCT02672527 Soft Tissue Sarcoma Phase 3 Completed - France ... More >> Gustave Roussy Cancer Campus Grand Paris Villejuif, Val De Marne, France, 94805 Less <<
NCT00529841 Adrenal Hyperplasia, Congenita... More >>l Less << Not Applicable Completed - United States, Texas ... More >> BCM, Texas Children's Hospital Clinic and General Clinical Research Center Houston, Texas, United States, 77030 Less <<
NCT01871350 Cancer Patients Receiving Chem... More >>otherapy or Chemoradiotherapy Less << Not Applicable Active, not recruiting October 2019 United States, Texas ... More >> Texas A&M University College Station, Texas, United States, 77843 Less <<
NCT01894568 Type 2 Diabetes Mellitus Phase 3 Completed - Japan ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Aichi, Japan, 455-8530 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chiba, Japan, 277-0825 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fukuoka, Japan, 807-0857 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hokkaido, Japan, 060-0062 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hyogo, Japan, 662-0971 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ibaraki, Japan, 311-0113 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kagawa, Japan, 765-0071 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kanagawa, Japan, 247-0056 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kumamoto, Japan, 862-0976 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kyoto, Japan, 6150035 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Miyagi, Japan, 980-0021 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Miyazaki, Japan, 880-0034 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nagano, Japan, 399-0006 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ooita, Japan, 8700039 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Osaka, Japan, 569-1096 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tochigi, Japan, 323-0022 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tokyo, Japan, 143-8541 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Yamaguchi, Japan, 751-0815 Korea, Republic of For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Daegu, Korea, Republic of, 700-712 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Incheon, Korea, Republic of, 405-760 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Pusan, Korea, Republic of, 602-739 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Seoul, Korea, Republic of, 158-710 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ulsan-Si, Korea, Republic of, 682-714 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Wonju-Si, Korea, Republic of, 220-701 Taiwan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Jhonghe City, Taiwan, 235 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sindian City, Taiwan, 23148 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Taichung County, Taiwan, 433 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Taichung, Taiwan, 404 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tainan, Taiwan, 70403 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Taipei, Taiwan, 220 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Yongkang City, Taiwan, 71004 Less <<
NCT03588117 - Completed - -
NCT03718715 - Not yet recruiting March 2021 -
NCT01530139 Dietary Modification Not Applicable Completed - Germany ... More >> Technische Universitaet Muenchen München, Germany Greece The Harokopio University Athens, Greece Ireland University College Dublin Dublin, Ireland Netherlands Maastricht University Maastricht, Netherlands Poland National Food and Nutritional Institute Warsaw, Poland Spain University of Navarra Navarra, Spain United Kingdom Newcastle University Newcastle, United Kingdom, NE45PL University of Reading Reading, United Kingdom Less <<
NCT02132338 Type 2 Diabetes Mellitus Early Phase 1 Unknown November 2017 Brazil ... More >> Federal University of Minas Gerais Belo Horizonte, Minas Gerais, Brazil Less <<
NCT02863211 - Active, not recruiting February 2022 Canada, Manitoba ... More >> St-Boniface Hospital Albrechtsen Research Center Winnipeg, Manitoba, Canada, R2H 2A6 Less <<
NCT00667732 - Completed - -
NCT02649140 Urolithiasis Not Applicable Unknown March 2016 China, Guangdong ... More >> Department of Urology, Minimally Invasive Surgery Center, The First Affiliated Hospital of Guangzhou Medical University Recruiting Guangzhou, Guangdong, China, 510230 Contact: Guohua Zeng, Ph.D and M.D    +86 13802916676    gzgyzgh@vip.tom.com    Principal Investigator: Guohua Zeng, Ph.D and M.D          Sub-Investigator: Zhou Yang Less <<
NCT00601250 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT00601250 - Completed - -
NCT00661921 Diabetes Mellitus Phase 2 Withdrawn(Program Development ... More >>discontinued) Less << October 2009 -
NCT02853435 Infections, Bacterial Phase 1 Completed - United States, California ... More >> GSK Investigational Site Anaheim, California, United States, 92801 United States, Texas GSK Investigational Site Austin, Texas, United States, 78744 Less <<
NCT00667732 Type 2 Diabetes Phase 4 Completed - United States, District of Col... More >>umbia Medstar Research Institute Washington DC, District of Columbia, United States, 20003 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, Oregon Oregon Health and Science University Portland, Oregon, United States, 97239 Less <<
NCT03600337 PCOS Not Applicable Recruiting March 31, 2019 United States, Texas ... More >> University of Texas at Austin Recruiting Austin, Texas, United States, 78712 Contact: Cara C Young, PhD Less <<
NCT02853435 - Completed - -
NCT02453711 Metabolism and Nutrition Disor... More >>der Obesity Less << Phase 2 Completed - -
NCT01114750 Diabetes Mellitus Phase 1 Suspended October 2010 Sweden ... More >> Karolinska Trial Alliance (KTA), Phase I Unit Stockholm, Sweden Less <<
NCT02176889 Healthy Phase 1 Completed - Canada, Ontario ... More >> KGK Synergize Inc. London, Ontario, Canada, N6A 5R8 Less <<
NCT02623894 - Unknown December 2017 Spain ... More >> Primary care Research unit. La Alamedilla health centre Recruiting Salamanca, Spain, 37003 Contact: Jose I Recio    0034 923124465    Lgarciao@usal.es    Principal Investigator: Manuel A Gomez Marcos, MD          Sub-Investigator: Luis Garcia Ortiz, MD          Sub-Investigator: José I Recio Rodríguez          Sub-Investigator: Yolanda Castaño Sánchez          Sub-Investigator: Emiliano Rodríguez Sanchez, MD          Sub-Investigator: Angel de Cabo Laso          Sub-Investigator: Benigna Sanchez Salgado          Manuel A Gómez Marcos Completed Salamanca, Spain, 37006 Less <<
NCT02865408 Critical Illness ... More >> Inflammation Malnutrition Less << Not Applicable Recruiting February 28, 2020 Canada, Quebec ... More >> McGill University health Centre Recruiting Montréal, Quebec, Canada, H4A 3J1 Contact: Arnold Kristof, MD    514-934-1934    arnold.kristof@mcgill.ca    Contact: Josie Campisi, MSc    514-934-1934 ext 65542    josie.campisi@muhc.mcgill.ca Less <<
NCT03762096 Diabetes Mellitus, Type 2 ... More >> Coronary Artery Disease Less << Not Applicable Recruiting December 31, 2021 United States, Maine ... More >> Maine Medical Center Recruiting Portland, Maine, United States, 04102 Less <<
NCT01670175 Malignant Solid Tumor ... More >> Childhood Solid Tumor Less << Phase 1 Completed - United States, California ... More >> UCSF Benioff Children's Hospital San Francisco, California, United States, 94143 Less <<
NCT02455765 Metabolic Diseases Not Applicable Completed - -
NCT03273517 - Recruiting November 1, 2017 Brazil ... More >> Santa Casa of São Paulo Medical School Recruiting São Paulo, SP, Brazil Contact: Débora de Oliveira Cumino       dcumino@gmail.com    Sub-Investigator: Carolina Lima Moura          Sub-Investigator: Fernanda Bourroul Villela Pedras          Sub-Investigator: Maíra Fernandes Gonçalves Less <<
NCT01697618 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 2 Completed - Netherlands ... More >> Novo Nordisk Investigational Site Alphen a/d Rijn, Netherlands United Kingdom Novo Nordisk Investigational Site Crawley, United Kingdom, RH11 9RT Less <<
NCT00312104 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 3 Completed - -
NCT00395486 - Completed - -
NCT00395486 Metabolic Syndrome X Phase 4 Completed - Korea, Republic of ... More >> Research Site Pusan, Korea, Republic of Research Site Seoul, Korea, Republic of Research Site Suwon, Korea, Republic of Less <<
NCT00321932 Leukemia Lymp... More >>homa Myelodysplastic Syndromes Osteoporosis Ovarian Cancer Less << Phase 2 Completed - United States, Minnesota ... More >> Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States, 55455 United States, Wisconsin University of Wisconsin Paul P. Carbone Comprehensive Cancer Center Madison, Wisconsin, United States, 53792-6164 Less <<
NCT00321932 - Completed - -
NCT00515463 Low Bone Mineral Density ... More >> Osteopenia Osteoporosis Less << Phase 3 Completed - -
NCT02157844 - Active, not recruiting February 2019 United States, Texas ... More >> Texas A&M University College Station, Texas, United States, 77843 Less <<
NCT03482830 - Recruiting February 2019 Denmark ... More >> Department of Surgery, Zealand University Hospital Recruiting Køge, Denmark, 2300 Contact: Sarah Ekeloef    +45 47323012    savb@regionsjaelland.dk Less <<
NCT01240499 Overweight Not Applicable Completed - Canada ... More >> INAF, Laval University Quebec, Canada, G1V 0A6 Less <<
NCT00515463 - Completed - -
NCT01307475 - Terminated(Most study procedur... More >>es incorporated into NCT01144741, some in NCT01306994) Less << - United States, West Virginia ... More >> Freeman-Sheldon Research Group, Inc. Headquarters Buckhannon, West Virginia, United States, 26201 Guatemala San Juan de Dios General Hospital Guatemala City, Guatemala Less <<
NCT01539798 Edema Periope... More >>rative/Postoperative Complications Less << Not Applicable Completed - Brazil ... More >> Hospital Universitario Julio Mullar Cuiaba, Mato Grosso, Brazil, 78000-000 Less <<
NCT01744067 Disorder Related to Renal Tran... More >>splantation Less << Phase 4 Completed - Norway ... More >> Oslo University Hospital Rikshospitalet Oslo, * Other, Norway, 0424 Oslo University Hospital, Rikshospitalet Oslo, Norway, 0027 Less <<
NCT01288326 - Completed - Belgium ... More >> Novo Nordisk Investigational Site Brussels, Belgium, 1070 Less <<
NCT02628392 Type2 Diabetes Mellitus Not Applicable Completed - Japan ... More >> Heishinkai Medical Group Incorporated OCROM Clinic Suita-shi, Osaka, Japan Less <<
NCT01756417 Healthy Phase 1 Completed - United States, New Jersey ... More >> Neptune, New Jersey, United States Less <<
NCT02226471 - Completed - -
NCT01805258 HIV/TB Co-infection Phase 3 Completed - India ... More >> All India Institute of Medical Sciences New Delhi, India, 110029 Less <<
NCT01914315 Heart Failure Not Applicable Unknown June 2016 Israel ... More >> Sheba medical Center Recruiting Ramat Gan, Israel Contact: Nava Levine Tiefenbrun, Dr.       Nava.LevineTiefenbrun@sheba.health.gov.il    Sheba Medical Center, Cardiac Rehabilitation Institute Not yet recruiting Tel Hashomer , Ramat Gan, Israel Contact: Robert Klempfner, MD    +972525506852    klempfner@gmail.com    Contact: Merav Moreno, Msc       Merav.Moreno@sheba.health.gov.il    Sub-Investigator: Robert Klempfner, MD Less <<
NCT00781625 Urinary Tract Infections Not Applicable Unknown December 2010 Norway ... More >> Akershus Universitetssykehus HF Recruiting Lørenskog, Akershus, Norway, 1478 Contact: Caroline U Skagemo, MD    +47 02900111    cask@ahus.no    Contact: Gunn Iren Meling, PhD, MD    +47 02900 111    gmel@ahus.no    Principal Investigator: Caroline U Skagemo, MD          St.Olavs Hospital Active, not recruiting Trondheim, Norway, 7006 Less <<
NCT02063633 - Unknown December 2015 Taiwan ... More >> Far Eastern Memorial Hospital Recruiting New Taipei City, Taiwan, 220 Contact: Shu-Wen Chang, Professor    +886-277282152    irb@mail.femh.otg.tw    Principal Investigator: Shan-Ying Wang, M.D. Less <<
NCT01185054 Gastroenteritis Phase 2 Completed - Canada, Ontario ... More >> The Hospital for Sick Children Toronto, Ontario, Canada, M5G 1X8 Less <<
NCT01352182 Severe Sepsis ... More >> Septic Shock Less << Phase 1 Phase 2 Completed - United States, Ohio ... More >> Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229 Less <<
NCT01511198 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 2 Completed - -
NCT03131687 Type 2 Diabetes Mellitus Phase 2 Completed - -
NCT01326351 Plantar Fasciitis Phase 4 Unknown February 2012 Canada, New Brunswick ... More >> Dr.-Georges-L.-Dumont University Hospital Centre Not yet recruiting Moncton, New Brunswick, Canada, E1C 2Z3 Contact: Richard Dumais, MD    506-862-4721    rdumais72@gmail.com    Principal Investigator: Richard Dumais, MD Less <<
NCT03407079 Healthy Volunteers ... More >> Overweight Less << Phase 2 Recruiting August 1, 2021 United States, Maryland ... More >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)    800-411-1222 ext TTY8664111010    prpl@cc.nih.gov Less <<
NCT01698944 Growth Hormone Disorder ... More >> Adult Growth Hormone Deficiency Less << Phase 4 Terminated(The trial was prema... More >>turely terminated due to low recruitment) Less << - Greece ... More >> Novo Nordisk Investigational Site Athens, Greece, GR-11527 Less <<
NCT02300571 - Recruiting January 2018 Italy ... More >> Fondazione del Piemonte per l'Oncologia Recruiting Candiolo, Italy, 10060 Contact: Luisa Gioeni, PharmD    +39011993 ext 3959    luisa.gioeni@ircc.it    Sub-Investigator: Fabrizio Carnevale Schianca, MD          Sub-Investigator: Daniela Caravelli, MD          Sub-Investigator: Dario Sangiolo, MD          Sub-Investigator: Susanna Gallo, MD          Sub-Investigator: Valentina Coha, MD          Sub-Investigator: Giovanni Grignani, MD          Sub-Investigator: Delia Rota Scalabrini, MD          Sub-Investigator: Marco Fizzotti, MD          Ospedale Regina Margherita Not yet recruiting Torino, Italy, 10126 Contact: Massimo Berger, MD    +39011.313 ext 5360    massimoberger@gmail.com    Principal Investigator: Franca Fagioli, MD          Sub-Investigator: Elena Vassallo, MD          Sub-Investigator: Massimo Berger, MD          Sub-Investigator: Francesca Nesi, MD          Sub-Investigator: Paola Quarello, MD Less <<
NCT02390141 Hypoglycemia Phase 1 Completed - Germany ... More >> Profil GmbH Neuss, Germany, 41460 Less <<
NCT01295229 Diabetes Mellitus, Type 2 ... More >> Obesity Less << Not Applicable Completed - United States, Washington ... More >> Group Health Research Institute Seattle, Washington, United States, 98101 Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109 Less <<
NCT00184561 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 4 Completed - China, Beijing ... More >> Novo Nordisk Investigational Site Beijing, Beijing, China, 100029 Novo Nordisk Investigational Site Beijing, Beijing, China, 100730 China, Guangdong Novo Nordisk Investigational Site Guangzhou, Guangdong, China, 510120 China, Hubei Novo Nordisk Investigational Site Wuhan, Hubei, China, 430022 China, Jiangsu Novo Nordisk Investigational Site Nanjing, Jiangsu, China, 210008 China, Shaanxi Novo Nordisk Investigational Site Xi'an, Shaanxi, China, 710032 China, Shanghai Novo Nordisk Investigational Site Shanghai, Shanghai, China, 200003 China, Tianjin Novo Nordisk Investigational Site Tianjin, Tianjin, China, 300070 Less <<
NCT00675506 Abdominal Obesity ... More >> Growth Hormone Deficiency Less << Phase 2 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT01824121 Progressive Supranuclear Palsy Phase 1 Phase 2 Unknown December 2014 Italy ... More >> ICP Parkinson Institute Recruiting Milano, Italy, 20126 Principal Investigator: Gianni Pezzoli, MD          Sub-Investigator: Margherita Canesi, MD Less <<
NCT02053766 Mitochondrial Diseases Not Applicable Recruiting December 2019 United States, Texas ... More >> University of Texas Health Science Center at Houston Recruiting Houston, Texas, United States, 77030 Contact: Adejumo, MBBS, MPH    713-500-7147    Rahmat.B.Adejumo@uth.tmc.edu    Principal Investigator: Maria Matuszczak, MD          Sub-Investigator: Mary Kay Koenig, MD          Sub-Investigator: Jael Carbajal, MD Less <<
NCT00937742 Cardiovascular Disease Not Applicable Completed - United States, Pennsylvania ... More >> Penn State University University Park, Pennsylvania, United States, 16802 Less <<
NCT00675506 - Completed - -
NCT02175654 Colorectal Neoplasms ... More >> Metastatic Disease Less << Phase 2 Terminated(The trial was prema... More >>turely closed due to lack of accrual) Less << - Spain ... More >> Spanish Cooperative Group for Digestive Tumour Therapy (TTD) Madrid, Spain, 28046 Less <<
NCT02143518 Hookworm Infection ... More >> Hookworm Disease Less << Phase 1 Completed - United States, District of Col... More >>umbia George Washington University Medical Faculty Associates Washington, D.C., District of Columbia, United States, 20036 Less <<
NCT01200836 - Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT03173963 Diabetic Kidney Disease ... More >> Diabetes Mellitus Type 2 Less << Phase 3 Recruiting June 30, 2023 United States, Arizona ... More >> NIDDK, Phoenix Recruiting Phoenix, Arizona, United States, 85014 Contact: Helen Looker    602-200-5215    helen.looker@nih.gov Less <<
NCT00433069 Chronic Hepatitis C Phase 2 Completed - Switzerland ... More >> Service de Gastroentérologie et d'Hépatologie, University Hospital Geneva, GE, Switzerland, 1211 Less <<
NCT01194830 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT01194830 - Completed - -
NCT02520167 Pregnancy Not Applicable Completed - United States, Colorado ... More >> Denver Health Eastside Family Health Center Denver, Colorado, United States, 80205 Less <<
NCT01578980 - Completed - -
NCT00095498 Rheumatoid Arthritis Phase 2 Completed - -
NCT00095498 - Completed - -
NCT01651754 Postcancer Fatigue ... More >> Chronic Fatigue Syndrome Less << Not Applicable Completed - Netherlands ... More >> University Medical Centre Nijmegen st Radboud Nijmegen, Netherlands Less <<
NCT03554590 Type 1 Diabetes Mellitus Not Applicable Recruiting January 2020 Italy ... More >> Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Recruiting Milan, Italy, 20133 Contact: Valeria Grancini, MD    00393926233299    valeria_grancini@hotmail.it Less <<
NCT01440127 Colon Cancer Phase 1 Terminated(Unable to accrue al... More >>l planned subjects in a timely fashion, but data collected will still be analyzed.) Less << - United States, Massachusetts ... More >> Tufts Medical Center Boston, Massachusetts, United States, 02111 Less <<
NCT01898611 Frailty Syndrome Phase 2 Completed - United States, Pennsylvania ... More >> Clinical and Translational Research Center, University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104-5160 Less <<
NCT01578980 Type 1 Diabetes Mellitus Not Applicable Completed - United States, California ... More >> Sansum Diabetes Research Institute Santa Barbara, California, United States, 93105 United States, Virginia University of Virginia Charlottesville, Virginia, United States, 22904 Less <<
NCT00455598 Type 2 Diabetes Mellitus Phase 2 Completed - Poland ... More >> Niepubliczny Zakład Opieki Zdrowotnej Specjalistyczny Ośrodek Internistyczno Bialystok, Poland, 15-435 Akademickie Centrum Kliniczne- Szpital Akademii Medycznej w Gdańsku Gdańsk, Poland, 80-952 Poradnia Neurologiczna i Poradnia Poznań, Poland, 61-289 Niepubliczny Zakład Opieki Radom, Poland, 26-610 Indywidualna Specjalistyczna Praktyka Lekarska Szczecin, Poland, 70-361 ll Oddzial Chorob Wewnetrznych Tychy, Poland, 43-100 Samodzielny Zespół Publicznych Zakladów Opieki Zdrowotnej Wolomin, Poland, 05-200 Romania Arad Emergency Clinical County Hospital, Clinic of Diabetes, Nutrition and Metabolic Diseases Arad, Romania, 310158 Cardiology Private PRactice "Dr. Calin Pop" Baia Mare, Romania, 430123 Private Practice SC "Diabol" SRL Brasov, Romania, 500365 Private Practice Nicodiab SRL Bucharest, Romania, 010507 Medical Centre of Diagnosis, Outpatient Treatment and Preventive Medicine, Department of Diabetes, Nutrition and Metabolic Diseases Bucharest, Romania, 011794 "Prof. Dr. N.C. Paulescu" National Institute of Diabetes, Nutrition and Metabolic Diseases, 1st Clinical Department of Diabetes, Nutrition and Metabolic Diseases Bucharest, Romania, 020475 "Nicolae Malaxa" Clinical Hospital, Department of Diabetes, Nutrition and Metabolic Diseases Bucharest, Romania, 022441 Cluj Emergency Clinical County Hospital Cluj-Napoca, Romania, 400006 Deva County Hospital, Department of Internal Medicine Deva, Romania, 330084 Private Practice "Morosanu V. Magdalena" Galati, Romania, 800371 Oradea Clinical County Hospital, Department of Diabetes, Nutrition and Metabolic Diseases Oradea, Romania, 410032 S.C. Diabmed Dr. Popescu Alexandrina SRL Ploiesti, Romania, 100163 Satu Mare County Hospital, Department of Diabetology and Nutrition Diseases Satu Mare, Romania, 440055 Sibiu Clinical County Hospital, Clinic of Diabetes, Nutrition and Metabolic Diseases Sibiu, Romania, 550245 "Sf. Ioan cel Nou" Suceava Emergencency County Hospital, Clinic of Diabetes, Nutrition and Metabolic Diseases Suceava, Romania, 720284 Private Practice "Dr. Gagiu Remus" Targoviste, Romania, 130083 Russian Federation State Institution of Healthcare "Kemerovo Regional Clinical Hospital" Kemerovo, Russian Federation, 650066 State Institution "Endocrinology Scientific Center of the RAMS", Moscow, Russian Federation, 115478 Medical Institution Public Corporation Polyclinic "Gazprom" Moscow, Russian Federation, 117420 Close Corporation "MEDSI" Moscow, Russian Federation, 123056 State Educational Institution of Continuing Professional Education "Russian Medical Academy of Postgraduate Education of the Federal Agency of Health and Social Development", Chair of Endocrinology and Diabetology, Non-State Institution of Public Hea Moscow, Russian Federation, 125315 State Institution "Moscow Regional Scientific Research Clinical Institute named after M.F. Vladimirsky Moscow, Russian Federation, 129110 Limited Liability Company "Clinic of New Medical Technologies" Moscow, Russian Federation, 140091 Regional State Institution of Healthcare "Novosibirsk State Regional Clinical Hospital" Novosibirsk, Russian Federation, 630087 State Institution Scientific Research Institute of Therapy of the Siberian Department of the Russian Academy of Medical Sciences Novosibirsk, Russian Federation, 630089 Federal State Institution "Federal Center of Heart, Blood and Endocrinology named after V.A. Almazov" of Federal Agency on High Technology Medical Care Saint-Petersburg, Russian Federation, 194156 Limited Liability Company "Center "Diabetes" Samara, Russian Federation, 443067 Public Medical Institution "City Outpatient Clinic # 20" of Saratov Administration Healthcare Saratov, Russian Federation, 410018 State Educational Institution of High Professional Education "Smolensk State Medical Academy of Federal Agency of Healthcare and Social Development Smolensk, Russian Federation, 214018 State Educational Institution of Higher Professional Education "Medical-Military Academy named after S.M. Kirov, Clinic of Therapy of Postgraduate Education named after N.S. Molchanov St. Petersburg, Russian Federation, 198013 State Educational Institution of High Professional Education Less <<
NCT01527604 Inflammation Not Applicable Completed - United States, Massachusetts ... More >> Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University Boston, Massachusetts, United States, 02111 Less <<
NCT01898611 - Completed - -
NCT02039414 - Completed - -
NCT01957332 Metastatic Breast Cancer Not Applicable Active, not recruiting October 2018 Netherlands ... More >> VU University Medical Center Amsterdam, Netherlands University Medical Center Groningen, Netherlands, 9700RB University Medical Center St. Radboud Nijmegen, Netherlands Less <<
NCT02039414 - Completed - United States, Missouri ... More >> Washington University in St. Louis St. Louis, Missouri, United States, 63108 Less <<
NCT02579265 Hospitalized Neonates and Infa... More >>nts, Expected to Require Parenteral Nutrition for 28 Days Less << Phase 3 Recruiting October 2019 United States, California ... More >> Lucile Packard Children's Hospital Recruiting Palo Alto, California, United States, 94304 Contact: Katherine McCallie, MD          UC San Diego Medical Center Recruiting San Diego, California, United States, 92103 Contact: Jae H Kim, MD, PhD          Rady Children's Hospital San Diego Recruiting San Diego, California, United States, 92123 Contact: Brian Lane, MD          United States, Connecticut Yale - New Haven Children's Hospital Recruiting New Haven, Connecticut, United States, 06510 Contact: Orly Levit, MD          United States, Illinois Ann & Robert H. Lurie Children's Hospital of Chicago Recruiting Chicago, Illinois, United States, 60611-2991 Contact: Daniel T Robinson, MD          United States, Massachusetts Boston Children's Hospital Withdrawn Boston, Massachusetts, United States, 02115 United States, Nebraska University of Nebraska Medical Center Recruiting Omaha, Nebraska, United States, 68198-1205 Contact: Ann Anderson Berry, MD, PhD          United States, New York Mount Sinai Hospital Recruiting New York, New York, United States, 10029 Contact: Joanne Lai, MD          Steven & Alexandra Cohen Children's Medical Center of NY Active, not recruiting New York, New York, United States, 11040 United States, Oklahoma The Children's Hospital at OU Medical Center Recruiting Oklahoma City, Oklahoma, United States, 73104 Contact: Kimberly Ernst, MD          United States, Pennsylvania Children's Hospital of Philadelphia Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Maria R Mascarenhas, MBBS          Children's Hospital of Pittsburgh of UPMC Recruiting Pittsburgh, Pennsylvania, United States, 15224 Contact: Jeffrey A Rudolph, MD          United States, Tennessee Vanderbilt Children's Hospital Recruiting Nashville, Tennessee, United States, 37345 Contact: William Walsh, MD          United States, Texas Texas Children's Hospital Recruiting Houston, Texas, United States, 77030 Contact: Amy B Hair, MD Less <<
NCT01236222 Prevention Not Applicable Completed - Denmark ... More >> University of Southern Denmark Odense, Denmark, 5230 Less <<
NCT03450837 - Completed - -
NCT00426920 Diabetes Mellitus Phase 1 Unknown - United States, California ... More >> Profil Institute for Clinical Research Incorporated Not yet recruiting Chula Vista, California, United States, 91911 Contact: Marcus hompesch, MD    619-427-1300       Contact: 24-hour emergency number    619-409-1277       Principal Investigator: Marcus Hompesch, MD Less <<
NCT02434744 Type 2 Diabetes Mellitus Phase 2 Completed - United States, Alabama ... More >> Achieve Clinical Research, LLC Birmingham, Alabama, United States, 35216 United States, California Axis Clinical Trials Los Angeles, California, United States, 90036 National Research Institute Los Angeles, California, United States, 90057 Infosphere Clinical Research, Inc West Hills, California, United States, 91307 United States, Florida Clinical Research of South Florida Coral Gables, Florida, United States, 33134 Med Research of Florida, LLC Miami, Florida, United States, 33186 United States, North Carolina High Point Clinical Trials Center High Point, North Carolina, United States, 27265 United States, South Carolina Coastal Carolina Research Center Mt. Pleasant, South Carolina, United States, 29464 United States, Texas Clinical Trial Network Houston, Texas, United States, 77074 United States, Virginia Clinical Research Associates of Tidewater Norfolk, Virginia, United States, 23507 Less <<
NCT00534313 Psoriatic Arthritis Phase 2 Terminated(Lack of efficacy wi... More >>th respect to skin-related lesions in the short-term phase) Less << - -
NCT01828528 - Completed - Israel ... More >> Liver Disease Center, Sheba Medical Center, Tel-Hashomer Ramat-Gan, Israel, 52621 Less <<
NCT02246543 Satiety Not Applicable Completed - United Kingdom ... More >> Rowett Institute of Nutrition & Health, University of Aberdeen Aberdeen, Aberdeen City, United Kingdom, AB21 9SB Less <<
NCT01174485 Healthy Subjects Early Phase 1 Completed - Brazil ... More >> Escola de Educação Física e Esporte da Universidade de São Paulo São Paulo, SP, Brazil, 05508-900 Less <<
NCT03373409 Asthma Phase 1 Completed - United States, North Carolina ... More >> North Carolina Clinical Research Raleigh, North Carolina, United States, 27607 Less <<
NCT00789750 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT02580604 Osteoporosis Early Phase 1 Recruiting December 2018 United States, Colorado ... More >> University of Colorado Hospital Recruiting Aurora, Colorado, United States, 80045 Contact: Sarah Wherry, PhD Less <<
NCT00455325 Metabolic Syndrome X ... More >> Overweight Hypertension Dyslipidemias Prediabetic State Less << Phase 2 Active, not recruiting January 2019 United States, Missouri ... More >> Washington University in St. Louis Saint Louis, Missouri, United States, 63110 Less <<
NCT02846545 Diabetes Mellitus, Type 1 Phase 2 Active, not recruiting May 25, 2020 -
NCT02011360 Prader Willi Syndrome ... More >> Syndromic Obesity Childhood Obesity Less << Not Applicable Completed - United States, North Carolina ... More >> Duke University Medical Center Durham, North Carolina, United States, 27705 Canada, Alberta University of Alberta Edmonton, Alberta, Canada, T6G 2B7 Less <<
NCT01874366 Overweight Di... More >>abetes Mellitus Type 2 in Obese Less << Phase 1 Unknown December 2015 United States, Florida ... More >> Phase I clinic: MRA Clinical Research Recruiting Miami, Florida, United States, 33143 Contact: Patricia Pardo, MD    305-722-0970 ext 5110    ppardo@miamiresearch.com Less <<
NCT01435057 Abdominal Obesity Not Applicable Unknown April 2016 Germany ... More >> University of Leipzig, Department of Medicine Recruiting Leipzig, Saxony, Germany, 04103 Contact: Matthias Blüher, prof., MD    +493419715984    bluma@medizin.uni-leipzig.de    Contact: Nicole Bauernfeind    +493419716266    nicole.bauernfeind@zks.uni-leipzig.de    Principal Investigator: Matthias Blüher, prof., MD Less <<
NCT00534313 - Terminated(Lack of efficacy wi... More >>th respect to skin-related lesions in the short-term phase) Less << - -
NCT00789750 - Completed - -
NCT03229057 PCOS Phase 3 Recruiting April 30, 2022 United States, Pennsylvania ... More >> University of Pennsylvania Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Anuja Dokras Less <<
NCT01181817 Failed Back Surgery Syndrome Not Applicable Unknown September 2011 Belgium ... More >> UZ Brussel Recruiting Brussel, Belgium, 1090 Contact: Maarten Moens, m    0032478884047    mtmoens@gmail.com    Principal Investigator: Maarten Moens, MD Less <<
NCT02098395 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 3 Completed - -
NCT02728453 Diabetes Mellitus Type 2 Phase 4 Active, not recruiting April 2019 Germany ... More >> Hannover Medical School Hannover, Germany, 30625 Less <<
NCT02098395 - Completed - -
NCT01001611 Diabetes Mellitus, Type 2 Phase 3 Completed - Korea, Republic of ... More >> The Inje University Busan-Paik Hospital Busan, Korea, Republic of Soon Chun Hyang University Cheonan Hospital Cheonan, Korea, Republic of The Hanyang University Medical Center Gyeonggi-do, Korea, Republic of Wonju Severance Christian Hospital Kangwon-Do, Korea, Republic of The Hallym University Medical Center Seoul, Korea, Republic of The Inje University Sanggye-Paik Hospital Seoul, Korea, Republic of The Korea University Anam Hospital Seoul, Korea, Republic of The Kyung Hee University Medical Center Seoul, Korea, Republic of The Seoul National University Bundang Hospital Seoul, Korea, Republic of Less <<
NCT03288805 - Recruiting December 31, 2020 China, Guangdong ... More >> Sun Yat-Sen University Recruiting Guangzhou, Guangdong, China, 510080 Contact: Min Xia, PhD    +86-2087332433    xiamin@mail.sysu.edu.cn    Contact: Min Xia    +86-2087332433    1186510653@qq.com Less <<
NCT00351832 Diabetes Mellitus, Type 2 Phase 3 Completed - Japan ... More >> Novartis Pharmaceuticals Tokyo, Japan Less <<
NCT02032459 - Completed - United States, New Jersey ... More >> Rowan University Stratford, New Jersey, United States, 08084 Less <<
NCT02213770 - Completed - Norway ... More >> OUS- Rikshospitalet Oslo, Norway, 0424 Less <<
NCT02931630 Abdominal Obesity ... More >> Metabolic Syndrome Type 2 Diabetes Cardiovascular Disease Less << Not Applicable Completed - Denmark ... More >> Aarhus University Hospital, Dep. of clinical nutrition research Aarhus, Denmark, 8000 Less <<
NCT00736996 Mild Cognitive Impairment Phase 2 Completed - United States, Colorado ... More >> University of Colorado, Denver Denver, Colorado, United States, 80045 Less <<
NCT01970345 Autism Spectrum Disorder Phase 2 Recruiting January 2020 United States, New York ... More >> Icahn School of Medicine at Mount Sinai Recruiting New York, New York, United States, 10029 Principal Investigator: Alexander Kolevzon, MD Less <<
NCT00736996 - Completed - -
NCT02533453 Type 2 Diabetes Mellitus Phase 4 Completed - Korea, Republic of ... More >> Research Site Busan, Korea, Republic of Research Site Daegu, Korea, Republic of Research Site Daejeon, Korea, Republic of Research Site Gwangju, Korea, Republic of Research Site Incheon, Korea, Republic of Research Site Seongnam-si, Korea, Republic of Research Site Seoul, Korea, Republic of Research Site Suwon-si, Korea, Republic of Research Site Wonju-si, Korea, Republic of Less <<
NCT01538511 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 1 Completed - Japan ... More >> Novo Nordisk Investigational Site Tokyo, Japan, 1000005 Less <<
NCT00893126 - Completed - United States, Michigan ... More >> University of Michigan Hospital Ann Arbor, Michigan, United States, 48109 Less <<
NCT02786953 Diabetes Mellitus, Type 1 Not Applicable Recruiting December 30, 2018 United States, Tennessee ... More >> Vanderbilte University Medical Center Recruiting Nashville, Tennessee, United States, 37232 Contact: Sarah S Jaser, PhD    615-343-6775       Contact: Emily Hamburger, MEd    615-875-8781    emily.hamburger@vanderbilt.edu Less <<
NCT02849080 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Active, not recruiting April 5, 2019 -
NCT03182322 Diabetes Mellitus, Type 1 Phase 2 Recruiting October 2019 Germany ... More >> Klinik und Poliklinik für Kinder und Jugendmedizin, Universitätsklinikum Carl Gustav Carus, Technische Universität Dresden, Fetscherstraße 74, 01307 Dresden, Germany Not yet recruiting Dresden, Germany, 01307 Contact: Reinhard Berner, Prof. Dr.    +49 351 458 ext 2508    kik-direktion@uniklinikum-dresden.de    Forschergruppe Diabetes, Klinikum rechts der Isar, Technische Universität München, Lehrstuhl für Diabetes und Gestationsdiabetes der Technischen Universität München Recruiting München, Germany, 80804 Contact: Anette-G. Ziegler, Prof. Dr., MD    +49 (0)800-828 48 68 Less <<
NCT00799643 Type 2 Diabetes Mellitus Phase 2 Phase 3 Completed - United States, Alabama ... More >> University of Alabama Birmingham, Alabama, United States United States, California University of California, San Diego San Diego, California, United States United States, Connecticut Chapel Medical Group New Haven, Connecticut, United States United States, Georgia Emory University School of Medicine Atlanta, Georgia, United States Kaiser Permanente Tucker, Georgia, United States United States, Indiana Indiana University Indianapolis, Indiana, United States United States, Louisiana Tulane University Health Sciences Center New Orleans, Louisiana, United States United States, Maryland Medstar Research Institute Hyattsville, Maryland, United States Dr. Rudo, Westminster, MD Westminster, Maryland, United States, 21157 United States, Massachusetts Joslin Diabetes Center Boston, Massachusetts, United States, 02215 United States, Michigan University of Michigan Ann Arbor, Michigan, United States, 48106 United States, Missouri Washington University School of Medicine Saint Louis, Missouri, United States United States, Nebraska University of Nebraska Medical Center Omaha, Nebraska, United States United States, New York North Shore Diabetes and Endocrine Associates New Hyde Park, New York, United States Columbia University New York, New York, United States Lang Medical Center Queens, New York, United States Albert Einstein College of Medicine The Bronx, New York, United States United States, North Carolina Carolina's Health Care Charlotte, North Carolina, United States University of North Carolina Durham, North Carolina, United States United States, Texas University of Texas Southwestern Dallas, Texas, United States Scott and White Temple, Texas, United States Less <<
NCT01620424 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 1 Completed - Japan ... More >> Novo Nordisk Investigational Site Tokyo, Japan, 1000005 Less <<
NCT02491684 Asthma Phase 2 Completed - Argentina ... More >> Research Site Buenos Aires, Argentina Research Site C.a.b.a., Argentina Research Site Ciudad Autonomade Buenos Aires, Argentina Research Site Quilmes, Argentina Australia Research Site Bedford Park, Australia Research Site New Lambton, Australia Research Site Westmead, Australia Research Site Woolloongabba, Australia Colombia Research Site Bogota, Colombia Research Site Bogotá, Colombia Research Site Floridablanca, Colombia France Research Site Brest Cedex, France Research Site Dijon, France Research Site Lyon Cedex 04, France Research Site Marseille, France Research Site Montpellier Cedex 5, France Research Site Paris Cedex 18, France Research Site Pessac, France Korea, Republic of Research Site Bucheon-si, Korea, Republic of Research Site Jeonju-si, Korea, Republic of Research Site Seoul, Korea, Republic of Spain Research Site Barcelona, Spain Research Site Marbella (Málaga), Spain Research Site Málaga, Spain Research Site Sevilla, Spain Research Site Valencia, Spain United Kingdom Research Site Blackpool, United Kingdom Research Site Bradford, United Kingdom Research Site Lancaster, United Kingdom Research Site Leeds, United Kingdom Research Site Manchester, United Kingdom Research Site Nottingham, United Kingdom Research Site Southampton, United Kingdom Less <<
NCT00799643 - Completed - -
NCT00618592 Coronary Artery Bypass Graft S... More >>urgery Spine Surgery Less << Not Applicable Completed - Canada, Ontario ... More >> St. Michael's Hospital Toronto, Ontario, Canada, M5B 1W8 Less <<
NCT00679705 Healthy Phase 1 Completed - Belgium ... More >> University Hospital Ghent Ghent, Belgium, 9000 Less <<
NCT01202175 Pre-hypertension ... More >> Hypertension Less << Phase 4 Completed - United States, California ... More >> University of California, San Diego La Jolla, California, United States, 92093 Less <<
NCT00494312 Diabetes Mellitus ... More >> Liver Less << Phase 4 Completed - -
NCT03176524 Type 1 Diabetes Mellitus Phase 1 Completed - Germany ... More >> Profil Institut für Stoffwechselforschung GmbH Neuss, Germany, 41460 Less <<
NCT02647736 Copeptin Blood Values Not Applicable Completed - Germany ... More >> University Hospital Würzburg Würzburg, Germany Switzerland University hospital Basel Basel, Switzerland Less <<
NCT01043523 - Completed - United States, California ... More >> Palo Alto, California, United States, 94304 United States, New York New York, New York, United States, 10032 United States, North Carolina Durham, North Carolina, United States, 27710 United States, Ohio Cinncinati, Ohio, United States, 45229 United States, Pennsylvania Hershey, Pennsylvania, United States, 17033 Italy Many Locations, Italy Japan Many Locations, Japan Singapore Many Locations, Singapore Taiwan Many Locations, Taiwan Less <<
NCT01954290 Acute Cerebrovascular Accident... More >> Cerebral Edema Less << Phase 2 Withdrawn(Investigator is leav... More >>ing the institution.) Less << - -
NCT02679989 Obesity, Abdominal Not Applicable Completed - United Kingdom ... More >> Diabetes & Nutritional Sciences Division, King's College London, Franklin-Wilkins Buiding, 150 Stamford St. London, England, United Kingdom, SE1 9NH Less <<
NCT02165228 Atherosclerosis ... More >> Diabetes Less << Not Applicable Completed - United States, Montana ... More >> Montana State University Bozeman, Montana, United States, 59717 Less <<
NCT02548702 Type 2 Diabetes Not Applicable Not yet recruiting June 2019 United Kingdom ... More >> Nottingham Trent University Not yet recruiting Nottingham, United Kingdom, NG11 8NS Contact: Mary E Nevill, PhD    0115 8483918    mary.nevill@ntu.ac.uk    Contact: John G Morris, PhD    0115 8488058    john.morris@ntu.ac.uk Less <<
NCT02486237 - Completed - Costa Rica ... More >> Clínica Los Yoses San Pedro de Montes de Oca, San José, Costa Rica, 1406-1200 Hospital CIMA San José, Costa Rica El Salvador Centro Panamericano de Ojos San Salvador, El Salvador INSACOR San Salvador, El Salvador Medicentro La Esperanza San Salvador, El Salvador Guatemala Clínica 1005 Guatemala, Guatemala Prevención en Salud S.A Guatemala, Guatemala Honduras Honduras Medical Center Tegucigalpa, Honduras Less <<
NCT01799057 Peripheral Arterial Disease ... More >> Intermittent Claudication Less << Phase 4 Terminated(The trial has been ... More >>terminated due to difficulties with recruitment.) Less << - Australia, Victoria ... More >> Baker IDI Heart and Diabetes Institute Melbourne, Victoria, Australia, 3004 Less <<
NCT01043523 - Completed - -
NCT00383708 Acromegaly Phase 3 Completed - Czechia ... More >> University Hospital, Charles University Hradec Kralove, Czechia, 500 05 Charles University Prague, Czechia, 120 00 PRAHA 2 Denmark Aarhus Kommunehospital Aarhus, Denmark France Groupe Hospitalier Henri Mondor- Albert Chenevier Créteil Cedex, France Hôpital Bicêtre Le Kremlin-Bicêtre, France, 94275 Clinique Marc Linquette Lille Cedex, France, 59037 Hôpital de la Timone Marseille Cedex, France, 13385 CHU de Rangueil Toulouse, France, 31054 Germany Charite Campus Mitte Berlin, Germany, 10117 Klinikum Johann Wolfgang Goethe-Universität Frankfurt, Germany, 605090 Medizinische Klinik Innenstadt Munchen, Germany, 80336 Greece Anticancer Hospital Metaxa Piraeus Piraeus, Greece, 18537 Italy Universitá degli Studi di Milano Milano, Italy, 20122 University Federico II Napoli, Italy, 80131 Universitá di Torino Torino, Italy, 10126 Netherlands Leiden University Medical Center Leiden, Netherlands, 2300 RC Dept. of Internal Medicine Erasmus MC Rotterdam, Netherlands, 3015 GD Spain Hospital General de Alicante Alicante, Spain, 03012 Clínica Puerta de Hierro Madrid, Spain, 28035 Hospital Clínico Universitario de Santiago de Compostela Santiago de Compostela, Spain, 15706 Sweden Sahlgrenska University Hospital Göteborg, Sweden, 413 45 Uppsala University Hospital Uppsala, Sweden, 75185 United Kingdom Christie Hospital and Holt Radium Institute Manchester, United Kingdom, M20 4BX Royal Hallamshire Hospital Sheffield, United Kingdom Less <<
NCT03123289 Joint Prosthesis Phase 2 Suspended(Pending QC update of... More >> the experimental radiotracer from the manufacturer. Once QC is received, the IND will be amended accordingly.) Less << December 30, 2020 United States, New Jersey ... More >> Rutgers New Jersey Medical School Newark, New Jersey, United States, 07103 Less <<
NCT00383708 - Completed - -
NCT01192529 Alzheimer's Disease ... More >> Parkinson's Disease Senile Dementia Less << Not Applicable Unknown December 2012 Spain ... More >> Clinical Nutrition and Dietetic Unit, University Hospital Virgen de las Nieves Recruiting Granada, Spain, 18014 Contact: Antonio J Pérez de la Cruz, MD, PhD    + 34 639 236 825    antonioj.perez.sspa@juntadeandalulcia.es    Principal Investigator: Antonio J Pérez de la Cruz, MD, PhD          Department of Biochemistry and Molecular Biology II. University of Granada Recruiting Granada, Spain, 18100 Contact: Ángel Gil Hernández, PhD    +34 695 466 922    agil@ugr.es    Principal Investigator: Ángel Gil Hernández, PhD          Neurological Unit, Complejo Asistencial de León Not yet recruiting León, Spain, 24071 Contact: Adrián Arés Luque, MD    +34 609 022 840    adrianares@telefonica.net    Principal Investigator: Adrián Arés Luque, MD Less <<
NCT00676260 Diabetes Mellitus Phase 2 Completed - United Kingdom ... More >> Exeter, United Kingdom Less <<
NCT03009500 Neuralgia Per... More >>ipheral Neuropathic Pain Less << Phase 3 Recruiting June 2019 Canada, Ontario ... More >> Toronto Western Hospital Recruiting Toronto, Ontario, Canada, M5T 2S8 Contact: Anuj Bhatia, MD FRCPC    (416) 603 5800 ext 6136    anuj.bhatia@uhn.ca    Contact: Jamal Kara    (416) 603 5800 ext 6237    jamal.kara@uhn.ca Less <<
NCT03259256 Type 1 Diabetic Phase 3 Recruiting June 30, 2019 China, Guangdong ... More >> The Second Affiliated Hospital of Guangzhou Medical University Recruiting Guangzhou, Guangdong, China, 510260 Contact: ping Xue, PhD    +86-020-34153080    gyeygdwk@qq.com Less <<
NCT01582230 Type 2 Diabetes Mellitus Phase 3 Completed - China, Beijing ... More >> Novartis Investigative Site Beijing, Beijing, China, 100730 China, Hunan Novartis Investigative Site Changsha City, Hunan, China, 410011 Novartis Investigative Site Changsha, Hunan, China, 410003 China, Jiangsu Novartis Investigative Site Nanjing, Jiangsu, China, 210006 Novartis Investigative Site Wu Xi, Jiangsu, China, 214023 China, Jiangxi Novartis Investigative Site Nanchang, Jiangxi, China, 330006 China, Liaoning Novartis Investigative Site Shenyang, Liaoning, China, 110003 China, Shandong Novartis Investigative Site Jinan, Shandong, China, 250031 China, Shanxi Novartis Investigative Site Xi'an, Shanxi, China, 710032 China, Sichuan Novartis Investigative Site Chengdu, Sichuan, China, 610072 China Novartis Investigative Site Beijing, China Novartis Investigative Site Shanghai, China, 200025 Novartis Investigative Site Tianjin, China, 300052 Philippines Novartis Investigative Site Metro Manila, Philippines, 1500 Novartis Investigative Site Pasay City, Philippines, 1300 Novartis Investigative Site Quezon City, Philippines, 1102 Singapore Novartis Investigative Site Singapore, Singapore, 169608 Novartis Investigative Site Singapore, Singapore, 768825 Thailand Novartis Investigative Site Bangkok, Thailand, 10330 Novartis Investigative Site Bangkok, Thailand, 10400 Novartis Investigative Site Khon Kaen, Thailand, 40002 Less <<
NCT00112385 - Completed - -
NCT00112385 Dermatomyositis Phase 1 Completed - United States, Massachusetts ... More >> Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Less <<
NCT02143765 Type 2 Diabetes Mellitus Phase 4 Completed - China, Jiangsu ... More >> The First People's Hospital of Changzhou Changzhou, Jiangsu, China The Second People's Hospital of Huai'an Huai'an, Jiangsu, China Department of Endocrinology, Zhongda Hospital, Institute of Diabetes, Southeast University Nanjing, Jiangsu, China Xuzhou Central Hospital Xuzhou, Jiangsu, China Yancheng City No.1 People's Hospital Yancheng, Jiangsu, China Zhenjiang First People's Hospital Zhenjiang, Jiangsu, China Less <<
NCT02106364 Diabetes Mellitus, Type 2 Phase 3 Withdrawn(Lilly's decision to ... More >>cancel this trial is due to regulatory uncertainty in China.) Less << June 2016 United States, Alabama ... More >> Rheumatology Associates PC Birmingham, Alabama, United States, 35205 United States, Florida Florida Medical Clinic PA Zephyrhills, Florida, United States, 33542-7505 United States, Indiana Diagnostic Rheumatology and Research Indianapolis, Indiana, United States, 46227 United States, Kansas Heartland Research Associates Wichita, Kansas, United States, 67207 United States, Missouri Washington University Medical Center Saint Louis, Missouri, United States, 63110 United States, New Mexico Albuquerque Rehabilitation & Rheumatology, PC Albuquerque, New Mexico, United States, 87102 United States, North Carolina PMG Research of Hickory, LLC Hickory, North Carolina, United States, 28602 Carolina Arthritis Associates Wilmington, North Carolina, United States, 28401 United States, Ohio STAT Research Dayton, Ohio, United States, 45417 United States, Washington Apex Clinical Research Kennewick, Washington, United States, 99336 Less <<
NCT03175120 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Active, not recruiting April 8, 2019 -
NCT02998892 Health Behavior Not Applicable Recruiting August 2019 United States, Colorado ... More >> University of Colorado Hospital Recruiting Aurora, Colorado, United States, 80045 Contact: Audrey Bergouignan, PhD    720-401-5840    audrey.bergouignan@ucdenver.edu    Contact: Nate DeJong, MPH    616-866-8544    nathan.dejong@ucdenver.edu    Principal Investigator: Audrey Bergouignan, PhD Less <<
NCT01841697 Type 2 Diabetes Phase 3 Completed - -
NCT02587572 Metabolic Disease ... More >> Endothelial Dysfunction Less << Phase 2 Not yet recruiting December 2019 -
NCT02243852 - Unknown - United Kingdom ... More >> MARIARC Recruiting Liverpool, Merseyside, United Kingdom, L69 3GE Contact: Graham J Kemp, PhD    +44-151-706-4086    g.j.kemp@liv.ac.uk    Principal Investigator: Graham J Kemp, PhD          University Hospital Aintree Recruiting Liverpool, Merseyside, United Kingdom, L9 7AL Contact: Daniel J Cuthbertson, PhD    +44 151 529 5911    daniel.cuthbertson@liverpool.ac.uk    Principal Investigator: Daniel J Cuthbertson, PhD Less <<
NCT01841697 - Completed - -
NCT02113332 Type 2 Diabetes Mellitus Phase 2 Completed - Sweden ... More >> Falu Hospital Falun, Sweden Clicical Trial Center Sahlgrenska Gothenburg, Sweden Halmstad Hospital Halmstad, Sweden Helsingborg Hospital Helsingborg, Sweden Öbacka Clinic Härnösand, Sweden Lindsdals Health Center Kalmar, Sweden Karlskoga Hospital Karlskoga, Sweden Kristianstad Hospital Kristianstad, Sweden Kungsbacka Hospital Kungsbacka, Sweden Malmö University Hospital Malmö, Sweden CityDiabetes Clinic Stockholm, Sweden NU-Hospital Organization Uddevalla, Sweden Värnamo Hospital Värnamo, Sweden Ängelholm Hospital Ängelholm, Sweden Less <<
NCT02321033 Healthy Not Applicable Completed - Germany ... More >> Institute of Nutritional Medicine, University of Hohenheim Stuttgart, Germany, 70599 Less <<
NCT02585830 - Completed - United States, Colorado ... More >> University of Colorado Anschutz Medical Campus/Children's Hospital Colorado Aurora, Colorado, United States, 80045 Less <<
NCT01536652 - Completed - Germany ... More >> Mainz, Germany, 55127 Less <<
NCT00772720 Healthy Volunteers Phase 1 Unknown March 2011 Spain ... More >> Hospital Clinic Recruiting Barcelona, Catalonia, Spain, 08036 Contact: Esteban Martinez, MD    0034932275400 ext 3310    esteban@fundsoriano.es Less <<
NCT01893918 - Unknown July 2013 Italy ... More >> Azienda Ospedaliero-Universitaria di Modena Recruiting Modena, Italy, 41100 Contact: Bianca Beghé, MD PhD    +39 059 4225814    bianca.beghe@unimore.it    Contact: Alessia Verduri, MD PhD    +39 059 4225769    alessia.verduri@unimore.it Less <<
NCT03672591 - Not yet recruiting March 31, 2019 -
NCT01896648 - Unknown June 2016 Italy ... More >> IRCCS Policlinico S. Matteo Foundation Recruiting Pavia, Italy, 27100 Contact: Giuseppe Derosa, MD, PhD       giuseppe.derosa@unipv.it    Contact: Pamela Maffioli, MD       pamelamaffioli@hotmail.it    Principal Investigator: Giuseppe Derosa, MD, PhD          Sub-Investigator: Pamela Maffioli, MD Less <<
NCT02967159 Chronic Obstructive Pulmonary ... More >>Disease (COPD) Asthma Less << Phase 1 Completed - Germany ... More >> Research Site Berlin, Germany, 14050 Less <<
NCT00311818 Type 2 Diabetes Mellitus Phase 4 Completed - -
NCT01943357 Type 2 Diabetes ... More >> Diabetes Less << Not Applicable Completed - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94306 Less <<
NCT03240055 Dose-Response Relationship, Dr... More >>ug Less << Not Applicable Completed - China, Ningxia ... More >> General Hospital of Ningxia Medical University Yinchuan, Ningxia, China, 750004 Less <<
NCT03462121 Mild to Moderate Dementia Due ... More >>to Alzheimer's Disease With or Without Coexisting Cerebrovascular Disease Less << Phase 2 Recruiting April 30, 2019 Canada, Ontario ... More >> Kawartha Centre - Redefining Healthy Aging Recruiting Peterborough, Ontario, Canada, K9H 2P4 Contact: Jennifer K Ingram, MD FRCPC    705-749-3906       Contact: Krista Gillis    05-930-2667 (24 Hr.)       Principal Investigator: Jennifer K Ingram, MD          Toronto Memory Program Recruiting Toronto, Ontario, Canada, M3B 2S7 Principal Investigator: Sharon Cohen, MD          Gerontion Research Inc., The Center for Memory & Aging Recruiting Toronto, Ontario, Canada, M4G 3E8 Principal Investigator: Giovanni Marotta, MD          Canada, Quebec Recherches Neuro-Hippocampe Inc. d/b/a Clinique de la Memoire de l'Outaouais Recruiting Gatineau, Quebec, Canada, J8T 8J1 Principal Investigator: Richard Bergeron, MD          Diex Recherche Sherbrooke Inc. Recruiting Sherbrooke, Quebec, Canada, J1L 0H8 Principal Investigator: Marcel Germain, MD Less <<
NCT00888719 Type 2 Diabetes Mellitus Phase 2 Completed - Korea, Republic of ... More >> Chonbuk National University Hospital Seoul, Korea, Republic of Ewha Womans University Mokdong Hospital Seoul, Korea, Republic of Gachon Medical School Gil Medical Center Seoul, Korea, Republic of Inha University Hospital Seoul, Korea, Republic of Korea University Guro Hospital Seoul, Korea, Republic of Kyungpook National University Hospital Seoul, Korea, Republic of Seoul National University Bundang Hopital Seoul, Korea, Republic of The Catholic University of Korea, Holly Family Hospital Seoul, Korea, Republic of The Catholic University of Korea, Seoul St. Mary's Hospital Seoul, Korea, Republic of The Catholic University of Korea, St. Vincent's Hospital Seoul, Korea, Republic of Less <<
NCT03049670 - Not yet recruiting March 1, 2018 -
NCT02607306 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT01742208 Type 1 Diabetes Mellitus Phase 2 Completed - United States, Colorado ... More >> Lexicon Investigational Site Aurora, Colorado, United States, 80045 United States, Georgia Lexicon Investigational Site Atlanta, Georgia, United States, 30318 United States, Louisiana Lexicon Investigational Site Baton Rouge, Louisiana, United States, 70808 United States, Nebraska Lexicon Investigational Site Omaha, Nebraska, United States, 68131 United States, New York Lexicon Investigational Site Bronx, New York, United States, 10467 United States, North Carolina Lexicon Investigational Site Durham, North Carolina, United States, 27713 United States, Texas Lexicon Investigational Site Dallas, Texas, United States, 75230 Less <<
NCT02011789 Hypercholesterolemia Not Applicable Completed - United States, California ... More >> USDA Western Human Nutrition Research Center Davis, California, United States, 95616 Less <<
NCT02787551 Type 2 Diabetes Mellitus Phase 3 Active, not recruiting November 20, 2018 -
NCT02241473 Obesity Not Applicable Unknown July 2015 Switzerland ... More >> Institute of Sport Sciences of the University of Lausanne Recruiting Lausanne, Vaud, Switzerland, 1015 Contact: Davide Malatesta, Dr    021 692 36 17 ext +41    davide.malatesta@unil.ch    Principal Investigator: Davide Malatesta, Dr Less <<
NCT00129792 Metabolic Syndrome X ... More >> Prediabetic State Insulin Resistance Obesity Metabolic Diseases Less << Not Applicable Completed - United States, Oregon ... More >> Oregon Health and Science University General Clinical Research Center Portland, Oregon, United States, 97239 Less <<
NCT01286922 Pre-diabetes Phase 1 Completed - United States, Louisiana ... More >> Pennington Biomedical Research Center Baton Rouge, Louisiana, United States, 70808 Less <<
NCT02798744 Diabetes Mellitus, Type 2 Phase 4 Recruiting June 2018 United Kingdom ... More >> Leicester Diabetes Centre Recruiting Leicester, United Kingdom, LE5 4PW Contact: Natasha Wileman, MSc    0116 258 8929 ext 8929    natasha.wileman@uhl-tr.nhs.uk    Contact: Lucy Ayres    0116 258 4499 ext 4499    lucy.ayres@uhl-tr.nhs.uk    Principal Investigator: Melanie Davies, MBBS MD FRCP Less <<
NCT01895257 Colorectal Cancer Phase 3 Recruiting December 2018 Belgium ... More >> University of Antwerp Recruiting Edegem, Antwerp, Belgium, 2650 Principal Investigator: Marc Peeters, MD, PhD          ASZ Aalst Active, not recruiting Aalst, Belgium, 9300 Institut Jules Bordet Active, not recruiting Brussels, Belgium, 1000 CUB Hôpital Erasme Active, not recruiting Brussels, Belgium, 1070 University of St-Luc Recruiting Brussels, Belgium, 1200 Principal Investigator: Marc Van den Eynde          Grand Hôpital de Charleroi Recruiting Charleroi, Belgium, 6000 Principal Investigator: Javier Carrasco, MD          ZOL Genk Recruiting Genk, Belgium, 3600 Contact: Jaarke Vannoote, MD          AZ St-Lucas Gent Not yet recruiting Gent, Belgium, 9000 Contact: Monique Troch, MD          AZ Groeninge Recruiting Kortrijk, Belgium, 8500 Contact: Philippe Vergauwe, MD          CHU de Liège Recruiting Liège, Belgium, 4000 Principal Investigator: Marc Polus, MD Less <<
NCT01025414 Pancreatic Fistula Phase 4 Completed - Poland ... More >> Nutrimed Medical Corporation Krakow, Malopolska, Poland, 30-798 Less <<
NCT02650336 - Completed - China, Guangdong ... More >> Xiaodong Zhaung Guangzhou, Guangdong, China, 510080 Less <<
NCT01901926 Diabetes Mellitus Type 2 Not Applicable Unknown October 2013 Pakistan ... More >> Pakistan Institute of Medical Sciences Islamabad, Federal Capital, Pakistan, 54000 Less <<
NCT03602846 - Completed - -
NCT02325648 - Completed - Korea, Republic of ... More >> Severance Hospital Seoul, South Korea, Korea, Republic of, 120-752 Less <<
NCT03216226 Hypoglycemia ... More >>Diabetes Mellitus, Type 1 Less << Phase 3 Completed - United States, Florida ... More >> Compass Research Orlando, Florida, United States, 32806 United States, Idaho Advanced Clinical Research Meridian, Idaho, United States, 83642 Austria CRC - Clinical Research Center, Medizinische Universität Graz Graz, Austria Canada LMC Manna Research Barrie, Canada LMC Calgary Calgary, Canada LMC Diabetes & Manna Research Toronto, Canada Germany Diabeteszentrum Hamburg West, Gemeinschaftspraxis für Innere Medizin Hamburg, Germany Less <<
NCT01891955 Type 2 Diabetes Not Applicable Completed - Spain ... More >> Hospital Insular de Lanzarote Arrecife, Las Palmas, Spain, 35500 Less <<
NCT01966978 Diabetes Mellitus, Type 2 ... More >> Diabetes Less << Phase 4 Completed - United States, Texas ... More >> UT Southwestern Medical Center Dallas, Texas, United States, 02720 Less <<
NCT03646721 Diabetes Mellitus, Type 2 Phase 1 Recruiting October 7, 2019 United States, California ... More >> Clinical Site Recruiting Chula Vista, California, United States, 91911 Contact: Julie Willard, MD    619-943-6328 ext 217    Julie.Willard@prosciento.com Less <<
NCT01231074 Obesity Weigh... More >>t Gain Psychotropic Induced Weight Gain Less << Phase 1 Unknown May 2011 United States, Ohio ... More >> Nationwide Children's Hospital Recruiting Columbus, Ohio, United States, 43205 Contact: Ihuoma Eneli, MD, MS    614-722-4089    ihuoma.eneli@nationwidechildrens.org    Contact: Mary Ann Murphy, MD, PhD    614-722-2291    maryann.murphy@nationwidechildrens.org Less <<
NCT02911948 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - Japan ... More >> Novo Nordisk Investigational Site Asahikawa-shi, Hokkaido, Japan, 078-8211 Novo Nordisk Investigational Site Bunkyo-ku, Tokyo, Japan, 113 8431 Novo Nordisk Investigational Site Chigasaki-shi, Kanagawa, Japan, 253-0044 Novo Nordisk Investigational Site Chitose, Hokkaido, Japan, 066-0032 Novo Nordisk Investigational Site Chiyoda-ku, Tokyo, Japan, 101-0024 Novo Nordisk Investigational Site Chuo-ku, Tokyo, Japan, 103 0027 Novo Nordisk Investigational Site Fujisawa-shi, Kanagawa, Japan, 251-0041 Novo Nordisk Investigational Site Fukui-shi, Fukui, Japan, 918-8503 Novo Nordisk Investigational Site Fukuoka-shi, Fukuoka, Japan, 810-0001 Novo Nordisk Investigational Site Fukuoka-shi, Fukuoka, Japan, 819-0006 Novo Nordisk Investigational Site Fukuoka, Japan, 830 8522 Novo Nordisk Investigational Site Kashiwara-shi, Osaka, Japan, 582 0005 Novo Nordisk Investigational Site Kawagoe-shi, Saitama, Japan, 350 0851 Novo Nordisk Investigational Site Kawaguchi-shi, Saitama, Japan, 332-0012 Novo Nordisk Investigational Site Koriyama-shi, Fukushima, Japan, 963 8851 Novo Nordisk Investigational Site Kumamoto-shi, Kumamoto, Japan, 862-0965 Novo Nordisk Investigational Site Kumamoto-shi,Kumamoto, Japan, 862 0976 Novo Nordisk Investigational Site Matsumoto-shi, Nagano, Japan, 390-8621 Novo Nordisk Investigational Site Miyazaki-shi, Japan, 880 0034 Novo Nordisk Investigational Site Naka-shi, Ibaraki, Japan, 311 0113 Novo Nordisk Investigational Site Nakagami, Okinawa, Japan, 901-2393 Novo Nordisk Investigational Site Neyagawa-shi, Osaka, Japan Novo Nordisk Investigational Site Niigata-shi, Niigata, Japan, 950 1104 Novo Nordisk Investigational Site Okawa-shi, Fukuoka, Japan, 831 0016 Novo Nordisk Investigational Site Osaka-shi, Osaka, Japan, 536-0001 Novo Nordisk Investigational Site Ota-ku, Tokyo, Japan, 1430015 Novo Nordisk Investigational Site Oyama-shi, Tochigi, Japan, 323 0022 Novo Nordisk Investigational Site Saitama-shi, Saitama, Japan, 336-0963 Novo Nordisk Investigational Site Sapporo-shi, Hokkaido, Japan, 060 0062 Novo Nordisk Investigational Site Sendai-shi, Japan, 980 0021 Novo Nordisk Investigational Site Shimotsuke-shi, Tochigi, Japan, 329 0433 Novo Nordisk Investigational Site Takatsuki-shi, Osaka, Japan, 569 1096 Novo Nordisk Investigational Site Tokyo, Japan, 103-0028 Novo Nordisk Investigational Site Tokyo, Japan, 181-0013 Novo Nordisk Investigational Site Tomigusuku-shi, Okinawa, Japan, 901-0243 Novo Nordisk Investigational Site Tomigusuku-shi, Okinawa, Japan, 901-0244 Novo Nordisk Investigational Site Yamaguchi-shi, Yamaguchi, Japan, 754-0002 Novo Nordisk Investigational Site Yokohama-shi, Japan, 235 0045 Less <<
NCT00538174 Diabetes Mellitus, Type 2 Phase 1 Completed - Japan ... More >> Local Institution Suita, Osaka, Japan, 5650853 Less <<
NCT01748526 Healthy Phase 1 Completed - India ... More >> Ahmedabad, India Less <<
NCT01930188 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT00466518 Kidney Transplant ... More >> Type 2 Diabetes Less << Not Applicable Completed - United States, Nebraska ... More >> University of Nebraska Medical Center Omaha, Nebraska, United States, 68198-1230 Less <<
NCT00481299 - Completed - Brazil ... More >> Clementino Fraga Filho University Hospital Rio de Janeiro, RJ, Brazil Less <<
NCT01977417 Prediabetes O... More >>bese Less << Phase 2 Active, not recruiting December 2019 United States, Iowa ... More >> University of Iowa Iowa City, Iowa, United States, 52240 Less <<
NCT01912209 Metabolic Syndrome ... More >> Cardiovascular Disease Atherosclerosis Obesity Less << Not Applicable Completed - United States, Florida ... More >> South Miami Heart Center Outpatient Services Miami, Florida, United States, 33143 Less <<
NCT02662855 Ebola Virus Disease Phase 2 Completed - -
NCT02370719 Type 2 Diabetes Mellitus Phase 3 Unknown July 2017 Canada, Ontario ... More >> Mount Sinai Hospital Recruiting Toronto, Ontario, Canada, M5T3L9 Contact: Warren McIsaac, MD    4165864800 Less <<
NCT02926508 Behaviour Not Applicable Enrolling by invitation September 2018 United Kingdom ... More >> Oxford University Department of Psychiatry Oxford, Oxfordshire, United Kingdom, OX3 7JX Less <<
NCT02779413 - Enrolling by invitation May 31, 2019 Korea, Republic of ... More >> Novo Nordisk Investigational Site Bucheon, Korea, Republic of, 14647 Novo Nordisk Investigational Site Busan, Korea, Republic of, 47227 Novo Nordisk Investigational Site Busan, Korea, Republic of, 47392 Novo Nordisk Investigational Site Busan, Korea, Republic of, 49241 Novo Nordisk Investigational Site Busan, Korea, Republic of, 49267 Novo Nordisk Investigational Site Busan, Korea, Republic of Novo Nordisk Investigational Site Chungcheongnam-do, Korea, Republic of Novo Nordisk Investigational Site Daegu, Korea, Republic of, 41199 Novo Nordisk Investigational Site Daegu, Korea, Republic of Novo Nordisk Investigational Site Daejeon, Korea, Republic of, 302-718 Novo Nordisk Investigational Site Daejeon, Korea, Republic of, 361-711 Novo Nordisk Investigational Site Gangwon-do, Korea, Republic of, 24253 Novo Nordisk Investigational Site Gangwon-do, Korea, Republic of, 25440 Novo Nordisk Investigational Site Gangwon-do, Korea, Republic of, 26426 Novo Nordisk Investigational Site Gyeonggi-do, Korea, Republic of, 10475 Novo Nordisk Investigational Site Gyeonggi-do, Korea, Republic of, 14754 Novo Nordisk Investigational Site Gyeonggi-do, Korea, Republic of Novo Nordisk Investigational Site Gyeongsangbuk-do, Korea, Republic of, 39295 Novo Nordisk Investigational Site Gyeongsangbuk-do, Korea, Republic of, 39371 Novo Nordisk Investigational Site Gyeongsangnam-do, Korea, Republic of Novo Nordisk Investigational Site Incheon, Korea, Republic of, 21431 Novo Nordisk Investigational Site Incheon, Korea, Republic of, 400-103 Novo Nordisk Investigational Site Incheon, Korea, Republic of, 405-220 Novo Nordisk Investigational Site Jeonju, Korea, Republic of, 54987 Novo Nordisk Investigational Site Pyungchon-Dong 896, Dongan-Gu, Korea, Republic of, 431-796 Novo Nordisk Investigational Site Seongnam-si, Korea, Republic of, 463-707 Novo Nordisk Investigational Site Seoul, Korea, Republic of, 03722 Novo Nordisk Investigational Site Seoul, Korea, Republic of, 04551 Novo Nordisk Investigational Site Seoul, Korea, Republic of, 04564 Novo Nordisk Investigational Site Seoul, Korea, Republic of, 05278 Novo Nordisk Investigational Site Seoul, Korea, Republic of, 06591 Novo Nordisk Investigational Site Seoul, Korea, Republic of, 07441 Novo Nordisk Investigational Site Seoul, Korea, Republic of, 135-720 Novo Nordisk Investigational Site Seoul, Korea, Republic of, 135710 Novo Nordisk Investigational Site Seoul, Korea, Republic of, 138-736 Novo Nordisk Investigational Site Seoul, Korea, Republic of, 139-707 Novo Nordisk Investigational Site Seoul, Korea, Republic of, 139-827 Novo Nordisk Investigational Site Seoul, Korea, Republic of, 150-713 Novo Nordisk Investigational Site Seoul, Korea, Republic of Novo Nordisk Investigational Site Suwon-si, Gyeonggi-do, Korea, Republic of, 16247 Novo Nordisk Investigational Site Suwon, Korea, Republic of, 16499 Novo Nordisk Investigational Site Ulsan, Korea, Republic of, 44455 Novo Nordisk Investigational Site Ulsan, Korea, Republic of, 682-060 Novo Nordisk Investigational Site Wonju, Korea, Republic of, 220-701 Less <<
NCT00940368 Nausea Vomiti... More >>ng Less << Phase 3 Unknown January 2010 India ... More >> Dr. B.R. Ambedkar Institute Rotary Cancer Hospital Recruiting New Delhi, Delhi, India, 110049 Contact: Anu K, BSc. Nursing    9109891661848    anukaiims@gmail.com    Contact: Kamlesh K Sharma, MSc. Nursing    91098911336985    kamlesh_con@yahoo.co.in    Principal Investigator: Anu K, BSc. Nursing Less <<
NCT01785615 Metabolic Syndrome Phase 1 Phase 2 Completed - United States, New York ... More >> University of Rochester Medical Center Rochester, New York, United States, 14642 Less <<
NCT00975065 Type 2 Diabetes Mellitus Phase 4 Completed - Korea, Republic of ... More >> Handok Pharmaceuticals Seoul, Korea, Republic of Less <<
NCT01700075 Myocardial Infarction ... More >> Coronary Artery Diseases Diabetes Mellitus, Type 2 Atherosclerosis of Femoral Artery Less << Phase 4 Completed - Kazakhstan ... More >> Scientific Research Institute of Cardiology and Internal Diseases Almaty, Kazakhstan, 050000 Less <<
NCT02868606 - Active, not recruiting June 2018 United States, New York ... More >> Winthrop-University Hospital Mineola, New York, United States, 11501 Less <<
NCT03668860 Preterm Birth ... More >> Antenatal Corticosteroids Less << Phase 1 Not yet recruiting March 2019 -
NCT01889810 Sub-optimal Vitamin D Status ... More >> Pre-diabetes Insulin Resistance Less << Not Applicable Completed - United Kingdom ... More >> Queen's University, Belfast Belfast, N. Ireland, United Kingdom, BT12 6BJ Less <<
NCT02653443 Healthy Phase 2 Terminated - United States, New Hampshire ... More >> Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States, 03766 United States, Ohio Hoxworth Blood Center Cincinnati, Ohio, United States, 45267 Less <<
NCT00504205 Lymphoma Unsp... More >>ecified Adult Solid Tumor, Protocol Specific Less << Not Applicable Terminated(Withdrawn as trial ... More >>was never activated by SuperGen) Less << - United States, Arizona ... More >> Virginia G. Piper Cancer Center at Scottsdale Healthcare - Shea Scottsdale, Arizona, United States, 85258-4512 United States, Texas South Texas Accelerated Research Therapeutics San Antonio, Texas, United States, 78229 Less <<
NCT01785615 - Completed - -
NCT03153046 Schizophrenia Not Applicable Active, not recruiting September 2018 United Kingdom ... More >> Warneford Hospital Oxford, Oxfordshire, United Kingdom, OX3 7JX Less <<
NCT02190097 Polycystic Ovarian Syndrome Not Applicable Recruiting June 2021 United States, California ... More >> UCSF Recruiting San Francisco, California, United States, 94143 Contact: heather huddleston, MD    415-353-3040    heather.huddleston@ucsf.edu Less <<
NCT03230786 Type 2 Diabetes Mellitus Phase 2 Completed - Czechia ... More >> Vdoviak Miroslav MUDr. - Interní Ambulance Karlovy Vary, Czechia, 360 17 General University Hospital Prague 2, Czechia, 128 00 Institute for Clinical and experimental Medicine Praha 4, Czechia, 140 21 Interní a Diabetologická ambulance, Clintrial s.r.o Praha, Czechia, 100 00 Endokrinologicky Ústav Praha, Czechia, 113 94 Diabet2 s.r.o Praha, Czechia Interní a Diabetologická ambulance Uherské Hradiště, Czechia, 68 601 Diabetologická a Obezitologická ambulance České Budějovice, Czechia Denmark Bispebjerg Hospital, Endokrinologisk Afdeling Bispebjerg, Copenhagen NV, Denmark, 2400 Bioclinica Ballerup, Copenhagen, Denmark, 2750 Bioclinica Aalborg, Jutland, Denmark, 9000 Aarhus University Hospital, Endocrinlogy Department Aarhus, Jutland, Denmark, 8000 Sydvestjysk Sygehus Esbjerg, Jutland, Denmark, 6700 Bioclinica Vejle, Jutland, Denmark, 7100 Holbæk Sygehus Holbæk, Denmark, 4300 Moldova, Republic of Rtl Sm Srl/Scr Chisinau, Moldova, Republic of, MD2025 Rtl Sm Srl Chisinau, Moldova, Republic of, MD2025 Poland Centrum Badań Klinicznych PI-House sp. z o.o. Gdańsk, Poland, 80-546 Specjalistyczna Praktyka Lekarska Piotr Kubalski Grudziądz, Poland, 86-302 Medyczne Centrum Diabetologiczno Endokrynologiczno Metaboliczno Kraków, Poland, 31-261 Prywatny Gabinet Lekarski M. Horodecki (budynek Medicus) Opole, Poland, 45-367 Centrum Medyczne Hygea Tychy, Poland, 43-100 Centrum Medyczne AMED Warsaw, Poland, 01-518 Prywatny Gabinet Lekarski i Wizyty Lekarskie Jan Ruxer Łódź, Poland, 90-074 Romania S.C. Policlinica CCBR S.R.L. Bucharest, Romania, 030463 Institutului Național de Diabet, Nutriție și Boli Metabolice "Prof.Dr. N.C. Paulescu" Bucharest, Romania S.C Nicodiab S.R.L. Bucharest, Romania S.C. Sfinx Medica S.R.L. Constanţa, Romania, 900412 S.C. Mediab S.R.L. Targu Mures, Romania S.C. Mediab S.R.L. Târgu-Mureş, Romania United Kingdom St. Pancras London, United Kingdom, WC1X 8QD Less <<
NCT02907502 Healthy Not Applicable Recruiting December 2026 Germany ... More >> Dr Von Hauner Children's hospital Recruiting Munich, Germany, 80337 Principal Investigator: Berthold Koletzko, Professor          Spain Hospital Universitari Joan 23 de Tarragona. Universitat Rovira i Virgili. Recruiting Tarragona, Spain Principal Investigator: Ricardo Closa-Monasterolo, Professor          Principal Investigator: Joaquín Escribano, Professor Less <<
NCT03545802 Type1diabetes Not Applicable Completed - United Kingdom ... More >> Liverpool John Moores University Liverpool, Merseyside, United Kingdom, L3 3AF Less <<
NCT03493789 Stage I Lung Cancer ... More >> Stage I Non-Small Cell Lung Cancer AJCC v7 Stage IA Non-Small Cell Lung Carcinoma AJCC v7 Stage IB Non-Small Cell Lung Carcinoma AJCC v7 Stage II Lung Cancer Stage II Non-Small Cell Lung Cancer AJCC v7 Stage IIA Non-Small Cell Lung Carcinoma AJCC v7 Stage IIB Non-Small Cell Lung Carcinoma AJCC v7 Less << Phase 1 Recruiting April 30, 2020 United States, Georgia ... More >> Emory University Hospital/Winship Cancer Institute Recruiting Atlanta, Georgia, United States, 30322 Contact: Lily Masoumy, MPH    404-778-1960    lily.masoumy@emory.edu Less <<
NCT00387452 Cardiovascular ... More >> Diabetic Less << Not Applicable Completed - Canada, British Columbia ... More >> Vancouver General Hospital Research Pavilion Vancouver, British Columbia, Canada, V5Z 1L8 Less <<
NCT03745937 Type 2 Diabetes Mellitus Phase 2 Not yet recruiting May 10, 2019 Germany ... More >> Research Site Not yet recruiting Neuss, Germany, 41460 Less <<
NCT00543309 - Terminated(DSMB recommended te... More >>rmination based on interim outcomes analysis) Less << - -
NCT00543309 Heart Defects, Congenital Phase 2 Terminated(DSMB recommended te... More >>rmination based on interim outcomes analysis) Less << - United States, Massachusetts ... More >> Children's Hospital Boston Boston, Massachusetts, United States, 02115 Less <<
NCT02730962 Pre-Diabetes Phase 2 Completed - United States, Minnesota ... More >> University of Minnesota Medical Center Minneapolis, Minnesota, United States, 55455 Less <<
NCT03207711 Diabetes Mellitus, Type 2 Not Applicable Recruiting July 1, 2018 United States, California ... More >> UCSF Osher Center for Integrative Medicine Recruiting San Francisco, California, United States, 94143 Contact: Rick Hecht, M.D.    415-514-8476    rick.hecht@ucsf.edu    Contact: Patty Moran    415-353-9745    patricia.moran@ucsf.edu    Principal Investigator: Frederick M Hecht, M.D.          Principal Investigator: Epel Elissa, PhD          Sub-Investigator: Mason Ashley, PhD          Sub-Investigator: Kim Sarah, MD          Sub-Investigator: Leung Cindy, PhD Less <<
NCT02081118 Type 2 Diabetes Phase 2 Completed - United States, Florida ... More >> Hanmi pharmaceutical Miami, Florida, United States Less <<
NCT00433017 Macular Degeneration ... More >> Choroidal Neovascularization Less << Phase 2 Phase 3 Terminated(Study was terminate... More >>d based on the results of analyses performed as planned at Month 12.) Less << - Austria ... More >> Novartis Investigative site Wien, Austria Belgium Novartis Investigative site Antwerpen, Belgium Denmark Novartis Investigative site Aalborg, Denmark France Novartis Investigative site Creteil, France Germany Novartis Investigative site Regensburg, Germany Hungary Novartis Investigative site Budapest, Hungary Italy Novartis Investigative site Firenze, Italy Netherlands Novartis Investigative site Rotterdam, Netherlands Poland Novartis Investigative site Warszawa, Poland Spain Novartis Investigative site Madrid, Spain Switzerland Novartis Investigative site Geneve, Switzerland United Kingdom Novartis Investigative site Manchester, United Kingdom Less <<
NCT00133809 Diabetes Mellitus, Type 1 Phase 2 Completed - United States, Georgia ... More >> The Emory Transplant Center Atlanta, Georgia, United States, 30322 Less <<
NCT00433017 - Terminated(Study was terminate... More >>d based on the results of analyses performed as planned at Month 12.) Less << - -
NCT00396357 Diabetes Mellitus, Type 2 Phase 3 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 Germany Novartis Investigative Site Investigative Centers, Germany Less <<
NCT00518167 Type 2 Diabetes Not Applicable Unknown December 2013 Finland ... More >> Diabetes Prevention Unit, Department of Health Promotion and Chronic Disease Prevention, National Institute for Health and Welfare Helsinki, Finland Department of Public Health and Clinical Nutrition, University of Eastern Finland Kuopio, Finland Department of Sports Medicine, Oulu Deaconess Institute Oulu, Finland The Diabetes Center, Finnish Diabetes Association Tampere, Finland Less <<
NCT03575143 - Recruiting July 15, 2022 United States, California ... More >> Altman Clinical and Translational Research Institute Recruiting San Diego, California, United States, 92093-0990 Contact: Pam Deyoung    858-246-2183 Less <<
NCT00133809 - Completed - -
NCT03719794 Metabolic Syndrome Not Applicable Recruiting September 2019 Canada, Quebec ... More >> Cardiovascular Prevention and Rehabilitation Center Recruiting Montreal, Quebec, Canada, H1T 1N6 Contact: Julie Lalongé    5143741480 ext 4259    julie.lalonge@icm-mhi.org    Principal Investigator: Anil Nigam, MD Less <<
NCT03304197 Healthy Not Applicable Completed - United Kingdom ... More >> School of Sports and Health Sciences Exeter, Devon, United Kingdom, EX1 2LU Less <<
NCT00388388 Pre-hypertension ... More >> Pre-diabetes Less << Phase 2 Terminated(Few subjects recrui... More >>ted, sponsor withdrew support.) Less << - Canada, Quebec ... More >> Cardiovascular Prevention Centre, Jewish General Hospital Montreal, Quebec, Canada, H3T 1E2 Less <<
NCT02728635 Obesity Not Applicable Recruiting December 2020 United States, Florida ... More >> Translational Research Institute for Metabolism and Diabetes Recruiting Orlando, Florida, United States, 32804 Contact: Quianna Stokes-Washington    407-303-7100       Principal Investigator: Steven R Smith, MD Less <<
NCT02862431 Diabetes Mellitus, Type 2 Phase 1 Terminated(manufacturing-relat... More >>ed issues) Less << - Germany ... More >> Neuss, Germany Less <<
NCT01828853 - Unknown December 2013 Israel ... More >> Hadassah Medical Organization, Jerusalem, Israel Not yet recruiting Jerusalem, Israel Contact: Kabiri       doronkabiri@gmail.com Less <<
NCT00935766 Metabolic Diseases ... More >> Endocrine System Diseases Heart Disease Vascular Diseases Diabetes Cardiovascular Disease Glucose Metabolism Disorders Hypertension Less << Phase 3 Terminated(The study was disco... More >>ntinued early due to lack of funding and slow enrollment) Less << - United States, Colorado ... More >> Denver Health and Hospital Authority Denver, Colorado, United States, 80204 Less <<
NCT02194517 Type 1 Diabetes Mellitus Not Applicable Completed - Poland ... More >> Medical University of Warsaw Warsaw, Poland Less <<
NCT02585778 Hypercholesterolaemia Phase 3 Completed - -
NCT01472809 Diabetes Phase 1 Suspended(Not achieved the obj... More >>ective till 4 mg single dose) Less << - India ... More >> Clinical R&D, Zydus Research Center, Cadila Healthcare Limited, NH No.8, Moraiya Ahmedabad, Gujarat, India, 382213 Less <<
NCT02585778 - Completed - -
NCT01636258 Prediabetes O... More >>verweight Less << Not Applicable Completed - United States, Ohio ... More >> Stephanie Tubbs Jones Health Center East Cleveland, Ohio, United States, 44112 Less <<
NCT03152552 Diabetes Type 2 With Heart Fai... More >>lure Less << Phase 2 Completed - -
NCT00935766 - Terminated(The study was disco... More >>ntinued early due to lack of funding and slow enrollment) Less << - -
NCT01682954 Prediabetes O... More >>verweight Obese Less << Not Applicable Completed - United States, Ohio ... More >> Ohio State University Columbus, Ohio, United States, 43210 Less <<
NCT01728714 - Active, not recruiting October 31, 2018 Portugal ... More >> Research Site Almada, Portugal Research Site Espinho, Portugal Research Site Loures, Portugal Research Site Oeiras, Portugal Research Site Santo Antonio Dos Cavaleiros, Portugal Less <<
NCT01636258 - Completed - -
NCT00742820 Hyperphosphatemia Phase 1 Completed - United States, Ohio ... More >> Community Research Cincinnati, Ohio, United States, 45206 Less <<
NCT01682954 - Completed - -
NCT03389100 Diabetes Mellitus, Type 2 ... More >> Pre-diabetes Less << Phase 2 Enrolling by invitation June 2021 United States, New York ... More >> Columbia University Medical Center New York, New York, United States, 10032 Less <<
NCT02646878 Type 1 Diabetes Not Applicable Withdrawn(Business decision) July 2016 -
NCT01066715 Type 2 Diabetes Mellitus Phase 2 Completed - -
NCT01408095 Diabetes Mellitus, Type 2 Phase 2 Withdrawn(Trial terminated no ... More >>patients were screened or enrolled) Less << September 2012 -
NCT00735501 - Completed - Denmark ... More >> Copenhagen S, Denmark, 2300 Sweden Stockholm, Sweden, 182 88 Less <<
NCT00775736 - Completed - Belgium ... More >> Novo Nordisk Investigational Site Brussels, Belgium, 1070 Luxembourg Novo Nordisk Investigational Site Luxembourg, Luxembourg Less <<
NCT02051842 NAFLD Pre-dia... More >>betes Less << Phase 4 Unknown January 2017 Mexico ... More >> Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán" Recruiting Mexico City, Mexico, 14000 Contact: Aldo Torre, M.D, M.Sc.    54870900 ext 2711    detoal@yahoo.com    Principal Investigator: Aldo Torre, MD MSci Less <<
NCT01852201 Ischemic Stroke Not Applicable Suspended January 2019 United States, Florida ... More >> Baptist Health Jacksonville, Florida, United States, 32207 United States, Massachusetts Univesity of Massachusetts-Worcester Worcester, Massachusetts, United States, 01655 United States, New Jersey Captial Health Trenton, New Jersey, United States, 08638 United States, New York Albany Medical Center Albany, New York, United States, 12208-3412 University of Buffalo Neurosurgery Buffalo, New York, United States, 14203 Stony Brook Medical Center Stony Brook, New York, United States, 11764 United States, Ohio Cleveland Clinic Cleveland, Ohio, United States, 44195 Ohio Health Columbus, Ohio, United States, 43214 United States, South Carolina Medical University of South Carolina Charleston, South Carolina, United States, 29461 United States, Tennessee Tennessee Interventional Associates Chattanooga, Tennessee, United States, 37403 Methodist Healthcare - Memphis Memphis, Tennessee, United States, 38104 Vanderbilt University Nashville, Tennessee, United States, 37232 United States, West Virginia West Virginia University Morgantown, West Virginia, United States, 26506 United States, Wisconsin Wisconsin University Madison, Wisconsin, United States, 98374 Less <<
NCT02620592 Diabetes Mellitus Phase 1 Completed - United States, California ... More >> Profil Institute for Clinical Research Chula Vista, California, United States, 91911 Less <<
NCT02345850 Acute Leukemia ... More >> Myelodysplasia Less << Phase 3 Recruiting September 2021 -
NCT02948569 Metabolic Syndrome Phase 1 Phase 2 Completed - United States, Missouri ... More >> University of Missouri Columbia, Missouri, United States, 65201 Less <<
NCT03440229 Healthy Not Applicable Recruiting September 2019 United States, Pennsylvania ... More >> Hospital of the University of Pennsylvania Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Brittaney Bonhomme, BA    267-788-8448    bobrit@pennmedicine.upenn.edu    Principal Investigator: James Lewis, MD, MSCE Less <<
NCT00877513 Cardiovascular Disease ... More >> Insulin Resistance Less << Not Applicable Terminated(Funding expired) - United States, California ... More >> Charles Drew University of Medicine and Science Los Angeles, California, United States, 90059 Less <<
NCT02317796 Type 2 Diabetes Phase 2 Completed - United States, Pennsylvania ... More >> Melior Pharmaceuticals I & Bukwang Pharm. Co., Ltd. USA and South Korea, Pennsylvania, United States Less <<
NCT00733304 Macular Degeneration Phase 2 Completed - United States, California ... More >> GSK Investigational Site Beverly Hills, California, United States, 90211 GSK Investigational Site Sacramento, California, United States, 95841 United States, Florida GSK Investigational Site Winter Haven, Florida, United States, 33880 United States, Indiana GSK Investigational Site Indianapolis, Indiana, United States, 46280 United States, Massachusetts GSK Investigational Site Boston, Massachusetts, United States, 02111 United States, Michigan GSK Investigational Site Ann Arbor, Michigan, United States, 48105 GSK Investigational Site Grand Rapids, Michigan, United States, 49525 United States, Utah GSK Investigational Site Salt Lake City, Utah, United States, 84132 Australia, New South Wales GSK Investigational Site Sydney, New South Wales, Australia, 2145 GSK Investigational Site Sydney, New South Wales, Australia, 2150 Australia, Victoria GSK Investigational Site Melbourne, Victoria, Australia Australia, Western Australia GSK Investigational Site Perth, Western Australia, Australia, 6009 Italy GSK Investigational Site Milano, Lombardia, Italy, 20132 GSK Investigational Site Milano, Lombardia, Italy, 20157 GSK Investigational Site Torino, Piemonte, Italy, 10122 GSK Investigational Site Firenze, Toscana, Italy, 50134 GSK Investigational Site Padova, Veneto, Italy, 35128 Less <<
NCT00729898 - Completed - Norway ... More >> Novo Nordisk Investigational Site Rud, Norway, 1309 Sweden Novo Nordisk Investigational Site Farsta, Sweden, 123 47 Less <<
NCT03446183 - Completed - -
NCT01698164 Menopausal Syndrome ... More >> Cardiovascular Disease Osteoporosis Breast Cancer Less << Phase 4 Unknown - China, Beijing ... More >> PUMCH Recruiting Peking, Beijing, China, 100730 Contact: Wei Xue, Bachelor Degree       xuewei8955@sina.com Less <<
NCT00733304 - Completed - -
NCT00383578 Diabetes Mellitus, Type 2 Phase 3 Completed - Germany ... More >> Investigative Centers Nurnberg, Germany Switzerland Novartis Pharmaceuticals Basel, Switzerland Less <<
NCT00242567 Prostate Cancer Phase 3 Completed - Australia ... More >> Novartis Investigative Site Adelaide, Australia Novartis Investigative Site Brisbane, Australia Novartis Investigative Site Melbourne, Australia Novartis Investigative Site Port Macquarie, Australia Novartis Investigative Site Sydney, Australia Brazil Novartis Investigative Site Porto Alegre, Brazil Novartis Investigative Site Santo Andre, Brazil Novartis Investigative Site Sao Paulo, Brazil China Novartis Investigative Site Beijing, China Novartis Investigative Site Chongqing, China Novartis Investigative Site Shanghai, China Korea, Republic of Novartis Investigative Site Busan, Korea, Republic of Novartis Investigative Site Kyunggi-do, Korea, Republic of Novartis Investigative Site Seoul, Korea, Republic of Kuwait Novartis Investigative Site Kuwait, Kuwait Lebanon Novartis Investigative Site Beirut, Lebanon New Zealand Novartis Investigative Site Auckland, New Zealand Novartis Investigative Site Christchurch, New Zealand Novartis Investigative Site Hamilton, New Zealand Novartis Investigative Site Tauranga, New Zealand Novartis Investigative Site Wellington, New Zealand Saudi Arabia Novartis Investigative Site Riyadh, Saudi Arabia Taiwan Novartis Investigative Site Taichung, Taiwan Novartis Investigative Site Taipei, Taiwan Novartis Investigative Site Taoyuan, Taiwan Thailand Novartis Investigative Site Bangkok, Thailand Novartis Investigative Site Songkhla, Thailand Less <<
NCT01353391 Type 2 Diabetes Phase 3 Active, not recruiting June 2019 Canada, Ontario ... More >> The Centre for Mother, Infant, and Child Research, Sunnybrook Research Institute Toronto, Ontario, Canada, M4N 3M5 Less <<
NCT00242567 - Completed - -
NCT02380924 Healthy Phase 1 Completed - United States, New Hampshire ... More >> Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States, 03576 Less <<
NCT00655850 Non-Small Cell Lung Cancer Phase 2 Completed - United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35294 - 0104 Less <<
NCT01316094 Type 2 Diabetes Mellitus Phase 3 Completed - Japan ... More >> Chubu, Japan Chugoku, Japan Hokkaido, Japan Kansai, Japan Kantou, Japan Kyushu, Japan Shikoku, Japan Touhoku, Japan Less <<
NCT00655850 - Completed - -
NCT00132132 - Completed - -
NCT03273140 Diabetic Patients, Gamificatio... More >>n, Diabetic Education Less << Not Applicable Completed - Singapore ... More >> 11 Jalan, Tan Tock Seng Hospital, Singapore, Noverna, Singapore, 308433 Less <<
NCT02752412 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT03503552 - Completed - Singapore ... More >> Clinical Nutrition Research Centre Singapore, Singapore, 117599 Less <<
NCT00132132 Obesity Not Applicable Completed - United States, Massachusetts ... More >> Caritas St. Elizabeth's Medical Center Boston, Massachusetts, United States, 02135 Less <<
NCT00325429 Diabetes Mellitus, Type 2 Phase 3 Completed - Japan ... More >> Novartis Pharmaceuticals Tokyo, Japan Less <<
NCT00697203 Dyslipidemia Phase 2 Completed - -
NCT00494013 Diabetes Mellitus Type 2 Phase 3 Completed - -
NCT03454711 Obesity Phase 2 Phase 3 Recruiting November 2020 France ... More >> CHU de Rennes Recruiting Rennes, France, 35033 Contact: Ronan Thibault, MD, PhD    +33 2 99 28 96 46    ronan.thibault@chu-rennes.fr    Contact: Mickaël Som, MD    06 67 68 86 71    mickael.som@gmail.com Less <<
NCT02004002 Obesity Not Applicable Completed - United States, Missouri ... More >> Washington University School of Medicine St Louis, Missouri, United States, 63110 Less <<
NCT00896389 - Completed - -
NCT00494013 - Completed - -
NCT00886821 Diabetes Mellitus, Type 2 Phase 1 Completed - United States, Florida ... More >> Cetero Research Miami Gardens, Florida, United States, 33169 United States, Texas Cetero Research - San Antonio San Antonio, Texas, United States, 78229 Less <<
NCT00896389 Hypertension Phase 4 Completed - United States, Pennsylvania ... More >> Amish Research Clinics Lancaster, Pennsylvania, United States, 17607 Less <<
NCT00377858 Diabetes Mellitus, Type 2 Phase 4 Completed - Australia, South Australia ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Keswick, South Australia, Australia, 5035 Australia, Victoria For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fitzroy, Victoria, Australia, 3065 Australia, Western Australia For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fremantle, Western Australia, Australia, 6160 Canada, Ontario For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. London, Ontario, Canada, N6A 4L2 Canada, Quebec For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Granby, Quebec, Canada, J2G 1T7 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sherbrooke, Quebec, Canada, J1G 5K2 Canada, Saskatchewan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Regina, Saskatchewan, Canada, S4P 0W5 France For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mantes La Jolie, France, 78200 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Menton, France, 06500 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Pau, France, 64000 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Poitiers, France, 86000 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Toulouse, France, 31082 Korea, Republic of For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Goyang-Si/Kyunggi-Do, Korea, Republic of, 410-719 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kwang Ju, Korea, Republic of, 501-757 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Seoul, Korea, Republic of, 110-746 Mexico For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chihuahua, Mexico, 31238 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Guadalajara, Mexico, 44620 Russian Federation For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Arkhangelsk, Russian Federation, 163045 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Moscow, Russian Federation, 117036 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Saint Petersburg, Russian Federation, 193257 Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Alicante, Spain, 03114 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Almeria, Spain, 04001 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Barcelona, Spain, 08017 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bilbao, Spain, 48013 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Malaga, Spain, 29010 Less <<
NCT00389415 Diabetes Mellitus, Type 2 Phase 3 Completed - Japan ... More >> Novartis Pharmaceuticals Tokyo, Japan Less <<
NCT02664064 Prediabetes O... More >>verweight Obesity Less << Not Applicable Completed - United States, California ... More >> LAC+USC Medical Center Los Angeles, California, United States, 90033 Northeast Valley Health Corporation San Fernando, California, United States, 91340 United States, Washington Providence Medical Group-Monroe Clinic Monroe, Washington, United States, 98272 Less <<
NCT00377858 - Completed - -
NCT02915198 Prediabetic State ... More >> Atherosclerosis Metformin Less << Phase 4 Not yet recruiting June 30, 2024 United States, Arizona ... More >> Phoenix VA Health Care System, Phoenix, AZ Not yet recruiting Phoenix, Arizona, United States, 85012 Contact: Peter Reaven, MD    602-277-5551 ext 6875    Peter.Reaven@va.gov    United States, California VA Loma Linda Healthcare System, Loma Linda, CA Not yet recruiting Loma Linda, California, United States, 92357 Contact: Alan Jacobson, MD    909-583-6050    alan.jacobson@va.gov    VA Long Beach Healthcare System, Long Beach, CA Not yet recruiting Long Beach, California, United States, 90822 Contact: Anthony Vo, MD    562-826-3497    Anthony.Vo@va.gov    VA Palo Alto Health Care System, Palo Alto, CA Not yet recruiting Palo Alto, California, United States, 94304-1290 Contact: Arlina Ahluwalia, MD    650-493-5000 ext 61755    Arlina.Ahluwalia@va.gov    Contact: Paul Heidenreich, MD    6504935000 ext 64069    Paul.Heidenreich@va.gov    VA Greater Los Angeles Healthcare System, West Los Angeles, CA Not yet recruiting West Los Angeles, California, United States, 90073 Contact: Tannaz Moin, MD    310-478-3711 ext 48380    Tannaz.Moin@va.gov; tmoin@mednet.ucla.edu    United States, Colorado Rocky Mountain Regional VA Medical Center, Aurora, CO Not yet recruiting Aurora, Colorado, United States, 80045 Contact: Allan V Prochazka, MD MSc    303-399-8020 ext 2144    Allan.Prochazka@va.gov    Study Chair: Gregory G. Schwartz, PhD MD          United States, Florida North Florida/South Georgia Veterans Health System, Gainesville, FL Not yet recruiting Gainesville, Florida, United States, 32608 Contact: Carsten Schmalfuss, MD    352-376-1611 ext 6052    Carsten.Schmalfuss@va.gov    Miami VA Healthcare System, Miami, FL Not yet recruiting Miami, Florida, United States, 33125 Contact: Ana Palacio, MD    305-926-3780    Ana.Palacio@va.gov    United States, Oregon VA Portland Health Care System, Portland, OR Not yet recruiting Portland, Oregon, United States, 97239 Contact: North Noelck, MD    503-220-8262 ext 56426    North.Noelck2@va.gov    Contact: Linda Humphrey, MD    5032208262 ext 57176    Linda.Humphrey@va.gov    United States, Utah VA Salt Lake City Health Care System, Salt Lake City, UT Not yet recruiting Salt Lake City, Utah, United States, 84148 Contact: Charles Lui, MD    801-582-1565    Charles.Lui@va.gov    United States, Virginia Salem VA Medical Center, Salem, VA Not yet recruiting Salem, Virginia, United States, 24153 Contact: Ali Iranmanesh, MD    540-983-1071    Ali.Iranmanesh@va.gov Less <<
NCT01406015 Obesity Insul... More >>in Resistance Less << Not Applicable Completed - United States, Massachusetts ... More >> Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Less <<
NCT02501161 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT03541460 - Recruiting December 2019 Israel ... More >> Rambam Health Care Campus Recruiting Haifa, North, Israel, 3109601 Contact: Tzvi Dwolatzky    502061183    tzvidov@gmail.com    Contact: Elad Rubin    972-524685038    e_rubin@rambam.health.gov.il Less <<
NCT01196104 Type 2 Diabetes Phase 3 Terminated(For Business Reason... More >>s) Less << - -
NCT00886821 - Completed - -
NCT03677622 Fluid Overload Not Applicable Completed - -
NCT02861261 Type 2 Diabetes Phase 3 Active, not recruiting August 2018 China, Shanghai ... More >> Ruijin hospital,Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai, China Less <<
NCT01965990 - Completed - Italy ... More >> Clinical Nutrition Unit - A.O.R.N. "San Giuseppe Moscati" Avellino, Italy, 83100 Less <<
NCT01406015 - Completed - -
NCT00277277 Diabetes Mellitus, Type 2 Not Applicable Completed - United States, Washington ... More >> Bastyr Center for Natural Health Seattle, Washington, United States, 98028 Less <<
NCT01196104 - Terminated(For Business Reason... More >>s) Less << - -
NCT00351884 Diabetes Mellitus, Type 2 Phase 3 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 Germany Novartis Investigative Site Investigative Centers, Germany Less <<
NCT03072407 Type2 Diabetes Mellitus Phase 1 Completed - United States, Florida ... More >> Clinical Pharmacology of Miami, Inc. Miami, Florida, United States, 33014 United States, New Jersey Frontage Clinical Services. Inc. Hackensack, New Jersey, United States, 07601 Less <<
NCT03547661 Premenstrual Syndrome Not Applicable Recruiting January 2020 Switzerland ... More >> University of Basel, Faculty of Psychology, Division of Clinical Psychology and Psychotherapy Recruiting Basel, Basel-Stadt, Switzerland, 4055 Contact: Antje Frey Nascimento, MSc          Contact: Cosima Locher, Dr. phil.          Principal Investigator: Jens Gaab, Prof. Dr. Less <<
NCT01775748 Obesity Overw... More >>eight Less << Not Applicable Completed - United States, Massachusetts ... More >> Boston University School of Medicine Boston, Massachusetts, United States, 02118 Less <<
NCT00815854 Schizophrenia Not Applicable Active, not recruiting June 2019 United States, Michigan ... More >> University of Michigan Ann Arbor, Michigan, United States, 48109 Less <<
NCT02819440 Healthy Obese Phase 2 Recruiting December 2020 United States, Tennessee ... More >> Vanderbilt University Medical Center Recruiting Nashville, Tennessee, United States, 37215 Contact: Karlis Draulis, BS    615-875-6028    karlis.j.draulis@vumc.org Less <<
NCT02469298 Virus Diseases Phase 2 Completed - -
NCT01973231 - Completed - -
NCT01449019 Diabetes Mellitus, Type 2 Phase 1 Completed - Germany ... More >> Ludwig Maximilians-University, Clinical Research Unit Munich, Germany, 80999 Clinical Research unit, Dept. of Internal Medicine II - Großhadern, University of Munich Munich, Germany, 81377 Less <<
NCT02469298 - Completed - -
NCT02354911 Type 1 Diabetes Phase 2 Not yet recruiting January 2019 -
NCT01969968 Obesity Not Applicable Active, not recruiting December 2018 France ... More >> Nice University Hospital Nice, France, 06000 Less <<
NCT00364312 Type 2 Diabetes Not Applicable Unknown - United States, Virginia ... More >> University of Virginia School of Medicine Charlottesville, Virginia, United States, 22908 Less <<
NCT00325117 Diabetes Mellitus, Type 2 Phase 3 Completed - Japan ... More >> Novartis Pharmaceuticals Tokyo, Japan Less <<
NCT02897349 Diabetes Mellitus, Type 2 Phase 3 Active, not recruiting January 30, 2019 China ... More >> China-Japan Friendship Hospital Beijing, China, 100029 Beijing Tongren Hospital Beijing, China, 100730 The General Hospital of Chinese People's Armed Police Forces Beijing, China, 100854 First Hospital of Jilin University Changchun, China, 130021 Fuzhou General Hospital of Nanjing Militray Command Fuzhou, China, 350025 Third Affiliated Hospital of Guangzhou Medical University Guangzhou, China, 510150 The Affiliated Hospital of Guizhou Medical University Guiyang, China, 550004 Hangzhou Second People's Hospital Hangzhou, China, 310015 General Hospital of Jinan Military Area Jinan, China, 250000 Nanjing First Hospital Nanjing, China, 210006 The affiliated hospital of medicalcollege qingdao university Qingdao, China, 266005 Centre Hospital of Putuo District, Shanghai Shanghai, China, 200062 Shanghai Tenth People's Hospital Shanghai, China, 200072 Yangpu Hospital, Tongji University Shanghai, China, 200090 Second Hospital Affiliated to Shantou Medical University Shantou, China, 515041 Shengjing Hospital of China Medical University Shengyang, China, 110072 Siping Central People's Hospital Siping, China, 136000 The First Affiliated Hospital of Soochow University Suzhou, China, 215006 Nankai University Affiliated Hospital Tianjin, China, 300000 The 2nd Hospital of Tianjin Medical University Tianjin, China, 300000 Tianjin Medical University General Hospital Tianjin, China, 30052 Renmin Hospital of Wuhan University Wuhan, China, 430060 First Affiliated Hospital of Xiamen University Xiamen, China, 361003 the first people hospital of Yue Yang Yueyang, China, 414000 Affiliated Hospital of Jiangsu University Zhenjiang, China, 212013 Less <<
NCT01055626 - Unknown December 2017 Spain ... More >> Clinica Universidad de Navarra - University of Navarra Recruiting Pamplona, Navarra, Spain, 31008 Contact: Gema Frühbeck, MD, PhD    34 948255400 ext 4484    gfruhbeck@unav.es    Sub-Investigator: Javier Gómez-Ambrosi, PhD          Clinica Universidad de Navarra Enrolling by invitation Pamplona, Spain Less <<
NCT00486941 Hypertension ... More >>Type 2 Diabetes Obesity Dyslipidemia Less << Phase 3 Completed - Sweden ... More >> Björknäs Health Centre Boden, Sweden, SE-96164 Less <<
NCT03683888 Obesity Pre D... More >>iabetes Less << Not Applicable Recruiting June 1, 2020 United States, Florida ... More >> University of Miami Recruiting Miami, Florida, United States, 33136 Contact: Gianluca Iacobellis, MD PhD    305-243-3636    giacobellis@med.miami.edu    Principal Investigator: Gianluca Iacobellis, MD PhD Less <<
NCT01226966 - Completed - France ... More >> Novo Nordisk Investigational Site Paris La défense cedex, France, 92932 Less <<
NCT01973231 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 4 Completed - -
NCT00229710 Diabetes Mellitus, Type 2 Phase 3 Terminated(The development pro... More >>gram has been terminated) Less << - -
NCT00231192 Diabetes Not Applicable Withdrawn(Unable to recruit an... More >>y subjects) Less << - United States, Pennsylvania ... More >> The Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104-4399 Less <<
NCT03700424 Acute Coronary Syndrome Phase 2 Not yet recruiting December 2019 -
NCT01247714 Hyperglycemia ... More >> Diabetics Metabolic Syndrome Less << Not Applicable Unknown May 2015 Spain ... More >> Department of Biochemistry and Molecular Biology II. University of Granada Granada, Spain, 18014 Less <<
NCT02002143 Type 2 Diabetes Mellitus (T2DM... More >>) Less << Not Applicable Recruiting February 2020 Canada, British Columbia ... More >> Gateway Clinic / Kent Place Clinic Recruiting Abbotsford, British Columbia, Canada, V2S 3N5 Sub-Investigator: Adriaan Windt, MD          Centre for Hip Health and Mobility (Vancouver Coastal Health Research Institute/University of British Columbia) Recruiting Vancouver, British Columbia, Canada, V5Z 1M9 Principal Investigator: Karim Miran-Khan, MD, PhD, MBA Less <<
NCT03305549 Acute Kidney Injury Not Applicable Enrolling by invitation January 1, 2020 United States, California ... More >> UCSF Medical Center Moffitt-Long Hospital San Francisco, California, United States, 94143 Less <<
NCT02039531 Knee Osteoarthritis Phase 3 Completed - Spain ... More >> Hospital Universitario Principe de Asturias Alcala de Henares, Madrid, Spain, 28805 Less <<
NCT00764127 - Completed - United States, New York ... More >> New York State Psychiatric Institute New York, New York, United States, 10032 Less <<
NCT00920348 - Active, not recruiting December 2022 Canada, Alberta ... More >> Health Sciences Centre Calgary, Alberta, Canada, T2N 4N1 Canada, British Columbia St-Paul's Hospital Vancouver, British Columbia, Canada, V6Z 1Y6 Canada, Nova Scotia Halifax Infirmary Halifax, Nova Scotia, Canada, B3H 3A7 Canada, Ontario Kingston General Hospital Kingston, Ontario, Canada, K7L 2V6 Ottawa Hospital General Ottawa, Ontario, Canada, K1H 8L6 University of Toronto Toronto, Ontario, Canada, M5T 2S8 Canada, Quebec Montreal Chest Institute Montreal, Quebec, Canada, H2X 2P4 Canada, Saskatchewan Royal University Hospital Saskatoon, Saskatchewan, Canada, S7N 0W8 Canada Institut universitaire de cardiologie et de pneumologie de Québec Quebec, Canada, G1V 4G5 Less <<
NCT00397553 Diabetes Mellitus, Type 1 Phase 3 Completed - Russian Federation ... More >> Sanofi-Aventis Moscow, Russian Federation Less <<
NCT02377362 Diabetes Mellitus, Type 2 Phase 1 Terminated(Insufficient effica... More >>cy for this indication) Less << - United States, Arizona ... More >> Celerion Tempe, Arizona, United States, 85283 United States, California Profil Institute for Clinical Research, Inc. Chula Vista, California, United States, 91911 United States, Florida Clinical Pharmacology of Miami, Inc. Miami, Florida, United States, 33014 United States, Texas Clinical Trials of Texas, Inc. San Antonio, Texas, United States, 78229 Less <<
NCT03491241 Pre-diabetes ... More >>Obesity Less << Not Applicable Completed - Italy ... More >> Raffaele Marfella Naples, Italy, 80138 Less <<
NCT01919541 Colon Cancer ... More >>Rectal Cancer Less << Not Applicable Withdrawn(difficulty in recrui... More >>ting patients) Less << December 2016 Canada, Quebec ... More >> Montreal General Hospital Montreal, Quebec, Canada, H3G 1A4 Less <<
NCT02607943 Acute Stroke ... More >>Hyperglycemia Less << Phase 3 Unknown November 2018 Taiwan ... More >> National Taiwan University Hospital Recruiting Taipei, Taiwan, 100 Contact: Sung-Chun Tang, MD. PhD    +88623123456 ext 63280    tangneuro@gmail.com Less <<
NCT02554643 Type 2 Diabetes Not Applicable Completed - Brazil ... More >> Laboratory of Medical Investigation - LIM 18, University of São Paulo São Paulo, Brazil, 01246-903 Less <<
NCT00272779 HIV Infections Phase 3 Completed - -
NCT01762540 Whole Body Catabolisme Induced... More >> by Glucocorticoids Less << Phase 2 Completed - Denmark ... More >> Medical Research Laboratory, Clinical Institute of Medicine, Aarhus University Hospital Aarhus, Denmark, 8000 Less <<
NCT00103857 - Completed - -
NCT01998113 - Completed - Spain ... More >> Hospital de la Santa Creu i Sant Pau Barcelona, Spain, 08025 Less <<
NCT00272779 - Completed - -
NCT00103857 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT01810016 - Terminated(Low recruitment due... More >> to change in standard of care) Less << - -
NCT01810016 Unresectable or Metastatic Mel... More >>anoma Less << Phase 1 Terminated(Low recruitment due... More >> to change in standard of care) Less << - United States, New York ... More >> Mount Sinai Medical Center New York, New York, United States, 10029 Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 United States, Pennsylvania University of Pittsburgh Cancer Center Pittsburgh, Pennsylvania, United States, 15213 United States, Virginia University of Virginia Cancer Center Charlottesville, Virginia, United States, 22908 Australia, Victoria Austin Health, Ludwig Oncology Unit Melbourne, Victoria, Australia Less <<
NCT00129259 Diabetes Mellitus, Type 1 Phase 2 Completed - United States, California ... More >> The Diabetes Center at UCSF San Francisco, California, United States, 94143 United States, Colorado Barbara Davis Center for Childhood Diabetes Denver, Colorado, United States, 80262 United States, Connecticut Yale University New Haven, Connecticut, United States, 06520 United States, Georgia Medical College of Georgia Augusta, Georgia, United States, 30912 United States, New York Dept. of Medicine, Division of Endocrinology and the Naomi Berrie Diabetes Center/Columbia University New York, New York, United States, 10032 United States, Washington Benaroya Research Institute Seattle, Washington, United States, 98108 Pacific Northwest Research Institute/University of Washington Seattle, Washington, United States, 98122 Less <<
NCT02969343 Central Line-Associated Bloods... More >>tream Infection (CLABSI) Venous Thromboembolism Patient Fall Catheter-Associated Infection Severe Hypoglycemia Opioid-Related Severe Adverse Drug Event Hospital Acquired Pressure Ulcer Adverse Drug Event Severe Hospital Acquired Delerium Rapid Response Related to Arrhythmia Less << Not Applicable Recruiting September 2018 United States, Massachusetts ... More >> Brigham and Women's Hospital Recruiting Boston, Massachusetts, United States, 02115 Contact: Alexandra C Businger    617-732-7063    abusinger@partners.org    Contact: Patricia Dykes, RN PhD    617-732-8925    pdykes@partners.org    Principal Investigator: David W Bates, MD MSc Less <<
NCT00223613 Type 1 Diabetes Phase 3 Unknown - Finland ... More >> Department of Pediatrics, University of Turku Recruiting Turku, Finland, FI-20520 Contact: Tuula T Simell, MPH, PhD    +358-2-313-3427    tuula.simell@utu.fi    Contact: Birgitta Nurmi, RN    +358-2-313-2465    birgitta.nurmi@tyks.fi    Sub-Investigator: Kirsti Näntö-Salonen, MD, PhD Less <<
NCT02202265 Coronary Artery Disease Not Applicable Recruiting December 2018 Brazil ... More >> Instituto de Cardiologia/Fundação Universitária de Cardiologia (IC/FUC) Recruiting Porto Alegre, Rio Grande do Sul, Brazil, 90.620-001 Contact: Aline Marcadenti, PhD    +55(51)3230-3600 ext 4134    marcadenti@yahoo.com.br    Principal Investigator: Aline Marcadenti, PhD          Sub-Investigator: Vera Portal, PhD          Sub-Investigator: Melissa Markoski, PhD          Sub-Investigator: Silvia Garofallo, MSc          Sub-Investigator: Camila Weschenfelder, Nutritionist          Sub-Investigator: Julia Lorenzon, Nutritionist          Sub-Investigator: Viviane Campos, Nutritionist          Sub-Investigator: Aline Oliveira, Nutritionist          Sub-Investigator: Alexandre Quadros, PhD          Sub-Investigator: Luana Machado, Nutritionist Less <<
NCT00129259 - Completed - -
NCT03760991 Type 2 Diabetes Mellitus Phase 4 Not yet recruiting April 2020 -
NCT03728621 Childhood Obesity ... More >> Obesity Pediatric Obesity Dyslipidemias Cardiovascular Risk Factor Life Style Less << Not Applicable Completed - Italy ... More >> Ospedale San Paolo Milan, Italy, 20142 Less <<
NCT02475421 Diabetes Not Applicable Completed - Denmark ... More >> Center for Diabetes Research, Department of Medicine, Gentofte Hospital Hellerup, Copenhagen, Denmark, 2900 Less <<
NCT00534352 HIV-1 Infection Phase 2 Completed - -
NCT01867216 Diabetes Mellitus, Type 2 Phase 1 Completed - United States, California ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chula Vista, California, United States, 91911 United States, New Jersey For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Eatontown, New Jersey, United States, 07724 United States, New York For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. New York, New York, United States, 10013 United States, Texas For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Dallas, Texas, United States, 75247 Less <<
NCT01867216 - Completed - -
NCT01243424 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT00534352 - Completed - -
NCT01195662 Type 2 Diabetes Phase 3 Completed - -
NCT02987335 - Not yet recruiting December 2022 -
NCT01195662 - Completed - -
NCT03214380 Type 2 Diabetes Mellitus Phase 3 Active, not recruiting March 4, 2019 -
NCT02351232 Type 1 Diabetes Phase 2 Phase 3 Completed - Denmark ... More >> Steno Diabetes Center Gentofte, Denmark, 2820 Hvidovre University Hospital Hvidovre, Denmark, 2650 Less <<
NCT02312427 Heart Failure ... More >> Diabetes Mellitus Less << Phase 4 Completed - Japan ... More >> Mitsui Memorial Hospital Taito-ku, Tokyo, Japan Less <<
NCT00424411 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT00923260 - Completed - -
NCT01543958 HIV-1 Infection Phase 2 Completed - United States, Alabama ... More >> Alabama Therapeutics CRS (5801) Birmingham, Alabama, United States, 35294 United States, California UCLA CARE Center CRS (601) Los Angeles, California, United States, 90095 Ucsf Aids Crs (801) San Francisco, California, United States, 94110 Harbor-UCLA Med. Ctr. CRS (603) Torrance, California, United States, 90502 United States, Colorado University of Colorado Hospital CRS (6101) Aurora, Colorado, United States, 80045 United States, Florida Univ. of Miami AIDS CRS (901) Miami, Florida, United States, 33136 United States, Illinois Northwestern University CRS (2701) Chicago, Illinois, United States, 60611 United States, Massachusetts Massachusetts General Hospital ACTG CRS (101) Boston, Massachusetts, United States, 02114 United States, Missouri Washington University CRS (2101) Saint Louis, Missouri, United States, 63110 United States, New York AIDS Care CRS (1108) Rochester, New York, United States, 14642 Univ. of Rochester ACTG CRS (1101) Rochester, New York, United States, 14642 United States, Ohio Univ. of Cincinnati CRS (2401) Cincinnati, Ohio, United States, 45267 Case CRS (2501) Cleveland, Ohio, United States, 44106 Metro Health CRS (2503) Cleveland, Ohio, United States, 44109 United States, Pennsylvania Hosp. of the Univ. of Pennsylvania CRS (6201) Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00923260 Metabolic Syndrome ... More >> Morbid Obesity Less << Not Applicable Completed - -
NCT01543958 - Completed - -
NCT02262013 Pediatric Obesity Not Applicable Completed - United States, Virginia ... More >> Children's Hospital of Richmond at VCU Healthy Lifestyles Center Henrico, Virginia, United States, 23239 Less <<
NCT00118963 Diabetes Mellitus, Type 2 Phase 4 Completed - Denmark ... More >> Steno Diabetes Center Gentofte, Denmark, 2820 Less <<
NCT03664089 Gestational Diabetes Not Applicable Enrolling by invitation December 31, 2021 United States, Ohio ... More >> Nationwide Children's Hospital Columbus, Ohio, United States, 43205 Less <<
NCT03248414 Obesity Not Applicable Completed - Korea, Republic of ... More >> Seoul National University Bundang Hospital Seongnam, Gyeonggi, Korea, Republic of, 463-707 Less <<
NCT00079573 Obesity Phase 2 Completed - United States, California ... More >> Stanford Prevention Research Center Stanford, California, United States, 94305 Less <<
NCT03363386 Type 2 Diabetes Mellitus Not Applicable Completed - -
NCT01410799 Hormone Deficiency ... More >> Aging Less << Phase 2 Terminated(Funding ended) - United States, Pennsylvania ... More >> University of Pennsylvania-UPHS Presbyterian Campus Philadelphia, Pennsylvania, United States, 19103 Less <<
NCT01402973 Healthy Adults Not Applicable Completed - United States, Maryland ... More >> USDA Beltsville Human Nutrition Research Center Beltsville, Maryland, United States, 20705 Less <<
NCT02496221 Diabetes Mellitus, Type 2 Phase 4 Completed - United States, Maryland ... More >> GSK Investigational Site Baltimore, Maryland, United States, 21225 Less <<
NCT02467920 Type 2 Diabetes Mellitus Phase 4 Completed - China, Hubei ... More >> Tongji Hospital, Tongji Medical College, Huazhong University of Science and technology Wuhan, Hubei, China, 430000 Less <<
NCT02171390 Hypogonadotrophic Hypogonadism Phase 4 Completed - Turkey ... More >> Gulhane School of Medicine Department of Endocrinology and Metabolism Ankara, NonUS, Turkey, 06018 Less <<
NCT03366168 - Recruiting December 31, 2022 United States, Maryland ... More >> National Institute of Aging, Clinical Research Unit Recruiting Baltimore, Maryland, United States, 21224 Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)    800-411-1222 ext TTY8664111010    prpl@cc.nih.gov Less <<
NCT02496221 - Completed - -
NCT03477916 Obesity Metab... More >>olic Syndrome Less << Phase 2 Recruiting April 1, 2020 Canada, Alberta ... More >> Royal Alexandra Hospital Recruiting Edmonton, Alberta, Canada, T5H 3V9 Contact: Basmina Aminzadah, HBSc    7807354912    basmina@ualberta.ca    Principal Investigator: Karen Madsen, PhD Less <<
NCT01095614 - Completed - France ... More >> CHU Clermont-Ferrand Clermont-Ferrand, France, 63003 Less <<
NCT03054948 Home Parenteral Nutrition ... More >> Short Bowel Syndrome Less << Phase 4 Withdrawn(Redesign of study pr... More >>otocol.) Less << March 20, 2018 United States, Minnesota ... More >> Mayo Clinic in Rochester Rochester, Minnesota, United States, 55905 Less <<
NCT01764386 Obesity Overw... More >>eight Less << Phase 3 Completed - United States, Colorado ... More >> Radiant Research Denver, Colorado, United States, 80239 United States, Missouri Radiant Research, Inc. Saint Louis, Missouri, United States, 63151 United States, North Carolina PMG Research of Raleigh Cary, North Carolina, United States, 27518 PMG Research of Winston-Salem Hickory, North Carolina, United States, 28601 PMG Research of Raleigh Raleigh, North Carolina, United States, 27609 PMG Research of Salisbury Salisbury, North Carolina, United States, 28144 PMG Research of Wilmington, LLC Wilmington, North Carolina, United States, 28401 United States, Ohio Radiant Research-Akron Akron, Ohio, United States, 44311 Radiant Research, Inc. Columbus, Ohio, United States, 43212 United States, South Carolina Radiant Research Anderson, South Carolina, United States, 29621 Radiant Research, Greer Greer, South Carolina, United States, 29651 PMG Research of Charleston Mount Pleasant, South Carolina, United States, 29464 United States, Tennessee PMG Research of Bristol Bristol, Tennessee, United States, 37620 United States, Texas Radiant Research Dallas-North Dallas, Texas, United States, 75231 United States, Utah Radiant Research, SLC Salt Lake City, Utah, United States, 84107 Less <<
NCT00303394 Type 2 Diabetes Phase 2 Completed - Denmark ... More >> Steno Diabetes Center Gentofte, Copenhagen, Denmark, 2280 Switzerland University Hospital of Zurich, Division of Endocrinology and Diabetes Zurich, Switzerland, 8091 Less <<
NCT00500370 Obesity Phase 2 Completed - United States, Arizona ... More >> Research Site Peoria, Arizona, United States Research Site Tucson, Arizona, United States United States, California Research Site Santa Ana, California, United States United States, Indiana Research Site Indianapolis, Indiana, United States United States, Kansas Research Site Topeka, Kansas, United States Research Site Wichita, Kansas, United States United States, Louisiana Research Site Baton Rouge, Louisiana, United States United States, Missouri Research Site St. Louis, Missouri, United States United States, Oklahoma Research Site Oklahoma City, Oklahoma, United States United States, South Carolina Research Site Goose Creek, South Carolina, United States Research Site Spartanburg, South Carolina, United States United States, Texas Research Site Dallas, Texas, United States Research Site San Antonio, Texas, United States United States, Washington Research Site Renton, Washington, United States Puerto Rico Research Site Ponce, Puerto Rico Research Site San Juan, Puerto Rico Less <<
NCT02454127 - Completed - -
NCT01764386 - Completed - -
NCT00830791 Type 2 Diabetes Phase 1 Terminated - -
NCT00830791 - Terminated - -
NCT02454127 Obesity Cardi... More >>ovascular Disease Metabolic Syndrome Less << Not Applicable Completed - -
NCT01907113 - Completed - -
NCT01907113 Diabetes Mellitus, Type 2 Phase 1 Completed - Germany ... More >> 1245.12.1 Boehringer Ingelheim Investigational Site Kiel, Germany 1245.12.2 Boehringer Ingelheim Investigational Site Neuss, Germany Less <<
NCT00500370 - Completed - -
NCT02509741 Obesity Not Applicable Recruiting - China, Chongqing ... More >> Southwest Hospital Recruiting Chongqing, Chongqing, China, 410013 Contact: Xiaolan Zhao    +86-23-68754919    zhaoxiaolan65@126.com    China, Zhejiang Hangzhou PLA sanatorium Recruiting Hangzhou, Zhejiang, China, 310000 Contact: Zili Zhong    +86-0571-87127082    zhongzili@nutriease.com Less <<
NCT02528305 Non-alcoholic Steatohepatitis ... More >> Non-alcoholic Fatty Liver Disease Less << Not Applicable Completed - United Kingdom ... More >> Abertay University Dundee, United Kingdom, DD1 1HG Ninewells Hospital Dundee, United Kingdom, DD1 9SY Less <<
NCT02075281 Obesity Phase 2 Completed - United States, California ... More >> Hanmi pharmaceutical Los angeles, California, United States Less <<
NCT02743286 Sedentary Lifestyle Not Applicable Completed - United States, California ... More >> University of California, San Diego La Jolla, California, United States, 92093 Less <<
NCT03538236 Obesity NASH ... More >>- Nonalcoholic Steatohepatitis Obesity, Morbid Less << Not Applicable Not yet recruiting May 30, 2020 -
NCT01881724 Type 2 Diabetes Mellitus Not Applicable Unknown December 2017 China ... More >> The Chinese University of Hong Kong Recruiting Hong Kong, China, Hong Kong Contact: Alice Kong, FRCP    +852 2632 3307    alicekong@cuhk.edu.hk    Contact: Risa Ozaki, MRCP    +852 2632 3663    risaozaki@cuhk.edu.hk    Sub-Investigator: Risa Ozaki, MRCP          Hong Kong Clinical Trial Centre, The Chinese University of Hong Kong, Prince of Wales Hospital Not yet recruiting Hong Kong, Hong Kong, Hong Kong Contact: Alice Kong, FRCP    (852)26323307    alicekong@cuhk.edu.hk    Contact: Tracy Cheng, RN    (852)26323663    tracycheng@cuhk.edu.hk Less <<
NCT01992783 Overweight Ob... More >>esity Less << Not Applicable Completed - Iran, Islamic Republic of ... More >> Urmia, Azerbaijan-gharbi, Iran, Islamic Republic of Less <<
NCT02528305 - Completed - -
NCT01728116 Type 2 Diabetes ... More >> Obesity Less << Not Applicable Terminated(Higher than anticip... More >>ated rate of Hepatic abscess (N=7)) Less << - -
NCT02305381 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT02386553 Spinal Muscular Atrophy Phase 2 Active, not recruiting January 25, 2022 United States, Colorado ... More >> Children's Hospital Colorado Aurora, Colorado, United States, 80045 United States, Florida Nemours Children's Clinic Orlando, Florida, United States, 32827 United States, Illinois Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States, 60611 United States, Maryland The Johns Hopkins Hospital Baltimore, Maryland, United States, 21287 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 United States, New York Columbia University Medical Center, The SMA Clinical Research Center New York, New York, United States, 10032 United States, Utah Primary Children's Medical Center Salt Lake City, Utah, United States, 84112 Australia, Victoria Royal Children's Hospital- Melbourne Parkville, Victoria, Australia, 3052 Germany Dept. of Neuropediatrics and Muscle Disorders Universitätsklinikum Freiburg Freiburg, Baden-Württemberg, Germany, 79106 Italy Bambino Gesu' Children's Research Hospital Roma, Lazio, Italy, 165 Fondazione Serena Onlus - Centro Clinico Nemo Milano, Italy, 20162 Qatar Hamad General Hospital Doha, Qatar, 3050 Taiwan Kaohsiung Medical University Hospital Kaohsiung City, Taiwan, 806 National Taiwan University Hospital Taipei, Taiwan, 100 Turkey Hacettepe University Medical Faculty Ankara, Sihhiye, Turkey, 6100 Less <<
NCT01728116 - Terminated(Higher than anticip... More >>ated rate of Hepatic abscess (N=7)) Less << - -
NCT02117193 Alcohol Intake ... More >> Sleep Deprivation Less << Not Applicable Completed - Brazil ... More >> Exercise Research Laboratory Porto Alegre, Rio Grande do Sul, Brazil, 90690200 Less <<
NCT00115570 Diabetes Mellitus, Insulin-Dep... More >>endent Less << Phase 3 Completed - United States, Pennsylvania ... More >> Childrens Hospital of Pittsburgh Pittsburgh, Pennsylvania, United States, 15213 Less <<
NCT02305381 - Completed - -
NCT00118456 Cancer Phase 1 Completed - United States, Connecticut ... More >> Yale Cancer Center New Haven, Connecticut, United States, 06520 United States, Nevada Nevada Cancer Institute Las Vegas, Nevada, United States, 89125 United States, Tennessee Sarah Cannon Research Institute Nashville, Tennessee, United States, 37203 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77054 Institute of Drug Development/Cancer Therapy and Research Center San Antonio, Texas, United States, 78229 Less <<
NCT02191332 - Completed - -
NCT02117193 - Completed - -
NCT02750007 Diabetes Mellitus, Type 2 Phase 1 Unknown - China, Hunan ... More >> The Second Xiangya Hospital of Central South University Recruiting Changsha, Hunan, China, 410011 Contact: Zhiguang Zhou, Professor    0731-85292097    zhouzg@hotmail.com Less <<
NCT00677807 COPD Phase 3 Completed - -
NCT03500458 Insulin Sensitivity ... More >> Sleep Dietary Habits Less << Not Applicable Recruiting June 2022 United States, Colorado ... More >> Children's Hospital Colorado Recruiting Aurora, Colorado, United States, 80045 Contact: Haseeb Rahat, BS    720-777-2660    Haseeb.Rahat@childrenscolorado.org Less <<
NCT01108796 - Completed - -
NCT01108796 - Completed - -
NCT00677807 - Completed - -
NCT01748994 Obesity Metab... More >>olic Syndrome Less << Not Applicable Completed - United States, Louisiana ... More >> Pennington Biomedical Research Center Baton Rouge, Louisiana, United States, 70808 Pennington Biomedical Research Center Baton Rouge, Louisiana, United States, 70809 Less <<
NCT00131378 Obesity Not Applicable Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT03348332 Pregnancy Not Applicable Completed - Spain ... More >> Universidad Politécnica de Madrid Madrid, Spain, 28040 Less <<
NCT00876694 Chronic Obstructive Pulmonary ... More >>Disease (COPD) Less << Phase 3 Completed - Japan ... More >> Novartis Investigator Site Asahikawa, Japan Novartis Investigator Site Bunkyo-ku, Japan Novartis Investigator Site Gifu, Japan Novartis Investigator Site Hamamatsu, Japan Novartis Investigator Site Himeji, Japan Novartis Investigator Site Hiroshima, Japan Novartis Investigator Site Iwata, Japan Novartis Investigator Site Kanazawa, Japan Novartis Investigator Site Kasaoka, Japan Novartis Investigator Site Kawasaki, Japan Novartis Investigator Site Kishiwada, Japan Novartis Investigator Site Kitakyushu, Japan Novartis Investigator Site Kochi, Japan Novartis Investigator Site Koga, Japan Novartis Investigator Site Kurume, Japan Novartis Investigator Site Kyoto, Japan Novartis Investigator Site Maebashi, Japan Novartis Investigator Site Matsusaka-city, Japan Novartis Investigator Site Morioka, Japan Novartis Investigator Site Nagaoka-city, Japan Novartis Investigator Site Nagoya, Japan Novartis Investigator Site Naka-gun, Japan Novartis Investigator Site Noda, Japan Novartis Investigator Site Obihiro, Japan Novartis Investigator Site Sakai, Japan Novartis Investigator site Sapporo, Japan Novartis Investigator Site Sendai, Japan Novartis Investigator Site Setagaya-ku, Japan Novartis Investigator Site Sumida-ku, Japan Novartis Investigator Site Tenri, Japan Novartis Investigator Site Tokyo, Japan Novartis Investigator Site Ube, Japan Novartis Investigator Site Wakayama, Japan Novartis Investigator Site Yabu, Japan Novartis Investigator Site Yanagawa, Japan Novartis Investigator Site Yokkaichi, Japan Novartis Investigator Site Yokohama, Japan Less <<
NCT00131378 - Completed - -
NCT01533129 Hypogonadotrophic Hypogonadism Phase 4 Completed - Turkey ... More >> Gulhane School of Medicine Department of Endocrinology and Metabolism Ankara, Non US, Turkey, 06018 Less <<
NCT02438540 - Completed - -
NCT00876694 - Completed - -
NCT01177813 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT01177813 - Completed - -
NCT00968253 Leukemia Acut... More >>e Lymphocytic Leukemia Less << Phase 1 Phase 2 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT03682861 Carbohydrate Metabolism Not Applicable Recruiting September 30, 2019 Canada, Ontario ... More >> Exercise Nutrition Laboratory (Western University) Recruiting London, Ontario, Canada, N6A 3K7 Contact: Peter Lemon, PhD    519 661-2111 ext 88139    plemon@uwo.ca Less <<
NCT01020123 - Completed - -
NCT02438540 Insulin Sensitivity ... More >> Obesity Less << Not Applicable Completed - -
NCT02442908 COPD Cachexia Not Applicable Completed - Sweden ... More >> Ladulaas kliniska studier Borås, Sweden, 50630 Pharmasite Helsingborg, Sweden, 25220 Pharmasite Malmö, Sweden, 21152 A+ Science City Site Stockholm, Sweden, 11157 Less <<
NCT02535832 Rheumatoid Arthritis ... More >> Insulin Resistance Less << Phase 1 Recruiting July 2020 United States, Alabama ... More >> University of Alabama at Birmingham Recruiting Birmingham, Alabama, United States, 35294 Contact: Beatriz Hanaoka, MD    205-996-0843    bhanaoka@uabmc.edu    Contact: Laura E Tudor    205-934-4021    ltudor@uabmc.edu Less <<
NCT00964574 Diabetes Mellitus, Type 1 Phase 4 Completed - Belarus ... More >> Sanofi-Aventis Administrative Office Minsk, Belarus Less <<
NCT00968253 - Completed - -
NCT02862912 Adverse Reaction to Spinal Ane... More >>sthetic Maternal Care for Cervical Incompetence Less << Phase 4 Recruiting December 31, 2018 United States, New York ... More >> New York Presbyterian Hospital Recruiting New York, New York, United States, 10032 Contact: Allison Lee, MD       al3196@columbia.edu    Principal Investigator: Richard Smiley, MD Less <<
NCT01020123 Type II Diabetes Mellitus Phase 2 Completed - -
NCT02679222 Healthy Adults Not Applicable Completed - Canada, Quebec ... More >> Research Centre on Aging (CSSS-IUGS - CIUSSS de l'Estrie - CHUS) Sherbrooke, Quebec, Canada, J1H4C4 Less <<
NCT00622960 Overweight Ob... More >>esity Type 2 Diabetes Less << Phase 1 Completed - United States, Ohio ... More >> University of Cincinnati Cincinnati, Ohio, United States, 45221 Less <<
NCT02028585 Metabolic Syndrome Not Applicable Completed - Korea, Republic of ... More >> Department of Endocrinology and Metabolism, Korea University Ansan Hospital Ansan-si, Gyeonggi-do, Korea, Republic of, 425-707 Less <<
NCT03107741 Metabolic Syndrome Not Applicable Recruiting June 2018 China ... More >> The Hong Kong Polytechnic University Recruiting Hong Kong, China, 852 Contact: Parco MF Siu, Phd    34008593 ext 8593    parco.siu@polyu.edu.hk    Contact: Angus PH Yu, Mphil    34008638 ext 8586    angus.yu@connect.polyu.hk    Principal Investigator: Parco MF Siu, PhD          Sub-Investigator: Angus PH Yu, Mphil          The Hong Kong Polytechnic University Recruiting Hong Kong, China, 852 Contact: Angus PH Yu, PHD    34008586 ext 8586    angus.yu@connect.polyu.hk Less <<
NCT01104922 Squamous Cell Carcinoma of the... More >> Head and Neck Less << Phase 2 Active, not recruiting July 2019 United States, Pennsylvania ... More >> University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States, 15232 Less <<
NCT02539355 Insulin Resistance ... More >> Diabetes Cancer Obesity Inflammation Less << Not Applicable Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109 Less <<
NCT00149227 - Completed - -
NCT02119819 Diabetes Mellitus, Type 2 Phase 2 Completed - -
NCT02559128 - Recruiting December 2019 Czechia ... More >> Diabetes Center, Institute of Clinical and Experimental Medicine Recruiting Prague, Prague 4, Czechia, 14021 Contact: Terezie Pelikanova, Prof., MD    +420 261 364 100    terezie.pelikanova@medicon.cz Less <<
NCT00149227 Hypertension ... More >>Ischemic Heart Disease Congestive Heart Failure Stroke Less << Phase 4 Completed - Japan ... More >> Kyoto Prefectural University of Medicine Kyoto, Japan, 602-8566 Less <<
NCT02752828 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT00836940 Type 2 Diabetes Mellitus Phase 2 Unknown October 2009 India ... More >> Glenmark Investigational site Mumbai, India Less <<
NCT02973321 Type 2 Diabetes Mellitus Phase 2 Completed - -
NCT03444467 Diabetes Diab... More >>etes Mellitus, Type 1 Diabetes Mellitus, Type 2 Less << Phase 1 Completed - Germany ... More >> Novo Nordisk Investigational Site Berlin, Germany, 10117 Less <<
NCT02023749 Metabolic Syndrome Not Applicable Completed - Korea, Republic of ... More >> Department of Endocrinology and Metabolism, Korea University Ansan Hospital Ansan-si, Gyeonggi-do, Korea, Republic of, 425-707 Less <<
NCT01899456 Hypertension ... More >>Chronic Kidney Disease Renal Transplantation Sympathetic Activity Less << Not Applicable Completed - Germany ... More >> 1. Medizinische Klinik und Poliklinik, Klinikum rechts der Isar, Technische Universität München Munich, Germany, 81675 Less <<
NCT03192410 - Active, not recruiting January 2040 Netherlands ... More >> Wageningen University, Division of Human Nutrition Wageningen, Netherlands, 6700 AA Less <<
NCT00438425 Hyperlipidemia ... More >> Cardiovascular Disease Less << Not Applicable Completed - Canada, British Columbia ... More >> Healthy Heart Program, St. Paul's Hospital Vancouver, British Columbia, Canada, V6Z 1Y6 Canada, Manitoba Richardson Centre for Functional Foods and Nutraceuticals, University of Manitoba Winnipeg, Manitoba, Canada, R3T 6C5 Canada, Ontario Sunnybrook Health Sciences Centre Toronto, Ontario, Canada, M4N 3M5 St. Michael's Hospital Toronto, Ontario, Canada, M5C 2T2 Canada, Quebec Institute on Nutraceuticals and Functional Foods and the Lipid Research Center, Laval University Hospital Research Center Quebec City, Quebec, Canada, G1V 4G2 Less <<
NCT03020758 Cardiovascular Diseases ... More >> Metabolic Syndrome Less << Not Applicable Recruiting December 2018 United States, Pennsylvania ... More >> Penn State University Recruiting University Park, Pennsylvania, United States, 16802 Contact: Valerie Sullivan, BS    814-863-8109    psudiet@gmail.com Less <<
NCT00509925 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 4 Terminated(See detailed descri... More >>ption) Less << - United Kingdom ... More >> Novo Nordisk Investigational Site Guildford, United Kingdom, GU2 7XX Less <<
NCT02682680 Type 2 Diabetes Mellitus Phase 4 Unknown December 2017 Canada, Alberta ... More >> LMC Calgary Not yet recruiting Calgary, Alberta, Canada Contact: Akshay Jain, MD    403-288-3224    calgaryresearch@lmc.ca    Canada, Ontario LMC Barrie Recruiting Barrie, Ontario, Canada Contact: Hani Alasaad, MBBS    705-737-0830    barrieresearch@lmc.ca    LMC Brampton Recruiting Brampton, Ontario, Canada, L6S 0C9 Contact: Harpreet Bajaj, MBBS, MPH    905-595-0560    bramptonresearch@lmc.ca    LMC Etobicoke Recruiting Etobicoke, Ontario, Canada Contact: Hasnain Khandwala, MBBS    416-645-1035    etobicokeresearch@lmc.ca    LMC Markham Recruiting Markham, Ontario, Canada Contact: Nikhil Gupta, MBBS, MPH    905-294-0800    markhamresearch@lmc.ca    LMC Oakville Recruiting Oakville, Ontario, Canada Contact: David Twum-Barima, MB ChB, MSc    905-337-0040    oakvilleresearch@lmc.ca    LMC Thornhill Recruiting Thornhill, Ontario, Canada Contact: Ronald Goldenberg, MD    905-763-8660    thornhillresearch@lmc.ca    LMC Bayview Recruiting Toronto, Ontario, Canada Contact: Ronnie Aronson, MD    416-645-2929    torontoresearch@lmc.ca Less <<
NCT01982630 Diabetes Mellitus Phase 1 Completed - -
NCT01435603 Diabetes Mellitus ... More >> Hyperglycemia Obesity Glucose Metabolism Disorders Metabolic Diseases Endocrine System Diseases Overnutrition Nutrition Disorders Overweight Body Weight Signs and Symptoms Less << Not Applicable Completed - United States, Illinois ... More >> YMCA of Metro Chicago Chicago, Illinois, United States, 60610 McGaw YMCA Evanston, Illinois, United States, 60201 Less <<
NCT01435603 - Completed - -
NCT00529191 Type 1 Diabetes Phase 2 Completed - United States, Pennsylvania ... More >> Diabetes Center for Children & Clinical Translational Research Center Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00509925 - Terminated(See detailed descri... More >>ption) Less << - -
NCT01804049 Prediabetes Phase 1 Phase 2 Completed - United States, Oregon ... More >> VA Portland Health Care System, Portland, OR Portland, Oregon, United States, 97239 Less <<
NCT02328027 Rheumatoid Arthritis ... More >> Ankylosing Spondylitis Less << Phase 1 Phase 2 Terminated(Low recruitment) - Switzerland ... More >> Centre Hospitalier Universitaire Vaudois Lausanne, Vaud, Switzerland, 1011 Less <<
NCT00529191 - Completed - -
NCT02740439 Obesity, Abdominal ... More >> Insulin Resistance Insulin Sensitivity Less << Not Applicable Recruiting February 2019 United States, Illinois ... More >> University of Illinois, Urbana-Champaign Recruiting Urbana, Illinois, United States, 61801 Contact: Ginger Reeser, MS, RD       pathstudy@illinois.edu Less <<
NCT03356262 - Active, not recruiting March 1, 2023 -
NCT03697577 - Not yet recruiting December 1, 2021 -
NCT03712501 Diabetes Mellitus, Type 2 ... More >> Cardiovascular Diseases Endothelial Dysfunction Insulin Resistance Oxidative Stress Less << Not Applicable Active, not recruiting December 30, 2018 United Kingdom ... More >> National Centre for Sport and Exercise Medicine, Loughborough University Loughborough, United Kingdom, LE11 3TU Less <<
NCT02906917 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT01970033 Type 2 Diabetes Phase 3 Unknown January 2015 China ... More >> Chinese PLA General Hospital Recruiting Beijing, China Contact: Changyu Pan, M.D.       panchy301@aliyun.com    Principal Investigator: Changyu Pan, M.D. Less <<
NCT01802853 Healthy Volunteer Phase 1 Completed - United Kingdom ... More >> Leeds, United Kingdom, LS2 9LH Less <<
NCT02906917 - Completed - -
NCT01572025 Infertility O... More >>varian Aging Diminished Ovarian Reserve (DOR) Predicted Poor-responders Less << Phase 3 Completed - United Kingdom ... More >> Nottingham University Research and Treatment Unit in Reproduction (NURTURE) Nottingham, Nottinghamshire, United Kingdom, NG7 2UH Less <<
NCT02313337 Anesthesia Phase 4 Unknown December 2015 -
NCT03172494 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Recruiting July 29, 2019 -
NCT02681718 Diabetes Not Applicable Completed - United States, Illinois ... More >> Mount Sinai Hospital Chicago, Illinois, United States, 60608 Less <<
NCT01983943 Cardiovascular Disease ... More >> Endothelial Function Less << Not Applicable Withdrawn(No participants were... More >> enrolled) Less << - United States, Minnesota ... More >> Mayo Clinic in Rochester Rochester, Minnesota, United States, 55905 Less <<
NCT02624583 - Unknown August 2016 Tunisia ... More >> Fattouma Bourguiba University Hospital Monastir, Tunisia, 5000 Less <<
NCT00623194 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 3 Completed - -
NCT00623194 - Completed - -
NCT03651622 Diabetes Mellitus, Type 1 ... More >> Overweight and Obesity Less << Not Applicable Recruiting September 2020 United States, California ... More >> Stanford University Recruiting Palo Alto, California, United States, 94304 Contact: Marissa Town    513-910-0081    marissah@stanford.edu    Principal Investigator: David Maahs, MD, PhD          United States, North Carolina University of North Carolina at Chapel Hill Recruiting Chapel Hill, North Carolina, United States, 27599 Contact: Katie Souris    919-966-5635    kjsouris@unc.edu    Contact: Joan Thomas    919-843-8423    joan_thomas@unc.edu    Principal Investigator: Elizabeth J Mayer-Davis, PhD          Sub-Investigator: Sue Kirkman, MD Less <<
NCT02548767 Chronic Disease of Cardiovascu... More >>lar System Type 2 Diabetes Obesity Less << Not Applicable Recruiting June 2020 United States, California ... More >> University of California, Davis Recruiting Davis, California, United States, 95616 Clinical Research Center Recruiting Sacramento, California, United States, 95655 Contact    916-843-9441       Touro University California Translational Research Clinic and Student Health Clinic Active, not recruiting Vallejo, California, United States, 94592 Less <<
NCT02455011 Type 2 Diabetes Mellitus ... More >> Diabetes Less << Phase 1 Phase 2 Completed - United States, Florida ... More >> Miami, Florida, United States United States, Texas San Antonio, Texas, United States United States, Washington Renton, Washington, United States Less <<
NCT03713138 Poly Cystic Ovary Syndrome Not Applicable Completed - Pakistan ... More >> Allama Iqbal Open University Islamabad, Punjab, Pakistan, 45710 Less <<
NCT01204086 Major Depressive Disorder ... More >> Antidepressive Agents Pharmacogenetics Venlafaxine Fluoxetine Less << Phase 4 Unknown February 2011 Taiwan ... More >> National Cheng-Kung University Hospital Recruiting Tainan, Taiwan, 704 Contact: Po See Chen, MD    +886-6-2353535 ext 5213    chenps@mail.ncku.edu.tw    Principal Investigator: Po See Chen, MD Less <<
NCT00789711 - Completed - Philippines ... More >> Novo Nordisk Investigational Site Manilla, Philippines, 1605 Less <<
NCT00834509 - Completed - United States, Pennsylvania ... More >> University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00351546 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT01616095 - Completed - Slovakia ... More >> V th Internal Clinic, Univeristy Hospital Bratislava, Comenius University Bratislava, Slovakia, 82606 Inst. Exp. Endocrinology Slovak Acad Sci Bratislava, Slovakia, 83306 National Institute of Endocrinology and Diabetology Lubochna, Slovakia, 03491 Less <<
NCT01931137 Diabetes Heal... More >>thy Less << Phase 1 Completed - Germany ... More >> Neuss, Germany, 41460 Less <<
NCT02863419 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT00481663 Type II Diabetes Mellitus Phase 2 Completed - -
NCT02205528 Diabetes Diab... More >>etes Mellitus Type 2 Less << Phase 2 Completed - United States, California ... More >> Novo Nordisk Investigational Site Chino, California, United States, 91710 Novo Nordisk Investigational Site Hawaiian Gardens, California, United States, 90716 Novo Nordisk Investigational Site Los Angeles, California, United States, 90057 Novo Nordisk Investigational Site Spring Valley, California, United States, 91978 United States, Florida Novo Nordisk Investigational Site Hialeah, Florida, United States, 33012 Novo Nordisk Investigational Site Port Orange, Florida, United States, 32127 Novo Nordisk Investigational Site Sanford, Florida, United States, 32771 United States, Illinois Novo Nordisk Investigational Site Chicago, Illinois, United States, 60607 Novo Nordisk Investigational Site Evanston, Illinois, United States, 60201 United States, Maryland Novo Nordisk Investigational Site Oxon Hill, Maryland, United States, 20745 United States, New Jersey Novo Nordisk Investigational Site Berlin, New Jersey, United States, 08009 United States, New Mexico Novo Nordisk Investigational Site Albuquerque, New Mexico, United States, 87102 United States, North Carolina Novo Nordisk Investigational Site Greensboro, North Carolina, United States, 27408 United States, Ohio Novo Nordisk Investigational Site Cincinnati, Ohio, United States, 45227 United States, Oklahoma Novo Nordisk Investigational Site Tulsa, Oklahoma, United States, 74136 United States, Oregon Novo Nordisk Investigational Site Eugene, Oregon, United States, 97404 United States, Tennessee Novo Nordisk Investigational Site Knoxville, Tennessee, United States, 37920 United States, Texas Novo Nordisk Investigational Site Corpus Christi, Texas, United States, 78404 Novo Nordisk Investigational Site Houston, Texas, United States, 77074 United States, Virginia Novo Nordisk Investigational Site Manassas, Virginia, United States, 20110 Less <<
NCT00547521 - Completed - -
NCT02343926 Type 2 Diabetes Mellitus Phase 3 Completed - Russian Federation ... More >> Investigational Site 03 Vladimir, Vladimirskaya Oblast, Russian Federation, 600023 Less <<
NCT03598374 Polycystic Ovarian Syndrome ... More >> Infertility, Female Less << Not Applicable Not yet recruiting December 31, 2021 -
NCT01877200 - Completed - Bangladesh ... More >> Dhaka, Bangladesh, 1206 Less <<
NCT00547521 Rheumatoid Arthritis (RA) Phase 3 Completed - -
NCT02143011 Metabolic Syndrome ... More >> Insulin Resistance Dyslipidemia Less << Not Applicable Active, not recruiting December 2018 United States, California ... More >> Clinical Research Center Sacramento, California, United States, 95655 Less <<
NCT00140816 Metabolic Syndrome X ... More >> Heart Disease Less << Not Applicable Completed - Norway ... More >> Lipidklinikken, Medisinsk avdeling, Rikshospitalet Oslo, Norway, 0027 Less <<
NCT01934673 - Completed - Malaysia ... More >> Selangor Darul Ehsan, Malaysia Less <<
NCT03075566 - Recruiting December 2017 Tunisia ... More >> Faculty of Pharmacy Recruiting Monastir, Ibn Sina Street, Tunisia, 5000 Contact: NADIA BOUZIDI, PhD    21622987518    nadiabouzidi1@gmail.com Less <<
NCT01957592 - Withdrawn December 2014 -
NCT00658021 Type 2 Diabetes Phase 3 Recruiting March 6, 2023 -
NCT01744236 Type 2 Diabetes Phase 4 Completed - Netherlands ... More >> VU University Medical Center Amsterdam, Netherlands, 1081HV Less <<
NCT01358981 Diabetes Mellitus, Type 2 Phase 1 Completed - Singapore ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Singapore, Singapore Less <<
NCT02515214 - Unknown September 2017 Belgium ... More >> UZ Leuven Recruiting Leuven, Belgium, 3000 Contact: Roland Devlieger, MD, PhD    +32 16 34 22 12    roland.devlieger@uzleuven.be    Principal Investigator: Roland Devlieger, MD, PhD          Sub-Investigator: Goele Jans, MSc Less <<
NCT03227497 Cardiovascular Risk Factor ... More >> Metabolic Syndrome Hypertension Less << Not Applicable Completed - Serbia ... More >> Center of Research Excellence in Nutrition and Metabolism, Institute for Medical Research, University of Belgrade Belgrade, Serbia, 11000 Less <<
NCT01157975 Hepatitis C Phase 2 Unknown September 2014 United States, California ... More >> University of California at San Diego Hospitals San Diego, California, United States, 92037 Egypt Agouza Hospital Giza, Egypt Less <<
NCT01979419 - Unknown October 2018 Korea, Republic of ... More >> Seong Yoon Kim Seoul, Korea, Republic of, 120752 Less <<
NCT03637075 Diabetes Mellitus, Type 2 Not Applicable Recruiting December 31, 2020 Germany ... More >> University of Tuebingen, Department of Internal Medicine IV Recruiting Tuebingen, Germany, 72076 Less <<
NCT02180035 Dietary Modification ... More >> Dyslipidemia Signs and Symptoms, Digestive HIV Less << Not Applicable Completed - Brazil ... More >> Outpatient Infectoparasitary Diseases, Hospital das Clinicas, Federal University of Goiás Goiânia, Goiás, Brazil, 74.605-020 Less <<
NCT01195142 - Completed - Ireland ... More >> Nutrigenomics Group, University College Dublin Dublin, Leinster, Ireland, Dublin 4 Diabetes Day Centre, The Adelaide and Meath Hosptial Dublin, Ireland, 24 Less <<
NCT01845701 Malaria Phase 3 Completed - Cameroon ... More >> L'Hopital de District Ngong, Garoua, Garoua, North, Cameroon Baptist Hospital Mutengene, South West, Cameroon Less <<
NCT02308735 - Unknown May 2017 United States, Oklahoma ... More >> Children's Hospital of Oklahoma Recruiting Oklahoma City, Oklahoma, United States, 73104 Principal Investigator: Douglas C Dannaway, MD Less <<
NCT01146197 Gitelman Syndrome Phase 1 Phase 2 Completed - France ... More >> Hopital Européen Georges Pompidou Paris, France, 75015 Less <<
NCT03264638 PCOS Phase 2 Recruiting August 31, 2018 China, China/Beiing ... More >> Lei Li Recruiting Beijing, China/Beiing, China, 100000 Contact: Lei L Li, MD    13911988831 ext +86    lileigh@163.com Less <<
NCT00155350 Coronary Atherosclerosis ... More >> Inflammation Coronary Heart Disease Less << Phase 4 Unknown - Taiwan ... More >> Division of Cardiology, Department of Internal Medicine and Department of Medical Imaging, National Taiwan University Hospital Recruiting Taipei, Taiwan, 100 Contact: Tzung-Dau Wang, MD, PhD    886-2-2312-3456 ext 5632    tdwang@ha.mc.ntu.edu.tw    Principal Investigator: Tzung-Dau Wang, MD, PhD          Sub-Investigator: Wen-Jeng Lee, MD Less <<
NCT00267839 Atrophy Phase 3 Terminated - Germany ... More >> Institute of Medical Physics University of Erlangen-Nurnberg Erlangen, Germany, 91052 Institute of Medical Physics Erlangen, Germany, 91052 Less <<
NCT03568214 Exercise Meta... More >>bolic Syndrome Less << Not Applicable Recruiting March 31, 2019 United States, Colorado ... More >> Western State Colorado University Recruiting Gunnison, Colorado, United States, 82123 Contact: Lance C Dalleck, PhD    970-943-7132    ldalleck@western.edu Less <<
NCT00422058 Metabolism and Nutrition Disor... More >>der Obesity Less << Phase 2 Completed - Belgium ... More >> Novo Nordisk Investigational Site Edegem, Belgium, 2650 Czechia Novo Nordisk Investigational Site Praha 1, Czechia, 116 94 Novo Nordisk Investigational Site Praha 2, Czechia, 128 08 Denmark Novo Nordisk Investigational Site Frederiksberg C, Denmark, 1958 Novo Nordisk Investigational Site Hvidovre, Denmark, 2650 Novo Nordisk Investigational Site Århus C, Denmark, 8000 Finland Novo Nordisk Investigational Site Helsinki, Finland, 00270 Novo Nordisk Investigational Site Kuopio, Finland, 70210 Novo Nordisk Investigational Site Oulu, Finland, 90220 Netherlands Novo Nordisk Investigational Site Almere, Netherlands, 1311RL Spain Novo Nordisk Investigational Site Barcelona, Spain, 08022 Novo Nordisk Investigational Site Madrid, Spain, 28006 Novo Nordisk Investigational Site Madrid, Spain, 28007 Novo Nordisk Investigational Site Pamplona, Spain, 31008 Sweden Novo Nordisk Investigational Site Malmö, Sweden, 205 02 Novo Nordisk Investigational Site Stockholm, Sweden, 141 86 United Kingdom Novo Nordisk Investigational Site Glasgow, United Kingdom, G322ER Novo Nordisk Investigational Site Luton, United Kingdom, LU4 0DZ Novo Nordisk Investigational Site Norwich, United Kingdom, NR4 7TJ Less <<
NCT02264366 Chronic Disease Not Applicable Unknown October 2017 Canada, Ontario ... More >> University Health Network Recruiting Toronto, Ontario, Canada, M4G 1R7 Contact: Paul Oh, FRCPC    (416) 597-3422 ext 5267    paul.oh@uhn.ca    Contact: Karolina Perraud, MA    416-597-3422 ext 5225    karolina.perraud@uhn.ca Less <<
NCT00795600 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 4 Completed - Spain ... More >> Málaga, Spain, 29009 Less <<
NCT01638325 Healthy Participants Phase 1 Completed - Singapore ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Singapore, Singapore, 117597 Less <<
NCT02862223 Obesity Overw... More >>eight Less << Phase 2 Completed - -
NCT02364089 Adrenal Incidentalomas Not Applicable Recruiting December 2021 France ... More >> Service de Médecine Interne, Endocrinologie et Nutrition - CHU de Strasbourg Recruiting Strasbourg, Alsace, France, 67000 Contact: Bernard GOICHOT, Professor    +33 3 88 12 75 93    Bernard.Goichot@chru-strasbourg.fr    Service Endocrinologie, Diabétologie, maladies métaboliques - CHU de Bordeaux Recruiting Pessac, Aquitaine, France, 33600 Contact: Antoine TABARIN, Professor    +33 5 57 65 64 33    antoine.tabarin@chu-bordeaux.fr    Contact: Sarah CAZENAVE    +33 5 57 65 62 77    sarah.cazenave@chu-bordeaux.fr    Service d'Endocrinologie - Niveau 18 - Caen CHU Côte de Nacre Recruiting Caen, Basse-Normandie, France, 14000 Contact: Yves REZNIK, Professor    +33 2 31 06 45 86    reznik-y@chu-caen.fr    Service d'Endocrinologie -Diabète-Nutrition - CHU de REIMS Not yet recruiting Reims, Champagne-Ardenne, France, 51000 Contact: Brigitte DELEMER, Doctor    +33 3 26 78 81 01    bdelemer@chu-reims.fr    Service d'Endocrinologie, Diabétologie, Nutrition - CHU d'Amiens Not yet recruiting Amiens, Haut De France, France, 80000 Contact: Rachel DESAILLOUD, Pr    03.22.45.58.97 ext +33    Desailloud.Rachel@chu-amiens.fr    Endocrinologie, Diabète et Maladies Métaboliques - CHU de Rouen Not yet recruiting Rouen, Haute-Normandie, France, 76000 Contact: Hervé LEFEBVRE, Professor    +33 2 32 88 90 81    Herve.Lefebvre@chu-rouen.fr    Service d'Endocrinologie et des Maladies de la Reproduction- Assistance Publique - Hôpitaux de Paris - Hôpial Bicêtre Recruiting Le Kremlin Bicêtre, ILE DE France, France, 94275 Contact: Jacques YOUNG       jacques.young@bct.ap-hop-paris.fr    Assistance Publique - Hôpitaux de Paris - Hôpital COCHIN Recruiting Paris, ILE DE France, France, 75014 Contact: Jérôme BERTHERAT, Professor    +33 1 58 41 18 95    jerome.bertherat@ch.aphp.fr    Service d'Endocrinologie et Gynécologie - Assistance Publique - Hôpitaux de Paris - Pitié-Salpêtrière Withdrawn Paris, ILE DE France, France, 75651 Service d'Hypertension et de Médecine Vasculaire - Assistance Publique - Hôpitaux de Paris - Hôpital européen Georges Pompidou Recruiting Paris, ILE DE France, France, 75908 Contact: Pierre-François PLOUIN, Professor    +33 1 56 09 37 71    pierre-francois.plouin@egp.aphp.fr    Service d'Endocrinologie - Saint-Antoine - AP-HP Not yet recruiting Paris, Ile De France, France Contact: Sophie CHRISTIN-MAITRE, Pr    01.49.28.24.10 ext +33    sophie.christin-maitre@aphp.fr    Service d'Endocrinologie - CHU de Nancy Withdrawn Nancy, Lorraine, France, 54000 Service d'Endocrinologie et Maladies Métabolique - CHU de Toulouse Recruiting Toulouse, Midi-Pyrénées, France, 31000 Contact: Philippe CARON, Professor    +33 5 67 77 17 01    caron.p@chu-toulouse.fr    Service d'Endocrinologie, Diabétologie et Métabolisme - CHRU de LILLE Recruiting Lille, Nord-Pas-de-Calais, France, 59000 Contact: Marie-Christine VANTYGHEM, Professor    +33 3 20 44 45 35    mc-vantyghem@chru-lille.fr    Département Endocrinologie-Diabétologie -Nutrition - CHU d'ANGERS Recruiting Angers, Pays De La Loire, France, 49000 Contact: Sandrine LABOUREAU-SOARES, Doctor    +33 2 41 35 45 93    sasoares@chu-angers.fr    CIC Endocrinologie-Nutrition - CHU de Nantes Recruiting Nantes, Pays De La Loire, France, 44000 Contact: Bertrand CARIOU, Professor    +33 2 53 48 27 07    bertrand.cariou@univ-nantes.fr    Service d'Endocrinologie, Diabète et Maladies Métaboliques - Assistance publique - Hôpitaux de Marseille Recruiting Marseille, Provence-Alpes-Côte d'Azur, France, 13000 Contact: Thierry BRUE, Professor    +33 4 91 38 65 97    Thierry.BRUE@ap-hm.fr    Service Endocrinologie - CHU de Saint-Etienne Withdrawn Saint-Etienne, Rhône-Alpes, France, 42000 CHU de Poiriers Not yet recruiting Poitiers, France, 86021 Contact: Mathilde FRATY, Dr       mathilde.fraty@chu-poitiers.fr    Germany Endokrinologie, Diabetes und Ernährungsmedizin, Campus Mitte, Medizinische Klinik - Charité - Universitätsmedizin Berlin Not yet recruiting Berlin, Germany, 10117 Contact: Tina Kienitz       tina.kienitz@charite.de    Medizinische Klinik und Poliklinik IV, Endocrine Research Unit - Ludwig-Maximilians-Universität Not yet recruiting München, Germany, 80336 Contact: Felix Beuschlein       Felix.Beuschlein@med.uni-muenchen.de    Department of Internal Medicine I, Endocrine and Diabetes Uni -University Hospital Würzburg Recruiting Würzburg, Germany, 97080 Contact: Martin FAßNACHT, Pr       Fassnacht_M@ukw.de    Italy Clinica di Endocrinologia e Malattie del Metabolismo, Azienda Ospedaliero-Universitaria Ospedali Riuniti di Ancona Not yet recruiting Ancona, Italy Contact: Giorgio Arnaldi       Giorgio.Arnaldi@ospedaliriuniti.marche.it    S Orsola-Malpighi Hospital Recruiting Bologna, Italy, 40138 Contact: Uberto Pagotto       uberto.pagotto@unibo.it    University-Hospital of Padova Not yet recruiting Padova, Italy, 35128 Contact: Carla Scaroni       carla.scaroni@unipd.it    "Casa Sollievo della Sofferenza" Hospital Not yet recruiting San Giovanni Rotondo, Italy, 71013 Contact: Alfredo Scillitani       endocrino@operapadrepio.it    Dipartimento di Scienze Cliniche e Biologiche, Università degli Studi di Torino Not yet recruiting Torino, Italy, 10043 Contact: Massimo Terzolo       massimo.terzolo@unito.it Less <<
NCT01797341 Kidney-Pancreas Transplantatio... More >>n Less << Phase 3 Completed - Canada, Ontario ... More >> Toronto General Hospital Toronto, Ontario, Canada, M5G 2N2 Less <<
NCT02088853 Healthy Conditions Not Applicable Completed - Sweden ... More >> Dept of Gastrosurgical R&E, Sahlgrenska Universityhospital Gothenburg, Sweden, SE41345 Less <<
NCT03569020 Gout Hyperuri... More >>cemia Less << Not Applicable Recruiting June 30, 2019 United States, Maryland ... More >> Johns Hopkins ProHealth Research Clinic Recruiting Woodlawn, Maryland, United States, 21207 Contact: Jeanne Charleston, RN    410-281-1600    digo@jhu.edu    Contact: Beiwen Wu, MSPH    410-281-1600    digo@jhu.edu    Principal Investigator: Edgar R Miller, MD, PhD          Sub-Investigator: Stephen P Juraschek, MD, PhD          United States, Massachusetts Massachusetts General Hospital Active, not recruiting Boston, Massachusetts, United States, 02114 Less <<
NCT01273571 Healthy Phase 1 Completed - -
NCT00422058 - Completed - -
NCT00459004 Obesity Phase 2 Completed - Japan ... More >> Sanofi-Aventis Tokyo, Japan Less <<
NCT01637168 Memory Deficit Phase 3 Unknown September 2014 Brazil ... More >> Cliníca Dr. Felício Savioli Not yet recruiting Cotia, São Paulo, Brazil, 06710-670 Less <<
NCT00842192 - Completed - Israel ... More >> Novo Nordisk Investigational Site Kfar Saba, Israel, 44425 Jordan Novo Nordisk Investigational Site Amman, Jordan, 11844 Lebanon Novo Nordisk Investigational Site Amman, Lebanon, 11844 Pakistan Novo Nordisk Investigational Site Karachi, Pakistan Less <<
NCT01691794 - Completed - -
NCT01691794 HIV, Pediatric Phase 4 Completed - United States, Arizona ... More >> Phoenix Children'S Hospital Phoenix, Arizona, United States, 85016 United States, Georgia Grady Health System Ponce Family And Youth Clinic Atlanta, Georgia, United States, 30322 United States, Texas Children'S Medical Center Of Dallas Dallas, Texas, United States, 75235 Argentina Local Institution Buenos Aires, Bs As, Buenos Aires, Argentina, 1141 Local Institution Buenos Aires, Argentina, 1181 Local Institution Buenos Aires, Argentina, 1425 Brazil Local Institution Salvador, Bahia, Brazil, 40110-160 Local Institution Salvador, Bahia, Brazil, 40110 Local Institution Porto Alegre, RIO Grande DO SUL, Brazil, 90035-903 Local Institution Porto Alegre, Rio Grande Do Sul, Brazil, 90035 Local Institution Sao Paulo, SP, Brazil, 01416-901 Local Institution Sao Paulo, Brazil, 01246 Chile Local Institution Santiago, Metropolitana, Chile, 8207257 Local Institution Santiago, Metropolitana, Chile, 8380418 Mexico Local Institution Guadalajara, Jalisco, Mexico, 44280 Local Institution Monterrey, Nuevo LEON, Mexico, 64000 Local Institution Merida, Yucatan, Mexico, 97000 Local Institution Puebla, Mexico, 72000 Peru Local Institution Lima, Peru, 1 Local Institution Lima, Peru, LIMA 10 Russian Federation Local Institution Moscow, Russian Federation, 129110 Local Institution St. Petersburg, Russian Federation, 190103 South Africa Local Institution Port Elizabeth, Eastern CAPE, South Africa, 6001 Local Institution Bloemfontein, FREE State, South Africa, 9301 Local Institution Soweto, Gauteng, South Africa, 2013 Local Institution Cape Town, Western CAPE, South Africa, 7505 Local Institution Cape Town, Western CAPE, South Africa, 7530 Less <<
NCT00677898 Schizophrenia ... More >> Psychotic Disorders Less << Not Applicable Completed - United States, Maryland ... More >> Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD Baltimore, Maryland, United States, 21201 Less <<
NCT00795600 - Completed - -
NCT00677898 - Completed - -
NCT01239550 Diabetes Obes... More >>ity Less << Not Applicable Active, not recruiting December 2019 United States, Tennessee ... More >> Vanderbilt University Nashville, Tennessee, United States, 37232 Less <<
NCT02446054 Type II Diabetes Mellitus Not Applicable Completed - Taiwan ... More >> NTUH Taipei, Taiwan Less <<
NCT01292863 End Stage Renal Disease Not Applicable Withdrawn(Study was modified t... More >>o in vitro design and no longer involves participants) Less << May 2012 -
NCT01114503 Graves Ophthalmopathy Phase 2 Terminated(Clinical study in G... More >>raves' ophthalmopathy terminated until there is a better understanding of an efficacious dose with Otelixizumab from other clinical studies.) Less << - United Kingdom ... More >> GSK Investigational Site Newcastle upon Tyne, United Kingdom, NE1 3BZ Less <<
NCT01945996 Diabetes Mellitus Not Applicable Completed - United States, California ... More >> LAC+USC Los Angeles, California, United States, 90033 Less <<
NCT01114503 - Terminated(Clinical study in G... More >>raves' ophthalmopathy terminated until there is a better understanding of an efficacious dose with Otelixizumab from other clinical studies.) Less << - -
NCT01945996 - Completed - -
NCT02325674 - Not yet recruiting October 2029 United States, New York ... More >> Research Centre Not yet recruiting Staten Island, New York, United States, 10314 Less <<
NCT00392678 Type 2 Diabetes Phase 2 Phase 3 Completed - United States, Connecticut ... More >> Chapel Medical Group New Haven, Connecticut, United States, 06511 United States, District of Columbia MedStar Research Institute Washington, District of Columbia, United States, 20003-4393 United States, Florida Endocrine Clinical Research Winter Park, Florida, United States, 32746 United States, Georgia Kaiser Permanente Atlanta, Georgia, United States, 30084 Emory School of Medicine Atlanta, Georgia, United States, 30303 United States, Illinois University of Illinois at Chicago Chicago, Illinois, United States, 60612 United States, Louisiana Tulane University New Orleans, Louisiana, United States, 70112 United States, Massachusetts Joslin Diabetes Center Boston, Massachusetts, United States, 02215 United States, Missouri Washington University School of Medicine Saint Louis, Missouri, United States, 63110 United States, Nebraska University of Nebraska Medical Center Omaha, Nebraska, United States, 68105 United States, New York Kaleida Health Center Buffalo, New York, United States, 14226 North Shore Diabetes and Endocrine Associates New Hyde Park, New York, United States, 11042 Columbia University New York, New York, United States, 10032 University of Rochester Medical Center Rochester, New York, United States, 14642 United States, North Carolina University of North Carolina Chapel Hill, North Carolina, United States, 27599 United States, Texas University of Texas Southwestern Dallas, Texas, United States, 75390 Less <<
NCT03495102 Diabetes Mellitus, Type 2 Phase 3 Active, not recruiting October 7, 2019 -
NCT03035916 Gastrostomy Not Applicable Completed - China, Jilin ... More >> China-Japan Union Hospital of Jilin University Changchun, Jilin, China, 130000 Less <<
NCT00392678 - Completed - -
NCT00495105 Blood Pressure, High Not Applicable Completed - United States, Kansas ... More >> University of Kansas Medical Center Kansas City, Kansas, United States, 66160 Less <<
NCT03035916 - Completed - -
NCT00817778 Type 2 Diabetes Phase 2 Completed - United States, Texas ... More >> Research Site San Antonio, Texas, United States Less <<
NCT00936364 Fasting in Malignant Solid Tum... More >>ors Less << Not Applicable Recruiting July 9, 2020 United States, California ... More >> USC/Norris Comprehenseive Cancer Center Recruiting Los Angeles, California, United States, 90033 Contact: America Casillas-Lopez    323-865-0804    America.Casillas-Lopez@med.usc.edu    Principal Investigator: David Quinn, MD Less <<
NCT01654653 Coronary Heart Disease Phase 4 Completed - Indonesia ... More >> National Cardiovascular Center Harapan Kita Jakarta, Indonesia, 11420 Less <<
NCT01050270 Overdose Phase 4 Completed - United Kingdom ... More >> Aberdeen Royal Infirmary Aberdeen, United Kingdom, AB25 2ZN Royal Infirmary of Edinburgh Edinburgh, United Kingdom, EH16 4SA Royal Victoria Infirmary Newcastle upon Tyne, United Kingdom, NE1 4LP Less <<
NCT02811484 Diabetes Mellitus, Type 2 Phase 4 Withdrawn(Inability to enroll ... More >>due to the widespread use of both classes of drugs in patients with T2DM, including those on concomitant insulin therapy.) Less << December 2018 United States, New York ... More >> Comprehensive Weight Control Center New York, New York, United States, 10065 Less <<
NCT00817778 - Completed - -
NCT00860288 Diabetes Mellitus, Type 2 Phase 2 Phase 3 Completed - -
NCT02350478 Type 2 Diabetes ... More >> Coronary Artery Disease Less << Phase 4 Completed - Austria ... More >> Medical University of Graz, Department for Internal Medicine Graz, Austria, 8036 Less <<
NCT01479192 High-Risk Cancer Phase 3 Terminated(very low rate of pa... More >>tient accrual) Less << - Italy ... More >> European Institute of Oncology Milan, Italy Less <<
NCT03338023 Type 1 Diabetes Phase 3 Recruiting September 8, 2020 China, Beijing ... More >> Peking University Peoples Hospital Recruiting Beijing, Beijing, China, 100044 Principal Investigator: Li Nong Ji          China, Guang Dong Province Shantou University Medical College No.2 Affiliated Hospital Recruiting Shantou, Guang Dong Province, China, 515041 Contact    8613502776666       Principal Investigator: LiShu Chen          China, Guangdong Guangdong Province People's Hospital Recruiting Guangzhou, Guangdong, China, 510080 Contact    8613802511168       Principal Investigator: Jian Kuang          The First Affiliated Hospital, Sun-Yat Sen University Recruiting Guangzhou, Guangdong, China, 510080 Contact    8613925111691       Principal Investigator: Yan Bing Li          Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University Recruiting Guangzhou, Guangdong, China, 510120 Contact    862081332518       Principal Investigator: Yan Li          China, Henan The 1st Affiliated Hospital of Henan Science and technology Recruiting Luoyang, Henan, China, 471003 Contact    8637964815362       Principal Investigator: Jie LIU          China, Hu Bei Wu Han Tongji Hospital Recruiting Wu Han, Hu Bei, China, 430030 Contact    862783663323       Principal Investigator: Xuefeng Yu          China, Hunan The Second Xiangya Hospital of Central South University Recruiting Changsha, Hunan, China, 410011 Contact    8613873104348       Principal Investigator: Zhou Zhiguang          China, Jiangsu Changzhou No.2 People's Hospital Recruiting Changzhou, Jiangsu, China, 213003 Contact    8613776803256       Principal Investigator: Yun Xue          The Second Affiliated Hospital of Nanjing Medical University Recruiting Nanjing, Jiangsu, China, 210011 Contact    8618951762690       Principal Investigator: Yi Bing LU          Nanjing First Hospital Recruiting Nanjing, Jiangsu, China, 210012 Contact    862552887091       Principal Investigator: Jianhua Ma          Affiliated Hospital of Jiangsu University Recruiting Zhenjiang, Jiangsu, China, 212001 Contact    86051185026805       Principal Investigator: Guoyue Yuan          China, Jilin No.2 Hospital Affiliated to Jilin University Recruiting Changchun City, Jilin, China, 130041 Contact    8643188796974       Principal Investigator: Han Qing Cai          China, Liao Ning Dalian Med. Univ. No 2 Affiliate Hospital Recruiting Dalian, Liao Ning, China, 116023 Contact    8615541178798       Principal Investigator: Benli Su          China, Nanjing The First Affiliated Hospital with Nanjing Medical Universit Recruiting Nanjing, Nanjing, China, 210029 Contact    862568136466       Principal Investigator: Tao Yang          China, Shanghai Shanghai Tenth People's Hospital Recruiting Shanghai, Shanghai, China, 200072 Contact    8613585792519       Principal Investigator: Shen Qu          China, Sichuan West China Hospital of Sichuan University Recruiting Chengdu, Sichuan, China, 610041 Contact    8613980548888       Principal Investigator: Zhenmei An          China, Yunnan First People's Hospital of Yunnan Province Recruiting Kunming, Yunnan, China, 650034 Contact    8613759143562       Principal Investigator: Heng Su          China Peking Union Medical College Hospital Recruiting Beijing, China, 88798 Contact    8613581705295       Principal Investigator: Yuxiu Li          Shanghai Putuo District Center Hospital Not yet recruiting Shanghai, China, 200062 Contact    8613611756518       Principal Investigator: Tao Lei Less <<
NCT03120299 Type 2 Diabetes Mellitus ... More >> Hypertriglyceridemia Less << Phase 4 Recruiting December 2018 China, Shanghai ... More >> Ruijin hospital, Shanghai Jiao-Tong University School of Medicine Recruiting Shanghai, Shanghai, China, 200025 Contact: Guang Ning, Professor    8621-64370045 ext 665344    feifei1116@hotmail.com    Principal Investigator: Guang Ning, Professor Less <<
NCT02091349 Tolerance Not Applicable Completed - -
NCT00508157 Metabolic Syndrome ... More >> Schizophrenia Less << Phase 4 Terminated(Slow Accrual) - Belgium ... More >> Local Institution Brussels, Belgium, 1160 Czech Republic Local Institution Brno, Czech Republic, 602 00 Local Institution Brno, Czech Republic, 625 00 Local Institution Havirov, Czech Republic, 736 01 Local Institution Hradec Kralove, Czech Republic, 500 05 Local Institution Prague, Czech Republic, 190 00 Local Institution Praha 10, Czech Republic, 100 00 Local Institution Praha 6, Czech Republic, 160 00 Local Institution Prerov, Czech Republic, 750 02 Local Institution Roudnice Nad Labem, Czech Republic, 41301 France Local Institution Fains Veel, France, 55000 Local Institution Lille Cedex, France, 59037 Local Institution Limoges Cedex, France, 87025 Local Institution Montpellier, France, 34295 Local Institution Paris Cedex 14, France, 75674 Local Institution Paris, France, 75013 Local Institution Poitiers, France, 86000 Local Institution Strasbourg, France, 67000 Germany Local Institution Ellwangen, Germany, 73479 Local Institution Werneck, Germany, 97440 Greece Local Institution Chania-Crete, Greece, 73300 Local Institution Corfu, Greece, 49100 Hungary Local Institution Budapest, Hungary, 1125 Local Institution Gyula, Hungary, 5700 Spain Local Institution Oviedo, Asturias, Spain, 33011 Local Institution Barcelona, Spain, 08025 Local Institution Barcelona, Spain, 08036 Local Institution Barcelona, Spain, 08907 Switzerland Local Institution Wetzikon, Switzerland, 8620 Turkey Local Institution Izmir, Turkey, 35370 Less <<
NCT00603239 Type 2 Diabetes Mellitus Phase 3 Completed - United States, Alabama ... More >> Research Site Birmingham, Alabama, United States United States, California Research Site Concord, California, United States Research Site Fresno, California, United States United States, Colorado Research Site Denver, Colorado, United States United States, Nevada Research Site Las Vegas, Nevada, United States United States, Ohio Research Site Mogadore, Ohio, United States United States, Oregon Research Site Corvallis, Oregon, United States Canada, British Columbia Research Site New Westminster, British Columbia, Canada Canada, Manitoba Research Site Winnipeg, Manitoba, Canada Canada, Ontario Research Site Ajax, Ontario, Canada Research Site Cambridge, Ontario, Canada Research Site Windsor, Ontario, Canada Mexico Research Site Mexico City, Distrito Federal, Mexico Research Site Celaya, Guanajuato, Mexico Research Site Monterrey, Nuevo Leon, Mexico Research Site Chihuahua, Mexico Research Site Mexico City, Mexico Romania Research Site Baia Mare, Romania Research Site Brasov, Romania Research Site Bucuresti, Romania Research Site Dolj, Romania Research Site Iasi, Romania Research Site Suceava, Romania South Africa Research Site Johannesburg, South Africa Research Site Pretoria, South Africa Less <<
NCT00834262 - Completed - Israel ... More >> Novo Nordisk Investigational Site Kfar Saba, Israel, 44425 Less <<
NCT00603239 - Completed - -
NCT02881697 - Active, not recruiting June 2019 -
NCT01250171 - Completed - -
NCT03176836 Li-Fraumeni Syndrome Not Applicable Enrolling by invitation December 31, 2019 Canada, Ontario ... More >> The Hospital for Sick Children Toronto, Ontario, Canada, M5G 1X8 Less <<
NCT01653041 Kidney Transplantation Phase 4 Completed - Brazil ... More >> Hospital do Rim e Hipertensão São Paulo, Brazil, 04038-002 Less <<
NCT01250171 Dry Eye Phase 2 Completed - United States, Massachusetts ... More >> Ora Inc, 300 Brickstone Square, Andover, Massachusetts, United States, 01810 Less <<
NCT01289925 Inflammation Not Applicable Terminated - United States, Maryland ... More >> Johns Hopkins Bayview Medical Center Baltimore, Maryland, United States, 21224 Less <<
NCT02158182 Hepatic Encephalopathy Phase 4 Completed - Mexico ... More >> Hospital General de Mexico Mexico City, Mexico, 06726 Less <<
NCT00263328 - Completed - -
NCT00263328 Kidney Transplantation Phase 2 Completed - United States, California ... More >> Multi Organ Transplant Center Los Angeles, California, United States, 90057 St. Vincent Medical Center Los Angeles, California, United States, 90057 Transplant Research Institute Los Angeles, California, United States, 90057 Stanford School of Medicine Palo Alto, California, United States, 94304 Balboa Institute of Transplantation San Diego, California, United States, 92123 California Institute of Renal Research San Diego, California, United States, 92123 Sharp Memorial Hospital San Diego, California, United States, 92123 California Pacific Medical Center San Francisco, California, United States, 94115 University of California, San Francisco, Kidney Transplant Unit San Francisco, California, United States, 94143 Stanford University Medical Center Stanford, California, United States, 94305 United States, Colorado University of Colorado Health Sciences Center Renal Clinical Trials Office Aurora, Colorado, United States, 80045 University of Colorado Health Sciences Center Aurora, Colorado, United States, 80045 United States, Illinois Northwestern Memorial Hospital Chicago, Illinois, United States, 60611 Northwestern University-Feinberg School of Medicine, Division of Organ Transplantation Chicago, Illinois, United States, 60611 United States, Missouri Washington University School of Medicine St. Louis, Missouri, United States, 63110 United States, New York Jack J Dreyfus Clinic New York, New York, United States, 10021 Recanati/Miller Transplantation Institute New York, New York, United States, 10029 New York Presbyterian Hospital / Weill Cornell Medical Center New York, New York, United States, 10065 United States, Oregon Legacy Good Samaritan Hospital Portland, Oregon, United States, 97210 Legacy Transplant Services Portland, Oregon, United States, 97210 Northwest Renal Clinic Portland, Oregon, United States, 97210 United States, Texas Dallas Transplant Institute Dallas, Texas, United States, 75204 Annette C & Harold C Simmons Transplant Institute Dallas, Texas, United States, 75246 Baylor University Medical Center Dallas, Texas, United States, 75246 Baylor All Saints Medical Center Fort Worth, Texas, United States, 76104 United States, Wisconsin Froedtert Memorial Lutheran Hospital Milwaukee, Wisconsin, United States, 53226 Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 Less <<
NCT02683746 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT00508157 - Terminated(Slow Accrual) - -
NCT00485017 Obesity Phase 2 Completed - Russian Federation ... More >> Investigational Site #62 Arkhangelsk, Russian Federation, 163045 Investigational Site #61 Moscow, Russian Federation, 107014 Investigational Site #51 Moscow, Russian Federation, 117036 Investigational Site #60 Moscow, Russian Federation, 121069 Investigational Site #57 Moscow, Russian Federation, 123056 Investigational Site #50 Moscow, Russian Federation, 125315 Investigational Site #54 Moscow, Russian Federation, 129010 Investigational Site #56 Saratov, Russian Federation, 410018 Investigational Site #63 St. Petersburg, Russian Federation, 192283 Investigational Site #67 St. Petersburg, Russian Federation, 194291 Investigational Site #53 St. Petersburg, Russian Federation, 194354 Investigational Site #66 St. Petersburg, Russian Federation, 194354 Investigational Site #59 St. Petersburg, Russian Federation, 195267 Investigational Site #65 St. Petersburg, Russian Federation, 197110 Investigational Site #55 St. Petersburg, Russian Federation, 197198 Investigational Site #58 St. Petersburg, Russian Federation, 198134 Investigational Site #64 St. Petersburg, Russian Federation, 199178 Sweden Investigational Site #12 Dalby, Sweden, SE-240 10 Investigational Site #11 Gothenburg, Sweden, SE-411 36 Investigational Site #13 Malmo, Sweden, SE-205 02 Less <<
NCT02967692 Melanoma Phase 3 Recruiting February 13, 2020 -
NCT02683746 - Completed - -
NCT03351530 - Enrolling by invitation February 9, 2019 Taiwan ... More >> General Biologicals Corporation Hsinchu, Taiwan Less <<
NCT02190318 Chronic Renal Disease Not Applicable Unknown December 2015 China, Hunan ... More >> Recruiting Changsha, Hunan, China, 410000 Contact: Hong Liu, MD,phD    86-0731-85292057    liuh0618@163.com    Principal Investigator: Hong Liu, MD,phD Less <<
NCT02794155 Type 1 Diabetes Mellitus Phase 2 Completed - United States, California ... More >> Hope & Wellness Clinical Trials, Inc. Corona, California, United States, 92882 National Research Institute Los Angeles, California, United States, 90057 California Medical Research Associates Inc. Northridge, California, United States, 91324 Bay Area Clinical Research San Carlos, California, United States, 94070 Mills-Peninsula Health Services San Mateo, California, United States, 94401 Orange County Research Center Tustin, California, United States, 92780 United States, Colorado Creekside Endocrine Associates, PC Denver, Colorado, United States, 80209 United States, Florida Advanced Pharma CR, LLC Miami, Florida, United States, 33147 Ormond Medical Arts Pharmaceutical Research Center Ormond Beach, Florida, United States, 32174 Progressive Medical Research Port Orange, Florida, United States, 32127 United States, Georgia Atlanta Diabetes Associates Atlanta, Georgia, United States, 30318 Endocrine Research Solutions, Inc. Roswell, Georgia, United States, 30076 United States, Idaho Rocky Mountain Diabetes & Osteoporosis Center, PA Idaho Falls, Idaho, United States, 83404 United States, Illinois Associates in Endocrinology Elgin, Illinois, United States, 60124 United States, Massachusetts University of Massachusetts Memorial Hospital Worcester, Massachusetts, United States, 01655 United States, Nevada Desert Endocrinology Clinical Research Center Henderson, Nevada, United States, 89052 United States, New York SUNY Upstate Medical University Syracuse, New York, United States, 13210 United States, Oklahoma LION Research Norman, Oklahoma, United States, 73072 United States, Texas Endocrine and Psychiatry Center Houston, Texas, United States, 77095 Clinical Trials of Texas, Inc. San Antonio, Texas, United States, 78229 United States, Washington Rainier Clinical Research Center, Inc. Renton, Washington, United States, 98057 Less <<
NCT01023503 - Withdrawn(Changes affecting Po... More >>st Authorization Study Regulatory effective from Dec09, impacted the requirements for Spanish studies at National and Regional level.) Less << July 2012 Spain ... More >> Research Site Barcelona, Spain Less <<
NCT01106690 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT02335853 - Unknown December 2015 Turkey ... More >> Bakirkoy Dr Sadi Konuk Training and Research Hospital Recruiting Istanbul, Bakirkoy, Turkey, 34140 Contact: hediye dagdeviren, md    5536161385    hediyedagdeviren@gmail.com    Principal Investigator: huseyin cengiz, md Less <<
NCT03770728 Type 2 Diabetes Mellitus Phase 3 Not yet recruiting April 2021 -
NCT02177643 Diabetes-Related Complications... More >> Diabetes Mellitus, Type 2 Insulin Resistance Less << Phase 2 Unknown - Brazil ... More >> Universidade Estadual de Feira de Santana Recruiting Feira de Santana, Bahia, Brazil Contact: Dra. Ana Mayra A. Oliveira, PhD    +55 (075) 3625-4027    anamayra@uol.com.br    Principal Investigator: Dra. Ana Mayra A. Oliveira, PhD          Centro de Estudos em Diabetes e Hipertensão Recruiting Fortaleza, Ceará, Brazil Contact: Dra. Adriana C. Forti, PhD    +55 (085) 3105-8300    cedh@cedh.med.br    Principal Investigator: Dra. Adriana C. Forti, PhD          Universidade Estadual de Campinas Recruiting Campinas, São Paulo, Brazil Contact: Dra. Maria Cândida R. Parisi, PhD    +55 (019) 98196-2242    emaildacandida@uol.com.br    Contact: Dr. Daniel Minuti, MD Msc    +55 (019) 98128-2535    danielminutti@yahoo.com.br    Sub-Investigator: Dr. Daniel Minuti, MD Msc Less <<
NCT01221519 Type 2 Diabetes Mellitus ... More >> High Blood Sugar Less << Phase 1 Completed - United States, Minnesota ... More >> Research Site St. Paul, Minnesota, United States Less <<
NCT01958671 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT02227303 Type 2 Diabetes Mellitus Not Applicable Completed - United States, Florida ... More >> Miami Research Associates (MRA) Miami, Florida, United States, 33143 Less <<
NCT01106690 - Completed - -
NCT01180764 Hypertriglyceridemia Phase 4 Withdrawn(Withdrawn for admini... More >>strative reasons.) Less << October 2012 United States, Utah ... More >> University of Utah Salt Lake City, Utah, United States, 84108 Less <<
NCT01958671 - Completed - -
NCT02729857 Healthy Famil... More >>ial Hypercholesterolemia Less << Not Applicable Completed - Norway ... More >> University of Oslo Oslo, Post box 1046, Blindern, Norway, 0317 Less <<
NCT00709683 - Completed - Tunisia ... More >> Tunisia, Tunisia, 1053 Less <<
NCT02723266 Gestational Diabetes Mellitus Not Applicable Recruiting March 1, 2020 United States, Oklahoma ... More >> Indian Health Resource Center of Tulsa Recruiting Tulsa, Oklahoma, United States, 73114 Contact: Nancy O'Banion, MS    918-382-2220    nobanion@IHCRC.org    Contact: Sharnella Goudeau, RN    918-619-4304    sharnella-gourdeau@ouhsc.edu Less <<
NCT00212199 1. Obesity Phase 4 Completed - United States, Texas ... More >> Baylor College of Medicine Houston, Texas, United States, 77030 Less <<
NCT00274274 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 4 Completed - Germany ... More >> Düsseldorf, Germany Less <<
NCT03684642 Type 2 Diabetes Mellitus Phase 3 Recruiting December 2020 United States, Alabama ... More >> Investigational Site Number 8400038 Recruiting Birmingham, Alabama, United States, 35211 United States, Arizona Investigational Site Number 8400035 Recruiting Chandler, Arizona, United States, 85224 Investigational Site Number 8400005 Recruiting Glendale, Arizona, United States, 85306 United States, California Investigational Site Number 8400040 Recruiting Tustin, California, United States, 92780 United States, Florida Investigational Site Number 8400041 Recruiting Pembroke Pines, Florida, United States, 33026 United States, Georgia Investigational Site Number 8400025 Recruiting Snellville, Georgia, United States, 30078 United States, Kentucky Investigational Site Number 8400044 Recruiting Lexington, Kentucky, United States, 40503 United States, New Jersey Investigational Site Number 8400001 Recruiting Bridgeton, New Jersey, United States, 08302 United States, North Carolina Investigational Site Number 8400036 Recruiting Morehead City, North Carolina, United States, 28557 United States, Utah Investigational Site Number 8400037 Recruiting Layton, Utah, United States, 84041 Less <<
NCT01678820 Type 2 Diabetes Mellitus Phase 3 Terminated(Merck terminated th... More >>e study for business reasons in November 2013.) Less << - -
NCT02302326 Polycystic Ovary Syndrome Not Applicable Recruiting December 2017 Spain ... More >> Antonio Hernández Recruiting Valencia, Spain, 46017 Contact: Antonio Hernández, Phd, MD    34961622492    hernandez_antmij@gva.es    Contact: Celia Bañuls, PhD    34961622757    celia.banuls@uv.es Less <<
NCT01973972 Diabetes Not Applicable Completed - United States, North Carolina ... More >> Durham VA Medical Center, Durham, NC Durham, North Carolina, United States, 27705 Less <<
NCT01678820 - Terminated(Merck terminated th... More >>e study for business reasons in November 2013.) Less << - -
NCT03765359 Diabetic Pregnancy ... More >> Insulin Resistance Type1diabetes Less << Phase 4 Not yet recruiting December 31, 2021 -
NCT00771680 - Completed - Russian Federation ... More >> Novo Nordisk Investigational Site Moscow, Russian Federation, 119330 Ukraine Novo Nordisk Investigational Site Kiev, Ukraine, 252030 Less <<
NCT02705430 Type 2 Diabetes Not Applicable Not yet recruiting March 2019 -
NCT03527641 Prediabetic State ... More >> Insulin Resistance Type2 Diabetes Stress Adolescent Development Family Research Less << Not Applicable Recruiting March 31, 2019 United States, Colorado ... More >> Colorado State University Recruiting Fort Collins, Colorado, United States, 80523 Contact: Lauren Shomaker, PhD          Salud Family Health Center Recruiting Fort Collins, Colorado, United States, 80524 Contact: Lauren Shomaker, PhD Less <<
NCT01477853 Type 2 Diabetes Mellitus Phase 3 Terminated(The study was termi... More >>nated early by the Sponsor for business reasons.) Less << - -
NCT01557673 Enteral Feeding ... More >> Nasogastric Feeding Diarrhoea Less << Phase 1 Phase 2 Completed - United Kingdom ... More >> Sir Peter Mansfield Magnetic Resonance Centre Nottingham, Nottinghamshire, United Kingdom, NG7 2RD Less <<
NCT01477853 - Terminated(The study was termi... More >>nated early by the Sponsor for business reasons.) Less << - -
NCT03238053 Laser-Induced Scar ... More >> Breast Cancer Endometrial Cancer Menopause Vaginal Atrophy Bladder, Overactive Less << Not Applicable Not yet recruiting December 31, 2021 Denmark ... More >> Gynecology Dept. Herning Hospital Herning, Denmark, 7400 Less <<
NCT02515032 Cachexia NSCL... More >>C Less << Not Applicable Completed - Croatia ... More >> GH Varaždin Varaždin, Croatia, 42 000 GH Zadar Zadar, Croatia, 23 000 CHC Sestre Milosrdnice Zagreb, Croatia, 10 000 CHC Zagreb, Zagreb, Croatia, 10 000 Italy Policlinico Universitario Campus Bio-Medico di Roma Rome, Italy, 00128 Policlinico Tor Vergata Rome, Italy, 00133 Azienda Ospedaliera San Camillo Forlanini Rome, Italy, 00151 Slovakia FNsP F.D. Roosvelta Banská Bystrica Banská Bystrica, Slovakia, 975 17 Nemocnica Sv. Jakuba Bardejov, Slovakia, 085 01 Východoslovenský onkologický ústav Košice, Slovakia, 041 91 NsP Štefana Kukuru Michalovce Michalovce, Slovakia, 071 01 FNsP J.A. Reimana Prešov, Slovakia, 081 81 Sweden Linkoping University Hospital Linkoping, Sweden, 58185 Akademiska hospital Uppsala, Sweden, 751 85 Less <<
NCT02858336 Normal Physiology ... More >> Healthy Less << Early Phase 1 Recruiting July 1, 2021 United States, North Carolina ... More >> NIEHS Clinical Research Unit (CRU) Recruiting Research Triangle Park, North Carolina, United States Contact: Lisa Barber, M.Ed.    919-541-9847    murphylb@mail.nih.gov Less <<
NCT01490762 Healthy Phase 1 Completed - United States, California ... More >> Profil Institute for Clinical Research Chula Vista, California, United States, 91911 Less <<
NCT03687125 Multiple Myeloma in Relapse ... More >> Multiple Myeloma Progression Multiple Myeloma With Failed Remission Less << Phase 1 Phase 2 Recruiting March 7, 2023 United States, Alabama ... More >> University of Alabama Recruiting Birmingham, Alabama, United States, 35294 Contact: Luciano Costa, MD          United States, Kansas University of Kansas Medical Center Kansas City Not yet recruiting Kansas City, Kansas, United States, 66160 Contact: Leyla Shune, MD          United States, New York Memorial Sloan Kettering Cancer Centre Not yet recruiting New York, New York, United States, 10065 Contact: Sergio Giralt, MD          United States, North Carolina Carolinas Healthcare System Not yet recruiting Charlotte, North Carolina, United States, 28204 Contact: Shebli Atrash          United States, Tennessee Vanderbilt-Ingram Cancer Center Not yet recruiting Nashville, Tennessee, United States, 37203 Contact: Michael Byrne, MD          United States, Texas University of Texas MD Anderson Cancer Center Not yet recruiting Houston, Texas, United States, 77030 Contact: Qaiser Bashir, MD          United States, Wisconsin Froedtert & Medical College of Wisconsin, Cancer Center - Froedtert Hospital Not yet recruiting Milwaukee, Wisconsin, United States, 53226 Contact: Anita D'Souza          Norway Oslo Myeloma Center, Oslo University Hospital Not yet recruiting Oslo, Norway Contact: Fredrik Hellem Schjesvold          Switzerland Universitatsspital Basel Not yet recruiting Basel, Switzerland Contact: Dominik Heim          Universitatsspital Bern Not yet recruiting Bern, Switzerland Contact: Thomas Pabst          Department of Clinical Research Oncology/Hematology, Kantonsspital St. Gallen Not yet recruiting Saint Gallen, Switzerland Contact: Dagmar Hess-Mildenberger          University Hospital Zurich Not yet recruiting Zürich, Switzerland Contact: Rouven Muller Less <<
NCT00118950 Diabetes Mellitus, Type 2 Phase 4 Completed - Denmark ... More >> Steno Diabetes Center Gentofte, Denmark, 2820 Less <<
NCT01625923 Idiopathic Gastroparesis Not Applicable Recruiting December 2019 United States, Massachusetts ... More >> Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: Braden Kuo, MD    617-726-0196       Principal Investigator: Braden Kuo, MD          United States, Michigan University of Michigan Recruiting Ann Arbor, Michigan, United States, 48109 Contact: Allen Lee, MD    734-936-9454       Principal Investigator: Allen Lee, MD          Sub-Investigator: William Hasler, MD Less <<
NCT02097277 Diabetes Mellitus Type 2 Phase 2 Completed - United States, Arkansas ... More >> Arkansas Clinical Research Little Rock, Arkansas, United States, 72205 United States, California Anaheim Clinical Trials Llc Anaheim, California, United States, 92801 National Research Institute Los Angeles, California, United States, 90057 Encompass Clinical Research Spring Valley, California, United States, 91978 United States, Florida All Medical Research, Llc Cooper City, Florida, United States, 33024 United States, Kentucky Central Kentucky Research Associates, Inc. Lexington, Kentucky, United States, 40509 United States, New Jersey Premier Research Trenton, New Jersey, United States, 08611 United States, North Carolina Metrolina Internal Medicine Charlotte, North Carolina, United States, 28204 United States, Ohio Sterling Research Grp, Ltd. Cincinnati, Ohio, United States, 45219 Canada, British Columbia Manna Research Vancouver Vancouver, British Columbia, Canada, V6J 1S3 Canada, Ontario Aggarwal And Associates Brampton, Ontario, Canada, L6T 0G1 Canada, Quebec Rhodin Recherche Clinique Drummondville, Quebec, Canada, J2B 7T1 Recherche Gcp Research Montreal, Quebec, Canada, H1M 1B1 Medexa Recherche Victoriaville, Quebec, Canada, G6P 6P6 Canada Alpha-Recherche Clinique Quebec, Canada, G3K 2P8 Less <<
NCT02066766 - Completed - Vietnam ... More >> Novo Nordisk Investigational Site Hanoi, Vietnam Less <<
NCT01606371 Diabetes Mellitus, Type 2 Phase 1 Completed - Singapore ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Singapore, Singapore Less <<
NCT03160105 HIV-1-infection ... More >> Antiretroviral Therapy Maintenance Therapy Less << Phase 4 Active, not recruiting July 2020 Switzerland ... More >> Department of Infectious Diseases and Hospital Epidemiology, University Hospital of Basel Basel, Switzerland Departement of Infectious Disease, Bern University Hospital Bern, Switzerland Infectious diseases consultation, University Hospitals of Geneva Genève, Switzerland Infectious Diseases Service, Lausanne University Hospital Lausanne, Switzerland Department of Infectious Diseases, Lugano Regional Hospital Lugano, Switzerland Division of Infectious Diseases and Hospital Epidemiology, Kantonspital St.Gallen St. Gallen, Switzerland Department of Infectious Diseases and Hospital Epidemiology, University Hospital of Zurich Zürich, Switzerland Less <<
NCT03664596 Non-alcoholic Steatohepatitis Not Applicable Recruiting June 2019 Kazakhstan ... More >> Medical Centre Hospital of the President's Affairs Administration Recruiting Astana, Kazakhstan, 010000 Contact: Bakytzhan Bimbetov, MD, PhD    +7701 383 6072    bimbetov2010@mail.ru    Sub-Investigator: Abay Zhangabylov, MD, PhD          Sub-Investigator: Marzhan Rakhimzhanova, MD, MPH Less <<
NCT02120976 Diabetes Mellitus Phase 1 Terminated - United States, Kansas ... More >> Overland Park, Kansas, United States United States, Texas Austin, Texas, United States Less <<
NCT01913171 Android Obesity, Metabolic Par... More >>ameters and Adipose Tissue (AT) Gene Expression Less << Not Applicable Completed - Finland ... More >> Department of Medicine, University of Helsinki Helsinki, Finland, FI-00290 Less <<
NCT01564498 Hypertension ... More >>Hypercholesterolemia Type II Diabetes Obesity Inflammation Less << Phase 1 Unknown December 2017 Canada, Ontario ... More >> Human Nutraceutical Research Unit Recruiting Guelph, Ontario, Canada, N1G2W1 Contact: Amanda J Wright, PhD    5198244120 ext 54697    ajwright@uoguelph.ca    Contact: Amy Tucker, PhD    5198244120 ext 53925       Principal Investigator: Kelly A Meckling, PhD          Sub-Investigator: Saqib Mannan, BSc          Sub-Investigator: Ricky Janssen, BSc Less <<
NCT02529449 Type 1 Diabetes Mellitus Phase 2 Completed - Japan ... More >> Site JP00006 Aichi, Japan Site JP00002 Fukuoka, Japan Site JP00009 Gunma, Japan Site JP00001 Ibaraki, Japan Site JP00005 Kanagawa, Japan Site JP00008 Kanagawa, Japan Site JP00003 Okayama, Japan Site JP00004 Osaka, Japan Site JP00010 Osaka, Japan Site JP00011 Osaka, Japan Site JP00007 Tokyo, Japan Less <<
NCT02158897 Healthy Volunteers Phase 1 Phase 2 Completed - United States, California ... More >> Davis School of Gerontology Los Angeles, California, United States, 90089 Less <<
NCT01485614 Diabetes Mellitus ... More >> Type 2 Diabetes Less << Phase 3 Active, not recruiting October 17, 2019 -
NCT02392117 - Completed - Denmark ... More >> Novo Nordisk Investigational Site Århus, Denmark, 8200 Germany Novo Nordisk Investigational Site München, Germany, 81925 Italy Novo Nordisk Investigational Site Padova, Italy, 35122 Netherlands Novo Nordisk Investigational Site Utrecht, Netherlands, 3508 GA Spain Novo Nordisk Investigational Site Palma de Mallorca, Spain, 07015 Sweden Novo Nordisk Investigational Site Karlstad, Sweden, 651 85 Switzerland Novo Nordisk Investigational Site Zürich, Switzerland, 8091 United Kingdom Novo Nordisk Investigational Site London, United Kingdom, SW10 9NH Less <<
NCT00583947 Asthma Phase 2 Completed - United States, California ... More >> Beverly Hills, California, United States, 90211 Orange, California, United States, 92868 United States, Georgia Savannah, Georgia, United States, 31406 United States, Illinois Normal, Illinois, United States, 61761 United States, Oklahoma Oklahoma City, Oklahoma, United States, 73112 Oklahoma City, Oklahoma, United States, 73120 United States, Oregon Medford, Oregon, United States, 97504 Portland, Oregon, United States, 97213 United States, Pennsylvania Upland, Pennsylvania, United States, 19013 United States, South Carolina Orangeburg, South Carolina, United States, 29118 Spartanburg, South Carolina, United States, 29303 United States, Texas Dallas, Texas, United States, 75230 United States, Virginia Burke, Virginia, United States, 22015 Richmond, Virginia, United States, 23229 Less <<
NCT00784537 Hodgkin's Lymphoma Phase 2 Phase 3 Completed - Italy ... More >> Centro di riferimento Oncologico Oncologia Medica A Aviano, Italy Università Policlinico di Bari - Divisione di Medicina A Bari, Italy Policlinco Sant'Orsola Isituto di Ematologia ed oncologia Medica Bologna, Italy Sezione di Ematologia Spedali Civili Brescia, Italy Ospedale di Circolo SC Oncologia Medica III Busto Arsizio, Italy Divisione di Ematologia Osp.Businco Cagliari, Italy Policlinico Careggi Cattedra di Ematologia Firenze, Italy ASLTO4 Ivrea, Italy Osp. Cardinale Panico Divisione di Ematologia Tricase Lecce, Italy Ospedale Niguarda Cà Granda Milano, Italy Università Avogadro Divisione di Ematologia Novara, Italy Ospedale San Francesco UO Ematologia e Centro Trapianti Nuoro, Italy Fondazione Policlinico San Matteo Clinica Ematologica Pavia, Italy Osp. Santa Maria delle Croci UO Ematologia Ravenna, Italy Ospedale Bianchi Melacrino Morelli Reggio Calabria, Italy Osp. degli Infermi Divisione di Oncologia Rimini, Italy Istituto Regina Elena IFO SC Ematologia Roma, Italy Osp.Sant'Eugenio Divisione di Ematologia Roma, Italy Università La Sapienza Dipartimento di Biotecnnologie Cellulari Roma, Italy Istituto Clinico Humanitas Divisione di Oncologia Medica ed Ematologia Rozzano (MI), Italy AO Universitaria di Sassari Sassari, Italy Policlinico Le Scotte Siena, Italy Struttura Complessa di Onco-Ematologia Terni, Italy IRCC Onco-Ematologia Candiolo Torino, Italy Osp. San Giovanni Battista_Molinette Ematologia 2 Torino, Italy Azienda Ospedaliero universitaria di Udine Udine, Italy ASL 14 UO Oncologia Verbania, Italy Less <<
NCT02191319 - Completed - -
NCT02183415 Diabetes Mellitus, Type 2 Phase 1 Completed - -
NCT01698775 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT02043886 Type 2 Diabetes ... More >> Postprandial Hypotension Less << Phase 2 Completed - Canada, British Columbia ... More >> VITALiTY Research Centre Vancouver, British Columbia, Canada, V5Z1M9 Less <<
NCT00583947 - Completed - -
NCT02318797 Chronic Disease ... More >> Mental Health Behavioral Health Cardiovascular Disease Diabetes Mellitus Type 2 Substance-related Disorders Vascular Diseases Less << Not Applicable Completed - United States, Pennsylvania ... More >> Community Care Behavioral Health Organizations Pittsburgh, Pennsylvania, United States, 15229 Less <<
NCT02185274 - Recruiting October 2019 Germany ... More >> Gynaecological department of the University hospital of Erlangen Recruiting Erlangen, Germany, 91054 Contact: Thomas Hildebrandt, MD    0049 91318533553    thomas.hildebrandt@uk-erlangen.de    Principal Investigator: Thomas Hildebrandt, MD          Institute for Sex Research and Forensic Psychiatry Recruiting Hamburg, Germany, 20246 Contact: Timo Nieder, PhD    +49 40 741054232    t.nieder@uke.de    Contact: Johannes Fuss, MD       joh.fuss@zi-mannheim.de    Principal Investigator: Timo Nieder, PhD          Hormon- und Stoffwechselzentrum München Recruiting Munich, Germany, 80333 Contact: Cornelia Bernutz, MD       cornelia.bernutz@gmx.de    Principal Investigator: Cornelia Bernutz, MD Less <<
NCT01916434 Cardiovascular Disease Not Applicable Completed - United Kingdom ... More >> Rowett Institute of Nutrition and Health, Human Nutrition Unit Aberdeen, United Kingdom, AB21 9SB Less <<
NCT02318797 - Completed - -
NCT01698775 - Completed - -
NCT03092960 Obesity Metab... More >>olic Syndrome Lifestyle Intervention Pre Diabetes Less << Not Applicable Active, not recruiting July 1, 2020 United States, California ... More >> Palo Alto Medical Foundation Palo Alto, California, United States, 94301 Less <<
NCT03406585 Type1 Diabetes Mellitus Phase 1 Phase 2 Recruiting June 1, 2020 Sweden ... More >> Karolinska Trial Alliance, Fas 1 enheten, Karolinska Universitetssjukhuset Huddinge Recruiting Stockholm, Sweden, 141 86 Contact: Sofia Sisay, PhD Less <<
NCT00806338 Diabetes Mellitus ... More >> Obesity Less << Phase 1 Completed - United States, Florida ... More >> Cetero Research Miami Gardens, Florida, United States, 33169 United States, Texas dgd Research San Antonio, Texas, United States, 78229 Less <<
NCT00993720 Diabetes Mellitus Phase 2 Phase 3 Completed - Denmark ... More >> Hvidovre University Hospital Hvidovre, Denmark, 2650 Less <<
NCT01165983 - Completed - -
NCT01909544 Pulmonary Disease, Chronic Obs... More >>tructive Less << Not Applicable Unknown - Canada, Quebec ... More >> Institut universitaire de cardiologie et de pneumologie de Québec Recruiting Québec, Quebec, Canada, G1V 4G5 Principal Investigator: François Maltais, MD          Sub-Investigator: Didier Saey, PhD          Sub-Investigator: Fernanda Ribeiro, PhD candidate Less <<
NCT03019757 - Recruiting December 2020 United States, Ohio ... More >> The Ohio State University Recruiting Columbus, Ohio, United States, 43210 Contact: Jennifer Icenhour    614-293-6882    jennifer.icenhour@osumc.edu Less <<
NCT01165983 Diabetes Type 2 Not Applicable Completed - United States, Massachusetts ... More >> Beth Israel Deaconess Medical Center, Joslin Foot Center & Microcirculation Laboratory Boston, Massachusetts, United States, 02215 Less <<
NCT01674777 Healthy Pharm... More >>acokinetics of ASP1941 Less << Phase 1 Completed - Japan ... More >> Kantou, Japan Less <<
NCT00521742 Diabetes Mellitus Phase 3 Completed - -
NCT02204202 - Recruiting May 2019 United States, Missouri ... More >> Washington University School of Medicine / Barnes-Jewish Hospital Recruiting Saint Louis, Missouri, United States, 63110 Contact: Delphine L Chen, MD    314-362-7029    chend@mir.wustl.edu    Principal Investigator: Delphine L Chen, MD Less <<
NCT01654120 Diabetes Mellitus, Type II Phase 4 Completed - United States, North Carolina ... More >> Mountain Diabetes and Endocrine Center Asheville, North Carolina, United States, 28803 Less <<
NCT01990560 Mild Hypercortisolism Phase 4 Completed - United States, New York ... More >> Icahn School of Medicine at Mount Sinai New York, New York, United States, 10029 Less <<
NCT01990560 - Completed - -
NCT00157729 Diabetes Mellitus Type 2 ... More >> Hypertension Metabolic Syndrome Less << Phase 2 Completed - Canada, Quebec ... More >> Centre Hospitalier Université Laval Sainte-Foy, Quebec, Canada, G1V 4G2 Less <<
NCT01610219 Diabetes Mellitus, Type 2 ... More >> Obesity Less << Not Applicable Completed - United States, Pennsylvania ... More >> University of Pennsylvania Center for Weight and Eating Disorders/Perelman School of Medicine Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00925977 Diabetes Type 1 Not Applicable Terminated - Israel ... More >> Soroka hospital Bear Sheva, Israel Rambam Hospital Haifa, Israel Health care unit- Jerusalem Jerusalem, Israel Schnider children medical center Petach-Tikva, Israel Less <<
NCT01322568 - Completed - Iceland ... More >> Icelandic Heart Association Research Institute Kopavogur, Iceland Less <<
NCT00877851 Diabetes Mellitus, Type 2 Not Applicable Completed - United Kingdom ... More >> Queen's University Belfast Belfast, Antrim, United Kingdom, BT12 6BJ Belfast Health and Social Care Trust Belfast, Antrim, United Kingdom Less <<
NCT00261443 - Completed - -
NCT00825643 - Completed - Canada ... More >> Novo Nordisk Investigational Site Mississauga, Canada, L4W 4XI China, Beijing Novo Nordisk Investigational Site Beijing, Beijing, China, 100004 Germany Novo Nordisk Investigational Site Mainz, Germany, 55127 Israel Novo Nordisk Investigational Site Kfar Saba, Israel, 44425 Italy Novo Nordisk Investigational Site Rome, Italy, 00144 Poland Novo Nordisk Investigational Site Warszawa, Poland, PL-02-274 Portugal Novo Nordisk Investigational Site Paco de Arcos, Portugal, 2780-730 Spain Novo Nordisk Investigational Site Madrid, Spain, 28033 Turkey Novo Nordisk Investigational Site Istanbul, Turkey, 34335 Less <<
NCT01394341 Type 2 Diabetes Mellitus ... More >> End-stage Renal Disease Less << Phase 4 Completed - Denmark ... More >> Department of Endocrinology PE, Copenhagen University Hospital, Rigshospitalet Copenhagen Ø, Copenhagen, Denmark, 2100 Department of Nephrology P, Copenhagen University Hospital, Rigshospitalet Copenhagen Ø, Copenhagen, Denmark, 2100 Department of Internal Medicine H, Hillerød Hospital Hillerød, Denmark, 3400 Less <<
NCT00356421 Diabetes Mellitus, Type 1 Phase 4 Terminated(See termination rea... More >>son in detailed description.) Less << - United States, New Jersey ... More >> Pfizer Investigational Site Hamilton, New Jersey, United States, 08610 Pfizer Investigational Site New Brunswick, New Jersey, United States, 08903 Austria Pfizer Investigational Site Vienna, Austria, A-1030 Pfizer Investigational Site Vienna, Austria, A-1130 Belgium Pfizer Investigational Site Edegem, Belgium, 2650 Pfizer Investigational Site Genk, Belgium, 3600 Pfizer Investigational Site Leuven, Belgium, 3000 Denmark Pfizer Investigational Site Aarhus, Denmark, 8000 Finland Pfizer Investigational Site Kuopio, Finland, 70211 France Pfizer Investigational Site Brest CEDEX, France, 29609 Pfizer Investigational Site Corbeil Essonnes Cedex, France, 91106 Pfizer Investigational Site Strasbourg Cedex, France, 67091 Ireland Pfizer Investigational Site Waterford, Ireland Netherlands Pfizer Investigational Site Amsterdam, Netherlands, NL-1105 AZ Norway Pfizer Investigational Site Stavanger, Norway, 4095 Portugal Pfizer Investigational Site Lisboa, Portugal, 1349-019 Spain Pfizer Investigational Site Las Palmas, Las Palmas de Gran Canaria, Spain, 35016 Pfizer Investigational Site Valencia, Spain, 46010 Sweden Pfizer Investigational Site Stockholm, Sweden, 171 76 Pfizer Investigational Site Stockholm, Sweden, 182 88 United Kingdom Pfizer Investigational Site Bournemouth, Dorset, United Kingdom, BH7 7DW Pfizer Investigational Site Dundee, Tayside, United Kingdom, DD1 9SY Pfizer Investigational Site Birmingham, West Midlands, United Kingdom, B9 5SS Less <<
NCT00356421 - Terminated(See termination rea... More >>son in detailed description.) Less << - -
NCT02806349 Diabetes Mellitus, Type 2 Phase 2 Completed - Canada, Ontario ... More >> Clinical Risk Factor and Modification Centre Toronto, Ontario, Canada, M5C 2T2 Less <<
NCT02125149 Pregnancy Obe... More >>se Less << Not Applicable Recruiting June 2020 United States, Arkansas ... More >> Arkansas Children's Nutrition Center Recruiting Little Rock, Arkansas, United States, 72202 Contact: Jill Harsch, BS    501-364-3309    acncstudies@uams.edu    Contact: Amanda Xaysuda, BS    501-364-3309    acncstudies@uams.edu Less <<
NCT00261443 Bipolar Disorder Phase 4 Completed - -
NCT01726647 - Completed - Switzerland ... More >> Nestlé Clinical Development Unit / Metabolic Unit Lausanne 26, Switzerland, 1000 University Hospitals, Service of endocrinology, diabetology, and metabolism Lausanne, Switzerland, 1011 Less <<
NCT00949091 Diabetes Mellitus, Type 2 Phase 1 Completed - -
NCT01218867 Metastatic Cancer ... More >> Metastatic Melanoma Renal Cancer Less << Phase 1 Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00924287 - Terminated(This study was term... More >>inated after the first patient treated on study died as a result of the treatment.) Less << - -
NCT02153021 Obesity; Phase 1 Unknown February 2015 Brazil ... More >> Unversidade Federal de São Carlos Not yet recruiting São Carlos, São Paulo, Brazil, 13565905 Contact: Antonio E de AquinoJunior, Master    +55XX16991721127    antonioaquino@ursa.ifsc.usp.br    Sub-Investigator: Antonio E de Aquino Junior, Master Less <<
NCT01686477 Adiposity Ins... More >>ulin Resistance Metabolomic Profile microRNA Profile Less << Not Applicable Unknown October 2016 United Kingdom ... More >> Chelsea and Westminster Hospital Neonatal Unit Recruiting London, United Kingdom, SW10 9NH Contact: Mary Tourette       research.development@chelwest.nhs.uk    Principal Investigator: Luke W Mills, MBChB Less <<
NCT01218867 - Completed - -
NCT00498433 Hypertension ... More >>Abdominal Obesity Less << Phase 2 Terminated(Early termination r... More >>esulted from interim analysis of the ALTITUDE trial) Less << - Germany ... More >> Novartis Investigative Site Berlin-Buch, Germany, 13125 Novartis Investigative Site Hannover, Germany, 30159 Less <<
NCT00924287 Metastatic Cancer Phase 1 Phase 2 Terminated(This study was term... More >>inated after the first patient treated on study died as a result of the treatment.) Less << - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT02948322 Acromegaly Not Applicable Unknown June 2018 France ... More >> AP-HP, Bicêtre Hospital Recruiting Le Kremlin Bicêtre, France, 94275 Contact: Peter KAMENICKY, MD    +33 (0) 1 45 21 37 06    peter.kamenicky@bct.aphp.fr Less <<
NCT00870194 - Completed - -
NCT00870194 Type 2 Diabetes Mellitus Phase 4 Completed - Argentina ... More >> Research Site Buenos Aires, Argentina Research Site Morón, Argentina Australia Research Site Adelaide, Australia Research Site Geelong, Australia Research Site Melbourne, Australia Germany Research Site Aschaffenburg, Germany Research Site Asslar, Germany Research Site Beckum-Neubeckum, Germany Research Site Berlin, Germany Research Site Bosenheim, Germany Research Site Essen, Germany Research Site Falkensee, Germany Research Site Furth im Wald, Germany Research Site Grevenbroich, Germany Research Site Hamburg-Othmarschen, Germany Research Site Hohenmolsen, Germany Research Site Leipzig, Germany Research Site Neuwied, Germany Research Site Pohlheim, Germany Research Site Speyer, Germany Greece Research Site Athens, Greece Research Site Thessaloniki, Greece India Research Site Ahmedabad, India Research Site Bangalore, India Research Site Coimbatore, India Research Site Indore, India Research Site Jaipur, India Korea, Republic of Research Site Daegu, Korea, Republic of Research Site Gwangju, Korea, Republic of Research Site Seoul, Korea, Republic of Research Site Ulsan, Korea, Republic of Mexico Research Site Coatzacoalcos, Mexico Research Site Guadalajara, Mexico Research Site Merida, Mexico Research Site Monterrey, Mexico Research Site Tampico, Mexico Less <<
NCT02655627 Type 2 Diabetes Not Applicable Completed - Turkey ... More >> Buket AKINCI Istanbul, Turkey Istanbul University Istanbul, Turkey Less <<
NCT00658099 - Completed - Romania ... More >> Novo Nordisk Investigational Site Bucharest, Romania, 010031 Less <<
NCT01765517 Diabetes Mellitus Type 2 Not Applicable Unknown February 2017 Saudi Arabia ... More >> Biomarkers Research Program, King Saud university Riyadh, Saudi Arabia, 11451 Less <<
NCT00375492 - Completed - -
NCT03300388 Obesity Aging... More >> Inflammation Less << Not Applicable Recruiting December 2022 Spain ... More >> Department of Nutrition, Food Science and Physiology. Centre for Nutrition Research. Recruiting Pamplona, Navarra, Spain, 31008 Contact: Blanca E Martínez de Morentin, MD    0034948255400 ext 2058    bmmoretin@unav.es    Contact: Elisa Felix-Soriano, PhD student    0034948425600 ext 806439    efelix@alumni.unav.es    Principal Investigator: María J Moreno-Aliaga, PhD          Principal Investigator: Silvia Lorente-Cebrián, PhD          Sub-Investigator: Pedro González-Muniesa, PhD          Sub-Investigator: Marta Cuervo, PhD          Sub-Investigator: María Soledad García-Unciti, PhD          Sub-Investigator: Pilar Lostao, PhD          Sub-Investigator: Javier Ibañez, MD, PhD          Sub-Investigator: Blanca Martínez de Morentin, MD Less <<
NCT03284346 Cancer Survivor ... More >> No Evidence of Disease Obesity Overweight Prostate Carcinoma Sedentary Lifestyle Stage I Breast Cancer Stage IA Breast Cancer Stage IB Breast Cancer Stage II Breast Cancer Stage IIA Breast Cancer Stage IIB Breast Cancer Stage III Breast Cancer Stage IIIA Breast Cancer Stage IIIB Breast Cancer Stage IIIC Breast Cancer Less << Not Applicable Recruiting August 17, 2021 United States, California ... More >> USC / Norris Comprehensive Cancer Center Recruiting Los Angeles, California, United States, 90033 Contact: Christina Dieli-Conwright, Ph.D.    323-442-2905    cdieli@usc.edu    Principal Investigator: Christina Dieli-Conwright, Ph.D. Less <<
NCT00709475 - Completed - Saudi Arabia ... More >> Novo Nordisk Investigational Site Riyadh, Saudi Arabia, 3542 Less <<
NCT00178074 Unipolar Depression Phase 4 Completed - United States, Pennsylvania ... More >> University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States, 15213 Less <<
NCT00617552 Postoperative Ileus Phase 2 Completed - United States, California ... More >> Office of Dr. Phillip Fleshner Los Angeles, California, United States, 90048 United States, Florida University of Miami Clinic Miami, Florida, United States, 33136 Renstar Medical Research Ocala, Florida, United States, 34471 United States, Illinois Northwestern University Chicago, Illinois, United States, 60611 United States, Maryland Univ. of Maryland, R.A. Cowley Shock Trauma Center Baltimore, Maryland, United States, 21201 United States, Massachusetts Baystate Medical Center/Baystate Health Springfield, Massachusetts, United States, 01199 United States, Michigan Michigan State/Spectrum Health Grand Rapids, Michigan, United States, 49503 United States, New York Stony Brook University Hospital Stony Brook, New York, United States, 11794 United States, North Dakota Mid Dakota Clinic, PC Bismarck, North Dakota, United States, 58501 United States, Texas The Methodist Hospital Houston, Texas, United States, 77030 India St. John's Hospital Bangalore, Karnataka, India Stanley Medical College Chennai, India, 600001 Amrita Institute of Medical Sciences Cochin, India, 682026 Lakeshore Hospital Cochin, India, 682304 Asian Institute of Gastroenterology Hyderabad, India, 500082 Nizams Institute of Medical Science Hyderabad, India, 500083 Mediciti Hospitals Hyderabad, India, 50063 Sanjay Gandhi Post-Graduate Institute of Medical Sciences Lucknow, India, 226014 Romania Spitalul Urg. SF. Pantelimon Bucharest, Romania, 021659 RO Spitalul Universitar Elias Bucharest, Romania Clinica de Chirugie General IV, Spitalul Universitar Bucuresti, Romania, 00000 RO Clinica de Chirugie Generala I, Spitalul Universitar Bucuresti, Romania, 00000 RO Clinica de Chirugie Generala III, Spitalul Universitar Bucuresti, Romania, 00000 RO Institul Clinic Fundeni Bucuresti, Romania, 00000 RO Spitalul Clinic Colentina Bucuresti, Romania, 00000 RO Spitalul Clinic Coltea Bucuresti, Romania, 00000 RO Spitalul Clinic de Urgenta Floreasca Bucuresti, Romania, 00000 RO Less <<
NCT00375492 Type 2 Diabetes Mellitus Phase 3 Completed - United States, Arizona ... More >> Research Site Peoria, Arizona, United States United States, Florida Research Site Jacksonville, Florida, United States Research Site Orlando, Florida, United States United States, Indiana Research Site Indianapolis, Indiana, United States United States, Massachusetts Research Site Boston, Massachusetts, United States United States, Minnesota Research Site Minneapolis, Minnesota, United States United States, Missouri Research Site St. Louis, Missouri, United States United States, South Carolina Research Site Spartanburg, South Carolina, United States United States, Texas Research Site San Antonio, Texas, United States United States, Washington Research Site Renton, Washington, United States Less <<
NCT02767089 Healthy Adults Phase 1 Completed - United States, Michigan ... More >> Jasper Clinic, Inc. Kalamazoo, Michigan, United States, 49007 Less <<
NCT01543269 Obesity Lipid... More >> Disorders Less << Phase 1 Terminated(Safety concerns) - India ... More >> Zydus Research Centre, Cadila Healthcare Limited Ahmedabad-, Gujarat, India, 382213 Less <<
NCT02009670 Type 2 Diabetes Mellitus ... More >> Obesity Less << Not Applicable Completed - Netherlands ... More >> Maastricht University Maastricht, Netherlands, 6229ER Less <<
NCT00732849 Gastrointestinal Surgery Phase 4 Completed - Poland ... More >> 1st Department of SUegy Krakow, _30978, Poland, 307981 Less <<
NCT00498433 - Terminated(Early termination r... More >>esulted from interim analysis of the ALTITUDE trial) Less << - -
NCT01199770 Healthy Appet... More >>ite Less << Not Applicable Active, not recruiting December 1, 2019 United States, Illinois ... More >> Clinical Nutrition Research Center Chicago, Illinois, United States, 60616 Less <<
NCT01073215 Obesity Not Applicable Completed - -
NCT01984762 Obesity Type ... More >>2 Diabetes Bariatric Surgery Less << Not Applicable Recruiting September 2020 Sweden ... More >> Sahlgrenska University Hospital Recruiting Gothenburg, Sweden, SE41345 Contact: Ville R Wallenius, MD, PhD, Assoc Prof    +46313428206    ville.wallenius@gastro.gu.se Less <<
NCT01696591 - Unknown September 2013 Korea, Republic of ... More >> Samsung Medical Center Recruiting Seoul, Korea, Republic of, 135-710 Contact: Duk L. Na, MD, PhD    +82-2-3410-3594    dukna@naver.com Less <<
NCT00283816 Polycystic Ovary Syndrome Phase 3 Completed - United States, New York ... More >> University of Rochester Medical Center Rochester, New York, United States, 14642 Less <<
NCT03624062 Type 1 Diabetes Mellitus Phase 1 Recruiting April 4, 2022 United States, Colorado ... More >> University of Colorado, Denver Recruiting Aurora, Colorado, United States, 80045 Contact: Mara Kinney    303-724-8272    mara.kinney@ucdenver.edu    Contact: Hali Broncucia    303-724-7526    hali.broncucia@ucdenver.edu    Principal Investigator: Peter Gottlieb, MD Less <<
NCT01866657 Hypoxia Not Applicable Unknown December 2014 United States, Ohio ... More >> University Hospitals Case Medical Center Not yet recruiting Cleveland, Ohio, United States, 44126 Principal Investigator: John C Klick, MD          Principal Investigator: Philip Linden, MD          Sub-Investigator: Edwin G Avery, MD          Sub-Investigator: James Rowbottom, MD          Sub-Investigator: Andrew Plante, MD          Sub-Investigator: Howard Nearman, MD, MBA          Sub-Investigator: Nichol.as Pesa, MD          Sub-Investigator: James D Reynolds, PhD Less <<
NCT00283816 - Completed - -
NCT00226330 Diabetes Mellitus, Type 2 Phase 3 Terminated(The development pro... More >>gram has been terminated) Less << - -
NCT00407680 Type 2 Diabetes Mellitus ... More >> Hypertension Less << Phase 4 Unknown March 2009 Japan ... More >> Kitasato University Recruiting 1-15-1 Kitasato Sagamihara, Kanagawa, Japan, 228-8111 Contact: Keiji Tanaka    +81-427-8111 ext 8706    keiji@med.kitasato-u.ac.jp    Principal Investigator: Keiji Tanaka, Keiji Tanaka Less <<
NCT01286155 - Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT01154582 Physiology Nu... More >>trition Less << Not Applicable Completed - France ... More >> Centre de recherche sur volontaires Bobigny, France, 93 Centre de recherche sur Volontaires Nantes, France, 44 Less <<
NCT00196755 Peritoneal Dialysis ... More >> Chronic Kidney Disease Less << Phase 3 Completed - Belgium ... More >> UZ Gasthuisberg Leuven, Belgium, B-3000 Denmark Fredericia Sygehus Fredericia, Denmark, DN-7000 Copenhagen University Hospital Herlev, Denmark, DN-2730 Aarhus University Hospital Århus N, Denmark, DN-8200 France CHRU Clémenceau Caen, France, FR-14033 Italy Ospedale civico e benfratelli Palermo, Italy, IT-90127 Ospedale San Bortolo Vicenza, Italy, IT-36100 Netherlands AMC Amsterdam, Netherlands, NL-1105 AZ Spain Fundacion Jimenez Diaz Madrid, Spain, ES-28040 Hospital Universitario La Paz Madrid, Spain, ES-28046 United Kingdom University Hospital ,Queen Elizabeth Hospital Birmingham, United Kingdom, B15 2TH High Wycombe Hospital Buckinghamshire, United Kingdom, HP11 2TT University of Wales College of Medicine Cardiff, United Kingdom, CF 14 4XN Glasgow Western Infirmary Glasgow, United Kingdom, G11 6NT Royal Hospital The Royal London London, United Kingdom, E1 1BB Milton Keynes General Hospital Milton Keynes, United Kingdom, MK6 5LD The Churchill Hospital, Oxford Radcliffe Hospitals NHS Trust Oxford, United Kingdom, OX3 7LJ Less <<
NCT01370811 Sialorrhoea Phase 2 Completed - United States, Michigan ... More >> QUEST Research Institute Bingham Farms, Michigan, United States, 48025 Less <<
NCT01814046 - Terminated(Investigator left t... More >>he National Institutes of Health (NIH)) Less << - -
NCT01495143 Trauma Not Applicable Completed - -
NCT02660502 Healthy Phase 1 Completed - Germany ... More >> Profil Institut für Stoffwechselforschung GmbH Neuss, Germany, 41460 Less <<
NCT02052089 Tennis Elbow Not Applicable Completed - Korea, Republic of ... More >> CM Chungmu Hospital Seoul, Yeongdeungpo-gu, Korea, Republic of, 150-034 Less <<
NCT01373346 Diabetes Mellitus Type 2 in No... More >>nobese Gastric Cancer Less << Not Applicable Completed - Korea, Republic of ... More >> GangNam Severance Hospital Seoul, Korea, Republic of, 146-92 Less <<
NCT00046462 Diabetes Mellitus Phase 3 Completed - United States, New Jersey ... More >> Aventis Bridgewater, New Jersey, United States, 08807 Less <<
NCT01373346 - Completed - -
NCT01444807 Metastatic Renal Cell Carcinom... More >>a Less << Phase 2 Recruiting September 2019 Italy ... More >> Istituto Tumori Milano Recruiting Milan, Mi, Italy, 20156 Contact: Giuseppe Procopio, MD    +390223902557    Giuseppe.Procopio@istitutotumori.mi.it    Contact: Elena Verzoni, MD    +390223902557    elena.verzoni@istitutotumori.mi.it    Principal Investigator: Giuseppe Procopio, MD          Cinzia Ortega Recruiting Alba, Italy Alessandra Bearz Recruiting Aviano, Italy Alfredo Berruti Recruiting Brescia, Italy Saverio Cinieri Recruiting Brindisi, Italy Francesco Atzori Recruiting Cagliari, Italy Rodolfo Passalaqua Recruiting Cremona, Italy Francesco Di Costanzo Recruiting Firenze, Italy Vincenzo Emanuele Chiuri Recruiting Lecce, Italy Alessandra Mosca Recruiting Novara, Italy Vittorio Gebbia Recruiting Palermo, Italy Enrico Cortesi Recruiting Roma, Italy Francesco Cognetti Recruiting Roma, Italy Contact: Michele Milella          Franco Morelli Recruiting San Giovanni Rotondo, Italy Less <<
NCT01559025 Type 1 Diabetes ... More >> Insulin Dependent Diabetes Juvenile Onset Diabetes Mellitus Autoimmune Diabetes Less << Phase 3 Unknown March 2017 Brazil ... More >> Federal University of São Paulo Recruiting São Paulo, Brazil, 04022-001 Contact: Tatiana Valente    55119614616    valentetati@yahoo.com.br    Contact: Sergio Dib    551197397776    sergio.dib@unifesp.br    Sub-Investigator: Monica Gabbay Less <<
NCT02122146 Neoplasms Phase 1 Terminated(The study was prema... More >>turely discontinued due to a business-related decision on 09-FEB-2016. The decision to terminate the trial was based on the overall results.) Less << - United States, California ... More >> Keck Hospital of USC Los Angeles, California, United States, 90033 LAC&USC Medical Center Los Angeles, California, United States, 90033 USC/Norris Comprehensive Cancer Center / Investigational Drug Services Los Angeles, California, United States, 90033 USC/Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 United States, Colorado Anschutz Cancer Pavilion Aurora, Colorado, United States, 80045 University of Colorado Denver CTO (CTRC) Aurora, Colorado, United States, 80045 University of Colorado Hospital Aurora, Colorado, United States, 80045 United States, Washington Swedish Medical Center Seattle, Washington, United States, 98104 Seattle Cancer Care Alliance Seattle, Washington, United States, 98109 University of Washington Medical Center Seattle, Washington, United States, 98195 Less <<
NCT00695526 Type 2 Diabetes Phase 3 Completed - Taiwan ... More >> outpatient clinic of the Division of Endocrinology and Metabolism in Taichung Veterans General Hospital Taichung, Taiwan, 407 Less <<
NCT02122146 - Terminated(The study was prema... More >>turely discontinued due to a business-related decision on 09-FEB-2016. The decision to terminate the trial was based on the overall results.) Less << - -
NCT01814046 Metastatic Ocular Melanoma ... More >> Metastatic Uveal Melanoma Less << Phase 2 Terminated(Investigator left t... More >>he National Institutes of Health (NIH)) Less << - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT03519529 - Completed - -
NCT01679899 Type 2 Diabetes Mellitus ... More >> Menopause Osteoporosis Osteopenia Less << Phase 4 Completed - Brazil ... More >> Centro de Diabetes Curitiba Curitiba, Parana, Brazil, 80810040 Less <<
NCT01666171 - Unknown - -
NCT01585428 - Completed - -
NCT01961128 Breast Cancer Not Applicable Completed - United States, Massachusetts ... More >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 Less <<
NCT01585428 Cervical Cancer ... More >> Oropharyngeal Cancer Vaginal Cancer Anal Cancer Penile Cancer Less << Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT02903264 - Completed - Brazil ... More >> Bauru School of Dentistry Bauru, Sao Paulo, Brazil, 17012-901 Less <<
NCT03082131 Gut Microbiota ... More >> Metabolism Metabolic Health Less << Not Applicable Recruiting December 2018 United States, California ... More >> Western Human Nutrition Research Center Recruiting Davis, California, United States, 95616 Contact: Ellen L Bonnel, PhD    530-752-4184    ellen.bonnel@ars.usda.gov    Principal Investigator: Nancy L Keim, PhD Less <<
NCT02111863 - Terminated(Study terminated du... More >>e to low accrual and change in research focus.) Less << - -
NCT02298790 Overweight Ob... More >>esity Prediabetes Meals Less << Not Applicable Recruiting April 2019 United States, Massachusetts ... More >> Brigham and Women's Hospital Recruiting Boston, Massachusetts, United States, 02115 Contact: Su Wei Heng    617-525-8655    sheng@bwh.harvard.edu    Contact: Nina Vujovic, PhD    617-278-0703    nvujovic@bwh.harvard.edu    Principal Investigator: Frank AJL Scheer, PhD Less <<
NCT02111863 Melanoma Skin... More >> Cancer Less << Phase 2 Terminated(Study terminated du... More >>e to low accrual and change in research focus.) Less << - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT01561482 Prostate Carcinoma Phase 2 Withdrawn(Study closed due to ... More >>slow/low enrollment; no subjects were enrolled.) Less << - United States, Texas ... More >> Baylor College of Medicine Houston, Texas, United States, 77030 Ben Taub General Hospital Houston, Texas, United States, 77030 Michael E. Debakey Veterans Affairs Medical Center Houston, Texas, United States, 77030 Less <<
NCT00570492 Rhinitis, Allergic, Perennial Phase 4 Completed - -
NCT00364403 Overweight Pr... More >>egnancy Less << Not Applicable Completed - United States, Massachusetts ... More >> Children's Hospital Boston Boston, Massachusetts, United States, 02115 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States Less <<
NCT00570492 - Completed - -
NCT01700868 Diabetes Mellitus, Type 2 Not Applicable Completed - United States, District of Col... More >>umbia Physicians Committee for Responsible Medicine Washington, District of Columbia, United States, 20016 Less <<
NCT02157155 Ketoacidosis ... More >>Diabetes Mellitus Type 1 Less << Not Applicable Completed - Denmark ... More >> Aarhus University Hospital Aarhus, Denmark, 8000 Less <<
NCT03211624 - Recruiting December 31, 2023 Netherlands ... More >> Dept of Medicine, Division of Endocrinology, and Center for Endocrine Tumors, Leiden University Medical Center Enrolling by invitation Leiden, Netherlands Spain Dept of Endocrinology, Hospital Sant Pau Recruiting Barcelona, Spain Contact: Susan Webb, MD, PhD       SWebb@santpau.cat    Sweden Sahlgrenska University Hospital Enrolling by invitation Gothenburg, Sweden, 41345 Less <<
NCT00379548 Diabetes Insu... More >>lin Resistance Inflammation Cardiovascular Disease Periodontal Disease Less << Not Applicable Completed - United States, Massachusetts ... More >> Joslin Diabetes Center Boston, Massachusetts, United States, 02215 Less <<
NCT02584582 Type 1 Diabetes Phase 2 Phase 3 Unknown - -
NCT01399346 Type 1 Diabetes Phase 1 Completed - Austria ... More >> Medical University of Graz Graz, Austria, 8036 Less <<
NCT01797211 Cardiovascular Diseases Phase 4 Completed - Italy ... More >> Section of Cardiovascular Diseases, Department of Emergency and Organ Transplantation, University of Bari Bari, Italy, 70124 Less <<
NCT02882477 Diabetes Mellitus ... More >> Iron Metabolism Disorders Gastroduodenal Ulcer Optic Atrophy Sensorineural Hearing Loss Platelet Dysfunction Less << Phase 2 Phase 3 Unknown December 2018 Israel ... More >> Hadassah medical center Recruiting Jerusalem, Israel Contact: David Zangen, Professor    0097507874488    zanegnd@hadassah.org.il    Contact: Ulla Najwa Abdulhag, MD    0097505172866    najwa.ped@gmail.com Less <<
NCT03394664 Obesity Not Applicable Recruiting July 2021 United States, Massachusetts ... More >> Warren Conference Center and Inn Recruiting Ashland, Massachusetts, United States, 01721 Less <<
NCT01479673 Mechanical Ventilation Complic... More >>ation Less << Not Applicable Unknown December 2014 Israel ... More >> Rabin Medical Center, Campus Beilinson Recruiting Petach Tikva, Israel, 49100 Contact: Pierre Singer, Professor ,MD    972-39376521    psinger@clalit.org.il    Contact: Milana Grinev, Study Coordinator    972-39376590    milang@clalit.org.il    Sub-Investigator: Ilya Kagan, MD          Sub-Investigator: Ronit Anbar, RD Less <<
NCT01968330 Obesity Sleep... More >> Disordered Breathing Weight Loss Postpartum Insomnia Less << Not Applicable Completed - United States, Florida ... More >> Tampa General Hospital Genesis Clinic Tampa, Florida, United States, 33610 Less <<
NCT01509742 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 1 Completed - Germany ... More >> Novo Nordisk Investigational Site Bad Lauterberg, Germany, 37431 Less <<
NCT02061267 Metabolic Syndrome Not Applicable Unknown December 2014 Spain ... More >> Instituto de la Grasa, CSIC Seville, Spain, 41012 Less <<
NCT00621140 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT00621140 - Completed - -
NCT02868788 Type 2 Diabetes Not Applicable Recruiting July 2018 United States, New York ... More >> ECMC Ambulatory Center, 3rd Floor Recruiting Buffalo, New York, United States, 14215 Contact: Paresh Dandona, MD    716-898-1940    pdandona@kaleidahealth.org    Contact: Jeanne Hejna, LPN    716-898-1944    jeannehe@buffalo.edu Less <<
NCT03279263 Type 2 Diabetes Mellitus Phase 2 Recruiting September 2019 United States, California ... More >> National Research Institute Recruiting Los Angeles, California, United States, 90057 Contact: Juan Frias, MD Less <<
NCT00761267 - Completed - -
NCT00224445 HIV Infections Phase 4 Completed - United States, California ... More >> Gilead Sciences, Inc. Foster City, California, United States, 94403 Less <<
NCT01712061 Diabetic Nephropathy Phase 2 Completed - -
NCT00761267 Candidemia Phase 3 Completed - -
NCT01686945 Diabetes Diab... More >>etes Mellitus, Type 2 Healthy Less << Phase 1 Completed - Germany ... More >> Novo Nordisk Investigational Site Berlin, Germany, 14050 Less <<
NCT00590070 Myocardial Infarction Phase 2 Phase 3 Completed - Italy ... More >> Dipartimento Medicina Cardiovascolare Rome, Italy, 00100 Less <<
NCT00331279 Polycystic Ovary Syndrome Phase 1 Completed - United States, New York ... More >> Center for Women's Reproductive Care New York, New York, United States, 10019 Less <<
NCT01712061 - Completed - -
NCT00256867 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT01679158 Obesity Not Applicable Completed - Spain ... More >> Centro Medico Barcelona, Catalonia, Spain, 08022 Less <<
NCT01968369 Endothelial Dysfunction Not Applicable Active, not recruiting December 2018 Italy ... More >> University of Verona Verona, Italy, 37134 Less <<
NCT02794792 Type 2 Diabetes Mellitus Phase 3 Completed - Russian Federation ... More >> Site RU70011 Moscow, Russian Federation, 117036 Site RU70005 Moscow, Russian Federation, 119034 Site RU70003 Moscow, Russian Federation, 121374 Site RU70009 Moscow, Russian Federation, 125315 Site RU70010 Nizhniy Novgorod, Russian Federation, 603018 Site RU70006 Samara, Russian Federation, 443067 Site RU70004 Saratov, Russian Federation, 410012 Site RU70008 St. Petersburg, Russian Federation, 191119 Site RU70014 St. Petersburg, Russian Federation, 194354 Site RU70007 St. Petersburg, Russian Federation, 197022 Site RU70002 St. Petersburg, Russian Federation, 197706 Site RU70015 Volgograd, Russian Federation, 400001 Site RU70001 Yaroslavl, Russian Federation, 150003 Site RU70013 Yaroslavl, Russian Federation, 150062 Less <<
NCT03660683 Diabetes Mellitus, Type 2 ... More >> Cardiovascular Diseases Less << Phase 4 Recruiting July 1, 2020 United States, District of Col... More >>umbia The GW Medical Faculty Associates Recruiting Washington, District of Columbia, United States, 20037 Contact: Hassan Awal, MD       hawal@mfa.gwu.edu Less <<
NCT02346331 Sepsis Severe... More >> Sepsis Septic Shock Less << Not Applicable Completed - Kenya ... More >> Moi Teaching and Referral Hospital Eldoret, Kenya Less <<
NCT03609775 Healthy Phase 1 Completed - Netherlands ... More >> Centre For Human Drug Research Leiden, Netherlands, 2333 Less <<
NCT01691846 Diabetes Mellitus Type 2 Phase 3 Completed - -
NCT00371826 Renal Transplanted Recipients Phase 4 Completed - Australia ... More >> Royal Prince Alfred Hospital NSW, Australia Westmead Hospital NSW, Australia Princess Alexandra Hospital QLD, Australia Monash Medical Centre Sale, Australia Queen Elizabeth Hospital Sale, Australia Royal Melbourne Hospital VIC, Australia Sir Charles Gairdner Hospital WA, Australia Less <<
NCT00371826 - Completed - -
NCT01691989 Diabetes Mellitus Type 2 Phase 3 Completed - -
NCT01691755 Diabetes Mellitus Type 2 Phase 3 Completed - -
NCT03490097 Chronic Hepatitis c ... More >> Metabolic Syndrome Less << Phase 2 Phase 3 Completed - Egypt ... More >> Kobri El koba Armed Forces Hospital Cairo, Egypt Less <<
NCT00256867 - Completed - -
NCT02644486 Obesity and Glomerulopathy Not Applicable Terminated(difficulty in enrol... More >>lment) Less << - China, Jiangsu ... More >> Research Institute of Nephrology, Jinling Hospital, Nanjing University School of Medicine Nanjing, Jiangsu, China, 210002 Less <<
NCT02499289 - Active, not recruiting November 2018 Egypt ... More >> Faculty of Medicine, Ain Shams University Cairo, Al Qahirah, Egypt Less <<
NCT01814904 Chronic Kidney Disease ... More >> Dialysis Hyperphosphatemia Paediatric Less << Phase 3 Terminated(This study has been... More >> terminated because of insufficient patient recruitment.) Less << - United Kingdom ... More >> Investigational site London, United Kingdom Less <<
NCT00800410 Diabetes Mellitus Phase 2 Completed - United States, Michigan ... More >> Community Health and Social Services (CHASS) Detroit, Michigan, United States, 48209 Less <<
NCT02827708 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT00204412 Metabolic Syndrome ... More >> Osteoporosis Less << Phase 3 Completed - Canada, Saskatchewan ... More >> University of Saskatchewan Saskatoon, Saskatchewan, Canada, S7N 5B2 Less <<
NCT03674866 - Enrolling by invitation January 18, 2019 Canada, Quebec ... More >> Novo Nordisk Investigational Site Montreal, Quebec, Canada, H4A 3T2 Less <<
NCT03596177 Diabetes Mellitus, Type II ... More >> Obesity Less << Phase 2 Recruiting June 10, 2019 United Kingdom ... More >> Research Site Recruiting Cambridge, United Kingdom, CB2 0QQ Less <<
NCT02191644 Prediabetes T... More >>ype-2 Diabetes Less << Phase 2 Completed - Korea, Republic of ... More >> Yonsei University Seoul, Korea, Republic of, 120-749 Less <<
NCT02092753 Quality of Life Not Applicable Completed - Germany ... More >> Rehaklinik Am Kurpark Bad Kissingen, Baden-Württemberg, Germany, 97688 Less <<
NCT01554618 Children and Adolescent With T... More >>ype 2 Diabetes Less << Phase 3 Recruiting June 29, 2023 -
NCT01530854 - Completed - United States, Ohio ... More >> Cleveland Clinic Cleveland, Ohio, United States, 44195 Less <<
NCT03766399 Asthma Phase 1 Recruiting December 5, 2019 United Kingdom ... More >> Research Site Recruiting Harrow, United Kingdom, HA1 3UJ Research Site Not yet recruiting Manchester, United Kingdom, M23 9GP Less <<
NCT03038789 - Recruiting January 31, 2020 Korea, Republic of ... More >> Research Site Recruiting Busan, Korea, Republic of Research Site Recruiting ChungCheong, Korea, Republic of Research Site Recruiting DaeGu, Korea, Republic of Research Site Recruiting DaeJeon, Korea, Republic of Research Site Recruiting GyeongGi, Korea, Republic of Research Site Active, not recruiting GyeongGi, Korea, Republic of Research Site Recruiting Seoul, Korea, Republic of Research Site Withdrawn Seoul, Korea, Republic of Research Site Recruiting WonJu, Korea, Republic of Less <<
NCT02870075 Adipose Tissue Gene Expression Not Applicable Completed - -
NCT03456219 Shift Work Type Circadian Rhyt... More >>hm Sleep Disorder Less << Not Applicable Completed - Brazil ... More >> Cibele Aparecida Crispim Uberlândia, Minas Gerais, Brazil, 38405-320 Less <<
NCT02211963 Diabetes Mellitus, Type 2 Phase 1 Completed - -
NCT02348372 Anaemia Phase 1 Completed - Australia, New South Wales ... More >> GSK Investigational Site Randwick, Sydney, New South Wales, Australia, 2031 Less <<
NCT02085109 Cardiovascular Diseases Not Applicable Completed - Netherlands ... More >> Maastricht University Hospital Maastricht, Netherlands, 6202 Less <<
NCT00736099 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT00330967 - Completed - United States, Arizona ... More >> Phoenix VA Health Care System Carl T. Hayden VA Medical Center, Phoenix, AZ Phoenix, Arizona, United States, 85012 Less <<
NCT00330967 - Completed - -
NCT01349478 Motor Complete Spinal Cord Inj... More >>ury Less << Phase 1 Phase 2 Completed - Israel ... More >> Sheba medical center Tel Hashomer, Israel, 52620 Less <<
NCT03385369 Safety Health... More >>y Subjects Less << Phase 1 Completed - United States, California ... More >> Research Site Anaheim, California, United States, 92801 Less <<
NCT01831791 Alopecia Phase 3 Completed - Japan ... More >> GSK Investigational Site Fukuoka, Japan, 812-0025 GSK Investigational Site Osaka, Japan, 530-0057 GSK Investigational Site Osaka, Japan, 532-0003 GSK Investigational Site Tokyo, Japan, 103-0028 GSK Investigational Site Tokyo, Japan, 160-0022 Less <<
NCT03503747 - Recruiting February 2021 United Kingdom ... More >> Oxford University Hospitals NHS Trust Recruiting Oxford, United Kingdom Contact: Manu Vatish, PhD    01865 221009    manu.vatish@obs-gyn.ox.ac.uk Less <<
NCT00867126 Pancreatic Cancer Early Phase 1 Terminated(low accrual) - United States, Texas ... More >> Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas Dallas, Texas, United States, 75390 Less <<
NCT01503047 Overweight Ob... More >>esity Less << Phase 4 Completed - Spain ... More >> Hospital Universitario La Paz Madrid, Spain, 28046 Less <<
NCT01831791 - Completed - -
NCT02731859 - Recruiting January 2019 Germany ... More >> Klinikum Augsburg Recruiting Augsburg, Germany Contact: Heinle          Donau-Ries Klinik Donauwörth Recruiting Donauwörth, Germany Contact: Eberl          St. Martinus Krankenhaus Düsseldorf Recruiting Düsseldorf, Germany, 40215 Contact: Gijbels          Klinikum Forchheim Recruiting Forchheim, Germany Contact: Dewald          Universitätsklinikum Freiburg- Abt. Innere Medizin II Recruiting Freiburg, Germany Contact: Dr. Laubner/Prof. Seufert          Marienhospital Gelsenkirchen Recruiting Gelsenkirchen, Germany Contact: Dederichs          Universitätsmedizin Göttingen Recruiting Göttingen, Germany Contact: Raddatz          Evangelisches Krankenhaus Köln-Weyertal Recruiting Köln, Germany Contact: Loeff          Krankenhaus Emmaus-Niesky Recruiting Niesky, Germany Contact: Stengel          Elisabeth Klinikum Schmalkalde Recruiting Schmalkalden, Germany Contact: Jung          Petrus Krankenhaus Wuppertal Recruiting Wuppertal, Germany Contact: Göbel Less <<
NCT02406976 Morbid Obesity Not Applicable Active, not recruiting November 2018 Brazil ... More >> Hospital de Clínicas de Porto Alegre Porto Alegre, Rio Grande do Sul, Brazil, 90035 903 Less <<
NCT01804504 Metabolic Syndrome Not Applicable Unknown October 2013 China, Shanghai ... More >> Changhai Hospital,Second Military Medical University Shanghai, Shanghai, China, 200433 Less <<
NCT03353350 Type 2 Diabetes Mellitus Phase 3 Recruiting August 2020 -
NCT01660191 Hypercholesterolemia Phase 4 Completed - United States, Kansas ... More >> University of Kansas Medical Center Kansas City, Kansas, United States, 66160 Less <<
NCT02490683 Obesity Cardi... More >>ovascular Risk Factors Less << Not Applicable Completed - United States, California ... More >> Loma Linda University School of Public Health Loma Linda, California, United States, 92350 Less <<
NCT01246687 Diabetes Mellitus, Type 2 ... More >> Intervention Studies Behavior Less << Not Applicable Completed - Malaysia ... More >> Hospital Selayang Batu Caves, Selangor, Malaysia, 68100 Hospital Serdang Kajang, Selangor, Malaysia, 43000 Hospital Putrajaya Putrajaya, Wilayah Persekutuan Putrajaya, Malaysia, 62250 Less <<
NCT01999101 Non Alcoholic Fatty Liver Dise... More >>ase Less << Phase 2 Completed - Austria ... More >> Division of Gastroenterology and Hepatology, Department of Internal Medicine III Vienna, Austria, 1090 Less <<
NCT02932826 Diabetes Mellitus, Type 1 Phase 1 Phase 2 Recruiting November 2020 China, Hunan ... More >> Institute of Metabolism and Endocrinology, Second Xiangya Hospital, Central South University Recruiting Changsha, Hunan, China, 410011 Contact: Zhiguang Zhou, MD/PhD    86-731-85292154    zhouzg@hotmail.com Less <<
NCT01235741 Obesity Phase 2 Terminated(Results from previo... More >>us study DFA102 demonstrated neutralizing activity to metreleptin in invitro assay in 2 participants.) Less << - United States, California ... More >> Research Site Greenbrae, California, United States Research Site La Jolla, California, United States United States, Colorado Research Site Denver, Colorado, United States United States, Florida Research Site Winter Park, Florida, United States United States, Illinois Research Site Chicago, Illinois, United States United States, Louisiana Research Site Baton Rouge, Louisiana, United States United States, Maryland Research Site Hyattsville, Maryland, United States United States, Massachusetts Research Site Boston, Massachusetts, United States United States, Missouri Research Site St. Louis, Missouri, United States United States, Montana Research Site Butte, Montana, United States United States, New York Research Site New York, New York, United States United States, Oklahoma Research Site Tulsa, Oklahoma, United States United States, Pennsylvania Research Site Philadelphia, Pennsylvania, United States United States, Texas Research Site Austin, Texas, United States United States, Utah Research Site Salt Lake City, Utah, United States United States, Virginia Research Site Arlington, Virginia, United States Research Site Norfolk, Virginia, United States Research Site Richmond, Virginia, United States Less <<
NCT01235741 - Terminated(Results from previo... More >>us study DFA102 demonstrated neutralizing activity to metreleptin in invitro assay in 2 participants.) Less << - -
NCT01660191 - Completed - -
NCT03465462 Nutritional Disorder ... More >> Hypertension Mineral Deficiency Less << Not Applicable Completed - Poland ... More >> Poznan University of Life Sciences Poznań, Poland, 60-624 Less <<
NCT02328404 - Completed - -
NCT01070212 The Null Hypothesis is That Fo... More >>od Rheology Will Have no Effect on These Indices. The Alternate Hypothesis is That Increased Mechanical Stimulation Will Result in Stronger Satiation/Satiety and Reduced Energy Intake. Further, it is Hypothesized That the Effects of Mastication Will be Less Evident in Obese Compared to Lean Individuals. Less << Not Applicable Completed - United States, Indiana ... More >> Purdue University West Lafayette, Indiana, United States, 17907 Purdue University West Lafayette, Indiana, United States, 47907 Less <<
NCT03713684 Type 2 Diabetes Mellitus Phase 3 Not yet recruiting April 2021 -
NCT02955875 Diabetes Mellitus, Type 2 Not Applicable Completed - -
NCT02328404 Polycystic Ovary Syndrome ... More >> Hypovitaminosis D Less << Phase 3 Completed - Jordan ... More >> King Abdullah University Hospital Irbid, Jordan, 22110 Less <<
NCT01752920 Solid Tumor Phase 1 Phase 2 Active, not recruiting December 2018 United States, Arizona ... More >> Scottsdale, Arizona, United States, 85258 United States, Georgia Atlanta, Georgia, United States, 30322 United States, Michigan Detroit, Michigan, United States, 48201 United States, Nevada Las Vegas, Nevada, United States, 89169 United States, New York Bronx, New York, United States, 10467 United States, Pennsylvania Philadelphia, Pennsylvania, United States, 19104 United States, Texas San Antonio, Texas, United States, 78229 United States, Washington Seattle, Washington, United States, 98109 Italy Milan, Italy, 20133 Padova, Italy, 35128 Pisa, Italy, 56126 Rozzano, Milan, Italy, 20089 Less <<
NCT00372112 Pulmonary Disease, Chronic Obs... More >>tructive Less << Phase 2 Completed - Australia, New South Wales ... More >> GSK Investigational Site Camperdown, New South Wales, Australia, 2050 Australia, Western Australia GSK Investigational Site Nedlands, Western Australia, Australia, 6009 Bulgaria GSK Investigational Site Ruse, Bulgaria, 7000 GSK Investigational Site Sofia, Bulgaria, 1431 GSK Investigational Site Sofia, Bulgaria, 1606 Germany GSK Investigational Site Weinheim, Baden-Wuerttemberg, Germany, 69469 GSK Investigational Site Hannover, Niedersachsen, Germany, 30159 GSK Investigational Site Geesthacht, Schleswig-Holstein, Germany, 21502 Netherlands GSK Investigational Site Breda, Netherlands, 4819 EV GSK Investigational Site Hoorn, Netherlands, 1624 NP New Zealand GSK Investigational Site Auckland, New Zealand, 1005 GSK Investigational Site Tauranga, New Zealand Romania GSK Investigational Site Bucharest, Romania, 050159 GSK Investigational Site Iasi, Romania, 700506 Less <<
NCT02367040 Lymphoma,Non-Hodgkin Phase 3 Recruiting August 28, 2020 -
NCT03552107 - Active, not recruiting April 11, 2019 United States, California ... More >> Scripps Whittier Diabetes Institute San Diego, California, United States, 92121 Less <<
NCT01332708 Overweight Ob... More >>ese Less << Not Applicable Unknown September 2011 -
NCT02767869 Metabolic Syndrome X Phase 2 Completed - Mexico ... More >> Intstituto de Terapeútica Experimental y Clínica. Centro Universitario de Ciencias de la Salud. Universidad de Guadalajara Guadalajara, Jalisco, Mexico, 45037 Less <<
NCT00135460 HIV-Associated Lipodystrophy S... More >>yndrome Less << Phase 4 Unknown - Denmark ... More >> Department of Infectious Diseases, Hvidovre University Hospital Hvidovre, Copenhagen, Denmark, 2650 Department of Infectious Diseases, Aalborg Hospital Aalborg, Denmark Department of Infectious Diseases, Aarhus University Hospital Aarhus, Denmark, 8200 Department of Infectious Diseases, Rigshospitalet Copenhagen, Denmark, 2100 Department of Infectious Diseases, Odense University Hospital Odense, Denmark, 5000 Less <<
NCT03043495 Dexamethasone ... More >> Supraclavicular Brachial Plexus Block Less << Phase 4 Recruiting June 1, 2018 Egypt ... More >> Faculty of medicine, Cairo University teaching hospitals (Kasr Alainy) Recruiting Cairo, Egypt Contact: Eslam A Shawki, M.D    `+201225771017    eslam.ayman@kasralainy.edu.eg Less <<
NCT02505893 Diabetes Mellitus, Type 1 Phase 2 Recruiting May 2018 Italy ... More >> IRCCS San Raffaele Scientific Institute Recruiting Milan, Italy, 20132 Contact: Lorenzo Piemonti, MD       piemonti.lorenzo@hsr.it    Contact: Paola Maffi, MD       paola.maffi@hsr.it    Sub-Investigator: Paola Maffi, MD          Principal Investigator: Emanuele Bosi, MD          Sub-Investigator: Andrea Bolla, MD Less <<
NCT02715661 Cardiovascular Disease Not Applicable Recruiting June 2019 Canada, Ontario ... More >> the University of Western Ontario Recruiting London, Ontario, Canada, N6A 5B9 Contact: Arlene Fleischhauer, RN Less <<
NCT01956838 Obesity Not Applicable Completed - Netherlands ... More >> Maastricht University Medical Center Maastricht, Netherlands Less <<
NCT01910935 Hypertension Not Applicable Completed - Mexico ... More >> Instituto Mexicano del Seguro Social. Morelos. HGR/MF. No, UMF 3, UMF 20, UMF 23 Cuernavaca, Morelos, Mexico, 62000 Less <<
NCT02537470 Type 2 Diabetes Mellitus ... More >> Diabetes Mellitus, Type 2 Less << Phase 2 Completed - United States, Arizona ... More >> Advanced Arizona Clinical Research Tucson, Arizona, United States, 85712 United States, California Long Beach Clinical Trials Long Beach, California, United States, 90806 Long Beach Center for Clinical Research Long Beach, California, United States, 90807 National Research Institute Los Angeles, California, United States, 90057 Orange County Research Center Tustin, California, United States, 92780 Diablo Clinical Research Walnut Creek, California, United States, 94598 United States, Connecticut Chase Medical Research Waterbury, Connecticut, United States, 06708 United States, Florida Medical Research Unlimited Hialeah, Florida, United States, 33012 Progressive Medical Research Port Orange, Florida, United States, 32127 Meridien Research Tampa, Florida, United States, 33634 United States, Nevada eStudySite, Las Vegas Las Vegas, Nevada, United States, 89109 United States, New Jersey Comprehensive Clinical Research Berlin, New Jersey, United States, 08009 United States, New Mexico Albuquerque Clinical Trials, Inc Albuquerque, New Mexico, United States, 87102 United States, South Carolina Mountain View Clinical Research Greer, South Carolina, United States, 29651 United States, Tennessee New Phase Research & Development Knoxville, Tennessee, United States, 37909 United States, Texas Austin Center for Clinical Research Austin, Texas, United States, 78756 Padre Coast Clinical Research Corpus Christi, Texas, United States, 78404 Juno Research, LLC Houston, Texas, United States, 77074 United States, Utah Wasatch Clinical Research Salt Lake City, Utah, United States, 84107 Less <<
NCT01606904 Obesity Hyper... More >>cholesterolemia Diabetes Mellitus, Type 2 Anhedonia Less << Not Applicable Completed - Finland ... More >> Deparment of Internal Medicine, Oulu University Hospital Oulu, Finland Less <<
NCT02537834 Type 2 Diabetes Mellitus Phase 4 Completed - Japan ... More >> Atsuta-ku, Aichi, Japan, 456-0058 Minato-ku, Aichi, Japan, 455-0018 Kisarazu, Chiba, Japan, 292-0038 Annaka, Gunma, Japan, 379-0116 Naka, Ibaraki, Japan, 311-0113 Sagamihara, Kanagawa, Japan, 252-0302 Kasaoka, Okayama, Japan, 714-0043 Shimono, Tochigi, Japan, 329-0433 Adachi-ku, Tokyo, Japan, 123-0845 Chuo-ku, Tokyo, Japan, 103-0027 Mitaka, Tokyo, Japan, 181-0013 Less <<
NCT00372112 - Completed - -
NCT03436316 Asthma Phase 1 Recruiting January 16, 2019 Germany ... More >> Research Site Recruiting Berlin, Germany, 14050 Less <<
NCT01817491 - Completed - -
NCT01817491 Cardiovascular Disease ... More >> Hypercholesterolemia Obesity Fatty Liver Less << Not Applicable Completed - United States, Ohio ... More >> Cleveland Clinic Cleveland, Ohio, United States, 44195 Less <<
NCT02103517 Suboptimal Health Status Phase 3 Completed - China, Beijing ... More >> Chinese PLA General Hospital Beijing, Beijing, China, 100853 China, Heilongjiang First Affiliated Hospital of Harbin Medical University Harbin, Heilongjiang, China, 150001 China, Sichuan Sichuan Province People's Hospital Chengdu, Sichuan, China, 610000 Less <<
NCT00532155 Carcinoma Non... More >> Small Cell Lung Less << Phase 3 Completed - -
NCT01798238 Type 2 Diabetes Mellitus Phase 3 Completed - Korea, Republic of ... More >> Handok INC Seoul, Gangnam-Gu, Korea, Republic of Handok Pharmaceuticals CO. LTD Seoul, Korea, Republic of Less <<
NCT00532155 - Completed - -
NCT02183922 Insulin Resistance ... More >> Oxidative Stress Lipid Profile Blood Pressure Anthropometric Measure Less << Not Applicable Completed - Brazil ... More >> Universidade Federal do Rio de Janeiro Rio de Janeiro, Brazil, 21941-902 Less <<
NCT02230501 Type 2 Diabetes Mellitus Not Applicable Recruiting December 2020 Germany ... More >> West German Centre of Diabetes and Health Recruiting Düsseldorf, Germany, 40591 Contact: Stephan Martin, MD    +49(0)211-5660360 ext 70    martin@wdgz.de    Contact: Kerstin Kempf, PhD    +49(0)211-5660360 ext 16    kerstin.kempf@wdgz.de    Principal Investigator: Stephan Martin, MD Less <<
NCT03406663 Type 2 Diabetes Mellitus Not Applicable Recruiting September 2020 Korea, Republic of ... More >> Seoul National University Hospital Recruiting Seoul, Korea, Republic of, 110-744 Contact: Young Min Cho, MD, PHD    82-2-2072-1965    ymchomd@snu.ac.kr Less <<
NCT00857376 Metabolic Syndrome Phase 2 Completed - -
NCT02330848 Diabetes Not Applicable Completed - United States, Connecticut ... More >> Yale-Griffin Prevention Research Center Derby, Connecticut, United States, 06418 Less <<
NCT01140282 Stage I Breast Cancer ... More >> Stage II Breast Cancer Stage IIIA Breast Cancer Stage IIIB Breast Cancer Stage IIIC Breast Cancer Less << Not Applicable Active, not recruiting May 21, 2020 United States, California ... More >> USC Norris Comprehensive Cancer Center Los Angeles, California, United States, 90089 Less <<
NCT02029066 Actinic Keratosis Phase 1 Completed - Taiwan ... More >> National Cheng Kung University Hospital Tainan, Taiwan, 70403 Less <<
NCT03495986 Spinal Cord Injuries ... More >> Metabolic Syndrome Dietary Modification Paraplegia Tetraplegia Less << Not Applicable Not yet recruiting July 2022 United States, Pennsylvania ... More >> Milton S. Hershey Medical Center Recruiting Hershey, Pennsylvania, United States, 17033 Contact: Research Coordinator    717-531-0003 ext 283816    PMR_Research@pennstatehealth.psu.edu Less <<
NCT03435276 Healthy Volunteers Phase 1 Completed - United Kingdom ... More >> Research Site Harrow, United Kingdom, HA1 3UJ Less <<
NCT00386386 Mass Casualty Incident ... More >> Dehydration Less << Phase 3 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT01705782 Febrile Illness Acute ... More >> Inflammation Metabolic Diseases Less << Not Applicable Completed - Denmark ... More >> Medical Department MEA, NBG, Aarhus University Hospital Aarhus C, Jylland, Denmark, 8000 Less <<
NCT01301196 Type 2 Diabetes Mellitus Not Applicable Unknown March 2012 United Kingdom ... More >> University Hospitals of Leicester Recruiting Leicester, Leics, United Kingdom Contact: Emma Wilmott, MB ChB       Emma.Wilmot@uhl-tr.nhs.uk    Sub-Investigator: Stuart Biddle, PhD          Principal Investigator: Melanie Davies, MD Less <<
NCT00453934 Type 1 Diabetes ... More >> Type 2 Diabetes Less << Phase 4 Terminated(Endpoint no longer ... More >>deemed meaningful) Less << - United States, Texas ... More >> Diabetes and Glandular Research San Antonio, Texas, United States, 78229 Less <<
NCT01978925 Medication Adherence ... More >> Hypertension Diabetes Mellitus Less << Not Applicable Completed - Brazil ... More >> Emergency Department - Hospital Moinhos de Vento Porto Alegre, Rio Grande do Sul, Brazil, 900350-001 Less <<
NCT02363816 - Withdrawn - -
NCT03453060 Thrombosis Phase 1 Active, not recruiting November 2018 United States, Arizona ... More >> Celerion Tempe, Arizona, United States, 85283 Less <<
NCT03612856 End Stage Renal Disease ... More >> Thrombosis Less << Phase 2 Recruiting May 2020 United States, Florida ... More >> Orlando Clinical Research Center Recruiting Orlando, Florida, United States, 32809 Contact: Charles Johnson    407-240-7876 Less <<
NCT02524184 Obesity Phase 4 Unknown September 2016 China, Hubei ... More >> Wuhan General Hospital Recruiting Wuhan, Hubei, China, 430070 Contact: Guangda Xiang, MD    13517275283    Guangda64@hotmail.com    Contact: Lin Xiang, MD    18627838901    xianglin832010@hotmail.com Less <<
NCT03165591 Pancreatic Cancer Non-resectab... More >>le Less << Phase 1 Phase 2 Recruiting December 31, 2020 Mongolia ... More >> Immunitor LLC Recruiting Ulaanbaatar, Mongolia Contact: Aldar Bourinbaiar, MD    97695130306    aldar@immunitor.com    Contact: Marina Tarakanovskaya, MD       marinatarakanovskaya@yahoo.com    Principal Investigator: Chinburen Jigjidsuren, MD          National Cancer Center Enrolling by invitation Ulaanbaatar, Mongolia Less <<
NCT01234506 Oxidative Stress ... More >> Inflammation Aging Dementia Pain Less << Phase 2 Completed - Canada, Saskatchewan ... More >> Saskatoon Health Region Saskatoon, Saskatchewan, Canada, S7K 5T6 Less <<
NCT01084928 Diabetes Obes... More >>ity Less << Not Applicable Completed - United States, Georgia ... More >> Emory University Atlanta, Georgia, United States, 30322 Less <<
NCT01041547 - Completed - United States, Alabama ... More >> University of Alabama Birmingham, Alabama, United States, 35243 Less <<
NCT03593785 Hypercholesterolemia Phase 1 Recruiting July 23, 2019 United States, California ... More >> Research Site Recruiting Glendale, California, United States, 91206 Less <<
NCT01618513 Acromegaly Phase 4 Completed - Denmark ... More >> Department of Endocrinology, Aarhus University Hospital Aarhus C, Denmark, 8000 Less <<
NCT03291249 NASH - Nonalcoholic Steatohepa... More >>titis NAFLD T2DM (Type 2 Diabetes Mellitus) Less << Phase 2 Not yet recruiting June 1, 2019 -
NCT02068872 Obesity Cardi... More >>ovascular Disease Type 2 Diabetes Hypertension Complication of Transplant Less << Phase 1 Completed - United States, Illinois ... More >> Northwestern University Chicago, Illinois, United States, 60611 Less <<
NCT02689882 Metabolic Disturbance Phase 1 Completed - United States, Washington ... More >> University of Washington Seattle, Washington, United States, 98195 Less <<
NCT03400488 Coronary Artery Disease Phase 1 Completed - United States, California ... More >> Research Site Glendale, California, United States, 91206 Less <<
NCT02488213 Type 2 Diabetes Mellitus Not Applicable Unknown December 2017 Brazil ... More >> Hospital de Clínicas de Porto Alegre Recruiting Porto Alegre, Rio Grande do Sul, Brazil, 90035-003 Contact: Juliana P Antonio    + 55 51 3359 8530    juantonio@hcpa.edu.br Less <<
NCT03217630 - Recruiting July 3, 2018 China, Sichuan ... More >> West China Hospital Recruiting Chengdu, Sichuan, China, 610041 Contact: Chunling Jiang, Doctor    18980601096    jiang_chunling@yahoo.com Less <<
NCT02963922 Metabolism and Nutrition Disor... More >>der Obesity Less << Phase 3 Completed - -
NCT00143247 Diabetes Mellitus Phase 2 Terminated(See termination rea... More >>son in detailed description.) Less << - United States, California ... More >> Pfizer Investigational Site San Diego, California, United States, 92123 United States, Connecticut Pfizer Investigational Site New Haven, Connecticut, United States, 06504 United States, Florida Pfizer Investigational Site Miami, Florida, United States, 33136 United States, Illinois Pfizer Investigational Site Chicago, Illinois, United States, 60610 United States, New Mexico Pfizer Investigational Site Albuquerque, New Mexico, United States, 87131-5666 United States, North Carolina Pfizer Investigational Site Durham, North Carolina, United States, 27710 Pfizer Investigational Site Winston Salem, North Carolina, United States, 27157 United States, Texas Pfizer Investigational Site Austin, Texas, United States, 78752 Pfizer Investigational Site Austin, Texas, United States, 78758 Pfizer Investigational Site Dallas, Texas, United States, 75230 Pfizer Investigational Site Dallas, Texas, United States, 75243 Pfizer Investigational Site San Antonio, Texas, United States, 78229 Less <<
NCT02161094 Type 2 Diabetes Not Applicable Unknown March 2016 China, Shanghai ... More >> Ruijin hospital, Shanghai Jiao-Tong University School of Medicine Shanghai, Shanghai, China, 200025 Less <<
NCT02062359 Metastatic Cancer ... More >> Metastatic Melanoma Less << Phase 2 Terminated(Study was closed du... More >>e to poor accrual.) Less << - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT01112683 Down Syndrome Phase 4 Completed - United States, Colorado ... More >> The Children's Hospital Aurora, Colorado, United States, 80045 Less <<
NCT02062359 - Terminated(Study was closed du... More >>e to poor accrual.) Less << - -
NCT02638805 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT01112683 - Completed - -
NCT01677208 Acute Stroke Phase 4 Recruiting June 2019 -
NCT00707460 Type 2 Diabetes Mellitus ... More >> Cardiovascular Disease Obesity Less << Phase 1 Completed - Canada, Ontario ... More >> Sandy Lake Health & Diabetes Project Research Office Sandy Lake, Ontario, Canada, P0V 1V0 Less <<
NCT02000219 Primary Hyperoxaluria Phase 2 Active, not recruiting February 2020 Germany ... More >> Universitätsklinikum Bonn, Department of Paediatric Nephrology Bonn, Germany, DE-53113 Less <<
NCT02787668 Non-alcoholic Fatty Liver Dise... More >>ase Childhood Obesity Insulin Resistance Less << Not Applicable Completed - United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35223 Less <<
NCT00458133 Type 2 Diabetes Not Applicable Completed - United States, Louisiana ... More >> Pennington Biomedical Research Center Baton Rouge, Louisiana, United States, 70817 Less <<
NCT00778622 Type 2 Diabetes Mellitus Phase 4 Completed - China, Beijing ... More >> Local Institution Beijing, Beijing, China, 100028 Local Institution Beijing, Beijing, China, 100034 Local Institution Beijing, Beijing, China, 100044 Local Institution Beijing, Beijing, China, 100088 Local Institution Beijing, Beijing, China, 100730 Local Institution Beijing, Beijing, China, 101100 Local Institution Beijing, Beijing, China, 200016 China, Guangdong Local Institution Guangdong Province, Guangdong, China, 510180 Local Institution Guangdong Province, Guangdong, China, 528000 Local Institution Guangdong, Guangdong, China, 510180 China, Shanghai Local Institution Shanghai, Shanghai, China, 200003 Local Institution Shanghai, Shanghai, China, 200092 Local Institution Shanghai, Shanghai, China, 201100 Local Institution Shanghai, Shanghai, China, 201200 Less <<
NCT01823367 Gestational Diabetes Mellitus ... More >> Pre-diabetes Less << Not Applicable Completed - United States, Indiana ... More >> Indiana University School of Medicine Indianapolis, Indiana, United States, 46202 Less <<
NCT00143247 - Terminated(See termination rea... More >>son in detailed description.) Less << - -
NCT00778622 - Completed - -
NCT02568891 End-stage Renal Disease Not Applicable Withdrawn(No funding obtained) January 2021 Austria ... More >> Department of Internal Medicine, Medical University of Graz Graz, Austria, 8010 Less <<
NCT02360956 Coronary Atherosclerosis Phase 4 Unknown June 2016 China ... More >> Chinese PLA General Hospital Recruiting Beijing, China, 100853 Contact: Chen Yundai    86-10-55499246    cyundai301@126.com Less <<
NCT02405260 Diabetes Mellitus, Type 2 Phase 2 Completed - United States, Arizona ... More >> Mesa, Arizona, United States, 85213 Tuscon, Arizona, United States, 85741 United States, California Canoga Park, California, United States, 91303 Huntington Park, California, United States, 90255 Los Angeles, California, United States, 90056 West Hills, California, United States, 91307 United States, Colorado Centennial, Colorado, United States, 80112 Littleton, Colorado, United States, 80127 United States, Connecticut Waterbury, Connecticut, United States, 06708 United States, Florida West Palm Beach, Florida, United States, 33409 United States, Illinois Gurnee, Illinois, United States, 60031 United States, Indiana Evansville, Indiana, United States, 47725 United States, Minnesota Rochester, Minnesota, United States, 55905 United States, North Carolina Greensboro, North Carolina, United States, 27408 United States, South Carolina Moncks Corner, South Carolina, United States, 29461 United States, Texas San Antonio, Texas, United States, 78209 San Antonio, Texas, United States, 78229 Schertz, Texas, United States, 78154 United States, Virginia Norfolk, Virginia, United States, 23507 United States, Washington Richland, Washington, United States, 99352 Less <<
NCT01762826 - Unknown September 2013 -
NCT02612805 Diabetes Mellitus, Type 2 Not Applicable Completed - -
NCT01217944 Pathological Myopia Phase 3 Completed - -
NCT03732209 Type 2 Diabetes Phase 1 Phase 2 Not yet recruiting July 31, 2020 United States, Virginia ... More >> Virginia Tech Carilion Research Institute Roanoke, Virginia, United States, 24016 Less <<
NCT01675713 Morbid Obesity Not Applicable Completed - Norway ... More >> Norwegian School of Sport Sciences Oslo, Norway, 0806 Less <<
NCT01872273 - Withdrawn(Project never funded... More >>. No subjects were recruited.) Less << - -
NCT01443156 - Completed - United States, Oregon ... More >> St. Charles Medical Center Bend, Oregon, United States, 97701 Less <<
NCT01217944 - Completed - -
NCT02528162 - Recruiting June 2019 Belgium ... More >> UZ Leuven Recruiting Leuven, Belgium, 3000 Contact: Katrien Benhalima    474677153    katrien.benhalima@uzleuven.be Less <<
NCT02176395 Acute Stroke Phase 4 Suspended - China, Liaoning ... More >> 202 Military Hospital of China Shenyang, Liaoning, China Less <<
NCT00819104 Primary Hypertension Phase 4 Completed - India ... More >> Research Site Hyderabad, Andhra Pradesh, India Research Site Ahmedabad, Gujarat, India Research Site Bangalore, Karnataka, India Research Site Calicut, Kerala, India Research Site Mumbai, Maharashtra, India Research Site Poona, Maharashtra, India Research Site Jaipur, Rajasthan, India Research Site Lucknow, Uttar Pradesh, India Research Site Kolkata, West Bengal, India Research Site Bangalore, India Research Site Delhi, India Less <<
NCT01070199 High and Increasing Contributi... More >>on of Energy From Beverages in the Diet May Enhance Positive Energy Balance and Weight Gain Less << Not Applicable Completed - United States, Indiana ... More >> Purdue University West Lafayette, Indiana, United States, 47907 Less <<
NCT02080325 Obesity Not Applicable Completed - United Kingdom ... More >> Rowett Institute of Nutrition and Health, University of Aberdeen Aberdeen, United Kingdom, AB21 9SB Less <<
NCT00817427 Chronic Kidney Disease Not Applicable Completed - United States, Illinois ... More >> The University of Chicago Chicago, Illinois, United States, 60637 Less <<
NCT01106625 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT02973412 - Recruiting June 2021 United Kingdom ... More >> Leicester Diabetes Centre, Leicester General Hospital Recruiting Leicester, United Kingdom, LE5 4PW Contact: Lois Daniels    0116 258 8070    Lois.J.Daniels@uhl-tr.nhs.uk    Contact: Emer Brady    0116 258 8959    Emer.Brady@uhl-tr.nhs.uk Less <<
NCT01855763 Gestational Diabetes ... More >> Type 2 Diabetes Pregnancy Less << Phase 2 Phase 3 Unknown December 2013 -
NCT00736099 - Completed - -
NCT00958269 Type 2 Diabetes Mellitus ... More >> Renal Impairment Less << Phase 3 Terminated(Technical/operation... More >>al issues) Less << November 2011 -
NCT01137812 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT01137812 - Completed - -
NCT00238472 Diabetes Mellitus, Type 2 Phase 4 Completed - -
NCT01518101 Type 2 Diabetes Phase 4 Completed - Germany ... More >> Novartis Investigative Site Berlin, Germany, 10115 Novartis Investigative Site Berlin, Germany, 13055 Novartis Investigative Site Dortmund, Germany, 44137 Novartis Investigative Site Falkensee, Germany, 14612 Novartis Investigative Site Meissen, Germany, 01662 Novartis Investigative Site Neunkirchen, Germany, 57290 Novartis Investigative Site Saarlouis, Germany, 66740 Novartis Investigative Site Völlkingen, Germany, 66333 Less <<
NCT01106625 - Completed - -
NCT00824330 Cardiovascular ... More >> Diabetes Orthostatic Hypotension Type 2 Diabetes Less << Not Applicable Completed - Canada, British Columbia ... More >> VITALiTY Research Centre - VGH Research Pavilion Vancouver, British Columbia, Canada, V5Z 1M9 Dr. Scott Lear's Lab, Simon Fraser University, Harbour Vancouver, British Columbia, Canada, V6B 5K3 Less <<
NCT00687453 Type 2 Diabetes Mellitus Phase 4 Completed - United States, California ... More >> Charles Drew University of Medicine and Science Los Angeles, California, United States, 90059 Less <<
NCT00687453 - Completed - -
NCT01861080 - Recruiting December 2019 Korea, Republic of ... More >> Hallym University Dongtan Sacred Heart Hospital, Recruiting Hwaseong, Gyeonggido, Korea, Republic of, 445-170 Contact: Kyu-Hyung Ryu, MD, PhD    +82-31-8086-2827    khryumd@hanmail.net    Contact: Suk-Won Choi, MD    +82-31-8086-2538    swchoi97@gmail.com    Principal Investigator: Kyu-Hyung Ryu, MD, PhD Less <<
NCT00740051 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT00740051 - Completed - -
NCT01542424 - Completed - Macedonia, The Former Yugoslav... More >> Republic of Novo Nordisk Investigational Site Skopje, Macedonia, The Former Yugoslav Republic of, MK-1000 Less <<
NCT00686972 Bariatric Surgery Phase 2 Terminated(PI left JHU) - United States, Maryland ... More >> Johns Hopkins Bayview Medical Center Baltimore, Maryland, United States, 21224 Less <<
NCT00686972 - Terminated(PI left JHU) - -
NCT01688752 - Withdrawn(Funding unavailable) - -
NCT01275846 Heart Failure Not Applicable Unknown March 2011 United States, Ohio ... More >> University Hospitals Home Care Services Warrensville Heights, Ohio, United States, 44128 Less <<
NCT02054897 - Completed - -
NCT01817439 Atrial Fibrillation Phase 3 Unknown May 2015 Israel ... More >> Western Galilee Hospital Not yet recruiting Naharia, Israel, 972 Contact: Lilach Shema-didi, PhD    507887538 ext 972    lilach.shema-didi@naharia.health.gov.il Less <<
NCT02599272 Cardiometabolic Risk Not Applicable Completed - Singapore ... More >> Clinical Nutrition Research Centre Singapore, Singapore, 117599 Less <<
NCT02614027 - Completed - Spain ... More >> Ramon y Cajal Hospital Madrid, Spain, 28034 Less <<
NCT02146027 HIV Phase 2 Completed - Brazil ... More >> University of Sao Paulo - General Hospital São Paulo, Brazil, 01246-903 Less <<
NCT03070704 - Withdrawn(Request for the stud... More >>y waived by Indian Health Authorities) Less << August 16, 2019 -
NCT01831765 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 3 Completed - -
NCT01831765 - Completed - -
NCT02609373 Breast Cancer Not Applicable Completed - Canada, British Columbia ... More >> University of British Columbia Vancouver, British Columbia, Canada, V6T1Z3 Less <<
NCT01387165 - Completed - -
NCT02634229 - Completed - -
NCT03537235 Overweight and Obesity Not Applicable Recruiting December 31, 2018 Poland ... More >> Metabolic Management Center "LINIA" Recruiting Katowice, Poland, 40-767 Contact: Magdalena Olszanecka-Glinianowicz, MD, PhD Less <<
NCT02212925 Diabetes Mellitus, Type 2 Phase 1 Terminated - -
NCT01516190 Breast Cancer Not Applicable Active, not recruiting September 2020 United States, Massachusetts ... More >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 Less <<
NCT02912455 Diabetes Mellitus, Type 2 ... More >> Obesity Less << Phase 4 Recruiting July 31, 2018 United States, Ohio ... More >> Cleveland Clinic Recruiting Cleveland, Ohio, United States, 44195 Contact: Sangeeta Kashyap, MD    216-445-2679    kashyas@ccf.org    Contact: Mario Scarcipino    216-444-3599    mascar@ccf.org    Principal Investigator: Sangeeta Kashyap, MD Less <<
NCT01993953 Overweight Not Applicable Completed - Norway ... More >> Norwegian School of Sports Sciences Oslo, Norway, 0806 Less <<
NCT02054897 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT02188186 Type 2 Diabetes Phase 4 Completed - Korea, Republic of ... More >> Seoul National University Bundang Hospital Seongnam, Gyeonggi, Korea, Republic of, 463-707 Less <<
NCT01522404 - Completed - -
NCT02801890 Ultra Filtration Failure Phase 1 Phase 2 Completed - Iran, Islamic Republic of ... More >> Royan Institute Tehran, Iran, Islamic Republic of Less <<
NCT01522404 Mild Cognitive Impairment Phase 2 Completed - United States, Georgia ... More >> Emory University School of Medicine Atlanta, Georgia, United States, 30322 Less <<
NCT01511822 PCOS Polycyst... More >>ic Ovary Syndrome Less << Phase 4 Completed - Italy ... More >> Istituto di Patologia Ostetrica e Ginecologica Catania, Italy Less <<
NCT03159299 Type 2 Diabetes Mellitus Not Applicable Recruiting February 28, 2019 United States, Connecticut ... More >> Yale School of Nursing Recruiting Orange, Connecticut, United States, 06477 Contact: Robin Whittemore, PhD          Principal Investigator: R Whittemore, PhD Less <<
NCT00174824 Diabetes Mellitus, Type 2 Phase 4 Completed - United States, New Jersey ... More >> Sanofi-Aventis Administrative Office Bridgewater, New Jersey, United States, 08807 Canada Sanofi-Aventis Administrative Office Laval, Canada Less <<
NCT01087502 - Completed - -
NCT03356106 Sleep Apnea, Obstructive ... More >> Pre-Eclampsia Hypertension, Pregnancy-Induced Less << Not Applicable Recruiting January 31, 2019 Thailand ... More >> Phramongkutklao Hospital Not yet recruiting Bangkok, Thailand, 10400 Contact: Prapun Kittivoravitkul, MD    (66)948951526    prapunn@hotmail.com    Rajavithi Hospital Recruiting Bangkok, Thailand, 10400 Contact: Surasak jantarasaengaram, MD    22003763    surasakjan@yahoo.com    Contact: , MD          Ramathibodi hospital Recruiting Bangkok, Thailand, 10400 Contact: Visasiri Tantrakul, MD    22003763    vtantrakul@gmail.com    Contact: Ammarin Thakkinstian, PhD    022001282    ammarin.tha@mahidol.ac.th Less <<
NCT01087502 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT02127021 Pancreaticoduodenectomy Phase 4 Recruiting December 2018 Korea, Republic of ... More >> Seoul National University Bundang Hospital Recruiting Seongnam, Bundang-gu, Korea, Republic of, 463-707 Contact: Ho‐Seong Han, M.D., PhD.    82-31-787-7091    hanhs@snubh.org    Principal Investigator: Ho‐Seong Han, M.D., PhD.          Sub-Investigator: Yoo-Seok Yoon, M.D., PhD.          Sub-Investigator: Hyun Jin Chun          Center for Liver Cancer, National Cancer Center Recruiting Goyang, Gyeonggi, Korea, Republic of, 410-769 Contact: Sang-Jae Park, M.D., Ph.D.       spark@ncc.re.kr    Principal Investigator: Sang-Jae Park, M.D., PhD.          Dongguk University Ilsan Medical Center Recruiting Goyang, Kyeonggi, Korea, Republic of, 410-773 Contact: In Woong Han, M.D.          Principal Investigator: In Wong Han, M.D.          Department of Surgery, Seoul National University College of Medicine Recruiting Seoul, Korea, Republic of, 110-744 Contact: Jin- Young Jang, M.D., PhD.    82-2-2072-2194    jangjy4@gmail.com    Contact: Wooil Kwon, M.D., PhD.    82-2-2072-2817    willdoc78@gmail.com    Principal Investigator: Jin- Young Jang, M.D., PhD.          Sub-Investigator: Sun- Whe Kim, M.D., PhD.          Sub-Investigator: Eunjung Kim, M.S          Sub-Investigator: Young Min Han, M.S          Sub-Investigator: Wooil Kwon, M.D, PhD.          Chung-Ang University Hospital Recruiting Seoul, Korea, Republic of, 156-755 Contact: Seung Eun Lee, M.D., PhD.          Principal Investigator: Seung Eun Lee, M.D., PhD.          Kangnam Severance Hospital Recruiting Seoul, Korea, Republic of Contact: Dongsup Yoon, M.D, PhD.       YDS6110@yuhs.ac Less <<
NCT01715090 Diabetes Mellitus, Type 2 Not Applicable Completed - Netherlands ... More >> Academic Medical Center Amsterdam, Netherlands Less <<
NCT02227212 Diabetes Mellitus Type 2 Phase 3 Completed - Germany ... More >> Investigational Site Number 276011 Augsburg, Germany, 86150 Investigational Site Number 276008 Berlin, Germany, 10115 Investigational Site Number 276009 Essen, Germany, 45355 Investigational Site Number 276002 Hamburg, Germany, 22607 Investigational Site Number 276001 Münster, Germany, 48145 Investigational Site Number 276007 Potsdam, Germany, 14469 Investigational Site Number 276004 Wangen, Germany, 88239 Less <<
NCT00545233 Hepatitis C, Chronic Phase 4 Completed - -
NCT02334202 Obesity Weigh... More >>t Gain Disordered Eating Eating Disorder Less << Not Applicable Completed - United States, Virginia ... More >> Fort Belvoir Community Hospital Fort Belvoir, Virginia, United States, 22060 Less <<
NCT01677611 Type 2 Diabetes Phase 1 Completed - Singapore ... More >> Alexandra Health, Khoo Teck Puat Hospital Singapore, Singapore, 768828 Less <<
NCT01520818 Diabetes Diab... More >>etes Mellitus, Type 1 Diabetes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT00545233 - Completed - -
NCT03351127 - Recruiting April 2019 -
NCT03208023 Inotropy Flui... More >>d Management Cardiac Event Perioperative Cardiac Risk Vascular Resistance Hemodynamic Monitoring Hemodynamic Management Fluid Responsiveness Less << Not Applicable Recruiting November 1, 2019 United States, Tennessee ... More >> Vanderbilt University Medical Center Recruiting Nashville, Tennessee, United States, 37212 Contact: Matthew D McEvoy, M.D.    615-936-5194    matthew.d.mcevoy@vanderbilt.edu    Contact: Gail Mayo, RN    615-936-1705    gail.mayo@vanderbilt.edu    Sub-Investigator: Adam B King, M.D.          Sub-Investigator: Tracy McGrane, M.D.          Sub-Investigator: Andrew Shaw, MB          Sub-Investigator: Kamran Idrees, M.D. Less <<
NCT01182025 Hand, Foot and Mouth Disease Not Applicable Unknown December 2011 China, Guangxi ... More >> Affiliated Hospital of Guilin Medical College Recruiting Guilin, Guangxi, China, 541001 Contact: Xiong Li    13737728526    yuanyanhui_888@163.com    Principal Investigator: Xiong Li          Liuzhou Worker's Hospital Recruiting Liuzhou, Guangxi, China, 541001 Contact: Liuping Tang    18977228768    yongren126zeng@126.com    Contact: Zhe Guo    13978009767    sdy761212@163.com    Principal Investigator: Liuping Tang          Principal Investigator: Zhe Guo          Liuzhou People's Hospital Recruiting Liuzhou, Guangxi, China, 545001 Contact: Tong Yang    13977286628    zhoubing-1995@163.com    Principal Investigator: Tong Yang          China, Guangzhou Shenzhen Maternity & Child Healthcare Hospital Recruiting Shenzhen, Guangzhou, China, 518028 Contact: Xinying Zou    13129559135    Xuzhiymr@yahoo.com.cn    Principal Investigator: Xinying Zou          China, Jiangxi Jiangxi Provincial Children's Hospital Recruiting Nanchang, Jiangxi, China, 330006 Contact: Qingxiong Zhu    15979003000    Zhuqingxiong2000@163.com    Principal Investigator: Qingxiong Zhu Less <<
NCT02216552 NAFLD TYPE 2 ... More >>DIABETES METABOLIC SYNDROME Less << Phase 2 Phase 3 Completed - Canada, Manitoba ... More >> Children's Hospital Research Institute of Manitoba/University of Manitoba Winnipeg, Manitoba, Canada, R3E 3P4 Less <<
NCT03243383 Diabetes Mellitus Not Applicable Recruiting June 1, 2019 United States, Pennsylvania ... More >> Temple University Hospital Recruiting Philadelphia, Pennsylvania, United States, 19140 Contact: Daniel J Rubin, MD, MSc    215-707-4746    daniel.rubin@tuhs.temple.edu    Contact: Shaneisha Allen    215-707-9731    Shaneisha.Allen@tuhs.temple.edu Less <<
NCT03042234 Obesity Insul... More >>in Resistance Adolescent Less << Not Applicable Not yet recruiting February 2, 2018 Brazil ... More >> Santa Casa of Sao Paulo School Sao Paulo, Brazil, 01221-020 Less <<
NCT03637829 Nutrition Cog... More >>nitive Change Food Intake Control Satiety Less << Not Applicable Recruiting November 1, 2018 Canada, Ontario ... More >> School of Nutrition, Ryerson University Recruiting Toronto, Ontario, Canada, M5B 2K3 Contact: Nick Bellissimo, PhD    416 979 5000 ext 3026    nick.bellissimo@ryerson.ca    Principal Investigator: Nick Bellissimo, PhD Less <<
NCT03336762 - Recruiting August 1, 2020 United Kingdom ... More >> St George's, University of London Recruiting London, United Kingdom, SW17 0RE Contact: Marios C Papadopoulos, MD    0208 7254179    mpapadop@sgul.ac.uk    Contact: Samira Saadoun, PhD    0208 7254179    ssaadoun@sgul.ac.uk Less <<
NCT02690467 Diabetes Mellitus Not Applicable Recruiting July 31, 2017 Italy ... More >> U.O. Malattie Metaboliche e Diabetologia - Ospedale Treviglio Recruiting Treviglio, BG, Italy, 24047 Contact: Antonio Bossi, MD    +39 0363 424261    antonio_bossi@ospedale.treviglio.bg.it    Struttura Semplice Dipartimentale di Diabetologia e Malattie Metaboliche - Az. Osp. S. Anna - PO Cantù Recruiting Mariano Comense, CO, Italy Contact: Luigi Sciangula, MD    +39 031 755355    luigi.sciangula@hsacomo.org    Struttura Semplice Dipartimentale Diabetologia, Endocrinologia e Nutrizione Clinica - Az. Osp. Desio e Vimercate Recruiting Desio, MI, Italy Contact: Giuseppe Marelli, MD    +39 0362383013    giuseppe.marelli@aovimercate.org    Struttura Complessa Dietologia - Diabetologia Malattie Metaboliche - Ospedale Pertini Recruiting Roma, RM, Italy, 00157 Contact: Sergio Leotta, MD    +39 06 41433402    s.leotta@tiscali.it Less <<
NCT01620463 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 1 Completed - Japan ... More >> Novo Nordisk Investigational Site Tokyo, Japan, 1000005 Less <<
NCT02516358 - Unknown September 2016 -
NCT00741559 Epilepsy Phase 3 Completed - Canada, Ontario ... More >> The Hospital for Sick Children Toronto, Ontario, Canada Less <<
NCT02643277 Type 2 Diabetes Mellitus Not Applicable Active, not recruiting December 2018 India ... More >> Dr.A.Ramachandran's Diabetes Hospitals Chennai, Tamil Nadu, India, 600 008 Less <<
NCT00666250 Hypertension ... More >>Dyslipidemia Hyperglycemia Less << Not Applicable Completed - United States, Utah ... More >> Cardiovascular Genetics, University of Utah Salt Lake City, Utah, United States, 84108 Less <<
NCT01724905 Weight Loss Not Applicable Completed - United States, Kansas ... More >> University of Kansas Medical Center Kansas City, Kansas, United States, 66160 Less <<
NCT03251014 Thrombosis Not Applicable Completed - -
NCT03745157 - Enrolling by invitation November 14, 2019 Japan ... More >> Novo Nordisk Investigational Site Arakawa-ku, Tokyo, Japan, 116-0012 Novo Nordisk Investigational Site Fukuoka-shi, Fukuoka, Japan, 819-0006 Novo Nordisk Investigational Site Higashiosaka-shi, Osaka, Japan Novo Nordisk Investigational Site Hosu-gun, Ishikawa, Japan, 927-0053 Novo Nordisk Investigational Site Kawagoe-shi, Saitama, Japan, 350-0851 Novo Nordisk Investigational Site Kisarazu-shi, Chiba, Japan, 292-0038 Novo Nordisk Investigational Site Kita-ku, Tokyo, Japan, 114-0001 Novo Nordisk Investigational Site Oyama-shi, Tochigi, Japan, 323-0022 Novo Nordisk Investigational Site Saitama-shi, Saitama, Japan, 336-0963 Novo Nordisk Investigational Site Sapporo-shi, Hokkaido, Japan, 060-0001 Novo Nordisk Investigational Site Sapporo-shi, Hokkaido, Japan, 062-0007 Novo Nordisk Investigational Site Sendai-shi, Miyagi, Japan, 980-0021 Novo Nordisk Investigational Site Shimotsuga-gun, Tochigi, Japan, 321-0204 Novo Nordisk Investigational Site Shimotsuke-shi, Tochigi, Japan, 329-0433 Novo Nordisk Investigational Site Shizuoka-shi, Shizuoka, Japan, 424-0853 Novo Nordisk Investigational Site Yaizu-shi, Shizuoka, Japan, 425-0022 Novo Nordisk Investigational Site Yokohama-shi, Kanagawa, Japan, 223-0066 Less <<
NCT01587898 Anaemia Phase 2 Completed - -
NCT03473990 High-Intensity Interval Traini... More >>ng Less << Not Applicable Recruiting August 1, 2019 United Kingdom ... More >> The University of Nottingham, Division of Medical Sciences and Graduate Entry Medicine, School of Medicine, Royal Derby Hospital Recruiting Derby, United Kingdom, DE22 3DT Contact: Bethan Philips, Assist. Prof    01332 724676    beth.phillips@nottingham.ac.uk Less <<
NCT02329470 Obstructive Sleep Apnea ... More >> Cardiovascular Disease Less << Not Applicable Completed - Sweden ... More >> Dept of Respiratory Medicine Umeå, Sweden, 901 85 Less <<
NCT01605435 - Completed - -
NCT01605435 The Frailty Syndrome Phase 2 Completed - United States, Pennsylvania ... More >> Clinical and Translational Research Center, University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00876733 - Completed - -
NCT02304081 Type2 Diabetes Mellitus Phase 4 Completed - Germany ... More >> Profil Mainz GmbH & Co. KG Mainz, Germany, 55116 Less <<
NCT02452632 Type 2 Diabetes Mellitus Phase 3 Completed - Korea, Republic of ... More >> Site KR00002 Busan, Korea, Republic of Site KR00003 Busan, Korea, Republic of Site KR00007 Daegu, Korea, Republic of Site KR00011 Daegu, Korea, Republic of Site KR00019 Dong Gu Gwangju, Korea, Republic of Site KR00008 Gangwon-do, Korea, Republic of Site KR00018 Gyeonggi-do, Korea, Republic of Site KR00022 Gyeonggi-do, Korea, Republic of Site KR00014 Incheon, Korea, Republic of Site KR00020 Jeollabuk-do, Korea, Republic of Site KR00021 Kyungsangnam-do, Korea, Republic of Site KR00001 Seoul, Korea, Republic of Site KR00004 Seoul, Korea, Republic of Site KR00005 Seoul, Korea, Republic of Site KR00006 Seoul, Korea, Republic of Site KR00009 Seoul, Korea, Republic of Site KR00010 Seoul, Korea, Republic of Site KR00012 Seoul, Korea, Republic of Site KR00013 Seoul, Korea, Republic of Site KR00016 Seoul, Korea, Republic of Site KR00017 Seoul, Korea, Republic of Site KR00015 Suwon, Korea, Republic of Less <<
NCT01871415 Diabetes Mellitus Type 2 Phase 3 Completed - China ... More >> Shanghai, China, 200003 ShenYang, China, 110004 Shiyan, China, 442000 Suzhou, China, 215004 Korea, Republic of Gyeonggi-do, Korea, Republic of, 463-712 Incheon, Korea, Republic of, 405-760 Seoul, Korea, Republic of, 150-950 Less <<
NCT00876733 - Completed - -
NCT02183350 Diabetes Mellitus, Type 2 Phase 1 Completed - -
NCT01587898 - Completed - -
NCT03021291 Overweight and Obesity Not Applicable Completed - United States, California ... More >> Arternis Institute for Clinical Research San Diego, California, United States, 92103 Clinical Trial Investigators Tustin, California, United States, 92780 United States, Colorado University of Colorado Aurora, Colorado, United States, 80045 United States, Florida Westside Center for Clinical Research Jacksonville, Florida, United States, 32205 United States, Louisiana Pennington Biomedical Research Baton Rouge, Louisiana, United States, 70808 United States, Massachusetts Boston University Medical Center Boston, Massachusetts, United States, 02118 United States, New York Cornell Weill Medical College New York, New York, United States, 10065 United States, Ohio Radiant Research Cincinnati, Ohio, United States, 45249 Aventiv Research Columbus, Ohio, United States, 43213 United States, Pennsylvania Geisinger Health System Danville, Pennsylvania, United States, 17822 United States, Texas Texas Diabetes and Endocrinology Round Rock, Texas, United States, 78681 Czechia Health & Care SRO Prague, Czechia, 182 00 Denmark University of Cophenhagen Copenhagen, Denmark, DK-1958 Italy IRCCS Policlinico San Donato Milan, Italy, 20097 University of Rome Rome, Italy, 00186 Spain University of Navarra Pamplona, Spain, 31008 Less <<
NCT03463486 - Active, not recruiting December 2020 Austria ... More >> Institute of Sports Medicine, Prevention and Rehabilitation, Paracelsus Medical University Salzburg, Austria, 5020 Less <<
NCT01871428 Diabetes Mellitus Type 2 Phase 3 Completed - China ... More >> Chongqing, China, 400016 Shanghai, China, 200003 Shiyan, China, 442000 Suzhou, China, 215004 Hong Kong Hong Kong, Hong Kong Malaysia Alor Setar, Malaysia, 05400 Perak, Malaysia, 33400 Less <<
NCT02635659 Body Weight Decreased Not Applicable Completed - Netherlands ... More >> Maastricht University Maastricht, Limburg, Netherlands, 6229 HX Less <<
NCT03328845 Type 1 Diabetes Mellitus Phase 4 Recruiting December 2019 Spain ... More >> Regional University Hospital of Málaga Recruiting Málaga, Spain Contact: Maria Soledad Ruiz de Adana, MD PhD    +34 629221089    solruizdeadana@gmail.com Less <<
NCT00447499 Acromegaly Phase 3 Completed - United States, California ... More >> Diabetes and Endocrine Associates La Mesa, California, United States, 91942 Cedars Sinai Medical Center Los Angeles, California, United States, 90048 United States, Colorado Denver VA Medical Center Denver, Colorado, United States, 80220 United States, Illinois Northwestern University The Feinberg School of Medicine Chicago, Illinois, United States, 60611 United States, Maryland Johns Hopkins University Baltimore, Maryland, United States, 21287 United States, Massachusetts Massachussetts General Hospital Boston, Massachusetts, United States, 02114 United States, New York NYU School of Medicine New York, New York, United States, 10010 Columbia University New York, New York, United States, 10032 Sisters of Charity Hospital, Buffalo Williamsville, New York, United States, 14221 United States, Oregon Oregon Health and Science University Portland, Oregon, United States, 97239 United States, Texas Research Institute of Dallas Dallas, Texas, United States, 75231 Baylor College of Medicine Houston, Texas, United States, 77030 University of Texas M.D. Anderson Cancer Center Houston, Texas, United States, 77230 Less <<
NCT03649828 Metabolic Syndrome ... More >> Cardiovascular Diseases Hypertension Less << Not Applicable Completed - -
NCT02769585 Obesity Diabe... More >>tes Mellitus, Type 2 Weight Reduction Less << Not Applicable Completed - -
NCT01473758 Chronic Obstructive Pulmonary ... More >>Disease With (Acute) Exacerbation Less << Phase 2 Terminated(Company decision No... More >> Safety or Efficacy Concerns) Less << - United Kingdom ... More >> Academic Unit of Respiratory Medicine, Royal Free Hospital, Jadwiga A. Wedzicha London, United Kingdom, NW3 2PF London, United Kingdom Less <<
NCT00447499 - Completed - -
NCT02689206 - Completed - -
NCT01511900 Type 2 Diabetes Phase 1 Completed - United States, California ... More >> Chula Vista, California, United States, 91911 Less <<
NCT01435018 HIV-1 Infection Phase 3 Active, not recruiting March 13, 2020 Brazil ... More >> Instituto de Pesquisa Clinica Evandro Chagas (12101) Rio de Janeiro, Brazil, 21045 Kenya Moi University International Clnical Trials Unit Eldoret, Kenya, 30100 KMRI / Walter Reed Project Clinical Research Center Kericho, Kenya Kenya Medical Research Institute/Center for Disease Control (KEMRI/CDC) CRS (31460) Kisumu, Kenya, 40100 Malawi Univ. of Malawi, John Hopkins Project Blantyre, Malawi South Africa Family Clinical Research Unit (FAM-CUR) CRS (8950) Cape Town, West Cape, South Africa, 7505 Durban Adult HIV CRS (11201) Durban, South Africa, 4013 SF University of Witwatersrand Johannesburg, South Africa Uganda Uganda Cancer Institute ACTG CRS Kampala, Uganda Zimbabwe UZ-Parirenyatwa CRS (30313) Harare, Zimbabwe Less <<
NCT01473758 - Terminated(Company decision No... More >> Safety or Efficacy Concerns) Less << - -
NCT02631902 Type 2 Diabetes Mellitus ... More >> Diabetes-Related Complications Less << Not Applicable Active, not recruiting December 2017 Portugal ... More >> University of Trás-os-Montes e Alto Douro Vila Real, Portugal, 5000-801 Less <<
NCT02348190 Other Fatty Acid Oxidation Dis... More >>orders Diabetes Mellitus Insulin Resistance Less << Not Applicable Completed - United States, Pennsylvania ... More >> Temple University Hospital Philadelphia, Pennsylvania, United States, 19140 Less <<
NCT02689206 Anaemia Phase 2 Completed - -
NCT01219465 Diabetes Mellitus ... More >> Diabetes Mellitus, Type 1 Mesenchymal Stem Cells Umbilical Cord Less << Phase 1 Phase 2 Unknown December 2012 China, Shandong ... More >> Stem Cell Research Center of Medical School Hospital of Qingdao University Qingdao, Shandong, China, 266003 Less <<
NCT02749890 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT00046267 HIV Infections ... More >> Hypercholesterolemia Hypertriglyceridemia Diabetes Mellitus Less << Not Applicable Completed - United States, California ... More >> UCLA School of Medicine Los Angeles, California, United States, 90095 Univ of California, San Diego Antirviral Research San Diego, California, United States, 92103 San Mateo County AIDS Program Stanford, California, United States, 94305 Stanford Univ Stanford, California, United States, 94305 Willow Clinic Stanford, California, United States, 94305 United States, Colorado Univ of Colorado Health Sciences Ctr, Denver Denver, Colorado, United States, 80262-3706 United States, Florida Univ of Miami School of Medicine Miami, Florida, United States, 33136-1013 United States, Indiana Indiana University Hospital Indianapolis, Indiana, United States, 46202 Methodist Hosp of Indiana Indianapolis, Indiana, United States, 46202 Wishard Hospital Indianapolis, Indiana, United States, 46202 United States, Minnesota Univ of Minnesota Minneapolis, Minnesota, United States, 55455-0392 United States, Missouri St. Louis Connect Care St. Louis, Missouri, United States, 63108 Washington Univ (St. Louis) St. Louis, Missouri, United States, 63108 United States, Ohio Univ of Cincinnati Cincinnati, Ohio, United States, 45267-0405 Case Western Reserve Univ Cleveland, Ohio, United States, 44106 United States, Pennsylvania Univ of Pittsburgh Pittsburgh, Pennsylvania, United States, 15213-2582 Less <<
NCT00066469 Lymphoproliferative Disorder Phase 2 Unknown - -
NCT03112382 Diabetes Mellitus, Type II Phase 4 Completed - Egypt ... More >> theoutpatient clinics, department of internal medicine, Cairo University teaching hospitals, Cairo, Egypt Less <<
NCT02963766 Type 2 Diabetes Phase 3 Recruiting January 27, 2022 -
NCT03560271 Diabetes Mellitus, Type 2 Phase 2 Recruiting July 15, 2019 United States, Alabama ... More >> Study Site 29 Recruiting Anniston, Alabama, United States, 36207 Contact: Maile Krumpschmidt, MD          Study Site 26 Recruiting Birmingham, Alabama, United States, 35216 Contact: Maile Krumpschmidt, MD          United States, California Study Site 27 Recruiting Chula Vista, California, United States, 91911 Contact: Maile Krumpschmidt, MD          Study Site 28 Recruiting La Mesa, California, United States, 91942 Contact: Maile Krumpschmidt, MD          Study Site 10 Recruiting Montclair, California, United States, 91763 Contact: Maile Krumpschmidt, MD          Study Site 23 Recruiting North Hollywood, California, United States, 91606 Contact: Maile Krumpschmidt, MD          United States, Florida Study Site 13 Recruiting Coral Gables, Florida, United States, 33134 Contact: Maile Krumpschmidt, MD          Study Site 19 Recruiting DeLand, Florida, United States, 32720 Contact: Maile Krumpschmidt, MD          Study Site 12 Recruiting Miami Beach, Florida, United States, 33140 Contact: Maile Krumpschmidt, MD          Study Site 14 Recruiting Miami, Florida, United States, 33155 Contact: Maile Krumpschmidt, MD          Study Site 15 Recruiting Orlando, Florida, United States, 32806 Contact: Maile Krumpschmidt, MD          Study Site 16 Recruiting Saint Petersburg, Florida, United States, 33711 Contact: Maile Krumpschmidt, MD          United States, Georgia Study Site 21 Recruiting Peachtree Corners, Georgia, United States, 30071 Contact: Maile Krumpschmidt, MD          Study Site 17 Recruiting Snellville, Georgia, United States, 30078 Contact: Maile Krumpschmidt, MD          United States, Massachusetts Study Site 20 Recruiting North Dartmouth, Massachusetts, United States, 02747 Contact: Maile Krumpschmidt, MD          United States, Michigan Study Site 30 Recruiting Caro, Michigan, United States, 48723 Contact: Maile Krumpschmidt, MD          United States, Nevada Study Site 24 Recruiting Las Vegas, Nevada, United States, 89106 Contact: Maile Krumpschmidt, MD          United States, Ohio Study Site 18 Recruiting Cleveland, Ohio, United States, 44142 Contact: Maile Krumpschmidt, MD          United States, Texas Study Site 22 Recruiting San Antonio, Texas, United States, 78220 Contact: Maile Krumpschmidt, MD          Study Site 11 Recruiting San Antonio, Texas, United States, 78249 Contact: Maile Krumpschmidt, MD Less <<
NCT02825836 Relapsed/Refractory B Cell Mal... More >>ignancies Mantle Cell Lymphoma and Diffuse Large B Cell Lymphoma Less << Phase 1 Phase 2 Active, not recruiting June 15, 2020 Italy ... More >> Azienda Ospedaliera Universitaria Bologna, Italy Poland Malopolskie Centrum Medyczne Krakow, Poland United Kingdom Research site 1 London, United Kingdom Research site 2 London, United Kingdom Research site Plymouth, United Kingdom Less <<
NCT00904306 Binge Eating Disorder Phase 1 Phase 2 Completed - -
NCT01657227 Type 2 Diabetes Mellitus Not Applicable Completed - Spain ... More >> Servicio de Evaluación del Servicio Canario de la Salud Santa Cruz de Tenerife, Spain, 38004 Less <<
NCT01354626 Hepatic Fat Accumulation ... More >> Nonalcoholic Fatty Liver Disease Less << Not Applicable Completed - Netherlands ... More >> Wageningen University, Division of Human Nutrition Wageningen, Gelderland, Netherlands, 6703 HD Less <<
NCT00066469 - Unknown - -
NCT02607865 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT03311724 Type 2 Diabetes Phase 2 Completed - United States, California ... More >> Valley Research Fresno, California, United States, 93720 National Research Institute Los Angeles, California, United States, 90057 Catalina Research Institute, LLC Montclair, California, United States, 91763 University Clinical Investigators, Inc. Tustin, California, United States, 92780 United States, Connecticut Chase Medical Research, LLC Waterbury, Connecticut, United States, 06708 United States, Florida Suncoast Research Group, LLC Miami, Florida, United States, 33135 United States, Idaho Solaris Clinical Research Meridian, Idaho, United States, 83646 United States, Kansas Cotton O'Neil Diabetes and Endocrinology Center Topeka, Kansas, United States, 66606 United States, Missouri Clinical Research Professionals Saint Louis, Missouri, United States, 63141 United States, Ohio Aventiv Research Columbus, Ohio, United States, 43213 United States, Tennessee New Phase Research & Development Knoxville, Tennessee, United States, 37909 United States, Texas Dallas Diabetes Endocrine Center Dallas, Texas, United States, 75230 Consano Clinical Research Shavano Park, Texas, United States, 78231 Less <<
NCT00517491 Acromegaly Phase 2 Withdrawn(Administrative reaso... More >>ns) Less << December 2008 Mexico ... More >> Centro Médico Nacional Siglo XXI, IMSS Mexico City, Mexico, 06720 Less <<
NCT03015519 Diabetes Mellitus, Type 2 Phase 3 Withdrawn(The study was stoppe... More >>d as the asset will be withdrawn from the market prior to study end.) Less << April 20, 2020 United States, Illinois ... More >> GSK Investigational Site Chicago, Illinois, United States, 60634 United States, North Carolina GSK Investigational Site Morehead City, North Carolina, United States, 28557 United States, Texas GSK Investigational Site El Paso, Texas, United States, 79935 Less <<
NCT03170518 Diabetes Mellitus, Type 2 Phase 3 Recruiting June 30, 2021 -
NCT01843127 Type 2 Diabetes Mellitus Phase 1 Completed - United States, California ... More >> Profil Institute for Clinical Research, Inc. Chula Vista, California, United States, 91911 United States, Florida SeaView Research, Inc Miami, Florida, United States, 33126 Translational Research Institute-Florida Hospital Orlando, Florida, United States, 32804 Less <<
NCT02962622 HIV Not Applicable Unknown December 2017 Puerto Rico ... More >> Medical Sciences Campus Recruiting San Juan, Puerto Rico, 00936 Contact: Farah A. Ramirez-Marrero, PhD    787-602-0088    farah.ramirez1@upr.edu    Contact: Valerie Wojna-Muniz, MD    787-758-252 ext 2819    valerie.wojna1@upr.edu Less <<
NCT01934686 - Completed - Indonesia ... More >> Jakarta, Indonesia, 12520 Less <<
NCT03624569 Cardiovascular Diseases ... More >> Endotoxemia Endothelial Dysfunction Postprandial Hyperglycemia Gut Health Less << Not Applicable Recruiting September 2020 United States, Ohio ... More >> Ohio State University Recruiting Columbus, Ohio, United States, 43210 Contact: Richard Bruno, PhD, RD Less <<
NCT01620489 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT01620489 - Completed - -
NCT00232583 - Completed - -
NCT02588690 - Active, not recruiting November 2019 United States, California ... More >> Cedars-Sinai Women's Heart Center Los Angeles, California, United States, 90048 Less <<
NCT03438617 Type 2 Diabetes Mellitus Not Applicable Active, not recruiting July 31, 2018 China, Shanghai ... More >> Shanghai Sixth People's Hospital Shanghai, Shanghai, China, 200235 An Ting Community Health Center Shanghai, Shanghai, China Cao He Jing Community Health Center Shanghai, Shanghai, China Cao Yang Community Health Center Shanghai, Shanghai, China Hong Mei Community Health Center Shanghai, Shanghai, China Kang Jian Community Health Center Shanghai, Shanghai, China Long Hua Community Health Center Shanghai, Shanghai, China Nan Jing Xi Road Community Health Center Shanghai, Shanghai, China Tao Pu Community Health Center Shanghai, Shanghai, China Tian Lin Community Health Center Shanghai, Shanghai, China Zhen Ru Community Health Center Shanghai, Shanghai, China Less <<
NCT01965639 Diabetes Mellitus, Type 2 Not Applicable Completed - United States, Mississippi ... More >> Mississippi Public Health Institute Madison, Mississippi, United States United States, North Carolina Durham County Department of Public Health Durham, North Carolina, United States Cabarrus Health Alliance Kannapolis, North Carolina, United States United States, West Virginia Williamson Health and Wellness Center Williamson, West Virginia, United States Less <<
NCT01355952 Obesity Weigh... More >>t Loss Schizophrenia Less << Not Applicable Completed - United States, Connecticut ... More >> Connecticut Mental Health Center New Haven, Connecticut, United States, 06519 Less <<
NCT01635114 Elevated Liver Fat Content and... More >> Insulin Resistance Less << Not Applicable Completed - Germany ... More >> University Hospital Tuebingen Tuebingen, Germany, 72076 Less <<
NCT01598233 Overweight Ob... More >>esity Metabolic Syndrome Less << Phase 3 Completed - Brazil ... More >> Universidade Estadual do Rio de Janeiro Rio de Janeiro, Brazil, 20.551-030 Less <<
NCT03437525 Type 2 Diabetes Treated With I... More >>nsulin Less << Not Applicable Active, not recruiting April 30, 2018 China, Shanghai ... More >> Shanghai Sixth People's Hospital Shanghai, Shanghai, China, 200235 An Ting Community Health Center Shanghai, Shanghai, China Cao He Jing Community Health Center Shanghai, Shanghai, China Cao Yang Community Health Center Shanghai, Shanghai, China Hong Mei Community Health Center Shanghai, Shanghai, China Kang Jian Community Health Center Shanghai, Shanghai, China Long Hua Community Health Center Shanghai, Shanghai, China Nan Jing Xi Road Community Health Center Shanghai, Shanghai, China Tao Pu Community Health Center Shanghai, Shanghai, China Tian Lin Community Health Center Shanghai, Shanghai, China Zhen Ru Community Health Center Shanghai, Shanghai, China Less <<
NCT03627182 Type2 Diabetes Phase 3 Recruiting February 10, 2023 Korea, Republic of ... More >> Severance Hospital, Yonsei University Health System Recruiting Seoul, Korea, Republic of Contact: BongSoo Cha, Ph.D    82-2-2228-1962    bscha@yuhs.ac Less <<
NCT00232583 Type 2 Diabetes Mellitus Not Applicable Completed - United States, Texas ... More >> University of Texas Southwestern Dallas, Texas, United States, 75390 Less <<
NCT03620890 Diabetes Mellitus, Type 2 Phase 4 Recruiting September 1, 2020 United States, Texas ... More >> University of Texas Health Science Center of Houston Recruiting Houston, Texas, United States, 77030 Contact: Michal Bartal Fishel, MD    713-500-6421    Michal.F.Bartal@uth.tmc.edu Less <<
NCT00674817 Pulmonary Disease, Chronic Obs... More >>tructive Less << Phase 2 Completed - New Zealand ... More >> GSK Investigational Site Wellington, New Zealand, 6035 Thailand GSK Investigational Site Chiangmai, Thailand, 50200 GSK Investigational Site Khon Kaen, Thailand, 40002 United Kingdom GSK Investigational Site Manchester, United Kingdom, M23 9LT Less <<
NCT03739125 Type2 Diabetes Phase 3 Recruiting May 21, 2021 Korea, Republic of ... More >> Severance Hospital, Yonsei University Health System Recruiting Seoul, Korea, Republic of Contact: BongSoo Cha, Ph.D    82-2-2228-1962    bscha@yuhs.ac Less <<
NCT03603041 Sleep Body Co... More >>mposition Strength Insulin Sensitivity Energy Expenditure Less << Not Applicable Recruiting December 31, 2020 United States, Arkansas ... More >> University of Arkansas Recruiting Fayetteville, Arkansas, United States, 72704 Contact: Jamie I Baum, PhD    479-575-4474    baum@uark.edu Less <<
NCT01018173 Diabetes Mellitus Type 2 Phase 3 Completed - -
NCT01565096 Diabetes Mellitus Type II Phase 4 Unknown - Germany ... More >> ikfe GmbH Recruiting Mainz, Germany, 55116 Contact: Thomas Forst, Prof., MD    +49 6131 576 36 16    thomasf@ikfe.de    Contact: Swantje Anders    +49 6131 327 90 22    s.anders@ikfe-cro.de Less <<
NCT00674817 - Completed - -
NCT03496558 Pregnant Woman With Single Pre... More >>gnancy Pregnant Woman With no Assisted Reproduction Less << Not Applicable Recruiting February 2020 Spain ... More >> Universidad de Granda Recruiting Granada, Spain, 18071 Contact: María José Aguilar Cordero, Professor    657841751 ext +34    mariajaguilar@telefonica.net Less <<
NCT02624908 Diabetes Mellitus, Type 2 Phase 4 Recruiting November 2018 United States, Georgia ... More >> Atlanta VA Medical Center Recruiting Decatur, Georgia, United States, 30033 Less <<
NCT03655301 Healthy Volunteers Phase 1 Active, not recruiting January 18, 2019 United States, Texas ... More >> Pharmaceutical Product Development, LLC Austin, Texas, United States, 78744 Less <<
NCT03641352 Type2 Diabetes Phase 3 Recruiting November 30, 2022 Korea, Republic of ... More >> The Catholic University of Korea, Seoul ST. Mary's Hospital Recruiting Seoul, Korea, Republic of Contact: kun ho yoon, Ph.D    82-2-2258-6007 Less <<
NCT01528644 Iron Deficiency ... More >> Anaemia Less << Not Applicable Completed - United Kingdom ... More >> Clinical Research and Trials Unit (CRTU)/ Norfolk and Norwich University Hospital (NNUH) Norwich, Norfolk, United Kingdom, NR4 7TJ Less <<
NCT01969084 Type II Diabetes Mellitus Phase 4 Completed - United States, Massachusetts ... More >> Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Less <<
NCT01969084 - Completed - -
NCT02339311 - Completed - -
NCT01724736 Pre Diabetic Not Applicable Completed - United States, Louisiana ... More >> Pennington Biomedical Research Center Baton Rouge, Louisiana, United States, 70808 Less <<
NCT02779790 - Unknown January 2018 Canada, Ontario ... More >> The Toronto 3D (Diet, Digestive tract and Disease) Knowledge Synthesis and Clinical Trials Unit, Clinical Nutrition and Risk Factor Modification Centre, St. Michael's Hospital Toronto, Ontario, Canada, M5C 2T2 Less <<
NCT03740126 Carcinoma, Non-Small-Cell Lung Not Applicable Recruiting October 2023 Denmark ... More >> Rigshospitalet Recruiting Copenhagen, Denmark, 2100 Contact: Mette Poehl, MD, PhD,       mette.poehl@regionh.dk    Gentofte Hospital Recruiting Gentofte, Denmark, 2900 Contact: Zaigham Sagir, MD PhD          Herlev Hospital Recruiting Herlev, Denmark, 2730 Contact: Kristin Skougaard, Ph.D    0045 38686515    Kristin.Skougaard@regionh.dk Less <<
NCT03399708 - Recruiting August 2019 United Kingdom ... More >> Glasgow Royal Infirmary Recruiting Glasgow, Scotland, United Kingdom, G31 2ER Contact: Lyn Ferguson, MBChB    0141 330 2627    lyn.ferguson@glasgow.ac.uk    Contact: Stefan Siebert, MBChB PhD    0141 330 3375    stefan.siebert@glasgow.ac.uk    Principal Investigator: Stefan Siebert, MBChB PhD Less <<
NCT02001142 Obesity Not Applicable Recruiting November 2025 United States, Michigan ... More >> Michigan Clincal Research Unit Recruiting Ann Arbor, Michigan, United States, 48109 Contact: Suzette Howton, RD    734-647-9850    suzetter@med.umich.edu    Principal Investigator: Jeffrey F Horowitz, PhD Less <<
NCT00936481 - Completed - United States, Tennessee ... More >> Vanderbilt University Medical Center,Department of Neurology Nashville, Tennessee, United States, 37232 Less <<
NCT02230839 Insulin Resistance ... More >> Sarcopenia Less << Not Applicable Active, not recruiting January 2019 United States, Florida ... More >> Translational Research Institute for Metabolism and Diabetes Orlando, Florida, United States, 32804 Less <<
NCT00936481 - Completed - -
NCT02204397 Type 1 Diabetes Mellitus Phase 2 Completed - Canada, Quebec ... More >> Montreal General Hospital Montreal, Quebec, Canada, H3G 1A4 Less <<
NCT01288664 Lupus Nephritis Phase 3 Withdrawn(sponsor withdraw fro... More >>m this study) Less << December 2012 China, Guangdong ... More >> The First Affiliated Hospital of Sun Yat-sen University Guangzhou, Guangdong, China, 510080 Less <<
NCT02829619 - Recruiting June 2021 Spain ... More >> University of Murcia Recruiting Murcia, Spain, 30100 Contact: Marta Garaulet, PHD    +34678996368    garaulet@um.es Less <<
NCT02205866 Infertility Not Applicable Completed - United States, California ... More >> Stamford University Palo Alto, California, United States, 94305-5101 United States, Texas Baylor College of Medicine Houston, Texas, United States, 77030 Spain IVI Valencia Valencia, Spain, 46015 Less <<
NCT02361489 Diabetes Type II Phase 4 Unknown April 2016 United States, Pennsylvania ... More >> Geisinger Recruiting Wilkes Barre, Pennsylvania, United States, 18702 Contact: Amy B Cartaya,, MSHA    570-214-9544    abcartaya@geisinger.edu    Contact: Natacha M Antunes, BS, MPH    570-214-6985    NMANTUNES@geisinger.edu Less <<
NCT03575988 - Not yet recruiting June 3, 2019 -
NCT00124371 Coronary Artery Disease Phase 2 Phase 3 Completed - United Kingdom ... More >> Royal Brompton and Harefield NHS Trust London, United Kingdom, SW3 6NP Less <<
NCT01244828 Schizophrenia Phase 3 Completed - -
NCT02230137 Type 1 Diabetes Not Applicable Completed - France ... More >> AP-HP Necker Paris, France, 75015 Less <<
NCT01244828 - Completed - -
NCT00242372 Type 2 Diabetes Mellitus Phase 3 Terminated(The development pro... More >>gram has been terminated) Less << - -
NCT01965210 Appetite Regulation Not Applicable Completed - Sweden ... More >> Paediatric Research Facility; The Children's Hospital at Uppsala University Hospital Uppsala, Sweden, SE-751 85 Less <<
NCT02595658 Low Fat Meal - Unadjusted Insu... More >>lin Dose High Fat Meal - Unadjusted Insulin Dose High Fat Meal - Adjusted Insulin Dose +30% High Fat Meal - Adjusted Insulin Dose +Split Dose Less << Not Applicable Completed - -
NCT03152084 Diabetes Mellitus, Type 2 ... More >> Kidney Function Tests Less << Phase 4 Recruiting July 1, 2019 Netherlands ... More >> Research Site Recruiting Almelo, Netherlands, 7600 Research Site Recruiting Amsterdam, Netherlands, 1081 HV Less <<
NCT00300105 Type 2 Diabetes Phase 3 Terminated(The development pro... More >>gram has been terminated) Less << - -
NCT00813566 - Recruiting July 2022 United States, Utah ... More >> Huntsman Cancer Institute Recruiting Salt Lake City, Utah, United States, 84112 Less <<
NCT03057873 Overweight Not Applicable Recruiting December 2018 United States, Illinois ... More >> Great Lakes Clinical Trials (of MB Clinical Research and Consulting, LLC) Recruiting Chicago, Illinois, United States, 60630 Contact: Steve Satek    773-275-3500    ssatek@greatlakesclinicaltrials.com    Canada, Ontario KGK Synergize Inc. Recruiting London, Ontario, Canada, N6A 58R Contact: Mal Evans, PhD    5194389374 ext 239    mevans@kgkscience.com    GI Labs, Inc. Recruiting Toronto, Ontario, Canada, M5C 2N8 Contact: Alexandra Jenkins, PhD, RD       AEzatagha@gilabs.com Less <<
NCT03421444 - Completed - -
NCT01209416 Metabolism In... More >>sulin Resistance Hypopituitarism Less << Not Applicable Completed - Denmark ... More >> University Hospital of Aarhus Aarhus, Denmark, 8000 Less <<
NCT00935129 Type 1 Diabetes Not Applicable Completed - Israel ... More >> Schnider children's medical center Petach-Tikva, Israel, 49202 Less <<
NCT01871116 Early Stage Breast Cancer Not Applicable Completed - United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21287-0013 Less <<
NCT00842894 - Completed - Macedonia, The Former Yugoslav... More >> Republic of Skopje, Macedonia, The Former Yugoslav Republic of, MK-1000 Less <<
NCT01434407 Obesity Type ... More >>2 Diabetes Insulin Resistance Cardiovascular Disease Less << Not Applicable Completed - Denmark ... More >> Department of Human Nutrition, University of Copenhagen Copenhagen, Frederiksberg C, Denmark, 1958 Less <<
NCT01209078 Skin Infections, Bacterial Phase 2 Completed - United States, Alabama ... More >> GSK Investigational Site Anniston, Alabama, United States, 36207 United States, California GSK Investigational Site Chula Vista, California, United States, 91911 GSK Investigational Site La Mesa, California, United States, 91942 GSK Investigational Site Long Beach, California, United States, 90813 GSK Investigational Site Oceanside, California, United States, 92056 United States, Hawaii GSK Investigational Site Honolulu, Hawaii, United States, 96813 United States, Pennsylvania GSK Investigational Site West Reading, Pennsylvania, United States, 19611 Less <<
NCT00504309 Hypertriglyceridemia Not Applicable Completed - United States, Pennsylvania ... More >> Penn State University General Clinical Research Center University Park, Pennsylvania, United States, 16802 Less <<
NCT03081598 Type 2 Diabetes Mellitus ... More >> Metabolic Syndrome Less << Phase 2 Terminated(Failure to meet rec... More >>ruitment target during the recruitment period) Less << - Canada, Alberta ... More >> C-Health Edmonton, Alberta, Canada Canada, Quebec Omnispec Clinical Research Mirabel, Quebec, Canada Canada LMC Clinical Research Inc. Barrie, Canada C-health - C-endo Division Calgary, Canada Centre de recherche clinique de Laval Laval, Canada Institut de Recherches Cliniques de Montreal (IRCM) Montréal, Canada LMC Clinical Research Inc. Montréal, Canada Manna Research Quebec City, Canada Synergy Medical Clinic Sherwood Park, Canada Manna Research Toronto, Canada Manna Research Vancouver, Canada Less <<
NCT00504309 - Completed - -
NCT02349243 Obesity Phase 1 Phase 2 Unknown November 2015 China, Shaanxi ... More >> Xijing Hospital of Digestive Diseases, Xijing Hospital, Fourth Military Medical University Recruiting Xi'an, Shaanxi, China, 710032 Contact: Kaichun Wu, MD, PhD    862984771502    kaicwu@fmmu.edu.cn    Contact: Shiqi Wang, MD, PhD    862984771533    wsqfmmu@126.com Less <<
NCT02352246 Type 2 Diabetes ... More >> Overweight (BMI > 25) Postmenopausal Women Less << Not Applicable Unknown December 2017 France ... More >> Chu Clermont Ferrand Clermont-Ferrand, France, 63003 Less <<
NCT03018041 Kidney Transplantation Phase 3 Recruiting August 31, 2021 Norway ... More >> Akershus University Hospital Recruiting Lørenskog, Akershus, Norway, 1478 Contact: My Svensson, MD, PhD    +45 50906736    m.h.s.svensson@medisin.uio.no    Principal Investigator: Joe Chan, MD          Drammen Hospital Recruiting Drammen, Buskerud, Norway, 3004 Contact: Morten Reier-Nilsen, MD    +47 915 03525    morten.reier.nilsen@vestreviken.no    Principal Investigator: Morten Reier-Nilsen, MD          Elverum Hospital Recruiting Elverum, Hedmark, Norway, 2409 Contact: Tone Granseth, MD    +47 915 06200    tone.granseth@sykehuset-innlandet.no    Principal Investigator: Tone Granseth, MD          Ullevaal University Hospital Recruiting Oslo, Norway, 0450 Contact: Branimir Draganov, MD    +47 915 02770    branimir.draganov@ous-hf.no    Principal Investigator: Branimir Draganov, MD Less <<
NCT03677609 Diabetes Diab... More >>etes Mellitus Hypertension Pre Diabetes Overweight and Obesity Less << Not Applicable Enrolling by invitation September 1, 2019 United States, California ... More >> Stanford University Stanford, California, United States, 94025 Less <<
NCT01209078 - Completed - -
NCT01821131 Above Optimal Plasma LDL Conce... More >>ntrations Less << Not Applicable Active, not recruiting September 2018 Canada, Manitoba ... More >> Asper Clinical Research Institute Winnipeg, Manitoba, Canada, R2H 2A6 Canada, Ontario Glycemic Index Laboratories Inc. Toronto, Ontario, Canada, M5C 2N8 Less <<
NCT01889784 Type 2 Diabetes Mellitus Not Applicable Unknown June 2017 Brazil ... More >> Universidade Federal de São Carlos Recruiting São Carlos, São Paulo, Brazil, 13565-905 Sub-Investigator: Cristina O Francisco, doctorate in progress          Principal Investigator: Aparecida M Catai, pHD Less <<
NCT01290575 Type 2 Diabetes Phase 1 Completed - United States, Arizona ... More >> Dedicated Phase I, Inc. Phoenix, Arizona, United States, 85013 United States, Arkansas Osborne Research Center Little Rock, Arkansas, United States, 72201 United States, Florida Clinical Pharmacology Of Miami Inc. Miami, Florida, United States, 33014 Mra Clinical Research Miami, Florida, United States, 33143 United States, Texas Cetero Research San Antonio, Texas, United States, 78229 Less <<
NCT03657186 Overweight We... More >>ight Loss Less << Not Applicable Recruiting August 2019 Germany ... More >> Analyze & Realize Recruiting Berlin, Germany, 10369 Contact: Udo Bongartz, Dr. med.          Barbara Grube Recruiting Berlin, Germany, 10709 Contact: Barbara Grube          Jörg Förstermann Recruiting Berlin, Germany, 14059 Contact: Jörg Förstermann Less <<
NCT02106104 Type 2 Diabetes Phase 4 Completed - Netherlands ... More >> VU University Medical Center Amsterdam, Netherlands, 1081 HV Less <<
NCT01641692 Asthma Phase 2 Completed - -
NCT00665808 - Completed - Germany ... More >> Novo Nordisk Investigational Site Mainz, Germany, 55127 Less <<
NCT03073577 Type 1 Diabetes Mellitus Phase 1 Active, not recruiting January 2019 Canada, Alberta ... More >> University of Alberta Edmonton, Alberta, Canada, T6G2C8 Less <<
NCT00191464 Diabetes Mellitus, Type 2 Phase 4 Completed - United States, New Hampshire ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lebanon, New Hampshire, United States, 03756 Australia, New South Wales For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. St Leonards, New South Wales, Australia, 2065 Greece For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Thessaloniki, Greece, 56429 India For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mumbai, Maharstra, India, 400 007 Netherlands For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Den Helder, Netherlands, 1783 GZ Poland For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Olesnica, Poland, 56-400 Puerto Rico For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ponce, Puerto Rico, 00731 Less <<
NCT01806506 Morbid Obesity ... More >> Metabolic Syndrome X Diabetes Mellitus Dyslipidemia Hypertension Less << Not Applicable Unknown - Poland ... More >> Department of General, Transplant and Liver Surgery, Public Central Teaching Hospital, Medical University of Warsaaw Warsaw, Poland, 02-097 Less <<
NCT00639756 Metabolic Syndrome Phase 2 Completed - Spain ... More >> Renal Unit, Mateo Orfila Hospital Menorca, Balearic Islands, Spain, 07703 Less <<
NCT01641692 - Completed - -
NCT02014584 - Completed - -
NCT03188029 Adrenocortical Abnormality Not Applicable Recruiting January 31, 2019 Tunisia ... More >> Razi Hospital Recruiting Tunis, La Manouba, Tunisia, 2010 Contact: BOUSSELMI RADHOUAN, MD    +21622622495    rdh.bousselmi@gmail.com    Contact: ZOGLAMI KARIMA, MD    +21621595524    zoghlamikarima@gmail.com Less <<
NCT03042767 Nonalcoholic Fatty Liver Disea... More >>se (NAFLD) Less << Phase 2 Recruiting May 2019 United States, Georgia ... More >> Children's Healthcare of Atlanta Recruiting Atlanta, Georgia, United States, 30322 Contact: Rebecca Cleeton, MPH    404-727-5383    rcleeto@emory.edu Less <<
NCT01654276 Gout Phase 4 Completed - United States, Texas ... More >> UT Southwestern Medical Center Dallas, Texas, United States, 75390-8885 Less <<
NCT02014584 Alopecia Phase 3 Completed - Chile ... More >> GSK Investigational Site Santiago, Región Metro De Santiago, Chile, 7580206 Hong Kong GSK Investigational Site Pokfulam, Hong Kong GSK Investigational Site Shatin, Hong Kong Korea, Republic of GSK Investigational Site Chungcheongnam-do, Korea, Republic of GSK Investigational Site Daejeon, Korea, Republic of, 301-721 GSK Investigational Site Gwangju, Korea, Republic of, 501-757 GSK Investigational Site Gyeonggi-do, Korea, Republic of, 463-707 GSK Investigational Site Incheon, Korea, Republic of, 400-711 GSK Investigational Site Jeonju-si, Jeollabuk-do, Korea, Republic of, 561-712 GSK Investigational Site Kangwon-Do, Korea, Republic of, 220-701 GSK Investigational Site Pusan, Korea, Republic of, 602-739 GSK Investigational Site Seoul, Korea, Republic of, 110-744 GSK Investigational Site Seoul, Korea, Republic of, 134-090 GSK Investigational Site Seoul, Korea, Republic of, 143-729 GSK Investigational Site Seoul, Korea, Republic of, 156-755 Singapore GSK Investigational Site Singapore, Singapore, 169608 Taiwan GSK Investigational Site Taipei, Taiwan, 106 GSK Investigational Site Taipei, Taiwan Less <<
NCT01654276 - Completed - -
NCT00214591 Diabetes Mellitus, Type 2 Phase 3 Terminated(The development pro... More >>gram has been terminated) Less << - -
NCT01351922 - Completed - India ... More >> Novo Nordisk Investigational Site Bangalore, India, 560001 Less <<
NCT03721991 Type 1 Diabetes Mellitus Not Applicable Recruiting July 1, 2019 Denmark ... More >> Steno Diabetes Center Copenhagen Recruiting Gentofte, Denmark, 2820 Contact: Peter Rossing, MD       peter.rossing@regionh.dk    Principal Investigator: Peter Rossing, MD Less <<
NCT01396915 - Completed - United States, Indiana ... More >> Purdue University W. Lafayette, Indiana, United States, 47907 Less <<
NCT00687063 - Completed - India ... More >> Bangalore, India, 560001 Less <<
NCT00214565 Diabetes Mellitus, Type 2 Phase 3 Terminated(The development pro... More >>gram has been terminated) Less << - -
NCT00715351 - Completed - Slovenia ... More >> Novo Nordisk Investigational Site Ljubljana, Slovenia, SI-1000 Less <<
NCT02642159 Dyslipidemia Phase 4 Completed - -
NCT01758380 Type 2 Diabetes Mellitus Phase 4 Completed - -
NCT01302002 Breast Cancer Early Phase 1 Withdrawn - Brazil ... More >> Hospital do Cancer III Rio de Janeiro, Brazil, 20560-120 Less <<
NCT00312156 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 3 Completed - -
NCT03033121 Growth Hormone Treatment Phase 3 Completed - Italy ... More >> Endocrinology - University of Palermo Palermo, Italy, 90127 Less <<
NCT02432924 Motor Activity ... More >> Cardiovascular Diseases Type 2 Diabetes Mellitus Less << Not Applicable Completed - United Kingdom ... More >> University of Bath: Department for Health Bath, United Kingdom, BA2 7AY Less <<
NCT01899001 Polycystic Ovary Syndrome (PCO... More >>S) Less << Not Applicable Completed - United States, Pennsylvania ... More >> Penn PCOS Center Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT02642159 - Completed - -
NCT00062764 - Completed - -
NCT02227043 - Completed - Sweden ... More >> Lipid laboratory Karolinska University Hospital Huddinge Stockholm, Sweden, 141 86 Less <<
NCT02929901 Type 2 Diabetes Nonalcoholic F... More >>atty Liver Less << Phase 2 Phase 3 Unknown December 2017 Iran, Islamic Republic of ... More >> NNFTRI clinic Tehran, Iran, Islamic Republic of, 19435 Less <<
NCT03717688 Diabetes Hear... More >>t Failure Less << Phase 4 Recruiting January 31, 2019 Denmark ... More >> University of Copenhagen Recruiting Copenhagen, Denmark, 2100 Contact: Peter Plomgaard, MD, PhD    35451397    Peter.Plomgaard@regionh.dk    Principal Investigator: Peter Plomgaard, MD, PhD Less <<
NCT00996645 Diabetes Mellitus, Type 2 ... More >> Coronary Artery Disease Less << Not Applicable Completed - Canada, Ontario ... More >> Sunnybrook Health Sciences Centre Toronto, Ontario, Canada, M4N 3M5 Less <<
NCT00062764 Hepatitis Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT03531905 Diabetes Diab... More >>etes Mellitus, Type 2 Cholesterolemia Less << Phase 2 Recruiting May 2019 United States, California ... More >> Clinical Trials Research Recruiting Lincoln, California, United States, 95648 United States, Florida FInlay Medical Research Recruiting Miami, Florida, United States, 33126 United States, Kentucky L-MARC Research Center Recruiting Louisville, Kentucky, United States, 40213 United States, Virginia Hampton Roads Center for Clinical Research Recruiting Suffolk, Virginia, United States, 23435 Less <<
NCT03674385 Clomiphene Citrate Resistant P... More >>olycystic Ovary Syndrome Less << Phase 2 Recruiting January 20, 2019 Egypt ... More >> Medical Center of Infertility Recruiting Beni-suef, Egypt, 62521 Contact: eman megahed, M.D-PHD    01095115944    dr_emanmojahed@hotmail.com Less <<
NCT01720719 Fatty Liver D... More >>yslipidemias Diabetes Mellitus Less << Phase 4 Unknown December 2016 China, Shanghai ... More >> Department of Endocrinology and Metabolism, Zhongshan Hospital, Fudan University Recruiting Shanghai, Shanghai, China, 200032 Contact: Xin Gao, doctor    862164041990 ext 8021    gao.xin@zs-hospital.sh.cn    Contact: Hongmei Yan, doctor    13761666976    yan.hongmei@zs-hospital.sh.cn    Principal Investigator: Xin Gao, doctor          Sub-Investigator: hongmei Yan, doctor          Sub-Investigator: Mingfeng Xia, doctor Less <<
NCT02247011 - Completed - -
NCT02535637 - Completed - -
NCT02949752 Antipsychotics Weight Gain Phase 4 Recruiting August 2017 Singapore ... More >> Institute of Mental Health Recruiting Singapore, Singapore, 556121 Contact: Bee Choo Lim    63892000 ext 3618    Bee_Choo_LIM@imh.com.sg    Contact: Jaclyn Ong    63892000 ext 2959    jaclyn_yy_ong@imh.com.sg Less <<
NCT02624011 Sedentary Lifestyle Not Applicable Completed - United Kingdom ... More >> School of Sport Exercise and Rehabilitation Sciences, University of Birmingham Birmingham, United Kingdom, B15 2TT Less <<
NCT02705807 Cardiovascular Disease Phase 4 Completed - Japan ... More >> GSK Investigational Site Okayama, Japan, 701-1192 Less <<
NCT02247011 Osteoporotic Fractures ... More >> Osteoporosis, Postmenopausal Less << Not Applicable Completed - China, Beijing ... More >> Department of Endocrinology, Peking Union Medical College Hospital Beijing, Beijing, China, 100730 Less <<
NCT03444558 Metabolic Syndrome Not Applicable Completed - Italy ... More >> University Hospital of Palermo Palermo, Palrmo, Italy, 90127 Less <<
NCT03708549 Schizophrenia ... More >> Metabolic Syndrome Berberine Metformin Less << Phase 4 Recruiting December 1, 2019 China, Tianjin ... More >> Tianjin Anding Hospital Recruiting Tianjin, Tianjin, China, 300222 Contact: Jie Li, Doctor    +86 022 88188006    tjlijie3827@163.com Less <<
NCT02705807 - Completed - -
NCT01328834 Nephritis, Lupus Phase 3 Completed - China, Guangdong ... More >> The First Affiliated Hospital of Sun Yat-sen University IRB Guangzhou, Guangdong, China, 510080 Less <<
NCT02048696 Myocardial Infarction ... More >> Heart Failure Coronary Artery Disease Less << Not Applicable Completed - Canada, Quebec ... More >> Centre for preventive medicine and physical activity of the Montreal Heart Institute (Centre ÉPIC) Montreal, Quebec, Canada, H1T 1N6 Less <<
NCT01877044 Obesity Overw... More >>eight Less << Not Applicable Completed - Netherlands ... More >> Maastricht University Medical Center Maastricht, Limburg, Netherlands, 6229 HX Less <<
NCT03735186 Cigarette Smoking ... More >> Coronary Heart Disease Cardiovascular Risk Factor Insulin Resistance Oxidative Stress Inflammation Less << Not Applicable Completed - United Kingdom ... More >> Loughborough University Loughborough, Leicestershire, United Kingdom, LE11 3TU Less <<
NCT02345161 Pulmonary Disease, Chronic Obs... More >>tructive Less << Phase 3 Completed - -
NCT03314506 Metabolic Disease ... More >> Adipose Tissue Less << Not Applicable Recruiting October 2024 United States, Michigan ... More >> University of Michigan Recruiting Ann Arbor, Michigan, United States, 48109 Contact: Jeffrey F Horowitz    734-647-1076    jeffhoro@umich.edu Less <<
NCT00624689 Infant Not Applicable Completed - Sweden ... More >> Dept of clinical sciences, pediatrics, Umeå University Umeå, Sweden, SE-90185 Less <<
NCT02345161 - Completed - -
NCT03610776 Portion Size Not Applicable Recruiting June 30, 2019 Spain ... More >> Centre for Nutrition Research, University of Navarra Recruiting Pamplona, Navarra, Spain, 31008 Contact: Eva Almiron-Roig, PhD    +34948425600 ext 803316    ealmiron@unav.es    Contact: María A. Vargas, MSc    +34644720497    nutconduc@unav.es    Sub-Investigator: J Alfredo Martínez, PhD          Sub-Investigator: Santiago Navas-Carretero, PhD          Sub-Investigator: Jeffrey M Brunstrom, PhD Less <<
NCT00851019 Type 2 Diabetes Mellitus Not Applicable Completed - United States, California ... More >> Charles Drew University of Medicine and Science Los Angeles, California, United States, 90059 Less <<
NCT01628419 Conditions Influencing Health ... More >>Status Less << Not Applicable Completed - Israel ... More >> Wingate Institute Netanya, Israel Less <<
NCT00071760 - Active, not recruiting - -
NCT00071760 Infection, Human Immunodeficie... More >>ncy Virus Less << Phase 2 Active, not recruiting June 2021 United States, Florida ... More >> GSK Investigational Site Jacksonville, Florida, United States, 32209 United States, North Carolina GSK Investigational Site Durham, North Carolina, United States, 27705 Argentina GSK Investigational Site Buenos Aires, Argentina, 1405 Mexico GSK Investigational Site Mexico, D.F., Mexico, 06720 GSK Investigational Site Mexico, Mexico, 6720 Portugal GSK Investigational Site Almada, Portugal, 2805-267 GSK Investigational Site Amadora, Portugal, 2700 GSK Investigational Site Lisboa, Portugal, 1649-035 Puerto Rico GSK Investigational Site San Juan, Puerto Rico, 00935 Russian Federation GSK Investigational Site Moscow, Russian Federation, 105275 GSK Investigational Site Moscow, Russian Federation, 129110 GSK Investigational Site St. Petersburg, Russian Federation, 196645 South Africa GSK Investigational Site Durban, KwaZulu- Natal, South Africa, 4013 GSK Investigational Site Parow Valley, Western Province, South Africa, 7505 GSK Investigational Site Soweto, South Africa, 2013 Less <<
NCT02519127 Metabolic Flexibility Not Applicable Completed - Netherlands ... More >> Maastricht University Medical Center Maastricht, Netherlands, 6200 MD Less <<
NCT00359112 Non-Insulin-Dependent Diabetes... More >> Mellitus Less << Phase 3 Completed - -
NCT03106480 - Recruiting March 2021 Tanzania ... More >> NIMR Research Clinic Recruiting Mwanza, Mwanza Region, Tanzania Contact: Bazil Kavishe, MD, MSc    255 28 2503012    basilbkavishe@gmail.com Less <<
NCT00749606 Obesity Not Applicable Completed - -
NCT03332927 PreDiabetes Not Applicable Recruiting September 1, 2018 United States, Illinois ... More >> Great Lakes Clinical Trials Recruiting Chicago, Illinois, United States, 60640 Contact: Rupal Trivedi, MD    773-275-3500    rtrivedi@greatlakesclinicaltrials.com    Contact: Cathleen Maki, MSN    630-460-6600 Less <<
NCT00749606 - Completed - -
NCT01411865 Diabetes Mellitus ... More >> Cardiovascular Disease Less << Not Applicable Completed - Canada, Ontario ... More >> Institute for Clinical Evaluative Sciences Toronto, Ontario, Canada, M4N 3M5 Less <<
NCT01529541 Type 2 Diabetes Mellitus Phase 3 Completed - Korea, Republic of ... More >> Kangbuk Samsung Hospital Seoul, Korea, Republic of Less <<
NCT02947503 Gestational Diabetes ... More >> Insulin Resistance Less << Phase 3 Not yet recruiting December 2040 -
NCT03279432 - Completed - -
NCT02284269 - Active, not recruiting - -
NCT01515592 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 1 Completed - Japan ... More >> Novo Nordisk Investigational Site Tokyo, Japan, 1000005 Less <<
NCT02361931 Diabetic Chronic Ulcers Phase 2 Unknown March 2017 Israel ... More >> Rambam Health Care Campus Recruiting Haifa, Israel Contact: Rinat Lasker    +972503312506    r_lasker@rambma.health.gov.il Less <<
NCT01615978 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 1 Completed - Japan ... More >> Novo Nordisk Investigational Site Tokyo, Japan, 1000005 Less <<
NCT03603782 Healthy Not Applicable Completed - Switzerland ... More >> Metabolic Unit Lausanne 25, Vaud, Switzerland, 1000 Less <<
NCT02790112 Puberty, Precocious ... More >> Adiposity Less << Not Applicable Unknown October 2018 Belgium ... More >> Cliniques Universitaires Saint-Luc Brussels, Belgium, 1200 Less <<
NCT01169142 Schizophrenia ... More >> Schizoaffective Disorder Less << Phase 4 Completed - United States, New York ... More >> Bronx Psychiatric Center Bronx, New York, United States, 10461 Less <<
NCT00436553 Macular Degeneration ... More >> Choroidal Neovascularization Less << Phase 3 Completed - -
NCT02765568 Coronary Artery Disease (CAD) Not Applicable Recruiting December 2019 Canada, Ontario ... More >> University of Ottawa Heart Insititue Recruiting Ottawa, Ontario, Canada, K1Y 4W7 Less <<
NCT01664247 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT00436553 - Completed - -
NCT03067324 - Recruiting July 1, 2021 France ... More >> Besançon University Hospital Recruiting Besancon, France Contact: Sophie BOROT, MD, PhD    +33 3 81 66 82 29    sophie.borot@univ-fcomte.fr    Principal Investigator: Sophie BOROT, MD, PhD          Clermont Ferrand University hospital Not yet recruiting Clermont-Ferrand, France Contact: Igor TAUVERON, MD, PhD    +33 4 73 75 15 29    itauveron@chu-clermontferrand.fr    Principal Investigator: Igor TAUVERON, MD, PhD          Grenoble University Hospital Recruiting Grenoble, France, 38000 Contact: Sandrine LABLANCHE    +33476769349    slablanche@chu-grenoble.fr    Contact: Myriam HADDOUCHE    +33476766983    mhaddouche@chu-grenoble.fr    Principal Investigator: Sandrine LABLANCHE          Sub-Investigator: Pierre-Yves BENHAMOU          Lyon University Hospital Recruiting Lyon, France, 69000 Contact: Charles THIVOLET, MD, PhD    +33 4 78 86 14 87    charles.thivolet@chu-lyon.fr    Principal Investigator: Charles THIVOLET, MD, PhD          Sub-Investigator: Emmanuel MORELON, MD, PhD          Sub-Investigator: Lionel BADET, MD, PhD          Sub-Investigator: Fanny BURON, MD          Montpellier University Hospital Recruiting Montpellier, France, 34000 Contact: Anne WOJTUSCISZYN, MD, PhD    +33 4 67 33 83 86    a-wojtusciszyn@chu-montpellier.fr    Principal Investigator: Anne WOJTUSCISZYN, MD, PhD          Sub-Investigator: Eric RENARD, MD, PhD          Nancy University hospital Not yet recruiting Nancy, France, 54511 Contact: Sophie GIRERD, MD, PhD    +33 3.83.15.31.69    s.girerd@chu-nancy.fr    Principal Investigator: Luc FRIMAT, MD, PhD          Sub-Investigator: Sophie GIRERD, MD, PhD          Sub-Investigator: Bruno GUERCI, MD, PhD          University hospital of Strasbourg Recruiting Strasbourg, France, 67000 Contact: Laurence KESSLER, MD, PhD    +33 3 88 11 62 67    laurence.kessler@chru-strasbourg.fr    Principal Investigator: Laurence KESSLER, MD, PhD          Switzerland Geneva University Hospital Active, not recruiting Geneva, Switzerland, CH-1211 Less <<
NCT02426229 Scleroderma I... More >>nterstitial Lung Disease Less << Phase 1 Completed - United States, South Carolina ... More >> Medical University of South Carolina Charleston, South Carolina, United States, 29425 Less <<
NCT02670928 Type 2 Diabetes Mellitus (T2DM... More >>) Less << Phase 4 Completed - Russian Federation ... More >> Novartis Investigative Site Kazan, Russian Federation, 420012 Novartis Investigative Site Moscow, Russian Federation, 117036 Less <<
NCT03621384 - Completed - Indonesia ... More >> dr. Cipto Mangunkusumo Hospital Jakarta Pusat, DKI Jakarta, Indonesia, 10430 Less <<
NCT03084822 Cardiovascular Diseases ... More >> Prevention Physical Activity Diet Modification Diabetes Hypertension High Cholesterol Pre Diabetes Smoking Cessation Obesity Less << Not Applicable Completed - -
NCT02710786 - Unknown January 2017 Sweden ... More >> Uppsala University Uppsala, Sweden, 751 85 Less <<
NCT01664247 - Completed - -
NCT00331487 Diabetes Mellitus Phase 3 Completed - -
NCT03590561 Obesity Diabe... More >>tes Mellitus, Type 2 Less << Not Applicable Recruiting March 2019 Germany ... More >> University of Tuebingen, Department of Internal Medicine IV Recruiting Tübingen, Germany, 72076 Contact: Martin Heni, MD    +49 7071 29 82714    martin.heni@med.uni-tuebingen.de    Contact: Andreas Fritsche, MD    +49 7071 29 82714    andreas.fritsche@med.uni-tuebingen.de    Principal Investigator: Stephanie Kullmann, PhD Less <<
NCT01529528 Type 2 Diabetes Mellitus Phase 3 Completed - Korea, Republic of ... More >> Kangbuk Samsung Hospital Seoul, Korea, Republic of Less <<
NCT01072006 - Completed - United States, California ... More >> Martinez Outpatient Clinic and Community Living Center, Martinez, CA Martinez, California, United States, 94553 Less <<
NCT01072006 - Completed - -
NCT03091712 Type 2 Diabetes Mellitus Not Applicable Recruiting April 2019 United States, California ... More >> Scripps Whittier Diabetes Institute Recruiting San Diego, California, United States, 92037 Contact: Athena Philis-Tsimikas, MD          Principal Investigator: Athena Philis-Tsimikas, MD Less <<
NCT00198757 Obesity Type ... More >>2 Diabetes Mellitus Less << Not Applicable Completed - -
NCT01769469 - Completed - United States, California ... More >> Children's Hopsital of Los Angeles Los Angeles, California, United States, 90027 United States, Colorado Children's Hospital of Denver Aurora, Colorado, United States, 80045 United States, Florida University of Miami Miami, Florida, United States, 33101 University of South Florida Tampa, Florida, United States, 33606 United States, Illinois Stroger Hospital and the CORE Center Chicago, Illinois, United States, 60612 United States, Louisiana Tulane University New Orleans, Louisiana, United States, 70112 United States, Maryland Johns Hopkins University Baltimore, Maryland, United States, 21287 United States, Massachusetts Fenway Institute Boston, Massachusetts, United States, 02215 United States, Michigan Wayne State University Detroit, Michigan, United States, 48201 United States, Pennsylvania Children's Hopsital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 United States, Tennessee St. Jude Childrens Research Hospital Memphis, Tennessee, United States, 38105 United States, Texas Baylor College of Medicine Houston, Texas, United States, 77030 Less <<
NCT03764774 Healthy Phase 1 Not yet recruiting August 22, 2019 United States, Florida ... More >> Covance Clinical Research Inc Recruiting Daytona Beach, Florida, United States, 32117 Contact    386-257-5717       Principal Investigator: Lawrence A Galitz Less <<
NCT02413762 - Unknown August 2017 United Arab Emirates ... More >> Imperial College London Diabetes Centre Recruiting Abu Dhabi, United Arab Emirates, 48338 Contact: Nader Lessan, MBBS MD FRCP    +971 2 404 0800    nlessan@icldc.ae    Contact: Adam J Buckley, MRCP MRes    +971 2 404 0800 ext 504    abuckley@icldc.ae    Principal Investigator: Nader Lessan, MBBS MD FRCP          Sub-Investigator: Adam J Buckley, MRCP MRes Less <<
NCT03338010 Type 2 Diabetes Phase 3 Recruiting January 29, 2020 -
NCT02714062 - Completed - -
NCT02714062 Pediatric Obesity ... More >> Childhood Obesity Less << Phase 4 Completed - United States, Louisiana ... More >> Research Facility Baton Rouge, Louisiana, United States, 70808 Research Facility Marrero, Louisiana, United States, 70072 United States, Ohio Research Facility Cincinnati, Ohio, United States, 45229 United States, South Carolina Research Facility Charleston, South Carolina, United States, 29403 Less <<
NCT03419624 Obesity Diabe... More >>tes Mellitus, Type 2 Less << Phase 3 Recruiting June 15, 2019 Germany ... More >> Diabeteszentrum Oldenburg Recruiting Oldenburg, Lower Saxony, Germany, 23758 Contact: Thomas Schaum, MD    +494361513622    info@diabeteszentrum-oldenburg.de    Principal Investigator: Thomas Schaum, MD          University Medical Center Hamburg-Eppendorf Recruiting Hamburg, Germany, 20246 Contact: Anne Lautenbach, MD    +4915222816188    a.lautenbach@uke.de    Contact: Hilko TD Wittmann       h.wittmann@uke.de    Diabetologische Schwerpunktpraxis Harburg Recruiting Hamburg, Germany, 21073 Contact: Bjoern Paschen, MD    +4940557753300    info@diabetologie-harburg.de    Principal Investigator: Bjoern Paschen, MD          Gemeinschaftspraxis für Innere Medizin und Diabetologie Recruiting Hamburg, Germany, 22607 Contact: Dominik Dahl, MD    +4940896295       Principal Investigator: Dominik Dahl, MD Less <<
NCT01945645 Type 2 Diabetes Mellitus ... More >> Behavior Less << Not Applicable Completed - Denmark ... More >> Department of Public health Aarhus, Denmark Less <<
NCT01022541 Metastatic Colorectal Cancer Phase 2 Completed - United Kingdom ... More >> David Cunningham Sutton, Surrey, United Kingdom, SM2 5PT Less <<
NCT00068055 West Nile Virus Phase 1 Phase 2 Completed - -
NCT00234988 Obesity Phase 4 Completed - United States, Illinois ... More >> Global Medical Information - Abbott North Chicago, Illinois, United States, 60064 Less <<
NCT00147264 Metabolic Syndrome X Phase 3 Completed - Canada, Ontario ... More >> Hamilton Health Sciences - Cardiovascular Obesity Research and Management Center Hamilton, Ontario, Canada, L8L 2X2 Less <<
NCT00861809 Gastroparesis Phase 2 Completed - Belgium ... More >> GSK Investigational Site Leuven, Belgium, 3000 Sweden GSK Investigational Site Stockholm, Sweden, SE-171 76 Less <<
NCT03625856 Type 2 Diabetes Mellitus Not Applicable Not yet recruiting September 1, 2019 Iran, Islamic Republic of ... More >> Amir Mahdi Hosseini Not yet recruiting Tehran, Iran, Islamic Republic of Contact: Amir Mahdi Hosseini Less <<
NCT02192047 Overweight Not Applicable Completed - Malaysia ... More >> University Putra Malaysia Serdang, Selangor, Malaysia, 43400 Less <<
NCT00304993 Metabolic Syndrome X ... More >> Insulin Resistance Less << Phase 4 Completed - United States, Florida ... More >> Foundation Research St. Petersburg, Florida, United States, 33705 Less <<
NCT01214239 Diabetes Mellitus, Type 2 Phase 3 Completed - China ... More >> 1218.66.86007 Boehringer Ingelheim Investigational Site Beijing, China 1218.66.86011 Boehringer Ingelheim Investigational Site Chongqing, China 1218.66.86008 Boehringer Ingelheim Investigational Site Dalian, China 1218.66.86010 Boehringer Ingelheim Investigational Site Fuzhou, China 1218.66.86014 Boehringer Ingelheim Investigational Site Hangzhou, China 1218.66.86005 Boehringer Ingelheim Investigational Site Hefei, China 1218.66.86006 Boehringer Ingelheim Investigational Site Hefei, China 1218.66.86012 Boehringer Ingelheim Investigational Site Nanjing, China 1218.66.86001 Boehringer Ingelheim Investigational Site Shanghai, China 1218.66.86002 Boehringer Ingelheim Investigational Site Shanghai, China 1218.66.86003 Boehringer Ingelheim Investigational Site Shanghai, China 1218.66.86004 Boehringer Ingelheim Investigational Site Suzhou, China 1218.66.86015 Boehringer Ingelheim Investigational Site Wenzhou, China 1218.66.86009 Boehringer Ingelheim Investigational Site Wuhan, China 1218.66.86013 Boehringer Ingelheim Investigational Site Yangzhou, China Malaysia 1218.66.60002 Boehringer Ingelheim Investigational Site Johor Bahru,, Malaysia 1218.66.60001 Boehringer Ingelheim Investigational Site Kelantan, Malaysia Philippines 1218.66.63001 Boehringer Ingelheim Investigational Site Marikina, Philippines 1218.66.63002 Boehringer Ingelheim Investigational Site San Juan, Philippines Less <<
NCT02854904 Spine; Arthrosis ... More >> Spondylolysis Spondylolysis, Multiple Sites in Spine Spondylolisthesis Less << Phase 2 Phase 3 Unknown June 2017 Brazil ... More >> Luciano Pereira Miranda Recruiting Brazilia, Federal District, Brazil, 70673103 Contact: Luciano P Miranda    +5561981866185    mirandalp@uol.com.br    Sub-Investigator: Frankin C Paes          Sub-Investigator: Felipe R Bressan          Sub-Investigator: Frederico S da Silva Guimaraes          Sub-Investigator: Hebert D Nogueira          Sub-Investigator: Marisa M Jreige          Principal Investigator: Luciano P Miranda Less <<
NCT01214239 - Completed - -
NCT02724605 Red Blood Cells Transfusion Phase 2 Completed - Egypt ... More >> Assiut university faculty of medicine Assiut, Egypt Less <<
NCT01626430 Metabolic Syndrome Not Applicable Completed - Malaysia ... More >> Malaysian Palm Oil Board (MPOB) Kajang, Selangor Darul Ehsan, Malaysia, 43000 Malaysia Palm Oil Board Kajang, Selangor, Malaysia, 43000 Less <<
NCT01215097 - Completed - -
NCT01270958 Rhinitis, Allergic, Perennial Phase 4 Completed - Vietnam ... More >> GSK Investigational Site Ha Noi, Vietnam, 084 Less <<
NCT01215097 Diabetes Mellitus, Type 2 Phase 3 Completed - China ... More >> 1218.65.86007 Boehringer Ingelheim Investigational Site Beijing, China 1218.65.86011 Boehringer Ingelheim Investigational Site Chongqing, China 1218.65.86008 Boehringer Ingelheim Investigational Site Dalian, China 1218.65.86010 Boehringer Ingelheim Investigational Site Fuzhou, China 1218.65.86014 Boehringer Ingelheim Investigational Site Hangzhou, China 1218.65.86005 Boehringer Ingelheim Investigational Site Hefei, China 1218.65.86006 Boehringer Ingelheim Investigational Site Hefei, China 1218.65.86012 Boehringer Ingelheim Investigational Site Nanjing, China 1218.65.86001 Boehringer Ingelheim Investigational Site Shanghai, China 1218.65.86002 Boehringer Ingelheim Investigational Site Shanghai, China 1218.65.86003 Boehringer Ingelheim Investigational Site Shanghai, China 1218.65.86004 Boehringer Ingelheim Investigational Site Suzhou, China 1218.65.86015 Boehringer Ingelheim Investigational Site Wenzhou, China 1218.65.86009 Boehringer Ingelheim Investigational Site Wuhan, China 1218.65.86013 Boehringer Ingelheim Investigational Site Yangzhou, China Malaysia 1218.65.60002 Boehringer Ingelheim Investigational Site Johor Bahru,, Malaysia 1218.65.60001 Boehringer Ingelheim Investigational Site Kelantan, Malaysia Philippines 1218.65.63001 Boehringer Ingelheim Investigational Site Marikina, Philippines 1218.65.63002 Boehringer Ingelheim Investigational Site San Juan, Philippines Less <<
NCT02550990 Stroke Patients With Cognitive... More >> Decline Less << Not Applicable Unknown - Taiwan ... More >> Chang Gung Memorial Hospital Recruiting Kwei-Shan, Taoyuan, Taiwan, 333 Contact: Ching-Yi Wu, ScD    886-3-2118800 ext 5761    cywu@mail.cgu.edu.tw    Chiayi Chang Gung Memorial Hospital Recruiting Chiayi City, Taiwan, 613 Contact: Shi-Zhe Lin, MS    +886-5-3621000 ext 2688    apirlline@cgmh.org.tw    Kaohsiung Chang Gung Memorial Hospital Recruiting Kaohsiung City, Taiwan, 83301 Contact: Ku-Chou Chang, MD    +886-7317123 ext 2285    kcchang@cgmh.org.tw    Keeling Chang Gung Memorial Hospital Recruiting Keelung City, Taiwan, 204 Contact: Chia-Ling Chen, PhD    +886-3-3281200 ext 8147    ccl1374@adm.cgmh.com.tw    Taipei Chang Gung Memorial Hospital Recruiting Taipei City, Taiwan, 105 Contact: Chia-Ling Chen, PhD    +886-3-3281200 ext 8147    ccl1374@adm.cgmh.com.tw    Taoyuan Chang Gung Memorial Hospital Recruiting Taoyuan City, Taiwan, 333 Contact: Chia-Ling Chen, PhD    +886-3-3281200 ext 8147    ccl1374@adm.cgmh.com.tw Less <<
NCT02410343 - Terminated(Business decision) - -
NCT01270958 - Completed - -
NCT02130635 - Completed - -
NCT01959646 Healthy Not Applicable Completed - United States, Florida ... More >> Food Science & Human Nutrition Building, University of Florida Gainesville, Florida, United States, 32611 University of Florida Gainesville, Florida, United States, 32611 Less <<
NCT02410343 Growth Hormone Deficiency Phase 3 Terminated(Business decision) - -
NCT01884714 Obesity Type-... More >>2 Diabetes Metabolic Syndrome Dyslipidemia Less << Not Applicable Completed - Canada, Ontario ... More >> University of Guelph, Human Nutraceutical Research Unit Guelph, Ontario, Canada, N1G 2W1 Less <<
NCT00124982 Rheumatoid Arthritis Phase 3 Completed - -
NCT02130635 Pulmonary Disease, Chronic Obs... More >>tructive Less << Phase 2 Completed - Germany ... More >> GSK Investigational Site Grosshansdorf, Schleswig-Holstein, Germany, 22927 GSK Investigational Site Berlin, Germany, 14050 Less <<
NCT00124982 - Completed - -
NCT00149695 Obesity Not Applicable Completed - Chile ... More >> INTA - University of Chile Santiago, Chile Less <<
NCT01379703 - Completed - -
NCT00834652 Depression Phase 4 Completed - United States, Missouri ... More >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Less <<
NCT00834652 - Completed - -
NCT01891786 Coronary Heart Disease ... More >> Type 2 Diabetes Less << Not Applicable Completed - United Kingdom ... More >> Addison House Surgery Harlow, Essex, United Kingdom, CM20 1DS Church Street Surgery Ware, Essex, United Kingdom, SG12 9EG Dolphin House Surgery Ware, Essex, United Kingdom, SG12 9HJ Wallace House Surgery Hertford, Hertfordshire, United Kingdom, SG14 1HZ Cambridgeshire Community Services NHS Trust Cambridgeshire, United Kingdom, PE27 4LG Chesterfield Drive Surgery Ipswich, United Kingdom, IP1 6DW Martlesham health Surgery Ipswich, United Kingdom, IP5 3SL Dr Taylor and Partners Woodbridge Suffolk, United Kingdom, IP12 1EE The Peninsula Practice Woodbridge Suffolk, United Kingdom, IP12 2NN Wickham Market Medical Centre Woodbridge Suffolk, United Kingdom, IP13 0SB Less <<
NCT03333772 Diabetes Mellitus Not Applicable Completed - United States, California ... More >> USC Center for Health Professionals Los Angeles, California, United States, 90033 Less <<
NCT03509610 Physical Activity Not Applicable Completed - United Kingdom ... More >> Department for Health, University of Bath Bath, United Kingdom, BA2 7AY Less <<
NCT01173484 - Terminated(Principal investiga... More >>tor has left the Institution) Less << - United States, Kentucky ... More >> University of Louisville Louisville, Kentucky, United States, 40205 Less <<
NCT01379703 - Completed - -
NCT02846571 Diabetes Phase 1 Phase 2 Not yet recruiting January 2022 United States, Florida ... More >> Bascom Palmer Eye Institute Not yet recruiting Miami, Florida, United States, 33136 Contact: Sonia H. Yoo, M.D.    305-326-6000 ext 6322    syoo@med.miami.edu    Contact: Jessica Taha, CCRC    305-482-5051    JTaha@med.miami.edu    Sub-Investigator: Sonia H Yoo, M.D.          Diabetes Research Institute, University of Miami Miller School of Medicine Not yet recruiting Miami, Florida, United States, 33136 Contact: Rodolfo Alejandro, M.D.    305-243-5324    ralejand@med.miami.edu    Contact: David A Baidal, M.D.    (305) 243-7740    dbaidal@med.miami.edu    Sub-Investigator: Rodolfo Alejandro, M.D.          Sub-Investigator: David A Baidal, M.D. Less <<
NCT03515889 Weight Loss Not Applicable Recruiting June 2019 United States, Louisiana ... More >> Bogalusa Heart Study Clinic Recruiting Bogalusa, Louisiana, United States, 70427 Contact: Jeanna Dawes, RN    985-735-9861 ext 9    jdawes@tulane.edu    Principal Investigator: Lydia A Bazzano, MD, PhD Less <<
NCT03723772 Diabetes Mellitus, Type 1 Phase 1 Recruiting December 8, 2019 Germany ... More >> Novo Nordisk Investigational Site Recruiting Neuss, Germany, 41460 Less <<
NCT02145780 Overfeeding Not Applicable Completed - France ... More >> Rhône Alpes Human Nutrition Center (CRNH Rhône-Alpes) Pierre-bénite, France, 69495 Less <<
NCT03686969 Dermatomyositis Phase 3 Recruiting June 2020 Russian Federation ... More >> I.M. SECHENOV FIRST MOSCOW STATE MEDICAL UNIVERSITY Rheumatology Department Of, Clinici Of Nephrology Recruiting Moscow, Russian Federation, 119992 Less <<
NCT01817127 - Active, not recruiting October 29, 2018 United States, California ... More >> University of California, Davis Davis, California, United States, 95616 Less <<
NCT01572792 - Completed - -
NCT03534921 - Active, not recruiting September 2019 United Kingdom ... More >> University of York York, Yorkshire, United Kingdom, YO10 5DD Less <<
NCT01572792 Chronic Obstructive Pulmonary ... More >>Disease Less << Phase 3 Completed - -
NCT02808533 Schizophrenia, Schizoaffective... More >> Disorder Less << Not Applicable Recruiting December 2018 Canada, Ontario ... More >> Center for Addiction and Mental Health Recruiting Toronto, Ontario, Canada, M5T 1R8 Contact: Margaret K Hahn, MD    4165358501 ext 34368    margaret.hahn@camh.ca    Contact: Zohra A Ahsan, HBSc    4165358501 ext 34103    zohra.ahsan@camh.ca    Principal Investigator: Margaret K Hahn, MD, PhD Less <<
NCT00895583 Graft Rejection ... More >> Kidney Transplant Renal Allograft Recipients Renal Transplant Less << Phase 4 Completed - -
NCT01048320 Advanced Pancreatic Cancer Phase 1 Completed - United Kingdom ... More >> Royal Marsden NHS Foundation Trust Sutton, Surrey, United Kingdom, SM2 5PT Less <<
NCT00273052 - Completed - -
NCT00172536 Diabetes Mellitus, Non-Insulin... More >>-Dependent Coronary Arteriosclerosis Post Coronary Artery Bypass Grafting Less << Not Applicable Completed - Taiwan ... More >> National Taiwan University Hospital Taipei, Taiwan, 100 Less <<
NCT00273052 Hypertension Phase 3 Completed - -
NCT02675257 Diabetes Mellitus ... More >> Affective Disorders Depression Depressive Symptoms Emotional Distress Diabetes Complications Less << Not Applicable Completed - Germany ... More >> Forschungsinstitut der Diabetes Akademie Mergentheim e. V. Bad Mergentheim, Baden-Württemberg, Germany, 97980 Diabetes Center Mergentheim Bad Mergentheim, BW, Germany, 97980 Less <<
NCT02722200 Obesity Phase 1 Active, not recruiting November 2018 United States, Connecticut ... More >> Yale University New Haven, Connecticut, United States, 06511 Less <<
NCT01724411 Overweight and Obesity Not Applicable Completed - United Kingdom ... More >> Rowett Institute of Nutrition and Health. University of Aberdeen Aberdeen, United Kingdom, AB219SB Less <<
NCT00208026 Netherton Syndrome Phase 1 Phase 2 Completed - United States, Pennsylvania ... More >> Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT02644577 Bipolar Disorder Phase 4 Completed - China, Liaoning ... More >> Department of Psychiatry, the First Hospital of China Medical University Shenyang, Liaoning, China, 110001 Less <<
NCT00208026 - Completed - -
NCT00631046 Obesity Growt... More >>h Metabolic Syndrome Cardiovascular Disease Less << Not Applicable Completed - Denmark ... More >> Dept. of Human Nutrition Copenhagen, Frederiksberg C, Denmark, DK-1958 Less <<
NCT02347007 Obesity Overw... More >>eight Fatty Liver Metabolic Syndrome X Less << Not Applicable Active, not recruiting December 31, 2018 United States, New York ... More >> New York Nutrition Obesity Research Center New York, New York, United States, 10032 Less <<
NCT02750930 - Terminated(The termination was... More >> result of GSK business considerations and not due to quality, safety or efficacy concerns with any albiglutide formulations or study conduct) Less << - -
NCT02750930 Diabetes Mellitus, Type 2 Phase 4 Terminated(The termination was... More >> result of GSK business considerations and not due to quality, safety or efficacy concerns with any albiglutide formulations or study conduct) Less << - -
NCT02490553 - Completed - -
NCT03183193 Non-Alcoholic Fatty Liver Dise... More >>ase Obese Overweight Less << Not Applicable Recruiting December 2019 Spain ... More >> Centre for Nutrition Research, University of Navarra Recruiting Pamplona, Navarra, Spain, 31008 Contact: M. Angeles Zulet, PhD    +34948425600 ext 806317    mazulet@unav.es    Contact: Itziar Abete, PhD    +34948425600 ext 806357    iabetego@unav.es Less <<
NCT00670683 - Completed - Korea, Republic of ... More >> Pusan, Korea, Republic of, 602-739 Less <<
NCT01173991 Diabetes Mellitus, Type 1 ... More >> Insulin Pump, Programmable Less << Phase 3 Completed - Italy ... More >> San Raffaele Scientific Institute Milano, Italy, 20132 Less <<
NCT02266576 Diabetes Mellitus, Type 2 ... More >> Metabolic Syndrome Insulin Resistance Less << Not Applicable Active, not recruiting September 30, 2017 United States, California ... More >> Timpany Center of San Jose State University San Jose, California, United States, 95128 Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT00895583 - Completed - -
NCT02679417 Non-alcoholic Fatty Liver Dise... More >>ase Less << Not Applicable Completed - Thailand ... More >> Faculty of Medicine Siriraj Hospital Bangkoknoi, Bangkok, Thailand, 10700 Less <<
NCT01746264 - Completed - -
NCT03219528 Irritable Bowel Syndrome Phase 4 Recruiting February 2020 United States, Michigan ... More >> University of Michigan Recruiting Ann Arbor, Michigan, United States, 48109 Contact: Deepa Chandhrasekhar          Contact: Amy Liu          Principal Investigator: Allen Lee Less <<
NCT02750293 Vitamin D Deficiency Phase 3 Completed - Norway ... More >> University Hospital of North Norway Tromsø, Norway, 9038 Less <<
NCT00142805 Alzheimer's Disease Phase 2 Completed - United States, Arizona ... More >> 21st Century Neurology, a division of Xenoscience Inc. Phoenix, Arizona, United States, 85013 United States, California Comprehensive NeuroScience Cerritos, California, United States, 90703 Pharmacology Research Institute Los Alamitos, California, United States, 90720 Pharmacology Research Institute Newport Beach, California, United States, 92660 Pharmacology Research Institute Northridge, California, United States, 91324 The Southwest Institute for Clinical Research Rancho Mirage, California, United States, 92270 Pharmacology Research Institute Riverside, California, United States, 92506 United States, Florida Baumel-Eisner Neuromedical Institute Boca Raton, Florida, United States, 33486 Meridien Research Brooksville, Florida, United States, 34613 Baumel-Eisner Neuromedical Institute, Inc. Ft. Lauderdale, Florida, United States, 33321 Sunrise Clinical Research Hollywood, Florida, United States, 33021 Comprehensive NeuroScience Melbourne, Florida, United States, 32935 Baumel-Eisner Neuromedical Institute Miami Beach, Florida, United States, 33154 Anchor Research Center Naples, Florida, United States, 34102 Renstar Medical Research Ocala, Florida, United States, 34471 Comprehensive NeuroScience St. Petersburg, Florida, United States, 33702 Meridien Research St. Petersburg, Florida, United States, 33709 Meridien Research Tampa, Florida, United States, 33609 United States, Illinois Radiant Research Chicago, Illinois, United States, 60610 United States, North Carolina Multi-Specialty Research Associates of North Carolina Raleigh, North Carolina, United States, 27609 United States, Oregon Radiant Research Portland, Oregon, United States, 97239 United States, Texas Radiant Research Dallas, Texas, United States, 75231 Research Across America Dallas, Texas, United States, 75234 Radiant Research San Antonio, Texas, United States, 78229 Grayline Clinical Drug Trials Wichita Falls, Texas, United States, 76309 Less <<
NCT01746264 Obesity Endot... More >>helial Dysfunction Vitamin D Deficiency Less << Phase 1 Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT02660736 Diabetes Mellitus, Type 2 Phase 1 Completed - United States, Texas ... More >> GSK Investigational Site Austin, Texas, United States, 78744 Less <<
NCT00920426 Infection, Human Immunodeficie... More >>ncy Virus Less << Phase 2 Completed - United States, Florida ... More >> GSK Investigational Site Fort Lauderdale, Florida, United States, 33308 GSK Investigational Site Orlando, Florida, United States, 32803 GSK Investigational Site Vero Beach, Florida, United States, 32960 United States, North Carolina GSK Investigational Site Charlotte, North Carolina, United States, 28209 Less <<
NCT01215032 Prostate Cancer Phase 2 Terminated(slow accrual, compe... More >>ting clinical trials) Less << - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT00920426 - Completed - -
NCT01215032 - Terminated(slow accrual, compe... More >>ting clinical trials) Less << - -
NCT03530566 - Not yet recruiting March 2019 -
NCT01752465 Psychotic Disorders ... More >> Metabolic Syndrome x Less << Not Applicable Unknown September 2016 Canada, British Columbia ... More >> Vancouver/Richmond Early Psychosis Intervention Clinic Vancouver, British Columbia, Canada, V5K 1Z9 Less <<
NCT00325559 Diabetes Mellitus, Type 1 ... More >> Exercise Less << Not Applicable Completed - Switzerland ... More >> Department of Endocrinology, Diabetes and Clinical Nutrition, University Hospital Bern, Switzerland, CH-3010 Less <<
NCT02580513 Diabetes Mellitus, Type 2 ... More >> Insulin Resistance Less << Not Applicable Completed - Netherlands ... More >> Maastricht University Maastricht, Netherlands Less <<
NCT02022111 Diabetes Depr... More >>ession Cardiovascular Risk Factor Less << Not Applicable Active, not recruiting December 31, 2019 India ... More >> Madras Diabetes Research Foundation Chennai, India Less <<
NCT01548248 - Completed - Slovakia ... More >> Novo Nordisk Investigational Site Bratislava, Slovakia, 811 05 Less <<
NCT02248467 - Completed - Italy ... More >> Ambulatori Medicina della Sessualità e Andrologia Florence, Italy Less <<
NCT03132571 Schizophrenia ... More >> Diabetes Mellitus, Type 2 Obesity Less << Phase 4 Recruiting March 31, 2020 United States, Connecticut ... More >> Connecticut Mental Health Center Recruiting New Haven, Connecticut, United States, 06519 Contact: Cenk Tek, MD    203-974-7484    cenk.tek@yale.edu    Principal Investigator: Cenk Tek, MD Less <<
NCT01573949 Diabetes Hear... More >>t Failure Less << Not Applicable Completed - United States, California ... More >> Ahmanson-UCLA Cardiomyopathy Center Los Angeles, California, United States, 90095 Less <<
NCT00325364 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT00625859 Diabetes Mellitus, Type 2 Phase 1 Completed - United States, New York ... More >> GSK Investigational Site Buffalo, New York, United States, 14202 Less <<
NCT02769728 Type 2 Diabetes ... More >> Obesity Less << Not Applicable Active, not recruiting November 2018 Austria ... More >> Dept. of Internal Medicine, Medical University of Graz Graz, Austria, 8036 Less <<
NCT01747967 Type 1 Diabetes Not Applicable Completed - France ... More >> INSERM U1016 - DeAR Lab Avenir, Hôpital Cochin Paris, France, 75014 Less <<
NCT03726983 Gestational Diabetes Mellitus ... More >>in Pregnancy Less << Not Applicable Completed - Taiwan ... More >> Chang Gung Memorail Hospital Taipei, Taiwan, 10507 Less <<
NCT01062009 Pediatric Critical Illness Phase 1 Phase 2 Completed - United States, California ... More >> Childrens' Hospital & Research Center Oakland Oakland, California, United States, 94611 Less <<
NCT00773383 - Terminated - -
NCT02644044 To Evaluate the Effect of Ther... More >>apy With IT MTX on the Disease Course of Patients With Progressive MS Less << Early Phase 1 Unknown January 2018 -
NCT00773383 Non-Small Cell Lung Cancer Phase 2 Terminated - United States, California ... More >> Santa Monica, California, United States, 90404 United States, Florida Miami, Florida, United States, 33101 United States, Massachusetts Boston, Massachusetts, United States, 02114 Boston, Massachusetts, United States, 02115 Boston, Massachusetts, United States, 02215 United States, North Carolina Hickory, North Carolina, United States, 28602 Canada, Alberta Calgary, Alberta, Canada, T2N 4N2 Canada, Ontario Ottawa, Ontario, Canada, K1H 8L6 Canada, Quebec Montreal, Quebec, Canada, H3A 1A1 Montreal, Quebec, Canada, H3G 1A4 France Marseille, France, 13015 Paris, France, 75230 Villejuif, France, 94805 Poland Gdansk, Poland, 80-211 Lublin, Poland, 20-950 Poznan, Poland, 60-569 Less <<
NCT01336621 Epilepsy Phase 3 Completed - -
NCT00697593 - Terminated(The study was termi... More >>nated after the European Medicines Agency recommended to suspend the marketing authorisation of Raptiva in the European Union) Less << - -
NCT00697593 Chronic Plaque Psoriasis Phase 4 Terminated(The study was termi... More >>nated after the European Medicines Agency recommended to suspend the marketing authorisation of Raptiva in the European Union) Less << - Canada, Ontario ... More >> Probity Medical Research City Waterloo, Ontario, Canada, N2J 1C4 Less <<
NCT01854723 Diabetes Phase 4 Unknown December 2015 United States, Oregon ... More >> Providence Medical Group Northeast Clinic Portland, Oregon, United States, 97213 Less <<
NCT01697657 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 3 Completed - Australia, New South Wales ... More >> Novo Nordisk Investigational Site Camperdown, New South Wales, Australia, 2050 Australia Novo Nordisk Investigational Site Ashford, Australia, 5035 Novo Nordisk Investigational Site Box Hill, Australia, 3128 Croatia Novo Nordisk Investigational Site Zagreb, Croatia, 10 000 Denmark Novo Nordisk Investigational Site Køge, Denmark, 4600 Novo Nordisk Investigational Site Århus C, Denmark, 8000 Italy Novo Nordisk Investigational Site Citta' Di Castello, Italy, 06012 Novo Nordisk Investigational Site Perugia, Italy, 06126 South Africa Novo Nordisk Investigational Site Cape Town, Western Cape, South Africa, 7925 Sweden Novo Nordisk Investigational Site Linköping, Sweden, 581 85 Novo Nordisk Investigational Site Trelleborg, Sweden, 231 85 Less <<
NCT01550445 Disorder Related to Renal Tran... More >>splantation Less << Phase 4 Unknown July 2012 Korea, Republic of ... More >> Ajou University Hospital Recruiting Suwon, Korea, Republic of, 443-749 Contact: chang-kwon oh, M.D.    82-10-91657281    OHCK@ajou.ac.kr    Principal Investigator: chang kwon oh, M.D Less <<
NCT01336621 - Completed - -
NCT01673178 Diabetes Melliuts, Type 2 Phase 1 Completed - United States, California ... More >> Anaheim Clinical Trials, LLC Anaheim, California, United States, 92801 Profil Institute for Clinical Research, Inc. Chula Vista, California, United States, 91911 Diablo Clinical Research, Inc. Walnut Creek, California, United States, 94598 United States, Florida Avail Clinical Research, LLC DeLand, Florida, United States, 32720 Elite Research Institute Miami, Florida, United States, 33169 Miami Research Associates, Inc. South Miami, Florida, United States, 33143 MRA Clinical Research, LLC South Miami, Florida, United States, 33143 United States, Kentucky Central Kentucky Research Associates, Inc. Lexington, Kentucky, United States, 40509 L-MARC Research Center Louisville, Kentucky, United States, 40213 United States, Minnesota Prism Research Saint Paul, Minnesota, United States, 55114 United States, North Carolina High Point Clinical Trials Center, LLC High Point, North Carolina, United States, 27265 Carolina Phase 1 Research Raleigh, North Carolina, United States, 27612 Wake Internal Medicine Consultants Raleigh, North Carolina, United States, 27612 United States, Ohio Medpace Clinical Pharmacology Unit Cincinnati, Ohio, United States, 45227 Community Research Cincinnati, Ohio, United States, 45255 Mercy Hospital Pharmacy Cincinnati, Ohio, United States, 45255 United States, Texas Covance Clinical Research Unit Dallas, Texas, United States, 75247 Less <<
NCT03615534 Atherogenic Dyslipidemia ... More >> Obesity Associated Disorder Less << Phase 4 Completed - Iraq ... More >> Al Kindy College of Medicine, University of Baghdad Baghdad, Iraq, 10045 Lewai S Abdulaziz Baghdad, Iraq, 10045 Less <<
NCT01155544 Substance Abuse ... More >> Substance Dependence Less << Phase 4 Withdrawn(Seems to have simply... More >> stopped.) Less << June 2014 United States, New York ... More >> The Zucker Hillside Hospital Glen Oaks, New York, United States, 11004 North Shore Hospital Manhasset, New York, United States, 11030 Less <<
NCT01229891 Type 2 Diabetes Phase 2 Completed - -
NCT01673178 - Completed - -
NCT03615534 - Completed - -
NCT01229891 - Completed - -
NCT00353691 Type 2 Diabetes Mellitus Phase 3 Completed - United States, New Jersey ... More >> Sanofi-Aventis Bridgewater, New Jersey, United States, 08807 Less <<
NCT01513122 - Completed - -
NCT03238690 Heart Failure Not Applicable Recruiting June 30, 2021 United States, Utah ... More >> University of Utah Recruiting Salt Lake City, Utah, United States, 84112 Contact: Stavros Drakos, MD    801-585-2340    stavros.drakos@hsc.utah.edu    Principal Investigator: Stavros Drakos, MD Less <<
NCT01654549 Non-alcoholic Fatty Liver Dise... More >>ase Less << Phase 2 Completed - Iran, Islamic Republic of ... More >> Gastroenterology clinic, Sina hospital. Tehran, Iran, Islamic Republic of Less <<
NCT01513122 HIV Phase 4 Completed - Argentina ... More >> CEADI Buenos Aires, Argentina India YRGCare Medical Centre Chennai, India, 600113 Malaysia University of Malaya Medical Centre Kuala Lumpur, Malaysia, 50603 South Africa JOSHA Research Bloemfontain, South Africa Desmond Tutu HIV Foundation Cape Town, South Africa, 7925 Chris Hani Baragwanath Hospital Soweto, South Africa Thailand HIV-NAT Program on AIDS - Thai Red Cross Bangkok, Thailand, 10330 Less <<
NCT03587051 Hypercholesterolemia Not Applicable Recruiting December 30, 2019 Canada, Saskatchewan ... More >> University of Saskatchewan Recruiting Saskatoon, Saskatchewan, Canada, S7N 5B2 Contact: Philip D Chilibeck, Ph.D.    3069661072    phil.chilibeck@usask.ca    Contact: Julianne Rooke, B.Sc.    3069661082    julianne.rooke@usask.ca    Principal Investigator: Philip Chilibeck, Ph.D.          Sub-Investigator: Gordon Zello, Ph.D. Less <<
NCT00420095 - Completed - -
NCT00420095 Diabetes Mellitus, Type 1 ... More >> Diabetes Mellitus, Type 2 Less << Phase 4 Completed - China ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Guang Zhou, China, 510120 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hangzhou, China, 310003 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Harbin, China, 150086 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hefei, China, 230022 Less <<
NCT00212173 Protocol #1:Behavioral Therapy... More >> + Placebo or Sibutramine Protocol #2: Behavioral Therapy + Meal Replacement or Conventional Food Less << Not Applicable Completed - -
NCT03406000 Type I Diabetes Mellitus Phase 4 Active, not recruiting January 2019 Brazil ... More >> Investigational Site Number 076013 Campinas, Brazil, 13092-132 Investigational Site Number 076016 Curitiba, Brazil, 80030-110 Investigational Site Number 076007 Curitiba, Brazil, 80810-140 Investigational Site Number 076005 Fortaleza, Brazil Investigational Site Number 076002 Goiânia, Brazil, 74175-100 Investigational Site Number 076004 Porto Alegre, Brazil, 91350-250 Investigational Site Number 076011 Ribeirão Preto, Brazil, 14049900 Investigational Site Number 076006 São José dos Campos, Brazil, 12243-280 Investigational Site Number 076015 São Paulo, Brazil, 04022-001 Investigational Site Number 076012 São Paulo, Brazil, 05403-000 Investigational Site Number 076001 SãO Paulo, Brazil Less <<
NCT01654549 - Completed - -
NCT02379559 Physical Activity ... More >> Metabolic Syndrome Prostate Cancer Less << Not Applicable Completed - United States, District of Col... More >>umbia Office of Minority Health and Health Disparities Research Washington, District of Columbia, United States, 20003 Less <<
NCT01438814 Diabetes Mellitus, Type 2 Phase 4 Completed - -
NCT01241370 - Completed - Germany ... More >> ikfe GmbH, clinic Mainz, Germany, 55116 Less <<
NCT01649570 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 4 Completed - Japan ... More >> Tokyo, Japan, 103 Less <<
NCT00584961 - Completed - -
NCT01243554 Pregnancy Obe... More >>sity Less << Not Applicable Completed - Norway ... More >> Norwegian University of Science and Technology Trondheim, Norway, 7489 Less <<
NCT01096446 Hypertriglyceridemia ... More >> Hyperglycemia Less << Not Applicable Terminated(To many infants in ... More >>the experimental group developed hypertriglyceridemia) Less << - United States, Illinois ... More >> Children's Hospital of Illinois at OSF Saint Francis Medical Center Peoria, Illinois, United States, 61637 Less <<
NCT02395003 - Recruiting November 2020 United States, Connecticut ... More >> Yale Recruiting New Haven, Connecticut, United States, 06511 Contact: Bridget Pierpont Less <<
NCT01438814 - Completed - -
NCT01715636 HIV Nonoccupational Post-expos... More >>ure Prophylaxis in Men Who Have Sex With Men Less << Phase 4 Completed - Australia, New South Wales ... More >> Sydney Sexual Heatlh Centre Sydney, New South Wales, Australia, 2000 St Vincents Hospital Sydney, New South Wales, Australia, 2010 Australia, Victoria The Alfred Hospital Melbourne, Victoria, Australia, 3004 Melbourne Sexual Health Centre Melbourne, Victoria, Australia, 3053 Less <<
NCT01096446 - Terminated(To many infants in ... More >>the experimental group developed hypertriglyceridemia) Less << - -
NCT01861717 Acromegaly Phase 4 Terminated(Didn't enroll enoug... More >>h subjects) Less << - United States, California ... More >> Brain Tumor Center and Pituitary Disorders Program, John Wayne Cancer Institute, Saint John's Health System Santa Monica, California, United States, 90404 Less <<
NCT00521820 Diabetes Mellitus Phase 3 Terminated(Higher incidence of... More >> hospitalization for congestive heart failure in pioglitazone-treated subjects compared to glyburide treated subjects.) Less << - -
NCT01500785 Myocardial Stunning Phase 4 Suspended(Change of schedule) September 15, 2018 Finland ... More >> Heart Center Co. Tampere university hospital Tampere, Finland, 33521 Less <<
NCT03115112 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT00961662 - Completed - -
NCT00337532 Head and Neck Cancer Phase 2 Phase 3 Completed - Korea, Republic of ... More >> Local Insitution Seoul, Korea, Republic of Local Institution Seoul, Korea, Republic of Less <<
NCT03568877 Metabolic Syndrome Not Applicable Completed - Spain ... More >> Universidad Miguel Hernandez de Elche Elche, Alicante, Spain, 03202 Less <<
NCT02307279 Overweight Ob... More >>esity Less << Not Applicable Completed - -
NCT01559428 Normocholesterolemic Not Applicable Completed - Netherlands ... More >> Maastricht University Medical Centre Maastricht, Limburg, Netherlands, 6229 ER Less <<
NCT00961662 Type 2 Diabetes Phase 2 Completed - United States, California ... More >> Probe Clinical Research Corp. Garden Grove, California, United States, 92843 United States, Florida Pharmax Research Clinic Miami, Florida, United States, 33126 United States, Georgia PMI Health Research Group Atlanta, Georgia, United States, 30312 Ialim Clinical Research Center Decatur, Georgia, United States, 30035 United States, Texas Juno Research, LLC Houston, Texas, United States, 77036 India Diabetes Care and Research Centre Patna, Bihar, India, 800 020 Bharti Research Institute of Diabetes and Endocrinology Karnal, Haryana, India, 132 001 Bangalore Endocrinology and Diabetes Research Centre Bangalore, Karnataka, India, 560 003 Medisys Clinisearch India Pvt. Ltd. Bangalore, Karnataka, India, 560 043 Belgaum Diabetes Centre Belgaum, Karnataka, India, 590 001 Krishna Diabetes Clinic and Educational Research Centre Bhopal, Madhya Pradesh, India, 462 003 Diabetes Thyroid Hormone Research Institute Pvt. Ltd Indore, Madhya Pradesh, India, 452 001 Research Health Institute in Diabetes Endocrinology and Metabolism Mumbai, Maharashtra, India, 400 014 Less <<
NCT02964585 Type 2 Diabetes Mellitus Phase 4 Recruiting May 2019 United States, District of Col... More >>umbia The George Washington University Medical Faculty Associates Recruiting Washington, District of Columbia, United States, 20037 Contact: Fiona Dore, BS    202-741-2342    fdore@mfa.gwu.edu Less <<
NCT01021748 Locally Advanced or Metastatic... More >> Solid Tumors Less << Phase 1 Completed - -
NCT00605137 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 3 Completed - Japan ... More >> Novo Nordisk Investigational Site Tokyo, Japan, 1000005 Less <<
NCT01021748 - Completed - -
NCT03504319 - Recruiting August 30, 2019 United States, Kentucky ... More >> Western Kentucky University Recruiting Bowling Green, Kentucky, United States, 42101 Contact: Rachel A Tinius, PhD    270-745-5026    rachel.tinius@wku.edu Less <<
NCT01574417 Hypercholesterolemia Not Applicable Completed - Netherlands ... More >> Maastricht University Medical Centre Maastricht, Limburg, Netherlands Less <<
NCT00732472 Pulmonary Disease, Chronic Obs... More >>tructive Less << Phase 2 Completed - United Kingdom ... More >> GSK Investigational Site Reading, Berkshire, United Kingdom, RG2 0TG GSK Investigational Site Buckshaw Village, Chorley, Lancashire, United Kingdom, PR7 7NA GSK Investigational Site Waterloo, Liverpool, Merseyside, United Kingdom, L22 0LG GSK Investigational Site Clydebank, Glasgow, United Kingdom, G81 2DR GSK Investigational Site Edgbaston, Birmingham, United Kingdom, B15 2SQ GSK Investigational Site Llanishen, United Kingdom, CF14 5GJ GSK Investigational Site Manchester, United Kingdom, M15 6SX Less <<
NCT00749190 Diabetes Mellitus, Type 2 Phase 2 Completed - -
NCT00732472 - Completed - -
NCT01347866 - Terminated(Refer to Detailed D... More >>escription for documentaion of Termination Statement.) Less << - -
NCT00749190 - Completed - -
NCT00468403 Type 1 Diabetes Mellitus Phase 2 Completed - United States, Georgia ... More >> Emory University Atlanta, Georgia, United States, 30322 Canada, Alberta University of Alberta Edmonton, Alberta, Canada, T6G028 Less <<
NCT00789035 Diabetes Mellitus, Type 2 Phase 2 Completed - -
NCT01347866 Advanced Cancer Phase 1 Terminated(Refer to Detailed D... More >>escription for documentaion of Termination Statement.) Less << - United States, California ... More >> Ronald Reagan UCLA Medical Center Los Angeles, California, United States, 90095-6984 Ronald Reagan UCLA Medical Center Los Angeles, California, United States, 90095 UCLA Medical Center Los Angeles, California, United States, 90095 UCLA Oncology Center Los Angeles, California, United States, 90095 Santa Monica - UCLA Medical Center and Orthopaedic Hospital Santa Monica, California, United States, 90404 UCLA Santa Monica Hematology Oncology Santa Monica, California, United States, 90404 United States, Colorado Anschutz Cancer Pavilion Aurora, Colorado, United States, 80045 University of Colorado Denver (CTRC) Aurora, Colorado, United States, 80045 University of Colorado Hospital Anschutz Inpatient Pavilion Aurora, Colorado, United States, 80045 University of Colorado Hospital Aurora, Colorado, United States, 80045 United States, South Carolina Medical University of South Carolina, Hollings Cancer Center Charleston, South Carolina, United States, 29425 Medical University of South Carolina Charleston, South Carolina, United States, 29425 MUSC, Investigational Drug Services Charleston, South Carolina, United States, 29425 MUSC Health East Cooper Mount Pleasant, South Carolina, United States, 29464 MUSC Specialty Care-North North Charleston, South Carolina, United States, 29406 Canada, Ontario Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Italy Ospedale San Raffaele Milano, Italy, 20132 Spain Hospital General Vall d'Hebron Barcelona, Spain, 08035 Less <<
NCT00789035 - Completed - -
NCT01103648 Prediabetes H... More >>ypercholesterolemia Inflammation Cardiovascular Risk Less << Not Applicable Completed - Brazil ... More >> Hospital do Rim e Hipertensao da UNIFESP Sao Paulo, Brazil, 04038-002 Less <<
NCT02018497 - Recruiting January 2020 Colombia ... More >> CES University Recruiting Medellín, Antioquia, Colombia, 00 Contact: Luis E Medina, MD    (57)3104055903    essentialhypotension@gmail.com    Sub-Investigator: Jose F Florez, PhD          Sub-Investigator: Jose M Cotes, PhD Less <<
NCT01734473 COPD Not Applicable Active, not recruiting February 2020 United States, Texas ... More >> Texas A&M University College Station, Texas, United States, 77843 Less <<
NCT00789308 Diabetes Mellitus, Type I Phase 2 Completed - Norway ... More >> University Hospital Rikshospitalet Oslo, Norway Sweden Karolinska University Hospital Stockholm, Sweden Uppsala University Hospital Uppsala, Sweden Less <<
NCT01824810 Whiplash Injury Not Applicable Unknown March 2016 Canada, British Columbia ... More >> CHANGEpain Clinic Recruiting Vancouver, British Columbia, Canada, V5Z3A4 Contact: Daphne S Galario    (604)566-9101       Principal Investigator: Brenda Lau, MD Less <<
NCT03321526 Depressive Disorder, Major Phase 2 Recruiting January 9, 2019 -
NCT03305237 Obesity Weigh... More >>t Loss Less << Not Applicable Recruiting June 2020 United Kingdom ... More >> The Rowett Institute Recruiting Aberdeen, United Kingdom, AB25 2ZD Contact: Leonie C Ruddick-Collins, PhD    +44 (0)1224 438752 ext 8752    leonie.ruddickcollins@abdn.ac.uk    Contact: Alexandra M Johnstone, PhD    +44 (0)1224 438614 ext 8614    Alex.Johnstone@abdn.ac.uk Less <<
NCT02815397 Diffuse Large B-Cell Lymphoma Phase 2 Terminated(Poor accrual) - United States, Illinois ... More >> Rush University Medical Center Chicago, Illinois, United States, 60612 Less <<
NCT00704574 - Completed - Sweden ... More >> Novo Nordisk Investigational Site Lund, Sweden, 221 85 Less <<
NCT02815397 - Terminated(Poor accrual) - -
NCT03216057 Hypertriglyceridemia ... More >> Pediatric Obesity Less << Not Applicable Completed - -
NCT00285844 Insulin Resistance ... More >> Obesity Metabolic Syndrome Less << Phase 1 Completed - United States, California ... More >> Stanford University Stanford, California, United States, 94305 Less <<
NCT01925547 Metabolic Syndrome, Protection... More >> Against Less << Phase 2 Completed - Germany ... More >> Institute of Biological Chemistry and Nutrition, University of Hohenheim Stuttgart, Baden-Württemberg, Germany, 70599 Less <<
NCT02818491 Postoperative Pain Phase 4 Recruiting November 2018 Belgium ... More >> AZ Groeninge Hospital Recruiting Kortrijk, Belgium, 8500 Contact: Matthias Desmet    +32 493 18 77 39    matthias.desmet@azgroeninge.be Less <<
NCT03085511 Obesity Not Applicable Recruiting May 2019 United States, Texas ... More >> Texas Tech University - Department of Nutritional Sciences Recruiting Lubbock, Texas, United States, 79409 Contact: Nikhil Dhurandhar, Ph.D.    806-834-6446    nikhil.dhurandhar@ttu.edu Less <<
NCT03210961 Plaque Psoriasis Phase 1 Active, not recruiting January 24, 2019 United States, California ... More >> Anaheim Clinical Trials, LLC Anaheim, California, United States, 92801 Less <<
NCT00858143 - Completed - -
NCT00858143 - Completed - -
NCT00940498 Neoplasms Phase 1 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Dana-Farber Cancer Insitute Boston, Massachusetts, United States, 02215 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10022 Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 United States, Tennessee Sarah Cannon Research Institute, Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37203-1632 Spain Hospital General Vall D'Hebron Barcelona, Spain, 08035 United Kingdom King's College London London, England, United Kingdom, SE1 9RT Less <<
NCT01242683 Obesity Phase 2 Completed - United States, California ... More >> Palo Alto Medical Foundation Research Institute Palo Alto, California, United States, 94301 San Mateo Medical Center, Fair Oaks Adult Clinic Redwood City, California, United States, 94025 El Concilio of San Mateo San Mateo, California, United States, 94010-4123 Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT00940173 Type 1 Diabetes Phase 1 Phase 2 Completed - New Zealand ... More >> Centre for Clinical Research and Effective Practice Auckland, New Zealand Less <<
NCT01785108 Diabetes Mellitus, Type 1 Phase 2 Completed - Sweden ... More >> Halmstad Hospital Halmstad, Sweden, SE-301 85 Astrid Lindgren Children's Hospital - Huddinge Huddinge, Sweden, SE-141 86 Kalmar Hospital Kalmar, Sweden, SE-391 85 Linköping University Linköping, Sweden, SE-581 85 Lund University Hospital Lund, Sweden, SE-221 85 Skåne University Hospital, UMAS Malmö, Sweden, SE-205 02 Sachsska, Södersjukhuset Stockholm, Sweden, SE-118 83 Astrid Lindgren Children's Hospital Stockholm, Sweden, SE-171 76 Uddevalla Hospital Uddevalla, Sweden, SE-451 80 Örebro University Hospital Örebro, Sweden, SE-701 85 Less <<
NCT01012037 Diabetes Mellitus, Type 2 Phase 2 Completed - -
NCT01191424 Asthma Phase 2 Completed - Denmark ... More >> Copenhagen University Hospital Copenhagen, Denmark, 2800 United Kingdom Medicines Evaluation Unit Manchester, United Kingdom, M23 9QZ Less <<
NCT00543803 - Completed - -
NCT01012037 - Completed - -
NCT00955474 Major Depressive Disorder With... More >> Psychotic Features Less << Phase 4 Terminated(AstraZeneca halted ... More >>funding; patent expired for Seroquel (Quetiapine) in 2012) Less << - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT00940498 - Completed - -
NCT00543803 - Completed - -
NCT00379171 Obesity Metab... More >>olic Syndrome Growth Blood Pressure Cardiovascular Disease Less << Not Applicable Completed - -
NCT03106688 Obesity Not Applicable Recruiting December 1, 2022 Finland ... More >> Turku PET Centre (Turku University Hospital) Recruiting Turku, Finland, 20521 Contact: Pirjo Nuutila, M.D., Ph.D.       pirnuu@utu.fi Less <<
NCT03596567 Renal Impairment Phase 1 Completed - United States, Florida ... More >> University of Miami Division of Clinical Pharmacology Miami, Florida, United States, 33136 University of Miami, Sylvester Comprehensive Cancer Center Miami, Florida, United States, 33136 United States, Minnesota Prism Clinical Research LLC Saint Paul, Minnesota, United States, 55114 Less <<
NCT01137474 Type 2 Diabetes Phase 3 Completed - -
NCT02079116 Obesity Not Applicable Completed - Brazil ... More >> Clinical Hospital of Ribeirao Preto Ribeirão Preto, Sao Paulo, Brazil, 14048-900 Less <<
NCT00869609 Diabetes Not Applicable Completed - United States, Pennsylvania ... More >> Diabetes Prevention Support Center Pittsburgh, Pennsylvania, United States, 15213 Less <<
NCT02662114 - Completed - Austria ... More >> Novo Nordisk Investigational Site Wien, Austria, 1130 Novo Nordisk Investigational Site Wien, Austria, 1230 Denmark Novo Nordisk Investigational Site Gentofte, Denmark, 2820 Germany Novo Nordisk Investigational Site München, Germany, 81925 Greece Novo Nordisk Investigational Site Athens, Greece, GR-11527 Italy Novo Nordisk Investigational Site Perugia, Italy, 06127 Switzerland Novo Nordisk Investigational Site St. Gallen, Switzerland, 9016 Less <<
NCT00869609 - Completed - -
NCT00955474 - Terminated(AstraZeneca halted ... More >>funding; patent expired for Seroquel (Quetiapine) in 2012) Less << - -
NCT02497859 Obesity Not Applicable Completed - United States, Texas ... More >> Texas Tech University - Department of Nutritional Sciences Lubbock, Texas, United States, 79409 Less <<
NCT02907684 Cardiovascular Disease Not Applicable Recruiting August 2018 United Kingdom ... More >> King's College London, Diabetes and Nutritional Sciences Division Recruiting London, United Kingdom, SE1 9NH Contact: Leanne Smith, BSc    2078484162    leanne.smith@kcl.ac.uk    Contact: Vita Dikariyanto, MSc    2078484162    vita.dikariyanto@kcl.ac.uk    Principal Investigator: Wendy L Hall, PhD          Principal Investigator: Sarah EE Berry, PhD Less <<
NCT01452477 Polycystic Ovary Syndrome Not Applicable Unknown July 2014 China, Heilongjiang ... More >> Heilongjiang University of Chinese Medicine Recruiting Harbin, Heilongjiang, China, 150040 Contact: Wenjuan Shen, doctor    +86-045182118464    shenwenjuankx@163.com    Contact: Yuehui Zhang, doctor    +86-045182118464    manbingPCOS@163.com    Principal Investigator: Wenjuan Shen, doctor          China, Jiangsu Huaian Maternal and Child Health Hospital Recruiting Huaian, Jiangsu, China, 223001 Contact: Huiying Xue, Scholar    +8613505238015    haxuehuiying@126.com    Principal Investigator: Huiying Xue, bachlor          Lianyungang Maternal and Child Health Hospital Active, not recruiting Lianyungang, Jiangsu, China, 222000 China, Jiangxi JiangXi University of Traditional Chinese Medicine Completed Nanchang, Jiangxi, China, 330000 Less <<
NCT01137474 - Completed - -
NCT03416855 - Enrolling by invitation June 30, 2020 Korea, Republic of ... More >> Novo Nordisk Investigational Site Busan, Korea, Republic of, 47392 Novo Nordisk Investigational Site Busan, Korea, Republic of, 49267 Novo Nordisk Investigational Site Daegu, Korea, Republic of Novo Nordisk Investigational Site Daejeon, Korea, Republic of, 330-721 Novo Nordisk Investigational Site Incheon, Korea, Republic of, 400-103 Novo Nordisk Investigational Site Jeonju, Korea, Republic of, 54987 Novo Nordisk Investigational Site Pyungchon-Dong 896, Dongan-Gu, Korea, Republic of, 431-796 Novo Nordisk Investigational Site Seoul, Korea, Republic of, 01450 Novo Nordisk Investigational Site Seoul, Korea, Republic of Novo Nordisk Investigational Site Ulsan, Korea, Republic of, 682-060 Less <<
NCT00520247 Plasma Total Homocysteine Leve... More >>l Blood Pressure Less << Phase 2 Completed - China, Anhui ... More >> Inistitute for Biomedicine, Anhui Medical University Hefei, Anhui, China, 230032 Less <<
NCT01041365 - Completed - United States, Alabama ... More >> University of Alabama Birmingham, Alabama, United States, 35243 Less <<
NCT02394301 - Suspended(Poor enrollment) December 2015 United States, Florida ... More >> The Medimix Specialty Pharmacy, LLC Jacksonville, Florida, United States, 32216 Less <<
NCT02810769 Ageing Not Applicable Completed - United Kingdom ... More >> Brain, Performance and Nutrition Research Centre Newcastle Upon-Tyne, United Kingdom, NE18ST Less <<
NCT03113916 Diabetes Weig... More >>ht Loss PreDiabetes Obesity Less << Not Applicable Active, not recruiting March 2019 -
NCT02352974 Diabetes Mellitus, Type 1 Phase 1 Active, not recruiting December 2019 Sweden ... More >> Linköping University Linköping, Sweden Less <<
NCT03232034 Obesity Diabe... More >>tes Less << Not Applicable Completed - United Kingdom ... More >> University of Bath Bath, United Kingdom Less <<
NCT01765946 Insulin Resistance ... More >> Prediabetes Aging Inflammation Less << Phase 4 Completed - Italy ... More >> University Hospital Diabetes Outpatient Clinic Padova, Italy, 35128 Less <<
NCT01730196 Diabetes Weig... More >>ht Loss Less << Not Applicable Completed - United States, Georgia ... More >> Georgia Health Sciences University Augusta, Georgia, United States, 30912 Less <<
NCT02316821 Chronic Kidney Disease ... More >> Type 2 Diabetes Less << Phase 2 Completed - Japan ... More >> Tokyo, Japan Less <<
NCT03718832 Type 2 Diabetes Not Applicable Not yet recruiting January 2022 United States, Pennsylvania ... More >> Fresh Food Farmacy Not yet recruiting Lewistown, Pennsylvania, United States, 17044 Contact: Andrea Feinberg, MD    570-271-8713    afeinberg@geisinger.edu    Fresh Food Farmacy Not yet recruiting Scranton, Pennsylvania, United States, 18508 Contact: Andrea Feinberg, MD    570-271-8713    afeinberg@geisinger.edu Less <<
NCT02247271 Diabetes Mellitus, Type 2 Not Applicable Completed - Canada, British Columbia ... More >> UVictoria Delta, British Columbia, Canada, V4K 2K6 Less <<
NCT02464033 Diabetes Mellitus, Type 1 Phase 2 Active, not recruiting November 2018 Sweden ... More >> Helsingborg Hospital Helsingborg, Sweden Linköping University Hospital Linköping, Sweden Lund University Hospital Lund, Sweden Skåne University Hospital, UMAS Malmö, Sweden Sachsska, Södersjukhuset Stockholm, Sweden Uddevalla Hospital Uddevalla, Sweden Västerås Hospital Västerås, Sweden Örebro University Hospital Örebro, Sweden Less <<
NCT00434811 Type 1 Diabetes Mellitus Phase 3 Completed - United States, California ... More >> University of Callifornia, San Francisco San Francisco, California, United States, 94143 United States, Florida University of Miami Miami, Florida, United States, 33136 United States, Georgia Emory University Atlanta, Georgia, United States, 30322 United States, Illinois Northwestern University Chicago, Illinois, United States, 60611 University of Illinois, Chicago Chicago, Illinois, United States, 60612 United States, Minnesota University of Minnesota Minneapolis, Minnesota, United States, 55455 United States, Pennsylvania University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Canada, Alberta University of Alberta Edmonton, Alberta, Canada, T6G028 Less <<
NCT01242059 Obesity Type ... More >>II Diabetes Mellitus Metabolic Syndrome Less << Not Applicable Completed - Canada, Ontario ... More >> University of Toronto - Department of Nutritional Sciences Toronto, Ontario, Canada, M5S 3E2 Less <<
NCT03698708 Type 1 Diabetes Mellitus Not Applicable Not yet recruiting July 2020 -
NCT03654287 - Not yet recruiting October 30, 2021 China ... More >> Children'S Hosptial of Fudan University Recruiting Shanghai, China Contact: LU guoping, dotor    18017590817    13788904150@163.com Less <<
NCT02282995 - Recruiting December 2017 Hong Kong ... More >> Prince of Wales Hospital Recruiting Hong Kong, Hong Kong Contact: Justin C.Y. Wu, MBChB(CUHK)    (852)35053476    justinwu@cuhk.edu.hk    Principal Investigator: Justin C.Y. Wu, MBChB(CUHK) Less <<
NCT02098603 Physical Activity ... More >> Nutrition Health Promotion Stress, Psychological Metabolic Syndrome Less << Not Applicable Completed - United States, Oregon ... More >> Oregon Health and Science University Portland, Oregon, United States, 97239 Less <<
NCT02382757 - Terminated - India ... More >> Bangalore, India, 560001 Less <<
NCT01638351 Diabetes Mellitus, Type 2 Not Applicable Completed - Taiwan ... More >> National Taiwan University Hospital Taipei City, Taiwan, 100 Less <<
NCT03442348 Metabolic Disease ... More >> Immune Function Cardiovascular Diseases Systemic Inflammation Less << Not Applicable Active, not recruiting February 28, 2020 United Kingdom ... More >> King's College London London, England, United Kingdom, SE1 7EH Less <<
NCT03431233 Healthy Subjects Not Applicable Recruiting June 2019 Korea, Republic of ... More >> Seoul National University Hospital Recruiting Seoul, Korea, Republic of, 110-744 Contact: Young Min Cho, MD, PHD    82-2-2072-1965    ymchomd@snu.ac.kr Less <<
NCT02309047 - Recruiting August 2020 Netherlands ... More >> University Medical Center Utrecht Recruiting Utrecht, Netherlands, 3508GA Contact: Bart CJ Fauser, professor    +31887557524    b.c.fauser@umcutrecht.nl    Contact: Nadine MP Daan, MD    +31877551044    n.m.p.daan@umcutrecht.nl    Principal Investigator: Bart CJ Fauser, prof MD PhD Less <<
NCT00958568 Treatment Resistant Depression Phase 3 Completed - -
NCT03377699 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 3 Recruiting April 14, 2021 -
NCT00958568 - Completed - -
NCT03533881 Metabolic Syndrome Not Applicable Recruiting April 15, 2019 Romania ... More >> Endocrinology Department Recruiting Cluj-Napoca, Cluj, Romania Contact: Monica Goia-Socol, MD    0740923197 ext 004    monicagoiasocol@gmail.com    Contact: Cornelia Chaumont, psih    0724269920 ext 004    corneliadecuchaumont@yahoo.fr Less <<
NCT01146678 Type 1 Diabetes Mellitus Phase 1 Completed - Germany ... More >> Sanofi-Aventis Administrative Office Berlin, Germany Less <<
NCT02917616 Healthy Participants Not Applicable Completed - -
NCT02383940 Type 1 Diabetes Mellitus Phase 2 Completed - United States, California ... More >> Lexicon Investigational Site Tustin, California, United States, 92780 United States, Colorado Lexicon Investigational Site Aurora, Colorado, United States, 80045 United States, Connecticut Lexicon Investigational Site New Haven, Connecticut, United States, 06519 United States, Florida Lexicon Investigational Site Tampa, Florida, United States, 33612 Lexicon Investigational Site West Palm Beach, Florida, United States, 33401 United States, Georgia Lexicon Investigational Site Atlanta, Georgia, United States, 30318 Lexicon Investigational Site Roswell, Georgia, United States, 30076 United States, Indiana Lexicon Investigational Site Indianapolis, Indiana, United States, 46202 United States, Louisiana Lexicon Investigational Site New Orleans, Louisiana, United States, 70121 United States, Maine Lexicon Investigational Site Auburn, Maine, United States, 04210 United States, Massachusetts Lexicon Investigational Site Boston, Massachusetts, United States, 02215 United States, New York Lexicon Investigational Site Buffalo, New York, United States, 14222 United States, North Carolina Lexicon Investigational Site Wilmington, North Carolina, United States, 28401 United States, Texas Lexicon Investigational Site Austin, Texas, United States, 78749 United States, Utah Lexicon Investigational Site Salt Lake City, Utah, United States, 84107 Less <<
NCT00558155 Gastric Cancer ... More >> Pancreatic Cancer Less << Phase 4 Completed - Poland ... More >> 1st Department of General Surgery Krakow, Poland, 30-798 Less <<
NCT00566020 Bipolar Disorder Phase 3 Completed - -
NCT02832739 Chronic Heart Failure ... More >> Diabetes Mellitus Chronic Obstructive Pulmonary Disease Special Orthopaedic Co-Morbidity After Hip/Knee Replacement Less << Not Applicable Active, not recruiting August 31, 2017 Israel ... More >> Assuta Medical Center Tel Aviv, Israel, 69710 Norway University Hospital North Norway Tromsoe, Norway, 9038 Less <<
NCT00767741 Diabetes Not Applicable Completed - Israel ... More >> Hadassah Medical center Jerusalem, Other, Israel, 97279 Less <<
NCT02409329 Diabetes Mellitus, Type 2 Not Applicable Active, not recruiting June 2019 United States, Tennessee ... More >> Federally Qualified Health Centers and Vanderbilt Primary Care Clinics Nashville, Tennessee, United States Less <<
NCT01381549 Infections, Urinary Tract Phase 2 Terminated(Microbiological fin... More >>dings of resistance on therapy in patients with complicated urinary tract infection) Less << - United States, California ... More >> GSK Investigational Site Los Angeles, California, United States, 90033 United States, Iowa GSK Investigational Site Council Bluffs, Iowa, United States, 51503 United States, Kansas GSK Investigational Site Topeka, Kansas, United States, 66604 United States, Texas GSK Investigational Site Corsicana, Texas, United States, 75110 Canada, Quebec GSK Investigational Site Chicoutimi, Quebec, Canada, G7H 5H6 GSK Investigational Site Sherbrooke, Quebec, Canada, J1H 5N4 France GSK Investigational Site Suresnes, France, 92151 GSK Investigational Site Toulouse cedex 9, France, 31059 Greece GSK Investigational Site Athens, Greece, 11527 GSK Investigational Site Chaidari, Greece, 12462 GSK Investigational Site Goudi, Athens, Greece, 11527 GSK Investigational Site Thessaloniki, Greece, 56429 Russian Federation GSK Investigational Site Irkutsk, Russian Federation, 664079 GSK Investigational Site Moscow, Russian Federation, 125367 GSK Investigational Site Rostov-on-Don, Russian Federation, 344022 GSK Investigational Site Smolensk, Russian Federation, 214018 GSK Investigational Site St'Petersburg, Russian Federation, 194354 Spain GSK Investigational Site Alicante, Spain, 03010 GSK Investigational Site Elche (Alicante), Spain, 03203 GSK Investigational Site Getafe/Madrid, Spain, 28905 GSK Investigational Site Granada, Spain, 18003 GSK Investigational Site Madrid, Spain, 28040 GSK Investigational Site Murcia, Spain GSK Investigational Site Pama de Mallorca, Spain, 07010 Less <<
NCT01303757 Obesity Metab... More >>olic Syndrome Less << Not Applicable Completed - United States, Massachusetts ... More >> Children's Hospital Boston Boston, Massachusetts, United States, 02115 United States, North Carolina University of North Carolina, Chapel Hill Chapel Hill, North Carolina, United States Less <<
NCT00566020 - Completed - -
NCT00856908 Type II Diabetes Phase 2 Completed - United States, California ... More >> Research Site Chula Vista, California, United States Less <<
NCT01381549 - Terminated(Microbiological fin... More >>dings of resistance on therapy in patients with complicated urinary tract infection) Less << - -
NCT01654172 Diabetes Not Applicable Completed - United Kingdom ... More >> University of Nottingham Nottingham, Notts, United Kingdom, NG72UH Less <<
NCT02716870 - Active, not recruiting January 2019 Canada, Ontario ... More >> The Toronto 3D (Diet, Digestive tract and Disease) Knowledge Synthesis and Clinical Trials Unit, Clinical Nutrition and Risk Factor Modification Centre, St. Michael's Hospital Toronto, Ontario, Canada, M5C 2T2 Less <<
NCT03777709 Cardiovascular Diseases ... More >> Physical Activity Diet Modification Less << Not Applicable Not yet recruiting July 7, 2021 United States, Minnesota ... More >> Mayo Clinic in Rochester Rochester, Minnesota, United States, 55905 Less <<
NCT01084005 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT01304992 Hypercholesterolemia Not Applicable Completed - Germany ... More >> Friedrich Schiller University Jena, Department of Nutritional Physiology Jena, Thuringia, Germany, 07743 Less <<
NCT00856908 - Completed - -
NCT00965458 New-onset Type 1 Diabetes Mell... More >>itus Less << Phase 2 Terminated(Manufacturer discon... More >>tinued production of Amevive® business decision.) Less << - United States, Arizona ... More >> University of Arizona Tucson, Arizona, United States, 85724 United States, California Children's Hospital of Los Angeles Los Angeles, California, United States, 90027 University of California - San Francisco San Francisco, California, United States, 94143 United States, Colorado Barbara Davis Center for Childhood Diabetes - University of Colorado Aurora, Colorado, United States, 80045 United States, Georgia Emory University Atlanta, Georgia, United States, 30322 United States, Indiana Indiana University Indianapolis, Indiana, United States, 46202 United States, Iowa University of Iowa Hospital & Clinics Iowa City, Iowa, United States, 52242 United States, Maryland University of Maryland Baltimore, Maryland, United States, 21201 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 United States, Missouri Children's Mercy Hospitals and Clinics Kansas City, Missouri, United States, 64108 United States, Nebraska Creighton University Omaha, Nebraska, United States, 68131 United States, North Carolina University of North Carolina Durham, North Carolina, United States, 27713 United States, Pennsylvania The Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 United States, Texas University of Texas Southwestern Medical Center Dallas, Texas, United States, 75390 United States, Washington Benaroya Research Institute at Virginia Mason Seattle, Washington, United States, 98101 Less <<
NCT01084005 - Completed - -
NCT00965458 - Terminated(Manufacturer discon... More >>tinued production of Amevive® business decision.) Less << - -
NCT01143051 Asthma Phase 1 Phase 2 Completed - United States, California ... More >> Amphastar Location 1 Cypress, California, United States, 90630 Less <<
NCT00991289 - Completed - -
NCT03683134 Cardiovascular Diseases ... More >> Cardiovascular Risk Factor Obesity Less << Not Applicable Completed - United States, Alabama ... More >> Auburn University Pharmaceutical Care Center Auburn, Alabama, United States, 36849 Less <<
NCT02092896 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 3 Completed - Denmark ... More >> Dept. of Endocrinology, Hvidovre University Hospital Hvidovre, Copenhagen, Denmark, 2650 Less <<
NCT02799719 - Completed - -
NCT00991289 HIV Infection ... More >> Hepatitis C Infection Less << Phase 2 Completed - United States, Alabama ... More >> Alabama Therapeutics CRS Birmingham, Alabama, United States, 35294-2050 United States, California UCLA CARE Center CRS Los Angeles, California, United States, 90035 Stanford AIDS Clinical Trials Unit CRS Palo Alto, California, United States, 94304-5350 UCSD Antiviral Research Center CRS San Diego, California, United States, 92103 Ucsf Hiv/Aids Crs San Francisco, California, United States, 94110 United States, Massachusetts Massachusetts General Hospital CRS (MGH CRS) Boston, Massachusetts, United States, 02114 United States, New Jersey New Jersey Medical School- Adult Clinical Research Ctr. CRS Newark, New Jersey, United States, 07103 United States, New York Weill Cornell Chelsea CRS New York, New York, United States, 10011 Columbia P&S CRS New York, New York, United States, 10032 Trillium Health ACTG CRS Rochester, New York, United States, 14607 Univ. of Rochester ACTG CRS Rochester, New York, United States, 14642 United States, North Carolina Chapel Hill CRS Chapel Hill, North Carolina, United States, 27514 United States, Ohio Cincinnati Clinical Research Site Cincinnati, Ohio, United States, 45267-0405 MetroHealth CRS Cleveland, Ohio, United States, 44109 United States, Pennsylvania Penn Therapeutics, CRS Philadelphia, Pennsylvania, United States, 19104 United States, Rhode Island The Miriam Hospital Clinical Research Site (TMH CRS) CRS Providence, Rhode Island, United States, 02906 United States, Virginia Virginia Commonwealth Univ. Medical Ctr. CRS Richmond, Virginia, United States, 23298 Puerto Rico Puerto Rico AIDS Clinical Trials Unit CRS San Juan, Puerto Rico, 00935 Less <<
NCT03713996 Type2 Diabetes ... More >> Insomnia Less << Not Applicable Not yet recruiting September 25, 2019 United States, Kansas ... More >> University of Kansas Medical Center Not yet recruiting Kansas City, Kansas, United States, 66160 Contact: Mohammed M Alshehri    412-551-2333    malshehri@kumc.edu Less <<
NCT02192450 Type 1 Diabetes Mellitus ... More >> Nocturnal Hypoglycemia Recurrent Severe Hypoglycaemia Less << Phase 4 Active, not recruiting April 2019 Denmark ... More >> Nordsjaellands Hospital Hilleroed, Denmark, 3400 Less <<
NCT00717457 Diabetes Mellitus Type 2 Phase 3 Completed - -
NCT02515773 Bipolar Disorder Phase 4 Recruiting October 2020 United States, Kentucky ... More >> The Children's Home of Northern Kentucky Recruiting Covington, Kentucky, United States, 41011 Contact: Joe Reiman    859-292-4122    jrieman@chnk.org    United States, New Jersey Jersey Shore Medical Center Not yet recruiting Neptune City, New Jersey, United States, 07753 Contact: Nicholas Remo    732-776-3498    NRemo@meridianhealth.com    United States, New York South Oaks Recruiting Amityville, New York, United States, 11701 Contact: Patricia Flaherty, LCSW-R,ACSW,    631-608-5222    pflaherty@northwell.edu    SUNY Downstate/ Kings County Hospital Not yet recruiting Brooklyn, New York, United States, 11203 Contact: Cathryn A. Galanter, M.D.    718-245-2502    cathryn.galanter@downstate.edu    Maimonides Not yet recruiting Brooklyn, New York, United States, 11219 Contact: George Alvarado, M.D.    718-283-8215    GAlvarado@maimonidesmed.org    NYCCC Not yet recruiting Brooklyn, New York, United States, 11233 Contact: Eva Sheridan    718-470-4391    eschenk@northwell.edu    Northwell Zucker Long Island Jewish Hospital Recruiting Glen Oaks, New York, United States, 11004 Contact: Arielle Carmel    718-470-8021    acarmel@northwell.edu    Mount Sinai Recruiting New York, New York, United States, 10029 Contact: Julia G Jones    212-241-3692    julia.george-jones@mssm.edu    LIJ Zucker Hillside Hospital Recruiting New York, New York, United States, 11004 Contact: Eva Shenck    718-470-4391    eschenk@northwell.edu    Child Center of New York, Recruiting Queens, New York, United States, 11373 Contact: Isaiah Mui    718-358-8288 ext 221    isaiahmui@childcenterny.org    Contact: Alla Weinstein    718.358.8288    allaweinstein@childcenterny.org    NorthShore Child and Family Guidance Recruiting Roslyn Heights, New York, United States, 11577 Contact: Esther Gonzalez    516-626-1971    EGonzalez@northshorechildguidance.org    StonyBrook Recruiting Stony Brook, New York, United States, 11794 Contact: Gabrielle A Carlson, MD    631-632-8840    Gabrielle.Carlson@stonybrookmedicine.edu    United States, Ohio Lighthouse Youth Services Recruiting Cincinnati, Ohio, United States, 45206 Contact: Jody Harding    513-487-6778    jarding@lys.org    Contact: Shannon Kiniyalocts    513-487-7706    skiniyalocts@lys.org    Central Clinic Recruiting Cincinnati, Ohio, United States, 45219 Contact: Maria Piombo, Ed.D.,LPCC-S    513-558-5890    piombom@ucmail.uc.edu    Children's Home Recruiting Cincinnati, Ohio, United States, 45227 Contact: Jessica Aritonovich    513-272-2800 ext 4352    jaritonovich@thechildrenshomecinti.org    Cincinnati Children's Hospital Medical Center Recruiting Cincinnati, Ohio, United States, 45229 Contact: Elizabeth Picard, MS    513-803-8898    elizabeth.picard@cchmc.org    Contact: Shelley Randall    513-803-2342    Shelley.randall@cchmc.org    Resident Mood Medication Clinic Recruiting Cincinnati, Ohio, United States, 45229 Contact: Christy Klein, MPH    513-558-5746    kleinci@ucmail.uc.edu    St. Aloysius Recruiting Cincinnati, Ohio, United States, 45237 Contact: Morrisa Gray, RN, BSN    513-482-7257    mgray@stalsorphanage.org    Talbert House Recruiting Cincinnati, Ohio, United States, 45238 Contact: Sharon Stanford, MD    513-265-6090    sharon.stanford@talberthouse.com    St. Joseph's Orphanage Recruiting Cincinnati, Ohio, United States, 45239 Contact: Tyann Godwin, RN    513-741-3100 ext 2166    tyann.godwin@sjokids.org    Child Focus Recruiting Cincinnati, Ohio, United States, 45244 Contact: Jessica Bowlin       JBowlin@child-focus.org    NECCO Recruiting Cincinnati, Ohio, United States, 45246 Contact: Jessica Parks, MSM, LISW-S    513-771-9600    jparks@necco.org    University Hospital Medical Center Cleveland Recruiting Cleveland, Ohio, United States, 44106 Contact: Elizabeth Deyling       Elizabeth.Deyling@UHhospitals.org    Nationwide Children's Hospital Columbus Recruiting Columbus, Ohio, United States, 43205 Contact: Raymond Troy       raymond.troy@nationwidechildrens.org    Ohio State University Recruiting Columbus, Ohio, United States, 43210 Contact: Ghada Lteif, MD    614-293-8237    ghada.lteif@osumc.edu    South Community Recruiting Dayton, Ohio, United States Contact: Mary Day, RN    937-245-6121    mday@southcommunity.com    Butler Behavioral Health Services Recruiting Hamilton, Ohio, United States, 45011 Contact: Randy Allman, LISW-S    513-881-7189 ext 3134    Rallman@bbhs.org    TCN Family Solutions Recruiting Xenia, Ohio, United States, 45385 Contact: Carmel Flores    937-427-3837    cflores@tcn.org    United States, Texas Seton Family of Hospitals Not yet recruiting Austin, Texas, United States, 78712 Contact: Ashleigh Smith       AJSmith2@seton.org Less <<
NCT01143051 - Completed - -
NCT03339427 Vitamin D Deficiency Not Applicable Completed - China, Beijing ... More >> PLA General Hospital Beijing, Beijing, China, 100853 Less <<
NCT02574767 Obesity Pregn... More >>ancy Less << Not Applicable Unknown March 2018 Chile ... More >> Institute of Nutrition and Food Technology Recruiting Santiago, Chile Contact: María Luisa Garmendia, PhD    56224583539    mgarmendia@inta.uchile.cl Less <<
NCT02526069 Type 1 Diabetes Not Applicable Terminated(No uptake from pote... More >>ntial participants) Less << - United Kingdom ... More >> University of Edinburgh Edinburgh, United Kingdom, EH8 9AG Less <<
NCT02951780 Healthy Phase 1 Completed - Singapore ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician. Singapore, Singapore Less <<
NCT03218293 Acute Ischemic Stroke, Cerebra... More >>l Embolism and Thrombosis Less << Not Applicable Recruiting June 30, 2020 China ... More >> The First Affiliated Hospital of Xi'an Jiaotong University Recruiting Xi'an, China, 710061 Contact: Guogang Luo, Ph.D.    86-13991974085 Less <<
NCT03671772 - Not yet recruiting August 31, 2021 Hong Kong ... More >> Department of psychiatry, Faculty of Medicine, The Chinese University of Hong Kong Enrolling by invitation Hong Kong, Hong Kong Less <<
NCT02499705 Insulin Resistance ... More >> Obesity Less << Not Applicable Terminated(Prematurely unblind... More >>ed based on outcome in other trial. 2 out of 3 particpants in one arm had clinically elevated fasting insulin. Adverse event was reported.) Less << - United States, Connecticut ... More >> The John B. Pierce Laboratory New Haven, Connecticut, United States, 06519 Less <<
NCT03568409 Type2 Diabetes Not Applicable Recruiting December 31, 2019 Italy ... More >> Azienda Ospedaliera Padova Recruiting Padova, Italy Contact: Roberto Vettor, Prof.          Sub-Investigator: Nino Cristiano Chilelli, Dr. Less <<
NCT03364205 Obesity Overw... More >>eight and Obesity Adolescent Obesity Less << Not Applicable Completed - Turkey ... More >> Cumhuriyet University Sivas, Turkey, 58140 Less <<
NCT00110669 Duchenne Muscular Dystrophy Phase 3 Completed - United States, District of Col... More >>umbia Children's National Medical Center Washington, District of Columbia, United States, 20010 Less <<
NCT03305718 Biomarkers of Food Intake in H... More >>ealthy Subjects Less << Not Applicable Completed - -
NCT00821977 Diabetes Mellitus, Type 2 Phase 2 Phase 3 Completed - -
NCT03582605 Inflammation at Mini-screw Ins... More >>ertion Site Mobility, Mini-screw Less << Early Phase 1 Recruiting October 2019 United States, Missouri ... More >> Saint Louis University Center for Advanced Dental Education Recruiting Saint Louis, Missouri, United States, 63104 Contact: John F Hatton, DMD    314-977-8353    hattonjf@slu.edu    Principal Investigator: Darren P Hallums, DDS          Sub-Investigator: Hiroshi Ueno, DDS          Sub-Investigator: Julie F McCray, DDS          Sub-Investigator: Ki Beom Kim, DDS, Ph.D          Sub-Investigator: David D Miley, DDS Less <<
NCT00272116 Diarrhea Pneu... More >>monia Acute Respiratory Tract Infection Less << Not Applicable Completed - India ... More >> All India Institute of Medical Sciences New Delhi, Delhi, India, 110029 Less <<
NCT02509962 Healthy Not Applicable Completed - Germany ... More >> Experimental & Clinical Research Center Berlin, Germany, 13125 Less <<
NCT00672854 - Completed - -
NCT01819129 - Completed - -
NCT02315235 Diabetic Neuropathy Not Applicable Withdrawn(Do not have a sutabl... More >>e subjects.) Less << March 2016 Korea, Republic of ... More >> SeoulNUH Seoul, Korea, Republic of Less <<
NCT00672854 Parenteral Nutrition Phase 2 Phase 3 Completed - United States, Georgia ... More >> Grady Memorial Hospital Atlanta, Georgia, United States, 30303 Emory University Hospital Atlanta, Georgia, United States, 30322 Less <<
NCT01454154 Traumatic Brain Injury Phase 2 Unknown September 2015 United States, California ... More >> University of California, San Diego San Diego, California, United States, 92103 United States, Maryland University of Maryland Medical Center, Shock Trauma Center Baltimore, Maryland, United States, 21201 United States, Pennsylvania UPMC Presbyterian Hospital Pittsburgh, Pennsylvania, United States, 15213 United States, Virginia VCU Medical Center Richmond, Virginia, United States, 23298 Less <<
NCT03579797 - Recruiting December 31, 2018 China, Jingan ... More >> Shanghai Eye Disease Prevention & Treatment Center Recruiting Shanghai, Jingan, China, 380 Kangding Road Contact: Zhu Xiaofeng, MM    8613917916016       Sub-Investigator: Zhu Xiaofeng, MM Less <<
NCT01819129 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT03422471 Hypoglycemia ... More >>Type2 Diabetes Less << Not Applicable Recruiting December 31, 2018 United States, Massachusetts ... More >> Brigham and Women's Hospital Recruiting Boston, Massachusetts, United States, 02115 Contact: Rebecca Easly, BA    617-525-7357    reasly@bwh.harvard.edu    Contact: Gillian Murray, BA    617-278-0305    gmurray6@bwh.harvard.edu    Principal Investigator: Gail K Adler, MD, PhD Less <<
NCT00338949 Schizophrenia ... More >> Metabolic Syndrome X Insulin Resistance Less << Phase 4 Completed - United States, California ... More >> VA San Diego Healthcare System San Diego, California, United States, 92161 Less <<
NCT03448965 - Not yet recruiting December 31, 2019 -
NCT03736785 Type 2 Diabetes Mellitus Phase 2 Recruiting December 30, 2019 -
NCT03482154 - Active, not recruiting July 26, 2020 United States, Colorado ... More >> Children's Hospital Colorado Aurora, Colorado, United States, 80045 Less <<
NCT00162305 Diabetes Mellitus, Type 2 Phase 2 Completed - United States, Florida ... More >> Local Institution Fort Lauderdale, Florida, United States, 33301 Local Institution Miami, Florida, United States, 33169 Local Institution Orlando, Florida, United States, 32809 United States, Louisiana Local Institution New Orleans, Louisiana, United States, 70119 United States, Texas Local Institution San Antonio, Texas, United States, 78229-3894 Less <<
NCT01597635 Lung Injury, Acute Phase 2 Completed - United States, California ... More >> GSK Investigational Site Sacramento, California, United States, 95817 United States, Illinois GSK Investigational Site Chicago, Illinois, United States, 60611 United States, Massachusetts GSK Investigational Site Springfield, Massachusetts, United States, 01199 United States, Michigan GSK Investigational Site Ann Arbor, Michigan, United States, 48109 United States, New York GSK Investigational Site New York, New York, United States, 10003 United States, North Carolina GSK Investigational Site Durham, North Carolina, United States, 27710 GSK Investigational Site Greensboro, North Carolina, United States, 27403 GSK Investigational Site Winston-Salem, North Carolina, United States, 27517 United States, Ohio GSK Investigational Site Columbus, Ohio, United States, 43215 United States, Oregon GSK Investigational Site Portland, Oregon, United States, 97239 United States, Pennsylvania GSK Investigational Site Philadelphia, Pennsylvania, United States, 19104 GSK Investigational Site Philadelphia, Pennsylvania, United States, 19107 United States, South Carolina GSK Investigational Site Charleston, South Carolina, United States, 29425 Canada, British Columbia GSK Investigational Site Vancouver, British Columbia, Canada, V5Z 1M9 GSK Investigational Site Vancouver, British Columbia, Canada, V6Z 1Y6 Canada, Nova Scotia GSK Investigational Site Halifax, Nova Scotia, Canada, B3H 2Y9 Canada, Ontario GSK Investigational Site Kingston, Ontario, Canada, K7L 2V7 Canada, Quebec GSK Investigational Site Greenfield Park, Quebec, Canada, J4V 2H1 GSK Investigational Site Sainte-Foy, Quebec, Canada, G1V 4G5 Less <<
NCT03429946 Hypoglycemia ... More >>Healthy Less << Phase 4 Recruiting December 31, 2018 United States, Massachusetts ... More >> Beth Israel Deaconess Medical Center Recruiting Boston, Massachusetts, United States, 02115 Contact: Jeffery White          Principal Investigator: Roy Freeman, MD          Brigham and Women's Hospital Recruiting Boston, Massachusetts, United States, 02115 Contact: Rebecca Easly, BA    617-525-7357    reasly@bwh.harvard.edu    Contact: Gillian Murray, BA    617-278-0305    gmurray6@bwh.harvard.edu    Principal Investigator: Gail K Adler, MD, PhD Less <<
NCT03171441 - Completed - -
NCT03735225 Hypoglycemia Phase 1 Recruiting February 20, 2019 Germany ... More >> CRS Clinical Research Services Mannheim GmbH Recruiting Mannheim, Germany, 68167 Contact: Friedeborg Seitz, MD    0049621150450    Friedeborg.Seitz@crs-group.de Less <<
NCT01597635 - Completed - -
NCT01409330 Type 2 Diabetes Phase 4 Unknown December 2013 Germany ... More >> German Diabetes Center Recruiting Duesseldorf, NRW, Germany, 40225 Contact: Lejla Zahiragic, MD    00492118104819    lejla.zahiragic@med.uni-duesseldorf.de    Contact: Bettina Nowotny, MD    00492113382-0 ext -575    bettina.nowotny@ddz.uni-duesseldorf.de    Sub-Investigator: Lejla Zahiragic, MD          Sub-Investigator: Bettina Nowotny, MD, M.Sc.          Principal Investigator: Michael Roden, Professor, MD          Charite, Department of Internal Medicine Active, not recruiting Berlin, Germany University Hospital, Department of Internal Medicine III Not yet recruiting Dresden, Germany Contact: Ulrike Schatz, MD          Sub-Investigator: Ulrike Schatz, MD          Principal Investigator: Stefan Bornstein, Professor, MD          University Hospital, Department of Internal Medicine I Recruiting Heidelberg, Germany Contact: Jan Groener, MD       jan.groener@med.uni-heidelberg.de    Sub-Investigator: Jan Groener, MD          Principal Investigator: Peter Nawroth, Professor, MD          Klinikum der Universität München (KUM) Active, not recruiting Munich, Germany University Hospital, Department of Internal Medicine IV Active, not recruiting Tübingen, Germany Less <<
NCT02880852 Systemic Lupus Erythematosus Phase 1 Completed - China ... More >> GSK Investigational Site Shanghai, China GSK Investigational Site Suzhou, China, 215004 Less <<
NCT02880852 - Completed - -
NCT01222078 - Terminated(A Phase 3 study rec... More >>ently reported and demonstrated that the dose of otelixizumab in OTX113390 is not effective.) Less << - -
NCT01222078 Diabetes Mellitus, Type 1 Phase 2 Terminated(A Phase 3 study rec... More >>ently reported and demonstrated that the dose of otelixizumab in OTX113390 is not effective.) Less << - France ... More >> GSK Investigational Site Paris Cedex 18, France, 75877 Germany GSK Investigational Site Ulm, Baden-Wuerttemberg, Germany, 89081 GSK Investigational Site Leipzig, Sachsen, Germany, 04103 Less <<
NCT01145066 Diabetes Meta... More >>bolic Syndrome x Less << Not Applicable Completed - United States, North Carolina ... More >> Wake Forest Baptist Medical Center Winston-Salem, North Carolina, United States, 27157 Less <<
NCT02255006 Healthy Not Applicable Unknown December 2014 Korea, Republic of ... More >> Kyung Hee University Medical Center Recruiting Seoul, Korea, Republic of, 130-701 Contact: Weon Kim, Professor    82-2-958-8176    mylovekw@hanmail.net Less <<
NCT00515502 - Completed - -
NCT00515502 Pulmonary Disease, Chronic Obs... More >>tructive Less << Phase 2 Completed - Germany ... More >> GSK Investigational Site Hannover, Niedersachsen, Germany, 30625 GSK Investigational Site Berlin, Germany, 14050 GSK Investigational Site Hamburg, Germany, 22291 Less <<
NCT02201199 Type 1 Diabetes Mellitus Phase 1 Completed - Germany ... More >> Investigational Site Number 276001 Neuss, Germany, 41460 Less <<
NCT01101633 Obesity Overw... More >>eight Less << Phase 1 Completed - Denmark ... More >> Department of Human Nutrtion, University of Copenhagen Frederiksberg, Copenhagen, Denmark, 1958 Less <<
NCT01600664 Type 1 Diabetes Not Applicable Completed - Israel ... More >> Schneider Medical Center Petach- Tikva, Israel Less <<
NCT00459121 - Terminated - -
NCT00416130 Breast Cancer Phase 1 Phase 2 Unknown January 2015 Singapore ... More >> National University Hospital Singapore, Singapore, 149547 National Cancer Centre Singapore, Singapore, 169610 Less <<
NCT00459121 Lung Cancer Phase 2 Terminated - United States, Michigan ... More >> Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201-1379 Less <<
NCT01818310 Critical Lower Limb Ischemia ... More >> Type-2 Diabetes Mellitus Less << Phase 2 Phase 3 Active, not recruiting October 2018 Czechia ... More >> University Hospital Ostrava Ostrava, Czechia, 708 52 Less <<
NCT02642172 Non-alcoholic Fatty Liver Dise... More >>ase Metabolic Syndrome Less << Not Applicable Recruiting January 2020 Israel ... More >> Kaplan Medical Center Recruiting Rechovot, Israel, 81207 Contact: Naama reshef    +972506705552    reshefn2@gmail.com Less <<
NCT02029833 Cardiovascular Disease ... More >> Diabetes Metabolic Syndrome Less << Not Applicable Completed - United States, Pennsylvania ... More >> The Pennsylvania State University University Park, Pennsylvania, United States, 16802 Canada, Manitoba St Boniface Hospital Research Winnipeg, Manitoba, Canada, R2H 2A6 Richardson Centre for Functional Foods and Nutraceuticals, University of Manitoba Winnipeg, Manitoba, Canada, R3T 6C5 Canada, Quebec Institute of Nutrition and Functional Foods, Laval University Quebec City, Quebec, Canada, G1V 0A6 Less <<
NCT03754920 Fasting Not Applicable Active, not recruiting September 9, 2019 China, Shanghai ... More >> Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine Shanghai, Shanghai, China, 200030 Less <<
NCT02481401 Promoting Cardiovascular Healt... More >>h in Adults Lifestyle Intervention Atherosclerosis Less << Not Applicable Active, not recruiting April 2019 United States, New York ... More >> Lutheran Social Services, Site 14 New York, New York, United States, 10027 West Harlem Community Organization, Inc. New York, New York, United States, 10027 East Harlem Community Organization, Inc., Site 2 New York, New York, United States, 10029 East Harlem Council for Human Services, Inc., Site 1 New York, New York, United States, 10029 Union Settlement Carver Childcare Center New York, New York, United States, 10029 Union Settlement Head Start at Franklin Plaza New York, New York, United States, 10029 Union Settlement Johnson New York, New York, United States, 10029 Union Settlement Leggett Memorial New York, New York, United States, 10029 Union Settlement Washington New York, New York, United States, 10029 Addie Mae Collins Head Start, Site 1 New York, New York, United States, 10035 Addie Mae Collins Head Start, Site 2 New York, New York, United States, 10035 Addie Mae Collins Head Start, Site 3 New York, New York, United States, 10035 Association to Benefit Children Graham School New York, New York, United States, 10035 Lutheran Social Services, Site 11 New York, New York, United States, 10039 Lutheran Social Services, Site 12 New York, New York, United States, 10039 Less <<
NCT02394158 Gestational Diabetes Mellitus Phase 4 Unknown July 2017 United Kingdom ... More >> Imperial College NHS Trust Recruiting London, United Kingdom, W2 1PG Contact: Stephen Robinson, FRCP, MD    0203 312 1253       Contact: Rochan Agha-Jaffar, BMBS, MRCP    0207 594 6140    r.agha-jaffar@imperial.ac.uk    London North West Healthcare Trust Recruiting London, United Kingdom Contact: Mushtaqur Rahman, FRCP, PhD          Contact: Rochan Agha-Jaffar, BMBS, MRCP    0207 594 6140    r.agha-jaffar@imperial.ac.uk Less <<
NCT03509519 Sarcopenia Not Applicable Not yet recruiting March 2020 -
NCT01788241 - Active, not recruiting April 2025 Netherlands ... More >> TweeSteden Hospital Tilburg Tilburg, Dr. Deelenlaan 5, Netherlands, 5042 AD Less <<
NCT02294682 Gonorrhea Phase 2 Completed - United States, California ... More >> GSK Investigational Site Fountain Valley, California, United States, 92708 GSK Investigational Site Los Angeles, California, United States, 90028 GSK Investigational Site Los Angeles, California, United States, 90069 GSK Investigational Site Palm Springs, California, United States, 92262 GSK Investigational Site San Francisco, California, United States, 94103 United States, Florida GSK Investigational Site Orlando, Florida, United States, 32806 United States, Georgia GSK Investigational Site Atlanta, Georgia, United States, 30308 United States, Indiana GSK Investigational Site Indianapolis, Indiana, United States, 46202 United States, Louisiana GSK Investigational Site New Orleans, Louisiana, United States, 70119 United States, Nebraska GSK Investigational Site Omaha, Nebraska, United States, 68114 United States, Ohio GSK Investigational Site Cleveland, Ohio, United States, 44109 United States, Pennsylvania GSK Investigational Site Jenkintown, Pennsylvania, United States, 19046 Puerto Rico GSK Investigational Site San Juan, Puerto Rico, 00927 United Kingdom GSK Investigational Site London, United Kingdom, SW10 9NH Less <<
NCT01588678 Advanced Solid Tumor ... More >> Lymphoma Less << Phase 1 Completed - United States, Texas ... More >> South Texas Accelerated Research Therapeutics San Antonio, Texas, United States, 78229 Less <<
NCT01838083 Type1 Diabetes Phase 1 Completed - Germany ... More >> Investigational Site Number 276001 Neuss, Germany, 41460 Less <<
NCT02974413 Diabetes Mellitus Not Applicable Unknown - Brazil ... More >> Universidade Estadual de Maringá Recruiting Maringá, Paraná, Brazil, 87020-900 Contact: Guilherme O Arruda, Master    4491663381    enfgoa@gmail.com Less <<
NCT02892331 Obesity Insul... More >>in Resistance Sedentary Lifestyle Less << Not Applicable Recruiting May 2019 United States, North Carolina ... More >> East Carolina University Recruiting Greenville, North Carolina, United States, 27858 Contact: Damon L Swift, Ph.D.    252-737-1338    swiftd@ecu.edu Less <<
NCT00903617 Dyslipidaemias Phase 2 Completed - United States, Florida ... More >> GSK Investigational Site Pembroke Pines, Florida, United States, 33026 United States, Indiana GSK Investigational Site Indianapolis, Indiana, United States, 46260 United States, Kentucky GSK Investigational Site Louisville, Kentucky, United States, 40213 United States, Maine GSK Investigational Site Auburn, Maine, United States, 04210 United States, Minnesota GSK Investigational Site Brooklyn Center, Minnesota, United States, 55430 United States, North Carolina GSK Investigational Site Statesville, North Carolina, United States, 28677 United States, Ohio GSK Investigational Site Cincinnati, Ohio, United States, 45246 United States, Texas GSK Investigational Site San Antonio, Texas, United States, 78205 United States, Virginia GSK Investigational Site Richmond, Virginia, United States, 23294 United States, Washington GSK Investigational Site Olympia, Washington, United States, 98502 GSK Investigational Site Seattle, Washington, United States, 98104 Less <<
NCT01332292 Asthma Phase 2 Completed - United States, California ... More >> GSK Investigational Site Cypress, California, United States, 90630 GSK Investigational Site Huntington Beach, California, United States, 92647 United States, Colorado GSK Investigational Site Denver, Colorado, United States, 80206 United States, Illinois GSK Investigational Site Normal, Illinois, United States, 61761 United States, Oregon GSK Investigational Site Medford, Oregon, United States, 97504 Less <<
NCT00903617 - Completed - -
NCT01332292 - Completed - -
NCT03063320 Cardiovascular Risk Factor Not Applicable Recruiting December 2018 United States, Pennsylvania ... More >> Penn State University Recruiting University Park, Pennsylvania, United States, 16802 Contact: Kristina S Petersen, PhD    814-863-8622    kup63@psu.edu    Contact: Jennifer Fleming    814-863-8056    jas@psu.edu    Sub-Investigator: Connie J Rogers, PhD          Sub-Investigator: Sheila G West, PhD Less <<
NCT02294682 - Completed - -
NCT00867386 - Completed - United States, Illinois ... More >> Northwestern University Chicago, Illinois, United States, 60611 Less <<
NCT03410537 Taurine Diabe... More >>tes Lower Extremity Artery Disease Less << Not Applicable Recruiting June 2018 China, Chongqing ... More >> The third hospital affiliated to the Third Military Medical University Recruiting Chongqing, Chongqing, China, 400042 Contact: Yan Zhencheng, MD    86-023-68757882    zhenchengyan@sina.com Less <<
NCT00289900 Mixed Hyperlipidemia Phase 3 Completed - -
NCT01251367 Post-stroke Spasticity ... More >> Spasticity Post-Traumatic Brain Injury Less << Phase 3 Completed - -
NCT00977600 Healthy Phase 1 Completed - Ukraine ... More >> Medical Sanitary Division #2 Kharkiv, Ukraine, 61011 Less <<
NCT00289900 - Completed - -
NCT00985179 Heart Diseases ... More >> Diabetes Mellitus, Type 2 Behavior Motivation Less << Not Applicable Completed - Germany ... More >> Freie Universitaet Berlin Berlin, Germany, 14195 Less <<
NCT02578836 Obesity Overw... More >>eight Weight Loss Less << Not Applicable Withdrawn(Study was withdrawn ... More >>due to PI decision) Less << November 2018 United States, Florida ... More >> University of Miami Clinical Research Building Miami, Florida, United States, 33136 Less <<
NCT00897390 - Completed - -
NCT01232491 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 4 Completed - -
NCT01251367 - Completed - -
NCT00897390 Type 2 Diabetes Mellitus Phase 1 Completed - United States, Nebraska ... More >> Mds Pharma Services Lincoln, Nebraska, United States, 68502 Less <<
NCT01232491 - Completed - -
NCT02548000 Diabetes Mellitus, Type 2 Not Applicable Completed - Brazil ... More >> Hospital de Clinicas de Porto Alegre Porto Alegre, Rio Grande do Sul, Brazil, 90035-903 Federal University of Rio Grande do Sul, Physical Education School Porto Alegre, Rio Grande do Sul, Brazil, 90690-000 Less <<
NCT03321305 - Completed - United States, Texas ... More >> University of Texas at Austin Austin, Texas, United States, 78712 Less <<
NCT02170428 - Completed - Denmark ... More >> Department of Human Nutrition, Faculty of Sciences, University of Copenhagen Frederiksberg, Denmark, 1958 Less <<
NCT00356785 Obesity Metab... More >>olic Syndrome Less << Not Applicable Completed - Germany ... More >> University Hospital, Department for Rehabilitation, Prevention and Sports Medicine Freiburg, Germany, 79106 Less <<
NCT02947568 - Recruiting December 2019 Hungary ... More >> 2nd Department of Medicine and Nephrological Center Recruiting Pécs, Baranya, Hungary, 7624 Contact: Gergo A Molnar, MD, PhD    +3672536050    gergo.molnar@aok.pte.hu    Contact: Eszter Sélley, MD    +3672536050    eszter.selley@aok.pte.hu    Sub-Investigator: Béla Melegh, MD          Sub-Investigator: Lilla Lakner, MD          Sub-Investigator: Kulcsár Imre, MD          Sub-Investigator: Bene Judit, MD          Principal Investigator: István Wittmann, MD Less <<
NCT02878486 Mild Cognitive Impairment Not Applicable Completed - United States, Kansas ... More >> University of Kansas Medical Center Kansas City, Kansas, United States, 66160 Less <<
NCT02533648 Type 2 Diabetes Mellitus Phase 3 Unknown May 2016 France ... More >> CRNH Rhône Alpes Recruiting Lyon, France, 69310 Contact: Martine LAVILLE, Professor    +33. 4 78 86 29 81    martine.laville@chu-lyon.fr    Contact: Nathalie FEUGIER    +33. 4 78 86 19 72    nathalie.feugier@chu-lyon.fr    Principal Investigator: Martine LAVILLE, professor Less <<
NCT01206647 Diabetes Mellitus, Type 2 Phase 4 Unknown February 2011 Germany ... More >> Diabetologische Schwerpunktpraxis Dr. Lorra / Dr. Bonnermann Bochum, Germany, 44869 Zentrum für klinische Studien Dresden, GWT-TUD GmbH Dresden, Germany, 01307 Gemeinschaftspraxis Partner der Gesundheit Essen, Germany, 45355 IKFE Institute for Clinical Research and Development Mainz, Germany, 55116 Zentrum für Diabetes und Gefäßerkrankungen Münster, Germany, 48145 Diabetes Zentrum Neuwied Neuwied, Germany, 56564 ikfe Studiencenter Potsdam GmbH Potsdam, Germany, 14469 Less <<
NCT01253252 Abdominal Aortic Aneurysm Not Applicable Completed - France ... More >> Le Bocage - Dijon's Hospital Dijon, France, 21 000 Cardiologic Hospital Lille, France, 59037 Brabois Hospital Nancy, France, 54500 Institut du Thorax, Nantes's Hospital Nantes, France, 44 093 Bichat Claude Bernard Hospital Paris, France, 75018 Georges Pompidou European Hospital Paris, France, 75908 CH.NICOLLE's Hospital Rouen, France, 76031 Less <<
NCT01183689 Weight Gain Not Applicable Active, not recruiting November 2018 United States, North Carolina ... More >> University of North Carolina Chapel Hill, North Carolina, United States, 27559 United States, Rhode Island The Miriam Hospital Providence, Rhode Island, United States, 02903 Less <<
NCT00147719 Type 2 Diabetes Phase 3 Completed - -
NCT01963390 - Completed - United States, Massachusetts ... More >> Men's Health Boston Chestnut Hill, Massachusetts, United States, 02467 Less <<
NCT00147758 Type 2 Diabetes Phase 3 Completed - -
NCT00285233 Type 1 Diabetes ... More >> Hypoglycemia Less << Phase 1 Phase 2 Completed - United States, Minnesota ... More >> University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT01888315 Hypertension ... More >>Heart Failure Chronic Kidney Disease Diabetes Heart Rhythm Disorders Less << Phase 1 Phase 2 Recruiting January 2021 Germany ... More >> University Hospital Saarland Recruiting Homburg/Saar, Germany, 66421 Contact: Michael Böhm, MD          Contact: Felix Mahfoud, MD Less <<
NCT01908634 Healthy Non-smoker Not Applicable Active, not recruiting September 2019 United States, Illinois ... More >> Clinical Nutrition Research Center Chicago, Illinois, United States, 60616 Less <<
NCT01813929 Type 1 Diabetes Phase 4 Active, not recruiting December 2018 United States, Colorado ... More >> University of Colorado Denver Aurora, Colorado, United States, 80045 Less <<
NCT01183689 - Active, not recruiting - -
NCT01662999 Type 2 Diabetes Mellitus Phase 1 Completed - United States, Nebraska ... More >> Icon Clinical Pharmacology Omaha, Nebraska, United States, 68154 Less <<
NCT00088465 Schizophrenic Disorders ... More >> Schizoaffective Disorder Less << Phase 3 Completed - -
NCT01662999 - Completed - -
NCT02538081 Schizophrenia Phase 1 Phase 2 Withdrawn(Withdrawn) - United States, Colorado ... More >> VA Eastern Colorado Health Care System, Denver, CO Denver, Colorado, United States, 80220 Less <<
NCT02518945 Type 1 Diabetes Mellitus Phase 3 Unknown - United States, New York ... More >> ECMC Ambulatory Center, 3rd Floor Recruiting Buffalo, New York, United States, 14215 Contact: Nitesh D Kuhadiya, MD, MPH    716-898-1940    nkuhadiya@gmail.com    Contact: Jeanne Hejna, LPN    716-898-1944    jeannehe@buffalo.edu Less <<
NCT02429791 - Active, not recruiting - -
NCT00088465 - Completed - -
NCT01561404 Disorder Related to Renal Tran... More >>splantation Exercise, Aerobic Muscle Strength Less << Phase 4 Terminated(lack of potential p... More >>atients) Less << - Spain ... More >> Nephrology Department. Hospital Universitari de Bellvitge L'Hospitalet de Llobregat, Barcelone, Spain, 08907 Less <<
NCT02429791 HIV Infections Phase 3 Active, not recruiting August 13, 2021 -
NCT03058562 Tourette Syndrome ... More >> Chronic Motor Tic Disorder Less << Phase 1 Completed - Germany ... More >> Medizinische Hochschule Hannover Hannover, Niedersachsen, Germany, 30625 Less <<
NCT02422797 - Active, not recruiting - -
NCT01730014 Diabetes Diab... More >>etes Mellitus, Type 1 Healthy Less << Phase 1 Completed - Germany ... More >> Neuss, Germany, 41460 Less <<
NCT02422797 HIV Infections Phase 3 Active, not recruiting August 12, 2021 -
NCT02294786 Cancer Phase 2 Terminated(study was stopped d... More >>ue to futility by the DMC in September 2016) Less << - -
NCT03573687 Healthy Not Applicable Completed - United States, Florida ... More >> Institute for Sports Sciences and Medicine, Florida State University Tallahassee, Florida, United States, 32306 Less <<
NCT03324373 Renal Cell Carcinoma Phase 1 Not yet recruiting April 30, 2021 United States, Iowa ... More >> University of Iowa Hospitals and Clinics Not yet recruiting Iowa City, Iowa, United States, 52242 Contact: Yousef Zakharia, MD    319-384-8076    yousef-zakharia@uiowa.edu Less <<
NCT01667679 Migraine Head... More >>aches Less << Phase 3 Completed - United States, California ... More >> San Francisco Clinical Research Center San Francisco, California, United States, 94109 California Medical Clinic for Headache Santa Monica, California, United States, 90404 United States, Connecticut Associated Neurologists of Southern CT, P.C. Fairfied, Connecticut, United States, 06824 United States, Florida Premiere Research Institute West Palm Beach, Florida, United States, 33407 United States, Massachusetts MedVadis Watertown, Massachusetts, United States, 02472 United States, Michigan Michigan Head and Pain Institute Ann Arbor, Michigan, United States, 48104-5199 United States, Missouri ClinVest Springfield, Missouri, United States, 65807 Mercy Health Research St. Louis, Missouri, United States, 63141 United States, New York DENT Neurologic Institute Amherst, New York, United States, 14226 United States, North Carolina Headache Welness Center Greensboro, North Carolina, United States, 27405 PMG Research of Winston Salem, LLC Winston Salem, North Carolina, United States, 27103 United States, Pennsylvania Jefferson Headache Center Philadelphia, Pennsylvania, United States, 19107 United States, South Carolina Coastal Carolina Research Center Mt. Pleasant, South Carolina, United States, 29464 Less <<
NCT01667679 - Completed - -
NCT01313312 Nervous System Disorders Phase 3 Completed - -
NCT01313312 - Completed - -
NCT03428542 Stress Anxiet... More >>y Depression Sleep Physiological Stress Less << Not Applicable Completed - Sweden ... More >> KFE, Skåne University Hospital in Malmö Malmö, Sweden, 20502 Less <<
NCT00465426 - Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT03430856 Type2 Diabetes Mellitus Phase 2 Phase 3 Recruiting September 2020 India ... More >> Diacon Hospital Recruiting Bangalore, Karnataka, India, 560010 Contact: Aravind Aravind, MBBS, DNB    8028085305    draravind@hotmail.com    Contact: Geethanjali Rangaswamy    9008465877    geethanjali.kst@gmail.com Less <<
NCT02702713 Metabolic Syndrome Not Applicable Terminated(The funding agency ... More >>set a mandatory deadline for the study in order to be able to conclude the project.) Less << - France ... More >> Centre de Récherche en Nutrition Humaine d'Auvergne Clermont-Ferrand, Auvergne, France, 63009 Germany Max Rubner-Institut Karlsruhe, Baden-Württemberg, Germany, 76131 Italy University of Bologna, Department of Medical and Surgical Sciences and Azienda Ospedaliero Universitaria di Bologna, Policlinico S.Orsola-Malpighi Bologna, BO, Italy, 40138 United Kingdom University of Leeds Leeds, United Kingdom, LS2 9JT Less <<
NCT02362737 Chronic Disease ... More >> Obesity Hypertension Diabetes Self Care Medication Adherence Less << Not Applicable Active, not recruiting June 30, 2018 United States, North Carolina ... More >> Gramercy Research Group Winston-Salem, North Carolina, United States, 27106 Less <<
NCT03225339 Diabetes Mellitus, Type 2 Not Applicable Recruiting November 30, 2019 Qatar ... More >> Primary Healthcare Corporation Recruiting Doha, Qatar, P.O. Box 26555 Contact: Dr Samya Ahmed Al- Abdulla    +974 40271400    saalabdulla@phcc.gov.qa    Hamad Medical Corporation Recruiting Doha, Qatar, PO Box 3050 Contact: Prof. Abdul Badi Abou-Samra    +974 4439 6577    asamra@hamad.qa Less <<
NCT02316665 Type 1 Diabetes ... More >> Sleep Apnea Syndrome Less << Not Applicable Completed - France ... More >> Grenoble University hospital Grenoble, France, 38043 Less <<
NCT00046501 Diabetes Mellitus Phase 3 Completed - United States, New Jersey ... More >> Aventis Bridgewater, New Jersey, United States, 08807 Less <<
NCT02306681 - Completed - Bangladesh ... More >> Novo Nordisk Investigational Site Dhaka, Bangladesh, 1000 Colombia Novo Nordisk Investigational Site Bogotá, Colombia, 1 Egypt Novo Nordisk Investigational Site Cairo, Egypt Philippines Novo Nordisk Investigational Site Manilla, Philippines, 1605 Singapore Novo Nordisk Investigational Site Singapore, Singapore, 169608 South Africa Novo Nordisk Investigational Site Pretoria, South Africa, 2 Turkey Novo Nordisk Investigational Site Ankara, Turkey, 06100 United Arab Emirates Novo Nordisk Investigational Site Ajman, United Arab Emirates, 21499 Less <<
NCT02978105 Obesity Phase 3 Completed - Italy ... More >> Città della Salute e della Scienza di Torino Turin, Italy, 10126 Less <<
NCT02513407 Healthy Subject Not Applicable Active, not recruiting June 2019 United States, California ... More >> City of Hope Medical Center Duarte, California, United States, 91010 Less <<
NCT00089583 Infection, Human Immunodeficie... More >>ncy Virus I Less << Phase 2 Completed - -
NCT01478308 Prostate Cancer Phase 2 Withdrawn(No accrual in initia... More >>l period, PI decided to close study.) Less << - -
NCT02404207 Cardiovascular Disease ... More >> Diabetes Metabolic Syndrome Less << Not Applicable Completed - United States, Maryland ... More >> USDA-ARS, Beltsville Human Nutrition Research Center Beltsville, Maryland, United States, 20705 Less <<
NCT02387827 Obesity Overw... More >>eight Less << Not Applicable Completed - Iran, Islamic Republic of ... More >> NovinDiet Clinic Tehran, Iran, Islamic Republic of, 1913635136 Less <<
NCT03221205 Sleep Apnea, Obstructive ... More >> Diabetes Mellitus, Type 2 Continuous Positive Airway Pressure Myocardial Dysfunction Echocardiography Obesity Less << Not Applicable Active, not recruiting November 1, 2017 Mexico ... More >> Insituto Nacional de Enfermedades Respiratorias Mexico City, Delegacion Tlalpan, Mexico, 14080 Less <<
NCT02348814 - Recruiting March 2018 United States, California ... More >> UCLA Clinical and Translational Research Center (CTRC) Recruiting Los Angeles, California, United States, 90095 Contact: Stephanie Okimoto, BA, CCRC    310-267-1040    sokimoto@mednet.ucla.edu Less <<
NCT02230618 - Completed - India ... More >> Novo Nordisk Investigational Site Guntur, Andhra Pradesh, India, 522001 Novo Nordisk Investigational Site Vijayawada, Andhra Pradesh, India, 520002 Novo Nordisk Investigational Site Visakhapatnam, Andhra Pradesh, India, 530002 Novo Nordisk Investigational Site Ahmedabad, Gujarat, India, 380007 Novo Nordisk Investigational Site Ahmedabad, Gujarat, India, 380052 Novo Nordisk Investigational Site Ahmedabad, Gujarat, India Novo Nordisk Investigational Site Gandhinagar, Gujarat, India, 382428 Novo Nordisk Investigational Site Ghuma, Gujarat, India Novo Nordisk Investigational Site Surat, Gujarat, India, 395002 Novo Nordisk Investigational Site Bangalore, Karnataka, India, 560092 Novo Nordisk Investigational Site Bangalore, Karnataka, India Novo Nordisk Investigational Site Mangalore, Karnataka, India, 575001 Novo Nordisk Investigational Site Angamaly, Kerala, India Novo Nordisk Investigational Site Kochi, Kerala, India, 682041 Novo Nordisk Investigational Site Thrissur, Kerala, India Novo Nordisk Investigational Site Trivandrum, Kerala, India Novo Nordisk Investigational Site Indore, Madhya Pradesh, India, 452008 Novo Nordisk Investigational Site Indore, Madhya Pradesh, India Novo Nordisk Investigational Site Mumbai, Maharashtra, India, 400053 Novo Nordisk Investigational Site Pune, Maharashtra, India, 411001 Novo Nordisk Investigational Site Amritsar, Punjab, India Novo Nordisk Investigational Site Chandigarh, Punjab, India Novo Nordisk Investigational Site Jaipur, Rajasthan, India, 302017 Novo Nordisk Investigational Site Jaipur, Rajasthan, India Novo Nordisk Investigational Site Chennai, Tamil Nadu, India, 600037 Novo Nordisk Investigational Site Chennai, Tamil Nadu, India, 600100 Novo Nordisk Investigational Site Chennai, Tamil Nadu, India Novo Nordisk Investigational Site Coimbatore, Tamil Nadu, India, 641009 Novo Nordisk Investigational Site Madurai, Tamil Nadu, India, 625 020 Novo Nordisk Investigational Site Lucknow, Uttar Pradesh, India, 226005 Novo Nordisk Investigational Site Lucknow, Uttar Pradesh, India Novo Nordisk Investigational Site Noida, Uttar Pradesh, India, 201301 Novo Nordisk Investigational Site Kolkata, West Bengal, India, 700054 Novo Nordisk Investigational Site Bilaspur, India, 495001 Novo Nordisk Investigational Site Thriruvananthapuram, India, 695 032 Less <<
NCT00089583 - Completed - -
NCT00903916 - Completed - United States, North Carolina ... More >> University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States, 27599 Less <<
NCT03766620 - Recruiting January 2020 Spain ... More >> Hospital Universitario de Cabueñes Not yet recruiting Gijón, Asturias, Spain, 33394 Hospital Universitario Germans Trias I Pujol Not yet recruiting Badalona, Barcelona, Spain, 08916 Hospital Punta Europa 3094 Not yet recruiting Algeciras, Cádiz, Spain, 11207 Hospital Punta Europa 3176 Not yet recruiting Algeciras, Cádiz, Spain, 11207 Hospital San Pedro Not yet recruiting Logroño, La Rioja, Spain, 26006 Hospital Costa del Sol 3095 Not yet recruiting Marbella, Málaga, Spain, 29603 Hospital Costa del Sol 3177 Not yet recruiting Marbella, Málaga, Spain, 29603 Hospital Costa del Sol 3178 Not yet recruiting Marbella, Málaga, Spain, 29603 Hospital de Navarra Recruiting Pamplona,, Navarra, Spain, 31008 Hospitalital de la Ribera Not yet recruiting Alcira, Valencia, Spain, 46600 Hospital del Mar Not yet recruiting Barcelona, Spain, 08003 Hospital Universitario Vall d´Hebrón Not yet recruiting Barcelona, Spain, 08035 Hospital Clinico San Carlos Not yet recruiting Madrid, Spain, 28040 Hospital Universitario La Paz Recruiting Madrid, Spain, 28046 Hospital Universitario Principe de Asturias 3092 Not yet recruiting Madrid, Spain, 28805 Hospital Universitario Principe de Asturias 3175 Not yet recruiting Madrid, Spain, 28805 Centro Médico San juan de la Cruz Recruiting Málaga, Spain, 29007 Hospital Clínico Universitario de Valladolid Recruiting Valladolid, Spain, 47003 Hospital General Universitario de Valencia Not yet recruiting València, Spain, 46014 Hospital Universitario y Politécnico de La Fe 3065 Not yet recruiting València, Spain, 46026 Hospital Universitario y Politécnico de La Fe 3096 Not yet recruiting València, Spain, 46026 Less <<
NCT03263871 Environmental Enteric Dysfunct... More >>ion Less << Not Applicable Recruiting June 30, 2019 Bangladesh ... More >> International Centre for Diarrhoeal Disease Research, Bangladesh Recruiting Dhaka, Bangladesh Contact: Rashidul Haque, MBBS, PhD Less <<
NCT00081328 - Completed - -
NCT00770640 Diabetes Mellitus Phase 2 Completed - Germany ... More >> Schwetzingen, Baden-Württemberg, Germany Wiesbaden, Hessen, Germany Bottrop, Nordrhein-Westfalen, Germany Düsseldorf, Nordrhein-Westfalen, Germany Lüdenscheid, Nordrhein-Westfalen, Germany Solingen, Nordrhein-Westfalen, Germany Alzey, Rheinland-Pfalz, Germany Ingelheim, Rheinland-Pfalz, Germany Mainz, Rheinland-Pfalz, Germany Less <<
NCT00842426 Obesity Pre-d... More >>iabetes Metabolic Syndrome Less << Phase 2 Completed - United States, California ... More >> Palo Alto Medical Foundation, Los Altos Center Palo Alto, California, United States, 94022 Less <<
NCT00081328 Diabetes Mellitus, Type II Phase 3 Completed - United States, California ... More >> Children's Hospital Los Angeles Los Angeles, California, United States, 90027 United States, Colorado University of Colorado Health Sciences Center, The Children's Hospital Denver, Colorado, United States, 80262 United States, Connecticut Yale University New Haven, Connecticut, United States, 06520 United States, Maryland George Washington University Biostatistics Center Rockville, Maryland, United States, 20852 United States, Massachusetts Massachusetts General Hospital Diabetes Center Boston, Massachusetts, United States, 02114 Joslin Diabetes Center Boston, Massachusetts, United States, 02215 United States, Missouri Saint Louis University Health Sciences Center St Louis, Missouri, United States, 63104 Washington University Department of Pediatrics St. Louis, Missouri, United States, 63110 United States, New York Columbia University Medical Center New York City, New York, United States, 10032 State University of New York Upstate Medical University Syracuse, New York, United States, 13210 United States, Ohio Case Western Reserve Cleveland, Ohio, United States, 44106 United States, Oklahoma University of Oklahoma Oklahoma City, Oklahoma, United States, 93104 United States, Pennsylvania Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 Children's Hospital of Pittsburgh Pittsburgh, Pennsylvania, United States, 15213 United States, Texas Baylor College of Medicine Houston, Texas, United States, 77030 University of Texas Health Science Center at San Antonio San Antonio, Texas, United States, 78229 Less <<
NCT00486746 Obstructive Sleep Apnea Not Applicable Active, not recruiting December 2018 Finland ... More >> Kuopio University Hospital Kuopio, Finland, 70211 Less <<
NCT00612040 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 2 Completed - -
NCT02368405 Spinal Cord Injury Not Applicable Recruiting May 2020 United States, North Carolina ... More >> Carolinas Rehabilitation Recruiting Charlotte, North Carolina, United States, 28203 Contact: Jesse A Lieberman, MD, MSPH    704-355-0649    Jesse.Lieberman@Carolinashealthcare.org    Contact: Sherri Stutts    704-355-4906    Sherri.R.Stutts@carolinashealthcare.org Less <<
NCT00308113 Duchenne Muscular Dystrophy Phase 3 Terminated(New enrollment has ... More >>been suspended, currently following previously enrolled participants) Less << - United States, Pennsylvania ... More >> University of Pittsburgh Pittsburgh, Pennsylvania, United States, 15213 Less <<
NCT03438097 - Completed - Canada, British Columbia ... More >> St Paul's Hospital Vancouver, British Columbia, Canada Vancouver General Hospital Vancouver, British Columbia, Canada Sweden ICU Halmstad Hospital Halmstad, Sweden ICU Helsingborg Hospital Helsingborg, Sweden ICU Kristianstad Hospital Kristianstad, Sweden ICU Skane University Hospital Lund, Sweden Department of Infections Diseases Malmö, Sweden ICU Skane University Hospital Malmö, Sweden ICU Ystad Hospital Ystad, Sweden Less <<
NCT00384488 Pre-Diabetes Not Applicable Completed - United States, Colorado ... More >> Kaiser-Permanente of Colorado Aurora, Colorado, United States, 80014 Less <<
NCT00612040 - Completed - -
NCT03699150 - Completed - -
NCT00501956 Malnutrition ... More >>Complication of Hemodialysis Less << Phase 4 Completed - Germany ... More >> Interneph e.V. Institute for Applied Nephrology Aachen, Germany, 52074 Less <<
NCT00108524 Diabetes Mellitus ... More >> Obesity Less << Not Applicable Completed - United States, North Carolina ... More >> Durham VA Medical Center HSR&D COE Durham, North Carolina, United States, 27705 Less <<
NCT03679364 - Not yet recruiting August 1, 2020 Vietnam ... More >> Bach Mai Hospital Not yet recruiting Hà Nội, Hà Nội, Vietnam Contact: Văn Thính Prof. Lê    +84903217699    levanthinh2006@fpt.vn    Principal Investigator: Văn Thính Prof. Lê, MD          Phu Tho General Hospital Not yet recruiting Tỉnh Phú, Phu Tho, Vietnam Contact: Huy Ngọc Nguyễn, MD. PhD.    +84 2106278888    benhvienphutho@bvpt.com    103 Military Hospital Not yet recruiting Hanoi, Vietnam Contact: Đình Đài Assoc. Prof. Phạm, MD    +84909982115    dr_nguyenhuythang@yahoo.com    115 Hospital Not yet recruiting Ho Chi Minh City, Vietnam Contact: Huy Thắng Assoc. Prof. Nguyễn, MD    +84909982115       108 Military Hospital Not yet recruiting Hà Nội, Vietnam Contact: Hoàng Ngọc Assoc. Prof. Nguyễn, MD    +84912319029    hoangngoc67@yahoo.com    Trưng Vương Hospital Not yet recruiting Phước Long, Vietnam Contact: Văn Minh Nguyễn, MD. Msc.    +84 02854484949    bv.cctv@tphcm.gov.vn Less <<
NCT00308113 - Terminated(New enrollment has ... More >>been suspended, currently following previously enrolled participants) Less << - -
NCT02053415 Healthy Not Applicable Completed - Norway ... More >> Department of Clinical Science, University of Bergen Bergen, Norway, 5020 Less <<
NCT03323216 - Recruiting March 31, 2024 Germany ... More >> University Hospital RWTH Aachen Recruiting Aachen, NRW, Germany, 52074 Contact: Ben A Kappel, MD PhD Less <<
NCT01560520 - Completed - Denmark ... More >> Hillerød Hospital Hillerød, Denmark, 3400 Less <<
NCT03407677 Diabetes Not Applicable Recruiting August 2019 Denmark ... More >> Department of Clinical Research, Nordsjællands Hospital Recruiting Hillerød, Denmark, 3400 Contact: Peter L Kristensen, MD, PHD    +45 40845013    peter.lommer.kristensen.01@regionh.dk Less <<
NCT00108524 - Completed - -
NCT03495362 Pre-diabetic Not Applicable Recruiting March 2019 China, Hubei ... More >> Huazhong University of Science and Technology Recruiting Wuhan, Hubei, China, 430030 Contact: Liegang Liu, MD, PhD    +86-27-83650522    liegangliu@gmail.com    Principal Investigator: Shufang Xu, PhD          Principal Investigator: Liangkai Chen, MD          Principal Investigator: Xiaoli Hu, MD          Principal Investigator: Qiang Wang, MD Less <<
NCT00869908 - Completed - -
NCT02568592 Dietary Modification Not Applicable Unknown June 2016 United Kingdom ... More >> University of Birmingham Birmingham, West Midlands, United Kingdom, B15 2TT Less <<
NCT03730142 Advanced Cancer Phase 1 Enrolling by invitation October 25, 2019 China ... More >> Shanghai East Hospital Shanghai, China Less <<
NCT01903356 - Completed - Korea, Republic of ... More >> One or multiple Investigational sites, Korea, Republic of Less <<
NCT01195168 - Completed - Ireland ... More >> Diabetes Day Centre, The Adelaide and Meath Hosptial Dublin, Leinster, Ireland, Dublin 24 Nutrigenomics Research Group, University College Dublin Dublin, Leinster, Ireland, Dublin 4 Less <<
NCT03296332 - Active, not recruiting December 2017 China, Beijing ... More >> The National Center for Chronic and Noncommunicable Disease Control and Prevention Beijing, Beijing, China, 100050 Less <<
NCT02669732 Type 2 Diabetes Mellitus Not Applicable Completed - Japan ... More >> SOUSEIKAI Hakata Clinic Hakata-ku, Fukuoka, Japan, 812-0025 Less <<
NCT00855907 - Unknown March 2011 Israel ... More >> Tel Aviv Sourasky Medical center Not yet recruiting Tel Aviv, Israel, 64239 Contact: Nitsan Maharshak, MD    972-3-6974282    nitsan_maharshak@walla.com    Principal Investigator: Nitsan Maharshak, MD Less <<
NCT01382303 - Completed - -
NCT03326206 - Completed - United States, Arizona ... More >> Chinle Comprehensive Health Care Facility Chinle, Arizona, United States, 86503 Tsehootsooi Medical Center Fort Defiance, Arizona, United States, 86504 Kayenta Health Center Kayenta, Arizona, United States, 86033 United States, New Mexico Crownpoint Health Center Facility Crownpoint, New Mexico, United States, 87313 Gallup Indian Medical Center Gallup, New Mexico, United States, 87301 Northern Navajo Medical Center Shiprock, New Mexico, United States, 87420 Less <<
NCT03621215 Gout Flare Go... More >>ut Attack Less << Not Applicable Not yet recruiting January 2021 United Kingdom ... More >> Food and Nutrition Group, Sheffield Hallam University Not yet recruiting Sheffield, United Kingdom, S1 1WB Contact: Tony Lynn, PhD    0114 2252065    T.Lynn@shu.ac.uk    Contact: Margo Barker, PhD    01142560765    Margo.Barker@shu.ac.uk    Principal Investigator: Margo Barker, PhD          Principal Investigator: Tony Lynn, PhD          Sub-Investigator: Kirstie Lamb, MMedSci Less <<
NCT01382303 Type 2 Diabetes Phase 4 Completed - Korea, Republic of ... More >> Ajou University Hospital Suwon, Korea, Republic of Less <<
NCT03036618 Change in Fasting Plasma LDL-c... More >>holesterol Concentration After the Consumption of Quinoa Less << Not Applicable Recruiting September 2018 United Kingdom ... More >> NU-Food Research Facility Recruiting Newcastle upon Tyne, Tyne and Wear, United Kingdom, NE1 7RU Contact: Anthony Watson, PhD       anthony.watson@ncl.ac.uk    Sub-Investigator: Liangkui Li          Principal Investigator: Chris Seal, PhD Less <<
NCT01746017 Diabetes Mellitus, Type 2 Phase 1 Completed - Singapore ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Singapore, Singapore Less <<
NCT01870297 Type 2 Diabetes Mellitus Phase 1 Completed - United States, California ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chula Vista, California, United States, 91911 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Orange, California, United States, 92868 United States, Florida For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Miami, Florida, United States, 33143 United States, Ohio For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Cincinnati, Ohio, United States, 45227 Less <<
NCT02973334 Normal Subjects Not Applicable Completed - Switzerland ... More >> University of Lausanne Lausanne, Switzerland, 1005 Less <<
NCT00663884 Diabetes Mellitus, Type 2 Phase 4 Completed - Korea, Republic of ... More >> The Catholic Univ. of Korea, Kangnam ST. Mary's Hospital Seoul, Korea, Republic of, 137-701 Less <<
NCT00399360 HIV Infections ... More >> Metabolic Syndrome X Less << Not Applicable Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT02457286 Non-alcoholic Fatty Liver Dise... More >>ase (NAFLD) Less << Phase 1 Withdrawn(patients do not want... More >> to participate) Less << - United States, New York ... More >> North Shore Hospital Manhasset, New York, United States, 11030 Less <<
NCT02730377 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 4 Active, not recruiting August 12, 2019 -
NCT01680146 Sarcopenia Not Applicable Completed - Netherlands ... More >> Maastricht University Maastricht, Limburg, Netherlands, 6200 MD Less <<
NCT01334125 - Completed - -
NCT02906930 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT01334125 Diabetes Mellitus Phase 3 Completed - United States, Massachusetts ... More >> UmassMemorial Medical Center Worcester, Massachusetts, United States, 01655 Less <<
NCT02691676 Acid Base Imbalance Phase 3 Completed - -
NCT01600066 - Completed - -
NCT01814917 Chronic Kidney Disease ... More >> Dialysis Hyperphosphatemia Paediatric Less << Phase 3 Terminated(This study has been... More >> terminated because of insufficient patient recruitment.) Less << - United Kingdom ... More >> Investigational site London, United Kingdom Less <<
NCT01468818 Metastatic Melanoma ... More >> Skin Cancer Less << Phase 2 Terminated(Study was closed pr... More >>ematurely due to slow and insufficient accrual.) Less << - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT01468818 - Terminated(Study was closed pr... More >>ematurely due to slow and insufficient accrual.) Less << - -
NCT03415880 Diabetes Mellitus ... More >> Physical Exercise Light Intensity Physical Activity Arterial Stiffness Aortic Stiffness Pulse Wave Velocity Type2 Diabetes Sedentary Lifestyle Artery Disease Physical Activity Less << Not Applicable Recruiting December 31, 2019 Netherlands ... More >> Academisch Ziekenhuis Maastricht Recruiting Maastricht, Netherlands Less <<
NCT01355627 Cerebrospinal Fluid Leaks Phase 3 Completed - -
NCT01355627 - Completed - -
NCT02495987 - Unknown April 2018 United Kingdom ... More >> Guy's & St Thomas' NHS Foundation Trust Recruiting London, United Kingdom, SE1 7EH Contact: Jenny Chambers    0208 3835285    jenny.chambers@imperial.ac.uk    Imperial College Healthcare NHS Trust Hammersmith Recruiting London, United Kingdom Contact: Jenny Chambers    0208 3835285 Less <<
NCT00399360 - Completed - -
NCT01778556 Lipodystrophy Phase 2 Recruiting December 31, 2019 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)    800-411-1222 ext TTY8664111010    prpl@cc.nih.gov Less <<
NCT01512108 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - Japan ... More >> Novo Nordisk Investigational Site Chuo-ku, Tokyo, Japan, 103 0002 Novo Nordisk Investigational Site Chuo-ku, Tokyo, Japan, 103 0027 Novo Nordisk Investigational Site Ehime, Japan, Japan, 790 0067 Novo Nordisk Investigational Site Fukuoka, Japan, Japan, 810 8798 Novo Nordisk Investigational Site Fukuoka-shi, Fukuoka, Japan, 815 8555 Novo Nordisk Investigational Site Fukuoka, Japan, 812 0025 Novo Nordisk Investigational Site Fukuoka, Japan, 818 8502 Novo Nordisk Investigational Site Fukuoka, Japan, 820 8505 Novo Nordisk Investigational Site Kamagaya-shi, Chiba, Japan, 273 0121 Novo Nordisk Investigational Site Kashiwara-shi, Osaka, Japan, 582 0005 Novo Nordisk Investigational Site Kawagoe-shi, Saitama, Japan, 350 0851 Novo Nordisk Investigational Site Kitakyushu-shi, Fukuoka, Japan, 800 0252 Novo Nordisk Investigational Site Koriyama-shi, Fukushima, Japan, 963 8851 Novo Nordisk Investigational Site Kumamoto-shi,Kumamoto, Japan, 862 0976 Novo Nordisk Investigational Site Kurume-shi, Fukuoka, Japan, 839 0863 Novo Nordisk Investigational Site Miyazaki-shi, Japan, 880 0034 Novo Nordisk Investigational Site Naka-shi, Ibaraki, Japan, 311 0113 Novo Nordisk Investigational Site Niigata-shi, Niigata, Japan, 950 1104 Novo Nordisk Investigational Site Oita, Japan, 870 8511 Novo Nordisk Investigational Site Okawa-shi, Fukuoka, Japan, 831 0016 Novo Nordisk Investigational Site Osaka-shi, Osaka, Japan, 532 0003 Novo Nordisk Investigational Site Osaka-shi, Osaka, Japan, 545 8586 Novo Nordisk Investigational Site Ota-ku, Tokyo, Japan, 144 0035 Novo Nordisk Investigational Site Oyama-shi, Tochigi, Japan, 323 0022 Novo Nordisk Investigational Site Sapporo-shi, Hokkaido, Japan, 060-0001 Novo Nordisk Investigational Site Sapporo-shi, Hokkaido, Japan, 062 0007 Novo Nordisk Investigational Site Shimotsuke-shi, Tochigi, Japan, 329 0433 Novo Nordisk Investigational Site Shizuoka-shi, Japan, 424 0853 Novo Nordisk Investigational Site Tagajo-shi, Japan, 985 0852 Novo Nordisk Investigational Site Takatsuki-shi, Osaka, Japan, 569 1096 Novo Nordisk Investigational Site Tochigi, Japan, 329 0498 Novo Nordisk Investigational Site Tokyo, Japan, 104 0044 Novo Nordisk Investigational Site Tokyo, Japan, 113 0031 Novo Nordisk Investigational Site Tokyo, Japan, 125 0054 Novo Nordisk Investigational Site Yamaguchi, Japan, 755 0067 Novo Nordisk Investigational Site Yokohama-shi, Japan, 235 0045 Less <<
NCT01196533 Accuracy of the TensorTip Devi... More >>ce Compared With Standard Hospital Physiology and Lab Measurements. Less << Not Applicable Completed - United States, New Jersey ... More >> Atlantic Health - Morristown Memorial Hospital- Cardiovascular Medicine Morristown, New Jersey, United States, 07962-1905 Less <<
NCT01512108 - Completed - -
NCT00612014 Gastroparesis ... More >> Diabetes Mellitus Less << Phase 2 Completed - United States, California ... More >> California Pacific Medical Center San Francisco, California, United States, 94115 United States, Indiana Central Indiana Gastroenterology Group Anderson, Indiana, United States, 46016-4346 United States, Kansas Kansas University Medical Center Kansas City, Kansas, United States, 66160 United States, Kentucky University of Louisville Louisville, Kentucky, United States, 40202 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 United States, North Carolina Wake Forest University Health Sciences Winston-Salem, North Carolina, United States, 27157 Denmark Aarhus University Hospital Aarhus, Denmark India Amrita Institute of Medical Sciences Research Center (AIMS) Cochin, Kerala, India, 682026 Norway Haukeland University Hospital Bergen, Norway Sweden Karolinska University Hospital Stockholm, Sweden United Kingdom Manchester Royal Infirmary Manchester, United Kingdom, M139WL Royal Hallamshire Hospital Sheffield, United Kingdom, S102JF Less <<
NCT03344341 Type 2 Diabetes Mellitus Phase 4 Recruiting August 31, 2019 China ... More >> Research Site Not yet recruiting Beijing, China, 100020 Research Site Not yet recruiting Beijing, China, 100034 Research Site Not yet recruiting Beijing, China, 100730 Research Site Not yet recruiting Changsha, China, 410008 Research Site Not yet recruiting Changsha, China, 410011 Research Site Not yet recruiting Changsha, China, 410013 Research Site Not yet recruiting Chengdu, China, 610041 Research Site Not yet recruiting Chongqing, China, 400016 Research Site Not yet recruiting Guangzhou, China Research Site Not yet recruiting Guiyang, China Research Site Recruiting Hangzhou, China, 310014 Research Site Not yet recruiting Hangzhou, China, 310016 Research Site Not yet recruiting Hefei, China, 230022 Research Site Not yet recruiting Jinan, China, 250012 Research Site Not yet recruiting Kunming, China, 650032 Research Site Not yet recruiting Nanjing, China, 2100008 Research Site Not yet recruiting Nanjing, China, 210029 Research Site Not yet recruiting Qingdao, China, 266003 Research Site Not yet recruiting Qingdao, China Research Site Not yet recruiting Shanghai, China, 200032 Research Site Recruiting Shanghai, China, 200233 Research Site Recruiting Shanghai, China, CN-200120 Research Site Not yet recruiting Shenyang, China, 100003 Research Site Not yet recruiting Shenyang, China, 110001 Research Site Not yet recruiting Suzhou, China, 215004 Research Site Not yet recruiting Tianjin, China, CN-300070 Research Site Not yet recruiting Urumqi, China, 830054 Research Site Not yet recruiting Xi'an, China, 710061 Research Site Not yet recruiting Xining, China, 810001 Research Site Not yet recruiting Yinchuan, China, 750004 Less <<
NCT01278485 - Completed - -
NCT02752308 Hypospadias Phase 2 Phase 3 Completed - -
NCT00843583 - Completed - Hong Kong ... More >> Department of Medicine, The University of Hong Kong, Queen Mary Hospital Hong Kong, Hong Kong, 852 Less <<
NCT00108004 Type 1 Diabetes Mellitus ... More >> Type 2 Diabetes Mellitus Less << Phase 3 Completed - -
NCT01345227 Type 1 Diabetes ... More >> Postpancreatectomy Hyperglycemia Less << Not Applicable Completed - Italy ... More >> IRCCS San Raffaele Milan, Italy, 20132 Less <<
NCT01999218 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT01355861 Sarcopenia Not Applicable Withdrawn(Project has been wit... More >>hdrawn from funding consideration) Less << June 2014 United States, District of Col... More >>umbia VA Medical Center, DC Washington, District of Columbia, United States, 20422 Less <<
NCT01278485 - Completed - -
NCT00372957 - Completed - -
NCT01467401 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 4 Completed - -
NCT00428935 Duchenne Muscular Dystrophy Phase 1 Completed - United States, Ohio ... More >> Columbus Children's Hospital Columbus, Ohio, United States, 43205 Less <<
NCT01550653 Healthy Phase 1 Completed - Germany ... More >> University of Luebeck, Department of Neuroendocrinology Luebeck, Germany, 23538 Less <<
NCT02053441 - Unknown September 2016 United Kingdom ... More >> University of Nottingham (Derby campus) Recruiting Derby, Derbyshire, United Kingdom, DE22 3NE Contact: Philip Atherton, PhD    0044 (0) 01332 724725    philip.atherton@nottingham.ac.uk    Contact: Syed SI Bukhari, MBBS    00447809239232    mzxsb@nottingham.ac.uk    Principal Investigator: Kenneth Smith, PhD Less <<
NCT00372957 Diabetes Mellitus, Type 2 Phase 2 Completed - -
NCT01362673 Healthy Phase 1 Completed - United States, California ... More >> Pfizer Investigational Site Glendale, California, United States, 91206 Less <<
NCT01999218 - Completed - -
NCT01206101 - Terminated(The decision to clo... More >>se the NN2211-3619 trial was based on the very low recruitment rate as well as challenges relating to trial execution and study completion.) Less << - -
NCT01659554 - Terminated(Principal Investiga... More >>tor left institution) Less << - -
NCT02581657 Type 2 Diabetes Mellitus Phase 2 Completed - United States, Alabama ... More >> Pinnacle Research Group, LLC Anniston, Alabama, United States, 36207 United States, California National Research Institute Huntington Park, California, United States, 90255 United States, Florida Meridien Research Bradenton, Florida, United States, 34208 Indago Research and Health Center, Inc. Hialeah, Florida, United States, 33012 United States, Louisiana New Orleans Center for Clinical Research New Orleans, Louisiana, United States, 70119 United States, Washington Rainier Clinical Research Renton, Washington, United States, 98057 Less <<
NCT01206101 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 2 Terminated(The decision to clo... More >>se the NN2211-3619 trial was based on the very low recruitment rate as well as challenges relating to trial execution and study completion.) Less << - United States, California ... More >> Novo Nordisk Investigational Site Duarte, California, United States, 91010 United States, Illinois Novo Nordisk Investigational Site Chicago, Illinois, United States, 60612 United States, Massachusetts Novo Nordisk Investigational Site Boston, Massachusetts, United States, 02114 United States, Wisconsin Novo Nordisk Investigational Site Madison, Wisconsin, United States, 53792-0001 Canada, Alberta Novo Nordisk Investigational Site Edmonton, Alberta, Canada, T6G 2C8 Canada, British Columbia Novo Nordisk Investigational Site Vancouver, British Columbia, Canada, V5Z 1M9 France Novo Nordisk Investigational Site Besancon, France, 25030 Novo Nordisk Investigational Site Grenoble, France, 38043 Novo Nordisk Investigational Site Lille, France, 59037 Novo Nordisk Investigational Site MONTPELLIER cedex 5, France, 34295 Novo Nordisk Investigational Site Strasbourg, France, 67091 Germany Novo Nordisk Investigational Site Dresden, Germany, 01307 Switzerland Novo Nordisk Investigational Site Genève 14, Switzerland, 1211 Novo Nordisk Investigational Site Zürich, Switzerland, 8091 United Kingdom Novo Nordisk Investigational Site Headington, United Kingdom, OX3 7LE Novo Nordisk Investigational Site London, United Kingdom, SE5 9RS Less <<
NCT01659554 Recurrent Ovarian Cancer ... More >> Fallopian Tube Cancer Less << Phase 2 Terminated(Principal Investiga... More >>tor left institution) Less << - United States, New York ... More >> Columbia University Medical Center New York, New York, United States, 10032 Less <<
NCT01588366 Diabetes Mellitus, Type 2 Phase 1 Completed - Singapore ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician. Singapore, Singapore Less <<
NCT01169103 Obesity Phase 2 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT01169103 - Completed - -
NCT00990925 Obesity Schiz... More >>ophrenia Schizoaffective Disorder Less << Not Applicable Completed - United States, Connecticut ... More >> Connecticut Mental Health Center New Haven, Connecticut, United States, 06519 Less <<
NCT02670265 Weight Loss P... More >>ancreatic Cancer Biliary Tract Cancer Less << Not Applicable Completed - -
NCT03018938 Type 2 Diabetes Mellitus Phase 4 Recruiting June 24, 2019 -
NCT01328639 Depression De... More >>pressive Symptoms Type 2 Diabetes Less << Not Applicable Completed - Canada, Alberta ... More >> Camrose PCN Edmonton, Alberta, Canada Leduc/Beaumont/ Devon PCN Edmonton, Alberta, Canada St. Albert & Sturgeon PCN Edmonton, Alberta, Canada Heartland PCN Fort Saskatchewan, Alberta, Canada Less <<
NCT03462069 Diabetes Mellitus Phase 2 Recruiting August 7, 2019 Germany ... More >> Investigational Site Number 2760001 Recruiting Berlin, Germany, 13353 Less <<
NCT01881919 Hyperuricemia ... More >> Gout Kidney Calculi Diabetes Cardiovascular Disease Less << Early Phase 1 Completed - United Kingdom ... More >> School of Food Science and Nutrition Leeds, West Yorkshire, United Kingdom, LS2 9JT Less <<
NCT01702051 - Recruiting October 2018 Italy ... More >> Ospedale San Raffaele (OSR) Recruiting Milan, Italy, 20132 Contact: Gianpaolo Balzano, MD    0226432664 ext 0039    balzano.gianpaolo@hsr.it    Principal Investigator: Lorenzo Piemonti, MD          Principal Investigator: Gianpaolo Balzano, MD          Principal Investigator: Paola Maffi, MD Less <<
NCT01487421 - Completed - Germany ... More >> Mainz, Germany, 55127 Less <<
NCT02409030 - Active, not recruiting November 2018 Belgium ... More >> AZ Sint Jan Brugge, Belgium, 8000 UCL St Luc Brussel, Belgium, B-1200 France Centre Hospitalier d'ARRAS Arras, France, 62000 Hôpital neurologique Pierre Wertheimer Bron, France, 69500 Clinique Neurologique CHRU Lille, France, 59037 Centre Mémoire paris Nord Ile de France GH Saint-Louis Lariboisière Fernand Widal Paris, France, 75010 Cognitive and Behavioral Disease Center and Alzheimer's Institute Paris, France, 75013 Spain Hospital Marqués de Valdecilla Santander, Cantabria, Spain, 39011 Hospital Virgen de la Arrixaca El Palmar, Murcia, Spain, 30120 CITA Alzheimer Donostia / San Sebastián, San Sebastián, Spain, 20009 Hospital Sant Pau Barcelona, Spain, 08026 Hospital Clinic Barcelona, Spain, 08036 Hospital Gregorio Marañón Madrid, Spain, 28007 Hospital Ramón y Cajal Madrid, Spain, 28034 Hospital La Paz Madrid, Spain, 28046 Hospital de Valladolid Valladolid, Spain, 47003 Less <<
NCT01486381 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 3 Completed - South Africa ... More >> Novo Nordisk Investigational Site Pretoria, Gauteng, South Africa, 0001 Novo Nordisk Investigational Site Cape Town, Western Cape, South Africa, 7925 Less <<
NCT01486940 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 3 Completed - -
NCT00962611 Neoplasms Phase 1 Completed - United States, Arizona ... More >> Scottsdale, Arizona, United States, 85258 United States, Pennsylvania Pittsburgh, Pennsylvania, United States, 15213 United States, Texas San Antonio, Texas, United States, 78229-3307 Less <<
NCT03349684 Diabetes Mellitus, Type 2 Phase 3 Recruiting September 11, 2019 -
NCT03340103 Antioxidant Role of the Lutein... More >> in Preterm Newborn Less << Not Applicable Recruiting October 1, 2018 Italy ... More >> Azienda Ospedaliera di Rilievo Nazionale Santobono-Pausilipon Recruiting Napoli, Italia, Italy, 80100 Contact: Giuseppe De Bernardo, M.D.    +393357441303    pinodebtin@gmail.com    Contact: Desiree Sordino, M.D.    +393383482584    dsordino@gmail.com    Principal Investigator: Giuseppe De Bernardo, M.D.          Azienda Ospedaliera Universitaria Padova Recruiting Padova, Italia, Italy, 35128 Contact: Daniele Trevisanuto, Prof.    +393406632734    daniele.trevisanuto@gmail.com    Sub-Investigator: Daniele Trevisanuto, Prof.          Azienda Ospedaliera Le Scotte Siena Recruiting Siena, Italia, Italy, 53100 Contact: Giuseppe Buonocore, Prof.    +393491770396    buonocore@unisi.it    Sub-Investigator: Giuseppe Buonocore, Prof.          Sub-Investigator: Mariangela Longini, Dr. Less <<
NCT01880736 - Completed - -
NCT01083524 Pulmonary Hypertension (Idiopa... More >>thic, Familial or Anorexigen-associated) Less << Phase 1 Completed - Canada, Alberta ... More >> University of Alberta Hospital Edmonton, Alberta, Canada, T6G 2B7 United Kingdom Imperial College London, United Kingdom Less <<
NCT01536639 - Completed - Slovakia ... More >> Novo Nordisk Investigational Site Bratislava, Slovakia, 811 05 Less <<
NCT03500640 Obesity PreDi... More >>abetes Aging Less << Not Applicable Recruiting December 31, 2022 United States, Pennsylvania ... More >> Western Psychiatric Institute and Clinic Recruiting Pittsburgh, Pennsylvania, United States, 15213 Contact: Betsy H Cwenar, BA    412-647-1845    cwenare@upmc.edu    Contact: Mary O Racek, MEd, BSN, RN    412-647-1845    racekm@upmc.edu    Principal Investigator: Elizabeth M Venditti, PhD Less <<
NCT02262806 Diabetes Lipo... More >>dystrophy Hyperlipidemia Less << Phase 3 Enrolling by invitation July 31, 2025 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00639535 - Completed - United States, New York ... More >> Central New York PET Center Liverpool, New York, United States, 13088 University Radiology Associates Syracuse, New York, United States, 13202 Institute For Human Performance Syracuse, New York, United States, 13210 Less <<
NCT03306550 Angina, Stable Not Applicable Not yet recruiting October 10, 2018 -
NCT01547585 Hypercholesterolemia ... More >> Cardiovascular Disease CRP Less << Not Applicable Completed - Canada, Manitoba ... More >> Canadian Centre for Agri-food Research in Health and Medicine Winnipeg, Manitoba, Canada, R2H 2A6 Canada, Ontario Human Nutraceutical Research Unit. University of Guelph Guelph, Ontario, Canada, N1G 2W1 Glycemic Index Laboratories, Inc Toronto, Ontario, Canada, M5C 2N8 Less <<
NCT02262832 Lipodystrophy ... More >> Diabetes Hyperlipidemia Less << Phase 3 Enrolling by invitation July 31, 2025 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT03352895 Chronic Kidney Disease Not Applicable Completed - Taiwan ... More >> Dalin Tzu Chi Hospital Chiayi City, Taiwan, 66247 Less <<
NCT00519714 Hypertriglyceridemia Phase 2 Phase 3 Completed - Canada, Quebec ... More >> Institut de Cardiologie de Montreal Montreal, Quebec, Canada, H1T 1C8 Less <<
NCT00579657 Overweight Ob... More >>esity Metabolic Syndrome Less << Not Applicable Completed - Germany ... More >> Deutsches Diabetes Zentrum; Heinrich Heine University Düsseldorf, Germany Diagnostic and Interventional Radiology, Klinikum Ernst von Bergmann, Academic Teaching Hospital, Charité University Medicine Berlin Potsdam, Germany Eberhard-Karls University Tübingen, Section on Experimental Radiology, Department of Diagnostic and Interventional Radiology Tübingen, Germany United Kingdom University Hospitals Coventry and Warwickshire NHS Trust Coventry, Warwickshire, United Kingdom, CV2 2DX Less <<
NCT01282983 Digestive Alteration [PE] Phase 1 Unknown September 2011 Brazil ... More >> University of São Paulo Recruiting São Paulo, SP, Brazil Contact: Dan L Waitzberg, MD PhD       dan@ganep.com.br    Contact: Lilian M Horie, RD MsC       mikahorie@gmail.com    Principal Investigator: Dan L Waitzberg, MD PhD          Sub-Investigator: Ana P Muniz Pereira, RD          Sub-Investigator: Cecilia Jardini Marques, RD          Sub-Investigator: Glaucia M Shiroma, RD          Sub-Investigator: Juliana Lopes Frias, RD          Sub-Investigator: Lidiane A Catalani, RD          Sub-Investigator: Lilian M Horie, RD MsC          Sub-Investigator: Liria Nubia Alvarenga, RD          Sub-Investigator: Maria Carolina Gonçalves Dias, RD MsC          Sub-Investigator: Maria Cláudia Ortolani, RD          Sub-Investigator: Maria de Lourdes Teixeira da Silva, MD MsC          Sub-Investigator: Maria Manuela Ferreira Alves, RD          Sub-Investigator: Priscila Carasin Garla, RD          Sub-Investigator: Ricardo Alexandre Garib, MD Less <<
NCT01601236 Diabetic Nephropathy Phase 2 Completed - United States, California ... More >> Questcor Investigational Site Roseville, California, United States, 95661 United States, Florida Questcor Investigational Site Cooper City, Florida, United States, 33024 Questcor Investigational Site Miami Springs, Florida, United States, 33166 United States, New York Questcor Investigational Site The Bronx, New York, United States, 10461 United States, Ohio Questcor Investigational Site Columbus, Ohio, United States, 43210 United States, Pennsylvania Questcor Investigational Site Bethlehem, Pennsylvania, United States, 18017 United States, Tennessee Questcor Investigational Site Chattanooga, Tennessee, United States, 37408 United States, Texas Questcor Investigational Site Greenville, Texas, United States, 75402 Questcor Investigational Site Houston, Texas, United States, 77030 Questcor Investigational Site San Antonio, Texas, United States, 78229 Less <<
NCT02804698 Diabetes Card... More >>iovascular Disease Less << Not Applicable Recruiting December 2021 Mexico ... More >> Ministry of Health Recruiting Hermosillo, Sonora, Mexico Contact: Kathleen C Denman, PhD    662-259-5300    cdenman@colson.edu.mx Less <<
NCT02884453 Gastrooesophageal Cancer Phase 2 Recruiting July 2019 United Kingdom ... More >> The Royal Marsden NHS Trust Recruiting Sutton, Surrey, United Kingdom, SM2 5PT Contact: Ye mong To    0208 661 3807    yemong.to@rmh.nhs.uk    Contact: Michael Davidson    020 8642 6011 ext 4374       Principal Investigator: Ian Chau          Sub-Investigator: Michael Davidson          Sub-Investigator: Irene Chong Less <<
NCT01601236 - Completed - -
NCT00136578 Solid Tumours Phase 1 Completed - United States, Tennessee ... More >> GSK Investigational Site Nashville, Tennessee, United States, 37203 United Kingdom GSK Investigational Site Newcastle Upon Tyne, Northumberland, United Kingdom, NE4 6BE Less <<
NCT00775671 - Completed - -
NCT01124864 - Completed - -
NCT00775671 Metabolic Syndrome Phase 4 Completed - United States, Tennessee ... More >> Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232 Less <<
NCT01124864 Non-small-cell Lung Cancer Phase 2 Completed - United States, California ... More >> University of California at Los Angeles UCLA - Santa Monica Los Angeles, California, United States, 90095 United States, Maryland Maryland Oncology Hematology, P.A. Dept. of Assoc. Onc/Hem Rockville, Maryland, United States, 20850 United States, Massachusetts Dana Farber Cancer Institute DFCI Boston, Massachusetts, United States, 02215 United States, Pennsylvania St. Luke's Hospital and Health Network St Luke's Bethlehem, Pennsylvania, United States Canada, Alberta Novartis Investigative Site Edmonton, Alberta, Canada, T6G 1Z2 Canada, Quebec Novartis Investigative Site Montreal, Quebec, Canada, H3T 1E2 France Novartis Investigative Site Creteil, France, 94000 Novartis Investigative Site Marseille cedex 20, France, 13915 Novartis Investigative Site Villejuif Cedex, France, 94805 Germany Novartis Investigative Site Berlin, Germany, 13125 Novartis Investigative Site Oldenburg, Germany, 26121 Korea, Republic of Novartis Investigative Site Seoul, Korea, Korea, Republic of, 05505 Novartis Investigative Site Seoul, Korea, Korea, Republic of, 06351 Novartis Investigative Site Seoul, Korea, Korea, Republic of, 110 744 Novartis Investigative Site Seoul, Korea, Korea, Republic of, 137-701 Netherlands Novartis Investigative Site Amsterdam, Netherlands, 1081 HV Novartis Investigative Site Groningen, Netherlands, 9713 GZ Norway Novartis Investigative Site Oslo, Norway, NO-0379 Singapore Novartis Investigative Site Singapore, Singapore, 119228 Spain Novartis Investigative Site Badalona, Catalunya, Spain, 08916 Novartis Investigative Site Barcelona, Catalunya, Spain, 08035 Turkey Novartis Investigative Site Izmir, Turkey, 35040 Less <<
NCT00622284 - Completed - -
NCT00622284 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT00296920 Major Depressive Disorder Phase 3 Completed - Canada, Ontario ... More >> University Health Network Toronto, Ontario, Canada, M5T 2S8 Less <<
NCT01294995 Cardiovascular Diseases Phase 1 Completed - China, Zhejiang ... More >> Department of food science and nutrition Hangzhou, Zhejiang, China, 310029 Less <<
NCT02239458 Cystic Fibrosis Not Applicable Unknown June 2016 Israel ... More >> Hadassah Ein Kerem/Har Hazofim Not yet recruiting Jerusalem, Israel, 91120 Contact: Ram Weiss, MD PhD       ramw@ekmd.huji.ac.il    Principal Investigator: Eitan Kerem, MD          Sub-Investigator: Limor Marko, MSc Less <<
NCT00942188 Type 2 Diabetes Phase 2 Completed - United States, Alabama ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mobile, Alabama, United States, 36689 United States, California For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Anaheim, California, United States, 92801 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chula Vista, California, United States, 91911 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. La Mesa, California, United States, 91942 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Walnut Creek, California, United States, 94598 United States, District of Columbia For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Washington, District of Columbia, United States, 20003 United States, Florida For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Miami Gardens, Florida, United States, 33169 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Miami, Florida, United States, 33169 United States, Idaho For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Boise, Idaho, United States, 83702 United States, Maryland For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Baltimore, Maryland, United States, 21287 United States, Michigan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Dearborn, Michigan, United States, 48126 United States, Pennsylvania For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Philadelphia, Pennsylvania, United States, 19107 United States, Texas For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Arlington, Texas, United States, 76014 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Dallas, Texas, United States, 75230 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. San Antonio, Texas, United States, 78229 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tomball, Texas, United States, 77375 United States, Utah For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Salt Lake City, Utah, United States, 84107 United States, Virginia For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Richmond, Virginia, United States, 23294 Less <<
NCT03016195 - Terminated(Poor return rate/hi... More >>gh dropout rate requiring alteration to study methodology) Less << - United Kingdom ... More >> Royal Hospital for Children Glasgow Glasgow, South Lanarkshire, United Kingdom, G51 4TF Less <<
NCT01325259 Alzheimer's Disease ... More >> Mild Cognitive Impairment Less << Phase 2 Completed - France ... More >> university hospital of CAEN Caen, France, 14000 University Hospital of Lille Lille, France, 59000 University Hospital of Toulouse Toulouse, France, 31000 University Hospital of Tours Tours, France, 37000 Less <<
NCT00942188 - Completed - -
NCT02401958 Rheumatoid Arthritis Phase 4 Completed - Brazil ... More >> Federal University of Sao Paulo Sao Paulo, SP, Brazil, 04023900 Less <<
NCT01735032 - Unknown May 2016 France ... More >> Hospices Civils de Lyon Recruiting Lyon, France Contact: Julien JUNG, Dr    0033 472 117 833 Less <<
NCT00836446 Obesity Cardi... More >>ovascular Disease Less << Not Applicable Completed - Mexico ... More >> Universidad Autonoma del Estado de Mexico Mexico, Toluca, Estado de Mexico, Mexico Less <<
NCT00808535 - Unknown March 2010 United States, California ... More >> UCLA Radiological Sciences Not yet recruiting Los Angeles, California, United States, 91324 Contact: Wanda C Marfori, MD    310-206-2531    wmarfori@mednet.ucla.edu    Contact: Stefan Ruehm, MD    3108250958    sruehm@mednet.ucla.edu    Principal Investigator: Stefan Ruehm, MD          Sub-Investigator: Jonathan Goldin, MD, PhD          Sub-Investigator: Mayil Krishnam, MD          Sub-Investigator: Christine Darwin, MD Less <<
NCT01849315 Childhood Obesity Not Applicable Completed - -
NCT02720133 - Completed - Tunisia ... More >> Emergency Departement Monastir, Non-US/Canada, Tunisia, 5000 Less <<
NCT01495806 Functional Gastrointestinal Di... More >>sorders Less << Phase 4 Completed - Poland ... More >> Dpt of Pediatrics Warsaw Medical University Warsaw, Poland, 01-410 Less <<
NCT02211768 Neurofibromatosis ... More >> MPNST Less << Phase 1 Recruiting July 31, 2019 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office    888-624-1937 Less <<
NCT00991640 Obesity Not Applicable Active, not recruiting June 2019 Canada, Quebec ... More >> Université de Sherbrooke Sherbrooke, Quebec, Canada, J1H 5N4 Less <<
NCT01786564 - Recruiting October 2017 United States, Illinois ... More >> Northwestern University Recruiting Chicago, Illinois, United States, 60611 Contact: Kristen Knutson, PhD    312-503-1526    kristen.knutson@northwestern.edu    Principal Investigator: Kristen Knutson, PhD Less <<
NCT02519309 Diabetes Mellitus, Type 2 ... More >> Pre-diabetes Metabolic Syndrome Less << Not Applicable Active, not recruiting June 2020 United States, Indiana ... More >> IU Health Arnett Medical Weight Loss West Lafayette, Indiana, United States, 47904 Less <<
NCT02784275 - Completed - -
NCT02880124 Carbohydrate Ingestion ... More >> Fuel Selection Athletic Performance Less << Not Applicable Recruiting December 2017 Canada, Quebec ... More >> Centre d'éducation physique et sportive de l'Université de Montréal (CEPSUM) Recruiting Montréal, Quebec, Canada, H3C 3J7 Contact: Mélanie F Paradis, M.Sc.    514-571-4122    melanie.paradis@umontreal.ca    Contact: Lorianne Lavoie, B.Sc.    514-466-3393    lorianne.lavoie@umontreal.ca    Principal Investigator: Jonathan Tremblay, Ph.D. Less <<
NCT02280174 Type 2 Diabetes Phase 4 Unknown October 2016 Argentina ... More >> National University of Formosa Recruiting Formosa, Argentina, 3600 Contact: Juan Pa Nogueira, MD/PhD    00543704425447    nogueirajuanpatricio@gmail.com Less <<
NCT00037193 - Completed - United States, Missouri ... More >> Washington University Medical School St. Louis, Missouri, United States, 63110 Less <<
NCT00950599 Type 2 Diabetes Mellitus Phase 2 Completed - -
NCT02147457 - Completed - Belgium ... More >> Research Center Eksel, Limburg, Belgium, 3941 Less <<
NCT02321202 Liver Cancer ... More >>Cirrhosis Less << Phase 4 Completed - China, Hubei ... More >> Hepatic Surgery Center of Tongji Hospital Wuhan, Hubei, China, 430030 Less <<
NCT00893685 Diabetes Mellitus ... More >> Chronic Heart Failure Chronic Obstructive Pulmonary Disease Less << Not Applicable Unknown December 2011 Denmark ... More >> Langeland Municipality Enrolling by invitation Langeland, Denmark, 5900 Estonia East Tallin Central Hospital Enrolling by invitation Tallin, Estonia, 10123 Germany Pflegwerk Berlin, Mediplus Enrolling by invitation Berlin, Germany, 10439 Italy Azienda per i Servizi Sanitari ASS N.1 Enrolling by invitation Trieste, Italy, 34128 Spain Servicio Aragones de Salud Enrolling by invitation Barbastro, Spain, 22300 Sweden GP Surgery Enrolling by invitation Heby, Sweden, 74432 Less <<
NCT01698528 - Completed - -
NCT00989846 - Unknown June 2010 Germany ... More >> Thoraxklinik Heidelberg, Dept. of Pneumology and Respiratory Critical care Recruiting Heidelberg, Germany, 69126 Contact: Michael Kreuter, MD    49 / 6221 / 396 ext 1201    michael.kreuter@thoraxklinik-heidelberg.de    Principal Investigator: Michael Kreuter, MD Less <<
NCT00744965 Mild Gestational Diabetes Phase 4 Completed - United States, Texas ... More >> Parkland Memorial Hospital Dallas, Texas, United States, 75235 Less <<
NCT00950599 - Completed - -
NCT01376648 - Unknown May 2012 China ... More >> Huashan Hospital Recruiting Shanghai, China, 200040 Contact: Zhaoyun Zhang, Dr.       zhaoyunzhang@fudan.edu.cn    Principal Investigator: Yiming Li, Dr. Less <<
NCT01413035 Type 2 Diabetes Phase 1 Phase 2 Unknown July 2014 China, Shandong ... More >> Department of Hematology of the 2nd Hospital of Shandong University Recruiting Jinan, Shandong, China, 250033 Contact: chengyun zheng, Ph. D    +86-531-85875635    chengyun.zheng@ki.se, kdx2002@126.com Less <<
NCT01698528 Type II Diabetes Not Applicable Completed - United States, Massachusetts ... More >> Joslin Diabetes Center Boston, Massachusetts, United States, 02215 Less <<
NCT00646724 Type 1 Diabetes Mellitus Phase 1 Phase 2 Unknown January 2014 China, Fujian ... More >> Fuzhou General Hospital Recruiting Fuzhou, Fujian, China, 350025 Less <<
NCT01075932 Cerebral Blood Flow ... More >> Cognitive Function Less << Not Applicable Completed - United Kingdom ... More >> Northumbria University Newcastle upon Tyne, Tyne and Wear, United Kingdom, NE1 8ST Less <<
NCT01422876 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT01123746 - Completed - Taiwan ... More >> Taipei Medical University-WanFang Hospital Taipei, Taiwan, 116 Less <<
NCT00428207 Type 1 Diabetes Mellitus Not Applicable Terminated(Treatment differenc... More >>es not detected with 7 point fingerstick monitoring) Less << - United States, Massachusetts ... More >> Joslin Diabetes Center Boston, Massachusetts, United States, 02215 Less <<
NCT01422876 - Completed - -
NCT01527617 Inflammation Not Applicable Completed - United States, Massachusetts ... More >> Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University Boston, Massachusetts, United States, 02111 United States, Washington Washington State University Pullman, Washington, United States, 99164 Less <<
NCT03652480 - Completed - -
NCT03394157 Diabetes Mellitus Type 2 in Ob... More >>ese Less << Not Applicable Completed - -
NCT02310555 Diabetes Mellitus ... More >> Obesity Less << Not Applicable Unknown May 2016 Spain ... More >> Hospital Clínico Universitario Virgen de la Arrixaca Recruiting El Palmar., Murcia, Spain, 30120 Contact: Juan A. Luján, Ph D    968369677       Principal Investigator: Juan A. Luján, Ph D Less <<
NCT00964249 Pulmonary Disease, Chronic Obs... More >>tructive Less << Phase 1 Completed - Japan ... More >> GSK Investigational Site Fukuoka, Japan, 812-0025 Less <<
NCT00428207 - Terminated(Treatment differenc... More >>es not detected with 7 point fingerstick monitoring) Less << - -
NCT01656057 To Assess the Impact of Bile A... More >>cids on Human Glukagon-like-peptide-1 Secretion Less << Not Applicable Completed - Denmark ... More >> University Hospital of Copenhagen, Gentofte Hospital, Diabetic Research Division Copenhagen, Hellerup, Denmark, 2900 Less <<
NCT01299831 Healthy Not Applicable Completed - Denmark ... More >> Department of medical endocrinology, University Hospital of Aarhus Aarhus, Denmark, 8000 Less <<
NCT02593656 Physical Performance Not Applicable Completed - -
NCT03003507 Critical Illness Phase 4 Completed - -
NCT02036346 Colorectal Resection ... More >> Ileostomy Less << Not Applicable Completed - Greece ... More >> University Hospital of Larissa Larissa, Thessaly, Greece, 41110 Less <<
NCT01934712 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 1 Completed - Japan ... More >> Novo Nordisk Investigational Site Fukuoka, Japan, 812-0025 Less <<
NCT00161447 Contraception Phase 1 Phase 2 Completed - United States, Washington ... More >> University of Washington Seattle, Washington, United States, 98195 Less <<
NCT01185743 Schizophrenia ... More >> Diabetes Less << Phase 4 Completed - Austria ... More >> Medical University of Vienna Vienna, Austria, 1090 Less <<
NCT01962779 Sleep Disordered Breathing ... More >> Alzheimer's Disease Less << Not Applicable Active, not recruiting April 30, 2019 United States, New York ... More >> NYU Sleep Disorders Center New York, New York, United States, 10016 NYU Center for Brain Health New York, New York, United States, 11222 Less <<
NCT02059993 Hypertension ... More >>Metabolic Disorder Less << Not Applicable Completed - -
NCT02202330 Stroke Not Applicable Completed - Pakistan ... More >> Aga Khan University, Clinical Trial Unit Karachi, Sindh, Pakistan, 74800 Less <<
NCT03732404 Cesarean Section Complications Not Applicable Not yet recruiting September 1, 2020 -
NCT00669630 Cardiovascular Disease ... More >> Hypertension Diabetes Obesity Less << Not Applicable Unknown June 2012 United States, Texas ... More >> UT Southwestern Medical Center Recruiting Dallas, Texas, United States, 75390 Contact: Mark J. DeHaven, Ph.D.    214-648-2974    mark.dehaven@utsouthwestern.edu    Contact: Janice Rookstool, MA    214-648-2973    janice.rookstool@utsouthwestern.edu    Principal Investigator: Mark J. DeHaven, Ph.D. Less <<
NCT00342927 - Recruiting - United States, Arizona ... More >> NIDDK, Phoenix Recruiting Phoenix, Arizona, United States, 85014 Contact: William Knowler, M.D.    602-200-5206    wknowler@phx.niddk.nih.gov Less <<
NCT03336554 - Recruiting December 31, 2018 China ... More >> Peking University People's Hospital Recruiting Beijing, China, 100044 Contact: Tingting Ren, Ph.D.    +86-13810095026    tumorcenter@163.com Less <<
NCT03324984 Return of Motor and Sensory Bl... More >>ockade Anesthesia, Spinal Decrease Discharge Time Status Post Hemmoriodectomy Less << Phase 2 Withdrawn(IND required for IRB... More >> approval) Less << November 20, 2019 -
NCT00676208 Diabetes Mellitus Not Applicable Completed - United States, Ohio ... More >> Louis Stokes VA Medical Center, Cleveland, OH Cleveland, Ohio, United States, 44106 Less <<
NCT00566566 - Unknown December 2008 -
NCT02500095 Healthy Not Applicable Completed - Denmark ... More >> Aarhus University Hospital Aarhus, Denmark, 8000 Less <<
NCT02157207 Healthy Not Applicable Completed - United States, Illinois ... More >> University of Illinois - Chicago Chicago, Illinois, United States, 60612 Less <<
NCT02059993 - Completed - -
NCT01231360 Claudication Not Applicable Unknown June 2014 United States, Massachusetts ... More >> Brigham and Women's Hospital Recruiting Boston, Massachusetts, United States, 02115 Contact: Jessica Milian, BA    617-732-6320    jmilian@partners.org    Principal Investigator: Reena Pande, MD Less <<
NCT01362283 - Completed - -
NCT00676208 - Completed - -
NCT00361153 Type 2 Diabetes Mellitus Phase 2 Completed - United States, Texas ... More >> Diabetes and Glandular Research Associates San Antonio, Texas, United States, 78229 Less <<
NCT01665469 Postprandial Oxidation and in?... More >>ammation Less << Not Applicable Completed - Israel ... More >> Tel Aviv Sourasky Medical Center Tel-Aviv, Israel Less <<
NCT01104168 - Completed - United States, Georgia ... More >> A.G. Rhodes Homes Atlanta, Georgia, United States, 30312 Bud Terrace Homes Atlanta, Georgia, United States, 30329 Less <<
NCT03173807 Metabolic Syndrome ... More >> Prostate Cancer Diet Modification Less << Not Applicable Withdrawn(Unable to find adequ... More >>ate funding) Less << December 31, 2021 -
NCT03011008 Type 1 Diabetes Mellitus ... More >> Autoimmune Diabetes Less << Phase 4 Recruiting June 2021 China, Hunan ... More >> Institute of Metabolism and Endocrinology, Second Xiangya Hospital, Central South University Recruiting Changsha, Hunan, China, 410011 Contact: Zhiguang Zhou, MD/PhD    86-731-85292154    zhouzg@hotmail.com Less <<
NCT00931034 Type 2 Diabetes Mellitus Not Applicable Completed - United States, California ... More >> Medicus Research Northridge, California, United States, 91325 United States, Florida SIBR Research Bradenton, Florida, United States, 34205 Miami Research Associates Miami, Florida, United States, 33143 United States, Nevada Nevada Alliance Against Diabetes Las Vegas, Nevada, United States, 89101 United States, New York Rochester Clinical Research Inc Rochester, New York, United States, 14609 United States, Virginia Chase Wellness & Research Center Virginia Beach, Virginia, United States, 23455 Less <<
NCT00318461 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT02700555 - Recruiting October 2022 Korea, Republic of ... More >> Kangbuk Samsung Hospital Recruiting Seoul, Korea, Republic of, 110-746 Contact: Dong-Hoe Koo, MD,PhD    +82-2-2001-8330    d.h.koo@samsung.com Less <<
NCT02955264 Congenital Disorders of Glycos... More >>ylation Less << Phase 2 Recruiting July 2019 United States, Louisiana ... More >> Tulane University Recruiting New Orleans, Louisiana, United States, 70112 Contact: Eva Morava-Kozicz, MD, PhD          Principal Investigator: Eva Morava-Kozicz, MD, PhD Less <<
NCT00564057 HIV Infections ... More >> Hypertension Less << Phase 4 Unknown September 2009 Italy ... More >> University of Insubria, Department of Clinical Medicine Recruiting Varese, Italy, 21100 Less <<
NCT00318461 - Completed - -
NCT02635386 Polycystic Ovary Syndrome ... More >> Obesity Less << Phase 3 Recruiting August 2019 United States, Louisiana ... More >> Woman's Hospital Recruiting Baton Rouge, Louisiana, United States, 70815 Contact: Karen Elkind-Hirsch, PhD.    225-231-5278       Contact: Ericka Seidemann, MS    225-231-5275    ericka.seidemann@womans.org    Principal Investigator: Karen Elkind-Hirsch, Ph.D.          Sub-Investigator: Renee Harris, M.D. Less <<
NCT00873964 - Unknown July 2013 United States, Virginia ... More >> McGuire VAMC Richmond, Virginia, United States, 23249 Less <<
NCT01048736 Obesity Older... More >> Adults Sedentary Less << Not Applicable Completed - United States, North Carolina ... More >> Wake Forest University Winston-Salem, North Carolina, United States Less <<
NCT00160407 Fatty Liver H... More >>epatitis Less << Phase 4 Completed - United States, Missouri ... More >> Saint Louis University St. Louis, Missouri, United States, 63110 United States, Texas Brooke Army Medical Center San Antonio, Texas, United States, 78234 Less <<
NCT01038752 Non-small Cell Lung Cancer Phase 2 Terminated - United States, Illinois ... More >> John H Stroger Jr Hospital of Cook County Chicago, Illinois, United States, 60612 United States, Virginia Virginia Commonwealth University Massey Cancer Center Richmond, Virginia, United States, 23298 Less <<
NCT01038752 - Terminated - -
NCT01168297 - Completed - Mexico ... More >> Centro de Investigacion en Alimentacion y Desarollo (CIAD) Hermosillo, Mexico Less <<
NCT01594697 Polycystic Ovary Syndrome Not Applicable Completed - Italy ... More >> Catholic University of Sacred Heart Rome, Italy, 00168 Less <<
NCT02071407 Traumatic Brain Injury Phase 4 Unknown - China, Jiangsu ... More >> Subei People's Hospital of Jiangsu Province Recruiting Yangzhou, Jiangsu, China, 225001 Contact: Ruiqiang Zheng, Doctor    18051060411    rqzh7@yahoo.com.cn    Principal Investigator: Ruiqiang Zheng, Doctor Less <<
NCT01797302 Obesity Vitam... More >>in D Deficiency Less << Not Applicable Recruiting January 31, 2019 United States, Pennsylvania ... More >> Primary Care Center, Children's Hospital of Pittsburgh of UPMC Recruiting Pittsburgh, Pennsylvania, United States, 15213 Principal Investigator: Kumaravel Rajakumar, MD, MS Less <<
NCT00763347 Diabetes Mellitus Phase 2 Terminated(Voluntarily termina... More >>ted based on preliminary non-clinical findings.) Less << - -
NCT03314467 - Recruiting August 31, 2018 Belgium ... More >> Centre Hospitalier Universitaire Saint Pièrre Recruiting Brussels, Belgium Contact: Marie Bruyneel, MD, PhD       marie_bruyneel@stpierre-bru.be    Contact: Pham Anh Hong Nguyen, MD       pham_nguyen@stpierre-bru.be Less <<
NCT00169702 Schizophrenia Not Applicable Completed - Germany ... More >> Heinrich-Heine-University, Rhineland State Clinics Düsseldorf Düsseldorf, Rhineland State, Germany, 40629 Less <<
NCT02012842 Metabolic Syndrome ... More >> Periodontal Disease Inflammatory Response Less << Not Applicable Active, not recruiting December 2017 Brazil ... More >> Faculty of Dentistry, Federal University of Rio Grande do Sul and Hospital de Clinicas de Porto Alegre Porto Alegre, RS, Brazil, 90035-003 Faculdade de Odontologia da UFRGS Porto Alegre, RS, Brazil, 90035003 Less <<
NCT03043586 - Recruiting July 2019 United States, New York ... More >> Neuroendocrine Unit; Columbia University Medical Center, 180 Fort Washington Avenue 9-970 Recruiting New York, New York, United States, 10032 Contact: Carlos Reyes-Vidal, MD    212-305-4921    csr52@cumc.columbia.edu    Contact: Krystal Hernandez, MD    212-305-4921       Principal Investigator: Pamela U Freda, M.D. Less <<
NCT00494559 Diabetes Mellitus ... More >> Coronary Artery Stenosis Less << Phase 4 Completed - Korea, Republic of ... More >> Korea University Anam Hospital Seoul, Korea, Republic of, 136-705 Less <<
NCT01088711 Type 2 Diabetes (T2D) Phase 1 Completed - -
NCT01088711 - Completed - -
NCT03320174 Healthy Volunteers Phase 2 Recruiting October 2020 Australia, Western Australia ... More >> Linear Clinical Research Recruiting Nedlands, Western Australia, Australia, 6009 Contact: Shashi Aggarwal, PhD    1300 546 327    enquiries@linear.org.au    Principal Investigator: Fred Chen, PhD, FRANZCO Less <<
NCT03230136 Thoracic Surgery ... More >> Cardiopulmonary Bypass Less << Not Applicable Recruiting November 1, 2019 France ... More >> CH Annecy Not yet recruiting Annecy, France Contact: Pascale BLANC, MD          Principal Investigator: Pascale BLANC, MD          Service d'Anesthésie-Réanimation, Hôpital Cardiologique et Pneumologique Louis Pradel Recruiting Bron, France, 69500 Contact: Jean-Luc FELLAHI, MD    4 72 11 89 33 ext +33    jean-luc.fellahi@chu-lyon.fr    Contact: Pascal CHIARI, MD    4 72 11 89 33 ext +33    pascal.chiari@chu-lyon.fr    Principal Investigator: Jean-Luc FELLAHI, MD          Sub-Investigator: Pascal CHIARI, MD          service de Chirurgie Cardiaque CHU Gabriel Montpied Not yet recruiting Clermont-Ferrand, France Contact: Anne MEDARD, MD       amedard@chu-clermontferrand.fr    Principal Investigator: Anne MEDARD, MD          Unité de Réanimation Cardiovasculaire et Thoracique, Hôpital Michallon Not yet recruiting Grenoble, France Contact: Michel DURAND, MD       MDurand@chu-grenoble.fr    Principal Investigator: Michel DURAND, MD          Institut Arnault Tzanck - Saint-Laurent du Var Not yet recruiting Saint-Laurent-du-Var, France Contact: Diane LENA-QUINTARD, MD          Principal Investigator: Diane LENA-QUINTARD, MD          CHU Saint-Etienne Not yet recruiting Saint-Étienne, France Contact: Nathalie GRAND, MD          Principal Investigator: Nathalie GRAND, MD Less <<
NCT01842399 Vascular Resistance ... More >> Aging Hypertension Antioxidants Aerobic Capacity Less << Phase 1 Phase 2 Recruiting September 1, 2019 United States, Maryland ... More >> National Institute of Aging, Clinical Research Unit Recruiting Baltimore, Maryland, United States, 21224 Less <<
NCT01966549 Pulmonary Disease, Chronic Obs... More >>tructive Less << Phase 2 Completed - -
NCT02755818 - Enrolling by invitation January 2020 -
NCT00375401 Obesity Phase 3 Terminated(See termination rea... More >>son in detailed description.) Less << - -
NCT02433730 Hypogonadism Phase 4 Recruiting October 2019 Denmark ... More >> Odense University Hospital Recruiting Odensen, Denmark Contact: Marianne Andersen    65412502    msa@dadlnet.dk    Contact    65412502    msa@dadlnet.dk Less <<
NCT00172211 Kidney Failure,Chronic Not Applicable Completed - Taiwan ... More >> Taiwan Universithy Hospital Taipei, Taiwan Less <<
NCT01486043 Acute Lymphoblastic Leukemia ... More >> Hyperglycemia Insulin Resistance Diabetes Mellitus Less << Not Applicable Terminated(The research projec... More >>t was terminated due to lower than projected patient recruitment within the period of time allowed for the study.) Less << - United States, California ... More >> Children's Hospital Los Angeles Los Angeles, California, United States, 90027 Less <<
NCT00575991 Overweight Not Applicable Completed - United States, Wisconsin ... More >> University of Wisconsin Department of Nutritional Sciences Madison, Wisconsin, United States, 53706 Less <<
NCT00004467 Acute Liver Failure Phase 3 Completed - -
NCT01843257 - Recruiting September 2021 United States, Missouri ... More >> University of Illinois at Urbana Champaign Recruiting Saint Louis, Missouri, United States, 63110 Contact: Maria B Acevedo, PhD    217-300-2374    mba17@illinois.edu    Contact: Marta Y Pepino, PhD    217-300-2374    ypepino@illinois.edu    Principal Investigator: Marta Y Pepino, PhD Less <<
NCT01486043 - Terminated(The research projec... More >>t was terminated due to lower than projected patient recruitment within the period of time allowed for the study.) Less << - -
NCT00916201 Schizophrenia Phase 1 Not yet recruiting December 2020 Germany ... More >> Dep. of Psychiatry and Psychotherapy, Central Institute of Mental Health Not yet recruiting Mannheim, BW, Germany, 68159 Contact: F. Markus Leweke, MD    +49 621 1703 ext 2321    leweke@cimh.de    Contact: Cathrin Rohleder, PhD    +49 621 1703 ext 2333    rohleder@cimh.de    Sub-Investigator: J. Malte Bumb, MD          Sub-Investigator: Cathrin Rohleder, PhD          Sub-Investigator: Till van der List, MD          Sub-Investigator: Juliane K. Mueller, MD          Sub-Investigator: Frank Enning, MD Less <<
NCT00294723 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Terminated(The trial was termi... More >>nated at week 195 due to an insufficient number of subjects remaining to obtain reasonable statistical power) Less << - -
NCT00175266 Type 1 Diabetes Phase 2 Completed - Canada, Alberta ... More >> University of Alberta - Clinical Islet Transplant Program Edmonton, Alberta, Canada, T6G2C8 Less <<
NCT03350100 Mood and Cognitive Performance Not Applicable Completed - United Kingdom ... More >> NU-Food Research Facility Newcastle upon Tyne, Tyne And Wear, United Kingdom, NE1 7RU Less <<
NCT00294723 - Terminated(The trial was termi... More >>nated at week 195 due to an insufficient number of subjects remaining to obtain reasonable statistical power) Less << - -
NCT00078091 - Terminated - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT03281434 Aging Not Applicable Recruiting February 2019 Canada, Ontario ... More >> Exercise Metabolism Research Laboratory, McMaster Univeristy Recruiting Hamilton, Ontario, Canada, L8S 4K1 Contact: Stuart M Phillips, Ph.D.    905-525-9140 ext 24465    phillis@mcmaster.ca    Principal Investigator: Stuart M Phillips, Ph.D.          Ivor Wynne Center Recruiting Hamilton, Ontario, Canada, L8S4K1 Contact: Sara Oikawa, MSc.    9055259140 ext 21918    oikawasy@mcmaster.ca Less <<
NCT00314561 Metabolic Syndrome Phase 4 Completed - Korea, Republic of ... More >> Korea University Anam Hospital Seoul, Korea, Republic of, 136-705 Less <<
NCT00082030 - Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT01400802 Bioequivalence in Healthy Subj... More >>ects Less << Phase 1 Withdrawn(Study was not initia... More >>ted) Less << June 2012 United States, California ... More >> Profil Institute for Clinical Research, Inc. San Diego, California, United States, 91911 Less <<
NCT02117765 Type 1 Diabetes Phase 1 Phase 2 Unknown June 2017 Canada, British Columbia ... More >> BC Diabetes Vancouver, British Columbia, Canada, V5Z 1M9 Less <<
NCT01851421 - Recruiting September 1, 2021 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)    800-411-1222 ext TTY8664111010    prpl@cc.nih.gov Less <<
NCT01400789 Bioequivalence in Healthy Subj... More >>ects Less << Phase 1 Withdrawn(Study was not initia... More >>ted) Less << - United States, California ... More >> Profil Institute for Clinical Research, Inc. San Diego, California, United States, 91911 Less <<
NCT02793154 Diabetes Mellitus, Type 2 Phase 4 Terminated(Early termination d... More >>ue to insufficient enrollment.) Less << - United States, Kentucky ... More >> GSK Investigational Site Louisville, Kentucky, United States, 40213 United States, Texas GSK Investigational Site Dallas, Texas, United States, 75230 Less <<
NCT02128854 Diabetes Mellitus, Type 2 ... More >> Diabetes Mellitus, Adult-Onset Diabetes Mellitus, Non-Insulin-Dependent Diabetes Mellitus, Noninsulin Dependent Diabetes Mellitus, Type II Less << Not Applicable Completed - United States, South Carolina ... More >> Medical University of South Carolina Charleston, South Carolina, United States, 29425 Less <<
NCT01399255 Bioequivalence in Healthy Subj... More >>ects Less << Phase 1 Withdrawn(Study was not initia... More >>ted) Less << June 2012 United States, California ... More >> Profil Institute for Clinical Research, Inc. Chula Vista, California, United States, 91911 Less <<
NCT02793154 - Terminated(Early termination d... More >>ue to insufficient enrollment.) Less << - -
NCT00754988 Diabetes Mellitus Type 2 Phase 3 Completed - -
NCT00662922 - Completed - Germany ... More >> Department of Anesthesiology and Intensive Care, University Hospital Münster Münster, Germany, D-48149 Less <<
NCT01883804 - Completed - -
NCT03645109 Vitamin D3 Ge... More >>stational Diabetes Mellitus in Pregnancy Less << Phase 3 Not yet recruiting December 20, 2019 -
NCT01883804 Diabetes Mellitus, Type 1 Not Applicable Completed - United States, Colorado ... More >> Barbara Davis Center for Diabetes, University of Colorado School of Medicine Aurora, Colorado, United States, 80045 Less <<
NCT03502304 Metabolic Disturbance Not Applicable Completed - Chile ... More >> Cristian Alvarez Los Lagos, Osorno, Chile, 000000000 Less <<
NCT00876980 Obstructive Sleep Apnea ... More >> Diabetes Mellitus Less << Not Applicable Completed - Hong Kong ... More >> Queen Mary Hospital, University Department of Medicine Pokfulam, Hong Kong, 0000 Less <<
NCT02993874 Intermittent Claudication Not Applicable Recruiting February 2019 Brazil ... More >> Israel Institute of Education and Research Albert Einstein Recruiting Sao Paulo, Brazil, 05652900 Contact: Wagner Domingues, MD    5511982841355    wagnerfef@gmail.com Less <<
NCT03643692 Diabetes Mellitus, Type 1 Not Applicable Not yet recruiting August 2020 United Kingdom ... More >> Imperial College Clinical Research Facility Not yet recruiting London, United Kingdom Contact: Nick Oliver, FRCP    0207 594 2460    nick.oliver@imperial.ac.uk    Principal Investigator: Nick Oliver Less <<
NCT02179788 Low Milk Supply ... More >> Pre-diabetes Insulin Resistance Suppressed Lactation Less << Phase 1 Phase 2 Completed - United States, Ohio ... More >> Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229-3039 Less <<
NCT00887510 Hypertension Phase 4 Completed - United States, Florida ... More >> University of Florida Gainesville, Florida, United States, 32610 Less <<
NCT03681691 Diabetes Type 2 ... More >> Dementia Less << Phase 1 Not yet recruiting October 2019 United States, North Carolina ... More >> Wake Forest University Health Sciences Not yet recruiting Winston-Salem, North Carolina, United States, 27157 Contact: Benita Bowman    336-713-5382    bmbowman@wakehealth.edu    Principal Investigator: Christina Hugenschmidt, PhD Less <<
NCT02281253 Metabolic X Syndrome ... More >> Overweight Dyslipidemias Less << Not Applicable Completed - -
NCT00887510 - Completed - -
NCT03332849 Type1 Diabetes Mellitus ... More >> Type2 Diabetes Mellitus Less << Phase 1 Active, not recruiting April 30, 2018 United States, California ... More >> Hanmi Investigative Site Chula Vista, California, United States, 91911 Less <<
NCT02484209 Diabetes Mellitus Phase 3 Withdrawn(Inclusion criteria t... More >>oo strict making it difficult to recruit in primary care) Less << November 2016 -
NCT00592332 Type 1 Diabetes Not Applicable Completed - United States, Tennessee ... More >> Vanderbilt University Nashville, Tennessee, United States, 37232 Less <<
NCT01601561 Cardiac Surgery Not Applicable Unknown - Canada, Quebec ... More >> Royal Victoria Hospital, McGill University Health Centre Recruiting Montreal, Quebec, Canada, H3A 1A1 Contact: Roupen Hatzakorzian, MD    514 934 1934 ext 31104    roupenhatz@hotmail.com    Contact: Thomas Schricker, MD PhD    514 934 1934 ext 36057    thomas.schricker@mcgill.ca Less <<
NCT01843075 Alzheimer's Disease Phase 2 Recruiting March 2019 United Kingdom ... More >> Imperial College, Hammersmith Hospital Recruiting London, United Kingdom, W12 0NN Contact: Victoria Scott, BSc    +44 (0) 283833704    victoria.scott@imperial.ac.uk    Principal Investigator: Paul Edison, PhD FRCP(I) Less <<
NCT00994266 Type 2 Diabetes Phase 3 Completed - Cuba ... More >> Diabetes Care Center. "Abel Santamaría Cuadrado" General Hospital Pinar del Río, Cuba, 20200 Less <<
NCT00712673 Diabetes Mellitus, Type 2 Phase 3 Completed - United States, New Jersey ... More >> Sanofi-Aventis Administrative Office Bridgewater, New Jersey, United States, 08807 Australia sanofi-aventis Australia & New Zealand administrative office Macquarie Park, Australia Canada Sanofi-Aventis Administrative Office Laval, Canada Chile Sanofi-Aventis Administrative Office Santiago, Chile Croatia Sanofi-Aventis Administrative Office Zagreb, Croatia Czech Republic Sanofi-Aventis Administrative Office Praha, Czech Republic Germany Sanofi-Aventis Administrative Office Berlin, Germany Mexico Sanofi-Aventis Administrative Office Mexico, Mexico Morocco Sanofi-Aventis Administrative Office Casablanca, Morocco Philippines Sanofi-Aventis Administrative Office Makati City, Philippines Romania Sanofi-Aventis Administrative Office Bucuresti, Romania Russian Federation Sanofi-Aventis Administrative Office Moscow, Russian Federation South Africa Sanofi-Aventis Administrative Office Midrand, South Africa Spain Sanofi-Aventis Administrative Office Barcelona, Spain Ukraine Sanofi-Aventis Administrative Office Kiev, Ukraine Venezuela Sanofi-Aventis Administrative Office Caracas, Venezuela Less <<
NCT00712673 - Completed - -
NCT02168660 Obesity Insul... More >>in Resistance Vitamin D Deficiency Less << Phase 2 Unknown December 2014 United States, Texas ... More >> UT Southwestern Medical Center Dallas, Texas, United States, 75390 Less <<
NCT02129595 Pre-diabetes Not Applicable Completed - Netherlands ... More >> Maastricht University Medical Centre Maastricht, Limburg, Netherlands, 6200 MD Less <<
NCT01977560 Type 2 Diabetes Not Applicable Completed - United States, Missouri ... More >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Less <<
NCT00609102 Type 2 Diabetes Early Phase 1 Completed - United States, Washington ... More >> Pacific Northwest Research Institute Seattle, Washington, United States, 98122 Less <<
NCT02660476 - Recruiting December 2018 Qatar ... More >> Clinical Research Core Recruiting Doha, Qatar Contact: Odette Chagoury, PhD    (+974) 4492 8439    olc2004@qatar-med.cornell.edu Less <<
NCT00318422 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT03096392 Diabetes Mellitus, Type 1 Phase 2 Completed - United States, Colorado ... More >> Barbara Davis Center for Diabetes, University of Colorado Aurora, Colorado, United States, 80045 United States, Florida Baptist Diabetes Associates Miami, Florida, United States, 33156 United States, North Carolina Lucas Research, Inc. Morehead City, North Carolina, United States, 28557 United States, Texas Texas Diabetes and Endocrinology Austin, Texas, United States, 78731 Texas Diabetes and Endocrinology Austin, Texas, United States, 78749 Less <<
NCT02691897 Diabetes Mellitus Early Phase 1 Enrolling by invitation December 2017 Iran, Islamic Republic of ... More >> Shahid Motahhari Clinic, Shiraz University of Medical Sciences Shiraz, Fars, Iran, Islamic Republic of Less <<
NCT03012386 Insulin Resistance ... More >> Endothelial Dysfunction Less << Phase 1 Phase 2 Recruiting December 2020 United States, Tennessee ... More >> Vanderbilt University Medical Center Recruiting Nashville, Tennessee, United States, 37232 Contact: Keisha Card, RN       keisha.card@vanderbilt.edu    Principal Investigator: Cyndya A Shibao, MD          Principal Investigator: Naji N Abumrad, MD Less <<
NCT03463564 Type 1 Diabetes Mellitus Phase 4 Recruiting December 2026 Italy ... More >> Unit of Diabetes Recruiting Naples, Italy, 80138 Contact: Katherine Esposito    +390815665031    katherine.esposito@unicampania.it    Principal Investigator: Katherine Esposito          Sub-Investigator: Giuseppe Bellastella          Sub-Investigator: Maria Ida Maiorino          Sub-Investigator: Michela Petrizzo Less <<
NCT02811289 Type 2 Diabetes Not Applicable Completed - Canada, Quebec ... More >> centre de recherche du CHUS Sherbrooke, Quebec, Canada, J1H 5N4 Less <<
NCT00418522 - Completed - -
NCT01588743 Type 2 Diabetes Mellitus Not Applicable Unknown - -
NCT03747016 Caesarean Section Not Applicable Recruiting December 31, 2019 China, Shanghai ... More >> Shanghai First Maternity and Infant Hospital, affiliated to Tongji University Recruiting Shanghai, Shanghai, China Contact: Qiwei Wu    13564621298    13564621298@163.com Less <<
NCT00742521 Type 1 Diabetes Not Applicable Completed - United States, Tennessee ... More >> Vanderbilt University Nashville, Tennessee, United States, 37232 Less <<
NCT02506972 Diabetes Mellitus Not Applicable Completed - Canada, Ontario ... More >> Glycemic Index Laboratories, Inc. Toronto, Ontario, Canada, M5C 2N8 Less <<
NCT01877460 Health Appeti... More >>te Regulation Glucose Metabolism Less << Not Applicable Completed - Canada, Ontario ... More >> Department of Nutritional Sciences, FitzGerald Building Toronto, Ontario, Canada, M5S 3E2 Less <<
NCT01811303 Reduction of Post-prandial Gly... More >>caemic Response Less << Not Applicable Completed - United Kingdom ... More >> Reading Scientific Services Ltd. Reading, United Kingdom, RG6 6LA Less <<
NCT00418522 Diabetes Mellitus, Type 2 Phase 4 Completed - -
NCT01811303 - Completed - -
NCT02081599 Type 2 Diabetes Mellitus Phase 4 Completed - Japan ... More >> Investigational site Chuo-ku, Tokyo, Japan Less <<
NCT02273193 - Completed - United States, Nevada ... More >> Mike O'Callaghan Federal Medical Center Nellis Air Force Base, Nevada, United States, 89191 Less <<
NCT02091323 Diabetes Mellitus, Non-Insulin... More >>-Dependent Less << Not Applicable Unknown December 2017 China, Guangdong ... More >> Wu Recruiting Guangzhou, Guangdong, China, 510010 Contact: Liangping Wu       drwulp@163.com    Contact: Yongtao Huang       zsh2014@foxmail.com    Principal Investigator: Yongtao Huang Less <<
NCT01829477 Diabetes Mellitus, Type 2 Phase 3 Terminated(Due to potential co... More >>ncerns about liver safety (See Detailed Description)) Less << - -
NCT02081599 - Completed - -
NCT01829477 - Terminated(Due to potential co... More >>ncerns about liver safety (See Detailed Description)) Less << - -
NCT02471092 Hyperglycemia ... More >> Lack of Satiety Less << Not Applicable Completed - Canada, Ontario ... More >> University of Guelph- Human Nutraceutical Research Unit Guelph, Ontario, Canada, N1G2W1 Less <<
NCT03775109 Alcoholic Hepatitis Phase 2 Recruiting December 2019 United Kingdom ... More >> Blackpool Teaching Hospitals Not yet recruiting Blackpool, United Kingdom Contact: Peter Isaacs          University Hospitals Bristol NHS Foundation Trust Not yet recruiting Bristol, United Kingdom Contact: Anne McCune          Cambridge University Hospitals NHS Foundation Trust Not yet recruiting Cambridge, United Kingdom Contact: Michael Allison          Derby Teaching Hospitals NHS Foundation Trust Not yet recruiting Derby, United Kingdom Contact: Andrew Austin          Glasgow Royal Infirmary, Greater Glasgow & Clyde Not yet recruiting Glasgow, United Kingdom, G4 0SF Contact: Ewan Forrest          Leeds Teaching Hospitals NHS Trust Not yet recruiting Leeds, United Kingdom Contact: Richard Parker          Aintree University Hospital Not yet recruiting Liverpool, United Kingdom Contact: Cyril SIEBERHAGEN          Royal Liverpool and Broadgreen University Hospitals NHS Trust Not yet recruiting Liverpool, United Kingdom Contact: Paul Richardson          Imperial College Healthcare NHS Foundation Trust Recruiting London, United Kingdom, W2 1NY Contact: Mark Thursz    020 3312 5359       Chelsea and Westminster Hospital NHS Foundation Trust Not yet recruiting London, United Kingdom Contact: Matthew Foxton          King's College Hospital NHS Foundation Trust Not yet recruiting London, United Kingdom Contact: Vishal Patel          Royal Free London NHS Foundation Trust Not yet recruiting London, United Kingdom Contact: David Patch          The Newcastle Upon Tyne Hospitals NHS Foundation Trust Not yet recruiting Newcastle Upon Tyne, United Kingdom Contact: Steve Masson          Nottingham University Hospitals NHS Trust Not yet recruiting Nottingham, United Kingdom Contact: Stephen Ryder          John Radcliffe Hospital, Oxford University NHS Foundation Trust Not yet recruiting Oxford, United Kingdom, OX3 9DU Contact: Jeremy Cobbold          Plymouth Hospitals NHS Trust Not yet recruiting Plymouth, United Kingdom Contact: Ashwin Dhanda          Sheffield Teaching Hospitals NHS Foundation Trust Not yet recruiting Sheffield, United Kingdom Contact: Amer Al-Joudeh          University Hospital Southampton NHS Foundation Trust Not yet recruiting Southampton, United Kingdom Contact: Mark Wright Less <<
NCT01947595 Diabetes Mellitus Type 2 Not Applicable Completed - Germany ... More >> Deutsches Institut für Ernährungsforschung / Charité Berlin Berlin, Germany University Hospital Dresden Dresden, Germany Deutsches Diabetes Zentrum Düsseldorf, Germany, 40225 Technische Universität München (TU Munich) Munich, Germany, 80333 Helmholtz Zentrum München Munich, Germany, 85764 Ludwig-Maximilians-University Munich, Germany University Hospital Tübingen Tübingen, Germany, 72076 Less <<
NCT03067662 Gestational Diabetes Mellitus ... More >>in Pregnancy Less << Not Applicable Recruiting December 30, 2018 Italy ... More >> Endocrinology, Diabetes and Metabolism Section, Department of Medicine, University of Verona and Azienda Ospedaliera Universitaria Integrata of Verona Recruiting Verona, Italy, 37126 Contact: Paolo Moghetti       paolo.moghetti@univr.it Less <<
NCT00732862 Type 2 Diabetes Not Applicable Completed - -
NCT00482404 Stress Hyperc... More >>holesterolemia Less << Early Phase 1 Completed - -
NCT01864460 Diabetes Neur... More >>opathy Impaired Glucose Tolerance Less << Not Applicable Recruiting December 1, 2020 United States, Maryland ... More >> Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD Recruiting Baltimore, Maryland, United States, 21201 Contact: James W Russell, MD    410-706-6689    James.Russell6@va.gov    Contact: Lindsay A Zilliox, MD    (410) 328-3100    lzilliox@som.umaryland.edu    Principal Investigator: James W Russell, MD Less <<
NCT03473262 - Completed - -
NCT02347293 Obesity Metab... More >>olic Syndrome Less << Early Phase 1 Completed - Sweden ... More >> Medicon Village Lund, Sweden Less <<
NCT02989688 Diabetes Chro... More >>nic Kidney Disease End Stage Renal Failure on Dialysis Less << Not Applicable Completed - United Kingdom ... More >> King's College Hospital London, United Kingdom, SE5 9RS Less <<
NCT02709356 Alzheimer's Disease Not Applicable Completed - Canada, Quebec ... More >> Research Centre on Aging (CSSS-IUGS - CIUSSS de l'Estrie - CHUS) Sherbrooke, Quebec, Canada, J1H4C4 Less <<
NCT00541229 Type 2 Diabetes Phase 1 Completed - -
NCT01829464 Diabetes Phase 3 Terminated(Due to potential co... More >>ncerns about liver safety (See Detailed Description)) Less << - -
NCT00718198 - Completed - United States, Illinois ... More >> John H. Stroger Jr. Hospital Chicago, Illinois, United States, 60612 Less <<
NCT01829464 - Terminated(Due to potential co... More >>ncerns about liver safety (See Detailed Description)) Less << - -
NCT03710850 Insulin Resistance ... More >> Microbiome Less << Not Applicable Recruiting December 31, 2021 Czechia ... More >> University Hospital Kralovske Vinohrady Recruiting Prague, Czechia, 10084 Contact: Jana Potočková    +420267163031    klinicka.fyziologie@lf3.cuni.cz Less <<
NCT03242122 Glycemic Index Not Applicable Completed - Canada, Ontario ... More >> Glycemic Index Laboratories Inc Toronto, Ontario, Canada, M5C 2N8 Less <<
NCT03305107 Glycemic Response ... More >> Cognitive Function Less << Not Applicable Completed - Canada, Ontario ... More >> School of Nutrition, Ryerson University Toronto, Ontario, Canada, M5B 2K3 Less <<
NCT02225379 Type 1 Diabetes ... More >> Nocturnal Hypoglycemia Less << Not Applicable Completed - Israel ... More >> Schneider Children's Medical Center Petah-Tikva, Israel, 49202 Less <<
NCT00631488 - Completed - -
NCT02571517 Bronchiolitis, Viral Phase 4 Completed - -
NCT02343380 - Completed - -
NCT03648307 - Completed - -
NCT00631488 Diabetes Mellitus, Type 2 Phase 2 Completed - -
NCT00924521 Metabolic Syndrome ... More >> Insulin Resistance Less << Not Applicable Completed - United States, Pennsylvania ... More >> Penn State University University Park, Pennsylvania, United States, 16802 Less <<
NCT01892280 Type 1 Diabetes Not Applicable Completed - United States, Massachusetts ... More >> Joslin Diabetes Center Boston, Massachusetts, United States, 02215 United States, Texas Texas Children's Hospital/Baylor College of Medicine Houston, Texas, United States, 77030 Less <<
NCT00524238 Hypothyroidism Not Applicable Completed - Denmark ... More >> Aarhus University Hospital Aarhus, Denmark, 8000 Less <<
NCT02127827 To Demonstrate That the Closed... More >> Loop System Can be Used Safely Over a Few Consecutive Days. To Assess Effectiveness in Maintaining Patients' Glucose Levels in the Target Range of 70 to 180 mg/dl, Measured by Blood Glucose Sensor. To Evaluate the User Experience With a Closed Loop System Less << Not Applicable Unknown - Israel ... More >> Sheba Medical Center Recruiting Ramat Gan, Israel Contact: Revital Dvir    972-3-5302021    endo.r@sheba.health.gov.il    Sub-Investigator: Jacob Ilany, Dr Less <<
NCT03178019 - Completed - -
NCT01648478 Insulin Resistance Not Applicable Completed - France ... More >> Centre de recherche en nutrition humaine Rhone-Alpes Pierre Bénite, France Less <<
NCT00177398 Type 2 Diabetes ... More >> Hyperglycemia Less << Phase 4 Completed - United States, Pennsylvania ... More >> University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States, 15213 Less <<
NCT01199926 - Completed - -
NCT00541229 - Completed - -
NCT02007577 - Completed - -
NCT02516657 - Unknown December 2018 United States, New York ... More >> Women and Children's Hospital of Buffalo Recruiting Buffalo, New York, United States, 14222 Contact: Lucy D Mastrandrea, MD, PhD    716-878-7588    lmastrandrea@upa.chob.edu Less <<
NCT01045954 Diabetes Mellitus Type 1 Not Applicable Unknown October 2010 United States, California ... More >> Diabetes Care Center Recruiting Salinas, California, United States, 93901 Contact: Gary S Wolfe, RN    831-769-9355    gwolfe@diabetescarecenter.com    Principal Investigator: Allen B King, MD          Sub-Investigator: Dawn Clark, NP Less <<
NCT02007577 Pre Diabetes ... More >>Insulin Resistant Less << Not Applicable Completed - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT00460304 Type 1 Diabetes Not Applicable Completed - -
NCT01957943 Ischemia Re-perfusion Injury Not Applicable Unknown March 2018 Egypt ... More >> Liver transplantation program - Gastroenterology surgical center - Mansoura university Recruiting Mansoura, Dakahlia, Egypt, 35511 Contact: Amr M Yassen, MD    +201001497044    amryassen@hotmail.com    Contact: waleed R elsarraf, MD    +201222322727    welsarraf@gmail.com Less <<
NCT02552706 Necrotizing Enterocolitis ... More >> Death Less << Not Applicable Unknown September 2017 China, Guangdong ... More >> Longhua People's Hospital of Shenzhen Active, not recruiting Shenzhen, Guangdong, China, 518100 Shenzhen Bao'an Maternal and Child Health Hospital Recruiting Shenzhen, Guangdong, China, 518100 Contact: Yuefeng Li, M.D.    +86-13751029103    liyuefeng111@sina.com    Shenzhen People's Hospital Recruiting Shenzhen, Guangdong, China, 518100 Contact: Benqing Wu, M.D.    +86-13902436593    wubenqing783@126.com    Shenzhen Sixth People's Hospital Active, not recruiting Shenzhen, Guangdong, China, 518100 Less <<
NCT02647827 Polycystic Ovary Syndrome ... More >> Insulin Resistance Hyperandrogenism Less << Phase 2 Recruiting December 2019 China ... More >> Peking University Recruiting Beijing, China, 100871 Contact: Jie Qiao, Professor    +8615611908108    jie.qiao@263.net    Contact: Haolin Zhang, PhD    +8613911533466    zoe@bjmu.edu.cn    Sweden Karolinska University Hospital Recruiting Stockholm, Sweden, 17176 Contact: Berit Legerstam, Study nurse    +46851773782    berit.legerstam@karolinska.se    Contact: Liselotte Blomberg, Study nurse    +46851773782    liselott.blomberg@karolinska.se    Principal Investigator: Elisabet Stener-Victorin, PhD          Sub-Investigator: Angelica Linden-Hirschberg, Professor          Sub-Investigator: Sebastian Gidlöf, PhD Less <<
NCT01199926 Obesity Insul... More >>in Resistance Inflammation Less << Phase 4 Completed - United States, Indiana ... More >> Wastl Human Performance Laboratory, Purdue University West Lafayette, Indiana, United States, 47907 Less <<
NCT00548444 Tuberculosis Phase 1 Completed - United Kingdom ... More >> University of Oxford Oxford, Oxfordshire, United Kingdom, OX3 7LJ Less <<
NCT03211182 PreDiabetes Not Applicable Recruiting December 31, 2018 Taiwan ... More >> YUANH Active, not recruiting Kaohsiung, Lingya Dist, Taiwan, 802 SKH Recruiting Taipei, Shilin Dist., Taiwan, 111 Contact: Yu-Ling Li, PhD student    +886227361661 ext 6512    evelyn.tmu@gmail.com    TMUH Recruiting Taipei, Sinyi District,, Taiwan, 110 Contact: Yu-Ling Li, PhD student    +886227361661 ext 6512    evelyn.tmu@gmail.com    MMH Recruiting Taipei, Zhongshan Dist., Taiwan, 104 Contact: Yu-Ling Li, PhD student    +886227361661 ext 6512    evelyn.tmu@gmail.com Less <<
NCT00458016 Type 2 Diabetes Mellitus Phase 2 Completed - -
NCT00780026 - Completed - -
NCT00780026 Liver Transplant Phase 4 Completed - United States, Michigan ... More >> University of Michigan Ann Arbor, Michigan, United States, 48109 Less <<
NCT01801631 Type 2 Diabetes ... More >> Acute Coronary Event Less << Not Applicable Completed - Netherlands ... More >> Meander Medical Center Amersfoort, Netherlands Gelre Hospitals Apeldoorn, Netherlands Lievensberg Hospital Bergen op Zoom, Netherlands Amphia Hospital Breda, Netherlands Gemini Hospital Den Helder, Netherlands Admiraal de Ruyter Hospital Goes, Netherlands Beatrix Hospital Gorinchem, Netherlands Westfriesgasthuis Hoorn, Netherlands Sint Antonius Hospital Nieuwegein, Netherlands Canisius Wilhelmina Hospital Nijmegen, Netherlands Diakonessenhuis Utrecht, Netherlands Sint Antonius Hospital Utrecht, Netherlands University Medical Center Utrecht, Netherlands Less <<
NCT00640328 Multiple Sclerosis Phase 2 Completed - -
NCT00640328 - Completed - -
NCT03633630 Metabolic Syndrome Phase 2 Phase 3 Not yet recruiting October 1, 2020 Mexico ... More >> Institute of Experimental and Clinical Therapeutics Not yet recruiting Guadalajara, Jalisco, Mexico, 44340 Contact: Mercedes Hernández-Jaime, PhD Student    523310585200 ext 34211    mercedes.hdezj@gmail.com Less <<
NCT02737267 Body Weight Changes Not Applicable Unknown December 2017 Spain ... More >> Centre for Nutrition Research, University of Navarra Pamplona, Navarra, Spain, 31008 Less <<
NCT03440736 Psoriasis Met... More >>abolic Syndrome Less << Phase 4 Recruiting March 30, 2021 -
NCT03397888 Hepatic Impairment Phase 1 Completed - United States, Florida ... More >> Clinical Pharmacology of Miami Hialeah, Florida, United States, 33014 Less <<
NCT00663208 Chronic Hepatitis C Phase 2 Completed - United States, California ... More >> Advanced Clinical Res Inst Anaheim, California, United States, 92801 West Coast Clinical Trials, Llc Cypress, California, United States, 90630 United States, Connecticut Yale University School of Medicine New Haven, Connecticut, United States, 06510 United States, Florida Elite Research Institute Miami, Florida, United States, 33169 Orlando Clinical Research Center Orlando, Florida, United States, 32809 United States, Maryland Parexel International Corporation Baltimore, Maryland, United States, 21225 United States, Texas Alamo Medical Research San Antonio, Texas, United States, 78215 Puerto Rico Local Institution Santurce, Puerto Rico, 00909 Less <<
NCT01043042 - Completed - United States, Tennessee ... More >> Vanderbilt University Hospital Nashville, Tennessee, United States, 37232 Less <<
NCT02763150 Gestational Diabetes Mellitus Not Applicable Recruiting March 2021 United States, California ... More >> California Polytechnic State University Recruiting San Luis Obispo, California, United States, 93401 Contact: Casey Heaney, B.S.    805-756-5365    heaney@calpoly.edu    Principal Investigator: Suzanne Phelan, PhD          United States, Rhode Island Miriam Hospital Recruiting Providence, Rhode Island, United States, 02906 Contact: Angelica McHugh, MS    401-793-8978    amchugh1@lifespan.org    Principal Investigator: Rena R Wing, PhD Less <<
NCT01999686 Polycystic Ovary Syndrome (PCO... More >>S) Insulin Resistance Less << Phase 3 Recruiting October 2018 Indonesia ... More >> Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Faculty of Medicine, University of Lambung Mangkurat, Ulin Banjarmasin Hospital Recruiting Banjarmasin, Indonesia Contact: Iwan D Putra, dr., SpOG-K    +62811503472    i_darmaputra@yahoo.com    Principal Investigator: Iwan D Putra, dr., SpOG-K          Sub-Investigator: Hardyan Sauqi, dr., SpOG          Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Faculty of Medicine, University of Udayana, Sanglah Hospital Recruiting Denpasar, Indonesia Contact: Putu Doster Mahayasa, dr., SpOG-K    +628123812259    dmahayasa@gmail.com    Principal Investigator: Putu Doster Mahayasa, dr., SpOG-K          Sub-Investigator: Anom Suardika, dr., SpOG          Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Faculty of Medicine, University of Hasanuddin, Dr. Wahidin Sudirohusodo Hospital Recruiting Makasar, Indonesia Contact: Nusratuddin Abdullah, Dr., dr., SpOG-K, MARS    +6281342752561    nusraya@yahoo.com    Principal Investigator: Nusratuddin Abdullah, Dr., dr., SpOG-K, MARS          Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Faculty of Medicine, University of Brawijaya, Dr. Saiful Anwar Hospital Recruiting Malang, Indonesia Contact: Arsana Wiyasa IW, Dr., dr., SpOG-K    +62811343876    abiyasa9@yahoo.com    Principal Investigator: Arsana Wiyasa IW, Dr., dr., SpOG-K          Sub-Investigator: Sutrisno Sutrisno, dr., SpOG-K          Sub-Investigator: Widjajanto Ngartjono, dr., SpOG-K          Sub-Investigator: Pande M Dwijayasa, dr., SpOG-K          Sub-Investigator: Hermawan Wibisono, dr., SpOG          Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Faculty of Medicine, University of Sam Ratulangi, Prof. Dr. Kandou Hospital Recruiting Manado, Indonesia Contact: Eddy Suparman, Prof., Dr., dr., SpOG-K    +62811431600    obsgyn_manado@yahoo.com.sg    Principal Investigator: Eddy Suparman, Prof., Dr., dr., SpOG-K          Sub-Investigator: Freddy W Wagey, Dr., dr., SpOG-K          Sub-Investigator: Maria F Loho, dr., SpOG-K          Sub-Investigator: Juneke J Kaeng, dr., SpOG-K          Sub-Investigator: Maya E Mewengkang, dr., SpOG          Sub-Investigator: Linda M Mamengko, dr., SpOG-K          Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Faculty of Medicine, Diponegoro University, Dr. Kariadi Hospital Recruiting Semarang, Indonesia Contact: Syarief Taufik, dr., SpOG-K    +628112715580    tofik_obg@yahoo.com    Principal Investigator: Syarief Taufik, dr., SpOG-K          Sub-Investigator: Inu Mulyantoro, dr., SpOG-K          Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Faculty of Medicine, University of Airlangga, Dr. Soetomo Hospital. Recruiting Surabaya, Indonesia Contact: Soehartono Ds, Prof., dr., SpOG-K    +62811347720    batabsby@yahoo.com    Principal Investigator: Soehartono Ds, Prof., dr., SpOG-K          Sub-Investigator: Budi Santoso, Prof., Dr., dr., SpOG-K          Sub-Investigator: Relly Y Primariawan, SpOG-K Less <<
NCT02377973 - Completed - Denmark ... More >> Department of Human Nutrition, Faculty of Sciences, University of Copenhagen Frederiksberg, Denmark, 1958 Less <<
NCT02010060 Central Obesity ... More >> Obesity Less << Not Applicable Completed - United States, North Carolina ... More >> East Carolina University Greenville, North Carolina, United States, 27858 Less <<
NCT01195532 - Unknown January 2011 Taiwan ... More >> Taipei Medical University - Municipal Wan Fang Hospital Recruiting Taipei, Taiwan, Taiwan Contact: Hsingjin E Liu, MD, PhD E Liu, MD, PhD    8862-29307930 ext 2548    liuxx086@yahoo.com.tw    Principal Investigator: Hsingjin E Liu, MD, PhD E Liu, MD, PhD Less <<
NCT02613910 Pemphigus Phase 3 Terminated(Novartis has acquir... More >>ed the rights to ofatumumab and terminated the OPV116910 and OPV117059 studies. This decision is not linked to any safety consideration.) Less << - United States, California ... More >> GSK Investigational Site Los Angeles, California, United States, 90045 United States, Michigan GSK Investigational Site Ann Arbor, Michigan, United States, 48103 Less <<
NCT00663208 - Completed - -
NCT01238016 Hypoglycemia Not Applicable Terminated(Replaced by new stu... More >>dy) Less << - Denmark ... More >> Esbjerg Sygehus Esbjerg, Denmark, 6700 Less <<
NCT02686502 Obesity Cardi... More >>ovascular Diseases Physical Conditioning Less << Not Applicable Recruiting May 2019 Finland ... More >> Helsinki University Hospital Recruiting Helsinki, Finland Contact: Maritta Poyhonen-Alho, PhD       maritta.poyhonen-alho@hus.fi    Vantaa Health Care and Social Services Recruiting Vantaa, Finland Contact: Niina Sahrakorpi, MD       niina.sahrakorpi@vantaa.fi Less <<
NCT01237509 - Completed - Denmark ... More >> Esbjerg Sygehus Esbjerg, Denmark, 6700 Less <<
NCT02527798 Bronchopulmonary Dysplasia Phase 2 Active, not recruiting June 2020 -
NCT00393172 Breast Cancer ... More >> Obesity Less << Phase 2 Phase 3 Completed - United States, Minnesota ... More >> University of Minnesota - St. Paul Campus St. Paul, Minnesota, United States, 55108 Less <<
NCT01317979 - Unknown December 2013 Taiwan ... More >> Min sheng general hospital Recruiting Taoyuan city, Taiwan MinSheng Genral Hospital Recruiting Taoyuan, Taiwan Contact: Lee WeiJei, M.D, Ph.D    886-3-3179599 ext 1599    wjlee_obessurg_tw@yahoo.com.tw Less <<
NCT03123510 Obesity Not Applicable Recruiting November 1, 2017 United States, South Dakota ... More >> South Dakota State University Recruiting Brookings, South Dakota, United States, 57007 Contact: Eduardo Huarte, PhD    605-688-6324    eduardo.huarte@sdstate.edu Less <<
NCT02613910 - Terminated(Novartis has acquir... More >>ed the rights to ofatumumab and terminated the OPV116910 and OPV117059 studies. This decision is not linked to any safety consideration.) Less << - -
NCT01384110 Hyperglycemia Phase 1 Completed - Canada ... More >> Institut des Nutraceutiques et des Aliments Fonctionnels (INAF) Quebec, Canada Less <<
NCT01394627 Hypoglycemia Not Applicable Completed - United States, Massachusetts ... More >> Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Less <<
NCT00514215 Kidney Cancer ... More >> Lung Cancer Metastatic Cancer Unspecified Adult Solid Tumor, Protocol Specific Less << Phase 2 Completed - United States, Michigan ... More >> Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201-1379 Less <<
NCT00514215 - Completed - -
NCT01401634 Hyperglycemia Phase 1 Completed - United States, California ... More >> University of Southern California Los Angeles, California, United States, 90033 Less <<
NCT02293915 Mild to Moderate Alzheimer Dis... More >>ease Cognitive Impairment Less << Phase 3 Completed - China, Beijing ... More >> Beijing Beijing, Beijing, China, 100005 China, Chongqing Chongqing Chongqing, Chongqing, China, 400010 China, Fujian Fujian Fuzhou, Fujian, China China, Guangdong Guangzhou Guangzhou, Guangdong, China China, Hubei Wuhan Wuhan, Hubei, China, 430077 China, Hunan Changsha Changsha, Hunan, China China, Jiangsu Nanjing Nanjing, Jiangsu, China Suzhou Suzhou, Jiangsu, China Yangzhou Yangzhou, Jiangsu, China China, Shandong Jinan Jinan, Shandong, China, 250021 China, Shanghai Shanghai Shanghai, Shanghai, China, 200030 China, Shanxi Xi'an Xi'an, Shanxi, China China, Sichuan Sichuan Chengdu, Sichuan, China, 610041 China, Tianjin Tianjin Tianjin, Tianjin, China, 300052 China, Zhejiang Hangzhou Hangzhou, Zhejiang, China, 310016 Wenzhou Wenzhou, Zhejiang, China Less <<
NCT01394627 - Completed - -
NCT01450592 - Completed - India ... More >> Many Locations, India Less <<
NCT02443155 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 2 Active, not recruiting March 1, 2019 -
NCT03002168 Healthy Participants Not Applicable Completed - United States, Minnesota ... More >> Mayo Clinic in Rochester Rochester, Minnesota, United States, 55905 Less <<
NCT02035644 Type 2 Diabetes ... More >> Dyslipidemia Less << Phase 4 Unknown - China, Shanghai ... More >> Guang Ning Not yet recruiting Shanghai, Shanghai, China, 200025 Less <<
NCT03672422 - Recruiting August 31, 2020 -
NCT01364844 Solid Tumor C... More >>olorectal Cancer Endometrial Cancer Less << Phase 1 Completed - United States, Michigan ... More >> Karmanos Cancer Institute Detroit, Michigan, United States, 48201 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 United States, Tennessee Sarah Cannon Research Institute Nashville, Tennessee, United States, 37203 Less <<
NCT00449423 Acute Heart Failure Phase 2 Terminated(due to slow recruit... More >>ment) Less << - Denmark ... More >> Aarhus University Hospital, Skejby Sygehus, Department of Cardiology Aarhus, Denmark, 8200 Less <<
NCT03214367 Type 1 Diabetes Mellitus Phase 3 Active, not recruiting September 5, 2019 -
NCT01477112 Diabetes Mellitus ... More >> Oxidative Stress Iron Metabolism Disorders Less << Not Applicable Completed - Venezuela ... More >> Hospital Baudilio Lara Barquisimeto, Lara, Venezuela Less <<
NCT02035046 Heterozygous Carriers of Gitel... More >>man Syndrome Less << Not Applicable Completed - France ... More >> Nephrology Department. Centre Hospitalier Universitaire, Hôpital Dupuytren Limoges, France, 87042 Limoges cedex Department of Functional Investigations. Hospices Civils de Lyon, Hôpital Edouard Herriot. Lyon, France, 69437 Lyon Department of Functional Investigations. Assistance Publique Hôpitaux de Paris, Hôpital Tenon Paris, France, 75020 Clinical Research Center. Assistance Publique Hôpitaux de Paris, Hôpital Européen Georges Pompidou. Paris, France, 75908 Department of Functional Investigations. Centre Hospitalier Universitaire, Hôpital de Rangueil. Toulouse, France, 31059 TOULOUSE cedex 9 Less <<
NCT01658137 Cardiovascular Diseases ... More >> Inflammation Dyslipidemias Blood Pressure Hyperglycemia Less << Not Applicable Unknown December 2016 Canada, Ontario ... More >> McMaster University Hamilton, Ontario, Canada, L8S 4K1 Less <<
NCT01544829 Cardiovascular Diseases Not Applicable Completed - France ... More >> Eurofins Optimed Gieres, France Less <<
NCT02715258 Type 2 Diabetes Mellitus Phase 3 Completed - United States, California ... More >> Research Site Canoga Park, California, United States, 91303 Research Site Chino, California, United States, 91710 Research Site Huntington Park, California, United States, 90255 Research Site Los Angeles, California, United States, 90057 Research Site San Diego, California, United States, 92103 United States, Florida Research Site Fort Lauderdale, Florida, United States, 33316 Research Site Hialeah, Florida, United States, 33012 Research Site Miami Lakes, Florida, United States, 33016 Research Site Orlando, Florida, United States, 32806 Research Site Port Orange, Florida, United States, 32127 United States, New Jersey Research Site Trenton, New Jersey, United States, 08611 United States, North Carolina Research Site Calabash, North Carolina, United States, 28467 Research Site Morehead City, North Carolina, United States, 28557 United States, Ohio Research Site Munroe Falls, Ohio, United States, 44262 United States, Oregon Research Site Portland, Oregon, United States, 97239 United States, South Carolina Research Site North Myrtle Beach, South Carolina, United States, 29582 United States, Texas Research Site DeSoto, Texas, United States, 75115 Research Site Fort Worth, Texas, United States, 76164 Canada, British Columbia Research Site Vancouver, British Columbia, Canada, V6J 1S3 Canada, Ontario Research Site Newmarket, Ontario, Canada, L3Y 5G8 Research Site 2 Toronto, Ontario, Canada, M9V 4B4 Research Site 1 Toronto, Ontario, Canada, M9W 4L6 Canada, Quebec Research Site Pointe-Claire, Quebec, Canada, H9R 4S3 Less <<
NCT03479346 Obesity Metab... More >>olic Syndrome Less << Not Applicable Recruiting December 1, 2020 Korea, Republic of ... More >> Gachon University Gil Oriental Medical Hospital Recruiting Incheon, Korea, Republic of Contact: youme Ko, MA    8229619278    meyougo@khu.ac.kr Less <<
NCT01545791 - Completed - Ireland ... More >> Novo Nordisk Investigational Site Dublin, Ireland, DUBLIN 15 United Kingdom Novo Nordisk Investigational Site London, United Kingdom, W12 OHS Less <<
NCT01769404 Diabetes Mellitus, Type 1 Phase 1 Completed - Germany ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Neuss, Germany, 41460 Less <<
NCT02310932 Chronic Disease ... More >> Depression Anxiety Less << Not Applicable Recruiting April 2019 India ... More >> St. John & Research Institute/St John & Medical College & Hospital Recruiting Bangalore, Karnataka, India, 560 034 Contact: Priya Shetty, MPH       priyashetty@sjri.res.in    Principal Investigator: Krishnamachari Srinivasan,, MD          Sub-Investigator: Prem Mony, MD Less <<
NCT02563678 Infection Phase 1 Recruiting December 2018 United States, Utah ... More >> Intermountain Medical Center Recruiting Murray, Utah, United States, 84157 Contact: Susan Churchill, APRN-NP    801-408-3623    susan.churchill@imail.org    Principal Investigator: Lindell K. Weaver, MD          Intermountain Healthcare, LDS Hospital Recruiting Salt Lake City, Utah, United States, 84143 Contact: Susan Churchill, APRN-NP    810-408-3623    Susan.Churchill@imail.org    Principal Investigator: Lindell K Weaver, MD          Sub-Investigator: Susan Churchill, APRN-NP Less <<
NCT01816893 Hypoglycemia Not Applicable Completed - United States, Massachusetts ... More >> Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02115 Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Less <<
NCT01816893 - Completed - -
NCT02897219 Type 1 Diabetes Mellitus Phase 3 Completed - Japan ... More >> Site JP00005 Aichi, Japan Site JP00028 Aichi, Japan Site JP00003 Chiba, Japan Site JP00013 Chiba, Japan Site JP00035 Chiba, Japan Site JP00022 Fukuoka, Japan Site JP00023 Fukuoka, Japan Site JP00031 Fukuoka, Japan Site JP00002 Gunma, Japan Site JP00011 Gunma, Japan Site JP00006 Hiroshima, Japan Site JP00033 Hokkaido, Japan Site JP00034 Hokkaido, Japan Site JP00021 Hyogo, Japan Site JP00009 Ibaraki, Japan Site JP00010 Ibaraki, Japan Site JP00004 Kanagawa, Japan Site JP00015 Kanagawa, Japan Site JP00016 Kanagawa, Japan Site JP00019 Mie, Japan Site JP00008 Nagasaki, Japan Site JP00024 Nagasaki, Japan Site JP00025 Nagasaki, Japan Site JP00032 Nagasaki, Japan Site JP00026 Niigata, Japan Site JP00020 Osaka, Japan Site JP00029 Osaka, Japan Site JP00036 Osaka, Japan Site JP00012 Saitama, Japan Site JP00017 Shizuoka, Japan Site JP00018 Shizuoka, Japan Site JP00001 Tochigi, Japan Site JP00030 Tokushima, Japan Site JP00014 Tokyo, Japan Site JP00027 Toyama, Japan Site JP00007 Yamaguchi, Japan Less <<
NCT01602562 - Completed - -
NCT03314714 Insulin Resistance, Diabetes ... More >> Lipid Metabolism Disorders Less << Not Applicable Recruiting June 2019 Germany ... More >> DDZ (Deutsches Diabetes Zentrum) Recruiting Düsseldorf, NRW, Germany, 40225 Contact: Michael Roden, Prof. Dr.    00492113382 ext 201    Michael.Roden@ddz.uni-duesseldorf.de    Contact: Dominik Pesta, PhD    00492113382 ext 229    Dominik.Pesta@ddz.uni-duesseldorf.de    Netherlands Maastricht University Recruiting Maastricht, Netherlands, 6200 Contact: Patrick Schrauwen, Prof. Dr.    0031433881502    p.schrauwen@maastrichtuniversity.nl    Contact: Yvo op den Kamp, MD MSc    0031433882124    y.opdenkamp@maastrichtuniversity.nl Less <<
NCT03077360 Diabetes Mellitus, Type 2 ... More >> Pre-diabetes Obesity Less << Not Applicable Recruiting January 31, 2021 United States, Colorado ... More >> University of Colorado Recruiting Aurora, Colorado, United States, 80045 Contact: Simona Zarini, PhD    303-724-3968    Simona.Zarini@ucdenver.edu Less <<
NCT03316131 Asymptomatic Hyperuricemia Phase 2 Completed - United States, California ... More >> Research Site Glendale, California, United States, 91206 United States, Maryland Research Site Baltimore, Maryland, United States, 21225 Less <<
NCT01602562 Herpes Simplex Phase 3 Completed - Japan ... More >> GSK Investigational Site Aichi, Japan, 446-8602 GSK Investigational Site Aichi, Japan, 453-8511 GSK Investigational Site Aichi, Japan, 466-8560 GSK Investigational Site Hiroshima, Japan, 734-8551 GSK Investigational Site Hyogo, Japan, 650-0047 GSK Investigational Site Hyogo, Japan, 654-0081 GSK Investigational Site Kagoshima, Japan, 890-8520 GSK Investigational Site Kanagawa, Japan, 259-1143 GSK Investigational Site Osaka, Japan, 594-1101 GSK Investigational Site Saitama, Japan, 339-8551 GSK Investigational Site Tokyo, Japan, 162-8655 Less <<
NCT01808313 Vascular Disease Phase 3 Completed - China, Heilongjiang ... More >> GSK Investigational Site Harbin, Heilongjiang, China, 150001 China, Hubei GSK Investigational Site Wuhan, Hubei, China, 430022 China, Hunan GSK Investigational Site Hunan, Hunan, China, 410008 China, Jilin GSK Investigational Site Changchun, Jilin, China, 130021 China, Shaanxi GSK Investigational Site Xian, Shaanxi, China, 710032 China, Shandong GSK Investigational Site Jinan, Shandong, China, 250012 China GSK Investigational Site Beijing, China, 100032 GSK Investigational Site Beijing, China, 100034 GSK Investigational Site Beijing, China, 100037 GSK Investigational Site Beijing, China, 100038 GSK Investigational Site Shanghai, China, 200001 GSK Investigational Site Shanghai, China, 200433 Less <<
NCT00501462 Type 2 Diabetes Mellitus ... More >> Diabetes Mellitus, Type 2 Renal Insufficiency Less << Phase 1 Completed - United States, Florida ... More >> GSK Investigational Site Orlando, Florida, United States, 32809 United States, Minnesota GSK Investigational Site Minneapolis, Minnesota, United States, 55404 United States, Tennessee GSK Investigational Site Knoxville, Tennessee, United States, 37920 United States, Texas GSK Investigational Site Austin, Texas, United States, 78752 Less <<
NCT01928927 HIV-1 Infection Phase 2 Completed - United States, California ... More >> UCLA CARE Center CRS (601) Los Angeles, California, United States, 90035 United States, Colorado University of Colorado Hospital CRS (6101) Aurora, Colorado, United States, 80045 United States, Massachusetts Massachusetts General Hospital ACTG CRS (101) Boston, Massachusetts, United States, 02114 United States, Missouri Washington U CRS (2101) Saint Louis, Missouri, United States, 63110 United States, New York University of Rochester Adult HIV Therapeutic Strategies Network CRS (31787) Rochester, New York, United States, 14642 United States, North Carolina Unc Aids Crs (3201) Chapel Hill, North Carolina, United States, 27514 United States, Ohio Univ. of Cincinnati CRS (2401) Cincinnati, Ohio, United States, 45267 Case CRS (2501) Cleveland, Ohio, United States, 44106 United States, Tennessee Vanderbilt Therapeutics CRS (3652) Nashville, Tennessee, United States, 37232 United States, Texas Houston AIDS Research Team CRS (31473) Houston, Texas, United States, 77030 United States, Washington University of Washington AIDS CRS (1401) Seattle, Washington, United States, 98104 Puerto Rico Puerto Rico-AIDS CRS (5401) San Juan, Puerto Rico, 00935 Less <<
NCT01928927 - Completed - -
NCT01808313 - Completed - -
NCT01493388 - Completed - Tunisia ... More >> Novo Nordisk Investigational Site Tunisia, Tunisia, 1053 Less <<
NCT01923688 Diabetes Not Applicable Completed - -
NCT02558296 Type 2 Diabetes Mellitus Phase 3 Active, not recruiting April 2019 -
NCT01921374 Other Diseases or Conditions Not Applicable Completed - Brazil ... More >> University Federal of São Paulo São Paulo, Brazil, 04024001 Less <<
NCT03260868 Type 1 Diabetes Mellitus Phase 4 Terminated(Due to "prolonged l... More >>ow patient recruitment") Less << - United States, Iowa ... More >> Investigational Site Number 8400002 West Des Moines, Iowa, United States, 50265 United States, Texas Investigational Site Number 8400004 Houston, Texas, United States, 77043 United States, West Virginia Investigational Site Number 8400003 Bridgeport, West Virginia, United States, 26330 Canada Investigational Site Number 1240001 Barrie, Canada, L4M 7G1 Investigational Site Number 1240003 Oakville, Canada, L6M 1M1 Investigational Site Number 1240002 Thornhill, Canada, L4J 8L7 Less <<
NCT00880139 - Terminated - Austria ... More >> Department of Clinical Pharmacology, Medical University of Vienna Vienna, Austria Less <<
NCT00812617 Healthy Not Applicable Completed - Japan ... More >> Hiroshima University Hiroshima, Japan, 734-8551 Less <<
NCT02044705 Overweight Ob... More >>esity Less << Not Applicable Completed - United States, California ... More >> Pittsburg Health Center Pittsburg, California, United States, 94565 West County Health Center San Pablo, California, United States, 94806 Less <<
NCT00048568 Rheumatoid Arthritis Phase 3 Completed - -
NCT03473704 Type 1 Diabetes Mellitus ... More >> Depression Less << Not Applicable Recruiting October 1, 2020 Spain ... More >> University of Malaga Recruiting Málaga, Spain, 29071 Contact: Mónica Carreira, PhD    +34 952136697    mcarreira@uma.es    Contact: Maria Teresa Anarte, PhD    +34 952132994    anarte@uma.es Less <<
NCT01643356 Overweight and Obesity ... More >> Pregnancy Less << Not Applicable Completed - United States, Massachusetts ... More >> Tufts Medical Center Boston, Massachusetts, United States, 02111 Tufts University Human Nutrition Research Center on Aging Boston, Massachusetts, United States, 02111 Less <<
NCT03669887 Gestational Diabetes ... More >> Diabetes Childhood Obesity Diabetes Mellitus Less << Not Applicable Recruiting December 2021 Hong Kong ... More >> Prince of Wales Hosptial Recruiting Shatin, Hong Kong Less <<
NCT00996840 - Completed - -
NCT00996840 Lung Injury, Acute Phase 2 Completed - United States, Kentucky ... More >> GSK Investigational Site Lexington, Kentucky, United States, 40536-0293 United States, North Carolina GSK Investigational Site Durham, North Carolina, United States, 27710 GSK Investigational Site Winston-Salem, North Carolina, United States, 27157 United States, Pennsylvania GSK Investigational Site Philadelphia, Pennsylvania, United States, 19104 GSK Investigational Site Pittsburgh, Pennsylvania, United States, 15213 United States, Tennessee GSK Investigational Site Nashville, Tennessee, United States, 37232-7110 Less <<
NCT01856257 Primary Renal Allograft Candid... More >>ate Kidney Transplantation Less << Phase 2 Terminated(Safety Stopping rul... More >>e not met.) Less << - United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35294 United States, California University of California, San Francisco San Francisco, California, United States, 94143 United States, Georgia Emory University Atlanta, Georgia, United States, 30322 Less <<
NCT02272556 Hyperglycemia Early Phase 1 Recruiting November 2019 United States, Connecticut ... More >> Yale University Recruiting New Haven, Connecticut, United States, 06519 Contact: Janice Hwang, MD    203-785-6222    janice.hwang@yale.edu Less <<
NCT00757783 HIV Phase 4 Completed - United States, California ... More >> Los Angeles, California, United States United States, Connecticut Glastonbury, Connecticut, United States United States, District of Columbia Washington, District of Columbia, United States United States, Florida Fort Lauderdale, Florida, United States Miami, Florida, United States Orlando, Florida, United States United States, Indiana Indianapolis, Indiana, United States United States, Massachusetts Boston, Massachusetts, United States United States, Minnesota Minneapolis, Minnesota, United States United States, Missouri Saint Louis, Missouri, United States United States, New Jersey Hillsborough, New Jersey, United States United States, New York New York, New York, United States United States, Ohio Cincinnati, Ohio, United States United States, Pennsylvania Philadelphia, Pennsylvania, United States United States, Texas Dallas, Texas, United States Less <<
NCT01856257 - Terminated(Safety Stopping rul... More >>e not met.) Less << - -
NCT02228642 - Completed - United States, Pennsylvania ... More >> University of Pittsburgh Medical Center PUH SSY Pittsburgh, Pennsylvania, United States, 15213 Less <<
NCT02721277 Cholestasis J... More >>aundice, Obstructive Less << Phase 1 Phase 2 Terminated - United States, Florida ... More >> University of Florida Gainesville, Florida, United States, 32610 Less <<
NCT00048568 - Completed - -
NCT03497546 Obesity, Morbid Not Applicable Recruiting December 2020 Spain ... More >> Complejo Hospitalario Torrecárdenas (CHT) Recruiting Almería, Spain, 04009 Contact: Juan Manuel García Torrecillas, MD Less <<
NCT03202680 Metabolic Syndrome ... More >> PreDiabetes Less << Not Applicable Active, not recruiting March 2019 United States, Florida ... More >> MB Clinical Research, LLC Boca Raton, Florida, United States, 33487 Less <<
NCT00757783 - Completed - -
NCT02721277 - Terminated - -
NCT02341313 - Unknown December 2015 United Kingdom ... More >> addenbrookes Hospital Recruiting Cambridge, United Kingdom Contact: Kathryn Beardsall    001223 746791       Principal Investigator: Kathryn Beardsall Less <<
NCT03103386 H. Pylori Infections ... More >> Non-communicable Diseases Less << Not Applicable Active, not recruiting December 2018 China, Shanghai ... More >> Dept. Nutrition and Food Hygiene, School of Public Health,Fudan University Shanghai, Shanghai, China, 200032 Less <<
NCT02347553 - Completed - United Kingdom ... More >> Royal Infirmary of Edinburgh Edinburgh, Midlothian, United Kingdom, EH16 4SA Less <<
NCT01767077 Hypercholesterolemia Not Applicable Completed - Sweden ... More >> Uppsala university, Dept of public health and caring sciences; Clinical nutrition and metabolism Uppsala, Sweden Less <<
NCT02803554 Aging Not Applicable Completed - -
NCT01362244 - Completed - -
NCT02744820 Healthy Type ... More >>2 Diabetes Mellitus Less << Phase 1 Terminated(It was considered b... More >>y the sponsor that the study objective has been met by dosing 13 instead of 15 patients) Less << - United Kingdom ... More >> BioKinetic Europe Ltd. Belfast, United Kingdom, BT2 7BA Simbec Research Ltd Merthyr Tydfil, United Kingdom, CF48 4DR Less <<
NCT01362244 Nasal Polyps Phase 2 Completed - Belgium ... More >> GSK Investigational Site Gent, Belgium, 9000 Netherlands GSK Investigational Site Amsterdam, Netherlands, 1105 AZ United Kingdom GSK Investigational Site Cambridge, United Kingdom GSK Investigational Site London, United Kingdom, EC1M 6BQ GSK Investigational Site London, United Kingdom, SE1 1YR GSK Investigational Site London, United Kingdom, SW3 6NP GSK Investigational Site London, United Kingdom, WC1X 8DA Less <<
NCT02402153 - Completed - -
NCT01848379 Chronic Periodontitis ... More >> Diabetes Mellitus, Type 2 Less << Not Applicable Active, not recruiting December 2017 Germany ... More >> Department of Periodontontology, ZentrumZMK Giessen, Germany, 35392 Less <<
NCT01436305 Kidney Transplantation ... More >> Renal Transplantation Less << Phase 2 Terminated(Secondary to safety... More >> concerns plus change in Campath® (alemtuzumab) availability.) Less << - United States, Alabama ... More >> University of Alabama Birmingham, Alabama, United States, 35294 United States, California University of California San Francisco San Francisco, California, United States, 94143 United States, Georgia Emory University Atlanta, Georgia, United States, 30322 Less <<
NCT00478738 Pulmonary Disease, Chronic Obs... More >>tructive Less << Phase 2 Completed - Germany ... More >> GSK Investigational Site Mainz, Rheinland-Pfalz, Germany, 55131 GSK Investigational Site Berlin, Germany, 14050 South Africa GSK Investigational Site Bloemfontein, South Africa, 9301 GSK Investigational Site George, South Africa, 6530 GSK Investigational Site Mowbray, South Africa, 7700 Less <<
NCT01560546 Type 2 Diabetes Mellitus ... More >> Hypogonadism Less << Phase 4 Completed - Denmark ... More >> Department of Endocrinology, Odense University Hospital Odense, Denmark, 5000 Less <<
NCT03393195 Obesity Insul... More >>in Resistance Less << Not Applicable Recruiting August 30, 2019 United States, California ... More >> UCSF Medical Center Recruiting San Francisco, California, United States, 94143 Contact: Dylan Lowe       dylan.lowe@ucsf.edu Less <<
NCT03531944 Diabetes Mellitus, Type 2 Not Applicable Recruiting May 31, 2020 Singapore ... More >> Keat Hong Family Medicine Clinic Recruiting Singapore, Singapore, 689687 Contact: Joyce Lee Less <<
NCT02716064 Diabetes Mellitus ... More >> Hypertension Less << Not Applicable Completed - Canada, Ontario ... More >> McMaster Family Practice Hamilton, Ontario, Canada, L8S 1A4 Stonechurch Family Health Centre (SFHC) Hamilton, Ontario, Canada, L8W3J6 Less <<
NCT01657773 - Completed - China, Zhejiang ... More >> Wenzhou Medical College Wenzhou, Zhejiang, China, 325000 Less <<
NCT02875925 Pain Hypoglyc... More >>emia Less << Not Applicable Completed - United States, Minnesota ... More >> HealthEast Care System Saint Paul, Minnesota, United States, 55103 Less <<
NCT02402153 Healthy Not Applicable Completed - Denmark ... More >> Sydvestjysk Hospital Esbjerg, Denmark, 6800 Less <<
NCT02496494 CYCLOSPORINE/TACROLIMUS Phase 4 Unknown December 2015 Korea, Republic of ... More >> Kyungpook National University Hospital Recruiting Daegu, Korea, Republic of Contact: Chan-Duck Kim       drcdkim@knu.ac.kr Less <<
NCT01436305 - Terminated(Secondary to safety... More >> concerns plus change in Campath® (alemtuzumab) availability.) Less << - -
NCT01816165 Type 1 Diabetes Phase 3 Active, not recruiting September 2018 United States, Colorado ... More >> University of Colorado Denver Aurora, Colorado, United States, 80045 Less <<
NCT00424437 Diabetes Mellitus, Type 1 Phase 3 Completed - -
NCT02957838 Alteration of Mitochondrial Me... More >>mbrane Type2 Diabetes Fatty Acid Deficiency Less << Not Applicable Completed - Germany ... More >> University of Heidelberg Heidelberg, Baden-Württemberg, Germany, 69123 Less <<
NCT00424333 Diabetes Mellitus, Type 1 Phase 3 Completed - -
NCT03182192 Hypoglycemia Phase 1 Recruiting February 1, 2019 Netherlands ... More >> Rijnstate hospital Recruiting Arnhem, Gelderland, Netherlands Contact: Laura Deden, Msc       l.deden@rijnstate.nl    Radboudumc Recruiting Nijmegen, Gelderland, Netherlands, 6500HB Contact: Marti Boss, Msc    +312436 ext 67243    marti.boss@radboudumc.nl Less <<
NCT00742508 - Completed - -
NCT03641768 Alzheimer Dementia ... More >> Posttraumatic Stress Disorder Traumatic Brain Injury Less << Not Applicable Withdrawn(Funding not received... More >>) Less << January 1, 2021 United States, North Carolina ... More >> Durham VA Durham, North Carolina, United States, 27705 Less <<
NCT02091583 Metabolic Syndrome Not Applicable Completed - Canada, Manitoba ... More >> Richardson Centre for Functional Foods and Nutraceuticals Winnipeg, Manitoba, Canada, R3T 2N2 Less <<
NCT03334773 Type 2 Diabetes Mellitus Not Applicable Recruiting December 31, 2018 South Africa ... More >> Steve Biko Academic Hospital Recruiting Pretoria, Gauteng, South Africa, 0001 Contact: Professor    +27 3543861 ext 3861    paul.rheeder@up.ac.za Less <<
NCT00742508 Heart Failure, Congestive Phase 1 Completed - Japan ... More >> GSK Investigational Site Chiba, Japan, 296-8602 GSK Investigational Site Ehime, Japan, 794-0006 GSK Investigational Site Hiroshima, Japan, 737-0023 GSK Investigational Site Hokkaido, Japan, 060-0033 GSK Investigational Site Hokkaido, Japan, 063-0005 GSK Investigational Site Kanagawa, Japan, 210-0852 GSK Investigational Site Kanagawa, Japan, 238-8558 GSK Investigational Site Mie, Japan, 511-0068 GSK Investigational Site Nagano, Japan, 397-8555 GSK Investigational Site Nagasaki, Japan, 859-3615 GSK Investigational Site Oita, Japan, 879-5593 GSK Investigational Site Osaka, Japan, 565-8565 GSK Investigational Site Saga, Japan, 843-0393 GSK Investigational Site Saitama, Japan, 364-8501 GSK Investigational Site Shizuoka, Japan, 410-2295 GSK Investigational Site Shizuoka, Japan, 411-8611 GSK Investigational Site Shizuoka, Japan, 427-8502 GSK Investigational Site Shizuoka, Japan, 430-8502 GSK Investigational Site Tokyo, Japan, 141-0001 GSK Investigational Site Tokyo, Japan, 142-8666 GSK Investigational Site Tokyo, Japan, 153-8515 GSK Investigational Site Tokyo, Japan, 196-0003 GSK Investigational Site Wakayama, Japan, 640-8158 Less <<
NCT01986881 Type 2 Diabetes Mellitus Phase 3 Active, not recruiting September 11, 2019 -
NCT00519844 Foetal Growth Problem ... More >> Small for Gestational Age Less << Phase 4 Completed - France ... More >> Lyon, France, 69000 Less <<
NCT01364961 Dyslipidemia Not Applicable Completed - Netherlands ... More >> Maastricht University Medical Center Maastricht, Netherlands Less <<
NCT03553862 Type2 Diabetes Not Applicable Recruiting March 2020 Singapore ... More >> Chua Chu Kang Polyclinic Recruiting Singapore, Singapore Contact: Keith Tsou, Doctor    (65) 6496 6773    keith_tsou@nuhs.edu.sg Less <<
NCT03364335 Obesity Phase 2 Completed - United States, Alabama ... More >> AMR Mobile, Alabama, United States, 36608 United States, California Catalina Research Institute Montclair, California, United States, 91763 Northern California Research Sacramento, California, United States, 95821 United States, Idaho ACR Meridian, Idaho, United States, 83642 United States, Illinois Synexus Chicago, Illinois, United States, 60602 United States, Louisiana Pennington Biomedical Research Center Baton Rouge, Louisiana, United States, 70808 Clinical Trials Management Metairie, Louisiana, United States, 70006 United States, Missouri Synexus Saint Louis, Missouri, United States, 63141 United States, Nevada AMR Las Vegas, Nevada, United States, 89119 United States, Ohio Rapid Medical Research Cleveland, Ohio, United States, 44122 United States, South Carolina Medical Research South Charleston, South Carolina, United States, 29407 United States, Tennessee Premier Clarksville, Tennessee, United States, 37040 United States, Texas Synexus Dallas, Texas, United States, 75234 Synexus San Antonio, Texas, United States, 78229 United States, Utah ACR Jordan, Utah, United States, 84088 Less <<
NCT02432053 Kidney Transplantation ... More >> Liver Transplantation Less << Phase 4 Completed - India ... More >> Andhra Pradesh, India Bangalore, India Chennai, India Mumbai, India New Delhi, India Tamil Nadu, India Uttar Pradesh, India Less <<
NCT03202901 Knee Injuries ... More >> Inflammation Knees Less << Not Applicable Not yet recruiting March 21, 2018 Spain ... More >> Technological Center of Nutrition and Health (CTNS) Not yet recruiting Reus, Spain, 43204 Contact: Francesc Puiggròs, PhD    977751382    francesc.puiggros@eurecat.org Less <<
NCT00310375 Epilepsy Phase 3 Completed - -
NCT00663169 Arthritis, Gouty Phase 2 Completed - United States, Alabama ... More >> Novartis Investigator Site Birmingham, Alabama, United States, 35249 United States, New Jersey Novartis Investigator Site New Brunswick, New Jersey, United States, 08901 Switzerland Novartis Investigator Site Lausanne, Switzerland United Kingdom Novartis Investigator Site Glasgow, United Kingdom Less <<
NCT00663169 - Completed - -
NCT01679197 Fatty Liver Disease, Nonalcoho... More >>lic Nonalcoholic Steatohepatitis Lipodystrophy Less << Phase 2 Completed - United States, Michigan ... More >> University of Michigan Ann Arbor, Michigan, United States, 48109 Less <<
NCT03364335 - Completed - -
NCT00310375 - Completed - -
NCT02789306 - Completed - Spain ... More >> Florencio Monje Gil Badajoz, Spain, 06001 Less <<
NCT01546792 Obstructive Sleep Apnoea ... More >> Obesity Less << Phase 2 Phase 3 Completed - United Kingdom ... More >> Centre for Sport and Exercise Science, Sheffield Hallam University Sheffield, South Yorkshire, United Kingdom, S10 2BP Pulmonary Function Unit, Northern General Hospital Sheffield, South Yorkshire, United Kingdom, S57AU Less <<
NCT01679197 - Completed - -
NCT02062710 Cough Reflex Sensitivity Phase 4 Completed - United States, New York ... More >> Einstein Division/Montefiore Medical Center Bronx, New York, United States, 10461 Less <<
NCT02266030 Coronary Artery Disease Phase 3 Completed - Korea, Republic of ... More >> Seoul National University Bundang Hospital Seongnam, Bundang-gu, Korea, Republic of, 463-707 Less <<
NCT02062710 - Completed - -
NCT02821026 Type 1 Diabetes Phase 1 Phase 2 Active, not recruiting September 2018 Canada, Alberta ... More >> Clinical Islet Transplant Program Edmonton, Alberta, Canada, T6G2C8 Less <<
NCT01783717 Hypothalamic Obesity ... More >> Diabetes Mellitus Less << Not Applicable Unknown July 2015 China, Shanghai ... More >> Department of Endocrinology and Metabolism Recruiting Shanghai, Shanghai, China, 200040 Contact: Ye h ying    86-21-52887027       Sub-Investigator: Zhang z yun Less <<
NCT03156985 - Recruiting October 30, 2019 China, Beijing/China ... More >> Research Site Not yet recruiting Beijing, Beijing/China, China China, Guizhou/China Research Site Not yet recruiting Guiyang, Guizhou/China, China China, Henan/China Research Site Recruiting Xinxiang, Henan/China, China China, Jiangsu/China Research Site Recruiting Nanjing, Jiangsu/China, China Research Site Not yet recruiting Xuzhou, Jiangsu/China, China China, Shanxi/China Research Site Not yet recruiting Xi'an, Shanxi/China, China China, Tianjin/China Research Site Not yet recruiting Tianjin, Tianjin/China, China Less <<
NCT01575288 Vascular Aging Not Applicable Completed - United States, Colorado ... More >> University of Colorado, Boulder Clinical Translational Research Center Boulder, Colorado, United States, 80309 Less <<
NCT02354794 Overweight Hy... More >>pertriglyceridemic Waist Less << Not Applicable Completed - France ... More >> Centre de Recherche sur Volontaires (CRV), Hospital Avicenne Bobigny, Ile-de-France, France, 93000 Less <<
NCT03439618 Feeding Behavior Not Applicable Recruiting August 30, 2020 China, Shandong ... More >> The affiliated hospital of qingdao university Recruiting Qingdao, Shandong, China, 266000 Contact: BO YAO, PHD    +86 053282912221    icuyaobo@126.com Less <<
NCT00004825 Hyperinsulinism Not Applicable Completed - -
NCT03581630 Breast Cancer ... More >> Obesity Overweight Less << Not Applicable Completed - Korea, Republic of ... More >> GangnamSeverance Hospital Seoul, Korea, Republic of Less <<
NCT02597101 Type 2 Diabetes Mellitus ... More >> Insulin Resistance Less << Phase 2 Active, not recruiting May 2019 United States, Pennsylvania ... More >> Allegheny Health Network Pittsburgh, Pennsylvania, United States, 15224 Less <<
NCT00005709 - Completed - -
NCT03420092 Coronary Artery Disease Phase 1 Completed - United Kingdom ... More >> Research Site London, United Kingdom, HA1 3UJ Less <<
NCT03029247 Anaemia Phase 2 Recruiting June 5, 2019 United States, California ... More >> GSK Investigational Site Recruiting La Mesa, California, United States, 91942 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    United States, Colorado GSK Investigational Site Not yet recruiting Lakewood, Colorado, United States, 80228 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    United States, Florida GSK Investigational Site Terminated Miami, Florida, United States, 33176 GSK Investigational Site Not yet recruiting Orlando, Florida, United States, 32809 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    United States, Illinois GSK Investigational Site Recruiting Chicago, Illinois, United States, 60643 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    United States, Minnesota GSK Investigational Site Completed Minneapolis, Minnesota, United States, 55404 United States, Texas GSK Investigational Site Not yet recruiting San Antonio, Texas, United States, 78215 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com Less <<
NCT00004700 Hyperinsulinism Phase 2 Completed - -
NCT00310388 Epilepsy Phase 3 Terminated(No longer any benef... More >>it in collecting data since retigabine has been withdrawn from market.) Less << - -
NCT01834300 Non Alcoholic Fatty Liver Dise... More >>ase Less << Not Applicable Unknown June 2015 United Kingdom ... More >> Royal Surrey County Hospital Guildford, Surrey, United Kingdom, GU16 7UJ University of Surrey Guildford, Surrey, United Kingdom, GU27WG John Moores University Liverpool, United Kingdom, L3 2ET University of Liverpool Liverpool, United Kingdom, L69 3GE Royal Liverpool University Hospital Liverpool, United Kingdom, L7 8XP Liverpool University Liverpool, United Kingdom, L9 7AL Imperial College London London, United Kingdom, W12 0HS Less <<
NCT03491930 Weight Loss O... More >>besity Pre-Diabetes Metabolic Syndrome Less << Not Applicable Withdrawn(Study never initiate... More >>d. PI withdrew protocol with the IRB.) Less << December 2018 United States, New York ... More >> Rockefeller University New York, New York, United States, 10065 Less <<
NCT03573856 Overweight/Obesity Not Applicable Recruiting August 2022 United States, Colorado ... More >> Childrens Hospital Colorado Recruiting Aurora, Colorado, United States, 80045 Contact: Katherine A Sauder, PhD Less <<
NCT03191331 Dietary Habits ... More >> Gestational Diabetes Weight Gain Overweight and Obesity Less << Not Applicable Recruiting July 31, 2019 Finland ... More >> Neulamäki antenatal care clinic Recruiting Kuopio, Finland Contact: Reeta Lamminpää, PhD    +358503816972    reeta.lampinen@uef.fi    Pyörö antenatal care clinic Recruiting Kuopio, Finland Contact: Reeta Lamminpää, PhD    +358503816972    reeta.lampinen@uef.fi Less <<
NCT00310388 - Terminated(No longer any benef... More >>it in collecting data since retigabine has been withdrawn from market.) Less << - -
NCT01916512 - Unknown - Japan ... More >> Osaka University Graduate School of Medicine Recruiting Suita, Osaka, Japan, 565-0879 Contact: Shizuya Yamashita, MD, PhD    +81-6-6879-3633    shizu@cardiology.med.osaka-u.ac.jp    Principal Investigator: Shizuya Yamashita, MD, PhD Less <<
NCT00256516 Hypercholesterolemia ... More >> Cardiovascular Diseases Less << Phase 2 Completed - Canada, Ontario ... More >> Risk Factor Modification Centre, St. Michael's Hospital Toronto, Ontario, Canada, M5C 2T2 Less <<
NCT01848769 Asthma Phase 2 Completed - Denmark ... More >> BorneAstmaKlinikken Copenhagen, Denmark, 2100 Less <<
NCT03139773 Obesity, Childhood Not Applicable Completed - United States, Arkansas ... More >> University of Arkansas Fayetteville, Arkansas, United States, 72704 Less <<
NCT02564042 Psoriasis Phase 2 Completed - -
NCT00392925 Overweight Ob... More >>esity Less << Phase 2 Completed - United States, Florida ... More >> Research Site Deland, Florida, United States United States, Illinois Research Site Chicago, Illinois, United States United States, Indiana Research Site Indianapolis, Indiana, United States United States, Kansas Research Site Overland Park, Kansas, United States United States, Louisiana Research Site Baton Rouge, Louisiana, United States United States, Michigan Research Site Detroit, Michigan, United States United States, Minnesota Research Site Edina, Minnesota, United States United States, Montana Research Site Butte, Montana, United States United States, Ohio Research Site Cincinnati, Ohio, United States United States, Oregon Research Site Portland, Oregon, United States United States, Utah Research Site Salt Lake City, Utah, United States United States, Washington Research Site Olympia, Washington, United States Less <<
NCT03450759 Healthy Volunteers Phase 1 Completed - United Kingdom ... More >> Research Site London, United Kingdom, HA1 3UJ Less <<
NCT01668654 - Terminated(FDA placed a clinic... More >>al hold on the Pediatric Program requiring retigabine discontinuation in subjects; early termination allows for timely reporting of results.) Less << - -
NCT02564042 - Completed - -
NCT00392925 - Completed - -
NCT00447213 Diabetes Mellitus, Type 1 Phase 2 Phase 3 Completed - Japan ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kanagawa, Japan, 235-0045 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tokyo, Japan, 160-0023 Taiwan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Changhua, Taiwan, 500 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Taipei, Taiwan, 104 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tao-Yuan, Taiwan, 333 Less <<
NCT03020186 Abdominal Obesity Metabolic Sy... More >>ndrome Less << Not Applicable Recruiting October 2020 Israel ... More >> Nuclear research center Negev Recruiting Dimona, Israel Contact: Dov Brikner, MD Less <<
NCT01668654 Epilepsy Phase 3 Terminated(FDA placed a clinic... More >>al hold on the Pediatric Program requiring retigabine discontinuation in subjects; early termination allows for timely reporting of results.) Less << - United States, California ... More >> GSK Investigational Site Los Angeles, California, United States, 90027 United States, Florida GSK Investigational Site Gulf Breeze, Florida, United States, 32561 GSK Investigational Site Port Charlotte, Florida, United States, 33952 GSK Investigational Site Wellington, Florida, United States, 33414 United States, Minnesota GSK Investigational Site Saint Paul, Minnesota, United States, 55102-2534 United States, North Carolina GSK Investigational Site Durham, North Carolina, United States, 27710 United States, Tennessee GSK Investigational Site Memphis, Tennessee, United States, 38105 United States, Texas GSK Investigational Site Austin, Texas, United States, 78723 GSK Investigational Site Dallas, Texas, United States, 75230-2507 Less <<
NCT02291952 Circadian Dysregulation Not Applicable Active, not recruiting March 2019 United States, Massachusetts ... More >> Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Less <<
NCT02038764 Diabetes Mellitus, Type 1 Phase 1 Completed - United States, California ... More >> VA San Diego Healthcare System (Drug Shipment) San Diego, California, United States, 92161 Veterans Administration San Diego Healthcare System San Diego, California, United States, 92161 University of California, San Francisco San Francisco, California, United States, 94143 United States, Colorado Barbara Davis Center Aurora, Colorado, United States, 80045 United States, Connecticut Yale School of Medicine New Haven, Connecticut, United States, 06510 Yale New Haven Hospital - Investigational Drug Services New Haven, Connecticut, United States, 06511 Yale University School of Medicine New Haven, Connecticut, United States, 06519 United States, Georgia Atlanta Diabetes Associates Atlanta, Georgia, United States, 30318 United States, Illinois Duchossois Center for Advanced Medicine Chicago, Illinois, United States, 60637 The University of Chicago Medical Center Chicago, Illinois, United States, 60637 University of Chicago Clinical Resource Center Chicago, Illinois, United States, 60637 University of Chicago Medical Center Chicago, Illinois, United States, 60637 United States, Massachusetts Umass Memorial Medical Center Worcester, Massachusetts, United States, 01655 University of Massachusetts Medical School Worcester, Massachusetts, United States, 01655 United States, Minnesota University Of Minnesota Fairview Pharmacy Services Minneapolis, Minnesota, United States, 55454 University Of Minnesota Medical School Minneapolis, Minnesota, United States, 55455 United States, Missouri Barnes- Jewish HOSP Att: Kathryn Vehe Saint Louis, Missouri, United States, 63110 Washington University - Center for Advanced Medicine Saint Louis, Missouri, United States, 63110 Washington University Saint Louis, Missouri, United States, 63110 United States, North Carolina Duke Clinical Research Unit Durham, North Carolina, United States, 27710 Duke University Health Systems (DUHS) Investigational Drug Services Durham, North Carolina, United States, 27710 Less <<
NCT02038764 - Completed - -
NCT00663104 Bone Diseases ... More >> Metabolic Syndrome X Coronary Disease Less << Phase 3 Terminated - Germany ... More >> Institute of Medical Physics Erlangen, Germany, 91052 Less <<
NCT00001624 Hyperinsulinemia Phase 1 Completed - United States, Maryland ... More >> National Heart, Lung and Blood Institute (NHLBI) Bethesda, Maryland, United States, 20892 Less <<
NCT03058029 Overweight and Obesity Not Applicable Recruiting February 2019 -
NCT01318915 Renal Transplant Recipients Early Phase 1 Terminated(The stopping rule f... More >>or incidence of acute rejection was met.) Less << - United States, California ... More >> University of California San Francisco Medical Center San Francisco, California, United States, 94143 United States, Maryland University of Maryland Medical Center Baltimore, Maryland, United States, 21201 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 United States, New York Rogosin Institute/New York Presbyterian-Cornell New York, New York, United States, 10021 United States, Pennsylvania Hospital at the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 United States, Wisconsin University of Wisconsin Madison, Wisconsin, United States, 53792 Less <<
NCT01887080 Acute Myocardial Infarction Not Applicable Completed - Portugal ... More >> Andreia Noites Porto, Vila Nova de Gaia, Portugal, 4400-303 Less <<
NCT02593318 Alzheimer's Disease (AD) Phase 1 Completed - United States, Kansas ... More >> University of Kansas Medical Center Kansas City, Kansas, United States, 66160 Less <<
NCT01364623 Female Sexual Dysfunction Phase 1 Completed - United States, Texas ... More >> Premier Research International LLC Austin, Texas, United States, 78705 Less <<
NCT02157233 Healthy and Physically Active ... More >>Young Men Less << Not Applicable Completed - France ... More >> CREPS Les Abymes, Guadeloupe, France Less <<
NCT01406418 Influenza Phase 1 Completed - United States, Kansas ... More >> Quintiles Early Clinical Development Overland Park, Kansas, United States, 66211 Less <<
NCT03739710 Neoplasms Phase 2 Not yet recruiting February 9, 2022 -
NCT03645434 Chronic Obstructive Pulmonary ... More >>Disease Less << Phase 2 Recruiting September 23, 2019 Germany ... More >> Research Site Not yet recruiting Berlin, Germany, 14050 Research Site Withdrawn Frankfurt, Germany, 60596 Research Site Not yet recruiting Grosshansdof, Germany, 22927 Research Site Not yet recruiting Wiesbaden, Germany, 65187 United Kingdom Research Site Recruiting London, United Kingdom, HA1 3UJ Research Site Not yet recruiting Manchester, United Kingdom, M23 9QZ Less <<
NCT01318915 - Terminated(The stopping rule f... More >>or incidence of acute rejection was met.) Less << - -
NCT01756950 Influenza Phase 1 Completed - United States, Kansas ... More >> Quintiles Early Clinical Development Overland Park, Kansas, United States, 66211 Less <<
NCT03184584 Alstr?m Syndrome Phase 2 Phase 3 Enrolling by invitation September 2020 United Kingdom ... More >> University Hospitals Birmingham NHS Foundation Trus Birmingham, United Kingdom, B15 2PR Less <<
NCT01710670 Healthy Volunteers Phase 1 Completed - Netherlands ... More >> Leiden, Netherlands Less <<
NCT01109017 - Completed - Japan ... More >> Tokyo, Japan, 1000005 Less <<
NCT00945282 Infection, Human Immunodeficie... More >>ncy Virus Less << Phase 2 Completed - Argentina ... More >> GSK Investigational Site Buenos Aires, Argentina, B1602DBG Less <<
NCT01707160 Diabetes Heal... More >>thy Less << Phase 1 Completed - United Kingdom ... More >> Novo Nordisk Investigational Site Leeds, United Kingdom, LS2 9NG Less <<
NCT00945282 - Completed - -
NCT02546609 - Completed - -
NCT01518764 Obesity Not Applicable Completed - Netherlands ... More >> VUMedicalCenter Amsterdam, Noord-Holland, Netherlands, 1081 HV Less <<
NCT02965443 Type 2 Diabetes Phase 4 Recruiting June 2020 Germany ... More >> University Hospital Tübingen Recruiting Tübingen, Germany, 72076 Contact: Norbert Stefan, Prof. Less <<
NCT01164501 Diabetes Mellitus, Type 2 ... More >> Renal Insufficiency Less << Phase 3 Completed - -
NCT02689791 Feeding Behavior Not Applicable Completed - -
NCT02546609 NAFLD Phase 2 Completed - United States, California ... More >> Catalina Research Institute Chino, California, United States, 91710 University of California San Diego San Diego, California, United States, 92103 United States, Colorado Rocky Mountain Research Wheat Ridge, Colorado, United States, 80033 United States, Georgia Atlanta Gastroenterology Associates Atlanta, Georgia, United States, 30312 GI Specialists of Georgia Marietta, Georgia, United States, 30060 United States, Illinois Northwestern University Chicago, Illinois, United States, 60611 United States, Indiana Indiana University Indianapolis, Indiana, United States, 46202 United States, North Carolina University of North Carolina Chapel Hill Chapel Hill, North Carolina, United States, 27599 United States, Ohio Sterling Research Cincinnati, Ohio, United States, 45246 United States, Tennessee Premier Clinical Research Clarksville, Tennessee, United States, 37043 Gastro One Germantown, Tennessee, United States, 38138 Quality Medical Research Nashville, Tennessee, United States, 37211 United States, Virginia Virginia Commonwealth University Richmond, Virginia, United States, 23298 Less <<
NCT00381667 Pulmonary Disease, Chronic Obs... More >>tructive Less << Phase 2 Completed - Australia, Victoria ... More >> GSK Investigational Site Clayton, Victoria, Australia, 3168 New Zealand GSK Investigational Site Wellington, New Zealand, 6001 Less <<
NCT01002547 Nonalcoholic Steatohepatitis Phase 4 Completed - United States, Florida ... More >> North Florida/South Georgia Veterans Health System, Gainesville, FL Gainesville, Florida, United States, 32608 United States, Texas South Texas Health Care System, San Antonio, TX San Antonio, Texas, United States, 78229 Less <<
NCT01002547 - Completed - -
NCT01164501 - Completed - -
NCT01298882 Type 2 Diabetes Mellitus ... More >> Overweight Obesity Less << Phase 2 Completed - Mexico ... More >> Unidad de Investigación Médica en Epidemiología Clínica Guadalajara, Jalisco, Mexico, 44380 Less <<
NCT03208010 Prediabetic State Not Applicable Recruiting March 2022 United States, Texas ... More >> Starr County Border Health Initiative Recruiting Rio Grande City, Texas, United States, 78582 Contact: Sharon A Brown, PhD       sabrown@mail.nur.utexas.edu Less <<
NCT00712933 Systemic Lupus Erythematosus Phase 3 Completed - -
NCT00712933 - Completed - -
NCT00282698 Cardiac Surgical Procedures ... More >> Hyperglycemia Less << Phase 3 Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT03754504 Overweight In... More >>sulin Resistance Microbiota Endotoxemia Metabolic Syndrome Less << Not Applicable Recruiting June 30, 2020 Canada ... More >> Institut sur la nutrition et les aliments fonctionnels Recruiting Québec, Canada, G1V 0A6 Contact: Julie Marois, M.Sc    418-656-2131 ext 5764    julie.marois@fsaa.ulaval.ca    Principal Investigator: André Marette, PhD          Sub-Investigator: Marie-Claude Vohl, PhD          Sub-Investigator: Charles Couillard, PhD          Sub-Investigator: Patrick Couture, Md, PhD Less <<
NCT02045797 Infections, Bacterial Phase 2 Completed - -
NCT01644539 Appetite Regulation Not Applicable Completed - Netherlands ... More >> UMC Utrecht - division Beeld Utrecht, Netherlands, 3684 CX Less <<
NCT00322660 Respiratory Distress ... More >> Hypoglycemia Less << Not Applicable Completed - Denmark ... More >> Hvidovre University Hospital Copenhagen, Hvidovre, Denmark, 2650 Hvidovre Hospital Kettegård Alle 31, Hvidovre, Denmark, 2650 Less <<
NCT02045797 - Completed - -
NCT03762434 Metabolic Syndrome Not Applicable Recruiting June 30, 2019 Hong Kong ... More >> Sai Kung community centre Recruiting Hong Kong, Hong Kong Contact: Eliza ML Wong Less <<
NCT00373854 - Completed - United States, Ohio ... More >> Ohio State University Columbus, Ohio, United States, 43210 Less <<
NCT03604198 Cushing Syndrome Phase 2 Recruiting July 2021 United States, Florida ... More >> Not Provided Recruiting Fort Lauderdale, Florida, United States, 33312 United States, Indiana Not Provided Recruiting Indianapolis, Indiana, United States, 46202 Less <<
NCT00724087 Sleep Sleep D... More >>eprivation Insulin Resistance Type 2 Diabetes Less << Not Applicable Completed - United States, Illinois ... More >> University of Chicago Chicago, Illinois, United States, 60637 Less <<
NCT00781937 Metabolism and Nutrition Disor... More >>der Obesity Less << Phase 3 Completed - -
NCT01594567 - Unknown December 2015 Canada, Ontario ... More >> The Toronto 3D (Diet, Digestive tract and Disease) Knowledge Synthesis and Clinical Trials Unit, Clinical Nutrition and Risk Factor Modification Centre, St. Michael's Hospital Toronto, Ontario, Canada, M5C 2T2 Less <<
NCT00781937 - Completed - -
NCT00433628 - Completed - United States, District of Col... More >>umbia Washington Hospital Center Washington, D.C., District of Columbia, United States, 20010 United States, Maryland National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00439569 Spinal Muscular Atrophy Type I... More >>I Spinal Muscular Atrophy Type III Less << Phase 1 Phase 2 Terminated(Due to poor complia... More >>nce with study drug administration.) Less << - United States, California ... More >> Stanford University Medical Center, 300 Pasteur Drive, Room A343 Stanford, California, United States, 94305-5235 United States, Missouri Washington University Medical School, Washington University, 660 S. Euclid Avenue, Box 8111 St. Louis, Missouri, United States, 63110 United States, New York Columbia University, 180 Fort Washington Avenue, 5th Floor New York, New York, United States, 10032 United States, Pennsylvania The Children's Hospital of Philadelphia, Clinical Trials Office, A-230, 34th St. and Civic Center Boulevard Philadelphia, Pennsylvania, United States, 19104-4399 United States, Texas University of Texas Southwestern Medical Center at Dallas, Division of Pediatric Neurology, Children's Medical Center of Dallas, Ambulatory Care Pavilion, 2350 Stemmons Freeway, Suite #5074 Dallas, Texas, United States, 75207 Less <<
NCT01018186 Asthma Phase 3 Completed - -
NCT00431665 Renal Circulation ... More >> Renal Plasma Flow Glomerular Filtration Rate Fatty Acids, Nonesterified Less << Not Applicable Completed - Austria ... More >> Department of Clinical Pharmacology, Medical University of Vienna Vienna, Austria, 1090 Less <<
NCT01574352 Children Over... More >>weight Obesity Metabolic Syndrome Less << Not Applicable Unknown July 2017 Denmark ... More >> Odense University Hospital Odense, Funen, Denmark, 5000 University of Southern Denmark Odense, Funen, Denmark, 5230 Less <<
NCT01018186 - Completed - -
NCT02999256 Healthy Metab... More >>olic Syndrome Less << Not Applicable Completed - -
NCT02896140 - Completed - United States, Massachusetts ... More >> Joslin Diabetes Center Boston, Massachusetts, United States, 02215 Less <<
NCT00604669 - Completed - United States, Georgia ... More >> Grady Memorial Hospital Atlanta, Georgia, United States, 30303 Less <<
NCT00605007 - Completed - United States, Georgia ... More >> Grady Memorial Hospital Atlanta, Georgia, United States, 30303 Less <<
NCT00604669 - Completed - -
NCT02895867 Type 2 Diabetes Not Applicable Completed - United States, Massachusetts ... More >> Joslin Diabetes Center Boston, Massachusetts, United States, 02215 Less <<
NCT02343978 Chronic Constipation Phase 2 Completed - Japan ... More >> Tokyo, Japan Less <<
NCT00819234 Obesity Phase 2 Completed - -
NCT00819234 - Completed - -
NCT02943291 Polycystic Ovary Syndrome Not Applicable Recruiting April 2019 Australia ... More >> Centre of Exercise and Nutrition, Mary MacKillop Institute for Health Research, AUC Not yet recruiting Melbourne, Australia Contact: Sofie Lionett, M.Sc       sofie.b.lionett@ntnu.no    Contact: John Hawley          Norway Department of circulation and medical imaging , NTNU Recruiting Trondheim, Norway, 7491 Contact: Trine Moholdt, phd    0047 97098594    trine.moholdt@ntnu.no Less <<
NCT02150005 Periodontitis ... More >> Coronariopathy Less << Not Applicable Completed - -
NCT03523026 Metabolic Syndrome ... More >> Coronary Artery Disease Less << Not Applicable Recruiting December 30, 2018 Turkey ... More >> Kıymet Muammer Recruiting Istanbul, Fatih/Istanbul, Turkey, 34096 Contact: Kıymet Muammer, MSc PT    0090212 4592000 ext 29530    kiymetmuammar@yahoo.com    Contact: Fatma Karantay Mutluay, Professor    0090216 4448544    fmutluay@medipol.edu.tr Less <<
NCT01810549 Postprandial Fatigue Phase 1 Completed - Switzerland ... More >> University Hospital Basel Basel, Switzerland, 4031 Less <<
NCT02099968 Hypertension ... More >>Metabolic Syndrome Less << Not Applicable Completed - Germany ... More >> Immanuel Hospital Berlin, Department of Internal and Complementary Medicine Berlin, Germany, 45276 Department of Internal and Integrative Medicine, Kliniken Essen-Mitte, Faculty of Medicine, University of Duisburg-Essen Essen, Germany, 45276 Less <<
NCT00439569 - Terminated(Due to poor complia... More >>nce with study drug administration.) Less << - -
NCT00624104 - Completed - Denmark ... More >> Department of Endocrinology M, Aarhus Hospital Aarhus C, Denmark, 8000 Less <<
NCT01347840 - Terminated(Study was terminate... More >>d for business reasons.) Less << - United States, Ohio ... More >> Veterans Affairs Medical Center Cincinnati, Ohio, United States, 45267 Less <<
NCT00816907 Schizophrenia Phase 4 Completed - United States, California ... More >> Stanford University Palo Alto, California, United States, 94305 United States, Florida Mental Health Advocates Boca Raton, Florida, United States, 33431 United States, Iowa University of Iowa Iowa City, Iowa, United States, 52242 United States, Kansas Clinical Research Institute Wichita, Kansas, United States, 67207 United States, Maryland Clinical Insights Glen Burnie, Maryland, United States, 21061 United States, Massachusetts Freedom Trail Clinic Boston, Massachusetts, United States, 02114 University of Massachusetts Worcester, Massachusetts, United States, 01605 United States, Minnesota University of Minnesota School of Medicine Minneapolis, Minnesota, United States, 55454 United States, New Mexico New Mexico VA Healthcare System Albuquerque, New Mexico, United States, 87108 United States, New York Research Foundation for Mental Hygiene New York, New York, United States, 10032 University of Rochester Rochester, New York, United States, 14623 United States, Ohio University of Cincinnati Cincinnati, Ohio, United States, 45267 United States, Tennessee Vanderbilt University Schizophrenia Research Nashville, Tennessee, United States, 37212 United States, Texas University of Texas Southwestern Medical Center Dallas, Texas, United States, 75235 Baylor College of Medicine Houston, Texas, United States, 77030 University of Texas Health Science Center at San Antonio San Antonio, Texas, United States, 78229 Less <<
NCT03018990 Liver Fibroses ... More >> Alcohol-Induced Disorders Less << Not Applicable Recruiting December 2019 Denmark ... More >> Odense University Hospital Recruiting Odense, Fyn, Denmark, 5000 Contact: Mads Israelsen, MD    + 45 20681060    mads.egerod.israelsen@rsyd.dk    Contact: Bjørn Madsen, MD       bjoern.staerh.madsen@rsyd.dk Less <<
NCT02806960 Diabetes Mellitus, Type 1 ... More >> Diabetes Mellitus, Type 2 Less << Phase 1 Terminated(Drug delivery was b... More >>elow target dose due to partial obstruction by aggregated particles.) Less << - Canada, Quebec ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mount-Royal, Quebec, Canada, H3P 3P1 Less <<
NCT00519376 Pulmonary Disease, Chronic Obs... More >>tructive Less << Phase 2 Completed - Germany ... More >> GSK Investigational Site Wiesbaden, Hessen, Germany, 65187 GSK Investigational Site Mainz, Rheinland-Pfalz, Germany, 55131 GSK Investigational Site Berlin, Germany, 14050 GSK Investigational Site Berlin, Germany, 14057 Less <<
NCT01347840 - Terminated(Study was terminate... More >>d for business reasons.) Less << - -
NCT03234036 Infection, Human Immunodeficie... More >>ncy Virus Less << Phase 1 Completed - United States, Maryland ... More >> GSK Investigational Site Baltimore, Maryland, United States, 21225 Less <<
NCT02215694 Hypertriglyceridemia Phase 3 Completed - Korea, Republic of ... More >> Laboratory of Clinical Nutrigenetics/Nutrigenomics Seoul, Korea, Republic of, 120-749 Less <<
NCT00519376 - Completed - -
NCT03379792 Diabetes Not Applicable Recruiting November 2019 United States, Florida ... More >> Translational Research Institute for Metabolism and Diabetes Recruiting Orlando, Florida, United States, 32804 Contact: Recruitment Department    407-303-7100    tri@flhosp.org Less <<
NCT03539926 Cystinuria Not Applicable Active, not recruiting February 2019 Spain ... More >> Fundacio Puigvert Barcelona, Spain, 08025 Less <<
NCT00603291 - Completed - -
NCT00827424 Obesity Not Applicable Completed - Israel ... More >> Clinical Research Unit, Clalit Health Services, Haifa and Western Galilee District . Haifa,, Israel, 35024 Less <<
NCT02202239 Hemodynamics ... More >>Oxidative Stress Anesthesia Less << Phase 4 Unknown August 2015 -
NCT00603291 Obesity Phase 3 Completed - United States, California ... More >> Arena Pharmaceuticals, Inc. San Diego, California, United States, 92121 Less <<
NCT00976508 - Terminated(See termination rea... More >>son in detailed description.) Less << - -
NCT00976508 Colorectal Neoplasms ... More >> Lung Neoplasms Breast Neoplasms Prostatic Neoplasms Sarcoma Less << Phase 1 Terminated(See termination rea... More >>son in detailed description.) Less << - United States, Minnesota ... More >> Pfizer Investigational Site Minneapolis, Minnesota, United States, 55455 Pfizer Investigational Site Rochester, Minnesota, United States, 55905 Canada, Quebec Pfizer Investigational Site Montreal, Quebec, Canada, H3T 1E2 Finland Pfizer Investigational Site Helsinki, Finland, 00290 Germany Pfizer Investigational Site Muenster, Germany, 48149 Less <<
NCT03386461 Metabolism Disorder ... More >> Adiposity Inflammatory Response Less << Not Applicable Recruiting December 2019 Czechia ... More >> Third Faculty of Medicine, Charles University Recruiting Prague, Czechia, 100 00 Contact: Michaela Siklova, PhD    +420 267 102 211    michaela.siklova@lf3.cuni.cz    Contact: Lenka Rossmeislova, PhD    +420 267 102 211    lenka.rossmeislova@lf3.cuni.cz    Principal Investigator: Michaela Siklova, PhD          Sub-Investigator: Martin Rossmeisl, PhD          Sub-Investigator: Vladimir Stich, prof. MUDr. Less <<
NCT02464878 Kidney Transplant ... More >> Type 1 Diabetes Less << Phase 2 Recruiting January 2020 United States, Massachusetts ... More >> Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: James F Markmann, MD, PhD    617-643-4533    jmarkmann@mgh.harvard.edu    Contact: Kerry Crisalli, RN, BSN    617-643-4087    kcrisalli@mgh.harvard.edu    Principal Investigator: James F Markmann, MD, PhD Less <<
NCT03096873 Obesity Not Applicable Completed - -
NCT00542113 Type 2 Diabetes ... More >> Obesity Less << Not Applicable Completed - United States, Colorado ... More >> Montezuma-Cortez School District Cortez, Colorado, United States, 81321 Putnam, Tavelli, Bennett and Dunn Elementary Schools Fort Collins, Colorado, United States, 80524 Less <<
NCT02750553 Healthy Phase 1 Completed - -
NCT00646776 Antivirals/HIV Phase 1 Completed - United States, New Jersey ... More >> Bristol-Myers Squibb Clinical Pharmacology Unit Hamilton, New Jersey, United States, 08690 Less <<
NCT02994628 Inflammation Not Applicable Completed - United States, North Carolina ... More >> Human Performance Lab, North Carolina Research Campus Kannapolis, North Carolina, United States, 28081 Less <<
NCT03729934 Obesity Overw... More >>eight and Obesity Overweight Triglycerides High Less << Not Applicable Not yet recruiting December 1, 2019 -
NCT00708552 Alzheimer's Disease Phase 2 Completed - -
NCT01426256 Cystic Fibrosis ... More >> Respiratory Tract Infections Less << Phase 3 Completed - United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35233 United States, Georgia Emory Hospital Atlanta, Georgia, United States, 30322 United States, Iowa University of Iowa Iowa City, Iowa, United States, 52242 United States, Ohio University of Cincinnati Cincinnati, Ohio, United States, 45267 Case Western Reserve University Cleveland, Ohio, United States, 44106 Less <<
NCT00692601 Healthy Phase 1 Completed - Canada, Ontario ... More >> Exercise Metabolism Research Laboratory, McMaster Univeristy Hamilton, Ontario, Canada, L8S 4K1 Less <<
NCT00708552 - Completed - -
NCT00646776 - Completed - -
NCT03385447 Cardiovascular Risk Factor ... More >> Sedentary Lifestyle Physical Activity Less << Not Applicable Completed - -
NCT03760068 Diabetes Mellitus, Type 1 Phase 3 Recruiting January 21, 2020 United States, Texas ... More >> Clinical Trials of Texas, Inc Recruiting San Antonio, Texas, United States, 78229 Contact: Lele Simmons    210-949-0122    lsimmons@cttexas.com    Principal Investigator: Douglas Denham, DO Less <<
NCT02931591 Small for Gestational Age Not Applicable Not yet recruiting June 2020 -
NCT02739217 Inflammation and Fibrosis ... More >> Diabetes Less << Phase 2 Completed - United Kingdom ... More >> University Hospitals Birmingham NHS Foundation Trust Birmingham, United Kingdom, B15 2PR Less <<
NCT00252772 Type 2 Diabetes Phase 3 Terminated(The development pro... More >>gram has been terminated) Less << - Finland ... More >> Research Site Hanko, Finland Research Site Helsinki, Finland Research Site Imatra, Finland Research Site Kokkola, Finland Research Site Kuopio, Finland Research Site Lahti, Finland Research Site Mikkeli, Finland Research Site Oulu, Finland Research Site Pattijoki, Finland Research Site Pietarsaari, Finland Research Site Pori, Finland Research Site Tampere, Finland Research Site Turku, Finland Research Site Ödet, Finland Less <<
NCT00991926 - Completed - -
NCT00252837 Type 2 Diabetes Phase 3 Terminated(The development pro... More >>gram has been terminated) Less << - -
NCT00596934 Fatty Liver Disease, Nonalcoho... More >>lic Less << Phase 2 Completed - United States, Michigan ... More >> University of Michigan Ann Arbor, Michigan, United States, 48109 Less <<
NCT01714271 Heart Disease ... More >> Cancer Less << Phase 2 Unknown October 2014 United States, California ... More >> Roybal Comprehensive Health Center Recruiting Los Angeles, California, United States, 90022 Principal Investigator: Anne Peters, MD Less <<
NCT03534024 Metabolic Syndrome Not Applicable Recruiting January 30, 2020 Iran, Islamic Republic of ... More >> Golbon Sohrab Recruiting Tehran, National Nutrition And Food Technology Research Institute, Iran, Islamic Republic of Contact: Golbon Sohrab, ph.D    009802122077424    golbonsohrab@yahoo.com    Contact: Zohre Bateni    009809129626018    zohre.bateni@yahoo.com Less <<
NCT01520467 Silver Russell Syndrome ... More >> Prader-Willi Syndrome Less << Not Applicable Unknown October 2016 France ... More >> Explorations Fonctionnelles d'Endocrinologie - Centre de Référence des Maladies Endocriniennes Rares de la Croissance Hôpital Armand Trousseau Paris, France, 75012 Less <<
NCT00306683 Hypothalamic-pituitary Lesions... More >> Craniopharyngiomas Less << Phase 3 Completed - France ... More >> Hopital Kremlin-Bicetre Paris, France, 94275 Less <<
NCT03590483 - Completed - Iraq ... More >> Kurdistan Board for Medical speciality Erbil, Kurdistan Region, Iraq, 44001 Less <<
NCT02749097 Healthy Phase 1 Completed - -
NCT00251940 Type 2 Diabetes Phase 3 Terminated(The development pro... More >>gram has been terminated) Less << - -
NCT00596934 - Completed - -
NCT03338296 Obesity Phase 4 Recruiting August 24, 2020 United States, California ... More >> Long Beach Clinical Trials Services, Inc Recruiting Long Beach, California, United States, 90806 United States, Florida Ocean Blue Medical Research Center, Inc Withdrawn Miami Springs, Florida, United States, 33166 Oviedo Medical Research, LLC Recruiting Oviedo, Florida, United States, 32765 United States, Indiana American Health Network of Indiana, LLC Terminated Muncie, Indiana, United States, 47304 United States, Kansas Heartland Research Associates, LLC Not yet recruiting Wichita, Kansas, United States, 67207 United States, Missouri The Center for Pharmaceutical Research Recruiting Kansas City, Missouri, United States, 64114 United States, Nevada Clinical Research Center of Nevada, LLC Recruiting Henderson, Nevada, United States, 89014 United States, Virginia National Clinical Research, Inc Recruiting Richmond, Virginia, United States, 23294 Less <<
NCT02746315 Healthy Phase 1 Completed - -
NCT03574987 Physical Activity ... More >> Diet Modification Less << Not Applicable Recruiting September 1, 2021 United Kingdom ... More >> Department for Health, University of Bath Recruiting Bath, United Kingdom, BA2 7AY Contact: Aaron Hengist, BSc    +44 (0) 1225 385434    A.Hengist@bath.ac.uk    Contact: Javier T Gonzalez, PhD    +44 (0) 1225 385518    J.T.Gonzalez@bath.ac.uk    Sub-Investigator: Russell Davies, BSc          Sub-Investigator: Francoise Koumanov, PhD          Sub-Investigator: Dylan Thompson, PhD          Sub-Investigator: James A Betts, PhD Less <<
NCT01147887 Healthy Phase 1 Completed - Belgium ... More >> Merksem, Belgium Less <<
NCT00474630 - Completed - -
NCT03040999 Head and Neck Neoplasms Phase 3 Recruiting June 29, 2023 -
NCT00474630 Obesity Overw... More >>eight Diabetes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT00940134 Obesity Not Applicable Completed - Denmark ... More >> Department of Human Nutrition, Faculty of Life Sciences, University of Copenhagen Copenhagen, Denmark, 1958 Less <<
NCT02048345 Healthy Not Applicable Unknown - Belgium ... More >> UZ Leuven Gasthuisberg Recruiting Leuven, Belgium, 3000 Contact: Bart Hens, Pharmacist    +3216330302    bart.hens@pharm.kuleuven.be    Principal Investigator: Jan Tack, PhD, MD Less <<
NCT01939522 Type 1 Diabetes Mellitus Phase 4 Completed - United Kingdom ... More >> Oxford University Hospitals NHS Trust Oxford, Oxfordshire, United Kingdom, OX3 9DU Less <<
NCT00603278 Asthma Phase 2 Completed - -
NCT00255541 Type 2 Diabetes Phase 3 Terminated(The development pro... More >>gram has been terminated) Less << - -
NCT02520076 Type 1 Diabetes Mellitus Phase 1 Phase 2 Active, not recruiting March 2020 Canada, Alberta ... More >> University of Alberta Edmonton, Alberta, Canada, T6G 2C8 Less <<
NCT00603278 - Completed - -
NCT02110927 Obesity, Abdominal Not Applicable Completed - Portugal ... More >> Andreia Noites Vila Nova de Gaia, Porto, Portugal, 4400-303 Less <<
NCT00603382 Asthma Phase 2 Completed - -
NCT02088034 Diabetes Phase 4 Unknown February 2016 United States, Pennsylvania ... More >> Temple University - Center for Obesity Research and Education Philadelphia, Pennsylvania, United States, 19140 Less <<
NCT00276250 Type 1 Diabetes Mellitus Phase 2 Completed - United States, Georgia ... More >> Emory University Atlanta, Georgia, United States, 30322 Less <<
NCT00603382 - Completed - -
NCT00793897 Advanced Solid Tumors ... More >> Metastatic Solid Tumors Less << Phase 1 Completed - Australia, Victoria ... More >> Local Institution East Melbourne, Victoria, Australia, 3002 Local Institution Parville, Victoria, Australia, 3050 Canada, Alberta Local Institution Edmonton, Alberta, Canada, T6G 1Z2 Canada, Ontario Local Institution Hamilton, Ontario, Canada, L8V 5C2 Korea, Republic of Local Institution Seoul, Korea, Republic of, 138-736 Less <<
NCT00276250 - Completed - -
NCT01323010 Asthma Childr... More >>en Less << Not Applicable Completed - Brazil ... More >> Instituto da Crianca HCFMUSP Sao Paulo, Brazil, 05403-010 Less <<
NCT01496183 Healthy Not Applicable Completed - United States, New York ... More >> Department of Psychiatry, The State University of New York at Buffalo Buffalo, New York, United States, 14215 Less <<
NCT01323010 - Completed - -
NCT00603746 Asthma Phase 2 Completed - -
NCT01496183 - Completed - -
NCT02656693 Obesity Not Applicable Active, not recruiting March 2019 United States, Massachusetts ... More >> Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Less <<
NCT03749070 Non-Alcoholic Fatty Liver Dise... More >>ase Less << Not Applicable Not yet recruiting June 30, 2021 -
NCT01529268 - Completed - -
NCT01529268 Nonalcoholic Fatty Liver Disea... More >>se (NAFLD) Less << Phase 2 Phase 3 Completed - United States, California ... More >> University of California, San Diego San Diego, California, United States, 92103 University of California, San Francisco San Francisco, California, United States, 94143 United States, Georgia Emory University Atlanta, Georgia, United States, 30322 United States, Illinois Ann & Robert H. Lurie Children's Hospital of Chicago (NWU) Chicago, Illinois, United States, 60611-2605 United States, Indiana Indiana University Indianapolis, Indiana, United States, 46202 United States, Missouri St. Louis University Saint Louis, Missouri, United States, 63104 United States, New York Columbia University New York, New York, United States, 10032 United States, Ohio Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229-3039 United States, Texas Texas Children's Hospital Houston, Texas, United States, 77030 United States, Washington University of Washington, Seattle Children's Hospital Seattle, Washington, United States, 98105 Less <<
NCT00442572 Hepatitis B, Chronic Phase 2 Completed - Bulgaria ... More >> Mhat St. Ivan Rilski; Clinic of Gastroenterology Sofia, Bulgaria, 1612 Less <<
NCT03195712 - Completed - United States, New York ... More >> Mount Sinai St, Luke's New York, New York, United States, 10025 Less <<
NCT00439218 Spinal Muscular Atrophy Type I Phase 1 Phase 2 Terminated(Extremely slow enro... More >>llment) Less << - United States, California ... More >> Stanford University Medical Center, 300 Pasteur Drive, Room A343 Stanford, California, United States, 94305-5235 United States, Massachusetts Children's Hospital, Boston, 300 Longwood Avenue, Fegan 11 Boston, Massachusetts, United States, 02115 United States, New York Columbia University, 180 Fort Washington Avenue, 5th Floor New York, New York, United States, 10032 United States, Pennsylvania The Children's Hospital of Philadelphia, Clinical Trials Office, A-230, 34th St. and Civic Center Boulevard Philadelphia, Pennsylvania, United States, 19104-4399 United States, Texas University of Texas Southwestern Medical Center at Dallas, Division of Pediatric Neurology, Children's Medical Center of Dallas, Ambulatory Care Pavilion, 2350 Stemmons Freeway, Suite #5074 Dallas, Texas, United States, 75207 Less <<
NCT00603746 - Completed - -
NCT00439218 - Terminated(Extremely slow enro... More >>llment) Less << - -
NCT00443508 Kidney Diseases Phase 4 Unknown - Israel ... More >> Transplantation department, rabin Medical Center Recruiting Petach Tikva, Israel, 49202 Contact: Eytan Mor, Prof    00937 3 9376528    tikim@clalit.org.il    Principal Investigator: Eytan Mor, Prof          Sub-Investigator: Ruti Rahamimov, Dr          Sub-Investigator: Alex Yusim, Dr Less <<
NCT00442572 - Completed - -
NCT03331900 Healthy Subjects Phase 1 Completed - United States, Ohio ... More >> Medpace Clinical Pharmacology Unit Cincinnati, Ohio, United States, 45227 Less <<
NCT00451321 Diabetes Mellitus, Type 1 Phase 2 Terminated - United States, Alabama ... More >> GSK Investigational Site Birmingham, Alabama, United States, 35294 United States, California GSK Investigational Site Walnut Creek, California, United States, 94598 United States, Colorado GSK Investigational Site Aurora, Colorado, United States, 80045 United States, District of Columbia GSK Investigational Site Washington, D.C., District of Columbia, United States, 20037 United States, Florida GSK Investigational Site Jacksonville, Florida, United States, 32207 GSK Investigational Site Pinellas Park, Florida, United States, 33781 United States, Illinois GSK Investigational Site Chicago, Illinois, United States, 60637 United States, Maryland GSK Investigational Site Baltimore, Maryland, United States, 21201 United States, Massachusetts GSK Investigational Site Worcester, Massachusetts, United States, 1655 United States, Michigan GSK Investigational Site Kalamazoo, Michigan, United States, 49048 United States, Minnesota GSK Investigational Site Minneapolis, Minnesota, United States, 55455 United States, Mississippi GSK Investigational Site Gulfport, Mississippi, United States, 39501 United States, Nebraska GSK Investigational Site Omaha, Nebraska, United States, 68131 United States, Ohio GSK Investigational Site Mentor, Ohio, United States, 44060 United States, South Dakota GSK Investigational Site Rapid City, South Dakota, United States, 57701 United States, Texas GSK Investigational Site San Antonio, Texas, United States, 78229-4801 Canada, Ontario GSK Investigational Site Toronto, Ontario, Canada, M4G 3E8 Less <<
NCT03652532 Overweight Ob... More >>esity Diet Modification Exercise Less << Not Applicable Completed - -
NCT03260452 Type2 Diabetes Not Applicable Recruiting December 2018 France ... More >> CHU de Toulouse - Rangueil Recruiting Toulouse, France, 31059 Contact: Pierre Gourdy, Pr    05 61 32 37 40 ext +33    gourdy.p@chu-toulouse.fr    Principal Investigator: Pierre Gourdy, MD          Sub-Investigator: Claire Thalamas, MD          Sub-Investigator: Fabienne Calvas, MD          Sub-Investigator: Monique Galitzky, MD Less <<
NCT03479008 - Recruiting March 2025 United States, Michigan ... More >> University of Michigan Recruiting Ann Arbor, Michigan, United States, 48109 Contact: Amanda J Pennington, MS    734-936-5947    amanpenn@med.umich.edu    Principal Investigator: Kevin E Ward, MD Less <<
NCT03207243 Asthma Phase 1 Phase 2 Active, not recruiting May 23, 2019 -
NCT01547169 Alzheimer's Disease ... More >> Mild Cognitive Impairment Less << Phase 2 Completed - United States, Washington ... More >> VA Puget Sound Health Care System Seattle, Washington, United States, 98108 Less <<
NCT00816907 - Completed - -
NCT01012167 Schizophrenia Phase 2 Completed - United States, Maryland ... More >> Baltimore VA Medical Center Baltimore, Maryland, United States, 21201 Community Mental Health Centers Baltimore, Maryland, United States, 21201 Keypoint Community Mental Health Centers Baltimore, Maryland, United States, 21222 Maryland Psychiatric Research Center Baltimore, Maryland, United States, 21228 Maryland Psychiatric Research Center Catonsville, Maryland, United States, 21228 Keypoint Mental health Center Dundalk, Maryland, United States, 21222 Less <<
NCT01268683 - Completed - -
NCT01268683 Ischemic Stroke Phase 1 Phase 2 Completed - United States, Illinois ... More >> Rush University Medical Center Chicago, Illinois, United States, 60612 United States, Maryland University of Maryland Medical Center Baltimore, Maryland, United States United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States United States, Pennsylvania University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States, 15213 Less <<
NCT00251953 Type 2 Diabetes Phase 3 Terminated(The development pro... More >>gram has been terminated) Less << - -
NCT01012167 - Completed - -
NCT01458496 Prediabetes P... More >>rehypertension Less << Not Applicable Completed - Canada, Newfoundland and Labra... More >>dor Memorial University of Newfoundland St. John's, Newfoundland and Labrador, Canada, A1B 3V6 Memorial University of Newfoundland St. John's, Newfoundland and Labrador, Canada, A1N 3V6 Less <<
NCT02760316 Rheumatoid Arthritis Phase 1 Completed - Germany ... More >> Research Site Berlin, Germany, 14050 United Kingdom Research Site Harrow, United Kingdom, HA1 3UJ Less <<
NCT02379585 - Terminated(PI Decision) - -
NCT02379585 HER2-positive Breast Cancer Phase 1 Phase 2 Terminated(PI Decision) - United States, Arizona ... More >> Western Regional Medical Center Goodyear, Arizona, United States, 85338 Less <<
NCT00451321 - Terminated - -
NCT03012516 Health Behavior ... More >> Activities of Daily Living Metabolic Syndrome X Quality of Life Less << Not Applicable Active, not recruiting November 2019 Sweden ... More >> Närhälsan FaR-teamet centrala och västra Göteborg Gothenburg, Region Västra Götaland, Sweden, 421 44 Less <<
NCT01398111 COPD Phase 1 Completed - Belgium ... More >> Clinical Pharmacology Unit - SGS Life Science Services Antwerpen, Lange Beeldekensstraat 267, Belgium, 2060 Less <<
NCT03446612 Anaemia Phase 2 Not yet recruiting December 2, 2019 United Kingdom ... More >> GSK Investigational Site Not yet recruiting Cambridge, Cambridgeshire, United Kingdom, CB2 0QQ Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    GSK Investigational Site Not yet recruiting Edinburgh, United Kingdom, EH16 4TJ Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com Less <<
NCT02409056 Chronic Disease ... More >> Cardiovascular Diseases Less << Not Applicable Recruiting July 2019 United States, Georgia ... More >> Madison County Schools Recruiting Danielsville, Georgia, United States, 30633 Contact: Heather Zuercher    706-542-8967    zuercher@uga.edu    City of Moultrie Completed Moultrie, Georgia, United States, 31768 Colquitt County Government Completed Moultrie, Georgia, United States, 31768 Colquitt County Schools Completed Moultrie, Georgia, United States, 31768 Colquitt Regional Medical Center Completed Moultrie, Georgia, United States, 31768 National Beef Active, not recruiting Moultrie, Georgia, United States, 31768 Southwest Georgia Bank Completed Moultrie, Georgia, United States, 31768 Southwest Georgia Community Action Council Completed Moultrie, Georgia, United States, 31768 Southwest Regional Technical College Recruiting Moultrie, Georgia, United States, 31768 Contact: Rich Gallagher    229-985-1154    rgallagher@moultrieymca.org    Turning Point Hospital Completed Moultrie, Georgia, United States, 31768 Lowndes County Recruiting Valdosta, Georgia, United States, 31602 Contact: Rich Gallagher    229-985-1154    rgallagher@moultrieymca.org    Valdosta City Schools Recruiting Valdosta, Georgia, United States, 31602 Contact: Rich Gallagher    229-985-1154    rgallagher@moultrieymca.org    Wiregrass Technical College Recruiting Valdosta, Georgia, United States, 31602 Contact: Rich Gallagher    229-985-1154    rgallagher@moultrieymca.org Less <<
NCT00279929 Aging Dehydro... More >>epiandosterone Replacement DHEA Replacement Less << Not Applicable Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT01495000 Osteoporosis, Postmenopausal Phase 3 Completed - India ... More >> GSK Investigational Site Ahmedabad, India, 380015 GSK Investigational Site Bangalore, India, 560043 GSK Investigational Site Bangalore, India, 560052 GSK Investigational Site Bangalore, India, 560054 GSK Investigational Site Delhi, India, 110060 GSK Investigational Site Mangalore, India, 575002 GSK Investigational Site Nagpur, India, 440010 GSK Investigational Site Nagpur, India, 440012 GSK Investigational Site Pune, India, 411030 GSK Investigational Site Trivandrum, India, 695011 GSK Investigational Site Vadodra, India, 390007 Less <<
NCT02878317 - Active, not recruiting August 2022 United Kingdom ... More >> Derby Hospitals NHS Foundation Trust Derby, Derbyshire, United Kingdom, DE22 3NE Less <<
NCT02564055 Dermatitis, Atopic Phase 2 Completed - -
NCT02692560 Obesity Seden... More >>tary Lifestyle Less << Not Applicable Completed - United States, Washington ... More >> Kaiser Permanente Washington Health Research Institute Seattle, Washington, United States, 98101 Less <<
NCT01087840 HIV Prevention ... More >> HIV Infections Less << Phase 4 Completed - Australia, New South Wales ... More >> Sydney Sexual Health, Sydney Hospital Sydney, New South Wales, Australia, 2000 St. Vincent's Hospital, 390 Victoria Rd, Darlinghurst Sydney, New South Wales, Australia, 2010 Less <<
NCT02692560 - Completed - -
NCT02746302 Healthy Phase 1 Completed - -
NCT01495000 - Completed - -
NCT01277094 Fatty Liver, Non-alcoholic Fat... More >>ty Liver Disease, NAFLD Less << Phase 1 Completed - Austria ... More >> Wien, Austria, 1090 Germany Dusseldorf, Germany, 40225 Nuthetal, Germany, 14558 Tübingen, Germany, 72076 Less <<
NCT03441984 HIV Infections Phase 1 Completed - United States, Texas ... More >> GSK Investigational Site Austin, Texas, United States, 78744 Less <<
NCT02462291 Alzheimer Disease ... More >> Behavioral Disorders Cognitive Impairment Less << Not Applicable Completed - Italy ... More >> Mons. Mazzali Foundation Mantua Italy, Mantua, Italy, 46100 Less <<
NCT00434915 Aging Not Applicable Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT03568942 Infections, Bacterial Phase 2 Recruiting December 14, 2018 United States, California ... More >> GSK Investigational Site Recruiting La Mesa, California, United States, 91942 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com Less <<
NCT02063165 Metabolic Syndrome Not Applicable Completed - United States, Ohio ... More >> The Ohio State University Exercise Physiology Lab Columbus, Ohio, United States, 43210 Less <<
NCT02564055 - Completed - -
NCT02462291 - Completed - -
NCT00724867 Systemic Lupus Erythematosus Phase 3 Completed - -
NCT00583362 Systemic Lupus Erythematosus Phase 2 Completed - -
NCT00583362 - Completed - -
NCT00263965 Type 2 Diabetes Phase 2 Terminated(The development pro... More >>gram has been terminated) Less << - Finland ... More >> Research Site Helsinki, Finland Italy Research Site Pisa, Italy United Kingdom Research Site Oxford, United Kingdom Less <<
NCT00724867 - Completed - -
NCT02711124 - Unknown August 2016 Croatia ... More >> The University Hospital Centre Zagreb, Department of cardiac surgery Recruiting Zagreb, Croatia, 10 000 Contact: Martina Zrno Mihaljević    00385 1 2367 529    martina_zrno@yahoo.com    Contact: Mate Petričević    00385 1 2367 529    petricevic.mate@gmail.com Less <<
NCT00170937 METABOLIC SYNDROME ... More >> HYPERTENSION PRE-HYPERTENSION Less << Phase 4 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals E. Hanover, New Jersey, United States, 07936 Less <<
NCT00135356 - Completed - -
NCT02931929 Gastrointestinal Stromal Tumor... More >>s Less << Phase 1 Phase 2 Unknown October 2017 -
NCT00993421 - Terminated(Clinical trial term... More >>inated due to results from recent nonclinical studies) Less << - -
NCT01437540 Chronic Obstructive Pulmonary ... More >>Disease Less << Phase 3 Completed - -
NCT00993421 Obesity Phase 2 Terminated(Clinical trial term... More >>inated due to results from recent nonclinical studies) Less << - -
NCT01170442 Diabetes Mellitus ... More >> Vitamin D Deficiency Less << Phase 3 Terminated(In adequate enrollm... More >>ent) Less << - Saudi Arabia ... More >> King Faisal Specialist Hospital & Research Center Riyadh, Saudi Arabia, 11211 Less <<
NCT01435005 Breast Neoplasms Not Applicable Completed - Canada, Alberta ... More >> Tom Baker Cancer Centre Calgary, Alberta, Canada, T2N 4N2 Cross Cancer Centre Edmonton, Alberta, Canada, T6G 1Z2 Less <<
NCT01668836 Vascular System Injuries ... More >> Lipid Metabolism Disorders Endothelial Disfunction Less << Not Applicable Completed - Brazil ... More >> INCOR - Heart Institute São Paulo, Brazil, 05403-900 Less <<
NCT00135356 HIV-Associated Lipodystrophy S... More >>yndrome Less << Phase 4 Completed - -
NCT02559622 Psoriasis Phase 3 Completed - Germany ... More >> Novartis Investigative Site Augsburg, Germany, 86179 Novartis Investigative Site Berlin, Germany, 10789 Novartis Investigative Site Berlin, Germany, 13187 Novartis Investigative Site Bielefeld, Germany, 33647 Novartis Investigative Site Bochum, Germany, 44791 Novartis Investigative Site Bonn, Germany, 53105 Novartis Investigative Site Darmstadt, Germany, 64283 Novartis Investigative Site Dresden, Germany, 01307 Novartis Investigative Site Duisburg, Germany, 47166 Novartis Investigative Site Essen, Germany, 45147 Novartis Investigative Site Frankfurt, Germany, 60590 Novartis Investigative Site Freiburg, Germany, 79104 Novartis Investigative Site Gera, Germany, 07548 Novartis Investigative Site Hamburg, Germany, 20354 Novartis Investigative Site Heidelberg, Germany, 69120 Novartis Investigative Site Homburg, Germany, 66421 Novartis Investigative Site Langenau, Germany, 89129 Novartis Investigative Site Lubeck, Germany, 23538 Novartis Investigative Site Mainz, Germany, 55131 Novartis Investigative Site Muenster, Germany, 48149 Novartis Investigative Site München, Germany, 81675 Novartis Investigative Site Stade, Germany, 21682 Novartis Investigative Site Ulm, Germany, 89081 Less <<
NCT01957696 - Recruiting October 2020 Norway ... More >> Oslo University Hospital Recruiting Oslo, Norway, 0027 Contact: Ole M Øyen, MD, PhD    +47 92264777    ole.oyen@ous-hf.no    Contact: Rune Horneland, MD    +47 91177121    rune.horneland@ous-hf.no    Principal Investigator: Ole M Øyen, MD, PhD Less <<
NCT01437540 - Completed - -
NCT03188094 - Not yet recruiting September 2021 -
NCT01668836 - Completed - -
NCT03754842 Muscle Injury Not Applicable Not yet recruiting July 1, 2020 -
NCT00128336 Obesity Type ... More >>2 Diabetes Mellitus Less << Phase 3 Completed - New Zealand ... More >> Department of Human Nutrition, University of Otago Dunedin, New Zealand, 9001 Less <<
NCT00468975 Asthma Phase 2 Completed - Germany ... More >> Pfizer Investigational Site Berlin, Germany, 14050 Pfizer Investigational Site Großhansdorf, Germany, 22927 Pfizer Investigational Site Wiesbaden, Germany, 65187 Sweden Pfizer Investigational Site Goteborg, Sweden, 413 45 Pfizer Investigational Site Lund, Sweden, 221 85 United Kingdom Pfizer Investigational Site Manchester, United Kingdom, M23 9QZ Less <<
NCT02027285 Aging Not Applicable Completed - Italy ... More >> University of Bologna-Department of Speciality, Diagnostic and Experimental Medicine Bologna, Italy, 40126 Less <<
NCT01881347 Diabetes Mellitus Not Applicable Completed - United States, Massachusetts ... More >> Boston University Medical Center Boston, Massachusetts, United States, 02118 Less <<
NCT03008070 Non-Alcoholic Steatohepatitis ... More >>(NASH) Less << Phase 2 Recruiting January 2020 -
NCT01701934 Chronic Obstructive Pulmonary ... More >>Disease Metabolic Syndrome Less << Phase 2 Terminated(The recruitment of ... More >>the study was prematurely stopped in July 2014 for the following reason; no more study medication.) Less << December 2014 Canada, British Columbia ... More >> St. Paul's Hospital Vancouver, British Columbia, Canada, V6Z 1Y6 Canada, Quebec Centre hospitalier de l'Université de Montréal Montréal, Quebec, Canada, H2W 1T8 Montreal Chest Institute Montréal, Quebec, Canada, H2X 2P4 Institut universitaire de cardiologie et de pneumologie de Québec Québec, Quebec, Canada, G1V 4G5 Hôpital régional de Saint-Jérôme Saint-Jérôme, Quebec, Canada, J7Z 5T3 Less <<
NCT02559622 - Completed - -
NCT03383614 Filariasis Phase 1 Recruiting October 1, 2018 United Kingdom ... More >> Hammersmith Medicines Research Limited Recruiting London, United Kingdom, NW10 7EW Contact: Jeremy Dennison, BSc MSc PhD MBChB    +44 20 89 63 45 46    jdennison@hmrlondon.com    Contact: Frans van den Berg    +44 20 89 61 41 30    fvandenberg@hmrlondon.com Less <<
NCT01766453 Obesity Not Applicable Completed - Canada, British Columbia ... More >> Simon Fraser University Vancouver, British Columbia, Canada, V6B5K3 Less <<
NCT02315001 Ischaemic Heart Disease ... More >> Coronary Heart Disease Chronic Stable Angina Less << Phase 2 Completed - United Kingdom ... More >> Guy's and St Thomas' NHS Foundation Trust London, Greater London, United Kingdom, SE17EH Less <<
NCT01220856 Pancreatic Islet Transplantati... More >>on in Type 1 Diabetes Mellitus Less << Phase 2 Completed - Germany ... More >> University Hospital Carl Gustav Carus Dresden Dresden, Germany, 01307 Italy Ospedale San Raffaele Milan, Italy, 20132 Less <<
NCT03181230 - Recruiting June 30, 2022 United States, Colorado ... More >> Children's Hospital Colorado Recruiting Aurora, Colorado, United States, 80045 Contact: Shanlee M Davis, MD    720-777-6073    shanlee.davis@childrenscolorado.org    Contact: Susan Howell, MS, CGC, MBA    720-777-8361    susan.howell@childrenscolorado.org    Principal Investigator: Shanlee M Davis, MD, MS          Sub-Investigator: Nicole Tartalia, MD, MS          Sub-Investigator: Amira Herstic, MS, CGC, MBA          Sub-Investigator: Kristen Nadeau, MD, MS Less <<
NCT03405818 Onychomycosis ... More >> Tinea Unguium Less << Phase 4 Completed - United States, California ... More >> Madera Family Medical Group Madera, California, United States, 93637 Stanford University School of Medicine Palo Alto, California, United States, 94304 United States, District of Columbia MedStar Health Research Institute - MedStar Georgetown University Hospital Washington, District of Columbia, United States, 20016 United States, Florida Doctors Research Network South Miami, Florida, United States, 33143 United States, New York University Hospital, SUNY Downstate Medical Center Brooklyn, New York, United States, 11203 Skin Specialty Dermatology New York, New York, United States, 10155 United States, Oregon Cyn3rgy Research Gresham, Oregon, United States, 97030 Oregon Dermatology & Research Center Portland, Oregon, United States, 97210 United States, Texas West Houston Clinical Research Services LLC Houston, Texas, United States, 77055 Texas Dermatology and Laser Specialists San Antonio, Texas, United States, 78218 United States, Utah Jordan Valley Dermatology Center West Jordan, Utah, United States, 84088 United States, Virginia PI Coor Clinical Research, LLC Burke, Virginia, United States, 22015 Less <<
NCT03405818 - Completed - -
NCT02627898 Type 2 Diabetes Mellitus Phase 2 Completed - -
NCT00673387 Overweight Ob... More >>esity Less << Phase 2 Completed - -
NCT00793780 Obesity Schiz... More >>ophrenia Schizoaffective Disorder Less << Not Applicable Completed - United States, Connecticut ... More >> Connecticut Mental Health Center New Haven, Connecticut, United States, 06519 Less <<
NCT02243150 Healthy Volunteers Phase 1 Completed - Netherlands ... More >> PRA Early Development Clinic Groningen, Netherlands Less <<
NCT00673387 - Completed - -
NCT03396978 Adipose Tissue ... More >> Microbiome Menopause Less << Not Applicable Enrolling by invitation June 30, 2021 United States, Colorado ... More >> University of Colorado Anschutz Medical Campus Aurora, Colorado, United States, 80045 Less <<
NCT02845063 Cardiovascular Disease Phase 2 Recruiting January 2020 Switzerland ... More >> Balgrist University Hospital Recruiting Zurich, Switzerland, 8008 Contact: Martin Flück, PhD    +41445107350    mflueck@research.balgrist.ch    Contact: Marco Toigo, PhD    +41445107351    mtoigo@research.balgrist.ch    University Hospital Zurich Not yet recruiting Zurich, Switzerland, 8091 Contact: Christian M Schmied, MD    +41 44 255 3478    Christian.Schmied@usz.ch    Contact: David Niederseer, MD    +41 44 255 1111    david.niederseer@usz.ch Less <<
NCT00449878 Cystic Fibrosis ... More >> Exocrine Pancreatic Insufficiency Less << Phase 3 Completed - -
NCT03740919 Type 1 Diabetes Mellitus Phase 3 Not yet recruiting December 3, 2020 -
NCT01290887 Eosinophilic Asthma Phase 3 Terminated(Business decision) - -
NCT01920568 Fractures, Bone Phase 3 Completed - China, Guangdong ... More >> GSK Investigational Site Guangzhou, Guangdong, China, 510060 GSK Investigational Site Guangzhou, Guangdong, China, 510120 GSK Investigational Site Guangzhou, Guangdong, China, 510515 China, Hubei GSK Investigational Site Wuhan, Hubei, China, 430030 China, Jiangsu GSK Investigational Site Nanjing, Jiangsu, China, 210002 GSK Investigational Site Nanjing, Jiangsu, China, 210009 China, Jilin GSK Investigational Site Changchun, Jilin, China, 130012 China, Sichuan GSK Investigational Site Chengdu, Sichuan, China, 610041 China, Zhejiang GSK Investigational Site Hangzhou, Zhejiang, China, 310003 China GSK Investigational Site Beijing, China, 100021 GSK Investigational Site Beijing, China, 100034 GSK Investigational Site Beijing, China, 100036 GSK Investigational Site Beijing, China, 100071 GSK Investigational Site Fuzhou, China, 350001 GSK Investigational Site Hangzhou, China, 310016 GSK Investigational Site Harbin, China GSK Investigational Site Shanghai, China, 200025 GSK Investigational Site Shanghai, China, 200032 GSK Investigational Site Shanghai, China, 200070 GSK Investigational Site Shanghai, China, 200080 GSK Investigational Site Shanghai, China, 200233 GSK Investigational Site Tianjin, China, 300060 Singapore GSK Investigational Site Singapore, Singapore, 119074 Taiwan GSK Investigational Site Taichung, Taiwan, 404 GSK Investigational Site Taoyuan, Taiwan, 333 Less <<
NCT00793780 - Completed - -
NCT02099032 Cardiometabolic Risk Not Applicable Completed - France ... More >> Université d'Auvergne-Laboratoire de Nutrition Humaine Clermont-Ferrand, France, 63001 Centre de Recherche en Nutrition Humaine Rhône-Alpes Pierre-Bénite (Lyon), France Less <<
NCT02646969 Healthy Term Infants Not Applicable Recruiting June 2022 France ... More >> CHU Pellegrin Recruiting Bordeaux, France, 33000 Contact: Claude Billeaud, Prof Less <<
NCT02701855 - Unknown December 2017 France ... More >> Unité de prévention des maladies cardiovasculaires Pôle Cardiologie/Métabolisme Hôpital Pitié-Salpétriêre, APHP, 83 bd de l'hôpital, Recruiting Paris, France, 75013 Contact: David Rosenbaum, Dr Less <<
NCT01777256 Systemic Lupus Erythematosus Phase 2 Terminated(This study met a pr... More >>otocol defined futility criterion and will be terminated following completion of the Follow Up Visit on the last subject randomised.) Less << - -
NCT03585413 Obesity Gastr... More >>ic Bypass NAFLD Less << Phase 3 Not yet recruiting August 2020 Germany ... More >> St. Franziskus-Hospital Not yet recruiting Cologne, Germany, 50825 Less <<
NCT01920568 - Completed - -
NCT02438059 Obesity Not Applicable Completed - -
NCT02196714 COPD Phase 1 Completed - United States, Maryland ... More >> SNBL Baltimore, Maryland, United States, 21201 Less <<
NCT00968708 - Completed - -
NCT01290887 - Terminated(Business decision) - -
NCT02544425 Extranodal NK-T-Cell Lymphoma Phase 2 Recruiting November 2019 Korea, Republic of ... More >> Samsung Medical Center Recruiting Seoul, Seoul, Korea, Republic Of, Korea, Republic of, 135-710 Contact: WonSeog Kim, M.D, Ph. D    234106548 ext 82    wskimsmc@skku.edu    Contact: SeokJin Kim, M.D,Ph. D    234101766 ext 82    seokjin88.kim@samsung.com    Samsung Medical Center Recruiting Seoul, Korea, Republic of, 135-710 Contact: Wonseog Kim, M.D., Ph.D.    82-2-3410-6548    wonseog.kim@samsung.com    Contact: Seokjin Kim, M.D., Ph.D.       seokjin88.kim@samsung.com    Sub-Investigator: Seokjin Kim, M.D., Ph.D.          Principal Investigator: Wonseog Kim, M.D. Ph.D Less <<
NCT02196714 - Completed - -
NCT00968708 Diabetes Mellitus, Type 2 ... More >> Acute Coronary Syndrome Less << Phase 3 Completed - -
NCT00250679 Chronic Obstructive Pulmonary ... More >>Disease Bronchitis Emphysema Less << Phase 3 Completed - -
NCT02951052 Infection, Human Immunodeficie... More >>ncy Virus Less << Phase 3 Active, not recruiting February 8, 2022 -
NCT00250679 - Completed - -
NCT01092325 Heart Failure Phase 1 Phase 2 Completed - United States, California ... More >> Orange County Clinical Research Center Tustin, California, United States, 92780 Less <<
NCT03510494 Obesity, Childhood ... More >> Risk Factor, Cardiovascular Sports Injury Physical Activity Motor Activity Less << Not Applicable Completed - Denmark ... More >> University of Southern Denmark Odense, Denmark, 5230 Less <<
NCT00877526 - Completed - Malaysia ... More >> Novo Nordisk Investigational Site Selangor Darul Ehsan, Malaysia Less <<
NCT02343588 Pediatric Obesity Not Applicable Completed - -
NCT00788853 - Completed - Indonesia ... More >> Jakarta, Indonesia, 12520 Less <<
NCT02403375 Diabetes Mellitus Type 1 Not Applicable Completed - Austria ... More >> Medical University Graz Graz, Austria, 8036 Universitatsklinik fur PadiatrieI, Padiatrische Diabetologie und Endokrinologie Innsbruck, Austria, 6020 Medical University of Vienna-Dept of Pediatrics Vienna, Austria, 1090 Germany Kinderkrankenhaus auf der Bult Hannover, Germany, 30173 Gemeinschaftspraxis für Kinder- und Jugendmedizin Herford, Germany, 32051 Practice for Pediatric and Adolescent Diabetology Munster, Germany, 48155 Universitatsklinikum Tubingen Tubingen, Germany, 72076 United Kingdom Birmingham Children's Hospital Foundation Trust Birmingham, United Kingdom, B46NH St. James's University Hospital Leeds, United Kingdom, LS97TF Less <<
NCT01374854 Type 1 Diabetes Mellitus Phase 1 Phase 2 Unknown December 2014 China, Fujian ... More >> Fuzhou General Hospital Fuzhou, Fujian, China, 350025 Less <<
NCT00887874 - Completed - Taiwan ... More >> Novo Nordisk Investigational Site Taipei, Taiwan Less <<
NCT03528031 Intra-abdominal Fat ... More >> Metabolic Syndrome High Cholesterol Triglycerides High Diet Habit High Blood Sugar Liver Fat Dietary Modification HDL Cholesterol, Low Serum Cardiovascular Diseases High Density Lipoprotein Deficiency Low-density-lipoprotein-type Cardiovascular Risk Factor Diabetes Less << Not Applicable Recruiting January 2022 United States, California ... More >> Loma Linda University Recruiting Loma Linda, California, United States, 92354 Contact: Amandeep Kaur       akaur1@llu.edu    Principal Investigator: Joan Sabate, MD, DrPH          University of California Los Angles (UCLA) Recruiting Los Angeles, California, United States, 90095 Contact: Anna Rasmussen    310-206-2962    uclahealthyavotrial@gmail.com    Principal Investigator: Zhaoping Li, MD, PhD          United States, Massachusetts Tufts University Recruiting Medford, Massachusetts, United States, 02155 Contact: Jean Galluccio       jean.galluccio@tufts.edu    Principal Investigator: Alice Lichtenstein, D.Sc.          United States, Pennsylvania Pennysylvania State University Recruiting University Park, Pennsylvania, United States, 16802 Contact: Kristin Davis    814-863-8056    psudiet@gmail.com    Principal Investigator: Penny Kris-Etherton, PhD, RD          Principal Investigator: Kristina Petersen, PhD Less <<
NCT01542476 - Completed - Netherlands ... More >> Alphen a/d Rijn, Netherlands Less <<
NCT00394667 Obesity Phase 2 Completed - Denmark ... More >> NeuroSearch A/S Ballerup, Denmark, 2750 Less <<
NCT00918151 - Completed - Korea, Republic of ... More >> Seoul, Korea, Republic of, 137-920 Less <<
NCT00872378 Morbid Obesity Phase 2 Phase 3 Unknown December 2010 United States, Oregon ... More >> Advanced Specialty Care Recruiting Bend, Oregon, United States, 97701 Contact: Megan E Boone, BS    541-322-1772    megan@advancedspecialtycare.com    Sub-Investigator: Ngocthuy Hughes, MD          Sub-Investigator: Stephen B Archer, MD FACS          Endocrinology Services NorthWest Recruiting Bend, Oregon, United States, 97701 Contact: Megan E Boone, BS    541-322-1772    megan@advancedspecialtycare.com    Principal Investigator: Patrick J McCarthy, MD          Sub-Investigator: Travis L Monchamp, MD Less <<
NCT01764113 Adolescent Obesity Phase 3 Completed - United States, Minnesota ... More >> Mayo Clinic in Rochester Rochester, Minnesota, United States, 55905 Less <<
NCT00320606 Liver Transplant ... More >> Liver Transplantation Less << Phase 1 Completed - United States, California ... More >> University of California, San Francisco San Francisco, California, United States, 94143 United States, Illinois Children's Memorial Hospital Chicago, Illinois, United States, 60614 United States, New York Columbia University Medical Center New York, New York, United States, 10032 Less <<
NCT03634943 - Recruiting July 15, 2020 Spain ... More >> Hospital Sant Joan d' Alacant Recruiting San Juan De Alicante, Alicante, Spain, 03550 Contact: Angel Sanchez-Miralles       an.sanchezm1@coma.es    Principal Investigator: Angel Sanchez-Miralles          Sub-Investigator: Enrique Marmol-Peis          Sub-Investigator: Miriam Ruiz -Miralles          Sub-Investigator: María Gonzalez-Sanz          Sub-Investigator: Arantzazu Server-Martinez          Hospital Universitari Germans Trias i Pujol Recruiting Badalona, Barcelona, Spain, 08916 Contact: Mª Luisa Bordeje-Laguna       luisabordeje@gmail.com    Principal Investigator: MªLuisa Bordeje-Laguna          Principal Investigator: Esther Mor-Marco          Sub-Investigator: Yaiza Rovira-Valles          Sub-Investigator: Viridiana Philibert          H. General de Granollers Recruiting Granollers, Barcelona, Spain, 08402 Contact: Rayden Iglesias-Rodriguez       riglesias@fhag.es    Principal Investigator: Rayden Iglesias-Rodriguez          Hospital Universitari de Bellvitge (Cardiology Unit) Recruiting L'Hospitalet de Llobregat, Barcelona, Spain, 08907 Contact: Fernando De Frutos       fdefrutos@bellvitgehospital.cat    Principal Investigator: Fernando De Frutos Seminario          Sub-Investigator: Oriol Rodriguez Queralto          Hospital Universitari de Bellvitge Recruiting L'Hospitalet de Llobregat, Barcelona, Spain, 08907 Contact: Juan Carlos Lopez-Delgado       juancarloslopezde@hotmail.com    Principal Investigator: Juan Carlos Lopez-Delgado          Sub-Investigator: Laura Anguela-Calvet          Sub-Investigator: Gloria Muñoz-Del Río          Sub-Investigator: Henry Alanez-Saavedra          Sub-Investigator: Pau Serra-Paya          Sub-Investigator: Pamela Alejandra Revelo-Esquibel          Sub-Investigator: Stephani Maria Luna-Solis          Sub-Investigator: Alvaro Salinas-Canovas          Principal Investigator: Africa Lores-Obradors          Sub-Investigator: Javiera Virginia Puentes-Yañez          Hospital de Mataró Recruiting Mataró, Barcelona, Spain, 08304 Contact: Itziar Martínez de Lagrán       itziarmz@hotmail.com    Principal Investigator: Itziar Martínez de Lagrán          Principal Investigator: Juan Carlos Yébenes- Reyes          Hospital Mutua Terrasa. Recruiting Terrassa, Barcelona, Spain, 08221 Contact: Elisabeth Navas       enavas@mutuaterrassa.es    Principal Investigator: Elisabeth Navas-Moya          Sub-Investigator: Carles Ferrer-Pereto          Sub-Investigator: Cristina Lluch-Candal          Sub-Investigator: Jessica Ruiz-Izquierdo          Sub-Investigator: Silvia Castor-Bekari          Hospital General Universitario de Castellón Recruiting Castelló de la Plana, Castellón, Spain, 12004 Contact: Lidón Mateu-Campos       mateuli@hotmail.com    Principal Investigator: Lidón Mateu-Campos          Sub-Investigator: Clara Martínez Valero          Sub-Investigator: Andrea Ortiz Suñer          Hospital Universitario de Puerto Real Recruiting Puerto Real, Cádiz, Spain, 11510 Contact: Pilar Martinez-Garcia       pilar.martinezgarcia@gmail.com    Principal Investigator: Pilar Martinez-Garcia          Sub-Investigator: Mª Immaculada Dominguez-Fernandez          Hospital de Barbastro Recruiting Barbastro, Huesca, Spain, 22300 Contact: Carlos Gonzalez-Iglesias       cgisalamanca@hotmail.com    Principal Investigator: Carlos Gonzalez-Iglesias          Sub-Investigator: Monica Zamora-Elson          H. Manacor Recruiting Manacor, Islas Baleares, Spain, 07500 Contact: Rosa Gastaldo-Simeon       rousgastaldi@hotmail.com    Principal Investigator: Rosa Gastaldo-Simeon          Sub-Investigator: Josefina Gimenez-Castellanos          Hospital Príncipe de Asturias Recruiting Alcalá de Henares, Madrid, Spain, 28805 Contact: Beatriz Llorente-Ruiz       bllorenteruiz@gmail.com    Principal Investigator: Beatriz Llorente-Ruiz          Sub-Investigator: María Cristina Martínez-Diaz          Sub-Investigator: María Trascasa-Muñoz De La Peña          Sub-Investigator: Diego Anibal Rodríguez-Serrano          Hospital Quirón Sur Not yet recruiting Alcorcón, Madrid, Spain, 28922 Contact: Amparo Paredes Sánchez       uci.hs@quironsalud.es    Principal Investigator: Amparo Paredes Sánchez          Hospital Universitario de Fuenlabrada Recruiting Fuenlabrada, Madrid, Spain, 28942 Contact: Beatriz Nieto-Martino       b.nietom@gmail.com    Principal Investigator: Beatriz Nieto-Martino          Sub-Investigator: Clara Vaquerizo-Alonso          Hospital Universitario de Getafe Recruiting Getafe, Madrid, Spain, 28905 Contact: Enrique Calvo Herranz       qqcalvo@gmail.com    Principal Investigator: Enrique Calvo-Herranz          Sub-Investigator: Diego Manzano-Moratinos          Hospital Universitario Severo Ochoa Recruiting Leganés, Madrid, Spain, 28911 Contact: Jose Luis Flordelis-Lasierra       makalyconru@hotmail.com    Principal Investigator: Jose Luis Flordelis-Lasierra          Sub-Investigator: José Ramón Mampaso-Recio          Sub-Investigator: José Manuel Rodríguez-Roldan          Sub-Investigator: Irene Jimenez-del Río          Hospital Infanta Cristina Recruiting Parla, Madrid, Spain, 28981 Contact: Belen Vila-Garcia       belenvilag@yahoo.es    Principal Investigator: Belen Vila-Garcia          Hospital Universitario Infanta Sofía Active, not recruiting San Sebastian de los Reyes, Madrid, Spain, 28703 Complejo Hospitalario de Navarra Recruiting Pamplona, Navarra, Spain, 31008 Contact: Laura Macaya-Redin       laura.macaya.redin@cfnavarra.es    Principal Investigator: Laura Macaya-Redin          Principal Investigator: Sara Aldunate-Calvo          Sub-Investigator: Raquel Flecha-Viguera          Hospital Álvaro Cunqueiro Recruiting Vigo, Pontevedra, Spain, 36312 Contact: Eva Maria Menor-Fernandez       Eva.Maria.Menor.Fernandez@sergas.es    Principal Investigator: Eva Maria Menor-Fernandez          Sub-Investigator: Lucas Lage-Cedon          Sub-Investigator: Alberto Touceda-Bravo          Hospital Universitario de A Coruña Not yet recruiting A Coruña, Spain, 15006 Contact: Mª Lourdes Cordero Lorenzana       MA.Lourdes.Cordero.Lorenzana@sergas.es    Principal Investigator: Mª Lourdes Cordero Lorenzana          Hospital General Universitario de Alicante Recruiting Alicante, Spain, 03010 Contact: Sonia Pérez-Quesada       sopeque@hotmail.com    Principal Investigator: Sonia Pérez-Quesada          Sub-Investigator: Susana Almanza-Lopez          Sub-Investigator: Jose Luis Anton-Pascual          Hospital del Mar Recruiting Barcelona, Spain, 08003 Contact: Judith Marin-Corral       jmarincorral@gmail.com    Principal Investigator: Judith Marin-Corral          Sub-Investigator: Maite Sistachs-Baquedano          Sub-Investigator: Maria Acer-Puig          Sub-Investigator: Marina Picornell-Noguera          Hospital Plató Recruiting Barcelona, Spain, 08006 Contact: Laura Sanchez-Ales       laura.sanchez@hospital.plato.com    Principal Investigator: Laura Sanchez-Ales          Sub-Investigator: Laura Almorin          Hospital de la Santa Creu i Sant Pau. Recruiting Barcelona, Spain, 08041 Contact: Paula Vera Artázcoz       pvera@santpau.cat    Principal Investigator: Paula Vera-Artázcoz          Sub-Investigator: Marta Izura-Gomez          Sub-Investigator: Susana Hernández-Duran          Hospital Universitario de Burgos Recruiting Burgos, Spain, 09006 Contact: Maria Gero-Escapa       Mariagero.esc@gmail.com    Principal Investigator: Maria Gero-Escapa          Sub-Investigator: Esther Martinez-Barrio          Sub-Investigator: Sergio Ossa-Echeverri          Hospital Universitari Josep Trueta Recruiting Girona, Spain, 17007 Contact: Carol Lorencio-Cardenas       carol_lorencio@hotmail.com    Principal Investigator: Carol Lorencio-Cardenas          Hospital General San Jorge Recruiting Huesca, Spain, 22004 Contact: Carlos Serón-Arbeloa       cseronar@gmail.com    Principal Investigator: Carlos Serón-Arbeloa          Sub-Investigator: Nestor Bueno-Vidales          Hospital Universitari Arnau de Vilanova Recruiting Lleida, Spain, 25198 Contact: Lluis Servia-Goixart       lserviag@gmail.com    Sub-Investigator: Joan Escobar-Ortiz          Sub-Investigator: Neus Montserrat-Ortiz          Sub-Investigator: Amalia Zapata-Rojas          Principal Investigator: Javier Trujillano-Cabello          Principal Investigator: Lluis Servia-Goixart          Hospital Universitario 12 de Octubre Recruiting Madrid, Spain, 28041 Contact: Teodoro Grau-Carmona       teograu2@gmail.com    Principal Investigator: Teodoro Grau-Carmona          Sub-Investigator: Juan Carlos Montejo-Gonzalez          Sub-Investigator: Susana Temprano-Vazquez          Sub-Investigator: Iris Bautista-Redondo          Sub-Investigator: Ana Cruz-Ramos          Sub-Investigator: Laura Diaz-Castellanos          Sub-Investigator: Mirian Morales-Cifuentes          Sub-Investigator: Montserrat Plaza-Bono          Sub-Investigator: Verónica Arjona-Diaz          Hospital Universitario 12 de Octubre (Trauma Unit) Recruiting Madrid, Spain Contact: Carlos Garcia-Fuentes       cgfuentes@salud.madrid.org    Principal Investigator: Carlos Garcia-Fuentes          Sub-Investigator: Carolina Mudarra-Reche          Sub-Investigator: Maria Orejana-Martin          Hospital General Universitario Reina Sofia Not yet recruiting Murcia, Spain, 30003 Contact: Fátima Martínez-Lozano Aranaga       fatiaranaga@hotmail.com    Principal Investigator: Fátima Martínez-Lozano Aranaga          Hosptial General Universitario Morales Meseguer Recruiting Murcia, Spain, 30008 Contact: Maravillas de las Nieves Alcázar Espín       mavialcazar@hotmail.com    Principal Investigator: Maravillas de las Nieves Alcázar Espín          Sub-Investigator: Áurea Higón Cañigral          Hospital Regional Universitario Carlos Haya Recruiting Málaga, Spain, 29010 Contact: Juan Francisco Fernandez-Ortega       jfezortega@gmail.com    Principal Investigator: Juan Francisco Fernandez-Ortega          Sub-Investigator: Juan Francisco Martinez-Carmona          Sub-Investigator: Esther Lopez-Luque          Sub-Investigator: Ane Ortega-Ordiales          Hospital Clinico Universitario de Valencia Not yet recruiting Valencia, Spain, 46010 Contact: Angela Jorda-Miñana       ajordaminana@gmail.com    Principal Investigator: Angela Jorda-Miñana          Sub-Investigator: Mar Juan-Diaz          Hospital Clínico Universitario de Valencia Not yet recruiting Valencia, Spain, 46010 Contact: Angela Jordana Miñana       ajordaminana@gmail.com    Principal Investigator: Angela Jordana Miñana          Principal Investigator: Mar Juan Díaz          Hospital Universitari Doctor Peset Recruiting Valencia, Spain, 46017 Contact: Monica Crespo-Gomez       monicrespogomez@gmail.com    Principal Investigator: Monica Crespo-Gomez          Sub-Investigator: Victor Ramirez-Montero          Sub-Investigator: Esther Lopez-Garcia          Sub-Investigator: Arturo Navarro-Lacalle          Hospital Clínico Universitario de Valladolid Recruiting Valladolid, Spain, 47003 Contact: Esther Portugal-Rodríguez       esther_burgos@hotmail.com    Principal Investigator: Esther Portugal-Rodríguez          Sub-Investigator: David Andaluz-Ojeda          Sub-Investigator: Laura Parra-Morais          Sub-Investigator: Rafael Citores-Gonzalez          Sub-Investigator: MªTeresa Garcia-Gonzalez          Sub-Investigator: Gloria RenedoSanchez-Giron          Hospital Rio Hortega Recruiting Valladolid, Spain, 47012 Contact: Ana Martin-Luengo       anauvi.aml@gmail.com    Principal Investigator: Ana Martin-Luengo          Hospital Virgen de la Concha Recruiting Zamora, Spain, 49022 Contact: Diana Donaire       dianadonaire@gmail.com    Principal Investigator: Diana Monge Donaire          Hospital Clínico Lozano Blesa Recruiting Zaragoza, Spain, 50009 Contact: Leticia Fernandez-Salvatierra       leticiazgz1983@hotmail.com    Principal Investigator: Leticia Fernandez-Salvatierra          Sub-Investigator: Mireia Barceló-Castelló          Sub-Investigator: Paula Millán-Taratiel          Hospital Miguel Servet Recruiting Zaragoza, Spain, 50009 Contact: Antonio Tejada       atbb1@hotmail.com    Principal Investigator: Antonio Tejada-Artigas          Sub-Investigator: Ines Martinez-Arroyo          Sub-Investigator: Pilar Araujo-Aguilar          Sub-Investigator: Maria Fuster-Cabré          Sub-Investigator: Laura Andres-Gines          Sub-Investigator: Sonia Soldado-Olmo          Hospital Royo Villanova Recruiting Zaragoza, Spain, 50015 Contact: Cristina León-Cinto       cleon@salud.aragon.es    Principal Investigator: Cristina León-Cinto Less <<
NCT01597960 Cardiovascular Disease Not Applicable Completed - United Kingdom ... More >> International Centre for Circulatory Health London, United Kingdom, W2 1LA Less <<
NCT02491333 Polycystic Ovary Syndrome ... More >> Insulin Resistance Less << Phase 3 Unknown December 2017 China, Guangdong ... More >> The First Affiliated Hospital of Guangzhou Medical University Recruiting Guangzhou, Guangdong, China, 510120 Contact: Wanting Wu, Master    15818153730       Contact: Meifang Li, Master    13544426679       Principal Investigator: Hongxia Ma, PhD Less <<
NCT00325806 Hypertension Phase 4 Completed - -
NCT03025009 Healthy Phase 1 Terminated(due to immunogenici... More >>ty rate, injection site reactions, and business reasons) Less << - Germany ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician. Neuss, Nordrhein-Westfalen, Germany, 41460 Less <<
NCT00759304 - Active, not recruiting December 2021 France ... More >> Centre Hospitalier de Saint-Etienne Saint-Etienne, France, 42055 Less <<
NCT00771108 Non-alcoholic Fatty Liver Dise... More >>ase (NAFLD) Less << Not Applicable Completed - United States, Missouri ... More >> Washington University School of Medicine St. Louis, Missouri, United States, 63110 Less <<
NCT03140761 - Recruiting August 2019 Denmark ... More >> Department of Internal medicine, Herlev & Gentofte Universtity Hospital Recruiting Hellerup, Denmark, 2900 Contact: Pradeesh Sivapalan Less <<
NCT00629304 Type 1 Diabetes Phase 3 Completed - France ... More >> Centre Hospitalier de Belfort Montbéliard Belfort, France, 90016 CHU Jean Minjoz Besancon, France, 25030 CH SUD Francilien Corbeil Essonnes, France, 91100 University Hospital Grenoble Grenoble, France, 38043 CHRU Lille Lille, France, 59037 Hopital Edouard Herriot Lyon, France, 69003 CHU Marseille Hôpitaux Sud Marseille, France, 13274 Chu Montpellier Montpellier, France, 34295 CHU Hôpital Jeanne d'Arc Nancy, France, 54201 CHU Nantes Nantes, France, 44093 Hopital Hotel Dieu Paris, France, 75004 Hopital COCHIN Paris, France, 75014 HOPITAL Saint Louis Paris, France, 75475 Hopital Haut Leveque Pessac, France, 33604 CHU Rennes Rennes, France, 35056 Hopital Bellevue Saint Etienne, France, 42055 Centre Hospitalier Strasbourg Strasbourg, France, 67000 CHU Toulouse Toulouse, France, 31403 Less <<
NCT02130687 Type 2 Diabetes Mellitus ... More >> Hypertension Less << Not Applicable Recruiting June 2020 United States, Tennessee ... More >> Vanderbilt University Recruiting Nashville, Tennessee, United States, 37232 Contact: Jessica R Wilson, M.D.       jessica.r.wilson@vanderbilt.edu    Contact: Scott Hubers, M.D.       scott.hubers@vanderbilt.edu    Principal Investigator: Nancy J Brown, M.D.          Sub-Investigator: Jessica Devin, M.D.          Sub-Investigator: Jessica R Wilson, M.D.          Sub-Investigator: Claudia E Ramirez, M.D.          Sub-Investigator: Scott Hubers, M.D. Less <<
NCT01767480 Stroke Not Applicable Completed - Taiwan ... More >> Chang Gung Memorial Hospital Kwei-Shan, Tao-Yuan, Taiwan, 333 Less <<
NCT02236546 - Terminated(loss of funding) - -
NCT02501460 Cancer Not Applicable Completed - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT02168647 Excessive Weight Gain in Pregn... More >>ancy With Baby Delivered Less << Not Applicable Completed - United States, Iowa ... More >> Iowa State University Ames, Iowa, United States, 50011 Less <<
NCT02236546 Recurrent Melanoma ... More >> Stage IIIA Melanoma Stage IIIB Melanoma Stage IIIC Melanoma Stage IV Melanoma Less << Not Applicable Terminated(loss of funding) - United States, Tennessee ... More >> Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232 Less <<
NCT00746824 Obesity Phase 2 Terminated(The IND was withdra... More >>wn.) Less << - -
NCT01111318 Hepatic Insufficiency ... More >> Healthy Less << Phase 1 Completed - Romania ... More >> 1245.13.40001 Boehringer Ingelheim Investigational Site Timisoara, Romania Less <<
NCT00479882 Primary Hypercholesterolemia ... More >> Mixed Dyslipidemia Less << Phase 3 Completed - -
NCT01027858 Vascular Cognitive Impairment Not Applicable Completed - Canada, British Columbia ... More >> University of British Columbia Vancouver, British Columbia, Canada Less <<
NCT00320606 - Completed - -
NCT00515099 New-onset Type 1 Diabetes Mell... More >>itus Less << Phase 2 Terminated(Slow accrual) - United States, California ... More >> Children's Hospital/USC School of Medicine Los Angeles, California, United States, 90027 Children's Hospital and Research Center Oakland, California, United States, 92609 UCSD/San Diego Children's Hospital San Diego, California, United States, 92123 Diabetes Center at UCSF San Francisco, California, United States, 94143 United States, Colorado Barbara Davis Center for Childhood Diabetes, University of Colorado Aurora, Colorado, United States, 80010 United States, Georgia Emory Children's Center Atlanta, Georgia, United States, 30322 United States, Minnesota University of Minnesota Minneapolis, Minnesota, United States, 55455 United States, Missouri Children's Mercy Hospital Kansas City, Missouri, United States, 64108 United States, Pennsylvania University of Pennsylvania/Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00777647 Obesity Metab... More >>olic; Complications Dietary Habits Less << Not Applicable Completed - Denmark ... More >> Department of Internal Medicine/Endocrinology C, Aarhus University Hospital Aarhus, Denmark, 8000 Less <<
NCT01111318 - Completed - -
NCT03203785 Fatigue Exerc... More >>ise-induced Muscle Damage Less << Not Applicable Completed - Brazil ... More >> Gabriella B. Möller Pôrto Alegre, Rio Grande Do Sul, Brazil, 90050170 Less <<
NCT00515099 - Terminated(Slow accrual) - -
NCT01818726 Aplastic Anemia Phase 4 Completed - Russian Federation ... More >> Novartis Investigative Site Moscow, Russian Federation, 125167 Less <<
NCT01748370 Hypogonadism Phase 4 Completed - Austria ... More >> Medical University of Graz, Department of Internal Medicine, Division of Endocrinology and Metabolism Graz, Austria, 8036 Less <<
NCT02577809 Post-operative Pain Phase 4 Completed - South Africa ... More >> Rahima Moosa Mother and Child Hospital Johannesburg, Gauteng, South Africa, 2000 Less <<
NCT00446264 Type 1 Diabetes ... More >> Hypoglycemia Metabolic Diseases Less << Phase 2 Completed - France ... More >> University Hospital of Lille Lille, France, 59037 Less <<
NCT00446264 - Completed - -
NCT00749411 Pulmonary Disease, Chronic Obs... More >>tructive Less << Phase 2 Completed - United States, Alabama ... More >> GSK Investigational Site Mobile, Alabama, United States, 36608 United States, Colorado GSK Investigational Site Wheat Ridge, Colorado, United States, 80033 United States, Maine GSK Investigational Site Biddeford, Maine, United States, 04005 United States, Missouri GSK Investigational Site St. Louis, Missouri, United States, 63141 United States, New Jersey GSK Investigational Site Summit, New Jersey, United States, 07091 United States, Oregon GSK Investigational Site Medford, Oregon, United States, 97504 United States, Pennsylvania GSK Investigational Site Erie, Pennsylvania, United States, 16508 United States, South Carolina GSK Investigational Site Greenville, South Carolina, United States, 29615 GSK Investigational Site Spartanburg, South Carolina, United States, 29303 United States, Tennessee GSK Investigational Site Johnson City, Tennessee, United States, 37601 United States, Texas GSK Investigational Site San Antonio, Texas, United States, 78229 United States, Washington GSK Investigational Site Spokane, Washington, United States, 99204 Less <<
NCT01542489 - Completed - Slovakia ... More >> Novo Nordisk Investigational Site Bratislava, Slovakia, 811 05 Less <<
NCT00479882 - Completed - -
NCT03489213 Cancer Survivor ... More >> Overweight Less << Not Applicable Active, not recruiting June 1, 2019 United States, Ohio ... More >> Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43210 Less <<
NCT00687700 Pulmonary Disease, Chronic Obs... More >>tructive Less << Phase 1 Completed - United Kingdom ... More >> GSK Investigational Site Harrow, Middlesex, United Kingdom, HA1 3UJ Less <<
NCT02537353 Upper Gastrointestinal Bleedin... More >>g Less << Phase 4 Unknown August 2017 -
NCT03676465 Type 1 Diabetes Mellitus Not Applicable Recruiting September 30, 2019 United States, Virginia ... More >> University of Virginia Center for Diabetes Technology Recruiting Charlottesville, Virginia, United States, 22904 Contact: Daniel Chernavvsky, MD, CRC    434-243-1395    drc2v@virginia.edu    Sub-Investigator: Mark DeBoer, MD          Sub-Investigator: Rupa Valdez, PhD          Sub-Investigator: Corbett John, MS Less <<
NCT01517100 Healthy Phase 1 Completed - United States, Maryland ... More >> National Institute of Aging, Clinical Research Unit Baltimore, Maryland, United States, 21224 Less <<
NCT01170754 Colon Cancer Phase 4 Completed - United States, Pennsylvania ... More >> Temple University Hospital Philadelphia, Pennsylvania, United States, 19140 Less <<
NCT02806973 Diabetes Mellitus, Type 1 ... More >> Diabetes Mellitus, Type 2 Less << Phase 1 Completed - Canada, Quebec ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mount-Royal, Quebec, Canada, H3P 3P1 Less <<
NCT01720147 Fanconi Anemia Phase 1 Recruiting December 2022 United States, Ohio ... More >> Cincinnati Children's Hospital Medical Center Recruiting Cincinnati, Ohio, United States, 45229 Principal Investigator: Parinda Mehta, MD Less <<
NCT01208558 Abdominal Obesity ... More >> Cardiovascular Diseases Diabetes Type 2 Hypertension Overweight Less << Phase 2 Phase 3 Completed - Sweden ... More >> Center for Primary Health Care Research, CRC, Lund University, Sweden Lund, Skane, Sweden Less <<
NCT02582684 HIV-1 Infection Phase 2 Completed - -
NCT02582684 - Completed - -
NCT00881725 Prostate Cancer Phase 2 Terminated(Slow Accrual) - Canada, Ontario ... More >> University Health Network Toronto, Ontario, Canada, M5G2M9 Less <<
NCT02872402 Dietary Modification ... More >> Weight Loss Physical Activity Breastfeeding Less << Not Applicable Recruiting December 2021 Canada, Quebec ... More >> Institut sur la nutrition et les aliments fonctionnels Recruiting Quebec City, Quebec, Canada, G1V0A6 Contact: Julie Perron    1-418-656-2131 ext 7124    julie.perron@fsaa.ulaval.ca Less <<
NCT00908024 Colorectal Cancer ... More >> Head and Neck Cancer Neoplasm Metastasis Less << Phase 1 Phase 2 Terminated - United States, Nebraska ... More >> Nebraska Methodist Hospital Omaha, Nebraska, United States, 68114 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 United States, Wisconsin University Of Wisconsin Madison, Wisconsin, United States, 53705 Canada, British Columbia Local Institution Vancouver, British Columbia, Canada, V5Z 4E6 Canada, Ontario Local Institution Toronto, Ontario, Canada, M5G 2M9 Less <<
NCT01170754 - Completed - -
NCT03165357 Supplementation ... More >> Sport Less << Phase 3 Completed - Poland ... More >> Poznan University of Life Sciences, ul.Wojska Polskiego 31 Poznań, Wielkopolska, Poland, 60-624 Less <<
NCT02581306 Healthy Volunteers Not Applicable Active, not recruiting October 2022 United States, Michigan ... More >> University of Michigan Ann Arbor, Michigan, United States, 48109 Less <<
NCT00318656 Non-Insulin-Dependent Diabetes... More >> Mellitus Less << Phase 4 Completed - -
NCT03471104 Diabetes Mellitus, Type 1 Not Applicable Not yet recruiting December 31, 2022 Norway ... More >> Haukeland University Hospital Recruiting Bergen, Hordaland, Norway, 5021 Contact: Lars Birger Nesje, MD    95890417 ext 0047    lars.birger.nesje@helse-bergen.no    Sub-Investigator: Ingvild Hernar, MSc          Principal Investigator: Anne Haugstvedt, PhD Less <<
NCT00318656 - Completed - -
NCT03724656 Gastrointestinal Dysfunction Not Applicable Not yet recruiting November 2021 -
NCT03006159 Type 2 Diabetic Patients Phase 1 Completed - -
NCT02080377 Pregnancy Ges... More >>tational Diabetes Less << Phase 3 Completed - United Kingdom ... More >> Princess Royal Infirmary Glasgow, Lanarkshire, United Kingdom, G31 2ER Simpson Centre for Reproductive Health, Royal Infirmary Hospital, Edinburgh Edinburgh, Lothian, United Kingdom, EH16 4SA Western General Hospital Edinburgh, Lothian, United Kingdom, EH4 2XU St Johns Hospital Livingston, West Lothian, United Kingdom Queen Elizabeth Hospital Glasgow, United Kingdom Less <<
NCT02723617 Healthy Volunteers Not Applicable Active, not recruiting May 2018 United States, Maryland ... More >> USDA-ARS, Beltsville Human Nutrition Research Center Beltsville, Maryland, United States, 20705 United States, Pennsylvania Penn State University University Park, Pennsylvania, United States, 16802 Less <<
NCT01301794 Moderate Hypertriglyceridemia. Phase 4 Unknown August 2014 United States, Massachusetts ... More >> Brigham and Women's Hospital Recruiting Boston, Massachusetts, United States, 02115 Contact: Sutanuka Lahiri    617-525-6823    Sutanuka Lahiri    Contact: Jorge Plutzky    326-055-200    jplutzky@rics.bwh.harvard.edu Less <<
NCT00311311 Atherosclerosis ... More >> Kidney Failure Less << Phase 3 Terminated(See termination rea... More >>son in detailed description.) Less << - United States, New York ... More >> Pfizer Investigational Site Rochester, New York, United States, 14642 Canada, Alberta Pfizer Investigational Site Calgary, Alberta, Canada, T2N 2T9 Pfizer Investigational Site Edmonton, Alberta, Canada, T6G 2B7 Canada, Ontario Pfizer Investigational Site Hamilton, Ontario, Canada, L8N 4A6 Pfizer Investigational Site London, Ontario, Canada, N6A 5A5 Pfizer Investigational Site Toronto, Ontario, Canada, M5B 1W8 Pfizer Investigational Site Toronto, Ontario, Canada, M5C 2T2 Canada, Quebec Pfizer Investigational Site Montreal, Quebec, Canada, H1T 2M4 Less <<
NCT00364793 - Completed - -
NCT00604825 Menopausal and Female Climacte... More >>ric States Less << Phase 2 Completed - -
NCT03100058 Obesity Overw... More >>eight Less << Phase 2 Completed - -
NCT00311311 - Terminated(See termination rea... More >>son in detailed description.) Less << - -
NCT00364793 HIV Infections Phase 1 Phase 2 Completed - Argentina ... More >> Local Institution Buenos Aires, Argentina, 1425 Local Institution Capital Federal, Argentina, 1425 Colombia Local Institution Cali, Colombia Mexico Local Institution Df, Distrito Federal, Mexico, 06720 Local Institution Guadalajara, Jalisco, Mexico, 44280 Local Institution Guadalajara, Jalisco, Mexico, 44520 Local Institution Morelia, Michioacan, Mexico, 58000 Local Institution Monterrey, Nuevo Leon, Mexico, 64460 Local Institution Colima, Mexico, 28019 Local Institution Puebla, Mexico, 72000 Local Institution San Luis Potosi, Mexico, 78240 Panama Local Institution Ciudad De Panama, Panama, 0816-00383 South Africa Local Institution Bloemfontein, Free State, South Africa, 9301 Local Institution Westdene, Gauteng, South Africa, 2092 Local Institution Cape Town, Western Cape, South Africa, 7505 Thailand Local Institution Bangkok, Thailand, 10330 Local Institution Bangkok, Thailand, 10700 Less <<
NCT03359681 Colon Cancer Phase 2 Not yet recruiting December 2018 Denmark ... More >> Department of Surgery, Slagelse Hospital Not yet recruiting Slagelse, Denmark, 4200 Contact: Emilie P Colov, MD    +45 61335122    eco@regionsjaelland.dk Less <<
NCT02999152 Bone Metastasis ... More >> Malignant Hemopathy Less << Not Applicable Recruiting December 31, 2019 France ... More >> Institut de Cancérologie Lucien Neuwirth Recruiting Saint-Priest en Jarez, France, 42270 Principal Investigator: Nicolas Magné, PhD          Sub-Investigator: Guy De Laroche, MD          Sub-Investigator: Grégoire Pigne, MD          Sub-Investigator: Denis Guyotat, PhD          Sub-Investigator: Jérôme Cornillon, MD          Institut Gustave Roussy Not yet recruiting Villejuif, France, 94800 Contact: Valentine Martin, MD          Principal Investigator: Valentine Martin, MD          Sub-Investigator: Angela Boros, MD Less <<
NCT03533179 Drug Overdose ... More >> Overdose of Beta-adrenergic Blocking Drug Less << Phase 4 Recruiting December 1, 2018 Denmark ... More >> University Hospital Bispebjerg Recruiting Copenhagen, Denmark Contact: Mikkel B Christensen, MD    004538635593    mikkel.bring.christensen@regionh.dk    Contact: Kasper M Petersen, MD    004538635805    kasper.meidahl.petersen.03@regionh.dk Less <<
NCT00670748 Metastatic Melanoma ... More >> Metastatic Renal Cell Cancer Metastatic Cancer Less << Phase 2 Terminated(A more highly selec... More >>ted protocol with ESO TCR opened for pts with melanoma) Less << - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00670748 - Terminated(A more highly selec... More >>ted protocol with ESO TCR opened for pts with melanoma) Less << - -
NCT03505346 Chronic Ischemic Heart Disease Phase 2 Recruiting December 1, 2019 Denmark ... More >> Department of Physiology, Nuclear Medicine and PET Recruiting Copenhagen, Region Hovedstaden, Denmark, 2100 Less <<
NCT00604825 - Completed - -
NCT03699683 Bariatric Surgery and Physical... More >> Activity Less << Not Applicable Completed - -
NCT00851799 - Completed - -
NCT03139877 - Recruiting December 31, 2020 United States, North Carolina ... More >> Duke University Health System Recruiting Durham, North Carolina, United States, 27710 Contact: Janet Wootton, RN    919-668-4809    janet.wootton@duke.edu Less <<
NCT03031496 Hypertension Phase 1 Completed - South Africa ... More >> GSK Investigational Site Bloemfontein, South Africa, 9301 Less <<
NCT00851799 - Completed - -
NCT02214433 Bacterial Infections Phase 1 Completed - United States, Maryland ... More >> Early Phase Clinical Unit Baltimore, Maryland, United States, 21225 Less <<
NCT03665948 Nutrition Ket... More >>ogenic Dieting Low Glycemic Index Diet Sport Crossfit Less << Not Applicable Completed - Poland ... More >> Institute of Human Nutrition and Dietetics, Poznan University of Life Sciences Poznań, Poland, 60-624 Less <<
NCT02330406 Dipeptidyl-Peptidase 4 Inhibit... More >>ors LDL Cholesterol Glycosylated Hemoglobin Diabetes Mellitus Coronary Disease Less << Phase 4 Active, not recruiting December 2018 Japan ... More >> Department of Cardiovascular Medicine, Tomishiro Central Hospital Tomishiro, Okinawa, Japan, 901-0243 Less <<
NCT00409422 Pediatric Obesity ... More >> Insulin Resistance Hyperinsulinemia Less << Not Applicable Completed - United States, Connecticut ... More >> Yale University School of Medicine New Haven, Connecticut, United States, 06520 Less <<
NCT01832181 - Recruiting July 2021 Canada, Ontario ... More >> Dr. Denice Feig Recruiting Toronto, Ontario, Canada Less <<
NCT03031496 - Completed - -
NCT00543647 Healthy Volunteers Phase 1 Completed - United Kingdom ... More >> Site 1 London, United Kingdom Less <<
NCT00812565 Alzheimer's Disease Phase 2 Completed - United States, New Jersey ... More >> Octapharma USA Hoboken, New Jersey, United States Less <<
NCT03360916 Cardiovascular Diseases Phase 4 Not yet recruiting July 1, 2022 United States, Kansas ... More >> University of Kansas Medical Center Not yet recruiting Kansas City, Kansas, United States, 66160 Less <<
NCT03445884 Acute Myocardial Infarction Phase 2 Recruiting October 30, 2019 Denmark ... More >> Department of Physiology, Nuclear Medicine and PET Recruiting Copenhagen, Region Hovedstaden, Denmark, 2100 Contact: Simon Bentsen, MD    +4535451793    simon.bentsen.01@regionh.dk    Contact: Rasmus Ripa, MD    +4535454011    rasmus.ripa@regionh.dk Less <<
NCT00700765 - Completed - Indonesia ... More >> Novo Nordisk Investigational Site Jakarta, Indonesia, 12520 Less <<
NCT01478672 Diabetes Hear... More >>t Disease Quality of Life Less << Not Applicable Completed - Sweden ... More >> Luleå University of Technology Luleå, Sweden, 971 87 Less <<
NCT00812565 - Completed - -
NCT03688919 Self-regulation ... More >> Medication Adherence Less << Not Applicable Not yet recruiting October 31, 2020 -
NCT01104701 - Completed - -
NCT00015691 HIV Infections ... More >> Lipodystrophy Hyperinsulinemia Less << Not Applicable Completed - -
NCT00502996 - Completed - -
NCT00928005 Overweight Ob... More >>esity Type 2 Diabetes Prediabetes Less << Phase 4 Completed - United States, Maryland ... More >> Johns Hopkins Bayview Medical Center Baltimore, Maryland, United States, 21224 Less <<
NCT00502996 Rheumatoid Arthritis Phase 3 Completed - -
NCT01257295 Healthy Male Subjects Not Applicable Completed - Netherlands ... More >> Wageningen University Wageningen, Netherlands, 6702 Less <<
NCT01104701 Type 2 Diabetes Phase 2 Completed - United States, Arizona ... More >> Research Site Phoenix, Arizona, United States United States, Nebraska Research Site Lincoln, Nebraska, United States Less <<
NCT00550459 Hyponatremia Phase 3 Completed - United States, California ... More >> Sarah. S. Olelewe, MD Hawthorne, California, United States, 90250 Progressive Clinical Research Vista, California, United States, 92083 United States, Colorado Pikes Peak Cardiology Colorado Springs, Colorado, United States, 80907 United States, Florida Innovative Research of West FL Largo, Florida, United States, 33770 Coastal Nephrology Assoc. Research Center Punta Gorda, Florida, United States, 33950 United States, Georgia Rockdale Medical Research Associates Conyers, Georgia, United States, 30094 United States, Louisiana Otis Barnum, DO Natchitoches, Louisiana, United States, 71457 United States, North Dakota Lillestol Research, LLC Fargo, North Dakota, United States, 58106 United States, South Carolina Carolina Research Associates Columbia, South Carolina, United States, 29201 United States, Tennessee Wayne O. Wells, MD Lebanon, Tennessee, United States, 37087 United States, Texas Memorial Clinical Associates Houston, Texas, United States, 77043 United States, Virginia Mitchell Rosner, MD Charlottesville, Virginia, United States, 22908 Less <<
NCT03247192 Body Composition ... More >> Healthy Less << Not Applicable Completed - -
NCT03145350 Fat; Liver NA... More >>FLD Less << Not Applicable Recruiting December 2019 United Kingdom ... More >> Oxford Centre for Diabetes, Endocrinology and Metabolism Recruiting Oxford, United Kingdom, OX3 7LE Contact: Sion A Parry, MSc    +447976359081    sion.parry@ocdem.ox.ac.uk    Principal Investigator: Leanne Hodson, PhD          Sub-Investigator: Sion A Parry, MSc Less <<
NCT00550459 - Completed - -
NCT02464345 Binge Eating Disorder ... More >> Bulimia Nervosa Eating Disorder Less << Phase 2 Phase 3 Unknown December 2018 Brazil ... More >> Universidade Federal de Sao Paulo (UNIFESP) Recruiting Sao Paulo, SP, Brazil Contact: Angelica Claudino, MD, Ph.D    50842187 Less <<
NCT00526669 Neoplasms, Gastrointestinal Tr... More >>act Less << Phase 2 Completed - United States, California ... More >> GSK Investigational Site Loma Linda, California, United States, 92354 GSK Investigational Site Los Angeles, California, United States, 90033 United States, District of Columbia GSK Investigational Site Washington, District of Columbia, United States, 20007 United States, Louisiana GSK Investigational Site Shreveport, Louisiana, United States, 71103 United States, Michigan GSK Investigational Site Ann Arbor, Michigan, United States, 48109 GSK Investigational Site Southgate, Michigan, United States, 48195 United States, Missouri GSK Investigational Site Jefferson City, Missouri, United States, 65109 United States, Texas GSK Investigational Site Dallas, Texas, United States, 75137 Canada, Quebec GSK Investigational Site Montreal, Quebec, Canada, H3T 1E2 Korea, Republic of GSK Investigational Site Hwasun, Korea, Republic of, 519-809 GSK Investigational Site Seoul, Korea, Republic of, 110-744 GSK Investigational Site Seoul, Korea, Republic of, 120-752 GSK Investigational Site Suwon, Gyeonggi-do, Korea, Republic of, 442-723 Mexico GSK Investigational Site Mexico City, Mexico, CP 14080 Russian Federation GSK Investigational Site Astrakhan, Russian Federation, 414044 GSK Investigational Site Chelyabinsk, Russian Federation, 454087 GSK Investigational Site St. Petersburg, Russian Federation, 197022 GSK Investigational Site Ufa,, Russian Federation, 450054 Taiwan GSK Investigational Site Changhua, Taiwan, 500 GSK Investigational Site Taipei, Taiwan, 100 GSK Investigational Site Taipei, Taiwan, 104 GSK Investigational Site Taipei, Taiwan, 112 Less <<
NCT02082860 Acute Intermittent Porphyria Phase 1 Completed - Spain ... More >> Clinica Universidad de Navarra Pamplona, Navarra, Spain, 31008 12 Octubre Hospital Madrid, Spain, 28041 Less <<
NCT02140918 Healthy Volunteers Phase 2 Completed - France ... More >> Rennes University Hospital Rennes, France, 35033 Less <<
NCT02973295 Non-Alcoholic Fatty Liver Dise... More >>ase Less << Phase 4 Not yet recruiting June 30, 2019 Croatia ... More >> Clinical Hospital Centre Rijeka, Kresimirova 42, Croatia, 51000 Less <<
NCT01445782 Healthy Phase 1 Completed - United Kingdom ... More >> Research Site London, UK, United Kingdom Less <<
NCT01788033 Diabetes Mellitus Type 1 Phase 2 Completed - Switzerland ... More >> University Hospital Basel Basel, Switzerland, 4031 Less <<
NCT02035150 Obesity Not Applicable Completed - -
NCT00516178 Coronary Artery Disease Phase 3 Completed - Switzerland ... More >> CHUV Lausanne, VD, Switzerland, 1011 Service of Adult Intensive Care - CHUV Lausanne, VD, Switzerland, 1011 Less <<
NCT00526669 - Completed - -
NCT01361022 Healthy Phase 1 Completed - Taiwan ... More >> 263.511.1 Boehringer Ingelheim Investigational Site Taipei, Taiwan Less <<
NCT00926263 Healthy Volunteers Phase 1 Terminated(See termination rea... More >>son in detailed description.) Less << - United States, Connecticut ... More >> Pfizer Investigational Site New Haven, Connecticut, United States, 06511-5473 Less <<
NCT01550432 Obesity Hyper... More >>lipidemia Insulin Resistance Hypertension Less << Not Applicable Completed - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT00926263 - Terminated(See termination rea... More >>son in detailed description.) Less << - -
NCT02482558 Healthy Not Applicable Completed - United Kingdom ... More >> Sir Peter Mansfield Magnetic Resonance Centre, University of Nottingham Nottingham, Nottinghamshire, United Kingdom, NG7 2QX Less <<
NCT01775020 Sepsis Septic... More >> Shock Less << Early Phase 1 Completed - -
NCT01118845 Non-Hodgkin's Lymphoma ... More >> Lymphoma, Large Cell Diffuse, Mantle Cell Lymphoma, Lymphoma Follicular Lymphoma Large B-Cell, Diffuse Less << Phase 2 Completed - Japan ... More >> Nagoya, Aichi, Japan Matsuyama, Ehime, Japan Kurume, Fukuoka, Japan Maebashi, Gunma, Japan Sapporo, Hokkaido, Japan Kanazawa, Ishikawa, Japan Isehara, Kanagawa, Japan Ninomaru, Kumamoto, Japan Sendai, Miyagi, Japan Kita-ku, Okayama, Japan Kurashiki, Okayama, Japan Hidaka, Saitama, Japan Izumo, Shimane, Japan Chuo-ku, Tokyo, Japan Akita, Japan Fukuoka, Japan Kagoshima, Japan Kyoto, Japan Korea, Republic of Seo-gu, Busan, Korea, Republic of Jung-gu, Daegu, Korea, Republic of Goyang-si, Gyeonggi-do, Korea, Republic of Hwasun-gun, Jeonnam, Korea, Republic of Gangnam-gu, Seoul, Korea, Republic of Seodaemun-gu, Seoul, Korea, Republic of Songpa-gu, Seoul, Korea, Republic of Less <<
NCT00898534 Type 1 Diabetes Mellitus ... More >> Glycemic Control Less << Phase 4 Completed - United States, Massachusetts ... More >> Children's Hospital Boston Boston, Massachusetts, United States, 02115 Less <<
NCT01261390 - Completed - -
NCT01118845 - Completed - -
NCT01630499 Breast Cancer Not Applicable Completed - United States, Florida ... More >> University of Florida Gainesville, Florida, United States, 32611 University of North Florida Jacksonville, Florida, United States, 32224 Less <<
NCT00608062 Arterial Stiffening ... More >> Aging Menopause Less << Not Applicable Active, not recruiting December 2018 United States, Colorado ... More >> University of Colorado Anschutz Medical Center, Clinical Translational Research Center and Exercise Research Laboratory Aurora, Colorado, United States, 80045 Less <<
NCT03315507 Pulmonary Arterial Hypertensio... More >>n Less << Phase 1 Active, not recruiting November 2018 United States, Ohio ... More >> The Ohio State University Wexner Medical Center Columbus, Ohio, United States, 43210 United States, Pennsylvania Allegheny General Hospital Pittsburgh, Pennsylvania, United States, 15212 Less <<
NCT01087944 Hepatitis C, Chronic Phase 1 Completed - United States, California ... More >> Los Angeles, California, United States, 90045 United States, Florida Bradenton, Florida, United States, 34209 Orlando, Florida, United States, 32803 United States, Georgia Marietta, Georgia, United States, 30060 United States, Massachusetts Framingham, Massachusetts, United States, 01702 United States, New Jersey Newark, New Jersey, United States, 07102 Vineland, New Jersey, United States, 08360 United States, New York New York, New York, United States, 10016 Poughkeepsie, New York, United States, 12601 United States, North Carolina Asheville, North Carolina, United States, 28801 United States, South Carolina Columbia, South Carolina, United States, 29204 United States, Texas San Antonio, Texas, United States, 78215 Less <<
NCT01261390 Obstructive Sleep Apnea Not Applicable Completed - United States, Massachusetts ... More >> Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Less <<
NCT02733679 Ataxia-Telangiectasia Phase 4 Completed - United Kingdom ... More >> Ninewells Hospital Dundee, Angus, United Kingdom, DD19SY Less <<
NCT01087944 - Completed - -
NCT01096706 Vascular Disease ... More >> Heart Disease Less << Not Applicable Completed - United Kingdom ... More >> Wellcome Trust Clinical Research Facility, Royal Infirmary of Edinburgh Edinburgh, Mid Lothian, United Kingdom, EH16 4SA Less <<
NCT01356758 - Completed - Denmark ... More >> Dep. of Dermatology Aarhus C, Denmark, 8000 Less <<
NCT00885456 Transient Ischemic Attack ... More >> Non-disabling Stroke Less << Phase 2 Completed - Canada, Nova Scotia ... More >> Halifax Infirmary Site, QEII Health Sciences Centre Halifax, Nova Scotia, Canada, B3H 3A7 Annapolis Valley Regional Hospital Kentville, Nova Scotia, Canada, B4N 5E3 Less <<
NCT03766802 Diabetes Mellitus, Type 2 Not Applicable Active, not recruiting May 5, 2019 Turkey ... More >> Faculty of Health Sciences Istanbul, Maltepe, Turkey, 1464185881 Less <<
NCT03355729 - Completed - -
NCT02112643 Thyroid Associated Ophthalmopa... More >>thies Less << Not Applicable Unknown July 2015 United States, Massachusetts ... More >> Massachusetts Eye and Ear Infirmary Not yet recruiting Boston, Massachusetts, United States, 02114 Contact: Suzanne Freitag, MD    617-842-0633    suzanne_freitag@meei.harvard.edu    Contact: Daniel Lefebvre, MD    617-571-5138    daniel_lefebvre@meei.harvard.edu    Sub-Investigator: Michael Yoon, MD          Principal Investigator: Suzanne Freitag, MD          Sub-Investigator: Daniel Lefebvre, MD          Sub-Investigator: Grace Lee, MD          Sub-Investigator: Francis Sutula, MD          Sub-Investigator: Lora R Dagi Glass, MD          United States, New York Edward S. Harkness Eye Institute, Columbia University Medical Center, New York-Presbyterian Hospital Recruiting New York, New York, United States, 10032 Contact: Michael Kazim, MD    212-305-5477    mk48@columbia.edu    Contact: Kelly Davis, BS    212-342-1095    kd2497@cumc.columbia.edu    Principal Investigator: Michael Kazim, MD          Sub-Investigator: Golnaz Moazami, MD          Sub-Investigator: Bryan Winn, MD          Sub-Investigator: Carisa Petris, MD          Sub-Investigator: Payal Patel, MD          United States, Ohio Ohio State University Not yet recruiting Columbus, Ohio, United States, 43215 Contact: Kenneth V. Cahill, M.D.    614-221-7464    kcahill@columbus.rr.com    Contact: Jill A. Foster, M.D.    614-221-7464    fosterj@jillfoster.com    Principal Investigator: Kenneth V. Cahill, M.D.          Sub-Investigator: Jill A. Foster, M.D.          Sub-Investigator: Cameron B. Nabavi, M.D.          Sub-Investigator: Craig N. Czyz, MD          Sub-Investigator: Daniel Straka, MD Less <<
NCT03384290 Healthy Subjects Phase 1 Active, not recruiting November 2018 Australia, Victoria ... More >> Nucleus Network Limited Melbourne, Victoria, Australia, 3004 Less <<
NCT01269632 HIV Infection ... More >> Young Adult Less << Not Applicable Active, not recruiting December 2019 France ... More >> Hôpitaux (voir liste jointe) De France, France Less <<
NCT03194022 - Not yet recruiting October 17, 2018 -
NCT02086448 Obese Pregnan... More >>cy Sleep Disordered Breathing Less << Not Applicable Recruiting May 2020 United States, Pennsylvania ... More >> Magee-Womens Hospital of the UPMC Recruiting Pittsburgh, Pennsylvania, United States, 15213 Less <<
NCT01908972 Hemangioma Phase 4 Completed - Korea, Republic of ... More >> Seould National University Hospital Seoul, Korea, Republic of, 110-744 Less <<
NCT01908972 - Completed - -
NCT01774994 Healthy Not Applicable Completed - -
NCT03574805 Asthma Phase 1 Recruiting October 20, 2019 Australia, South Australia ... More >> CMAX Recruiting Adelaide, South Australia, Australia, 500 Contact: Kate Richardson    61 8 7088 7900    Kathryn.Richardson@cmax.com.au    Principal Investigator: Thomas Polasek, MD          Australia, Victoria Nucleus Network Limited Recruiting Melbourne, Victoria, Australia, 3004 Contact: Jessica Faggian    61 3 9076 8900    j.faggian@nucleusnetwork.com.au    Principal Investigator: Oscar Walsh, MD          Australia Linear Recruiting Perth, Australia Contact: Nicola Norton, RN    61 0 414 416 034    nnorton@linear.org.au    Contact: Simon Scott, BSc, MPharmMed    61 0 432 149 680    sscott@linear.org.au    Principal Investigator: Lara Hatchuel, MD Less <<
NCT01079962 Hypertension Phase 4 Completed - Korea, Republic of ... More >> Severance Hosptial, 250, Seongsanno, Seodaemungu Seoul, Korea, Republic of Less <<
NCT01079962 - Completed - -
NCT02902380 Spinal Stenosis Not Applicable Completed - Korea, Republic of ... More >> Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine Seoul, Korea, Republic of, 03722 Less <<
NCT03356639 Schizophrenia Phase 1 Completed - United States, California ... More >> Cctmg/Parexel Glendale, California, United States, 91206 United States, Texas Community Clinical Research Austin, Texas, United States, 78754 Less <<
NCT03467594 High-intensity Interval Traini... More >>ng Less << Not Applicable Active, not recruiting October 31, 2018 United Kingdom ... More >> Teesside University Middlesbrough, United Kingdom Less <<
NCT03655522 Safety Phase 1 Completed - -
NCT03450187 Bacterial Infections Phase 1 Recruiting January 2019 United States, Texas ... More >> PPD Phase I Clinic Recruiting Austin, Texas, United States, 78744 Contact: Dane Eckols    512-747-4729    dane.eckols@ppdi.com    Contact: Emma Pinnick    1223775243    emma.pinnick@ppdi.com Less <<
NCT00005111 - Completed - United States, Maryland ... More >> National Institute of Neurological Disorders and Stroke (NINDS) Bethesda, Maryland, United States, 20892 Less <<
NCT03557931 Schizophrenia Phase 2 Recruiting December 2019 United States, Arkansas ... More >> Woodland Research Northwest, LLC Recruiting Rogers, Arkansas, United States, 72758 United States, California CNS Research Science, Inc. Recruiting Cerritos, California, United States, 90703 Collaborative Neuroscience Network, LLC Recruiting Garden Grove, California, United States, 92845 Synergy East Recruiting Lemon Grove, California, United States, 91945 Pacific Research Partners, LLC Recruiting Oakland, California, United States, 94607 California Neuropsychopharmacology Clinical Research Institute-LA, LLC Recruiting Pico Rivera, California, United States, 90660 Artemis Institute for Clinical Research Recruiting San Diego, California, United States, 92103 Sharp Mesa Vista Hospital Recruiting San Diego, California, United States, 92123 Collaborative Neuroscience Network, LLC Recruiting Torrance, California, United States, 90502 United States, Georgia Radiant Research, Inc. Recruiting Atlanta, Georgia, United States, 30328 Atlanta Center for Medical Research Recruiting Atlanta, Georgia, United States, 30331 United States, Illinois Alam Medical Research Inc. Recruiting Chicago, Illinois, United States, 60612 Uptown Research Institute Recruiting Chicago, Illinois, United States, 60640 United States, Michigan Michigan Clinical Research Institute PC Recruiting Ann Arbor, Michigan, United States, 48105 Cherry Street Services, Inc. Recruiting Grand Rapids, Michigan, United States, 49503 United States, New Jersey Hassman Research Institute Recruiting Berlin, New Jersey, United States, 08009 United States, New Mexico Albuquerque Neuroscience Inc. Recruiting Albuquerque, New Mexico, United States, 87109 United States, New York SPRI Clinical Trials, LLC Recruiting Brooklyn, New York, United States, 11235 CNS Research Science, Inc. Recruiting Jamaica, New York, United States, 11432 Manhattan Psychiatric Center's 125th Street Clinic Recruiting New York, New York, United States, 10035 United States, Ohio Midwest Clinical Research Center Recruiting Dayton, Ohio, United States, 45417 United States, Texas InSite Clinical Research, LLC Recruiting DeSoto, Texas, United States, 75115 Pillar Clinical Research, LLC Recruiting Garland, Texas, United States, 75042 Pillar Clinical Research, LLC Recruiting Richardson, Texas, United States, 75080 Less <<
NCT01560260 Carney Complex ... More >> Chondrosarcoma Gastrointestinal Stromal Tumor Paraganglioma Less << Phase 2 Completed - United States, California ... More >> Stanford Cancer Institute Palo Alto, California, United States, 94304 United States, Iowa University of Iowa/Holden Comprehensive Cancer Center Iowa City, Iowa, United States, 52242 United States, Maryland National Institutes of Health Clinical Center Bethesda, Maryland, United States, 20892 United States, Massachusetts Dana-Farber/Harvard Cancer Center Boston, Massachusetts, United States, 02115 United States, Michigan Sarcoma Alliance for Research Through Collaboration Ann Arbor, Michigan, United States, 48106 University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States, 48109 United States, Oregon Oregon Health and Science University Portland, Oregon, United States, 97239 United States, Pennsylvania Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 Less <<
NCT03579823 Healthy Volunteers Phase 1 Active, not recruiting August 15, 2018 Australia, Victoria ... More >> Nucleus Network Melbourne, Victoria, Australia, 3004 Less <<
NCT00812929 Asthma Phase 2 Completed - United States, Colorado ... More >> GSK Investigational Site Denver, Colorado, United States, 80230 United States, Massachusetts GSK Investigational Site North Dartmouth, Massachusetts, United States, 02747 United States, Oklahoma GSK Investigational Site Oklahoma City, Oklahoma, United States, 73120 United States, Pennsylvania GSK Investigational Site Pittsburgh, Pennsylvania, United States, 15213 United States, South Carolina GSK Investigational Site Orangeburg, South Carolina, United States, 29118 United States, Texas GSK Investigational Site El Paso, Texas, United States, 79925 Less <<
NCT01560260 - Completed - -
NCT01193660 Cerebral Palsy Not Applicable Completed - Korea, Republic of ... More >> CHA Bundang Medical Center Seongnam-si, Gyeonggi-do, Korea, Republic of Less <<
NCT01424514 Rhinitis Phase 2 Completed - Canada, Ontario ... More >> GSK Investigational Site Mississauga, Ontario, Canada, L4W 1N2 Less <<
NCT03055494 Plaque Psoriasis Phase 4 Recruiting April 5, 2019 United States, Arkansas ... More >> Novartis Investigative Site Recruiting Hot Springs, Arkansas, United States, 71913 United States, California Novartis Investigative Site Recruiting Los Angeles, California, United States, 90033 Novartis Investigative Site Recruiting Santa Ana, California, United States, 92701 United States, Georgia Novartis Investigative Site Recruiting Atlanta, Georgia, United States, 30342 United States, Indiana Novartis Investigative Site Recruiting Indianapolis, Indiana, United States, 46256 United States, New Jersey Novartis Investigative Site Recruiting East Windsor, New Jersey, United States, 08520 Novartis Investigative Site Recruiting West Orange, New Jersey, United States, 07052 United States, New York Novartis Investigative Site Recruiting Buffalo, New York, United States, 14203 Novartis Investigative Site Active, not recruiting New York, New York, United States, 10025 1737 Novartis Investigative Site Recruiting New York, New York, United States, 10065 United States, Oregon Novartis Investigative Site Recruiting Portland, Oregon, United States, 97223 United States, Pennsylvania Novartis Investigative Site Recruiting Pittsburgh, Pennsylvania, United States, 15213-3403 United States, Texas Novartis Investigative Site Recruiting Webster, Texas, United States, 77004 United States, Utah Novartis Investigative Site Recruiting Murray, Utah, United States, 84107 United States, Virginia Novartis Investigative Site Recruiting Norfolk, Virginia, United States, 23507 United States, Wisconsin Novartis Investigative Site Completed Milwaukee, Wisconsin, United States, 53226 Less <<
NCT00812929 - Completed - -
NCT02664844 Obesity Not Applicable Completed - France ... More >> CHU Clermont-Ferrand Clermont-Ferrand, France, 63003 Less <<
NCT03628079 Cancer of the Gastrointestinal... More >> Tract Cancer of Unknown Origin Less << Phase 1 Phase 2 Recruiting June 2020 Sweden ... More >> Dept of oncology, University Hospital Recruiting Uppsala, Sweden, 75185 Less <<
NCT01424514 - Completed - -
NCT01747330 Pancreatic Exocrine Insufficie... More >>ncy Less << Phase 3 Completed - Russian Federation ... More >> Site Reference ID/Investigator# 80716 Barnaul, Russian Federation, 656019 Site Reference ID/Investigator# 80693 Moscow, Russian Federation, 117997 Site Reference ID/Investigator# 80698 Novosibirsk, Russian Federation, 630091 Site Reference ID/Investigator# 80713 Novosibirsk, Russian Federation Site Reference ID/Investigator# 80715 Orenburg, Russian Federation, 460000 Site Reference ID/Investigator# 80694 St. Petersburg, Russian Federation, 194156 Site Reference ID/Investigator# 80714 Tomsk, Russian Federation, 634050 Site Reference ID/Investigator# 80697 Voronezh, Russian Federation, 394036 Site Reference ID/Investigator# 80696 Yaroslavl, Russian Federation, 150003 Less <<
NCT02829268 Wolfram Syndrome ... More >> Diabetes Mellitus Optic Nerve Atrophy Ataxia Less << Phase 1 Phase 2 Recruiting March 2021 United States, Missouri ... More >> Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: Ashley Simpson, RN, BSN, CPN    314-286-1550    ashley.simpson@wustl.edu    Contact: Fumihiko Urano, MD    314-362-8683    urano@wustl.edu    Principal Investigator: Fumihiko Urano, MD Less <<
NCT02612051 Idiopathic Pulmonary Fibrosis Phase 1 Completed - United Kingdom ... More >> GSK Investigational Site London, United Kingdom, SE1 1YR Less <<
NCT01193660 - Completed - -
NCT01747330 - Completed - -
NCT01586364 Atrophy Vagin... More >>al Diseases Less << Phase 3 Completed - -
NCT00610311 - Terminated(The study was termi... More >>nated due to low accrual.) Less << - -
NCT01586364 - Completed - -
NCT03430115 - Recruiting December 31, 2021 United States, North Carolina ... More >> Wake Forest Baptist Medical Center Recruiting Winston-Salem, North Carolina, United States, 27157 Contact: Denise Houston, Ph.D.    336-713-8217    dhouston@wakehealth.edu    Contact: Kimberly Kennedy    336-713-8567    kkennedy@wakehealth.edu Less <<
NCT03721497 Bariatric Surgery Candidate ... More >> Male Hypogonadism Muscle Loss Less << Phase 4 Not yet recruiting February 2021 -
NCT00610311 Metastatic Melanoma ... More >> Skin Cancer Less << Phase 2 Terminated(The study was termi... More >>nated due to low accrual.) Less << - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT02316717 Non-alcoholic Steatohepatitis ... More >>(NASH) Less << Phase 2 Completed - -
NCT01745549 Type 1 Diabetes ... More >> Type 2 Diabetes Less << Not Applicable Completed - Italy ... More >> UO Malattie Metaboliche e Diabetologia - Ospedale di Treviglio-Caravaggio Treviglio, BG, Italy, 24047 UO Diabetologia per Trattamento e Educazione dei Diabetici - Spedali Civili di Brescia Brescia, BS, Italy, 25123 U.O.S. Diabetologia e Malattie Metaboliche - PO Cantù - Mariano Comense Mariano Comense, CO, Italy, 22066 Struttura Complessa Dietologia-Diabetologia Malattie Metaboliche - Ospedale Pertini Roma, RM, Italy, 00157 Less <<
NCT00728195 Schizophrenia Phase 2 Completed - -
NCT03734367 Type1 Diabetes Mellitus Not Applicable Recruiting December 2021 Spain ... More >> Hospital Universitario Virgen Macarena Recruiting Sevilla, Spain, 41009 Contact: María Asunción Martínez Brocca, Physician Less <<
NCT02742662 Obesity Overw... More >>eight Prediabetes Weight Loss Lifestyle Less << Not Applicable Completed - United States, Pennsylvania ... More >> Temple University Philadelphia, Pennsylvania, United States, 19140 Less <<
NCT02459314 Hypercholesterolemia Not Applicable Completed - Thailand ... More >> Clinical trial Unit, Faculty of Medicine, Chiang Mai University Muang, ChiangMai, Thailand, 50200 Less <<
NCT01934036 Obesity Overw... More >>eight Less << Phase 2 Phase 3 Completed - Spain ... More >> Universidad Autónoma de Madrid Ciudad Universitaria de Cantoblanco, Madrid, Spain, 28049 Less <<
NCT01981681 Healthy Phase 1 Completed - Belgium ... More >> Pfizer Investigational Site Brussels, Belgium, B-1070 Less <<
NCT01271218 Knee Osteoarthritis Phase 4 Completed - United States, Texas ... More >> Exercise & Sport Nutrition Lab College Station, Texas, United States, 78843 Less <<
NCT02947555 - Recruiting December 2018 Hungary ... More >> 2nd Department of Medicine and Nephrological Center Recruiting Pécs, Baranya, Hungary, 7624 Contact: Gergo A Molnar, MD, PhD    +3672536050    gergo.molnar@aok.pte.hu    Contact: Eszter Sélley, MD    +3672536050    eszter.selley@aok.pte.hu Less <<
NCT03107442 Systemic Lupus Erythematosus Not Applicable Completed - Spain ... More >> Virgen de las Nieves University Hospital Granada, Spain, 18014 Less <<
NCT02634073 Infection, Human Immunodeficie... More >>ncy Virus Less << Phase 4 Completed - United States, Kansas ... More >> GSK Investigational Site Overland Park, Kansas, United States, 66211 Less <<
NCT02960542 Obesity Cance... More >>r Less << Not Applicable Completed - United States, Virginia ... More >> Danville Regional Medical Center Danville, Virginia, United States, 24541 Less <<
NCT02333461 Overweight Ob... More >>esity Less << Not Applicable Completed - -
NCT00448916 Epilepsies, Partial Phase 3 Completed - United States, Alabama ... More >> University of South Alabama Mobile, Alabama, United States, 36604 University of South Alabama Department of Neurology Mobile, Alabama, United States, 36693 United States, Arizona Phoenix Children's Hospital Phoenix, Arizona, United States, 85016 United States, Arkansas The Children's Clinica of Jonesboro, P.A Jonesboro, Arkansas, United States, 72401 Clinical Study Centers, L. L. C. Little Rock, Arkansas, United States, 72205 United States, California UCSF Neurology Clinic San Francisco, California, United States, 94143 United States, Florida Child Neurology Center of Northwest Florida Gulf Breeze, Florida, United States, 32561 The Office of Sergio J Jacinto, MD Tampa, Florida, United States, 33603 Pediatric Epilepsy & Neurology Specialists Tampa, Florida, United States, 33609 United States, Missouri St. John's Clinic Springfield, Missouri, United States, 65804 St. John's Hospital Springfield, Missouri, United States, 65804 United States, New York Women and Children's Hospital of Buffalo Buffalo, New York, United States, 14222 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 United States, Texas Baylor College of Medicine - Texas Children's Hospital Houston, Texas, United States, 77030 Texas Children's Hospital Houston, Texas, United States, 77030 Road Runner Research, Ltd. San Antonio, Texas, United States, 78258 Korea, Republic of Yonsei University College of Medicine Severance Hospital / Department of Pediatric Neurology Seoul, Korea, Republic of, 120-752 Mexico Antiguo Hospital Civil de Guadalajara Fray Antonio Alcalde Guadalajara, Jalisco, Mexico, 44280 Less <<
NCT03059121 - Recruiting August 2022 United States, Ohio ... More >> University Hospitals Case Medical Center Recruiting Cleveland, Ohio, United States, 44106 Contact: Danielle Labbato, BSN    216-844-2739    danielle.labbato@uhhospitals.org Less <<
NCT02634073 - Completed - -
NCT02043405 Diabetes Pre-... More >>diabetes Less << Not Applicable Enrolling by invitation December 2018 United States, Colorado ... More >> University of Colorado Aurora, Colorado, United States, 80045 Less <<
NCT03201601 Polycystic Ovarian Syndrome ... More >> Infertility Less << Phase 2 Phase 3 Unknown October 31, 2017 -
NCT02933840 Fractures, Bone ... More >> Cardiovascular Abnormalities Respiratory System Abnormalities Hemorrhage Less << Not Applicable Unknown March 2018 -
NCT01788358 Hypertension Phase 3 Completed - -
NCT01343589 Coronary Heart Disease ... More >> Type-2 Diabetes Less << Not Applicable Completed - Denmark ... More >> Department of Human Nutrition Frederiksberg, Denmark, 1958 Less <<
NCT02730767 Late-effects of Childhood Canc... More >>er Less << Not Applicable Enrolling by invitation March 2019 Switzerland ... More >> University Children's Hospital Basel (UKBB) Basel, Switzerland, 4056 Less <<
NCT00448916 - Completed - -
NCT01788358 - Completed - -
NCT01025115 Metabolic Syndrome Phase 3 Completed - Cuba ... More >> National Institute of Endocrinology Havana City, Havana, Cuba, 10400 Less <<
NCT00658359 Kidney Transplantation Phase 2 Completed - -
NCT03550339 Obesity Appet... More >>itive Behavior Less << Not Applicable Unknown December 2018 -
NCT03615859 - Recruiting April 2, 2021 United Kingdom ... More >> Imperial College Healthcare NHS Trust Recruiting London, United Kingdom, W12 8RF Contact: Sirazum Choudhury, MBBS BSc    07555717544    steroids@imperial.ac.uk Less <<
NCT00215111 Childhood Obesity Not Applicable Completed - United States, Ohio ... More >> Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229 Less <<
NCT01426399 Healthy Phase 1 Completed - Korea, Republic of ... More >> Seoul National University Hospital Seoul, Korea, Republic of Less <<
NCT02377427 Asthma Phase 2 Completed - United States, California ... More >> GSK Investigational Site San Diego, California, United States, 92123 United States, North Carolina GSK Investigational Site Chapel Hill, North Carolina, United States, 27599-7310 United States, Oklahoma GSK Investigational Site Oklahoma City, Oklahoma, United States, 73112 United States, Oregon GSK Investigational Site Medford, Oregon, United States, 97504 United States, Wisconsin GSK Investigational Site Madison, Wisconsin, United States, 53792-9988 Japan GSK Investigational Site Fukuoka, Japan, 811-1394 GSK Investigational Site Hiroshima, Japan, 720-8520 GSK Investigational Site Hiroshima, Japan, 721-8511 GSK Investigational Site Wakayama, Japan, 646-8558 Poland GSK Investigational Site Lodz, Poland, 90-329 GSK Investigational Site Tarnow, Poland, 33-100 GSK Investigational Site Wroclaw, Poland, 53-201 United Kingdom GSK Investigational Site Glasgow, United Kingdom, G514TF GSK Investigational Site Leicester, United Kingdom, LE27LX GSK Investigational Site Liverpool, United Kingdom, L12 2AP GSK Investigational Site London, United Kingdom, SE5 9RS GSK Investigational Site London, United Kingdom, SW3 6NP GSK Investigational Site Oxford, United Kingdom, OX3 9DU GSK Investigational Site Sheffield, United Kingdom, S10 2TH Less <<
NCT00787137 Arthritis, Psoriatic Phase 1 Terminated(poor recruitment) - Serbia ... More >> Professor Nemanja Damjanov Belgrade, Serbia Less <<
NCT00658359 - Completed - -
NCT01524874 Hypovitaminosis D ... More >> Insulin Resistance Diabetes Less << Not Applicable Completed - United States, Hawaii ... More >> Lokahi Health Center Kailua Kona, Hawaii, United States, 96740 United States, Washington Bastyr University Kenmore, Washington, United States, 98028 Less <<
NCT02293486 Oxidative Stress Early Phase 1 Completed - -
NCT00787137 - Terminated(poor recruitment) - -
NCT03009695 Obesity Food ... More >>Craving Appetite and General Nutritional Disorders Less << Not Applicable Recruiting December 2018 Italy ... More >> San Donato Hospital Recruiting San Donato Milanese, MI, Italy, 20097 Contact: Anna Ferrulli, MD       anna.ferrulli@grupposandonato.it Less <<
NCT01466062 Respiratory Syncytial Virus In... More >>fection Less << Phase 3 Completed - Japan ... More >> Site Reference ID/Investigator# 56847 Hyogo, Japan Site Reference ID/Investigator# 56845 Shimotsuke, Japan Site Reference ID/Investigator# 56842 Tokyo, Japan Site Reference ID/Investigator# 56844 Tokyo, Japan Site Reference ID/Investigator# 56846 Tokyo, Japan Site Reference ID/Investigator# 56843 Yokohama, Japan Less <<
NCT02377427 - Completed - -
NCT03186508 Obesity Sleep Not Applicable Recruiting June 30, 2022 United States, Pennsylvania ... More >> Temple University Recruiting Philadelphia, Pennsylvania, United States, 19122-6091 Contact: Ashley Greer, MPH    215-707-5782    ashley.greer@temple.edu    Contact: Chantelle Hart    2157078998    chantelle.hart@temple.edu Less <<
NCT03651934 Pregnant Women Not Applicable Not yet recruiting June 1, 2020 -
NCT01147107 Hepatitis C, Chronic ... More >> HIV Infection Less << Phase 4 Active, not recruiting June 2017 Vietnam ... More >> Viet Tiep General Hospital Hai Phong, Vietnam Hospital for Tropical Diseases Ho Chi Minh City, Vietnam Less <<
NCT01350531 Obesity Not Applicable Unknown June 2014 United States, Michigan ... More >> Wayne State University Recruiting Detroit, Michigan, United States, 48201 Contact: Shetoya Rice    313-557-6556    srice1@med.wayne.edu Less <<
NCT01351441 Medication Adherence ... More >> Health Literacy Geriatric Patient Care Improvement Pharmacy Economic Improvement Less << Not Applicable Unknown November 2012 United States, New York ... More >> VascuScript Pharmacy Recruiting Cheektowaga, New York, United States, 14225 Contact: Scott V Monte, Pharm.D    716-713-0368    svmonte@buffalo.edu    Contact: Patrick T Comerford, Pharm.D    716-984-0457    pcomerford@vascuscript.com    Principal Investigator: Scott V Monte, Pharm.D          Sub-Investigator: Patrick T Comerford, Pharm.D          Sub-Investigator: Yen Nien Hou, BA          Sub-Investigator: Dean Trzewieczynski, BS          Sub-Investigator: Kenneth Andrus, BS          Sub-Investigator: Nicole Paolini-Albanese, Pharm.D Less <<
NCT03700034 Gestational Diabetes ... More >> PIH Pregnancy Induced Hypertension Less << Not Applicable Not yet recruiting January 2022 India ... More >> Primary Health Centres Not yet recruiting Ranga Reddy, Telangana, India Contact: Kalpana Basany, MD    9849569712    kalpanabasany@gmail.com    Primary Health Centres Not yet recruiting Sanga Reddy, Telangana, India Contact: Kalpana Basany, MS    9849569712    kalpanabasany@gmail.com    Nepal Primary Health Centres Not yet recruiting Dhulikhel, Nepal Contact: Biraj Karmacharya    977011415100    birajmk@gmail.com Less <<
NCT02151825 Gut Microbiota ... More >> Adiposity Less << Not Applicable Completed - United States, Texas ... More >> Texas State University San Marcos, Texas, United States, 78666 Less <<
NCT00912132 - Completed - United States, Alabama ... More >> University of Alabama Birmingham, Alabama, United States United States, California Fountain Valley Regional Hospital Fountain Valley, California, United States, 92708 University of California-Long Beach Long Beach, California, United States, 90806 University of California, Irvine Medical Center Orange, California, United States, 92668 United States, Delaware Christiana Care Health Services Newark, Delaware, United States United States, Illinois Northwestern University Chicago, Illinois, United States, 60611 United States, New Jersey Saint Peters University Hospital New Brunswick, New Jersey, United States, 08901 United States, New York New York Presbyterian Healthcare System Flushing, New York, United States, 11355 Columbia University New York, New York, United States, 10032-3784 United States, Rhode Island Women and Infants Providence, Rhode Island, United States, 02905 United States, South Carolina Medical University of South Carolina Charleston, South Carolina, United States Less <<
NCT01466062 - Completed - -
NCT01721317 Seizures Phase 4 Terminated(After reevaluation ... More >>of the benefit risk profile of ezogabine/retigabine, GSK does not believe the early adjunctive treatment study population is appropriate.) Less << - United States, California ... More >> GSK Investigational Site Fresno, California, United States, 93710 GSK Investigational Site Newport Beach, California, United States, 92658 GSK Investigational Site Newport Beach, California, United States, 92663 GSK Investigational Site Santa Monica, California, United States, 90404 United States, Colorado GSK Investigational Site Colorado Springs, Colorado, United States, 80907 United States, Florida GSK Investigational Site Pensacola, Florida, United States, 32514 GSK Investigational Site Port Charlotte, Florida, United States, 33952 United States, Illinois GSK Investigational Site Peoria, Illinois, United States, 61637 United States, Maryland GSK Investigational Site Bethesda, Maryland, United States, 20817 United States, Minnesota GSK Investigational Site Golden Valley, Minnesota, United States, 55422 United States, New Jersey GSK Investigational Site Hackensack, New Jersey, United States, 07601 GSK Investigational Site Livingston, New Jersey, United States, 07039 United States, Oregon GSK Investigational Site Medford, Oregon, United States, 97504 United States, Texas GSK Investigational Site Arlington, Texas, United States, 76017 GSK Investigational Site Dallas, Texas, United States, 75251 GSK Investigational Site Kingwood, Texas, United States, 77339 GSK Investigational Site San Antonio, Texas, United States, 78229 GSK Investigational Site Temple, Texas, United States, 76508 United States, Washington GSK Investigational Site Spokane, Washington, United States, 99204 Greece GSK Investigational Site Athens, Greece, 10676 GSK Investigational Site Thessaloniki, Greece, 57010 Less <<
NCT03759951 High-Intensity Interval Traini... More >>ng Body Composition Performance Habitual Physical Activity Less << Not Applicable Not yet recruiting November 1, 2020 -
NCT01793324 - Completed - -
NCT01018823 Healthy Volunteer Phase 1 Completed - -
NCT00708396 OCD Schizophr... More >>enia Less << Phase 4 Unknown July 2010 Israel ... More >> Beer-Yaacov MHC Recruiting Beer-Yaacov, Israel, 70350 Contact: Rafael O Stryjer, MD    972-8-9258396    research@beerness.health.gov.il Less <<
NCT02827630 Hypertension ... More >>Diabetes Mellitus, Type 2 Hypercholesterolemia Less << Not Applicable Completed - -
NCT01721317 - Terminated(After reevaluation ... More >>of the benefit risk profile of ezogabine/retigabine, GSK does not believe the early adjunctive treatment study population is appropriate.) Less << - -
NCT01875978 - Completed - -
NCT00979875 - Completed - -
NCT02348801 Diabetes Mellitus ... More >> Aging Overweight Less << Phase 3 Active, not recruiting - United States, Texas ... More >> Michael E DeBakey VA Medical Center Houston, Texas, United States, 77030 Less <<
NCT01875978 Non-alcoholic Fatty Liver Dise... More >>ase Less << Not Applicable Completed - Taiwan ... More >> China Medical University Hospital Taichung, Taiwan Less <<
NCT02497937 Heart Failure Phase 2 Completed - United States, Minnesota ... More >> GSK Investigational Site Minneapolis, Minnesota, United States, 55415 GSK Investigational Site Rochester, Minnesota, United States, 55905 Less <<
NCT00979875 Healthy Phase 1 Completed - United States, California ... More >> Profil Institute for Clinical Research, Inc. Chula Vista, California, United States, 91911 Less <<
NCT03261999 Prostatic Neoplasms Phase 3 Active, not recruiting November 2018 United States, Alabama ... More >> Urology Centers of Alabama Homewood, Alabama, United States, 35209 United States, Arizona Arizona Institute of Urology Tucson, Arizona, United States, 85704 United States, Colorado The Urology Center of Colorado Denver, Colorado, United States, 80211 United States, North Carolina Carolina Clinical Trials, LLC Concord, North Carolina, United States, 28025 United States, Texas Urology San Antonio, P.A San Antonio, Texas, United States, 78229 United States, Virginia Urology of Virginia, PLLC Virginia Beach, Virginia, United States, 23462 Czechia Fakultní nemocnice Hradec Králové, Urologická klinika Hradec Králové, Czechia, 500 05 Uromedical Center Olomouc Olomouc, Czechia, 779 00 Thomayerova nemocnice, Urologické oddělení Praha, Czechia, 140 59 Korea, Republic of Pusan National University Hospital Busan, Korea, Republic of, 49241 Keimyung University Dongsan Medical Center Daegu, Korea, Republic of, 41931 National Cancer Center Gyeonggi-do, Korea, Republic of, 10408 Seoul National University Bundang Hosptal Gyeonggi-do, Korea, Republic of, 13620 Hallym University Sacred Heart Hospital Gyeonggi-do, Korea, Republic of, 14068 Korea University Anam Hospital Seoul, Korea, Republic of, 02841 Lithuania Hospital of Lithuanian University of Health Sciences Kauno klinikos Kaunas, Lithuania, 50009 Klaipėda University Hospital Klaipėda, Lithuania, 92288 National Cancer Institute Vilnius, Lithuania, 08660 Vilnius University Hospital, Santaros klinikos Vilnius, Lithuania, 08661 Slovakia UROCENTRUM MILAB, s.r.o. Prešov, Slovakia, 080 01 Fakultná nemocnica s poliklinikou Žilina Urológia Žilina, Slovakia, 012 07 Less <<
NCT03619330 Hypogonadism ... More >>Obesity Less << Phase 4 Completed - Slovenia ... More >> University Medical Center Ljubljana Ljubljana, Slovenia, 1000 Less <<
NCT00870948 Healthy Phase 1 Completed - United States, Indiana ... More >> Site Reference ID/Investigator # 16001 Evansville, Indiana, United States, 47710 Less <<
NCT03490747 Cardiovascular Risk Factor ... More >> Diabetes Mellitus, Type 2 Anxiety Depression Musculoskeletal Injury Cardiovascular Diseases Cancer Obesity Metabolic Syndrome Physical Activity Less << Not Applicable Active, not recruiting March 2019 United Kingdom ... More >> Liverpool John Moores University Liverpool, Merseyside, United Kingdom, L3 2AT Less <<
NCT02647970 Healthy Obesi... More >>ty Less << Not Applicable Completed - Norway ... More >> University of Oslo Oslo, Norway Less <<
NCT03741686 Insulin Resistance Syndrome Phase 2 Completed - -
NCT03292978 Healthy Not Applicable Recruiting December 31, 2018 China, Guangdong ... More >> SunYat-sen University Recruiting Guangzhou, Guangdong, China, 510080 Contact: Zhu Huilian Less <<
NCT03657732 - Recruiting January 1, 2028 -
NCT03502109 Cardiovascular Diseases ... More >> Medication Adherence Drug Use Hypertension Type 2 Diabetes Mellitus Dyslipidemias Less << Not Applicable Active, not recruiting June 30, 2019 Chile ... More >> Pontificia Universidad Católica de Chile, Facultad de Química. Santiago, Chile, 7820436 Less <<
NCT03752359 Body Weight H... More >>ealthy Less << Not Applicable Completed - Brazil ... More >> Hellen Clair Garcez Nabuco Cuiabá, Mount, Brazil, 78032143 Less <<
NCT01900184 Essential Hypertension Phase 1 Completed - France ... More >> Biotrial PARIS Rueil-Malmaison, France, 92502 Less <<
NCT02497937 - Completed - -
NCT01791205 - Completed - Italy ... More >> Reggio Calabria, Calabria, Italy, 89133 Napoli, Campania, Italy, 80131 Telese Terme, Campania, Italy, 82037 Bologna, Emilia-Romagna, Italy, 40138 Roma, Lazio, Italy, 00133 Roma, Lazio, Italy, 00152 Roma, Lazio, Italy, 00161 Roma, Lazio, Italy, 00189 Legnano, Lombardia, Italy, 20025 Milano, Lombardia, Italy, 20157 Milano, Lombardia, Italy, 20162 Monza, Lombardia, Italy, 20052 Pavia, Lombardia, Italy, 27100 Ancona, Marche, Italy, 60020 Jesi, Marche, Italy, 60035 Torino, Piemonte, Italy, 10126 Torino, Piemonte, Italy, 10128 Bari, Puglia, Italy, 70124 Martina Franca, Puglia, Italy, 74015 Sassari, Sardegna, Italy, 07100 Firenze, Toscana, Italy, 50139 Pisa, Toscana, Italy, 56100 Prato, Toscana, Italy, 59100 Siena, Toscana, Italy, 53100 Perugia, Umbria, Italy, 06122 Cona (Ferrara), Veneto, Italy, 44124 Padova, Veneto, Italy, 35128 Verona, Veneto, Italy, 37126 Less <<
NCT01900171 Essential Hypertension Phase 1 Completed - France ... More >> Biotrial PARIS Rueil-Malmaison, France, 92502 Less <<
NCT03141957 - Completed - France ... More >> Hopital Cochin Paris, France, 75014 Less <<
NCT02286167 Glioblastoma Multiforme Not Applicable Recruiting April 2019 United States, Maryland ... More >> The Johns Hopkins Hospital Recruiting Baltimore, Maryland, United States, 21287 Contact: Roy E Strowd, MD       rstrowd@wakehealth.edu    Contact: Lindsay K Blair, CRNP    (410) 955-8009    lblair1@jhmi.edu    United States, North Carolina Wake Forest School of Medicine Recruiting Winston-Salem, North Carolina, United States, 27157 Contact: Roy Strowd, MD       rstrowd@wakehealth.edu    Contact: Sandra Norona       snorona@wakehealth.edu Less <<
NCT00976742 Cardiovascular Disease Risk Fa... More >>ctors Less << Not Applicable Completed - United States, Maryland ... More >> University of Maryland Dept of Kinesiology College Park, Maryland, United States, 20742-2611 Less <<
NCT01134939 - Completed - Germany ... More >> Boehringer Ingelheim Investigational Site 23 Aachen, Germany Boehringer Ingelheim Investigational Site 10 Berlin, Germany Boehringer Ingelheim Investigational Site 11 Berlin, Germany Boehringer Ingelheim Investigational Site 14 Berlin, Germany Boehringer Ingelheim Investigational Site 19 Berlin, Germany Boehringer Ingelheim Investigational Site 26 Berlin, Germany Boehringer Ingelheim Investigational Site 28 Berlin, Germany Boehringer Ingelheim Investigational Site 33 Berlin, Germany Boehringer Ingelheim Investigational Site 4 Berlin, Germany Boehringer Ingelheim Investigational Site 5 Berlin, Germany Boehringer Ingelheim Investigational Site 8 Berlin, Germany Boehringer Ingelheim Investigational Site 9 Berlin, Germany Boehringer Ingelheim Investigational Site 31 Chemnitz, Germany Boehringer Ingelheim Investigational Site 29 Dortmund, Germany Boehringer Ingelheim Investigational Site 27 Düsseldorf, Germany Boehringer Ingelheim Investigational Site 17 Frankfurt, Germany Boehringer Ingelheim Investigational Site 1 Frankfurt, Germany Boehringer Ingelheim Investigational Site 2 Freiburg, Germany Boehringer Ingelheim Investigational Site 34 Giessen, Germany Boehringer Ingelheim Investigational Site 22 Hamburg, Germany Boehringer Ingelheim Investigational Site 6 Hamburg, Germany Boehringer Ingelheim Investigational Site 12 Hannover, Germany Boehringer Ingelheim Investigational Site 16 Hannover, Germany Boehringer Ingelheim Investigational Site 32 Karlsruhe, Germany Boehringer Ingelheim Investigational Site 15 Koblenz, Germany Boehringer Ingelheim Investigational Site 25 Köln, Germany Boehringer Ingelheim Investigational Site 21 Leipzig, Germany Boehringer Ingelheim Investigational Site 20 München, Germany Boehringer Ingelheim Investigational Site 24 München, Germany Boehringer Ingelheim Investigational Site 3 München, Germany Boehringer Ingelheim Investigational Site 7 München, Germany Boehringer Ingelheim Investigational Site 13 Münster, Germany Boehringer Ingelheim Investigational Site 18 Osnabrück, Germany Boehringer Ingelheim Investigational Site 30 Stuttgart, Germany Less <<
NCT02722213 Heart Diseases ... More >> Heart Failure Myocardial Infarction Chronic Stable Angina Coronary Artery Bypass Angioplasty Less << Not Applicable Active, not recruiting September 2017 United States, Minnesota ... More >> University of Minnesota Medical Center Minneapolsi, Minnesota, United States, 55455 Less <<
NCT01791205 - Completed - -
NCT01134939 - Completed - -
NCT00542269 - Terminated(Early termination o... More >>f the study due to slow recruitment.) Less << - -
NCT03353298 Renal Transplant Donor of Left... More >> Kidney Renal Transplant Donor of Right Kidney Less << Phase 2 Recruiting December 31, 2021 Norway ... More >> Oslo University Hospital Recruiting Oslo, Norway Contact: NE Langberg       nlangb@ous-hf.no    Contact: DO Dahle       dagdah@ous-hf.no    Principal Investigator: DO Dahle Less <<
NCT02054624 Obesity Not Applicable Active, not recruiting April 2019 United States, Florida ... More >> Levy County Bronson, Florida, United States, 32621 Flagler County Bunnell, Florida, United States, 32110 Dixie County Cross City, Florida, United States, 32628 Hamilton County Jasper, Florida, United States, 32052 Union County Lake Butler, Florida, United States, 32054 Columbia County Lake City, Florida, United States, 32055 Suwannee County Live Oak, Florida, United States, 32064 Baker County Macclenny, Florida, United States, 32063 Madison County Madison, Florida, United States, 32340 Lafayette County Mayo, Florida, United States, 32066 Putnam County Palatka, Florida, United States, 32131 Taylor County Perry, Florida, United States, 32348 Bradford County Starke, Florida, United States, 32091 Gilchrist County Trenton, Florida, United States, 32693 Less <<
NCT01729728 Postoperative Pain ... More >> Acute Pain Less << Phase 2 Completed - United States, Utah ... More >> Jean Brown Research Salt Lake City, Utah, United States, 84124 Less <<
NCT00542269 Hypertension With Metabolic Sy... More >>ndrome Less << Phase 4 Terminated(Early termination o... More >>f the study due to slow recruitment.) Less << - United Kingdom ... More >> Addenbrookes Hospital Cambridge, United Kingdom Less <<
NCT03308747 Inflammaging ... More >>Sarcopenia Less << Not Applicable Completed - Greece ... More >> Exercise Biochemistry Laboratory, School of Physical Education & Sports Sciences, University of Thessaly Tríkala, Greece, 42100 Less <<
NCT02695186 - Unknown June 2016 Greece ... More >> General Hospital of Filiates Recruiting Filiates, Epirus, Greece, 46300 Contact: Georgios Pappas-Gogos, MD, MSc    +302663360227    pappasg8@gmail.com    Principal Investigator: Georgios Pappas-Gogos, MD, MSc          Principal Investigator: Spyridon Gogos, MD          Principal Investigator: Panagiota Aggeli, MD          Principal Investigator: Alexandros Tselepis, MD, PhD Less <<
NCT00375830 Cancer Phase 4 Suspended(Logistics) December 2019 United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT00393029 Anti-p53 TCR-Gene Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Bethesda, Maryland, United States, 20892 Less <<
NCT01729728 - Completed - -
NCT00393029 - Completed - -
NCT01899768 Cough Phase 2 Completed - United Kingdom ... More >> GSK Investigational Site Manchester, Lancashire, United Kingdom, M23 9LT GSK Investigational Site Belfast, United Kingdom, BT9 7AB Less <<
NCT02064985 - Completed - -
NCT02064985 Stable Coronary Heart Disease ... More >>(CHD) Less << Phase 4 Completed - China ... More >> Research Site Beijing, China Less <<
NCT00927823 Cancer Phase 1 Completed - United States, California ... More >> Pfizer Investigational Site Los Angeles, California, United States, 90095-6984 Pfizer Investigational Site Los Angeles, California, United States, 90095 Pfizer Investigational Site Los Angeles, California, United States, 90404 Pfizer Investigational Site Santa Monica, California, United States, 90404 United States, Michigan Pfizer Investigational Site Detroit, Michigan, United States, 48201 United States, New York Pfizer Investigational Site Amherst, New York, United States, 14221 Pfizer Investigational Site Buffalo, New York, United States, 14263 Less <<
NCT02366052 Non-alcoholic Fatty Liver Dise... More >>ase Fatty Liver, Nonalcoholic Less << Phase 2 Completed - Germany ... More >> Institut für Ernährungswissenschaften, University Jena Jena, Germany, 07743 University Medical Center of the Johannes Gutenber Univeristy Mainz, Germany, 55131 Less <<
NCT01274260 Acute Respiratory Distress Syn... More >>drome (ARDS) Acute Lung Injury (ALI) Less << Phase 2 Unknown December 2014 United States, Tennessee ... More >> Le Bonheur Children's Hospital Memphis, Tennessee, United States, 38103 Less <<
NCT03525002 Obesity Phase 2 Recruiting December 2021 Germany ... More >> University Hospital Cologne Recruiting Cologne, Germany Contact: Michael Faust, MD          University Hospital Luebeck Recruiting Luebeck, Germany Contact: Sebastian Schmid, MD          University of Tuebingen, Department of Internal Medicine IV Recruiting Tübingen, Germany, 72076 Contact: Martin Heni, MD    +49 7071 29 82714    martin.heni@med.uni-tuebingen.de    Contact: Andreas Fritsche, MD    +49 7071 29 82714    andreas.fritsche@med.uni-tuebingen.de    Principal Investigator: Stephanie Kullmann, PhD Less <<
NCT01316731 Exercise Musc... More >>le Gene Expression Myokine Less << Not Applicable Completed - Netherlands ... More >> Division of Human Nutrition, Wageningen University Wageningen, Gelderland, Netherlands, 6703 HA Less <<
NCT00927823 - Completed - -
NCT02015299 Type 2 Diabetes Mellitus Phase 3 Completed - Netherlands ... More >> University Medical Center Groningen Groningen, Netherlands, 9700 RB Less <<
NCT01552590 Hyponatremia and Extracellular... More >> Fluid in Cirrhotic Less << Phase 4 Unknown January 2013 Korea, Republic of ... More >> Hallym Univ. Chuncheon Sacred Heart Hospital Recruiting Bucheon, Korea, Republic of Contact: KiTae Suk, Assistant professor          Principal Investigator: KiTae Suk, Assistant professor          Soonchunhyang Univ. Bucheon Hospital Recruiting Bucheon, Korea, Republic of Contact: YoungSeok Kim, Associate professor          Principal Investigator: YoungSeok Kim, Associate professor          Wonju Christian Hospital Recruiting Wonju, Korea, Republic of Contact: SoonKoo Baik, Professor          Principal Investigator: SoonKoo Baik, Professor Less <<
NCT00612222 Metastatic Melanoma ... More >> Skin Cancer Less << Phase 2 Terminated(The study was termi... More >>nated due to low accrual.) Less << - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT01899768 - Completed - -
NCT01160224 Asthma Phase 2 Completed - Canada, Alberta ... More >> GSK Investigational Site Calgary, Alberta, Canada, T2N 4Z6 Canada, Ontario GSK Investigational Site Hamilton, Ontario, Canada, L8N 4A6 Canada, Quebec GSK Investigational Site Montreal, Quebec, Canada, H2X 2P4 GSK Investigational Site Montreal, Quebec, Canada, H4J 1C5 Canada GSK Investigational Site Quebec, Canada, G1V 4G5 Less <<
NCT00049140 Head and Neck Cancer Phase 2 Completed - United States, North Carolina ... More >> Duke Comprehensive Cancer Center Durham, North Carolina, United States, 27710 Less <<
NCT00612222 - Terminated(The study was termi... More >>nated due to low accrual.) Less << - -
NCT02866786 Polycystic Ovary Syndrome Phase 4 Completed - India ... More >> Department of Obstetrics & Gynecology Cuttack, Odisha, India, 753007 Less <<
NCT02524938 Diabetes Mellitus, Type 2 ... More >> Renal Insufficiency, Chronic Less << Not Applicable Recruiting March 2018 United Kingdom ... More >> NHS Greater Glasgow and Clyde Recruiting Glasgow, United Kingdom University of Glasgow Recruiting Glasgow, United Kingdom Less <<
NCT00350727 Glioma Phase 2 Completed - -
NCT01739582 Secondary Hypogonadism Phase 3 Completed - -
NCT00350727 - Completed - -
NCT02252484 Prostate Cancer Not Applicable Completed - United States, Kansas ... More >> University of Kansas Medical Center Kansas City, Kansas, United States, 66160 Less <<
NCT00811954 HIV Infection Phase 3 Completed - -
NCT01884545 - Completed - -
NCT02716350 Healthy Phase 2 Phase 3 Unknown July 2017 United Kingdom ... More >> General Hospital Jersey Recruiting Saint Helier, Jersey, United Kingdom Contact: rupert simpson, md       R.Simpson2@health.gov.je Less <<
NCT00811954 - Completed - -
NCT02992106 Endothelial Dysfunction ... More >> Childhood Obesity Less << Not Applicable Enrolling by invitation August 2020 Belgium ... More >> University Hospital of Brussels Brussels, Belgium, 1090 Less <<
NCT03012360 Mechanical Ventilation Complic... More >>ation Critical Illness Less << Phase 4 Recruiting September 2020 France ... More >> Hôpital Roger Salengro, CHRU Recruiting Lille, France Principal Investigator: Saad NSEIR, MD,PhD Less <<
NCT01884545 Coronary Heart Disease, Suscep... More >>tibility to, 5 Prediabetic State Less << Not Applicable Completed - United States, California ... More >> David Grant Medical Center Fairfield, California, United States, 94535 Less <<
NCT00207090 Advanced Solid Tumors ... More >> Neoplasms Less << Phase 1 Completed - United States, Ohio ... More >> The Cleveland Clinic Foundation Cleveland, Ohio, United States, 44195 Less <<
NCT02416284 Dietary Modification Not Applicable Completed - Norway ... More >> University of Oslo Oslo, Norway, 0316 Less <<
NCT00207090 - Completed - -
NCT02310724 - Enrolling by invitation February 2021 United States, California ... More >> Children's Hospital Los Angeles Los Angeles, California, United States, 90027 United States, Colorado University of Colorado Denver Children's Hospital Aurora, Colorado, United States, 80045 United States, Connecticut Yale University School of Medicine Department of Pediatrics New Haven, Connecticut, United States, 06520 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Joslin Diabetes Center Boston, Massachusetts, United States, 02215 United States, Missouri Saint Louis University Saint Louis, Missouri, United States, 63104 Washington University Saint Louis, Missouri, United States, 63110 United States, New York Columbia University Naomi Berrie Diabetes Center New York, New York, United States, 10032 SUNY Upstate New York University Syracuse, New York, United States, 13210 United States, Ohio Case Western Reserve University Rainbow Babies and Children's Hospital Cleveland, Ohio, United States, 44106 United States, Oklahoma University of Oklahoma Health Science Center Oklahoma City, Oklahoma, United States, 73104 United States, Pennsylvania Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 Children's Hospital of Pittsburgh Pittsburgh, Pennsylvania, United States, 15224 United States, Texas Baylor College of Medicine Houston, Texas, United States, 77030 University of Texas Health Sciences Center San Antonio, Texas, United States, 78229 Less <<
NCT01222949 Malaria, Falciparum Phase 1 Completed - Australia ... More >> CMAX, a division of IDT Australia Limited Adelaide, Australia, SA 5000 Nucleus Network Limited Melbourne, Australia, VIC 3004 Less <<
NCT03112109 - Completed - -
NCT02117622 - Completed - India ... More >> Novo Nordisk Investigational Site Guntur, Andhra Pradesh, India, 522001 Novo Nordisk Investigational Site Hyderabad, Andhra Pradesh, India, 500001 Novo Nordisk Investigational Site Hyderabad, Andhra Pradesh, India, 500004 Novo Nordisk Investigational Site Hyderabad, Andhra Pradesh, India, 500072 Novo Nordisk Investigational Site Hyderabad, Andhra Pradesh, India Novo Nordisk Investigational Site Vijayawada, Andhra Pradesh, India, 520002 Novo Nordisk Investigational Site Guwahati, Assam, India, 781006 Novo Nordisk Investigational Site Ahmedabad, Gujarat, India, 380007 Novo Nordisk Investigational Site Ahmedabad, Gujarat, India Novo Nordisk Investigational Site Ghuma, Gujarat, India Novo Nordisk Investigational Site Gurgaon, Haryana, India Novo Nordisk Investigational Site Bangalore, Karnataka, India, 560092 Novo Nordisk Investigational Site Thrissur, Kerala, India Novo Nordisk Investigational Site Bhopal, Madhya Pradesh, India, 462037 Novo Nordisk Investigational Site Indore, Madhya Pradesh, India, 452010 Novo Nordisk Investigational Site Indore, Madhya Pradesh, India Novo Nordisk Investigational Site Mumbai, Maharashtra, India, 400053 Novo Nordisk Investigational Site Nagpur, Maharashtra, India, 440010 Novo Nordisk Investigational Site Pune, Maharashtra, India, 411001 Novo Nordisk Investigational Site Pune, Maharashtra, India, 411040 Novo Nordisk Investigational Site Pune, Maharashtra, India Novo Nordisk Investigational Site Delhi, New Delhi, India, 110076 Novo Nordisk Investigational Site Delhi, New Delhi, India Novo Nordisk Investigational Site Mohali, Punjab, India, 160062 Novo Nordisk Investigational Site Chennai, Tamil Nadu, India, 600037 Novo Nordisk Investigational Site Chennai, Tamil Nadu, India, 600040 Novo Nordisk Investigational Site Chennai, Tamil Nadu, India, 600086 Novo Nordisk Investigational Site Chennai, Tamil Nadu, India, 600100 Novo Nordisk Investigational Site Coimbatore, Tamil Nadu, India, 641009 Novo Nordisk Investigational Site Coimbatore, Tamil Nadu, India, 641018 Novo Nordisk Investigational Site Madurai, Tamil Nadu, India, 625 020 Novo Nordisk Investigational Site Noida, Uttar Pradesh, India, 201301 Novo Nordisk Investigational Site Noida, Uttar Pradesh, India Novo Nordisk Investigational Site Kolkata, West Bengal, India, 700054 Novo Nordisk Investigational Site Kolkata, West Bengal, India, 700094 Novo Nordisk Investigational Site Chennai, India, 600008 Novo Nordisk Investigational Site New Delhi, India, 110088 Novo Nordisk Investigational Site Thriruvananthapuram, India, 695 032 Less <<
NCT02019264 Cardiovascular Disease ... More >> High Cardiovascular Risk Obesity Overweight Type 2 Diabetes Less << Phase 4 Completed - -
NCT02063048 Body Weight B... More >>ody Weight Changes Prediabetic State Prediabetes Less << Not Applicable Completed - United States, Colorado ... More >> Denver Health Denver, Colorado, United States, 80204 Less <<
NCT02020889 Churg-Strauss Syndrome Phase 3 Completed - -
NCT00017797 - Completed - -
NCT02020889 - Completed - -
NCT00115063 Obesity Phase 4 Terminated(ethical issues of c... More >>ontinuing control group without treatment) Less << - United States, Louisiana ... More >> Pennington Management of Clinical Trials Baton Rouge, Louisiana, United States, 70808 Less <<
NCT03002090 Iron Deficiency Without Anemia Not Applicable Completed - China, Yunnan ... More >> Kunming Medical University, Department of Nursing, Chenggong, Yunnan, China Less <<
NCT03050229 Nocturnal Hypertension ... More >> T2DM (Type 2 Diabetes Mellitus) Less << Phase 4 Completed - Japan ... More >> Fukuoka University Chikushi Hospital Fukuoka, Japan Kotake Hospital Fukuoka, Japan Onga Hospital Fukuoka, Japan Ishiguro Clinic Gifu, Japan Higashiagatsuma-machi National Health Insurance Clinic Gunma, Japan Katsuya Iin Hyogo, Japan Minamisanriku Hospital Miyagi, Japan Shibuya Clinic Saitama, Japan International University of Health and Welfare Hospital Tochigi, Japan Jichi Medical University hospital Tochigi, Japan Utsunomiya higashi hospital Tochigi, Japan Kato Clinic Tokyo, Japan Less <<
NCT00115063 - Terminated(ethical issues of c... More >>ontinuing control group without treatment) Less << - -
NCT01222962 Malaria, Falciparum Phase 1 Completed - Australia ... More >> CMAX, a division of IDT Australia Limited Adelaide, Australia, SA 5000 Less <<
NCT00849342 - Completed - Netherlands ... More >> Alphen a/d Rijn, Netherlands Slovenia Ljubljana, Slovenia, SI-1000 Less <<
NCT01244984 - Completed - -
NCT01244984 Asthma Phase 3 Completed - Japan ... More >> GSK Investigational Site Chiba, Japan, 277-0863 GSK Investigational Site Fukuoka, Japan, 802-0083 GSK Investigational Site Fukuoka, Japan, 816-0813 GSK Investigational Site Gifu, Japan, 501-6062 GSK Investigational Site Gunma, Japan, 373-0021 GSK Investigational Site Hiroshima, Japan, 730-0844 GSK Investigational Site Hiroshima, Japan, 732-0062 GSK Investigational Site Hiroshima, Japan, 739-0402 GSK Investigational Site Hyogo, Japan, 665-0827 GSK Investigational Site Hyogo, Japan, 670-0046 GSK Investigational Site Hyogo, Japan, 672-8064 GSK Investigational Site Ibaraki, Japan, 302-0022 GSK Investigational Site Kanagawa, Japan, 231-8682 GSK Investigational Site Kanagawa, Japan, 253-0041 GSK Investigational Site Kyoto, Japan, 601-1495 GSK Investigational Site Kyoto, Japan, 615-8087 GSK Investigational Site Miyagi, Japan, 983-0824 GSK Investigational Site Miyagi, Japan, 983-8520 GSK Investigational Site Nagano, Japan, 390-0303 GSK Investigational Site Nagano, Japan, 390-8510 GSK Investigational Site Okayama, Japan, 700-0862 GSK Investigational Site Okayama, Japan, 701-0304 GSK Investigational Site Okayama, Japan, 714-0081 GSK Investigational Site Osaka, Japan, 545-8586 GSK Investigational Site Osaka, Japan, 569-1192 GSK Investigational Site Osaka, Japan, 589-0022 GSK Investigational Site Tokyo, Japan, 105-0004 GSK Investigational Site Tokyo, Japan, 134-0083 GSK Investigational Site Tokyo, Japan, 185-0014 GSK Investigational Site Toyama, Japan, 937-0066 Less <<
NCT03174847 - Recruiting January 30, 2020 Singapore ... More >> Changi General Hospital Recruiting Singapore, Singapore, 529889 Contact: troy h puar, mrcp    +65 68503967    troy_puar@cgh.com.sg    Principal Investigator: Troy H Puar, MRCP Less <<
NCT01568892 HIV Infections Phase 3 Completed - -
NCT02751307 Metabolic Syndrome Phase 4 Completed - -
NCT00516139 Epilepsy Phase 3 Completed - -
NCT03127020 Lymphoma Non-... More >>Hodgkin Lymphoma Less << Phase 2 Active, not recruiting December 2018 Germany ... More >> University Hospital Freiburg General Medicine I Freiburg, Baden Würtenberg, Germany, 79106 Medizinische Klinik und Poliklinik III Munich, Bavaria, Germany, 81377 Charite Universitaetsmedizin Berlin Berlin, Germany, 10117 Klinikum Stuttgart Stuttgart, Germany Switzerland Basel University Hospital Basel, Switzerland, 4031 Less <<
NCT03406234 - Completed - China, Guangdong ... More >> Shenzhen Center for Chronic Disease Control Shenzhen, Guangdong, China, 518020 Less <<
NCT00516139 - Completed - -
NCT02014467 Osteoporosis, Postmenopausal Phase 3 Completed - China, Sichuan ... More >> GSK Investigational Site Chengdu, Sichuan, China, 610041 GSK Investigational Site Chengdu, Sichuan, China, 610072 China GSK Investigational Site Beijing, China, 100035 GSK Investigational Site Beijing, China, 100050 GSK Investigational Site Beijing, China, 100730 GSK Investigational Site Chengdu, China, 610083 GSK Investigational Site Shanghai, China, 200040 GSK Investigational Site Shanghai, China, 200233 Less <<
NCT02798978 Cancer Phase 1 Completed - Germany ... More >> GSK Investigational Site Berlin, Germany, 14050 Less <<
NCT00385671 Diabetic Neuropathy, Painful Phase 4 Completed - United States, California ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Torrance, California, United States, 90503 United States, Connecticut For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Cromwell, Connecticut, United States, 06416 United States, New York For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Staten Island, New York, United States, 10312 United States, North Carolina For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Greenville, North Carolina, United States, 27834 United States, Utah For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Midvale, Utah, United States, 84047 Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bochum, Germany, D-44805 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Dresden, Germany, 01307 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hamburg, Germany, 20354 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Siegen, Germany, 57072 Less <<
NCT03027570 Body Mass Index ... More >> Blood; Sugar, High Lipid Disorder Body Image Less << Not Applicable Completed - Israel ... More >> Centers for the treatment of overweight children - MACCABI health organization Beer sheva, Israel Less <<
NCT02261376 Healthy Phase 1 Completed - United Kingdom ... More >> Hammersmith Medicines Research Ltd London, United Kingdom, NW10 7EW Less <<
NCT02818699 Overweight Ob... More >>ese Less << Not Applicable Recruiting January 2018 United States, Massachusetts ... More >> Human Nutrition Research Center on Aging at Tufts University Recruiting Boston, Massachusetts, United States, 02111 Less <<
NCT03608943 - Recruiting March 20, 2023 United Kingdom ... More >> Imperial College Healthcare NHS Trust Recruiting London, United Kingdom, W12 8RF Contact: Sirazum Choudhury, MBBS BSc    07555717544    steroids@imperial.ac.uk Less <<
NCT02999841 Diabetes Mellitus, Type 2 ... More >> Obesity Less << Phase 4 Unknown January 2018 China, Beijing ... More >> Beijing Pinggu Hospital Recruiting Beijing, Beijing, China, 101200 Contact: Yufeng Li, MD    +86 139 1108 0328       Principal Investigator: Yufeng Li, MD Less <<
NCT01568892 - Completed - -
NCT02922920 Cardiovascular Risk Factors ... More >> Age-Related Cognitive Decline Less << Not Applicable Completed - United States, Delaware ... More >> University of Delaware Newark, Delaware, United States, 19716 Less <<
NCT00385671 - Completed - -
NCT01494584 Epilepsy Phase 2 Terminated(Terminated after pl... More >>acing the study on hold at the request of the FDA) Less << - United States, California ... More >> GSK Investigational Site Los Angeles, California, United States, 90027 United States, Florida GSK Investigational Site Gulf Breeze, Florida, United States, 32561 GSK Investigational Site Port Charlotte, Florida, United States, 33952 GSK Investigational Site Wellington, Florida, United States, 33414 United States, Minnesota GSK Investigational Site Saint Paul, Minnesota, United States, 55102-2534 United States, North Carolina GSK Investigational Site Durham, North Carolina, United States, 27710 United States, Tennessee GSK Investigational Site Memphis, Tennessee, United States, 38105 United States, Texas GSK Investigational Site Austin, Texas, United States, 78723 GSK Investigational Site Dallas, Texas, United States, 75230-2507 Less <<
NCT01705210 - Completed - Netherlands ... More >> Maastricht University Medical Center Maastricht, Netherlands, 6202 AZ Less <<
NCT02014467 - Completed - -
NCT03499327 Vitamin D3 Deficiency Not Applicable Completed - Germany ... More >> Friedrich-Schiller-University Jena, Thuringia, Germany, 07743 Less <<
NCT01494584 - Terminated(Terminated after pl... More >>acing the study on hold at the request of the FDA) Less << - -
NCT01316887 Pulmonary Disease, Chronic Obs... More >>tructive Less << Phase 3 Completed - -
NCT01290016 Healthy Obesi... More >>ty Less << Not Applicable Completed - Canada, Quebec ... More >> Mary Emily Clinical Nutrition Research Unit of McGill University Sainte Anne-de-Bellevue, Quebec, Canada, H9X 2E3 Less <<
NCT02363946 Alpha-1 Antitrypsin Deficiency Phase 1 Terminated(Company decision to... More >> terminate the trial) Less << - Australia, Victoria ... More >> Nucleus Network Ltd Melbourne, Victoria, Australia, 3004 Germany Universitatsklinikum des Saarlandes Homburg, Germany Netherlands Leiden University Medical Center Leiden, Netherlands, 2333ZA United Kingdom Queen Elizabeth Hospital Edgbaston, Birmingham, United Kingdom, B15 2WB Less <<
NCT01316887 - Completed - -
NCT01086137 - Completed - United States, West Virginia ... More >> West Virginia School of Osteopathic Medicine Lewisburg, West Virginia, United States, 24901 Less <<
NCT02363946 - Terminated(Company decision to... More >> terminate the trial) Less << - -
NCT02716740 Obesity Not Applicable Recruiting December 2018 France ... More >> Department of Endocrinology, metabolic diseases and nutrition Recruiting Toulouse, France, 31059 Contact: Patrick Ritz, MD, PhD    0567771638 ext +33    ritz.p@chu-toulouse.fr    Contact: Amandine Pauze    0561778434 ext +33    pauze.a@chu-toulouse.fr    Principal Investigator: Patrick Ritz, MD, PhD Less <<
NCT03601884 Diabetes Mellitus ... More >> Chronic Illness Less << Not Applicable Recruiting September 30, 2020 Malaysia ... More >> Klinik Kesihatan Presint 11 Recruiting Putrajaya, Malaysia, 62300 Contact: AIDA FARHANA    0147137929    aida.hjsuhaimi@gmail.com    Klinik Kesihatan Presint 14 Recruiting Putrajaya, Malaysia, 62300 Contact: AIDA FARHANA    0147137929    aida.hjsuhaimi@gmail.com    Klinik Kesihatan Presint 18 Recruiting Putrajaya, Malaysia, 62300 Contact: AIDA FARHANA    0147137929    aida.hjsuhaimi@gmail.com    Klinik Kesihatan Presint 9 Recruiting Putrajaya, Malaysia, 62300 Contact: AIDA FARHANA    147137929    aida.hjsuhaimi@gmail.com Less <<
NCT01627912 Healthy, Postprandial Not Applicable Unknown October 2012 Greece ... More >> Department of Nutrition-Dietetics, Harokopio University Athens, Greece, 17671 Less <<
NCT01960530 Adrenal Insufficiency Phase 1 Completed - United Kingdom ... More >> Simbec Research Limited Merthyr Tydfil, United Kingdom, CF48 4DR Less <<
NCT01595646 - Completed - -
NCT00699179 - Completed - Former Serbia and Montenegro ... More >> Novo Nordisk Investigational Site Belgrade, Former Serbia and Montenegro, 11 070 Less <<
NCT02462759 Spinal Muscular Atrophy Phase 2 Active, not recruiting April 9, 2019 United States, California ... More >> David Geffen School of Medicine at UCLA Los Angeles, California, United States, 90095-8344 United States, Connecticut Connecticut Childrens Medical Hartford, Connecticut, United States, 06106 United States, Maryland The Johns Hopkins Hospital Baltimore, Maryland, United States, 21287 United States, Minnesota Gillette Children's Specialty Healthcare Saint Paul, Minnesota, United States, 55101 United States, Texas The University of Texas Southwestern Medical Center Dallas, Texas, United States, 75235 United States, Washington Seattle Children's Research Institute Seattle, Washington, United States, 98105 Germany LMU-Campus Innenstadt Muenchen, Germany, 80337 Less <<
NCT01595646 Alzheimer's Disease ... More >> Mild Cognitive Impairment Less << Phase 2 Completed - United States, North Carolina ... More >> Wake Forest Baptist Hospital Winston-Salem, North Carolina, United States, 27157 United States, Washington VA Puget Sound Health Care System - American Lake Division Tacoma, Washington, United States, 98493 Less <<
NCT03613571 Amyotrophic Lateral Sclerosis Phase 2 Enrolling by invitation June 1, 2019 Sweden ... More >> Sahlgrenska University Hospital Gothenburg, Sweden Less <<
NCT02625636 Type 1 Diabetes Mellitus Phase 1 Completed - United States, California ... More >> Investigational Site Number 840001 Chula Vista, California, United States, 91911 Less <<
NCT03640286 Obesity Not Applicable Not yet recruiting March 1, 2020 United States, California ... More >> University of California San Diego Not yet recruiting La Jolla, California, United States, 92093 Contact: Jeff Ledford-Mills, BA    619-786-2854    jhmills@ucsd.edu    Contact: Baharin Abdullah, MD       baabdullah@ucsd.edu    Principal Investigator: Erik Viirre, MD PhD          Sub-Investigator: Jeff Ledord-Mills, BA          Sub-Investigator: Baharin Abdullah, MD          Sub-Investigator: Donna Brusch, MA          Sub-Investigator: Sharon Quigley, MSc          Sub-Investigator: Cynthia Knott, RDN          Sub-Investigator: Maeve Taaffe, RN          United Kingdom Univeristy of Ulster Not yet recruiting Coleraine, United Kingdom Contact: Julie Sittlington, PhD       jj.sittlington@ulster.ac.uk    Contact: Ruth Price, PhD       rk.price@ulster.ac.uk    Sub-Investigator: Ruth Price, PhD          Principal Investigator: Julie Sittlington, PhD Less <<
NCT02017210 Insulin Sensitivity/Resistance... More >> Obesity Weight Loss Less << Not Applicable Completed - Australia, New South Wales ... More >> Garvan Institute of Medical Research Darlinghurst, New South Wales, Australia, 2010 Less <<
NCT01960530 - Completed - -
NCT00837967 - Completed - -
NCT03597035 Type2 Diabetes ... More >> Hyperkalemia Less << Phase 4 Recruiting July 31, 2018 United States, Ohio ... More >> University Hospitals Cleveland Medical Center Recruiting Cleveland, Ohio, United States, 44106 Contact: Heather Conger, BS    216-286-6550    heather.conger2@uhhospitals.org    Principal Investigator: Sanjay Rajagopalan, MBBS          Sub-Investigator: Mirela Dobre, MD Less <<
NCT03582020 Nutritional Evaluation Not Applicable Recruiting June 3, 2020 Germany ... More >> Friedrich-Schiller-University Recruiting Jena, Thuringia, Germany, 07743 Contact: Christine Dawczynski, PhD    +49 3641 949656    christine.dawczynski@uni-jena.de    Contact: Stefan Lorkowski, PhD    +49 3641 949711    stefan.lorkowski@uni-jena.de Less <<
NCT03052062 Obese Phase 1 Phase 2 Completed - France ... More >> Centre d'Investigation Clinique Clermont-Ferrand, France, 63000 Less <<
NCT00837967 Asthma Phase 3 Completed - Japan ... More >> Research Site Ibaragi, Japan Research Site Tokyo, Japan Less <<
NCT02507167 Gastrointestinal Hormones Phase 1 Completed - Germany ... More >> Department of Clinical Pharmacology Greifswald, Germany, 17489 Less <<
NCT03386890 - Recruiting December 31, 2018 China, Beijing ... More >> Beijing Friendship Hospital Recruiting Beijing, Beijing, China, 100000 Contact: Qianyi Wang    86-13811629824    wangqy1001@hotmail.com Less <<
NCT01066052 - Completed - -
NCT01066052 Turner's Syndrome Phase 4 Completed - France ... More >> Hôpital Robert Debré Paris, France, 75935 Less <<
NCT01447901 - Terminated(Business reason) - Canada, Quebec ... More >> ECOGENE-21 Clinical Trial Center Chicoutimi, Quebec, Canada, G7H 7P2 Less <<
NCT01153490 Cannabis Dependence Phase 4 Completed - United States, New York ... More >> The Zucker Hillside Hospital Glen Oaks, New York, United States, 11004 General Clinical Research Center Manhasset, New York, United States, 11030 Less <<
NCT01894438 Non-alcoholic Fatty Liver Dise... More >>ase (NAFLD) Non-alcoholic Steatohepatitis (NASH) Less << Not Applicable Completed - Greece ... More >> Harokopio University Kallithea, Attiki, Greece, 17671 Less <<
NCT02545140 - Unknown - United Kingdom ... More >> University Hospitals of Leicester Recruiting Leicester, United Kingdom, LE4 5pW Contact: Emer Brady, Senior Research Associate    0116 258 8959 ext 8959    emer.brady@uhl-tr.nhs.uk    Contact: Georgie K Surridge, Trial Manager    0116 258 8929 ext 8929    georgie.surridge@uhl-tr.nhs.uk Less <<
NCT01205451 Spasticity, Post-Stroke Phase 3 Completed - China, Guangdong ... More >> GSK Investigational Site Guangzhou, Guangdong, China China, Heilongjiang GSK Investigational Site Haerbin, Heilongjiang, China, 150001 China, Hubei GSK Investigational Site Wuhan, Hubei, China, 430060 China, Jiangsu GSK Investigational Site Nanjing, Jiangsu, China, 210029 GSK Investigational Site Suzhou, Jiangsu, China, 215004 China, Liaoning GSK Investigational Site Shenyang, Liaoning, China, 110001 China, Sichuan GSK Investigational Site Chengdu, Sichuan, China, 610041 China GSK Investigational Site Beijing, China, 100050 GSK Investigational Site Beijing, China, 100068 GSK Investigational Site Beijing, China, 100730 GSK Investigational Site Hangzhou, China, 310016 GSK Investigational Site Shanghai, China, 200025 GSK Investigational Site Shanghai, China, 200040 Less <<
NCT01822951 Alzheimer Disease Phase 4 Withdrawn December 2016 Austria ... More >> AKh Allgemeines Krankenhaus der Stadt Linz GmbH Linz, Austria, 4021 Less <<
NCT01136096 Diabetes Mellitus Not Applicable Completed - Taiwan ... More >> National Taiwan University Hospital Taipei, Taiwan, 100 Less <<
NCT01720589 Childhood Obesity Not Applicable Completed - United States, New York ... More >> St. Luke's/Roosevelt Hospital New York, New York, United States, 10025 Less <<
NCT00622661 Healthy Overw... More >>eight Less << Not Applicable Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109 Less <<
NCT01086410 - Completed - -
NCT01205451 - Completed - -
NCT01086410 Asthma Phase 3 Completed - United States, California ... More >> GSK Investigational Site Cypress, California, United States, 90630 GSK Investigational Site Huntington Beach, California, United States, 92647 United States, Oklahoma GSK Investigational Site Oklahoma City, Oklahoma, United States, 73103 United States, Texas GSK Investigational Site San Antonio, Texas, United States, 78229 Germany GSK Investigational Site Frankfurt, Hessen, Germany, 60596 GSK Investigational Site Magdeburg, Sachsen-Anhalt, Germany, 39112 GSK Investigational Site Grosshansdorf, Schleswig-Holstein, Germany, 22927 GSK Investigational Site Berlin, Germany, 10117 GSK Investigational Site Berlin, Germany, 10787 GSK Investigational Site Hamburg, Germany, 20253 Poland GSK Investigational Site Bialystok, Poland, 15-010 GSK Investigational Site Gdansk, Poland, 80-405 GSK Investigational Site Gidle, Poland, 97-540 GSK Investigational Site Krakow, Poland, 31-023 GSK Investigational Site Lodz, Poland, 93-513 GSK Investigational Site Olsztyn, Poland, 10-357 GSK Investigational Site Warszawa, Poland, 01-138 Less <<
NCT02925676 Diabetes Mellitus, Type 1 Early Phase 1 Recruiting December 2018 Denmark ... More >> Odense University Hospital Recruiting Odense, Denmark, 5000 Contact: Kurt Højlund, MD, DMSci          Principal Investigator: Kurt Højlund, MD, DMSci Less <<
NCT02088294 Obesity Insul... More >>in Resistance Stress Less << Not Applicable Completed - United States, California ... More >> University of Southern California Los Angeles, California, United States, 90033 Less <<
NCT03019263 Dyslipidemia Not Applicable Completed - Italy ... More >> Fondazione IRCCS Policlinico San Matteo Pavia, Italy, 27100 Less <<
NCT01934192 Gastroparesis Phase 2 Terminated - United States, Colorado ... More >> GSK Investigational Site Aurora, Colorado, United States, 80045 United States, Georgia GSK Investigational Site Augusta, Georgia, United States, 30909 United States, Kentucky GSK Investigational Site Louisville, Kentucky, United States, 40202 United States, Pennsylvania GSK Investigational Site Philadelphia, Pennsylvania, United States, 19104 Australia, New South Wales GSK Investigational Site Randwick, New South Wales, Australia, 2031 Australia, Queensland GSK Investigational Site Southport, Queensland, Australia, 4215 Australia, South Australia GSK Investigational Site Adelaide, South Australia, Australia, 5000 GSK Investigational Site Woodville, South Australia, Australia, 5011 Canada, Alberta GSK Investigational Site Calgary, Alberta, Canada, T1Y 6J4 GSK Investigational Site Calgary, Alberta, Canada, T2N 2T9 Canada, Ontario GSK Investigational Site Hamilton, Ontario, Canada, L8L 2X2 GSK Investigational Site Kingston, Ontario, Canada, K7L 2V7 GSK Investigational Site Ottawa, Ontario, Canada, K1H 8L6 GSK Investigational Site Ottawa, Ontario, Canada, K1Y 4E9 GSK Investigational Site Toronto, Ontario, Canada, M5G 1X5 Canada, Quebec GSK Investigational Site Montreal, Quebec, Canada, H2X 3J4 GSK Investigational Site Sainte-Foy, Quebec, Canada, G1V 4G5 GSK Investigational Site Sherbrooke, Quebec, Canada, J1H 5N4 Canada GSK Investigational Site Quebec, Canada, G1J 1Z4 Less <<
NCT01795326 - Completed - -
NCT03739424 Bone Health C... More >>ognitive Health Less << Not Applicable Recruiting March 2020 United States, Georgia ... More >> University of Georgia Recruiting Athens, Georgia, United States, 30606 Contact: Richard D Lewis, PhD    706-542-4901    rdlewis@uga.edu    Contact: Lauren M Coheley, RDN, LD, CDE    404-316-5860    coheley1@uga.edu    Sub-Investigator: Emma M Laing, PhD          Sub-Investigator: Kirk Kealey, PhD          Sub-Investigator: Assaf Oshri, PhD          Sub-Investigator: Jon Udwadia, MD          Sub-Investigator: Patrick J O'Connor Less <<
NCT01934192 - Terminated - -
NCT02969291 Breast Cancer Not Applicable Active, not recruiting October 2018 United States, Massachusetts ... More >> Baystate Medical Center Springfield, Massachusetts, United States, 01109 Less <<
NCT02360046 Hypopituitarism ... More >> Hydrocortisone Lipids Fatty Acids, Nonesterified Insulin Sensitivity Less << Not Applicable Terminated - Switzerland ... More >> Division of Endocrinology, Diabetes and Clinical Nutrition, University Hospital Berne Berne, Switzerland, 3010 Less <<
NCT02299375 Pulmonary Disease, Chronic Obs... More >>tructive Less << Phase 2 Completed - -
NCT02230345 Inflammation ... More >>Dyslipidemia Less << Not Applicable Completed - Switzerland ... More >> Clinical research center, Lausanne University hospital Lausanne, Vaud, Switzerland, 1011 Less <<
NCT00320489 Schizophrenia Phase 3 Completed - -
NCT00106236 Diabetes Mellitus ... More >> Hypertension Hyperlipidemia Less << Phase 1 Phase 2 Completed - Japan ... More >> Sapporo Health Promotion Center Sapporo, Hokkaido, Japan, 060-0063 Less <<
NCT02299375 - Completed - -
NCT01034319 Pre-diabetes ... More >>Overweight Metabolic Syndrome Less << Phase 2 Unknown December 2012 United States, Massachusetts ... More >> Massachusetts General Hospital Practice Based Research Network Boston, Massachusetts, United States, 02114 Less <<
NCT02292771 Obstetric Labour, Premature Phase 3 Terminated(The study was stopp... More >>ed due to the feasibility of recruiting the study in a timely manner) Less << - -
NCT03439540 Obesity Not Applicable Recruiting December 31, 2018 Poland ... More >> Poznan University of Life Sciences Recruiting Poznań, Poland, 60-624 Contact: Joanna Suliburska, Assoc. Prof.    +48 618487334    jsulibur@up.poznan.pl Less <<
NCT02638155 - Unknown December 2016 United States, Texas ... More >> TTU College of Human Sciences Recruiting Lubbock, Texas, United States, 79409 Contact: Allison Childress    806-834-6371    allison.childress@ttu.edu    Contact: Cynthia Dsauza    8067437335 Less <<
NCT01602549 Gastroparesis Phase 2 Completed - Australia, New South Wales ... More >> GSK Investigational Site Randwick, New South Wales, Australia, 2031 Germany GSK Investigational Site Ulm, Baden-Wuerttemberg, Germany, 89081 GSK Investigational Site Bochum, Nordrhein-Westfalen, Germany, 44791 GSK Investigational Site Bonn, Nordrhein-Westfalen, Germany, 53105 GSK Investigational Site Koeln, Nordrhein-Westfalen, Germany, 50937 GSK Investigational Site Jena, Thueringen, Germany, 07747 GSK Investigational Site Berlin, Germany, 13088 Sweden GSK Investigational Site Uppsala, Sweden, SE-751 85 United Kingdom GSK Investigational Site Cambridge, United Kingdom, C2B 2PY GSK Investigational Site Newcastle Upon Tyne, United Kingdom, NE4 5PL GSK Investigational Site Norwich, United Kingdom, NR4 7UY Less <<
NCT03642405 - Active, not recruiting January 1, 2022 Denmark ... More >> Herlev Hospital Herlev, Denmark, 2730 Less <<
NCT01578837 Diabetes Mellitus Type 2 ... More >> Hypertension Less << Phase 1 Phase 2 Completed - Canada, Ontario ... More >> Clinical Nutrition and Risk Factor Modification Centre, St. Michael's Hospital Toronto, Ontario, Canada, M5B 1W8 Croatia Clinical Centre Vuk Vrhovac Zagreb, Croatia, 10000 Less <<
NCT00320489 - Completed - -
NCT01602549 - Completed - -
NCT00841347 Obesity Not Applicable Completed - France ... More >> Hospices Civils de Lyon Lyon, France, 69 002 Less <<
NCT03459703 Obesity Not Applicable Recruiting May 2019 United States, Alabama ... More >> UAB Weight Loss Medicine Clinic Recruiting Birmingham, Alabama, United States, 35205 Contact: David Bryan, M.A.    205-975-0269    dbryan@uab.edu Less <<
NCT01258257 Aneurysmal Subarachnoid Hemorr... More >>hage Less << Phase 3 Completed - Germany ... More >> Charité University Medicine Department of Neurosurgery Campus Virchow Klinikum Berlin, Germany, 13353 Less <<
NCT00444964 Prader-Willi Syndrome Phase 3 Unknown - United States, Missouri ... More >> The Children's Mercy Hospital Recruiting Kansas City, Missouri, United States, 64108 Contact: Merlin G Butler, MD    816-234-3290    mgbutler@cmh.edu    Contact: Wayne Moore, MD    816-234-3844    wmoore@cmh.edu    Principal Investigator: Merlin G Butler, MD Less <<
NCT00986999 HIV Infections ... More >> Cardiovascular Disease Less << Phase 2 Phase 3 Terminated(poor enrollment) - United States, Hawaii ... More >> Hawaii Center for AIDS Honolulu, Hawaii, United States, 96813 Less <<
NCT00986999 - Terminated(poor enrollment) - -
NCT01585948 - Active, not recruiting December 2017 Greece ... More >> Cardiology Department, University Hospital of Ioannina Ioannina, Greece, 45110 Less <<
NCT02292771 - Terminated(The study was stopp... More >>ed due to the feasibility of recruiting the study in a timely manner) Less << - -
NCT00711412 Esophageal Cancer Phase 2 Completed - United States, Illinois ... More >> Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States, 60611-3013 Less <<
NCT01910402 Infection, Human Immunodeficie... More >>ncy Virus Less << Phase 3 Active, not recruiting December 31, 2020 -
NCT00711412 - Completed - -
NCT03732820 Metastatic Castration-resistan... More >>t Prostate Cancer Less << Phase 3 Recruiting August 17, 2022 -
NCT01408056 Infantile Hemangiomas Phase 2 Withdrawn(Difficulty with recr... More >>uitment) Less << - United States, Pennsylvania ... More >> Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT03544281 Multiple Myeloma Phase 2 Recruiting November 28, 2022 United States, Alabama ... More >> GSK Investigational Site Recruiting Birmingham, Alabama, United States, 35294 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com Less <<
NCT02377466 Obstetric Labour, Premature Phase 3 Terminated(Asset terminated by... More >> PIB) Less << - -
NCT01437488 Urothelial Carcinoma Phase 2 Completed - United States, Maryland ... More >> National Cancer Institute Bethesda, Maryland, United States, 20892 United States, Pennsylvania University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Thomas Jefferson University Philadelphia, Pennsylvania, United States, 19107 Less <<
NCT02377466 - Terminated(Asset terminated by... More >> PIB) Less << - -
NCT01437488 - Completed - -
NCT01262898 Gastroparesis Phase 2 Completed - -
NCT00998699 Type 1 Diabetes Phase 2 Completed - Switzerland ... More >> Basel, Switzerland Zurich, Switzerland Less <<
NCT01262898 - Completed - -
NCT01910402 - Active, not recruiting - -
NCT01207609 Morbid Obesity Not Applicable Completed - United States, Georgia ... More >> Hamilton Medical Center Dalton, Georgia, United States, 30722 United States, Tennessee Chattanooga Bariatrics Chattanooga, Tennessee, United States, 37421 Less <<
NCT02681939 Obesity Phase 2 Completed - India ... More >> All India Institute of Medical Sciences, Bhubaneswar Bhubaneswar, Odisha, India, 751019 Less <<
NCT01542242 Diabetes Mellitus Type 2 ... More >> Prader Willi Syndrome Less << Phase 4 Terminated(Subject withdrew) - Canada, British Columbia ... More >> Vancouver General Hospital - Diamond Center Vancouver, British Columbia, Canada, V5Z 1M9 Less <<
NCT03584828 Heart Diseases Not Applicable Not yet recruiting July 2020 Israel ... More >> Sheba Medical Center, Cardiac Rehabilitation Institute Tel Hashomer, Israel, 52621 Less <<
NCT00349778 - Completed - -
NCT03201588 Ophthalmological Disorder Not Applicable Recruiting December 31, 2019 Sweden ... More >> Queen Silvias Childrens Hospital Recruiting Göteborg, Sweden, 41650 Contact: Karin Savman, MD,PhD    +46 ext 739940937    karin.savman@vgregion.se    Contact: Svetlana Najm, MD    +46 ext 738999992    svatlana.najm@vgregion.se    Skanes Universitetssjukhus Recruiting Lund, Sweden Contact: David Ley, Professor    +46 ext 709264824    david.ley@med.lu.se    Contact: Ingrid Pupp, MD,PhD    +46 ext 761712021    ingrid.pupp@med.lu.se    KI Recruiting Stockholm, Sweden, 14157 Contact: Boubou Hallberg, MD.PhD    +46 ext 700021010    boubou.hallberg@karolinska.se    Contact: Dirk Wackernagel, MD    +46 ext 700011758    dirk.wackernagel@karolinska.se Less <<
NCT00266292 Cardiovascular Heart Disease ... More >> Metabolic Syndrome Less << Not Applicable Unknown - Denmark ... More >> Department of Human Nutrition Frederiksberg, Denmark, DK-1958 Less <<
NCT00349778 Multiple Myeloma Phase 2 Completed - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT00140244 HAART-induced Lipodystrophy an... More >>d Metabolic Syndrome Less << Phase 2 Completed - United States, Massachusetts ... More >> Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Less <<
NCT00286962 Diabetes Mellitus, Type 1 Phase 3 Completed - Netherlands ... More >> Isala Klinieken Zwolle, Netherlands, 8000 GM Less <<
NCT03550287 Hypercholesterolemia ... More >> Hyperlipidemias Dietary Supplements Cardiovascular Risk Factor Less << Phase 4 Completed - Spain ... More >> Institute for Health Research IdiPAZ Madrid, Spain, 28046 Less <<
NCT02090114 Prostate Cancer Phase 2 Recruiting April 2019 United States, Maryland ... More >> The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Recruiting Baltimore, Maryland, United States, 21231 Contact: Irina Rifkind, RN, MSN    410-502-2043    irifkin1@jhmi.edu    Contact: Rana Sullivan, RN, BSN    410-614-6337    tomalra@jhmi.edu    Principal Investigator: Samuel Denmeade, MD Less <<
NCT01527253 Metabolic Syndrome ... More >> Insulin Resistance Less << Not Applicable Completed - Sweden ... More >> Antidiabetic Food Centre, Chemical Centre. Lund University Lund, Skane, Sweden, 221 00 Less <<
NCT01764425 Healthy, Overweight and/or Obe... More >>se Subjects Less << Phase 1 Terminated - India ... More >> Piramal Clinical Research Hyderabad, Andhra Pradesh, India, 500013 Veeda Clinical Research Ahmedabad, Gujarat, India, 380015 Less <<
NCT01413646 Metabolic Syndrome Not Applicable Completed - United States, Connecticut ... More >> Yale-Griffin Prevention Research Center Derby, Connecticut, United States, 06418 Less <<
NCT01719913 Metabolic Diseases ... More >> Injury of Gastrointestinal Tract Less << Not Applicable Completed - Denmark ... More >> The Novo Nordisk Foundation of Basic Metabolic Health, Section for Metabolic Genetics Copenhagen, Denmark, 2100 Less <<
NCT03230253 Stroke Patients With Cognitive... More >> Decline Less << Not Applicable Not yet recruiting July 31, 2019 Taiwan ... More >> Kaohsiung Municipal Siaogang Hospital Not yet recruiting Kaohsiung, Taiwan, 812 Contact: Guang Sheng Ho    886-7-8036783 ext 3530 Less <<
NCT02573688 Obesity Not Applicable Completed - Brazil ... More >> GEO - Obesity Study Group Santos, Sao Paulo, Brazil, 11045301 Less <<
NCT03005990 Exercise Addiction ... More >> Sleep Disorder Less << Not Applicable Active, not recruiting January 2020 Taiwan ... More >> National Taiwan University Taipei, Taiwan Less <<
NCT02877680 Diabetes Mellitus, Type 1 Not Applicable Recruiting June 2018 United States, Texas ... More >> Texas Children's Hospital Recruiting Houston, Texas, United States, 77030 Contact: Marisa Hilliard, PhD    832-824-7209    marisa.hilliard@bcm.edu    Contact: Sahar Eshtehardi, MS    832-824-0907    sahar.eshtehardi@bcm.edu Less <<
NCT00687128 Insulin Resistance ... More >> Metabolic Syndrome Obesity Less << Not Applicable Completed - United States, California ... More >> Charles Drew University of Medicine and Science Los Angeles, California, United States, 90059 Less <<
NCT01142817 - Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT02621866 Hypertension Not Applicable Recruiting January 2019 United Kingdom ... More >> Clinical Research Centre and Pharmacology Unit, Western General Hospital Recruiting Edinburgh, United Kingdom, EH4 2XU Contact: Vanessa Melville, RGN    0131 537 2008       Contact: Richard Weller, MD    01315362041 Less <<
NCT03595462 Appetitive Behavior Not Applicable Recruiting December 2018 United States, Indiana ... More >> Purdue University Recruiting West Lafayette, Indiana, United States, 47907 Contact: Heather Leidy, PhD    765-496-0184    hleidy@purdue.edu Less <<
NCT03649698 Sarcopenia Not Applicable Recruiting June 2020 Belgium ... More >> Gerontology and Geriatrics, Department of chronic diseases, metabolism and ageing (CHROMETA) KU Leuven Recruiting Leuven, Vlaams-Brabant, Belgium, 3000 Contact: Lenore Dedeyne, MSc    +32 16 34 01 35    Lenore.dedeyne@kuleuven.be    Principal Investigator: Evelien Gielen, Prof MD PhD Less <<
NCT02671292 Obesity Overw... More >>eight Binge Eating Less << Not Applicable Recruiting May 2021 United States, Maryland ... More >> Uniformed Services University of the Health Sciences Recruiting Bethesda, Maryland, United States, 20814 Contact: Abigail Pine, B.A.    301-295-1598    abigail.pine.ctr@usuhs.edu    Contact: Mary Quattlebaum, B.A.    301-295-0864    mary.quattlebaum.ctr@usuhs.edu    United States, Virginia Fort Belvoir Community Hospital Recruiting Fort Belvoir, Virginia, United States, 22060 Contact: Abigail Pine, B.A.    301-295-1598    abigail.pine.ctr@usuhs.edu    Contact: Mary Quattlebaum, B.A.    301-295-0864    mary.quattlebaum.ctr@usuhs.edu    Principal Investigator: David Klein, MD Less <<
NCT03529695 Obesity Obesi... More >>ty, Childhood Obesity; Familial Less << Not Applicable Not yet recruiting May 31, 2022 United States, California ... More >> University of Southern California Not yet recruiting Los Angeles, California, United States, 90089-9239 Contact: Daniel Soto, MPH    323-442-8211    danielws@usc.edu    Contact: Kayla de la Haye, PhD    (323) 442-8228    delahaye@usc.edu Less <<
NCT02660333 Morbid Obesity Not Applicable Completed - Brazil ... More >> Polydoro Ernani de São Thiago University Hospital Florianópolis, SC, Brazil, 88040900 Less <<
NCT02783989 Cardiovascular Disease Not Applicable Recruiting June 2018 Spain ... More >> IMIM (Hospital del Mar Medical Research Institute) Recruiting Barcelona, Spain, 08003 Contact: Rafael De la Torre Fornell, PharmD, PhD    00343160780 ext 1780    rtorre@imim.es Less <<
NCT03777215 Obesity Early Phase 1 Not yet recruiting June 2022 -
NCT02652975 Breast Neoplasms ... More >> Endothelial Dysfunction Cardiovascular Disease Metabolic Syndrome Less << Not Applicable Active, not recruiting October 2019 Denmark ... More >> Aarhus University Hospital Aarhus, Jutland, Denmark, 8000 Less <<
NCT02245399 Type 2 Diabetes ... More >> Obesity Overweight Cardiovascular Diseases Less << Not Applicable Completed - Canada, Manitoba ... More >> Richardson Centre for Functional Foods and Nutraceuticals, University of Manitoba Winnipeg, Manitoba, Canada, R3T 6C5 Canada, Ontario Risk Factor Modification Centre, St. Michael's Hospital Toronto, Ontario, Canada, M5C 2T2 Canada, Quebec Institute of Nutraceuticals and Functional Foods, Laval University Quebec City, Quebec, Canada, G1V 4G2 Less <<
NCT03310242 Vitamin D Deficiency ... More >> Cardiometabolic Risk Factors Less << Not Applicable Completed - -
NCT03416634 Physical Activity Not Applicable Recruiting December 2018 United States, Georgia ... More >> Paul W. Seavey Internal Medicine Clinic Recruiting Atlanta, Georgia, United States, 30322 Contact: Sharon Berquist, MD    404-778-0480    exerciseismedicine@emory.edu    Contact: Roberto Felipe Lobelo, MD, PhD       felipelobelo@emory.edu Less <<
NCT03625245 Overweight Not Applicable Active, not recruiting September 30, 2018 Spain ... More >> La Paz University Hospital Madrid, Spain Less <<
NCT00140244 - Completed - -
NCT01450423 Epilepsy Epil... More >>epsia Epileptic Seizures Seizure Disorder Less << Phase 2 Unknown May 2012 Denmark ... More >> Center of Research in Childhood Health, University of Southern Denmark Recruiting Odense, Region of Southern Denmark, Denmark, 5000 Contact: Lars Bo Andersen, Professor    +4565504380    lboandersen@health.sdu.dk    Contact: Karsten Froberg, Ass. prof.    +4565503457    kfroberg@health.sdu.dk    Sub-Investigator: Karsten Froberg, ass.prof.          Sub-Investigator: Anne K Thorsen, Stud.scient          Principal Investigator: Lars Bo Andersen, Professor          Epilepsy clinic, Odense University Hospital Recruiting Odense, Region of Southern Denmark, Denmark, 5000 Contact: Ioannis Tsiropoulos, consult.ph.d    +45 65412438    ioannis.tsiropoulos@ouh.regionsyddanmark.dk    Principal Investigator: Ioannis Tsiropoulos, consult.ph.d          Sub-Investigator: Anne K Thorsen, Stud.scient. Less <<
NCT03254329 - Recruiting May 1, 2020 Bangladesh ... More >> International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b) Recruiting Dhaka, Bangladesh, 1212 Contact: Md. Munirul Islam, MD, PhD    +880 2 9827001-10 ext 2352    mislam@icddrb.org    Principal Investigator: Munir Islam, Ph.D.          Brazil Federal University of Rio de Janeiro Recruiting Rio de Janeiro, Brazil, RJ21941-590 Contact: Gilberto Kac, MD, PhD       Gilberto.Kac@gmail.com    Contact: Erica Barros       ericabarros86@gmail.com    Denmark University of Copenhagen Recruiting Copenhagen, Frederiksberg, Denmark, 1958 Contact: Kim F Michaelsen, MD, PhD    +45 35 33 22 21    kfm@nexs.ku.dk    Contact: Kamilla G Eriksen, PhD    +45 35 32 61 76    kge@nexs.ku.dk    Gambia Medical Research Council Gambia Recruiting Bakau, Kombo Saint Mary's, Gambia Contact: Sophie Moore, PhD       sophie.moore@kcl.ac.uk    Contact: Andrew Doel    +44 758081041    andrew.doel@kcl.ac.uk Less <<
NCT01899703 Cholestasis, Intrahepatic Phase 2 Completed - United Kingdom ... More >> GSK Investigational Site Birmingham, West Midlands, United Kingdom, B15 2WB GSK Investigational Site Cambridge, United Kingdom GSK Investigational Site Newcastle upon Tyne, United Kingdom, NE1 4LP Less <<
NCT02547519 Diabetes Mellitus, Type 1 Phase 2 Completed - Germany ... More >> Forschergruppe Diabetes, Klinikum rechts der Isar, Technische Universität München, Lehrstuhl für Diabetes und Gestationsdiabetes der Technischen Universität München München, Germany, 80804 Less <<
NCT02407899 Diabetes Mellitus, Type 1 Phase 4 Recruiting June 2018 China, Hunan ... More >> Institute of Metabolism and Endocrinology, Second Xiangya Hospital, Central South University Recruiting Changsha, Hunan, China, 410011 Contact: Zhiguang Zhou, MD/PhD    86-731-85292154    zhouzg@hotmail.com Less <<
NCT02893150 Overweight Ob... More >>esity Less << Not Applicable Enrolling by invitation July 2019 Brazil ... More >> Centro Mente Aberta de Mindfulness e Promoção de Saúde São Paulo, SP, Brazil Less <<
NCT00701155 - Completed - Egypt ... More >> Giza, Egypt, 0020 Less <<
NCT01403623 Hypothermia, Newborn Phase 4 Completed - Zambia ... More >> University Teaching Hospital Lusaka, Zambia Less <<
NCT00673309 Burns Phase 2 Phase 3 Completed - United States, Texas ... More >> University of Texas Medical Branch Galveston, Texas, United States, 77550 Less <<
NCT02568371 - Unknown September 2018 France ... More >> Centre Hospitalier Universitaire de Bordeaux - PELLEGRIN Recruiting Bordeaux, Aquitaine, France Contact: Stephanie DEBETTE, MD, PhD    +33 5 57 57 16 59    stephanie.debette@u-bordeaux.fr    Contact: Aurore CAPELLI    +33 5 47 30 42 24    aurore.capelli@isped.u-bordeaux2.fr    Sub-Investigator: Christophe TZOURIO, MD, PhD Less <<
NCT03771690 Appetitive Behavior ... More >> Obesity Genetic Predisposition to Disease Less << Not Applicable Completed - United Kingdom ... More >> Loughborough University Loughborough, Leicestershire, United Kingdom, LE11 3TU Less <<
NCT01604434 Hypothermia Not Applicable Recruiting October 2019 Zambia ... More >> University Teaching Hospital Recruiting Lusaka, Zambia Contact: Elwyn Chomba, MD       echomba@zamnet.zm    Sub-Investigator: Theodore C Belsches, MS4          Sub-Investigator: Rohan Kambeyanda, MS4          Sub-Investigator: Tonya R Miller, MS4          Sub-Investigator: Alyssa E Tilly, MS4 Less <<
NCT01604447 Hypothermia Phase 4 Completed - Zambia ... More >> University Teaching Hospital Lusaka, Zambia Less <<
NCT00692562 Type 1 Diabetes Mellitus ... More >> End-stage Renal Disease Less << Phase 1 Phase 2 Completed - China, Fujian ... More >> Fuzhou General Hospital Fuzhou, Fujian, China, 350025 Less <<
NCT01334840 Cardiovascular Diseases Not Applicable Completed - Spain ... More >> Institute of Food Science, Technology and Nutrition (ICTAN), Spanish National Research Council (CISC) Madrid, Spain, 28040 Less <<
NCT03154216 Hyperlipemia, Carbohydrate Ind... More >>ucible Less << Not Applicable Recruiting January 1, 2019 Canada, Saskatchewan (SK) ... More >> College of Kinesiology, University of Saskatchewan Recruiting Saskatoon, Saskatchewan (SK), Canada, S7N5B2 Contact: Philip Chilibeck, PhD    3069661072    phil.chilibeck@usask.ca    Contact: Julianne Gordon, MSc    3069661082    julianne.gordon@usask.ca    Sub-Investigator: Gordon Zello, PhD Less <<
NCT03299049 HIV Infections Phase 3 Active, not recruiting March 11, 2022 -
NCT03417128 Metabolic Syndrome X ... More >> Nutritional and Metabolic Diseases Health Behavior Less << Not Applicable Active, not recruiting March 2021 -
NCT00782535 Chronic Obstructive Pulmonary ... More >>Disease Less << Phase 2 Completed - United States, Florida ... More >> University Clinical Research DeLand, LLC DeLand, Florida, United States, 32720 United States, Kentucky Commonwealth Biomedical Research, LLC Madisonville, Kentucky, United States, 42431 United States, Ohio New Horizons Clinical Research Center Cincinnati, Ohio, United States, 45242 United States, Oregon Clinical Research Institute of Southern Oregon, PC Medford, Oregon, United States, 97504 United States, South Carolina Spartanburg Medical Research Spartanburg, South Carolina, United States, 29303 Less <<
NCT02706834 Dose Finding Study Phase 1 Completed - United States, Maryland ... More >> Baltimore, Maryland, United States United States, Texas Austin, Texas, United States Less <<
NCT03639311 HIV Infections Phase 2 Not yet recruiting November 30, 2020 United States, Florida ... More >> GSK Investigational Site Not yet recruiting Fort Lauderdale, Florida, United States, 33316 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    United States, Texas GSK Investigational Site Not yet recruiting Dallas, Texas, United States, 75246 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com Less <<
NCT02706834 - Completed - -
NCT02957630 Contraception ... More >> Liver Metabolism Hemostasis Parameter Less << Phase 1 Phase 2 Completed - Netherlands ... More >> Dinox BV Groningen, Netherlands, 9713 GZ Less <<
NCT01900860 Age-Related Osteoporosis Not Applicable Active, not recruiting September 30, 2018 Canada, Alberta ... More >> The University of Calgary Calgary, Alberta, Canada, T2N 4Z6 Less <<
NCT02731755 Healthy Not Applicable Unknown December 2016 United Kingdom ... More >> Hugh Sinclair Unit of Human Nutrition Recruiting Reading, Berkshire, United Kingdom, RG6 6AP Contact: Jeremy P Spencer, PhD    +44(0)1183788724    j.p.spencer@reading.ac.uk    Principal Investigator: Jeremy P Spencer, PhD          Hugh Sinclair Unit of Human Nutrition Recruiting Reading, United Kingdom, RG66AP Contact: Sarah Hargreaves, Unit Manager    0118 378 7771    s.e.hargreaves@reading.ac.uk    Contact: Angelika Kristek, Research assistant    0118 378 7771    a.kristek@reading.ac.uk    Principal Investigator: Jeremy Spencer, Professor Less <<
NCT02810873 - Terminated(Study terminated by... More >> PI) Less << - -
NCT03376854 Respiratory Distress Syndrome,... More >> Adult Less << Not Applicable Recruiting June 30, 2020 United States, Maryland ... More >> University of Maryland Medical Center Recruiting Baltimore, Maryland, United States, 21201 Contact: Jeffrey D Hasday, MD    410-328-8141    jhasday@som.umaryland.edu    Contact: Carl B Shanholtz, MD    410-328-8141    cshanhol@som.umaryland.edu Less <<
NCT02668172 Acromegaly Phase 4 Unknown June 2017 Netherlands ... More >> Erasmus Medical Center Rotterdam, South Holland, Netherlands, 3000CA Less <<
NCT02256722 Healthy Phase 1 Completed - -
NCT00118937 Diabetes Mellitus, Type 1 Phase 4 Completed - -
NCT02810873 Breast Carcinoma Not Applicable Terminated(Study terminated by... More >> PI) Less << - -
NCT03630588 Obesity, Abdominal Phase 2 Not yet recruiting November 2018 Spain ... More >> Centro Tecnológico de Nutrición y Salud (Eurecat-Reus) Recruiting Reus, Tarragona, Spain Contact: Rosa Solà, Dr       rosa.sola@urv.cat Less <<
NCT00794131 Advanced Cancers (Solid Tumors... More >>) Less << Phase 1 Completed - United Kingdom ... More >> Royal Marsden Hospital Surrey, United Kingdom Less <<
NCT01891513 - Completed - United States, Florida ... More >> UF Institute on Aging Clinical and Translational Research Building Gainesville, Florida, United States, 32611 Less <<
NCT01817959 Islet Transplantation in Diabe... More >>tes Mellitus Type 1 Less << Phase 3 Completed - United States, Illinois ... More >> The University of Chicago Medical Center, Department of Surgery, Division of Abdominal Organ Transplantation Chicago, Illinois, United States, 60637 Czechia Institute for Clinical and Experimental Medicine (IKEM), Diabetes Centre; Department of Diabetes. Praha, Czechia, 14021 Italy Dipartimento di Medicina Interna e Specialistica; IRCCS Ospedale San Raffaele Milan, Italy, 20132 S.S.D. Diabetologia, Azienda Ospedaliera Ospedale Niguarda Ca' Granda, Piazza Ospedale Maggiore 3 Milan, Italy, 20162 Sweden Transplant Institute - Sahlgrenska University Hospital Göteborg, Sweden, 41345 Department of Nephrology and Transplantation; Skane University Hospital Malmö, Sweden, 20502 Department of Transplantation Surgery; The Karolinska University Hospital Stockholm, Sweden, 14186 Division for Transplantation and Liver Surgery; Department of Surgery; Uppsala University Hospital Uppsala, Sweden, 75185 United Kingdom Institute of Transplantation, Newcastle upon Tyne Hospitals - NHS Foundation Trust, Freeman Hospital Newcastle upon Tyne, United Kingdom, NE7 7DN Less <<
NCT02189746 Hypothermia, Newborn Not Applicable Completed - Zambia ... More >> University Teaching Hospital Lusaka, Zambia Less <<
NCT02432586 Type 1 Diabetes Mellitus Not Applicable Completed - -
NCT01577277 - Completed - Denmark ... More >> Department of Human Nutrition, Faculty of Life Sciences, University of Copenhagen Copenhagen, Denmark Copenhagen, Denmark, 1958 Less <<
NCT02230631 - Completed - Brazil ... More >> Säo Paulo, Brazil, 05001-400 Less <<
NCT01911910 Cardiovascular Disease Not Applicable Completed - United Kingdom ... More >> Centre for Advanced Cardiovascular Imaging, William Harvey Research Institute, Queen May University of London London, United Kingdom, E2 9JX Less <<
NCT02284009 Diabetes Mellitus, Type 1 Phase 2 Completed - France ... More >> GSK Investigational Site Amiens Cedex 1, France, 80054 GSK Investigational Site Bois-Guillaume, France, 76230 GSK Investigational Site Caen Cedex 9, France, 14033 GSK Investigational Site Lille Cedex, France, 59037 GSK Investigational Site Strasbourg cedex, France, 67091 Germany GSK Investigational Site Muenchen, Bayern, Germany, 80804 GSK Investigational Site Frankfurt, Hessen, Germany, 60590 GSK Investigational Site Duesseldorf, Nordrhein-Westfalen, Germany, 40225 GSK Investigational Site Dresden, Sachsen, Germany, 01307 Italy GSK Investigational Site Latina, Lazio, Italy, 04100 GSK Investigational Site Milano, Lombardia, Italy, 20132 GSK Investigational Site Roma, Italy, 00128 Spain GSK Investigational Site Alzira/Valencia, Spain, 46600 GSK Investigational Site Badalona, Spain, 08916 GSK Investigational Site Barcelona, Spain, 08036 GSK Investigational Site Granada, Spain, 18012 GSK Investigational Site Hospitalet de Llobregat, Spain, 08907 GSK Investigational Site Lleida, Spain, 25198 GSK Investigational Site Madrid, Spain, 28006 GSK Investigational Site Málaga, Spain, 29010 GSK Investigational Site Pama de Mallorca, Spain, 07010 GSK Investigational Site San Juan (Alicante), Spain, 03550 GSK Investigational Site Sevilla, Spain, 41014 United Kingdom GSK Investigational Site Ayr, United Kingdom, KA6 6DX GSK Investigational Site Birmingham, United Kingdom, B9 5SS GSK Investigational Site Bristol, United Kingdom, BS2 8HW GSK Investigational Site Cardiff, United Kingdom, CF14 4XN GSK Investigational Site Darlington, United Kingdom, DL3 6HX GSK Investigational Site Dundee, United Kingdom, DD1 9SY GSK Investigational Site Durham, United Kingdom, DH1 5TW GSK Investigational Site Glasgow, United Kingdom, G31 2ER GSK Investigational Site Liverpool, United Kingdom, L7 8XP GSK Investigational Site London, United Kingdom, E1 2AT GSK Investigational Site Newcastle upon Tyne, United Kingdom, NE1 4LP GSK Investigational Site Sheffield, United Kingdom, S5 7AU Less <<
NCT01514942 PCOS Phase 4 Completed - Italy ... More >> Istituto di Patologia Ostetrica e Ginecologica Catania, Italy Less <<
NCT01561612 Effect of Breastfeeding on Mat... More >>ernal and Child Health Outcomes Less << Not Applicable Completed - Belarus ... More >> Maternal and Child Health Center Minsk, Belarus Less <<
NCT01711892 Prostatic Neoplasms ... More >> Exercise Soccer Training Androgen Deprivation Therapy Less << Not Applicable Completed - Denmark ... More >> University of Copenhagen, Centre of Integrated Rehabilitation of Cancer Patients Copenhagen, Denmark, 2100 Less <<
NCT00773279 Diabetes Diab... More >>etes Mellitus, Type 1 Diabetes Mellitus, Type 2 Delivery Systems Less << Phase 3 Completed - -
NCT00773279 - Completed - -
NCT02012985 Primary Hyperoxaluria Phase 1 Phase 2 Completed - France ... More >> Hôpital Robert-Debré, Néphrologie Pédiatrique Paris, Cedex 19, France, 75945 Hôpital des Enfants, Centre de référence maladies rénales rares du Sud-Ouest (SORARE), CHU de Bordeaux Bordeaux, France, 33076 Hôpital Femme Mère Enfant, Lyon - Paediatric Dept Lyon, France, 69677 Bron Hôpital Necker-Enfants Malades,Centre de référence des Maladies Rénales Héréditaires de l'Enfant et de l'Adulte (MARHEA) Paris, France, 75015 Germany Universitätsklinikum Bonn, Dept of Paediatric Nephrology Bonn, Germany, DE-53113 United Kingdom Birmingham Children's Hospital NHS Foundation Trust - Dept of Nephrology Birmingham, United Kingdom, B4 6NH Royal Free Hospital -UCL Centre for Nephrology London, United Kingdom, NW3 2QG Great Ormond Street Hospital for Children NHS Trust London, United Kingdom, WCIN 3JH Less <<
NCT01522742 - Terminated - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT01370720 Irritable Bowel Syndrome Phase 2 Unknown January 2013 Italy ... More >> Dept Internal Medicine and Gastroenterology, Policlinico Sant'Orsola-Malpighi Recruiting Bologna, Italy, I-40138 Contact: Vincenzo Stanghellini, MD    +39 051 6364101    Prof. Vincenzo Stanghellini    Contact: Rosanna Cogliandro, MD    +39 051 6364103    rosanna.cogliandro@aosp.bo.it    Principal Investigator: Vincenzo Stanghellini, MD Less <<
NCT01129206 Adenocarcinoma of the Esophagu... More >>s Adenocarcinomas of the Gastroesophageal Junction Recurrent Esophageal Cancer Squamous Cell Carcinoma of the Esophagus Stage IV Esophageal Cancer Less << Phase 2 Completed - United States, Ohio ... More >> Ohio State University Columbus, Ohio, United States, 43210 Less <<
NCT03077048 Renal Insufficiency, Chronic Phase 1 Phase 2 Completed - Czechia ... More >> Thomayer Hospital Clinical - Pharmacology Unit (CPU) Prague, Czechia, 140 59 Less <<
NCT03348163 HIV Infections Phase 4 Recruiting April 1, 2020 United States, Texas ... More >> Thomas Street Health Center Recruiting Houston, Texas, United States, 77009 Contact: Anastasia Teper, MA    713-500-6797    Anastasia.Teper@uth.tmc.edu Less <<
NCT01129206 - Completed - -
NCT00111332 HIV Infections Not Applicable Completed - United States, Massachusetts ... More >> Mass General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT00600067 - Completed - -
NCT01378767 Effects of Krill Oil on Human ... More >>Health Less << Not Applicable Completed - United States, Tennessee ... More >> Cardiorespiratory/Metabolic Laboratory Memphis, Tennessee, United States, 38152 Less <<
NCT00600067 Diabetes Phase 2 Completed - United States, Alabama ... More >> Research Site Birmingham, Alabama, United States United States, California Research Site Los Angeles, California, United States Research Site San Francisco, California, United States Research Site Spring Valley, California, United States Research Site Walnut Creek, California, United States United States, Maryland Research Site Bethesda, Maryland, United States United States, Texas Research Site Austin, Texas, United States Research Site San Antonio, Texas, United States United States, Virginia Research Site Richmond, Virginia, United States Less <<
NCT02569073 Esophageal Diseases Phase 4 Suspended(Funding) October 2020 United States, Pennsylvania ... More >> Temple University Hospital Philadelphia, Pennsylvania, United States, 19140 Less <<
NCT00737633 - Terminated(Limited regulatory ... More >>value to uncontrolled trials. No safety/efficacy concerns.) Less << - -
NCT02485158 Healthy Not Applicable Completed - -
NCT03378999 Cholesterol Metabolism Not Applicable Recruiting December 2018 Netherlands ... More >> Maastricht University Medical Center Recruiting Maastricht, Limburg, Netherlands, 6229 ER Contact: José van den Driessche, MSc    +31 43 3881313    j.vandendriessche@maastrichtuniversity.nl Less <<
NCT02560493 Childhood Obesity Not Applicable Completed - United States, Louisiana ... More >> Pennington Biomedical Research Center Baton Rouge, Louisiana, United States, 70808 Less <<
NCT00737633 Diabetes Phase 2 Terminated(Limited regulatory ... More >>value to uncontrolled trials. No safety/efficacy concerns.) Less << - United States, Alabama ... More >> Research Site Birmingham, Alabama, United States United States, California Research Site Los Angeles, California, United States Research Site San Francisco, California, United States Research Site Spring Valley, California, United States Research Site Walnut Creek, California, United States United States, Maryland Research Site Bethesda, Maryland, United States United States, Texas Research Site Austin, Texas, United States Research Site San Antonio, Texas, United States United States, Virginia Research Site Richmond, Virginia, United States Less <<
NCT00457002 Venous Thrombosis ... More >> Pulmonary Embolism Less << Phase 3 Completed - -
NCT01396356 - Completed - United States, Kansas ... More >> The University of Kansas Medical Center Kansas City, Kansas, United States, 66160 Less <<
NCT03478969 Diabetes Mellitus, Type 1 Not Applicable Recruiting February 29, 2020 Austria ... More >> LKH Graz, Medizinische Universität Graz Recruiting Graz, Austria, 8036 Medizinische Universität Innsbruck Recruiting Innsbruck, Austria, 6020 Salzburger Landeskliniken - Universitätsklinikum Salzburg (SALK) Recruiting Salzburg, Austria, 5020 Diakonissen & Wehrle Privatklinik GmbH, Standort Andräviertel Recruiting Salzburg, Austria, 5026 Hietzing Hospital Not yet recruiting Vienna, Austria, 1130 Germany Diabetes Klinik Bad Mergentheim GmbH Not yet recruiting Bad Mergentheim, Germany, 97980 Diabeteszentrum am Sophie-Charlotte-Platz Not yet recruiting Berlin, Germany, 10627 InnoDiab Forschung GmbH Recruiting Essen, Germany, 45136 Gemeinschaftspraxis Drs Bieber Kraus Nolte Vortherms Recruiting Lage, Germany, 32791 Diabeteszentrum am CKQ Recruiting Quakenbrueck, Germany, 49610 Diabendo Praxiszentrum Recruiting Rostock, Germany, 18057 Poland Regionalne Centrum Diabetologii - Uniwersyteckie Centrum Kliniczne Not yet recruiting Gdansk, Poland, 80-952 Jagiellonian University Not yet recruiting Krakow, Poland, 31-501 Central Clinical Hospital of the MSWiA in Warsaw Not yet recruiting Warsaw, Poland, 02-507 United Kingdom Queen Elizabeth Hospital Not yet recruiting Birmingham, United Kingdom, B15 2TH Addenbrookes Hospital Not yet recruiting Cambridge, United Kingdom, CB2 2QQ King's College Hospital London Not yet recruiting London, United Kingdom, SE5 9RJ Imperial College Healthcare - St. Mary's Hospital Not yet recruiting London, United Kingdom, W2 1NY Manchester Royal Infirmary, University Hospital Not yet recruiting Manchester, United Kingdom, M13 9WL Less <<
NCT01387659 Diabetes Immu... More >>nosuppression Less << Phase 4 Terminated(Study terminated du... More >>e to slow enrollment) Less << - United States, Texas ... More >> University of Texas Medical Branch Galveston, Texas, United States, 77555 Less <<
NCT01457794 Metabolic Syndrome X Not Applicable Completed - Denmark ... More >> Department of Human Nutrition, Faculty of Life Sciences, University of Copenhagen Copenhagen, Denmark, 1958 Less <<
NCT02485158 - Completed - -
NCT01621308 - Completed - Netherlands ... More >> Diaconessenhuis Hospital Meppel, Drenthe, Netherlands Isala clinics Zwolle, Overijssel, Netherlands, 8000GK Less <<
NCT00191282 Diabetes Mellitus, Type 2 ... More >> Acute Myocardial Infarction Less << Phase 4 Completed - -
NCT00191282 - Completed - -
NCT02249429 Lymphoma, Malignant Phase 1 Phase 2 Completed - United States, New York ... More >> Weill Cornell Medicine New York, New York, United States, 10065 Bosnia and Herzegovina University Clinical Center Republic of Srpska Banja Luka, Bosnia and Herzegovina, 78000 University Clinical Center Sarajevo Sarajevo, Bosnia and Herzegovina, 71000 France Insitute Curie Saint-Cloud, Paris, France, 92210 Israel Univeristy Hospital Haifa Haifa, Israel Serbia Institute for Oncology and radiology of Serbia Belgrade, Serbia, 110000 Clinical Center Kragujevac Kragujevac, Serbia, 34000 Clinical Center Nis Nis, Serbia, 118000 United Kingdom Guy's Hospital London, United Kingdom, SE1 9RT Royal Marsden NHS Foundation Trust London, United Kingdom University College Hospital London London, United Kingdom Churchill Hospital Oxford, United Kingdom, OX3 7DQ Less <<
NCT02487888 Pain Chronic ... More >>Pain Mental Disorders Cardiovascular Diseases Diabetes Mellitus, Type 2 Arthritis Less << Not Applicable Unknown December 2016 -
NCT00457002 - Completed - -
NCT01963845 Non-alcoholic Fatty Liver Dise... More >>ase Less << Phase 2 Completed - United States, California ... More >> University of California, San Diego San Diego, California, United States, 92103 Less <<
NCT01262781 - Completed - United States, California ... More >> San Francisco General Hospital San Francisco, California, United States, 94110 Less <<
NCT02168062 Prostate Adenocarcinoma Phase 2 Suspended(Funding) December 31, 2020 United States, California ... More >> UCSF Medical Center-Mount Zion San Francisco, California, United States, 94115 Less <<
NCT01886482 Body Mass Index Quantitative T... More >>rait Locus 7 Disorder Tangier Disease Less << Phase 3 Completed - Iran, Islamic Republic of ... More >> Isfahan University of Medical Sciences Isfahan, Iran, Islamic Republic of Less <<
NCT03088332 Obesity Not Applicable Recruiting December 31, 2017 Brazil ... More >> Mario Covas Hospital Recruiting Santo André, SP, Brazil, 09190-615 Contact: Eduardo Grecco       dreduardogrecco@gmail.com    Kaiser Day hospital Recruiting Sao Jose do Rio Preto, SP, Brazil Contact: Luiz Gustavo de Quadros, MD       gustavo_quadros@hotmail.com    9 de Julho Hospital Recruiting Sao Paulo, SP, Brazil, 01409-002 Contact: Manoel Galvao Neto       galvaon@gmail.com Less <<
NCT01581177 Asthma Phase 2 Completed - United States, California ... More >> Amphastar Site 0001 San Jose, California, United States, 95117 United States, Oregon Amphastar Site 0025 Medford, Oregon, United States, 97504 United States, Texas Amphastar Site 0030 New Braunfels, Texas, United States, 78130 Amphastar Site 0032 San Antonio, Texas, United States, 78229 Less <<
NCT01564732 - Terminated(Sponsor withdrew fu... More >>nding.) Less << - -
NCT03344016 Pheochromocytoma ... More >> Paraganglioma Less << Not Applicable Recruiting November 2040 Germany ... More >> Klinikum der Universität München Recruiting München, Germany, 80336 Contact: Felix Beuschlein, M.D.    +41 44 255 36 25    felix.beuschlein@med.uni-muenchen.de    Contact: Martin Reincke, M.D.    +49 89 4400 52100    martin.reincke@med.uni-muenchen.de Less <<
NCT03020316 Coronary Artery Disease Not Applicable Recruiting January 1, 2025 United States, New York ... More >> HeartHealth - Weill Cornell Medical College Recruiting New York, New York, United States, 10021 Contact: Jody Goldman    646-962-4278    4StepsTrial@med.cornell.edu Less <<
NCT03301948 Metabolic Disease ... More >> Appetitive Behavior Less << Not Applicable Recruiting April 2018 United Kingdom ... More >> Leeds Beckett University Recruiting Leeds, United Kingdom, LS6 3QS Contact: Kevin Deighton    0113 81 23582 ext 23582    K.Deighton@leedsbeckett.ac.uk Less <<
NCT01564732 Morbid Obesity Not Applicable Terminated(Sponsor withdrew fu... More >>nding.) Less << - United States, Pennsylvania ... More >> University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States, 15213 Less <<
NCT00953004 Obesity Not Applicable Unknown December 2009 Denmark ... More >> University of Copenhagen, Department og Human Nutrition Frederiksberg C, Denmark, 1958 Less <<
NCT03228979 Stroke Not Applicable Not yet recruiting November 30, 2021 India ... More >> Christian Medical College and Hospital Ludhiana, Punjab, India, 141008 Less <<
NCT03002259 Inflammatory Response Phase 4 Not yet recruiting May 2021 -
NCT02398253 Obesity Overw... More >>eight Less << Not Applicable Completed - Iran, Islamic Republic of ... More >> NovinDiet Clinic Tehran, Iran, Islamic Republic of, 1913635136 Less <<
NCT01963845 - Completed - -
NCT02246998 HIV-1 Infection Phase 4 Completed - Belgium ... More >> Brussels, Belgium Ghent, Belgium France Lyon, France Paris, France Rennes, France Tourcoing, France Ireland Dublin, Ireland Spain Barcelona, Spain Madrid, Spain Seville, Spain United Kingdom Birmingham, United Kingdom Bournemouth, United Kingdom Brighton, United Kingdom Bristol, United Kingdom Coventry, United Kingdom Liverpool, United Kingdom London, United Kingdom Manchester, United Kingdom Newcastle, United Kingdom Sheffield, United Kingdom Less <<
NCT01962402 Weight Gain Phase 4 Unknown - United States, California ... More >> VA Long Beach Recruiting Long Beach, California, United States, 90822 Contact: Susan Shakib, Pharm.D.    562-826-8000 ext 4564    susan.shakib@va.gov Less <<
NCT02063334 Vitamin D Receptor Target Gene... More >> Expression Serum 25(OH)D Concentration Less << Phase 1 Completed - Finland ... More >> University of Eastern Finland Kuopio, Finland, 70211 Less <<
NCT03155139 - Recruiting April 30, 2019 China, Chongqing ... More >> The First Affiliated Hospital of Chongqing Medical University Recruiting Chongqing, Chongqing, China, 400016 Contact: Qifu Li, PhD    +86 23 89011552    liqifu@yeah.net Less <<
NCT01397227 Malaria Phase 1 Phase 2 Completed - United States, Washington ... More >> Malaria Clinical Trials Center at Seattle Biomedical Research Institute Seattle, Washington, United States, 98109 Less <<
NCT02319577 Non Small Cell Lung Cancer Phase 2 Unknown December 2015 Italy ... More >> IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro Recruiting Genova, Italy, 16132 Contact: Francesco Grossi, MD    +39 010 5600385    francesco.grossi@hsanmartino.it Less <<
NCT02786238 Obesity Not Applicable Active, not recruiting August 2020 -
NCT03437616 Coronary Heart Disease Not Applicable Enrolling by invitation December 2029 Finland ... More >> Rehabilitation Foundation Helsinki, Malminkartano, Finland, 00410 Less <<
NCT01300676 Postmenopausal Syndrome Phase 2 Phase 3 Completed - Malaysia ... More >> Clinical Trial Unit, Hospital USM Kubang Kerian, Kelantan, Malaysia, 16150 Less <<
NCT00127634 Diabetes Mellitus, Type 1 Phase 3 Completed - -
NCT02259205 Cardiovascular Diseases Not Applicable Unknown October 2015 Greece ... More >> Harokopio University, Department of Nutrition and Dietetics Recruiting Athens, Attiki, Greece, 17671 Contact: George Milias, PhD    +302109549100 ext 181    gmilias@yahoo.com    Contact: Costas Anastasiou, PhD    +302109549100 ext 181    acostas@hua.gr Less <<
NCT00597285 - Terminated - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT02246998 - Completed - -
NCT01663753 Cancer of the Uterine Cervix Not Applicable Active, not recruiting May 2018 France ... More >> Service de Médecine Nucléaire, Institut de cancérologie de l'Ouest - Site Paul Papin Angers, France, 49933 Service Gynécologie Obstétrique, Hôpital Pellegrin, CHU Bordeaux Bordeaux, France, 33076 Service de Gynécologie, Hôpital Femme Mère Enfant, Hospices Civils de Lyon Bron, France, 69677 Service de Chirurgie Oncologique, Centre de Lutte Contre le Cancer Georges-François Leclerc Dijon, France, 21079 Centre Oscar Lambret Lille, France, 59020 Service de Gynécologie Obstétrique, Hôpital de la Croix-Rousse, Hospices Civils de Lyon Lyon, France, 69004 Service de Gynécologie Obstétrique, Hôpital Nord Marseille, France, 13915 Service de Chirurgie Gynécologique, Hôpital Arnaud de Villeneuve Montpellier, France, 34295 Service de Radiothérapie, C.R.L.C. Val d'Aurelle Montpellier, France, 34298 Service de Gynécologie, Hôpital Archet II Nice, France, 06200 Service de Gynécologie, Hôpital Européen Georges Pompidou, APHP Paris, France, 75015 Service de Gynécologie Obstétrique, Hôpital Tenon, APHP Paris, France, 75020 Service de Chirurgie Gynécologique, Institut Curie Paris, France, 75248 Service de Gynécologie Obstétrique, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon Pierre-Bénite, France, 69310 Service de Gynécologie Obstétrique, CHU la Milétrie Poitiers, France, 86021 Service de Gynécologie Obstétrique, CHU Anne de Bretagne Hôpital Sud Rennes, France, 35000 Département des Radiations, Centre Eugène Marquis Rennes, France, 35042 Service de Chirurgie, Centre Henri Becquerel Rouen, France, 76038 Service de Chirurgie Gynécologique, Institut Curie - Hôpital René Huguenin Saint-Cloud, France, 92210 Service de Gynécologie Obstétrique, CHU St-Etienne Saint-Etienne, France, 42055 Servce de Médecine Nucléaire, Centre René Gauducheau, CRLCC Nantes Atlantique Saint-Herblain, France, 44805 Département de Radiothérapie, Institut de Cancérologie de la Loire Saint-Priest en Jarez, France, 42271 Service de Chirurgie Oncologique, Institut de Cancérologie de Lorraine Vandoeuvre lès Nancy, France, 54519 Service de Médecine Nucléaire, Hôpital Brabois Vandoeuvre-lès-Nancy, France, 54511 Less <<
NCT02459639 - Unknown May 2017 -
NCT02024425 Obesity and Overweight Phase 4 Completed - Spain ... More >> Hospital Universitario La Paz Madrid, Spain, 28061 Less <<
NCT02991079 Healthy Not Applicable Completed - Spain ... More >> Primary Care Research Unit - The Alamedilla Center for Health Salamanca, Spain, 37003 Less <<
NCT03444233 Non-Alcoholic Fatty Liver Dise... More >>ase Obesity Less << Phase 4 Completed - -
NCT01213394 Kidney Transplantation ... More >> Cardiovascular Diseases Less << Phase 3 Terminated(Poor recruitment.) - Canada, Ontario ... More >> St. Michael's Hospital Toronto, Ontario, Canada, M5C 2T2 Less <<
NCT01401387 Adenocarcinoma of the Pancreas... More >> Normal Pancreatic Exocrine Function Less << Phase 4 Withdrawn(study never started) May 2013 Netherlands ... More >> Erasmus Medical Center Rotterdam, Zuid-Holland, Netherlands, 3000 WB Less <<
NCT02918032 - Recruiting October 2020 United States, California ... More >> Stanford University Recruiting Stanford, California, United States, 94305-2004 Contact: Sean M Wu    650-723-2300       United States, New York Columbia University Recruiting New York, New York, United States, 10027 Contact: Salvatore DiMauro    212-854-1754       Austria University of Graz Recruiting Graz, Steiermark, Austria, 8010 Contact: Rudolf Zechner    +43-316-380-0       China, Beijing Peking University First Hospital Recruiting Beijing, Beijing, China, 100034 Contact: Yun Yuan    +86-66551122       France Pitié-Salpêtrière Hospital Recruiting Paris, France, 75013 Contact: Pascal Laforêt    +33-1-42-16-00-00       Contact: Karim Wahbi    +33-1-42-16-00-00       Germany Ludwig-Maximilians University Recruiting Munich, Bayern, Germany, 80539 Contact: Peter Reilich    +49-89-2180-0       Italy Sapienza University of Rome Recruiting Rome, Lazio, Italy, 00185 Contact: Marcello Arca    +39-6-49911       A.C.O. San Filippo Neri Hospital Recruiting Rome, Lazio, Italy, 00193 Contact: Elena M Pennisi, MD, Ph.D.    +39-6-33061       Catholic University Recruiting Milano, Lombardia, Italy, 20123 Contact: Daniela Tavian, MD    +39-2-72341       University of Padova Recruiting Padova, Veneto, Italy, 35122 Contact: Corrado Angelini    +39-49-827-5111       Japan Graduate School of Osaka University Recruiting Suita-city, Osaka-prefecture, Japan, 565-0874 Contact: Kenichi Hirano, MD, Ph.D.    +81-6-6872-8215       National Center of Neurology and Psychiatry Recruiting Kodaira-city, Tokyo, Japan, 187-8551 Contact: Ichizo Nishino    +81-42-341-2711       Netherlands Maastricht University Recruiting Maastricht, Limburg, Netherlands, 6211 Contact: Matthijs Hesselink    +31-43-388-2222       United Kingdom Harefield Hospital Recruiting Harefield, London, United Kingdom, UB9 6JH Contact: Nick Banner    +44-1895-823-737       New Castle University Recruiting Newcastle upon Tyne, Tyne And Wear, United Kingdom, NE1 7RU Contact: Rita Horvath    +44-191-208-6000 Less <<
NCT02253732 Mild Cognitive Impairment ... More >> Alzheimer Disease Parkinson Disease Healthy Volunteers Less << Not Applicable Completed - Slovakia ... More >> Univeristy Hospital in Bratislava Bratislava, Slovakia, 81369 Inst. Exp. Endocrinology Slovak Acad Sci Bratislava, Slovakia, 83306 Less <<
NCT03764085 Sepsis Intoxi... More >>cation; Septic Less << Phase 4 Recruiting October 31, 2019 Georgia ... More >> "Unimedi Adjara" LLC Recruiting Batumi, Georgia Contact: Sophio Beridze          Kutaisi Referral Hospital Recruiting Kutaisi, Georgia Contact: Nino Babunashvili          "Unimedi Kakheti" Ltd Recruiting Telavi, Georgia Contact: Maya Makkhetelashvili          Kazakhstan Hospital of the Medical Center of the Administration of the President of the Republic of Kazakhstan Recruiting Astana, Kazakhstan Contact: Nasrulla Shanazarov          Moldova, Republic of Institute of Ambulance Recruiting Chisinau, Moldova, Republic of Contact: Adrian Belyy          State Clinical Hospital of Traumatology and Orthopedy Recruiting Chisinau, Moldova, Republic of Contact: Octavian Cherempey          State Clinical Hospital Recruiting Chisinau, Moldova, Republic of Contact: Victor Cojocaru          Ukraine Dnipro`s Medical Academy of Ministry of Health of Ukraine Recruiting Dnipro, Ukraine, 49005 Contact: Yurii Kobelyatsky          Zaicev's Institute of general and urgent surgery NMA Ukraine Recruiting Kharkiv, Ukraine, 61018 Contact: Stanislav Peev          HSEE of Ukraine "Ukrainian Medical Stomatological Academy"; Poltava Central District Hospital Recruiting Poltava, Ukraine Contact: Alexey Lyhonenko          Zaporizka Medical Academy of postgraduate education, Zaporizkyi Clinical Hospital N9 Recruiting Zaporizhzhya, Ukraine, 69065 Contact: Volodymyr Koshlya          Uzbekistan Republic Centre of Ambulance Recruiting Tashkent, Uzbekistan Contact: Vіsolat Sharipova Less <<
NCT02342301 Sedentary Lifestyle Not Applicable Completed - Canada, Prince Edward Island ... More >> Human Performance and Health Research Lab, University of Prince Edward Island Charlottetown, Prince Edward Island, Canada, C1A4P3 Less <<
NCT03295968 Appetitive Behavior ... More >> Pediatric Obesity Less << Not Applicable Completed - Canada, Ontario ... More >> University of Toronto Toronto, Ontario, Canada, M5S 3E2 Less <<
NCT03337412 Obesity Not Applicable Not yet recruiting May 2, 2019 -
NCT02264743 Venous Thrombosis ... More >> Insulin Resistance Less << Phase 4 Unknown November 2015 United Kingdom ... More >> Chelsea and Westminster NHS Foundation Trust Recruiting London, United Kingdom, SW10 9NH Contact: Nick Panay, MBBS, MRCOG    0203 331 8112    n.panay@imperial.ac.uk    Sub-Investigator: Nick Panay, MBBS,MRCOG          Royal Brompton and Harefield NHS Trust Recruiting London, United Kingdom, SW3 6NP Principal Investigator: John Stevenson, MBBS          Imperial College Healthcare NHS Trust Recruiting London, United Kingdom, W12 0HS Contact: Nick Panay, MBBS, MRCOG    0203 331 8112    n.panay@imperial.ac.uk    Sub-Investigator: Nick Panay, MBBS, MRCOG Less <<
NCT00350064 Metabolic Syndrome Not Applicable Unknown December 2008 United States, Virginia ... More >> University of Virginia General Clinical Research Center Charlottesville, Virginia, United States, 22904 Less <<
NCT03302260 Pre-Eclampsia Not Applicable Not yet recruiting November 2019 -
NCT00411788 Breast Cancer Phase 2 Completed - United States, Connecticut ... More >> Bridgeport Hospital Bridgeport, Connecticut, United States, 06610 Yale Comprehensive Cancer Center at Yale University School of Medicine New Haven, Connecticut, United States, 06519 Less <<
NCT01249742 Diabetes Mellitus Not Applicable Completed - Netherlands ... More >> Children's Diabetes Center Nijmegen Nijmegen, Gelderland, Netherlands, Postbus 9015; 6500 GS Less <<
NCT03699371 Nutrition Aspect of Cancer Not Applicable Not yet recruiting May 1, 2021 Poland ... More >> 2nd Department of Anesthesiology and Critical Care, Medical University of Lublin Not yet recruiting Lublin, Lubelskie, Poland, 20-059 Contact: Paweł Piwowarczyk, MD PhD    511285352 ext +48    piwowarczyk.pawel@gmail.com    Sub-Investigator: Mirosław Czuczwar, MD PhD          Sub-Investigator: Michał Borys, MD PhD          Department of Anesthesiology and Intensive Care, Uniwersytecki Szpital Kliniczny w Opolu Opole, Silesia, Poland, 45-401 Less <<
NCT02775175 Healthy Volunteers Not Applicable Completed - Germany ... More >> Department of Internal and Integrative Medicine, Kliniken Essen-Mitte Essen, Germany, 45276 Less <<
NCT02480504 Obesity CVD ... More >> Dietary Modification Less << Not Applicable Completed - Norway ... More >> Oslo Universitetssykehus, Ullevål, avdeling for preventiv kardiologi Oslo, Norway, 0424 Less <<
NCT02521805 Healthy Not Applicable Completed - Denmark ... More >> University of Copenhagen Frederiksberg, Denmark, 1958 Less <<
NCT03248401 Type 2 Diabetes Mellitus ... More >> Carotid Atherosclerosis Less << Phase 4 Active, not recruiting December 30, 2018 Korea, Republic of ... More >> Seoul National University Bundang Hospital Seongnam, Gyeonggi, Korea, Republic of, 463-707 Less <<
NCT00605891 Chronic Obstructive Pulmonary ... More >>Disease Less << Phase 2 Completed - -
NCT00411788 - Completed - -
NCT02295514 Sepsis Not Applicable Completed - France ... More >> Rouen University Hospital Rouen, France Less <<
NCT02480816 Dyslipidemia Not Applicable Completed - -
NCT02210156 Respiratory Tract Infection Not Applicable Completed - Mexico ... More >> Omnilife Guadalajara, Jalisco, Mexico, 44500 Less <<
NCT03032731 Overweight/Obesity Not Applicable Completed - United Kingdom ... More >> University of Bath Bath, United Kingdom, BA2 7AY Less <<
NCT02478658 Healthy Not Applicable Completed - United States, Texas ... More >> Exercise and Sport Sciences Building Lubbock, Texas, United States, 79423 Less <<
NCT03718988 Microbiome Im... More >>mune Function Cardiovascular Diseases Less << Not Applicable Recruiting December 2019 United States, California ... More >> Stanford University Recruiting Stanford, California, United States, 94305 Contact: Taylor Streaty, BS    650-724-8310    jlmorris@stanford.edu Less <<
NCT01310231 Metastatic Breast Cancer Phase 2 Completed - Canada, Ontario ... More >> London Regional Cancer Program London, Ontario, Canada St. Michael's Hospital Toronto, Ontario, Canada, M5B 1N9 Mount Sinai Hospital Toronto, Ontario, Canada, M5G 1X5 Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Windsor Regional Cancer Centre Windsor, Ontario, Canada, N8W 2X3 Less <<
NCT03585738 Polycystic Ovary Syndrome Not Applicable Not yet recruiting December 31, 2022 -
NCT01779245 Lipid Metabolism Not Applicable Completed - United Kingdom ... More >> Northumbria University Newcastle upon Tyne, Tyne and Wear, United Kingdom, NE1 8ST Less <<
NCT00306098 Diabetes Mellitus, Type I Phase 2 Active, not recruiting May 2021 United States, Florida ... More >> University of Miami, Diabetes Research Institute Miami, Florida, United States, 33136 Less <<
NCT03661294 Spinal Cord Injury, Acute Not Applicable Recruiting August 2019 United Kingdom ... More >> Northern General Hospital Recruiting Sheffield, United Kingdom, S5 7AU Contact: Kidangalil Mathew, Dr       kidangalil.mathew@sth.nhs.uk    Contact: Aimee Card       aimee.card@sth.nhs.uk Less <<
NCT03341429 Obesity Phase 4 Not yet recruiting November 2019 -
NCT03520244 Celiac Disease Not Applicable Completed - Canada, Alberta ... More >> University of Calgary Calgary, Alberta, Canada, T3E4E5 Less <<
NCT03680768 - Recruiting January 1, 2019 Denmark ... More >> University of Copenhagen, Department of Biomedical Sciences Recruiting Copenhagen, Denmark, 2200 Contact: Karina LS Husted, Phd.stud    +4528127945    karinalu@sund.ku.dk    Contact: Jørn W Helge, Prof.    +4535327506    jhelge@sund.ku.dk    Principal Investigator: Jørn W Helge, Prof. Less <<
NCT03075280 Complication Not Applicable Recruiting December 1, 2018 China, Chongqing ... More >> Third Military Medical University Not yet recruiting Chongqing, Chongqing, China, 400038 Contact: Leida Zhang, M. D.    +86 13508320249    zld666@aliyun.com    China, Gansu The first hospital of Lanzhou university Recruiting Lanzhou, Gansu, China, 730000 Contact: Wence Zhou, M. D.    +8609318356919    zhouwc129@163.com    Contact: Wenbo Meng, M. D.    +8609318356213    mengwb@lzu.edu.cn    China, Guangdong The Second Affiliated Hospital of Guangzhou Medical University Not yet recruiting Guangzhou, Guangdong, China, 510260 Contact: Ping Xue, M. D.    +8613316118977    drxueping@medmail.com.cn    China, Hebei The Second Hospital of Hebei Medical University Not yet recruiting Shijiazhuang, Hebei, China, 050000 Contact: Senlin Hou, M. D.    +8615803219882    housenlin2006@126.com    China, Hubei Tongji medical collage,Huazhong University of science and technology Not yet recruiting Wuhan, Hubei, China, 430022 Contact: Kailin Cai, M. D.    +86 13971086496    caikailin@hust.edu.cn    China, Hunan Second Xiangya Hospital, Central South University Not yet recruiting Changsha, Hunan, China, 410011 Contact: Wei Liu, M. D.    +86 13873194825    liuwei0217@gmail.com    China, Jilin The First Hospital of Jilin University Not yet recruiting Changchun, Jilin, China, 130021 Contact: Meng Wang, M. D.    +86 15804300199    wmgdwk@163.com    China, Ningxia General Hospital of Ningxia Medical University Not yet recruiting Yingchuan, Ningxia, China, 750004 Contact: Qi Wang, M. D.    +86 13895098592    wq-6562@163.com    China, Shaanxi The first affiliated hospital of Xi 'an jiaotong university Not yet recruiting Xi'an, Shaanxi, China, 710061 Contact: Hao Sun, M. D.    +86 13891813691    sunhaoxjfy@126.com    China, Shandong Shandong jiaotong Hospital Not yet recruiting Jinan, Shandong, China, 250000 Contact: Kai Zhang, M. D.    +86 13805312159    zhangkai.2159@163.com    China, Shanghai Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine Not yet recruiting Shanghai, Shanghai, China, 200092 Contact: Xuefeng Wang, M. D.    +86 13601833209    wxxfd@live.cn    China, Shanxi Taiyuan Iron and Steel Corporation Hospital Not yet recruiting Taiyuan, Shanxi, China, 030008 Contact: Jijun Zhang, M. D.    +8613700500462    zjj3210@hotmail.com    China, Tianjin Tianjin Nankai Hospital Not yet recruiting Tianjin, Tianjin, China, 300100 Contact: Zhenyu Wang, M. D.    +86 15302021661    Wangzytj@163.com    China, Xinjiang The First Teaching Hospital of Xinjiang Medical University Not yet recruiting Ürümqi, Xinjiang, China, 830054 Contact: Yingmei Shao, M. D.    +86 13579858830    syingmei3000@163.com    China, Zhejiang Shulan Hospital of Zhejiang University Not yet recruiting Hangzhou, Zhejiang, China, 310003 Contact: Qiyong Li, M. D.    +86 13588451838    liqiyong@zju.edu.cn Less <<
NCT03583593 Diabetic Foot Ulcer ... More >> Diabetic Foot Diabetes Mellitus, Type 2 Less << Phase 2 Completed - Cuba ... More >> National Institute of Endocrinology Vedado, Havana, Cuba, 10400 Less <<
NCT00063128 Diabetes Mellitus, Type 1 Phase 2 Completed - -
NCT03690999 Microbiome Im... More >>mune Function Inflammation Less << Not Applicable Not yet recruiting January 1, 2020 United States, California ... More >> Stanford University Not yet recruiting Stanford, California, United States, 94305 Contact: Jennifer Robinson, PhD    650-736-8577    jlmorris@stanford.edu    Sub-Investigator: Christopher D Gardner, PhD Less <<
NCT01935128 Renal Transplant Phase 4 Active, not recruiting December 2020 United States, Ohio ... More >> University of Toledo, Health Science Campus Toledo, Ohio, United States, 43614 Less <<
NCT03362918 Polycystic Ovary Syndrome Not Applicable Recruiting December 1, 2019 Canada, Alberta ... More >> University of Calgary Clinical Trials Unit Recruiting Calgary, Alberta, Canada, T2T 5C7 Contact: Jamie L Benham, MD    4039558325    jlbenham@ucalgary.ca Less <<
NCT01871324 Behavioral Changes Not Applicable Withdrawn(technical issues) March 2019 Israel ... More >> Hadassah Medical Organization, Jerusalem, Israel Jerusalem, Israel Less <<
NCT02310334 Body Temperature Changes Not Applicable Completed - United States, Maryland ... More >> Beltsville Human Nutrition Research Center Beltsville, Maryland, United States, 20705 Less <<
NCT02561221 Obesity Not Applicable Active, not recruiting December 2019 United States, Louisiana ... More >> Pennington Biomedical Research Center Baton Rouge, Louisiana, United States, 70808 Less <<
NCT03192475 Obesity Cardi... More >>ovascular Risk Factor Eating Behavior Diet Modification Physical Activity Quality of Life Mobility Limitation Less << Not Applicable Completed - -
NCT03022214 Dietary Supplementation During... More >> Exercise Less << Not Applicable Completed - United Kingdom ... More >> University of Aberdeen, The Rowett Institute Aberdeen, United Kingdom, AB25 2ZD Less <<
NCT02811900 - Recruiting December 2026 France ... More >> Service de Chirurgie Digestive et Endocrinienne Recruiting Strasbourg, France, 67000 Contact: Didier Mutter, MD, PhD    +33 (0)3 90 11 90 41    didier.mutter@chru-strasbourg.fr    Contact: Michel Vix, MD    +33 (0)3 69 55 10 52    michel.vix@chru-strasbourg.fr Less <<
NCT01382056 Peripheral Artery Disease Not Applicable Completed - Canada, Manitoba ... More >> I.H Asper Clinical Research Institute Winnipeg, Manitoba, Canada, R2H 2A6 Less <<
NCT02763995 HIV Not Applicable Completed - Spain ... More >> Hospital Universitario Virgen de las Nieves Granada, Spain Less <<
NCT03211299 - Completed - Netherlands ... More >> Maastricht University Medical Center Maastricht, Limburg, Netherlands, 6229 ER Less <<
NCT02205476 Hypertrophic Scars Resulting F... More >>rom Prior Breast Scar Revision Surgery Less << Phase 2 Terminated(B5301001 study did ... More >>not meet its predefined efficacy endpoints, the long term follow up study B5301012 was terminated in 1/6/2015. No safety concerns identified.) Less << - United States, Florida ... More >> Stephan Baker MD PA Coral Gables, Florida, United States, 33146 Bayside Ambulatory Center Miami, Florida, United States, 33133 United States, Georgia Kavali Plastic Surgery and Skin Renewal Center Atlanta, Georgia, United States, 30328 Primeter outpatient surgery center Atlanta, Georgia, United States, 30328 United States, Missouri Body Aesthetic Research Center Saint Louis, Missouri, United States, 63141 Less <<
NCT03299972 Sarcopenia Mu... More >>scle Atrophy Less << Not Applicable Recruiting January 2020 United Kingdom ... More >> Coventry University Recruiting Coventry, West Midlands, United Kingdom, CV1 5FB Contact: Corbin Griffen, MSc       griffenc@uni.coventry.ac.uk    Contact: Derek Renshaw, PhD       ab9598@coventry.ac.uk Less <<
NCT00350194 Metabolic Syndrome X Early Phase 1 Unknown June 2012 United States, Washington ... More >> Northwest Lipid Research Clinic (University of Washington Affiliated) Seattle, Washington, United States, 98104 Less <<
NCT02205476 - Terminated(B5301001 study did ... More >>not meet its predefined efficacy endpoints, the long term follow up study B5301012 was terminated in 1/6/2015. No safety concerns identified.) Less << - -
NCT02283242 Abdominal Obesity Metabolic Sy... More >>ndrome Less << Phase 4 Completed - Brazil ... More >> University of São Paulo, Heart Institute, Medical School São Paulo, Brazil, 05403-900 Less <<
NCT03604575 Clamp Study Not Applicable Completed - Russian Federation ... More >> LLL "BioEq" Saint Petersburg, Russian Federation, 197342 Less <<
NCT03410173 Taurine Cogni... More >>tive Decline Diabetes Mellitus Less << Not Applicable Recruiting June 2018 China, Chongqing ... More >> The third hospital affiliated to the Third Military Medical University Recruiting Chongqing, Chongqing, China, 400042 Contact: Yan Zhencheng, MD    86-023-68757882    zhenchengyan@sina.com Less <<
NCT00857818 - Terminated(Slow Accrual) - -
NCT00857818 Schizophrenia ... More >> Schizoaffective Disorder Bipolar I Disorder Metabolic Syndrome Less << Phase 3 Terminated(Slow Accrual) - Canada, Alberta ... More >> Local Institution Calgary, Alberta, Canada, T2N 2T9 Canada, British Columbia Local Institution Pentincton, British Columbia, Canada, V2A 4M4 Local Institution Vancouver, British Columbia, Canada, V6T 2A1 Canada, Ontario Local Institution Hamilton, Ontario, Canada, L8N 3K7 Local Institution London, Ontario, Canada, N6H 4V1 Local Institution Markham, Ontario, Canada, L6B 1A1 Local Institution Mississauga, Ontario, Canada, L5M 4N4 Local Institution Toronto, Ontario, Canada, M5T 1R8 Local Institution Toronto, Ontario, Canada, M5T 2S8 Canada, Quebec Local Institution Montreal, Quebec, Canada, H1N 3M5 Local Institution Montreal, Quebec, Canada, H3A 1A1 Local Institution Montreal, Quebec, Canada, H3M 3A9 Local Institution Montreal, Quebec, Canada, H4H 1R3 Canada Local Institution Quebec, Canada, G1R 2W8 Less <<
NCT03111004 - Completed - -
NCT01572090 Obesity Not Applicable Unknown December 2017 Spain ... More >> Clinica Universidad de Navarra Pamplona, Spain Less <<
NCT02694172 Type 2 Diabetes ... More >> Healthy Overweight Less << Not Applicable Completed - -
NCT00446992 Schizophrenia Phase 1 Phase 2 Completed - Spain ... More >> Unitat Hospitalitzacio - Servei de Psiquiatria G096, Hospital Clinic C/Villarroel, 170 Barcelona, Spain, 08036 Less <<
NCT02064023 Type 1 Diabetes ... More >> Type 2 Diabetes Pregnancy Less << Not Applicable Terminated(Some sites withdrew... More >> because no contract with insulin pump supplier) Less << - Canada, British Columbia ... More >> Jim Pattison Outpatient Care and Surgery Centre Surrey, British Columbia, Canada, V3T 0G9 B.C. Women's Hospital Vancouver, British Columbia, Canada Less <<
NCT02802514 Diabetes Mellitus Phase 4 Terminated - United States, Massachusetts ... More >> GSK Investigational Site Boston, Massachusetts, United States, 02114 Less <<
NCT00446992 - Completed - -
NCT03236337 Physical Activity ... More >> Obesity Children Cardiovascular Cardiorespiratory Fitness Less << Not Applicable Completed - Spain ... More >> Health and Social Research Centre, University of Castilla-La Mancha Cuenca, Spain, 16071 Mairena Sánchez-López Cuenca, Spain, 16071 Less <<
NCT03369145 Insulin Resistance ... More >> Type2 Diabetes Mellitus Non-Alcoholic Fatty Liver Disease Obesity Less << Not Applicable Recruiting October 2018 United Kingdom ... More >> National Centre for Sport and Exercise Medicine, Loughborough University Recruiting Loughborough, Leicestershire, United Kingdom, LE11 3TU Contact: Scott A Willis, MSc    +44 7950 938 338    s.willis2@lboro.ac.uk    Contact: James A King, PhD    +44 1509 228457    J.A.King@lboro.ac.uk    Principal Investigator: Scott A Willis, MSc          Principal Investigator: James A King, PhD          Sub-Investigator: David J Stensel, Professor          Sub-Investigator: Carl J Hulston, PhD          Sub-Investigator: Rachel Woods, PhD          Clifton Campus, Nottingham Trent University Not yet recruiting Nottingham, Nottinghamshire, United Kingdom, NG1 4FQ Contact: David Clayton, PhD    +44 115 941 8418    david.clayton@ntu.ac.uk    Principal Investigator: David Clayton, PhD          Sub-Investigator: Ian Varley, PhD Less <<
NCT02877823 Childhood Obesity Not Applicable Enrolling by invitation August 2020 -
NCT00850629 Obesity Weigh... More >>t Loss Weight Gain Hormone Disturbance Adipose Tissue Insulin Resistance Skeletal Muscle Less << Not Applicable Completed - Germany ... More >> Charite Berlin, Germany, 12200 Less <<
NCT02343497 Dyslipidemias Not Applicable Completed - France ... More >> Centre Nutrition Clinique Naturalpha Lille, France, 59020 Less <<
NCT03120455 Obesity Overw... More >>eight Less << Not Applicable Completed - Iran, Islamic Republic of ... More >> NovinDiet Clinic Tehran, Iran, Islamic Republic of Less <<
NCT03357016 Overweight Po... More >>st Menopausal Women Less << Not Applicable Completed - France ... More >> CREPS Vichy Auvergne Bellerive-sur-Allier, France, 03321 Less <<
NCT02622711 Breast Cancer Not Applicable Active, not recruiting December 2019 Italy ... More >> IEO Istituto Europeo di Oncologia Milan, Italy, 20141 Less <<
NCT03524404 Diabetes Not Applicable Recruiting December 2019 United States, New York ... More >> New York University School of Medicine Recruiting New York, New York, United States, 10016 Contact: Lindsay M Kirshner    646-501-4681    Lindsay.Kirshner@nyumc.org    Principal Investigator: Jeannette Beasley, PhD, MPH, RD Less <<
NCT03530579 Diabetes Prevention Not Applicable Completed - -
NCT03531177 Type2 Diabetes Not Applicable Recruiting March 30, 2019 United Kingdom ... More >> Guys and St Thomas NHS Foundation Trust Recruiting London, United Kingdom, SE1 9RT Contact: Amanda Moore, MSc    +44 20 7848 6023    amanda.moore@kcl.ac.uk Less <<
NCT03526237 Diabetes Mellitus Risk ... More >> Obesity Cardiovascular Risk Factor Less << Not Applicable Completed - -
NCT03542084 Diabetes Mellitus Not Applicable Not yet recruiting June 2020 United States, Massachusetts ... More >> Massachusetts General Hospital Not yet recruiting Boston, Massachusetts, United States, 02114 Contact: Daniel Horn, MD Less <<
NCT03549845 Cardiovascular Diseases ... More >> Cardiovascular Risk Factor Diabetes Mellitus Less << Not Applicable Recruiting December 2021 Canada, Quebec ... More >> Centre de recherche du CHUM Recruiting Montréal, Quebec, Canada, H2X 0A9 Contact: Magali Girard Less <<
NCT03544645 Diabetes Mellitus Not Applicable Completed - Saudi Arabia ... More >> King Saud bin Abdulaziz University for Health Sciences Riyadh, Saudi Arabia, 14611 Less <<
NCT03527667 Smoking Cessation ... More >> Diabetes Mellitus, Type 2 Less << Not Applicable Recruiting December 31, 2018 United States, Oklahoma ... More >> University of Oklahoma Health Sciences Center Recruiting Oklahoma City, Oklahoma, United States, 73104 Contact: Sydney Martinez, PhD    405-271-2229 ext 48087    sydney-martinez@ouhsc.edu    Contact: Afsheen Hasan, MPH    405-271-2229 ext 48597    afsheen-hasan@ouhsc.edu    United Kingdom University of Strathclyde Recruiting Glasgow, Scotland, United Kingdom Contact: Fiona Mitchell, PhD       fiona.c.mitchell@strath.ac.uk    Contact: Kathryn McMillan       kathryn.mcmillan@strath.ac.uk Less <<
NCT03562767 Diabetes Mellitus, Type 2 Not Applicable Recruiting November 2019 United States, Georgia ... More >> Emory Dunwoody Clinic Recruiting Atlanta, Georgia, United States, 30338 Contact: Ambar Kulshreshtha    404-778-6920    akulshr@emory.edu Less <<
NCT03577184 - Not yet recruiting March 2019 -
NCT03565458 Type 2 Diabetes Mellitus Phase 1 Active, not recruiting December 22, 2018 Korea, Republic of ... More >> LG chem Seoul, Gangseo-Gu, Korea, Republic of, 07795 Less <<
NCT03538743 Type 2 Diabetes Mellitus Phase 1 Recruiting April 20, 2019 United States, California ... More >> Anaheim Clinical Trials, LLC Recruiting Anaheim, California, United States, 92801 United States, Florida Qps-Mra, Llc Recruiting South Miami, Florida, United States, 33143 Qps-Mra,Llc Recruiting South Miami, Florida, United States, 33143 United States, Kansas Vince & Associates Clinical Research, Inc. Recruiting Overland Park, Kansas, United States, 66212 Vince and Associates Clinical Research, Inc. Recruiting Overland Park, Kansas, United States, 66212 Less <<
NCT03271580 - Recruiting August 1, 2018 United States, Ohio ... More >> The Ohio State University Hospital East Recruiting Columbus, Ohio, United States, 43203 Contact: Amy Hoover, LPN    614-293-0390    amy.hoover@osumc.edu    Contact: Samir Zaparde, BS    614-313-4921    samir.zaparde@osumc.edu    Principal Investigator: Sashwati Roy, Ph.D          Comprehsive Wound Care Centers,The Ohio State University Hospital Recruiting Columbus, Ohio, United States, 43210 Contact: Amy Hoover, LPN    614-293-0390    amy.hoover@osumc.edu    Contact: Samir Zaparde, MD    614-313-4921    Samir.Zaparde@osumc.edu    Principal Investigator: Sashwati Roy, Ph.D          Davis Heart and Lung Research Institute Recruiting Columbus, Ohio, United States, 43210 Contact: Sashwati Roy, Ph.D    614-906-4612    sashwati.roy@osumc.edu    Contact: Amy Hoover, LPN    6142930390    amy.hoover@osumc.edu    Principal Investigator: Sashwati Roy, Ph.D          Martha Morehouse Medical Plaza Recruiting Columbus, Ohio, United States, 43221 Contact: Amy Hoover, LPN    614-293-0390    amy.hoover@osumc.edu    Contact: Samir Zaparde, MD    614-313-4921    samir.zaparde@osumc.edu    Principal Investigator: Sashwati Roy, Ph.D` Less <<
NCT03270436 Diabetes Mellitus, Type 2 Not Applicable Recruiting January 31, 2020 United States, Arkansas ... More >> University of Arkansas for Medical Sciences Northwest Recruiting Fayetteville, Arkansas, United States, 72703 Contact: Ralph Wilmoth, MPH, MPA    479-713-8692    rowilmoth@uams.edu    Contact: Ayoola Carleton, MA    479-713-8657    acarleton@uams.edu Less <<
NCT03563456 Type 2 Diabetes Mellitus ... More >> High-Intensity Interval Training Resistance Training Oxidative Stress Physical Fitness Less << Not Applicable Completed - Indonesia ... More >> Center for Sports and Exercise Studies, Indonesian Medical and Research Institute, Faculty of Medicine Universitas Indonesia Jakarta, Jakarta Pusat, Indonesia, 10430 Less <<
NCT03274362 Diabetes Mellitus Not Applicable Not yet recruiting December 2017 -
NCT03278483 Diabetes Mellitus ... More >> Tuberculin (Skin Test) Positive Less << Phase 4 Active, not recruiting July 15, 2019 Mexico ... More >> Instituto Nacional de Ciencias Medicas y Nutrición Mexico City, Mexico, 14000 Less <<
NCT03278704 Type 2 Diabetes Mellitus Not Applicable Terminated(Enrollment goal not... More >> met in allotted recruitment period) Less << - United Kingdom ... More >> School of Sport, Exercise and Rehabilitation Sciences, University of Birmingham Birmingham, United Kingdom, B15 2TT Less <<
NCT03269058 Type-2 Diabetes ... More >> Oral Antidiabetics Less << Phase 4 Not yet recruiting March 2019 France ... More >> CHU Dijon Bourgogne Not yet recruiting Dijon, France, 21079 Contact: Bruno VERGES, MD    03 80 29 38 54 ext +33    bruno.verges@chu-dijon.fr    CHU de Nantes Not yet recruiting Nantes, France, 44093 Contact: Michel KREMPF, MD    02 53 48 27 07 ext +33    michel.krempf@univ-nantes.fr Less <<
NCT03259789 Type2 Diabetes Mellitus Phase 3 Active, not recruiting January 2019 -
NCT03288740 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 1 Completed - China ... More >> Novo Nordisk Investigational Site Beijing, China, 100730 Less <<
NCT03292185 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 1 Completed - China, Beijing ... More >> Novo Nordisk Investigational Site Beijing, Beijing, China, 100032 Less <<
NCT03298295 Diabetes Mellitus Not Applicable Recruiting December 31, 2019 Austria ... More >> Division of Plastic, Aesthetic and Reconstructive Surgery Recruiting Graz, Austria, 8036 Contact: Birgit Michelitsch, BSc    +43316385 ext 30357    birgit.michelitsch@medunigraz.at    Contact: Alexandru Tuca, MD    +43316385 ext 30742    alexandru.tuca@medunigraz.at Less <<
NCT03283774 - Completed - Spain ... More >> IDIAP Jordi Gol Barcelona, Spain Less <<
NCT03299010 - Recruiting June 2019 Hong Kong ... More >> The University of Hong Kong Recruiting Hong Kong, Hong Kong Contact: Cindy L.K. Lam    (852) 25185653    clklam@hku.hk Less <<
NCT03279627 - Recruiting December 31, 2019 United States, Pennsylvania ... More >> University of Pittsburgh Medical Center Recruiting Pittsburgh, Pennsylvania, United States, 15213 Contact: Mary T Korytkowski, MD    412-586-9706    mtk7@pitt.edu    Sub-Investigator: Linda Siminerio, PhD          Sub-Investigator: Neeti Patel, MD          Sub-Investigator: Amy Donihi, PharmD          Sub-Investigator: Janya Swami, MD Less <<
NCT03302377 Physical Activity ... More >> Type 2 Diabetes Mellitus Less << Not Applicable Recruiting May 31, 2019 United States, California ... More >> University of California, San Diego Recruiting La Jolla, California, United States, 92093-0628 Contact: Britta Larsen, PhD    858-534-8429    blarsen@ucsd.edu Less <<
NCT03310749 Diabetes Mellitus, Type 2 Phase 1 Completed - Mexico ... More >> Unidad de Farmacología Clínica de la Facultad de Medicina de la Universidad Nacional Autónoma de México Nezahualcóyotl, Estado de México, Mexico, 57740 Less <<
NCT03313297 Diabetes Mellitus, Type 2 Phase 2 Recruiting April 1, 2019 United Kingdom ... More >> Leeds Teaching Hospitals Trust Recruiting Leeds, United Kingdom, LS9 7TF Contact: Ana Tiganescu, PhD    00441133438336    a.tiganescu@leeds.ac.uk Less <<
NCT02907112 Lipidemia Not Applicable Completed - United Kingdom ... More >> David Greenfield Human Physiology Unit Nottingham, Notts, United Kingdom, NG72UH Less <<
NCT03317028 T2DM With Inadequate Glycemic ... More >>Control Less << Phase 2 Recruiting March 31, 2021 United States, Florida ... More >> Clinical Research of South Florida Recruiting Coral Gables, Florida, United States, 33134 Contact: Rosen Jeffrey, MD    305-445-5637    jrosen@crsouthflorida.com    Principal Investigator: Rosen Jeffrey, MD          The Community Research of South Florida Recruiting Hialeah, Florida, United States, 33016 Contact: Carpio Jose, MD    305-441-6611    jcarpio@thecommunityresearch.com    Principal Investigator: Carpio Jose, MD          Taiwan Kaohsiung Veterans General Hospital Recruiting Kaohsiung, Taiwan, 81362 Contact: Chih-Hsun Chu, MD    +886-7-3422-121 ext 8089    chchu@vghks.gov.tw    Principal Investigator: Chih-Hsun Chu, MD          Kaohsiung Chang Gung Memorial Hospital Recruiting Kaohsiung, Taiwan, 833 Contact: Jung-Fu Chen, MD    +886-7-733-7166    0722cjf@cgmh.org.tw    Principal Investigator: Jung-Fu Chen, MD          Chung Shan Medical University Hospital Recruiting Taichung, Taiwan, 402 Contact: Chien-Ning Huang, MD    +886-4-2473-9595 ext 11600    cshy049@csh.org.tw    Principal Investigator: Chien-Ning Huang, MD          China Medical University Hospital Recruiting Taichung, Taiwan, 404 Contact: Ching-Chu Chen, MD    +886-4-2206-2121 ext 3489    d1918@mail.cmuh.org.tw    Principal Investigator: Ching-Chu Chen, MD          Taichung Veterans General Hospital Recruiting Taichung, Taiwan, 40705 Contact: I-Te Lee, MD, PhD    +886-933-553-211    itlee@vghtc.gov.tw    Principal Investigator: I-Te Lee, MD, PhD          Chi-Mei Medical Center Recruiting Tainan, Taiwan, 710 Contact: Kai-Jen Tien, MD    +886-6-2816-31    tkzzkimo@gmail.com    Principal Investigator: Kai-Jen Tien, MD          National Taiwan University Hospital Recruiting Taipei, Taiwan, 10048 Contact: Chih-Yuan Wang, MD, PhD    +886-938-036-246    cyw1965@gmail.com    Principal Investigator: Chih-Yuan Wang, MD, PhD          Taipei Veterans general Hospital Recruiting Taipei, Taiwan, 11217 Contact: Harn-Shen Chen, MD, PhD    +886-2-2875-7516    chenhs@vghtpe.gov.tw    Principal Investigator: Harn-Shen Chen, MD, PhD          Tri-Service General Hospital Recruiting Taipei, Taiwan, 114 Contact: Chang-Hsun Hsieh, MD    +886-2-8792-7182    10324@yahoo.com.tw    Principal Investigator: Chang-Hsun Hsieh, MD          Chang Gung Memorial Hospital_Linkou Not yet recruiting Taoyuan, Taiwan, 333 Contact: Yu-Yao Huang, MD, PhD    +886-975-368-137    yyh@cgmh.org.tw    Principal Investigator: Yu-Yao Huang, MD, PhD Less <<
NCT03323788 - Recruiting August 1, 2018 United States, Arizona ... More >> The University of Arizona Recruiting Tucson, Arizona, United States, 85724 Contact: Oscar Parra, MADM    520-626-6485    oscardp@email.arizona.edu    Principal Investigator: Lawrence Mandarino, PhD Less <<
NCT03294265 Type 2 Diabetes Mellitus Not Applicable Enrolling by invitation August 1, 2018 Mexico ... More >> Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán Mexico City, Mexico, 14000 Less <<
NCT03324971 Diabetes Mellitus Not Applicable Completed - Egypt ... More >> Cairo university hospitals Cairo, Egypt Less <<
NCT03329261 Diabetes Mellitus, Type 2 ... More >> NSTEMI - Non-ST Segment Elevation MI Coronary Angioplasty Less << Phase 4 Not yet recruiting September 30, 2019 -
NCT03324451 Type 2 Diabetes Mellitus Not Applicable Recruiting October 1, 2019 Taiwan ... More >> Lee's clinic Recruiting Kaohsiung, Taiwan, 807 Less <<
NCT03333044 HbA1c Diabete... More >>s Less << Not Applicable Not yet recruiting December 2021 -
NCT03332771 Type 2 Diabetes Mellitus Phase 3 Active, not recruiting August 6, 2019 -
NCT03315728 - Recruiting December 31, 2019 Canada, Ontario ... More >> Western University Recruiting London, Ontario, Canada, N6C 4Z9 Contact: Stewart Harris    519-858-5028    stewart.harris@schulich.uwo.ca    Contact: Mariam Hayward    519-661-2111 ext 20067    mariam.hayward@schulich.uwo.ca Less <<
NCT03338439 - Completed - Italy ... More >> IRCCS Policlinico San Matteo Foundation Pavia, PV, Italy, 27100 Less <<
NCT03336476 Diabetes Mellitus Not Applicable Recruiting May 31, 2018 Turkey ... More >> University of Health Sciences Diskapi Yildirim Beyazit Training and Research Hospita Recruiting Ankara, Turkey Contact: Dilek Yazicioglu, Assoc Prof    +905336957855    dilek.yazicioglu@hotmail.com    Contact: Burak Nalbant, Dr    +905962553    buraknalbant@gmail.com Less <<
NCT03318913 Diabetes Mellitus, Type 2 Not Applicable Completed - -
NCT03341793 Diabete Type 2 Not Applicable Recruiting October 1, 2021 Belgium ... More >> Cliniques universitaires Saint-Luc Recruiting Brussel, Belgium, 1200 Contact: Jean-Paul Thissen, MD, PhD    0032 2764 ext 1812    jeanpaul.thissen@uclouvain.be Less <<
NCT03338803 - Completed - United States, Minnesota ... More >> Optum Eden Prairie, Minnesota, United States, 55344 Less <<
NCT01953549 Stroke Phase 3 Completed - Germany ... More >> Beelitz Heilstätten Beelitz Heilstatten, Brandenburg, Germany, 14547 Median Klinik Grünheide Grunheide, Brandenburg, Germany, 15537 Charité - Universitätsmedizin Berlin Berlin, Germany, 10117 Charité Campus Benjamin Franklin Berlin, Germany, 12200 Vivantes Klinikum Neukölln Berlin, Germany, 12351 Evanglisches Geriatriezentrum Berlin Berlin, Germany, 13347 Medical Park Berlin Berlin, Germany, 13507 Less <<
NCT03355040 - Recruiting January 1, 2019 France ... More >> Uhmontpellier Recruiting Montpellier, France, 34295 Contact: florent FUCHS, PhD       f-fuchs@chu-montpellier.fr Less <<
NCT03334370 - Completed - Hong Kong ... More >> The University of Hong Kong Hong Kong, Hksar, Hong Kong Less <<
NCT03358264 Type 2 Diabetes Mellitus Not Applicable Recruiting December 31, 2018 Jordan ... More >> The University of Jordan Recruiting Amman, Jordan, 11942 Contact: Alia Shatanawi, PhD, DDS    +96265355000 ext 23458    a.shatanawi@ju.edu.jo    Contact: Munir N Gharaibeh, PhD, MD    +96265355000 ext 23456    mgharaib@ju.edu.jo    Sub-Investigator: Munther S Momani, MD          Principal Investigator: Alia Shatanawi, PhD, DDS Less <<
NCT03362112 - Completed - -
NCT03361878 Diabetes Mellitus, Type 2 ... More >> Metformin Adverse Reaction Less << Phase 4 Completed - -
NCT03353818 Type2 Diabetes Not Applicable Active, not recruiting July 1, 2018 Denmark ... More >> Department of Public Health, Research Unit and Section of General Practice, University of Aarhus, , Aarhus, Denmark Center for Diabetes Research, Gentofte Hospital Hellerup, Denmark, 2900 Less <<
NCT03363100 Diabetes Mellitus, Type 2 Not Applicable Active, not recruiting January 2019 United States, California ... More >> Evidation Health San Mateo, California, United States, 94401 Less <<
NCT03363594 - Recruiting December 31, 2018 -
NCT03358797 Diabetes Heal... More >>th Behavior Less << Not Applicable Active, not recruiting December 31, 2018 -
NCT03367806 - Completed - -
NCT03369626 Type2 Diabetes Not Applicable Active, not recruiting February 28, 2018 United States, California ... More >> FareWell LLC San Francisco, California, United States, 94108 Less <<
NCT03362762 - Completed - Guadeloupe ... More >> University Hospital Center of Pointe-à-Pitre Pointe-à-Pitre, Guadeloupe, 97159 Less <<
NCT03372018 PreDiabetes O... More >>besity Metabolic Disease Body Weight Changes Diabetes Mellitus Less << Not Applicable Recruiting January 31, 2019 United States, Illinois ... More >> Northwestern Univeristy Recruiting Chicago, Illinois, United States, 60611 Contact: Maria Vargas    312-503-7419    maria.vargas@northwestern.edu Less <<
NCT03371108 Diabetes Mellitus, Type 2 Phase 3 Recruiting January 31, 2020 -
NCT03367455 - Completed - -
NCT03377127 Diabetes Mellitus, Type 2 Not Applicable Recruiting March 31, 2020 United States, Michigan ... More >> Beaumont Geriatric Assessment Center Recruiting Berkley, Michigan, United States, 48072 Contact: Bobbie Lewis    248-551-5958    Bobbie.Lewis@beaumont.org    Beaumont Outpatient Clinic Recruiting Royal Oak, Michigan, United States, 48073 Contact: Bobbie Lewis, RN    248-551-5958    Bobbie.Lewis@beaumont.org    Principal Investigator: Alexandra Halalau, MD          Beaumont Internal Medicine Center Recruiting Southfield, Michigan, United States, 48034 Contact: Bobbie Lewis    248-551-5958    Bobbie.Lewis@beaumont.org    Norton, Klein, Hug, Sabin and Maddens Internal Medicine & Primary Care Practice Recruiting Troy, Michigan, United States, 48084 Contact: Bobbie Lewis    248-551-5958    Bobbie.Lewis@beaumont.org Less <<
NCT03353376 Diabetes Mellitus ... More >> Group Meetings Less << Not Applicable Completed - -
NCT03374774 - Completed - India ... More >> Novo Nordisk Investigational Site Guwahati, Assam, India, 781006 Novo Nordisk Investigational Site Ahmedabad, Gujarat, India, 380054 Novo Nordisk Investigational Site Bangalore, Karnataka, India, 560092 Novo Nordisk Investigational Site Bangalore, Karnataka, India Novo Nordisk Investigational Site Gulbarga, Karnataka, India, 585105 Novo Nordisk Investigational Site Mysore, Karnataka, India, 570004 Novo Nordisk Investigational Site Kolhapur, Maharashtra, India Novo Nordisk Investigational Site Nasik, Maharashtra, India Novo Nordisk Investigational Site Pune, Maharashtra, India Novo Nordisk Investigational Site Coimbatore, Tamil Nadu, India, 641009 Novo Nordisk Investigational Site Coimbatore, Tamil Nadu, India, 641018 Novo Nordisk Investigational Site Madurai, Tamil Nadu, India, 625 020 Novo Nordisk Investigational Site Lucknow, Uttar Pradesh, India, 226005 Novo Nordisk Investigational Site Lucknow, Uttar Pradesh, India Novo Nordisk Investigational Site Kolkata, West Bengal, India, 700054 Novo Nordisk Investigational Site Belgaum, India, 590010 Novo Nordisk Investigational Site New Delhi, India, 110017 Novo Nordisk Investigational Site Thriruvananthapuram, India, 695 032 Less <<
NCT03394313 - Recruiting December 31, 2027 Qatar ... More >> Hamad Medical Coorporation Recruiting Doha, Qatar, 3050 Contact: Jassim Al-Suwaidi, MD    55823041 Less <<
NCT03394456 Diabetes Mellitus, Type 2 Not Applicable Recruiting March 31, 2022 United States, Texas ... More >> Baylor College of Medicine Recruiting Houston, Texas, United States, 77030 Contact: Elizabeth Vaughan, DO    713-873-3560    Elizabeth.vaughan@bcm.edu Less <<
NCT03387657 Type 2 Diabetes Mellitus Phase 1 Completed - United States, Texas ... More >> Investigational Site Number 8400001 Dallas, Texas, United States, 75247 Less <<
NCT03397225 Diabetes Mellitus, Noninsulin-... More >>Dependent Diabetes, Type 2 Less << Not Applicable Completed - Kuwait ... More >> Al-Rehab polyclinic Kuwait, Farwaniyah, Kuwait, 18750571 United Kingdom University of Reading Reading, Berkshire, United Kingdom, RG6 6AP Less <<
NCT03380832 - Recruiting June 1, 2019 United States, Massachusetts ... More >> Massachusetts Eye and Ear Infirmary Recruiting Boston, Massachusetts, United States, 02114 Contact: Faisal Karmali    410-218-7614    faisal_karmali@meei.harvard.edu Less <<
NCT03387683 Diabetes Mellitus Type 2 Phase 4 Recruiting April 1, 2019 Finland ... More >> Research Site Recruiting Turku, Finland, 20520 Sweden Research Site Recruiting Uppsala, Sweden, SE-751 85 Less <<
NCT03406923 Diabetes Mellitus Not Applicable Recruiting December 31, 2020 United States, Wisconsin ... More >> William S. Middleton Memorial Veterans Hospital Recruiting Madison, Wisconsin, United States, 53705 Contact: Denise W Pigarelli, PharmD    608-280-7077    Denise.walbrandt-pigarelli@va.gov Less <<
NCT03405532 - Recruiting January 5, 2020 Sweden ... More >> Sahlgrenska University Hospital Recruiting Gothenburg, Sweden Contact: Maria Tholén, MD    +46313428789    maria.tholen@vgregion.se    Contact: Sven-Erik Ricksten, Prof    +46313427433    sven-erik.ricksten@aniv.gu.se Less <<
NCT03406975 Obesity Hyper... More >>tension Diabetes Mellitus, Type 2 Less << Not Applicable Recruiting December 31, 2020 United States, Florida ... More >> Orlando Health Recruiting Orlando, Florida, United States, 32806 Contact: Paula Willett    321-841-9623    Paula.Willett@orlandohealth.com    Principal Investigator: Andre Teixeira, MD          United States, Illinois NorthShore University Health System Recruiting Evanston, Illinois, United States, 60201 Contact: Eliza Conaty    847-570-1239    EConaty@northshore.org    Principal Investigator: Michael Ujiki, MD          United States, Maryland Johns Hopkins University Recruiting Baltimore, Maryland, United States, 21224 Contact: Lea Fayad, MD    410-550-0796    leafayad3@jhmi.edu    Principal Investigator: Vivek Kumbhari, MD          United States, Massachusetts Brigham and Women's Hospital Recruiting Boston, Massachusetts, United States, 02115 Contact: Michele Ryan    617-732-6389    MRYAN@BWH.HARVARD.EDU    Principal Investigator: Christopher Thompson, MD          United States, Minnesota Mayo Clinic in Rochester Recruiting Rochester, Minnesota, United States, 55905 Contact: Erik Hyland    507-266-0516    hyland.erik@mayo.edu    Contact: Monika Rizk Salib       salib.monika@mayo.edu    Principal Investigator: Barham K Abu Dayyeh          United States, South Dakota Avera McKennan Hospital & University Health Center Recruiting Sioux Falls, South Dakota, United States, 57105 Contact: Kim McCoy    605-322-1320    Kim.McCoy@avera.org    Principal Investigator: Bradley Thaemert, MD          United States, Texas University of Texas Recruiting Houston, Texas, United States, 77401 Contact: Angie Riveria    713-486-1350    Angielyn.R.Rivera@uth.tmc.edu    Principal Investigator: Erik Wilson, MD Less <<
NCT03409523 - Enrolling by invitation December 2018 United States, New York ... More >> New York University School of Medicine New York, New York, United States, 10016 Less <<
NCT02399280 Obesity Overw... More >>eight Less << Not Applicable Completed - Iran, Islamic Republic of ... More >> NovinDiet Clinic Tehran, Iran, Islamic Republic of, 1913635136 Less <<
NCT03399565 - Recruiting December 31, 2018 China, Jiangxi ... More >> The Second Affiliated Hospital Of Nanchang University Recruiting Nanchang, Jiangxi, China, 330000 Contact: Yunfeng Shen    18970819455    1023744018@qq.com    Contact: Meihua Wu    18970819455    1023744018@qq.com Less <<
NCT03417076 Type 2 Diabetes Mellitus Phase 1 Withdrawn(Sponsor decision to ... More >>not initiate study due to sufficient bioavailability information) Less << September 16, 2018 United States, Wisconsin ... More >> Clinical Research Site Madison, Wisconsin, United States, 53704 Less <<
NCT03422263 - Recruiting December 31, 2019 Switzerland ... More >> Berner Klinik Montana Recruiting Crans-Montana, Valais, Switzerland, 3963 Contact: Devine S Frundi, MD    +41 274855242    devine.frundi@bernerklinik.ch Less <<
NCT03407196 - Completed - Turkey ... More >> Keçiören Training and Research Hospital Ankara, Turkey, 06280 Less <<
NCT03426566 - Completed - Poland ... More >> Department and Division of Medical Rehabilitation Wroclaw, Lower Silesia, Poland, 54-438 Less <<
NCT02848807 Toxicity Due to Chemotherapy ... More >> Cancer Cachexia Metastatic Colorectal Cancer Quality of Life Dietary Modification Less << Not Applicable Unknown December 2016 Poland ... More >> University Clinical Centre Recruiting Gdansk, Poland Contact: Sylwia Malgorzewicz, MD, PhD    +48 58 3492724    sylwiam@gumed.edu.pl    Principal Investigator: Sylwia Malgorzewicz, MD, PhD Less <<
NCT03414723 Diabetes Mellitus ... More >> Healthy Subjects Less << Phase 1 Completed - Germany ... More >> Investigational Site Number 2760001 Berlin, Germany, 14050 Less <<
NCT03442595 - Active, not recruiting December 31, 2018 -
NCT03440502 - Not yet recruiting May 1, 2020 -
NCT03423355 Type 2 Diabetes Mellitus (T2DM... More >>) Less << Phase 4 Not yet recruiting March 31, 2020 Germany ... More >> Technical University Dresden University Hospital Carl Gustav Carus Not yet recruiting Dresden, Germany, 01307 Contact: Andreas Birkenfeld, Prof. Dr.    +49 (0) 351 458 13651 ext 13651    andreas.birkenfeld@uniklinikum-dresden.de Less <<
NCT00035932 HIV Infections Phase 3 Completed - -
NCT03423108 Type2 Diabetes Not Applicable Recruiting August 1, 2020 Brazil ... More >> Hospital de Clinicas de Porto Alegre Recruiting Porto Alegre, Rio Grande Do Sul, Brazil Contact: Angélica De Nardi, MSc    +55 51 3359-6332    atnardi@hcpa.edu.br    Contact: Lucinéia Pfeifer, MSc    +55 51 3359-6332    lpfeifer@hcpa.edu.br    Principal Investigator: Daniel Umpierre, PhD          Sub-Investigator: Beatriz D'Agord Schaan, MD, PhD Less <<
NCT03455101 - Completed - Turkey ... More >> Gulhane School of Medicine Department of Endocrinology and Metabolism Ankara, Turkey, 06018 Less <<
NCT00035932 - Completed - -
NCT03457012 - Enrolling by invitation November 25, 2019 Canada, Ontario ... More >> Novo Nordisk Investigational Site Cambridge, Ontario, Canada, N1R 7L6 Less <<
NCT03443986 Diabetes Mellitus, Type 2 Not Applicable Not yet recruiting February 25, 2019 -
NCT03453970 Diabetes Mellitus, Type 2 Not Applicable Enrolling by invitation December 1, 2019 Spain ... More >> Public Health Service of Andalucía Málaga, Spain Less <<
NCT01020617 Metabolic Syndrome ... More >> Inflammation Obesity Less << Not Applicable Completed - Denmark ... More >> Copenhagen University Frederiksberg, Denmark, 1958 Less <<
NCT03466567 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 1 Completed - Germany ... More >> Novo Nordisk Investigational Site Berlin, Germany, 14050 Less <<
NCT03467932 T2DM (Type 2 Diabetes Mellitus... More >>) Less << Phase 2 Recruiting June 2019 United States, Michigan ... More >> AA MRC Recruiting Flint, Michigan, United States, 48504 Contact: Fayyaz Shah    810-237-1125    fshah@aamrc.net    Principal Investigator: Ahmed Arif, M. D. Less <<
NCT03445702 Diabetes Mellitus, Type 2 ... More >> Metformin Adverse Reaction Less << Early Phase 1 Recruiting December 2019 United States, Missouri ... More >> Saint Louis University Recruiting Saint Louis, Missouri, United States, 63110 Contact: Linda Eggemeyer-Sharpe, RN    314-977-9350    linda.eggemeyersharpe@health.slu.edu Less <<
NCT03477786 Type 2 Diabetes Mellitus ... More >> Hypertension Less << Not Applicable Recruiting December 31, 2023 Taiwan ... More >> Kaohsiung Medical University Hospital Recruiting Kaohsiung, Taiwan Contact: Kun-Der Lin, PhD          Min-Sheng General Hospital Recruiting Taoyuan, Taiwan Contact: Chih-Cheng Hsu    886-37-246166 ext 36336    cch@nhri.org.tw Less <<
NCT03464812 Type2 Diabetes Not Applicable Active, not recruiting December 31, 2018 United States, California ... More >> Mary & Dick Allen Diabetes Center, Hoag Hospital Newport Beach, California, United States, 92663 Less <<
NCT03480945 Type 2 Diabetes Mellitus Phase 2 Recruiting - Sweden ... More >> Karolinska Institutet, Karolinska University Hospital Recruiting Stockholm, Sweden, 17176 Contact: John Pernow, Dr    +46851775876    john.pernow@ki.se Less <<
NCT03478202 Diabetes Mellitus, Type II Not Applicable Completed - United States, Indiana ... More >> Buynak Clinical Research Valparaiso, Indiana, United States, 46385 Less <<
NCT03484689 Diabetes Mellitus, Type 2 Not Applicable Recruiting November 30, 2018 Hong Kong ... More >> Pok Oi Hopsital Recruiting Hong Kong, Hong Kong Contact: Kam Pui Lee, Msc    +852 60996560    Lkp032@cuhk.edu.hk    Principal Investigator: Kam pui Lee, Msc Less <<
NCT03482674 Health Behavior ... More >> Health Knowledge, Attitudes, Practice Literacy Diabetes Mellitus, Type 2 Diabetes Less << Not Applicable Recruiting July 1, 2020 Germany ... More >> docevent GmbH Recruiting Schleswig, Schleswig-Holstein, Germany, 24837 Contact: Carsten Petersen, Dr.    +494621-855 425    c.petersen@internisten-schleswig.de Less <<
NCT03569852 Fasting Inter... More >>mittent Fasting Athletic Performance Cardiovascular Risk Factor Resting Energy Expenditure Less << Not Applicable Recruiting July 15, 2020 United States, California ... More >> UC Davis, Western Human Nutrition Research Center Recruiting Davis, California, United States, 95616 Less <<
NCT03481335 Diabetes Mellitus, Type 2 ... More >> Hypertension Less << Not Applicable Recruiting December 31, 2019 Philippines ... More >> Ateneo de Zamboanga University Recruiting Zamboanga City, Zamboanga Del Sur, Philippines, 7000 Contact: Floro Dave Arnuco, MD Less <<
NCT03496298 Type 2 Diabetes Mellitus Phase 3 Recruiting April 2021 -
NCT03503045 - Completed - Turkey ... More >> Gulhane School of Medicine Ankara, Turkey, 06018 Less <<
NCT03516864 - Not yet recruiting May 1, 2019 -
NCT03508323 Type 2 Diabetes Mellitus Phase 4 Recruiting January 2020 Korea, Republic of ... More >> Samsung Medical Center Recruiting Seoul, Korea, Republic of Contact: JH Kim    +82-2-527-5114    handok.@handok.com Less <<
NCT03489083 Type 2 Diabetes Mellitus ... More >> Aging Less << Not Applicable Completed - Brazil ... More >> Universidade Federal do Rio Grande do Sul Porto Alegre, RS, Brazil, 90040-060 Less <<
NCT03517527 Type 2 Diabetes Mellitus Not Applicable Completed - -
NCT03487692 Type 2 Diabetes Mellitus Not Applicable Not yet recruiting December 31, 2021 -
NCT03506230 Type2 Diabetes Mellitus Not Applicable Recruiting December 2019 Israel ... More >> Clalit health services Recruiting Jerusalem, Israel Contact: Ayelet Prigozin    972506617448    prigozin4@gmail.com Less <<
NCT02068885 Obesity Diabe... More >>tes Cardiovascular Disease Less << Not Applicable Completed - United States, Massachusetts ... More >> Framingham State University Framingham, Massachusetts, United States, 01702 Less <<
NCT01169428 Obesity Phase 2 Completed - United States, North Carolina ... More >> Duke University - Duke Integrative Medicine Durham, North Carolina, United States, 27705 United States, Pennsylvania University of Pennsylvania, Program for Mindfulness Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT03520413 Telemedicine Not Applicable Not yet recruiting May 30, 2021 United States, North Carolina ... More >> Durham VA Medical Center, Durham, NC Not yet recruiting Durham, North Carolina, United States, 27705 Contact: Susanne M Danus, BS    919-286-6936    Susanne.Danus@va.gov    Contact: Dana C Tucker, BA    (919) 286-0411 ext 5741    dana.tucker@va.gov    Sub-Investigator: David Edelman, MD MHS          Sub-Investigator: Hayden B Bosworth, PhD          Principal Investigator: Matthew Crowley, MD          Sub-Investigator: Valerie Smith, DrPH          United States, Virginia Hunter Holmes McGuire VA Medical Center, Richmond, VA Not yet recruiting Richmond, Virginia, United States, 23249 Contact: Phillip E Tarkington    804-675-5000 ext 6836    Phillip.Tarkington@va.gov    Contact: Franklin J Zieve, MD PhD    (804) 675-5151    franklin.zieve@va.gov    Sub-Investigator: Phillip E Tarkington Less <<
NCT03580226 - Completed - -
NCT03579420 Diabetes Mellitus, Type 2 Not Applicable Recruiting April 1, 2022 Italy ... More >> Diabetologia AOU Careggi Recruiting Florence, Italy, 50134 Contact: Matteo Monami, MD    3384027484    matteo.monami@unifi.it Less <<
NCT03587948 - Recruiting January 1, 2028 China, Shanghai ... More >> Shanghai Eye Disease Prevention & Treatment Center Recruiting Shanghai, Shanghai, China, 200040 Contact: Haidong Zou, Ph.D    8613311986528    zouhaidong@263.net Less <<
NCT03586830 Obesity and Diabetes Mellitus,... More >> Type 2 Less << Phase 2 Recruiting April 4, 2019 -
NCT03585153 - Recruiting June 2043 United States, Tennessee ... More >> Vanderbilt University Medical Center Recruiting Nashville, Tennessee, United States, 37232 Contact: Jonathan M Williams, PhD    615-875-9200    jon.williams@vumc.org    Principal Investigator: Alvin C Powers, MD          Sub-Investigator: Daniel J Moore, MD, PhD          Sub-Investigator: Melissa Hilmes, MD          Sub-Investigator: John Virostko, PhD Less <<
NCT03590223 - Completed - Switzerland ... More >> Herzchirurgie University Hospital Basel Basel, Switzerland, 4031 Less <<
NCT03596450 Diabetes Mellitus, Type 2 Phase 4 Recruiting November 19, 2021 United States, California ... More >> Novo Nordisk Investigational Site Not yet recruiting Monterey, California, United States, 93940 Novo Nordisk Investigational Site Not yet recruiting San Jose, California, United States, 95148 Novo Nordisk Investigational Site Not yet recruiting Tulare, California, United States, 93274 United States, Connecticut Novo Nordisk Investigational Site Not yet recruiting Milford, Connecticut, United States, 06460 United States, Georgia Novo Nordisk Investigational Site Not yet recruiting Lilburn, Georgia, United States, 30047 Novo Nordisk Investigational Site Not yet recruiting Sandersville, Georgia, United States, 31082 Novo Nordisk Investigational Site Not yet recruiting Savannah, Georgia, United States, 31406 Novo Nordisk Investigational Site Recruiting Statesboro, Georgia, United States, 30461 Novo Nordisk Investigational Site Not yet recruiting Stockbridge, Georgia, United States, 30281 Novo Nordisk Investigational Site Not yet recruiting Swainsboro, Georgia, United States, 30401 United States, Kentucky Novo Nordisk Investigational Site Not yet recruiting Covington, Kentucky, United States, 41011 Novo Nordisk Investigational Site Not yet recruiting Owensboro, Kentucky, United States, 42303 United States, Virginia Novo Nordisk Investigational Site Not yet recruiting Chatham, Virginia, United States, 24531 Novo Nordisk Investigational Site Not yet recruiting Colonial Heights, Virginia, United States, 23834 Novo Nordisk Investigational Site Not yet recruiting Falls Church, Virginia, United States, 22044 Novo Nordisk Investigational Site Not yet recruiting Lynchburg, Virginia, United States, 24501 Novo Nordisk Investigational Site Not yet recruiting Warrenton, Virginia, United States, 20186 Less <<
NCT03598621 Diabetes Mellitus, Type 2 Phase 1 Active, not recruiting January 17, 2019 Germany ... More >> Novo Nordisk Investigational Site Mainz, Germany, 55116 Novo Nordisk Investigational Site Neuss, Germany, 41460 Less <<
NCT03598855 Type 2 Diabetes Mellitus Not Applicable Completed - United Kingdom ... More >> Research Institute for Sport and Exercise Sciences (RISES) Liverpool, Merseyside, United Kingdom, L33AF Less <<
NCT03601910 Type II Diabetes Mellitus Phase 1 Active, not recruiting November 9, 2018 Korea, Republic of ... More >> The Catholic University of Korea, Seoul ST. Mary's Hospital Seoul, Korea, Republic of Less <<
NCT03595384 Diabetes Not Applicable Recruiting December 2018 United States, Georgia ... More >> Emory University Rollins School of Public Health Recruiting Atlanta, Georgia, United States, 30322 Contact: Felipe Lobelo, MD    404-727-5403    felipelobelo@emory.edu Less <<
NCT03598738 Diabetes Mellitus, Type 2 Not Applicable Completed - -
NCT03607617 - Not yet recruiting August 2022 -
NCT03616171 Diabetes Mellitus, Type 2 Not Applicable Recruiting September 2019 United States, Georgia ... More >> Emory University Recruiting Atlanta, Georgia, United States, 30322 Contact: Ashley Coombe, PhD, RN, CNE    404-712-9313    ashley.coombe@emory.edu Less <<
NCT03617081 Diabetes Mellitus, Type 2 Phase 1 Active, not recruiting January 16, 2019 United States, Texas ... More >> Novo Nordisk Investigational Site San Antonio, Texas, United States, 78209 Less <<
NCT03617146 Diabetes Distress Not Applicable Recruiting December 2019 United States, Texas ... More >> Baylor Family Medicine Recruiting Houston, Texas, United States, 77098 Contact: Jason Salemi, PhD, MPH Less <<
NCT03611322 Diabetes Mellitus, Type 2 Phase 1 Active, not recruiting January 2, 2019 Germany ... More >> Novo Nordisk Investigational Site Berlin, Germany, 10117 Less <<
NCT02958956 - Completed - -
NCT02953262 Diabetes Mellitus Not Applicable Not yet recruiting January 31, 2020 United States, Massachusetts ... More >> Edith Nourse Rogers Memorial Veterans Hospital, Bedford, MA Not yet recruiting Bedford, Massachusetts, United States, 01730 Contact: Joseph Squicciarini    781-687-2926    Joe.Squicciarini@va.gov    Contact: P. B Cipolloni, MD    (781) 687-2838    pb.cipolloni@va.gov    Principal Investigator: Stephanie L Shimada, PhD          Sub-Investigator: Varsha Vimalananda, MD MPH          VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA Not yet recruiting Boston, Massachusetts, United States, 02130 Contact: Stephanie L Shimada, PhD    781-687-2208    stephanie.shimada@va.gov    Sub-Investigator: Mark S Bauer, MD Less <<
NCT03616392 Diabetes Mellitus, Type II Phase 1 Completed - Korea, Republic of ... More >> Chonbuk National University Hospital Jeonju, Korea, Republic of Less <<
NCT02961517 - Recruiting November 2019 United Kingdom ... More >> Leicester Diabetes Centre Recruiting Leicester, United Kingdom, LE5 4PW Contact: Lois Daniels    01162588070    Lois.J.Daniels@uhl-tr.nhs.uk Less <<
NCT02952352 Diabetes Not Applicable Recruiting September 15, 2019 United States, Washington ... More >> Confederated Tribes of the Colville Reservation Recruiting Nespelem, Washington, United States, 99155 Contact: Sonny Sellars, BS    509-322-8132    sonny.sellars@wsu.edu    Contact: Korey Carden, AA    5096371140    korey.carden@wsu.edu    Principal Investigator: Kaimi Sinclair, PhD          IREACH Not yet recruiting Seattle, Washington, United States, 98101 Contact: Kaimi Sinclair, PhD, MPH    206-708-8633    kaimi.sinclair@wsu.edu Less <<
NCT02958995 - Completed - -
NCT02971241 Type 2 Diabetes Mellitus Not Applicable Unknown November 2017 Taiwan ... More >> HualienTzu Chi Hospital Recruiting Hualien, Taiwan Contact: YiChuan Tseng, Master    886905286282    yichuant@usc.edu    Principal Investigator: Duan Wu, MD          Taipei Tzu Chi Hospital Active, not recruiting Taipei, Taiwan Less <<
NCT02958995 - Completed - -
NCT03203460 Prostate Cancer Not Applicable Active, not recruiting December 31, 2019 Canada, Alberta ... More >> University of Alberta Edmonton, Alberta, Canada, T6G 2H9 Less <<
NCT02972996 Type2 Diabetes Not Applicable Active, not recruiting August 31, 2018 United States, New York ... More >> Stratton V.A. Medical Center Albany, New York, United States, 12208 Less <<
NCT02971865 Diabetes Mellitus, Type 2 Not Applicable Completed - United States, Oregon ... More >> Community Wellness Center West Linn, Oregon, United States, 97068 Less <<
NCT02969954 Diabetes Mellitus Not Applicable Completed - United States, Minnesota ... More >> Mayo Clinic in Rochester Rochester, Minnesota, United States, 55905 Less <<
NCT02977130 Diabetes Mellitus ... More >> Health Knowledge, Attitudes, Practice Health Behavior Glycated Hemoglobin (HbA1c) Less << Not Applicable Completed - -
NCT02977039 Type 2 Diabetes Mellitus in Ob... More >>ese Less << Not Applicable Not yet recruiting June 2020 United States, Massachusetts ... More >> Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Less <<
NCT02994095 Type2 Diabetes Not Applicable Completed - -
NCT02998008 Diabetes Mellitus, Type 2 Not Applicable Terminated(due to difficulties... More >> to attract participants) Less << - Norway ... More >> Department of Circulation and Medical Imaging, NTNU Trondheim, Norway Less <<
NCT02958956 - Completed - -
NCT03515122 - Enrolling by invitation December 2019 Sweden ... More >> Rehabilitation medicine Research Group Lund, Sweden Less <<
NCT02998970 Diabetes Card... More >>iovascular Disease Less << Phase 4 Active, not recruiting September 2018 Canada, Ontario ... More >> St. Michael's Hospital Toronto, Ontario, Canada, M5B 1W8 Less <<
NCT02999386 - Recruiting December 2019 Qatar ... More >> Hamad Medical Coorporation Recruiting Doha, Qatar, 3050 Contact: Ayman El-Menyar, MD    +974-44394029    elmenyar@yahoo.com    Contact: Mohammad Asim, Ph.D    +974-44394032    asim.jmi@gmail.com    Sub-Investigator: Hassan Al-Thani, MD          Sub-Investigator: Ashok Peralta, MD          Sub-Investigator: Hisham Al Jogol, MD          Sub-Investigator: Husham Abdelrahman, MD          Sub-Investigator: Ahmed Elfaramawy, MD          Sub-Investigator: Ismail Y Mahmoud, MD          Sub-Investigator: Zafar Nawaz, MD          Sub-Investigator: Fayaz A Mir, Ph.D          Sub-Investigator: Ruben Peralta, MD Less <<
NCT02990299 Diabetes Mellitus, Type 2 Not Applicable Enrolling by invitation June 2021 United States, Illinois ... More >> University of Illinois Hospital and Health Sciences System Chicago, Illinois, United States, 60612 Less <<
NCT03006666 Diabetes Mellitus Not Applicable Recruiting December 2021 United States, New York ... More >> New York University Medical Center Recruiting New York, New York, United States, 10016 Contact: Shana Johnson    646-501-3546    shana.johnson@nyulangone.org    Principal Investigator: Mark Schwartz, MD Less <<
NCT02985502 - Unknown June 2018 Taiwan ... More >> National Taiwan University Hospital Recruiting Taipei, Taiwan Contact: Hsuan-Ju Kuo, MSN    +886929215939    kuo108041@gmail.com    Principal Investigator: Shiow-Ching Shun, PhD          Sub-Investigator: Hsuan-Ju Kuo, MSN Less <<
NCT03001999 Type 2 Diabetes ... More >> Emotions Patient Compliance Less << Not Applicable Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT03009513 Diabetes Mellitus Phase 1 Completed - -
NCT03001336 - Completed - -
NCT03008395 Type2 Diabetes Mellitus Not Applicable Withdrawn(Unable to secure cli... More >>nic support for conducting research) Less << August 2018 -
NCT03014479 Type 2 Diabetes Phase 4 Completed - Japan ... More >> Nagoya, Aichi, Japan Kanra, Gunma, Japan Kobe, Hyogo, Japan Koga, Ibaraki, Japan Kawasaki, Kanagawa, Japan Sagamihara, Kanagawa, Japan Yamato, Kanagawa, Japan Sendai, Miyagi, Japan Kashihara, Nara, Japan Kashiwara, Osaka, Japan Suita, Osaka, Japan Okegawa, Saitama, Japan Oyama, Tochigi, Japan Adachi-ku, Tokyo, Japan Chuo-ku, Tokyo, Japan Edogawa-ku, Tokyo, Japan Musashino, Tokyo, Japan Oota-ku, Tokyo, Japan Shibuya-ku, Tokyo, Japan Shinagawa-ku, Tokyo, Japan Shinjuku-ku, Tokyo, Japan Shinjyuku-ku, Tokyo, Japan Osaka, Japan Less <<
NCT03024788 - Active, not recruiting - -
NCT03008057 Type2 Diabetes Phase 4 Unknown June 2017 -
NCT03027934 Diabetes Mellitus Phase 4 Not yet recruiting October 31, 2017 -
NCT03037099 Type 2 Diabetes Not Applicable Completed - Canada, Alberta ... More >> Athabasca University Athabasca, Alberta, Canada, T9S 3A3 Alliance for Canadain Health Outcomes Research in Diabetes Edmonton, Alberta, Canada, T6G 2E1 Less <<
NCT03011177 Type2 Diabetes Mellitus Phase 4 Recruiting April 2019 Korea, Republic of ... More >> Asan Medical Center Recruiting Seoul, Korea, Republic of Contact: JY Park    82216887575 Less <<
NCT03039569 Diabetes Mellitus, Type 2 Not Applicable Recruiting August 2018 United States, Nebraska ... More >> University of Nebraska-Lincoln (with Methodist Hospital System) Recruiting Lincoln, Nebraska, United States, 68583-0806 Contact: Weiwen Chai, PhD    402-472-7822    wchai2@unl.edu    Contact: Martha Nepper, PhD, RD    402-354-5768    martha.nepper@nmhs.org Less <<
NCT03039075 Diabetes Mellitus Phase 4 Recruiting December 2018 China, Chongqing ... More >> The First Affiliated Hospital of Chongqing Medical University Recruiting Chongqing, Chongqing, China, 400016 Contact: Qifu Li, PhD    +86 23 89011552    liqifu@yeah.net Less <<
NCT03044860 Type2 Diabetes Not Applicable Completed - -
NCT03055702 Appointments and Schedules ... More >> Diabetes Mellitus, Type 2 Less << Not Applicable Recruiting March 30, 2018 Hong Kong ... More >> Ha Kwai Chung General Outpatient Clinic Recruiting Kwai Chung, Hong Kong, 000 Contact: Man Chi Dao    +85236515411    thomasmcdao@gmail.com    Principal Investigator: Man Chi Dao, M.B.B.S.          Sub-Investigator: Sau Nga Fu, M.B.B.S. Less <<
NCT03053336 Type 2 Diabetes Mellitus ... More >> Exercise Less << Not Applicable Active, not recruiting June 2019 Sweden ... More >> Karolinska Institutet Stockholm, Sweden Less <<
NCT03059056 Diabetes Mellitus Phase 1 Completed - -
NCT03059069 Type2 Diabetes With Depressive... More >> Mood Less << Phase 4 Recruiting June 30, 2019 Korea, Republic of ... More >> Yonsei University College of Medicine, Department of Internal Medicine, Division of Endocrinology, Severance Hospital, Diabetes Center Recruiting Seoul, Korea, Republic of, 03722 Contact: Bong Soo Cha, MD    +82-2-2228-1932    bscha@yuhs.ac Less <<
NCT03059719 Type II Diabetes Mellitus Phase 1 Completed - China, Beijing ... More >> No.1 Hospital of Peking University Beijing, Beijing, China, 100191 Less <<
NCT03025607 Prediabetic State ... More >> Diabetes Mellitus Less << Not Applicable Completed - United States, Michigan ... More >> University of Michigan Ann Arbor, Michigan, United States, 48109 Less <<
NCT03062774 Type2 Diabetes Mellitus Phase 1 Completed - China, Beijing ... More >> Peking University First Hospital Beijing, Beijing, China, 100191 Less <<
NCT03070106 Diabetes Type... More >> 2 Diabetes Type 2 Diabetes Treated With Insulin Less << Not Applicable Recruiting January 2020 United States, Ohio ... More >> The Cleveland Clinic Foundation Recruiting Cleveland, Ohio, United States, 44195 Contact: Mario A Scarcipino    216-444-3599    mascar@ccf.org Less <<
NCT03046498 Diabetes Not Applicable Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT03071432 Anesthesia Di... More >>abetes Mellitus, Type 2 Less << Not Applicable Completed - Netherlands ... More >> Academic Medical Center Amsterdam, Noord-Holland, Netherlands, 1105AZ Less <<
NCT03074383 Type 2 Diabetes Mellitus Not Applicable Recruiting December 31, 2018 Brazil ... More >> Hospital de Clinicas de Porto Alegre Recruiting Porto Alegre, Rio Grande do Sul, Brazil, 90035-903 Contact: SHEILA P GARCIA, MD    55 51993186620    sheilapiccoligarcia@gmail.com Less <<
NCT03060980 Diabetes Mellitus, Type 2 Phase 3 Terminated(Decision by Sponsor... More >>) Less << - -
NCT03084965 - Completed - Taiwan ... More >> Research Site Changhua, Taiwan Research Site Chiayi, Taiwan Research Site Kaohsiung, Taiwan Research Site New Taipei, Taiwan Research Site Taichung, Taiwan Research Site Tainan, Taiwan Research Site Taipei, Taiwan Research Site Taoyuan, Taiwan Less <<
NCT03078049 - Completed - United States, Delaware ... More >> Research Site Wilmington, Delaware, United States, 19803 Less <<
NCT03089528 Anesthesia Di... More >>abetes Mellitus Intubation;Difficult Videolaryngoscopy Less << Not Applicable Recruiting November 2017 Turkey ... More >> University of Health Sciences Diskapi Yildirim Beyazit Training and Research Hospital Recruiting Ankara, Turkey Contact: Dilek Yazicioglu, Dr    +903125962553    dilek.yazicioglu@hotmail.com    Contact: Burak Nalbant, Dr    +905962553    buraknalbant@gmail.com Less <<
NCT03090464 - Completed - -
NCT03092752 - Completed - Japan ... More >> Medical Data Vision Co. Ltd Shinagawa-ku, Japan Less <<
NCT02845791 Type 2 Diabetes ... More >> Chronic Disease Obesity Less << Not Applicable Unknown May 2017 United Kingdom ... More >> University Hospitals of Leicester Not yet recruiting Leicester, United Kingdom, LE4 5PW Contact: Emer Brady, PhD    0116 258 8959    emer.brady@uhl-tr.nhs.uk    Contact: Georgie K Surridge    0116 258 8929 ext 8929    georgie.surridge@uhl-tr.nhs.uk    Principal Investigator: Melanie J Davies, MD Less <<
NCT03061981 Diabetes Mellitus, Type 2 Phase 1 Completed - United States, Maryland ... More >> Early Phase Clinical Unit Baltimore, Maryland, United States, 21225 Less <<
NCT03104829 Diabetes Mellitus Not Applicable Recruiting October 2018 Thailand ... More >> Ornsuda Lertbannaphong Recruiting Bangkok Noi, Bangkok, Thailand, 10700 Contact: Ornsuda Lertbannaphong, MD    024197000 ext 5676    ornsuda110@hotmail.com Less <<
NCT03099928 - Completed - -
NCT02377960 Hypertension ... More >>Blood Pressure Patient Compliance Patient Adherence Medication Adherence Less << Not Applicable Completed - Finland ... More >> Health Centre of Jyväskylä Cooperation Area Jyväskylä, Finland, 40100 Mehiläinen Jyväskylä Occupational Health Services Jyväskylä, Finland, 40100 Central Finland Hospital District (Perusterveydenhuollon liikelaitos Seututerveyskeskus) Jyväskylä, Finland, 40620 Oma Lääkärisi Tikkakoski Jyväskylä, Finland, 41160 Oma Lääkärisi Korpilahti Jyväskylä, Finland, 41800 Sote kuntayhtymä/Perusturvaliikelaitos Saarikka Saarijärvi, Finland, 43101 Less <<
NCT03092882 Diabetes Mellitus, Type 2 Not Applicable Completed - United States, California ... More >> Evidation Health San Mateo, California, United States, 94401 Less <<
NCT03125694 Uncontrolled Type 2 Diabetes M... More >>ellitus Less << Phase 3 Completed - Iran, Islamic Republic of ... More >> Tehran University of Medical Sciences Tehran, Iran, Islamic Republic of Less <<
NCT03115099 Diabetes Mellitus, Type 2 Phase 1 Completed - Singapore ... More >> For additional information regarding investigative sites for this trial, contact 1-888-545-5972 Mon - Fri, 9 AM to 4 PM or 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time or speak with your personal physician. Singapore, Singapore, 117597 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician. Singapore, Singapore Less <<
NCT03123237 Diabetes Mellitus ... More >> Hypertension Less << Phase 4 Recruiting December 2017 Egypt ... More >> Assiut university Recruiting Assiut, Egypt Less <<
NCT03130244 Type 2 Diabetes ... More >> Obesity Less << Not Applicable Recruiting March 2021 Argentina ... More >> Aleman Hospital Recruiting Buenos Aires, Argentina, C1118AAT Contact: Rudolf H Buxhoeveden, MD    541148277000 ext 2808    rbuxhoeveden@hospitalaleman.com Less <<
NCT03133156 Healthy Obese... More >> Diabetes Mellitus, Type 2 Less << Not Applicable Recruiting December 15, 2018 United States, Massachusetts ... More >> Joslin Diabetes Center Recruiting Boston, Massachusetts, United States, 02215 Contact: Jeffrey J Richard, MS    617-309-4378    exercise.research@joslin.harvard.edu    Principal Investigator: Laurie J Goodyear, PhD Less <<
NCT03121508 Type 2 Diabetes Mellitus Not Applicable Withdrawn(not enough funding t... More >>o complete the project as planned) Less << June 24, 2018 United States, Colorado ... More >> Family Medicine Center Fort Collins, Colorado, United States, 80524 Less <<
NCT03138356 Type 2 Diabetes Mellitus Phase 1 Completed - United Kingdom ... More >> Research Site Harrow, United Kingdom, HA1 3UJ Less <<
NCT03150199 Type2 Diabetes Not Applicable Recruiting June 30, 2019 United States, Massachusetts ... More >> Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Principal Investigator: Jeff C Huffman, MD Less <<
NCT03160196 Diabetes Mellitus, Type 2 Not Applicable Not yet recruiting September 2019 -
NCT03144505 Type 2 Diabetes Not Applicable Completed - -
NCT03143764 Diabetes Mellitus, Type 2 Not Applicable Completed - Norway ... More >> Department of Global Public Health and Primary Care, University of Bergen Bergen, Norway, 5018 Department of Public Health, Sport and Nutrition, University of Agder Kristiansand, Norway Department of Education and Sports Science, University of Stavanger Stavanger, Norway Less <<
NCT03165084 Diabetes Type 2 Not Applicable Recruiting May 31, 2018 Sweden ... More >> Department of Nursing, Umeå University Recruiting Umeå, Sweden, 901 87 Contact: Ulrika Öberg, RN, MSc, PhD student       ulrika.oberg@umu.se    Contact: Åsa Hörnsten, Professor       asa.hornsten@umu.se Less <<
NCT03167866 Diabetes Mellitus, Type 2 Not Applicable Not yet recruiting December 1, 2020 Israel ... More >> Rambam Health Care Campus Haifa, Israel Less <<
NCT03164538 Type 2 Diabetes Mellitus Not Applicable Recruiting June 30, 2019 United States, Massachusetts ... More >> Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Principal Investigator: Jeff C Huffman, MD Less <<
NCT03166852 Diabetes Mellitus, Type 2 ... More >> Exercise Technology Less << Not Applicable Completed - -
NCT03077997 Diabetes Not Applicable Terminated(logistics recruitme... More >>nt) Less << - United Kingdom ... More >> Barnet, Enfield, and Haringey Mental Health Trust Enfield, United Kingdom, EN2 0JB Less <<
NCT03174548 Diabetes Mellitus Phase 1 Completed - United Kingdom ... More >> Investigational Site Number 826001 Leeds, United Kingdom, LS2 9LH Less <<
NCT03172260 - Completed - Canada, Ontario ... More >> Hamilton Medical Research Group Hamilton, Ontario, Canada, L8M 1K7 Less <<
NCT03165877 Diabetes Mellitus, Type 2 Not Applicable Completed - -
NCT03185741 Diabetes Mellitus, Type 2 ... More >> Medication Adherence Less << Not Applicable Recruiting July 31, 2021 United States, Illinois ... More >> Northwestern University Recruiting Chicago, Illinois, United States, 60611 Contact: Rachel O'Conor, MPH    312-503-3240    r-oconor@northwestern.edu    United States, New York Mount Sinai School of Medicine Not yet recruiting New York, New York, United States, 10029 Contact: Angela Sanchez    212-824-7727    angela.sanchez-munoz@mountsinai.org Less <<
NCT03182712 Type2 Diabetes Mellitus Not Applicable Completed - Brazil ... More >> Clinical Hospital of Porto Alegre Pôrto Alegre, RS, Brazil, 90035-903 Less <<
NCT02449460 - Recruiting December 2022 Russian Federation ... More >> Orenburg Medical Academi Recruiting Orenburg, Russian Federation Contact: Roman Libis, Prof    79111555524    libis@mail.ru    Principal Investigator: Roman Libis, Prof          Samara Medical University Recruiting Samara, Russian Federation Contact: Dmitry Duplyakov    79277297273    dyplyakov@yahoo.com    Principal Investigator: Dmitriy Duplyakov, prof Less <<
NCT03182231 Diabetes Mellitus, Type 2 ... More >> Bariatric Surgery Candidate Less << Phase 1 Phase 2 Recruiting December 1, 2019 Netherlands ... More >> Rijnstate hospital Recruiting Arnhem, Netherlands Contact: Laura Deden, MSc       l.deden@rijnstate.nl    Radboudumc Recruiting Nijmegen, Netherlands, 6500HB Contact: Marti Boss, Msc    +312436 ext 67243    marti.boss@radboudumc.nl Less <<
NCT03197324 Type2 Diabetes Mellitus Phase 1 Completed - United States, Florida ... More >> Covance CRU Daytona Beach, Florida, United States, 32117 Less <<
NCT03189732 Diabetes Mellitus, Type 2 Not Applicable Active, not recruiting December 2017 Czechia ... More >> Third Faculty of Medicine, Charles University Prague, Czechia, 100 00 Less <<
NCT02198703 Moderate Hypercholesterolemia Not Applicable Completed - France ... More >> Naturalpha Lille, France, 59020 Biofortis Saint-Herblain, France, 44800 Less <<
NCT03203278 Diabetes Mellitus, Type 2 Not Applicable Completed - United Kingdom ... More >> NHS Greater Glasgow and Clyde Glasgow, United Kingdom Less <<
NCT03196024 Risk Reduction Behavior ... More >> Diabetes Mellitus, Type 2 Cardiovascular Diseases Less << Not Applicable Recruiting July 31, 2021 United States, Kentucky ... More >> University of Kentucky Recruiting Lexington, Kentucky, United States, 40536-0232 Contact: Gia Mudd-Martin, PhD, RN    859-494-7073    Gia.Mudd@uky.edu    Contact: Rosa Martin    859-323-4305    Rosa.Martin@uky.edu Less <<
NCT01236599 Nursing Care Not Applicable Completed - Mexico ... More >> Hospital General de Zona N 4. Instituto Mexicano del Seguro Social Celaya, Guanajuato, Mexico, 38060 Less <<
NCT03211832 Diabetes Chro... More >>nic Disease Pathologic Processes Disease Attributes Less << Not Applicable Active, not recruiting June 2021 United States, Missouri ... More >> Prevention Research Center, Brown School, Washington University in St. Louis Saint Louis, Missouri, United States, 63130 Less <<
NCT03211195 Type 2 Diabetes Mellitus Phase 1 Completed - United States, Florida ... More >> Investigational Site Number 840001 Miami, Florida, United States, 33014 Less <<
NCT03225209 Type 2 Diabetes Mellitus Phase 2 Active, not recruiting August 15, 2018 United States, North Carolina ... More >> Department of Veteran Affairs, Greenville Health Care Center Greenville, North Carolina, United States, 27834 Less <<
NCT03228706 Medication Adherence ... More >> Type 2 Diabetes Mellitus Less << Not Applicable Recruiting June 30, 2019 Malaysia ... More >> Kota Samarahan Health Clinic Recruiting Kota Samarahan, Sarawak, Malaysia, 94300 Contact: Talin Benodict Apok, BPharm    +60146997578    benodict@moh.gov.my    Principal Investigator: Talin Benodict Apok, BPharm          Petra Jaya Health Clinic Recruiting Kuching, Sarawak, Malaysia, 93050 Contact: Abd Jabar Abu Hassan Alshaari, BPharm    +6082473200    abu.hassan@moh.gov.my    Principal Investigator: Abd Jabar Abu Hassan Alshaari, BPharm Less <<
NCT03169413 - Not yet recruiting August 2020 -
NCT00125866 Hypertension Not Applicable Completed - United Kingdom ... More >> Imperial College London Paddington, London, United Kingdom, W2 1PG Less <<
NCT03229850 Diabetes Mellitus ... More >> Lipohypertrophy Less << Not Applicable Not yet recruiting December 2020 Canada, British Columbia ... More >> University of British Columbia - Gerontology Research Lab Not yet recruiting Vancouver, British Columbia, Canada, V5Z 1M9 Contact: Boris Feldman    604-875-5115    boris.feldman@vch.ca    Principal Investigator: Graydon S Meneilly, MD          Sub-Investigator: Jordanna Kapeluto, MD Less <<
NCT03209089 - Active, not recruiting December 16, 2018 Russian Federation ... More >> Research Site Belgorod Region, Shebekino, Russian Federation, D1690R00037 Research Site Belgorod Region, Volokonovsky R-n, P. Volokonovka, Russian Federation, D1690R00037 Research Site Gis-Khrustalny, Russian Federation, D1690R00037 Research Site Izhevsk, Russian Federation, D1690R00037 Research Site Kazan, Russian Federation, D1690R00037 Research Site Lipetsk, Russian Federation, D1690R00037 Research Site N. Novgorod Region, Russian Federation, D1690R00037 Research Site N. Novgorod, Russian Federation, D1690R00037 Research Site Novomoskovsk, Russian Federation, D1690R00037 Research Site Novosibirsk, Russian Federation, D1690R00037 Research Site Perm, Russian Federation, D1690R00037 Research Site Ryazan, Russian Federation, D1690R00037 Research Site Samara, Russian Federation, D1690R00037 Research Site St-petersburg, Russian Federation, D1690R00037 Research Site Tambov Region, Russian Federation, D1690R00037 Research Site Volzhsk, Russian Federation, D1690R00037 Research Site Voronezh Region, Novovoronezh, Russian Federation, D1690R00037 Research Site Voronezh, Russian Federation, D1690R00037 Research Site Yaroslavl, Russian Federation, D1690R00037 Research Site Yoshkar-Ola, Russian Federation, D1690R00037 Less <<
NCT03235492 Diabetes Mellitus Not Applicable Recruiting August 15, 2019 United States, Maryland ... More >> University of Maryland Recruiting Baltimore, Maryland, United States, 21201 Contact: Maka S Hedrington, MD    410-706-5623    mhedrington@som.umaryland.edu Less <<
NCT03243136 - Completed - -
NCT03249077 Diabetes Not Applicable Active, not recruiting June 2021 United States, Oregon ... More >> Kaiser Permanente Center for Health Research Portland, Oregon, United States, 97227 Less <<
NCT03234322 Type 2 Diabetes Mellitus ... More >> Primary Prevention Less << Not Applicable Enrolling by invitation December 2020 Germany ... More >> German Diabetes Center, Institute for Biometrics and Epidemiology Düsseldorf, North Rhine-Westphalia, Germany, 40225 Less <<
NCT03631186 - Enrolling by invitation May 25, 2020 Switzerland ... More >> Novo Nordisk Investigational Site Ascona, Switzerland, 6612 Novo Nordisk Investigational Site Baden, Switzerland, 5400 Novo Nordisk Investigational Site Baden, Switzerland, 5404 Novo Nordisk Investigational Site Basel, Switzerland, 4031 Novo Nordisk Investigational Site Bellinzona, Switzerland, 6500 Novo Nordisk Investigational Site Binningen, Switzerland, 4102 Novo Nordisk Investigational Site Blonay, Switzerland, 1807 Novo Nordisk Investigational Site Chiasso, Switzerland, 6830 Novo Nordisk Investigational Site Estavayer-le-Lac, Switzerland, 1470 Novo Nordisk Investigational Site Frauenfeld, Switzerland, 8500 Novo Nordisk Investigational Site Fribourg, Switzerland, 1700 Novo Nordisk Investigational Site Genève, Switzerland, 1206 Novo Nordisk Investigational Site Kleinhüningen, Switzerland, 4057 Novo Nordisk Investigational Site Lausanne, Switzerland, 1010 Novo Nordisk Investigational Site Lugano, Switzerland, 6900 Novo Nordisk Investigational Site Nürensdorf, Switzerland, 8309 Novo Nordisk Investigational Site Olten, Switzerland, 4600 Novo Nordisk Investigational Site Schaffhausen, Switzerland, 8208 Novo Nordisk Investigational Site Solothurn, Switzerland, 4500 Novo Nordisk Investigational Site St. Gallen, Switzerland, 9016 Novo Nordisk Investigational Site Viganello, Switzerland, 6962 Novo Nordisk Investigational Site Zürich, Switzerland, 8008 Novo Nordisk Investigational Site Zürich, Switzerland, 8046 Less <<
NCT03248206 Diabetes Mellitus ... More >> Exercise Less << Not Applicable Recruiting December 2018 Taiwan ... More >> National Cheng-Kung University Hospital Recruiting Tainan, Taiwan, 704 Contact: Hsiu-Yun Hsu, Ph.D.    886-6-2353535 ext 2669    hyhsu@mail.ncku.edu.tw Less <<
NCT03636243 Bariatric Surgery ... More >> Obese Type2 Diabetes Less << Not Applicable Not yet recruiting January 2021 France ... More >> CHU Nimes Not yet recruiting Nîmes, France, 30029 Contact: Anissa Megzari    04.66.68.30.52    drc@chu-nimes.fr    Sub-Investigator: Anne-Marie Guedj, MD          Sub-Investigator: Véronique TAILLARD, MD          Sub-Investigator: Jean-Christophe GRIS, MD          Sub-Investigator: Sylvie BOUVIER, MD          Sub-Investigator: Ion DONICI, MD          Sub-Investigator: Michel PRUDHOMME, MD          Sub-Investigator: Isabelle AICHOUN, MD          Sub-Investigator: Sarah COUDRAY, MD          Sub-Investigator: Jérémy LAURENT, MD Less <<
NCT03623607 - Active, not recruiting March 31, 2019 United States, District of Col... More >>umbia MedStar Washington Hospital Center Washington, District of Columbia, United States, 20010 Less <<
NCT03638778 Diabetes Mellitus, Type 2 Phase 1 Completed - Germany ... More >> Novo Nordisk Investigational Site Berlin, Germany, 14050 Less <<
NCT03642717 - Recruiting March 31, 2020 Korea, Republic of ... More >> Hyewon Medical Foundation Sejong Hospital Recruiting Bucheon, Korea, Republic of, 14754 Inje University Busan Paik Hospital Recruiting Busan, Korea, Republic of, 47392 Keimyung University Dongsan Hospital Recruiting Daegu, Korea, Republic of, 41931 Inha University Hospital Recruiting Incheon, Korea, Republic of, 22332 Seoul Medical Center Recruiting Seoul, Korea, Republic of, 02053 Hongik Hospital Recruiting Seoul, Korea, Republic of, 07937 Ajou University Hospital Recruiting Suwon, Korea, Republic of, 16499 Yonsei University Wonju Severance Christian Hospital Recruiting Wonju, Korea, Republic of, 26426 Less <<
NCT03231709 Type 2 Diabetes Mellitus Phase 4 Completed - Japan ... More >> OCROM Clinic Suita, Osaka, Japan ToCROM Clinic Shinjuku, Tokyo, Japan Less <<
NCT03644134 Type 2 Diabetes Mellitus Not Applicable Completed - -
NCT03647306 Type2 Diabetes Mellitus ... More >> Cardiovascular Diseases Less << Not Applicable Recruiting January 1, 2022 United States, Illinois ... More >> University of Chicago Recruiting Chicago, Illinois, United States, 60637 Contact: Eve Van Cauter, PhD    773-702-0169    evcauter@medicine.bsd.uchicago.edu Less <<
NCT03648424 - Active, not recruiting January 1, 2019 United States, Massachusetts ... More >> Brigham and Women's Hospital Boston, Massachusetts, United States, 02120 Less <<
NCT03258723 Diabetes Phase 4 Not yet recruiting June 2021 United States, New York ... More >> Flatbush Family Health Center at NYU Langone Not yet recruiting Brooklyn, New York, United States, 11203 Contact: Paula Pollard-Thomas, MD    347-380-0377    Paula.Pollard-Thomas@nyumc.org    Contact: La Sharra Bennett    718-630-2197 ext 4040       Internal Medicine Associates at Mt. Sinai Not yet recruiting New York, New York, United States, 10029 Contact: Victoria L Mayer, MD    212-659-9194    victoria.mayer@mountsinai.org    Contact: Carol Horowitz, MD    212-659-8551    carol.horowitz@mountsinai.org    Barbados University of the West Indies, Cavehill and Barbados Ministry of Health Polyclinics Not yet recruiting Bridgetown, Barbados Contact: Joseph Herbert, MD    2462347715    familymedicinebarbados@gmail.com    Contact: Natasha Sobers, MD    2462400313    natasha.sobers@cavehill.uwi.edu    Puerto Rico Internal Medicine Clinic at the University of Puerto Rico Hospital Not yet recruiting Carolina, Puerto Rico, 00984 Contact: Elsie Cruz, MD       elsie.cruz1@upr.edu    Contact: Enid J Garcia-Rivera, MD    (787) 701-1121    enid.garcia3@upr.edu    Trinidad and Tobago Southwest Regional Health Authority, La Romaine Health Center Not yet recruiting San Fernando, Trinidad and Tobago Contact: Albert Persaud, MD    1-868-225-1802    albertpersaud@swrha.co.tt    Contact: Kavita Dharamraj, MD    1-868-730-3418    kavitadharamraj@swrha.co.tt Less <<
NCT03660631 Hypertension ... More >>Diabetes Mellitus Less << Not Applicable Enrolling by invitation August 1, 2022 United States, Iowa ... More >> University of Iowa Iowa City, Iowa, United States, 52242 Less <<
NCT03646916 Diabetes Mellitus Phase 4 Not yet recruiting January 31, 2020 United States, Michigan ... More >> Genesys Regional Medical Center Grand Blanc, Michigan, United States, 48439 Less <<
NCT02501746 Cardiovascular Disease ... More >> Diabetes Less << Not Applicable Recruiting September 2020 Kenya ... More >> Moi University College of Health Sciences Recruiting Eldoret, Kenya Contact: Jemima Kamano, MBChB, MMed       shoine.hoine@gmail.com    Principal Investigator: Jemima Kamano, MBChB, MMed Less <<
NCT03653013 Diabetes Glyc... More >>inemia Less << Not Applicable Not yet recruiting October 2020 -
NCT03031951 Obesity Not Applicable Recruiting January 2020 Portugal ... More >> Faculdade de Motricidade Humana Recruiting Oeiras, Cruz-Quebrada, Portugal, 1409-002 Contact: Analiza Silva    962903643    analiza@fmh.ulisboa.pt Less <<
NCT03648281 - Enrolling by invitation June 22, 2020 Denmark ... More >> Novo Nordisk Investigational Site Søborg, Denmark Less <<
NCT02713321 - Recruiting February 2021 United States, New York ... More >> Icahn School of Medicine at Mount Sinai Recruiting New York, New York, United States, 10029 Principal Investigator: Victoria L Mayer, MD, MS Less <<
NCT02715791 Type 2 Diabetes Mellitus ... More >> Hypertension Less << Not Applicable Completed - Canada, Ontario ... More >> McMaster Family Health Practice Hamilton, Ontario, Canada, L8P 1H6 McMaster University Department of Family Medicine Hamilton, Ontario, Canada, L8P 1H6 Stonechurch Family Health Centre Hamilton, Ontario, Canada, L8W 3J6 Less <<
NCT02712632 - Recruiting January 2019 United Kingdom ... More >> University of Dundee Recruiting Dundee, Tayside, United Kingdom, DD1 9SY Contact: Louise Greig, RGN, MBA    01382 383208    louise.greig@nhs.net Less <<
NCT02718950 Obesity Type ... More >>2 Diabetes Mellitus Less << Phase 3 Unknown April 2017 -
NCT02722239 Diabetes Mellitus, Type 2 Phase 1 Completed - Russian Federation ... More >> Research Site Moscow, Russian Federation, 123423 Less <<
NCT02714660 - Completed - -
NCT02723019 Type 2 Diabetes Mellitus ... More >> Cardiometabolic Conditions Behavioral Health Concerns Less << Not Applicable Recruiting August 2020 United States, California ... More >> Scripps Mercy Chula Vista Recruiting Chula Vista, California, United States, 91910 Contact: Athena Philis-Tsimikas, MD       philis-tsimikas.athena@scrippshealth.org    Contact: Addie Fortmann, PhD       fortmann.addie@scrippshealth.org Less <<
NCT02730078 Type 2 Diabetes Mellitus Not Applicable Completed - -
NCT02730754 - Completed - -
NCT03383484 Polycystic Ovary Syndrome Not Applicable Completed - -
NCT02722239 - Completed - -
NCT02745470 Diabetes Mellitus Not Applicable Completed - Korea, Republic of ... More >> Seoul National University Hospital Seoul, Korea, Republic of, 110-744 Less <<
NCT02737891 Type 2 Diabetes Mellitus Phase 2 Unknown - Germany ... More >> Profil Institut für Stoffwechselforschung GmbH Neuss, Germany, D-41460 Less <<
NCT02746861 Diabetes Not Applicable Unknown June 2017 United States, New Jersey ... More >> InquisitHealth Recruiting River Edge, New Jersey, United States, 07661 Contact: Ashwin Patel    855-412-1787 Less <<
NCT02748122 Diabetes Not Applicable Recruiting May 2019 United States, New York ... More >> New York University Langone Medical Center Recruiting New York, New York, United States, 10016 Principal Investigator: Preneet Brar, MD Less <<
NCT02748239 Type 2 Diabetes Not Applicable Completed - Germany ... More >> Diabetes Centre Mergentheim Bad Mergentheim, Germany, 97980 Less <<
NCT02751398 Type 2 Diabetes Mellitus Phase 4 Unknown December 2017 Korea, Republic of ... More >> Division of Cardiology, Yonsei Cardiovascular Hospital, Yonsei University College of Medicine Recruiting Seoul, Korea, Republic of, 120-752 Contact: Geu-Ru Hong, MD, PhD    82-2-2228-8443    GRHONG@yuhs.ac Less <<
NCT02749435 - Terminated(The study was stopp... More >>ed due to lack of recruitment.) Less << - United Kingdom ... More >> Research Site Dundee, Angus, United Kingdom Research Site Cardiff, Cardiff [Caerdydd GB-CRD], United Kingdom Research Site Muirhead, Dundee City, United Kingdom Research Site Flintshire, Flintshire [Sir y Fflint GB-FF, United Kingdom Research Site London, Harrow, United Kingdom Research Site Manchester, Lancashire, United Kingdom Research Site Oldham, Manchester, United Kingdom Research Site Bonnyrigg, Midlothian, United Kingdom Research Site Edinburgh, Midlothian, United Kingdom Research Site Fife, United Kingdom Research Site Leicester, United Kingdom Research Site London, United Kingdom Research Site Mid Glamorgan, United Kingdom Research Site Stockport, United Kingdom Less <<
NCT02757937 Diabetes Mellitus, Type 2 Not Applicable Completed - -
NCT02761018 Type II Diabetes Mellitus Not Applicable Completed - United States, Nevada ... More >> Mike O'Callaghan Federal Medical Center Nellis Air Force Base, Nevada, United States, 89191 Less <<
NCT02763007 Diabetes Mellitus, Type 2 Phase 4 Recruiting September 2020 Korea, Republic of ... More >> Seoul St Mary's Hospital, The Catholic University of Korea Recruiting Seoul, Korea, Republic of, 137-701 Contact: YOON HEE CHOI, MD          Principal Investigator: Kun-Ho Yoon, MD, PhD          Sub-Investigator: Yoon-Hee Choi, MD, PhD          Sub-Investigator: Eun-Young Lee, MD, PhD Less <<
NCT02767596 Diabetes Mellitus Type 2 Phase 4 Terminated(Insufficient recrui... More >>tment rate) Less << - Israel ... More >> Bildirici Diabetes Center, Laniado Hospital Netanya, Israel, 42150 Less <<
NCT02768480 Diabetes Mellitus Not Applicable Active, not recruiting December 2018 Brazil ... More >> Hospital de Clinicas de Porto Alegre Porto Alegre, Rio Grande do Sul, Brazil, 90035-903 Less <<
NCT02736084 Type 2 Diabetes Not Applicable Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT02769481 Type 2 Diabetes Mellitus Phase 3 Active, not recruiting December 2019 -
NCT02771821 Diabetes Mellitus, Type 2 ... More >> Aged Health Behavior Group Processes Less << Not Applicable Completed - Brazil ... More >> Federal University of Pernambuco Recife, Pernambuco, Brazil, 50670-901 Less <<
NCT02774733 - Completed - -
NCT02763943 Cardiovascular Diseases ... More >> Diabetes Mellitus Medication Adherence Less << Not Applicable Completed - United States, South Carolina ... More >> Medical University of South Carolina Charleston, South Carolina, United States, 29425 Less <<
NCT02779556 Diabetes Not Applicable Recruiting February 2020 United States, Arkansas ... More >> UAMS Family Medical Center Northwest Active, not recruiting Fayetteville, Arkansas, United States, 72703 UAMS Family Medical Center Fort Smith Recruiting Fort Smith, Arkansas, United States, 72901 Contact: Jennifer Gan    501-296-1568    jgan@uams.edu    UAMS Family Medical Center Jonesboro Recruiting Jonesboro, Arkansas, United States, 72401 Contact: Jennifer Gan    501-296-1568    jgan@uams.edu    UAMS Family Medical Center Magnolia Recruiting Magnolia, Arkansas, United States, 71753 Contact: Jennifer Gan    501-296-1568    jgan@uams.edu    UAMS Family Medical Center Pine Bluff Recruiting Pine Bluff, Arkansas, United States, 71603 Contact: Jennifer Gan    501-296-1568    jgan@uams.edu    UAMS Family Medical Center Texarkana Recruiting Texarkana, Arkansas, United States, 71854 Contact: Jennifer Gan    501-296-1568    jgan@uams.edu Less <<
NCT02776397 Diabetes Mellitus Not Applicable Unknown July 2018 Singapore ... More >> Tan Tock Seng Hospital Recruiting Singapore, Singapore, 308433 Contact: Rinkoo Dalan, MBBS,FRCP    65-81263176    rinkoo_dalan@ttsh.com.sg    Principal Investigator: Rinkoo Dalan, MBBS,FRCP Less <<
NCT02788903 - Active, not recruiting February 2021 -
NCT02775253 Type 2 Diabetes ... More >> Cold Acclimation Less << Phase 4 Unknown August 2016 China, Hubei ... More >> Wuhan General Hospital Recruiting Wuhan, Hubei, China, 430070 Contact: Guangda Xiang, MD, PhD    +8602750772918    Guangda64@hotmail.com Less <<
NCT02722655 - Recruiting December 2030 Mexico ... More >> Hospital Regional de Alta Especialidad del Bajío Recruiting Leon, Guanajuato, Mexico, 37660 Contact: María L Evia-Viscarra    +52 (477) 2672000 ext 1504    mlola.evia@hraeb.gob.mx    Sub-Investigator: Edel R Rodea-Montero          Sub-Investigator: Rodolfo Guardado-Mendoza Less <<
NCT02804932 Type 2 Diabetes Not Applicable Recruiting January 2019 United States, Iowa ... More >> University of Iowa Recruiting Iowa City, Iowa, United States, 52242 Less <<
NCT02796170 Type 2 Diabetes ... More >> Hypertension Less << Phase 4 Recruiting December 2019 United States, Louisiana ... More >> Tulane University Recruiting New Orleans, Louisiana, United States, 70112 Contact: Bonnie L Katalenich, MPH    504-988-6200    bkatalen@tulane.edu Less <<
NCT02805283 - Completed - United States, Minnesota ... More >> Reasearch Site Eden Prairie, Minnesota, United States Less <<
NCT02798198 - Completed - -
NCT02754817 - Completed - Austria ... More >> Novo Nordisk Investigational Site Wien, Austria, 1130 Germany Novo Nordisk Investigational Site Leipzig, Germany, 04103 Sweden Novo Nordisk Investigational Site Stockholm, Sweden, 111 57 Switzerland Novo Nordisk Investigational Site St. Gallen, Switzerland, 9016 United Kingdom Novo Nordisk Investigational Site Stevenage, United Kingdom, SG1 4AB Less <<
NCT02805543 - Completed - -
NCT02806700 Diabetes Card... More >>iovascular Disease Less << Not Applicable Completed - United States, Pennsylvania ... More >> University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT02813759 Diabetes Mellitus, Type 2 Not Applicable Completed - -
NCT02822534 Type 2 Diabetes Phase 1 Unknown - China, Jilin ... More >> the First Hosital of Jilin University Recruiting Changchun, Jilin, China Contact: Yanhua Ding, docter    0431-88782168    dingyanhua2003@126.com Less <<
NCT02824003 Type 2 Diabetes Phase 2 Completed - Austria ... More >> Ionis Investigator Site Vienna, Austria, A-1130 Less <<
NCT02826759 - Unknown November 2016 China, Shaanxi ... More >> The First Affiliated Hospital of Xi'an Jiaotong University Not yet recruiting Xi'an, Shaanxi, China, 710061 Contact: Bingyin Shi    0086-13700298366    shibingy@126.com    Contact: jing Sui    0086-18991989230    suijing1029@163.com    Principal Investigator: Huairong Zhang Less <<
NCT02811874 Diabetes Not Applicable Completed - Brazil ... More >> Hospital de Clínicas de Porto Alegre Porto Alegre, Rio Grande do Sul, Brazil, 90035-903 UBS São Pedro Porto Alegre, Rio Grande do Sul, Brazil, 91570-000 Less <<
NCT02827890 Diabetes Mellitus Type 2 Phase 1 Completed - Korea, Republic of ... More >> Chonbuk National University Hospital Jeonju-si, Korea, Republic of Less <<
NCT02831361 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT02834923 Diabetes Mellitus, Type 2 Not Applicable Enrolling by invitation September 2020 United States, California ... More >> University of California, San Francisco San Francisco, California, United States, 94143 Less <<
NCT02835989 Cardiovascular Disease ... More >> Diabetes Mellitus Accidental Falls Social Isolation Food Insecurity Less << Not Applicable Recruiting September 2019 Canada, Ontario ... More >> McMaster University Recruiting Hamilton, Ontario, Canada, L8S4K1 Contact: Francine Marzanek    9055259140    mlefebv@mcmaster.ca Less <<
NCT02828995 - Completed - United States, Tennessee ... More >> Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232-2372 Less <<
NCT02840630 Diabetes Mellitus, Type 2 Not Applicable Recruiting December 2018 United Kingdom ... More >> University of Aberdeen Rowett Institute of Nutrition and Health Recruiting Aberdeen, United Kingdom, AB21 9SB Contact: Nigel Hoggard          Contact       N.Hoggard@abdn.ac.uk    Principal Investigator: Nigel Hoggard, PhD Less <<
NCT02791295 Type 2 Diabetes Treated With I... More >>nsulin Less << Not Applicable Recruiting July 2021 France ... More >> Annecy-Genevois Hospital Recruiting Annecy, France, 74370 Contact: Hafid Amougay, MD    +33 450636363    hamougay@ch-annecygenevois.fr    Principal Investigator: Hafid Amougay, MD          Sub-Investigator: Marlène Rousset, MD          Pierre Oudot Hospital Recruiting Bourgoin-Jallieu, France, 38302 Contact: Hala Rachidi-Koussa, MD    +33 469157343    hrachidi@ch-bourguoin.fr    Principal Investigator: Hala Rachidi-Koussa, MD          Sub-Investigator: Alexandra Crand, MD          Métropole Savoie Hospital Recruiting Chambéry, France, 73000 Contact: Hélène Du-Boullay, MD    +33 0479965094    helene.du-boullay@ch-metropole-savoie.fr    Principal Investigator: Hélène Du-Boullay, MD          Alpes Léman Hospital Terminated Contamine-sur-Arve, France, 74130 Grenoble University Hospital Recruiting Grenoble, France, 38043 Contact: Anne-Laure Borel, MD PhD    +33 476765836    alborel@chu-grenoble.fr    Contact: Matthieu Lesgoirres       mlesgoirres@chu-grenoble.fr    Sub-Investigator: Sandrine Lablanche, MD PhD          Sub-Investigator: Pierre-Yves Benhamou, Pr MD PhD          Sub-Investigator: Jean-Louis Pépin, Pr MD PhD          Sub-Investigator: Stéphane Doutreleau, MD          Marseille European Hospital Recruiting Marseille, France, 13003 Contact: Martin Carvalho, MD    +33 413427000    martin.carvalho@orange.fr    Principal Investigator: Martin Carvalho, MD Less <<
NCT02576821 Patients With Cognitive Distur... More >>bances Less << Not Applicable Recruiting October 2020 France ... More >> Neurologie de la mémoire et du langage, Service de Neurologie, Centre Hospitalier Sainte-Anne Recruiting Paris, France, 75014 Contact: Marie SARAZIN, MD, PhD    00 33 1 45 65 61 72    m.sarazin@ch-sainte-anne.fr    Contact: Marie GODARD    00 33 1 45 65 77 28    m.godard@ch-sainte-anne.fr Less <<
NCT02824874 Diabetes Mellitus, Type II Phase 1 Completed - Korea, Republic of ... More >> Chonbuk National University Hospital Jeonju-si, Korea, Republic of Less <<
NCT02843399 - Completed - United States, Delaware ... More >> Research site Wilmington, Delaware, United States Less <<
NCT02848833 - Recruiting December 31, 2019 Korea, Republic of ... More >> Recruiting Multiple Locations, Korea, Republic of Less <<
NCT02836015 Diabetes Mellitus Type 2 Not Applicable Completed - United States, Nebraska ... More >> Midtown Clinic Omaha, Nebraska, United States, 68131 Less <<
NCT02846779 Diabetes Not Applicable Completed - United States, New Jersey ... More >> Horizon Blue Cross Blue Shield of New Jersey Newark, New Jersey, United States, 07105-2200 Less <<
NCT02854748 Diabetes Mellitus, Type II Phase 1 Unknown September 2016 Korea, Republic of ... More >> Dong A University Hospital Seo-gu, Busan, Korea, Republic of, 49201 Less <<
NCT02855645 Diabetes Mellitus Phase 2 Phase 3 Unknown - Taiwan ... More >> China Medical University Hospital Recruiting Taichung, Taiwan, 404 Contact: Ching-Liang Hsieh, professor    +886-4-22053366 ext 3500    clhsieh@mail.cmuh.org.tw Less <<
NCT02845219 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 1 Completed - Germany ... More >> Novo Nordisk Investigational Site Berlin, Germany, 14050 Less <<
NCT02872922 Diabetes Mellitus, Type 2 Not Applicable Completed - Brazil ... More >> Universidade Federal do Rio Grande Rio Grande, RS, Brazil, 96200-190 Less <<
NCT02877355 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 1 Completed - Germany ... More >> Novo Nordisk Investigational Site Mainz, Germany, 55116 Novo Nordisk Investigational Site Neuss, Germany, 41460 Less <<
NCT02854423 - Completed - -
NCT02879383 Diabetes Mellitus, Type 2 ... More >> Noninsulin-Dependent Diabetes Mellitus Less << Not Applicable Active, not recruiting January 2020 Belgium ... More >> Hopital Erasme Brussels, Belgium, 1070 UZ Leuven Leuven, Belgium Brazil Hospital das Clinicas da Faculdade de medicina da Universidade de São Paulo Sao Paulo, Brazil ABC Hospital São Paulo, Brazil Italy Policlinico Gemelli (Sacro Cuore) Rome, Lazio, Italy Humanitas Research Hospital & Humanitas University Via Manzoni 56, Rozzano Milano, Italy, 20089 Netherlands Amsterdam University Medical Center Amsterdam, Netherlands, 1105 AZ United Kingdom Glasgow Royal Infirmary Glasgow, United Kingdom, G4 0SF University College London Hospitals London, United Kingdom, NW1 2BU King's College, Denmark Hill London, United Kingdom Queens Medical Centre campus, Nottingham University Hospitals NHS Trust, Derby Road Nottingham, United Kingdom, NG7 2UH Less <<
NCT02886884 Diabetes Mellitus Phase 1 Phase 2 Recruiting September 2024 United States, Florida ... More >> University of Miami Miller School of Medicine Recruiting Miami, Florida, United States, 33136 Contact: Ivonne Schulman, RN, BSN    305-243-7444    ISchulman@med.miami.edu Less <<
NCT02868931 Diabetes Mellitus Not Applicable Completed - Germany ... More >> Diabetologische Schwerpunktpraxis Neuss Neuss, Germany, 41462 Less <<
NCT02881164 Diabetes Mellitus, Type 2 Not Applicable Completed - -
NCT02889172 Diabetes Mellitus, Type 2 Not Applicable Unknown December 2017 Mexico ... More >> Instituto Nacional de Psiquiatría Dr. Ramón de la Fuente Recruiting Mexico city, Mexico, 14370 Contact: Valerio Villamil, Master    0051(55)41605247    valemil_2000@yahoo.com Less <<
NCT02891382 Diabetes Mellitus, Type 2 Not Applicable Completed - Peru ... More >> Hospital Nacional Arzobispo Loayza Lima, Peru Less <<
NCT01561235 Obesity Not Applicable Completed - Denmark ... More >> Department of human Nutrition Frederiksberg, Denmark, 1958 Less <<
NCT02890745 Diabetes Mellitus, Type 2 Phase 2 Unknown - Denmark ... More >> Center for Diabetes Research, Gentofte Hospital Recruiting Hellerup, Denmark, 2900 Contact: Jørgen Rungby, DMSc    +45 3977 7539    jr@biomed.au.dk    Principal Investigator: Jørgen Rungby, Professor, DMSc Less <<
NCT02893891 Grade III Obesity ... More >> Type 2 Diabetes Mellitus Less << Not Applicable Completed - Czechia ... More >> Vítkovice Hospital Ostrava Ostrava, Moravian-Silesian Region, Czechia, 703 00 University Hospital Ostrava Ostrava, Moravian-Silesian Region, Czechia, 708 52 Less <<
NCT02899949 - Completed - -
NCT02898493 - Recruiting December 2019 France ... More >> University Hospital of Reunion Island Recruiting Saint Denis, Reunion Island, France, 97400 Contact: LAETITIA HUIART, DR    0262906882    laetitia.huiart@chu-reunion.fr    Contact: sophie LAFARGE    0262359491    sophie.lafarge@chu-reunion.fr    Principal Investigator: Xavier DEBUSSCHE, DR          Principal Investigator: Nathalie LE MOULLEC, DR Less <<
NCT02895672 - Completed - -
NCT02910141 - Completed - -
NCT02911792 Diabetes Mellitus, Type 2 Phase 4 Recruiting April 2019 United States, Florida ... More >> Sanford Burnham Prebys Medical Discovery Institute Not yet recruiting Orlando, Florida, United States, 32827 Contact: Richard Pratley, MD    407-745-2145    rpratley@SBPdiscovery.org    United States, Illinois Northwestern Medical School Not yet recruiting Chicago, Illinois, United States, 60611 Contact: Mark Molitch, MD    312-503-4130    molitch@northwestern.edu    The University of Chicago Not yet recruiting Chicago, Illinois, United States, 60637 Contact: George Bakris, MD    773-702-7936    gbakris@medicine.bsd.uchicago.edu    United States, Texas The University of Texas Health Science Center at San Antonio Not yet recruiting San Antonio, Texas, United States, 78229 Contact: Ralph A DeFronzo, MD    210-567-6691    defronzo@uthscsa.edu    Contact: Monica Palomo, BS    210-567-6710    palomom@uthscsa.edu    Sub-Investigator: Ralph A DeFronzo, MD          Principal Investigator: Eugenio Cersosimo, MD          University Health Systems Texas Diabetic Institute Recruiting San Antonio, Texas, United States Contact: Eugenio Cersosimo, MD    210-358-7200    cersosimo@uthscsa.edu    United States, Washington Sacred Heart Medical Center Not yet recruiting Spokane, Washington, United States, 99204 Contact: Katherine Tuttle, MD    509-340-0930       Australia, Victoria Baker Medical Research Institute and Alfred Hospital Not yet recruiting Melbourne, Victoria, Australia Contact: Mark Cooper, MD    61385321362    mark.cooper@bakeridi.edu.au Less <<
NCT02910089 Diabetes Mellitus Type 2 Phase 4 Completed - United States, Massachusetts ... More >> Research Site Boston, Massachusetts, United States, 2115 Less <<
NCT02919059 Diabetes Mellitus, Type 2 Phase 4 Recruiting August 2019 Spain ... More >> Hospital Nuestra Señora de la Esperanza Recruiting Santiago de Compostela, Galicia, Spain, 15705 Contact: Álvaro Hermida, MD, PhD    0034 981 552 200    alvaro.hermida.ameijeiras@sergas.es Less <<
NCT03710460 Obesity Phase 4 Recruiting June 30, 2019 Mexico ... More >> Instituto de Terapeútica Experimental y Clínica. Centro Universitario de Ciencias de la Salud. Universidad de Guadalajara Recruiting Guadalajara, Jalisco, Mexico, 44340 Contact: Manuel Gonzalez, PhD    +52-10-58-52-00 ext 34212    uiec@prodigy.net.mx    Contact: Esperanza Martinez, PhD    +52-10-58-52-00 ext 34212    esperanzamartnezabundi@yahoo.com Less <<
NCT02924064 Type 2 Diabetes Mellitus Phase 3 Completed - China ... More >> Investigational center Beijing, China Less <<
NCT02889510 Type 2 Diabetes Phase 3 Unknown September 2018 Spain ... More >> Hospital Universitari Germans Trias i Pujol Not yet recruiting Badalona, Barcelona, Spain, 08916 Contact: Manuel Puig-Domingo    +34 934978653    mpuig.germanstrias@gencat.cat    Contact: Silvia Pellitero    +34 625391561    spellitero.germanstrias@gencat.cat    Sub-Investigator: Silvia Pellitero          Clínica Universidad de Navarra Not yet recruiting Pamplona, Navarra, Spain, 31008 Contact: Javier Salvador    +34 660597980    jsalvador@unav.es    Hospital Universitari Vall d´Hebrón Not yet recruiting Barcelona, Spain, 08035 Contact: Rafael Simó       rafael.simo@vhir.org    Contact: Lorena Ramos    +34 934894198    lorena.ramos@vhir.org    Sub-Investigator: Andrea Ciudín          Hospital Universitari Arnau de Vilanova de Lleida Recruiting Lleida, Spain, 25198 Contact: Albert Lecube, PhD    +34 973705183    alecube@gmail.com    Contact: Raquel Martí       rmarti@irblleida.cat    Sub-Investigator: Carolina López          Sub-Investigator: Cecilia Turino          Sub-Investigator: Asunción Seminario          Hospital Universitario Virgen de la Victoria Not yet recruiting Málaga, Spain, 29010 Contact: Francisco Tinahones    +34 951034016    fjtinahones@hotmail.com    Contact: Inmaculada Picón    +34 638430738    ipiconcesar@gmail.com    Sub-Investigator: Baldomera Martínez          Sub-Investigator: Paloma Romero          Hospital Universitario Virgen del Rocío Not yet recruiting Sevilla, Spain, 41013 Contact: Pedro Pablo García    +34 607686901    garcialunapp@yahoo.es    Sub-Investigator: Francisco Ortega          Sub-Investigator: Antonio Jesús Martínez Less <<
NCT02924207 Diabetes Mellitus Not Applicable Active, not recruiting February 2019 United States, Kentucky ... More >> St. Elizabeth Healthcare Covington, Kentucky, United States, 41011 Less <<
NCT02916706 Type 2 Diabetes Mellitus Phase 3 Completed - China ... More >> Investigational center Beijing, China Less <<
NCT02928952 Diabetes Mellitus Not Applicable Recruiting June 30, 2019 United States, Pennsylvania ... More >> VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA Recruiting Pittsburgh, Pennsylvania, United States, 15240 Contact: Monica M DiNardo, PhD ARNP CDE    (412) 360-2262    Monica.Dinardo@va.gov    Contact: Nicole M Beyer, MA    (412) 360-2198    nicole.beyer@va.gov    Sub-Investigator: Ada O. Youk, PhD          Sub-Investigator: Carol M. Greco, PhD          Sub-Investigator: Carolyn T. Thorpe, PhD MPH          Sub-Investigator: Keri L. Rodriguez, PhD          Sub-Investigator: Lauren M. Broyles, PhD RN          Sub-Investigator: Linda M. Siminerio, PhD RN          Principal Investigator: Monica M. DiNardo, PhD ARNP CDE          Sub-Investigator: R. Harsha Rao, MD Less <<
NCT02917902 Diabetes Mellitus, Type 2 Not Applicable Completed - -
NCT02925312 Diabetes Not Applicable Unknown December 2016 -
NCT02937987 - Enrolling by invitation March 2018 -
NCT02938026 Diabetes Mellitus Type 2 in Ob... More >>ese Less << Not Applicable Completed - -
NCT02935712 Male Subjects With Type II Dia... More >>betes (T2DM) Less << Phase 1 Completed - Germany ... More >> Research Site Berlin, Germany, 14050 Less <<
NCT02940275 - Unknown December 2018 Taiwan ... More >> National Taiwan University Hospital Recruiting Taipei, Taiwan, 100 Contact: Yu-Chang Yeh, MD, PhD    886-9-10513711    tonyyeh@ntuh.gov.tw Less <<
NCT02932436 Diabetes Mellitus, Type 2 ... More >> Diastolic Dysfunction Less << Phase 4 Recruiting June 2019 Germany ... More >> Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Zentrum für Kardiologie, Präventive Kardiologie und Medizinische Prävention Recruiting Mainz, Germany, 55131 Contact: Philipp Wild, MD    00496131 ext 17 170    philipp.wild@unimedizin-mainz.de    Contact: Tommaso Gori, MD    00496131 ext 17 170    tommaso.gori@unimedizin-mainz.de Less <<
NCT02940379 Type 2 Diabetes Mellitus Phase 1 Completed - United States, Tennessee ... More >> Investigational Site Number 840001 Knoxville, Tennessee, United States, 37920 Less <<
NCT02948777 Type2 Diabetes Mellitus Phase 4 Completed - Finland ... More >> Helsinki University Hospital, Biomedicum 2U Helsinki, Finland Less <<
NCT02933788 Type 2 Diabetes Mellitus Phase 4 Unknown December 2018 -
NCT02946632 Diabetes Mellitus, Type II Phase 3 Not yet recruiting December 2019 Korea, Republic of ... More >> Korea University Anam Hospital Seoul, Korea, Republic of Less <<
NCT02951260 Diabetes Mellitus, Type 2 Not Applicable Completed - Denmark ... More >> Center for aktiv sundhed Copenhagen, Copenhagen N, Denmark, 2200 Less <<
NCT03056508 Subjective Cognitive Decline ... More >> Age-Related Cognitive Decline Less << Not Applicable Recruiting May 2021 Canada, Ontario ... More >> Toronto Rehabilitation Institute Rumsey Centre Not yet recruiting Toronto, Ontario, Canada, M4G 2V6 Contact: Susan Marzolini, PhD    (416) 597-3422    Susan.Marzolini@uhn.ca    The Centre for Memory and Aging Recruiting Toronto, Ontario, Canada, M4G 3E8 Contact: Mayrose Cornejo    416-663-6897    mcornejo@memorycentre.ca    Sunnybrook Health Sciences Centre Not yet recruiting Toronto, Ontario, Canada, M4N 3M5 Contact: Bradley MacIntosh, PhD    416-480-6100 ext 7277    bmac@sri.utoronto.ca    Rotman Research Institute Recruiting Toronto, Ontario, Canada, M6A 2E1 Contact: Carol E Greenwood, PhD    416-785-2500 ext 2785    carol.greenwood@utoronto.ca    Contact: Noah Koblinsky, MSc    416-785-2500 ext 3363    nkoblinsky@research.baycrest.org    Principal Investigator: Nicole D Anderson, PhD Less <<
NCT03668301 - Completed - -
NCT03559101 Dehydration Not Applicable Completed - United States, Pennsylvania ... More >> Pennsylvania State University University Park, Pennsylvania, United States, 16802 Less <<
NCT02945332 Obesity Diabe... More >>tes Mellitus Less << Not Applicable Completed - United States, Texas ... More >> Lubbock Dream Center Lubbock, Texas, United States, 79411 Less <<
NCT03675165 Diabetes Mellitus, Type 2 Not Applicable Recruiting December 2018 United Kingdom ... More >> Liverpool John Moores University Recruiting Liverpool, Merseyside, United Kingdom, L3 5AF Contact: Benjamin D Gibson Less <<
NCT03678896 Diabetes Not Applicable Completed - -
NCT03673111 Diabetes Mellitus ... More >> Obesity Less << Phase 1 Recruiting October 2018 United Kingdom ... More >> Covance Clinical Research Unit Recruiting Leeds, United Kingdom, LS2 9LH Contact: Tracey Oxley, MSc, CPM    +44 (0)113 301 3726    Tracey.Oxley@covance.com    Principal Investigator: Jim Bush, PhD, MRCS Less <<
NCT03680482 Diabetes Mellitus, Type 2 Not Applicable Completed - -
NCT03682445 Type2 Diabetes Mellitus ... More >> Exercise Less << Not Applicable Not yet recruiting December 31, 2020 Turkey ... More >> Pamukkale University Denizli, Turkey, 21600 Less <<
NCT03670043 Type2 Diabetes Mellitus Phase 4 Not yet recruiting November 2020 -
NCT03686917 - Not yet recruiting February 1, 2019 -
NCT03692208 Diabetes Mellitus, Type 2 Not Applicable Not yet recruiting June 2020 -
NCT03683784 - Completed - -
NCT03708380 Diabetes Not Applicable Not yet recruiting January 1, 2021 United States, New York ... More >> New York University School of Medicine Not yet recruiting New York, New York, United States, 10016 Contact: Marcela Osorio    646-501-6810       Principal Investigator: David Lee, MD Less <<
NCT03702660 Type2 Diabetes Not Applicable Completed - Denmark ... More >> Center for Diabetes Research, Gentofte Hospital Hellerup, Denmark, 2900 Less <<
NCT03709966 Diabetes Mellitus, Type 2 ... More >> Physical Activity Motivation Less << Not Applicable Recruiting March 31, 2019 Canada ... More >> GMF-UMF Laval-Québec Recruiting Québec, Canada, G1V0B7 Contact: Caroline Rhéaume, MD,PhD    418-656-4795    caroline.rheaume@criucpq.ulaval.ca Less <<
NCT02467790 Type 2 Diabetes Mellitus Phase 1 Unknown May 2016 China, Hunan ... More >> Third Xiangya Hospital, Central South Univety Recruiting Chang Sha, Hunan, China Contact: Hao Zhang, MD    13975806919    zhanghaoliaoqin@163.com    Contact: Guoping Yang, MD    13974817168    ygp9880@163.com Less <<
NCT02469207 - Recruiting June 2020 United Kingdom ... More >> Addenbrooke's Hospital Recruiting Cambridge, United Kingdom, CB2 0QQ Contact: Andrew Bradley, PhD, FRCS    (3)36976 (7)62001    jab52@cam.ac.uk Less <<
NCT03244852 - Not yet recruiting June 2020 United States, Massachusetts ... More >> Massachusetts General Hospital Not yet recruiting Charlestown, Massachusetts, United States, 02129 Contact: Aishwarya K Gosai, BA    617-724-0244    agosai@partners.org    Principal Investigator: Darin D Dougherty, MD Less <<
NCT02466880 Diabetes Mellitus Not Applicable Completed - Malaysia ... More >> Klinik Kesihatan Pandamaran Klang, Selangor, Malaysia, 42000 Less <<
NCT02473926 Motor Activity ... More >> Health Behavior Diabetes Mellitus, Type 2 Less << Not Applicable Recruiting December 2018 United States, Colorado ... More >> University of Colorado Denver | Anschutz Medical Campus Recruiting Aurora, Colorado, United States, 80045 Contact: Kristina Chapman, BS    720-848-6690    kristina.chapman@ucdenver.edu    Principal Investigator: Amy Huebschmann, MD, MS Less <<
NCT01452178 - Completed - Sweden ... More >> Center of Clinical Research, Uppsala university, Central Hospital Västerås, Sweden, SE-72189 Less <<
NCT02471963 Diabetes Mellitus Type 2 Phase 3 Completed - Germany ... More >> University of Erlangen-Nuremberg Erlangen, Bavaria, Germany, 91054 Less <<
NCT03761589 Cardiovascular Fitness ... More >> Physical Activity Less << Not Applicable Completed - United States, California ... More >> Institute for Behavioral and Community Health San Diego, California, United States, 92123 Less <<
NCT02481596 Diabetes Mellitus, Type 2 Not Applicable Completed - United States, Tennessee ... More >> Federally Qualified Health Centers & Vanderbilt Primary Care Clinics Nashville, Tennessee, United States Less <<
NCT03723785 Diabetes Mellitus, Type 2 Phase 1 Recruiting November 15, 2019 Germany ... More >> Novo Nordisk Investigational Site Recruiting Berlin, Germany, 10117 Less <<
NCT03692884 - Recruiting July 1, 2030 China, Chongqing ... More >> Qifu Li Recruiting Chongqing, Chongqing, China, 400016 Contact: Qifu Li, PhD    +86 23 89011552    liqifu@yeah.net    Sub-Investigator: Zhihong Wang, phD          Sub-Investigator: Qingfeng Cheng, phD          Sub-Investigator: Shumin Yang, phD          Sub-Investigator: Jinbo Hu, phD          Sub-Investigator: Yue Wang, phD          Sub-Investigator: Lilin Gong, phD Less <<
NCT02480465 Diabetes Mellitus, Type 2 Phase 4 Unknown March 2017 Korea, Republic of ... More >> Korea University Anam Hospital Recruiting Seoul, Korea, Republic of Contact: Dong-sub Choi Less <<
NCT02489968 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT02488733 Type 2 Diabetes Mellitus Not Applicable Recruiting September 2024 Italy ... More >> Ospedale Sandro Pertini Recruiting Rome, Italy Principal Investigator: Paola D'Angelo, Dr.          Sub-Investigator: Lucia Fontana, Dr.          Azienda Ospedaliera Santa Maria Recruiting Terni, Italy, 05100 Principal Investigator: Amilcare Parisi, MD          Sub-Investigator: Giuseppe Fatati, MD          Sub-Investigator: Stefano Trastulli          Sub-Investigator: Jacopo Desiderio Less <<
NCT02493374 - Recruiting June 2019 United States, Minnesota ... More >> University of Minnesota Recruiting Minneapolis, Minnesota, United States, 55455 Contact: P. Nordberg, MHA, PhD    612-672-6737    mnordbe2@fairview.org Less <<
NCT02486172 Type 2 Diabetes ... More >> Peer Group Less << Not Applicable Unknown February 2017 -
NCT02497170 Type 2 Diabetes Not Applicable Completed - United States, New Jersey ... More >> Melissa Souza Somerdale, New Jersey, United States, 08083 Less <<
NCT02489968 - Completed - -
NCT02504086 Diabetes Mellitus Type 2 Not Applicable Terminated(Difficulty recruiti... More >>ng participants) Less << August 2016 Canada, British Columbia ... More >> Vancouver primary care offices Vancouver, British Columbia, Canada, V6T 2B5 Less <<
NCT02518503 - Completed - -
NCT02118766 - Completed - -
NCT02518581 Diabetes Not Applicable Active, not recruiting July 2019 Germany ... More >> Profil Institut für Stoffwechselforschung GmbH Neuss, Germany, 41460 Less <<
NCT02500303 - Active, not recruiting December 2018 United Kingdom ... More >> Western Infirmary Glasgow, United Kingdom, G11 6NT Less <<
NCT02479399 - Completed - Japan ... More >> Chubu, Japan Chugoku, Japan Hokkaido, Japan Kansai, Japan Kantou, Japan Kyushu, Japan Shikoku, Japan Tohoku, Japan Less <<
NCT02526524 Type 2 Diabetes Mellitus Phase 2 Completed - -
NCT02522494 Diabetes Mellitus Not Applicable Recruiting June 28, 2019 United States, Colorado ... More >> Rocky Mountain Regional VA Medical Center, Aurora, CO Recruiting Aurora, Colorado, United States, 80045 Contact: Ravi K Gopal, PhD    303-399-8020 ext 2663    Ravi.Gopal@va.gov    Sub-Investigator: Ravi K. Gopal, PhD          United States, Illinois Jesse Brown VA Medical Center, Chicago, IL Recruiting Chicago, Illinois, United States, 60612 Contact: Karen M Lenehan    312-569-6343    Karen.Lenehan@va.gov    Principal Investigator: Howard S. Gordon, MD BS          Sub-Investigator: Saul J. Weiner, MD Less <<
NCT02118766 Dermatitis, Atopic Phase 3 Completed - United States, Georgia ... More >> Anacor Investigational Site Stockbridge, Georgia, United States Less <<
NCT02529982 Non Insulin Dependent Diabetes Phase 2 Phase 3 Unknown - Iran, Islamic Republic of ... More >> NNFTRI clinic Recruiting Tehran, Iran, Islamic Republic of, 19435 Contact: Golbon Sohrab, PhD    09123069156    golbonsohrab@yahoo.com Less <<
NCT02529969 Non Insulin Dependent Diabetes Phase 2 Phase 3 Unknown - Iran, Islamic Republic of ... More >> NNFTRI clinic Recruiting Tehran, Iran, Islamic Republic of, 19435 Contact: Golbon Sohrab, PhD    9123069156    golbonsohrab@yahoo.com Less <<
NCT02526524 - Completed - -
NCT02541734 Diabetes Mellitus, Non-Insulin... More >>-Dependent Diabetes Mellitus Less << Phase 1 Phase 2 Completed - -
NCT02538848 Type 2 Diabetes Mellitus Phase 1 Completed - Australia ... More >> Linear Clinical Research Limited Perth, Australia, WA6009 Less <<
NCT02531776 Diabetes Mellitus, Type 2 Not Applicable Completed - Denmark ... More >> University of Copenhagen Copenhagen, Denmark, 2200 Less <<
NCT02555631 - Completed - -
NCT02555631 Type 2 Diabetes ... More >> Men Less << Not Applicable Completed - United States, New York ... More >> Albert Einstein College of Medicine Bronx, New York, United States, 10461 Less <<
NCT02548273 - Completed - -
NCT02564211 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT02564211 - Completed - -
NCT02548741 Type 2 Diabetes Mellitus Not Applicable Unknown August 2017 -
NCT02565368 Diabetes Mellitus, Type II Phase 1 Completed - Korea, Republic of ... More >> Chonbuk National University Hospital Jeonju-si, Jeollabuk-do, Korea, Republic of Less <<
NCT02567994 Type 2 Diabetes Mellitus Phase 3 Completed - Korea, Republic of ... More >> Samsung Medical Center Seoul, Korea, Republic of Less <<
NCT02561338 Diabetes Mellitus, Type 2 Phase 2 Completed - China, Jiangsu ... More >> Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School Nanjing, Jiangsu, China Less <<
NCT02569151 - Not yet recruiting April 2027 -
NCT02569684 Diabetes Type 2 Not Applicable Active, not recruiting December 2019 Norway ... More >> Oslo University Hospital Oslo, Norway, 0424 Less <<
NCT02564926 Diabetes Mellitus, Type 2 Phase 4 Completed - Korea, Republic of ... More >> Research Site Ansan-si, Korea, Republic of, 15355 Research Site Changwon-si, Korea, Republic of, 51353 Research Site Daegu, Korea, Republic of, 41931 Research Site Daejeon-si, Korea, Republic of, 35233 Research Site Goyang-si, Korea, Republic of, 10326 Research Site Incheon, Korea, Republic of, 21565 Research Site Seongnam-si, Korea, Republic of, 13620 Research Site Seoul, Korea, Republic of, 01830 Research Site Seoul, Korea, Republic of, 04401 Research Site Seoul, Korea, Republic of, 05278 Research Site Seoul, Korea, Republic of, 06273 Research Site Suwon-si, Korea, Republic of, 16499 Research Site Uijeongbu-si, Korea, Republic of, 11765 Research Site Wonju-si, Korea, Republic of, 220-701 Less <<
NCT02583919 Type 2 Diabetes Phase 2 Completed - United States, California ... More >> Ionis Investigational Site Greenbrae, California, United States, 94904 Ionis Investigational Site Huntington Park, California, United States, 90255 Ionis Investigational Site La Mesa, California, United States, 91942 Ionis Investigational Site Los Angeles, California, United States, 90057 Isis Investigational Site Spring Valley, California, United States, 91978 United States, Florida Ionis Investigational Site Port Orange, Florida, United States, 32127 United States, Georgia Ionis Investigational Site Marietta, Georgia, United States, 30060 United States, Maryland Ionis Investigational Site Oxon Hill, Maryland, United States, 20745 United States, New York Ionis Investigational Site New York, New York, United States, 10016 United States, North Carolina Ionis Investigational Site Greensboro, North Carolina, United States, 27410 Ionis Investigational Site Morehead City, North Carolina, United States, 28557 United States, Ohio Ionis Investigational Site Cincinnati, Ohio, United States, 45219 Ionis Investigational Site Cincinnati, Ohio, United States, 45245 United States, Oregon Ionis Investigational Site Eugene, Oregon, United States, 97404 United States, South Carolina Ionis Investigational Site Spartanburg, South Carolina, United States, 29303 United States, Texas Ionis Investigational Site Houston, Texas, United States, 77036 Ionis Investigational Site Houston, Texas, United States, 77074 Ionis Investigational Site Katy, Texas, United States, 77450 United States, Washington Ionis Investigational Site Olympia, Washington, United States, 98502 Less <<
NCT02564913 - Completed - -
NCT02575599 Type 2 Diabetes Not Applicable Not yet recruiting January 1, 2020 -
NCT02588859 - Completed - India ... More >> Research Site Nellure, Andhra Pradesh, India Research Site Vishakhapatnam, Andhra Pradesh, India Research Site Guwahati, Assam, India Research Site New Delhi, Delhi, India Research Site Ahmedabad, Gujarat, India Research Site Rajkot, Gujarat, India Research Site Vadodara, Gujarat, India Research Site Karnal, Haryana, India Research Site Yamunanagar, Haryana, India Research Site Bangalore, Karnataka, India Research Site Trivandrum, Kerala, India Research Site Cochin, Kochi, India Research Site Bhopal, Madhya Pradesh, India Research Site Indore, Madhya Pradesh, India Research Site Mumbai, Maharashtra, India Research Site Pune, Maharashtra, India Research Site Amritsar, Punjab, India Research Site Chandigarh, Punjab, India Research Site Ludhiana, Punjab, India Research Site Jaipur, Rajasthan, India Research Site Udaipur, Rajasthan, India Research Site Madurai, Tamiladu, India Research Site Chennai, Tamilnadu, India Research Site Hyderabad, Telangana, India Research Site Hyderebad, Telangana, India Research Site Allahabad, Uttar Pradesh, India Research Site Kanpur, Uttar Pradesh, India Research Site Lucknow, Uttar Pradesh, India Research Site Noida, Uttar Pradesh, India Research Site Kolkata, West Bengal, India Research Site new Delhi, India Less <<
NCT02585505 Diabetes Mellitus, Non-Insulin... More >>-Dependent Less << Phase 1 Phase 2 Completed - -
NCT02586545 Diabetes Mellitus, Type 2 Not Applicable Active, not recruiting November 2019 Denmark ... More >> Center for Diabetes Research, Gentofte Hospital, University of Copenhagen Hellerup, Denmark, DK-2900 Less <<
NCT02589730 Diabetes Mellitus Not Applicable Unknown October 2016 China, Shanghai ... More >> Shanghai Six People`s Hospital Recruiting Shanghai, Shanghai, China, 200233 Contact: Lei Zhang, MM    +86-18930173806    stonez78@hotmail.com Less <<
NCT02589639 Diabetes Mellitus, Type 2 Phase 4 Completed - Japan ... More >> Nakayama Clinic Aichi, Japan, 456-0058 Kashiwa City Hospital Chiba, Kashiwa, Japan, 277-0825 Saiseikai Fukuoka General Hospital Fukuoka, Fukuoka, Japan, 810-0001 Seiwakai Medical Corporation Nagata Hospital Fukuoka, Yanagawa, Japan, 832-0059 Kunisaki Makoto Clinic Fukuoka, Japan, 819-0168 Saiseikai Maebashi Hospital Gunma, Maebashi, Japan, 371-0821 Nippon Kokan Fukuyama Hospital Hiroshima, Fukuyama, Japan, 721-0927 Jiyugaoka Yokoyama Naika Clinic Hokkaido, Obihiro, Japan, 080-0016 Jiyugaoka Yamada Clinic Hokkaido, Obihiro, Japan, 080-0848 Souen Diabetes Clinic Hokkaido, Sapporo, Japan, 060-0011 Kotani Diabetes Clinic Hyogo, Kobe, Japan, 657-0028 Nishinomiya Municipal Central Hospital Hyogo, Nishinomiya, Japan, 663-8014 Noritake Clinic Ibaraki, Ushiku, Japan, 300-1207 Yokoi Medical Clinic, Kagawa, I.M. Kagawa, Japan, 761-8075 Izuro Imamura Hospital Kagoshima, Kagoshima, Japan, 892-0824 Wakamatsu Memorial Hospital Kagoshima, Satsumasendai, Japan, 895-0052 Fukumoto clinic Kagoshima, Japan, 891-0401 STOP DM SUZUKI DIABETES CLINIC, Kanagawa, I.M. Kanagawa, Atsugi, Japan, 243-0035 Takai Naika Clinic Kanagawa, Kamakura, Japan, 247-0056 Kokan Clinic Kanagawa, Kawasaki, Japan, 210-0852 Yoshimasa Diabetes & Endocrine Clinic Kyoto, Kyoto, Japan, 604-8151 Medical Corporation KEISEIKAI Kajiyama clinic Kyoto, kyoto, Japan, 615-0035 Saka General Clinic Miyagi, Tagajo, Japan, 985-0835 North Alps Medical Center Azumi Hospital Nagano, Kitaazumi-gun, Japan, 399-8695 Asama Nanroku Komoro Medical center Nagano, Komoro, Japan, 384-8588 Abe Clinic Oita, Oita, Japan, 870-0039 Tsuyama Chuo Hospital Okayama, Tsuyama, Japan, 708-0841 Medical Corporation Kyojinkai Clinic Komatsu Osaka, Neyagawa, Japan, 572-8567 Minamiosaka Hospital Osaka, Osaka, Japan, 559-0012 OCROM Clinic Osaka, Suita, Japan, 565-0853 AMC Nishi-umeda Clinic Osaka, Japan, 530-0001 Shiraiwa Medical Clinic Osaka, Japan, 582-0005 Ageo Central General Hospital Saitama, Ageo, Japan, 362-8588 Medical Corporation Kaishinkai Masunaga Clinic Saitama, Fujimi, Japan, 354-0031 Medical Corporation Fusa Shimizu Clinic Fusa Saitama, Saitama, Japan, 336-0963 Seiwa Clinic Tokyo, Adachi-ku, Japan, 123-0845 Juntendo University Hospital Tokyo, Bunkyo-ku, Japan, 113-8431 Chiyoda Houjin Clinic Tokyo, Chiyoda-ku, Japan, 101-0024 HDC Atlas Clinic Tokyo, Chiyoda-ku, Japan, 102-0082 Fukuwa Clinic Tokyo, Chuo-ku, Japan, 103-0027 Tokyo-Eki Center-building Clinic Tokyo, Chuo-ku, Japan, 103-0027 Tokyo Center Clinic Tokyo, Chuo-ku, Japan, 103-0028 Shin Clinic Tokyo, Ota-ku, Japan, 144-0051 Shinjuku Research Park Clinic Tokyo, Shinjuku-ku, Japan, 169-0073 Sumida Chuou Hospital Tokyo, Sumida-ku, Japan, 131-0046 Sagae City Hospital Yamagata, Sagae, Japan, 991-8508 Clinic Sugiyama Yamagata, Yamagata, Japan, 990-0885 Yamanashi Prefectural Central Hospital Yamanashi, Kofu, Japan, 400-8506 Less <<
NCT02571608 Diabetes Mellitus Type 2 Phase 4 Not yet recruiting June 2020 -
NCT02594748 Diabetes Mellitus, Type 2 Not Applicable Suspended(The voluntary attend... More >>ance rate for intervention is low.) Less << December 2019 China, Jiangsu ... More >> The First People Hospital, Affiliated hospital of Nantong University Nantong, Jiangsu, China, 226001 Less <<
NCT03284775 Pituitary Adenoma Not Applicable Not yet recruiting August 2021 -
NCT02589626 Diabetes Mellitus, Type 2 Phase 4 Completed - Japan ... More >> 1245.106.81011 Boehringer Ingelheim Investigational Site Fukuoka, Fukuoka, Japan 1245.106.81001 Boehringer Ingelheim Investigational Site Fukushima, Koriyama, Japan 1245.106.81010 Boehringer Ingelheim Investigational Site Hiroshima, Fukuyama-shi, Japan 1245.106.81005 Boehringer Ingelheim Investigational Site Ibaraki, Naka, Japan 1245.106.81007 Boehringer Ingelheim Investigational Site Kanagawa, Kawasaki, Japan 1245.106.81016 Boehringer Ingelheim Investigational Site Kanagawa, Yamato-shi, Japan 1245.106.81015 Boehringer Ingelheim Investigational Site Kanagawa, Yokohama-shi, Japan 1245.106.81008 Boehringer Ingelheim Investigational Site Mie, Yokkaichi, Japan 1245.106.81012 Boehringer Ingelheim Investigational Site Osaka, Kashiwara-shi, Japan 1245.106.81013 Boehringer Ingelheim Investigational Site Osaka, Osaka-shi, Japan 1245.106.81009 Boehringer Ingelheim Investigational Site Osaka, Suita, Japan 1245.106.81003 Boehringer Ingelheim Investigational Site Tokyo, Chuo-ku, Japan 1245.106.81006 Boehringer Ingelheim Investigational Site Tokyo, Chuo-ku, Japan 1245.106.81014 Boehringer Ingelheim Investigational Site Tokyo, Hachioji-shi, Japan 1245.106.81002 Boehringer Ingelheim Investigational Site Tokyo, Shinjuku-ku, Japan 1245.106.81004 Boehringer Ingelheim Investigational Site Tokyo, Shinjuku-ku, Japan Less <<
NCT02607566 Diabetes Mellitus, Type 2 Not Applicable Completed - United States, Rhode Island ... More >> The Miriam Hospital Providence, Rhode Island, United States, 02906 Less <<
NCT02607410 Type 2 Diabetes Mellitus Phase 4 Completed - Brazil ... More >> University of Sao Paulo General Hospital Sao Paulo, Brazil, 05403-000 Less <<
NCT02592616 Diabetes Mellitus, Type 2 Not Applicable Unknown October 2016 Denmark ... More >> Center for Physical Activity Research (CFAS) Copenhagen, Denmark, 2100 Less <<
NCT02616263 Diabetes Mellitus Not Applicable Active, not recruiting February 2021 United States, Missouri ... More >> Washington University Saint Louis, Missouri, United States, 63108 Less <<
NCT02616666 Type 2 Diabetes Mellitus Phase 4 Recruiting December 31, 2021 -
NCT02597309 Diabetes, Obesity Phase 4 Withdrawn July 2017 United States, Massachusetts ... More >> Joslin Diabetes Center Boston, Massachusetts, United States, 02215 Less <<
NCT02627027 Diabetes Mellitus, Type II Phase 1 Completed - Korea, Republic of ... More >> Chonbuk National University Hospital Jeonju-si, Jeollabuk-do, Korea, Republic of Less <<
NCT02621476 Diabetes Mellitus Not Applicable Active, not recruiting May 2019 United States, California ... More >> Division of Research Oakland, California, United States, 94501 Less <<
NCT02608853 - Completed - United States, New Jersey ... More >> Novo Nordisk Clinical Trial Call Center Princeton, New Jersey, United States, 08540 Less <<
NCT02615444 Metabolic Syndrome X ... More >> Cardiovascular Diseases Less << Not Applicable Unknown December 2016 United Kingdom ... More >> Queen Margaret University, Edinburgh Musselburgh, East Lothain, United Kingdom, EH21 6UU Less <<
NCT03097224 Colon Cancer ... More >>Fragility Less << Not Applicable Recruiting July 1, 2019 Belgium ... More >> Cliniques universitaires Saint-Luc Recruiting Brussels, Woluwé-Saint-Lambert, Belgium, 1200 Contact: Gilles Caty       gilles.caty@uclouvain.be    Contact: Elise Piraux       elise.piraux@uclouvain.be Less <<
NCT02617693 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 4 Completed - Malaysia ... More >> Novo Nordisk Investigational Site Seremban, Negeri Sembilan, Malaysia, 70400 Less <<
NCT02641548 Diabetes Complications Not Applicable Recruiting May 2021 Sweden ... More >> Örebro University Hospital Recruiting Örebro, Sweden Contact: Gustav Jarl       gustav.jarl@regionorebrolan.se Less <<
NCT01399268 Postoperative Inflammatory Res... More >>ponse Less << Phase 4 Completed - United States, New York ... More >> Hospital for Special Surgery New York, New York, United States, 10021 Less <<
NCT03096951 Colon Cancer Not Applicable Recruiting July 1, 2019 Belgium ... More >> Cliniques universitaires Saint-Luc Recruiting Brussels, Woluwé-Saint-Lambert, Belgium, 1200 Contact: Gilles Caty       gilles.caty@uclouvain.be    Contact: Elise Piraux       elise.piraux@uclouvain.be Less <<
NCT02645799 Diabetes Mellitus Phase 2 Active, not recruiting November 2018 Israel ... More >> Kaplan Medical Center Rehovot, Israel Less <<
NCT02643797 Type 2 Diabetes Mellitus (T2DM... More >>) Less << Not Applicable Active, not recruiting June 2020 United States, California ... More >> Scripps Whittier Diabetes Institute La Jolla, California, United States, 92037 Less <<
NCT02637609 - Unknown June 2016 United States, Maryland ... More >> Johns Hopkins Bloomberg School of Public Health Baltimore, Maryland, United States, 21205 Less <<
NCT02650726 Diabetes Mellitus，Type 2 Early Phase 1 Completed - China, Guangdong ... More >> Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Department of Nutrition, School of Public Health, Sun Yat-Sen University (Northern Campus) Guangzhou, Guangdong, China, 510080 Less <<
NCT02655770 Diabetes Mellitus Type 2 ... More >> Diastolic Dysfunction Cardiac MRI Myocardial Perfusion Less << Phase 4 Recruiting July 2019 Denmark ... More >> The department of cardiology, Rigshospitalet Denmark Recruiting Copenhagen Ø, Denmark, 210 Contact: Annemie S Bojer, MD    +4522857526    asbojer@gmail.com    Contact: Niels Vejlstrup, MD DPhil    +45 26114145    niels.vejlstrup@regionh.dk    Principal Investigator: Annemie s Bojer, MD          Sub-Investigator: Peter H Gaede, Med.Sc.D          Sub-Investigator: Martin H Soerensen, MD          Sub-Investigator: Per L Madsen, Med.Sc.D Less <<
NCT01399268 - Completed - -
NCT02661581 Diabetes Not Applicable Unknown September 2017 Canada, British Columbia ... More >> St. Paul's Hospital Vancouver, British Columbia, Canada, V6Z 1Y6 Less <<
NCT02661165 - Completed - United Kingdom ... More >> University of Southampton Southampton, Hampshire, United Kingdom Less <<
NCT02648854 Diabetes Mellitus, Type II Phase 1 Completed - Korea, Republic of ... More >> Chonbuk National University Hospital Deokjin-gu, Jeonju-si, Jeollabuk-do, Korea, Republic of, 561-712 Less <<
NCT02664233 Diabetes Mellitus, Type 2 ... More >> Obesity Less << Early Phase 1 Completed - United States, Pennsylvania ... More >> University of Pittsburgh Pittsburgh, Pennsylvania, United States, 77030 United States, Texas The University of Texas Health Science Center at Houston Houston, Texas, United States, 77030 Less <<
NCT02666521 - Completed - United Kingdom ... More >> Diabetes Research Centre, University of Leicester Leicester, United Kingdom, LE5 4PW Less <<
NCT03509597 Schizophrenia Not Applicable Recruiting June 1, 2020 Spain ... More >> Hospital Psiquiatrico de Alava. Red Salud Mental de Araba Recruiting Vitoria, Alava, Spain, 01006 Contact: Pedro M. S Gomez, MD    +34 945006555 ext 6558    gomepe@mac.com    Contact: Edorta J Elizagarate Zabala, MD    +34 945 00 6555    eduardojose.elizagaratezabala@osakidetza.eus Less <<
NCT02668328 Diabetes Mellitus Type 2 in Ob... More >>ese Less << Not Applicable Withdrawn September 2018 -
NCT02667652 Type 2 Diabetes ... More >> Obesity Less << Not Applicable Unknown January 2018 China, Chongqing ... More >> Daping hospital Chongqing, Chongqing, China, 400042 Less <<
NCT02663245 Type 2 Diabetes Mellitus Not Applicable Recruiting December 2018 Spain ... More >> Laura Montero Recruiting Tàrrega, LLeida, Spain, 25300 Contact: Laura Montero, MD    +34 973 310852    lmontero.lleida.ics@gencat.cat Less <<
NCT02672176 Diabetes Mellitus Not Applicable Completed - United States, California ... More >> School of Nursing, University of California, Davis and UC Davis Health System Sacramento, California, United States, 95817 Less <<
NCT02672839 Type 2 Diabetes Mellitus (T2DM... More >>) Less << Phase 1 Completed - United States, Ohio ... More >> Medpace, Inc Cincinnati, Ohio, United States, 45227 Less <<
NCT02666807 Type 2 Diabetes Mellitus Not Applicable Completed - -
NCT02681185 Diabetes Mellitus Not Applicable Recruiting June 2020 Canada, British Columbia ... More >> Endocrine Research Society Recruiting Vancouver, British Columbia, Canada, V6J4Y3 Contact: Tristan Jeffery, BSc    604 689 1055    tristanjeffery.ers@gmail.com    Principal Investigator: Adam White, MD Less <<
NCT02671331 - Terminated(Principal investiga... More >>tor terminated study due to low enrollment.) Less << - United States, Wisconsin ... More >> Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 Less <<
NCT02678676 - Completed - -
NCT02685774 Diabetes Mellitus, Type II Phase 1 Completed - Korea, Republic of ... More >> Chonbuk National University Hospital Jeonju-si, Jeollabuk-do, Korea, Republic of Less <<
NCT02685384 - Active, not recruiting August 2020 -
NCT02678676 - Completed - -
NCT02688075 - Completed - Canada, Alberta ... More >> Calgary, Alberta, Canada Edmonton, Alberta, Canada Canada, British Columbia Coquitlam, British Columbia, Canada Surrey, British Columbia, Canada Canada, Manitoba Winnipeg, Manitoba, Canada Canada, Ontario Brampton, Ontario, Canada Downsview, Ontario, Canada Guelph, Ontario, Canada London, Ontario, Canada Mississauga, Ontario, Canada Ohsweken, Ontario, Canada Ottawa, Ontario, Canada Smiths Falls, Ontario, Canada Toronto, Ontario, Canada Canada, Quebec Laval, Quebec, Canada Longueuil, Quebec, Canada Montreal, Quebec, Canada Saint-Jean-Sur-Richelieu, Quebec, Canada Sherbrooke, Quebec, Canada St Marc Des Carrieres, Quebec, Canada Toronto, Quebec, Canada Westmont, Quebec, Canada Canada, Saskatchewan Saskatoon, Saskatchewan, Canada Less <<
NCT02681497 - Completed - Canada, Ontario ... More >> Western University London, Ontario, Canada, N6A 3K7 Less <<
NCT02687152 Type 2 Diabetes Mellitus Phase 1 Phase 2 Completed - Sweden ... More >> Karolinska Institutet Stockholm, Sweden, 17176 Less <<
NCT02692040 Diabetes Mellitus ... More >> Obesity Less << Phase 1 Unknown December 2016 United Kingdom ... More >> Covance Clinical Research Unit Recruiting Leeds, United Kingdom, LS2 9LH Contact: Jim Bush, PhD MRCS    +44 113 301 3500    Jim.bush@covance.com    Contact: Catherine Laing    +44 113 301 3725    Catherine.Laing@covance.com    Principal Investigator: Jim Bush, PhD MRCS Less <<
NCT02691273 Diabetes Mellitus, Type 2 Not Applicable Completed - Israel ... More >> Hadassah Medical Organization Jerusalem, Israel, 9112- Less <<
NCT02692716 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT02699307 Diabetes Mellitus, Type 2 Not Applicable Completed - United States, Michigan ... More >> University of Michigan Ann Arbor, Michigan, United States, 48104 Less <<
NCT02699541 Health Behavior ... More >> Diabetes Mellitus, Type 2 Less << Not Applicable Completed - Jordan ... More >> Jordan University Hospital Amman, Jordan Prince Hamzeh Hospital Amman, Jordan Less <<
NCT02700503 Diabetes Mellitus, Type 2 ... More >> Prediabetic State Less << Not Applicable Recruiting June 2019 United States, Indiana ... More >> Riley Children's Specialties Recruiting Carmel, Indiana, United States, 46032 Principal Investigator: Tamara Hannon, MD          Indiana University School of Medicine Recruiting Indianapolis, Indiana, United States, 46202 Contact: Tamara Hannon    317-278-5608    tshannon@iu.edu    Principal Investigator: Tamara S Hannon, MD          Riley Children's Hospital Recruiting Indianapolis, Indiana, United States, 46202 Principal Investigator: Tamara S Hannon, MD Less <<
NCT02709577 Type 2 Diabetes Phase 1 Phase 2 Completed - -
NCT02707380 Type 2 Diabetes (T2DM) ... More >> Cardiovascular Disease Less << Not Applicable Completed - United States, New York ... More >> New York University School of Medicine New York, New York, United States, 10016 Less <<
NCT02698618 Diabetes Mellitus, Type 2 Phase 4 Unknown March 2017 Spain ... More >> Hospital Universitario Marqués de Valdecilla Not yet recruiting Santander, Cantabria, Spain, 39008 Contact: José M de la Torre, MD, PhD    +34 942202520       Principal Investigator: José M de la Torre, MD, PhD          Hospital Galdakao-Usansolo Not yet recruiting Bilbao, Vizcaya, Spain, 48960 Contact: José R Rumoroso, MD, PhD    +34 944007000       Principal Investigator: José R Rumoroso, MD, PhD          Hospital San Carlos Not yet recruiting Madrid, Spain, 28040 Contact: Javier Escaned, MD, PhD    +34913303438    javier.escaned@salud.madrid.org    Contact: Enrico Cerrato, MD       enrico.cerrato@gmail.com    Principal Investigator: Javier Escaned, MD, PhD          Sub-Investigator: Alicia Quirós, PhD Less <<
NCT03724981 Diabetes Mellitus, Type 2 Phase 4 Not yet recruiting March 15, 2019 United States, Maryland ... More >> Evidera Not yet recruiting Bethesda, Maryland, United States, 20814 Principal Investigator: Louis Matza Less <<
NCT02688920 - Enrolling by invitation August 2018 United States, Florida ... More >> Mayo Clinic in Florida Jacksonville, Florida, United States, 32224 Less <<
NCT03730168 Diabetes Mellitus Not Applicable Completed - Egypt ... More >> Cairo University Giza, Cairo, Egypt, 12613 Less <<
NCT03136393 Maternal Exposure During Pregn... More >>ancy Less << Not Applicable Active, not recruiting December 31, 2017 Malawi ... More >> Monkey bay community hospital Mangochi, Malawi Less <<
NCT03728647 Type 2 Diabetes Mellitus ... More >> Insulin Education Less << Not Applicable Completed - -
NCT03731637 - Recruiting December 2025 United States, California ... More >> Kaiser Permanente Southern California Recruiting Los Angeles, California, United States, 90027 Contact: Bechien Wu, MD    323-783-7890    Bechien.U.Wu@kp.org    Cedars Sinai Medical Center Not yet recruiting Los Angeles, California, United States, 90048 Contact: Stephen Pandol, MD    310-423-6082    stephen.pandol@cshs.org    Kaiser Permanente Northern California Not yet recruiting Oakland, California, United States, 94612 Contact: Stephen Van Den Eeden, MD    510-591-3718    Stephen.VanDenEeden@kp.org    Stanford University Medical Center Recruiting Palo Alto, California, United States, 94605 Contact: Walter Park, MD    650-723-4102    wgpark@stanford.edu    United States, Florida University of Florida Not yet recruiting Gainesville, Florida, United States, 32608 Contact: Steven Hughes, MD    352-265-0761    Steven.Hughes@surgery.ufl.edu    United States, Indiana Univeristy Hospital, Indian University Health Recruiting Indianapolis, Indiana, United States, 46202 Contact: Kieren Mather, MD    317-278-7826    kmather@iu.edu    United States, Michigan St. Joseph Mercy Health System Not yet recruiting Ypsilanti, Michigan, United States, 48197 Contact: Tareq Al Baghdadi, MD    732-712-1000    tareq_albaghdadi@ihacares.com    United States, Minnesota Mayo Clinic Not yet recruiting Rochester, Minnesota, United States, 55905 Contact: Suresh Chari, MD    507-255-5713    Chari.Suresh@mayo.edu    Principal Investigator: Suresh Chari, MD          United States, Ohio The Ohio State University Wexner Medical Center Not yet recruiting Columbus, Ohio, United States, 43210 Contact: David Bradley, MD    614-685-3333    david.bradley@osumc.edu    United States, Pennsylvania University of Pittsburgh Medical Center Recruiting Pittsburgh, Pennsylvania, United States, 15213 Contact: Randall Brand, MD    412-623-0021    brandre@upmc.edu    United States, Texas Baylor College of Medicine Not yet recruiting Houston, Texas, United States, 77030 Contact: William Fisher, MD    713-798-4321    wfisher@bcm.edu Less <<
NCT03731533 Type 2 Diabetes Mellitus Not Applicable Not yet recruiting July 1, 2020 United States, Ohio ... More >> Ohio University Not yet recruiting Athens, Ohio, United States, 45701 Contact: David S Drozek, DO    678-447-2509    drozek@ohio.edu    Contact: Rachel Clift, MSN, RN    740-593-2233    cliftr@ohio.edu    Principal Investigator: David S Drozek, DO Less <<
NCT02709577 - Completed - -
NCT03737799 - Recruiting December 31, 2022 United Kingdom ... More >> Anita Hill Recruiting Exeter, Devon, United Kingdom, EX2 5DW Contact: Anita V Hill    +44 (0) 1392 408184    Anita.Hill2@nhs.net    Contact: Robert Bolt    +44 (0) 1392 408181    r.bolt@nhs.net    Principal Investigator: Angus G Jones, MBBS MRCP Less <<
NCT03738449 Type 2 Diabetes Mellitus Phase 1 Not yet recruiting December 26, 2018 Korea, Republic of ... More >> Severance Hospital Not yet recruiting Seoul, Korea, Republic of, 03722 Contact: Min Soo Park, Ph.D. M.D    +82-2-2228-0270    minspark@yuhs.ac    Principal Investigator: Minsoo Park, Ph.D. M.D Less <<
NCT03736486 - Enrolling by invitation December 2018 United States, California ... More >> Sansum Diabetes Research Institute Santa Barbara, California, United States, 93105 Less <<
NCT03745885 Diabetes Mellitus, Type 2 Phase 1 Not yet recruiting December 17, 2019 -
NCT03743779 - Recruiting July 1, 2019 United States, Ohio ... More >> Ohio University Recruiting Athens, Ohio, United States, 45701 Contact: David S Drozek, DO    678-447-2509    drozek@ohio.edu    Principal Investigator: David S Drozek, DO Less <<
NCT03744975 Diabetes Mellitus, Type 2 ... More >> Diastolic Dysfunction Less << Phase 2 Recruiting December 30, 2021 United States, Minnesota ... More >> Mayo Clinic in Rochester Recruiting Rochester, Minnesota, United States, 55905 Contact: Horng H Chen, M.D.    507-284-4343    chen.horng@mayo.edu    Contact: Lynn K Harstad, A.S.    507-284-4838    harstad.lynn@mayo.edu Less <<
NCT02206074 Type 2 Diabetes Not Applicable Completed - United Kingdom ... More >> Peninsula NIHr Exeter Clinical Research Facility Exeter, Devon, United Kingdom, EX2 5DW Less <<
NCT03348683 Induction of Labor Affected Fe... More >>tus / Newborn Less << Phase 2 Completed - United States, New York ... More >> Icahn School of Medicine at Mount Sinai New York, New York, United States, 10029 Less <<
NCT02210871 Diabetes Diab... More >>etes Mellitus, Type 2 Hepatic Impaired Less << Phase 1 Completed - Poland ... More >> Novo Nordisk Investigational Site Warszawa, Poland, 02-507 Novo Nordisk Investigational Site Wolomin, Poland, 05-200 Slovakia Novo Nordisk Investigational Site Bratislava, Slovakia, 83101 Novo Nordisk Investigational Site Bratislava, Slovakia, 833 05 Less <<
NCT02211651 - Completed - United States, Florida ... More >> Translational Research Institute for Metabolism and Diabetes Orlando, Florida, United States, 32804 Less <<
NCT03747471 Diabetes Mellitus ... More >> Diabetes Self Efficacy Diabetes Mellitus, Type 2 Less << Not Applicable Not yet recruiting April 1, 2019 Pakistan ... More >> Dow University of Health Sciences Not yet recruiting Karachi, Sindh, Pakistan Contact: Rubina Qasim, MSc    00923332404304    qasim.ruby@gmail.com    Sub-Investigator: Sarfaraz Masih, MSc          Sub-Investigator: Mehwish Hussain, PhD          Sub-Investigator: Akhter Ali, FRCP Less <<
NCT02211261 - Completed - -
NCT02223065 Type 2 Diabetes Mellitus Phase 1 Completed - -
NCT02223065 - Completed - -
NCT02211261 Type 2 Diabetes Mellitus Phase 1 Completed - United States, California ... More >> Profil Institute for Clinical Research, Inc. Chula Vista, California, United States, 91911 Profil Institute for Clinical Research, Incorporated Chula Vista, California, United States, 91911 United States, Florida Avail Clinical Research, LLC DeLand, Florida, United States, 32720 Orlando Clinical Research Center Orlando, Florida, United States, 32809 Qps Mra, Llc South Miami, Florida, United States, 33143 Qps-Mra Llc South Miami, Florida, United States, 33143 United States, North Carolina High Point Clinical Trials Center, LLC High Point, North Carolina, United States, 27265 Less <<
NCT02226640 - Completed - United States, Florida ... More >> Translational Research Institute for Metabolism and Diabetes Orlando, Florida, United States, 32804 Less <<
NCT02212665 Prevention of Developing Type ... More >>2 Diabetes Less << Not Applicable Active, not recruiting December 30, 2017 Denmark ... More >> Center for Diabetes Research, Gentofte Hospital Hellerup, Denmark, 2900 Less <<
NCT02227875 Type 2 Diabetes Phase 3 Completed - -
NCT02231736 - Unknown - Austria ... More >> University of Vienna Recruiting Vienna, Austria, 1090 Contact: Karl-Heinz Wagner, PhD    004314277 ext 54930    Karl-Heinz.wagner@univie.ac.at    Contact: Annemarie Grindel    004314277 ext 54901    annemarie.grindel@univie.ac.at    Sub-Investigator: Helmuth Brath, MD Less <<
NCT02234973 - Active, not recruiting June 30, 2019 Canada, Ontario ... More >> Centre for Studies in Family Medicine, Western University London, Ontario, Canada, N6G2M1 Less <<
NCT02214329 Diabetes Not Applicable Unknown December 2015 United States, Arizona ... More >> University Medical Center Recruiting Tucson, Arizona, United States, 85724 Contact: David G Armstrong, DPM, MD, PhD    520-626-1349    dga@email.arizona.edu    Contact: Bijan Najafi, PhD    520 626 7097    bnajafi@surgery.arizona.edu    Principal Investigator: David G Armstrong, DPM, MD, PhD Less <<
NCT02594514 - Completed - Brazil ... More >> HCFUMSP Sao Paulo, SP, Brazil, 0543-010 Less <<
NCT02255266 - Completed - Italy ... More >> Novo Nordisk Investigational Site Rome, Italy, 00144 Less <<
NCT02229110 Diabetes Mellitus Not Applicable Completed - Netherlands ... More >> Diamuraal-associated GP practices Amersfoort, Netherlands Meander Medical Center Amersfoort, Netherlands Less <<
NCT02261545 Diabetes Mellitus Type II Phase 4 Unknown February 2016 -
NCT02268916 Type 2 Diabetes Mellitus Not Applicable Active, not recruiting December 31, 2019 United States, Michigan ... More >> VA Ann Arbor Healthcare System, Ann Arbor, MI Ann Arbor, Michigan, United States, 48105 Less <<
NCT00461552 HIV Infections ... More >> Lipodystrophy Less << Phase 2 Completed - United States, Texas ... More >> UT Southwestern Medical Center Dallas, Texas, United States, 75390 Less <<
NCT02274844 Diabetes Mellitus ... More >> Medication Adherence Less << Not Applicable Active, not recruiting January 31, 2019 United States, Alabama ... More >> Univeristy of Alabama at Birmingham Birmingham, Alabama, United States, 35210 Less <<
NCT02259634 HIV/AIDS Diab... More >>etes Mellitus Hypertension Substance Use Less << Not Applicable Terminated(Target sample size ... More >>not reached for enrollment.) Less << - United States, New York ... More >> Mount Sinai St. Luke's New York, New York, United States, 10025 Hunter College at The City University of New York New York, New York, United States, 10065 Less <<
NCT02274207 Diabetes Mellitus Phase 4 Unknown August 2016 Korea, Republic of ... More >> Severance Hospital Recruiting Seoul, Korea, Republic of, 120-752 Contact: Woojin Choi, MD    82)2-2228-2195    choiwj@yuhs.ac    Contact: Heiji Han, bechelor    82)2-2228-2195    bohemi_han@naver.com Less <<
NCT02285881 Type 2 Diabetes Mellitus Not Applicable Completed - Netherlands ... More >> Julius Centre for Health Sciences and Primary Care Utrecht, Netherlands, 3584CG Less <<
NCT02244164 Type 2 Diabetes ... More >> Incretinomimetics Pancreas Less << Not Applicable Recruiting - Belgium ... More >> Gastroenterology Department Erasme Hospital Recruiting Brussels, Belgium, 1070 Contact: Vincent Huberty, MD    +3225553715    vincent.huberty@erasme.ulb.ac.be Less <<
NCT02286128 - Completed - Thailand ... More >> Mattabhorn Phornputkul Chiang Mai, Thailand, 50200 Less <<
NCT02290301 - Unknown - Korea, Republic of ... More >> Multicenters including Daegu Catholic Univercity Medical Center Multiplace, Korea, Republic of Less <<
NCT02282046 - Active, not recruiting May 2019 United States, Texas ... More >> University of Texas Health Science Center At San Antonio San Antonio, Texas, United States, 78229-3900 Less <<
NCT02292290 Type 2 Diabetes Phase 4 Completed - United Kingdom ... More >> University Hospitals of Leicester Leicester, Leicestershire, United Kingdom University Hospital Birmingham Birmingham, West Midlands, United Kingdom Less <<
NCT02278913 Hyperglycemia ... More >> Diabetes Less << Phase 4 Completed - Paraguay ... More >> Clínica Médica del Hospital de Clínicas, Universidad Nacional de Asunción, Asuncion, Paraguay Less <<
NCT02292511 Type 2 Diabetes Mellitus Not Applicable Completed - Canada, Ontario ... More >> St. Joseph's Primary Care Diabetes Support Program London, Ontario, Canada Less <<
NCT02287506 Diabetes Not Applicable Not yet recruiting March 2019 -
NCT02294110 - Completed - -
NCT01556633 Healthy Volunteer Phase 1 Completed - New Zealand ... More >> Christchurch, New Zealand, 8011 Grafton, New Zealand, 1010 Less <<
NCT01556633 - Completed - -
NCT02295696 Diabetes Mellitus, Type 2 Not Applicable Unknown November 2017 Denmark ... More >> Gitte R Husted Recruiting Gentofte, Denmark, 2820 Contact: Gitte R Husted, PhD    4530753035    grhu@steno.dk Less <<
NCT02297620 - Completed - Japan ... More >> Chubu, Japan Chugoku, Japan Hokkaido, Japan Kansai, Japan Kantou, Japan Kyusyu, Japan Shikoku, Japan Tohoku, Japan Less <<
NCT02299791 Diabetes Mellitus ... More >> Cardiovascular Diseases Less << Not Applicable Completed - -
NCT02307968 - Completed - China, Zhejiang ... More >> Department of Endocrinology, the First Affiliated Hospital to Zhejiang University School of Medicine Hangzhou, Zhejiang, China, 310003 Less <<
NCT02302443 Diabetes Mellitus Phase 1 Completed - Korea, Republic of ... More >> Hanmi Pharmaceutical Company Seoul, Korea, Republic of Less <<
NCT02299791 - Completed - -
NCT02312375 Diabetes Mellitus ... More >> Hypertension Less << Not Applicable Completed - Korea, Republic of ... More >> Seoul National University Hospital Seoul, Korea, Republic of, 110-144 Less <<
NCT02311244 - Recruiting November 2023 Italy ... More >> University of Roma La Sapienza Recruiting Rome, RM, Italy, 00161 Contact: Vincenzo Trischitta, MD    +390644160534    vincenzo.trischitta@uniroma1.it    Contact: Giuseppe Pugliese, MD, PhD    +390633775440    giuseppe.pugliese@uniroma1.it Less <<
NCT03472157 Surgery Obesi... More >>ty NASH - Nonalcoholic Steatohepatitis Cirrhosis Less << Not Applicable Recruiting March 2023 France ... More >> Hôpital Claude Huriez, CHRU Recruiting Lille, France Principal Investigator: Guillaume Lassailly, MD Less <<
NCT02320461 - Active, not recruiting December 2020 -
NCT02311075 Diabetes Mellitus, Type 2 Not Applicable Completed - France ... More >> Rouen University Hospital Rouen, France, 76031 Less <<
NCT02320253 Type 2 Diabetes Mellitus ... More >> Obesity Less << Not Applicable Active, not recruiting December 2019 United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Charlestown HealthCare Center Charlestown, Massachusetts, United States, 02129 Chelsea HealthCare Center Chelsea, Massachusetts, United States, 02150 Revere HealthCare Center Revere, Massachusetts, United States, 02151 Less <<
NCT02322268 Type 2 Diabetes Mellitus ... More >> Obesity Less << Not Applicable Completed - Malaysia ... More >> Hospital Serdang Serdang, Selangor, Malaysia, 43400 Less <<
NCT02321878 - Completed - Japan ... More >> Novo Nordisk Investigational Site Chichibu-city, Japan, 368-0004 Novo Nordisk Investigational Site Koriyama-shi, Fukushima, Japan, 963 8851 Novo Nordisk Investigational Site Oyama-shi, Tochigi, Japan, 323 0022 Novo Nordisk Investigational Site Tagajo-shi, Japan, 985 0852 Novo Nordisk Investigational Site Tokyo, Japan, 1000005 Less <<
NCT02318108 Diabetes Mellitus, Type 2 Not Applicable Active, not recruiting August 2018 -
NCT02327429 Type 2 Diabetes Not Applicable Completed - -
NCT02325531 Diabetes Mellitus ... More >> Cardiovascular Disease Less << Not Applicable Active, not recruiting May 2019 United States, Oregon ... More >> Kaiser Permanente - Center for Health Research Portland, Oregon, United States, 97227 Less <<
NCT02313805 Diabetes Mellitus Not Applicable Unknown - Barbados ... More >> The University of the West Indies, Cave Hill Campus Recruiting Bridgetown, St. Michael, Barbados Contact: Charles Taylor, MBBS MA MRCP    (246)2537871    charles.taylor@cavehill.uwi.edu    Principal Investigator: Charles Taylor, MBBS MA MRCP Less <<
NCT02330484 Type 2 Diabetes Not Applicable Unknown June 2015 China, Shanghai ... More >> Ruijin hospital, Shanghai Jiao-Tong University School of Medicine Shanghai, Shanghai, China, 200025 Less <<
NCT02328599 - Enrolling by invitation June 2022 United States, Massachusetts ... More >> Joslin Diabetes Center Boston, Massachusetts, United States, 02215 United States, Ohio Cleveland Clinic Bariatric and Metabolic Institute Cleveland, Ohio, United States, 44195 United States, Pennsylvania University of Pittsburg Medical Center Pittsburgh, Pennsylvania, United States, 15213 United States, Washington University of Washington Seattle, Washington, United States, 98108 Less <<
NCT02322762 - Active, not recruiting June 30, 2019 -
NCT02332824 Type 2 Diabetes Mellitus and M... More >>icroalbuminuria Less << Phase 2 Completed - -
NCT02340260 Diabetes Mellitus, Type 2 Not Applicable Completed - Norway ... More >> Department Circulation and Medical Imaging, NTNU Trondheim, Norway Less <<
NCT02332824 - Completed - -
NCT02341690 Diabetes Mellitus, Type 2 Not Applicable Completed - Denmark ... More >> University of Copenhagen Copenhagen, Denmark, 1014 Less <<
NCT02324036 Diabetes Mellitus, Type 2 Early Phase 1 Completed - United States, California ... More >> Health Policy Research Institute Irvine, California, United States, 92697 Less <<
NCT02327429 - Completed - -
NCT02812264 Weight Loss H... More >>ealth Behavior Less << Not Applicable Recruiting August 2018 United States, Pennsylvania ... More >> Coeus Health Offices Recruiting State College, Pennsylvania, United States, 16801 Contact: Shawna E Doerksen, PhD    814-954-2564    shawna@coeusapis.com    Contact: Kathleen Wolin, PhD    6178694929    kate@coeusapis.com Less <<
NCT02346344 - Completed - United States, Arizona ... More >> Celerion Tempe, Arizona, United States, 85283 United States, Texas ICON Development Solutions, Gault Lane San Antonio, Texas, United States, 78209 Less <<
NCT02342535 - Completed - -
NCT02342535 Diabetes Mellitus ... More >> Physical Activity Less << Not Applicable Completed - United States, Illinois ... More >> Northwestern University-Feinberg School of Medicine Chicago, Illinois, United States, 60611 Metropolitan Asian Family Services Chicago, Illinois, United States, 60645 Less <<
NCT02348099 - Recruiting December 2018 Canada, British Columbia ... More >> Vancouver General Hospital Recruiting Vancouver, British Columbia, Canada, V5Z 1M9 Contact: Boris Feldman    604-875-5115    boris.feldman@vch.ca    Principal Investigator: Graydon S Meneilly, MD          Sub-Investigator: Jordanna Kapeluto, MD          Sub-Investigator: Breay Paty, MD          Sub-Investigator: Silvia Chang, MD Less <<
NCT02346669 Diabetes Mellitus, Type 2 ... More >> Obesity Less << Phase 2 Unknown - Israel ... More >> Department of Gastroentherology Recruiting Tel Aviv, Israel, 64239 Contact: Nitsan Maharshak, MD    972-3-6972488    nitsanm@tlvmc.gov.il    Principal Investigator: Nitsan Maharshak, MD          Sub-Investigator: Zamir Halpern, Prof.          Sub-Investigator: Nethaniel Cohen, MD          Sub-Investigator: Meirav Ben-Yehoyada, PHD          Sub-Investigator: Iddo Bar Yishay, MD          Sub-Investigator: Ronnie Baruch, B.Sc Nut          Sub-Investigator: Eran Segal, Prof. Less <<
NCT02359461 Type 2 Diabetes Not Applicable Completed - France ... More >> CHU de Clermont-Ferrand Clermont-Ferrand, France, 63003 Less <<
NCT02355145 - Completed - Bulgaria ... More >> Research Site Pleven, Bulgaria Research Site Sofia, Bulgaria Research Site Stara Zagora, Bulgaria Less <<
NCT02351323 Diabetes Phase 1 Completed - United States, Massachusetts ... More >> Boston Medical Center Boston, Massachusetts, United States, 02118 Less <<
NCT02372955 Diabetes Mellitus Type 2 Phase 4 Unknown December 2016 United States, Louisiana ... More >> Gulf Regional Research & Educational Services, LLC Recruiting Metairie, Louisiana, United States, 70002 Contact: Thomas D Giles, MD    504-834-8668    tgiles4@cox.net    Contact: Louise E Roffidal, BSN, MPH    504.220.6275    lroffidal.grres@gmail.com Less <<
NCT02371759 - Completed - -
NCT02371759 Diabetes Mellitus ... More >> Local Anesthesia Less << Phase 3 Completed - Serbia ... More >> School of Dental Medicine, University of Belgrade Belgrade, Serbia, 11000 Less <<
NCT02379078 Diabetes Mellitus Not Applicable Active, not recruiting December 2018 -
NCT02383238 Diabetes Mellitus Type 2 Phase 3 Completed - Germany ... More >> University Erlangen-Nuernberg Erlangen, Germany, 91054 Less <<
NCT02347514 Diabetes Not Applicable Completed - United States, Illinois ... More >> University of Chicago Chicago, Illinois, United States, 60637 Less <<
NCT02383537 - Not yet recruiting February 2020 -
NCT02375139 Type 2 Diabetes Mellitus Phase 1 Completed - Korea, Republic of ... More >> Clinical Trial Center, Seoul National University Hospital Seoul, Korea, Republic of, 110-744 Less <<
NCT02390973 Bariatric Surgery Candidate ... More >> Diabetes Less << Phase 4 Recruiting March 2021 Canada ... More >> Institut Universitaire de Cardiologie et de Pneumologie de Québec Recruiting Québec, Canada, G1V 4G5 Contact: Melanie Nadeau, MSc    418-565-8711 ext 3490    melanie.nadeau@criucpq.ulaval.ca    Contact: Suzy Laroche    418-656-8711 ext 4810    suzy_laroche@ssss.gouv.qc.ca    Principal Investigator: Laurent Biertho, MD          Principal Investigator: Andre Tchernof, PhD          Sub-Investigator: François Dube, MD          Sub-Investigator: Paul Poirier, MD Less <<
NCT02375932 Diabetes Mellitus, Type 2 Not Applicable Completed - -
NCT02386540 Diabetes Mellitus ... More >> Hypertension Less << Not Applicable Active, not recruiting March 2019 United States, California ... More >> Highland Hospital - Alameda Health System Oakland, California, United States, 94602 Less <<
NCT02395315 - Recruiting August 2018 United States, Minnesota ... More >> University of Minnesota Advanced Education in Periodontology Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Tamir Shalev, DMD    612-323-1399    shale007@umn.edu    Contact: James E Hinrichs, DDS    6126255166    Hinri001@umn.edu    United States, Texas University of Texas Recruiting Houston, Texas, United States, 78229-39000 Contact: Nikola Angelov, DDS, PhD       nikola.angelov@uth.tmc.edu    United States, Washington University of Washington Recruiting Seattle, Washington, United States, 98195-7444 Contact: George Kotsakis, DDS       kotsakis@uw.edu Less <<
NCT02407132 Diabetes Not Applicable Completed - United States, Arkansas ... More >> University of Arkansas for Medical Sciences Northwest Fayetteville, Arkansas, United States, 72703 Less <<
NCT02411929 Type 2 Diabetes Mellitus Phase 1 Completed - -
NCT02393872 Obesity Type ... More >>2 Diabetes Less << Not Applicable Recruiting August 2019 Greece ... More >> Harokopio University of Athens Recruiting Kallithea, Attica, Greece, 17671 Contact: Yannis Manios, PhD    +302109549156    manios.toybox@hua.gr Less <<
NCT02419612 Diabetes Phase 3 Active, not recruiting August 15, 2019 -
NCT02411929 - Completed - -
NCT02419612 - Active, not recruiting - -
NCT02421393 Type 2 Diabetes Not Applicable Recruiting November 1, 2024 Italy ... More >> S. Andrea Hospital Recruiting Rome, RM, Italy, 00189 Contact: Giuseppe Pugliese, MD, PhD    +39063377 ext 5440    giuseppe.pugliese@uniroma1.it    Contact: Francesco G Conti, MD, PhD    +39063377 ext 5440    francesco.conti@uniroma1.it    Sub-Investigator: Lucilla Bollanti, MD Less <<
NCT02949115 Overweight Ob... More >>esity Aging Menopause Less << Phase 2 Active, not recruiting June 2019 United States, Colorado ... More >> Department of Food Science and Human Nutrition, Colorado State University Fort Collins, Colorado, United States, 80523-1571 Less <<
NCT02426294 Type 2 Diabetes Mellitus Phase 4 Unknown May 2016 Korea, Republic of ... More >> Pusan National University Hospital Recruiting Busan, Korea, Republic of, 602-739 Contact: Sang Soo Kim, MD., PhD.    +82-51-240-7228    drsskim7@gmail.com    Contact: Jong Ho Kim, MD.    +82-51-240-7983    bedaya@hanmail.net Less <<
NCT02421055 - Active, not recruiting December 2018 United Kingdom ... More >> Imperial Weight Centre London, United Kingdom, W2 1NY Less <<
NCT02401880 Type 2 Diabetes Mellitus Phase 4 Completed - Germany ... More >> Profil Mainz GmbH & Co. KG Mainz, Germany, 55116 Profil Institut für Stoffwechselforschung GmbH Neuss, Germany, 41460 Less <<
NCT02933554 Obesity Weigh... More >>t Loss Body Weight Nonalcoholic Steatohepatitis Nonalcoholic Fatty Liver Disease NAFLD Less << Not Applicable Not yet recruiting December 2019 United States, Missouri ... More >> Saint Louis University Saint Louis, Missouri, United States, 63110 Less <<
NCT02430870 Type 2 Diabetes Mellitus Phase 1 Completed - United States, California ... More >> Anaheim, California, United States Chula Vista, California, United States Less <<
NCT02430870 - Completed - -
NCT02426138 Diabetes Not Applicable Active, not recruiting April 2020 United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT02436369 Diabetes Mellitus Not Applicable Completed - -
NCT01938235 Myocardial Infarction Phase 2 Unknown January 2018 Canada, Alberta ... More >> Foothills Medical Centre Recruiting Calgary, Alberta, Canada, T2N 4Z6 Contact: Linda Manasterski    403-210-8548    linda.manasterski@albertahealthservices.ca    Principal Investigator: Faisal Al Qoofi, MD          Royal Alexandra Hospital Recruiting Edmonton, Alberta, Canada, T5H 3V9 Contact: Linda Kvill    780-735-5255    linda.kvill@albertahealthservices.ca    Principal Investigator: Neil Brass, MD          University of Alberta Hospital Recruiting Edmonton, Alberta, Canada, T6G 2B7 Contact: Suzanne Welsh    780-407-3572    suzanne.welsh@albertahealthservices.ca    Principal Investigator: Robert Welsh, MD          Canada, Ontario Hamilton Health Sciences - General Site Recruiting Hamilton, Ontario, Canada, L8L 2X2 Contact: Sonya Brons    905-527-4322 ext 44602    bronsson@hhsc.ca    Principal Investigator: Sanjit Jolly, MD          London Health Sciences Centre Recruiting London, Ontario, Canada, N6A 5A5 Contact: Mistre Alemayehu    519-685-8500 ext 35625    mistre.alemayehu@lhsc.on.ca    Principal Investigator: Shahar Lavi, MD          Southlake Regional Health Centre Recruiting Newmarket, Ontario, Canada, L3Y 2P7 Contact: Kim Robbins    905-235-5966    kim.yorkpci@gmail.com    Principal Investigator: Warren Cantor, MD          Sunnybrook Health Sciences Centre Recruiting Toronto, Ontario, Canada, M4N 3M5 Contact: Suneet Khurana    416-480-4520    suneet.khurana@sunnybrook.ca    Principal Investigator: Mina Madan, MD          St. Michael's Hospital Recruiting Toronto, Ontario, Canada, M5B 1W8 Contact: Brigita Zile    416-864-6060 ext 4130    zileb@smh.ca    Principal Investigator: John J Graham, MD          Toronto General Hospital, University Health Network Recruiting Toronto, Ontario, Canada, M5G 2C4 Contact: Nadia Asif    416-340-4800 ext 4969    nadia.asif@uhn.ca    Principal Investigator: Vladimir Dzavik, MD          Canada, Quebec Institut universitaire de cardiologie et de pneumologie de Quebec (Hopital Laval) Recruiting Quebec City, Quebec, Canada, G1V 4G5 Contact: Michele Jadin    418-656-8711 ext 3007    michele.jadin@criucpq.ulaval.ca    Principal Investigator: Olivier Bertrand, MD Less <<
NCT03119610 Obesity Sarco... More >>penic Obesity Sarcopenia Aging Sedentary Lifestyle Less << Phase 1 Phase 2 Recruiting September 2019 United States, Texas ... More >> Texas Diabetic Institute Recruiting San Antonio, Texas, United States, 78207 Contact: Sara E Espinoza, MD    210-617-5197    espinozas2@uthscsa.edu    Contact: Nicolas Musi, MD    210-617-5197    musi@uthscsa.edu Less <<
NCT02441023 Type 2 Diabetes Not Applicable Completed - Mexico ... More >> Unidad de Investigación en Epidemiología Clínica, Hospital Regional 1 Carlos Mac Gregor Sanchez Navarro, IMSS Mexico, Distrito Federal, Mexico, 03100 Less <<
NCT02413567 Diabetes Mellitus, Type 2 ... More >> Diabetes Mellitus Less << Not Applicable Active, not recruiting June 2019 Belgium ... More >> Hopital Erasme Brussels, Belgium, 1070 UZ Leuven Leuven, Belgium Chile Centro Clinico de Obesidad Santiago, Chile Italy Università Cattolica del Sacro Cuore, Policlinico A. Gemelli Rome, Lazio, Italy, 00168 Netherlands Academic Medical Center Amsterdam, Netherlands, 1105 United Kingdom University College London Hospitals London, United Kingdom, NW1 2BU King's College Hospital NHS Foundation Trust London, United Kingdom, SE5 9RS Less <<
NCT02448498 Diabetes Mellitus Not Applicable Recruiting March 2019 United States, California ... More >> Stanford Recruiting Palo Alto, California, United States, 94304 Contact: Latha Palaniappan, MD    650-736-2743 Less <<
NCT02935478 Obesity Weigh... More >>t Loss Body Weight Hepatocellular Carcinoma HCC Hepatitis C Cirrhosis Less << Not Applicable Recruiting December 2020 United States, Missouri ... More >> Saint Louis University Recruiting Saint Louis, Missouri, United States, 63110 Less <<
NCT02453555 Diabetes Mellitus, Type 2 Phase 3 Completed - Japan ... More >> 1275.19.81519 Boehringer Ingelheim Investigational Site Aichi, Nagoya, Japan 1275.19.81536 Boehringer Ingelheim Investigational Site Chiba, Kashiwa, Japan 1275.19.81530 Boehringer Ingelheim Investigational Site Fukuoka, Fukuoka, Japan 1275.19.81529 Boehringer Ingelheim Investigational Site Fukuoka, Itoshima, Japan 1275.19.81531 Boehringer Ingelheim Investigational Site Fukuoka, Kurume, Japan 1275.19.81504 Boehringer Ingelheim Investigational Site Fukushima, Koriyama, Japan 1275.19.81528 Boehringer Ingelheim Investigational Site Hiroshima, Hiroshima, Japan 1275.19.81501 Boehringer Ingelheim Investigational Site Hokkaido, Sapporo, Japan 1275.19.81502 Boehringer Ingelheim Investigational Site Hokkaido, Sapporo, Japan 1275.19.81503 Boehringer Ingelheim Investigational Site Hokkaido, Sapporo, Japan 1275.19.81532 Boehringer Ingelheim Investigational Site Hokkaido, Sapporo, Japan 1275.19.81505 Boehringer Ingelheim Investigational Site Ibaraki, Koga, Japan 1275.19.81533 Boehringer Ingelheim Investigational Site Ibaraki, Naka, Japan 1275.19.81516 Boehringer Ingelheim Investigational Site Kanagawa, Kawasaki, Japan 1275.19.81537 Boehringer Ingelheim Investigational Site Kanagawa, Sagamihara, Japan 1275.19.81538 Boehringer Ingelheim Investigational Site Kanagawa, Yokohama, Japan 1275.19.81520 Boehringer Ingelheim Investigational Site Kyoto, Kyoto, Japan 1275.19.81521 Boehringer Ingelheim Investigational Site Kyoto, Kyoto, Japan 1275.19.81539 Boehringer Ingelheim Investigational Site Kyoto, Kyoto, Japan 1275.19.81517 Boehringer Ingelheim Investigational Site Nagano, Matsumoto, Japan 1275.19.81518 Boehringer Ingelheim Investigational Site Nagano, Matsumoto, Japan 1275.19.81525 Boehringer Ingelheim Investigational Site Osaka, Higashi-Osaka, Japan 1275.19.81523 Boehringer Ingelheim Investigational Site Osaka, Osaka, Japan 1275.19.81526 Boehringer Ingelheim Investigational Site Osaka, Osaka, Japan 1275.19.81527 Boehringer Ingelheim Investigational Site Osaka, Osaka, Japan 1275.19.81540 Boehringer Ingelheim Investigational Site Osaka, Osaka, Japan 1275.19.81522 Boehringer Ingelheim Investigational Site Osaka, Suita, Japan 1275.19.81524 Boehringer Ingelheim Investigational Site Osaka, Takatsuki, Japan 1275.19.81535 Boehringer Ingelheim Investigational Site Saitama, Hanno, Japan 1275.19.81506 Boehringer Ingelheim Investigational Site Saitama, Kawagoe, Japan 1275.19.81507 Boehringer Ingelheim Investigational Site Saitama, Saitama, Japan 1275.19.81534 Boehringer Ingelheim Investigational Site Saitama, Tokorozawa, Japan 1275.19.81509 Boehringer Ingelheim Investigational Site Tokyo, Chiyoda-ku, Japan 1275.19.81508 Boehringer Ingelheim Investigational Site Tokyo, Chuo-ku, Japan 1275.19.81512 Boehringer Ingelheim Investigational Site Tokyo, Chuo-ku, Japan 1275.19.81515 Boehringer Ingelheim Investigational Site Tokyo, Hachioji, Japan 1275.19.81511 Boehringer Ingelheim Investigational Site Tokyo, Koto-ku, Japan 1275.19.81513 Boehringer Ingelheim Investigational Site Tokyo, Meguro-ku, Japan 1275.19.81514 Boehringer Ingelheim Investigational Site Tokyo, Shinagawa-ku, Japan 1275.19.81510 Boehringer Ingelheim Investigational Site Tokyo, Shinjuku-ku, Japan Less <<
NCT02447601 Type 2 Diabetes Mellitus Phase 1 Completed - China, Shanghai ... More >> Shanghai Mental Health Center (SMHC) Shanghai, Shanghai, China, 200122 Less <<
NCT02456064 Diabetes Mellitus, Type 2 Not Applicable Completed - -
NCT02460718 Diabetes Mellitus Not Applicable Completed - -
NCT02444364 Type 2 Diabetes Early Phase 1 Withdrawn(Funding withdrawn; n... More >>o participants enrolled.) Less << - United States, Missouri ... More >> University of Missouri-Columbia: Diabetes Center Columbia, Missouri, United States, 65212 Less <<
NCT03752567 - Recruiting October 31, 2019 Italy ... More >> Farmacia La Regina dott. Rocco Vito Recruiting San Rufo, Salerno, Italy, 84030 Contact: Raffaele La Regina    0975395336    raffaele.laregina@gmail.com Less <<
NCT02462057 - Completed - -
NCT03761719 - Recruiting December 31, 2019 Hong Kong ... More >> The Chinese University of Hong Kong Recruiting Hong Kong, Hong Kong Contact: Hazel Mok    +852 35053990    hazelmok@cuhk.edu.hk Less <<
NCT03753568 Anticoagulant Drugs ... More >> Diabetes Mellitus, Type 2 Less << Not Applicable Recruiting September 1, 2019 Finland ... More >> Helsinki University Hospital Recruiting Helsinki, Finland, 00029 Contact: Leo Niskanen, M.D. Ph.D    +358500675727    leo.niskanen@fimnet.fi    Contact: Janne Sahlman, M.D. Ph.D    +358405586611    janne.m.sahlman@gmail.com Less <<
NCT03761797 - Not yet recruiting April 30, 2021 -
NCT03766750 Type2 Diabetes Mellitus Phase 3 Not yet recruiting October 2020 -
NCT02462057 Diabetes Diet... More >> Incentives Messaging Less << Not Applicable Completed - -
NCT02453685 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 4 Completed - Australia, New South Wales ... More >> Novo Nordisk Investigational Site Coffs Harbour, New South Wales, Australia, 2450 Bulgaria Novo Nordisk Investigational Site Petrich, Bulgaria, 2850 Hungary Novo Nordisk Investigational Site Budapest, Hungary, 1042 India Novo Nordisk Investigational Site New Delhi, India, 110001 Korea, Republic of Novo Nordisk Investigational Site Seoul, Korea, Republic of, 138-736 Serbia Novo Nordisk Investigational Site Belgrade, Serbia, 11080 Thailand Novo Nordisk Investigational Site Bangkok, Thailand, 10330 Turkey Novo Nordisk Investigational Site Istanbul, Turkey, 34752 United Arab Emirates Novo Nordisk Investigational Site Ras Al Khaimah, United Arab Emirates, 4727 Less <<
NCT03447600 Overweight and Obesity Not Applicable Recruiting June 30, 2019 United Kingdom ... More >> University of Leeds Recruiting Leeds, West Yorkshire, United Kingdom, LS2 9JT Contact: Mark Hopkins, PhD    +441133436990    M.Hopkins@leeds.ac.uk    Principal Investigator: Graham S Finlayson, PhD Less <<
NCT03776227 Type 2 Diabetes Mellitus ... More >> Healthy Subjects Less << Phase 1 Not yet recruiting May 2019 -
NCT03768973 - Not yet recruiting June 2020 Hungary ... More >> Cardiology Centre Cardiac Surgical Unit and Second Department of Internal Medicine, University of Szeged Not yet recruiting Szeged, Csongrad Megye, Hungary, 6725 Contact: Barna Babik, MD, PhD    +36 62 542349    babikbarna@gmail.com    Principal Investigator: Barna Babik, MD, PhD          Principal Investigator: Ferenc Petak, PhD, DSc          Sub-Investigator: Gergely Fodor, MD, PhD          Sub-Investigator: Roberta Sudy, MD          Sub-Investigator: Liliana Kiss Less <<
NCT03571425 Healthy Not Applicable Recruiting December 2020 United Kingdom ... More >> University of Exeter Recruiting Exeter, Devon, United Kingdom, EX1 2LU Contact: Sport and Health Sciences    +44 (0)1392 725496    sshs-school-office@ex.ac.uk Less <<
NCT02367287 - Recruiting March 2019 United States, California ... More >> USDA, Western Human Nutrition Research Center Recruiting Davis, California, United States, 95616 Contact: Ellen L Bonnel, PhD    530-752-4184    ellen.bonnel@ars.usda.gov Less <<
NCT01960062 Type 2 Diabetes Mellitus Not Applicable Withdrawn(no potential partici... More >>pants met the inclusion criteria) Less << - United States, Georgia ... More >> Kaiser Permanente Georgia Region Atlanta, Georgia, United States, 30305 Less <<
NCT01959529 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT03769870 Diabete Mellitus Phase 1 Not yet recruiting July 2019 -
NCT01963130 - Completed - Turkey ... More >> Bezmialem VU Istanbul, Turkey, 34093 Less <<
NCT01961466 - Unknown - France ... More >> CHU Dijon Recruiting Dijon, France, 21079 Contact: Jean-Christophe CHAUVET-GELINIER    3 80 29 37 69 ext 33    jean-christophe.gelinier@chu-dijon.fr Less <<
NCT01965665 Diabetes Mellitus ... More >> Open Reduction External Fixation Less << Not Applicable Completed - United States, North Carolina ... More >> Duke University Medical Center/Duke South Clinics/3J Durham, North Carolina, United States, 27710 Less <<
NCT01963546 Diabetes Stre... More >>ss Anesthesia Less << Not Applicable Unknown October 2015 China, Guangdong ... More >> The General Hospital Of Guangzhou Military Command Recruiting Guangzhou, Guangdong, China, 510000 Contact: Tu wei feng, Postdoctoral    +86020-86653504    wftuyx02@163.com Less <<
NCT01972412 Diabetes Mellitus Not Applicable Unknown March 2014 Brazil ... More >> University of São Paulo at Ribeirão Preto College of Nursing Recruiting Ribeirão Preto, São Paulo, Brazil, 14040-902 Contact: Carla Regina S Teixeira, Doctor    551636023434    carlarst@eerp.usp.br    Principal Investigator: Tânia A Canata Becker, Master          Universidade de São Paulo Recruiting Ribeirão Preto, São Paulo, Brazil Contact: Carla Regina S Teixeira, Doctor    551636023434    carlarst@eerp.usp.br    Principal Investigator: Tânia A Canata Becker, Master Less <<
NCT01965665 - Completed - -
NCT01977495 Diabetes Hype... More >>rtension Less << Not Applicable Completed - United States, Pennsylvania ... More >> University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT02728570 Metabolic Syndrome X ... More >> Inflammation Less << Not Applicable Completed - United States, Utah ... More >> Utah State University, Center for Human Nutrition Studies Logan, Utah, United States, 84322-9815 Less <<
NCT01983007 Diabetes Mellitus Not Applicable Completed - Brazil ... More >> Prevention and Cardiovascular Rehabilitation Unit Unicardio, in Hospital Santa Catarina Blumenau, Santa Catarina, Brazil Less <<
NCT01959529 - Completed - -
NCT01963663 Type 2 Diabetes Mellitus Not Applicable Completed - Iran, Islamic Republic of ... More >> Diabetes Clinic, Vali-Asr Hospital, Tehran University of Medical Sciences Tehran, Iran, Islamic Republic of, 13145-784 Less <<
NCT01968265 Type 2 Diabetes Mellitus Phase 2 Completed - Canada, Alberta ... More >> Isis Investigative Site Red Deer, Alberta, Canada Canada, British Columbia Isis Investigative Site Penticton, British Columbia, Canada Canada, Ontario Isis Investigative Site Cornwall, Ontario, Canada Isis Investigative Site Courtice, Ontario, Canada Isis Investigative Site Sudbury, Ontario, Canada Canada, Quebec Isis Investigative Site Montreal, Quebec, Canada, H2R1V6 Romania Isis Investigative Site Cluj Napoca, Cluj, Romania, 400349 Isis Investigative Site Bucharest, Romania, 010507 Isis Investigative Site Bucharest, Romania, 011794 Isis Investigative site Bucharest, Romania, 022441 South Africa Isis Investigative Site Bloemfontein, Free State, South Africa, 9300 Isis Investigative Site Benoni, Gauteng, South Africa, 1501 Isis Investigative Site Soweto, Gauteng, South Africa, 1818 Isis Investigative Site Somerset West, Western Cape, South Africa, 7130 Less <<
NCT03770442 Muscle Weakness Not Applicable Not yet recruiting January 2020 -
NCT01989962 Diabetes Mellitus Type 2 ... More >> Cultural Competency Less << Phase 2 Unknown November 2016 Canada, Ontario ... More >> Centre for Studies in Primary Care, Department of Family Medicine, Queen's University Kingston, Ontario, Canada, K7L 5E9 Less <<
NCT01984606 Diabetes Mellitus, Type 2 Phase 3 Withdrawn February 2017 -
NCT01983917 Diabetes Mellitus Not Applicable Withdrawn - United States, California ... More >> Jules Stein Eye Institute Los Angeles, California, United States, 90095 Less <<
NCT01993121 Type 2 Diabetes Not Applicable Completed - United States, Colorado ... More >> University of Colorado, Anschutz Medical Campus Aurora, Colorado, United States, 80045 Less <<
NCT01991769 Diabetes Mellitus, Type 2 Not Applicable Completed - Norway ... More >> Forskningsposten, St Olavs Hospital Trondheim, Norway ISB Trondheim, Norway Less <<
NCT02001753 Type 2 Diabetes Phase 4 Completed - China, Hubei ... More >> Guangda Xiang Wuhan, Hubei, China, 430070 Less <<
NCT03770767 Diabetes Mellitus ... More >> Pregnancy Complications Less << Phase 4 Not yet recruiting August 31, 2022 -
NCT01991795 Diabetes Mellitus, Type 2 Phase 3 Active, not recruiting December 28, 2018 -
NCT02002091 - Completed - -
NCT02002611 Type 2 Diabetes Mellitus Phase 1 Completed - Korea, Republic of ... More >> Samsung Medical Center Seoul, Korea, Republic of Less <<
NCT02008942 Diabetes Mellitus, Type 2 Phase 3 Completed - United States, Florida ... More >> Miami Research Associates Miami, Florida, United States, 33143 United States, Kansas PRA Clinical Pharmacology Center Lenexa, Kansas, United States, 66219 United States, Ohio Medpace Clinical Pharmacology Cincinnati, Ohio, United States, 45227 Less <<
NCT02002091 - Completed - Algeria ... More >> Internal Medicine department - Ain-Taya's Hospital Ain - Taya, Algiers, Algeria, 16019 Less <<
NCT02008942 - Completed - -
NCT01989975 - Completed - Denmark ... More >> Steno Diabetes Center Gentofte, Denmark, 2820 Netherlands Diabeter Rotterdam, Netherlands, 3011 Less <<
NCT02010684 - Completed - -
NCT02011529 Diabetes Not Applicable Completed - United States, Washington ... More >> Harborview Medical Center Seattle, Washington, United States, 98104 Less <<
NCT02010684 Diabetes Mellitus, Type 2 Not Applicable Completed - United States, California ... More >> UCLA Psychr & Biobehav Sci Los Angeles, California, United States, 90095 Less <<
NCT02012972 - Active, not recruiting December 2018 South Africa ... More >> Thuthukani Health Centre Johannesburg, Gauteng, South Africa Less <<
NCT02016911 Diabetes Diab... More >>etes Mellitus, Type 2 Healthy Less << Phase 1 Completed - Czechia ... More >> Novo Nordisk Investigational Site Praha 10, Czechia, 10034 Novo Nordisk Investigational Site Praha 7, Czechia, 17000 Poland Novo Nordisk Investigational Site Bialystok, Poland, 15-879 Novo Nordisk Investigational Site Warszawa, Poland, 02-507 Novo Nordisk Investigational Site Wolomin, Poland, 05-200 Slovakia Novo Nordisk Investigational Site Bratislava, Slovakia, 83101 Less <<
NCT02011633 Diabetes Mellitus Phase 1 Completed - Korea, Republic of ... More >> Samsung Medical Center Seoul, Korea, Republic of, 135-710 Less <<
NCT02022254 Diabetes Diab... More >>etes Mellitus, Type 2 Healthy Less << Phase 1 Completed - Germany ... More >> Novo Nordisk Investigational Site Berlin, Germany, 10117 Less <<
NCT02026817 Diabetes Mellitus Phase 1 Completed - Korea, Republic of ... More >> Samsung Medical Center Seoul, Korea, Republic of, 135-710 Less <<
NCT02027740 Cardiovascular Diseases Not Applicable Completed - India ... More >> Fortis Flt Lt Hospital Delhi, India Less <<
NCT02021695 - Recruiting December 2018 Qatar ... More >> Hamad Medical Corporation Recruiting Doha, Qatar Contact: Amal Robay    +974-4492-8494    amr2018@qatar-med.cornell.edu    Principal Investigator: Charbel Abi Khalil, MD Less <<
NCT02028975 Type 2 Diabetes or Obesity Wit... More >>hout Diabetes Less << Not Applicable Unknown - France ... More >> CHU Dijon Recruiting Dijon, France, 21079 Contact: Isabelle ROBIN    3 80 29 33 32 ext +33    isabelle.simoneau-robin@chu-dijon.fr Less <<
NCT02032108 Diabetes Mellitus Not Applicable Completed - Rwanda ... More >> Kigali University Teaching Hospital Kigali, Rwanda, 655 Less <<
NCT02026024 - Completed - Taiwan ... More >> Chang Gung Memorial Hospital Taoyuan, Taiwan, 333 Less <<
NCT02028091 - Completed - Austria ... More >> Medical University of Vienna Vienna, Austria, 1090 Less <<
NCT02034695 - Completed - Hong Kong ... More >> The University of Hong Kong Hong Kong, Hong Kong Less <<
NCT02040038 Diabetes Mellitus, Type 2 Not Applicable Completed - United States, New York ... More >> New York University New York, New York, United States, 10003 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 Less <<
NCT02041598 Diabetes Mellitus, Type 2 Not Applicable Completed - United States, New York ... More >> New York University School of Medicine, Dept of Population Health New York, New York, United States, 10016 Less <<
NCT02048189 Patient With Type 2 Diabetes T... More >>reated With Insulin Using a Baseline/Bolus Strategy Less << Phase 4 Unknown - France ... More >> CHU de Besancon Recruiting Besancon, France, 25000 Contact: Alfred PENFORMIS          CHU de Dijon Recruiting Dijon, France, 21079 Contact: Sabine BAILLOT-RUDONI    3.80.29.34.53 ext +33    sabine.rudoni@chu-dijon.fr    Contact: Isabelle SIMONEAU-ROBIN    3 80 29 33 32 ext +33    isabelle.simoneau-robin@chu-dijon.fr Less <<
NCT02036892 Type 2 Diabetes Phase 3 Unknown June 2014 Canada, Ontario ... More >> Black Creek Community Health Centre Recruiting Toronto, Ontario, Canada, M3M1A4 Contact: Paul Ritvo, PhD    4165808021    pritvo@yorku.ca    Contact: Noah Wayne, MSc    4168897289    NoahWayne@gmail.com    Sub-Investigator: Noah Wayne, MSc Less <<
NCT02061579 Diabetes Mellitus Not Applicable Recruiting April 2018 United States, California ... More >> Stanford University Recruiting Palo Alto, California, United States, 94304 Contact: Latha P. Palaniappan, MD, MS    650-721-6403    diabeticstudy@stanford.edu    Contact: Lida Faroqi, DPM    650-721-6403    diabeticstudy@stanford.edu    Principal Investigator: Latha P Palaniappan, MD, MS Less <<
NCT02060201 Type 2 Diabetes Mellitus Phase 1 Completed - -
NCT02042339 Diabetes Mellitus Phase 3 Not yet recruiting October 2021 Austria ... More >> Division of Thoracic and Hyperbaric Surgery Not yet recruiting Graz, Styria, Austria, A-8036 Contact: Freyja M Smolle-Juettner, M.D.    0043-316-385 ext 13302    freyja.smolle@medunigraz.at    Contact: Lars P Kamolz, M.D.    0043-316-385 ext 82819    lars.kamolz@medunigraz.at    Principal Investigator: Freyja M Smolle-Juettner, M.D.          Sub-Investigator: Lars P Kamolz, M.D.          Sub-Investigator: Michael Schintler, M.D.          Sub-Investigator: Barbara Obermayer-Pietsch, M.D.          Sub-Investigator: Gerd Koehler, M.D.          Sub-Investigator: Gerlies Bock, M.D.          Sub-Investigator: Joerg Lindenmann, M.D.          Sub-Investigator: Nicole Neuboeck, M.D.          Sub-Investigator: Christian Porubsky, M.D. Less <<
NCT02064335 Diabetes Mellitus, Type 2 Not Applicable Completed - Belgium ... More >> KU Leuven Leuven, Vlaams Brabant, Belgium, 3000 Less <<
NCT02053714 Diabetes Not Applicable Completed - United States, North Carolina ... More >> University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States, 27599 Less <<
NCT02065050 Diabetes Not Applicable Completed - United States, Massachusetts ... More >> Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Less <<
NCT02076555 Diabetes Mellitus Not Applicable Recruiting December 2018 Germany ... More >> Research Institute of the Diabetes Academy Mergentheim (FIDAM) Recruiting Bad Mergentheim, Germany, 97980 Contact: Norbert Hermanns, PhD       hermanns@diabetes-zentrum.de    Principal Investigator: Bernhard Kulzer, PhD          Sub-Investigator: Nikola Bergis-Jurgan, MSc          Sub-Investigator: Dominic Ehrmann, MSc          Zentrum für Diabetologie Bergedorf Recruiting Hamburg, Germany, 21029 Contact: Jens Kröger, M.D.       diabeteszentrumhamburg@t-online.de    Principal Investigator: Jens Kröger, M.D          Diabeteszentrum Ludwigsburg Recruiting Ludwigsburg, Germany, 71634 Contact: Jörg Gloyer, M.D       kontakt@diabeteszentrum-ludwigsburg.de    Principal Investigator: Jörg Gloyer, M.D          Diabetologische Schwerpunktpraxis Neuss Recruiting Neuss, Germany, 41462 Contact: Rainer Betzholz, M.D       info@dr-betzholz.de    Principal Investigator: Rainer Betzholz, M.D Less <<
NCT03658564 Insulin Resistance Not Applicable Recruiting January 2019 China, Liaoning ... More >> The Second Hospital of Dalian Medical University Recruiting Dalian, Liaoning, China, 116000 Contact: yang z Xiao, MD,PhD    0866-17709873399 Less <<
NCT02061618 Diabetes Mellitus Not Applicable Completed - United States, California ... More >> Palo Alto Medical Foundation Research Institute Palo Alto, California, United States, 94301 Less <<
NCT02077946 - Completed - Sweden ... More >> Novo Nordisk Investigational Site Malmö, Sweden, 202 15 Less <<
NCT02078440 Type 2 Diabetes Phase 1 Completed - United States, Arizona ... More >> Hope Research Institute, Llc Phoenix, Arizona, United States, 85018 United States, Connecticut Yale Center for Clinical Investigation New Haven, Connecticut, United States, 06511 United States, Florida Columbus Clinical Services LLC Miami, Florida, United States, 33165 United States, Missouri The Children's Mercy Hospital Kansas City, Missouri, United States, 64108 United States, Pennsylvania Children's Hosptial of Philadelphia Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT02001337 - Active, not recruiting June 2019 United States, Minnesota ... More >> Mayo Clinic in Rochester Rochester, Minnesota, United States, 55905 Less <<
NCT02081573 Diabetes Mellitus, Type 2 Not Applicable Completed - United States, Pennsylvania ... More >> University of Pittsburgh School of Nursing Pittsburgh, Pennsylvania, United States, 15261 Less <<
NCT02081573 - Completed - -
NCT02077686 Diabetes Mellitus Not Applicable Recruiting December 2018 Germany ... More >> Research Institute of the Diabetes Academy Mergentheim (FIDAM) Recruiting Bad Mergentheim, Germany, 97980 Contact: Norbert Hermanns, PhD       hermanns@diabetes-zentrum.de    Principal Investigator: Bernhard Kulzer, PhD          Sub-Investigator: Nikola Bergis-Jurgan, MSc          Sub-Investigator: Dominic Ehrmann, MSc          Zentrum für Diabetologie Bergedorf Recruiting Hamburg, Germany, 21029 Contact: Jens Kröger, M.D.       diabeteszentrumhamburg@t-online.de    Principal Investigator: Jens Kröger, M.D          Diabeteszentrum Ludwigsburg Recruiting Ludwigsburg, Germany, 71634 Contact: Jörg Gloyer, M.D       kontakt@diabeteszentrum-ludwigsburg.de    Principal Investigator: Jörg Gloyer, M.D          Diabetologische Schwerpunktpraxis Neuss Recruiting Neuss, Germany, 41462 Contact: Rainer Betzholz, M.D       info@dr-betzholz.de    Principal Investigator: Rainer Betzholz, M.D Less <<
NCT02081586 Diabetes Mellitus, Type 2 Not Applicable Completed - United States, Pennsylvania ... More >> University of Pittsburgh School of Nursing Pittsburgh, Pennsylvania, United States, 15261 Less <<
NCT02081586 - Completed - -
NCT02089126 Type 2 Diabetes Mellitus Phase 3 Unknown - Korea, Republic of ... More >> The Catholic University of Korea Seoul St. Mary's Hospital Not yet recruiting Seoul, Korea, Republic of Contact: Cha       songppm@cmcnu.or.kr Less <<
NCT02076568 Diabetes Mellitus Not Applicable Recruiting December 2018 Germany ... More >> Research Institute of the Diabetes Academy Mergentheim (FIDAM) Recruiting Bad Mergentheim, Germany, 97980 Contact: Norbert Hermanns, PhD       hermanns@diabetes-zentrum.de    Principal Investigator: Bernhard Kulzer, PhD          Sub-Investigator: Nikola Bergis-Jurgan, MSc          Sub-Investigator: Dominic Ehrmann, MSc          Zentrum für Diabetologie Bergedorf Recruiting Hamburg, Germany, 21029 Contact: Jens Kröger, M.D.       diabeteszentrumhamburg@t-online.de    Principal Investigator: Jens Kröger, M.D          Diabeteszentrum Ludwigsburg Recruiting Ludwigsburg, Germany, 71634 Contact: Jörg Gloyer, M.D       kontakt@diabeteszentrum-ludwigsburg.de    Principal Investigator: Jörg Gloyer, M.D          Diabetologische Schwerpunktpraxis Neuss Recruiting Neuss, Germany, 41462 Contact: Rainer Betzholz, M.D       info@dr-betzholz.de    Principal Investigator: Rainer Betzholz, M.D Less <<
NCT02091362 Type 2 Diabetes Mellitus Phase 2 Completed - -
NCT02079376 Type 2 Diabetes Not Applicable Unknown December 2016 Australia ... More >> Epworth Research Institute Recruiting Richmond, Victoria, Australia Contact: Spiros Fourlanos, MD       spiros.fourlanos@nh.org.au    Austria Tilak Innsbruck Withdrawn Innsbruck, Austria Greece "Attikon" Hospital Active, not recruiting AThens, Greece "Evgenidio " Hospital Recruiting Athens, Greece Contact: Nikolaos Arkadopoulos, Prof.    306937106217       Italy Clinica Pineta Grande Recruiting Rome, Italy Contact: Dott. Cristiano Giardiello, MD    +39335406848       The Università Cattolica del Sacro Cuore Recruiting Rome, Italy Contact: Gertrude Mingrone, Prof.       paolo.ferrazza@lnage.it    Poland Medical University Recruiting Bialystok, Poland Contact: Maria Górska, MD, PhD    48857468239       Medical University Recruiting Bydgoszcz, Poland Contact: Roman Junik, MD, PhD    48525854020       "Diabeta-Care" Recruiting Lubin, Poland Contact: Irena Szykowna, MD, PhD    48693729109       Medical University Recruiting Szczecin, Poland Contact: Syrenicz Anhelli, MD, PhD    4860170884       Centre for Postgraduate Medical Education (CMKP) Recruiting Warsaw, Poland Contact: Wiesław Tarnowski, MD, PhD    +48602346242       Serbia Klinika za digestivnu hirurgiju Recruiting Belgrade, Serbia Contact: Miloš BJELOVIĆ, Prof. dr       acerimanovic@hungarotrial.com    Principal Investigator: Miloš BJELOVIĆ, Prof. dr          Institut za pluće bolesti Vojvodine Recruiting Kamenica, Serbia Contact: Miroslav ILIĆ, Prof. dr       acerimanovic@hungarotrial.com    Principal Investigator: Miroslav ILIĆ, Prof. dr Less <<
NCT02092597 Type 2 Diabetes Mellitus Phase 4 Completed - Czechia ... More >> General University Hospital Prague, Czechia, 128 08 Less <<
NCT02091362 - Completed - -
NCT02082704 Diabetes Not Applicable Completed - United States, Massachusetts ... More >> Veterans Affairs Boston Healthcare System Boston, Massachusetts, United States, 02130 Less <<
NCT02094846 Type 2 Diabetes Mellitus Not Applicable Completed - Mexico ... More >> Unidad de Investigación en Epidemiología y Servicios de Salud del Instituto Mexicano del Seguro Social Cuernavaca, Morelos, Mexico, 62450 Less <<
NCT02093702 - Completed - -
NCT02083991 Diabetes Mellitus Phase 4 Unknown January 2017 Sweden ... More >> Transplant Institute, Sahlgrenska University Hospital Recruiting Gothenburg, Sweden, 41345 Contact: Per Lindnér, MD    +46705548400    per.lindner@vgregion.se    Contact: Jana Ekberg    +46313421000    jana.ekberg@vgregion.se Less <<
NCT03134235 Hypertension ... More >>Elevated Cholesterol Overweight and Obesity Less << Not Applicable Completed - United States, Texas ... More >> Montgomery Heart & Wellness Houston, Texas, United States, 77025 Less <<
NCT02110979 Diabetes Mellitus, Type 2 Not Applicable Completed - United States, Illinois ... More >> EPI-Q Inc Oak Brook, Illinois, United States, 60523 EPI-Q Oak Brook, Illinois, United States, 60523 Less <<
NCT02093702 Type 2 Diabetes Mellitus Not Applicable Completed - Canada, Ontario ... More >> Barrie and Community Family Health Team Diabetes Program Barrie, Ontario, Canada, L4M 6L2 Less <<
NCT02123251 Diabetes Mellitus Not Applicable Unknown June 2016 United States, Hawaii ... More >> Kaiser Permanente Hawaii Honolulu, Hawaii, United States, 96813 Less <<
NCT02106585 Diabetes Mellitus Phase 1 Completed - United States, Florida ... More >> Orlando, Florida, United States Less <<
NCT02122250 Type 2 Diabetes Not Applicable Completed - -
NCT02138097 - Completed - United States, Massachusetts ... More >> 1218.161.1 Boehringer Ingelheim Investigational Site Boston, Massachusetts, United States Less <<
NCT02138097 - Completed - -
NCT02128815 Type 2 Diabetes Not Applicable Completed - Canada, Ontario ... More >> Langs Community Health Centre Cambridge, Ontario, Canada, N3H 4L6 McMaster University Hamilton, Ontario, Canada, L8S 4K1 Less <<
NCT02140645 - Completed - -
NCT02048501 Obesity Weigh... More >>t Loss Less << Not Applicable Completed - United States, North Carolina ... More >> Duke Center for Metabolic and Weight Loss Surgery Durham, North Carolina, United States, 27704 Less <<
NCT02140645 - Completed - United States, Massachusetts ... More >> Boehringer Ingelheim Investigational Site Boston, Massachusetts, United States Less <<
NCT02144948 Diabetes Mellitus Type II Phase 3 Completed - Germany ... More >> Carus-Hausarztpraxis Dresden, Germany, 01307 Less <<
NCT02146079 Diabetes Diab... More >>etes Mellitus, Type 2 Healthy Less << Phase 1 Completed - Japan ... More >> Novo Nordisk Investigational Site Tokyo, Japan, 130-0004 Less <<
NCT02137720 Type 2 Diabetes Not Applicable Active, not recruiting June 2019 United States, New York ... More >> New York City Department of Health and Mental Hygiene New York, New York, United States, 11101 Less <<
NCT02152891 Cardiovascular Diseases ... More >> Diabetes Mellitus Less << Not Applicable Active, not recruiting November 2018 Canada, Ontario ... More >> Guelph-Wellington Emergency Medical Services and County of Wellington Social Services Department - Housing Services Guelph, Ontario, Canada, N1H 3A1 Hamilton Paramedic Services Hamilton, Ontario, Canada, L8P 4Y5 County of Simcoe Simcoe, Ontario, Canada, L0L 1X0 City of Greater Sudbury Sudbury, Ontario, Canada, P3A 5P3 York Region York Region, Ontario, Canada, L3Y 6Z1 Less <<
NCT02144909 Diabetes Mellitus, Type 2 Not Applicable Completed - United States, Hawaii ... More >> Kula no na Po'e Hawai'i Honolulu, Hawaii, United States, 96813 Ke Ola Mamao Honolulu, Hawaii, United States, 96817 Kokua Kalihi Valley Honolulu, Hawaii, United States, 96819 Less <<
NCT02152852 Type 2 Diabetes Not Applicable Completed - -
NCT02162212 Diabetes Mellitus Not Applicable Completed - United States, Missouri ... More >> Washington University School of Medicine Saint Louis, Missouri, United States, 63108 Less <<
NCT02154347 Type 2 Diabetes Mellitus Phase 4 Completed - Japan ... More >> Tokyo and Other Japanese City, Japan Less <<
NCT02163278 Diabetes Mellitus, Type 2 Phase 1 Completed - Taiwan ... More >> Taipei Medical University - Taipei Medical University Hospital Taipei, Taiwan, 11031 Less <<
NCT02167061 Type 2 Diabetes Mellitus Phase 1 Completed - Korea, Republic of ... More >> Clinical Trial Center, Seoul National University Hospital Seoul, Korea, Republic of Less <<
NCT02161588 Diabetes Diab... More >>etes Mellitus, Type 2 Healthy Less << Phase 1 Completed - Japan ... More >> Tokyo, Japan, 130-0004 Less <<
NCT02156037 Diabetes Not Applicable Completed - United States, Massachusetts ... More >> Baystate Medical Center Springfield, Massachusetts, United States, 01199 Less <<
NCT02183324 Diabetes Mellitus, Type 2 Phase 2 Completed - -
NCT02185963 Diabetes Phase 4 Completed - Korea, Republic of ... More >> Seoul National University Bundang Hospital Seongnam, Korea, Republic of Less <<
NCT02169531 Type 2 Diabetes Mellitus ... More >> Hyperglycemia Less << Phase 1 Completed - China, Guangdong ... More >> The 12th People's Hospital of Guangzhou Guangzhou, Guangdong, China, 510620 The 12th People's Hospital of Shenzhen Shenzhen, Guangdong, China, 518001 Less <<
NCT02196272 Diabetes Mellitus, Non-Insulin... More >>-Dependent Less << Not Applicable Unknown - -
NCT02197078 - Active, not recruiting January 30, 2019 United States, Massachusetts ... More >> Brigham and Women's Hospital Boston, Massachusetts, United States, 02120 Less <<
NCT02173834 Obesity Type ... More >>2 Diabetes Mellitus Less << Not Applicable Completed - Netherlands ... More >> Academic Medical Center Amsterdam, Netherlands, 1105AZ Less <<
NCT02200627 - Completed - Japan ... More >> Research Site Aichi, Japan Research Site Akita, Japan Research Site Aomori, Japan Research Site Chiba, Japan Research Site Ehime, Japan Research Site Fukui, Japan Research Site Fukuoka, Japan Research Site Fukushima, Japan Research Site Gifu, Japan Research Site Gunma, Japan Research Site Hiroshima, Japan Research Site Hokkaido, Japan Research Site Hyogo, Japan Research Site Ibaraki, Japan Research Site Ishikawa, Japan Research Site Iwate, Japan Research Site Kagawa, Japan Research Site Kagoshima, Japan Research Site Kanagawa, Japan Research Site Kochi, Japan Research Site Kumamoto, Japan Research Site Kyoto, Japan Research Site Mie, Japan Research Site Miyagi, Japan Research Site Miyazaki, Japan Research Site Nagano, Japan Research Site Nagasaki, Japan Research Site Nara, Japan Research Site Niigata, Japan Research Site Oita, Japan Research Site Okayama, Japan Research Site Osaka, Japan Research Site Saga, Japan Research Site Saitama, Japan Research Site Shiga, Japan Research Site Shimane, Japan Research Site Shizuoka, Japan Research Site Tochigi, Japan Research Site Tokushima, Japan Research Site Tokyo, Japan Research Site Tottori, Japan Research Site Toyama, Japan Research Site Wakayama, Japan Research Site Yamagata, Japan Research Site Yamaguchi, Japan Research Site Yamanashi, Japan Less <<
NCT02199834 Diabetes Not Applicable Completed - China ... More >> Prince of Wales Hospital, Chinese University of Hong Kong Hong Kong SAR, China, 999077 Less <<
NCT02193984 Diabetes Mellitus Not Applicable Active, not recruiting September 2017 United States, California ... More >> San Diego State University Research Foundation Calexico, California, United States, 92232 San Diego State University Research Foundation San Diego, California, United States, 92123 Less <<
NCT02201550 - Completed - Denmark ... More >> Hvidovre University Hospital Hvidovre, Denmark, 2650 Less <<
NCT02200965 Diabetes Care... More >> Delivery Less << Not Applicable Completed - United Kingdom ... More >> Diabetes Centre, New Cross Hospital Wolverhampton, United Kingdom, WV10 0QP Less <<
NCT03202654 Healthy Men and Women Not Applicable Completed - United States, Florida ... More >> MB Clinical Research Boca Raton, Florida, United States, 33487 United States, Illinois Great Lakes Clinical Trials Chicago, Illinois, United States, 60640 Less <<
NCT02694874 Malaria Not Applicable Recruiting December 2019 Mozambique ... More >> Centro de Investigação em Saude da Manhiça Recruiting Manhiça, Maputo, Mozambique, CP1929 Contact: Quique Bassat, PhD          Contact: Eusebio Macete, PhD Less <<
NCT02200666 - Active, not recruiting July 31, 2019 Japan ... More >> Research Site Aichi, D1692c00014, Japan, D1692C00014 Research Site Akita, D1692c00014, Japan, D1692C00014 Research Site Aomori, D1692c00014, Japan, D1692C00014 Research Site Chiba, D1692c00014, Japan, D1692C00014 Research Site Ehime, D1692c00014, Japan, D1692C00014 Research Site Fukui, D1692c00014, Japan, D1692C00014 Research Site Fukuoka, D1692c00014, Japan, D1692C00014 Research Site Fukushima, D1692c00014, Japan, D1692C00014 Research Site Gifu, D1692c00014, Japan, D1692C00014 Research Site Gunma, D1692c00014, Japan, D1692C00014 Research Site Hiroshima, D1692c00014, Japan, D1692C00014 Research Site Hokkaido, D1692c00014, Japan, D1692C00014 Research Site Hyogo, D1692c00014, Japan, D1692C00014 Research Site Ibaraki, D1692c00014, Japan, D1692C00014 Research Site Ishikawa, D1692c00014, Japan, D1692C00014 Research Site Iwate, D1692c00014, Japan, D1692C00014 Research Site Kagawa, D1692c00014, Japan, D1692C00014 Research Site Kagoshima, D1692c00014, Japan, D1692C00014 Research Site Kanagawa, D1692c00014, Japan, D1692C00014 Research Site Kochi, D1692c00014, Japan, D1692C00014 Research Site Kumamoto, D1692c00014, Japan, D1692C00014 Research Site Kyoto, D1692c00014, Japan, D1692C00014 Research Site Mie, D1692c00014, Japan, D1692C00014 Research Site Miyagi, D1692c00014, Japan, D1692C00014 Research Site Miyazaki, D1692c00014, Japan, D1692C00014 Research Site Nagano, D1692c00014, Japan, D1692C00014 Research Site Nagasaki, D1692c00014, Japan, D1692C00014 Research Site Nara, D1692c00014, Japan, D1692C00014 Research Site Niigata, D1692c00014, Japan, D1692C00014 Research Site Oita, D1692c00014, Japan, D1692C00014 Research Site Okayama, D1692c00014, Japan, D1692C00014 Research Site Okinawa, D1692c00014, Japan, D1692C00014 Research Site Osaka, D1692c00014, Japan, D1692C00014 Research Site Saga, D1692c00014, Japan, D1692C00014 Research Site Saitama, D1692c00014, Japan, D1692C00014 Research Site Shiga, D1692c00014, Japan, D1692C00014 Research Site Shimane, D1692c00014, Japan, D1692C00014 Research Site Shizuoka, D1692c00014, Japan, D1692C00014 Research Site Tochigi, D1692c00014, Japan, D1692C00014 Research Site Tokushima, D1692c00014, Japan, D1692C00014 Research Site Tokyo, D1692c00014, Japan, D1692C00014 Research Site Tottori, D1692c00014, Japan, D1692C00014 Research Site Toyama, D1692c00014, Japan, D1692C00014 Research Site Wakayama, D1692c00014, Japan, D1692C00014 Research Site Yamagata, D1692c00014, Japan, D1692C00014 Research Site Yamaguchi, D1692c00014, Japan, D1692C00014 Research Site Yamanashi, D1692c00014, Japan, D1692C00014 Less <<
NCT01155141 Kidney Diseases Phase 4 Completed - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT03051451 Overweight and Obesity Phase 2 Suspended(Business decision) November 2018 Mexico ... More >> Laboratorios SIlanes S.A. de C.V, Mexico Distrito Federal, Mexico City, Mexico, 03100 Less <<
NCT01155141 - Completed - -
NCT02965521 Colon Cancer ... More >>Rectal Cancer ColoRectal Cancer Less << Not Applicable Recruiting December 2019 United States, California ... More >> University of California, San Francisco Recruiting San Francisco, California, United States, 94158 Contact: Jennifer Luan    415-514-6220    jennifer.luan@ucsf.edu    Principal Investigator: Erin Van Blarigan Less <<
NCT03120260 Obesity Overw... More >>eight Less << Not Applicable Completed - Iran, Islamic Republic of ... More >> NovinDiet Clinic Tehran, Iran, Islamic Republic of Less <<
NCT01894451 Inflammatory Breast Carcinoma Early Phase 1 Active, not recruiting October 2020 United States, Massachusetts ... More >> Brigham and Womens Hospital Boston, Massachusetts, United States, 02215 Dana Farber Cancer Institute Boston, Massachusetts, United States, 02215 Less <<
NCT03169985 Coronary Artery Disease Phase 4 Recruiting December 31, 2023 Korea, Republic of ... More >> Samsung Medical Center Recruiting Seoul, Korea, Republic of, 06351 Contact: Joo-Yong Hahn, MD, PhD    82-2-3410-6653    ichjy1@gmail.com    Contact: Joo Myung Lee, MD, MPH    82-2-3410-1246    drone80@hanmail.net Less <<
NCT01573546 Cognitive Impairment, no Demen... More >>tia (CIND) Less << Not Applicable Completed - United States, North Carolina ... More >> Duke University Medical Center Durham, North Carolina, United States, 27710 Less <<
NCT03667430 Safety Issues Not Applicable Completed - -
NCT03147625 Elderly Not Applicable Not yet recruiting July 31, 2020 -
NCT01010841 Metabolic Syndrome ... More >> Overweight Obesity Hypercholesterolemia Less << Not Applicable Completed - United States, Florida ... More >> Mark McIntosh MD Jacksonville, Florida, United States, 32209 Less <<
NCT03702335 Aging Age Pro... More >>blem Age-related Cognitive Decline Age-Related Atrophy Less << Not Applicable Not yet recruiting December 2019 Singapore ... More >> National University of Singapaore Singapore, Singapore, 117546 Hannah Senior Activity Centre Singapore, Singapore, 590021 Less <<
NCT02605291 Dietary Manipulation Not Applicable Completed - United Kingdom ... More >> School of Sport Exercise and Rehabilitation Sciences, University of Birmingham Birmingham, United Kingdom, B15 2TT Less <<
NCT02581813 Overweight Ob... More >>esity Children Less << Not Applicable Active, not recruiting December 2018 Canada, Ontario ... More >> Brock University St. Catharines, Ontario, Canada, L2S3A1 Less <<
NCT02306070 HIV Infection ... More >> Hepatitis C Less << Phase 2 Withdrawn(insufficient funding... More >>) Less << April 3, 2018 Canada, Ontario ... More >> The Ottawa Hospital, General Campus Ottawa, Ontario, Canada Less <<
NCT01735643 Type 2 Diabetes Mellitus Early Phase 1 Completed - Germany ... More >> West German Center of Diabetes and Health Düsseldorf, Germany, 40591 Less <<
NCT01738802 Type 2 Diabetes Not Applicable Completed - United States, Maryland ... More >> Walter Reed National Military Medical Center Bethesda, Maryland, United States, 20889-5600 Walter Reed National Military Medical Center Bethesda, Maryland, United States, 20889 Less <<
NCT01743599 - Completed - Denmark ... More >> Fertility Clinic, Odense University Hospital Odense, Denmark, 5000 Less <<
NCT01743963 Diabetes Mellitus Not Applicable Completed - United States, Colorado ... More >> Liron Caplan Aurora, Colorado, United States, 80045 Less <<
NCT01743963 - Completed - -
NCT02540252 - Active, not recruiting April 2017 Denmark ... More >> University Hospital of Copenhagen, Hvidovre Hvidovre, Copenhagen, Denmark, 2650 Less <<
NCT03189511 Adipose Tissue, Brown ... More >> Insulin Resistance Clinical Trial Less << Phase 4 Completed - Switzerland ... More >> University Hospital of Zurich, PET/MR Center Schlieren, Zurich, Switzerland, 8952 University Hospital of Basel Basel, Switzerland, 4031 Less <<
NCT00259272 Bipolar Disorder I or II Phase 3 Completed - France ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Andilly, France, 95580 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bordeaux, France, 33076 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Cornebarrieu, France, 31700 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Creteil, France, 94010 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. La Rochelle, France, 17000 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. La Seyne Sur Mer, France, 83500 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lyon, France, 69322 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Marseille, France, 13385 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Montpellier, France, 34094 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nimes, France, 30029 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Orvault, France, 44700 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Paris, France, 75019 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Pin Balma, France, 31130 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Plaisir, France, 78373 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Poitiers, France, 86021 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Toulouse, France, 31300 Less <<
NCT03203317 Exercise Insu... More >>lin Sensitivity Less << Not Applicable Completed - Denmark ... More >> August Krogh Building Copenahgen, Denmark Less <<
NCT00259272 - Completed - -
NCT01755494 Type 2 Diabetes Mellitus(T2DM) Phase 1 Completed - China ... More >> Research Site Beijing, China Less <<
NCT01749345 - Completed - United States, South Carolina ... More >> Ralph H. Johnson VA Medical Center Charleston, South Carolina, United States, 29401 Medical University of South Carolina Charleston, South Carolina, United States, 29425 Less <<
NCT01087619 Primary Hyperparathyroidism Not Applicable Recruiting June 2021 Sweden ... More >> Skåne University Hospital, Department of Surgery, Lund Recruiting Lund, Sweden, 22185 Contact: Anders OJ Bergenfelz, MD, PhD    +46 46 17 20 86    anders.bergenfelz@med.lu.se    Contact: Erik Nordenström, MD, PhD    +46 46 17 23 05    erik.nordenstrom@skane.se    Sub-Investigator: Erik Nordenström, MD, PhD          Sub-Investigator: Martin Almqvist, MD, PhD Less <<
NCT01736124 Diabetes Mellitus, Type 2 Not Applicable Active, not recruiting September 30, 2019 United States, Michigan ... More >> VA Ann Arbor Healthcare System, Ann Arbor, MI Ann Arbor, Michigan, United States, 48105 United States, New York James J. Peters VA Medical Center, Bronx, NY Bronx, New York, United States, 10468 Less <<
NCT01771835 - Completed - Switzerland ... More >> University of Basel, Dept. of Ophthalmology Basel, Switzerland, 4031 Less <<
NCT01907906 - Completed - -
NCT01907906 Focus of Study: Radiolabel Rec... More >>overy and Survival of RBCs Less << Phase 1 Completed - United States, Ohio ... More >> Hoxworth Blood Center Cincinnati, Ohio, United States, 45267 United States, Washington Puget Sound Blood Center Seattle, Washington, United States, 98104 Less <<
NCT01775579 Diabetes Mellitus Phase 1 Completed - Korea, Republic of ... More >> Samgsung Seoul Hospital Seoul, Korea, Republic of Less <<
NCT01767389 - Completed - -
NCT01776099 Type 2 Diabetes Not Applicable Unknown December 2018 Germany ... More >> Charité-Klinikum Benjamin Franklin Recruiting Berlin, Germany, 12203 Contact: Stefan Kabisch, Dr. med.    030 450 514 ext 429    stefan.kabisch@charite.de    Contact       diabetes@charite.de    Sub-Investigator: Stefan Kabisch, Dr. med. Less <<
NCT01778751 - Completed - -
NCT01779596 Type 2 Diabetes Mellitus Phase 4 Completed - Netherlands ... More >> Radboud University Nijmegen Medical Centre Nijmegen, Gelderland, Netherlands, 6525 EX Less <<
NCT01778751 Diabetes Early Phase 1 Completed - United States, North Carolina ... More >> Durham VA Medical Center, Durham, NC Durham, North Carolina, United States, 27705 Less <<
NCT01780051 Diabetes Mellitus, Type 2 Phase 1 Completed - Korea, Republic of ... More >> Chounbuk National University Hospital Jeonju, Jeonbuk, Korea, Republic of Less <<
NCT01776528 Diabetes Mellitus Phase 1 Completed - Australia, Western Australia ... More >> NGM Clinical Study Site Perth, Western Australia, Australia, 6009 Less <<
NCT01779609 Type 2 Diabetes Mellitus Phase 4 Completed - Netherlands ... More >> Radboud University Nijmegen Medical Centre Nijmegen, Gelderland, Netherlands, 6525 EX Less <<
NCT01786707 Type 2 Diabetes Mellitus Phase 1 Phase 2 Completed - United States, Florida ... More >> Diabetes Research Institute, University of Miami Miller School of Medicine Miami, Florida, United States, 33136 Less <<
NCT01785771 Type 2 Diabetes Phase 3 Terminated(Decision by Sponsor... More >>) Less << - -
NCT01787396 Type 2 Diabetes Mellitus Phase 3 Completed - Korea, Republic of ... More >> LG Life Sciences Seoul, Korea, Republic of, 110-062 Less <<
NCT01786707 - Completed - -
NCT01793909 Type 2 Diabetes Not Applicable Completed - United States, Colorado ... More >> University of Colorado Denver, Anschutz Medical Campus Aurora, Colorado, United States, 80045 Less <<
NCT01794091 Diabetes Mellitus, Type II Phase 1 Unknown - United States, Massachusetts ... More >> Brigham and Women's Hospital Not yet recruiting Boston, Massachusetts, United States, 02114 Less <<
NCT01794143 Type 2 Diabetes ... More >> Comparative Effectiveness of Glycemia-lowering Medications Less << Phase 3 Active, not recruiting - -
NCT01795144 Monogenic Diabetes Phase 1 Completed - United States, Illinois ... More >> University of Chicago Chicago, Illinois, United States, 60637 Less <<
NCT01796834 Diabetes Mellitus Not Applicable Completed - United States, Minnesota ... More >> HealthPartners Institute for Education and Research Bloomington, Minnesota, United States, 55425 Less <<
NCT01789788 Diabetes Mellitus Type 2 Phase 1 Completed - United States, California ... More >> Chula Vista, California, United States, 91911 United States, Ohio Cincinnati, Ohio, United States, 45227 Less <<
NCT01809093 - Completed - United States, Pennsylvania ... More >> Mid Atlantic Retina- Wills Eye Institute Philadelphia, Pennsylvania, United States, 19107 Less <<
NCT02770274 Peripheral Arterial Disease Phase 3 Recruiting December 2019 Greece ... More >> Patras Universityu Hospital Recruiting Patras, Achaia, Greece Contact: Dimitris Karnabatidis, MD, PhD    +302613603 ext 219    karnaby@med.upatras.gr    Contact: Panagiotis Kitrou, MD, PhD    +302613603 ext 218    panoskitrou@gmail.com    Principal Investigator: Dimitris Karnabatidis, MD, PhD          Sub-Investigator: Panagiotis Kitrou, MD, PhD          Sub-Investigator: Kostantinos Katsanos, MD, PhD          Attikon university General Hospital Recruiting Athens, Attiki, Greece, 15343 Contact: Stavros Spiliopoulos, MD, PhD    +30210581 ext 1832    stavspiliop@med.uoa.gr    Contact: Lazaros Reppas, MD    +3021058 ext 1844    l.reppas@yahoo.com    Principal Investigator: Elias Brountzos, MD, PhD          Sub-Investigator: Stavros Spiliopoulos, MD, PhD          Sub-Investigator: Lazaros Reppas, MD          Sub-Investigator: Maria Tsitskari, MD          Sub-Investigator: George Geroulakos, MD, PhD          Sub-Investigator: Christos Kakkisis, MD, PhD          Sub-Investigator: Andreas Lazaris, MD, PhD Less <<
NCT01806194 Type 2 Diabetes Mellitus Not Applicable Completed - United States, North Carolina ... More >> East Carolina University Greenville, North Carolina, United States, 27834 Less <<
NCT01814787 - Completed - -
NCT01814787 Type 2 Diabetes Not Applicable Completed - United States, Indiana ... More >> Indiana University School of Medicine Indianapolis, Indiana, United States, 46202 Less <<
NCT01819493 Diabetes Prevention Not Applicable Completed - United States, North Carolina ... More >> Wake Forest Baptist Health Winston-Salem, North Carolina, United States, 27157 Less <<
NCT01821846 - Completed - Korea, Republic of ... More >> Novo Nordisk Investigational Site Pyungchon-Dong 896, Dongan-Gu, Korea, Republic of, 431-796 Novo Nordisk Investigational Site Seoul, Korea, Republic of, 02447 Novo Nordisk Investigational Site Seoul, Korea, Republic of, 03080 Novo Nordisk Investigational Site Seoul, Korea, Republic of, 150-950 Novo Nordisk Investigational Site Ulsan, Korea, Republic of, 44455 Novo Nordisk Investigational Site Ulsan, Korea, Republic of, 682-060 Novo Nordisk Investigational Site Wonju, Korea, Republic of, 220-701 Less <<
NCT01812811 - Completed - Denmark ... More >> Medical department, Diagnostic Center, Regional Hospital Silkeborg Silkeborg, Denmark, 8600 Less <<
NCT01813708 Type 2 Diabetes Not Applicable Completed - Mexico ... More >> Unidad de Investigación en Epidemiología Clínica, UMAE Hospital de Especialidades, Centro Médico Siglo XXI, IMSS Mexico City, Distrito Federal, Mexico, 06720 Less <<
NCT01826370 - Terminated - -
NCT01826370 - Terminated - -
NCT01822548 Type 2 Diabetes Phase 3 Completed - Italy ... More >> Azienda Opedaliera-Universitaria Parma, Italy, 43126 Azienda Ospedaliera-Universitaria Parma, Italy, 43126 Less <<
NCT01830569 Diabetes Mellitus, Type 2 Not Applicable Active, not recruiting March 2019 Belgium ... More >> Katholieke Universiteit Leuven Leuven, Vlaams-Brabant, Belgium, 3000 Less <<
NCT01832441 Diabetes Mellitus. Phase 1 Phase 2 Unknown September 2016 India ... More >> Chaitanya Hospital Recruiting Pune, Maharashtra, India, 411009 Contact: Sachin S Jamadar, D ORTHO    +918888788880    sac2751982@gmail.com    Principal Investigator: Anant E Bagul, MS Less <<
NCT03300271 Metabolic Syndrome Not Applicable Recruiting July 31, 2018 Korea, Republic of ... More >> Yonsei University College of Medicine Recruiting Seoul, Korea, Republic of, 03722 Contact: Hyeon Chang Kim    82-2-222-1873    hckim@yuhs.ac Less <<
NCT03309761 - Recruiting December 2019 France ... More >> CHU Nimes Not yet recruiting Nîmes, France, 30029 Contact: Anissa Megzari       drc@chu-nimes.fr    Principal Investigator: Pierre Corbeau, MD          Sub-Investigator: Jean-Philippe Lavigne, MD          Sub-Investigator: Robert Sabatier, MD          Centre d'examen de santé de la Sécurité Sociale de Nîmes Recruiting Nîmes, France Contact: Elisabeth Maggia    04 30 67 94 70    elisabeth.maggia@cpam-nimes.cnamts.fr    Principal Investigator: Elisabeth Maggia          Sub-Investigator: Patricia Le Merre Less <<
NCT01842620 - Completed - -
NCT01822548 - Completed - -
NCT01849731 Diabetes Mellitus Type 2 Not Applicable Completed - Spain ... More >> Andalussian School of Public Health Granada, Spain, 18011 Less <<
NCT01850134 Diabetes Not Applicable Withdrawn July 2013 United States, Illinois ... More >> Biofortis Clinical Research Addison, Illinois, United States, 60101 United States, Ohio Radiant Research Cincinnati, Ohio, United States, 45249 Less <<
NCT01842620 Diabetes Mellitus, Type 2 Phase 4 Completed - -
NCT01861756 Diabetes Mellitus, Type 2 Not Applicable Completed - Greece ... More >> Tzanio General Hospital Piraeus, Attiki, Greece Nea Michaniona Health Center Nea Michaniona, Thessaloniki, Greece Private practice Neapoli, Thessaloniki, Greece Thermi S.A. Thermi, Thessaloniki, Greece Alexandroupoli University Hospital Alexandroupoli, Greece NIMTS Military Hospital Athens, Greece Polikliniki General Hospital Athens, Greece Private practice Serres, Greece Less <<
NCT01836172 Diabetic Complication Phase 2 Unknown January 2017 Korea, Republic of ... More >> Internal medicine, Seoul National University Hospital Seoul, Korea, Republic of, 110-744 Less <<
NCT03348371 Insulin Resistance ... More >> Ethanol Incretin Effect Less << Not Applicable Completed - -
NCT01865474 Type 2 Diabetes Mellitus Phase 4 Completed - Indonesia ... More >> Department of Internal Medicine, Faculty of Medicine, University of Andalas/ dr. M. Djamil Padang Hospital Padang, Sumatera Barat, Indonesia Less <<
NCT00991835 - Unknown December 2014 Japan ... More >> Hiroshima University Graduate School of Biomedical and Health Sciences, Department of Cardiovascular Medicine Hiroshima, Japan, 734-8551 Less <<
NCT01850810 Diabetes Not Applicable Completed - United States, Illinois ... More >> Radiant Research Chicago, Illinois, United States, 60654 United States, Ohio Radiant Research Cincinnati, Ohio, United States, 45249 Less <<
NCT01874483 Diabetes Mellitus, Type 2 Phase 1 Completed - Germany ... More >> 1307.2.1 Boehringer Ingelheim Investigational Site Neuss, Germany Less <<
NCT01883258 Type 2 Diabetes Not Applicable Recruiting November 2019 United States, Florida ... More >> University of Florida Recruiting Gainesville, Florida, United States, 32611 Contact: Demetra D Christou, Ph.D    352-294-1715    ddchristou@ufl.edu    Principal Investigator: Demetra D Christou, Ph.D Less <<
NCT01861756 - Completed - -
NCT01886170 Diabetes Not Applicable Completed - United States, Pennsylvania ... More >> University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT02637778 Cardiovascular Diseases Not Applicable Completed - -
NCT03338868 - Recruiting December 30, 2017 Turkey ... More >> Ataturk Training and Research Hospital Active, not recruiting Ankara, Cankaya, Turkey, 06800 Ataturk Training and Research Hospital Recruiting Ankara, Cankaya, Turkey, 06800 Contact: Seyda Toprak Celenay, Assist Prof    +90 530 041 39 86    sydtoprak@hotmail.com Less <<
NCT01890993 - Completed - France ... More >> Paris La défense cedex, France, 92932 Germany Mainz, Germany, 55127 Spain Madrid, Spain, 28033 United Kingdom Crawley, United Kingdom, RH11 9RT Less <<
NCT01897532 Diabetes Mellitus, Type 2 Phase 4 Completed - -
NCT01885260 Type 2 Diabetes Mellitus Phase 2 Completed - United States, Alabama ... More >> Isis Investigational Site Birmingham, Alabama, United States, 35216 Isis Investigational Site Muscle Shoals, Alabama, United States, 35662 United States, California Isis Investigational Site Anaheim, California, United States, 92801 Isis Investigational Site Chino, California, United States, 91710 Isis Investigational Site Los Angeles, California, United States, 90057 United States, Florida Isis Investigational Site Deland, Florida, United States, 32720 Isis Investigational Site Ft. Lauderdale, Florida, United States, 33306 Isis Investigational Site Miami, Florida, United States, 33143 United States, Georgia Isis Investigational Site Marietta, Georgia, United States, 30066 United States, Nevada Isis Investigational Site Las Vegas, Nevada, United States, 89101 United States, Ohio Isis Investigational Site Cincinnati, Ohio, United States, 45245 United States, Oklahoma Isis Investigational Site Oklahoma City, Oklahoma, United States, 73103 United States, Oregon Isis Investigational Site Eugene, Oregon, United States, 97404 United States, Texas Isis Investigational Site Corpus Christi, Texas, United States, 78404 Isis Investigational Site Katy, Texas, United States, 77450 United States, Utah Isis Investigational Site Salt Lake City, Utah, United States, 84107 United States, Washington Isis Investigational Site Renton, Washington, United States, 98057 Isis Investigational Site Spokane, Washington, United States, 99202 South Africa Isis Investigational Site Lenasia South, Gauteng, South Africa, 1829 Isis Investigational Site Soweto, Gauteng, South Africa, 1818 Isis Investigational Site Durban, KwaZulu-Natal, South Africa, 4091 Isis Investigational Site Cape Town, Western Cape, South Africa, 7700 Isis Investigational Site Parow, Cape Town, Western Cape, South Africa, 7500 Isis Investigational Site Western Cape, South Africa, 7130 Less <<
NCT01901757 Diabetes Mellitus Phase 1 Completed - Korea, Republic of ... More >> Samsung Medical Center Seoul, Korea, Republic of, 135-710 Less <<
NCT01876849 Type 2 Diabetes Mellitus Phase 3 Completed - United States, Washington ... More >> Research Site Renton, Washington, United States Less <<
NCT01902043 - Active, not recruiting December 2021 Switzerland ... More >> University of Lausanne Hospitals Lausanne, Switzerland Less <<
NCT01898702 Diabetes Mellitus, Type 2 Not Applicable Unknown December 2015 Spain ... More >> Catalan Health Institute, Barcelona District health Authority Not yet recruiting Barcelona, Catalonia, Spain, 08007 Contact: Pere Roura-Poch, MD, MPH       proura@chv.cat    Sub-Investigator: Asunción González-Mestre, RN          Sub-Investigator: Paloma Amil, RN          Sub-Investigator: Claustre Solé, RN          Sub-Investigator: Ester Gil, RN          Catalan Health Institute, Sud metropolitan District health Authority Not yet recruiting L'Hospitalet de Llobregat, Catalonia, Spain, 08908 Contact: Pere Roura-Poch, MD, MPH       proura@chv.cat    Sub-Investigator: Rosa M García-Cerdán, RN          Catalan Health Institute, Catalonia midlands District health Authority Recruiting Sant Fruitós de Bages, Catalonia, Spain, 08272 Contact: Pere Roura-Poch, MD, MPH    +34.93.693.00.40    proura@chv.cat    Principal Investigator: Carme Boix, RN          Sub-Investigator: Pere Roura-Poch, MD, MPH          Sub-Investigator: Dolores Álamo-Junquera, MD, MPH          Sub-Investigator: Núria Sala, RN, MPH          Sub-Investigator: Joan P Millet, MD, MPH, PhD          Sub-Investigator: Joan Tobías, MD          Sub-Investigator: Marta A Palou, RN          Sub-Investigator: Montserrat Sallés, RN Less <<
NCT01904383 - Completed - Brazil ... More >> Hospital Felício Rocho Belo Horizonte, Brazil, 30110-060 Less <<
NCT01898572 - Unknown June 2015 Spain ... More >> Hospital Clinic of Barcelona Barcelona, Cataluña, Spain, 08036 Less <<
NCT01908348 Type 2 Diabetes Mellitus Not Applicable Completed - United States, Massachusetts ... More >> Boston University School of Medicine Boston, Massachusetts, United States, 02118 Less <<
NCT01906294 - Terminated(Representativeness ... More >>and results about treatment and health condition available) Less << - Germany ... More >> Praxis Dr. med. Birgit Böttger Frankfurt am Main, Germany, 60325 Less <<
NCT01901861 Type 2 Diabetes Not Applicable Completed - Sweden ... More >> Department of Clinical Science Lund,Lund University Lund, Sweden Less <<
NCT01911104 Type 2 Diabetes Not Applicable Active, not recruiting October 2019 United States, Florida ... More >> Translational Research Institute for Metabolism and Diabetes Orlando, Florida, United States, 32804 Less <<
NCT01906086 Diabetes Mellitus, Type 2 Not Applicable Completed - Iran, Islamic Republic of ... More >> Isfahan University of Medical Sciences Isfahan, Iran, Islamic Republic of Less <<
NCT01910727 Diabetes Not Applicable Completed - United States, Maryland ... More >> Johns Hopkins Center for American Indian Health Baltimore, Maryland, United States, 21205 Less <<
NCT01915550 Diabetes Mellitus Phase 3 Completed - Egypt ... More >> Ain Shams University Maternity Hospital Cairo, Egypt, 19931 Less <<
NCT01916174 Diabetes Diab... More >>etes Mellitus, Type 2 Healthy Less << Phase 1 Completed - Germany ... More >> Neuss, Germany, 41460 Less <<
NCT01910194 Diabetes Mellitus Phase 2 Completed - Germany ... More >> St. Josef-Hospital, University Hospital, Ruhr Bochum, Germany, 44791 Profil Institut für Stoffwechselforschung GmbH Neuss, Germany, 41460 Less <<
NCT01919684 Type 2 Diabetes Mellitus Phase 1 Completed - United States, Ohio ... More >> Medpace Clinical Pharmacology Cincinnati, Ohio, United States, 45227 Less <<
NCT01923181 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 2 Completed - -
NCT02008084 Hypertriglyceridemia ... More >> Mixed Hyperlipidemia Less << Phase 2 Completed - Canada, Alberta ... More >> Crowfoot Village Family Practice Calgary, Alberta, Canada, T3G0b4 Dr. Senaratne Professional Corporation Edmonton, Alberta, Canada, T6K 4C1 The Bailey Clinic Red Deer, Alberta, Canada, T4N 6V7 Canada, British Columbia Manna Research Vancouver Vancouver, British Columbia, Canada, V6J 1S3 Canada, New Brunswick GA Research Associates, Ltd Moncton, New Brunswick, Canada, E1G 1A7 Canada, Newfoundland and Labrador Commonwealth Medical Clinic Mount Pearl, Newfoundland and Labrador, Canada, A1N 1W7 Canada, Ontario Scisco Clinical Research Cornwall, Ontario, Canada, K6H 4M4 Sameh Fikry Medicine Professional Corp Kitchener, Ontario, Canada, N2G 1H6 Aging, Rehabilitation & Geriatric Care, Lawson Health Research Institute-St Joseph's Health Care, Parkwood London, Ontario, Canada, N6C 5J1 Prime Health Clinical Research Toronto, Ontario, Canada, M4S 1Y2 Manna Research Inc. Toronto, Ontario, Canada, M9W 4L6 Canada, Quebec Rhodin Recherche Drummondville, Quebec, Canada, J2B 7T1 Recherche Invascor, Inc. Longueuil, Quebec, Canada, J4N 1C2 Montreal Heart Institute Montreal, Quebec, Canada, H1T 1C8 Diex Recherche Sherbrooke Sherbrooke, Quebec, Canada, J1H 1Z1 Centre de santé et de services sociaux de Trois-Rivières Trois-Rivières, Quebec, Canada, G8Z 3R9 Canada Clinique des Maladies Lipidiques de Quebec, Inc. Quebec, Canada, G1V 4M6 Less <<
NCT01925443 Diabetes Mellitus Non-insulin-... More >>dependent Less << Not Applicable Suspended(technical problems w... More >>ith equipment from the main outcome) Less << June 2017 Brazil ... More >> University of Nove de Julho São Paulo, Brazil, 01504-001 Less <<
NCT01927562 Type II Diabetes Not Applicable Active, not recruiting June 2019 Chile ... More >> INDISA Santiago, Chile Less <<
NCT01915264 - Withdrawn March 2017 -
NCT03452267 Insulin Sensitivity Phase 2 Phase 3 Not yet recruiting June 2020 -
NCT01929512 Diabetes Mellitus Phase 1 Completed - Korea, Republic of ... More >> Samsung Medical Center Seoul, Korea, Republic of, 135-710 Less <<
NCT01923389 - Terminated(The study was termi... More >>nated on December 19th, 2013 due to a business decision by the Sponsor. No safety concerns have been observed in this study.) Less << - -
NCT01940302 Type 2 Diabetes Early Phase 1 Completed - China, Guangdong ... More >> Shaoguan University Shaoguan, Guangdong, China, 512005 Less <<
NCT01941199 Type 2 Diabetes Mellitus Phase 1 Completed - Korea, Republic of ... More >> Clinical Trial Center, Seoul National University Hospital Seoul, Korea, Republic of, 110-744 Less <<
NCT01923389 Type 2 Diabetes Mellitus (T2DM... More >>) Less << Phase 1 Terminated(The study was termi... More >>nated on December 19th, 2013 due to a business decision by the Sponsor. No safety concerns have been observed in this study.) Less << - United States, Florida ... More >> Pfizer Investigational Site Orlando, Florida, United States, 32803 Pfizer Investigational Site Orlando, Florida, United States, 32804 Less <<
NCT01948037 Diabetes Lowe... More >>r Extremity Arterial Disease Less << Not Applicable Unknown December 2013 China, Jiangsu ... More >> Nanjing Jinling Hospital Recruiting Nanjing, Jiangsu, China, 210002 Contact: Jia Wei, Master    86-025-80805491    1736429392@qq.com    Principal Investigator: Qiu Y Bin, Bachelor Less <<
NCT01945918 Diabetes Mellitus, Type 2 Not Applicable Completed - United States, Colorado ... More >> University of Colorado at Denver and Health Sciences Center Aurora, Colorado, United States, 80045 Less <<
NCT01937702 Diabetes Mellitus Phase 1 Completed - Germany ... More >> Profil Mainz GmbH & Co. KG Mainz, Rheinland-Pfalz, Germany, 55116 Less <<
NCT01950806 Cardiovascular Disease Risk ... More >> Type 2 Diabetes Risk Less << Not Applicable Completed - United States, Massachusetts ... More >> Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University Boston, Massachusetts, United States, 02111 Less <<
NCT01951235 Type 2 Diabetes Mellitus Phase 2 Completed - Latvia ... More >> Pauls Stradins Clinical University Hospital Riga, Latvia Less <<
NCT01943214 - Unknown December 2016 Taiwan ... More >> Taichung Veterans General Hospital Recruiting Taichung, Taiwan, 40765 Contact: Chia I Tsai, doctor    886-4-23592525 ext 4755    citsai777@gmail.com    Principal Investigator: Chia I Tsai, doctor Less <<
NCT01956851 - Completed - India ... More >> Ganga Care Hospital Nagpur, Maharashtra, India, 440010 Less <<
NCT01950676 Diabetes Mellitus Not Applicable Completed - Singapore ... More >> Singapore General Hospital Department of Endocrinology Singapore, Singapore, 169608 Less <<
NCT01959334 Drug-specific Antibodies ... More >> Hypoglycemia Diabetes Mellitus Less << Phase 3 Completed - Canada, Quebec ... More >> Algorithme Pharma Inc. Laval, Quebec, Canada, H7V 4B3 Less <<
NCT01951339 Type 2 Diabetes ... More >> Cardiovascular Disease Less << Not Applicable Completed - United States, Colorado ... More >> University of Colorado Anschutz Medical Campus Aurora, Colorado, United States, 80045 Less <<
NCT01950637 - Completed - United States, New Jersey ... More >> Novo Nordisk Investigational Site Princeton, New Jersey, United States, 08540 Canada Novo Nordisk Investigational Site Mississauga, Canada, L4W 4XI Denmark Novo Nordisk Investigational Site Copenhagen S, Denmark, 2300 Germany Novo Nordisk Investigational Site Mainz, Germany, 55127 Japan Novo Nordisk Investigational Site Tokyo, Japan, 1000005 United Kingdom Novo Nordisk Investigational Site Crawley, United Kingdom, RH11 9RT Less <<
NCT01521962 Diabetes Mellitus Phase 3 Completed - Japan ... More >> Aomori-shi, Aomori, Japan Hirosaki-shi, Aomori, Japan Kashiwa-shi, Chiba, Japan Kisarazu-shi, Chiba, Japan Kitakyushu-shi, Fukuoka, Japan Aki-gun, Hiroshima, Japan Fukuyama-shi, Hiroshima, Japan Nishinomiya-shi, Hyogo, Japan Koga-shi, Ibaraki, Japan Ushiku-shi, Ibaraki, Japan Kahoku-gun, Ishikawa, Japan Hanamaki-shi, Iwate, Japan Morioka-shi, Iwate, Japan Kagoshima-shi, Kagoshima, Japan Satsuma-sendai-shi, Kagoshima, Japan Kumamoto-shi, Kumamoto, Japan Minamata-shi, Kumamoto, Japan Miyazaki-shi, Miyazaki, Japan Nigata-shi, Nigata, Japan Hirakata-shi, Osaka, Japan Osaka-sayama-shi, Osaka, Japan Osaka-shi, Osaka, Japan Takatsuki-shi, Osaka, Japan Yao-shi, Osaka, Japan Kuki-shi, Saitama, Japan Otsu-shi, Shiga, Japan Hamamatsu-shi, Shizuoka, Japan Shizuoka-shi, Shizuoka, Japan Shimotsuke-shi, Tochigi, Japan Shinagawa-ku, Tokyo, Japan Toyama-shi, Toyama, Japan Sagae-shi, Yamagata, Japan Yamagata-shi, Yamagata, Japan Less <<
NCT01524770 Diabetes Mellitus, Type 2 Phase 1 Completed - United States, Florida ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Daytona Beach, Florida, United States, 32117 Less <<
NCT01525225 Type 2 Diabetes Mellitus Phase 1 Terminated(Release of Post Mar... More >>keting Requirement for this study. Terminated November 2013.) Less << - United States, Arkansas ... More >> Osborne Research Center Little Rock, Arkansas, United States, 72201 United States, California Axis Clinical Trials Los Angeles, California, United States, 90036 United States, Kentucky Kosair Charities Pediatric Clinical Research Unit Louisville, Kentucky, United States, 40202 United States, Missouri The Children'S Mercy Hospital And Clinics Kansas City, Missouri, United States, 64108 United States, Ohio Promedica Toledo Children'S Hospital Toledo, Ohio, United States, 43606 Promedica Toledo Childrens Hospital Toledo, Ohio, United States, 43606 United States, Pennsylvania Childrens Hospital Of Pittsburgh Of Upmc Pittsburgh, Pennsylvania, United States, 15224 Less <<
NCT01523405 - Completed - -
NCT01527539 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - Canada, Nova Scotia ... More >> Novo Nordisk Investigational Site Halifax, Nova Scotia, Canada, B3H 1V7 Canada, Ontario Novo Nordisk Investigational Site Toronto, Ontario, Canada, M5B 1W8 Canada Novo Nordisk Investigational Site Edmonton, Canada, T5H 3V9 Novo Nordisk Investigational Site Windsor, Canada, N8W 3K2 Less <<
NCT01527630 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 1 Completed - Japan ... More >> Novo Nordisk Investigational Site Tokyo, Japan, 1000005 Less <<
NCT01529918 Diabetes Not Applicable Unknown March 2012 -
NCT01525225 - Terminated(Release of Post Mar... More >>keting Requirement for this study. Terminated November 2013.) Less << - -
NCT01533688 Diabetes Mellitus Not Applicable Completed - United States, Oklahoma ... More >> Oklahoma VA Medical Center Oklahoma City, Oklahoma, United States, 73104 Less <<
NCT02851498 Insulin Resistance Not Applicable Unknown September 2016 -
NCT01533688 - Completed - -
NCT01535677 Type 2 Diabetes Mellitus Phase 1 Completed - United Kingdom ... More >> Research Site London, United Kingdom Less <<
NCT02470936 Prostate Cancer Not Applicable Active, not recruiting December 2018 United States, California ... More >> University of California, San Francisco (UCSF) San Francisco, California, United States, 94143 Less <<
NCT01536626 - Completed - Netherlands ... More >> Novo Nordisk Investigational Site Alphen a/d Rijn, Netherlands Less <<
NCT01538290 - Completed - Denmark ... More >> Aarhus University Hospital, Skejby, Department of Cardiology Aarhus, Denmark, 8000 Less <<
NCT01541735 Type 2 Diabetes Phase 2 Phase 3 Completed - Mexico ... More >> Instituto Mexicano del Seguro Social. Hospital de Especialidades. Guadalajara, Jalisco, Mexico, 44380 Less <<
NCT01176942 Metabolic Endotoxemia ... More >> Metabolic Syndrome Less << Not Applicable Completed - France ... More >> CHU Toulouse Hospital Toulouse, Cedex 9, France Less <<
NCT01537497 Diabetes Mellitus, Type 2 Phase 1 Completed - United States, Florida ... More >> Pfizer Investigational Site South Miami, Florida, United States, 33143 Less <<
NCT01545024 - Unknown January 2013 Japan ... More >> Nagaoka Red Cross Hospital Recruiting Nagaoka, Niigata, Japan, 940-2085 Contact: Kyuzi Kamoi, MD    +81-0258-28-3600    kkam-int@echigo.ne.jp    Principal Investigator: Kyuzi Kamoi, MD Less <<
NCT01545570 Diabetes Mellitus, Type 2 Phase 1 Completed - United States, Minnesota ... More >> GSK Investigational Site Minneapolis, Minnesota, United States, 55404 Less <<
NCT01541735 - Completed - -
NCT01546844 Type II Diabetes Mellitus Not Applicable Unknown February 2013 United States, Utah ... More >> Coalville Health Center Coalville, Utah, United States, 84017 Pioneer Comprehensive Medical Draper, Utah, United States, 84020 Holladay Family Practice Holladay, Utah, United States, 84117 Olympus Clinic Holladay, Utah, United States, 84117 Exodus Healthcare - Main Office - Magna Magna, Utah, United States, 84044 Community Health Centers Inc. - 72nd Street Clinic Midvale, Utah, United States, 84115 Park City Healthcare, Inc. Park City, Utah, United States, 84068 Riverton Family Health Center Riverton, Utah, United States, 84065 Granger Medical-Riverton Riverton, Utah, United States, 84096 Wasatch Homeless Health Care - 4th Street Clinic Salt Lake City, Utah, United States, 84101 Alpine Internal Medicine Salt Lake City, Utah, United States, 84102 HealthInsight Salt Lake City, Utah, United States, 84107 Central City Community Health Center Health First Family Medicine Salt Lake City, Utah, United States, 84111 Evolutionary Healthcare, Llc Salt Lake City, Utah, United States, 84111 Health Clinic Of Utah - SLC Salt Lake City, Utah, United States, 84115 Stephen D. Ratcliffe Community Health Center Salt Lake City, Utah, United States, 84116 Jordan Ridge Family Medicine Salt Lake City, Utah, United States, 84123 Utah Healthcare Institute - St. Mark's Family Medicine Salt Lake City, Utah, United States, 84124 Utah Physicians Care Centers - St Mark's Internal Medicine Salt Lake City, Utah, United States, 84124 Wasatch Internal Medicine Salt Lake City, Utah, United States, 84124 Barbara E. Rizzardi, M.D. Sandy, Utah, United States, 84093 Copperview Medical Center, Llc South Jordan, Utah, United States, 84095 Community Health Centers Inc. - Oquirrh View Taylorsville, Utah, United States, 84118 Advanced Practice Medical Clinic Tooele, Utah, United States, 84074 Valley Family Medicine Tooele, Utah, United States, 84074 Granger Medical - Jordan Medical Arts West Jordan, Utah, United States, 84088 Jordan Meadows Medical Center West Jordan, Utah, United States, 84088 Granger Medical Clinic Inc. - Main Office West Valley City, Utah, United States, 84120 Kathryn Allen, MD West Valley City, Utah, United States, 84120 West Valley Family And Preventive Medicine West Valley City, Utah, United States, 84120 Less <<
NCT01552005 - Completed - -
NCT01524770 - Completed - -
NCT01556529 Diabetes Mellitus Type 2 Not Applicable Completed - Germany ... More >> Philipps University Marburg Medical Center Marburg, Germany, 35043 Less <<
NCT01553266 - Completed - -
NCT01546597 Type 2 Diabetes Mellitus Phase 1 Completed - United States, Texas ... More >> Cetero Research San Antonio, Texas, United States, 78229 Less <<
NCT01557504 Type 2 Diabetes Mellitus Phase 1 Completed - -
NCT01557504 - Completed - -
NCT01546558 Type 2 Diabetes Mellitus Phase 1 Completed - United States, Florida ... More >> SeaView Research Inc. Miami, Florida, United States, 33126 Less <<
NCT01556984 - Completed - China, Hubei ... More >> Wuhan General Hospital Wuhan, Hubei, China, 430070 Less <<
NCT01569243 Type 2 Diabetes Mellitus Phase 2 Completed - United States, Massachusetts ... More >> Center for Connected Health Boston, Massachusetts, United States, 02114 Partners Healthcare Center for Connected Health Boston, Massachusetts, United States, 02114 Less <<
NCT01561976 Diabetes Mellitus, Type 2 Not Applicable Completed - -
NCT01561976 - Completed - -
NCT01568125 - Unknown January 2014 Japan ... More >> Nagaoka Red Cross Hospital Nagaoka, Niigata, Japan, 940-2085 Less <<
NCT01570140 - Completed - Netherlands ... More >> Isala Clinics Zwolle, Netherlands Less <<
NCT01566981 - Completed - -
NCT01572753 Diabetes Diab... More >>etes Mellitus, Type 2 Healthy Less << Phase 1 Completed - Germany ... More >> Novo Nordisk Investigational Site Berlin, Germany, 14050 Less <<
NCT01557972 - Unknown March 2013 Japan ... More >> Nagaoka Red Cross Hospital Nagaoka, Niigata, Japan, 940-2085 Less <<
NCT01566981 Diabetes Mellitus Type II, Not Applicable Completed - Slovenia ... More >> Department of family medicine in Ljubljana Ljubljana, Slovenia, 1000 Department of Family medicine, Medical Faculty Ljubljana, Slovenia, 1000 Less <<
NCT01579136 Hypertension ... More >>Diabetes Mellitus Less << Not Applicable Terminated(Lack of subjects) - United States, Colorado ... More >> Caritas Clinic, Exempla Saint Joseph Hospital Denver, Colorado, United States, 80218 Less <<
NCT01576328 Type 2 Diabetes Phase 1 Phase 2 Completed - United States, California ... More >> SC Clinical Research Garden Grove, California, United States, 92844 United States, Florida Diabetes Research Institute Miami, Florida, United States, 33136 Compass Research Orlando, Florida, United States, 32806 United States, Louisiana Pennington Biomedical Research Center Baton Rouge, Louisiana, United States Tulane University Medical Center New Orleans, Louisiana, United States United States, Montana Big Sky Clinical Research Butte, Montana, United States, 59701 United States, Nevada Desert Endocrinology Clinical Research Center-Henderson Henderson, Nevada, United States, 89052 Alliance Against Diabetes/AAD Clinical Research Las Vegas, Nevada, United States, 89101 United States, New Hampshire Active Practices and Research Newington, New Hampshire, United States, 03801 United States, Ohio The Carl and Edyth Lindner Center for Research and Education at The Christ Hospital Cincinnati, Ohio, United States, 45219 Providence Health Partners - Center for Clinical Reseach Dayton, Ohio, United States, 45439 United States, Texas Dallas Diabetes and Endocrine Center Dallas, Texas, United States, 75230 West Houston Clinical Research Services Houston, Texas, United States Paragon Research Center San Antonio, Texas, United States, 78205 United States, Utah Wasatch Clinical Research Salt Lake City, Utah, United States United States, Virginia National Clinical Research - Norfolk, Inc Norfolk, Virginia, United States, 23502 National Clinical Research - Richmond, Inc. Richmond, Virginia, United States, 23294 United States, Washington Capital Clinical Research Center Olympia, Washington, United States, 98502 Less <<
NCT01575301 Diabetes Not Applicable Completed - United Kingdom ... More >> Ninewells Hospital Dundee, Angus, United Kingdom, DD1 9SY Royal Devon and Exeter NHS Foundation Trust Exeter, Devon, United Kingdom, EX2 5DW Oxford Hospitals NHS Trust Oxford, Oxfordshire, United Kingdom, OX3 7LJ Newcastle Hospitals NHS Trust Newcastle, Teeside, United Kingdom, NE1 4LP Less <<
NCT01582308 Type 2 Diabetes Mellitus Phase 1 Completed - -
NCT01580098 Diabetes Mellitus Type 2 Not Applicable Completed - Austria ... More >> Klinikum Klagenfurt Klagenfurt, Carinthia, Austria, 9020 LKH Laas Kötschach, Carinthia, Austria, 9640 LKH Villach Villach, Carinthia, Austria, 9500 Less <<
NCT01582308 - Completed - -
NCT01590771 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT01590771 - Completed - -
NCT01580098 - Completed - -
NCT01597154 Type 2 Diabetes Mellitus Not Applicable Completed - Canada, Manitoba ... More >> Manitoba Institute of Child Health Winnipeg, Manitoba, Canada, R3E 0P4 Less <<
NCT01593371 Type 2 Diabetes Mellitus Not Applicable Completed - Iran, Islamic Republic of ... More >> Tehran University of Medical Sciences Tehran, Iran, Islamic Republic of, 13145-784 Less <<
NCT01588587 - Unknown December 2017 Japan ... More >> Kurume University Not yet recruiting Kurume, Fukuoka, Japan, 830-0111 Contact: Sho-ichi Yamagishi, MD    +81-942-31-7873    shoichi@med.kurume-u.ac.jp    Sub-Investigator: Sho-ichi Yamagishi, MD          Nagaoka Red Cross Hospital Not yet recruiting Nagaoka, Niigata, Japan, 940-2085 Contact: Kyuzi Kamoi, MD    +81-0258-28-3600    kkam-int@echogo.ne.jp    Principal Investigator: Kyuzi Kamoi, MD          Sub-Investigator: Sho-ichi Yamagishi, MD Less <<
NCT01597531 Type 2 Diabetes ... More >> Gastric Banding Less << Phase 4 Terminated(Difficulty recruiti... More >>ng patients) Less << - United States, North Carolina ... More >> Brody School of Medicine at East Carolina University Greenville, North Carolina, United States, 28590 Less <<
NCT02505854 Obesity Not Applicable Active, not recruiting December 2018 Brazil ... More >> Louise Crovesy de Oliveira Rio de Janeiro, Brazil, 21 Less <<
NCT01593137 Type 2 Diabetes Phase 4 Withdrawn(Lack of patients wit... More >>h the criteria established in the protocol.) Less << December 2014 Spain ... More >> Hospital Clínico San Carlos Madrid, Spain, 28040 Less <<
NCT01602003 Type 2 Diabetes Mellitus Phase 3 Completed - Korea, Republic of ... More >> LG Life Sciences Seoul, Korea, Republic of, 110-062 Less <<
NCT03335631 Prostate Cancer Not Applicable Recruiting March 31, 2019 Canada, Alberta ... More >> University of Calgary/Tom Baker Cancer Centre Recruiting Calgary, Alberta, Canada Contact: Nicole Culos-Reed, PhD       nculosre@ucalgary.ca    Contact: Jessica Danyluk, MKin    403-210-6983    jmdanylu@ucalgary.ca    Canada, Ontario Scarborough and Rouge Hospital Recruiting Scarborough, Ontario, Canada, M1P 2T7 Contact: James Chiarotto, MD          Contact: Riyad Akbarali       rakbarali@rougevalley.ca    University Health Network Recruiting Toronto, Ontario, Canada, M5G 2C4 Contact: Shabbir MH Alibhai, MD, MSc    416-340-5125    shabbir.alibhai@uhn.ca    Contact: Amna Iqbal    416-581-8452    amna.iqbal@uhnresearch.ca Less <<
NCT01585506 - Completed - Poland ... More >> Novo Nordisk Investigational Site Warszawa, Poland, PL-02-274 Less <<
NCT01607385 Diabetes Mellitus, Type 2 Phase 1 Completed - United States, Maryland ... More >> GSK Investigational Site Baltimore, Maryland, United States, 21225 Less <<
NCT01609088 Type 2 Diabetes Mellitus Not Applicable Completed - United States, Massachusetts ... More >> Boston University School of Medicine Boston, Massachusetts, United States, 02118 Less <<
NCT01601990 Type 2 Diabetes Mellitus Phase 3 Completed - Korea, Republic of ... More >> LG Life Sciences Seoul, Korea, Republic of, 110-062 Less <<
NCT01610674 Diabetes Mellitus ... More >> Surgery Less << Not Applicable Unknown May 2013 Netherlands ... More >> Radboud University Nijmegen Medical Centre Nijmegen, Netherlands, 6500 HB Less <<
NCT01611168 Type 2 Diabetes Not Applicable Completed - United States, Pennsylvania ... More >> University of Pittsburgh Medical Center Community Medicine Inc. (UPMC CMI) Primary Care Practices Pittsburgh, Pennsylvania, United States, 15213 Less <<
NCT01559441 Dyslipidemia Not Applicable Completed - Netherlands ... More >> Maastricht University Medical Center Maastricht, Netherlands Less <<
NCT01612520 Type 2 Diabetes Mellitus ... More >> Telenursing Less << Not Applicable Completed - -
NCT01609582 Type 2 Diabetes ... More >> Cardiovascular Disease Less << Phase 3 Terminated(Due to potential co... More >>ncerns about liver safety (See Detailed Description)) Less << - -
NCT03720574 Obesity Phase 3 Not yet recruiting July 6, 2021 -
NCT01609582 - Terminated(Due to potential co... More >>ncerns about liver safety (See Detailed Description)) Less << - -
NCT02986893 Multiple Sclerosis Not Applicable Completed - United States, New York ... More >> Icahn School of Medicine at Mount Sinai New York, New York, United States, 10029 Less <<
NCT02427295 Acromegaly Phase 4 Recruiting December 2019 Korea, Republic of ... More >> Asan Medical Center Recruiting Seoul, Korea, Republic of, 138-736 Contact: minseon Kim, PhD    82-2-3010-3245    mskim@amc.seoul.kr Less <<
NCT03479086 Alcohol Dependence Phase 3 Recruiting November 1, 2020 Australia, New South Wales ... More >> Drug Health Services, Royal Prince Alfred Hospital Recruiting Sydney, New South Wales, Australia, 2050 Contact: Kirsten C Morley, PhD    +61295153636    kirsten.morley@sydney.edu.au    Contact: Central Intake    95157611    sydneyalcoholtreatmentgroup@gmail.com    Principal Investigator: Paul Haber, MBBS Less <<
NCT01626469 Type 2 Diabetes Mellitus Phase 1 Phase 2 Recruiting September 2019 United States, Massachusetts ... More >> Brigham and Women's Hospital Recruiting Boston, Massachusetts, United States, 02115 Less <<
NCT01626053 Type 2 Diabetes Mellitus Not Applicable Completed - United States, Indiana ... More >> Northern Lakes Medicine Warsaw, Indiana, United States, 46580 Less <<
NCT01642394 Diabetes Mellitus Not Applicable Completed - Spain ... More >> Osakidetza Gasteiz / Vitoria, Alava, Spain, 01006 Less <<
NCT01647308 Type 2 Diabetes Phase 2 Terminated(The study was termi... More >>nated for business planning purposes. Assessments of APOCIIIRx in this population will be explored in a larger efficacy study) Less << - United States, California ... More >> Profil Institute for Clinical Research Chula Vista, California, United States, 91911 Less <<
NCT01634282 Diabetes, Type 2 Phase 3 Completed - Japan ... More >> Chubu Region, Japan Chugoku Region, Japan Kansai Region, Japan Kanto Region, Japan Kyushu Region, Japan Shikoku Region, Japan Tohoku Region, Japan Less <<
NCT01650324 - Completed - -
NCT01653951 Diabetes Not Applicable Completed - -
NCT01663220 - Completed - United States, Texas ... More >> ICON Development Solutions, Gault Lane San Antonio, Texas, United States, 78209 Less <<
NCT01650324 Diabetes Mellitus, Type 2 Phase 1 Completed - Taiwan ... More >> Taipei Medical University - Wanfang Hospital Taipei, Taiwan, 116 Less <<
NCT03034291 Insulin Resistance Not Applicable Completed - -
NCT03039647 - Recruiting January 1, 2022 United States, California ... More >> Stanford Psychiatry Building Recruiting Stanford, California, United States, 94305 Contact: Siena Roat-Shumway, B.S.    650-724-4559    sienar@stanford.edu    Contact: Alison Myoraku, B.S.    6507362182    myoraku@stanford.edu    Principal Investigator: Natalie Rasgon, M.D., Ph.D. Less <<
NCT01664676 Type 2 Diabetes Mellitus Phase 4 Completed - Denmark ... More >> Aarhus University Hospital, Department of Endocrinology and Diabetes Aarhus, Denmark, 8000 Less <<
NCT01665989 Type 2 Diabetes ... More >> Obesity Less << Not Applicable Completed - United States, Massachusetts ... More >> Diabetes Research Center - Massachusetts General Hospiral Boston, Massachusetts, United States, 02114 Less <<
NCT01650259 - Completed - Germany ... More >> CTMS MIGRATION CENTER representing all obvious CTMS Dummy Sites Ingelheim am Rhein, Germany, 55216 Less <<
NCT01671189 Diabetes Mellitus Type 2 ... More >> Adult-onset Diabetes Less << Early Phase 1 Unknown December 2013 United States, California ... More >> San Mateo Medical Center Not yet recruiting San Mateo, California, United States, 94403 Contact: Mike Aratow, Dr.       MAratow@smcgov.org    Contact: Jeanette Aviles, Dr.       javiles@smcgov.org Less <<
NCT01671345 Diabetes Mellitus Not Applicable Completed - United States, Illinois ... More >> Jesse Brown VA Medical Center, Chicago, IL Chicago, Illinois, United States, 60612 Less <<
NCT03065140 Diabetes Not Applicable Recruiting August 2018 United Kingdom ... More >> Cardiac Research Office Recruiting Aberdeen, Aberdeenshire, United Kingdom, AB25 2ZN Contact: Alice Mezincescu, MD    01224559573    alice.mezincescu@abdn.ac.uk    Contact: Amelia Rudd, HND    01224559573    a.e.rudd@abdn.ac.uk Less <<
NCT01667783 Obesity Type ... More >>2 Diabetes Less << Phase 2 Phase 3 Completed - United States, Maryland ... More >> Johns Hopkins Bayview Medical Center Baltimore, Maryland, United States, 21224 Less <<
NCT01680926 Type 2 Diabetes Mellitus Early Phase 1 Completed - Germany ... More >> West German Center of Diabetes and Health Düsseldorf, Germany, 40591 Less <<
NCT01677013 Type 2 Diabetes Mellitus Phase 1 Phase 2 Completed - China, Beijing ... More >> Division of Hematology and Endocrinology, Peking University Aerospace Centre Hospital Beijing, Beijing, China, 100049 Less <<
NCT01684709 Type 2 Diabetes Mellitus Not Applicable Completed - United States, Michigan ... More >> University of Michigan Ann Arbor, Michigan, United States, 48105 Hamilton Health Center Flint, Michigan, United States, 48504 Center for Family Health Jackson, Michigan, United States, 49201 Alcona Health Center Lincoln, Michigan, United States, 48742 Muskegon Family Care Muskegon Heights, Michigan, United States, 49444 St. John Masonic Medical Center Saint Clair Shores, Michigan, United States, 48082 Less <<
NCT01685502 - Completed - Japan ... More >> Many Locations, Japan Less <<
NCT01690208 Diabetes Obes... More >>ity Less << Not Applicable Unknown December 2017 Hong Kong ... More >> DMEC Centre, Prince of Wales Hospital Recruiting Shatin, Hong Kong Contact: Rebecca Wong       wongymr@ha.org.hk    Contact: Tammy So       tammytyso@yahoo.com.hk Less <<
NCT01681550 Type 2 Diabetes Mellitus Not Applicable Unknown October 2018 Japan ... More >> Nagaoka Red Cross Hospital Not yet recruiting Nagaoka, Niigata, Japan, 940-2085 Contact: Kyuzi Kamoi, MD    -81-0256-28-3600    kkam-int@echigo.ne.jp Less <<
NCT01690169 Diabetes Diab... More >>etes Mellitus, Type 2 Healthy Less << Phase 1 Completed - United Kingdom ... More >> Novo Nordisk Investigational Site Nottingham, United Kingdom, NG11 6JS Less <<
NCT01694173 Type 2 Diabetes Mellitus Phase 2 Phase 3 Unknown February 2013 India ... More >> PGIMER Recruiting Chandigarh, India Contact: Vikas Sood, MBBS, DRM    009779737349    vikasvineeta@rediffmail.com    Contact: Anil Bhansali, MBBS,MD,DM    001722756583    anilbhansali_endocrine@rediffmail.com Less <<
NCT01695278 Diabetes Complications ... More >> Diabetes Mellitus, Type 2 Less << Phase 3 Completed - United States, Illinois ... More >> Northwestern University Chicago, Illinois, United States, 60611 Less <<
NCT01694758 - Completed - Bulgaria ... More >> Research Site Blagoevgrad, Bulgaria Research Site Pleven, Bulgaria Research Site Plovdiv, Bulgaria Research Site Sofia, Bulgaria Romania Research Site Alexandria, Romania Research Site Brasov, Romania Research Site Bucuresti, Romania Research Site Cluj, Romania Research Site Constanta, Romania Research Site Craiova, Romania Research Site Galati, Romania Research Site Giurgiu, Romania Research Site Iasi, Romania Research Site Oradea, Romania Research Site Pitesti, Romania Research Site Ploiesti, Romania Research Site Satu Mare, Romania Research Site Tg Jiu, Romania Research Site Tg Mures, Romania Research Site Timisoara, Romania Less <<
NCT01688778 Type 2 Diabetes ... More >> Poor Glycemic Control Medication Adherence Less << Not Applicable Completed - Denmark ... More >> Endocrine Section, Dept. of Internal Medicine I, Bispebjerg Hospital Copenhagen, Copenhagen NV, Denmark, DK-2400 Less <<
NCT01703286 Diabetes Mellitus, Type 2 Phase 1 Completed - Germany ... More >> 1218.105.001 Boehringer Ingelheim Investigational Site Neuss, Germany Less <<
NCT01703286 - Completed - -
NCT01703611 Type 2 Diabetes Mellitus Not Applicable Completed - India ... More >> Nagajuna Hospital Vijayawada, Andhra Pradesh, India, 520007 Barman Diabetes Specialties Guwahati, Assam, India Dia Care 1 & 2 Amadavad, Gujarat, India, 380015 Fortis Escorts Hospital Faridabad, Haryana, India, 121007 Asian Institute of Medical Sciences Faridabad, Haryana, India Malabar Institute of Medical Sciences Calicut, Kerala, India Caritis Hospital Kottayam, Kerala, India BhaktiVedanta Hospital Mumbai, Maharashtra, India Star Hospitals Hyderabad, Pradesh, India Santokba Durlabji Memorial Hospital Jaipur, Rajasthan, India, 302015 Sundaram Medical Foundation Chennai, Tamilnadu, India, 600040 PSG Hospitals Coimbatore, Tamilnadu, India, 641004 Sanjay Gandhi Post Graduate Institute Lucknow, India, 226014 Fortis Hospital Uttar Pradesh, India Less <<
NCT03090997 Postmenopausal ... More >> Insulin Resistance Less << Not Applicable Recruiting August 20, 2020 Mexico ... More >> Instituto Nacional de Perinatología Isidro Espinosa de los Reyes Recruiting Mexico City, Mexico, 11000 Contact: Araceli Montoya-Estrada, MD    +525555209900 ext 257    ara_mones@hotmail.com    Contact: Enrique Reyes-Muñoz, MD, PhD.    +525555209900 ext 307    dr.enriquereyes@gmail.com Less <<
NCT01714674 Type 2 Diabetes Mellitus Not Applicable Unknown May 2013 Netherlands ... More >> Maastricht UMC Recruiting Maastricht, Netherlands, 6214 AD Sub-Investigator: Jan-Willem van Dijk, MSc          Principal Investigator: Luc van Loon, PhD Less <<
NCT01724502 Diabetes Obes... More >>e Less << Not Applicable Completed - United States, Arizona ... More >> Mayo Clinic in Arizona Scottsdale, Arizona, United States, 85259 Less <<
NCT01659294 Type 2 Diabetes Not Applicable Completed - Canada, British Columbia ... More >> Bcdiabetes.Ca Vancouver, British Columbia, Canada, V6R 1B6 Less <<
NCT01699737 Type 2 Diabetes Mellitus Phase 2 Completed - -
NCT01321905 Cystic Fibrosis Phase 2 Unknown - Sweden ... More >> Stockholm Cystic Fibrosis Center, Karolinska University Hospital Huddinge Recruiting Stockholm, Sweden, 141 86 Contact: Lena Hjelte, Professor    0046858587359    Lena.Hjelte@karolinska.se Less <<
NCT01719640 Diabetes Mellitus, Type 2 Phase 1 Phase 2 Completed - China, Fujian ... More >> Fuzhou General Hospital, Xiamen Univ Fuzhou, Fujian, China, 350025 Less <<
NCT01730534 Diabetes Mellitus, Non-Insulin... More >>-Dependent High Risk for Cardiovascular Event Less << Phase 3 Completed - -
NCT01725672 Diabetes Mellitus, Type 2 Phase 1 Terminated(Due to changes in E... More >>MA guidelines on modified release dosage forms (Feb 2013; EMA/CHMP/EWP/280/96). The Part B formulation would not meet the new guidelines.) Less << - Australia, New South Wales ... More >> GSK Investigational Site Randwick, New South Wales, Australia, 2031 Less <<
NCT01724515 Diabetes Obes... More >>e Less << Not Applicable Completed - United States, Arizona ... More >> Mayo Clinic in Arizona Scottsdale, Arizona, United States, 85259 Less <<
NCT01372852 - Unknown December 2011 China, Shaanxi ... More >> Xijing Hospital Recruiting Xi'an, Shaanxi, China, 710032 Contact: Ling Tao, MD,PhD    +86-15002955798    lingtao2006@gmail.com Less <<
NCT01374568 Type 2 Diabetes Mellitus Phase 4 Terminated(Study closed by spo... More >>nsor. Funding ended.) Less << - United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35294 Less <<
NCT01374568 - Terminated(Study closed by spo... More >>nsor. Funding ended.) Less << - -
NCT01384045 Type II Diabetes Not Applicable Completed - United States, Colorado ... More >> University of Colorado Hopspital Aurora, Colorado, United States, 80045 Less <<
NCT01383356 - Completed - -
NCT01381926 Type 2 Diabetes Mellitus ... More >> Bone Remodeling Less << Phase 4 Terminated(unavailability of s... More >>tudy drug and matching placebo) Less << - United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35294 Less <<
NCT01381926 - Terminated(unavailability of s... More >>tudy drug and matching placebo) Less << - -
NCT01387984 - Completed - Taiwan ... More >> National Taiwan University Hospital Yun-Lin Branch Douliu City, Yunlin County, Taiwan, 640 Less <<
NCT01387334 Type 2 Diabetes Phase 2 Completed - Thailand ... More >> Prince of Songkla University Hat Yai, Songkhla, Thailand, 90110 Less <<
NCT01383356 Diabetes Mellitus, Type 2 Phase 1 Completed - Canada, Ontario ... More >> 1288.19.1 Boehringer Ingelheim Investigational Site Toronto, Ontario, Canada Less <<
NCT01393808 Type 2 Diabetes Phase 2 Completed - Italy ... More >> ASL of Ponte San Pietro - Diabetologic Unit Brembate, Bergamo, Italy, 24030 Clinical Research Center fo Rare Diseases Aldo and Cele Daccò Ranica, Bergamo, Italy, 24020 Azienda Ospedaliera di Treviglio e Caravaggio - Unit of Diabetology and Metabolic Diseases Romano di Lombardia, BG, Italy Azienda Ospedaliera Bolognini - Unità di Medicina Seriate, BG, Italy Azienda Ospedaliera di Treviglio e Caravaggio - Unit of Diabetology and Metabolic Diseases Treviglio, BG, Italy Azienda Ospedaliera Ospedali Riuniti di Bergamo Bergamo, Italy Less <<
NCT01392898 Type 2 Diabetes Mellitus Not Applicable Unknown May 2014 Netherlands ... More >> Radboud University Nijmegen Medical Centre Nijmegen, Netherlands Less <<
NCT01393275 Diabetes Diab... More >>etes Mellitus, Non-Insulin-Dependent Less << Not Applicable Completed - Germany ... More >> University of Giessen Giessen, Hessen, Germany, 35394 Sportpark Zwickau, Glauchau, Meerane Zwickau, Sachsen, Germany, 08056 Less <<
NCT01396161 - Completed - -
NCT01394952 Cardiovascular Disease ... More >> Diabetes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT02880657 Healthy Volunteers Not Applicable Unknown August 2018 -
NCT01403025 - Completed - Japan ... More >> Novo Nordisk Investigational Site Tokyo, Japan, 1000005 Less <<
NCT01396161 Diabetes Mellitus, Type 2 Phase 1 Completed - United States, Florida ... More >> Miami Research Associates South Miami, Florida, United States, 33143 MRA Clinical Research South Miami, Florida, United States, 33143 Pulmonary Physicians of South Florida South Miami, Florida, United States, 33143 Less <<
NCT01406262 Diabetes Mellitus, Type 2 Phase 1 Completed - -
NCT01408888 Diabetes Mellitus, Type 2 Phase 1 Completed - United States, Florida ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Daytona Beach, Florida, United States, 32117 United States, Hawaii For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Honolulu, Hawaii, United States, 96814 United States, Texas For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Dallas, Texas, United States, 75247 Less <<
NCT01405261 Diabetes Diab... More >>etes Mellitus, Type 2 Healthy Less << Phase 1 Completed - United Kingdom ... More >> Nottingham, United Kingdom, NG11 6JS Less <<
NCT01417845 Type 2 Diabetes Not Applicable Completed - United States, Arkansas ... More >> University of Central Arkansas Conway, Arkansas, United States, 72035 Less <<
NCT01416324 Diabetes Mellitus, Type 2 Phase 1 Completed - United States, Minnesota ... More >> GSK Investigational Site Minneapolis, Minnesota, United States, 55404 Less <<
NCT01398267 Diabetes Mellitus Type 2 Phase 1 Completed - United States, California ... More >> Chula Vista, California, United States, 91911 United States, Nebraska Omaha, Nebraska, United States, 68154 United States, Texas Dallas, Texas, United States, 75247 San Antonio, Texas, United States, 78209 Less <<
NCT01420692 Type 2 Diabetes Mellitus Not Applicable Completed - Turkey ... More >> Ankara University Medical Faculty Dept. of Endocrinology and Metabolism Ankara, Turkey, 06100 Less <<
NCT01418911 - Unknown December 2013 Israel ... More >> Maccabi Healthcare Services Not yet recruiting Tel Aviv, Israel Contact: Liza Cnaani, MA       abarbnel_l@mac.org.il Less <<
NCT01431807 Diabetes Mellitus Phase 3 Completed - Japan ... More >> Akita-shi, Akita, Japan Kisarazu-shi, Chiba, Japan Fukuoka-shi, Fukuoka, Japan Munakata-shi, Fukuoka, Japan Koriyama-shi, Fukushima, Japan Gihu-shi, Gihu, Japan Fukuyama-shi, Hiroshima, Japan Hiroshima-shi, Hiroshima, Japan Eniwa-shi, Hokkaido, Japan Ishikari-shi, Hokkaido, Japan Nakagawa-gun, Hokkaido, Japan Obihiro-shi, Hokkaido, Japan Sapporo-shi, Hokkaido, Japan Kobe-shi, Hyogo, Japan Mito-shi, Ibaragi, Japan Naka-shi, Ibaragi, Japan Takamatsu-shi, Kagawa, Japan Sagamihara-shi, Kanagawa, Japan Yokohama-shi, Kanagawa, Japan Kumamoto-shi, Kumamoto, Japan Tamana-shi, Kumamoto, Japan Kyoto-shi, Kyoto, Japan Nagano-shi, Nagano, Japan Nagawaki-shi, Nagasaki, Japan Oita-shi, Oita, Japan Mino-shi, Osaka, Japan Osaka-shi, Osaka, Japan Sakai-shi, Osaka, Japan Ageo-shi, Saitama, Japan Kawaguchi-shi, Saitama, Japan Koshigaya-shi, Saitama, Japan Kuki-shi, Saitama, Japan Saitama-shi, Saitama, Japan Suntou-gun, Shizuoka, Japan Oyama-shi, Tochigi, Japan Chuo-ku, Tokyo, Japan Koganei-shi, Tokyo, Japan Meguro-ku, Tokyo, Japan Shibuya-ku, Tokyo, Japan Tama-shi, Tokyo, Japan Tiyoda-ku, Tokyo, Japan Less <<
NCT01408888 - Completed - -
NCT01427699 Type 2 Diabetes Phase 2 Completed - Switzerland ... More >> University Hospital of Basel Basel, Switzerland, CH-4031 Less <<
NCT01432938 Diabetes Mellitus, Type 2 Phase 1 Completed - United States, Texas ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Dallas, Texas, United States, 75247 Less <<
NCT01433380 Diabetes Mellitus, Type 2 Phase 1 Completed - United States, Louisiana ... More >> Pfizer Investigational Site Baton Rouge, Louisiana, United States, 70808 Less <<
NCT01427660 Diabetes, Type 2 Not Applicable Completed - United States, Michigan ... More >> Community Health and Social Service (CHASS) Detroit, Michigan, United States, 48209 Less <<
NCT01433406 Diabetes Mellitus Phase 3 Completed - -
NCT01432938 - Completed - -
NCT01433419 Diabetes Mellitus Phase 3 Completed - Japan ... More >> Katori-shi, Chiba, Japan Niihama-shi, Ehime, Japan Chikushino-shi, Fukuoka, Japan Fukuoka-shi, Fukuoka, Japan Onga-gun, Fukuoka, Japan Yukuhashi-shi, Fukuoka, Japan Hiroshima-shi, Hiroshima, Japan Chitose-shi, Hokkaido, Japan Sapporo-shi, Hokkaido, Japan Koga-shi, Ibaragi, Japan Ushiku-shi, Ibaragi, Japan Chigasaki-shi, Kanagawa, Japan Kamakura-shi, Kanagawa, Japan Minamata-shi, Kumamoto, Japan Yatsushiro-shi, Kumamoto, Japan Sasebo-shi, Nagasaki, Japan Kashihara-shi, Nara, Japan Okinawa-shi, Okinawa, Japan Izumi-shi, Osaka, Japan Suita-shi, Osaka, Japan Fujimi-shi, Saitama, Japan Shimotsuga-gun, Tochigi, Japan Komatsushima-shi, Tokushima, Japan Bunkyo-ku, Tokyo, Japan Chiyoda-ku, Tokyo, Japan Mitaka-shi, Tokyo, Japan Shibuya-ku, Tokyo, Japan Shinjuku-ku, Tokyo, Japan Toshima-ku, Tokyo, Japan Shunan-shi, Yamaguchi, Japan Ube-shi, Yamaguchi, Japan Less <<
NCT01433393 Diabetes Mellitus Phase 3 Completed - Japan ... More >> Kisarazu-shi, Chiba, Japan Matsuyama-shi, Ehime, Japan Fukuoka-shi Nishi-ku, Fukuoka, Japan Kasuga-shi, Fukuoka, Japan Naka-shi, Ibaragi, Japan Tsuchiura-shi, Ibaragi, Japan Takamatsu-shi, Kagawa, Japan Kyoto-shi Fushimi-ku, Kyoto, Japan Nagasaki-shi, Nagasaki, Japan Kashihara-shi, Nara, Japan Kashiwara-shi, Osaka, Japan Osaka-shi Tsurumi-ku, Osaka, Japan Sakai-shi Nishi-ku, Osaka, Japan Shimotsuke-shi, Tochigi, Japan Chiyoda-ku, Tokyo, Japan Itabashi-ku, Tokyo, Japan Ota-ku, Tokyo, Japan Shinjuku-ku, Tokyo, Japan Toshima-ku, Tokyo, Japan Less <<
NCT01434186 Diabetes Mellitus, Type 2 Phase 3 Completed - United States, California ... More >> Research Site Los Angeles, California, United States United States, Florida Research Site Tallahassee, Florida, United States United States, Michigan Research Site Dearborn, Michigan, United States United States, Minnesota Research Site St. Paul, Minnesota, United States United States, New York Research Site Mineola, New York, United States United States, Ohio Research Site Cleveland, Ohio, United States United States, Tennessee Research Site Memphis, Tennessee, United States Belgium Research Site Namur, Belgium Canada, Alberta Research Site Calgary, Alberta, Canada India Research Site Bangalore, India Mexico Research Site Aguascalientes, Mexico Research Site Meridas, Mexico Research Site Monterrey, Mexico Research Site Veracruz, Mexico Taiwan Research Site Taichung, Taiwan United Kingdom Research Site Leicester, United Kingdom Less <<
NCT01434186 - Completed - -
NCT01598649 Hypercholesterolemia Not Applicable Completed - Germany ... More >> Friedrich Schiller University Jena, Department of Nutritional Physiology Jena, Thuringia, Germany Less <<
NCT01436201 Diabetes Mellitus, Type 2 Phase 1 Completed - United States, Florida ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Daytona Beach, Florida, United States, 32117 Less <<
NCT01436201 - Completed - -
NCT01427257 Diabetes Mellitus, Type 2 Phase 1 Completed - United States, Minnesota ... More >> Prism Research Saint Paul, Minnesota, United States, 55114 Less <<
NCT01439178 Complications of Diabetes Mell... More >>itus Less << Not Applicable Unknown November 2011 Korea, Republic of ... More >> Seoul Saint Mary's hospital Recruiting Seoul, Korea, Republic of, 137-070 Contact: Won ki Lee , M.D. Ph.D    82-2-2258-1188    wklee@catholic.ac.kr Less <<
NCT02700698 - Completed - United States, Arkansas ... More >> Arkansas Children's Nutrition Center Little Rock, Arkansas, United States, 72202 UAMS Little Rock, Arkansas, United States, 72202 Less <<
NCT02190136 Obesity Insul... More >>in Resistance Less << Not Applicable Completed - United States, New York ... More >> Human Nutrition and Metabolism Laboratory Saratoga Springs, New York, United States, 12866 Less <<
NCT01435980 Type 2 Diabetes Phase 4 Unknown February 2016 China, Chongqing ... More >> Endocrine Department, the south west Hospital of the Third Military Medical University Recruiting Chongqing, Chongqing, China, 400038 Contact: wu qi nan, master    13452867542 ext 02368765216    wqn11@126.com    Principal Investigator: liang zi wen, doctor Less <<
NCT02708394 Adverse Effect of Other Antips... More >>ychotics and Neuroleptics Insulin Resistance Less << Phase 2 Recruiting July 2024 United States, Michigan ... More >> Wayne State University Clinical Research Center Recruiting Detroit, Michigan, United States, 48202 Contact: Jackie Parker          Principal Investigator: Kyle J Burghardt, PharmD Less <<
NCT01449773 Type 2 Diabetes Not Applicable Completed - Canada ... More >> Laval University Quebec, Canada, G1V 0A6 Less <<
NCT01440530 Diabetes Mellitus Type 2 Not Applicable Completed - United States, Pennsylvania ... More >> Geisinger Medical Center Danville, Pennsylvania, United States, 17822 Geisinger Clinic - Gray's Woods Port Matilda, Pennsylvania, United States, 16870 Geisinger Clinic - Kistler Wilkes-Barre, Pennsylvania, United States, 18702 Less <<
NCT01452113 Diabetes Mellitus Phase 2 Completed - France ... More >> UH Toulouse Toulouse, France, 31059 Less <<
NCT01453751 Diabetes Mellitus Type II Not Applicable Withdrawn(company dissolved) December 2017 United States, Florida ... More >> Ageless Regenerative Institute LLC Aventura, Florida, United States, 33180 Less <<
NCT01455883 Type 2 Diabetes Phase 3 Withdrawn July 2014 United States, California ... More >> Intarcia Therapeutics, Inc Hayward, California, United States, 94545 Less <<
NCT01455870 Type 2 Diabetes Phase 3 Completed - -
NCT02697201 Insulin Resistance Early Phase 1 Recruiting February 2021 United States, Louisiana ... More >> Pennington Biomedical Research Center Recruiting Baton Rouge, Louisiana, United States, 70808 Contact: John Kirwan       John.Kirwan@pbrc.edu    Contact: Christopher Axelrod       Christopher.Axelrod@pbrc.edu Less <<
NCT01455896 Type 2 Diabetes Phase 3 Completed - -
NCT01455727 Diabetes Mellitus Not Applicable Completed - Taiwan ... More >> Nantou Hospital Nantou, Taiwan, 540 Less <<
NCT01455857 Type 2 Diabetes Phase 3 Completed - -
NCT01458210 Diabetes Mellitus, Type 2 Phase 1 Completed - United States, Texas ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Dallas, Texas, United States Less <<
NCT01455909 Type 2 Diabetes Phase 3 Withdrawn July 2014 United States, California ... More >> Intarcia Therapeutics, Inc Hayward, California, United States, 94545 Less <<
NCT01456026 Type 2 Diabetes Mellitus Not Applicable Completed - Germany ... More >> Heart and Diabetes Center North-Rhine Westfalia Bad Oeynhausen, NRW, Germany, 32545 Less <<
NCT01455922 Type 2 Diabetes Phase 3 Withdrawn July 2014 United States, California ... More >> Intarcia Therapeutics, Inc Hayward, California, United States, 94545 Less <<
NCT01460368 - Completed - -
NCT01460368 Diabetes Mellitus, Type 2 Phase 1 Completed - United States, Texas ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Dallas, Texas, United States Less <<
NCT01469468 Type 2 Diabetes Mellitus Phase 1 Completed - United States, Florida ... More >> Pfizer Investigational Site South Miami, Florida, United States, 33143 Less <<
NCT01467375 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - Australia, New South Wales ... More >> Novo Nordisk Investigational Site Broadmeadow, New South Wales, Australia, 2292 Australia, Victoria Novo Nordisk Investigational Site Parkville, Victoria, Australia, 3052 Australia Novo Nordisk Investigational Site Ashford, Australia, 5035 Novo Nordisk Investigational Site Auchenflower, Australia, 4066 Novo Nordisk Investigational Site Launceston, Australia, 7250 Novo Nordisk Investigational Site Nowra, Australia, 2540 Novo Nordisk Investigational Site Ringwood, Australia, 3134 Novo Nordisk Investigational Site Rooty Hill, Australia, 2766 Canada Novo Nordisk Investigational Site Hull, Canada, J8Y 1W1 Novo Nordisk Investigational Site London, Canada, N6A 4L6 Novo Nordisk Investigational Site Quebec, Canada, G1V 4G2 Novo Nordisk Investigational Site Saskatoon, Canada, S7N 0W8 Less <<
NCT01458210 - Completed - -
NCT01471808 Diabetes Mellitus, Type 2 Phase 4 Enrolling by invitation December 2021 -
NCT03571048 Obesity Not Applicable Recruiting May 30, 2019 United States, Colorado ... More >> University of Colorado Anschutz Health and Wellness Center Recruiting Aurora, Colorado, United States, 80045 Contact: Corey Rynders, PhD    720-848-6461    TRF-Study@ucdenver.edu Less <<
NCT01154400 Chronic Obstructive Pulmonary ... More >>Disease Less << Not Applicable Completed - United States, Arkansas ... More >> University of Arkansas for Medical Sciences Little Rock, Arkansas, United States, 72205 Less <<
NCT01473329 Diabetes Not Applicable Completed - -
NCT01465152 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 4 Completed - Spain ... More >> Novo Nordisk Investigational Site Barcelona, Spain, 08020 Novo Nordisk Investigational Site Benamargosa, Spain, 29718 Novo Nordisk Investigational Site Burlada, Spain, 31600 Novo Nordisk Investigational Site Camas, Spain, 41900 Novo Nordisk Investigational Site Fuenlabrada, Spain, 28942 Novo Nordisk Investigational Site Gijón, Spain, 33212 Novo Nordisk Investigational Site Granada, Spain, 18012 Novo Nordisk Investigational Site Lugo, Spain, 27004 Novo Nordisk Investigational Site Madrid, Spain, 28021 Novo Nordisk Investigational Site Madrid, Spain, 28030 Novo Nordisk Investigational Site Madrid, Spain, 28035 Novo Nordisk Investigational Site Portugalete, Spain, 48920 Novo Nordisk Investigational Site San Adria del Besos, Spain, 08930 Novo Nordisk Investigational Site Santander, Spain, 39009 Novo Nordisk Investigational Site Santander, Spain, 39011 Novo Nordisk Investigational Site Tegueste, Spain, 38280 Novo Nordisk Investigational Site Valencia, Spain, 46021 Novo Nordisk Investigational Site Zaragoza, Spain, 50007 Less <<
NCT01473017 Type 2 Diabetes ... More >> Anxiety Depression Less << Not Applicable Unknown September 2013 United Kingdom ... More >> Raigmore Hospital Not yet recruiting Inverness, Highlands, United Kingdom, IV2 4NZ Contact: Eleanor Oswald    07584422971    eleanor.oswald@nhs.net Less <<
NCT01474018 Diabetes Mellitus, Type 2 Phase 4 Completed - United States, Texas ... More >> UT Southwestern Medical Center Dallas, Texas, United States, 75390 UT Southwestern Dallas, Texas, United States, 75390 Less <<
NCT01472328 Obesity Non-i... More >>nsulin-dependent Diabetes Mellitus Less << Not Applicable Unknown August 2015 Germany ... More >> Deutsches Diabetes Zentrum Not yet recruiting Düsseldorf, Germany, 40225 Contact: Julia Szendrödi, MD, PhD    0049 0211 3382 203    julia.szendrödi@ddz.uni-duesseldorf.de Less <<
NCT01474161 Type 2 Diabetes ... More >> Diabetes Mellitus, Type 2 Metabolic Diseases Cardiovascular Diseases Obese Dyslipidemia Less << Phase 1 Completed - France ... More >> SGS Aster S.A.S. - Phase I Clinical Unit Paris, France, 75015 Less <<
NCT01475435 Diabetes Mellitus Type 2 Early Phase 1 Unknown August 2013 Brazil ... More >> University of São Paulo Recruiting São Paulo, SP, Brazil, 05508-000 Contact: Luiz Antônio Pugliesi Alves de Lima, PhD    55-11-30917833    lapalima@usp.br    Contact: Ana Paula Sassá Benedete    55-11-30917833    abenedete@gmail.com Less <<
NCT01475552 Diabetes Mellitus Phase 4 Completed - Korea, Republic of ... More >> Seoul National University Bundang Hospital Seongnam, Korea, Republic of Less <<
NCT01480804 Diabetes Not Applicable Completed - United States, Massachusetts ... More >> Beth Isreal Deaconess Medical Center Boston, Massachusetts, United States, 02215 Joslin Diabetes Center Boston, Massachusetts, United States, 02215 Less <<
NCT01483781 Diabetes Mellitus, Type 2 ... More >> Plasma Volume Less << Phase 1 Completed - Germany ... More >> Neuss, Germany Less <<
NCT01484262 - Completed - Germany ... More >> Novo Nordisk Investigational Site Mainz, Germany, 55127 Less <<
NCT01486290 Diabetes Not Applicable Completed - United States, Massachusetts ... More >> Joslin Diabetes Center Boston, Massachusetts, United States, 02215 Less <<
NCT01486862 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 4 Completed - Mexico ... More >> Pachuca, Mexico, 42060 Less <<
NCT01487798 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 4 Completed - United Kingdom ... More >> Novo Nordisk Investigational Site Bolton, United Kingdom, BL1 4QS Novo Nordisk Investigational Site Cardiff, United Kingdom, CF14 4XW Novo Nordisk Investigational Site Derby, United Kingdom, DE7 1DY Novo Nordisk Investigational Site Dundee, United Kingdom, DD1 9SY Novo Nordisk Investigational Site Exeter, United Kingdom, EX2 5AX Novo Nordisk Investigational Site Galway, United Kingdom, EIRE Novo Nordisk Investigational Site Glasgow, United Kingdom, G4 0SF Novo Nordisk Investigational Site Leicester, United Kingdom, LE1 5WW Novo Nordisk Investigational Site Liverpool, United Kingdom, L7 8XP Novo Nordisk Investigational Site London, United Kingdom, NW10 7NS Novo Nordisk Investigational Site London, United Kingdom, SE1 7EH Novo Nordisk Investigational Site Newcastle, United Kingdom, NE7 7DN Novo Nordisk Investigational Site Nottingham, United Kingdom, NG7 2UH Novo Nordisk Investigational Site Sheffield, United Kingdom, S5 7AU Novo Nordisk Investigational Site Upton, United Kingdom, L49 5PE Novo Nordisk Investigational Site Wirral, Merseyside, United Kingdom, CH63 4JY Novo Nordisk Investigational Site York, United Kingdom, YO3 7HE Less <<
NCT01473953 Diabetes Diab... More >>etes Mellitus, Type 2 Healthy Less << Phase 1 Completed - United States, Indiana ... More >> Novo Nordisk Investigational Site Evansville, Indiana, United States, 47710 Less <<
NCT01494298 - Completed - United States, Georgia ... More >> Grady Health System Atlanta, Georgia, United States, 30303 Mercer Univeristy College of Pharmacy and Health Sciences Atlanta, Georgia, United States, 30341 Less <<
NCT01490918 Type-II Diabetes Mellitus Phase 3 Completed - Korea, Republic of ... More >> MedicalExcellence Seoul, Korea, Republic of, 137-701 Less <<
NCT02362906 Pneumonia Not Applicable Unknown - China, Beijing ... More >> Affiliated Children's Hospital of Capital University of Medical Sciences Recruiting Beijing, Beijing, China, 100045 Contact: Kunling Shen, Ph. D    0086-13910727586       Principal Investigator: Kunling Shen, Ph. D          China, Guangdong Guangzhou Children's Hospital Recruiting Guangzhou, Guangdong, China, 510120 Contact: Li Deng, Master's    0086-13711220382       Principal Investigator: Li Deng, Master's          Affiliated hospital of Guangzhou university of Chinese Medicine Recruiting Guangzhou, Guangdong, China, 510405 Contact: Hua Xu, Ph.D    13724885258       China, Guangxi Affiliated Hospital of Guangxi University of Chinese Medicine Recruiting Nanning, Guangxi, China, 530023 Contact: Lining Wang, Ph.D    13607717743       China, Jilin Affiliated Hospital of Changchun University of TCM Recruiting Changchun, Jilin, China, 130103 Contact: Xiaochun Feng, Ph.D    13578696998       China, Liaoning Affiliated Children's Hospital of Dalian Medical University Recruiting Dalian, Liaoning, China, 116044 Contact: Zhenze Cui, Ph. D    0086-13904084058       Principal Investigator: Zhenze Cui, Ph. D          Affiliated Hospital of Liaoning University of TCM Recruiting Shenyang, Liaoning, China, 110032 Contact: Xuefeng Wang, Ph.D.    0086-13840208807       Principal Investigator: Xuefeng Wang, Ph. D          China, Shandong Affiliated Hospital of Shandong University of TCM Recruiting Ji'nan, Shandong, China, 250011 Contact: Yanning Li, Ph. D    0086-13905313077       Principal Investigator: Yanning Li, Ph. D          China, Shanghai Affiliated Longhua Hospital of Shanghai University of TCM Recruiting Shanghai, Shanghai, China, 200032 Contact: Zhiyan Jiang, Bachelor's    0086-13801868578       Principal Investigator: Zhiyan Jiang, Bachelor's          China, Tianjin First teaching hospital of Tianjin university of TCM Recruiting Tianjin, Tianjin, China, 300193 Contact: Rong Ma, Ph.D    13902095399 Less <<
NCT01473953 - Completed - -
NCT01499108 Type 2 Diabetes Phase 4 Completed - Denmark ... More >> Steno Diabetes Center Gentofte, Denmark, 2820 Less <<
NCT01490658 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 1 Completed - United States, Texas ... More >> Novo Nordisk Investigational Site Austin, Texas, United States, 78744 Less <<
NCT01505036 Diabetes Mellitus Not Applicable Completed - Korea, Republic of ... More >> Medicrostar Seoul, Korea, Republic of, 137-701 Less <<
NCT01494298 - Completed - -
NCT01498159 Diabetes Mellitus Not Applicable Completed - United States, Illinois ... More >> University of Illinois Medical Center Chicago, Illinois, United States, 60612 Less <<
NCT01507311 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 1 Completed - Denmark ... More >> Novo Nordisk Investigational Site Århus C, Denmark, 8000 Less <<
NCT01489644 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 1 Completed - United States, Florida ... More >> Novo Nordisk Investigational Site Miami, Florida, United States, 33169 United States, Washington Novo Nordisk Investigational Site Tacoma, Washington, United States, 98418 Less <<
NCT01508858 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 1 Completed - Sweden ... More >> Novo Nordisk Investigational Site Uppsala, Sweden, 75323 Less <<
NCT01507285 Diabetes Diab... More >>etes Mellitus, Type 2 Healthy Less << Phase 1 Completed - United Kingdom ... More >> Novo Nordisk Investigational Site Manchester, United Kingdom, M15 6SH Less <<
NCT01507389 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 1 Completed - Poland ... More >> Warszawa, Poland, 01-201 Less <<
NCT01508949 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 2 Completed - Denmark ... More >> Novo Nordisk Investigational Site Frederiksberg C, Denmark, 1958 Less <<
NCT01510509 Diabetes Mellitus ... More >> Percutaneous Coronary Intervention Less << Phase 4 Unknown - Finland ... More >> Heart Center, Satakunta Hospital, Pori, Finland Satakunta, Pori, Finland, 28500 Spain Hospital de Torrevieja Torrevieja, Alicante, Spain, 03180 Hospital Puerto Real de Cádiz Puerto Real, Cadiz, Spain, 11510 Hospital Universitario Puerta de Hierro Majadahonda Majadahonda, Madrid, Spain, 28222 Hospital Universitario Infanta Cristina Badajoz, Spain, 06006 Hospital Juan Ramón Jiménez de Huelva Huelva, Spain, 21005 Hospital Virgen de la Salud de Toledo Toledo, Spain, 45004 Hospital General Universitario de Valencia Valencia, Spain, 46014 Less <<
NCT01510522 Diabetes Mellitus Type 2 Phase 4 Withdrawn - -
NCT01477944 - Completed - -
NCT03095768 Chronic Disease Not Applicable Completed - United States, Ohio ... More >> Warrensville Heights Senior Center Warrensville Heights, Ohio, United States, 44128 Less <<
NCT01513798 Diabetes Mellitus, Type 2 Not Applicable Completed - Sweden ... More >> Department of Public Health and Clinical Medicine, Medicine Umeå, Sweden, 90187 Less <<
NCT01508806 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 1 Completed - Australia ... More >> Novo Nordisk Investigational Site Christchurch, Australia, 2856 Less <<
NCT01514149 - Terminated(Business decision) - -
NCT01511692 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 1 Completed - Australia, South Australia ... More >> Novo Nordisk Investigational Site Adelaide, South Australia, Australia, 5005 Germany Novo Nordisk Investigational Site Neuss, Germany, 41460 Less <<
NCT01515202 Type 2 Diabetes Mellitus Phase 1 Completed - Japan ... More >> Local Institution Hachioji-Shi, Tokyo, Japan, 1920071 Less <<
NCT01515657 - Completed - -
NCT01516255 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 1 Completed - United States, North Dakota ... More >> Novo Nordisk Investigational Site Fargo, North Dakota, United States, 58104 Less <<
NCT01515657 Diabetes Mellitus, Type 2 Phase 3 Completed - United States, Ohio ... More >> MedPace Clinical Pharmacology Cincinnati, Ohio, United States, 45212 Less <<
NCT01521624 Type 2 Diabetes Mellitus Not Applicable Completed - Iran, Islamic Republic of ... More >> Tehran University of Medical Sciences Tehran, Iran, Islamic Republic of, 13145-784 Less <<
NCT01511042 - Active, not recruiting June 2018 United States, Massachusetts ... More >> Brigham and Women's Hospital- 221 Longwood Avenue Boston, Massachusetts, United States, 02115 Less <<
NCT01514149 Type 2 Diabetes Mellitus (T2DM... More >>) Less << Phase 2 Terminated(Business decision) - -
NCT01207349 - Completed - France ... More >> GHSR Saint Pierre, La Réunion, France, 97448 Less <<
NCT01212133 - Completed - India ... More >> Novo Nordisk Investigational Site Bangalore, India, 560001 Less <<
NCT01211197 - Completed - -
NCT01212198 - Unknown March 2014 Korea, Republic of ... More >> Hanyang University Medical Center Recruiting Kuri, Kyunggi, Korea, Republic of, 471-020 Contact: Yongsoo Park, MD, PhD    +82-31-553-7369    parkys@hanyang.ac.kr    Principal Investigator: Yongsoo Park, MD, PhD          Gachon University Gil Hospital Recruiting In Cheon, Namdong, Korea, Republic of Contact: Ie-Byung Park, MD, PhD    +82-32-460-3213    park712@gilhospital.com    Principal Investigator: Ie-Byung Park, MD, PhD          Yeungnam University Medical Center Recruiting Daegu, Korea, Republic of, 705-717 Contact: Hyoung Woo Lee, MD, PhD    +82-53-620-3839    helee@med.yu.ac.kr    Principal Investigator: Hyoung Woo Lee, MD, PhD          Inha University Hospital Recruiting In Cheon, Korea, Republic of, 400-711 Contact: Moon-Suk Nam, MD, PhD    +82-32-890-3495    namms@inha.ac.kr    Principal Investigator: Moon-Suk Nam, MD, PhD          Pusan National University Hospital Recruiting Pusan, Korea, Republic of, 602-739 Contact: In-Ju Kim, MD, PhD    +82-51-240-7970    injkim@pusan.ac.kr    Principal Investigator: In-Ju Kim, MD, PhD          Cheil General Hospital Recruiting Seoul, Korea, Republic of, 100-380 Contact: SungHoon Kim, MD, PhD    +82-2-2000-7271    hoonie.kim@cgh.co.kr    Principal Investigator: SungHoon Kim, MD, PhD          Kyunghee University Medical Center Recruiting Seoul, Korea, Republic of, 130-702 Contact: Young-Seol Kim, MD, PhD    +82-2-958-8339    kimys@khmc.or.kr    Contact: Suk Chon, MD, PhD    +82-2-958-8843    imdrjs@khu.ac.kr    Sub-Investigator: Jeong-taek Woo, MD, PhD          Principal Investigator: Young-Seol Kim, MD, PhD          Sub-Investigator: Suk Chon, MD, PhD          Sub-Investigator: Seungjoon Oh, MD, PhD          Sub-Investigator: Sung-Woon Kim, MD, PhD          Sub-Investigator: Jin-Woo Kim, MD, PhD          Sub-Investigator: Yun Jung Lee, MD          Sub-Investigator: Moon Chan Choi, MD          Kangdong Sacred Heart Hospital Hallym University Recruiting Seoul, Korea, Republic of, 134-701 Contact: DooMan Kim, MD, PhD    +82-2-2224-2575    dm@hallym.or.kr    Principal Investigator: DooMan Kim, MD, PhD          Inje University Sanggye-Paik Hospital Recruiting Seoul, Korea, Republic of, 139-707 Contact: Kyung Soo Ko, MD, PhD    +82-2-950-1114    kskomd@sanggyepaik.ac.kr    Principal Investigator: Kyung Soo Ko, MD, PhD          Korea University Guro Hospital Recruiting Seoul, Korea, Republic of, 152-730 Contact: Sei Hyun Baik, MD, PhD    +82-2-818-6645    103hyun@korea.ac.kr    Principal Investigator: Sei Hyun Baik, MD, PhD          Kyung Hee University East West Neo Medical Center Recruiting Seoul, Korea, Republic of Contact: Kyu-Jeung Ahn, MD, PhD    +82-2-440-7055    ahn_kyujeung@yahoo.ca    Principal Investigator: Kyu-Jeung Ahn, MD, PhD          Ajou University Medical Center Recruiting Suwon, Korea, Republic of, 443-721 Contact: Kwan-Woo Lee, MD, PhD    +82-31-219-4526    LKW65@ajou.ac.kr    Principal Investigator: Kwan-Woo Lee, MD, PhD Less <<
NCT01215968 Diabetes Mellitus, Type 2 Phase 1 Completed - United Kingdom ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Glasgow, United Kingdom Less <<
NCT01215968 - Completed - -
NCT01211197 Diabetes Mellitus, Type 2 Phase 1 Completed - Germany ... More >> 1276.5.1 Boehringer Ingelheim Investigational Site Biberach, Germany Less <<
NCT01219400 Diabetes Phase 4 Completed - Sweden ... More >> Lund University Lund, Sweden, 22184 Less <<
NCT01220310 Diabetes Mellitus Phase 3 Completed - United States, California ... More >> Alameda County Medical Center Oakland, California, United States, 94602 O'Connor Hospital San Jose, California, United States, 95128 Santa Clara Valley Medical Center San Jose, California, United States, 95128 Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT01223456 - Terminated(Inability to recrui... More >>t adequate number of patients within the specified time period.) Less << - Philippines ... More >> Research Site Batangas City, Batangas, Philippines Research Site Cebu City, Cebu, Philippines Research Site Davao City, Davao, Philippines Research Site Iloilo City, Iloilo, Philippines Research Site Las Pinas City, Manila, Philippines Research Site Makati, Manila, Philippines Research Site Pasig, Manila, Philippines Research Site Quezon City, Manila, Philippines Research Site Mabalacat, Pampanga, Philippines Research Site Manila, Philippines Less <<
NCT01224366 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT01225939 Type 2 Diabetes Mellitus Phase 1 Completed - United Kingdom ... More >> Research Site London Bridge, United Kingdom Less <<
NCT01206725 Diabetes Type 2 Not Applicable Completed - Norway ... More >> Institutt for sirkulasjon og bildediagnostikk, Det medisinske fakultet,NTNU, Postboks 8905 Trondheim, Sør-Trøndelag, Norway, 7491 Less <<
NCT01231308 Type 2 Diabetes Not Applicable Unknown October 2014 United States, New York ... More >> Weill Cornell Medical College Recruiting New York, New York, United States, 10065 Contact: Melissa Marine    212-746-5725    mem9065@med.cornell.edu    Principal Investigator: Francesco Rubino, MD Less <<
NCT01233622 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT01236846 Type 2 Diabetes Mellitus Not Applicable Completed - Iran, Islamic Republic of ... More >> National Nutrition and Food Technology Research Institute Tehran, Iran, Islamic Republic of, 19395-4741 National Nutrition and Food Technology Research Institute Tehran, Iran, Islamic Republic of, 1981619573 Tirang Neyestani Tehran, Iran, Islamic Republic of Tehran, Iran, Islamic Republic of Less <<
NCT00063180 - Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT01040819 Type 2 Diabetes Mellitus Phase 4 Completed - United States, Texas ... More >> Baylor Clinics Houston, Texas, United States, 77030 Baylor College of Medicine HOuston, Texas, United States, 77030 Less <<
NCT01040819 - Completed - -
NCT01043965 Type 2 Diabetes Phase 1 Phase 2 Completed - -
NCT01041768 Diabetes Mellitus Not Applicable Unknown December 2015 Italy ... More >> Azienda Ospedaliera Universitaria "San Martino" Recruiting Genova, Italy, 15067 Contact: Nicola Scopinaro, MD    +39 010 3537301    nicola.scopinaro@unige.it    Principal Investigator: Nicola Scopinaro, MD Less <<
NCT01040806 Diabetes Type 2 Not Applicable Completed - United States, California ... More >> San Francisco General Hospital San Francisco, California, United States, 94110 Less <<
NCT01235429 Type 2 Diabetes Not Applicable Completed - United States, Hawaii ... More >> University of Hawaii Honolulu, Hawaii, United States, 96813 Less <<
NCT01049737 - Completed - Sweden ... More >> Department of Medical and Health Sciences, Linköping University Linköping, Sweden, SE-581 83 Less <<
NCT01051089 Type 2 Diabetes Mellitus Not Applicable Unknown December 2010 Korea, Republic of ... More >> Inha University Hospital Recruiting Incheon, Korea, Republic of Contact: Moonsuk Nam, MD, PhD    82-32-890-3689    namms@inha.ac.kr    Principal Investigator: Moonsuk Nam, MD, PhD Less <<
NCT01228240 Diabetes Mellitus, Type 2 AND ... More >>Metformin Less << Not Applicable Completed - -
NCT01046994 Type 2 Diabetes Mellitus ... More >> Bariatric Surgery Biliopancreatic Diversion Less << Phase 3 Unknown December 2016 Italy ... More >> Ospedale San Martino Recruiting Genova, Italy, 16132 Contact: Nicola Scopinaro, MD    +39 010 3537301    nicola.scopinaro@unige.it    Principal Investigator: Nicola Scopinaro, MD Less <<
NCT01051245 Diabetes Mellitus, Type 2 Not Applicable Completed - Argentina ... More >> Hospital Italiano de Buenos Aires Buenos Aires, Argentina, (C1181ACH) Less <<
NCT01050803 Type 2 Diabetes Mellitus Not Applicable Completed - -
NCT02437812 Epithelial Ovarian Carcinoma Phase 2 Recruiting April 2021 United States, California ... More >> Gynecologic Oncology Associates Recruiting Newport Beach, California, United States, 92663 Contact: Katrina Lopez, CCRC    949-642-5165 ext 259    Katrinal@gynoncology.com Less <<
NCT01060332 - Unknown July 2010 Taiwan ... More >> Taichung Veterans General Hospital Recruiting Taichung, Taiwan, 40705 Contact: Chia-I Tsai, master    886-4-23592525 ext 4755    josepho777@yahoo.com.tw    Principal Investigator: Chia-I Tsai, master Less <<
NCT01061060 Type 2 Diabetes Mellitus ... More >> Peripheral Microvascular Symptoms Less << Phase 4 Completed - Korea, Republic of ... More >> Seoul, Seodaemun-gu, Korea, Republic of, 120-752 Less <<
NCT01055652 Type 2 Diabetes Mellitus Phase 1 Completed - Japan ... More >> Research Site Moriya, Japan Research Site Osaka, Japan Less <<
NCT01068678 - Completed - -
NCT01055808 - Completed - Japan ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hyogo, Japan, 651-0086 Less <<
NCT01068678 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT01068743 Type 2 Diabetes Mellitus Phase 1 Completed - United States, Texas ... More >> PPD Development, LP Austin, Texas, United States, 78744 Less <<
NCT01068730 Type 2 Diabetes Mellitus Phase 1 Completed - United States, Texas ... More >> PPD Development, LP Austin, Texas, United States, 78744 Less <<
NCT01073826 Diabetes Mellitus, Type 2 ... More >> Obesity Less << Not Applicable Completed - Switzerland ... More >> University Hospital Zurich Zurich, Switzerland Less <<
NCT01068743 - Completed - -
NCT01068756 Type 2 Diabetes Mellitus Phase 1 Terminated - United States, Texas ... More >> Ppd Development Austin, Texas, United States, 78744 Less <<
NCT01068730 - Completed - -
NCT01077505 Diabetes Mellitus, Type 2 Phase 1 Completed - United States, Texas ... More >> GSK Investigational Site Austin, Texas, United States, 78744 Less <<
NCT01076023 - Unknown March 2013 China, Shanghai ... More >> Weiqing Wang Shanghai, Shanghai, China, 200025 Less <<
NCT01076647 - Completed - -
NCT01079195 - Completed - -
NCT01079637 Diabetes Mellitus 1 or 2 ... More >> Midfoot Charcot Neuroarthropathy Less << Not Applicable Terminated(The study was stopp... More >>ed because there were not enough eligible patients to complete the study.) Less << - Germany ... More >> Dept. of Trauma and Reconstructive Surgery, University of Rostock Rostock, Germany, 18055 Less <<
NCT01079195 - Completed - -
NCT01081938 Diabetes Mellitus, Type 2 Phase 4 Terminated(Recruitment challen... More >>ges) Less << - Brazil ... More >> Sanofi-Aventis Investigational Site Number 076-007 Belo Horizonte, Brazil, 30150-120 Sanofi-Aventis Investigational Site Number 076-011 Curitiba, Brazil, 80420-011 Sanofi-Aventis Investigational Site Number 076-005 Joinville, Brazil Sanofi-Aventis Investigational Site Number 076-001 Porto Alegre, Brazil, 90035-001 Sanofi-Aventis Investigational Site Number 076-004 Porto Alegre, Brazil, 90035-003 Sanofi-Aventis Investigational Site Number 076-006 São José do Rio Preto, Brazil, 15090-000 Sanofi-Aventis Investigational Site Number 076-010 São Paulo, Brazil, 01232-010 Sanofi-Aventis Investigational Site Number 076-008 São Paulo, Brazil, 01308-050 Sanofi-Aventis Investigational Site Number 076-003 São Paulo, Brazil, 01323-020 Sanofi-Aventis Investigational Site Number 076-009 São Paulo, Brazil, 01323-900 Less <<
NCT01080976 - Completed - -
NCT01076647 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT01082120 Type 2 Diabetes Mellitus Phase 1 Completed - United States, California ... More >> Research Site Chula Vista, California, United States Less <<
NCT01084850 - Unknown September 2010 Denmark ... More >> Frederiksberg University Eye Clinque Recruiting Frederiksberg, Denmark, 2000 Contact: Allan Storr-Paulsen, MD    +4538163646    allanstorr@dadlnet.dk Less <<
NCT01086306 - Completed - -
NCT02203461 Insulin Resistance Phase 1 Completed - Germany ... More >> University Hospital Klinikum rechts der Isar (TUM) Munich, Bavaria, Germany, 81675 Less <<
NCT01080976 - Completed - United States, Massachusetts ... More >> Charles Safran Brookline, Massachusetts, United States, 02446 Less <<
NCT02621086 Obesity Not Applicable Active, not recruiting April 2019 United Kingdom ... More >> David Greenfield Human Physiology Unit Nottingham, Notts, United Kingdom, NG72UH Less <<
NCT01087541 Diabetes Mellitus Not Applicable Completed - Spain ... More >> Primary Health Care. Catalan Health Institute. Tarragona-Reus Reus, Tarragona, Spain, 43202 Less <<
NCT01087541 - Completed - -
NCT01086280 - Completed - -
NCT01085292 Type 2 Diabetes Mellitus Phase 1 Phase 2 Completed - Germany ... More >> CTC North MediGate GmbH Hamburg, Germany, 20246 Medizinische Hochschule Hannover Hannover, Germany, 30625 Itecra GmbH Köln, Germany, 50931 ikfe GmbH Mainz, Germany, 55116 Profil Institut fuer Stoffwechselforschung GmbH Neuss, Germany, D-41460 Less <<
NCT01091909 Type 2 Diabetes Not Applicable Completed - Brazil ... More >> School of Dentistry of University of São Paulo São Paulo, SP, Brazil, 055508-000 Less <<
NCT01092806 Post Transplant Diabetes Melli... More >>tus Less << Phase 4 Completed - Norway ... More >> Oslo univeristy hospital, Rikshospitalet Oslo, Norway, 0027 Less <<
NCT01095965 Diabetes Mellitus, Type II [No... More >>n-insulin Dependent Type] [NIDDM Type] Uncontrolled Less << Not Applicable Completed - South Africa ... More >> Moretele Health Sub-District Hammanskraal, North West Province, South Africa, 0400 Less <<
NCT01087645 Diabetes Diab... More >>etes Mellitus, Type 2 Healthy Less << Phase 1 Completed - United Kingdom ... More >> Novo Nordisk Investigational Site Nottingham, United Kingdom, NG11 6JS Less <<
NCT01088594 Type 2 Diabetes Mellitus Phase 1 Completed - United Kingdom ... More >> S337.1.004 Site # London, United Kingdom Less <<
NCT01095068 Type 2 Diabetes Mellitus Not Applicable Terminated - France ... More >> Médecine Interne et Nutrition, Hôpital Civil, Hôpitaux universitaires de Strasbourg Strasbourg, France, 67091 Service de Physiologie et d'Explorations Fonctionnelles, Nouvel Hôpital Civil, Hôpitaux universitaires de Strasbourg Strasbourg, France, 67091 Service de Médecine Interne et Nutrition, Hôpital de Hautepierre, Hôpitaux universitaires de Strasbourg Strasbourg, France, 67098 Less <<
NCT01096277 Type 2 Diabetes Mellitus Phase 4 Unknown December 2012 Germany ... More >> Hannover Medical School Not yet recruiting Hannover, Germany, 30625 Contact: Sajoscha A. Sorrentino, MD       sorrentino.sajoscha@mh-hannover.de    Principal Investigator: Sajoscha A. Sorrentino, MD Less <<
NCT00427388 Cardiac Surgical Procedures ... More >> Cardiopulmonary Bypass Systemic Inflammatory Response Syndrome Less << Phase 4 Unknown August 2014 Canada, Ontario ... More >> Hamilton General Hospital Hamilton, Ontario, Canada, L8L 2X2 Less <<
NCT01101568 Diabetes Mellitus, Type 2 Phase 1 Completed - United States, Texas ... More >> GSK Investigational Site Austin, Texas, United States, 78744 Less <<
NCT01102699 Diabetes Mellitus Phase 4 Completed - Italy ... More >> University Hospital, Division of Metabolic Diseases Padova, Italy, 35100 Less <<
NCT01095991 Type 2 Diabetes Mellitus Phase 1 Completed - Germany ... More >> Research Site Neuss, Germany Less <<
NCT01105429 Diabetes Mellitus, Non-Insulin... More >>-Dependent Less << Phase 1 Completed - United States, California ... More >> Profil Institute For Clinical Research, Inc. (Picr) Chula Vista, California, United States, 91911 United States, Florida Clinical Pharmacology Of Miami Inc. Miami, Florida, United States, 33014 Elite Research Institute Miami, Florida, United States, 33169 Less <<
NCT01099163 Type 2 Diabetes Mellitus Not Applicable Completed - Iran, Islamic Republic of ... More >> Taleghani Hospital Tehran, Iran, Islamic Republic of, 1981619573 Less <<
NCT01102959 Diabetes Mellitus Not Applicable Unknown June 2010 Brazil ... More >> University of São Paulo General Hospital Recruiting São Paulo, Brazil, 05403000 Contact: Alexandre A. Ferraro, PHD    ( 5511) 30698672    ferraro@usp.br    Principal Investigator: Adriana S. Gandolfo, Dietitian Less <<
NCT01114438 Type 2 Diabetes ... More >> Obesity Less << Not Applicable Completed - United Kingdom ... More >> Imperial College/St. Mary's Hospital London, United Kingdom Trafford General Hospital/NOSC Manchester, United Kingdom Southampton General Hospital Southampton, United Kingdom Less <<
NCT01113671 Diabetes Mellitus Type 2 Phase 2 Phase 3 Completed - Israel ... More >> Laboratory of Vascular Medicine, Technion Faculty of Medicine Haifa, Israel Less <<
NCT01117103 - Completed - Singapore ... More >> Kevin Tan Clinic For Diabetes, Thyroid & Hormones Pte Ltd Mount Elizabeth, Singapore Less <<
NCT01107886 Type 2 Diabetes Mellitus Phase 4 Completed - -
NCT01127269 Diabetes Mellitus, Type 2 Phase 4 Completed - Argentina ... More >> Investigational Site Number 10 C.a.b.a., Argentina, C1050AAK Investigational Site Number 14 C.a.b.a., Argentina, C1419AHN Investigational Site Number 01 C.a.b.a., Argentina Investigational Site Number 11 C.a.b.a., Argentina Investigational Site Number 12 C.a.b.a., Argentina Investigational Site Number 17 C.a.b.a., Argentina Investigational Site Number 9 C.a.b.a., Argentina Investigational Site Number 03 Caba, Argentina Investigational Site Number 06 Caba, Argentina Investigational Site Number 15 Caba, Argentina Investigational Site Number 16 Caba, Argentina Investigational Site Number 18 Caba, Argentina Investigational Site Number 26 Capital Federal, Argentina Investigational Site Number 22 Mar del Plata, Argentina, 7600 Investigational Site Number 13 Mar del Plata, Argentina, B7602CBM Investigational Site Number 02 Mar del Plata, Argentina Investigational Site Number 021 Moreno -Pcia. de Bs. As.-, Argentina Investigational Site Number 07 Morón, Argentina Investigational Site Number 04 Paraná, Argentina Investigational Site Number 8 Salta, Argentina Investigational Site Number 05 Sarandí, Argentina Investigational Site Number 20 Tandil, Argentina, 7000 Investigational Site Number 25 Zárate, Argentina, 2800 Less <<
NCT01135901 Diabetes Mellitus Type 2 ... More >> Obesity Less << Not Applicable Active, not recruiting December 2018 Norway ... More >> Vaernesregionen: Meraker, Stjørdal, Selbu, Tydal Stjørdal, Norway Less <<
NCT01131676 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT01142297 Partially Edentulous Mandible ... More >> Type 2 Diabetes Less << Not Applicable Completed - United States, Texas ... More >> University of Texas Health Science Center at San Antonio San Antonio, Texas, United States, 78229-3900 Less <<
NCT01107886 - Completed - -
NCT01127308 Type 2 Diabetes Mellitus (T2DM... More >>) Less << Phase 1 Completed - -
NCT01123239 Diabetes Mellitus, Type 2 Not Applicable Completed - United States, California ... More >> Mary and Dick Allen Diabetes Center at Hoag Hospital Newport Beach, California, United States, 92663 University of California Irvine Medical Center Orange, California, United States, 92868 Westminster Medical Center Westminster, California, United States, 92683 Less <<
NCT01131676 - Completed - -
NCT01142297 - Completed - -
NCT01114438 - Completed - -
NCT01142895 - Completed - -
NCT02291406 Insulin Resistance Not Applicable Unknown July 2015 Sweden ... More >> Örebro Univeristy Hospital Recruiting Örebro, Sweden Contact: Lena Wijk, MD    +46196022040    lena.wijk@oru.se    Contact: Kerstin Nilsson, MD, PhD    +46196022389    kerstin.nilsson@orebroll.se Less <<
NCT01143870 Diabetes Mellitus Not Applicable Completed - United States, Pennsylvania ... More >> University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT01146886 Diabetes Mellitus, Type 2 Phase 1 Completed - Germany ... More >> 1283.1.1 Boehringer Ingelheim Investigational Site Biberach, Germany Less <<
NCT01143870 - Completed - -
NCT01144338 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT01147731 Diabetes Mellitus, Type 2 Phase 1 Completed - United States, Texas ... More >> GSK Investigational Site Austin, Texas, United States, 78744 Less <<
NCT01147718 Diabetes Mellitus, Type 2 Phase 1 Completed - United States, Texas ... More >> GSK Investigational Site Austin, Texas, United States, 78744 Less <<
NCT01154348 Type 2 Diabetes Mellitus Phase 1 Completed - United States, Texas ... More >> Dennis Ruff, MD San Antonio, Texas, United States, 78209 Less <<
NCT01158625 Diabetes Mellitus, Type 2 ... More >> Hypertension Less << Not Applicable Completed - Denmark ... More >> Aarhus University Hospital Aarhus, Denmark, 8000 Regional Hospital Silkeborg Silkeborg, Denmark, 8600 Less <<
NCT01167881 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT01154413 Diabetes Mellitus Type 2 Not Applicable Completed - -
NCT01144338 - Completed - -
NCT01165190 - Unknown - United States, Arizona ... More >> Clinical Research Unit Recruiting 550 East Orange Street, Arizona, United States, 85287 Contact: Christian Meyer, MD    (480) 965-2473    Christian.Meyer@asu.edu Less <<
NCT01151293 - Completed - -
NCT01147692 Diabetes Mellitus, Type 2 Phase 1 Completed - United States, Texas ... More >> GSK Investigational Site Austin, Texas, United States, 78744 Less <<
NCT02335021 Impairment of Oral Perception ... More >> Insulin Resistance Less << Not Applicable Recruiting February 2019 United States, Connecticut ... More >> The John B Pierce Laboratory Recruiting New Haven, Connecticut, United States, 06519 Principal Investigator: Dana M Small, PhD Less <<
NCT01167881 - Completed - -
NCT01176656 - Completed - -
NCT01179048 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT01179815 - Recruiting January 2099 Switzerland ... More >> Universitätspoliklinik für Endokrinologie, Diabetologie und Klinische Ernährung, Inselspital Bern Recruiting Bern, Switzerland, 3010 Contact: Christoph Stettler, Prof    +41 31 632 40 70    christoph.stettler@insel.ch    Principal Investigator: Christoph Stettler, Prof.          Sub-Investigator: Peter Diem, Prof.          Sub-Investigator: Katja Müller-Fischer, Dr. med.          Sub-Investigator: Markus Laimer, PD Dr. med.          Klinik für Endokrinologie, Diabetologie, Osteologie und Stoffwechselerkrankungen, Kantonsspital St.Gallen Recruiting St. Gallen, Switzerland, 9007 Principal Investigator: Michael Brändle, Prof. Dr. med., M.Sc.          Sub-Investigator: Katrin Schimke, Dr. med.          Klinik für Endokrinologie, Diabetologie und Klinische Ernährung, Universitätsspital Zürich Recruiting Zürich, Switzerland, 8091 Principal Investigator: Roger Lehmann, Prof. Dr. med.          Sub-Investigator: Jan Krützfeld, Prof. Dr. med.          Sub-Investigator: Giatgen Spinas, Prof. Dr. med.          Sub-Investigator: Philipp Gerber, PD Dr. med. Less <<
NCT01172743 - Suspended(Closed Administrativ... More >>ely) Less << December 2020 Qatar ... More >> Hamad Medical Corporation Doha, Qatar Less <<
NCT01183715 Diabetes Mellitus, Type 2 Phase 1 Completed - United States, Connecticut ... More >> Pfizer Investigational Site New Haven, Connecticut, United States, 06511 Less <<
NCT01186354 Diabetes Mellitus, Type 2 Not Applicable Completed - United States, North Carolina ... More >> Duke University Medical Center Durham, North Carolina, United States, 27708 Less <<
NCT02353416 Type 2 Diabetes ... More >> Insulin Resistance Obesity Cardiovascular Disease Less << Not Applicable Completed - Italy ... More >> Laboratory of Epidemiology and Biostatistics, IRCCS Saverio de Bellis Castellana Grotte, BA, Italy, 70013 Laboratory of Epidemiology and Biostatistics Castellana Grotte, BA, Italy, 70013 Less <<
NCT01192139 Diabetes Mellitus Phase 1 Completed - United States, Texas ... More >> Ppd Development, Lp Austin, Texas, United States, 78744 Less <<
NCT01179048 - Completed - -
NCT01182701 Type 2 Diabetes Not Applicable Completed - United States, Hawaii ... More >> University of Hawaii School of Nursing & Dental Hygiene Honolulu, Hawaii, United States, 96822 Less <<
NCT01192139 - Completed - -
NCT01187069 Type 2 Diabetes Not Applicable Completed - Denmark ... More >> Department of General Practice, School of Public Health, Aarhus University Aarhus, Denmark, 8000 Less <<
NCT01193179 Diabetes, Type 2 Phase 3 Completed - Japan ... More >> Kanto Rigeon, Japan Kinki Region, Japan Kyushu Region, Japan Tohoku Region, Japan Less <<
NCT01186965 Type 2 Diabetes Not Applicable Completed - United States, North Carolina ... More >> Duke University Medical Center Durham, North Carolina, United States, 27710 Less <<
NCT01192152 - Completed - -
NCT01193218 Diabetes Mellitus, Type 2 Phase 2 Completed - Japan ... More >> 1245.38.016 Boehringer Ingelheim Investigational Site Chiyoda-ku, Tokyo, Japan 1245.38.001 Boehringer Ingelheim Investigational Site Chuo-ku, Tokyo, Japan 1245.38.003 Boehringer Ingelheim Investigational Site Chuo-ku, Tokyo, Japan 1245.38.002 Boehringer Ingelheim Investigational Site Hachioji, Tokyo, Japan 1245.38.010 Boehringer Ingelheim Investigational Site Hanamaki, Iwate, Japan 1245.38.005 Boehringer Ingelheim Investigational Site Kamakura, Kanagawa, Japan 1245.38.020 Boehringer Ingelheim Investigational Site Kanazawa, Ishikawa, Japan 1245.38.013 Boehringer Ingelheim Investigational Site Kashiwa, Chiba, Japan 1245.38.019 Boehringer Ingelheim Investigational Site Katsushika-ku, Tokyo, Japan 1245.38.021 Boehringer Ingelheim Investigational Site Kyoto, Kyoto, Japan 1245.38.024 Boehringer Ingelheim Investigational Site Matsuyama, Ehime, Japan 1245.38.004 Boehringer Ingelheim Investigational Site Minato-ku, Tokyo, Japan 1245.38.011 Boehringer Ingelheim Investigational Site Moriya, Ibaraki, Japan 1245.38.030 Boehringer Ingelheim Investigational Site Naha, Okinawa, Japan 1245.38.032 Boehringer Ingelheim Investigational Site Okawa, Fukuoka, Japan 1245.38.031 Boehringer Ingelheim Investigational Site Okinawa, Okinawa, Japan 1245.38.025 Boehringer Ingelheim Investigational Site Saga, Saga, Japan 1245.38.014 Boehringer Ingelheim Investigational Site Saitama, Saitama, Japan 1245.38.006 Boehringer Ingelheim Investigational Site Sapporo, Hokkaido, Japan 1245.38.007 Boehringer Ingelheim Investigational Site Sapporo, Hokkaido, Japan 1245.38.008 Boehringer Ingelheim Investigational Site Sapporo, Hokkaido, Japan 1245.38.009 Boehringer Ingelheim Investigational Site Sapporo, Hokkaido, Japan 1245.38.012 Boehringer Ingelheim Investigational Site Sasima-gun, Ibaraki, Japan 1245.38.015 Boehringer Ingelheim Investigational Site Shinjuku-ku, Tokyo, Japan 1245.38.018 Boehringer Ingelheim Investigational Site Shinjuku-ku, Tokyo, Japan 1245.38.017 Boehringer Ingelheim Investigational Site Suginami-ku, Tokyo, Japan 1245.38.022 Boehringer Ingelheim Investigational Site Suita, Osaka, Japan 1245.38.023 Boehringer Ingelheim Investigational Site Ube, Yamaguchi, Japan 1245.38.026 Boehringer Ingelheim Investigational Site Urasoe, Okinawa, Japan 1245.38.027 Boehringer Ingelheim Investigational Site Urasoe, Okinawa, Japan 1245.38.028 Boehringer Ingelheim Investigational Site Urasoe, Okinawa, Japan 1245.38.029 Boehringer Ingelheim Investigational Site Urasoe, Okinawa, Japan Less <<
NCT01192152 Diabetes Mellitus Phase 1 Completed - United States, Texas ... More >> PPD Development, LP Austin, Texas, United States, 78744 Less <<
NCT01193218 - Completed - -
NCT01195259 - Completed - -
NCT01196728 Type II Diabetes Mellitus Phase 1 Completed - Germany ... More >> Parexel International GmbH Berlin, Germany, 14050 Less <<
NCT01196546 Type 2 Diabetes Mellitus Phase 4 Completed - Thailand ... More >> BMA Medical College and Vajira Hospital Bangkok, Thailand King Chulalongkorn Memorial Hospital Bangkok, Thailand Phamongkutklao Hospital Bangkok, Thailand Police General Hospital Bangkok, Thailand Siriraj Hospital Bangkok, Thailand Khon Kaen Hospital Khon Kaen, Thailand Fort Suranaree Hospital Nakhon Ratchasima, Thailand Maharat Nakhon Ratchasima Hospital Nakhon Ratchasima, Thailand Less <<
NCT01853332 - Completed - -
NCT01427452 - Completed - United States, Arizona ... More >> University of Arizona Tucson, Arizona, United States United States, Iowa University of Iowa Iowa City, Iowa, United States United States, Maine Maine Medical Center Portland, Maine, United States United States, Massachusetts Beth Israel Deaconess Medical Center Boston, Massachusetts, United States United States, New York Montefiore Medical Center Bronx, New York, United States United States, Ohio Cleveland Clinic Cleveland, Ohio, United States United States, Rhode Island Rhode Island Hospital Providence, Rhode Island, United States Less <<
NCT01853332 - Completed - United States, Massachusetts ... More >> Judge Baker Children's Center Boston, Massachusetts, United States, 02120 Less <<
NCT01204294 Diabetes Mellitus, Type 2 Phase 3 Completed - Japan ... More >> 1218.78.008 Boehringer Ingelheim Investigational Site Akishima, Tokyo, Japan 1218.78.030 Boehringer Ingelheim Investigational Site Amagasaki, Hyogo, Japan 1218.78.017 Boehringer Ingelheim Investigational Site Annaka, Gunma, Japan 1218.78.006 Boehringer Ingelheim Investigational Site Aomori, Aomori, Japan 1218.78.007 Boehringer Ingelheim Investigational Site Aomori, Aomori, Japan 1218.78.009 Boehringer Ingelheim Investigational Site Chuo-ku, Tokyo, Japan 1218.78.013 Boehringer Ingelheim Investigational Site Chuo-ku, Tokyo, Japan 1218.78.032 Boehringer Ingelheim Investigational Site Fukuoka, Fukuoka, Japan 1218.78.040 Boehringer Ingelheim Investigational Site Fukuoka, Fukuoka, Japan 1218.78.037 Boehringer Ingelheim Investigational Site Higashi Osaka, Osaka, Japan 1218.78.043 Boehringer Ingelheim Investigational Site Hitachinaka, Ibaraki, Japan 1218.78.019 Boehringer Ingelheim Investigational Site Isesaki, Gunma, Japan 1218.78.036 Boehringer Ingelheim Investigational Site Kashiwara, Osaka, Japan 1218.78.026 Boehringer Ingelheim Investigational Site Kasugai, Aichi, Japan 1218.78.038 Boehringer Ingelheim Investigational Site Kawachinagano, Osaka, Japan 1218.78.021 Boehringer Ingelheim Investigational Site Kitaazumi-gun, Nagano, Japan 1218.78.022 Boehringer Ingelheim Investigational Site Matsumoto, Nagano, Japan 1218.78.033 Boehringer Ingelheim Investigational Site Matsumoto, Nagano, Japan 1218.78.012 Boehringer Ingelheim Investigational Site Meguro-ku, Tokyo, Japan 1218.78.041 Boehringer Ingelheim Investigational Site Meguro-ku, Tokyo, Japan 1218.78.034 Boehringer Ingelheim Investigational Site Morioka, Iwate, Japan 1218.78.035 Boehringer Ingelheim Investigational Site Morioka, Iwate, Japan 1218.78.018 Boehringer Ingelheim Investigational Site Moriya, Ibaraki, Japan 1218.78.024 Boehringer Ingelheim Investigational Site Nagoya, Aichi, Japan 1218.78.025 Boehringer Ingelheim Investigational Site Nagoya, Aichi, Japan 1218.78.027 Boehringer Ingelheim Investigational Site Nagoya, Aichi, Japan 1218.78.028 Boehringer Ingelheim Investigational Site Nagoya, Aichi, Japan 1218.78.031 Boehringer Ingelheim Investigational Site Nagoya, Aichi, Japan 1218.78.039 Boehringer Ingelheim Investigational Site Oita, Oita, Japan 1218.78.004 Boehringer Ingelheim Investigational Site Okinawa, Okinawa, Japan 1218.78.016 Boehringer Ingelheim Investigational Site Sagae, Yamagata, Japan 1218.78.001 Boehringer Ingelheim Investigational Site Sapporo, Hokkaido, Japan 1218.78.020 Boehringer Ingelheim Investigational Site Sapporo, Hokkaido, Japan 1218.78.042 Boehringer Ingelheim Investigational Site Sapporo, Hokkaido, Japan 1218.78.005 Boehringer Ingelheim Investigational Site Shimajiri-gun, Okinawa, Japan 1218.78.014 Boehringer Ingelheim Investigational Site Shinjuku-ku, Tokyo, Japan 1218.78.002 Boehringer Ingelheim Investigational Site Shinjyuku-ku. Tokyo, Japan 1218.78.011 Boehringer Ingelheim Investigational Site Shizuoka, Shizuoka, Japan 1218.78.003 Boehringer Ingelheim Investigational Site Suita, Osaka, Japan 1218.78.023 Boehringer Ingelheim Investigational Site Tokorozawa, Saitama, Japan 1218.78.029 Boehringer Ingelheim Investigational Site Tokorozawa, Saitama, Japan 1218.78.010 Boehringer Ingelheim Investigational Site Tsuchiura, Ibaraki, Japan 1218.78.015 Boehringer Ingelheim Investigational Site Yamagata, Yamagata, Japan Less <<
NCT02370043 Healthy Volunteers ... More >> Insulin Resistance Less << Phase 1 Completed - Canada, Quebec ... More >> Inventiv Montreal, Quebec, Canada, H3X 2Hp Canada inVentiv Quebec, Canada, G1P 0A2 Less <<
NCT01197092 Diabetes Mellitus, Type II Phase 2 Unknown January 2011 Germany ... More >> CFI Centrum für Integrative Medizin Recruiting Speyer, Germany, D-67346 Contact: Rainer Mutschler, MD    06232 - 28 90 88 0    mutschler@cfi-speyer.de    Principal Investigator: Rainer Mutschler, MD Less <<
NCT01204775 Type 2 Diabetes Phase 3 Completed - United States, California ... More >> Research Site Los Angeles, California, United States Research Site San Diego, California, United States United States, Florida Research Site Hollywood, Florida, United States Research Site Tallahassee, Florida, United States Research Site Tampa, Florida, United States United States, Michigan Research Site Dearborn, Michigan, United States United States, New York Research Site Buffalo, New York, United States United States, Tennessee Research Site Memphis, Tennessee, United States United States, Virginia Research Site Richmond, Virginia, United States Russian Federation Research Site Moscow, Russian Federation Research Site Novosibirsk, Russian Federation Research Site Saint Petersburg, Russian Federation South Africa Research Site Cape Town, South Africa Research Site Pretoria, South Africa Taiwan Research Site Taichung, Taiwan Research Site Taipei, Taiwan Less <<
NCT01202266 Diabetes Mellitus, Type 2 Phase 1 Terminated(The study was termi... More >>nated on October 29, 2010 due to gastrointestinal adverse events.) Less << - United States, Connecticut ... More >> Pfizer Investigational Site New Haven, Connecticut, United States, 06511 Less <<
NCT01204775 - Completed - -
NCT01206322 Type 2 Diabetes Mellitus Phase 2 Completed - United States, Massachusetts ... More >> Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Less <<
NCT01206322 - Completed - -
NCT01206400 - Unknown January 2012 India ... More >> PGIMER Recruiting Chandigarh, India, 160012 Contact: Dr sridhar subbiah, MD    9914411026    drsridharjipmer@gmail.com    Principal Investigator: Dr Anil Bhansali, MD.DM Less <<
NCT01244646 - Terminated - Netherlands ... More >> Research Site Alkmaar, Netherlands Research Site Den Haag, Netherlands Research Site Edam, Netherlands Research Site Gorinchem, Netherlands Research Site Heerhugowaard, Netherlands Research Site Heiloo, Netherlands Research Site Hoogvliet, Netherlands Research Site Lichtenvoorde, Netherlands Research Site Limmen, Netherlands Research Site Maasbracht, Netherlands Research Site Noord-Scharwoude, Netherlands Research Site Poortvliet, Netherlands Research Site Rotterdam, Netherlands Research Site Spijkenisse, Netherlands Research Site Tuitjenhorn, Netherlands Research Site Vaassen, Netherlands Research Site Valkenswaard, Netherlands Research Site Voerendaal, Netherlands Research Site Volendam, Netherlands Research Site Wamel, Netherlands Research Site Zuid-Scharwoude, Netherlands Research Site Zutphen, Netherlands Less <<
NCT01204294 - Completed - -
NCT01244971 Diabetes Mellitus Type 2 Phase 4 Completed - Sweden ... More >> Enheten för Metabol Kontroll, Endokrinkliniken, Karolinska University Hospital Stockholm, Sweden, 17176 Less <<
NCT01240070 Type 2 Diabetes Phase 4 Unknown December 2011 Italy ... More >> Francesco Giorgino Bari, Italy Maria Dolci Carrara, Italy Lamberto De Giorgio La Spezia, Italy Giuseppe Derosa Pavia, Italy PierPaolo DeFeo Perugia, Italy Donatella Zavaroni Piacenza, Italy Roberto Miccoli Pisa, Italy Giovanni Ghirlanda Roma, Italy Mariela Trovati Torino, Italy Less <<
NCT01239849 Diabetes Mellitus, Hypercholes... More >>sterolemia Less << Phase 4 Unknown February 2011 Korea, Republic of ... More >> Sung Rae Kim Recruiting Bucheon, Kyeongki, Korea, Republic of, 420-717 Contact: SUNG RAE KIM, A. Professor    +82-32-340-2025    kimsungrae@catholic.ac.kr    Principal Investigator: JAE HYUNG CHO, Professor          Principal Investigator: KI HO SONG, Professor          Principal Investigator: SEUNG JUN OH, Professor          Principal Investigator: HYE SOON KIM, Professor          Principal Investigator: KYUNG MOOK CHOI, Professor          Principal Investigator: IN JOO KIM, Professor          Principal Investigator: SOO KYOUNG KIM, Professor          Principal Investigator: SUNG HEE CHOI, Professor          Principal Investigator: JONG WHA KIM, Professor          Principal Investigator: CHAN HEE JUNG, Professor          Principal Investigator: MIN KYOUNG MOON, Professor          Principal Investigator: HYE JIN KIM, Professor          Principal Investigator: YOUNG IL KIM, Professor          Principal Investigator: KANG SEO PARK, Professor          Principal Investigator: DONG JOON KIM, Professor          Principal Investigator: SANG YOUNG KIM, Professor          Principal Investigator: CHANG BUM LEE, Professor Less <<
NCT01247896 Diabetes Mellitus, Type II Phase 1 Completed - Belgium ... More >> Pfizer Investigational Site Bruxelles, Belgium, B-1070 Less <<
NCT01251016 - Unknown July 2016 Brazil ... More >> Clinics Hospital of the University of São Paulo Medical School Recruiting São Paulo, Brazil, 05403-000 Contact: Clinics Hospital FMUSP    +55 11 30696000    webmaster@hcnet.usp.br Less <<
NCT01250639 - Unknown December 2013 Taiwan ... More >> China Medical University Hospital Recruiting Taichung, Taiwan, 40447 Contact: Fuu-Jen Tsai, PHD    886-4-22052121 ext 2041    yhliang@mail.cmuh.org.tw Less <<
NCT01251757 Diabetes Mellitus ... More >> Cardiovascular Disease Less << Not Applicable Completed - United States, Georgia ... More >> Center for Health Research, Kaiser Permanente Southeast Atlanta, Georgia, United States, 30305 United States, Hawaii Center for Health Research, Kaiser Permanente Hawaii Honolulu, Hawaii, United States, 96817 United States, Oregon Center for Health Research, Kaiser Permanente Northwest Portland, Oregon, United States, 97227 Less <<
NCT01251497 Type 2 Diabetes, Hispanic/Lati... More >>nos, Diabetes Self-management Education Less << Early Phase 1 Completed - -
NCT01251757 - Completed - -
NCT01257334 Type 2 Diabetes Phase 3 Unknown July 2012 Taiwan ... More >> Taipei Medical University - WanFang Hospital Taipei, Taiwan Less <<
NCT01252524 Diabetes Mellitus Type II Not Applicable Completed - United States, North Carolina ... More >> East Carolina University Family Medicine Center Greenville, North Carolina, United States, 27834 Less <<
NCT01253304 - Completed - -
NCT01259206 - Completed - Turkey ... More >> Gulhane School of Medicine Etlik Ankara, Turkey, 06600 Less <<
NCT01269996 Type 2 Diabetes Mellitus Phase 4 Completed - Hong Kong ... More >> Department of Medicine & Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong Hong Kong, Hong Kong Less <<
NCT01253304 Diabetes Mellitus, Type 2 Phase 1 Completed - Germany ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Munich, Germany, 81241 Hungary For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Budapest, Hungary, 1032 Less <<
NCT01274663 Diabetes Mellitus, Type 2 Phase 1 Completed - United States, Florida ... More >> Pfizer Investigational Site South Miami, Florida, United States, 33143 Less <<
NCT00892151 Diabetes Mellitus Not Applicable Completed - United States, California ... More >> AMCR Institute Escondido, California, United States, 92026 Less <<
NCT01264809 Diabetes Mellitus, Type 2 Not Applicable Unknown March 2013 France ... More >> CHU de Fort-de-France- Hôpital Pierre Zobda Quitman Not yet recruiting Fort-de-France, Martinique, France, 97261 Contact: Cédric FAGOUR, MD    (0)596552241 ext +596    cedric.fagour@chu-fortdefrance.fr    Contact: Miguelle ROSETTE-NARECE, MD    (0)596552241 ext +596    miguelle.rosette-narece@chu-fortdefrance.fr    Principal Investigator: Cedric FAGOUR, MD          Sub-Investigator: Miguelle ROSETTE-NARECE, MD          CHU de Bordeaux - Hôpital Haut Lévêque Not yet recruiting Pessac, France, 33604 Contact: Vincent RIGALLEAU, MD-PhD    (0)556795679 ext +33    vincent.rigalleau@chu-bordeaux.fr    Contact: Henri GIN, MD-PhD    (0)556795679 ext +33    henri.gin@chu-bordeaux.fr    Principal Investigator: Vincent RIGALLEAU, MD-PhD          Sub-Investigator: Henri GIN, MD-PhD Less <<
NCT00892151 - Completed - -
NCT01272973 Diabetes Diab... More >>etes Mellitus, Type 2 Healthy Less << Phase 1 Completed - Germany ... More >> Berlin, Germany, 14050 Less <<
NCT00899470 Type 2 Diabetes Mellitus Phase 1 Completed - United States, Nebraska ... More >> Mds Pharma Services Lincoln, Nebraska, United States, 68502 Less <<
NCT00894270 Diabetes Mellitus Phase 4 Completed - New Zealand ... More >> Liggins Institute Auckland, New Zealand, 1001 Less <<
NCT00904761 Diabetes Mellitus Not Applicable Completed - Taiwan ... More >> National Taiwan University Hospital Taipei, Taiwan, 100 Less <<
NCT00906919 Diabetes Mellitus, Type 2 Not Applicable Completed - Canada, British Columbia ... More >> University of Victoria - Centre on Aging (Ladner Office), Suite 210, 4907 Chisholm Street Delta, British Columbia, Canada, V4K 2K6 Less <<
NCT00899470 - Completed - -
NCT00908271 Type 2 Diabetes Mellitus Phase 1 Completed - United States, Wisconsin ... More >> Covance Clinical Research Unit, Inc. Madison, Wisconsin, United States, 53704 Less <<
NCT00904176 Type 2 Diabetes Mellitus Phase 1 Completed - United States, Kansas ... More >> Pra International Lenexa, Kansas, United States, 66219 Less <<
NCT00910507 Diabetes Mellitus, Type 2 Not Applicable Completed - United States, Arkansas ... More >> University of Central Arkansas Conway, Arkansas, United States, 72035 Less <<
NCT01971229 Insulin Resistance Not Applicable Completed - Canada, Quebec ... More >> Montreal General Hospital Montreal, Quebec, Canada, H3G 1A4 Less <<
NCT00905528 - Completed - Germany ... More >> University of Erlangen-Nuremberg Erlangen, Bavaria, Germany, 91054 Less <<
NCT00915772 - Completed - -
NCT00924105 Type 2 Diabetes Mellitus Phase 1 Completed - Germany ... More >> Cytos Investigator sites Hamburg, Germany Switzerland Cytos Investigator sites Basel, Switzerland Cytos Investigator sites Zuerich, Switzerland Less <<
NCT00915772 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT00924573 Type 2 Diabetes Mellitus Phase 3 Completed - Japan ... More >> Sanofi-Aventis Administrative Office Tokyo, Japan Less <<
NCT00925717 - Completed - Korea, Republic of ... More >> Research Site Cheonan-si, Chungchungnam-do, Korea, Republic of Research Site Ansan-si, Gyeonggi-do, Korea, Republic of Research Site Anyang-si, Gyeonggi-do, Korea, Republic of Research Site Bucheon-si, Gyeonggi-do, Korea, Republic of Research Site Goyang-si, Gyeonggi-do, Korea, Republic of Research Site Seongnam-si, Gyeonggi-do, Korea, Republic of Research Site Suwon-si, Gyeonggi-do, Korea, Republic of Research Site Uijeongbu-si, Gyeonggi-do, Korea, Republic of Research Site Gwangju-si, Jeollanam-do, Korea, Republic of Research Site Suncheon, Jeollanam-do, Korea, Republic of Research Site Jeonju-si, Jeonllabuk-do, Korea, Republic of Research Site Chuncheon-si, Kangwon-do, Korea, Republic of Research Site Chuncheon, Kangwon-do, Korea, Republic of Research Site Kang-Neung, Kangwon-do, Korea, Republic of Research Site Wonju-si, Kangwon-do, Korea, Republic of Research Site Busan-si, Korea, Republic of Research Site Cheonju-si, Korea, Republic of Research Site Daegu-si, Korea, Republic of Research Site Daejeon-si, Korea, Republic of Research Site Incheon-si, Korea, Republic of Research Site Incheon, Korea, Republic of Research Site Jeonju-si, Korea, Republic of Research Site Kwangju-si, Korea, Republic of Research Site Seoul, Korea, Republic of Less <<
NCT00913367 Type 2 Diabetes Mellitus Phase 4 Completed - Korea, Republic of ... More >> HeeYoung Lee Seoul, Korea, Republic of Less <<
NCT00929201 Type 2 Diabetes Mellitus Phase 1 Completed - -
NCT00924430 Type 2 Diabetes Mellitus Phase 1 Completed - United Kingdom ... More >> Site 1 London, United Kingdom Less <<
NCT00929201 - Completed - -
NCT00930865 Type 2 Diabetes Mellitus Phase 1 Completed - United States, Texas ... More >> Ppd Development, Lp Austin, Texas, United States, 78744 Less <<
NCT00933062 Diabetes Mellitus, Type 2 Phase 1 Completed - United Kingdom ... More >> GSK Investigational Site Merthyr Tydfill, Glamorgan, United Kingdom, CF48 4DR Less <<
NCT00901992 Type 2 Diabetes Not Applicable Completed - Germany ... More >> Diabetes Centre Mergentheim Bad Mergentheim, Germany, 97980 Less <<
NCT03210597 Metabolic Syndrome Not Applicable Completed - -
NCT00933491 - Completed - -
NCT00933530 Diabetes Mellitus, Type 2 ... More >> Healthy Volunteer Less << Phase 1 Completed - United Kingdom ... More >> GSK Investigational Site Merthyr Tydfill, Glamorgan, United Kingdom, CF48 4DR Less <<
NCT00935064 Diabetes Not Applicable Completed - United States, Delaware ... More >> Christiana Care Health Services Newark, Delaware, United States, 19713 Less <<
NCT00935064 - Completed - -
NCT00933491 - Completed - United States, Michigan ... More >> Michigan Center for Oral Health Research Ann Arbor, Michigan, United States, 48106 Less <<
NCT00935220 Diabetes Mellitus, Type 2 Phase 1 Completed - United States, California ... More >> 1218.55.0006 Boehringer Ingelheim Investigational Site Cypress, California, United States United States, Florida 1218.55.0008 Boehringer Ingelheim Investigational Site Deland, Florida, United States 1218.55.0004 Boehringer Ingelheim Investigational Site Miami, Florida, United States United States, Maryland 1218.55.0005 Boehringer Ingelheim Investigational Site Baltimore, Maryland, United States United States, New York 1218.55.0003 Boehringer Ingelheim Investigational Site New York, New York, United States United States, Texas 1218.55.0001 Boehringer Ingelheim Investigational Site Dallas, Texas, United States Less <<
NCT00935220 - Completed - -
NCT00934414 Diabetes Type 2 Phase 2 Completed - United States, California ... More >> Profil Institute for Clinical Research Chula Vista, California, United States, 91911 Less <<
NCT00937872 Diabetes Mellitus, Type 2 Phase 1 Completed - United Kingdom ... More >> GSK Investigational Site Nottingham, United Kingdom, NG11 6JS Less <<
NCT00929539 Type II Diabetes Mellitus Phase 2 Completed - -
NCT00938119 - Terminated(the product was del... More >>isted.) Less << - -
NCT00938158 Diabetes Mellitus, Type 2 Phase 1 Completed - United States, Alabama ... More >> GSK Investigational Site Anniston, Alabama, United States, 36207 United States, Florida GSK Investigational Site Miami, Florida, United States, 33169 GSK Investigational Site Orlando, Florida, United States, 32809 United States, Louisiana GSK Investigational Site Baton Rouge, Louisiana, United States, 70806 United States, Minnesota GSK Investigational Site Minneapolis, Minnesota, United States, 55404 South Africa GSK Investigational Site Parktown, Gauteng, South Africa, 2193 GSK Investigational Site Somerset West, South Africa, 07129 Less <<
NCT00935467 Type 2 Diabetes Mellitus Phase 1 Completed - United States, Texas ... More >> Ppd Development, Lp Austin, Texas, United States, 78744 Less <<
NCT00935441 Diabetes Mellitus Not Applicable Completed - United States, Minnesota ... More >> Minneapolis VAMC Minneapolis, Minnesota, United States, 55417 Less <<
NCT01971723 Supplement Not Applicable Completed - United States, Florida ... More >> Florida State University Tallahassee, Florida, United States, 32306 Less <<
NCT00938275 Diabetes Mellitus, Type 2 Phase 1 Completed - United Kingdom ... More >> GSK Investigational Site Merthyr Tydfill, Glamorgan, United Kingdom, CF48 4DR Less <<
NCT01971723 - Completed - -
NCT00943917 Type 2 Diabetes Phase 2 Completed - -
NCT03584581 Cholesterol; Metabolic Disorde... More >>r Metabolic Syndrome Less << Phase 2 Recruiting December 31, 2018 Spain ... More >> General University Hospital of Elda Recruiting Elda, Alicante, Spain, 03690 Contact: Vicente F Gil-Guillén, MD, PhD    +34966975017    vte.gil@gmail.com    Principal Investigator: Ernesto Cortés-Castell, PhD          Sub-Investigator: Antonio Palazón-Bru, PhD          Sub-Investigator: María M Rizo-Baeza, PhD          Sub-Investigator: Vicente F Gil-Guillén, MD, PhD          Sub-Investigator: Luís Torró-Montell, MPharm          Sub-Investigator: Enrique Hermida-Campa, MD, PhD Less <<
NCT02009813 Obesity Type ... More >>2 Diabetes Less << Not Applicable Completed - Australia, South Australia ... More >> Royal Adelaide Hospital Adelaide, South Australia, Australia, 5000 Less <<
NCT00944450 Type 2 Diabetes Mellitus Phase 1 Completed - -
NCT02006394 Insulin Resistance ... More >> Obesity Metabolic Syndrome Less << Not Applicable Completed - United States, California ... More >> University of California, San Diego San Diego, California, United States, 92093 Less <<
NCT00950313 Diabetes Not Applicable Completed - United Kingdom ... More >> Leicester City PCT Leicester, Leicestershire, United Kingdom Less <<
NCT02020343 - Completed - United States, Missouri ... More >> University of Missouri Columbia, Missouri, United States, 65212 Less <<
NCT00943917 - Completed - -
NCT00944450 - Completed - -
NCT00956735 Cardiovascular Disease ... More >> Type 2 Diabetes Less << Not Applicable Completed - United States, Pennsylvania ... More >> Penn State University - General Clinical Research Center University Park, Pennsylvania, United States, 16802-6501 Less <<
NCT00957268 Diabetes Mellitus, Type 2 Phase 1 Completed - United States, Florida ... More >> Miami, Florida, United States Pineallas Park, Florida, United States United States, Kentucky Louisville, Kentucky, United States United States, North Carolina Durham, North Carolina, United States United States, Pennsylvania Philadelphia, Pennsylvania, United States United States, Tennessee Memphis, Tennessee, United States United States, Texas San Antonio, Texas, United States Less <<
NCT00945204 Type 2 Diabetes Not Applicable Completed - United Kingdom ... More >> University of Leicester :Leicester, Leicestershire, United Kingdom, LE1 6TP Less <<
NCT00959595 Diabetes Mellitus Phase 3 Completed - Sweden ... More >> Department of Hand Surgery, Malmö University Hospital Malmö, Sweden, SE-205 02 Less <<
NCT00960076 Type 2 Diabetes Phase 3 Completed - -
NCT00954967 Diabetes Mellitus ... More >> Smoking Cessation Less << Not Applicable Completed - Spain ... More >> IDIAP Jordi Gol Barcelona, Spain, 08007 Less <<
NCT00964184 Diabetes Mellitus, Type 2 Phase 4 Completed - India ... More >> Fortis Flt Lt Rajan Dhall Hospital New Delhi, Delhi, India, 110070 Less <<
NCT00965510 Type 2 Diabetes Not Applicable Terminated(insufficient recrui... More >>tment of control and study patients) Less << - United States, New Hampshire ... More >> Exeter Family Care Exeter, New Hampshire, United States, 03833 Less <<
NCT00957268 - Completed - -
NCT00967642 Diabetes Mellitus ... More >> Percutaneous Coronary Intervention Less << Not Applicable Terminated - -
NCT00960453 Diabetes Mellitus Phase 1 Completed - Korea, Republic of ... More >> Clinical Trials Center; Seoul National University Hospital Seoul, Korea, Republic of, 110-744 Less <<
NCT00965549 Diabetes Mellitus, Type 2 Phase 4 Completed - -
NCT00968812 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT00960076 - Completed - -
NCT00971516 Type 2 Diabetes ... More >> Dental Implants Less << Not Applicable Completed - -
NCT00968812 - Completed - -
NCT00968006 Type 2 Diabetes Mellitus Phase 4 Completed - Italy ... More >> University of Padova, Medical School Padova, Italy, 35100 Less <<
NCT00975533 Type 2 Diabetes Mellitus Phase 3 Unknown October 2011 China, Hong Kong ... More >> Prince of Wales Hospital Not yet recruiting Shatin, Hong Kong, China Principal Investigator: Simon KH Wong, MBChB          Sub-Investigator: Alice PS Kong, MBChB          Sub-Investigator: Ronald CW Ma, MBChB          Sub-Investigator: Juliana CN Chan, MBBS          Sub-Investigator: Enders KW Ng, MBChB          Sub-Investigator: Vannessa WS Ng, MBChB          Sub-Investigator: Francis CC Chow, MBBS          Sub-Investigator: Wing Yee So, MBChB          Sub-Investigator: Winnie CW Chu, MBChB Less <<
NCT00970294 - Completed - -
NCT00970294 Diabetes Not Applicable Completed - United States, Kansas ... More >> Patricia Kluding PhD Kansas City, Kansas, United States, 66160 Less <<
NCT00973830 Diabetes Knowledge Not Applicable Unknown July 2010 United States, Illinois ... More >> Northwestern University Recruiting Chicago, Illinois, United States, 60611 Contact: Stacy Bailey, MPH    312-503-5586    stacy-bailey@northwestern.edu Less <<
NCT03148483 Periodontitis ... More >> Inflammation Less << Not Applicable Recruiting March 1, 2019 Brazil ... More >> Centro Municipal de Saúde de Duque de Caxias & Policlínica Hospital Duque de Caxias Recruiting Rio de Janeiro, Brazil Contact: Cocate    +55 (21) 39386595    paulacocate@gmail.com    Principal Investigator: Amanda R A Adegboye, PhD          Principal Investigator: Berit L Heitmann, Prof          Principal Investigator: Gilberto Kac, Prof Less <<
NCT00979394 - Terminated - -
NCT00976495 Type 2 Diabetes Mellitus Phase 2 Completed - United States, California ... More >> Advanced Clinical Res Inst Anaheim, California, United States, 92801 Torrance Clinical Research Lomita, California, United States, 90717 United States, Florida Elite Research Institute Miami, Florida, United States, 33169 Compass Research, Llc Orlando, Florida, United States, 32806 Orlando Clinical Research Center Orlando, Florida, United States, 32809 United States, Michigan University Of Michigan Ann Arbor, Michigan, United States, 48106 United States, Minnesota Prism Research St. Paul, Minnesota, United States, 55114 United States, Rhode Island Memorial Hospital Of Rhode Island Pawtucket, Rhode Island, United States, 02860 United States, Wisconsin Zablocki Veterans Affairs Medical Center Milwaukee, Wisconsin, United States, 53295 Canada, Ontario Local Institution Toronto, Ontario, Canada, M4G 3E8 Canada, Quebec Local Institution Laval, Quebec, Canada, H7T 2P5 Netherlands Local Institution Groningen, Netherlands, 9713 GZ Less <<
NCT00982371 - Completed - Canada, Ontario ... More >> McMaster University Hamilton, Ontario, Canada, L8N 3Z5 Less <<
NCT00981448 Diabetes Not Applicable Completed - United States, Pennsylvania ... More >> Amish Research Clinic Lancaster, Pennsylvania, United States, 17601 Less <<
NCT00976495 - Completed - -
NCT00985101 - Unknown - -
NCT00985114 Type II Diabetes Not Applicable Completed - Netherlands ... More >> Ziekenhuis Rijnstate Arnhem Arnhem, Netherlands Medisch Centrum Parkstad Heerlen, Netherlands University Hospital Maastricht Maastricht, Netherlands Less <<
NCT00979823 Type 2 Diabetes Not Applicable Completed - United States, Minnesota ... More >> HealthPartners Research Foundation Minneapolis, Minnesota, United States, 55440 Less <<
NCT00985361 Type 2 Diabetes Mellitus Not Applicable Completed - United States, Ohio ... More >> Flower Hospital Family Medicine Residency Sylvania, Ohio, United States, 43560 Center for Health Services Toledo, Ohio, United States, 43606 Toledo Hospital Family Medicine Residency Toledo, Ohio, United States, 43606 Less <<
NCT00986375 Diabetes Mellitus, Type 2 Not Applicable Completed - Germany ... More >> Freie Universitaet Berlin Berlin, Germany, 14195 Less <<
NCT00984841 Diabetes Mellitus Not Applicable Completed - United States, Pennsylvania ... More >> Scranton-Temple Health Center Scranton, Pennsylvania, United States, 18510 Less <<
NCT00989924 - Unknown - Taiwan ... More >> National Taiwan University Hospital Recruiting Taipei, Taiwan, 100 Contact: Lee-Ming Chuang, MD. Ph.D.    886-2-23123456 ext 65038    leeming@ntu.edu.tw    Principal Investigator: Lee-Ming Chuang, MD. Ph.D. Less <<
NCT01672840 Hypertension Not Applicable Completed - United States, Connecticut ... More >> Griffin Hospital Derby, Connecticut, United States, 06418 United States, Massachusetts Boston University School of Medicine Boston, Massachusetts, United States, 02118 Less <<
NCT00985114 - Completed - -
NCT00991380 Type 2 Diabetes Not Applicable Completed - Canada, Alberta ... More >> The Alliance for Canadian Health Outcomes Research in Diabetes Edmonton, Alberta, Canada Less <<
NCT02084641 Insulin Resistance ... More >> Obesity Less << Not Applicable Unknown December 2016 United States, California ... More >> Stanford University Recruiting Stanford, California, United States, 94305 Contact: Craig, MD    650-736-2056       Contact: Lamendola, NP    650-736-2056 Less <<
NCT00996294 Type 2 Diabetes Mellitus ... More >> Bariatric Surgery Biliopancreatic Diversion Gastric Bypass Less << Not Applicable Unknown October 2013 Italy ... More >> Ospedale San Martino Genova, Italy, 16132 Less <<
NCT00987285 Type 2 Diabetes Mellitus Not Applicable Completed - United States, Colorado ... More >> Kaiser Permanente of Colorado Denver, Colorado, United States, 80237-8066 Less <<
NCT00995995 - Completed - -
NCT01617499 - Completed - United States, Missouri ... More >> Washington University St. Louis, Missouri, United States, 63108 Less <<
NCT01000519 Diabetes Mellitus, Type 2 Not Applicable Completed - Singapore ... More >> Singapore General Hospital Singapore, Singapore, 169608 Less <<
NCT01000363 - Completed - United States, Georgia ... More >> Grady North DeKalb Clinic Chamblee, Georgia, United States, 30340 Less <<
NCT00991055 Type 2 Diabetes Phase 4 Unknown October 2010 Taiwan ... More >> National Cheng Kung University Hospital Recruiting Tainan, Taiwan Contact: Ta-Jen Wu, Dr    886-6-2353535 ext 5387    djwu@mail.ncku.edu.tw    Principal Investigator: Ta-Jen Wu, Dr. Less <<
NCT01005498 Diabetes Phase 1 Phase 2 Completed - Sweden ... More >> Vårdcentralen Lyckorna Motala, Östergötland, Sweden, S-59185 Less <<
NCT01002807 Type 2 Diabetes Mellitus (T2DM... More >>) Less << Phase 1 Completed - United States, Texas ... More >> Ppd Development, Lp Austin, Texas, United States, 78744 Less <<
NCT00999050 Diabetes Mellitus, Type 2 Not Applicable Unknown November 2013 United States, New York ... More >> Weill Cornell Medical College New York Prysbyterian Hosptial Recruiting New York, New York, United States, 10065 Contact: Francisco Rubino, MD    212-746-5925    frr2007@med.cornell.edu    Contact: Gladys W Strain, PhD    212-746-5661    gls2010@med.cornell.edu Less <<
NCT01010594 Diabetes Mellitus, Type 2 Not Applicable Terminated(PI changed job and ... More >>project was not economically viable and therefor terminated) Less << - Denmark ... More >> Department of nutrition, Regional Hospital West Jutland Holstebro, Denmark, 7500 Less <<
NCT01010035 - Completed - Brazil ... More >> Endocrinology service and Lipid laboratory of Heart Institute of University of São Paulo São Paulo, Brazil, 05423000 Less <<
NCT01002521 - Unknown June 2012 Barbados ... More >> Chronic Disease Research Centre Not yet recruiting Bridgetown, St Michael, Barbados, BB11115 Contact: R C Landis, PhD    (246) 426-6416    clive.landis@cavehill.uwi.edu    Contact: Andre R Greenidge, BSc    246) 426-6416    andre.greenidge@cavehill.uwi.edu    Principal Investigator: Robert C Landis, PhD          Sub-Investigator: Andre R Greenidge, BSc Less <<
NCT01018628 Diabetes Mellitus, Type 2 Phase 1 Completed - United Kingdom ... More >> GSK Investigational Site Merthyr Tydfill, Glamorgan, United Kingdom, CF48 4DR Less <<
NCT01023165 Diabetes Mellitus ... More >> Metabolic Integrity Less << Phase 3 Unknown November 2015 United States, Mississippi ... More >> Global Infusion and Aspiration Systems, LLC Recruiting Batesville, Mississippi, United States, 38606 Contact: Lee Garner, BA    662-267-2025    lg@global-infusions.com    Principal Investigator: Michael Cockrell, MD Less <<
NCT02101996 - Completed - United States, Missouri ... More >> University of Missouri Columbia, Missouri, United States, 65212 Less <<
NCT01026688 Diabetes Mellitus ... More >> Cardiovascular Disease Less << Not Applicable Completed - Canada, Ontario ... More >> Institute for Clinical Evaluative Sciences Toronto, Ontario, Canada, M4N 3M5 Less <<
NCT01025973 - Completed - Canada, Quebec ... More >> Centre de recherche clinique Etienne-Le Bel du CHUS Sherbrooke, Quebec, Canada, J1H 5N4 Less <<
NCT01017848 - Completed - United States, New York ... More >> Staten Island University Hospital Staten Island, New York, United States, 10305 Less <<
NCT01038089 Type 2 Diabetes Mellitus Not Applicable Completed - United States, Massachusetts ... More >> Boston Medical Center Boston, Massachusetts, United States, 02118 Less <<
NCT01037582 Diabetes Diab... More >>etes Mellitus, Type 2 Healthy Less << Phase 1 Completed - United Kingdom ... More >> Novo Nordisk Investigational Site Harrow, United Kingdom, HA1 3UJ Less <<
NCT01025856 Postprandial Lipids Metabolism... More >> Type 2 Diabetes Less << Not Applicable Completed - -
NCT01040676 Diabetes Mellitus Not Applicable Completed - United States, California ... More >> La Clinica de la Raza Oakland, California, United States, 94623 Less <<
NCT01039896 Diabetes Mellitus Phase 1 Completed - -
NCT01029288 Diabetes Not Applicable Completed - United States, Minnesota ... More >> MCHS-Albert Lea Albert Lea, Minnesota, United States, 56007 MCHS-Austin Austin, Minnesota, United States, 55912 Mayo Family Clinic Kasson, Minnesota, United States, 55944 Olmsted Medical Center Rochester, Minnesota, United States, 55904 Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT03260582 Myocardial Infarction Not Applicable Active, not recruiting April 2021 Sweden ... More >> Dept of Cardiology, Skane University Hospital Lund, Sweden, 222 41 Dept of Cardiology, Skane University Hospital Malmo, Sweden, 20502 Dept of Cardiology Umeå, Sweden, 907 46 Less <<
NCT01039116 Type 2 Diabetes Not Applicable Completed - United States, California ... More >> YMCA of the East Bay, Oakland, CA 94612 Oakland, California, United States, 94612 Less <<
NCT01277900 - Unknown December 2013 Taiwan ... More >> BMI Surgery Center, E-DA Hospital Not yet recruiting Kaohsiung, Taiwan, 824 Contact: Chih-Kun Huang, Doctor    +886-7-6150011 ext 5266    dr.ckhuang@hotmail.com Less <<
NCT01278121 Obesity Diabe... More >>tes Mellitus, Type 2 Cardiovascular Diseases Less << Not Applicable Completed - Norway ... More >> NTNU Department of Biology Trondheim, Norway, 7491 Less <<
NCT01276106 Type 2 Diabetes Mellitus Phase 2 Completed - United States, California ... More >> Catalina Research Institute, LLC Chino, California, United States National Research Institute Los Angeles, California, United States United States, Florida Clinical Research of South Florida Coral Gables, Florida, United States Jacksonville Impotence Treatment Center Jacksonville, Florida, United States United States, Illinois Chicago Clinical Research Institute, Inc. Chicago, Illinois, United States Clinical Investigation Specialists, Inc. Gurnee, Illinois, United States United States, Indiana Midwest Institute for Clinical Research, Inc. Indianapolis, Indiana, United States United States, Kentucky L-MARC Research Center Louisville, Kentucky, United States United States, Louisiana New Orleans Center for Clinical Research New Orleans, Louisiana, United States United States, Ohio Sterling Research Group, Ltd Cincinnati, Ohio, United States PriMed Clinical Research Kettering, Ohio, United States United States, Virginia National Clinical Research-Richmond, Inc. Richmond, Virginia, United States United States, Washington Rainier Clinical Research Center, Inc. Renton, Washington, United States Taiwan Changhua Christian Hospital Changhua, Taiwan Cheng Ching General Hospital Taichung, Taiwan Chung Shan Medical University Hospital Taichung, Taiwan Kuang Tien General Hospital Taichung, Taiwan Cardinal Tien Hospital Taipei, Taiwan Taipei Medical University Hospital Taipei, Taiwan Taipei Medical University-Shuang Ho Hospital Taipei, Taiwan Tri-Service General Hospital Taipei, Taiwan Less <<
NCT01039532 - Completed - India ... More >> AnilBhansali Chandigarh, India, 160012 Less <<
NCT01278823 Obesity Type ... More >>2 Diabetes Less << Not Applicable Completed - United States, Ohio ... More >> Cleveland Clinic Bariatric and Metabolic Institute, Department of Pathobiology Cleveland, Ohio, United States, 44195 Less <<
NCT01276106 - Completed - -
NCT01285076 - Completed - Taiwan ... More >> Merck Sharp & Dohme (I.A.) Corp. Taipei, Taiwan, 106 Less <<
NCT01282970 Diabetes Mellitus, Type 2 Phase 1 Completed - Germany ... More >> 1283.2.1 Boehringer Ingelheim Investigational Site Neuss, Germany Less <<
NCT01284465 Type 2 Diabetes Not Applicable Completed - United States, Tennessee ... More >> Meharry medical College Nashville, Tennessee, United States, 37208 Less <<
NCT01288300 Diabetes Not Applicable Completed - United States, Illinois ... More >> Centro de Salud y Esperanza Chicago, Illinois, United States Our Lady of Tepeyac Church Chicago, Illinois, United States St. Agnes of Bohemia Church Chicago, Illinois, United States Less <<
NCT01288729 Diabetes Mellitus Not Applicable Completed - -
NCT01289587 Diabetes Not Applicable Unknown October 2017 Switzerland ... More >> University of Lausanne Hospitals Lausanne, Switzerland, 1011 Less <<
NCT01285076 - Completed - -
NCT01289145 Obesity Diabe... More >>tes Mellitus, Type 2 Less << Not Applicable Completed - Germany ... More >> Freie Universität Berlin Berlin, Germany, 14195 Less <<
NCT01288729 - Completed - -
NCT01294553 - Completed - -
NCT01294436 Type2 Diabetes ... More >> High Blood Sugar Less << Phase 3 Completed - Japan ... More >> Research Site Nagoya, Aichi, Japan Research Site Owariasahi, Aichi, Japan Research Site Toyohashi, Aichi, Japan Research Site Hirosaki, Aomori, Japan Research Site Niihama, Ehime, Japan Research Site Itoshima, Fukuoka, Japan Research Site Yukuhashi, Fukuoka, Japan Research Site Annaka, Gunma, Japan Research Site OTA, Gunma, Japan Research Site Aki-gun, Hiroshima, Japan Research Site Sapporo, Hokkaido, Japan Research Site Sanuki, Kagawa, Japan Research Site Takamatsu, Kagawa, Japan Research Site Kamakura, Kanagawa, Japan Research Site Kawasaki, Kanagawa, Japan Research Site Yokohamashi, Kanagawa, Japan Research Site Yokohama, Kanagawa, Japan Research Site Zushi, Kanagawa, Japan Research Site Sendai, Miyagi, Japan Research Site Matsumoto, Nagano, Japan Research Site Suita, Osaka, Japan Research Site Otsu, Shiga, Japan Research Site Atami, Shizuoka, Japan Research Site Komatsushima, Tokushima, Japan Research Site Chiyoda, Tokyo, Japan Research Site Chuo, Tokyo, Japan Research Site Mitaka, Tokyo, Japan Research Site OTA, Tokyo, Japan Research Site Shibuya, Tokyo, Japan Research Site Shinjuku, Tokyo, Japan Research Site Taito, Tokyo, Japan Research Site Takaoka, Toyama, Japan Research Site UBE, Yamaguchi, Japan Research Site Fukuoka, Japan Research Site Hiroshima, Japan Research Site Kochi, Japan Research Site Osaka, Japan Research Site Shizuoka, Japan Research Site Toyama, Japan Less <<
NCT01294553 - Completed - -
NCT00715585 Diabetes Not Applicable Completed - United States, Tennessee ... More >> Vanderbilt Nashville, Tennessee, United States, 37215 Less <<
NCT00715780 - Completed - Indonesia ... More >> Novo Nordisk Investigational Site Jakarta, Indonesia, 12520 Less <<
NCT00712478 - Completed - France ... More >> Paris La Défense, France, 92936 Less <<
NCT00717158 Diabetes Mellitus, Type 2 ... More >> Obesity Less << Not Applicable Completed - United States, Virginia ... More >> University of Virginia School of Medicine Charlottesville, Virginia, United States, 22908 Less <<
NCT00721084 - Completed - United States, Illinois ... More >> The University of Chicago Chicago, Illinois, United States, 60637 Less <<
NCT00728351 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT01294436 - Completed - -
NCT00353054 Obesity Overw... More >>eight Less << Phase 4 Completed - Canada ... More >> Université Laval Quebec, Canada, G1K 7P4 Less <<
NCT00729079 Diabetes Prevention Not Applicable Completed - United States, New York ... More >> Clinton Medical Associated Rochester, New York, United States, 14620 Therapeutic Lifestyle Changes Rochester, New York, United States, 14620 Less <<
NCT02135562 Endometrial Cancer ... More >> Obesity Less << Not Applicable Completed - United States, Ohio ... More >> Cleveland Medical Center, University Hospitals, Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5065 MetroHealth Medical Center Cleveland, Ohio, United States, 44109 Less <<
NCT03009292 Solid Tumor Phase 1 Recruiting December 2019 China, Beijing ... More >> Beijing Cancer Hospital Recruiting Beijing, Beijing, China Contact: Lin Shen    86100881211226561       China, Heilongjiang Harbin Medical University Cancer Hospital Recruiting Harbin, Heilongjiang, China Contact: Yuxian Bai    8645186298694 Less <<
NCT00734591 - Completed - -
NCT00711152 Type 2 Diabetes Mellitus Phase 4 Completed - Hong Kong ... More >> Asia Diabetes Foundation Hong Kong, Hong Kong Less <<
NCT00737880 Diabetes Mellitus ... More >> Pancreas Transplantation Less << Phase 4 Completed - Austria ... More >> Center of Operative Medicine / Department of Visceral, Transplant and Thoracic Surgery / Medical University Innsbruck Innsbruck, Tyrol, Austria, 6020 Belgium Department of General, Hepato-Biliary and Transplantation Surgery Gent, Belgium, 9000 Germany Department of General, Visceral and Transplantation Surgery, Charite Campus Virchow Klinikum, Humboldt University Berlin Berlin, Germany, 13353 Department of General, Vascular, Thoracic and Transplantation Surgery, University of Rostock Rostock, Germany, 18057 Less <<
NCT00734591 - Completed - -
NCT00742547 Type 2 Diabetes Mellitus Not Applicable Completed - Germany ... More >> Christoph Lücke, MD Beilstein, Baden-Württemberg, Germany, 71717 Andrea Walliser-Klöpfer, MD Benningen am Neckar, Baden-Württemberg, Germany, 71724 Nader Heydari, MD Fellbach, Baden-Württemberg, Germany, 70737 Adelheid Halttunen, MD Gemmingen, Baden-Württemberg, Germany, 75050 Hans-Joachim Essich, MD Heilbronn, Baden-Württemberg, Germany, 74072 Jürgen Wollweber, MD Heilbronn, Baden-Württemberg, Germany, 74072 Volker Naser, MD Heilbronn, Baden-Württemberg, Germany, 74076 Andreas Wößner, MD Heilbronn, Baden-Württemberg, Germany, 74078 Ullrich Barthelmes, MD Heilbronn, Baden-Württemberg, Germany, 74080 Axel Möller, MD Heilbronn, Baden-Württemberg, Germany, 74081 Miroslaw Wyszynski, MD Heilbronn, Baden-Württemberg, Germany, 74081 Ulrich Hofmann, MD Ilsfeld-Auenstein, Baden-Württemberg, Germany, 74360 Hans Martin Schweizer, MD Korntal, Baden-Württemberg, Germany, 70825 Eberhard Rieker, MD Lauffen am Neckar, Baden-Württemberg, Germany, 74348 Bernd Leuchs, MD Leonberg, Baden-Württemberg, Germany, 71229 Gerhard Günther, MD Leonberg, Baden-Württemberg, Germany, 71229 Thomas Baartz, MD Leonberg, Baden-Württemberg, Germany, 71229 Monika Muhler, MD Loewenstein, Baden-Württemberg, Germany, 74245 Ulrich Wagner, MD Ludwigsburg, Baden-Württemberg, Germany, 71634 Martin Heinrich, MD Ludwigsburg, Baden-Württemberg, Germany, 71640 Franz Lang, MD Marbach am Neckar, Baden-Württemberg, Germany, 71672 Jürgen Wirth, MD Marbach am Neckar, Baden-Württemberg, Germany, 71672 Alfred Preisner, MD Massenbachhausen, Baden-Württemberg, Germany, 74252 Michael Spiel, MD Murr, Baden-Württemberg, Germany, 71711 Hans-Jürgen Sommerer, MD Neckarsulm, Baden-Württemberg, Germany, 74081 Dietmar Kunz, MD Neckarsulm, Baden-Württemberg, Germany, 74172 Hartmut Jungjohann, MD Neckarsulm, Baden-Württemberg, Germany, 74172 Jürgen Herbers, MD Pleidelsheim, Baden-Württemberg, Germany, 74385 Ulf-Michael Werner, MD Remshalden, Baden-Württemberg, Germany, 73630 Frank Röder, MD Schwaikheim, Baden-Württemberg, Germany, 71409 Gisela Gramlich, MD Untergruppenbach, Baden-Württemberg, Germany, 74199 Ildiko Tasic Vaihingen-Enz, Baden-Württemberg, Germany, 71665 Karl Schütz, MD Weinsberg, Baden-Württemberg, Germany, 74189 Sigmund Jakob Weinsberg, Baden-Württemberg, Germany, 74189 Kurt Weber, MD Weissach, Baden-Württemberg, Germany, 71287 Dietmar Zinßer, MD Winnenden, Baden-Württemberg, Germany, 71364 Odilo Schnabel, MD Zaberfeld, Baden-Württemberg, Germany, 74374 Less <<
NCT03042039 - Active, not recruiting October 1, 2017 Croatia ... More >> Higher or Secondary Education Establishments Zagreb, Croatia, 10000 Italy Agenzia Regionale Sanitaria Pugliese Bari, Italy, 70126 Poland Urzad Marszalkowski Wojewodztwa Dolnoslaskiego Wroclaw, Poland, 50-411 Spain Servicio Vasco de Salud Osakidetza Vitoria-Gasteiz, Spain United Kingdom Bronllys Hospital Bronllys, United Kingdom, LD3 0LS Less <<
NCT00725257 Type 2 Diabetes Mellitus Not Applicable Completed - Italy ... More >> Department of Geriatrics and Metabolic Diseases Naples, Italy, 80138 Less <<
NCT01781169 Obesity Insul... More >>in Resistance Less << Not Applicable Completed - China, Guangdong ... More >> Shenzhen Center for Chronic Disease Control Shenzhen, Guangdong, China, 518020 Less <<
NCT02938520 HIV Infections Phase 2 Phase 3 Active, not recruiting July 7, 2022 -
NCT00732511 Endothelial Function ... More >> Diabetes Mellitus Hypertension Less << Phase 4 Unknown April 2009 United States, New York ... More >> SUNY Downstate Medical Center Recruiting Brooklyn, New York, United States, 11203 Contact: Nathaniel Winer, M.D.    718-270-6320    nathaniel.winer@downstate.edu    Contact: Rozina Rana, M.D.    516-279-8092    rrana786@gmail.com Less <<
NCT00754130 - Completed - -
NCT01769976 Insulin Resistance Not Applicable Completed - Australia, South Australia ... More >> Royal Adelaide Hospital Adelaide, South Australia, Australia, 5005 Less <<
NCT00754624 Type 2 Diabetes Mellitus Phase 2 Completed - -
NCT01781169 - Completed - -
NCT00757601 Type 2 Diabetes Mellitus Phase 1 Completed - -
NCT00754130 Diabetes Mellitus, Non-Insulin... More >>-Dependent Less << Phase 1 Completed - -
NCT00760292 - Unknown April 2011 Denmark ... More >> Dept. of Endocrinology, Odense University Hospital Odense, Funen, Denmark, 5000 Less <<
NCT00766441 Diabetes Hypo... More >>glycemia Less << Phase 4 Terminated(inadequate recruitm... More >>ent) Less << - United Kingdom ... More >> Wellcome Trust Clinical Research Facility Manchester, United Kingdom, M13 9NT Less <<
NCT00762242 - Terminated(Study enrollment wa... More >>s no adequate.) Less << February 2018 United States, Massachusetts ... More >> Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Less <<
NCT00767260 Type 2 Diabetes Mellitus Phase 1 Phase 2 Completed - China, Fujian ... More >> Fuzhou General Hospital Fuzhou, Fujian, China, 350025 Less <<
NCT00770926 Diabetes Not Applicable Completed - United States, California ... More >> University of California San Francisco San Francisco, California, United States, 94118 Less <<
NCT00770367 Diabetes Phase 4 Completed - United States, South Carolina ... More >> Department of Family Medicine, MUSC Charleston, South Carolina, United States, 29425 Less <<
NCT00757601 - Completed - -
NCT00775216 Type 2 Diabetes Mellitus ... More >> Exercise Obesity Behavioral Research Less << Not Applicable Terminated(grant funding ended... More >> and lack of sufficient participants to complete trial) Less << - United States, Tennessee ... More >> Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232 Less <<
NCT00775541 Type 2 Diabetes Not Applicable Terminated(Insufficient dose f... More >>or MRI scanning) Less << - United States, Kansas ... More >> University of Kansas Medical Center Kansas City, Kansas, United States, 66160 Less <<
NCT00770367 - Completed - -
NCT01122108 Healthy Phase 4 Completed - United States, Kentucky ... More >> L-MARC Research Center Louisville, Kentucky, United States, 40213 Less <<
NCT00754624 - Completed - -
NCT00781313 - Completed - United States, Texas ... More >> Texas Children Hospital Houston, Texas, United States, 77054 Less <<
NCT01122108 - Completed - -
NCT02123121 Mitochondrial Function ... More >> Physical Function Less << Phase 2 Active, not recruiting May 2019 United States, Florida ... More >> UF Institute on Aging Clinical and Translational Research Building Gainesville, Florida, United States, 32611 Less <<
NCT00786019 Type 2 Diabetes Not Applicable Completed - United States, Colorado ... More >> University of Colorado Denver Aurora, Colorado, United States, 80045 Less <<
NCT00784433 Diabetes Pred... More >>iabetes Less << Phase 3 Unknown May 2012 -
NCT00787670 Obesity Type ... More >>2 Diabetes Mellitus Less << Not Applicable Completed - United States, North Carolina ... More >> Duke University Health system Durham, North Carolina, United States, 27704 Less <<
NCT00780559 Diabetes Phys... More >>ical Activity Less << Phase 2 Completed - United States, Maryland ... More >> University of Maryland Baltimore, Maryland, United States, 20742 Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD Baltimore, Maryland, United States, 21201 United States, Michigan VA Ann Arbor Healthcare System, Ann Arbor, MI Ann Arbor, Michigan, United States, 48105 Less <<
NCT00786019 - Completed - -
NCT00767351 - Completed - -
NCT00790205 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT00787475 Diabetes Not Applicable Completed - United States, New York ... More >> Columbia University Medical Center New York, New York, United States, 10032 Less <<
NCT00788840 Type 2 Diabetes Mellitus ... More >> Obesity Less << Phase 4 Unknown - United Kingdom ... More >> Cedar Centre, Royal Surrey County Hospital Recruiting Guildford, Surrey, United Kingdom, GU2 7XX Contact: Benjamin Sheldon, MB BS    01483571122 ext 2405    benjamin.sheldon@nhs.net    Sub-Investigator: Benjamin Sheldon, MB BS Less <<
NCT00790530 Diabetes Mellitus Not Applicable Completed - United States, Massachusetts ... More >> Harvard Pilgrim Health Care Boston, Massachusetts, United States, 02215 Less <<
NCT00790660 Diabetes Mellitus, Type 2 Phase 2 Completed - United States, Texas ... More >> San Antonio, Texas, United States, 78229 Less <<
NCT00791453 - Completed - United States, Mississippi ... More >> The University of Mississippi Medical Center Jackson, Mississippi, United States, 39216 Less <<
NCT00793754 Diabetes Mellitus Phase 4 Completed - Argentina ... More >> Centro de Educación Médica e Investigaciones Clínicas (CEMIC) Buenos Aires, Argentina Less <<
NCT00793884 - Recruiting December 2020 United States, Georgia ... More >> Emory University School of Medicine Recruiting Atlanta, Georgia, United States, 30303 Contact: Ina Flores, MS, RD, CDE, LD    404-251-8976    ina.flores@emory.edu    Principal Investigator: Guillermo Umpierrez, MD Less <<
NCT00800176 Diabetes Mellitus Type 2 Phase 2 Completed - -
NCT00791895 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 4 Completed - United States, Arizona ... More >> Novo Nordisk Investigational Site Phoenix, Arizona, United States, 85006 United States, California Novo Nordisk Investigational Site La Jolla, California, United States, 92093-0694 Novo Nordisk Investigational Site La Jolla, California, United States, 92093-0831 United States, Florida Novo Nordisk Investigational Site Deland, Florida, United States, 32720 United States, Kansas Novo Nordisk Investigational Site Wichita, Kansas, United States, 67205 United States, Nebraska Novo Nordisk Investigational Site Omaha, Nebraska, United States, 68114 United States, New York Novo Nordisk Investigational Site Albany, New York, United States, 12206 United States, Ohio Novo Nordisk Investigational Site Cleveland, Ohio, United States, 44115 United States, Oregon Novo Nordisk Investigational Site Medford, Oregon, United States, 97504 United States, Tennessee Novo Nordisk Investigational Site Memphis, Tennessee, United States, 38119 United States, Texas Novo Nordisk Investigational Site Dallas, Texas, United States, 75231 Novo Nordisk Investigational Site Houston, Texas, United States, 77030 United States, Utah Novo Nordisk Investigational Site Ogden, Utah, United States, 84403 United States, Washington Novo Nordisk Investigational Site Renton, Washington, United States, 98057 United States, Wisconsin Novo Nordisk Investigational Site Milwaukee, Wisconsin, United States, 53209 Less <<
NCT00797069 Diabetes Mellitus, Type 2 Phase 3 Completed - Spain ... More >> Hospital Clinico San Carlos Madrid, Spain, 28040 Hospital Universitario Virgen de la Victoria Malaga, Spain, 29010 Hospital Universitario Miguel Servet Zaragoza, Spain, 50009 Less <<
NCT00806897 - Completed - Lithuania ... More >> Novo Nordisk Investigational Site Vilnius, Lithuania, 01112 Less <<
NCT00790205 - Completed - -
NCT01849068 Metabolic Syndrome X Phase 3 Completed - Canada ... More >> Laval University Quebec, Canada, G1V 0A6 Less <<
NCT00804232 Diabetes, Type I Not Applicable Unknown December 2015 Sweden ... More >> Queen Silvia's Childrens' hospital Recruiting Gothenburg, Sweden, 41685 Contact: Gun Forsander, PhD    +46 31 3438247    Gun.Forsander@vgregion.se    Lund University Childrens' hospital Recruiting Lund, Sweden, 221 00 Contact: Inger Hallström, PhD, Professor    +46 46 2221896    Inger.Hallstrom@med.lu.se Less <<
NCT00809705 Diabetes Mellitus Type 2 Phase 3 Completed - Germany ... More >> Berlin, Germany, 14050 Neuss, Germany, 41460 United Kingdom London, United Kingdom, HA1 3UJ Less <<
NCT00790348 - Unknown - United States, Michigan ... More >> Wayne State University Recruiting Detroit, Michigan, United States, 48201 Contact: Berhane Seyoum, MD    313-745-4008    bseyoum@med.wayne.edu    Principal Investigator: Berhane Seyoum, MD, MPH Less <<
NCT00812578 Type 2 Diabetes ... More >> Vitamin D Insufficiency Less << Phase 2 Completed - Denmark ... More >> Medical Research Unit, Medical Department M, Aarhus University Hospital Aarhus, Denmark, 8000 Less <<
NCT00813020 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 1 Completed - Germany ... More >> Berlin, Germany, 14050 Less <<
NCT00811460 Diabetes Mellitus Type 2 Phase 1 Completed - Germany ... More >> Neuss, Germany, 41460 Less <<
NCT00813215 Type 2 Diabetes Mellitus Not Applicable Unknown August 2011 Denmark ... More >> Aarhus University Hospital Aarhus, Denmark, 8000 Less <<
NCT00812032 Type 2 Diabetes Mellitus Phase 4 Completed - Sweden ... More >> Department of Medicine, Clinical pharmacology Unit, Karolinska University Hospital, Solna. Stockholm, Sweden Less <<
NCT03157557 Lifestyle Men... More >>tal Disorders, Severe Less << Not Applicable Recruiting September 2018 Netherlands ... More >> Veldwijk Recruiting Ermelo, Gelderland, Netherlands, 3853LC Contact: Jeroen Deenik, MSc    +31622049534    j.deenik@ggzcentraal.nl Less <<
NCT01860911 Obesity Insul... More >>in Resistance Less << Phase 1 Active, not recruiting September 19, 2019 United States, Arizona ... More >> Mayo Clinic in Arizona Scottsdale, Arizona, United States, 85259 Less <<
NCT00817622 Diabetes Mellitus Phase 4 Completed - Iran, Islamic Republic of ... More >> Tehran University Of Medical Sciences Tehran, Iran, Islamic Republic of Less <<
NCT00819455 Type 2 Diabetes Not Applicable Completed - India ... More >> Dr.Ambady Ramachandran Chennai, TamilNadu, India, 600 008 Less <<
NCT00822471 Diabetes Card... More >>iovascular Disease Less << Not Applicable Completed - United States, District of Col... More >>umbia Washington Hospital Center Washington, District of Columbia, United States, 20010 Less <<
NCT00823953 Type 2 Diabetes Phase 2 Withdrawn(IP could not be made... More >> available in sufficient quantity for the expected enrollment) Less << - Pakistan ... More >> Services Hospital Lahore, Punjab, Pakistan, 54000 Less <<
NCT01849068 - Completed - -
NCT00831519 - Completed - Israel ... More >> Western Galilee Hospital- Nahariya Nahariya, Israel Less <<
NCT00829569 Type 2 Diabetes Not Applicable Completed - Norway ... More >> Department of Medicine, Division of Endocrinology, St. Olavs Hospital Trondheim, Norway, N-7006 Less <<
NCT03528278 - Completed - Norway ... More >> Skjelfoss Psychiatric Centre Hobøl, Norway, 1827 Oslo University Hospital Oslo, Norway, 0450 Less <<
NCT00832390 Diabetes Mellitus Phase 4 Completed - -
NCT00832390 - Completed - -
NCT00824499 Diabetes Type 2 Not Applicable Unknown June 2009 -
NCT00833677 Type 2 Diabetes Mellitus Not Applicable Completed - United States, California ... More >> School of Nursing, University of California, San Francisco San Francisco, California, United States, 94143 Less <<
NCT00813085 Diabetes Not Applicable Completed - Canada, Ontario ... More >> St Joseph's Healthcare & Mcmaster University Hamilton, Ontario, Canada Less <<
NCT00833027 - Completed - -
NCT00834938 - Completed - Brazil ... More >> LIMED (Laboratory of Investigation of Metabolism and Diabetes)/GASTROCENTRO/Univeristy of Campinas (UNICAMP) Campinas, São Paulo, Brazil Less <<
NCT00833027 Diabetes Mellitus Phase 4 Completed - -
NCT00834626 - Completed - -
NCT00838825 Diabetes Phase 2 Completed - -
NCT00839683 Type 2 Diabetes Mellitus Phase 1 Completed - United States, New Jersey ... More >> Mds Pharma Services (Us) Inc. Neptune, New Jersey, United States, 07753 Less <<
NCT00834626 Diabetes Not Applicable Completed - India ... More >> Kirloskar Hospital Hyderabad, AP, India, 500063 Less <<
NCT00841048 Diabetes Mellitus Type 2 Phase 1 Completed - Sweden ... More >> Research Site Gothenburg, Sweden Less <<
NCT00842556 Type 2 Diabetes Mellitus Phase 1 Completed - United States, Texas ... More >> Ppd Development Austin, Texas, United States, 78744 Less <<
NCT00836225 Type 2 Diabetes Mellitus Phase 1 Completed - Netherlands ... More >> Center for Human Drug Research Leiden, Netherlands Less <<
NCT00845130 - Completed - -
NCT00848315 Type 2 Diabetes ... More >> Glycemic Control Less << Phase 2 Completed - United States, Massachusetts ... More >> Northgate Medical Center Springfield, Massachusetts, United States, 01103 Brightwood Health Center Springfield, Massachusetts, United States, 01107 High Street Health Center Springfield, Massachusetts, United States, 01199 Plumley Village Worcester, Massachusetts, United States, 01608 Family Health Center Worcester, Massachusetts, United States, 01610 Less <<
NCT00845130 Type 2 Diabetes ... More >> Oxidative Stress Less << Not Applicable Completed - United States, Kansas ... More >> University of Kansas Medical Center Kansas City, Kansas, United States, 66160 Less <<
NCT00849563 Diabetes Mellitus, Type 2 Not Applicable Completed - United States, North Carolina ... More >> Duke Family Medicine at Pickens Durham, North Carolina, United States, 27705 Duke Health Center at Pickett Rd Durham, North Carolina, United States, 27705 Less <<
NCT00850824 Type 2 Diabetes Mellitus Not Applicable Completed - American Samoa ... More >> Tafuna Family Health Center Pago Pago, American Samoa, 96799 Less <<
NCT00840164 - Unknown December 2013 Taiwan ... More >> Plasty surgery department, National Taiwan University Hospital Recruiting Taipei, Taiwan, 100 Principal Investigator: Jung-Hsien Hsieh Less <<
NCT00862251 Cardiovascular Disorder ... More >> Diabetes Mellitus Less << Phase 3 Completed - -
NCT00848757 Type 2 Diabetes Mellitus Not Applicable Completed - United States, Connecticut ... More >> Fair Haven Community Health Center New Haven, Connecticut, United States, 06513 Less <<
NCT00862251 - Completed - -
NCT00869076 Diabetes Mellitus Phase 4 Completed - United States, Michigan ... More >> Advantage Health Physican Network Grand Rapids, Michigan, United States, 49503 Less <<
NCT00865124 - Completed - -
NCT01910246 Insulin Resistance Phase 4 Withdrawn(No funding) - United States, California ... More >> UCSF, Radiology and Biomedical Imaging San Francisco, California, United States, 94143 Less <<
NCT00869362 - Completed - -
NCT00869362 Diabetes Mellitus, Type 2 Not Applicable Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT00865124 Type 2 Diabetes Mellitus ... More >> Vascular Disease Less << Not Applicable Completed - United States, Massachusetts ... More >> Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Less <<
NCT00875394 Diabetes Mellitus, Non-Insulin... More >>-Dependent Less << Phase 3 Completed - -
NCT00871936 Type 2 Diabetes Phase 2 Completed - United States, California ... More >> Anaheim, California, United States, 92801 Burbank, California, United States, 91505 Los Angeles, California, United States, 90036 Los Angeles, California, United States, 90057 United States, Florida West Palm Beach, Florida, United States, 33401 United States, Illinois Addison, Illinois, United States, 60101 United States, Maine Auburn, Maine, United States, 04210 United States, North Carolina Charlotte, North Carolina, United States, 28211 Hickory, North Carolina, United States, 28602 Winston-Salem, North Carolina, United States, 27103 United States, South Carolina Greenville, South Carolina, United States, 29615 United States, Texas San Antonio, Texas, United States, 78229 Less <<
NCT00875394 - Completed - -
NCT00873223 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 1 Completed - United States, California ... More >> Novo Nordisk Investigational Site Chula Vista, California, United States, 91911 Less <<
NCT00877864 Diabetes Mellitus Early Phase 1 Unknown December 2012 Canada, Alberta ... More >> University of Calgary Calgary, Alberta, Canada, T2T 5C7 Less <<
NCT00886574 Type 2 Diabetes Mellitus Phase 4 Unknown February 2014 Korea, Republic of ... More >> Inha University Hospital In Cheon, Korea, Republic of Hallym University Hospital Pyungcheon, Korea, Republic of Hallym University Hospital Seoul, Korea, Republic of Korea University Guro Hospital Seoul, Korea, Republic of Kyung hee University Medical Center Seoul, Korea, Republic of Ajou University Hospital Suwon, Korea, Republic of Less <<
NCT01295177 Diabetes Mellitus ... More >> Wounds Less << Phase 1 Phase 2 Completed - -
NCT00887302 - Unknown - United States, North Carolina ... More >> East Carolina University Brody School of Medicine Not yet recruiting Greenville, North Carolina, United States, 2783 Contact: Kelly E Jernigan, BS Biology    252-744-3361    jernigank@ecu.edu    Contact: Rita Bowden, RN    252-744-3361    bowdenr@ecu.edu Less <<
NCT01299844 Diabetes Mellitus, Non-Insulin... More >>-Dependent Less << Not Applicable Completed - United States, Connecticut ... More >> University of Connecticut Storrs, Connecticut, United States, 06269-4017 Less <<
NCT01301092 Diabetes Mellitus, Type II Phase 1 Completed - United States, Indiana ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Evansville, Indiana, United States Less <<
NCT00889785 Adolescents With Type 2 Diabet... More >>es Less << Not Applicable Completed - United States, Tennessee ... More >> Vanderbilt Univ Medical Center Nashville, Tennessee, United States, 37232 Less <<
NCT01303302 Diabetes Mellitus, Type 2 Not Applicable Completed - Austria ... More >> Medical University of Vienna Vienna, Austria Germany Gemeinschaftspraxis Drs. Klausmann Aschaffenburg, Germany, D-63739. Arzt für Innere Medizin und Endokrinologie Bad Nauheim, Germany Krankenhaus Sachsenhausen Frankfurt, Germany, 60594 Diabetes-Praxis Muenster Munster, Germany, 48153 Italy Università Cattolica S. Cuore Rome, Italy, 00168 Poland CMKP- Centrum Medyczne Kształcenia Podyplomowego Warszawa, Poland, 01-813 Less <<
NCT00882726 Diabetes Mellitus, Type 2 Phase 1 Completed - United States, Florida ... More >> Miramar, Florida, United States United States, Texas San Antonio, Texas, United States United States, Washington Tacoma, Washington, United States Less <<
NCT01308008 Diabetes Mellitus Type 2 Not Applicable Completed - United States, Michigan ... More >> VA Ann Arbor Healthcare System, Ann Arbor, MI Ann Arbor, Michigan, United States, 48105 Less <<
NCT02684279 Binge Eating Disorder Phase 3 Enrolling by invitation November 30, 2019 -
NCT01308008 - Completed - -
NCT01301092 - Completed - -
NCT01315808 - Terminated(Due to lack of fund... More >>s to continue this study.) Less << September 2012 United States, New York ... More >> Wyckoff Heights Medical Center Brooklyn, New York, United States, 11237 Less <<
NCT01313949 Diabetes Not Applicable Completed - Hong Kong ... More >> Diabetes Ambulatory Care Centre, UCH Kwun Tong, Kowloon, Hong Kong Kwai Chung out-patient clinic Kwai Chung, New Territories, Hong Kong CUHK YCK, Prince of Wales Hospital Shatin, New Territories, Hong Kong Diabetes & Endocrine Centre, Prince of Wales Hospital Shatin, New Territories, Hong Kong Diabetes Centre, North District Hospital Sheung Shui, New Territories, Hong Kong Diabetes Centre, Tung Wah Eastern Hospital Causeway Bay, Hong Kong Diabetes Hong Kong Central, Hong Kong Diabetes Ambulatory Centre, PYNEH Chai Wan, Hong Kong Diabetes Centre, Kwong Wah Hospital Kowloon, Hong Kong Diabetes Centre, Queen Elizabeth Hospital Kowloon, Hong Kong PMH, Diabetes Care Centre, Princess Margaret Hospital Kowloon, Hong Kong Lam Tin Health Clinic Lam Tin, Hong Kong Diabetes Centre, Queen Mary Hospital Pok Fu Lam, Hong Kong Sai Wan Ho Health Centre Sai Wan Ho, Hong Kong Diabetes Centre, Ruttonjee Hospital Wan Chai, Hong Kong Less <<
NCT01309620 Diabetes Mellitus, Non-Insulin... More >>-Dependent Less << Phase 2 Phase 3 Completed - -
NCT01319734 Type 2 Diabetes Mellitus Phase 1 Unknown - Sudan ... More >> Jaber abo aliz Recruiting Khartoum, Sudan, 1111 Contact: Khaled H Bakheet, MD,PhD    +249912957764    khalid2_3456@yahoo.com    Principal Investigator: Hamdan Z Hamdan, MBBS,MSc Less <<
NCT01316835 - Unknown December 2011 Taiwan ... More >> Kaohsiung Chang Gung Memorial Hospita Recruiting Kaohsiung, Taiwan Contact: Ching-Jung Hsieh, MD    886-7-7317123    rose@adm.cgmh.org.tw Less <<
NCT01315977 Type 2 Diabetes Mellitus Phase 1 Phase 2 Unknown April 2012 China, Hong Kong ... More >> Our Lady of Maryknoll Hospital Recruiting Kowloon, Hong Kong, China Contact: Siu Wai CHOI, PhD    +852 3400 8598    htswchoi@inet.polyu.edu.hk Less <<
NCT00551876 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT02408107 Breast Cancer Phase 3 Completed - -
NCT01316783 - Enrolling by invitation - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00554671 Diabetes Mellitus ... More >> Cardiovascular Diseases Less << Not Applicable Completed - United States, Connecticut ... More >> VA Connecticut Health Care System (West Haven) West Haven, Connecticut, United States, 06516 United States, Hawaii VA Pacific Islands Health Care System, Honolulu Honolulu, Hawaii, United States, 96819-1522 United States, Rhode Island Providence VA Medical Center, Providence, RI Providence, Rhode Island, United States, 02908 Less <<
NCT00554671 - Completed - -
NCT00550329 - Completed - Singapore ... More >> Pfizer Investigational Site Singapore, Singapore, 188770 Less <<
NCT00555854 Diabetes Not Applicable Completed - Denmark ... More >> Department of Endocrinology, Odense University Hospital Odense, Funen, Denmark, 5000 Less <<
NCT00554697 - Terminated(Unable to recruit s... More >>ubjects) Less << - -
NCT00552994 Diabetes Mellitus Not Applicable Completed - Denmark ... More >> Odense University Hospital Odense, Denmark, 5000 Less <<
NCT00562250 Diabetes Mellitus, Type 2 Phase 1 Completed - Argentina ... More >> Local Institution Vicente Lopez, Buenos Aires, Argentina, 1602 Less <<
NCT00559884 Type 2 Diabetes Mellitus ... More >> Diabetes Mellitus, Type 2 Less << Phase 1 Completed - United States, Ohio ... More >> GSK Investigational Site Columbus, Ohio, United States, 43212 Less <<
NCT00552227 Diabetes Mellitus Phase 1 Completed - United States, Pennsylvania ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 am to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Philadelphia, Pennsylvania, United States Less <<
NCT00565162 Diabetes Mellitus Phase 4 Completed - Finland ... More >> Sanofi-Aventis Helsinki, Finland Netherlands Sanofi-Aventis Amsterdam, Netherlands Sweden Sanofi-Aventis Stockholm, Sweden United Kingdom Sanofi-Aventis Leicester, United Kingdom Less <<
NCT00566358 Diabetes Mellitus, Type 2 Phase 1 Phase 2 Completed - Brazil ... More >> LIMED (Laboratory of Investigation of Metabolism and Diabetes)/GASTROCENTRO/Univeristy of Campinas (UNICAMP) Campinas, SP, Brazil Less <<
NCT00558909 Diabetes Mellitus, Type 2 Phase 1 Completed - Germany ... More >> 1224.4.49002 Boehringer Ingelheim Investigational Site Berlin, Germany 1224.4.49003 Boehringer Ingelheim Investigational Site Mainz, Germany 1224.4.49001 Boehringer Ingelheim Investigational Site Neuss, Germany Netherlands 1224.4.31001 Boehringer Ingelheim Investigational Site Zuidlaren, Netherlands Less <<
NCT00567112 Type 2 Diabetes Mellitus Phase 1 Completed - -
NCT00564668 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - Japan ... More >> Novo Nordisk Investigational Site Tokyo, Japan, 1000005 Less <<
NCT00567112 - Completed - -
NCT00569556 Diabetes Mellitus Not Applicable Completed - United States, Minnesota ... More >> Minneapolis Veterans Affairs Medical Center Minneapolis, Minnesota, United States, 55417 Less <<
NCT00567905 Type 2 Diabetes Phase 2 Phase 3 Completed - Taiwan ... More >> Branch of Chinese Medicine, Taipei City Hospital Taipei, Taiwan, 886 Branch of Chinese Medicine Taipei, Taiwan, 886 Less <<
NCT00566865 Type 2 Diabetes Mellitus Phase 1 Completed - -
NCT00573456 Diabetes Mellitus Phase 1 Unknown April 2009 Canada, Ontario ... More >> The Centre for Incurable Diseases Toronto, Ontario, Canada, M4V 1L5 Less <<
NCT00572650 Type 2 Diabetes Mellitus Phase 1 Completed - Germany ... More >> Novartis Investigator Site Kiel, Germany Less <<
NCT00570466 Type 2 Diabetes Not Applicable Completed - United States, Texas ... More >> Baylor College of Medicine Houston, Texas, United States, 77030 Less <<
NCT00577590 Diabetes Mellitus, Type II Not Applicable Completed - United States, Missouri ... More >> Washington University in St. Louis Saint Louis, Missouri, United States, 63110 Less <<
NCT00563225 Diabetes Mellitus Type II Phase 3 Completed - -
NCT00577590 - Completed - -
NCT00592241 Diabetes Mellitus Not Applicable Completed - Israel ... More >> RAMBAM Medical center Haifa, Israel, 34636 Less <<
NCT00576862 Diabetes Mellitus Phase 4 Completed - Belgium ... More >> Sanofi-Aventis Brussels, Belgium Less <<
NCT02918448 Metabolic Syndrome Phase 2 Completed - -
NCT00596973 Diabetes Phase 4 Withdrawn(Business Reasons) - United States, New York ... More >> Mount Sinai School of Medicine New York, New York, United States, 10029 Less <<
NCT01959763 Metabolic Syndrome ... More >> Obesity Overweight Cardiovascular Disease Less << Not Applicable Active, not recruiting March 2019 Finland ... More >> Oulu University Hospital Oulu, Finland, 90220 Less <<
NCT00575172 - Completed - Japan ... More >> Osaka Saiseikai Nakatsu Hospital Osaka, Japan, 503-0012 Less <<
NCT00605449 Type 2 Diabetes Mellitus Phase 1 Completed - United States, Texas ... More >> GSK Investigational Site Austin, Texas, United States, 78744 Less <<
NCT00592397 Obesity Diabe... More >>tes Mellitus Cardiovascular Diseases Less << Not Applicable Completed - Norway ... More >> Norwegian University of Science and Technology Trondheim, Mid-Norway, Norway, 7491 Less <<
NCT00602472 - Completed - -
NCT00607906 Diabetes Mellitus, Type 2 Phase 1 Completed - United States, Minnesota ... More >> GSK Investigational Site Minneapolis, Minnesota, United States, 55404 Less <<
NCT00608387 Cardiovascular Diseases ... More >> Diabetes Mellitus, Type 2 Hypertension Obesity Tobacco Use Cessation Less << Not Applicable Completed - United States, South Dakota ... More >> Black Hills Center for American Indian Health Rapid City, South Dakota, United States, 57701 Less <<
NCT00602472 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT00610038 Diabetes Mellitus Phase 2 Completed - France ... More >> Necker Hospital - Endocrinology Gynecology Pediatric unit Paris, France, 75015 Less <<
NCT00606112 Diabetes Mellitus ... More >> Obesity Less << Phase 1 Completed - United States, Texas ... More >> dgd Research San Antonio, Texas, United States, 78229 Less <<
NCT00607737 Diabetes Mellitus Phase 4 Completed - Denmark ... More >> Steno Diabetes Center Gentofte, Denmark, 2820 Less <<
NCT00615212 Diabetes Mellitus, Type 2 Phase 1 Completed - United States, New York ... More >> GSK Investigational Site Buffalo, New York, United States, 14202 Less <<
NCT00618995 Type 2 Diabetes Mellitus Phase 1 Completed - -
NCT00612144 Type 2 Diabetes Mellitus Phase 4 Completed - Korea, Republic of ... More >> Handok Pharmaceuticals, Co., LTD Seoul, Korea, Republic of Less <<
NCT00622323 - Completed - Philippines ... More >> Research Site Paranaque City, Philippines Research Site Pasig City, Philippines Research Site Taytay, Philippines Less <<
NCT00629434 Diabetes Mellitus Not Applicable Unknown August 2008 United States, New York ... More >> Joslin Diabetes Center Affiliate at SUNY Upstate Medical University Syracuse, New York, United States, 13214 Less <<
NCT00618995 - Completed - -
NCT02248350 Prostate Cancer ... More >> Physical Activity Side-effects Less << Not Applicable Completed - United States, District of Col... More >>umbia Office of Minority Health and Health Disparities Research Washington, District of Columbia, United States, 20003 Less <<
NCT00627471 Type 2 Diabetes Phase 4 Terminated(Low recruitment in ... More >>spite of strategies implemented) Less << - Argentina ... More >> Sanofi-aventis administrative office Argentina Buenos Aires, Argentina Less <<
NCT03687073 Smoking Phase 1 Recruiting July 2019 United States, Minnesota ... More >> Masonic Cancer Center at University of Minnesota Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Hanna Vanderloo, RN, MSN Less <<
NCT00633997 Diabetes Mellitus, Type 2 Phase 1 Phase 2 Terminated(After analysis of t... More >>he existing data, it was determined that additional skin biopsy samples would not be required to determine study outcome.) Less << - United States, Maryland ... More >> Novartis Investigator Site Baltimore, Maryland, United States, 21225 Less <<
NCT00639080 - Completed - Canada, British Columbia ... More >> Endocrine Research Society Vancouver, British Columbia, Canada, V6E 1M7 Less <<
NCT00638716 - Completed - -
NCT00641043 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT00638716 Type 2 Diabetes Mellitus Phase 2 Completed - Canada, Quebec ... More >> ConjuChem Biotechnologies Inc. Montreal, Quebec, Canada, H2X 3Y8 Less <<
NCT00641043 - Completed - -
NCT00643773 Type 2 Diabetes Phase 2 Phase 3 Completed - Netherlands ... More >> Maastricht University Maastricht, Netherlands, 6229 ER Less <<
NCT00645528 Diabetes Mellitus, Type 2 Not Applicable Completed - United States, Virginia ... More >> Hunter Holmes McGuire VA Medical Center Richmond, Virginia, United States, 23249 Less <<
NCT00641251 Type 2 Diabetes ... More >> Cardiovascular Disease Less << Not Applicable Completed - United States, Minnesota ... More >> University of Minnesota Minneapolis, Minnesota, United States, 55414 Mayo Clinic Rochester, Minnesota, United States, 55905 United States, New York Columbia University New York, New York, United States, 10032 Taiwan Min-Sheng General Hospital Taipei, Taiwan National Taiwan University Hospital Taipei, Taiwan Less <<
NCT00648284 - Completed - -
NCT00642798 Diabetes Mellitus Non-insulin-... More >>dependent Less << Phase 1 Completed - -
NCT00645528 - Completed - -
NCT00656682 Hyperglycemia ... More >> Obesity Diabetes Mellitus Less << Not Applicable Completed - United States, Illinois ... More >> Northwestern University Chicago, Illinois, United States, 60611 Less <<
NCT00653341 Diabetes Mellitus, Type 2 Phase 3 Completed - United States, New Jersey ... More >> Sanofi-aventis administrative office Bridgewater, New Jersey, United States, 08807 Canada Sanofi-aventis administrative office Laval, Canada Less <<
NCT00641407 Type 2 Diabetes Mellitus ... More >> Hypoglycemia Less << Phase 4 Completed - Italy ... More >> Department of Geriatrics and Metabolic Disease Naples, Italy, 80138 Less <<
NCT00657319 - Completed - Hungary ... More >> Novo Nordisk Investigational Site Budapest, Hungary, 1025 Less <<
NCT00657800 Diabetes Not Applicable Completed - United States, Pennsylvania ... More >> University of Pittsburgh Department of Medicine Pittsburgh, Pennsylvania, United States, 15213 Less <<
NCT00652509 Type 2 Diabetes Mellitus Not Applicable Completed - -
NCT00659932 Diabetes Mellitus Type 2 Not Applicable Completed - Australia, New South Wales ... More >> Royal Newcastle Hospital Newcastle, New South Wales, Australia, 2300 Less <<
NCT00659282 - Completed - Canada ... More >> Novo Nordisk Investigational Site Mississauga, Canada, L4W 4XI China, Beijing Novo Nordisk Investigational Site Beijing, Beijing, China, 100004 Greece Novo Nordisk Investigational Site Vouliagment, Greece, 16671 India Novo Nordisk Investigational Site Bangalore, India, 560001 Iran, Islamic Republic of Novo Nordisk Investigational Site Teheran, Iran, Islamic Republic of Italy Novo Nordisk Investigational Site Rome, Italy, 00144 Japan Novo Nordisk Investigational Site Tokyo, Japan, 1000005 Korea, Republic of Novo Nordisk Investigational Site Seoul, Korea, Republic of, 137-920 Poland Novo Nordisk Investigational Site Warszawa, Poland, PL-02-274 Russian Federation Novo Nordisk Investigational Site Moscow, Russian Federation, 119330 Saudi Arabia Novo Nordisk Investigational Site Riyadh, Saudi Arabia, 3542 Less <<
NCT00660790 - Completed - Austria ... More >> Department of Internal Medicine, Medical University of Graz Graz, Austria, 8036 Less <<
NCT03112083 Adverse Drug Event ... More >> Side Effects of Drugs Less << Not Applicable Completed - Finland ... More >> Oy Medfiles Ltd Kuopio, Finland, 70701 Less <<
NCT00657930 - Completed - Hungary ... More >> Budapest, Hungary, 1025 Less <<
NCT00660907 Type 2 Diabetes Phase 3 Completed - -
NCT00661908 - Completed - -
NCT00660309 - Completed - -
NCT00671424 Type 2 Diabetes Mellitus ... More >> Diabetes Mellitus, Type 2 Less << Phase 1 Completed - United States, Ohio ... More >> GSK Investigational Site Columbus, Ohio, United States, 43212 Less <<
NCT00660907 - Completed - -
NCT00668590 Diabetes Not Applicable Completed - United States, California ... More >> UCLA Internal Medicine practices Los Angeles, California, United States, 90024 Community-based primary care practices Los Angeles, California, United States, 90291 Less <<
NCT00666094 Diabetes Mellitus, Type 2 ... More >> Hyperglycemia Less << Not Applicable Completed - Norway ... More >> NTNU Trondheim, Norway Less <<
NCT00674050 Diabetes Mellitus ... More >> Healthy Subjects Less << Phase 1 Completed - United Kingdom ... More >> ICON Development Solutions Manchester, United Kingdom, United Kingdom Less <<
NCT00660309 Type 2 Diabetes Mellitus Phase 4 Completed - United States, Massachusetts ... More >> Novartis Investigator Site Boston, Massachusetts, United States, 02115 Less <<
NCT00668850 Diabetes Mellitus Phase 3 Unknown September 2011 -
NCT00680849 - Completed - United States, Oregon ... More >> Oregon Research Institute Eugene, Oregon, United States, 97403 Less <<
NCT02219581 Postoperative Pain ... More >> Inflammation Osteoarthritis Less << Phase 4 Recruiting September 25, 2020 United States, Georgia ... More >> Emory Orthopedic and Spine Hospital Recruiting Tucker, Georgia, United States, 30084 Contact: Thomas L Bradbury, MD       tom.bradbury@emory.edu    Principal Investigator: Thomas L Bradbury, MD          Sub-Investigator: James Roberson, MD          Sub-Investigator: Jimmy H Daruwalla, MD          Sub-Investigator: Greg Erens, MD          Sub-Investigator: Christina M Lomba, MS Less <<
NCT00679939 - Completed - -
NCT00679939 Diabetes Mellitus, Type 2 Phase 4 Completed - -
NCT00686634 - Completed - -
NCT00687284 - Completed - Slovakia ... More >> Novo Nordisk Investigational Site Kosice, Slovakia, 040 01 Less <<
NCT00677599 Cardiovascular Disease ... More >> Diabetes Less << Not Applicable Completed - United Kingdom ... More >> University of East Anglia (UK); School of Medicine, Health Policy and Practice Norwich, Norfolk, United Kingdom, NR47TJ Less <<
NCT00690638 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT00686634 Type 2 Diabetes Mellitus Phase 4 Completed - United States, California ... More >> Charles Drew University of Medicine and Science Los Angeles, California, United States, 90059 Less <<
NCT00692237 Diabetes Mellitus, Type 2 ... More >> Endothelial Dysfunction Less << Phase 4 Completed - Italy ... More >> Dipartimento di Fisiopatologia Medica - Policlinico Umberto I Rome, Italy, 00161 Less <<
NCT00692237 - Completed - -
NCT00693511 Obesity and Type 2 Diabetes Not Applicable Completed - United States, California ... More >> Veronica Atkins Lifestyle Intervention Laboratory Los Angeles, California, United States, 90033 Less <<
NCT00694070 - Completed - -
NCT00696163 - Completed - India ... More >> Novo Nordisk Investigational Site Bangalore, India, 560001 Less <<
NCT00681850 - Completed - -
NCT00696722 Type 2 Diabetes Mellitus Relat... More >>ed Endothelial Dysfunction Less << Phase 2 Completed - Netherlands ... More >> Radboud University Nijmegen Medical Centre Nijmegen, Gelderland, Netherlands, 6500 Less <<
NCT00697450 - Completed - Czech Republic ... More >> Novo Nordisk Investigational Site Prague, Czech Republic, 16000 Less <<
NCT00694278 - Unknown - United States, New York ... More >> Lutheran Medical Center Recruiting Brooklyn, New York, United States, 11220 Contact: George Ferzli, MD    718-630-7351 Less <<
NCT00699413 Obesity Diabe... More >>tes Mellitus, Type 2 Less << Phase 4 Terminated(Sponsor decided to ... More >>withdraw from study.) Less << - United States, California ... More >> USC - Preventive Medicine Los Angeles, California, United States, 90033 Less <<
NCT00698126 - Completed - Italy ... More >> Novo Nordisk Investigational Site Rome, Italy, 00144 Less <<
NCT00699426 Type 2 Diabetes Phase 3 Completed - -
NCT00700908 Type 2 Diabetes Not Applicable Completed - United States, Minnesota ... More >> Primary Care Center University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT00701831 Diabetes Mellitus, Type 2 Phase 4 Completed - Turkey ... More >> Sanofi-Aventis Administrative Office Istanbul, Turkey Less <<
NCT00699413 - Terminated(Sponsor decided to ... More >>withdraw from study.) Less << - -
NCT00703482 Patients With Type 2 Diabetes Phase 2 Completed - Australia ... More >> Site 002 Fremantle, Australia Site 003 Nedlands, Australia Site 001 Perth, Australia Less <<
NCT00704223 - Completed - Austria ... More >> Wien, Austria, 1140 Less <<
NCT00709917 - Completed - Belgium ... More >> Brussels, Belgium, 1070 Luxembourg Luxembourg, Luxembourg Less <<
NCT00700856 Type 2 Diabetes Mellitus ... More >> Cardiovascular Disease Less << Phase 4 Unknown December 2018 -
NCT00703027 - Completed - -
NCT00707590 Type 2 Diabetes Mellitus Phase 1 Terminated - Canada ... More >> Local Institution Quebec, Canada, G1P 0A2 Less <<
NCT01323114 Type 2 Diabetes Mellitus Not Applicable Unknown May 2014 United States, Michigan ... More >> McKenzie Health System Recruiting Sandusky, Michigan, United States, 48471 Contact: Marcus K Free, M.D.    810-648-9707    drfree@mckenziehealth.org    Contact: Steve Barnett, M.S.    810-648-3770 Less <<
NCT00694070 - Completed - United States, California ... More >> AMCR Institute Escondido, California, United States, 92026 Less <<
NCT01324388 Diabetes Mellitus, Type 2 Phase 1 Completed - United States, Hawaii ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Honolulu, Hawaii, United States, 96813 United States, Indiana For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Evansville, Indiana, United States, 47710 United States, Texas For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Dallas, Texas, United States, 75247 Less <<
NCT01847690 Addison Disease Phase 2 Unknown March 2014 Norway ... More >> Haukeland Universitetessykehus, Department of Medicine Bergen, Norway, 5021 Less <<
NCT01324388 - Completed - -
NCT01330121 Diabetes Mellitus Type 2 Not Applicable Completed - United States, Illinois ... More >> John H. Stroger Jr. Hospital of Cook County Chicago, Illinois, United States, 60612 Less <<
NCT00710008 Type 2 Diabetes Mellitus Not Applicable Completed - Austria ... More >> Landsteiner Institute Vienna, Austria, 1140 Less <<
NCT01330563 Type 2 Diabetes Mellitus Phase 1 Completed - Korea, Republic of ... More >> Severance Hospital Seoul, Korea, Republic of, 120-752 Less <<
NCT01332071 Diabetes Mellitus, Type 2 Phase 1 Completed - Brazil ... More >> GSK Investigational Site Goiania, Goiás, Brazil Less <<
NCT01324011 Diabetes Mellitus Not Applicable Completed - United States, North Carolina ... More >> UNC Center for Health Promotion and Disease Prevention (HPDP) Chapel Hill, North Carolina, United States, 27599-7426 Less <<
NCT01332071 - Completed - -
NCT01332370 - Completed - -
NCT01324505 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 1 Completed - Germany ... More >> Novo Nordisk Investigational Site Neuss, Germany, 41460 Less <<
NCT02042742 Healthy Phase 4 Completed - Spain ... More >> Hospital Universitario La Paz Madrid, Spain, 28061 Less <<
NCT01333592 - Completed - -
NCT01339520 Type 2 Diabetes Not Applicable Completed - United States, District of Col... More >>umbia Medical Faculty Associates, George Washington University Washington, D.C., District of Columbia, United States, 20037 Less <<
NCT00436176 Diabetes Phase 3 Completed - United States, Massachusetts ... More >> Harvard Vanguard Medical Associates Newton, Massachusetts, United States, 02466 Less <<
NCT00437008 Endothelial Dysfunction ... More >> Type 2 Diabetes Mellitus Less << Phase 4 Completed - Germany ... More >> Heart and Diabetes Center NRW Bad Oeynhausen, Germany, 32545 Less <<
NCT00437970 Diabetes Mellitus, Type 2 Phase 4 Withdrawn(Unable to secure sup... More >>ply of the study medication) Less << February 2009 Australia, Northern Territory ... More >> Menzies School of Health Research Darwin, Northern Territory, Australia, 0810 Less <<
NCT01336673 - Terminated(The study was sched... More >>uled for completion February 2013. Because of difficulties encountered in completing the trial the study was terminated by sponsor June 2013.) Less << - Thailand ... More >> Faculty of Medicine Vajira Hospital Bangkok, Thailand Less <<
NCT00437112 Diabetes Mellitus, Type 2 Phase 3 Completed - United States, California ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Greenbrae, California, United States, 94904 United States, Kansas For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Topeka, Kansas, United States, 66606 United States, New Jersey For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Toms River, New Jersey, United States, 08753 United States, New Mexico For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Albuquerque, New Mexico, United States, 87108 United States, Texas For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. New Braunfels, Texas, United States, 78130 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. San Antonio, Texas, United States, 78229 Brazil For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Porto Alegre, Brazil, 90035-003 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sao Paulo, Brazil, 04025-011 India For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Cochin, India, 682026 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Indore, India, 452 003 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Pune, India, 411005 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Vellore, India, 632 004 Puerto Rico For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Manatí, Puerto Rico, 00674 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. San Juan, Puerto Rico, 00907 Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Barakaldo, Spain, 48903 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Dos Hermanas, Spain, 41014 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Madrid, Spain, 28006 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Requena, Spain, 46340 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sabadell, Spain, 08208 Less <<
NCT01333592 Type 2 Diabetes Phase 3 Completed - Japan ... More >> Japan Kanto region, Chugoku region, Kyushu region, Japan Less <<
NCT00444392 Obese Patients ... More >> Type 2 Diabetes Mellitus Less << Phase 3 Completed - United States, Tennessee ... More >> Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232 Less <<
NCT00437164 Type 2 Diabetes Mellitus ... More >> Diabetes Mellitus, Type 2 Less << Phase 2 Terminated(Company decision no... More >>t related to safety.) Less << - United States, California ... More >> GSK Investigational Site Beverly Hills, California, United States, 90211 Less <<
NCT00440375 Type 2 Diabetes Mellitus ... More >> Obesity Menopause Less << Phase 4 Completed - -
NCT00444483 Impact of Structured DTTP on Q... More >>uality of Life Insulin Therapy Metabolic Control Psychological Aspects Less << Not Applicable Completed - -
NCT00447629 Diabetes Mellitus Phase 1 Completed - United States, Arizona ... More >> Phoenix, Arizona, United States, 85044 Less <<
NCT00448032 Diabetes Mellitus Phase 1 Completed - Japan ... More >> Tokyo, Japan, 171-0014 Less <<
NCT00449605 Diabetes Mellitus, Type 2 Phase 3 Terminated(Company decision ta... More >>ken in light of demands by certain national health authorities) Less << - United States, New Jersey ... More >> Sanofi-Aventis Administrative Office Bridgewater, New Jersey, United States, 08807 Chile Sanofi-Aventis Administrative Office Santiago, Chile Sanofi-aventis adminsitrative office Santiago, Chile Denmark Sanofi-Aventis Administrative Office Horsholm, Denmark Finland Sanofi-Aventis Administrative Office Helsinki, Finland Hungary Sanofi-Aventis Administrative Office Budapest, Hungary India Sanofi-Aventis Administrative Office Mumbai, India Italy Sanofi-Aventis Administrative Office Milan, Italy Korea, Republic of Sanofi-Aventis Administrative Office Seoul, Korea, Republic of Mexico Sanofi-Aventis Administrative Office Mexico, Mexico Puerto Rico Sanofi-Aventis Administrative Office Puerto Rico, Puerto Rico Romania Sanofi-Aventis Administrative Office Bucuresti, Romania Russian Federation Sanofi-Aventis Administrative Office Moscow, Russian Federation Spain Sanofi-Aventis Administrative Office Barcelona, Spain Sweden Sanofi-Aventis Administrative Office Bromma, Sweden Less <<
NCT00449930 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT00454623 Diabetes Mellitus Not Applicable Unknown June 2007 United States, New Jersey ... More >> Cooper University Hospital Camden, New Jersey, United States, 08103 Less <<
NCT00446810 Diabetes Mellitus, Type 2 Phase 4 Unknown December 2008 Germany ... More >> Herz- und Diabeteszentrum NRW, Georgstr. 11 Recruiting Bad Oeynhausen, North Rhine-Westphalia, Germany, 32545 Principal Investigator: Alin O Stirban, Dr. med. Less <<
NCT00461136 Diabetes Type 2 Phase 1 Phase 2 Completed - Denmark ... More >> Novartis Gentofte, Denmark, 2820 Less <<
NCT01411033 - Unknown - -
NCT01426529 Hypertension ... More >>Insulin Resistance Less << Phase 1 Active, not recruiting October 15, 2019 United States, Massachusetts ... More >> Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Less <<
NCT03771170 Peritonitis I... More >>ntoxication Less << Phase 4 Recruiting January 31, 2020 Georgia ... More >> "Unimedi Adjara" LLC Recruiting Batumi, Georgia Contact: Kahaber Kishibadje, MD          Principal Investigator: Kahaber Kishibadje, MD          Kutaisi Referral Hospital Recruiting Kutaisi, Georgia Contact: David Tevdoradze          Principal Investigator: David Tevdoradze          JSC EVEX/LTD Traumatology Recruiting Tbilisi, Georgia Contact: Jano Vashadze, MD          Principal Investigator: Jano Vashadze, MD          Moldova, Republic of Institute of Ambulance Recruiting Chisinau, Moldova, Republic of Contact: Adrian Beliy, MD          Principal Investigator: Adrian Beliy, MD          Municipal Clinical Hospital Recruiting Chisinau, Moldova, Republic of Contact: Silvia Agop, MD          Principal Investigator: Silvia Agop, MD          Republican Clinical Hospital Recruiting Chisinau, Moldova, Republic of Contact: Victor Cojocaru, MD          Principal Investigator: Viktor Kogokaru          Ukraine Institute of General and Urgent Surgery of the National Academy of Medical Sciences of Ukraine Recruiting Kharkov, Ukraine Contact: Peev Stanislav, MD          Principal Investigator: Peev Stanislav, MD          Kyiv City Clinical Hospital No.4; National Medical University named after O.O. Bogomolets Recruiting Kyiv, Ukraine Contact: Igor Kolosovich, MD          Principal Investigator: Igor Kolosovich, MD          HSEE of Ukraine "Ukrainian Medical Stomatological Academy"; Poltava Central District Hospital Recruiting Poltava, Ukraine Contact: Alexey Ligonenko, MD          Principal Investigator: Alexey Ligonenko, MD          Vinnytsa Regional Clinical Hospital Active, not recruiting Vinnitsa, Ukraine Uzbekistan Republic Centre of Ambulance Recruiting Tashkent, Uzbekistan Contact: Visolat Sharipova, MD          Principal Investigator: Visolat Sharipova, MD Less <<
NCT00440284 Type 2 Diabetes Phase 3 Unknown - Germany ... More >> Medical School, Friedrich Schiller University Jena Jena, Thuringia, Germany, 07740 Less <<
NCT00466362 - Unknown December 2008 Norway ... More >> Evjeklinikken AS Recruiting Evje og Hornnes, Evjemoen, Norway, 4735 Contact: Tor I Karlsen, RN, Cand. Polit.    0047 900 60 536    tik@evjeklinikken.no Less <<
NCT00467168 Type 2 Diabetes Mellitus Phase 1 Phase 2 Completed - China, Guangdong ... More >> Department of Clinical Nutrition, School of Public Health, Sun Yat-sen University Guangzhou, Guangdong, China, 510080 Department of Endocrinology, The First Hospital, Sun Yat-sen University Guangzhou, Guangdong, China, 510080 Less <<
NCT00463502 Diabetes Mellitus, Type 2 Phase 4 Completed - -
NCT00469105 Type 2 Diabetes Phase 4 Completed - United States, North Carolina ... More >> University of North Carolina at Chapel Hill, General Medicine Clinic Chapel Hill, North Carolina, United States, 27599 Less <<
NCT00470860 Diabetes Mellitus Not Applicable Completed - United States, California ... More >> Charles R. Drew University Los Angeles, California, United States, 90059 UCLA Medical Center Los Angeles, California, United States, 90095 Less <<
NCT00475371 Diabetes Mellitus, Type 2 ... More >> Healthy Males Less << Phase 1 Completed - Netherlands ... More >> University Medical Centre Groningen Zuidlaren, Netherlands, 9470 AE Less <<
NCT00449930 - Completed - -
NCT00476437 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - Japan ... More >> Tokyo, Japan, 1000005 Less <<
NCT00480805 Type 2 Diabetes Mellitus ... More >> Hypertension Less << Phase 3 Completed - -
NCT00472095 Type 2 Diabetes Not Applicable Unknown June 2017 United States, California ... More >> Adventist Health Selma Recruiting Fresno, California, United States Contact: Roger Mortimer, MD          Clinica Sierra Vista Recruiting Fresno, California, United States Contact: Roger Mortimer, MD          Deran Colegian Ambulatory Care Center Recruiting Fresno, California, United States Contact: Roger Mortimer, MD          Principal Investigator: Roger Mortimer, MD Less <<
NCT00481429 Diabetes Mellitus, Type 2 Not Applicable Completed - United Kingdom ... More >> Addenbrooke's Hospital Cambridge, United Kingdom, CB2 2GG Ealing Hospital London, United Kingdom, UB1 3HW Imperial College London - Hammersmith Campus London, United Kingdom, W12 ONN Charing Cross Hospital London, United Kingdom, W6 8RF Less <<
NCT01452048 - Recruiting July 2025 United States, Michigan ... More >> Michigan Clincal Research Unit Recruiting Ann Arbor, Michigan, United States, 48109 Contact: Suzette Howton, RD    734-647-9850    suzetter@med.umich.edu    Principal Investigator: Jeffrey F Horowitz, Ph.D. Less <<
NCT00464594 Diabetes Mellitus Not Applicable Unknown - Japan ... More >> Tokyo Medical and Dental University Recruiting Tokyo, Japan, 113-8519 Contact    03-3813-6111 Less <<
NCT00482079 Diabetes Mellitus, Type II Phase 2 Completed - -
NCT00471926 - Unknown April 2008 Taiwan ... More >> Martin M-T Fuh Recruiting Taichung, Taiwan, 404 Contact: Martin Fuh, MDSci    886-4-22062121 ext 4124    mmtfuh@www.cmuh.org.tw    Principal Investigator: Martin Fuh, MD,DMSci Less <<
NCT00482976 Diabetes Mellitus Phase 2 Completed - United States, Massachusetts ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Boston, Massachusetts, United States Less <<
NCT00485758 Diabetes Mellitus Type 2 Phase 3 Completed - -
NCT00482950 Type 2 Diabetes Mellitus Phase 2 Unknown February 2008 -
NCT00485758 - Completed - -
NCT00486291 Type 2 Diabetes Mellitus Phase 2 Completed - United States, Alabama ... More >> Research Site Birmingham, Alabama, United States United States, California Research Site Los Angeles, California, United States Research Site San Francisco, California, United States Research Site Spring Valley, California, United States Research Site Walnut Creek, California, United States United States, Maryland Research Site Bethesda, Maryland, United States United States, Texas Research Site Austin, Texas, United States Research Site San Antonio, Texas, United States United States, Virginia Research Site Richmond, Virginia, United States Less <<
NCT00484198 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT00486291 - Completed - -
NCT00489242 Diabetes Mellitus Not Applicable Completed - United States, New York ... More >> Mount Sinai School of Medicine New York, New York, United States, 10029 Less <<
NCT00486187 Type 2 Diabetes Mellitus Not Applicable Completed - Canada, Ontario ... More >> Partners Research Brampton, Ontario, Canada, L6V 1B4 Less <<
NCT00490893 Diabetes Mellitus ... More >> Hypoglycemia Less << Phase 4 Terminated - Germany ... More >> University of Tübingen, Medical Department Tübingen, Germany, 72076 Less <<
NCT00490854 Diabetes Mellitus, Type 2 Phase 2 Phase 3 Completed - Japan ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Aichi, Japan, 451-8511 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chiba, Japan, 2892511 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fukuoka, Japan, 830-8543 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fukushima, Japan, 963-8851 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Gunma, Japan, 370-2393 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hokkaido, Japan, 060-8648 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hyogo, Japan, 663-8501 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kanagawa, Japan, 235-0045 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nara, Japan, 632-8552 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Osaka, Japan, 569-1096 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Shiga, Japan, 520-2192 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tokyo, Japan, 150-8935 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Toyama, Japan, 930-8550 Less <<
NCT00487526 Diabetes Mellitus Phase 1 Unknown - Dominican Republic ... More >> Center for Advance Medicine Abel Gonzalez Recruiting Santo Domingo, Dominican Republic Contact: Abel Gonzalez, MD    809 543 79 81    abelcayo@yahoo.com    Contact    809 227 22 35 Less <<
NCT01466816 Obesity Insul... More >>in Resistance Less << Not Applicable Completed - Netherlands ... More >> Maastricht University Medical Centre + Maastricht, Limburg, Netherlands, 6229ER Less <<
NCT00499707 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT01470534 Obesity Phase 4 Unknown November 2012 United Kingdom ... More >> University of Nottingham Recruiting Nottingham, United Kingdom, NG7 2UH Contact: Dileep Lobo       dileep.lobo@nottingham.ac.uk    Principal Investigator: Dileep Lodo Less <<
NCT00478322 Diabetes Mellitus, Type 2 ... More >> Obesity Less << Phase 2 Completed - United States, California ... More >> Chula Vista, California, United States, 91911 United States, New York Bronx, New York, United States, 10461 United States, Texas San Antonio, Texas, United States, 78229 Less <<
NCT00496145 Type 2 Diabetes Not Applicable Completed - United States, California ... More >> Stanford Patient Education Research Center Palo Alto, California, United States, 94304 Less <<
NCT00500955 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT00499824 Type 2 Diabetes Mellitus Not Applicable Completed - China, Hong Kong ... More >> Department of Medicine & Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong Shatin, Hong Kong, China China Department of Endocrinology & Metabolism, Peking University People's Hospital Beijing, China, 100044 Indonesia Diabetes and Nutrition Center, Dr. Soetomo Teaching Hospital - Airlangga University, Surabaya, Indonesia, 60286 Korea, Republic of Department of Endocrinology & Metabolism, Kangnam St. Mary's Hospital, The Catholic University of Medicine Seoul, Korea, Republic of Malaysia School of Medicine and Health Sciences, Monash University House Johor Bahru, Malaysia, 80100 Philippines Section of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of the Philippines College of Medicine Manila, Philippines Singapore Diabetes, Lipid and Endocrine Practice, Gleneagles Medical Centre Singapore, Singapore, 258499 Taiwan Dept of Medical Research and Education, Taipei Veterans General Hospital, Taipei, Taiwan Thailand Diabetes and Endocrinology Unit, Department of Medicine, Rajavithi Hospital, Bangkok, Thailand, 10400 Vietnam National Hospital of Endocrinology, Hanoi, Dongda district, Vietnam Less <<
NCT00494715 Diabetes Phase 3 Completed - Italy ... More >> Clinical Research Center for Rare Diseases "Aldo e Cele Daccò" Ranica, Bergamo, Italy Hospital "Bolognini" Seriate, Bergamo, Italy Hospital "S.Marta e S.Venera" Acireale, Catania, Italy Hospital " Casa Sollievo della Sofferenza" - Unit of Nephrology San Giovanni Rotondo, Foggia, Italy Hospital "Azienda Ospedaliera Ospedali Riuniti di Bergamo" - Unit of Diabetology Bergamo, Italy Hospital "Vittorio Emanuele-Ferrarotto-Santo Bambino" Catania, Italy IRCCS San Raffaele - Unit of General Medicine Milan, Italy University "Federico II" Napoli, Italy Hospital "Azienda Ospedaliera di Parma" - Unit of Nephrology Parma, Italy Hospital "Azienda Ospedaliera di Treviglio e Caravaggio" - Ambulatory of Ponte San Pietro Ponte San Pietro, Italy Hospital "Azienda Ospedaliera di Treviglio e Caravaggio" Unit of Diabetology and Metabolic Diseases Romano di Lombardia, Italy University - AUSL 1 - Institute of Medical Pathology Sassari, Italy Hospital "G:Mazzini" Teramo, Italy Hospital "Azienda Ospedaliera di Treviglio-Caravaggio"Unit of Diabetology and Metabolic Diseases Treviglio, Italy Slovenia Clinical Department of Endocrinology, Diabetes and Metabolic Diseases University Medical Centre Ljubljana Ljubljana, Slovenia, 1000 Less <<
NCT00501930 Type 2 Diabetes Mellitus ... More >> Diabetes Mellitus, Type 2 Less << Phase 1 Completed - United States, Wisconsin ... More >> GSK Investigational Site Madison, Wisconsin, United States, 53704 Less <<
NCT00501488 - Completed - China, Hunan ... More >> Central South University Changsha, Hunan, China, 410078 Less <<
NCT00501683 Type 2 Diabetes Mellitus ... More >> Diabetes Mellitus, Type 2 Less << Phase 1 Completed - United States, Wisconsin ... More >> GSK Investigational Site Madison, Wisconsin, United States, 53704 Less <<
NCT00501020 Diabetes Mellitus, Type 2 Phase 4 Completed - -
NCT01487993 Obesity Insul... More >>in Resistance Less << Phase 3 Completed - Netherlands ... More >> Jeroen Bosch Hospital 's Hertogenbosch, Netherlands St. Antonius Hospital Nieuwegein, Netherlands, 3430EM Less <<
NCT00503152 Diabetes Phase 3 Completed - Italy ... More >> Hospital "Azienda Ospedaliera di Treviglio e Caravaggio" - Diabetologic Ambulatory of Ponte San Pietro Ponte San Pietro, Bergamo, Italy Clinical Research Center for Rare Diseases "Aldo e Cele Daccò" Ranica, Bergamo, Italy Hospital "Azienda Ospedaliera di Treviglio e Caravaggio" Unit of Diabetology and Metabolic Diseases Romano di Lombardia, Bergamo, Italy Hospital "Bolognini" Seriate, Bergamo, Italy Hospital "Azienda Ospedaliera di Treviglio-Caravaggio"Unit of Diabetology and Metabolic Diseases Treviglio, Bergamo, Italy Hospital "Casa Sollievo della Sofferenza" - Division of Endocrinology San Giovanni Rotondo, Foggia, Italy Hospital "Azienda Ospedaliera Ospedali Riuniti di Bergamo" - Unit of Diabetology Bergamo, Italy IRCCS San Raffaele - Unit of General Medicine Milano, Italy Azienda USL 2 Olbia, Italy Less <<
NCT01496092 Insulin Resistance Phase 3 Completed - China, Beijing ... More >> Jie Dong Beijing, Beijing, China, 100034 Less <<
NCT00511667 Type 2 Diabetes Mellitus Phase 1 Completed - -
NCT00511667 - Completed - -
NCT00513214 Type 2 Diabetes Phase 1 Phase 2 Completed - United States, California ... More >> Escondido, California, United States, 92026 United States, Florida Miami Gardens, Florida, United States, 33169 United States, Nebraska Omaha, Nebraska, United States, 68154 United States, Texas San Antonio, Texas, United States, 78229 Less <<
NCT00516048 Type 2 Diabetes Mellitus Phase 3 Completed - Australia, South Australia ... More >> Research Site Keswick, South Australia, Australia Canada, Alberta Research Site Calgary, Alberta, Canada Canada, British Columbia Research Site Vancouver, British Columbia, Canada Canada, Ontario Research Site London, Ontario, Canada Hungary Research Site Budapest, Hungary Research Site Gyula, Hungary Research Site Zalaegerszeg, Hungary Italy Research Site Milan, Italy Research Site Perugia, Italy Research Site Rome, Italy Korea, Republic of Research Site Seonnam City, Korea, Republic of Research Site Seoul, Korea, Republic of Research Site Suwon City, Korea, Republic of Less <<
NCT00504816 Type 2 Diabetes Mellitus ... More >> Diabetes Mellitus, Type 2 Less << Phase 1 Completed - United States, Florida ... More >> GSK Investigational Site Miramar, Florida, United States, 33025 Less <<
NCT00517283 Type 2 Diabetes Mellitus Phase 1 Completed - United Kingdom ... More >> Research Site Nottingham, United Kingdom Less <<
NCT00516074 Type 2 Diabetes Mellitus Phase 3 Completed - Canada, Nova Scotia ... More >> Research Site Halifax, Nova Scotia, Canada Canada, Ontario Research Site Toronto, Ontario, Canada Netherlands Research Site Etten-Leur, Netherlands Research Site Leiden, Netherlands Research Site Rotterdam, Netherlands Research Site Utrecht, Netherlands Less <<
NCT00516074 - Completed - -
NCT00518427 Diabetes Type 2 Phase 4 Completed - Sweden ... More >> Sanofi-Aventis Administrative Office Bromma, Sweden Less <<
NCT00519727 Type 2 Diabetes Mellitus Phase 1 Completed - Netherlands ... More >> Centre for Human Drug Research Leiden, Netherlands Less <<
NCT00518102 - Completed - -
NCT00522158 Type 2 Diabetes Mellitus ... More >> Cardiovascular Disease LDL Cholesterol Cognition Less << Phase 4 Completed - -
NCT03648554 Diabetes Mellitus, Type 2 ... More >> NASH - Nonalcoholic Steatohepatitis Less << Phase 4 Not yet recruiting May 30, 2023 France ... More >> CHU de CAEN Not yet recruiting Caen, France, 14033 Contact: Michael JOUBERT          Principal Investigator: Michael JOUBERT          CHU de DIJON Not yet recruiting Dijon, France, 21079 Contact: Jean-Michel PETIT          Principal Investigator: Jean-Michel PETIT          CHRU de MONTPELLIER Not yet recruiting Montpellier, France, 34295 Contact: Stéphanie FAURE          Principal Investigator: Stéphanie FAURE          CHU de REIMS Not yet recruiting Reims, France, 51092 Contact: Brigitte DELEMER          Principal Investigator: Brigitte DELEMER          CHU de ROUEN Not yet recruiting Rouen, France, 76031 Contact: Gaëtan PREVOST          Principal Investigator: Gaëtan PREVOST          CHU de TOULOUSE Not yet recruiting Toulouse, France, 31059 Contact: Hélène HANAIRE          Principal Investigator: Hélène HANAIRE          CHRU de NANCY Not yet recruiting Vandœuvre-lès-Nancy, France, 54500 Contact: Siham BENZIRAR    +33 3 83 15 50 56    s.benzirar@chru-nancy.fr    Contact: Amandine SEIWERT    +33 3 83 15 35 63    A.SEIWERT@chru-nancy.fr    Principal Investigator: Bruno GUERCI          G.H.M les Portes du Sud Not yet recruiting Venissieux, France, 69200 Contact: Pierre SERUSCLAT          Principal Investigator: Pierre SERUSCLAT Less <<
NCT00523913 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT00516048 - Completed - -
NCT00527995 Type 2 Diabetes Mellitus ... More >> Endothelial Dysfunction Less << Phase 3 Completed - Germany ... More >> German Diabetes Center Duesseldorf, North Rhine-Westphalia, Germany, 40225 Less <<
NCT00513201 Diabetes Mellitus ... More >> Cirrhosis Less << Phase 4 Completed - Italy ... More >> Department of Medicine Naples, Italy, 80131 Less <<
NCT02250989 - Unknown February 2016 Brazil ... More >> Clinics Hospital Recruiting Campinas, Sao Paulo, Brazil, 13083-888 Contact: Andrei C Sposito, PhD, MD    +55 19 3521-7554    brasiliaheartstudy@gmail.com    Principal Investigator: Andrei C Sposito, PhD, MD          Sub-Investigator: Riobaldo R Cintra, MD          Sub-Investigator: Thiago Quinaglia, PhD, MD          Sub-Investigator: Valeria N Figueiredo, PhD Less <<
NCT00522470 Type 2 Diabetes Mellitus ... More >> Obesity Less << Phase 4 Completed - Turkey ... More >> Baskent University Hospital Department of Endocrinology Ankara, Bahçelievler, Turkey, 06490 Less <<
NCT00532610 Type 2 Diabetes Mellitus ... More >> Diabetes Mellitus, Type 2 Less << Phase 1 Completed - United States, Wisconsin ... More >> GSK Investigational Site Madison, Wisconsin, United States, 53704 Less <<
NCT00530309 Diabetes Mellitus, Type 2 Phase 1 Completed - Japan ... More >> GSK Investigational Site Fukuoka, Japan, 812-0025 GSK Investigational Site Tokyo, Japan, 130-0004 GSK Investigational Site Tokyo, Japan, 160-0017 Less <<
NCT00534547 Diabetes Not Applicable Withdrawn(business reasons) - -
NCT00532506 Type 2 Diabetes Mellitus Phase 2 Completed - Japan ... More >> Fukuoka, Japan Gifu, Japan Gunma, Japan Hokkaido, Japan Ibaragi, Japan Kanagawa, Japan Kumamoto, Japan Oita, Japan Okinawa, Japan Tokyo, Japan Less <<
NCT00539409 Diabetes Mellitus, With Compli... More >>cations Less << Phase 2 Phase 3 Terminated(Administrative) - United States, Florida ... More >> Florida Atlantic University Boca Raton, Florida, United States, 33431 Less <<
NCT00533494 Type 2 Diabetes Mellitus Phase 3 Completed - Israel ... More >> Clalit Health Services Beersheva, Afula, Migdal Haemek, Israel Less <<
NCT03706690 Carcinoma, Non-Small-Cell Lung Phase 3 Recruiting January 31, 2025 -
NCT00540462 Type II Diabetes Mellitus Phase 4 Unknown December 2008 Taiwan ... More >> MinSheng Genral Hospital Recruiting Taoyuan, Taiwan Contact: Lee WeiJei, M.D, Ph.D    886-3-3179599 ext 1599    wjlee_obessurg_tw@yahoo.com.tw Less <<
NCT00540709 Diabetes Mellitus Phase 4 Completed - -
NCT00539890 Diabetes Type 2 Phase 3 Completed - Russian Federation ... More >> Ural State Medical Academy of Post-Graduate Education Municipal Clinical Hospital # 3 Chelyabinsk, RUS, Russian Federation, 454021 NHI Kemerovo Regional Clinical Hospital Kemerovo, RUS, Russian Federation, 650061 NI Principal Military Clinical Hospital n a academician N.N. Burdenko of the Ministry of Defense Moscow, RUS, Russian Federation, 105229 Moscow State Medico-Stomatological University City Hospital # 23 Moscow, RUS, Russian Federation, 109240 Russian State Medical University Moscow, RUS, Russian Federation, 109263 Clinical Research Institute of Physic-Chemical Medicine Hospital # 29 Moscow, RUS, Russian Federation, 111020 NEI HPE Moscow State University of Medicine and Dentistry of FAHSD City Clinical Hospital #70 Moscow, RUS, Russian Federation, 111399 Russian State Medical University City Hospital # 4 Moscow, RUS, Russian Federation, 113093 Russian Academy of Medical Sciences National Research Ctr for Endocrinology Institute of Diabetes Moscow, RUS, Russian Federation, 117036 Moscow Hospital of Glavmosstroy State Unitary Enterprise Medical Centre Medical Sanitary Unit #47 Moscow, RUS, Russian Federation, 117192 Russian State Medical University Central Clinical Hospital Russian Science Academy Moscow, RUS, Russian Federation, 117593 Sechenov Moscow Medical Academy Moscow, RUS, Russian Federation, 119881 Moscow Medical Academy Moscow, RUS, Russian Federation, 123478 Moscow, RUS, Russian Federation, 125315 SIH of Moscow City Clinical Hopsital #81 Endocrinology and Diabetology Moscow, RUS, Russian Federation, 127644 Moscow State Medical Stomatology University Municipal Hospital # 63 Endocrinology Diabetology Moscow, RUS, Russian Federation, 129090 Moscow City Clinical Hospital # 20 Moscow, RUS, Russian Federation, 129327 Municipal Clinical Hospital #13 Moscow, RUS, Russian Federation, 150062 Nizhni Novgorod regional hospital na Semashko N Novgorod, RUS, Russian Federation, 603126 Center Diabetes LLC Samara, RUS, Russian Federation, 443067 Saratov City Outpatient Clinic # 20 Saratov, RUS, Russian Federation, 410038 Saratov Medical University Faculty Therapy Chair Clinical Hospital # 3 Saratov, RUS, Russian Federation, 410054 NEI HPE Smolensk State Medical Academy of FAHSD RNHI Smolensk Regional Clinical Hospital Smolensk, RUS, Russian Federation, 214018 St Petersburg NHI City Polytclinic #77 City Diabetological Center #4 St Petersburg, RUS, Russian Federation, 193012 Central Medical Sanitary Unit #122 St Petersburg, RUS, Russian Federation, 194291 SPb Diabetological Center St Petersburg, RUS, Russian Federation, 194354 St Petersburg Medical Academy St Elizabeth Hospital St Petersburg, RUS, Russian Federation, 195257 Pavlov State Medical Univ of St Petersburg St Petersburg, RUS, Russian Federation, 197022 City Outpatient Clinic # 34 St Petersburg, RUS, Russian Federation, 197198 TUV Medico-Military Academy St Petersburg, RUS, Russian Federation, 198013 St Petersburg NHI Municipal Multi-Speciality Hospital # 2 St. Petersburg, RUS, Russian Federation, 194354 MHI Clinical Hospital for Emergency Care na NV Soloviev Yaroslavl, RUS, Russian Federation, 150003 Yaroslavl Regional Clinical Hospital Yaroslavl, RUS, Russian Federation, 150062 Less <<
NCT00541372 Diabetes Mellitus Phase 4 Completed - Netherlands ... More >> University Medical Centre Groningen Groningen, Netherlands Less <<
NCT00541437 - Completed - Taiwan ... More >> National Taiwan university hospital Taipei, Taiwan Less <<
NCT00537719 Diabetes Mellitus, Type 2 Phase 1 Completed - United States, Kentucky ... More >> GSK Investigational Site Lexington, Kentucky, United States, 40503 Less <<
NCT00543010 Diabetes Mellitus, Type 2 Phase 3 Terminated - -
NCT00541983 Type 2 Diabetes Phase 1 Completed - Switzerland ... More >> Covance Clinical Research (formerly Swiss Pharma Contract) Allschwil, Switzerland Zurich, Switzerland Less <<
NCT00541697 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT00543816 Diabetes Mellitus, Type 2 Phase 3 Terminated - -
NCT02352740 Overweight Hy... More >>pertriglyceridemic Waist Less << Not Applicable Completed - France ... More >> Centre de Recherche sur Volontaires (CRV), Hospital Avicenne Bobigny, Ile-de-France, France, 93000 Less <<
NCT00548158 - Completed - -
NCT00543738 Diabetes Mellitus Phase 3 Terminated - -
NCT00547027 Type 2 Diabetes ... More >> Physical Activity Less << Phase 2 Phase 3 Completed - United States, Florida ... More >> Florida State University Tallahassee, Florida, United States, 32306 Less <<
NCT00549133 Hypertension ... More >>Diabetes Mellitus Type 2 Less << Phase 4 Completed - Turkey ... More >> Sanofi-Aventis Istanbul, Turkey Less <<
NCT00549887 - Completed - Austria ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Purkersdorf, Austria, 3002 Czech Republic For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Beroun, Czech Republic, 26601 Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bad Homburg, Germany, D-61350 Greece For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Athens, Greece, 11527 Hungary For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bekescsaba, Hungary, 5600 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Budapest, Hungary, H-1139 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Dombovar, Hungary, 7200 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Dunaujvaros, Hungary, 2400 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Eger, Hungary, 3300 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Esztergom, Hungary, 2500 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Gyula, Hungary, 5700 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hodmezovasarhely, Hungary, H-6800 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kaposvar, Hungary, 7400 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Karcag, Hungary, 5301 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kecskemet, Hungary, 6000 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kisber, Hungary For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mako, Hungary, 6900 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mosonmagyarovar, Hungary, 9200 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nagykanizsa, Hungary, 8800 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Oroshaza, Hungary, 5901 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Papa, Hungary, 8500 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Pecs, Hungary, 7623 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Szekszard, Hungary, 7100 Poland For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Olesnica, Poland Romania For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bucharest, Romania, 020045 Slovakia For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bratislava, Slovakia, 85101 Turkey For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Konya, Turkey, 42075 Less <<
NCT00549757 Type 2 Diabetes Mellitus ... More >> Cardiovascular Disease Less << Phase 3 Terminated(Lack of benefit and... More >> safety concern) Less << - -
NCT01340079 Type 2 Diabetes Phase 1 Phase 2 Completed - United States, Massachusetts ... More >> Boston Medical Center Boston, Massachusetts, United States, 02118 Less <<
NCT01341392 Type 2 Diabetes Mellitus Phase 1 Completed - Korea, Republic of ... More >> Severance Hospital Seoul, Korea, Republic of, 120-752 Less <<
NCT00548639 Diabetes Not Applicable Unknown - United States, New York ... More >> Mount Sinai School of Medicine New York, New York, United States, 10029 Less <<
NCT01341717 Diabetes Mellitus, Type 2 Phase 4 Completed - India ... More >> Jothydev's Diabetes and Research Center Thiruvananthapuram, Kerala, India, 695032 Less <<
NCT01343056 Diabetes Mellitus Not Applicable Completed - United States, Pennsylvania ... More >> Pennsylvania State University Hershey, Pennsylvania, United States, 17033 University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States, 15213 Less <<
NCT00549757 - Terminated(Lack of benefit and... More >> safety concern) Less << - -
NCT00539851 - Completed - -
NCT01343056 - Completed - -
NCT00940602 Myelodysplastic Syndromes Phase 2 Completed - -
NCT01344668 Type 2 Diabetes Not Applicable Completed - United States, Tennessee ... More >> Vanderbilt University Nashville, Tennessee, United States, 37232 Less <<
NCT01345734 - Completed - Philippines ... More >> Novo Nordisk Investigational Site Manilla, Philippines, 1605 Less <<
NCT01340911 Diabetes Mellitus, Type 2 Phase 1 Completed - United Kingdom ... More >> GSK Investigational Site Harrow, Middlesex, United Kingdom, HA1 3UJ Less <<
NCT01346033 - Completed - United States, California ... More >> San Diego Convention Center San Diego, California, United States, 92111 Less <<
NCT00259896 Type 2 Diabetes Mellitus ... More >> Diabetes Mellitus, Type 2 Less << Phase 1 Completed - -
NCT01346527 - Completed - United States, Missouri ... More >> Washington University Saint Louis, Missouri, United States, 63110 Less <<
NCT00262548 Diabetes Mellitus, Type 2 Phase 4 Completed - Mexico ... More >> Research site Cuernavaca, Morelos, Mexico Less <<
NCT01347814 Diabetes Mellitus Not Applicable Completed - Ireland ... More >> Department of Physical Education & Sport Sciences, University of Limerick Limerick, Ireland Less <<
NCT00262704 Diabetes Mellitus Not Applicable Completed - United States, Minnesota ... More >> HealthPartners Research Foundation Minneapolis, Minnesota, United States, 55440 Less <<
NCT00260156 Diabetes Mellitus, Type 2 Phase 3 Completed - Switzerland ... More >> Novartis Pharmaceuticals Basel, Switzerland Less <<
NCT00266253 Diabetes Mellitus Type 2 Phase 2 Completed - -
NCT00264901 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 4 Completed - United States, New Jersey ... More >> Novo Nordisk Investigational Site Plainsboro, New Jersey, United States, 08536 Less <<
NCT00262977 Diabetes Mellitus Not Applicable Completed - United States, Illinois ... More >> Northwestern University, Division of General Internal Medicine Chicago, Illinois, United States, 60611 Less <<
NCT01346046 - Completed - United States, New Mexico ... More >> Albuquerque Convention Center Albuquerque, New Mexico, United States, 87102 Less <<
NCT00266240 Diabetes Mellitus Type 2 Phase 2 Completed - -
NCT01931982 Type 2 Diabetes ... More >> Microvascular Dysfunction Less << Phase 4 Completed - Denmark ... More >> Bispebjerg Hospital Copenhagen, Capital region, Denmark, 2400 Less <<
NCT00269061 Non-Insulin-Dependent Diabetes... More >> Mellitus Less << Phase 1 Completed - United States, Massachusetts ... More >> GSK Investigational Site Belmont, Massachusetts, United States, 02478 Less <<
NCT00263835 Diabetes Hype... More >>rtension Less << Phase 2 Completed - -
NCT00282945 Type 2 Diabetes Mellitus Not Applicable Terminated(See statement in De... More >>tailed Description.) Less << - Israel ... More >> Pfizer Investigational Site Holon, Israel, 58100 Pfizer Investigational Site Jerusalem, Israel, 91120 Less <<
NCT01134809 - Completed - United Kingdom ... More >> University Hospitals Nottingham Queen's Medical Centre Nottingham, United Kingdom, NG7 2UH Less <<
NCT01141777 Insulin Resistance ... More >> HIV/AIDS Less << Not Applicable Completed - Cameroon ... More >> National Obesity Centre, Yaounde Central Hospital Yaounde, Centre, Cameroon Less <<
NCT01151605 Insulin Resistance Phase 2 Unknown December 2013 United States, New York ... More >> Millard Fillmore Gates Hospital Buffalo, New York, United States, 14209 Less <<
NCT01150981 Metabolic Syndrome ... More >> Insulin Resistance Less << Phase 2 Completed - United States, Massachusetts ... More >> UMass Medical School Worcester, Massachusetts, United States, 01655 Less <<
NCT01150981 - Completed - -
NCT00288132 Diabetes Mellitus, Type 2 Not Applicable Completed - United States, South Carolina ... More >> CareSouth Bennettsville Bennettsville, South Carolina, United States, 29512 Less <<
NCT00290394 Diabetes Mellitus, Type 2 Phase 4 Completed - Turkey ... More >> Baskent University Ankara Hospital Ankara, Turkey, 06490 Less <<
NCT00297063 Diabetes Mellitus, Type 2 Phase 3 Completed - Japan ... More >> GSK Investigational Site Hokkaido, Japan, 051-0005 GSK Investigational Site Ibaraki, Japan, 311-0113 GSK Investigational Site Kanagawa, Japan, 224-0024 GSK Investigational Site Tokyo, Japan, 125-0054 GSK Investigational Site Tokyo, Japan, 130-0004 Less <<
NCT00287404 - Completed - United States, North Carolina ... More >> University of North Carolina Diabetes Care Center Durham, North Carolina, United States, 27713 Less <<
NCT00302224 Type 2 Diabetes Phase 1 Phase 2 Completed - United States, District of Col... More >>umbia Asha Thomas, MD - Medstar Washington DC, District of Columbia, United States, 20003 United States, Nebraska Marc Rendell, MD - Creighton University Omaha, Nebraska, United States, 68131 United States, Oregon Dr. Andrew Ahmann, MD - Radiant Research Portland, Oregon, United States, 97239 United States, Texas Carlos Arauz-Pacheco, MD - Radiant Research Dallas, Texas, United States, 75247 Sherwin Schwartz, MD - Diabetes and Glandular Disease Clinic San Antonio, Texas, United States, 78229 Less <<
NCT00291590 Diabetes Phase 3 Completed - United States, Washington ... More >> Puget Sound Veterans Administration Seattle, Washington, United States, 98101 Less <<
NCT00304603 - Completed - -
NCT00306176 Type II Diabetes Mellitus Phase 4 Completed - Greece ... More >> AHEPA University Hospital of Thessaloniki Thessaloniki, Greece, 54454 Less <<
NCT00298844 - Unknown January 2010 Denmark ... More >> Odense University Hospital Recruiting Odense, Denmark, 5000 Contact: Mikael K. Poulsen, PhD student    +45 6541 4365    doc_mkp@hotmail.com    Contact: Jan Erik Henriksen, MD, PhD    +45 6541 4364    jan.erik.henriksen@ouh.fyns-amt.dk    Principal Investigator: Mikael K Poulsen, PhD student Less <<
NCT00311324 Type 2 Diabetes Not Applicable Completed - United States, North Carolina ... More >> Center for Health Promotion and Disease Prevention/UNC-Chapel Hill Chapel Hill, North Carolina, United States, 27599 Less <<
NCT03171415 Obesity Weigh... More >>t Loss Overweight and Obesity Less << Phase 2 Active, not recruiting January 2019 United States, Wisconsin ... More >> Spaulding Clinical West Bend, Wisconsin, United States, 53095 Less <<
NCT00317915 Type 2 Diabetes ... More >> Microalbuminuria Hypertension Less << Phase 3 Completed - -
NCT00306696 Diabetes Mellitus Phase 4 Completed - -
NCT00316758 Diabetes Mellitus Type 2 Phase 2 Completed - -
NCT00318032 Type 2 Diabetes Mellitus Not Applicable Unknown November 2015 United Kingdom ... More >> University Hospitals of Leicester, Leicester Royal Infirmary Leicester, Leicestershire, United Kingdom, LE4 0AW Less <<
NCT00320086 - Unknown November 2008 United States, New Mexico ... More >> University of New Mexico Recruiting Albuquerque, New Mexico, United States, 87131 Contact: Franceska Kelly    505-272-9889    FMKelly@salud.unm.edu Less <<
NCT00321542 - Unknown September 2017 Israel ... More >> Lady Davis Carmel Medical Center Haifa, Israel, 34362 Less <<
NCT03635177 Stroke, Lacunar Not Applicable Not yet recruiting August 20, 2020 Denmark ... More >> University of Copenhagen Not yet recruiting Copenhagen, Denmark Contact: Lasse Gliemann, PhD       gliemann@nexs.ku.dk    Contact: Nicolai R Mortensen, MSc    22131945    nim@nexs.ku.dk    Principal Investigator: Ylva Hellsten, PhD          Sub-Investigator: Christina Kruuse, MD PhD Less <<
NCT00326222 Diabetes Mellitus Not Applicable Completed - Norway ... More >> Nord-Trondelag Hospital Trust Levanger, Nord-Trondelag, Norway, 7600 Less <<
NCT01224886 Obesity Physi... More >>cal Inactivity Aging Less << Not Applicable Recruiting October 2019 Switzerland ... More >> University of Bern Active, not recruiting Bern, Switzerland UNIL and CHUV Recruiting Lausanne, Switzerland, 1005 Contact: Francesca Amati, MD, PhD    +41 21 692 5552    francesca.amati@unil.ch    Principal Investigator: Francesca Amati, MD, PhD          Sub-Investigator: Luc Tappy, MD Less <<
NCT00324792 Diabetes Mellitus ... More >> Leucotrienes Less << Not Applicable Completed - France ... More >> Département d'urologie, néphrologie et endocrinologie-University Hospital of Grenoble Grenoble, France, 38043 Less <<
NCT00332488 - Completed - -
NCT00334113 Diabetes Mellitus, Type 2 ... More >> Obesity Less << Not Applicable Completed - United States, Massachusetts ... More >> VA Medical Center, Jamaica Plain Campus Boston, Massachusetts, United States, 02130 Less <<
NCT00332488 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT00334399 Type 2 Diabetes Mellitus Phase 3 Completed - Japan ... More >> Aichi, Japan Chiba, Japan Fukuoka, Japan Gifu, Japan Gunma, Japan Hokkaido, Japan Ibaragi, Japan Kanagawa, Japan Kumamoto, Japan Miyazaki, Japan Osaka, Japan Saitama, Japan Tochigi, Japan Less <<
NCT00333723 Diabetes Mellitus, Type 2 Phase 4 Completed - -
NCT00311922 Diabetes Not Applicable Completed - United States, Tennessee ... More >> Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232 Less <<
NCT00334503 Type 2 Diabetes Mellitus Phase 3 Completed - Japan ... More >> Aichi, Japan Chiba, Japan Fukuoka, Japan Gunma, Japan Hokkaido, Japan Ibaragi, Japan Kagoshima, Japan Kanagawa, Japan Kumamoto, Japan Miyazaki, Japan Oita, Japan Osaka, Japan Saitama, Japan Less <<
NCT00337610 Type 2 Diabetes Mellitus (T2DM... More >>) Less << Phase 3 Completed - -
NCT00334113 - Completed - -
NCT00337610 - Completed - -
NCT00340093 Diabetes Phase 1 Completed - United States, Maryland ... More >> Johns Hopkins University Baltimore, Maryland, United States, 21205 Mount Washington Pediatric Hospital Baltimore, Maryland, United States Less <<
NCT00337038 Hypertension ... More >>Diabetes Mellitus Type 2 Less << Early Phase 1 Completed - -
NCT00347100 Diabetes Mellitus, Type 2 Phase 4 Completed - China ... More >> Sanofi-Aventis Beijing, China Less <<
NCT00349986 Diabetes Mellitus, Type 2 Phase 4 Terminated(prematurely termina... More >>ted due to loss of interest) Less << - Hungary ... More >> Sanofi-Aventis Budapest, Hungary Less <<
NCT00344240 Type 2 Diabetes Not Applicable Completed - United States, Michigan ... More >> Mobility Research Center Ann Arbor, Michigan, United States, 48105 Less <<
NCT02050607 Metabolic Syndrome Phase 3 Unknown August 2016 Italy ... More >> Catholic University of Sacred Heart - "A. Gemelli" University Hospital Not yet recruiting Rome, Italy, 00168 Contact: Giovanni Cammarota, MD    +390630155948    gcammarota@rm.unicatt.it    Principal Investigator: Giovanni Cammarota, MD          Sub-Investigator: Gianluca Ianiro, MD          Sub-Investigator: Andrea Giaccari, MD          Sub-Investigator: Caterina Conte, MD          Sub-Investigator: Antonio Gasbarrini, MD Less <<
NCT00355849 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT00354536 Diabetes Mellitus, Type 2 Phase 2 Completed - United States, Florida ... More >> GSK Investigational Site Miramar, Florida, United States, 33025 GSK Investigational Site Orlando, Florida, United States, 32809 United States, Hawaii GSK Investigational Site Honolulu, Hawaii, United States, 96814-4224 United States, Oregon GSK Investigational Site Portland, Oregon, United States, 97239 United States, Texas GSK Investigational Site San Antonio, Texas, United States, 78229 Less <<
NCT00284609 Type 2 Diabetes Mellitus Not Applicable Completed - Denmark ... More >> Endocrine Section, Dept Internal Medicine I, Bispebjerg Hospital, University of Copenhagen Copenhagen, Copenhagen NV, Denmark, DK-2400 Less <<
NCT00358254 - Completed - United States, New Mexico ... More >> InLight Solutions Albuquerque, New Mexico, United States, 87106 Tricore Reference Laboratory- Presbyterian Professional Building Albuquerque, New Mexico, United States, 87106 Less <<
NCT00353990 Diabetes Mellitus Phase 1 Phase 2 Completed - Denmark ... More >> Medical Department M Aarhus, Denmark, DK-8000 C Less <<
NCT00359801 Diabetes Mellitus Phase 4 Completed - -
NCT00358124 Type 2 Diabetes Mellitus Phase 4 Completed - United States, New Jersey ... More >> Sanofi-Aventis Bridgewater, New Jersey, United States, 08807 Less <<
NCT00359801 - Completed - -
NCT00361907 Diabetes Mellitus Phase 2 Phase 3 Terminated(Administrative - Su... More >>spended by IRB) Less << - United States, Florida ... More >> Florida Atlantic University Center for Complex Systems and Brain Sciences Boca Raton, Florida, United States, 33431 Less <<
NCT00365781 Type 2 Diabetes Mellitus Phase 1 Completed - United States, California ... More >> Therapeutics Clinical Research San Diego, California, United States, 92121 Less <<
NCT00366301 Type 2 Diabetes Phase 4 Terminated(Interim analyses de... More >>monstrated futility. Thus, recruitment curtailed 10/08.) Less << - United States, Massachusetts ... More >> Brigham and Women's Hospital Boston, Massachusetts, United States, 02215 Less <<
NCT00366301 - Terminated(Interim analyses de... More >>monstrated futility. Thus, recruitment curtailed 10/08.) Less << - -
NCT00368134 Diabetes Mellitus, Type 2 Phase 3 Completed - Japan ... More >> Novartis Pharmaceuticals Tokyo, Japan Less <<
NCT00370942 Diabetes Mellitus, Type 2 Phase 2 Terminated(Safety issue) - Japan ... More >> GSK Investigational Site Hokkaido, Japan, 051-0005 GSK Investigational Site Miyagi, Japan, 985-0852 GSK Investigational Site Tokyo, Japan, 130-0004 GSK Investigational Site Tokyo, Japan, 160-0017 Less <<
NCT00372463 Type 2 Diabetes Phase 2 Completed - United States, California ... More >> Stanford Patient Education Research Center Palo Alto, California, United States, 94304 Less <<
NCT00375388 Type 2 Diabetes Mellitus Phase 3 Completed - Netherlands ... More >> Bethesda General Hospital and Bethesda Diabetes Center Hoogeveen, Drenthe, Netherlands, 7909 AA Less <<
NCT00377676 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT00376038 Type 2 Diabetes Mellitus ... More >> Diabetes Mellitus, Type 2 Less << Phase 1 Completed - Mexico ... More >> GSK Investigational Site Mexico, D.F., Mexico, 14050 Less <<
NCT00380445 Diabetes Mellitus, Type 2 Phase 3 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 Germany Novartis Investigative Site Investigative Centers, Germany Less <<
NCT00380822 Type 2 Diabetes Mellitus Phase 3 Completed - Japan ... More >> Aichi, Japan Chiba, Japan Fukuoka, Japan Gunma, Japan Hiroshima, Japan Hyogo, Japan Ibaragi, Japan Ishikawa, Japan Iwate, Japan Kumamoto, Japan Kyoto, Japan Mie, Japan Miyagi, Japan Nagasaki, Japan Niigata, Japan Oita, Japan Okayama, Japan Osaka, Japan Saga, Japan Saitama, Japan Shiga, Japan Shimane, Japan Shizuoka, Japan Tokyo, Japan Toyama, Japan Yamagata, Japan Yamaguchi, Japan Less <<
NCT00384215 Diabetes Mellitus, Type 2 Phase 4 Completed - United States, New Jersey ... More >> Sanofi-Aventis Bridgewater, New Jersey, United States, 08807 Less <<
NCT00383110 - Completed - -
NCT00377676 - Completed - -
NCT00391040 Diabetes Mellitus Not Applicable Completed - Germany ... More >> Bethesda Hospital Stuttgart, Baden Württemberg, Germany, 70184 Less <<
NCT00394030 Diabetes Mellitus, Type 2 Phase 1 Completed - United States, California ... More >> GSK Investigational Site Long Beach, California, United States, 90806 GSK Investigational Site Walnut Creek, California, United States, 94598 United States, Florida GSK Investigational Site Miramar, Florida, United States, 33025 GSK Investigational Site Orlando, Florida, United States, 32809 United States, North Carolina GSK Investigational Site Morrisville, North Carolina, United States, 27560 United States, Texas GSK Investigational Site San Antonio, Texas, United States, 78229 Less <<
NCT00383110 - Completed - United States, South Carolina ... More >> Ralph H. Johnson VA Medical Center, Charleston, SC Charleston, South Carolina, United States, 29401-5799 Less <<
NCT00359996 Diabetes Not Applicable Completed - United States, Illinois ... More >> The University of Chicago Chicago, Illinois, United States, 60637 Less <<
NCT00394875 Diabetes Mellitus, Type 2 Not Applicable Completed - Netherlands ... More >> Isala Clinics Zwolle, Netherlands, 8025 AB Less <<
NCT00395603 Cardiovascular Diseases ... More >> Diabetes Mellitus Less << Phase 3 Terminated(This study was term... More >>inated early due to poor recruitment.) Less << - -
NCT00398892 Diabetes Mellitus, Type 2 Phase 2 Unknown January 2011 United Kingdom ... More >> Diabetes Department, St John's Hospital Recruiting Livingston, Scotland, United Kingdom, EH54 6PP Principal Investigator: James D Walker, MD Less <<
NCT00399204 Type 2 Diabetes Phase 4 Unknown - India ... More >> PGIMER Recruiting Chandigarh, India, 160012 Contact: Samir Malhotra, MD, DM       samirmalhotra345@yahoo.com    Sub-Investigator: Samir Malhotra, MD,DM Less <<
NCT00399347 - Unknown - Israel ... More >> Primary care clinics Afula, Israel Less <<
NCT00400283 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 1 Completed - Germany ... More >> Novo Nordisk Investigational Site Berlin, Germany, 14050 Less <<
NCT00400491 Type 2 Diabetes Phase 2 Completed - Norway ... More >> Clinical Research Unit, University Hospital of North Norway Tromsø, Norway, 9038 Less <<
NCT00403091 Diabetes Mellitus Type 2 Not Applicable Completed - United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35294 University of Alabama Tuscaloosa, Alabama, United States, 35487 Less <<
NCT00403741 Diabetes Mellitus, Type 2 Not Applicable Completed - -
NCT00404027 - Completed - United States, Iowa ... More >> Iowa City VA Health Care System, Iowa City, IA Iowa City, Iowa, United States, 52246-2208 Less <<
NCT00407641 Diabetes Mellitus ... More >> Hemodialysis Less << Phase 4 Withdrawn(Financial and admini... More >>strative matters did not allow collaboration among centers.) Less << - Romania ... More >> Baia Mare County Hospital Baia Mare, Romania "Sarah" Hemodialysis Centre Brasov, Romania "Dr Carol Davila" Teaching Hospital of Nephrology Bucharest, Romania, 010731 "N Paulescu" Institute Bucharest, Romania Fundeni Clinical Hospital Bucharest, Romania Cluj University Hospital Cluj, Romania Dolj County Hospital Craiova, Romania Vrancea County Hospital Focsani, Romania "CI Parhon" Clinical Hospital Iasi, Romania Bihor County Hospital Oradea, Romania Prahova County Hospital Ploiesti, Romania Dambovita County Hospital Targoviste, Romania Timisoara County Hospital Timisoara, Romania Less <<
NCT01555385 Healthy Subjects Not Applicable Completed - Finland ... More >> University of Helsinki, Institute of Biomedicine Helsinki, Finland, 00014 Less <<
NCT01351324 Cardiovascular Risk Factors Not Applicable Completed - United Kingdom ... More >> University of Reading Reading, United Kingdom Less <<
NCT00419302 Diabetes Mellitus, Type 2 Phase 2 Completed - Germany ... More >> Profil Institute for Metabolic Research Hellersbergstr, Germany, D-41460 Less <<
NCT00421850 Diabetes Mellitus Not Applicable Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT01361971 Obesity Type ... More >>2 Diabetes Less << Not Applicable Completed - Australia, South Australia ... More >> University of Adelaide Adelaide, South Australia, Australia Less <<
NCT03172533 Anorexia Nervosa Phase 2 Recruiting March 15, 2019 Germany ... More >> Department of Psychosomatic Medicine and Psychotherapy, University Hospital Erlangen Recruiting Erlangen, Bavaria, Germany, 91054 Contact: Georgios Paslakis, MD, PhD    0049-9131-8534898    georgios.paslakis@uk-erlangen.de Less <<
NCT00424762 Diabetes Mellitus, Type 2 Phase 4 Completed - United States, Texas ... More >> University of Texas Southwestern Medical Center Dallas, Texas, United States, 75390-9034 Less <<
NCT00427271 Diabetes Mellitus ... More >> Microalbuminuria Less << Phase 4 Unknown - Brazil ... More >> Hospital de Clínicas de Porto Aelgre Recruiting Porto Alegre, RS, Brazil, 900035900 Contact: Sandra P Silveiro, MD    55 51 33325188    sandrasilveiro@terra.com.br    Principal Investigator: Sandra P Silveiro, MD          Sub-Investigator: Eduardo G Camargo, MD Less <<
NCT00424762 - Completed - -
NCT02056691 Colorectal Cancer Not Applicable Completed - United Kingdom ... More >> The Royal Bournemouth Hospital Bournemouth, Dorset, United Kingdom, BH7 7DW Poole Hospital Poole, Dorset, United Kingdom, BH15 2JB Less <<
NCT00423501 Diabetes Mellitus Type 2 Phase 2 Completed - -
NCT00404599 Diabetes Mellitus ... More >> Hypertension Less << Phase 4 Unknown July 2009 Netherlands ... More >> VU University Medical Center Recruiting Amsterdam, Netherlands, 1007 MB Less <<
NCT02620072 Diabetes Mellitus, Type 1 Phase 2 Recruiting June 2021 Germany ... More >> Forschergruppe Diabetes, Klinikum rechts der Isar, Technische Universität München, Lehrstuhl für Diabetes und Gestationsdiabetes, der Technischen Universität München Recruiting München, Deutschland (deu), Germany, 80804 Contact: Anette-G. Ziegler, Prof. Dr., MD    +49 (0)800 464 ext 8835    diabetes.frueherkennung@helmholtz-muenchen.de Less <<
NCT00432679 Diabetes Mellitus, Type 2 Phase 3 Completed - Japan ... More >> GSK Investigational Site Kumamoto, Japan, 862-0976 GSK Investigational Site Oita, Japan, 870-0039 Less <<
NCT00289887 Hypertension Phase 3 Completed - -
NCT00289887 - Completed - -
NCT03390985 - Completed - -
NCT01349387 Type 2 Diabetes Not Applicable Completed - France ... More >> Centre Hospitalier Sud Francilien Corbeil Essonnes, France, 91106 Less <<
NCT01354990 - Completed - -
NCT01357109 Type 2 Diabetes Mellitus Phase 2 Completed - Sweden ... More >> Karolinska Institutet, Karolinska University Hospital Stockholm, Sweden, 17176 Less <<
NCT00430742 Obesity Type 2 Diabetes Mellit... More >>us Type 2 Diabetes Mellitus Less << Phase 3 Terminated(The overall profile... More >> does not support development for obesity) Less << - -
NCT01357135 - Completed - -
NCT01355718 - Completed - Korea, Republic of ... More >> Seoul, Korea, Republic of, 137-920 Less <<
NCT01354990 - Completed - -
NCT01357148 - Terminated(Completion of MK-04... More >>31A-235 was rendered unnecessary, as the local oversight authority accepted in its stead the results of another study [MK-0431-234].) Less << - -
NCT01357135 - Completed - -
NCT01915433 Multiple Sclerosis Not Applicable Completed - United States, Iowa ... More >> Univeristy of Iowa Iowa City, Iowa, United States, 52240 Univeristy of Iowa Iowa City, Iowa, United States, 52246 Less <<
NCT01364584 Type 2 Diabetes Not Applicable Completed - United States, Colorado ... More >> University of Colorado Anschutz Medical Campus Aurora, Colorado, United States, 80045 Less <<
NCT01357148 - Terminated(Completion of MK-04... More >>31A-235 was rendered unnecessary, as the local oversight authority accepted in its stead the results of another study [MK-0431-234].) Less << - -
NCT01364584 - Completed - -
NCT01366287 Diabetes Mellitus, Type 2 Phase 1 Completed - Belgium ... More >> Pfizer Investigational Site Bruxelles, Belgium, 1070 Less <<
NCT01368081 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT01365091 Type 2 Diabetes Mellitus Phase 1 Completed - Brazil ... More >> Local Institution Campinas, Sao Paulo, Brazil, 13073 Less <<
NCT00856882 Diabetes Card... More >>iovascular Risk Less << Not Applicable Completed - -
NCT00094770 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT01365091 - Completed - -
NCT00094263 - Completed - -
NCT00094770 - Completed - -
NCT00095030 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT01368328 Type 2 Diabetes Phase 3 Unknown September 2011 Brazil ... More >> Goiania Municipal Health Departament Goiânia, Goiás, Brazil, 74000000 Less <<
NCT00884494 Obesity Insul... More >>in Resistance Normal Weight,Healthy Controls Less << Phase 1 Completed - United States, Tennessee ... More >> Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232 Less <<
NCT00331448 - Unknown - -
NCT00883038 Insulin Resistance Phase 1 Completed - Czech Republic ... More >> Institute for Clinical and Experimental Medicine Prague, Czech Republic Less <<
NCT01368081 - Completed - -
NCT00099333 Type 2 Diabetes Mellitus Phase 2 Completed - United States, California ... More >> Research Site Chula Vista, California, United States United States, Montana Research Site Butte, Montana, United States United States, Oregon Research Site Portland, Oregon, United States United States, Tennessee Research Site Nashville, Tennessee, United States United States, Texas Research Site San Antonio, Texas, United States Less <<
NCT00099151 Aging Cardiov... More >>ascular Disease Diabetes Mellitus Less << Not Applicable Completed - United States, Louisiana ... More >> Pennington Biomedical Research Center, 6400 Perkins Road Baton Rouge, Louisiana, United States, 70808 Less <<
NCT00874341 Cardiovascular Disease Phase 1 Completed - United Kingdom ... More >> Queen's University Belfast Belfast, Northern Ireland, United Kingdom, BT12 6BJ Royal Victoria Hospital Belfast, United Kingdom, BT12 6BJ Less <<
NCT02163798 Physical Activity Not Applicable Completed - Hong Kong ... More >> Chinese University of Hong Kong Hong Kong, Hong Kong Less <<
NCT00287430 Cystic Fibrosis Not Applicable Unknown - -
NCT00005137 Cardiovascular Diseases ... More >> Heart Diseases Diabetes Mellitus, Non-insulin Dependent Diabetes Mellitus Less << Not Applicable Completed - -
NCT00005380 - Completed - -
NCT00005193 - Completed - -
NCT00005530 - Completed - -
NCT00123110 Insulin Resistance ... More >> Postmenopause Less << Phase 2 Completed - United States, Pennsylvania ... More >> University of Pennsylvania Clinical and Translational Research Center Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT02021682 - Completed - United States, Missouri ... More >> Washington University in St. Louis Saint Louis, Missouri, United States, 63110 Less <<
NCT00006163 Diabetes Mellitus, Type 2 Phase 4 Completed - United States, Colorado ... More >> AMC Cancer Research center Denver, Colorado, United States, 80214 Less <<
NCT00005146 - Completed - -
NCT00005745 - Completed - -
NCT00006165 Diabetes Mellitus, Type 2 Not Applicable Completed - United States, Hawaii ... More >> University of Hawaii, John A. Burns School of Medicine Honolulu, Hawaii, United States, 96813 Less <<
NCT00099957 Diabetes Mellitus, Type 2 Phase 2 Completed - Switzerland ... More >> Novartis Pharmaceuticals Basel, Switzerland Less <<
NCT00197132 Insulin Resistance Phase 3 Completed - Netherlands ... More >> GSK Clinical Trials Call Center Nijmegen, Netherlands, 6525EZ Less <<
NCT00006159 Diabetes Not Applicable Completed - United States, New Mexico ... More >> University of New Mexico School of Medicine Albuquerque, New Mexico, United States, 87131 Less <<
NCT00208637 Insulin Resistance Not Applicable Completed - New Zealand ... More >> Edgar National Centre for Diabetes Research Dunedin, Otago, New Zealand, 9001 Less <<
NCT00222924 Diabetes Obes... More >>ity Less << Not Applicable Completed - United States, Pennsylvania ... More >> University of Pittsburgh Pittsburgh, Pennsylvania, United States, 15213 Less <<
NCT03168867 Type 1 Diabetes Mellitus Not Applicable Recruiting March 2022 United States, Illinois ... More >> Ann & Robert H. Lurie Children's Hospital of Chicago Recruiting Chicago, Illinois, United States, 60611 Contact: Meredyth Evans, Ph.D.    312-227-3441    MAEvans@luriechildrens.org    Principal Investigator: Jill Weissberg-Benchell, Ph.D.          Children's Hospital University of Illinois Recruiting Chicago, Illinois, United States, 60612 Contact: Meredyth Evans, Ph.D.    312-227-3441    MAEvans@luriechildrens.org    Principal Investigator: Jill Weissberg-Benchell, Ph.D.          La Rabida Children's Hospital Recruiting Chicago, Illinois, United States, 60649 Contact: Meredyth Evans, Ph.D.    312-227-3441    MAEvans@luriechildrens.org    Principal Investigator: Jill Weissberg-Benchell, Ph.D.          United States, Michigan Children's Hospital of Michigan Recruiting Detroit, Michigan, United States, 48201 Contact: Jillian Rhind    313-577-6997    jrhind@med.wayne.edu    Principal Investigator: Deborah A Ellis, Ph.D. Less <<
NCT03359577 Psoriasis Vulgaris Not Applicable Active, not recruiting August 31, 2018 Norway ... More >> Haukeland Universitetssjukehus Bergen, Norway, 5021 Less <<
NCT00006068 Diabetes Mellitus Not Applicable Unknown - -
NCT00011141 Diabetes Mellitus Not Applicable Completed - United States, New York ... More >> Cornell University New York, New York, United States, 10021 Less <<
NCT00012649 - Completed - United States, California ... More >> VA Palo Alto Health Care System, Palo Alto, CA Palo Alto, California, United States, 94304-1290 United States, Michigan VA Ann Arbor Healthcare System, Ann Arbor, MI Ann Arbor, Michigan, United States, 48105 United States, North Carolina Durham VA Medical Center, Durham, NC Durham, North Carolina, United States, 27705 United States, Wisconsin William S. Middleton Memorial Veterans Hospital, Madison, WI Madison, Wisconsin, United States, 53705 Less <<
NCT03631173 Pancreatic Cancer ... More >> Pancreatic Neoplasms Biliary Tract Cancer Duodenal Cancer Pancreatic Fistula Less << Not Applicable Not yet recruiting November 1, 2022 -
NCT00012662 Diabetes Mellitus Self Managem... More >>ent Education Hyperglycemic Control High Risk Diabetes Less << Not Applicable Completed - United States, Kansas ... More >> Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD Baltimore, Kansas, United States, 21201 Less <<
NCT00012688 Diabetes Mellitus ... More >> Poor Glycemic Control Peridontal Disease Less << Not Applicable Completed - United States, Massachusetts ... More >> Edith Nourse Rogers Memorial Veterans Hospital, Bedford, MA Bedford, Massachusetts, United States, 01730 Less <<
NCT00013208 Diabetes Mellitus Not Applicable Completed - United States, Michigan ... More >> VA Ann Arbor Healthcare System, Ann Arbor, MI Ann Arbor, Michigan, United States, 48105 Less <<
NCT00152945 Insulin Resistance Not Applicable Completed - Canada, Ontario ... More >> University Health Network Toronto, Ontario, Canada, M5G 2c4 Less <<
NCT00013117 Diabetes Mellitus Not Applicable Completed - United States, Ohio ... More >> Louis Stokes VA Medical Center, Cleveland, OH Cleveland, Ohio, United States, 44106 Less <<
NCT00007696 - Completed - United States, North Carolina ... More >> VA Medical Center Durham, North Carolina, United States, 27705 Less <<
NCT03008551 Polycystic Ovary Syndrome Phase 2 Phase 3 Completed - United Kingdom ... More >> Michael White Centre for Diabetes and Endocrinology Hull, East Yorkshire, United Kingdom, HU3 2RW Less <<
NCT00285805 Insulin Resistance Not Applicable Completed - Netherlands ... More >> Radboud University Nijmegen medical centre Nijmegen, Netherlands, 6500 HB Less <<
NCT00012753 Diabetes Phase 3 Completed - United States, Michigan ... More >> VA Palo Alto Health Care System, Palo Alto, CA Palo Alto, Michigan, United States, 94304-1290 Less <<
NCT03210545 Addison Disease Phase 4 Not yet recruiting December 1, 2020 Sweden ... More >> Centrum for Endocrinology and Metabolism, Sahlgenska University Hospital Not yet recruiting Gothenburg, Sweden, 413 45 Contact: Johanna Mc Queen, MD       johanna.mcqueen@gu.se    Sub-Investigator: Johanna Mc Queen, MD Less <<
NCT01928940 - Completed - -
NCT01928940 Solid Tumours Phase 2 Completed - Japan ... More >> GSK Investigational Site Shizuoka, Japan, 411-8777 GSK Investigational Site Tokyo, Japan, 104-0045 Less <<
NCT00018239 Diabetes Mellitus Not Applicable Completed - United States, Maryland ... More >> VA Maryland Health Care System Baltimore, Maryland, United States, 21201 Less <<
NCT00275223 - Completed - United States, Georgia ... More >> Emory University Hospital Atlanta, Georgia, United States, 30322 Less <<
NCT00021879 - Completed - -
NCT03380416 Diabetes Type 2 ... More >> NAFLD Less << Not Applicable Recruiting December 2019 Italy ... More >> Department of Clinical Medicine and Surgery Recruiting Naples, Italy, 80131 Contact: Angela A Rivellese    +39 0817462154    rivelles@unina.it Less <<
NCT00022750 Diabetes Mellitus, Type 2 Not Applicable Completed - United States, Maryland ... More >> The Johns Hopkins Medical Institutions Baltimore, Maryland, United States, 21205 Less <<
NCT01199848 Nutritional and Metabolic Dise... More >>ases Inflammation Physiological Responses Less << Not Applicable Active, not recruiting October 15, 2019 United States, Illinois ... More >> Clinical Nutrition Research Center Chicago, Illinois, United States, 60616 Less <<
NCT00345436 - Completed - United States, District of Col... More >>umbia Childrens National Medical Center Washington, D.C., District of Columbia, United States Less <<
NCT01329770 Fragile X Syndrome Phase 2 Completed - Spain ... More >> Psychiatric Service. Hospital Carlos Haya Malaga, Spain, 29009 Less <<
NCT00032487 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT00868387 Obesity Not Applicable Completed - Germany ... More >> Heart Center North Rhine-Westfalia Bad Oeynhausen, North Rhine-Westfalia, Germany, 32545 Less <<
NCT03401970 Adiposity Not Applicable Enrolling by invitation December 2020 Norway ... More >> Forskningsenhet for helseundersøkelser (research unit for clinical trials), Department of Clinical Science, University of Bergen Bergen, Norway, 5021 Less <<
NCT00036192 Diabetes Mellitus Phase 2 Completed - -
NCT00032487 - Completed - -
NCT00398619 Insulin Resistance ... More >> Obesity Less << Phase 1 Completed - United States, California ... More >> Beverly Hills, California, United States, 90211 Chula Vista, California, United States, 91911 Less <<
NCT00035542 Diabetes Mellitus, Non-Insulin... More >>-Dependent Less << Phase 3 Completed - -
NCT00401791 Insulin Resistance Phase 4 Unknown October 2016 United States, Louisiana ... More >> Pennington Biomedical Research Center Baton Rouge, Louisiana, United States, 70808 Less <<
NCT01876875 Plaque-type Psoriasis ... More >> Obesity (Body Mass Index >30 kg/m2) Less << Phase 4 Completed - Italy ... More >> federico II University Naples, Italy, 80129 Less <<
NCT00036504 Type 2 Diabetes Mellitus Phase 4 Completed - United States, California ... More >> LaJolla, California, United States Walnut Creek, California, United States United States, Connecticut New Britain, Connecticut, United States United States, Florida Longwood, Florida, United States United States, Georgia Atlanta, Georgia, United States Fayetteville, Georgia, United States United States, Idaho Boise, Idaho, United States United States, Illinois Springfield, Illinois, United States United States, New Jersey Mt. Laurel, New Jersey, United States New Brunswick, New Jersey, United States United States, New York Syracuse, New York, United States United States, Tennessee Chattanooga, Tennessee, United States United States, Texas Dallas, Texas, United States Less <<
NCT01948414 Hyperalimentation and Obesity Not Applicable Completed - France ... More >> CRNH Rhône-Alpes /CENS Centre Européen pour la Nutrition et la Santé Centre Hospitalier Lyon Sud - Pavillon médical 165, chemin du Grand Revoyet Pierre Bénite, France, 69310 Less <<
NCT03495336 Cardiovascular Diseases Not Applicable Completed - Cyprus ... More >> Eastern Mediterrenean University Famagusta, Cyprus, 99450 Less <<
NCT00439491 Obesity Insul... More >>in Resistance Less << Not Applicable Completed - Czech Republic ... More >> Third Faculty of Medicine, Charles University in Prague Prague, Czech Republic, 100 00 Less <<
NCT03338855 Diabetes Mellitus, Type 2 ... More >> Skeletal Muscle Insulin Sensitivity Less << Phase 4 Recruiting December 16, 2019 Netherlands ... More >> Research Site Recruiting Maastricht, Netherlands, 6229 HX Less <<
NCT03685552 Gastrointestinal Symptoms Not Applicable Completed - United States, Utah ... More >> The Hughes Center for Research and Innovation Lehi, Utah, United States, 84043 Less <<
NCT00044707 Diabetes Mellitus, Non-Insulin... More >>-Dependent Less << Phase 2 Completed - United States, Florida ... More >> ICSL-Clinical Studies Fort Lauderdale, Florida, United States, 33301 Less <<
NCT03027336 Dyslipidemias Phase 2 Completed - Italy ... More >> Endocrinology Unit Parma, Italy, 43126 Less <<
NCT02883127 - Recruiting March 2019 Denmark ... More >> Center for Pregnant Women with Diabetes Recruiting Copenhagen, Østerbro, Denmark, 2100 Contact: Björg Ásbjörnsdóttir, MD    +45 2285 6797    bjoerg.asbjoernsdottir.01@regionh.dk Less <<
NCT00044447 Diabetes Mellitus, Non-Insulin... More >>-Dependent Less << Phase 3 Completed - United States, Texas ... More >> Dallas Diabetes & Endocrine Center Dallas, Texas, United States, 75230 Less <<
NCT00477997 Insulin Resistance Not Applicable Completed - Denmark ... More >> Department M (endocrinology and diabetes) Aarhus, Denmark, 8000 Less <<
NCT02482402 Chronic Left Ventricular Failu... More >>re Pulmonary Hypertension Less << Phase 2 Withdrawn(Delay in recruitment... More >>) Less << - Germany ... More >> Klinik für Thorax- und Kardiovaskularchirurgie Bad Oeynhausen, Germany, 32545 Thoraxclinic at the University of Heidelberg Heidelberg, Germany, 69126 Less <<
NCT00483210 Tissue Lipid Metabolism Not Applicable Withdrawn(The study goals were... More >> accomplished by a similar study at UAMS. (W.J. Evans)) Less << - -
NCT01063569 Addison's Disease Phase 2 Phase 3 Completed - Norway ... More >> Haukeland University Hospital Bergen, Norway, 5021 Sweden Karolinska Institutet Stockholm, Sweden Uppsala University Uppsala, Sweden Less <<
NCT00512525 Healthy Subjects Phase 1 Completed - -
NCT00057317 Diabetes Phase 2 Completed - -
NCT03658213 Breast Cancer Phase 3 Not yet recruiting December 31, 2020 China, Beijing ... More >> The 307th hospital of Chinese People's Liberation Army Not yet recruiting Beijing, Beijing, China Contact: Zefei JIANG Less <<
NCT00555451 Insulin Resistance Phase 1 Completed - United States, Louisiana ... More >> Baton Rouge, Louisiana, United States, 70808 United States, Texas dgd Research, Inc. San Antonio, Texas, United States, 78229 Less <<
NCT00057304 Diabetes Phase 2 Completed - -
NCT00568568 Insulin Resistance Not Applicable Completed - Denmark ... More >> Department M (endocrinology and diabets) Aarhus, Denmark, 8000 Less <<
NCT00063674 Obesity Diabe... More >>tes Mellitus Prediabetic State Less << Phase 2 Phase 3 Completed - United States, California ... More >> Stanford University School of Medicine Palo Alto, California, United States, 94304 Less <<
NCT02820402 - Active, not recruiting December 2021 -
NCT03764670 - Not yet recruiting December 2020 Taiwan ... More >> National Taiwan University Hospital Not yet recruiting Taipei, Taiwan Contact: Meng-Kun Tsai, Professor    +886-972651461    mengkuntsai@ntu.edu.tw Less <<
NCT00068887 - Withdrawn(NOT A CLINICAL TRIAL... More >>) Less << - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT03687476 Niemann-Pick Disease, Type C Phase 2 Not yet recruiting October 30, 2022 -
NCT03639623 Non-alcoholic Fatty Liver Dise... More >>ase in Liver Transplant Recipients Less << Phase 2 Recruiting July 2020 United States, Virginia ... More >> Virginia Commonwealth University Recruiting Richmond, Virginia, United States, 23298 Contact: Sherry Boyett, RN    804-828-5434 Less <<
NCT00438126 Prediabetes M... More >>etabolic Syndrome Overweight Obesity Less << Not Applicable Completed - United States, New Mexico ... More >> University of New Mexico School of Medicine Albuquerque, New Mexico, United States, 87110 Less <<
NCT00065312 Diabetes Mellitus, Non-Insulin... More >>-Dependent Less << Phase 2 Completed - -
NCT03406065 Supplementation ... More >> Sport Less << Phase 2 Phase 3 Completed - Poland ... More >> Poznan University of Life Sciences, ul.Wojska Polskiego 31 Poznań, Wielkopolska, Poland, 60-624 Less <<
NCT00069836 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT02358122 Gastrointestinal Diseases ... More >> Cardiovascular Diseases Obesity Less << Not Applicable Unknown December 2015 -
NCT00617435 Insulin Resistance ... More >> Obesity Less << Not Applicable Completed - France ... More >> Centre de Recherche en Nutrition Humaine Auvergne Clermont Ferrand, France, 63000 Centre de Recherche en Nutrition Humaine Rhônes-Alpes Lyon, France, 69000 Less <<
NCT00646698 - Completed - Denmark ... More >> Medical Research Laboratories Aarhus, Denmark, 8000 Less <<
NCT00071422 Diabetes Mellitus, Non-Insulin... More >>-Dependent Less << Phase 2 Completed - United States, California ... More >> Diabetes and Endocrine Associates La Jolla, California, United States, 92037 VA Hospital UCSD San Diego, California, United States, 92161 Diablo Clinical Research Walnut Creek, California, United States, 94598 United States, Colorado Denver, Colorado, United States, 80209 Longmont Medical Research Network Longmont, Colorado, United States, 80501 United States, District of Columbia MedStar Clinical Research Center Washington, District of Columbia, United States, 20003 United States, Massachusetts Future Care Studies Springfield, Massachusetts, United States, 01107 United States, Montana Mercury Street Medical Butte, Montana, United States, 59701 United States, New York Diabetes-Endocrinology Center of WNY Buffalo, New York, United States, 14209 United States, North Carolina UNC Diabetes Care Center Durham, North Carolina, United States, 27713 Piedmont Medical Group Winston-Salem, North Carolina, United States, 27103 United States, Oregon Clinical Research Institute of Southern Oregon Medford, Oregon, United States, 97504 United States, South Carolina Mountain View Clinical Research Greer, South Carolina, United States, 29651 United States, Texas Dallas Diabetes and Endocrine Center Dallas, Texas, United States, 75230 University of Texas Health Science Center - Texas Diabetes Institute San Antonio, Texas, United States, 78207 DGD Research Associates San Antonio, Texas, United States, 78229 United States, Virginia Charlottesville Medical Research Charlottesville, Virginia, United States, 22911 Less <<
NCT02546050 Healthy Phase 1 Completed - Denmark ... More >> The Novo Nordisk Foundation Center of Basic Metabolic Research, Section for Metabolic Genetics, University of Copenhagen Copenhagen, Copenhagen Ø, Denmark, 2100 Less <<
NCT00668928 Insulin Resistance Phase 1 Completed - -
NCT03108950 Multiple Sclerosis ... More >> Stroke Less << Not Applicable Recruiting December 2018 United States, Alabama ... More >> Lakeshore Foundation Recruiting Birmingham, Alabama, United States, 35209 Contact: Casey L Herman    205-403-5504    caseyh@lakeshore.org Less <<
NCT00680797 Aging Insulin... More >> Resistance Less << Not Applicable Completed - United States, California ... More >> VA Greater Los Angeles Healthcare System, West Los Angeles, CA West Los Angeles, California, United States, 90073 Less <<
NCT01013051 - Completed - Canada, Alberta ... More >> University of Alberta Hospital Clinical Investigation Unity Edmonton, Alberta, Canada, T6G2B7 Less <<
NCT01062269 Healthy Phase 4 Completed - United States, Kentucky ... More >> L-MARC Research Center Louisville, Kentucky, United States, 40213 Less <<
NCT01062269 - Completed - -
NCT00750438 Obesity Not Applicable Completed - United Kingdom ... More >> Hammersmith Hospital London, UK, United Kingdom, W12 0NN Less <<
NCT02936336 Metabolic Disease Not Applicable Completed - Taiwan ... More >> Sports Medicine Center, Chang Gung Memorial Hospital Pizi, Taiwan, 613 Less <<
NCT00755729 Colorectal Disease Phase 4 Completed - China, Shanghai ... More >> Department of General Surgery, Shanghai Chang Zheng Hospital, Shanghai, Shanghai, China, 200003 Less <<
NCT00765505 Obesity Not Applicable Completed - United States, Pennsylvania ... More >> University of Pittsburgh Pittsburgh, Pennsylvania, United States, 15213 Less <<
NCT00765596 - Completed - United States, Tennessee ... More >> Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232 Less <<
NCT00763074 Insulin Sensitivity ... More >> Type 2 Diabetes Less << Not Applicable Completed - -
NCT02613715 Overweight and Obesity ... More >> Healthy Less << Phase 1 Completed - Portugal ... More >> CINTESIS - Faculty of Medicine of the University of Porto Porto, Portugal, 4200-450 Less <<
NCT00775164 Obesity Insul... More >>in Resistance Less << Phase 4 Withdrawn(Inadequate enrollmen... More >>t) Less << February 2011 -
NCT00787761 Myeloproliferative Disorders ... More >> Kidney Cancer Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases Less << Phase 2 Completed - United States, Georgia ... More >> Blood and Marrow Transplant Group of Georgia Atlanta, Georgia, United States, 30342 Less <<
NCT02456636 Obesity Not Applicable Active, not recruiting April 2020 United States, Kansas ... More >> University of Kansas Medical Center Kansas City, Kansas, United States, 66160 Less <<
NCT00801645 Obesity Not Applicable Completed - Switzerland ... More >> Department of Child and Adolescent, University Hospital of Geneva Geneva, Switzerland, 1205 Less <<
NCT00906724 - Unknown December 2009 United States, District of Col... More >>umbia Children's National Medical Center Washington, District of Columbia, United States, 20010 Less <<
NCT03394651 - Recruiting April 1, 2022 China, Shanghai ... More >> Changhai Hospital Recruiting Shanghai, Shanghai, China, 200433 Contact: Qi-Xiang Song, MD    8615021223013    rex_song918@qq.com Less <<
NCT00101478 - Completed - United States, Maryland ... More >> University of Maryland Baltimore Baltimore, Maryland, United States, 21201 Bon Secours Hospital Baltimore, Maryland, United States, 21223 Less <<
NCT03718728 Overweight and Obesity Not Applicable Recruiting December 31, 2020 Spain ... More >> Department of Personality Assesment and Psychological Treatments of the Faculty of Psychology of the Basque Country University (UPV/EHU) Recruiting Donostia-San Sebastian, Gipuzkoa, Spain, 20018 Contact: Edurne Maiz Aldalur, PhD    +34 943 01 8343    edurne.maiz@ehu.eus    Contact: Idoia Iturbe Telleria, Graduate    +34 943 01 5655    idoia.iturbe@ehu.eus    Principal Investigator: Edurne Maiz Aldalur, PhD          Principal Investigator: Enrique Echeburúa Odriozola, Professor          Sub-Investigator: María Soledad Cruz Saez, PhD          Sub-Investigator: Eva Pereda Pereda, Graduate          Sub-Investigator: Idoia Iturbe Telleria, Graduate Less <<
NCT00101530 - Completed - United States, Colorado ... More >> Denver Health Medical Center Denver, Colorado, United States, 80204 Less <<
NCT00108927 - Completed - United States, Minnesota ... More >> Dept of Family Medicine and Community Health, University of Minnesota Medical School Minneapolis, Minnesota, United States, 55414 Less <<
NCT00680797 - Completed - -
NCT00106808 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT00109369 Diabetes Mellitus Not Applicable Completed - United States, Vermont ... More >> University of Vermont Burlington, Vermont, United States, 05401 Less <<
NCT00787761 - Completed - -
NCT00983554 Obesity Insul... More >>in Resistance Less << Not Applicable Unknown October 2009 United States, California ... More >> University of California, San Diego San Diego, California, United States, 92103 VA San Diego Healthcare System San Diego, California, United States, 92161 Less <<
NCT00111631 Diabetes Mellitus Type 2 Phase 2 Completed - -
NCT00962195 Health Blood ... More >>Pressure Liver Function Insulin Resistance Less << Not Applicable Completed - Netherlands ... More >> TNO Quality of Life Zeist, Utrecht, Netherlands Less <<
NCT00111670 Diabetes Mellitus Type 2 Phase 2 Completed - -
NCT00989339 Diabetes Hype... More >>rtension Obesity Less << Phase 2 Phase 3 Withdrawn(Sub-investigator lef... More >>t facility prior to study initiation) Less << - -
NCT01733459 Polycystic Ovary Syndrome (PCO... More >>S) Less << Phase 3 Completed - Indonesia ... More >> Department of Obstetrics and Gynecology, Faculty of Medicine, University of Padjadjaran, Hasan Sadikin Hospital Bandung, West Java, Indonesia, 40161 Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Faculty of Medicine, University of Indonesia, dr. Cipto Mangunkusumo Hospital Jakarta, Indonesia, 10430 Less <<
NCT00119938 Diabetes Mellitus, Type 2 Not Applicable Completed - United States, Colorado ... More >> University of Colorado Hospital Aurora, Colorado, United States, 80045 Less <<
NCT03752060 Cardiovascular Risk Factor ... More >> Menopause Related Conditions Neuromuscular Function Aerobic Capacity Inflammation Less << Not Applicable Not yet recruiting December 30, 2020 United States, Oklahoma ... More >> 192 Colvin Recreation Center Stillwater, Oklahoma, United States, 74074 Less <<
NCT03554200 Diabetes Mellitus, Type 2 ... More >> Acute Heart Failure Less << Phase 2 Recruiting May 2020 Germany ... More >> Department of Internal Medicine I RWTH Aachen University Hospital Recruiting Aachen, NRW, Germany, 52074 Contact: Michael Lehrke, PD Dr. med.    +49 241 80 85152    mlehrke@ukaachen.de    Principal Investigator: Michael Lehrke, PD Dr. med.          Sub-Investigator: Nikolaus Marx, Univ.-Prof. Dr. med. Less <<
NCT03513523 Fatty Liver Not Applicable Recruiting May 2019 United States, Florida ... More >> Indago Research and Health Center Recruiting Hialeah, Florida, United States, 33012 Altus Research, Inc. Recruiting Lake Worth, Florida, United States, 33461 Lone Star Research Center Recruiting Miami, Florida, United States, 33145 Med-Care Research Corp Recruiting Miami, Florida, United States, 33165 Legacy Clinical Solutions: Sensible Healthcare, LLC Recruiting Ocoee, Florida, United States, 34761 Contact: Jennifer Millan    407-654-2724    jmillan@sensiblehealthcare.net    Principal Investigator: William Bowman, MD          IMIC, Inc Recruiting Palmetto Bay, Florida, United States, 33157 Lenus Research & Medical Group Recruiting Sweetwater, Florida, United States, 33172 United States, Nebraska Barrett Clinic, P.C. Recruiting La Vista, Nebraska, United States, 68128 Contact: Amy Workman    402-991-9500    aworkman@barrettclinic.com    Principal Investigator: Kevin Ahlers, MD          United States, North Carolina Trial Management Associates, LLC Recruiting Wilmington, North Carolina, United States, 28403 Contact: Gail Threatt    910-338-1555    gthreatt@trialmgt.com    Principal Investigator: Barton Williams, MD Less <<
NCT02976974 Shoulder Pain Not Applicable Recruiting December 2020 Spain ... More >> Las Albarizas primary care centre Recruiting Fuengirola, Malaga, Spain, 29603 Contact: Juan Luis Díaz Cerrillo, PT    +34627911441    juanlu1x2@hotmail.com    Contact: Susana Clavero Cano, PT    +34600142510    susclavero@gmail.com    Las Lagunas Care Centre Recruiting Fuengirola, Malaga, Spain, 29651 Contact: Antonio Rondón Ramos, PT    +34600142611    antonio.rondon.sspa@juntadeandalucia.es    San Pedro primary care centre Recruiting Marbella, Malaga, Spain, 29670 Contact: Gina Rocío Ariza Hurtado, PT       ginarizado@gmail.com Less <<
NCT00114998 - Completed - United States, Ohio ... More >> Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229 Less <<
NCT03215173 Cardiovascular Diseases ... More >> Diabetes Gestational Diabetes Preeclampsia Gestational Hypertension Small for Gestational Age at Delivery Preterm Birth Overweight and Obesity Less << Not Applicable Recruiting December 31, 2021 United States, Colorado ... More >> University of Colorado Recruiting Aurora, Colorado, United States, 80045 Contact: Jacinda Nicklas, MD, MPH, MA    303-724-9028    jacinda.nicklas@ucdenver.edu Less <<
NCT03426111 Non-Alcoholic Fatty Liver Dise... More >>ase Obesity Less << Not Applicable Recruiting December 2020 Spain ... More >> Jose Luis Calleja Recruiting Majadahonda, Madrid, Spain, 28222 Contact: Jose Luis Calleja, Prof    +34911916000 ext 417175    joseluis.calleja@uam.es    Contact: Javier Abad, MD    +34650814289    jabad@salud.madrid.org    Principal Investigator: Jose Luis Calleja, Prof          Sub-Investigator: Elba Llop, PhD          Sub-Investigator: Jose Luis Martinez, PhD          Sub-Investigator: Marta Hernandez, MD          Sub-Investigator: Javier Abad, MD Less <<
NCT03501082 Microbial Colonization Not Applicable Not yet recruiting October 31, 2019 Canada, Alberta ... More >> University of Alberta Not yet recruiting Edmonton, Alberta, Canada, T6G 2E1 Contact: Janis Cole, BSc    7804929506    jbaarda@ualberta.ca    Contact: Anissa Armet, BSc, RD       aarmet@ualberta.ca Less <<
NCT00221793 Parkinson Disease Not Applicable Completed - France ... More >> Service de neurologie Hôpital Haut-Lévêque Pessac, France, 33604 Less <<
NCT03636035 Mild Knee Osteoarthritis Not Applicable Not yet recruiting December 31, 2019 -
NCT01567540 Hepatitis C Phase 1 Terminated(New treatments avai... More >>lable, which prevents additional recruitment.) Less << - France ... More >> Centre Hospitalier Victor Dupuy Argenteuil, France, 95100 Centre Hospitalier Intercommunal Créteil Créteil, France, 94010 Henri Mondor Hospital Créteil, France, 94010 Cochin Hospital Paris, France, 75014 Less <<
NCT01761890 - Recruiting November 2020 Italy ... More >> Centro Oncologico Basilicata Not yet recruiting Rionero in Vulture, Potenza, Italy Contact: Pellegrino Musto, MD, PhD          Principal Investigator: Pellegrino MUSTO, Pr.          Sub-Investigator: Giuseppe Pietrantuono, Dr.          S.O.C. di Ematologia - Azienda Ospedaliera - SS. Antonio e Biagio e Cesare Arrigo Recruiting Alessandria, Italy Contact: Massimo Pini          Sub-Investigator: Gioacchino Catania          Principal Investigator: Massimo Pini          Azienda Ospedaliera - Nuovo Ospedale "Torrette" Recruiting Ancona, Italy Contact: Serena Rupoli          Principal Investigator: Serena Rupoli          Sub-Investigator: Anna Rita          U.O.C. Ematologia e Terapia Cellulare - Ospedale "C. e G. Mazzoni" di Ascoli Piceno Not yet recruiting Ascoli Piceno, Italy Contact: Catia Bigazzi          Principal Investigator: Catia Bigazzi          Az.Ospedaliera S.G.Moscati Not yet recruiting Avellino, Italy Contact: Fausto Palmieri          Principal Investigator: Fausto Palmieri          Sub-Investigator: Antonio Volpe          UO Ematologia con trapianto-Università degli Studi di Bari Aldo Moro Not yet recruiting Bari, Italy Contact: Giorina Specchia          Principal Investigator: Giorgina Specchia          Sub-Investigator: Antonella Russo          Azienda Ospedaliera Di Bologna Policlinico S. Orsola - Malpighi Recruiting Bologna, Italy, 40138 Contact: Gianantonio Rosti, Dr.       gianantonio.rosti@unibo.it    Principal Investigator: Gianantonio Rosti, Dr.          U.O.C. di Onco-Ematologia - Centro di Ricerca e Formazione ad Alta tecnologia nelle Scienze Biomediche Not yet recruiting Campobasso, Italy Contact: Sergio Storti          Principal Investigator: Sergio Storti          Sub-Investigator: Cristiana Gasbarrino, Dr.          US Dipartimentale - Centro per le malattie del sangue - Ospedale Civile - S.Giacomo Not yet recruiting Castelfranco Veneto, Italy Contact: Giuseppe Tagariello, Dr.          Principal Investigator: Giuseppe Tagariello, Dr.          Sub-Investigator: Roberto Sartori, Dr.          Università di Catania - Cattedra di Ematologia - Ospedale "Ferrarotto" Recruiting Catania, Italy Contact: Fabio Stagno          Principal Investigator: Fabio Stagno          Azienda Ospedaliero Universitaria Arcispedale Sant'Anna Dipartimento di Scienze Mediche Sezione di Ematologia e Fisiopatologia dell'Emostasi Not yet recruiting Ferrara, Italy Contact: Antonio Cuneo          Principal Investigator: Antonio Cuneo          Sub-Investigator: Francesco Cavazzini          Azienda Ospedaliera di Firenze Not yet recruiting Firenze, Italy, 50011 Contact: Alberto BOSI, Pr.          Principal Investigator: Alberto BOSI, Pr.          Sub-Investigator: Antonella Gozzini, Dr.          Centro Aziendale di Ematologia ASL N. 6 Not yet recruiting Livorno, Italy Contact: Enrico CAPOCHIANI    0586223111    e.capochiani@nord.usl6.toscana.it    Principal Investigator: Enrico Capochiani, MD          Azienda Ospedaliera Universitaria - Policlinico G. Martino Dipartimento di Medicina Interna - U.O. Messina Not yet recruiting Messina, Italy Contact: Caterina Musolino          Principal Investigator: Caterina Musolino          Sub-Investigator: Alessandro Allegra          Divisione di Ematologia - Azienda Ospedaliera Ospedali Riuniti "Papardo Piemonte" Not yet recruiting Messina, Italy Contact: Maura Brugiatelli          Principal Investigator: Maura Brugiatelli          Sub-Investigator: Laura Nocilli          Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico UOC Oncoematologia- Padiglione Marcora 2° piano Recruiting Milano, Italy Contact: Alessandra Iurlo          Principal Investigator: Alessandra Iurlo          Ospedale San Gennaro - ASL Napoli 1 Not yet recruiting Napoli, Italy Contact: Lucia Mastrullo          Principal Investigator: Lucia Mastrullo          Sub-Investigator: Maria Rosaria          zienda Ospedaliera Universitaria - Università degli Studi di Napoli "Federico II" - Facoltà di Medicina e Chirurgia Not yet recruiting Napoli, Italy Contact: Fabrizio Pane          Principal Investigator: Fabrizio Pane          Sub-Investigator: Luigia Luciano          Dip. di Scienze Cliniche e Biologiche - Ospedale S. Luigi Gonzaga-Medicina Interna 2 Not yet recruiting Orbassano, Italy Contact: Giovanna Rege          Principal Investigator: Giovanna Rege          Sub-Investigator: Carmen Fava          La Maddalena Casa di Cura di Alta Specialità Dipartimento Oncologico di III Livello Not yet recruiting Palermo, Italy Contact: Maurizio Musso          Principal Investigator: Maurizio Musso          Sub-Investigator: Ferdinando Porretto          zienda Ospedaliera Universitaria - Università degli Studi di Napoli "Federico II" - Facoltà di Medicina e Chirurgia Not yet recruiting Palermo, Italy Contact: Diamante Turri          Principal Investigator: Diamante Turri          Cattedra di Ematologia CTMO Università degli Studi di Parma Not yet recruiting Parma, Italy Contact: Monica Crugnola          Principal Investigator: Monica Crugnola          Sub-Investigator: Franco Aversa          U.O. Ematologia Clinica - Azienda USL di Pescara Not yet recruiting Pescara, Italy Contact: Roberto Di Lorenzo          Principal Investigator: Roberto Di Lorenzo          Sub-Investigator: Giuseppina Ricciuti          Unità Operativa Ematologia e Centro Trapianti - Dipartimento di Oncologia ed Ematologia - AUSL Ospedale di Piacenza Not yet recruiting Piacenza, Italy Contact: Daniele Vallisa, Dr.          Principal Investigator: Daniele Vallisa, Dr.          Sub-Investigator: Elena Trabacchi, Dr.          Dipartimento Emato-Oncologia A.O."Bianchi-Melacrino-Morelli" Not yet recruiting Reggio Calabria, Italy Contact: Francesco Nobile          Principal Investigator: Francesco Nobile          Sub-Investigator: Bruno Martino          Unità Operativa Complessa di Ematologia - Arcispedale S. Maria Nuova Not yet recruiting Reggio Emilia, Italy Contact: Paolo Avanzini          Principal Investigator: Paolo Avanzini          Sub-Investigator: Isabella Capodanno          Az. Ospedaliera "Sant' Andrea"-Università la Sapienza Seconda Facoltà di Medicina e Chirurgia Not yet recruiting Roma, Italy Contact: Enrico Montefusco          Principal Investigator: Enrico Montefusco          Sub-Investigator: Raffaele Porrini          Complesso Ospedaliero S. Giovanni Addolorata Not yet recruiting Roma, Italy Contact: Michele Cedrone, Dr.          Sub-Investigator: Barbara Anaclerico, Dr.          Principal Investigator: Michele Cedrone, Dr.          Padiglione Cesalpino - I piano - Divisione di Ematologia - Ospedale S. Camillo Not yet recruiting Roma, Italy Contact: Leonardo Pacilli          Principal Investigator: Leonardo Pacilli          S.C. di Ematologia e Trapianti - I.F.O. Istituto Nazionale Tumori Regina Elena Not yet recruiting Roma, Italy Contact: Atelda Romano, Dr.          Principal Investigator: Atelda Romano, Dr.          Sub-Investigator: Laura Nocilli, Dr.          U.O.C. Ematologia - Ospedale S.Eugenio Not yet recruiting Roma, Italy Contact: Elisabetta Abruzzese          Principal Investigator: Elisabetta Abruzzese          Sub-Investigator: Monika Trawinska          Università Cattolica del Sacro Cuore - Policlinico A. Gemelli Not yet recruiting Roma, Italy Contact: Simona Sica          Principal Investigator: Simona Sica          Sub-Investigator: Federica Sorà          Rotondo Istituto di Ematologia - IRCCS Ospedale Casa Sollievo della Sofferenza Not yet recruiting San Giovanni Rotondo, Italy Contact: Nicola Cascavilla          Principal Investigator: Nicola Cascavilla          Sub-Investigator: Antonietta Pia          U.O.C. Ematologia e Trapianti - A.O. Senese - Policlinico " Le Scotte" Not yet recruiting Siena, Italy Contact: Monica Bocchia          Principal Investigator: Monica Bocchia          Sub-Investigator: Lara Aprile          Dipartimento di Oncologia ed Ematologia S.C. Ematologia 2 A.O. Città della Salute e della Scienza di Torino San Giovanni Battista Not yet recruiting Torino, Italy Contact: Patrizia Pregno          Principal Investigator: Patrizia Pregno          Sub-Investigator: Paola Riccomagno          Clinica Ematologica - Policlinico Universitario Not yet recruiting Udine, Italy Contact: Mario Tiribelli          Principal Investigator: Mario Tiribelli          Sub-Investigator: Luciana Marin          Università degli Studi di Verona - A. O. - Istituti Ospitalieri di Verona- Div. di Ematologia - Policlinico G.B. Rossi Not yet recruiting Verona, Italy Contact: Giovanni Pizzolo          Principal Investigator: Giovanni Pizzolo          Sub-Investigator: Massimiliano Bonifacio Less <<
NCT01915030 Obesity Not Applicable Completed - Netherlands ... More >> Wageningen University Wageningen, Gelderland, Netherlands, 6703HD Less <<
NCT03248128 Asthma Phase 3 Recruiting October 31, 2020 -
NCT03660397 Uncontrolled Hypertension Phase 3 Recruiting January 1, 2020 China, Chongqing ... More >> The third hospital affiliated to the Third Military Medical University Recruiting Chongqing, Chongqing, China, 400042 Contact: Hongbo He, MD.    86-23-68757880    cqhehongbo@gmail.com    Principal Investigator: Zhiming Zhu, MD. Less <<
NCT01243320 Healthy Phase 1 Phase 2 Completed - United States, Utah ... More >> University of Utah Hospital and Clinics Salt Lake City, Utah, United States, 84132 Less <<
NCT00927537 - Completed - Switzerland ... More >> Many Locations, Switzerland Less <<
NCT01744561 Cystic Fibrosis Not Applicable Completed - United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35294-1212 United States, Pennsylvania Children's Hospital of Pittsburgh of UPMC Pittsburgh, Pennsylvania, United States, 15224 Austria Mukoviszidose-Ambulanz, Universitätsklinik für Kinder- und Jugendheilkunde, Graz, Austria, 8036 Cystische Fibrose Zentrum für Kinder, Jugendliche und Erwachsene Innsbruck, Austria, 6020 Canada, Quebec Montreal Children's Hospital, McGill University Health Centre - Glen Site Monrtreal, Quebec, Canada, H4A 3J1 France Hôpital Renée Sabran, Service : Maladies respiratoires Hyeres, France, 83406 Hôpital Calmette, Service Pneumologie-immuno-allergologie boulevard du Pr Leclercq Lille cedex, France, 59037 Hôpital Jeanne de Flandre, Service: Pneumologie et allergologie pédiatriques Lille cedex, France, 59037 Hôpital Arnaud de Villeneuve, Service: Maladies respiratoires Montpellier cedex 5, France, 34295 Hôpital Necker, Service : Pneumologie et allergologie pédiatriques Paris, France, 75015 Hôpital Maison Blanche, Service : Maladies respiratoires Reims, France, 51092 Germany Olgahospital, Klinikum Stuttgart Stuttgart, Baden-Württemberg, Germany, 70174 Klinik für Kinder- und Jugendmedizin, Universitätsklinikum Tübingen Tübingen, Baden-Württemberg, Germany, 72076 Children´s Hospital of the University Würzburg, Bavaria, Germany, 97080 Pediatric Pulmonology and CF centre, Children´s Hospital, Ruhr University Bochum, Germany, 44791 Klinik und Poliklinik für Kinderheilkunde - Universitäts-Mukoviszidose-Centrum Dresden, Germany, 01307 Christiane Herzog CF-Zentrum, Goethe Universität Frankfurt, Germany, 60323 CF Zentrum Hamburg-Altona, Kinderarztpraxis Runge, Sextro,Held Hamburg, Germany, 22763 CF- Ambulanz, Kinderklinik, Pädiatrische Pneumologie, Allergologie und Neonatologie Hannover, Germany, 30625 Zentrum für Kinder- und Jugendmedizin, Pädiatrische Pneumologie, Allergologie und Mukoviszidose Mainz, Germany, 55101 Praxis für Lungen- und Bronchialheilkunde Munich, Germany, 81241 Klinik für Kinder- und Jugendmedizin / Universitätsklinikum Münster, Germany, 48149 Netherlands University Medical Center, Child Development & Exercise Center, Wilhelmina Children's Hospital Utrecht, Netherlands Switzerland QuartierBleu, Praxis für Pneumologie am Lindenhofspital Bern, Switzerland, 3001 Inselspital, Universitätsklinik für Kinderheilkunde, Pneumologie Bern, Switzerland Kinderspital, Pneumologie Zurich, Switzerland, 8032 UniversitätsSpital, Klinik für Pneumologie Zurich, Switzerland, 8091 United Kingdom Royal Hospital for Sick Children Edinburgh, Scottland, United Kingdom, EH9 1LF Less <<
NCT01066039 Hypertension ... More >>Diabetes Mellitus, Type II Less << Phase 4 Completed - Korea, Republic of ... More >> Seoul St. Mary´s Hospital Seoul, Korea, Republic of Less <<
NCT03639350 Visceral Fat Not Applicable Completed - -
NCT01454232 Obesity Metab... More >>olic Diseases Nutrition Disorders Body Weight Less << Not Applicable Active, not recruiting October 2018 France ... More >> Pitié Salpêtrière Hospital Paris, France, 75013 Less <<
NCT02586155 Diabetes Mellitus, Type 2 ... More >> Coronary Artery Disease Cardiovascular Diseases Less << Phase 3 Recruiting October 2018 Israel ... More >> Lady Davis Carmel Medical Center Recruiting Haifa, Israel, 34362 Contact: Basil Lewis, MD Less <<
NCT01243320 - Completed - -
NCT00214786 - Completed - -
NCT00214786 Type 1 Diabetes Phase 1 Completed - United States, Texas ... More >> Baylor Regional Transplant Institute - Baylor University Medical Center Dallas, Texas, United States, 75246 Less <<
NCT02103140 Metabolic Syndrome ... More >> Obesity Less << Not Applicable Active, not recruiting January 2020 United States, District of Col... More >>umbia Georgetown Lombardi Office of Minority Health community site Washington, District of Columbia, United States, 20003 Less <<
NCT01115127 Pre-menopausal Irregular Cycle... More >>s and Bleedings Less << Phase 2 Phase 3 Completed - Italy ... More >> University Hospital Messina, Italy, 98100 Less <<
NCT03420989 Snack Food Not Applicable Recruiting December 2018 Spain ... More >> Daniel de Luis Roman Recruiting Valladolid, Spain, 47003 Contact: Daniel de Luis Roman, MD Ph    670560484 ext 86660    dadluis@yahoo.es    Contact: Rocio Allerde la Fuente, MD Ph    680251083 ext 86660    roaller@yahoo.es Less <<
NCT02562573 Type 2 Diabetes ... More >> Metabolic Syndrome Less << Phase 2 Completed - Canada, Alberta ... More >> Edmonton, Alberta, Canada Less <<
NCT01714102 Obesity Insul... More >>in Resistance Metabolic Syndrome Less << Not Applicable Completed - United States, New York ... More >> The Rockefeller University New York, New York, United States, 10065 Less <<
NCT02575976 Cardiovascular Disease ... More >> Coronary Disease Less << Not Applicable Completed - Brazil ... More >> Federal University of Minas Gerais Belo Horizonte, Minas Gerais, Brazil, 31270-901 Less <<
NCT00169910 Cardiovascular Disease Phase 4 Completed - Netherlands ... More >> Leiden University Medical Center Leiden, Netherlands, 2300 RC Less <<
NCT02063477 Blood Pressure ... More >> Hypertension Less << Not Applicable Completed - Spain ... More >> Technological Center of Nutrition and Health (CTNS) Reus, Tarragona, Spain, 43204 Less <<
NCT01321086 Peripheral Arterial Disease Not Applicable Completed - United States, Kansas ... More >> Clinical and Translational Science Unit Fairway, Kansas, United States, 66205 KU School of Medicine-Wichita Wichita, Kansas, United States, 67214 Less <<
NCT03033953 Healthy Young... More >> Elderly Less << Not Applicable Completed - Norway ... More >> Norwegian School of Sport Sciences Oslo, Norway, 0863 Less <<
NCT00720902 Growth Hormone Deficiency Not Applicable Terminated(poor enrollment) - United States, New York ... More >> Columbia University, College of Physicians and Surgeons New York, New York, United States, 10032 Less <<
NCT02117063 Polycystic Ovary Syndrome ... More >> Abnormal Weight Gain Excess Weight Insulin Resistance Premature Adrenarche Type 2 Diabetes Mellitus Less << Not Applicable Recruiting April 2019 United States, Virginia ... More >> Center for Research in Reproduction, University of Virginia Recruiting Charlottesville, Virginia, United States, 22908 Contact: Deborah Sanderson    434-243-6911    pcos@virginia.edu    Contact: Christine M Burt Solorzano, MD    434-924-9084    pcos@virginia.edu    Principal Investigator: Christine M Burt Solorzano, MD Less <<
NCT01272232 Metabolism and Nutrition Disor... More >>der Obesity Less << Phase 3 Completed - -
NCT01945801 Obstructive Sleep Apnea Phase 4 Completed - Brazil ... More >> Hospital de Clinicas de Porto Alegre Porto Alegre, RS, Brazil, 90035-903 Less <<
NCT01272232 - Completed - -
NCT00692367 Obesity Not Applicable Completed - United States, North Carolina ... More >> East Carolina University Greenville, North Carolina, United States, 27858 United States, Pennsylvania Montefiore Hospital, N807 Pittsburgh, Pennsylvania, United States, 15213 Less <<
NCT03003754 Metabolism Disorder ... More >> Insulin Sensitivity Obesity, Pediatric Less << Not Applicable Completed - Colombia ... More >> Robinson Ramírez-Vélez Bogota Distrito Especial, Cundinamarca, Colombia, 000000000 Less <<
NCT02483663 - Completed - United States, Washington ... More >> University of Washington Seattle, Washington, United States, 98195 Less <<
NCT02591069 Chronic Consciousness Disorder... More >>s Vegetative State Minimally Conscious State Akinetic Mutism Less << Not Applicable Recruiting January 2020 France ... More >> Hôpital Neurologique de Lyon Pierre Wertheimer Recruiting Bron, France, 69500 Contact: Jacques Luauté, MD    4 72 35 78 95 ext 0033    jacques.luaute@chu-lyon.fr Less <<
NCT01240213 Breast Cancer ... More >> Obesity Hypovitaminosis D Less << Not Applicable Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109 Less <<
NCT02792166 Obesity Morbi... More >>d Obesity Less << Not Applicable Recruiting June 2024 Canada, Quebec ... More >> McGill University Health Center Recruiting Montreal, Quebec, Canada, H3G 1A4 Contact: Amin Andalib, MD MSc FRCSC    514-934-1934 ext 31531    amin.andalib@mcgill.ca Less <<
NCT00455065 Metabolic Syndrome Not Applicable Completed - -
NCT01601704 Obesity Overw... More >>eight Less << Phase 3 Terminated - -
NCT01601704 - Terminated - -
NCT02115932 Diabetic Neuropathies ... More >> Peripheral Nervous System Diseases Less << Not Applicable Completed - Singapore ... More >> National University of Singapore; National University Hospital Singapore, Singapore Less <<
NCT03118713 Type 2 Diabetes Mellitus Phase 4 Active, not recruiting January 2019 Korea, Republic of ... More >> Site 13 Busan, Korea, Republic of Site 02 Deagu, Korea, Republic of Site 11 Guri-si, Korea, Republic of Site 01 Seoul, Korea, Republic of Site 05 Seoul, Korea, Republic of Site 07 Seoul, Korea, Republic of Site 09 Seoul, Korea, Republic of Site 12 Suwon-si, Korea, Republic of Less <<
NCT03753581 Electric Stimulation Therapy Not Applicable Enrolling by invitation March 30, 2020 Spain ... More >> Juan Avendaño-Coy Toledo, Spain, 45071 Less <<
NCT01272219 Metabolism and Nutrition Disor... More >>der Obesity Less << Phase 3 Completed - -
NCT02629926 - Unknown - United Kingdom ... More >> The Leeds Teaching Hospitals NHS Trust Recruiting Leeds, United Kingdom, LS9 7TF Contact: R&I Administrator    0113 392 0152    leedsth-tr.lthtresearch@nhs.net Less <<
NCT03159741 Healthy Not Applicable Completed - Denmark ... More >> Hvidovre University Hospital Hvidovre, Denmark, 2650 Less <<
NCT00322322 Complication of Hemodialysis ... More >> Hyperthyroidism Treated or Under Control Less << Phase 3 Completed - France ... More >> Assistance Publique Hopitaux de Paris Paris, France, 75004 HOPITAL LA PITIE SALPETRIERE, service de Néphrologie Paris, France, 75013 Less <<
NCT01272219 - Completed - -
NCT00992797 Diabetes Mellitus Type 2 ... More >> Hypovitaminosis D Less << Phase 2 Unknown December 2011 Norway ... More >> Diabetes Laboratory, Oslo University Hospital Aker Recruiting Oslo, Norway, 0514 Contact    4722894745    diabeteslab@aus.no    Principal Investigator: Kåre I Birkeland, MD PhD Less <<
NCT03453749 Head Trauma I... More >>ntensive Care Neurological Disorder Edema Brain Less << Phase 2 Withdrawn(New study in plannin... More >>g) Less << - -
NCT00788333 Breast Cancer Phase 1 Phase 2 Completed - Australia, South Australia ... More >> Local Institution Kurralta Park, South Australia, Australia, 5037 Australia, Victoria Local Institution Frankston, Victoria, Australia, 3199 Local Institution Geelong, Victoria, Australia, 3220 Belgium Local Institution Brussels, Belgium, 1000 Canada, Ontario Local Institution Ottawa, Ontario, Canada, K1H 8L6 Local Institution Toronto, Ontario, Canada, M5G 1X5 Hungary Local Institution Budapest, Hungary, 1122 Local Institution Miskolc, Hungary, 3526 United Kingdom Local Institution Newcastle Upon Tyne, Tyne And Wear, United Kingdom, NE7 7DN Less <<
NCT02697734 Cushing's Disease Phase 3 Recruiting October 25, 2019 -
NCT03675074 Type2 Diabetes Mellitus ... More >> Obesity Less << Not Applicable Recruiting September 2024 Czechia ... More >> Institute for Clinical and Experimental Medicine (IKEM) Not yet recruiting Prague, Czechia Contact: Jan Martinek, MD          Principal Investigator: Jan Martinek, MD          Sub-Investigator: Tomas Hucl, MD          Sub-Investigator: Martin Haluzik, MD          Panama Consultorio Medico Patilla and Clinica Hospital San Fernando Recruiting Panama city, Panama Contact: Guadalupe L Perez, MD          Principal Investigator: Guadalupe L Perez, MD          Sub-Investigator: Jorge Orillac, MD          Sub-Investigator: Jose Dutari, MD Less <<
NCT00853801 Pre-Diabetes ... More >>Metabolic Syndrome Type 2 Diabetes Less << Not Applicable Completed - United States, Illinois ... More >> John H Stroger Hospital Chicago, Illinois, United States, 60612 Less <<
NCT03722602 Rehabilitation ... More >> Stroke Body Composition Less << Not Applicable Completed - Poland ... More >> University of Rzeszów Rzeszów, Poland, 35-205 Less <<
NCT00335699 Hypercholesterolemia Phase 4 Completed - Korea, Republic of ... More >> Research Site DaeGu, Korea, Republic of Research Site IkSan, Korea, Republic of Research Site JeonJu, Korea, Republic of Research Site JinJu, Korea, Republic of Research Site KwangJu, Korea, Republic of Research Site Pusan, Korea, Republic of Research Site Ulsan, Korea, Republic of Less <<
NCT03355469 Metabolic Syndrome Phase 4 Recruiting January 31, 2022 United States, Virginia ... More >> University of Virginia Recruiting Charlottesville, Virginia, United States, 22904 Contact: Stephanie Miller, M.S.Ed.    434-243-8677    slm4ps@virginia.edu    Sub-Investigator: Emily Heiston, M.S.Ed          Sub-Investigator: Monique Francois, PhD          Principal Investigator: Steven K Malin, PhD Less <<
NCT00407420 Childhood Obesity Not Applicable Completed - United Kingdom ... More >> Bristol Royal Hospital for Children Bristol, United Kingdom, BS2 8AE Less <<
NCT02810821 - Active, not recruiting June 2021 China, Shandong ... More >> Shandong Provincial Hospital Jinan, Shandong, China, 250021 Less <<
NCT01827735 Type 1 Diabetes Phase 1 Phase 2 Completed - United Kingdom ... More >> Wellcome Trust Clinical Research Facility, Addenbrooke's Hospital Cambridge, United Kingdom, CB2 0QQ Less <<
NCT02692469 Obesity Not Applicable Not yet recruiting April 2026 -
NCT02482831 - Unknown August 2015 China, Beijing ... More >> Peking Union Medical College Hospital Recruiting Beijing, Beijing, China Contact: Shuai Tang, MD    13718754540    tangshuai@pumch.cn    Principal Investigator: Yuguang Huang, MD Less <<
NCT02928354 Asthma, Chronic Obstructive Pu... More >>lmonary Disease (COPD) Less << Phase 1 Completed - Germany ... More >> Research Site Berlin, Germany, 14050 Less <<
NCT03019965 Sepsis Not Applicable Recruiting February 2019 Mexico ... More >> Hospital Infantil de México Federico Gómez Recruiting Mexico, Distrito Federal, Mexico, 06720 Contact: Rodolfo Norberto Jiménez    52(55)55-88-7238 ext 2331    dr.jimenezjuarez@gmail.com    Contact: Sarbelio Moreno    52(55)52-28-9917 ext 2331    sarbelio.infecto@gmail.com    Sub-Investigator: Fortino Solórzano          Instituto Mexicano del Seguro Social Recruiting Mexico, Distrito Federal, Mexico, 06720 Contact: José Guillermo Vázquez    52(55)56-27-6900 ext 22462    vazguill@aol.com    Contact: Ma. Guadalupe Miranda    52(55)56-27-6900 ext 22507    uepidemiologia@live.com.mx Less <<
NCT02510664 Type 1 Diabetes Not Applicable Completed - United States, Texas ... More >> Baylor College of Medicine Houston, Texas, United States, 77030 Less <<
NCT03551535 Exercise Mobi... More >>le Health Pregnancy Gestational Diabetes Less << Not Applicable Recruiting July 1, 2020 United States, Maryland ... More >> Johns Hopkins Hospital Recruiting Baltimore, Maryland, United States, 21205 Contact: Ben K Kogutt, MD    214-883-3409    ben@jhmi.edu Less <<
NCT00169299 Vasomotor Symptoms Associated ... More >>With Menopause Less << Phase 4 Unknown - United States, Washington ... More >> Group Health Cooperative, Center for Health Studies Seattle, Washington, United States, 98101-1448 Less <<
NCT03258203 Overweight and Obesity Not Applicable Completed - -
NCT02310412 Healthy Phase 2 Completed - -
NCT01647438 Obesity Hyper... More >>lipidemia Hypertension Pre-diabetes Diabetes Less << Not Applicable Completed - United States, Illinois ... More >> Northwestern University-Feinberg School of Medicine Chicago, Illinois, United States, 60611 Metropolitan Asian Family Services Chicago, Illinois, United States, 60645 Less <<
NCT01308814 - Completed - -
NCT02970188 Aging Phase 1 Phase 2 Recruiting January 2019 United States, Colorado ... More >> Integrative Physiology of Aging Laboratory Recruiting Boulder, Colorado, United States, 80309 Contact: Melanie R Zigler, M.S.    303-492-2485    melanie.connell@colorado.edu Less <<
NCT01647438 - Completed - -
NCT01308814 Perimenopause ... More >> Menopause Depression Less << Phase 2 Phase 3 Completed - United States, North Carolina ... More >> University of North Carolina Chapel Hill, North Carolina, United States, 27599 Less <<
NCT02786875 Breast Cancer Phase 3 Recruiting November 2019 Italy ... More >> Centro Riferimento Oncologico Not yet recruiting Aviano, Italy Azienda Ospedaliera Cannizzaro Recruiting Catania, Italy Clinica Mediterranea Recruiting Napoli, Italy Istituto Nazionale Tumori Fondazione G. Pascale Recruiting Napoli, Italy Istituto Oncologico Veneto Not yet recruiting Padova, Italy Ospedale San Vincenzo Recruiting Taormina, Italy Less <<
NCT01043770 Metabolic Syndrome Not Applicable Completed - United Kingdom ... More >> University of Leicester Leicester, United Kingdom, LE9 6PE Less <<
NCT02325089 Obstructive Sleep Apnea ... More >> Hypertension Cardiovascular Disease Less << Phase 4 Recruiting December 2020 Brazil ... More >> Hospital de Clínicas de Porto Alegre Recruiting Porto Alegre, Rio Grande do Sul, Brazil, 95700-000 Contact: Denis Martinez, MD, PhD    555130222282    denis@ufrgs.br    Contact: Cintia Z Fiori          Hospital de Clinicas de Porto Alegre Recruiting Porto Alegre, RS, Brazil, 90035-903 Contact: Cintia Z Fiori, MSc    555133598289    cintiazfiori@gmail.com    Sub-Investigator: Cintia Z Fiori, MSc Less <<
NCT00395135 Obesity Phase 3 Completed - United States, California ... More >> Arena Pharmaceuticals, Inc. San Diego, California, United States, 92121 Less <<
NCT01859806 Pancreatic Fistula After Pancr... More >>eaticoduodenectomy Less << Not Applicable Completed - Egypt ... More >> Ayman El Nakeeb Mansoura, Egypt, 35111 Less <<
NCT02899390 Prediabetes O... More >>besity Overweight Less << Not Applicable Completed - Mexico ... More >> Centro de Investigación en Alimentación y Desarrollo Hermosillo, Sonora, Mexico, 83304 Centro de Salud Urbano Los Naranjos Hermosillo, Sonora, Mexico Elementary School Lázaro Mercado Hermosillo, Sonora, Mexico Less <<
NCT00659568 Breast Cancer ... More >> Endometrial Cancer Kidney Cancer Lung Cancer Lymphoma Unspecified Adult Solid Tumor, Protocol Specific Less << Phase 1 Completed - Canada, Ontario ... More >> London Regional Cancer Program at London Health Sciences Centre London, Ontario, Canada, N6A 4L6 Less <<
NCT00395135 - Completed - -
NCT03299790 Diabetic Cardiomyopathies ... More >> Type2 Diabetes Less << Not Applicable Recruiting December 31, 2018 Belgium ... More >> Jessa Ziekenhuis Recruiting Hasselt, Belgium, 3500 Contact: Dominque Hansen, prof.dr.    +32 11 29 21 26    dominique.hansen@uhasselt.be    Contact: Lisa Van Ryckeghem, drs.    + 32 11 26 93 70    lisa.vanryckeghem@uhasselt.be Less <<
NCT03509441 - Recruiting November 11, 2019 United States, California ... More >> Stanford University Recruiting Stanford, California, United States, 94305 Contact: Krystal Solis    650-723-8138    krsolis@stanfordhealthcare.org    Contact: Kathleen M Gallagher    (650) 723-8138    kgallagh@stanford.edu Less <<
NCT02265809 Type 1 Diabetes Phase 1 Phase 2 Completed - United Kingdom ... More >> Wellcome Trust Clinical Research Facility, Addenbrookes Hospital Cambridge, Cambridgeshire, United Kingdom, CB2 0QQ Less <<
NCT01355536 - Completed - Norway ... More >> Namsos Hospital, Nord- Trøndelag Hospital Trust Namsos, Nord- Trøndelag, Norway, 7800 Less <<
NCT01784848 Systemic Hypertension ... More >> Obesity Less << Not Applicable Active, not recruiting May 2021 Brazil ... More >> Instituto Dante Pazzanese de Cardiologia São Paulo, SP, Brazil, 04004-060 Instituto do Coração - Hospital das Clínicas de São Paulo São Paulo, SP, Brazil, 04004-060 Hospital do Coração - Research Institute Sao Paulo, Brazil, 04005-000 Less <<
NCT01823705 Obesity Not Applicable Completed - United States, Arizona ... More >> Scottsdale, Arizona, United States, 85258 United States, Kentucky Louisville, Kentucky, United States, 40202 United States, Tennessee Nashville, Tennessee, United States, 37232 Netherlands Maastricht, Netherlands, 6229 Less <<
NCT03653845 Primary Aldosteronism ... More >> Hypertension Less << Phase 3 Recruiting January 1, 2020 China, Chongqing ... More >> The third hospital affiliated to the Third Military Medical University Recruiting Chongqing, Chongqing, China, 400042 Contact: Hongbo He, MD.    86-23-68757880    cqhehongbo@gmail.com    Principal Investigator: Zhiming Zhu, MD.          China The third hospital affiliated to the Third Military Medical University Recruiting Chongqing, China, 400042 Contact: Zhiming Zhu, MD, PhD    86-023-68705094    zhuzm@yahoo.com    Principal Investigator: Zhiming Zhu, MD, PhD Less <<
NCT03097965 Obesity Not Applicable Completed - -
NCT00603902 - Completed - -
NCT00023543 Cardiovascular Diseases ... More >> Atherosclerosis Postmenopause Heart Diseases Less << Phase 2 Completed - United States, Pennsylvania ... More >> University of Pittsburgh Pittsburgh, Pennsylvania, United States, 15261 Less <<
NCT00603902 Obesity Phase 3 Completed - United States, California ... More >> Arena Pharmaceuticals, Inc. San Diego, California, United States, 92121 Less <<
NCT00389402 HIV Infections Phase 4 Completed - Netherlands ... More >> Academic Medical Centre, University of Amsterdam Amsterdam, Netherlands, 1105 AZ Less <<
NCT02597530 Acupuncture Not Applicable Unknown December 2016 -
NCT03098056 Obesity Not Applicable Completed - -
NCT02329613 Institutionalization Not Applicable Completed - France ... More >> CHRU de Nîmes - Centre de Gérontologie de Serre Cavalier Nîmes, France, 30029 Less <<
NCT00889876 Cardiovascular Diseases Not Applicable Unknown December 2012 Sweden ... More >> Karolinska Institutet, Karolinska University Hospital Huddinge Recruiting Stockholm, Sweden, 141 86 Contact: Maria Westerståhl, PhD    +468 585 873 96    maria.westerstahl@ki.se    Contact: Pernilla Hedvall, PhDstudent    +468 585 873 96    pernilla.hedvall@ki.se    Principal Investigator: Claude Marcus, Professor Less <<
NCT02144597 Morbid Obesity ... More >> Liver Fat Less << Not Applicable Completed - United Kingdom ... More >> Imperial Clinical research facility London, greater London, United Kingdom, W12 0NN Less <<
NCT02360787 Overweight Ob... More >>esity Less << Not Applicable Completed - United States, Indiana ... More >> Purdue University West Lafayette, Indiana, United States, 47907 Less <<
NCT01059760 - Completed - -
NCT02239419 Critical Lower Limb Ischemia ... More >> Critical Limb Ischemia Foot Ulcer Skin Ulceration Less << Not Applicable Unknown December 2016 Canada, Manitoba ... More >> St. Boniface General Hospital Recruiting Winnipeg, Manitoba, Canada, R2H 2A6 Contact: Paramjit Tappia, PhD    204-258-1230    ptappia@sbrc.ca    Contact: Bram Ramjiawan, PhD    204-235-3372    bramjiawan@sbgh.mb.ca    Principal Investigator: Chris Sathianathan, MD          Sub-Investigator: Mauro Verrelli, MD          Health Sciences Centre- Rehabilitation Hospital Recruiting Winnipeg, Manitoba, Canada, R3A 1A4 Contact: Amarjit S Arneja, MD    204-787-2270       Principal Investigator: Amarjit S Arneja, MD Less <<
NCT03577145 Healthy Adults Not Applicable Recruiting March 31, 2019 United Kingdom ... More >> School of Medicine, Nursing and Dentistry, College of MVLS, University of Glasgow Recruiting Glasgow, Lanarkshire, United Kingdom, G31 2ER Contact: Christine Edwards, PhD    01412018685    Christine.Edwards@glasgow.ac.uk    Contact: Emilie Combet Aspray, PhD    01412018527    Emilie.CombetAspray@glasgow.ac.uk Less <<
NCT01059760 Cardiovascular Disease Not Applicable Completed - United States, Utah ... More >> Intermountain Medical Center Murray, Utah, United States, 84107-5701 Less <<
NCT00888628 Diabetes Mellitus, Type I Phase 1 Phase 2 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT01581957 Critically Ill Not Applicable Completed - Switzerland ... More >> Department of Intensive Care Medicine. Bern University Hospital Bern, Switzerland Less <<
NCT03560544 Sedentary Lifestyle Not Applicable Active, not recruiting December 31, 2018 United Kingdom ... More >> Bedford Borough Council Bedford, Bedfordshire, United Kingdom, MK42 9AP University of Bedfordshire Luton, Bedfordshire, United Kingdom, LU1 3JU Less <<
NCT00888628 - Completed - -
NCT01186952 Overweight Ob... More >>esity Type 2 Diabetes Less << Not Applicable Completed - Canada, Quebec ... More >> Institut de recherches cliniques de Montréal (IRCM) Montreal, Quebec, Canada, H2W 1R7 Less <<
NCT03383809 Healthy Not Applicable Recruiting April 30, 2019 United Kingdom ... More >> School of Medicine, Nursing and Dentistry, College of MVLS, University of Glasgow Recruiting Glasgow, Lanarkshire, United Kingdom, G31 2ER Contact: Christine Edwards, PhD    01412018685    Christine.Edwards@glasgow.ac.uk    Contact: Emilie Combet, PhD    01412018527    Emilie.CombetAspray@glasgow.ac.uk Less <<
NCT03613649 Electrocardiogram Repolarisati... More >>on Abnormality Gonococcal Infection Less << Phase 1 Active, not recruiting January 6, 2019 United States, Kansas ... More >> Vince and Associates Clinical Research Overland Park, Kansas, United States, 66212 Less <<
NCT02355795 Healthy Not Applicable Completed - China, Zhejiang ... More >> Zhejiang University Hangzhou, Zhejiang, China, 310058 Less <<
NCT03520205 Renal Transplant Donor of Left... More >> Kidney Less << Not Applicable Recruiting December 31, 2018 Indonesia ... More >> Cipto Mangunkusumo Cental National Hospital Recruiting Jakarta, DKI Jakarta, Indonesia, 10430 Contact: Aida R Tantri, Consultant    +628161832487    aidatantri@yahoo.com Less <<
NCT03047447 Metabolic Syndrome ... More >> Diabetes Mellitus, Type 2 Pre Diabetes Less << Not Applicable Completed - United States, Minnesota ... More >> Bristlecone Behavioral Health, Inc. Maple Grove, Minnesota, United States, 55311 Less <<
NCT02970838 Obesity Diabe... More >>tes Type 2 Weight Loss Less << Not Applicable Completed - Germany ... More >> University Medicine Greifswald Greifswald, Germany, 17475 Less <<
NCT02271971 Psoriasis Met... More >>abolic Syndrome Vitamin D Deficiency Less << Not Applicable Completed - Chile ... More >> Pontificia Universidad Católica de Chile Santiago, Región Metropolitana, Chile Less <<
NCT03047447 - Completed - -
NCT03672786 Genetic Change ... More >> Athlete Less << Not Applicable Completed - Spain ... More >> Universidad de Granada Granada, Spain, 18071 Less <<
NCT02780882 Ectopic ACTH Syndrome Phase 2 Withdrawn(Due to stringent inc... More >>lusion/exclusion criteria, study investigator deemed it not feasible.) Less << June 2019 United States, California ... More >> Cedars-Sinai Medical Center Los Angeles, California, United States, 90048 Less <<
NCT01066039 - Completed - -
NCT01457950 - Completed - -
NCT00656422 Diabetes Obes... More >>ity Less << Phase 3 Terminated - Austria ... More >> Medical University Graz Graz, Austria, 8036 University Hospital Graz Graz, Austria, 8036 Medical University Vienna Vienna, Austria, 1090 Germany University Hospital of Tübingen Tübingen, Germany, 72076 Switzerland University Hospital Bern, Switzerland, 3010 Less <<
NCT01405794 Healthy Phase 1 Phase 2 Completed - United States, Utah ... More >> University of Utah Salt Lake City, Utah, United States, 84112-5820 Less <<
NCT02985242 Diabetes Mellitus, Type II Phase 4 Terminated(difficulties to rec... More >>ruit planned numbers of patients within reasonable time frame) Less << - Germany ... More >> Hannover Medical School, University Eye Hospital and CRC Core Facility Hannover Hanover, Lower Saxony, Germany, 30625 Less <<
NCT03509818 Healthy Population Not Applicable Enrolling by invitation September 5, 2018 Spain ... More >> Escuela de Doctorado e Invesitgacion, Universidad Europea Madrid, Villaviciosa De Odon, Spain, 28670 Less <<
NCT02280772 Obesity Overw... More >>eight Less << Phase 4 Completed - Poland ... More >> The Medical University of Warsaw, Department of Paediatrics Warsaw, Mazowieckie, Poland, 02-091 Less <<
NCT01405794 - Completed - -
NCT01457950 Osteoporosis, Postmenopausal Phase 3 Completed - Korea, Republic of ... More >> GSK Investigational Site Busan, Korea, Republic of, 602-739 GSK Investigational Site Daegu, Korea, Republic of GSK Investigational Site Gwangju, Korea, Republic of, 501-757 GSK Investigational Site Seoul, Korea, Republic of, 100-380 GSK Investigational Site Seoul, Korea, Republic of, 110-744 GSK Investigational Site Seoul, Korea, Republic of, 120-752 GSK Investigational Site Seoul, Korea, Republic of, 135-710 GSK Investigational Site Seoul, Korea, Republic of, 137-701 GSK Investigational Site songpa-gu, Seoul, Korea, Republic of, 138-736 GSK Investigational Site Suwon, Korea, Republic of, 443-721 Less <<
NCT03455868 - Recruiting December 1, 2020 Canada, Quebec ... More >> The Research Institute of the McGill University Health Centre Not yet recruiting Montréal, Quebec, Canada, H3H 2R9 Contact: Vanessa Tardio, Dr       vanessa.tardio@mail.mcgill.ca    Principal Investigator: Vanessa Tardio, Dr          Canada Centre de recherche du CHU de Québec - Université Laval Active, not recruiting Quebec, Canada, G1V 4G2 Centre de recherche de l'IUCPQ Recruiting Québec, Canada, G1V 4G5 Contact: Sarah Chouinard-Castonguay    4185254444 ext 48729    Sarah.Chouinard-Castonguay@crchudequebec.ulaval.ca    Principal Investigator: Gagnon Claudia, Dr Less <<
NCT02211924 Healthy Phase 1 Completed - -
NCT02699372 Healthy Volunteer Phase 1 Completed - Netherlands ... More >> PRA Health Sciences Early Development Services Zuidlaren, Netherlands, 9471 GP Less <<
NCT02209844 Healthy Phase 1 Completed - -
NCT00149383 Falciparum Malaria Phase 1 Phase 2 Completed - Thailand ... More >> Faculty of Tropical Medicine, Mahidol University Bangkok, Thailand, 10400 Less <<
NCT02411084 Graft vs Host Disease Phase 3 Terminated(Insufficient rate o... More >>f accrual) Less << - -
NCT02924636 Obesity Pregn... More >>ancy Less << Not Applicable Recruiting January 2019 France ... More >> CHU Lille Recruiting Lille, France Contact: Sylvie Deghilage    0320446467    sylvie.deghilage@chru-lille.fr Less <<
NCT01736033 Benign Prostate Hyperplasia Phase 4 Unknown June 2017 Korea, Republic of ... More >> Chungbuk National University Hospital Cheongju, Chungbuk, Korea, Republic of Soon Chun Hyang University Hospital Cheonan Cheonan, Chungnam, Korea, Republic of Hallym University Sacred Heart Hospital Anyang, Gyeoggi, Korea, Republic of Bucheon St. Mary's Hospital Bucheon, Gyeonggi, Korea, Republic of Soon Chun Hyang University Hospital Bucheon Bucheon, Gyeonggi, Korea, Republic of Seoul National University Bundang Hospital Seongnam, Gyeonggi, Korea, Republic of Ajou University Hospital Suwon, Gyeonggi, Korea, Republic of Chonnam National University Hwasun Hospital Hwasun, Jeonnam, Korea, Republic of Pusan National University Hospital Busan, Korea, Republic of Seoul National University Hospital Seoul, Korea, Republic of, 110-744 Eulji General Hospital Seoul, Korea, Republic of Less <<
NCT02356952 Metabolic Syndrome X Not Applicable Completed - Italy ... More >> Laboratory of Epidemiology and Biostatistics-IRCCS Saverio de Bellis Castellana Grotte, BA, Italy, 70013 Less <<
NCT01561131 Prevention of Obesity Not Applicable Completed - Denmark ... More >> Department of Human Nutrition, University of Copenhagen Frederiksberg, Copenhagen, Denmark, 1958 Less <<
NCT02727712 Coronary Heart Disease Phase 4 Unknown December 2016 China, Hunan ... More >> Xiangya Hospital of Central South University Changsha, Hunan, China, 410078 Less <<
NCT02823301 Sedentary Lifestyle Not Applicable Active, not recruiting September 2019 Brazil ... More >> Universidade Federal de Santa Catarina Florianopolis, Santa Catarina, Brazil, 88040-900 Less <<
NCT00458211 Schizophrenia ... More >> Schizoaffective Disorder Less << Phase 4 Completed - United States, New York ... More >> Bronx Psychiatric Center Bronx, New York, United States, 10461 Buffalo Psychiatric Center Buffalo, New York, United States, 14213 Less <<
NCT03352544 Exercise Therapy Not Applicable Completed - Spain ... More >> Universidad Pablo de Olavide Sevilla, Spain Less <<
NCT02741804 Mild Cognitive Impairment Not Applicable Not yet recruiting May 2019 United States, California ... More >> Cedars-Sinai Medical Center Not yet recruiting Los Angeles, California, United States, 90048 Contact: Wendy Weissberg    310-423-5357    weissbergg@cshs.org    Contact: Georgia Rochester    3104236587    georgia.rochester@cshs.org    Sub-Investigator: Dean Sherzai, MD, MAS          Principal Investigator: Ayesha Sherzai, MD Less <<
NCT00331708 Malaria Not Applicable Terminated(Lack of suitable pa... More >>rticipants) Less << - Mozambique ... More >> Ndlavela Health Centre Ndlavela, Maputo, Mozambique Less <<
NCT02243969 Hypertension ... More >>Lipid Metabolism Disorders Less << Not Applicable Completed - Netherlands ... More >> Maastricht University Medical Center Maastricht, Limburg, Netherlands, 6229 ER Less <<
NCT01297959 Infections Phase 3 Unknown June 2016 -
NCT01253720 Acute Lymphoblastic Leukemia ... More >> Cancer Obesity Less << Not Applicable Completed - United States, California ... More >> UC San Diego La Jolla, California, United States, 92093 Less <<
NCT02540759 Healthy Phase 1 Completed - Canada, New Brunswick ... More >> Université de Moncton Moncton, New Brunswick, Canada, E1A 3E9 Less <<
NCT03032601 Multiple Sclerosis Not Applicable Recruiting January 5, 2020 United States, Pennsylvania ... More >> Thomas Jefferson University Recruiting Philadelphia, Pennsylvania, United States, 19107 Contact: Nancy Wintering, LCSW, CCRP    215-503-3423    nancy.wintering@jefferson.edu    Principal Investigator: Daniel A Monti, MD, MBA          Sub-Investigator: Andrew B Newberg, MD          Sub-Investigator: Thomas Leist, MD Less <<
NCT00458211 - Completed - -
NCT00162266 Rheumatoid Arthritis Phase 2 Completed - -
NCT03335956 Healthy Phase 1 Completed - United Kingdom ... More >> Hammersmith Medicines Research London, United Kingdom Less <<
NCT00922688 Colon Carcinoma Not Applicable Unknown May 2013 Netherlands ... More >> Medical Center Alkmaar Recruiting Alkmaar, Noord holland, Netherlands, 1815 JD Contact: Hamit Cakir, MD    0031725484444    h.cakir@mca.nl    Principal Investigator: Alexander PJ Houdijk, MD, PhD          Sub-Investigator: Hamit Cakir, MD Less <<
NCT01072825 - Recruiting January 2020 Belgium ... More >> Genderteam UZ Gent Recruiting Gent, Belgium Contact: Guy T'Sjoen, MD       guy.tsjoen@ugent.be    Principal Investigator: Guy T'Sjoen, MD          Italy Recruiting Florence, Italy Contact: Alessandra Fisher, MD          Principal Investigator: Alessandra Fisher, MD          Netherlands VU University Medical CenterAmsterdam Recruiting Amsterdam, Netherlands Contact: Michael van Trotsenburg, MD       m.vantrotsenburg@vumc.nl    Principal Investigator: Michael van Trotsenburg, MD          Norway Rikshospitalet University Hospital, University of Oslo Recruiting Oslo, Norway Contact: Thomas Schreiner       thomas.schreiner@rikshospitalet.no    Principal Investigator: Thomas Schreiner, MD Less <<
NCT02823379 Physical Activity Not Applicable Active, not recruiting June 2020 United States, Arizona ... More >> Rodney P. Joseph Phoenix, Arizona, United States, 85004 Less <<
NCT00401089 Schizophrenia ... More >> Schizoaffective Disorder Tardive Dyskinesia Insulin Resistance Obesity Less << Phase 1 Phase 2 Completed - Canada, Ontario ... More >> Queen's University Kingston, Ontario, Canada Regional Mental Health Care London St. Thomas, Ontario, Canada, N5P 3V9 Northern Ontario Medical School Thunder Bay, Ontario, Canada United Kingdom Northwick Park Hospital Harrow, Middlesex, United Kingdom, HA13UJ Less <<
NCT00162266 - Completed - -
NCT02068183 - Completed - United States, New York ... More >> NYU School of Medicine New York, New York, United States, 10016 Less <<
NCT02774655 Cardiovascular Diseases ... More >> Obesity Less << Not Applicable Completed - Norway ... More >> Institutt for sirkulasjon og bildediagnostikk Trondheim, Norway Less <<
NCT00146328 HIV Infections Phase 2 Phase 3 Completed - -
NCT01411046 - Recruiting December 2017 Denmark ... More >> Rigshospitalet Recruiting Copenhagen, Denmark, 2100 Contact: Ulla Feldt-Rasmussen, Professor    +4535451023    ulla.feldt-rasmussen@dadlnet.dk    Principal Investigator: Ulla Feldt-Rasmussen, Professor Less <<
NCT02234388 - Recruiting - United States, New York ... More >> Hospital for Special Surgery Recruiting New York, New York, United States, 10021 Contact: Eliza Pelrine, BA    212-774-2123    pelrinee@hss.edu    Contact: Chris Hatzis, BA    212-774-7194    hatzisc@hss.edu    Principal Investigator: Lisa Sammaritano, MD Less <<
NCT01438424 Hepatitis B Virus ... More >> HBV Less << Phase 2 Completed - -
NCT01487083 Schizophrenia Phase 3 Terminated(The decision to sto... More >>p the trial was based on efficacy results in the overall schizophrenia participant population.) Less << - -
NCT00146328 - Completed - -
NCT02120352 Infection, Human Immunodeficie... More >>ncy Virus Less << Phase 2 Active, not recruiting December 31, 2020 -
NCT00351819 Pain Hypogona... More >>dism Less << Phase 2 Completed - United States, Massachusetts ... More >> Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Less <<
NCT02847312 Healthy Not Applicable Unknown April 2017 United Kingdom ... More >> Hugh Sinclair Unit of Human Nutrition Recruiting Reading, United Kingdom, RG66AP Contact: Michelle Weech, Mananger    01183787771    m.weech@reading.ac.uk    Contact: Angelika Kristek, Assistant    0118378771    a.kristek@reading.ac.uk    Sub-Investigator: Manuel Y Schar, PDRA          Principal Investigator: Jeremy P Spencer, Professor Less <<
NCT02703753 Overweight Ob... More >>esity Pregnancy Complications Less << Not Applicable Recruiting December 2021 Netherlands ... More >> Maastricht University Medical Center Recruiting Maastricht, Limburg, Netherlands, 6229HX Contact: Yvon Timmermans, Drs.    +31433875521    yvon.timmermans@mumc.nl Less <<
NCT01609959 Hypertension Phase 4 Completed - Japan ... More >> First Department of Nara Medical University Kashihara, Nara, Japan, 634-8522 Less <<
NCT00351819 - Completed - -
NCT01922167 Frail Elderly Not Applicable Active, not recruiting August 2018 Canada, Quebec ... More >> Institut Universitaire de Gériatrie de Montréal Montreal, Quebec, Canada, H3W 1W5 Royal Victoria Hospital - Glen Site Montreal, Quebec, Canada, H4A 3J1 Less <<
NCT01594190 Acute Ischemic Stroke ... More >> Physical Activity Accelerometer Less << Not Applicable Unknown September 2014 Denmark ... More >> Hillerød Hospital Not yet recruiting Hillerød, Denmark, 3400 Contact: Anna Maria Strømmen, MD    +4548297353    amic@noh.regionh.dk    Principal Investigator: Anna Maria Strømmen, MD Less <<
NCT02649205 - Completed - Hungary ... More >> Velencei-tavi Kistérségi Járóbeteg Szakellátó Közhasznú Nonprofit Kft Velence, Hungary, 2481 Less <<
NCT02756520 - Completed - China, Beijing ... More >> Prof. Xiangmei Beijing, Beijing, China Less <<
NCT01710722 Obesity Not Applicable Completed - United States, Louisiana ... More >> Pennington Biomedical Research Center Baton Rouge, Louisiana, United States, 70808 Less <<
NCT00879814 Meningitis, Meningococcal Phase 1 Completed - United States, Florida ... More >> Miami Research Associates, Inc. South Miami, Florida, United States, 33143 Less <<
NCT01438424 - Completed - -
NCT02334904 - Unknown June 2016 Canada, British Columbia ... More >> BC Mental Health & Addictions Research Institute Recruiting Vancouver, British Columbia, Canada, V5Z 4H4 Contact: Delrae Fawcett, MSc    604-875-2000 ext 6115    delrae.fawcett@ubc.ca Less <<
NCT02746133 - Active, not recruiting December 2018 Russian Federation ... More >> Moscow, Russian Federation Saint Petersburg, Russian Federation Less <<
NCT02053259 Physical Activity ... More >> Behavior Overweight Motor Activity Less << Not Applicable Unknown January 2018 United States, Arizona ... More >> Arizona State Univertsity, School of Nutrition and Health Promotion Phoenix, Arizona, United States, 85004 Less <<
NCT00380146 Malaria Not Applicable Completed - Mozambique ... More >> Ndlavela Health Centre Ndlavela, Maputo, Mozambique Less <<
NCT02520739 Cardiovascular Diseases Phase 3 Unknown December 2016 Spain ... More >> University Hospital Virgen de las Nieves Granada, Spain, 18012 Less <<
NCT03688932 Frail Elderly Syndrome Not Applicable Recruiting March 30, 2019 Brazil ... More >> Federal University of Pernambuco Recruiting Recife, Pernambuco, Brazil Contact: Helga C Muniz de Souza, Master    (55)999146267    helgamuniz@yahoo.com.br    Principal Investigator: Helga C Muniz de Souza, Master Less <<
NCT00879814 - Completed - -
NCT01986036 Healthy Not Applicable Unknown May 2014 United Kingdom ... More >> Northumbria University Newcastle upon Tyne, Tyne and Wear, United Kingdom, NE1 8ST Less <<
NCT00230919 Obesity Metab... More >>olic Syndrome Less << Not Applicable Completed - Norway ... More >> Ulleval University Hospital, dep. of preventive cardiology Oslo, Norway, N-0407 Less <<
NCT02472509 Hemolytic Disorders ... More >> Gallstones Less << Phase 4 Terminated(Study not feasible ... More >>- very low recruitment rate) Less << - Israel ... More >> Shaare Zedek Medical Center Jerusalem, Israel, 91031 Less <<
NCT02787577 Sleep Not Applicable Completed - United Kingdom ... More >> Diabetes & Nutritional Sciences Division, King's College London London, United Kingdom, SE1 9NH Less <<
NCT00428415 Obesity Phase 1 Phase 2 Completed - Denmark ... More >> NeuroSearch A/S Ballerup, Denmark, 2750 Less <<
NCT02251574 Obstructive Sleep Apnea Not Applicable Completed - United States, Kansas ... More >> University of Kansas Medical Center Kansas City, Kansas, United States, 66160 Less <<
NCT03507387 Elective Cesarean Section ... More >> Spinal Anesthesia Less << Not Applicable Recruiting June 1, 2019 China, Jiangsu ... More >> The Affiliated Hospital of Xuzhou Medical University Recruiting Xuzhou, Jiangsu, China, 221000 Contact: Chao Xu, M.D    +86-18752113017    qdy0828@163.com Less <<
NCT01820429 - Completed - Brazil ... More >> Instituto do Coração (Heart Institute) - Clinical Hospitals, University of São Paulo Medical School São Paulo, Brazil, 05403900 Less <<
NCT02342314 Healthy Phase 1 Completed - United Kingdom ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Leeds, United Kingdom, LS2 9LH Less <<
NCT00939679 Obesity Not Applicable Completed - Denmark ... More >> Department of Human Nutrition, Faculty of Life Sciences, University of Copenhagen Copenhagen, Denmark, 1958 Hvidovre Hospital Copenhagen, Denmark, 2650 Less <<
NCT01530048 Diabetes Heal... More >>thy Less << Phase 1 Completed - Denmark ... More >> Novo Nordisk Investigational Site Hvidovre, Denmark, 2650 Less <<
NCT02735330 Chronic Calcific Pancreatitis Not Applicable Active, not recruiting September 2019 -
NCT00924937 Myocardial Infarction ... More >> Unstable Angina Malignancy Cognitive Decline Diabetes Mellitus Metabolic Syndrome Less << Not Applicable Active, not recruiting September 2019 Spain ... More >> Reina Sofia University Hospital Cordoba, Spain, 14001 Less <<
NCT02378298 Ophthalmopathy, Thyroid-Associ... More >>ated Less << Phase 4 Recruiting December 2019 Sweden ... More >> Center for Endocrinology and Metabolism, Sahlgrenska University Hospital Recruiting Gothenburg, Sweden Contact: Ann-Charlotte Olofsson, Nurse          MedTech West, Institute of Neuro Science and Physiology, Department for Clinical Neuro Science and Rehabilitation, Sahlgrenska Academy, University of Gothenburg Active, not recruiting Gothenburg, Sweden Department of Ophthalmology, Sahlgrenska University Hospital/Mölndal Recruiting Mölndal, Sweden Contact: Lena Sjödell, Dr          Department of Rheumatology, Sahlgrenska University Hospital/Mölndal Active, not recruiting Mölndal, Sweden Department of Radiology, Karolinska University Hospital Active, not recruiting Stockholm, Sweden Less <<
NCT00573417 Schizophrenia Phase 4 Completed - United States, Massachusetts ... More >> Freedom Trail Clinic Boston, Massachusetts, United States, 02114 Less <<
NCT00724022 Disorder Related to Renal Tran... More >>splantation Less << Phase 4 Completed - Germany ... More >> Universitaetsklinikum Berlin Berlin, Germany, 13353 Universitaetsklinikum Bonn Bonn, Germany, 53105 Klinikum Bremen-Mitte Bremen, Germany, 28177 Carl Gustav Carus Universitätsklinikum Dresden, Germany, 01307 Universitaetsklinikum Erlangen Erlangen, Germany, 91054 Universitaetsklinikum Essen Essen, Germany, 45122 Universitätsklinikum Frankfurt Frankfurt am Main, Germany, 60590 Universitaetsklinikum Freiburg Freiburg, Germany, 79106 Nephrologisches Zentrum Niedersachsen Hannoversch-Münden, Germany, 34346 Universitätsklinikum Heidelberg Heidelberg, Germany, 69120 Universitätsklinikum Jena Jena, Germany, 07747 Transplantationszentrum Kaiserslautern Kaiserslautern, Germany, 67655 Universitaetsklinikum Koeln Koeln, Germany, 50924 Kliniken der Stadt Köln gGmbH - Krankenhaus Köln-Merheim Koeln, Germany, 51109 Universitätsklinikum Leipzig Leipzig, Germany, 04103 Universitätsklinikum Schleswig-Holstein Campus Lübeck Lübeck, Germany, 23538 Universitätsklinikum Mainz Mainz, Germany, 55131 Universitaetsklinikum Mannheim Mannheim, Germany, 68167 Universitätsklinikum München LMU München, Germany, 81377 Klinikum rechts der Isar der TU München München, Germany, 81675 Universitaetsklinikum der WWU Münster Münster, Germany, 48149 Universitätsklinikum Regensburg Regensburg, Germany, 93053 Universitätsklinikum Rostock Rostock, Germany, 18057 Universitätsklinikum Tübingen Tübingen, Germany, 72076 Universitaetsklinikum Würzburg Würzburg, Germany, 97080 Less <<
NCT01814111 Hypertension ... More >>Atrial Fibrillation Less << Not Applicable Unknown June 2015 China, Jiangsu ... More >> First Affiliated Hospital of Nanjing Medical University Recruiting Nanjing, Jiangsu, China, 210000 Contact: qijun shan, professor    0086 025 68136407    qjshan@njmu.edu.cn    Principal Investigator: qijun shan, professor Less <<
NCT02657759 HYPERCHOLESTEROLEMIA Not Applicable Unknown May 2016 France ... More >> Biofortis Recruiting Saint-Herblain, France, 44800 Contact: Patrice CHAUVEAU    + 33 (0)2 40 20 45 65    patrice.chauveau@mxns.com    Principal Investigator: David GENDRE, M.D. Less <<
NCT01702740 Lupus Erythematosus, Cutaneous... More >> Lupus Erythematosus, Systemic Less << Phase 1 Completed - -
NCT03470415 - Not yet recruiting December 2019 -
NCT01175837 Malignant Neoplasm Not Applicable Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT00870012 Nonalcoholic Fatty Liver Disea... More >>se Less << Not Applicable Completed - China ... More >> Cheng Suen Man Shook Hepatitis Center, Institute of Digestive Disease, The Chinese University of Hong Kong, Prince of Wales Hospital Hong Kong SAR, China Less <<
NCT01685957 Obesity Overw... More >>eight Less << Not Applicable Completed - Denmark ... More >> Department of Nutrition, Regional Hospital West Jutland, Denmark Holstebro, Denmark, 7500 Less <<
NCT00302952 Rheumatoid Arthritis Phase 2 Completed - United States, Alabama ... More >> University of Alabama Birmingham, Alabama, United States, 35294 United States, California University of California, San Francisco San Francisco, California, United States, 94143 United States, Colorado University of Colorado Aurora, Colorado, United States, 80095 United States, Illinois University of Chicago Medical Center Chicago, Illinois, United States, 60637 United States, Michigan Justus J. Fiechtner, MD, PLLC Lansing, Michigan, United States, 48910 United States, New York Feinstein Institute for Medical Research NS-LIJ Health System Manhasset, New York, United States, 11030 University of Rochester Rochester, New York, United States, 14642 United States, North Carolina Carolina Bone and Joint Charlotte, North Carolina, United States, 29425 Duke University Medical Center Durham, North Carolina, United States, 27710 United States, Oklahoma Oklahoma Medical Research Foundation Oklahoma City, Oklahoma, United States, 73104 United States, Pennsylvania Altoona Center for Clinical Research Duncansville, Pennsylvania, United States, 16635 University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States, 15261 United States, South Carolina Medical University of South Carolina Charleston, South Carolina, United States, 29425 United States, Texas Baylor Research Institute Dallas, Texas, United States, 75231 United States, Utah University of Utah Salt Lake City, Utah, United States, 84132 Less <<
NCT00302952 - Completed - -
NCT02427347 Abdominal Obesity ... More >> Metabolic Syndrome Less << Not Applicable Completed - China, Beijing ... More >> Department of Acupuncture and Moxibustion, Dongfang Hospital, Beijing University of Chinese Medicine Beijing, Beijing, China, 100078 Less <<
NCT01652040 Spinal Cord Injury Phase 2 Phase 3 Completed - United States, Virginia ... More >> Hunter Holmes McGuire VA Medical Center, Richmond, VA Richmond, Virginia, United States, 23249 Less <<
NCT03646370 - Recruiting July 24, 2019 United States, Pennsylvania ... More >> Thomas Jeffeson University Recruiting Philadelphia, Pennsylvania, United States, 19107 Contact: Jason J Schafer, PharmD    215-503-7522    jason.schafer@jefferson.edu Less <<
NCT03142633 - Recruiting June 1, 2017 Denmark ... More >> Fertility Clinic,Department of Gynecology and Obstetrics Recruiting Holbaek, Denmark, 4300 Contact: Pernille B Udesen, MD    +45 59 48 42 67    peud@regionsjaelland.dk    Principal Investigator: Pernille B Udesen, MD Less <<
NCT00343395 Coronary Artery Disease Phase 4 Terminated(FDA concerns regard... More >>ing Avandamet) Less << - United States, Utah ... More >> Intermountain Medical Center Murray, Utah, United States, 84157 Less <<
NCT03257085 Cardiometabolic Risk Not Applicable Completed - United Kingdom ... More >> Liverpool John Moores University Liverpool, Merseyside, United Kingdom, L17 6BD Less <<
NCT00303251 Melanoma Phase 1 Phase 2 Completed - United States, Kentucky ... More >> James Graham Brown Cancer Center Louisville, Kentucky, United States, 40202 United States, Pennsylvania University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States, 15232 United States, Texas MD Anderson Cancer Houston, Texas, United States, 77030 Less <<
NCT00483171 Obesity Phase 3 Terminated(See termination rea... More >>son in detailed description.) Less << - -
NCT01652040 - Completed - -
NCT00303602 Schizophrenia ... More >> Schizoaffective Disorder Bipolar Disorder Less << Phase 4 Completed - United States, California ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Escondido, California, United States, 92025 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Garden Grove, California, United States, 92845 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. National City, California, United States, 91950 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Orange, California, United States, 92868 United States, Georgia For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Atlanta, Georgia, United States, 30308 United States, Nevada For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Las Vegas, Nevada, United States, 89102 United States, New York For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Staten Island, New York, United States, 10312 Canada, British Columbia For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Penticton, British Columbia, Canada, V2A 4M4 Canada, Manitoba For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Winnipeg, Manitoba, Canada, R3E 3N4 Canada, Nova Scotia For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Dartmouth, Nova Scotia, Canada, B2Y 3Z9 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Halifax, Nova Scotia, Canada, B3H 2E2 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sydney, Nova Scotia, Canada, B1S 2E8 Canada, Ontario For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chatham, Ontario, Canada, N7L 1B7 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kingston, Ontario, Canada, K7L 4X3 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sudbury, Ontario, Canada, P3C 1T4 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Windsor, Ontario, Canada, N9C 3Z4 Canada, Quebec For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sherbrooke, Quebec, Canada, J1G 1W4 Mexico For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mexico City, Mexico, 01030 Netherlands For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Amersfoort, Netherlands, 3816 CP For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Rotterdam, Netherlands, 3015 GD Puerto Rico For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. San Juan, Puerto Rico, 00918 Less <<
NCT00303602 - Completed - -
NCT00715403 - Completed - -
NCT00095732 Cystic Fibrosis ... More >> Pancreatic Insufficiency Less << Phase 2 Completed - -
NCT02248701 Spinal Cord Injury ... More >> Spinal Cord Injuries Trauma, Nervous System Wounds and Injuries Central Nervous System Diseases Nervous System Diseases Spinal Cord Diseases Gonadal Disorders Endocrine System Diseases Hypogonadism Genital Diseases, Male Less << Phase 2 Recruiting June 1, 2019 United States, Florida ... More >> North Florida/South Georgia Veterans Health System, Gainesville, FL Recruiting Gainesville, Florida, United States, 32608 Contact: Joshua F Yarrow, PhD MS BS    352-376-1611 ext 6477    joshua.yarrow@va.gov    Contact: Dana M Otzel, PhD    (352) 376-1611 ext 6917    Dana.Otzel@va.gov    Principal Investigator: Joshua F Yarrow, PhD MS BS          James A. Haley Veterans' Hospital, Tampa, FL Recruiting Tampa, Florida, United States, 33612 Contact: Joshua F Yarrow, PhD    352-376-1611 ext 6477    Joshua.Yarrow@va.gov    Contact: Dana M Otzel, PhD    3523761611 ext 6917    Dana.Otzel@va.gov Less <<
NCT01527565 Diabetes Heal... More >>thy Less << Phase 1 Completed - South Africa ... More >> Novo Nordisk Investigational Site Bloemfontein, South Africa, 9324 Less <<
NCT00715403 Neoplasms Phase 1 Completed - France ... More >> 1199.16.3306A Boehringer Ingelheim Investigational Site Bordeaux cedex, France 1199.16.3311A Boehringer Ingelheim Investigational Site Clichy Cedex, France 1199.16.3311B Boehringer Ingelheim Investigational Site Clichy Cedex, France 1199.16.3313A Boehringer Ingelheim Investigational Site Paris Cedex 10, France 1199.16.3313E Boehringer Ingelheim Investigational Site Paris Cedex 10, France 1199.16.3302A Boehringer Ingelheim Investigational Site Paris cedex 15, France 1199.16.3312A Boehringer Ingelheim Investigational Site Paris, France Germany 1199.16.49001 Boehringer Ingelheim Investigational Site Freiburg/Breisgau, Germany 1199.16.49004 Boehringer Ingelheim Investigational Site Grosshansdorf, Germany 1199.16.49008 Boehringer Ingelheim Investigational Site Tübingen, Germany 1199.16.49005 Boehringer Ingelheim Investigational Site Wiesbaden, Germany Less <<
NCT00750113 Hypertension Phase 4 Completed - Italy ... More >> Pozzilli, Isernia, Italy, 86077 Monza, Monza-Brianza, Italy, 20052 Somma Lombardo, Varese, Italy, 21013 Ancona, Italy, 60126 Bologna, Italy, 40138 Brescia, Italy, 25123 Broni, Italy, 27043 Catania, Italy, 95126 Cinisello Balsamo, Italy, 20092 Ferrara, Italy, 44100 L'Aquila, Italy, 67100 Milano, Italy, 20143 Napoli, Italy, 80136 Napoli, Italy, 80141 Novara, Italy, 28100 Padova, Italy, 35128 Palermo, Italy, 90127 Pavia, Italy, 27100 Perugia, Italy, 06129 Pisa, Italy, 56126 Reggio Emilia, Italy, 42100 Roma, Italy, 00152 Roma, Italy, 00157 Roma, Italy, 00161 Sassari, Italy, 07100 Siena, Italy, 53100 Siracusa, Italy, 96100 Treviso, Italy, 31100 Trieste, Italy, 34149 Varese, Italy, 21100 Venezia, Italy, 30122 Spain Ferrol, A Coruña, Spain, 15405 Gijón, Asturias, Spain, 33394 Badalona, Barcelona, Spain, 08916 Jerez de la Frontera, Cádiz, Spain, 11407 Las Palmas de Gran Canaria, Las Palmas, Spain, 35020 Beniganim, Valencia, Spain, 46830 Badajoz, Spain, 06080 Ciudad Real, Spain, 13005 Madrid, Spain, 28040 Madrid, Spain, 28041 Málaga, Spain, 29010 Valencia, Spain, 46006 Less <<
NCT01551381 Type 2 Diabetes Phase 2 Terminated(Interim review indi... More >>cated that the dose selected was too high for diabetics) Less << - Germany ... More >> Profil Institut für Stoffwechselforschung GmbH Neuss, Germany Less <<
NCT01527552 Diabetes Heal... More >>thy Less << Phase 1 Completed - South Africa ... More >> Novo Nordisk Investigational Site Bloemfontein, South Africa, 9324 Less <<
NCT00668161 Colon Cancer Prevention Phase 2 Phase 3 Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98102 Less <<
NCT00163189 - Completed - -
NCT00373230 Overweight Not Applicable Unknown February 2010 United States, Pennsylvania ... More >> Geisinger Medical Center Recruiting Danville, Pennsylvania, United States, 17822 Contact: Timothy McConnell, PhD    570-271-8067    tmcconnell@geisinger.edu    Temple University Recruiting Philadelphia, Pennsylvania, United States, 19140 Contact: Linda Zamora, RN, BSN    215-707-9733    zamoralc@temple.edu    Contact: Maggie Kerper, RN, BSN    215 707-9731    kerpermm@tuhs.temple.edu    Principal Investigator: Guenther Boden, MD Less <<
NCT00163189 Growth Hormone Deficiency Phase 3 Completed - France ... More >> Hôpital Nord Amiens, France, 80030 Centre Hospitalier Intercommunal d'Annemasse-Bonneville, Service de Pédiatrie et Néonatologie Annemasse Cedex, France, 74107 Hôpital Saint Jacques Besancon Cedex, France, 25030 Groupe hospitalier Est- Hôpital Femme, Mère, Enfant Bron, France, 69677 Groupe hospitalier Est-Hôpital Femme, Mère, Enfant Bron, France, 69677 CHU d'Estaing Clermont-Ferrand Cedex 1, France, 63003 CHU de Grenoble, Hôpital Couple enfant. Grenoble Cedex 9, France, 38043 CHU Timone Enfants Marseille Cedex 5, France, 13385 Hôpital Arnaud De Villeneuve Montpellier, France, 34059 CHU de Nantes, Hôpital Mère Enfant Nantes cedex 1, France, 44093 Hôpital Lenval Nice, France, 06200 Groupe Hospitalier Necker - Enfants Malades Paris cedex 15, France, 75743 Hôpital Robert Debré Paris, France, 75019 Hôpital Armand Trousseau Paris, France, 75571 Centre de Perharidy Roscoff Cedex, France, 29684 CHU Charles Nicolle Rouen Cedex, France, 76031 Service de Pédiatrie- Centre Hospitalier Intercommunal Saint Germain-en-Laye Cedex, France, 78105 Hôpital des Enfants Toulouse Cedex 9, France, 31059 CHU Tours - Centre Pediatrique Gatien de Cocheville Tours Cedex 1, France, 37044 Less <<
NCT02483858 Cancer Phase 1 Active, not recruiting December 2018 United States, Minnesota ... More >> Mayo Clinic Rochester Rochester, Minnesota, United States, 55905 United States, New York Roswell Park Cancer Buffalo, New York, United States, 14263 United States, Ohio University Hospitals of Cleveland Cleveland, Ohio, United States, 44106 United States, Texas MD Anderson Cancer Houston, Texas, United States, 77030 Spain Vall d'Hebron University Hospital Barcelona, Spain, 08035 Switzerland Basel University Hospital Basel, Switzerland, 4031 United Kingdom University College Hospital London London, United Kingdom Churchill Hospital Oxford, United Kingdom, OX3 7DQ Less <<
NCT03328546 - Active, not recruiting December 2023 -
NCT02434497 Homozygous Familial Hyperchole... More >>sterolemia (HoFH) Less << Phase 3 Completed - Belgium ... More >> Research Site Brussels (Woluwé-St-Lambert), Belgium, 1200 Canada, Quebec Research Site Chicoutimi, Quebec, Canada, G7H 7K9 Denmark Research Site Copenhagen, Denmark, DK-2100 Israel Research Site Halfa, Israel, 31096 Malaysia Research Site Kubang Kerian, Malaysia, 16150 Taiwan Research Site Taipei City, Taiwan, 11217 Less <<
NCT02853734 Parodontitis ... More >>Obesity Metabolism Disorders Less << Not Applicable Not yet recruiting June 2020 -
NCT02712320 - Completed - -
NCT02434497 - Completed - -
NCT00391196 Obesity Phase 3 Terminated(See termination rea... More >>son in detailed description.) Less << - -
NCT01937520 - Completed - -
NCT02712320 Prostatic Neoplasms Phase 3 Completed - United States, Alabama ... More >> Urology Centers of Alabama Homewood, Alabama, United States, 35209 United States, California Genesis Research, LLC San Diego, California, United States, 92123 United States, Idaho Idaho Urologic Institute - Meridian Meridian, Idaho, United States, 83642 United States, New Jersey AdvanceMed Research Lawrenceville, New Jersey, United States, 08648 United States, North Carolina Carolina Clinical Trials, LLC Concord, North Carolina, United States, 28025 United States, South Carolina Carolina Urologic Research Center Myrtle Beach, South Carolina, United States, 29572 United States, Washington Seattle Urology Research Center Burien, Washington, United States, 98166 Less <<
NCT01937520 Thyroid or Parathyroid Surgery Not Applicable Completed - United States, New Jersey ... More >> University Hospital Newark, New Jersey, United States, 07101 Less <<
NCT02467881 Sedentary Lifestyle ... More >> Physical Activity Less << Not Applicable Active, not recruiting December 2018 United States, Pennsylvania ... More >> University of Pittsburgh, Epidemiology Department Pittsburgh, Pennsylvania, United States, 15213 Less <<
NCT03411369 Ischemic Heart Disease Not Applicable Completed - -
NCT01310140 - Terminated(PI left Massachuset... More >>ts General Hospital Inpatient service) Less << - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT00315770 Overweight Me... More >>tabolic Syndrome X Bone Resorption Less << Phase 1 Active, not recruiting April 2020 -
NCT03585868 Sarcopenia Fr... More >>ail Elderly Syndrome Less << Not Applicable Completed - -
NCT00140543 Diabetes Mellitus, Type 1 ... More >> Diabetic Nephropathy Less << Phase 3 Unknown - Austria ... More >> Universitätsklinik Innsbruck, Austria, 6020 Belgium Cliniques Universitaires Saint Luc Brussels, Belgium, 1200 UZ Gent Gent, Belgium, 9000 UZ Gasthuisberg Leuven, Belgium, 3000 Czech Republic Institute for clinical and experimental medicine-IKEM Prague, Czech Republic, 14021 Germany Charite Campus Virchow Klinikum Berlin, Germany, 13353 Knappschaftskrankenhaus Bochum-Langendreer, Germany, 44892 Goethe University Frankfurt am Main, Germany, 60590 Chirurgische Universitätsklinik Freiburg, Germany, 79111 Klinikum Grosshadern-University of Munich Munich, Germany, 81366 Klinikum Innenstadt der Universität München Munich, Germany, 90336 Israel Tel Aviv Sourasky Medical Center Tel Aviv, Israel, 64239 Spain Hospital Clinico Barcelona, Spain, 08036 Switzerland Hôpital Cantonal de Geneve Geneva, Switzerland, 1211 Less <<
NCT00101738 Kidney Transplantation Phase 3 Completed - -
NCT03203486 NAFLD Steatos... More >>is of Liver Less << Not Applicable Completed - -
NCT02455973 Obesity Overw... More >>eight Less << Not Applicable Unknown December 2017 Brazil ... More >> Pontifical Catholic University of Rio Grande do Sul Recruiting Porto Alegre, RS, Brazil Contact: Andréia da Silva Gustavo, PHD    (51) 3320.3500    andreia.gustavo@pucrs.br    Contact: Ana Maria Pandolfo Feoli, PHD    (51) 33203646 ext 3646    anafeoli@pucrs.br Less <<
NCT02240966 - Completed - Denmark ... More >> Rigshospitalet Copenhagen, Denmark, 2100 Less <<
NCT01960699 - Active, not recruiting December 2019 Austria ... More >> Medical University of Vienna Vienna, Austria, 1090 Less <<
NCT01649687 Cerebellar Ataxia Phase 1 Phase 2 Completed - Taiwan ... More >> Taipei Veterans General Hospital Taipei, Taiwan Less <<
NCT03261609 - Active, not recruiting February 28, 2019 Canada, Quebec ... More >> StJustine's Hospital Montréal, Quebec, Canada, H3T 1C5 Less <<
NCT00664521 - Completed - -
NCT00664521 Rheumatoid Arthritis Phase 2 Completed - France ... More >> Research Site Nice, France Research Site Paris, France Research Site Strasbourg, France Netherlands Research Site Amsterdam, Netherlands Sweden Research Site Malmö, Sweden Research Site Stockholm, Sweden United Kingdom Research Site Newcastle, United Kingdom Research Site Norwich, United Kingdom Less <<
NCT01751646 HIV Infection Not Applicable Completed - United States, California ... More >> Children's Hopsital of Los Angeles Los Angeles, California, United States, 90027 University of Southern California - NICHD Westat Site Los Angeles, California, United States, 90033 United States, District of Columbia Childrens National Medical Center Washington, District of Columbia, United States, 20010 United States, Florida Children's Diagnostic and Treatment Center - NICHD Westat Site Fort Lauderdale, Florida, United States, 33316 University of Florida Jacksonville - NICHD Westat Site Jacksonville, Florida, United States, 32211 University of Miami School of Medicine Miami, Florida, United States, 33101 University of South Florida Tampa, Florida, United States, 33606 United States, Illinois Stroger Hospital and the CORE Center Chicago, Illinois, United States, 60612 United States, Louisiana Tulane Medical Center New Orleans, Louisiana, United States, 70112 United States, Maryland Johns Hopkins University - NICHD Westat Site Baltimore, Maryland, United States, 21287 Johns Hopkins University Baltimore, Maryland, United States, 21287 United States, Massachusetts Fenway Institute Boston, Massachusetts, United States, 02215 United States, Michigan Wayne State University Detroit, Michigan, United States, 48201 United States, New York Montefiore Medical Center Bronx, New York, United States, 10467 United States, Pennsylvania Children's Hopsital of Philadelphia - NICHD Westat Site Philadelphia, Pennsylvania, United States, 19104 Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 United States, Tennessee St. Jude Childrens Research Hospital Memphis, Tennessee, United States, 38105 United States, Texas Baylor College of Medicine Houston, Texas, United States, 77030 Puerto Rico San Juan City Hospital (Puerto Rico) - NICHD Westat Site San Juan, Puerto Rico, 00936-5067 Less <<
NCT02018627 Type 1 Diabetes Phase 2 Phase 3 Active, not recruiting December 2018 United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT01910571 Healthy Phase 1 Completed - United States, California ... More >> Facility: Profil® Institute for Clinical Research, Inc. Chula Vista, California, United States, 91911 Less <<
NCT01528436 Cerebral Palsy Phase 2 Completed - Korea, Republic of ... More >> CHA Bundang Medical Center, CHA University Seongnam-si, Gyeonggi-do, Korea, Republic of, 463-712 Less <<
NCT03304938 Diabetes Mellitus, Type 2 ... More >> Sleep Disturbance Less << Not Applicable Recruiting February 18, 2018 Iran, Islamic Republic of ... More >> Shiraz University of Medical Sciences Recruiting Shiraz, Fars, Iran, Islamic Republic of Contact: Zeinab Nasiri Lari, M.D.    09173139409    dr.znasiri@gmail.com Less <<
NCT03643874 Asthma Phase 2 Recruiting September 30, 2018 United States, North Carolina ... More >> North Carolina Clinical Research Recruiting Raleigh, North Carolina, United States, 27607 Contact: Patti Becherer, RN    919-881-0309    pattib@nccr.com    Contact: Jan Pochis    919 881 0309    jpochis@nccr.com    Principal Investigator: Craig F LaForce, MD Less <<
NCT01596309 Cardiovascular Risk Factors Not Applicable Completed - Spain ... More >> Department of Nutrition, Food Science, Physiology and Toxicology. University of Navarra Pamplona, Navarra, Spain, 31008 Less <<
NCT02013856 Blood Pressure Not Applicable Completed - United Kingdom ... More >> Institute of Food Research Norwich, Norfolk, United Kingdom, NR4 7UA Less <<
NCT02921217 Obesity Intra... More >>-Abdominal Fat Subcutaneous Fat, Abdominal Less << Phase 3 Unknown August 2017 Spain ... More >> Technological Centre of Nutrition and Health (CTNS) Recruiting Reus, Tarragona, Spain, 43204 Contact: Rosa Maria Valls, PhD    +34 636 944 723    estudis@ctns.cat    Sub-Investigator: Anna Pedret, PhD          Sub-Investigator: Ignasi Papell-Garcia, BSc Less <<
NCT00254215 Overweight Ob... More >>esity Less << Phase 1 Completed - Australia, New South Wales ... More >> University of Sydney Sydney, New South Wales, Australia, 2006 Less <<
NCT00005000 HIV Infections Phase 4 Unknown - United States, California ... More >> Agouron Pharmaceuticals Inc San Diego, California, United States, 92121 Less <<
NCT02819219 Healthy Not Applicable Completed - -
NCT01655797 Insomnia Not Applicable Completed - Sweden ... More >> Uppsala University Uppsala, Sweden, 75105 Less <<
NCT02775448 Dyslipidemia ... More >>Menopause Obesity Less << Phase 2 Unknown July 2017 Mexico ... More >> Hospital Nacional Homeopático Recruiting Mexico City, Mexico Contact: Emma del Carmen Macias-Cortes, PhD    15519165947    ecmc2008@hotmail.es    Contact: Gloria Hernández-Ruiz, MD    +5215591958511 Less <<
NCT03107026 Binge Eating Disorder Phase 3 Completed - -
NCT02547935 Type 2 Diabetes Mellitus, CKD ... More >>and Albuminuria Less << Phase 2 Phase 3 Completed - -
NCT02826122 Obesity Not Applicable Completed - Norway ... More >> LHL-Klinikkene Røros, Norway Less <<
NCT00244751 Cirrhosis, Liver Phase 2 Completed - -
NCT03618160 Healthy Phase 1 Recruiting July 3, 2019 Japan ... More >> Souseikai Hakata Clinic Recruiting Fukuoka, Japan, 812-0025 Sumida Hospital Recruiting Tokyo, Japan, 130-0004 Less <<
NCT01114568 Healthy Phase 1 Completed - -
NCT00244751 - Completed - -
NCT03196557 Immunoscience Phase 1 Completed - United States, Texas ... More >> Local Institution Austin, Texas, United States, 78759 Less <<
NCT03552757 Obesity Overw... More >>eight Less << Phase 3 Recruiting May 4, 2020 -
NCT00425945 Hypertension Not Applicable Completed - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT03726762 Type 2 Diabetes ... More >> Overweight Obese Less << Not Applicable Completed - Iran, Islamic Republic of ... More >> NovinDiet Clinic Tehran, Iran, Islamic Republic of, 1913635136 Less <<
NCT01669408 Stroke Phase 2 Unknown September 2013 Germany ... More >> Rescue service, Dept. of Anesthesiology, University Hospital Heidelberg Recruiting Heidelberg, Germany, 69120 Contact: Sven Poli, Dr. med.    0049 6221 56 ext 0    sven.poli@med.uni-heidelberg.de    Contact: Erik Popp, PD Dr. med.    0049 6221 56 ext 0    erik.popp@med.uni-heidelberg.de    Principal Investigator: Sven Poli, Dr. med.          Principal Investigator: Erik Popp, PD Dr. med.          Sub-Investigator: Christian Hametner, Dr. med.          Sub-Investigator: Jan Purrucker, Dr. med.          Sub-Investigator: Miriam Priglinger, Dr. med.          Sub-Investigator: Maxim Bartz Less <<
NCT03042520 - Recruiting September 2022 Korea, Democratic People's Rep... More >>ublic of Korea University Ansan Hospital Recruiting Ansan, Korea, Democratic People's Republic of Contact: Hyung Joon Yim          Asan Medical Center Recruiting Asan, Korea, Democratic People's Republic of Contact: Young-Suk Lim          Soon Chun Hyang University Hospital Bucheon. Recruiting Bucheon, Korea, Democratic People's Republic of Contact: Young Seok Kim          Dong-A University Hospital Recruiting Busan, Korea, Democratic People's Republic of Contact: Sang-Young Han          Inje University Busan Paik Hospital Recruiting Busan, Korea, Democratic People's Republic of Contact: Youn-Jae Lee          Kyungpook National University Hospital Recruiting Daegu, Korea, Democratic People's Republic of Contact: Won Young Tak          Gachon University Gil Hospital Recruiting Incheon, Korea, Democratic People's Republic of Contact: Ju-Hyun Kim          Pusan National University Hospital Recruiting Pusan, Korea, Democratic People's Republic of Contact: Heo Jeong          Korea University Guro Hospital Recruiting Seoul, Korea, Democratic People's Republic of Contact: Yoon Jun Kim          Samsung Medical Center Recruiting Seoul, Korea, Democratic People's Republic of Contact: Seung Woon Paik          Seoul National University Bundang Hosptial Recruiting Seoul, Korea, Democratic People's Republic of Contact: Sook-Hyang Jeong          Seoul National University Hospital Recruiting Seoul, Korea, Democratic People's Republic of Contact: Kwan Soo Byun          Seoul St. Mary's Hospital Recruiting Seoul, Korea, Democratic People's Republic of Contact: Seung-Kew Yoon          Severance Hospital Recruiting Seoul, Korea, Democratic People's Republic of Contact: Sang Hoon Ahn          Korea, Republic of Gangnam Severance Hospital Recruiting Seoul, Korea, Republic of Contact: Kwan Sik Lee          Taiwan Changhua Christian Hospital Recruiting Changhua, Taiwan Contact: Yu-Chun Hsu          Kaohsiung Chang Gung Memorial Hospital Recruiting Kaohsiung, Taiwan Contact: Tsung-Hui Hu          Kaoshiung Medical University Hospital Recruiting Kaoshiung City, Taiwan Contact: Wan-Long Chuang    0975-356064    waloch@kmu.edu.tw    Keelung Chang Gung Memorial Hospital Recruiting Keelung, Taiwan Contact: Rong-Nan Chien          China Medical University Recruiting Taichung, Taiwan Contact: Cheng-Yuan Peng          Chi Mei Liouying Hospital Recruiting Tainan, Taiwan Contact: Chih-Chou Chen          MacKay Memorial Hospital Recruiting Taipei, Taiwan Contact: Horng-Yuan Wang          National Cheng Kung University Hospital Recruiting Taipei, Taiwan Contact: Ting-Tsung Chang          National Taiwan University Hospital Recruiting Taipei, Taiwan Contact: Jia-Horng Kao          Taipei Veterans General Hospital Recruiting Taipei, Taiwan Contact: Chi-Jen Chu          Linkou Chang Gung Memorial Hospital Recruiting Taoyuan, Taiwan Contact: I-Shyan Sheen Less <<
NCT00425945 - Completed - -
NCT02527200 Metabolism and Nutrition Disor... More >>der Obesity Less << Phase 3 Recruiting August 10, 2020 -
NCT01009138 - Completed - -
NCT02127762 Diabetes Mellitus ... More >> Type I Diabetes Type II Diabetes Diabetic Peripheral Neuropathy Chronic Pain Less << Not Applicable Completed - Canada, Ontario ... More >> The Ottawa Hospital Ottawa, Ontario, Canada, K1H 8L6 Less <<
NCT01477034 Vitamin D Deficiency ... More >> Obesity Type 2 Diabetes Mellitus Intestinal Permeability Less << Not Applicable Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109 Less <<
NCT03464266 Bone Demineralization ... More >> Hypoestrogenism Subclinical Kidney Injury Bone Microarchitecture Less << Phase 4 Recruiting August 2021 Uganda ... More >> Infectious Disease Institute Recruiting Kampala, Uganda Contact: Andrew Mujugira, MBChB       Andrew Mujugira    Contact: Elly Katabira, MBChB       ekatabira@chs.mak.ac.ug Less <<
NCT00773708 HIV Infections Phase 4 Completed - Spain ... More >> H.U. Germans Trias i Pujol Badalona, Barcelona, Spain, 08916 Less <<
NCT02130193 Pulmonary Disease, Chronic Obs... More >>tructive Less << Phase 2 Completed - United States, Alabama ... More >> GSK Investigational Site Birmingham, Alabama, United States, 35294 United States, Colorado GSK Investigational Site Denver, Colorado, United States, 80206 United States, Iowa GSK Investigational Site Iowa City, Iowa, United States, 52242 United States, Pennsylvania GSK Investigational Site Oaks, Pennsylvania, United States, 19456 GSK Investigational Site Philadelphia, Pennsylvania, United States, 19140 United States, South Carolina GSK Investigational Site Spartanburg, South Carolina, United States, 29303 Germany GSK Investigational Site Frankfurt, Hessen, Germany, 60596 GSK Investigational Site Neu isenburg, Hessen, Germany, 63263 GSK Investigational Site Dueren, Nordrhein-Westfalen, Germany, 52349 GSK Investigational Site Essen, Nordrhein-Westfalen, Germany, 45359 GSK Investigational Site Magdeburg, Sachsen-Anhalt, Germany, 39112 GSK Investigational Site Leipzig, Sachsen, Germany, 04207 GSK Investigational Site Leipzig, Sachsen, Germany, 04275 GSK Investigational Site Grosshansdorf, Schleswig-Holstein, Germany, 22927 GSK Investigational Site Berlin, Germany, 10787 GSK Investigational Site Berlin, Germany, 10789 Less <<
NCT01803087 Asthma Phase 2 Completed - Poland ... More >> Uniwersytecki Szpital Kliniczny nr 1 Lodz, Poland, 90153 Less <<
NCT02751424 - Terminated(Study data is curre... More >>ntly under review.) Less << - -
NCT01932203 Cerebral Small Vessel Disease Phase 4 Unknown October 2018 Korea, Republic of ... More >> Myongji Hospital Goyang-si, Gyeonggi-do, Korea, Republic of, 412-270 National Health Insurance Corporation Ilsan Hospital Goyang-si, Gyeonggi-do, Korea, Republic of Dongtan Sacred Heart Hospital, Hallym University College of Medicine Hwaseong-si, Gyeonggi-do, Korea, Republic of Wonkwang University Iksan Hospital Iksan, Jeollabuk-do, Korea, Republic of Hallym University Medical Center Anyang, Korea, Republic of Bucheon St.Mary's Hospital Bucheon, Korea, Republic of Soonchunhyang University Bucheon Hospital Bucheon, Korea, Republic of Eulji University School of Medicine Daejeon, Korea, Republic of Konyang University Hospital Daejeon, Korea, Republic of Chonnam National University Hospital Gwangju, Korea, Republic of Inha University Hospital Incheon, Korea, Republic of, 400-711 Gachon University Gil Medical Incheon, Korea, Republic of Dong-A University Hospital Pusan, Korea, Republic of Pusan National University Hospital Pusan, Korea, Republic of Asan Medical Center Seoul, Korea, Republic of Chungang University Hospital Seoul, Korea, Republic of Ewha Womans University Mokdong Hospital Seoul, Korea, Republic of Kyung Hee University Hospital Seoul, Korea, Republic of Samsung Medical Center Seoul, Korea, Republic of Less <<
NCT02130193 - Completed - -
NCT01009138 Depressive Symptoms ... More >> Diabetes Mellitus Less << Not Applicable Completed - Germany ... More >> Forschungsinstitut der Diabetes Akademie Mergentheim e. V. Bad Mergentheim, Baden-Württemberg, Germany, 97980 Less <<
NCT03513380 Sedentary Lifestyle Not Applicable Active, not recruiting June 2019 Norway ... More >> Department of Circulation and Medical Imaging Trondheim, Norway, 7491 Less <<
NCT02663089 Pulmonary Disease, Chronic Obs... More >>tructive Less << Phase 1 Completed - United Kingdom ... More >> GSK Investigational Site London, United Kingdom, NW10 7EW Less <<
NCT02751424 Infections, Bacterial Phase 1 Terminated(Study data is curre... More >>ntly under review.) Less << - Australia, South Australia ... More >> GSK Investigational Site Adelaide, South Australia, Australia, 5000 Less <<
NCT03717896 Diabetic Ketoacidosis Phase 2 Not yet recruiting October 1, 2023 United States, Massachusetts ... More >> Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Less <<
NCT02850744 Glioblastoma Multiforme Phase 2 Terminated - Switzerland ... More >> University Hospital Zurich, Neurology Zurich, Switzerland, 8091 Less <<
NCT03408405 Steroid-Resistant Nephrotic Sy... More >>ndrome Less << Phase 4 Not yet recruiting July 2021 -
NCT03663699 Sedentary Lifestyle Not Applicable Not yet recruiting November 2019 Norway ... More >> Department of Circulation and Medical Imaging Trondheim, Norway, 7491 Less <<
NCT00636649 - Completed - -
NCT00864994 - Unknown April 2015 Netherlands ... More >> Maastricht University Medical Center, Dept. of Respiratory Medicine Not yet recruiting Maastricht, Limburg, Netherlands, 6200 MD Contact: Annemie Schols, Prof. dr. ir.    +31 43 387 50 46    a.schols@pul.unimaas.nl    Principal Investigator: Emiel Wouters, Prof. dr. MD Less <<
NCT02119260 Oedema, Pulmonary Phase 2 Completed - United Kingdom ... More >> GSK Investigational Site Cambridge, United Kingdom, CB2 2GG GSK Investigational Site London, United Kingdom, NW10 7EW Less <<
NCT00636649 Night Eating Syndrome Not Applicable Completed - United States, Missouri ... More >> Saint Louis University St. Louis, Missouri, United States, 63103 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 Less <<
NCT00729157 - Completed - -
NCT03404167 Gonorrhoea Phase 1 Completed - United States, Kansas ... More >> Quintiles Phase I Services - Overland Park Overland Park, Kansas, United States, 66211-1553 Less <<
NCT01165203 Herpes Zoster Phase 2 Completed - United States, California ... More >> GSK Investigational Site Long Beach, California, United States, 90813 GSK Investigational Site San Francisco, California, United States, 94115 United States, Florida GSK Investigational Site Orlando, Florida, United States, 32803 United States, New Mexico GSK Investigational Site Santa Fe, New Mexico, United States, 87505 United States, Texas GSK Investigational Site Dallas, Texas, United States, 75246 Germany GSK Investigational Site Hannover, Niedersachsen, Germany, 30625 GSK Investigational Site Bochum, Nordrhein-Westfalen, Germany, 44791 GSK Investigational Site Duesseldorf, Nordrhein-Westfalen, Germany, 40237 GSK Investigational Site Essen, Nordrhein-Westfalen, Germany, 45122 GSK Investigational Site Berlin, Germany, 13353 GSK Investigational Site Hamburg, Germany, 20146 United Kingdom GSK Investigational Site Woolwich, London, London, United Kingdom, SE18 4QH GSK Investigational Site London, United Kingdom, E1 1BB GSK Investigational Site London, United Kingdom, NW3 2QG GSK Investigational Site London, United Kingdom, SW10 9TH Less <<
NCT00729157 Recurrent Thyroid Gland Carcin... More >>oma Stage III Thyroid Gland Follicular Carcinoma Stage III Thyroid Gland Papillary Carcinoma Stage IV Thyroid Gland Follicular Carcinoma Stage IV Thyroid Gland Papillary Carcinoma Less << Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT02119260 - Completed - -
NCT01157130 Early Stage Breast Cancer (Sta... More >>ge 0-III) Less << Not Applicable Unknown - United States, Nevada ... More >> Nevada Cancer Institute Recruiting Las Vegas, Nevada, United States, 89135 Contact: Breanne Eddington    702-821-0062    beddington@nvcancer.org    Contact: Karen Milligan, MD    702-822-5433       Principal Investigator: Karen Milligan, MD Less <<
NCT02350465 Sarcopenia Not Applicable Recruiting March 31, 2020 United States, District of Col... More >>umbia Howard University Recruiting Washington, District of Columbia, United States, 20060 Contact: Alice Ukaegbu, MSN    202-865-4272    gcrc@howard.edu    Washington DC VA Medical Center, Washington, DC Recruiting Washington, District of Columbia, United States, 20422 Contact: Michael Harris-Love, DSc MPT BS    202-745-8240    michael.harris-love@va.gov    Sub-Investigator: Haniel J Hernandez, DPT          Sub-Investigator: Marc R Blackman, MD          Principal Investigator: Michael Harris-Love, DSc MPT BS Less <<
NCT02918279 Metabolism and Nutrition Disor... More >>der Obesity Less << Phase 3 Active, not recruiting August 8, 2019 -
NCT02680847 Moderate-severe Pain Phase 4 Terminated(The trial was termi... More >>nated on 08FEB2018. Pfizer has decided to withdraw the New Drug Application and has notified FDA. There are no efficacy or safety concerns.) Less << - United States, California ... More >> Research Center For Clinical Studies-West, Inc. Lancaster, California, United States, 93534 Children's Hopsital Los Angeles Los Angeles, California, United States, 90027 Children's Hospital Of Los Angeles - University Of Southern California School Of Medicine Los Angeles, California, United States, 90027 Shriners Hospitals For Children Northern California Sacramento, California, United States, 95817 UC Davis Health Attn: Peter Trovitch, PharmD Sacramento, California, United States, 95817 University of California Davis Sacramento, California, United States, 95817 United States, Illinois University of Illinois at Chicago Clinical Research Center Chicago, Illinois, United States, 60612 University of Illinois Hospital and Health Sciences Systems Chicago, Illinois, United States, 60612 University of Illinois Hospital at the Medical Center Chicago, Illinois, United States, 60612 United States, North Carolina East Carolina University Brody School of Medicine(ECU) Greenville, North Carolina, United States, 27834 Leo Jenkins Cancer Center Pharmacy Greenville, North Carolina, United States, 27834 United States, South Carolina Medical University of South Carolina Children's Hospital Charleston, South Carolina, United States, 29425 Medical University of South Carolina, Investigational Drugs Services Charleston, South Carolina, United States, 29425 Medical University of South Carolina, Rutledge Tower, Pediatric Clinic Charleston, South Carolina, United States, 29425 Medical University of South Carolina, SCTR Research Nexus Charleston, South Carolina, United States, 29425 United States, Texas Road Runner Research, Ltd San Antonio, Texas, United States, 78249 Less <<
NCT01923480 - Terminated - -
NCT01923480 Parenteral Nutrition (No Prima... More >>ry Condition Studied) Less << Phase 4 Terminated - United States, Arkansas ... More >> University of Arkansas for Medical Sciences Little Rock, Arkansas, United States, 72205 United States, Texas Texas A&M University, Center for Translational Research in Aging & Longevity College Station, Texas, United States, 77843-4253 Less <<
NCT01876563 Type 2 Diabetes Phase 4 Unknown July 2014 Iran, Islamic Republic of ... More >> Tehran University of Medical Sciences Tehran, Iran, Islamic Republic of Less <<
NCT02680847 - Terminated(The trial was termi... More >>nated on 08FEB2018. Pfizer has decided to withdraw the New Drug Application and has notified FDA. There are no efficacy or safety concerns.) Less << - -
NCT01807364 - Completed - France ... More >> Pitié Salpêtrière Hospital Paris, France, 75013 Less <<
NCT03593707 Healthy Volunteers Phase 1 Suspended(Sponsor elected to v... More >>oluntarily pause study.) Less << February 12, 2019 Belgium ... More >> Pfizer Clinical Research Unit Brussels, Belgium, B-1070 Less <<
NCT01513369 Type 2 Diabetes Mellitus ... More >> Iron Deficiency Less << Phase 3 Active, not recruiting January 2019 Germany ... More >> Gemeinschaftspraxis Dres. Grüneberg, Mehring, Stude Herne, Nordrhein-Westfalen, Germany, 32545 Univesitätsklinikum Carl Gustav Carus Dresden, Sachsen, Germany, 01307 Herz- und Diabeteszentrum NRW Ruhr-Universität Bochum Bad Oeynhausen, Germany, 32545 Studienzentrum Professor Hanefeld Abakus Büropark Dresden, Germany, 01307 Medizinische Hochschule Hannover Klinisches Forschungszentrum CRC Hannover, Germany, 30625 Diabetesinstitut Heidelberg Heidelberg, Germany, 69115 Less <<
NCT01165203 - Completed - -
NCT03182543 Exercise-induced Oxidative Str... More >>ess Less << Not Applicable Completed - -
NCT02919332 - Recruiting June 2022 United States, California ... More >> UCLA / Jonsson Comprehensive Cancer Center Recruiting Los Angeles, California, United States, 90095 Contact: Johannes Czernin    310-794-1005       Principal Investigator: Johannes Czernin Less <<
NCT01229345 Energy Balance, ... More >> Appetite, Cognitive Function. Less << Not Applicable Completed - United Kingdom ... More >> Brain, Performance and Nutrition Centre, Northumbria University Newcastle Upon Tyne, Tyne and Wear, United Kingdom, NE1 8ST Less <<
NCT03203915 Dyslipidemia ... More >>Obesity Less << Not Applicable Recruiting August 2019 United States, California ... More >> Western Human Nutrition Research Center Recruiting Davis, California, United States, 95616 Contact: Ellen L Bonnel, PhD    530-752-4184    ellen.bonnel@ars.usda.gov    Principal Investigator: Nancy L Keim, PhD Less <<
NCT00402324 - Completed - -
NCT00402324 Bipolar I Disorder Phase 4 Completed - United States, Florida ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hialeah, Florida, United States, 33016 Less <<
NCT02696772 Deficiency; Calorie Not Applicable Completed - -
NCT00285220 Morbid Obesity Not Applicable Completed - United States, California ... More >> University of California at San Francisco, Dept of Pediatrics San Francisco, California, United States, 94143 United States, New York Strong Health Bariatric Center at Highland Hospital Rochester, New York, United States, 14624 Less <<
NCT02013466 Sarcopenia Phase 1 Completed - Netherlands ... More >> Ampha Nijmegen, Netherlands Less <<
NCT02295072 Cognitive Function 1, Social ... More >> Mental Health Wellness 1 Obesity Overweight Less << Not Applicable Completed - -
NCT01066377 Influenza Not Applicable Unknown January 2013 United Kingdom ... More >> University of Reading Reading, United Kingdom, RG6 6AP Less <<
NCT01584427 Metabolic Syndrome Not Applicable Completed - Denmark ... More >> Aarhus University Hospital Aarhus, Denmark, 8000 Less <<
NCT00839774 Cardiovascular Disease Phase 2 Completed - Canada, Manitoba ... More >> University of Manitoba - Richardson Centre for Functional Foods and Nutraceuticals Winnipeg, Manitoba, Canada, R3T 2N2 Less <<
NCT01363791 - Unknown March 2016 Canada, Ontario ... More >> The Toronto 3D (Diet, Digestive tract and Disease) Knowledge Synthesis and Clinical Trials Unit, Clinical Nutrition and Risk Factor Modification Centre, St. Micheal's Hospital Toronto, Ontario, Canada, M5C 2N8 Less <<
NCT03575949 Metastatic Head and Neck Squam... More >>ous Cell Carcinoma Metastatic Malignant Neoplasm in the Uterine Cervix Positive Lymph Node Less << Not Applicable Recruiting December 31, 2019 United States, Texas ... More >> M D Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Jason M. Johnson    713-792-8443       Principal Investigator: Jason M. Johnson Less <<
NCT00683020 - Completed - -
NCT00138710 Hypogonadotrophic Hypogonadism... More >> Obesity Less << Phase 3 Completed - Netherlands ... More >> Rijnstate Hospital Arnhem, Netherlands, 6815 AM Less <<
NCT01410357 Diabetes Mellitus ... More >> Bipolar Disorder Depression Psychotic Disorders Schizophrenia Less << Not Applicable Completed - United States, Ohio ... More >> MetroHealth Medical Center Cleveland, Ohio, United States, 44109 Less <<
NCT00683020 Diabetes Not Applicable Completed - United States, California ... More >> Center for Vulnerable Populations San Francisco, California, United States, 94110 Less <<
NCT01279941 Physical Activity ... More >> Nutrition Health Promotion Stress, Psychological Cardiovascular Diseases Cancer Less << Not Applicable Completed - United States, Oregon ... More >> Oregon Health and Science University Portland, Oregon, United States, 97239 Less <<
NCT00722345 Obesity Not Applicable Completed - Canada, Quebec ... More >> Centre Hospitalier Universitaire Ste-Justine Montreal, Quebec, Canada, H3T 1C5 Less <<
NCT01410357 - Completed - -
NCT02931747 Healthy Phase 1 Completed - Thailand ... More >> Jitanaporn Wattanathorn Khon Kaen, Thailand, 40002 Less <<
NCT02142452 Pregnancy Wei... More >>ght Gain Less << Not Applicable Unknown August 2016 United States, California ... More >> Stanford Hospital and Clinics Stanford, California, United States, 94305 Less <<
NCT01745263 Improve Healthy Ageing in Seni... More >>ors; Prevent Disease at Older Age Less << Phase 3 Completed - Austria ... More >> University of Innsbruck Innsbruck, Austria France University of Toulouse - Centre de Recherche - Gérontopôle Hôpital La Grave Toulouse, France Germany Charité Berlin Berlin, Germany Portugal University of Coimbra - Clínica Universitária de Reumatologia Coimbra, Portugal Switzerland Centre on Aging and Mobility, University of Zurich and City Hospital Waid Zurich, ZH, Switzerland, 8091 Basel University Basel, Switzerland Hôpitaux Universitaires de Genève Geneva, Switzerland Less <<
NCT01105143 Weight Loss O... More >>besity Skeletal Muscle Insulin Sensitivity/Resistance Less << Not Applicable Completed - Germany ... More >> Charite Berlin, Germany, 10117 Less <<
NCT01858649 Metastatic Colorectal Cancer Phase 2 Recruiting May 2019 Belgium ... More >> Clinique Saint Luc Recruiting Bouge, Belgium, 5004 Contact: Laurence Jacqmin       laurence.jacqmin@slbo.be    CHIREC Recruiting Brussels, Belgium, 1180 Contact: sandrine roland, MD    02.434.46.64    roland_sandrine@yahoo.fr    Contact: eugene mucyo    02.434.46.64    datamanagercci@skynet.be    Cliniques universitaires Saint-Luc Recruiting Brussels, Belgium, 1200 Contact: Marc Van den Eynde, MD    0032764 ext 1041    marc.vandeneynde@uclouvain.be    Principal Investigator: Marc Van den Eynde, MD          Grand Hopital de Charleroi Recruiting Charleroi, Belgium, 6000 Contact: Javier Carrasco, MD PhD    00327110 ext 4701    javier.carrasco@ghdc.be    Principal Investigator: Javier Carrasco, MD PhD          AZ Groeninge Recruiting Kortrijk, Belgium, 8500 Contact: philippe vergauwe, MD       philippe.vergauwe@azgroeninge.be    Contact: Fien Verplancke    056 63 33 38    fien.verplancke@azgroeninge.be    Centre Hospitalier Jolimont Lobbes Recruiting La Louvière, Belgium, 7100 Contact: Benedicte Petit, MD    +32.64.23.39.87    benedicte.petit@entitejolimontoise.be    Principal Investigator: Benedicte Petit, MD          CHC Liège clinique Saint Joseph Recruiting Liège, Belgium, 4000 Contact: Gauthier Demolin, MD    +32.4.224.89.92    gauthier.demolin@chc.be    Principal Investigator: Gauthier Demolin, MD          CHU liège (Sart Timan) Recruiting Liège, Belgium, 4000 Contact: Daniel Van Daele, MD    +32.04.242.55.21    daniel.vandaele@chu.ulg.ac.be    Principal Investigator: Daniel Van Daele, MD          Clinique Maternité Saint Elisabeth Recruiting Namur, Belgium, 5000 Contact: Jean-Charles Goeminne, MD    +32.81.720.761    jeancharles.goeminne@cmsenamur.be    Principal Investigator: Jean-Charles Goeminne, MD          Clinique Saint Pierre Ottignies Recruiting Ottignies, Belgium, 1340 Contact: Jean-Charles Coche, MD    +32.10.437.479    jc.coche@skynet.be    Principal Investigator: Jean-Charles Coche, MD          CHU-UCL Dinant-Godinne Recruiting Yvoir, Belgium, 5530 Contact: Lionel D'hondt, MD PhD    +32.81.42.38.53    lionel.dhondt@uclouvain.be    Principal Investigator: Lionel D'Hondt, MD PhD Less <<
NCT00872599 - Completed - -
NCT02489565 Coronary Artery Disease Not Applicable Unknown November 2017 Brazil ... More >> Instituto de Avaliação de Tecnologia em Saúde (Institute of Technology Assessment in Health) Recruiting Porto Alegre, Rio Grande do Sul, Brazil, 90035-903 Contact: Carisi A Polanczyk, PhD    +555133596359    carisi.anne@gmail.com    Contact: Joanna L Batista, PhD    +555133596325    joannalyra@gmail.com    Sub-Investigator: Mariana V Furtado, PhD          Sub-Investigator: Natan Katz, MsC Less <<
NCT00872599 Hypertension Phase 4 Completed - United States, Tennessee ... More >> Vanderbilt University Nashville, Tennessee, United States, 37232 Less <<
NCT01852786 - Unknown February 2016 Lithuania ... More >> Lithuanian University of Health Sciences Kaunas, Lithuania, LT- 50009 Less <<
NCT02493959 Healthy Early Phase 1 Completed - Denmark ... More >> Department of Endocrinology, Hvidovre Hospital Hvidovre, Denmark, DK-2650 Less <<
NCT01113346 Viral Gastroenteritis Phase 2 Phase 3 Unknown February 2011 Russian Federation ... More >> Arhangelsk Regional Children's Clinical Hospital named after P.G. Vizshletsov Recruiting Arhangelsk, Arhangelskaya oblast, Russian Federation, 163062 Contact: Larisa Titova, MD, PhD    +7-8182-280433    irina-bul@yandex.ru    Contact: Olga Samodova, MD, DrSc    +7-8182-22-95-42    samodova@atknet.ru    Principal Investigator: Larisa Titova, MD, PhD          Sub-Investigator: Olga Samodova, MD, DrSc          St. Vladimir Children's Moscow Clinical Hospital Recruiting Moscow, Russian Federation, 107014 Contact: Elena Meskina, MD, DrSc    +7-916-1216172    meskinaelena@mail.ru    Contact: Lyudmila Feklisova, MD, DrSc    +7-495-2682226    vespamen@yandex.ru    Sub-Investigator: Lyudmila Feklisova, MD, DrSc          Principal Investigator: Elena Meskina, MD, DrSc Less <<
NCT00623597 HIV Infections Phase 2 Completed - Argentina ... More >> Buenos Aires, Argentina, 1202 Buenos Aires, Argentina, 1425 Santa Fe, Argentina, 3000 Spain Madrid, Spain, 28046 Madrid, Spain, 28905 Valencia, Spain, 46009 Thailand Bangkok, Thailand, 10400 Khon Kaen, Thailand, 40002 Pathumwan, Thailand, 10330 Payathai, Thailand, 10400 Less <<
NCT01307566 Sleep Apnea T... More >>ype 2 Diabetes Less << Not Applicable Completed - Spain ... More >> Granollers General Hospital Granollers, Barcelnoa, Spain, 08402 Less <<
NCT01745042 - Completed - Brazil ... More >> Optics Group from Physics Institute of São Carlos (IFSC), University of São Paulo (USP) São Carlos, São Paulo, Brazil, 676 Less <<
NCT03563846 Lactose Intolerance Phase 1 Completed - United States, Florida ... More >> Syneos Health Miami, Florida, United States, 33136 Less <<
NCT03320746 Exercise Agin... More >>g Retirement Less << Not Applicable Active, not recruiting August 31, 2020 Finland ... More >> University of Turku /Department of Public Health Turku, Finland, 20520 Less <<
NCT00706004 Constipation ... More >>Cystic Fibrosis Less << Not Applicable Completed - United States, Arkansas ... More >> University of Arkansas for Medical Sciences Little Rock, Arkansas, United States, 72205 Less <<
NCT02919631 Glycogen Storage Disease Type ... More >>V Less << Phase 2 Unknown - -
NCT00623597 - Completed - -
NCT00706004 - Completed - -
NCT02110602 Dietary Intake of Branched Cha... More >>in Amino Acids Less << Not Applicable Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT02441231 HIV-1 Infection Phase 2 Recruiting May 2019 Canada, Ontario ... More >> Maple Leaf Medical Clinic Recruiting Toronto, Ontario, Canada, M5G 1K2 Contact: Colin Kovacs, MD    416-465-3252    ckovacs@mlmedical.com    Principal Investigator: Colin Kovacs, MD          Toronto General Hospital, UHN Recruiting Toronto, Ontario, Canada, M5G 2N2 Contact: Sharon Walmsley, MD    416-340-3871    sharon.walmsley@uhn.ca    Principal Investigator: Sharon Walmsley, MD Less <<
NCT03578991 Patients Aged 65-85 (Both Incl... More >>uded) Diagnosed of Mild Cognitive Impairment Diagnosed of Type 2 Diabetes in Active Treatment (Hypoglycemic Agents) for a Period ≥5 Years Less << Not Applicable Not yet recruiting May 2020 Spain ... More >> Fundació Privada Hospital Asil de Granollers (HAG) Not yet recruiting Granollers, Barcelona, Spain, 08402 Contact: Sergio Ariño, MD, PhD          Principal Investigator: Sergio Ariño, MD, PhD          Sub-Investigator: Diana Navarro Llobet, PhD          Sub-Investigator: Gemma Molist Señé, PhD          Sub-Investigator: Juliana Valencia Robledo, MD          Clínica Universitària de la Fundació Universitària del Bages (FUB) Not yet recruiting Manresa, Barcelona, Spain, 08242 Contact: Xavier Gironès García, PhD          Principal Investigator: Xavier Gironès García, PhD          Sub-Investigator: Lluïsa Sort García, management          Sub-Investigator: Antonia Puiggrós Binefa, PhD          Sub-Investigator: Daniel García, PhD          Sub-Investigator: Ester Colillas Malet, PhD          Sub-Investigator: Núria Obradors Rial, PhD          Sub-Investigator: Marina Mateu Capell, PhD          Sub-Investigator: Montserrat Soler Sellarés, PhD          Sub-Investigator: Sara Sevilla Martínez, Nurse          Sub-Investigator: Jordi Franch Pareja PhD, PhD          Fundació Althaia (FA) Not yet recruiting Manresa, Barcelona, Spain, 08243 Contact: María Cruz Crespo Maraver, PhD          Principal Investigator: María Cruz Crespo Maraver, PhD          Sub-Investigator: Jesús Montesinos, BMBS          Sub-Investigator: Anna Arnau Bartés, PhD          Sub-Investigator: Irantzu Elorz, BCh          Sub-Investigator: Eduard Pons Villanueva, BMBS          Sub-Investigator: Jordi Aligué Capsada, BMBS          Sub-Investigator: Jordi Giménez Salinas, BMBS          Sub-Investigator: Judit Bonet Álvarez, BMBS          Fundació Recerca Mútua Terrassa (FMT) Not yet recruiting Terrassa, Barcelona, Spain, 08221 Contact: María José Barahona Constanzo, MD, PhD          Principal Investigator: María José Barahona Constanzo, MD, PhD          Sub-Investigator: Laura Casas, PhD          Sub-Investigator: Carmen Quiros Lopez, MD, PhD          Sub-Investigator: Jerzy Krupinski, MD, PhD          Sub-Investigator: Laura Buguñá Hoffmann, Enginyer          Sub-Investigator: Verónica Perea Castilla, MD          Sub-Investigator: Nuria Alonso Carril, Nurse          Sub-Investigator: Jessica Molina Seguín, MD          Sub-Investigator: Marta Almería Vivo, Psychologist          Sub-Investigator: Sonia Arribas Pardo, Psychologist          Sub-Investigator: Dolors Badenes Guia, Psychologist          Sub-Investigator: Maria Teresa Buongiorno, MD          Sub-Investigator: Andreu Simó Servat, MD          Consorci Sanitari de Terrassa (CST) Not yet recruiting Terrassa, Barcelona, Spain, 08227 Contact: Maite Franco Romero          Principal Investigator: Maite Franco Romero, Graduate.          Sub-Investigator: Ramón Roca Puig, MD, PhD          Sub-Investigator: Clara Romero Rascón, PhD          Sub-Investigator: Ció Tor Figueras, Graduate.          Sub-Investigator: Antonio Rey, BMBS          Sub-Investigator: María José Sender, BMBS          Sub-Investigator: Laia Pijuan, BMBS          Sub-Investigator: Julia Grau, BMBS          Sub-Investigator: Laura Palenzuela, BMBS          Consorci Hospitalari de Vic (CHV) Not yet recruiting Vic, Barcelona, Spain, 08500 Contact: Joan Carles Rovira Pascual, MD          Sub-Investigator: Núria Roger Casals, MD, PhD          Sub-Investigator: Emi Chirveches, PhD          Sub-Investigator: Joan Espaulella Panicot, MD, PhD          Sub-Investigator: Isabel Ramon Bofarull, MD          Sub-Investigator: Antoni Casals Pascual, MD, PhD          Sub-Investigator: Francesc Escabila, MD          Sub-Investigator: Anna Bartés Plans, MSc          Sub-Investigator: Jordina Muñoz Padrós, MSc          Sub-Investigator: Laura Espinosa Lopez          Sub-Investigator: Emma Puigoriol Juvanteny          Mind the byte Not yet recruiting Barcelona, Spain, 08007 Contact: David Bermúdez          Principal Investigator: David Bermúdez, PhD          Sub-Investigator: Oscar Villacañas Pérez, PhD          Sub-Investigator: Laia Casafont, management          Parc Sanitari Pere Virgili Barcelona, Spain, 08023 LambdaLoopers Not yet recruiting Barcelona, Spain, 08034 Contact: Adrià Batlle          Principal Investigator: Adrià Batlle          University Hospital Vall d'Hebron - Vall d'Hebron Institute of Research Not yet recruiting Barcelona, Spain, 08035 Contact: Rafael Simó Canonge, MD, PhD          Contact: Cristina Hernaández Pascual, MD, PhD          Sub-Investigator: Andreea Ciudin, MD, PhD Less <<
NCT03119142 - Recruiting July 2, 2019 Italy ... More >> Irccs Neuromed Recruiting Campobasso, Italy, 86100 Contact: Marialaura Bonaccio    3394995848       Contact: Mariarosaria Persichillo, MSc       mariarosaria.persichillo@neuromed.it    Sub-Investigator: Mariarosaria Persichillo, MSc Less <<
NCT02515071 Obstructive Sleep Apnoea Syndr... More >>ome Less << Not Applicable Completed - Ireland ... More >> Connolly Hospital, Blanchardstown Dublin, Ireland, D15 Less <<
NCT00798681 Parenteral Nutrition Phase 4 Completed - Argentina ... More >> Sanatorio Los Arcos Buenos Aires, Argentina Sanatorio Trinidad Palermo Buenos Aires, Argentina Brazil Fernandes Tavora Hospital Fortaleza, CE, Brazil, 60.115-000 Hospital Santa Luzia Brasilia, DF, Brazil, 70390-010 Hospital da Polícia Militar Rio de Janeiro, RJ, Brazil, 22271-110 Hospital Samaritano Rio de Janeiro, RJ, Brazil, 22271-110 Hospital Bandeirantes São Paulo, SP, Brazil, 01506-000 Guatemala Hospital Roosevelt Guatemala City, Guatemala Less <<
NCT00830999 Cardiovascular Diseases Not Applicable Completed - United States, Missouri ... More >> Washington University in Saint Louis Saint Louis, Missouri, United States, 63110 Less <<
NCT00855010 Obesity Type ... More >>2 Diabetes Less << Not Applicable Completed - United States, Texas ... More >> UT Southwestern Medical Center Dallas, Texas, United States, 75390 Less <<
NCT01597609 Obesity Phase 1 Completed - United Kingdom ... More >> GSK Investigational Site Cambridge, Cambridgeshire, United Kingdom, CB2 2GG Less <<
NCT02421835 Pre Hypertension Not Applicable Completed - United Kingdom ... More >> Hugh Sinclair Unit of Human Nutrition Reading, Berkshire, United Kingdom, RG6 6AP Less <<
NCT00670462 - Completed - -
NCT00855010 - Completed - -
NCT02232347 Head Trauma Phase 2 Unknown May 2017 France ... More >> Sainte Anne Military Teaching Hospital Not yet recruiting Toulon, France, 83130 Sub-Investigator: Pierre Julien CUNGI, MD          Sub-Investigator: Eric MEAUDRE, MD          Sub-Investigator: Henry BORET, MD Less <<
NCT01545830 Metabolic Syndrome Phase 2 Completed - United States, Minnesota ... More >> Allina Health Minneapolis, Minnesota, United States, 55407 Less <<
NCT00670462 Obesity Not Applicable Completed - United States, Minnesota ... More >> University of Minnesota, School of Public Health Minneapolis, Minnesota, United States, 55454 Less <<
NCT00157339 Diabetes Mellitus ... More >> Asthma Pulmonary Disease, Chronic Obstructive Less << Phase 3 Completed - -
NCT00442689 - Completed - -
NCT03047837 Tertiary Prevention in Colon C... More >>ancer Less << Phase 2 Recruiting March 15, 2020 Italy ... More >> Medical Oncology Ente Ospedaliero Ospedali Galliera Recruiting Genova, Italy, 16128 Contact: Andrea De Censi, MD    +39010 5634501    andrea.decensi@galliera.it    Contact: Marilena Petrera, PhD    00390105634580    marilena.petrera@galliera.it Less <<
NCT00406315 Schizophrenia ... More >> Schizoaffective Disorder Less << Phase 4 Completed - -
NCT01231685 HIV Hepatitis... More >> C Liver Fibrosis Less << Phase 2 Completed - Canada, British Columbia ... More >> Providence Health Care- St. Paul's Hospital Vancouver, British Columbia, Canada, V6Z 1Y6 Canada, Ontario University Health Network - Toronto General Hospital Division Toronto, Ontario, Canada, M5G2N2 Canada, Quebec Montreal Chest Institute Montreal, Quebec, Canada Less <<
NCT00406315 - Completed - -
NCT00763256 - Completed - -
NCT00763256 Periodontal Disease Phase 3 Completed - Australia ... More >> Logan Hospital Oral Health Clinic Queensland, Australia Less <<
NCT00442689 Polycystic Ovary Syndrome ... More >> Metabolic Syndrome Less << Not Applicable Completed - United States, Illinois ... More >> Northwestern Memorial Hospital Chicago, Illinois, United States, 60611 Less <<
NCT03657030 Healthy Phase 1 Recruiting May 2019 United States, Texas ... More >> PPD Development, LP Recruiting Austin, Texas, United States, 78744 Contact: Antonia M Davidson, MD    512-447-2985       Contact: Kristi Wheeler    512-747-4764    Kristi.Wheeler@ppdi.com Less <<
NCT02074332 Pediatric Obesity Not Applicable Completed - -
NCT03649165 Neurofibromatosis Type 1 (NF1)... More >>-Related Plexiform Neurofibromas (PNs) Healthy Participants Less << Phase 1 Completed - United States, Maryland ... More >> Research Site Baltimore, Maryland, United States, 21225 Less <<
NCT00128492 - Completed - -
NCT02860923 Craniopharyngiomas ... More >> Hypothalamic Obesity Less << Phase 3 Completed - France ... More >> CHU d'Angers Angers, France CHU de Brest Brest, France CHU de Grenoble Grenoble, France CHU de Lyon Lyon, France APHM Marseille, France Hôpital Bicêtre Paris, France Hôpital Cochin Paris, France Hôpital Européen Georges Pompidou Paris, France Hôpital Pitié Salpétrière (APHP) Paris, France Hôpital Haut-Lévêque Pessac, France CHU de Toulouse Toulouse, France Less <<
NCT00128492 Cystic Fibrosis Phase 3 Completed - -
NCT01899274 Diabetes Mellitus, Type 1 Not Applicable Completed - Canada, Ontario ... More >> Trillium Health Partners Mississauga, Ontario, Canada, L5B 1B8 The Hostpital for Sick Children Toronto, Ontario, Canada, M5G 1X8 Less <<
NCT00004419 Insulin Resistance ... More >> Hyperglycemia Less << Not Applicable Completed - United States, Massachusetts ... More >> Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Less <<
NCT03532022 Congenital Adrenal Hyperplasia Phase 3 Suspended(Protocol re-design r... More >>equired following inconclusive EU Phase III results) Less << October 2021 United States, North Carolina ... More >> Diabetes and Endocrinology Consultants PC Morehead City, North Carolina, United States, 28557 Less <<
NCT03116022 Dyspareunia M... More >>enopause Sexual Dysfunction Less << Phase 1 Recruiting January 31, 2019 Brazil ... More >> Hospital das Clínicas de Ribeirão Preto Recruiting Ribeirão Preto, SP, Brazil, 14049-900 Contact: Sergio Okano, MD    16988120532 Less <<
NCT03137329 Obesity Not Applicable Active, not recruiting June 30, 2019 United States, Massachusetts ... More >> Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Less <<
NCT03397147 Type 1 Diabetes Mellitus Not Applicable Recruiting April 30, 2019 United States, Tennessee ... More >> Vanderbilt University Medical Center Recruiting Nashville, Tennessee, United States, 37232 Contact: Sarah S Jaser, PhD    615-343-6775       Contact: Emily Hamburger, MEd    615-875-8781 Less <<
NCT00005164 - Completed - -
NCT01523041 Diabetes Heal... More >>thy Less << Phase 1 Completed - United Kingdom ... More >> Novo Nordisk Investigational Site Leeds, United Kingdom, LS2 9NG Less <<
NCT03517254 Anterior Cruciate Ligament Rec... More >>onstruction Less << Not Applicable Recruiting April 2019 Mexico ... More >> Instituto Nacional de Rehabilitación Recruiting Mexico City, Mexico, 14389 Contact: Sandra Hernández Valencia, MSc    +5255 5999-1000 ext 15212    sandrahv710@gmail.com    Contact: Saúl León Ballesteros, MD, MSc    +5255 5999-1000 ext 15212    saulno1@yahoo.com    Principal Investigator: Sandra Hernández Valencia, MSc,PhD (c)          Principal Investigator: Saúl León, MD,MSc          Sub-Investigator: Laura Moreno Altamirano, MD,MSc,PhD          Sub-Investigator: Patricia Clark Peralta, MD,MSc,PhD          Sub-Investigator: Guadalupe Gomez Pineda, MD          Sub-Investigator: Juan Manuel Mejía Aranguré, MD,MSc,PhD          Sub-Investigator: Rebeca Salas Romero, MSc          Sub-Investigator: Andrea Pegueros Pérez, MSc Less <<
NCT02703805 Cerebrovascular Accident Not Applicable Recruiting September 2018 Canada, Ontario ... More >> The Brantford Family YMCA Recruiting Brantford, Ontario, Canada Downtown Hamilton YMCA Recruiting Hamilton, Ontario, Canada, L8P 2Z1 The Walker Family YMCA Recruiting St. Catharines, Ontario, Canada, L2N 7P9 Less <<
NCT01749020 Insulin Resistance Not Applicable Completed - United Kingdom ... More >> Queen Margaret University Lab Musselburgh, East Lothian, United Kingdom, EH21 6UU Less <<
NCT01597388 Advanced Metastatic Breast Can... More >>cer Less << Phase 1 Active, not recruiting December 17, 2018 United States, Florida ... More >> Research Site Sarasota, Florida, United States, 34232 United States, Michigan Research Site Detroit, Michigan, United States, 48201 United States, Oklahoma Research Site Oklahoma City, Oklahoma, United States, 73104 United States, South Carolina Research Site Greenville, South Carolina, United States, 29605 United States, Tennessee Research Site Nashville, Tennessee, United States, 37203 Less <<
NCT01293604 Healthy Not Applicable Completed - United States, Maryland ... More >> USDA Beltsville Human Nutrition Research Center Beltsville, Maryland, United States, 20705 Less <<
NCT00567255 - Completed - -
NCT01554202 Alzheimer's Disease Not Applicable Active, not recruiting - France ... More >> University Hospital Côte de Nacre Caen, France, 14033 University Hospital Roger Salengro Lille, France, 59037 University Hospital Pontchaillou Rennes, France, 35033 University Hospital Rouen Rouen, France, 76031 University Hospital Tours Tours, France, 37044 Less <<
NCT03525769 - Recruiting December 31, 2025 China, Guangdong ... More >> Hepatology Unit, Department of Infectious Diseases, Nanfang Hospital, Southern Medical University Recruiting Guangzhou, Guangdong, China, 510515 Contact: Jinjun Chen    86-18588531001    chjj@smu.edu.cn    Contact: Yali Ji    8615210580706    jiyl09@163.com Less <<
NCT00567255 Obesity Overw... More >>eight Less << Phase 3 Completed - -
NCT03550976 Gestational Diabetes Not Applicable Not yet recruiting June 1, 2020 -
NCT02651454 Metabolic Syndrome ... More >> Obesity Less << Phase 4 Recruiting December 2019 Korea, Republic of ... More >> Gachon University Gil Oriental Medical Hospital Recruiting Incheon, Korea, Republic of Contact: , Chang-Hyun Park, KMD    82327701300    chpark104@naver.com Less <<
NCT03589092 - Recruiting January 1, 2019 United Arab Emirates ... More >> Imperial College London Diabetes Centre Recruiting Abu Dhabi, United Arab Emirates, 48338 Contact: Hinda Daggag, PhD    +971 2 404 0800    hdaggag@icldc.ae Less <<
NCT03590626 Non Alcoholic Fatty Liver Dise... More >>ase Type2 Diabetes Mellitus Less << Not Applicable Recruiting February 2020 India ... More >> Division Of Endocrinology & Diabetes, Medanta The Medicity Recruiting Gurgaon, Haryana, India, 122001 Contact: Surender , MSc    01244141414 ext 6596    yadavsurender89@gmail.com    Contact: Mohammad Shafi Kuchay, MBBS, MD,DM    01244141414 ext 6596    drshafikuchay@gmail.com    Principal Investigator: Mohammad Shafi Kuchay, MBBS, MD,DM          Sub-Investigator: Ambrish Mithal, MBBS, MD,DM Less <<
NCT01623453 - Terminated(Difficulty recruiti... More >>ng subjects) Less << - Korea, Republic of ... More >> DaeHang Hospital Seoul, Korea, Republic of Seoul National University Hospital Seoul, Korea, Republic of Less <<
NCT03574909 Pre-Gestational Diabetes Phase 3 Not yet recruiting September 2021 -
NCT03670797 - Not yet recruiting August 2019 -
NCT03648918 - Recruiting January 2050 United States, Wisconsin ... More >> Medical College of Wisconsin Recruiting Milwaukee, Wisconsin, United States, 53226 Contact: Martin Hessner, PhD    414-955-4903    t1dinfo@mcw.edu Less <<
NCT03758144 Type2 Diabetes Not Applicable Recruiting July 1, 2019 Egypt ... More >> Zagazig University Recruiting Zagazig, Sharkia, Egypt, 44519 Contact: Amr Hanafy, md    +201100061861    dr_amr_hanafy@yahoo.com Less <<
NCT03775902 Type 2 Diabetes Mellitus Not Applicable Not yet recruiting January 1, 2020 -
NCT02272946 HIV Cardiovas... More >>cular Disease Less << Phase 2 Active, not recruiting June 2020 United States, California ... More >> San Francisco General Hospital San Francisco, California, United States, 94110 Quest Clinical Research San Francisco, California, United States, 94115 Less <<
NCT03756688 Diabetes Mellitus, Type 2 ... More >> Penile Diseases Less << Not Applicable Recruiting November 2021 United States, Minnesota ... More >> Mayo Clinic in Rochester Recruiting Rochester, Minnesota, United States, 55905 Contact: Brett Milazzo    507-538-6151    milazzo.brett@mayo.edu Less <<
NCT03010514 - Recruiting October 2019 China ... More >> Beijing Anzhen Hospital Recruiting Beijing, China, 100029 Contact: ke-xu Yang    86-010-64426153    EC@anzhenGCP.com Less <<
NCT03741530 Intracerebral Hemorrhage Not Applicable Enrolling by invitation October 31, 2020 China, Shaanxi ... More >> Xijing Hospital Xi'an, Shaanxi, China, 710032 Less <<
NCT01597388 - Active, not recruiting - -
NCT01286610 Respiratory Failure ... More >> Sepsis Brain Injury Less << Not Applicable Completed - Germany ... More >> Charite University, Berlin, Germany Berlin, Germany, 13353 Less <<
NCT02635945 Asthma Phase 2 Recruiting November 2019 Spain ... More >> Unitat de Pneumologia Experimental Recruiting Barcelona, Spain, 08025 Principal Investigator: David Ramos Barbón, MD, PhD Less <<
NCT01638949 Alzheimer's Disease Not Applicable Recruiting - France ... More >> GIP Cyceron Active, not recruiting Caen, Calvados, France, 14000 Inserm - EPHE - University of Caen U1077 Active, not recruiting Caen, France, 14000 University Hospital Côte de Nacre Recruiting Caen, France, 14033 University Hospital Roger Salengro Recruiting Lille, France, 59037 University Hospital Pontchaillou Not yet recruiting Rennes, France, 35033 University Hospital Rouen Recruiting Rouen, France, 76031 University Hospital Tours Not yet recruiting Tours, France, 37044 Less <<
NCT00857454 - Completed - -
NCT02069665 Pneumonia Not Applicable Completed - China, Beijing ... More >> Affiliated Children's Hospital of Capital University of Medical Sciences Beijing, Beijing, China, 100045 China, Guangdong Guangzhou Children's Hospital Guangzhou, Guangdong, China, 510120 China, Liaoning Affiliated Children's Hospital of Dalian Medical University Dalian, Liaoning, China, 116044 Affiliated Hospital of Liaoning University of TCM Shenyang, Liaoning, China, 110032 China, Shandong Affiliated Hospital of Shandong University of TCM Ji'nan, Shandong, China, 250011 China, Shanghai Affiliated Longhua Hospital of Shanghai University of TCM Shanghai, Shanghai, China, 200032 Less <<
NCT00857454 Hypogonadism Phase 3 Completed - United States, Alabama ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Birmingham, Alabama, United States United States, Arizona For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tuscon, Arizona, United States United States, California For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Burbank, California, United States United States, Colorado For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Colorado Springs, Colorado, United States United States, Connecticut For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. New Britain,, Connecticut, United States United States, Florida For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ocala, Florida, United States United States, Idaho For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Boise, Idaho, United States United States, Kansas For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Shawnee Mission, Kansas, United States United States, Louisiana For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Shreveport, Louisiana, United States United States, Nebraska For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Omaha, Nebraska, United States United States, Texas For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. San Antonio, Texas, United States Less <<
NCT00168831 Pulmonary Disease, Chronic Obs... More >>tructive Less << Phase 3 Completed - -
NCT00168844 Pulmonary Disease, Chronic Obs... More >>tructive Less << Phase 3 Completed - -
NCT01475201 Type 2 Diabetes ... More >> Hypertension Less << Not Applicable Completed - Canada, Quebec ... More >> Institut de recherches cliniques de Montréal Montreal, Quebec, Canada, H2W 1R7 McGill University Health Centre - Royal Victoria Hosptial Montreal, Quebec, Canada, H3A 1A1 McGill University Health Centre - Montreal General Hospital Montreal, Quebec, Canada, H3G 1A4 Jewish General Hospital Montreal, Quebec, Canada, H3T 1E2 St. Mary's Hospital Center Montreal, Quebec, Canada, H3T 1M5 Lakeshore General Hospital Montreal, Quebec, Canada, H9R 2Y2 Less <<
NCT00168831 - Completed - -
NCT02970929 Schizophrenia Phase 2 Recruiting February 28, 2019 United States, Arkansas ... More >> Woodland International research Group Recruiting Little Rock, Arkansas, United States, 72211 Contact: Jim G Aukstuolis, MD    501-222-9052       United States, California CNRI-Los Angeles, LLC Recruiting Pico Rivera, California, United States, 90660 Contact: Raymond Manning, MD    562-928-8601       United States, Georgia Atlanta Center for Medical Research Recruiting Atlanta, Georgia, United States, 30331 Contact: Robert Riesenberg, MD    404-881-5800       United States, Louisiana Kashinath Yadalam Recruiting Lake Charles, Louisiana, United States, 70629 Contact: Kashinath Yadalam, MD    337-564-6405       United States, Texas Pillar Clinical Research, LLC Recruiting Dallas, Texas, United States, 75243 Contact: Scott Bartley, MD    214-396-4844       Hungary Bugát Pál Kórház-Rendelőintézet, Rehabilitációs Elmegyógyászati Osztály Recruiting Gyongyos, Dózsa György, Hungary, út 20-22 Contact: Tibor Kelemen, MD    +3612108139       Bekes Megyei Kozponti Korhaz Pandy Kalman Tagkorhaza, Pszichiatriai Osztaly Recruiting Gyula, Hungary, 5700 Contact: Gabor Vincze, MD    +3666526534       Romania Spitalul Universitar de Urgenta Militar Central "Dr. Carol Davila" Recruiting Bucuresti, Romania, 010825 Contact: Daniel Vasile, aProf    +40213112255       Centrul de Evaluarea si Tratament al Toxicodependentelor pentru Tineri "Sf. Stelian", Sectia Psihiatrie Recruiting Bucuresti, Romania, 060222 Contact: Malina Ioana Simu, MD    +40213220107       spitalul Clinic de Neuropsihiatrie Craiova ,Clinica II Psihiatrie Recruiting Craiova, Romania, 200473 Contact: George Mihai Badescu, MD    +40251957857       Institutul de Psihiatrie Socola Iasi, Sectia Psihiatrie III Acuti Recruiting Iasi, Romania, 700282 Contact: Ovidiu-Eugen Alexinsch, MD    +40232230990       Russian Federation Sverdlov Regional Psychiatric Clinical Hospital Recruiting Ekaterinburg, Russian Federation, 620030 Contact: Anna Malakhova, MD    +73432299827       St-Petersburg SHI Psychiatrical hospital #1 n.a. Kaschenko Recruiting Gatchina, Russian Federation, 188357 Contact: Boris Andreev, Prof.    +78137156384       SPHI "City Mental Hospital #3 n.a. I.I.Skvortsov-Stepanov" Recruiting Saint-Petersburg, Russian Federation, 197341 Contact: Mikhail Popov, MD    +78123061115       SHI Regional Clinical Psychiatry Hospital of St. Sofia Recruiting Saratov, Russian Federation, 410060 Contact: Irina Ivlieva, MD    +78452955038       FSBEI HE "Smolensk State Medical University" of the MoH of the RF Recruiting Smolensk, Russian Federation, 214019 Contact: Alexander Okhapkin, Professor    +74812611301       City Psychiatric Hospital of St. Nikolay Chudotvorets Recruiting St. Petersburg, Russian Federation, 190121 Contact: Evgeny Snedkov, MD    +89217413545       FB=SBI"Saint Petersburg Scientific and Research Psychoneurological Institute n.a. V.M. Bekhterev" Recruiting St. Petersburg, Russian Federation, 192019 Contact: Mikhail Ivanov, Professor    +89219306167       SPb SBIH "City Psychoneurological Dispensary #7 (with inpatient facilities)" Recruiting St. Petersburg, Russian Federation, 198020 Contact: Natalia Dobrovolskaya, MD    +78122519333       Ukraine Regional Psychoneurological Hospital #3, Dept of Crisis Cond & Primary Psych Episode #1 Recruiting Ivano Frankivsk, Ukraine, 76014 Contact: Myron Mulyk, MD    +380342774968       CHI Kharkiv RCPH#3 Center of Emerg PsychSI Inst of Neur, Psych & Narc of NAMSU, Unit of Emergency Psychiatry and Narcology Recruiting Kharkiv, Ukraine, 61068 Contact: Igor Linskiy, MD    +380577381536       CHI Kharkiv Regional Clinical Psychiatric Hospital #3, Psychiatric Department of Primary Psychotic Episod Recruiting Kharkiv, Ukraine, 61068 Contact: Viktor Kovalenko, MD    +38077384153       CI Kherson Regional Psychiatric Hospital of Kherson RC Recruiting Kherson, Vil Stepanivka, Ukraine, 73488 Contact: Pavlo Palamarchuk, MD    +380552543700       TMA Psychiatry in Kyiv Center of NT & Rehabilitation of Psychotic Conditions Recruiting Kyiv, Ukraine, 04080 Contact: Yuliya Blazhevych, MD    +380444684147       CI Odesa Regional Medical Center of Mental Health Recruiting Odesa, Ukraine, 65006 Contact: Anatolii Voloshchuk, MD    +380487200787       CI Cherkasy Regional Psychiatric Hospital of ChRC, Femail Dept #11, Male Dept #12 Recruiting Smila, Ukraine, 20708 Contact: Iryna Kosenkova, MD    +380473343264       Ternopil RCCPH Depts of Psychiatry #2 (m) & Psychiatry #6 Ternopil I.ya. Gorbachevskyi SMU Recruiting Ternopil, Ukraine, 46020 Contact: Olena Venger, MD    +380352435771       Transcarpathian Regional Narcological Dispensary Recruiting Uzhgorod, Ukraine, 88000 Contact: Oksana Serebrennikova, MD    +380432554707       CI O.I. Yuschenko VRPsH Depts #7 & #10 M.I. Pyrogov VNMU Recruiting Vinnytsia, Ukraine, 21005 Contact: Sofia Rymsha, Prof.    +380432357341 Less <<
NCT03766256 Gestational Diabetes Not Applicable Not yet recruiting December 31, 2019 United States, California ... More >> Toluca Lake Health Center Burbank, California, United States, 91505 100 Medical Plaza Primary Care Suites 455 & 490 Los Angeles, California, United States, 90024 Internal Medicine Women's Health Clinic Suites 250 & 290 Los Angeles, California, United States, 90024 UCLA Internal Medicine Family Westwood Suite 465 Los Angeles, California, United States, 90024 UCLA Internal Medicine Geriatrics Suite 365 & 420 Los Angeles, California, United States, 90024 CPN Brentwood Los Angeles, California, United States, 90049 CPN West Washington Internal Medicine Los Angeles, California, United States, 90066 Pacific Palisades Pacific Palisades, California, United States, 90272 12th Street Clinic Santa Monica, California, United States, 90401 Wilshire Office Santa Monica, California, United States, 90401 CPN Santa Monica 15th Street Family Medicine Practice Santa Monica, California, United States, 90404 CPN/Santa Monica Parkside Santa Monica, California, United States, 90404 Santa Moica Bay Physicians/20th Street 10th Floor Santa Monica, California, United States, 90404 Santa Monica Bay Physicians Plaza Santa Monica, California, United States, 90404 Santa Monica Bay Physicians/20th Street 3rd Floor Santa Monica, California, United States, 90404 Santa Monica Internal Medicine Santa Monica, California, United States, 90404 UCLA Family Health Clinic Santa Monica, California, United States, 90404 Santa Moica Bay Physicians Ocean Park Santa Monica, California, United States, 90405 Jack H. Skirball Health Center Woodland Hills, California, United States, 91364 CPN Woodland Hills Practice Woodland Hills, California, United States, 91367 Less <<
NCT00168844 - Completed - -
NCT03505762 B-Cell Non-Hodgkin Lymphoma Phase 2 Recruiting June 2024 United States, North Carolina ... More >> Wake Forest University Health Sciences Recruiting Winston-Salem, North Carolina, United States, 27157 Contact: Zanetta S. Lamar    336-716-5847    zlamar@wakehealth.edu    Principal Investigator: Zanetta S. Lamar Less <<
NCT02912936 Alzheimer's Disease Not Applicable Recruiting December 2019 Canada, British Columbia ... More >> Djavad Mowafaghian Centre for Brain Health Recruiting Vancouver, British Columbia, Canada, V6T 1Z3 Contact: Penny Slack, MSc    604-822-6379    pslack@mail.ubc.ca    Principal Investigator: Haakon Nygaard, MD, PhD Less <<
NCT02217943 Diabetes Obes... More >>ity Less << Not Applicable Active, not recruiting July 1, 2021 China ... More >> Beijing Shijitan Hospital Beijing, China China-Japan Union Hospital of Jilin University Changchun, China Guangzhou Overseas Chinese Hospital Guangzhou, China Jiangsu Province Hospital Jiangsu, China Shanghai East Hospital Shanghai, China Shanghai No. 6 People's Hospital Shanghai, China Less <<
NCT02672163 Heart Failure Not Applicable Unknown December 2017 Finland ... More >> Annu Nummi Recruiting Helsinki, Finland, 00029 Contact: annu nummi, MD       annu.nummi@hus.fi    Contact: annu nummi, MD Less <<
NCT01218204 Dyslipidaemias Phase 2 Completed - -
NCT02608554 Polycystic Ovary Syndrome Not Applicable Recruiting July 2019 China, Heilongjiang ... More >> First Affiliated Hospital, Heilongjiang University of Chinese Medicine Recruiting Harbin, Heilongjiang, China, 150040 Contact: Lihui Hou, Bachelor    86-451-82111401    houlihui2007@sina.com Less <<
NCT02324010 Gastroparesis ... More >> Diabetes Mellitus Less << Phase 2 Completed - Australia, South Australia ... More >> University of Adelaide, Discipline of Medicine, Royal Adelaide Hospital Adelaide, South Australia, Australia, 5000 Less <<
NCT02964195 Cirrhosis Eso... More >>phageal and Gastric Varices Gastrointestinal Hemorrhage Less << Not Applicable Unknown April 2018 China, Shanghai ... More >> 180 Fenglin Road Recruiting Shanghai, Shanghai, China, 200032 Contact: Xiaoquan HUANG, M.D.    +86-18801733835    huangxiaoquan1010@aliyun.com    Principal Investigator: Shiyao Chen, Professor Less <<
NCT01218204 - Completed - -
NCT00618748 - Completed - -
NCT03446053 Healthy Volunteers ... More >> Anti-Bacterial Agents Methicillin-Resistant Staphylococcus Aureus Methicillin-Sensitive Staphylococcus Aureus Infection Less << Phase 1 Recruiting October 2019 Korea, Republic of ... More >> Seoul National University Hospital Recruiting Seoul, Korea, Republic of, 110-744 Contact: In Jin Jang, M.D., Ph. D    82-2-740-8290    ijjang@snu.ac.kr    Contact: Jun Gi Hwang Hwang, M.D    82-2-742-9252    hjk17@snu.ac.kr    Principal Investigator: In Jin Jang, M.D., Ph. D          Sub-Investigator: Jun Gi Hwang, M.D Less <<
NCT03526588 Congenital Diaphragmatic Herni... More >>a Less << Phase 1 Recruiting November 1, 2027 United States, Texas ... More >> The University of Texas Health Science Center at Houston Recruiting Houston, Texas, United States, 77030 Contact: Matthew T. Harting, MD, MS    855-566-6273 Less <<
NCT01886326 Obesity Overw... More >>eight Hyperlipidemia Less << Not Applicable Completed - United States, Indiana ... More >> Purdue University West Lafayette, Indiana, United States, 47907 Less <<
NCT02831374 Impacted Third Molar Tooth Early Phase 1 Completed - -
NCT01596062 Renal Transplantation Phase 2 Completed - France ... More >> Novartis Investigative Site Bordeaux Cedex, France, 33076 Novartis Investigative Site Paris cedex 15, France, 75015 Novartis Investigative Site Tours Cedex, France, 37044 Less <<
NCT00618748 Bipolar I Disorder Phase 3 Completed - Japan ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Aichi, Japan, 470-1168 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chiba, Japan, 270-1694 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hiroshima, Japan, 731-0501 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Iwate, Japan, 023-0801 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kanagawa, Japan, 231-0027 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kyoto, Japan, 616-8421 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Saitama, Japan, 332-0012 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Shiga, Japan, 525-0037 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tokyo, Japan, 170-0002 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Yamaguchi, Japan, 755-8505 Less <<
NCT01478776 Type 2 Diabetes Phase 4 Unknown September 2013 Iran, Islamic Republic of ... More >> Tehran University of Medical Sciences Tehran, Iran, Islamic Republic of Less <<
NCT03534310 Obesity Not Applicable Completed - Italy ... More >> Catholic University School of Medicine Rome, Italy, 00168 Less <<
NCT02041195 Overweight Phase 1 Phase 2 Completed - United States, Texas ... More >> Dallas, Texas, United States United States, Wisconsin Madison, Wisconsin, United States Less <<
NCT01265498 Nonalcoholic Fatty Liver Disea... More >>se (NAFLD) Nonalcoholic Steatohepatitis (NASH) Less << Phase 2 Completed - United States, California ... More >> University of California, San Diego San Diego, California, United States, 92103 University of California, San Francisco San Francisco, California, United States, 94143 United States, Indiana Indiana University Indianapolis, Indiana, United States, 46202 United States, Missouri St. Louis University Saint Louis, Missouri, United States, 63104 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 United States, Ohio Case Western Reserve University Cleveland, Ohio, United States, 44109 Cleveland Clinic Foundation Cleveland, Ohio, United States, 44195 United States, Virginia Virginia Commonwealth University Richmond, Virginia, United States, 23298 United States, Washington Virginia Mason Medical Center Seattle, Washington, United States, 98101 Less <<
NCT01596062 - Completed - -
NCT00090012 Schizophrenia ... More >> Schizoaffective Disorder Less << Phase 4 Completed - -
NCT01433913 Adenocarcinoma of the Prostate... More >> Recurrent Prostate Cancer Stage I Prostate Cancer Stage IIA Prostate Cancer Stage IIB Prostate Cancer Less << Phase 2 Completed - United States, Arizona ... More >> Arizona Cancer Center - Tucson Tucson, Arizona, United States, 85724-5024 University of Arizona Health Sciences Center Tucson, Arizona, United States, 85724 United States, California University of Southern California/Norris Cancer Center Los Angeles, California, United States, 90033 Less <<
NCT01265498 - Completed - -
NCT00702910 Pulmonary Disease, Chronic Obs... More >>tructive Less << Phase 1 Completed - Australia, Queensland ... More >> GSK Investigational Site Auchenflower, Queensland, Australia, 4066 Australia, Victoria GSK Investigational Site Clayton, Victoria, Australia, 3168 New Zealand GSK Investigational Site Wellington, New Zealand, 6035 Less <<
NCT01433913 - Completed - -
NCT01447433 Obesity Overw... More >>eight Less << Phase 4 Completed - China ... More >> Changhai Hospital Shanghai, China, 200433 Less <<
NCT00413699 - Completed - -
NCT02054832 - Completed - Canada, Quebec ... More >> Montreal Children's hospital Montreal, Quebec, Canada, H3H1P3 Less <<
NCT02275104 - Completed - France ... More >> Hôpital cardiologique du Haut-Lévêque Pessac, France, 33604 Less <<
NCT01447433 - Completed - -
NCT02269631 Obesity Color... More >>ectal Carcinoma Less << Not Applicable Completed - United States, Georgia ... More >> Morehouse Atlanta, Georgia, United States, 30310 Emory ACTSI Atlanta, Georgia, United States, 30322 Less <<
NCT01483053 Major Depressive Disorder (MDD... More >>) Less << Phase 4 Unknown February 2015 Australia, Victoria ... More >> Monash Medical Centre - Monash Health Not yet recruiting Clayton, Victoria, Australia, 3168 Principal Investigator: David Barton          Sub-Investigator: Arup Dhar          Sub-Investigator: Sarah Tremethick          Sub-Investigator: Jennifer Grigo          Sub-Investigator: Krishna Vaddadi          Alfred and Baker Medical Unit - Alfred Hospital Not yet recruiting Melbourne, Victoria, Australia, 3004 Principal Investigator: Gavin Lambert          Sub-Investigator: Arup Dhar          Sub-Investigator: Sarah Tremethick          Sub-Investigator: Jennifer Grigo          Sub-Investigator: Markus Schlaich          Sub-Investigator: Elisabeth Lambert          Sub-Investigator: Murray Esler          Sub-Investigator: Geoff Head          Sub-Investigator: Nina Eikelis          Sub-Investigator: Carolina Ika Sari          Sub-Investigator: Petra Marusic          Sub-Investigator: Toni Rice          Sub-Investigator: Mariee Grima          Sub-Investigator: Donna Vizi          Sub-Investigator: Louise Hammond          Sub-Investigator: David Barton          Sub-Investigator: Dagmara Hering          Baker IDI Heart & Diabetes Institute Not yet recruiting Melbourne, Victoria, Australia, 3004 Principal Investigator: Gavin Lambert          Sub-Investigator: Arup Dhar          Sub-Investigator: Sarah Tremethick          Sub-Investigator: Jennifer Grigo          Sub-Investigator: Markus Schlaich          Sub-Investigator: Elisabeth Lambert          Sub-Investigator: Murray Esler          Sub-Investigator: Geoff Head          Sub-Investigator: Nina Eikelis          Sub-Investigator: Carolina Ika Sari          Sub-Investigator: Petra Marusic          Sub-Investigator: Toni Rice          Sub-Investigator: Mariee Grima          Sub-Investigator: Donna Vizi          Sub-Investigator: Louise Hammond          Sub-Investigator: David Barton          Sub-Investigator: Dagmara Hering Less <<
NCT02191293 - Completed - -
NCT00413699 Arthritis, Rheumatoid Phase 3 Completed - -
NCT03211403 Gout Hyperuri... More >>cemia Less << Phase 1 Completed - Australia, New South Wales ... More >> Atridia Pty Limited Sydney, New South Wales, Australia, 2000 Less <<
NCT03518515 Obesity Not Applicable Recruiting July 2019 United States, Alabama ... More >> University of Alabama at Birmingham Recruiting Birmingham, Alabama, United States, 35294 Contact: Daniel Smith, PhD          Principal Investigator: Daniel Smith, PhD Less <<
NCT02882386 Healthy Participants Not Applicable Completed - -
NCT01568307 Major Depressive Disorder Phase 4 Recruiting December 2020 Australia, Victoria ... More >> Ballarat Health Service Psychiatric Services Recruiting Ballarat, Victoria, Australia, 3350 Principal Investigator: Abdul Khalid          Sub-Investigator: Rajul Tandon          Sub-Investigator: Arup Dhar          Sub-Investigator: Sarah Tremethick          Sub-Investigator: Jennifer Grigo          Sub-Investigator: Sonia Ghai          Sub-Investigator: Pella Karalis          Monash Medical Centre - Monash Health Recruiting Clayton, Victoria, Australia, 3168 Principal Investigator: David Barton          Sub-Investigator: Arup Dhar          Sub-Investigator: Sarah Tremethick          Sub-Investigator: Jennifer Grigo          Sub-Investigator: Krishna Vaddadi          Alfred and Baker Medical Unit - Alfred Hospital Recruiting Melbourne, Victoria, Australia, 3004 Principal Investigator: Gavin Lambert          Sub-Investigator: Markus Schlaich          Sub-Investigator: Elisabeth Lambert          Sub-Investigator: Murray Esler          Sub-Investigator: Geoff Head          Sub-Investigator: Dagmara Hering          Sub-Investigator: Nina Eikelis          Sub-Investigator: Carolina Ika Sari          Sub-Investigator: Petra Marusic          Sub-Investigator: Toni Rice          Sub-Investigator: Mariee Grima          Sub-Investigator: David Barton          Sub-Investigator: Arup Dhar          Sub-Investigator: Sarah Tremethick          Sub-Investigator: Jennifer Grigo          Sub-Investigator: Donna Vizi          Sub-Investigator: Louise Hammond          Baker IDI Heart & Diabetes Institute Recruiting Melbourne, Victoria, Australia, 3004 Principal Investigator: Gavin Lambert          Sub-Investigator: Markus Schlaich          Sub-Investigator: Elisabeth Lambert          Sub-Investigator: Murray Esler          Sub-Investigator: Geoff Head          Sub-Investigator: Dagmara Hering          Sub-Investigator: Nina Eikelis          Sub-Investigator: Carolina Ika Sari          Sub-Investigator: Petra Marusic          Sub-Investigator: Toni Rice          Sub-Investigator: Mariee Grima          Sub-Investigator: David Barton          Sub-Investigator: Arup Dhar          Sub-Investigator: Sarah Tremethick          Sub-Investigator: Jennifer Grigo          Sub-Investigator: Donna Vizi          Sub-Investigator: Louise Hammond Less <<
NCT00617058 - Terminated(Terminated in lieu ... More >>of similar,competing large, multi-site study.) Less << - -
NCT01626443 PCOS Phase 4 Completed - Italy ... More >> University of Pisa - Department of Endocrinology Pisa, Italy Less <<
NCT03493191 Acute Pain Phase 1 Recruiting September 2018 Australia ... More >> Linear Clinical Research Limited Recruiting Nedlands, Australia Contact: Sarah Powell    +61 (0) 411 062 165    spowell@linear.org.au Less <<
NCT00617058 Weight Gain Phase 2 Terminated(Terminated in lieu ... More >>of similar,competing large, multi-site study.) Less << - United States, North Carolina ... More >> University of North Carolina, Department of Psychiatry Chapel HIll, North Carolina, United States, 27599 Less <<
NCT03701867 Energy Metabolism Not Applicable Recruiting December 2018 United States, Nebraska ... More >> University of Nebraska Recruiting Lincoln, Nebraska, United States, 68508 Principal Investigator: Joel Cramer, PhD Less <<
NCT02182869 Pulmonary Disease, Chronic Obs... More >>tructive Less << Phase 2 Terminated - -
NCT01420523 Human Immunodeficiency Virus ... More >> Lipohypertrophy Less << Phase 2 Terminated - France ... More >> Hôpital Pitié Salpétrière Paris, France, 75013 Less <<
NCT03685123 Obesity Seden... More >>tary Lifestyle Insulin Resistance Less << Not Applicable Not yet recruiting August 14, 2019 United States, North Carolina ... More >> East Carolina University Greenville, North Carolina, United States, 27858 Less <<
NCT02172261 Healthy Phase 1 Completed - -
NCT02516254 Healthy Phase 2 Completed - -
NCT02933827 Moderate to Severe Chronic Kid... More >>ney Disease Less << Phase 1 Phase 2 Recruiting December 2019 Taiwan ... More >> Taipei Medical University Shuang Ho Hospital Recruiting New Taipei City, Taiwan, 235 Contact: Eva Chen          Principal Investigator: Mai-Szu Wu, PhD Less <<
NCT01774045 - Completed - -
NCT02475473 Healthy Not Applicable Completed - United States, Texas ... More >> Exercise and Sport Sciences Building Lubbock, Texas, United States, 79423 Less <<
NCT01990794 - Completed - -
NCT01774045 Major Depressive Disorder Phase 1 Completed - Taiwan ... More >> Taipei Veterans General Hospital Taipei, Taiwan, 112 Less <<
NCT00532948 Glioma Phase 1 Completed - United States, California ... More >> San Francisco, California, United States, 94143-0780 United States, District of Columbia Washington, District of Columbia, United States, 20010 United States, Illinois Chicago, Illinois, United States, 60614 United States, Massachusetts Boston, Massachusetts, United States, 02115-6084 United States, North Carolina Durham, North Carolina, United States, 27710 United States, Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Pittsburgh, Pennsylvania, United States, 15261 United States, Texas Houston, Texas, United States, 77030 United States, Washington Seattle, Washington, United States, 98105 Less <<
NCT01990794 - Completed - -
NCT00532948 - Completed - -
NCT02037321 - Unknown December 2017 Canada, Ontario ... More >> Toronto 3-D (Diet, Digestive tract and Disease) Knowledge Synthesis and Clinical Trials Unit, Clinical Nutrition and Risk Factor Modification Centre, St. Michael's Hospital Toronto, Ontario, Canada, M5C 2T2 Less <<
NCT02529293 Healthy Phase 1 Completed - Germany ... More >> Profil Institut für Stoffwechselforschung GmbH Neuss, Germany, 41460 Less <<
NCT00106639 - Completed - -
NCT00106639 Kidney Transplantation Phase 2 Completed - United States, California ... More >> Pfizer Investigational Site Los Angeles, California, United States, 90057 Pfizer Investigational Site Los Angeles, California, United States, 92356 Pfizer Investigational Site Palo Alto, California, United States, 94304 Pfizer Investigational Site San Diego, California, United States, 92123 Pfizer Investigational Site San Francisco, California, United States, 94115 Pfizer Investigational Site San Francisco, California, United States, 94143-0780 Pfizer Investigational Site Stanford, California, United States, 94305 United States, Colorado Pfizer Investigational Site Denver, Colorado, United States, 80262 United States, Illinois Pfizer Investigational Site Chicago, Illinois, United States, 60611 United States, Louisiana Pfizer Investigational Site New Orleans, Louisiana, United States, 70112 United States, Missouri Pfizer Investigational Site St. Louis, Missouri, United States, 63110-1092 Pfizer Investigational Site St. Louis, Missouri, United States, 63110 United States, New Jersey Pfizer Investigational Site Livingston, New Jersey, United States, 07039 United States, New York Pfizer Investigational Site New York, New York, United States, 10021 Pfizer Investigational Site New York, New York, United States, 10029 United States, Oregon Pfizer Investigational Site Portland, Oregon, United States, 97210 United States, Texas Pfizer Investigational Site Dallas, Texas, United States, 75204 Pfizer Investigational Site Dallas, Texas, United States, 75246 United States, Virginia Pfizer Investigational Site Richmond, Virginia, United States, 23298 United States, Wisconsin Pfizer Investigational Site Milwaukee, Wisconsin, United States, 53226 Less <<
NCT03531554 VLCAD Deficiency ... More >> Fatty Acid Oxidation Defects Less << Not Applicable Completed - Netherlands ... More >> Academic Medical Center Amsterdam, Noord-Holland, Netherlands, 1105 AZ Dept of Neuroscience/ Neuroimaging Center Groningen, Netherlands, 9700RB Less <<
NCT02135848 - Completed - -
NCT02929498 Myelodysplastic Syndrome Phase 2 Recruiting May 15, 2019 United States, Pennsylvania ... More >> GSK Investigational Site Recruiting Philadelphia, Pennsylvania, United States, 19111 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com Less <<
NCT02717858 Metabolism and Nutrition Disor... More >>der Obesity Less << Phase 1 Completed - Denmark ... More >> Novo Nordisk Investigational Site Hellerup, Denmark, 2900 Less <<
NCT02135848 Vascular Disease, Peripheral Phase 2 Completed - United States, California ... More >> GSK Investigational Site Palo Alto, California, United States, 94304 GSK Investigational Site Vista, California, United States, 92083 United States, Florida GSK Investigational Site Clearwater, Florida, United States, 33761 GSK Investigational Site Sarasota, Florida, United States, 34239 United States, Illinois GSK Investigational Site Chicago, Illinois, United States, 60612 United States, Indiana GSK Investigational Site Indianapolis, Indiana, United States, 46290 United States, North Carolina GSK Investigational Site Boone, North Carolina, United States, 28607 GSK Investigational Site Durham, North Carolina, United States, 27705 United States, Ohio GSK Investigational Site Toledo, Ohio, United States, 43606 United States, Pennsylvania GSK Investigational Site Philadelphia, Pennsylvania, United States, 19104 United States, Texas GSK Investigational Site San Antonio, Texas, United States, 78229 United States, Virginia GSK Investigational Site Norfolk, Virginia, United States, 23502 Less <<
NCT02441088 Neuroendocrine Tumors ... More >> Carcinoid Tumors Neuroblastoma Medulloblastoma Less << Phase 2 Active, not recruiting October 25, 2020 United States, Iowa ... More >> University of Iowa Hospitals and Clinics Iowa City, Iowa, United States, 52242 Less <<
NCT01263691 Bacillus Anthracis (Anthrax) I... More >>nfection Less << Phase 1 Completed - United States, Florida ... More >> Miami Research Associates Miami, Florida, United States, 33143 United States, North Carolina North Carolina Clinical Research Raleigh, North Carolina, United States, 27607 United States, Utah Jean Brown Research Salt Lake City, Utah, United States, 84124 Less <<
NCT01478334 Rheumatoid Arthritis Not Applicable Completed - Norway ... More >> Norwegian University of Science and Technology, Faculty of medicine, Department of circulation and medical imaging, Trondheim, Norway, 7006 Less <<
NCT03198572 Non-alcoholic Steatohepatitis Phase 4 Not yet recruiting July 2020 China, Shanghai ... More >> Department of Endocrinology and Metabolism,Shanghai 6th People's Hospital Shanghai, Shanghai, China China The Affiliated Hospital of Hangzhou Normal University Not yet recruiting Hangzhou, China Contact: Jun-Ping Shi          Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine Not yet recruiting Shanghai, China Contact: Lun-Gen Lu          Xinhua Hospital, Shanghai Jiao Tong University School of Medicine Not yet recruiting Shanghai, China Contact: Jian-Gao Fan          Tianjin Third Central Hospital Not yet recruiting Tianjin, China Contact: Fu-Sheng Di          Xinjiang Medical University Not yet recruiting Urumqi, China Contact: Fang-Ping He Less <<
NCT01263691 - Completed - -
NCT00271193 Healthy Phase 3 Completed - United States, Pennsylvania ... More >> Edward S. Cooper Internal Medicine Practice Philadelphia, Pennsylvania, United States, 19104 Presbyterian Medical Group Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT01485887 Major Depressive Disorder Phase 3 Completed - Japan ... More >> Nippon Medical School Chiba Hokusoh Hospital Inzai, Chiba, Japan, 270-1694 Nakamoto Clinic Noda City, Chiba, Japan, 278-0033 Stress Care Yoshimura Clinic Fukuoka-shi, Fukuoka, Japan, 810-0041 Hatakeyama Clinic Kitakyushu, Fukuoka, Japan, 802-0064 Shiranui Hospital Omuta, Fukuoka, Japan, 836-0004 Fujikawa Clinic Hatsukaichi, Hiroshima, Japan, 738-0023 Takahashi Psychiatric Clinic Ashiya, Hyogo, Japan, 659-0093 Ikeuchi Psycho Induced Internal Med.Clinic Kobe, Hyogo, Japan, 655-0037 National Hospital Organization Kanazawa Medical Center Kanazawa, Ishikawa, Japan, 920-8650 Medical Corporation Seishinkai Kishiro Mental Clinic Kawasaki, Kanagawa, Japan, 214-0014 Yutaka Clinic Sagamihara-shi, Kanagawa, Japan, 252-0303 Tawara Clinic Yokohama, Kanagawa, Japan, 221-0835 Shioiri Mental Clinic Yokosuka city, Kanagawa, Japan, 238-0042 Shibamoto Clinic Osakasayama-shi, Osaka, Japan, 589-0011 Suzuki Hospital Adachi-ku, Tokyo, Japan, 120-0033 Sangenjaya Nakamura Mental Clinic Setagaya-ku, Tokyo, Japan, 154-0004 Omotesando Mental Clinic Shibuya-ku, Tokyo, Japan, 150-0001 Maynds Tower Mental Clinic Shibuya-ku, Tokyo, Japan, 151-0053 Tokyo Kosei Nenkin Hospital Shinjuku-ku, Tokyo, Japan, 162-8543 Himorogi Psychiatric Institute Toshima-ku, Tokyo, Japan, 170-0002 Tenjin Mental Clinic Fukuoka, Japan, 810-0004 Stress Care Yoshimura Clinic Fukuoka, Japan, 810-0041 Kuranari Psychiatry Clinic Fukuoka, Japan, 810-0801 Medical Corporation Toyokokai Tawara Clinic Kanagawa, Japan, 221-0835 Sagaarashiyama-Tanaka Clinic Kyoto, Japan, 616-8421 Less <<
NCT03563222 Malnutrition, Child Phase 4 Not yet recruiting November 2020 -
NCT02932150 Chronic Hepatitis B Phase 2 Recruiting November 2023 -
NCT02177812 Leukaemia, Myelocytic, Acute Phase 1 Terminated(The risk benefit in... More >> relapsed refractory AML does not favor continuation of the study.) Less << - United States, Georgia ... More >> GSK Investigational Site Augusta, Georgia, United States, 30912 United States, New York GSK Investigational Site Bronx, New York, United States, 10461 GSK Investigational Site Bronx, New York, United States, 10467 GSK Investigational Site New York, New York, United States, 10065 United States, Texas GSK Investigational Site Houston, Texas, United States, 77030 Australia, Victoria GSK Investigational Site Melbourne, Victoria, Australia, 3004 Canada, Ontario GSK Investigational Site Toronto, Ontario, Canada, M5G 2M9 GSK Investigational Site Toronto, Ontario, Canada, M5G 2M Less <<
NCT03339440 Childhood Obesity ... More >> Pediatric Obesity Quality of Life Cardiovascular Risk Factor Less << Not Applicable Recruiting December 2021 United States, North Carolina ... More >> Duke Children's Primary Care Roxboro Street Recruiting Durham, North Carolina, United States, 27704 Contact: Sarah Armstrong, MD          Durham Pediatrics at North Duke Street Recruiting Durham, North Carolina, United States, 27704 Contact: Sarah Armstrong, MD          Regional Pediatrics - North Durham Recruiting Durham, North Carolina, United States, 27704 Contact: Sarah Armstrong, MD Less <<
NCT00446017 Cardiac Output, Low Phase 3 Completed - -
NCT03708185 Healthy Not Applicable Recruiting September 30, 2020 United Kingdom ... More >> School of Sports and Health Sciences Recruiting Exeter, Devon, United Kingdom, EX4 4JA Contact: David J Childs    01392 722771 ext 2771    d.j.childs@exeter.ac.uk Less <<
NCT03223935 Normal Weight ... More >> Overweight Normoglycemic Less << Not Applicable Completed - Canada, Manitoba ... More >> Richardson Centre for Functional Foods and Nutraceuticals, University of Manitoba Winnipeg, Manitoba, Canada, R3T 6C5 Less <<
NCT01220089 Obesity Not Applicable Completed - United States, Colorado ... More >> Center for Human Nutrition Denver, Colorado, United States, 80220 Less <<
NCT01852981 Physical Activity Not Applicable Completed - Brazil ... More >> University of Sao Paulo Sao Paulo, SP, Brazil, 03828000 School of Arts, Sciences and Humanities, University of Sao Paulo Sao Paulo, Brazil Less <<
NCT01369082 - Completed - United States, California ... More >> University of California, San Francisco San Francisco, California, United States, 94143 United States, Florida University of Miami Miami, Florida, United States, 33136 United States, Georgia Emory University Atlanta, Georgia, United States, 30322 United States, Illinois Northwestern University Chicago, Illinois, United States, 60611 University of Illinois Chicago, Illinois, United States, 60612 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02493 United States, Minnesota University of Minnesota Minneapolis, Minnesota, United States, 55455 United States, Pennsylvania University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00381797 Childhood Cerebral Anaplastic ... More >>Astrocytoma Childhood Oligodendroglioma Childhood Spinal Cord Neoplasm Recurrent Childhood Brain Stem Glioma Recurrent Childhood Ependymoma Recurrent Childhood Medulloblastoma Less << Phase 2 Completed - United States, California ... More >> UCSF Medical Center-Mount Zion San Francisco, California, United States, 94115 United States, District of Columbia Children's National Medical Center Washington, D.C., District of Columbia, United States, 20010 United States, Illinois Lurie Children's Hospital-Chicago Chicago, Illinois, United States, 60611 United States, Massachusetts Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 United States, Pennsylvania Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 Children's Hospital of Pittsburgh of UPMC Pittsburgh, Pennsylvania, United States, 15224 United States, Tennessee Pediatric Brain Tumor Consortium Memphis, Tennessee, United States, 38105 St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 United States, Texas Texas Children's Hospital Houston, Texas, United States, 77030 United States, Washington Seattle Children's Hospital Seattle, Washington, United States, 98105 Less <<
NCT02719704 Physical Fitness ... More >> Body Image Less << Not Applicable Completed - Brazil ... More >> Federal University of Santa Catarina Florianópolis, Santa Catarina, Brazil, 88040900 Less <<
NCT02125955 Overweight Ob... More >>esity Less << Not Applicable Completed - Canada, Alberta ... More >> University of Calgary Calgary, Alberta, Canada, T2N 1N4 Less <<
NCT02253316 Multiple Myeloma Phase 2 Recruiting January 31, 2023 United States, California ... More >> City of Hope Recruiting Duarte, California, United States, 91010 Contact: Nitya Nathwani, MD    626-256-4673 ext 65295    nnathwani@coh.org    Principal Investigator: Nitya Nathwani, MD          Sub-Investigator: Ahmed Aribi, MD          Sub-Investigator: Ibrahim Aldoss, MD          Sub-Investigator: Monzr Al-Malki, MD          Sub-Investigator: Elizabeth Budde, MD          Sub-Investigator: Ji-Lian Cai, MD          Sub-Investigator: Thai Cao, MD          Sub-Investigator: Robert Chen, MD          Sub-Investigator: Leonardo Farol, MD          Sub-Investigator: Stephen Forman, MD          Sub-Investigator: Alex Herrera, MD          Sub-Investigator: Myo Htut, MD          Sub-Investigator: Chatchada Karanes, MD          Sub-Investigator: Khaled Samer, MD          Sub-Investigator: Amrita Krishnan, MD          Sub-Investigator: Matthew Mei, MD          Sub-Investigator: Auayporn Nademanee, MD          Sub-Investigator: Ryotaro Nakamura, MD          Sub-Investigator: Margaret O'Donnell, MD          Sub-Investigator: Pablo Parker, MD          Sub-Investigator: Leslie Popplewell, MD          Sub-Investigator: Michael Rosenzweig, MD          Sub-Investigator: Firoozeh Sahebi, MD          Sub-Investigator: Amandeep Salhotra, MD          Sub-Investigator: Tanya Siddiqi, MD          Sub-Investigator: David Snyeder, MD          Sub-Investigator: George Somlo, MD          Sub-Investigator: Ricardo Spielberger, MD          Sub-Investigator: Anthony Stein, MD          Sub-Investigator: Jasmine Zain, MD          University of California, San Francisco Recruiting San Francisco, California, United States, 94143 Contact: Thomas G. Martin, MD    415-353-2051    tom.martin@ucsf.edu    Principal Investigator: Thomas G. Martin, MD          United States, Colorado Colorado Blood Cancer Institute Recruiting Denver, Colorado, United States, 80218 Contact: Tara K Gregory, M.D.    720-754-4800    Tara.Gregory@HealthONECares.com    Principal Investigator: Tara K Gregory, M.D.          Sub-Investigator: Alireza B Maris, M.D.          Sub-Investigator: Jeffrey V Matous, M.D.          Sub-Investigator: Peter A McSweeney, M.D.          Sub-Investigator: Richard Nash, M.D.          Sub-Investigator: Marcello Rotta, M.D.          Sub-Investigator: Michael T Tees, M.D.          United States, Georgia Emory University - Winship Cancer Institute Recruiting Atlanta, Georgia, United States, 30322 Contact: Jonathan L Kaufman, MD    404-778-1900    jlkaufm@emory.edu    United States, Michigan Karmanos Cancer Institute Recruiting Detroit, Michigan, United States, 48201 Contact: Jeffrey A Zonder, MD    313-576-8732    zonderj@karmanos.org    Principal Investigator: Jeffrey A. Zonder, M.D.          Sub-Investigator: Abhinav Deol, MD          Sub-Investigator: Radhakrishnan Ramchandren, MD          Sub-Investigator: Melissa Runge-Morris, MD          Sub-Investigator: Charles Schiffer, MD          Sub-Investigator: Jay Yang, MD          Sub-Investigator: Steven Burt, MD          United States, Minnesota Mayo Clinic Recruiting Rochester, Minnesota, United States, 55905 Contact: Francis K Buadi, M.D.    (507) 538-3270    Buadi.Francis@mayo.edu    Principal Investigator: Francis K Buadi, M.D.          Sub-Investigator: Angela Dispenzieri, M.D.          Sub-Investigator: Matthew T Drake, M.D., Ph.D.          Sub-Investigator: Amie L Fonder, PA-C          Sub-Investigator: Morie Gertz, M.D.          Sub-Investigator: Ronald S Go, M.D.          Sub-Investigator: Wilson I Gonsalves, M.D.          Sub-Investigator: Suzanne R Hayman, M.D.          Sub-Investigator: Miriam A Hobbs, APRN, CNP, DNP          Sub-Investigator: Yi (Lisa) L Hwa, APRN, CNP, DNP          Sub-Investigator: Prashant Kapoor, M.D.          Sub-Investigator: Taxiarchis Kourelis, M.D.          Sub-Investigator: Shaji K Kumar, M.D.          Sub-Investigator: Nelson Leung, M.D.          Sub-Investigator: Yi Lin, M.D., Ph.D.          Sub-Investigator: John A Lust, M.D., Ph.D.          Sub-Investigator: S. Vincent Rajkumar, M.D.          Sub-Investigator: Stephen J Russell, M.D., Ph.D.          Sub-Investigator: Thomas E Witzig, M.D.          Sub-Investigator: Steven R Zeldenrust, M.D, Ph.D.          United States, Missouri Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 62864 Contact: Ravi Vij, M.D.    314-454-8323    rvij@wustl.edu    Principal Investigator: Ravi Vij, M.D.          Sub-Investigator: Camille Abboud, M.D.          Sub-Investigator: John DiPersio, M.D., Ph.D.          Sub-Investigator: Todd Fehniger, M.D., Ph.D.          Sub-Investigator: Armin Ghobadi, M.D.          Sub-Investigator: Megan Jacoby, M.D., Ph.D.          Sub-Investigator: Jesse Keller, M.D.          Sub-Investigator: Iskra Pusic, M.D.          Sub-Investigator: Rizwan Romee, M.D.          Sub-Investigator: Mark Schreoder, M.D.          Sub-Investigator: Keith Stockerl-Goldstein, M.D.          Sub-Investigator: Michael Tomasson, M.D.          Sub-Investigator: Geoffrey Uy, M.D.          Sub-Investigator: Matthew Walter, M.D.          Sub-Investigator: Lukas Wartman, M.D.          Sub-Investigator: John Welch, M.D., Ph.D.          Sub-Investigator: Peter Westervelt, M.D., Ph.D.          United States, New York Icahn School of Medicine at Mount Sinai Recruiting New York, New York, United States, 10029 Contact: Ajai Chari, M.D.    212-241-7873    ajai.chari@mountsinai.org    Principal Investigator: Ajai Chari, M.D.          Sub-Investigator: Sundar Jagannath, M.D.          Sub-Investigator: Hearn Cho, M.D.          Sub-Investigator: Samir Parekh, M.D.          Sub-Investigator: Deepu Madduri, M.D.          United States, Ohio Ohio State University Comprehensive Cancer Center Recruiting Columbus, Ohio, United States, 43210 Contact: Ashley Rosko, M.D.    614-293-7807    Ashley.Rosko@osumc.edu    Principal Investigator: Ashley Rosko, M.D.          Sub-Investigator: Don Benson, Jr., M.D., Ph.D.          Sub-Investigator: Jonathan Brammer, M.D.          United States, Tennessee Tennessee Oncology, PLLC Recruiting Nashville, Tennessee, United States, 37203 Contact: Jesus Berdeja, M.D.    615-329-7274    jberdeja@tnonc.com    Principal Investigator: Jesus Berdeja, M.D. Less <<
NCT01485887 - Completed - -
NCT00381797 - Completed - -
NCT00730327 Obesity Not Applicable Completed - United States, Texas ... More >> Apollo Endosurgery Austin, Texas, United States, 78746 Less <<
NCT01513902 Juvenile Idiopathic Arthritis Phase 1 Completed - United States, Minnesota ... More >> Explorer Clinic, University of Minnesota Children's Hospital Minneapolis, Minnesota, United States, 55454 Clinical and Translational Science Institute Masonic Clinical Research Unit (Administration Only) Minneapolis, Minnesota, United States, 55455 United States, Ohio Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229 United States, Oregon Randall Children's Hospital at Legacy Emanuel Portland, Oregon, United States, 97227 Germany PRI - Pediatric Rheumatology Research Institute GmbH Bad Bramstedt, Germany, 24576 Hamburger Zentrum fuer Kinder-und Jugendrheumatologie SchoenKlinik Hamburg Eilbek Hamburg, Germany, 22081 Asklepios Klinik Sankt Augustin Gmbh St. Augustin, Germany, 53757 Poland Wojewodzki Specjalistyczny Szpital Dzieciecy im. Sw. Ludwika w Krakowie Krakow, Poland, 31-503 Klinika Kardiologii i Reumatologii Dzieciecej Lodz, Poland, 91-738 Slovakia Narodny ustav reumatickych chorob Piestany, Slovakia, 921 12 Less <<
NCT00635245 Breast Cancer Phase 1 Withdrawn - -
NCT01513902 - Completed - -
NCT02193659 Overweight Not Applicable Completed - Spain ... More >> Pharmacy Iborra Campos Elche, Alicante, Spain, 03202 Less <<
NCT03364985 Healthy Phase 1 Recruiting December 2018 Korea, Republic of ... More >> Seoul National University Hospital Recruiting Seoul, Korea, Republic of Contact: Kyung-Sang Yu, MD, PhD    82-2-2072-1920    ksyu@snu.ac.kr Less <<
NCT01075867 - Unknown December 2016 Switzerland ... More >> University Hospital Recruiting Bern, Switzerland Contact: Pierre-Frédéric Keller, MD          Contact: Stephan Windecker          Sub-Investigator: Peter Jüni, MD          Sub-Investigator: Lorenz Raeber, MD          University Hospitals Recruiting Geneva, Switzerland Contact: François Mach, MD          Contact: David Carballo, MD          Sub-Investigator: Sebastian Carballo, MD          Sub-Investigator: David Carballo, MD          Sub-Investigator: Thomas Perneger, MD          Sub-Investigator: Marco Roffi, MD          Sub-Investigator: Baris Gencer, MD          University Hospital Recruiting Lausanne, Switzerland Contact: Nicolas Rodondi, MD          Sub-Investigator: Reto Auer, MD          University Hospital, Recruiting Zürich, Switzerland Contact: Thomas F Luscher, MD          Contact: Christian Matter, MD          Sub-Investigator: Roland Klingenberg, MD Less <<
NCT00730327 - Completed - -
NCT02281331 Aging Not Applicable Completed - Canada, Ontario ... More >> McMaster Univeristy Hamilton, Ontario, Canada, L8S 4K1 Less <<
NCT03483454 Pediatric Obesity Not Applicable Completed - United States, Pennsylvania ... More >> Penn State Hershey Medical Center Hershey, Pennsylvania, United States, 17033 Less <<
NCT03742492 Healthy Volunteers Phase 2 Recruiting April 2019 Portugal ... More >> CINTESIS - Faculty of Medicine of the University of Porto Recruiting Porto, Portugal, 4200-450 Contact: André Rosário, MSc    +351 225 513 622 ext 26928    andrerosario@med.up.pt    Contact: António Soares, PhD    +351 225 513 622    ajasoares@cintesis.eu Less <<
NCT02342275 Hemangioma Phase 3 Completed - China, Sichuan ... More >> West China Hospital of Sichuan University Chengdu, Sichuan, China, 610041 Less <<
NCT03422172 HIV Infections Phase 1 Active, not recruiting April 28, 2020 China, Zhejiang ... More >> GSK Investigational Site Hangzhou, Zhejiang, China, 310000 China GSK Investigational Site Beijing, China, 100069 GSK Investigational Site Shanghai, China, 201508 Less <<
NCT03578497 Polycystic Ovary Syndrome Phase 2 Recruiting August 2019 Switzerland ... More >> University Hospital Basel Endocrinology, Diabetes and Metabolism Recruiting Basel, Switzerland, 4031 Contact: Mirjam Christ-Crain, Prof.Dr. med    +41 61 265 48 96    mirjam.christ-crain@usb.ch    Contact: Milica Popovic       milica.popovic@usb.ch    Sub-Investigator: Gideon Sartorius, PD Dr.med          Sub-Investigator: Marc Donath, Prof. Dr.med          Sub-Investigator: Fahim Ebrahimi, Dr. med Less <<
NCT02218762 Asthma Phase 1 Withdrawn(It was decided that ... More >>data from this study are no longer required and therefore it is not necessary to expose patients to the study medication) Less << June 2015 -
NCT02776436 Breast Cancer ... More >> Prostate Cancer Less << Phase 1 Recruiting January 2019 Netherlands ... More >> Reinier de Graaf hospital Recruiting Delft, Netherlands Contact: V.O. Dezentje, MD, PhD          Haga hospital Recruiting Den Haag, Netherlands Contact: D. Houtsma, MD          Leiden university medical center Recruiting Leiden, Netherlands Contact: J.R. Kroep, MD, PhD Less <<
NCT03727152 HIV Phase 3 Not yet recruiting December 31, 2021 Thailand ... More >> HIV-NAT, Thai Red Cross AIDS Research Centre Not yet recruiting Bangkok, Thailand, 10330 Contact: Sivaporn Gatechompol, MD    662 6523040 ext 171    sivaporn.k@hivnat.org    Principal Investigator: Sivaporn Gatechompol, MD          Police General Hospital Not yet recruiting Bangkok, Thailand, 10330 Contact: Jirayu Visutranukul, MD    +66 (02) 207 6000    nutjv@yahoo.com    Principal Investigator: Jirayu Visutranukul, MD Less <<
NCT02074683 Pedal Pad Atrophy ... More >> Diabetes Mellitus Less << Not Applicable Completed - United States, Pennsylvania ... More >> University of Pittsburgh Department of Plastic Medicine Pittsburgh, Pennsylvania, United States, 15213 Less <<
NCT02077309 Diabetes Mellitus Type 2 (T2DM... More >>) Vascular Inflammation Plaque Morphology Less << Phase 3 Terminated(bad recruitment of ... More >>suitable participants, just 4 patients in one year) Less << - Germany ... More >> Department of Internal Medicine I, University Hospital Aachen, Germany, 52074 Netherlands Cardiovascular Research Institute Maastricht (CARIM) Maastricht, Netherlands, 6229 Less <<
NCT03041272 - Enrolling by invitation June 2017 United States, Connecticut ... More >> Middlesex Hospital Middletown, Connecticut, United States, 06457 Yale New Haven Hospital- St. Raphael New Haven, Connecticut, United States, 06511 Yale New Haven Hospital Primary Care Center New Haven, Connecticut, United States, 06519 Less <<
NCT02080741 Patients With Type 1 or Type 2... More >> Diabetes Patients With a Type A or B Behaviour Profile Less << Not Applicable Unknown - France ... More >> CHU de DIJON Recruiting Dijon, France, 21079 Contact: Jean-Christophe CHAUVET-GELINIER    3.80.29.37.69 ext +33    jean-christophe.chauvet-gelinier@chu-dijon.fr Less <<
NCT02115347 Type 2 Diabetes Mellitus ... More >> Hepatic Impairment Less << Phase 1 Completed - -
NCT03646799 Type II Diabetes Phase 1 Recruiting September 14, 2018 Korea, Republic of ... More >> Yonsei University Severance Hospital Recruiting Soeul, Korea, Republic of Contact: Min Soo Park, Ph.D. M.D    +82 2 2228 0400    minspark@yuhs.ac    Principal Investigator: Min Soo Park, Ph.D. M.D Less <<
NCT02125682 Dyslipidemia in Patients With ... More >>Diabetes Mellitus Less << Phase 4 Completed - Lebanon ... More >> Hotel Dieu de France Hospital Beirut, Lebanon, Beirut Less <<
NCT02153879 Type 2 Diabetes Mellitus ... More >> Dyslipidemia Less << Phase 4 Completed - Spain ... More >> Hospital Universitari Sant Joan Reus, Tarragona, Spain, 43204 Less <<
NCT03773731 Prediabetic State Not Applicable Not yet recruiting February 2021 Austria ... More >> MUVienna Vienna, Austria, 1090 Less <<
NCT00724711 HIV Infection Phase 4 Completed - -
NCT02115347 - Completed - -
NCT00724711 - Completed - -
NCT02240420 Gestational Diabetes Mellitus ... More >> Type 2 Diabetes Mellitus Less << Not Applicable Unknown May 2017 United States, California ... More >> San Francisco General Hospital Recruiting San Francisco, California, United States, 94110 Contact: Margaret Handley, PhD    415-206-5333    handleym@medsfgh.ucsf.edu    Contact: Judy Quan, PhD    415-206-4962    judy.quan@ucsf.edu Less <<
NCT02242149 Diabetes Mellitus, Type 2 ... More >> Non-alcoholic Fatty Liver Disease Less << Phase 3 Completed - Brazil ... More >> Program of Arterial Hypertension, University Hospital Clementino Fraga Filho Rio de Janeiro, Brazil, 21941913 Less <<
NCT03208751 Exercise Training ... More >> Coronary Artery Disease Diabetes Mellitus, Type 2 Less << Not Applicable Recruiting January 1, 2018 Germany ... More >> Klinikum rechts der Isar/ Technische Universitaet Muenchen Recruiting Munich, Germany, 81675 Contact: Alessandra Boscheri, M.A.    +4916084190949    aboscheri@hotmail.com    Principal Investigator: Martin Halle, M.D., PhD          Sub-Investigator: Alessandra Boscheri, M.D.          Sub-Investigator: Jeffrey W Christle, M.A. Less <<
NCT02266758 Gestational Diabetes ... More >> Obesity Pregnancy Less << Not Applicable Enrolling by invitation December 2020 -
NCT02276950 - Active, not recruiting March 2020 -
NCT02218099 Chronic Kidney Disease (CKD) ... More >> Type 2 Diabetes Mellitus (T2DM) Healthy Subjects Pharmacokinetics of ASP8232 Pharmacodynamics of ASP8232 Less << Phase 1 Phase 2 Completed - Bulgaria ... More >> Site: 35901 Sofia, Bulgaria, 1612 Moldova, Republic of Site: 37301 Chisinau, Moldova, Republic of Romania Site: 40001 Bucharest, Romania, 10731 Less <<
NCT02316483 - Recruiting December 2018 Qatar ... More >> Hamad Medical Corporation Recruiting Doha, Qatar Contact: Omar Chidiac    +974-4492-8919    omc2002@qatar-med.cornell.edu    Principal Investigator: Charbel Abi Khalil, MD Less <<
NCT02355197 Gestational Diabetes Mellitus Phase 4 Completed - Egypt ... More >> Kasr Alainy medical school Cairo, Egypt, 12151 Less <<
NCT03457870 Aging Cogniti... More >>ve Decline Less << Not Applicable Recruiting March 2019 United Kingdom ... More >> Diabetes & Nutritional Sciences Division, King's College London, Franklin-Wilkins Building, 150 Stamford St Recruiting London, England, United Kingdom, SE1 9NH Contact: Wendy L Hall, PhD    02078484197    wendy.hall@kcl.ac.uk    Contact: Curie Kim, MSc    02078484345    curie.kim@kcl.ac.uk Less <<
NCT02386579 - Unknown - -
NCT00725764 - Completed - -
NCT02285985 Type 2 Diabetes Mellitus (T2DM... More >>) Less << Phase 4 Active, not recruiting December 2018 United States, Arizona ... More >> Carl T. Hayden VA Medical Hospital Phoenix, Arizona, United States, 85012 Less <<
NCT03179657 - Active, not recruiting December 2027 -
NCT02603172 Amyloidosis Phase 1 Terminated(A new study will be... More >> initiated in order to specifically investigate cardiac safety) Less << - United Kingdom ... More >> GSK Investigational Site Cambridge, United Kingdom, CB2 2GG Less <<
NCT02459106 - Active, not recruiting April 2018 United States, Florida ... More >> Translational Research Institute for Metabolism and Diabetes Orlando, Florida, United States, 32804 Less <<
NCT02473081 Diabetes Mellitus, Type 2 ... More >> Depression Less << Not Applicable Completed - -
NCT02478853 - Active, not recruiting December 2020 Canada, Quebec ... More >> Centre de recherche du CHUS Sherbrooke, Quebec, Canada, J1H 5N4 Less <<
NCT00725764 Neoplasms, Head and Neck Phase 2 Completed - United States, Georgia ... More >> GSK Investigational Site Atlanta, Georgia, United States, 30309 United States, Illinois GSK Investigational Site Chicago, Illinois, United States, 60637 United States, Indiana GSK Investigational Site Indianapolis, Indiana, United States, 46254 United States, Minnesota GSK Investigational Site Minneapolis, Minnesota, United States, 55407-3799 United States, Missouri GSK Investigational Site Saint Louis, Missouri, United States, 63110 United States, New Hampshire GSK Investigational Site Lebanon, New Hampshire, United States, 03756 United States, South Carolina GSK Investigational Site Charleston, South Carolina, United States, 29403 United States, Tennessee GSK Investigational Site Nashville, Tennessee, United States, 37203 United States, Texas GSK Investigational Site Houston, Texas, United States, 77030 GSK Investigational Site San Antonio, Texas, United States, 78229 United States, West Virginia GSK Investigational Site Morgantown, West Virginia, United States, 28506 Less <<
NCT02520336 Diabetes, Gestational Not Applicable Unknown - United States, Pennsylvania ... More >> Thomas Jefferson University Hospital Recruiting Philadelphia, Pennsylvania, United States, 19107 Contact: Adeeb Khalifeh, MD       adeeb.khalifeh@jefferson.edu Less <<
NCT02505321 Diabetes Mellitus Not Applicable Completed - United Kingdom ... More >> University of Exeter Exeter, Devon, United Kingdom, EX2 5DW Less <<
NCT02436551 - Active, not recruiting July 2018 Germany ... More >> Med. Dept. 2, University Munich Munich, Germany, 81377 Less <<
NCT02557022 - Unknown March 2017 Canada, Ontario ... More >> The Toronto 3D (Diet, Digestive tract and Disease) Knowledge Synthesis and Clinical Trials Unit, Clinical Nutrition and Risk Factor Modification Centre, St. Michael's Hospital Toronto, Ontario, Canada, M5C 2T2 Less <<
NCT02502929 Diabetes Depr... More >>ession Less << Not Applicable Recruiting September 2020 United States, Connecticut ... More >> Uconn Health Recruiting Farmington, Connecticut, United States, 06030 Contact: Julie Wagner, PhD    860-679-4508       Khmer Health Advocates Recruiting West Hartford, Connecticut, United States, 06110 Contact: Mary Scully    860-561-3345    mfs47@aol.com    United States, Rhode Island Center for Southeast Asians Recruiting Providence, Rhode Island, United States, 02907 Contact: Channavy Chhay    401-274-8811 ext x12    channavy.chhay@cseari.org Less <<
NCT02558452 - Not yet recruiting January 2028 -
NCT02580266 - Recruiting September 2025 United Kingdom ... More >> Unit for Metabolic Medicine, King's College London Recruiting London, United Kingdom, SE1 9RT Contact: Luigi Gnudi, MD, PhD    +442078484413    luigi.gnudi@kcl.ac.uk Less <<
NCT03603665 Botulism Phase 1 Recruiting September 7, 2019 United States, North Carolina ... More >> Duke University School of Medicine - Duke Clinical Research Institute - Duke Clinical Research Unit Recruiting Durham, North Carolina, United States, 27710-4000 Less <<
NCT02586129 Dyslipidemia ... More >>Type II Diabetes Less << Phase 3 Completed - Korea, Republic of ... More >> Seoul National Universitiy Bundang Hospital Seongnam-Si, Gyeonggi-Do, Korea, Republic of, 463-707 Less <<
NCT02600091 Anxiety Depre... More >>ssion Diabetes Less << Not Applicable Completed - United Kingdom ... More >> University of Aberdeen Aberdeen, United Kingdom, AB25 2ZD Less <<
NCT02483949 Diabetes Mellitus Gestational ... More >>Previous Pregnancy Less << Not Applicable Completed - Canada, Alberta ... More >> Athabasca University Athabasca, Alberta, Canada, T9S 3A3 Alliance for Canadian Health Outcomes Research in Diabetes Edmonton, Alberta, Canada Less <<
NCT02637973 Type 2 Diabetes ... More >> Non-alcoholic Fatty Liver Disease Less << Phase 4 Unknown July 2018 Germany ... More >> Charite Universitaetsmedizin Berlin Recruiting Berlin, Germany Contact: Gabriele Klampke    +49 30 450514422    gabriele.klampke@charite.de    Principal Investigator: Andreas Pfeiffer, Professor          Sub-Investigator: Stefan Kabisch, MD          Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden Recruiting Dresden, Germany, 01307 Contact: Andreas Birkenfeld, Prof., M.D.       andreas.birkenfeld@uniklinikum-dresden.de    German Diabetes Center Recruiting Dusseldorf, Germany Contact: Sofiya Gancheva, MD    +49 221 3382 698    sofiya.gancheva@ddz.uni-duesseldorf.de    Contact: Michael Roden, Professor    +49 211 3382 201    michael.roden@ddz.uni-duesseldorf.de    Principal Investigator: Michael Roden, Professor          Sub-Investigator: Sofiya Gancheva, MD          University Clinic Heidelberg Recruiting Heidelberg, Germany Contact: Bischoff Sandra    +49 6221 56 8606    sandra.bischoff@med.uni-heidelberg.de    Principal Investigator: Christian Kasperk, Professor          Sub-Investigator: Stefan Kopf, MD          University Clinic Tübingen Recruiting Tübingen, Germany Contact: Louise Fritsche, PhD    +49 7071 29 80687    Louise.Fritsche@med.uni-tuebingen.de    Principal Investigator: Norbert Stefan, Professor          Sub-Investigator: Andreas Fritsche, Professor Less <<
NCT02649374 Gestational Diabetes Mellitus Not Applicable Recruiting December 2019 Israel ... More >> Rabin Medical Center Recruiting Petach-Tikva, Israel, 49100 Contact: Eran Hadar, MD    972-3-9739400    eranh42@gmail.com    Contact: Lihi Rotman    972-3-9739400    lihiro@clalit.org.il Less <<
NCT02710448 Renal Disorder Associated With... More >> Type II Diabetes Mellitus Less << Phase 2 Completed - France ... More >> Service d'Endocrinologie, Maladies Métaboliques et Nutrition Amiens, France, 80054 Less <<
NCT02586831 Diabetes Mellitus, Type 1 ... More >> Hypoglycemia Autoimmune Diseases Diabetes Mellitus Less << Phase 1 Phase 2 Not yet recruiting December 2021 United States, Florida ... More >> Diabetes Research Institute, University of Miami Miller School of Medicine Not yet recruiting Miami, Florida, United States, 33136 Contact: Rodolfo Alejandro, M.D.    305-243-5324    ralejand@med.miami.edu    Contact: David A Baidal, M.D.    (305) 243-7740    dbaidal@med.miami.edu    Principal Investigator: Rodolfo Alejandro, M.D.          Principal Investigator: David A Baidal, M.D. Less <<
NCT02726100 Diabetes Mellitus, Type 2 ... More >> Hypertension Dyslipidemias Less << Not Applicable Recruiting April 2020 China, Hebei ... More >> Hebei Medical University Recruiting Shijiazhuang, Hebei, China, 050017 Contact: Yuxia Ma, PhD          Center of Disease Control and Prevention, Luquan Recruiting Shijiazhuang, Hebei, China, 050200 Contact: Yaosen Zhang Less <<
NCT02953665 Parkinson Disease Phase 2 Recruiting September 2019 United States, California ... More >> Cedars Sinai Medical Center Recruiting Los Angeles, California, United States, 90048 Contact: Tina Wu    424-315-2870    tina.wux@cshs.org Less <<
NCT02827903 Type 2 Diabetes ... More >> Dyslipidemia Less << Phase 3 Completed - Korea, Republic of ... More >> Buchoen St. mary's Hospital Bucheon, Korea, Republic of SeJong Hostpital Bucheon, Korea, Republic of SoonChunHyang University Bucheon Hospital Bucheon, Korea, Republic of InJe University Busan paik Hospital Busan, Korea, Republic of Inje University Haeundae paik hospital Busan, Korea, Republic of Daegu Catholic University Medical Center Daegu, Korea, Republic of Youngnam University Hostpital Daegu, Korea, Republic of Daeheon Eulji Medical Center Daejeon, Korea, Republic of KonYang University Hostpital Daejeon, Korea, Republic of Chosun University Hospital Gwangju, Korea, Republic of BunDang Jesang Hospital(DMC) Gyeonggi-do, Korea, Republic of Hallym University Sacred Heart hospital Gyeonggi-do, Korea, Republic of HanYang University Guri Hospital Gyeonggi-do, Korea, Republic of Inje University Ilsan paik hospital Gyeonggi-do, Korea, Republic of Myoung Ji Hospital Gyeonggi-do, Korea, Republic of Gachon Gil Hospital Incheon, Korea, Republic of Inchoen St. mary's Hospital Incheon, Korea, Republic of Eulji Hospital Nowon Seoul, Korea, Republic of Hallym University Kangnam Sacred Heart hospital Seoul, Korea, Republic of KangBuk SamSung Hospital Seoul, Korea, Republic of Kangdong Sacred Heart Hospital Seoul, Korea, Republic of KonKuk University Medical Center Seoul, Korea, Republic of Korea University Anam Hospital Seoul, Korea, Republic of KyungHee University Hospital at Gangdong Seoul, Korea, Republic of Samsung Medical Center Seoul, Korea, Republic of Seoul National University Hospital(Famlily medicine) Seoul, Korea, Republic of Seoul National University Hospital Seoul, Korea, Republic of Severance hospital Seoul, Korea, Republic of SoonChunHayng University Hospital Seoul Seoul, Korea, Republic of The catholic University of Korea YEOUIDO St mary's Hospital Seoul, Korea, Republic of Korea University Guro hospital Soeul, Korea, Republic of Ajou University hospital Suwon, Korea, Republic of Wonju Severance Christian hospital Wŏnju, Korea, Republic of Less <<
NCT02551315 - Recruiting September 2019 Switzerland ... More >> University Department of Internal Medicine, University Basel, Kantonsspital Not yet recruiting Aarau, AG, Switzerland, 5001 Contact: Beat Müller, Prof. MD          Contact: Anne Katrin Borm, MD          Department of Internal Medicine, Kantonsspital Bruderholz Recruiting Binningen, BL, Switzerland, 4101 Contact: Barbara Felix, MD          Department of Internal Medicine, Kantonsspital Luzern Recruiting Luzern, LU, Switzerland, 6000 Contact: Christoph Henzen, PD MD          Department of Medicine, St. Anna Hospital Hirslanden Not yet recruiting Luzern, LU, Switzerland, 6006 Contact: Reto Krapf, Prof. MD          Division of Endocrinology, Diabetology and Metabolism, University Hospital Basel Recruiting Basel, Switzerland, 4031 Contact: Janina Vavanikunnel, MD    +41(0)61 265 50 78    janina.vavanikunnel@usb.ch    Contact: Christian Meier, Prof. MD    +41(0)61 264 97 97    christian.meier@unibas.ch    Sub-Investigator: Marc Donath, Prof. MD          Sub-Investigator: Marius Kränzlin, Prof. MD          Sub-Investigator: Norbert Suhm, Prof. MD Less <<
NCT02835287 Diabetes Hype... More >>rtension Dyslipidemia Cardiovascular Disease Less << Not Applicable Recruiting June 2020 United States, Louisiana ... More >> Tulane University Recruiting New Orleans, Louisiana, United States, 70112 Contact: Jiang He    504-988-5165    jhe@tulane.edu    China, Fujian Xiamen Diabetes Institute, Xiamen University Recruiting Xiamen, Fujian, China, 361003 Contact: Xuejun Li, MD, PhD    +86-592-2137710    Xmlixuejun@163.com    Principal Investigator: Xuejun Li, MD Less <<
NCT02852980 - Active, not recruiting June 2017 France ... More >> Rene Dubos Hospital Pontoise, Val d'Oise, France, 95303 Less <<
NCT03748030 - Not yet recruiting December 31, 2021 Canada, Ontario ... More >> Lawson Health Research Institute London, Ontario, Canada, N6C 2R5 Less <<
NCT02872974 - Recruiting August 2020 Switzerland ... More >> Lausanne University Hospital Recruiting Lausanne, Vaud, Switzerland, 1005 Contact: Nicole Sekarski, Prof       nicole.sekarski@chuv.ch    Contact: Sandrine Estoppey       Sandrine.Estoppey@chuv.ch    Principal Investigator: Nicole Sekarski, Prof          Sub-Investigator: Yvan Mivelaz, MD          Sub-Investigator: Stefano Di Bernardo, MD          Sub-Investigator: Yvan Vial, MD          Sub-Investigator: Pascal Bovet, Prof          Sub-Investigator: Umberto Simeoni, Prof          Sub-Investigator: Arnaud Chiolero, MD PhD Less <<
NCT02839044 Arterial Calcification ... More >> Diabetes Mellitus Type 2 Less << Not Applicable Active, not recruiting December 2018 Netherlands ... More >> UMC Utrecht Utrecht, Netherlands Less <<
NCT02905487 - Recruiting June 2019 France ... More >> Centre Universitaire de La Réunion Recruiting Saint Pierre, France, 97448 Contact: Olivier Maillard, PharmD    +262262359492    olivier.maillard@chu-reunion.fr Less <<
NCT02916667 GDM Not Applicable Unknown December 2018 -
NCT01899755 Psoriasis Phase 1 Completed - United Kingdom ... More >> GSK Investigational Site London, United Kingdom, NW10 7EW Less <<
NCT01825798 - Completed - -
NCT02968628 - Recruiting January 2019 United States, New York ... More >> University of Rochester Medical Center Recruiting Rochester, New York, United States, 14642 Contact: Laura Price Less <<
NCT02001805 - Unknown December 2013 Denmark ... More >> Center of Inflammation and Metabolism, Rigshospitalet Recruiting Copenhagen, Denmark, 2100 Principal Investigator: Matthew Laye, Post Doc          Sub-Investigator: Louise S Hansen, Cand Scient          Sub-Investigator: Mille B Nielsen, Stud. Med Less <<
NCT01825798 Overweight Au... More >>tism Spectrum Disorder Less << Phase 3 Completed - United States, Ohio ... More >> Ohio State University/Nationwide Children's Hospital Columbus, Ohio, United States, 43210 United States, Pennsylvania University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States, 15203 United States, Tennessee Vanderbilt University Nashville, Tennessee, United States, 37212 Canada, Ontario Holland Bloorview Kids Rehabilitation Hospital Toronto, Ontario, Canada, M4G 1R8 Less <<
NCT03226197 Out-Of-Hospital Cardiac Arrest Not Applicable Recruiting January 2019 United Kingdom ... More >> Barts Heart Centre Recruiting London, United Kingdom Contact: Ajay Jain       Ajay.jain@bartshealth.nhs.uk Less <<
NCT02977442 Insulin Resistance, Diabetes Not Applicable Recruiting February 2022 United States, Louisiana ... More >> Pennington Biomedical Research Center Recruiting Baton Rouge, Louisiana, United States, 70808 Contact: Christopher Axelrod    225-763-3171    Christopher.Axelrod@pbrc.edu    Contact: John Kirwan       John.Kirwan@pbrc.edu Less <<
NCT03746769 Diabetes Mellitus, Type 1 Phase 1 Phase 2 Not yet recruiting December 2023 United States, California ... More >> City of Hope Medical Center Not yet recruiting Duarte, California, United States, 91010 Principal Investigator: Fouad Kandeel, MD, PhD Less <<
NCT02243956 Cognitive Performance ... More >> Mood Cardiometabolic Risk Markers Less << Not Applicable Completed - Sweden ... More >> Lund Univercity, Medicon village, Functional Food Science Centre Lund, Sweden, 223 81 Less <<
NCT00963547 - Terminated - -
NCT03037593 Gestational Diabetes Phase 1 Phase 2 Recruiting June 2020 United States, Minnesota ... More >> University of Minnesota Medical Center Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Samantha Hoffman, MD    612-626-3111    kehoe018@umn.edu    Sub-Investigator: Laura Hanson, MD          Sub-Investigator: Sarah Westberg, PharmD Less <<
NCT01026402 Advanced Solid Malignancies Phase 1 Completed - United Kingdom ... More >> Research Site Manchester, United Kingdom Research Site Sutton, United Kingdom Less <<
NCT00963547 Advanced Solid Tumors ... More >> Breast Cancer Less << Phase 1 Terminated - -
NCT03060538 Diabetes Mellitus, Type 2 ... More >> Non-Alcoholic Fatty Liver Disease Less << Phase 1 Recruiting June 7, 2019 United States, Alabama ... More >> Pinnacle Research Group Cullman Not yet recruiting Anniston, Alabama, United States, 36207 Pinnacle Research Group; Llc, Central Recruiting Anniston, Alabama, United States, 36207 United States, California Southern California Research Center, Inc. Recruiting Coronado, California, United States, 92118 National Research Inst. Terminated Los Angeles, California, United States, 90057 Northern California Research Terminated Sacramento, California, United States, 95821 Stanford Health Care Recruiting Stanford, California, United States, 94305 Diabetes Research Center Recruiting Tustin, California, United States, 92780 United States, Florida MD Clinical Recruiting Hallandale Beach, Florida, United States, 33009 Premier Research Associate, Inc Recruiting Miami, Florida, United States, 33165 United States, Georgia Agile Clinical Research Trials Recruiting Atlanta, Georgia, United States, 30328 United States, New Jersey Hassman Research Institute Recruiting Berlin, New Jersey, United States, 08009 United States, New York Diabetes Endocrinology Center of WNY Terminated Buffalo, New York, United States, 14221 United States, North Carolina Carolina Research Center at Jones Family Practice Recruiting Shelby, North Carolina, United States, 28150 United States, Tennessee New Orleans Center for Clinical Research Recruiting Knoxville, Tennessee, United States, 37920 United States, Texas Dallas Diabetes & Endocrine Center Recruiting Dallas, Texas, United States, 75230 Northeast Clinical Research of San Antonio LLC Recruiting San Antonio, Texas, United States, 78249 Consano Clinical Research Recruiting Shavano Park, Texas, United States, 78231 Canada, Quebec inVentiv Health Clinical Recruiting Montreal, Quebec, Canada, H3X 2H9 Less <<
NCT02495584 25-hydroxyvitamin D Concentrat... More >>ion (Vitamin D Status) Less << Not Applicable Completed - United Kingdom ... More >> Human Intervention Studies Unit Coleraine, United Kingdom, BT52 1SA Less <<
NCT03052400 Type 2 Diabetes Mellitus ... More >> Insulin Resistance Less << Phase 2 Recruiting May 2020 United States, California ... More >> Charles Drew University of Medicine and Science Recruiting Los Angeles, California, United States, 90059 Contact: Stanley H Hsia, MD    323-357-3633    stanleyhsia@cdrewu.edu    Principal Investigator: Stanley Hsia, MD Less <<
NCT03071692 Type2 Diabetes ... More >> Dyslipidemia Less << Phase 3 Recruiting May 2022 -
NCT03127696 Type2 Diabetes ... More >> Type 2 Diabetes Mellitus Obese Less << Not Applicable Recruiting September 30, 2020 Hong Kong ... More >> The Chinese University of Hong Kong Recruiting Sha Tin, Hong Kong, 000000 Contact: Siew Chien Ng, PhD    35053996    siewchienng@cuhk.edu.hk Less <<
NCT03205865 - Active, not recruiting December 2020 -
NCT03008824 - Unknown June 2018 United Kingdom ... More >> University of Warwick Recruiting Coventry, United Kingdom, CV47AL Contact: Ponnusamy Saravanan, FRCP PhD    00442476865329    p.saravanan@warwick.ac.uk    Contact: Amitha Gopinath, MBA    00442476153592    amitha.gopinath@geh.nhs.uk    Principal Investigator: Ponnusamy Saravanan, FRCP PhD          Sub-Investigator: Nigel Stallard, PhD Less <<
NCT00456521 Obesity Overw... More >>eight Less << Phase 3 Completed - United States, California ... More >> University of California, San Diego: Dept of Family & Preventive Medicine La Jolla, California, United States, 92093 United States, Colorado Center for Human Nutrition, University of Colorado Health Services Center Denver, Colorado, United States, 80220 United States, Florida Univ. of Florida, College of Public Health, and Health Professions Gainesville, Florida, United States, 32611 United States, Missouri Washington Univ. Center for Human Nutrition St. Louis, Missouri, United States, 63110 United States, New York New York Obesity Research Center, St. Luke's-Roosevelt Hospital Center New York, New York, United States, 10025 United States, Pennsylvania Center for Weight and Eating Disorders, School of Med., University of Penn. Philadelphia, Pennsylvania, United States, 19104 Center for Obesity Research and Education, Temple University Philadelphia, Pennsylvania, United States, 19140 United States, South Carolina Medical University of S. Carolina Weight Management Center Charleston, South Carolina, United States, 29425 United States, Texas Behavioral Medicine Research Center Houston, Texas, United States, 77030 Less <<
NCT01026402 - Completed - -
NCT03182296 Gestational Diabetes Not Applicable Recruiting May 1, 2019 Netherlands ... More >> Radboudumc Recruiting Nijmegen, Gelderland, Netherlands, 6500HB Contact: Marti Boss, Msc    +312436 ext 67243    marti.boss@radboudumc.nl    Contact: Martin Gotthardt, Prof.    +312436 ext 55229    martin.gotthardt@radboudumc.nl Less <<
NCT03235362 Dyslipidemia ... More >>Type 2 Diabetes Mellitus Less << Phase 1 Completed - Korea, Republic of ... More >> Chonbuk National University Hospital Jeonju, Korea, Republic of Less <<
NCT00456521 - Completed - -
NCT03193125 Diabetes Mellitus, Type 2 ... More >> Insulin Resistance Obesity Less << Not Applicable Recruiting June 4, 2018 United States, Louisiana ... More >> Pennington Biomedical Research Center Recruiting Baton Rouge, Louisiana, United States, 70808 Contact: Robert Leonhard    225-763-0948    Robert.Leonhard@pbrc.edu Less <<
NCT03196154 - Completed - Malaysia ... More >> Clinical Research Centre, Sarawak General Hospital Kuching, Sarawak, Malaysia, 93586 Less <<
NCT03240874 Diabetes Mellitus in Pregnancy Not Applicable Recruiting June 2019 United States, Illinois ... More >> Northwestern Memorial Hospital Recruiting Chicago, Illinois, United States, 60611 Contact: Lynn M Yee, MD, MPH    312-472-4685    lynn.yee@northwestern.edu Less <<
NCT03258281 Diabetes Mellitus, Type 2 ... More >> Dyslipidemia Associated With Type II Diabetes Mellitus Percutaneous Coronary Intervention Less << Early Phase 1 Recruiting December 1, 2019 United States, Virginia ... More >> Inova Fairfax Hospital Recruiting Falls Church, Virginia, United States, 22042 Contact: Kevin Bliden, BS/MBA    703-776-7702    kevin.bliden@inova.org Less <<
NCT03257449 - Active, not recruiting November 2017 Canada, Ontario ... More >> The Toronto 3D Knowledge Synthesis and Clinical Trials Unit, Clinical Nutrition and Risk Factor Modification Centre Toronto, Ontario, Canada, M5C 2T2 Less <<
NCT03240289 Gestational Diabetes ... More >> Pregnancy in Diabetics Less << Not Applicable Completed - -
NCT03258840 Diabetes Mellitus Type II Not Applicable Completed - Iran, Islamic Republic of ... More >> Tehran University of Medical Sciences (TUMS), School of Nutritional Sciences and Dietetics, Department of Cellular and Molecular Nutrition Tehran, Iran, Islamic Republic of, 1471613151 Less <<
NCT03259984 - Recruiting August 1, 2018 United States, Arizona ... More >> University of Arizona Recruiting Tucson, Arizona, United States, 85724 Contact: Maria Gordon    520-626-5472    mgordon@email.arizona.edu    Principal Investigator: Dawn K Coletta, Ph.D. Less <<
NCT03250533 Ulcer Diabete... More >>s Mellitus Less << Not Applicable Not yet recruiting June 30, 2021 Brazil ... More >> University of Sao Paulo Ribeirao Preto, Sao Paulo, Brazil, 14049-900 Less <<
NCT03283657 PreDiabetes D... More >>iabetes Mellitus Diabetes Mellitus, Type 2 Body Weight Body Weight Changes Less << Not Applicable Enrolling by invitation March 31, 2019 United States, Illinois ... More >> Northwestern University Chicago, Illinois, United States, 60611 Less <<
NCT03289338 Charcot Arthropathy ... More >> Diabetes Complications Less << Phase 2 Phase 3 Recruiting June 1, 2018 India ... More >> Department of Endocrinology, PGIMER Recruiting Chandigarh, India, 160012 Contact: Anil Bhansali, DM    01722756585    ashuendo@gmail.com    Contact: Ashu Rastogi, DM    01722756585    ashuendo@gmail.com    Principal Investigator: Ashu Rastogi, MD, DM Less <<
NCT03313024 - Recruiting October 2027 Germany ... More >> Experimental and Clinical Research Center (ECRC) Recruiting Berlin, Germany, 13125 Contact: Florian Herse, PhD    +49 30 450 540 434    florian.herse@charite.de    Principal Investigator: Florian Herse, PhD Less <<
NCT03323294 - Recruiting October 2019 United States, Arkansas ... More >> Arkansas Children's Hospital Recruiting Little Rock, Arkansas, United States, 72202 Contact: Leanna Delhey, BS, MPH    501-364-4519    delheylm@archildrens.org    Principal Investigator: Eugenia Carvalho, PhD          Sub-Investigator: Shannon Rose, PhD          Sub-Investigator: Elisabet Borsheim, PhD          Sub-Investigator: Jon Oden, MD          Sub-Investigator: Shipra Bansal, MD          Sub-Investigator: Emir Tas, MD          Sub-Investigator: Stepan Melnyk, MD, PhD          Sub-Investigator: Judith Weber, PhD, RD Less <<
NCT03281083 Non-Alcoholic Fatty Liver Dise... More >>ase Diabetes Mellitus, Type 2 Less << Phase 2 Terminated(Difficult recruitme... More >>nt and end of funding.) Less << - -
NCT03320694 Gestational Diabetes Mellitus ... More >>in Pregnancy Less << Phase 3 Completed - Pakistan ... More >> Services Institute of Medical Sciences Lahore, Punjab, Pakistan Less <<
NCT03213288 Hyperlipidemia Not Applicable Active, not recruiting December 2019 United Kingdom ... More >> Quadram Institute Bioscience Norwich, United Kingdom, NR4 7UA Less <<
NCT01725139 Idiopathic Pulmonary Fibrosis Phase 1 Completed - United Kingdom ... More >> GSK Investigational Site London, United Kingdom, SW3 6NP Less <<
NCT03360058 Weight Management ... More >> Diabetes Mellitus, Type 2 Less << Not Applicable Completed - United Kingdom ... More >> Glasgow Cardiovascular Research Centre Glasgow, Scotland, United Kingdom, G12 8TA Less <<
NCT02881658 Dyslipidemia Not Applicable Completed - Hong Kong ... More >> Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam Hong Kong, Hong Kong Less <<
NCT03406910 - Completed - United States, California ... More >> Loma Linda University Loma Linda, California, United States, 92350 Less <<
NCT03330054 - Not yet recruiting June 1, 2018 -
NCT03430141 Chronic Disease ... More >> Cancer Cardiovascular Diseases Diabetes Mellitus Lifestyle-related Condition Mental Health Wellness 1 Sleep Nutritional and Metabolic Disease Nutrition Related Cancer Nutritional Imbalance Thyroid Less << Not Applicable Recruiting December 31, 2030 United States, Arizona ... More >> Northern Arizona University Recruiting Flagstaff, Arizona, United States, 86011 Contact: Jay T Sutliffe, PhD,RD    928-523-7450    jay.sutliffe@nau.edu    Contact: Wendy S Wetzel, RN,MSN,FNP    928-523-6954    nwhs@nau.edu    Principal Investigator: Jay T Sutliffe, PhD, RD          Principal Investigator: Wendy S Wetzel, RN,MSN, FNP          Sub-Investigator: Julia C Scheid, BS, CHES          Sub-Investigator: Joel H Fuhrman, MD Less <<
NCT02881658 - Completed - -
NCT00532779 - Completed - -
NCT03456271 - Recruiting October 31, 2021 China, Guangdong ... More >> Baiyun Community Taihe Town Recruiting Guangzhou, Guangdong, China, 510000 Contact: Li Yang, MD    +86 13924207196    yangli19762009@163.com    Guangzhou No.12 People's Hospital Recruiting Guangzhou, Guangdong, China, 510000 Contact: Li Yang, MD    +86 13924207196    yangli19762009@163.com    Haizhu Changgang Community Recruiting Guangzhou, Guangdong, China, 510000 Contact: Li Yang, MD    +86 13924207196    yangli19762009@163.com    Tianhe Community Recruiting Guangzhou, Guangdong, China, 510000 Contact: Li Yang, MD    +86 13924207196    yangli19762009@163.com    Zhujiang Hospital Recruiting Guangzhou, Guangdong, China, 510000 Contact: Li Yang, MD    +86 13924207196    yangli19762009@163.com Less <<
NCT03437109 - Recruiting August 2018 Russian Federation ... More >> ENC Not yet recruiting Moscow, Russian Federation, 117036 Contact: Marina Shestakova, academician          Central Clinical Hospital Recruiting Moscow, Russian Federation, 121359 Contact: Daria Ladygina, phd Less <<
NCT03492580 - Completed - United States, New Jersey ... More >> Janssen Investigative Site Titusville, New Jersey, United States, 08560 Less <<
NCT00532779 Obesity Overw... More >>eight Less << Phase 3 Completed - -
NCT03437902 Type 2 Diabetes Mellitus Phase 2 Phase 3 Completed - Egypt ... More >> Ain Shams University Cairo, Egypt Less <<
NCT03741660 Type2 Diabetes ... More >> Coronary Heart Disease Less << Phase 2 Completed - -
NCT03403556 Atherosclerotic Cardiovascular... More >> Disease Type 2 Diabetes Less << Phase 4 Not yet recruiting February 2019 Korea, Republic of ... More >> Daegu Catholic University Medical Center Not yet recruiting Daegu, Korea, Republic of Keimyung University Dongsan Medical Center Not yet recruiting Daegu, Korea, Republic of Kyungpook National University Hospital Not yet recruiting Daegu, Korea, Republic of Yeungnam University Medical Center Not yet recruiting Daegu, Korea, Republic of The Catholic University of Korea, St. Vincent's Hospital Not yet recruiting Gyeonggi-do, Korea, Republic of Korea University Anam Hospital Not yet recruiting Seoul, Korea, Republic of Less <<
NCT02760303 Type 1 Diabetes Not Applicable Completed - United States, Michigan ... More >> Wayne State University School of Medicine Detroit, Michigan, United States, 48202 Less <<
NCT03597412 Atherosclerotic Cardiovascular... More >> Disease Type 2 Diabetes Mellitus Less << Phase 4 Not yet recruiting March 30, 2020 Korea, Republic of ... More >> Kangbuk Samsung Hospital Not yet recruiting Seoul, Korea, Republic of Less <<
NCT02969577 Prostate Cancer Not Applicable Recruiting July 2020 United States, California ... More >> University of California, Los Angeles Completed Los Angeles, California, United States, 90095 United States, Kansas University of Kansas Medical Center Recruiting Kansas City, Kansas, United States, 66160 Less <<
NCT02516293 Chagas Disease ... More >> Chagas Cardiomyopathy Less << Phase 2 Phase 3 Completed - Brazil ... More >> Evandro Chagas National Institute of Infectious Disease Rio de Janeiro, RJ, Brazil, 21040-360 Less <<
NCT02772640 Hypercholesterolemia Phase 4 Unknown December 2016 Poland ... More >> Cardiology Department, Dr. A. Jurasz University Hospital Recruiting Bydgoszcz, Kujawsko-Pomorskie, Poland, 85-094 Contact: Karolina Obońska, MD, PhD    +48 52 5854023    kalaobonska@op.pl Less <<
NCT02449590 Blood Pressure ... More >> Coagulation Delay Less << Not Applicable Completed - Denmark ... More >> Dep. Human Nutrition, LIFE, University of Copenhagen Frederiksberg C, Denmark, 1958 Department of Nutrition, Exercise and Sports, University of Copenhagen Frederiksberg C, Denmark, 1958 Less <<
NCT01837433 Subacute Thyroiditis Phase 4 Completed - China, Chongqing ... More >> The Second Affiliated Hospital, Third Military Medical University Chongqing, Chongqing, China, 400037 Less <<
NCT03108963 PCOS Phase 2 Completed - Egypt ... More >> Zagazig University Zagazig, Egypt Less <<
NCT00099697 Aging Obesity... More >> Insulin Resistance Less << Not Applicable Completed - United States, Missouri ... More >> Washington University School of Medicine St. Louis, Missouri, United States, 63110 Less <<
NCT01051674 Obesity Type ... More >>2 Diabetes Less << Phase 4 Completed - United States, California ... More >> Loma Linda U Medical Center Diabetes Treatment Center Loma Linda, California, United States, 92354 Less <<
NCT02256189 Type 2 Diabetes Phase 4 Completed - Sweden ... More >> Skane University Hospital Malmö Malmö, Sweden, 20502 Less <<
NCT01106885 Diabetes Depr... More >>ession Less << Not Applicable Completed - United States, Michigan ... More >> VA Ann Arbor Healthcare System Ann Arbor, Michigan, United States, 48105 University of Michigan Health System Ann Arbor, Michigan, United States, 48109 Genesys Regional Medical Center Grand Blanc, Michigan, United States, 48439 Less <<
NCT00405197 Insulin Resistance ... More >> Metabolic Syndrome X Dyslipidemia Hypertension Overweight Less << Not Applicable Completed - Netherlands ... More >> Hospital Gelderse Vallei Ede, Netherlands, 6710 HN Wageningen University, Division of Human Nutrition Wageningen, Netherlands Less <<
NCT01144091 Contrast Induced Nephropathy ... More >> Diabetes Mellitus Less << Not Applicable Withdrawn December 2013 -
NCT02277509 Prediabetes Not Applicable Suspended(Completed pilot and ... More >>larger scale trial requires additional funding.) Less << December 2019 United States, New York ... More >> Albert Einstein College of Medicine Bronx, New York, United States, 10461 Less <<
NCT01102530 - Completed - United States, Massachusetts ... More >> Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Less <<
NCT01158131 Gestational Diabetes Mellitus Phase 2 Completed - United States, Massachusetts ... More >> Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Less <<
NCT03528473 Breast Neoplasms ... More >> Exercise Exercise Therapy Insulin Resistance Oxidative Stress Microcirculation Quality of Life Atherosclerosis Less << Not Applicable Not yet recruiting June 21, 2020 -
NCT01928407 HIV-1 Infection ... More >> Immunosuppression-related Infectious Disease Less << Phase 4 Completed - France ... More >> Hopital Zobda Quitman Fort De France, Martinique, France, 97261 Centre Hospitalier D'Argenteuil Argenteuil, France, 95107 Hopital Saint-Jacques Besancon, France, 25000 Hopital Avicenne Bobigny, France, 93000 Hopital Jean Verdier Bondy, France, 93143 Hopital Saint-Andre Bordeaux, France, 33075 Chu Cote de Nacre Caen, France, 14033 Hopital Louis Mourier Colombes, France, 92700 Hopital Le Bocage Dijon, France, 21034 Hopital Raymond Poincare Garches, France, 92380 C.H.D de Vendee La Roche Sur Yon, France, 85925 Hopital Dupuytren Limoges, France, 87000 Hopital Sainte-Marguerite Marseille, France, 13274 Centre Hospitalier de Melun Melun, France, 77011 Hopital L'Archet Nice, France, 06202 Hopital Lariboisiere Paris, France, 75010 Hopital Saint Antoine Paris, France, 75012 Hopital Pitie-Salpetriere Paris, France, 75013 Hopital Necker Paris, France, 75015 Hopital Bichat Paris, France, 75018 Hopital Tenon Paris, France, 75020 Hopital Pitie-Salpetriere Paris, France, 75651 Hopital Cochin Paris, France, 75674 Hopital Europeen Georges Pompidou Paris, France, 75908 Hopital Saint-Jean Roussillon Perpignan, France, 66046 Hopital Rene Dubos Pontoise, France, 95303 C.H.R.A Pringy, France, 74374 Hopital Civil Strasbourg, France, 67000 Hopital Gustave Dron Tourcoing, France, 59208 Hopital Bretonneau Tours, France, 37044 Less <<
NCT01171456 Gestational Diabetes Mellitus Not Applicable Withdrawn(Insufficient funding... More >> for enrollment of patients. The invesitgators realized the study could not be performed.) Less << - United States, Utah ... More >> Intermountain Medical Center Murray, Utah, United States, 84107 Less <<
NCT01176279 Critical Illness ... More >> Hyperglycemia Less << Phase 4 Unknown December 2011 Spain ... More >> Vic Hospital Consortium - Consorci Hospitalari de Vic Recruiting Vic, Catalonia, Spain, 08243 Sub-Investigator: Rosa-Maria Catalan-Ibars, MD          Sub-Investigator: Cesar Del-Llano          Sub-Investigator: Dolors Almirall-Solsona Less <<
NCT03036488 Triple Negative Breast Neoplas... More >>ms Less << Phase 3 Active, not recruiting March 14, 2025 -
NCT01734538 Effect of Omega-3 Fatty Acid S... More >>upplementation Physical Fitness Less << Not Applicable Unknown November 2013 Canada, Ontario ... More >> The University of Guelph Not yet recruiting Guelph, Ontario, Canada, N1G2W1 Less <<
NCT01641367 HIV-1 Infection Phase 4 Active, not recruiting December 2018 Brazil ... More >> Hospital Nossa Senhora da Conceicao CRS (12201) Porto Alegre, RS, Brazil, 9043010 Instituto de Pesquisa Clinica Evandro Chagas (12101) Rio de Janeiro, Brazil, 21045 Haiti Les Centres GHESKIO CRS (30022) Port-au-Prince, Bicentaire, Haiti, HT-6110 GHESKIO Institute of Infectious Diseases and Reproductive Health (GHESKIO - IMIS) CRS Port Au Prince, Haiti India BJ Medical College CRS (31441) Pune, Maharashtra, India, 411001 Chennai Antiviral Research and Treatment (CART) CRS (11701) Chennai, Taramani, India, 600113 Kenya AMPATH at Moi Univ. Teaching Hosp. Eldoret CRS (12601) Eldoret, Kenya, 30100 Kenya Medical Research Institute/Center for Disease Control (KEMRI/CDC) CRS (31460) Kisumu, Kenya, 40100 Malawi Malawi CRS (12001) Lilongwe, Malawi Peru San Miguel CRS (11302) San Miguel, Lima, Peru Barranco CRS (11301) Lima, Peru, 18 PE South Africa University of the Witwatersrand Helen Joseph (WITS HJH) CRS (11101) Johannesburg, Gauteng, South Africa, 2193 Family Clinical Research Unit (FAM-CUR) CRS (8950) Cape Town, West Cape, South Africa, 7505 Durban Adult HIV CRS (11201) Durban, South Africa, 4013 SF Soweto ACTG CRS (12301) Johannesburg, South Africa Thailand 31802 Thai Red Cross AIDS Research Centre (TRC-ARC) CRS Bangkok, Patumwan, Thailand, 10330 31784 Chiang Mai University HIV Treatment CRS Chiang Mai, Thailand, 50200 Uganda JCRC CRS Kampala, Uganda Zimbabwe UZ-Parirenyatwa CRS (30313) Harare, Zimbabwe Less <<
NCT02293135 Type 2 Diabetes Not Applicable Unknown June 2015 France ... More >> Hôpital Jean Verdier, Service d'Endocrinologie Diabétologie Nutrition Recruiting Bondy, France, 93143 Less <<
NCT02105987 Infection, Human Immunodeficie... More >>ncy Virus Less << Phase 3 Completed - -
NCT02316054 - Completed - France ... More >> university Hospital Grenoble, France, 38000 Less <<
NCT02105987 - Completed - -
NCT01208701 Nephropathy C... More >>ardiovascular Diseases Diabetes Mellitus Less << Phase 2 Completed - Denmark ... More >> Medicinsk Forskning, Regionshospitalet Holstebro Holstebro, Denmark, 7500 Less <<
NCT00401973 - Completed - -
NCT00401973 Schizophrenia ... More >> Schizoaffective Disorders Less << Phase 3 Completed - United States, California ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. National City, California, United States, 91950 United States, Ohio For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Canton, Ohio, United States, 44708 United States, Tennessee For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Johnson City, Tennessee, United States, 37614 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Memphis, Tennessee, United States, 38105 United States, Texas For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Desoto, Texas, United States, 75115 Brazil For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Rio De Janeiro, Brazil, 21020-130 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Salvador, Brazil, 40301500 Israel For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Beer Yaacov, Israel, 70350 Korea, Republic of For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Seoul, Korea, Republic of, 143-711 Mexico For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mexico City, Mexico, 14050 Puerto Rico For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bayamon, Puerto Rico, 00961 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ponce, Puerto Rico, 00717 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. San Juan, Puerto Rico, 00907 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. San Juan, Puerto Rico Russian Federation For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Moscow, Russian Federation, 117603 Less <<
NCT02386930 Type 2 Diabetes Not Applicable Completed - United Arab Emirates ... More >> Rashid Centre for Diabetes and Research Ajman, United Arab Emirates Less <<
NCT02384109 Prediabetic State Not Applicable Active, not recruiting June 2019 United States, California ... More >> Toluca Lake Health Center Burbank, California, United States, 91505 100 Medical Plaza Primary Care Suites 455 & 490 Los Angeles, California, United States, 90024 Internal Medicine Women's Health Clinic Suites 250 & 290 Los Angeles, California, United States, 90024 UCLA Internal Medicine Family Westwood Suite 465 Los Angeles, California, United States, 90024 UCLA Internal Medicine Geriatrics Suite 365 & 420 Los Angeles, California, United States, 90024 CPN Brentwood Los Angeles, California, United States, 90049 CPN West Washington Internal Medicine Los Angeles, California, United States, 90066 Pacific Palisades Pacific Palisades, California, United States, 90272 12th Street Clinic Santa Monica, California, United States, 90401 Wilshire Office Santa Monica, California, United States, 90401 CPN Santa Monica 15th Street Family Medicine Practice Santa Monica, California, United States, 90404 CPN/Santa Monica Parkside Santa Monica, California, United States, 90404 Santa Moica Bay Physicians/20th Street 10th Floor Santa Monica, California, United States, 90404 Santa Monica Bay Physicians Plaza Santa Monica, California, United States, 90404 Santa Monica Bay Physicians/20th Street 3rd Floor Santa Monica, California, United States, 90404 Santa Monica Internal Medicine Santa Monica, California, United States, 90404 UCLA Family Health Clinic Santa Monica, California, United States, 90404 Santa Moica Bay Physicians Ocean Park Santa Monica, California, United States, 90405 Jack H. Skirball Health Center Woodland Hills, California, United States, 91364 CPN Woodland Hills Practice Woodland Hills, California, United States, 91367 Less <<
NCT01243138 - Completed - -
NCT01255384 - Unknown - Israel ... More >> Hadassah Medical Organization, Jerusalem, Israel Not yet recruiting Jerusalem, Israel Contact: Arik Tzukert, DMD    00 972 2 6776095    arik@hadassah.org.il    Contact: Hadas Lemberg, PhD    00 972 2 6777572    lhadas@hadassah.org.il    Principal Investigator: Asher Ornoy, MD          Principal Investigator: Zivanit Ergaz shaltiel, MD          Sub-Investigator: Drorit Hochner, MD          Sub-Investigator: Simcha Yagel, MD          Sub-Investigator: Uri Elchalal, MD Less <<
NCT01641367 - Active, not recruiting - -
NCT01215331 Gestational Diabetes Mellitus Phase 3 Completed - Canada, Quebec ... More >> Centre de recherche clinique du CHUS Sherbrooke, Quebec, Canada, J1H 5N4 Less <<
NCT02443922 Type 2 Diabetes Not Applicable Unknown December 2015 -
NCT02406443 Type 2 Diabetes Phase 4 Completed - Canada, Ontario ... More >> University Health Network - Division of Nephrology Toronto, Ontario, Canada, M5G 2N2 Less <<
NCT02406443 - Completed - -
NCT02471794 Type II Diabetes Not Applicable Completed - United States, North Carolina ... More >> Duke Family Medicine Center Durham, North Carolina, United States, 27705 Less <<
NCT00460746 HIV Phase 3 Completed - United States, California ... More >> Los Angeles, California, United States Less <<
NCT01909245 Type 1 Diabetes Mellitus Phase 2 Recruiting July 2021 United States, California ... More >> City of Hope Medical Center Recruiting Duarte, California, United States, 91010 Contact: Islet Cell Transplant Program    866-444-7538    islets@coh.org    Principal Investigator: Fouad Kandeel, MD, PhD Less <<
NCT01302639 Obesity, Insulin Sensitivity, ... More >>Type 2 Diabetes Mellitus Less << Not Applicable Completed - Netherlands ... More >> Maastricht University Maastricht, Netherlands, 6200 MD Less <<
NCT01256892 Gestational Diabetes Mellitus Not Applicable Completed - -
NCT00307164 HIV Infections ... More >> Lipoatrophy Less << Phase 2 Phase 3 Completed - -
NCT00702650 Hypogonadism Phase 3 Completed - -
NCT00702650 - Completed - -
NCT00460746 - Completed - -
NCT02405507 Healthy Volunteers Phase 2 Completed - Portugal ... More >> PtCRIN Lisbon, Portugal CINTESIS - Faculty of Medicine of the University of Porto Porto, Portugal, 4200-450 Less <<
NCT01323075 - Completed - France ... More >> Centre Hospitalier Universitaire de Nîmes Nîmes Cedex 09, Gard, France, 30029 Hôpital Lapeyronnie CHU de Montpellier Montpellier Cedex 05, France, 34295 Hôpital Privé Claude Galien Quincy-sous-Sénart, France, 91480 Less <<
NCT01344278 Gestational Diabetes ... More >> Obesity Less << Not Applicable Completed - United States, California ... More >> Division of Research Northern California Oakland, California, United States, 94612 Less <<
NCT01351675 Renal Insufficiency, Chronic ... More >> Diabetes Mellitus, Type 2 Less << Phase 3 Terminated(IDMC recommendation... More >> for safety concerns) Less << - -
NCT01358994 - Completed - Sweden ... More >> Dept of Nephrology Malmö, Sweden, SE 20502 Less <<
NCT01336777 - Unknown August 2014 United States, California ... More >> Stanford University Stanford, California, United States, 94305 Less <<
NCT03094936 Obesity Not Applicable Recruiting October 2018 Brazil ... More >> Hospital das Clinicas da Faculdade de Medicina da USP Recruiting Sao Paulo, Brazil, 05403-000 Contact: Vitor O Brunaldi, MD    1126616467    vitor.brunaldi@usp.br    Contact: Eduardo GH de Moura, PhD    1126616467    eduardoghdemoura@gmail.com Less <<
NCT01399645 Nonalcoholic Fatty Liver Disea... More >>se Nonalcoholic Steatohepatitis Type 2 Diabetes Less << Phase 2 Completed - Canada, Quebec ... More >> Centre hospitalier de l'Université de Montréal Montréal, Quebec, Canada, H2W 1T7 Less <<
NCT02686177 Type 2 Diabetes Phase 4 Recruiting June 18, 2019 France ... More >> Nutrition department, pole ENDO - Assistance Publique Hôpitaux Marseille Recruiting Marseille, France, 13005 Contact: Anne DUTOUR, MD, PhD    33 4 91 38 29 63    anne.dutour@ap-hm.fr Less <<
NCT01425645 Diabetes Prevention Not Applicable Completed - Canada, Ontario ... More >> St Josephs Health Care London, Ontario, Canada, N6A 4V2 Less <<
NCT00307164 - Completed - -
NCT02772887 Type 2 Diabetes Not Applicable Recruiting December 2020 United States, Pennsylvania ... More >> Magee-Womens Hospital of UPMC Recruiting Pittsburgh, Pennsylvania, United States, 15213 Contact: Robert W Powers, PhD    412-641-6005    powersrw@upmc.edu    Sub-Investigator: Arun Jeyabalan, MD Less <<
NCT02612402 Diabetes Type 2 ... More >> Hematologic Malignancy Less << Not Applicable Unknown July 2017 Israel ... More >> Rambam Health Care Campus Recruiting Haifa, Israel Contact: Irit Hochberg, MD/PhD    +972-4-7772150    i_hochberg@rambam.health.gov.il Less <<
NCT02773095 Cardiovascular Disease ... More >> Diabetes Type II Breast Cancer Asthma Less << Not Applicable Active, not recruiting September 2019 -
NCT01418716 Diabetes Mellitus, Type 2 ... More >> Hypertension Dyslipidemias Cholesterol, LDL Comorbitdity Less << Not Applicable Completed - Canada, Quebec ... More >> Centre de santé et de services sociaux de Laval Laval, Quebec, Canada, H7M 3L9 Less <<
NCT02797314 Type 2 Diabetes Not Applicable Recruiting April 2019 France ... More >> Hôpital Edouard Herriot, Hospices Civisl de Lyon Recruiting Lyon, France, 69437 Contact: Julien WEGRZYN, MD          Principal Investigator: Julien WEGRZYN, MD          Hôpital Nord, CHU de Saint-Etienne Recruiting Saint-Etienne, France, 42055 Contact: Marie-Hélène LAFAGE-PROUST, MD          Principal Investigator: Marie-Hélène LAFAGE-PROUST, MD Less <<
NCT00296504 Infection, Human Immunodeficie... More >>ncy Virus Less << Phase 3 Completed - United States, California ... More >> GSK Investigational Site Fountain Valley, California, United States, 92708 GSK Investigational Site San Francisco, California, United States, 94115-1931 United States, Colorado GSK Investigational Site Denver, Colorado, United States, 80262 United States, Florida GSK Investigational Site Fort Lauderdale, Florida, United States, 33145 GSK Investigational Site Orlando, Florida, United States, 32804 GSK Investigational Site Orlando, Florida, United States, 32806 GSK Investigational Site Sarasota, Florida, United States, 34239 GSK Investigational Site Tampa, Florida, United States, 33614 United States, New York GSK Investigational Site Manhasset, New York, United States, 11030 United States, Texas GSK Investigational Site Galveston, Texas, United States, 77555-1188 Brazil GSK Investigational Site Campinas, São Paulo, Brazil, 13083970 Chile GSK Investigational Site Santiago, Región Metro De Santiago, Chile France GSK Investigational Site Le Kremlin Bicêtre Cedex, France, 94275 GSK Investigational Site Marseille, France, 13005 GSK Investigational Site Paris Cedex 10, France, 75475 GSK Investigational Site Paris Cedex 20, France, 75970 GSK Investigational Site Vandoeuvre Les Nancy Cedex, France, 54511 GSK Investigational Site Villejuif Cedex, France, 94805 Italy GSK Investigational Site Genova, Liguria, Italy, 16128 Portugal GSK Investigational Site Coimbra, Portugal, 3000-075 Spain GSK Investigational Site Badajoz, Spain, 6080 GSK Investigational Site Barcelona, Spain, 08036 United Kingdom GSK Investigational Site London, United Kingdom, NW3 2QG GSK Investigational Site London, United Kingdom, SE1 7EH Less <<
NCT02756117 Healthy Pre-d... More >>iabetic Less << Phase 1 Completed - -
NCT01551446 Renal Insufficiency, Chronic ... More >> Diabetes Mellitus, Type 2 Less << Phase 1 Withdrawn(IDMC recommendation ... More >>for safety concerns) Less << October 2013 -
NCT01549769 Renal Insufficiency, Chronic ... More >> Diabetes Mellitus, Type 2 Less << Phase 1 Terminated(IDMC recommendation... More >> for safety concerns) Less << - -
NCT01498614 Diabetes Mellitus ... More >> Depression Alexithymia Anxiety Less << Not Applicable Terminated(Investigator no lon... More >>ger at LU.) Less << - Sweden ... More >> Landstinget Kronoberg Vaxjo, Kronoberg, Sweden, s-35251 Less <<
NCT01574157 Chronic Renal Insufficiency ... More >> Diabetes Mellitus Less << Not Applicable Completed - United States, Utah ... More >> VA Salt Lake City Health Care System, Salt Lake City, UT Salt Lake City, Utah, United States, 84148 Less <<
NCT02921425 Prediabetic State Not Applicable Completed - United States, Florida ... More >> Miami VA Healthcare System, Miami, FL Miami, Florida, United States, 33125 Less <<
NCT02961192 Type II; Diabetes ... More >> Obesity Less << Not Applicable Enrolling by invitation June 2019 United States, Pennsylvania ... More >> University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT01580813 Type 2 Diabetes Not Applicable Recruiting December 2018 United States, Colorado ... More >> University of Colorado Anschutz Medical Campus Recruiting Aurora, Colorado, United States, 80045 Principal Investigator: Irene Schauer, MD, PhD Less <<
NCT01655186 Renal Insufficiency, Chronic ... More >> Diabetes Mellitus, Type 2 Less << Phase 2 Withdrawn(IDMC recommendation ... More >>for safety concerns) Less << October 2013 -
NCT03234738 Bacterial Infections Phase 1 Active, not recruiting February 28, 2019 United States, Texas ... More >> PPD Phase 1 Clinic Austin, Texas, United States, 78744 Less <<
NCT01706289 - Unknown May 2014 Taiwan ... More >> National Taiwan University Hospital Recruiting Yun Lin, Taiwan Contact: Ying-Chuen Lai    886-05-5323911 ext 5125    ying.chuen@msa.hinet.net    Principal Investigator: Ying-Chuen Lai Less <<
NCT02921425 - Completed - -
NCT00296504 - Completed - -
NCT02028624 Rheumatoid Arthritis Not Applicable Completed - Greece ... More >> Euroclinic Private Hopsital Athens, Greece, 11521 Laiko General Hospital Athens, Greece, 15773 Less <<
NCT01613937 Diabetes Not Applicable Completed - -
NCT02798003 - Unknown September 2018 Netherlands ... More >> Maastricht UMC Recruiting Maastricht, Limburg, Netherlands, 6200MD Contact: Karin Sanders, MD    0031433884597    k.sanders@maastrichtuniversity.nl Less <<
NCT01564550 - Completed - Denmark ... More >> Department of Endocrinology MEA, Aarhus Hospital Aarhus C, Denmark, 8000 Less <<
NCT03107884 Atrophy Insul... More >>in Resistance Less << Early Phase 1 Recruiting July 1, 2021 United States, Utah ... More >> University of Utah Recruiting Salt Lake City, Utah, United States, 84108 Contact: Amy Rogers    801-585-5961    amy.rogers@hsc.utah.edu Less <<
NCT01732705 Type 2 Diabetes Not Applicable Completed - Denmark ... More >> Xlab, Department of Biomedical Sciences, University of Copenhagen Copenhagen N, Denmark, 2200 Less <<
NCT01714986 Diabetes Mellitus ... More >> Depression Alexithymia Anxiety Less << Not Applicable Enrolling by invitation December 2024 -
NCT01726491 - Completed - United States, Arizona ... More >> Mayo Clinic in Arizona Scottsdale, Arizona, United States, 85259 Less <<
NCT03136289 - Completed - -
NCT01735123 Diabetes Mellitus, Type 1 Not Applicable Completed - Finland ... More >> Tampere University Hospital Tampere, Finland, 33521 Less <<
NCT01731431 Diabetes Gest... More >>ational Less << Phase 3 Completed - France ... More >> Marie-Victoire Senat Paris, France, 94270 Less <<
NCT01756105 Gestational Diabetes ... More >> Metformin Treatment Oxidative Stress Less << Phase 2 Terminated - France ... More >> Hôpitaux Civils de Colmar Colmar, France, 68024 CHU Dijon, Dijon, France, 21030 Centre hospitalier de Mulhouse Mulhouse, France, 68070 CHU de Reims Reims, France, 51092 Hôpitaux Universitaires de Strasbourg Strasbourg, France, 67091 Less <<
NCT01752842 Type II Diabetes Mellitus ... More >> Diabetes Complications Less << Not Applicable Completed - United States, Missouri ... More >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Less <<
NCT01754662 Type 2 Diabetes ... More >> Dietary Intervention Less << Not Applicable Completed - United Kingdom ... More >> Michael White Diabetes Centre Hull, North Humberside, United Kingdom, HU3 2RW Less <<
NCT01758016 - Unknown June 2017 Israel ... More >> Soroka Medical Center Recruiting Be'er Sheva`, Israel Contact: Ofer beharier, M.D    001972525398676    oferbeharie@gmail.com    Sub-Investigator: Ofer Beharie, M.D          Principal Investigator: Eyal Sheiner, M.D          Rambam Health Care Cmpus Recruiting Haifa, Israel Principal Investigator: Ron Beloosesky, M.D          Sub-Investigator: Nizzar KHATIB, M.D          Meir Hospital Recruiting Kfar Saba, Israel Contact: Tal Biron-Shental, M.D    011972528362331    Tal.Biron-Shental@clalit.org.il    Principal Investigator: Tal Biron-Shental, M/D Less <<
NCT01774942 Type 2 Diabetes Mellitus With ... More >>Periodontal Complication Inflammation Dental Implant Failed Less << Not Applicable Completed - Pakistan ... More >> Rahman & Rahman Dental Surgeons Lahore, Punjab, Pakistan Less <<
NCT03273738 - Not yet recruiting November 15, 2018 -
NCT03664583 Multiple Chronic Conditions ... More >> Diabetes Mellitus Less << Not Applicable Not yet recruiting March 1, 2022 -
NCT03200535 PreDiabetes O... More >>besity Less << Not Applicable Completed - United States, Colorado ... More >> Kaiser Permanente Coloado Denver, Colorado, United States, 80014 Less <<
NCT03355092 Type2 Diabetes ... More >> Obesity Less << Not Applicable Enrolling by invitation January 2019 United States, California ... More >> Kaiser Permanente South Bay Medical Center Harbor City, California, United States, 90710 Less <<
NCT03388229 - Completed - United Arab Emirates ... More >> Rashid Centre for Diabetes and Research Ajman, United Arab Emirates Less <<
NCT01904032 Diabetes Depr... More >>ession Quality of Life Less << Phase 2 Completed - United States, Illinois ... More >> Loyola University Medical Center Maywood, Illinois, United States, 60153 Less <<
NCT03297879 Type2 Diabetes Phase 4 Completed - -
NCT01910805 Diabetes Mellitus ... More >> Diabetes, Gestational Less << Not Applicable Completed - United States, Massachusetts ... More >> Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Less <<
NCT03426423 Smoking Cessation ... More >> Diabetes Type 2 Less << Not Applicable Recruiting December 31, 2020 Switzerland ... More >> Policlinique Médicale Universitaire Recruiting Lausanne, Vaud, Switzerland, 1011 Contact: Carole Clair, MD, MSc    +41 79 556 81 46    carole.clair@hospvd.ch    Contact: Priska Birrer, RN    + 41 79 556 18 23    Priska.birrer@hospvd.ch Less <<
NCT01873859 - Completed - -
NCT03441750 PreDiabetes Phase 4 Recruiting December 31, 2022 China, Beijing ... More >> Fuwai hospital Recruiting Beijing, Beijing, China, 100037 Contact: Qiuhong Gong Less <<
NCT03435328 Diabetes type2 ... More >> Hyposalivation Less << Not Applicable Recruiting May 2018 Egypt ... More >> Cairo University Hospitals Recruiting Giza, Cairo, Egypt, 11511 Contact: Hala MH Ezzeldeen, professor    02 01006626043    hm_2@yahoo.com Less <<
NCT01934660 - Recruiting July 15, 2029 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)    800-411-1222 ext TTY8664111010    prpl@cc.nih.gov Less <<
NCT03475069 Type2 Diabetes ... More >> Physical Activity Less << Not Applicable Completed - Turkey ... More >> Başar Öztürk Istanbul, Turkey Less <<
NCT03429088 Physical Activity ... More >> PreDiabetes Diabetes Less << Not Applicable Completed - -
NCT00017719 HIV Infections ... More >> Pregnancy Less << Phase 3 Completed - -
NCT01997424 Non-alcoholic Fatty Liver Dise... More >>ase (NAFLD) Less << Not Applicable Unknown December 2014 Germany ... More >> University Hospital Frankfurt Recruiting Frankfurt am Main, Hessen, Germany, 60590 Contact: Mireen Friedrich-Rust, MD Less <<
NCT01971125 - Completed - Italy ... More >> Casa di Cura Pineta del Carso Duino - Aurisina, Friuli - Venezia Giulia, Italy, 34011 A.O.- Univ. Ospedali Riuniti Trieste, Friuli - Venezia Giulia, Italy, 34100 Azienda Servizi Sanitari N°1 Triestina Trieste, Friuli - Venezia Giulia, Italy, 34100 Presidio Ospedaliero Sanremo, Liguria, Italy, 18038 Ospedali Riuniti Bergamo, Lombardia, Italy, 24100 Spedali Civili Brescia, Lombardia, Italy, 25100 Ospedale San Raffaele Milano, Lombardia, Italy, 20010 Ospedale San Paolo Milano, Lombardia, Italy, 20100 Istituto Clinico Humanitas Rozzano, Lombardia, Italy, 20089 IRCCS Policlinico Multimedica Sesto San Giovanni, Lombardia, Italy, 20099 Ospedale Maggiore Chieri, Piemonte, Italy, 10023 A.O. Santa Croce e Carle Cuneo, Piemonte, Italy, 12100 Ospedale Mauriziano Torino, Piemonte, Italy, 10125 Ospedale Civile Mirano, Veneto, Italy, 30035 Less <<
NCT01873859 Diabetes Mellitus ... More >> Lactic Acidosis Less << Not Applicable Completed - Iran, Islamic Republic of ... More >> Cardiovascular research center, Modarres hospital. Tehran, Iran, Islamic Republic of Less <<
NCT03549754 - Recruiting December 31, 2025 -
NCT02011620 Endothelial Dysfunction ... More >> Bone Disease Less << Phase 4 Unknown September 2015 United Kingdom ... More >> Tameside General Hospital NHS Foundation Trust Not yet recruiting Manchester, United Kingdom, OL6 9RW Contact: Edward Jude, MD, MRCP    01619226964    edward.jude@tgh.nhs.uk    Contact: John Goodenough    01613316006    john.goodenough@tgh.nhs.uk Less <<
NCT01213173 - Completed - -
NCT02407522 Metabolic Syndrome X Phase 2 Phase 3 Completed - -
NCT02035995 - Completed - Turkey ... More >> Kayseri Education and Research Hospital Kayseri, Turkey, 38210 Less <<
NCT02000024 Prediabetes G... More >>estational Diabetes Mellitus Obesity Less << Not Applicable Completed - United States, Indiana ... More >> Indiana University School of Medicine Indianapolis, Indiana, United States, 46202 Less <<
NCT02039934 Type 2 Diabetes Not Applicable Recruiting August 2018 Germany ... More >> Deutsches Diabetes Zentrum Recruiting Düsseldorf, Nordrhein-Westfalen, Germany, 40225 Contact: Julia Szendrödi, MD, PhD    0049 211 3382 203    julia.szendroedi@ddz.uni-duesseldorf.de Less <<
NCT00000539 Arterial Occlusive Diseases ... More >> Cardiovascular Diseases Heart Diseases Vascular Diseases Diabetes Mellitus Less << Phase 3 Completed - -
NCT01213173 Angina Pectoris Phase 4 Completed - China, Beijing ... More >> Research Site Beijing, Beijing, China China, Guangdong Research Site Guangzhou, Guangdong, China China, Hebei Research Site Tangshan, Hebei, China China, Henan Research Site Zhengzhou, Henan, China China, Jiangsu Research Site Nanjing, Jiangsu, China China, Liaoning Research Site Jingzhou, Liaoning, China Research Site Shenyang, Liaoning, China China, Shanghai Research Site Shanghai, Shanghai, China China, Shanxi Research Site Taiyuan, Shanxi, China China Research Site Tianjing, China Less <<
NCT03561571 Type2 Diabetes Not Applicable Recruiting October 2019 France ... More >> Hôpital Louis Pradel - department of endocrinology Recruiting Bron, France, 69500 Contact: philippe Moulin, MD PhD    4 72 35 74 68 ext +33    philippe.moulin@chu-lyon.fr Less <<
NCT00004572 - Unknown - -
NCT03398785 Primary Aldosteronism ... More >> Hypertension Less << Phase 3 Recruiting April 30, 2019 China, Chongqing ... More >> The third hospital affiliated to the Third Military Medical University Recruiting Chongqing, Chongqing, China, 400042 Contact: Hongbo He, MD.    86-23-68757880    cqhehongbo@gmail.com    Principal Investigator: Zhiming Zhu, MD. Less <<
NCT00510146 Depression, Bipolar Phase 3 Completed - China ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Beijing, China, 100088 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Changsha, China, 410008 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chengdu, China, 610041 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Guang Zhou, China, 510370 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hangzhou, China, 310003 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Harbin, China, 150001 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kunming, China, 650032 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nanjing, China, 210029 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Shanghai, China, 200030 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Wu Han, China, 430060 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Xi'An, China, 710032 Japan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hiroshima, Japan, 731-0501 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Shiga, Japan, 525-0037 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tokyo, Japan, 170-0002 Korea, Republic of For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Seongnam-Si, Korea, Republic of, 463-707 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Seoul, Korea, Republic of, 110-744 Less <<
NCT00122421 Diabetes Mellitus Not Applicable Completed - United States, Massachusetts ... More >> Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Less <<
NCT02153983 Obesity Metab... More >>olic Disease Less << Phase 1 Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00123604 Hypertension ... More >>Type 2 Diabetes Mellitus Less << Phase 4 Completed - United States, Minnesota ... More >> St. Paul Heart Clinic St. Paul, Minnesota, United States, 55102 Less <<
NCT00510146 - Completed - -
NCT00139035 Chronic Renal Failure Phase 4 Completed - Norway ... More >> Rikshospitalet, Section of Nephrology Oslo, Norway, 0027 Less <<
NCT00123604 - Completed - -
NCT00123643 Type 2 Diabetes Mellitus Phase 4 Completed - United States, Minnesota ... More >> St. Paul Heart Clinic St. Paul, Minnesota, United States, 55102 Less <<
NCT00123643 - Completed - -
NCT00126126 Amputation Stumps ... More >> Diabetes Mellitus Less << Not Applicable Completed - United States, Florida ... More >> VA Medical Center, Miami Miami, Florida, United States, 33125 Less <<
NCT02893163 Metabolic Syndrome ... More >> Risk Factors Less << Not Applicable Enrolling by invitation August 2020 -
NCT01572402 Type 2 Diabetes ... More >> Postprandial Oxidative Stress Less << Not Applicable Completed - Czech Republic ... More >> Hana Kahleova Praha, Czech Republic, 140 21 Less <<
NCT00124397 Type 2 Diabetes Mellitus Phase 4 Completed - Denmark ... More >> Department of Medical Research SHF Svendborg, Svendborg, Denmark, 5700 Less <<
NCT00566215 Diabetes Mellitus, Type 2 ... More >> Insulin Resistance Obesity Less << Phase 1 Phase 2 Terminated(Benefit of duodenal... More >> exclusion alone less than expected for treatment of type 2 diabetes; an additional effect of combination with omentectomy not observed) Less << - Brazil ... More >> LIMED (Laboratory of Investigation of Metabolism and Diabetes)/GASTROCENTRO/Univeristy of Campinas (UNICAMP) Campinas, SP, Brazil Less <<
NCT00571506 Diabetes Mellitus, Type 2 ... More >> Vascular Diseases Less << Phase 4 Completed - United States, Arkansas ... More >> University of Arkansas for Medical Sciences Little Rock, Arkansas, United States, 72205 Less <<
NCT00576784 Type 2 Diabetes Mellitus ... More >> Insulin Resistance Less << Phase 4 Completed - Germany ... More >> IKFE Mainz, Germany, 55116 Less <<
NCT00550979 - Unknown January 2014 United States, Massachusetts ... More >> Brigham and Women's Hospital, Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02115 Principal Investigator: Rhonda Bentley-Lewis, MD          Sub-Investigator: Florence Brown, MD          Sub-Investigator: David Nathan, MD          Sub-Investigator: Mark Creager, MD          Brigham and Women's Hospital Recruiting Boston, Massachusetts, United States, 02115 Less <<
NCT01589835 Prediabetes Phase 2 Completed - Canada, British Columbia ... More >> UBC Family Practice Vancouver, British Columbia, Canada, V6T 1Z3 Less <<
NCT02982967 Physical Activity ... More >> Endothelial Dysfunction Metabolic Syndrome x Less << Not Applicable Completed - Brazil ... More >> Physiology Department - Federal University of são Paulo Sao Paulo, São Paulo, Brazil, 04023-062 Less <<
NCT00621608 Diabetes Mellitus ... More >> Chronic Ulcers of the Lower Limb Less << Phase 4 Completed - Canada, Ontario ... More >> Judy Dan Wound Care Centre/University Health Network Toronto, Ontario, Canada, M2R 1N5 Less <<
NCT01638780 Type 2 Diabetes Not Applicable Unknown December 2014 Netherlands ... More >> Maastricht University Medical Center Maastricht, Limburg, Netherlands, 6200MD Less <<
NCT01550328 - Terminated(Protocol no longer ... More >>meets sponsor objectives) Less << - United States, New Mexico ... More >> VeraLight Albuquerque, New Mexico, United States, 87106 Less <<
NCT00627783 Type 2 Diabetes Not Applicable Terminated(Poor recruiting sta... More >>tus) Less << - France ... More >> Hopital Louis Pradel Bron, France, 69500 Less <<
NCT02064309 Long-standing Type 1 Diabetes ... More >>Mellitus Less << Phase 1 Phase 2 Active, not recruiting May 2019 Sweden ... More >> Uppsala University Hospital Uppsala, Sweden, SE-75123 Less <<
NCT00634673 Dyslipidemia ... More >>Type 2 Diabetes Mellitus Less << Not Applicable Completed - Brazil ... More >> Hospital de Clínicas de Porto Alegre Porto Alegre, Rio Grande do Sul, Brazil, 90035-003 Less <<
NCT02763735 Pulmonary Arterial Hypertensio... More >>n Healthy Less << Not Applicable Enrolling by invitation June 2019 United States, Tennessee ... More >> Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232 Less <<
NCT01977885 Metabolic Syndrome Not Applicable Completed - United States, Georgia ... More >> Body Composition and Metabolism Lab, UGA, Ramsey Student Center Athens, Georgia, United States, 30602 Less <<
NCT00406848 Major Depressive Disorder Phase 4 Completed - -
NCT00907881 - Completed - -
NCT00626249 Mild Nephropathy ... More >> Moderate Nephropathy Diabetes Mellitus Less << Phase 1 Completed - United States, Minnesota ... More >> Davita Clinical Research Minneapolis, Minnesota, United States, 55404 United States, Nebraska Qualia Clinical Research Omaha, Nebraska, United States, 68154 United States, Texas Diabetes & Glandular Disease Research Assoc PA San Antonio, Texas, United States, 78229 Less <<
NCT00902616 Type 2 Diabetes Phase 4 Completed - United Kingdom ... More >> Tameside General Hospital Ashton-under-Lyne, Cheshire, United Kingdom, OL6 9RW Less <<
NCT00406848 - Completed - -
NCT02006810 Metabolic Syndrome Not Applicable Completed - France ... More >> CHU de Clermont-Ferrand Clermont-Ferrand, France, 63003 Less <<
NCT00102297 Diabetes Mellitus Phase 1 Completed - United States, California ... More >> UCLA - LA BioMed Los Angeles, California, United States, 90502 United States, Massachusetts Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 United States, Texas Radiant Research Dallas, Texas, United States, 75231 Diabetes & Glandular Disease San Antonio, Texas, United States, 78229 United States, Virginia University of Virginia Charlottesville, Virginia, United States, 22908 Less <<
NCT00907881 - Completed - -
NCT03683225 Idiopathic Parkinson Disease Phase 2 Not yet recruiting March 1, 2020 -
NCT00934570 Obesity Type ... More >>2 Diabetes Less << Phase 4 Completed - Canada, Ontario ... More >> Children's Hospital, London Health Sciences Centre London, Ontario, Canada, N6A 5W9 Less <<
NCT00947726 Foot Transepidermal Water Loss... More >> in Patients in NIDDM Foot Dryness in Patients With NIDDM Less << Not Applicable Completed - -
NCT00959426 Obesity Overw... More >>eight Healthy Less << Phase 1 Completed - United States, Connecticut ... More >> Pfizer Investigational Site New Haven, Connecticut, United States, 06511 Less <<
NCT00950040 At-risk Drinking ... More >> Type 2 Diabetes Less << Not Applicable Completed - United States, Rhode Island ... More >> Rhode Island Hospital Providence, Rhode Island, United States, 02903 Less <<
NCT00955747 - Completed - -
NCT02069379 Depression In... More >>sulin Resistance Metabolic Syndrome Less << Phase 4 Completed - United States, Michigan ... More >> University of Michigan Medical School Ann Arbor, Michigan, United States, 48103 Less <<
NCT00955747 Type 2 Diabetes Phase 3 Completed - -
NCT02069379 - Completed - -
NCT02083133 - Unknown October 2014 United States, Illinois ... More >> John H Stroger Hospital of Cook County Chicago, Illinois, United States, 60612 Less <<
NCT03298373 Healthy Men M... More >>ale Contraception Less << Phase 1 Recruiting December 2018 United States, California ... More >> Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center Recruiting Torrance, California, United States, 90509 Contact: Christina Wang, MD    310-222-2503    wang@labiomed.org    United States, Washington University of Washington Medical Center & Health Sciences Recruiting Seattle, Washington, United States, 98195 Contact: Stephanie Page, MD, PhD    206-616-1818    page@uw.edu Less <<
NCT00977262 Cardiovascular Disease ... More >> Diabetes Type 2 Obesity Less << Not Applicable Completed - Netherlands ... More >> Wageningen University, Division of Human Nutrition Wageningen, Gelderland, Netherlands, 6700 EV Wageningen University, Division of Human Nutrition Wageningen, Netherlands, 6700 EV Less <<
NCT01024790 Type 2 Diabetes Phase 1 Completed - United States, Massachusetts ... More >> University of Massachusetts Medical School Worcester, Massachusetts, United States, 01655 Less <<
NCT01022658 Type 2 Diabetes Not Applicable Completed - France ... More >> Jean Verdier hospital, Department of Endocrinology-Diabetology-Nutrition Bondy, France, 93140 Less <<
NCT00964587 Type 2 Diabetes Not Applicable Completed - United States, Maryland ... More >> Johns Hopkins School of Medicine/General Clinical Research Center Baltimore, Maryland, United States, 21205 Johns Hopkins Bayview Medical Center/General Clinical Research Center Baltimore, Maryland, United States, 21224 Johns Hopkins School of Medicine/General Internal Medicine Baltimore, Maryland, United States, 21287 Less <<
NCT02148653 Metabolic Syndrome ... More >> Insulin Resistance Overweight Less << Not Applicable Completed - Sweden ... More >> Functional Food Science Centre. Lund University Medicon Village Lund, Sweden, SE 223 81 Less <<
NCT00123227 Diabetes Mellitus, Type 2 ... More >> Vascular Diseases Hypertension Less << Phase 3 Unknown - United Kingdom ... More >> Cardiovascular Magnetic Resonance Unit, Royal Brompton Hospital London, United Kingdom, SW3 6NP St Mary's NHS Trust London, United Kingdom, W2 1NY Less <<
NCT01000688 Type 2 Diabetes ... More >> Endothelial Dysfunction Less << Phase 3 Completed - Netherlands ... More >> Radboud University Nijmegen Medical Centre Nijmegen, Netherlands, 6500 HB Less <<
NCT00141492 Type 2 Diabetes ... More >> Hypogonadism Less << Phase 2 Completed - -
NCT00157508 Type 2 Diabetes ... More >> Early Nephropathy Less << Phase 2 Terminated - Italy ... More >> Clinical Research Center for Rare Diseases Ranica, Bergamo, Italy, 24020 Less <<
NCT02106208 Metabolic Syndrome Not Applicable Completed - Canada, Manitoba ... More >> Richardson Centre for Functional Foods and Nutraceuticals Winnipeg, Manitoba, Canada, R3T 6C5 Canada Institute of Nutrition and Funtional Foods Quebec, Canada, G1V 0A6 Less <<
NCT02205021 - Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT00139516 Cardiovascular Diseases ... More >> Heart Diseases Lung Diseases Diabetes Mellitus Chronic Obstructive Pulmonary Disease Less << Not Applicable Completed - -
NCT00167778 - Completed - -
NCT03318614 Irritable Bowel Syndrome ... More >> Abdominal Pain Small Intestinal Bacterial Overgrowth Less << Phase 2 Phase 3 Completed - -
NCT00230087 Non-Alcoholic Fatty Liver Dise... More >>ase Diabetes Mellitus Less << Phase 2 Completed - United States, Washington ... More >> University of Washington Medical Center Seattle, Washington, United States, 98195 Less <<
NCT00167778 Diabetes Mellitus ... More >> Leg Injuries Traumatic Amputation Less << Not Applicable Completed - United States, Washington ... More >> VA Puget Sound Health Care System, Seattle Seattle, Washington, United States, 98108 Less <<
NCT02235805 Metabolic Syndrome ... More >> Obesity Less << Not Applicable Completed - Netherlands ... More >> Maastricht University Medical Center Maastricht, Netherlands Less <<
NCT00185159 Diabetes Mellitus, Type 2 ... More >> Cardiovascular Disease Kidney Disease Less << Phase 3 Completed - Germany ... More >> Darmstadt, Germany Less <<
NCT02227628 Cardiovascular Disease ... More >> Metabolic Syndrome Obesity Less << Not Applicable Completed - United States, Texas ... More >> Exercise & Sport Nutrition Laboratory (ESNL) in the Department of Health and Kinesiology at Texas A&M University College station, Texas, United States, 77845 Less <<
NCT00253240 - Completed - Canada, Ontario ... More >> London Intercommunity Health Centre London, Ontario, Canada, N5W 2Z1 Less <<
NCT00249314 - Unknown December 2007 Canada, Ontario ... More >> Hamilton Health Sciences - Cardiovascular Obesity Research and Management Center Recruiting Hamilton, Ontario, Canada, L8L 2X2 Principal Investigator: Arya M Sharma, MD, FRCPC Less <<
NCT02227420 Metabolic Syndrome ... More >> Hypersecretion; Cortisol Less << Phase 3 Completed - Switzerland ... More >> University Hopsital Basel Basel, Switzerland Less <<
NCT00256646 - Completed - United States, Arizona ... More >> Carl T. Hayden VA Medical Center Phoenix, Arizona, United States, 85012 Southern Arizona VA Health Care System, Tucson Tucson, Arizona, United States, 85723 United States, California VA Central California Health Care System, Fresno Fresno, California, United States, 93703 VA Medical Center, Long Beach Long Beach, California, United States, 90822 VA San Diego Healthcare System, San Diego San Diego, California, United States, 92161 United States, Florida Miami VA Healthcare System, Miami, FL Miami, Florida, United States, 33125 United States, Illinois Edward Hines, Jr. VA Hospital Hines, Illinois, United States, 60141-5000 United States, Indiana Richard Roudebush VA Medical Center, Indianapolis Indianapolis, Indiana, United States, 46202-2884 United States, Kentucky VA Medical Center, Lexington Lexington, Kentucky, United States, 40502 United States, Minnesota VA Medical Center, Minneapolis Minneapolis, Minnesota, United States, 55417 United States, Nebraska VA Medical Center, Omaha Omaha, Nebraska, United States, 68105-1873 United States, New Jersey VA New Jersey Health Care System, East Orange East Orange, New Jersey, United States, 07018 United States, Pennsylvania VA Pittsburgh Health Care System Pittsburgh, Pennsylvania, United States, 15240 United States, Texas Michael E. DeBakey VA Medical Center (152) Houston, Texas, United States, 77030 VA South Texas Health Care System, San Antonio San Antonio, Texas, United States, 78229 United States, Virginia VA Medical Center, Salem VA Salem, Virginia, United States, 24153 Puerto Rico VA Medical Center, San Juan San Juan, Puerto Rico, 00921 Less <<
NCT01093794 Type 2 Diabetes Phase 1 Completed - -
NCT00254501 Type I or Type II Diabetes (Ex... More >>cludes Gestational Diabetes) Less << Phase 3 Completed - -
NCT02268292 Metabolic Cardiovascular Syndr... More >>ome Less << Phase 4 Completed - -
NCT01093794 - Completed - -
NCT00254501 - Completed - -
NCT02292329 Cardiovascular Diseases Not Applicable Completed - United Kingdom ... More >> Hugh Sinclair Unit of Human Nutrition Reading, Berkshire, United Kingdom, RG6 6AP Less <<
NCT00265746 Type 2 Diabetes Mellitus Phase 4 Unknown - Poland ... More >> Department of Endocrinology and Isotope Therapy, Polish Mother’s Memorial Hospital, Research Institute, Lodz Recruiting Lodz, Poland Contact: Katarzyna Cypryk, M D, PhD , Habilitation    0048422711159    kcypryk@mp.pl    Principal Investigator: Katarzyna Cypryk, PhD, MD ,          Sub-Investigator: Marcin Kosiński, MD Less <<
NCT00272831 Diabetes Mellitus, Type 2 ... More >> Diabetes Complications Less << Phase 4 Completed - -
NCT02323828 Metabolic Syndrome Early Phase 1 Completed - -
NCT01154933 Type 2 Diabetes Phase 2 Completed - United States, New York ... More >> Millard Fillmore Gates Hospital Buffalo, New York, United States, 14209 Less <<
NCT00268541 Type 2 Diabetes Mellitus ... More >> Cardiovascular Diseases Less << Not Applicable Completed - United Kingdom ... More >> University of Glasgow Glasgow, United Kingdom, G12 8QQ Less <<
NCT02338856 Metabolic Syndrome Phase 1 Completed - Korea, Republic of ... More >> Kyungpook National University Hospital Daegu, Dongduck-ro, Jung-gu, Korea, Republic of, 700-721 Less <<
NCT01474941 Healthy Phase 1 Completed - Belgium ... More >> Pfizer Investigational Site Bruxelles, Belgium, B-1070 Less <<
NCT00979420 - Completed - -
NCT00306644 Diabetes Mellitus, Type 2 Phase 4 Completed - Sweden ... More >> GSK Investigational Site Malmö, Sweden, SE-205 02 Less <<
NCT00308347 Type 2 Diabetes ... More >> Nephropathy Less << Phase 3 Completed - -
NCT00979420 - Completed - -
NCT00309751 - Completed - -
NCT01217905 Type 2 Diabetes ... More >> Obesity Less << Phase 1 Completed - United Kingdom ... More >> Research site Croydon, United Kingdom Less <<
NCT00309712 Type II Diabetes Mellitus ... More >> Mixed Dyslipidemia Less << Not Applicable Completed - United States, Utah ... More >> McKay Dee Hospital Ogden, Utah, United States, 84403 LDS Hospital Salt Lake City, Utah, United States, 84143 Less <<
NCT01231178 Obesity Type ... More >>2 Diabetes Cardiovascular Disease Less << Not Applicable Completed - Denmark ... More >> Department of Human Nutrition Frederiksberg, Copenhagen, Denmark, 1958 Less <<
NCT00309751 Type II Diabetes Mellitus ... More >> Dyslipidemia Less << Phase 3 Completed - Denmark ... More >> CCBR Aalborg Aalborg, Denmark CCBR A/S Ballerup, Denmark CCBR Vejle Vejle, Denmark Germany Gemeinschaftspraxis am Bahnhof Berlin-Spandau, Germany Pharmakologisches Studienzentum Chemnitz Chemnitz, Germany Internistische Diabetische Schwerpunktpraxis Dr. Frankfurt Am Main, Germany Internistische Gemeinschaftspraxis Mainz, Germany Gemeinschaftspraxis Dr. Senftleber, Dr. Kohler Messkirch, Germany India Bhagwan Mahaveer Jain Heart Centre Bangalore, India Sri Ramachandra Medical College Hospital Chennai, India Apollo Hospitals Hyderabaad, India CARE Group of Hospitals Hyderabaad, India PD Hinduja Hospital Mumbai, India Netherlands Andromed Breda Breda, Netherlands Andromed Eindhoven Eindhoven, Netherlands Andromed Noord Groningen, Netherlands Andromed Leiden Leiden, Netherlands Andromed Nijmegen Nijmegen, Netherlands Andromed Rotterdam Rotterdam, Netherlands Andromed Oost Velp, Netherlands Andromed Zoetermeer Zoetermeer, Netherlands Poland Podlaski Osrodek Kardiologii Bialystok, Poland NZOZ GCP Dobra Praktyka Lekaska Gruziadz, Poland NZOZ Terapia Optima Katowice, Poland NZOZ Esculap, Przychodnia Lekary Rodzinnych Losice, Poland NZOZ Centrum, Poradnia Kardiologiczna Siedlce, Poland Spec. Gab. Lek. Internistyczno-Kardiologicznly Tarnow, Poland Woj.Szp.Spec.Nr 1 im. Prof. J. Gasinskiego Tychy, Poland Instytut Zywnosci i Zywienia Warszawa, Poland Lecznica PROSEN SMO Warszawa, Poland Szpital Wolski,im. Dr A. Gostynskiej Warszawa, Poland United Kingdom Synexus Reading Clinical Research Centre Berkshire, United Kingdom Synexus Lancashire Clinical Research Centre Lancashire, United Kingdom Synexus Merseyside Clinical Research Centre Liverpool, United Kingdom Synexus Manchester Clinical Research Centre Manchester, United Kingdom Less <<
NCT00342992 - Completed - Finland ... More >> National Institute of Health and Welfare, Helsinki, Finland Helsinki, Finland Less <<
NCT02145936 Dyslipidemia Not Applicable Completed - United States, Massachusetts ... More >> Jean Mayer Human Nutrition Research Center on Aging Boston, Massachusetts, United States, 02111 Less <<
NCT00344370 Type II Diabetes Mellitus ... More >> Dyslipidemia Less << Phase 3 Completed - Denmark ... More >> CCBR Aalborg Aalborg, Denmark CCBR A/S Vejle, Denmark CCBR Vejle Vejle, Denmark Germany Gemeinschaftspraxis am Bahnhof Berlin-Spandau, Germany Pharmakologisches Studienzentum Chemnitz Chemnitz, Germany Internistische Diabetische Schwerpunktpraxis Dr. Frankfurt Am Main, Germany Internistische Gemeinschaftspraxis Mainz, Germany Gemeinschaftspraxis Dr. Senftleber, Dr. Kohler Messkirch, Germany India Bhagwan Mahaveer Jain Heart Centre Bangalore, India Sri Ramachandra Medical College Hospital Chennai, India Apollo Hospitals Hyderabaad, India CARE Group of Hospitals Hyderabaad, India PD Hinduja Hospital Mumbai, India Netherlands Andromed Breda Breda, Netherlands Andromed Eindhoven Eindhoven, Netherlands Andromed Noord Groningen, Netherlands Andromed Leiden Leiden, Netherlands Andromed Nijmegen Nijmegen, Netherlands Andromed Rotterdam Rotterdam, Netherlands Andromed Oost Velp, Netherlands Andromed Zoetermeer Zoetermeer, Netherlands Poland Podlaski Osrodek Kardiologii Bialystok, Poland NZOZ GCP Dobra Praktyka Lekaska Gruziadz, Poland NZOZ Terapia Optima Katowice, Poland NZOZ Esculap, Przychodnia Lekary Rodzinnych Losice, Poland NZOZ Centrum, Poradnia Kardiologiczna Siedlce, Poland Spec. Gab. Lek. Internistyczno-Kardiologicznly Tarnow, Poland Woj.Szp.Spec.Nr 1 im. Prof. J. Gasinskiego Tychy, Poland Instytut Zywnosci i Zywienia Warszawa, Poland Lecznica PROSEN SMO Warszawa, Poland Szpital Wolski,im. Dr A. Gostynskiej Warszawa, Poland United Kingdom Synexus Reading Clinical Research Centre Berkshire, United Kingdom Synexus Lancashire Clinical Research Centre Lancashire, United Kingdom Synexus Merseyside Clinical Research Centre Liverpool, United Kingdom Synexus Manchester Clinical Research Centre Manchester, United Kingdom Less <<
NCT00344370 - Completed - -
NCT00349362 Hypogonadism ... More >>Diabetes Less << Phase 4 Completed - United Kingdom ... More >> Barnsley Hospital NHS Foundation Trust Barnsley, South Yorkshire, United Kingdom, S75 2EP Less <<
NCT00298129 - Completed - Japan ... More >> Yokohama City University Center Hospital Yokohama, Japan, 232-0024 Less <<
NCT00350701 Diabetes Mellitus Type 2 Phase 4 Unknown July 2013 United States, New York ... More >> Diabetes-Endocrinology Center of Western NY, 115 flint road Buffalo, New York, United States, 14221 Less <<
NCT03644355 Obesity, Childhood ... More >> Asthma in Children Inflammatory Response Metabolic Syndrome Nutrition Poor Physical Activity Behavior, Eating Molecular Biology, Restriction Fragment Length Polymorphisms Maternal Exposure Genetic Change Less << Not Applicable Completed - United States, Louisiana ... More >> Louisiana State University Health Sciences Center New Orleans, Louisiana, United States, 70112 Less <<
NCT01260337 Obesity Not Applicable Completed - United States, Pennsylvania ... More >> University of Pennsylvania, Center for Weight and Eating Disorders Philadelphia, Pennsylvania, United States, 19104 Temple University, The Center for Obesity Research and Education Philadelphia, Pennsylvania, United States, 19140 Less <<
NCT02967406 Dementia Diab... More >>etes Mellitus Chronic Kidney Disease Cardiovascular Diseases Malignancy Chronic Obstructive Pulmonary Disease Less << Not Applicable Active, not recruiting August 2027 Thailand ... More >> Sanpasitthiprasong Hospital Muaeng, Ubon Ratchathani, Thailand, 34000 Less <<
NCT01257685 - Completed - Korea, Republic of ... More >> Hae Yoon Choi Seoul, Korea, Republic of, 152-703 Less <<
NCT00857857 Asthma Phase 2 Completed - Germany ... More >> GSK Investigational Site Wiesbaden, Hessen, Germany, 65187 GSK Investigational Site Hannover, Niedersachsen, Germany, 30625 GSK Investigational Site Grosshansdorf, Schleswig-Holstein, Germany, 22927 GSK Investigational Site Berlin, Germany, 14050 Less <<
NCT01275794 - Completed - Russian Federation ... More >> Research Site Arkhangelsk, Russian Federation Research Site Astrakhan, Russian Federation Research Site Barnaul, Russian Federation Research Site Chelyabinsk, Russian Federation Research Site Izhevsk, Russian Federation Research Site Joshkar-Ola, Russian Federation Research Site Kazan, Russian Federation Research Site Khemerovo, Russian Federation Research Site Kirov, Russian Federation Research Site Kurgan, Russian Federation Research Site Moscow, Russian Federation Research Site Nizhni Novgorod, Russian Federation Research Site Perm, Russian Federation Research Site Petrozavodsk, Russian Federation Research Site Rostov-on-Don, Russian Federation Research Site Samara, Russian Federation Research Site Seversk, Russian Federation Research Site Smolensk, Russian Federation Research Site St-Peterburg, Russian Federation Research Site Tomsk, Russian Federation Research Site Tyumen, Russian Federation Research Site Ufa, Russian Federation Research Site Yaroslavl, Russian Federation Less <<
NCT00857857 - Completed - -
NCT01339208 Type 2 Diabetes Not Applicable Completed - United States, Pennsylvania ... More >> UPMC Northwest Seneca, Pennsylvania, United States, 16346 Less <<
NCT03138369 Obesity Obesi... More >>ty, Abdominal Metabolic Syndrome Weight Loss Less << Not Applicable Active, not recruiting December 2019 United States, California ... More >> Altman Clinical and Translation Research Institute, UC San Diego San Diego, California, United States, 92037 Less <<
NCT01190566 - Completed - Korea, Republic of ... More >> Seoul National University Hospital Seoul, Korea, Republic of, 110-744 Less <<
NCT01190566 - Completed - -
NCT01341795 - Unknown - Korea, Republic of ... More >> Ajou University School of Medicine Recruiting Suwon, Gyeonggi, Korea, Republic of, 433-721 Contact: Doo-Yeoun Cho, MD    +82-31-219-4271    dooycho@ajou.ac.kr    Sub-Investigator: Young-Sang Kim, MD Less <<
NCT02754089 Body Weight Not Applicable Completed - Iran, Islamic Republic of ... More >> Shahid Motahhari Clinic, Shiraz University of Medical Sciences Shiraz, Fars, Iran, Islamic Republic of Less <<
NCT01330251 - Completed - Finland ... More >> Oulu University Hospital Oulu, Finland, 90220 Less <<
NCT00414245 Gestational Diabetes ... More >> Diabetes Mellitus Type 2 Less << Phase 3 Unknown - Israel ... More >> Division of Obstetrics and Gynecology, Soroka University Medical Center Not yet recruiting Beer-Sheva, Israel Contact: Boaz Sheizaf, MD    972-54-2401191    bsheizaf@bgu.ac.il    Principal Investigator: Boaz Sheizaf, MD Less <<
NCT01350843 Insulin Resistance ... More >> Obesity Dyslipidemia Less << Not Applicable Completed - United Kingdom ... More >> David Greenfield Human Physiology Unit, University of Nottingham Nottingham, Notts, United Kingdom, NG72UH Less <<
NCT01365013 Prediabetic State Phase 4 Completed - Spain ... More >> Primary Care Research Unit of Bizkaia Bilbao, Spain, E48014 Less <<
NCT00409240 - Completed - -
NCT01415726 Type 2 Diabetes Phase 1 Phase 2 Completed - China, Shandong ... More >> General Hospital of Jinan Military Command Jinan, Shandong, China, 250031 Less <<
NCT00415428 - Completed - -
NCT01416649 - Unknown December 2016 United States, Illinois ... More >> The University of Chicago Active, not recruiting Chicago, Illinois, United States, 60637 The University of Chicago Recruiting Chicago, Illinois, United States, 60637 Contact: Annette Miller, MSN    773-834-8871    amiller@medicine.bsd.uchicago.edu    Principal Investigator: Silvana Pannain, MD Less <<
NCT02691325 Pulmonary Disease, Chronic Obs... More >>tructive Less << Phase 1 Completed - United States, Maryland ... More >> GSK Investigational Site Baltimore, Maryland, United States, 21225 Less <<
NCT00437775 - Unknown - Israel ... More >> Assaf Harofeh Medical Center Recruiting Zerifin, Israel, 70300 Contact: Alina Alperovich, B.Pharm    972-547616736    golik@asaf.health.gov.il Less <<
NCT02745613 Insulin Sensitivity/Resistance Not Applicable Recruiting August 2019 United States, Texas ... More >> University of Texas at El Paso Recruiting El Paso, Texas, United States, 79968 Contact: Manuel Amador, B.S.    915-747-7882    mamador2@miners.utep.edu    Contact: Daniel Conde, M.S.    9157477882    daconde@miners.utep.edu    Principal Investigator: Sudip Bajpeyi, PhD. Less <<
NCT01454973 - Completed - United States, Texas ... More >> ICON Development Solutions, Gault Lane San Antonio, Texas, United States, 78209 Less <<
NCT00490178 Diabetes Mellitus, Type 2 ... More >> Dyslipidemia Less << Phase 3 Completed - France ... More >> Site 3 Marseille, France Site 1 Nantes, France Site 2 Tours, France Less <<
NCT00464776 Diabetes Mellitus, Type 2 Phase 1 Phase 2 Completed - Denmark ... More >> Novartis Gentofte, Denmark, 2820 Less <<
NCT01487291 - Completed - Brazil ... More >> Institudo de Psiquiatria da UFRJ Rio de Janeiro, Brazil, 22290-140 Less <<
NCT00506961 Diabetes Mellitus ... More >> Dyslipidemia Less << Phase 4 Completed - Taiwan ... More >> Taichung Veterans General Hospital Taichung, Taiwan Taipei Veterans General Hospital Taipei, Taiwan Less <<
NCT00409240 Diabetes Hype... More >>rtension Dyslipidemia Less << Phase 3 Completed - United States, Rhode Island ... More >> Providence VAMC PRovidence, Rhode Island, United States, 02908 Less <<
NCT01501877 Smoking Type ... More >>2 Diabetes Less << Not Applicable Completed - United States, Rhode Island ... More >> Rhode Island Hospital Providence, Rhode Island, United States, 02903 Less <<
NCT00425308 Renal Transplantation Phase 3 Completed - France ... More >> Novartis Investigative Site Paris, France Less <<
NCT03375918 Hypertension Not Applicable Recruiting January 31, 2022 United States, Massachusetts ... More >> Barre Family Health Center Recruiting Barre, Massachusetts, United States, 01005 Contact: Susan Begley          Tri River Family Health Center Recruiting Uxbridge, Massachusetts, United States, 01569 Contact: Maribeth Beaudoin          Edward M Kennedy Community Health Center Recruiting Worcester, Massachusetts, United States, 01605 Contact: Jose Ramirez, MD          UMass Memorial Hahnemann Family Health Center Recruiting Worcester, Massachusetts, United States, 01605 Contact: Colleen Bregman          UMass Memorial Medical Center -- Benedict Building Recruiting Worcester, Massachusetts, United States, 01605 Contact: Tanya Cournoyer Less <<
NCT00526552 - Completed - Korea, Republic of ... More >> Research Site Seoul, Jongro-gu, Korea, Republic of Research Site Seoul, Kangnam-gu, Korea, Republic of Research Site Seoul, Songpa-gu, Korea, Republic of Less <<
NCT01407237 - Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT02268201 Kidney Transplant Recipients Phase 4 Terminated(Due to difficulty e... More >>nrolling patients) Less << - China ... More >> Beijing, China Fuzhou, China Guangzhou, China Jinan, China Nanchang, China Shanghai, China Xi'an, China Less <<
NCT02865200 Metabolic Syndrome ... More >> Physical Activity Quality of Life Less << Not Applicable Completed - -
NCT00425308 - Completed - -
NCT00430677 - Terminated(Terminated due to f... More >>ailure to meet the primary efficacy endpoint in the Short-term Period) Less << - -
NCT01547403 - Withdrawn(Protocol no longer m... More >>eeting sponsor objectives) Less << - United States, New Mexico ... More >> VeraLight Albuquerque, New Mexico, United States, 87106 Less <<
NCT00547274 Diabetes Mellitus, Type II ... More >> Dyslipidemia Less << Phase 3 Terminated - -
NCT03627494 Muscular Dystrophies Phase 1 Recruiting June 30, 2019 United States, Maryland ... More >> GSK Investigational Site Recruiting Baltimore, Maryland, United States, 21225 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com Less <<
NCT00638209 Human Physiology of Energy Hom... More >>eostasis Less << Not Applicable Unknown - Germany ... More >> University Hospital Tuebingen, Internal Medicine IV Recruiting Tuebingen, Germany, 72076 University Hospital Tuebingen Recruiting Tuebingen, Germany, 72076 Contact: Andreas Fritsche    +49 7071 29 80590    andreas.fritsche@med.uni-tuebingen.de Less <<
NCT00649246 - Completed - United States, Florida ... More >> University of Florida Gainesville, Florida, United States, 32608 United States, South Carolina Medical University of South Carolina Charleston, South Carolina, United States, 29425 University of South Carolina Columbia, South Carolina, United States, 29208 Less <<
NCT00430677 Systemic Lupus Erythematosus Phase 2 Phase 3 Terminated(Terminated due to f... More >>ailure to meet the primary efficacy endpoint in the Short-term Period) Less << - -
NCT01420081 Endometrial Neoplasms Phase 2 Terminated(See termination rea... More >>son in detailed description.) Less << - -
NCT01660386 Type 2 Diabetes Phase 4 Unknown March 2013 China ... More >> Shanghai Jiao Tong University School of Medicine Recruiting Shanghai, China, 200021 Contact: Guang Ning, MD,PHD    +8621-64370045 ext 665340    guangning@medmail.com.cn    Principal Investigator: Guang Ning, MD,PHD Less <<
NCT00654056 Type 2 Diabetes Mellitus Not Applicable Completed - -
NCT00642681 - Completed - -
NCT00539435 Diabetes Mellitus, With Compli... More >>cations Less << Phase 3 Withdrawn(Administrative) - United States, Florida ... More >> Betty Tuller PhD Boca Raton, Florida, United States, 33431 Less <<
NCT03111693 - Recruiting December 2017 France ... More >> CHU Clermont-Ferrand Recruiting Clermont-Ferrand, France, 63003 Contact: Patrick LACARIN    04 73 75 11 95    placarin@chu-clermontferrand.fr    Principal Investigator: Lucie CASSAGNES Less <<
NCT03115866 Metabolic Syndrome Not Applicable Active, not recruiting January 15, 2019 -
NCT00690326 Type 2 Diabetes Mellitus Not Applicable Completed - India ... More >> Diabetic clinic,Thiruvananthapuram medical college hospital Thiruvananthapuram, Kerala, India, 695011 Less <<
NCT03426995 Arthritis, Rheumatoid Phase 1 Recruiting July 29, 2019 United Kingdom ... More >> GSK Investigational Site Recruiting Cambridge, United Kingdom, CB2 2GG Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com Less <<
NCT01713764 Diabetes Type II Phase 2 Completed - United States, California ... More >> Osher Center for Integrative Medicine San Francisco, California, United States, 94143 Less <<
NCT01704612 Diabetes Type 2 Phase 4 Completed - France ... More >> APHP Pitié-Sampetriere Paris, France, 75013 Less <<
NCT00613314 - Completed - -
NCT00613314 - Completed - -
NCT00616057 Obesity Not Applicable Completed - Belgium ... More >> Cliniques universitaires Saint Luc Bruxelles, Branbant Wallon, Belgium, 1200 Less <<
NCT00657605 Obesity Metab... More >>olic Syndrome Diabetes Less << Phase 2 Unknown December 2010 United States, Florida ... More >> University of Miami Miller School of Medicine, Center on Pharmacogenomics Miami, Florida, United States, 33136 Less <<
NCT00659828 Obesity Metab... More >>olic Syndrome Diabetes Less << Phase 2 Unknown December 2010 United States, Florida ... More >> University of Miami, Center on Pharmacogenomics Miami, Florida, United States, 33132 Less <<
NCT01977859 Obesity Cardi... More >>ovascular Disease Hypertension Diabetes Less << Phase 1 Completed - United States, Florida ... More >> Translational Research Institute for Metabolism and Diabetes Orlando, Florida, United States, 32804 Less <<
NCT02671383 HIV Infections Phase 3 Completed - South Africa ... More >> Charlotte Maxeke Johannesburg Academic Hospital Johannesburg, Gauteng, South Africa, 2196 Less <<
NCT00793767 Insulin Sensitivity Not Applicable Completed - Denmark ... More >> Medicinsk forsknings laboratorium Århus C, Denmark, 8000 Less <<
NCT01420081 - Terminated(See termination rea... More >>son in detailed description.) Less << - -
NCT02293161 Autoimmune Diseases Phase 1 Completed - United Kingdom ... More >> GSK Investigational Site Cambridge, United Kingdom, CB2 2GG Less <<
NCT03138382 Obesity Metab... More >>olic Syndrome Less << Not Applicable Completed - United States, California ... More >> UC San Diego San Diego, California, United States, 92093 Less <<
NCT00795860 Insulin Resistance and Type 2 ... More >>Diabetes Less << Not Applicable Completed - United States, Michigan ... More >> University of Michigan Ann Arbor, Michigan, United States, 48109 Less <<
NCT00810290 Metabolic Syndrome Not Applicable Completed - United States, Massachusetts ... More >> Lawrence Senior Center Lawrence, Massachusetts, United States, 01840 Less <<
NCT01439971 Hemophilia A Phase 1 Completed - United States, California ... More >> University of California San Diego Medical Center San Diego, California, United States, 92103-8651 United States, Connecticut New Haven Clinical Research Unit New Haven, Connecticut, United States, 06511 United States, Illinois Rush University Medical Center Chicago, Illinois, United States, 60612 United States, Ohio Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229 United States, Oregon Doernbecher Children's Hospital Portland, Oregon, United States, 97239 OHSU Investigational Pharmacy Portland, Oregon, United States, 97239 Oregon Health & Science University Portland, Oregon, United States, 97239 United States, Pennsylvania CTRC Philadelphia, Pennsylvania, United States, 19104 Penn Comprehensive Hemophilia Program - Center for Blood Disorders Philadelphia, Pennsylvania, United States, 19104 Belgium Pfizer Clinical Research Unit Bruxelles, Belgium, B-1070 Hungary Semmelweis Egyetem Altalanos Orvostudomanyi Kar/ I.sz. Belgyogyaszati Klinika Budapest, Hungary, 1083 Italy Dipartimento di Medicina Clinica 1-Centro Regionale per le Malattie del Sangue Castelfranco Veneto (TV), Italy, 31033 Servizio Farmacia- Ospedale Castelfranco Veneto Castelfranco Veneto - Treviso, Italy, 31033 Centro Emofilia e Trombosi "Angelo Bianchi Bonomi" U.O.S. Dipartimentale per la Diagnosi e la Terapi Milano, Italy, 20122 Servizio Farmacia Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico Milano, Italy, 20122 Centro Malattie Emorragiche e Trombotiche - Ematologia Vicenza, Italy, 36100 Farmacia Ospedaliera Ospedale San Bortolo Vicenza, Italy, 36100 New Zealand Christchurch Clinical Studies Trust Christchurch, New Zealand, 08011 South Africa Phoenix Pharma (Pty) Ltd Port Elizabeth, Eastern Cape, South Africa, 6001 Turkey Ege University Tip Fakultesi Izmir, Turkey, 35100 United Kingdom Royal Free Hampstead NHS Trust, Royal Free Hospital London, United Kingdom, NW3 2QG Haematology Department London, United Kingdom, W12 0HS Central Manchester Universtiy Hospitals NHS Foundation Trust Manchester, United Kingdom, M13 9WL Less <<
NCT00673023 Metabolic Syndrome Not Applicable Completed - -
NCT01481402 Heart Failure ... More >> Low T3 Syndrome Less << Not Applicable Completed - Denmark ... More >> Herlev Hospital, Dept. of Endocrinology Herlev, Denmark, 2730 Less <<
NCT01354574 Exogenous Obesity ... More >> Dietary Modification Less << Not Applicable Completed - United States, California ... More >> Western Human Nutrition Research Center Davis, California, United States, 95616 Less <<
NCT01935323 Metabolism Ph... More >>ysical Fitness Less << Not Applicable Completed - United States, Alabama ... More >> UAB Physiology Lab Birmingham, Alabama, United States, 35294 Less <<
NCT03144128 Cancer Cachexia ... More >> Vitamin D Deficiency Less << Not Applicable Recruiting December 2021 United States, Kentucky ... More >> Markey Cancer Center Recruiting Lexington, Kentucky, United States, 40536 Contact: Elizabeth Rush Less <<
NCT03056417 Chronic Pain Not Applicable Enrolling by invitation December 2018 United States, Ohio ... More >> Ohio University Athens, Ohio, United States, 45701 Less <<
NCT00823381 Obesity Metab... More >>olic Syndrome Diabetes Aging Less << Not Applicable Completed - United States, Missouri ... More >> Washington University School of Medicine St. Louis, Missouri, United States, 63110 Less <<
NCT03374358 HIV Seropositivity ... More >> Metabolic Syndrome Fatty Liver Less << Phase 4 Enrolling by invitation May 31, 2019 Finland ... More >> Aurora hospital, Department of Infectious Diseases Helsinki, Finland Less <<
NCT01549626 Adult Women O... More >>verweight Obese Less << Not Applicable Completed - Brazil ... More >> Clementino Fraga Filho University Hospital Rio de Janeiro, Brazil, 21.941-913 Less <<
NCT02778477 Normal Healthy Phase 1 Terminated(Preliminary analysi... More >>s of accrued data failed to indicate any meaningful pharmacodynamic response.) Less << - Belgium ... More >> Pfizer Clinical Research Unit Brussels, Belgium, B-1070 Less <<
NCT02061800 Chronic Myeloid Leukemia (CML)... More >> Acute Myelogenous Leukemia (AML) Myelodysplastic Syndrome (MDS) Juvenile Myelomonocytic Leukemia (JMML) Acute Lymphoblastic Leukemia (ALL) Lymphoma (Hodgkin's and Non-Hodgkin's) Less << Phase 1 Phase 2 Recruiting December 2018 United States, New York ... More >> Columbia University Medical Center Recruiting New York, New York, United States, 10032 Contact: Jean Sosna, RN    212-305-2050       Principal Investigator: Diane George, MD Less <<
NCT01232309 Cardiovascular Not Applicable Completed - United States, Illinois ... More >> Provident Clinical Research and Consulting Addison, Illinois, United States, 60101 United States, Kentucky Louisville Metabolic and Atherosclerosis Research Center (L-MARC) Louisville, Kentucky, United States, 40213 Canada, Ontario KGK Synergize London, Ontario, Canada, N6A 5R8 Less <<
NCT00529568 Hepatitis C, Chronic Phase 3 Completed - -
NCT02886169 Cardiovascular Diseases Not Applicable Unknown November 2017 Colombia ... More >> University of San Buenaventura Cartagena, Bolívar, Colombia, 130010 Less <<
NCT02168075 Supratentorial Neoplasms Not Applicable Unknown - Korea, Republic of ... More >> Seoul National University of Hospital Recruiting Seoul, Korea, Republic of, 110-799 Contact: Hee Pyung Park, MD PhD    82-2-2072-2466    hppark@snu.ac.kr    Contact: Eugene Kim, MD    82-2-2072-3108    tomomie@hanmail.net    Principal Investigator: Eugene Kim, MD Less <<
NCT01901718 - Terminated(Enrollment was more... More >> challenging than anticipated.) Less << - United States, Kansas ... More >> International Clinical Research Institute Overland Park, Kansas, United States, 66210 Less <<
NCT00279994 Intermittent Claudication Not Applicable Unknown May 2009 Netherlands ... More >> Atrium Medical Centre Heerlen, P.O.box 4446, Netherlands, 6401 CX Less <<
NCT02627105 Weight Loss Not Applicable Completed - United States, Colorado ... More >> University of Colorado Denver Aurora, Colorado, United States, 80045 Less <<
NCT02459132 Cardiovascular Diseases ... More >> Testicular Neoplasms Less << Not Applicable Completed - -
NCT00529568 - Completed - -
NCT02471053 Neoplasms Hea... More >>rt; Disease, Functional Inflammation Less << Not Applicable Completed - Canada, Nova Scotia ... More >> QEII Health Science Center, Nova Scotia Health Authority Halifax, Nova Scotia, Canada, B3H 3A7 Less <<
NCT02563899 Hyperhidrosis Phase 2 Completed - United States, North Carolina ... More >> GSK Investigational Site Raleigh, North Carolina, United States, 27612 United States, Texas GSK Investigational Site Austin, Texas, United States, 78759 Canada, Quebec GSK Investigational Site Montreal, Quebec, Canada, H2K 4L5 Less <<
NCT00167700 Allergic Disease ... More >> Obesity Immunology Less << Not Applicable Unknown December 2015 Finland ... More >> Turku University Central Hospital Recruiting Turku, Finland, 20520 Contact: Erika Isolauri, MD, PhD    +358 2 313 0000 ext 2433    erika.isolauri@utu.fi    Principal Investigator: Erika Isolauri, MD, PhD          Principal Investigator: Seppo Salminen, PhD          Principal Investigator: Kirsi Laitinen, PhD          Sub-Investigator: Marko Kalliomäki, MD, PhD          Sub-Investigator: Samuli Rautava, MD, PhD          Sub-Investigator: Minna-Maija Grönlund, MD, PhD          Sub-Investigator: Merja Nermes, MD, PhD          Sub-Investigator: Maria Carmen Collado, PhD          Sub-Investigator: Ulla Hoppu, PhD          Sub-Investigator: Raakel Luoto, MD, PhD          Sub-Investigator: Jonna Normia, MD, PhD Less <<
NCT02069158 Breast Cancer ... More >> NSCLC Ovary Cancer Endometrial Cancer Small Cell Lung Cancer (SCLC) Head and Neck (HNSCC) Less << Phase 1 Active, not recruiting December 2019 Switzerland ... More >> Oncology Institute of Southern Switzerland (IOSI) Bellinzona, TI, Switzerland, 6500 Less <<
NCT00974727 Overweight Not Applicable Completed - United States, Wisconsin ... More >> University of Wisconsin Madison, Wisconsin, United States, 53706 Less <<
NCT03261817 Schizophrenia ... More >> Physical Activity Schizo Affective Disorder Less << Not Applicable Recruiting December 31, 2022 France ... More >> Caen University Hospital Recruiting Caen, France, 14033 Contact: Sonia Dollfus, MD, PhD    + 33 2 31 06 5018    dollfus-s@chu-caen.fr    Principal Investigator: Sonia Dollfus, MD, PhD Less <<
NCT02650609 Chronic Subdural Hematomas Phase 3 Recruiting June 24, 2019 France ... More >> CHU Amiens Recruiting Amiens, France Contact: Patrick TOUSSAINT          Contact: Cyrille CAPEL          CHU Angers Terminated Angers, France CHU Besançon Recruiting Besançon, France Contact: Laurent THINES          CHU Bordeaux Neurochirurgie A Recruiting Bordeaux, France Contact: Jean-Rodolphe VIGNES          Contact: Vincent JECKO          CHU Bordeaux Neurochirurgie B Recruiting Bordeaux, France Contact: Emmanuel CUNY          CHU Brest Recruiting Brest, France Contact: Phong DAM HIEU          CHU Caen Recruiting Caen, France Contact: Thomas GABEREL          CHU Lille Terminated Lille, France HC Lyon Recruiting Lyon, France Contact: Emmanuel JOUANNEAU          AP-HM - Hôpital La Timone Recruiting Marseille, France Contact: Pierre-Hugues ROCHE          CHU Nancy Active, not recruiting Nancy, France CHU Nantes Recruiting Nantes, France Contact: Eric BORD          Contact: Luc TERREAUX          CHU Poitiers Recruiting Poitiers, France Contact: Michel WAGER          CHU Rouen Recruiting Rouen, France Contact: Sophie CUREY          CHU Saint Etienne Recruiting Saint Etienne, France Contact: Romain MANET          Contact: François VASSAL          CHU Strasbourg Recruiting Strasbourg, France Contact: François PROUST          Contact: Hélène CEBULA          CHU Tours Recruiting Tours, France Contact: Patrick FRANCOIS Less <<
NCT02222493 Rheumatoid Arthritis Phase 3 Completed - -
NCT01991990 Healthy Volunteer Phase 4 Completed - United Kingdom ... More >> Cambridge, United Kingdom, CB2 0QQ Less <<
NCT02121327 Ischemic Stroke Not Applicable Completed - Japan ... More >> Hiroshima University Hiroshima city, Hiroshima, Japan, 734-8553 Less <<
NCT02234206 Oligospermia Phase 2 Completed - India ... More >> National institute of siddha Chennai, Tamilnadu, India, 600047 Less <<
NCT03129841 Obesity Overw... More >>eight Less << Not Applicable Completed - Iran, Islamic Republic of ... More >> NovinDiet Clinic Tehran, Iran, Islamic Republic of Less <<
NCT03171922 Obesity Overw... More >>eight Less << Not Applicable Active, not recruiting November 2018 Iran, Islamic Republic of ... More >> NovinDiet Clinic Tehran, Iran, Islamic Republic of NovinDiet Clinic Tehrān, Iran, Islamic Republic of Less <<
NCT01991990 - Completed - -
NCT03171948 Obesity Overw... More >>eight Less << Not Applicable Active, not recruiting January 2019 Iran, Islamic Republic of ... More >> NovinDiet Clinic Tehran, Iran, Islamic Republic of Less <<
NCT03171961 Obesity Overw... More >>eight Less << Not Applicable Active, not recruiting April 2019 Iran, Islamic Republic of ... More >> NovinDiet Clinic Tehran, Iran, Islamic Republic of NovinDiet Clinic Tehrān, Iran, Islamic Republic of Less <<
NCT03120429 Obesity Overw... More >>eight Less << Not Applicable Active, not recruiting April 2019 Iran, Islamic Republic of ... More >> NovinDiet Clinic Tehran, Iran, Islamic Republic of Less <<
NCT01766271 Coronary Heart Disease Risk Not Applicable Completed - -
NCT02631473 HIV Phase 1 Suspended(Study is on hold whi... More >>lst a grant application for further funding is put together) Less << - United Kingdom ... More >> St Stephen's Centre London, United Kingdom, SW10 9NH Less <<
NCT02354079 Hypobetalipoproteinemia Not Applicable Recruiting December 2028 France ... More >> CHU de Nantes Recruiting Nantes, France, 44093 Contact: Bertrand Cariou, Pr    +(33)2 53 48 27 10    bertrand.cariou@chu-nantes.fr    Contact: Matthieu Pichelin    +(33)2 28 08 01 65    matthieu.pichelin@univ-nantes.fr Less <<
NCT02601092 Obesity Bypas... More >>s Complications Less << Not Applicable Recruiting December 2020 Switzerland ... More >> Spital Limmattal Recruiting Schlieren, Zürich, Switzerland, 8952 Contact: Marko Kraljevic, MD       marko.kraljevic@gmail.com    Contact: Urs Zingg, MD       urs.zingg@spital-limmattal.ch Less <<
NCT01501994 Weight Well B... More >>eing Less << Not Applicable Completed - -
NCT01502007 Overweight Ob... More >>esity Less << Not Applicable Completed - United States, Minnesota ... More >> Mayo Clinic in Rochester Rochester, Minnesota, United States, 55905 Less <<
NCT02968888 Healthy Young... More >> Elderly Less << Not Applicable Completed - Norway ... More >> Norwegian School of Sport Sciences Oslo, Norway, 0863 Less <<
NCT01804855 Obesity Impai... More >>red Health Psychosocial Problem Physical Activity General Nutrition Disorder Less << Not Applicable Active, not recruiting June 2018 Ireland ... More >> Temple Street Children's University Hospital Dublin, Ireland, Dublin 1 Temple Street Children's University Hospital Dublin, Ireland Less <<
NCT02329067 Lipid Metabolism Disorders Not Applicable Completed - Germany ... More >> Medical Department 2, University Munich Munich, Germany, 81377 Less <<
NCT02516540 Hereditary Breast and Ovarian ... More >>Cancer Less << Not Applicable Recruiting December 2021 Germany ... More >> Humboldt Universität zu Berlin Recruiting Berlin, Germany Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden Recruiting Dresden, Germany Universitätsklinikum Düsseldorf Recruiting Düsseldorf, Germany Kliniken Essen-Mitte Recruiting Essen, Germany Universitätsklinikum Essen Recruiting Essen, Germany Universitätsklinikum Freiburg Recruiting Freiburg, Germany Universitätsmedizin Göttingen Recruiting Göttingen, Germany Universitätsklinikum Hamburg-Eppendorf Recruiting Hamburg, Germany Medizinische Hochschule Hannover Recruiting Hannover, Germany Universitätsklinium Heidelberg Recruiting Heidelberg, Germany Universitätsklinikum Schleswig-Holstein, Campus Kiel Recruiting Kiel, Germany Uniklinikum Köln Recruiting Köln, Germany Universitätsklinikum Leipzig Not yet recruiting Leipzig, Germany Technische Universität München Recruiting München, Germany Universität Regensburg Recruiting Regensburg, Germany Interdisziplinäres Brustzentrum am Diakonieklinikum Recruiting Stuttgart, Germany Universitätsklinikum Tübingen Recruiting Tübingen, Germany Universität Ulm Recruiting Ulm, Germany Universitätsklinikum Würzburg Recruiting Würzburg, Germany Less <<
NCT02027077 Obesity Preve... More >>ntion of Weight Gain Less << Not Applicable Active, not recruiting February 2018 Canada, Ontario ... More >> School of Kinesiology and Helath Studies Kingston, Ontario, Canada, K7L 3N6 Less <<
NCT02222493 - Completed - -
NCT02893943 Obesity Not Applicable Active, not recruiting - Canada, Manitoba ... More >> Richardson Centre for Functional Foods and Nutraceuticals Winnipeg, Manitoba, Canada, R3T 2N2 Less <<
NCT02678611 Safety: Healthy Subjects Phase 1 Completed - Canada, Ontario ... More >> KGK Synergize Inc. London, Ontario, Canada, N6A 5R8 Less <<
NCT02491320 Polycystic Ovary Syndrome Phase 3 Unknown December 2017 China, Guangdong ... More >> The First Affiliated Hospital of Guangzhou Medical University Recruiting Guangzhou, Guangdong, China, 510120 Contact: Wanting Wu, Master    15818153730       Contact: Meifang Li, Master    13544426679       Principal Investigator: Hongxia Ma, PhD Less <<
NCT03584269 Chronic Obstructive Pulmonary ... More >>Disease Less << Not Applicable Recruiting April 10, 2020 France ... More >> University Hospital Grenoble Recruiting La Tronche, France, 38700 Contact: Jean-Louis Pépin, Pr, PhD    +33 476 768 473    JPepin@chu-grenoble.fr    Contact: Marjorie Dole, CRA    +33 476 766 918    mdole2@chu-grenoble.fr    Principal Investigator: Christian Brambilla, Pr          Sub-Investigator: Renaud Tamisier, Pr          Sub-Investigator: Marie Destors, MD Less <<
NCT03691532 Spinal Cord Injuries Not Applicable Active, not recruiting July 2020 United States, Florida ... More >> Lois Pope Life Center Miami, Florida, United States, 33143 Less <<
NCT03076580 - Recruiting December 31, 2021 China, Beijing ... More >> Beijing Institute of heart, lung and blood vessel diseases Recruiting Beijing, Beijing, China Contact: Jie Du       jiedubj@126.com    Contact: Yulin Li       lyllyl_1111@163.com    Sub-Investigator: Yang Li, PhD          Sub-Investigator: Hongzhao You, MS          Beijing Institute of heart, lung and blood vessel diseases Recruiting Beijing, Beijing, China Contact: Jie Du       jiedubj@126.com    Contact: Yulin Li       lyllyl_1111@163.com    Sub-Investigator: Yang Li, PhD          Sub-Investigator: Hongzhao You, MS          Principal Investigator: Yongqiang Lai, MD          China Shijie You Enrolling by invitation Beijing, China Less <<
NCT02932748 Weight Loss O... More >>besity Body Weight Less << Not Applicable Recruiting June 2021 United States, Kansas ... More >> Energy Balance Lab, The University of Kansas Recruiting Lawrence, Kansas, United States, 66045 Contact: Joseph Donnelly, EdD    785-864-0797    jdonnelly@ku.edu    Principal Investigator: Joseph Donnelly, EdD Less <<
NCT03126058 Colorectal Cancer Not Applicable Recruiting December 31, 2018 China, Jiangsu ... More >> The First People's Hospital of Changzhou Recruiting Changzhou, Jiangsu, China, 213003 Contact: Qicheng LU, M.D.       changyiluqicheng@sina.com    Principal Investigator: Qicheng LU, M.D.          Changzhou Second People's Hospital Affiliated to Nanjing Medical University Recruiting Changzhou, Jiangsu, China, 213164 Contact: Liming TANG, M.D.       drtanglm@gmail.com    Principal Investigator: Liming TANG, M.D.          The First People's Hospital of Lianyungang City Recruiting Lianyungang, Jiangsu, China, 222002 Contact: Huiyu CHEN, M.D.          Contact: Zengtao BAO, M.D.          Principal Investigator: Huiyu CHEN, M.D.          The Second People's Hospital of Lianyungang City Recruiting Lianyungang, Jiangsu, China, 222006 Contact: Yongchang MIAO, M.D.       lygmiao@sina.com    Contact: Gang WANG    M.D.       Principal Investigator: Yongchang MIAO, M.D.          Nanjing First Hospital Recruiting Nanjing, Jiangsu, China, 210000 Contact: Hongyong CAO, M.D.       caohongy6167@163.com    Principal Investigator: Hongyong CAO, M.D.          Jinling Hospital, Medical School of Nanjing University Recruiting Nanjing, Jiangsu, China, 210002 Contact: Zhi-Wei JIANG, Ph.D.    8602580860034    nzjiangzhiwei@163.com    Contact: Jian ZHAO, Ph.D.    8602580860034    zhaojiangogo@163.com    Principal Investigator: Zhi-Wei JIANG, Ph.D.          Sub-Investigator: Gang WANG, Ph.D.          Sub-Investigator: Jian ZHAO, Ph.D.          Sub-Investigator: Jiang LIU, M.D.          Zhongda Hospital, Southeast University Recruiting Nanjing, Jiangsu, China, 210009 Contact: Jingmin WANG, M.D.       wjm730222@163.com    Principal Investigator: Jingmin WANG, M.D.          The Second Affiliated Hospital of Nanjing Medical University Recruiting Nanjing, Jiangsu, China, 210011 Contact: Jianping ZHANG, M.D.       zhang_jp64@aliyun.com    Contact: Qinghong ZHAO, M.D.       njzhqh@sina.com    Principal Investigator: Jianping ZHANG, M.D.          Principal Investigator: Qinghong ZHAO, M.D.          The First Affiliated Hospital of Nanjing Medical University Recruiting Nanjing, Jiangsu, China, 210029 Contact: Lizong SHEN, M.D.       shenlz@njmu.edu.cn    Contact: Yongbin DING, M.D.          Principal Investigator: Lizong SHEN, M.D.          Suqian People's Hospital, Nanjing Drum Tower Hospital Recruiting Suqian, Jiangsu, China, 223800 Contact: Jianqiang WU, M.D.       wjq-10@163.com    Principal Investigator: Jianqiang WU, M.D.          Suzhou Municipal Hospital Recruiting Suzhou, Jiangsu, China, 215000 Contact: Xinhua GU, M.D.          Contact: Renbin SHEN    M.D.       Principal Investigator: Xinhua GU, M.D.          The Second Affiliated Hospital of Soochow University Recruiting Suzhou, Jiangsu, China, 215004 Contact: Haorong WU, M.D.       wuhaorong666@126.com    Contact: Yongyou WU, M.D.       13338706607@126.com    Principal Investigator: Haorong WU, M.D.          Principal Investigator: Yongyou WU, M.D.          The First Affiliated Hospital of Soochow University Recruiting Suzhou, Jiangsu, China, 215006 Contact: Xinguo ZHU, M.D.       zxg45@hotmail.com    Contact: Zhongqi MAO    M.D.    maozq31@hotmail.com    Principal Investigator: Xinguo ZHU, M.D.          Principal Investigator: Zhongqi MAO, M.D.          The First People's Hospital of Taicang Recruiting Suzhou, Jiangsu, China, 215400 Contact: Yi WANG, M.D.          Contact: Bing WANG, M.D.          Principal Investigator: Yi WANG, M.D.          The Second People's Hospital of Changshu City Recruiting Suzhou, Jiangsu, China, 215500 Contact: Guoqiang ZHOU, M.D.          Principal Investigator: Guoqiang ZHOU, M.D.          Zhangjiagang First People's Hospital Recruiting Suzhou, Jiangsu, China, 215600 Contact: Shusheng WANG, M.D.       Wsszyy2005@163.com    Principal Investigator: Shusheng WANG, M.D.          Sub-Investigator: Liang ZHOU, M.D.          The Taizhou People's Hospital Recruiting Taizhou, Jiangsu, China, 225300 Contact: Qinghong LIU, M.D.          Contact: Honggang WANG, M.D.          Principal Investigator: Qinghong LIU, M.D.          The 101 Hospital of the Chinese People's Liberation Army Recruiting Wuxi, Jiangsu, China, 214000 Contact: Guozhong WU, M.D.       jfj101hwugz@sina.cn    Principal Investigator: Guozhong WU, M.D.          Affiliated Hospital of Jiangnan University, The Forth People's Hospital of Wuxi Recruiting Wuxi, Jiangsu, China, 214062 Contact: Bojian FEI, M.D.       wx4yfbj@163.com    Principal Investigator: Bojian FEI, M.D.          Xuzhou Central Hospital Recruiting Xuzhou, Jiangsu, China, 221009 Contact: Xiaopeng LV, M.D.       18952171977@126.com    Principal Investigator: Xiaopeng LV, M.D.          Northern Jiangsu People's Hospital Recruiting Yangzhou, Jiangsu, China, 225001 Contact: Ping CHEN, M.D.       chen86ky@126.com    Contact: Xinxin LIU, M.D.          Principal Investigator: Ping CHEN, M.D.          Principal Investigator: Daorong WANG, M.D.          Sub-Investigator: Xinxin LIU, M.D.          Affiliated Hospital of Jiangsu University Recruiting Zhenjiang, Jiangsu, China, 212001 Contact: Jixiang CHEN, M.D.       cyok9@163.com    Principal Investigator: Jixiang CHEN, M.D.          Affiliated People's Hospital of Jiangsu University Recruiting Zhenjiang, Jiangsu, China, 212002 Contact: Pengcheng JIANG, M.D.       jpc18906106623@126.com    Contact: Shouliang ZHANG, M.D.          Principal Investigator: Pengcheng JIANG, M.D. Less <<
NCT02084758 Chronic Obstructive Pulmonary ... More >>Disease Less << Not Applicable Completed - Netherlands ... More >> Maastricht University Medical Center Maastricht, Limburg, Netherlands Less <<
NCT01358890 Over Weight O... More >>besity Less << Phase 2 Phase 3 Completed - China, Shanghai ... More >> Institute for Nutritional Sciences, Chinese Academy of Sciences Shanghai, Shanghai, China, 200031 Less <<
NCT03282955 Patients Requiring Home Parent... More >>eral Nutrition Less << Phase 4 Recruiting September 1, 2019 France ... More >> Hospices Civiles de Lyon - Centre hospitalier Lyon Sud Recruiting Pierre-Bénite, France Contact: Cécile Chambrier, Dr.          Italy Department of Medical and Surgical Science, University of Bologna, Center for Chronic Intestinal Failure, Department of Digestive System, St. Orsola-Malpighi Hospital Recruiting Bologna, Italy Contact: Loris Pironi, Prof.          Netherlands Radboud university medical center Recruiting Nijmegen, Netherlands Contact: Geert Wanten, Dr.          Poland Stanley Dudrick`s Memorial Hospital Recruiting Skawina, Poland Contact: Stanislaw Klek, Prof.          Principal Investigator: Stanislaw Klek, Prof.          Samodzielny Publiczny Szpital Kliniczny, im. prof. dr W. Orlowskiego, Centrum Medycznego Ksztalcenia Podyplomowego, Oddzial Kliniczny Zywienia i Chirurgii Recruiting Warszawa, Poland Contact: Jacek Sobocki, Dr.          Wojewódzkim Specjalistycznym Szpitalem im. M. Pirogowa w Łodzi , Oddział Chirurgii Ogólnej i Naczyniowej Recruiting Łódź, Poland Contact: Marek Kunecki, Dr.          United Kingdom University of East Anglia, Faculty of Medicine and Health Sciences Not yet recruiting Norwich, United Kingdom Contact: Alastair Forbes, Prof. Less <<
NCT03617458 Pulmonary Artery Hypertension Phase 2 Recruiting December 2022 United States, Tennessee ... More >> Vanderbilt University Medical Center Recruiting Nashville, Tennessee, United States, 37232 Less <<
NCT03404271 Healthy Active Females Not Applicable Completed - United States, Texas ... More >> Texas Tech University Lubbock, Texas, United States, 79409 Less <<
NCT03656744 Fatty Liver, Nonalcoholic ... More >> NAFLD Nonalcoholic Fatty Liver Disease Nonalcoholic Steatohepatitis Digestive System Diseases Less << Phase 2 Recruiting October 31, 2019 United States, Florida ... More >> Florida Research Institute Recruiting Lakewood Ranch, Florida, United States, 34211 Contact: Tracy L. Balentine, RN, MS, CCRC    941-727-7772    tracy.balentine@fdhs.com    Contact: Johanna Valentin, MBA    941-727-7772    johanna.valentin@fdhs.com    United States, Texas Pinnacle Clinical Research Recruiting Austin, Texas, United States, 78746 Contact: Nadege Gunn, MD    512-384-4560    ngunn@pinnacleresearch.com    Pinnacle Clinical Research Recruiting San Antonio, Texas, United States, 78229 Contact: Leslie M. DeHart, MSN, FNP-C    210-982-0320 ext 1451    ldehart@pinnacleresearch.com Less <<
NCT00453479 Pulmonary Disease, Chronic Obs... More >>tructive Less << Phase 2 Completed - Netherlands ... More >> GSK Investigational Site Eindhoven, Netherlands, 5623 EJ GSK Investigational Site Harderwijk, Netherlands, 3844 DG GSK Investigational Site Utrecht, Netherlands, 3584 CJ GSK Investigational Site Zuidlaren, Netherlands, 9471 GP Less <<
NCT02936505 Lung Transplantation ... More >> Allografts Less << Not Applicable Recruiting February 2023 Denmark ... More >> Rigshospitalet Recruiting Copenhagen, Denmark Contact: Thomas Kromann Lund, MD          Finland Helsinki University Hospital Recruiting Helsinki, Finland Contact: Peter Raivio, MD          Norway Oslo University Hospital Recruiting Oslo, Norway Contact: Inga Leukfeldt, MD          Sweden Sahlgrenska Univ Hospital Recruiting Göteborg, Sweden Contact: Göran Dellgren, MD          Principal Investigator: Gerdt Riise, MD          Skåne University Hospital Recruiting Lund, Sweden Contact: Johan Svahn, MD, PhD Less <<
NCT03029572 Obesity Baria... More >>tric Surgery Candidate Less << Not Applicable Completed - Switzerland ... More >> University Hospitals of Geneva Geneva, Switzerland, 1206 Less <<
NCT03516721 Obesity Adole... More >>scent Obesity Less << Not Applicable Completed - Belgium ... More >> Jessa Ziekenhuis Hasselt, Belgium, 3500 Less <<
NCT00661349 HIV Infections Phase 4 Terminated(It has been impossi... More >>ble to achieve the number of patients defined by protocol) Less << - Spain ... More >> Hospital Son Dureta Palma de Mallorca, Baleares, Spain, 07014 H.U. Germans Trias i Pujol - Unitat VIH, Fundació Lluita contra la Sida Badalona, Barcelona, Spain, 08916 Hospital General Universitario de Alicante Alicante, Spain, 03010 Hospital Clínic i Provincial de Barcelona Barcelona, Spain, 08036 Hospital Universitario Príncipe de Asturias Madrid, Spain, 28005 Hospital Clínico San Carlos Madrid, Spain, 28040 Hospital Universitario la Paz Madrid, Spain, 28046 Hospital Clínico de Salamanca Salamanca, Spain, 37007 Hospital Universitario de Valme Sevilla, Spain, 41014 Less <<
NCT00453479 - Completed - -
NCT01773304 Obesity Bone ... More >>Metabolism Less << Not Applicable Completed - Denmark ... More >> Department of Human Nutrition, University of Copenhagen Copenhagen, Frederiksberg C, Denmark, 1958 Less <<
NCT03674957 - Active, not recruiting March 2019 Canada, Manitoba ... More >> University of Manitoba Winnipeg, Manitoba, Canada, R3T 6C5 Less <<
NCT01502943 Coronary Heart Disease ... More >> Stable Angina Pectoris Less << Phase 4 Completed - China, Jilin ... More >> Affiliated hospital of Changchun university of TCM Changchun, Jilin, China, 110000 Jilin integrative Chinese and western medicine hospital Changchun, Jilin, China, 110000 China, Liaoning Dalian integrative of Chinese and Western medicine hospital Dalian, Liaoning, China, 110000 Dandong TCM hospital Dandong, Liaoning, China, 110000 Fuxin TCM hospital Fuxin, Liaoning, China, 110000 Affiliated hospital of Liaoning university of TCM 2 Shenyang, Liaoning, China, 110000 Affiliated hospital of Liaoning university of TCM Shenyang, Liaoning, China, 110000 Shengjing Hospital of China Medical University Shenyang, Liaoning, China, 110000 Yingkou TCM hospital Yingkou, Liaoning, China, 110000 China, Tianjin Affiliated hospital of Tianjin university of TCM Tianjin, Tianjin, China, 110000 Less <<
NCT01446068 Nutritional Intervention ... More >> Nutritional and Metabolic Diseases Obesity Less << Early Phase 1 Completed - Switzerland ... More >> Agroscope Liebefeld-Posieux ALP Research Station Berne, Switzerland, 3003 University Hospital Inselspital, Berne Berne, Switzerland, 3010 Less <<
NCT03210805 Healthy Not Applicable Active, not recruiting January 2018 -
NCT03121729 Gastric Cancer Not Applicable Recruiting December 2018 China, Jiangsu ... More >> The First People's Hospital of Changzhou Recruiting Changzhou, Jiangsu, China, 213003 Contact: Qicheng LU, M.D.       changyiluqicheng@sina.com    Principal Investigator: Qicheng LU, M.D.          Changzhou Second People's Hospital Affiliated to Nanjing Medical University Recruiting Changzhou, Jiangsu, China, 213164 Contact: Liming TANG, M.D.       drtanglm@gmail.com    Principal Investigator: Liming TANG, M.D.          The First People's Hospital of Lianyungang City Recruiting Lianyungang, Jiangsu, China, 222002 Contact: Huiyu CHEN, M.D.          Contact: Zengtao BAO, M.D.          Principal Investigator: Huiyu CHEN, M.D.          The Second People's Hospital of Lianyungang City Recruiting Lianyungang, Jiangsu, China, 222006 Contact: Yongchang MIAO, M.D.       lygmiao@sina.com    Contact: Gang WANG, M.D.          Principal Investigator: Yongchang MIAO, M.D.          Jiangsu Cancer Hospital Recruiting Nanjing, Jiangsu, China, 210000 Contact: Gang LI, M.D.       gang_lee@medmail.com.cn    Principal Investigator: Gang LI, M.D.          Nanjing First Hospital Recruiting Nanjing, Jiangsu, China, 210000 Contact: Hongyong CAO, M.D.       caohongy6167@163.com    Principal Investigator: Hongyong CAO, M.D.          Jinling Hospital, Medical School of Nanjing University Recruiting Nanjing, Jiangsu, China, 210002 Contact: Zhi-Wei JIANG, Ph.D.    8602580860034    nzjiangzhiwei@163.com    Contact: Jian ZHAO, Ph.D.    8602580860034    zhaojiangogo@163.com    Principal Investigator: Zhi-Wei JIANG, Ph.D.          Sub-Investigator: Gang WANG, Ph.D.          Sub-Investigator: Jian ZHAO, Ph.D.          Sub-Investigator: Jiang LIU, M.D.          Zhongda Hospital, Southeast University Recruiting Nanjing, Jiangsu, China, 210009 Contact: Jingmin WANG, M.D.       wjm730222@163.com    Principal Investigator: Jingmin WANG, M.D.          the Second Affiliated Hospital of Nanjing Medical University Recruiting Nanjing, Jiangsu, China, 210011 Contact: Jianping ZHANG, M.D.       zhang_jp64@aliyun.com    Contact: Qinghong ZHAO, M.D.       njzhqh@sina.com    Principal Investigator: Jianping ZHANG, M.D.          Principal Investigator: Qinghong ZHAO, M.D.          the First Affiliated Hospital of Nanjing Medical University Recruiting Nanjing, Jiangsu, China, 210029 Contact: Lizong SHEN, M.D.       shenlz@njmu.edu.cn    Contact: Yongbin DING, M.D.          Principal Investigator: Lizong SHEN, M.D.          Suqian People's Hospital, Nanjing Drum Tower Hospital Recruiting Suqian, Jiangsu, China, 223800 Contact: Jianqiang WU, M.D.       wjq-10@163.com    Principal Investigator: Jianqiang WU, M.D.          Suzhou Municipal Hospital Recruiting Suzhou, Jiangsu, China, 215000 Contact: Xinhua GU, M.D.          Contact: Renbin SHEN, M.D.          Principal Investigator: Xinhua GU, M.D.          The Second Affiliated Hospital of Soochow University Recruiting Suzhou, Jiangsu, China, 215004 Contact: Haorong WU, M.D.       wuhaorong666@126.com    Contact: Yongyou WU, M.D.       13338706607@126.com    Principal Investigator: Haorong WU, M.D.          Principal Investigator: Yongyou WU, M.D.          The First Affiliated Hospital of Soochow University Recruiting Suzhou, Jiangsu, China, 215006 Contact: Xinguo ZHU, M.D.       zxg45@hotmail.com    Contact: Zhongqi MAO, M.D.       maozq31@hotmail.com    Principal Investigator: Xinguo ZHU, M.D.          Principal Investigator: Zhongqi MAO, M.D.          The First People's Hospital of Taicang Recruiting Suzhou, Jiangsu, China, 215400 Contact: Yi WANG, M.D.          Contact: Bing WANG, M.D.          Principal Investigator: Yi WANG, M.D.          Zhangjiagang First People's Hospital Recruiting Suzhou, Jiangsu, China, 215600 Contact: Shusheng WANG, M.D.       Wsszyy2005@163.com    Principal Investigator: Shusheng WANG, M.D.          Sub-Investigator: Liang ZHOU, M.D.          the Taizhou People's Hospital Recruiting Taizhou, Jiangsu, China, 225300 Contact: Qinghong LIU, M.D.          Contact: Honggang WANG, M.D.          Principal Investigator: Qinghong LIU, M.D.          The 101 Hospital of the Chinese People's Liberation Army Recruiting Wuxi, Jiangsu, China, 214000 Contact: Guozhong WU, M.D.       jfj101hwugz@sina.cn    Principal Investigator: Guozhong WU, M.D.          Affiliated Hospital of Jiangnan University, The Forth People's Hospital of Wuxi City Recruiting Wuxi, Jiangsu, China, 214062 Contact: Bojian FEI, M.D.       wx4yfbj@163.com    Principal Investigator: Bojian FEI, M.D.          Xuzhou Central Hospital Recruiting Xuzhou, Jiangsu, China, 221009 Contact: Xiaopeng LV, M.D.       18952171977@126.com    Principal Investigator: Xiaopeng LV, M.D.          Northern Jiangsu People's Hospital Recruiting Yangzhou, Jiangsu, China, 225001 Contact: Ping CHEN, M.D.       chen86ky@126.com    Contact: Xinxin LIU, M.D.          Principal Investigator: Ping CHEN, M.D.          Principal Investigator: Daorong WANG, M.D.          Sub-Investigator: Xinxin LIU, M.D.          Affiliated Hospital of Jiangsu University Recruiting Zhenjiang, Jiangsu, China, 212001 Contact: Jixiang CHEN, M.D.       cyok9@163.com    Principal Investigator: Jixiang CHEN, M.D.          Affiliated People's Hospital of Jiangsu University Recruiting Zhenjiang, Jiangsu, China, 212002 Contact: Pengcheng JIANG, M.D.       jpc18906106623@126.com    Contact: Shouliang ZHANG, M.D.          Principal Investigator: Pengcheng JIANG, M.D. Less <<
NCT02899377 Autoimmune Diseases Phase 1 Completed - United Kingdom ... More >> GSK Investigational Site Cambridge, United Kingdom, CB2 0GG GSK Investigational Site Cambridge, United Kingdom, CB2 0QQ GSK Investigational Site London, United Kingdom, E1 4DG GSK Investigational Site London, United Kingdom, NW1 2PG GSK Investigational Site London, United Kingdom Less <<
NCT01990612 Labor and Delivery Not Applicable Completed - United States, Alabama ... More >> University of Alabama - Birmingham Birmingham, Alabama, United States, 35233 United States, California Stanford University Stanford, California, United States, 94305-5317 United States, Colorado University of Colorado Denver, Colorado, United States, 80045 United States, Illinois Northwestern University-Prentice Hospital Chicago, Illinois, United States, 60611 United States, New York Columbia University-St. Luke's Hospital New York, New York, United States, 10032 United States, North Carolina University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States, 27599 Duke University Durham, North Carolina, United States, 27710 United States, Ohio Case Western Reserve University Cleveland, Ohio, United States, 44109 Ohio State University Hospital Columbus, Ohio, United States, 43210 United States, Pennsylvania Hospital of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Magee Womens Hospital of UPMC Pittsburgh, Pennsylvania, United States, 15213 United States, Rhode Island Brown University Providence, Rhode Island, United States, 02905 United States, Texas Dept of OB/GYN, Southwestern Medical Center, University of Texas Dallas, Texas, United States, 75235-9032 University of Texas - Galveston Galveston, Texas, United States, 77555 University of Texas - Houston Houston, Texas, United States, 77030 United States, Utah University of Utah Salt Lake City, Utah, United States, 84132 Less <<
NCT00725712 Neoplasms, Gastrointestinal Tr... More >>act Less << Phase 2 Completed - United States, Alabama ... More >> GSK Investigational Site Birmingham, Alabama, United States, 35294 United States, Arizona GSK Investigational Site Scottsdale, Arizona, United States, 85258 United States, California GSK Investigational Site Los Angeles, California, United States, 90024 GSK Investigational Site Stanford, California, United States, 94305 United States, District of Columbia GSK Investigational Site Washington, D.C., District of Columbia, United States, 20007 United States, Georgia GSK Investigational Site Atlanta, Georgia, United States, 30309 United States, Illinois GSK Investigational Site Chicago, Illinois, United States, 60637 United States, Massachusetts GSK Investigational Site Boston, Massachusetts, United States, 02114 United States, Michigan GSK Investigational Site Detroit, Michigan, United States, 48201 United States, Montana GSK Investigational Site Billings, Montana, United States, 59101 United States, New Mexico GSK Investigational Site Albuquerque, New Mexico, United States, 87131 United States, New York GSK Investigational Site New York, New York, United States, 10016 GSK Investigational Site New York, New York, United States, 10021 United States, North Carolina GSK Investigational Site Durham, North Carolina, United States, 27710 United States, Oregon GSK Investigational Site Portland, Oregon, United States, 97239 United States, Texas GSK Investigational Site Austin, Texas, United States, 78705 United States, Wisconsin GSK Investigational Site Madison, Wisconsin, United States, 53792 Less <<
NCT03336840 Polycystic Ovary Syndrome Not Applicable Recruiting June 2019 China, Jiangsu ... More >> Division of Endocrinology, the Affiliated Drum Tower Hospital of Nanjing University Recruiting Nanjing, Jiangsu, China, 210008 Contact: Dalong Zhu, MD,PhD    86-25-83-105302    zhudldr@gmail.com Less <<
NCT00725712 - Completed - -
NCT03242109 - Completed - Italy ... More >> Irccs Neuromed Pozzilli, Italy, 86067 Less <<
NCT00450801 - Completed - -
NCT02917278 End-Stage Renal Disease ... More >> Meals Hemodialysis Less << Not Applicable Completed - United States, Indiana ... More >> Purdue University West Lafayette, Indiana, United States, 47907 Less <<
NCT00450801 Lymphoma Phase 2 Completed - United States, Florida ... More >> University of Miami Sylvester Comprehensive Cancer Center - Miami Miami, Florida, United States, 33136 Less <<
NCT02548832 Mixed Dyslipidemia Phase 2 Unknown July 2016 Mexico ... More >> Institute of Experimental and Clinical Therapeutics (INTEC), CUCS, University of Guadalajara Recruiting Guadalajara, Jalisco, Mexico, 44340 Contact: Esperanza Martínez Abundis, PhD Science    (33) 1058-5200 ext 34211    esperanzamartnezabundi@yahoo.com Less <<
NCT00308425 De Novo Renal Transplantation Phase 3 Completed - -
NCT01069445 Healthy Elderly People Not Applicable Completed - France ... More >> Pôle de gerontology Clinique Hôpital Xavier Arnozan , University Hospital, Bordeaux Pessac, France, 33600 Less <<
NCT01771328 Adrenal Hyperplasia, Congenita... More >>l Less << Phase 2 Unknown January 2017 Norway ... More >> Haukeland Universitetssykehus, Department of Medicine Recruiting Bergen, Norway, 5021 Contact: Kristian Løvås, MD, PhD    +4755977996    kral@helse-bergen.no    Contact: Katerina Simunkova, MD, PhD    +4755974603    katerina.simunkova@med.uib.no    Principal Investigator: Kristian Løvås, MD, PhD          Sub-Investigator: Marianne Øksnes, MD          Sub-Investigator: Ingrid Nermoen, MD          Sub-Investigator: Paal Methlie, MD          Sub-Investigator: Eystein S Husebye, prof., MD          Principal Investigator: Katerina Simunkova, MD, PhD Less <<
NCT03680105 Critical Limb Ischemia Phase 1 Recruiting March 2019 United States, Texas ... More >> ICON Early Phase Services Recruiting San Antonio, Texas, United States, 78209 Contact: Dennis A Ruff, MD Less <<
NCT02809508 Cardiometabolic Health ... More >> Cognitive Function Less << Not Applicable Completed - Denmark ... More >> Department of Nutrition, Exercise and Sports, University of Copenhagen Frederiksberg C, Denmark Less <<
NCT03173586 - Completed - United States, Massachusetts ... More >> Harvard T.H. Chan School of Public Health Boston, Massachusetts, United States, 02115 Less <<
NCT01724099 Obesity Phase 2 Phase 3 Completed - Korea, Republic of ... More >> Gachon University Gil Medical Center Incheon, Korea, Republic of, 405-760 Less <<
NCT00111930 Healthy Not Applicable Completed - United States, Colorado ... More >> University of Colorado at Denver and Health Sciences Center Denver, Colorado, United States, 80262 Less <<
NCT00419146 Schizophrenia ... More >> Schizophreniform Disorders Schizoaffective Disorder Psychotic Disorders Less << Phase 2 Phase 3 Completed - Norway ... More >> Aker University Hospital Oslo, Norway, 0320 Less <<
NCT03232554 Iron-Deficiency Anemia Phase 2 Recruiting February 28, 2019 China, Beijing ... More >> Lei Li Recruiting Beijing, Beijing, China, 10000 Contact: Lei L Li, MD    13911988831 ext ＋86    lileigh@163.com Less <<
NCT02005003 Dietary Supplements ... More >> Probiotics Metabolism Food Preferences Microbiota Less << Not Applicable Unknown December 2015 Sweden ... More >> Department of Neuroscience, Uppsala University Recruiting Uppsala, Sweden, 75324 Contact: Jonathan Cedernaes, M.D., PhD       jonathan.cedernaes@neuro.uu.se    Contact: Christian Benedict, PhD       christian.benedict@neuro.uu.se    Principal Investigator: Christian Benedict, PhD Less <<
NCT01673490 Prostatic Hyperplasia Phase 4 Terminated(The sole investigat... More >>ive site refused to accept the amended protocol and declined to continue the study. There was no safety signal nor any other reason.) Less << - Vietnam ... More >> GSK Investigational Site Ho Chi Minh, Vietnam Less <<
NCT03175757 Cholesterol Health Not Applicable Completed - United States, Florida ... More >> Life Extension Clinical Research, Inc. Fort Lauderdale, Florida, United States, 33308 Less <<
NCT01673490 - Terminated(The sole investigat... More >>ive site refused to accept the amended protocol and declined to continue the study. There was no safety signal nor any other reason.) Less << - -
NCT00290121 Schizophrenia Phase 4 Completed - Canada, Quebec ... More >> Centre de recherche Fernand-Seguin Montréal, Quebec, Canada, H1N 3V2 Less <<
NCT01858662 Metastatic Colorectal Cancer Phase 2 Terminated(due to poor recrutm... More >>ent) Less << - Belgium ... More >> Grand Hôpital de Charleroi Charleroi, Hainaut, Belgium, 6000 clinique Saint Luc Bouge, Belgium, 5004 Cliniques universitaires Saint-Luc - UCL Brussels, Belgium, 1200 Centre Hospitalier Jolimont Lobbes La Louvière, Belgium, 7100 CHU liège (Sart Timan) Liège, Belgium, 4000 Clinique Saint Pierre Ottignies Ottignies, Belgium, 1340 CHU-UCL Dinant-Godinne Yvoir, Belgium, 5530 Less <<
NCT02795754 Infection, Human Immunodeficie... More >>ncy Virus Less << Phase 1 Completed - United States, Maryland ... More >> GSK Investigational Site Baltimore, Maryland, United States, 21225 Less <<
NCT03414294 Healthy Phase 1 Recruiting February 27, 2020 Australia, South Australia ... More >> CMAX, Clinical Research Pty Ltd Recruiting Adelaide, South Australia, Australia, 5000 Less <<
NCT01846702 Healthy Volunteers Phase 1 Completed - Singapore ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Singapore, Singapore, 117597 Less <<
NCT02384551 Gastroesophageal Reflux Diseas... More >>e Obesity Less << Early Phase 1 Recruiting December 31, 2020 United States, Tennessee ... More >> Tennessee Valley Healthcare System Nashville Campus, Nashville, TN Recruiting Nashville, Tennessee, United States, 37212-2637 Contact: Kevin D Niswender, MD PhD    615-936-0500    Kevin.Niswender@va.gov    Contact: Heidi J Silver, PhD    (615) 593-1299    heidi.j.silver@vanderbilt.edu    Principal Investigator: Kevin D Niswender, MD PhD Less <<
NCT01846702 - Completed - -
NCT03019874 - Recruiting June 2019 Germany ... More >> Charité Hochschulambulanz für Naturheilkunde am Immanuel Krankenhaus Recruiting Berlin, Germany, 14109 Contact: Miriam Rösner, Study nurse    00493080505682    m.roesner@immanuel.de Less <<
NCT01135576 Iron-deficiency Anemia Not Applicable Completed - -
NCT03030365 - Not yet recruiting February 15, 2020 -
NCT01211301 Obesity Body ... More >>Weight Weight Loss Overweight Nutrition Disorders Less << Not Applicable Completed - United States, Alabama ... More >> University of Alabama at Birmingham Division of Preventive Medicine Birmingham, Alabama, United States, 35205 Less <<
NCT00733980 Depressive Disorder, Major Phase 2 Completed - United States, California ... More >> GSK Investigational Site Cerritos, California, United States, 90703 GSK Investigational Site San Diego, California, United States, 92108 GSK Investigational Site Torrance, California, United States, 90502 United States, Florida GSK Investigational Site Jacksonville, Florida, United States, 32216 GSK Investigational Site Miami, Florida, United States, 33125 United States, Georgia GSK Investigational Site Atlanta, Georgia, United States, 30322 GSK Investigational Site Marietta, Georgia, United States, 30060 United States, Illinois GSK Investigational Site Chicago, Illinois, United States, 60612 GSK Investigational Site Skokie, Illinois, United States, 60076 United States, Louisiana GSK Investigational Site Shreveport, Louisiana, United States, 71104 United States, Maryland GSK Investigational Site Rockville, Maryland, United States, 20852 United States, New Mexico GSK Investigational Site Albuquerque, New Mexico, United States, 87109 United States, North Carolina GSK Investigational Site Raleigh, North Carolina, United States, 27609 United States, Ohio GSK Investigational Site Cincinnati, Ohio, United States, 45219-0516 United States, Pennsylvania GSK Investigational Site Philadelphia, Pennsylvania, United States, 19104 United States, Tennessee GSK Investigational Site Memphis, Tennessee, United States, 38119 United States, Wisconsin GSK Investigational Site Brown Deer, Wisconsin, United States, 53223 GSK Investigational Site Madison, Wisconsin, United States, 53719 Less <<
NCT01860547 Type 2 Diabetes ... More >> Atherosclerosis Less << Not Applicable Completed - Finland ... More >> University of Turku, Dept of Biochemistry and Food Chemistry Turku, Finland, FI-20014 Less <<
NCT00733980 - Completed - -
NCT01207089 Overweight He... More >>althy Male Less << Phase 1 Completed - United Kingdom ... More >> Research Site London, United Kingdom Less <<
NCT01343576 Coronary Heart Disease Not Applicable Completed - Denmark ... More >> Department of Human Nutrition Frederiksberg, Denmark, 1958 Less <<
NCT03125993 Obesity Not Applicable Not yet recruiting August 30, 2017 -
NCT03269747 Brown Adipose Tissue Phase 4 Recruiting June 30, 2019 Switzerland ... More >> University Hospital Basel, Department of Endocrinology Recruiting Basel, BS, Switzerland, 4031 Contact: Matthias J Betz, MD    0041 61 265 5078    matthias.betz@usb.ch Less <<
NCT01176890 Vagotomy, Truncal Not Applicable Unknown December 2012 Denmark ... More >> Department of Internal Medicine F' laboratory Hellerup, Copenhagen, Denmark, 2900 Less <<
NCT00533897 Rheumatoid Arthritis Phase 3 Completed - -
NCT03081065 Clinical Trial ... More >> Depression Mediterranean, Diet Less << Not Applicable Not yet recruiting November 30, 2019 -
NCT03285737 Aging Muscle ... More >>Loss Less << Not Applicable Completed - Canada, Ontario ... More >> Exercise Metabolism Research Laboratory, McMaster Univeristy Hamilton, Ontario, Canada, L8S 4K1 Less <<
NCT01576094 Low Cardiac Output Syndrome Phase 1 Phase 2 Completed - Spain ... More >> Hospital Universitario La Paz Madrid, Spain, 28046 Less <<
NCT00533897 - Completed - -
NCT02507791 Obesity Not Applicable Unknown April 2016 United States, Ohio ... More >> UH Rainbow Babies and Children's Hospital Recruiting Cleveland, Ohio, United States, 44106 Contact: Ryan M Farrell, MD    216-844-3661    ryan.farrell@uhhospitals.org    Contact: Naveen Uli, MD    216-844-3661    Naveen.Uli1@uhhospitals.org Less <<
NCT00520507 Bipolar Disorder ... More >> Depression Depressive Disorder Less << Phase 4 Completed - Canada, Ontario ... More >> Queen's University, Providence Care-Mental Health Services Kingston, Ontario, Canada, K7L 4X3 Less <<
NCT03311308 Advanced Melanoma Phase 1 Recruiting December 2028 United States, Pennsylvania ... More >> Univ of Pittsburgh Medical Center Hillman Cancer Center Recruiting Pittsburgh, Pennsylvania, United States, 15232 Contact: Amy Rose, RN    412-647-8587 Less <<
NCT01449110 Cardiovascular Diseases Phase 2 Completed - Spain ... More >> University Hospital Morales Meseguer Murcia, Spain, 30008 Less <<
NCT02417623 Obesity Not Applicable Unknown January 2017 Spain ... More >> Primary Health Care La Granja- Torreforta Recruiting Tarragona, Spain, 43006 Contact: Gemma Flores Mateo, PhD    0034977778515    gflores@idiapjgol.org    Sub-Investigator: Mar Sorlí, Bsc Less <<
NCT00044278 Epilepsy Phase 2 Completed - -
NCT02563899 - Completed - -
NCT02165553 Cardiovascular Diseases Not Applicable Completed - United Kingdom ... More >> Department of Food and Nutritional Sciences, University of Reading, Reading, Berkshire, United Kingdom, RG6 6AP Less <<
NCT01534208 Secondary Hypogonadism Phase 3 Completed - United States, Arizona ... More >> Clinical Research Advantage Glendale, Arizona, United States, 85306 Clinical Research Advantage Phoenix, Arizona, United States, 85020 United States, Arkansas Baptist Health Center for Clinical Research Little Rock, Arkansas, United States, 72205 United States, California Catalina Research Institute Chino, California, United States, 91710 SC Clinical Research Garden Grove, California, United States, 92844 South Orange County Endocrinology Laguna Hills, California, United States, 92653 Anthony Mills, MD Los Angeles, California, United States, 90069 SD Uro-Research San Diego, California, United States, 92103 San Diego Sexual Medicine San Diego, California, United States, 92120 SC Clinical Research Santa Ana, California, United States, 92703 West Coast Clinical Research Tarzana, California, United States, 91356 United States, Colorado Clinical Research Advantage Colorado Springs, Colorado, United States, 80906 Clinical Research Advantage Colorado Springs, Colorado, United States, 80922 United States, Florida Meridien Research Bradenton, Florida, United States, 34208 Florida Fertility Institute Clearwater, Florida, United States, 33759 Therafirst Medical Center Fort Lauderdale, Florida, United States, 33308 East Coast Institute for Clinical Research Jacksonville, Florida, United States, 32204 East Coast Institute for Research Jacksonville, Florida, United States, 32204 East Coast Institute for Research Jacksonville, Florida, United States, 32258 Cetero Research Miami Gardens, Florida, United States, 33169 Well Pharma Medical Research Miami, Florida, United States, 33143 DMI Research Pinellas Park, Florida, United States, 33782 Ebon Bourne, MD Plantation, Florida, United States, 33324 Meridien Research St. Petersburg, Florida, United States, 33709 United States, Maryland IRC Clinics Towson, Maryland, United States, 21204 United States, New Jersey Premier Urology Associates Lawrenceville, New Jersey, United States, 08648 United States, Texas Advances in Health Houston, Texas, United States, 77030 Breco Research Sugar Land, Texas, United States, 77479 Center of Reproductive Medicine Webster, Texas, United States, 77598 United States, Utah Lone Peak Family Medicine Draper, Utah, United States, 84020 Granger Medical Clin ic Riverton, Utah, United States, 84065 Less <<
NCT02481999 - Terminated - Germany ... More >> Department of Anesthesiology and Operative Intensive Care Medicine (CCM, CVK), Charité - University Medicine Berlin Berlin, Germany, 13353 Less <<
NCT01534208 - Completed - -
NCT02529709 Dyslipidemia Not Applicable Completed - United States, Texas ... More >> Texas Christian University Fort Worth, Texas, United States, 76129 Less <<
NCT02756819 - Completed - -
NCT01790594 Simultaneous Kidney and Pancre... More >>as Transplantation Less << Phase 2 Terminated(Slow accrual within... More >> enrollment time period projected accrual goal not achieved.) Less << - United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35294 United States, California University of California San Francisco Medical Center San Francisco, California, United States, 94143-0780 United States, Georgia Emory University Atlanta, Georgia, United States, 30322 United States, Indiana Indiana University Hospital Indianapolis, Indiana, United States, 46202 United States, Wisconsin University of Wisconsin Madison, Wisconsin, United States, 53792 Less <<
NCT00083551 Multiple Myeloma Phase 3 Completed - United States, Arkansas ... More >> University of Arkansas for Medical Sciences/MIRT Little Rock, Arkansas, United States, 72205 Less <<
NCT00197145 - Terminated - -
NCT03032861 Intestinal Diseases Not Applicable Completed - Brazil ... More >> Sao Paulo State University "Julio de Mesquita Filho", Faculdade de Ciências Farmacêuticas Araraquara, Sao Paulo, Brazil, 14800-903 Less <<
NCT01790594 - Terminated(Slow accrual within... More >> enrollment time period projected accrual goal not achieved.) Less << - -
NCT00197145 Infection, Human Immunodeficie... More >>ncy Virus I Less << Phase 3 Terminated - -
NCT01805830 Type 2 Diabetes Phase 3 Completed - Korea, Republic of ... More >> Handok Pharmaceuticals CO. LTD Seoul, Korea, Republic of Less <<
NCT03270527 Lipids Lipid ... More >>Metabolism Healthy Less << Not Applicable Recruiting June 2020 United Kingdom ... More >> Department of Food and Nutritional Sciences, University of Reading Recruiting Reading, Berkshire, United Kingdom, RG6 6AP Contact: Julie Lovegrove, PhD          Sub-Investigator: Glenn Gibson, PhD          Sub-Investigator: Kim Jackson, PhD          Sub-Investigator: Athanasios Koutsos, PhD          Department of Nutritional Sciences, University of Surrey Not yet recruiting Guildford, Surrey, United Kingdom, GU2 7WG Contact: Bruce Griffin, PhD          Sub-Investigator: Barbara Fielding, PhD          Sub-Investigator: Denise Robertson, PhD          Sub-Investigator: Rona Antoni, PhD Less <<
NCT02600377 - Unknown November 2016 -
NCT00083551 - Completed - -
NCT03776552 Obesity Not Applicable Not yet recruiting December 31, 2022 -
NCT03310853 Pregnancy Phase 2 Recruiting October 31, 2020 Canada, Quebec ... More >> Clinique OVO Recruiting Montreal, Quebec, Canada Contact: Sophie Leblanc    514-798-2000 ext 755    s.leblanc@cliniqueovo.com Less <<
NCT03641027 Obesity Physi... More >>cal Activity Less << Not Applicable Recruiting December 31, 2019 Sweden ... More >> Sahlgrenska University Hospital Recruiting Gothenburg, Sweden, 413 45 Contact: Monika Fagevik Olsén, PhD    +46 31 342 11 95    monika.fagevik-olsen@vgregion.se Less <<
NCT03097237 Overweight Ob... More >>esity Less << Not Applicable Unknown August 2018 Sweden ... More >> Swedish University of Agricultural Sciences Recruiting Uppsala, Sweden Contact: Kia Nöhr Iversen, MSc    +46702567405    kia.nohr.iversen@slu.se    Contact: Rikard Landberg, Dr       rikard.landberg@slu.se    Principal Investigator: Rikard Landberg, Dr Less <<
NCT00613600 Overweight Ob... More >>esity Less << Phase 2 Completed - United States, Illinois ... More >> Rush University Medical Center Chicago, Illinois, United States, 60612 Less <<
NCT02723955 Cancer Phase 1 Recruiting May 18, 2020 United States, California ... More >> GSK Investigational Site Recruiting Duarte, California, United States, 91010 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    United States, New York GSK Investigational Site Recruiting New York, New York, United States, 10016 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    GSK Investigational Site Recruiting New York, New York, United States, 10032 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    United States, Pennsylvania GSK Investigational Site Recruiting Philadelphia, Pennsylvania, United States, 19111 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    United States, Tennessee GSK Investigational Site Recruiting Nashville, Tennessee, United States, 37203 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    GSK Investigational Site Not yet recruiting Nashville, Tennessee, United States, 37232-6307 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    Australia, Victoria GSK Investigational Site Recruiting Heidelberg, Victoria, Australia, 3084 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    GSK Investigational Site Recruiting Melbourne, Victoria, Australia, 3000 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    Australia, Western Australia GSK Investigational Site Recruiting Nedlands, Western Australia, Australia, 6009 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    Canada, Ontario GSK Investigational Site Recruiting Toronto, Ontario, Canada, M5G 2M9 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    France GSK Investigational Site Not yet recruiting Bordeaux Cedex, France, 33076 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    GSK Investigational Site Not yet recruiting Lyon cedex 08, France, 69373 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    GSK Investigational Site Recruiting Paris, France, 75005 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    GSK Investigational Site Recruiting Villejuif cedex, France, 94805 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    Italy GSK Investigational Site Recruiting Siena, Toscana, Italy, 53100 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    Netherlands GSK Investigational Site Recruiting Amsterdam, Netherlands, 1066 CX Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    Spain GSK Investigational Site Recruiting Barcelona, Spain, 08035 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    GSK Investigational Site Recruiting Barcelona, Spain, 08036 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    GSK Investigational Site Recruiting Madrid, Spain, 28040 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    GSK Investigational Site Recruiting Málaga, Spain, 29010 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    GSK Investigational Site Recruiting Sevilla, Spain, 41009 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com Less <<
NCT03671733 Obesity Phase 3 Recruiting September 1, 2020 China, Hunan ... More >> Xiangya Hospital of Central South University Recruiting Changsha, Hunan, China, 410008 Contact: Jing Wu    +86-13574120508    wujing0731@163.com Less <<
NCT03590613 Autoimmune Diseases Phase 1 Active, not recruiting September 21, 2018 Japan ... More >> GSK Investigational Site Fukuoka, Japan, 812-0025 Less <<
NCT00095173 Juvenile Rheumatoid Arthritis Phase 3 Completed - -
NCT01063374 Type 2 Diabetes Phase 2 Completed - Canada, Ontario ... More >> Sunnybrook Health Sciences Centre Toronto, Ontario, Canada, M4N 3M5 Clinical Nutrition & Risk Factor Modification Centre, St. Michael's Hospital Health Centre Toronto, Ontario, Canada, M5C 2T2 Less <<
NCT03044353 Amyloidosis Phase 2 Suspended(Pending data review.... More >>) Less << September 23, 2021 United States, Massachusetts ... More >> GSK Investigational Site Boston, Massachusetts, United States, 02115 United Kingdom GSK Investigational Site Cambridge, United Kingdom, CB2 0GG GSK Investigational Site London, United Kingdom, NW10 7EW Less <<
NCT00095173 - Completed - -
NCT02927457 Lupus Erythematosus, Cutaneous Phase 1 Completed - Germany ... More >> GSK Investigational Site Tuebingen, Baden-Wuerttemberg, Germany, 72076 GSK Investigational Site Erlangen, Bayern, Germany, 91054 GSK Investigational Site Bonn, Nordrhein-Westfalen, Germany, 53127 GSK Investigational Site Muenster, Nordrhein-Westfalen, Germany, 48149 GSK Investigational Site Wuppertal, Nordrhein-Westfalen, Germany, 42283 GSK Investigational Site Mainz, Rheinland-Pfalz, Germany, 55131 GSK Investigational Site Berlin, Germany, 10117 Less <<
NCT02172222 Healthy Phase 1 Completed - -
NCT02197130 Huntington's Disease Phase 2 Completed - -
NCT02903966 Colitis, Ulcerative Phase 2 Recruiting May 7, 2019 United States, California ... More >> GSK Investigational Site Recruiting Moreno Valley, California, United States, 92555 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    GSK Investigational Site Terminated Oceanside, California, United States, 92056 GSK Investigational Site Recruiting San Diego, California, United States, 92115 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    United States, Louisiana GSK Investigational Site Not yet recruiting Marrero, Louisiana, United States, 70072 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    United States, Michigan GSK Investigational Site Recruiting Chesterfield, Michigan, United States, 48047 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    United States, New York GSK Investigational Site Recruiting Great Neck, New York, United States, 11021 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    United States, Washington GSK Investigational Site Not yet recruiting Seattle, Washington, United States, 98195 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    Germany GSK Investigational Site Recruiting Ulm, Baden-Wuerttemberg, Germany, 89081 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    GSK Investigational Site Not yet recruiting Frankfurt, Hessen, Germany, 60431 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    GSK Investigational Site Not yet recruiting Kiel, Schleswig-Holstein, Germany, 24105 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    Netherlands GSK Investigational Site Recruiting Amsterdam, Netherlands, 1105 AZ Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    Poland GSK Investigational Site Recruiting Katowice, Poland, 40-660 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    GSK Investigational Site Recruiting Ksawerow, Poland, 95-054 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    GSK Investigational Site Not yet recruiting Wroclaw, Poland Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    Russian Federation GSK Investigational Site Recruiting Rostov-on-Don, Russian Federation, 344091 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    GSK Investigational Site Recruiting St Pertersburg, Russian Federation, 196247 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    GSK Investigational Site Not yet recruiting Stavropol, Russian Federation, 355018 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    GSK Investigational Site Recruiting Ufa, Russian Federation, 450071 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    Sweden GSK Investigational Site Recruiting Stockholm, Sweden, SE-171 76 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    GSK Investigational Site Recruiting Stockholm, Sweden, SE-182 88 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    GSK Investigational Site Recruiting Uppsala, Sweden, SE-752 37 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    United Kingdom GSK Investigational Site Recruiting Stockport, Cheshire, United Kingdom, SK2 7JE Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    GSK Investigational Site Recruiting Belfast, United Kingdom, BT16 1RH Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    GSK Investigational Site Recruiting Dudley, United Kingdom, DY1 2HQ Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    GSK Investigational Site Not yet recruiting Edgbaston, Birmingham, United Kingdom, B15 2GW Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com Less <<
NCT02439099 - Recruiting December 2018 Germany ... More >> Department of Psychiatry, Charité - Campus Benjamin Franklin Recruiting Berlin, Germany, 12203 Less <<
NCT02197130 - Completed - -
NCT01198405 Coronary Artery Disease Not Applicable Unknown September 2013 China, Guangdong ... More >> The 1st Affiliated Hospital of Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510080 Contact: Gui-fu Wu, M.D. & Ph.D.    +86-135-7001-0112    eecpchina@yahoo.com.cn    Contact: Da-ya Yang, M.D.    +86-135-7056-7490    y2kchocolate@163.com    Principal Investigator: Zhi-min Du, M.D.          The 2nd Affiliated Hospital of Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510080 Contact: Jing-feng Wang, M.D.    +86-136-0289-0860       Contact: Ru-qiong Nie, M.D.    +86-136-0047-9016       The 3rd Affiliated Hospital of Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510080 Contact: Lin Chen, M.D.    +86-138-0251-8615       Contact: Xiao-xian Qian, M.D.    +86-137-1926-1500       The 5th Affiliated Hospital of Sun Yat-sen University Recruiting Zhuhai, Guangdong, China, 519000 Contact: Jian Peng, M.D.    +86-136-0036-1608 Less <<
NCT00232882 Hypertension Phase 4 Completed - Canada, Quebec ... More >> Institut de Recherches Cliniques de Montréal Montréal, Quebec, Canada, H2W 1R7 Less <<
NCT02452489 Diabetic Gastroparesis Phase 1 Unknown August 2018 China, Jilin ... More >> The Affiliated Hospital To Changchun University of Chinese Medicine Recruiting Changchun, Jilin, China, 130117 Contact: Tie Li, Ph.D    +86 0431 86714973    zusanli_1999@126.com Less <<
NCT01685944 Obesity Not Applicable Completed - Japan ... More >> Hiroshima University Hiroshima, Japan, 734-8551 Less <<
NCT01845558 Muscle Injury ... More >> Muscle Soreness Exercise Induced Muscle Damage Less << Phase 4 Completed - Germany ... More >> Sportschule FFb Puch GmbH Fürstenfeld Bruck, Germany, 82256 Less <<
NCT01735357 Healthy Not Applicable Completed - United Kingdom ... More >> Diabetes & Nutritional Sciences Division, King's College London London, United Kingdom, SE1 9NH Less <<
NCT02358109 Cardiovascular Diseases ... More >> Diabetes Dyslipidemias Metabolic Syndrome Quality of Life Less << Not Applicable Completed - Spain ... More >> Department of Physiology, Faculty of Farmacy, University of Granada Granada, Andalucía, Spain, 18071 Less <<
NCT02172209 Healthy Phase 1 Completed - -
NCT01819636 Hypertriglyceridemia Not Applicable Completed - France ... More >> OPTIMED Gières, France, 38610 Naturalpha Lille, France, 59020 Biofortis Saint Herblain, France, 44800 Less <<
NCT02796989 Healthy Obese Phase 1 Phase 2 Completed - Belgium ... More >> KU Leuven Leuven, Vlaams-Brabant, Belgium, 3000 Less <<
NCT03041961 Healthy Young Men Not Applicable Completed - United Kingdom ... More >> Department of Life Sciences and Medecine London, Central London, United Kingdom, SE1 9NH Less <<
NCT01913470 NAFLD Phase 2 Completed - United States, Georgia ... More >> Emory University / Children's Healthcare of Atlanta Atlanta, Georgia, United States, 30322 Less <<
NCT02219191 Rheumatoid Arthritis Not Applicable Active, not recruiting December 2018 China, Sichuan ... More >> 270 Rongdu street, Jin-niu district,Rheumatology Center of Integrated Medicine, General Hospital of Chengdu Military Area Command PLA， Chengdu city, Sichuan, China, 610083 Less <<
NCT01384032 Cardiovascular Diseases Not Applicable Completed - United Kingdom ... More >> Department of Food and Nutritional Sciences, University of Reading Reading, United Kingdom, RG6 6AP Less <<
NCT01913470 - Completed - -
NCT00981981 Hypercholesterolemia Phase 2 Completed - Australia, New South Wales ... More >> SUGiRS Human Nutrition Unit, School of Molecular & Microbial Biosciences, Unviersity of Sydney Sydney, New South Wales, Australia, 2006 Canada, Ontario Human Nutraceutical Research Unit, Department of Human Health and Nutritional Sciences, University of Guelph Guelph, Ontario, Canada, N1G 2W1 Glycemic Index Laboratories, Inc. Toronto, Ontario, Canada, M5C 2X3 Canada, Quebec Nutraceuticals and Functional Foods Institute, Faculte des science de l'agriculture et de l'alimentation, Universite Laval Laval, Quebec, Canada United Kingdom Reading Scientific Services, Ltd (RSSL) Reading, Berkshire, United Kingdom, RG6 6LA Less <<
NCT03520699 - Recruiting December 31, 2028 China ... More >> Beijing Friendship Hospital Recruiting Beijing, China Contact: Zhongtao Zhang, M.D.    +86-13801060364    zhangzht@ccmu.edu.cn Less <<
NCT01009060 Schizophrenia Phase 2 Completed - United States, California ... More >> GSK Investigational Site Garden Grove, California, United States, 92845 GSK Investigational Site Los Angeles, California, United States, 90073 GSK Investigational Site National City, California, United States, 91950 GSK Investigational Site Sacramento, California, United States, 95817 GSK Investigational Site San Diego, California, United States, 92102 GSK Investigational Site Torrance, California, United States, 90502 United States, Illinois GSK Investigational Site Chicago, Illinois, United States, 60611 United States, Indiana GSK Investigational Site Indianapolis, Indiana, United States, 46222 United States, Maryland GSK Investigational Site Catonsville, Maryland, United States, 21228 United States, Massachusetts GSK Investigational Site Boston, Massachusetts, United States, 02114 GSK Investigational Site Jamaica Plain, Massachusetts, United States, 02130 United States, New Jersey GSK Investigational Site Mount Laurel, New Jersey, United States, 08054 United States, New York GSK Investigational Site New York, New York, United States, 10016 GSK Investigational Site New York, New York, United States, 10032 United States, North Carolina GSK Investigational Site Butner, North Carolina, United States, 27509 Less <<
NCT01142726 Rheumatoid Arthritis Phase 3 Completed - -
NCT03708068 Enteral Nutrition Not Applicable Not yet recruiting December 2020 Canada, Alberta ... More >> Peter Lougheed Hospital Not yet recruiting Calgary, Alberta, Canada, T1Y6J4 Contact: Belal Alshaikh, MD          Sub-Investigator: Essa Al Awad, MD          Sub-Investigator: Nalini Singhal, MD          Foothills Medical Centre Not yet recruiting Calgary, Alberta, Canada, T2N2T9 Contact: Belal Alshaikh, MD          Principal Investigator: Belal Alshaikh, MD          Sub-Investigator: Dinesh Dharel, MD          Rockyview General Hospital Not yet recruiting Calgary, Alberta, Canada, T2V1P9 Contact: Belal Alshaikh, MD          Sub-Investigator: Jeanne Scotland, NNP          South Health Campus Not yet recruiting Calgary, Alberta, Canada, T3M1P9 Contact: Belal Alshaikh, MD          Principal Investigator: Belal Alshaikh, MD          Sub-Investigator: Ruma Jain, MD Less <<
NCT02611102 Hyperlipidemia Not Applicable Recruiting July 2019 United States, Maryland ... More >> Walter Reed National Military Medical Center Recruiting Bethesda, Maryland, United States, 20889-5600 Sub-Investigator: Henry Burch, MD          Principal Investigator: Karl Nadolsky, DO          Principal Investigator: Alicia L Warnock, MD          Principal Investigator: Todd Villines, MD          Principal Investigator: Matthew Jezior, MD Less <<
NCT02539576 Infection, Human Immunodeficie... More >>ncy Virus Less << Phase 1 Completed - United States, California ... More >> GSK Investigational Site Glendale, California, United States, 91206 Less <<
NCT01009060 - Completed - -
NCT03029364 - Recruiting June 30, 2024 United Kingdom ... More >> Department for Health, University of Bath Recruiting Bath, United Kingdom, BA2 7AY Contact: Oliver J Chrzanowski-Smith, MSc    +44 (0) 1225384654    o.j.chrzanowski-smith@bath.ac.uk    Contact: Javier T Gonzalez, PhD    +44 (0) 1225 38 5518    J.T.Gonzalez@bath.ac.uk Less <<
NCT01522001 Acute Coronary Syndrome ... More >> Myocardial Ischemia Acute Myocardial Infarction: Rehabilitation Phase Less << Phase 4 Completed - Denmark ... More >> Silkeborg Hospital Silkeborg, Region Midt, Denmark, 8600 Aarhus University Hospital. Department of Cardiology and Medicine Aarhus, Denmark, 8000 Viborg Hospital, Hospital Unit of Viborg, Silkeborg, Hammel and Skive Viborg, Denmark, 8800 Less <<
NCT02511860 Hypertension Not Applicable Unknown February 2016 -
NCT02708342 - Completed - -
NCT02993627 Obesity Not Applicable Recruiting November 2017 Iran, Islamic Republic of ... More >> Clinical Nutrition and Diet Therapy Clinic of Shahid Beheshti University of Medical Sciences Recruiting Tehran, Iran, Islamic Republic of, 1981619573 Contact: Reyhaneh yousefi, MSc. student    0098191998669    yousefi.ryhn@yahoo.com    Contact: Atoosa Saidpour, PHD    00989123026088    atoosa.saidpour@gmail.com    Sub-Investigator: Azadeh Mottaghi, PHD Less <<
NCT03669757 Psoriasis Vulgaris Phase 1 Recruiting February 2019 Germany ... More >> Investigational Site Recruiting Schwerin, Mecklenburg-Vorpommern, Germany, 19055 Investigational Site Recruiting Hamburg, Germany, 20095 Less <<
NCT01142726 - Completed - -
NCT02418728 - Completed - Belgium ... More >> Hasselt University Diepenbeek, Belgium, 3590 Less <<
NCT03532659 Overweight and Obesity ... More >> Cardiovascular Risk Factor Physical Activity Less << Not Applicable Active, not recruiting October 2018 Brazil ... More >> Escola Municipal de Ensino Fundamental Governador Antônio Mariz Campina Grande, PB, Brazil, 58415483 Escola Municipal de Ensino Fundamental Tiradentes Campina Grande, PB, Brazil, 58416336 Less <<
NCT03152617 - Recruiting December 2027 Sweden ... More >> Department of Gastrosurgical R & E, the Sahlgrenska Academy,University of Gothenburg Recruiting Göteborg, Sweden, SE41345 Contact: Lars Fandriks, M.D., PhD.    +46313424123    lars.fandriks@gastro.gu.se Less <<
NCT02520232 Alzheimer's Disease Not Applicable Recruiting September 2018 France ... More >> University Hospital Bordeaux, France Recruiting Bordeaux, France, 33076 Contact: Michèle ALLARD    0556765540    michele.allard@chu-bordeaux.fr    Contact: Philippe FERNANDEZ       philippe.ferandez@chu-bordeaux.fr    Sub-Investigator: Jean François DARTIGUES          Sub-Investigator: Jean-Simon ARNOULD          Sub-Investigator: Alexandra FOUBERT          University Hospital, Poitiers Not yet recruiting Poitiers, France, 86021 Contact: Marc PACCALIN       Marc.PACCALIN@chu-poitiers.fr Less <<
NCT02615392 Healthy Not Applicable Completed - Singapore ... More >> Khoo Teck Puat Hospital Singapore, Singapore, 768828 Less <<
NCT03326648 Sarcopenia Not Applicable Completed - Norway ... More >> Norwegian School of Sport Sciences Oslo, Norway, 0863 Less <<
NCT02160730 Cushings Disease Phase 2 Terminated(NIH grant ended.) - United States, California ... More >> Cedars-Sinai Medical Center Los Angeles, California, United States, 90048 Less <<
NCT02206126 Obstructive Sleep Apnea Not Applicable Completed - Brazil ... More >> Discipline of Clinical and Experimental Pathophysiology, CLINEX Rio de Janeiro, Brazil, 20.551-030 Less <<
NCT03625531 Polycystic Ovary Syndrome Phase 3 Not yet recruiting October 7, 2021 -
NCT02836106 Healthy Overw... More >>eight Obesity Less << Not Applicable Completed - Norway ... More >> University of Oslo Oslo, Norway Less <<
NCT03308565 Spinal Cord Injuries ... More >> Paralysis Less << Phase 1 Recruiting November 2023 United States, Minnesota ... More >> Mayo Clinic Recruiting Rochester, Minnesota, United States, 55905 Less <<
NCT02127671 Cardiovascular Risk Factors ... More >> Serious Mental Illness Less << Not Applicable Active, not recruiting November 2018 United States, Maryland ... More >> Johns Hopkins ProHealth Clinical Research Facility Woodlawn, Maryland, United States Less <<
NCT03652584 Muscle Loss P... More >>hysical Disability Less << Not Applicable Active, not recruiting June 2019 -
NCT03342183 Chronic Kidney Disease Not Applicable Recruiting January 1, 2021 Canada, Ontario ... More >> London Health Sciences Centre Recruiting London, Ontario, Canada, N6A 5W9 Contact: Chris McIntyre, MD    519-685-8500 ext 58502    christopher.mcintyre@lhsc.on.ca    Contact: Jarrin Penny    519-685-8500 ext 58765    jarrin.penny@lhsc.on.ca    Principal Investigator: Christopher W McIntyre, MD Less <<
NCT02542813 Postpartum Hemorrhage Phase 1 Completed - United Kingdom ... More >> GSK Investigational Site Cambridge, United Kingdom, CB2 2GG Less <<
NCT03749785 Exercise Not Applicable Recruiting June 30, 2019 United Kingdom ... More >> Department for Health, University of Bath Recruiting Bath, United Kingdom, BA2 7AY Contact: James Betts, PhD    +44 1225 383 448    J.Betts@bath.ac.uk Less <<
NCT02100020 Multiple Sclerosis Not Applicable Completed - Canada, Ontario ... More >> McMaster University, Physical Activity Centre for Excellence Hamilton, Ontario, Canada, L8S 4K1 Queens University Kingston, Ontario, Canada, K7L 3N6 Less <<
NCT03064932 Cardiovascular Disease ... More >> Inflammation Less << Not Applicable Recruiting December 2018 United States, Pennsylvania ... More >> Penn State University Recruiting University Park, Pennsylvania, United States, 16802 Contact: Kristina Petersen, PhD    814-863-8622    kup63@psu.edu    Principal Investigator: Penny Kris-Etherton, PhD          Sub-Investigator: Sheila West, PhD          Sub-Investigator: Connie Rogers, PhD          Sub-Investigator: David Proctor, PhD          Sub-Investigator: Kristina Petersen, PhD Less <<
NCT00345982 Schizophrenia Not Applicable Completed - Denmark ... More >> Aalborg Psychiatric Hospital Aalborg, Denmark, 9000 Less <<
NCT02868710 Cardiovascular Disease Not Applicable Completed - United States, Colorado ... More >> Western State Colorado University Gunnison, Colorado, United States, 82131 Less <<
NCT00411359 Angina Pectoris ... More >> Coronary Disease Less << Phase 3 Completed - United Kingdom ... More >> National Heart and Lung Institute, Imperial College London London, United Kingdom, SW3 6LY Less <<
NCT02418975 Perioperative/Postoperative Co... More >>mplications Less << Not Applicable Recruiting December 2017 Italy ... More >> A.O.R.N. "San Giuseppe Moscati" Recruiting Avellino, Italy Contact: Giuseppe Castaldo, MD    00390825203358    lavoronep@yahoo.it Less <<
NCT02482974 - Completed - Turkey ... More >> Ege University Izmir, Turkey, 35100 Less <<
NCT00731510 Hypoxia Not Applicable Completed - United Kingdom ... More >> Medical Expeditions Ltd Pinfold, Hyssington, Montgomery, Powys, United Kingdom, SY15 6AY Less <<
NCT03677583 Gastrointestinal Complication Not Applicable Completed - Netherlands ... More >> Stichting Wageningen Research Wageningen, Gelderland, Netherlands, 6708 WG Less <<
NCT03625284 Non Alcoholic Fatty Liver Not Applicable Not yet recruiting December 10, 2019 -
NCT03774446 Cushing Disease Phase 2 Recruiting November 2022 United States, California ... More >> Cedars-Sinai Medical Center Recruiting Los Angeles, California, United States, 90048 Contact: Vivian Hwe    424-315-4489    Vivian.Hwe@cshs.org    Principal Investigator: Shlomo Melmed, MD          Sub-Investigator: Ning-Ai Liu, MD Less <<
NCT03523403 Obesity, Abdominal ... More >> Hyperlipidemias Inflammation Dysbiosis Less << Not Applicable Recruiting December 31, 2018 Canada, Ontario ... More >> Human Nutraceutical Research Unit, University of Guelph Recruiting Guelph, Ontario, Canada, N1G 2W1 Contact: Lindsay E Robinson, PhD    519-824-4120 ext 52297    lrobinso@uoguelph.ca    Contact: Amanda J Wright, PhD    519-824-4120 ext 54697    ajwright@uoguelph.ca Less <<
NCT02494739 Oxidative Stress ... More >> Inflammation Less << Not Applicable Completed - Greece ... More >> Department of Physical Education & Sport Science of the University of Thessaly Trikala, Karyes, Greece, 42100 Less <<
NCT00149604 Postmenopause Phase 2 Completed - United States, Colorado ... More >> University of Colorado at Denver and Health Sciences Center Denver, Colorado, United States, 80262 Less <<
NCT02957318 Fecal Fat Increased ... More >> Obesity Appetite Less << Not Applicable Completed - Denmark ... More >> University of Copenhagen, Department of Nutrition, Exercise and Sports Copenhagen, Denmark, 1958 Less <<
NCT02109445 - Terminated(The study was termi... More >>nated on 24JUN15 due to change in strategy of PF-03084014 development.No safety/efficacy concerns were behind the reason of trial termination) Less << - -
NCT01195610 Obesity Not Applicable Completed - Denmark ... More >> Department of Human Nutrition Frederiksberg, Denmark, 1958 Less <<
NCT00516321 Hepatitis C, Chronic Phase 3 Completed - -
NCT00170820 Renal Transplantation Phase 4 Completed - Switzerland ... More >> Novartis Basel, Switzerland Less <<
NCT00908037 Purpura, Thrombocytopaenic, Id... More >>iopathic Less << Phase 2 Completed - -
NCT03102372 Muscle Loss Not Applicable Completed - -
NCT00516321 - Completed - -
NCT02109445 Metastatic Cancer Pancreas Phase 2 Terminated(The study was termi... More >>nated on 24JUN15 due to change in strategy of PF-03084014 development.No safety/efficacy concerns were behind the reason of trial termination) Less << - United States, Colorado ... More >> Anschutz Inpatient Pavilion Aurora, Colorado, United States, 80045 Drug Shipment: Anschutz Cancer Pavilion Aurora, Colorado, United States, 80045 University of Colorado Cancer Center Aurora, Colorado, United States, 80045 University of Colorado Denver, CTO (CTRC) Aurora, Colorado, United States, 80045 United States, New York University of Rochester Investigational Drug Pharmacy Rochester, New York, United States, 14642 University of Rochester Rochester, New York, United States, 14642 Less <<
NCT01003873 - Completed - France ... More >> Haut Lévêque Hospital, Endocrine department Pessac, France, 33600 Less <<
NCT02453204 Older Adults Not Applicable Completed - United Kingdom ... More >> BHF Glasgow Cardiovascular Research Centre, University of Glasgow, 126 University Avenue Glasgow, United Kingdom, G12 8TA Leicester Diabetes Centre, Diabetes Research Unit, University of Leicester, Leicester General Hospital Leicester, United Kingdom, LE5 4PW Less <<
NCT02954367 Dietary Modification Not Applicable Unknown - -
NCT01882881 Cardiovascular Disease Not Applicable Completed - United States, Pennsylvania ... More >> Penn State Clinical Research Center, Noll Lab University Park, Pennsylvania, United States, 16802 Less <<
NCT00549497 Asthma Phase 1 Completed - Australia, Queensland ... More >> GSK Investigational Site Herston, Queensland, Australia, 4006 Less <<
NCT00908037 - Completed - -
NCT01877967 Alteration of Cognitive Functi... More >>on Disturbance in Affect (Finding) Less << Not Applicable Unknown July 2015 Ireland ... More >> Institute of Neuroscience, Trinity College, Dublin Dublin, Co. Dublin, Ireland, 0000 Less <<
NCT02287779 Non-Alcoholic Steatohepatitis Phase 1 Completed - United States, Tennessee ... More >> New Orleans Center for Clinical Research Knoxsville, Tennessee, United States, 37920 Less <<
NCT01305291 Lack of Satiety Not Applicable Completed - United States, Iowa ... More >> Nutrition and Wellness Research Center Ames, Iowa, United States, 50011 Less <<
NCT01173354 Chronic Obstructive Pulmonary ... More >>Disease Less << Not Applicable Active, not recruiting June 2018 United States, Arkansas ... More >> University of Arkansas for Medical Sciences Little Rock, Arkansas, United States, 72205 Less <<
NCT01064778 Obesity Not Applicable Completed - United States, Massachusetts ... More >> Children's Hospital Boston Boston, Massachusetts, United States, 02115 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Brigham and Women's Hospital Boston, Massachusetts, United States, 02215 Less <<
NCT02287779 - Completed - -
NCT02512900 - Completed - -
NCT01655979 Countermeasure Evaluation Not Applicable Completed - Germany ... More >> DLR German Aerospace Center Cologne, Germany, 51147 Less <<
NCT01172301 Cystic Fibrosis Not Applicable Completed - United States, Arkansas ... More >> University of Arkansas for Medical Sciences Little Rock, Arkansas, United States, 72205 Less <<
NCT02581345 Chronic Plaque Psoriasis ... More >> Psoriasis Less << Phase 3 Completed - -
NCT02512900 Asthma Phase 1 Completed - Poland ... More >> Research Site Kielce, Poland, 25-040 Research Site Wrocław, Poland, 51-162 Research Site Wrocław, Poland, 53-201 Research Site Łódź, Poland, 71-329 Less <<
NCT01963416 Vascular Stiffness Not Applicable Completed - United Kingdom ... More >> University of Reading Reading, Berkshire, United Kingdom, RG2 9AR Less <<
NCT01549015 Urea Cycle Disorders Not Applicable Completed - Germany ... More >> CRS Clinical Research Services GmbH (Phase I Unit), Mönchengladbach, Germany, 41061 Medizinische Hochschule Hannover, Klinik für Kinderheilkunde Hannover, Germany, 30625 Universitätsklinikum Heidelberg Klinik für Kinderheilkunde I Heidelberg, Germany, D-69120 Universitätsklinikum Münster, Zentrum für Kinder- und Jugendmedizin Münster, Germany, 48149 Less <<
NCT00838110 - Completed - -
NCT00838110 Alzheimer's Disease Phase 3 Completed - -
NCT02581345 - Completed - -
NCT01427140 Healthy Not Applicable Completed - Sweden ... More >> Uppsala University Hospital, Uppsala Science Park Uppsala, Sweden Less <<
NCT02776033 Psoriasis Phase 2 Completed - Canada, Ontario ... More >> GSK Investigational Site Markham, Ontario, Canada, L3P1X2 GSK Investigational Site Peterborough, Ontario, Canada, K9J 5K2 GSK Investigational Site Waterloo, Ontario, Canada, N2J 1C4 Canada, Quebec GSK Investigational Site Montreal, Quebec, Canada, H2K 4L5 Less <<
NCT00795678 - Completed - United States, New York ... More >> Memorial Sloan Kettering New York, New York, United States, 10065 United States, Ohio Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44195 Less <<
NCT03303521 Hyperkalemia Phase 3 Completed - -
NCT03213717 Obesity Edema Not Applicable Completed - Sweden ... More >> University of Gothenburg Göteborg, Box 100, Sweden, S-405 30 Less <<
NCT01226316 Advanced Solid Malignancy ... More >> Safety and Tolerability Pharmacokinetics Pharmacodynamics Tumour Response Advanced or Metastatic Breast Cancer Ovarian Cancer Cervical Cancer Endometrial Cancer PIK3CA AKT1 PTEN ER Positive HER2 Positive Less << Phase 1 Recruiting November 15, 2019 -
NCT02914249 Obesity Not Applicable Completed - -
NCT01484353 Type 2 Diabetes Not Applicable Withdrawn(This study was cance... More >>lled.) Less << - United States, California ... More >> Kaiser Permanente Riverside Medical Center Riverside, California, United States, 92505 Less <<
NCT03372109 Body Weight Changes Not Applicable Completed - United States, Florida ... More >> Life Extension Clinical Research, Inc. Fort Lauderdale, Florida, United States, 33308 Less <<
NCT03545347 Hip Fractures Phase 2 Recruiting December 2019 Denmark ... More >> Hvidovre Hospital Recruiting Hvidovre, Denmark, 2650 Contact: Morten Tange Kristensen    38626191    morten.tange.kristensen@regionh.dk Less <<
NCT02495285 - Recruiting May 2019 Bulgaria ... More >> National Cardiology Hospital Recruiting Sofia, Bulgaria, 1606 Contact: Dimitar Pechilkov, Dr.          Germany Auf der Bult Recruiting Hannover, Germany, 30173 Contact: Christoph Eich, Prof. Dr. med.    +49 511 8115 ext 6611    eich@hka.de    Medizinische Hochschule Hannover, Pädiatrische Kardiologie und Intensivmedizin Recruiting Hannover, Germany, 30625 Contact: Robert Sümpelmann, Prof. Dr. med.    +49 5 11532 ext 9080    suempelmann.robert@mh-hannover.de    Principal Investigator: Robert Sümpelmann, Prof.          Klinik Hallerwiese/Cnopf´sche Kinderklinik Recruiting Nuernberg, Germany, 90419 Contact: Karin Becke, Dr. med.    +49-911-3340 ext 4900    Karin.Becke@diakonieneuendettelsau.de    Klinikum Stuttgart, Olgahospital und Frauenklinik Recruiting Stuttgart, Germany, 70174 Contact: Franz-Josef Kretz, Prof. Dr.          Italy Azienda Policlinico Universitaria G. Rodolico -Vittorio Emanuele Recruiting Catania, Italy, I-95100 Contact: Marinella Astuto, Prof. Dr.       astmar@tiscali.it    Ospedale dei Bambini Vittore Buzzi Recruiting Milano, Italy, I-20154 Contact: Anna Camporesi, Dr.       anna.camporesi@asst-fbf-sacco.it    United Kingdom Alder Hey Children's NHS FT Recruiting Liverpool, United Kingdom, L12 2AP Contact: Peter Murphy, Dr.       Peter.Murphy@alderhey.nhs.uk Less <<
NCT03570541 Postoperative Pain Phase 4 Recruiting August 30, 2019 Denmark ... More >> Zealand University Hospital, Department of Anaesthesiology Recruiting Roskilde, Denmark, 4000 Contact: Jens Børglum, Phd    +45 30700120    jedn@regionsjaelland.dk    Sub-Investigator: Mette Dam, Phd Student          Sub-Investigator: Christian Hansen, Phd Student          Sub-Investigator: Martin Vedel, Phd Student          Principal Investigator: Katrine Tanggaard, Phd Student          Sub-Investigator: Rune Hasselager, Phd Student Less <<
NCT01815203 Eating Behavior ... More >> Obesity Less << Not Applicable Completed - Sweden ... More >> Uppsala University Uppsala, Sweden, 75319 Less <<
NCT03004846 Psoriasis Phase 2 Completed - Germany ... More >> GSK Investigational Site Hamburg, Germany, 20095 Less <<
NCT01382212 End-Stage Renal Disease ... More >> Secondary Hyperparathyroidism Less << Phase 3 Completed - -
NCT03693430 Overweight Ob... More >>esity Less << Phase 3 Recruiting March 19, 2021 -
NCT03605992 Cardiovascular Diseases ... More >> Coronary Disease Less << Not Applicable Recruiting October 30, 2019 Brazil ... More >> Federal University of Minas Gerais Recruiting Belo Horizonte, Minas Gerais, Brazil, 31270-901 Contact: Raquel R Britto, Post doc    5531999704527    r3britto@gmail.com    Contact: Ana Paula Lima, MD    5531991066066    analimafisio@yahoo.com.br Less <<
NCT01382212 - Completed - -
NCT00896012 Kidney Transplantation Phase 4 Unknown December 2010 United States, New York ... More >> Buffalo General Hospital Multi-Organ Transplant Department Buffalo, New York, United States, 14203 Less <<
NCT02832648 Osteoporosis Phase 3 Active, not recruiting September 2018 United Kingdom ... More >> Sheffield Teaching Hospitals NHS Foundation Trust Sheffield, United Kingdom, S10 2JF Less <<
NCT03417674 Overweight and Obesity Not Applicable Active, not recruiting December 31, 2018 Germany ... More >> West-German Centre of Diabetes and Health Düsseldorf, Germany, 40591 Less <<
NCT02585622 Diabetic Kidney Disease Phase 1 Phase 2 Recruiting December 2020 Ireland ... More >> National University of ireland - Galway University Hospital -Regenerative Medicine Institute Recruiting Galway, Ireland Contact: Matthew Griffin, MD    00353 91 495107    matthew.griffin@nuigalway.ie    Italy ASST - Papa Giovanni XXIII - U.O. Nefrologia e Dialisi/ Mario Negri Institute for Pharmacological Research - Clinical Research Center for Rare Diseases Aldo e Cele Daccò Recruiting Bergamo, BG, Italy, 24027 Contact: Giuseppe Remuzzi, MD    0039 035 45351    giuseppe.remuzzi@marionegri.it    United Kingdom Belfast Health and Social Care Trust - Belfast City Hospital Recruiting Belfast, United Kingdom Contact: Peter Maxwell, MD    0044 28 95049751    peter.maxwell@belfasttrust.hscni.net.as    University Hospital Birmingham NHS Foundation Trust - Queen Elizabeth Medical Centre Recruiting Birmingham, United Kingdom Contact: Paul Cockwell, MD    0044 121 3714181    paul.cockwell@uhb.nhs.uk Less <<
NCT02607436 Coronary Artery Disease Phase 4 Completed - Korea, Republic of ... More >> Seoul National University Bundang Hospital Seongnam, Gyeonggi, Korea, Republic of, 463-707 Less <<
NCT02628275 Atherosclerosis Not Applicable Recruiting September 2019 Canada, Quebec ... More >> Institut universitaire de cardiologie et de pneumologie de Québec - Université Laval Recruiting Québec, Quebec, Canada, G1V 4G5 Contact: Karine Bibeau, PhD    418-656-8711 ext 3386    karine.bibeau@criucpq.ulaval.ca    Sub-Investigator: James Brophy, MD, PhD          Sub-Investigator: Jean-Pierre Després, PhD          Sub-Investigator: Paul Poirier, MD, PhD Less <<
NCT03136991 Cardiovascular Disease Phase 1 Completed - United States, California ... More >> Research Site Glendale, California, United States, 91206 Less <<
NCT03019146 Perioperative Hypertension ... More >> Hypertension Less << Not Applicable Recruiting - United Kingdom ... More >> University Of Nottingham Recruiting Derby, United Kingdom, DE22 3NE Contact: Philip Herrod, BMBS       philip.herrod@nottingham.ac.uk    Sub-Investigator: Philip Herrod, BMBS          Principal Investigator: Beth Philips, PhD          Sub-Investigator: Jon Lund, PhD Less <<
NCT03194516 - Enrolling by invitation May 2021 United States, Maryland ... More >> University of Maryland GCCC Baltimore, Maryland, United States, 21201 Less <<
NCT03447314 Neoplasms Phase 1 Recruiting February 14, 2020 United States, Missouri ... More >> GSK Investigational Site Not yet recruiting Saint Louis, Missouri, United States, 63110 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    United States, Texas GSK Investigational Site Recruiting Dallas, Texas, United States, 75230 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    GSK Investigational Site Recruiting Houston, Texas, United States, 77030 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    United States, Washington GSK Investigational Site Recruiting Tacoma, Washington, United States, 98405 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    Netherlands GSK Investigational Site Not yet recruiting Amsterdam, Netherlands, 1066 CX Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    Spain GSK Investigational Site Not yet recruiting Barcelona, Spain, 08035 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com Less <<
NCT03069989 Idiopathic Pulmonary Fibrosis Phase 1 Active, not recruiting May 23, 2019 United Kingdom ... More >> GSK Investigational Site London, United Kingdom, SW3 6HP GSK Investigational Site London, United Kingdom, WC1E 6JF GSK Investigational Site London, United Kingdom Less <<
NCT02542748 Hypotension O... More >>bstetrical Complication of Anesthesia Complications; Cesarean Section Less << Not Applicable Completed - China, Shaanxi ... More >> Xijing Hospital,Fourth Military Medical University Xi'an, Shaanxi, China, 710032 Less <<
NCT03773900 Cardiometabolic Risk ... More >> Abdominal Obesity Less << Not Applicable Recruiting November 7, 2019 France ... More >> Centre de Recherche en Nutrition Humaine Rhône-Alpes - Centre hospitalier Lyon Sud Recruiting Pierre-Bénite, France, 69310 Contact: Martine MD LAVILLE, PhD    4 78 86 29 81 ext +33    martine.laville@univ-lyon1.fr    Contact: Julie-Anne NAZARE, PhD    4 78 86 29 81 ext +33    julie-anne.nazare@univ-lyon1.fr    Principal Investigator: Martine MD LAVILLE, PhD          Sub-Investigator: Emmanuel MD DISSE, PhD          Sub-Investigator: Nathalie MD FEUGIER-FAVIER          Sub-Investigator: Stéphanie MD LAMBERT-PORCHERON          Sub-Investigator: Bérénice MD SEGRESTIN Less <<
NCT02380833 Healthy Not Applicable Completed - United States, South Carolina ... More >> Clemson University Clemson, South Carolina, United States, 29631 Less <<
NCT00131547 Obstructive Sleep Apnea Not Applicable Completed - Canada, Ontario ... More >> London Health Sciences Centre London, Ontario, Canada, N6A 4G5 Less <<
NCT03011203 Glycogen Storage Disease IIIA Not Applicable Completed - Netherlands ... More >> University of Groningen, UMC Groningen Groningen, Netherlands Less <<
NCT01573858 Pregnancy Pol... More >>ycystic Ovary Syndrome Infertility Less << Not Applicable Unknown December 2014 -
NCT03562117 Infections, Bacterial Phase 1 Recruiting April 10, 2019 United States, Florida ... More >> GSK Investigational Site Recruiting Miami, Florida, United States, 33136 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    GSK Investigational Site Recruiting Orlando, Florida, United States, 32809 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com Less <<
NCT02172248 Healthy Phase 1 Completed - -
NCT03359473 Cachexia Phase 2 Recruiting November 3, 2019 United States, California ... More >> GSK Investigational Site Not yet recruiting Torrance, California, United States, 90502 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    United States, Florida GSK Investigational Site Recruiting Jacksonville, Florida, United States, 32216 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    United States, North Carolina GSK Investigational Site Recruiting High Point, North Carolina, United States, 27262 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    United States, South Carolina GSK Investigational Site Recruiting Spartanburg, South Carolina, United States, 29303 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    Germany GSK Investigational Site Recruiting Frankfurt, Hessen, Germany, 60596 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    GSK Investigational Site Recruiting Grosshansdorf, Schleswig-Holstein, Germany, 22927 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com Less <<
NCT01273584 Pregnancy Complications ... More >> Obesity Less << Phase 2 Phase 3 Completed - United Kingdom ... More >> Medway Hospital NHS Trust Gillingham, Kent, United Kingdom, ME7 5NY Epsom and St Helier University Hospitals NHS Trust Carshalton, Surrey, United Kingdom, SM5 1AA Kings College, London London, United Kingdom, SE5 8RX Less <<
NCT02941770 Overweight Not Applicable Recruiting February 2019 Portugal ... More >> Hospital de Santa Maria Recruiting Lisbon, Portugal, 1649-035 Contact: António Videira-Silva, MSc    969172368    antonioascenso@campus.ul.pt Less <<
NCT01353937 Diabetic Ulcer Phase 1 Withdrawn(Never Activated) September 2016 United States, New York ... More >> Helen L. & Martin S. Kimmel Wound Healing Center at the NYU Hospital for Joint Diseases New York, New York, United States, 10003 Less <<
NCT03678714 Polycystic Ovary Syndrome Not Applicable Recruiting May 2020 United Kingdom ... More >> Centre for Sports and Exercise Science, Sheffield Hallam University Recruiting Sheffield, England, United Kingdom, S10 2BP Contact    (+44) 0114225569       Principal Investigator: Amie Woodward, MSc          Sub-Investigator: Markos Klonizakis, PhD          Sub-Investigator: David Broom, PhD Less <<
NCT03450655 Visceral Obesity Not Applicable Enrolling by invitation September 28, 2018 Sweden ... More >> Livsmedicin (LIFE) Umeå, Västerbotten, Sweden, 907 36 Less <<
NCT01755572 Type 2 Diabetes ... More >> Systolic Hypertension Less << Phase 4 Completed - Canada, Ontario ... More >> Leadership Sinai Centre for Diabetes, Mount Sinai Hospital, Canada Toronto, Ontario, Canada Less <<
NCT03136380 Pulmonary Disease, Chronic Obs... More >>tructive Less << Phase 1 Completed - Japan ... More >> GSK Investigational Site Tokyo, Japan, 162-0053 Less <<
NCT02432768 Glycogen Storage Disease Type ... More >>V Less << Phase 2 Recruiting January 2019 Denmark ... More >> Copenhagen Neuromuscular Center, 3342, Rigshospitalet Recruiting Copenhagen, Denmark, 2100 Contact: Karen L Madsen, MD    +45 35456126    karen.lindhardt.madsen@regionh.dk Less <<
NCT02738385 Metabolic Diseases Not Applicable Completed - Colombia ... More >> Robinson Ramírez Vélez Ph.D Bogotá, Colombia Less <<
NCT03623529 Catecholamine-resistant Hypote... More >>nsion (CRH) Distributive Shock High Output Shock Septic Shock Less << Phase 2 Recruiting April 2023 Belgium ... More >> Investigational Site Not yet recruiting Brussels, Belgium Lithuania Investigational Site Recruiting Vilnius, Lithuania, 08406 Less <<
NCT02495727 Muscular Atrophy Not Applicable Completed - United Kingdom ... More >> University of Bath Bath, Avon, United Kingdom, BA2 7AY Less <<
NCT02322242 Shoulder Surgery ... More >> Nerve Block Less << Phase 4 Active, not recruiting December 2019 Canada, Ontario ... More >> Sunnybrook Health Sciences Centre Toronto, Ontario, Canada, M4N 3M5 Less <<
NCT03048487 - Completed - United States, Pennsylvania ... More >> Geisinger Medical Center Danville, Pennsylvania, United States, 17822 Geisinger Community Medical Center, Scranton, PA Scranton, Pennsylvania, United States, 18510 Geisinger Wyoming Valley Medical Center Wilkes-Barre, Pennsylvania, United States, 18711 Less <<
NCT01058239 Post-transplant Lymphoprolifer... More >>ative Disease Solid Organ Transplant Stem Cell Transplant (Bone Marrow Transplant) Epstein Barr Virus Infections Less << Phase 2 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Less <<
NCT01999088 Low Risk for Cardiovascular Di... More >>sease Less << Phase 4 Completed - Spain ... More >> Hospital Universitario La Paz Madrid, Maadrid, Spain, 28046 Less <<
NCT01058239 - Completed - -
NCT01728896 Acute Pancreatitis Not Applicable Unknown - New Zealand ... More >> University of Auckland; Auckland City Hospital Recruiting Auckland, New Zealand Contact: Max S Petrov, MD, MPH, PhD       max.petrov@gmail.com    Principal Investigator: Max S Petrov, MD, MPH, PhD Less <<
NCT02970942 Hepatobiliary Disorders ... More >> Non-alcoholic Steatohepatitis Less << Phase 2 Active, not recruiting April 2, 2020 -
NCT02256995 - Unknown June 2015 Bangladesh ... More >> Hope Hospital for Women and Children Cox's Bazar, Bangladesh, 4700 Less <<
NCT02919488 Endothelial Dysfunction Not Applicable Completed - United States, Texas ... More >> Texas Christian University Fort Worth, Texas, United States, 76129 Less <<
NCT01992900 Malaria,Falciparum Phase 2 Completed - Burkina Faso ... More >> Centre Muraz Bobo Dioulasso, Burkina Faso Centre National de Recherche et de Formation en Paludisme Ouagadougou, Burkina Faso Congo, The Democratic Republic of the Kinshasa School of Public Health, School of Medicine, University of Kinshasa Kinshasa, Congo, The Democratic Republic of the Gambia Medical Research Council Fajara, Gambia Mozambique Manica's Health Research Centre Manica, Mozambique Tanzania Bagamoyo Research center, Ifakara Heath Institute Bagamoyo, Tanzania National Insititute for Medical Research Tanga, Tanzania Less <<
NCT01760239 Hypertension ... More >>Pre Hypertension Obesity Less << Not Applicable Completed - United States, Minnesota ... More >> HealthPartners Medical Group Minneapolis, Minnesota, United States, 55440 Less <<
NCT01494025 Obesity Not Applicable Completed - United States, California ... More >> Western Human Nutrition Research Center Davis, California, United States, 95616 Less <<
NCT02848599 Postoperative Cognitive Dysfun... More >>ction Less << Phase 2 Recruiting December 2017 Croatia ... More >> Clinical Hospital Centre Osijek Recruiting Osijek, Croatia, 31000 Contact: Gordana Kristek, MD    +385915115746    gordanaldrmed@yahoo.com    Sub-Investigator: Sonja Škiljić, MD          Sub-Investigator: Nenad Nešković, MD Less <<
NCT02950441 Aging Phase 2 Recruiting September 2019 United Kingdom ... More >> University Hospitals Birmingham NHS Foundation Trust Recruiting Birmingham, West Midlands, United Kingdom, B15 2TH Contact: Yasir Elhassan, MRCP    +441214158705    y.mohamedelhassan@bham.ac.uk Less <<
NCT03462589 Diabetes Phase 1 Recruiting November 30, 2018 China, Jiangsu ... More >> The First Affiliated Hospital of Nanjing Medical University Recruiting Nanjing, Jiangsu, China, 210029 Contact: Feng Shao, Doctor    086-025-83672212 ext 10-86    shaofengnj@163.com Less <<
NCT02579252 Alzheimer's Disease Phase 2 Active, not recruiting June 2019 -
NCT03614520 Healthy Phase 1 Recruiting December 29, 2018 Spain ... More >> Consorci Parc de Salut Mar Recruiting Barcelona, Spain, 08017 Contact: Julian Mateus, doctor pharmacólogo    933160491 ext +34    jmateus@imim.es Less <<
NCT00048035 Anemia Phase 2 Completed - United States, Alabama ... More >> Birmingham, Alabama, United States, 35211 United States, California Los Angeles, California, United States, 90095 United States, Illinois Maywood, Illinois, United States, 60153 United States, Kentucky Louisville, Kentucky, United States, 40202-1718 United States, Michigan Detroit, Michigan, United States, 48202-2689 Detroit, Michigan, United States, 48236 United States, Minnesota Brooklyn Center, Minnesota, United States, 55430 United States, Nevada Las Vegas, Nevada, United States, 89106 United States, New Jersey Paterson, New Jersey, United States, 07503 United States, New York Brooklyn, New York, United States, 11203 Mineola, New York, United States, 11501 New York, New York, United States, 10128 United States, Tennessee Nashville, Tennessee, United States, 37232 United States, West Virginia Morgantown, West Virginia, United States, 26506 Less <<
NCT02800395 Alzheimer Disease Not Applicable Recruiting December 2024 France ... More >> Service de Médecine Gériatrique. Groupement Hospitalier Sud. Hospices Civils de Lyon. Recruiting Pierre Benite, France, 69495 Contact: Marc BONNEFOY, Pr    (0)4 78 86 15 81 ext +33    marc.bonnefoy@chu-lyon.fr Less <<
NCT00960505 Coronary Heart Disease ... More >> Obesity Weight Loss Less << Not Applicable Completed - United States, Illinois ... More >> University of Illinois, Chicago Chicago, Illinois, United States, 60622 Less <<
NCT02501239 Depression Ob... More >>esity Less << Not Applicable Completed - United States, New Hampshire ... More >> Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States, 03766 Less <<
NCT02210767 Cardiovascular Disease Not Applicable Completed - United States, Pennsylvania ... More >> Penn State University University Park, Pennsylvania, United States, 16802 Less <<
NCT03318731 Muscle Damage ... More >> Inflammation Less << Not Applicable Recruiting September 2018 United States, Texas ... More >> UMHB Human Performance Lab Recruiting Belton, Texas, United States, 76513 Contact: Stacie L Urbina, MsEd    254-295-4280 ext 4280    surbina@umhb.edu    Contact: Lem W Taylor, PhD    254-295-4895 ext 4895    ltyalor@umhb.edu    Sub-Investigator: Katelyn B Villa, B.S.          Sub-Investigator: Allyson K Bermea          Sub-Investigator: Torrey Boggs          Sub-Investigator: Matthias R Tinnin, B.S.          Sub-Investigator: Javier A Zaragoza          Sub-Investigator: Seth M Bates          Sub-Investigator: Colin D Wilborn, PhD          Sub-Investigator: Cliffa Foster, EdD Less <<
NCT02944097 Safety After Oral Intake ... More >> Pharmacokinetics After Oral Intake Less << Early Phase 1 Completed - Germany ... More >> University of Hohenheim Stuttgart, Baden-Württemberg, Germany, 70599 Less <<
NCT02944084 Safety After Oral Intake ... More >> Pharmacokinetics After Oral Intake Less << Early Phase 1 Completed - Germany ... More >> University of Hohenheim Stuttgart, Baden-Württemberg, Germany, 70599 Less <<
NCT02342067 Healthy Phase 1 Completed - United States, Colorado ... More >> DaVita Clinical Research Lakewood, Colorado, United States, 80228 Less <<
NCT00635089 Eosinophilic Esophagitis Phase 3 Completed - -
NCT00048035 - Completed - -
NCT00635089 - Completed - -
NCT01739907 Iron Deficiency Not Applicable Completed - -
NCT03140397 Safety After Oral Intake ... More >> Pharmacokinetics After Oral Intake Immune Cells Activity Less << Early Phase 1 Completed - Germany ... More >> University of Hohenheim Stuttgart, Baden-Württemberg, Germany, 70599 Eberhard Karls University Tuebingen Tübingen, Baden-Württemberg, Germany, 72076 Less <<
NCT02874287 Coronary Artery Disease Phase 4 Recruiting May 2018 China, Shanxi ... More >> First Affiliated Hospital of Xi'an Jiaotong University Recruiting Xi'an, Shanxi, China Contact: Yue Wu, Professor    0086-029-8532-3664    imyuewu@qq.com Less <<
NCT01935674 HIV Hyperchol... More >>esterolaemia Less << Phase 4 Completed - Spain ... More >> Hospital Clinic of Barcelona Barcelona, Spain, 08036 Less <<
NCT03286777 Safety of Native vs. Micellar ... More >>6-PN After Oral Intake Pharmacokinetics of Native vs. Micellar 6-PN After Oral Intake PBMC Activity After Native vs. Micellar 6-PN Oral Intake Less << Not Applicable Completed - Germany ... More >> University of Hohenheim Stuttgart, Baden-Württemberg, Germany, 70599 Eberhard Karls University Tuebingen Tübingen, Baden-Württemberg, Germany, 72076 Less <<
NCT01267097 Obesity Child Not Applicable Completed - Canada, Alberta ... More >> Pediatric Centre for Weight and Health Edmonton, Alberta, Canada, T5K 0L4 Less <<
NCT02257359 Embryo Transfer Phase 1 Completed - United States, Kansas ... More >> GSK Investigational Site Overland Park, Kansas, United States, 66211 Less <<
NCT02836184 Hyperphosphatemia Phase 4 Unknown September 2016 China, Jiangxi ... More >> Jiujiang NO.1 People's Hospital Recruiting Jiujiang, Jiangxi, China, 332000 Less <<
NCT02752100 PAD Not Applicable Recruiting May 2020 China ... More >> The third hospital affiliated to the Third Military Medical University Recruiting Chongqing, China, 400042 Contact: Zhiming Zhu, MD, PhD    86-023-68705094    zhuzm@yahoo.com    Principal Investigator: Zhiming Zhu, MD, PhD Less <<
NCT02566330 - Completed - Netherlands ... More >> Maastricht University Medical Center Maastricht, Limburg, Netherlands, 6229 HX Less <<
NCT02488252 Diabetic Nephropathies Phase 2 Phase 3 Recruiting December 2019 Hong Kong ... More >> Queen Mary Hospital Recruiting Hong Kong, Hong Kong Contact: Sydney CW TANG, MD, PhD    +852 22553879    scwtang@hku.hk    Contact: Kam Wa CHAN, BCM, MCM, MSc.(PH)    +852 22553207    chriskwcchan@hku.hk    Sub-Investigator: YB FENG, PhD Less <<
NCT00123214 Sleep Deprivation Not Applicable Completed - United States, New York ... More >> Saint Vincent's Hospital New York, New York, United States, 10011 Less <<
NCT01369550 Healthy Volunteers ... More >> Markers of Cardiovascular Risk Less << Not Applicable Completed - United States, Florida ... More >> Meridien Research St. Petersburg, Florida, United States, 33709 United States, Illinois Provident Clinical Research & Consulting, Inc. Addison, Illinois, United States Less <<
NCT00633022 - Completed - -
NCT02593539 Activated PI3K-delta Syndrome Phase 2 Recruiting December 11, 2019 United Kingdom ... More >> GSK Investigational Site Recruiting Cambridge, United Kingdom, CB2 0GG Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com Less <<
NCT03347162 - Recruiting December 31, 2022 Denmark ... More >> Rigshospitalet Recruiting Copenhagen, Denmark Contact: Jesper F Christensen, PhD Less <<
NCT00779519 Obesity Phase 2 Completed - United States, California ... More >> Los Angeles, California, United States, 90095 San Diego, California, United States, 92130 United States, Georgia Augusta, Georgia, United States, 30909 United States, Illinois Springfield, Illinois, United States, 26704 United States, Nevada Reno, Nevada, United States, 89502 United States, New York New York, New York, United States, 10065 United States, North Carolina Charlotte, North Carolina, United States, 28277 United States, Virginia Norfolk, Virginia, United States, 23502 Richmond, Virginia, United States, 23294 Canada, Nova Scotia Halifax, Nova Scotia, Canada, B3K 5R3 Canada, Ontario Oakville, Ontario, Canada, L6H 3P1 Toronto, Ontario, Canada Less <<
NCT00633022 Atherosclerosis Phase 2 Completed - United Kingdom ... More >> GSK Investigational Site Oxford, Oxfordshire, United Kingdom, OX3 9DU GSK Investigational Site Cambridge, United Kingdom, CB2 2GG GSK Investigational Site London, United Kingdom, E1 1B3 GSK Investigational Site London, United Kingdom, Se1 7EH Less <<
NCT02778568 Peripheral Artery Disease ... More >> Intermittent Claudication Less << Not Applicable Completed - Brazil ... More >> Emergency Hospital of Pernambuco - PROCAPE Recife, PE, Brazil, 50100-060 Less <<
NCT02314936 Functional Constipation Phase 2 Completed - Canada, Ontario ... More >> KGK Synergize Inc. London, Ontario, Canada, N6A 5R8 Less <<
NCT02314936 - Completed - -
NCT03055754 Obesity Weigh... More >>t Gain Less << Not Applicable Active, not recruiting January 2018 Brazil ... More >> Kaiser Clinic and Day Hospital Sao Jose do Rio Preto, SP, Brazil, 15015-110 Less <<
NCT02856997 Peripheral T Cell Lymphoma Phase 2 Not yet recruiting - -
NCT03045991 Stroke Patients With Cognitive... More >> Decline Less << Not Applicable Recruiting August 2019 Taiwan ... More >> Chang Gung Memorial Hospital Recruiting Kwei-Shan, Taoyuan, Taiwan, 333 Contact: Ching-Yi Wu, ScD    886-3-2118800 ext 5761    cywu@mail.cgu.edu.tw    Chiayi Chang Gung Memorial Hospital Recruiting Chiayi City, Taiwan, 613 Contact: Shi-Zhe Lin, MS    +886-5-3621000 ext 2688    apirlline@cgmh.org.tw    Kaohsiung Chang Gung Memorial Hospital Recruiting Kaohsiung City, Taiwan, 83301 Contact: Ku-Chou Chang, MD    +886-7317123 ext 2285    kcchang@cgmh.org.tw    Keeling Chang Gung Memorial Hospital Recruiting Keelung City, Taiwan, 204 Contact: Chia-Ling Chen, PhD    +886-3-3281200 ext 8147    ccl1374@adm.cgmh.com.tw    Taipei Chang Gung Memorial Hospital Recruiting Taipei City, Taiwan, 105 Contact: Chia-Ling Chen, PhD    +886-3-3281200 ext 8147    ccl1374@adm.cgmh.com.tw    Taoyuan Chang Gung Memorial Hospital Recruiting Taoyuan City, Taiwan, 333 Contact: Chia-Ling Chen, PhD    +886-3-3281200 ext 8147    ccl1374@adm.cgmh.com.tw Less <<
NCT02832414 Sleep Apnea, Obstructive ... More >> Obesity Less << Not Applicable Recruiting - Spain ... More >> Hospital Universitari de Bellvitge Recruiting L'Hospitalet de Llobregat, Barcelona, Spain Contact: Carmen Monasterio Less <<
NCT01607372 Asthma and Rhinitis Phase 2 Completed - Canada, Ontario ... More >> GSK Investigational Site Toronto, Ontario, Canada, M5V 2T3 Less <<
NCT03523455 Iron-deficiency Not Applicable Terminated(Unable to recruit q... More >>ualified participants) Less << - United States, Texas ... More >> UMHB Human Performance Lab Belton, Texas, United States, 76513 Less <<
NCT02625207 Healthy Subjects Phase 1 Completed - United States, Connecticut ... More >> Pfizer New Haven Clinical Research Unit New Haven, Connecticut, United States, 06511 Less <<
NCT02878278 Lymphoma, Extranodal NK-T-Cell... More >> EBV Less << Phase 2 Not yet recruiting September 2019 -
NCT02625207 - Completed - -
NCT03323359 Hepatectomy C... More >>ancer, Metastatic Hemostasis Less << Not Applicable Recruiting March 17, 2019 Italy ... More >> Policlinico Universitario Agostino Gemelli Recruiting Rome, Italy, 00168 Contact: Pacelli    00390630155133 ext 4477    fabio.pacelli@policlinicogemelli.it    Principal Investigator: Fabio FP Pacelli, MD Less <<
NCT03457727 Pulmonary Disease, Chronic Obs... More >>tructive Less << Phase 1 Completed - United States, Kansas ... More >> GSK Investigational Site Overland Park, Kansas, United States, 66211 Less <<
NCT02723877 Metastatic Breast Cancer Phase 1 Phase 2 Completed - Spain ... More >> Hospital Universitarsi Vall d'Hebron Barcelona, Catalan, Spain, 08035 Insitut Català d´Oncologia Barcelona, Spain Fundación Instituto Valenciano de Oncología Valencia, Spain United Kingdom Barts Cancer Institute London, United Kingdom Churchill hospital Oxford, United Kingdom Less <<
NCT03508895 Hypertension Not Applicable Recruiting March 2020 Canada, Manitoba ... More >> Richarson Centre for Funtional Foods and Nutraceuticals Recruiting Winnipeg, Manitoba, Canada, R3T 6C5 Contact: Peter JH Jones, PhD    204-474-8883    peter.jones@umanitoba.ca    Principal Investigator: Peter JH Jones, PhD Less <<
NCT01714817 Lupus Nephritis Phase 3 Completed - -
NCT01646190 Colorectal Disorders Not Applicable Unknown December 2013 Switzerland ... More >> University Hospital, Geneva Recruiting Geneva, Switzerland, 1211 Contact: Sandrine Ostermann, MD, PhD    +41 79 55 34161    sandrine.ostermann@hcuge.ch    Contact: Philippe Morel, Pr, Head    +41 22 37 27702    philippe.morel@hcuge.ch    Principal Investigator: Sandrine Ostermann, MD, PhD          Sub-Investigator: Philippe Morel, Pr Less <<
NCT01714817 - Completed - -
NCT03184987 Asthma Phase 3 Active, not recruiting June 24, 2019 Japan ... More >> GSK Investigational Site Gifu, Japan, 509-6134 GSK Investigational Site Gunma, Japan, 372-0831 GSK Investigational Site Gunma, Japan, 373-0807 GSK Investigational Site Hiroshima, Japan, 732-0052 GSK Investigational Site Kagawa, Japan, 762-8550 GSK Investigational Site Kanagawa, Japan, 236-0004 GSK Investigational Site Kyoto, Japan, 607-8062 GSK Investigational Site Okinawa, Japan, 901-2121 GSK Investigational Site Tokyo, Japan, 103-0027 GSK Investigational Site Tokyo, Japan, 134-0083 GSK Investigational Site Tokyo, Japan, 157-0066 GSK Investigational Site Tokyo, Japan, 169-0073 GSK Investigational Site Toyama, Japan, 937-0042 Less <<
NCT01310023 - Recruiting July 2020 United States, Alabama ... More >> University of Alabama Recruiting Birmingham, Alabama, United States, 35294 Principal Investigator: Marilyn Crain, MD          United States, California University of California San Diego Recruiting La Jolla, California, United States, 92093 Principal Investigator: Stephen Spector, MD          University of Southern California Recruiting Los Angeles, California, United States, 90033 Principal Investigator: Toinette Frederick, PhD          United States, Colorado University of Colorado Denver Health Sciences Center Recruiting Aurora, Colorado, United States, 80045 Principal Investigator: Elizabeth McFarland, MD          United States, Florida Children's Diagnostic & Treatment Center Recruiting Fort Lauderdale, Florida, United States, 33316 Principal Investigator: Ana Puga, MD          University of Florida Health Science Center Recruiting Jacksonville, Florida, United States, 32209 Principal Investigator: Mobeen Rathore, MD          University of Miami Recruiting Miami, Florida, United States, 33136 Principal Investigator: Gwendolyn Scott, MD          United States, Illinois University of Illinois, Chicago Recruiting Chicago, Illinois, United States, 60612 Principal Investigator: Karen Hayani, MD          Ann and Robert H. Lurie Children's Hospital Recruiting Chicago, Illinois, United States, 60614 Principal Investigator: Ram Yogev, MD          United States, Louisiana Tulane University Health Sciences Center Recruiting New Orleans, Louisiana, United States, 70112 Principal Investigator: Russell Van Dyke, MD          United States, Maryland University of Maryland Terminated Baltimore, Maryland, United States, 21201 United States, New Jersey Rutgers - New Jersey Medical School Recruiting Newark, New Jersey, United States, 07101-1709 Principal Investigator: Arry Dieudonne, MD          United States, New York Bronx Lebanon Hospital Center Recruiting Bronx, New York, United States, 10457 Principal Investigator: Murli Purswani, MD          Jacobi Medical Center Terminated Bronx, New York, United States, 10461 SUNY Downstate Medical Center Recruiting Brooklyn, New York, United States, 11203-2098 Principal Investigator: Hermann Mendez, MD          New York University School of Medicine Recruiting New York, New York, United States, 10016 Principal Investigator: William Borkowsky, MD          SUNY Stony Brook Terminated Stony Brook, New York, United States, 11794 United States, Pennsylvania Children's Hospital of Philadelphia Terminated Philadelphia, Pennsylvania, United States, 19104-4318 United States, Tennessee St. Jude Children's Research Hospital Recruiting Memphis, Tennessee, United States, 38105-2764 Principal Investigator: Katherine Knapp, MD          United States, Texas Baylor College of Medicine Recruiting Houston, Texas, United States, 77030-3498 Principal Investigator: Wililam Shearer, MD, PhD          Puerto Rico University of Puerto Rico Medical Center Recruiting San Juan, Puerto Rico, 00935 Principal Investigator: Zoe Rodriguez, MD          San Juan Research Hospital Recruiting San Juan, Puerto Rico, 00936-8344 Principal Investigator: Nicolas Rosario-Matos, MD Less <<
NCT03465306 Search MeSH Not Applicable Active, not recruiting April 20, 2018 Korea, Republic of ... More >> Seoul National University Hospital Seoul, Korea, Republic of, 03080 Less <<
NCT03337971 Bone and Bones ... More >> Osteoporosis Risk Osteoporosis, Postmenopausal Less << Not Applicable Recruiting April 4, 2019 Ireland ... More >> University of Limerick Recruiting Limerick, Co Limerick, Ireland Contact: Philip Jakeman, PhD    +35361202800 ext 2800    phil.jakeman@ul.ie    Contact: Catherine Norton, PhD    +35361204780 ext 4780    catherine.norton@ul.ie    Principal Investigator: Philip Jakeman, PhD          Sub-Investigator: Catherine Norton, PhD Less <<
NCT01620398 Cardiovascular Diseases Not Applicable Completed - Brazil ... More >> Universidade Federal de Alagoas Maceió, Alagoas, Brazil Hospital Universitário Francisca Mendes Manaus, Amazonas, Brazil Hospital Universitário Professor Edgard Santos / ENUFBA / UFBA Salvador, Bahia, Brazil Hospital de Messejana Fortaleza, Ceará, Brazil Universidade de Fortaleza Fortaleza, Ceará, Brazil Hospital das Clínicas de Goiânia Goiânia, Goiás, Brazil, 90630000 Hospital Universitário Federal Presidente Dutra São Luiz, Maranhão, Brazil Hospital Universitário Maria Aparecida Pedrossian Campo Grande, Mato Grosso Do Sul, Brazil Universidade Federal do Mato Grosso Cuiabá, Mato Grosso, Brazil Universidade Federal de Viçosa Viçosa, Minas Gerais, Brazil Hospital Universitário Alcides Carneiro Campina Grande, Paraiba, Brazil Hospital de Clínicas da Universidade Federal do Paraná Curitiba, Paraná, Brazil Hospital das Clínicas Gaspar Viana Belém, Pará, Brazil Pronto Socorro Cardiológico Universitário de Pernambuco Recife, Pernambuco, Brazil Hospital Universitário Ana Bezerra Santa Cruz, Rio Grande Do Norte, Brazil URCAMP Bagé, Rio Grande Do Sul, Brazil Hospital Universitário AESC Canoas, Rio Grande Do Sul, Brazil, 90630000 BIOSERV Passo Fundo, Rio Grande Do Sul, Brazil, 90630000 Universidade Federal de Pelotas Pelotas, Rio Grande Do Sul, Brazil COTENUT Porto Alegre, Rio Grande Do Sul, Brazil, 90630000 Hospital de Clínicas de Porto Alegre Porto Alegre, Rio Grande Do Sul, Brazil, 90630000 Hospital São Lucas da Pontifícia Universidade Católica do Rio Grande do Sul Porto Alegre, Rio Grande Do Sul, Brazil, 90630000 Instituto de Cardiologia do Rio Grande do Sul Porto Alegre, Rio Grande Do Sul, Brazil Associação Veranense de Assistência em Saúde (AVAES) Veranópolis, Rio Grande Do Sul, Brazil, 90630000 IECAC Rio de Janeiro, RJ, Brazil Universidade Vale do Itajaí Itajaí, Santa Catarina, Brazil Hospital São Lucas Aracaju, Sergipe, Brazil Hospital Universitário FUFSE Aracaju, Sergipe, Brazil Universidade Federal de Tocantins Palmas, Tocantins, Brazil Hospital Universitário de Brasília Brasília, Brazil Hospital Universitario Pedro Ernesto Rio de Janeiro, Brazil Instituto Nacional de Cardiologia Rio de Janeiro, Brazil Hospital do Coração São Paulo, Brazil Instituto Dante Pazzanese de Cardiologia São Paulo, Brazil Universidade Federal de São Paulo São Paulo, Brazil Less <<
NCT03308578 Sleep Apnea, Obstructive Phase 1 Phase 2 Enrolling by invitation July 2023 United States, Minnesota ... More >> Mayo Clinic in Rochester Rochester, Minnesota, United States, 55905 Less <<
NCT01954472 Cardiovascular Diseases ... More >> Type 2 Diabetes Hypercholesterolemia Less << Not Applicable Withdrawn(This study was combi... More >>ned with another CIHR funded study (NCT02078635). Both studies involve the same dietary portfolio and the same study population.) Less << - Canada, British Columbia ... More >> Healthy Heart Lipid Clinic, St. Paul's Hospital Vancouver, British Columbia, Canada, V6Z 1Y6 Canada, Manitoba Richardson Center for Functional Foods and Nutraceuticals and the St. Boniface Hospital Cardiovascular Center, University of Manitoba Winnipeg, Manitoba, Canada, R3T 6C5 Canada, Ontario Risk Factor Modification Centre, St. Michael's Hospital Toronto, Ontario, Canada, M5C 2T2 Canada, Quebec Institute of Nutraceuticals and Functional Foods and the Quebec Heart and Lung Institute, Laval University Quebec City, Quebec, Canada, G1V 4G2 Less <<
NCT01641770 Malnutrition Phase 3 Completed - India ... More >> King George Hospital / Andhra Medical College Andhra Pradesh, India St. Theresa's Hospital Andhra Pradesh, India Care Hospital- Hyderabad Hyderabad, India Advanced Medicare and Research Institute Kolkata, India Sengupta Hospital & Research Institute Maharashtra, India Lokmanya Tilak Muncipal Medical College & Lokmanya Thilak Municipal General Hospital Mumbai, India Seth GS Medical College and KEM Hospital Mumbai, India TN Medical College & BYL Nair Hospital Mumbai, India Abhinav Hospital Nagpur, India Sir Ganga Ram Hospital New Delhi, India Metro Multispecialty Hospital- X-1,Sector Noida, India Jehangir Clinical Development Centre Pvt. Ltd., Jehangir Hospital Pune, India Immunology at Dayanand Medical College & Hospital Punjab, India Less <<
NCT00394394 Hypertension Phase 2 Completed - Brazil ... More >> Hospital de Clínicas de Porto Alegre Porto Alegre, Rio Grande do Sul, Brazil, 90035-903 Less <<
NCT00825903 Asthma, Bronchial Not Applicable Completed - United States, Washington ... More >> Washington State University Pullman, Washington, United States, 99164 Less <<
NCT02251431 Type 2 Diabetes Mellitus ... More >> Chronic Kidney Disease Left Ventricular Diastolic Dysfunction Less << Phase 3 Recruiting March 2020 United States, Texas ... More >> Baylor Scott and White Research Institute- Baylor Heart and Vascular Hospital Recruiting Dallas, Texas, United States, 75226 Contact: Laura Clariday, BS    214-820-7224    laura.clariday@bswhealth.org    Contact: Rebecca Baker, MSN, RN, ACNS-BS    214-820-7965    rebecca.baker2@bswhealth.org Less <<
NCT03639389 Radical Prostatectomy ... More >> Postoperative Pain Less << Phase 3 Not yet recruiting September 1, 2021 Sweden ... More >> Karolinska Hospital, Solna Stockholm, Sweden, 17176 Less <<
NCT00573794 Ulcerative Colitis Phase 3 Completed - -
NCT01791478 Estrogen Receptor-positive Bre... More >>ast Cancer HER2-negative Breast Cancer Invasive Ductal Breast Carcinoma Progesterone Receptor-positive Breast Cancer Recurrent Breast Cancer Stage IV Breast Cancer Less << Phase 1 Active, not recruiting September 2019 United States, Massachusetts ... More >> Massachusetts General Hospital, Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02114 United States, Tennessee Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232-6838 Less <<
NCT00898716 Neoplasms Phase 1 Completed - Japan ... More >> Local Institution Chuo-Ku, Tokyo, Japan, 104-0045 Less <<
NCT03026569 Chronic Infection Not Applicable Completed - Brazil ... More >> Sao Paulo State University "Julio de Mesquita Filho" Araraquara, Sao Paulo, Brazil, 14800-903 Less <<
NCT02922140 Acute Coronary Syndrome Not Applicable Unknown August 2017 Egypt ... More >> Ain Shams University Cairo, Egypt Less <<
NCT03307330 - Recruiting July 1, 2023 United States, Minnesota ... More >> Mayo Clinic Recruiting Rochester, Minnesota, United States, 55901 Contact: Somers_CPL LAB    507-255-8794    cplsleep@mayo.edu    Contact: Virend Somers, MD, Ph.D    507-255-1144    somers.virend@mayo.edu Less <<
NCT00291824 Hypertension ... More >>Hyperlipidemia Hyperglycemia Cardiovascular Disease Smoking Less << Phase 1 Unknown - Canada, Ontario ... More >> Caroline Medical Group Recruiting Burlington, Ontario, Canada, L7R4C7 Contact: Michael Mills, MD CCFP          Contact: Donna Landry    905.632.8007 ext 103       Sub-Investigator: Lori Chalklin, MD CCFP          Sub-Investigator: David Wallik, MD CCFP          Sub-Investigator: James Kraemer, MD CCFP          Sub-Investigator: Stephen Duncan, MD CCFP          Sub-Investigator: Chris Williams, MD CCFP Less <<
NCT02342548 Huntington's Disease Phase 2 Terminated(Study terminated on... More >> 15DEC2016 due to study A8241021 showing no significant difference on primary endpoint between PF-02545920 & placebo. No safety concerns.) Less << - -
NCT00573794 - Completed - -
NCT01620476 Diabetes Heal... More >>thy Less << Phase 1 Completed - Japan ... More >> Novo Nordisk Investigational Site Tokyo, Japan, 1000005 Less <<
NCT01376388 - Completed - -
NCT00880646 Obesity Not Applicable Completed - Japan ... More >> Hiroshima University Hiroshima, Japan, 734-8551 Less <<
NCT01376388 Pulmonary Disease, Chronic Obs... More >>tructive Less << Phase 3 Completed - Japan ... More >> GSK Investigational Site Fukuoka, Japan, 802-0083 GSK Investigational Site Gunma, Japan, 371-0048 GSK Investigational Site Hiroshima, Japan, 732-0052 GSK Investigational Site Hiroshima, Japan, 732-0057 GSK Investigational Site Hokkaido, Japan, 064-0915 GSK Investigational Site Hokkaido, Japan, 080-0805 GSK Investigational Site Hyogo, Japan, 665-0827 GSK Investigational Site Hyogo, Japan, 670-0849 GSK Investigational Site Ibaraki, Japan, 300-0053 GSK Investigational Site Kagawa, Japan, 763-8502 GSK Investigational Site Kanagawa, Japan, 239-0821 GSK Investigational Site Kyoto, Japan, 615-8087 GSK Investigational Site Oita, Japan, 870-0921 GSK Investigational Site Oita, Japan, 876-0047 GSK Investigational Site Osaka, Japan, 576-0016 GSK Investigational Site Osaka, Japan, 589-0022 GSK Investigational Site Osaka, Japan, 590-0064 GSK Investigational Site Shizuoka, Japan, 436-0022 GSK Investigational Site Tokyo, Japan, 105-0004 GSK Investigational Site Tokyo, Japan, 185-0014 GSK Investigational Site Tokyo, Japan, 187-0024 GSK Investigational Site Wakayama, Japan, 641-8510 GSK Investigational Site Yamanashi, Japan, 400-0031 Less <<
NCT02342548 - Terminated(Study terminated on... More >> 15DEC2016 due to study A8241021 showing no significant difference on primary endpoint between PF-02545920 & placebo. No safety concerns.) Less << - -
NCT00770497 Inflammation ... More >>Hypertension Less << Phase 2 Completed - Germany ... More >> Deggingen, Baden-Württemberg, Germany Rottweil, Baden-Württemberg, Germany Spaichingen, Baden-Württemberg, Germany Weilersbach, Bayern, Germany Hannover, Niedersachsen, Germany Essen, Nordrhein-Westfalen, Germany Köln, Nordrhein-Westfalen, Germany Werne, Nordrhein-Westfalen, Germany Mainz, Rheinland-Pfalz, Germany Schauenburg, Rheinland-Pfalz, Germany Dresden, Sachsen, Germany Blankenhain, Thüringen, Germany Berlin, Germany Less <<
NCT02362256 Opiate Addiction Not Applicable Completed - Lithuania ... More >> Republic Vilnius University Hospital Vilnius, Lithuania, LT-04130 Less <<
NCT02239835 HIV Infections Phase 2 Terminated - -
NCT02533882 Multiple Sclerosis ... More >> Stroke Less << Not Applicable Recruiting July 2019 United States, Alabama ... More >> Lakeshore Foundation Recruiting Birmingham, Alabama, United States, 35209 Contact: Casey L Herman    205-403-5504    caseyh@lakeshore.org Less <<
NCT02647580 - Completed - Denmark ... More >> Hvidovre University Hospital Hvidovre, Denmark, 2650 Less <<
NCT02349555 Other Endocrine/Nutritional/Me... More >>tabolic Disorder Less << Not Applicable Completed - United States, Texas ... More >> Texas Diabetes & Endocrinology Austin, Texas, United States, 78731 United States, Utah Utah State University Logan, Utah, United States, 84322 Less <<
NCT03717311 Healthy Not Applicable Recruiting March 2019 France ... More >> Centre de Recherche en Nutrition Humaine Rhône-Alpes Recruiting Pierre-Bénite, France Contact: Martine LAVILLE, MD    04 78 86 29 81 ext +33    martine.laville@univ-lyon1.fr    Contact: Julie-Anne NAZARE, PhD    04 78 86 29 81 ext +33    julie-anne.nazare@univ-lyon1.fr    Principal Investigator: Martine LAVILLE, MD          Sub-Investigator: Emmanuel DISSE, MD          Sub-Investigator: Nathalie FEUGIER-FAVIER, MD          Sub-Investigator: Stéphanie LAMBERT-PORCHERON, MD          Sub-Investigator: Bérénice SEGRESTIN, MD Less <<
NCT01421589 Obese Growth ... More >>Hormone Secretion Abnormality Less << Not Applicable Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT01421589 - Completed - -
NCT02767440 Obesity Child... More >>hood Obesity Hypertension Diabetes Dyslipidemia Less << Not Applicable Completed - United States, North Carolina ... More >> Duke Pediatrics Healthy Lifestyles Clinic Durham, NC, North Carolina, United States, 27704 Less <<
NCT03494270 ASCVD Phase 4 Recruiting December 2019 Korea, Republic of ... More >> Seoul National University Bundang Hospital Recruiting Seongnam, Korea, Republic of Contact: In-ho Chae    82-31-787-7012    ihchae@snu.ac.kr Less <<
NCT03432416 Healthy Women ... More >> Female Contraception Less << Phase 2 Recruiting June 20, 2020 United States, California ... More >> Essential Access Health Recruiting Los Angeles, California, United States, 30010 Contact: Kieumai Vo    213-386-5614 ext 4592    KVo@essentialaccess.org    Contact: Ron Frezeries    213-386-5614 ext 4403    RFrezieres@essentialaccess.org    Principal Investigator: Anita Nelson          University of California, Davis Recruiting Sacramento, California, United States, 95817 Contact: Courtney Overstreet    916-734-6846    cboverstreet@ucdavis.edu    Contact: Aubrey Blanton    916-734-6846    akblanton@ucdavis.edu    Principal Investigator: Mitchell Creinin          United States, Colorado University of Colorado Denver Recruiting Aurora, Colorado, United States, 80045 Contact: Ines Crato    303-724-5559    INES.CRATO@UCDENVER.EDU    Contact: Rebecca Seale    303-724-2013    REBECCA.SEALE@UCDENVER.EDU    Principal Investigator: Stephanie Teal          United States, Maryland Johns Hopkins Bayview Medical Center Recruiting Baltimore, Maryland, United States, 21224 Contact: Katrina Thaler    410-550-8506    kstouff3@jhmi.edu    Contact: Lauren Beal    410-550-4825    lbeal2@jhu.edu    Principal Investigator: Anne Burke          United States, New York Bellevue Hospital Center Recruiting New York, New York, United States, 10016 Contact: Anna Davis    212-263-6253    anna.davis@nyumc.org    Principal Investigator: Treasure Walker          Columbia University Recruiting New York, New York, United States, 10032 Contact: Subrina Bisnauth    212-305-8031    Snb2147@cumc.columbia.edu    Contact: Connie Colon    212-305-6098    cc3238@cumc.columbia.edu    Principal Investigator: Carolyn Westhoff          United States, Ohio University of Cincinnati Recruiting Cincinnati, Ohio, United States, 45267 Contact: Deborah Boerschig    513-584-4100    BOERSCDA@UCMAIL.UC.EDU    Contact: Tiffany Rupert    513-584-4100    tiffany.rupert@uc.edu    Principal Investigator: Michael Thomas          United States, Oregon Oregon Health Science University Recruiting Portland, Oregon, United States, 97239 Contact: Ariela Schnyer    503-494-3173    schnyer@ohsu.edu    Contact: Alison Edelman    503-494-5949    edelmana@ohsu.edu    Principal Investigator: Jeffrey Jensen          United States, Pennsylvania University of Pennsylvania School of Medicine Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Andrea Morley    215-615-4202    Andrea.morley@uphs.upenn.edu    Contact: Kieran Alessi    215-615-3664    Kieran.Alessi@uphs.upenn.edu    Principal Investigator: Kurt Barnhart          United States, Utah University of Utah Recruiting Salt Lake City, Utah, United States, 84132 Contact: Jasmin Alcantra    801-213-3796    jasmin.alcantara@hsc.utah.edu    Contact: Amy Orr    801-213-2774    amy.orr@hsc.utah.edu    Principal Investigator: David Turok          United States, Virginia Eastern Virginia Medical School Recruiting Norfolk, Virginia, United States, 23507 Contact: Jackie Rocccazella    757-446-7161    roccazj@evms.edu    Contact: Kim Pitts    757-446-8925    pittska@evms.edu    Principal Investigator: David Archer Less <<
NCT03010098 Anesthesia Phase 4 Not yet recruiting July 2017 China, Guangdong ... More >> Guangzhou Military Region General Hospital, Department of Anesthesiology Recruiting Guangzhou, Guangdong, China, 510010 Contact: bo xu    88653387 ext 020    xubo333@hotmail.com    Contact: li ma    13602445723    603706566@qq.com Less <<
NCT02511366 Eating Obesit... More >>y Ileal Brake Less << Not Applicable Completed - Netherlands ... More >> Maastricht University Medical Center Maastricht, Netherlands Less <<
NCT03531658 - Active, not recruiting - Singapore ... More >> KK Women's and Children's Hospital Singapore, Singapore Less <<
NCT03232515 Chronic Renal Failure ... More >> Dialysis Dry Weight Blood Pressure Less << Not Applicable Completed - Mexico ... More >> Hospital General del Estado de Sonora "Dr. Ernesto Ramos Bours" Hermosillo, Sonora, Mexico, 83000 Less <<
NCT03771924 Cardiovascular Risk Factor Not Applicable Not yet recruiting August 2020 Germany ... More >> Martin-Luther-University Institute of Agriculture and Nutritional Science Halle, Saxony Anhalt, Germany, 06120 Less <<
NCT01254123 Patients With a First Acute My... More >>ocardial Infarction to be Treated With Primary Percutaneous Coronary Intervention (PCI). Less << Phase 3 Unknown - Netherlands ... More >> VU Medical Center Recruiting Amsterdam, Netherlands, 1081 HV Contact: Yolande Appelman, Dr.    0031204442441    Y.Appelman@vumc.nl    Principal Investigator: Yolande Appelman, Dr. Less <<
NCT03237689 Hiv Early Phase 1 Recruiting August 31, 2022 United States, Maryland ... More >> Johns Hopkins University School of Medicine Recruiting Baltimore, Maryland, United States, 21224 Contact: Leah Rubin       lrubin1@jhu.edu Less <<
NCT00562380 Lymphoma Pros... More >>tate Cancer Sarcoma Small Intestine Cancer Unspecified Adult Solid Tumor, Protocol Specific Less << Phase 1 Completed - United States, Tennessee ... More >> Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232-6838 Less <<
NCT02669511 Primary Central Nervous System... More >> Lymphoma Less << Phase 2 Completed - United States, California ... More >> UC Irvine - Medical Center Orange, California, United States, 92686 Kaiser Permanente-Sacramento Redwood Estates, California, United States, 94063 Kaiser Permanente-Sacramento Sacramento, California, United States, 95825 Germany University Hospital Freiburg General Medicine I Freiburg im Breisgau, Baden Würtenberg, Germany, 79106 Medizinische Klinik und Poliklinik III Munich, Bavaria, Germany, 81377 Charite Universitaetsmedizin Berlin Berlin, Germany Neurologische University Hospital Bochum Bochum, Germany, 44892 Klinik für Hämatologie, Onkologie und Palliativmedizin Stuttgart, Germany, 70174 Switzerland University Hospital Zurich, Neurology Zurich, Switzerland, 8091 Less <<
NCT03726593 Plasmodium Falciparum Malaria ... More >>(Drug Resistant) Less << Phase 4 Recruiting June 30, 2021 Cambodia ... More >> Kratie Referral Hospital Not yet recruiting Kratie, Cambodia Contact: Somaly Kieng, M.D    +855 72 971 755       Contact: Chanthap Lon, M.D    855 23 881 845    chanthapl@afrims.org    Sub-Investigator: Darapiseth Sea, MD          Sub-Investigator: Dysoley Lek, MD          Anlong Veng Referral Hospital Recruiting Ânlóng Vêng, Cambodia Contact: Phan Kong, M.A    016 51 09 09       Principal Investigator: Chanthap Lon, MD          Sub-Investigator: Darapiseth Sea, MD          Sub-Investigator: Dysoley Lek, MD Less <<
NCT03000140 Metabolism Disorder ... More >> Hypertension Less << Not Applicable Completed - Chile ... More >> Cristian Alvarez Osorno, Chile Less <<
NCT00555321 Immunosuppression in Solid Org... More >>an Transplant Less << Phase 2 Terminated - -
NCT03534414 - Active, not recruiting October 1, 2018 Canada, Ontario ... More >> The Toronto 3D (Diet, Digestive tract and Disease) Knowledge Synthesis and Clinical Trials Unit, Clinical Nutrition and Risk Factor Modification Centre, St. Micheal's Hospital Toronto, Ontario, Canada, M5C 2T2 Less <<
NCT02736474 Obese Cigaret... More >>te-smoking Schizophrenia Less << Phase 4 Completed - -
NCT01583582 Hypertension ... More >>Blood Pressure Less << Phase 2 Completed - Finland ... More >> Oy Foodfiles Ltd Kuopio, Finland, 70210 Less <<
NCT03721848 Mental Stress ... More >> Hypertension Diabetes Less << Not Applicable Active, not recruiting April 30, 2019 Jordan ... More >> Royal health Awareness Society Amman, Jordan Less <<
NCT00555321 - Terminated - -
NCT03548935 Metabolism and Nutrition Disor... More >>der Overweight or Obesity Less << Phase 3 Recruiting April 20, 2020 -
NCT02814656 Chronic Obstructive Pulmonary ... More >>Disease Less << Phase 1 Completed - United Kingdom ... More >> Research Site London, United Kingdom Less <<
NCT03120000 Primary Central Nervous System... More >> Lymphoma Less << Phase 2 Withdrawn(Withdrawn) December 2019 France ... More >> Aix-Marseilles Université Marseille, France, 13305 Service de Neurology CHRU de Nancy Nancy, France, 54035 Hôpital Pitié-Sâlpétrier, Paris, France, 75013 Hématologie, Départment d'ongolgie médicale Saint-Herblain, France, 44800 Less <<
NCT03054194 Healthy Participants Phase 1 Completed - United States, Texas ... More >> Eisai Trial Site San Antonio, Texas, United States, 78217 Less <<
NCT03353441 Healthy Stres... More >>s, Psychological Cognitive Impairment Less << Not Applicable Completed - Germany ... More >> daacro GmbH & Co. KG Trier, Rhineland-Palatinate, Germany, 54296 Less <<
NCT02706535 Drug Interactions Phase 1 Completed - United States, Maryland ... More >> GSK Investigational Site Baltimore, Maryland, United States, 21225 Less <<
NCT00978224 Chronic Inflammatory Syndrome Phase 3 Suspended(Decision of the inve... More >>stigator) Less << September 2011 Cuba ... More >> Institute of Nephrology "Dr. Abelardo Buch López" Havana, Cuba, 10400 Less <<
NCT01451528 Traumatic Brain Injury Not Applicable Withdrawn(The research fund, w... More >>hich is yet to be raised and expected to take for a while) Less << December 2015 Korea, Republic of ... More >> CHA Bundang Medical Center, CHA University Seongnam-si, Gyeonggi-do, Korea, Republic of, 463-712 Less <<
NCT03040388 - Recruiting September 30, 2019 Denmark ... More >> Mental Health Centre Glostrup Recruiting Glostrup, The Capital Region, Denmark, 2600 Contact: Krzysztof Gbyl, MD,PhD stud.    004524457209    krzysztof.gbyl@regionh.dk    Principal Investigator: Poul Videbech, Professor          Sub-Investigator: Krzysztof Gbyl, MD,PhD stud. Less <<
NCT02882659 Colorectal Neoplasms ... More >> Hepatocellular Carcinoma Neoplasm Metastasis Less << Phase 1 Unknown December 2017 -
NCT02348853 Overweight Ob... More >>esity Less << Not Applicable Active, not recruiting April 2019 United States, Massachusetts ... More >> Tufts University Human Nutrition Research Center on Aging Boston, Massachusetts, United States, 02111 Less <<
NCT02946606 Adult Growth Hormone Deficienc... More >>y Less << Phase 2 Completed - Korea, Republic of ... More >> Severance Hospital Seoul, Korea, Republic of Less <<
NCT02590445 Obsessive-Compulsive Disorder Phase 2 Phase 3 Unknown April 2018 China, Shanghai ... More >> Shanghai Ruijin Hospital Recruiting Shanghai, Shanghai, China, 200025 Contact: Chencheng Zhang, MD    +86 18217122884    i@cczhang.com Less <<
NCT02217631 Healthy Phase 1 Completed - -
NCT01924286 Immune Reconstitution Inflamma... More >>tory Syndrome HIV Tuberculosis Less << Phase 3 Completed - South Africa ... More >> Site B Khayelitsha HIV/TB clinic Cape Town, Western Cape, South Africa, 7784 Less <<
NCT00816400 Cancer Phase 1 Completed - United States, Colorado ... More >> Research Site Denver, Colorado, United States United States, Indiana Research Site Indianapolis, Indiana, United States United States, Nevada Research Site Las Vegas, Nevada, United States United States, Texas Research Site Dallas, Texas, United States United States, Virginia Research Site Norfolk, Virginia, United States Less <<
NCT01769716 Global Developmental Delay Not Applicable Completed - Korea, Republic of ... More >> CHA Bundang Medical Center, CHA University Seongnam-si, Gyeonggi-do, Korea, Republic of, 463-712 Less <<
NCT02191202 - Completed - -
NCT01169415 Glioblastoma Multiforme Not Applicable Withdrawn(Funding not obtained... More >>) Less << - -
NCT01218165 Aged Healthy Early Phase 1 Completed - Germany ... More >> Charité - Universitätsmedizin Berlin Berlin, Germany, 10117 Less <<
NCT00816400 - Completed - -
NCT03688503 Blood Pressure Not Applicable Not yet recruiting November 2020 -
NCT03266172 Autoimmune Diseases Phase 1 Recruiting November 13, 2018 United Kingdom ... More >> GSK Investigational Site Recruiting Nottingham, United Kingdom, NG11 6JS Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com Less <<
NCT03327857 Steroid-refractory Acute Graft... More >>-versus-Host Disease Less << Phase 1 Recruiting June 2020 United States, California ... More >> City of Hope Recruiting Duarte, California, United States, 91010 Contact: Roxanne Garcia       roxgarcia@coh.org    Contact: Golnaz Namdar    626-218-0061    gnamdar@coh.org    Principal Investigator: Haris Ali          United States, Georgia Emory University Not yet recruiting Atlanta, Georgia, United States, 30322 Contact: Shantoria Mayes    404-778-6547    shantoria.mayes@emory.edu    Principal Investigator: Edmund Waller          United States, Illinois University of Chicago Not yet recruiting Chicago, Illinois, United States, 60637 Principal Investigator: Michael Bishop          United States, Michigan University of Michigan Recruiting Ann Arbor, Michigan, United States, 48109 Contact: Lynne Bischoff    734-615-5939    lloisros@med.umich.edu    Principal Investigator: Sarah Anand, MD          United States, Minnesota University of Minnesota Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Amy Hays    612-626-0461    hays0024@umn.edu    Principal Investigator: Shernan Holtan, MD          United States, Tennessee Vanderbilt-Ingram Cancer Center Recruiting Nashville, Tennessee, United States, 37232 Contact: Delia Darst    615-343-7190    delia.h.darst@vumc.org    Principal Investigator: Madan Jagasia, MD          United States, Washington Fred Hutchinson Recruiting Seattle, Washington, United States, 98109 Contact: Lisa Grimm    206-667-2353    lgrimm@fredhutch.org    Principal Investigator: Paul Martin, MD          Sub-Investigator: Marco Mielcarek          United States, Wisconsin Medical College of Wisconsin Recruiting Milwaukee, Wisconsin, United States, 53226 Contact: Kaylee Meisinger    414-805-8926    kmeisinger@mcw.edu    Principal Investigator: Sameem Abedin, MD          Sub-Investigator: Mehdi Hamadani, MD Less <<
NCT02438020 Acanthosis Nigricans Phase 4 Unknown October 2016 Mexico ... More >> Hospital Central Dr.Ignacio Morones Prieto Active, not recruiting San Luis Potosi, SLP, Mexico, 78210 Less <<
NCT02226354 Healthy Phase 1 Completed - Canada, New Brunswick ... More >> Université de Moncton Moncton, New Brunswick, Canada, E1A 3E9 Less <<
NCT01728675 Aging Muscle ... More >>Damage Oxidative Stress Less << Not Applicable Completed - Cyprus ... More >> European University Cyprus Nicosia, Cyprus, 1516 Less <<
NCT01884155 Stroke Phase 1 Completed - Korea, Republic of ... More >> CHA Bundang Medical Center, CHA University Seongnam-si, Gyeonggi-do, Korea, Republic of, 463-712 Less <<
NCT02800967 Hypertension ... More >>Overweight Less << Not Applicable Unknown June 2017 Serbia ... More >> Centre of Research Excellence in Nutrition and Metabolism, Institute for Medical Research, University of Belgrade Belgrade, Serbia, 11000 Less <<
NCT03458650 Healthy Phase 1 Completed - China, Shanghai ... More >> Huashan Hospital, Fudan University Shanghai, Shanghai, China, 200040 Less <<
NCT02211950 Healthy Phase 1 Completed - -
NCT01885663 Acquired Brain Injury Phase 1 Completed - Korea, Republic of ... More >> CHA Bundang Medical Center, CHA University Seongnam-si, Gyeonggi-do, Korea, Republic of, 463-712 Less <<
NCT00299988 Alzheimer's Disease Phase 2 Completed - United States, New York ... More >> Weill Medical College of Cornell University New York City, New York, United States, 10021 Less <<
NCT01936675 Coronary Artery Disease ... More >> Myocardial Infarction Genomic Risk Communication Less << Not Applicable Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT03468894 Cardiovascular Risk Factor ... More >> Type2 Diabetes Sedentary Lifestyle Less << Not Applicable Not yet recruiting October 30, 2018 -
NCT03555890 Rhinitis Phase 1 Completed - Japan ... More >> GSK Investigational Site Fukuoka, Japan, 812-0025 Less <<
NCT03488212 Overweight and Obesity Not Applicable Not yet recruiting April 30, 2021 -
NCT02339155 Infections, Bacterial Phase 4 Completed - United States, Florida ... More >> GSK Investigational Site Edgewater, Florida, United States, 32132 United States, Kansas GSK Investigational Site Overland Park, Kansas, United States, 66211 United States, Tennessee GSK Investigational Site Knoxville, Tennessee, United States, 37920 Less <<
NCT03397641 Atrial Fibrillation Phase 1 Completed - United Kingdom ... More >> Quotient Clinical Nottingham, United Kingdom, NG11 6JS Less <<
NCT02715063 Metabolic Diseases ... More >> Overweight Motor Activity Less << Not Applicable Completed - Colombia ... More >> Robinson Ramírez Vélez Ph.D Bogotá, Cundinamarca, Colombia Less <<
NCT03324191 Lipid Metabolism ... More >> Diabetes Less << Not Applicable Active, not recruiting September 2018 United Kingdom ... More >> University of Bath Bath, Avon, United Kingdom, BA2 7AY Less <<
NCT02590887 Healthy Volunteers Phase 1 Phase 2 Unknown - Spain ... More >> Hospital Universitario Virgen del Rocío Seville, Spain, 41013 Less <<
NCT00555880 - Completed - -
NCT02339155 - Completed - -
NCT00555880 Hypotension, Orthostatic Phase 4 Completed - United States, Indiana ... More >> Fort Wayne Neurological Center Fort Wayne, Indiana, United States, 46805 United States, Massachusetts Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 United States, Michigan University of Michigan Ann Arbor, Michigan, United States, 48109 United States, Minnesota Minnesota VA Medical Center Minneapolis, Minnesota, United States, 55417 United States, Missouri Forest Park Neurophysiology Saint Louis, Missouri, United States, 63139 United States, New York Mount Sinai Medical Center New York, New York, United States, 10029 United States, North Carolina Raleigh Neurology Associates Raleigh, North Carolina, United States, 27607 United States, Ohio University Hospitals of Cleveland Cleveland, Ohio, United States, 44106 United States, South Carolina Absher Neurology, PA Greenville, South Carolina, United States, 29615 United States, Tennessee Vanderbilt University Nashville, Tennessee, United States, 37212 United States, Texas Diabetes and Glandular Disease research Associates, PA San Antonio, Texas, United States, 78229 Less <<
NCT02963935 Metabolism and Nutrition Disor... More >>der Obesity Less << Phase 3 Completed - United States, Florida ... More >> Novo Nordisk Investigational Site Jacksonville, Florida, United States, 32205 Novo Nordisk Investigational Site Plantation, Florida, United States, 33324 United States, Illinois Novo Nordisk Investigational Site Chicago, Illinois, United States, 60607 United States, North Carolina Novo Nordisk Investigational Site Greensboro, North Carolina, United States, 27408 Novo Nordisk Investigational Site Salisbury, North Carolina, United States, 28144 United States, Ohio Novo Nordisk Investigational Site Wadsworth, Ohio, United States, 44281-9236 United States, Pennsylvania Novo Nordisk Investigational Site Philadelphia, Pennsylvania, United States, 19104-3317 United States, South Carolina Novo Nordisk Investigational Site Charleston, South Carolina, United States, 29425 United States, Texas Novo Nordisk Investigational Site Dallas, Texas, United States, 75251 United States, Virginia Novo Nordisk Investigational Site Arlington, Virginia, United States, 22201 Less <<
NCT03086460 Asthma Phase 2 Completed - United States, Arizona ... More >> Chiesi Investigational Site Tucson, Arizona, United States, 85710 United States, California Chiesi Investigational Site Los Angeles, California, United States, 90048 United States, Maryland Chiesi Investigational Site Lutherville, Maryland, United States, 21093 United States, Missouri Chiesi Investigational Site Saint Louis, Missouri, United States, 63141 United States, North Carolina Chiesi Investigational Site Raleigh, North Carolina, United States, 27607 United States, South Carolina Chiesi Investigational Site Greenville, South Carolina, United States, 29615 Chiesi Investigational Site Orangeburg, South Carolina, United States, 29118 Chiesi Investigational Site Spartanburg, South Carolina, United States, 29303 United States, Tennessee Chiesi Investigational Site Knoxville, Tennessee, United States, 37909 United States, Washington Chiesi Investigational Site Richland, Washington, United States, 99352 Less <<
NCT03033004 Subcutaneous Fat Disorder Not Applicable Completed - Brazil ... More >> Centro de Estudos e Formação Avançada Ibramed. Amparo, São Paulo, Brazil Less <<
NCT03707834 Obesity Overw... More >>eight Pregnancy Related Less << Not Applicable Active, not recruiting June 30, 2023 United States, Pennsylvania ... More >> Temple University Philadelphia, Pennsylvania, United States, 19140 Less <<
NCT00119483 Hypogonadism Not Applicable Completed - Norway ... More >> Department of Medicine, University Hospital of North Norway Tromsø, Norway, 9038 Less <<
NCT03708055 Anatomic Stage I Breast Cancer... More >> AJCC v8 Anatomic Stage IA Breast Cancer AJCC v8 Anatomic Stage IB Breast Cancer AJCC v8 Anatomic Stage II Breast Cancer AJCC v8 Anatomic Stage IIA Breast Cancer AJCC v8 Anatomic Stage IIB Breast Cancer AJCC v8 Anatomic Stage IIIA Breast Cancer AJCC v8 Cancer Survivor Overweight Postmenopausal Prognostic Stage I Breast Cancer AJCC v8 Prognostic Stage IA Breast Cancer AJCC v8 Prognostic Stage IB Breast Cancer AJCC v8 Prognostic Stage II Breast Cancer AJCC v8 Prognostic Stage IIA Breast Cancer AJCC v8 Prognostic Stage IIB Breast Cancer AJCC v8 Prognostic Stage IIIA Breast Cancer AJCC v8 Less << Not Applicable Completed - United States, Arizona ... More >> The University of Arizona Medical Center-University Campus Tucson, Arizona, United States, 85724 Less <<
NCT02609438 Sedentary Lifestyle Not Applicable Completed - -
NCT01900340 Appetite and General Nutrition... More >>al Disorders Less << Phase 1 Completed - Switzerland ... More >> University Hospital Basel, Phase 1 Research Unit Basel, Switzerland Less <<
NCT02926456 - Completed - -
NCT02694848 Angina Phase 4 Unknown March 2017 China, Beijing ... More >> Xiyuan Hospital of China Academy of Chinese Medical Sciences Not yet recruiting Beijing, Beijing, China, 100091 Contact: Keji Chen, Academician    86-13521781839    wlxing@126.com    Contact: Mei Xue, doctor    86-13581801296    meiar@126.com Less <<
NCT03355534 Aneurysm Cerebral Not Applicable Recruiting December 30, 2019 China, Shaanxi ... More >> Xijing Hospital Recruiting Xi'an, Shaanxi, China, 710032 Contact: zhihong lu    86-29-84775343    deerlu23@163.com Less <<
NCT00402168 - Completed - -
NCT00402168 Renal Transplant Phase 2 Completed - -
NCT01192191 Pulmonary Disease, Chronic Obs... More >>tructive Less << Phase 3 Completed - Japan ... More >> GSK Investigational Site Fukuoka, Japan, 811-2201 GSK Investigational Site Fukuoka, Japan, 819-8555 GSK Investigational Site Fukushima, Japan, 964-0871 GSK Investigational Site Gunma, Japan, 371-0048 GSK Investigational Site Hiroshima, Japan, 732-0057 GSK Investigational Site Hokkaido, Japan, 001-0901 GSK Investigational Site Hokkaido, Japan, 064-0915 GSK Investigational Site Hokkaido, Japan, 070-8644 GSK Investigational Site Hyogo, Japan, 651-0073 GSK Investigational Site Ibaraki, Japan, 300-0053 GSK Investigational Site Ibaraki, Japan, 310-0015 GSK Investigational Site Ishikawa, Japan, 920-8610 GSK Investigational Site Kagawa, Japan, 760-0073 GSK Investigational Site Kagawa, Japan, 763-8502 GSK Investigational Site Kanagawa, Japan, 239-0821 GSK Investigational Site Kyoto, Japan, 601-1495 GSK Investigational Site Kyoto, Japan, 615-8087 GSK Investigational Site Miyagi, Japan, 981-8563 GSK Investigational Site Miyagi, Japan, 984-8560 GSK Investigational Site Nagano, Japan, 390-0303 GSK Investigational Site Nagano, Japan, 390-0832 GSK Investigational Site Nagano, Japan, 390-8601 GSK Investigational Site Nagano, Japan, 391-0011 GSK Investigational Site Oita, Japan, 870-0921 GSK Investigational Site Oita, Japan, 876-0047 GSK Investigational Site Okayama, Japan, 701-0304 GSK Investigational Site Osaka, Japan, 530-0012 GSK Investigational Site Osaka, Japan, 545-8586 GSK Investigational Site Osaka, Japan, 576-0016 GSK Investigational Site Osaka, Japan, 589-0022 GSK Investigational Site Tokyo, Japan, 185-0014 GSK Investigational Site Tokyo, Japan, 187-0024 GSK Investigational Site Toyama, Japan, 930-0194 GSK Investigational Site Wakayama, Japan, 641-8510 GSK Investigational Site Yamanashi, Japan, 400-0031 Less <<
NCT02478463 Infection, Human Immunodeficie... More >>ncy Virus Less << Phase 1 Active, not recruiting September 10, 2019 United States, Maryland ... More >> GSK Investigational Site Baltimore, Maryland, United States, 21287-5554 United States, Pennsylvania GSK Investigational Site Pittsburgh, Pennsylvania, United States, 15213 Less <<
NCT01192191 - Completed - -
NCT02183363 Healthy Phase 1 Completed - -
NCT02432066 Tobacco Use Disorder Phase 2 Not yet recruiting December 29, 2020 United States, Florida ... More >> Neurocognitive Lab, University of Florida, Department of Psychiatry Not yet recruiting Gainesville, Florida, United States, 32610 Contact: Robert A Prather, BA    352-294-4942    rprather@ufl.edu    Contact: Ben Lewis, PhD    3522944920    benlewis@ufl.edu    Principal Investigator: Sara J Nixon, PhD Less <<
NCT01243333 Malignant Neoplasm Not Applicable Terminated - United States, Utah ... More >> Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States, 84112 Less <<
NCT00480922 Hepatic Steatosis Not Applicable Completed - United States, Massachusetts ... More >> Children's Hospital Boston, Massachusetts, United States, 02115 Less <<
NCT02683304 Headache Not Applicable Recruiting July 2018 France ... More >> CHRU de Nîmes - Hôpital Universitaire Carémeau Recruiting Nîmes Cedex 09, France, 30029 Principal Investigator: Romain Genre Grandpierre, MD          Sub-Investigator: Xavier Bobbia, MD          Sub-Investigator: Rémi Perrin-Bayard, MD          Sub-Investigator: Stéphane Pommet, MD          Sub-Investigator: Alexandre Moreau, MD          Sub-Investigator: Pierre-Géraud Claret, MD          Sub-Investigator: Yan Bodin, MD Less <<
NCT00612456 Macular Degeneration Phase 2 Completed - -
NCT03312660 Prebiotics Not Applicable Completed - Spain ... More >> A Estrada Primary Care Centre A Estrada, Pontevedra, Spain, 36680 Less <<
NCT01832389 Aneurysmal Subarachnoid Haemor... More >>rhage SAH Less << Not Applicable Completed - Germany ... More >> Klinik für Anaesthesiologie, Klinikum rechts der Isar der Technischen Universität München München, Germany, 81675 Less <<
NCT00392405 Contrast Induced Nephropathy Phase 2 Unknown - United States, Virginia ... More >> Norton Community Hospital Norton, Virginia, United States, 24273 Less <<
NCT02433717 Schizophrenia ... More >> Schizoaffective Disorder Less << Phase 4 Unknown February 2016 Taiwan ... More >> Department of Psychiatry, National Taiwan University Hospital Not yet recruiting Taipei, Test2, Taiwan, test3 Contact: Yi-Ting Lin    +886-972-653-797    p98421013@ntu.edu.tw    Sub-Investigator: Ming H. Hsieh          Sub-Investigator: Yi-Lin Chien          Sub-Investigator: Chih-Min Liu          Sub-Investigator: Tzung-Jeng Hwang          Sub-Investigator: Chen-Chung Liu          National Taiwan University Hospital Recruiting Taipei, Taiwan Contact: Yi-Ting Lin, MD    +886-2-23123456 ext 67990    p98421013@ntu.edu.tw    Principal Investigator: Yi-Ting Lin, MD          Sub-Investigator: Chin-Min Liu, MD, PhD          Sub-Investigator: Ming H Hsieh, MD, PhD          Sub-Investigator: Tzung-Jeng Hwang, MD, PhD          Sub-Investigator: Chen-Chung Liu, MD, PhD          Principal Investigator: Yi-Ling Chien, MD, PhD Less <<
NCT03493386 Anaemia Phase 1 Completed - Japan ... More >> GSK Investigational Site Fukuoka, Japan, 813-0017 Less <<
NCT03611582 Overweight Ob... More >>esity Less << Phase 3 Active, not recruiting May 6, 2020 -
NCT03548987 Metabolism and Nutrition Disor... More >>der Obesity Less << Phase 3 Active, not recruiting March 23, 2020 -
NCT00827450 Hepatic Steatosis Not Applicable Completed - Switzerland ... More >> Centre d'investigations cliniques "cardiomet"/ CHUV Lausanne, Switzerland, CH-1011 Less <<
NCT01538836 Obesity Menop... More >>ause Osteoporosis Sarcopenia Less << Not Applicable Completed - United States, Missouri ... More >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Less <<
NCT03515642 Metabolic Disturbance Not Applicable Recruiting August 30, 2019 Colombia ... More >> Robinson Ramírez-Vélez Recruiting Bogotá, Cundinamarca, Colombia, 111221 Contact: Robinson Ramírez-Vélez, Ph.D    +57 (1) 2970200    robin640@hotmail.com    Contact: Jorge E Correa-Bautista, Ph.D    +57 (1) 2970200    jorge.correa@urosario.edu.co    Sub-Investigator: Viviana Aya, MSc          Sub-Investigator: Mikel Izquierdo, Ph.D          Sub-Investigator: Juan D Ramírez, Ph.D          Sub-Investigator: Miguel Barajas, Ph.D          Sub-Investigator: Joaquín Fernández-Irigoyen, Ph.D          Sub-Investigator: Enrique Santamaría, Ph.D          Sub-Investigator: Jorge E Correa-Bautista, Ph.D          Principal Investigator: Robinson Ramírez-Vélez, Ph.D Less <<
NCT00612456 - Completed - -
NCT01343706 Healthy Phase 1 Completed - Germany ... More >> 1289.1.1 Boehringer Ingelheim Investigational Site Ingelheim, Germany Less <<
NCT03682848 HIV Infections Phase 3 Not yet recruiting December 29, 2023 -
NCT01711086 Asthma Phase 1 Phase 2 Unknown December 2012 Israel ... More >> Schneider Children Hospital Not yet recruiting Petach - Tikva, Israel Contact: Guy Steuer, M.D.    +972524249925    kids.lung@gmail.com    Principal Investigator: Guy Steuer, M.D. Less <<
NCT00400582 Heart Failure Phase 4 Completed - Canada, Quebec ... More >> Montreal Heart Institute Montreal, Quebec, Canada, H1T 1C8 Less <<
NCT02593240 Obesity Overw... More >>eight Quality of Life Less << Not Applicable Completed - United States, Massachusetts ... More >> Tufts University Human Nutrition Research Center on Aging Boston, Massachusetts, United States, 02111 Less <<
NCT01702363 - Completed - -
NCT03507023 Blood Pressure Not Applicable Enrolling by invitation September 2018 Spain ... More >> Universidad Miguel Hernandez de Elche Elche, Alicante, Spain, 03202 Less <<
NCT00073775 - Completed - -
NCT01702363 Pulmonary Disease, Chronic Obs... More >>tructive Less << Phase 3 Completed - Japan ... More >> GSK Investigational Site Fukuoka, Japan, 811-1347 GSK Investigational Site Gunma, Japan, 371-0048 GSK Investigational Site Hokkaido, Japan, 080-0805 GSK Investigational Site Hyogo, Japan, 670-0849 GSK Investigational Site Ibaraki, Japan, 300-0053 GSK Investigational Site Ibaraki, Japan, 302-0022 GSK Investigational Site Ishikawa, Japan, 920-8610 GSK Investigational Site Kanagawa, Japan, 239-0821 GSK Investigational Site Kyoto, Japan, 601-1495 GSK Investigational Site Miyagi, Japan, 983-0824 GSK Investigational Site Nagano, Japan, 391-0011 GSK Investigational Site Oita, Japan, 870-0921 GSK Investigational Site Oita, Japan, 876-0047 GSK Investigational Site Osaka, Japan, 530-0001 GSK Investigational Site Osaka, Japan, 589-0022 GSK Investigational Site Shizuoka, Japan, 436-0022 GSK Investigational Site Tokyo, Japan, 103-0027 GSK Investigational Site Tokyo, Japan, 153-8934 GSK Investigational Site Tokyo, Japan, 192-0903 GSK Investigational Site Yamanashi, Japan, 400-0031 Less <<
NCT01835197 Healthy Phase 1 Completed - United States, Connecticut ... More >> Pfizer Investigational Site New Haven, Connecticut, United States, 06511 Less <<
NCT02876484 Severe Obesity Phase 4 Recruiting February 2019 Denmark ... More >> Hvidovre University Hospital Recruiting Hvidovre, Denmark, DK-2650 Contact: Maria S Svane, MD    +45 38626357    Maria.Saur.Svane@regionh.dk    Contact: Sten Madsbad, MD, DMSc          Sub-Investigator: Isabella Jonsson Less <<
NCT00847574 Obesity Cardi... More >>ovascular Disease Less << Not Applicable Completed - United States, Pennsylvania ... More >> Penn State University University Park, Pennsylvania, United States, 16802 Less <<
NCT02952963 Severe Obesity Phase 4 Unknown February 2017 Denmark ... More >> Hvidovre University Hospital Recruiting Hvidovre, DK, Denmark, 2650 Contact: Maria S Svane, MD    +4538626357    maria.saur.svane@regionh.dk    Contact: Sten Madsbad, MD          Sub-Investigator: Isabella Jonsson, stud.med. Less <<
NCT01545934 Obesity Not Applicable Active, not recruiting June 2021 United States, California ... More >> California Polytechnic State University San Luis Obispo, California, United States, 93401 United States, Rhode Island Miriam Hospital Providence, Rhode Island, United States, 02906 Less <<
NCT01546987 Prostate Cancer Phase 3 Active, not recruiting June 2024 -
NCT00074451 - Completed - -
NCT02021630 - Completed - United States, Pennsylvania ... More >> Geisinger Clinic Danville, Pennsylvania, United States, 17822-2111 Less <<
NCT02273089 - Terminated(Recruitment stopped... More >> due to time restrains) Less << - Portugal ... More >> Consulta de Sono, Departamento de Pneumologia, Centro Hospitalar de Lisboa Central Lisboa, Portugal, 1169-024 Núcleo de Hipertensão Arterial, Consulta de Medicina do Hospital de Santa Marta, Centro Hospitalar de Lisboa Central Lisboa, Portugal, 1169-024 Less <<
NCT02765516 Hypercholesterolemia ... More >> Cardiovascular Disease Less << Not Applicable Recruiting December 2019 Canada, Manitoba ... More >> Department of Human Nutritional sciences, University of Manitoba Recruiting Winnipeg, Manitoba, Canada, R3T2N2 Contact: James House, PhD    204-474-6837    james.house@umanitoba.ca    Principal Investigator: James House, PhD Less <<
NCT00698841 Advanced Cancer Phase 2 Completed - United States, Alabama ... More >> Northwest Alabama Cancer Center Muscle Shoals, Alabama, United States, 35661 United States, Arizona Donald W. Hill, MD Casa Grande, Arizona, United States, 85222 United States, California Compassionate Cancer Care Medical Group, Inc Corona, California, United States, 92879 Compassionate Cancer Care Medical Group Inc Fountain Valley, California, United States, 92708 Pacific Shores Medical Group Long Beach, California, United States, 90813 Desert Hospital Comprehensive Cancer Center Palm Springs, California, United States, 92262 Compassionate Cancer Care Medical Group, Inc Riverside, California, United States, 92501 American Institute Research Whittier, California, United States, 90603 United States, District of Columbia Georgetown University Medical Center Washington, District of Columbia, United States, 20007 United States, Florida Baptist Cancer Institute Jacksonville, Florida, United States, 32207 Ocala Oncology Center Ocala, Florida, United States, 34471 United States, Louisiana Brinz, Burroff, Gurtler, & Russo Metairie, Louisiana, United States, 70006 United States, Oklahoma Cancer Specialists Of Oklahoma Oklahoma City, Oklahoma, United States, 73112 United States, Rhode Island Pharma Resource East Providence, Rhode Island, United States, 02915 United States, Texas Austin Cancer Centers Austin, Texas, United States, 78759 Puerto Rico Local Institution San Juan, Puerto Rico, 00910 Less <<
NCT03569189 Inflammation ... More >>Obesity Inflammatory Response Cardiovascular Diseases Less << Not Applicable Recruiting March 31, 2020 United Kingdom ... More >> Loughborough University Recruiting Loughborough, Leicestershire, United Kingdom, LE11 3TU Less <<
NCT02636270 Short Stature Phase 1 Phase 2 Active, not recruiting December 2020 -
NCT02750826 Breast Carcinoma Phase 3 Recruiting - -
NCT03172117 Alzheimer's Disease Phase 1 Phase 2 Recruiting December 31, 2021 Korea, Republic of ... More >> Samsung Medical Center Recruiting Seoul, Korea, Republic of Contact: Heejin Choi, MD    +82-2-3410-1947    evekhj@gmail.com    Principal Investigator: Duk L Na, MD Less <<
NCT00195858 Obesity Phase 2 Phase 3 Completed - Canada, Ontario ... More >> Ottawa Hospital Research Institute Ottawa, Ontario, Canada, K1Y 4E9 Less <<
NCT03539081 Restless Legs Syndrome ... More >> Neuropathic Pain Less << Not Applicable Recruiting May 1, 2020 United States, Iowa ... More >> University of Iowa Hospitals and Clinics Recruiting Iowa City, Iowa, United States, 52242 Contact: Nataliya S Hramakova, BSN    319-384-9164    nataliya-hramakova@uiowa.edu    Contact: Marshall Holland, MD    319-356-2771    marshall-holland@uiowa.edu    Principal Investigator: Marshall Holland, MD Less <<
NCT00698841 - Completed - -
NCT02717130 Schizophrenia Not Applicable Unknown December 2018 United States, Missouri ... More >> University of Missouri Recruiting Columbia, Missouri, United States, 65211 Contact: John Lauriello, MD    573-882-8913    laurielloj@health.missouri.edu    Contact: Christopher Sinkler    573-884-1073    sinklercs@health.missouri.edu    University of Missouri Recruiting Kansas City, Missouri, United States, 64108 Contact: Roger Sommi, PharmD    816-512-7475    SommiR@umkc.edu    Burrell Behavioral Health Not yet recruiting Springfield, Missouri, United States, 65804 Contact: Paul Thomlinson, PhD    417-761-5015    Paul.Thomlinson@burrellcenter.com    Washington University Recruiting St. Louis, Missouri, United States, 63110 Contact: Ginger Nicol, MD    314-362-2461    nicolg@psychiatry.wustl.edu    Contact: Julie Schweiger, CCRC    314-362-3153    schweigj@psychiatry.wustl.edu Less <<
NCT01762163 Ischemic Stroke Phase 4 Completed - China, Guangxi ... More >> The First Affiliated Hospital of Guangxi University of Chinese Medicine Nanning, Guangxi, China, 530023 China, Hebei Langfang TCM Hospital Langfang, Hebei, China China, Henan Luohe Hospital of Chinese Medicine Luohe, Henan, China, 462000 the First affiliated Hospital of Henan University of TCM Zhengzhou, Henan, China China, Jilin the affiliated Hospital to Changchun University of Chinese Medicine Changchun, Jilin, China China, Liaoning 201 Hospital of People's Liberation Army Dalian, Liaoning, China Zhongshan Hospital Dalian University Dalian, Liaoning, China Second Hospital affiliated to Liaoning University of Traditional Chinese Medicine Shenyang, Liaoning, China China, Sichuan Teaching Hospital of Chengdu University of Traditional Chinese Medicine Chengdu, Sichuan, China, 610075 West China Hospital,Sichuan University Chengdu, Sichuan, China China Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine Beijing, China, 100700 Guang'anmen Hospital Nan District,China Academy of Chinese Medical Sciences Beijing, China First Teaching Hospital of Tianjin University of TCM Tianjin, China Less <<
NCT02652793 Human Immunodeficiency Virus Not Applicable Unknown December 2017 Spain ... More >> Hospital Clínic i Provincial de Barcelona Recruiting Barcelona, Spain, 08036 Contact: Jose Luis Blanco, MD    +34 93 227 54 00 Less <<
NCT02709629 Diabetes Olde... More >>r Diabetic Persons Without Dementia Less << Not Applicable Completed - Israel ... More >> Joseph Sagol Neuroscience Center, Sheba Medical Center Ramat-Gan, Australian National University, Israel, 0200 Less <<
NCT02879110 Autism Spectrum Disorder Not Applicable Recruiting August 2019 China, Guangdong ... More >> Guangzhou Huiai Hospital Not yet recruiting Guangzhou, Guangdong, China, 510000 Contact: Daomeng Cheng, M.D.       4336032@qq.com    China, Hunan The second Xiangya hospital of central south university Recruiting Changsha, Hunan, China, 410001 Contact: Jianjun Ou, M.D., Ph.D    86-18694971485    oujianjun08@163.com    Contact: Yanan Liu, Master    86-18008422158    610122024@qq.com    Sub-Investigator: Yidong Shen, M.D., Ph.D          Sub-Investigator: Yamin Li, M.D., Ph.D          Sub-Investigator: Yanan Liu, Master          Sub-Investigator: Lijuan Shi, Ph.D          Sub-Investigator: Xilong Cui, Ph.D          Sub-Investigator: Li Liu, Master          Sub-Investigator: Yan Qiu, Master          Sub-Investigator: Lu Xiao, Master Less <<
NCT00673270 Renin Angiotensin Phase 1 Phase 2 Terminated - France ... More >> Unité d'Investigation Clinique - Hôpital de Pontchaillou Rennes, France, 35033 Less <<
NCT02760264 Duchenne Muscular Dystrophy Phase 2 Completed - United States, California ... More >> University of California Davis Davis, California, United States, 95616 United States, Florida University of Florida Gainesville, Florida, United States, 32611 Nemours Children's Hospital Orlando, Florida, United States, 32827 United States, Illinois Ann & Robert H. Lurie Children's Hospital Chicago, Illinois, United States, 60611 United States, North Carolina Duke University Durham, North Carolina, United States, 27710 United States, Texas University of Texas Southwestern Medical Center Dallas, Texas, United States, 75207 Australia Royal Children's Hospital Melbourne, Australia Sydney Children's Hospital Westmead, Australia Canada, Alberta Alberta Children's Hospital Calgary, Alberta, Canada, T3B 6A8 Israel Schneider Children's Medical Center Petah Tikvah, Israel, 49202 Sweden Queen Silvia Children's Hospital Gothenburg, Sweden, 41685 United Kingdom Newcastle upon Tyne Hospitals NHS Foundation Trust Newcastle upon Tyne, United Kingdom, NE7 7DN Less <<
NCT00895206 Kidney Transplantation Phase 4 Completed - Belgium ... More >> University Hospital Ghent Ghent, Belgium, 9000 Less <<
NCT01790126 Prostate Cancer Phase 2 Active, not recruiting December 31, 2019 United States, Arizona ... More >> Scottsdale, Arizona, United States United States, California San Francisco, California, United States United States, Illinois Chicago, Illinois, United States United States, Oregon Portland, Oregon, United States United States, Washington Seattle, Washington, United States Less <<
NCT02704962 Schizophrenia Phase 4 Completed - Taiwan ... More >> Kai-Suan Psychiatric Hospital Kaohsiung, Taiwan, 802 Kai-Suan Psychiatric Hospital Kaohsiung, Taiwan Less <<
NCT02564588 Binge Eating Disorder Phase 2 Phase 3 Completed - -
NCT02184364 Menopause Phase 3 Completed - -
NCT01661764 - Completed - -
NCT02062047 Periodontitis ... More >> Diabetes Less << Phase 4 Completed - -
NCT01661764 Colorectal Adenomatous Polyps Phase 2 Completed - United States, Tennessee ... More >> Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232 Less <<
NCT03039452 Knee Osteoarthritis Not Applicable Completed - United States, North Carolina ... More >> Applied Physiology Laboratory Chapel Hill, North Carolina, United States, 27599 Less <<
NCT01498081 COPD Phase 2 Completed - Poland ... More >> Research Site Bialystok, Poland Research Site Leczna, Poland Research Site Lodz, Poland Research Site Proszowice, Poland Sweden Research Site Goteborg, Sweden Research Site Lund, Sweden Less <<
NCT03452111 Healthy Men ... More >> Male Contraception Less << Phase 2 Recruiting September 2021 United States, California ... More >> Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center Recruiting Torrance, California, United States, 90509 Contact: Xiaodan Han    310-222-1865    xhan@labiomed.org    Principal Investigator: Christina Wang          United States, Kansas University of Kansas Recruiting Kansas City, Kansas, United States, 66160 Contact: Katie Glavin    913-588-8721    kglavin@kumc.edu    Principal Investigator: Ajay Nangia, MBBS, FACS          United States, Washington University of Washington Medical Center & Health Sciences Recruiting Seattle, Washington, United States, 98195 Contact: Stephanie Page, MD, PhD    206-616-1818    page@uw.edu    Chile Chilean Institute of Reproductive Medicine Not yet recruiting Santiago, Chile Contact: Veronica Reyes       vreyes@icmer.org    Principal Investigator: Gabriela Noe, MS          Italy University of Bologna Not yet recruiting Bologna, Italy Contact: Giulia Gava       gava.giulia@hotmail.it    Principal Investigator: Cristina Meriggiola          Kenya Kenyatta National Hospital Not yet recruiting Nairobi, Kenya Contact: Sheila Eshiwani       seshiwanin@gmail.com    Principal Investigator: John Kinuthia, MBChB, MPH          Sweden Karolinska Institutet Not yet recruiting Stockholm, Sweden Contact: Eva Broberg    46(8)517 721 28    eva.k.broberg@karolinska.se    Principal Investigator: Kristina Gemzell Danielsson, MD          United Kingdom University of Edinburgh Not yet recruiting Edinburgh, United Kingdom Contact: Anne Saunderson    0131 242 2669    A.Saunderson@ed.ac.uk    Principal Investigator: Richard Anderson, MD, PhD          University of Manchester Not yet recruiting Manchester, United Kingdom Contact: Kate Barugh    0161 27 66201    Kate.Barugh@cmft.nhs.uk    Principal Investigator: Cheryl Fitzgerald, MD Less <<
NCT01339442 Estrogen Receptor-positive Bre... More >>ast Cancer Recurrent Breast Cancer Stage IV Breast Cancer Less << Phase 1 Completed - United States, Missouri ... More >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Less <<
NCT03185273 - Recruiting June 9, 2020 Hong Kong ... More >> The University of Hong Kong Recruiting Hong Kong, Hong Kong Contact: Esther Yee Tak Yu    (852) 25524640    ytyu@hku.hk Less <<
NCT03296098 Contraception ... More >> Healthy Female Less << Phase 2 Not yet recruiting December 2020 United States, California ... More >> Essential Access Not yet recruiting Los Angeles, California, United States, 90010 Contact: Anita L. Nelson, MD    213-386-5614 ext 4403    nelsona@cfhc.org    Contact: Kieumai Vo    213-386-5614 ext 4592    kvo@essentialaccess.org    Principal Investigator: Anita L. Nelson, MD          Principal Investigator: Ron Freizeres          University of California, Davis Not yet recruiting Sacramento, California, United States, 95817 Contact: Mitchell D Creinin, MD    916-734-6886       Contact: Courtney Overstreet    916-734-6227    cboverstreet@ucdavis.edu    University of California, San Francisco Not yet recruiting San Francisco, California, United States, 94110 Contact: Abby Sokoloff, MPH    415-206-8715    abby.sokoloff@ucsf.edu    Principal Investigator: Phillip Darney, MD          United States, Colorado University of Colorado Not yet recruiting Denver, Colorado, United States, 80045 Contact: Ines Crato    303-724-5559    ines.crato@ucdenver.edu    Principal Investigator: Stephanie Teal, MD          United States, Hawaii University of Hawaii Not yet recruiting Honolulu, Hawaii, United States, 96826 Contact: Bliss Kaneshiro          Contact: Tiana Fontanilla, MPH    808-203-6598       United States, Illinois University of Chicago Not yet recruiting Chicago, Illinois, United States, 60637 Contact: Sadia Haider          Contact: Kate Lewis    773-834-5437    klewis2@uchicago.edu    United States, Maryland Johns Hopkins Bayview Medical Center Not yet recruiting Baltimore, Maryland, United States, 21224 Contact: Anne E. Burke, MD, MPH    410-550-0335    aburke@jhmi.edu    Contact: Katrina Thaler, MPH    410-550-8506    kstouff3@jhmi.edu    Principal Investigator: Anne E. Burke, MD, MPH          United States, Massachusetts Planned Parenthood League of Massachusetts Not yet recruiting Boston, Massachusetts, United States, 02215 Contact: Jennifer Fortin       jfortin@pplm.org    Principal Investigator: Alisa Goldberg, MD          United States, New York New York University, School of Medicine Not yet recruiting New York, New York, United States, 10016 Contact: Treasure Walker          Contact: Anna Davis    212-263-6253    anna.davis@nyumc.org    Columbia University Not yet recruiting New York, New York, United States, 10032 Contact: Carolyn Westhoff, MD    212-305-4805    clw3@columbia.edu    Contact: Claudia Roca    212-342-2986    cr479@mail.cumc.columbia.edu    Principal Investigator: Carolyn Westhoff, MD          United States, Ohio University of Cincinnati Not yet recruiting Cincinnati, Ohio, United States, 45267 Contact: Michael Thomas, MD    513-584-4130       Contact: Tiffany Rupert    513-584-4130    rupertts@ucmail.uc.edu    University Hospitals of Cleveland MacDonald Women's Hospital Not yet recruiting Cleveland, Ohio, United States, 44106 Contact: James H. Liu, MD    440-720-3250    james.liu@uhhs.com    Contact: Bridget Ermlich    216-844-8091    bridget.ermlich@uhhospitals.org    Principal Investigator: James H. Liu, MD          United States, Oregon Oregon Health & Science University Not yet recruiting Portland, Oregon, United States, 97239 Contact: Jeffrey Jensen          Contact: Sumi Maristany    503-494-0585    maristan@ohsu.edu    United States, Pennsylvania University of Pennsylvania Medical Center Not yet recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Kurt T. Barnhart, MD    215-662-2974    kbarnhart@obgyn.upenn.edu    Contact: Andrea Morley    215-615-4202    andrea.morley@uphs.upenn.edu    Principal Investigator: Kurt T. Barnhart, MD          Univeristy of Pittsburgh School of Medicine Not yet recruiting Pittsburgh, Pennsylvania, United States, 15213 Contact: Beatrice Chen, MD    412-641-5496    chenba@upmc.edu    Contact: Jenelle Mock    412-641-4791    mockj@upmc.edu    Principal Investigator: Beatrice Chen, MD          United States, Rhode Island Women & Infants Hospital of Rhode Island Not yet recruiting Providence, Rhode Island, United States, 02905 Contact: Rebecca Allen          Contact: Mindy Marshall       mamarshall@wihri.org    United States, Utah University of Utah Not yet recruiting Salt Lake City, Utah, United States, 84106 Contact: David Turok, MD    801-213-2774       Contact: Amy Orr    801-213-2774    amy.orr@hsc.utah.edu    United States, Virginia Eastern Virginia Medical School (EVMS) Not yet recruiting Norfolk, Virginia, United States, 23507 Contact: David E Archer, MD    757-446-7422       Contact: Erin Maple, MPH    757-446-7971    mapleel@evms.edu Less <<
NCT02344290 HIV Infections ... More >> Cardiovascular Diseases Less << Phase 3 Recruiting April 1, 2022 -
NCT01893515 Dyslipidemia Phase 2 Completed - -
NCT02760277 Duchenne Muscular Dystrophy Phase 2 Completed - United States, California ... More >> University of California Davis Davis, California, United States, 95616 United States, Florida University of Florida Gainesville, Florida, United States, 32611 Nemours Children's Hospital Orlando, Florida, United States, 32827 United States, Illinois Ann & Robert H. Lurie Children's Hospital Chicago, Illinois, United States, 60611 United States, North Carolina Duke University Durham, North Carolina, United States, 27710 United States, Texas University of Texas Southwestern Medical Center Dallas, Texas, United States, 75207 Australia Royal Children's Hospital Melbourne, Australia Sydney Children's Hospital Westmead, Australia Canada, Alberta Alberta Children's Hospital Calgary, Alberta, Canada, T3B 6A8 Israel Schneider Children's Medical Center Petah Tikwah, Israel, 49202 Sweden Queen Silvia Children's Hospital Gothenburg, Sweden, 41685 United Kingdom Newcastle upon Tyne Hospitals NHS Foundation Trust Newcastle upon Tyne, United Kingdom, NE7 7DN Less <<
NCT03038399 Duchenne Muscular Dystrophy Phase 2 Enrolling by invitation January 2021 United States, California ... More >> University of California Davis Davis, California, United States, 95616 United States, Florida University of Florida Gainesville, Florida, United States, 32611 Nemours Children's Hospital Orlando, Florida, United States, 32827 United States, Illinois Ann & Robert H. Lurie Children's Hospital Chicago, Illinois, United States, 60611 United States, North Carolina Duke University Durham, North Carolina, United States, 27710 United States, Texas University of Texas Southwestern Medical Center Dallas, Texas, United States, 75207 Australia Royal Children's Hospital Melbourne, Australia Sydney Children's Hospital Westmead, Australia Canada, Alberta Alberta Children's Hospital Calgary, Alberta, Canada, T3B 6A8 Israel Schneider Children's Medical Center Petah Tikwah, Israel, 49202 Sweden Queen Silvia Children's Hospital Gothenburg, Sweden, 41685 United Kingdom Newcastle upon Tyne Hospitals NHS Foundation Trust Newcastle upon Tyne, United Kingdom, NE7 7DN Less <<
NCT02777229 HIV-1 Infection Phase 3 Active, not recruiting July 2018 Cameroon ... More >> Cité verte Hospital Yaoundé, Cameroon Hopital Central Yaoundé, Cameroon Military Hospital Yaoundé, Cameroon Less <<
NCT02656940 Obesity Not Applicable Completed - -
NCT01672632 Over Eating Not Applicable Active, not recruiting May 2019 United States, Louisiana ... More >> Pennington Biomedical Research Center Baton Rouge, Louisiana, United States, 70808 Less <<
NCT00679237 Coronary Heart Disease Not Applicable Active, not recruiting December 2024 Norway ... More >> Sorlandet Hospital Arendal, Norway Less <<
NCT01274780 HIV-1 Phase 4 Completed - Spain ... More >> Hospital Clinic Barcelona, Spain, 08036 Less <<
NCT02314793 Healthy Subjects ... More >> Pharmacokinetics of ASP2205 Less << Phase 1 Terminated(The study has been ... More >>terminated because of operational reasons.) Less << - United Kingdom ... More >> Site GB44001 Harrow, United Kingdom, HA1 3UJ Less <<
NCT01677273 Increased Energy Expenditure ... More >> Increased Satiety Less << Not Applicable Completed - Denmark ... More >> Department of Human Nutrion Frederiksberg, Denmark, 1958 Less <<
NCT01972178 Dyslipidemia Phase 2 Terminated - -
NCT01559415 Obesity Weigh... More >>t Loss Diet Less << Not Applicable Completed - Netherlands ... More >> Maastricht University Maastricht, Limburg, Netherlands, 6200 MD Less <<
NCT01217307 ST Elevation Myocardial Infarc... More >>tion (STEMI) Coronary Artery Disease Heart Failure Diabetes Less << Phase 2 Phase 3 Completed - Netherlands ... More >> University Medical Center Groningen Groningen, Netherlands, 9700RB Less <<
NCT02493140 Weight Loss Not Applicable Unknown February 2016 France ... More >> Clinical Nutrition Center Naturalpha (CNCN) Recruiting Lille, France, 59020 Contact: CNCN    +33(0)320877575    cncn@naturalpha.com    Principal Investigator: Xavier Deplanque Less <<
NCT01217307 - Completed - -
NCT01826019 Hypertension ... More >>Cardiovascular Disease Less << Phase 4 Active, not recruiting October 2018 Canada, British Columbia ... More >> Simon Fraser University Burnaby, British Columbia, Canada, V5A 1S6 Canada, Ontario Population Health Research Institute Hamilton, Ontario, Canada, L8L 2X2 Colombia FOSCAL Floridablanca, Santander, Colombia Malaysia UniversitiTeknologi MARA (UiTM) Sungai Buloh, Selangor, Malaysia, 47000 Less <<
NCT03159442 Chronic Obstructive Pulmonary ... More >>Disease - COPD Less << Phase 1 Completed - United Kingdom ... More >> Research Site London, United Kingdom, HA1 3UJ Less <<
NCT02622425 Overweight Ob... More >>esity Less << Phase 2 Completed - Netherlands ... More >> MUMC+ Maastricht, Limburg, Netherlands, 6229HX Less <<
NCT01154101 Psoriasis Phase 2 Completed - United States, Missouri ... More >> GSK Investigational Site Saint Louis, Missouri, United States, 63117 United States, New York GSK Investigational Site New York, New York, United States, 10016 GSK Investigational Site New York, New York, United States, 10065 United States, Oregon GSK Investigational Site Portland, Oregon, United States, 97223 United States, Pennsylvania GSK Investigational Site Philadelphia, Pennsylvania, United States, 19103 United States, Rhode Island GSK Investigational Site Johnston, Rhode Island, United States, 02919 United States, Texas GSK Investigational Site Dallas, Texas, United States, 75246 United States, Washington GSK Investigational Site Seattle, Washington, United States, 98101 Less <<
NCT02936973 Obesity Not Applicable Recruiting December 2018 China, Hubei ... More >> Hubei Provincial Hospital of Traditional Chinese Medicine Recruiting Wuhan, Hubei, China, 430061 Contact: Zhou Zhongyu, Professor    +86 18672308659    2209447940@qq.com    Contact: Huang Wei    +86 13986083982    13986083982@qq.com Less <<
NCT01251991 Hypercholesterolemia Phase 4 Completed - Denmark ... More >> The Lipid Clinic, Aalborg Hospital Aalborg, RN, Denmark, 9000 Less <<
NCT01154101 - Completed - -
NCT01629615 Breast Cancer Phase 2 Completed - United States, Massachusetts ... More >> Dana-Farber at Faulkner Hospital Boston, Massachusetts, United States, 02130 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 Spain Hospital Universitario Vall d´Hebron Barcelona, Spain, 08035 Hospital Universitario 12 de Octubre Madrid, Spain, 28041 Instituto Valenciano de Oncología Valencia, Spain, 46009 Hospital Clínico Universitario de Valencia Valencia, Spain, 46010 Less <<
NCT02535910 Hypovitaminosis D ... More >> Cardiovascular Diseases Less << Not Applicable Unknown May 2016 United Kingdom ... More >> Hugh Sinclair Unit of Human Nutrition, Department of Food and Nutritional Sciences, University of Reading Reading, Berkshire, United Kingdom, RG6 6AP Less <<
NCT02278965 Stage 0 Breast Carcinoma ... More >> Breast Neoplasms Stage I Breast Carcinoma Stage II Breast Carcinoma Stage III Breast Carcinoma Less << Phase 1 Active, not recruiting October 2018 United States, New York ... More >> Columbia University New York, New York, United States, 10032 Less <<
NCT00647946 Lipodystrophy Phase 2 Completed - United Kingdom ... More >> Gilead Sciences Abingdon, Cambridge, United Kingdom, CB1 6GT Less <<
NCT01923597 Diabetic Nephropathy ... More >> Hypertension Less << Phase 2 Completed - Brazil ... More >> Unicamp Campinas, São Paulo, Brazil, 13084-971 Less <<
NCT02384967 HIV INFECTION Phase 2 Completed - France ... More >> Hôpital Saint Louis Paris, France, 75010 Less <<
NCT01172314 Non-small Cell Lung Cancer Not Applicable Active, not recruiting February 2019 United States, Arkansas ... More >> University of Arkansas for Medical Sciences Little Rock, Arkansas, United States, 72205 Less <<
NCT00881478 Obesity Not Applicable Completed - Canada, Alberta ... More >> Alberta Children's Hospital Calgary, Alberta, Canada, T3B 6A8 Less <<
NCT01781403 Rectal Cancer Phase 1 Active, not recruiting December 2018 Korea, Republic of ... More >> Asan Medical Center Seoul, Songpa-gu, Korea, Republic of, 138-736 Less <<
NCT03045120 - Recruiting July 31, 2021 -
NCT01913678 Obesity Not Applicable Completed - Denmark ... More >> Department of Nutrition, Exercise and Sports Frederiksberg, Copenhagen, Denmark, 1958 Less <<
NCT02720302 Overweight Not Applicable Active, not recruiting January 31, 2021 Sweden ... More >> Barnmedicin Malmö, Scania, Sweden, 20502 Less <<
NCT03128697 Obesity Appet... More >>ite Disorders Less << Not Applicable Completed - Canada ... More >> Laval University Quebec, Canada, G1V 0A6 Laval Hospital Quebec, Canada, G2B 4H4 Less <<
NCT02916355 Adiposity Not Applicable Completed - Switzerland ... More >> University Hospital Basel, Department of Endocrinology, Diabetes and Metabolism Basel, Switzerland, CH-4031 Basel Less <<
NCT02135952 Periodontitis Phase 4 Unknown October 2014 Brazil ... More >> University of Guarulhos Guarulhos, São Paulo, Brazil, 07023-070 Less <<
NCT01781403 - Active, not recruiting - -
NCT02706678 Renal Transplant Recipients Phase 4 Completed - China ... More >> Beijing, China Changchun, China Chengdu, China Guangzhou, China Nanjing, China Nanning, China Shanghai, China Shenyang, China Wuhan, China Less <<
NCT03320941 Obesity Phase 2 Completed - Japan ... More >> Novartis Investigative Site Matsudo city, Chiba, Japan, 271 0077 Novartis Investigative Site Chikushino-city, Fukuoka, Japan, 818-0036 Novartis Investigative Site Fukuoka-city, Fukuoka, Japan, 810-0066 Novartis Investigative Site Fukuoka-city, Fukuoka, Japan, 819-0006 Novartis Investigative Site Kitakyushu-city, Fukuoka, Japan, 807-0857 Novartis Investigative Site Kakogawa-city, Hyogo, Japan, 675-0101 Novartis Investigative Site Yokohama-city, Kanagawa, Japan, 231-0023 Novartis Investigative Site Kumamoto City, Kumamoto, Japan, 860-0863 Novartis Investigative Site Kumamoto-city, Kumamoto, Japan, 860-8039 Novartis Investigative Site Kyoto city, Kyoto, Japan, 600-8898 Novartis Investigative Site Kyoto-city, Kyoto, Japan, 615-8125 Novartis Investigative Site Nagasaki city, Nagasaki, Japan, 850 0045 Novartis Investigative Site Higashiosaka-city, Osaka, Japan, 577-0802 Novartis Investigative Site Higashiosaka-city, Osaka, Japan, 577-0803 Novartis Investigative Site Ageo-city, Saitama, Japan, 362-8588 Novartis Investigative Site Kawaguchi-sity, Saitama, Japan, 332 0021 Novartis Investigative Site Tokorozawa-city, Saitama, Japan, 359-0042 Novartis Investigative Site Tokorozawa, Saitama, Japan Novartis Investigative Site Hachioji-city, Tokyo, Japan, 192-0046 Novartis Investigative Site Kiyose-city, Tokyo, Japan, 204-0021 Novartis Investigative Site Minato-ku, Tokyo, Japan, 108-0075 Novartis Investigative Site Shinagawa-ku, Tokyo, Japan, 141-0032 Novartis Investigative Site Toshima-ku, Tokyo, Japan, 171-0021 Novartis Investigative Site Hyogo, Japan, 674-0081 Less <<
NCT00760955 Diabetic Neuropathies Phase 2 Completed - -
NCT02069288 Septic Shock Phase 3 Withdrawn(Problems of drugs su... More >>pply by the manufacturer) Less << - France ... More >> Service de Réanimation Chirurgicale - Hôpital de Pontchaillou Rennes, France, 35033 Less <<
NCT02135939 Coronary Artery Disease ... More >> Inflammation Less << Not Applicable Completed - United States, New York ... More >> NYUMC Tisch Hospital, HCC 14 New York, New York, United States, 10016 Less <<
NCT03672981 Hematopoietic and Lymphoid Cel... More >>l Neoplasm Hematopoietic Cell Transplantation Recipient Less << Not Applicable Not yet recruiting October 1, 2019 United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Not yet recruiting Seattle, Washington, United States, 98109 Contact: Tyler Ketterl    206-667-5327       Principal Investigator: Tyler Ketterl Less <<
NCT00775814 Obesity Hyper... More >>tension Less << Phase 4 Completed - Germany ... More >> Bad Dürrheim, Baden-Württemberg, Germany Balingen, Baden-Württemberg, Germany Deggingen, Baden-Württemberg, Germany Rottweil, Baden-Württemberg, Germany Spaichingen, Baden-Württemberg, Germany Ingolstadt, Bayern, Germany München, Bayern, Germany Passau, Bayern, Germany Schauenburg, Hessen, Germany Bocholt, Nordrhein-Westfalen, Germany Essen, Nordrhein-Westfalen, Germany Isselburg, Nordrhein-Westfalen, Germany Köln, Nordrhein-Westfalen, Germany Roetgen, Nordrhein-Westfalen, Germany Troisdorf, Nordrhein-Westfalen, Germany Wesseling, Nordrhein-Westfalen, Germany Roedersheim-Gronau, Rheinland-Pfalz, Germany Dresden, Sachsen, Germany Freital, Sachsen, Germany Machem, Sachsen, Germany Markkleeberg, Sachsen, Germany Wermsdorf, Sachsen, Germany Bad Segeberg, Schleswig-Holstein, Germany Berlin, Germany Less <<
NCT00408148 Obesity Phase 3 Terminated(Company decision ha... More >>s been taken in light of recent demands by certain national health authorities) Less << - Australia ... More >> Sanofi-Aventis Administrative Office North Ryde, Australia Finland Sanofi-Aventis Administrative Office Helsinki, Finland France Sanofi-Aventis Administrative Office Paris, France United Kingdom Sanofi-Aventis Administrative Office Guildford, United Kingdom Less <<
NCT02804308 Breast Cancer ... More >> Aromatase Inhibitors Postmenopausal Less << Not Applicable Completed - -
NCT02616315 Weight Regain Post Bariatric S... More >>urgery Less << Phase 4 Withdrawn December 2017 United States, Illinois ... More >> Chicago, Illinois, United States United States, Massachusetts Boston, Massachusetts, United States Less <<
NCT03243786 Breast Cancer Not Applicable Recruiting March 31, 2021 United States, Wisconsin ... More >> Medical College of Wisconsin Recruiting Milwaukee, Wisconsin, United States, 53226 Contact: Kathleen Jensik    414-955-2114    kjensik@mcw.edu    Contact: Collette Bien    414-805-8769    cbien@mcw.edu Less <<
NCT02105571 Obesity Not Applicable Completed - United States, Oregon ... More >> Oregon Health and Science University Portland, Oregon, United States, 97239 Less <<
NCT01173120 - Completed - -
NCT02989753 Hypercholesterolemia ... More >> Hypertriglyceridemia Less << Phase 1 Phase 2 Completed - France ... More >> Biofortis Mérieux NutriSciences Clinical Investigation Center Saint Herblain, France, 44800 Less <<
NCT02467309 - Unknown June 2016 -
NCT01618071 Postprandial Period ... More >> Lipemia Vasodilation Vascular Resistance Nitric Oxide Less << Not Applicable Completed - United Kingdom ... More >> Diabetes & Nutritional Sciences Division, King's College London London, United Kingdom, SE1 9NH Less <<
NCT00633698 Elevated Lipoprotein(a) Levels Phase 3 Unknown March 2010 Germany ... More >> Institute of Social Medicine, Epidemiology and Health Economics Berlin, Germany, 10098 Less <<
NCT02496507 Physical Activity Not Applicable Completed - United Kingdom ... More >> Liverpool John Moores University Liverpool, Merseyside, United Kingdom, L3 2AT Less <<
NCT01173120 Rheumatoid Arthritis (RA) Phase 3 Completed - -
NCT01078636 - Completed - -
NCT03080818 Aging Not Applicable Recruiting January 1, 2018 United States, Ohio ... More >> Kent State Uniersity Recruiting Kent, Ohio, United States, 44242 Contact: John Gunstad, Ph.D.    330-672-2589    jgunstad@kent.edu Less <<
NCT01028339 Traumatic Brain Injury Phase 3 Terminated(No patients enrolle... More >>d during 2 years) Less << December 2012 France ... More >> HIA Sainte Anne Toulon, France, 83130 Less <<
NCT00339014 Obesity Phase 2 Completed - United States, Alabama ... More >> SelfCenter, PC Fairhope, Alabama, United States, 36532 United States, California UCLA Center for Human Nutrition Los Angeles, California, United States, 90095 Scripps Clinic Del Mar San Diego, California, United States, 92130 United States, Colorado Center for Human Nutrition University of Colorado Health Sciences Center Denver, Colorado, United States, 80220 United States, District of Columbia George Washington University Weight Management Program Washington, District of Columbia, United States, 20037 United States, Georgia CSRA Partners in Health, Inc Augusta, Georgia, United States, 30909 United States, Illinois Springfield Diabetes and Endocrine Center Springfield, Illinois, United States, 62704 United States, Louisiana Pennington Biomedical Research Center Baton Rouge, Louisiana, United States, 70808 United States, Massachusetts Nutrition and Weight Mangement Center Boston Medical Center Boston, Massachusetts, United States, 02118 United States, Nevada Center for Nutrition and Metabolic Diseases Reno, Nevada, United States, 89557 United States, New York Comprehensive Weight Control Program New York, New York, United States, 10021 United States, North Carolina Center for Nutrition and Preventive Medicine Charlotte, North Carolina, United States, 28211 United States, South Carolina MUSC Weight Mnagement Center Charleston, South Carolina, United States, 29425 United States, Texas The Cooper Institute Dallas, Texas, United States, 75230 Baylor Endocrine Center Dallas, Texas, United States, 75246 Less <<
NCT02855021 Parkinson Disease Not Applicable Not yet recruiting September 2019 France ... More >> Henri Mondor Hospital Not yet recruiting Creteil, France, 94010 Less <<
NCT03186859 Non-Alcoholic Fatty Liver Dise... More >>ase Non Alcoholic Fatty Liver Bariatric Surgery Candidate Obesity, Morbid Less << Not Applicable Recruiting August 2019 United Kingdom ... More >> University of Oxford Recruiting Oxford, United Kingdom Contact: Jeremy W Tomlinson, MD PhD    44(0)1865 857359    jeremy.tomlinson@ocdem.ox.ac.uk    Contact: Leanne Hodson, PhD       leanne.hodson@ocdem.ox.ac.uk    Sub-Investigator: Niall Dempster, MD          Sub-Investigator: Garry Tan, MD          Sub-Investigator: Bruno Sgromo, MD          Sub-Investigator: Richard Gillies, MD Less <<
NCT00880958 Obesity Not Applicable Completed - Japan ... More >> Hiroshima University Hiroshima, Japan, 734-8551 Less <<
NCT01231971 - Active, not recruiting October 2018 -
NCT01439373 - Completed - -
NCT02856776 Vitamin D Insufficiency Not Applicable Recruiting June 2019 United States, Massachusetts ... More >> Boston University Medical Campus Recruiting Boston, Massachusetts, United States, 02118 Contact: Michael F Holick, MD PhD    617-638-4546    mfholick@bu.edu    Contact: Tyler A Kalajian, MS    617 638 4546    tylerk@bu.edu Less <<
NCT02854033 - Recruiting October 2021 -
NCT01439373 Hepatitis C, Chronic Phase 2 Completed - United States, California ... More >> GSK Investigational Site Anaheim, California, United States, 92801 GSK Investigational Site Chula Vista, California, United States, 91911 GSK Investigational Site Coronado, California, United States, 92118 GSK Investigational Site La Mesa, California, United States, 91942 GSK Investigational Site Oceanside, California, United States, 92056 United States, Florida GSK Investigational Site Miramar, Florida, United States, 33025 United States, Nevada GSK Investigational Site Las Vegas, Nevada, United States, 89109 United States, Oklahoma GSK Investigational Site Tulsa, Oklahoma, United States, 74104 United States, Texas GSK Investigational Site Houston, Texas, United States, 77004 Puerto Rico GSK Investigational Site San Juan, Puerto Rico, 00927 Less <<
NCT03733288 Sedentary Lifestyle ... More >> Physical Activity Less << Not Applicable Active, not recruiting May 2019 United Kingdom ... More >> Liverpool John Moores University Liverpool, United Kingdom Less <<
NCT02980393 Congenital Heart Disease ... More >> Pediatric Obesity Less << Not Applicable Completed - -
NCT02238314 HIV Infections Phase 2 Completed - -
NCT03485365 Pain, Inflammatory Phase 1 Recruiting November 27, 2019 United Kingdom ... More >> GSK Investigational Site Recruiting Cambridge, United Kingdom, CB2 0GG Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com Less <<
NCT00101517 - Completed - United States, Georgia ... More >> Morehouse School of Medicine Atlanta, Georgia, United States, 30310 Emory University School Atlanta, Georgia, United States, 30322 Less <<
NCT03236740 PCOS Phase 4 Completed - India ... More >> SCB Medical College Cuttack, Orissa, India, 753007 Less <<
NCT01204632 - Completed - United States, Florida ... More >> The Miami Project to Cure Paralysis Miami, Florida, United States, 33136 Less <<
NCT00105989 Depressive Disorder, Major Phase 3 Completed - United States, California ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Newport Beach, California, United States For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sherman Oaks, California, United States United States, Maryland For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Baltimore, Maryland, United States For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Gaithersburg, Maryland, United States United States, New York For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Brooklyn, New York, United States France For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Angouleme, France For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Douai, France For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fains, France For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. La Rochelle, France For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lille, France For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nimes, France For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Roubaix, France For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Strasbourg, France Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Berlin, Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ellwangen, Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hamburg, Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hildesheim, Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Leipzig, Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Munchen, Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Wurzburg, Germany Italy For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Catania, Italy For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ferrara, Italy For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Firenze, Italy For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Parma, Italy For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Roma, Italy For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Torino, Italy Russian Federation For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Moscow, Russian Federation For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. St. Petersburg, Russian Federation For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Village Nikolskoe, Russian Federation Sweden For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Halmstad, Sweden For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lund, Sweden For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Malmo, Sweden For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Stockholm, Sweden For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sundsvall, Sweden Less <<
NCT00119795 Cardiovascular Diseases ... More >> Heart Diseases Metabolic Syndrome X Obesity Less << Not Applicable Completed - United States, North Carolina ... More >> Guilford County, North Carolina Cooperative Extension Center Greensboro, North Carolina, United States, 27405 Davidson County Coopertive Extension Lexington, North Carolina, United States, 27292 Forsyth County Cooperative Extension Center Winston-Salem, North Carolina, United States, 27105 Less <<
NCT00134290 Body Weight I... More >>nsulin Resistance Less << Phase 4 Completed - Belgium ... More >> University Hospital Ghent Ghent, Belgium, 9000 Less <<
NCT01223365 - Completed - -
NCT00354874 Asthma Phase 2 Completed - Germany ... More >> GSK Investigational Site Wiesbaden, Hessen, Germany, 65187 GSK Investigational Site Grosshansdorf, Schleswig-Holstein, Germany, 22927 Sweden GSK Investigational Site Göteborg, Sweden, SE-413 45 Less <<
NCT01223365 Chronic Pain Phase 3 Completed - -
NCT00125853 Hypertension Not Applicable Completed - United Kingdom ... More >> Imperial College London Paddington, London, United Kingdom, W2 1PG Less <<
NCT00184899 Obesity Metab... More >>olic Syndrome X Less << Not Applicable Completed - Netherlands ... More >> Radboud University Nijmegen Medical Centre Nijmegen, Netherlands, 6500HB Less <<
NCT02231398 - Active, not recruiting April 30, 2019 United States, California ... More >> Fountain Valley Regional Hospital and Medical Center- UCI MFM private practice Fountain Valley, California, United States, 92708 Long Beach Memorial Medical Center, Women's and Children's Hospital - Women's Perinatal Group, OB Clinic Long Beach, California, United States, 90801 University of California, Irvine, Medical Center - Prenatal care clinics and private practice Orange, California, United States, 92868 United States, Delaware Christiana Care Health Systems Newark, Delaware, United States, 19718 United States, Illinois Northwestern University Chicago, Illinois, United States, 60611 United States, Indiana Indiana University School of Medicine OB/GYN Indianapolis, Indiana, United States, 46202 United States, New York Columbia University Medical Center- Department of OB/GYN Division of Maternal Fetal Medicine New York, New York, United States, 10032 United States, Ohio Case Western Reserve University, MetroHealth Medical Center Cleveland, Ohio, United States, 44109 United States, Pennsylvania University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Magee Womens Hospital Pittsburgh, Pennsylvania, United States, 15213 United States, Utah McKay Dee Hospital Ogden, Utah, United States, 84403 Utah Valley Regional Medical Center Provo, Utah, United States, 84604 University of Utah Salt Lake City, Utah, United States, 84106 Intermountain Medical Center Salt Lake City, Utah, United States, 84107 LDS Hospital Salt Lake City, Utah, United States, 84143 Less <<
NCT00119769 HIV Infections ... More >> Lipodystrophy Less << Phase 4 Completed - Denmark ... More >> Clinical Research Unit, Hvidovre University Hospital Hvidovre, Denmark, 2650 Less <<
NCT02572934 - Recruiting September 2019 Netherlands ... More >> University Medical Center Groningen Recruiting Groningen, Netherlands, 9713 GZ Contact: J. A. Gietema, MD, PhD    +31 50 361 2821    j.a.gietema@umcg.nl Less <<
NCT01494688 Advanced Solid Tumors Phase 1 Completed - United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 United States, Pennsylvania Univ of Pennsylvania Med Ctr Philadelphia, Pennsylvania, United States, 19104 France Institut Bergonie; Oncologie Bordeaux, France, 33076 Centre Leon Berard; Departement Oncologie Medicale Lyon, France, 69373 Institut Curie; Oncologie Medicale Paris, France, 75231 Ico Rene Gauducheau; Oncologie Saint Herblain, France, 44805 Institut Claudius Regaud; Departement Oncologie Medicale Toulouse, France, 31059 Less <<
NCT02899091 Alzheimer's Disease Phase 1 Phase 2 Unknown June 2018 Korea, Republic of ... More >> Bundang Medical Center Not yet recruiting Seongnam-si, Gyeonggi-do, Korea, Republic of Contact: HyunSook Kim, MD, PhD Less <<
NCT01592201 Schizophrenia Phase 4 Terminated(This study was earl... More >>y terminated due to insufficient enrollment required for hypothesis testing.) Less << - Korea, Republic of ... More >> Busan, Korea, Republic of Cheonan City, Korea, Republic of Chuncheon-Si, Korea, Republic of Chungju-Si, Korea, Republic of Dae-Gu, Korea, Republic of Daejeon, Korea, Republic of Goyang-Si, Korea, Republic of Gyeonggi-Do, Korea, Republic of Seoul, Korea, Republic of Less <<
NCT00105989 - Completed - -
NCT01998841 Alzheimer's Disease Phase 2 Active, not recruiting February 25, 2022 Colombia ... More >> Fundacion Cardiomet Armenia, Colombia Clínica de Marly Bogota, Colombia Grupo Neurociencias de Antioquia Medellin, Colombia Hospital San Juan de Dios Yarumal, Colombia Less <<
NCT01922739 Low Back Pain Phase 3 Completed - -
NCT00798772 HIV Infection Not Applicable Completed - Canada, Ontario ... More >> The Ottawa Hospital, General Campus Ottawa, Ontario, Canada, K1H 8L6 Less <<
NCT01922739 - Completed - -
NCT00238992 Kidney de Novo Transplant Phase 3 Completed - -
NCT01200862 Obese Hypogonadotropic Hypogon... More >>adism Less << Phase 2 Terminated - United States, Arizona ... More >> Novartis Investigative Site Tucson, Arizona, United States, 85712 United States, California Novartis Investigative Site San Diego, California, United States, 92120 United States, Florida Novartis Investigative Site Miramar, Florida, United States, 33025 United States, Utah Novartis Investigative Site West Valley City, Utah, United States, 84120 Canada, Quebec Novartis Investigative Site Montreal, Quebec, Canada, H3X 2H9 Less <<
NCT01317797 - Completed - -
NCT01285492 Chronic Obstructive Pulmonary ... More >>Disease (COPD) Less << Phase 3 Completed - Japan ... More >> Novartis Investigative Site Anjo, Aichi, Japan, 446-8602 Novartis Investigative Site Nagoya, Aichi, Japan, 457-8511 Novartis Investigative Site Nishio-city, Aichi, Japan, 445-8510 Novartis Investigative Site Kasuga-city, Fukuoka, Japan, 816-0813 Novartis Investigative Site Kitakyushu, Fukuoka, Japan, 820-0052 Novartis Investigative Site Kurume, Fukuoka, Japan, 830-0011 Novartis Investigative Site Yanagawa, Fukuoka, Japan, 832-0059 Novartis Investigative Site Asahikawa, Hokkaido, Japan, 070-8644 Novartis Investigative Site Obihiro, Hokkaido, Japan, 080-0805 Novartis Investigative Site Sapporo-city, Hokkaido, Japan, 060-8648 Novartis Investigative Site Himeji-city, Hyogo, Japan, 672-8064 Novartis Investigative Site Kanazawa, Ishikawa, Japan, 920-8610 Novartis Investigative Site Takamatsu, Kagawa, Japan, 760-8538 Novartis Investigative Site Kawasaki, Kanagawa, Japan, 210-0852 Novartis Investigative Site Yokohama, Kanagawa, Japan, 236-0051 Novartis Investigative Site Koshi-city, Kumamoto, Japan, 861-1196 Novartis Investigative Site Matsusaka-city, Mie, Japan, 515-8544 Novartis Investigative Site Ueda, Nagano, Japan, 386-8610 Novartis Investigative Site Osaka-city, Osaka, Japan, 545-8586 Novartis Investigative Site Osakasayama, Osaka, Japan, 589-0022 Novartis Investigative Site Takatsuki, Osaka, Japan, 569-1192 Novartis Investigative Site Toyonaka, Osaka, Japan, 560-8552 Novartis Investigative Site Kawaguhi-city, Saitama, Japan, 333-0833 Novartis Investigative Site Hamamatsu, Shizuoka, Japan, 430-8525 Novartis Investigative Site Fuchu, Tokyo, Japan, 183-8524 Novartis Investigative Site Meguro, Tokyo, Japan, 152-8902 Novartis Investigative Site Yamagata city, Yamagata, Japan, 990-8533 Novartis Investigative Site Ube, Yamaguchi, Japan, 755-0241 Novartis Investigative Site Akita, Japan, 010-0933 Novartis Investigative Site Fukuoka, Japan, 811-0213 Novartis Investigative Site Fukuoka, Japan, 812-0033 Novartis Investigative Site Fukuoka, Japan, 815-8588 Novartis Investigative Site Kochi, Japan, 780-8077 Novartis Investigative Site Osaka, Japan, 558-8558 Novartis Investigative Site Wakayama, Japan, 641-8510 Less <<
NCT01918423 - Completed - Denmark ... More >> Department of Endocrinology, Odense University Hospital Odense, Denmark, 5000 Less <<
NCT02329080 Diffuse Large B-cell Lymphoma Phase 2 Recruiting December 2023 Czechia ... More >> Facultni nemocnice Recruiting Brno, Czechia Contact: Andrea Janikova          Principal Investigator: Andrea Janikova          FNKV (Facultni Nemocnice Kralovske Vinohrady) Recruiting Praha, Czechia Contact: Heidi Mocikova          Principal Investigator: Heidi Mocikova          Vseobecna facultni nemocnice v Praze Not yet recruiting Praha, Czechia Contact: Robert Pytlik          Principal Investigator: Robert Pytlik          Italy Spedali Civili Recruiting Brescia, Italy Contact: Giuseppe Rossi          Principal Investigator: Giuseppe Rossi          UO Ematologia e CTMO, PO Businco Recruiting Cagliari, Italy Contact: Giuseppina Cabras          Principal Investigator: Giuseppina Cabras          IRST Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori Recruiting Meldola, Italy Contact: Gerardo Musuraca          Principal Investigator: Gerardo Musuraca          UO Ematoliga Ospedale dell'Angelo Recruiting Mestre, Italy Contact: Renato Bassan          Principal Investigator: Renato Bassan          Istituto Nazionale Tumori Recruiting Milano, Italy Principal Investigator: Liliana Devizzi          Ospedale Maggiore Policlinico Recruiting Milano, Italy Contact: Maria Cecilia Goldaniga          Principal Investigator: Maria Cecilia Goldaniga          San Raffaele H Scientific Institute Recruiting Milan, Italy Contact: Andres Ferreri, MD       ferreri.andres@hsr.it    Principal Investigator: Andrés JM Ferreri, MD          AOU Policlinico di Modena Recruiting Modena, Italy Contact: Franco Narni          Principal Investigator: Franco Narni          SCDU Ematologia Recruiting Novara, Italy Contact: Gianluca Gaidano          Principal Investigator: Gianluca Gaidano          Ematologia ed Immunologia Clinica - AO di Padova Recruiting Padova, Italy Contact: Renato Zambello          Principal Investigator: Renato Zambello          UO Oncoematologia Ospedale Tortora Recruiting Pagani, Italy Contact: Catello Califano          Principal Investigator: Catello Califano          Villa Sofia - Cervello Recruiting Palermo, Italy Contact: Caterina Patti          Principal Investigator: Caterina Patti          Ematologia AOU Recruiting Parma, Italy Contact: Francesca Re          Principal Investigator: Francesca Re          Ematologia Ospedale S.Maria delle Croci Recruiting Ravenna, Italy Contact: Claudia Cellini          Principal Investigator: Claudia Cellini          A.O. Bianchi-Melacrino-Morelli, Divisione di Ematologia Recruiting Reggio Calabria, Italy Contact: Caterina Stelitano, MD          Principal Investigator: Caterina Stelitano, MD          Arcispedale Santa Maria Nuova, Azienda Ospedaliera di Reggio Emilia Recruiting Reggio Emilia, Italy Contact: Fiorella Ilariucci          Principal Investigator: Fiorella Ilariucci          Ematologia Università La Sapienza Recruiting Roma, Italy Contact: Maurizio Martelli          Principal Investigator: Maurizio Martelli          IRCCS Istituto Regina Elena (IFO) Recruiting Roma, Italy Contact: Francesca Palombi          Principal Investigator: Francesca Palombi          Policlinico Universitario Campus Bio-Medico Recruiting Rome, Italy Contact: Ombretta Annibali          Principal Investigator: Ombretta Annibali          IRCCS Casa Sollievo Della Sofferenza Recruiting San Giovanni Rotondo, Italy Contact: Nicola Cascavilla          Principal Investigator: Nicola Cascavilla          AOU Senese Recruiting Siena, Italy Contact: Alberto Fabbri          Principal Investigator: Alberto Fabbri          AO S.Maria di Terni Recruiting Terni, Italy Contact: Anna Marina Liberati          Principal Investigator: Anna Marina Liberati          SC Ematologia AO Città della Salute e della Scienza Recruiting Torino, Italy Contact: Barbara Botto          Principal Investigator: Barbara Botto          UO Ematologia Ospedale Panico Recruiting Tricase, Italy Contact: Vincenzo Pavone          Principal Investigator: Vincenzo Pavone          AOU Santa Maria della Misericordia Recruiting Udine, Italy Contact: Francesco Zaja          Principal Investigator: Francesco Zaja          UOC Ematologia Policlinico Rossi Recruiting Verona, Italy Contact: Achille Ambrosetti          Principal Investigator: Achille Ambrosetti          Ematologia Ospedale S. Bortolo Recruiting Vicenza, Italy Contact: Maurizio Frezzato          Principal Investigator: Maurizio Frezzato          Netherlands Erasmus MC Recruiting Rotterdam, Netherlands Contact: Jeanette Doorduijn          Principal Investigator: Jeanette Doorduijn          United Kingdom Beatson Cancer Center Recruiting Glasgow, United Kingdom Contact: Pam Mc Kay          Principal Investigator: Pam Mc Kay          Liverpool Aintree Recruiting Liverpool, United Kingdom Contact: Jeffery Smith          Principal Investigator: Jeffery Smith          UCLH University College London Hospitals NHS foundation trust Recruiting London, United Kingdom Contact: Kate Cwynarski          Principal Investigator: Kate Cwynarski          The Christie Hospital Recruiting Manchester, United Kingdom Contact: Kim Linton          Principal Investigator: Kim Linton          Southampton General Hospital Not yet recruiting Southampton, United Kingdom Contact: Andrew Davies          Principal Investigator: Andrew Davies Less <<
NCT02305940 Chronic Obstructive Pulmonary ... More >>Disease (COPD) Less << Phase 3 Completed - United Kingdom ... More >> Aintree University Hospital NHS Foundation Trust Liverpool, United Kingdom, L9 7AL St Georges University Hospitals NHS Foundation Trust London, United Kingdom, SW17 0RE Royal Brompton and Harefield Hospital NHS Foundation Trust London, United Kingdom, SW36NP Less <<
NCT02481466 Cardiovascular Diseases ... More >> Hypercholesterolemia Type 2 Diabetes Metabolic Syndrome Less << Not Applicable Recruiting December 2022 Canada, British Columbia ... More >> Healthy Heart Lipid Clinic, St. Paul's Hospital Recruiting Vancouver, British Columbia, Canada, V6Z 1Y6 Principal Investigator: Jiri Frohlich, MD          Canada, Manitoba Richardson Centre for Functional Foods and Nutraceuticals, University of Manitoba Not yet recruiting Winnipeg, Manitoba, Canada, R3T 6C5 Contact: Peter Jones, PhD          Principal Investigator: Peter Jones, PhD          Canada, Ontario Risk Factor Modification Centre, St. Michael's Hospital Recruiting Toronto, Ontario, Canada, M5C 2T2 Contact: David J Jenkins, MD PhD    416-867-7475    David.jenkins@utoronto.ca    Contact: Dorothea A Faulkner, PhD    416-360-4000 ext 48175    FaulknerD@smh.ca    Principal Investigator: David J Jenkins, MD PhD          Sub-Investigator: Cyril Kendall, PhD          Sub-Investigator: Robert Josse, MD          Sub-Investigator: Lawrence Leiter, MD          Sub-Investigator: John Sievenpiper, MD PhD          Sub-Investigator: Anish Kirpalani, MD          Canada, Quebec Institute of Nutraceuticals and Functional Foods, Laval University Recruiting Quebec City, Quebec, Canada, G1V 4G2 Contact: Benoit Lamarche, PhD          Principal Investigator: Benoit Lamarche, PhD Less <<
NCT01317797 Rheumatoid Arthritis Phase 1 Completed - Bulgaria ... More >> Nycomed Investigational Site Sofia, Bulgaria Netherlands Nycomed Investigational Site Leids, Netherlands Less <<
NCT02922062 Cardiovascular Diseases ... More >> Inflammation Less << Not Applicable Completed - United States, Ohio ... More >> Physical Activity and Education Services (PAES) Building Columbus, Ohio, United States, 43210 Less <<
NCT02759887 Down Syndrome ... More >> Alzheimer's Dementia Less << Not Applicable Recruiting June 2019 United States, Arizona ... More >> St. Joseph's Hospital and Medical Center Recruiting Phoenix, Arizona, United States, 85013 Contact: Lisa Arnold    602-406-9593    lisa.arnold@dignityhealth.org    Principal Investigator: Marwan Sabbagh, MD Less <<
NCT01285492 - Completed - -
NCT03455075 Healthy Men ... More >> Male Contraception Less << Phase 2 Recruiting June 2020 United States, California ... More >> Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center Recruiting Torrance, California, United States, 90509 Contact: Xiaodan Han    310-222-1865    xhan@labiomed.org    Principal Investigator: Christina Wang          United States, Washington University of Washington Medical Center & Health Sciences Recruiting Seattle, Washington, United States, 98195 Contact: Stephanie Page, MD, PhD    206-616-1818    page@uw.edu Less <<
NCT01047761 Myasthenia Gravis Phase 1 Recruiting December 2020 United States, Maryland ... More >> University of Maryland and Baltimore VA Medical Center Recruiting Baltimore, Maryland, United States, 21201 Principal Investigator: Charlene Hafer-Macko, MD Less <<
NCT03452228 Severe Hypertriglyceridemia (s... More >>HTG) Less << Phase 2 Recruiting January 22, 2021 United States, Colorado ... More >> Regeneron Research Facility Recruiting Aurora, Colorado, United States, 80045 United States, Kansas Regeneron Research Facility Recruiting Kansas City, Kansas, United States, 66160 United States, Pennsylvania Regeneron Research Facility Recruiting Philadelphia, Pennsylvania, United States, 19104 Regeneron Research Facility Recruiting Pittsburgh, Pennsylvania, United States, 15261 United States, Texas Regeneron Research Facility Recruiting Houston, Texas, United States, 77030 Canada, Quebec Regeneron Research Facility Recruiting Chicoutimi, Quebec, Canada, G7H7K9 Regeneron Research Facility Recruiting Québec, Quebec, Canada, G1V4W2 Less <<
NCT00284921 De Novo Kidney Transplant Phase 3 Terminated - -
NCT00869466 - Completed - United Kingdom ... More >> Wellcome Trust Clinical Research Facility Manchester, England, United Kingdom, M13 9WL Christie Hospital Manchester, England, United Kingdom, M20 4BX Nightingale Centre and Genesis Prevention Centre at Wythenshawe Hospital Manchester, England, United Kingdom, M23 9LT South Manchester University Hospital Manchester, England, United Kingdom, M23 9LT Cancer Care Research Centre at University of Stirling Stirling, England, United Kingdom, FK9 4NF Less <<
NCT02491229 Non-alcoholic Fatty Liver Dise... More >>ase (NAFLD) Obesity Less << Not Applicable Completed - Germany ... More >> University of Hohenheim Stuttgart, Germany, 70599 Less <<
NCT00903201 Cystic Fibrosis Phase 2 Completed - -
NCT02207023 Stroke Apople... More >>xy Cerebral Stroke Cerebrovascular Accident Cerebrovascular Accident, Acute Cerebrovascular Apoplexy Cerebrovascular Stroke CVA Stroke, Acute Vascular Accident, Brain Less << Not Applicable Recruiting December 2018 Canada, British Columbia ... More >> Royal Columbian Hospital Not yet recruiting New Westminster, British Columbia, Canada, V3L 3W7 Contact: Brodie Sakakibara, PhD    604-737-6310    brodie@alumni.ubc.ca    University Hospital of Northern BC Recruiting Prince George, British Columbia, Canada, V2M 1S2 Contact: Brodie Sakakibara, PhD    604-737-6310    brodie@alumni.ubc.ca    Surrey Memorial Hospital Recruiting Surrey, British Columbia, Canada, V3V 1Z2 Contact: Brodie Sakakibara, PhD    604-737-6310    brodie@alumni.ubc.ca    Holy Family Hospital Not yet recruiting Vancouver, British Columbia, Canada, V5P 3L6 Contact: Brodie Sakakibara, PhD    604-737-6310    brodie@alumni.ubc.ca    Vancouver General Hospital Recruiting Vancouver, British Columbia, Canada, V5Z 1M9 Contact: Brodie Sakakibara, PhD    604-737-6310    brodie@alumni.ubc.ca    GF Strong Rehabilitation Centre Recruiting Vancouver, British Columbia, Canada, V5Z 2G9 Contact: Chihya J Hung, MScPT    604-714-4117    Chihya.Hung@ubc.ca    Principal Investigator: Janice Eng, PhD          St. Paul's Hospital Recruiting Vancouver, British Columbia, Canada, V6Z 1Y6 Contact: Brodie Sakakibara, PhD    604-737-6310    brodie@alumni.ubc.ca Less <<
NCT00903201 - Completed - -
NCT02172196 Healthy Phase 1 Completed - -
NCT01048515 Healthy Elder... More >>ly Less << Phase 4 Completed - Denmark ... More >> Surgical Research Department Herning, Midtjylland, Denmark, 7400 Less <<
NCT01918319 Offspring BMI Standard Deviati... More >>on Score. Childhood Obesity Adiposity Body Composition Metabolic Risk Factors Less << Not Applicable Completed - Denmark ... More >> Department of Endocrinology, Odense University Hospital Odense, Denmark, 5000 Less <<
NCT02014272 Healthy Volunteers Phase 1 Completed - Singapore ... More >> Pfizer Investigational Site Singapore, Singapore, 188770 Less <<
NCT03263234 Elderly Housing Residents With... More >> Frailty or Dementia Less << Not Applicable Enrolling by invitation March 22, 2018 Denmark ... More >> Clinical Research Centre Hvidovre, Denmark, 2650 Less <<
NCT03715868 Acute Renal Failure ... More >> Acute Kidney Injury Less << Not Applicable Not yet recruiting May 2022 Germany ... More >> University Hospital of Cologne Not yet recruiting Cologne, Germany, 50937 Contact: Volker Burst, MD    +49(0)221 478 86285    volker.burst@uk-koeln.de    Principal Investigator: Volker Burst, MD          Sub-Investigator: Claas Gloistein, MD          Sub-Investigator: Franziska Grundmann, MD          Sub-Investigator: Roman Müller, MD          Sub-Investigator: Thorsten Wahlers, MD          Sub-Investigator: Michael Faust, MD Less <<
NCT03692403 Endometriosis-related Pain Phase 2 Recruiting February 10, 2020 -
NCT00941148 Type 2 Diabetic Patients ... More >> Insufficient Metabolic Control OAD Treatment Less << Phase 4 Completed - Germany ... More >> ikfe GmbH, Clinic Department Mainz, RLP, Germany, 55116 Less <<
NCT00710398 Overweight Ob... More >>esity Less << Not Applicable Completed - Canada, Ontario ... More >> McMaster University Hamilton, Ontario, Canada, L8S4K1 Less <<
NCT02276365 Healthy Phase 1 Completed - -
NCT02014272 - Completed - -
NCT00935610 Aging Sarcope... More >>nia Less << Phase 2 Completed - Canada, Quebec ... More >> Institut de recherches cliniques de Montréal Montreal, Quebec, Canada, H2W 1R7 Less <<
NCT03535571 Healthy Phase 1 Completed - Canada, Ontario ... More >> KGK Science Inc. London, Ontario, Canada, N6A 5R8 Less <<
NCT01196156 - Active, not recruiting February 29, 2020 Spain ... More >> Hospital Universitario Príncipe de Asturias Alcalá De Henares, Madrid, Spain Hospital General de Alicante Alicante, Spain Hospital Nostra Senyora de Meritxell Andorra, Spain Hospital San Agustin Avilés), Spain Hospital San Agustín Avilés, Spain Hospital Materno Infantil de Badajoz Badajoz, Spain Hospital de Cruces-Baracaldo Baracaldo, Spain Hospital Sagrado Corazón Barcelona, Spain Hospital Puerta del Mar de Cádiz Cadiz, Spain Hospital Comarcal de Don Benito Don Benito, Spain Hospital de Elche Elche, Spain Hospital General de Elda Elda, Spain Hospital Clínico San Cecilio Granada, Spain Hospital SAS Jerez de la Frontera Jerez de la Frontera, Spain Hospital Severo Ochoa Leganés, Madrid, Spain Hospital Universitari Arnau de Vilanova Lleida, Spain Hospital Univ. La Paz Madrid, Spain Hospital Materno Infantil de Malaga, Spain Hospital Virgen de la Arrixaca Murcia, Spain Hospital Central de Asturias Oviedo, Spain Hospital Son Espases Palma de Mallorca, Spain Hospital Virgen del Camino Pamplona, Spain Hospital Sant Joan de Reus Reus, Spain Hospital Parc Taulí de Sabadell Sabadell, Spain Hospital Clínico de Salamanca Salamanca, Spain Hospital Clínico Universitario Santiago, Spain Hospital de Valme. Seville Sevilla, Spain Hospital Virgen Macarena Sevilla, Spain Less <<
NCT02987530 HIV-1 Infection Phase 3 Active, not recruiting December 2019 France ... More >> All The Regions Of The Country (40 Centers), France Less <<
NCT01658176 Breast Neoplasms Phase 2 Withdrawn April 2015 -
NCT01996891 Asthma Not Applicable Terminated(Unable to recruit a... More >>dequate number of participants and high attrition rate) Less << - United States, Massachusetts ... More >> Boston Children's Hospital Boston, Massachusetts, United States, 02115 Less <<
NCT02338479 - Active, not recruiting February 2020 -
NCT02761694 Cancer Solid ... More >>Tumors Less << Phase 1 Recruiting March 2020 United States, Nevada ... More >> Completed Las Vegas, Nevada, United States, 89169 United States, Oklahoma Stephenson Cancer Center Recruiting Oklahoma City, Oklahoma, United States, 73104 Contact: ArQule, Inc.    781-994-0300    ClinicalTrials@arqule.com    United States, Tennessee The Sarah Cannon Research Institute Recruiting Nashville, Tennessee, United States, 37203 Contact: ArQule, Inc.    781-994-0300    ClinicalTrials@arqule.com    United States, Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: ArQule, Inc.    781-994-0300    ClinicalTrials@arqule.com Less <<
NCT01610492 Glomerulonephritis, Membranous Phase 2 Completed - United Kingdom ... More >> GSK Investigational Site Exeter, Devon, United Kingdom, EX2 5DW GSK Investigational Site Stevenage, Hertfordshire, United Kingdom, SG1 4AB GSK Investigational Site Cambridge, United Kingdom, CB2 0QQ GSK Investigational Site Glasgow, United Kingdom, G11 6NT GSK Investigational Site Manchester, United Kingdom, M13 9WL GSK Investigational Site Reading, United Kingdom, RG1 5AN GSK Investigational Site Salford, United Kingdom, M6 8HD GSK Investigational Site Whitechapel, London, United Kingdom, E1 1BB Less <<
NCT02968979 - Completed - France ... More >> Chugai Pharma France Paris, France, 92042 Less <<
NCT01074359 Neuromuscular Disease Phase 2 Terminated(Terminated for Comm... More >>ercial Reasons. There were no safety issues involved in the decision to terminate the study.) Less << - United Kingdom ... More >> University of Newcastle upon Tyne Newcastle, Framlington Place, United Kingdom, NE2 4HH Less <<
NCT00294164 Human Immunodeficiency Virus-a... More >>ssociated Adipose Redistribution Syndrome (HARS) Human Immunodeficiency Virus Infections Less << Phase 2 Phase 3 Completed - -
NCT01610492 - Completed - -
NCT02591667 Colorectal Cancer ... More >> Peritoneal Metastasis Less << Phase 2 Recruiting February 2020 Austria ... More >> Medical University of Vienna, Department of Internal Medicine I Recruiting Vienna, Austria, 1090 Contact: Gerald Prager, MD    +43-1-40400 ext 44240    gerald.prager@meduniwien.ac.at    Contact: Anja Grah    +43-1-40400 ext 44240    anja.grah@meduniwien.ac.at    Medical University of Vienna, Department of Surgery Recruiting Vienna, Austria, 1090 Contact: Thomas Bachleitner-Hofmann, MD    +43-1-40400 ext 56210    thomas.bachleitner-hofmann@meduniwien.ac.at    Contact: Daniela Truzla    +43-1-40400 ext 69430    carcinosis@meduniwien.ac.at Less <<
NCT00120393 HIV Infections Phase 3 Completed - United States, Arizona ... More >> Local Institution Phoenix, Arizona, United States United States, California Local Institution Bakersfield, California, United States Local Institution Los Angeles, California, United States Local Institution San Francisco, California, United States United States, Florida Local Institution Miami, Florida, United States United States, Massachusetts Local Institution Boston, Massachusetts, United States United States, New York Local Institution New York, New York, United States United States, Ohio Local Institution Cincinnati, Ohio, United States United States, Oregon Local Institution Portland, Oregon, United States United States, Pennsylvania Local Institution Philadelphia, Pennsylvania, United States United States, South Carolina Local Institution Columbia, South Carolina, United States United States, Texas Local Institution Dallas, Texas, United States Canada, Ontario Local Institution Hamilton, Ontario, Canada Canada, Quebec Local Institution Montreal, Quebec, Canada Less <<
NCT02708979 Stress Not Applicable Unknown August 2016 Denmark ... More >> Nutrition, Exercise and Sports Recruiting Frederiksberg, Denmark, 1958 Contact: Mads F Hjorth, PhD    35332489 ext 0045    madsfiil@nexs.ku.dk    Contact: Julie B Schmidt, PhD    35333650 ext 0045    jbs@nexs.ku.dk Less <<
NCT00138970 Renal Transplant Recipients Phase 4 Completed - -
NCT02128828 AIDS Dementia Complex ... More >> HIV-1-Associated Cognitive Motor Complex Human Immunodeficiency Virus Less << Phase 2 Completed - United States, Hawaii ... More >> Clint Spencer Clinic Honolulu, Hawaii, United States, 96813 Less <<
NCT02164643 Alzheimer's Disease (AD) and R... More >>elated Disorders Less << Phase 3 Active, not recruiting December 2018 France ... More >> CHU d'Angers Angers, France CHU de Besançon Besancon, France APHP - Avicenne Bobigny, France CHU de Bordeaux - Pellegrin Bordeaux, France, 33000 CHU de Bordeaux - Hôpital Xavier-Arnozan Bordeaux, France CHU de Brest Brest, France CHU de Clermont-Ferrand Clermont-ferrand, France CHU de Dijon Dijon, France CHU de Grenoble Grenoble, France CHU de Lille Lille, France Hospices civils de Lyon Lyon, France AP-HM Marseille, France CHU de Montpellier Montpellier, France CHU de Nancy Nancy, France CHU de Nice Nice, France AP-HP - Hôpital BROCA Paris, France AP-HP - Hôpital LARIBOISIERE Paris, France Ap-Hp La Pitié-Salpêtrière Paris, France CHU de Poitiers Poitiers, France CHU de Rouen Rouen, France CHU de Saint-Etienne Saint-etienne, France CHU de Strasbourg Strasbourg, France CHU de Toulouse - Hôpital Purpan Toulouse, France CHU de Toulouse Toulouse, France CHU de Tours Tours, France Less <<
NCT02126449 Fasting Mimicking Diet ... More >> Breast Cancer Neoadjuvant Chemotherapy Pathological Complete Response Less << Phase 2 Phase 3 Recruiting December 2019 Netherlands ... More >> Leids Universitair Medisch Centrum Recruiting Leiden, Zuid-holland, Netherlands, 2333ZA Contact: Judith R Kroep, MD, PhD    +31715263464    j.r.kroep@lumc.nl    Contact: Stefanie de Groot, MD    +31715263464    s.de_groot2@lumc.nl    Principal Investigator: J R Kroep, MD, PhD          Principal Investigator: H Pijl, MD PhD          Principal Investigator: J JM van der Hoeven, Md PhD Ir          Medisch Centrum Alkmaar Recruiting Alkmaar, Netherlands Contact: M P Hendriks, MD PhD          OLVG Not yet recruiting Amsterdam, Netherlands Contact: J M Meerum Terwogt, MD PhD          Alexander Monro hospital Not yet recruiting Bilthoven, Netherlands Contact: E. Goker , MD          Amphia Hospital Recruiting Breda, Netherlands Contact: J B Heijns, MD PhD          Deventer Hospital Recruiting Deventer, Netherlands Contact: A LT Imholz, MD, PhD          Contact: L W Kessels, MD, PhD          Ziekenhuis Gelderse Valei Recruiting Ede, Netherlands Contact: A Baars, MD, PhD          , Catharina ziekenhuis Hospital Recruiting Eindhoven, Netherlands Contact: B EPJ Vriens, MD          Kennemer gasthuis Not yet recruiting Haarlem, Netherlands Contact: G.J. Klerk, MD          Medisch Centrum Leeuwarden Recruiting Leeuwarden, Netherlands Contact: H de Graaf, MD PhD          Bronovo Hospital Recruiting The Hague, Netherlands Contact: N I Weijl, MD PhD          Haga Hospital Recruiting The Hague, Netherlands Contact: J Portielje, MD PhD          VieCurie Hospital Recruiting Venlo, Netherlands Contact: Y van de Wouw, Md PhD          Lange Land Hospital Recruiting Zoetermeer, Netherlands Contact: A JM Pas, MD          Isala Recruiting Zwolle, Netherlands Contact: A H Honkoop, MD PhD Less <<
NCT03591471 Henoch-Sch?nlein Purpura Nephr... More >>itis Less << Phase 1 Phase 2 Recruiting December 2018 China, Henan ... More >> Children's Hospital, The First Affiliated Hospital of HUTCM Recruiting Zhengzhou, Henan, China, 450000 Contact: Ying Ding, Director    +86-13503840642    dingying3236@sina.com    Contact: Xia Zhang, secretary    +86-13838276039    zhangxia_125@163.com    Principal Investigator: Ying Ding, Director          The First Affiliated Hospital of Henan University of Traditional Chinese Medicine Recruiting Zhengzhou, Henan, China, 450000 Contact: Ying Ding, MD    +86-371-66221361    dingying3236@sina.com    Contact: Xia zhang, MD    +86-371-13213210370    ardar123@sina.com    Principal Investigator: Jiansheng Li, MD Less <<
NCT02460588 Idiopathic Pulmonary Fibrosis Phase 3 Recruiting July 2019 France ... More >> Hôpital Tenon Recruiting Paris, France Contact: Jean-Marc NACCACHE    33 (0)1 56 01 61 96    jean-marc.naccache@tnn.aphp.fr Less <<
NCT03462199 Functional Constipation ... More >> Healthy Less << Phase 2 Recruiting November 2018 Canada, Ontario ... More >> KGK Clinical Trial Centers Recruiting London, Ontario, Canada, N6A 5R8 Contact: Mal Evans, PhD    5194389374    mevans@kgkscience.com    Principal Investigator: David Crowley, MD Less <<
NCT01641016 HIV Phase 2 Phase 3 Unknown June 2016 United States, Tennessee ... More >> St Jude Children's Research Hospital Memphis, Tennessee, United States France INSERM Villejuif, France Germany Universitätsklinikum Frankfurt Frankfurt, Frankfurt am Main, Germany, 60596 Ireland Our Lady's Children's Hospital Dublin, Ireland Thailand Program for HIV Prevention and Treatment (PHPT)/IRD 174 Changklan, Muang, Chiang Mai, Thailand, 50100 HIV-NAT Thai Red Cross AIDS Research Centre Bangkok, Thailand Uganda Joint Clinical Research Centre Kampala, Uganda Ukraine Kiev City AIDS Center Kiev, Vidpochynku 11, Ukraine, 03115 United Kingdom Birmingham Heartlands Hospital Birmingham, United Kingdom University Hospital Bristol Bristol, United Kingdom Leeds General Infirmary Leeds, United Kingdom Leicester Royal Infirmary Leicester, United Kingdom Evelina Children's Hospital London, United Kingdom Great Ormond Street Hospital London, United Kingdom Mortimer Market Centre London, United Kingdom St George's Hospital London, United Kingdom Nottingham University Hospital Nottingham, United Kingdom John Radcliffe Hospital Oxford, United Kingdom Less <<
NCT01021644 Alzheimer's Disease Not Applicable Completed - United States, District of Col... More >>umbia Howard University General Clinical Research Center (GCRC) Washington, District of Columbia, United States, 20060 United States, Pennsylvania Temple University Exercise Physiology Laboratory Philadelphia, Pennsylvania, United States, 19140 Less <<
NCT01418027 Non-alcoholic Fatty Liver Dise... More >>ase (NAFLD) Less << Phase 3 Completed - China ... More >> The First Hospital Affiliated to Xiamen University Xiamen, China Less <<
NCT02509286 Esophageal Adenocarcinoma (UIC... More >>C TNM7) Adenocarcinoma of the Esophagogastric Junction Less << Phase 3 Recruiting June 2024 Germany ... More >> Uniklinik RWTH Aachen Recruiting Aachen, Germany Principal Investigator: Ulf Peter Neumann, Professor          Sub-Investigator: Christian Klink, PD Dr.          Charité Berlin - Campus Benjamin Franklin (CBF) Recruiting Berlin, Germany, 12203 Contact: Severin Daum, PD Dr.          Principal Investigator: Severin Daum, PD Dr.          Sub-Investigator: Hendrik Seeliger, PD Dr.          Charité Berlin Campus Virchow-Klinikum (CVK) Recruiting Berlin, Germany, 13353 Principal Investigator: Peter Thuß-Patience, PD Dr.          Sub-Investigator: Matthias Biebl, PD Dr.          Klinikum Dortmund gGmbH Recruiting Dortmund, Germany, 44137 Contact: Maximilian Schmeding, Prof.          Principal Investigator: Maximilian Schmeding, Prof.          Sub-Investigator: Michael Heike, Prof.          Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden Recruiting Dresden, Germany, 03107 Principal Investigator: Gunnar Folprecht, PD Dr.          Sub-Investigator: Thilo Welsch, Prof.          Universitätsklinikum Düsseldorf Recruiting Düsseldorf, Germany Principal Investigator: Matthias Schauer, PD Dr.          Sub-Investigator: Wolfram Knoefel, Prof.          Universitätsklinikum Erlangen Recruiting Erlangen, Germany, 91054 Contact: Robert Grützmann, Prof.          Principal Investigator: Robert Grützmann, Prof.          Sub-Investigator: Dimitrios Raptis, Dr.          Universitätsklinikum Frankfurt Recruiting Frankfurt am Main, Germany, 60590 Contact: Detlef Imhoff, Dr.          Principal Investigator: Detlef Imhoff, Dr.          Sub-Investigator: Christian Keller, Dr.          Universitätsklinikum Freiburg Recruiting Freiburg, Germany Principal Investigator: Jens Hoeppner, Professor          Sub-Investigator: Ralph Fritsch, Dr.          Universitätsmedizin Göttingen Recruiting Göttingen, Germany, 37099 Principal Investigator: Jochen Gaedcke, PD Dr.          Sub-Investigator: Alexander König, Dr.          Universitätsklinikum Hamburg-Eppendorf Recruiting Hamburg, Germany Principal Investigator: Jakob R. Izbicki, Professor          Sub-Investigator: Cordula Petersen, Professor          Universitätsklinikum des Saarlandes Recruiting Homburg, Germany, 66421 Contact: Frank Lammert, Prof.          Principal Investigator: Frank Lammert, Prof.          Sub-Investigator: Simone Zimmermann          Universitätsklinikum Schleswig-Holstein, Campus Kiel Recruiting Kiel, Germany Principal Investigator: Thomas Becker, Professor          Sub-Investigator: Benedikt Reichert, Dr.          Uniklinik Köln Recruiting Köln, Germany, 50937 Contact: Christiane Bruns, Prof.          Principal Investigator: Christiane Bruns, Prof.          Sub-Investigator: Thomas Zander, PD Dr.          Sub-Investigator: Armin Tuchscherer, Dr.          Universitätsklinikum Leipzig Recruiting Leipzig, Germany Principal Investigator: Ines Gockel, Professor          Sub-Investigator: Orestis Lyros, Dr.          Universitätsklinikum Schleswig-Holstein, Campus Lübeck Recruiting Lübeck, Germany Principal Investigator: Tobias Keck, Professor          Sub-Investigator: Ralf Bouchard, Dr.          Universitätsklinikum Magdeburg Recruiting Magdeburg, Germany Principal Investigator: Frank Benedix, Prof.          Sub-Investigator: Marino Venerito, Dr.          Universitätsmedizin Mainz Recruiting Mainz, Germany Principal Investigator: Peter Grimminger, PD Dr.          Sub-Investigator: Stefan Heinrich, PD Dr.          Johannes Wesling Klinikum Minden Recruiting Minden, Germany, 32429 Contact: Kai Wille, Dr.          Principal Investigator: Kai Wille, Dr.          Sub-Investigator: Emil Sagynaliev, Dr.          Klinikum der Universität München (LMU) Recruiting München, Germany Principal Investigator: Jens Werner, Professor          Sub-Investigator: Martin Angele, Professor          Universitätsklinikum Münster Recruiting Münster, Germany Principal Investigator: Andreas Pascher, Professor          Sub-Investigator: Mike Laukötter, PD Dr.          Ruppiner Kliniken GmbH Recruiting Neuruppin, Germany, 16816 Contact: Andreas Loew, Dr.          Principal Investigator: Andreas Loew, Dr.          Sub-Investigator: Christoph Löschner, Dr.          Sana Klinikum Offenbach GmbH Recruiting Offenbach, Germany, 63069 Principal Investigator: Thomas Haist, Dr.          Sub-Investigator: Mate Knabe, Dr.          Universitätsklinikum Regensburg Recruiting Regensburg, Germany, 93053 Contact: Felix Steger, Dr.          Principal Investigator: Felix Steger, Dr.          Sub-Investigator: Matthias Hautmann, Dr.          Universitätsmedizin Rostock Recruiting Rostock, Germany, 18059 Contact: Guido Hildebrandt, Prof.          Principal Investigator: Guido Hildebrandt, Prof.          Sub-Investigator: Marcella Szücs, Dr.          Klinikum Stuttgart Recruiting Stuttgart, Germany, 70174 Contact: Gerald Illerhaus, Professor          Principal Investigator: Gerald Illerhaus, Gerald, Prof., Professor          Sub-Investigator: Pascale Regincos, Dr.          Robert-Bosch-Krankenhaus Stuttgart Recruiting Stuttgart, Germany, 70376 Contact: Annette Steckkönig, Dr.          Principal Investigator: Annette Steckkönig, Dr.          Sub-Investigator: Anette Hoferer, Dr.          Klinikum Mutterhaus Recruiting Trier, Germany, 54290 Contact: Rolf Mahlberg, Dr.          Principal Investigator: Rolf Mahlberg, Dr.          Sub-Investigator: Stefan Heidel, Dr.          Universitätsklinikum Würzburg Recruiting Würzburg, Germany Principal Investigator: Burkhard von Rahden, PD Dr.          Principal Investigator: Volker Kunzmann, Professor Less <<
NCT01362296 Lung Cancer, Non-Small Cell Phase 2 Completed - -
NCT00229138 Kidney Transplantation Phase 4 Completed - United States, New Jersey ... More >> Novartis East Hanover, New Jersey, United States, 07936 Less <<
NCT02634749 Infant Development ... More >> Body Composition, Beneficial Dietary Modification Less << Not Applicable Active, not recruiting January 2020 Sweden ... More >> Paediatrics, Department of Clinical Sciences Umeå, Sweden, 90185 Less <<
NCT01362296 - Completed - -
NCT01160289 Erectile Dysfunction Phase 2 Completed - -
NCT02054208 Alzheimer's Disease Phase 1 Phase 2 Recruiting July 2019 Korea, Republic of ... More >> Samsung Medical Center Recruiting Seoul, Korea, Republic of Contact: Yunkyung Choi, MD    82-2-3410-6486    yk221.choi@samsung.com    Principal Investigator: Duk L. Na, MD Less <<
NCT03045887 Asthma Phase 1 Completed - United Kingdom ... More >> GSK Investigational Site Cambridge, United Kingdom, CB2 2GG Less <<
NCT00362193 Type 2 Diabetes Phase 4 Completed - -
NCT00470119 Breast Cancer ... More >> Obesity Weight Changes Less << Not Applicable Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109-1024 Less <<
NCT02824432 Hyperlipidemia Phase 4 Completed - Japan ... More >> Yufu, Oita, Japan Shinjyuku, Tokyo, Japan Kagoshima, Japan Oita, Japan Less <<
NCT03298009 Type2 Diabetes ... More >> Heart Failure Less << Not Applicable Withdrawn(end of contract nego... More >>ciations) Less << January 1, 2019 -
NCT02657941 Schizophrenia Not Applicable Terminated(inclusion problem) - France ... More >> Centre Hospitalier Le Vinatier Bron Cedex, France, 69678 Less <<
NCT03029182 Obesity Breas... More >>t Cancer Less << Not Applicable Completed - United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35233 Less <<
NCT01051024 Polycystic Ovary Syndrome Phase 3 Completed - Cuba ... More >> "Ramón González Coro" Gynecologic and Obstetric Hospital Havana City, Havana, Cuba, 10400 Less <<
NCT01283984 Chronic Obstructive Pulmonary ... More >>Disease Lung Disease Causing Persistent Narrowing of the Airways Less << Phase 1 Completed - United Kingdom ... More >> Research Site London, UK, United Kingdom Less <<
NCT01749774 Testicular Cancer Not Applicable Completed - Norway ... More >> Oslo university hospital Oslo, Norway Less <<
NCT02141971 - Completed - United States, California ... More >> University of California, San Diego La Jolla, California, United States, 92037 Less <<
NCT02680548 CHRONIC POST-TRAUMATIC NEUROPA... More >>THIC PAIN IN ANKLE AND FOOT Less << Early Phase 1 Completed - Canada, Ontario ... More >> Toronto Western Hospital Toronto, Ontario, Canada, M5T2S8 Less <<
NCT00148252 Renal Transplantation Phase 4 Terminated(To high rejection r... More >>ate in CsA withdrawal arm) Less << - Norway ... More >> Haukeland sykehus Bergen, Norway, 5021 Lillehammer hospital Lillehammer, Norway, 2609 Akershus Hospital Nordbyhagen, Norway, 1474 Rikshospitalet, Section of Nephrology Oslo, Norway, 0027 Ullevål hospital Oslo, Norway, 0450 Hospital Telemark Skien, Norway, 3710 Sentralsykehuset i Rogaland Stavanger, Norway, 4068 Tromsø hospital Tromsø, Norway, 9038 St. Olavs hospital Trondheim, Norway, 7030 Less <<
NCT02189174 Advanced Solid Tumor Phase 1 Terminated - United States, Massachusetts ... More >> Massachusetts General Hospital SC-9 Boston, Massachusetts, United States, 02114 United States, New York Memorial Sloan Kettering SC-4 New York, New York, United States, 10017 United States, Tennessee Tennessee Oncology SC Nashville, Tennessee, United States, 37203 Canada, Ontario Novartis Investigative Site Toronto, Ontario, Canada, M5G 1X6 Japan Novartis Investigative Site Kashiwa, Chiba, Japan, 277-8577 Singapore Novartis Investigative Site Singapore, Singapore, 169610 Spain Novartis Investigative Site Barcelona, Catalunya, Spain, 08035 Less <<
NCT02285855 Lung Cancer Phase 2 Active, not recruiting February 2020 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT02778100 Common Cold Phase 1 Completed - Canada, Quebec ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mount-Royal, Quebec, Canada, H3P 3P1 Less <<
NCT03198585 Heart Failure With Reduced Eje... More >>ction Fraction Less << Phase 2 Recruiting October 2019 Denmark ... More >> Herlev and Gentofte University Hospital Recruiting Copenhagen, Denmark, 2730 Contact: Jesper Jensen, MD    +45 38686258    jesper.jensen.06@regionh.dk    Principal Investigator: Morten Schou, MD          Sub-Investigator: Jesper Jensen, MD          Odense University Hospital Recruiting Odense, Denmark, 5000 Contact: Massar Omar, MD    +45 608400609    massar.omar@rsyd.dk    Principal Investigator: Jacob E Moller, MD          Sub-Investigator: Massar Omar, MD Less <<
NCT01539369 Weight Loss Not Applicable Completed - United Kingdom ... More >> Institute of Psychological Sciences Leeds, United Kingdom, LS2 9JT Less <<
NCT00213213 Pain Infant, ... More >>Newborn Diabetes Less << Not Applicable Unknown - Canada, Ontario ... More >> Mount Sinai Hospital Toronto, Ontario, Canada, M5G 1X5 Less <<
NCT03439670 Duchenne Muscular Dystrophy Phase 2 Recruiting May 1, 2020 United States, Colorado ... More >> Children's Hospital Colorado Recruiting Aurora, Colorado, United States, 80045 Contact: Kyle Kusmik    720-777-8599    Kyle.kusmik@childrenscolorado.org    Principal Investigator: Michele Yang, M.D.          United States, Florida Nemours Children's Hospital Recruiting Orlando, Florida, United States, 32827 Contact: Kristin McCrary    407-650-7175    kristin.mccracy@nemours.org    Principal Investigator: Richard Finkel, M.D.          United States, North Carolina Duke Children's Hospital Not yet recruiting Durham, North Carolina, United States, 27710 Contact: Debra Heydt    919-668-2843    debra.heydt@duke.edu    Principal Investigator: Edward Smith, M.D.          United States, Virginia Children's Hospital of Virginia of Virginia Commonwealth University Recruiting Richmond, Virginia, United States, 23219 Contact: Kathryn O'Hara    804-828-3862    kathryn.ohara@vcuhealth.org    Principal Investigator: Amy Harper, MD          United States, Washington Seattle Children's Hospital Not yet recruiting Seattle, Washington, United States, 98105 Contact: Marissa Robertson    206-987-5457    Marissa.Robertson@seattlechildrens.org    Principal Investigator: Susan Apkon, M.D.          Canada, Alberta Alberta's Children Hospital Not yet recruiting Calgary, Alberta, Canada, AB T3B 6A8 Contact: Brenda Turley    403-955-3184    Brenda.Turley@ahs.ca    Principal Investigator: Jean Mah, M.D.          Canada, British Columbia British Columbia Children's Hospital Recruiting Vancouver, British Columbia, Canada, V6H 3N1 Contact: Ajay Grewal    604-875-2345 ext 7132    ajay.grewal@cw.bc.ca    Principal Investigator: Kathryn Selby          Canada, Ontario Children's Hospital of Eastern Ontario Recruiting Ottawa, Ontario, Canada, K1H 8L1 Contact: Rosa Ramos    613-737-7600 ext 6058    rramos@cheo.on.ca    Principal Investigator: Hugh McMillan Less <<
NCT03542370 - Active, not recruiting June 1, 2019 Canada, Ontario ... More >> The Toronto 3D (Diet, Digestive tract and Disease) Knowledge Synthesis and Clinical Trials Unit, Clinical Nutrition and Risk Factor Modification Centre, St. Michael's Hospital Toronto, Ontario, Canada, M5C 2T2 Less <<
NCT02778113 Healthy Phase 1 Completed - Canada, Quebec ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mount-Royal, Quebec, Canada, H3P 3P1 Less <<
NCT03460652 ADHD Phase 3 Recruiting March 2019 United States, Arkansas ... More >> Woodland International Research Recruiting Little Rock, Arkansas, United States, 72211 Contact: Lacey Earls    501-221-8681    lacey@woodlandintlresearchgrp.com    Principal Investigator: Jim Aukstuolis, MD          United States, Colorado MCB Clinical Research Centers Recruiting Colorado Springs, Colorado, United States, 80910 Contact: Nichole Gonzalez    719-634-6576    ngonzalez@mcbcrc.com    Principal Investigator: Andrew Sedillo, MD          United States, Florida Meridien Research Recruiting Bradenton, Florida, United States, 34201 Contact: Margaret Bell    941-756-8680    mbell@meridienresearch.net    Principal Investigator: Andrew Cutler, MD          Clinical Neuroscience Solutions, Inc. Recruiting Jacksonville, Florida, United States, 32256 Contact: Sandeep Jandir    904-281-5757    sjandir@cnshealthcare.com    Principal Investigator: Nandita Jones, MD          Innovative Clinical Research, Inc. Recruiting Lauderhill, Florida, United States, 33319 Contact: Kadian Watson    954-990-6326    kwatson@segaltrials.com    Principal Investigator: Rishi Kakar, MD          Meridien Research Recruiting Maitland, Florida, United States, 32751 Contact: Sondra Chapman    407-644-1165    schapman@meridienresearch.net    Principal Investigator: Andrea Marraffino, MD          Clinical Neuroscience Solutions, Inc. Recruiting Orlando, Florida, United States, 32801 Contact: Rebecca Klipper    407-425-5100    rklipper@cnshealthcare.com    Principal Investigator: Robert Molpus, MD          United States, Illinois Capstone Clinical Research Recruiting Libertyville, Illinois, United States, 60048 Contact: Kelly Burns    847-549-7214    kburns@capstoneclinical.com    Principal Investigator: Michael Greenbaum, MD          United States, Kansas Psychiatric Associates Recruiting Overland Park, Kansas, United States, 66211 Contact: Glynis Murphy, PhD    913-438-8221    research@murphyclinic.com    Principal Investigator: William Murphy, MD          United States, Nevada Center for Psychiatry and Behavioral Medicine, Inc. Recruiting Las Vegas, Nevada, United States, 89128 Contact: Jordan Karbins    702-838-0742    jordankabins@gmail.com    Principal Investigator: Ann Childress, MD          United States, New Jersey Hassman Research Institute Recruiting Berlin, New Jersey, United States, 08009 Contact: Vania Dasilva    856-753-7335    vdasilva@hritrials.com    Principal Investigator: Howard Hassman, MD          United States, Ohio Neuro-Behavioral Clinical Research Recruiting Canton, Ohio, United States, 44718 Contact: Natalie Kuemerle    330-493-1118    nkuemerle@nb-cr.com    Principal Investigator: Shishuka Malhotra, MD          Midwest Clinical Research Center, LLC Recruiting Dayton, Ohio, United States, 45417 Contact: Rebecca Vernon    937-424-1050    rvernon@midwestclinical.com    Principal Investigator: Otto Dueno, MD          United States, Oregon Oregon Center for Clinical Investigations, Inc. Recruiting Portland, Oregon, United States, 97214 Contact: Christina Friesen    503-276-6224    christina.friesen@occi.org    Principal Investigator: Beal Essink, MD          Oregon Center for Clinical Investigations, Inc. Recruiting Salem, Oregon, United States, 97301 Contact: Emily Valdez    503-540-0100    emily.valdez@occi.org    Principal Investigator: Drissana Tran, MD          United States, Tennessee Clinical Neuroscience Solutions, Inc. Recruiting Memphis, Tennessee, United States, 38119 Contact: Kelly Iskiwitz, BS    901-843-1045    kiskiwitz@cnshealthcare.com    Principal Investigator: Valerie Arnold, MD          United States, Texas FutureSearch Trials Recruiting Austin, Texas, United States, 78731 Contact: Erin Ashmore    214-369-2600 ext 109    erina@fstrials.com    Principal Investigator: Michael Downing, MD          Bayou City Research, Ltd. Recruiting Houston, Texas, United States, 77007 Contact: Kathy Harpst    832-251-7000 ext 302       Principal Investigator: Matthew Brams, MD          Houston Clinical Trials Recruiting Houston, Texas, United States, 77098 Contact: Janice Roggenkamp    713-527-8448    jroggenkamp@houstonclintrials.com    Principal Investigator: Alain Katic, MD Less <<
NCT01673152 Obesity Not Applicable Completed - Poland ... More >> Samodzielny Publiczny Dziecięcy Szpital Kliniczny Warsaw, Poland Less <<
NCT00272597 Psychosis Sch... More >>izophrenia Less << Phase 4 Completed - Canada, British Columbia ... More >> Riverview Hospital Coquitlam, British Columbia, Canada Less <<
NCT02021318 Anemia in Chronic Kidney Disea... More >>se in Non-dialysis Patients Less << Phase 3 Active, not recruiting November 2019 -
NCT01342926 Atrophy, Geographic Phase 2 Completed - -
NCT00313040 Overweight Ob... More >>esity Less << Phase 1 Phase 2 Completed - United States, California ... More >> Stanford University Medical Center Stanford, California, United States, 94305-5722 Less <<
NCT01221220 Obesity Phase 2 Unknown February 2015 United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT01887600 Anemia in Chronic Kidney Disea... More >>se in Non-dialysis Patients Less << Phase 3 Completed - -
NCT00452530 - Completed - -
NCT03223389 Overweight and Obesity ... More >> Type 2 Diabetes Bariatric Surgery Gut Hormones Dietary Fat Less << Not Applicable Not yet recruiting December 2018 Denmark ... More >> Dept. of Endocrinology Recruiting Hvidovre, Denmark, 2650 Contact: Christoffer Martinussen, MD    +4538623032    christoffer.martinussen@regionh.dk    Principal Investigator: Christoffer Martinussen, MD Less <<
NCT00452530 Deep Vein Thrombosis ... More >> Pulmonary Embolism Less << Phase 3 Completed - -
NCT01036022 Colitis, Ulcerative Phase 2 Completed - Belgium ... More >> GSK Investigational Site Bonheiden, Belgium, 2820 GSK Investigational Site Brussels, Belgium, 1200 GSK Investigational Site Gent, Belgium, 9000 Canada, Alberta GSK Investigational Site Edmonton, Alberta, Canada, T6G 2C8 Canada, Ontario GSK Investigational Site Kingston, Ontario, Canada, K7L 5G2 GSK Investigational Site London, Ontario, Canada, N6A 4G5 GSK Investigational Site Vaughan, Ontario, Canada, L4L 4Y7 Canada GSK Investigational Site Quebec, Canada, G1S 4L8 Germany GSK Investigational Site Hannover, Niedersachsen, Germany, 30625 GSK Investigational Site Muenster, Nordrhein-Westfalen, Germany, 48149 GSK Investigational Site Ludwigshafen, Rheinland-Pfalz, Germany, 67067 GSK Investigational Site Dresden, Sachsen, Germany, 01307 GSK Investigational Site Leipzig, Sachsen, Germany, 04129 GSK Investigational Site Kiel, Schleswig-Holstein, Germany, 24105 GSK Investigational Site Jena, Thueringen, Germany, 07747 GSK Investigational Site Berlin, Germany, 10117 GSK Investigational Site Hamburg, Germany, 20148 GSK Investigational Site Hamburg, Germany, 20246 Norway GSK Investigational Site Lørenskog, Norway, 1478 GSK Investigational Site Oslo, Norway, 0514 GSK Investigational Site Oslo, Norway, N-0456 GSK Investigational Site Tønsberg, Norway, 3116 Sweden GSK Investigational Site Göteborg, Sweden, SE-416 85 GSK Investigational Site Lund, Sweden, SE-221 85 GSK Investigational Site Stockholm, Sweden, SE-111 86 GSK Investigational Site Stockholm, Sweden, SE-171 76 Less <<
NCT01352715 - Completed - -
NCT00298272 Rheumatoid Arthritis Phase 2 Terminated(Sponsor decided to ... More >>end long term extension phase for business reasons unrelated to safety.) Less << - United States, Alabama ... More >> Research Site Huntsville, Alabama, United States, 35801 United States, Arizona Research Site Paradise Valley, Arizona, United States, 85253 United States, California Research Site Palm Desert, California, United States, 92260 United States, Florida Research Site Jupiter, Florida, United States, 33458 Research Site Sarasota, Florida, United States, 34239 United States, Idaho Research Site Boise, Idaho, United States, 83702 United States, Michigan Research Site Kalamazoo, Michigan, United States, 49048 United States, Missouri Research Site St. Louis, Missouri, United States, 63141 United States, Ohio Research site Chardon, Ohio, United States, 44024 Research Site Mayfield Village, Ohio, United States, 44143 United States, Oklahoma Research Site Oklahoma City, Oklahoma, United States, 73103 Research Site Tulsa, Oklahoma, United States, 74135 United States, Pennsylvania Research Site Duncansville, Pennsylvania, United States, 16635 United States, Texas Research Site Dallas, Texas, United States, 75231 Research Site Houston, Texas, United States, 77074 Research Site San Antonio, Texas, United States, 78217 United States, Utah Research Site Salt Lake City, Utah, United States, 84132 United States, Vermont Research Site Burlington, Vermont, United States, 05401 Less <<
NCT01036022 - Completed - -
NCT01342926 - Completed - -
NCT00298272 - Terminated(Sponsor decided to ... More >>end long term extension phase for business reasons unrelated to safety.) Less << - -
NCT01352715 HIV-1 Infection Phase 3 Completed - Brazil ... More >> Instituto de Pesquisa Clinica Evandro Chagas (12101) Rio de Janeiro, Brazil, 21045 India BJ Medical College CRS (31441) Pune, Maharashtra, India, 411001 NARI Pune CRS Pune, Maharashtra, India Y.R.G Ctr, for AIDS Research and Education (11701) Chennai, India Kenya AMPATH at Moi Univ. Teaching Hosp. Eldoret CRS (12601) Eldoret, Kenya, 30100 Malawi College of Med. JHU CRS (30301) Blantyre, Malawi University of North Carolina Lilongwe CRS (12001) Lilongwe, Malawi Peru San Miguel CRS San Miguel, Lima, Peru Barranco CRS (11301) Lima, Peru, 18 PE South Africa Wits HIV CRS (11101) Johannesburg, Gauteng, South Africa Durban Adult HIV CRS (11201) Durban, South Africa, 4013 SF Soweto ACTG CRS (12301) Johannesburg, South Africa Univ. of Witwatersrand CRS (11101) Johannesburg, South Africa Tanzania Kilimanjaro Christian Medical CRS Kilimanjaro Region, Moshi, Tanzania Thailand Chiang Mai University ACTG CRS (11501) Chiang Mai, Thailand, 50202 Zimbabwe UZ-Parirenyatwa CRS (30313) Harare, Zimbabwe Less <<
NCT01826929 Ischemic Heart Disease Not Applicable Unknown - Spain ... More >> Recruiting San Juan de Alicante, Alicante, Spain Contact: Domingo Orozco-Beltran    0034965919309    dorozcobeltran@gmail.com    Principal Investigator: Domingo Orozco-Beltran          Recruiting Castellon, Spain Sub-Investigator: Enrique Soler-Bahilo          Recruiting Valencia, Spain Sub-Investigator: Jorge Navarro-Perez Less <<
NCT03567499 Amyloidosis Phase 1 Withdrawn(The decision to end ... More >>the study was made for GSK portfolio reasons. No subjects were randomised into the study.) Less << May 3, 2019 United Kingdom ... More >> GSK Investigational Site London, United Kingdom, NW10 7EW Less <<
NCT00336869 - Completed - United States, Georgia ... More >> Morehouse CRC Atlanta, Georgia, United States, 30310 Emory GCRC Atlanta, Georgia, United States, 30329 Less <<
NCT00363181 - Unknown - United States, California ... More >> VA Palo Alto Health Care System Recruiting Palo Alto, California, United States, 94304-1290 Principal Investigator: Steven E Lindley, MD, PhD Less <<
NCT03020225 Men With Mild Abdominal Obesit... More >>y Less << Not Applicable Recruiting July 2017 Israel ... More >> nuclear research center Negev Recruiting Dimona, Israel Contact: Dov Brikner, MD Less <<
NCT03291834 - Completed - Belgium ... More >> Jessa Hospital Hasselt, Limburg, Belgium, B3500 Less <<
NCT03298542 Pre-Symptomatic Type 1 Diabete... More >>s Less << Phase 1 Recruiting July 7, 2021 United States, Colorado ... More >> UC Denver-Colorado Barbara Davis Center, University of Colorado SOM Pediatric Endocrinology Recruiting Aurora, Colorado, United States, 80045 United States, Georgia Emory-Children's Pediatric Research Center Not yet recruiting Atlanta, Georgia, United States, 30322 Finland Oulu University Hosp. - Oulu Recruiting Oulu, Finland, FI-90014 Tampere University Hospital Recruiting Tampere, Finland, FI-33521 Turku University Hospital Recruiting Turku, Finland, 20520 Sweden Linkoping University Hospital Recruiting Linkoping, Sweden, SE 58185 Lund University Hospital/Skåne Recruiting Lund/Malmo, Sweden, 205 02 Less <<
NCT03315143 Type 2 Diabetes Mellitus ... More >> Chronic Kidney Diseases Less << Phase 3 Recruiting March 2022 -
NCT03324438 Type 1 Diabetes Mellitus Not Applicable Recruiting December 31, 2020 United States, Colorado ... More >> Barbara Davis Center for Childhood Diabetes Recruiting Aurora, Colorado, United States, 80045 Contact: Kimberly Driscoll, PhD    303-724-9910    kimberly.driscoll@ucdenver.edu Less <<
NCT03335371 Diabetes Mellitus, Type 1 Phase 1 Phase 2 Recruiting December 2019 United States, North Carolina ... More >> Site 01 Recruiting Chapel Hill, North Carolina, United States, 27517 Site 03 Recruiting Durham, North Carolina, United States, 27710 Site 04 Recruiting Morehead City, North Carolina, United States, 28557 Site 02 Recruiting Winston-Salem, North Carolina, United States, 27104 Less <<
NCT03369821 - Recruiting February 28, 2021 United States, California ... More >> Diabetes and Metabolism Institute Not yet recruiting Hope, California, United States, 91010 Contact: Bart Roep    626-256-4673    broep@crh.org    United States, Washington Benaroya Research Institute Not yet recruiting Seattle, Washington, United States, 98101-2795 Contact: Cate Speake    206-342-6500    cspeake@benaroyaresearch.org    United Kingdom Royal Devon & Exeter NHS Foundation Trust Recruiting Exeter, Devon, United Kingdom, EX2 5DW Contact: Richard Oram    +44 (0) 1392 408538    r.oram@exeter.ac.uk    Contact: Michelle Hudson    +44 (0) 1392 408183    m.hudson@exeter.ac.uk    Sub-Investigator: Andrew T Hattersley          Sub-Investigator: Timothy McDonald          King's College London Active, not recruiting London, United Kingdom, SE1 9RT Less <<
NCT03365349 Type1diabetes Not Applicable Completed - -
NCT03310944 Type 1 Diabetes Mellitus ... More >> Type 2 Diabetes Mellitus Less << Phase 1 Completed - Germany ... More >> Investigational Site Number 276001 Neuss, Germany, 41460 Less <<
NCT03316261 - Recruiting April 2021 Germany ... More >> Institut für Diabetesforschung, Helmholtz Zentrum München Recruiting Munich, Germany Contact: Anette-G. Ziegler, Prof. Dr. Less <<
NCT03378895 Chronic Disease ... More >> Cardiovascular Diseases Cancers Diabetes Mellitus Obesity Less << Not Applicable Not yet recruiting November 30, 2020 France ... More >> CHU Clermont-Ferrand Not yet recruiting Clermont-Ferrand, France, 63003 Contact: Patrick LACARIN    04 73 75 11 95    placarin@chu-clermontferrand.fr    Principal Investigator: Ruddy RICHARD          Sub-Investigator: Juliette HAZART Less <<
NCT03371082 Diabetes Mellitus, Type 1 Phase 3 Recruiting January 31, 2020 -
NCT03393715 Diabetes Mellitus, Type 2 ... More >> Hypertension Less << Phase 4 Completed - -
NCT03392441 Diabetes Mellitus, Type 1 ... More >> Diabetes Diabetes Complications Less << Not Applicable Active, not recruiting June 30, 2019 United States, Minnesota ... More >> Mayo Clinic in Rochester Rochester, Minnesota, United States, 55905 Less <<
NCT03358394 Diabetes Mellitus, Type 1 Not Applicable Active, not recruiting May 16, 2018 Kuwait ... More >> Shahah Altammar Kuwait, Kuwait, 0000 Less <<
NCT03406897 Diabetes Mellitus, Type 1 ... More >> Hypoglycemia Diabetes Mellitus Diabetes, Autoimmune Less << Phase 1 Phase 2 Recruiting December 2022 United States, Florida ... More >> Diabetes Research Institute, University of Miami Miller School of Medicine Recruiting Miami, Florida, United States, 33136 Contact: Rodolfo Alejandro, M.D.    305-243-5324    ralejand@med.miami.edu    Contact: David A Baidal, M.D.    (305) 243-7740    dbaidal@med.miami.edu    Principal Investigator: Rodolfo Alejandro, M.D.          Principal Investigator: David A Baidal, M.D. Less <<
NCT03416270 Type 2 Diabetes Mellitus ... More >> Heart Failure Less << Phase 2 Not yet recruiting March 1, 2021 -
NCT03396146 Type1diabetes Not Applicable Recruiting June 2019 France ... More >> Cochin Hospital Recruiting Paris, France, 75014 Contact: Léa DEHGHANI, MD, PhD    + 33 1 58 41 39 63    lea.dehghani@aphp.fr Less <<
NCT03419195 Type 2 Diabetes Mellitus ... More >> Healthy Overweight Cardiovascular Risk Factor Less << Not Applicable Recruiting December 31, 2021 United States, Colorado ... More >> University of Colorado, Anschutz Medical Campus Recruiting Aurora, Colorado, United States, 80045 Contact: Deirdre Rafferty, MS    720-848-6688    deirdre.rafferty@ucdenver.edu    Contact: Kristina Chapman, BS    720-848-6690    kristina.chapman@ucdenver.edu    Principal Investigator: Judy Regensteiner, PhD          Principal Investigator: Jane Reusch, MD Less <<
NCT03396484 Type1 Diabetes Mellitus Phase 2 Not yet recruiting March 2021 -
NCT03376789 Diabetes Mellitus, Type 1 Phase 3 Active, not recruiting December 2018 United States, California ... More >> Valley Research Fresno, California, United States, 93720 Less <<
NCT03437694 HIV/AIDS Diab... More >>etes Mellitus, Type 2 Hypertension Less << Not Applicable Not yet recruiting July 2021 United States, Texas ... More >> University of North Texas Not yet recruiting Fort Worth, Texas, United States, 76107 Contact: Patrick G Clay, PharmD    817-735-2798    Patrick.Clay@unthsc.edu Less <<
NCT03436992 Diabetes Mellitus, Type 1 Not Applicable Recruiting May 1, 2024 United States, Georgia ... More >> Augusta University Recruiting Augusta, Georgia, United States, 30912 Contact: Ryan A Harris, PhD    706-721-5998    ryharris@augusta.edu    Georgia Prevention Institute Recruiting Augusta, Georgia, United States, 30912 Contact: Ryan Harris, PhD, CES    706-721-5998    ryharris@augusta.edu    Contact: Jacob Looney, BS    706-721-5483    jlooney@augusta.edu Less <<
NCT03436628 Type 1 Diabetes Mellitus ... More >> Adolescent Behavior Parent-Child Relations Communication Less << Not Applicable Enrolling by invitation December 2019 United States, Michigan ... More >> Michigan State University East Lansing, Michigan, United States, 48824 Less <<
NCT03444363 Diabetes Mellitus ... More >> Periodontal Disease Less << Not Applicable Completed - Turkey ... More >> Abubekir Eltas Malatya, Turkey, 44000 Less <<
NCT03451201 Type 1 Diabetes Mellitus ... More >> Endothelial Dysfunction Less << Not Applicable Completed - Brazil ... More >> Serviço de Endocrinologia e Metabologia do HCPA Porto Alegre, RS, Brazil, 90035-0033 Less <<
NCT03437720 Non-alcoholic Steatohepatitis ... More >> Type 2 Diabetes Mellitus Less << Phase 2 Not yet recruiting August 25, 2021 -
NCT03470441 Acute Myocardial Infarction ... More >> STEMI Less << Phase 2 Not yet recruiting December 2018 -
NCT03462420 Adhesive Capsulitis ... More >> Diabetes Mellitus Less << Not Applicable Not yet recruiting December 2019 Canada, Ontario ... More >> St. Joseph's Health Care London Not yet recruiting London, Ontario, Canada, N6A 4V2 Contact: Joy C MacDermid, PhD       jmacderm@uwo.ca    Sub-Investigator: Sanaa A Alsubheen, PHDc          Sub-Investigator: Kenneth Faber, MD          Sub-Investigator: Tom Overend, PhD Less <<
NCT03452605 Type 1 Diabetes Mellitus Not Applicable Completed - -
NCT03475108 Type 1 Diabetes Mellitus ... More >> Psychosocial Problem Compliance, Patient Diabetes Mellitus Less << Not Applicable Recruiting July 1, 2020 United States, Pennsylvania ... More >> Children's Hospital of Philadelphia Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Colin Hawkes, MD PhD    215-590-3174    hawkesc@email.chop.edu Less <<
NCT03470961 CKD (Chronic Kidney Disease) S... More >>tage 5T Diabetes Mellitus Simultaneous Pancreas Kidney Transplantation Less << Phase 4 Active, not recruiting March 1, 2021 China ... More >> Tianjin First central hospital Tianjin, China Less <<
NCT03353948 Polycystic Ovary Syndrome ... More >> Obesity Infertility, Female Less << Phase 4 Completed - -
NCT03481374 Diabetes Mellitus, Type 1 Not Applicable Completed - Belgium ... More >> Jessa Ziekenhuis Hasselt, Belgium, 3500 Less <<
NCT03481218 - Completed - Slovenia ... More >> University Children's Hospital Ljubljana Ljubljana, Slovenija/Osrednja Regija, Slovenia, 1000 University of Ljubljana, Faculty of Arts, Department of psychology Ljubljana, Slovenija/Osrednja Regija, Slovenia, 1000 Less <<
NCT03466866 Diabetes Mellitus Phase 3 Not yet recruiting March 2022 United States, Pennsylvania ... More >> Thomas Jefferson University Philadelphia, Pennsylvania, United States, 19107 Less <<
NCT03501511 Diabetes Mellitus, Type 1 ... More >> Fasting Less << Not Applicable Completed - Egypt ... More >> Ain-Shams University-Faculty of Medicine- Ain-Shams University Hospitals -Internal Medicine Department -Endocrinology and Metabolism Unit Cairo, Egypt, 11591 Less <<
NCT03478254 - Recruiting December 1, 2018 Spain ... More >> Obispo Rafael Torija, St. Recruiting Ciudad Real, Spain, 13005 Contact: Jesus Moreno-Fernandez, MD, PhD    926278000 ext 79509    jmorenof@sescam.jccm.es Less <<
NCT03490773 - Recruiting September 30, 2018 Netherlands ... More >> Leiden University Medical Center Active, not recruiting Leiden, Netherlands United Kingdom Royal Devon & Exeter NHS Foundation Trust Recruiting Exeter, Devon, United Kingdom, EX2 5DW Contact: Richard Oram    +44 (0) 1392 408538    r.oram@exeter.ac.uk    Contact: Anita Hill    +44 (0) 1392 408184    Anita.Hill2@nhs.net    Principal Investigator: Andrew T Hattersley          Sub-Investigator: Timothy McDonald          King's College London Active, not recruiting London, United Kingdom, SE1 9RT Less <<
NCT03513939 Type 1 Diabetes Mellitus Phase 1 Phase 2 Recruiting July 2021 United States, Illinois ... More >> University of Chicago Medical Center Recruiting Chicago, Illinois, United States, 60637 Contact: Lindsay Basto, RN, MSN    773-702-2504    Lindsay.basto@uchospitals.edu    Contact: Piotr Witkowski, MD, PhD    773 702-2447    pwitkowski@surgery.bsd.uchicago.edu    Principal Investigator: Piotr Witkowski, MD, PhD Less <<
NCT03505268 Type 1 Diabetes Mellitus Not Applicable Recruiting May 3, 2019 Israel ... More >> AssutaHA Recruiting Tel Aviv, Israel Contact: Zohar Landau, MD    +972544822792    landau.zohar@gmail.com Less <<
NCT03489031 - Completed - -
NCT03517111 Diet Modification ... More >> Substance Use Disorders Diabetes Mellitus Risk Cardiovascular Risk Factor Lifestyle Risk Reduction Parenting Less << Not Applicable Not yet recruiting September 2022 United States, Arizona ... More >> Arizona State University Not yet recruiting Phoenix, Arizona, United States, 85004 Less <<
NCT03504605 Diabetes Mellitus, Type 1 ... More >> Epilepsy Asthma Shame Self-Compassion Stress Perfectionistic Cognitions Less << Not Applicable Recruiting May 2019 United Kingdom ... More >> Sheffield Childrens Hospital Recruiting Sheffield, United Kingdom Contact: Rachel Calvert          Contact: Catherine Lilley          Principal Investigator: Catherine Lilley Less <<
NCT03485092 Heart Failure ... More >> Diabetes Mellitus Less << Phase 4 Recruiting February 28, 2020 United Kingdom ... More >> Queen Elizabeth University Hospital Recruiting Glasgow, Scotland, United Kingdom, G51 4TF Contact: Mathew Lee, MBChB    0141 232 7600    matthewlee1@nhs.net    Contact: Ann Wright, RCN    0141 232 7600    ann.wright@nhs.net    Principal Investigator: Mark Petrie, MBChB Less <<
NCT03526289 Type 2 Diabetes Mellitus ... More >> Overweight and Obesity Less << Not Applicable Completed - Denmark ... More >> Center for diabetes research Hellerup, Denmark, DK-2900 Less <<
NCT03520855 Type 1 Diabetes Not Applicable Not yet recruiting April 2021 France ... More >> Necker Hospital Not yet recruiting Paris, France, 75015 Contact: Jacques BELTRAND, MD, PhD    01 44 38 15 45    jacques.beltrand@aphp.fr Less <<
NCT03521934 Heart Failure-Type 2 Diabetes ... More >>Mellitus Less << Phase 3 Recruiting January 2021 -
NCT03534544 - Recruiting April 2019 United States, Connecticut ... More >> Yale University School of Medicine Recruiting New Haven, Connecticut, United States, 06520 Contact: Lori Carria    203-737-3595    lori.carria@yale.edu    Principal Investigator: Stuart Weinzimer, MD          United States, Massachusetts Joslin Diabetes Center Recruiting Boston, Massachusetts, United States, 02215 Contact: Lindsay Roethke    617-309-4477    lindsay.roethke@joslin.harvard.edu    Principal Investigator: Lori Laffel, MD, MPH Less <<
NCT03531021 Type1diabetes ... More >> Cardiovascular Risk Factor Less << Not Applicable Recruiting November 30, 2018 United States, Massachusetts ... More >> Joslin Diabetes Center Recruiting Boston, Massachusetts, United States, 02215 Contact: Michelle L Katz, MD    617-732-2603    michelle.katz@joslin.harvard.edu    Contact: Charnice Charmant, BA    617-309-4726    charnice.charmant@joslin.harvard.edu    Principal Investigator: Michelle L Katz, MD          Sub-Investigator: Lori Laffel, MD Less <<
NCT03528226 Type1diabetes Not Applicable Not yet recruiting March 2025 -
NCT03546062 - Completed - Italy ... More >> Raffaele Marfella Naples, Italy, 80138 Less <<
NCT03544541 - Recruiting December 30, 2018 Slovenia ... More >> UMC-University Children's Hospital Recruiting Ljubljana, Slovenia Contact: Brigita Mali    +386 1 522 92 35    brigita.mali@kclj.si Less <<
NCT03538106 - Completed - France ... More >> Uhmontpellier Montpellier, France, 34295 Less <<
NCT03556631 Type 1 Diabetes Mellitus ... More >> Probiotics Less << Phase 4 Not yet recruiting June 30, 2021 -
NCT03558581 Diabetes Mellitus ... More >> Chronic Kidney Diseases Less << Not Applicable Active, not recruiting August 2018 Brazil ... More >> Pontificia Universidade Católica Rio Grande do Sul Porto Alegre, Rio Grande Do Sul, Brazil, 90.619-900 Less <<
NCT03547440 - Active, not recruiting September 18, 2018 Italy ... More >> Pediatric Clinic - Hospital "Maggiore della Carità" of Novara Novara, Italy Dept. of Public Health and Pediatrics Torino, Italy, 10126 Dep. of Medicine Science Turin, Italy Less <<
NCT03565770 Diabetes type1 Not Applicable Not yet recruiting June 2020 -
NCT03574558 Type1diabetes Not Applicable Recruiting April 15, 2019 Israel ... More >> Schnider children's medical center Recruiting Petach-Tikva, Israel, 49202 Contact: Revital Nimri, MD    972-3-9253778    Ravitaln@clalit.org.il    Sub-Investigator: Liat De Vries, Dr.          Sub-Investigator: Liora Lazar, Dr.          Sub-Investigator: Tal Oron, Dr.          Sub-Investigator: Ariel Tenennbaum, Dr.          Sub-Investigator: Shlomit Shalitin, Dr.          Sub-Investigator: Sari Karpel, Dr          Sub-Investigator: Sharon Demol, Dr          Sub-Investigator: Rachel Bello, Dr          Sub-Investigator: Michal Nevo, Dr          Sub-Investigator: Marie Muller, Dr Less <<
NCT03555994 Type 2 Diabetes Mellitus Phase 2 Recruiting December 27, 2019 Sweden ... More >> Research Site Recruiting Uppsala, Sweden, 752 37 Less <<
NCT03582878 Diabetes Mellitus, Type 1 Phase 4 Recruiting January 1, 2020 Czechia ... More >> Institute for Clinical and Experimental Medicine Recruiting Prague, Czechia, 14021 Contact: František Saudek, prof.    420261364107    frsa@ikem.cz    Contact: Peter Girman, M.D.    420 2 6136 8172    pegi@ikem.cz Less <<
NCT03580330 Diabetes Mellitus ... More >> Hypertension Less << Not Applicable Completed - -
NCT03562208 Diabetes Mellitus Progression ... More >> Diabetes Complications Less << Phase 2 Phase 3 Recruiting June 2020 Bahamas ... More >> Doctors Hospital Recruiting Nassau, New Providence, Bahamas Principal Investigator: Alejandro D Mesples, MD          Principal Investigator: Sy C Pierre, MD Less <<
NCT03607604 - Active, not recruiting December 31, 2018 United Arab Emirates ... More >> Imperial College London Diabetes Centre Abu Dhabi, United Arab Emirates, 48338 Less <<
NCT03590262 Type 1 Diabetes Mellitus ... More >> Metformin Less << Phase 4 Recruiting September 30, 2019 China, Guangdong ... More >> Shenzhen People's Hospital Recruiting Shenzhen, Guangdong, China, 518020 Contact: Xiuzhen Zhang, MD    0086-755-22943422    876538754@qq.com Less <<
NCT03561987 - Enrolling by invitation January 15, 2022 -
NCT03635437 Type 1 Diabetes Mellitus Phase 1 Phase 2 Recruiting April 30, 2020 Sweden ... More >> Uppsala University Hospital Recruiting Uppsala, Sweden, 75185 Contact: Per-Ola P Carlsson, MD, PhD    +46702721167    per-ola.carlsson@mcb.uu.se Less <<
NCT03639545 Vascular Stiffness ... More >> Hypoglycemic Agents Diabetes Complications Diabetes Mellitus, Type 1 Less << Phase 4 Recruiting January 30, 2019 Slovenia ... More >> University Medical Centre Ljubljana Recruiting Ljubljana, Slovenia, SI-1000 Contact: Mojca Lunder, MD, PhD    +386 1 5223140    mojca.lunder@kclj.si    Contact: Andrej Janez, Prof    +386 1 5223564    andrej.janez@kclj.si    Principal Investigator: Miodrag Janic, MD, PhD          Principal Investigator: Miso Sabovic, Prof Less <<
NCT03588234 - Recruiting June 21, 2019 Canada, Quebec ... More >> McGill University Recruiting Montréal, Quebec, Canada, H9X3V9 Contact: Vanessa Maggio    5147584995    vanessa.maggio@mail.mcgill.ca Less <<
NCT03642483 - Enrolling by invitation October 2020 Switzerland ... More >> University Children's Hospital Zurich Zürich, Switzerland Less <<
NCT03642470 - Enrolling by invitation March 2020 Switzerland ... More >> University Children's Hospital Zurich Zurich, Switzerland Less <<
NCT03632759 Type 1 Diabetes Mellitus Early Phase 1 Recruiting June 2020 United States, Idaho ... More >> Rocky Mountain Diabetes and Osteoporosis Center Not yet recruiting Idaho Falls, Idaho, United States, 83404 United States, Washington Benaroya Research Institute Recruiting Seattle, Washington, United States, 98101 Less <<
NCT03680079 Type 1 Diabetes Mellitus Not Applicable Recruiting June 30, 2019 United States, Missouri ... More >> St. Louis Children's Hospital Recruiting Saint Louis, Missouri, United States, 63110 Contact: Ellen Kim, MD    314-454-6051    eekim@wustl.edu    Contact: Pamela Stone    314-454-4659    stone.p@wustl.edu Less <<
NCT03682250 - Recruiting December 31, 2020 Canada, Quebec ... More >> Institut de recherches cliniques de Montréal Recruiting Montreal, Quebec, Canada, H2W 1R7 Contact: Remi Rabasa-Lhoret Less <<
NCT03713502 - Not yet recruiting October 2021 Tanzania ... More >> NIMR Research Clinic Active, not recruiting Mwanza, Mwanza Region, Tanzania Less <<
NCT03618628 Diabetes Mellitus ... More >> Peripheral Neuropathy Orthotic Device Less << Not Applicable Completed - United States, Missouri ... More >> Washington University Saint Louis, Missouri, United States, 63108 Less <<
NCT03699189 Diabetes Mellitus, Type 1 Not Applicable Completed - -
NCT03660293 Diabetes Mellitus, Type 1 Not Applicable Recruiting April 2019 Egypt ... More >> Faculty of Medicine- Tanta University Recruiting Tanta, Gharbia, Egypt, 0000 Contact: Rasha M Gamal, MD    +201227405988    rashagamal1978@gmail.com    Principal Investigator: Osama A El Razaky, MD          Principal Investigator: Adel A Erfan, MD          Principal Investigator: Amal A Elbendary, MD          Principal Investigator: Doaa M El Amrousy, MD          Principal Investigator: Alshimaa M Badr Eldeen, MsC Less <<
NCT03720912 Diabetes Mellitus, Type 1 Not Applicable Recruiting June 30, 2021 United States, California ... More >> University of California-Davis Recruiting Sacramento, California, United States, 95817 Contact: Hadley Sauers-Ford, MPH    916-734-4729    hsauersford@ucdavis.edu Less <<
NCT03720197 - Not yet recruiting March 31, 2022 Canada, Quebec ... More >> Institut de recherches cliniques de Montréal Not yet recruiting Montreal, Quebec, Canada, H7K3Y8 Contact: Virginie Messier    514-987-5500 ext 3227    virginie.messier@ircm.qc.ca    Principal Investigator: Remi Rabasa-Lhoret          Canada Centre Hospitalier de l'Université de Montréal Not yet recruiting Montreal, Canada Contact: Remi Rabasa-Lhoret    514-987-5500 ext 3227    remi.rabasa-lhoret@ircm.qc.ca    Principal Investigator: Remi Rabasa-Lhoret          Centre Hospitalier Universitaire Sainte-Justine Not yet recruiting Montreal, Canada Contact: Catherine Pelletier       catherine.pelletier@recherche-ste-justine.qc.ca    Principal Investigator: Melanie Henderson          McGill University Health Centre Montreal, Canada Centre Hospitalier Universitaire de Québec-Université Laval Not yet recruiting Quebec, Canada Contact: Claudia Gagnon       claudia.gagnon@crchudequebec.ulaval.ca    Principal Investigator: Claudia Gagnon          Centre hospitalier universitaire de Sherbrooke Not yet recruiting Sherbrooke, Canada Contact: Andre Carpentier       andre.carpentier@usherbrooke.ca    Principal Investigator: Andre Carpentier Less <<
NCT03703440 Diabetes Mellitus, Type 1 ... More >> Type1diabetes Insulin Dependent Diabetes Less << Not Applicable Not yet recruiting January 2023 Canada, Quebec ... More >> Centre Hospitalier Universitaire Sainte-Justine (CHUSJ) Not yet recruiting Montreal, Quebec, Canada, H3T 1C5 Contact: Catherine Pelletier, MSc    514-345-4931 ext 3551    catherine.pelletier@recherche-ste-justine.qc.ca    Principal Investigator: Melanie Henderson, MD, PhD          Montreal Children's Hospital - McGill University Health Centre (MUHC) Not yet recruiting Montreal, Quebec, Canada, H4A 3J1 Contact: Elise Mok, PhD    514-412-4400 ext 23527    elise.mok@muhc.mcgill.ca    Principal Investigator: Meranda Nakhla, MD, MSc          Sub-Investigator: Kaberi Dasgupta, MD, MSc          Sub-Investigator: Elham Rahme, PhD          Sub-Investigator: Mohammad Hajizadeh, PhD          Sub-Investigator: Lorraine Bell, MD          Sub-Investigator: Melinda Prevost Less <<
NCT03725657 - Completed - Italy ... More >> Centro di Diabetologia Pediatrica "G.Stoppoloni" Naples, Italy, 80100 Less <<
NCT03723759 Diabetes Mellitus, Type 1 Phase 1 Recruiting March 29, 2019 Germany ... More >> Novo Nordisk Investigational Site Recruiting Neuss, Germany, 41460 Less <<
NCT03747978 Diabetes Mellitus, Type 2 ... More >> Hypertension Less << Phase 4 Completed - Cameroon ... More >> National Obesity Centre, Yaounde Central Hospital Yaounde, Centre, Cameroon Less <<
NCT03717194 Type2 Diabetes ... More >> Heart Failure Less << Phase 3 Not yet recruiting October 30, 2020 Korea, Republic of ... More >> Seoul National University Bundang Hospita; Not yet recruiting Seongnam-si, Gyeonggi-do, Korea, Republic of, 13620 Less <<
NCT03729323 Type 2 Diabetes Mellitus ... More >> Systemic Arterial Hypertension Less << Not Applicable Enrolling by invitation March 10, 2019 Brazil ... More >> Nossa Senhora da Conceição Hospital Porto Alegre, RS, Brazil, 91350-200 Less <<
NCT03751007 Diabetes Mellitus, Type 1 Phase 1 Phase 2 Recruiting June 30, 2020 -
NCT00466869 Hypercholesterolemia Phase 2 Terminated(Sponsor decision) - Israel ... More >> Internal Medicine Department A-Wolfson Medical Center Holon, Israel Internal Medicine Department A-Meir Medical Center Kfar Saba, Israel Less <<
NCT00109525 - Completed - United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35233 United States, California Stanford University Palo Alto, California, United States, 94304 University of California at San Diego San Diego, California, United States, 92103-8774 United States, Connecticut Yale University New Haven, Connecticut, United States, 06504 United States, Florida University of Miami Miami, Florida, United States, 33136 United States, Georgia Emory University Atlanta, Georgia, United States, 30303 United States, Indiana Indiana University Indianapolis, Indiana, United States, 46202 United States, Iowa University of Iowa Iowa City, Iowa, United States, 52242 United States, Massachusetts Tufts Medical Center Boston, Massachusetts, United States, 02111 United States, Michigan Wayne State University Detroit, Michigan, United States, 48201 United States, New Mexico University of New Mexico Albuquerque, New Mexico, United States, 87131 United States, New York University of Rochester Rochester, New York, United States, 14642 United States, North Carolina Wake Forest University Charlotte, North Carolina, United States, 27157 RTI International Durham, North Carolina, United States, 27705 Duke University Durham, North Carolina, United States, 27710 United States, Ohio Cincinnati Children's Medical Center Cincinnati, Ohio, United States, 45267 Case Western Reserve University, Rainbow Babies and Children's Hospital Cleveland, Ohio, United States, 44106 United States, Rhode Island Brown University, Women & Infants Hospital of Rhode Island Providence, Rhode Island, United States, 02905 United States, Texas University of Texas Southwestern Medical Center at Dallas Dallas, Texas, United States, 75235 University of Texas Health Science Center at Houston Houston, Texas, United States, 77030 Less <<
NCT03751839 Type 1 Diabetes Mellitus Not Applicable Recruiting May 2019 Switzerland ... More >> Department of Endocrinology, Diabetology and Metabolism, University Hospital Basel Recruiting Basel, Basel Stadt, Switzerland, 4031 Contact: Christian Meier, Prof.    0041612649797    christian.meier@unibas.ch    Contact: Lilian Sewing, Dr.    0041612649797    Lilian.Sewing@usb.ch Less <<
NCT03763669 Gestational Diabetes Not Applicable Recruiting February 2020 Italy ... More >> Department of Obstetrics & Gynecology - Policlinico "G. Martino" Recruiting Messina, Italy, 98125 Contact: FRANCESCO CORRADO, professor    +39090221 ext 2182    fcorrado@unime.it    Sub-Investigator: ROSARIO D'ANNA, professor          Sub-Investigator: ANTONINO DI BENEDETTO, professor Less <<
NCT03728296 Type 1 Diabetes Early Phase 1 Not yet recruiting January 2021 -
NCT03763474 Diabetes Mellitus, Type 1 Not Applicable Completed - Greece ... More >> Endocrine Unit of 3rd Department of Pediatrics of Aristotle University of Thessaloniki, Hippokration General Hospital Thessaloniki, Greece, 54642 Less <<
NCT01642836 Obesity Phase 2 Unknown April 2017 United States, California ... More >> Stanford University Stanford, California, United States, 94305 Less <<
NCT02598557 Estrogen Receptor Positive ... More >> Postmenopausal Stage 0 Breast Cancer AJCC v6 and v7 Stage I Breast Cancer AJCC v7 Stage IA Breast Cancer AJCC v7 Stage IB Breast Cancer AJCC v7 Stage II Breast Cancer AJCC v6 and v7 Stage IIA Breast Cancer AJCC v6 and v7 Stage IIB Breast Cancer AJCC v6 and v7 Less << Phase 2 Recruiting - United States, Florida ... More >> Moffitt Cancer Center Recruiting Tampa, Florida, United States, 33612 Contact: Nagi B. Kumar    813-745-6885    nagi.kumar@moffitt.org    Principal Investigator: Nagi B. Kumar          United States, New York Columbia University/Herbert Irving Cancer Center Recruiting New York, New York, United States, 10032 Contact: Katherine D. Crew    212-305-1732    kd59@cumc.columbia.edu    Principal Investigator: Katherine D. Crew          United States, Texas M D Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Powel H. Brown    713-792-4509    phbrown@mdanderson.org    Principal Investigator: Powel H. Brown          Italy Galliera Hospital Recruiting Genoa, Italy, 16128 Contact: Andrea Decensi    39-010 5634501    andrea.decensi@galliera.it    Principal Investigator: Andrea Decensi          European Institute of Oncology Recruiting Milano, Italy, 20141 Contact: Bernardo Bonanni    39-0257489022    bernardo.bonanni@ieo.it    Principal Investigator: Bernardo Bonanni Less <<
NCT02113371 Wounds and Injuries ... More >> Health Promotion Less << Not Applicable Completed - United States, Oregon ... More >> Oregon Health and Science University Portland, Oregon, United States, 97239 Less <<
NCT03222206 Non Alcoholic Fatty Liver ... More >> Osteo Arthritis Less << Phase 4 Active, not recruiting February 22, 2019 Korea, Republic of ... More >> Korea University Guro Hospital Seoul, Korea, Republic of, 08308 Less <<
NCT01483235 Cardiovascular Disease ... More >> Obesity Dyslipidemia Less << Not Applicable Completed - Canada, British Columbia ... More >> St Paul's Hospital Vancouver, British Columbia, Canada, V6Z 1Y6 Less <<
NCT02909959 Autism Spectrum Disorder ... More >> Autistic Disorder Neurodevelopmental Disorder Childhood Developmental Disorders, Pervasive Less << Phase 2 Recruiting November 2019 United States, North Carolina ... More >> Carolina Institute for Developmental Disabilities, University of North Carolina School of Medicine Recruiting Carrboro, North Carolina, United States, 27510 Contact: Laura Politte, M.D.    919-445-4160    laura.politte@cidd.unc.edu    Contact: Morgan Parlier, MSW    919-843-8122    morgan.parlier@cidd.unc.edu Less <<
NCT00386854 Lipid Metabolism ... More >> Insulin Resistance Inflammation Less << Not Applicable Completed - Austria ... More >> Vorarlberg Institute of Vascular Investigation and Treatment Feldkirch, Vorarlberg, Austria, 6807 Less <<
NCT00432952 Cardiovascular Diseases ... More >> Metabolic Syndrome Less << Not Applicable Unknown January 2009 Denmark ... More >> Institute of Human Nutrition, University of Copenhagen Frederiksberg C, Denmark, 1958 Less <<
NCT02188732 Schizophrenia ... More >> Schizoaffective Disorder Bipolar Disorder Depression Less << Not Applicable Active, not recruiting August 2019 United States, Massachusetts ... More >> Bay Cove Human Services Boston, Massachusetts, United States, 02114 Vinfen Cambridge, Massachusetts, United States, 02141-1001 Less <<
NCT03398577 Coronary Disease With Diabetes... More >> Mellitus Less << Phase 4 Not yet recruiting December 31, 2018 Israel ... More >> Sheba Medical Center, Cardiac Rehabilitation Institute Tel Hashomer, Israel, 52621 Less <<
NCT03217604 Healthy Volunteers Phase 1 Completed - Belgium ... More >> Pfizer Clinical Research Unit Brussels, Belgium, B-1070 Less <<
NCT00362180 - Completed - -
NCT00362180 Lipid Metabolism, Inborn Error... More >>s Hyperlipidemias Metabolic Diseases Hypolipoproteinemia Hypolipoproteinemias Hypobetalipoproteinemias Metabolism, Inborn Errors Genetic Diseases, Inborn Infant, Newborn, Diseases Congenital Abnormalities Metabolic Disorder Hypercholesterolemia Dyslipidemias Lipid Metabolism Disorders Less << Phase 2 Completed - Netherlands ... More >> Amsterdam, Netherlands, 1105 AZ Less <<
NCT01967589 Diabetes Heal... More >>thy Less << Phase 1 Completed - United Kingdom ... More >> Harrow, United Kingdom, HA1 3UJ Less <<
NCT03753087 Heart Failure, Diastolic ... More >> Diabetes Mellitus, Type 2 Less << Phase 4 Not yet recruiting May 2020 Russian Federation ... More >> National Medical Research Center for Cardiology Not yet recruiting Moscow, Russian Federation, 121552 Contact: Anton Borisov, MD       AntonBorisovMD@gmail.com Less <<
NCT02927210 Healthy Men M... More >>ale Contraception Less << Phase 1 Recruiting October 2019 United States, California ... More >> Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center Recruiting Torrance, California, United States, 90509 Contact: Xiaodan Han    310-222-1865    xhan@labiomed.org    Principal Investigator: Christina Wang, MD          United States, Washington University of Washington Medical Center & Health Sciences Recruiting Seattle, Washington, United States, 98195 Contact: Kathy Winter    206-616-0484    klwinter@uw.edu    Principal Investigator: Stephanie Page, MD, PhD Less <<
NCT00465296 Metabolic Syndrome Phase 3 Terminated(Funding Discontinue... More >>d) Less << - United States, District of Col... More >>umbia Washington Hospital Center Washington, District of Columbia, United States, 20010 Less <<
NCT02705560 Healthy Not Applicable Unknown May 2018 Switzerland ... More >> Service of Endocrinology, Diabetes and Metabolism, University Hospital, CHUV Recruiting Lausanne, VD, Switzerland, 1011 Contact: François Pralong, MD    004121 314 05 96    francois.pralong@chuv.ch Less <<
NCT01120717 Chronic Obstructive Pulmonary ... More >>Disease Less << Phase 3 Completed - -
NCT00170352 Traumatic Brain Injury Phase 2 Completed - United States, Minnesota ... More >> Hennepin County Medical Center Minneapolis, Minnesota, United States, 55415 Less <<
NCT00515021 Metabolic Syndrome X Phase 4 Unknown April 2010 United States, Tennessee ... More >> Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232-8802 Less <<
NCT02070939 Healthy Phase 1 Completed - United States, Connecticut ... More >> New Haven Clinical Research Unit New Haven, Connecticut, United States, 06511 Less <<
NCT02772679 Type 1 Diabetes Mellitus Phase 1 Suspended(New enrollment suspe... More >>nded to allow time for additional analyses) Less << December 2021 United States, California ... More >> University of California, San Francisco Medical Center San Francisco, California, United States, 94143 United States, Connecticut Yale University New Haven, Connecticut, United States, 06519 Less <<
NCT01025817 Kidney Transplant Phase 3 Completed - -
NCT01120717 - Completed - -
NCT02784236 Metabolic Impact Not Applicable Completed - Spain ... More >> FIMABIS Malaga, Spain, 29010 Less <<
NCT01025817 - Completed - -
NCT02801942 Diabetes Mellitus, Type 1 Not Applicable Completed - United Kingdom ... More >> GSK Investigational Site Cambridge, United Kingdom, CB2 0QQ GSK Investigational Site Cardiff, United Kingdom, CF14 4XN Less <<
NCT02790645 Diabetes Mellitus, Type 1 Not Applicable Completed - -
NCT02804165 Type 1 Diabetes Not Applicable Withdrawn July 2022 France ... More >> Hospices Civils de Lyon Lyon, France, 69000 Less <<
NCT02790892 Coping Behavior ... More >> Emotional Distress Diabetes Mellitus, Type 1 Diabetes Mellitus, Type 2 Less << Not Applicable Recruiting December 2018 Canada, Manitoba ... More >> University of Manitoba Recruiting Winnipeg, Manitoba, Canada, R3E 3P4 Contact: Catherine A MacDonald, BFAH    204-789-3719    cmacdonald@chrim.ca Less <<
NCT02803892 Diabetes Mellitus, Type 1 Phase 2 Recruiting March 2019 Italy ... More >> IRCCS San Raffaele Scientific Institute Recruiting Milan, Italy, 20132 Contact: Lorenzo Piemonti, MD       piemonti.lorenzo@hsr.it    Contact: Andrea Bolla, MD       andrea.bolla@hsr.it    Principal Investigator: Andrea Bolla, MD          Principal Investigator: Lorenzo Piemonti, MD          Principal Investigator: Emanuele Bosi, MD Less <<
NCT02808351 Diabetes Mellitus ... More >> Chronic Kidney Disease Less << Phase 4 Recruiting August 2020 China, Jiangsu ... More >> Nanjing First Hospital Recruiting Nanjing, Jiangsu, China, 210006 Contact: Shaoliang Chen, PhD    +86-025-52271351    chmengx@126.com    Contact: Jing Kan, MPH    +86-025-52271398    kanjingok@126.com    Sub-Investigator: Xiaobo Li, PhD Less <<
NCT02807155 Type 1 Diabetes Mellitus Not Applicable Completed - United States, California ... More >> University of Southern California Los Angeles, California, United States, 90033 Less <<
NCT02811055 Type 2 Diabetes ... More >> Hypertension Less << Phase 2 Recruiting July 2019 France ... More >> Rouen University Hospital Recruiting Rouen, France Principal Investigator: Gaétan PREVOST, MD Less <<
NCT02812303 - Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT02814838 Diabetes Mellitus, Insulin-Dep... More >>endent Less << Phase 2 Active, not recruiting September 2019 Belgium ... More >> Universitair Ziekenhuis Brussel Diabetes Clinic Brussels, Belgium, 1090 Universitair Ziekenhuis Leuven Campus Gasthuisberg Endocrinology Leuven, Belgium, 3000 Germany Med. Klinik und Poliklinik 3, Universitätsklinikum Giessen und Marburg GmbH Giessen, Germany, 32392 Zentrum für Diabetes und Gefäßerkrankungen Münster, Germany, 48145 Italy Università Aldo Moro-Ospedale Policlinico Bari, Italy, 70124 Presidio Policlinico di Monserrato Cagliari, Italy, 88554 Internal Medicine - Diabetes & Endocrinology Unit, San Raffaele Hospital Milan Milan, Italy, 20132 Unità Operativa Complessa di Endocrinologia e Dialettologia. Università Campus Bio-Medico di Roma Rome, Italy, 00128 Less <<
NCT02887469 Hyponatremia Symptomatic Phase 4 Recruiting July 2018 Korea, Republic of ... More >> Seoul National University Bundang Hospital Clinical Trial Center Recruiting Seongnam, Gyeonggi-do, Korea, Republic of, 13605 Contact: Hyunjin Cho    82 31 787 7030    10871@snubh.org Less <<
NCT02835131 - - - United States, New York ... More >> Montefiore Medical Center Bronx, New York, United States, 10461 Contact: Erika F Brutsaert, MD, MPH    866-633-8255       Principal Investigator: Erika F Brutsaert, MD, MPH Less <<
NCT02835014 - Active, not recruiting June 2020 United States, Texas ... More >> Texas Tech University Health Sciences Center Lubbock, Texas, United States, 79430 Less <<
NCT02812498 Type 1 Diabetes Mellitus Not Applicable Unknown July 2017 Italy ... More >> AO Ospedale Civile Legnano Legnano Recruiting Legnano, Italy, 20025 Contact: Ilario Stefani, MD          ASST Grande Ospedale Metropolitano Niguarda Recruiting Milano, Italy, 20162 Contact: Federico Bertuzzi, MD    0039026444 ext 2464    federico.bertuzzi@ospedaleniguarda.it Less <<
NCT02839031 Diabetes Mellitus, Type 1 Not Applicable Recruiting October 2018 France ... More >> Montpellier University Hospital Recruiting Montpellier, France, 34295 Contact: Diane PURPER-OUAKIL Less <<
NCT02836873 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT02845024 Diabetes Mellitus With Periodo... More >>ntal Disease Less << Not Applicable Completed - -
NCT02860611 - Completed - Turkey ... More >> Medeniyet University Goztepe Training and Research Hospital Istanbul, Turkey, 34730 Less <<
NCT02820558 Diabetes Mellitus, Type 1 Phase 1 Unknown September 2017 Canada, Ontario ... More >> Hospital for Sick Children Recruiting Toronto, Ontario, Canada Contact: Holly Tschirhart    416-813-7654 ext 204517    holly.tschirhart@sickkids.ca    Contact: Catherine Pastor    416-813-7654 ext 204396    catherine.pastor@sickkids.ca Less <<
NCT02862067 - Completed - United States, Virginia ... More >> Virginia Commonwealth University Richmond, Virginia, United States, 23298 Less <<
NCT02839174 - Completed - United States, Massachusetts ... More >> Boston Children's Hospital Boston, Massachusetts, United States, 02115 Less <<
NCT02874612 - Active, not recruiting September 2018 United States, Ohio ... More >> Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229 Less <<
NCT02859779 Type 1 Diabetes in Adolescence Not Applicable Unknown December 2018 France ... More >> Hôpital de la Timone Assistance Publique Hôpitaux de Marseille Recruiting Marseille, France, 13354 Contact: Marie-Claude SIMEONI-LAGOUANELLE    04 91 38 30 00    marie.lagouanelle@ap-hm.fr Less <<
NCT02883829 Diabetes Mellitus, Type 1 Not Applicable Completed - United States, Massachusetts ... More >> Boston Children's Hospital Boston, Massachusetts, United States, 02115 Less <<
NCT02888951 - Recruiting January 2019 Canada, Ontario ... More >> Toronto Western Hospital Recruiting Toronto, Ontario, Canada, M5T 2S8 Contact: Richelle Kruisselbrink, MD    4166035800    richelle.kruisselbrink@uhn.ca    Contact: Barjind Pandher    4166035800 ext 2016    barjind.pandher@uhnresearch.ca    Principal Investigator: Richelle Kruisselbrink, MD          Sub-Investigator: Anahi Perlas, MD          Sub-Investigator: Vincent Chan, MD          Sub-Investigator: Akhilesh Tiwari, MD Less <<
NCT02859818 Type 1 Pediatric Diabetes Not Applicable Not yet recruiting May 2020 France ... More >> Assistance Publique Hôpitaux de Marseille Not yet recruiting Marseille, France, 13354 Contact: Sébastien COLSON    0491383267    sebastien.colson@ap-hm.fr Less <<
NCT02906579 Diabetes Mellitus, Type 2 ... More >> Hypertension Less << Phase 2 Completed - United States, Texas ... More >> ICON Early Phase Unit San Antonio, Texas, United States, 78209 Less <<
NCT02914743 Type II Diabetes ... More >> Periodontal Disease Less << Not Applicable Active, not recruiting October 2018 United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT02867436 Type 1 Diabetes Not Applicable Recruiting December 2019 Czech Republic ... More >> University Hospital Královské Vinohrady Recruiting Prague, Czech Republic, 10000 Contact: Jan Vosáhlo, MD    +420267161111    vosahlo@fnkv.cz    University Hospital Motol Recruiting Prague, Czech Republic, 15006 Contact: Zdenek Sumnik, MD    +420702000087    zdenek.sumnik@lfmotol.cuni.cz    Contact: Ondrej Cinek, MD    +420224432026    ondrej.cinek@lfmotol.cuni.cz Less <<
NCT02918175 Diabetes Mellitus ... More >> Heart Failure Less << Not Applicable Recruiting May 2020 United States, California ... More >> Stanford University School of Medicine Recruiting Stanford, California, United States, 94305 Contact: Jhina Patro       jhina@stanford.edu    Principal Investigator: Dipanjan Banerjee, MD          United States, Massachusetts Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: Hannah Wilkins    617-643-9324    hwilkins1@mgh.harvard.edu    Principal Investigator: Maulik Majmudar, MD          United States, New York NewYork-Presbyterian Brooklyn Methodist Hospital Recruiting Brooklyn, New York, United States, 11215 Contact: John Heitner, MD       jfh9003@nyp.org    Principal Investigator: John Heitner, MD          United States, North Carolina Duke University Medical Center Recruiting Durham, North Carolina, United States, 27705 Contact: Jennifer Wilson       j.wilson@duke.edu    Principal Investigator: Robert Mentz, MD          United States, Virginia Inova Health System Recruiting Fairfax, Virginia, United States, 22042-3300 Contact: Lauren Cooper, MD       Lauren.Cooper@inova.org    Principal Investigator: Lauren Cooper, MD Less <<
NCT02920918 Heart Failure, Systolic ... More >> Diabetes Mellitus, Type 2 Less << Phase 4 Active, not recruiting March 2019 United States, Virginia ... More >> Virginia Commonwealth University Richmond, Virginia, United States, 23298 Less <<
NCT02927639 Diabetes Mellitus, Type 1 Not Applicable Recruiting November 2018 United States, Pennsylvania ... More >> Children's Hospital of Philadelphia Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Tara Kaushal, MD    267-357-3678    Kaushalt@email.chop.edu    Contact: Terri Lipman, PhD    (267) 239-7052    Lipman@email.chop.edu Less <<
NCT02908087 Type 1 Diabetes Phase 2 Enrolling by invitation July 2018 Finland ... More >> University of Oulu and Oulu University Hospital, Dept of Children and Adolescents Oulu, Finland, 90029 University of Tampere and Tampere University Hospital Tampere, Finland, 33520 University of Turku and Turku University Hospital Turku, Finland, 20520 Sweden Lund University and Skåne University Hospital Malmö, Sweden, 205 02 Less <<
NCT02939118 - Enrolling by invitation November 2021 -
NCT02953249 - Recruiting May 2019 Brazil ... More >> Dental School of University of Sao Paulo Recruiting Sao Paulo, SP, Brazil, 05508000 Contact: Marina Gallottini, PhD    11997578016    mhcgmaga@usp.br    Contact: Gilmara Ribeiro, secretary    55 11 30917859    gilmara@usp.br    Sub-Investigator: Talita Castro, MSc          Sub-Investigator: Karin Fernandes, PhD          Sub-Investigator: Rubens Caliento, MSc Less <<
NCT02940418 Diabetes Mellitus Type 1 Phase 1 Recruiting November 2019 Jordan ... More >> Cell Therapy Center Recruiting Amman, Jordan, 11942 Contact: Abdalla Awidi, MD    0096265355000 ext 23960    abdalla.awidi@gmail.com Less <<
NCT02957513 Diabetes Mellitus ... More >> Chronic Disease Less << Not Applicable Recruiting May 2020 United States, Mississippi ... More >> Hawkins Family Medicine Recruiting Holly Springs, Mississippi, United States, 38635 Contact: Cassandra Hawkins, MD    901-516-9800    Cassandra.hawkins@mlh.org    Contact: Therea Cole    662-252-6416    Theresa.cole@mlh.org    United States, Tennessee Eastmoreland Internal Medicine Recruiting Memphis, Tennessee, United States, 38104 Contact: Stanley Dowell, MD    901-516-9800    Stanley.dowell@mlh.org    Contact: Eileen Thomas    901-516-7117    Elleen.thomas@mlh.org    Christ Community Health Services - Third Street Health Center Recruiting Memphis, Tennessee, United States, 38109 Contact: Steve Sittnick, MD    901-260-8500    Steve.sittnick@christchs.org    Contact: Charnette Johnson    901-701-2510    Charnette.johnson@christchs.org    TriState Medical Group PLLC Recruiting Memphis, Tennessee, United States, 38116-6442 Contact: Janet Walker, NP    901-690-2671    Walkerjanet_49@yahoo.com    Contact: Kazi Zaman, MD    662-252-6416    kazaman@midsouthima.com    University of Tennessee Methodist Physicians Recruiting Memphis, Tennessee, United States, 38116 Contact: Helmut Steinberg, MD    901-448-5240    Hsteinb1@uthsc.edu    Contact: Keith Paden    901-272-7797    dangelis.paden@mlh.org    Christ Community Health Center - Raleigh Health Center Recruiting Memphis, Tennessee, United States, 38128 Contact: Natalie Burch, PA    901-485-8509       Contact: Steve Sittnick, MD    901-260-8500    Steve.sittnick@christchs.org Less <<
NCT02915263 Diabetes Complications ... More >> Diabetes Mellitus Diabetic Neuropathies Less << Phase 2 Recruiting September 2019 United States, Massachusetts ... More >> Beth Israel Deaconness Medical Center Recruiting Boston, Massachusetts, United States, 02215 Principal Investigator: Christopher Gibbons, MD Less <<
NCT03005288 Diabetes Mellitus, Type 2 Phase 2 Active, not recruiting May 8, 2019 United States, California ... More >> Novartis Investigative Site Anaheim, California, United States, 92801 United States, Florida Novartis Investigative Site Miami Lakes, Florida, United States, 33014 Novartis Investigative Site Miami, Florida, United States, 33126 Novartis Investigative Site Miami, Florida, United States, 33143 Novartis Investigative Site Orlando, Florida, United States, 32804 United States, Louisiana Novartis Investigative Site Baton Rouge, Louisiana, United States, 70808 United States, New Jersey Novartis Investigative Site Berlin, New Jersey, United States, 08009 United States, New York Novartis Investigative Site New York, New York, United States, 10019 United Kingdom Novartis Investigative Site Merthyr Tydfil, Mid Glamorgan, United Kingdom, CF484DR Less <<
NCT02996539 - Completed - China, Yunnan ... More >> Internal medicine department, Kunming First People's Hospital Kunming, Yunnan, China, 650000 Less <<
NCT03010956 - Completed - Greece ... More >> ''Attikon'' University General Hospital Athens, Attiki, Greece, 12462 Less <<
NCT03011021 Type1 Diabetes Mellitus ... More >> Autoimmune Diabetes Less << Phase 1 Phase 2 Recruiting November 2019 China, Hunan ... More >> Institute of Metabolism and Endocrinology, Second Xiangya Hospital, Central South University Recruiting Changsha, Hunan, China, 410011 Contact: Zhiguang Zhou, MD/PhD    86-731-85292154    zhouzg@hotmail.com Less <<
NCT03014908 - Completed - Belgium ... More >> Hasselt University Hasselt, Limburg, Belgium, 3500 Less <<
NCT03046927 Type 1 Diabetes Phase 2 Phase 3 Recruiting July 31, 2020 United States, Massachusetts ... More >> University of Massachusetts Medical School Recruiting Worcester, Massachusetts, United States, 01655 Contact: Deepa Patel, MPH       Deepa.Patel@umassmed.edu    Contact: Antonio Villalobos-Ortiz, MS       Antonio.Villalobos-Ortiz@umassmed.edu Less <<
NCT03066284 - Recruiting March 13, 2019 Kuwait ... More >> Dasman Diabetes Institute Recruiting Sharq, Kuwait City, Kuwait, 15462/1180 Contact: Nehad A. Taha, MSc.    +96522242999 ext 2202    nehad.taha@dasmaninstitute.org    Contact: Zahraa N. Rahme, MSc.    +96522242999 ext 2207    zahraa.rahme@dasmaninstitute.org    Principal Investigator: Naglaa I. Mesbah, MSc. Less <<
NCT03069196 - Recruiting December 31, 2020 India ... More >> Diabetes Unit, Kem Hospital Research Centre Recruiting Pune, Maharashtra, India, 411014 Contact: Chittaranjan S Yajnik, MD          Principal Investigator: Chittaranjan S Yajnik, MD , FRCP Less <<
NCT03032991 - Recruiting December 2020 Spain ... More >> Elvira Larqué Recruiting Murcia, Spain, 30100 Contact: Elvira Larqué, Dr    0034868884239    elvirada@um.es    Contact: Cristina Campoy, MD    0034958240740    ccampoy@ugr.es Less <<
NCT03083899 Diabetes Mellitus, Type 1 ... More >> Patient Reported Outcome Health Care Economics and Organizations Less << Not Applicable Recruiting November 30, 2019 Denmark ... More >> Hospital of South West Jutland Recruiting Esbjerg, Denmark, 6700 Contact: Claus B Juhl, MD, PhD    +4560867172    claus.bogh.juhl@rsyd.dk    Contact: Nina Drojdahl Ryg, MSc, PhD    +4579182049    nina.droejdahl.ryg@rsyd.dk Less <<
NCT03056014 Ameliorating Oxidative Stress ... More >>in Type 1 Diabetes Less << Early Phase 1 Not yet recruiting June 2020 -
NCT02970357 Diabetes Mellitus, Type I ... More >> Program Evaluation Therapeutic Education Children Less << Not Applicable Completed - France ... More >> GHRMSA Mulhouse, France Less <<
NCT03084900 Diabetes Mellitus Not Applicable Recruiting March 31, 2021 United States, Indiana ... More >> Riley Hospital for Children Recruiting Indianapolis, Indiana, United States, 46202 Contact: Lisa Smith    317-278-9615 Less <<
NCT03083795 Diabetes Mellitus, Type 2 ... More >> Psychological Distress Less << Not Applicable Not yet recruiting December 2017 -
NCT03087032 Type 2 Diabetes Patients ... More >> Overweight and Obesity Hyperglycaemia (Diabetic) Less << Phase 4 Recruiting December 31, 2020 China, Fujian ... More >> The first afilliated hospital of Xiamen university Recruiting Xiamen, Fujian, China, 361003 Contact: Changqin Liu, MD    +86-133 7698 6106    liuchangqin@xmu.edu.cn Less <<
NCT02893306 Type 1 Diabetes Mellitus Phase 2 Unknown March 2017 Chile ... More >> Clinica Alemana de Santiago Santiago, Region Metropolitana, Chile Less <<
NCT03095196 - Completed - -
NCT03091920 Diabetes Mellitus, Type 2 ... More >> Hypertension Less << Phase 2 Completed - United States, California ... More >> ProSciento, Inc. Chula Vista, California, United States, 91911 Less <<
NCT03111433 Diabetes Mellitus, Type 1 Phase 2 Completed - Egypt ... More >> Ainshams university pediatric's hospital Cairo, Egypt Less <<
NCT03136471 - Recruiting December 2020 United States, Louisiana ... More >> Tulane School of Public Health and Tropical Medicine Recruiting New Orleans, Louisiana, United States, 70112 Contact: Shuqian Liu, PhD    504-988-1939    sliu9@tulane.edu Less <<
NCT03136939 - Completed - China, Zhejiang ... More >> Department of Endocrinology, the First Affiliated Hospital to Zhejiang University School of Medicine Hangzhou, Zhejiang, China, 310003 Less <<
NCT03121755 - Completed - -
NCT03147274 Type 1 Diabetes Mellitus Not Applicable Active, not recruiting January 2019 United States, Massachusetts ... More >> Boston Children's Hospital Boston, Massachusetts, United States, 02115 Less <<
NCT03149770 Diabetes Mellitus, Type 1 Phase 2 Recruiting December 2020 United States, Minnesota ... More >> University of Minnesota Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Anjali Kumar, PA-C    612-301-7040    studydiabetes@umn.edu Less <<
NCT00086359 HIV Infections Phase 3 Completed - United States, California ... More >> Usc La Nichd Crs Los Angeles, California, United States, 90033 UCSD Mother-Child-Adolescent Program CRS San Diego, California, United States, 92103 United States, Florida Univ. of Miami Ped. Perinatal HIV/AIDS CRS Miami, Florida, United States, 33136 United States, Illinois Mt. Sinai Hosp. Med. Ctr. - Chicago, Womens & Childrens HIV Program Chicago, Illinois, United States, 60608 United States, New York Bronx-Lebanon CRS Bronx, New York, United States, 10457 United States, Tennessee Regional Med. Ctr. at Memphis Memphis, Tennessee, United States, 38105-2794 United States, Texas Texas Children's Hosp. CRS Houston, Texas, United States, 77030 Puerto Rico San Juan City Hosp. PR NICHD CRS San Juan, Puerto Rico Less <<
NCT03156179 - Completed - United States, New York ... More >> Univeristy of Rochester Medical Center Rochester, New York, United States, 14642 Less <<
NCT03315091 Solid Tumours Phase 1 Completed - France ... More >> Research Site Bordeaux Cedex, France, 33075 Research Site Saint Herblain, France, 44805 Netherlands Research Site Amsterdam, Netherlands, 1066 CX Research Site Amsterdam, Netherlands, 1081 HV Research Site Maastricht, Netherlands, 6229 HX United Kingdom Research Site Glasgow, United Kingdom, G12 0YN Research Site Manchester, United Kingdom, M20 4BX Less <<
NCT03139019 Diabetes Prevention Not Applicable Completed - United States, New York ... More >> NYS Department of Health Albany, New York, United States, 12201 Less <<
NCT03159832 Renal Insufficiency,Type 2 Dia... More >>betes Less << Phase 1 Unknown December 2017 China, Sichuan ... More >> Chinese people's liberation army general hospital of Chengdu military area Recruiting Chengdu, Sichuan, China Contact: xiaolan yong Less <<
NCT03162926 Type 1 Diabetes Mellitus Phase 1 Completed - Canada, Alberta ... More >> University of Alberta Edmonton, Alberta, Canada Less <<
NCT03158415 Type1diabetes ... More >> Parents Less << Not Applicable Completed - United States, Florida ... More >> University of Florida Gainesville, Florida, United States, 32611 Less <<
NCT03170752 Cardiovascular Risk Factor ... More >> Smoking Diabetes Mellitus Dyslipidemias Hypertension Physical Activity Stress, Psychological Less << Not Applicable Recruiting September 2018 Canada, Newfoundland and Labra... More >>dor Memorial University of Newfoundland Recruiting St. John's, Newfoundland and Labrador, Canada, A1B3V6 Contact: Jill Bruneau, PhD (c)    7097777258    jill.bruneau@mun.ca    Contact: Donna Moralejo, PhD    7098643603    moralejo@mun.ca Less <<
NCT03170089 Health Attitude ... More >> Diabetes type1 Less << Not Applicable Not yet recruiting December 30, 2017 -
NCT03306849 - Recruiting December 2018 United States, New York ... More >> Clinical and Translational Science Center Recruiting New York, New York, United States, 10065 Contact: Adaobi Onunkwo, BA    646-962-8311    ado2007@med.cornell.edu    Principal Investigator: Steven Spandorfer, MD Less <<
NCT03179423 Diabetes Mellitus Type 1 Phase 2 Active, not recruiting March 1, 2019 Australia, New South Wales ... More >> Macquarie University Hospital Macquarie University, New South Wales, Australia AIM Centre Merewether, New South Wales, Australia Northern Sydney Local Health District - Royal North Shore Hospital St Leonards, New South Wales, Australia Australia, Queensland Ipswich Research Centre Ipswich, Queensland, Australia Mater Misericordiae Ltd and Mater Medical Research Institute Limited South Brisbane, Queensland, Australia Gold Coast Hospital and Health Service Southport, Queensland, Australia Australia, South Australia Southern Adelaide Local Health Network - Repatriation General Hospital Adelaide, South Australia, Australia Northern Adelaide Local Health Network Incorporated, operating as Lyell McEwin Hospital Elizabeth Vale, South Australia, Australia Australia, Victoria Eastern Health Box Hill, Victoria, Australia St Vincent's Hospital (Melbourne) Limited Fitzroy, Victoria, Australia Barwon Health - University of Geelong Geelong, Victoria, Australia Heidelberg Repatriation Hospital Heidelberg, Victoria, Australia Australia, Western Australia Keogh Institute of Medical Research Nedlands, Western Australia, Australia Less <<
NCT03182426 Diabetes Mellitus, Type 1 Phase 1 Phase 2 Recruiting December 31, 2022 Canada, Alberta ... More >> University of Alberta Recruiting Edmonton, Alberta, Canada, T6G 2C8 Contact: Andrew Malcolm, PhD    (780) 407-6952    andrew.malcolm@ualberta.ca    Contact: Parastoo Dinyari, BSc    (780) 407-3904    parastoo@islet.ca    Principal Investigator: James Shapiro, MD PhD Less <<
NCT03184662 Type2 Diabetes ... More >> Diabetic Kidney Disease Less << Not Applicable Recruiting June 2021 France ... More >> Bordeaux University Hospital Recruiting Bordeaux, France, 33000 Contact: Vincent Rigalleau          Clermont Ferrand University Hospital Recruiting Clermont Ferrand, France, 63000 Contact: Igor Tauveron          Nantes University Hospital Recruiting Nantes, France, 44000 Contact: Bertrand Cariou          Poitiers University Hospital Recruiting Poitiers, France, 86000 Contact: Samy Hadjadj Less <<
NCT03188757 Hyperglycemia ... More >> Type 1 Diabetes Mellitus Less << Not Applicable Completed - Slovenia ... More >> Medical Faculty - University of Ljubljana Ljubljana, Slovenia, 1000 Less <<
NCT03220425 Diabetes Mellitus, Type 1 Phase 3 Completed - -
NCT03174288 Type 1 Diabetes Not Applicable Recruiting December 2021 United States, Virginia ... More >> University of Virginia Recruiting Charlottesville, Virginia, United States, 22906 Contact: Eugene Barrett, MD, PhD    434-924-1175    ejb8x@virginia.edu    Contact: Zhenqi Liu, MD       zl3e@virginia.edu Less <<
NCT03185078 Frozen Shoulder ... More >> Diabetes Mellitus Less << Not Applicable Not yet recruiting December 30, 2019 -
NCT03236558 Type1 Diabetes Not Applicable Not yet recruiting February 2019 France ... More >> CHU de Toulouse Not yet recruiting Toulouse, Midi-Pyrénées, France, 31059 Contact: Claire Le Tallec, MD    5 34 55 85 79 ext 33    letallec.c@chu-toulouse.fr    Contact: Françoise Auriol    5 67 77 10 95 ext 33    auriol.f@chu-toulouse.fr    Principal Investigator: Claire Le Tallec, MD          Sub-Investigator: Carole Morin, MD          Sub-Investigator: Zeina Ajaltouni, MD Less <<
NCT03222180 Type 1 Diabetes Mellitus Not Applicable Recruiting June 30, 2019 United States, Florida ... More >> Nemours Children's Clinic Recruiting Jacksonville, Florida, United States, 32207 Contact: Alex Taylor, MACP    904-697-3507    ataylor@nemours.org    Contact: Amy Milkes, MS    904-697-3047    amilkes@nemours.org    Principal Investigator: Tim Wysocki, Ph.D. Less <<
NCT03164785 Type 2 Diabetes Mellitus ... More >> Diabetic Kidney Disease Less << Phase 2 Phase 3 Recruiting April 2019 China, Hunan ... More >> The Second Xiangya Hospital of Central South University Recruiting Changsha, Hunan, China, 410011 Contact: Zhou Zhiguang, PhD    +8613873104348    zhouzg@hotmail.com    Contact: Cao Chuqing, MD    +8615073136917    csuccq@163.com    Principal Investigator: Zhou Zhiguang, PhD          Sub-Investigator: Cao Chuqing, MD          Sub-Investigator: Yang Shuting, BA Less <<
NCT03202732 Type1 Diabetes Mellitus Not Applicable Recruiting February 1, 2020 Denmark ... More >> Aahurs University Hospital Recruiting Aarhus, Denmark, 8000 Contact: Annesofie L. Jenesen, Postdoc    +45 20 47 02 60    anejns@rm.dk    Contact: Troels K. Hansen, Professor    +45 7 46 22 39    troeha@rm.dk Less <<
NCT03243058 Diabetes Mellitus, Type 1 ... More >> Diabetes Diabetes, Autoimmune Less << Phase 1 Phase 2 Not yet recruiting December 2024 -
NCT03254524 - Active, not recruiting December 31, 2020 United States, New York ... More >> New York University School of Medicine New York, New York, United States, 10016 Less <<
NCT03260673 - Completed - -
NCT03198832 Type 2 Diabetes Mellitus With ... More >>Periodontal Disease Less << Not Applicable Completed - Brazil ... More >> São Jose dos Campos, São Paulo, Brazil, 12245 000 Less <<
NCT00389194 HIV Infections Phase 4 Completed - Netherlands ... More >> Academic Medical Centre Amsterdam, Netherlands Less <<
NCT03269084 - Recruiting December 31, 2017 Finland ... More >> University of Oulu and Oulu University Hospital Recruiting Oulu, Finland, 90029 Contact: Riitta Veijola, MD    +358 8 3155129    riitta.veijola@oulu.fi    Principal Investigator: Riitta Veijola, MD          University of Tampere and Tampere University Hospital Recruiting Tampere, Finland, 33520 Contact: Mikael Knip, MD       mikael.knip@helsinki.fi    Principal Investigator: Mikael Knip, MD          University of Turku and Turku University Hospital Recruiting Turku, Finland, 20520 Contact: Jorma Toppari, MD       jorma.toppari@utu.fi    Principal Investigator: Jorma Toppari, MD Less <<
NCT03264352 Diabetes Mellitus, Type 2 ... More >> Stroke Blood Pressure Prehypertension Cardiovascular Risk Factor Less << Phase 4 Not yet recruiting September 2022 China, Guangdong ... More >> Guangdong General Hospital Guangzhou, Guangdong, China, 501080 Less <<
NCT03242005 Diabetes Mellitus, Type 1 Not Applicable Withdrawn(Sponsor decision to ... More >>not proceed with study - no subjects enrolled) Less << February 2018 -
NCT03282136 Type 2 Diabetes Mellitus ... More >> Heart Failure Less << Phase 4 Completed - Italy ... More >> Raffaele Marfella Naples, Italy, 80128 Less <<
NCT03284996 - Not yet recruiting September 1, 2019 -
NCT03286816 Type 1 Diabetes Mellitus With ... More >>Hypoglycemia Less << Not Applicable Completed - Netherlands ... More >> Radboud umc Nijmegen, Netherlands Less <<
NCT03260998 - Not yet recruiting January 2019 -
NCT00770575 Cardiovascular Diseases Phase 2 Completed - -
NCT00841217 Obesity Lipid... More >> Disorders Cardiovascular Disease Less << Phase 4 Completed - Australia, Western Australia ... More >> University of Western Australia Perth, Western Australia, Australia, 6000 Less <<
NCT00695448 Solid Tumours Phase 1 Terminated(This study was term... More >>inated prematurely due to lack of sufficient exposure following single- and repeat-dosing.) Less << - United States, Tennessee ... More >> GSK Investigational Site Nashville, Tennessee, United States, 37203 United States, Texas GSK Investigational Site Houston, Texas, United States, 77030-4009 Less <<
NCT00932087 - Completed - France ... More >> Fédération d'Endocrinologie-Diabétologie-Maladies métaboliques-Nutrition - Hôpital Cardiovasculaire et Pneumologique Lyon Cedex 03, France, 69394 Less <<
NCT01439971 - Completed - -
NCT03265392 Glycemic Index ... More >> Gastric Emptying Appetite Less << Not Applicable Not yet recruiting May 2018 -
NCT03514199 Sleep Apnea Not Applicable Not yet recruiting December 31, 2019 -
NCT03285386 Type 1 Diabetes Mellitus Not Applicable Not yet recruiting December 1, 2018 -
NCT01736475 Hemophilia A Phase 2 Phase 3 Completed - -
NCT00001853 - Recruiting - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)    800-411-1222 ext TTY8664111010    prpl@cc.nih.gov Less <<
NCT01000194 Cardiovascular Disease ... More >> The Metabolic Syndrome Less << Not Applicable Completed - Netherlands ... More >> Wageningen University Wageningen, Gelderland, Netherlands, 6700 AH Less <<
NCT03358407 Inflammatory Bowel Diseases Phase 1 Recruiting September 16, 2019 United Kingdom ... More >> GSK Investigational Site Recruiting Cambridge, Cambridgeshire, United Kingdom, CB2 2GG Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com Less <<
NCT00001987 - Recruiting - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)    800-411-1222 ext TTY8664111010    prpl@cc.nih.gov Less <<
NCT00988650 Cardiovascular Disease Not Applicable Completed - Canada ... More >> Institute of Nutraceutical and Functional Foods (INAF), Laval University Quebec, Canada, G1V 0A6 Less <<
NCT01736475 - Completed - -
NCT02144337 - Completed - -
NCT02138331 Diabetes Mellitus Type 1 Phase 2 Phase 3 Unknown September 2014 Egypt ... More >> Sahel Teaching Hospital Sahel, Cairo, Egypt, 11522 Sahel Teaching Hospital - General Committee of Teaching Hospitals and Institutes Shubra, Cairo, Egypt, 11522 Sahel Teaching Hospital, General Commettee of Teaching Hospitals and Institutes. Shubra, Cairo, Egypt, 11522 Less <<
NCT02145611 Type 2 Diabetes Mellitus ... More >> Hypertension Endothelial Dysfunction Less << Phase 4 Completed - Brazil ... More >> Fundação Faculdade Regional de Medicina de São José do Rio Preto São José do Rio Preto, São Paulo, Brazil, 15090-000 Less <<
NCT02170870 Dyspepsia Dia... More >>betes Mellitus With Gastrointestinal Symptoms Less << Phase 1 Completed - United States, Minnesota ... More >> Mayo Clinic in Rochester Rochester, Minnesota, United States, 55905 Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT02147041 Diabetes Mellitus ... More >> Hyperlipidemia Less << Phase 2 Phase 3 Unknown August 2014 Taiwan ... More >> Taipei City Hospital Taipei, Taiwan Less <<
NCT02144337 Type 1 Diabetes Mellitus ... More >> Physical Activity Less << Not Applicable Completed - United Kingdom ... More >> Nottingham University Hospitals Nhs Trust Nottingham, United Kingdom Less <<
NCT00113308 Arthritis, Rheumatoid Phase 3 Completed - -
NCT02172716 Diabetes Mellitus, Type 2 ... More >> Type 2 Diabetes Mellitus Periodontal Diseases Periodontitis Chronic Periodontitis Less << Not Applicable Completed - Brazil ... More >> University of Sao Paulo Sao Paulo, SP, Brazil, 05508-900 Less <<
NCT01453452 Anxiety Disorder ... More >> Breast Cancer Cognitive/Functional Effects Colorectal Cancer Depression Fatigue Pain Psychosocial Effects of Cancer and Its Treatment Weight Changes Less << Phase 2 Completed - -
NCT02208115 Type 1 Diabetes Mellitus Not Applicable Completed - United Kingdom ... More >> Clinical Research Facility, Royal Victoria Infirmary Newcastle upon Tyne, Tyne and Wear, United Kingdom, NE1 4LP Less <<
NCT02206568 Type 1 Diabetes Mellitus Phase 1 Withdrawn - Germany ... More >> Profil Institut fur Stoffwechselforschung GmbH Neuss, Germany Less <<
NCT02175732 Type 1 Diabetes Mellitus Not Applicable Active, not recruiting December 2018 United States, California ... More >> UC San Francisco, Family and Community Medicine Dept. San Francisco, California, United States, 94143 Less <<
NCT02218619 Type 1 Diabetes Phase 2 Active, not recruiting October 1, 2019 United States, New York ... More >> Naomi Berrie Diabetes Center, Columbia University, 1150 St. Nicholas Ave. New York, New York, United States, 10032 Less <<
NCT02212522 - Unknown June 2018 France ... More >> Inserm U986 Recruiting Le Kremlin Bicêtre, France, 94276 Contact: Sophie Le Fur, PhD    + 33 1 49 59 53 43    sophie.le-fur@inserm.fr    Contact: Laurence Lecomte, PhD    +33 1 71 19 64 94    laurence.lecomte@nck.aphp.fr Less <<
NCT02199470 - Completed - Turkey ... More >> Medeniyet University Goztepe Training and Research Hospital Istanbul, Turkey, 34730 Less <<
NCT02220296 Healthy Diabe... More >>tes Diabetes Mellitus, Type 1 Less << Phase 1 Completed - Germany ... More >> Novo Nordisk Investigational Site Neuss, Germany, 41460 Less <<
NCT02220257 - Unknown December 2015 Poland ... More >> Franciszek Raszeja Hospital; Poznan University of Medical Science Poznań, Greater Poland, Poland, 60-834 Less <<
NCT02227862 Type 1 Diabetes Phase 3 Completed - -
NCT02212158 Diabetes Mellitus, Type 1 Not Applicable Unknown November 2015 Canada, Manitoba ... More >> Diabetes Resource for Children and Adolescence Not yet recruiting Winnipeg, Manitoba, Canada, R3E 0Z9 Principal Investigator: Heather MacKenzie, PhD Less <<
NCT02221323 Diabetes Mellitus Phase 2 Completed - Germany ... More >> Profil Institut für Stoffwechselforschung GmbH Neuss, NRW, Germany, 41460 Less <<
NCT02234947 - Active, not recruiting March 2019 United States, Florida ... More >> University of Florida Gainesville, Florida, United States, 32610 Less <<
NCT02239354 Type 1 Diabetes Mellitus Phase 1 Phase 2 Active, not recruiting January 2021 United States, California ... More >> University of California at San Diego San Diego, California, United States Canada, Alberta University of Alberta Hospital Edmonton, Alberta, Canada, T6G 2B7 Less <<
NCT02220751 Periodontitis ... More >> Type 2 Diabetes Mellitus Less << Phase 3 Completed - Brazil ... More >> Mario Taba Jr Ribeirao Preto, Sao Paulo, Brazil, 14040-904 Less <<
NCT02236754 Healthy Volunteers ... More >> Diabetes Mellitus, Type 1 Less << Early Phase 1 Withdrawn(Could not recruit pa... More >>rticipants) Less << March 1, 2017 United States, New York ... More >> Naomi Berrie Diabetes Center New York, New York, United States, 10032 Less <<
NCT02258945 - Completed - United Kingdom ... More >> Royal Liverpool and Broadgreen University Hospital Liverpool, Merseyside, United Kingdom, L7 8XP Less <<
NCT02272348 Type 1 Diabetes ... More >> Basal-bolus Multiple-dily Insulin Injections Insulin Pump (CSII) Less << Not Applicable Unknown October 2015 France ... More >> Lapeyronie Hospital - CHU de Montpellier Active, not recruiting Montpellier, France, 34295 Less <<
NCT02208921 - Completed - India ... More >> Research Site Ahmedabad, India Research Site Bangalore, India Research Site Chandigarh, India Research Site Chennai, India Research Site Coimbatore, India Research Site Delhi, India Research Site Ghaziabad, India Research Site Hyderabad, India Research Site Jaipur, India Research Site Kanpur, India Research Site Karnal, India Research Site Kolkata, India Research Site Ludhiana, India Research Site Mumbai, India Research Site Noida, India Research Site Pune, India Research Site Rohtak, India Research Site Trivandrum, India Less <<
NCT02274103 Type 1 Diabetes Phase 4 Completed - -
NCT02256293 Type 1 Diabetes Mellitus Phase 1 Phase 2 Withdrawn - -
NCT02258932 - Completed - United Kingdom ... More >> Royal Liverpool and Broadgreen University Hospital Liverpool, Merseyside, United Kingdom, L7 8XP Less <<
NCT02289066 - Completed - United States, Nevada ... More >> University of Nevada School of Medicine Las Vegas, Nevada, United States, 89102 Less <<
NCT02299388 Diabetes Mellitus, Non-Insulin... More >>-Dependent Hypertensive Disease Less << Phase 4 Completed - United States, Louisiana ... More >> Tulane University Health Science Center, Tidewater building and Tulane Hospital and Clinics New Orleans, Louisiana, United States, 70112 Less <<
NCT02284815 Diabetes Mellitus, Type 1 Early Phase 1 Unknown August 2015 -
NCT02335931 - Unknown July 2017 Denmark ... More >> Bispebjerg Hospital København NV, Denmark, 2400 Less <<
NCT02275091 - Recruiting October 2020 United States, District of Col... More >>umbia Georgetown-Howard Universities Center Recruiting Washington, District of Columbia, United States, 20007 Contact: Stephanie Gubb    202-444-1210       Principal Investigator: Evgenia Gourgari, MD Less <<
NCT01011413 HIV Infections Phase 3 Completed - Australia, New South Wales ... More >> St Vincent's Hospital Sydney, New South Wales, Australia, 2010 Less <<
NCT02348294 Pressure Ulcer ... More >> Diabetes Mellitus Type 2 Charcot- Osteoarthropathy Less << Not Applicable Unknown - -
NCT02344641 Type 2 Diabetes Mellitus ... More >> Heart Failure Less << Not Applicable Unknown December 2016 -
NCT02330549 Prediabetic State ... More >> Non-alcoholic Fatty Liver Disease Type 2 Diabetes Mellitus Less << Phase 2 Completed - United States, Texas ... More >> Brooke Army Medical Center Fort Sam Houston, Texas, United States, 78234 Gastroenterology Consultants of San Antonio Live Oak, Texas, United States, 78233 Puerto Rico Fundación de Investigación San Juan, Puerto Rico, 00927 Less <<
NCT02361606 Type 1 Diabetes Not Applicable Completed - -
NCT02365129 Obesity Diabe... More >>tes Mellitus Metabolic Syndrome X Less << Not Applicable Unknown July 2017 Spain ... More >> University of Granada Recruiting Granada, Spain, 18011 Contact: Jonatan R Ruiz, PhD    0034958242754    ruizj@ugr.es    Principal Investigator: Jonatan Ruiz, PhD Less <<
NCT02344602 Type 1 Diabetes Mellitus Phase 4 Completed - Canada, Ontario ... More >> Renal Physiology Laboratory, University Health Network Toronto, Ontario, Canada, M5G 2N2 Less <<
NCT02370537 Diabetes Mellitus, Type 2 ... More >> Exocrine Pancreatic Insufficiency Less << Phase 2 Completed - Denmark ... More >> Research Site Frederiksberg, Denmark Research Site København NV, Denmark Research Site Århus, Denmark Hungary Research Site Balatonfüred, Hungary Research Site Budapest, Hungary Research Site Létavértes, Hungary Latvia Research Site Daugavpils, Latvia Research Site Jekabpils, Latvia Research Site Riga, Latvia Poland Research Site Białystok, Poland Research Site Puławy, Poland Research Site Staszów, Poland Research Site Zamość, Poland Slovakia Research Site Bardejov, Slovakia Research Site Bratislava, Slovakia Research Site Lubochna, Slovakia Sweden Research Site Göteborg, Sweden Research Site Linköping, Sweden Research Site Lund, Sweden Research Site Malmo, Sweden Research Site Stockholm, Sweden Research Site Uppsala, Sweden Less <<
NCT02365233 - Terminated(IRB withheld the da... More >>ta due to inadequate supporting documentation) Less << - -
NCT02350374 Type 1 Diabetes Not Applicable Completed - France ... More >> Fondation Lenval Nice, France, 06200 Less <<
NCT02372630 Type 2 Diabetes Phase 4 Active, not recruiting May 2018 United States, New York ... More >> ECMC Ambulatory Center, 3rd Floor Buffalo, New York, United States, 14215 Less <<
NCT02377583 - Unknown February 2016 France ... More >> Service d'endocrinologie pédiatrique CHG Bayonne Centre Hospitalier de la Côte Basque Recruiting Bayonne, Aquitaine, France, 64000 Contact: Aurélie VALADE, Doctor    05 59 44 38 74    aurelieanne33@yahoo.fr    CHU de Bordeaux Hôpital Pellegrin Recruiting Bordeaux, Aquitaine, France, 33000 Contact: Pascal BARAT, Professor    05 56 79 87 25       Contact: Virginie SAINTIGNAN    05 57 82 02 04    virginie.saintignan@chu-bordeaux.fr    Service d'endocrinologie pédiatrique - Hôpital de la mère et de l'enfant - CHU de LIMOGES Recruiting Limoges, Limousin, France, 87000 Contact: Anne LIENHARDT, Professor    05 55 05 63 58    anne.lienhardt@chu-limoges.fr    Contact: Cécile ETOUBLEAU-JACOT, Doctor       cecile.etoubleau@chu-limoges.fr Less <<
NCT02365233 Type II Diabetes ... More >> Nonalcoholic Fatty Liver Less << Phase 4 Terminated(IRB withheld the da... More >>ta due to inadequate supporting documentation) Less << - United States, Texas ... More >> University of Texas Medical Branch -Galveston Galveston, Texas, United States, 77555 Less <<
NCT02402439 Diabetes Mellitus, Type 1 Phase 1 Recruiting January 2021 United States, California ... More >> University of California, San Francisco Recruiting San Francisco, California, United States, 94143-0780 Contact: Study Coordinator    415-353-8893    islettransplant@ucsf.edu Less <<
NCT02411253 Type 1 Diabetes Phase 2 Unknown December 2018 Belgium ... More >> Pediatric Department, Centre Hospitalier Régional de la Citadelle Not yet recruiting Liège, Province de Liège, Belgium, 4000 Contact: Ramona C NICOLESCU, Dr    0032 42 25 71 02    rcnicolescu@yahoo.com    France Centre d'Investigations Cliniques, CHU-HOPITAL HAUTEPIERRE Active, not recruiting Strasbourg, Alsace, France, 67098 Centre d'Investigations Cliniques, HÔPITAL CIVIL Active, not recruiting Strasbourg, Alsace, France, 67098 Service de pédiatrie 1CHU de HAUTEPIERRE Recruiting Strasbourg, Alsace, France, 67098 Contact: Marie MANSILLA       marie.mansilla@chru-strasbourg.fr    Structure d'Endocrinologie-Diabète-Nutrition et Addictologie HOPITAUX UNIVERSITAIRES NHC Recruiting Strasbourg, Alsace, France, BP421 - 67091 Contact: Laurence KESSLER, Pr       laurence.kessler@chru-strasbourg.fr    Endocrinologie et diabétologie pédiatrique, Hôpital des Enfants - CHU-Bordeaux Withdrawn Bordeaux, Aquitaine, France, 33076 Bordeaux Cedex Service d'endocrinologie, diabétologie, maladies métaboliques, et nutrition, CHU de Bordeaux, Hôpital Haut Levêque Recruiting Pessac, Aquitaine, France, 33604 Contact: Vincent RIGALLEAU, Pr.    06 63 24 45 51    vincent.rigalleau@chu-bordeaux.fr    Service d' Endocrinologie HOPITAL CAVALE BLANCHE Recruiting Brest, Brittany, France, 29609 Contact: Emmanuel SONNET, Pr    02 98 34 71 19    emmanuel.sonnet@chu-brest.fr    Service de Pédiatrie, HOPITAL MORVAN Recruiting Brest, Brittany, France, 29609 Contact: Chantal METZ, MD    00 33 2 29 02 00 04    chantal.metz@chu-brest.fr    Service de Pédiatrie CHRU DE NANTES Recruiting Nantes, Brittany, France, 44093 Contact: Sabine BARON, Pr       sabine.baron@chu-nantes.fr    Contact: celine ROBIN, CRC    02 40 08 78 04    celine.robin@chu-nantes.fr    Service d' Endocrinologie Diabétologie CHRU DE RENNES Not yet recruiting Rennes, Brittany, France, 35033 Contact: Marc De Kerdanet, Pr    00 33 2 99 26 71 36    marc.de.kerdanet@chu-rennes.fr    Médecine pédiatrique, CHU Jean Minjoz Recruiting Besançon, Franche-Compté, France, 59037 Contact: Anne-Marie Bertrand, Dr.    03 81 21 81 34    bertrand.anne-marie@wanadoo.fr    Service Diabétologie -Endocrinologie, CHU Jean Minjoz Recruiting Besançon, Franche-Comté, France, 59037 Contact: Sophie Borot, Dr.    06 89 16 22 46    sophie.borot@gmail.com    Service MME, ENDOCRINOLOGIE, GHU CAREMEAU Recruiting Nimes Cedex 9, Gard, France, 30029 Contact: Valeria COSMA, Pr       valeria.COSMA@chu-nimes.fr    CIC Paris-Est (Adultes), Hôpitaux Universitaires Pitié-Salpêtrière, Charles Foix Active, not recruiting Paris, Ile de france, France, 75013 CIC pédiatrique Hôpital Necker Enfants Malades Active, not recruiting Paris, Ile De france, France, 75015 Endocrinologie gynécologie diabétologie pédiatriques, Hôpital Universitaire Necker Enfants Malades. Recruiting Paris, Ile De France, France, 75015 Contact: Michel Polak, Pr    +33 (0)1 44 49 48 02    michel.polak@nck.aphp.fr    CIC Pédiatrique, Hôpital d'enfants Robert Debré Active, not recruiting Paris, Ile de France, France, 75019 Institut E3M, Hôpital Pitié-Salpêtrière Recruiting Paris, Ile-de France, France, 75013 Contact: Agnés Hartemann, Pr.    01 42 17 81 18 ext 80 70    agnes.hartemann@psl.aphp.fr    Service d'Endocrinologie Pédiatrique, Hôpital d'enfants Robert Debré Recruiting Paris, Ile-de France, France, 75019 Contact: Jean-Claude CAREL, Pr    01 40 03 53 03    jean-claude.carel@inserm.fr    Service de Diabétologie Endocrinologie Hôpital LARIBOISIERE Not yet recruiting Paris, Ile-de-France, France, 75010 Contact: Jean-François Gautier, Pr       jean-francois.gautier@aphp.fr    Service Pédiatrie - Pôle femmes enfants, CHU de Nîmes, Hôpital Universitaire Carémeau Recruiting Nïmes, Languedoc-Roussillon, France, 30029 Cédex 9 Contact: Tu Anh TRAN, Pr.    04 66 68 32 84 ext 32 85    tu.anh.tran@chu-nimes.fr    Service Pédiatrie - Gastro-entérologie, Hépatologie, Nutrition, Diabétologie, Hôpital des Enfants Pôle Enfants Not yet recruiting Toulouse, Midi Pyrénnées, France, 31059 Toulouse cedex 9 Contact: Claire LE TALLEC, Dr    05 34 55 85 64    letallec.c@chu-toulouse.fr    CHRU de Lille, Hôpital Claude Huriez Service d'endocrinologie Recruiting Lille, Nord-Pas-de-Calais, France, 59037 Contact: Pierre FONTAINE    03 20 44 45 13    pierre.fontaine@chru-lille.fr    Service d'endocrinologie-diabétologie gynécologie pédiatriques, CHRU de Lille, Hôpital Jeanne de Flandre, Recruiting Lille, Nord-Pas-de-Calais, France, 59037 Contact: Jacques WEILL, Pr.    03 20 44 46 95    Jacques.WEILL@CHRU-LILLE.FR    Service d' Endocrinologie, maladies métaboliques HOPITAL NORD Not yet recruiting Marseille, Paca, France, 13015 Contact: Anne DUTOUR, Pr       AnneEveSophie.MEYER@ap-hm.fr    Service de Nutrition - Maladies Métaboliques - Endocrinologie HOPITAL DE LA CONCEPTION Not yet recruiting Marseille, Paca, France, 13385 Contact: René VALERO, Pr       rene.valero@ap-hm.fr    Contact: Catherine ZEVACO, Pr       Catherine.ZEVACO@ap-hm.fr    Hopital G&R Laënnec , Endocrinologie, Maladies Métaboliques et Nutrition Recruiting Saint Herblain, Pays de la Loire, France, 44093 NANTES Cedex 1 Contact: Lucy Chaillous, Pr       lucy.chaillous@chu-nantes.fr    Unité d'Endocrinologie et Diabétologie Pédiatriques, CHU de Marseille, Hôpital La Timone Enfants Recruiting Marseille, Provence-Alpes-Côte-d'Azur, France, 13385 Marseille Cedex 5 Contact: Rachel Reynaud, Pr.    04 91 38 80 40 ext 67 30    Rachel.REYNAUD@ap-hm.fr    Endocrinologie-Diabétologie-Maladies de la nutrition, Centre Hospitalier Lyon-Sud Recruiting Lyon, Rhones-Alpes, France, 69495 Contact: Charles THIVOLET, Pr.    04 78 86 14 87    charles.thivolet@chu-lyon.fr    Service d'Endocrinologie pédiatrique - HFME Not yet recruiting Lyon-bron, France, 69677 Contact: Delphine Bernoux, Pr    00 33 4 72 35 79 99    delphine.bernoux@chu-lyon.fr    Germany Division of Endocrinology and Diabetology, Department of Internal Medicine II, University Hospital of Freiburg Not yet recruiting Freiburg, Baden-Württemberg, Germany, 79106 Contact: Jochen SEUFERT, Pr    Tel. +49 761 270 34200    jochen.seufert@uniklinik-freiburg.de    Division of Endocrinology, Diabetology and Metabolic Diseases, University Hospital of Freiburg, Department for children and adolescents Not yet recruiting Freiburg, Baden-Württemberg, Germany, 79106 Contact: Karl O SCHWAB, Pr    +49 761 270 44140    karl.otfried.schwab@uniklinik-freiburg.de    Institute of Diabetes Research, Helmholtz Zentrum München Recruiting München, Bayern, Germany, D 80804 Contact: Annette G ZIEGLER, Pr    00 49 089 3187 2896    anette-g.ziegler@helmholtz-muenchen.de    Institute of Diabetes Research, Helmholtz Zentrum München Not yet recruiting München, Bayern, Germany, D 80804 Contact: Katharina Warncke, Pr    00 49 089 3187 2896    Katharina.Warncke@lrz.tu-muenchen.de    Netherlands Center for Pediatric and Adolescent Diabetes Care and Research Not yet recruiting Rotterdam, Randstad Holland, Netherlands, 3011 TG Rotterdam Contact: Henk-Jan AANSTOOT, Dr.    +31-10-280-7277 ext 9872    h.j.aanstoot@diabeter.nl    Sweden Dept. of Clinical Sciences Lund University, Skåne University Hospital. Not yet recruiting Malmö, Öresund Region, Sweden, 205 02 Malmö Contact: Corrado M. CILIO, Pr.    +46-70 43 30338 ext +46-40-391127    corrado.cilio@med.lu.se    Switzerland Endocrinology and Diabetes department, University Hospital of Basel Not yet recruiting Basel, Bâle-Ville, Switzerland, 4031 Basel Contact: Marc Donath, Pr.       mdonath@uhbs.ch Less <<
NCT02422043 Type 1 Diabetes Not Applicable Unknown January 2018 France ... More >> Hôpital de la Timone Assistance Publique Hôpitaux de Marseille Recruiting Marseille, France, 13354 Contact: Rachel REYNAUD    04 91 38 80 40    rachel.reynaud@ap-hm.fr Less <<
NCT02420054 Diabetes Mellitus ... More >> Non-alcoholic Fatty Liver Disease Metabolic Syndrome Obesity Less << Not Applicable Active, not recruiting April 2018 Denmark ... More >> Xlab, Department of Biomedical Sciences, University of Copenhagen Copenhagen N, Denmark, 2200 Less <<
NCT02370537 - Completed - -
NCT02389335 - Completed - Turkey ... More >> Medeniyet University Goztepe Training and Research Hospital Istanbul, Turkey, 34730 Less <<
NCT02441504 Diabetes Mellitus, Type 1 Not Applicable Completed - -
NCT02429297 Hypertension ... More >>Diabetes Less << Not Applicable Completed - Bolivia ... More >> El Servicio Departmental de Salud (SEDES) affiliated clinics La Paz, Bolivia Less <<
NCT02384889 Type 1 Diabetes Phase 1 Recruiting December 2020 United States, Indiana ... More >> Riley Hospital for Children Recruiting Indianapolis, Indiana, United States, 46202 Contact: Stephanie Woerner, FNP    317-944-2573    sestein@iu.edu    United States, New York Women and Children's Hospital of Buffalo Recruiting Buffalo, New York, United States, 14222 Contact: Michelle Ecker, RD, CDN, CDE    716-878-7609    mecker@upa.chob.edu    Principal Investigator: Lucy Mastrandrea, MD, PhD          United States, Wisconsin Children's Hospital of Wisconsin Recruiting Wauwatosa, Wisconsin, United States, 53226 Contact: Joanna Kramer, CCRC    414-955-8486    jkramer@mcw.edu    Principal Investigator: Susanne Crabrera, MD Less <<
NCT02459899 Type 1 Diabetes Mellitus Phase 2 Completed - United States, California ... More >> Lexicon Investigational Site Concord, California, United States, 94520 Lexicon Investigational Site Ventura, California, United States, 93003 United States, Colorado Lexicon Investigational Site Denver, Colorado, United States, 80209 United States, Florida Lexicon Investigational Site Jacksonville, Florida, United States, 32225 Lexicon Investigational Site Miami, Florida, United States, 33175 United States, Louisiana Lexicon Investigational Site Metairie, Louisiana, United States, 70006 United States, Maine Lexicon Investigational Site Auburn, Maine, United States, 04210 United States, Maryland Lexicon Investigational Site Rockville, Maryland, United States, 20852 United States, Montana Lexicon Investigational Site Great Falls, Montana, United States, 59405 United States, Nebraska Lexicon Investigational Site Omaha, Nebraska, United States, 68114 United States, North Carolina Lexicon Investigational Site High Point, North Carolina, United States, 27265 United States, Ohio Lexicon Investigational Site Columbus, Ohio, United States, 43213 United States, Texas Lexicon Investigational Site San Antonio, Texas, United States, 78229 United States, Utah Lexicon Investigational Site Salt Lake City, Utah, United States, 84107 United States, Virginia Lexicon Investigational Site Manassas, Virginia, United States, 20110 Less <<
NCT01116167 Polycystic Ovary Syndrome Not Applicable Unknown December 2013 China, Anhui ... More >> Affiliated Hospital of Anhui University of Chinese Medicine Active, not recruiting Hefei, Anhui, China China, Guangdong Affiliated Hospital of Guangzhou Medical University Active, not recruiting Guangzhou, Guangdong, China Guangzhou Medical School First Affiliated Hospital Recruiting Guangzhou, Guangdong, China Principal Investigator: Hongxia Ma, MD          China, Heilongjiang Daqing LongNa Hospital Active, not recruiting Daqing, Heilongjiang, China, 163000 Daqing Longnan hospital Active, not recruiting Daqing, Heilongjiang, China Obstetrics and Gynecology,Heilongjiang University of Chinese Medicine Recruiting Harbin, Heilongjiang, China, 150040 Contact: Xiaoke Wu, MD.PhD.    86-451-8213 0094    xiaokewu2002@vip.sina.com    Contact: Lihui Hou, MD.    86-451-8213 0094    houlihui2007@sina.com    Principal Investigator: Lihui Hou, MD.          Principal Investigator: Xiaoke Wu, MD.PhD.          First Affliated Hospital of Harbin Medical University Active, not recruiting Harbin, Heilongjiang, China Mudanjiang maternal and children hospital Active, not recruiting Mudanjiang, Heilongjiang, China China, Henan 2nd Affiliated Hospital of Henan University of Chinese Medicine Active, not recruiting Zhengzhou, Henan, China China, Hunan First Affiliated Hospital of Hunan University of Chinese Active, not recruiting Changsha, Hunan, China China, Jiangsu SuqianMaternal and Child Health Hospital Active, not recruiting Suqian, Jiangsu, China China, Jiangxi First Hospital, Jiangxi college of Chinese Medicine Active, not recruiting Nanchang, Jiangxi, China China, Liaoning Dalian Maternal and Child Health Hospital Active, not recruiting Dalian, Liaoning, China China, Shanxi Shanxi Hospital of Chinese Medicine Active, not recruiting Taiyuan, Shanxi, China China, Tianjin First Affiliated Hospital of Tianjin University of Chinese Medicine Active, not recruiting Tianjin, Tianjin, China Second Affiliated Hospital, Tianjin University of Chinese Medicine Active, not recruiting Tianjin, Tianjin, China China, Zhejiang Zhejiang province hospital of integrated traditional and western medicine Active, not recruiting Hangzhou, Zhejiang, China China Second Affiliated Hospital of Heilongjiang University of Chinese Medicine Active, not recruiting Harbin, China Less <<
NCT02425410 - Unknown June 2018 France ... More >> Inserm U986 Recruiting Le Kremlin Bicêtre, France, 94276 Contact: Sophie Le Fur, PhD    + 33 1 49 59 53 43    sophie.le-fur@inserm.fr    Contact: Laurence Lecomte, PhD    +33 1 71 19 64 94    laurence.lecomte@nck.aphp.fr Less <<
NCT02463097 - Completed - -
NCT02463097 Type 1 Diabetes Not Applicable Completed - United States, California ... More >> AMCR Institute Escondido, California, United States, 92026 Stanford University Medical Center Palo Alto, California, United States, 94035 United States, Colorado Barbara Davis Center for Childhood Diabetes (Adult) Aurora, Colorado, United States, 80045 Barbara Davis Center for Childhood Diabetes (Pediatric) Aurora, Colorado, United States, 80045 United States, Connecticut Yale University School of Medicine New Haven, Connecticut, United States, 06520 United States, Georgia Atlanta Diabetes Associates Atlanta, Georgia, United States, 30318 United States, Minnesota Park Nicollet Clinic-International Diabetes Center - Adult and Pediatric Minneapolis, Minnesota, United States, 55416 United States, Virginia University of Virginia Charlottesville, Virginia, United States, 22903 United States, Washington Rainer Clinical Research Center Renton, Washington, United States, 98057 Israel Institute of Endocrinology, Sheba Medical Center Tel Aviv, Israel, 52621 Less <<
NCT02456428 - Completed - Canada, Quebec ... More >> Lady Davis Institute for Medical Research, Jewish General Hospital Montreal, Quebec, Canada, H3T1E2 Less <<
NCT02481479 Diabetes Mellitus, Non-Insulin... More >>-Dependent Heart Failure Less << Phase 4 Unknown December 2017 Canada, Ontario ... More >> St Michael's Hospital Recruiting Toronto, Ontario, Canada, M5B1W8 Less <<
NCT02498119 - Unknown September 2016 Malaysia ... More >> University Malaya Medical Center (UMMC) Recruiting Petaling Jaya, Kuala Lumpur, Malaysia, 50603 Contact: Gracie Ong Siok Yan    019-3105617    gracieong@gmail.com    Contact: Komathi Perumal    010-2114913    komathi_thesis@yahoo.com Less <<
NCT02462785 Type 1 Diabetes Mellitus Not Applicable Completed - Canada, Ontario ... More >> The Hospital for Sick Children (SickKids) Toronto, Ontario, Canada, M5G 1X8 Less <<
NCT02525263 Chronic Kidney Disease ... More >> Type 2 Diabetes Less << Phase 2 Completed - United States, North Carolina ... More >> University of North Carolina- Chapel Hill Chapel Hill, North Carolina, United States, 27599 Less <<
NCT00296621 Muscular Dystrophy, Duchenne Phase 2 Completed - France ... More >> Centre d'Investigation Clinique, Hôpital Cardiologique, CHR&U de Lille Lille, France, 59037 Service d'Hépato Gastro Entérologie, Hôpital Jeanne de Flandre, CHR&U de Lille Lille, France, 59037 Service de Neuropédiatrie, Hôpital Roger Salengro, CHR&U de Lille Lille, France, 59037 Centre d'Investigation Clinique (CIC9202), Hôpital Robert Debré, Assistance Publique-Hôpitaux de Paris Paris, France, 75935 Pédiatrie Multidisciplinaire et Nutrition de l'Enfant, Centre Hospitalier Universitaire de Poitiers Poitiers, France, 86000 Less <<
NCT02476760 - Completed - Canada, Quebec ... More >> Lady Davis Institute for Medical Research, Jewish General Hospital Montreal, Quebec, Canada, H3T1E2 Less <<
NCT02538120 Diabetes Mellitus Type 1 Not Applicable Completed - France ... More >> University Hospital Angers, France, 49000 Less <<
NCT02540993 Diabetic Kidney Disease Phase 3 Active, not recruiting May 25, 2020 -
NCT02517866 Essential Hypertension ... More >> Type 2 Diabetes Mellitus Less << Phase 4 Completed - China, Hong Kong ... More >> Hong Kong, Hong Kong, China Taiwan Changhua county, Taiwan Kaohsiung City, Taiwan Kaohsiung, Taiwan Taichung, Taiwan Tainan City, Taiwan Taipei, Taiwan Taoyuan County, Taiwan Thailand Bangkok, Thailand Chiang Mai, Thailand Khon Kaen, Thailand Pathumtani, Thailand Less <<
NCT02574195 - Completed - Russian Federation ... More >> Endocrinology Scientific Center Moscow, Russian Federation Less <<
NCT02549495 - Active, not recruiting August 2018 United States, Massachusetts ... More >> Brigham and Women's Hospital Boston, Massachusetts, United States, 02130 Less <<
NCT02533219 - - - United States, Texas ... More >> Texas Children's Hospital Houston, Texas, United States, 77030 Contact: Victor Seghers, PhD, MD    832-822-0429    vjsegher@texaschildrens.org Less <<
NCT02603510 Type 1 Diabetes Mellitus Phase 1 Completed - United States, Arkansas ... More >> Investigational Site Number 840002 Little Rock, Arkansas, United States, 72205 United States, Colorado Investigational Site Number 840001 Denver, Colorado, United States, 80262 Less <<
NCT02589873 Diabetes Mellitus, Type 2 ... More >> Overweight Obesity Less << Not Applicable Completed - United States, California ... More >> City and County of San Francisco San Francisco, California, United States, 94103 Less <<
NCT02545049 Diabetic Kidney Disease Phase 3 Active, not recruiting July 21, 2021 -
NCT02619487 Diabetes Mellitus, Type 1 Not Applicable Withdrawn(Due to limited staff... More >> resources, we were unable to start enrolling participants.) Less << December 13, 2019 United States, Kentucky ... More >> University of Louisville Louisville, Kentucky, United States, 40202 Less <<
NCT02624804 Diabetes Mellitus Type 1 Phase 1 Recruiting June 2020 United States, New Jersey ... More >> Hackensack University Medical Center - John Theurer Cancer Center Recruiting Hackensack, New Jersey, United States, 07601 Contact: Mariefel Vendivil    551-996-5828    Mariefel.Vendivil@HackensackMeridian.org    Contact: Andrea Ortega    551-996-3923    Andre.Ortega@HackensackMeridian.org    Principal Investigator: Michele Donato, MD          Sub-Investigator: Robert Korngold, PhD          Sub-Investigator: Steven Ghanny, MD          Sub-Investigator: Scott Rowley, MD          Sub-Investigator: Alan Skarbnik, MD          Sub-Investigator: Phyllis McKiernan, APN          Sub-Investigator: David Vesole, MD, PhD          Sub-Investigator: Melissa Baker, APN          Sub-Investigator: Mary DiLorenzo, APN          Sub-Investigator: Michele Simone, APN          Sub-Investigator: Michele Boonstra, APN Less <<
NCT02575001 - Unknown December 2015 Slovenia ... More >> University of Ljubljana, Faculty of Medicine Recruiting Ljubljana, Slovenia, 1000 Contact: Tadej Battelino, PhD    +386 1 522 92 35    tadej.battelino@mf.uni-lj.si    Sub-Investigator: Natasa Bratina, PhD, MD          Principal Investigator: Tadej Battelino, PhD, MD          Sub-Investigator: Maja Drobnic Radobuljac, PhD, MD          Sub-Investigator: Simona Klemencic, PhD          Sub-Investigator: Jasna Klara Lipovsek, MD          Sub-Investigator: Vedrana Đurasin          Sub-Investigator: Miha Rutar Less <<
NCT02632383 Diabetes Mellitus, Type 1 Not Applicable Completed - Denmark ... More >> Steno Diabetes Center Gentofte, Denmark, 2820 Pediatric and Adolescent Department, Herlev Hospital Herlev, Denmark, 2730 Department of Cardiology, Nephrology and Endocrinology, Nordsjællands Hospital, Hillerød Hillerød, Denmark, 3400 Pediatric and Adolescent Department, Nordsjællands Hospital, Hillerød Hillerød, Denmark, 3400 Department of Endocrinology, Køge Hospital Køge, Denmark, 4600 Pediatric Department, Roskilde Hospital Roskilde, Denmark, 4000 Less <<
NCT02610530 - Unknown October 2016 -
NCT02641522 Type 1 Diabetes Early Phase 1 Completed - United States, Washington ... More >> Benaroya Research Institute Seattle, Washington, United States, 98101 Less <<
NCT02627287 Diabetes Diab... More >>etes Mellitus, Type 1 Diabetes Mellitus, Type 2 Less << Phase 1 Completed - Germany ... More >> Novo Nordisk Investigational Site Mainz, Germany, 55116 Novo Nordisk Investigational Site Neuss, Germany, 41460 Less <<
NCT02641522 - Completed - -
NCT02632747 Diabetes Mellitus, Type 1 ... More >> Diabetes Mellitus, Type 2 Obesity Less << Phase 2 Recruiting September 9, 2019 Canada, Ontario ... More >> Toronto General Hospital Recruiting Toronto, Ontario, Canada, M5G 2N2 Less <<
NCT02653300 Non-Alcoholic Steatohepatitis ... More >>(NASH) Type2 Diabetes Mellitus Less << Phase 2 Recruiting April 2019 Israel ... More >> Hadassah Medical Center Recruiting Jerusalem, Israel Contact: Rifat Safadi, M. D.    972 (0) 2 6777337    safadi@hadassah.org.il    Contact: Rifat Safadi, M.D.    972 (0)2 6777337    safadi@hadassah.org.il Less <<
NCT02691247 Diabetes Mellitus Phase 2 Active, not recruiting March 2020 United States, California ... More >> Rady Children's Hospital San Diego, California, United States, 92123 University of California, San Francisco San Francisco, California, United States, 94143 United States, Colorado Barbara Davis Center for Diabetes Aurora, Colorado, United States, 80045 United States, Connecticut Yale University School of Medicine New Haven, Connecticut, United States, 06519 United States, Florida University of Florida Gainesville, Florida, United States, 32610 University of Miami, Diabetes Research Institute Miami, Florida, United States, 33136 United States, Indiana Indiana University Indianapolis, Indiana, United States, 46202 United States, Massachusetts Joslin Diabetes Center Boston, Massachusetts, United States, 02215 United States, Minnesota University of Minnesota Minneapolis, Minnesota, United States, 55455 United States, Missouri Children's Mercy Kansas City Kansas City, Missouri, United States, 64108 United States, North Dakota Sanford Research Fargo, North Dakota, United States, 58122 United States, Oregon Oregon Health Science University Portland, Oregon, United States, 97239 United States, South Dakota Sanford Research Sioux Falls, South Dakota, United States, 57104 United States, Tennessee Vanderbilt Eskind Diabetes Clinic Nashville, Tennessee, United States, 37232 United States, Texas Baylor College of Medicine / Texas Children's Hospital Houston, Texas, United States, 77030 Less <<
NCT02651480 Overweight Bl... More >>ood Pressure Diabetes Mellitus, Type 2 Less << Not Applicable Suspended(Sponsor put plans on... More >> hold) Less << May 2019 United States, District of Col... More >>umbia Physicians Committee for Responsible Medicine Washington, District of Columbia, United States, 20016 Less <<
NCT02605564 Type 1 Diabetes Mellitus Not Applicable Enrolling by invitation March 2020 -
NCT02692547 Type 1 Diabetes Not Applicable Withdrawn(Study Cancelled) - -
NCT02674893 Type 2 Diabetes ... More >> Overweight Less << Phase 4 Unknown November 2018 France ... More >> CHU de DIJON Recruiting Dijon, France, 21079 Contact: Marie-Claude BRINDISI    03.80.29.34.53 ext 33    marie-claude.brindisi@chu-dijon.fr Less <<
NCT02713841 Type 1 Diabetes Mellitus Phase 1 Phase 2 Completed - -
NCT02660827 Type 1 Diabetes Not Applicable Recruiting November 2018 United States, California ... More >> AMCR Institute Active, not recruiting Escondido, California, United States, 92025 Stanford Hospital and Clinics Recruiting Palo Alto, California, United States, 94305 Contact: Jasmine Doiev    650-736-6660    jdoiev@stanford.edu    Principal Investigator: Bruce Buckingham, MD          SoCal Diabetes Active, not recruiting Torrance, California, United States, 90505 United States, Colorado Barbara Davis Center Recruiting Aurora, Colorado, United States, 80045 Contact: Maninderpal Sethi    303-724-6773    maninderpal.sethi@ucdenver.edu    Principal Investigator: Greg Forlenza, MD          United States, Florida Nemours Children's Clinic Recruiting Jacksonville, Florida, United States, 32207 Contact: Joseph Permuy    904-697-3910    Joseph.Permuy@nemours.org    Principal Investigator: Larry Fox, MD          Sub-Investigator: Lydia Snyder, MD          University of South Florida - USF Health Recruiting Tampa, Florida, United States, 33620 Contact: Emily Eyth    813-974-2793    emilyeyth@health.usf.edu    Principal Investigator: Dorothy Shulman, MD          United States, Georgia Atlanta Diabetes Associates Active, not recruiting Atlanta, Georgia, United States, 30318 United States, Idaho Rocky Mountain Diabetes and Osteoporosis Center Active, not recruiting Idaho Falls, Idaho, United States, 83404 United States, Indiana Indiana University Recruiting Indianapolis, Indiana, United States, 46202 Contact: Stephanie Woerner    317-944-3889    sestein@iu.edu    Principal Investigator: Linda DiMeglio, MD          Sub-Investigator: Stephanie Woerner          Sub-Investigator: Juan Sanchez          Sub-Investigator: Tina Pottorff          United States, Michigan University of Michigan Recruiting Ann Arbor, Michigan, United States, 48109 Contact: Janet Dominowski    734-764-5175    jandomin@med.umich.edu    Principal Investigator: Michael Wood, MD          Israel Sheba Medical Center Active, not recruiting Tel Aviv, Israel Less <<
NCT03714685 Healthy Males Phase 1 Not yet recruiting April 2019 -
NCT02693964 - Completed - United States, Colorado ... More >> Barbara Davis Center for Diabetes Aurora, Colorado, United States, 80045 Less <<
NCT02735837 Diabetes Mellitus With Periodo... More >>ntal Disease Less << Phase 2 Phase 3 Completed - -
NCT01615185 Schizophrenia Phase 4 Terminated - Taiwan ... More >> Kai-Suan Psychiatric Hospital Kaohsiung, Taiwan, 802 Less <<
NCT01253655 Healthy Phase 1 Completed - United States, Connecticut ... More >> Pfizer Investigational Site New Haven, Connecticut, United States, 06511 Pfizer Investigational Site New Haven, Connecticut, United States, 06519 Pfizer Investigational Site New Haven, Connecticut, United States, 06520 Less <<
NCT02762695 Hypertension ... More >>Diabetes Mellitus, Type 2 Less << Not Applicable Active, not recruiting June 2018 Chile ... More >> CESFAM La Faena Peñalolén, RM, Chile Less <<
NCT02758275 Diabetes Mellitus, Type 2 ... More >> Hypertension Less << Not Applicable Completed - Colombia ... More >> Empresa Social del Estado Instituto de Salud de Bucaramanga (ESE ISABU) Bucaramanga, Santander, Colombia, 680001393 Nursing School, Universidad Industrial de Santander Bucaramanga, Santander, Colombia, 680002212 Less <<
NCT02769091 Nonalcoholic Steatohepatitis ... More >> Type 2 Diabetes Mellitus Less << Phase 2 Withdrawn(Business decision) February 28, 2018 -
NCT01005420 Insulin Sensitivity Not Applicable Completed - United States, Louisiana ... More >> Pennington Biomedical Research Center Baton Rouge, Louisiana, United States, 70808 Less <<
NCT00005262 - Completed - -
NCT02772263 Cardiovascular Diseases ... More >> Diabetes Mellitus Less << Not Applicable Completed - Canada, Ontario ... More >> McMaster University Hamilton, Ontario, Canada, L8S4K1 Less <<
NCT00005248 - Completed - -
NCT01046682 HIV Endotheli... More >>al Dysfunction Inflammation Insulin Resistance Less << Phase 2 Completed - United States, Ohio ... More >> University Hospitals Case Medical Center Cleveland, Ohio, United States, 44106 Less <<
NCT01019642 Diabetes Low-... More >>intensity Chronic Inflammation Insulin Resistance Less << Phase 3 Completed - Mexico ... More >> Instituto Mexicano del Seguro Social Cuernavaca, Morelos, Mexico, 62450 Less <<
NCT01046682 - Completed - -
NCT02741674 - Completed - -
NCT00159211 Type 2 Diabetes Not Applicable Terminated(inclusion was finis... More >>hed) Less << - France ... More >> Sce de Diabétologie, hôpital de la Pitié-salpêtrière, 83bld de l'hôpital Paris, France, 75013 Less <<
NCT00192803 NIDDM Phase 4 Unknown - Israel ... More >> Internal Ward "A", Rambam Medical Center Not yet recruiting Haifa, Israel Contact: Ayelet Raz, MD    972-4-8543072       Sub-Investigator: Ayelet Raz, MD Less <<
NCT00138684 Insulin Resistance ... More >> Iron Overload Less << Phase 2 Completed - France ... More >> CHU Nantes Nantes, France Unité d'Investigation Clinique - Hôpital Pontchaillou Rennes, France, 35033 Less <<
NCT00007098 - Completed - -
NCT00239187 Type 2 Diabetes Phase 1 Completed - United States, California ... More >> Profil Institute for Clinical Research Inc. Chula Vista, California, United States, 91911 United States, Florida Clinical Research of West Florida Clearwater, Florida, United States, 33765-2616 United States, Texas Diabetes and Glandular Disease Research Associates San Antonio, Texas, United States, 78229-4801 Less <<
NCT01054989 Healthy Adults With Normal BMI Phase 4 Unknown October 2012 -
NCT00251680 Type 2 Diabetes Phase 3 Completed - -
NCT03305419 Autoimmune Diseases Phase 1 Recruiting October 22, 2018 United Kingdom ... More >> GSK Investigational Site Recruiting Cambridge, United Kingdom, CB2 2GG Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com Less <<
NCT02972905 Pulmonary Disease, Chronic Obs... More >>tructive Less << Phase 1 Completed - Japan ... More >> GSK Investigational Site Fukuoka, Japan, 813-0017 Less <<
NCT00261352 Type 2 Diabetes Phase 3 Terminated(The development pro... More >>gram has been terminated) Less << - -
NCT01154478 Metabolic Syndrome Not Applicable Completed - Italy ... More >> Federico II University Napoli, Naples, Italy, 80131 Less <<
NCT00650143 Acute Myocardial Infarction Phase 2 Phase 3 Unknown December 2013 Germany ... More >> Clinic of the University of Munich-Grosshadern, Department of Cardiology Recruiting Munich, Germany, 81377 Sub-Investigator: Hans D Theiss, Dr. Less <<
NCT01119989 Metabolic Syndrome Not Applicable Completed - Switzerland ... More >> Centre Hospitalier Universitaire Vaudois Lausanne, VD, Switzerland, CH-1011 Less <<
NCT01691287 Type 1 Diabetes Not Applicable Completed - Israel ... More >> Schneider Medical Center Petah-TTikva, Israel, 49202 Less <<
NCT01684956 Type 1 Diabetes Phase 2 Unknown December 2017 United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT01625507 Type 2 Diabetes Phase 2 Completed - Canada, Alberta ... More >> Alberta Diabetes Institute Edmonton, Alberta, Canada, T6G 2R3 Less <<
NCT01625507 - Completed - -
NCT01707134 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 3 Completed - -
NCT03610893 Pain, Postoperative ... More >> Pain, Acute Upper Extremity Injury Less << Not Applicable Recruiting August 1, 2019 Chile ... More >> Hospital Clínico Universidad de Chile Recruiting Santiago, Metropolitana, Chile, 8380456 Contact: Julian Aliste, MD    56998189445    julian.aliste@uchile.cl    Contact: Daniela Bravo, MD    56984276252    dbravoadvis@uchile.cl Less <<
NCT01709929 Diabetes Diab... More >>etes Mellitus, Type 1 Diabetes Mellitus, Type 2 Less << Phase 3 Completed - Canada ... More >> Mississauga, Canada, L4W 4XI Less <<
NCT01859663 - Active, not recruiting December 2018 United States, New York ... More >> Human Metabolic Research Unit, Cornell University Ithaca, New York, United States, 14853 Strong Fertility Center Rochester, New York, United States, 14623 CRC at University of Rochester Medical Center Rochester, New York, United States, 14642 Less <<
NCT01722513 Kidney Diseases ... More >> Diabetes Mellitus Acute Kidney Injury Kidney Failure, Chronic Renal Insufficiency Less << Phase 4 Unknown February 2014 China, Shanghai ... More >> Department of Cardiology, Shanghai Tenth People's Hospital Shanghai, Shanghai, China, 200072 Less <<
NCT00255645 - Terminated(The development pro... More >>gram has been terminated) Less << - -
NCT01706133 Stroke Ischem... More >>ic Attack Diabetes Mellitus Hypertension Fragility Less << Not Applicable Completed - Mexico ... More >> XXI Century National Medical Mexico, Distrito Federal, Mexico, 06725 Less <<
NCT01726621 Type 1 Diabetes ... More >> Type 2 Diabetes Less << Not Applicable Completed - Australia ... More >> St Vincent Hospital and The University of Melbourne Fitzroy, Australia, 3065 The Royal Melbourne Hospital Patkville, Australia, 3050 Denmark Herlev Hospital Herlev, Denmark Spain Barcelona University Hospital Barcelona, Spain, 08036 United Kingdom University College Hospital London, United Kingdom, NW1 2PG King's College London London, United Kingdom, SE5 9NU Less <<
NCT01726621 - Completed - -
NCT01727661 - Completed - Taiwan ... More >> National Taiwan University Hospital Taipei, Taiwan, 100 Less <<
NCT01724190 Type 1 Diabetes Not Applicable Completed - United States, Ohio ... More >> Nationwide Children's Hospital Columbus, Ohio, United States, 43205 Less <<
NCT03178396 Prehypertension ... More >> Healthy Less << Not Applicable Completed - United States, Pennsylvania ... More >> Thomas Jefferson University Philadelphia, Pennsylvania, United States, 19107 Less <<
NCT01724814 Healthy Type ... More >>1 Diabetes Mellitus Type 2 Diabetes Mellitus Less << Phase 1 Completed - United States, California ... More >> Hanmi pharma Chula Vista, California, United States, 91911 Less <<
NCT01736228 Type 1 Diabetes Phase 2 Completed - Argentina ... More >> Hospital Interzonal General de Agudos Eva Perón San Martin, Buenos Aires, Argentina, 3200 Less <<
NCT01751399 - Completed - -
NCT01760707 Diabetes Mellitus ... More >> Peripheral Neuropathy Less << Not Applicable Completed - Taiwan ... More >> National Taiwan University Hospital Taipei, Taiwan, 100 Less <<
NCT01759953 Diabetes Mellitus, Type 1 ... More >> Diabetes Mellitus, Type 2 Knowledge, Attitudes, Practice Less << Not Applicable Completed - Brazil ... More >> Hospital Universitário de Londrina Londrina, PR, Brazil, 86038440 Less <<
NCT01771250 Diabetes Mellitus, Type 1 Phase 1 Completed - Denmark ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Aarhus, Denmark, 8000 Less <<
NCT01751399 Healthy Volunteers ... More >> Hepatic Insufficiency Diabetes Mellitus, Type 2 Less << Phase 1 Completed - Germany ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Munich, Germany, 81241 Hungary For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Balatonfured, Hungary, 8230 Less <<
NCT01775059 Diabetes Mellitus Type I ... More >> Diabetes Mellitus Type II Less << Not Applicable Unknown - Denmark ... More >> Fredericia Hospital Recruiting Fredericia, Denmark, 7000 Contact: Hans Gjessing, MD       hans.gjessing@slb.regionsyddanmark.dk    Principal Investigator: Hans Gjessing, MD          Hilleroed Hospital Recruiting Hilleroed, Denmark, 3400 Contact: Ulrik Pedersen-Bjergaard, MD       ulrik.pedersen-bjergaard@regionh.dk    Principal Investigator: Ulrik Pedersen-Bjergaard, MD          Hvidovre Hospital Recruiting Hvidovre, Denmark, 2650 Contact: Kirsten Norgaard, MD       kirsten.noergaard@regionh.dk    Principal Investigator: Kirsten Noergaard, MD Less <<
NCT01739829 Type 1 Diabetes Phase 1 Phase 2 Completed - Argentina ... More >> Hospital Interzonal General de Agudos Eva Perón Buenos Aires, Argentina Less <<
NCT01779115 - Enrolling by invitation - Israel ... More >> Maccabi Healthcare Services Tel Aviv, Israel, 68125 Less <<
NCT01762657 Type 1 Diabetes Phase 3 Withdrawn(Study stopped prior ... More >>to Patient Enrollment) Less << September 2015 -
NCT01927432 - Recruiting December 2018 United States, New York ... More >> Human Metabolic Research Unit, Cornell University Recruiting Ithaca, New York, United States, 14853 Contact: Erica Bender, MSN, CNM    607-255-9417    eb572@cornell.edu    Principal Investigator: Marla E. Lujan, PhD Less <<
NCT01781975 - Completed - -
NCT01791907 Diabetes Mellitus, Type 1 Not Applicable Completed - -
NCT01783327 Diabetes Mellitus, Type 1 Not Applicable Completed - United States, Connecticut ... More >> Yale University School of Nursing New Haven, Connecticut, United States, 06519 United States, Pennsylvania Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT01781975 Diabetes Mellitus, Type I ... More >> Diabetes Mellitus, Insulin-Dependent, 1 Type 1 Diabetes Mellitus Insulin-Dependent Diabetes Mellitus 1 IDDM Less << Phase 2 Completed - United States, California ... More >> University of California-San Francisco San Francisco, California, United States, 94143 United States, Colorado Barbara Davis Center Aurora, Colorado, United States, 80045 United States, Georgia Emory University Atlanta, Georgia, United States, 30322 United States, Indiana Indiana University Indianapolis, Indiana, United States, 46202 United States, Iowa University of Iowa Iowa City, Iowa, United States, 52242 United States, Massachusetts Joslin Diabetes Center Boston, Massachusetts, United States, 02215 United States, Pennsylvania Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 United States, Texas University of Texas Southwestern Dallas, Texas, United States, 75390 Australia, Victoria Walter and Eliza Hall Institute of Medical Research Melbourne, Victoria, Australia, 3050 Less <<
NCT01793974 - Completed - United States, Pennsylvania ... More >> The Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 United Kingdom The University of Leicester Leicester, United Kingdom Less <<
NCT01798225 Periodontal Disease ... More >> Type 2 Diabetes Mellitus Less << Phase 4 Completed - -
NCT01794052 Hypertension ... More >>Type 2 Diabetes Mellitus Less << Not Applicable Completed - India ... More >> CHCs and District Hospital of Solan District Solan, Himachal Pradesh, India, 173212 Less <<
NCT01798225 - Completed - -
NCT01807377 Diabetes Mellitus Type 2 Phase 1 Completed - United States, California ... More >> Pfizer Investigational Site Chula Vista, California, United States, 91911 Less <<
NCT01782547 Type 1 Diabetes Mellitus Not Applicable Completed - United States, Massachusetts ... More >> Boston Children's Hospital Boston, Massachusetts, United States, 02115 Less <<
NCT01811849 Type 1 Diabetes Phase 1 Completed - -
NCT01832311 Cataract Type... More >> 2 Diabetes Mellitus Less << Phase 4 Completed - Croatia ... More >> Department of Ophtalmology, General Hospital "Dr. J. Bencevic" Slavonski brod, Brodsko-posavska zupanija, Croatia, 35000 Department of Physiology and Immunology, University of Zagreb School of Medicine Zagreb, Grad Zagreb, Croatia, 10000 Less <<
NCT02090621 Hepatic Insufficiency Phase 2 Completed - Spain ... More >> Jose Antonio Pons, MD Murcia, El Palmar, Spain, 30120 Less <<
NCT01802541 Insulin Sensitivity ... More >> Type 2 Diabetes Cardiovascular Disease Less << Not Applicable Completed - -
NCT01844037 Hypertension ... More >>Heart Failure Diabetes Mellitus Sleep Apnea Less << Phase 2 Phase 3 Terminated - Italy ... More >> Hospital San Raffaele Milano, Italy Less <<
NCT01845857 Diabetes Mellitus, Type 2 ... More >> Chronic Disease Less << Not Applicable Completed - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT01846312 - Completed - United States, New Jersey ... More >> Novo Nordisk Clinical Trial Call Center Princeton, New Jersey, United States, 08540 Less <<
NCT01852136 - Completed - United States, New Jersey ... More >> Physicians Research Center Toms River, New Jersey, United States, 08755 United States, North Carolina Mountain Diabetes and Endocrine Center Asheville, North Carolina, United States, 28803 United States, Tennessee Holston Medical Group Kingsport, Tennessee, United States, 37660 United States, Virginia Corporation Lane Internal Medicine and Research Center Virginia Beach, Virginia, United States, 23462 Canada, Ontario LMC Endocrinology Center Toronto, Ontario, Canada, M4G3E8 Less <<
NCT01862120 Type 1 Diabetes Phase 2 Unknown March 2017 France ... More >> Service d'Endocrinologie Pédiatrique Le Kremlin Bicetre, France, 94275 Service de Pédiatrie - CHU de Nîmes Nimes, France, 30029 cedex 9 CIC pédiatrique - CHU de Necker Paris, France, 75015 Service d'endocrinologie pédiatrique - CHU de Necker Paris, France, 75015 CIC 9202 CHU Rober Débré Paris, France, 75019 Service d'endocrinologie Diabétologie pédiatrique CHU Robert Débré Paris, France, 75019 Less <<
NCT01872299 - Completed - Germany ... More >> Charité- University Medicine Berlin, Campus Virchow Klinikum Berlin, Germany, 13353 Hannover Medical School Hannover, Germany, 30625 Italy IRCCS San Raffaele Rom, Italy, 00163 Poland Wroclaw, Medical University Wroclaw, Poland, 50-367 Silesian Centre for Heart Diseases Zabrze, Poland, 41800 Russian Federation Lomonosov Moscow State University Moscow, Moskow, Russian Federation, 119192 Russian Cardiology Research and Production Complex Moscow, Russian Federation, 12552 Almazov Federal Center for Heart, Blood & Endocrinology St. Petersburg, Russian Federation, 197341 Institute of Cardiology, Siberian Branch, Russian Academy of Medical Sciences Tomsk, Russian Federation, 634012 Slovenia University Clinic of Respiratory and Allergic diseases Golnik Golnik, Slovenia, 4204 United Kingdom University of HULL Hull, United Kingdom, HU16 5JQ Less <<
NCT01874431 Diabetic Nephropathies Phase 2 Completed - -
NCT01878045 - Enrolling by invitation January 25, 2035 United States, Arizona ... More >> NIDDK, Phoenix Phoenix, Arizona, United States, 85014 Less <<
NCT01887431 Type 1 Diabetes Mellitus Not Applicable Completed - Israel ... More >> Maccabi Healthcare Services Ra'anana, Israel Less <<
NCT01889706 - Unknown February 2014 Poland ... More >> Department of Internal Medicine and Diabetology, Raszeja Hospital Recruiting Poznan, Great Poland, Poland, 60-834 Contact: Agnieszka Zawada, MD       aga.zawada@gmail.com Less <<
NCT01879917 Diabetes Mellitus, Type 1 Phase 2 Phase 3 Active, not recruiting December 2018 Denmark ... More >> Dep. of Endocrinology, Hvidovre University Hospital Hvidovre, Capital, Denmark, 2650 Less <<
NCT01899872 Type 1 Diabetes Mellitus Not Applicable Unknown December 2013 Brazil ... More >> Hospital de Clínicas de Porto Alegre Recruiting Porto Alegre, Rio Grande do Sul, Brazil, 90035903 Contact: Gustavo Waclawovsky, Masters    51-33596332    gwsaude@yahoo.com.br Less <<
NCT01892319 - Active, not recruiting December 31, 2019 -
NCT01900834 - Completed - United States, New Jersey ... More >> Novo Nordisk Investigational Site Princeton, New Jersey, United States, 08540 Less <<
NCT01925989 Type 1 Diabetes Mellitus Phase 1 Completed - United States, Florida ... More >> Translational Research Institute for Metabolism and Diabetes Orlando, Florida, United States, 32804 Less <<
NCT01789190 - Terminated(The study has concl... More >>uded normally) Less << - Spain ... More >> Endocrinology Service of the University Hospital Complex of A Coruña (Spain) A Coruna, Spain Less <<
NCT01935349 - Completed - Hong Kong ... More >> The University of Hong Kong Hong Kong Island, Hong Kong Less <<
NCT01708668 Labor Pain Pa... More >>in Neurologic Manifestations Signs and Symptoms Pathological Conditions, Signs and Symptoms Less << Not Applicable Unknown June 2017 China, Jiangsu ... More >> Nanjing Maternal and Child Health Care Hospital Affiliated to Nanjing Medical University Recruiting Nanjing, Jiangsu, China, 210004 Contact: Shanwu Feng, M.D.    +86 25 52226112    shanwufeng@163.com    Principal Investigator: Shanwu Feng, M.D. Less <<
NCT01950650 - Completed - United States, New Jersey ... More >> Novo Nordisk Investigational Site Princeton, New Jersey, United States, 08540 China, Beijing Novo Nordisk Investigational Site Beijing, Beijing, China, 100004 France Novo Nordisk Investigational Site Paris La défense cedex, France, 92932 Germany Novo Nordisk Investigational Site Mainz, Germany, 55127 India Novo Nordisk Investigational Site Bangalore, India, 560001 Japan Novo Nordisk Investigational Site Tokyo, Japan, 1000005 Russian Federation Novo Nordisk Investigational Site Moscow, Russian Federation, 119330 Spain Novo Nordisk Investigational Site Madrid, Spain, 28033 Turkey Novo Nordisk Investigational Site Istanbul, Turkey, 34335 United Kingdom Novo Nordisk Investigational Site Crawley, United Kingdom, RH11 9RT Less <<
NCT01938807 Type 1 Diabetes Phase 1 Unknown - -
NCT01955746 - Completed - Taiwan ... More >> Chang Gung Memorial Hospital Taoyuan, Taiwan, 333 Less <<
NCT00916747 Progeria Phase 2 Enrolling by invitation July 2020 United States, Massachusetts ... More >> Children's Hospital Boston Boston, Massachusetts, United States, 02115 Less <<
NCT01908894 Diabetes Mellitus Phase 1 Completed - -
NCT01966432 Diabetes Mellitus, Type 2 ... More >> Substance-related Disorders Less << Not Applicable Completed - United States, North Carolina ... More >> Durham County Department of Public Health Durham, North Carolina, United States, 27701 Less <<
NCT01964612 - Unknown - Taiwan ... More >> National Taiwan University Hopital Recruiting Taipei, Taiwan, 100 Contact: Bee-Horng Lue, MD    886-2-23123456    grace@ntu.edu.tw Less <<
NCT01840358 Type 1 Diabetes Not Applicable Unknown - Canada, Quebec ... More >> CHU Sainte-Justine Recruiting Montreal, Quebec, Canada, H3T 1C5 Contact: Patricia Olivier, MD    514-345-4931 ext 5486    patricia.olivier.hsj@ssss.gouv.qc.ca    Principal Investigator: Patricia Olivier, MD Less <<
NCT01968044 Type 2 DM Patients With Modera... More >>te or Severe Renal Impairment Less << Phase 3 Completed - Korea, Republic of ... More >> Seoul, Korea, Republic of Less <<
NCT01978886 - Completed - Denmark ... More >> Amager Hospital Amager, Copenhagen, Denmark, 2300 Sygehus Lillebaelt Kolding, Denmark, 6000 Vejle Sygehus Vejle, Denmark, 7100 Less <<
NCT01968668 Diabetic Nephropathies Phase 2 Completed - Japan ... More >> Nagoya, Aichi, Japan, 456-0058 Nagoya, Aichi, Japan, 466-0815 Saijo, Ehime, Japan, 793-0027 Kurume, Fukuoka, Japan, 830-8522 Kurume, Fukuoka, Japan, 830-8543 Obihiro, Hokkaido, Japan, 080-0848 Amagasaki, Hyogo, Japan, 660-0828 Koga, Ibaraki, Japan, 306-0232 Tsuchiura, Ibaraki, Japan, 300-0835 Tsukuba, Ibaraki, Japan, 305-0812 Kahoku-gun, Ishikawa, Japan, 920-0293 Sakaide, Kagawa, Japan, 762-0007 Izumisano, Osaka, Japan, 598-8577 Yao, Osaka, Japan, 581-0011 Katsushika, Tokyo, Japan, 125-0054 Osaka, Japan, 530-0001 Less <<
NCT01963156 Chronic Disease ... More >> Cardiovascular Disease Diabetes Mellitus Less << Not Applicable Terminated - United States, Rhode Island ... More >> CVS Caremark Woonsocket, Rhode Island, United States, 02895 Less <<
NCT01966432 - Completed - -
NCT01986231 Type 1 Diabetes Mellitus Not Applicable Completed - United States, Oregon ... More >> Oregon Health and Science University Portland, Oregon, United States, 97239 Less <<
NCT01991548 - Completed - -
NCT01991548 Type 1 Diabetes ... More >> Type 2 Diabetes Less << Not Applicable Completed - Australia ... More >> St Vincent Hospital and The University of Melbourne Fitzroy, Australia, 3050 The Royal Melbourne Hospital Patkville, Australia, 3050 United Kingdom University College Hospital London, United Kingdom, NW1 2PG King's College London London, United Kingdom, SE5 9NU Less <<
NCT01986231 - Completed - -
NCT01984372 - Active, not recruiting April 30, 2019 Japan ... More >> Novo Nordisk Investigational Site Tokyo, Japan, 1000005 Less <<
NCT01999361 Type 1 Diabetes Mellitus Not Applicable Recruiting December 2023 United States, Florida ... More >> Diabetes Research Institute Recruiting Miami, Florida, United States, 33136 Contact: Rodolfo Alejandro, MD    305-243-5321    islet@med.miami.edu    Principal Investigator: Rodolfo Alejandro, MD Less <<
NCT01996228 Type 1 Diabetes Phase 1 Phase 2 Unknown - China, Hunan ... More >> The Second Xiangya Hospital Recruiting Changsha, Hunan, China, 410011 Contact: Xia Li, MD, PhD       info.T1D@tianhecell.com Less <<
NCT02000687 - Recruiting July 2023 United States, Florida ... More >> Diabetes Research Institute Recruiting Miami, Florida, United States, 33136 Contact: Rodolfo Alejandro, MD    305-243-5321    islet@med.miami.edu    Principal Investigator: Rodolfo Alejandro, MD Less <<
NCT02002130 Type I Diabetes Phase 1 Active, not recruiting June 2020 United States, Alabama ... More >> Children's of Alabama Birmingham, Alabama, United States, 35233 Less <<
NCT01999374 - Recruiting December 2024 United States, Florida ... More >> Diabetes Research Institute Recruiting Miami, Florida, United States, 33136 Contact: Rodolfo Alejandro, MD    305-243-5321    islet@med.miami.edu    Principal Investigator: Rodolfo Alejandro, MD Less <<
NCT02009410 Exocrine Pancreatic Insufficie... More >>ncy in Subjects With Diabetes Mellitus Type 2 Less << Phase 4 Withdrawn August 2014 Germany ... More >> Site reference no. 113456 Bochum, Germany, 44789 Site reference no. 113477 Frankfurt, Germany, 60594 Site reference no. 113476 Pohlheim, Germany, 35415 Site reference no. 113475 Ulm, Germany, 89073 Spain Site reference no. 112519 Madrid, Spain, 28034 Site reference no. 112520 Málaga, Spain, 29071 Site reference no. 112495 Santiago de Compostela, Spain, 15706 Site reference no. 112518 Segovia, Spain, 40002 Site reference no. 112496 Sevilla, Spain, 41014 Site reference no. 112517 Ávila, Spain, 05004 Less <<
NCT02005848 New Onset Type-1 Diabetes Phase 2 Completed - Israel ... More >> Soroka Medical Center Beer Sheva, Israel Rambam Medical Center Haifa, Israel Schneider Children's Medical Center Pethach Tikva, Israel Assaf Harofe Medical Center Zerifin, Israel Less <<
NCT02002975 - Completed - -
NCT02019186 Type 1 Diabetes Mellitus Phase 4 Completed - United States, Ohio ... More >> Research Institute at Nationwide Children's Hospital Columbus, Ohio, United States, 43205 Less <<
NCT02024750 Diabetes Mellitus, Type 1 Not Applicable Completed - United States, Wisconsin ... More >> University of Wisconsin - Madison Madison, Wisconsin, United States, 53792 Children's Hospital of Wisconsin Milwaukee, Wisconsin, United States, 53201 Less <<
NCT02004964 - Completed - United States, Florida ... More >> Diabetes Research Institute Miami, Florida, United States, 33136 Less <<
NCT02035371 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 1 Completed - Germany ... More >> Novo Nordisk Investigational Site Hannover, Germany, 30173 Less <<
NCT02035891 Diabetic Nephropathy Not Applicable Active, not recruiting June 2023 China, Chongqing ... More >> The First Affiliated Hospital of Chongqing Medical University Chongqing, Chongqing, China, 400016 Less <<
NCT02014259 Diabetes Diab... More >>etes Mellitus, Type 2 Healthy Less << Phase 1 Completed - Czechia ... More >> Novo Nordisk Investigational Site Hradec Králové, Czechia, 50005 Novo Nordisk Investigational Site Praha 7, Czechia, 17000 Hungary Novo Nordisk Investigational Site Budapest, Hungary, 1076 Novo Nordisk Investigational Site Budapest, Hungary, 1115 Less <<
NCT02044848 - Terminated(This study was term... More >>inated prematurely by the Sponsor for business reasons only.) Less << - -
NCT02044848 Type 1 Diabetes Mellitus Phase 2 Terminated(This study was term... More >>inated prematurely by the Sponsor for business reasons only.) Less << - United States, New York ... More >> Novartis Investigative Site New York City, New York, United States, 10032 United States, Washington Novartis Investigative Site Seattle, Washington, United States, 98122 Less <<
NCT02034266 Type 1 Diabetes Phase 2 Completed - Canada, Ontario ... More >> University Health Network, Division of Neurology, Toronto General Hospital Toronto, Ontario, Canada, M5G 2C4 Less <<
NCT02057497 - Withdrawn(It has been decided ... More >>by the Sponsor not to conduct the trial.) Less << - -
NCT02057211 Type 1 Diabetes Mellitus Phase 2 Suspended(Updated regulations ... More >>of culture procedure) Less << May 2020 Sweden ... More >> Uppsala University Hospital Uppsala, Sweden, SE-75185 Less <<
NCT02040337 - Completed - United States, Texas ... More >> University of Texas Physicians at Trinity Austin, Texas, United States, 78701 Less <<
NCT02082132 - Recruiting June 2021 United Kingdom ... More >> Imperial College Clinical Research Facility Recruiting London, United Kingdom Contact: Shivani Misra, MBBS, MRCP    0207 594 2460    s.misra@imperial.ac.uk    Principal Investigator: Shivani Misra, MBBS, MRCP Less <<
NCT02081326 Diabetes Mellitus, Type One ... More >> Diabetes Mellitus, Type I Autoimmune Diabetes Less << Phase 2 Recruiting July 2023 United States, Massachusetts ... More >> Immunobiology Labs CNY 149 Recruiting Charlestown, Massachusetts, United States, 02129 Contact: Denise L Faustman, MD, PhD    617-726-4084    diabetestrial@partners.org    Principal Investigator: Denise L. Faustman, MD, PhD Less <<
NCT02046395 Type 2 Diabetes ... More >> Hypertension Less << Phase 4 Recruiting December 2019 United States, Louisiana ... More >> Tulane University Health Sciences Center Recruiting New Orleans, Louisiana, United States, 70112 Contact: Bonnie L Katalenich, MPH    504-988-0200    bkatalen@tulane.edu    Principal Investigator: Tina Thethi, MD, MPH Less <<
NCT02109029 Diabetes Mellitus, Type 1 Phase 1 Completed - Austria ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Graz, Austria, 8036 Less <<
NCT02117518 - Unknown May 2016 Israel ... More >> Ziv Medical Center Not yet recruiting Safed, Israel, 13100 Contact: Gideon Gross, PhD    +97246953554    gidi@migal.org.il Less <<
NCT02122835 Heart Failure ... More >> Type 2 Diabetes Less << Not Applicable Withdrawn(Lack of funding/pati... More >>ent availability) Less << - United States, North Carolina ... More >> Duke University Medical Center Durham, North Carolina, United States, 27710 Less <<
NCT02065791 Diabetes Mellitus, Type 2 ... More >> Diabetic Nephropathy Less << Phase 3 Active, not recruiting June 28, 2019 -
NCT02122731 Hypertension ... More >>Type 2 Diabetes Mellitus Microalbuminuria Less << Phase 4 Completed - Denmark ... More >> Sydvestjysk Hospital, Esbjerg Esbjerg, Denmark Sygehus Lillebaelt. Fredericia, Denmark Steno Diabetes Center Gentofte, Denmark Odense University Hospital, Department of Endocrinology Odense, Denmark Less <<
NCT01043380 Hypercholesterolemia ... More >> Coronary Artery Disease Less << Phase 4 Completed - Japan ... More >> Kumamoto University Kumamoto, Japan, 8608556 Less <<
NCT00281632 Peritoneal Cancer ... More >> Ovarian Cancer Neoplasms, Ovarian Fallopian Tube Cancer Less << Phase 2 Completed - United States, Georgia ... More >> GSK Investigational Site Atlanta, Georgia, United States, 30342 United States, Texas GSK Investigational Site Austin, Texas, United States, 78731 GSK Investigational Site Bedford, Texas, United States, 76022 GSK Investigational Site Dallas, Texas, United States, 75246 GSK Investigational Site Fort Worth, Texas, United States, 76104 Australia, New South Wales GSK Investigational Site Randwick, New South Wales, Australia, 2031 Australia, Queensland GSK Investigational Site Herston, Queensland, Australia, 4029 Australia GSK Investigational Site Melbourne, Australia, 3084 Singapore GSK Investigational Site Singapore, Singapore, 119074 GSK Investigational Site Singapore, Singapore, 229899 Less <<
NCT02103595 Diabetes Mellitus Type 2, Diab... More >>etes Mellitus Type 1 Less << Not Applicable Completed - Germany ... More >> Aschaffenburg, Germany, 63739 Berlin, Germany, 01627 Berlin, Germany, 13597 Rostock, Germany, 18057 Ulm, Germany, 89081 Less <<
NCT02131675 - Completed - United States, New York ... More >> Icahn School of Medicine at Mount Sinai New York, New York, United States, 11103 Less <<
NCT01808261 Cerebrovascular Accident Phase 2 Terminated(This study was term... More >>inated for futility.) Less << - -
NCT01808261 - Terminated(This study was term... More >>inated for futility.) Less << - -
NCT01190384 Metabolic Syndrome Not Applicable Completed - United States, California ... More >> Ragle Human Nutrition Research Center Davis, California, United States, 95616 Less <<
NCT01200043 Obesity Metab... More >>olic Syndrome Less << Not Applicable Completed - United States, California ... More >> UCSF San Francisco, California, United States, 94143 Less <<
NCT00308646 - Terminated - -
NCT00281632 - Completed - -
NCT01219478 - Completed - Taiwan ... More >> Taipei Medical University - WanFang Hospital Taipei, Taiwan Less <<
NCT00295334 Type 2 Diabetes Phase 2 Unknown - -
NCT01285388 Metabolic Syndrome ... More >> Obesity Less << Phase 1 Completed - -
NCT02704403 Nonalcoholic Steatohepatitis (... More >>NASH) With Fibrosis Less << Phase 3 Recruiting - -
NCT01293162 - Completed - Italy ... More >> Ambulatorio Ipertensione e Unità Coronarica Federico II University Napoli, Italy, 80131 Less <<
NCT01277913 Diabetes Mellitus Type 1 Phase 4 Completed - Poland ... More >> Department of Pediatrics Warsaw, Poland, 01-410 Less <<
NCT00116831 Atherosclerosis Phase 3 Completed - -
NCT01285934 Diabetes Mellitus, Type 1 Phase 1 Phase 2 Withdrawn(No participant enrol... More >>led) Less << - -
NCT01280682 Diabetes Mellitus, Type 1 Phase 4 Unknown December 2013 China, Jiangsu ... More >> First Affiliated Hospital, Nanjing Medical University Recruiting Nanjing, Jiangsu, China, 210029 Contact: Tao Yang, PhD    86-25-83718836 ext 6466    yangt@njmu.edu.cn    Principal Investigator: Tao Yang, PhD Less <<
NCT00024583 - Completed - -
NCT01296438 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 1 Completed - Germany ... More >> Neuss, Germany, 41460 Less <<
NCT01297738 Obesity Diabe... More >>tes Mellitus Type 2 Less << Not Applicable Completed - Netherlands ... More >> Academic Medical Center Amsterdam, Noord-Holland, Netherlands, 1105 AZ Less <<
NCT00116831 - Completed - -
NCT01291875 Type 2 Diabetes Mellitus ... More >> Periodontal Disease Less << Not Applicable Unknown February 2014 Brazil ... More >> School of Dentistry - University of São Paulo Recruiting São Paulo, Brazil, 05508-900 Contact: Giuseppe A Romito, PhD    +55 11 30917833    garomito@usp.br    Contact: Adriana Foz, MDS    +55 11 30917833    didafoz@uol.com.br    Principal Investigator: Giuseppe A Romito, PhD Less <<
NCT01304537 Type 1 Diabetes Mellitus Phase 1 Phase 2 Completed - Israel ... More >> Institute for Endocrinology and Diabetes, National Center for Childhood Diabetes at Schneider Children's Medical Center of Israel Petach Tikva 49202, Israel, 49202 Assaf Haroffeh Medical Center Zerifin, Israel, 70300 Less <<
NCT00078403 HIV Infections ... More >> Hepatitis C Liver Disease Less << Phase 2 Completed - -
NCT01283113 - Completed - United States, Massachusetts ... More >> Joslin Diabetes Center Boston, Massachusetts, United States, 02215 Less <<
NCT01302028 Type 2 Diabetes Mellitus Phase 1 Completed - Czechia ... More >> Brno, Czechia, 62500 Prague, Czechia, 16900 Hungary Balatonfured, Hungary, 8230 Poland Warsaw, Poland, 02-097 Slovakia Bratislava, Slovakia, 83305 Less <<
NCT01317459 Diabetes Not Applicable Active, not recruiting December 2021 Norway ... More >> Helse Vest HF, Haukeland University Hospital Bergen, Norway, 5021 Less <<
NCT00078403 - Completed - -
NCT01319331 Diabetes Type... More >> 1 Diabetes Less << Phase 1 Completed - United States, Colorado ... More >> Barbara Davis Center for Childhood Diabetes Aurora, Colorado, United States, 80045 Less <<
NCT01309022 - - - United States, Florida ... More >> University of Miami Miami, Florida, United States, 33136 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 United States, Missouri Washington University St. Louis, Missouri, United States, 63110 Less <<
NCT01322321 Diabetes Mellitus ... More >> Diabetes Type 1 Less << Phase 2 Withdrawn - United States, Wisconsin ... More >> Aurora St Luke's Medical Center, Endocrine & Diabetes Center Milwaukee, Wisconsin, United States Canada, Ontario LMC Endocrinology Centres (Barrie) Ltd Barrie, Ontario, Canada LMC Endocrinology Centres (Bayview) Ltd Toronto, Ontario, Canada Germany Novartis Investigative Site Dusseldorf, Germany Novartis Investigative Site Hannover, Germany Novartis Investigative Site Neuwied, Germany United Kingdom Novartis Investigative Site Bristol, United Kingdom Novartis Investigative Site Exeter, United Kingdom Novartis Investigative Site Hull, United Kingdom Novartis Investigative Site Liverpool, United Kingdom Less <<
NCT01322789 Diabetes Mellitus, Insulin-Dep... More >>endent Less << Phase 1 Phase 2 Unknown December 2015 Brazil ... More >> Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo Recruiting Ribeirão Preto, São Paulo, Brazil Contact: Julio C Voltarelli, MD, PhD    +551621019369    jcvoltar@fmrp.usp.br    Contact: Carlos E Couri, MD, PhD    +551691495151    ce.couri@yahoo.com.br    Principal Investigator: Julio Voltarelli, MD, PhD          Sub-Investigator: Carlos E Couri, MD, PhD Less <<
NCT01337947 - Completed - United States, Virginia ... More >> University of Virginia Charlottesville, Virginia, United States, 22903 Less <<
NCT01339390 - Completed - -
NCT01338922 Diabetes Mellitus, Insulin-Dep... More >>endent Less << Not Applicable Completed - Germany ... More >> Endokrinologikum Berlin Berlin, Germany, 10117 Kinderklinik Charite Berlin, Germany, 13353 Klinik für Kinder- und Jugendmedizin, Ruhr-Universität-Bochum Bochum, Germany, 44791 PRIMA Kinderkliniken Darmstadt Darmstadt, Germany, 64287 Marienhospital / Kinderklinik Gelsenkirchen, Germany, 45138 Universitätsklinik Gießen Gießen, Germany, 35392 Klinik am Eichert Göppingen, Germany, 73035 Kinderkrankenhaus Wilhelmstift Hamburg, Germany, 22149 Altonaer Kinderkrankenhaus Hamburg, Germany, 22763 Gemeinschaftskrankenhaus Herdecke, Germany, 58313 Praxis für Kinder- und Jugendmedizin Herford, Germany, 32052 Kinderklinik Städt. Klinikum Karlsruhe, Germany, 76133 UK-SH, Klinik für Allg. Pädiatrie Kiel, Germany, 24105 Kinderkrankenhaus Kliniken der Stadt Köln GmbH Köln, Germany, 50735 Universität Leipzig, Kinderklinik Leipzig, Germany, 04103 UK SH Campus Lübeck, Klinik für Kinder- und Jugendmedizin Lübeck, Germany, 23538 Ev.Krankenhaus Oberhausen, Germany, 46047 Kinderhospital Osnabrück Osnabrück, Germany, 49082 Klinik f. Kinder- und Jugendmedizin Ravensburg, Germany, 88212 Universitäts- Kinder- und Jugendklinik Rostock, Germany, 18057 Bethlehem Gesundheitszentrum Stolberg Stolberg, Germany, 52222 Olgahospital Stuttgart, Germany, 70176 Universitätsklinik Tübingen Tübingen, Germany, 72706 HSK-Kinderklinik Wiesbaden, Germany, 65199 Less <<
NCT01341899 Type 1 Diabetes Phase 2 Completed - China, Jiangsu ... More >> at Division of Endocrinology, the Affiliated Drum Tower Hospital of Nanjing University Nanjing, Jiangsu, China, 210008 Less <<
NCT01351857 Type 1 Diabetes Phase 4 Completed - Canada, Ontario ... More >> St. Joseph's Health Care London, Ontario, Canada, N6A 4V2 London Health Sciences Centre - Children's Hospital London, Ontario, Canada, N6A 5W9 Trillium Pediatric Diabetes Clinic Mississauga, Ontario, Canada, L5B 1B8 Children's Hospital of Eastern Ontario Ottawa, Ontario, Canada, K1H 8L1 Less <<
NCT01339390 Obesity Overw... More >>eight Hypertension Diabetes Mellitus Less << Not Applicable Completed - United States, Wisconsin ... More >> Clement J. Zablocki VA Medical Center, Milwaukee, WI Milwaukee, Wisconsin, United States, 53295-1000 Less <<
NCT01354288 Type 1 Diabetes ... More >> Diabetes Mellitus Less << Not Applicable Unknown July 2016 France ... More >> Bicêtre Hospital Le Kremlin Bicêtre, France, 94275 Less <<
NCT01353833 Type 1 Diabetes Phase 1 Phase 2 Completed - France ... More >> Hôpital Pitié-Salpêtrière Paris, France, 75013 Less <<
NCT01350219 Type 1 Diabetes Phase 2 Unknown September 2014 China, Hebei ... More >> The First Hospital of Hebei Medical University Recruiting Shijiazhuang, Hebei, China, 050031 Contact: Huimin Zhou, MD       zhouhuimindoctor@163.com    Principal Investigator: Huimin Zhou, MD          China, Hunan The Second Xiangya Hospital of Central South University Recruiting Changsha, Hunan, China, 410011 Contact: Xia Li, MD       T1DMCT@gmail.com    Principal Investigator: Zhiguang Zhou, MD, PhD          China, Shandong General Hospital of Jinan Military Command Recruiting Jinan, Shandong, China, 250031 Contact: Zhaoshun Jiang, MD    86 13953104251       Sub-Investigator: Zhaoshun Jiang, MD          Spain Hospital Universitario Central de Asturias Recruiting Oviedo, Asturias, Spain, 33006 Contact: Elias Delgado, MD    34 985108000    delgadoelias@uniovi.es    Contact: Jesus Otero, MD    34 985108778    jesus.otero@sespa.princast.es    Principal Investigator: Elias Delgado, MD          Sub-Investigator: Jesus Otero, MD Less <<
NCT01368978 Type 1 Diabetes Mellitus Phase 3 Completed - United States, Connecticut ... More >> Yale University New Haven, Connecticut, United States Less <<
NCT01368536 - Terminated(Based on results fr... More >>om an ALTITUDE study interim analysis, testing aliskiren concomitantly with an ACE inhibitor or ARB, in diabetics with renal impairment) Less << - -
NCT01368536 Hypertension ... More >>Stage 2 Hypertension Diabetes Less << Phase 4 Terminated(Based on results fr... More >>om an ALTITUDE study interim analysis, testing aliskiren concomitantly with an ACE inhibitor or ARB, in diabetics with renal impairment) Less << - -
NCT01382459 - Unknown - Israel ... More >> Soroka medical center Not yet recruiting Beer Sheva, Israel Contact: Eli Hershkovitz, PI    972-522629025    elih@bgu.ac.il Less <<
NCT02628301 Insulin Resistance ... More >> Type 2 Diabetes Obesity Less << Not Applicable Completed - Netherlands ... More >> VU University Medical Center Amsterdam, Noord-Holland, Netherlands, 1081 HV Less <<
NCT01390480 Type 1 Diabetes Phase 4 Completed - Austria ... More >> Medical University Graz Graz, Austria Less <<
NCT01369602 Type 2 Diabetes Mellitus ... More >> Healthy Less << Phase 1 Completed - United States, California ... More >> Pfizer Investigational Site Anaheim, California, United States, 92801 United States, Florida Pfizer Investigational Site DeLand, Florida, United States, 32720 Less <<
NCT01397513 Diabetes Mellitus, Type 1 Phase 4 Completed - Sweden ... More >> Karolinska Institutet, Department of Clinical Sciences, Danderyd Hospital Stockholm, Sweden, 18288 Less <<
NCT01392560 - Completed - -
NCT01386801 - Active, not recruiting June 2050 United States, Indiana ... More >> American Health Network Avon, Indiana, United States Investigator's Research Group Brownsburg, Indiana, United States American Health Network Franklin, Indiana, United States American Health Network Greenfield, Indiana, United States IU School of Medicine/CTSI Indianapolis (Downtown), Indiana, United States Alivio Medical Center Indianapolis (Spanish speaking), Indiana, United States IU Medical Group Indianapolis (Spanish/English speaking), Indiana, United States American Health Network Indianapolis, Indiana, United States Krannert Cardiology Indianapolis, Indiana, United States Oral Health Research Institute Indianapolis, Indiana, United States American Health Network Muncie, Indiana, United States Less <<
NCT01400971 - Completed - -
NCT01392560 Diabetes Mellitus, Type 1 Phase 2 Completed - Canada, Ontario ... More >> 1245.46.10001 Boehringer Ingelheim Investigational Site Toronto, Ontario, Canada Less <<
NCT01407276 Chronic Renal Insufficiency ... More >> Type 2 Diabetes Mellitus Less << Phase 1 Completed - -
NCT01407640 Diabetes Mellitus, Type 1 ... More >> Diabetes Mellitus, Type 2 Hypersensitivity Immediate Hypersensitivity Allergy Less << Not Applicable Completed - France ... More >> Cochin Hospital Paris, France, 75005 Less <<
NCT01398423 Hypertension ... More >>Diabetes Mellitus, Type 2 Less << Phase 2 Completed - United States, California ... More >> Garden Grove, California, United States, 92844 La Mesa, California, United States, 91942 Northridge, California, United States, 91324 Riverside, California, United States, 92505 Tustin, California, United States, 92780 United States, Florida Kissimmee, Florida, United States, 34741 Miami, Florida, United States, 33015 United States, Georgia Macon, Georgia, United States, 31217 Tucker, Georgia, United States, 30084 United States, Maryland Reisterstown, Maryland, United States, 21136 United States, Minnesota Brooklyn Center, Minnesota, United States, 55430 United States, North Carolina Cary, North Carolina, United States, 27511 Greenville, North Carolina, United States, 27834 New Bern, North Carolina, United States, 28562 Raleigh, North Carolina, United States, 27610 United States, South Carolina Aiken, South Carolina, United States, 29801 United States, Texas San Antonio, Texas, United States, 78215 San Antonio, Texas, United States, 78228 United States, Virginia Norfolk, Virginia, United States, 23507 Less <<
NCT01407276 - Completed - -
NCT01423266 Heart Failure ... More >> Diabetes Mellitus Less << Not Applicable Completed - United States, California ... More >> University of California Medical Center Orange, California, United States, 92868 Less <<
NCT01416766 Hypertension ... More >>Diabetes Mellitus Less << Not Applicable Completed - United States, Massachusetts ... More >> Reliant Medical Group Worcester, Massachusetts, United States, 01605 Less <<
NCT01342614 Diabetes Mellitus ... More >> Essential Hypertension Less << Not Applicable Completed - -
NCT01424046 Type 1 Diabetes Not Applicable Completed - Rwanda ... More >> Association Rwandese des Diabetiques Kigali, Kigali Provence, Rwanda Less <<
NCT01425580 Congestive Heart Failure ... More >> Type 2 Diabetes Mellitus Less << Phase 2 Completed - Sweden ... More >> Karolinska Institutet, Department of Clinical Science and Education, Södersjukhuset Stockholm, Sweden, 118 83 Karolinska Institutet, Division of Internal Medicine Södersjukhuset AB Stockholm, Sweden, 118 83 Less <<
NCT01415115 - Completed - United States, Maryland ... More >> Medstar Health Research Institute Hyattsville, Maryland, United States, 20783 Less <<
NCT01437072 - Completed - Portugal ... More >> Novo Nordisk Investigational Site Paco de Arcos, Portugal, 2780-730 Saudi Arabia Novo Nordisk Investigational Site Riyadh, Saudi Arabia, 3542 United Arab Emirates Novo Nordisk Investigational Site Dubai, United Arab Emirates Less <<
NCT01440517 Diabetes Mellitus ... More >> Heart Failure Less << Phase 2 Terminated(Lack of Subject Rec... More >>ruitment) Less << - United States, New Jersey ... More >> GE Healthcare Princeton, New Jersey, United States, 08540 Less <<
NCT01440517 - Terminated(Lack of Subject Rec... More >>ruitment) Less << - -
NCT01447147 Diabetic Nephropathy ... More >> Type 2 Diabetes Mellitus Less << Phase 2 Completed - -
NCT01435642 - Completed - Algeria ... More >> Novo Nordisk Investigational Site Blida, Algeria, 16009 Less <<
NCT01447940 Diabetes Mellitus, Type 1 Phase 3 Unknown December 2015 France ... More >> University Hospital of Caen (Hospital Côte de nacre) Caen, Basse-Normandie, France, 14033 University Hospital of Besancon - Hospital Jean Minjoz Besancon, Franche Comté, France, 25030 Hospital Sud Francilien Corbeil Essonne, Ile de France, France, 91100 Hospital University of Montpellier Montpellier, Languedoc-Roussillon, France, 34295 University Hospital of Reims Reims, Marne, France, 51110 University Hospital of Nantes Nantes, Pays-de-la-Loire, France, 44093 University Hospital, Department of Endocrinology Grenoble, Rhône-Alpes, France, 38043 University Hospital of Lyon (HCL Lyon sud) Lyon, Rhônes-Alpes, France, 69310 Less <<
NCT01464099 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 1 Completed - United States, California ... More >> Novo Nordisk Investigational Site Chula Vista, California, United States, 91911 Less <<
NCT01461499 - Completed - -
NCT01409408 Hypertension ... More >>Diabetes Mellitus Less << Phase 4 Withdrawn(Due to preliminary r... More >>esults of Altitude Trial.) Less << December 2013 Brazil ... More >> Hospital Universitario Pedro Ernesto Rio de Janeiro, Brazil, 20551030 Less <<
NCT01467141 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 4 Completed - Germany ... More >> Novo Nordisk Investigational Site Berlin, Germany, 13353 Novo Nordisk Investigational Site Dresden, Germany, 01307 Novo Nordisk Investigational Site Hagen, Germany, 58095 Novo Nordisk Investigational Site Hamburg, Germany, 22149 Novo Nordisk Investigational Site Hannover, Germany, 30173 Novo Nordisk Investigational Site Osnabrück, Germany, 49082 Less <<
NCT01469143 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 1 Completed - Germany ... More >> Neuss, Germany, 41460 Less <<
NCT01468454 Congenital Hyperinsulinism (CH... More >>I) Persistent Hyperinsulinemic Hypoglycemia of Infancy (PHHI) Less << Phase 2 Completed - United States, Pennsylvania ... More >> The Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT01483560 Diabetes Mellitus, Type 1 Phase 3 Completed - Australia ... More >> Royal Melbourne Hospital Melbourne, Australia St Vincent's Hospital Melbourne, Australia Royal Prince Albert Hospital Sydney, Australia Canada St Joseph's Health Care Ontario, Canada Ottawa Hospital Riverside Campus Ottawa, Canada Denmark Steno Diabetes Centre Gentofte, Denmark Netherlands Maastricht University Medical Centre Maastricht, Netherlands United Kingdom Aberdeen Royal Infirmary Aberdeen, United Kingdom Ayr Hospital Ayr, United Kingdom, KA6 6DX University Hospitals Bristol Bristol, United Kingdom, BS2 8HW Diabetes Support Unit, Ninewells Hospital and Medical School Dundee, United Kingdom University Hospital North Durham Durham, United Kingdom Edinburgh Royal Infirmary Edinburgh, United Kingdom Edinburgh Western Infirmary Edinburgh, United Kingdom Peninsula NIHR Clinical Research Facility, Royal Devon and Exeter NHS Foundation Trust Exeter, United Kingdom Stobhill Hospital, Diabetes Clinic Glasgow, United Kingdom Gloucestershire Royal Hospital Gloucester, United Kingdom, GL1 3NN Michael White Diabetes Centre, Hull Royal Infirmary Hull, United Kingdom Clinical Sciences Centre, University Hospital Liverpool, United Kingdom Clinical Investigation Unit, International Centre for Circulatory Health, Imperial College Healthcare NHS Trust London, United Kingdom Wellcome Trust Clinical Research Facility, Manchester Royal Infirmary Manchester, United Kingdom Newcastle NIHR Clinical Research Facility, Royal Victoria Hospital Newcastle, United Kingdom Diabetes Clinical Research Centre, Plymouth Plymouth, United Kingdom Salford Royal NHS Foundation Trust Salford, United Kingdom Less <<
NCT01487369 - Completed - Japan ... More >> Tokyo, Japan, 1000005 Less <<
NCT01454024 - Completed - Pakistan ... More >> Karachi, Pakistan Less <<
NCT01490619 Type 1 Diabetes Not Applicable Active, not recruiting September 2017 United States, Illinois ... More >> Ann and Robert H Lurie Children's Hospital of Chicago Chicago, Illinois, United States, 60611 Less <<
NCT01487408 - Completed - Japan ... More >> Tokyo, Japan, 1000005 Less <<
NCT01478399 Diabetes Mellitus, Type 2 Phase 1 Completed - United States, Minnesota ... More >> Prism Research Saint Paul, Minnesota, United States, 55114 United States, Tennessee New Orleans Center for Clinical Research Knoxville, Tennessee, United States, 37920 Less <<
NCT01492205 - Completed - Indonesia ... More >> Novo Nordisk Investigational Site Jakarta, Indonesia, 12520 Less <<
NCT01492218 - Completed - Philippines ... More >> Novo Nordisk Investigational Site Manilla, Philippines, 1605 Less <<
NCT01487382 - Completed - Japan ... More >> Tokyo, Japan, 1000005 Less <<
NCT01500590 Diabetes Hype... More >>rtensive Disease Less << Phase 4 Active, not recruiting August 2019 China ... More >> Hospital Authority, HKEC, FM&PHC Hong Kong, China Less <<
NCT01497574 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 1 Completed - Germany ... More >> Novo Nordisk Investigational Site Hannover, Germany, 30173 Less <<
NCT01461499 Type 2 Diabetes Mellitus ... More >> Hypertension Less << Phase 4 Completed - Japan ... More >> Shiga University of Medical Science Otsu, Shiga, Japan, 520-2192 Less <<
NCT01515384 Type 1 Diabetes ... More >> Type 2 Diabetes Less << Phase 1 Suspended April 2013 United States, New York ... More >> Research Site New York, New York, United States, 10027 Less <<
NCT01516242 - Completed - Slovakia ... More >> Novo Nordisk Investigational Site Bratislava, Slovakia, 811 05 Less <<
NCT01492959 - Completed - Korea, Republic of ... More >> Novo Nordisk Investigational Site Seoul, Korea, Republic of, 137-920 Less <<
NCT01520428 Diabetes Mellitus, Type 1 Not Applicable Unknown January 2014 Austria ... More >> Medical University of Vienna Vienna, Austria, 1090 Less <<
NCT01521520 - Active, not recruiting - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT01507116 - Completed - -
NCT01536431 Type 1 Diabetes Phase 1 Phase 2 Completed - United Kingdom ... More >> Countess of Chester Chester, England, United Kingdom, CH2 1UL Bristol Royal Infirmary Bristol, United Kingdom University Hospital of Wales Cardiff, United Kingdom Guy's Hospital London, United Kingdom Royal Victoria Hospital Newcastle, United Kingdom Less <<
NCT01524809 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 1 Completed - Denmark ... More >> Novo Nordisk Investigational Site Århus C, Denmark, 8000 Less <<
NCT01517269 Type 1 Diabetes Phase 3 Completed - United States, Massachusetts ... More >> University of Massachusetts, Worcester Worcester, Massachusetts, United States, 01655 Less <<
NCT01554566 Type 1 Diabetes Mellitus Phase 2 Completed - Egypt ... More >> National Institute of Diabetes and Endocrinology Cairo, Kasr El Ainy, Egypt Less <<
NCT01561508 Diabetes Mellitus Phase 2 Withdrawn(Unable to obtain IND... More >> currently) Less << - United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35233 Less <<
NCT01500798 Chronic Kidney Disease ... More >> Type 2 Diabetes Less << Phase 1 Terminated(IDMC recommendation... More >> for safety concerns) Less << - -
NCT01574365 Chronic Kidney Disease ... More >> Type 2 Diabetes Less << Phase 2 Terminated - Japan ... More >> Toride City, Ibaraki, Japan Less <<
NCT01572610 Chronic Kidney Disease ... More >> Type 2 Diabetes Less << Phase 2 Terminated - Japan ... More >> Koga city, Ibaraki, Japan Less <<
NCT01538589 - Completed - Japan ... More >> Tokyo, Japan, 1000005 Less <<
NCT01581476 Type 1 Diabetes Phase 3 Completed - Australia ... More >> University of Western Australia Perth, Australia Canada, Ontario Hospital for Sick Children Toronto, Ontario, Canada Less <<
NCT01580462 - Unknown October 2012 Poland ... More >> Outpatient Diabetes Clinic of the Institute of Mother and Child Recruiting Warsaw, Mazowieckie, Poland, 01-211 Principal Investigator: Katarzyna A Gajewska, MSc Less <<
NCT01538576 - Completed - Japan ... More >> Tokyo, Japan, 1000005 Less <<
NCT01600924 - Recruiting September 2021 Italy ... More >> University of Rome La Sapienza, Department of Clinical and Molecular Medicine, Sant'Andrea Hospital, Diabetes Unit Recruiting Rome, RM, Italy, 00189 Contact: Laura Salvi, MD    +39 0633775249    adamas83@hotmail.it    Sub-Investigator: Laura Salvi, MD Less <<
NCT01586897 Diabetes Mellitus, Type 2 ... More >> Hypertension Hyperlipidemia Less << Not Applicable Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT01603121 Type 1 Diabetes Mellitus Phase 1 Phase 2 Terminated(Unable to enroll su... More >>fficient number of subjects) Less << - United States, Virginia ... More >> Eastern Virginia Medical School Strelitz Diabetes Center Norfolk, Virginia, United States, 23510 Less <<
NCT01599338 Type 2 Diabetes Mellitus ... More >> Overweight Less << Not Applicable Completed - France ... More >> CHU Dijon Dijon, Bourgogne, France, 21000 Less <<
NCT01603121 - Terminated(Unable to enroll su... More >>fficient number of subjects) Less << - -
NCT01586897 - Completed - -
NCT01614782 Type 2 Diabetes Mellitus Phase 1 Terminated - -
NCT01603940 Hypertension ... More >>Diabetes Mellitus Less << Phase 4 Completed - Brazil ... More >> Hospital Universitario Pedro Ernesto Rio de Janeiro, RJ, Brazil, 20551030 Less <<
NCT01606085 Diabetes Mellitus ... More >> Heart Failure Less << Not Applicable Completed - United States, Georgia ... More >> Emory University School of Nursing Atlanta, Georgia, United States, 30322 Less <<
NCT01638299 Type 1 Diabetes Mellitus Phase 1 Completed - United States, California ... More >> Samsum Diabetes Reserach Inst. Santa Barbara, California, United States, 93105 United States, Virginia UVA Diabetes Technology Center Charlottesville, Virginia, United States, 22903 Less <<
NCT01605149 - Completed - United States, Nebraska ... More >> Creighton University Omaha, Nebraska, United States, 68131 Less <<
NCT01603940 - Completed - -
NCT01648296 Heart Failure ... More >> Obesity Type 2 Diabetes Mellitus Health Normal Volunteer Subjects Less << Early Phase 1 Active, not recruiting June 4, 2018 United States, Missouri ... More >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Less <<
NCT01630850 Diabetes Mellitus, Type 1 Not Applicable Recruiting June 2030 United States, Illinois ... More >> University of Chicago Medical Center Recruiting Chicago, Illinois, United States, 60637 Contact: Lindsay Schenck, RN, BSN    773-702-2504    Lschenck@surgery.bsd.uchicago.edu    Principal Investigator: Piotr Witkowski, MD, PhD Less <<
NCT01626586 Type 1 Diabetes Mellitus Not Applicable Recruiting August 2020 United States, Ohio ... More >> Cincinnati Children's Hospital Medical Center Recruiting Cincinnati, Ohio, United States, 45229 Contact: Jessica Kichler, PhD    414-636-4336    jessica.kichler@cchmc.org    Principal Investigator: Jessica Kichler, PhD          Sub-Investigator: Lawrence Dolan, MD          Sub-Investigator: Astrida Kaugars, PhD Less <<
NCT01667614 Type 2 Diabetes Mellitus ... More >> Diabetic Nephropathy Essential Hypertension Less << Phase 2 Completed - Iran, Islamic Republic of ... More >> Tehran University of Medical Sciences, Vali-asr hospital, Endocrinology and Metabolism Research Center Tehran, Iran, Islamic Republic of, 13145-784 Less <<
NCT01665716 - Completed - Netherlands ... More >> University Medical Center Utrecht Utrecht, Netherlands, 3508 GA Less <<
NCT01669473 Diabetes Mellitus Type I ... More >> Diabetes Mellitus Type II Less << Not Applicable Completed - United States, Illinois ... More >> Northwestern University Chicago, Illinois, United States, 60611 University of Illinois at Chicago Chicago, Illinois, United States, 60654 Less <<
NCT01678183 Diabetes Mellitus ... More >> Hypertension Hyperlipidemia Less << Not Applicable Completed - United States, Massachusetts ... More >> Boston Medical Center Boston, Massachusetts, United States, 02118 Less <<
NCT01680328 Diabetes Diab... More >>etes Mellitus, Type 1 Diabetes Mellitus, Type 2 Delivery Systems Less << Phase 1 Completed - Germany ... More >> Novo Nordisk Investigational Site Neuss, Germany, 41460 Less <<
NCT01661192 Type 1 Diabetes ... More >> Beta Cell Preservation Less << Phase 2 Completed - Israel ... More >> Schneider Children's Medical Center Petah-Tikva, Israel, 49202 Assaf Haroffeh Medical Center Zerifin, Israel Less <<
NCT00032474 Type 2 Diabetes Mellitus Phase 1 Phase 2 Completed - United States, Texas ... More >> University of Texas Health Sciences Center San Antonio, Texas, United States, 78229 Less <<
NCT03686423 - Not yet recruiting December 2022 United States, New York ... More >> New York University School of Medicine Not yet recruiting New York, New York, United States, 10016 Contact: Danielle Costanzo    212-263-0380    danielle.costanzo@nyumc.org    Principal Investigator: Ryan Brown, PhD Less <<
NCT01360268 - Unknown December 2013 Taiwan ... More >> Ming-Ling Chang Recruiting Taiwan, Taiwan, 33305 Less <<
NCT01680328 - Completed - -
NCT02541201 Dyslipidemia Phase 2 Completed - -
NCT01351012 Metabolic Syndrome Not Applicable Completed - Canada, Manitoba ... More >> Richardson Centre for Functional Foods and Nutraceuticals Winnipeg, Manitoba, Canada, R3T 2N2 Less <<
NCT01430338 - Completed - Korea, Republic of ... More >> korea University Guro Hospital Seoul, Korea, Republic of Less <<
NCT00455988 - Unknown December 2007 Korea, Republic of ... More >> Eulji University Hospital Recruiting Seoul, Korea, Republic of, 139-711 Contact: Song Yi Back    82-2-970-8459    glorialin@hanmail.net    Contact: Ji Sun Min    82-2-970-8459       Principal Investigator: Kyung Wan Min, MD., PhD          Sub-Investigator: Kyung Ah Han, MD., PhD          Sub-Investigator: Hyo Jeong Kim, MD., PhD Less <<
NCT01452035 Obesity Not Applicable Completed - United States, Michigan ... More >> Michigan Clincal Research Unit Ann Arbor, Michigan, United States, 48109 Less <<
NCT00471549 Type 2 Diabetes Phase 4 Completed - -
NCT00451113 Type 2 Diabetes Phase 2 Completed - Canada, British Columbia ... More >> University of British Columbia Gerontology & Diabetes Research Centre Vancouver, British Columbia, Canada Less <<
NCT00498030 - Completed - United States, South Dakota ... More >> Rosebud Indian Reservation Rosebud, South Dakota, United States, 57570 Less <<
NCT01552694 Inflammation ... More >>Macrophage Infiltration Cardiovascular Disease Less << Phase 3 Completed - United States, Missouri ... More >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Less <<
NCT01444677 Metabolic Syndrome ... More >> Obesity Less << Phase 1 Completed - Korea, Republic of ... More >> Clinical Research Institute of Seoul National University Hospital Seoul, Daehang-ro, Jongno-Gu, Korea, Republic of, 110-774 Less <<
NCT01472640 Hyperglycemia ... More >> Chronic Heart Failure Less << Not Applicable Completed - Denmark ... More >> Skejby University Hospital Aarhus, Denmark, 8200 Steno Diabetes Center Gentofte, Denmark, 2820 Herlev University Hospital Herlev, Denmark, 2730 Odense University Hospital Odense, Denmark, 5000 Less <<
NCT01552694 - Completed - -
NCT00575588 Type 2 Diabetes Phase 3 Completed - -
NCT01597076 Oxidative Stress ... More >> Quality of Life Metabolic Syndrome Less << Phase 1 Completed - Indonesia ... More >> Department of Nutrition, Faculty of Medicine, University of Indonesia Jakarta, Indonesia, 10430 Less <<
NCT01616563 Metabolic Syndrome Not Applicable Completed - Canada, Alberta ... More >> Edmonton Oliver Primary Care Network Edmonton, Alberta, Canada Canada, Ontario Canadian Phase Onward Inc. Toronto, Ontario, Canada, M3H 5S4 Athletic Edge Sports Medicine Toronto, Ontario, Canada, M5H 3T9 Canada Clinique de kinésiologie de l'Université Laval Quebec, Canada, G1K 7P4 Less <<
NCT03087266 Periodontitis ... More >> Diabetes Less << Not Applicable Recruiting June 2019 Italy ... More >> University Hospital of Pisa Recruiting Pisa, Italy, 56126 Contact: Filippo Graziani, DDS, MClinDent, PhD       filippo.graziani@med.unipi.it Less <<
NCT00068094 Fatty Liver H... More >>epatic Steatosis Diabetes Mellitus Liver Diseases Less << Phase 1 Phase 2 Terminated - United States, Maryland ... More >> Johns Hopkins University Baltimore, Maryland, United States, 21205 Less <<
NCT00639613 - Completed - Denmark ... More >> Department of Internal Medicine F' laboratory Hellerup, Copenhagen County, Denmark, 2900 Less <<
NCT00575588 - Completed - -
NCT00905073 Type 1 Diabetes Mellitus Not Applicable Completed - United States, District of Col... More >>umbia Georgetown University Washington DC, District of Columbia, United States, 20007 Less <<
NCT00637546 Diabetes Type 2 Phase 2 Phase 3 Completed - Switzerland ... More >> University Hospital of Geneva Geneva, Switzerland, 1205 Less <<
NCT03522597 - Not yet recruiting January 2021 United States, Minnesota ... More >> University of Minnesota Not yet recruiting Minneapolis, Minnesota, United States, 55454 Contact: Ellen W Demerath, Ph.D.    612-624-8231    ewd@umn.edu    Contact: Laurie Foster, M.Ed.    612-361-7363    mnmoms@umn.edu    Principal Investigator: Ellen W Demerath, Ph.D.          Principal Investigator: Cheryl A Gale, M.D.          Principal Investigator: Katherine Jacobs, M.D.          Sub-Investigator: Samantha Hoffman, M.D.          Sub-Investigator: Dan Knights, Ph.D. Less <<
NCT00913393 Type 2 Diabetes Mellitus ... More >> Diabetic Nephropathy Diabetic Kidney Disease Less << Phase 2 Terminated(Sub-optimal study d... More >>esign) Less << - -
NCT00913562 Glaucoma Diab... More >>etes Less << Phase 4 Withdrawn - Austria ... More >> Department of Clinical Pharmacology, Medical University of Vienna Vienna, Austria, 1090 Less <<
NCT00678522 Healthy Subjects Phase 4 Completed - Denmark ... More >> Medical Reseach, Holstebro Hospital Holstebro, Denmark, 5500 Department of Medical Research, Holstebro Hospital Holstebro, Denmark, 7500 Less <<
NCT00918801 - Completed - United States, Missouri ... More >> Washington University School of Medicine St. Louis, Missouri, United States, 63110 Less <<
NCT00914706 - Completed - Canada, Ontario ... More >> Brockville Family Health Team Brockcillw, Ontario, Canada, K6C 0A5 Delhi Family Health Team Delhi, Ontario, Canada, N4B 2L8 Summerville Family Health Team Etobicoke, Ontario, Canada, M9C 5N2 Harrow Health Centre Harrow, Ontario, Canada, N0R 1G0 Leamington and Area Family Health Team Lemington, Ontario, Canada, N8H 1N9 Sherbourne Family Health Team Toronto, Ontario, Canada, M5A 2S5 Less <<
NCT00911482 - Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT00073294 Diabetes Mellitus, Type 2 Not Applicable Withdrawn(Trial was not funded... More >>) Less << - United States, New York ... More >> Columbia Presbyterian Medical Center/ Irving Center New York, New York, United States, 10032 Russ Berrie Pavilion New York, New York, United States, 10032 Less <<
NCT00927394 - Completed - -
NCT02443740 Healthy Phase 1 Completed - United States, Connecticut ... More >> New Haven Clinical Research Unit New Haven, Connecticut, United States, 06511 Less <<
NCT00934336 Type 1 Diabetes Not Applicable Completed - France ... More >> CH sud francilien Corbeil Essonnes, France, 91106 Less <<
NCT00927394 Hypertension Phase 4 Completed - United States, Delaware ... More >> Investigative Site Newark, Delaware, United States, USA United States, Missouri Investigative Site Kansas, Missouri, United States United States, New Jersey Investigative Site Camden, New Jersey, United States United States, Pennsylvania Investigative Site Philadelphia, Pennsylvania, United States Less <<
NCT02443740 - Completed - -
NCT00946517 - Terminated(PI left the institu... More >>tion) Less << - United States, Ohio ... More >> Nationwide Children's Hospital Columbus, Ohio, United States, 43205 Less <<
NCT00946257 Diabetes Mellitus, Type 1 Phase 1 Completed - Belgium ... More >> GSK Investigational Site Brussels, Belgium, 1090 GSK Investigational Site Bruxelles, Belgium, 1070 GSK Investigational Site Gent, Belgium, 9000 GSK Investigational Site Leuven, Belgium, 3000 GSK Investigational Site Liège, Belgium, 4000 GSK Investigational Site Merksem, Belgium, 2170 Less <<
NCT00936234 SDF-1 is an Important Cytokine... More >> for Neovascularization. Cleavage of SDF-1 is Reduced by DPPIV Inhibitors Less << Phase 2 Phase 3 Unknown November 2012 Germany ... More >> Department of Cardiology Recruiting Frankfurt, Germany, 60590 Contact: Florian H Seeger, MD    0049 69 6301 7343       Sub-Investigator: Florian H Seeger, MD Less <<
NCT00948493 - - - -
NCT00948116 - Unknown October 2011 United Kingdom ... More >> The London Chest Hospital Recruiting London, United Kingdom, E2 9JX Contact: AKHIL KAPUR    0208 983 2413    akhil.kapur@bartsandthelondon.nhs.uk    Contact: KATIE QURESHI    0208 983 2477    katie.qureshi@bartsandthelondon.nhs.uk    Principal Investigator: AKHIL KAPUR          Sub-Investigator: KATIE QURESHI          Principal Investigator: MAGDI YAQOOB Less <<
NCT00920582 Type 1 Diabetes Mellitus Phase 3 Completed - -
NCT00365859 Autistic Disorder ... More >> Behavioral Symptoms Less << Phase 3 Completed - -
NCT00950963 Type 1 Diabetes ... More >> Type 2 Diabetes Less << Not Applicable Completed - United States, Colorado ... More >> Denver Health, Westside Clinic Denver, Colorado, United States, 80204 Less <<
NCT00962026 Type 1 Diabetes Mellitus Phase 1 Completed - United States, Texas ... More >> Children's Medical Center Dallas, Texas, United States, 75235 Less <<
NCT03602950 Diabetes, Gestational ... More >> Wound Complication Less << Phase 2 Phase 3 Not yet recruiting February 28, 2019 -
NCT00365859 - Completed - -
NCT02037867 - Recruiting May 2033 United Kingdom ... More >> NIHR Nottingham Digestive Diseases Biomedical Research Unit Recruiting Nottingham, Notts, United Kingdom, NG7 2UH Contact: Neil Guha, MRCP, PhD    01159249924 ext 70609    neil.guha@nottingham.ac.uk    Contact: Rebecca Harris, BMedSci, BMBS    01159249924 ext 70616    rebecca.harris@nottingham.ac.uk    Principal Investigator: Neil Guha, MRCP, PhD          Sub-Investigator: David J Harman, BMedSci, BMBS, MRCP          Sub-Investigator: Guruprasad P Aithal, FRCP, PhD          Sub-Investigator: Stephen D Ryder, MRCP, PhD          Sub-Investigator: Martin W James, MRCP, PhD          Sub-Investigator: Emilie A Wilkes, MRCP, PhD          Sub-Investigator: Rebecca Harris, BMedSci, BMBS, MRCP          Sub-Investigator: Timothy R Card, MRCP, PhD          Sub-Investigator: Toby E Delahooke, MRCP, MD Less <<
NCT00964964 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 1 Completed - Germany ... More >> Neuss, Germany, 41460 Less <<
NCT00960635 Type 1 Diabetes Phase 2 Completed - Germany ... More >> Institut fuer Diabetesforschung Munich, Germany, 80804 Less <<
NCT00950963 - Completed - -
NCT00974740 Type 1 Diabetes Phase 1 Terminated(for lack of recruit... More >>ment) Less << - Germany ... More >> Diabetes-Zentrum Mergentheim Bad Mergentheim, Germany, 97980 Gemeinschaftskrankenhaus Havelhöhe Berlin, Germany, 14089 Helios Klinikum Emil von Behring Berlin, Germany, 14165 Praxis Dr. Friedhelm Schmitten Bestwig-Ramsbeck, Germany, 59909 DDZ Deutsches Diabetes Zentrum Düsseldorf, Germany, 40221 St. Josefs Krankenhaus Heidelberg, Germany, 69115 St. Antonius Krankenhaus, Med. Klinik Köln, Germany, 50968 Praxisklinik Leipzig Leipzig, Germany, 04103 Praxis Dr. Gerhard Willms Leverkusen, Germany, 51373 Praxis Dr. Heinz-Georg Ley Marl, Germany, 45770 Diabetologische Schwerpunktpraxis, Angiologie Münster, Germany, 48145 Praxis Dr. Werner Stürmer Würzburg, Germany, 97070 Less <<
NCT00978835 Diabetes Hype... More >>rtension Less << Not Applicable Completed - United States, North Carolina ... More >> Duke University Medical Center Durham, North Carolina, United States, 27705 Less <<
NCT01369225 Alzheimer's Disease Phase 1 Completed - United States, Florida ... More >> MD Clinical Hallandale Beach, Florida, United States, 33009 Munroe Regional Medical Center Ocala, Florida, United States, 34471 Renstar Medical Research Ocala, Florida, United States, 34471 Trinity Care Solutions Ocala, Florida, United States, 34471 Advanced Imaging of Ocala Ocala, Florida, United States, 34481 United States, Georgia Atlanta Center for Medical Research Atlanta, Georgia, United States, 30308 United States, Maryland Foers Medical Arts Pharmacy Bethesda, Maryland, United States, 20814 CBH Health, LLC Rockville, Maryland, United States, 20850 United States, Michigan Borgess Medical Center Kalamazoo, Michigan, United States, 49048 Borgess Research Institute Kalamazoo, Michigan, United States, 49048 KNI Southwest Michigan Imaging Center, LLC Kalamazoo, Michigan, United States, 49048 United States, Missouri Millennium Psychiatric Associates, LLC Creve Coeur, Missouri, United States, 63141 DePaul Health Center-MRI Department St. Louis, Missouri, United States, 63044 United States, New Jersey Memory Enhancement Center of America, Inc. Eatontown, New Jersey, United States, 07724 Central Jersey Radiology Oakhurst, New Jersey, United States, 07755 Korea, Republic of Seoul National University Hospital, Department Neurology Seongnam-si, Gyeonggi-do, Korea, Republic of, 463-707 Inha University Hospital, Department of Neurology Incheon, Korea, Republic of, 400-711 Samsung Medical Center, Department of Neurology Seoul, Korea, Republic of, 1350710 Korea University Anam Hospital IRB Seoul, Korea, Republic of, 136-705 ASAN Medical Center Seoul, Korea, Republic of, 138-736 Konkuk University Medical Center, Department of Neurology Seoul, Korea, Republic of, 143914 Less <<
NCT03696368 - Not yet recruiting November 2025 United States, Indiana ... More >> IU Health Methodist Hospital Indianapolis, Indiana, United States, 46202 Sidney and Lois Eskenazi Hospital Indianapolis, Indiana, United States, 46202 Less <<
NCT00995540 Type 1 Diabetes Mellitus Phase 2 Terminated(Preserve clinical s... More >>upplies) Less << - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Canada, Quebec McGill University - Montreal General Hospital Montreal, Quebec, Canada, H3G 1A4 Less <<
NCT03749889 Gestational Diabetes Not Applicable Recruiting May 5, 2020 United States, New York ... More >> SUNY Buffalo Recruiting Buffalo, New York, United States, 14214 Contact: Kai Ling Kong, PhD    716-829-2261    kkong4@buffalo.edu Less <<
NCT02126358 Type 2 Diabetes ... More >> Dyslipidemia Less << Phase 3 Completed - Korea, Republic of ... More >> Severance hospital Seoul, Korea, Republic of Less <<
NCT01369225 - Completed - -
NCT02224664 Parkinson`s Disease Phase 1 Completed - United States, California ... More >> Orange Coast Memorial Medical Center Fountain Valley, California, United States, 92708 The Parkinson's and Movement Disorder Institute Fountain Valley, California, United States, 92708 Collaborative Neuroscience Network, LLC Long Beach, California, United States, 90806 United States, Colorado Rocky Mountain Movement Disorders Center Englewood, Colorado, United States, 80113 Davita Clinical Research Center Lakewood, Colorado, United States, 80228 United States, Florida MD Clinical Hallandale Beach, Florida, United States, 33009 Compass Research, LLC Orlando, Florida, United States, 32806 United States, Georgia Atlanta Center for Medical Research Atlanta, Georgia, United States, 30331 United States, Massachusetts Massachusetts General Hospital -- FOR DRUG SHIPMENT ONLY Boston, Massachusetts, United States, 02114 Massachusetts General Hospital Boston, Massachusetts, United States, 02114 United States, Michigan Quest Research Institute Farmington Hills, Michigan, United States, 48334 United States, New Jersey PRA International Marlton, New Jersey, United States, 08053 United States, North Carolina Carolina Phase I Research, LLC Raleigh, North Carolina, United States, 27612 United States, Oklahoma Lynn Health Science Institute Oklahoma City, Oklahoma, United States, 73112 United States, Texas Neurology Consultants of Dallas, PA Dallas, Texas, United States, 75231 Walnut Hill Medical Center Dallas, Texas, United States, 75231 Belgium Pfizer Clinical Research Unit Brussels, Belgium, B-1070 Less <<
NCT02062307 - Completed - Turkey ... More >> Gulhane School of Medicine Ankara, Turkey, 06018 Less <<
NCT01030471 Type 1 Diabetes Not Applicable Unknown September 2012 United States, Ohio ... More >> Cincinnati Children's Hospital Medical Center Recruiting Cincinnati, Ohio, United States, 45229 Contact: Korey K Hood, PhD    513-803-0405    korey.hood@cchmc.org    Sub-Investigator: Lawrence Dolan, MD          Principal Investigator: Korey K Hood, PhD          Sub-Investigator: Richard Ittenbach, PhD Less <<
NCT01030926 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 1 Completed - Germany ... More >> Novo Nordisk Investigational Site Hannover, Germany, 30173 Less <<
NCT02224664 - Completed - -
NCT01035320 Diabetes Mellitus ... More >> Renal Impairment Less << Phase 4 Completed - Sweden ... More >> Department of Medicine, Clinical Pharmacology Unit, Karolinska University Hospital (Solna) Stockholm, Sweden, 171 76 Less <<
NCT01017718 - Completed - Austria ... More >> Department of Pediatrics, University Teaching Hospital, Landeskrankenhaus Feldkirch Feldkirch, Austria, 6800 Less <<
NCT01043029 Diabetes Mellitus Type 2 Phase 2 Completed - -
NCT01042301 Type 1 Diabetes Not Applicable Completed - France ... More >> CHU de Nantes Nantes, France, 44093 Less <<
NCT01045005 Type 1 Diabetes Mellitus Not Applicable Unknown May 2011 United Kingdom ... More >> Department of Therapeutics and Pharmacology, Queens University Belfast Recruiting Belfast, Antrim, United Kingdom, BT9 7RL Contact: Gary E McVeigh, MD PhD FRCP    +442890 974772    g.mcveigh@qub.ac.uk    Principal Investigator: Gary E McVeigh, MD PhD FRCP          Sub-Investigator: Mark T Harbinson, MD FRCP Less <<
NCT01049633 - - - United States, Pennsylvania ... More >> Hospital of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT01050166 - Unknown December 2015 Czech Republic ... More >> Diabetes Center, Institute for Clinical and Experimental Medicine Recruiting Prague, Czech Republic, 14000 Contact: Saudek    +420261364107    frsa@ikem.cz    Principal Investigator: Frantisek Saudek, MD, DrSc          Sub-Investigator: Milan Hajek          Sub-Investigator: Peter Girman, MD, PhD          Sub-Investigator: Monika Dezortova Less <<
NCT01052597 Type 2 Diabetes Mellitus ... More >> Cardiovascular Abnormalities Less << Phase 4 Unknown March 2010 Thailand ... More >> HRH Princess Maha Chakri Sirindhorn Medical Center Recruiting Ongkarak, Nakornnayok, Thailand, 26120 Contact: Somlak Chuengsamarn, Medical Doctor    +6637-39-5085    somlukc@swu.ac.th    Principal Investigator: Somlak Chuengsamarn, Medical Doctor Less <<
NCT01069393 Type 1 Diabetes Mellitus Not Applicable Completed - United Kingdom ... More >> Cambridge University Hospitals NHS Foundation Trust Cambridge, United Kingdom NHS Greater Glasgow & Clyde Glasgow, United Kingdom East Lancashire Hospitals NHS Trust Lancashire, United Kingdom University Hospitals, Leicester Leicester, United Kingdom University College London London, United Kingdom Norfolk and Norwich University Hospitals NHS Foundation Trust Norfolk, United Kingdom Northumbria Healthcare NHS Foundation Trust Northumbria, United Kingdom Less <<
NCT01068951 Type 1 Diabetes Not Applicable Completed - Sweden ... More >> Uppsala University Hospital Uppsala, Sweden, SE-75185 Less <<
NCT01069549 - Completed - India ... More >> Postgraduate Institute of Medical Education & Research Chandigarh, India, 1610012 Less <<
NCT01077323 - Completed - United States, Massachusetts ... More >> Research Site Waltham, Massachusetts, United States Less <<
NCT01056367 - Completed - Denmark ... More >> Department of Medical Research, Svendborg Hospital Svendborg, Denmark, 5700 Less <<
NCT01077323 - Completed - -
NCT01078103 - Completed - Denmark ... More >> Frederiksberg Hospital Copenhagen, Denmark, 2000 Less <<
NCT01097551 - Completed - France ... More >> Hôpital LARIBOISIERE Service d'Ophtalmologie Paris, France, 75010 Less <<
NCT01086293 - Completed - -
NCT03751813 Gestational Diabetes Not Applicable Not yet recruiting January 2021 -
NCT01769040 Liver Cirrhosis ... More >> Ascites Less << Phase 4 Completed - Denmark ... More >> Copenhagen University hospital Hvidovre Hvidovre, Denmark, 2650 Less <<
NCT01094899 Type 1 Diabetes ... More >> Type 2 Diabetes Less << Not Applicable Unknown March 2013 France ... More >> Hotel Dieu Recruiting Paris, France, 75004 Contact: gonfroy-leymarie    06.23.17.49.25    celine.gonfroy@mail.com    Sub-Investigator: gonfroy-leymarie céline Less <<
NCT01099618 - Completed - -
NCT01033500 Islets of Langerhans Transplan... More >>tation Diabetes Mellitus, Type 1 Kidney Transplantation Less << Not Applicable Withdrawn(Insufficient funding... More >>) Less << - United States, Wisconsin ... More >> University of Wisconsin Madison, Wisconsin, United States, 53792 Less <<
NCT01099618 Ketosis Prone Diabetes ... More >> Diabetes Ketoacidosis Hyperglycemia Less << Phase 4 Completed - United States, Georgia ... More >> Grady Memorial Hospital Atlanta, Georgia, United States, 30303 Less <<
NCT01103817 Diabetes Mellitus, Type 1 Phase 2 Completed - Canada, Ontario ... More >> The Hospital for Sick Children Toronto, Ontario, Canada Less <<
NCT01103284 Type 1 Diabetes Mellitus Phase 3 Completed - -
NCT01109797 Type 1 Diabetes Not Applicable Completed - United States, Kansas ... More >> University of Kansas Medical Center Kansas City, Kansas, United States, 66160 Less <<
NCT01120119 Diabetes Mellitus, Type 1 Phase 2 Completed - Italy ... More >> University Campus Bio Medico Rome, Italy, 00128 Bambino Gesù Children's Hospital Rome, Italy Catholic University, Rome, Italy Sandro Pertini Hospital Rome, Italy University Sapienza Rome, Italy Less <<
NCT01115621 Type 1 Diabetes Not Applicable Unknown December 2016 Germany ... More >> Institut für Diabetesforschung München, Germany, 80804 Less <<
NCT01103284 - Completed - -
NCT01128374 Type 2 Diabetes Mellitus ... More >> Periodontal Disease Less << Not Applicable Completed - United States, Texas ... More >> The University of Texas Health Science Center Houston, Dental Branch Houston, Texas, United States, 77030 Less <<
NCT01123187 Type 1 Diabetes ... More >> Organ Transplantation Immunosuppression Less << Not Applicable Completed - France ... More >> University Hospital of Lille Lille, Nord, France, 59000 Less <<
NCT01121029 Type 1 Diabetes Mellitus Phase 1 Phase 2 Completed - Mexico ... More >> Hospital Universitario Dr. José Eleuterio González Monterrey, Nuevo Leon, Mexico, 64460 Less <<
NCT02284477 Insulin Resistance ... More >> Decreased Pulmonary Function Less << Not Applicable Unknown April 2015 Korea, Republic of ... More >> Department of Preventive Medicine, College of Medicine, Seoul National University Recruiting Seoul, Korea, Republic of, 110-799 Contact: Sanghyuk Bae, MD    8227408572    sanghyukbae@snu.ac.kr    Principal Investigator: Yun-Chul Hong, MD, PhD Less <<
NCT01138488 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 1 Completed - Germany ... More >> Novo Nordisk Investigational Site Hannover, Germany, 30173 Less <<
NCT01121289 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 1 Completed - Germany ... More >> Neuss, Germany, 41460 Less <<
NCT01147276 Diabetes Hypo... More >>glycemia Less << Phase 4 Completed - Sweden ... More >> Department of Clinical Sciences Lund, Lund University Lund, Sweden, 221 84 Less <<
NCT01131091 Type 2 Diabetes Mellitus Phase 1 Completed - United States, Florida ... More >> Orlando, Florida, United States United States, Minnesota Minneapolis, Minnesota, United States Less <<
NCT01140438 Diabetes Not Applicable Active, not recruiting December 2018 Norway ... More >> Valdemar Grill Trondheim, Norway, 7006 Less <<
NCT01155284 Type 1 Diabetes Phase 2 Completed - United States, California ... More >> Rady Children's Hospital San Diego, California, United States, 92123-4282 United States, Minnesota Children's - St. Paul Saint Paul, Minnesota, United States, 55102 United States, South Dakota Sanford Research/USD Sioux Falls, South Dakota, United States, 57104 Less <<
NCT01148238 - Withdrawn(changed research pla... More >>n) Less << - -
NCT01155284 - Completed - -
NCT01180530 - Completed - Canada ... More >> Novo Nordisk Investigational Site Mississauga, Canada, L4W 4XI Finland Novo Nordisk Investigational Site Espoo, Finland, FI-02600 Israel Novo Nordisk Investigational Site Kfar Saba, Israel, 44425 Sweden Novo Nordisk Investigational Site Malmö, Sweden, 202 15 Novo Nordisk Investigational Site Malmö, Sweden, SE-202 15 Less <<
NCT01183455 Diabetes Mellitus, Type 1 Phase 2 Withdrawn(Sponsor decision-lac... More >>k of mechanistic signal and competing industry studies) Less << - United States, California ... More >> University of California San Diego La Jolla, California, United States, 92093 United States, Colorado Barbara Davis Center Aurora, Colorado, United States, 80045 United States, Connecticut Yale University New Haven, Connecticut, United States, 06511 United States, Georgia Atlanta Diabetes Associates Atlanta, Georgia, United States, 30309 Emory University Atlanta, Georgia, United States, 30322 United States, Iowa University of Iowa Iowa City, Iowa, United States, 52242 United States, Maryland University of Maryland Medical Center Baltimore, Maryland, United States, 21201 Calvert Memorial Hospital Prince Frederick, Maryland, United States, 20678 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Joslin Diabetes Center Boston, Massachusetts, United States, 02215 University of Massachusetts Medical School Worchester, Massachusetts, United States, 01655 United States, New York Columbia University New York, New York, United States, 10027 United States, Ohio Nationwide Children's Hospital Columbus, Ohio, United States, 43205 United States, Pennsylvania The Children's Hospital of Philadelphia Philadephia, Pennsylvania, United States, 19104 United States, Texas Cetero Research San Antonio San Antonio, Texas, United States, 78229 Less <<
NCT01148680 Diabetes Mellitus, Type 1 Phase 3 Active, not recruiting December 2017 France ... More >> University Hospital, Department of Endocrinology Strasbourg, Alsace, France, 67000 University Hospital Gabriel Montpied, Department of Endocrinology Clermont Ferrand, Auvergne, France, 63003 University Hospital Besançon, Department of Endocrinology Besançon, Franche-Comté, France, 25000 University Hospital, Department of Endocrinology Montpellier, Languedoc-Roussillon, France, 34000 University Hospital, Department of Endocrinology Nancy, Lorraine, France, 54000 University Hospital, Department of General Surgery and Endocrinology Lille, Nord Pas de Calais, France, 59000 University Hospital, Department of Endocrinology Grenoble, Rhône-Alpes, France, 38000 HCL Sud, Department of Endocrinology Lyon, Rhône-Alpes, France, 69000 Switzerland Hopitaux Universitaires de Genève, Department of Visceral Surgery and Transplant Geneve, Switzerland, CH-1211 Less <<
NCT01189422 Type 1 Diabetes Mellitus Phase 1 Terminated - -
NCT01184703 Diabetes Mellitus, Type 1 Phase 3 Completed - Denmark ... More >> Steno Diabetes Center Gentofte, Denmark, DK-2820 Less <<
NCT01176253 - Completed - United States, California ... More >> City of Hope National Medical Center-Department of Diabetes, Endocrinology, & Metabolism Duarte, California, United States, 91010 Loma Linda Medical Center Loma Linda, California, United States, 92354 Less <<
NCT01191866 - Unknown - Israel ... More >> Assaf Harofeh Pediatric Diabetes Clinic Recruiting Zerifin, Israel, 70300 Contact: Shacham       shirashacham1@gmail.com    Principal Investigator: Shira Shacham, MD Less <<
NCT01194882 Diabetes Mellitus, Type 1 Phase 3 Completed - Belgium ... More >> Investigational Site Number 056-001 Leuven, Belgium, 3000 France Investigational Site Number 250-004 Corbeil Essonnes, France, 91100 Investigational Site Number 250-008 Dijon, France, 21000 Investigational Site Number 250-003 Dommartin Les Toul, France, 54200 Investigational Site Number 250-012 Le Mans Cedex 9, France, 72037 Investigational Site Number 250-009 LILLE Cedex, France, 59037 Investigational Site Number 250-007 Marseille, France, 13385 Investigational Site Number 250-001 MONTPELLIER Cedex 5, France, 34295 Investigational Site Number 250-005 Paris, France, 75014 Investigational Site Number 250-010 Pessac Cedex, France, 33604 Investigational Site Number 250-011 ST PRIEST EN JAREZ Cedex, France, 42277 Investigational Site Number 250-002 Strasbourg, France, 67091 Investigational Site Number 250-006 TOULOUSE Cedex 9, France, 31059 Netherlands Investigational Site Number 528003 Den Haag, Netherlands, 2512VA Investigational Site Number 528002 Roermond, Netherlands, 6043CV Investigational Site Number 528001 Zwolle, Netherlands, 8025AB Sweden Investigational Site Number 752-001 Stockholm, Sweden Less <<
NCT01183468 - Terminated(Due to lack of mech... More >>anistic signal and competing industry studies) Less << - -
NCT01220349 Diabetes Mellitus, Type 1 Not Applicable Completed - France ... More >> Hôpital Cardiologique du Haut-Lévêque, Service de Cardiologie et Maladies Vasculaires Pessac, France, 33604 Less <<
NCT01183468 Diabetes Mellitus, Type 1 Phase 1 Terminated(Due to lack of mech... More >>anistic signal and competing industry studies) Less << - United States, California ... More >> RADY Children's Hospital (University of California, San Diego) San Diego, California, United States, 92093 United States, Colorado Barbara Davis Center (University of Colorado) Aurora, Colorado, United States, 80045 United States, Connecticut Yale University New Haven, Connecticut, United States, 06520 United States, Georgia Atlanta Diabetes Associates Atlanta, Georgia, United States, 30309 Children's Hospital of Atlanta (Emory University) Atlanta, Georgia, United States, 30322 United States, Iowa University of Iowa Children's Hospital Iowa City, Iowa, United States, 52242 United States, Maryland University of Maryland Medical Center Baltimore, Maryland, United States, 21201 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Joslin Diabetes Center Boston, Massachusetts, United States, 02215 University of Massachusetts Memorial Medical Center Worcester, Massachusetts, United States, 01655 United States, Missouri Children's Mercy Hospital Kansas City, Missouri, United States, 64108 United States, New York Naomi Berrie Diabetes Center (Columbia University) New York, New York, United States, 10032 United States, Ohio Nationwide Children's Hospital Columbus, Ohio, United States, 43205 United States, Pennsylvania Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 United States, Washington Pacific Northwest Research Institute-University of Washington Seattle, Washington, United States, 98122 Less <<
NCT01227538 - Completed - United Kingdom ... More >> Joint Clinical Research Unit, UHBristol NHS Foundation Trust Bristol, Avon, United Kingdom, BS1 8HW Less <<
NCT01210664 - Completed - -
NCT01210664 Type 1 Diabetes Mellitus Phase 1 Completed - United States, California ... More >> University of California, San Francisco Medical Center San Francisco, California, United States, 94143 United States, Connecticut Yale University New Haven, Connecticut, United States, 06519 Less <<
NCT01220479 Type 1 Diabetes Mellitus Not Applicable Completed - Switzerland ... More >> University Hospital of Geneva Geneva, Switzerland, 1205 Less <<
NCT01241864 Diabetes Mellitus, Type 1 Phase 2 Active, not recruiting December 2025 United States, Illinois ... More >> The University of Chicago Chicago, Illinois, United States, 60637 Less <<
NCT01201928 - Terminated(Parent trials were ... More >>either not initiated or terminated) Less << - United States, California ... More >> Valley Research Fresno, California, United States, 93720 Health Care Partners Medical Group Long Beach, California, United States, 90806 United States, Georgia Laureate Clinical Research Group Atlanta, Georgia, United States, 30308 Atlanta Diabetes Associates Atlanta, Georgia, United States, 30309 Alta Pharmaceutical Research Center Dunwoody, Georgia, United States, 30338 United States, Indiana LaPorte County Institute for Clinical Research Inc. Michigan City, Indiana, United States, 46360 United States, Missouri Washington University School of Medicine St. Louis, Missouri, United States, 63110 United States, Montana Billings Clinic Research Center Billings, Montana, United States, 59101 United States, New York Winthrop University Hospital Mineola, New York, United States, 11501 North Shore Diabetes and Endocrine Associates New Hyde Park, New York, United States, 11042 United States, North Carolina Endocrine Research Physicians East PA Greenville, North Carolina, United States, 27834 United States, Texas Israel Hartman MD Arlington, Texas, United States, 76014 Dallas Diabetes & Endocrine Center Dallas, Texas, United States, 75230 SAM Clinical Research Center San Antonio, Texas, United States, 78229 Less <<
NCT01235819 Type 1 Diabetes Phase 4 Completed - India ... More >> Command Hospital Lucknow, UP, India, 226002 Less <<
NCT01260246 Type 2 Diabetes ... More >> Nonalcoholic Steatohepatitis Less << Not Applicable Terminated(Slow recruitment) - Canada, Ontario ... More >> St. Joseph's Health Care London, Ontario, Canada, N6A 4L6 Less <<
NCT01806896 Huntington's Disease Phase 2 Completed - France ... More >> Centre d'Investigation Clinique (CIC)/ Institut du Cerveau et de la Möelle Epinière (ICM) Paris Cedex 13, France, 75651 Less <<
NCT01244152 Diabetes Phase 2 Completed - United States, Illinois ... More >> Rush University Medical Center Chicago, Illinois, United States, 60612 Less <<
NCT02459691 Prediabetic State ... More >> Metabolic Syndrome X Insulin Resistance Less << Not Applicable Active, not recruiting August 2019 United States, California ... More >> Palo Alto Medical Foundation Palo Alto, California, United States, 94301 Less <<
NCT01267175 - Completed - -
NCT01268813 Metabolic Syndrome ... More >> Diabetes Less << Phase 1 Unknown March 2013 Israel ... More >> Rambam Medical Center - Inst. Endocrinology, Diabetes & Metabolism Not yet recruiting Haifa, Israel, 31096 Principal Investigator: Eddy Karnieli, MD          Sub-Investigator: Sagit Zolotov, MD Less <<
NCT02467244 - Active, not recruiting December 30, 2018 India ... More >> AIIMS, Bhubaneswar Bhubaneshwar, Odisha, India, 751019 Less <<
NCT03134014 Breakfast App... More >>etitive Behavior Less << Not Applicable Recruiting December 12, 2018 United States, Indiana ... More >> Purdue University Recruiting West Lafayette, Indiana, United States, 47907 Contact: Heather Leidy, PhD    765-496-0184    hleidy@purdue.edu Less <<
NCT01806896 - Completed - -
NCT01269606 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 1 Completed - Japan ... More >> Fukuoka, Japan, 812-0025 Less <<
NCT01271517 Diabetes Mellitus Type 1 Phase 4 Unknown - Sweden ... More >> Division of Pediatrics, Karolinska University Hospital Stockholm, Sweden, 17176 Less <<
NCT01267175 Diabetes Mellitus, Type 1 Phase 4 Completed - United Kingdom ... More >> Addenbrookes Hospital Cambridge, Cambridgeshire, United Kingdom, CB2 0QQ Royal Bournemouth Hospital Bournemouth, Dorset, United Kingdom, BH7 7DW Kings College Hospital Denmark Hill, London, United Kingdom, SE5 9RS Harrogate District Hospital Harrogate, N. Yorkshire, United Kingdom, HG2 7SX Newcastle General Hospital Newcastle Upon Tyne, Tyne and Wear, United Kingdom, NE4 6BE Guy's Hospital London, United Kingdom, SE1 9RT Less <<
NCT01276743 - Completed - Greece ... More >> Unit of Pediatric Endocrinology, Diabetes and Metabolism, 4th Department of Pediatrics, Medical School, Aristotle University of Thessaloniki Thessaloniki, Greece, 54603 Less <<
NCT01267591 - Unknown - Belgium ... More >> University Hospital Leuven Recruiting Leuven, Belgium Contact: kristina casteels, MD PhD    00-32-16-343801 Less <<
NCT01391013 - Completed - -
NCT00684528 Diabetes Type 2 Phase 3 Unknown December 2012 Israel ... More >> Clalit Health services center Recruiting Tel Aviv, Israel, 62098 Contact: Zinger    972-5062-63652       Principal Investigator: Zinger Joel, MD Less <<
NCT00697580 Obesity Type ... More >>2 Diabetes Cardiovascular Risk Cancer Less << Not Applicable Completed - United States, California ... More >> Veronica Atkins Lifestyle Intervention Laboratory Los Angeles, California, United States, 90033-9073 Less <<
NCT01391013 Human Immunodeficiency Virus 1 Phase 2 Completed - -
NCT00726674 - Completed - Israel ... More >> Sanofi-Aventis Administrative Office Natanya, Israel Less <<
NCT00174460 - Completed - -
NCT00727896 Type 2 Diabetes Phase 1 Completed - India ... More >> India Diabetes Research Foundation and Dr.A.Ramachandran's Diabetes Hospitals Chennai, Tamil nadu, India, 600 008 Less <<
NCT01793896 Metabolic Syndrome Not Applicable Terminated() - Chile ... More >> Institute of Nutrition & Food Technology (INTA) Santiago, Metropolitan Region, Chile, 7830490 Less <<
NCT00174460 Growth Hormone Therapy ... More >> Infant, Very Low Birth Weight Less << Phase 2 Completed - Germany ... More >> Pfizer Investigational Site Chemnitz, Germany, 09009 Pfizer Investigational Site Erlangen, Germany, 91054 Pfizer Investigational Site Freiburg, Germany, 79106 Pfizer Investigational Site Heidelberg, Germany, 69120 Pfizer Investigational Site Homburg, Germany, 66424 Pfizer Investigational Site Koeln, Germany, 50937 Pfizer Investigational Site Leipzig, Germany, 04103 Pfizer Investigational Site Tuebingen, Germany, 72076 Less <<
NCT00085800 - Completed - -
NCT00714844 - Completed - -
NCT01864226 Healthy Volunteer Phase 1 Completed - Netherlands ... More >> Zuidlaren, Netherlands, 9471 GP Less <<
NCT01858948 Bipolar Youth Treated With Sec... More >>ond-generation Antipsychotics Less << Phase 3 Completed - United States, Ohio ... More >> University of Cincinnati Cincinnati, Ohio, United States, 45219 Less <<
NCT01847456 Insulin Sensitivity Not Applicable Completed - Germany ... More >> University of Tuebingen, Internal medicine IV Tuebingen, Germany, 72074 Less <<
NCT00790153 Type 2 Diabetes Phase 1 Completed - United States, California ... More >> Research Site Chula Vista, California, United States Less <<
NCT00845793 Type 2 Diabetes Not Applicable Unknown December 2011 Israel ... More >> Hadassah Medical Center Not yet recruiting Jerusalem, Israel, 91120 Principal Investigator: Ram Weiss, MD PhD Less <<
NCT00810173 Behavior Change Not Applicable Completed - -
NCT00093015 Kidney Disease ... More >> Diabetes Mellitus Anemia Less << Phase 3 Completed - -
NCT01920659 Insulin Sensitivity ... More >> Physical Activity Less << Not Applicable Completed - United Kingdom ... More >> Loughborough University Loughborough, Leicestershire, United Kingdom, LE11 5TN Less <<
NCT01934543 Metabolic Syndrome Not Applicable Completed - Canada ... More >> Institute of Nutrition and Functional Foods (INAF) Quebec, Canada, G1V 0A6 Less <<
NCT01939509 Hypertension ... More >>Metabolic Syndrome Less << Phase 4 Completed - Argentina ... More >> Hospital Italiano de Buenos Aires Buenos Aires, Argentina, C1181ACH Hospital Italiano de Buenos Aires Buenos Aires, Argentina, c118ach Hospital Italiano de Buenos Aires Buenos Aires, Argentina Less <<
NCT00882882 Type II Diabetes Phase 1 Completed - -
NCT01944579 Metabolic Syndrome Not Applicable Completed - United States, Maryland ... More >> Beltsville Human Nutrition Research Center Beltsville, Maryland, United States, 20906 Less <<
NCT00498394 Obesity Phase 1 Completed - United States, Ohio ... More >> University of Cincinnati Cincinnati, Ohio, United States, 45221-0038 Less <<
NCT01644942 Obesity Insul... More >>in Resistance Hyperlipidemia Less << Not Applicable Completed - France ... More >> CHRU Montpellier Montpellier, France, 34295 Less <<
NCT00627146 Diabetes Mellitus, Type 1 Phase 2 Completed - Belgium ... More >> Universitair Ziekenhuis Antwerpen Antwerpen, Belgium Universitair Ziekenhuis and Diabetes Research Center - Brussels Free University-VUB Brussels, Belgium, 1090 Hopital Erasme Brussel, Belgium Department of Endocrinology and Nephrology, UZ Gasthuisberg, Katholieke Universiteit Leuven -KUL Leuven, Belgium, 3000 Germany Hopital Schwabbing Munich, Germany Less <<
NCT01947972 Metabolic Syndrome Not Applicable Completed - Greece ... More >> Hippokration Hospital Thessaloniki Thessaloniki, Greece Less <<
NCT00639600 Type 1 Diabetes Mellitus Phase 1 Phase 2 Terminated(a new study has beg... More >>an recently) Less << - France ... More >> University Hospital Besancon, France, 25000 University Hospital, Department of Endocrinology Grenoble, France, 38043 University Hospital, Department of Endocrinology Lyon, France, 69000 University Hospital, Department of Endocrinology Montpellier, France, 34000 University Hospital, Department of Endocrinology Nancy, France, 54000 University Hospital, Department of Endocrinology Strasbourg, France, 66000 Switzerland University Hospital, Department of Surgery Geneva, Switzerland, 1211 Less <<
NCT01360996 - Completed - -
NCT00623610 Diabetes Mellitus, Type 1 Phase 1 Phase 2 Completed - Belgium ... More >> Universitair Ziekenhuis and Diabetes Research Center - Brussels Free University-VUB Brussels, Belgium, 1090 Department of Endocrinology and Nephrology, UZ Gasthuisberg, Katholieke Universiteit Leuven -KUL Leuven, Belgium, 3000 Less <<
NCT00640549 Hyperlipidemia ... More >> Diabetes Mellitus, Type 2 Non-Insulin Dependent Diabetes Mellitus Less << Phase 4 Terminated(See termination rea... More >>son in detailed description.) Less << - Germany ... More >> Pfizer Investigational Site Bad Muenster Am Stein, Germany, 55583 Pfizer Investigational Site Bosenheim, Germany, 55545 Pfizer Investigational Site Bretten, Germany, 75015 Pfizer Investigational Site Dresden, Germany, 01307 Pfizer Investigational Site Duisburg, Germany, 47199 Pfizer Investigational Site Essen, Germany, 45217 Pfizer Investigational Site Goch, Germany, 47574 Pfizer Investigational Site Heidelberg, Germany, 69120 Pfizer Investigational Site Kuenzing, Germany, 94550 Pfizer Investigational Site Offenbach, Germany, 63067 Pfizer Investigational Site Offenbach, Germany, 63071 Pfizer Investigational Site Offenbach, Germany, 63073 Pfizer Investigational Site Rain, Germany, 94369 Pfizer Investigational Site Schwabenheim, Germany, 55270 Less <<
NCT02322112 Overweight and Obesity Not Applicable Recruiting December 2020 Canada, Alberta ... More >> Alberta Diabetes Institute Clinical Research Unit Recruiting Edmonton, Alberta, Canada, T6G 2E1 Less <<
NCT01360996 Polycystic Ovary Syndrome Phase 4 Completed - United States, Louisiana ... More >> Woman's Hospital Baton Rouge, Louisiana, United States, 70815 Less <<
NCT00646542 Diabetes Mellitus, Type 2 Phase 3 Completed - Argentina ... More >> Buenos Aires, Argentina Australia Heidelberg Heights, Australia Canada Winnipeg, Canada Costa Rica Cartago, Costa Rica Finland Tampere, Finland France Angers, France Germany Dormagen, Germany India Chennai, India Norway Oslo, Norway Russian Federation Saint Petersburg, Russian Federation Spain Alicante, Spain Sweden Lund, Sweden Less <<
NCT00645840 Type 1 Diabetes Mellitus Phase 1 Phase 2 Completed - United States, Texas ... More >> Children's Medical Center Dallas, Texas, United States, 75235 Less <<
NCT00639665 - Completed - United States, Massachusetts ... More >> Brigham & Women's Hospital Boston, Massachusetts, United States, 02115 Less <<
NCT00655200 - Completed - Philippines ... More >> Manilla, Philippines, 1605 Less <<
NCT00655044 - Completed - Russian Federation ... More >> Novo Nordisk Investigational Site Moscow, Russian Federation, 119330 Less <<
NCT00659165 - Completed - -
NCT00654121 Diabetes, Type I Phase 2 Completed - Belgium ... More >> Universitair Ziekenhuis Antwerpen Antwerpen, Belgium Academisch Ziekenhuis and Diabetes Research Center - Brussels Free University-VUB Brussels, Belgium, 1090 Department of Endocrinology and Nephrology, UZ Gasthuisberg, Katholieke Universiteit Leuven -KUL Leuven, Belgium, 3000 Less <<
NCT00659295 - Completed - Belgium ... More >> Novo Nordisk Investigational Site Brussels, Belgium, 1070 Czech Republic Novo Nordisk Investigational Site Prague, Czech Republic, 16000 Denmark Novo Nordisk Investigational Site Copenhagen S, Denmark, 2300 Finland Novo Nordisk Investigational Site Espoo, Finland, FI-02600 France Novo Nordisk Investigational Site Paris La défense cedex, France, 92932 Greece Novo Nordisk Investigational Site Vouliagment, Greece, 16671 Ireland Novo Nordisk Investigational Site Dublin 2, Ireland Israel Novo Nordisk Investigational Site Kfar Saba, Israel, 44425 Italy Novo Nordisk Investigational Site Rome, Italy, 00144 Korea, Republic of Novo Nordisk Investigational Site Seoul, Korea, Republic of, 137-920 Sweden Novo Nordisk Investigational Site Malmö, Sweden, 202 15 Turkey Novo Nordisk Investigational Site Istanbul, Turkey, 34335 United Kingdom Novo Nordisk Investigational Site Crawley, United Kingdom, RH11 9RT Less <<
NCT00093015 - Completed - -
NCT00659165 Diabetes Mellitus Not Applicable Completed - United States, New Mexico ... More >> University of New Mexico Health Sciences Center Albuquerque, New Mexico, United States, 87131 Less <<
NCT00662857 Diabetes Mellitus: Type 1 Phase 2 Completed - United States, California ... More >> Profil Institute for Clinical Research Inc. Chula Vista, California, United States, 91911 United States, Texas Diabetes & Glandular Disease Research Assoc PA San Antonio, Texas, United States, 78229 Less <<
NCT00659295 - Completed - -
NCT03072563 - Recruiting March 7, 2019 Canada, Ontario ... More >> St. Michael's Hospital Recruiting Toronto, Ontario, Canada, M5B1W8 Contact: Howard Berger, MD    416-864-6060 ext 8408    BergerH@smh.toronto.on.ca    Contact: Leanne R De Souza, PhD    416-864-6060 ext 8047    DeSouzaL@smh.toronto.on.ca    Principal Investigator: Howard Berger, MD Less <<
NCT03073343 Non-Alcoholic Fatty Liver Dise... More >>ase Non Insulin Dependent Diabetes ALT Less << Not Applicable Recruiting June 30, 2020 United States, California ... More >> VA Long Beach Healthcare System Recruiting Long Beach, California, United States, 90822 Contact: Aliya Asghar, MPH    562-826-5212    aliya.asghar@va.gov    Contact: Timothy R Morgan, MD    562-826-5212    timothy.morgan@va.gov Less <<
NCT00662519 Type 1 Diabetes Phase 1 Completed - United States, Florida ... More >> University of Florida Gainesville, Florida, United States, 32610 Less <<
NCT00662857 - Completed - -
NCT00659451 Essential Hypertension ... More >> Diabetes Mellitus Less << Phase 3 Unknown April 2009 Italy ... More >> University of Pavia Recruiting Pavia, Italy Contact: Paola Preti, MD    +39 0382 526217       Sub-Investigator: Paola Preti Less <<
NCT00665093 - Completed - Macedonia, The Former Yugoslav... More >> Republic of Novo Nordisk Investigational Site Skopje, Macedonia, The Former Yugoslav Republic of, MK-1000 Less <<
NCT00675220 - Completed - Philippines ... More >> Novo Nordisk Investigational Site Manilla, Philippines, 1605 Less <<
NCT00674440 Congenital Hyperinsulinism ... More >> Hyperinsulinism Persistent Hyperinsulinemic Hypoglycemia of Infancy CHI PHHI Less << Phase 2 Completed - United States, Pennsylvania ... More >> Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00678990 Type 1 Diabetes Mellitus Not Applicable Not yet recruiting December 2019 Sweden ... More >> Department of Transplantation Surgery, Karolinska University Hospital Not yet recruiting Stockholm, Sweden, SE-141 86 Contact: Torbjörn Lundgren, MD    +46 73 6994946    torbjorn.lundgren@karolinska.se    Principal Investigator: Torbjörn Lundgren, MD          Department of Transplantation and Liver Surgery, Uppsala University Hospital Not yet recruiting Uppsala, Sweden, SE-751 85 Contact: Tomas Lorant, MD    +46 18 6110000    tomas.lorant@surgsci.uu.se    Principal Investigator: Tomas Lorant, MD Less <<
NCT00671008 - Completed - Bosnia and Herzegovina ... More >> Sarajevo, Bosnia and Herzegovina Less <<
NCT03119584 Chronic Constipation ... More >> Diabete Mellitus Less << Phase 4 Active, not recruiting October 30, 2018 United States, Texas ... More >> Texas Tech University Health Sciences Center El Paso, Texas, United States, 79905 Less <<
NCT00681278 - Completed - Korea, Republic of ... More >> Research Site Bucheon, Gyeonggi, Korea, Republic of Research Site Goyang, Gyeonggi, Korea, Republic of Research Site Guri, Gyeonggi, Korea, Republic of Research Site Sungnam, Gyeonggi, Korea, Republic of Research Site Jeonju, Keollabuk, Korea, Republic of Research Site Busan, Korea, Republic of Research Site Deagu, Korea, Republic of Research Site Deajeon, Korea, Republic of Research Site Incheon, Korea, Republic of Research Site Kwangju, Korea, Republic of Research Site Seoul, Korea, Republic of Research Site Suwon, Korea, Republic of Research Site Wonju, Korea, Republic of Less <<
NCT00689026 Diabetes Mellitus, Type 1 ... More >> Diabetes Mellitus, Type 2 Less << Not Applicable Terminated - United States, Georgia ... More >> Medical College of Georgia Augusta, Georgia, United States, 30912 Less <<
NCT00689026 - Terminated - -
NCT00335270 HIV Phase 4 Completed - United States, Florida ... More >> University of Miami School of Medicine Miami, Florida, United States, 33136 Less <<
NCT00698269 - Completed - Saudi Arabia ... More >> Novo Nordisk Investigational Site Riyadh, Saudi Arabia, 3542 Less <<
NCT00684658 Type 1 Diabetes Phase 3 Completed - United States, Arizona ... More >> University of Arizona Tucson, Arizona, United States, 85721 United States, Connecticut Yale University School of Nursing New Haven, Connecticut, United States, 06519 United States, Florida University of Miami Miami, Florida, United States, 33136 United States, Pennsylvania Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00717223 - Completed - United States, Texas ... More >> Diabetes Clinic, Texas Children's Hospital Houston, Texas, United States, 77030 Less <<
NCT00708604 Diabetes Mellitus Phase 1 Completed - United States, California ... More >> City of Hope Medical Center Duarte, California, United States, 91010 Less <<
NCT00690066 Type 1 Diabetes Mellitus ... More >> Type 1 Diabetes Diabetes Mellitus, Insulin-Dependent Juvenile Diabetes Less << Phase 2 Completed - United States, Alabama ... More >> University of Alabama, Division of Endocrinology & Metabolism Birmingham, Alabama, United States, 35294 United States, California Scripps Whittier Diabetes Institute LaJolla, California, United States, 92037 Stanford University Stanford, California, United States, 94305 United States, Florida University of Florida Gainesville, Florida, United States, 32610 Diabetes Research Institute Miami, Florida, United States, 33136 United States, Kentucky University of Kentucky Lexington, Kentucky, United States, 40502 United States, Minnesota University of Minnesota Minneapolis, Minnesota, United States, 55455 United States, Nevada Desert Endocrinology CRC Henderson, Nevada, United States, 89052 Nevada Alliance Against Diabetes Las Vegas, Nevada, United States, 89101 United States, North Carolina University of North Carolina Diabetes Care Center Chapel Hill, North Carolina, United States, 27599 American Health Research, Inc. Charlotte, North Carolina, United States, 28207 United States, Ohio The Lindner Clinical Trial Center Cincinnati, Ohio, United States, 45219 Providence Health Partners - Center for Clinical Research Dayton, Ohio, United States, 45439 United States, Pennsylvania Cumberland Valley Endocrinology Carlisle, Pennsylvania, United States, 17015 United States, Tennessee AM Diabetes & Endocrinology Center Bartlett, Tennessee, United States United States, Texas The University of Texas Southwestern Medical Center Dallas, Texas, United States, 75390 United States, Utah Optimum Clinical Research, Inc. Salt Lake City, Utah, United States, 84102 United States, Virginia The Strelitz Diabetes Center, Eastern VA Medical School Norfolk, Virginia, United States, 23510 United States, Wisconsin University of Wisconsin Health- West Clinic Madison, Wisconsin, United States, 53717 Clinical and Transitional Science Institute Milwaukee, Wisconsin, United States, 53226 Less <<
NCT00723411 Type 1 Diabetes Mellitus Phase 3 Terminated(The primary endpoin... More >>t at 15 months was not met.) Less << - -
NCT00703599 Type 1 Diabetes Mellitus Phase 1 Phase 2 Unknown December 2009 Philippines ... More >> Beverly Hills Medical Group Recruiting Makati City, Manila, Philippines Contact: Florencio Q Lucero, MD    63-917-896-6411    dr-flucero@pldtdsl.net    Principal Investigator: Florencio Q Lucero, MD          Veterens Memorial Medical Centre Recruiting Quezon City, Manila, Philippines, 1229 Contact: Emerita A Barrenechea, MD    63-917-811-1008    emieab@yahoo.com    Principal Investigator: Emerita A Barrenechea, MD Less <<
NCT00725036 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 3 Completed - Australia, New South Wales ... More >> Novo Nordisk Investigational Site Broadmeadow, New South Wales, Australia, 2292 Novo Nordisk Investigational Site Camperdown, New South Wales, Australia, 2050 Novo Nordisk Investigational Site St Leonards, New South Wales, Australia, 2065 Novo Nordisk Investigational Site Wollongong, New South Wales, Australia, 2500 Australia, Queensland Novo Nordisk Investigational Site Woolloongabba, Queensland, Australia, 4102 Australia, South Australia Novo Nordisk Investigational Site Keswick, South Australia, Australia, 5035 Australia, Western Australia Novo Nordisk Investigational Site Fremantle, Western Australia, Australia, 6160 Australia Novo Nordisk Investigational Site Ashford, Australia, 5035 Novo Nordisk Investigational Site Auckland, Australia Novo Nordisk Investigational Site Box Hill, Australia, 3128 Novo Nordisk Investigational Site Christchurch, Australia Novo Nordisk Investigational Site Clayton, Australia, 3168 Novo Nordisk Investigational Site Garran, Australia, 2605 Novo Nordisk Investigational Site Heidelberg, Australia, 3085 Novo Nordisk Investigational Site Parkville, Australia, 3050 Novo Nordisk Investigational Site Perth, Australia, 6000 Novo Nordisk Investigational Site Randwick, Australia, 2031 Novo Nordisk Investigational Site Stones Corner, Australia, 4120 Less <<
NCT00729365 Type 1 Diabetes Phase 3 Terminated(Data from other stu... More >>dies showed that study could not be completef successfully) Less << - United States, Florida ... More >> University of Florida Gainesville, Florida, United States, 32611 United States, Illinois Northwestern University Feinberg School of Medicine Chicago, Illinois, United States, 60611 Rush University Medical Center, Endocrinology Section Chicago, Illinois, United States, 60612 University of Illinois at Chicago Chicago, Illinois, United States, 60612 University of Chicago Chicago, Illinois, United States, 60637 Loyola University Chicago Maywood, Illinois, United States, 60153 Less <<
NCT00700648 - Completed - India ... More >> Novo Nordisk Investigational Site Bangalore, India, 560001 Less <<
NCT00729365 - Terminated(Data from other stu... More >>dies showed that study could not be completef successfully) Less << - -
NCT00737763 Diabetes Mellitus, Type 1 Phase 2 Withdrawn(drug withdrawn from ... More >>market) Less << - -
NCT00738153 - Completed - Morocco ... More >> Casablanca, Morocco, 20000 Less <<
NCT01258712 Rheumatoid Arthritis (RA) Phase 3 Completed - Taiwan ... More >> Buddhist Dalin Tzu Chi General Hospital Chiayi, Taiwan Chang Gung Memorial Hospital -Kaohsiung Kaohsiung, Taiwan Kaohsiung Medical University Hospital Kaohsiung, Taiwan Kaohsiung Veterans General Hospital Kaohsiung, Taiwan Chung Shan Medical University Hospital Taichung, Taiwan Taichung Veterans General Hospital Taichung, Taiwan National Cheng Kung University Hospital Tainan, Taiwan Cathay General Hospital Taipei, Taiwan National Taiwan University Hospital Taipei, Taiwan Taipei Veterans General Hospital Taipei, Taiwan Tri-Service General Hospital Taipei, Taiwan Chang Gung Memorial Hospital - Linkou Taoyuan, Taiwan Less <<
NCT00741429 - Completed - -
NCT00741702 Hypertension ... More >>Diabetes Mellitus Less << Not Applicable Completed - -
NCT00730392 Type 1 Diabetes Phase 1 Phase 2 Completed - -
NCT00751842 Type 1 Diabetes Mellitus Phase 3 Terminated(Based on other clin... More >>ical trial results it was unlikely the study would meet the efficacy endpoints) Less << - -
NCT00754143 Diabetes Mellitus ... More >> Diabetic Nephropathy Less << Phase 1 Completed - United States, Alabama ... More >> Birmingham, Alabama, United States United States, Arizona Tempe, Arizona, United States United States, California La Mesa, California, United States Torrance, California, United States United States, Florida Kissimmee, Florida, United States United States, Georgia Atlanta, Georgia, United States United States, Massachusetts Springfield, Massachusetts, United States United States, Nebraska Omaha, Nebraska, United States United States, New York Flushing, New York, United States New York, New York, United States United States, North Carolina Chapel Hill, North Carolina, United States United States, Ohio Cleveland, Ohio, United States United States, Oregon Portland, Oregon, United States United States, Pennsylvania Hershey, Pennsylvania, United States United States, Texas Dallas, Texas, United States Houston, Texas, United States San Antonio, Texas, United States United States, Virginia Fairfax, Virginia, United States Less <<
NCT00738907 - Completed - -
NCT00758927 Diabetes Mellitus, Type 2 ... More >> Hypercholesterolemia Hypertriglyceridemia Less << Phase 4 Unknown July 2010 Korea, Republic of ... More >> Dong-A University Medical Center Recruiting Busan, Korea, Republic of, 602-715 Contact: Duk K Kim, M.D., Ph.D.    82-51-240-5030    dkkim@dau.ac.kr    Paik Diabetes Center Recruiting Busan, Korea, Republic of, 614-735 Contact: Jeong H Park, M.D., Ph.D.    82-51-890-6074    pjhdoc@chol.com    Contact: Sang H Byun, RN, CDE, MS    82-51-890-6471    busanmed260@hanmail.net    Endocrinology and Metabolism, Maryknoll General Hospital Recruiting Busan, Korea, Republic of Contact: Mikyung Kim, MD PhD    82-10-4547-9288    kmkdoc@yahoo.co.kr    Principal Investigator: Mikyung Kim, MD PhD Less <<
NCT00761852 Type 1 Diabetes Mellitus ... More >> Type 2 Diabetes Mellitus Less << Phase 2 Phase 3 Completed - -
NCT00745342 Type 1 Diabetes Mellitus Not Applicable Completed - United States, Massachusetts ... More >> Joslin Diabetes Center Boston, Massachusetts, United States, 02215 Less <<
NCT00765830 Diabetes Mellitus, Type 2 ... More >> Renal Insufficiency Less << Phase 3 Completed - -
NCT00763087 Diabetes Mellitus ... More >> Peripheral Neuropathy Less << Not Applicable Completed - United States, Missouri ... More >> Program in Physical Therapy, Washington University in St. Louis Saint Louis, Missouri, United States, 63108 Less <<
NCT00758082 Type 1 Diabetes Mellitus Phase 3 Completed - France ... More >> University Hospital Grenoble Grenoble, France, 38043 Less <<
NCT00782639 - Terminated(This study was term... More >>inated early due to slow enrollment.) Less << - -
NCT00782639 Chronic Renal Impairment ... More >> Diabetes Mellitus Less << Phase 4 Terminated(This study was term... More >>inated early due to slow enrollment.) Less << - United States, New Jersey ... More >> Bracco Diagnostics Inc. Princeton, New Jersey, United States, 08540 Less <<
NCT00787605 Hypertension ... More >>Diabetes Mellitus Less << Phase 4 Completed - United States, New Jersey ... More >> Sites in USA East Hanover, New Jersey, United States, 07936 Less <<
NCT00762671 Type 1 Diabetes Mellitus ... More >> Type 2 Diabetes Mellitus Less << Phase 2 Phase 3 Completed - United States, Massachusetts ... More >> Brigham and Women's Hosptial Boston, Massachusetts, United States, 02115 Less <<
NCT00788827 Type 1 Diabetes ... More >> Type 2 Diabetes Less << Phase 1 Completed - United Kingdom ... More >> Imperial College NHS Healthcare Trust, Hammersmith Hospital London, United Kingdom, W12 0HS Less <<
NCT00781495 - Unknown December 2011 Netherlands ... More >> Jeroen Bosch Hospital Recruiting 's-Hertogenbosch, Brabant, Netherlands, 3400 NL Contact: Paetrick Netten, MD, PhD          Sub-Investigator: Paetrick Netten, MD, PhD          Jeroen Bosch Hospital Recruiting 's-Hertogenbosch, Brabant, Netherlands Contact: Linda Kemink, MD, PhD          Sub-Investigator: Linda Kemink, MD, PhD          Radboud University Nijmegen Medical Centre Recruiting Nijmegen, Gelderland, Netherlands, 6500 HB Contact: Henry Jansen, M          Principal Investigator: Henry Jansen, MD Less <<
NCT00786136 Diabetes Mellitus ... More >> Chronic Kidney Disease Less << Phase 4 Completed - -
NCT00789282 Diabetes Mellitus, Type 2 Not Applicable Terminated(Recruitment challen... More >>ges.) Less << - Canada, Alberta ... More >> University of Alberta, Dept of Family Medicicne Edmonton, Alberta, Canada, T6G - 2C8 Less <<
NCT00787605 - Completed - -
NCT00771069 - Completed - Korea, Republic of ... More >> Research Site Bucheon, Gyeonggi, Korea, Republic of Research Site Goyang, Gyeonggi, Korea, Republic of Research Site Guri, Gyeonggi, Korea, Republic of Research Site Sungnam, Gyeonggi, Korea, Republic of Research Site Suwon, Gyeonggi, Korea, Republic of Research Site Wonju, Kangwon, Korea, Republic of Research Site Jeonju, Keollabuk, Korea, Republic of Research Site Busan, Korea, Republic of Research Site Deagu, Korea, Republic of Research Site Deajeon, Korea, Republic of Research Site Incheon, Korea, Republic of Research Site Kwangju, Korea, Republic of Research Site Seoul, Korea, Republic of Less <<
NCT00790699 Type 1 Diabetes ... More >> Type 2 Diabetes Less << Not Applicable Terminated(Lack of patient pop... More >>ulation) Less << - United States, Texas ... More >> Texas Diabetes & Endocrinology, PA Austin, Texas, United States, 78731 Less <<
NCT00793481 - Completed - United States, California ... More >> Beckman Laser Institute Medical clinic Irvine, California, United States, 92612 Less <<
NCT00790439 Diabetes Mellitus, Type I Phase 2 Withdrawn(Due to funding limit... More >>ations) Less << - -
NCT00795262 Diabetes Hype... More >>rtension Less << Not Applicable Completed - United States, Georgia ... More >> Atlanta Vascular Research Foundation Tucker, Georgia, United States, 30084 Less <<
NCT00800683 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT00800683 - Completed - -
NCT00806585 Type 2 Diabetes Mellitus ... More >> Hypertension Less << Phase 2 Terminated - -
NCT00798785 Diabetes Mellitus, Type 1 Phase 1 Phase 2 Unknown December 2014 Belgium ... More >> Universitair Ziekenhuis Antwerpen Recruiting Antwerpen, Belgium Contact: Christophe De Block, MD,PhD          Principal Investigator: Christophe de Block, MD,PhD          University Hospital Brussels Recruiting Brussels, Belgium, 1090 Contact: Bart Keymeulen, MD PhD    +32 2 477 61 11    bart.keymeulen@uzbrussel.be    Principal Investigator: Bart Keymeulen, MD PhD          Hopital Erasme Recruiting Brussel, Belgium Contact: Laurent Crenier, MD          Principal Investigator: Laurent Crenier, MD          University Hospital Leuven Recruiting Leuven, Belgium, 3000 Contact: Pieter Gillard, MD PhD    +32 16 34 85 54    pieter.gillard@uz.kuleuven.ac.be    Contact: Da Hae Lee, MD    +32 16 34 23 98    dahae.lee@uzleuven.be    Sub-Investigator: Pieter Gillard, MD          Principal Investigator: Chantal Mathieu, MD PhD Less <<
NCT00806585 - Terminated - -
NCT00806858 - Completed - China, Beijing ... More >> Novo Nordisk Investigational Site Beijing, Beijing, China, 100004 Less <<
NCT00790257 Type 1 Diabetes Mellitus Phase 1 Withdrawn - Belgium ... More >> University clinical Hospital Saint-Luc Brussels, Belgium, 1200 Less <<
NCT00806572 Diabetes Mellitus, Type 1 Phase 2 Terminated(Adverse events rela... More >>ted to drug lot) Less << - United States, California ... More >> University of California San Francisco San Francisco, California, United States, 94143 United States, New York Naomie Berrie Diabetes Center, Columbia University New York, New York, United States, 10032 United States, Washington Benaroya Research Institute Seattle, Washington, United States, 98101 Less <<
NCT00808795 Radiocontrast-Induced Nephropa... More >>thy Chronic Kidney Disease Diabetes Mellitus Less << Phase 3 Completed - Iran, Islamic Republic of ... More >> Tehran Heart center Tehran, Iran, Islamic Republic of, 1411713138 Less <<
NCT00807651 Type 1 Diabetes Mellitus Phase 2 Unknown December 2016 China, Shanghai ... More >> Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai, China, 200025 Less <<
NCT00813228 Diabetes Mellitus Type 1 ... More >> Diabetes Mellitus Type 2 Less << Phase 1 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00819975 Postprandial Lipemia ... More >> Type 2 Diabetes Less << Not Applicable Completed - Denmark ... More >> Department of Clinical Nutrition Aarhus, Denmark, 8000 Less <<
NCT00810420 - Completed - Denmark ... More >> Odense University Hospital Odense, Denmark, 5000 Less <<
NCT03383185 - Completed - Brazil ... More >> Federal University of Sao Paulo - Unifesp São Paulo, SP, Brazil, 0-4023- 062 Less <<
NCT00833716 Diabetes Diab... More >>etes Mellitus, Type 2 Renal Impairment Less << Phase 1 Completed - United States, Florida ... More >> Novo Nordisk Investigational Site Miami, Florida, United States, 33014 Novo Nordisk Investigational Site Orlando, Florida, United States, 32806 United States, Tennessee Novo Nordisk Investigational Site Knoxville, Tennessee, United States, 37920 Less <<
NCT00836030 - Completed - Singapore ... More >> Novo Nordisk Investigational Site Singapore, Singapore, 307684 Less <<
NCT00817973 Type 2 Diabetes ... More >> Postprandial Lipemia Less << Not Applicable Completed - Denmark ... More >> Department of Clinical Nutrition Aarhus, Denmark Less <<
NCT00837512 - Completed - -
NCT00837759 Diabetes Mellitus Type 1 ... More >> Autoimmune Diabetes Less << Phase 2 Terminated(Changes to study pe... More >>rsonnel.) Less << - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT02961023 Pulmonary Arterial Hypertensio... More >>n Less << Not Applicable Unknown November 2017 United Kingdom ... More >> Dr Martin Johnson Recruiting Glasgow City, United Kingdom, G81 4DY Contact: Martin K Johnson, MD    +44 141 951 5497    mjohnson4@nhs.net    Contact: Alison M MacKenzie, MD    +44 141 951 5497    alisonmackenzie2@nhs.net Less <<
NCT00839878 - Completed - Bangladesh ... More >> Novo Nordisk Investigational Site Dhaka, Bangladesh, 1206 Less <<
NCT00843388 Diabetes Mellitus ... More >> Nephropathy Blood Pressure Less << Phase 4 Unknown March 2010 -
NCT00837512 Type 1 Diabetes Mellitus Phase 2 Phase 3 Completed - United States, Georgia ... More >> Emory University Atlanta, Georgia, United States, 30322 Less <<
NCT00846300 Diabetes Mellitus, Type 2 ... More >> Hyperlipidemia Hypertension Less << Not Applicable Completed - United States, Texas ... More >> Christus Memorial Hospital Corpus Christi, Texas, United States, 78405 Valley Baptist Family Medicine Residency Program Harlingen, Texas, United States, 78550 Laredo Medical Group Laredo, Texas, United States McAllen Family Medicine Residency Program McAllen, Texas, United States, 78503 Family Medicine Residency Program, Christus Santa Rosa Hospital San Antonio, Texas, United States, 78207 Dept Family & Community Medicine, UTHSCSA San Antonio, Texas, United States, 78229 Less <<
NCT00821899 Type 1 Diabetes Mellitus Not Applicable Completed - Spain ... More >> Enric Esmatjes Barcelona, Spain, 08036 Hospital Clinic Barcelona, Spain, 08036 Less <<
NCT00837759 - Terminated(Changes to study pe... More >>rsonnel.) Less << - -
NCT00867594 Brittle Type I Diabetes Mellit... More >>us Less << Phase 2 Completed - Israel ... More >> Hadassah University Hospital Jerusalem, Israel, 91120 Less <<
NCT00846716 Type 2 Diabetes Mellitus Not Applicable Unknown November 2011 Japan ... More >> Shiga University of Medical Science Recruiting Otsu, Shiga, Japan, 520-2192 Contact: Hiroshi Maegawa, PhD    +81-77-548-2222    maegawa@belle.shiga-med.ac.jp    Contact: Takashi Uzu, PhD    +81-77-548-2222    tuzu@belle.shiga-med.ac.jp    Principal Investigator: Yoshihiko Nishio, PhD          Principal Investigator: Takashi Uzu, PhD          Principal Investigator: Masato Ohji, PhD          Sub-Investigator: Osamu Sawada, PhD          Principal Investigator: Daisuke Koya, PhD Less <<
NCT00870818 Type 1 Diabetes Mellitus Phase 2 Phase 3 Terminated - United States, Georgia ... More >> Atlanta Diabetes Associates Atlanta, Georgia, United States, 30309 Less <<
NCT00871416 Diabetes Diab... More >>etes Mellitus, Type 1 Diabetes Mellitus, Type 2 Delivery Systems Less << Phase 3 Completed - Denmark ... More >> Novo Nordisk Investigational Site Århus, Denmark, 8000 Less <<
NCT00872560 Diabetes Diab... More >>etes Mellitus, Type 1 Delivery Systems Less << Phase 3 Completed - Italy ... More >> Novo Nordisk Investigational Site Chieti, Italy, 66100 Less <<
NCT00848705 Adolescent Type 1 Diabetes Early Phase 1 Completed - United States, Tennessee ... More >> Vanderbilt University Medical Center Nashville, Tennessee, United States, 37240 Less <<
NCT00874159 - Completed - Philippines ... More >> Manilla, Philippines, 1605 Less <<
NCT01941277 Prediabetic State Not Applicable Terminated(funding withdrawn) - United Kingdom ... More >> Manchester University Manchester, United Kingdom, M23 9QZ Move Lab Newcastle upon Tyne, United Kingdom, NE1 7RU Less <<
NCT03649412 Autoimmune Diseases Phase 1 Recruiting April 24, 2019 United Kingdom ... More >> GSK Investigational Site Recruiting Nottingham, United Kingdom, NG11 6JS Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com Less <<
NCT00894868 Congestive Heart Failure ... More >> Type II Diabetes Mellitus Less << Phase 4 Completed - -
NCT00886340 Prediabetes Phase 2 Completed - -
NCT01947790 LVM Type 2 Di... More >>abetic Patients With IHD Endothelial Function Less << Phase 4 Completed - China, Hubei ... More >> Wuhan City, Hubei, China, 43000 Xiang Guangda Wuhan, Hubei, China, 430070 Less <<
NCT00711009 Human Immunodeficiency Virus I... More >>nfection Less << Phase 3 Completed - -
NCT00886340 - Completed - -
NCT03245619 Pancreatitis, Acute Necrotizin... More >>g Less << Phase 1 Terminated(Sponsor decision pe... More >>nding review of data.) Less << - United Kingdom ... More >> GSK Investigational Site Cambridge, United Kingdom, CB2 0GG Less <<
NCT03187158 - Enrolling by invitation August 15, 2019 India ... More >> Council of Scientific and Industrial Research-Institute of Genomics and Integrative Biology New Delhi, India, 110007 Less <<
NCT00873561 Type 1 Diabetes Mellitus Phase 1 Completed - Canada, Ontario ... More >> Children's Hospital of Eastern Ontario Ottawa, Ontario, Canada Canada, Quebec Center Hospitalier Universitaire de Sherbrooke Sherbrooke, Quebec, Canada Canada Centre de recherche clinique de Laval Laval, Canada Czech Republic University Hospital and School of Medicine Olomouc, Czech Republic Faculty Hospital Motol Prague, Czech Republic Finland Helsinki University Hospital Helsinki, Finland France Hôpital Debrousse Lyons, France Hôpital St Vincent de Paul Paris, France Germany Diabetes Center for Children and Adolescents Hannover, Germany Institut für Diabetesforschung Munchen, Germany South Africa New Groote Schuur Hospital Cape Town, South Africa Parklands Medical Center Durban, South Africa Center for Diabetes and Endocrinology Johannesburg, South Africa Donald Gordon Medical Center Johannesburg, South Africa Medigate Medical Center KwaZulu Natal, South Africa Helderberg Diabetic Clinic and Practice Somerset West, South Africa Spain Hospital Clinic de Barcelona Barcelona, Spain Hospital de Cruces Cruces-Baracado, Spain Hospital Materno-Infantil Malaga, Spain University Hospital Virgen del Rocío Sevilla, Spain United Kingdom Maternal and Child Health Services 2 Dundee, United Kingdom Less <<
NCT03203863 - Completed - -
NCT03190785 Obesity Metab... More >>olic Syndrome Less << Not Applicable Recruiting July 2019 United States, North Carolina ... More >> Brody School of Medicine at East Carolina University Recruiting Greenville, North Carolina, United States, 27834 Contact: David N Collier, MD, PhD    252-744-4994    collierd@ecu.edu    Contact: Patricia Brophy, MS    252 737 1600    brophyp@ecu.edu Less <<
NCT01768208 Type 2 Diabetes Phase 4 Unknown December 2017 China, Shanghai ... More >> Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai, China, 200025 Less <<
NCT01782092 - Completed - United States, Georgia ... More >> Life University Marietta, Georgia, United States, 30060 Less <<
NCT03215888 - Recruiting December 31, 2020 United States, Minnesota ... More >> Clinical and Translational Science Institute and Center for Magnetic Resonance Research, University of Minnesota Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Amir Moheet, MD    612-624-3209    mohee002@umn.edu    Principal Investigator: Amir Moheet, MD Less <<
NCT00769275 - Completed - United States, Connecticut ... More >> Yale University School of Medicine New Haven, Connecticut, United States, 06520 Less <<
NCT00711009 - Completed - -
NCT01766752 Type 2 Diabetes Phase 3 Completed - Austria ... More >> Medical University of Graz Graz, Austria, 8036 Less <<
NCT03272854 - Active, not recruiting August 2031 -
NCT00286741 - Completed - -
NCT03260387 - Recruiting April 1, 2021 United States, California ... More >> University of California, San Francisco Recruiting San Francisco, California, United States, 94143 Contact: Samvika Mehra    415-476-2574    Samvika.Mehra@ucsf.edu    United States, Illinois The University of Chicago Medical Center Recruiting Chicago, Illinois, United States, 60637 Contact: Lindsay Basto    773-702-2504    Lindsay.basto@uchospitals.edu    United States, Kentucky University of Louisville Recruiting Louisville, Kentucky, United States, 40292 Contact: Mechelle Kaufman    502-852-7507    mechelle.stoner@louisville.edu    United States, Maryland Johns Hopkins Hospital Recruiting Baltimore, Maryland, United States, 21287 Contact: Mahya Faghih    443-761-9157    mfaghih2@jhu.edu    United States, Minnesota University of Minnesota Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Peggy Ptacek    612-626-5905    vorwa001@umn.edu    United States, New Hampshire Dartmouth-Hitchcock Medical Center Recruiting Lebanon, New Hampshire, United States, 03756 Contact: Jessica Chevalier    603-653-9033    jessica.i.chevalier@hitchcock.org    United States, Ohio Cincinnati Children's Hospital Medical Center Recruiting Cincinnati, Ohio, United States, 45229 Contact: Misty Troutt    513-803-1971    Misty.troutt@cchmc.org    The Ohio State University Wexner Medical Center Recruiting Columbus, Ohio, United States, 43210 Contact: Casey McClurkin    614-688-9575    Casey.McClurkin@osumc.edu    United States, Pennsylvania University of Pittsburgh Medical Center, Thomas E. Starzl Transplantation Institute Recruiting Pittsburgh, Pennsylvania, United States, 15213 Contact: Sheila Fedorek    412-692-2207    fedoreksp@upmc.edu    United States, South Carolina Medical University of South Carolina Recruiting Charleston, South Carolina, United States, 29425 Contact: Caitlin Schaffner    843-792-7558    schaffne@musc.edu    United States, Texas Baylor University Medical Center Recruiting Dallas, Texas, United States, 75246 Contact: Sharon Primeaux    214-818-7876    Sharon.Primeaux@bswhealth.org Less <<
NCT00286741 Diabetes Hype... More >>rtension Less << Phase 3 Completed - United States, North Carolina ... More >> Durham VA Medical Center, Durham, NC Durham, North Carolina, United States, 27705 United States, Virginia Hunter Holmes McGuire VA Medical Center, Richmond, VA Richmond, Virginia, United States, 23249 Less <<
NCT00449891 - Completed - United States, California ... More >> Stanford University Stanford, California, United States, 94305 Less <<
NCT02332993 - Active, not recruiting December 2020 United States, Ohio ... More >> University East Hospital Columbus, Ohio, United States, 43205 Martha Morehouse Medical Plaza Columbus, Ohio, United States, 43221 Less <<
NCT02262754 Chronic Low Back Pain Phase 2 Completed - -
NCT00290979 Diabetes Mellitus, Type 1 Phase 3 Completed - Japan ... More >> Sanofi-Aventis Tokyo, Japan Less <<
NCT02228395 Healthy Phase 1 Completed - United States, Connecticut ... More >> New Haven Clinical Research Unit New Haven, Connecticut, United States, 06511 Less <<
NCT02228395 - Completed - -
NCT00296296 - Completed - -
NCT00297401 Diabetes Mellitus, Type 1 Phase 3 Completed - Canada, Ontario ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM - 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physcian. Toronto, Ontario, Canada Less <<
NCT00299169 Diabetes Card... More >>iovascular Disease Hyperlipidemia Less << Phase 4 Terminated(insufficient recrui... More >>tment/enrollment) Less << - Canada, Ontario ... More >> St. Joseph's Health Care London London, Ontario, Canada, N6A 4V2 Less <<
NCT01173315 Type 2 Diabetes Phase 2 Completed - -
NCT00296296 Kidney Transplant ... More >> Diabetes Mellitus, Type 2 Diabetic Nephropathy Less << Phase 4 Completed - United States, California ... More >> Stanford university Hospital and Clinics Stanford, California, United States, 94305 Less <<
NCT00305344 Type 1 Diabetes Mellitus Phase 1 Phase 2 Completed - United States, Florida ... More >> University of Florida Gainesville, Florida, United States, 32610 Less <<
NCT00300911 Diabetes Mellitus, Type 2 Phase 4 Completed - Turkey ... More >> Baskent University Ankara Hospital Ankara, Turkey, 06490 Less <<
NCT00305344 - Completed - -
NCT02262754 - Completed - -
NCT00313183 Type 1 Diabetes Mellitus Phase 2 Completed - United States, Colorado ... More >> Research Site Aurora, Colorado, United States United States, Missouri Research Site Kansas City, Missouri, United States United States, New York Research Site New York, New York, United States Less <<
NCT00315133 Type 1 Diabetes Mellitus Phase 1 Phase 2 Completed - Brazil ... More >> Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo Ribeirão Preto, Brazil, 14048-900 Less <<
NCT00308256 Type 1 Diabetes Not Applicable Completed - France ... More >> Marc Nicolino Lyon, France, 69005 Less <<
NCT00315588 - Completed - -
NCT00315614 Type 1 Diabetes Mellitus Phase 2 Terminated(We did not achieve ... More >>a tolerogenic profile. Subjects withdrew from protocol and enrolled in other islet transplant trials.) Less << - United States, Florida ... More >> Diabetes Research Institute Miami, Florida, United States, 33136 Less <<
NCT00315588 Diabetes Mellitus, Type 1 Phase 2 Completed - United States, Florida ... More >> Diabetes Research Institute Miami, Florida, United States, 33136 Less <<
NCT00320853 Diabetes Mellitus, Non-Insulin... More >>-Dependent Less << Not Applicable Completed - India ... More >> Sitaram Bhartia Institute of Science and Research New Delhi, Delhi, India, 110016 Less <<
NCT00315627 - Completed - -
NCT00315614 - Terminated(We did not achieve ... More >>a tolerogenic profile. Subjects withdrew from protocol and enrolled in other islet transplant trials.) Less << - -
NCT00325910 Diabetes Mellitus, Type 2 ... More >> Heart Failure, Congestive Less << Phase 3 Terminated(Insufficient study ... More >>participants) Less << - Canada, Alberta ... More >> Misericordia Hospital Edmonton, Alberta, Canada, T5R 4H5 University of Alberta Hospital Edmonton, Alberta, Canada, T6G 2B7 Less <<
NCT00328393 Hypertension ... More >>Diabetes Mellitus Type 2 Less << Phase 3 Completed - Germany ... More >> CRC Medical Department IV Erlangen, Germany, 91054 Less <<
NCT00324207 - Completed - United States, Missouri ... More >> Children's Mercy Hospital Kansas City, Missouri, United States, 64108 Less <<
NCT00333554 Type 1 Diabetes Mellitus Not Applicable Completed - United States, California ... More >> Childrens Hospital of Los Angeles Los Angeles, California, United States, 90027 Children's Hospital of Orange County Orange, California, United States, 92868-3835 University of California, San Francisco San Francisco, California, United States, 94143 United States, Indiana Indiana University-Riley Hospital for Children Indianapolis, Indiana, United States, 46202 United States, Iowa University of Iowa Health Care Iowa City, Iowa, United States, 52242 United States, Massachusetts Joslin Diabetes Center Boston, Massachusetts, United States, 02215 United States, Minnesota University of Minnesota Minneapolis, Minnesota, United States, 55455 United States, Missouri The Children's Mercy Hospital Kansas City, Missouri, United States, 64108-9898 United States, Utah Utah Diabetes Center Salt Lake City, Utah, United States, 84108 Less <<
NCT00330954 - Completed - United States, Missouri ... More >> Children's Mercy Hospital Kansas City, Missouri, United States, 64108 Less <<
NCT00340938 Diabetes Type... More >> 1 Diabetes Less << Phase 1 Completed - United States, Illinois ... More >> Childrens Memorial Hospital, Chicago Chicago, Illinois, United States, 60614-3394 United States, Massachusetts Joslin Diabetes Center Boston, Massachusetts, United States, 02215 United States, Texas Texas Children's Hospital Houston, Texas, United States, 77030 Less <<
NCT00315627 Type 1 Diabetes Mellitus Phase 2 Completed - United States, Florida ... More >> Diabetes Research Institute Miami, Florida, United States, 33136 Less <<
NCT00340639 - Completed - United States, Maryland ... More >> National Institute of Child Health and Human Development (NICHD) Bethesda, Maryland, United States, 20892 Less <<
NCT00343343 Diabetes Diab... More >>etes Mellitus, Type 1 Diabetes Mellitus, Type 2 Delivery Systems Less << Phase 2 Completed - Denmark ... More >> Novo Nordisk Investigational Site Ålborg, Denmark, 9100 Novo Nordisk Investigational Site Århus C, Denmark, 8000 Less <<
NCT00356109 Diabetes Mellitus, Type 1 Phase 3 Completed - -
NCT02459249 Obesity High ... More >>Blood Pressure Hyperglycemia Dyslipidemia Less << Not Applicable Unknown July 2016 Mexico ... More >> National Institute of Public Health Recruiting Cuernavaca, Morelos, Mexico, 62100 Contact: Ismael R Campos, PhD    527773293000 ext 7427    icampos@insp.mx Less <<
NCT00339781 - Completed - United Kingdom ... More >> St. Bartholomew's Hospital London, United Kingdom Less <<
NCT00360061 Type 1 Diabetes Mellitus Not Applicable Completed - United Kingdom ... More >> Bristol Royal Hospital for Children Bristol, United Kingdom, BS2 8BJ Less <<
NCT00328965 Diabetes Mellitus, Type 2 ... More >> Essential Hypertension Less << Phase 4 Completed - -
NCT00358059 Type 1 Diabetes Mellitus Phase 3 Completed - United States, Florida ... More >> Nemours Children's Clinic Jacksonville, Florida, United States, 32207 United States, Missouri Washington University in St. Louis School of Medicine St. Louis, Missouri, United States, 63110 Less <<
NCT00362128 - Completed - -
NCT00362128 - Completed - United States, New York ... More >> New York Downtown Hospital New York, New York, United States, 10038 Less <<
NCT00357890 Diabetes Mellitus, Insulin-Dep... More >>endent Less << Not Applicable Completed - United States, Florida ... More >> Nemours Children's Clinic Jacksonville, Florida, United States, 32207 Less <<
NCT00370656 Diabetes Mellitus ... More >> Peripheral Neuropathies Less << Phase 2 Phase 3 Completed - United Kingdom ... More >> Royal Bournemouth Hospital Bournemouth, Dorset, United Kingdom, BH7 7DW Poole General Hospital Poole, Dorset, United Kingdom, BH15 2JB University of Surrey Clinical Research Centre Guildford, Surrey, United Kingdom, GU2 7XP Less <<
NCT00374270 Hypertension ... More >>Diabetes Mellitus, Type 1 Diabetes Mellitus, Type 2 Less << Phase 4 Completed - Canada, Alberta ... More >> University of Alberta Edmonton, Alberta, Canada, T6G 2C8 Less <<
NCT00360893 - Active, not recruiting June 2022 United States, California ... More >> University of California, San Diego San Diego, California, United States, 92093 United States, Maryland George Washington University, Biostatistics Center, Data Coordinating Center Bethesda, Maryland, United States, 20852 National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Bethesda, Maryland, United States, 20892 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 United States, Michigan University of Michigan Ann Arbor, Michigan, United States, 48109 United States, Ohio Case Western Reserve University, Clinical Coordinating Center Cleveland, Ohio, United States, 44106 Canada, Ontario University of Toronto, Mount Sinai Hospital Toronto, Ontario, Canada, M5t 3L9 Less <<
NCT00378508 - Completed - -
NCT00365170 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 4 Completed - -
NCT00374361 - Completed - United States, Ohio ... More >> Ohio State University Columbus, Ohio, United States, 43210 Less <<
NCT00398944 Diabetes Mellitus ... More >> Hypertension Less << Not Applicable Completed - France ... More >> SFTG Paris, France, 75013 Less <<
NCT00385697 Type 1 Diabetes Mellitus Phase 2 Phase 3 Completed - -
NCT00378508 Type 1 Diabetes Mellitus Phase 2 Completed - United States, California ... More >> University of California at San Francisco San Francisco, California, United States, 94143 United States, Colorado Barbara Davis Diabetes Center Aurora, Colorado, United States, 80045 United States, Connecticut Yale University New Haven, Connecticut, United States, 06520 United States, Pennsylvania Children's Hospital of Philadelphia (CHOP) Philadelphia, Pennsylvania, United States, 10194 Less <<
NCT00410033 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Not Applicable Completed - Sweden ... More >> Novo Nordisk Investigational Site Linköping, Sweden, 581 85 Less <<
NCT00412165 Obesity Overw... More >>eight Diabetes Less << Not Applicable Completed - United States, California ... More >> UCSD - CALIT2- Atkinson Hall La Jolla, California, United States, 92037 Less <<
NCT00417924 Diabetes Mellitus, Type 1 ... More >> Diabetes Mellitus, Type 2 Less << Early Phase 1 Completed - United States, Florida ... More >> Sanford L. Ziff Health Center Ft. Lauderdale, Florida, United States, 33328 Less <<
NCT00382473 Diabetes Mellitus, Type 2 ... More >> Overweight Less << Not Applicable Terminated(lack of funding) - United States, Pennsylvania ... More >> University of Pittsburgh, Montefiore Hospital Pittsburgh, Pennsylvania, United States, 15213 Less <<
NCT01354249 Acute Phase Response ... More >> Insulin Resistance Less << Not Applicable Completed - Brazil ... More >> Hospital Julio Muller Cuiaba, Mato Grosso, Brazil, 78000-000 Less <<
NCT00399997 Metabolic Syndrome X ... More >> Diabetes Mellitus, Type 2 Cardiovascular Diseases Less << Phase 2 Phase 3 Unknown - Denmark ... More >> Centre of Applied and Clinical Exercise Sciences, Institute of Sports Science and Clinical Biomechanics, University of Southern Denmark Odense, Denmark, DK-5230 Less <<
NCT00419562 Diabetes Mellitus, Type 1 Phase 3 Active, not recruiting June 2017 United States, California ... More >> University of California-San Francisco San Francisco, California, United States, 94143 Stanford University Stanford, California, United States, 94305 United States, Colorado Barbara Davis Center for Childhood Diabetes Aurora, Colorado, United States, 80010 United States, Connecticut Yale University New Haven, Connecticut, United States, 06520 United States, Florida University of Florida Gainesville, Florida, United States, 32610-0296 University of Miami Miami, Florida, United States, 33136 United States, Indiana Indiana University-Riley Hospital for Children Indianapolis, Indiana, United States, 46202 United States, Minnesota University of Minnesota Minneapolis, Minnesota, United States, 55455 United States, New York Columbia University New York, New York, United States, 10032 United States, Pennsylvania Childrens Hospital of Pittsburgh Pittsburgh, Pennsylvania, United States, 15213 United States, Tennessee Vanderbilt Eskind Diabetes Clinic Nashville, Tennessee, United States, 37232-8160 United States, Texas University of Texas Dallas, Texas, United States, 75235-8858 United States, Washington Benaroya Research Institute Seattle, Washington, United States, 98101 Australia, Victoria Walter and Eliza Hall Institute Parkville, Victoria, Australia, 3050 Canada, Ontario The Hospital for Sick Children Toronto, Ontario, Canada, M5G1X8 Finland University of Turku Turku, Finland, FIN-20520 Italy San Raffaele Hospital Milan, Italy, 20132 United Kingdom University of Bristol Bristol, United Kingdom, BS10 5NB Less <<
NCT00419718 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 1 Completed - Austria ... More >> Novo Nordisk Investigational Site Graz, Austria, 8036 Less <<
NCT03372603 Cough Phase 2 Active, not recruiting April 22, 2019 United Kingdom ... More >> GSK Investigational Site Manchester, Lancashire, United Kingdom, M23 9LT GSK Investigational Site Belfast, United Kingdom, BT9 7BL GSK Investigational Site Cottingham, United Kingdom, HU16 5JQ GSK Investigational Site North Shields, United Kingdom, NE29 8NH Less <<
NCT00435019 - Completed - -
NCT00435981 Type 1 Diabetes Phase 2 Completed - Sweden ... More >> Borås Hospital Borås, Sweden, SE-501 82 The Queen Silvia Children´s Hospital Göteborg, Sweden, SE-416 85 Halmstad Hospital Halmstad, Sweden, SE-301 85 Ryhov Hospital Jönköping, Sweden, SE-551 85 Linköping University Linköping, Sweden, SE-581 85 University Hospital, MAS Malmö, Sweden, SE-205 02 Astrid Lindgren Children´s Hospital Stockholm, Sweden, SE-171 76 Örebro University Hospital Örebro, Sweden, SE-701 85 Less <<
NCT00435019 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 3 Completed - -
NCT00444899 Type 1 Diabetes ... More >> Type 2 Diabetes Less << Not Applicable Active, not recruiting December 2018 Canada, Quebec ... More >> Centre de recherche clinique Étienne-Le Bel du CHUS Sherbrooke, Quebec, Canada, J1H 5N4 Less <<
NCT00445913 Type 1 Diabetes Phase 1 Completed - United States, Pennsylvania ... More >> University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States, 15213 Less <<
NCT00430040 Diabetes Mellitus, Type 2 ... More >> Hypertension Less << Phase 4 Unknown May 2013 United States, New York ... More >> Diabetes - Endocrinology Center of Western New York Buffalo, New York, United States, 14221 Less <<
NCT00450489 - Withdrawn December 2009 United States, Missouri ... More >> Children's Mercy Hospital Kansas City, Missouri, United States, 64108 Less <<
NCT00439985 Type 1 Diabetes Mellitus Not Applicable Terminated(decreased enrollmen... More >>t. (there are no data results for this study)) Less << - United States, New York ... More >> Mount Sinai School of Medicine New York, New York, United States, 10029-6574 Less <<
NCT02600338 - Unknown September 2016 Canada, Ontario ... More >> Toronto 3-D (Diet, Digestive tract and Disease) Knowledge Synthesis and Clinical Trials Unit, Clinical Nutrition and Risk Factor Modification Centre, St. Michael's Hospital Toronto, Ontario, Canada, M5C 2T2 Less <<
NCT00476788 - Completed - -
NCT00476788 Type 1 Diabetes Mellitus Not Applicable Completed - United States, Alabama ... More >> Children's Hospital Birmingham, Alabama, United States, 35233 Less <<
NCT00462371 Diabetes Mellitus, Type 1 ... More >> Child Less << Phase 4 Completed - Netherlands ... More >> ErasmusMC/Sophia´s children´s Hospital Rotterdam, Netherlands, 3015 GJ Less <<
NCT00486109 Type 1 Diabetes ... More >> Type 2 Diabetes Less << Not Applicable Completed - United States, Georgia ... More >> Atlanta Diabetes Associates Atlanta, Georgia, United States, 30309 United States, Nebraska Diabetes and Endocrine Associates Omaha, Nebraska, United States, 68131 United States, Texas Texas Diabetes & Endocrinology Austin, Texas, United States, 78731 Research Institute of Dallas Dallas, Texas, United States, 75231 Diabetes and Glandular Disease Clinic San Antonio, Texas, United States, 78729 Less <<
NCT00489190 Diabetes Mellitus, Type 1 Phase 4 Completed - Kazakhstan ... More >> Sanofi-Aventis Almaty, Kazakhstan Less <<
NCT00495014 Type 2 Diabetes Mellitus Phase 1 Completed - United States, Indiana ... More >> GSK Investigational Site Evansville, Indiana, United States, 47714 Less <<
NCT01478841 Healthy Volunteers ... More >> Insulin Resistance Type 2 Diabetes (T2D) Less << Not Applicable Completed - France ... More >> Montpellier University Hospital Montpellier, France, 34295 Less <<
NCT00501878 Diabetes Mellitus Phase 4 Completed - Thailand ... More >> Srinagarind Hospital Eye Clinic Khon Kaen, Thailand, 40002 Less <<
NCT01457625 - Unknown January 2014 Taiwan ... More >> Far Eastern Memorial Hospital Completed New Taipei city, Taiwan Far eastern memorial hospital Recruiting New Taipei City, Taiwan Contact: Hung-Yuan Chen, MD    +886-2-89667000 ext 1163    alexander220tw@yahoo.com Less <<
NCT00504673 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - Spain ... More >> La Coruña, Spain, 15006 Less <<
NCT00521378 - Completed - United States, Texas ... More >> San Antonio, Texas, United States Less <<
NCT02796456 - Completed - France ... More >> Hôpital Jeanne de Flandre - CHRU de Lille Lille, France Less <<
NCT00522210 Type 1 Diabetes Not Applicable Completed - Canada, Alberta ... More >> Alberta Children's Hospital Calgary, Alberta, Canada, T3B 6A8 Less <<
NCT00525889 Diabetes Mellitus, Type 1 Phase 1 Completed - United States, New York ... More >> Naomi Berrie Diabetes Center, Columbia University New York, New York, United States, 10032 United States, Oregon Oregon Health Sciences University Portland, Oregon, United States, 97239 United States, Washington Benaroya Research Institute Seattle, Washington, United States, 98101 Less <<
NCT00467246 Diabetes Mellitus Not Applicable Withdrawn(Ethics approval deni... More >>ed) Less << - -
NCT03472742 - Recruiting July 31, 2021 Japan ... More >> Niigata University Medical & Dental Hospital Recruiting Niigata, Japan, 951-8510 Contact: Division of Gastroenterology and Hepatology Less <<
NCT00497536 Type 1 Diabetes Mellitus Phase 4 Completed - Denmark ... More >> Medicinsk Endokrinologisk Afdeling M Aarhus C, Region Midtjylland, Denmark, 8000 Less <<
NCT00545857 Type 1 Diabetes Mellitus Phase 1 Completed - United States, New York ... More >> Thomas A. Wilson, MD Stony Brook, New York, United States, 11794-8111 Less <<
NCT00537251 Diabetes Mellitus, Type 1 Phase 3 Completed - -
NCT00539448 Diabetes Mellitus, Type 1 Phase 4 Completed - Bahrain ... More >> Sanofi-aventis administrative office Manama, Bahrain Kuwait Sanofi-aventis administrative office Kuwait City, Kuwait Qatar Sanofi-Aventis Administrative Office Doha, Qatar United Arab Emirates Sanofi-aventis administrative office Dubai, United Arab Emirates Less <<
NCT00547482 Type 2 Diabetes Mellitus ... More >> Overweight Less << Not Applicable Terminated(Protocol design und... More >>er review.) Less << - United States, California ... More >> Scripps Clinic Del Mar La Jolla / San Diego, California, United States, 92130 Cedars Sinai Los Angeles, California, United States, 90048 United States, Colorado University of Colorado at Denver Health Sciences Center Denver, Colorado, United States, 80262 United States, Missouri Washington University School of Medicine in St. Louis St. Louis, Missouri, United States, 63110 United States, New York Kaleida Health, Diabetes-Endocrinology Center of Western New York Buffalo, New York, United States, 14209 Comprehensive Weight Control Program Cornell Medical Center New York, New York, United States, 10021 Mt. Sinai School of Medicine NY, New York, United States, 10029-6574 United States, Pennsylvania University of Pennsylvania Pennsylvania, Pennsylvania, United States, 19104-3309 United States, Tennessee Vanderbilt University School of Medicine Nashville, Tennessee, United States, 37232 United States, Texas Diabetes and Glandular Disease Clinic (DGD) San Antonio, Texas, United States, 78229 Less <<
NCT00567775 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 2 Completed - Denmark ... More >> Novo Nordisk Investigational Site Glostrup, Denmark, 2600 Less <<
NCT00569400 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 3 Completed - Australia, New South Wales ... More >> Novo Nordisk Investigational Site Broadmeadow, New South Wales, Australia, 2292 Australia, South Australia Novo Nordisk Investigational Site Keswick, South Australia, Australia, 5035 Australia Novo Nordisk Investigational Site Dunedin, Australia, NZ Novo Nordisk Investigational Site Hamilton, Australia, NZ Novo Nordisk Investigational Site Kippa Ring, Australia, 4021 Novo Nordisk Investigational Site Miranda, Australia, 2228 Novo Nordisk Investigational Site Stones Corner, Australia, 4120 Hong Kong Novo Nordisk Investigational Site Shatin, New Territories, Hong Kong Malaysia Novo Nordisk Investigational Site Cheras, Malaysia, 56000 Novo Nordisk Investigational Site Georgetown, Penang, Malaysia, 10450 Novo Nordisk Investigational Site Kota Bharu, Kelantan, Malaysia, 16150 Philippines Novo Nordisk Investigational Site Cebu City, Philippines, 6000 Novo Nordisk Investigational Site Iloilo, Philippines Novo Nordisk Investigational Site Makati City, Philippines, 1200 Novo Nordisk Investigational Site Marikina City, Philippines, 1800 Less <<
NCT01323283 Lifestyle-related Condition ... More >> Overweight and Obesity Essential Fatty Acid Deficiency Less << Not Applicable Completed - Sweden ... More >> Karolinska Universitetssjukhuset Huddinge, Södermanland, Sweden, 14186 Less <<
NCT00569426 Diabetes Diab... More >>etes Mellitus, Type 1 Diabetes Mellitus, Type 2 Delivery Systems Less << Phase 4 Completed - United Kingdom ... More >> Novo Nordisk Investigational Site Cambridge, United Kingdom, CB2 2QQ Novo Nordisk Investigational Site Cardiff, United Kingdom, CF14 4XW Novo Nordisk Investigational Site Church Village, United Kingdom, CF38 1AB Novo Nordisk Investigational Site Dundee, United Kingdom, DD1 9SY Novo Nordisk Investigational Site Haywards Heath, United Kingdom, RH16 4EX Novo Nordisk Investigational Site Liverpool, United Kingdom, L9 7AL Novo Nordisk Investigational Site Livingstone, United Kingdom, EH54 6PP Novo Nordisk Investigational Site Penarth, United Kingdom, CF64 2XX Novo Nordisk Investigational Site Plymouth, United Kingdom, PL8 8DQ Novo Nordisk Investigational Site Sheffield, United Kingdom, S5 7AU Less <<
NCT00559286 Arterial Hypertension ... More >> Diabetes Mellitus Type 2 IRC or NIR Less << Phase 4 Terminated(logistic reasons, p... More >>atients could not be recruited) Less << - Germany ... More >> University Hospital Aachen, NRW, Germany, 52074 Less <<
NCT00564018 Type 1 Diabetes Not Applicable Terminated(Presumed loss of cl... More >>inical equipoise between the agents being investigated) Less << - United States, Texas ... More >> Children's Medical Center Dallas, Texas, United States, 75235 Less <<
NCT00569998 Diabetes Diab... More >>etes Mellitus, Type 1 Diabetes Mellitus, Type 2 Delivery Systems Less << Phase 3 Completed - Austria ... More >> Novo Nordisk Investigational Site Wien, Austria, 1090 Novo Nordisk Investigational Site Wien, Austria, A 1090 Germany Novo Nordisk Investigational Site Köln, Germany, 50858 Novo Nordisk Investigational Site Leverkusen, Germany, 51373 Novo Nordisk Investigational Site München, Germany, 81377 Novo Nordisk Investigational Site Speyer, Germany, 67346 Novo Nordisk Investigational Site St. Ingbert, Germany, 66386 Novo Nordisk Investigational Site Völklingen, Germany, 66333 Italy Novo Nordisk Investigational Site Catania, Italy, 95122 Novo Nordisk Investigational Site Palermo, Italy, 90127 Novo Nordisk Investigational Site Parma, Italy, 43100 Novo Nordisk Investigational Site Roma, Italy, 00165 Novo Nordisk Investigational Site Torino, Italy, 10144 Netherlands Novo Nordisk Investigational Site Almere, Netherlands, 1315 RA Novo Nordisk Investigational Site Amsterdam, Netherlands, 1081 HV Novo Nordisk Investigational Site Den Haag, Netherlands, 2512 VA Novo Nordisk Investigational Site Heerlen, Netherlands, 6419 PC Novo Nordisk Investigational Site Rotterdam, Netherlands, 3015 GD Novo Nordisk Investigational Site Veldhoven, Netherlands, 5504 DB United Kingdom Novo Nordisk Investigational Site Belfast, United Kingdom, BT12 6BE Novo Nordisk Investigational Site Belfast, United Kingdom, BT37 9RH Novo Nordisk Investigational Site Leeds, United Kingdom, LS9 7TF Novo Nordisk Investigational Site Sidcup, United Kingdom, DA14 6LT Less <<
NCT00569452 Diabetes Mellitus Type 1 Not Applicable Completed - Germany ... More >> Ulm, Germany, 89081 Less <<
NCT00570102 Type 1 Diabetes Mellitus Phase 2 Completed - Finland ... More >> Jorvi Hospital Espoo, Finland, 02740 University of Helsinki, Department of Obstetrics and Gynecology Helsinki, Finland, 00290 National Public Health Institute Helsinki, Finland, 00300 Helsinki University Hospital, Maternity Hospital Helsinki, Finland, 00610 University of Helsinki, Hospital for Children and Adolescents Helsinki, Finland, FIN-00290 Kanta-Häme Central Hospital, Department of Pediatrics Hämeenlinna, Finland, 13530 North Karelia Central Hospital Joensuu, Finland, 80210 Central Finland Central Hospital Jyväskylä, Finland, 40620 Kymenlaakso Central Hospital, Department of Pediatrics Kotka, Finland, 48210 University of Kuopio, Department of Pediatrics Kuopio, Finland, 70210 Päijät-Häme Central Hospital Lahti, Finland, 15850 South Karelia Central Hospital Lappeenranta, Finland, 53130 University of Oulu, Department of Pediatrics Oulu, Finland, 90014 Satakunta Central Hospital Pori, Finland, 28500 South Ostrobothnia Central Hospital Seinäjoki, Finland, 60220 Tampere University Hospital, Department of Pediatrics Tampere, Finland, 33520 University of Turku, Department of Virology Turku, Finland, 20520 Vaasa Central Hospital Vaasa, Finland, 65130 Less <<
NCT00585936 - Completed - United States, Massachusetts ... More >> Joslin Diabetes Center Boston, Massachusetts, United States, 02215 Less <<
NCT00569465 Type 2 Diabetes Mellitus ... More >> Hypertension Less << Phase 4 Terminated(End of the study) - Italy ... More >> "San Giovanni Battista" Hospital of Turin Turin, Italy, 10126 Less <<
NCT00592072 Diabetes Mellitus, Type 1 Not Applicable Completed - United States, Connecticut ... More >> Yale University School of Medicine New Haven, Connecticut, United States, 06520 Less <<
NCT00604656 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 3 Completed - Czech Republic ... More >> Novo Nordisk Investigational Site Hradec Králové, Czech Republic, 500 36 Novo Nordisk Investigational Site Praha 5, Czech Republic, 15018 Germany Novo Nordisk Investigational Site Bad Kreuznach, Germany, 55545 Novo Nordisk Investigational Site Bad Neuenahr-Ahrweiler, Germany, 53474 Novo Nordisk Investigational Site Diez, Germany, 65582 Novo Nordisk Investigational Site Frankfurt, Germany, 60325 Novo Nordisk Investigational Site Friedrichsthal, Germany, 66299 Novo Nordisk Investigational Site Karlsruhe, Germany, 76133 Novo Nordisk Investigational Site Marktheidenfeld, Germany, 97828 Novo Nordisk Investigational Site Marl, Germany, 45770 Novo Nordisk Investigational Site Oberursel, Germany, 61440 Novo Nordisk Investigational Site Rehlingen-Siersburg, Germany, 66780 Novo Nordisk Investigational Site Saarbrücken, Germany, 66121 Novo Nordisk Investigational Site Simmern, Germany, 55469 Novo Nordisk Investigational Site Speyer, Germany, 67346 Novo Nordisk Investigational Site St. Ingbert, Germany, 66386 Novo Nordisk Investigational Site Würzburg, Germany, 97072 Hungary Novo Nordisk Investigational Site Budapest, Hungary, 1096 Novo Nordisk Investigational Site Nyíregyháza, Hungary, 4400 Italy Novo Nordisk Investigational Site Cagliari, Italy, 09124 Novo Nordisk Investigational Site Chiavari, Italy, 16043 Novo Nordisk Investigational Site Citta' Di Castello, Italy, 06012 Novo Nordisk Investigational Site Lucca, Italy, 55100 Novo Nordisk Investigational Site Orvieto, Italy, 05018 Novo Nordisk Investigational Site Parma, Italy, 43100 Novo Nordisk Investigational Site Perugia, Italy, 06126 Novo Nordisk Investigational Site Rimini, Italy, 47900 Novo Nordisk Investigational Site Roma, Italy, 00128 Novo Nordisk Investigational Site Roma, Italy, 00133 Poland Novo Nordisk Investigational Site Bytom, Poland, 41-902 Novo Nordisk Investigational Site Mazowieckie, Poland, 09-400 Novo Nordisk Investigational Site Radom, Poland, 26-600 Novo Nordisk Investigational Site Warsaw, Poland, 03-242 Novo Nordisk Investigational Site Wroclaw, Poland, 50-306 Less <<
NCT02983643 - Unknown March 2018 Lebanon ... More >> American University of Beirut Medical Center Recruiting Beirut, Lebanon Contact: Jana Jabbour, LD, MPH    +961759668    jj13@aub.edu.lb    Contact: Jean El Cheikh, MD    +961350000 ext 7811    je46@aub.edu.lb    Principal Investigator: Jean El Cheikh, MD          Sub-Investigator: Jana Jabbour, LD, MPH          Sub-Investigator: Batoul Manana, LD          Sub-Investigator: Charbel Saadeh, PhD          Sub-Investigator: Ali Bazarbachi, MD          Sub-Investigator: Didier Blaise, MD          Sub-Investigator: Iman Abou Dalle, MD Less <<
NCT00579371 Islets of Langerhans Transplan... More >>tation Diabetes Mellitus, Type 1 Less << Phase 1 Phase 2 Terminated(Per Coordinator Stu... More >>dy was closed and data was never analyzed) Less << - United States, Nebraska ... More >> The Nebraska Medical Center Omaha, Nebraska, United States, 68198 Less <<
NCT00605592 Diabetes Mellitus, Type 1 Phase 1 Unknown January 2012 United States, Virginia ... More >> University of Virginia Charlottesville, Virginia, United States, 22908 Less <<
NCT00595569 - Completed - Switzerland ... More >> University of Basel Hospital Basel, Switzerland Less <<
NCT00607230 Type 1 Diabetes Mellitus Phase 1 Completed - United States, Massachusetts ... More >> Diabetes Research Center at Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT00622271 Type 1 Diabetes Mellitus Not Applicable Completed - United States, Wisconsin ... More >> Children's Hospital of Wisconsin Child and Adolescent Psychiatry and Behavioral Medicine Center and the Diabetes Clinic Milwaukee, Wisconsin, United States, 53201 Less <<
NCT00615264 - Completed - -
NCT00592072 - Completed - -
NCT01812694 Obesity Diet ... More >>Therapy Diabetes Type 2 Less << Phase 3 Completed - United States, Arizona ... More >> NIDDK, Phoenix Phoenix, Arizona, United States, 85014 Less <<
NCT00615264 Type 1 Diabetes Phase 3 Completed - -
NCT01820377 Type 2 Diabetes ... More >> Obesity Less << Not Applicable Completed - Canada, Manitoba ... More >> Children's Hospital Research Institute of Manitoba Winnipeg, Manitoba, Canada, R3E 3P4 Less <<
NCT01824017 Type 2 Diabetes Not Applicable Completed - United States, California ... More >> City of Hope Medical Center Duarte, California, United States, 91010 Less <<
NCT02314208 Spastic Paraplegia, Hereditary Phase 2 Completed - France ... More >> Pitié-Salpêtrière Hospital Paris, France Less <<
NCT00815828 Gestational Diabetes Not Applicable Completed - Brazil ... More >> Faculty of Medicine from University of Sao Paulo Sao Paulo, Brazil, 05403900 Less <<
NCT01876108 Fatty Liver L... More >>iver Dysfunction Insulin Resistance Less << Phase 2 Completed - Iran, Islamic Republic of ... More >> Gastroenterology clinic, Sina Hospital Tehran, Iran, Islamic Republic of Less <<
NCT01820273 - Completed - Sweden ... More >> Kalmar County Hospital Kalmar, Sweden, 39185 Less <<
NCT00831779 - Completed - -
NCT00831779 Type 2 Diabetes Mellitus Phase 2 Completed - United States, California ... More >> Va San Diego Healthcare System San Diego, California, United States, 92161 United States, Louisiana Pennington Biomedical Research Center Baton Rouge, Louisiana, United States, 70808 United States, Pennsylvania Temple University General Clinical Research Center Philadelphia, Pennsylvania, United States, 19140 Less <<
NCT01882907 Type 2 Diabetes Phase 4 Completed - Korea, Republic of ... More >> Busan Saint Mary's Medical Center Busan, Korea, Republic of Dong-AUniversity Medical Center Busan, Korea, Republic of Inje University Baik Hospital Busan, Korea, Republic of Kosin University Hospital Busan, Korea, Republic of Pusan National University Hospital Busan, Korea, Republic of Changwon Fatima Hospital Changwon, Korea, Republic of Daegu Catholic University Medical Center Daegu, Korea, Republic of Keimyung University Dongsan Medical Center Daegu, Korea, Republic of Kyungbuk National Universtiy Hospital Daegu, Korea, Republic of Chonnam National University Hospital Gwangju, Korea, Republic of Chosun University Hospital Gwangju, Korea, Republic of Chonbuk National University Hospital Jeonju, Korea, Republic of Gyeongsang National University Hospital Jinju, Korea, Republic of Masan Samsung Medical Center Masan, Korea, Republic of Ulsan University Hospital Ulsan, Korea, Republic of Less <<
NCT03370419 Metabolic Syndrome Not Applicable Completed - -
NCT01882907 - Completed - -
NCT00828425 - Completed - -
NCT03418857 Metabolic Syndrome Phase 1 Phase 2 Recruiting December 2019 United States, Pennsylvania ... More >> The Pennsylvania State University Recruiting University Park, Pennsylvania, United States, 16802 Contact: Connie J Rogers       cjr102@psu.edu    Principal Investigator: Connie J Rogers, PhD, MPH Less <<
NCT00855166 Type 2 Diabetes Mellitus Phase 3 Completed - Bulgaria ... More >> Research Site Blagoevgrad, Bulgaria Research Site Sofia, Bulgaria Czech Republic Research Site Beroun, Czech Republic Research Site Brno, Czech Republic Research Site Praha, Czech Republic Research Site Semily, Czech Republic Research Site Slany, Czech Republic Hungary Research Site Balatonfured, Hungary Research Site Budapest, Hungary Research Site Csongrad, Hungary Research Site Kecskemet, Hungary Research Site TAT, Hungary Poland Research Site Elblag, Poland Research Site Krakow, Poland Research Site Torun, Poland Sweden Research Site Goteborg, Sweden Research Site Jarfalla, Sweden Research Site Lund, Sweden Research Site Malmo, Sweden Research Site Stockholm, Sweden Research Site Uppsala, Sweden Less <<
NCT03409172 Obesity and Metabolic Syndrome Not Applicable Completed - -
NCT00867022 - Completed - Finland ... More >> Department of Obstet and Gyn, Helsinki University Hospital Helsinki, Uusimaa, Finland, 00290 Less <<
NCT01907958 - Unknown June 2014 Canada, Quebec ... More >> Medpharmgene Recruiting Montreal, Quebec, Canada, H1Y 3L1 Contact: Marie-Renée Guertin, Project manager    514 249 4209 ext 222    m-r.guertin@medpharmgene.ca    Principal Investigator: Pavel Hamet Less <<
NCT02720263 Schizophrenia Phase 1 Completed - United States, California ... More >> Site US10001 Glendale, California, United States, 91206 Less <<
NCT03488992 Metabolic Syndrome Not Applicable Completed - Canada, Ontario ... More >> KGK Synergize London, Ontario, Canada, N6A 5R8 Less <<
NCT00855166 - Completed - -
NCT00892372 - Completed - Japan ... More >> Department of Diabetes and Endocrinology, Saitama Medical Center, Saitama Medical University Kawagoe, Saitama, Japan, 350-8550 Less <<
NCT02035592 Insulin Resistance ... More >> Metabolic Syndrome X Less << Not Applicable Completed - United States, Massachusetts ... More >> Harvard School of Public Health Boston, Massachusetts, United States, 02115 United Kingdom Addenbrooke's hospital Cambridge, Cambridgeshire, United Kingdom, CB2 0QQ Norwich Medical School University of East Anglia Norwich, Norfolk, United Kingdom, NR4 7TJ Norfolk and Norwich University Hospital Norwich, Norfolk, United Kingdom, NR4 7UY Less <<
NCT01094158 Non-Alcoholic Fatty Liver Dise... More >>ase Nonalcoholic Steatohepatitis Metabolic Syndrome Less << Phase 2 Completed - Israel ... More >> Soroka Medical Center Beer Sheva, Israel, 84101 Hillel Yaffe Medical Center Hadera, Israel, 38100 Rambam Haifa, Israel, 31096 The Lady Davis Carmel Medical Center Haifa, Israel, 34362 Hadassah Ein Kerem M.C Jerusalem, Israel, 91120 Meir Medical Center Kfar Saba, Israel, 44281 Holy Family HOSPITAL Nazareth, Israel Belinson,Rabin Medical Center Petah Tikva, Israel, 49100 Kaplan M.C Rehovot, Israel, 76100 Safed Ziv Hospital Safed, Israel, 13100 The Tel Aviv Sourasky Medical Center Tel Aviv, Israel, 64239 Less <<
NCT00879125 - Completed - United States, Tennessee ... More >> Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232 Less <<
NCT00008801 Diabetes Mellitus, Insulin-Dep... More >>endent Diabetes Mellitus, Experimental Transplantation, Homologous Islets of Langerhans Transplantation Less << Phase 1 Phase 2 Unknown - United States, Minnesota ... More >> University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT00275145 Cardiovascular Diseases ... More >> Heart Diseases Obesity Hyperlipidemia Insulin Resistance Metabolic Syndrome X Less << Phase 2 Completed - United States, North Carolina ... More >> Duke University Durham, North Carolina, United States, 27710 Less <<
NCT01110577 - Completed - -
NCT00285909 Cardiovascular Disease ... More >> Type 2 Diabetes Less << Not Applicable Completed - -
NCT03477773 Metabolic Syndrome Not Applicable Completed - United Kingdom ... More >> Sheffield Hallam University Sheffield, South Yorkshire, United Kingdom, S102BP Less <<
NCT00292578 Allergy Fatig... More >>ue Hypoglycemia Hyperglycemia Indigestion Less << Phase 1 Phase 2 Completed - United States, California ... More >> 6714-32 Beach Blvd., Buena park, California, United States, 90621 Less <<
NCT00016835 Periodontal Disease ... More >> Diabetes Mellitus, Type 2 Less << Phase 2 Completed - United States, Michigan ... More >> Department of Cariology, Restorative Sciences and Endodontics Ann Arbor, Michigan, United States, 48109-1078 Less <<
NCT01222494 Child Mental Disorders ... More >> Obesity Metabolic Syndrome Less << Not Applicable Completed - United States, Missouri ... More >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Less <<
NCT00705367 Lupus Nephritis Phase 1 Completed - China, Shanghai ... More >> Local Institution Shanghai, Shanghai, China, 200001 Less <<
NCT01222494 - Completed - -
NCT01244503 Metabolic Syndrome ... More >> Nonalcoholic Fatty Liver Disease Less << Phase 2 Terminated(Budgetary Issues) - United States, Texas ... More >> Baylor College of Medicine Houston, Texas, United States, 77030 United States, Virginia Virginia Commonwealth University Richmond, Virginia, United States, 23298 Less <<
NCT01280409 Diabetes, Gestational Phase 4 Completed - United States, Texas ... More >> Memorial Hermann Hospital, Texas Medical Center Houston, Texas, United States, 77030 University of Texas Health Science Center at Houston, Professional Building Houston, Texas, United States, 77030 Less <<
NCT02956590 Dyslipidemia ... More >>Obesity Less << Phase 3 Recruiting May 31, 2022 United States, Delaware ... More >> Nemours/Alfred I duPont Hospital for Children Not yet recruiting Wilmington, Delaware, United States, 19803 Contact: Samuel Gidding, MD       sgidding@nemours.org    Principal Investigator: Samuel Gidding, MD          United States, District of Columbia Children's National Health System Not yet recruiting Washington, District of Columbia, United States, 20010 Contact: Michele Mietus-Snyder, MD       mmsynder@childrensnational.org    Principal Investigator: Michele Mietus-Snyder, MD          United States, Georgia Emory University School of Medicine Not yet recruiting Atlanta, Georgia, United States, 30322 Contact: Miriam Voss, MD, MSPH       mvos@emory.edu    Principal Investigator: Miriam Vos, MD, MSPH          United States, Indiana Riley Hospital for Children at IU Health Not yet recruiting Indianapolis, Indiana, United States, 46202 Contact: Jacqueline Maiers, MD       jmaiers@iu.edu    Principal Investigator: Jacqueline Maiers, MD          United States, Massachusetts Boston Children's Hospital Not yet recruiting Boston, Massachusetts, United States, 02114 Contact: Sarah de Ferranti, MD, MPH       sarah.deferranti@cardio.chboston.org    Principal Investigator: Sarah de Ferranti, MD, MPH          United States, Michigan University of Michigan Health System Recruiting Ann Arbor, Michigan, United States, 48109 Contact: Caren Goldberg, MD, MS       cgoldberg@umich.edu    Principal Investigator: Caren Goldberg, MD, MS          United States, Ohio Cincinnati Children's Hospital Medical Center Recruiting Cincinnati, Ohio, United States, 45229 Contact: Nicolas Madsen, MD, MPH       nicolas.madsen@cchmc.org    Principal Investigator: Nicolas Madsen, MD, MPH          United States, Pennsylvania The Children's Hospital of Philadelphia Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Julie Brothers, MD, FAAP       brothersj@email.chop.edu    Principal Investigator: Julie Brothers, MD, FAAp          Children's Hospital of Pittsburgh Recruiting Pittsburgh, Pennsylvania, United States, 15224 Contact: Silva Arslanian, MD       silva.arslanian@chp.edu    Principal Investigator: Silva Arslanian, MD          United States, South Carolina Medical University of South Carolina Not yet recruiting Charleston, South Carolina, United States, 29425 Contact: Andrew Atz, MD       atzam@musc.edu    Principal Investigator: Andrew Atz, MD          United States, Texas Texas Children's Hospital Not yet recruiting Houston, Texas, United States, 77030 Contact: S. Kristen Sexson, MD, Phd       sxsexson@texaschildrens.org    Principal Investigator: S. Kristen Sexson, MD, Phd          United States, Utah Primary Children's Hospital, University of Utah Not yet recruiting Salt Lake City, Utah, United States, 84108 Contact: Adam Ware, MD       adam.ware@hsc.utah.edu    Principal Investigator: Adam Ware, MD          Canada, Ontario The Hospital for Sick Children Not yet recruiting Toronto, Ontario, Canada, M5g 1X8 Contact: Brian McCrindle, MD, MPH       brian.mccrindle@sickkids.ca    Principal Investigator: Brian McCrindle, MD, MPH Less <<
NCT01280409 - Completed - -
NCT02277275 Weight Loss I... More >>nsulin Resistance Less << Not Applicable Active, not recruiting July 31, 2018 Singapore ... More >> Clinical Nutrition Research Center Singapore, Singapore, 117599 Less <<
NCT01244503 - Terminated(Budgetary Issues) - -
NCT00034255 Diabetes Mellitus, Type 1 ... More >> Diabetes Mellitus, Type 2 Less << Phase 1 Phase 2 Completed - United States, California ... More >> VASDHS Medical Center San Diego, California, United States, 92161 United States, District of Columbia MedStar Research Institute - Clinical Research Center Washington, District of Columbia, United States, 20003 United States, North Carolina UNC Diabetes, Endocrinology, Metabolism Clinic Durham, North Carolina, United States, 27713 United States, Texas Texas Diabetes Institute San Antonio, Texas, United States, 78284 Less <<
NCT00032864 - Completed - -
NCT00042471 Diabetes Mellitus, Type 1 ... More >> Diabetes Mellitus, Type 2 Less << Phase 2 Completed - United States, Florida ... More >> Orlando Clinical Research Center Orlando, Florida, United States United States, Louisiana New Orleans Center for Clinical Research New Orleans, Louisiana, United States United States, Minnesota DaVita Clinical Research Minneapolis, Minnesota, United States United States, Texas CEDRA Clinical Research, LLC Austin, Texas, United States Less <<
NCT01403961 - Unknown December 2017 Argentina ... More >> Hospital Italiano de Buenos Aires Recruiting Buenos Aires, Argentina, C1181ACH Contact: Javier Giunta, MD    541149590200 ext 4419    javier.giunta@hospitalitaliano.org.ar    Principal Investigator: Diego Giunta, MD Less <<
NCT00470990 Hypogonadism Not Applicable Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02143 Less <<
NCT01371396 Metabolic Syndrome ... More >> Non-alcoholic Fatty Liver Disease Obesity Less << Not Applicable Unknown June 2014 United States, Texas ... More >> Center for Human Nutrition Dallas, Texas, United States, 75390-9052 Less <<
NCT01427855 Cardiovascular Disease ... More >> Dyslipidemia Insulin Resistance Inflammation Less << Not Applicable Completed - United States, California ... More >> Cholesterol Research Center, Children's Hospital Research Institute Berkeley, California, United States, 94705 Less <<
NCT00169832 Diabetes Coro... More >>nary Artery Bypass Grafting Less << Phase 3 Completed - Canada, Nova Scotia ... More >> QEII Health Sciences Center - Halifax Infirmary Halifax, Nova Scotia, Canada, B3H 3A7 Canada, Ontario Hamilton Health Sciences - Mc Master Clinic Hamilton, Ontario, Canada, L8L 2X2 Toronto General Hospital Toronto, Ontario, Canada, M5G 2C4 Canada, Quebec CRMSBC Bonaventure, Quebec, Canada, G0C 1E0 CHUM Notre-Dame Hospital Montreal, Quebec, Canada, H2L 4M1 Laval Hospital Sainte-Foy, Quebec, Canada, G1V 4G5 Spain Hospital Del Mar Barcelona, Spain Hospital Universitari Vall D'Hebron Barcelona, Spain Hospital Universitarion Son Dureta Palma de Mallorca, Spain Less <<
NCT00705367 - Completed - -
NCT00058981 Diabetes, Autoimmune Phase 2 Terminated - United States, Alabama ... More >> University of Alabama at Birmingham Endocrinology Department Birmingham, Alabama, United States, 35294 United States, Colorado University of Colorado Hospital Endocrinology Practice Aurora, Colorado, United States, 80010 United States, Kentucky University of Kentucky Department of Internal Medicine Lexington, Kentucky, United States, 40536 United States, Missouri Washington University School of Medicine Endocrinology/Metabolic Dept Saint Louis, Missouri, United States, 63110 United States, New York North Shore Diabetes and Endocrine Associates New Hyde Park, New York, United States, 11042 United States, Texas Diabetes & Glandular Disease Research Associates San Antonio, Texas, United States, 78229-4801 United States, Washington DVA Puget Sound Health Care System Endocrinology (III) Department Seattle, Washington, United States, 98108 Less <<
NCT00057499 Insulin-dependent Diabetes Mel... More >>litus Diabetes Mellitus Less << Phase 1 Completed - United States, Massachusetts ... More >> Children's Hospital Boston, Massachusetts, United States, 02115 Joslin Diabetes Center Boston, Massachusetts, United States, 02215 Less <<
NCT03594734 Traumatic Brain Injury Not Applicable Recruiting September 30, 2022 United States, Texas ... More >> Baylor Scott & White Institute for Rehabilitation Recruiting Dallas, Texas, United States, 75246 Contact: Evan E Rainey, MS    214-818-2993    EvanElizabeth.Rainey@BSWHealth.org    Principal Investigator: Simon Driver, PhD          Sub-Investigator: Rosmary Dubiel, DO          Sub-Investigator: Shannon Juengst, PhD Less <<
NCT02593331 Insulin Resistance Phase 1 Completed - United States, California ... More >> Profil Institute for Clinical Research Inc. Chula Vista, California, United States, 91911 Less <<
NCT02623777 Metabolic Syndrome Not Applicable Completed - -
NCT00555217 Kidney Disease ... More >> Nephropathy Type 2 Diabetes Less << Phase 3 Terminated(It was stopped prim... More >>arily because of safety concerns along with low conditional power to detect a treatment effect on the primary outcome.) Less << - -
NCT02205333 Advanced Solid Tumors ... More >> Aggressive B-cell Lymphomas Less << Phase 1 Phase 2 Terminated(The study was termi... More >>nated early at the sponsor's discretion.) Less << - United States, Arizona ... More >> Research Site Scottsdale, Arizona, United States, 85259 United States, California Research Site Sacramento, California, United States, 95817 Research Site Santa Monica, California, United States, 90404 United States, District of Columbia Research Site Washington, D.C., District of Columbia, United States, 20007 United States, Florida Research Site Tampa, Florida, United States, 33612 United States, Illinois Research Site Chicago, Illinois, United States, 60611 United States, Michigan Research Site Detroit, Michigan, United States, 48202 United States, Nevada Research Site Las Vegas, Nevada, United States, 89169 United States, New Jersey Research Site Hackensack, New Jersey, United States, 7601 United States, North Carolina Research Site Huntersville, North Carolina, United States, 28078 United States, Oregon Research Site Portland, Oregon, United States, 97213 United States, Tennessee Research Site Memphis, Tennessee, United States, 38120 United States, Texas Research Site Houston, Texas, United States, 77030 Less <<
NCT02732509 - Recruiting December 2019 United States, Minnesota ... More >> Mayo Clinic Recruiting Rochester, Minnesota, United States, 55905 Contact: Ian R Lanza, PhD    507-255-8147    lanza.ian@mayo.edu Less <<
NCT02205333 - Terminated(The study was termi... More >>nated early at the sponsor's discretion.) Less << - -
NCT00555217 - Terminated(It was stopped prim... More >>arily because of safety concerns along with low conditional power to detect a treatment effect on the primary outcome.) Less << - -
NCT00071526 - Recruiting - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)    800-411-1222 ext TTY8664111010    prpl@cc.nih.gov Less <<
NCT00067678 Diabetic Nephropathy ... More >> Diabetes Mellitus Less << Phase 1 Phase 2 Completed - United States, Kentucky ... More >> University of Kentucky Lexington, Kentucky, United States, 40536 Less <<
NCT01675401 Metabolic Syndrome ... More >> Obesity Less << Not Applicable Completed - Netherlands ... More >> Maastricht University Medical Center Maastricht, Netherlands Less <<
NCT00072891 Diabetes Mellitus, Type 2 ... More >> Hypertension Hyperlipidemia Less << Not Applicable Completed - United States, Pennsylvania ... More >> University of Pittsburgh School of Nursing Pittsburgh, Pennsylvania, United States, 15261 Less <<
NCT00073255 Diabetes Mellitus, Insulin-Dep... More >>endent Less << Phase 1 Completed - United States, New York ... More >> Columbia University New York, New York, United States, 10032 Less <<
NCT00063583 Diabetes Mellitus ... More >> Diabetic Nephropathy Less << Phase 1 Phase 2 Completed - United States, Maryland ... More >> National Institute of Diabetes and Digestive and Kidney Disease (NIDDK) Bethesda, Maryland, United States, 20892 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, Pennsylvania The Center for Diabetic Kidney Disease at Thomas Jefferson University Philadelphia, Pennsylvania, United States, 19107 Less <<
NCT00073281 Diabetes Mellitus, Type 1 Phase 1 Completed - United States, New York ... More >> Columbia Presbyterian Medical Center New York, New York, United States, 10032 Less <<
NCT02698553 Depressive Disorder, Major Phase 1 Completed - China ... More >> GSK Investigational Site Shanghai, China, 200030 Less <<
NCT02947620 Type II Diabetes ... More >> Dyslipidemia Less << Phase 3 Unknown - Korea, Republic of ... More >> Samsung Medical Center Recruiting Seoul, Korea, Republic of Contact: Daewoong Clinical Less <<
NCT00820651 Nonalcoholic Steatohepatitis ... More >> Insulin Resistance Less << Phase 3 Completed - Cuba ... More >> National Institute of Gastroenterology Vedado, Havana, Cuba, 10400 Less <<
NCT03324685 Drug Interactions Phase 1 Completed - United States, Florida ... More >> Research Site Daytona Beach, Florida, United States, 32117 Less <<
NCT03087721 Metabolic Syndrome ... More >> Insulin Resistance Less << Not Applicable Recruiting May 31, 2019 Colombia ... More >> IPS-Universitaria Recruiting Medellin, Antioquia, Colombia Contact: Jaime Gallo, MD, MSc    +5742196060    jaime.gallo@udea.edu.co Less <<
NCT03147339 Metabolic Syndrome Not Applicable Completed - Iran, Islamic Republic of ... More >> National Nutrition and Food Technology Research Institute Tehrān, Tehran, Iran, Islamic Republic of, 19395-4741 Less <<
NCT02899910 Metabolic Syndrome ... More >> Obesity Insulin Resistance Less << Phase 2 Completed - -
NCT00097071 Diabetes Diab... More >>etes Mellitus, Type 1 Less << Phase 3 Completed - -
NCT01935518 Amyotrophic Lateral Sclerosis Phase 2 Unknown May 2015 China ... More >> Peking University Third Hospital Recruiting Beijing, China, 100191 Contact: Xiaolu Liu, MD    0086-1082265032    liuxiaolupku@gmail.com    Principal Investigator: Dongsheng Fan, MD, PhD Less <<
NCT02578953 Prostatic Hyperplasia Phase 1 Completed - Japan ... More >> GSK Investigational Site Fukuoka, Japan, 813-0017 Less <<
NCT03275662 Metabolic Syndrome ... More >> Microbiome Immune Function Inflammation Less << Not Applicable Completed - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT00107107 Diabetes Mellitus, Type 1 Phase 3 Completed - -
NCT00105352 Diabetes Mellitus, Type 1 Not Applicable Completed - United States, California ... More >> Children's Hospital Los Angeles Los Angeles, California, United States, 90027 University of California San Francisco San Francisco, California, United States, 94143-0434 Stanford University Medical Center Stanford, California, United States, 94305-5208 United States, Colorado Barbara Davis Center for Childhood Diabetes, University of Colorado Denver, Colorado, United States, 80262 United States, Florida University of Florida Gainesville,, Florida, United States, 32610 University of Miami School of Medicine Miami, Florida, United States, 33101 United States, Indiana Riley Hospital for Children, Indiana University Indianapolis, Indiana, United States, 46202 United States, Massachusetts Joslin Diabetes Center/ Children's Hospital Boston Boston, Massachusetts, United States, 02215 United States, Minnesota University of Minnesota Minneapolis, Minnesota, United States, 58944 United States, New York Naomi Berrie Diabetes Center, Columbia University New York, New York, United States, 10032 United States, Pennsylvania Children's Hospital of Pittsburgh of UPMC Pittsburgh, Pennsylvania, United States, 15213 United States, Texas University of Texas Medical Center at Dallas Dallas, Texas, United States, 75390-8858 United States, Washington Benaroya Research Institute Seattle, Washington, United States, 358285 Australia, Victoria Walter and Eliza Hall Institute of Medical Research Parkville, Victoria, Australia, 3050 Canada, Ontario University of Toronto Toronto, Ontario, Canada, M5G-1X8 Finland University of Turku Turku, Finland, FIN-20520 Italy Vita-Salute San Raffaele University Milan, Italy, +39-02-2643 2818 United Kingdom University of Bristol Bristol, United Kingdom, BS10 5NB UK Less <<
NCT00117026 Diabetes Mellitus, Type 1 Phase 1 Phase 2 Completed - Norway ... More >> Aker University Hospital Oslo, Norway, 0514 Less <<
NCT00095446 Diabetes Diab... More >>etes Mellitus, Type 1 Diabetes Mellitus, Type 2 Less << Phase 4 Completed - United States, New Jersey ... More >> Novo Nordisk Investigational Site Princeton, New Jersey, United States, 08540 Less <<
NCT02670382 Metabolic Syndrome Not Applicable Active, not recruiting April 2019 United States, Massachusetts ... More >> Jean Mayer Human Nutrition Research Center on Aging at Tufts University Boston, Massachusetts, United States, 02111 Less <<
NCT02136602 - Completed - Egypt ... More >> AinShamsU Cairo, Egypt, 3285 Less <<
NCT00119054 Diabetes Mellitus ... More >> Hypertension Less << Not Applicable Completed - United States, Iowa ... More >> Iowa City VA Health Care System, Iowa City, IA Iowa City, Iowa, United States, 52246-2208 Less <<
NCT00119041 Diabetes Mellitus Type 2 ... More >> Diabetes Mellitus, Type 1 Primary Care Provider Less << Not Applicable Completed - United States, Michigan ... More >> VA Ann Arbor Healthcare System Ann Arbor, Michigan, United States, 48113-0170 United States, Ohio Louis Stokes VA Medical Center Cleveland, Ohio, United States, 44106-3800 Less <<
NCT02739971 Mild Cognitive Impairment Not Applicable Unknown December 2018 Israel ... More >> Joseph Sagol Neuroscience center, Sheba Medical Center Recruiting Ramat Gan, Israel Contact: Roni Lotan    972-3-5407262    roni.loten@sheba.health.gov.il Less <<
NCT01055080 Beta-cell Autoimmunity Not Applicable Completed - -
NCT00130481 Type 1 Diabetes Mellitus ... More >> Type 2 Diabetes Mellitus Less << Not Applicable Completed - United States, Florida ... More >> University of Florida Gainesville, Florida, United States, 32610 Less <<
NCT03481465 - Enrolling by invitation February 2020 Spain ... More >> University Hospital Marqués de Valdecilla Santander, Cantabria, Spain, 39008 Less <<
NCT03478046 Obesity Metab... More >>olic Syndrome Less << Not Applicable Completed - United States, Alabama ... More >> Auburn University Auburn, Alabama, United States, 36849 Less <<
NCT00143104 Diabetes Mellitus, Type 1 Phase 2 Completed - United States, Arizona ... More >> Pfizer Investigational Site Glendale, Arizona, United States United States, California Pfizer Investigational Site Fresno, California, United States United States, Texas Pfizer Investigational Site San Antonio, Texas, United States Less <<
NCT00119041 - Completed - -
NCT00141986 Type 1 Diabetes Phase 1 Completed - Canada, Manitoba ... More >> Manitoba Institute of Child Health Winnipeg, Manitoba, Canada Less <<
NCT00160160 Hypertension ... More >>Type 2 Diabetes Less << Not Applicable Completed - -
NCT00173641 - Unknown - Taiwan ... More >> National Taiwan University Hospital Recruiting Taipei, Taiwan Contact: Yi-Ching Tung, MD    886-2-23123456 ext 5130    dtped004@yahoo.com.tw    Sub-Investigator: Yi-Ching Tung, MD Less <<
NCT00123435 Cardiovascular Diseases ... More >> Diabetes Mellitus Hyperlipidemia Hypertension Obesity Less << Not Applicable Completed - United States, Michigan ... More >> VA Ann Arbor Healthcare System, Ann Arbor, MI Ann Arbor, Michigan, United States, 48105 Less <<
NCT00175721 Kidney Diseases ... More >> Heart Diseases Diabetes Mellitus Less << Not Applicable Completed - Canada, British Columbia ... More >> St. Paul's Hospital Vancouver, British Columbia, Canada Less <<
NCT00144144 Hypertension ... More >>Diabetes Mellitus, Type 2 Less << Phase 4 Unknown - Japan ... More >> Dept. of Clinical Immunology, Clinical Bioinformatics Research Unit, Graduate School of Medicine, the University of Tokyo Hongo, Bunkyo-ku, Tokyo, Japan, 113-8655 Less <<
NCT00187564 Diabetes Mellitus, Type 1 Not Applicable Completed - United States, California ... More >> UCSF Division of Pediatric Endocrinology San Francisco, California, United States, 94143-0434 Less <<
NCT00194558 Diabetes Mellitus, Type 1 Not Applicable Completed - United States, Washington ... More >> University of Washington, Diabetes Care Center Seattle, Washington, United States, 98195 Less <<
NCT00142922 Type 1 Diabetes ... More >> Type 2 Diabetes Less << Not Applicable Completed - United States, Massachusetts ... More >> Joslin Diabetes Center Boston, Massachusetts, United States, 02215 Less <<
NCT00194896 Type 2 Diabetes Mellitus Not Applicable Completed - United States, Washington ... More >> DVA Puget Sound Health Care System Seattle, Washington, United States, 98108 Less <<
NCT00209417 Renal Insufficiency ... More >> Diabetes Mellitus Less << Phase 4 Terminated(Supported by prelim... More >>inary interim analysis. Not based on any safety signals in study or any quality issues that could affect efficacy of the product.) Less << - United States, New Jersey ... More >> GE Healthcare Princeton, New Jersey, United States, 08540 United Kingdom GE Healthcare Amersham, United Kingdom, HP7 9LL Less <<
NCT00194896 - Completed - -
NCT00190502 Diabetes Mellitus, Type 1 Not Applicable Unknown - Czech Republic ... More >> Institute for Clinical and Experimental Medicine, Department of Diabetes Recruiting Prague, Czech Republic, 14021 Contact: Frantisek Saudek, MD.       frsa@medicon.cz    Principal Investigator: Frantisek Saudek, MD          Sub-Investigator: Petr Boucek, MD.          Sub-Investigator: Tereza Havrdova Less <<
NCT00209417 - Terminated(Supported by prelim... More >>inary interim analysis. Not based on any safety signals in study or any quality issues that could affect efficacy of the product.) Less << - -
NCT00212303 Type 2 Diabetes ... More >> Hypertension Less << Phase 4 Completed - United States, Maryland ... More >> Johns Hopkins Bayview Medical Center Baltimore, Maryland, United States, 21224 Less <<
NCT00212329 - Completed - United States, California ... More >> Childrens Hospital of Los Angeles Los Angeles, California, United States, 90027 University of California, San Francisco San Francisco, California, United States, 94143-0136 Stanford University Medical Center Stanford, California, United States, 94305-5208 United States, Colorado Barbara Davis Center for Childhood Diabetes Denver, Colorado, United States, 80010 United States, Florida University of Florida Gainesville, Florida, United States, 32608 University of Miami School of Medicine Miami, Florida, United States, 33136 United States, Indiana Riley Hospital for Children Indianapolis, Indiana, United States, 46202 United States, Massachusetts Joslin Diabetes Center Boston, Massachusetts, United States, 02215 United States, Minnesota University of Minnesota Minneapolis, Minnesota, United States, 55455 United States, New York Naomi Berrie Diabetes Center, Columbia University New York, New York, United States, 10032 United States, Pennsylvania Children's Hospital of Pittsburgh of UPMC Pittsburgh, Pennsylvania, United States, 15213 United States, Texas University of Texas Southwestern Medical Center at Dallas Dallas, Texas, United States, 75235 United States, Washington Benaroya Research Institute at Virginia Mason Seattle, Washington, United States, 98101 United Kingdom University of Bristol Bristol, United Kingdom, BS10 5NB Less <<
NCT00213109 Type 1 Diabetes Mellitus Phase 3 Completed - Japan ... More >> Chiba, Japan Fukuoka, Japan Gifu, Japan Ibaraki, Japan Kanagawa, Japan Kumamoto, Japan Oita, Japan Less <<
NCT00214214 New Onset Type 1 Diabetes Mell... More >>itus Less << Phase 1 Withdrawn - United States, Wisconsin ... More >> University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States, 53792 Less <<
NCT00219089 Hypertension, Diabetes Mellitu... More >>s Less << Phase 3 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 Germany Investigative Centers, Germany Less <<
NCT00217061 Diabetes Mellitus ... More >> Dyslipidemia Hypercholesterolemia Cardiovascular Disease Less << Phase 3 Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT00221455 Diabetes Mellitus Phase 1 Completed - United States, Ohio ... More >> The Cleveland Clinic Foundation Cleveland, Ohio, United States, 44195 Less <<
NCT03514108 Heart Failure ... More >> Diabetes Less << Phase 4 Recruiting September 1, 2023 Denmark ... More >> Sygehus Sønderjylland, Aabenraa Not yet recruiting Aabenraa, Denmark Contact: Bartlomiej Jonczy          Aalborg University Hospital Not yet recruiting Aalborg, Denmark Contact: Søren Vraa          Aarhus University Hospital Recruiting Aarhus, Denmark Contact: Henrik Wiggers    +45 40136627    henrikwiggers@dadlnet.dk    Sub-Investigator: Anders Jorsal          Amager Hospital Not yet recruiting Copenhagen, Denmark Contact: Margrethe Ege Olsen          Bispebjerg Hospital Not yet recruiting Copenhagen, Denmark Contact: Olav Wendelbo Nielsen          Gentofte Hospital Recruiting Copenhagen, Denmark Contact: Morten Schou          Glostrup Hospital Not yet recruiting Copenhagen, Denmark Contact: Morten Petersen          Herlev Hospital Recruiting Copenhagen, Denmark Contact: Morten Schou          Hvidovre Hospital Not yet recruiting Copenhagen, Denmark Contact: Jens Hove          Rigshospitalet Recruiting Copenhagen, Denmark Contact: Lars Køber          Principal Investigator: Finn Gustafsson          Sydvestjysk Sygehus, Esbjerg Not yet recruiting Esbjerg, Denmark Contact: Kirsten Vilain Mikkelsen          Herning Hospital Not yet recruiting Herning, Denmark Contact: Morten Bøttcher          Regionshospital Nordjylland, Hjørring Not yet recruiting Hjørring, Denmark Contact: Gitte Nielsen          Holbæk Hospital Not yet recruiting Holbæk, Denmark Contact: Ilan Raymond          Horsens Hospital Not yet recruiting Horsens, Denmark Contact: Karen Kaae Dodt          Kolding Hospital Not yet recruiting Kolding, Denmark Contact: Monica Petronela Poenaru          Nykøbing Falster Hospital Not yet recruiting Nykøbing Falster, Denmark Contact: Lisbeth Tingsted          Odense University Hospital Not yet recruiting Odense, Denmark Contact: Mikael Kjær Poulsen          Sjællands Universitetshospital, Roskilde Not yet recruiting Roskilde, Denmark Contact: Nina Pernille Gardshodn Buch          Silkeborg Hospital Not yet recruiting Silkeborg, Denmark Contact: Anne Sejr Knudsen          Slagelse Sygehus Not yet recruiting Slagelse, Denmark Contact: Henrik Ryde          Vejle Hospital Not yet recruiting Vejle, Denmark Contact: Vibeke Brogaard          Viborg Hospital Not yet recruiting Viborg, Denmark Contact: Anne Pauline Schrøder Less <<
NCT03510221 Hypertension ... More >>Oxidative Stress Autonomic Imbalance Insulin Resistance Less << Not Applicable Completed - -
NCT00182494 Diabetes Mellitus ... More >> Schizophrenia Less << Phase 4 Unknown - Canada, Ontario ... More >> McMaster University Recruiting Hamilton, Ontario, Canada Contact: Lakshmi P Voruganti, MD    905-522-1155 ext 6355    vorugl@mcmaster.ca    Contact: Susan Strong, MSc    905 522 1155    strongs@mcmaster.ca    Principal Investigator: Lakshmi P Voruganti, MD Less <<
NCT00239538 Hypertension ... More >>Diabetes Mellitus, Type 2 Less << Phase 4 Completed - -
NCT00237952 Diabetic Nephropathies ... More >> Diabetes Mellitus, Type II Less << Not Applicable Completed - China, Taiwan ... More >> Chang Gung Memorial Hospital, Lin-Kou Medical Center Taipei, Taiwan, China, 105 Chang Gung Memorial Hospital Taipei, Taiwan, China, 105 Less <<
NCT00225849 Hypertension ... More >>Hyperlipidemia Diabetes Mellitus Less << Phase 4 Unknown - Japan ... More >> Keio University School of Medicine Recruiting Tokyo, Japan, 160-8582 Contact: Yasuo Ikeda, MD    +81-3-3353-1211 ext 62421    yikeda@sc.itc.keio.ac.jp    Principal Investigator: Yasuo Ikeda, MD Less <<
NCT00265473 - Completed - -
NCT00270439 Diabetes Mellitus Type 2 ... More >> Dyslipidemia Hypercholesterolemia Obesity Less << Phase 1 Completed - United States, Tennessee ... More >> Vanderbilt University Nashville, Tennessee, United States, 37232 Less <<
NCT01084369 Type 2 Diabetes ... More >> Hypogonadism Less << Phase 4 Unknown May 2015 United Kingdom ... More >> Tameside General Hospital Recruiting Ashton-under-Lyne, Lancashire, United Kingdom, OL6 9RW Tameside Hospital NHS Foundatoin Trust Recruiting Ashton under Lyne, United Kingdom, OL69RW Less <<
NCT01127659 - Completed - -
NCT00272402 Diabetes Mellitus ... More >> Hypertension Hyperlipidemia Less << Not Applicable Completed - United States, Minnesota ... More >> HealthPartners Research Foundation Minneapolis, Minnesota, United States, 55440 Less <<
NCT00265473 Type 1 Diabetes Mellitus ... More >> Hypoglycemia Less << Phase 1 Phase 2 Completed - United States, Minnesota ... More >> University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT00273286 Diabetes Mellitus, Type 1 Phase 2 Completed - United States, Florida ... More >> Nemours Children's Clinic Jacksonville, Florida, United States, 32207-8426 United States, Illinois Children's Memorial Hospital Chicago, Illinois, United States, 60614 United States, Massachusetts Joslin Diabetes Center Boston, Massachusetts, United States, 02215 United States, Texas Texas Children's Hospital Houston, Texas, United States, 77030 Less <<
NCT00274118 Hypertension ... More >>Diabetes Mellitus, Type 2 Less << Phase 3 Completed - Denmark ... More >> Boehringer Ingelheim Investigational Site Frederiksberg C, Denmark, DK-1900 Apopleksiafsnittet Frederiksberg, Denmark, DK-2000 Lungemedicinsk Forskning Hellerup, Denmark, DK-2900 Medical Dept. B0642 Hillerød, Denmark, DK-3400 Hvidovre Hospital Hvidovre, Denmark, DK-2650 Gynækologisk/obstetrisk afd. Kolding, Denmark, 6000 Finland Boehringer Ingelheim Investigational Site Hyvinkää, Finland, 05850 Boehringer Ingelheim Investigational Site Jyväskylä, Finland, FIN-40100 Kuopion yliopistollinen sairaala, Keuhkoklinikka Kuopio, Finland, FI-70211 Boehringer Ingelheim Investigational Site Riihimäki, Finland, 11100 Boehringer Ingelheim Investigational Site Tampere, Finland, 33520 Netherlands Bosch Medicentrum Den Bosch, Netherlands, 5223 GV Dept. of Internal Medicine Utrecht, Netherlands, 3584 CX Norway Boehringer Ingelheim Investigational Site Arendal, Norway, N-4841 Boehringer Ingelheim Investigational Site Jessheim, Norway, N-2050 Boehringer Ingelheim Investigational Site Skogn, Norway, N-7620 Hjertelaget Research Foundation Stavanger, Norway, N-4011 Sweden Medicinkliniken Eksjö, Sweden, 575 81 Medicinkliniken Helsingborg, Sweden, 251 87 Boehringer Ingelheim Investigational Site Helsingborg, Sweden, 254 67 Boehringer Ingelheim Investigational Site Munkedal, Sweden, 455 30 Boehringer Ingelheim Investigational Site Tranås, Sweden, 573 83 Boehringer Ingelheim Investigational Site Uddevalla, Sweden, 451 40 Samariterhemmets sjukhus Uppsala, Sweden, 751 25 Boehringer Ingelheim Investigational Site Vetlanda, Sweden, 574 28 United Kingdom Boehringer Ingelheim Investigational Site Atherstone, United Kingdom, CV9 1EU Boehringer Ingelheim Investigational Site Barry, United Kingdom, CF62 7EB Dept. of Diabetes Birmingham, United Kingdom, B18 7QH Department of Respiratory Medicine Birmingham, United Kingdom, B9 5SS Royal Bournemouth Hospital Bournemouth, United Kingdom, BH7 7DW Finance Office (Research Unit) Newcastle-Upon-Tyne, United Kingdom, NE1 7RU Northampton General Hospital Northampton, United Kingdom, NN1 5BD Boehringer Ingelheim Investigational Site Northampton, United Kingdom, NN5 7AQ Diabetes Centre, Nuneaton,, United Kingdom, CV10 7DJ Lucille Packard Children's Health Services at Stanford Palo Alto, United Kingdom, 94304-5786 Boehringer Ingelheim Investigational Site Pontyclun, United Kingdom, CF72 9AA Diabetes Centre Rugby, United Kingdom, CV22 5PX Less <<
NCT01127659 Hypogonadism Phase 4 Completed - United States, New York ... More >> 115 Flint Road Williamsville, New York, United States, 14221 Less <<
NCT00279266 Peripheral Neuropathy ... More >> Diabetes Mellitus Diabetes Complications Less << Not Applicable Withdrawn(inadequate recruitme... More >>nt) Less << - United States, California ... More >> Loma Linda University Department of Neurology Loma Linda, California, United States, 92354 Less <<
NCT00276406 - Completed - -
NCT00198146 Newly Diagnosed With Type 1 Di... More >>abetes Less << Phase 2 Completed - United States, Indiana ... More >> Indiana University - Riley Hospital for Children Indianapolis, Indiana, United States, 46202 Less <<
NCT00286624 Type 1 Diabetes Mellitus ... More >> Hypoglycemia Less << Phase 1 Phase 2 Completed - United States, Minnesota ... More >> University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT00286598 Diabetes Mellitus ... More >> Peripheral Neuropathies Less << Phase 1 Completed - United States, Missouri ... More >> University of Missouri Columbia, Missouri, United States, 65212 Less <<
NCT00276406 Constipation ... More >>Diabetes Mellitus Colonic Transit Gastric Emptying Less << Phase 1 Phase 2 Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT03436303 Menopause Syndrome Phase 4 Active, not recruiting December 1, 2018 China, China/Beiing ... More >> Lei Li Beijing, China/Beiing, China, 100000 Less <<
NCT00916188 Type 2 Diabetes Mellitus Not Applicable Completed - Iran, Islamic Republic of ... More >> National Nutrition and Food Technology Research Institute Tehran, Iran, Islamic Republic of, 19395-4741 Less <<
NCT00279318 - Active, not recruiting September 2025 United States, Colorado ... More >> University of Colorado Health Sciences Center Denver, Colorado, United States, 80262 United States, Florida Augusta University Gainesville, Florida, United States, 32608 United States, Georgia Augusta University Atlanta, Georgia, United States, 30342 Augusta University Augusta, Georgia, United States, 30912 United States, Pennsylvania Children's Hospital of Pittsburgh of UPMC (this site is only screening babies whose mother, father or full sibiling have type 1 diabetes) Pittsburgh, Pennsylvania, United States, 15213 United States, Washington Pacific Northwest Diabetes Research Institute Seattle, Washington, United States, 98122 Finland Turku University Central Hospital Turku, Finland, 20520 Germany Diabetes Research Institute Munich, Germany, 80804 Sweden Lund University Malmo, Sweden, 20502 Less <<
NCT00924599 Gestational Diabetes Not Applicable Completed - United States, California ... More >> Sierra Vista Regional Medical Center San Luis Obispo, California, United States, 93405 Less <<
NCT03515460 Metabolic Syndrome Not Applicable Recruiting January 2019 Brazil ... More >> National Institute of Cardiology, Ministry of Health, Brazil Recruiting Rio de Janeiro, Brazil, 22240-006 Contact: Eduardo V Tibirica, MD, PhD    +55-21-999146075    etibi@uol.com.br Less <<
NCT02004366 Type 2 Diabetes Phase 4 Completed - United States, Colorado ... More >> University of Colorado Denver, Colorado, United States, 80220 United States, Georgia Emory University Hospital Atlanta, Georgia, United States, 30322 Grady Memorial Hospital Atlanta, Georgia, United States United States, Illinois Rush University Medical Center Chicago, Illinois, United States, 60612 United States, Massachusetts Boston Medical Center Boston, Massachusetts, United States, 02118 Less <<
NCT01976858 Type 2 Diabetes Phase 1 Completed - China, Beijing ... More >> Beijing tongren hospital Beijing, Beijing, China Less <<
NCT00949351 Type 2 Diabetes With Nephropat... More >>hy Less << Phase 4 Unknown September 2010 Thailand ... More >> Lerdsin General Hospital Not yet recruiting Bangkok, Thailand, 10500 Contact: Krissanapong Manotham, Dr    662 3539799 ext 2501    kmanotham@hotmail.com    Contact: Tanaporn Ratanasuwan, Dr       tratanas@hotmail.com    Principal Investigator: Krissanapong Manotham, Dr Less <<
NCT02004366 - Completed - -
NCT03596983 Insomnia Not Applicable Not yet recruiting July 2020 -
NCT03561363 Insulin Sensitivity Not Applicable Completed - -
NCT02029261 - Unknown May 2018 United States, Massachusetts ... More >> Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Sub-Investigator: Masao Kaneki, MD, PhD Less <<
NCT02024516 Type 2 Diabetes Not Applicable Unknown - Iran, Islamic Republic of ... More >> Ahvaz Jundishapoor University of Medical Sciences Recruiting Ahvaz, Khoozestan, Iran, Islamic Republic of Contact: Farideh Shishebor, Nutrition PhD    +986113738319    shishehbor-f@ajums.ac.ir    Principal Investigator: Maryam Zare, MS condidate Less <<
NCT03586011 - Active, not recruiting December 1, 2018 Sweden ... More >> Närhälsan Göteborg centrum för fysisk aktivitet Gothenburg, Region Västra Götaland, Sweden, 421 44 Less <<
NCT02414893 - Completed - Spain ... More >> Consorci Sanitari del Maresme Mataró, Barcelona, Spain, 08304 Less <<
NCT03608800 Metabolic Syndrome Not Applicable Recruiting December 30, 2019 China, Guangdong ... More >> Department of Nutrition and Food Hygiene Recruiting Guangzhou, Guangdong, China, 510080 Contact: Min Xia, Doctor Less <<
NCT03636529 Hyperuricemia ... More >> Insulin Resistance Obesity CVD Less << Not Applicable Completed - -
NCT02048904 Type 2 Diabetes ... More >> Microalbuminuria Less << Phase 4 Terminated(Original Principal ... More >>Investigator left institution. No data analyzed.) Less << - United States, Missouri ... More >> University of Missouri-Columbia: Diabetes Center Columbia, Missouri, United States, 65212 Less <<
NCT03544931 Periodontal Diseases Not Applicable Completed - Italy ... More >> University Hospital of Pisa Pisa, Italy, 56126 Less <<
NCT02055014 Type 2 Diabetes ... More >> Obesity Diabesity Less << Phase 4 Unknown March 2017 United Kingdom ... More >> Department of Diabetes, City Hospital Birmingham, United Kingdom, B18 7QH Glasgow Royal Infirmary Glasgow, United Kingdom, G0 Department of Diabetes, Guy's and St Thomas' Hospitals London, United Kingdom, SE1 Diabetes Research Group, King's College London London, United Kingdom, SE5 9RS Less <<
NCT02074540 - Unknown December 2014 -
NCT00979368 Diabetes Mellitus, Non-Insulin... More >>-Dependent Dyslipidemia Less << Phase 1 Completed - Australia, Victoria ... More >> Local Institution Melbourne, Victoria, Australia, 3004 Less <<
NCT03698955 Overweight Ob... More >>esity Insulin Resistance Less << Not Applicable Recruiting November 2019 United States, District of Col... More >>umbia Physicians Committee for Responsible Medicine Recruiting Washington, District of Columbia, United States, 20016 Contact: Jihad Alwarith Less <<
NCT02089477 Type 2 Diabetes Not Applicable Completed - Denmark ... More >> Center of Inflammation and Metabolism Copenhagen, Denmark, 2200 Less <<
NCT03701425 Cardiovascular Diseases ... More >> Metabolic Syndrome x Mediterranean Diet Less << Not Applicable Enrolling by invitation December 1, 2024 Mexico ... More >> National Medical Center "20 de Noviembre", ISSSTE Mexico City, Mexico, 03100 Less <<
NCT00998712 - Unknown January 2014 United States, Massachusetts ... More >> Brigham and Women's Hospital, Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02115 Principal Investigator: Rhonda Bentley-Lewis, MD          Sub-Investigator: Mark Creager, MD          Sub-Investigator: David Nathan, MD          Sub-Investigator: Florence Brown, MD Less <<
NCT02666287 Pulmonary Disease, Chronic Obs... More >>tructive Less << Phase 1 Completed - United Kingdom ... More >> GSK Investigational Site London, United Kingdom, NW10 7EW Less <<
NCT03590093 Periodontal Diseases Not Applicable Completed - Italy ... More >> University Hospital of Pisa Pisa, Italy, 56126 Less <<
NCT00700401 - Completed - Brazil ... More >> Brasilia, DF, Brazil, 70335900 Vitoria, ES, Brazil, 29043-260 Sao Luis, MA, Brazil, 65020560 Rio de Janeiro, RJ, Brazil, 20020-022 Porto Alegre, RS, Brazil, 90020-090 Porto Alegre, RS, Brazil, 90035-003 Campinas, SP, Brazil, 13060-803 Campinas, SP, Brazil, 13083-888 Ribeirao Preto, SP, Brazil, 14049-900 Santo Andre, SP, Brazil, 09060-650 Sao Paulo, SP, Brazil, 04040-003 Sorocaba, SP, Brazil, 18047-600 Less <<
NCT00381238 Alzheimer's Disease Phase 2 Completed - United States, Arizona ... More >> GSK Investigational Site Litchfield Park, Arizona, United States, 85340 GSK Investigational Site Phoenix, Arizona, United States, 85006 GSK Investigational Site Sun City, Arizona, United States, 85351 United States, Massachusetts GSK Investigational Site Belmont, Massachusetts, United States, 02478 United States, Michigan GSK Investigational Site Ann Arbor, Michigan, United States, 48109 United States, North Carolina GSK Investigational Site Durham, North Carolina, United States, 27705 Canada, Quebec GSK Investigational Site Montreal, Quebec, Canada, H4H 1R3 Less <<
NCT00381238 - Completed - -
NCT01687803 Obesity Seden... More >>tary Lifestyle Body Weight Less << Not Applicable Completed - -
NCT00700401 - Completed - -
NCT01577745 - Completed - -
NCT01693666 Pregnancy Obe... More >>sity Weight Gain Obstetric Complications Less << Not Applicable Completed - United States, Missouri ... More >> Saint Louis University Saint Louis, Missouri, United States, 63110 Less <<
NCT01577745 Solid Tumors Phase 1 Completed - United States, California ... More >> Research Site Los Angeles, California, United States, 90404 United States, Connecticut Research Site New Haven, Connecticut, United States, 06513 United States, Massachusetts Research Site Boston, Massachusetts, United States United States, Michigan Research Site Ann Arbor, Michigan, United States, 48103 United States, Minnesota Research Site Minneapolis, Minnesota, United States United States, New York Research Site New York, New York, United States, 10002 United States, Ohio Research Site Cincinnati, Ohio, United States, 45201 Research Site Cleveland, Ohio, United States, 44105 United States, Texas Research Site Houston, Texas, United States, 77030 United States, Washington Research Site Seattle, Washington, United States, 98112 Research Site Tacoma, Washington, United States, 98405 Less <<
NCT01745952 - Completed - -
NCT02048904 - Terminated(Original Principal ... More >>Investigator left institution. No data analyzed.) Less << - -
NCT02093234 Diabetes Type 2 Not Applicable Completed - United States, District of Col... More >>umbia Medical Faculty Assoc Inc, GWUniv Washington, District of Columbia, United States, 20037 Less <<
NCT02884011 - Completed - United States, Illinois ... More >> Rush Univeristy Medical Center Chicago, Illinois, United States, 60612 Less <<
NCT01745952 Epilepsies, Partial Not Applicable Completed - Belgium ... More >> University Hospitals Leuven, department of Neurology Leuven, Belgium, 3000 Less <<
NCT00105066 Obesity Hyper... More >>tension Hypercholesterolemia Hyperglycemia Less << Phase 2 Completed - United States, Maryland ... More >> National Institute on Aging (NIA), Harbor Hospital Baltimore, Maryland, United States, 21225 Less <<
NCT03038750 - Recruiting July 2022 United Kingdom ... More >> Department of Public Health and Primary Care Recruiting Cambridge, United Kingdom, CB1 8RN Contact: Dirk Paul, PhD    01223 761918    dsp35@medschl.cam.ac.uk    Principal Investigator: Dirk Paul, PhD Less <<
NCT00397891 Alzheimer Disease Phase 1 Completed - Japan ... More >> Pfizer Investigational Site Chiba, Japan Pfizer Investigational Site Saitama, Japan Pfizer Investigational Site Shizuoka, Japan Pfizer Investigational Site Tokyo, Japan Less <<
NCT03025880 Advanced Breast Cancer Phase 2 Recruiting July 2020 Spain ... More >> Institut Català d'Oncologia. Hospital Universitario Germans Trias i Pujol Recruiting Badalona, Barcelona, Spain, 08916 Hospital Universitario de Canarias Recruiting La Laguna, Canarias, Spain, 38320 Hospital Universitario Virgen de la Arrixaca Recruiting El Palmar, Murcia, Spain, 30120 Clínica Universitaria de Navarra Recruiting Pamplona, Navarra, Spain, 31008 Centro Oncológico de Galicia Recruiting A Coruña, Spain, 15009 Complejo Hospitalario Universitario Reina Sofía Recruiting Cordoba, Spain, 14004 Hospital Universitario Ramón y Cajal Recruiting Madrid, Spain, 28034 Hospital Clínico Universitario San Carlos Recruiting Madrid, Spain, 28040 Hospital Universitario Virgen de la Macarena Recruiting Sevilla, Spain, 41009 Hospital Clínico Universitario de Zaragoza "Lozano Blesa" Recruiting Zaragoza, Spain, 50009 Less <<
NCT00397891 - Completed - -
NCT02084446 Transplantation Infection ... More >> Cytomegalovirus Infections Less << Phase 4 Unknown August 2015 Brazil ... More >> Hospital Geral de Fortaleza Fortaleza, Ceará, Brazil, 60175-295 Less <<
NCT03284398 - Recruiting November 2019 Spain ... More >> Hospital de Manacor Recruiting Manacor, Islas Baleares, Spain, 7500 Contact: Rosa G. Simeón          Principal Investigator: Rosa G. Simeón          Hospital Universitario 12 de Octubre Recruiting Madrid, Spain, 28041 Contact: Juan Carlos M. González          Principal Investigator: Juan Carlos M. González Less <<
NCT00983437 - Terminated(Study has been stop... More >>ped by sponsor decision) Less << - -
NCT00929695 Graft Versus Host Disease ... More >> Recurrent Adult Acute Lymphoblastic Leukemia Less << Phase 3 Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT00929695 - Completed - -
NCT03398421 Pulmonary Disease, Chronic Obs... More >>tructive Less << Phase 1 Completed - United States, Kansas ... More >> GSK Investigational Site Overland Park, Kansas, United States, 66211 Less <<
NCT00105066 - Completed - -
NCT02400333 Bioavailability ... More >> Healthy Subjects Less << Phase 1 Completed - Germany ... More >> Research Site Berlin, Germany Less <<
NCT00077636 Hepatitis C, Chronic Phase 4 Completed - -
NCT02829229 Obesity Overw... More >>eight Less << Not Applicable Recruiting December 2020 United States, Pennsylvania ... More >> Temple University Recruiting Philadelphia, Pennsylvania, United States, 19140 Contact: Sharon J Herring, MD, MPH    215-707-2234    Sharon.Herring@temple.edu    Contact: Veronica Bersani, MPH    215-707-8664    tuf59011@temple.edu    Principal Investigator: Sharon J. Herring, MD, MPH Less <<
NCT00077636 - Completed - -
NCT02400333 - Completed - -
NCT02446171 Bioavailability ... More >> Healthy Subjects Less << Phase 1 Completed - Germany ... More >> Research Site Berlin, Germany Less <<
NCT02436577 - Completed - -
NCT02436577 Bioequivalence ... More >> Healthy Japanese Subjects Pharmacokinetics Less << Phase 1 Completed - United Kingdom ... More >> Research Site Harrow, United Kingdom Less <<
NCT02446171 - Completed - -
NCT00420056 - Completed - -
NCT02194504 Abdominal Obesity ... More >> Liver Fat Less << Not Applicable Completed - -
NCT00983437 Traumatic Brain Injury Phase 3 Terminated(Study has been stop... More >>ped by sponsor decision) Less << - -
NCT02502812 Cardiovascular Disease Phase 1 Completed - India ... More >> GSK Investigational Site Telangana, India, 500 013 Less <<
NCT00420056 Lymphoma, Mantle-Cell Phase 1 Completed - United States, Massachusetts ... More >> Brigham & Women's Hospital Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 New York Presbyterian Hospital New York, New York, United States, 10021 Weill Medical College of Cornell University - New York Presbyterian Hospital New York, New York, United States, 10021 United States, Pennsylvania Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 Less <<
NCT03417830 Amyloidosis Phase 1 Terminated(Change in benefit/r... More >>isk profile.) Less << - Sweden ... More >> GSK Investigational Site Uppsala, Sweden, SE-751 85 GSK Investigational Site Uppsala, Sweden, SE-751 Less <<
NCT02751294 Malaria, Vivax Phase 1 Completed - United States, Maryland ... More >> GSK Investigational Site Baltimore, Maryland, United States, 21225 Less <<
NCT00364221 Metabolic Syndrome ... More >> Insulin Resistance Less << Phase 4 Completed - United States, Colorado ... More >> University of Colorado at Denver and Health Sciences Center General Clinical Research Center Denver, Colorado, United States, 80262 Less <<
NCT01774721 Non-small Cell Lung Cancer Wit... More >>h EGFR-Activating Mutations Less << Phase 3 Active, not recruiting March 29, 2019 -
NCT00366080 Narcolepsy Phase 2 Terminated(Study was terminate... More >>d based on the interim results of a futility test.) Less << - Austria ... More >> GSK Investigational Site Innsbruck, Austria, A-6020 GSK Investigational Site Vienna, Austria, A-1190 Finland GSK Investigational Site Espoo, Finland, 02980 Germany GSK Investigational Site Regensburg, Bayern, Germany, 93053 GSK Investigational Site Schwalmstadt, Hessen, Germany, 34613 GSK Investigational Site Schwerin, Mecklenburg-Vorpommern, Germany, 19053 GSK Investigational Site Bochum, Nordrhein-Westfalen, Germany, 44789 GSK Investigational Site Berlin, Germany, 14050 Netherlands GSK Investigational Site Leiden, Netherlands, 2333 CL Spain GSK Investigational Site Barcelona, Spain, 08035 GSK Investigational Site Barcelona, Spain, 08036 United Kingdom GSK Investigational Site Cambridge, Cambridgeshire, United Kingdom, CB3 8RE GSK Investigational Site Edinburgh, United Kingdom, EH3 6HP GSK Investigational Site London, United Kingdom, W1G 6BF Less <<
NCT02118792 Dermatitis, Atopic Phase 3 Completed - United States, Virginia ... More >> Anacor Investigational Site Henrico, Virginia, United States Less <<
NCT01774721 - Active, not recruiting - -
NCT00382057 Metabolic Syndrome Phase 2 Withdrawn March 2011 -
NCT00264641 - Completed - -
NCT02211352 Hypertension Phase 2 Completed - Korea, Republic of ... More >> Daegu Catholic University Medical Center Daegu, Korea, Republic of, 705-718 Less <<
NCT02118792 - Completed - -
NCT00452166 Chronic Kidney Disease ... More >> Insulin Resistance Less << Phase 3 Terminated(it was not possible... More >> to recruit new patients anymore) Less << - Netherlands ... More >> LUMC Leiden, Netherlands Less <<
NCT00264641 Hypoglycemia ... More >>Cognitive Impairment Less << Not Applicable Completed - Denmark ... More >> Medical Department I, Hillerød Hospital Hillerød, Denmark, 3400 Less <<
NCT00403689 Overweight Not Applicable Completed - Germany ... More >> German Institute of Human Nutrition, Department of Clinical Nutrition, Potsdam-Rehbrücke Nuthetal, Germany, 14558 Less <<
NCT00473876 Congestive Heart Failure ... More >> Insulin Resistance Less << Phase 4 Completed - United Kingdom ... More >> Medicine and Therapeutics, Ninewells Hospital Dundee, Scotland, United Kingdom, DD1 9SY Less <<
NCT00486967 - Unknown - United Kingdom ... More >> University of Dundee Recruiting Dundee, United Kingdom, DD1 9SY Contact: James Houston    0044(0)1382384664    j.z.houston@dundee.ac.uk    Sub-Investigator: MATLOOBA A ALZadjali, BSC,MD,MPH Less <<
NCT00438321 Metabolic Syndrome Phase 1 Terminated(PI relocated) - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT00473876 - Completed - -
NCT00552487 Hashimoto Disease ... More >> Adrenal Insufficiency Less << Not Applicable Completed - Germany ... More >> University of Wuerzburg, Department of Endocrinology Wuerzburg, Bavaria, Germany, 97080 Less <<
NCT00664222 Chronic Stable Heart Failure Phase 4 Completed - -
NCT00700245 Obesity Healt... More >>hy Less << Not Applicable Unknown March 2009 Denmark ... More >> Department of Medicine and Endocrinology C Recruiting Aarhus, Denmark, 8000 Contact: Bjørn Richelsen, Professor dr.med    004589497696    brich@dadlnet.dk    Principal Investigator: Tore Christiansen, M. Health S. Less <<
NCT01476098 Rhinitis Phase 2 Completed - United Kingdom ... More >> GSK Investigational Site Manchester, United Kingdom, M23 9QZ Less <<
NCT00549536 Hypertension ... More >>Diabetes Insulin Resistance Less << Phase 4 Completed - Greece ... More >> AHEPA University Hospital Thessaloniki, Greece, 54636 Less <<
NCT03034733 Arthroplasty, Knee Replacement... More >> Pain, Postoperative Less << Phase 4 Terminated(Principal investiga... More >>tor (M.K.) left for another workplace. Patient recruitment more difficult than expected.) Less << - Finland ... More >> Oulu University Hospital Oulu, OYS, Finland, 90029 Less <<
NCT00742066 Hypertension ... More >>Insulin Resistance Microcirculation Less << Not Applicable Unknown July 2009 Netherlands ... More >> University Hospital Maastricht Maastricht, P.O. Box 5800, Netherlands, 6202 AZ Less <<
NCT02925546 Heart Failure, Congestive Phase 1 Completed - United States, Kansas ... More >> GSK Investigational Site Overland Park, Kansas, United States, 66211 Less <<
NCT02509117 Healthy Subjects Phase 1 Completed - United States, California ... More >> California Clinical Trials Medical Group, Inc Glendale, California, United States, 91206 Glendale Adventist Medical Center Glendale, California, United States, 91206 Less <<
NCT01984658 Pancreatic Cancer Phase 1 Terminated(recruitment difficu... More >>lties as a new treatment for this indication available) Less << - Denmark ... More >> Kirurgisk afdeling K, Bispebjerg Hospital Copenhagen, Denmark, DK-2400 Less <<
NCT03557281 Tuberculosis Phase 2 Not yet recruiting September 13, 2020 -
NCT00240266 Metabolic Syndrome ... More >> Dyslipidemia Less << Phase 3 Completed - Australia, Victoria ... More >> Research Site Melbourne, Victoria, Australia Less <<
NCT00155961 - Completed - Denmark ... More >> Department of Endocrinology, Odense University Hospital Odense, Funen, Denmark, 5000 Less <<
NCT02332798 Schizophrenia Phase 1 Completed - United States, California ... More >> Collaborative Neuroscience Network, LLC. Long Beach, California, United States, 90806 Less <<
NCT02509117 - Completed - -
NCT02332798 - Completed - -
NCT02691702 Healthy Adult Subjects ... More >> Healthy Elderly Subjects Less << Phase 1 Completed - United States, Florida ... More >> QPS-MRA, LLC (Miami Research Associates) South Miami, Florida, United States, 33143 Qps-Mra, Llc South Miami, Florida, United States, 33143 Less <<
NCT01124318 Atopic Dermatitis Phase 2 Phase 3 Completed - Russian Federation ... More >> Moscow Dermatovenerologic Clinical Dispensary № 1 Moscow, Russian Federation, 119071 Moscow State University of Medicine and Dentistry Moscow, Russian Federation, 127473 Less <<
NCT03250689 Pulmonary Disease, Chronic Obs... More >>tructive Less << Phase 2 Active, not recruiting December 3, 2018 United Kingdom ... More >> GSK Investigational Site Dundee, United Kingdom, DD1 9SY Less <<
NCT02793232 Healthy Subjects Phase 1 Completed - Belgium ... More >> Pfizer Clinical Research Unit Brussels, Belgium, B-1070 Less <<
NCT00441116 Alopecia Phase 3 Completed - -
NCT02893488 Infection, Human Immunodeficie... More >>ncy Virus Less << Phase 1 Completed - United States, Kansas ... More >> GSK Investigational Site Overland Park, Kansas, United States, 66211 Less <<
NCT00537654 Prostatic Hyperplasia Phase 1 Completed - United States, Indiana ... More >> GSK Investigational Site Evansville, Indiana, United States, 47714 United States, Texas GSK Investigational Site Austin, Texas, United States, 78752 Less <<
NCT00441116 - Completed - -
NCT00385658 Dyslipidemia Phase 4 Completed - Germany ... More >> Investigative Centers, Germany Switzerland Novartis Pharma AG Basel, Switzerland Less <<
NCT02691702 - Completed - -
NCT00400231 Metabolic Syndrome x Phase 2 Completed - United States, Pennsylvania ... More >> University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00841334 Overweight Ob... More >>esity Insulin Resistance Less << Phase 1 Phase 2 Completed - United States, New Mexico ... More >> University of New Mexio Albuquerque, New Mexico, United States, 87131-0001 Less <<
NCT02964507 Neoplasms Phase 2 Recruiting June 1, 2020 -
NCT01182727 Schizophrenia ... More >> Insulin Resistance Less << Not Applicable Completed - United States, Maryland ... More >> Baltimore VA Medical Center Baltimore, Maryland, United States, 21201 Maryland Psychiatric Research Center Baltimore, Maryland, United States, 21228 Less <<
NCT02914964 Multiple Sclerosis ... More >> Multiple Sclerosis, Relapsing-Remitting Less << Not Applicable Recruiting January 2020 United States, Iowa ... More >> University of Iowa Hospitals and Clinics Recruiting Iowa City, Iowa, United States, 52242 Contact: Mary Ehlinger, BS    319-384-5002    MSDietStudy@healthcare.uiowa.edu    Contact: Michaella Fowler, BS    319-384-5002    MSDietStudy@healthcare.uiowa.edu    Principal Investigator: Terry L Wahls, MD, MBA Less <<
NCT02025595 - Completed - Netherlands ... More >> VU University Medical Center Amsterdam, Netherlands, 1081HV Less <<
NCT03149848 Infection, Human Immunodeficie... More >>ncy Virus Less << Phase 1 Completed - United Kingdom ... More >> GSK Investigational Site Cambridge, United Kingdom Less <<
NCT00514618 Diabetes, Gestational Not Applicable Terminated(Poor enrollment) - United States, California ... More >> Long Beach Memorial Medical Center Long Beach, California, United States, 90806 Less <<
NCT02190721 Neutropenia Phase 2 Completed - -
NCT02793232 - Completed - -
NCT03258762 Toxoplasmosis Phase 1 Completed - Australia, Victoria ... More >> GSK Investigational Site Melbourne, Victoria, Australia, 3004 Less <<
NCT01451970 Overweight/Obese Women Not Applicable Active, not recruiting January 2020 United States, Michigan ... More >> Michigan Clincal Research Unit Ann Arbor, Michigan, United States, 48109 Less <<
NCT02190721 - Completed - -
NCT01182727 - Completed - -
NCT00655018 Inflammation ... More >>Fibrosis Insulin Resistance Less << Phase 2 Phase 3 Completed - Italy ... More >> Dept. Of HepatoGastoEnterology and Nutrition, Liver Unit Rome, Italy, 00165 Less <<
NCT01474603 - Completed - Austria ... More >> Dept. Medicine III, Medical University of Vienna Vienna, Austria, 1090 Less <<
NCT03511105 Healthy Volunteers Phase 1 Recruiting February 3, 2019 Germany ... More >> GSK Investigational Site Recruiting Hannover, Niedersachsen, Germany, 30625 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com Less <<
NCT02837380 Pulmonary Disease, Chronic Obs... More >>tructive Less << Phase 1 Completed - China ... More >> GSK Investigational Site Shanghai, China, 200030 Less <<
NCT01362348 - Terminated(Lack of efficacy id... More >>entified during a preliminary analysis) Less << - -
NCT02253693 - Completed - Spain ... More >> University of Valencia Valencia, Spain, 46010 Hospital Universitari i Politècnic La Fe de Valencia Valencia, Spain, 46026 Less <<
NCT01362348 Macular Degeneration Phase 2 Terminated(Lack of efficacy id... More >>entified during a preliminary analysis) Less << - United States, Arizona ... More >> GSK Investigational Site Phoenix, Arizona, United States, 85014 United States, Florida GSK Investigational Site Miami, Florida, United States, 33143 GSK Investigational Site Winter Haven, Florida, United States, 33880 United States, Georgia GSK Investigational Site Decatur, Georgia, United States, 30030 United States, Massachusetts GSK Investigational Site Boston, Massachusetts, United States, 02114 United States, Michigan GSK Investigational Site Grand Rapids, Michigan, United States, 49525 United States, Ohio GSK Investigational Site Cleveland, Ohio, United States, 44195 United States, Texas GSK Investigational Site Austin, Texas, United States, 78705 GSK Investigational Site Houston, Texas, United States, 77030 France GSK Investigational Site Paris cedex 10, France, 75475 GSK Investigational Site Paris cedex 12, France, 75571 Germany GSK Investigational Site Muenchen, Bayern, Germany, 80336 GSK Investigational Site Bonn, Nordrhein-Westfalen, Germany, 53127 GSK Investigational Site Muenster, Nordrhein-Westfalen, Germany, 48145 GSK Investigational Site Leipzig, Sachsen, Germany, 04103 Less <<
NCT03575962 HIV Infections Phase 1 Completed - United Kingdom ... More >> GSK Investigational Site Nottingham, United Kingdom, NG11 6JS Less <<
NCT01163253 Psoriasis Phase 3 Terminated - -
NCT03273127 Asthma Phase 1 Completed - Germany ... More >> Research Site Berlin, Germany, 14050 Less <<
NCT02059759 Amyotrophic Lateral Sclerosis Phase 2 Completed - France ... More >> CHRU de Montpellier - Hôpital Gui de Chauliac Montpellier, France, 34295 Less <<
NCT01999309 Schizophrenia ... More >> Schizoaffective Disorder Schizophreniform Disorder Psychosis NOS Less << Phase 3 Recruiting April 2019 Netherlands ... More >> University Medical Center Groningen Recruiting Groningen, Netherlands, 9700 RB Contact: Erna Van 't Hag    +31 50 361 4106    e.van.t.hag@umcg.nl    Contact: Meike Bak    +31 50 361 4181    m.bak@umcg.nl    University Medical Center Utrecht Recruiting Utrecht, Netherlands, 3584 CX Contact: Sanne Schuite-Koops, MSc    +31 88 7558672    S.koops@umcutrecht.nl    Contact: Jantina Brummelman, MSc    +31 88 7550880    j.t.h.brummelman-2@umcutrecht.nl    Principal Investigator: Iris EC Sommer, Prof. dr. Less <<
NCT00572624 - Completed - -
NCT02333916 Overfeeding and Exercise Not Applicable Terminated(Recruitment target ... More >>could not be met) Less << - Netherlands ... More >> Maastricht University Maastricht, Limburg, Netherlands, 6200 Less <<
NCT01163253 - Terminated - -
NCT00963118 Metabolic Syndrome Not Applicable Completed - United States, Massachusetts ... More >> Jean Mayer USDA-Human Nutrition Research Center on Aging at Tufts University Boston, Massachusetts, United States, 02111 Less <<
NCT03329573 Anxiety Disorders Phase 1 Completed - China ... More >> GSK Investigational Site Shanghai, China, 201508 Less <<
NCT00572624 Obesity Not Applicable Completed - United States, Missouri ... More >> Washington University Medical School Saint Louis, Missouri, United States, 63110 Less <<
NCT03000686 Healthy Volunteers Phase 1 Recruiting June 14, 2019 Germany ... More >> GSK Investigational Site Recruiting Hannover, Niedersachsen, Germany, 30625 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com Less <<
NCT02310750 Plaque Psoriasis Phase 1 Completed - United States, California ... More >> Anaheim Clinical Trials, LLC Anaheim, California, United States, 92801 Less <<
NCT02723786 Kidney Transplantation (Status... More >> Post) Less << Phase 2 Recruiting November 23, 2018 Spain ... More >> GSK Investigational Site Not yet recruiting Barcelona, Spain, 08035 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    GSK Investigational Site Not yet recruiting Barcelona, Spain, 08036 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    GSK Investigational Site Recruiting L'Hospitalet de Llobregat, Spain, 08907 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    United Kingdom GSK Investigational Site Recruiting Cambridge, United Kingdom, CB2 0QQ Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    GSK Investigational Site Not yet recruiting Cardiff, United Kingdom, CF14 4XW Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    GSK Investigational Site Not yet recruiting Edinburgh, United Kingdom, EH16 4SA Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    GSK Investigational Site Recruiting Glasgow., United Kingdom, G51 4TF Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    GSK Investigational Site Recruiting Newcastle upon Tyne., United Kingdom, NE7 7DN Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    GSK Investigational Site Not yet recruiting Oxford, United Kingdom, OX3 7LE Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com Less <<
NCT03697824 Neoplasms Phase 2 Not yet recruiting July 17, 2022 -
NCT00004984 Diabetes Mellitus, Type 1 Phase 3 Completed - United States, California ... More >> Childrens Hospital of Los Angeles, Division of Endocrinology Los Angeles, California, United States, 90027 University of California-San Francisco, Milberry Union East RM 405, 500 Parnassus Ave Box 0136 San Francisco, California, United States, 94143 Stanford University Stanford, California, United States, 94305-5208 United States, Colorado University of Colorado Barbara Davis Center for Childhood Diabetes Denver, Colorado, United States, 80262 United States, Florida University of Florida Diabetes Research Center Gainesville, Florida, United States, 32610-0296 DPT-1 Operations Coordinating Center Miami, Florida, United States, 33136 University of Miami School of Medicine, Jackson Medical Tower Miami, Florida, United States, 33136 United States, Indiana Indiana University, James Whitcomb Riley Hospital for Children, 702 Barnhill Dr, Ste 5960 Indianapolis, Indiana, United States, 46202 United States, Massachusetts Joslin Diabetes Center Boston, Massachusetts, United States, 02215 United States, Minnesota University of Minnesota Minneapolis, Minnesota, United States, 55455 United States, New York Naomi Berrie Diabetes Center, Columbia University, 1150 St. Nicholas Ave New York, New York, United States, 10032 United States, Pennsylvania Children's Hospital of Pittsburgh, Dept/Pediatric Endocrinology, 3705 5th Ave Pittsburgh, Pennsylvania, United States, 15213 United States, Texas University of Texas, Children's Medical Center, 6300 Harry Hines Ste 1200 Dallas, Texas, United States, 75235 United States, Washington Virginia Mason Research Center, 1201 Ninth Avenue Seattle, Washington, United States, 98101 Canada, Ontario Hospital for Sick Children, Division of Endocrinology, 555 University Ave, Rm 5110 Toronto, Ontario, Canada, M5G-1X8 Less <<
NCT00001859 - Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00005665 Diabetes Mellitus, Type 1 Phase 2 Unknown - United States, Texas ... More >> Dept. of Neurology, Rm MSB 7.044 Univ. of Texas-Houston Medical School Houston, Texas, United States, 77030 Less <<
NCT00005539 - Completed - -
NCT01055223 - Completed - -
NCT01055223 - Completed - -
NCT02738931 Infection, Human Immunodeficie... More >>ncy Virus Less << Phase 1 Completed - United States, Kansas ... More >> GSK Investigational Site Overland Park, Kansas, United States, 66211 Less <<
NCT02093234 - Completed - -
NCT00006160 Insulin-Dependent Diabetes Mel... More >>litus Less << Not Applicable Completed - United States, Ohio ... More >> Case Western Reserve University Cleveland, Ohio, United States Less <<
NCT01018602 Insulin-dependent Gestational ... More >>Diabetes Less << Phase 2 Unknown June 2015 Germany ... More >> Institut fuer Diabetesforschung Recruiting Munich, Germany, 80804 Contact: Anette G Ziegler, MD    +49 (0)89 3068 2917 ext 2917    anziegler@lrz.uni-muenchen.de    Principal Investigator: Anette G Ziegler, MD Less <<
NCT02310750 - Completed - -
NCT02135328 Type 2 Diabetes Not Applicable Completed - -
NCT01053936 Renal Insufficiency, Chronic ... More >> Diabetes Mellitus, Type 2 Less << Phase 2 Completed - -
NCT02753231 Obesity Metab... More >>olic Syndrome X Lipid Metabolism Disorders Body Composition, Beneficial Mental Health Wellness 1 Less << Not Applicable Completed - -
NCT01058772 Gestational Diabetes ... More >> Gestational Diabetes Mellitus Diabetes Mellitus, Gestational Pregnancy-Induced Diabetes Diabetes, Pregnancy Induced Less << Not Applicable Completed - Israel ... More >> Helen Schneider's Hospital for Women - Rabin Medical Center Petah-Tiqva, Israel, 49100 Italy I Ostetricia Spedali Civili Brescia, Italy, 25100 Department of Gynecology Perinatology and Human Reproduction Florence, Italy, 50141 Unità Operativa di Ostetricia e Ginecologia - Ospedale Buzzi Milan, Italy, 20154 Institute for Maternal and Child Health - IRCCS Burlo Garofolo Trieste, Italy, 34100 Dipartimento di Discipline Ginecologiche ed Ostetriche - Università di Torino Turin, Italy, 10126 Netherlands Division Woman and Baby - UMC Utrecht/ Wilhelmina Children's Hospital Utrecht, Netherlands, 3508 AB Slovenia Department of ob/gyn, Division of perinatology - University Medical Centre Ljubljana, Slovenia, SI-1000 Sri Lanka Department of Obstetrics and Gynecology - University of Colombo Colombo, Sri Lanka, Colombo 08 Less <<
NCT03287310 Asthma Phase 1 Recruiting September 24, 2019 Germany ... More >> GSK Investigational Site Recruiting Hannover, Niedersachsen, Germany, 30625 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    GSK Investigational Site Recruiting Berlin, Germany, 14050 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    United Kingdom GSK Investigational Site Recruiting Harrow, Middlesex, United Kingdom, HA1 3UJ Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    GSK Investigational Site Recruiting Cambridge, United Kingdom, CB2 2GG Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    GSK Investigational Site Recruiting London, United Kingdom, NW10 7EW Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    GSK Investigational Site Recruiting Manchester, United Kingdom, M23 9QZ Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com Less <<
NCT00200993 Cardiovascular Diseases ... More >> Heart Diseases Obesity Hyperlipidemia Insulin Resistance Metabolic Syndrome X Less << Phase 2 Completed - -
NCT02179385 Type 2 Diabetes Not Applicable Unknown - -
NCT02178839 Non Alcoholic Fatty Liver Dise... More >>ase Less << Not Applicable Unknown - Iran, Islamic Republic of ... More >> Shekh-al- rais Clinic Not yet recruiting Tabriz, Iran, Islamic Republic of Contact: Navideh Youshari, MSc. Student       navideh_youshari@yahoo.co.uk    Principal Investigator: Mohammad Alizadeh, PhD          Principal Investigator: Mehrangiz Ebrahimi Mameghani, PhD Less <<
NCT02187029 - Terminated(B7911002 was premat... More >>urely discontinued due to a safety concern that led to decision to terminate the study on 10 Nov 2014) Less << - -
NCT01086319 - Completed - -
NCT01087372 - Completed - Spain ... More >> Hospital Universitari Son Dureta. Intensive Care Unit Palma de Mallorca, Illes Balears, Spain, 07014 Less <<
NCT01067963 Diabetes Mellitus, Type 2 ... More >> Renal Insufficiency, Chronic Less << Not Applicable Terminated - United States, Colorado ... More >> University of Colorado Hospital Aurora, Colorado, United States, 80045 VA Eastern Colorado Hospital Denver, Colorado, United States, 80220 Less <<
NCT01439204 - Completed - -
NCT00126126 - Completed - -
NCT03455179 Aging Not Applicable Completed - Spain ... More >> Faculty of Physical Activity and Sports Sciences Valencia, Spain, 46010 Municipal Center of Activities for Older People of Campanar Valencia, Spain, 46015 Municipal Center of Activities for Older People of Nou Benicalap Valencia, Spain, 46025 Less <<
NCT02187029 Gout Phase 1 Terminated(B7911002 was premat... More >>urely discontinued due to a safety concern that led to decision to terminate the study on 10 Nov 2014) Less << - United States, Florida ... More >> MRA Clinical Research, LLC Miami, Florida, United States, 33143 Miami Research Associates, Inc. South Miami, Florida, United States, 33143 United States, Kansas Vince and Associates Clinical Research Inc. Overland Park, Kansas, United States, 66211 Vince and Associates Clinical Research, Inc. Overland Park, Kansas, United States, 66212 Less <<
NCT03603392 Bariatric Surgery and Physical... More >> Activity Less << Not Applicable Completed - Spain ... More >> Manuel Elche, Alicante, Spain, 03202 Less <<
NCT01087866 Gestational Diabetes Mellitus Phase 2 Phase 3 Completed - Finland ... More >> Oulu University Hospital Oulu, Finland, 90029 Less <<
NCT00471237 Osteoporosis Phase 2 Terminated(Terminated for futi... More >>lity by sponsor after a pre-planned interim review of data) Less << - -
NCT03154268 - Completed - -
NCT00471237 - Terminated(Terminated for futi... More >>lity by sponsor after a pre-planned interim review of data) Less << - -
NCT01229436 Dupuytren's Contracture Phase 3 Completed - Denmark ... More >> Pfizer Investigational Site Copenhagen, Denmark, 1402 K Pfizer Investigational Site Silkeborg, Denmark, 8600 France Pfizer Investigational Site Montpellier cedex 5, France, 34295 Pfizer Investigational Site Nice, France, 06000 Pfizer Investigational Site Paris, France, 75016 Pfizer Investigational Site Paris, France, Cedex 15 75908 Germany Pfizer Investigational Site Bad Neustadt, Germany, 97616 Pfizer Investigational Site Berlin, Germany, 10627 Pfizer Investigational Site Bonn, Germany, 53123 Pfizer Investigational Site Muenster, Germany, 48149 Pfizer Investigational Site Nurnberg, Germany, 90471 Pfizer Investigational Site Tubingen, Germany, 72076 Hungary Pfizer Investigational Site Miskolc, Hungary, 3526 Italy Pfizer Investigational Site Sesto San Giovanni, Milano, Italy, 20099 Pfizer Investigational Site Modena, Italy, 41124 Pfizer Investigational Site Savona, Italy, 17100 Spain Pfizer Investigational Site Elche, Alicante, Spain, 03203 Pfizer Investigational Site Hospitalet De Llobregat, Barcelona/ Spain, Spain, 08907 Pfizer Investigational Site Barcelona, Spain, 08022 Pfizer Investigational Site Barcelona, Spain, 08036 Pfizer Investigational Site Málaga, Spain, 29010 Sweden Pfizer Investigational Site Malmö, Sweden, SE-205 02 Pfizer Investigational Site Stockholm, Sweden, SE 118 83 Pfizer Investigational Site Uppsala, Sweden, 751 85 United Kingdom Pfizer Investigational Site Derby, United Kingdom, DE22 3NE Pfizer Investigational Site Glasgow, United Kingdom, G4 0SF Pfizer Investigational Site Norwich, United Kingdom, NR4 7UY Pfizer Investigational Site Southampton, United Kingdom, SO16 6YD Less <<
NCT01294761 HIV Infections Not Applicable Completed - Japan ... More >> National Center for Global Health and Medicine Shinjuku, Tokyo, Japan, 1628655 Less <<
NCT01229436 - Completed - -
NCT03712761 - Active, not recruiting May 1, 2019 Canada, Ontario ... More >> Exercise Metabolism Research Laboratory, McMaster Univeristy Hamilton, Ontario, Canada, L8S 4K1 Less <<
NCT01925274 Metastatic Colorectal Cancer Phase 2 Terminated(Enrollment to the s... More >>tudy was terminated on 11Nvo2014 due to slow recruitment. There were no safety or efficacy issues that contributed to this decision.) Less << - United States, California ... More >> CBCC Global Research, Inc. at Comprehensive Blood and Cancer Center Bakersfield, California, United States, 93309 Drug Management Only: UCLA West Medical Pharmacy, Att: Steven L Wong, Pharm D Los Angeles, California, United States, 90095-7349 Drug Management Only: UCLA West Medical Pharmacy Los Angeles, California, United States, 90095-7349 UCLA West Medical Pharmacy Los Angeles, California, United States, 90095-7349 Regulatory Management Only: TRIO-US Central Administration Los Angeles, California, United States, 90095 TRIO-US Central Administration (Regulatory Management only) Los Angeles, California, United States, 90095 TRIO_US Los Angeles, California, United States, 90095 West Valley Hematology/Oncology Med Group Northridge, California, United States, 91328 United States, Missouri Siteman Cancer Center - West County Creve Coeur, Missouri, United States, 63141 Barnes-Jewish Hospital Saint Louis, Missouri, United States, 63110 Drug Shipping Address: Washington University Infusion Center Pharmacy Saint Louis, Missouri, United States, 63110 Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Siteman Cancer Center - South County Saint Louis, Missouri, United States, 63129 Siteman Cancer Center - St Peters Saint Peters, Missouri, United States, 63376 United States, Nevada Regulatory Office: Comprehensive Cancer Centers of Nevada Henderson, Nevada, United States, 89014 Comprehensive Cancer Centers of Nevada Henderson, Nevada, United States, 89052 Comprehensive Cancer Centers of Nevada Henderson, Nevada, United States, 89074 Comprehensive Cancer Centers of Nevada Las Vegas, Nevada, United States, 89128 Comprehensive Cancer Centers of Nevada Las Vegas, Nevada, United States, 89148 Comprehensive Cancer Centers of Nevada Las Vegas, Nevada, United States, 89169 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263 United States, Washington Kadlec Clinic Hematology and Oncology Kennewick, Washington, United States, 99336 Kadlec Medical Center Richland, Washington, United States, 99352 Outpatient Imaging Center Richland, Washington, United States, 99352 Spokane Valley Cancer Center Spokane Valley, Washington, United States, 99216 Medical Oncology Associates, PS Spokane, Washington, United States, 99208 Japan Aichi cancer center central hospital Nagoya, Aichi, Japan, 464-8681 National Cancer Center Hospital East Kashiwa, Chiba, Japan, 277-8577 Korea, Republic of National Cancer Center Goyang-si, Gyeonggi-do, Korea, Republic of, 410-769 Seoul National University Hospital / Department of Internal Medicine Seoul, Korea, Republic of, 110-744 Samsung Medical Center Seoul, Korea, Republic of, 135-710 Asan Medical Center Seoul, Korea, Republic of, 138-736 Spain Hospital General Universitario Gregorio Marañón Madrid, Spain, 28009 Less <<
NCT01727791 Healthy Lactating Women Phase 4 Completed - Belgium ... More >> Pfizer Clinical Research Unit Brussels, Belgium, B-1070 Less <<
NCT01925274 - Terminated(Enrollment to the s... More >>tudy was terminated on 11Nvo2014 due to slow recruitment. There were no safety or efficacy issues that contributed to this decision.) Less << - -
NCT01727791 - Completed - -
NCT03538119 Cardiac Patients Not Applicable Recruiting June 30, 2019 Portugal ... More >> Catarina Gonçalves Recruiting São Bartolomeu de Messines, Faro, Portugal, 8375-127 Contact: Catarina Gonçalves, MSc    +351964526057    catarinajg3@gmail.com    Contact: Armando Raimundo, Ph.D.    +351917586909    ammr@uevora.pt    Principal Investigator: Catarina Gonçalves, MSc          Principal Investigator: Armando Raimundo, Ph.D.          Principal Investigator: Jorge Bravo, Ph.D. Less <<
NCT03168074 Breast Cancer Phase 2 Recruiting March 28, 2021 Singapore ... More >> Nationa University Hospital Recruiting Singapore, Singapore Contact: Soo Chin Lee, MBBS, MRCP    +65 6779 5555    Soo_Chin_Lee@nuhs.edu.sg    Principal Investigator: Soo Chin Lee, MBBS, MRCP Less <<
NCT00742885 Influenza Phase 2 Completed - Japan ... More >> GSK Investigational Site Fukuoka, Japan, 813-8588 GSK Investigational Site Tokyo, Japan, 204-8585 Less <<
NCT00896363 Depressive Disorder Phase 2 Completed - Russian Federation ... More >> GSK Investigational Site Ekaterinburg, Russian Federation, 620030 GSK Investigational Site Kemerovo, Russian Federation, 650036 GSK Investigational Site Lipetsk Region, Russian Federation, 399083 GSK Investigational Site Moscow, Russian Federation, 119992 GSK Investigational Site Nizhny Novgorod, Russian Federation, 603107 GSK Investigational Site Saint Petersburg, Russian Federation, 190005 GSK Investigational Site Saint Petersburg, Russian Federation, 191180 GSK Investigational Site Saint-Petersburg, Russian Federation GSK Investigational Site Saratov, Russian Federation, 410060 GSK Investigational Site Smolensk, Russian Federation, 214 019 GSK Investigational Site St-Petersburg, Russian Federation, 197341 GSK Investigational Site St. Petersburg, Russian Federation, 190121 GSK Investigational Site St. Petersburg, Russian Federation, 194044 GSK Investigational Site St.Petersburg, Russian Federation, 193167 GSK Investigational Site Tomsk, Russian Federation, 634014 Less <<
NCT02412852 Diabetes Phase 2 Unknown January 2016 United States, Ohio ... More >> Ohio Pain Clinic Centerville, Ohio, United States, 45458 Less <<
NCT01462565 - Completed - -
NCT00742885 - Completed - -
NCT00266630 Manic or Mixed Episode Associa... More >>ted With Bipolar I Disorder Less << Phase 3 Completed - Japan ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Akita, Japan, 010-1654 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chiba, Japan, 292-0061 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fukuoka, Japan, 812-8582 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Gunma, Japan, 371-8511 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hokkaido, Japan, 005-0004 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hyogo, Japan, 663-8501 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nara, Japan, 634-8522 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Okayama, Japan, 710-0055 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Okinawa, Japan, 900-0005 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Saitama, Japan, 343-0032 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tokyo, Japan, 151-0053 Less <<
NCT00387764 Carcinoma, Renal Cell Phase 3 Completed - -
NCT00266630 - Completed - -
NCT01462565 Hypertension, Pulmonary Phase 4 Completed - United States, Florida ... More >> GSK Investigational Site Miami Beach, Florida, United States, 33140 United States, Illinois GSK Investigational Site Chicago, Illinois, United States, 60637 United States, Maryland GSK Investigational Site Baltimore, Maryland, United States, 21205 United States, Massachusetts GSK Investigational Site Boston, Massachusetts, United States, 02118-2393 United States, Ohio GSK Investigational Site Columbus, Ohio, United States, 43221 United States, Texas GSK Investigational Site Dallas, Texas, United States, 75390-8550 Canada GSK Investigational Site Quebec, Canada, G1V 4G5 Netherlands GSK Investigational Site Amsterdam, Netherlands, 1081 HV Less <<
NCT02969044 Rheumatoid Arthritis Phase 2 Completed - -
NCT01351740 HIV Infection Phase 4 Completed - Canada, British Columbia ... More >> Immunodeficiency Clinic, St. Paul's Hospital Vancouver, British Columbia, Canada, V6Z1Y6 Less <<
NCT00896363 - Completed - -
NCT00387764 - Completed - -
NCT01179789 Aged Healthy Early Phase 1 Completed - Germany ... More >> Charité - Universitätsmedizin Berlin Berlin, Germany, 10117 Less <<
NCT02969044 - Completed - -
NCT03274648 BehçEt Disease Not Applicable Not yet recruiting January 2018 -
NCT01970865 ALK-positive Non Small Cell Lu... More >>ng Cancer (NSCLC) and ROS1-positive NSCLC Less << Phase 2 Active, not recruiting February 19, 2019 -
NCT01351740 - Completed - -
NCT01464073 Obesity Not Applicable Completed - France ... More >> Centre Hospitalier Universitaire Saint Pierre, île de La Réunion, France, 97448 Less <<
NCT00404768 - Completed - -
NCT01728493 - Completed - Netherlands ... More >> Radboud university medical center Nijmegen, Gelderland, Netherlands, 6500 HB Less <<
NCT00404768 Obstetric Labour, Premature Phase 2 Completed - -
NCT02220803 Obstructive Sleep Apnea ... More >> Sleep-Disordered Breathing Blood Pressure Hypertension Less << Phase 2 Completed - Sweden ... More >> Center for Sleep and Vigilance disorders Gothenburg, Vastra Gotaland, Sweden, 40530 Less <<
NCT02003924 Nonmetastatic Castration-Resis... More >>tant Prostate Cancer Prostate Cancer Cancer of the Prostate Less << Phase 3 Active, not recruiting May 31, 2020 -
NCT00993967 Freidreich's Ataxia Phase 3 Completed - Austria ... More >> Universitätsklinik Innsbruck Innsbruck, Austria Belgium Hôpital Erasme - Univeristé Libre de Bruxelles Bruxelles, Belgium, 1070 France Hôpital de la Salpétrière - INSERM U679, Neurologie et Thérapeutique expérimentale Paris, France, 75651 Germany HELIOS Klinikum Berlin Berlin, Germany, 13125 Neurologische Universitätsklinik und Ploklinik - Universitätsklimikum Bonn Bonn, Germany, 53105 Klinik II, Neuropädiatrie und Muskelerkrankungen - Universitätsklinik Freiburg Freiburg, Germany, 79106 Zentrum für Neurologische Medizin Göttingen, Germany, 37073 UKE Hamburg Neuropädiatrie - Zentrum für Frauen, Kinder und Jugendmedizin Hamburg, Germany, 20246 Neurologische Klinik - Klinikum Grosshadern München, Germany, 81377 Neurologische Universitätsklinik und Poliklinik Tübingen, Germany, 72076 Netherlands University medical Center Groningen Groningen, Netherlands, 9700 RB Less <<
NCT03085277 Enteral Feeding Intolerance ... More >> Necrotizing Enterocolitis Late-Onset Neonatal Sepsis Less << Not Applicable Recruiting December 31, 2019 China, Guangdong ... More >> Foshan Maternal and Child Health Hospital Not yet recruiting Foshan, Guangdong, China Contact: Yiheng Dai       daiyiheng@163.com    Contact: Xiaoyan Gao       gxy270000@sina.com    Principal Investigator: Yiheng Dai          Sub-Investigator: Xiaoyan Gao          The First Affiliated Hospital of Jinan Medical University Not yet recruiting Guangzhou, Guangdong, China Contact: Guosheng Liu       tlgs@jnu.edu.cn    Contact: Wenchao Chen       follen@163.com    Principal Investigator: Guosheng Liu          Sub-Investigator: Wenchao Chen          Sub-Investigator: Xia Wu          The Sixth Affiliated Hospital of Sun Yat-sen University Recruiting Guangzhou, Guangdong, China Contact: Hu Hao       freehaotiger@126.com    Contact: Fei Ma       maf.0@163.com    Principal Investigator: Hu Hao          Sub-Investigator: Mengxian Liu          Longgang District Central Hospital of Shenzhen Not yet recruiting Shenzhen, Guangdong, China Contact: Huixian Qiu       szlgqhx@126.com    Contact: Xunbin Huang       hxb_2710@163.com    Principal Investigator: Huixian Qiu          Sub-Investigator: Xunbin Huang          Sub-Investigator: Shujuan Zeng          Shenzhen Guangming People's Hospital Not yet recruiting Shenzhen, Guangdong, China Contact: Zhenzhi Ye       zhenzhiye2@163.com    Contact: Xiaoli Chen       fmcxl213@126.com    Principal Investigator: Zhenzhi Ye          Sub-Investigator: Xiaoli Chen          Shenzhen Luohu Maternal and Child Health Hospital Recruiting Shenzhen, Guangdong, China Contact: Yuefeng Li       liyuefeng111@sina.com    Contact: Xuelei Gong       gongxuelei1987@163.com    Principal Investigator: Yuefeng Li          Sub-Investigator: Xuelei Gong          Shenzhen Nanshan Maternal and Child Health Hospital Recruiting Shenzhen, Guangdong, China Contact: Luanying Tian       1782701141@qq.com    Contact: Xiujuan Wu       wuxiujuan1978@126.com    Principal Investigator: Luanying Tian          Sub-Investigator: Xiujuan Wu          Shenzhen People's Hospital Recruiting Shenzhen, Guangdong, China Contact: Benqing Wu    +86 139 0243 6593    wubenqing783@126.com    Contact: Lu Ding    +86 13922851709    459208691@qq.com    Principal Investigator: Benqing Wu          Sub-Investigator: Ding Lu          Sub-Investigator: Jinzhen Su          Taiwan China Medical University Children Hospital Not yet recruiting Taichung, Taiwan Contact: Hung-Chih Lin       d0373.cmuh@gmail.com    Contact: Hsiang-Yu Lin       hylin.neo@gmail.com    Principal Investigator: Hung-Chih Lin          Sub-Investigator: Hsiang-Yu Lin Less <<
NCT01344525 Obesity Weigh... More >>t Loss Less << Not Applicable Recruiting May 2029 Germany ... More >> University of Heidelberg Recruiting Heidelberg, Germany, 69120 University of Hohenheim Recruiting Stuttgart, Germany, 70599 University of Tübingen Recruiting Tübingen, Germany, 72076 Less <<
NCT01970865 - Active, not recruiting - -
NCT03013543 Pro-opiomelanocortin (POMC) De... More >>ficiency Obesity (Heterozygous or Epigenetic) Leptin Receptor Deficiency Obesity Bardet-Biedl Syndrome Alstrom Syndrome Smith-Magenis Syndrome Less << Phase 2 Phase 3 Recruiting August 2021 United States, California ... More >> Axis Clinical Trials Headquarters Recruiting Los Angeles, California, United States, 90036 Contact: Elianet De La Cruz    310-289-8242 ext 165       Principal Investigator: Lydie Hazan          Axis Clinical Trials-Downtown Recruiting Los Angeles, California, United States Contact: Sylvia Orellana    213-484-0180       Principal Investigator: Patrick Clark          United States, Colorado University of Colorado Hospital Recruiting Aurora, Colorado, United States, 80045 Contact: Hoda Farajpour, MD    720-848-5596    hoda.farajpour@ucdenver.edu    Principal Investigator: Neda Rasouli, MD          United States, Florida University of Florida College of Medicine Recruiting Gainesville, Florida, United States, 32610 Contact: Beverly Giordano    352-294-5280    bgiordano@ufl.edu    Principal Investigator: Jennifer Miller, MD          United States, Maryland NIH Hatfield Clinical Research Center Recruiting Bethesda, Maryland, United States, 20892 Contact: Sheila Brady    301-451-3783    bradys@mail.nih.gov    Principal Investigator: Jack A Yanovski, MD          United States, Nevada Impact Clinical Trials Recruiting Las Vegas, Nevada, United States, 89106 Contact: Fabiola Vazquez    702-889-0061       Principal Investigator: Constance Brown          United States, New York Icahn School of Medicine at Mount Sinai Recruiting New York, New York, United States, 10029-6574 Contact: Jeanine Albu       Jeanine.AlbuMD@mountsinai.org    Principal Investigator: Deena Adimoolam          United States, North Carolina Wake Research Inc. Recruiting Raleigh, North Carolina, United States, 27612 Contact: Kim Jolly    919-781-2514       Principal Investigator: Wayne Harper          United States, Pennsylvania Obesity Institute, Geisinger Clinic Recruiting Danville, Pennsylvania, United States, 17822 Contact: Marianne Yohn    570-214-1004    mmyohn2@geisinger.edu    Principal Investigator: Christopher Still, MD          United States, Tennessee Le Bonheur Children's Hospital Recruiting Memphis, Tennessee, United States, 38103 Contact: Raquel Mack          Contact    901-    rmack7@uthsc.edu    Principal Investigator: Joan Han, MD          Vanderbilt University School of Medicine Not yet recruiting Nashville, Tennessee, United States, 37212-3157 Contact: Bethany Oates    615-322-8068    bethany.l.oates@vanderbilt.edu    Principal Investigator: Ashley Shoemaker          United States, Wisconsin Marshfield Clinic Recruiting Marshfield, Wisconsin, United States, 54449 Contact: Kristina Fletty          Principal Investigator: Robert M Haws, MD          Spain Universidad Autónoma de Madrid Not yet recruiting Madrid, Spain, 65 28009 Principal Investigator: Jesús Argente          United Kingdom Marshfield Clinic Recruiting Birmingham, United Kingdom, B152TH Contact: Vishy Veeranna    44 (0) 121 371 6694    Vishy.Veeranna@uhb.nhs.uk    Principal Investigator: Tarekegn Hiwot, MD Less <<
NCT02621931 Migraine Phase 3 Completed - -
NCT00993967 - Completed - -
NCT02629861 - Completed - -
NCT02011178 Diabetic Kidney Disease Not Applicable Withdrawn(No subjects have bee... More >>n enrolled) Less << December 2017 Sweden ... More >> Ersta hospital Stockholm, Sweden, 116 28 Switzerland St:Claraspital Basel, Switzerland, 4058 Less <<
NCT02716194 Hemophilia A Phase 1 Completed - Bulgaria ... More >> UMHAT "Sv. Georgi", EAD Plovdiv, Bulgaria, 4000 Germany Werlhof-Institut Hannover, Niedersachsen, Germany, 30159 Medizinische Hochschule Hannover Hannover, Niedersachsen, Germany, 30625 Vivantes Klinikum im Friedrichshain - Landsberger Allee Berlin, Germany, 10249 Universitaetsklinikum des Saarlandes Homburg, Germany, 66421 Universitaetsklinikum Gießen Marburg, Germany, 35043 Hungary Semmelweis Egyetem AOK I.sz. Belgyogyaszati Klinika Budapest, Hungary, 1083 Italy Presidio Ospedaliero di Castelfranco Veneto Castelfranco Veneto, Treviso, Italy, 31033 Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milano, Italy, 20122 Policlinico Umberto I di Roma-Università di Roma La Sapienza Roma, Italy, 00144 Netherlands Radboud University Nijmegen Medical Centre Nijmegen, Netherlands, 6525 GA Erasmus Medisch Centrum Rotterdam, Netherlands, 3015 AA Poland Instytut Hematologii i Transfuzjologii Warszawa, Poland, 02-776 Russian Federation FSBI "Kirov SR Institute of Hematology and Blood Transfusion FMBA" Kirov, Russian Federation, 610027 FSBI "Hematological Research Center" MoH of RF Moscow, Russian Federation, 125167 SBEI HPE "Samara State Medical University" of the MoH of the RF Samara, Russian Federation, 443099 Spain Complejo Hospitalario Universitario A Coruña A Coruña, La Coruña, Spain, 15006 Hospital General Universitario de Alicante Alicante, Spain, 03010 Hospital Universitari Vall d'Hebron Barcelona, Spain, 08035 Hospital Universitario La Paz Madrid, Spain, 28046 Hospital Regional Universitario de Malaga Malaga, Spain, 29010 Hospital Universitario Son Espases Palma de Mallorca, Spain, 07120 United Kingdom Royal Cornwall Hospital Truro, Cornwall, United Kingdom, TR1 3LJ Royal London Hospital London, Greater London, United Kingdom, E1 1BB Royal Free Hospital London, Greater London, United Kingdom, NW3 2QG St Thomas' Hospital Centre for Haemostasis & Thrombosis London, Greater London, United Kingdom, SE1 7EH Manchester Royal Infirmary Manchester, Greater Manchester, United Kingdom, M13 9WL University Hospital of Wales Cardiff, West Glamorgan, United Kingdom, CF14 4XW Less <<
NCT02716194 - Completed - -
NCT00239356 Schizophrenia Phase 3 Completed - Canada, Ontario ... More >> Local Institution Ottawa, Ontario, Canada Canada, Quebec Local Institution Sherbrooke, Quebec, Canada Croatia Local Institution Rijeka, Croatia Local Institution Zagreb, Croatia Czech Republic Local Institution Hradec Kralove, Czech Republic Local Institution Prague 6, Czech Republic France Local Institution Nantes Orvault, France Local Institution Rennes Cedex, France Local Institution Uzes, France Hungary Local Institution Budapest, Hungary Local Institution Gyor, Hungary Netherlands Local Institution Vught, Netherlands Poland Local Institution Krakow, Poland Local Institution Poznan, Poland Romania Local Institution Bucharest, Romania Russian Federation Local Institution St. Petersburg, Russian Federation South Africa Local Institution Westdene, Free State, South Africa Local Institution Johannesburg, Gauteng, South Africa Local Institution Cape Town, Western Cape, South Africa United Kingdom Local Institution Antrim, United Kingdom Less <<
NCT02629861 Migraine Phase 3 Completed - -
NCT00239356 - Completed - -
NCT03665090 - Enrolling by invitation December 31, 2020 -
NCT02354508 Acromegaly Phase 3 Completed - -
NCT02578004 - Completed - Tunisia ... More >> Latifa KHLIFI Sousse, Tunisia, 4000 Less <<
NCT03632694 Cancer Not Applicable Completed - -
NCT02621931 - Completed - -
NCT00435045 Hypertriglyceridemia Phase 3 Completed - -
NCT00053482 Smallpox Phase 2 Completed - United States, Kansas ... More >> PRA International Lenexa, Kansas, United States, 66219 United States, Missouri Bio-Kinetic Clinical Applications Springfield, Missouri, United States, 65802 United States, Rhode Island Memorial Hospital of Rhode Island Division of Infectious Diseases Pawtucket, Rhode Island, United States, 02860 Less <<
NCT00053482 - Completed - -
NCT02147938 - Completed - France ... More >> Site Amiens, France Site Angers, France Site Besancon, France Site Brest, France Site Caen, France Site Clermond-Ferrand, France Site Creteil, France Site Dijon, France Site Le Krémlin-Bicêtre, France Site Lille, France Site Limoges, France Site Lyon 3, France Site Marseille, France Site Montpellier, France Site Nancy, France Site Nantes, France Site Nice, France Site Paris 10, France Site Paris Cedex 13, France Site Poitiers, France Site Rennes, France Site Rouen, France Site Saint Etienne, France Site Strasbourg, France Site Suresnes, France Site Toulouse, France Site Tours, France Less <<
NCT00435045 - Completed - -
NCT03263962 - Completed - Italy ... More >> IRCCS Policlinico San Matteo Pavia, Italy, 27100 Less <<
NCT00910962 Acute Coronary Syndrome Phase 2 Completed - -
NCT02278471 Hypertension ... More >>Hyperlipidemia Less << Phase 2 Completed - United States, Alabama ... More >> Franklin Primary Health Center Mobile, Alabama, United States, 36603 Less <<
NCT01536379 Transplantation, Organ Phase 2 Completed - United Kingdom ... More >> GSK Investigational Site Cambridge, United Kingdom, CB2 0QQ GSK Investigational Site London, United Kingdom, SE1 9RT Less <<
NCT02003924 - Active, not recruiting - -
NCT02896192 Pro-opiomelanocortin (POMC) De... More >>ficiency Obesity Less << Phase 2 Phase 3 Recruiting October 2019 United States, Arizona ... More >> Honor Health Research Institute Recruiting Scottsdale, Arizona, United States, 85258 Contact: James Swain, MD    480-882-7460    james.swain@honorhealth.com    Principal Investigator: James Swain, MD          Belgium UZ Gent Recruiting Gent, Belgium, 9000 Contact: Kathleen De Waele, MD    32 9 332 4825    Kathleen.dewaele@uzgent.be    Principal Investigator: Kathleen De Waele, MD          Canada, Ontario Peel Memorial Hospital Recruiting Brampton, Ontario, Canada, L6W 2Z8 Contact: Karlee Trafford       karlee.trafford@illingworthresearch.com    Principal Investigator: Allison Bahm, MD          France Institute of Cardiometabolism and Nutrition / Pitié-Salpêtrière Hospital Recruiting Paris, France, 75013 Contact: Karine Clement, MD, PhD       karine.clement@aphp.fr    Germany Charite Campus Virchow-Klinikum / Institute for Experimental Paediatric Endocrinology Recruiting Berlin, Germany, 13353 Contact: Peter Kuhnen, MD       Peter.Kuehnen@charite.de    Spain Universidad Autonoma de Madrid University Hospital Nino Jesus Not yet recruiting Madrid, Spain, 28009 Contact: Naciba Zetchi       nzetchi@rhythmtx.com    Principal Investigator: Jesus Argente, MD          Principal Investigator: Gabriel A Martos Moreno, MD          United Kingdom University of Cambridge Metabolic Research Laboratories Not yet recruiting Cambridge, United Kingdom, CB2 0QQ Contact: Sadaf Farooqi, PhD FRCP FMedSci       isf20@medschl.cam.ac.uk Less <<
NCT00910962 - Completed - -
NCT03169257 Obesity, Childhood ... More >> Cardiovascular Diseases Less << Not Applicable Active, not recruiting December 2019 -
NCT02054091 Feeding Intolerance ... More >> Extrauterine Growth Retardation Necrotizing Enterocolitis Sepsis Meningitis Less << Phase 1 Phase 2 Completed - China, Guangdong ... More >> Foshan Women and Children's Hospital (FWCH) Foshan, Guangdong, China, 528000 Shenzheng Baoan Maternity and Child Healthcare Hospital (SBMCH) Shenzhen, Guangdong, China, 518133 Denmark Rigshospitalet (RH) Copenhagen, Denmark, 2100 Hvidovre Hospital (HH) Hvidovre, Denmark, 2650 Less <<
NCT03287960 Leptin Receptor Deficiency Obe... More >>sity Less << Phase 3 Recruiting January 2020 United States, New York ... More >> Columbia University Recruiting New York, New York, United States, 10032 Contact: Wendy Chung, MD       wkc15@cumc.columbia.edu    France Institute of Cardiometabolism and Nutrition / Pitié-Salpêtrière Hospital Recruiting Paris, France, 75013 Contact: Karine Clement, MD PhD       karine.clement@aphp.fr    Germany University of Ulm Recruiting Ulm, Germany Contact: Martin Wabitsch, MD       Martin.Wabitsch@uniklinik-ulm.de    Netherlands Erasmus Medical Center Recruiting Rotterdam, Netherlands Contact: Erica van den Akker, MD       e.l.t.vandenakker@erasmusmc.nl    United Kingdom University of Cambridge Metabolic Research Laboratories Recruiting Cambridge, United Kingdom, CB2 0QQ Contact: Sadaf Farooqi, PhD FRCP FMedSci       isf20@medschl.cam.ac.uk Less <<
NCT01536379 - Completed - -
NCT02377388 Platelet Aggregation During Ac... More >>ute Myocardial Infarction Less << Phase 3 Recruiting December 2019 Brazil ... More >> Heart Institute(InCor)-Acute Coronary Care Unit Recruiting São Paulo, SP, Brazil, 01406000 Contact: Paulo R Genestreti, MD    55 11 2661-5058    paulo.gen@ig.com.br    Principal Investigator: Jose C Nicolau, MD,PhD          Sub-Investigator: Paulo R Genestreti, MD Less <<
NCT03316898 Alzheimer's Disease Phase 1 Withdrawn(Business decision to... More >> stop the study.) Less << November 4, 2018 United States, California ... More >> ATP Clinical Research Costa Mesa, California, United States, 94105 Irvine Center for Clinical Research Irvine, California, United States, 92614 Synergy Research Centers Lemon Grove, California, United States, 91945 Collaborative Neuroscience Long Beach, California, United States, 90806 Alliance Research Long Beach, California, United States, 90807 Syrentis Clinical Research Santa Ana, California, United States, 92705 Less <<
NCT01265615 Cardiorenal Syndrome ... More >> Chronic Allograft Nephropathy Less << Phase 4 Completed - Netherlands ... More >> De Haar Research Foundation Rotterdam, South Holland, Netherlands, 3071PR Russian Federation Ural Institute of Cardiology Yekaterinburg, Russian Federation, 620144 Less <<
NCT00053495 - Completed - -
NCT00053495 Smallpox Phase 2 Completed - United States, Florida ... More >> Orlando Clinical Research Center Orlando, Florida, United States, 32806 United States, Kansas PRA International Lenexa, Kansas, United States, 66219 United States, Missouri Bio-Kinetic Clinical Applications Springfield, Missouri, United States, 65802 United States, Rhode Island Memorial Hospital of Rhode IslandDivision of Infectious Diseases Pawtucket, Rhode Island, United States, 02860 Less <<
NCT03258515 Solid Tumors Phase 1 Completed - United States, Maryland ... More >> Research Site Baltimore, Maryland, United States, 21225 Less <<
NCT01050998 Rheumatoid Arthritis Phase 2 Completed - -
NCT02565628 Idiopathic Parkinson's Disease Phase 1 Completed - United States, Connecticut ... More >> Pfizer New Haven Clinical Research Unit New Haven, Connecticut, United States, 06511 United States, Florida MD Clinical Hallandale Beach, Florida, United States, 33009 QPS-MRA, LLC (Broward Research Group) Hollywood, Florida, United States, 33024 Qps-Mra Llc South Miami, Florida, United States, 33143 QPS-MRA, LLC (Miami research Associates) South Miami, Florida, United States, 33143 QPS-MRA, LLC (MRA Clinical Research) South Miami, Florida, United States, 33143 United States, Georgia Atlanta Center for Medical Research Atlanta, Georgia, United States, 30331 United States, New Jersey CRI Worldwide, LLC Marlton, New Jersey, United States, 08053 United States, Ohio CTI Clinical Research Center Cincinnati, Ohio, United States, 45255 Less <<
NCT02565628 - Completed - -
NCT01050998 - Completed - -
NCT01147523 Fatty Liver S... More >>teatohepatitis Less << Phase 2 Completed - Greece ... More >> Second Medical Clinic, Medical School, Aristotle University of Thessaloniki, Ippokration Hospital Thessaloniki, Greece, 54642 Less <<
NCT01265615 - Completed - -
NCT01172847 Healthy Volunteer Phase 1 Completed - United States, Arkansas ... More >> Little Rock, Arkansas, United States, 72204 Less <<
NCT02193815 Psoriasis Vulgaris Phase 1 Completed - Germany ... More >> Bioskin GmbH Hamburg, Germany, 20095 Less <<
NCT02193815 - Completed - -
NCT01172847 - Completed - -
NCT01510028 Metachromatic Leukodystrophy (... More >>MLD) Less << Phase 1 Phase 2 Completed - Australia ... More >> The Children's Hospital at Westmead Westmead, Australia, 2145 Denmark Rigshospitalet København, Denmark, 2100 France Hopital de Bicetre Le Kremlin Bicetre, Ile-de-France, France, 94275 Germany Center for Pediatric Clinical Studies Tubingen, Baden-Wuerttemberg, Germany, 72076 Japan Osaka University Hospital Suita, Japan, 565-0871 Less <<
NCT01754714 Non Alcoholic Fatty Liver Dise... More >>ase Less << Phase 3 Completed - France ... More >> Site Reference ID 93914 Amiens, France, 80054 Site Reference ID 93895 Angers, France, 49933 Site Reference ID 93894 Bobigny, France, 93009 Site Reference ID 93913 Montpellier, France, 34295 Site Reference ID 93916 Nice, France, 06202 Site Reference ID 93915 Paris, France, 75012 Site Reference ID 93893 Paris, France, 75651 Site Reference ID 93896 Pessac, France, 33604 Germany Site Reference ID 93953 Bonn, Germany, 53127 Site Reference ID 93954 Frankfurt, Germany, 60594 Site Reference ID 93935 Freiburg, Germany, 79106 Site Reference ID 93955 Halle, Germany, 06120 Site Reference ID 93917 Hannover, Germany, 30625 Site Reference ID 93933 Homburg, Germany, 66424 Site Reference ID 94015 Leipzig, Germany, 04103 Site Reference ID 93918 Mainz, Germany, 55131 Site Reference ID 94014 Ulm, Germany, 89081 Poland Site reference ID/Investigator # 109455 Bydgoszcz, Poland, 85-030 Site Reference ID 93958 Chorzow, Poland, 41-500 Site Reference ID 93973 Krakow, Poland, 31-531 Site Reference ID 93956 Lodz, Poland, 91-347 Site Reference ID 93957 Myslowice, Poland, 41-400 Site Reference ID 93974 Warsaw, Poland, 02-507 Site Reference ID 93975 Wroclaw, Poland, 50-220 Russian Federation Site reference ID ORG-000905 Krasnoyarsk, Russian Federation, 660022 Site reference ID ORG-000906 Moscow, Russian Federation, 119435 Site reference ID ORG-000900 Nizhniy Novgorod, Russian Federation, 603126 Site reference ID ORG-000907 Novosibirsk, Russian Federation, 630084 Site reference ID ORG-000903 Omsk, Russian Federation, 644043 Site reference ID ORG-000920 Rostov-on-Don, Russian Federation, 344022 Site reference ID ORG-000904 Samara, Russian Federation, 443011 Site reference ID ORG-000901 Stavropol, Russian Federation, 355017 Less <<
NCT01739153 Hyperlipidemia Not Applicable Completed - Denmark ... More >> Department of Nutrition, Exercise and Sports Copenhagen, Frederiksberg, Denmark, 1958 Less <<
NCT02479581 Valvular Heart Disease Phase 2 Completed - China, Hunan ... More >> Xiangya Hospital of Central South University Changsha, Hunan, China, 410078 Less <<
NCT02767739 Cardiovascular Diseases ... More >> Quality of Life Less << Not Applicable Completed - -
NCT00281684 Toothache Phase 2 Completed - Italy ... More >> GSK Investigational Site Verona, Veneto, Italy, 37134 Korea, Republic of GSK Investigational Site Seoul, Korea, Republic of, 110-768 United Kingdom GSK Investigational Site Croydon, Surrey, United Kingdom, CR7 7YE GSK Investigational Site Leeds, United Kingdom, LS2 9NG GSK Investigational Site Manchester, United Kingdom, M13 9WL Less <<
NCT01510028 - Completed - -
NCT02135055 Inflammatory Disorder of Immun... More >>e System Sepsis Less << Phase 4 Unknown March 2015 -
NCT00358449 Oesophagitis, Eosinophilic Phase 2 Completed - -
NCT00984620 Hepatitis C Phase 2 Completed - -
NCT01754714 - Completed - -
NCT00358449 - Completed - -
NCT00529789 Major Depressive Disorder Phase 2 Completed - -
NCT00984620 - Completed - -
NCT01114620 Influenza Phase 4 Completed - Japan ... More >> GSK Investigational Site Fukuoka, Japan, 813-8588 Less <<
NCT00529789 - Completed - -
NCT01189396 Asthma Bronch... More >>ospasm Chronic Obstructive Pulmonary Disease (COPD) Less << Phase 2 Completed - United States, Oregon ... More >> Amphastar Site 0025 Medford, Oregon, United States, 97504 Amphastar Site 0026 Portland, Oregon, United States, 97213 United States, Texas Amphastar Site 0032 San Antonio, Texas, United States, 78229 United States, Washington Amphastar Site 0034 Seattle, Washington, United States, 98105 Less <<
NCT02135575 Menopause Car... More >>diac Function Impaired Cardiovascular Diseases Blood Platelet Disorders Metabolic Diseases Less << Not Applicable Completed - Denmark ... More >> University of Copenhagen Copenhagen, Denmark Less <<
NCT03036774 Diabetes Not Applicable Recruiting June 2019 France ... More >> Fondation Ophtalmologique Adolphe de Rotschild Recruiting Paris, France, 75019 Contact: Jean Michel Devys, MD-PhD    +33(0)148036776    jmdevys@fo-rothschild.fr    Principal Investigator: Jean Michel Devys          AP-HP Hopital Tenon Completed Paris, France, 75020 Hopital Foch Completed Suresnes, France, 92150 Less <<
NCT03256331 Advanced Solid Tumors Phase 1 Recruiting December 31, 2019 Taiwan ... More >> National Cheng Kung University Hospital Recruiting Tainan, Taiwan, 704 Contact: Wu-Chou Su, MD    886-6-2353535 ext 3107    sunnysu@mail.ncku.edu.tw    Contact: Melody Lin, BS    886-6-2353535 ext 3977    melodyllj120124@gmail.com    National Taiwan University Hospital Not yet recruiting Taipei, Taiwan, 100 Contact: Chia-Chi Lin, MD, PhD    886-2-23123456 ext 67680    cclin1@ntu.edu.tw    Contact: Hsiao-yi Hung, BS    886-2-23123456 ext 63462    lovelyeffie@ntuh.gov.tw Less <<
NCT03298555 Gestational Mothers ... More >> Weight Gain Less << Not Applicable Recruiting December 31, 2019 Sweden ... More >> Karolinska Institutet Recruiting Stockholm, Sweden Contact: Marie Löf       marie.lof@ki.se Less <<
NCT02729051 Pulmonary Disease, Chronic Obs... More >>tructive Less << Phase 3 Completed - -
NCT01114620 - Completed - -
NCT01431352 Polycystic Ovary Syndrome Not Applicable Unknown August 2014 China, Anhui ... More >> Affiliated Hospital of Anhui University of Chinese Medicine Active, not recruiting Hefei, Anhui, China China, Guangdong Guangzhou Medical School First Affiliated Hospital Active, not recruiting Guangzhou, Guangdong, China China, Heilongjiang Daqing Longnan hospital Active, not recruiting Daqing, Heilongjiang, China Daqing Oilfield General Hospital Active, not recruiting Daqing, Heilongjiang, China First Affliated Hospital of Harbin Medical University Recruiting Harbin, Heilongjiang, China, 150001 Contact: Muer An, MD          Principal Investigator: Muer An, MD          Dept Obs & Gyn, First Affiliated Hospital National Key Discipline and Trial Base Heilongjiang University of Chinese Medicine Recruiting Herbin, Heilongjiang, China, 150040 Contact: Lihui Hou , MD.    86-451-82130094       Principal Investigator: Lihui Hou, MD.          Mudanjiang maternal and children hospital Active, not recruiting Mudanjiang, Heilongjiang, China China, Henan 2nd Affiliated Hospital of Henan University of Chinese Medicine Active, not recruiting Zhengzhou, Henan, China China, Hunan First Affiliated Hospital of Hunan University of Chinese Active, not recruiting Changsha, Hunan, China China, Jiangsu SuqianMaternal and Child Health Hospital Active, not recruiting Suqian, Jiangsu, China Maternal and Child Health Hospital of Xuzhou Active, not recruiting Xuzhou, Jiangsu, China China, Jiangxi First Hospital, Jiangxi college of Chinese Medicine Active, not recruiting Nanchang, Jiangxi, China China, Liaoning Dalian Maternal and Child Health Hospital Recruiting Dalian, Liaoning, China Principal Investigator: Xiaoguang Shao, MD          China, Shanxi Shanxi Hospital of Chinese Medicine Active, not recruiting Taiyuan, Shanxi, China China, Tianjin First Affiliated Hospital of Tianjin University of Chinese Medicine Active, not recruiting Tianjin, Tianjin, China Second Affiliated Hospital, Tianjin University of Chinese Medicine Active, not recruiting Tianjin, Tianjin, China China, Zhejiang Zhejiang province hospital of integrated traditional and western medicine Recruiting Hangzhou, Zhejiang, China Contact: Xin Sun, MD          Principal Investigator: Xin Sun, MD          China Second Affiliated Hospital of Heilongjiang University of Chinese Medicine Active, not recruiting Harbin, China Less <<
NCT02373202 Rheumatoid Arthritis Phase 3 Completed - Japan ... More >> Investigational Site Number 392010 Asahi-Shi, Japan Investigational Site Number 392001 Asahikawa-Shi, Japan Investigational Site Number 392070 Beppu-Shi, Japan Investigational Site Number 392036 Chiba-Shi, Japan Investigational Site Number 392083 Chuo-Ku, Japan Investigational Site Number 392004 Fukui-Shi, Japan Investigational Site Number 392039 Fukuoka-Shi, Japan Investigational Site Number 392030 Ichinomiya-Shi, Japan Investigational Site Number 392002 Iizuka-Shi, Japan Investigational Site Number 392019 Kagoshima-Shi, Japan Investigational Site Number 392066 Kamakura-Shi, Japan Investigational Site Number 392050 Kato-Shi, Japan Investigational Site Number 392037 Kawachi-Nagano-Shi, Japan Investigational Site Number 392099 Kawasaki-Shi, Japan Investigational Site Number 392013 Kitakyushu-Shi, Japan Investigational Site Number 392097 Kochi-Shi, Japan Investigational Site Number 392065 Kushiro-Shi, Japan Investigational Site Number 392026 Matsuyama-Shi, Japan Investigational Site Number 392034 Miyagi-Gun, Japan Investigational Site Number 392076 Nagoya-Shi, Japan Investigational Site Number 392080 Nagoya-Shi, Japan Investigational Site Number 392046 Narashino-Shi, Japan Investigational Site Number 392059 Oita-Shi, Japan Investigational Site Number 392062 Okayama-Shi, Japan Investigational Site Number 392027 Osaki-Shi, Japan Investigational Site Number 392049 Sagamihara-Shi, Japan Investigational Site Number 392014 Sapporo-Shi, Japan Investigational Site Number 392041 Sapporo-Shi, Japan Investigational Site Number 392073 Sapporo-Shi, Japan Investigational Site Number 392006 Sasebo-Shi, Japan Investigational Site Number 392021 Sendai-Shi, Japan Investigational Site Number 392022 Sendai-Shi, Japan Investigational Site Number 392033 Sendai-Shi, Japan Investigational Site Number 392071 Sendai-Shi, Japan Investigational Site Number 392029 Shizuoka-Shi, Japan Investigational Site Number 392023 Takaoka-Shi, Japan Investigational Site Number 392003 Tomakomai-Shi, Japan Investigational Site Number 392074 Urasoe-Shi, Japan Investigational Site Number 392079 Urayasu-Shi, Japan Investigational Site Number 392048 Yokohama-Shi, Japan Less <<
NCT02373202 - Completed - -
NCT01734993 - Completed - -
NCT03254563 - Not yet recruiting March 1, 2019 United States, Colorado ... More >> University of Colorado Not yet recruiting Aurora, Colorado, United States, 80045 Contact: Thomas Jensen, MD    720-848-2650       Contact: Kristen Nadeau, MD    720-777-2855    Kristen.Nadeau@childrenscolorado.org Less <<
NCT01734993 Rheumatoid Arthritis Phase 3 Completed - France ... More >> Bordeaux, France, 33076 Montpellier, France, 34295 Nantes, France, 44035 Paris, France, 75679 Strasbourg, France, 67098 Toulouse, France, 31059 Less <<
NCT03260166 Cutaneous Lupus Erythematosus ... More >> Systemic Lupus Erythematosus Rash Less << Phase 2 Recruiting February 2019 China, Hunan ... More >> The Second Xiangya Hospital of Central South University Recruiting Changsha, Hunan, China, 410011 Contact: Xiangqi Tang, MD, PhD    +86-731-84896038    xiangyagcp@126.com    Principal Investigator: Qianjin Lu, MD, PhD          Sub-Investigator: Hai Long, MD, PhD Less <<
NCT00077766 Anemia Phase 3 Completed - -
NCT00077766 - Completed - -
NCT01649700 The Sequelae Caused by Severe ... More >>Brain Injury Less << Phase 1 Phase 2 Completed - Taiwan ... More >> Taipei Veterans General Hospital Taipei, Taiwan Less <<
NCT00833989 Ischaemic Attack, Transient Phase 2 Completed - United States, California ... More >> GSK Investigational Site Los Angeles, California, United States, 90095-6984 GSK Investigational Site Orange, California, United States, 92868-4280 United States, Colorado GSK Investigational Site Fort Collins, Colorado, United States, 80524 United States, Michigan GSK Investigational Site Detroit, Michigan, United States, 48201 United States, Oregon GSK Investigational Site Portland, Oregon, United States, 97239 Canada, Ontario GSK Investigational Site Toronto, Ontario, Canada, M4N 3M5 Canada, Quebec GSK Investigational Site Montreal, Quebec, Canada, H3T 1E2 Germany GSK Investigational Site Ulm, Baden-Wuerttemberg, Germany, 89081 GSK Investigational Site Wiesbaden, Hessen, Germany, 65199 GSK Investigational Site Celle, Niedersachsen, Germany, 29223 GSK Investigational Site Hannover, Niedersachsen, Germany, 30625 GSK Investigational Site Essen, Nordrhein-Westfalen, Germany, 45122 GSK Investigational Site Koeln, Nordrhein-Westfalen, Germany, 50937 GSK Investigational Site Mainz, Rheinland-Pfalz, Germany, 55131 GSK Investigational Site Leipzig, Sachsen, Germany, 04103 Less <<
NCT02114203 - Completed - -
NCT00833989 - Completed - -
NCT00269087 Pulmonary Disease, Chronic Obs... More >>tructive Less << Phase 3 Completed - Japan ... More >> GSK Investigational Site Kodaira, Japan, 187-0002 GSK Investigational Site Kyoto, Japan, 612-0026 GSK Investigational Site Osaka, Japan, 596-8501 GSK Investigational Site Tokyo, Japan, 164-0012 Less <<
NCT02114203 Phase 1 Sickle Cell Phase 1 Completed - United States, Illinois ... More >> University of Illinois Hospital and Health Sciences System Chicago, Illinois, United States, 60612-5836 University of Illinois at Chicago Clinical Research Center Chicago, Illinois, United States, 60612 University of Illinois Hospital and Health Sciences System Chicago, Illinois, United States, 60612 United States, Massachusetts Boston Medical Center E7E Boston, Massachusetts, United States, 02118 Boston Medical Center Boston, Massachusetts, United States, 02118 Boston University Medical Center Boston, Massachusetts, United States, 02118 United States, New York Interfaith Medical Center Brooklyn, New York, United States, 11213 Interfaith Medical Center Brooklyn, New York, United States, 11238 United States, North Carolina UNC Hospitals' Investigational Drug Service Pharmacy Chapel Hill, North Carolina, United States, 27514 UNC School of Medicine Clinical and Translational Research Center Chapel Hill, North Carolina, United States, 27599 United States, Virginia Investigational Drug Services Richmond, Virginia, United States, 23298 Virginia Commonwealth University Richmond, Virginia, United States, 23298 Belgium Pfizer Clinical Research Unit Brussels, Belgium, B-1070 Italy Fondazione IRCCS Ca'Granda Ospedale Maggiore Policlinico Milano, Italy, 20122 A.O.O.R Villa Sofia - V. Cervello Palermo, Italy, 90146 Netherlands Centre for Human Drug Research Leiden, Netherlands, 2333 CL United Kingdom Royal Liverpool and Broadgreen University Hospital Trust Liverpool, Merseyside, United Kingdom, L7 8XP Guy's and St Thomas' NHS Foundation Trust London, United Kingdom, SE1 9RT King's College Hospital NHS Foundation Trust London, United Kingdom, SE5 9RS Imperial College Healthcare NHS Trust London, United Kingdom, W12 0HS Central Manchester University Hospitals NHS Foundation Trust Manchester, United Kingdom, M13 9WL Manchester Royal Infirmary Manchester, United Kingdom, M13 9WL Oxford University Hospitals NHS Trust Oxford, United Kingdom, OX3 7LE Less <<
NCT00138424 - Terminated - -
NCT00138424 BK Virus (Nephropathy) Phase 1 Phase 2 Terminated - United States, Alabama ... More >> University of Alabama Hospital - Nephrology Birmingham, Alabama, United States, 35249-0001 United States, California California Pacific Medical Center - Sutter Pacific Medical Foundation - Transplant Nephrology San Francisco, California, United States, 94115-1932 University of California San Francisco Medical Center at Parnassus - Organ Transplant San Francisco, California, United States, 94143-2204 United States, Colorado University of Colorado Denver Aurora, Colorado, United States, 80045-2541 United States, Illinois Northwestern University - Comprehensive Transplant Center Chicago, Illinois, United States, 60611-2927 The University of Chicago Medical Center - Kindney Trasnplant - Nephrology Chicago, Illinois, United States, 60637-1447 United States, Minnesota University of Minnesota Medical Center, Fairview - Infectious Diseases and International Medicine Minneapolis, Minnesota, United States, 55455-0356 Mayo Clinic, Rochester - Infectious Diseases Rochester, Minnesota, United States, 55905-0001 United States, New Hampshire Dartmouth-Hitchcock Medical Center - Infectious Disease Lebanon, New Hampshire, United States, 03756-1000 United States, Texas Dallas Nephrology Associates - Dallas Transplant Institute Dallas, Texas, United States, 75204-6168 United States, Washington University of Washington - Medicine Seattle, Washington, United States, 98195-7110 United States, Wisconsin University of Wisconsin Hospital and Clinics - Clinical Science Center - Nephrology Madison, Wisconsin, United States, 53792-0001 Less <<
NCT01439204 Rheumatoid Arthritis Phase 1 Completed - United States, Nebraska ... More >> Icon Clinical Pharmacology Unit, Llc Omaha, Nebraska, United States, 68154 Less <<
NCT03528681 Hyperkalemia Phase 3 Not yet recruiting October 7, 2019 -
NCT00389207 HIV Infections Phase 3 Completed - -
NCT00389207 - Completed - -
NCT02871570 Moderate Hepatic Impairment ... More >> Normal Hepatic Function Less << Phase 1 Completed - United States, Florida ... More >> Orlando Clincial Research Center Orlando, Florida, United States, 32809 Less <<
NCT02871570 - Completed - -
NCT02722044 Rheumatoid Arthritis Phase 3 Completed - United States, Michigan ... More >> Henry Ford Health System Detroit, Michigan, United States, 48202 United States, North Carolina Medication Management, LLC Greensboro, North Carolina, United States, 27408 United States, Oklahoma Lynn Health Science Institute Oklahoma City, Oklahoma, United States, 73112 United States, Pennsylvania Altoona Center for Clinical Research, PC Duncansville, Pennsylvania, United States, 16635 United States, Texas Austin Regional Clinic, PA Austin, Texas, United States, 78731 Accurate Clinical Management Houston, Texas, United States, 77004 Accurate Clinical Research, Inc. Houston, Texas, United States, 77034 Less <<
NCT01028911 Alzheimer's Disease Phase 1 Terminated(This study terminat... More >>ed 27Apr2010 due to slow recruitment and the need to use the existing information to determine dosing for another study.) Less << - United States, Kansas ... More >> Pfizer Investigational Site Wichita, Kansas, United States, 67207 Pfizer Investigational Site Wichita, Kansas, United States, 67211 Less <<
NCT02722044 - Completed - -
NCT03514420 Familial Partial Lipodystrophy Phase 2 Recruiting April 30, 2019 United States, Michigan ... More >> Clinical Site Recruiting Ann Arbor, Michigan, United States, 48105 Contact: Clinical Site Less <<
NCT02287350 Pain Phase 4 Completed - United States, Alabama ... More >> Sheffield, Alabama, United States United States, California Stanford, California, United States United States, Missouri Saint Peters, Missouri, United States United States, Texas Dallas, Texas, United States United States, Wisconsin Milwaukee, Wisconsin, United States Less <<
NCT00663702 Arthritis, Rheumatoid Phase 3 Completed - -
NCT02287350 - Completed - -
NCT03395704 Hereditary Hemochromatosis Phase 2 Recruiting December 2018 United States, Arkansas ... More >> Investigative Site Recruiting North Little Rock, Arkansas, United States, 72117 United States, California Investigative Site Recruiting Palo Alto, California, United States, 94305 Investigative Site Recruiting Rialto, California, United States, 92377 Investigational Site Recruiting San Diego, California, United States, 91942 United States, Michigan Investigative Site Recruiting Wyoming, Michigan, United States, 49519 United States, Mississippi Investigative Site Recruiting Jackson, Mississippi, United States, 39216 United States, New York Investigative Site Recruiting East Setauket, New York, United States, 11733 Investigative Site Recruiting Manhasset, New York, United States, 11030 Investigative Site Recruiting New York, New York, United States, 10029 United States, Texas Investigative Site Recruiting Dallas, Texas, United States, 75246 Investigative Site Recruiting Fort Worth, Texas, United States, 76104 Investigative Site Recruiting Houston, Texas, United States, 77058 Investigative Site Recruiting San Antonio, Texas, United States, 78215 United States, Washington Investigative Site Recruiting Seattle, Washington, United States, 98104 Australia, New South Wales Investigative Site Recruiting Westmead, New South Wales, Australia, 2145 Australia, Queensland Investigative Site Recruiting Brisbane, Queensland, Australia, 4120 Investigative Site Recruiting Herston, Queensland, Australia, 4029 Australia, Victoria Investigative Site Recruiting Melbourne, Victoria, Australia, 3004 France Investigative Site Recruiting Bondy, France, 93140 Investigative Site Recruiting Orléans, France, 45000 Investigative Site Recruiting Pessac, France, 33604 Investigative Site Recruiting Rennes Cedex 9, France, 35033 United Kingdom Investigative Site Recruiting Bradford, England, United Kingdom, BD9 6RJ Investigative Site Recruiting Newcastle Upon Tyne, England, United Kingdom, NE7 7DN Investigative Site Recruiting Portsmouth, England, United Kingdom, PO6 3LY Less <<
NCT00663702 - Completed - -
NCT01028911 - Terminated(This study terminat... More >>ed 27Apr2010 due to slow recruitment and the need to use the existing information to determine dosing for another study.) Less << - -
NCT01040663 Obesity Not Applicable Completed - United States, New York ... More >> The Rockefeller University New York, New York, United States, 10065 Less <<
NCT00127296 Diabetes Diab... More >>etes Mellitus, Type 2 Delivery Systems Less << Phase 1 Completed - United States, Texas ... More >> Novo Nordisk Investigational Site San Antonio, Texas, United States, 78229 Less <<
NCT02287376 Migraine Phase 4 Completed - United States, Florida ... More >> Tampa, Florida, United States United States, New York Amherst, New York, United States Less <<
NCT00128089 Diabetes Mellitus, Type 2 Phase 1 Terminated - United States, Virginia ... More >> Manassas Internal Medicine Manassas, Virginia, United States, 20110 Less <<
NCT00130806 Type 2 Diabetes Mellitus Phase 3 Terminated - -
NCT00135057 Diabetes Mellitus, Type 2 Phase 3 Completed - United States, New Jersey ... More >> Sanofi-Aventis Bridgewater, New Jersey, United States, 08807 Less <<
NCT02287376 - Completed - -
NCT00135083 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT00135096 Diabetes Mellitus, Type 2 Phase 3 Completed - United States, New Jersey ... More >> Sanofi-aventis Bridgewater, New Jersey, United States, 08807 Less <<
NCT02922348 Primary Ovarian Insufficiency Phase 3 Recruiting April 2018 United States, Pennsylvania ... More >> Penn Fertility Care Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Natalie C Stentz, MD    215-614-1414    stentzn@uphs.upenn.edu    Contact: Clarisa R Gracia, MD, MSCE    215-614-1414    cgracia@uphs.upenn.edu Less <<
NCT00132288 Diabetes Mellitus ... More >> Aging Less << Not Applicable Completed - United States, Washington ... More >> Southeast Senior Center Seattle, Washington, United States, 98118 Less <<
NCT00139763 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT00143338 Diabetes Mellitus, Type 2 Phase 2 Completed - United States, California ... More >> Pfizer Investigational Site Fresno, California, United States United States, Texas Pfizer Investigational Site San Antonio, Texas, United States Less <<
NCT00135226 Diabetes Mellitus Phase 4 Active, not recruiting July 31, 2037 United Kingdom ... More >> Clinical Trial Service Unit, University of Oxford Oxford, United Kingdom, OX3 7LF Less <<
NCT00143520 Type 2 Diabetes Phase 2 Phase 3 Completed - -
NCT01058135 Insulin Resistance Not Applicable Completed - United States, Illinois ... More >> Provident Clinical Research and Consulting, Inc Glen Ellyn, Illinois, United States, 60137 Less <<
NCT01454167 - Unknown April 2016 Israel ... More >> Carmel Medical Center Recruiting Haifa, Israel Contact: Nir Gal Or       nirgalor@gmail.com    Principal Investigator: Nir Gal Or, Dr Less <<
NCT00114777 Renal Transplantation Phase 3 Completed - -
NCT02179918 - Completed - -
NCT03630627 Healthy Volunteers Phase 1 Recruiting August 20, 2020 United States, California ... More >> PAREXEL International Recruiting Glendale, California, United States, 91206 Contact    888-228-7425 Less <<
NCT02216097 Post-Traumatic Stress Disorder Phase 2 Terminated(The study stopped b... More >>ased on Pfizer portfolio prioritization and not due to safety and/or efficacy concern or change in benefitrisk assessment of PF-04457845.) Less << - United States, New York ... More >> Clinical and Translational Science Institute (CTSI) New York, New York, United States, 10016 NYU CTSI Research Pharmacy (Drug Shipment Address) New York, New York, United States, 10016 NYU School of Medicine New York, New York, United States, 10016 Less <<
NCT02179918 Advanced Solid Tumors Phase 1 Completed - United States, California ... More >> Research Administration Office Los Angeles, California, United States, 90095 Ronald Reagan UCLA Medical Center, Drug Information Center Los Angeles, California, United States, 90095 UCLA Hematology-Oncology Clinic Los Angeles, California, United States, 90095 UCLA Oncology Center Los Angeles, California, United States, 90095 United States, Connecticut Smilow Cancer Center at Yale-New Haven Hospital New Haven, Connecticut, United States, 06510 Smilow Cancer Hospital at Yale-New Haven New Haven, Connecticut, United States, 06510 United States, Texas South Texas Accelerated Research Therapeutics, LLC San Antonio, Texas, United States, 78229 United States, Washington Seattle Cancer Care Alliance Seattle, Washington, United States, 98109 University of Washington Medical Center Seattle, Washington, United States, 98195 Less <<
NCT00141232 Diabetes, Type 2 Phase 4 Completed - -
NCT02216097 - Terminated(The study stopped b... More >>ased on Pfizer portfolio prioritization and not due to safety and/or efficacy concern or change in benefitrisk assessment of PF-04457845.) Less << - -
NCT00114777 - Completed - -
NCT03268733 Polycystic Ovary Syndrome Phase 1 Phase 2 Recruiting September 1, 2019 Sudan ... More >> Saad Abul ella fertility Centre Recruiting Khartoum, Sudan, 11111 Contact: Mohammed ibrahim Awad    00249900904060    awad22mohd@gmail.com Less <<
NCT00490568 - Terminated(Based on preliminar... More >>y parent study results) Less << - -
NCT02660905 Human Immunodeficiency Virus ... More >> Hepatitis C, Chronic Less << Phase 3 Active, not recruiting December 2017 Canada, Ontario ... More >> The Ottawa Hospital, General Campus Ottawa, Ontario, Canada Canada, Quebec The Research Institute of the McGill University Health Centre Montreal, Quebec, Canada, H4A 3J1 Less <<
NCT00490568 Alzheimer's Disease Phase 3 Terminated(Based on preliminar... More >>y parent study results) Less << - -
NCT01376167 Malaria, Vivax Phase 2 Completed - Bangladesh ... More >> GSK Investigational Site Bandarban, Bangladesh Brazil GSK Investigational Site Manaus, Amazonas, Brazil, 69040-000 GSK Investigational Site Porto Velho, Rondônia, Brazil, 76812-329 Cambodia GSK Investigational Site Oddar Meancheay Province, Cambodia Ethiopia GSK Investigational Site Gondar, Ethiopia GSK Investigational Site Jimma, Ethiopia India GSK Investigational Site Bikaner, India GSK Investigational Site Chennai, India, 600016 GSK Investigational Site Lucknow, India, 226003 GSK Investigational Site Secunderabad, India, 500 003 Peru GSK Investigational Site Iquitos, Loreto, Peru, Iqui 01 Philippines GSK Investigational Site Rio Tuba, Bataraza, Philippines, 5306 Thailand GSK Investigational Site Bangkok, Thailand, 10400 GSK Investigational Site Tak, Thailand, 63110 Less <<
NCT01691859 Asthma Phase 3 Completed - -
NCT02821104 - Recruiting June 2018 United States, Ohio ... More >> Ohio State University Recruiting Columbus, Ohio, United States, 43210 Contact: Robert P Hoffman, MD    614-722-4425    hoffmanr@pediatrics.ohio-state.edu    Principal Investigator: Robert P Hoffman, MD Less <<
NCT01376167 - Completed - -
NCT02475590 Morbid Obesity Not Applicable Active, not recruiting July 2022 France ... More >> Service de Chirurgie Digestive et Endocrinienne Strasbourg, France, 67 000 Less <<
NCT01691859 - Completed - -
NCT01744470 De Novo Transplant Disease Phase 4 Unknown March 2015 France ... More >> Hôpital Sud Amiens, France CHU de Angers Angers, France Hôpital Bois-Guillaume Bois-Guillaume, France, 76130 Hôpital Cavale Blanche Brest, France CHU de Caen Caen, France Hôpital Gabriel Montpied Clermont-Ferrand, France Hôpital Bicêtre Le Kremlin Bicêtre, France Hôpital Dupuytren Limoges, France Hôpital Archet II Nice, France HEGP Paris, France, 75015 Hôpital Necker Paris, France Hôpital Maison Blanche Reims, France Hôpital Pontchaillou Rennes, France Hôpital Civil Strasbourg, France CHU de Toulouse Toulouse, France CHRU de Tours Tours, France Less <<
NCT02019719 - Completed - -
NCT00850642 Asthma Phase 2 Terminated - Canada, Ontario ... More >> GSK Investigational Site Hamilton, Ontario, Canada, L8N 4A6 GSK Investigational Site Kingston, Ontario, Canada, K7L 2V6 Canada, Quebec GSK Investigational Site Montreal, Quebec, Canada, H4J 1C5 GSK Investigational Site Sainte-Foy, Quebec, Canada, G1V 4G5 United Kingdom GSK Investigational Site Glasgow, Lanarkshire, United Kingdom, G12 0YN GSK Investigational Site Leicester, Leicestershire, United Kingdom, LE3 9QP GSK Investigational Site London, United Kingdom, NW10 7EW GSK Investigational Site Manchester, United Kingdom, M23 9QZ Less <<
NCT00077649 - Completed - -
NCT02019719 Anaemia Phase 2 Completed - Japan ... More >> GSK Investigational Site Aichi, Japan, 446-0053 GSK Investigational Site Aichi, Japan, 446-0065 GSK Investigational Site Aichi, Japan, 454-0932 GSK Investigational Site Aichi, Japan, 455-0021 GSK Investigational Site Aichi, Japan, 465-0025 GSK Investigational Site Aichi, Japan, 470-1201 GSK Investigational Site Chiba, Japan, 276-0031 GSK Investigational Site Fukuoka, Japan, 804-0094 GSK Investigational Site Ibaraki, Japan, 300-0835 GSK Investigational Site Ibaraki, Japan, 305-0861 GSK Investigational Site Ibaraki, Japan, 310-0844 GSK Investigational Site Kagawa, Japan, 761-8024 GSK Investigational Site Kanagawa, Japan, 216-0007 GSK Investigational Site Miyagi, Japan, 981-0911 GSK Investigational Site Nagano, Japan, 390-0821 GSK Investigational Site Nagano, Japan, 390-1401 GSK Investigational Site Niigata, Japan, 950-2038 GSK Investigational Site Osaka, Japan, 543-0052 GSK Investigational Site Osaka, Japan, 547-0024 GSK Investigational Site Tokyo, Japan, 158-0094 GSK Investigational Site Toyama, Japan, 930-0964 Less <<
NCT02785198 Diabetic Foot Ulcers Not Applicable Unknown September 2018 Denmark ... More >> Herlev Hospital Recruiting Herlev, Capital region of Denmark, Denmark, 2730 Contact: Tue Smith Joergensen, MD    0045 38681473    tuesmith@gmail.com Less <<
NCT00077649 Hepatitis C, Chronic Phase 4 Completed - -
NCT01686204 Intestinal Barrier Function ... More >> Chronic Inflammation Less << Not Applicable Completed - United States, Wisconsin ... More >> Department of Food Science, Babcock Hall Madison, Wisconsin, United States, 53706 Less <<
NCT00850642 - Terminated - -
NCT00762411 Alzheimer's Disease Phase 3 Completed - -
NCT01919021 Functional Dyspepsia ... More >> Diabetic Gastroparesis Less << Not Applicable Completed - United Kingdom ... More >> National Institute of Health Research Biomedical Research Unit, Nottingham Digestve Diseases Centre, University of Nottingham, Nottingham, United Kingdom, NG7 2YH Less <<
NCT02278861 Actinic Keratosis Phase 2 Completed - Brazil ... More >> Dermatology Outpatient Clinic - Hospital das Clínicas - Federal University of Goias (UFG) Goiânia, Goiás, Brazil, 74605-020 Less <<
NCT03511820 - Completed - Taiwan ... More >> Changhua Christian Hospital Changhua, Taiwan, 500 Kaohsiung Veterans General Hospital Kaohsiung, Taiwan, 81362 Kaohsiung Chang Gung Memorial Hospital Kaohsiung, Taiwan, 833 Keelung Chang Gung Memorial Hospital Keelung, Taiwan, 204 China Medical University Hospital Taichung City, Taiwan, 40447 Tri-Service General Hospital Taipei city, Taiwan, 114 Taipei Veterans General Hospital Taipei, Taiwan, 11212 Taipei Mucinipal Wanfang Hospital Taipei, Taiwan, 116 Chang Guang Memorial Hospital at LinKou Taoyuan, Taiwan, 333 Less <<
NCT00681629 Schizophrenia ... More >> Schizoaffective Disorder Schizophreniform Disorder Less << Phase 4 Terminated(Difficulty finding ... More >>eligible sites/patients; current situation in health policy cause negative effect on existing/planned contracts for integrated care program) Less << - Germany ... More >> Research Site Munchen, Bayern, Germany Research Site Oranienburg, Brandenburg, Germany Research Site Luneburg, Niedersachsen, Germany Research Site Oldenburg, Niedersachsen, Germany Research Site Chemnitz, Sachsen, Germany Research Site Berlin, Germany Research Site Hamburg, Germany Research Site Stolberg, Germany Less <<
NCT03746977 Overweight Ob... More >>esity Abdominal Obesity Less << Not Applicable Active, not recruiting April 30, 2019 Germany ... More >> Institute of Medical Physics University of Erlangen-Nurnberg Erlangen, Germany, 91052 Less <<
NCT00681629 - Terminated(Difficulty finding ... More >>eligible sites/patients; current situation in health policy cause negative effect on existing/planned contracts for integrated care program) Less << - -
NCT00762411 - Completed - -
NCT02429804 Hormone-Resistant Prostate Can... More >>cer Metastatic Malignant Neoplasm in the Bone Metastatic Prostate Carcinoma Less << Phase 1 Terminated(Accrual factor) - United States, California ... More >> Stanford University, School of Medicine Stanford, California, United States, 94305 Less <<
NCT01920555 Treatment Resistant Depression Phase 2 Completed - United States, California ... More >> Stanford University Palo Alto, California, United States, 94304 United States, Connecticut Yale University New Haven, Connecticut, United States, 06520 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 United States, New York Mount Sinai School of Medicine New York, New York, United States, 10029 United States, Texas University of Texas Southwestern Dallas, Texas, United States, 75390 Baylor College of Medicine Houston, Texas, United States, 77030 Less <<
NCT02829307 - Completed - -
NCT02829307 Drug-Related Side Effects and ... More >>Adverse Reactions Less << Phase 1 Completed - Netherlands ... More >> GSK Investigational Site Zuidlaren, Netherlands, 9471 GP Less <<
NCT00643201 Venous Thrombosis Phase 3 Completed - -
NCT00853112 Hypertension, Pulmonary Phase 2 Terminated(See termination rea... More >>son in detailed description.) Less << - -
NCT01920555 - Completed - -
NCT00853112 - Terminated(See termination rea... More >>son in detailed description.) Less << - -
NCT00759564 Pneumonia Phase 1 Completed - United States, Indiana ... More >> Centurion Clinical Research Indianapolis, Indiana, United States, 46260 Belgium Pfizer Clinical Research Unit Bruxelles, Belgium, 1070 Less <<
NCT00424294 - Terminated(See Detailed Descri... More >>ption field) Less << - -
NCT03211754 Obesity Not Applicable Completed - -
NCT00643201 - Completed - -
NCT00424294 Arthritis, Rheumatoid Phase 2 Terminated(See Detailed Descri... More >>ption field) Less << - -
NCT01175135 Schizophrenia Phase 2 Completed - -
NCT03517345 Bariatric Surgery Not Applicable Completed - -
NCT00442416 Anemia Phase 3 Terminated(Strategic decision ... More >>unrelated to safety or efficacy) Less << - -
NCT00759564 - Completed - -
NCT03709706 Neoplasms Phase 2 Not yet recruiting April 22, 2021 -
NCT00569062 Depressive Disorder, Major Phase 2 Terminated(Negative data from ... More >>a GSK PoC study in RA combined with evidence of greater sensitivity of toll-like receptor pathways to p38 inhibition.) Less << - Estonia ... More >> GSK Investigational Site Tartu, Estonia, 50417 India GSK Investigational Site Bangalore, India, 560029 GSK Investigational Site Bangalore, India, 560034 GSK Investigational Site Ludhiana, India, 141001 GSK Investigational Site Manipal,, India, 576 104 GSK Investigational Site Mumbai, India, 400010 GSK Investigational Site Pune, India, 411004 Russian Federation GSK Investigational Site Moscow, Russian Federation, 107076 GSK Investigational Site Moscow, Russian Federation, 115522 GSK Investigational Site Moscow, Russian Federation, 119992 GSK Investigational Site Moscow, Russian Federation, 123367 GSK Investigational Site Nizhny Novgorod, Russian Federation, 603115 GSK Investigational Site Smolensk, Russian Federation, 214 019 GSK Investigational Site St-Petersburg, Russian Federation GSK Investigational Site St.Petersburg, Russian Federation, 193167 Less <<
NCT00442416 - Terminated(Strategic decision ... More >>unrelated to safety or efficacy) Less << - -
NCT02584283 Liver Failure ... More >> End Stage Liver Disease Biliary Tract Diseases Less << Phase 3 Recruiting October 2019 Belgium ... More >> Ghent University Hospital Not yet recruiting Gent, De Pintelaan 185, Belgium, 9000 Contact: Roberto I Troisi, MD, PhD    +3293325519    roberto.troisi@ugent.be    University Hospitals Leuven Recruiting Leuven, Herestraat 49, Belgium, 3000 Contact: Diethard Monbaliu, MD, PhD    +3216348727    diethard.monbaliu@uzleuven.be    Netherlands Leiden Universtiy Medical Center Not yet recruiting Leiden, Zuid-Holland, Netherlands, 2333 ZA Contact: Bart van Hoek, MD, PhD    +31715299756    b.van_hoek@lumc.nl    University Medical Center Groningen Recruiting Groningen, Netherlands, 9700 RB Contact: Rianne van Rijn, MD    +31652724616    r.van.rijn@umcg.nl    Contact: Robert J Porte, MD, PhD    +31503619027    r.j.porte@umcg.nl    Erasmus Medical Center Recruiting Rotterdam, Netherlands, 3015 CE Contact: Jeroen de Jonge, MD, PhD    +31633330449    j.dejonge.1@umcg.nl Less <<
NCT01771276 Obesity Not Applicable Completed - Spain ... More >> Centro Medico Teknon Barcelona, Spain, 08022 Less <<
NCT01175135 - Completed - -
NCT03625596 Nitric Oxide ... More >>Vascular Function L-Arginine Nitrate / Nitrite Postprandial Metabolism Less << Not Applicable Not yet recruiting June 1, 2019 Netherlands ... More >> Maastricht University Medical Center Not yet recruiting Maastricht, Limburg, Netherlands, 6229 ER Contact: Peter J Joris, PhD    0031433881311    p.joris@maastrichtuniversity.nl Less <<
NCT00163293 - Completed - -
NCT00785577 Diabetic Neuropathy, Painful Phase 2 Completed - United States, California ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Greenbrae, California, United States, 94904 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tustin, California, United States, 92780 United States, Florida For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Deland, Florida, United States, 32720 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fort Myers, Florida, United States, 33912 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Jacksonville, Florida, United States, 32216 United States, Missouri For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. St Louis, Missouri, United States, 63141 United States, Oklahoma For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Oklahoma City, Oklahoma, United States, 73109 United States, Texas For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Dallas, Texas, United States, 75231 Mexico For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Aguascalientes, Mexico, 20217 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mexico City, Mexico, 11850 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Monterrey, Mexico, 64000 Puerto Rico For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hato Rey, Puerto Rico, 00917 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ponce, Puerto Rico, 00716 Less <<
NCT00163293 Asthma Phase 3 Completed - Canada ... More >> Altana Pharma/Nycomed Calgary, Canada, T2T5C7 Altana Pharma/Nycomed Fleurimont, Canada, J1H 5M4 Altana Pharma/Nycomed London,ON, Canada, N6A1V2 Altana Pharma/Nycomed London, Canada, N6C 4Y7 Altana Pharma/Nycomed Winnipeg, Canada, R3A1R9 Hungary Altana Pharma/Nycomed Budapest, Hungary South Africa Altana Pharma/Nycomed Kapstadt, South Africa Less <<
NCT01342211 Hypercholesterolemia ... More >> Dyslipidemia Less << Phase 2 Completed - -
NCT02011685 Stroke Hypert... More >>ension Less << Not Applicable Active, not recruiting December 2018 United States, New York ... More >> NYU School of Medicine New York, New York, United States, 10016 Less <<
NCT02294734 Pulmonary Disease, Chronic Obs... More >>tructive Less << Phase 2 Completed - Belgium ... More >> GSK Investigational Site Edegem, Belgium, 2650 GSK Investigational Site Erpent, Belgium, 5101 Denmark GSK Investigational Site Aalborg, Denmark, DK-9100 GSK Investigational Site Hellerup, Denmark, 2900 GSK Investigational Site Hvidovre, Denmark, 2650 GSK Investigational Site Kobenhavn, Denmark, DK-2400 GSK Investigational Site Odense, Denmark, 5000 Odense C Netherlands GSK Investigational Site Almelo, Netherlands, 7609 PP GSK Investigational Site Eindhoven, Netherlands, 5623 EJ GSK Investigational Site Zutphen, Netherlands, 7207 AE Romania GSK Investigational Site Bucharest, Romania, 050159 GSK Investigational Site Timisoara, Romania, 300310 Russian Federation GSK Investigational Site Ekaterinburg, Russian Federation, 620109 GSK Investigational Site Kemerovo, Russian Federation, 650002 GSK Investigational Site Moscow, Russian Federation, 105 077 GSK Investigational Site Saint Petersburg, Russian Federation, 194291 GSK Investigational Site Vladimir, Russian Federation, 600023 GSK Investigational Site Yaroslavl, Russian Federation, 150003 Less <<
NCT00596947 Transplants and Implants Phase 4 Terminated(due to low study en... More >>rollment) Less << - United States, Pennsylvania ... More >> Hospital of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00785577 - Completed - -
NCT01370018 HIV Disease Not Applicable Completed - United States, New York ... More >> Cabrini Medical Center New York, New York, United States, 10003 Less <<
NCT00596947 - Terminated(due to low study en... More >>rollment) Less << - -
NCT02610686 Plasmodium Vivax Phase 4 Unknown December 2016 Vietnam ... More >> Chu R Cam Recruiting Pleiku, Gia Lai, Vietnam Contact: Phuc Bui, MD, PhD    +84 913522874    phucnimpe@yahoo.com    Contact: Hong Nguyen, MD    +84 01668188919    nvhong1982@yahoo.com    Sub-Investigator: Annette Erhart, MD, PhD          Sub-Investigator: Edu Rovira Vallbona, PhD Less <<
NCT01332331 Hypertension, Pulmonary Phase 2 Suspended(Ongoing juvenile rat... More >> toxicology studies.) Less << February 1, 2019 -
NCT02294734 - Completed - -
NCT01260194 - Terminated - -
NCT01342952 Hypertension, Pulmonary Phase 2 Recruiting October 24, 2024 -
NCT01260194 Gastric Cancer Phase 4 Terminated - India ... More >> New Delhi, Delhi, India, 110085 Bangalore, Karnataka, India, 560027 Bangalore, India, 560029 Nagpur, India, 440012 Noida, India, 201 301 Vishakpatnam, India, 530002 Less <<
NCT01342211 - Completed - -
NCT01642407 Pulmonary Arterial Hypertensio... More >>n Hypertension, Pulmonary Less << Phase 4 Completed - Japan ... More >> Kitasato University Hospital Sagamihara, Kanagawa, Japan, 252-0375 Osaka University Hospital Suita, Osaka, Japan, 565-0871 Toho University Omori Medical Center Ota-ku, Tokyo, Japan, 143-8541 National Center for Child Health and Development Setagaya-ku, Tokyo, Japan, 157-8535 Shizuoka Children's Hospital Shizuoka, Japan, 420-8660 Less <<
NCT03411356 Obesity Not Applicable Recruiting June 2022 United States, Colorado ... More >> Kristen Bing Recruiting Aurora, Colorado, United States, 80045 Contact: Kristen Bing    303-724-9098    kristen.bing@ucdenver.edu    Principal Investigator: Victoria Catenacci, MD Less <<
NCT01642407 - Completed - -
NCT00594568 Alzheimer's Disease Phase 3 Completed - -
NCT01072175 Cancer Phase 2 Completed - United States, California ... More >> Novartis Investigative Site Los Angeles, California, United States, 90025 Novartis Investigative Site San Francisco, California, United States, 94115 United States, Colorado Novartis Investigative Site Aurora, Colorado, United States, 80045 United States, Connecticut Novartis Investigative Site New Haven, Connecticut, United States, 06520 United States, Florida Novartis Investigative Site Tampa, Florida, United States, 33612 United States, Maryland Novartis Investigative Site Lutherville-Timonium, Maryland, United States, 21093 United States, Massachusetts Novartis Investigative Site Boston, Massachusetts, United States, 02114 Novartis Investigative Site Boston, Massachusetts, United States, 02215 United States, Minnesota Novartis Investigative Site Rochester, Minnesota, United States, 55905 United States, Pennsylvania Novartis Investigative Site Philadelphia, Pennsylvania, United States, 19104 United States, Tennessee Novartis Investigative Site Nashville, Tennessee, United States, 37203 Novartis Investigative Site Nashville, Tennessee, United States, 37232 United States, Texas Novartis Investigative Site Houston, Texas, United States, 77030-4009 Australia, New South Wales Novartis Investigative Site Westmead, New South Wales, Australia, 2145 Australia, Victoria Novartis Investigative Site Heidelberg, Victoria, Australia, 3084 Less <<
NCT00594568 - Completed - -
NCT02226341 Lupus Nephritis Phase 4 Recruiting July 2024 United States, New York ... More >> Columbia University - Herbert Irving Pavilion Recruiting New York, New York, United States, 10032 Contact: Pooja Mahadeshwar    212-342-9051    pm2844@cumc.columbia.edu    Contact: Samantha C Nguyen    212-342-1587    scn2119@cumc.columbia.edu    Sub-Investigator: Rachel A Drolet, RN, MSN, AGNP-BC          Principal Investigator: Anca D Askanase, MD, MPH Less <<
NCT02719730 Obesity Not Applicable Terminated(Change in study des... More >>ign to be a pilot with no randomization to intervention/control) Less << - United States, California ... More >> UCSF Benioff Children's Hospital Oakland Oakland, California, United States, 94609 Less <<
NCT03521401 Life Experiences Not Applicable Recruiting March 31, 2019 United States, Oklahoma ... More >> 192 Colvin Recreation Center Recruiting Stillwater, Oklahoma, United States, 74074 Contact: Nathaniel Jenkins, Ph.D.    405-744-9315    nathaniel.jenkins@okstate.edu    Contact: Patrick Tomko, MEd, MFn       ptomko@okstate.edu Less <<
NCT00989235 Rheumatoid Arthritis Phase 3 Completed - -
NCT00385580 Prostate Cancer Phase 2 Completed - United States, California ... More >> Cedars Sinai Medical Center Los Angeles, California, United States, 90048 United States, Illinois University Of Chicago Chicago, Illinois, United States, 60637 United States, Maryland The Bunting Blaustein Cancer Research Building Baltimore, Maryland, United States, 21231 United States, New York Memorial Sloan-Kettering Cancer Center-Sidney Kimmel Center New York, New York, United States, 10021 United States, Pennsylvania Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 United States, Washington Seattle Cancer Care Alliance Seattle, Washington, United States, 98109 United States, Wisconsin University Of Wisconsin Paul P Carbone Comprehensive Ca Ctr Madison, Wisconsin, United States, 53792 France Local Institution Montpellier, France, 34298 Local Institution Paris, France, 75015 Local Institution Villejuif Cedex, France, 94800 Italy Local Institution Rome, Italy, 00152 Less <<
NCT00678392 Kidney Neoplasms Phase 3 Completed - -
NCT03438084 Healthy Adults Not Applicable Not yet recruiting June 30, 2019 United Kingdom ... More >> Department of Nutritional Sciences, Faculty of Life Sciences and Medicine, Kings College London London, United Kingdom, SE1 9NH King's College London London, United Kingdom, SE1 9NH Less <<
NCT00385580 - Completed - -
NCT00678392 - Completed - -
NCT00134693 Arthritis, Rheumatoid Phase 2 Completed - Australia, New South Wales ... More >> GSK Investigational Site Darlinghurst, New South Wales, Australia, 2010 Australia, Queensland GSK Investigational Site Douglas, Queensland, Australia, 4814 GSK Investigational Site Woolloongabba, Queensland, Australia, 4102 Australia, South Australia GSK Investigational Site Daw Park, South Australia, Australia, 5041 GSK Investigational Site Woodville, South Australia, Australia, 5011 Australia, Tasmania GSK Investigational Site Hobart, Tasmania, Australia, 7000 Australia, Western Australia GSK Investigational Site Shenton Park, Western Australia, Australia, 6008 France GSK Investigational Site Amiens, Picardie, France, 80054 GSK Investigational Site Montpellier Cedex 5, France, 34295 Germany GSK Investigational Site Villingen-Schwenningen, Baden-Wuerttemberg, Germany, 78054 GSK Investigational Site Hildesheim, Niedersachsen, Germany, 31134 GSK Investigational Site Chemnitz, Sachsen, Germany, 09111 GSK Investigational Site Leipzig, Sachsen, Germany, 04107 GSK Investigational Site Leipzig, Sachsen, Germany, 04229 GSK Investigational Site Berlin, Germany, 12163 GSK Investigational Site Berlin, Germany, 13125 GSK Investigational Site Berlin, Germany, 14059 GSK Investigational Site Berlin, Germany, 14109 Russian Federation GSK Investigational Site Ekaterinburg, Russian Federation, 620102 GSK Investigational Site Moscow, Russian Federation, 115522 GSK Investigational Site Ryazan, Russian Federation, 390026 GSK Investigational Site Yaroslavl, Russian Federation, 150003 United Kingdom GSK Investigational Site Cambridge, Cambridgeshire, United Kingdom, CB2 0QQ GSK Investigational Site Wigan, Lancashire, United Kingdom, WN6 9EP GSK Investigational Site Liverpool, Merseyside, United Kingdom, L9 7AL GSK Investigational Site Newcastle, Northumberland, United Kingdom, NE1 4LP GSK Investigational Site Oxford, United Kingdom, OX3 7LP GSK Investigational Site Sheffield, United Kingdom, S10 2RX Less <<
NCT01072175 - Completed - -
NCT00989235 - Completed - -
NCT02137460 - Active, not recruiting February 2020 Korea, Republic of ... More >> Seoul National University College of Medicine Seoul, Korea, Republic of, 110-744 Less <<
NCT03034967 Pulmonary Disease, Chronic Obs... More >>tructive Less << Phase 2 Completed - -
NCT02566031 COPD Phase 4 Completed - Korea, Republic of ... More >> Novartis Investigative Site Chuncheon, Gangwon-do, Korea, Republic of, 24253 Novartis Investigative Site Wonju, Gangwon-Do, Korea, Republic of, 26426 Novartis Investigative Site Anyang-si, Gyeonggi-do, Korea, Republic of, 14068 Novartis Investigative Site Guri-si, Gyeonggi-do, Korea, Republic of, 471-701 Novartis Investigative Site Seongnam-si, Gyeonggi-do, Korea, Republic of, 463-712 Novartis Investigative Site Suwon-si, Gyeonggi-do, Korea, Republic of, 16499 Novartis Investigative Site Jeonju-si, Jeollabuk-do, Korea, Republic of, 561-712 Novartis Investigative Site Seoul, Korea, Korea, Republic of, 02559 Novartis Investigative Site Seoul, Korea, Korea, Republic of, 06351 Novartis Investigative Site Seoul, Korea, Korea, Republic of, 08308 Novartis Investigative Site Koyang, Kyunggi, Korea, Republic of, 410-719 Novartis Investigative Site Gwangju, Korea, Republic of, 61469 Novartis Investigative Site Incheon, Korea, Republic of, 403-720 Novartis Investigative Site Incheon, Korea, Republic of, 405 760 Novartis Investigative Site Jeju, Korea, Republic of, 63241 Novartis Investigative Site Seoul, Korea, Republic of, 03722 Novartis Investigative Site Seoul, Korea, Republic of, 04763 Novartis Investigative Site Seoul, Korea, Republic of, 05030 Novartis Investigative Site Seoul, Korea, Republic of, 06273 Novartis Investigative Site Seoul, Korea, Republic of, 06591 Novartis Investigative Site Seoul, Korea, Republic of, 110-746 Novartis Investigative Site Seoul, Korea, Republic of, 150-713 Novartis Investigative Site Seoul, Korea, Republic of, 156-707 Novartis Investigative Site Ulsan, Korea, Republic of, 44033 Less <<
NCT03613766 Bariatric Surgery Candidate ... More >> Physical Activity Less << Not Applicable Completed - -
NCT02078687 Infant, Very Low Birth Weight ... More >> Metabolic Syndrome, Protection Against Allergy Dietary Modification Less << Not Applicable Completed - Denmark ... More >> HC Anderson Children´s Hospital, OUH Odense, Denmark, 5000 Less <<
NCT01396148 Gastrointestinal Stromal Tumor... More >>s Less << Phase 2 Completed - United States, California ... More >> Children's Center for Cancer and Blood Diseases, Children's Hospital Los Angeles Los Angeles, California, United States, 90027 United States, Massachusetts Children's Hospital Boston Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 Czechia Fakultni nemocnice Brno Brno, Czechia, 613 00 FN Brno Brno, Czechia, 625 00 Masarykuv onkologicky ustav Brno, Czechia, 656 33 France CHU de La Timone, Hopital enfants Marseille cedex 5, France, 13385 Hopital d'Enfants de la Timone Marseille cedex 5, France, 13385 Hopital de la Timone Marseille cedex 5, France, 13385 Less <<
NCT01396148 - Completed - -
NCT01684215 Neoplasms Bre... More >>ast Neoplasms Less << Phase 2 Completed - Japan ... More >> Aichi Cancer Center Hospital Nagoya, Aichi, Japan, 464-8681 National Cancer Center Hospital East Kashiwa, Chiba, Japan, 277-8577 National Hospital Organization Hokkaido Cancer Center Sapporo, Hokkaido, Japan, 003-0804 Kumamoto Shinto General Hospital Kumamoto-city, Kumamoto, Japan, 862-8655 Saitama Cancer Center Kita-adachi-gun, Saitama, Japan, 362-0806 National Cancer Center Hospital Chuo-Ku, Tokyo, Japan, 104-0045 Chiba Cancer Center Chiba, Japan, 260-8717 National Hospital Organization Shikoku Cancer Center Ehime, Japan, 791-0280 National Hospital Organization Kyushu Cancer Center Fukuoka, Japan, 811-1395 Hiroshima City Hiroshima Citizens Hospital Hiroshima, Japan, 730-8518 Iwate Medical University Hospital Iwate, Japan, 020-8505 Hakuaikai Medical Corporation Sagara Hospital Kagoshima, Japan, 892-0833 Kumamoto University Hospital Kumamoto, Japan, 860-8556 Kumamoto City Hospital Kumamoto, Japan, 862-8505 Kyoto University Hospital Kyoto, Japan, 606-8507 National Hospital Organization Osaka National Hospital Osaka, Japan, 540-0006 Less <<
NCT01226888 - Terminated(Slow accrual) - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02214 Less <<
NCT01512160 Post-surgical Dental Pain Phase 2 Terminated(See termination rea... More >>son in detailed description.) Less << - United States, Texas ... More >> Pfizer Investigational Site Austin, Texas, United States, 78744 Less <<
NCT01383928 Multiple Myeloma Phase 1 Phase 2 Completed - United States, California ... More >> UCSF Medical Center Berkeley, California, United States, 94704 City of Hope National Medical Center Duarte, California, United States, 91010 Stanford University Stanford, California, United States, 94305 United States, Florida H Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 United States, Illinois University of Chicago Medical Center Chicago, Illinois, United States, 60637 United States, Maryland Associates of Oncology/Hematology PC Rockville, Maryland, United States, 20850 United States, Massachusetts Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Michigan University of Michigan Ann Arbor, Michigan, United States, 48109 Michigan State University Lansing, Michigan, United States, 48910 United States, New Jersey Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10021 Mount Sinai Hospital New York, New York, United States, 31406 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27705 United States, Ohio Ohio State University Columbus, Ohio, United States, 43210 Mercy St Anne Hospital Toledo, Ohio, United States, 43623 United States, Oregon Oregon Health and Science University Portland, Oregon, United States, 97239 United States, Tennessee SCRI Tennessee Oncology Nashville Nashville, Tennessee, United States, 37203 United States, Texas Baylor Sammons Cancer Center Dallas, Texas, United States, 75246 United States, Virginia Virginia Cancer Care Specialist Fairfax, Virginia, United States, 22031 Virginia Cancer Specialists PC Fairfax, Virginia, United States, 22031 Less <<
NCT01366521 Asthma Phase 2 Completed - United States, North Carolina ... More >> GSK Investigational Site Winston-Salem, North Carolina, United States, 27103 United States, Pennsylvania GSK Investigational Site Pittsburgh, Pennsylvania, United States, 15213 Estonia GSK Investigational Site Tallinn, Estonia, 13619 GSK Investigational Site Tartu, Estonia, 51014 France GSK Investigational Site Marseille cedex 20, France, 13915 GSK Investigational Site Montpellier, France, 34295 GSK Investigational Site Pessac Cedex, France, 33604 Germany GSK Investigational Site Gauting, Bayern, Germany, 82131 GSK Investigational Site Frankfurt am Main, Hessen, Germany, 60596 GSK Investigational Site Frankfurt, Hessen, Germany, 60596 GSK Investigational Site Magdeburg, Sachsen-Anhalt, Germany, 39112 GSK Investigational Site Berlin, Germany, 14050 Less <<
NCT01383928 - Completed - -
NCT01684215 - Completed - -
NCT02319148 Healthy Volunteers Phase 1 Completed - Belgium ... More >> Pfizer Clinical Research Unit Brussels, Belgium, B-1070 Less <<
NCT01366521 - Completed - -
NCT03161756 Melanoma Stage Iv ... More >> Melanoma Stage Iii Melanoma Less << Phase 1 Phase 2 Recruiting June 2023 Australia, Queensland ... More >> Royal Brisbane and Women's Hospital Recruiting Herston, Queensland, Australia, 4029 Principal Investigator: Dr. Melissa Eastgate          Australia, Victoria Box Hill Hospital Recruiting Box Hill, Victoria, Australia, 3128 Principal Investigator: A/Prof. Phillip Parente          Austin Health Recruiting Heidelberg, Victoria, Australia, 3084 Principal Investigator: A/Prof. Jonathan Cebon          Peter MacCallum Cancer Centre Recruiting Melbourne, Victoria, Australia, 3000 Principal Investigator: Dr. Shahneen Sandhu Less <<
NCT02237365 Tuberculous Meningitis Phase 2 Completed - Vietnam ... More >> Hospital for Tropical Diseases Ho Chi Minh City, Vietnam Less <<
NCT02319148 - Completed - -
NCT01529346 Postoperative Dental Pain Phase 2 Completed - United States, Texas ... More >> Central Texas Oral Surgery Associates Austin, Texas, United States, 78705 Premier Research Group Limited Austin, Texas, United States, 78705 PPD Development, LP Austin, Texas, United States, 78744 Less <<
NCT01437696 Vitamin D Deficiency Phase 4 Completed - Canada, Quebec ... More >> Ste. Anne's Hospital Ste. Anne-de-Bellevue, Quebec, Canada, H9X1Y9 Less <<
NCT01512160 - Terminated(See termination rea... More >>son in detailed description.) Less << - -
NCT02341482 Healthy Phase 1 Completed - United States, Connecticut ... More >> Pfizer New Haven Clinical Research Unit New Haven, Connecticut, United States, 06511 Less <<
NCT01529346 - Completed - -
NCT00266656 - Completed - -
NCT03693300 Non-small Cell Lung Cancer (NS... More >>CLC) Less << Phase 2 Not yet recruiting December 30, 2022 United States, Tennessee ... More >> Research Site Not yet recruiting Knoxville, Tennessee, United States, 37920 France Research Site Not yet recruiting Saint Priest en Jarez, France, 42270 United Kingdom Research Site Not yet recruiting Leeds, United Kingdom, LS9 7TF Less <<
NCT03049696 Obesity Baria... More >>tric Surgery Roux-En-Y Gastric Bypass Exercise Quality of Life Less << Not Applicable Recruiting January 2019 Canada, Manitoba ... More >> Centre for Metabolic and Bariatric Surgery (CMBS) Recruiting Winnipeg, Manitoba, Canada, R3T 2EB Contact: Krista Hardy, MD    204-258-1479    khardy@sbgh.mb.ca    Contact: Kathleen Clouston, PhD    204-258-1479    kclouston@sbgh.mb.ca    Principal Investigator: Krista Hardy, MD          Principal Investigator: Todd Duhamel, PhD          Sub-Investigator: Kathleen Clouston, PhD          Sub-Investigator: Alex Edye-Mazowita Less <<
NCT02341482 - Completed - -
NCT00266656 Turner Syndrome Phase 4 Completed - United States, California ... More >> Childrens Hospital of Los Angeles Los Angeles, California, United States, 90027 United States, Colorado Children's Hospital Aurora, Colorado, United States, 80045 United States, Connecticut Connecticut Children's Medical Center Hartford, Connecticut, United States, 06106 United States, Illinois Children's Hospital of Chicago Research Center Chicago, Illinois, United States, 60611 United States, Indiana Riley Hosptial for Children Indianapolis, Indiana, United States, 46202 United States, Missouri Children's Mercy Hospital Kansas City, Missouri, United States, 64108 United States, North Carolina University of NC at Chapel Hill School of Medicine Chapel Hill, North Carolina, United States, 27514 United States, Pennsylvania Thomas Jefferson University Philadelphia, Pennsylvania, United States, 19107 United States, Washington Childrens Hospital and Medical Center Seattle, Washington, United States, 98105 Less <<
NCT01577381 - Terminated(See termination rea... More >>son in detailed description.) Less << - -
NCT01577381 Age-Related Maculopathy Phase 2 Terminated(See termination rea... More >>son in detailed description.) Less << - -
NCT01819922 - Completed - -
NCT00282919 - Completed - -
NCT00282919 Falciparum Malaria Phase 2 Completed - Colombia ... More >> Pfizer Investigational Site San Andres de Tumaco, Narino, Colombia India Pfizer Investigational Site Bambolim, Goa, India, 403002 Less <<
NCT03250468 Insomnia Card... More >>iovascular Diseases Less << Not Applicable Recruiting September 1, 2019 Canada, Ontario ... More >> University of Ottawa Heart Institute Recruiting Ottawa, Ontario, Canada, K1Y4W7 Contact: Heather Tulloch    613-696-7000 ext 19705 Less <<
NCT00195260 Neoplasms Phase 1 Completed - United States, Alabama ... More >> Pfizer Investigational Site Birmington, Alabama, United States, 35233 United States, Arizona Pfizer Investigational Site Scottsdale, Arizona, United States, 85258 United States, California Pfizer Investigational Site Los Angeles, California, United States, 90033 United States, Florida Pfizer Investigational Site Tampa, Florida, United States, 33612 United States, Georgia Pfizer Investigational Site Atlanta, Georgia, United States, 30341 United States, Indiana Pfizer Investigational Site Indianpolis, Indiana, United States, 46202 United States, Maryland Pfizer Investigational Site Baltimore, Maryland, United States, 21287 United States, Michigan Pfizer Investigational Site Detroit, Michigan, United States, 48202 Pfizer Investigational Site Lansing, Michigan, United States, 48910 United States, New York Pfizer Investigational Site New York, New York, United States, 10016 Pfizer Investigational Site New York, New York, United States, 10032 United States, North Carolina Pfizer Investigational Site Charlotte, North Carolina, United States, 28203 Pfizer Investigational Site Charlotte, North Carolina, United States, 28211 Pfizer Investigational Site UNC Chapel Hill, North Carolina, United States, 27514 Pfizer Investigational Site UNC Chapel Hill, North Carolina, United States, 27759 United States, Ohio Pfizer Investigational Site Cleveland, Ohio, United States, 44106-1736 United States, Texas Pfizer Investigational Site San Antonio, Texas, United States, 78258 Pfizer Investigational Site Tyler, Texas, United States, 75702 United States, Washington Pfizer Investigational Site Seattle, Washington, United States, 98104 Less <<
NCT01819922 Healthy Phase 1 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT00708110 - Completed - -
NCT03529357 - Completed - Denmark ... More >> University of Copenhagen, Department of Biomedical Sciences Copenhagen, Denmark, 2200 Less <<
NCT00159783 Bipolar Disorder Phase 3 Completed - -
NCT00159783 - Completed - -
NCT00195260 - Completed - -
NCT00272987 Neoplasms, Breast Phase 3 Active, not recruiting December 31, 2018 -
NCT01274988 Addiction Not Applicable Unknown December 2015 China, Shaanxi ... More >> Department of neurosurgery, Tangdu Hospital Recruiting Xi'an, Shaanxi, China, 710038 Contact: Guo-dong Gao, M.D.    +86 29 84777435    gguodong@fmmu.edu.cn    Sub-Investigator: Xue-lian Wang, M.D. Less <<
NCT01802112 Constipation Not Applicable Completed - Spain ... More >> San Antonio Catholic University of Murcia Guadalupe, Murcia, Spain, 30107 Less <<
NCT00630487 Growth Hormone Deficiency Phase 3 Terminated(See termination rea... More >>son in detailed description.) Less << - Germany ... More >> Pfizer Investigational Site Bad Aibling, Germany, 83043 Pfizer Investigational Site Muenchen, Germany, 80804 Less <<
NCT00272987 - Active, not recruiting - -
NCT01119937 Chronic Obstructive Pulmonary ... More >>Disease Less << Phase 3 Completed - Japan ... More >> Novartis Investigative Site Iizuka, Fukuoka, Japan, 820-8505 Novartis Investigative Site Kitakyushu, Fukuoka, Japan, 802-0083 Novartis Investigative Site Kitakyushu, Fukuoka, Japan, 820-0052 Novartis Investigative Site Kurume, Fukuoka, Japan, 830-0011 Novartis Investigative Site Onojo, Fukuoka, Japan, 816-0931 Novartis Investigative Site Yanagawa, Fukuoka, Japan, 832-0059 Novartis Investigative Site Asahikawa, Hokkaido, Japan, 070-8644 Novartis Investigative Site Obihiro, Hokkaido, Japan, 080-0805 Novartis Investigative Site Sapporo, Hokkaido, Japan, 060-8648 Novartis Investigative Site Himeji-city, Hyogo, Japan, 672-8064 Novartis Investigative Site Takarazuka, Hyogo, Japan, 665-0827 Novartis Investigative Site Yabu, Hyogo, Japan, 667-8555 Novartis Investigative Site Inashiki-gun, Ibaraki, Japan, 300-0395 Novartis Investigative Site Naka-gun, Ibaraki, Japan, 319-1113 Novartis Investigative Site Sashima-gun, Ibaraki, Japan, 306-0433 Novartis Investigative Site Morioka, Iwate, Japan, 020-0055 Novartis Investigative Site Kawasaki, Kanagawa, Japan, 210-0852 Novartis Investigative Site Yokohama, Kanagawa, Japan, 232-0021 Novartis Investigative Site Yokohama, Kanagawa, Japan, 236-0051 Novartis Investigative Site Uji, Kyoto, Japan, 611-0042 Novartis Investigative Site Matsusaka-city, Mie, Japan, 515-8544 Novartis Investigative Site Sendai, Miyagi, Japan, 981-8563 Novartis Investigative Site Nagaoka-City, Niigata, Japan, 940-2085 Novartis Investigative Site Nagaoka, Niigata, Japan, 940-8653 Novartis Investigative Site Kasaoka, Okayama, Japan, 714-0081 Novartis Investigative Site Tsuyama, Okayama, Japan, 708-0841 Novartis Investigative Site Osakasayama, Osaka, Japan, 589-0022 Novartis Investigative Site Sakai, Osaka, Japan, 591-8555 Novartis Investigative Site Takatsuki, Osaka, Japan, 569-1096 Novartis Investigative Site Shimotsuka-gun, Tochigi, Japan, 321-0293 Novartis Investigative Site Bunkyo-ku, Tokyo, Japan, 113-8431 Novartis Investigative Site Nakano-ku, Tokyo, Japan, 164-0012 Novartis Investigative Site Ohta-ku, Tokyo, Japan, 140-0063 Novartis Investigative Site Yamagata city, Yamagata, Japan, 990-8533 Novartis Investigative Site Ube, Yamaguchi, Japan, 755-0241 Novartis Investigative Site Fukuoka, Japan, 812-0033 Novartis Investigative Site Kochi, Japan, 780-8077 Novartis Investigative Site Osaka, Japan, 530-0012 Novartis Investigative Site Osaka, Japan, 545-8586 Novartis Investigative Site Saitama, Japan, 337-0012 Less <<
NCT01119937 - Completed - -
NCT00630487 - Terminated(See termination rea... More >>son in detailed description.) Less << - -
NCT03118882 Lifestyle Risk Reduction ... More >> Weight Changes, Body Breast Cancer Colorectal Cancer Less << Not Applicable Completed - Italy ... More >> S.C.D.O. Epidemiologia dei Tumori - Azienda Ospedaliera S. Giovanni Battista di Torino Torino, Piedmont, Italy, 10123 Less <<
NCT00122382 - Completed - -
NCT00122382 Rheumatoid Arthritis Phase 3 Completed - -
NCT03673085 Thalassemia Phase 1 Recruiting December 2018 China, Zhejiang ... More >> The first affiliated hospital, Zhejiang University Recruiting Hangzhou, Zhejiang, China, 310003 Contact: Jianzhong Shentu    13957111817    stjz@zju.edu.cn Less <<
NCT00708110 Infection, Human Immunodeficie... More >>ncy Virus Less << Phase 2 Completed - United States, California ... More >> GSK Investigational Site Bakersfield, California, United States, 93301 GSK Investigational Site Long Beach, California, United States, 90813 GSK Investigational Site Newport Beach, California, United States, 92663 GSK Investigational Site Northridge, California, United States, 91325 GSK Investigational Site San Francisco, California, United States, 94115 United States, Colorado GSK Investigational Site Denver, Colorado, United States, 80220 United States, District of Columbia GSK Investigational Site Washington, District of Columbia, United States, 20009 United States, Florida GSK Investigational Site Fort Lauderdale, Florida, United States, 33316 GSK Investigational Site Ft. Lauderdale, Florida, United States, 33306 GSK Investigational Site Orlando, Florida, United States, 32803 GSK Investigational Site Vero Beach, Florida, United States, 32960 United States, Georgia GSK Investigational Site Atlanta, Georgia, United States, 30308 United States, New Jersey GSK Investigational Site Hillsborough, New Jersey, United States, 08844 GSK Investigational Site Voorhees, New Jersey, United States, 08043 United States, New Mexico GSK Investigational Site Santa Fe, New Mexico, United States, 87505 United States, North Carolina GSK Investigational Site Charlotte, North Carolina, United States, 28209 United States, Texas GSK Investigational Site Dallas, Texas, United States, 75204 GSK Investigational Site Dallas, Texas, United States, 75246 Less <<
NCT00920140 - Completed - -
NCT03089593 Healthy Volunteers Not Applicable Completed - Brazil ... More >> Hospital das Clínicas Belo Horizonte, Minas Gerais, Brazil, 30130-100 Less <<
NCT00920140 Cancer Phase 2 Completed - -
NCT00155142 - Unknown - Taiwan ... More >> Department of Anatomy and Cell Biology, National Taiwan University College of Medicine Recruiting Taipei, Taiwan Contact: Sung-Tsang Hsieh, PhD    886-2-23123456 ext 8182    sthsieh@ha.mc.ntu.edu.tw Less <<
NCT00151190 Diabetes Mellitus Phase 3 Completed - United States, Texas ... More >> Central Dallas Ministries Community Health Services Clinic Dallas, Texas, United States, 75246 Less <<
NCT00151021 Diabetes Mellitus, Type 2 Not Applicable Completed - United States, Michigan ... More >> University of Michigan, Department of Family Medicine Ann Arbor, Michigan, United States, 48109 Less <<
NCT00155610 - Terminated(No clinical signifi... More >>cant) Less << - -
NCT00156364 - Completed - United States, Minnesota ... More >> Universtity of Minnesota, Department of Pediatric Nephrology Minneapolis, Minnesota, United States, 55455 Less <<
NCT00147836 Type 2 Diabetes Mellitus Not Applicable Completed - China, Guangdong ... More >> the first Affiliated Hospital of Sun Yat-Sen university Guangzhou, Guangdong, China, 510080 Less <<
NCT00157482 Type 2 Diabetes Phase 2 Completed - Italy ... More >> ASl of Ponte San Pietro - Diabetologic Unit Ponte San Pietro, Bergamo, Italy, 24036 Clinical Research Center for Rare Diseases Ranica, Bergamo, Italy, 24020 Hospital "Treviglio Caravaggio " - Diabetologic Unit Treviglio, Bergamo, Italy, 24047 Hospital "Ospedali Riuniti di Bergamo" - Diabetologic Unit Bergamo, Italy, 24128 Less <<
NCT00156897 Non-Insulin-Dependent Diabetes... More >> Mellitus Obesity Less << Phase 2 Completed - Denmark ... More >> Aalborg Sygehus Nord Aalborg, Denmark Aarhus University Hospital Aarhus, Denmark, DK-8000 Bispebjerg Hospital Copenhagen, Denmark, DK-2400 Gentofte Hospital Hellerup, Denmark, DK-2900 Hvidovre Hospital Hvidovre, Denmark, DK-2650 Odense University Hospital Odense, Denmark Finland Lääkärikeskus Minerva Eura, Finland, 27510 Obesity Research Unit Helsinki, Finland, 00100 Suomen Terveystalo Jyvaskyla, Finland, 40100 Oy Foodfiles Limited Kuopio, Finland Oulun Diakonissalaitos Oulu, Finland, 90100 University of Oulu Oulu, Finland Turku University Hospital Turku, Finland, 20520 Netherlands Allevon Den Bosch Ziekenhuis, Netherlands Allevon DN de Bilt, Netherlands Zeikenhuisgroep Twente Hengelo, Netherlands Nederlandse Obesitas Klinik Hilversum, Netherlands Sint Franciscus Gasthuis Rotterdam, Netherlands Sweden Sahlgrenska University Hospital Goteborg, Sweden Linkoping University Hospital Linkoping, Sweden Karolinsaka University Hospital Stockholm, Sweden Norrlands Universitetssjukhus Umea, Sweden Samariterhemmets Sjukhus Uppsala, Sweden United Kingdom Aberdeen Royal Infirmary Aberdeen, United Kingdom Royal United Hospital Bath, United Kingdom Clinical Research Centre Edgbaston Birmingham, United Kingdom Walsgrave Hospital Coventry, United Kingdom Glasgow Royal Infirmary Glasgow, United Kingdom Clinical Research Centre, Crosby Liverpool, United Kingdom Liverpool University Hospital Liverpool, United Kingdom Queen Mary's School of Medicine & Dentistry London, United Kingdom, E1 2AA Hammersmith Hospital London, United Kingdom Luton & Dunstable Hospital Luton, United Kingdom Clinical Research Centre Manchester, United Kingdom James Cook University Hospital Middlesborough, United Kingdom Royal Shrewsbury Hospital Shrewsbury, United Kingdom Clinical Research Centre Wigan, United Kingdom Less <<
NCT00157586 Type 2 Diabetes Phase 3 Completed - Italy ... More >> ASL of Ponte San Pietro - Diabetologic Unit Ponte San Pietro, Bergamo, Italy, 24036 Clinical Research Center for Rare Diseases Ranica, Bergamo, Italy, 24020 Hospital of Romano di Lombardia - Diabetologic Unit Romano di Lombardia, Bergamo, Italy, 24058 Hospital " Bolognini " - Medicine Unit Seriate, Bergamo, Italy, 24068 Hospital " Treviglio Caravaggio" - Diabetologic Unit Treviglio, Bergamo, Italy, 24128 Humanitas Institute - Endocrinology and Diabetologic Unit Rozzano, Milano, Italy, 20089 Hospital "Ospedali Riuniti di Bergamo" - Diabetologic Unit Bergamo, Italy, 24128 Slovenia Department of Endocrinolgy, Diabetes and Metabolic Disease - University Medical Center Lubiana, Slovenia Less <<
NCT00160927 - Unknown January 2008 France ... More >> Centre hospitalier universitaire Recruiting Angers, France, 49933 Contact: Pierre Abraham, MD, PhD          Sub-Investigator: Pierre Abraham, MD PhD Less <<
NCT00162240 Diabetes Mellitus Phase 3 Completed - -
NCT00160017 - Completed - -
NCT00162344 Diabetes Phase 4 Completed - United States, California ... More >> Local Institution Mission Viejo, California, United States Local Institution Rancho Santa Fe, California, United States Local Institution San Diego, California, United States United States, Illinois Local Institution Chicago, Illinois, United States United States, Indiana Local Institution Indianapolis, Indiana, United States United States, Michigan Local Institution Detroit, Michigan, United States United States, Minnesota Local Institution Minneapolis, Minnesota, United States United States, New York Local Institution Albany, New York, United States Local Institution Roslyn, New York, United States United States, Ohio Local Institution Columbus, Ohio, United States United States, Texas Local Institution Houston, Texas, United States Canada, Quebec Local Institution Montreal, Quebec, Canada Less <<
NCT00593606 Parkinson's Disease Phase 3 Completed - -
NCT00423319 Deep Vein Thrombosis ... More >> Pulmonary Embolism Less << Phase 3 Completed - -
NCT00177138 Diabetes Mellitus Phase 4 Terminated(The clinical use of... More >> Campath for transplant patients was temporarily suspended.) Less << - United States, Minnesota ... More >> University of Minnesota-Fairview Minneapolis, Minnesota, United States, 55414 Less <<
NCT00423319 - Completed - -
NCT03555734 - Active, not recruiting July 31, 2018 Canada, Ontario ... More >> The Toronto 3D (Diet, Digestive tract and Disease) Knowledge Synthesis and Clinical Trials Unit, Clinical Nutrition and Risk Factor Modification Centre, St. Michael's Hospital Toronto, Ontario, Canada, M5C 2T2 Less <<
NCT00167284 Diabetes Not Applicable Completed - -
NCT01021553 Premature Ejaculation Phase 2 Completed - United States, California ... More >> GSK Investigational Site San Diego, California, United States, 92120 GSK Investigational Site San Jose, California, United States, 95128 United States, Indiana GSK Investigational Site Fort Wayne, Indiana, United States, 46825 United States, New York GSK Investigational Site New York, New York, United States, 10016 United States, Pennsylvania GSK Investigational Site Bala-Cynwyd, Pennsylvania, United States, 19004 GSK Investigational Site Philadelphia, Pennsylvania, United States, 19104 Netherlands GSK Investigational Site Amsterdam, Netherlands, 1081 HV GSK Investigational Site Utrecht, Netherlands, 3584 CJ Less <<
NCT03609463 Diabetes Mellitus, Type 2 ... More >> Overweight and Obesity Less << Not Applicable Recruiting September 2019 Italy ... More >> Struttura Semplice di Endocrinologia e Metabolismo, Ospedale Oglio Po Not yet recruiting Casalmaggiore, Cremona, Italy, 26041 Contact: Giada Benasi, MS    +393343453946    giada.benasi2@unibo.it    Servizio Endocrinologia e Diabetologia, Ospedale Bufalini Recruiting Cesena, Forlì-Cesena, Italy, 47521 Contact: Giada Benasi, MS    +393343453946    giada.benasi2@unibo.it Less <<
NCT03509454 - Completed - Denmark ... More >> Steno Diabetes Center Gentofte, Copenhagen, Denmark, 2820 Less <<
NCT01021553 - Completed - -
NCT02639975 Glaucoma Phase 1 Completed - -
NCT03653533 Type I Diabetes Not Applicable Not yet recruiting November 2019 -
NCT00496769 Atrial Fibrillation Phase 3 Completed - -
NCT01926522 Complications of Diabetes Mell... More >>itus Diabetic Neuropathies Less << Not Applicable Completed - Italy ... More >> Habilita, Ospedale di Sarnico Sarnico, Bergamo, Italy, 24067 Less <<
NCT03655067 Type 1 Diabetes Mellitus ... More >> Depressive Symptoms Less << Not Applicable Not yet recruiting December 2019 United States, Texas ... More >> Children's Medical Center Not yet recruiting Dallas, Texas, United States, 75235 Contact: Yasmin Dominguez       YASMIN.DOMINGUEZ@childrens.com Less <<
NCT01930448 - Withdrawn(PI relocated to anot... More >>her Institution) Less << - United States, New York ... More >> St. Luke's Roosevelt Hospital-New York Obesity Nutrition Research Center New York, New York, United States, 10025 Less <<
NCT03512132 - Recruiting December 2020 France ... More >> Chu Dijon Bourogne Recruiting Dijon, France, 21000 Contact: Laurence DUVILLARD    03.80.29.34.53    laurence.duvillard@chu-dijon.fr Less <<
NCT00496769 - Completed - -
NCT03654313 Atherosclerosis ... More >> Cardiovascular Disease Less << Phase 1 Recruiting November 13, 2019 United States, Alabama ... More >> Research Site Not yet recruiting Anniston, Alabama, United States, 36207 United States, Florida Research Site Recruiting Jacksonville, Florida, United States, 32216 Research Site Not yet recruiting Miami, Florida, United States, 33014 Research Site Not yet recruiting Miami, Florida, United States, 33143 United States, North Carolina Research Site Not yet recruiting High Point, North Carolina, United States, 27265 Research Site Not yet recruiting Raleigh, North Carolina, United States, 27612 United States, Ohio Research Site Recruiting Cincinnati, Ohio, United States, 45227 United States, Tennessee Research Site Not yet recruiting Knoxville, Tennessee, United States, 37920 Less <<
NCT01940835 - Recruiting July 2019 United States, Minnesota ... More >> Mayo Clinic Recruiting Rochester, Minnesota, United States, 55905 Contact: Carol Van Dyke    507-266-7842    vandyke.carol@mayo.edu    Principal Investigator: Joseph Murray, M.D. Less <<
NCT01299610 Dermatitis, Atopic Phase 2 Completed - Germany ... More >> GSK Investigational Site Berlin, Germany, 10117 Less <<
NCT03618420 Diabetes Mellitus, Type 1 ... More >> Nephropathy Diabetic Nephropathies Juvenile Diabetes Diabetes Mellitus Complication Autoimmune Diabetes Type 1 Diabetes Mellitus Less << Phase 1 Phase 2 Recruiting August 2020 United States, Colorado ... More >> Children's Hospital Colorado Recruiting Aurora, Colorado, United States, 80045 Contact: Petter Bjornstad, MD    720-777-4659    petter.bjornstad@childrenscolorado.org    Principal Investigator: Petter Bjornstad, M.D.          Sub-Investigator: Kristin Nadeau, M.D. Less <<
NCT02027259 Diabetes Depr... More >>ession Less << Not Applicable Active, not recruiting December 2017 United States, Rhode Island ... More >> Providence VAMC Providence, Rhode Island, United States, 02908 Less <<
NCT02001532 - Completed - Denmark ... More >> Department of Medical Endocrinology, Aarhus University Hospital Aarhus, Denmark, 8000 Less <<
NCT02034045 Diabetes Mellitus (DM) ... More >> Congestive Heart Failure (CHF) Chronic Obstructive Pulmonary Disease (COPD) Less << Not Applicable Unknown December 2016 Canada, Ontario ... More >> Health for All and Markham Family Health Team Markham, Ontario, Canada Aurora-Newmarket Family Health Team Newmarket, Ontario, Canada Owen Sound Family Health Team Owen Sound, Ontario, Canada Stouffville Medical Centre Stouffville, Ontario, Canada Less <<
NCT00077610 Anemia Phase 3 Completed - -
NCT01299610 - Completed - -
NCT02517476 Malnutrition Phase 4 Completed - Switzerland ... More >> University Clinic, Kantonsspital Aarau Aarau, AG, Switzerland, 5000 Less <<
NCT00077610 - Completed - -
NCT02109315 Type 1 Diabetes Mellitus Phase 1 Unknown May 2015 Spain ... More >> Hospital Clinic i Provincial de Barcelona Not yet recruiting Barcelona, Spain, 08036 Contact: Anna Cruceta    932275400 ext 4380 Less <<
NCT02113163 Diabetes Mellitus, Non-Insulin... More >>-Dependent Hypertriglyceridemia Less << Phase 1 Unknown July 2014 United States, Louisiana ... More >> Pennington Biomedical Research Center Recruiting Baton Rouge, Louisiana, United States, 70808 Principal Investigator: Frank Greenway, MD Less <<
NCT02115412 - Unknown - United Kingdom ... More >> Swan Lane Medical Centre Recruiting Bolton, Greater Manchester, United Kingdom, BL3 6TL Contact: Nuwani Edirisinghe    +44(0)1223 427 545    Nuwani.edirisinghe@philips.com    Principal Investigator: Ian D Caldwell, MBBS Less <<
NCT02108730 - Completed - Germany ... More >> Pediatric Surgery Greifswald, Germany, D-17475 Less <<
NCT02174146 Chronic Periodontitis ... More >> Type 2 Diabetes Mellitus Less << Not Applicable Completed - Egypt ... More >> Faculty of oral and dental medicine Cairo, Egypt Less <<
NCT02061059 Diabetes Mellitus ... More >> Polyneuropathies Less << Not Applicable Unknown June 2015 Netherlands ... More >> Maastricht University Not yet recruiting Maastricht, Netherlands, 6200MD Sub-Investigator: Tom Melai, PhD          Smeets Loopcomfort Not yet recruiting Sittard, Netherlands, 6135 LE Sub-Investigator: Tom Melai, PhD Less <<
NCT02178176 Depression Ty... More >>pe 2 Diabetes Mellitus Less << Not Applicable Completed - United States, Pennsylvania ... More >> University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT02211612 Obesity Overf... More >>eeding Muscle Mass Body Composition Ectopic Fat Less << Not Applicable Completed - Sweden ... More >> Uppsala University; Clinical nutrition and metabolism; Dept of public health and caring sciences Uppsala, Please Select, Sweden, 75185 Less <<
NCT00455013 - Completed - -
NCT00455013 Disorder Related to Renal Tran... More >>splantation Less << Phase 2 Completed - United States, California ... More >> Ucsf San Francisco, California, United States, 94143 United States, Colorado Denver Nephrology, Pc Denver, Colorado, United States, 80218 University Of Colorado Health Sciences Center Denver, Colorado, United States, 80262 United States, Georgia Medical College Of Georgia Augusta, Georgia, United States, 30912 United States, Illinois Northwestern University Feinberg School Of Medicine Chicago, Illinois, United States, 60611 United States, Michigan Henry Ford Hospital Detriot, Michigan, United States, 48202 United States, New York Albany Medical College Albany, New York, United States, 12208 United States, North Carolina Carolinas Medical Center Charlotte, North Carolina, United States, 28203 United States, Ohio University Of Cincinnati Cincinnati, Ohio, United States, 45267 Ohio State University Medical Center Columbus, Ohio, United States, 43210 United States, Tennessee Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232 Italy Local Institution Bologna, Italy, 40138 Local Institution Brescia, Italy, 25123 Local Institution Padova, Italy, 35128 Local Institution Roma, Italy, 00168 Spain Local Institution Barcelona, Spain, 08907 Local Institution Sevilla, Spain, 41013 Less <<
NCT02174562 Type 2 Diabetes ... More >> Mild Cognitive Impairment Less << Phase 3 Recruiting June 2018 United States, Pennsylvania ... More >> Thomas Jefferson University Recruiting Philadelphia, Pennsylvania, United States, 19107 Less <<
NCT01724567 Ischemic Heart Disease ... More >> Obesity Less << Not Applicable Completed - Denmark ... More >> Bispebjerg Hospital Copenhagen, Denmark, 2400 Less <<
NCT02207777 Obesity Type ... More >>2 Diabetes Less << Not Applicable Active, not recruiting September 2019 United States, Missouri ... More >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Less <<
NCT02297399 Diabetes Mellitus ... More >> Colonic Diseases Less << Phase 3 Completed - Spain ... More >> Hospital Germans Trias i Pujol Badalona, Barcelona, Spain, 08916 Hospital del Mar Barcelona, Spain, 08003 Less <<
NCT02263352 Positive Regulation of Oxidati... More >>ve Stress Process Less << Phase 4 Completed - India ... More >> Panineeya Mahavidhyalaya Institute of Dental Sciences and Research Centre Hyderabad, India, 500060 Less <<
NCT02223793 Cardiovascular Diseases ... More >> Hypercholesterolemia Dyslipidemia Hypertensive Disease Diabetes Mellitus, Type 2 Less << Not Applicable Active, not recruiting February 2022 Norway ... More >> University of Oslo Oslo, P.B. 1046 Blinderen, Norway, 0317 Less <<
NCT02317003 Sedentary Lifestyle ... More >> Cardiovascular Diseases Hypertension Hypercholesterolemia Diabetes Mellitus, Type 2 Less << Not Applicable Active, not recruiting April 2019 France ... More >> Angers University Hospital Angers, France, 49933 Less <<
NCT02305355 Diabetes Mellitus, Type 2 ... More >> Hypertriglycemia Less << Phase 4 Completed - Korea, Republic of ... More >> Bucheon St. Mary's Hospital Bucheon, Korea, Republic of Less <<
NCT02304497 - Completed - -
NCT02375828 Neonatal Diabetes Secondary to... More >> Mutation in the Potassium Channel Less << Phase 3 Completed - France ... More >> Hôpital Universitaire Necker Enfants Malades Paris, France, 7501 Less <<
NCT02386020 Chronic Periodontitis Phase 2 Phase 3 Completed - -
NCT02373332 - Active, not recruiting May 2019 United States, Michigan ... More >> University of Michigan Ann Arbor, Michigan, United States, 48109 United States, Pennsylvania Thomas Jefferson University Philadelphia, Pennsylvania, United States, 19107 Less <<
NCT01300234 Hepatitis B Phase 3 Completed - China, Guangdong ... More >> GSK Investigational Site Guangzhou, Guangdong, China, 510060 GSK Investigational Site Guangzhou, Guangdong, China, 510515 GSK Investigational Site Guangzhou, Guangdong, China, 510630 China, Hubei GSK Investigational Site Wuhan, Hubei, China, 430030 China, Hunan GSK Investigational Site Changsha, Hunan, China, 410008 China, Jiangsu GSK Investigational Site Nanjing, Jiangsu, China, 210003 GSK Investigational Site Nanjing, Jiangsu, China, 210029 China, Jilin GSK Investigational Site Changchun, Jilin, China, 130021 China, Sichuan GSK Investigational Site Chengdu, Sichuan, China, 610041 China, Zhejiang GSK Investigational Site Hangzhou, Zhejiang, China, 310003 China GSK Investigational Site Beijing, China, 100015 GSK Investigational Site Beijing, China, 100044 GSK Investigational Site Beijing, China, 100050 GSK Investigational Site Chongqing, China, 400038 GSK Investigational Site Fuzhou, China, 350025 GSK Investigational Site Jinan, China, 250021 GSK Investigational Site Shanghai, China, 200001 GSK Investigational Site Shanghai, China, 200025 GSK Investigational Site Shanghai, China, 200040 GSK Investigational Site Shanghai, China, 201508 Less <<
NCT00214682 Depression De... More >>pressive Disorder Less << Phase 2 Completed - Australia, Australian Capital ... More >>Territory Australian National University Canberra, Australian Capital Territory, Australia, 0200 Less <<
NCT02388958 - Completed - United States, Tennessee ... More >> Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232-8300 Less <<
NCT02437747 Diabetes Mellitus ... More >> Chronic Periodontitis Less << Phase 4 Completed - -
NCT00976560 Depressive Disorder, Major Phase 2 Completed - United States, Illinois ... More >> GSK Investigational Site Hoffman Estates, Illinois, United States, 60169 GSK Investigational Site Park Ridge, Illinois, United States, 60068 United States, New York GSK Investigational Site New York, New York, United States, 10128 United States, Ohio GSK Investigational Site Columbus, Ohio, United States, 43210 Bulgaria GSK Investigational Site Pazardzhik, Bulgaria, 4400 GSK Investigational Site Plovdiv, Bulgaria, 4000 GSK Investigational Site Ruse, Bulgaria GSK Investigational Site Sofia, Bulgaria, 1113 Estonia GSK Investigational Site Tartu, Estonia, 50417 Germany GSK Investigational Site Huettenberg, Hessen, Germany, 35625 GSK Investigational Site Schwerin, Mecklenburg-Vorpommern, Germany, 19053 GSK Investigational Site Achim, Niedersachsen, Germany, 28832 GSK Investigational Site Westerstede, Niedersachsen, Germany, 26655 GSK Investigational Site Bielefeld, Nordrhein-Westfalen, Germany, 33647 GSK Investigational Site Dresden, Sachsen, Germany, 01097 GSK Investigational Site Berlin, Germany, 10629 Russian Federation GSK Investigational Site Moscow, Russian Federation, 107076 GSK Investigational Site Moscow, Russian Federation, 125367 GSK Investigational Site Samara, Russian Federation, 443016 GSK Investigational Site Smolensk, Russian Federation, 214 019 GSK Investigational Site St-Petersburg, Russian Federation Less <<
NCT02429232 Osteoporosis ... More >>Diabetes Mellitus Less << Phase 4 Unknown December 2017 -
NCT02449330 Diabetes Mellitus, Type 2 Phase 4 Recruiting June 2023 Japan ... More >> National Cerebral and Cardiovascular Center Recruiting Suita, Japan, 565-8565 Contact: Satoshi Yasuda, M.D.    06-6833-5012    yasuda.satoshi.hp@ncvc.go.jp Less <<
NCT02300779 Diabetes Mellitus ... More >> Colonic Diseases Less << Phase 3 Completed - Spain ... More >> Hospital Germans Trias i Pujol Badalona, Barcelona, Spain, 08916 Hospital del Mar Barcelona, Spain, 08003 Less <<
NCT02460354 Diabetes Insipidus Phase 1 Terminated(Lack of effect in i... More >>nitial subjects) Less << - United States, Georgia ... More >> Childen's Healthcare of Atlanta Atlanta, Georgia, United States, 30322 Emory University Hospital - Atlanta Clinical and Translational Science Institute (ACTSI) Atlanta, Georgia, United States, 30322 Emory University Hospital Atlanta, Georgia, United States, 30322 Less <<
NCT02378259 Obesity Diabe... More >>tes Hypertension Steatohepatitis Inflammation Less << Phase 3 Active, not recruiting June 2034 Sweden ... More >> Sahlgrenska University hospital Gothenburg, Sweden, 41345 Skåne University Hospital Malmö, Sweden Karolinska University hospital Stockholm, Sweden Less <<
NCT02268188 Cancer Survivor Not Applicable Active, not recruiting April 2019 United States, Ohio ... More >> Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center Columbus, Ohio, United States, 43210 Less <<
NCT02544347 Chronic Periodontitis ... More >> Diabetes Mellitus Less << Not Applicable Completed - -
NCT00976560 - Completed - -
NCT02573519 Diabetic Autonomic Neuropathy ... More >> Gastrointestinal Motility Disorder Diabetes Mellitus Change of Transit or Circulation Less << Not Applicable Recruiting August 2019 Denmark ... More >> Department of Hematology and Gastroenterology, Aarhus University Hospital Recruiting Aarhus, Denmark, 8000 Contact: Mette Winther Andersen    +45 22635197    meteader@rm.dk    Contact: Klaus Krogh, Professor    +45 23385937    klaukrog@rm.dk    Sub-Investigator: Anne-Mette Haase, P.hD.          Sub-Investigator: Lotte Fynne, P.hD. Less <<
NCT02588898 - Completed - Germany ... More >> University of Saarland Homburg, Saarland, Germany, 66424 Less <<
NCT02587975 Diabetes Mellitus, Type 2 ... More >> Osteoporosis Less << Phase 4 Unknown March 2017 Korea, Republic of ... More >> Dongguk University Ilsan Hospital Recruiting Goyang, Gyeonggi, Korea, Republic of, 410-773 Contact: Namyi Gu, MD, PhD    +82-31-961-8440    namyi.gu@gmail.com Less <<
NCT01300234 - Completed - -
NCT02589314 Chronic Periodontitis ... More >> Diabetes Type 2 Less << Not Applicable Active, not recruiting December 2017 Brazil ... More >> Priscilla Farias Naiff Brasilia, Distrito Federal, Brazil, 70790-123 Less <<
NCT02496390 Diabetes Mellitus ... More >> Non-alcoholic Fatty Liver Disease Less << Phase 1 Phase 2 Completed - Canada, Ontario ... More >> Michael Silverman London, Ontario, Canada, N6A 4V2 Less <<
NCT02596581 Chronic Periodontitis ... More >> Diabetes Mellitus Less << Not Applicable Completed - -
NCT02652026 Chronic Periodontitis ... More >> Type 2 Diabetes Mellitus Less << Not Applicable Completed - -
NCT02671136 Diabetes Peri... More >>odontitis Less << Not Applicable Terminated(Lack of subjects) - United States, California ... More >> Loma Linda University Loma Linda, California, United States, 92346 Less <<
NCT02490124 - Completed - United States, Virginia ... More >> University of Virginia Charlottesville, Virginia, United States, 22903 Less <<
NCT02629497 Thrombosis Ty... More >>pe 2 Diabetes Mellitus Less << Early Phase 1 Active, not recruiting May 2019 United States, Michigan ... More >> University of Michigan Ann Arbor, Michigan, United States, 48109 Less <<
NCT02765347 Diabetes Mellitus, Type 1 Phase 4 Completed - China, Guangdong ... More >> The Third Affliated Hospital of Sun Yat-sen University Guangzhou, Guangdong, China, 510630 Less <<
NCT02627534 Chronic Periodontitis ... More >> Diabetes Mellitus Less << Not Applicable Completed - Brazil ... More >> Instituto de Ciência e Tecnologia de São José dos Campos - UNESP Sâo José dos Campos, São Paulo, Brazil, 12245-000 Less <<
NCT02738671 - Recruiting May 2020 China, Jiangsu ... More >> at Division of Endocrinology, the Affiliated Drum Tower Hospital of Nanjing University Recruiting Nanjing, Jiangsu, China, 210008 Contact: Dalong Zhu, MD,PhD    86-25-83-105302    zhudldr@gmail.com    Contact: Yan Bi, MD,PhD    86-25-83-105302    biyan@nju.edu.cn    Principal Investigator: Dalong Zhu, MD,PhD          Sub-Investigator: Yan Bi, MD,PhD Less <<
NCT02787785 Tachycardia D... More >>iabetes Mellitus Cardiovascular Disease Less << Not Applicable Active, not recruiting March 2022 -
NCT02786979 Type 2 Diabetes Mellitus Phase 4 Terminated(Upon interim analys... More >>is, sponsor's decision due to absence of demonstration of efficacy.) Less << - China, Beijing ... More >> Site CN00001 Beijing, Beijing, China Site CN00002 Beijing, Beijing, China China, Guangdong Site CN00004 Guangzhou, Guangdong, China China, Shanghai Site CN00003 Shanghai, Shanghai, China China, Sichuan Site CN00005 Chengdu, Sichuan, China China, Tianjin Site CN00006 Tianjin, Tianjin, China Less <<
NCT02702375 - Unknown September 2018 Canada, Ontario ... More >> The Toronto 3D (Diet, Digestive tract and Disease) Knowledge Synthesis and Clinical Trials Unit, Clinical Nutrition and Risk Factor Modification Centre, St. Micheal's Hospital Toronto, Ontario, Canada, M5C 2T2 Less <<
NCT02800252 Diabetes Mellitus ... More >> Chronic Periodontitis Less << Not Applicable Unknown December 2018 Brazil ... More >> UNESP Recruiting São José dos Campos, SP, Brazil, 12245-000 Contact: Nidia C Santos, MS    5512991021346    nidia.santos@ict.unesp.br    Contact: Mauro P Santamaria, PhD    551239479379    mauro.santamaria@ict.unesp.br    Sub-Investigator: Cássia F Araujo, DDS          Principal Investigator: Nídia C Santos, MS          Principal Investigator: Mauro P Santamaria, PhD Less <<
NCT02775266 Diabetes Mellitus ... More >> Periodontitis Less << Not Applicable Completed - India ... More >> Mohans Diabetic Centre Hyderabad, Telangana, India, 500029 Less <<
NCT02768987 Diabetes Mellitus, Type 1 Not Applicable Completed - United States, Connecticut ... More >> Yale Children's Diabetes Program New Haven, Connecticut, United States, 06511 Less <<
NCT02851745 Diabetes Mellitus, Type 2 ... More >> Left Ventricular Systolic Dysfunction Less << Phase 3 Active, not recruiting April 2019 Italy ... More >> Azienda Ospedaliera Papa Giovanni Xxiii Bergamo, BG, Italy, 24127 P.O. Garibaldi-Nesima Catania, CT, Italy, 95122 Ospedale Casa Sollievo Della Sofferenza San Giovanni Rotondo, FG, Italy, 71013 Ospedale Villa Scassi Genova, GE, Italy, 16149 Iclas-Istituto Clinico Ligure Alta Spec. Rapallo, GE, Italy, 16035 Ospedale San Giuseppe Da Copertino Copertino, LE, Italy, 73043 Ospedale San Raffaele Milano, Lombardia, Italy, 20010 Policlinico G. Martino Messina, ME, Italy, 98124 Irccs Policlinico Multimedica Sesto San Giovanni, MI, Italy, 20099 A.O. Santa Croce e Carle Cuneo, Piemonte, Italy, 12100 Ospedale Sandro Pertini Roma, RM, Italy, 00157 Ospedale Maggiore Chieri, TO, Italy, 10023 Ospedale Mauriziano Torino, TO, Italy, 10128 Azienda Ospedaliera Santa Maria Terni, TR, Italy, 05100 Aas 1 Triestina Trieste, TS, Italy, 34148 Centro Cardiologico Monzino Milano, Italy, 20138 Aorn Osp. Dei Colli- Po Vincenzo Monaldi Napoli, Italy, 80131 Seconda Universita' Di Napoli Napoli, Italy, 80131 Casa di Cura Villa Bianca Trento, Italy, 38100 Less <<
NCT02817152 Chronic Periodontitis ... More >> Diabetes Mellitus Less << Not Applicable Completed - -
NCT02225028 Spinal Cord Injury Not Applicable Completed - United States, Washington ... More >> Harborview Medical Center Seattle, Washington, United States, 98104 University of Washington Medical Center Seattle, Washington, United States, 98195 Less <<
NCT02863523 Type 2 Diabetes Mellitus ... More >> Diabetes-related Distress Depression Less << Not Applicable Unknown February 2017 United States, North Carolina ... More >> East Carolina University Greenville, North Carolina, United States, 27834 Less <<
NCT02874963 Periodontitis ... More >> Type 2 Diabetes Mellitus Less << Not Applicable Unknown October 2016 Kosovo ... More >> Oral Surgery, Dental Polyclinic (HUCSK) Recruiting Peja, Kosovo, 10000 Contact: Sheribane Anadolli, Dr    +38139433-291    qshm_peja@hotmail.com    Principal Investigator: Dashnor Bukleta, Dr Less <<
NCT03065322 - Recruiting January 11, 2020 United Kingdom ... More >> University Hospitals Coventry & Warwickshire NHS Trust Recruiting Coventry, West Midlands, United Kingdom, CV2 2DX Contact: Hassan Kahal Less <<
NCT01762761 Purpura, Thrombocytopenic, Idi... More >>opathic and Hepatitis C Less << Phase 3 Active, not recruiting November 15, 2018 China, Fujian ... More >> Novartis Investigative Site Fuzhou, Fujian, China, 350001 China, Guangdong Novartis Investigative Site Guangzhou, Guangdong, China, 510080 Novartis Investigative Site Guangzhou, Guangdong, China, 510515 Novartis Investigative Site Zhongshan, Guangdong, China, 528403 China, Hunan Novartis Investigative Site Changsha, Hunan, China, 410013 China, Jiangsu Novartis Investigative Site Nanjing, Jiangsu, China, 210029 China, Jiangxi Novartis Investigative Site Nanchang, Jiangxi, China, 330006 China, Shandong Novartis Investigative Site Jianan, Shandong, China, 250012 China, Zhejiang Novartis Investigative Site Hangzhou, Zhejiang, China, 310003 China Novartis Investigative Site Beijing, China, 100034 Novartis Investigative Site Beijing, China, 100044 Novartis Investigative Site Beijing, China, 100083 Novartis Investigative Site Beijing, China, 100730 Novartis Investigative Site Chengdu, China, 610041 Novartis Investigative Site Jiang Su Province, China, 215006 Novartis Investigative Site Shanghai, China, 200025 Novartis Investigative Site Shanghai, China Novartis Investigative Site Tianjin, China, 300020 Less <<
NCT02949739 Type 2 Diabetes Phase 2 Phase 3 Recruiting December 2019 United Kingdom ... More >> Imperial College London Recruiting London, United Kingdom, W2 1PG Contact: John Chambers, PhD       john.chambers@imperial.ac.uk    Contact: Ninha Silva, MSc    020 7594 1530    ninha.silva@imperial.ac.uk Less <<
NCT02985099 Chronic Periodontitis ... More >> Type2 Diabetes Less << Phase 2 Phase 3 Completed - India ... More >> Government Dental College and Research Institute Bangalore, Karnataka, India, 560002 Less <<
NCT02967653 Lithium Use, Nephrogenic Diabe... More >>tes Insipidus Less << Phase 2 Recruiting January 2020 Canada, Quebec ... More >> McGill University Health Centre Not yet recruiting Montréal, Quebec, Canada, H3A1A1 Contact: Jocelyn Fotso Soh, MSc    514-340-8222 ext 25205    jfs702@mun.ca    Principal Investigator: Pablo Cervantes, MD          Jewish General Hospital Not yet recruiting Montréal, Quebec, Canada, H3T1E4 Contact: Jocelyn Fotso Soh, MSc    514-340-8222 ext 25025    jfs702@mun.ca    Principal Investigator: Soham Rej, MD, MSc          Douglas Mental Health University Institute Recruiting Montréal, Quebec, Canada, H4H1R3 Contact: Soham Rej, MD, MSc    514-340-8222 ext 25205    soham.rej@gmail.mcgill.ca    Contact: Jocelyn Fotso Soh, MSc    5147156942    jfs702@mun.ca    Principal Investigator: Soham Rej, MD, MSc Less <<
NCT01762761 - Active, not recruiting - -
NCT02964715 Type2 Diabetes ... More >> NAFLD Less << Phase 4 Recruiting November 2018 Malaysia ... More >> University of Malaya Recruiting Kuala Lumpur, Wilayah Persekutuan, Malaysia Contact: Shireene R Vethakkan, MD    0162093355    shireene.vethakkan@gmail.com    Sub-Investigator: Wah K Chan, MRCP Less <<
NCT01163851 - Completed - -
NCT02895113 Diabetes Phase 3 Unknown September 2018 Italy ... More >> Internal and Medical Specialities Department - Policlinico Umberto I Rome, Italy, 00161 Less <<
NCT03010241 Type 2 Diabetes Mellitus Early Phase 1 Not yet recruiting May 2020 -
NCT01163851 Hypercholesterolemia ... More >> Dyslipidemia Less << Phase 1 Completed - United States, Arizona ... More >> Premier Research Group, Limited Peoria, Arizona, United States, 85381 Dedicated Phase 1, Inc. Phoenix, Arizona, United States, 85013 Premier Research Group Limited Phoenix, Arizona, United States, 85027 United States, Kansas Vince and Associates Clinical Research Overland Park, Kansas, United States, 66211 Vince and Associates Clinical Research Overland Park, Kansas, United States, 66212 Less <<
NCT03574103 Overweight and Obesity Not Applicable Recruiting November 2020 Brazil ... More >> Hospital da Clínicas Recruiting Belo Horizonte, MG, Brazil, 30130-100 Contact: Adaliene VM Ferreira, PhD    +553134093680    adaliene@gmail.com    Hospital das Clínicas Recruiting Belo Horizonte, Minas Gerais, Brazil, 30130-100 Contact: Adaliene VM Ferreira, PhD    +553134093680    adaliene@gmail.com Less <<
NCT01890473 - Completed - -
NCT03055468 Diabetes Mellitus ... More >> Depression Less << Not Applicable Not yet recruiting March 30, 2018 -
NCT01890473 Rheumatoid Arthritis Phase 1 Completed - -
NCT03031834 Diabetic Autonomic Neuropathy Phase 4 Completed - -
NCT03132129 - Recruiting June 2022 United Kingdom ... More >> University of Leicester Recruiting Leicester, United Kingdom Contact: Gaurav S Gulsin, MRCP(UK) Less <<
NCT03099837 - Active, not recruiting January 10, 2023 -
NCT03103009 Hyperinsulinemic Hypoglycemia ... More >> Post Gastrointestinal Tract Surgery Hypoglycaemia Less << Phase 1 Recruiting March 22, 2019 United States, Colorado ... More >> University of Colorado Denver Recruiting Aurora, Colorado, United States, 80045 Less <<
NCT03254446 Diabetes Dysl... More >>ipidemias Hypertension Less << Phase 3 Recruiting August 2020 Brazil ... More >> Comitê de ética em Pesquisa do Hospital Pró Cardíaco Recruiting Rio De Janeiro, Botafogo, Brazil, 22270-005 Contact: Luis Augusto Russo, MD PhD, MBA    55 21 99988 0336       Contact: Joselita S Bodart, MD, Physian    55 21 986961073       Avenida Angélica Recruiting São Paulo, CEP, Brazil, 01228-200 Contact: Freddy G Eliaschewitz, Endocrino    55 11 27110298    freddy.g@uol.com.br    Contact: Denise R Franco, Endocrino    55 11 27110298    d9franco@gmail.com    Rua Silva Jardim Recruiting São Bernardo Do Campo, SP, Brazil, 09715-090 - Contact: Claudia M de Brito, MD, Physian    55 11 95369-9341       Contact: Andrea S Audi, MD, Physian    55 11 95369-9341       India BAPS Pramukh Swami Hospital, Recruiting Sūrat, Gujarat, India, 395009 Contact: Dr. Parshottam Koradia, MBBS, MD    9825312027    purushottam_koradia@yahoo.co.in    Contact: Dr. Anand Modi, DNB    9825312027    purushottam_koradia@yahoo.co.in    Bangalore Diabetes Centre, No. 426, 4th Cross, 2nd block, kalyan nagar, Recruiting Bangalore, Karnataka, India, 560043 Contact: Paramesh Shamanna, MBBS, MD    9845010610    drparamesh2@gmail.com    Contact: Dr. Ambrish Chandrappa, MBBS, MD    9845895911    ambidrcool@gmail.com    Government Medical College, Government Medical College Campus, Recruiting Calicut, Kerala, India, 673008 Contact: Neeraj Manikath, MBBS, DNB    9447391055    nmanikath@gmail.com    Contact: Dr.Chyandni R., MBBS,MD,PHD          Lisie Hospital Recruiting Kochi, Kerala, India, 682017 Contact: Paulose George, MBBS, MD    9895021667    geepee44@yahoo.com    Contact: Jabir Abdullakutty, MBBS, DM    9447011773    drjabi@yahoo.co.in    Indian Institute of Diabetes Recruiting Thiruvananthapuram, Kerala, India, 695031 Contact: Jabbar P, MBBS, MD    0471-2559388    iidtvm@yahoo.com    Contact: Abhilash Nair, MBBS,MD    9495378383    abhimck@gmail.com    Supe Heart and Diabetes Hospital and Research Centre, Recruiting Nashik, Maharashtra, India, 422002 Contact: PRAVIN SUPE, M.D.    +91-253-2232487    pravinsupe@ymail.com    Contact: ANUPAMA SUPE, M.B.B.S    +91-253-2232487    pravinsupe@ymail.com    Medipoint Hospitals Pvt. Ltd Recruiting Pune, Maharashtra, India, 411007, Contact: Girish Bhatia, MD    +917387003636    drbhatia.pentagon@gmail.com    Contact: Shailaja G Bhatia, MBBS,MD    +919527016688       Ashirwad Hospital & Research Centre Recruiting Ulhasnagar, Maharashtra, India, 421004 Contact: Shrikant Deshpande, MBBS, MD    9822017445    writetoshrikant@rediffmail.com    Contact: R. M. Mundada, MBBS,MD    9822676212    drrm03@gmail.com    Dayanand Medical College & Hospital Recruiting Ludhiana, Punjab, India, 141001 Contact: Parminder Singh, MBBS, MD, DM    9814077536    pam.endo@yahoo.co.in;    Contact: damandeep P Kaur    9814066999       S.R Kalla Memorial Gastro and General Hospital Recruiting Jaipur, Rajasthan, India, 302001 Contact: Dr. Nikhil Parikh, MBBS,MD,DM    9829054944    drnikhilpareek@gmail.com    Contact: Dr. Rajiv Tiwari, MBBS, MD    +91-141-5112042    drrajeevtiwari@rediffmail.com    Diabetes ,Thyroid and Endocrine Centre Recruiting Jaipur, Rajasthan, India, 302006 Contact: Surendra K Sharma, MBBS.MD,DM    9829010233    sksharmacr@gmail.com    Contact: Sheela Sharma, MBBS.MD    +91 1412451946    sheelasharmacr2016@gmail.com    Apollo Hospitals, PR No. 3-5-836 to 838, Near Old MLA Quarters, Recruiting Hyderabad, Telangana, India, 500029 Contact: Harikishan Boorugu, M.B.B.S.M.D.    9642767757    drharikishan@gmail.com    Contact: Dr.Arshad Pujani, M.B.B.S.    9866081267    arpunjani@gmail.com    Philippines De La Salle Heath Sciences Institute Recruiting Dasmariñas, Cavite, Philippines, 4114 Contact: Dr. Olivia P Roderos, Endocrlogist       oliveproderos@gmail.com    Contact: Wendy Cudiamat       wcudiamat74@gmail.com    Angeles University Foundation Medical Center Recruiting Angeles City, Pampanga, Philippines, 2009 Contact: Dr. Gabriel Jocson, Cardiologist       jocsongabriel@gmail.com    Contact: Rose A Barranda, Coordinator       roseann.barranda@yahoo.com    St. Paul's Hospital Recruiting General Luna, Saint Iloilo City, Philippines, 5000 Contact: Ygpuara M Lallaine, Int.Med          Contact: Dr. Efren E Jr, Int.Med       efrenestocejr@yahoo.com    Davao Doctors Hospital Recruiting Davao City, Philippines, 8000 Contact: Aquitania Grace, Int.Med          Contact: Emily R Doliente, Int.Med Less <<
NCT03062475 Gestational Diabetes Mellitus ... More >>(GDM) Less << Not Applicable Not yet recruiting December 31, 2019 -
NCT03269799 Diabetes Mellitus Type 2 With ... More >>Hyperglycemia Periodontitis Less << Phase 2 Recruiting August 19, 2018 Thailand ... More >> Burapha University Hospital Recruiting Chon Buri, Thailand, 20130 Contact: Piyapat Kunsongkeit, DDS    +66870491014    pkunsongkeit@gmail.com    Contact: Pechngam Chaivanit, MD    +6638386554 Less <<
NCT02210091 Hemophilia A Phase 3 Completed - -
NCT03294044 Hypertension ... More >>Dyslipidemias Diabetes Mellitus Less << Not Applicable Completed - Korea, Republic of ... More >> Seoul National University Seoul, Korea, Republic of Less <<
NCT02210091 - Completed - -
NCT03339336 Small Fibre Neuropathy ... More >> Diabetes Mellitus Less << Phase 2 Recruiting August 27, 2020 -
NCT03371940 Type2 Diabetes ... More >> Depression Less << Not Applicable Completed - United States, Indiana ... More >> Indiana University Indianapolis, Indiana, United States, 46202 United States, Ohio Ohio University Athens, Ohio, United States, 45701 United States, West Virginia West Virginia University Morgantown, West Virginia, United States, 26506 Less <<
NCT03288623 Oxidative Stress ... More >> Athletes Heart Physical Activity Less << Not Applicable Recruiting December 2018 Italy ... More >> Sapienza University of Rome, Policlinico Umberto I Recruiting Rome, Italy, 00161 Contact: Elena Cavarretta, MD, PhD    +390649973154    elena.cavarretta@uniroma1.it    Principal Investigator: Elena Cavarretta, MD, PhD          Principal Investigator: Giacomo Frati, MD          Principal Investigator: Roberto Carnevale, PhD          Sub-Investigator: Riccardo Del Vescovo, MD, PhD          Sub-Investigator: Sebastiano Sciarretta, MD, PhD          Sub-Investigator: Giuseppe Biondi-Zoccai, MD          Sub-Investigator: Mariangela Peruzzi, MD, PhD          Sub-Investigator: Andrea Serdoz, MD          Sub-Investigator: Roberto Ferrara, MD Less <<
NCT03217409 Diabetes Mellitus and Hypercho... More >>lesterolemia Less << Phase 4 Recruiting July 2018 Korea, Republic of ... More >> Soon Chun Hyang University Hospital Cheonan Recruiting Cheonan, Korea, Republic of Soon Chun Hyang University Hospital Gumi Recruiting Gumi, Korea, Republic of Soon Chun Hyang University Hospital Bucheon Recruiting Gyeonggi-do, Korea, Republic of Soon Chun Hyang University Hospital Seoul Recruiting Seoul, Korea, Republic of Less <<
NCT03582709 - Enrolling by invitation December 31, 2026 -
NCT02807324 - Recruiting June 2022 Netherlands ... More >> Maastricht University Medical Center (MUMC+) Recruiting Maastricht, Netherlands, 6202 AZ Contact: Jolien Oben, Msc    043 - 38774145 ext 0031    jolien.oben@mumc.nl    Contact: Marc Spaanderman, MD, PhD    043 - 38774774 ext 0031    marc.spaanderman@mumc.nl Less <<
NCT03446261 Type 2 Diabetes Mellitus ... More >> Hypercholesterolemia Less << Phase 4 Not yet recruiting April 2019 Korea, Republic of ... More >> Asan Medical Center Not yet recruiting Seoul, Korea, Republic of Inje University Sanggye Paik Hospital Not yet recruiting Seoul, Korea, Republic of Kangbuk Samsung Hospital Not yet recruiting Seoul, Korea, Republic of Konkuk University Medical Center Not yet recruiting Seoul, Korea, Republic of Kyung Hee University Hospital at Gangdong Not yet recruiting Seoul, Korea, Republic of Less <<
NCT03452085 Xerostomia Due to Hyposecretio... More >>n of Salivary Gland Diabetes Mellitus, Type 2 Less << Not Applicable Completed - Italy ... More >> Irwin Labs, University of Chieti Chieti, PE, Italy, 65010 Less <<
NCT03413215 Diabetes Mellitus, Type 2 ... More >> Diabetic Nephropathy Hypertension Less << Not Applicable Not yet recruiting December 31, 2022 -
NCT03490253 Diabetes Depr... More >>ession Physical Activity Less << Not Applicable Not yet recruiting September 2020 -
NCT03374176 Periodontitis ... More >> Periodontal Pocket Diabetes Mellitus Less << Phase 3 Completed - -
NCT03457818 Diabetes Mellitus, Type 2 ... More >> Osteoporosis Less << Phase 2 Recruiting August 2021 United States, New York ... More >> Columbia University Medical Center - Harkness Pavillion Recruiting New York, New York, United States, 10032 Contact: Rukshana Majeed Clinical Research Coordinator    212-305-9489    rm3324@columbia.edu    Contact: Beatriz Omeragic Clinical Research Coordinator    212-305-7364    bo2248@columbia.edu    Principal Investigator: Mishaela Rubin, M.D.          Sub-Investigator: Jessica Starr, M.D. Less <<
NCT03664414 Chronic Kidney Disease stage3 ... More >>and 4 Type 2 Diabetes Mellitus Less << Phase 4 Recruiting December 31, 2021 Mexico ... More >> Cibimi - Hgz 83 Imss Recruiting Morelia, Michoacán, Mexico, 58290 Contact: Oliva Mejía - Rodríguez, PhD    01 4431853008    oliva.mejia@imss.gob.mx Less <<
NCT00256750 Kidney Transplantation ... More >> Chronic Kidney Failure Less << Phase 3 Completed - -
NCT03741153 - Not yet recruiting March 14, 2021 -
NCT03742219 Cardiovascular Diseases ... More >> Diabetes Mellitus Hypertension Dyslipidemias Overweight and Obesity Less << Not Applicable Recruiting June 30, 2027 United States, Ohio ... More >> Ohio University Recruiting Athens, Ohio, United States, 45701 Contact: David S Drozek, DO    678-447-2509    drozek@ohio.edu    Principal Investigator: David S Drozek, DO Less <<
NCT03745300 Chronic Periodontitis Wth Diab... More >>etes Mellitus Less << Phase 2 Phase 3 Completed - India ... More >> Department of Periodontics, GDCRI Bangalore Bangalore, Karnataka, India, 560002 Less <<
NCT03704389 Prostate Specific Antigen ... More >> Asymptomatic Bacteriuria Type 2 Diabetes Mellitus Less << Not Applicable Not yet recruiting September 2019 -
NCT01842607 Asthma Phase 3 Completed - -
NCT03768518 - Recruiting February 1, 2019 Netherlands ... More >> Radboudumc Recruiting Nijmegen, Netherlands, 6500HB Contact: Marti Boss    +31243667243    marti.boss@radboudumc.nl Less <<
NCT03701087 Vitamin D Intake in First Trim... More >>ester and Incidence of Gestational Diabetes Recurrence Less << Early Phase 1 Recruiting April 2, 2020 Egypt ... More >> Kasr El Ainy Recruiting Cairo, Egypt, 02 Contact: mohamed saad, lecturer    01244336666    msaad@scimitar.com Less <<
NCT03765385 Aged Not Applicable Not yet recruiting June 2020 -
NCT01842607 - Completed - -
NCT00256750 - Completed - -
NCT01337895 Obesity Overw... More >>eight Less << Phase 4 Withdrawn(Grant not funded, st... More >>udy will not launch) Less << December 2014 Canada, Ontario ... More >> Body Composition and Metabolism Lab, University of Guelph Guelph, Ontario, Canada, N1G 2W1 Less <<
NCT03754608 Small Vessel Disease of Diabet... More >>es Mellitus Less << Not Applicable Recruiting September 1, 2020 United States, Connecticut ... More >> Yale University School of Medicine Recruiting New Haven, Connecticut, United States, 06510 Contact: Arash Salardini, MD    203-785-4085    arash.salardini@yale.edu    Contact: Emily Laltoo, BS    703-398-8833    emily.laltoo@yale.edu Less <<
NCT02392741 Obesity Pregn... More >>ancy Less << Not Applicable Unknown March 2017 -
NCT02552888 Chronic Kidney Disease Phase 2 Completed - United States, Louisiana ... More >> Tulane School of Medicine New Orleans, Louisiana, United States, 70112 Less <<
NCT00831194 Obesity Type ... More >>2 Diabetes Less << Not Applicable Completed - United States, Maryland ... More >> Johns Hopkins Bloomberg School of Public Health Baltimore, Maryland, United States, 21205 Less <<
NCT02210000 Gastroparesis Phase 2 Completed - -
NCT00569803 - Completed - -
NCT00839150 - Completed - France ... More >> Hopital Lariboisiere Paris, France, 75010 Less <<
NCT00569803 Transplantation Phase 1 Completed - United States, Texas ... More >> Ppd Development Austin, Texas, United States, 78744 Less <<
NCT03412006 Diabetic Kidney Disease Phase 2 Recruiting September 23, 2019 Bulgaria ... More >> Med Centre Diamedical 2013 Recruiting Dimitrovgrad, Bulgaria, 6400 MCOMH Preventsia-2000 Recruiting Stara Zagora, Bulgaria, 6000 Med. Center Equita Recruiting Varna, Bulgaria, 9000 Denmark Rigshospitalet Copenhagen Recruiting Copenhagen, Denmark, 2100 Steno Diabetes Center Recruiting Gentofte, Denmark, 2820 Nordsjællands Hospital Recruiting Hillerød, Denmark, 3400 Finland Terveystalo Oulu Recruiting Oulu, Finland, FI-90100 TAYS TKI Keskus Tutkimusvastaanotto Recruiting Tampere, Finland, 33520 Turun yliopistollinen keskussairaala, kantasairaala Recruiting Turku, Finland, FIN-20520 Israel Barzilai Medical Center Recruiting Ashkelon, Israel, 7827804 Edith Wolfson Medical Center Recruiting Holon, Israel, 58100 Hadassah Hebrew University Hospital Ein Kerem Recruiting Jerusalem, Israel, 9112001 The Nazareth Trust Hospital EMMS Recruiting Nazareth, Israel, 16100 DMC - Diabetes Medical Center Recruiting Tel Aviv, Israel, 6937947 Assaf Harofeh Medical Center Recruiting Zerifin, Israel, 6093000 Italy A.O.U. Policlinico Federico II Napoli Not yet recruiting Napoli, Campania, Italy, 80131 IRCCS Casa Sollievo della Sofferenza Recruiting Foggia, Puglia, Italy, 71013 A.O. di Padova Recruiting Padova, Veneto, Italy, 35128 Spain Complexo Hospitalario Universitario de Ferrol Recruiting Ferrol, A Coruña, Spain, 15405 Hospital de Galdakao Recruiting Galdakao, Vizcaya, Spain, 48960 Hospital Fundació Puigvert Recruiting Barcelona, Spain, 08025 Sweden Centralsjukhuset Kristianstad Recruiting Kristianstad, Sweden, 29185 Akardo MedSite AB Recruiting Stockholm, Sweden, 114 46 S3 Clinical Research Centers Recruiting Vällingby, Sweden, 162 68 Universitetssjukhuset Örebro Recruiting Örebro, Sweden, 701 85 Less <<
NCT03321227 Nutrition Cog... More >>nitive Performance Appetite Less << Not Applicable Recruiting December 1, 2018 Canada, Ontario ... More >> School of Nutrition, Ryerson University Recruiting Toronto, Ontario, Canada, M5B 2K3 Contact: Nick Bellissimo, PhD    416 979 5000 ext 3026    nick.bellissimo@ryerson.ca    Principal Investigator: Nick Bellissimo, PhD Less <<
NCT00889226 Hypercholesterolemia With Type... More >>2DM Less << Phase 4 Completed - -
NCT01898286 - Terminated(A corporate decisio... More >>n to suspend development of DiaPep277®) Less << - -
NCT00939250 Type 2 Diabetes ... More >> Major Depressive Disorder Less << Phase 4 Completed - United States, Texas ... More >> Family and Community Medicine Clinic, University of Texas Southwestern Medical Center Dallas, Texas, United States, 75390 Less <<
NCT02008968 Hyperuricemia ... More >> Prediabetes Insulin Resistance Less << Not Applicable Unknown August 2014 Turkey ... More >> Istanbul Medeniyet University Goztepe Training and Research Hospital Recruiting Istanbul, Marmara, Turkey, 34353 Contact: Mehmet Kanbay, Associate Professor    +902165709294    drkanbay@yahoo.com    Principal Investigator: Mehmet Kanbay Less <<
NCT02008851 Chronic Kidney Disease Phase 1 Terminated(Lack of funding) - United States, Illinois ... More >> University of Chicago Medicine Chicago, Illinois, United States, 60637 United States, Louisiana LSU Health Care Services New Orleans, Louisiana, United States, 70112 United States, Massachusetts Brigham & Women's Hospital Boston, Massachusetts, United States, 02120 United States, North Carolina UNC Medical Center Chapel Hill, North Carolina, United States, 27514 United States, Tennessee Vanderbilt University Nashville, Tennessee, United States, 37235 Less <<
NCT00976729 Chronic Inflammatory Diseases ... More >> Type 2 Diabetes Mellitus Systemic Lupus Erythematosus Less << Phase 1 Completed - -
NCT01898286 Type 1 Diabetes Phase 3 Terminated(A corporate decisio... More >>n to suspend development of DiaPep277®) Less << - United States, Georgia ... More >> Atlanta Diabetes associates Atlanta, Georgia, United States, 30318 United States, Michigan Henry Ford Medical Centers - New Center One Detroit, Michigan, United States, 48202 United States, North Carolina Mountain Diabetes and Endocrine Center Asheville, North Carolina, United States, 28803 Less <<
NCT03537365 Growth Necrot... More >>izing Enterocolitis Late-Onset Sepsis Feeding Intolerance Less << Not Applicable Recruiting December 1, 2022 Denmark ... More >> Aarhus University Hospital Recruiting Aarhus, Denmark, 8200 Contact: Bente Hoest, MD       benthoes@rm.dk    Rigshospitalet (RH) Recruiting Copenhagen, Denmark, 2100 Contact: Lise Aunsholt, MD.,PhD       lise.aunsholt@regionh.dk    Herlev Hospital Recruiting Herlev, Denmark, 2730 Contact: Bo Moelholm Hansen, MD., PhD       bo.moelholm.hansen.01@regionh.dk    North Zealand Hospital Not yet recruiting Hillerød, Denmark, 3400 Contact: Mia Bjerager, MD       mia.bjerager@regionh.dk    Hvidovre Hospital (HH) Recruiting Hvidovre, Denmark, 2650 Contact: Heidi Smedegaard, MD       heidi.smedegaard@regionh.dk    Kolding Hospital Recruiting Kolding, Denmark, 6000 Contact: Anja Klamer, MD       anja.klamer@rsyd.dk    Odense University Hospital Recruiting Odense, Denmark, 5000 Contact: Gitte Zachariassen, MD., PhD    +45 21 36 04 26    Gitte.Zachariassen@rsyd.dk    Principal Investigator: Gitte Zachariassen, MD., PhD Less <<
NCT01465867 Pregnancy Inf... More >>ertility Auto-immune Thyroiditis Less << Not Applicable Completed - Italy ... More >> Azienda ospedaliero-universitaria Careggi Florence, Italy, 50134 Istituto Auxologico Italiano Milan, Italy, 20095 Ospedale Maggiore Policlinico Milan, Italy, 20122 University Federico II Naples, Italy, 80131 University "Piemonte Orientale, A. Avogadro" Novara, Italy, 28100 Torvergata University of Rome - Ospedale S. Eugenio Rome, Italy, 00145 European Hospital Rome, Italy, 00148 Ospedale S. Giovanni Calibita Fatebenefratelli Rome, Italy, 00153 Department of Experimental Medicine, "Sapienza" University of Rome Rome, Italy, 00161 Department of Gynecological/Obstetric/Urological Sciences, "Sapienza" University of Rome Rome, Italy, 00161 Dpt of Experimental Medicine Rome, Italy, 00161 Less <<
NCT00987168 Congenital Hyperinsulinism Phase 2 Completed - France ... More >> Necker Hospital Paris, France, 75015 Less <<
NCT00943059 Diabetes Mellitus, Type 2 ... More >> Cardiomyopathy, Dilated Less << Not Applicable Completed - Netherlands ... More >> Maastricht University Medical Centre Maastricht, Netherlands, 6200MD Less <<
NCT02105103 Type 2 Diabetes, Type 1 Diabet... More >>es Less << Not Applicable Completed - Austria ... More >> Graz, Austria, 8036 Vienna, Austria, 1130 United Kingdom Birmingham, United Kingdom, B15 2WB Birmingham, United Kingdom, B9 SSS Blackburn, United Kingdom, BB23HH Leicester, United Kingdom, LE15WW Middlesborough, United Kingdom, TS4 3BW Stafford, United Kingdom, ST16 2ST Less <<
NCT02088190 - Recruiting April 2019 United States, Ohio ... More >> The Ohio State University Recruiting Columbus, Ohio, United States, 43210 Principal Investigator: David Bradley, MD, MS Less <<
NCT01469884 Renal Allograft ... More >> Hepatitis C Less << Phase 4 Completed - Brazil ... More >> Irmandade Da Santa Casa de Misericórdia de Porto Alegre Porto Alegre, Rio Grande Do Sul, Brazil, 90020090 Less <<
NCT03654105 Inflammation ... More >>Smoking Cessation Diet Modification Physical Activity Lung Cancer Less << Phase 2 Not yet recruiting October 2020 Italy ... More >> Fondazione IRCCS Istituto Nazionale dei Tumori Milan, Italy, 20133 Less <<
NCT02120794 - Completed - -
NCT02120794 Type 1 Diabetes Not Applicable Completed - United States, California ... More >> Children's Hospital Los Angeles Los Angeles, California, United States, 90027 Children's Hospital of Orange County Orange, California, United States, 92868 Sutter Institute for Medical Research Excellence in Diabetes and Endocrinology Sacramento, California, United States, 95821 Madison Clinic for Pediatric Diabetes at UCSF San Francisco, California, United States, 94158 Stanford University Stanford, California, United States, 94305 SoCal Diabetes Torrance, California, United States, 90505 United States, Colorado University of Colorado Health Science Center, Barbara Davis Center for Childhood Diabetes Aurora, Colorado, United States, 80045 United States, Connecticut Yale University School of Medicine New Haven, Connecticut, United States, 06519 United States, Florida Nemours Children's Health System Jacksonville, Florida, United States, 32207 United States, Minnesota Park Nicollet Clinic - International Diabetes Center Minneapolis, Minnesota, United States, 55416 University of Minnesota Pediatric Endocrinology Clinic Minneapolis, Minnesota, United States, 55454 Children's Hospital and Clinics of Minnesota Saint Paul, Minnesota, United States, 55102 United States, Nevada The Pediatric and Endocrine Diabetes Specialists Las Vegas, Nevada, United States, 89148 United States, New York Stony Brook Children's Hospital East Setauket, New York, United States, 11733 United States, Pennsylvania Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 United States, Texas Texas Children Hospital/Baylor College of Medicine Houston, Texas, United States, 77030 Less <<
NCT02184676 Type 1 Diabetes Not Applicable Recruiting February 2020 France ... More >> Cochin Hospital Recruiting Paris, France, 75014 Contact: Roberto Mallone, MD PhD    + 33 1 76 53 55 83    roberto.mallone@inserm.fr Less <<
NCT02137174 Diabetes Type 1 Phase 2 Phase 3 Completed - Israel ... More >> Pediatric Endocrinology Unit, Soroka Medical Center Beer Sheva, Israel, 84101 Less <<
NCT01098253 Type 2 Diabetes Mellitus ... More >> Depression Less << Not Applicable Completed - United States, Pennsylvania ... More >> University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT01098994 Type 1 Diabetes ... More >> Heart Disease Less << Not Applicable Completed - United States, Pennsylvania ... More >> University of Pittsburgh Diabetes and Lipid Research Clinic Pittsburgh, Pennsylvania, United States, 15213 Less <<
NCT01040104 - Completed - Austria ... More >> Division of Plastic and Reconstructive Surgery, Department of Surgery, Medical University of Vienna Vienna, Austria, 1090 Less <<
NCT01098253 - Completed - -
NCT01125150 - Completed - United States, Michigan ... More >> Department of Dermatology, NEW CENTER ONE Detroit, Michigan, United States, 48202 Less <<
NCT02248454 Type 1 Diabetes Not Applicable Completed - -
NCT01099956 - Completed - France ... More >> Children Hospital, Endocrinology Unit Bordeaux, France, 33076 Less <<
NCT01108978 Type 2 Diabetes Mellitus ... More >> Cardiovascular Disease Hypercholesterolemia Less << Phase 4 Terminated - Taiwan ... More >> Nang Kuang Pharmaceutical Co., LTD Tainan, Xinhua Township, Taiwan, 712 Less <<
NCT01789970 Low Back Pain Phase 3 Completed - -
NCT02457858 Type 1 Diabetes Phase 1 Completed - Canada, Alberta ... More >> University of Alberta Edmonton, Alberta, Canada, T6G 2C8 Less <<
NCT02442544 Type 1 Diabetes Early Phase 1 Active, not recruiting June 2018 Canada, Alberta ... More >> Alberta Children's Hospital Calgary, Alberta, Canada Less <<
NCT01215994 - Unknown March 2016 Greece ... More >> AHEPA University Hospital of Thessaloniki Recruiting Thessaloniki, Greece, 54636 Sub-Investigator: Alexandra Ntemka, MD          Principal Investigator: Fotios Iliadis, PhD, MD Less <<
NCT01789970 - Completed - -
NCT01274715 - Completed - -
NCT01274715 Diabetes Depr... More >>ession Less << Not Applicable Completed - United States, Texas ... More >> MEDVAMC Houston, Texas, United States, 77030 Less <<
NCT03272230 Apathy Fronto... More >>temporal Dementia Parkinson Disease Depressive Symptoms Less << Not Applicable Recruiting July 31, 2019 France ... More >> ICM / Pitié-Salpêtrière Hospital AP-HP / CIC Recruiting Paris, France, 75013 Contact: Armelle Ramettilacroux, Master       armelle.ramettilacroux@icm-institute.org Less <<
NCT01306110 - Completed - France ... More >> Service Hepato-Gastroentérologie Hopital Haut-Leveque Pessac, France, 33604 Less <<
NCT01296308 - Completed - Germany ... More >> Kliniken Essen-Mitte Essen, NRW, Germany, 45276 Less <<
NCT00680901 Neoplasms, Gastrointestinal Tr... More >>act Less << Phase 3 Active, not recruiting December 31, 2020 -
NCT01322711 Type 2 Diabetes Mellitus ... More >> Hypercholesterolemia Less << Phase 4 Unknown December 2015 Italy ... More >> Stefania Basili Rome, Italy, 00161 Less <<
NCT01327404 - Unknown April 2013 United States, Illinois ... More >> University of Illinois Recruiting Chicago, Illinois, United States, 60612 Contact: Monya Meinel, BA, CCRC    312-996-6201    mmeinel@psych.uic.edu    Contact: Piotr Daranowski, MA    312-413-8223    pdaranowski@psych.uic.edu    Principal Investigator: Anand Kumar, MD          Sub-Investigator: Olusola Ajilore, MD, PhD Less <<
NCT01353066 Atherosclerotic Cardiovascular... More >> Disease Subclinical Disease and/or Syndrome Less << Phase 2 Phase 3 Unknown - Spain ... More >> Hospital Clínic de Barcelona Not yet recruiting Barcelona, Catalunya, Spain, 08036 Principal Investigator: Josep Vidal, MD Less <<
NCT01277432 - Completed - China ... More >> 1st Affiliated Hosp, Peking University Beijing, China China-Japan Friendship Hospital Beijing, China Peking Union Hospital Beijing, China Peking University People's Hospital Bejing, China Third Affiliated Hospital of Sun Yat-Sen University Guangzhou, China Shanghai Sixth People's Hospital Shanghai, China Hong Kong YCK Diabetes Assessment Centre, Prince of Wales Hospital Shatin, Hong Kong Less <<
NCT01373814 - Enrolling by invitation February 2019 United States, Missouri ... More >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Less <<
NCT02620917 - Active, not recruiting December 1, 2017 Italy ... More >> University of Padova Padova, Italy Less <<
NCT00680901 - Active, not recruiting - -
NCT01377935 - Completed - -
NCT01421355 - Completed - -
NCT02547311 Type 1 Diabetes Not Applicable Unknown April 2018 United States, Colorado ... More >> University of Colorado Denver School of Medicine Barbara Davis Center Recruiting Aurora, Colorado, United States, 80045 Contact: Jackie Shea    303-724-7861    jacqueline.shea@ucdenver.edu    Contact: Agnes Furlaga    3037246769    agnes.furlaga@ucdenver.edu Less <<
NCT01421355 Type 1 Diabetes Mellitus Phase 1 Completed - United States, Massachusetts ... More >> Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Less <<
NCT02674828 Type 1 Diabetes Not Applicable Active, not recruiting January 2019 United States, Connecticut ... More >> Yale University School of Medicine New Haven, Connecticut, United States, 06520 Less <<
NCT02580877 Type 1 Diabetes Phase 2 Active, not recruiting March 2018 United States, California ... More >> University of California - San Francisco San Francisco, California, United States, 94158-2549 Stanford University Stanford, California, United States, 94305 United States, Colorado Barbara Davis Center for Childhood Diabetes Aurora, Colorado, United States, 80109 United States, Florida University of Florida Gainesville, Florida, United States, 32610 University of Miami Miami, Florida, United States, 33136 University of South Florida Tampa, Florida, United States, 33612 United States, Georgia Emory Children's Center Atlanta, Georgia, United States, 30322 United States, Illinois University of Chicago Chicago, Illinois, United States, 60637 United States, Indiana Indiana University-Riley Hospital for Children Indianapolis, Indiana, United States, 46202 United States, Massachusetts Joslin Diabetes Center Boston, Massachusetts, United States, 02215 United States, New York Columbia University-Naomi Berrie Diabetes Center New York, New York, United States, 10032 United States, Pennsylvania University of Pittsburgh Pittsburgh, Pennsylvania, United States, 15224 United States, Tennessee Vanderbilt University Nashville, Tennessee, United States, 37232 United States, Texas University of Texas Southwestern Dallas, Texas, United States, 75390 Baylor College of Medicine Houston, Texas, United States, 77030 United States, Washington Benaroya Research Institute Seattle, Washington, United States, 98101 Australia, Victoria Walter and Eliza Hall Institute of Medical Research Parkville, Victoria, Australia, 3050 Canada, Ontario The Hospital for Sick Children Toronto, Ontario, Canada Italy San Raffaele Hospital Milan, Italy Less <<
NCT01430143 Overweight In... More >>sulin Resistance Diabetes Mellitus, Type 2 Less << Not Applicable Completed - Denmark ... More >> Department of Biomedical Sciences, The University of Copenhagen Copenhagen, Denmark, DK-2200 Less <<
NCT01384058 Diabetes Mellitus Type 2 ... More >> Hypercholesterolemia Less << Phase 4 Completed - Germany ... More >> Institut für Stoffwechselforschung Frankfurt, Germany, 60322 Stephan Jacob, MD Villingen-.Schwenningen, Germany, 78048 Less <<
NCT02739984 Hypercholesterolemia ... More >> Mixed Dyslipidemia Type 2 Diabetes Less << Phase 3 Completed - -
NCT02721888 Type 2 Diabetes Phase 4 Unknown - France ... More >> CHU de Dijon Recruiting Dijon, France, 21079 Contact: Bruno VERGES    03.80.29.34.53 ext 33    bruno.verges@chu-dijon.fr Less <<
NCT00420199 - Completed - -
NCT01480934 - Completed - -
NCT01467674 - Completed - Turkey ... More >> Suleyman Demirel University Isparta, Turkey, 32260 Less <<
NCT00420199 Active Rheumatoid Arthritis Phase 3 Completed - Belgium ... More >> Local Institution Bruxelles, Belgium, 1200 Local Institution Yvoir, Belgium, 5530 Germany Local Institution Berlin, Germany, 14059 Local Institution Berlin, Germany, BE-10117 Netherlands Local Institution Amsterdam, Netherlands, 1105 AZ Spain Local Institution Barcelona, Spain, 08036 Local Institution Barcelona, Spain, 08907 Sweden Local Institution Stockholm, Sweden, 171 76 United Kingdom Local Institution London, Greater London, United Kingdom, SE19RT Local Institution Leeds, North Yorkshire, United Kingdom, LS7 4SA Less <<
NCT01487109 Type 2 Diabetes Mellitus ... More >> Chronic Kidney Disease Less << Phase 2 Completed - -
NCT01497912 Type 1 Diabetes Mellitus ... More >> Dyslipidemia Less << Phase 4 Completed - Sweden ... More >> Karolinska Institutet, Department of Clinical Sciences, Danderyd Hospital Stockholm, Sweden, 182 88 Less <<
NCT02588469 Pediatric Obesity ... More >> Sleep Apnea, Obstructive Less << Not Applicable Completed - France ... More >> Centre de soins de suite et de réadaptation La Beline Salins-les-Bains, France, 39110 Less <<
NCT02816099 diabète de Type 1 Not Applicable Unknown - France ... More >> CHU de Besançon Recruiting Besancon, France, 25030 Contact: Sophie BOROT    03.81.66.80.29 ext 33    sophie.borot@univ-fcomte.fr    CHU Dijon Bourgogne Recruiting Dijon, France, 21079 Contact: Benjamin BOUILLET    03.80.29.34.53 ext 33    benjamin.bouillet@chu-dijon.fr Less <<
NCT02739984 - Completed - -
NCT02793427 Type 1 Diabetes in Children Not Applicable Active, not recruiting - France ... More >> Chu Reims Reims, France, 51092 Less <<
NCT02844153 - Recruiting March 2020 France ... More >> Claude Bernard University, Lyon, France, Lyon Sud university hospital Recruiting Pierre-Bénite, France, 69310 Contact: Denis FOUQUE, Pr, MD PhD    (0)4 7267 8704 ext +33    denis.fouque@univ-lyon1.fr Less <<
NCT01531569 Diabetes Mellitus, Type 2 ... More >> Hypercholesterolemia Less << Phase 2 Completed - Canada, Saskatchewan ... More >> Saskatoon Centre for Patient Oriented Research - Saskatoon City Hospital Saskatoon, Saskatchewan, Canada, S7K 0M7 Less <<
NCT02875821 Type 2 Diabetes With Non-alcoh... More >>olic Fatty Liver (NAFLD) Less << Phase 4 Completed - Korea, Republic of ... More >> Yonsei University College of Medicine, Department of internal Medicine, Division of Endocrinology, Severance Hospital, Diabetes Center Seoul, Korea, Republic of, 03722 Less <<
NCT02770079 - Recruiting June 2020 Denmark ... More >> Aarhus University Hospital, NBG Recruiting Aarhus, Denmark, 8000 Contact: Gitte O Skajaa, MD       gitteoskajaa@clin.au.dk    Contact: Ullla K Opstrup, MD PhD Less <<
NCT01562678 Diabetes Effe... More >>cts of Liraglutide Administration on Brain Activity Weight Loss Hunger Less << Phase 4 Completed - United States, Massachusetts ... More >> Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Less <<
NCT03122977 Periodontal Diseases ... More >> Obesity Less << Not Applicable Recruiting January 1, 2020 Italy ... More >> University Hospital of Pisa Recruiting Pisa, Italy, 56121 Contact: Filippo Graziani, DDS, PhD    0039050992939    filippo.graziani@med.unipi.it Less <<
NCT01536808 Type 2 Diabetes Mellitus Not Applicable Completed - France ... More >> Laboratoire d'échocardiographie Bron, France, 69500 Less <<
NCT03122990 Periodontitis ... More >> Hypertension Less << Not Applicable Recruiting June 30, 2019 Italy ... More >> University Hospital of Pisa Recruiting Pisa, Italy, 56121 Contact: Filippo Graziani, DDS, PhD    0039050992939    filippo.graziani@med.unipi.it Less <<
NCT01562678 - Completed - -
NCT01576887 End-Stage Renal Disease ... More >> Type 2 Diabetes Mellitus Less << Phase 2 Withdrawn(IDMC recommendation ... More >>for safety concerns) Less << October 2013 -
NCT00833482 - Completed - -
NCT03370991 Menopause Ele... More >>vated Blood Pressure Hypertension Endothelial Dysfunction Less << Phase 2 Phase 3 Recruiting December 31, 2019 United States, Colorado ... More >> Department of Food Science and Human Nutrition, Colorado State University Recruiting Fort Collins, Colorado, United States, 80523-1571 Contact: Nicole S. Litwin, MS, RD    970-491-0464    Nicole.Litwin@colostate.edu    Contact: Sarah A. Johnson, PhD, RDN    (970) 491-3807    Sarah.Johnson@colostate.edu Less <<
NCT00833482 Human Immunodeficiency Virus T... More >>ype 1 (HIV-1) HIV Infections Less << Phase 1 Completed - United States, California ... More >> West Coast Clinical Trials, Llc Cypress, California, United States, 90630 Netherlands Local Institution Nijmegen, Netherlands, 6425 GA Less <<
NCT02956577 - Completed - Denmark ... More >> Cardiovascular Research Unit, OUH Svendborg Hospital Svendborg, Denmark, 5700 Less <<
NCT02837094 Type 1 Diabetes Phase 1 Recruiting December 31, 2018 United Kingdom ... More >> Cardiff and Vale University Health Board Recruiting Cardiff, United Kingdom, CF14 4XW Contact: Alexandra Howell    +44 (0)29 20746710 ext 46710    HowellA4@cardiff.ac.uk Less <<
NCT01516151 Hypertriglyceridemia Phase 2 Completed - -
NCT02962492 Evaluate Ketogenic Stress Phase 4 Unknown October 2018 United States, New York ... More >> ECMC Ambulatory Center, 3rd Floor Buffalo, New York, United States, 14215 Less <<
NCT01644201 Type II Diabetes Mellitus ... More >> Obesity Less << Phase 3 Unknown - Canada, Ontario ... More >> Wharton Medical Clinic and Weight Management Centre Recruiting Hamilton, Ontario, Canada Contact: Teresa Caterini       teresa@whartonmedicalclinic.com    Principal Investigator: Dr. Sean Wharton, MD, FRCPC, PharmD Less <<
NCT03047200 Islet Cell Transplantation ... More >> Type 1 Diabetes Less << Phase 1 Withdrawn(There were not patie... More >>nts that meet inclusion/exclusion criteria. Site decided to close study.) Less << - United States, Texas ... More >> Baylor University Medical Center Dallas, Texas, United States, 75246 Less <<
NCT01286779 - Completed - -
NCT02416960 Female Infertility ... More >> Obesity Less << Not Applicable Completed - Brazil ... More >> Hospital de Clínicas de Porto Alegre Porto Alegre, RS, Brazil Less <<
NCT03174353 Pancreatic Leak ... More >> Pancreatic Fistula Pancreaticoduodenal; Fistula Pancreatectomy; Hyperglycemia Less << Phase 2 Recruiting April 1, 2021 United States, Washington ... More >> University of Washington Medical Center Recruiting Seattle, Washington, United States, 98195 Contact: Venu G Pillarisetty    206-616-4924    vgp@uw.edu    Principal Investigator: Venu Pillarisetty, MD Less <<
NCT02265263 - Recruiting January 2020 Germany ... More >> Department of Anesthesiology and Intensive Care Medicine, CCM and CVK, Charité - Universitätsmedizin Berlin Recruiting Berlin, Germany, 13353 Contact: Claudia Spies, MD, Prof.    +49 30 450 551001    claudia.spies@charite.de    Principal Investigator: Claudia Spies, MD, Prof.          Sub-Investigator: Anika Müller, MD          Sub-Investigator: Fatima Yürek, MD          Sub-Investigator: Georg Winterer, MD, PhD          Sub-Investigator: Friedrich Borchers, MD          Sub-Investigator: Björn Weiss, MD          Sub-Investigator: Alida Günsberg, MD          Sub-Investigator: Annika Wiegandt, MD          Sub-Investigator: Alissa Wolf, MD          Sub-Investigator: Gunnar Lachmann, MD          Sub-Investigator: Maria Olbert, MD          Sub-Investigator: Rudolf Mörgeli, MD          Sub-Investigator: Daniel Hadzidiakos, MD          Sub-Investigator: Sina Rosenblender, MD          Netherlands Department of Intensive Care Medicine, University Medical Center Utrecht Recruiting Utrecht, Netherlands, 3584 CX Contact: A.J.C. (Arjen) Slooter, MD, PhD    +31 (0) 88 75 61116    A.Slooter-3@umtrecht.nl    Principal Investigator: A.J.C. (Arjen) Slooter, MD, PhD          Sub-Investigator: D.S. (Judy) Veldhuijzen, PhD          Sub-Investigator: Jeroen Hendrikse, MD, PhD          Sub-Investigator: I.M.J. Kant, MSc          Sub-Investigator: S.J.T. van Montfort, MSc Less <<
NCT01474759 Obesity Not Applicable Completed - United States, Pennsylvania ... More >> Penn State University Laboratory for the Study of Human Ingestive Behavior University Park, Pennsylvania, United States, 16803 Less <<
NCT01286779 Hemophilia B Phase 3 Completed - -
NCT03273855 Obesity, Morbid Not Applicable Not yet recruiting February 1, 2020 -
NCT03230266 Type1diabetes Not Applicable Active, not recruiting December 17, 2018 France ... More >> Montpellier University Hospital Montpellier, France, 34295 Less <<
NCT01786421 - Completed - Netherlands ... More >> Sint Franciscus Gasthuis Rotterdam, Netherlands, 10900 Utrecht University Medical Center Utrecht, Netherlands Less <<
NCT01792206 Type 2 Diabetes ... More >> Chronic Kidney Disease Less << Not Applicable Unknown February 2013 United States, Georgia ... More >> Emory University Atlanta, Georgia, United States, 30303 United States, Louisiana Tulane University New Orleans, Louisiana, United States, 70112 United States, Massachusetts Joslin Diabetes Clinic, Inc. Boston, Massachusetts, United States, 02215 United States, Nebraska Omaha VA Medical Center Omaha, Nebraska, United States, 68105 Less <<
NCT01832077 - Unknown August 2015 China, Guangdong ... More >> Zhongshan Ophthalmic Center, No.54, Xianlienan Road Guangzhou, Guangdong, China, 510060 Less <<
NCT01845870 - Completed - China, Tianjin ... More >> General Hospital of Tianjin Medical University Tianjin, Tianjin, China, 300052 Less <<
NCT01781013 Depression Di... More >>abetes Mellitus Less << Not Applicable Completed - United States, California ... More >> El Monte Comprehensive Health Center El Monte, California, United States, 91731 High Desert Comprehensive Health Center Lancaster, California, United States, 93536 Long Beach Comprehensive Health Center Long Beach, California, United States, 90813 H. Claude Hudson Comprehensive Health Center Los Angeles, California, United States, 90007 Roybal Comprehensive Health Center Los Angeles, California, United States, 90022 Olive View-UCLA Medical Center Diabetes Clinic Sylmar, California, United States, 91342 Mid-Valley Comprehensive Health Center Van Nuys, California, United States, 91405 Harbor Comprehensive Health Center Wilmington, California, United States, 90744 Less <<
NCT03291171 Chronic Disease Not Applicable Recruiting June 30, 2019 Belgium ... More >> Department of Movement and Sports Sciences Recruiting Ghent, Belgium, 9000 Contact: Louise Poppe       louise.poppe@ugent.be    Contact: Maïté Verloigne       maite.verloigne@ugent.be Less <<
NCT03334214 Hepatic Steatosis Phase 2 Completed - Canada, Nova Scotia ... More >> Ionis Investigational Site Halifax, Nova Scotia, Canada, B3H 2Y9 Canada, Quebec Ionis Investigational Site Chicoutimi, Quebec, Canada, G7H 7K9 Hungary Ionis Investigational Site Budapest, Hungary, 1036 Ionis Investigational Site Budapest, Hungary, 1083 Ionis Investigational Site Budapest, Hungary, 1088 Ionis Investigational Site Hatvan, Hungary, 3000 Ionis Investigational Site Miskolc, Hungary, 3529 Ionis Investigational Site Szekesfehervar, Hungary, 8000 Poland Ionis Investigational Site Bydgoszcz, Poland, 85-863 Ionis Investigational Site Bytom, Poland, 41-902 Ionis Investigational Site Chełm, Poland, 22-100 Ionis Investigational Site Katowice, Poland, 40-752 Ionis Investigational Site Kraków, Poland, 31-501 Ionis Investigational Site Kraków, Poland, 31-530 Ionis Investigational Site Mysłowice, Poland, 41-400 Ionis Investigational Site Wierzchosławice, Poland, 33-122 Ionis Investigational Site Wrocław, Poland, 50-127 Ionis Investigational Site Wrocław, Poland, 50-220 Ionis Investigational Site Wrocław, Poland, 50-349 Ionis Investigational Site Łódź, Poland, 93-509 United Kingdom Ionis Investigational Site Dundee, United Kingdom, DD1 9SY Ionis Investigational Site Nottingham, United Kingdom, NG7 2UH Less <<
NCT03143075 Major Depressive Disorder Not Applicable Recruiting May 2019 Sweden ... More >> Lund University, Dept of Psychiatry Recruiting Lund, Sweden, 221 85 Contact: Daniel Lindqvist, MD, PhD    +46-46-173885    Daniel.lindqvist@med.lu.se    Contact: Johan Olsson, RS    +46-46-17 48 01    Johan.I.Olsson@skane.se Less <<
NCT01846533 - Unknown December 2015 Taiwan ... More >> National Taiwan University Hospital Recruiting Taipei, Taiwan, 100 Contact: Kuo Chin Huang, PhD    886-23123456 ext 66081    bretthuang@ntu.edu.tw Less <<
NCT03423862 - Recruiting September 30, 2020 United States, Wisconsin ... More >> Medical College of Wisconsin Recruiting Milwaukee, Wisconsin, United States, 53226 Contact: Susanne Cabrera, MD    414-955-4903    t1dinfo@mcw.edu Less <<
NCT01904422 Diabetes Mellitus. ... More >> Chronic Periodontitis Less << Not Applicable Completed - Chile ... More >> Joan Alsina Polyclinic San Bernardo, Metropolitan, Chile, 8340518 Less <<
NCT03086161 Obesity Adole... More >>scent Development Pregnancy Related Insulin Sensitivity Interpersonal Relations Stress Less << Not Applicable Recruiting November 2020 United States, Colorado ... More >> Children's Hospital Colorado Recruiting Aurora, Colorado, United States, 80045 Contact: Lauren Shomaker, PhD    970-491-3217    lauren.shomaker@colostate.edu Less <<
NCT01888796 Diabetes Mellitus Type 2 (T2DM... More >>) Left Ventricular Diastolic Dysfunction Less << Phase 3 Terminated(bad recruitment of ... More >>suitable participants, just 8 patients in one year) Less << - Germany ... More >> Department of Internal Medicine I, University Hospital Aachen, Germany, 52074 Less <<
NCT01885234 Pregnancy Ges... More >>tational Diabetes Mellitus Chronic Hypertension in Obstetric Context Less << Not Applicable Completed - Brazil ... More >> Hospital de Clínicas de Porto Alegre Porto Alegre, RS, Brazil, 90035-903 Less <<
NCT02667691 Overweight Not Applicable Unknown January 2018 -
NCT03443180 Type1diabetes Not Applicable Recruiting December 31, 2020 United States, Wisconsin ... More >> Medical College of Wisconsin Recruiting Milwaukee, Wisconsin, United States, 53226 Contact: Susanne Cabrera, MD    414-955-4903    t1dinfo@mcw.edu Less <<
NCT01754012 Aging Not Applicable Completed - France ... More >> Auvergne Research Center on Human Nutrition Clermont-Ferrand, France, 63009 Italy University of Bologna-Department of Speciality, Diagnostic and Experimental Medicine Bologna, Italy, 40126 Netherlands University of Wageningen-Division of Human Nutrition Wageningen, Netherlands, 6703 HD Poland Warsaw University of Life Science SGGW-WULS-Department of Human Nutrition Warsaw, Poland, 02-776 United Kingdom Department of Nurition-University of East Anglia Norwich, United Kingdom, NR4 7TJ Less <<
NCT01991002 Overweight: 25 Not Applicable Unknown June 2015 Israel ... More >> Assuta medical centers Tel Aviv, Israel Less <<
NCT02210000 - Completed - -
NCT03558776 Endogenous Conversion of Alpha... More >> Linolenic Acid Less << Not Applicable Active, not recruiting December 31, 2018 Germany ... More >> Friedrich-Schiller-University Jena, Thuringia, Germany, 07743 Less <<
NCT02419482 Polycystic Ovary Syndrome Not Applicable Recruiting April 2019 Australia ... More >> Centre of Exercise and Nutrition, Mary MacKillop Institute for Health Research, AUC Recruiting Melbourne, Australia Contact: Sofie Lionett, M.Sc       sofie.b.lionett@ntnu.no    Contact: John Hawley          Norway Department of circulation and medical imaging , NTNU Recruiting Trondheim, Norway, 7491 Contact: Ida Almenning    0047 97032036    ida.almenning@ntnu.no    Contact: Trine Moholdt, phd    0047 97098594    trine.moholdt@ntnu.no Less <<
NCT03539601 Atopic Dermatitis Phase 4 Recruiting May 25, 2020 United States, Arkansas ... More >> Dermatology Trial Associates Recruiting Bryant, Arkansas, United States, 72022 United States, California California Dermatology & Clinical Research Institute Recruiting Encinitas, California, United States, 92024 United States, Florida Park Avenue Dermatology Recruiting Orange Park, Florida, United States, 32073 Forward Clinical Trials, Inc. Recruiting Tampa, Florida, United States, 33624 United States, Kentucky DS Research Recruiting Louisville, Kentucky, United States, 40241 United States, North Carolina M3-Wake Research, Inc. Recruiting Raleigh, North Carolina, United States, 27612 United States, Texas Arlington Research Center Inc Recruiting Arlington, Texas, United States, 76011 United States, Virginia Virginia Clinical Research, Inc Recruiting Norfolk, Virginia, United States, 23502 Less <<
NCT01091116 - Completed - -
NCT01091116 Osteoarthritis, Knee Phase 2 Completed - France ... More >> Centre Hospitalier Régional - Hôpital Porte Madeleine Orléans, France, 45000 Hôtel Dieu - GHU Ouest Paris, France, 75181 Department of Rheumatology, Purpan University Hospital Toulouse, France, 31300 Germany Rheumatologie/Immunologie - Rheumazentrum, Krankenhaus Doberan Bad Doberan, Germany, 18209 Klinik für Rheumatologie und Klinische Immunologie, Charité - Campus Charité Mitte Berlin, Germany, 10117 Orthopädische Praxis Dr. Wagenitz Berlin, Germany, 12247 ClinPharm International, Prüfzentrum Bochum Bochum, Germany, 44787 ClinPharm International, Prüfzentrum Dresden Dresden, Germany, 01067 Medizinische Klinik 3, Universität Erlangen-Nürnberg Erlangen, Germany, 91054 ClinPharm Prüfzentrum Frankfurt / aM Frankfurt, Germany, 60596 ClinPharm Prüfzentrum Görlitz Görlitz, Germany, 02826 Clinical Research Hamburg Hamburg, Germany, 22143 Orthopädie Zentrum Altona Hamburg, Germany, 22767 ClinPharm International, Prüfzentrum Leipzig Leipzig, Germany, 04103 ClinPharm Prüfzentrum Magdeburg Magdeburg, Germany, 39104 Italy Servizio di Reumatologia, Ospedale Privato Accreditato Nigrisoli Bologna, Italy, 40138 Dipartimento di Biomedicina - SOD Reumatologia - Azienda Ospedaliera Universitaria Careggi Firenze, Italy, 50139 Dipartimento di Medicina Interna Azienda Ospedaliero Universitaria Pisana-Stabilimento di Santa Chiara Pisa Pisa, Italy, 56126 Istituto di Reumatologia, "Policlinico Le Scotte" Università degli Studi di Siena Siena, Italy, 53100 Spain Servicio de Reumatologia, Hospital de Basurto Bilbao, Spain, 48013 Servicio de Reumatologia, Hospital Universitario La Paz Madrid, Spain, 28046 Servicio de Reumatologia, Corporacio Sanitaria Parc Tauli, Hospital de Sabadell Sabadell, Spain, 08208 Servicio de Reumatologia, Hospital Universitario Virgen Macarena Sevilla, Spain, 41009 Less <<
NCT01272115 State; Climacteric Not Applicable Completed - Mexico ... More >> Instituto Mexicano del Seguro Social México, México DF, Mexico, 06725 Less <<
NCT01895075 Bronchopulmonary Dysplasia Phase 2 Withdrawn(Insufficient funding... More >>) Less << September 1, 2020 Canada, Ontario ... More >> Sunnybrook Health Sciences Centre Toronto, Ontario, Canada, M4N 3M5 Less <<
NCT03356977 Atopic Dermatitis Phase 4 Recruiting February 23, 2019 -
NCT00872807 Obesity Overw... More >>eight Less << Not Applicable Completed - Norway ... More >> Childrens departement Finnmark Hospital, Norway Hammerfest, Norway, 9600 Less <<
NCT01134055 Macular Degeneration Phase 2 Completed - -
NCT01268566 - Completed - -
NCT01134055 - Completed - -
NCT03565978 ST Segment Elevation Myocardia... More >>l Infarction Non-ST Segment Elevation Myocardial Infarction Unstable Angina Less << Not Applicable Active, not recruiting July 30, 2018 China ... More >> Division of Cardiology, Peking University First Hospital Beijing, China, 100034 Less <<
NCT01268566 Glioblastoma Multiforme Phase 2 Completed - United States, Arizona ... More >> Research Site Tucson, Arizona, United States United States, California Research Site Los Angeles, California, United States Research Site Stanford, California, United States United States, Illinois Research Site Chicago, Illinois, United States United States, Massachusetts Research Site Boston, Massachusetts, United States United States, Michigan Research Site Detroit, Michigan, United States United States, New York Research Site New York, New York, United States United States, Ohio Research Site Canton, Ohio, United States United States, Pennsylvania Research Site Pittsburgh, Pennsylvania, United States United States, Tennessee Research Site Nashville, Tennessee, United States United States, Texas Research Site San Antonio, Texas, United States United States, Washington Research Site Seattle, Washington, United States Less <<
NCT01636778 - Completed - -
NCT00867087 Lymphoma, B-Cell Phase 2 Completed - -
NCT02070081 Obesity Not Applicable Completed - Denmark ... More >> Faculty of Science, NEXS Frederiksberg, Denmark, 1958 Less <<
NCT01636778 Hepatitis C, Chronic Phase 2 Completed - Japan ... More >> GSK Investigational Site Aichi, Japan, 467-8602 GSK Investigational Site Fukui, Japan, 918-8503 GSK Investigational Site Fukuoka, Japan, 803-8505 GSK Investigational Site Fukuoka, Japan, 830-0011 GSK Investigational Site Gunma, Japan, 370-0829 GSK Investigational Site Hyogo, Japan, 663-8501 GSK Investigational Site Ibaraki, Japan, 317-0077 GSK Investigational Site Kagawa, Japan, 760-0017 GSK Investigational Site Kagawa, Japan, 760-8557 GSK Investigational Site Kagoshima, Japan, 899-5112 GSK Investigational Site Kanagawa, Japan, 213-8587 GSK Investigational Site Nagasaki, Japan, 856-8562 GSK Investigational Site Oita, Japan, 879-5593 GSK Investigational Site Osaka, Japan, 540-0006 GSK Investigational Site Tokyo, Japan, 105-8470 GSK Investigational Site Wakayama, Japan, 646-8558 Less <<
NCT00710684 Alzheimer's Disease Phase 2 Completed - -
NCT02283047 Hypertension ... More >>Overweight Sedentary Less << Not Applicable Completed - Spain ... More >> Faculty of Physical Activity and Sport Sciences Vitoria-gasteiz, Araba/alava, Spain, 01007 Less <<
NCT00867087 - Completed - -
NCT00879203 - Completed - United States, Missouri ... More >> Washington University School of Medicine St. Louis, Missouri, United States, 63110 Less <<
NCT03066440 Diabetic Ketoacidosis Phase 4 Recruiting June 30, 2020 United States, New York ... More >> John R. Oishei Children's Hospital Recruiting Buffalo, New York, United States, 14203 Contact: Amanda B Hassinger, MD, MS    716-323-0199    albrooks@buffalo.edu    Contact: Haiping Qiao    716-323-0055    hqiao@upa.chob.edu Less <<
NCT00710684 - Completed - -
NCT00910130 - Unknown - Italy ... More >> Giovanni Piotti Recruiting Pavia, Italy, 27100 Contact: Giovanni Piotti, MD    +390382502590    gpiotti@yahoo.it    Contact: Teresa Rampino, MD    +390382503896    t.rampino@smatteo.pv.it    Principal Investigator: Giovanni Piotti, MD          Sub-Investigator: Elisa Gabanti          Sub-Investigator: Esposito Pasquale, MD          Sub-Investigator: Marilena Gregorini, MD, PHD          Sub-Investigator: Giulia Bedino, MD          Principal Investigator: Francesca Bosio, MD Less <<
NCT01407692 - Completed - United States, California ... More >> USDA, ARS, Western Human Nutrition Research Center Davis, California, United States, 95616 Less <<
NCT02079831 Pediatric Obesity Not Applicable Completed - United States, Louisiana ... More >> Pennington Biomedical Research Center Baton Rouge, Louisiana, United States, 70808 Less <<
NCT01287039 Eosinophilic Asthma Phase 3 Completed - -
NCT01287039 - Completed - -
NCT01023750 - Completed - United States, Alabama ... More >> UAB Kirklin Clinic Birmingham, Alabama, United States, 35294 Less <<
NCT01927926 Obesity Not Applicable Completed - United Kingdom ... More >> University of Nottingham Nottingham, United Kingdom Less <<
NCT03463941 Peer Support and Chronic Disea... More >>se Obesity Type II Diabetes Cardiovascular Disease Cancer Less << Not Applicable Recruiting July 2019 United States, North Carolina ... More >> Faithful Families Program Recruiting Raleigh, North Carolina, United States, 27695 Contact: Annie Hardison-Moody, PhD    919-515-8478    amhardis@ncsu.edu    Contact: Julia Yao, MPH    919-707-5226    julia.yao@dhhs.nc.gov Less <<
NCT00110435 Type 2 Diabetes Mellitus ... More >> Hypercholesterolemia Less << Phase 3 Completed - -
NCT02136472 - Unknown May 2016 Netherlands ... More >> Maastricht University Medical Centre Recruiting Maastricht, Netherlands, 6229 HX Contact: Desiree APM Pattinaja    +31433876543 ext 66370    desiree.pattinaja@mumc.nl    Sub-Investigator: Desiree Pattinaja, PhD candidate, MD          Principal Investigator: Ron van Golde, PhD, MD Less <<
NCT01055951 Type 1 Diabetes ... More >> Insulin Pump Users Less << Phase 1 Completed - Austria ... More >> Medical University Graz Gratz, Austria, A - 8036 Israel Rambam Healthcare Campus Haifa, Israel, 31096 Sourasky Medical Center Tel-Aviv, Israel Less <<
NCT02180152 Obesity Gesta... More >>tional Diabetes Preeclampsia Less << Not Applicable Unknown - Brazil ... More >> Instituto de Medicina Integral Professor Fernando Figueira Not yet recruiting Recife, Pernambuco, Brazil, 50070-550 Contact: Joao GB Alves, PhD    +448121224122    joaoguilherme@imip.org.br    Contact: Isabelle EA Pontes, master    +448199058897    isabelle.eunice@gmail.com    Principal Investigator: Joao GB Alves, PhD Less <<
NCT00209170 Diabetes Depr... More >>ession Less << Phase 4 Completed - United States, Georgia ... More >> Grady Hospital Diabetes Clinic Atlanta, Georgia, United States, 30303 Less <<
NCT00224276 - Completed - -
NCT00209170 - Completed - -
NCT03529903 Lifestyle-related Condition ... More >> Obesity Sedentary Lifestyle PreDiabetes Hypertension Less << Not Applicable Recruiting June 2019 United States, California ... More >> UCLA Medicine - Pediatrics Comprehensive Care Center Recruiting Santa Monica, California, United States, 90404 Contact: Daniel M Croymans, MD Less <<
NCT01738087 Asthmatic Phase 2 Completed - United Kingdom ... More >> The Medicine Evaluation Unit Manchester, United Kingdom, M23 9QZ Less <<
NCT00252018 Diabetes Mellitus ... More >> Hypertension Hypercholesterolemia Cardiovascular Disease Less << Not Applicable Completed - Denmark ... More >> Bispebjerg Hospital Copenhagen, Denmark, 2400 Less <<
NCT01609894 Postnatal Growth Disorder ... More >> Neurodevelopment Less << Not Applicable Unknown - Canada, Ontario ... More >> Faculty of Health Science, McMaster Children's Hospital Recruiting Hamilton, Ontario, Canada, L8S 4K1 Contact: Christoph Fusch, MD, PhD, FRCPC    +1 905 521 2100 ext 75721    fusch@mcmaster.ca    Principal Investigator: Christoph Fusch, MD, PhD, FRCPC          Sub-Investigator: Niels Rochow, MD          Sub-Investigator: Gerhard Fusch, PhD          Sub-Investigator: Salhab el Helou, MD, FRCPC          Sub-Investigator: Sabiha Ahmad          Sub-Investigator: Akshdeep Singh Bhatia          Sub-Investigator: Klaus Wutzke, PhD Less <<
NCT00254124 Type 2 Diabetes Mellitus ... More >> Obesity Less << Not Applicable Completed - Canada, Alberta ... More >> Diabetes Education Center, Colonel Belcher Hospital Calgary, Alberta, Canada, T2R 0K5 Less <<
NCT00142701 Cardiovascular Diseases ... More >> Heart Diseases Coronary Disease Coronary Heart Disease Risk Reduction Diabetes Mellitus, Non-insulin Dependent Less << Not Applicable Completed - -
NCT01506245 Childhood Obesity Not Applicable Unknown December 2012 Switzerland ... More >> University Hospital of Geneva Geneva, Switzerland, 1205 Less <<
NCT01171248 - Completed - Denmark ... More >> Steno Diabetes Center Gentofte, Denmark, 2820 Less <<
NCT01129050 Obesity Hyper... More >>triglyceridemia Insulin Resistance Hypertension Less << Not Applicable Completed - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT00309127 Type 2 Diabetes Mellitus ... More >> DM Nephropathy Less << Not Applicable Completed - China ... More >> The Chinese University of Hong Kong Hong Kong, China Less <<
NCT03667183 Eating Disorder ... More >> Female Adolescents Less << Not Applicable Completed - -
NCT01205308 Type 1 Diabetes Not Applicable Completed - Finland ... More >> University of Eastern Finland Kuopio, Finland, FIN-70211 Less <<
NCT01584648 Melanoma Phase 3 Active, not recruiting October 15, 2018 -
NCT01220557 Type 1 Diabetes Not Applicable Completed - -
NCT01220557 - Completed - -
NCT03482895 - Recruiting December 20, 2018 France ... More >> AP-HP - Hôpital Européen Georges-Pompidou Recruiting Paris, Île-de-France, France, 75015 Contact: Claire Carette, MD       claire.carette@aphp.fr Less <<
NCT01265017 Type 1 Diabetes Phase 1 Withdrawn(Insufficient funding... More >>) Less << June 2020 United States, California ... More >> Sansum Diabetes Research Institute Santa Barbara, California, United States, 93105 Less <<
NCT01667835 Cardiovascular Disease Phase 1 Unknown August 2015 Canada, British Columbia ... More >> The Jim Pattison Outpatient Care and Surgery Services, Cardiovascular Outpatient Clinic Recruiting Surrey, British Columbia, Canada, V3T 0G9 Contact: Amandah L Hoogbruin, PhD    604 599 3144    amandah.hoogbruin@kwantlen.ca    Contact: Raymond Dong, FRCP(c)    604 686 6372    raydongheart@gmail.com    Kwantlen Polytechnic University Not yet recruiting Surrey, British Columbia, Canada, V3W 2M8 Contact: Amandah L Hoogbruin, PhD    604 599 3144    amandah.hoogbruin@kwantlen.ca    Contact: Raymond Dong, FRCPC    604 838 8418    raydongcardio@gmail.com    Principal Investigator: Amandah L Hoogbruin, PhD Less <<
NCT03058458 Healthy Volunteers ... More >> Asthma Less << Phase 1 Completed - United Kingdom ... More >> Investigator Site Harrow, United Kingdom Less <<
NCT01272583 Type 1 Diabetes ... More >> Hypoglycemia Less << Not Applicable Completed - Netherlands ... More >> Academic Medical Center Amsterdam, Noord Holland, Netherlands, 1100DD Less <<
NCT00726323 Carcinoma, Renal Cell Phase 2 Completed - United States, California ... More >> GSK Investigational Site Greenbrae, California, United States, 94904-2007 GSK Investigational Site San Francisco, California, United States, 94115 GSK Investigational Site Stanford, California, United States, 94305 United States, Indiana GSK Investigational Site Indianapolis, Indiana, United States, 46202 United States, Maryland GSK Investigational Site Bethesda, Maryland, United States, 20892 United States, Massachusetts GSK Investigational Site Boston, Massachusetts, United States, 02115 United States, Michigan GSK Investigational Site Detroit, Michigan, United States, 48201 United States, New Jersey GSK Investigational Site New Brunswick, New Jersey, United States, 08901 United States, Ohio GSK Investigational Site Cleveland, Ohio, United States, 44195 United States, Pennsylvania GSK Investigational Site Philadelphia, Pennsylvania, United States, 19104 United States, Tennessee GSK Investigational Site Nashville, Tennessee, United States, 37232 United States, Texas GSK Investigational Site San Antonio, Texas, United States, 78229 Less <<
NCT01116180 Type 1 Diabetes ... More >> Hypoglycemia Less << Not Applicable Completed - Denmark ... More >> Department of Cardiology and Endocrinology, Hillerød Hospital Hillerød, Denmark, 3400 Less <<
NCT00361608 - Withdrawn - Israel ... More >> Schneider Children's Medical Center of Israel Petah-Tikva, Israel, 49202 Less <<
NCT00726323 - Completed - -
NCT02505451 Diabetes-related Complications Not Applicable Recruiting January 2019 France ... More >> Hospital Henri Duffaut Recruiting Avignon, Paca, France, 84000 Contact: Falah Aboukhoudir, MD    +33622085526    faboukhoudir@ch-avignon.fr Less <<
NCT01272583 - Completed - -
NCT00371683 - Completed - -
NCT01308437 Type I Diabetes Phase 3 Terminated(Business reasons) - United States, California ... More >> University Clinical Investigators, Inc. dba Diabetes Research Center Tustin,, California, United States, 92780 United States, Florida International Research Associates Hialeah, Florida, United States, 33012 The Center for Diabetes and Endocrine Care Hollywood, Florida, United States, 33021 Baptist Diabetes Associates, PA Miami, Florida, United States, 33156 Suncoast Clinical Research New Port Richie, Florida, United States, 34652 Ormond Medical Arts Pharmaceutical Research Center Ormond Beach, Florida, United States, 32174 Suncoast Clinical Research Palm Harbor, Florida, United States, 34684 International Clinical Research - US, LLC Sanford, Florida, United States, 32771 United States, Kansas Cotton-O'Neil Clinical Research Center, Diabetes & Endocrinology Topeka, Kansas, United States, 66606 United States, Kentucky Kentucky Diabetes Endocrinology Center Lexington, Kentucky, United States, 40503 United States, Maryland Endocrine & Metabolic Consultants Rockville,, Maryland, United States, 20852 United States, Massachusetts ActivMed Practices and Research Haverhill, Massachusetts, United States, 01830 United States, Michigan Alzohaili Medical Consultants Dearborn, Michigan, United States, 48124 United States, New Hampshire ActivMed Practices and Research Rochester, New Hampshire, United States, 03867 United States, Tennessee University Diabetes & Endocrine Association Chattanooga, Tennessee, United States, 37411 United States, Texas Sergio Rovner, MD El Paso, Texas, United States, 79925 United States, Utah Optimum Clinical Research, Inc. Salt Lake City, Utah, United States, 84102 India Dr Rakesh Sahay Hyderabad, Andhra Pradesh, India, 500012 Dia Care - A Complete Diabetes Care Centre Ahmedabad, Gujrat, India, 380015 Dr Sanjay Kalra Karnal, Haryana, India, 132001 Dr Mala Dharmalingam Bangalore, Karnataka, India, 560003 Bangalore Diabetes Hospital Bangalore, Karnataka, India, 560052 Dr Sharad Pendsey Nagpur, Maharashtra, India, 440012 Diabetes Thyroid &Endocrine Centre Jaipur, Rajasthan, India, 302006 Bhandari's Clinic Jaipur, Rajasthan, India, 302015 Less <<
NCT00371683 Deep Vein Thrombosis ... More >> Pulmonary Embolism Less << Phase 3 Completed - -
NCT01644396 Moderate to Severe Plaque Psor... More >>iasis Less << Phase 4 Completed - Russian Federation ... More >> Site Reference ID/Investigator# 67547 Ekaterinburg, Russian Federation, 620076 Site Reference ID/Investigator# 78433 Kazan, Russian Federation, 420012 Site Reference ID/Investigator# 67542 Moscow, Russian Federation, 107076 Site Reference ID/Investigator# 67546 Saratov, Russian Federation, 410028 Site Reference ID/Investigator# 78417 Smolensk, Russian Federation, 214018 Site Reference ID/Investigator# 78413 St. Petersburg, Russian Federation, 190013 Site Reference ID/Investigator# 67545 St. Petersburg, Russian Federation, 194044 Less <<
NCT02519543 Bipolar Disorder Phase 3 Recruiting September 2019 United States, Pennsylvania ... More >> Western Psychiatric Institute and Clinic, University of Pittsburgh Medical Center, University of Pittsburgh Recruiting Pittsburgh, Pennsylvania, United States, 15213-2593 Contact: Roy Chengappa, MD FRCPC       chengappakn@upmc.edu    Contact: Patricia Schlicht, BN    412-246-5258    schlpx@UPMC.EDU    Principal Investigator: Roy Chengappa, MD FRCPC          Canada, Nova Scotia Nova Scotia Health Authority - Dept. of Psychiatry Recruiting Halifax, Nova Scotia, Canada, B3H 2E2 Contact: Julie S Garnham, BN    (902) 473 7144    jgarnham@dal.ca    Principal Investigator: Cynthia Calkin, MD FRCPC Less <<
NCT03238326 Schizophrenia Phase 3 Recruiting December 2022 United States, New York ... More >> Finger Lakes Clinical Research Recruiting Rochester, New York, United States, 14618 Ukraine SI Institute of Neurology, Psychiatry and Narcology of NAMSU, Department of Clinical, Social and Child Psychiatry Recruiting Kharkiv, Ukraine, 61068 Less <<
NCT01644396 - Completed - -
NCT01584648 - Active, not recruiting - -
NCT01337362 Hypoglycaemia Not Applicable Completed - Denmark ... More >> Hillerod Hospital Hillerød, Denmark, 3400 Less <<
NCT01329822 Type 2 Diabetes ... More >> Overweight Less << Not Applicable Completed - Korea, Republic of ... More >> Eulji University Hospital Seoul, Korea, Republic of, 139-711 Less <<
NCT01352663 Type I Diabetes Phase 3 Unknown January 2017 -
NCT01360567 Type 2 Diabetes ... More >> Hyperlipidemia Less << Phase 3 Completed - Taiwan ... More >> Chung-Hua Hsu Taipei, Taiwan, 886 Taipei City Hospital Taipei, Taiwan, 886 Less <<
NCT01345500 Overweight Ob... More >>ese Obesity Diabetic Type 2 Diabetes Less << Not Applicable Completed - United States, California ... More >> University of California, San Diego La Jolla, California, United States, 92093-0901 United States, Minnesota HealthPartners Research Foundation and University of Minnesota Minneapolis, Minnesota, United States Less <<
NCT01379729 Type 1 Diabetes Phase 2 Unknown May 2018 Belgium ... More >> UZ Brussel Recruiting Brussels, Belgium, 1090 Contact: Bart Keymeulen, MD PhD    +32 2 477 61 11    bart.keymeulen@uzbrussel.be    Principal Investigator: Bart Keymeulen, MD PhD          UZ Leuven Recruiting Leuven, Belgium, 3000 Contact: Pieter , Gillard       pieter.gillard@uzleuven.be    Contact: Da Hae Lee, MD    +32 16 34 23 98    dahae.lee@uzleuven.be    Sub-Investigator: Pieter Gillard, MD PhD Less <<
NCT00316693 Infections, Papillomavirus Phase 2 Completed - Japan ... More >> GSK Investigational Site Kagoshima, Japan, 892-0824 GSK Investigational Site Tokyo, Japan, 160-0017 GSK Investigational Site Tokyo, Japan, 183-0056 Less <<
NCT01405547 - Completed - Canada, Ontario ... More >> Mount Sinai Hospital Toronto, Ontario, Canada, M5T 3L9 Less <<
NCT00441844 Type 1 Diabetes Phase 2 Completed - United States, California ... More >> UCDavis Medical Center Sacramento, California, United States, 95817 Less <<
NCT00316693 - Completed - -
NCT00467285 - Completed - -
NCT00472953 Diabetes Diab... More >>etes Mellitus, Type 1 Diabetes Mellitus, Type 2 Chronic Obstructive Pulmonary Disease Less << Phase 3 Terminated(See termination rea... More >>son in detailed description) Less << - Argentina ... More >> Novo Nordisk Investigational Site Buenos Aires, Argentina, B1636DSU Novo Nordisk Investigational Site Buenos Aires, Argentina, C1425AGC Novo Nordisk Investigational Site Ciudad de Buenos Aires, Argentina, 1280 India Novo Nordisk Investigational Site Chandigarh, Punjab, India, 160012 Novo Nordisk Investigational Site Vellore, Tamil Nadu, India, 632004 Novo Nordisk Investigational Site Kolkata, West Bengal, India, 700020 Novo Nordisk Investigational Site Hyderabad, India, 600034 Novo Nordisk Investigational Site Mumbai, India, 400 067 Novo Nordisk Investigational Site Pune, India, 411011 Romania Novo Nordisk Investigational Site Bucharest, Romania, 020475 Novo Nordisk Investigational Site Bucharest, Romania, 020992 Slovakia Novo Nordisk Investigational Site Kosice, Slovakia, 04190 Novo Nordisk Investigational Site Lubochna, Slovakia, 03491 Novo Nordisk Investigational Site Moldava nad Bodvou, Slovakia, 045 01 Novo Nordisk Investigational Site Zilina, Slovakia, 01001 Novo Nordisk Investigational Site Zilina, Slovakia, 01207 Taiwan Novo Nordisk Investigational Site Changhua, Taiwan, 500 Novo Nordisk Investigational Site Chiayi City, Taiwan, 600 Novo Nordisk Investigational Site Taipei, Taiwan, 231 Thailand Novo Nordisk Investigational Site Bangkok, Thailand, 10330 Novo Nordisk Investigational Site Bangkok, Thailand, 10700 Turkey Novo Nordisk Investigational Site Erzurum, Turkey, 25240 Novo Nordisk Investigational Site Gaziantep, Turkey, 27070 Novo Nordisk Investigational Site Istanbul, Turkey, 34400 Novo Nordisk Investigational Site Istanbul, Turkey, 34722 Novo Nordisk Investigational Site Istanbul, Turkey, 34890 Novo Nordisk Investigational Site Kocaeli, Turkey, 41380 Less <<
NCT00467285 - Completed - -
NCT01398670 Type I Diabetes Phase 3 Withdrawn(Study was not initia... More >>ted) Less << May 2013 -
NCT03672474 Alzheimer Disease Not Applicable Recruiting October 19, 2019 France ... More >> Montpellier University Hospital, Gui de Chauliac Recruiting Montpellier, France, 34295 Contact: Audrey Gabelle, MD, PhD    0467336029    a-gabelle@chu-montpellier.fr Less <<
NCT01443741 Diabetes Insulin Dependent Phase 2 Unknown July 2015 France ... More >> University Hospital of Brest Not yet recruiting Brest, Bretagne, France, 29200 Contact: Chantal Metz, MD    (0)2 98 22 33 88 ext 33    chantal.metz@chu-brest.fr    University Hospital of Toulouse Not yet recruiting Toulouse, Midi-Pyrénées, France, 31059 Contact: Claire Le Tallec, MD    (0)5 34 55 85 64 ext 33    letallec.c@chu-toulouse.fr    University Hospital of Angers Service of Pediatric Diabetology and Endocrinology Not yet recruiting Angers, Pays de Loire, France, 49933 Contact: Regis Coutant, MD-PhD    33(0)2-41-35-56-55    ReCoutant@chu-angers.fr    Contact: Natacha Bouhours-Nouet, MD    33(0)2-41-35-44-06    NaBouhours-Nouet@chu-angers.fr    Sub-Investigator: Natacha Bouhours-Nouet, MD          Sub-Investigator: Sylvie Dufresne, MD          Sub-Investigator: Frédérique Gatelais, MD          University Hospital of Nantes Not yet recruiting Nantes, Pays de Loire, France, 44093 Contact: Sabine Baron, MD    (0)2 40 08 33 33 ext 33    sabine.baron@chu-nantes.fr    University Hospital of Lyon Not yet recruiting Lyon, Rhône Alpes, France, 69000 Contact: Marc Nicolino, MD-PhD    (0)4 72 38 58 73 ext 33    marc.nicolino@chu-lyon.fr    University Hospital of Tours Not yet recruiting Tours, Région Centre, France, 37000 Contact: Myriam Pépin-Donat, MD    (0)2 47 47 38 68 ext 33    m.pepin-donat@chu-tours.fr Less <<
NCT00477204 Type 1 Diabetes Mellitus ... More >> Dyslipidemia Less << Phase 2 Completed - United States, Colorado ... More >> Barbara Davis Center for Childhood Diabetes Aurora, Colorado, United States, 80045 Less <<
NCT00426413 - Completed - United States, Georgia ... More >> Grady Memorial Hospital Atlanta, Georgia, United States, 30303 Less <<
NCT00478335 - Completed - -
NCT01488877 Type 2 Diabetic Nephropathy Phase 1 Terminated(See termination rea... More >>son in detailed description.) Less << - United States, California ... More >> Pfizer Investigational Site Chula Vista, California, United States, 91911 Pfizer Investigational Site San Diego, California, United States, 92123 United States, Florida Pfizer Investigational Site DeLand, Florida, United States, 32720 Pfizer Investigational Site Miami, Florida, United States, 33169 United States, Michigan Pfizer Investigational Site Kalamazoo, Michigan, United States, 49007 United States, New York Pfizer Investigational Site New York, New York, United States, 10019 Less <<
NCT01460251 Type 1 Diabetes Phase 3 Terminated - Israel ... More >> Hadassah Medical Center Jerusalem, Israel, 91120 Schneider Children's Medical Center Petah-Tikva, Israel, 49202 Less <<
NCT01488877 - Terminated(See termination rea... More >>son in detailed description.) Less << - -
NCT00478335 Nephrogenic Diabetes Insipidus Not Applicable Completed - United States, Colorado ... More >> University of Colorado at Denver and Health Sciences Center Aurora, Colorado, United States, 80045 Denmark University of Aarhus Aarhus, Denmark Less <<
NCT02816814 Menopause Met... More >>abolic Syndrome Hepatic Steatosis Less << Not Applicable Unknown June 2018 Italy ... More >> Azienda ospedaliera Specializzata in Gastroenterologia Saverio de Bellis Castellana Grotte, Bari, Italy, 70013 Less <<
NCT01500928 Type 1 Diabetes Not Applicable Unknown - Israel ... More >> Schneider Medical Center Recruiting Petach Tikva, Israel Contact: Alona Hamou          Principal Investigator: Shlomit Shalitin, MD          Sourasky Medical Center, Recruiting Tel Aviv, Israel Contact: Miri MArgaliot    +972-3-697-3732       Principal Investigator: Naftali Stern, PhD Less <<
NCT01552811 - Completed - Sweden ... More >> Uppsala University Hospital Uppsala, Sweden, SE-75185 Less <<
NCT00477204 - Completed - -
NCT01153763 - Completed - -
NCT00552409 Diabetes Mellitus ... More >> Chronic Kidney Disease Diabetic Kidney Disease Less << Phase 2 Phase 3 Completed - United States, Washington ... More >> University of Washington Seattle, Washington, United States, 98195 Less <<
NCT00552409 - Completed - -
NCT01571817 Type 1 Diabetes Phase 1 Unknown December 2014 United States, California ... More >> University of California, San Francisco San Francisco, California, United States, 94143 Less <<
NCT01153763 Melanoma Phase 2 Completed - United States, California ... More >> GSK Investigational Site Los Angeles, California, United States, 90025 GSK Investigational Site Los Angeles, California, United States, 90095 GSK Investigational Site San Francisco, California, United States, 94115 United States, Pennsylvania GSK Investigational Site Philadelphia, Pennsylvania, United States, 19104 United States, Tennessee GSK Investigational Site Nashville, Tennessee, United States, 37232 United States, Texas GSK Investigational Site Houston, Texas, United States, 77030-4009 Australia, New South Wales GSK Investigational Site Newcastle, New South Wales, Australia, 2300 GSK Investigational Site Westmead, New South Wales, Australia, 2145 Australia, Western Australia GSK Investigational Site Nedlands, Western Australia, Australia, 6009 France GSK Investigational Site Bordeaux, France, 33075 GSK Investigational Site Boulogne-Billancourt, France, 92100 GSK Investigational Site Lille, France, 59037 GSK Investigational Site Marseille Cedex 5, France, 13385 GSK Investigational Site Montpellier, France, 34295 GSK Investigational Site Paris Cedex 10, France, 75475 GSK Investigational Site Villejuif, France, 94805 Germany GSK Investigational Site Essen, Nordrhein-Westfalen, Germany, 45122 GSK Investigational Site Kiel, Schleswig-Holstein, Germany, 24105 GSK Investigational Site Luebeck, Schleswig-Holstein, Germany, 23538 GSK Investigational Site Berlin, Germany, 10117 Italy GSK Investigational Site Napoli, Campania, Italy, 80131 GSK Investigational Site Genova, Liguria, Italy, 16132 GSK Investigational Site Padova, Veneto, Italy, 35128 Less <<
NCT00593424 Hypertriglyceridemia ... More >> Diabetes Mellitus Less << Not Applicable Completed - United States, Arkansas ... More >> Central Arkansas Veterans Healthcare System Little Rock, Arkansas, United States, 72205 Less <<
NCT01595594 Periodontal Disease ... More >> Type 2 Diabetes Less << Phase 3 Completed - Brazil ... More >> Faculdade de Odontologia de Ribeirão Preto Ribeirão Preto, São Paulo, Brazil, 14040-904 Less <<
NCT01563887 Type 1 Diabetes ... More >> Hypoglycemia Less << Not Applicable Completed - United States, Virginia ... More >> University of Virginia Charlottesville, Virginia, United States, 22908 Less <<
NCT00609856 Type 2 Diabetes ... More >> Secondary Drug Failure Less << Phase 4 Completed - Sweden ... More >> Malmö University Hospital Malmö, Sweden, 20502 Less <<
NCT00624013 Diabetes Depr... More >>ession Less << Phase 4 Completed - United States, California ... More >> Charles Drew University Los Angeles, California, United States, 90059 Less <<
NCT01617824 Type 2 Diabetes ... More >> Chronic Renal Failure Less << Phase 4 Completed - Italy ... More >> University Hospital Diabetes Outpatient Clinic Padova, Italy, 35100 Less <<
NCT00753688 - Completed - -
NCT01640210 Type1diabetes Not Applicable Completed - France ... More >> CHU Jean Minjoz Besancon, France, 25030 University Hospital Grenoble Grenoble, France, 38043 Less <<
NCT01652911 Type I Diabetes Phase 1 Phase 2 Terminated - Canada, Alberta ... More >> University of Alberta - Clinical Islet Transplant Program Edmonton, Alberta, Canada, T6G 2C8 Less <<
NCT03048708 Thyroid Obesi... More >>ty Insulin Resistance Autoimmune Thyroiditis Less << Not Applicable Completed - -
NCT00753688 Sarcoma, Soft Tissue Phase 3 Completed - -
NCT00650897 Major Depression ... More >> Diabetes Mellitus Less << Phase 4 Unknown October 2009 Israel ... More >> Sheba Medical Center Not yet recruiting Tel Hashomer, Israel Principal Investigator: Raz Gross, MD; MPH          Sub-Investigator: Ohad Cohen, MD          Sub-Investigator: Galit Geulayov, MSc Less <<
NCT00624013 - Completed - -
NCT01684943 Type 1 Diabetes Phase 2 Active, not recruiting December 2017 United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT00579150 - Terminated - United States, North Carolina ... More >> Research Site Wilmington, North Carolina, United States Less <<
NCT01693510 Excessive Weight Gain in Pregn... More >>ancy as Antepartum Condition Obesity Weight Gain Type 2 Diabetes Less << Not Applicable Recruiting April 30, 2019 Canada, Ontario ... More >> McMaster University Medical Centre Recruiting Hamilton, Ontario, Canada, L8S 4K1 Contact: Stephanie Atkinson, PhD    905-521-2100 ext 75644       Principal Investigator: Stephanie A. Atkinson, PhD Less <<
NCT02334228 Schizophrenia ... More >> Bipolar Disorder Schizoaffective Disorder Major Depressive Disorder Less << Not Applicable Completed - United States, New Hampshire ... More >> Riverbend Community Mental Health Concord, New Hampshire, United States, 03301 Less <<
NCT00112294 - Completed - -
NCT00112294 Non-Small-Cell Lung Carcinoma Phase 3 Completed - -
NCT03093441 Healthy Not Applicable Active, not recruiting December 8, 2018 United States, Michigan ... More >> Oakland University Rochester, Michigan, United States, 48309 Less <<
NCT00696982 Diabetes Mellitus ... More >> Arterial Stiffness Less << Not Applicable Unknown June 2009 Israel ... More >> Department of Internal Medicine A , Research & Development unit Assaf Harofeh Medical Center, Zerifin, affiliated to Sackler School of Medicine, Tel Aviv, Israel Recruiting Zrifin, Israel, 70300 Contact: Shlomit Koren, MD    972-546-888=385    shlomitks@gmail.com    Contact: Shai Efrati, MD    972-577-346-364    efratishai@013.net    Principal Investigator: Shlomit Koren, MD Less <<
NCT00737347 Type 2 Diabetes ... More >> Obesity Less << Phase 3 Completed - United States, Illinois ... More >> Northwestern Memorial Hospital Wellness Institute Chicago, Illinois, United States, 60611 Less <<
NCT01737658 Obesity Not Applicable Completed - United States, New York ... More >> Winthrop University Hospital Mineola, New York, United States, 11501 Less <<
NCT01687582 Type 2 Diabetes ... More >> Psoriasis Less << Not Applicable Unknown March 2013 Belgium ... More >> Cliniques universitaires Saint-Luc Recruiting Brussels, Belgium, 1200 Contact: Martin Buysschaert, PhD    +3227645475    martin.buysschaert@uclouvain.be    Contact: Vanessa Preumont, MD    +3227645475    vanessa.preumont@uclouvain.be    Principal Investigator: Martin Buysschaert, PhD Less <<
NCT01782261 Type 1 Diabetes Phase 2 Completed - Austria ... More >> Medical University Graz Graz, Austria, 8036 Less <<
NCT00790309 - Completed - -
NCT01246739 Adrenal Tumour With Mild Hyper... More >>cortisolism Less << Not Applicable Recruiting December 2022 Denmark ... More >> Århus University Hospital Recruiting Århus, Denmark, 8000 Contact: Per Poulsen, MD, PhD,DMSc    +4578462008    logstrup.@dadlnet.dk    Norway Haukeland University Hospital Recruiting Bergen, Norway, 5021 Contact: Anette Heie, MD    +4797647525    anette.heie@helse-bergen.no    Sub-Investigator: Grethe Åström Ueland, MD          Principal Investigator: Hrafnkell B Thordarson, MD          Sub-Investigator: Turid Aas, MD          Sub-Investigator: Eystein S Husebye, MD, PhD          Sweden Sahlgrenska University Hospital Recruiting Gothenburg, Sweden, 41345 Contact: Oskar Ragnarsson, MD, PhD    +46707292228    oskar.ragnarsson@medic.gu.se    Skåne University Hospital-Lund, Department of Surgery Recruiting Lund, Sweden, 22185 Contact: Anders OJ Bergenfelz, PhD    +46703772086    anders.bergenfelz@med.lu.se    Sub-Investigator: Erik Nordenström, MD, PhD          Sub-Investigator: Martin Almqvist, MD, PhD Less <<
NCT01781884 Type 1 Diabetes Not Applicable Unknown December 2014 China, Shanghai ... More >> Department of Endocrinology and Metabolism，Huashan hospital Recruiting Shanghai, Shanghai, China, 200040 Contact: Zhaoyun Zhang    86-21-52888286       Contact: Yi Wang    86-21-52887022       Principal Investigator: Yiming Li          Principal Investigator: Qinghua Wang, Doctor Less <<
NCT00791128 Type 2 Diabetes ... More >> Obesity Less << Phase 2 Completed - Brazil ... More >> Dr. Eduardo Guimaraes Hourneauz de Moura Sao Paulo, SP, Brazil, 05493900 Less <<
NCT01843387 Diabetic Nephropathy ... More >> Type 2 Diabetes Less << Phase 1 Phase 2 Completed - Australia ... More >> Monash Universtiy Clayton, Australia Melbourne Renal Research Group Melbourne, Australia Less <<
NCT00757276 - Completed - Switzerland ... More >> University Hospital Basel Basel, Switzerland, 4031 Less <<
NCT00811889 Chronic Kidney Disease ... More >> Type 2 Diabetes Diabetic Nephropathy Less << Phase 2 Completed - -
NCT00791128 - Completed - -
NCT00823849 Type 2 Diabetes Mellitus ... More >> Arteriosclerosis Obliterans Less << Phase 4 Completed - China ... More >> Peking University First Hospital Beijing, China Less <<
NCT00813657 Gestational Age ... More >> Birth Weight Anaemia Gestational Diabetes Mellitus Type of Delivery Less << Phase 4 Completed - -
NCT03077295 Obesity Weigh... More >>t Loss Less << Not Applicable Recruiting May 2019 United Kingdom ... More >> The Rowett Institute Recruiting Aberdeen, United Kingdom, AB25 2ZD Contact: Claire Fyfe, BSc    01224 438752 ext 8752    c.fyfe@abdn.ac.uk    Contact: Alexandra Johnstone, PhD    01224 438614 ext 8614    Alex.Johnstone@abdn.ac.uk Less <<
NCT00509028 - Completed - -
NCT00509028 Asthma Phase 3 Completed - Japan ... More >> Research Site Takizawa, Iwate, Japan Less <<
NCT02567708 Pulmonary Disease, Chronic Obs... More >>tructive Less << Phase 2 Completed - Germany ... More >> GSK Investigational Site Muenchen, Bayern, Germany, 80539 GSK Investigational Site Ruedersdorf, Brandenburg, Germany, 15562 GSK Investigational Site Frankfurt, Hessen, Germany, 60389 GSK Investigational Site Frankfurt, Hessen, Germany, 60596 GSK Investigational Site Homburg, Saarland, Germany, 66421 GSK Investigational Site Leipzig, Sachsen, Germany, 04275 GSK Investigational Site Leipzig, Sachsen, Germany, 04357 GSK Investigational Site Luebeck, Schleswig-Holstein, Germany, 23552 GSK Investigational Site Berlin, Germany, 10119 GSK Investigational Site Berlin, Germany, 10717 GSK Investigational Site Berlin, Germany, 10787 GSK Investigational Site Magdeburg, Germany, 39120 Less <<
NCT01246570 Coronary Disease Not Applicable Completed - Norway ... More >> Norwegian University of Science and Technology Trondheim, Norway Less <<
NCT01812161 Polycystic Ovary Syndrome Not Applicable Completed - China, Hubei ... More >> Department of Integrated Traditional Chinese and Western Medicine Tongji hospital of Huazhong University of Science and Technology Wuhan, Hubei, China, 027 Less <<
NCT00790517 Weight Loss D... More >>iabetes Mellitus, Type 2 Psychotic Disorders Less << Phase 2 Completed - United States, Oregon ... More >> Cascadia Behavioral Healthcare Portland, Oregon, United States, 97207 Center for Health Research, Kaiser Permanente Northwest Portland, Oregon, United States, 97227-1110 LifeWorks Northwest Portland, Oregon, United States, 97229 Less <<
NCT03014674 Asthma Phase 3 Completed - United States, Maryland ... More >> GSK Investigational Site Baltimore, Maryland, United States, 21225 Germany GSK Investigational Site Berlin, Germany, 14050 United Kingdom GSK Investigational Site Harrow, Middlesex, United Kingdom, HA1 3UJ Less <<
NCT00550420 Alzheimer's Disease Phase 3 Terminated(Based on preliminar... More >>y parent study results) Less << - -
NCT03014674 - Completed - -
NCT01997970 Overweight Ob... More >>esity Less << Not Applicable Completed - Sweden ... More >> Umeå University Umeå, Sweden Less <<
NCT00550420 - Terminated(Based on preliminar... More >>y parent study results) Less << - -
NCT02567708 - Completed - -
NCT01336634 Cancer Phase 2 Active, not recruiting December 1, 2020 -
NCT02125409 Colorectal Cancer Phase 3 Unknown - Spain ... More >> Hospital Clínico Universitario Lozano Blesa Not yet recruiting Zaragoza, Spain, 50009 Contact: Angel Lanas Arbeloa, Physician    +34 976 765786    alanas@unizar.es    Principal Investigator: Angel Lanas Arbeloa, Physician Less <<
NCT02851602 Metabolic Syndrome Not Applicable Completed - France ... More >> CHU Dijon Bourgogne Dijon, France, 21079 Less <<
NCT01718977 Spinal Cord Injury Not Applicable Recruiting March 31, 2019 Canada, British Columbia ... More >> International Collaboration On Repair Discoveries Recruiting Vancouver, British Columbia, Canada, V5Z 1M9 Contact: Martina Franz, MSc    604-675-8820    franz@icord.org    Contact: Tom E Nightingale, PhD    778-798-2710    tnightingale@icord.org    Principal Investigator: Andrei V Krassioukov, MD, PhD          Canada, Ontario McMaster University Completed Hamilton, Ontario, Canada, L8S 4L8 Toronto Rehabilitation Institute Active, not recruiting Toronto, Ontario, Canada Less <<
NCT02889211 Depression In... More >>sulin Resistance Less << Not Applicable Terminated(Principal Investiga... More >>tor Left University) Less << - United States, Pennsylvania ... More >> Western Psychiatric Institute and Clinic at University of Pittsburgh Pittsburgh, Pennsylvania, United States, 15213 Less <<
NCT03630354 Domestic Partners ... More >> Prostate Cancer Breast Cancer Colorectal Cancer Less << Not Applicable Recruiting March 31, 2023 United States, Oregon ... More >> OHSU Knight Cancer Institute Recruiting Portland, Oregon, United States, 97239 Contact: Cassie Boisvert, MS, RD    503-494-0444    exercise@ohsu.edu    Contact: Carolyn Guidarelli, MPH    503-494-0444    exercise@ohsu.edu Less <<
NCT01336634 - Active, not recruiting - -
NCT02918422 Metabolic Syndrome X Not Applicable Active, not recruiting September 2018 United States, Ohio ... More >> Physical Activity and Education Services - PAES Columbus, Ohio, United States, 43210 Less <<
NCT01902394 Digestive Health and Immune Fu... More >>nction Less << Not Applicable Completed - United States, Massachusetts ... More >> HNCRA at Tufts University Boston, Massachusetts, United States, 02111 Less <<
NCT02969720 Metabolic Syndrome x Phase 3 Unknown December 2017 -
NCT02960711 Metabolic Syndrome Phase 3 Unknown July 2018 Italy ... More >> Fondazione IRCCS Istituto Nazionale Tumori Recruiting Milan, Italy, 20133 Contact: Franco Berrino, MD    +390223903515    Franco.berrino@istitutotumori.mi.it    Contact: Patrizia Pasanisi, MD    +390223903513    trialcenter@istitutotumori.mi.it Less <<
NCT02968160 Metabolic Syndrome Phase 4 Recruiting July 2018 Korea, Republic of ... More >> Dongguk University Medical Center Recruiting Ilsan, Korea, Republic of, 10326 Less <<
NCT00285194 Type 1 Diabetes ... More >> Hypoglycemia Less << Phase 1 Phase 2 Completed - United States, Minnesota ... More >> Universtiy of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT01160341 Hypogonadism Phase 4 Completed - Turkey ... More >> Gulhane School of Medicine Ankara, Turkey, 06018 Less <<
NCT02036138 Overweight Di... More >>abetes Type 2 Less << Phase 2 Phase 3 Recruiting March 2019 Israel ... More >> Hadassah Medical Organization, Jerusalem, Israel Recruiting Jerusalem, Israel Contact: Hadas Lemberg, PhD    972-6777111 Less <<
NCT00021918 - Completed - -
NCT00309231 - Withdrawn(no funding) - Canada, Ontario ... More >> London Health Sciences Centre University Campus London, Ontario, Canada, N6A 4L6 Less <<
NCT02970214 - Recruiting December 2022 Germany ... More >> Department of Internal Medicine B, University Medicine Greifswald Recruiting Greifswald, MV, Germany, 17475 Contact: Marcus Dörr, MD    +49383486 ext 80500    mdoerr@uni-greifswald.de    Contact: Stephan B Felix, MD    +49383486 ext 80500    felix@uni-greifswald.de    Sub-Investigator: Kristin Lehnert, MD          Sub-Investigator: Sabine Kaczmarek, MD          Sub-Investigator: Ann Lousie Pedersen, MD Less <<
NCT03054779 Cardiovascular Disease ... More >> Metabolic Syndrome Less << Not Applicable Completed - United States, Pennsylvania ... More >> Penn State University University Park, Pennsylvania, United States, 16802 Less <<
NCT01205087 Nonalcoholic Steatohepatitis Phase 2 Completed - Israel ... More >> Hadassah University Hospital, Liver Unit Jerusalem, Israel Less <<
NCT03036332 Metabolic Syndrome Not Applicable Completed - -
NCT03059355 Endothelial Dysfunction ... More >> Metabolic Syndrome Chronic Inflammation Less << Phase 1 Phase 2 Recruiting June 2026 United States, Florida ... More >> ISCI / University of Miami Miller School of Medicine Recruiting Miami, Florida, United States, 33136 Contact: Joshua M Hare, MD    305-243-5579    jhare@med.miami.edu    Contact: Coordinators    305-243-7444    ISCIStudyInfo@miami.edu    Principal Investigator: Joshua M Hare, MD Less <<
NCT03058016 Metabolic Syndrome Not Applicable Not yet recruiting April 1, 2022 -
NCT02238795 - Recruiting September 2019 Germany ... More >> University Hospital Jena, Klinik für Anästhesiologie und Intensivmedizin Recruiting Jena, Germany Contact: Andreas Kortgen, PD Dr. med.          University Hospital Jena, Klinik für Kinder- und Jugendmedizin Recruiting Jena, Germany Contact: Hans Proquitté, Prof.          Klinikum der Universität München Recruiting Munich, Germany, 80337 Contact: Martin Olivieri, MD    +49 89 4400 52811    martin.olivieri@med.uni-muenchen.de Less <<
NCT03119493 Metabolic Syndrome ... More >> Metabolic Syndrome X Less << Not Applicable Completed - Brazil ... More >> Laís Manata Vanzella Presidente Prudente, São Paulo, Brazil, 19.060-900 Less <<
NCT00423891 - Completed - -
NCT03056937 - Recruiting December 1, 2018 Brazil ... More >> University of Cruz Alta Recruiting Cruz Alta, Rio Grande do Sul, Brazil, 9800050 Contact: Carine C Callegaro       ccallegaro@unicruz.edu.br Less <<
NCT00346996 Type 1 Diabetes Phase 4 Completed - Denmark ... More >> Steno Diabetes Center Gentofte, Denmark, DK-2820 Less <<
NCT00348179 Type 1 Diabetes Not Applicable Completed - United States, Missouri ... More >> Children's Mercy Hospital Kansas City, Missouri, United States, 64108 Less <<
NCT00423891 Hepatitis B, Chronic Phase 1 Phase 2 Completed - -
NCT03170375 Heart Failure Not Applicable Not yet recruiting December 30, 2022 United States, Michigan ... More >> VA Ann Arbor Healthcare System, Ann Arbor, MI Not yet recruiting Ann Arbor, Michigan, United States, 48105 Contact: Alysia J Drummond, MPH RD CHES    734-222-7563    Alysia.Drummond@va.gov    Contact: Scott L Hummel, MD       Scott.Hummel@va.gov    Principal Investigator: Scott L. Hummel, MD Less <<
NCT03160755 - Active, not recruiting October 8, 2018 United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT00335413 Hypertension Phase 4 Completed - -
NCT02091076 Late Complication From Skin Gr... More >>aft Infection of Skin Donor Site Impaired Wound Healing Pain, Intractable Less << Phase 1 Phase 2 Completed - Thailand ... More >> Chulalongkorn Hospital Bangkok, Thailand, 10330 Less <<
NCT02668146 Essential Tremor Phase 2 Unknown June 2017 United States, California ... More >> VA Greater Los Angeles Los Angeles, California, United States, 90073 Less <<
NCT03214068 - Not yet recruiting December 5, 2018 -
NCT00037297 - Completed - -
NCT03374033 Infant, Very Low Birth Weight Not Applicable Recruiting July 30, 2022 Italy ... More >> Ospedale G. Salesi Recruiting Ancona, Italy, 60123 Contact: Virgilio P. Carnielli, MD, PhD    00390715962045    v.carnielli@univpm.it    Contact: Chiara Biagetti, MD    00390715962014    chiara.biagetti@ospedaliriuniti.marche.it Less <<
NCT03293264 Metabolic Syndrome Not Applicable Recruiting May 26, 2020 Germany ... More >> HannoverMS Recruiting Hannover, Lower Saxony, Germany, 30625 Contact: Uwe Tegtbur, Prof.    +49 (0) 511 532 5499    tegtbur.uwe@mh-hannover.de    Principal Investigator: Uwe Tegtbur, Prof.          Sub-Investigator: Sven Haufe, PD Less <<
NCT00037258 - Completed - -
NCT03265184 Metabolic Syndrome Not Applicable Completed - -
NCT02635594 Healthy Volunteers ... More >> Recovery Endothelial Function Less << Not Applicable Completed - Germany ... More >> BioTeSys GmbH Esslingen, Baden-Württemberg, Germany, 73728 Less <<
NCT03301675 Metabolic Syndrome Not Applicable Unknown December 2018 -
NCT03296514 Metabolic Syndrome Not Applicable Recruiting July 1, 2018 United States, Connecticut ... More >> Yale University Recruiting New Haven, Connecticut, United States, 06511 Contact: kathleen Williams, MBA    475-331-1501    kathleen.williams@yale.edu    Contact: Joan Monin, PhD    412 519-5621    joan.monin@yale.edu Less <<
NCT00409461 Islet Transplantation ... More >> Type 1 Diabetes Less << Not Applicable Terminated - Belgium ... More >> Academisch Ziekenhuis and Diabetes Research Center – Brussels Free University-VUB Brussels, Belgium, 1090 Department of Endocrinology and Nephrology, UZ Gasthuisberg, Katholieke Universiteit Leuven –KUL Leuven, Belgium, 3000 Less <<
NCT02435095 Schizophrenia Phase 4 Recruiting April 2019 Germany ... More >> RWTH University Hospital Aachen Recruiting Aachen, NRW, Germany, 52074 Contact: Sabrina Schaffrath       saschaffrath@ukaachen.de    Contact: Sarah Lammertz       slammertz@ukaachen.de    Alexianer Aachen GmbH Not yet recruiting Aachen, Germany, 52062 Zentrum für Neurologie und Seelische Gesundheit im Kapuziner Karree Aachen Not yet recruiting Aachen, Germany, 52062 Contact: Frank Bergmann, Dr. med.          LVR Klinik Bonn Recruiting Bonn, Germany, 53111 LVR Klinik Düren Not yet recruiting Düren, Germany, 52353 Klinik und Poliklinik für Psychiatrie und Psychotherapie der Heinrich-Heine-Universität Düsseldorf Recruiting Düsseldorf, Germany, 40629 LVR Klinik Essen Not yet recruiting Essen, Germany, 45147 ViaNobis Gangelt Recruiting Gangelt, Germany, 52538 Klinik Königshof (Abteilung für Allgemeine Psychiatrie) Recruiting Krefeld, Germany, 47807 LVR Klinik Langenfeld Recruiting Langenfeld, Germany, 40764 LVR Klinik Viersen Not yet recruiting Viersen, Germany, 41749 Less <<
NCT03306056 Overweight and Obesity ... More >> Metabolic Syndrome Less << Not Applicable Recruiting September 30, 2020 Germany ... More >> Department of Medicine 1, Hector Center for Nutrition, Exercise and Sports, Recruiting Erlangen, Germany, 91052 Contact: Dejan Reljic, Dr.    +49 9131 8545218    dejan.reljic@uk-erlangen.de    Contact: Yurdaguel Zopf, Prof.    +49 9131 8545218    yurdaguel.zopf@uk-erlangen.de Less <<
NCT02067481 Breast Cancer Phase 2 Completed - Spain ... More >> Instituto Catalá de Oncología Barcelona, L´Hospitalet de Llobregat, Spain, 08908 Less <<
NCT03306069 Overweight and Obesity ... More >> Metabolic Syndrome Less << Not Applicable Recruiting September 30, 2020 Germany ... More >> Department of Medicine 1, Hector Center for Nutrition, Exercise and Sports, Recruiting Erlangen, Germany, 91052 Contact: Dejan Reljic, Dr.    +49 9131 8545218    dejan.reljic@uk-erlangen.de    Contact: Yurdaguel Zopf, Prof.    +49 9131 8545218    yurdaguel.zopf@uk-erlangen.de Less <<
NCT00417131 - Completed - Sweden ... More >> Karolinska University Hospital, Dept. of Transplantation surgery Stockholm, Sweden, S-141 86 Uppsala University Hospital, Dept of Transplantation Surgery Uppsala, Sweden, S-751 85 Less <<
NCT00047424 Atherosclerosis ... More >> Cardiovascular Diseases Heart Diseases Diabetes Mellitus Hypertension Less << Phase 3 Completed - -
NCT02422420 Prediabetic State Not Applicable Completed - United States, Minnesota ... More >> Minnesota Department of Health St. Paul, Minnesota, United States, 55164-0882 Less <<
NCT00044421 Diabetic Neuropathies ... More >> Diabetes Mellitus Less << Phase 3 Completed - -
NCT03448185 Obesity Heart... More >> Failure, Diastolic Metabolic Syndrome Less << Not Applicable Recruiting June 1, 2019 United States, Texas ... More >> The Institute for Exercise and Environmental Medicine Recruiting Dallas, Texas, United States, 75231 Contact: Mary B Childers    214-345-6459    MaryBChilders@texashealth.org    Principal Investigator: Benjamin D Levine, M.D. Less <<
NCT02443415 - Completed - United States, Georgia ... More >> Grady Health System Atlanta, Georgia, United States, 30303 Emory University School of Medicine Atlanta, Georgia, United States, 30322 Less <<
NCT03137849 Hypertension ... More >>Postmenopausal Symptoms Less << Not Applicable Enrolling by invitation December 20, 2018 Brazil ... More >> Cardiology Institute of Rio Grande do Sul Pôrto Alegre, Rio Grande do Sul, Brazil Less <<
NCT00001963 Diabetes Mellitus ... More >> Healthy Hypercholesterolemia Hypertension Less << Phase 1 Completed - United States, Maryland ... More >> National Heart, Lung and Blood Institute (NHLBI) Bethesda, Maryland, United States, 20892 Less <<
NCT00480493 Type 1 Diabetes Phase 3 Completed - United States, Massachusetts ... More >> University of Massachusetts, Worcester Worcester, Massachusetts, United States, 01655 Less <<
NCT03435315 Metabolic Syndrome Not Applicable Not yet recruiting July 2019 -
NCT00480493 - Completed - -
NCT00481897 Overweight Ty... More >>pe 2 Diabetes Less << Not Applicable Completed - United States, District of Col... More >>umbia Washington Center for Clinical Research Washington, District of Columbia, United States, 20016 Less <<
NCT03473886 Metabolic Syndrome Not Applicable Recruiting October 27, 2018 United States, Massachusetts ... More >> Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: Rachel Millstein, PhD    617-724-2047    ramillstein@mgh.harvard.edu Less <<
NCT03514667 Metabolic Syndrome Not Applicable Recruiting January 30, 2020 Iran, Islamic Republic of ... More >> Golbon Sohrab Recruiting Tehran, National Nutrition And Food Technology Research Institute, Iran, Islamic Republic of Contact: golbon sohrab, ph.D    009802122077424    golbonsohrab@yahoo.com    Contact: zohre bateni    009809129626018    zohre.bateni@yahoo.com Less <<
NCT03469115 Metabolic Syndrome Not Applicable Not yet recruiting September 2019 Israel ... More >> Hille Yaffe Medical Center Not yet recruiting Hadera, Israel, 38100 Contact: Eias Kassem, MD       eiask@hy.health.gov.il Less <<
NCT00054925 Cardiovascular Diseases ... More >> Heart Diseases Obesity Diabetes Mellitus, Non-insulin Dependent Hypertension Less << Not Applicable Completed - -
NCT01147809 - Completed - -
NCT03638895 Obesity Sever... More >>e Obesity Sleep Apnoea Less << Not Applicable Not yet recruiting December 31, 2020 -
NCT00533442 Type 1 Diabetes Phase 2 Completed - United States, Florida ... More >> University of Miami, Miller School of Medicine Miami, Florida, United States, 33136 Less <<
NCT00533442 - Completed - -
NCT00535925 Diabetic Nephropathy Phase 4 Unknown September 2012 Italy ... More >> Department of Clinical and Experimental Medicine, Second University of Naples Naples, Italy, I-80131 Less <<
NCT01147809 Thrombocytopaenia Phase 2 Completed - -
NCT00548522 - Terminated(Difficulty in findi... More >>ng staff to help with study) Less << - Canada, Alberta ... More >> University of Alberta Hospital Edmonton, Alberta, Canada, T6G 2B7 University of Alberta Edmonton, Alberta, Canada, T6G 2S2 Less <<
NCT03681756 Physical Activity ... More >> Metabolic Syndrome Lifestyle, Sedentary Less << Not Applicable Recruiting April 2019 United States, California ... More >> University of California, San Francisco Recruiting San Francisco, California, United States, 94118 Contact: Juhyun Cho    415-350-4183       Contact       walk.study@ucsf.edu    Principal Investigator: JiWon Choi, PhD Less <<
NCT00530686 Islet Cell Transplantation ... More >> Type 1 Diabetes Less << Phase 1 Completed - United States, Texas ... More >> Annette C. & Harold C. Simmons Transplant Institute - Baylor University Medical Center, Dallas Texas, USA - Baylor All Saints Medical Center, Fort Worth Texas, USA Dallas, Texas, United States, 75246 Less <<
NCT00501709 Type 1 Diabetes Phase 1 Phase 2 Completed - United States, California ... More >> University of California, San Francisco San Francisco, California, United States, 94143 Less <<
NCT01266967 Melanoma and Brain Metastases Phase 2 Completed - -
NCT03692806 Metabolic Syndrome Not Applicable Recruiting December 2019 France ... More >> Biofortis Recruiting Saint Herblain, France, 44800 Contact: Biofortis    +33240205799 Less <<
NCT01508936 - Completed - -
NCT01508936 Eosinophilic Asthma Phase 3 Completed - -
NCT03723330 Cardiovascular Diseases ... More >> Endothelial Dysfunction Metabolic Syndrome Diet Modification Less << Not Applicable Not yet recruiting May 2020 -
NCT03103984 Obesity Liver... More >> Transplantation Less << Not Applicable Completed - Brazil ... More >> Hospital da Clínicas da UFMG Belo Horizonte, MG, Brazil Less <<
NCT01266967 - Completed - -
NCT03734874 Metabolic Syndrome Not Applicable Recruiting December 1, 2018 Iran, Islamic Republic of ... More >> National Nutrition and Food Technology Research Institute Recruiting Tehran, Iran, Islamic Republic of Contact: azita hekmatdoost, MD,PhD Less <<
NCT00536211 Metabolic Syndrome X ... More >> Insulin Resistance Hypertension Hypercholesterolemia Obesity Less << Not Applicable Withdrawn(protocol not approve... More >>d by VA R&D) Less << December 2011 United States, Missouri ... More >> Harry S. Truman Memorial Veterans' Hospital Columbia, Missouri, United States, 65201 Less <<
NCT03734835 Metabolic Syndrome Not Applicable Recruiting March 1, 2019 Iran, Islamic Republic of ... More >> National Nutrition and Food Technology Research Institute Recruiting Tehran, Iran (the Islamic Republic Of), Iran, Islamic Republic of, 1981619573 Contact: Azits Hekmatdoost, MD,PhD    +982122357484 Less <<
NCT03214016 Hypertension Not Applicable Active, not recruiting August 31, 2018 Brazil ... More >> University Federal of Santa Maria Santa Maria, RS, Brazil, 97.105-900 Less <<
NCT02633488 Metabolic Syndrome ... More >> Insulin Sensitivity Less << Not Applicable Completed - United States, Virginia ... More >> University of Virginia Charlottesville, Virginia, United States, 22903 Less <<
NCT03737422 Metabolic Syndrome Not Applicable Recruiting December 1, 2018 Iran, Islamic Republic of ... More >> National Nutrition and Food Technology Research Institute Recruiting Tehran, Iran, Islamic Republic of Contact: azita hekmatdoost, MD,PhD Less <<
NCT03773718 - Recruiting December 20, 2022 Russian Federation ... More >> Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology Recruiting Moscow, Russian Federation, 117997 Contact: Alexander F Karelin, PhD    +74952876570    alexandr.karelin@gmail.com    Sub-Investigator: Anna E Gavrilova, PhD Less <<
NCT00600730 Type 1 Diabetes Not Applicable Withdrawn(Funding not availabl... More >>e. Could not start this study.) Less << - -
NCT00615368 Type 1 Diabetes ... More >> Hypoglycemia Less << Not Applicable Completed - Denmark ... More >> Hillerød Hospital Hillerød, Denmark, 3400 Less <<
NCT03340935 Malignant Neoplasm ... More >> Cancer Less << Not Applicable Recruiting June 30, 2018 Italy ... More >> Fondazione IRCCS Istituto Nazionale dei Tumori Recruiting Milan, Italy, 20133 Contact: Claudio Vernieri, M.D., Ph.D.    +39 02 23903066    claudio.vernieri@istitutotumori.mi.it Less <<
NCT01270464 Eosinophilic Asthma Phase 3 Completed - -
NCT01642680 Metabolic Syndrome ... More >> Vascular Disorders Cardiovascular Risk Factors Fatigue Less << Not Applicable Recruiting September 2020 Netherlands ... More >> University Medical Centre Groningen Recruiting Groningen, Netherlands, 9713GZ Principal Investigator: Annemiek ME Walenkamp, MD, PHD          Principal Investigator: Jourik A Gietema, MD, PhD          Principal Investigator: Ellen van Weert, PhD          Sub-Investigator: Nico-Derk L Westerink, MD Less <<
NCT00074633 Hypercholesterolemia ... More >> Hypertension Depression Diabetes Mellitus, Type 2 Less << Not Applicable Completed - United States, California ... More >> Nutrition Department, University of California, Davis Davis, California, United States, 95616 Western Human Nutrition Research Center Davis, California, United States, 95616 Less <<
NCT01270464 - Completed - -
NCT00644501 Type 1 Diabetes Phase 3 Completed - Israel ... More >> Wolfson Medical Centre Holon, Israel, 58100 Diabetic Unit, Hadassah Medical Center Jerusalem, Israel, 91120 Schneider Children's Medical Centre Petach Tikva, Israel, 49202 Less <<
NCT01717040 Bipolar Disorder ... More >> Insulin Resistance Less << Phase 4 Terminated(The study ended ear... More >>ly due to budgetary issues) Less << - United States, Ohio ... More >> University Hospitals Cleveland Medical Center - Mood Disorders Program Cleveland, Ohio, United States, 44106 Less <<
NCT01717040 - Terminated(The study ended ear... More >>ly due to budgetary issues) Less << - -
NCT01443455 Post Menopausal Not Applicable Completed - United States, Pennsylvania ... More >> University of Pittsburgh Pittsburgh, Pennsylvania, United States, 15213 Less <<
NCT03128528 Chronic Heart Failure Phase 2 Recruiting December 31, 2019 Germany ... More >> Clinical Research Center, Department of Nephrology and Hypertension, University of Erlangen-Nuremberg Recruiting Erlangen, Germany, 91054 Contact: Roland E Schmieder, MD    +49-9131-85 ext 36245    roland.schmieder@uk-erlangen.de    Contact: , MD          Principal Investigator: Roland E Schmieder, MD Less <<
NCT00700622 Diabetes, Type 1 Phase 3 Terminated(Sponsor stopped dev... More >>elopment of the MedTone inhaler in favor of an improved device (Gen2 inhaler)) Less << - -
NCT00703989 Type 1 Diabetes Not Applicable Completed - United States, New York ... More >> GCRC, Albert Einstein College of Medicine Bronx, New York, United States, 10461 Less <<
NCT02730741 Antidiarrhoea Phase 2 Recruiting - France ... More >> BIOSE Recruiting Aurillac, France Contact: NIVOLIEZ Mr Adrien    +330471465101    a.nivoliez@biose.com    Principal Investigator: Pr. Jacques MOREAU Less <<
NCT01285323 Eosinophilic Asthma Phase 3 Completed - -
NCT00700622 - Terminated(Sponsor stopped dev... More >>elopment of the MedTone inhaler in favor of an improved device (Gen2 inhaler)) Less << - -
NCT01285323 - Completed - -
NCT02972567 Metabolic Syndrome X Phase 2 Unknown June 2017 Spain ... More >> Complejo Hospitalario Universitario de Jaen Recruiting Jaen, Spain, 23007 Contact: Maria-José Martínez-Ramírez, MD    34 953 00 80 00       Contact: Carmen Tenorio, MD    34 953 00 80 00 Less <<
NCT01991106 Obesity Not Applicable Completed - Australia ... More >> University of Queensland Brisbane, Australia Norway St Olavs Hospital Trondheim, Norway Less <<
NCT00699023 Postprandial Lipemia ... More >> Type 2 Diabetes Less << Phase 4 Completed - Italy ... More >> Department of Clinical and Experimental Medicine, Federico II University Hospital, Naples, Italy, 80131 Less <<
NCT00424255 Neoplasms, Head and Neck Phase 3 Completed - -
NCT00771576 - Completed - United States, New York ... More >> Naomi Berrie Diabetes Cener New York, New York, United States, 10032 Kreitchman PET Center Columbia University Medical Center New York, New York, United States, 19932 Less <<
NCT02599480 Hypertrophy, Left Ventricular Phase 2 Enrolling by invitation January 2020 Belgium ... More >> Cliniques universitaires Saint-Luc Brussels, Belgium, 1200 France Nantes university hospital (CHU Nantes) Nantes, France, 44000 Germany Center for Cardiovascular Research Berlin (CCR/Charité) Berlin, Germany, 10115 University Medical Center Göttingen (UMG-GOE) Göttingen, Germany, 37099 Greece Athens University Medical School (NKUA) Athens, Greece, 115 27 Italy Hospital "Papa Giovanni XXIII" (HPG23) Bergamo, Italy, 1 - 24127 Poland Department of Heart Diseases at Wroclaw Medical University (UMW) Wroclaw, Poland, 50-981 Portugal Association for Research and Development of the Faculty of Medicine (AIDFM) Lisbon, Portugal, 1649-028 United Kingdom University of Oxford - Division of Cardiovascular Medicine (UOXF) Oxford, United Kingdom, OX3 9DU Less <<
NCT02059811 Hypertension ... More >>Chronic Kidney Disease Less << Not Applicable Completed - United States, North Carolina ... More >> Stedman Nutrition and Metabolism Center, Center for Living Durham, North Carolina, United States, 27705 Less <<
NCT03159312 Bariatric Surgery Candidate Not Applicable Active, not recruiting March 13, 2018 Spain ... More >> Universidad de Granada Granada, Spain, 18071 Less <<
NCT00424255 - Completed - -
NCT03672513 Menopause Nut... More >>ritional Intervention Bone Diseases Less << Not Applicable Completed - Spain ... More >> Universidad de Granada Granada, Spain, 18071 Less <<
NCT01174446 Hemophilia B Phase 3 Completed - -
NCT02310178 Obesity, Morbid ... More >> Bariatric Surgery Candidate Less << Phase 4 Unknown May 2016 France ... More >> CHRU - Hôpital Saint Eloi Recruiting Montpellier, France, 34295 Contact: David NOCCA, PUPH    0467337731 ext +33    d-nocca@chu-montpellier.fr Less <<
NCT03027960 Heart Failure ... More >> Type II; Diabetes Less << Phase 2 Enrolling by invitation June 2022 United States, Connecticut ... More >> Yale New Haven Hospital New Haven, Connecticut, United States, 06511 Less <<
NCT01405196 Lupus Erythematosus, Systemic Phase 2 Completed - -
NCT01174446 - Completed - -
NCT02271984 Healthy Phase 1 Completed - Germany ... More >> Please contact the Merck KGaA Communication Center Darmstadt, Germany Less <<
NCT02271984 - Completed - -
NCT00048165 Heart Transplantation Phase 4 Completed - -
NCT01405196 - Completed - -
NCT03576001 Spinal Cord Injuries Phase 2 Not yet recruiting June 2023 -
NCT01466556 - Unknown August 2012 Israel ... More >> Hillel Yaffe Medical Center Recruiting Hadera, Israel Principal Investigator: Renata Yaakobov, MD Less <<
NCT03487185 Obstructive Sleep Apnea of Adu... More >>lt Preeclampsia Obstetrical Complications Less << Not Applicable Recruiting June 2024 United States, Alabama ... More >> University of Alabama - Birmingham Recruiting Birmingham, Alabama, United States, 35233 Contact: Stacy Harris, RN    205-996-6262    stacylharris@uabmc.edu    Principal Investigator: Alan TN Tita, MD          United States, Illinois Northwestern University Recruiting Chicago, Illinois, United States, 60611 Contact: Gail Mallett, RN    312-503-3200    g-mallett@northwestern.edu    Principal Investigator: William Grobman, MD          United States, New York Columbia University Recruiting New York, New York, United States, 10032 Contact: Sabine Bousleiman, RN    212-305-4348    sb1080@columbia.edu    Principal Investigator: Cynthia Gyamfi-Bannerman, MD          United States, North Carolina University of North Carolina - Chapel Hill Recruiting Chapel Hill, North Carolina, United States, 27599 Contact: Kelly Clark, RN    919-350-6117    kelly_clark@med.unc.edu    Principal Investigator: John M Thorp, MD          United States, Ohio Case Western Reserve-Metro Health Recruiting Cleveland, Ohio, United States, 44109 Contact: Wendy Dalton, RN    216-778-7533    wdalton@metrohealth.org    Principal Investigator: Edward Chien, MD          Ohio State University Hospital Recruiting Columbus, Ohio, United States, 43210 Contact: Anna Bartholomew, RN    614-685-3229    anna.bartholomew@osumc.edu    Principal Investigator: Mark Landon, MD          United States, Pennsylvania Hospital of the University of Pennsylvania Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Jennifer Craig, BSN    212-662-3926    jennifer.craig@uphs.upenn.edu    Principal Investigator: Samuel Parry, MD          Magee Women's Hospital of UPMC Recruiting Pittsburgh, Pennsylvania, United States, 15213 Contact: Melissa Bickus, RN    412-641-4072    mbickus@mail.magee.edu    Principal Investigator: Hyagriv Simhan, MD          United States, Rhode Island Brown Univeristy Recruiting Providence, Rhode Island, United States, 02905 Contact: Donna Allard, RN    401-274-1122    dallard@wihri.org    Principal Investigator: Dwight J Rouse, MD          United States, Texas University of Texas Medical Branch Recruiting Galveston, Texas, United States, 77555 Contact: Ashley Salazar, MSN    409-772-0312    assalaza@utmb.edu    Principal Investigator: George R Saade, MD          University of Texas - Houston Recruiting Houston, Texas, United States, 77030 Contact: Felecia Ortiz, RN    713-500-6467    felecia.ortiz@uth.tmc.edu    Principal Investigator: Suneet Chauhan, MD          United States, Utah University of Utah Medical Center Recruiting Salt Lake City, Utah, United States, 84132 Contact: Kim Hill, RN    801-585-7645    kim.hill@hsc.utah.edu    Principal Investigator: Michael W Varner, MD Less <<
NCT01468220 Metabolic Syndrome Not Applicable Active, not recruiting March 2018 Germany ... More >> Charite University Medicine, ECRC Berlin, Germany, 13125 Less <<
NCT03419039 Dementia Infl... More >>ammation Mild Cognitive Impairment Coronary Artery Disease Less << Not Applicable Recruiting December 31, 2020 Norway ... More >> Stavanger University Hospital Recruiting Stavanger, Rogaland, Norway Contact: Anne Katrine Bergland, MD    +47 91595103    anne.katrine.bergland@sus.no Less <<
NCT01038778 Clear Cell Renal Cell Carcinom... More >>a Metastatic Renal Cell Cancer Stage III Renal Cell Cancer AJCC v7 Stage IV Renal Cell Cancer AJCC v7 Less << Phase 1 Phase 2 Active, not recruiting - United States, California ... More >> USC / Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 United States, Maryland Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States, 21287 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263 United States, Ohio Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43210 Less <<
NCT00175071 Hyperlipidemias ... More >> Metabolic Syndrome X Cardiovascular Diseases Less << Not Applicable Completed - United States, Massachusetts ... More >> Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University Boston, Massachusetts, United States, 02111 Less <<
NCT00885313 Fatty Liver L... More >>iver Fibrosis Obesity Metabolic Syndrome Nonalcoholic Fatty Liver Disease Less << Phase 1 Phase 2 Completed - Italy ... More >> Bambino Gesù Hospital and Research Institute Rome, Italy, 00165 Less <<
NCT00087607 Hepatitis C, Chronic Phase 4 Completed - -
NCT00175084 Hyperlipidemias ... More >> Metabolic Syndrome X Cardiovascular Diseases Less << Not Applicable Completed - United States, Massachusetts ... More >> Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University Boston, Massachusetts, United States, 02111 Less <<
NCT01475968 Metabolic Syndrome Not Applicable Completed - United States, North Carolina ... More >> EPA Human Studies Facility Chapel Hill, North Carolina, United States, 27599 Less <<
NCT03769675 Painful Diabetic Neuropathy Not Applicable Recruiting December 2021 United States, Minnesota ... More >> Mayo Clinic in Rochester Recruiting Rochester, Minnesota, United States, 55905 Contact: Anita D Stoltenberg, RRT, MHA    507-422-0582    Stoltenberg.Anita@mayo.edu    Contact: Lavonne M Liedl, RRT    866-265-9263    Liedl.Lavonne@mayo.edu    Principal Investigator: Narayan R Kissoon, M.D. Less <<
NCT00087607 - Completed - -
NCT00951119 Hypertension in Type 2 Diabete... More >>s Less << Phase 3 Completed - Netherlands ... More >> Isala Clinics, Diabetes Centre Zwolle, Netherlands, 8000 GM Isala clinics Zwolle, Netherlands, 8000 GM Less <<
NCT01571947 Metabolic Syndrome Not Applicable Completed - Malaysia ... More >> Malaysia Palm oil Board Kajang, Selangor, Malaysia, 43000 Malaysian Palm Oil Board (MPOB) Kajang, Selangor, Malaysia, 43000 Less <<
NCT00994253 Hypertension ... More >>Diabetes Type 2 Less << Phase 4 Withdrawn(Due to safety concer... More >>ns re the concomitant use of aliskiren with an ACEi or ARB.) Less << December 2012 United States, Michigan ... More >> William Beaumont Hospital Royal Oak, Michigan, United States, 48073 Less <<
NCT01595828 Metabolic Syndrome Phase 1 Completed - United Kingdom ... More >> Kowa Research Europe Ltd. Wokingham, United Kingdom Less <<
NCT00048165 - Completed - -
NCT01618526 Metabolic Syndrome Not Applicable Completed - Denmark ... More >> Aarhus University Aarhus, Denmark, 8000 Less <<
NCT00308672 - Unknown - Taiwan ... More >> China Medical University Hospital Recruiting Taichung city, Taiwan, 404 Contact: Li C Ing, MS    886-4-22052121 ext 4263    a6446@www.cmuh.org.tw Less <<
NCT01001962 Hypertension ... More >>Type II Diabetes Less << Phase 4 Not yet recruiting January 2020 Greece ... More >> Hypertension 24h ABPM center Papageorgiou Hospital Not yet recruiting Thessaloniki, Greece Contact: VASILEIOS KOTSIS, PROF          Principal Investigator: VASILEIOS KOTSIS, PROF Less <<
NCT01668888 - Completed - Korea, Republic of ... More >> Korea University Guro Hospital Seoul, Korea, Republic of Less <<
NCT01034436 Weight Reduction and Insulin S... More >>ensitivity Less << Not Applicable Completed - Norway ... More >> Akershus University College Oslo, Lillestrom, Norway, 2001 Less <<
NCT01038895 Hypertension ... More >>Type 2 Diabetes Less << Phase 4 Unknown June 2011 Italy ... More >> University of Pavia Recruiting Pavia, PV, Italy, 27100 Contact: Amedeo Mugellini, MD    +39 0382 526217    amedeo.mugellini@unipv.it    Principal Investigator: Amedeo Mugellini, MD Less <<
NCT03709680 Solid Tumors ... More >>Ewing Sarcoma Rhabdoid Tumor Rhabdomyosarcoma Neuroblastoma Medulloblastoma Less << Phase 1 Not yet recruiting September 27, 2023 -
NCT01700530 Metabolic Syndrome ... More >> Obese Sedentary Less << Not Applicable Completed - United States, Missouri ... More >> University of Missouri Columbia, Missouri, United States, 65211 Less <<
NCT01713465 Metabolic Syndrome Not Applicable Unknown April 2013 India ... More >> Center for Public Health informatics, AIPH Recruiting Bhubaneshwar, Orissa, India, 751002 Contact: Shruti Mehta, PGDHHM    8763717844    drshruti.mehta1@gmail.com Less <<
NCT00349284 Hyperlipidemia Combined Phase 3 Completed - Belgium ... More >> Site 113 Charleroi, Belgium Site 112 Couillet, Belgium Site 115 Dessel, Belgium Site 114 Dour, Belgium Site 106 Genk, Belgium Site 102 Genly, Belgium Site 111 Komen, Belgium Site 109 Kortessem, Belgium Site 104 Kortrijk, Belgium Site 108 Luik, Belgium Site 107 Menen, Belgium Site 105 Moen, Belgium Site 101 Oosteeklo, Belgium Site 110 Oostham, Belgium Site 116 Seraing, Belgium Site 103 Turnhout, Belgium France Site 213 Bondy, France Site 211 Le Beausset, France Site 209 Nantes, France Site 202 Orvault, France Site 212 Paris Cedex, France Site 206 Paris, France Site 208 Paris, France Site 203 Saint Cyr, France Site 210 Six Fours les Plages, France Site 201 St Sébastian sur Loire, France Site 205 St Sébastian sur Loire, France Site 207 St Sébastian sur Loire, France Site 204 Toulon, France Germany Site 313 Borna, Germany Site 307 Bretten, Germany Site 306 Dresden, Germany Site 305 Erbach, Germany Site 304 Frankfurt, Germany Site 308 Frankfurt, Germany Site 311 Frankfurt, Germany Site 301 Ilvesheim, Germany Site 302 Leipzig, Germany Site 303 Leipzig, Germany Site 314 Mannheim, Germany Site 309 Offenbach, Germany Site 312 Offenbach, Germany Site 310 Rodgau, Germany Less <<
NCT01080404 Obstructive Sleep Apnea ... More >> Obesity Less << Not Applicable Recruiting November 2018 Finland ... More >> Helsinki University hospital Not yet recruiting Helsinki, Finland, 00029 Contact: Marja Leivonen, MD, PhD       marja.leivonen@hus.fi    Principal Investigator: Marja Leivonen, MD, PhD          Sub-Investigator: Anne Juuti, MD, PhD          National Institute for Health and Welfare Not yet recruiting Helsinki, Finland, 00271 Contact: Markku Peltonen, PhD       markku.peltonen@thl.fi    Principal Investigator: Markku Peltonen, PhD          Helsinki Sleep Center Not yet recruiting Helsinki, Finland, 00420 Contact: Markku Partinen, MD, PhD       markku.partinen@helsinki.fi    Principal Investigator: Markku Partinen, MD, PhD          Eastern Finland Laboratory Centre Recruiting Kuopio, Finland, 70211 Contact: Kari Punnonen, MD, PhD       kari.punnonen@islab.fi    Principal Investigator: Kari Punnonen, MD, PhD          Kuopio University hospital Recruiting Kuopio, Finland, 70211 Contact: Juha Seppä, MD, PhD       juha.seppä@kuh.fi    Sub-Investigator: Matti Pääkkönen, MD, PhD          Sub-Investigator: Sari Grönlund, MD, PhD          Principal Investigator: Henri Tuomilehto, MD, PhD          Principal Investigator: Jussi Pihlajamäki, MD, PhD          Sub-Investigator: Juha Seppä, MD, PhD          Sub-Investigator: Helena Gylling, MD, PhD          Sub-Investigator: Matti Uusitupa, MD, PhD          Sub-Investigator: Esa Mervaala, MD, PhD          Päijät-Häme Central hospital Not yet recruiting Lahti, Finland, 15850 Contact: Jyrki Kössi, MD, PhD       jyrki.kossi@phks.fi    Principal Investigator: Jyrki Kössi, MD, PhD          Oulu University hospital Not yet recruiting Oulu, Finland, 90029 Contact: Vesa Koivukangas, MD, PhD       vesa.koivukangas@ppshp.fi    Principal Investigator: Vesa Koivukangas, MD, PhD          Sub-Investigator: Timo Heikkinen, MD, PhD          Turku University hospital Not yet recruiting Turku, Finland, 20521 Contact: Paulina Salminen, MD, PhD       paulina.salminen@tyks.fi    Principal Investigator: Paulina Salminen, MD, PhD          Sub-Investigator: Jari Ovaska, MD, PhD          Vaasa Central hospital Recruiting Vaasa, Finland, 65100 Contact: Mikael Victorzon, MD, PhD       mikael.victorzon@vshp.fi    Principal Investigator: Mikael Victorzon, MD, PhD          Sub-Investigator: Pipsa Peromaa, MD Less <<
NCT01700530 - Completed - -
NCT01755104 Metabolic Syndrome Not Applicable Completed - Canada, Quebec ... More >> Institut des Nutraceutiques et des Aliments Fonctionnels (INAF) Laval, Quebec, Canada France Institut CardioMetabolisme et Nutrition (ICAN) Paris, France Less <<
NCT01758601 Cardiovascular Risk Factors ... More >> Metabolic Syndrome Less << Phase 3 Completed - Spain ... More >> Hospital Universitario Ramón y Cajal Madrid, Spain, 28034 Less <<
NCT01676870 Metabolic Syndrome Not Applicable Active, not recruiting December 31, 2019 Australia ... More >> School of Human Movement Studies, University of Queensland St Lucia, Australia Brazil University of Sao Paulo São Paulo, Brazil Ecuador KJ Fisioterapi Guayaquil, Ecuador Germany Internal Medicine, Cardiology, Sports Medicine Chair Dep. Prevention, Rehabilitation and Sports Medicine Faculty of Medicine University Hospital Munich, Germany Norway Stavanger University Hospital Stavanger, Norway St. Olavs hospital Trondheim, Norway Less <<
NCT02711618 Unwanted Fat Not Applicable Active, not recruiting November 2017 United States, Florida ... More >> Sanctuary Plastic Surgery Boca Raton, Florida, United States, 33431 United States, New York 833 Northern Boulevard Great Neck, New York, United States, 11021 Laser and Skin Surgery Center New York, New York, United States, 10016 Less <<
NCT01741298 Metabolic Syndrome Not Applicable Completed - -
NCT01688622 Metabolic Syndrome ... More >> Obesity Less << Not Applicable Completed - Korea, Republic of ... More >> Korea University Guro Hospital Seoul, Korea, Republic of Less <<
NCT01826357 - Unknown February 2014 Taiwan ... More >> WanFang Medical Center at Taipei Medical University Recruiting Taipei City, Taiwan, 116 Contact: Ming I Hsu, MD    886-2-2930-7930 ext 2508    hsumingi@yahoo.com.tw Less <<
NCT01847807 Metabolic Syndrome Phase 3 Completed - China, Gansu ... More >> Lanzhou University Second Hospital Lanzhou, Gansu, China, 730030 Less <<
NCT01829945 - Completed - Canada ... More >> Institute of Nutrition and Functional Foods (INAF) Quebec, Canada, G1V 0A6 Less <<
NCT01901978 Obesity Insul... More >>in Resistance Less << Not Applicable Active, not recruiting August 2018 United States, Connecticut ... More >> Yale University New Haven, Connecticut, United States, 06520 Less <<
NCT01911078 Metabolic Syndrome Not Applicable Completed - Greece ... More >> Hippocration Hospital, University of Athens Athens, Greece Less <<
NCT01958424 - Completed - Israel ... More >> Sapir Medical Center, Meir Hospital Kfar-Saba, Israel Less <<
NCT01357304 Type 2 Diabetes ... More >> Hypertension Less << Not Applicable Completed - Sweden ... More >> Center for Primary Health Care Research, Lund University/Region Skane Malmö, Sweden Less <<
NCT01691404 Hypertension ... More >>Endothelial Dysfunction Less << Not Applicable Completed - Netherlands ... More >> Wageningen University Wageningen, Netherlands, 6703 HD Less <<
NCT02069717 - Withdrawn - Korea, Republic of ... More >> Chonnam national university hospital Gwangju, Korea, Republic of, 501-757 Less <<
NCT02013947 Metabolic Syndrome Not Applicable Unknown December 2014 Italy ... More >> Gutwenger Ivana Bressanone, Bolzano, Italy, 39042 Less <<
NCT00601172 Nausea and Vomiting, Chemother... More >>apy-Induced Less << Phase 3 Completed - -
NCT00583999 - Completed - United States, California ... More >> UC Davis Medical Center Sacramento, California, United States, 95817 Less <<
NCT02082106 - Completed - Austria ... More >> University Institute of Sports Medicine, Prevention and Rehabilitation Salzburg, Austria, A-5020 Less <<
NCT00950859 Infection, Human Immunodeficie... More >>ncy Virus Less << Phase 2 Completed - -
NCT00601172 - Completed - -
NCT01614990 Cancer Cachexia Phase 2 Recruiting December 2020 United States, Washington ... More >> Veterans Affairs Puget Sound Health Care System Recruiting Seattle, Washington, United States, 98108 Contact: Jose M Garcia, MD, PhD    206-764-2984    jg77@uw.edu    Contact: Lindsey J Anderson, PhD    206-277-6719 ext 6719    lindsey.anderson@va.gov    Principal Investigator: Jose M Garcia, MD, PhD Less <<
NCT02130336 Metabolic Syndrome X ... More >> Exercise Physical Activity Less << Not Applicable Unknown July 2015 Taiwan ... More >> National Taiwan University Hospital Recruiting Taipei, Taiwan, 100 Contact: Meng-Yueh Chien, Ph.D    886-2-33668141    mychien@ntu.edu.tw Less <<
NCT00950859 - Completed - -
NCT02737306 Graft Vs Host Disease Phase 2 Recruiting December 2019 United States, Florida ... More >> University of Miami Sylvester Comprehensive Cancer Center Recruiting Miami, Florida, United States, 33136 United States, Illinois Loyola University Medical Center Cardinal Bernardin Cancer Center Recruiting Maywood, Illinois, United States, 60153 United States, Michigan Barbara Ann Karmanos Cancer Institute Recruiting Detroit, Michigan, United States, 48201 United States, Minnesota University of Minnesota Recruiting Minneapolis, Minnesota, United States, 55409 United States, North Carolina Wake Forest Baptist Health Recruiting Winston-Salem, North Carolina, United States, 27157 United States, Pennsylvania University of Pennsylvania Recruiting Philadelphia, Pennsylvania, United States, 19104 United States, Texas Texas Transplant Institute Methodist Hospital Recruiting San Antonio, Texas, United States, 78229 United States, West Virginia West Virginia University Medicine Recruiting Morgantown, West Virginia, United States, 26506 Less <<
NCT02143349 Metabolic Syndrome ... More >> Obesity Less << Phase 3 Unknown May 2015 Australia, Victoria ... More >> College of Health and Biomedicine Victoria University Recruiting St. Albans, Victoria, Australia, 14428 Contact: Dr. Xiao Su    +61399192318    xiao.su@vu.edu.au    Contact: A/Prof Michael Mathai    +61399192211    michael.mathai@vu.edu.au    Principal Investigator: Dr. Xiao Su          Sub-Investigator: A/Prof Michael Mathai Less <<
NCT02136615 - Completed - Australia, South Australia ... More >> Hyperbaric Medicine Unit, Royal Adelaide Hospital Adelaide, South Australia, Australia, 5000 Less <<
NCT02008838 Metabolic Syndrome Phase 2 Phase 3 Completed - -
NCT00632840 Obesity Lipid... More >> Disorders Hypertriglyceridemia Cardiovascular Disease Less << Phase 4 Completed - -
NCT01372176 Critical Illness ... More >> Intensive Care (ICU) Myopathy Muscle Wasting Loss of Physical Function Mechanical Ventilation Less << Phase 4 Completed - Denmark ... More >> Department of Intensive Care, Rigshospitalet Copenhagen, Denmark, 2100 Less <<
NCT03582137 Parkinson Disease Phase 2 Not yet recruiting June 2019 -
NCT03128450 Parkinson Disease Phase 2 Phase 3 Enrolling by invitation November 1, 2018 China, Jiangsu ... More >> Department of Neurology, Second Affiliated Hospital of Soochow University Suzhou, Jiangsu, China, 215004 Less <<
NCT02219906 Metabolic Syndrome Phase 3 Enrolling by invitation December 2018 United States, Tennessee ... More >> Vanderbilt University Nashville, Tennessee, United States, 37232 United States, Texas Baylor University Houston, Texas, United States, 77004 Less <<
NCT02252081 Chronic Kidney Disease ... More >> Cardiovascular Disease Metabolic Syndrome Less << Phase 2 Recruiting December 31, 2019 United States, Tennessee ... More >> Tennessee Valley Healthcare System Nashville Campus, Nashville, TN Recruiting Nashville, Tennessee, United States, 37212-2637 Contact: Adriana M Hung, MD MPH    615-873-6731    Adriana.Hung@va.gov    Contact: Cindy A Booker    (615) 343-5828    cindy.a.booker@vanderbilt.edu    Principal Investigator: Adriana M Hung, MD MPH Less <<
NCT02143479 - Completed - France ... More >> Site Besancon, France Site Bordeaux, France Site Caen, France Site Chambray les Tours, France Site Clichy, France Site Creteil, France Site Grenoble, France Site Lille, France Site Limoges, France Site Lyon 3, France Site Lyon 4, France Site Marseille, France Site Montpellier, France Site Nice, France Site Paris, France Site Rennes, France Site Toulouse, France Site Villejuif, France Less <<
NCT02254850 Metabolic Syndrome Phase 4 Completed - Italy ... More >> Ugo Oliviero Via Pansini, 5, Napoli, Italy, 80131 Less <<
NCT03718338 Prostate Adenocarcinoma Not Applicable Not yet recruiting July 25, 2022 United States, Washington ... More >> Fred Hutch/University of Washington Not yet recruiting Seattle, Washington, United States, 98109 Contact: Celestia Higano Less <<
NCT02297555 Metabolic Syndrome Not Applicable Terminated - France ... More >> Hôpital Avicenne Bobigny, France Hopital Ambroise Pare (Ap-Hp) Boulogne Billancourt, France Hopital Louis Mourier Colombes, France University Hospital Lille Lille, France, 59000 Hospice civils de Lyon Lyon, France Assistance Publique des Hôpitaux de Marseille Marseille, France Centre Hospitalier Universitaire Montpellier, France Centre Hospitalier Universitaire Nantes, France Nouvel Hôpital Civil Strasbourg, France Hopital Larrey- Chu Toulouse, France Less <<
NCT02298621 Metabolic Syndrome Not Applicable Completed - Iran, Islamic Republic of ... More >> Urmia University of Medical Sciences Urmia, Iran, Islamic Republic of, +98 Less <<
NCT00700024 Hypogonadism ... More >>Metabolic Syndrome Less << Phase 4 Unknown February 2010 Denmark ... More >> Odense University Hospital Odense, Denmark, 5000 Less <<
NCT00770016 Hypothyroidism Not Applicable Terminated(no longer intereste... More >>d in doing the study) Less << January 2011 Denmark ... More >> Medical department M (Endocrinology and Diabetes), Aarhus University Hospital, Aarhus Sygehus, Aarhus, Denmark, 8000 Less <<
NCT02384694 Metabolic Syndrome Not Applicable Completed - Switzerland ... More >> Department for Sports, Exercise and Health, Sports and Exercise Medicine, University of Basel Basel, Switzerland, 4052 Less <<
NCT01174732 Asthma Bronch... More >>ospasm Less << Phase 2 Completed - United States, California ... More >> Amphastar Site 0001 San Jose, California, United States, 95117 United States, Colorado Amphastar Site 0007 Centennial, Colorado, United States, 80112 Amphastar Site 0008 Denver, Colorado, United States, 80230 Amphastar Site 0039 Lakewood, Colorado, United States, 80401 Less <<
NCT02409173 Metabolic Syndrome Not Applicable Enrolling by invitation July 2020 Brazil ... More >> Gastromed Anápolis, GO, Brazil, 75083-515 Department of Surgery of Santa Casa of Sao Paulo Medical School Sao Paulo, SP, Brazil, 01221-010 Pulmonary Function Laboratory of Santa Casa of Sao Paulo Medical School Sao Paulo, SP, Brazil, 01221010 Less <<
NCT02379702 - Completed - Turkey ... More >> Ankara University Ankara, Turkey Gazi University Ankara, Turkey Yuksek Ihtisas Hospital Ankara, Turkey Istanbul Cerrahpasa University Istanbul, Turkey Istanbul Medeniyet University Istanbul, Turkey Prof. Dr. Omer Kozan İzmir, Turkey Less <<
NCT02497352 Metabolic Syndrome Phase 2 Phase 3 Completed - -
NCT02406664 Metabolic Syndrome Not Applicable Unknown December 2017 Korea, Republic of ... More >> Hanyang University Hospital Recruiting Seoul, Korea, Republic of, 133-792 Contact: Tae Kyung Ha, MD, PhD    82-2-2290-8444    missurgeon@hanyang.ac.kr Less <<
NCT02518854 - Completed - Taiwan ... More >> Kaohsiung Chang Gung Memorial Hospital Kaohsiung, Taiwan, 833 Less <<
NCT02447523 - Completed - -
NCT02930161 Non-alcoholic Fatty Liver Dise... More >>ase Less << Phase 2 Recruiting November 2020 Russian Federation ... More >> Company "Clinic of professor Gorbakov" Ltd. Recruiting Krasnogorsk, Russian Federation, 143405 City Hospital of the Holy Martyr Elizabeth Recruiting Saint-Petersburg, Russian Federation, 197706 Medical Company "Hepatologist" Ltd. Recruiting Samara, Russian Federation, 443063 Less <<
NCT02542176 Metabolic Syndrome X Not Applicable Completed - United States, Connecticut ... More >> University of Connecticut Storrs, Connecticut, United States, 06269 Less <<
NCT02531334 Metabolic Syndrome X Not Applicable Completed - United States, Connecticut ... More >> University of Connecticut Storrs, Connecticut, United States, 06269 Less <<
NCT03767959 Pancreaticoduodenectomy Not Applicable Not yet recruiting July 2020 -
NCT03128905 Chondrocalcinosis Phase 3 Recruiting August 5, 2019 France ... More >> CH Valenciennes Not yet recruiting Valenciennes, Hauts-de-France, France, 59322 Contact: Xavier Deprez, MD    03 27 14 33 95 ext +33    deprez-x@ch-valenciennes.fr    Principal Investigator: Xavier Deprez, MD          Hôpital Bichat Not yet recruiting Paris, Ile De France, France, 75018 Contact: Sébastien OTTAVIANI, MD    01 40 25 74 01 ext +33       CHRU Lille Not yet recruiting Lille, Nord Pas De Calais, France, 59000 Contact: René-Marc Flipo, MD, PhD    03 20 44 61 20 ext +33    Rene-marc.flipo@chru-lille.fr    Principal Investigator: René-Marc Flipo, MD, PhD          Sub-Investigator: François Puisieux, MD, PhD          Lille Catholic Hospital Recruiting Lille, Nord Pas De Calais, France, 59462 Contact: Amélie Lansiaux, MD, PhD    03 20 22 57 41 ext +33    Lansiaux.amelie@ghicl.net    Contact: Marine Deseur    03 20 22 57 01 ext +33    deseur.marine@ghicl.net    Principal Investigator: Tristan Pascart, MD          Principal Investigator: Eric Houvenagel, MD, PhD          Sub-Investigator: Stéphanie Vancompernolle, MD          Sub-Investigator: Pierre Graux, MD, PhD          Sub-Investigator: Damien Lucidarme, MD, PhD          Sub-Investigator: Hélène Bulckaen, MD          Sub-Investigator: Pierre Robinet, MD          Sub-Investigator: Philippe Delecluse, MD          Sub-Investigator: Jean-François Desrousseaux, MD, PhD          Principal Investigator: Xavier Deplanque, MD          Sub-Investigator: Jean-Jacques Leduc, MD          Hôpital de Lariboisière Not yet recruiting Paris, Île De France, France, 75010 Contact: Pascal RICHETTE, MD, PhD    01 49 95 63 06 ext +33 Less <<
NCT03223038 - Enrolling by invitation March 31, 2019 United States, Massachusetts ... More >> Boston Children's Hospital Boston, Massachusetts, United States, 02115 Less <<
NCT00374322 Neoplasms, Breast Phase 3 Completed - -
NCT02633891 Metabolic Syndrome ... More >> Autonomic Neuropathy Less << Not Applicable Recruiting December 31, 2020 United States, Maryland ... More >> Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD Recruiting Baltimore, Maryland, United States, 21201 Contact: Lindsay A Zilliox, MD    410-328-3100    lzilliox@som.umaryland.edu    Principal Investigator: Lindsay A Zilliox, MD Less <<
NCT02696304 Metabolic Syndrome X Not Applicable Unknown December 2016 France ... More >> Assistance Publique Hopitaux de Marseille Recruiting Marseille, France, 13354 Contact: Claire Oudin       claire.oudin@ap-hm.fr    Principal Investigator: Claire Oudin, MD Less <<
NCT00641550 Preeclampsia ... More >>Gestational Diabetes Less << Not Applicable Unknown December 2011 Brazil ... More >> Universidade Estadual da Paraiba Recruiting Campina Grande, Paraiba, Brazil, 58100-000 Contact: Adriana Melo, MSc    55-83-99732726    asomelo@gmail.com    Contact: Melania Amorim, PhD    55-83-88221514    melamorim@uol.com.br    Principal Investigator: Adriana Melo, MSc          Universidade Estadual da Paraíba Recruiting Campina Grande, Paraíba, Brazil, 58100-000 Contact: Adriana Melo, MSc    55-83-99732726    asomelo@gmail.com    Contact: Melania Amorim, PhD    55-83-88221514    melamorim@uol.com.br    Principal Investigator: Adriana Melo, MSc Less <<
NCT00374322 - Completed - -
NCT00004363 - Completed - United States, Illinois ... More >> Northwestern University Medical School Chicago, Illinois, United States, 60611 Less <<
NCT01881074 - Completed - United States, Florida ... More >> University of Florida Gainesville, Florida, United States, 32610 Less <<
NCT01862029 - Completed - -
NCT01862029 Obesity Phase 1 Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT02746887 - Unknown - Korea, Republic of ... More >> Seung Han Shin Recruiting Seoul, Korea, Republic of, 110-744 Contact: Seung Han Shin, MD    +82-2072-7230    revival421@empas.com    Sub-Investigator: Young Hwa Jung, MD Less <<
NCT00005131 - Completed - -
NCT02948439 Pregnancy Not Applicable Recruiting December 2019 Canada, Alberta ... More >> Program for Pregnancy and Postpartum Health, University of Alberta Recruiting Edmonton, Alberta, Canada, T6G 2E1 Contact: Margie Davenport, PhD    780-492-0642    mdavenpo@ualberta.ca Less <<
NCT00089973 Neoplasms, Breast Phase 2 Completed - United States, Florida ... More >> GSK Investigational Site Jacksonville, Florida, United States, 32224 United States, Indiana GSK Investigational Site Indianapolis, Indiana, United States, 46202 United States, North Carolina GSK Investigational Site Chapel Hill, North Carolina, United States, 27599 United States, Pennsylvania GSK Investigational Site Pittsburgh, Pennsylvania, United States, 15213 Belgium GSK Investigational Site Bruxelles, Belgium, 1000 Malaysia GSK Investigational Site Bandar Tun Razak, Cheras, Malaysia, 56000 GSK Investigational Site Bandar Tun Razak, Cheras, Malaysia, 59100 Singapore GSK Investigational Site Singapore, Singapore, 119074 GSK Investigational Site Singapore, Singapore, 169610 United Kingdom GSK Investigational Site Southampton, Hampshire, United Kingdom, SO16 6YD GSK Investigational Site Manchester, Lancashire, United Kingdom, M20 4BX GSK Investigational Site Newcastle Upon Tyne, Northumberland, United Kingdom, NE4 6BE GSK Investigational Site London, United Kingdom, W12 0NN Less <<
NCT00089973 - Completed - -
NCT01934777 Fatty Liver L... More >>iver Fibrosis Obesity Metabolic Syndrome Nonalcoholic Fatty Liver Disease Less << Phase 3 Completed - Italy ... More >> Bambino Gesù Hospital and Research Institute Rome, Rome, Italy, Italy, 00165 Less <<
NCT02817620 Metabolic Syndrome Not Applicable Completed - France ... More >> Biofortis Mérieux NutriSciences Clinical Investigation Center Saint Herblain, France, 44800 Less <<
NCT00006192 - Completed - -
NCT00143949 Type 1 Diabetes Phase 2 Completed - Canada, Ontario ... More >> Mt Sinai Hospital, University of Toronto (Clinical Ctr) Toronto, Ontario, Canada, M5G 1X5 Canada, Quebec Royal Victoria Hospital, McGill University (Data Center) Montreal, Quebec, Canada, H3A 1A1 Montreal Childrens Hospital, McGill University (Clinical Ctr) Montreal, Quebec, Canada, H3H 1P3 Less <<
NCT00173628 - Unknown - Taiwan ... More >> National Taiwan University Hospital Recruiting Taipei, Taiwan Contact: Yi-Ching Tung, MD    886-2-23123456 ext 5130    dtped004@yahoo.com.tw Less <<
NCT03454282 Breast Cancer ... More >> Melanoma, Malignant Less << Not Applicable Not yet recruiting December 31, 2020 Italy ... More >> Fondazione IRCCS Istituto Nazionale dei Tumori Milan, Italy, 20133 Less <<
NCT00005481 - Completed - -
NCT00222807 - Completed - United States, Pennsylvania ... More >> University of Pittsburgh Pittsburgh, Pennsylvania, United States, 15213 Less <<
NCT00214253 Type 1 Diabetes Phase 1 Completed - United States, Wisconsin ... More >> University of Wisconsin Madison, Wisconsin, United States, 53792 Less <<
NCT01023906 - Completed - United States, Massachusetts ... More >> Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University Boston, Massachusetts, United States, 02111 Less <<
NCT00077623 Anemia Phase 3 Completed - -
NCT01316939 Crohn's Disease Phase 3 Terminated(This study was term... More >>inated due to the lack of efficacy of GSK1605786A in Crohn's disease based on the results of Study CCX114151.) Less << - -
NCT02736669 Overweight Ob... More >>esity Less << Not Applicable Recruiting April 2020 United States, Alabama ... More >> University of Alabama at Birmingham, Medical Towers Building Recruiting Birmingham, Alabama, United States, 35205 Contact: Amy E Dobelstein    205-975-1059    adobelst@uabmc.edu Less <<
NCT00077623 - Completed - -
NCT00175253 Type 1 Diabetes Phase 2 Completed - Canada, Alberta ... More >> University of Alberta - Clinical Islet Transplant Program Edmonton, Alberta, Canada, T6G2C8 Less <<
NCT00817063 Eczema Phase 3 Completed - -
NCT03418896 Hypogonadism ... More >>Calcium Disorder Renal Disease Less << Not Applicable Recruiting December 31, 2019 Denmark ... More >> Department of Growth and Reproduction, Rigshospitalet Recruiting Copenhagen, Denmark, 2100 Contact: Li Juel Mortensen, MD    +4535459456       Rigshospitalet Recruiting Copenhagen, Denmark, 2100 Contact: Martin Blomberg Jensen, MD    +4535451865    blombergjensen@gmail.com    Principal Investigator: Martin Blomberg Jensen, MD Less <<
NCT02748317 Lower Urinary Tract Symptoms Phase 2 Active, not recruiting December 31, 2018 United States, District of Col... More >>umbia Children's National Medical Center Washington, District of Columbia, United States, 20010 MedStar National Rehabilitation Hospital Washington, District of Columbia, United States, 20010 Less <<
NCT00817063 - Completed - -
NCT01624792 Chronic Obstructive Pulmonary ... More >>Disease Muscle Wasting Less << Not Applicable Active, not recruiting April 2019 United States, Texas ... More >> Texas A&M University College Station, Texas, United States, 77843 Less <<
NCT02748356 Lower Urinary Tract Symptoms Phase 2 Active, not recruiting December 31, 2018 United States, District of Col... More >>umbia Children's National Medical Center Washington, District of Columbia, United States, 20010 MedStar National Rehabilitation Hospital Washington, District of Columbia, United States, 20010 Less <<
NCT01316939 - Terminated(This study was term... More >>inated due to the lack of efficacy of GSK1605786A in Crohn's disease based on the results of Study CCX114151.) Less << - -
NCT02034916 Breast Neoplasms ... More >> BRCA 1 Gene Mutation BRCA 2 Gene Mutation Less << Phase 2 Completed - -
NCT00843193 - Completed - -
NCT00843193 Asthma Phase 2 Completed - -
NCT03675815 HIV Infections Phase 4 Not yet recruiting January 15, 2022 -
NCT03070548 Advanced Solid Tumors Phase 1 Completed - Hungary ... More >> PRA Magyarorszag Kft, Fazis I-es Klinikai Farmakologiai Vizsgalohely Budapest, Hungary, 1077 Less <<
NCT03070548 - Completed - -
NCT02034916 - Completed - -
NCT01318993 Crohn's Disease Phase 3 Terminated(This study was term... More >>inated due to the lack of efficacy of GSK1605786A in Crohn's disease based on the results of Study CCX114151.) Less << - -
NCT01318993 - Terminated(This study was term... More >>inated due to the lack of efficacy of GSK1605786A in Crohn's disease based on the results of Study CCX114151.) Less << - -
NCT02467205 Rheumatoid Arthritis Not Applicable Completed - United Kingdom ... More >> Western Infimary Glasgow, Glasgow, UK, United Kingdom, G11 6NT Less <<
NCT01090492 - Completed - -
NCT00793871 Gastrointestinal Neoplasms, Ga... More >>strointestinal Stromal Tumors Less << Phase 4 Completed - China, Jiangsu ... More >> Nanjing Bayi Hospital Nanjing, Jiangsu, China, 210002 China Beijing Cancer Hospital Beijing, China, 100035 307 Hospital of PLA Beijing, China, 100071 Cancer Institute & Hospital Chinese Academy of Medical Sciences and PUMC Bejing, China, 100021 Less <<
NCT02673619 Hyperhidrosis Phase 2 Completed - United States, Nebraska ... More >> GSK Investigational Site Omaha, Nebraska, United States, 68134 United States, North Carolina GSK Investigational Site Raleigh, North Carolina, United States, 27612 United States, Texas GSK Investigational Site Austin, Texas, United States, 78759 GSK Investigational Site College Station, Texas, United States, 77845 GSK Investigational Site Houston, Texas, United States, 77030 Canada, Quebec GSK Investigational Site Montreal, Quebec, Canada, H2K 4L5 Less <<
NCT01090492 Raynaud's Disease ... More >> Peripheral Vascular Disease Less << Phase 2 Completed - -
NCT02293902 Rheumatoid Arthritis Phase 3 Completed - -
NCT02673619 - Completed - -
NCT00793871 - Completed - -
NCT02293902 - Completed - -
NCT00416741 - Completed - Greece ... More >> Hellenic Atherosclerosis Society Thessaloniki, Greece, 55132 Less <<
NCT00429195 Metabolic Syndrome Not Applicable Completed - Ireland ... More >> Nutrigenomics Research Group, Institute of Molecular Medicine, University of Dublin, Trinity College Dublin, Ireland, 8 Less <<
NCT01286272 Ann Arbor Stage III Grade 1 Fo... More >>llicular Lymphoma Ann Arbor Stage III Grade 2 Follicular Lymphoma Ann Arbor Stage III Grade 3 Follicular Lymphoma Ann Arbor Stage IV Grade 1 Follicular Lymphoma Ann Arbor Stage IV Grade 2 Follicular Lymphoma Ann Arbor Stage IV Grade 3 Follicular Lymphoma Grade 3a Follicular Lymphoma Less << Phase 2 Completed - -
NCT00429390 Metabolic Syndrome Not Applicable Completed - -
NCT00444717 Metabolic Syndrome ... More >> Oxidative Stress Inflammation Less << Phase 4 Completed - Japan ... More >> Tatsuaki Matsubara Nagoya, Aichi, Japan, 464-8651 Less <<
NCT03401632 - Active, not recruiting December 31, 2018 Spain ... More >> Hospital Universitario Puerto Real Cadiz, Andalucía, Spain, 11510 Hospital Regional Universitario de Málaga Málaga, Andalucía, Spain, 29010 Hospital de San Jorge Huesca, Aragón, Spain, 22004 Hospital de Barbastro Huesca, Aragón, Spain, 22300 Hospital Universitario Miguel Servet Zaragoza, Aragón, Spain, 50009 Hospital Universitario Río Hortega Valladolid, Castilla Y León, Spain, 47012 Hospital Universitario de Bellvitge Barcelona, Cataluña, Spain, 08907 Hospital Universitario Germans Trias i Pujol Barcelona, Cataluña, Spain, 08916 Hospital Universitario de Girona Josep Trueta Gerona, Cataluña, Spain, 17007 Hospital Universitario Arnau de Villanova Lérida, Cataluña, Spain, 25198 Hospital Universitario Mútua Terrassa Terrassa, Cataluña, Spain, 08221 Hospital General Universitario de Castellón Castelló de la Plana, Comunidad Valenciana, Spain, 12004 Hospital Clínico Universitario de Valencia Valencia, Comunidad Valenciana, Spain, 46010 Complejo Hospitalario Universitario A Coruña A Coruña, Galicia, Spain, 15006 Hospital Universitario Lucus Augusti Lugo, Galicia, Spain, 27003 Hospital de Manacor. Palma De Mallorca, Islas Baleares, Spain, 07500 Hospital Universitario del Tajo Aranjuez, Madrid, Spain, 28300 Hospital Universitario de Fuenlabrada Fuenlabrada, Madrid, Spain, 28942 Hospital Universitario Severo Ochoa Leganés., Madrid, Spain, 28911 Hospital Universitario Infanta Cristina Parla, Madrid, Spain, 28981 Hospital Universitario Clínico San Carlos Madrid, Spain, 28040 Hospital Universitario 12 de Octubre Madrid, Spain, 28041 Hospital Universitario La Paz Madrid, Spain, 28046 Hospital General Universitario Reina Sofía Murcia, Spain, 30003 Less <<
NCT00433082 Metabolic Syndrome Not Applicable Completed - -
NCT00452192 Metabolic Syndrome Phase 3 Completed - Germany ... More >> Clinical Research Center, Department of Nephrology and Hypertension, University of Erlangen-Nürnberg Erlangen, Germany, 91054 Less <<
NCT00515476 Metabolic Syndrome X Not Applicable Completed - Germany ... More >> Hannover Medical School Hannover, Germany Less <<
NCT00409318 Metabolic Syndrome Not Applicable Completed - United States, Massachusetts ... More >> MGH Boston, Massachusetts, United States, 02114 Less <<
NCT00493259 - Unknown June 2008 United States, Missouri ... More >> Children's Mercy Hospital Recruiting Kansas City, Missouri, United States, 64108 Contact: Adrienne Platt, MS CPNP    816-234-6456    aplatt@cmh.edu    Contact: Amy Fox    816-802-1208    arfox@cmh.edu    Principal Investigator: Adrienne Platt, MS, CPNP Less <<
NCT02517632 Chagas Disease ... More >> Chagas Cardiomyopathy Less << Phase 3 Completed - Brazil ... More >> Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation. Rio de Janeiro, Brazil, 21040-360 Less <<
NCT00543985 - Completed - -
NCT01436942 Ankylosing Spondyliti Not Applicable Completed - Norway ... More >> Diakonhjemmet Hospital Oslo, Norway Less <<
NCT00534183 Metabolic Syndrome ... More >> Diabetes Obesity Less << Not Applicable Completed - India ... More >> Central Institute of Psychiatry Ranchi, India, 834009 Less <<
NCT02333240 Pre-Eclampsia ... More >> Hypertension, Pregnancy-Induced Less << Not Applicable Completed - United Kingdom ... More >> Royal Berkshire NHS Foundation Trust Reading, Berkshire, United Kingdom, RG1 5AN Northampton General Hospital NHS Trust Northampton, Northamptonshire, United Kingdom, NN1 5BD Oxford University Hospitals NHS Foundation Trust Oxford, Oxfordshire, United Kingdom, OX3 9DU Stoke Mandeville Hospital Aylesbury, United Kingdom, HP21 8AL Horton General Hospital Banbury, United Kingdom, OX16 9AL Less <<
NCT00543985 Metabolic Syndrome ... More >> Obesity Less << Not Applicable Completed - -
NCT00627757 - Unknown December 2010 Denmark ... More >> Psychiatric University Center Glostrup Recruiting Copenhagen, Glostrup, Denmark, 2600 Contact: Henrik Lublin, MD DMSc    045-43233540    henlub01@glo.regionh.dk    Principal Investigator: Henrik Lublin, MD DMSc          Psychiatric University Center Glostrup Not yet recruiting Copenhagen, Glostrup, Denmark, 2600 Contact: Henrik Lublin, MD DMSc    045-43233540    henlub01@glo.regionh.dk    Principal Investigator: Henrik Lublin, MD DMSc Less <<
NCT02975726 Liver Cirrhosis ... More >> Ascites Less << Not Applicable Active, not recruiting February 2019 Canada, Manitoba ... More >> Health Sciences Centre Winnipeg, Manitoba, Canada, R3E 3P4 Less <<
NCT00988754 Obesity Cardi... More >>ovascular Risk Less << Not Applicable Completed - Germany ... More >> Department of Medicine, Division of Prevention, Rehabilitation and Sports Medicine, Technical University Munich Munich, Bavaria, Germany, 80992 Less <<
NCT00640783 Metabolic Syndrome Not Applicable Completed - Italy ... More >> Department of Geriatrics and Metabolic Diseases Naples, Italy, 80138 Less <<
NCT00644475 Essential Hypertension Phase 3 Unknown March 2009 Italy ... More >> University of Pavia Recruiting Pavia, Italy, 27100 Contact: Giuseppe Derosa, MD    +39 0382 502614    giuseppe.derosa@unipv.it    Contact: Roberto Fogari, MD    +39 0382 526217    r.fogari@unipv.it    Principal Investigator: Giuseppe Derosa, MD Less <<
NCT00636753 - Suspended(this study has not f... More >>inding place) Less << - Denmark ... More >> Psychiatric Center Glostrup Copenhagen, Nordre Ringvej 28-69, Glostrup, Denmark, 2600 Psychiatric Center Glostrup Nordre Ringvej 28-69, Glostrup, Denmark, 2600 Less <<
NCT00664742 - Completed - -
NCT03221621 Hidradenitis Suppurativa Phase 4 Not yet recruiting August 1, 2021 Netherlands ... More >> Erasmus MC Not yet recruiting Rotterdam, Netherlands Contact: Kelsey van Straalen, MD    + 31 107040110    k.vanstraalen@erasmusmc.nl    Principal Investigator: Martijn van Doorn, MD, PhD          Sub-Investigator: Errol Prens, MD, PhD          Sub-Investigator: Hessel van der Zee, MD, PhD          Sub-Investigator: Allard Vossen, MD          Sub-Investigator: Kelsey van Straalen, MD Less <<
NCT00664742 Metabolic Syndrome Phase 4 Completed - Turkey ... More >> Götzepe Education and Research Hospital Istanbul, Turkey Less <<
NCT00676845 Metabolic Syndrome ... More >> Hypertension Less << Phase 3 Completed - Belgium ... More >> Ghent, Belgium Germany Nurnberg, Germany Italy Monza, Italy Less <<
NCT00689455 - Completed - Italy ... More >> Research Site Rieti, Italy Research Site ROme, Italy Research Site Viterbo, Italy Less <<
NCT00179127 - Completed - -
NCT00464880 Diabetes Type 2 Phase 1 Phase 2 Completed - Denmark ... More >> Novartis Gentofte, Denmark, 2820 Less <<
NCT00748787 Metabolic Syndrome Phase 2 Terminated(It was very difficu... More >>lt to fulfill the inclusion criteria, therefore the expected time of inclusion was delayed so much time.) Less << - Spain ... More >> Hospital Universitari San Joan de Reus Reus, Tarragona, Spain, 43201 Less <<
NCT00179127 Diabetic Ketoacidosis Not Applicable Completed - United States, Tennessee ... More >> Vanderbilt University Monroe Carell Children's Hospital Nashville, Tennessee, United States, 37232 Less <<
NCT03624582 - Recruiting June 30, 2019 United States, Louisiana ... More >> Pennington Biomedical Research Center Recruiting Baton Rouge, Louisiana, United States, 70808 Contact: S. Nicole Fearnbach    225-763-2612    Nicole.Fearnbach@pbrc.edu    Contact: Jessica St. Romain    225-763-2921    Jessica.Stromain@pbrc.edu    Principal Investigator: S. Nicole Fearnbach, PhD          Sub-Investigator: Corby K. Martin, PhD          Sub-Investigator: Amanda E. Staiano, PhD          Sub-Investigator: Robert L. Newton, PhD          Sub-Investigator: Steven B. Heymsfield, MD          Sub-Investigator: Daniel S. Hsia, MD          Sub-Investigator: Owen T. Carmichael, PhD          Sub-Investigator: Neil M. Johannsen, PhD Less <<
NCT00783445 Metabolic Syndrome Phase 3 Completed - United States, Maryland ... More >> Johns Hopkins Bayview Institute for Clinical Translational Research Baltimore, Maryland, United States, 21287 Less <<
NCT00716300 - Unknown December 2009 Australia, Western Australia ... More >> University of Western Australia Recruiting Perth, Western Australia, Australia, 6000 Contact: Dick C Chan, PhD    61-8-92240268    dick.chan@uwa.edu.au Less <<
NCT00790946 Hypertension ... More >>Obesity Less << Phase 4 Unknown December 2009 Japan ... More >> Chuwa Tei,MD,FACC,FAHA Recruiting Kagoshima, Japan, 890-8520 Contact: Chuwa Tei, MD,FACC,FAHA       tei@m.kufm.kagoshima-u.ac.jp    Contact: Masaaki Miyata, MD,PhD、FACC       miyatam@m3.kufm.kagoshima-u.ac.jp Less <<
NCT00797316 Hypertension Phase 4 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 Less <<
NCT00759291 Metabolic Syndrome Phase 2 Phase 3 Completed - United States, Massachusetts ... More >> Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Less <<
NCT00302042 Prediabetic State ... More >> Overweight Obesity Less << Not Applicable Completed - United States, Indiana ... More >> Indiana University Diabetes Prevention and Control Center Indianapolis, Indiana, United States, 46202 Less <<
NCT00302055 Pre-diabetic State ... More >> Overweight Obesity Less << Not Applicable Completed - United States, Indiana ... More >> IU Medical Group Westside Clinic Indianapolis, Indiana, United States, 46222 IU Medical Group Banta Road Clinic Indianapolis, Indiana, United States, 46227 Less <<
NCT00302055 - Completed - -
NCT00797316 - Completed - -
NCT00808158 - Completed - United States, New York ... More >> University of Rochester Rochester, New York, United States, 14642 Less <<
NCT00815659 Metabolic Syndrome Phase 4 Completed - Turkey ... More >> Research site Ankara, Besevler, Turkey Research site Kayseri, Erciyes, Turkey Research site Istanbul, Haseki, Turkey Research site Kocaeli, Umuttepe, Turkey Research Site Izmir, Turkey Research Site Trabzon, Turkey Less <<
NCT02789761 Healthy Not Applicable Unknown June 2016 -
NCT00815659 - Completed - -
NCT00686244 Metabolic Syndrome Not Applicable Completed - Germany ... More >> Lehrstuhl für Praeventive und Rehabilitative Sportmedizin Klinikum Rechts der Isar, Technical University of Munich Munich, Germany, 80809 Less <<
NCT00817843 Metabolic Syndrome Phase 4 Completed - Netherlands ... More >> Academic Medical Center Amsterdam, Netherlands, 1005 AZ Vascular Research Center Hoorn Hoorn, Netherlands, 1624 NP Department of Vascular Medicine UMC Utrecht Utrecht, Netherlands, 3584 CX Tweesteden Ziekenhuis Waalwijk, Netherlands, 5141 BM Spain Hospital Arnau de Vilanova Lleida, Spain, E-25198 Less <<
NCT01919632 Endothelial Function (Reactive... More >> Hyperemia) Less << Not Applicable Completed - Germany ... More >> Klinikum rechts der Isar, Technische Universität München Munich, Bavaria, Germany, 80992 BP Lingen Lingen, Emsland, Germany, 49808 Less <<
NCT00819403 - Completed - -
NCT00302042 - Completed - -
NCT00817843 - Completed - -
NCT00852475 Metabolic Syndrome Not Applicable Completed - United States, Maryland ... More >> VA Maryland Health Care System, Baltimore Baltimore, Maryland, United States, 21201 Less <<
NCT02139813 Obesity Not Applicable Completed - France ... More >> Clinique Universitaire de Chirurgie Digestive et de l'Urgence - CHU de Grenoble Grenoble, France, 38043 Cabinet de chirurgie générale, digestive et de l'obésité - Hôpital Privé Drôme et Ardèche Guilherand-Granges, France, 07500 Service de Chirurgie Générale et Endocrinienne - Hôpital Claude Huriez - CHU de Lille Lille, France, 59037 Service de Chirurgie Digestive - Hôpital Edouard Herriot - Hospices Civils de Lyon Lyon, France, 69437 Service de Chirurgie Digestive et Hépato-Bilio-Pancréatique et Transplantation Hépatique - Hôpital de la Pitié Salpêtrière Paris, France, 75013 Service de Chirurgie Digestive, Générale et Cancérologique - Hôpital Européen Georges Pompidou - APHP Paris, France, 75908 Service de Chirurgie Générale - Hôpital Privé de la Loire Saint Etienne, France, 42100 Service de Chirurgie Digestive et Hépato-Biliaire-Centre Hospitalier Privé Saint Grégoire Saint Grégoire, France, 35768 Service de Chirurgie Générale, Digestive et Viscérale - Centre Hospitalier Intercommunal de Poissy / Saint Gerrmain en Laye Saint-germain-en-laye, France, 78100 Less <<
NCT00819403 Metabolic Syndrome Phase 4 Completed - United States, Maryland ... More >> VA Maryland Health Care System Baltimore, Maryland, United States, 21201 University of Maryland Medical Center Baltimore, Maryland, United States, 21202 Johns Hopkins Hospital Baltimore, Maryland, United States, 21287 Less <<
NCT00821574 Hypertension, Dyslypidaemia Phase 4 Completed - -
NCT00852475 - Completed - -
NCT00874952 - Completed - Italy ... More >> Research Site Torino, Italy Less <<
NCT00911885 Metabolic Syndrome Not Applicable Completed - United States, Massachusetts ... More >> University of Massachusetts Medical School Worcester, Massachusetts, United States, 01655 Less <<
NCT00907127 Metabolic Syndrome Phase 1 Completed - United States, Michigan ... More >> The University of Michigan Health System Ann Arbor, Michigan, United States, 48109 Less <<
NCT01674751 Dietary Habits Not Applicable Completed - United States, Pennsylvania ... More >> Albert Einstein Healthcare Network Philadelphia, Pennsylvania, United States, 19141 Less <<
NCT00914251 Endothelial Dysfunction ... More >> Metabolic Syndrome Less << Phase 2 Unknown December 2010 Italy ... More >> University of Rome Tor Vergata Recruiting Rome, Italy, 00133 Contact: Stefano Rizza, MD       rizza@med.uniroma2.it    Principal Investigator: Stefano Rizza, MD          Sub-Investigator: Manfredi Tesauro, MD          Sub-Investigator: Davide Lauro, MD Less <<
NCT00926341 Metabolic Syndrome Phase 4 Completed - India ... More >> Department of Medicine, J.N.Medical,College, AMU,Aligarh Aligarh, Uttar Pradesh, India, 202002 Less <<
NCT00929500 Metabolic Syndrome Not Applicable Completed - United States, Massachusetts ... More >> Beth Israel Deaconess Medical Center, Harvard University Boston, Massachusetts, United States, 02215 Less <<
NCT00929500 - Completed - -
NCT00917917 Metabolic Syndrome Not Applicable Completed - France ... More >> CHU Clermont-Ferrand Clermont-Ferrand, France, 63003 Less <<
NCT00943254 Metabolic Cardiovascular Syndr... More >>ome Less << Not Applicable Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT00933010 - Completed - Italy ... More >> Research Foligno, Italy Research Site Perugia, Italy Research Site Terni, Italy Less <<
NCT00954824 Metabolic Syndrome X Not Applicable Completed - United States, Pennsylvania ... More >> Clinical and Translational Research Center, Hospital of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00954824 - Completed - -
NCT00929552 Metabolic Syndrome Not Applicable Completed - Denmark ... More >> Department of Human Nutrition Frederiksberg, Denmark, 1958 Less <<
NCT02732444 - Completed - Brazil ... More >> Hospital of clinics of the federal university of uberlândia Uberlandia, Minas Gerais, Brazil Less <<
NCT00976274 - Completed - -
NCT00956189 Metabolic Syndrome X Not Applicable Completed - Taiwan ... More >> Yu-Li Hospital Yu-Li, Hualien County, Taiwan, 981 Yu-Li Veterans Hospital Yu-Li, Hualien County, Taiwan, 981 National Taiwan University Hospital Taipei, Taiwan, 10002 Less <<
NCT00986024 Metabolic Syndrome Not Applicable Completed - -
NCT00982761 - Completed - -
NCT01007227 Metabolic Syndrome Not Applicable Completed - Japan ... More >> Kumamoto University Hospital Kumamoto, Japan, 860-8556 Less <<
NCT00976274 Metabolic Syndrome Not Applicable Completed - Korea, Republic of ... More >> Yonsei Univeristy College of Medicine, Gangnam Severance Hospital Seoul, Korea, Republic of, 135-720 Less <<
NCT02927028 Obesity Not Applicable Unknown December 2016 United States, Indiana ... More >> Purdue University West Lafayette, Indiana, United States, 47906 Less <<
NCT03116256 Overweight and Obesity Not Applicable Recruiting June 30, 2019 United Kingdom ... More >> MRC-ARUK Centre of Excellence for Musculoskeletal Ageing, School of Medicine, University of Nottingham, Recruiting Derby, Derbyshire, United Kingdom, DE22 3DT Contact: Muhammad Hariz Abdul Aziz    +447729182321    stxmhab@nottingham.ac.uk    Contact: Iskandar Idris       iskandar.idris@nottingham.ac.uk Less <<
NCT01046500 Metabolic Syndrome Phase 2 Unknown December 2014 Italy ... More >> University Hospital Recruiting Messina, Italy Contact: Rosario D'Anna, associate professor    +39 090 2217324    rosariodanna@tin.it    Principal Investigator: Rosario D'Anna, associate professor Less <<
NCT01082835 - Unknown August 2010 China, Beijing ... More >> Beijing Medical University ,Dongzhimen Hospital Not yet recruiting Beijing, Beijing, China Contact: Weixing Lu    0086-013601067938    weixinglu918@sina.com    Beijing Medical University,Dongfang Hospital Not yet recruiting Beijing, Beijing, China Contact: Qian Lin    0086-013910565673    dfluyao@126.com    China Academy of Chinese Medical Sciences,Guang'anmen Hospital Not yet recruiting Beijing, Beijing, China Contact: Qiang Zhou    0086-015101016416    tiantianlanzhouqiang@126.com    Chinese Academy of Medical Sciences Fu Wai Cardiovascular Hospital Not yet recruiting Beijing, Beijing, China Contact: Jianfeng Huang    0086-010-88396403    jianfhuang918@sina.com    Capital University of Medical, Anzhen Hospital Not yet recruiting Beijng, Beijing, China Contact: Zhenqiu Yu    0086-010-64456577    yuzhenqiu@yahoo.com.cn Less <<
NCT00988364 Metabolic Syndrome Phase 4 Unknown July 2010 United States, Texas ... More >> Baylor College of Medicine Active, not recruiting Houston, Texas, United States, 77030 Less <<
NCT01093560 Metabolic Syndrome Not Applicable Unknown September 2011 United States, Washington ... More >> University of Washington Seattle, Washington, United States, 98104 Less <<
NCT03286842 HER2-ve Metastatic Breast Canc... More >>er Germline BRCA1/2 Mutations Somatic BRCA1/2 Mutations Less << Phase 3 Recruiting November 30, 2020 -
NCT01114763 - Completed - Finland ... More >> Linnan Klinikka Hämeenlinna, Finland, 13100 Central Hospital of Kanta-Häme Hämeenlinna, Finland, 13530 Less <<
NCT02786030 Asthma Chroni... More >>c Obstructive Pulmonary Disease Less << Not Applicable Recruiting March 31, 2019 Brazil ... More >> Florianopolis City Health Department Recruiting Florianopolis, Santa Catarina, Brazil, 88.040-400 Contact: Matheus Pacheco de Andrade, MD    +55 48 3239-1547    mpandrade.trabalho@gmail.com    Contact: Ronaldo Zonta, MD    +55 48 3239-1545    ronaldozonta@gmail.com Less <<
NCT01034046 Obesity Insul... More >>in Resistance Metabolic Syndrome Less << Not Applicable Unknown June 2011 United States, Nevada ... More >> Center for Nutrition and Metabolism at the University of Nevada School of Medicine, Reno Reno, Nevada, United States, 89557 Less <<
NCT00549679 Pulmonary Disease, Chronic Obs... More >>tructive Less << Phase 2 Completed - Estonia ... More >> GSK Investigational Site Tallinn, Estonia, 13419 Finland GSK Investigational Site Tampere, Finland, 33520 Germany GSK Investigational Site Gauting, Bayern, Germany, 82131 GSK Investigational Site Berlin, Germany, 10717 GSK Investigational Site Hamburg, Germany, 22291 Netherlands GSK Investigational Site Hoorn, Netherlands, 1624 NP GSK Investigational Site Horn, Netherlands, 6085 NM GSK Investigational Site Veldhoven, Netherlands, 5504 DB Russian Federation GSK Investigational Site Barnaul, Russian Federation, 656 045 GSK Investigational Site Moscow, Russian Federation, 105 077 GSK Investigational Site St. Petersburg, Russian Federation, 197022 GSK Investigational Site Yaroslavl, Russian Federation, 150003 Slovakia GSK Investigational Site Bratislava, Slovakia, 826 06 GSK Investigational Site Kosice, Slovakia, 041 90 GSK Investigational Site Martin, Slovakia, 036 59 Less <<
NCT01176630 - Completed - United States, New York ... More >> Winthrop University Hospital Outpatient Dialysis Unit Mineola, New York, United States, 11501 Less <<
NCT01125501 Metabolic Syndrome Not Applicable Withdrawn(funding not availabl... More >>e) Less << June 2010 United States, Colorado ... More >> University of Colorado Denver Aurora, Colorado, United States, 80045 Less <<
NCT02554786 Asthma Phase 3 Recruiting June 24, 2019 -
NCT01224743 Metabolic Syndrome Phase 1 Phase 2 Completed - United States, Connecticut ... More >> Griffin Hospital Derby, Connecticut, United States, 06418 Less <<
NCT02875301 Healthy Cogni... More >>tive Function 1, Social Less << Phase 3 Recruiting September 2022 United States, Illinois ... More >> University of Illinois Not yet recruiting Champaign, Illinois, United States, 15218 Contact: Edward McAuley, PhD          Principal Investigator: Edward McAuley, PhD          Sub-Investigator: Bradley Sutton, PhD          United States, Kansas University of Kansas Recruiting Kansas City, Kansas, United States, 66205 Contact: Jeffrey Burns, MD    913-588-0555       Principal Investigator: Jeffrey Burns, MD          Sub-Investigator: Eric Vidoni, PhD          United States, Massachusetts Northeastern University Recruiting Boston, Massachusetts, United States, 02115 Contact: Arthur Kramer, PhD    617-373-2129    a.kramer@neu.edu    Principal Investigator: Arthur Kramer, PhD          Sub-Investigator: Charles Hillman, PhD          United States, Pennsylvania University of Pittsburgh Recruiting Pittsburgh, Pennsylvania, United States, 15213 Contact: George A Grove, Masters    412-624-4556    ggrove@pitt.edu    Principal Investigator: Kirk I Erickson, PhD          Sub-Investigator: Becker James, PhD          Sub-Investigator: Butters Meryl, PhD          Sub-Investigator: Marsland Anna, PhD          Sub-Investigator: Jakicic John, PhD          Sub-Investigator: Klunk William, PhD          Sub-Investigator: Kamboh M. Ilyas, PhD          Sub-Investigator: Tseng George, PhD          Sub-Investigator: Mountz James, PhD          Sub-Investigator: Kang Chae Ryon, PhD          Sub-Investigator: Forman Daniel, MD          Sub-Investigator: Mettenburg Joseph, MD          Sub-Investigator: Ruszkiewicz James, PhD          Carnegie Mellon University Not yet recruiting Pittsburgh, Pennsylvania, United States, 51260 Contact: Tim Verstynen, PhD          Sub-Investigator: Tim Verstynen, PhD Less <<
NCT01235208 Overweight Ob... More >>esity Metabolic Syndrome Less << Not Applicable Completed - Norway ... More >> Dr. Fedon Lindbergs Klinikk Oslo, Norway Less <<
NCT02466204 Infertility Phase 4 Completed - Vietnam ... More >> My Duc Hospital Ho Chi Minh City, Vietnam, 70000 Research Center for Genetics and Reproductive Health Ho Chi Minh City, Vietnam, 70000 Less <<
NCT03755362 Carotid Stenosis ... More >> Mild Cognitive Impairment Periodontitis Less << Not Applicable Not yet recruiting October 31, 2021 -
NCT01268696 - Unknown January 2015 Poland ... More >> Department of medical biotechnology Medical University of Lodz Lodz, Poland Less <<
NCT01654640 Schizophrenia Phase 4 Terminated(Failure to recruit ... More >>the planned number of participants) Less << - Korea, Republic of ... More >> Seoul National University Hospital Seoul, Korea, Republic of Less <<
NCT02188251 Body Weight Phase 2 Completed - Canada, Ontario ... More >> KGK Synergize Inc. London, Ontario, Canada, N6A 5R8 Less <<
NCT02107365 Hepatitis C Virus Genotype 4 I... More >>nfection Less << Phase 2 Completed - France ... More >> Hôpital AVICENNE Bobigny, France, 93009 Hôpital Jean Verdier Bondy, France, 93140 Hôpital de Haut Lévêque Bordeaux Pessac, France, 33601 Hôpital Beaujon Clichy, France, 92110 Centre Hospitalier Intercommunal Créteil, France, 94010 Hôpital Henri Mondor Créteil, France, 94010 Hôpital Albert Michallon Grenoble, France, 38043 Hôpital Claude Huriez Lille, France, 59037 Hôpital Dupuytren Limoges, France, 87042 Hôpital de la Croix Rousse Lyon, France, 69317 Fondation Hôpital Saint Joseph Marseille, France, 13285 Hôpital Saint Eloi Montpellier, France, 34295 Hôpital de Brabois Nancy, France, 54511 Hôpital de l'Hôtel Dieu Nantes, France, 44093 Hôpital de l'Archet Nice, France, 06202 Hôpital de La Source Orléans, France Hôpital Saint Antoine Paris, France, 75571 Hôpital Pitié Salpêtrière Paris, France, 75651 Hôpital Cochin Paris, France, 75679 Hôpital Tenon Paris, France, 75970 Hôpital Pontchaillou Rennes, France, 35000 Hôpital Charles Nicolle Rouen, France, 76031 Institut Arnault Tzank Saint Laurent du Var, France, 06721 Hôpital Purpan Toulouse, France, 31059 Hôpital Paul Brousse Villejuif, France, 94804 Less <<
NCT01326416 Obesity Metab... More >>olic Syndrome Less << Not Applicable Completed - France ... More >> University Hospital of Rouen Rouen Cedex, France, 76031 Less <<
NCT00742976 Diabetes Type 2 ... More >> Weight Gain Less << Phase 4 Completed - Denmark ... More >> Dept of Endocrinology, Rigshospitalet Copenhagen, København Ø, Denmark, DK_2100 Less <<
NCT01299519 Insulin Resistance ... More >> Obesity Less << Not Applicable Completed - United States, Missouri ... More >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Less <<
NCT01399138 Metabolic Syndrome Not Applicable Unknown April 2014 United States, Louisiana ... More >> Pennington Biomedical Research Center Baton Rouge, Louisiana, United States, 70816 Less <<
NCT01400724 Metabolic Syndrome ... More >> Postmenopausal Disorder Less << Not Applicable Completed - Italy ... More >> University Hospital Messina, Italy, 98100 Less <<
NCT02787304 Non-Alcoholic Steatohepatitis Phase 2 Terminated - -
NCT03160976 Subcutaneous Fat Not Applicable Not yet recruiting October 25, 2017 Brazil ... More >> Federal University of Health Science of Porto Alegre Not yet recruiting Porto Alegre, Rio Grande do Sul, Brazil, 90050170 Contact: Rodrigo DM Plentz, PhD    55 51 998419044    roplentz@yahoo.com.br Less <<
NCT01412476 - Completed - Taiwan ... More >> Ping-Ting Lin Taichung, Taiwan Less <<
NCT01367431 - Completed - United States, Oregon ... More >> Oregon Health & Science University Portland, Oregon, United States, 97201 Less <<
NCT01456221 Obesity Insul... More >>in Resistance Less << Not Applicable Completed - Mexico ... More >> Unit or research in Medical Nutrition, Pediatric Hospital CMN "Siglo XXI", Instituto Mexicano del Seguro Social Mexico City, Mexico, 06720 Less <<
NCT01411293 Cardiovascular Disease ... More >> Metabolic Syndrome Obesity Less << Not Applicable Completed - United States, Connecticut ... More >> University of Connecticut Storrs, Connecticut, United States, 06269 Less <<
NCT01567956 Ulcerative Colitis Phase 3 Terminated(Evidence of very lo... More >>w probability to success. No safety issues) Less << - -
NCT01646827 Schizophrenia Phase 1 Completed - United States, California ... More >> Comprehensive Clinical Development, Inc. Cerritos, California, United States, 90703 Collaborative Neuroscience Network, Inc. Garden Grove, California, United States, 92845 CNRI - San Diego San Diego, California, United States, 92102 Neuropsychiatric Research Center of Orange County Santa Ana, California, United States, 92701 United States, District of Columbia Comprehensive Clinical Development, Inc. Washington, District of Columbia, United States, 20016 United States, Texas Community Clinical Research, Inc. Austin, Texas, United States, 78754 Less <<
NCT03030053 Mental Processes Not Applicable Active, not recruiting December 2018 United Kingdom ... More >> Hugh Sinclair Unit of Human Nutrition, University of Reading Reading, Berkshire, United Kingdom, RG6 5SG Less <<
NCT01646827 - Completed - -
NCT01240915 Colitis, Ulcerative Phase 2 Completed - -
NCT03775538 Parkinson Disease ... More >> Movement Disorders Neuro-Degenerative Disease Nervous System Diseases Brain Diseases Less << Phase 1 Phase 2 Recruiting September 30, 2020 Finland ... More >> Helsinki University Hospital Not yet recruiting Helsinki, Finland, 00029 Contact: Filip Scheperjans, Ph.D, MD    +358 (0)50-4284113    parkinson.tutkimus@gmail.com    Sweden Skåne University Hospital Not yet recruiting Lund, Sweden, 221 85 Contact: Håkan Widner, Ph.D, MD    +46 (0)46-17 14 25    Hakan.Widner@med.lu.se    Contact: Gesine Paul-Visse, Ph.D, MD    +46 (0)46-17 77 66    Gesine.Paul-Visse@med.lu.se    Karolinska University Hospital Recruiting Stockholm, Sweden, 14186 Contact: Per Svenningsson, Ph.D, MD    +46 8 585 87271    per.svenningsson@ki.se    Contact: Lisa Hainke    +46 8 585 84710    lisa.hainke@sll.se Less <<
NCT03602144 Body Weight Changes ... More >> Body Composition Muscle Mass Energy Expenditure Nutrition Less << Not Applicable Recruiting September 30, 2019 United States, Arkansas ... More >> University of Arkansas Recruiting Fayetteville, Arkansas, United States, 72704 Contact: Jamie I Baum, PhD    479-575-4474    baum@uark.edu Less <<
NCT03728127 Coronary Artery Disease ... More >> Myocardial Infarction Less << Not Applicable Not yet recruiting December 2020 -
NCT01622283 Rhinitis, Allergic, Perennial ... More >>and Seasonal Less << Phase 1 Completed - Japan ... More >> GSK Investigational Site Kagoshima, Japan, 890-0081 Less <<
NCT01240915 - Completed - -
NCT01920594 Surgical Procedures Phase 2 Completed - United States, Alabama ... More >> GSK Investigational Site Birmingham, Alabama, United States, 35233 United States, California GSK Investigational Site Los Angeles, California, United States, 90048 United States, Colorado GSK Investigational Site Aurora, Colorado, United States, 80045 United States, Georgia GSK Investigational Site Atlanta, Georgia, United States, 30322 United States, Michigan GSK Investigational Site Ann Arbor, Michigan, United States, 48109-5864 United States, Minnesota GSK Investigational Site Rochester, Minnesota, United States, 55905 United States, North Carolina GSK Investigational Site Durham, North Carolina, United States, 27710 United States, Ohio GSK Investigational Site Cleveland, Ohio, United States, 44195 United States, Pennsylvania GSK Investigational Site Philadelphia, Pennsylvania, United States, 19104 GSK Investigational Site Pittsburgh, Pennsylvania, United States, 308902 United States, Texas GSK Investigational Site Houston, Texas, United States, 77030 United States, Virginia GSK Investigational Site Charlottesville, Virginia, United States, 22908 GSK Investigational Site Richmond, Virginia, United States, 23298 Canada, Alberta GSK Investigational Site Calgary, Alberta, Canada, T2N 2T9 Canada, Quebec GSK Investigational Site Quebec City, Quebec, Canada, G1V 4G5 Less <<
NCT02730338 Prostate Cancer Metastatic Not Applicable Recruiting December 2022 United States, California ... More >> Cedars Sinai Medical Centre Recruiting Los Angeles, California, United States Contact: Stephen Freedland       Stephen.Freedland@cshs.org    UCSF Not yet recruiting San Francisco, California, United States Contact: Charles Ryan          Sub-Investigator: June Chan          United States, Colorado UC Denver Not yet recruiting Denver, Colorado, United States Contact: Elizabeth Kessler          United States, Oregon Oregon Health & Science University Recruiting Portland, Oregon, United States Contact: Kerri Winters-Stone       wintersk@ohsu.edu    United States, Washington Fred Hutchinson Cancer Centre Not yet recruiting Seattle, Washington, United States Contact: Stephen Plymate          Australia, Queensland Australian Prostate Cncr Research Centre Recruiting Brisbane, Queensland, Australia Contact: Colleen Nelson       colleen.nelson@qut.edu.au    Australia, Victoria Deakin University Not yet recruiting Boxhill, Victoria, Australia Contact: Aaron Russell          Australia, Western Australia Edith Cowan University Recruiting Perth, Western Australia, Australia Contact: Robert Newton       r.newton@ecu.edu.au    Canada, Alberta University of Alberta Recruiting Edmonton, Alberta, Canada Contact: Kerry Courneya       kerry.courneya@ualberta.ca    Canada, Ontario Princess Margaret Cancer Centre Not yet recruiting Toronto, Ontario, Canada Canada Centre Hospitalier de l'Université de Montréal (CRCHUM) Not yet recruiting Montreal, Canada Contact: Fred Saad       fred.saad@umontreal.ca    Germany German Sport University Cologne Recruiting Cologne, Germany Contact: Wilhelm Bolch       w.bloch@dshs-koeln.de    Ireland Trinity University Not yet recruiting Dublin, Ireland Contact: Stephen Finn          Netherlands Erasmus MC Not yet recruiting Rotterdam, Netherlands Contact: Monique Roobol          United Kingdom University of Surrey Not yet recruiting Guildford, Surrey, United Kingdom Contact: Ralph Manders          Queen's University Belfast Not yet recruiting Belfast, United Kingdom Contact: Joe O'Sullivan          Bristol Urology Not yet recruiting Bristol, United Kingdom Contact: Raj Persad          University of Glasgow Not yet recruiting Glasgow, United Kingdom Contact: Hing Leung          Kings College London Not yet recruiting London, United Kingdom Contact: Mieke Van Hemelrijck Less <<
NCT01902186 HIV Infection ... More >> Osteopenia Less << Phase 4 Terminated(Low enrollment) - Italy ... More >> University of Milano Milano, Italy University of Torino Torino, Italy Less <<
NCT02204371 Telangiectasia, Hereditary Hem... More >>orrhagic Less << Phase 2 Terminated(The study was termi... More >>nated as the asset was sold to another company who decided not to pursue this indication with this drug.) Less << - United States, California ... More >> GSK Investigational Site Los Angeles, California, United States, 90095 United States, Georgia GSK Investigational Site Augusta, Georgia, United States, 30912-3135 United States, Missouri GSK Investigational Site Saint Louis, Missouri, United States, 63110 United States, Ohio GSK Investigational Site Cleveland, Ohio, United States, 44195 United States, Utah GSK Investigational Site Salt Lake City, Utah, United States, 84132 Canada, Ontario GSK Investigational Site Toronto, Ontario, Canada, M5B 1W8 Less <<
NCT01920594 - Completed - -
NCT01491932 Dyskinesias P... More >>arkinson Disease Movement Disorders Parkinsonian Disorders Anti-Dyskinesia Agents Less << Phase 2 Completed - -
NCT02399423 Diabetes Weig... More >>ht Gain Weight Loss Cardiovascular Disease Obesity Less << Not Applicable Unknown August 2017 United Kingdom ... More >> University of Glasgow Recruiting Glasgow, United Kingdom, G12 8TA Contact: James M McLaren, MBChB, MRCP    0141 3302748    james.mclaren@glasgow.ac.uk Less <<
NCT02204371 - Terminated(The study was termi... More >>nated as the asset was sold to another company who decided not to pursue this indication with this drug.) Less << - -
NCT00555906 Multiple Myeloma Phase 2 Completed - United States, Illinois ... More >> Northwestern Medical Faculty Foundation Chicago, Illinois, United States, 60611 Northwestern Memorial Hospital/Main Labs Chicago, Illinois, United States, 60611 United States, Kansas University of Kansas Medical Center Kansas City, Kansas, United States, 66160 University of Kansas Cancer Center and Medical Pavilion Westwood, Kansas, United States, 66205 United States, Maryland University of Maryland Baltimore, Maryland, United States, 21201 United States, Michigan Karmanos Cancer Institute Detroit, Michigan, United States, 48201 United States, Missouri Washington University School of Medicine St. Louis, Missouri, United States, 63110-1093 Barnes-Jewish Hospital St. Louis, Missouri, United States, 63110 Washington University School of Medicine St. Louis, Missouri, United States, 63110 United States, Nebraska Nebraska Methodist Hospital Omaha, Nebraska, United States, 68114 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263 New York Presbyterian, Weill Cornell Medical College New York, New York, United States, 10065 United States, Pennsylvania University of Pennsylvania Abramson Cancer Center Philadelphia, Pennsylvania, United States, 19104 University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States, 15232 United States, South Carolina Hollings Cancer Center Charleston, South Carolina, United States, 29425 Medical University of South Carolina Charleston, South Carolina, United States, 29425 Czech Republic Vseobecna fakultni nemocnice v Praze Praha 2, Czech Republic, 12808 Germany Universitaetsklinikum Heidelberg Heidelberg, Germany, 69120 Klinikum Johannes-Gutenberg -Universitaet, III. Medizinische Klinik und Poliklinik Mainz, Germany, 55131 Less <<
NCT03351751 Healthy Volunteers Phase 1 Completed - United States, Connecticut ... More >> Pfizer New Haven Clinical Research Unit New Haven, Connecticut, United States, 06511 Less <<
NCT02461992 Hemophilia A Phase 1 Completed - China ... More >> Phase I Unit, Clinical Pharmacology Research Center, Peking Union Medical College Hospital Beijing, China, 100032 Hematology Department,Beijing Children's Hospital, Capital Medical University Beijing, China, 100045 Less <<
NCT00593606 - Completed - -
NCT01733901 Coronary Heart Disease Not Applicable Unknown July 2015 China, Jiangsu ... More >> First Affiliated Hospital of Nanjing Medical University Recruiting Nanjing, Jiangsu, China, 210000 Principal Investigator: Qijun Shan, Professor          Principal Investigator: Zhijian Yang, Professor          Principal Investigator: Chun Chen, Professor          Principal Investigator: Xiujuan Zhou, Professor          Sub-Investigator: Weichong Qian, Professor          Sub-Investigator: Zhenhua Dai, Doctor          Sub-Investigator: Jie Gen, Master          Sub-Investigator: Zhongxia Zhou, Master          Sub-Investigator: Min Qiu, Doctor Less <<
NCT02180217 Cushing's Disease Phase 3 Active, not recruiting December 9, 2019 -
NCT02812615 Malnutrition ... More >>Infection Less << Not Applicable Recruiting October 31, 2019 Bangladesh ... More >> Mirpur Recruiting Dhaka, Bangladesh, 1216 Contact: Tahmeed Ahmed, Ph.D    +88029827001-10 ext 2300    tahmeed@icddrb.org    Contact: Mustafa Mustafa, MPH    9840523-32 ext 2304    mustafa@icddrb.org    Principal Investigator: Mustafa Mustafa, MPH Less <<
NCT00555906 - Completed - -
NCT02876952 Myocardial Infarction Not Applicable Recruiting June 2018 Spain ... More >> Department of Physical Education and Sport. Faculty of Education and Sport-Physical Activity and Sport Section. University of the Basque Country Recruiting Vitoria-gasteiz, Araba/álava, Spain, 01007 Contact: SARA MALDONADO-MARTIN, PhD       sara.maldonado@ehu.eus    Sub-Investigator: Juan Jose GOIRIENA, PhD Less <<
NCT02461992 - Completed - -
NCT01222247 Pregnancy Res... More >>piratory Distress Syndrome Pregnancy Outcomes Preterm Birth Less << Phase 3 Active, not recruiting May 2022 United States, Alabama ... More >> University of Alabama - Birmingham Birmingham, Alabama, United States, 35233 United States, California Stanford University Stanford, California, United States, 94305 United States, Colorado University of Colorado Denver, Colorado, United States, 80045 United States, Illinois Northwestern University Chicago, Illinois, United States, 60611 United States, Michigan Wayne State University Detroit, Michigan, United States, 48201 United States, New York Columbia University New York, New York, United States, 10032 United States, North Carolina University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States, 27599 Duke University Durham, North Carolina, United States, 27710 United States, Ohio Case Western Reserve University Cleveland, Ohio, United States, 44109 Ohio State University Columbus, Ohio, United States, 43210 United States, Oregon Oregon Health & Science University Portland, Oregon, United States, 97239 United States, Pennsylvania University of Pittsburgh Magee Womens Hospital Pittsburgh, Pennsylvania, United States, 15213 United States, Rhode Island Brown University Providence, Rhode Island, United States, 02905 United States, Texas University of Texas - Southwest Dallas, Texas, United States, 75235 University of Texas - Galveston Galveston, Texas, United States, 77555 University of Texas - Houston Houston, Texas, United States, 77030 United States, Utah University of Utah Medical Center Salt Lake City, Utah, United States, 84132 Less <<
NCT03565510 Dietary Modification Not Applicable Recruiting September 1, 2020 Canada, Alberta ... More >> University of Alberta Recruiting Edmonton, Alberta, Canada, T6G 2E1 Contact: Camila Oliveira, MSc    7804924182    camila@ualberta.ca Less <<
NCT03249688 Alzheimer Disease; Prodromal Not Applicable Recruiting September 1, 2019 Sweden ... More >> Karolinska University Hospital Recruiting Huddinge, Sweden, 14186 Contact: Miia Kivipelto, MD, PhD    +46739940922    miia.kivipelto@ki.se    Contact: Shireen Sindi, PhD    +46735508703    shireen.sindi@ki.se Less <<
NCT03676478 Esophageal Cancer ... More >> Nutrition Aspect of Cancer Postoperative Complications Muscle Weakness Sarcopenia Jejunostomy; Complications Less << Not Applicable Not yet recruiting December 1, 2022 -
NCT01619215 - Recruiting July 2018 Saudi Arabia ... More >> King Khalid University Hospital Recruiting Riyadh, Saudi Arabia, 7805 Contact: Tamader AlDoheyan, (MBBSc)    +966500083720    AlDoheyan.Tamader@gmail.com    Contact: Maram AlKhamash    +966548327049    Malkhamash.c@KSU.EDU.SA    Sub-Investigator: Fahad Bamehriz, MBBS          Sub-Investigator: Hisham Al-Khalidi, MBBS          Sub-Investigator: Talal Al-Tuwaijri, MBBS          Sub-Investigator: Amna Al-Mulhim, MBBS          Sub-Investigator: Atheer Al-Sabhan, MBBS          Sub-Investigator: Shaden Al-Amro, MBBS          Sub-Investigator: Tamader AlDoheyan, (MBBSc)          King Khalid University Hospital Recruiting Riyadh, Saudi Arabia, 7805 Contact: Tamader Al-Doheyan, (MBBSc)    +966500083720    AlDoheyan.Tamader@gmail.com    Contact: Maram AlKhamash    +966548327049    Malkhamash.c@KSU.EDU.SA Less <<
NCT03008785 Bloodpressure Not Applicable Completed - Brazil ... More >> Guilherme Morais Puga Uberlandia, Minas Gerais, Brazil, 38400-678 Less <<
NCT03330847 Metastatic Triple Negative Bre... More >>ast Cancer Less << Phase 2 Recruiting January 20, 2021 -
NCT02431676 Breast Cancer ... More >> Prostate Cancer Lung Cancer Colon Cancer Melanoma of Skin Endometrial Cancer Liver Cancer Pancreatic Cancer Rectal Cancer Kidney Cancer Other Solid Malignant Tumors Less << Phase 2 Active, not recruiting June 2019 United States, Maryland ... More >> Johns Hopkins ProHealth Baltimore, Maryland, United States, 21207 Less <<
NCT03380507 Septic Shock ... More >>Critical Illness Less << Phase 2 Phase 3 Recruiting May 30, 2019 Qatar ... More >> Hamad Medical Corporation Recruiting Doha, Qatar, 3050 Less <<
NCT03436420 Non-Alcoholic Fatty Liver Dise... More >>ase Less << Phase 2 Active, not recruiting August 2019 United States, Georgia ... More >> Children's Healthcare of Atlanta / Emory University Atlanta, Georgia, United States, 30322 Less <<
NCT01491529 Dyskinesias P... More >>arkinson Disease Movement Disorders Parkinsonian Disorders Anti-Dyskinesia Agents Less << Phase 2 Completed - -
NCT01737138 Chronic Kidney Disease Not Applicable Unknown April 2018 China, Jiangsu ... More >> First Affiliated Hospital of Nanjing Medical University Recruiting Nanjing, Jiangsu, China, 210000 Contact: Shan Qi Jun, Professor    0086 025 68136407    qjshan@njmu.edu.cn    Principal Investigator: Shan Qi Jun, Professor          Principal Investigator: Xing Ch Ying, Professor          Principal Investigator: Chen Chun, Professor          Sub-Investigator: Zhou X Juan, Professor          Sub-Investigator: Qian W Chong, Professor          Sub-Investigator: Liu Jia, Professor          Sub-Investigator: Yu X Bao, Professor          Sub-Investigator: Mao H Juan, Professor          Sub-Investigator: Yao Jing, Doctor          Sub-Investigator: Xu X Qiang, Doctor          Sub-Investigator: Wang X Mei, Nurse          Sub-Investigator: Duan X Yan, Master          Sub-Investigator: Qiu Min, Master          Sub-Investigator: Geng Jie, Master Less <<
NCT01432639 Coronary Artery Disease Not Applicable Completed - Portugal ... More >> Centro Hospitalar de Vila Nova de Gaia/Espinho Vila Nova de Gaia, Portugal, 4434-502 Less <<
NCT03431077 Catecholamine-resistant Hypote... More >>nsion (CRH) Distributive Shock High Output Shock Sepsis Less << Phase 2 Completed - United States, North Carolina ... More >> Investigational Site Charlotte, North Carolina, United States, 28203 United States, Ohio Investigational Site Cincinnati, Ohio, United States, 45229 United States, Texas Investigational Site San Antonio, Texas, United States, 78207 Less <<
NCT03417531 Sarcopenia Fr... More >>ailty Malnutrition; Protein Fall Less << Not Applicable Recruiting October 2021 Switzerland ... More >> Centre on Aging and Mobility, University of Zurich and City Hospital Waid Recruiting Zurich, ZH, Switzerland, 8037 Contact: Heike A Bischoff-Ferrari, MD, DrPH    +41 44 255 27 57    Heike.Bischoff@usz.ch    Contact: Annemarie Fridrich, PhD    +41 44 366 3048    Annemarie.Fridrich@waid.zuerich.ch    Principal Investigator: Heike A Bischoff-Ferrari, MD, DrPH          Basel University Centre for Medicine of Aging, Felix Platter-Hospital, Basel Recruiting Basel, Switzerland, 4012 Contact: Reto W Kressig, MD    +41 61 326 40 22    RetoW.Kressig@fps-basel.ch    Contact: Stephanie Bridenbaugh, MD    +41 61 326 48 21    Stephanie.Bridenbaugh@fps-basel.ch    Principal Investigator: Reto W Kressig, MD Less <<
NCT01767181 Healthy Night Shift Workers Not Applicable Completed - Germany ... More >> University Medical Center Hamburg-Eppendorf Hamburg, Germany, 20246 Less <<
NCT00385099 Irritable Colon Phase 2 Completed - United Kingdom ... More >> GSK Investigational Site London, United Kingdom, NW1 2BU Less <<
NCT03622112 Asthma Phase 2 Not yet recruiting September 6, 2019 -
NCT03249181 HIV-1-infection ... More >> Pregnancy Related Less << Phase 3 Active, not recruiting March 2021 South Africa ... More >> University of Cape Town Cape Town, Western Cape, South Africa Uganda Infectious Diseases Institute Kampala, Uganda Less <<
NCT01481636 - Completed - United Kingdom ... More >> Betsi Cadwaladr University Health Board Bangor, Gwynedd, United Kingdom, LL57 2PW Less <<
NCT03483090 Osteoarthritis, Knee Phase 2 Recruiting July 30, 2020 Australia, Queensland ... More >> University of the Sunshine Coast Clinical Trials Centre, Morayfield Health Hub Recruiting Morayfield, Queensland, Australia, 4506 Contact: Jessica Baird    +61 7 5456 3797    trials@usc.edu.au    Contact: Georgina Street    +61 7 5456 3798    gstreet@usc.edu.au    Principal Investigator: Susan Thackwray          University of the Sunshine Coast Clinical Trials Centre, USC Health Clinics Recruiting Sippy Downs, Queensland, Australia, 4556 Contact: Jessica Baird    +61 7 5456 3797    trials@usc.edu.au    Contact: Georgina Street    +61 7 5456 3798    gstreet@usc.edu.au    Principal Investigator: Susan Thackwray          Australia, South Australia CSIRO Nutrition and Health Research Clinic Recruiting Adelaide, South Australia, Australia, 5000 Contact: Bianca Benassi-Evans          Australia, Victoria Emeritus Research Recruiting Camberwell, Victoria, Australia, 3124 Contact: Edwin Young    +61 3 950 96166    edwinyoung@emeritusresearch.com    Contact: Teresa Ringeri    +61 3 950 96166    teresaringeri@emeritusresearch.com    Principal Investigator: Andrew Ostor Less <<
NCT01709643 Postprandial IHL and IMCL Dyna... More >>mics Less << Not Applicable Completed - Netherlands ... More >> Maastricht University Medical Center + Maastricht, Netherlands Less <<
NCT03525678 Multiple Myeloma Phase 2 Recruiting June 30, 2020 -
NCT00562965 Lymphoma, Follicular Phase 3 Terminated(See termination rea... More >>son in detailed description.) Less << - -
NCT03282682 Hypogonadism, Male ... More >> Physical Activity Testosterone Deficiency Less << Not Applicable Recruiting December 31, 2018 Slovakia ... More >> Comenius University in Bratislava, Faculty of physical education and sport Recruiting Bratislava, Slovakia, 814 69 Contact: Michal Kralik    +421 910272863    michal.kralik@uniba.sk Less <<
NCT00488891 - Terminated(The study was termi... More >>nated because it was not enrolling at the expected rate) Less << - -
NCT01846832 Hepatitis C, Chronic ... More >> Infection Less << Phase 3 Completed - Austria ... More >> Linz, Austria Wien, Austria Belgium Brussels, Belgium Brussel, Belgium Edegem, Belgium France Clichy, France Limoges Cedex, France Orleans, France St Laurent Du Var, France Germany Berlin, Germany Düsseldorf, Germany Frankfurt, Germany Hamburg, Germany Würzburg, Germany Saudi Arabia Riyadh, Saudi Arabia Spain Barcelona, Spain Madrid, Spain Valencia, Spain Valme, Spain United Kingdom Glasgow, United Kingdom London, United Kingdom Less <<
NCT02834416 Prostate Cancer Phase 3 Recruiting May 2019 Canada, Alberta ... More >> University of Calgary/Tom Baker Cancer Centre Recruiting Calgary, Alberta, Canada, T2N 1N4 Contact: Jessica Danyluk, MKin    403-210-8482    jmdanylu@ucalgary.ca    Principal Investigator: Nicole Culos-Reed, PhD          Canada, Ontario Southlake Regional Health Centre Recruiting Newmarket, Ontario, Canada Contact: Paul Ritvo, PhD       paul.ritvo@gmail.com    Principal Investigator: Paul Ritvo, PhD          Scarborough and Rouge Hospital Recruiting Toronto, Ontario, Canada, M1P 2T7 Contact: Riyad Akbarali       rakbarali@rougevalley.ca    Principal Investigator: Jim Chiarotto, MD          Princess Margaret Cancer Centre Recruiting Toronto, Ontario, Canada, M5G2C4 Contact: Sara Durbano, MSc    416-581-8452    sara.durbano@uhnresearch.ca    Contact: Amna Iqbal, MPK    416-581-8452    amna.iqbal@uhnresearch.ca    Principal Investigator: Shabbir MH Alibhai, MD, MSc Less <<
NCT00562965 - Terminated(See termination rea... More >>son in detailed description.) Less << - -
NCT02785120 Ischemic Stroke Phase 2 Recruiting December 2020 -
NCT01233869 Polycystic Kidney, Autosomal D... More >>ominant Less << Phase 2 Completed - -
NCT02041299 Iron Overload ... More >> Sickle Cell Disease Other Anemias Less << Phase 4 Recruiting September 2019 -
NCT03758716 Atopic Dermatitis Phase 2 Active, not recruiting December 31, 2018 Taiwan ... More >> National Taiwan University Hospital Taipei, Taiwan Less <<
NCT02966834 Cholestasis Phase 2 Recruiting April 1, 2020 -
NCT02322450 Essential Hypertension Phase 2 Completed - France ... More >> Hôpital Arthur Gardiner Dinard, France, 35800 Hôpital Cardiologique, CHRU de Lille Lille, France, 59037 Hospices Civils de Lyon - Hôpital de la Croix Rousse Lyon, France, 69317 Hôpital Européen Georges Pompidou Paris, France, 75015 Less <<
NCT01233869 - Completed - -
NCT03677596 Leukemia Prec... More >>ursor b-Cell Lymphoblastic Leukemia-Lymphoma ACUTE LYMPHOBLASTIC LEUKEMIA Less << Phase 4 Not yet recruiting May 16, 2025 -
NCT03374475 Depressive Disorder, Major Phase 1 Recruiting May 6, 2019 United States, California ... More >> Artemis Institute for Clinical Research Recruiting San Diego, California, United States, 92103 Artemis Institute for Clinical Research Not yet recruiting San Marcos, California, United States, 92078 United States, Florida Qps-Mra, Llc Recruiting Miami, Florida, United States, 33143 Belgium SGS Phase 1 Unit AZ St-Maarten Recruiting Mechelen, Belgium, 2800 Clinical Pharmacology Unit Recruiting Merksem, Belgium, 2170 Germany Charité Research Organisation GmbH Recruiting Berlin, Germany, 10117 Emovis GmbH Recruiting Berlin, Germany, 10629 CTC North GmbH & Co. KGim Spectrum am UKE Withdrawn Hamburg, Germany, 20251 Fraunhofer-Institut für Toxikologie und Experimentelle Medizin Recruiting Hannover, Germany, 30625 Somni Bene GmbH Recruiting Schwerin, Germany, 19053 Netherlands Centre for Human Drug Research Recruiting Leiden, Netherlands, 2333 CL United Kingdom MAC Clinical Research Recruiting Blackpool, United Kingdom, FY2 0JH MAC Clinical Research Recruiting Liverpool, United Kingdom, L34 1BH Hammersmith Medicines Research Recruiting London, United Kingdom, NW10 7EW MAC Clinical Research Recruiting Manchester, United Kingdom, M13 9NQ Less <<
NCT02832362 Common Cold Phase 1 Completed - Canada, Quebec ... More >> GSK Investigational Site Quebec City, Quebec, Canada, G1P 0A2 Less <<
NCT03329547 Infections, Bacterial Phase 1 Withdrawn(Change in commercial... More >> strategy) Less << February 2, 2018 -
NCT01865253 Hypertension Phase 4 Terminated(No new participants... More >> enrolled. Protocol superseded.) Less << - Australia, Victoria ... More >> Baker IDI Heart & Diabetes Institute Melbourne, Victoria, Australia, 3004 Less <<
NCT03393806 Asthma Phase 2 Recruiting October 10, 2019 France ... More >> GSK Investigational Site Not yet recruiting Brest Cedex, France, 29609 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    GSK Investigational Site Not yet recruiting Marseille, France, 13015 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    GSK Investigational Site Recruiting Montpellier cedex 5, France, 34295 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    Netherlands GSK Investigational Site Recruiting Amsterdam, Netherlands, 1105 AZ Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    United Kingdom GSK Investigational Site Recruiting Wythenshawe, Greater Manchester, United Kingdom, M23 9LT Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    GSK Investigational Site Recruiting Leicester, Leicestershire, United Kingdom, LE3 9QP Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    GSK Investigational Site Not yet recruiting Liverpool, Merseyside, United Kingdom, L7 8XP Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    GSK Investigational Site Recruiting Birmingham, United Kingdom, B9 5SS Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    GSK Investigational Site Recruiting Bradford, United Kingdom, BD9 6RJ Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    GSK Investigational Site Recruiting Edgbaston, United Kingdom, B15 2GW Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com Less <<
NCT01865240 Hypertension Phase 4 Terminated(No new participants... More >> enrolled. Protocol has been superseded) Less << - Australia, Victoria ... More >> Baker IDI Heart & Diabetes Inst Melbourne, Victoria, Australia, 3004 Less <<
NCT03498924 - Recruiting August 1, 2020 Spain ... More >> Tatiana Cuesta-Guardiola Recruiting Leon, Spain, 24080 Contact: Tatiana Cuesta-Guardiola, Medicine    0034987237400 ext 42277    tguardio@hotmail.com Less <<
NCT02924454 Drug Overdose ... More >> Overdose of Beta-adrenergic Blocking Drug Blood Pressure Less << Phase 4 Completed - Denmark ... More >> Bispebjerg University Hospital Copenhagen Copenhagen NW, Capital Region of Denmark, Denmark, 2400 Less <<
NCT02899026 Polymyalgia Rheumatica Phase 3 Withdrawn(GSK decision to retu... More >>rn rights to sirukumab to Janssen and discontinue sirukumab development in polymyalgia rheumatica.) Less << August 26, 2021 -
NCT03562195 Asthma Phase 3 Recruiting April 2, 2021 China, Guangdong ... More >> GSK Investigational Site Not yet recruiting Guangzhou, Guangdong, China, 510120 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    China, Jilin GSK Investigational Site Not yet recruiting Changchun, Jilin, China, 130041 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    China, Xinjiang GSK Investigational Site Not yet recruiting Urumqi, Xinjiang, China, 830054 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    China, Zhejiang GSK Investigational Site Recruiting Wenzhou, Zhejiang, China, 323027 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    China GSK Investigational Site Not yet recruiting Guangzhou, China, 511400 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    GSK Investigational Site Recruiting Shanghai, China Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com Less <<
NCT03345407 Pulmonary Disease, Chronic Obs... More >>tructive Less << Phase 2 Active, not recruiting January 10, 2019 -
NCT02794519 Asthma Phase 2 Withdrawn(This study has suspe... More >>nded participant recruitment.) Less << October 4, 2016 United States, California ... More >> GSK Investigational Site Long Beach, California, United States, 90808 United States, Florida GSK Investigational Site Aventura, Florida, United States, 33180 United States, Ohio GSK Investigational Site Cincinnati, Ohio, United States, 45231 United States, Virginia GSK Investigational Site Richmond, Virginia, United States, 23225 GSK Investigational Site Richmond, Virginia, United States, 23229 Spain GSK Investigational Site Alcorcón (Madrid), Spain, 28922 GSK Investigational Site Gerona, Spain, 17005 GSK Investigational Site Santiago De Compostela. La Coruña., Spain, 15706 Less <<
NCT01709838 Non-transfusion Dependent Thal... More >>assemia Less << Phase 4 Active, not recruiting January 17, 2019 China, Guangxi ... More >> Novartis Investigative Site Nanning, Guangxi, China, 530021 Greece Novartis Investigative Site Athens, GR, Greece, GR-115 27 Italy Novartis Investigative Site Cagliari, CA, Italy, 09121 Novartis Investigative Site Milano, MI, Italy, 20122 Lebanon Novartis Investigative Site Hazmiyeh, Beirut, Lebanon, PO BOX 213 Thailand Novartis Investigative Site Bangkok, Thailand, 10700 Tunisia Novartis Investigative Site Tunis, Tunisia, 1006 Turkey Novartis Investigative Site Adana, Turkey, 01330 Novartis Investigative Site Istanbul, Turkey, 34093 Novartis Investigative Site Izmir, Turkey, 35040 United Kingdom Novartis Investigative Site Leicester, United Kingdom, LE1 5WW Novartis Investigative Site London, United Kingdom, NW1 2PJ Less <<
NCT02924688 Asthma Phase 3 Active, not recruiting February 21, 2019 -
NCT01794377 Obesity Not Applicable Completed - France ... More >> CHU de La Réunion Saint Pierre, La Réunion, France, 97448 Less <<
NCT03055195 Dermatitis, Atopic Phase 2 Terminated(Study reached pre-d... More >>etermined futility criteria following interim analysis. No safety concerns were noted.) Less << - -
NCT01573403 Gastric pH Regulation in Healt... More >>hy Volunteers Less << Phase 1 Phase 2 Completed - Indonesia ... More >> Division of Gastroenterology, Department of Internal Medicine, dr. Cipto Mangunkusumo Hospital Jakarta Center, Jakarta, Indonesia, 10430 Less <<
NCT03408392 Infections, Bacterial Phase 1 Completed - South Africa ... More >> GSK Investigational Site Bloemfontein, Free State, South Africa, 9300 Less <<
NCT02571777 Asthma Phase 3 Recruiting June 3, 2019 -
NCT03393975 Congenital Thrombotic Thromboc... More >>ytopenic Purpura Less << Phase 3 Active, not recruiting January 21, 2021 United Kingdom ... More >> University College London Hospitals London, Greater London, United Kingdom, NW1 2PG Less <<
NCT01427049 - Completed - Netherlands ... More >> UMC Utrecht Utrecht, Netherlands Less <<
NCT01739998 Obesity Phase 4 Completed - -
NCT02016573 Hypertension Not Applicable Withdrawn(No participants enro... More >>lled into study and protocol has been superseded) Less << April 2015 -
NCT03223844 Schizophrenia ... More >> Psychosis Sensitisation Less << Not Applicable Recruiting December 2021 Austria ... More >> Medical University of Vienna Recruiting Vienna, Austria, 1090 Contact: Ana Weidenauer, MD    0043140400 ext 35470    ana.weidenauer@meduniwien.ac.at Less <<
NCT02156440 Osteoarthritis of the Knee Phase 2 Completed - Canada, Ontario ... More >> KGK Synergize Inc. London, Ontario, Canada, N6A 5R8 Less <<
NCT02351908 HIV Phase 4 Completed - United Kingdom ... More >> SSAT Clinical Research Facility London, United Kingdom, SW10 9NH Less <<
NCT00004266 Diabetic Nephropathy Phase 3 Completed - United States, Minnesota ... More >> Hennepin County Medical Center Minneapolis, Minnesota, United States, 55415 Less <<
NCT03468842 Caries Phase 1 Completed - Spain ... More >> Lluis Alcanyis Foundation dental clinic, University of Valencia Valencia, Spain, 46010 Less <<
NCT02210962 Schizophrenia Phase 4 Unknown February 2015 Poland ... More >> Department of Affective and Psychotic Disorders Medical University of Lodz Lodz, Poland, 92216 Less <<
NCT02246699 Overweight and Obese Volunteer... More >>s. Less << Not Applicable Completed - France ... More >> Clinical Nutrition Center Naturalpha (CNCN) Lille, France, 59120 Less <<
NCT02647502 Relapsing Remitting Multiple S... More >>clerosis Less << Not Applicable Completed - United States, Maryland ... More >> Johns Hopkins University Baltimore, Maryland, United States, 21287 Less <<
NCT03744221 Intestinal Barrier Function ... More >> Protein Digestion Kinetics Less << Not Applicable Recruiting December 20, 2018 Netherlands ... More >> Stichting Wageningen Research Recruiting Wageningen, Gelderland, Netherlands, 6708 WG Contact: Diederik Esser, Dr       diederik.esser@wur.nl Less <<
NCT02118025 - Completed - Spain ... More >> Hospital de la Santa Creu i Sant Pau Barcelona, Spain, 08026 Less <<
NCT00111956 Metabolic Syndrome X Phase 2 Phase 3 Completed - United States, Massachusetts ... More >> Mass General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT01447095 Subarachnoid Hemorrhage Phase 2 Completed - Denmark ... More >> Rigshospitalet, dep. of neurosurgery Copenhagen, Denmark, 2200 Less <<
NCT00138528 Metabolic Syndrome Phase 4 Completed - Germany ... More >> Novartis Nürnberg, Germany Less <<
NCT03666013 - Recruiting October 1, 2019 Netherlands ... More >> Maastricht University Recruiting Maastricht, Limburg, Netherlands, 6200 MD Contact: Lotte Grevendonk, M. Sc.    +31 43 388 1390    l.grevendonk@maastrichtuniversity.nl Less <<
NCT01610232 Healthy Phase 1 Completed - Brazil ... More >> Optics Group from Physics Institute of São Carlos (IFSC), University of São Paulo (USP) São Carlos, São Paulo, Brazil, 369 Less <<
NCT00159952 Severe Sepsis ... More >> Septic Shock Less << Phase 2 Phase 3 Completed - Italy ... More >> Hospital "S.Paolo" Milan, Italy Policlinico Hospital Milan, Italy Hospital "S.Gerardo" Monza, Italy Less <<
NCT00171548 - Completed - Switzerland ... More >> Novartis Pharmaceuticals Basel, Switzerland Less <<
NCT01816334 Sciatica Phase 4 Completed - France ... More >> CHU Hôpital Sud Echirolles, France, 38130 CH d'Uriage Uriage, France, 38410 Less <<
NCT00546182 - Completed - Korea, Republic of ... More >> Gil Medical Center, Gachon University Incheon, Korea, Republic of, 405760 Less <<
NCT00163943 Metabolic Syndrome X Not Applicable Unknown December 2007 Australia, Victoria ... More >> Baker Heart Research Institute Recruiting Melbourne, Victoria, Australia, 8008 Contact: Nora E Straznicky, BPharm, PhD, MPH    61 3 8532 1371    Nora.Straznicky@baker.edu.au    Principal Investigator: Nora E Straznicky, BPharm, PhD, MPH Less <<
NCT01781247 Stress Disorders, Post-Traumat... More >>ic Myocardial Infarction Less << Not Applicable Terminated(Population of eligi... More >>ble patients smaller than anticipated) Less << - Switzerland ... More >> Dep. of General Internal Medicine, Bern University Hospital Bern, Switzerland, 3010 Less <<
NCT00242814 Hypertension ... More >>Metabolic Syndrome X Less << Phase 4 Completed - France ... More >> 502.486.3302A Cabinet Médical Angers, France 502.486.3302B Cabinet Médical Angers, France 502.486.3303A Boehringer Ingelheim Investigational Site Angers, France 502.486.3305A Cabinet Médical Angers, France 502.486.3323A Cabinet Médical Angers, France 502.486.3323B Cabinet Médical Angers, France 502.486.3324A Cabinet Médical Angers, France 502.486.3324B Cabinet Médical Angers, France 502.486.3325A Cabinet médical Angers, France 502.486.3326A Cabinet Médical Angers, France 502.486.3328A Cabinet Médical Angers, France 502.486.3306A Cabinet Médical Briollay, France 502.486.3307A Cabinet Médical Chemille, France 502.486.3319A Cabinet Médical Cherbourg, France 502.486.3320A Cabinet Médical Cherbourg, France 502.486.3320B Cabinet Médical Cherbourg, France 502.486.3321A Cabinet Médical Equeurdreville, France 502.486.3322A Boehringer Ingelheim Investigational Site Evron, France 502.486.3312A Cabinet Médical Feneu, France 502.486.3315A Cabinet Médical La Rochelle, France 502.486.3308A Cabinet Médical Montrevault, France 502.486.3316A Boehringer Ingelheim Investigational Site Nieul sur Mer, France 502.486 3301A Boehringer Ingelheim Investigational Site Paris, France 502.486.3301B Hôpital Pitié Salpêtrière Paris, France 502.486.3310A Cabinet Médical Saint Pierre Montlimard, France 502.486.3327A Cabinet Médical Saumur, France 502.486.3309A Cabinet Médical Jean Charcot Segre, France 502.486.3311A Cabinet Médical Tierce, France 502.486.3311B Cabinet Médical Tierce, France 502.486.3311C Cabinet Médical Tierce, France 502.486.3311D Cabinet Médical Tierce, France Less <<
NCT00273572 Metabolic Syndrome ... More >> Diabetes Less << Not Applicable Completed - Israel ... More >> Unit of Cardiovascular Epidemiology, Gertner Institute for Epidemiology & Health Policy Research, Sheba Medical Center Tel-Hashomer, Ramat-Gan, Israel, 52621 Less <<
NCT03289026 Acute Schizophrenia Episode Phase 4 Not yet recruiting December 2018 China, Anhui ... More >> The Fourth People's Hospital of Hefei Not yet recruiting Hefei, Anhui, China, 230000 Contact: Jianliang Gao, MD.    8617756065210    793354604@qq.com    China, Beijing Beijing Anding Hospital, Capital Medical University Not yet recruiting Beijing, Beijing, China, 100069 Contact: Yang Yang, MD.    8613581528424    271558711@qq.com    Beijing HuiLongGuan Hospital Not yet recruiting Beijing, Beijing, China, 100096 Contact: Shaoxiao Yan, MD.    861062715511    393831968@qq.com    Peking University Sixth Hospital Not yet recruiting Beijing, Beijing, China, 100191 Contact: Tianmei Si, PhD.    861062723748    si.tian-mei@163.com    China, Heilongjiang The First Haerbin Psychiatric Hospital Not yet recruiting Ha'erbin, Heilongjiang, China, 150056 Contact: Jia Xu, MD.    86045182404870    xujiaxujia132129@sina.com    China, Henan The First Affiliated Hospital of Zhengzhou University Not yet recruiting Zhengzhou, Henan, China, 450052 Contact: Shuying Li, PhD.    8613525520821    lishuying6112@126.com    China, Hubei Wuhan Mental Health Center Not yet recruiting Wuhan, Hubei, China, 430000 Contact: Maosheng Fang, MD.    8613553013182    fangmaosheng@126.com    China, Jiangsu 102 Miltary Hospital of China Not yet recruiting Changzhou, Jiangsu, China, 213003 Contact: Haiying Yu, MD.    86051983064711    cpyhy_102@163.com    China, Shandong Shandong Mental Health Center Not yet recruiting Jinan, Shandong, China, 250014 Contact: Jintong Liu, MD.    86053186336610    jintongliu@sdu.edu.cn    China, Shanghai Shanghai Mental Health Center Not yet recruiting Shanghai, Shanghai, China, 200003 Contact: Peifen Yao, MD.    8602164387250    ypf93@163.com    China, Sichuan The Fourth People's Hospital of Chengdu Not yet recruiting Chengdu, Sichuan, China, 610036 Contact: Mingjun Duan, MD.    8618980717307    316437342@qq.com    China, Zhejiang Hangzhou Seventh People's Hospital Not yet recruiting Hanzhou, Zhejiang, China, 310013 Contact: Zhiyu Chen, MD.    86057185129503    hzczy536@163.com Less <<
NCT00269646 Metabolic Syndrome X Not Applicable Unknown August 2009 United States, Virginia ... More >> University of Virginia General Clinical Research Center Charlottesville, Virginia, United States, 22904 Less <<
NCT00296803 Metabolic Syndrome x Phase 4 Completed - United States, New Jersey ... More >> Sanofi-Aventis Bridgewater, New Jersey, United States, 08807 Less <<
NCT00297154 Heart Failure, Congestive ... More >> Metabolic Syndrome X Obesity Less << Not Applicable Unknown - United States, Texas ... More >> Ben Taub General Hospital Recruiting Houston, Texas, United States, 77030 Less <<
NCT00300365 Metabolic Syndrome Phase 2 Completed - United States, Pennsylvania ... More >> University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00307411 Metabolic Syndrome Phase 4 Unknown - China ... More >> Prince of Wales Hospital, The Chinese University of Hong Kong Not yet recruiting Hong Kong SAR, China Contact: Alice PS Kong, M.B.,Ch.B.    852-2632 3123    kongps@yahoo.com    Principal Investigator: Alice PS Kong, M.B.,Ch.B. Less <<
NCT01575041 Hypertension ... More >>Blood Pressure Vascular Function Renal Function Less << Not Applicable Completed - Netherlands ... More >> Wageningen University Wageningen, Netherlands, 6703 HD Less <<
NCT00327002 Metabolic Syndrome X Phase 2 Completed - United States, Pennsylvania ... More >> John Millar Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00346970 Metabolic Syndrome Phase 4 Completed - Germany ... More >> Hannover Medical School Hannover, Germany, 30625 Less <<
NCT01702480 Alzheimer's Disease Phase 1 Completed - United Kingdom ... More >> GSK Investigational Site Cambridge, Cambridgeshire, United Kingdom, CB2 2GG Less <<
NCT02475655 HIV Infections Phase 2 Completed - United States, Alabama ... More >> Alabama CRS Birmingham, Alabama, United States, 35294 United States, California UCLA CARE Center CRS Los Angeles, California, United States, 90035 UCSD Antiviral Research Center CRS San Diego, California, United States, 92103 Ucsf Hiv/Aids Crs San Francisco, California, United States, 94110 United States, Illinois Northwestern University CRS Chicago, Illinois, United States, 60611 United States, Missouri Washington University Therapeutics (WT) CRS Saint Louis, Missouri, United States, 63110-1010 United States, New York Weill Cornell Chelsea CRS New York, New York, United States, 10010 Weill Cornell Uptown CRS New York, New York, United States, 10065 University of Rochester Adult HIV Therapeutic Strategies Network CRS Rochester, New York, United States, 14642 United States, Ohio Cincinnati Clinical Research Site Cincinnati, Ohio, United States, 45219 Case Clinical Research Site Cleveland, Ohio, United States, 44106 United States, Pennsylvania Penn Therapeutics, CRS Philadelphia, Pennsylvania, United States, 19104 United States, Rhode Island The Miriam Hospital Clinical Research Site (TMH CRS) CRS Providence, Rhode Island, United States, 02906 United States, Tennessee Vanderbilt Therapeutics (VT) CRS Nashville, Tennessee, United States, 37204 Less <<
NCT00745836 Hypercholesterolemia Phase 4 Completed - Korea, Republic of ... More >> Gil Medical Center Incheon, Korea, Republic of, 405760 Less <<
NCT00399932 - Unknown May 2010 Belgium ... More >> StLuc University Hospital Recruiting Brussels, Belgium, 1200 Principal Investigator: Michel Hermans, M.D., Ph.D Less <<
NCT00408850 Metabolic Syndrome Phase 3 Unknown February 2013 Australia, Victoria ... More >> Baker Heart Research Institute Recruiting Melbourne, Victoria, Australia, 8008 Principal Investigator: Nora E Straznicky, PhD MPH Less <<
NCT00179374 Diabetes Mellitus, Type 2 Not Applicable Completed - United States, New York ... More >> Albert Einstein College of Medicine Bronx, New York, United States, 10461 Less <<
NCT00182286 - Completed - Canada, Ontario ... More >> Group Health Centre Sault Ste. Marie, Ontario, Canada, P6B 1Y5 Less <<
NCT00189774 Type 2 Diabetes Mellitus ... More >> Diabetes Mellitus, Type II Less << Phase 2 Phase 3 Completed - Japan ... More >> Chubu region, Japan Chugoku region, Japan Hokkaido region, Japan Kanto region, Japan Kinki region, Japan Kyushu region, Japan Tohoku region, Japan Less <<
NCT00194506 Diabetes Mellitus, Type 2 Not Applicable Completed - United States, Washington ... More >> University of Washington, General Internal Medicine Clinic, Roosevelt Seattle, Washington, United States, 98195 Less <<
NCT00198900 - Completed - United States, Maryland ... More >> Johns Hopkins University Lutherville, Maryland, United States, 21093 Less <<
NCT01516528 - Completed - -
NCT00195884 Diabetes Mellitus, Type 2 ... More >> Diabetes Mellitus Less << Not Applicable Completed - Canada, Ontario ... More >> Ottawa Hospital Research Institute Ottawa, Ontario, Canada, K1H 7W9 Less <<
NCT00185601 Diabetes Mellitus, Type 2 Not Applicable Completed - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT00204009 - Completed - United States, Illinois ... More >> The University of Chicago, Biological Sciences Division, Pritzker School of Medicine Chicago, Illinois, United States, 60637 Less <<
NCT00202748 Type 2 Diabetes Phase 3 Unknown - Norway ... More >> Sorlandet Hospital Kristiansand, Serviceboks 416, Norway, 4604 Less <<
NCT00213070 Type 2 Diabetes Mellitus Phase 3 Completed - Japan ... More >> Aichi, Japan Chiba, Japan Fukuoka, Japan Gifu, Japan Gunma, Japan Hokkaido, Japan Ibaraki, Japan Kagoshima, Japan Kanagawa, Japan Kumamoto, Japan Miyazaki, Japan Oita, Japan Okinawa, Japan Saitama, Japan Shiga, Japan Tokyo, Japan Less <<
NCT00300365 - Completed - -
NCT00220207 Diabetes Mellitus, Type 2 Not Applicable Completed - United States, Washington ... More >> Harborview Medical Center Seattle, Washington, United States, 98104 Less <<
NCT00210275 Education, Medical, Continuing... More >> Practice Patterns Hypertension Diabetes Mellitus, Type 2 Less << Not Applicable Unknown July 2016 -
NCT00225888 Type 2 Diabetes Not Applicable Terminated(Investigators left ... More >>Joslin) Less << - United States, Massachusetts ... More >> Joslin Diabetes Center Boston, Massachusetts, United States, 02215 Less <<
NCT03325114 Type 1 Diabetes Mellitus ... More >> Hypercalciuria Less << Phase 2 Not yet recruiting June 30, 2020 United States, New York ... More >> University of Rochester Rochester, New York, United States, 14642 Less <<
NCT00223340 Diabetes Not Applicable Completed - United States, Texas ... More >> The University of Texas Health Science Center at San Antonio (Texas) San Antonio, Texas, United States, 78229 Less <<
NCT03330756 Obesity, Morbid ... More >> Type 2 Diabetes Mellitus Less << Not Applicable Recruiting November 1, 2021 Netherlands ... More >> medical Center Slotervaart Recruiting Amsterdam, Noord-Holland, Netherlands, 1066EC Contact: Anne-Sophie van Rijswijk, MD    +31205014460    anne-sophie.vanrijswijk@slz.nl    Contact: Maurtis de Brauw, MD PhD       maurits.debrauw@slz.nl Less <<
NCT03333642 Diabetes Mellitus ... More >> Obesity Overweight Less << Not Applicable Recruiting July 2021 Brazil ... More >> Hospital Federal de Bonsucesso Recruiting Rio de Janeiro, Brazil, 21041-020 Contact: Leonardo R Ferraz, MD    +55 21 996462422    lrferraz1@1hotmail.com    Contact: Thiago B Abreu, MD    +55 21 996487500    boechat1@yahoo.com.br    Sub-Investigator: Miguel Madeira, PhD          Sub-Investigator: Luciana El Kadre, PhD          Sub-Investigator: Aureo L de Paula, PhD Less <<
NCT03327896 - Active, not recruiting August 2018 -
NCT03348280 - Recruiting December 31, 2020 United States, Missouri ... More >> Barnes-Jewish & Washington University Diabetes Center Recruiting Saint Louis, Missouri, United States, 63110 Contact: Veronica Worth    314-362-0934       Contact: E          Washington University Recruiting Saint Louis, Missouri, United States, 63110 Contact: Carlos Bernal-Mizrachi, MD    314-362-0934    cbernal@dom.wustl.edu    Principal Investigator: Carlos Bernal-Mizrachi, MD Less <<
NCT03361631 Erectile Dysfunction ... More >> Stem Cells Diabetes Mellitus, Type 1 Less << Phase 1 Not yet recruiting December 31, 2019 -
NCT03376698 Colchicine Di... More >>abetes Mellitus, Type 2 Coronary Artery Disease White Blood Cell Inflammation Diarrhea Less << Phase 2 Recruiting June 2018 Japan ... More >> Hiroshima University Hospital Recruiting Hiroshima, Japan Contact: Yukihito Higashi, PhD          Kitasato University Hospital Recruiting Kanagawa, Japan Contact: Junya Ako, PhD          Urasoe Sogo Hospital Recruiting Okinawa, Japan Contact: Hiroki Uehara          Dokkyo Medical University Nikko Medical Center Recruiting Tochigi, Japan Contact: Takanori Yasu, PhD          Showa University Hospital Recruiting Tokyo, Japan Contact: Shinji Koba, PhD Less <<
NCT00210262 Diabetes Not Applicable Completed - Canada, Ontario ... More >> ICES Toronto, Ontario, Canada Less <<
NCT03362983 Diabetes Mellitus ... More >> Chronic Kidney Diseases Cardiovascular Diseases Chronic Disease Multimorbidity Less << Not Applicable Recruiting March 1, 2019 Sweden ... More >> HND centrum, Danderyd University Hospital Recruiting Stockholm, Stockholms LAN, Sweden, 18261 Contact: Jonas Spaak, MD, PhD    +46 76 2014178    jonas.spaak@ki.se Less <<
NCT03383146 Gastroparesis ... More >> Diabetes Mellitus Less << Phase 3 Recruiting September 28, 2020 -
NCT03385135 Diabetes Mellitus ... More >> Coronary Artery Disease Less << Not Applicable Recruiting June 2018 Tunisia ... More >> Cardiology Department, Abderrahmen Mami Hospital Recruiting Ariana, Tunisia, 2008 Contact: Sami Kasbaoui, MD    +21622560059    kas.sami77@gmail.com    Contact: Marouane Boukhris, MD    +21622557125    mar1bou@hotmail.com Less <<
NCT03361709 Diabetes Mellitus ... More >> Corneal Endothelial Cell Loss Dexamethasone Adverse Reaction Corneal Endothelial Decompensation Less << Phase 4 Not yet recruiting July 1, 2018 -
NCT03384758 Peripheral Arterial Disease ... More >> Diabetes Mellitus Leg Edema Less << Not Applicable Not yet recruiting March 1, 2019 -
NCT03399357 - Recruiting February 28, 2019 Singapore ... More >> Tan Tock Seng Hospital Recruiting Singapore, Singapore, 308433 Contact: Sapna P. Sadarangani, MBBS    88091031 ext 63577442    Sapna_Sadarangani@ttsh.com.sg    Contact: Mei Xuan Tan    +65-85229946 ext 64783062    Mei_Xuan_Tan@ttsh.com.sg    Principal Investigator: Sapna P Sadarangani, MBBS          Sub-Investigator: Barnaby Young, MB BChir, MSc          Sub-Investigator: Rinkoo Dalan, MBBS          Sub-Investigator: Ezlyn Izzharudin, MBBS          Sub-Investigator: Anis Larbi, PhD Less <<
NCT03404037 - Completed - Egypt ... More >> Zagazig University, Faculty of Medicine Zagazig, Egypt, 44519 Less <<
NCT03395509 - Enrolling by invitation August 1, 2025 Denmark ... More >> Cardiovascular research Center (KVC), Viborg Hospital Viborg, Denmark, 8800 Less <<
NCT03407508 Diabetes Mellitus ... More >> Gingivitis Less << Phase 1 Phase 2 Not yet recruiting December 2019 Sweden ... More >> University of Kristianstad Kristianstad, Skåne, Sweden, 29188 Less <<
NCT03420781 Gastroparesis ... More >> Diabetes Mellitus Less << Phase 3 Enrolling by invitation December 6, 2020 -
NCT03422965 Retinal Vascular ... More >> Retinal Disease Retinal Ischemia Retinal Ischaemia Due to Type 1 Diabetes Mellitus Diabetes Mellitus Diabetic Retinopathy Diabetes Mellitus, Type 1 Vessels; Retina, Tortuous Less << Not Applicable Recruiting December 31, 2020 Spain ... More >> Institut Clinic de Oftalmologia (ICOF), Hospital Clínic de Barcelona Recruiting Barcelona, Spain, 08028 Contact: Javier Zarranz-Ventura, MD PhD FEBO    +342275400 ext 5667    zarranz@clinic.cat    Principal Investigator: Javier Zarranz-Ventura, MD PhD FEBO          Sub-Investigator: Anibal Alé-Chilet, MD          Sub-Investigator: Marina Barraso-Rodrigo, MD          Sub-Investigator: Teresa Hernandez, OD          Sub-Investigator: Cristian Oliva-Parra, OD          Sub-Investigator: Jesus Gascón, OD          Sub-Investigator: Anna Sala-Puigdollers, MD          Sub-Investigator: Marc Figueras-Roca, MD          Sub-Investigator: Alfredo Adan, MD PhD          Diabetes Unit, Institut Clinic de Malalties Digestives i Métaboliques (ICMDM), Hospital Clínic de Barcelona Recruiting Barcelona, Spain, 08036 Contact: Emilio Ortega, MD PhD    +34932275400 ext 3029    eortega1@clinic.cat    Sub-Investigator: Emilio Ortega, MD PhD          Sub-Investigator: Irene Vinagre, MD PhD          Sub-Investigator: Enric Esmatjes, MD PhD Less <<
NCT03426345 Gastroparesis ... More >> Diabetes Mellitus Less << Phase 3 Recruiting January 18, 2020 -
NCT03428308 Ischemia Card... More >>iac Insufficiency Diabetes Mellitus, Type 2 Hypertension Hypercholesterolemia Severe Mental Disorder Less << Not Applicable Not yet recruiting December 2019 -
NCT03423589 Type1diabetes ... More >> Type1 Diabetes Mellitus Less << Not Applicable Enrolling by invitation December 31, 2018 United States, Wisconsin ... More >> Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 Less <<
NCT03434288 - Active, not recruiting October 1, 2018 France ... More >> Uhmontpellier Montpellier, France, 34295 Less <<
NCT03437044 Diabetes Mellitus, Type 2 ... More >> Coronary Artery Disease Less << Phase 4 Recruiting July 2019 United States, Florida ... More >> University of Florida Recruiting Jacksonville, Florida, United States, 32209 Contact: Dominick J Angiolillo, MD, PhD       dominick.angiolillo@jax.ufl.edu    Principal Investigator: Dominick J Angiolillo, MD, PhD Less <<
NCT03447275 - Completed - -
NCT03325322 Chronic Kidney Diseases ... More >> Diabetes Mellitus Diabetic Nephropathies Less << Phase 2 Recruiting April 2022 United States, Minnesota ... More >> Mayo Clinic in Rochester Recruiting Rochester, Minnesota, United States, 55905 Contact: Tammie Volkman, RN    507-266-1944    volkman.tammie@mayo.edu    Contact: Erin Wissler Gerdes    507-266-1944    Wisslergerdes.erin@mayo.edu Less <<
NCT03439592 - Recruiting June 1, 2018 Italy ... More >> Raffaele Marfella Recruiting Naples, Italy, 80138 Contact: Raffaele Marfella, MD, PhD    +39 0810815665110    raffaele.marfella@unicampania.it    Contact: Celestino Sardu, MD, MSc, PhD    +393336664543    drsarducele@gmail.com Less <<
NCT03447964 - Completed - France ... More >> Groupe Hospitalier Pitié-Salpêtrière Paris, France, 75013 Less <<
NCT03460769 - Recruiting November 2020 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact       yyuan@mdanderson.org Less <<
NCT03462017 Microvascular Coronary Artery ... More >>Disease Less << Phase 1 Recruiting December 21, 2018 Germany ... More >> Investigational Site Number 2760002 Recruiting Mainz, Germany, 55116 Investigational Site Number 2760001 Recruiting Neuss, Germany, 41460 Less <<
NCT03458338 - Completed - Switzerland ... More >> Universitätsspital Basel Basel, Switzerland, 4031 Less <<
NCT03479788 - Recruiting November 2022 Singapore ... More >> Lee Chi-Hang Ronald Recruiting Singapore, Singapore, 119228 Contact: Lee C Ronald, MD    67795555 ext 5597    ronald_lee@nuhs.edu.sg Less <<
NCT03479619 Diabetes Mellitus, Type 1 ... More >> Diabetes Mellitus, Type 2 Less << Not Applicable Completed - Poland ... More >> Nzoz Magmed Lodz, Poland, 91-738 Less <<
NCT03495765 Diabetic Macular Oedema Phase 3 Completed - Australia, New South Wales ... More >> Marsden Eye Specialists Paramatta, New South Wales, Australia, 2150 Less <<
NCT03481361 - Recruiting September 2019 United Kingdom ... More >> Birmingham Heartlands Hospital, Heart of England NHS Foundation Trust Recruiting Birmingham, United Kingdom, B9 5SS Contact: Ziyad Alshehri, MSc          Principal Investigator: Abd Tahrani, MD Less <<
NCT03506711 Type 1 Diabetes Mellitus ... More >> Coronary Artery Disease Less << Not Applicable Recruiting December 30, 2019 Switzerland ... More >> Pediatric Endocrinology, Diabetology and Obesity Unit, Service of Pediatrics, Lausanne University Hospital Recruiting Lausanne, Vaud, Switzerland, 1011 Contact: Michael Hauschild, MD    +41213148773    Michael.Hauschild@chuv.ch Less <<
NCT03486535 - Recruiting January 31, 2019 Turkey ... More >> Istanbul University, Medical Faculty of Istanbul Recruiting Istanbul, Turkey, 34093 Contact: Emine A Salviz, MD,AssocProf    00905325225599    aysusalviz@gmail.com    Contact: Nukhet Sivrikoz, MD    00905325117387    ntsz06@gmail.com    Metin Sabancı Baltalimanı Kemik Hastalıkları Training and Research Hospital Recruiting Istanbul, Turkey, 34470 Contact: Nur Canbolat, MD    0095325162583    nurekiz@gmail.com    Contact: Tugce Yeniocak, MD    00905327692602    tugcekusku@yahoo.com Less <<
NCT03499223 Diabetes Mellitus ... More >> Diabetic Retinopathy Macular Edema Less << Phase 2 Recruiting June 2019 Belgium ... More >> CHU Brugmann Recruiting Brussels, Belgium, 1020 UZ Leuven Recruiting Leuven, Belgium, 3000 France Centre Rétine Gallien Recruiting Bordeaux, France, 33000 Centre Hospitalier Intercommunal de Créteil Recruiting Créteil, France, 94010 CHU Dijon Recruiting Dijon, France, 21079 Hôpital de la Croix Rousse Recruiting Lyon, France, 69004 Hôpital Saint-Joseph Recruiting Marseille, France, 13285 Centre Hospitalier Universitaire de Nice, Hôpital Pasteur Recruiting Nice, France, 06001 Centre Ophtalmologique de l'Odéon Recruiting Paris, France, 75006 Hôpital Lariboisière Recruiting Paris, France, 75475 Centre Ophtalmologique Maison Rouge Recruiting Strasbourg, France, 67000 Germany Charite Universitaetsmedizin Berlin Recruiting Berlin, Germany, 12203 Universitaetsklinikum Dresden Recruiting Dresden, Germany, 01307 Universitaetsklinikum Frankfurt Recruiting Frankfurt am Main, Germany, 60590 Universitaetsklinikum Leipzig Recruiting Leipzig, Germany, 04103 Klinikum der Stadt Ludwigshafen am Rhein Recruiting Ludwigshafen am Rhein, Germany, 67063 Philipps-Universität Marburg Recruiting Marburg, Germany, 35043 Slovakia Univerzitná nemocnica Bratislava, Nemocnica Ružinov Recruiting Bratislava, Slovakia, 826 06 Univerzitná nemocnica Bratislava, Nemocnica Sv. Cyrila a Metoda Recruiting Bratislava, Slovakia, 851 07 Nemocnica Poprad, a.s. Recruiting Poprad, Slovakia, 058 01 Fakultná nemocnica Trenčín Recruiting Trenčín, Slovakia, 911 71 Fakultná nemocnica s polikliniku Žilina Recruiting Žilina, Slovakia, 012 07 Spain Centro Médico Téknon Recruiting Barcelona, Spain, 08022 Hospital Clinic de Barcelona Recruiting Barcelona, Spain, 08028 Hospital general de Cataluña Recruiting Barcelona, Spain, 08195 Hospital Universitari de Bellvitge Recruiting L'Hospitalet De Llobregat, Spain, 08907 Vissum Madrid Recruiting Madrid, Spain, 28002 Hospital General Universitario de Valencia Recruiting Valencia, Spain, 46014 Oftalvist IMED Valencia Recruiting Valencia, Spain, 46100 Hospital Universitario Miguel Servet Recruiting Zaragoza, Spain, 50009 United Kingdom Royal Surrey County Hospital NHS Foundation Trust Recruiting Guildford, United Kingdom, GU2 7XX Leeds Teaching Hospitals NHS Trust Recruiting Leeds, United Kingdom, LS9 7TF Moorfields Eye Hospital NHS Foundation Trust Recruiting London, United Kingdom, EC1V 2PD Kings College Hospital NHS Foundation Trust Recruiting London, United Kingdom, SE5 9RS City Hospitals Sunderland NHS Foundation Trust Recruiting Sunderland, United Kingdom, SR2 9HP Less <<
NCT03498534 Latent Tuberculosis ... More >> Diabetes Mellitus Less << Phase 4 Withdrawn(Due to administrativ... More >>e procedures) Less << December 2013 -
NCT03511898 Diabetes Mellitus ... More >> Diabetic Retinopathy Diabetic Macular Edema Less << Phase 1 Recruiting March 2019 United States, Arizona ... More >> Retina Consultants of Arizona Recruiting Phoenix, Arizona, United States, 85053 United States, Massachusetts Ophthalmic Consultants of Boston Recruiting Boston, Massachusetts, United States, 02114 United States, Nevada Sierra Eye Associates Recruiting Reno, Nevada, United States, 89502 United States, Pennsylvania Mid Atlantic Retina Recruiting Huntingdon Valley, Pennsylvania, United States, 19006 United States, Texas Retina Research Institute of Texas Recruiting Abilene, Texas, United States, 79606 Retinal Research Center, PLLC Recruiting Austin, Texas, United States, 78705 Retina Consultants of Houston Recruiting Houston, Texas, United States, 77030 Less <<
NCT03387826 Myocardial Infarction ... More >> Diabetes Mellitus Coronary Artery Disease Renal Disease Less << Phase 4 Recruiting January 2019 Greece ... More >> Attikon University Hospital Recruiting Chaidari, Greece, 12462 Contact: DIMITRIOS ALEXOPOULOS, MD    30-6944314398    dalex@med.uoa.gr    Contact: Danai Sfantou, MD    6975023693    danaes8@yahoo.gr Less <<
NCT03528811 Peripheral Vascular Disease in... More >> Diabetes Less << Phase 1 Recruiting July 31, 2018 China ... More >> Shanghai Tenth People's Hospital, Tong ji University Recruiting Shanghai, China Contact: Mao Q Li, Ph.D    02166313506    cjr.limaoquan@vip.163.com Less <<
NCT03520660 - Recruiting December 31, 2032 United States, Maryland ... More >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)    800-411-1222 ext TTY8664111010    prpl@cc.nih.gov Less <<
NCT03530176 Atherosclerosis ... More >> Complications of Diabetes Mellitus Less << Not Applicable Completed - Canada, Alberta ... More >> University Hospital of Alberta Edmonton, Alberta, Canada, T6G 2B7 Less <<
NCT03571139 - Recruiting January 2019 Jordan ... More >> German Eye Center Recruiting Amman, Jordan Contact: Ibrahim Al-Nawaiseh, MD    00962795667760    i-nawaiseh@hotmail.com Less <<
NCT03539627 - Not yet recruiting June 2021 -
NCT03569735 - Recruiting December 30, 2028 China, Guangdong ... More >> Department of Non-communicable Disease Prevention and Control, Shenzhen Nanshan Center for Chronic Disease Control Recruiting Shenzhen, Guangdong, China, 518054 Contact: Changyi Wang, PhD    +86 15813830525    wangchangyi2002@163.com    China Department of Medical Statistics & Epidemiology, School of Public Health, Sun Yat-sen University Withdrawn Guangzhou, China, 510080 Less <<
NCT03592355 Heart Failure ... More >> Hypertension Diabetes Mellitus Stroke BPH Hyperlipidemia Less << Not Applicable Enrolling by invitation March 1, 2020 United States, Massachusetts ... More >> Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Less <<
NCT03530930 Osteoarthritis ... More >> Diabetes Mellitus Less << Phase 4 Recruiting September 2018 Russian Federation ... More >> Laboratory of Clinical Immunopharmacology Recruiting Novosibirsk, Russian Federation, 630047 Contact: Ivan Shirinsky, MD, PhD    +73832282547    ivan.shirinsky@gmail.com    Contact: Valery Shirinsky, Professor    +73832282547    valery.shirinsky@gmail.com Less <<
NCT03594344 Diabetes Mellitus ... More >> Claudication, Intermittent Critical Limb Ischemia Osteomyelitis Amputation Lower Extremity Ulcer Diabetic Angiopathy Diabetic Neuropathies Diabetic Foot Less << Not Applicable Recruiting December 31, 2023 Norway ... More >> Orthopedic Center, Ullevål University Hopspital Recruiting Oslo, Norway, 0407 Contact: Elisabeth Ellingsen Husebye, MD, phD    +47 23027884       Contact: Jonas Thomassen    +47 99621124    jonas_thomassen@hotmail.com    Principal Investigator: Elisabeth Ellingsen Husebye, MD          Principal Investigator: Jonas Thomassen Less <<
NCT03602638 Atherosclerosis Type 2 Diabete... More >>s Mellitus Dipeptidyl Peptidase-4 Inhibitor GLP-1 Less << Phase 4 Not yet recruiting December 1, 2020 -
NCT03605329 Sleep Apnea, Obstructive ... More >> Diabetes Mellitus, Type 1 Less << Not Applicable Not yet recruiting July 31, 2020 -
NCT03576300 - Recruiting July 1, 2018 China, Beijing ... More >> Peking University Third Hospital Recruiting Beijing, Beijing, China, 100191 Contact: Hong Qi, MD       doctorqihong@163.com Less <<
NCT03622359 - Recruiting December 31, 2021 United States, Ohio ... More >> Nationwide Children's Hospital Recruiting Columbus, Ohio, United States, 43205 Contact: Mitchel R Stacy, Ph.D.    614-355-5836    Mitchel.Stacy@nationwidechildrens.org Less <<
NCT03615755 Hyperbaric Oxygen Therapy ... More >> Diabetic Foot Ulcer Type II Diabetes Mellitus Less << Not Applicable Completed - -
NCT03594591 - Recruiting January 1, 2020 Spain ... More >> Hospital Clínic de Barcelona Recruiting Barcelona, Spain, 08036 Contact: Emilio Ortega, MD, PhD    +34932279846    eortega1@clinic.ub.es    Sub-Investigator: Antonio J Amor, MD          Sub-Investigator: Marc Figueras, MD          Sub-Investigator: Rosa Gilabert, MD, PhD          Sub-Investigator: Montserrat Cofán, PhD          Sub-Investigator: Laura Boswell, MD          Sub-Investigator: Mireia Hereu          Sub-Investigator: Aleix Sala-Vila, PhD Less <<
NCT03627455 - Completed - -
NCT03629912 Activities of Daily Living ... More >> Accidental Fall Sarcopenia Arteriosclerosis Diabetes Mellitus, Type 2 Hypertension Cognitive Decline Executive Function Cognitive Aging Less << Not Applicable Recruiting August 13, 2021 United States, Kentucky ... More >> Webster County Senior Center Recruiting Dixon, Kentucky, United States, 42409 Contact: Matthew Shake, PhD    270-745-3550    casha@wku.edu    United States, Tennessee Chester County Senior Center Recruiting Henderson, Tennessee, United States, 38340 Contact: Matthew Shake    270-745-3550    casha@wku.edu    Johnson County Senior Center Recruiting Johnson City, Tennessee, United States, 37601 Contact: Matthew Shake, PhD    270-745-3550    casha@wku.edu    Scotts Hill Senior Center Recruiting Scotts Hill, Tennessee, United States, 38374 Contact: Matthew Shake, PhD    270-745-3550    casha@wku.edu Less <<
NCT03620773 Type 2 Diabetes Mellitus ... More >> Obesity Bariatric Surgery Candidate Nephropathy Diabetic Kidney Disease Diabetes Mellitus, Type 2 Diabetes Mellitus Diabetes Complications Weight Loss Diabetic Nephropathies Adolescent Obesity Pediatric Obesity Less << Phase 1 Phase 2 Recruiting August 2023 United States, Colorado ... More >> Children's Hospital Colorado Recruiting Aurora, Colorado, United States, 80045 Contact: Petter Bjornstad, MD    720-777-4659    petter.bjornstad@childrenscolorado.org    Principal Investigator: Petter Bjornstad, M.D.          Sub-Investigator: Kristin Nadeau, M.D. Less <<
NCT03636867 - Recruiting August 31, 2025 Italy ... More >> Maria Cecilia Hospital Recruiting Cotignola, Ravenna, Italy, 48010 Contact: Luca Dalla Paola, MD          Sub-Investigator: Paolo Sbarzaglia, MD          Principal Investigator: Luca Dalla Paola, MD Less <<
NCT03635970 Peripheral Arterial Disease ... More >> Diabetes Mellitus Less << Not Applicable Active, not recruiting May 18, 2019 Mexico ... More >> Instituto Mexicano Del Seguro Social León, Guanajuato, Mexico, 37660 Less <<
NCT03626623 Diabetes Diab... More >>etic Foot Diabetes Mellitus, Type 2 Diabetes Mellitus, Type 1 Less << Not Applicable Not yet recruiting September 2020 United States, Louisiana ... More >> Louisiana State University Health Science Center (LSUHSC) Not yet recruiting New Orleans, Louisiana, United States, 70112 Contact: Alison Fleury, RN    504-903-9000    afleur@lsuhsc.edu    Principal Investigator: John T. Paige, MD          Sub-Investigator: Jace Landry, MD          United States, New Jersey University Hospital Not yet recruiting Newark, New Jersey, United States, 07101 Contact: Oscar M. Alvarez, PhD, CCT    973-972-3556    alvareom@uhnj.org    Contact: Arlene Wallen, MS, CCRP       wallenar@uhnj.org    Principal Investigator: Oscar M. Alvarez, PhD, CCT          United States, Pennsylvania University of Pittsburgh Medical Center (UPMC) Not yet recruiting Pittsburgh, Pennsylvania, United States, 15261 Contact: Patsy Simon, RN, BS, CCRC    412-648-9207    simonpa@upmc.edu    Principal Investigator: J. Peter Rubin, MD Less <<
NCT03651180 - Active, not recruiting October 1, 2023 Italy ... More >> San Giovanni Bosco Hospital - ASL Città di Torino Turin, Italy, 10154 Less <<
NCT03649243 - Completed - -
NCT03572166 Diabetes Insipidus ... More >> Polydipsia, Primary Less << Not Applicable Recruiting December 2022 Switzerland ... More >> University Hospital Basel, Department of Endocrinology Recruiting Basel, Basel Stadt, Switzerland, 4031 Contact: Julie Refardt, Dr., MD    +41 61 328 76 08    julie.refardt@usb.ch Less <<
NCT03666923 Diabetes Mellitus ... More >> Diabetic Retinopathy Diabetic Macular Edema Less << Phase 1 Recruiting June 2019 United States, Florida ... More >> Center for Retina and Macular Disease Recruiting Winter Haven, Florida, United States, 33880 United States, Indiana Midwest Eye Institute Recruiting Indianapolis, Indiana, United States, 46290 United States, Michigan Associated Retinal Consultants Recruiting Royal Oak, Michigan, United States, 48073 United States, New Jersey Retina Center of New Jersey, LLC Recruiting Bloomfield, New Jersey, United States, 07003 United States, South Carolina Palmetto Retinal Center Recruiting West Columbia, South Carolina, United States, 29169 United States, Texas Retina Research Institute of Texas Recruiting Abilene, Texas, United States, 79606-1224 Valley Retina Institute, PA Recruiting McAllen, Texas, United States, 78503 Less <<
NCT03666117 - Not yet recruiting January 1, 2020 Egypt ... More >> Assiut children hospital Recruiting Assiut, Egypt, 17100551 Contact: Manar Khalifa, Resident    01127670977    ma.peddr450@gmail.com Less <<
NCT03645382 Overweight Di... More >>abetes Mellitus Obesity Less << Not Applicable Completed - Korea, Republic of ... More >> Laboratory of Clinical Nutrigenetics/Nutrigenomics, Yonsei University. Seoul, Korea, Republic of, 03722 Less <<
NCT03693560 Coronary Artery Disease ... More >> Diabetes Mellitus, Type 2 Less << Phase 4 Active, not recruiting February 2019 Egypt ... More >> Faculty of Pharmacy - Damanhour University. Damanhūr, Egypt Less <<
NCT03693521 Diabetes Mellitus, Type 2 ... More >> Physical Activity Muscular Weakness Less << Not Applicable Not yet recruiting October 1, 2020 -
NCT03665870 Diabetes Mellitus ... More >> Hypoglycemia Unawareness Hypoglycemia Hypoglycemia Acute Less << Not Applicable Recruiting October 24, 2019 United States, Alabama ... More >> Birmingham Fire and Rescue Service Recruiting Birmingham, Alabama, United States, 35209 Contact: Ben Thompson    205-569-7883    benjamin.thompson@birminghamal.gov Less <<
NCT03700528 Diabetes Mellitus ... More >> Painful Diabetic Neuropathy Less << Not Applicable Recruiting October 1, 2019 United Kingdom ... More >> St Thomas' NHS Foundation Trust (Diabetes Clinic) Recruiting London, United Kingdom, SE1 7EH Contact: Stephen Thomas    +44 (0)20 7188 1981    stephen.m.thomas@gstt.nhs.uk    Guy's hospital NHS Foundation Trust (Diabetes Clinic) Recruiting London, United Kingdom, SE1 9RT Contact: Stephen Thomas    +44 (0)20 7188 1981    stephen.m.thomas@gstt.nhs.uk Less <<
NCT03700645 Diabetes Mellitus ... More >> Ischemic Heart Disease Multi Vessel Coronary Artery Disease Less << Phase 4 Not yet recruiting January 31, 2020 -
NCT03667300 Type2 Diabetes Mellitus ... More >> Albuminuria Renal Insufficiency Less << Phase 2 Enrolling by invitation January 31, 2019 Korea, Republic of ... More >> Samsung Medical Center Seoul, Korea, Republic of, 135-710 Less <<
NCT03717233 Diabetic Foot Ulcer ... More >> Diabetic Foot Ulcer Associated With Type II Diabetes Mellitus Less << Not Applicable Recruiting January 18, 2019 United States, Connecticut ... More >> Southern CT State University Recruiting New Haven, Connecticut, United States, 06515 Contact: Robert Gregory, PhD    203-392-6039    GregoryR3@southernct.edu Less <<
NCT03723707 Diabetes Deme... More >>ntia Alzheimer Disease Less << Not Applicable Not yet recruiting March 2022 United States, New York ... More >> NYU Langone Health Not yet recruiting New York, New York, United States, 10016 Contact: Roda Ferris       rosa.ferris@nyulangone.org Less <<
NCT03751735 Erectile Dysfunction Associate... More >>d With Type 2 Diabetes Mellitus Less << Phase 1 Phase 2 Recruiting January 2019 Jordan ... More >> Cell Therapy Center Recruiting Amman, Jordan, 11942 Contact: Sophia W AlAdwan, Msc    009625355000 ext 23960    sophia.adwan@gmail.com    Contact: Dana M Hattab, PhD    009625355000 ext 23960    d.hattab@ju.edu.jo    Principal Investigator: Saddam Dmour, MD          Sub-Investigator: Abdallah Awidi, MD Less <<
NCT03695731 Diabetes Mellitus, Type 1 Not Applicable Not yet recruiting October 15, 2019 -
NCT03737942 - Recruiting March 2019 Egypt ... More >> Assiut governorate Recruiting Assiut, Egypt Contact: Ghada M Aboelfadl, MD    01005802086    ghadafadl77@gmail.com Less <<
NCT03715582 Diabetes Mellitus ... More >> Angina, Unstable Less << Phase 3 Recruiting October 1, 2021 Brazil ... More >> Instituto do Coração - HMFMUSP Recruiting São Paulo, Brazil, 05403000 Contact: Alexandre Soeiro, MD    5511-2661-5299    alexandre.soeiro@bol.com.br Less <<
NCT03767608 - Completed - Mexico ... More >> Clinical Nutrition and Obesity Research Center. School of Medicine, TEC Salud, Tecnológico de Monterrey Monterrey, Nuevo Leon, Mexico, 64710 Less <<
NCT03765112 Diabetes Mellitus ... More >> Diabetic Retinopathy Less << Not Applicable Recruiting March 31, 2020 Canada ... More >> Eye Care Center Recruiting Vancouver, Canada, V5Z 3N9 Contact: Eduardo Navajas, MD    604 875 5475    edunavajas@gmail.com    Contact: Theresa Wiens, MSc    604-875-4111 ext 62544    twiens@eyecarecentre.org    Sub-Investigator: Sonja Karst, MD Less <<
NCT02034760 Sarcopenia Mu... More >>scle Loss Less << Not Applicable Recruiting February 2019 Denmark ... More >> Bispbebjerg Hospital Recruiting Copenhagen NV, Denmark, 2400 Contact: Jacob Bülow, MD, Ph.d.stu    +45 38 35366    jacob.bulow@live.dk    Contact: Søren Reitelseder, M.Sc, Ph.d.    +45 38 35366    s.reitelseder@gmail.com    Principal Investigator: Jacob Bülow, MD, Ph.d.stu          Sub-Investigator: Lars Holm, M.Sc., Ph.d.          Sub-Investigator: Søren Reitelseder, M.Sc., Ph.d. Less <<
NCT03771417 Aging Sarcope... More >>nia Disability Physical Cardiovascular Diseases Insulin Resistance Diabetes Mellitus Less << Not Applicable Recruiting June 30, 2022 United States, Louisiana ... More >> Lousiana State University Recruiting Baton Rouge, Louisiana, United States, 70803 Contact: Brian Irving, PhD    225-578-7179    brianairving@lsu.edu    Contact: Guillaume Spielmann, PhD    225-578- 2926    gspielmann@lsu.edu    Sub-Investigator: Guillaume Spielmann, PhD          Sub-Investigator: Neil Johannsen, PhD          Pennington Biomedical Research Center Recruiting Baton Rouge, Louisiana, United States, 70808 Contact: Bethany Gildersleeve, RD    225-763-2709    Bethany.Gildersleeve@pbrc.edu    Sub-Investigator: Frank Greenway, MD Less <<
NCT03774394 Chronic Kidney Disease (CKD) ... More >> Type 2 Diabetes Mellitus (T2DM) Coronary Artery Disease (CAD) Less << Phase 4 Not yet recruiting June 2020 United States, Florida ... More >> University of Florida Jacksonville Not yet recruiting Jacksonville, Florida, United States, 32209 Contact: Francesco Franchi, MD Less <<
NCT03764631 - Recruiting December 31, 2020 Saudi Arabia ... More >> Al Hada Armed Forces Hospital Recruiting Taif, Saudi Arabia, 21944 Less <<
NCT03587142 Gastroparesis Phase 2 Not yet recruiting June 2020 United States, Kentucky ... More >> University of Louisville Not yet recruiting Louisville, Kentucky, United States, 40202 Principal Investigator: Thomas Abell, MD          United States, Maryland Johns Hopkins Hospital Not yet recruiting Baltimore, Maryland, United States, 21287 Principal Investigator: Pankaj J Pasricha, MD          United States, Massachusetts Massachusetts General Hospital Not yet recruiting Boston, Massachusetts, United States, 02114 Principal Investigator: Braden Kuo, MD          United States, North Carolina Wake Forest University Health Sciences Not yet recruiting Winston-Salem, North Carolina, United States, 27157 Principal Investigator: Kenneth Koch, MD          United States, Pennsylvania Temple University Not yet recruiting Philadelphia, Pennsylvania, United States, 19140 Principal Investigator: Henry P Parkman, MD          United States, Texas Texas Tech University Health Science Center Not yet recruiting El Paso, Texas, United States, 79905 Principal Investigator: Richard W McCallum, MD Less <<
NCT01476501 Sub-optimal Vitamin D Status ... More >> Bone Disease Diabetic Nephropathy Less << Phase 2 Unknown December 2015 Canada, Alberta ... More >> Clinical Research Unit, University of Alberta Edmonton, Alberta, Canada, T6G 0K2 Less <<
NCT03262714 Aging Cardiov... More >>ascular Risk Factor Physical Activity Less << Not Applicable Recruiting August 2018 Brazil ... More >> Universidade Federal do Rio Grande do Sul Recruiting Porto Alegre, Rio Grande do Sul, Brazil Contact: Josianne Rodrigues-Krause, MSc    55-51-999101821    rodrigues.krause@ufrgs.br    Contact: Alvaro Reischak-Oliveira, PhD    55-51-3308-5862    alvaro.oliveira@ufrgs.br    Sub-Investigator: Josianne Rodrigues-Krause, MSc Less <<
NCT01703624 Chronic Obstructive Pulmonary ... More >>Disease Less << Phase 2 Completed - United Kingdom ... More >> Medicines Evaluation Unit Manchester, United Kingdom, M23 9QZ Less <<
NCT02357498 Pituitary Adenoma Not Applicable Active, not recruiting February 2020 United States, Arizona ... More >> Barrow Neurological Institute/St. Joseph's Hospital and Medical Center Phoenix, Arizona, United States, 85013 United States, California Ronald Reagan UCLA Medical Center Los Angeles, California, United States, 90095 John Wayne Cancer Institute Santa Monica, California, United States, 90404 United States, Illinois Northwestern University Chicago, Illinois, United States, 60611 United States, Missouri Washington University School of Medicine Saint Louis, Missouri, United States, 63110 United States, Ohio Ohio State University Medical Center Columbus, Ohio, United States, 43210 United States, Washington Swedish Neuroscience Institute Seattle, Washington, United States, 98122 Less <<
NCT02042495 Endometrial Cancer Phase 2 Withdrawn(Did not obtain Healt... More >>h Canda approval for drug use in reasonable time and moved onward to new trial) Less << - Canada, Quebec ... More >> Jewish General Hospital Montreal, Quebec, Canada, H3T1E2 Less <<
NCT03233568 - Completed - Italy ... More >> San Donato Hospital San Donato Milanese, MI, Italy, 20097 Less <<
NCT02483299 PCOS Obesity Phase 4 Completed - Slovenia ... More >> University Medical Center Ljubljana Ljubljana, Slovenia, 1000 Less <<
NCT02443636 - Recruiting January 2025 Canada, Nova Scotia ... More >> Nova Scotia Health Authority Recruiting Halifax, Nova Scotia, Canada, B3H 2E2 Contact: Erin E McDougall, MSc    902-473-5313    beth.mcdougall@nshealth.ca    Contact: Rudolf Uher, MD, PhD    902-473-7209    uher@dal.ca Less <<
NCT03008954 Overweight Ob... More >>esity Less << Not Applicable Completed - Czechia ... More >> Hradec Králové Hradec, Czechia, 500 00 Charles University Prague, Czechia, 121 08 Denmark University of Cophenhagen Copenhagen, Denmark, DK-1958 Italy Federico University Hospital Naples, Italy, 80131 Policlinico Umberto I Rome, Italy, 00161 Less <<
NCT03069716 Pulmonary Arterial Hypertensio... More >>n Idiopathic Pulmonary Arterial Hypertension Heritable Pulmonary Arterial Hypertension Associated Pulmonary Arterial Hypertension Less << Not Applicable Recruiting February 2020 United States, Tennessee ... More >> Vanderbilt University Medical Center Recruiting Nashville, Tennessee, United States, 37232 Contact: Rezzan Hekmat, MHS    615-875-8937    rezzan.hekmat.1@vanderbilt.edu    Principal Investigator: Evan Brittain, MD Less <<
NCT02791685 Cardiovascular Disease ... More >> Coronary Artery Disease Less << Not Applicable Recruiting December 2020 United States, Georgia ... More >> Atlanta VA Medical Center Recruiting Atlanta, Georgia, United States, 30033 Contact: Abarmard Zafari, MD    404-327-4019    azafari@emory.edu Less <<
NCT01792531 Obesity Not Applicable Active, not recruiting November 2021 Sweden ... More >> Karolinska Institute Stockholm, Sweden, 141 57 Less <<
NCT03259919 Polycystic Ovary Syndrome Phase 2 Completed - Norway ... More >> Departments of Obstetrics and Gynecology and Endocrinology, St. Olav's Hospital Trondheim, Norway Less <<
NCT00231387 Non-insulin-dependent Diabetes... More >> Mellitus Less << Phase 3 Completed - United Kingdom ... More >> GSK Clinical Trials Call Center London, United Kingdom, W2 1NY Less <<
NCT00229684 Diabetes Mellitus, Type 2 Phase 2 Terminated(The development pro... More >>gram has been terminated) Less << - United States, California ... More >> Research Site Pasadena, California, United States United States, District of Columbia Research Site Washington, District of Columbia, United States United States, Florida Research Site Gainesville, Florida, United States Research Site Miami, Florida, United States Research Site Orlando, Florida, United States United States, Georgia Research Site Augusta, Georgia, United States Research Site Columbus, Georgia, United States United States, Louisiana Research Site New Orleans, Louisiana, United States United States, Nevada Research Site Reno, Nevada, United States United States, New York Research Site Flushing, New York, United States United States, North Carolina Research Site Durham, North Carolina, United States United States, Ohio Research Site Cleveland, Ohio, United States Research Site Columbus, Ohio, United States United States, Oklahoma Research Site Tulsa, Oklahoma, United States United States, Pennsylvania Research Site Cheswick, Pennsylvania, United States Research Site Philadelphia, Pennsylvania, United States United States, Tennessee Research Site Nashville, Tennessee, United States United States, Texas Research Site Midland, Texas, United States Research Site San Antonio, Texas, United States United States, Washington Research Site Gig Harbor, Washington, United States Research Site Seattle, Washington, United States Less <<
NCT00228878 Diabetes Mellitus Phase 2 Phase 3 Terminated(Administrative) - United States, Florida ... More >> Florida Atlantic University Boca Raton, Florida, United States, 33487 Less <<
NCT00231660 Obesity Diabe... More >>tes Mellitus, Type 2 Diabetes Mellitus, Adult-Onset Less << Phase 3 Completed - -
NCT00231725 Type 2 Diabetes Mellitus Phase 3 Completed - United States, Tennessee ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Memphis, Tennessee, United States Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Pamplona, Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Requena, Spain United Kingdom For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Middlesbrough, United Kingdom Less <<
NCT00232362 Type 2 Diabetes Mellitus Phase 1 Withdrawn(This study was not c... More >>onducted as the Principal Investigator left the institution) Less << June 2008 -
NCT02652962 Healthy Overweight Obese Not Applicable Completed - Canada, Quebec ... More >> Quebec City, Quebec, Canada Less <<
NCT01080339 - Terminated(Unable to recruit p... More >>articipants.) Less << - United States, Massachusetts ... More >> Children's Hospital Boston Boston, Massachusetts, United States, 02115 Less <<
NCT00233649 - Completed - -
NCT00231634 Obesity Diabe... More >>tes Mellitus, Type 2 Diabetes Mellitus, Adult-Onset Less << Phase 3 Terminated(Program discontinue... More >>d) Less << - -
NCT02288585 Vascular Diseases ... More >> Hypercholesterolemia Diabetes Mellitus Less << Not Applicable Completed - Australia ... More >> CSIRO Adelaide, Australia CSIRO, North Ryde Sydney, Australia Less <<
NCT00240383 Diabetes Mellitus II Phase 2 Phase 3 Completed - -
NCT00242645 Diabetes Diab... More >>etes Mellitus Hypertension Less << Phase 1 Terminated(Administratively te... More >>rminated.) Less << - -
NCT00237094 Diabetes Mellitus Not Applicable Completed - United States, Montana ... More >> Deaconess Billings Clinic Center on Aging Billings, Montana, United States, 59101 Less <<
NCT02738086 Amputation Di... More >>abetes Mellitus, Type 2 Peripheral Artery Disease Less << Not Applicable Recruiting June 28, 2019 United States, Colorado ... More >> Rocky Mountain Regional VA Medical Center, Aurora, CO Recruiting Aurora, Colorado, United States, 80045 Contact: Pamela Rice, PhD    303-399-8020 ext 3846    Pamela.Rice@va.gov    Contact: Laurie P Grevious    (720) 857-5107    Laurie.Grevious@va.gov    Principal Investigator: Cory L. Christiansen, PhD Less <<
NCT02737722 Diabetic Foot Infections Phase 1 Phase 2 Active, not recruiting November 2017 United States, California ... More >> Center for Clinical Research, Inc. San Francisco, California, United States, 94115 United States, Florida Journey Research, Inc. Oldsmar, Florida, United States, 34677 United States, Tennessee Clinical Research Solutions Franklin, Tennessee, United States, 37067 Less <<
NCT02742987 Coronary Artery Disease ... More >> Diabetes Mellitus Less << Phase 4 Completed - -
NCT02742987 - Completed - -
NCT02743598 HIV Infection ... More >> Diabetes Mellitus Type 2 Obesity Overweight Metabolic Syndrome Less << Phase 4 Recruiting May 2019 United States, Pennsylvania ... More >> Cherie Vaz Recruiting Philadelphia, Pennsylvania, United States, 19140 Contact: Cherie Vaz, MD Dipl.ABOM       cherie.vaz@tuhs.temple.edu Less <<
NCT00245882 Diabetes Not Applicable Completed - United States, Pennsylvania ... More >> VA Pittsburgh Healthcare System Pittsburgh, Pennsylvania, United States, 15240 Less <<
NCT02745821 Diabetes Mellitus ... More >> Coronary Artery Disease Less << Not Applicable Recruiting November 2019 Canada, Ontario ... More >> University of Ottawa Heart Institute Recruiting Ottawa, Ontario, Canada, K1Y 4W7 Contact: Colleen Chilton    613 6967000 ext 14646    cchilton@ottawaheart.ca    Contact: Lyne Stuewe    613 6967000 ext 14646    lstuewe@ottawaheart.ca Less <<
NCT02748980 - Recruiting - China, Shaanxi ... More >> Shaanxi Provincial People's Hospital Recruiting Xi'an, Shaanxi, China, 710068 Contact: Na Zhu, Doctor    86-29-85251331 ext 3194    axemaxme2@sina.com Less <<
NCT02748330 Coronary Artery Disease ... More >> Diabetes Mellitus, Type 2 Less << Phase 4 Recruiting January 2019 China, Beijing ... More >> Peking Union Medical College Hospital Recruiting Beijing, Beijing, China, 100730 Contact: Zhenyu Liu, M.D.    +861069155068    pumch_lzy@163.com    Contact: Shuyang Zhang, M.D.    +861069155068    shuyangzhang103@163.com Less <<
NCT02750527 - Enrolling by invitation December 2028 -
NCT00233259 Cardiovascular Diseases ... More >> Heart Diseases Diabetes Mellitus, Type 2 Less << Not Applicable Completed - United States, Colorado ... More >> Institute for Health Research Denver, Colorado, United States, 80237 Less <<
NCT02770235 Diabetes Mellitus, Non-Insulin... More >>-Dependent Erectile Dysfunction Less << Not Applicable Recruiting March 2019 France ... More >> CHU Amiens Recruiting Amiens, France, 80000 Contact: Jean-Daniel LALAU, MD PhD       lalau.jean-daniel@chu-amiens.fr Less <<
NCT02745808 Erectile Dysfunction ... More >> Type 1 Diabetes Mellitus Type 2 Diabetes Mellitus Less << Phase 1 Unknown June 2018 China, Jiangsu ... More >> The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School Recruiting Nanjing, Jiangsu, China, 210008 Contact: Yutian Dai, M.D.    86-25-83106666 ext 70502    13913957628@163.com    Contact: LeiLei Zhu, M.D.    86-25-83106666 ext 70502    zhuleilei68n@163.com Less <<
NCT02783677 - Recruiting December 2020 Taiwan ... More >> National Taiwan University Hospital Taipei, Taiwan Recruiting Taipei, Taiwan Contact: Shyang-Rong Shih, PhD    886-2-23123456 ext 61613    srshih@ntu.edu.tw    Principal Investigator: Shyang-Rong Shih, PhD Less <<
NCT03121911 Expiratory Flow Limitation ... More >> Recent Myocardial Infarction Less << Not Applicable Not yet recruiting October 31, 2020 -
NCT02786134 Coronary Heart Disease ... More >> Metabolic Syndrome Diabetes Mellitus Less << Phase 3 Active, not recruiting March 2019 United States, Massachusetts ... More >> Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Less <<
NCT00240422 Diabetes Mellitus, Type 2 ... More >> Hypertension Less << Phase 4 Completed - France ... More >> Boehringer Ingelheim Investigational Site Lyon, France Boehringer Ingelheim Investigational Site Montpellier, France Germany Friedrich-Alexander-Universität Erlangen, Germany, 91054 Boehringer Ingelheim Investigational Site Nürnberg, Germany, 90402 Universität Erlangen-Nürnberg Nürnberg, Germany, 90471 Spain Edificio de Medicina Comunitaria Madrid, Spain, 28041 Less <<
NCT02802644 Acute Coronary Syndrome ... More >> Diabetes Mellitus, Type 2 Less << Phase 4 Recruiting - Korea, Republic of ... More >> Keimyung University Hospital Not yet recruiting Daegu, Korea, Republic of Principal Investigator: Chang-Wook Nam, MD, PhD          Chonnam National University Hospital Not yet recruiting Gwangju, Korea, Republic of Principal Investigator: Young Joon Hong, MD, PhD          Jeju National University Hospital Not yet recruiting Jeju, Korea, Republic of Principal Investigator: Ki-Seok Kim, MD, PhD          Chung-Ang University Hospital Recruiting Seoul, Korea, Republic of, 06973 Principal Investigator: Sang-Wook Kim, MD, PhD          Korea University Guro Hospital Not yet recruiting Seoul, Korea, Republic of Principal Investigator: Seung-Woon Rha, MD, PhD          Ajou University Hospital Not yet recruiting Suwon, Korea, Republic of Principal Investigator: So-Yeon Choi, MD, PhD Less <<
NCT02818192 - Recruiting December 2021 Canada, Manitoba ... More >> Children's Hospital Research Institute of Manitoba/University of Manitoba Recruiting Winnipeg, Manitoba, Canada, R3E 3P4 Contact: Brandy A Wicklow, MD, MSc    2047871222    bwicklow@hsc.mb.ca    Principal Investigator: Brandy A Wicklow, MD, MSc          Principal Investigator: Allison Dart, MD, MSc Less <<
NCT02821585 Type 1 Diabetes ... More >> Metabolic Syndrome Less << Not Applicable Completed - Canada, Quebec ... More >> Institut de recherches cliniques de Montréal Montréal, Quebec, Canada, H2W1R7 Less <<
NCT02791204 Peripheral Arterial Disease ... More >> Diabetes Mellitus Less << Not Applicable Recruiting December 2020 United States, Connecticut ... More >> Yale-New Haven Hospital Recruiting New Haven, Connecticut, United States, 06510 Contact: Albert J Sinusas, MD    203-785-5005    albert.sinusas@yale.edu    Contact: Donna McMahon       donna.mcmahon@yale.edu Less <<
NCT02861157 Diabetes Mellitus, Type 1 Phase 2 Completed - United States, North Carolina ... More >> 3-C Institute for Social Development Durham, North Carolina, United States, 27713 Less <<
NCT02856633 - Completed - Canada, Ontario ... More >> Oakville Trafalgar Memorial Hospital Oakville, Ontario, Canada, L6M 0L8 Less <<
NCT02861781 - Recruiting January 2020 France ... More >> Hôpital Saint Eloi Recruiting Montpellier, France, 34295 Contact: Florence Galtier, MD       f-galtier@chu-montpellier.fr    Principal Investigator: Florence Galtier, MD Less <<
NCT02865525 - Unknown December 2017 France ... More >> Grenoble University Hospital Recruiting Grenoble cedex 9, France, 38043 Contact: Audrey Lehmann, PharmD, PHD student    0033476769209    alehmann@chu-grenoble.fr    Contact: Benoit Allenet, PharmD PHD    0033476765497    ballenet@chu-grenoble.fr    Principal Investigator: Audrey Lehmann, PharmD, PHD student          Sub-Investigator: Carine Meslot, PHD Student          Principal Investigator: Benoît Allenet, PharmD, PHD          Sub-Investigator: Aurelie Gauchet, PHD          Sub-Investigator: Matthieu Roustit, PharmD, PHD          Sub-Investigator: Pierrick Bedouch, PharmD, PHD          Sub-Investigator: Jean-Luc Bosson, MD, PHD Less <<
NCT02187250 PCOS Obesity Phase 4 Completed - Slovenia ... More >> University Medical Center Ljubljana Ljubljana, Slovenia, 1000 Less <<
NCT02906319 - Completed - -
NCT02876393 - Unknown - United Kingdom ... More >> NI clinical Research Facility,51 Lisburn Road Recruiting Belfast, United Kingdom, BT9 7AB Contact: Dr Radha Das, FRCS(G),M.S.    07511523914    rdas02@qub.ac.uk    Principal Investigator: Prof Usha Chakravarthy, PhD FRCOphth          Sub-Investigator: Dr Ruth Hogg, PhD Less <<
NCT02910271 - Completed - Spain ... More >> Diabetes, Obesity and Human Reproduction Research Group, Department of Endocrinology and Nutrition, Hospital Universitario Ramón y Cajal, Universidad de Alcalá, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS) Madrid, Spain Less <<
NCT02758899 - Unknown June 2018 United States, Missouri ... More >> Washington University School of Medicine Recruiting St. Louis, Missouri, United States, 63110 Contact: Alaina Landstrom, BSN, RN    314-362-3114    landstroma@wudosis.wustl.edu    Principal Investigator: Wilson Z. Ray, MD Less <<
NCT02928666 Type 2 Diabetes Mellitus ... More >> Lung Diseases, Obstructive Osteoporosis Hypertension Osteoarthritis Less << Not Applicable Not yet recruiting September 2019 -
NCT02883751 Diabetes Mellitus ... More >> Amputation Stumps Diabetic Foot Less << Not Applicable Unknown December 2018 Brazil ... More >> Universidade Nove de Julho São Paulo, SP, Brazil, 01504015 Less <<
NCT02929953 - Unknown December 2017 Israel ... More >> Assaf Harofeh Medical Center Zerifin, Israel, 70300 Less <<
NCT02936843 Type 1 Diabetes ... More >> Peripheral Neuropathy Less << Phase 2 Phase 3 Recruiting December 2020 United States, Michigan ... More >> University of Michigan Health System Recruiting Ann Arbor, Michigan, United States, 48109 Contact: Ginny Leone, MA    734-936-8656    vleone@med.umich.edu    Contact: Jacob Reiss, BS    734-763-0177    jereiss@med.umich.edu    Principal Investigator: Rodica Pop-Busui, MD, PhD          Sub-Investigator: Lynn Ang, MD          Principal Investigator: Eva Feldman, MD, PhD          Sub-Investigator: Kara Mizukami-Stout, MD Less <<
NCT02919345 Diabetes Mellitus, Type 2 ... More >> Coronary Artery Disease Carotid Artery Diseases Less << Phase 4 Unknown October 2017 Brazil ... More >> State University of Campinas Campinas, Sao Paulo, Brazil, 13083-887 Less <<
NCT02947828 - Recruiting September 2019 Denmark ... More >> Danish Pain Research Center, Aarhus University Hospital Recruiting Aarhus, Denmark, 8000 Contact: Sif Gylfadottir, MD    +45 7846 3287    sifgyl@clin.au.dk    Contact: Nanna B. Finnerup, MD, DrMedSc    +45 7846 4230    finnerup@clin.au.dk    Principal Investigator: Sif Gylfadottir, MD          Odense University Hospital Active, not recruiting Odense, Denmark, 5000 Less <<
NCT02829177 Type 1 Diabetes ... More >> Diabetic Nephropathy Less << Phase 4 Completed - Denmark ... More >> Steno Diabetes Center Gentofte, Denmark, 2820 Less <<
NCT02938806 - Active, not recruiting December 2018 United States, California ... More >> Rady Children's Hospital Endocrinology Department San Diego, California, United States, 92123 Less <<
NCT02955238 Atherosclerosis ... More >> High Blood Pressure Type 2 Diabetes Mellitus Heart Disease Hypercholesterolemia Less << Not Applicable Completed - United States, California ... More >> South Bay Latino Research Center Chula Vista, California, United States, 91910 Less <<
NCT02950142 Diabetes Mellitus ... More >> Hypertension Cardiovascular Diseases Fatigue Anemia Liver Diseases Medication Monitoring Gout Chronic Kidney Diseases Lung Embolism Acute Coronary Syndrome Diarrhea Thyroid Diseases Sexually Transmitted Diseases Rheumatoid Arthritis Obesity General Check-up Less << Not Applicable Active, not recruiting October 1, 2020 Belgium ... More >> Academic Centre for General Practice Leuven, Belgium, B-3000 Less <<
NCT02949687 Diabetes Mellitus ... More >> Obesity Less << Not Applicable Enrolling by invitation March 2019 -
NCT02961595 Enterovirus Infection ... More >> Type 1 Diabetes Prediabetic State Less << Phase 1 Completed - -
NCT02945449 Erectile Dysfunction Associate... More >>d With Type 2 Diabetes Mellitus Less << Phase 1 Completed - Jordan ... More >> Cell Therapy Center Amman, Jordan, 11942 Less <<
NCT02983214 Ischemic Stroke ... More >> Peripheral Artery Disease Diabetes Mellitus, Type 2 Less << Phase 4 Recruiting October 2018 Greece ... More >> Atherothrombosis Research Centre / Laboratory of Biochemistry, University of Ioannina Recruiting Ioannina, Epirus, Greece, 45110 Contact: Alexandros D Tselepis, Professor    +302651008365    atselep@uoi.gr Less <<
NCT02998944 - Completed - -
NCT02992431 Hypertension ... More >>Ischemic Heart Disease Diabetes Mellitus Less << Not Applicable Recruiting December 2023 Finland ... More >> Siilinjärvi Health Center Recruiting Siilinjärvi, Finland, 71800 Contact: Nina Marika Tusa, MD    +358469220643    nina.tusa@uef.fi Less <<
NCT02956811 Type 2 Diabetes ... More >> Left Ventricular Hypertrophy Less << Phase 4 Active, not recruiting March 2019 United Kingdom ... More >> Ninewells Hospital Dundee, United Kingdom Less <<
NCT02986256 Diabetes Mellitus ... More >> Ulcer Foot Less << Not Applicable Recruiting March 2020 France ... More >> Centre Hospitalier Sud-Francilien Recruiting Corbeil-Essonnes, France, 91100 Contact: Dured Dardari, MD          Principal Investigator: Dured Dardari, MD Less <<
NCT02989740 - Recruiting August 2020 Netherlands ... More >> Isala Recruiting Zwolle, Overijssel, Netherlands, 8025 AB Contact: H van de Wetering, Ma ANP    ++31(0)384262999    combine.registry@diagram-zwolle.nl    Contact: I Kalter, Msc    ++31(0)384262999    combine.registry@diagram-zwolle.nl    Principal Investigator: E Kedhi, MD, PHD Less <<
NCT03002155 Diabetic Foot Ulcer ... More >> Diabetes Mellitus, Type 2 Less << Not Applicable Completed - United States, Washington ... More >> Northwest Hospital Seattle, Washington, United States, 98133 Less <<
NCT03016910 - Recruiting September 2019 Denmark ... More >> University Hospital of Odense (OUH) Svendborg Hospital Recruiting Svendborg, Fyn, Denmark, 5700 Contact: Laurits J Heinsen, MD    +4563202429    lauritsheinsen@gmail.com    Contact: kenneth Egstrup, Prof. DMSci    +4563202402    kenneth.egstrup@rsyd.dk    Principal Investigator: Laurits J Heinsen, MD Less <<
NCT02991534 Cardiovascular Diseases ... More >> Hypertension Hyperlipidemias Dyslipidemias Obesity Diabetes Mellitus Tobacco Use Disorder Overweight Less << Not Applicable Recruiting September 30, 2020 United States, California ... More >> VA Greater Los Angeles Healthcare System, Sepulveda, CA Recruiting Sepulveda, California, United States, 91343 Contact: Bevanne A Bean-Mayberry, MD MHS    818-891-7711 ext 36009    bevanne.bean-mayberry@va.gov    Contact: Melissa M Farmer Coste, PhD MS    (818) 891-7711 ext 36046    Melissa.Farmer@va.gov    Principal Investigator: Melissa M Farmer Coste, PhD MS          VA Greater Los Angeles Healthcare System, West Los Angeles, CA Recruiting West Los Angeles, California, United States, 90073 Contact: Hemen N Saifu, MPH    310-478-3711 ext 40782    Hemen.Saifu@va.gov    Contact: Ismelda A Canelo, MPA    (818) 891-7711 ext 36069    Ismelda.Canelo@va.gov    Principal Investigator: Bevanne A Bean-Mayberry, MD MHS          United States, Connecticut VA Connecticut Healthcare System West Haven Campus, West Haven, CT Recruiting West Haven, Connecticut, United States, 06516 Contact: Mary Driscoll, PhD       Mary.Driscoll3@va.gov Less <<
NCT03015480 Chronic Kidney Disease ... More >> Diabetes Mellitus Albuminuria Less << Not Applicable Active, not recruiting February 2019 -
NCT03029351 Type2 Diabetes ... More >> Kidney Diseases Less << Phase 4 Not yet recruiting February 2020 -
NCT03026426 Depression Di... More >>abetes Hypertension Less << Phase 3 Active, not recruiting March 30, 2019 Peru ... More >> Policlínico Bellavista Callao, Peru, 07011 Policlínico Hermana María Donrose Sutmöller Callao, Peru, 07051 Hospital Nacional Dos de Mayo Lima, Peru, 15003 Policlínico Juan José Rodríguez Lazo Lima, Peru, 15054 Hospital Nacional Arzobispo Loayza Lima, Peru, 15082 Hospital Nacional Cayetano Heredia Lima, Peru, 15102 CAP III Carabayllo Lima, Peru, 15316 Universidad Peruana Cayetano Heredia Lima, Peru Less <<
NCT03022682 - Recruiting December 2020 United States, California ... More >> University of California San Francisco Recruiting San Francisco, California, United States, 94143 Contact: Suneil Koliwad, MD,PhD    415-476-4661    ob.cohort@ucsf.edu    Contact: Diana Alba, MD    415-476-9847    ob.cohort@ucsf.edu    Sub-Investigator: Diana L Alba, MD Less <<
NCT03037255 - Active, not recruiting January 2018 -
NCT03036800 Obesity Weigh... More >>t Loss Diabetes Mellitus Less << Phase 4 Recruiting January 2021 Ireland ... More >> St Vincent's University Hospital Recruiting Dublin, Ireland Contact: Carel Le Roux, Prof    0171 66 831    carel.leroux@ucd.ie    Principal Investigator: Carel LeRoux, Prof          Sub-Investigator: Donel O'Shea, Prof          United Kingdom NHS Greater Glasgow and Clyde West Glasgow Ambulatory Care Hospital Not yet recruiting Glasgow, United Kingdom Contact: Mike Lean, Prof    0141 201 8604    mike.lean@glasgow.ac.uk    University Hospitals of Leicester NHS Trust, Leicester General Hospital Recruiting Leicester, United Kingdom Contact: Melanie Davies, Prof    0116 258 6481    melanie.davies@uhl-tr.nhs.uk    Sub-Investigator: David Webb, Dr          University Hospital Aintree Recruiting Liverpool, United Kingdom Contact: John Wilding, Prof    0151 529 5899    J.P.H.Wilding@liverpool.ac.uk    Guy's and St Thomas' NHS Foundation Trust Recruiting London, United Kingdom Contact: Barbara McGowan, Dr    020 7188 1912    barbara.mcGowan@gstt.nhs.uk Less <<
NCT03037190 Diabetes Mellitus, Type 1 ... More >> Remission Celiac Disease in Children Less << Not Applicable Recruiting December 2020 Sweden ... More >> Skanes University Hospital Recruiting Lund, Region Skane, Sweden, 22185 Contact: Annelie Carlsson, MD PhD    +46768267170    annelie.carlsson@med.lu.se    Contact: Iren Tiberg, PhD, nurse       iren.tiberg@med.lu.se Less <<
NCT03049709 - Completed - Germany ... More >> Universitätsmedizin Mannheim Mannheim, Germany Less <<
NCT03047278 Neuropathic Pain ... More >> Type 2 Diabetes Mellitus Diabetic Neuropathy, Painful Less << Phase 4 Enrolling by invitation July 1, 2019 -
NCT03042442 - Recruiting September 30, 2018 Romania ... More >> Regional Institute of Gastroenterology and Hepatology Recruiting Cluj Napoca, Cluj, Romania, 400192 Contact: Livia Petrusel, MD,PhD    0040724402389    livia.cutas@umfcluj.ro    Contact: Andrada Seicean, MD,PhD    0040745657100    andradaseicean@gmail.com Less <<
NCT03062072 - Recruiting December 2022 Korea, Republic of ... More >> National Cancer Center, Korea Recruiting Goyang, Korea, Republic of Contact: Su Jeong Go          Principal Investigator: Eun Kyung Lee          Seoul National University Boramae Medical Center Recruiting Seoul, Korea, Republic of Contact: Bo Kyung Koo    +82-31-920-1743    sjgo@ncc.re.kr    Principal Investigator: Min Kyong Moon          Sub-Investigator: Bo Kyung Koo Less <<
NCT03054454 Diabetes Mellitus ... More >> Endstage Renal Disease Less << Not Applicable Not yet recruiting June 2017 -
NCT03058926 - Recruiting January 2021 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Clinical Research Operations       CR_Study_Registration@mdanderson.org Less <<
NCT03076697 - Enrolling by invitation August 30, 2025 -
NCT03077386 Hypertension ... More >>Diabetes Mellitus, Type 2 Chronic Kidney Diseases Ischemic Heart Disease Congestive Heart Failure Chronic Obstructive Pulmonary Disease Asthma Less << Not Applicable Not yet recruiting December 2021 Canada, Alberta ... More >> Mosaic Primary Care Network Recruiting Calgary, Alberta, Canada Contact: Rachel AC Clare, MSW    403-464-3145    rachel.clare@mosaicpcn.ca    Contact: Amanda Brockmann, MHA    403-700-4286    amanda.brockmann@mosaicpcn.ca Less <<
NCT03085524 - Recruiting August 31, 2020 -
NCT03089333 Hypertension ... More >>Diabetes Mellitus, Type 2 Blood Pressure Obesity Cardiac Hypertrophy Microalbuminuria Vascular Stiffness Less << Phase 4 Completed - Brazil ... More >> University of Campinas (UNICAMP) Campinas, São Paulo, Brazil, 13083970 Less <<
NCT03063138 - Completed - Denmark ... More >> University Centre of Wound Healing, Odense University Hospital (OUH) Odense, Denmark, 5000 Less <<
NCT03085550 Diabetes Mellitus Foot Ulcer Not Applicable Recruiting October 2019 United Kingdom ... More >> Royal Free Hospital Recruiting London, United Kingdom, NW3 2QG Contact: Neil Hubbard    020 7794 0500 ext 36316    n.hubbard@nhs.net Less <<
NCT03103854 Diabetes Mellitus, Type 2 ... More >> Myocardial Infarction Coronary Artery Disease Atrial Fibrillation Congestive Heart Failure Less << Not Applicable Recruiting December 31, 2019 Canada, Ontario ... More >> Cambridge Cardiac Rehab Recruiting Cambridge, Ontario, Canada, N1R 6V6 Contact: A. Shekhar Pandey, BSc, MD    5195906127    pandey@rogers.com    Contact: M. Michelle Pandey, B Pharm    (519) 624-3511    michellepandey@rogers.com    Principal Investigator: Avinash Pandey Less <<
NCT03106246 - Recruiting July 2019 Canada, Quebec ... More >> McGill University Health Center Recruiting Montreal, Quebec, Canada, H4A 3J1 Contact: Sarita Negi    514-934-1934    Sarita.negi@muhc.mcgill.ca    Principal Investigator: Steven Paraskevas, MD PhD Less <<
NCT03094910 Raynaud Disease ... More >> Raynaud Phenomenon Hand and Arm Vibration Syndrome Diabetes Mellitus Parkinson Disease Glaucoma Autonomic Neuropathy Autonomic Imbalance Less << Not Applicable Recruiting December 31, 2018 Denmark ... More >> Department of Clinical Physiology and Nuclear Medicine, Herlev Hospital Recruiting Herlev, Capital Region, Denmark, 2730 Contact: Lotte Lindberg, MD    0045 3868 6563    lotte.lindberg.01@regionh.dk    Contact: Lars T Jensen, DMSc    0045 3868 1237    lars.thorbjoern.jensen@regionh.dk Less <<
NCT03111238 Peripheral Arterial Disease (P... More >>AD) Diabetes Mellitus (DM) Diabetes Mellitus, Type 1 Diabetes Mellitus, Type 2 Cardiovascular Disease Critical Limb Ischemia (CLI) Less << Phase 3 Recruiting October 2020 Spain ... More >> First site: Hospital Reina Sofía de Córdoba Recruiting Cordoba, Córdoba, Spain, 14004 Contact: Jose García-Revillo, MD Less <<
NCT03118050 Sarcopenia Di... More >>abetes Mellitus Aging Less << Not Applicable Recruiting December 2022 United States, Texas ... More >> Sealy Center on Aging, University of Texas Medical Branch Recruiting Galveston, Texas, United States, 77550 Contact: Roxana Hirst, MS, CCRP    409-266-9641    rmhirst@utmb.edu    Contact: Paula Skinkis, MEd, CCRP    (409)772-1907    pskinkis@utmb.edu    Principal Investigator: Elena Volpi, MD, PhD Less <<
NCT03128229 - Recruiting June 2019 United States, Colorado ... More >> Children's Hospital Colorado Recruiting Aurora, Colorado, United States, 80238 Contact: Petter Bjornstad, M.D.          Principal Investigator: Petter Bjornstad, M.D.          Sub-Investigator: Kristen Nadeau, M.D. Less <<
NCT03085771 Diabetes Mellitus, Type 1 Phase 2 Recruiting December 12, 2022 Sweden ... More >> Karolinska University Hospital Recruiting Stockholm, Sweden, 17176 Contact: Sergiu Catrina, ass prof MD    +46-8-51770000    sergiu-bogdan.Catrina@ki.se    Contact: Neda Ekberg, PhD, MD    +46-(0)8 51775449    Neda.Ekberg@ki.se Less <<
NCT02310269 - Recruiting September 27, 2023 -
NCT03126513 Gastroparesis Postoperative ... More >> Gastroparesis Due to Diabetes Mellitus Idiopathic Gastric Stasis Less << Not Applicable Recruiting October 1, 2018 Mexico ... More >> Centro Medico Nacional Siglo XXI Hospital de Especialidades Recruiting Mexico, Mexico City, Mexico, 06700 Contact: Oscar V Hernandez Mondragon, MD    +525556276900 ext 21317-8    mondragonmd@yahoo.co.uk    Contact: Raquel Palos Cuellar, MD    +525556276900 ext 21317-8    palosc5092@gmail.com Less <<
NCT03133819 Diabetes; Neuropathy, Polyneur... More >>opathy (Manifestation) Less << Not Applicable Enrolling by invitation April 2019 -
NCT03146208 - Not yet recruiting January 20, 2019 -
NCT03174522 Peripheral Arterial Disease (P... More >>AD) Diabetes Mellitus (DM) Diabetes Mellitus, Type 1 Diabetes Mellitus, Type 2 Cardiovascular Disease Critical Limb Ischemia (CLI) Less << Phase 3 Recruiting October 31, 2021 Spain ... More >> First site: Hospital Reina Sofía de Córdoba Recruiting Cordoba, Córdoba, Spain, 14004 Contact: Jose García-Revillo, MD          Contact: Antonio Chacón, MD Less <<
NCT03089463 - Recruiting April 1, 2019 United Kingdom ... More >> Staffordshire University Recruiting Stoke-on-Trent, Staffordshire, United Kingdom, ST4 2DF Contact: David Allan, MSc    +441728 294034 ext 4034    david.allan@research.staffs.ac.uk    Contact: Roozbeh Naemi, PhD    +441782 295879 ext 5879    R.Naemi@staffs.ac.uk    Principal Investigator: Roozbeh Naemi, PhD          Sub-Investigator: David Allan, MSc Less <<
NCT03163511 Type 1 Diabetes Mellitus With ... More >>Hypoglycemia Less << Phase 1 Phase 2 Recruiting December 2020 United States, California ... More >> University of California San Diego Recruiting San Diego, California, United States, 92121 Contact: Study Coordinator    844-317-7836    alphastemcellclinic@ucsd.edu    United States, Maryland Johns Hopkins University Recruiting Baltimore, Maryland, United States, 21205 Contact: Study Coordinator    410-614-0905    doluka1@jhmi.edu    United States, Minnesota University of Minnesota Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Study Coordinator    612-626-4993    kreel001@umn.edu    United States, Ohio Ohio State University Recruiting Columbus, Ohio, United States, 43203 Contact: Study Coordinator    614-688-6885    ashley.mintos@osumc.edu    Canada, Alberta University of Alberta Recruiting Edmonton, Alberta, Canada Contact: Study Coordinator    780-407-1501    parastoo@islet.ca    Canada, British Columbia University of British Columbia Enrolling by invitation Vancouver, British Columbia, Canada Less <<
NCT03179137 - Recruiting October 1, 2020 Croatia ... More >> School of Medicine, University of Split Recruiting Split, Croatia, 21000 Contact: Jasna Marinovic, MD PhD    +385 21 557 946    jasna.marinovic@mefst.hr    Principal Investigator: Cristijan Bulat, MD PhD Less <<
NCT03122093 - Recruiting May 2020 Canada, Ontario ... More >> McMaster University Not yet recruiting Hamilton, Ontario, Canada Contact: Ada Smith    905-525-9140 ext 22205       Contact: Tracy Tazzeo    905-525-9140 ext 22166       Kingston General Hospital Not yet recruiting Kingston, Ontario, Canada Contact: Adriana Breen    613-549-6666 ext 4927       London Health Sciences Not yet recruiting London, Ontario, Canada Contact: Marge Lovell    519-685-8500 ext 77548    marg.lovell@lhsc.on.ca    St. Joseph's Healthcare Not yet recruiting London, Ontario, Canada Contact: Charlotte McDonald, MD    519-646-6170    charlotte.mcdonald@sjhc.london.on.ca    The Ottawa Hospital Not yet recruiting Ottawa, Ontario, Canada Contact: Denise Decurtis    613-738-8400 ext 81961       The Hospital for Sick Children Recruiting Toronto, Ontario, Canada, M5V1X8 Principal Investigator: Farid Mahmud, MD Less <<
NCT03188484 - Recruiting October 2019 Spain ... More >> SAP Terres de l'Ebre Recruiting Tortosa, Tarragona, Spain, 43500 Contact: Josep Lluis Clúa-Espuny, Md, PhD    34 977510018    jlclua.ebre.ics@gencat.cat    SAP Muntanya Recruiting Barcelona, Spain, 08035 Contact: Miguel Angel Muñoz-Pérez, MD, PhD    34 932075752    mamunoz.bcn.ics@gencat.cat    Contact: Alejandro Bustamante, MD, PhD    34 934894029 ext 4940    alejandro.bustamante@vhir.org Less <<
NCT03217591 Type 2 Diabetes Mellitus With ... More >>Diabetic Nephropathy Less << Phase 2 Recruiting March 2019 -
NCT03159221 Diabetes Mellitus, Type 2 ... More >> Childhood Obesity Less << Not Applicable Completed - United States, Florida ... More >> Nemours Children's Specialty Care Jacksonville, Florida, United States, 32207 Less <<
NCT03242343 Arterio-Venous Fistula ... More >> ESRD Steal Syndrome Aneurysm Renal Failure Renal Disease Diabetes Mellitus Kidney Failure Less << Not Applicable Recruiting November 2020 United States, Arizona ... More >> Arizona Kidney Disease & Hypertension Center Recruiting Phoenix, Arizona, United States, 85012 Contact: Shouwen Wang, Dr.          United States, Massachusetts Brigham and Women's Hospital Recruiting Boston, Massachusetts, United States, 02115 Contact: Samir Shah, Dr.          Boston Medical Center Recruiting Boston, Massachusetts, United States, 02118 Contact: Alik Farber, Dr.          Beth Israel Deaconess Medical Center Recruiting Boston, Massachusetts, United States, 02215 Contact: Yael Vin, Dr.          United States, Michigan University of Michigan Recruiting Ann Arbor, Michigan, United States, 48109 Contact: Kenneth Woodside, Dr.          United States, New York Albany Medical College Recruiting Albany, New York, United States, 12208 Contact: Paul B. Kreienberg, Dr.          Montefiore Medical Center Recruiting New York, New York, United States, 10467 Contact: Stuart Greenstein, Dr.          Montefiore Medical Center Recruiting New York, New York, United States, 10467 Contact: Larry Scher, Dr.          United States, North Carolina Charlotte PA Recruiting Charlotte, North Carolina, United States, 28207 Contact: Jason Burgess, Dr.          United States, Ohio Cleveland Clinic Main Campus Recruiting Cleveland, Ohio, United States, 44195 Contact: Levester Kirksey, Dr.          Ohio State University Wexner Meidcal Center Recruiting Columbus, Ohio, United States, 43210 Contact: Ronald P. Pelletier          United States, South Carolina Greenville Health System Recruiting Greenville, South Carolina, United States, 29615 Contact: Joe Blas, Dr.          United States, Texas Methodist DeBakey Heart and Vascular Center,The Methodist Hospital Recruiting Houston, Texas, United States, 77030 Contact: Eric Peden, Dr. Less <<
NCT03193944 Vitamin D Deficiency ... More >> Diabetes Mellitus Hypertension Lipid Metabolism Disorders Obesity, Abdominal Less << Phase 2 Completed - Iran, Islamic Republic of ... More >> Maryam Zarei Karaj, Alborz, Iran, Islamic Republic of Less <<
NCT03208465 Diabetes Mellitus ... More >> Coronary Disease Less << Phase 4 Recruiting April 30, 2021 Korea, Republic of ... More >> Asan Medical Center Recruiting Seoul, Korea, Republic of Contact: Cheol-whan Lee, MD    +82230103150    cheolwlee@amc.seoul.kr    Principal Investigator: Cheol-Whan Lee, MD Less <<
NCT03178253 - Enrolling by invitation June 30, 2018 Egypt ... More >> Maria Hamdy Assuit, Egypt Less <<
NCT03238898 Muscle Cramps Aggravated ... More >> Diabetes Mellitus Less << Phase 2 Completed - -
NCT03252132 Diabetes Mellitus, Type 2 ... More >> Polyneuropathy Diabetes Diabetes Complications Diabetic Peripheral Neuropathy Muscle Weakness Fall Patients Less << Not Applicable Recruiting June 1, 2019 Denmark ... More >> Danish Pain Research Center, Aarhus University Hospital Recruiting Aarhus, Denmark, 8000 Contact: Karolina Snopek, MD    +45 7846 3287    kasnop@clin.au.dk    Contact: Henning Andersen, Prof.       hennande@rm.dk    Principal Investigator: Karolina Snopek, MD Less <<
NCT03250078 - Recruiting November 2023 United States, Connecticut ... More >> Danbury Hospital Recruiting Danbury, Connecticut, United States, 06810 New Milford Hospital Recruiting New Milford, Connecticut, United States, 06676 Norwalk Hospital Recruiting Norwalk, Connecticut, United States, 06856 Less <<
NCT03236415 Coronary Artery Disease ... More >> Diabetes Mellitus Less << Not Applicable Withdrawn(Global sales of the ... More >>Absorb BVS halted effective September 14, 2017.) Less << July 2019 -
NCT03268941 Diabetes Mellitus and Gastropa... More >>resis, Idiopathic Gastroparesis Less << Phase 1 Completed - United States, Arizona ... More >> 9171 West Thunderbird Road Peoria, Arizona, United States, 85381 850 North Kolb Road Tucson, Arizona, United States, 85710 United States, Arkansas 11219 Financial Centre Parkway Little Rock, Arkansas, United States, 72211 United States, Florida 13055 Southwest 42nd Street Miami, Florida, United States, 33175 8200 Southwest 117th Avenue Miami, Florida, United States, 33183 United States, Georgia 125 Clairemont Avenue Decatur, Georgia, United States, 30030 United States, Louisiana 616 South Washington Street Bastrop, Louisiana, United States, 71220 United States, Tennessee 6035 Shallowford Road Chattanooga, Tennessee, United States, 37421 26 Stonecreek Circle Jackson, Tennessee, United States, 38305 Less <<
NCT03263728 Diabetes Mellitus, Type 2 ... More >> Coronary Artery Disease Less << Not Applicable Recruiting September 2018 Hong Kong ... More >> The University of Hong Kong Recruiting Hong Kong, Hong Kong Contact: Ming Yen Ng, BMBS    53376007    myng2@hku.hk Less <<
NCT03274089 Hypertension ... More >>Hyperlipidemia; Mixed Diabetes Mellitus Less << Not Applicable Recruiting September 2019 Singapore ... More >> SingHealth Polyclinics - Punggol Recruiting Singapore, Singapore Contact: Executive    6643 6969 Less <<
NCT03321032 Coronary Artery Disease ... More >> Diabetes Mellitus Less << Phase 4 Recruiting October 2023 Spain ... More >> Hospital Universitari de Bellvitge Recruiting L'Hospitalet de Llobregat, Barcelona, Spain, 08907 Contact: Rafael Romaguera, MD    +34932607500    rafaromaguera@gmail.com    Principal Investigator: Rafael Romaguera, MD          Hospital Clínico San Carlos Recruiting Madrid, Spain, 28040 Contact: Pablo Salinas, MD    913303001    salinas.pablo@gmail.com    Principal Investigator: Pablo Salinas, MD Less <<
NCT03253328 Diabetes Mellitus ... More >> Critical Limb Ischemia Lower Limb Amputation Knee Peripheral Arterial Disease Less << Not Applicable Recruiting December 31, 2018 United States, Missouri ... More >> Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: Mohamed Zayed, M.D.    314-362-5648    zayedm@wustl.edu    Principal Investigator: Mohamed Zayed, M.D. Less <<
NCT00252525 - Completed - United States, Arizona ... More >> Carl T. Hayden VA Medical Center Phoenix, Arizona, United States, 85012 United States, California VA Medical Center, Long Beach Long Beach, California, United States, 90822 United States, Florida Miami VA Healthcare System, Miami, FL Miami, Florida, United States, 33125 United States, Nebraska VA Medical Center, Omaha Omaha, Nebraska, United States, 68105-1873 United States, New Jersey VA New Jersey Health Care System, East Orange East Orange, New Jersey, United States, 07018 United States, Texas VA South Texas Health Care System, San Antonio San Antonio, Texas, United States, 78229 United States, Virginia Hunter Holmes McGuire VA Medical Center Richmond, Virginia, United States, 23249 Less <<
NCT01370681 Diabetes Mellitus Phase 1 Completed - -
NCT00258674 Diabetes Mellitus Not Applicable Completed - United States, Texas ... More >> Baylor Health Care System Institute for Health Care Research and Improvement Dallas, Texas, United States, 75206 Less <<
NCT00256633 - Completed - United States, Arizona ... More >> Carl T. Hayden VA Medical Center Phoenix, Arizona, United States, 85012 Southern Arizona VA Health Care System, Tucson Tucson, Arizona, United States, 85723 United States, California VA Central California Health Care System, Fresno Fresno, California, United States, 93703 VA San Diego Healthcare System, San Diego San Diego, California, United States, 92161 United States, Florida VA Medical Center, Miami Miami, Florida, United States, 33125 United States, Illinois Edward Hines, Jr. VA Hospital Hines, Illinois, United States, 60141-5000 United States, Indiana Richard Roudebush VA Medical Center, Indianapolis Indianapolis, Indiana, United States, 46202-2884 United States, Kentucky VA Medical Center, Lexington Lexington, Kentucky, United States, 40502 United States, Minnesota VA Medical Center, Minneapolis Minneapolis, Minnesota, United States, 55417 United States, Nebraska VA Medical Center, Omaha Omaha, Nebraska, United States, 68105-1873 United States, New Jersey VA New Jersey Health Care System, East Orange East Orange, New Jersey, United States, 07018 United States, Pennsylvania VA Pittsburgh Health Care System Pittsburgh, Pennsylvania, United States, 15240 United States, Tennessee VA Medical Center Nashville, Tennessee, United States, 37212-2637 United States, Texas VA South Texas Health Care System, San Antonio San Antonio, Texas, United States, 78229 United States, Virginia VA Medical Center, Salem VA Salem, Virginia, United States, 24153 Puerto Rico VA Medical Center, San Juan San Juan, Puerto Rico, 00921 Less <<
NCT01372163 Diabetes Mellitus, Type 2 Phase 1 Terminated(B3301002 was discon... More >>tinued on 18 April 2012 for strategic reasons.There were no safety concerns leading to discontinuation of this study.) Less << - United States, Connecticut ... More >> Pfizer Investigational Site New Haven, Connecticut, United States, 06511 Less <<
NCT00258674 - Completed - -
NCT03285308 Gastroparesis ... More >> Diabetes Mellitus Less << Phase 3 Recruiting November 23, 2019 -
NCT02123628 Diabetes Mellitus Phase 4 Completed - France ... More >> Dron Hospital Tourcoing, Nord, France, 59200 Less <<
NCT03742011 - Recruiting December 31, 2038 China, Guangdong ... More >> Guangzhou Women and Children's Medical Center, China Recruiting Guangzhou, Guangdong, China, 510623 Contact: Xiu Qiu, PhD    0086 20 38367160    qxiu0161@163.com    Contact: Zehong Zhou, MD    0086 20 38367162    rainbow_0706@163.com Less <<
NCT02138045 Diabetes Mellitus, Type 1 ... More >> Type 1 Diabetes Mellitus Less << Not Applicable Unknown February 2017 Denmark ... More >> Mech-Sense, Department of Medical Gastroenterology, Aalborg University Hospital Aalborg, Jutland, Denmark, 9000 Less <<
NCT02148991 - Completed - Greece ... More >> Georgios Gennimatas General State Hospital Athens, Holargos, Greece, 11527 Georgios Gennimatas General State Hospital Athens, Greece, 10682 Less <<
NCT02150707 - Completed - Ireland ... More >> Mater Misericordiae University Hospital Dublin, Ireland, Dublin 7 Less <<
NCT02164279 Type 1 Diabetes Mellitus With ... More >>Diabetic Nephropathy Less << Not Applicable Completed - France ... More >> Purpan Children Hospital Toulouse, France, 31059 Rangueil Hospital Toulouse, France, 31059 Less <<
NCT02169167 Diabetes Mellitus ... More >> Diabetes Complications Diabetic Neuropathies Wound Infection Less << Not Applicable Completed - Poland ... More >> Diabetic Foot Clinic Regional Diabetic Centre, Department of Hypertension and Diabetology Gdańsk, Poland, 80-952 Less <<
NCT02175537 Diabetes Mellitus, Type II ... More >> Overweight and Obesity Hypertension Behavioral Lifestyle Change Social Change Less << Not Applicable Completed - Qatar ... More >> Qatar Diabetes Association Doha, Qatar Less <<
NCT02180191 - Completed - Turkey ... More >> Department of Endocrinology and Metabolism, Gulhane School of Medicine Ankara, Turkey, 06180 Less <<
NCT01899430 PCOS Obesity Phase 4 Completed - Slovenia ... More >> University Medical Center Ljubljana Ljubljana, Slovenia, 1000 Less <<
NCT02159014 Cardiac Diseases ... More >> Stroke Diabetes Mellitus Dementia Mild Cognitive Impairment Less << Not Applicable Completed - United Kingdom ... More >> Chigwell Medical Centre Chigwell, Essex, United Kingdom, IG6 2TA Less <<
NCT01911468 PCOS Obesity Phase 4 Completed - Slovenia ... More >> University Medical Center Ljubljana Ljubljana, Slovenia, 1000 Less <<
NCT02145572 - Active, not recruiting December 2018 United States, California ... More >> Rady Children's Hospital San Diego, California, United States, 92123 Less <<
NCT02186080 Type 2 Diabetes Mellitus Not Applicable Completed - Korea, Republic of ... More >> Seoul National University Hospital Seoul, Korea, Republic of, 110-744 Less <<
NCT02203084 - Completed - Canada, British Columbia ... More >> BC's Children's Hospital Vancouver, British Columbia, Canada, V6H 3V4 Less <<
NCT02214654 - Unknown June 2015 China, Tianjin ... More >> Tianjin First Central Hospital Not yet recruiting Tianjin, Tianjin, China, 300192 China Tianjin First Central Hospital Not yet recruiting Tianjin, China, 300192 Contact: Xiaofei Wang, doctor       wangxiaofei@medmail.com.cn Less <<
NCT02219646 Type 2 Diabetes Mellitus (T2DM... More >>) Endothelial Dysfunction Erectile Dysfunction Less << Phase 2 Completed - Italy ... More >> Unit of Endocrinology Azienda USL Modena, Italy, 41126 Less <<
NCT02184455 Diabetes Type I ... More >> Diabetes Type II Less << Phase 1 Unknown December 2017 Canada, Nova Scotia ... More >> Queen Elizabeth II Health Sciences Center Recruiting Halifax, Nova Scotia, Canada, B3H3A7 Principal Investigator: Mark Glazebrook, PhD,MD,FRSC          Sub-Investigator: Jason G Williams, MD,FRCSC          Sub-Investigator: Martin R LeBlanc, MD,FRCS(C)          Canada, Ontario St. Michael's Hospital Recruiting Toronto, Ontario, Canada, M5B 1W8 Contact: Ryan M Khan, CCRP    (416) 864-6060 ext 3890    khanry@smh.ca    Contact: Timothy R Daniels, MD, FRSC    (416) 864-5392    danielst@smh.ca    Principal Investigator: Timothy R Daniels, MD, FRSC Less <<
NCT02231658 Diabetes Mellitus Phase 1 Terminated(Too challenging to ... More >>recruit appropriate participants at an acceptable speed.) Less << - Germany ... More >> St. Josef-Hospital, Universitätsklinik Bochum, Germany, 44791 Profil Institut für Stoffwechselforschung GmbH Neuss, Germany, 41460 Less <<
NCT02232503 - Completed - -
NCT02248311 - Active, not recruiting October 2018 Spain ... More >> Hospital Universitario Valle de Hebron Barcelona, Spain, 08035 Less <<
NCT02217306 - Completed - Mexico ... More >> Hospital Juarez de Mexico Mexico City, Mexico, 07760 Less <<
NCT02287831 Diabetes Peri... More >>pheral Arterial Disease Less << Phase 1 Phase 2 Unknown - -
NCT02246712 Neuropathic Pain ... More >> Type 1 Diabetes Mellitus Type 2 Diabetes Mellitus Less << Phase 4 Completed - Brazil ... More >> Universidade Estadual Paulista Julio de Mesquita Filho Araraquara, SP, Brazil, 14801902 Less <<
NCT02290418 Obesity, Severe ... More >> Diabetes Mellitus, Type 2 Less << Not Applicable Unknown December 2018 Czech Republic ... More >> Bariatric Clinic, Breclav Hospital Breclav, Czech Republic, 690 74 Less <<
NCT02294643 Coronary Artery Disease ... More >> Diabetes Mellitus Renal Insufficiency, Chronic Less << Phase 3 Completed - Korea, Republic of ... More >> Seoul National University Bundang Hospital Seongnam, Korea, Republic of, 463-707 Less <<
NCT03528005 Fragility Mul... More >>timorbidity Less << Not Applicable Recruiting December 31, 2019 Taiwan ... More >> Hualien Tzu Chi Hospital,Buddhist Tzu Chi Medical Foundation Recruiting Hualien City, Taiwan, 970 Contact: Sheng-lun Kao, MD    88638561825 ext 9    stevenkao7434@gmail.com    Shulin Primary Care center Recruiting New Taipei City, Taiwan, 238 Contact: Chia-Yun Chang, MD    886226812134       Yingge Primary Health Care center Recruiting New Taipei City, Taiwan, 239 Contact: Tzu-Hsing Hung, MD    886226702304    tpc252@ntpc.gov.tw    Cheng's primary care clinic Not yet recruiting New Taipei City, Taiwan, 241 Contact: Ting-Ching Tang, MD       drmichelletang@gmail.com    National Yang-Ming University Hospital Recruiting Yilan, Taiwan, 264 Contact: Chun-feng Huang, MDPhD    88639325192    16083@ymuh.ym.edu.tw    Taipei Veterans General Hospital Yuanshan Branch Recruiting Yilan, Taiwan, 264 Contact: Wei-Ju Lee, MDPhD    8869222141 ext 5210    leewju@gmail.com Less <<
NCT03141918 HIV Infections Not Applicable Completed - Brazil ... More >> Universidade Federal Do Rio Grande Do Norte Natal, RN, Brazil, 59078970 Less <<
NCT02305862 Arteriosclerosis ... More >> Diabetes Mellitus Lipid Disorder Less << Not Applicable Unknown July 2017 China ... More >> Beijing Tiantan Hospital, Capital Medical University Recruiting Beijing, China, 100050 Contact: Qiang Fu, Dr    861067096562    fuqiang66882000@hotmail.com    Principal Investigator: Buxing Chen, Dr Less <<
NCT02317172 Xerostomia Hy... More >>pertension Diabetes Mellitus Less << Not Applicable Completed - Thailand ... More >> Department of Health, Ministry of Health Nonthaburi, Thailand, 11000 Less <<
NCT03467217 NAFLD - Nonalcoholic Fatty Liv... More >>er Disease Less << Phase 2 Recruiting August 30, 2019 United States, California ... More >> University of California, San Diego Recruiting San Diego, California, United States, 92103 Contact: Janis Durelle    619-543-5226    jdurelle@ucsd.edu    Principal Investigator: Jeffrey Schwimmer, MD          University of California, San Francisco Recruiting San Francisco, California, United States, 94143 Contact: Camille Langlois    415-476-1756    Camille.Langlois@ucsf.edu    Principal Investigator: Philip Rosenthal, MD          United States, Georgia Emory University Recruiting Atlanta, Georgia, United States, 30322 Contact: Miriam Vos, MD, MSPH    404-727-1463    Mvos@emory.edu    Contact: Rebecca Cleeton    (404) 727-5383    rcleeto@emory.edu    Principal Investigator: Miriam Vos, MD, PhD          United States, Illinois Northwestern Univ-Ann & Robert H. Lurie Children's Hospital of Chicago Recruiting Chicago, Illinois, United States, 60611-2605 Contact: Joy Ito    312-227-4559    jito@luriechildrens.org    Contact: Mary Riordan    (312) 227.4558    mriordan@luriechildrens.org    Principal Investigator: Mark Fishbein, MD          United States, Indiana Indiana University Recruiting Indianapolis, Indiana, United States, 46202 Contact: Ann Klipsch    317-274-9605    aeye@iupui.edu    Contact: Laura Walker    (317) 944-4490    walkerlk@iu.edu    Principal Investigator: Jean Molleston, MD          United States, Missouri St. Louis University Recruiting Saint Louis, Missouri, United States, 63104 Contact: Theresa Cattoor, BSN,MA,CCRC    314-977-9335    theresa.cattoor@health.slu.edu    Principal Investigator: Ajay Jain, MD          United States, New York Columbia University Recruiting New York, New York, United States, 10032 Contact: Elena Reynoso    212-305-6274    er2564@columbia.edu    Principal Investigator: Joel Lavine, MD, PhD          United States, Ohio Cincinnati Children's Hospital Medical Center Recruiting Cincinnati, Ohio, United States, 45229-3039 Contact: April Carr    513-803-7744    april.carr@cchmc.org    Contact: Kimberlee Bernstein, BS, CCRP    (513)636-4406    Kimberlee.bernstein@cchmc.org    Principal Investigator: Stavra Xanthakos, MD          United States, Texas Texas Children's Hospital Recruiting Houston, Texas, United States, 77030 Contact: Tamir Miloh, MD    832-822-3648    tamiloh@texaschildrens.org    Contact: Alicia Lawson    (832) 824-3848    alicia.lawson@bcm.edu    Principal Investigator: Tamir Miloh, MD          United States, Washington University of Washington Recruiting Seattle, Washington, United States, 98195 Contact: Melissa Young    206-987-1037    melissa.young@seattlechildrens.org    Sub-Investigator: Niviann Blondet, MD          Principal Investigator: Karen Murray, MD Less <<
NCT01715753 Weight Loss Not Applicable Completed - United States, North Carolina ... More >> Duke University Medical Center Durham, North Carolina, United States, 27710 Less <<
NCT02328521 Angina, Unstable ... More >> Diabetes Mellitus Less << Phase 4 Unknown July 2016 China, Beijing ... More >> Chinese PLA General Hospital Recruiting Beijing, Beijing, China, 100853 Contact: Yundai Chen, M.D.    86-010-55499309    cyundai@medmail.com.cn Less <<
NCT02302079 Diabetes Mellitus ... More >> Diabetic Macular Edema Less << Phase 2 Completed - United States, Arizona ... More >> Site US10021 Phoenix, Arizona, United States, 85104 Site US10025 Tucson, Arizona, United States, 85704 United States, California Site US10006 Arcadia, California, United States, 91007 Site US10004 Beverly Hills, California, United States, 90211 Site US10007 Palm Desert, California, United States, 92260 Site US10011 Sacramento, California, United States, 95819 Site US10031 Santa Ana, California, United States, 92705 United States, Colorado Site US10029 Golden, Colorado, United States, 80401 United States, Florida Site US10016 Miami, Florida, United States, 33126 Site US10005 Winter Haven, Florida, United States, 33880 United States, Georgia Site US10036 Augusta, Georgia, United States, 30909 United States, Massachusetts Site US10002 Boston, Massachusetts, United States, 02114 United States, Nebraska Site US10001 Omaha, Nebraska, United States, 985540 United States, Nevada Site US10027 Reno, Nevada, United States, 89511 United States, Tennessee Site US10012 Nashville, Tennessee, United States, 37203 United States, Texas Site US10010 Abilene, Texas, United States, 79606 Site US10015 Austin, Texas, United States, 78705 Site US10013 Houston, Texas, United States, 77030 Site US10030 McAllen, Texas, United States, 78503 Site US10009 San Antonio, Texas, United States, 78240-1502 United States, Virginia Site US10017 Charlottesville, Virginia, United States, 22903 Less <<
NCT02331420 Obesity Diabe... More >>tes Mellitus, Type 2 Atherosclerosis Less << Not Applicable Unknown July 2017 -
NCT02343107 Abdominal Obesity ... More >> Type 2 Diabetes Less << Not Applicable Completed - France ... More >> Groupe Hospitalier Pitié Salpetrière Paris, France, 75013 Less <<
NCT02324218 - Completed - -
NCT02356848 Diabetes Foot... More >> Ulcer Less << Not Applicable Recruiting March 1, 2019 United States, New York ... More >> Manhattan Campus of the VA NY Harbor Healthcare System, New York, NY Recruiting New York, New York, United States, 10010 Contact: John G Hay, MD    212-686-7500 ext 3860    john.hay@va.gov    Contact: David S Goldfarb, MD    (212) 686-7500 ext 3877    David.Goldfarb@va.gov    Principal Investigator: Sundar Natarajan, MD MSc Less <<
NCT02357420 Diabetes Mellitus ... More >> Diabetes Mellitus Complications Gastroparesis Less << Phase 2 Completed - -
NCT02372149 Peripheral Neuropathy ... More >> Diabetes Mellitus Chronic Inflammatory Demyelinating Polyneuropathy Less << Phase 4 Unknown February 2018 Canada, Ontario ... More >> Toronto General Hospital / Toronto Western Hospital Recruiting Toronto, Ontario, Canada, M5G 2C4 Contact: Eduardo Ng, MD    416-340-4184    eduardo.ng@uhn.ca Less <<
NCT02355288 Coronary Artery Disease ... More >> Diabetes Mellitus Less << Not Applicable Withdrawn(Insufficient funding... More >> available to complete study.) Less << October 1, 2020 -
NCT02325466 Peripheral Artery Disease ... More >> Type 2 Diabetes Less << Phase 3 Completed - United States, New York ... More >> Icahn School of Medicine at Mount Sinai New York, New York, United States, 10029 Less <<
NCT02384226 - Active, not recruiting December 2018 United States, Colorado ... More >> University of Colorado Hospital Aurora, Colorado, United States Less <<
NCT02399657 Diabetes Mellitus ... More >> Macular Edema Retinal Exudates and Deposits Less << Phase 4 Unknown December 2016 Korea, Republic of ... More >> Gyeongsang National University Hospital Recruiting Jinju, Gyeongsangnam-do, Korea, Republic of, 660-702 Contact: In Young Chung, M.D.          Kosin University Gospel Hospital Recruiting Busan, Korea, Republic of, 602-702 Contact: Sang Joon Lee, M.D.          Dong-A University hospital Recruiting Busan, Korea, Republic of, 602-715 Contact: Woo Jin Jeung, M.D.          Pusan national university hospital Recruiting Busan, Korea, Republic of, 602-739 Contact: Ji Eun Lee, M.D.          Inje University Haeundae Paik hospital Recruiting Busan, Korea, Republic of, 612-030 Contact: Joo Eun Lee, M.D.          Inje University Busan Paik hospital Recruiting Busan, Korea, Republic of, 614-735 Contact: Hyun Woong Kim, M.D.          Kyungpook National University Hospital Recruiting Daegu, Korea, Republic of, 700-721 Contact: Jae Pil Shin, M.D.          Yeungnam University Medical Center Recruiting Daegu, Korea, Republic of, 705-717 Contact: Woo Hyok Chang, M.D. Less <<
NCT02423850 - Active, not recruiting December 2018 Denmark ... More >> University Centre of Wound Healing, Odense University Hospital (OUH) Odense, Denmark, 5000 Less <<
NCT02418884 Coronary Artery Disease Phase 4 Unknown March 2018 -
NCT02360527 - Completed - Spain ... More >> Vall d´Hebron Research Institute VHIR Barcelona, Catalunya, Spain, 08035 Less <<
NCT02423434 - Enrolling by invitation August 2018 United States, Michigan ... More >> University of Michigan Ann Arbor, Michigan, United States, 48105 Australia Queensland University of Technology Brisbane, Australia, 4059 Canada, Alberta University of Calgary Calgary, Alberta, Canada, T3B6A8 Canada, Ontario Mount Sinai Hospital and University Health Network Toronto, Ontario, Canada, M5G 2C4 United Kingdom University of Manchester Manchester, United Kingdom, M139PT Less <<
NCT02358096 Chronic Kidney Disease ... More >> Type 2 Diabetes Less << Phase 2 Completed - -
NCT02445079 - Recruiting December 2018 Uganda ... More >> Mbarara University of Science and Technology Recruiting Mbarara, Uganda Contact: Okello Samson, MD    +256-485-21623    okello.samson@must.ac.ug Less <<
NCT02451722 Diabetes Mellitus Type 2 ... More >> Sensory Neuropathy Foot Ulcer, Diabetic Less << Not Applicable Completed - Israel ... More >> Orthopedic Rehabilitation out-patient clinic, Sheba Medical Center Ramat Gan, Israel Less <<
NCT02426099 Hypertension, Resistant to Con... More >>ventional Therapy Diabetes Mellitus Less << Phase 4 Completed - Cameroon ... More >> National Obesity Centre, Yaounde Central Hospital Yaounde, Centre, Cameroon Less <<
NCT02456051 - Terminated(enrollment was term... More >>inated because of the poor recruitment rate) Less << - Italy ... More >> Università Sapienza di Roma, Azienda Ospedaliera Sant'Andrea Roma, Italy, 00100 Less <<
NCT02455414 - Completed - United States, Missouri ... More >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Less <<
NCT02457130 Coronary Artery Disease ... More >> Diabetes Mellitus. Type 2 Less << Phase 4 Unknown February 2017 Spain ... More >> Hospital Universitari de Bellvitge - IDIBELL Recruiting L'Hospitalet de Llobregat, Barcelona, Spain, 08907 Principal Investigator: José Luis Ferreiro, MD          Hospital Clínico San Carlos Not yet recruiting Madrid, Spain, 28040 Principal Investigator: David Vivas, PhD          Hospital Clínico Universitario Virgen de la Arrixaca Not yet recruiting Murcia, Spain, 30120 Principal Investigator: Antonio Tello-Montoliu, PhD Less <<
NCT02499185 Acute Kidney Injury ... More >> Arterial Hypertension Obesity Cardio Vascular Disease Diabetes Mellitus Chronic Liver Disease Hypercholesterolemia Less << Phase 4 Terminated(No patients with re... More >>nal failure) Less << - Belgium ... More >> Universitair Ziekenhuis Brussel Jette, Brussels, Belgium, 1090 Less <<
NCT02460783 Alzheimer's Disease ... More >> Obesity Diabetes Mellitus Less << Phase 2 Recruiting July 1, 2019 United States, Maryland ... More >> National Institute of Aging, Clinical Research Unit Recruiting Baltimore, Maryland, United States, 21224 Less <<
NCT02500628 Fibromyalgia ... More >>Mitochondrial Diseases Movement Disorders Diabetes Mellitus, Type 2 Less << Phase 2 Completed - United States, Washington ... More >> Woodinville Psychiatric Associates Woodinville, Washington, United States, 98072 Less <<
NCT02501876 - Completed - Spain ... More >> Vall d´Hebron University Hospital Barcelona, Spain, 08035 Less <<
NCT01689246 Alzheimer's Disease Phase 3 Completed - -
NCT02475499 - Completed - Canada, Quebec ... More >> Lady Davis Institute for Medical Research, Jewish General Hospital Montreal, Quebec, Canada, H3T1E2 Less <<
NCT02538055 Diabetes Mellitus ... More >> Chronic Pain Less << Not Applicable Completed - -
NCT03594799 Weightlessness ... More >> Weightlessness; Adverse Effect Less << Not Applicable Active, not recruiting December 2020 France ... More >> Medes-Imps Toulouse, France, 31400 Less <<
NCT02539160 Coronary Artery Disease ... More >> Diabetes Mellitus Less << Phase 4 Recruiting March 2019 United States, Florida ... More >> University of Florida Recruiting Jacksonville, Florida, United States, 32209 Contact: Dominick Angiolillo       dominick.angiolillo@jax.ufl.edu Less <<
NCT02540733 - Recruiting December 31, 2018 China, Zhejiang ... More >> The 2nd Affiliated Hospital of Zhejiang University, School of Medicine, Recruiting Hangzhou, Zhejiang, China, 310009 Contact: Xinfeng Yu, PhD    86-18758187391    angek-4125@163.com    Principal Investigator: Minming Zhang, PhD Less <<
NCT02548650 Myocardial Infarction ... More >> Diabetes Mellitus Peripheral Arterial Disease Less << Phase 4 Recruiting February 2019 United States, Florida ... More >> University of Florida Recruiting Jacksonville, Florida, United States, 32209 Contact: Dominick J Angiolillo, MD, PhD       dominick.angiolillo@jax.ufl.edu    Principal Investigator: Dominick J Angiolillo, MD, PhD Less <<
NCT02526901 - Recruiting - China, Guangdong ... More >> Guangzhou Women and Children's Medical Center Recruiting Guangzhou, Guangdong, China, 510623 Contact: Xiu Qiu, PhD    0086 20 38367160    qxiu0161@163.com    Contact: Jianrong He, MS    0086 20 38367160    hjr0703@163.com Less <<
NCT02579655 Coronary Disease ... More >> Stroke Chronic Kidney Disease Heart Failure Diabetes Mellitus Hypertension Hypercholesterolemia Less << Not Applicable Active, not recruiting January 2022 Canada, Alberta ... More >> University of Calgary Calgary, Alberta, Canada, T2N 4Z6 Less <<
NCT02581098 - Recruiting December 2020 United States, Ohio ... More >> OSU Hospital East Recruiting Columbus, Ohio, United States, 43205 Contact: Amy Hoover, LPN    614-366-2783    Amy.Hoover@osumc.edu    Contact: Elizabeth Murphy, BS    614-685-3173    elizabeth.murphy@osumc.edu    Davis Heart and Lung Research Institute Recruiting Columbus, Ohio, United States, 43210 Contact: Sashwati Roy, Ph.D    614-247-7657    sashwati.roy@osumc.edu    Contact: Elizabeth Murphy, BS    614-685-3173    elizabeth.murphy@osumc.edu    Principal Investigator: Chandan K. Sen, Ph.D.          Martha Morehouse Medical Plaza Recruiting Columbus, Ohio, United States, 43221 Contact: Elizabeth Murphy, BS    614-685-3173    elizabeth.murphy@osumc.edu    Contact: Amy Hoover, LPN    614-293-0390 ext LPN    Amy.Hoover@osumc.edu Less <<
NCT02500628 - Completed - -
NCT02565862 Hepatitis C D... More >>iabetes Mellitus Insulin Resistance Less << Phase 1 Completed - Netherlands ... More >> CRCN, Radboud University Medical Center Nijmegen, Netherlands Less <<
NCT02587936 Chronic Kidney Disease ... More >> Diabetes Hypertension High BP Type 2 Diabetes Less << Not Applicable Recruiting February 2020 United States, Connecticut ... More >> ProHealth Recruiting Farmington, Connecticut, United States, 06034 Contact: Tom Meehan, MD, MPH    860-284-5288    tmeehan@prohealthmd.com    Contact: Stephanie Gemant, PharmD    860-674-7233    sgernant@ProHealthMD.com    Principal Investigator: Tom Meehan, MD, MPH          Sub-Investigator: Stepanie Gernant, PharmD          United States, Texas Texas Health Resources Recruiting Arlington, Texas, United States, 76011 Contact: Ferdinand Velasco, MD    682-236-6061    ferdinandvelasco@TexasHealth.org    Contact: Lynn Myers, MD    817-991-5198    LynnMyers@texashealth.org    Principal Investigator: Ferdinand Velasco, MD          Sub-Investigator: Lynn Myers, MD          Veteran's Administration Recruiting Dallas, Texas, United States, 75216 Contact: Tyler Miller, MD    214-648-7214    tyler.miller@va.gov    Contact: Anuoluwapo Adelodun, MD, MPH    435-557-0696    ANUOLUWAPO.ADELODUN@va.gov    Sub-Investigator: Tyler Miller, MD          Sub-Investigator: Anuoluwapo Adelodun, MD, MPH          Parkland Health and Hospital System Recruiting Dallas, Texas, United States, 75235 Contact: Noel Santini, MD    214-266-1224    NOEL.SANTINI@phhs.org    Contact: Jill Sommerhauser, RN    214-266-1102    JILL.SOMMERHAUSER@phhs.org    Principal Investigator: Noel Santini, MD          Sub-Investigator: Jill SOMMERHAUSER, MSN, RN, BBA          Sub-Investigator: Kristin Ashton, LVN, (BSN) Less <<
NCT02579837 Diabetes Mellitus ... More >> Diabetic Retinopathy Less << Not Applicable Recruiting March 2019 Canada, Ontario ... More >> St. Joseph's Hospital Recruiting London, Ontario, Canada, N6A 4V2 Principal Investigator: Selina L Liu, MD MSc FRCPC Less <<
NCT02612493 - Completed - -
NCT02586519 Diabetes Diab... More >>etes Complications Neuropathy Peripheral Neuropathy Diabetic Foot Ulcer Less << Not Applicable Recruiting January 2021 Canada, Alberta ... More >> Diabetic Foot & Limb Preservation Centre- Peter Lougheed Centre Recruiting Calgary, Alberta, Canada, T1Y 6J4 Contact: Karim Manji, DPM, AACFAS    4032292273    karim.manji@ucalgary.ca Less <<
NCT02579148 Erectile Dysfunction ... More >> Type 1 Diabetes Mellitus Type 2 Diabetes Mellitus Less << Phase 1 Withdrawn April 2017 China, Jiangsu ... More >> Drum Tower Hospital Nanjing, Jiangsu, China, 210000 Less <<
NCT02595606 Dry Eye Syndromes ... More >> Diabetes Mellitus Less << Phase 4 Unknown March 2016 China, Guangdong ... More >> Clinical Research Center Recruiting Guangzhou, Guangdong, China, 510000 Contact: Wang Zhichong, M.D.    02087333391    wzc001@hotmail.com    Contact: Gao Xinbo, M.D.    02087330484    936319557@qq.com Less <<
NCT02632292 Coronary Artery Disease ... More >> Diabetes Mellitus Less << Phase 4 Terminated(Slow enrollment) January 2019 Germany ... More >> University of Luebeck Luebeck, Germany, 23538 Less <<
NCT02639988 - Recruiting April 2025 France ... More >> AP-HP, Cochin hospital Recruiting Paris, France, 75014 Contact: Jerôme Avouac, MD, PhD    +33158412563    jerome.avouac@aphp.fr Less <<
NCT02593032 Diabetes Mellitus ... More >> Hypertension Hyperlipidemia Less << Not Applicable Completed - United States, Pennsylvania ... More >> University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT02643225 - Completed - -
NCT02643225 - Completed - -
NCT02629406 - Completed - Sweden ... More >> Karolinska University Hospital Stockholm, Sweden, 17176 Less <<
NCT02037672 PCOS Obesity Phase 4 Completed - Slovenia ... More >> University Medical Center Ljubljana Ljubljana, Slovenia, 1000 Less <<
NCT02644590 Diabetes Mellitus, Type 1 ... More >> Hypertension Less << Early Phase 1 Unknown February 2017 -
NCT02655757 Atherosclerosis ... More >> Type 2 Diabetes Mellitus Less << Phase 4 Completed - China, Beijing ... More >> The General Hospital of PLA Beijing, Beijing, China, 100853 Less <<
NCT02663713 Myocardial Infarction ... More >> Diabetes Mellitus Renal Disease Coronary Artery Disease Less << Phase 4 Completed - Greece ... More >> Cardiology Department Patras University Hospital Rio, Achaia, Greece, 26500 Less <<
NCT02664207 Obesity Myelo... More >>meningocele Pregnancy Diabetes Mellitus in Pregnancy Fetal Anomaly Less << Not Applicable Recruiting January 2025 United States, Texas ... More >> Children's Memorial Hermann Hospital Recruiting Houston, Texas, United States, 77030 Contact: Kuojen Tsao, MD    713-500-7327    KuoJen.Tsao@uth.tmc.edu    Contact: Meagan Sosa, M.A.    713-486-6573    Meagan.D.Sosa@uth.tmc.edu    The Fetal Center at UTHealth Recruiting Houston, Texas, United States, 77030 Contact: Kuojen Tsao, MD    713-500-7327    KuoJen.Tsao@uth.tmc.edu    Contact: Meagan Sosa, M.A.    713-486-6573    Meagan.D.Sosa@uth.tmc.edu Less <<
NCT02646072 Cystoid Macular Edema, Postope... More >>rative Diabetes Mellitus Less << Phase 4 Completed - Malaysia ... More >> University of Malaya Kuala Lumpur, Wilayah Persekutuan, Malaysia, 50603 Less <<
NCT02690766 Diabetes Mellitus, Non-Insulin... More >>-Dependent Breast Cancer Endometrial Cancer Less << Phase 2 Completed - -
NCT02689570 - Unknown - Belgium ... More >> Antwerp University Hospital Recruiting Edegem, Belgium, 2650 Contact: Christophe De Block, MD PhD    +3238214364    christophe.de.block@uza.be    Contact: Luc Van Gaal, MD PhD          Principal Investigator: Christophe De Block, MD PhD          Principal Investigator: Luc Van Gaal, MD PhD Less <<
NCT02662010 - Recruiting February 2019 United States, Colorado ... More >> Universtiy of Colorado Recruiting Aurora, Colorado, United States, 80045 Contact: Levi Bonnell, MPH    303-848-5039    levi.bonnell@ucdenver.edu Less <<
NCT02702440 - Unknown December 2016 Canada, Ontario ... More >> The Toronto 3D (Diet, Digestive tract and Disease) Knowledge Synthesis and Clinical Trials Unit, Clinical Nutrition and Risk Factor Modification Centre, St. Michael's Hospital Toronto, Ontario, Canada, M5C 2T2 Less <<
NCT02672436 Diabetic Foot ... More >> Foot Ulcer Diabetes Mellitus Wounds Less << Phase 2 Recruiting December 2018 Taiwan ... More >> Tri-Service General Hospital Recruiting Taipei, Taiwan Contact: Niann-Tzyy Dai, MD. PhD.    886-2-8792-7195       Principal Investigator: Niann-Tzyy Dai, MD. PhD. Less <<
NCT02716623 Bladder Cancer ... More >> Diabetes Mellitus Less << Not Applicable Recruiting July 1, 2018 United States, Kansas ... More >> University of Kansas Cancer Center Recruiting Kansas City, Kansas, United States, 66160 University of Kansas Medical Center Recruiting Kansas City, Kansas, United States, 66160 Less <<
NCT02710799 Diabetes Mellitus ... More >> Hypothyroidism Hyperthyroidism Goiter Thyroid Nodule Obesity Less << Not Applicable Completed - Brazil ... More >> Secretaria Estadual da Saúde Porto Alegre, Rio Grande do Sul, Brazil, 90110-150 Less <<
NCT02699736 - Enrolling by invitation December 2030 -
NCT02685475 - Completed - Turkey ... More >> Istanbul University, Department of Anesthesiology Istanbul, Fatih, Turkey, 34093 Less <<
NCT02730949 Type 1 Diabetes Phase 3 Completed - Italy ... More >> University Campus Bio Medico Rome, Italy, 00128 Less <<
NCT02709031 Arterial Hypertension ... More >> Diabetes Hypokalemia Hyponatremia Less << Phase 1 Phase 2 Unknown September 2017 -
NCT02718547 Complications of Diabetes Mell... More >>itus Less << Not Applicable Recruiting July 2018 Israel ... More >> Meir Medical center Recruiting Kfar Saba, Israel, 69419 Contact: Nimrod Dar, MD    +972545937757    nimrod.dar@gmail.com Less <<
NCT02732886 Diabetes Mellitus ... More >> Foot Ulcer Less << Not Applicable Completed - Korea, Republic of ... More >> Inje University Sanggye Paik Hospital Seoul, Korea, Republic of Less <<
NCT03022344 Diabetes Plaq... More >>ue Atherosclerosis Less << Not Applicable Active, not recruiting October 2021 Denmark ... More >> Sydvestjysk sygehus Esbjerg, Denmark, DK-6700 Less <<
NCT01653119 Acute Coronary Syndrome ... More >> Diabetes Mellitus Less << Not Applicable Unknown December 2015 China, Beijing ... More >> Peking University Third Hospital Recruiting Beijing, Beijing, China, 100191 Contact: Wei Gao, Master    +8613901366179    dr_gaowei@medmail.com.cn    Contact: Wei Zhao, Doctor    +8618600017812    beate_vv@bjmu.edu.cn Less <<
NCT03045250 Diabetic Neuropathies Not Applicable Withdrawn(Lack of funding) February 1, 2020 -
NCT01651065 Diabetes Mellitus, Type II ... More >> Heart Disease Obesity Hypertension Dyslipidemia Less << Not Applicable Completed - United States, Kentucky ... More >> Bell County Health Department Pineville, Kentucky, United States, 40977 Less <<
NCT01671306 - Completed - -
NCT03041571 - Suspended(PI is no longer with... More >> UF. No New PI assigned to date.) Less << December 31, 2019 United States, Florida ... More >> University of Florida Gainesville, Florida, United States, 32611 Less <<
NCT01673191 Macular Edema ... More >> Diabetes Mellitus Less << Phase 2 Completed - United States, Arizona ... More >> Retinal Consultants of Arizona Phoenix, Arizona, United States, 85014 Less <<
NCT01673191 - Completed - -
NCT01689090 Diabetes Mellitus Type 1 ... More >> Diabetic Maculopathy Less << Not Applicable Completed - Denmark ... More >> Department of Ophthalmology, Aarhus University Hospital Aarhus, Denmark, 8000 Less <<
NCT01680978 Diabetes Mellitus Type 2 Phase 2 Completed - United Kingdom ... More >> Oxford, United Kingdom, OX3 9DU Less <<
NCT01686139 Type I Diabetes Mellitus With ... More >>Ulcer Type II Diabetes Mellitus With Ulcer Less << Phase 1 Unknown December 2017 Israel ... More >> Orthopedic Rehabilitation out-patient clinic, Sheba Medical Center Not yet recruiting Ramat Gan, Israel Contact: Itzhak Siev-Ner, MD    03-530-3701    zivner@netvision.net.il    Principal Investigator: Itzhak Siev-Ner, MD Less <<
NCT01690572 Coronary Disease ... More >> Diabetes Mellitus Less << Not Applicable Terminated(recruitment was not... More >> sufficient.) Less << - Germany ... More >> Department of Cardiology and Angiology I, Heart Center, Freiburg, Baden-Württemberg, Germany, 79106 Less <<
NCT03109587 Obesity, Childhood Not Applicable Not yet recruiting March 2019 -
NCT03057158 - Active, not recruiting January 18, 2020 United States, North Carolina ... More >> Duke University Durham, North Carolina, United States, 27707 Less <<
NCT01741181 Diabetes Mellitus Type 2 ... More >> Vitamin D Deficiency Less << Phase 4 Completed - Singapore ... More >> Tan Tock Seng Hospital Singapore, Singapore, 308433 Less <<
NCT01729130 - Active, not recruiting January 2018 United States, Texas ... More >> The University of Texas Medical Branch (UTMB) Galveston, Texas, United States, 77555 Less <<
NCT01655810 Vitamin D Deficiency ... More >> Type 2 Diabetes Mellitus Cardiovascular Disease Less << Not Applicable Active, not recruiting December 2018 United States, Missouri ... More >> Washington University Saint Louis, Missouri, United States, 63110 Less <<
NCT01741480 Congestive Heart Failure ... More >> Chronic Obstructive Pulmonary Disease Cancer Diabetes Mellitus Obstructive Sleep Apnea Less << Not Applicable Completed - United States, Missouri ... More >> Barnes-Jewish Hospital Saint Louis, Missouri, United States, 63110 Less <<
NCT01710748 Coronary Artery Disease ... More >> Diabetes Mellitus Less << Phase 3 Unknown October 2014 Spain ... More >> Hospital Clínic i Provincial Barcelona, Spain Hospital Universitari de Bellvitge Barcelona, Spain Hospital Clínico San Carlos Madrid, Spain Hospital Virgen de la Arrixaca Murcia, Spain Less <<
NCT01711385 Prediabetic State ... More >> Type 2 Diabetes Mellitus With Oral Complications Periodontal Pocket Tooth Loss Less << Not Applicable Unknown June 2013 United States, New York ... More >> Columbia University College of Dental Medicine New York, New York, United States, 10032 Less <<
NCT01741480 - Completed - -
NCT01754259 - Completed - -
NCT01743014 Diabetes Type 2 ... More >> Diabetic Nephropathy Vascular Disease Less << Phase 4 Unknown July 2015 Greece ... More >> AHEPA University Hospital Recruiting Thessaloniki, Greece, 546 36 Contact: Fotios S Iliadis, Lecturer of Internal Medicine    +302310993587    iliadis@med.auth.gr    Contact: Vaia F Bougatsa, Resident of Internal Medicine    +306944334265    vaiabou@yahoo.gr    Aristotle University of Thessaloniki/ AHEPA University Hospital Recruiting Thessaloniki, Greece Principal Investigator: Vaia F Bougatsa, MD Less <<
NCT01754259 Diabetes, Type I ... More >> Diabetes, Type II Angina Coronary Artery Disease Less << Phase 3 Completed - United States, Massachusetts ... More >> Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Less <<
NCT03202095 Major Depressive Disorder Phase 4 Recruiting November 1, 2019 United States, Utah ... More >> University of Utah Recruiting Salt Lake City, Utah, United States, 84108 Contact: Lindsay Scholl, BS    801-386-4773    lindsay.scholl@utah.edu Less <<
NCT01744132 Diabetic Retinopathy ... More >> Diabetes Mellitus Less << Not Applicable Completed - United States, Pennsylvania ... More >> Jefferson Pharmacy Philadelphia, Pennsylvania, United States, 19107 Less <<
NCT01770964 Diabetes Mellitus ... More >> Painful Distal Symmetric Sensorimotor Polyneuropathy Less << Phase 4 Unknown July 2013 United States, Massachusetts ... More >> St. Elizabeth's Medica Center Recruiting Brighton, Massachusetts, United States, 02135 Contact: Cameron Keith, BSN, RN    617-789-2763       Principal Investigator: Frederic J Gerges, MD          Sub-Investigator: Andrew L Sternlicht, MD          Sub-Investigator: Magid A Al-Kimawi, MD          MedVadis Research Corporation Recruiting Watertown, Massachusetts, United States, 02472 Contact: Alice Brown, MD    617-744-1310       Sub-Investigator: Alice Brown, MD          Principal Investigator: Egilius Spierings, MD Phd          United States, New York Neuro Care Medical Associates Recruiting Johnson City, New York, United States, 13790 Contact: Kathe Rooney    607-729-1521 ext 308       Principal Investigator: Aamir Rasheed, MD          Sub-Investigator: Taseer Ahmed Minhas, MD          Sub-Investigator: Sherrie A Adler, FNP          University of Rochester Recruiting Rochester, New York, United States, 14618 Contact: Maria Frazer    585-340-8926       Principal Investigator: Armando A Villarreal, MD          Sub-Investigator: John D Markman, MD          United States, Pennsylvania Blair Medical Associates, Inc. Recruiting Altoona, Pennsylvania, United States, 16602 Contact: Julia E Benton, RN, CCRC    814-946-7569       Principal Investigator: Anthony J Bartkowiak, Jr., MD, FACP, CPI          Sub-Investigator: Jessica L Dilling, CRNP          Sub-Investigator: Andrea Jill Runk, CRNP          Sub-Investigator: Harry L Penny, DPM          United States, Rhode Island Clinical Partners Recruiting Johnston, Rhode Island, United States, 02919 Contact: Caroline DiGiulio, RN    401-454-3800       Principal Investigator: Albert J Marano, MD          Sub-Investigator: William J Beliveau, MD Less <<
NCT01770483 Hepatitis C, Chronic ... More >> DIABETES MELLITUS Type 2 Less << Phase 4 Completed - Pakistan ... More >> Endocrinology and Diabetes management centre Lahore, Punjab, Pakistan Less <<
NCT01770483 - Completed - -
NCT01774474 Cystoid Macular Edema ... More >> Cataract Diabetes Mellitus Less << Phase 3 Completed - Austria ... More >> Vienna Institute for Research in Ocular Surgery, Hanusch Krankenhaus Vienna, Austria, A-1140 Hospital of the Brothers of Saint John of God Vienna, Austria Belgium University Hospital Antwerp Edegem, Belgium, B-2650 Germany Goethe University Frankfurt am Main, Germany, 60590 Hungary Semmelweis University Budapest, Hungary, H-1085 Netherlands VU University Medical Center Amsterdam, Netherlands, 1081 HZ Academic Medical Center Amsterdam, Netherlands Amphia Hospital Breda Breda, Netherlands Zuyderland Medical Center Heerlen, Netherlands, 6419 PC Eye Hospital Zonnestraal Hilversum, Netherlands University Eye Clinic Maastricht UMC+ Maastricht, Netherlands, 6202 AZ Medical Centre Haaglanden the Hague, Netherlands St. Elisabeth Hospital Tilburg, Netherlands Máxima Medical Center Veldhoven Veldhoven, Netherlands Portugal University Hospital Coimbra Coimbra, Portugal, 3000-075 Spain Instituto Microcirurgia Ocular Barcelona, Spain, 08035 Less <<
NCT01785524 - Completed - -
NCT01785524 Peripheral Arterial Disease ... More >> Type II Diabetes Mellitus Less << Phase 2 Completed - United States, North Carolina ... More >> Duke Diet & Fitness Center Durham, North Carolina, United States, 27710 Less <<
NCT01785667 - Completed - Denmark ... More >> Department of Ophthalmology, Odense University Hospital Odense, Fyn, Denmark, 5000 Less <<
NCT01792518 - Completed - -
NCT03251755 Exercise Promotion Not Applicable Recruiting May 31, 2018 Taiwan ... More >> Division of Endocrinology and Metabolism in Taichung Veterans General Hospital Recruiting Taichung, Taiwan, 407 Contact: I Te Lee, MD    886-4-23741340    itlee@vghtc.gov.tw    Sub-Investigator: I Te Lee, MD Less <<
NCT01798914 - - - United States, Alabama ... More >> Endocrinology Associates Montgomery, Alabama, United States, 36106 Diabetes and Endocrine Consultants P.C. Montgomery, Alabama, United States, 36117 United States, Florida University of Miami Diabetes Research Institute Miami, Florida, United States, 33136 United States, Illinois Dr. Rife and Associates Family Medicine Orland Park, Illinois, United States, 60467 United States, Louisiana Highland Clini-Endocrinology Shreveport, Louisiana, United States, 71105 United States, Maryland Annapolis Internal Medicine LLC Annapolis, Maryland, United States, 21401 Nallin Family Healthcare Cumberland, Maryland, United States, 21502 United States, New Hampshire Center for Diabetes and Endocrinology Portsmouth, New Hampshire, United States, 03801 United States, New York North Country Community Physicians Glen Cove, New York, United States, 11542 Great Neck Medical Group Great Neck, New York, United States, 11021 North Shore Diabetes and Endocrine Associates New Hyde Park, New York, United States, 11042 United States, North Carolina Mountain Diabetes and Endocrine Center Asheville, North Carolina, United States, 28803 United States, Rhode Island Primary Care Wakefield Wakefield, Rhode Island, United States, 02879 United States, Virginia Endocrinology Associates Inc. Roanoke, Virginia, United States, 24016 Less <<
NCT03257566 - Not yet recruiting September 2019 -
NCT01792518 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT01803828 Diabetic Cardiomyopathy ... More >> Diabetes Mellitus Type 2 Left Ventricular Hypertrophy Less << Phase 4 Recruiting January 2019 Italy ... More >> Dipartimento di Medicina Sperimentale - Sezione di Fisiopatologia Medica - Sapienza Università di Roma Recruiting Rome, Italy, 00161 Contact: Andrea M Isidori, MD,PhD    39-06-4997-0540    andrea.isidori@uniroma1.it    Principal Investigator: Andrea M Isidori, MD,PhD          Sub-Investigator: Elisa Giannetta, MD,PhD Less <<
NCT01801150 Diabetes Slee... More >>p Apnea Less << Phase 4 Completed - Spain ... More >> Hospital Universitario La Paz- IdiPaz Madrid, Spain, 28046 Less <<
NCT01804777 Proteinuria H... More >>ypertension Type II Diabetes Less << Early Phase 1 Terminated(Currently closed fo... More >>r data analysis.) Less << - United States, New Mexico ... More >> University of New Mexico Hospital; Clinical & Translational Science Center Albuquerque, New Mexico, United States, 87131 Less <<
NCT01813305 Diabetic Foot Ulcer ... More >> Diabetes Mellitus Wounds Less << Phase 2 Recruiting September 2019 Taiwan ... More >> Kaohsiung Medical University Chung-Ho Memorial Hospital Recruiting Kaohsiung, Taiwan Contact: Su-Shin Lee, MD    886-7-3208176    sushin@kmu.edu.tw Less <<
NCT01821053 - Completed - Denmark ... More >> Gynelogical Obstetrical Department Skejby, Aarhus N, Denmark, 8200 Less <<
NCT03260881 Type2 Diabetes ... More >> Coronary Artery Disease Less << Phase 4 Recruiting June 30, 2020 United States, Florida ... More >> University of Miami Recruiting Miami, Florida, United States, 33136 Contact: Gianluca Iacobellis, MD PhD    305-243-3636    giacobellis@med.miami.edu    Principal Investigator: Gianluca Iacobellis, MD PhD          University of Miami Recruiting Miami, Florida, United States, 33136 Contact: Gianluca Iacobellis, MD, PhD    305-243-3636    giacobellis@med.miami.edu Less <<
NCT01847092 Chronic Kidney Disease ... More >> Type 2 Diabetes Mellitus Less << Phase 2 Completed - United States, Colorado ... More >> Creekside Endocrine Associates PC Denver, Colorado, United States, 80209 Less <<
NCT01838122 - Unknown November 2013 India ... More >> Southern Cross Fertility Centre Mumbai, Maharashtra, India, 400025 Less <<
NCT01807221 Heart Failure Phase 2 Completed - -
NCT01846377 Obesity Type ... More >>2 Diabetes Less << Not Applicable Completed - United States, Texas ... More >> Children's Nutrition Research Center, Baylor College of Medicine Houston, Texas, United States, 77030 Less <<
NCT01823510 - Completed - -
NCT01823510 Type-2 Diabetes Mellitus ... More >> Coronary Artery Disease Less << Phase 4 Completed - United States, New York ... More >> Icahn School of Medicine at Mount Sinai New York, New York, United States, 10029 Less <<
NCT03330301 - Completed - Denmark ... More >> Parker Institute Frederiksberg, Denmark, 2000 Less <<
NCT01852214 - Completed - -
NCT02046837 Prostate Cancer Phase 2 Completed - Canada, Alberta ... More >> University of Calgary/Tom Baker Cancer Centre Calgary, Alberta, Canada, T2N 1N4 Canada, Ontario Princess Margaret Cancer Centre Toronto, Ontario, Canada, M5T 2M9 Less <<
NCT01852214 Diabetes Mellitus ... More >> Coronary Artery Disease Less << Not Applicable Completed - United States, Florida ... More >> University of Florida Jacksonville, Florida, United States, 32209 Less <<
NCT01859793 Diabetes Athe... More >>rosclerosis Less << Phase 4 Completed - United States, Wisconsin ... More >> Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 Less <<
NCT01859793 - Completed - -
NCT01870934 - Unknown November 2013 Denmark ... More >> Odense University Hospital Recruiting Odense, Denmark, 5000 Contact: Benjamin Sc Rasmussen, M.D.       benjamin.rasmussen@ouh.regionsyddanmark.dk    Sub-Investigator: Knud Yderstræde, M.D, Phd. Less <<
NCT01857076 Obesity Type ... More >>2 Diabetes Mellitus Less << Not Applicable Completed - Brazil ... More >> Hospital Sírio Libanês Teaching and Research Center São Paulo, Brazil, 01308060 Less <<
NCT01875783 Diabetes Diab... More >>etic Macular Edema Diabetic Retinopathy Less << Not Applicable Completed - United States, Massachusetts ... More >> Joslin Diabetes Center Boston, Massachusetts, United States, 02215 OuterCape Health Services, Inc Wellfleet, Massachusetts, United States, 02667 United States, New York SUNY Upstate Medical University Syracuse, New York, United States, 13210 United States, Tennessee University of Endocrine Consultants Chattanooga, Tennessee, United States, 37411 Less <<
NCT01893242 Diabetes Mellitus Type 2, Kidn... More >>ey Disease, Chronic Less << Phase 3 Withdrawn January 2019 -
NCT01875783 - Completed - -
NCT01863914 End-stage Kidney Disease ... More >> Diabetes Mellitus Arteriovenous Fistula Less << Phase 2 Recruiting December 2018 Taiwan ... More >> National Cheng Kung University Hospital Recruiting Tainan, Taiwan, 704 Contact: Chen-Fuh Lam, MD, PhD    8866-2353535 ext 5348    lamcf@mail.ncku.edu.tw    Principal Investigator: Chen-Fuh Lam, MD, PhD          Sub-Investigator: Jun-Neng Roan, MD Less <<
NCT03401697 - Recruiting August 2021 United States, New York ... More >> Icahn School of Medicine at Mount Sinai Recruiting New York, New York, United States, 10029 Contact: Andrea D. Branch, PhD    212-659-8371    andrea.branch@mssm.edu    Principal Investigator: Andrea Branch Less <<
NCT03419767 Carotid Stenosis Phase 4 Recruiting June 1, 2018 China ... More >> Peking Union Medical College Hospital Recruiting Beijing, China, 100730 Contact: Changwei Liu, MD    69152500    liucw@vip.sina.com    Principal Investigator: Changwei Liu, MD Less <<
NCT01881828 Type 1 Diabetes Phase 3 Unknown December 2014 United States, Florida ... More >> Jaeb Center for Health Research Tampa, Florida, United States, 33647 Less <<
NCT01930136 Type 2 Diabetes ... More >> Obesity Less << Not Applicable Active, not recruiting September 2019 Italy ... More >> Clinical Research Center for Rare Diseases Ranica, Bergamo, Italy, 24020 Less <<
NCT01916148 - - - United States, Pennsylvania ... More >> Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 Principal Investigator: Lisa States, MD Less <<
NCT01895712 - Completed - Israel ... More >> Rambam medical Center Haifa, Israel, 31096 Carmel medical Center Haifa, Israel, 34362 Hadassah medical Center Jerusalem, Israel, 91120 Meir medical Center Kfar Saba, Israel, 44410 Rabin Medical Center Petah Tikva, Israel, 49104 Sheba medical Center Tel Hashomer, Israel, 52621 Less <<
NCT01935765 Type 1 Diabetes, Sleep Apnea S... More >>yndrome Less << Early Phase 1 Unknown September 2016 France ... More >> Véronique Viot-Blanc Recruiting Paris, Ile de France, France, 75010 Contact: Véronique Viot-Blanc, MD    +33 1 49 95 83 14    veronique.viot-blanc@lrb.aphp.fr    Principal Investigator: Véronique Viot-Blanc, MD Less <<
NCT01932671 - Unknown - Netherlands ... More >> UMC Utrecht Utrecht, Netherlands, 3508 GA Less <<
NCT01862237 Type II Diabetes Not Applicable Unknown January 2017 France ... More >> Hospices Civils de Lyon - Hôpital Louis Pradel Recruiting Lyon, France Contact: Hélène THIBAULT    4 72 35 73 32 ext +33    helene.thibault@chu-lyon.fr    Principal Investigator: Hélène THIBAULT Less <<
NCT01941290 - Completed - China ... More >> Queen Mary Hospital Hong Kong, China India KMC Manjpal Manial, Karnataka, India Fortis Hospitals-Bannerghatta Road Bangalore, India, KA 560076 Fortis Hospitals Bannerghatta Road Bangalore, India GKNM Hospital Coimbatore, India Divine Heart and Multi-Specialty Hospital Lucknow, India King George Medical University Lucknow, India Fortis Hospital Mohali, India Holy Family Hospital Mumbai, India BLK Super Speciality Hospital New Delhi, India Dharma Vira Heart Centre, Sir Ganga Ram Hospital New Delhi, India Fortis Escort Heart Institute New Delhi, India Ruby Hall Clinic Pune, India Malaysia Institut Jantung Negara Kuala Lumpur, Malaysia Sri Lanka Lanka Hospital Colombo, Sri Lanka National Hospital of Sri Lanka Colombo, Sri Lanka Sri Jaiewardenepura General Hospital Colombo, Sri Lanka Vietnam Bach Mai Hospital Hanoi, Vietnam Cho Ray Hospital Ho Chi Minh City, Vietnam Less <<
NCT01940614 - Completed - Switzerland ... More >> Univerisity Hospital Basel Basel, Basel-Stadt, Switzerland, 4031 Less <<
NCT01932476 Type 1 Diabetes ... More >> Celiac Disease Less << Not Applicable Completed - United States, Massachusetts ... More >> Joslin Diabetes Center Boston, Massachusetts, United States, 02215 Less <<
NCT01946997 - Completed - -
NCT01947036 - Terminated(Lack of enrollment.... More >>) Less << - United States, Connecticut ... More >> Yale University New Haven, Connecticut, United States, 06511 United States, Georgia Emory University Atlanta, Georgia, United States, 30322 United States, New York Feinstein Institute for Medical Research Manhasset, New York, United States, 11030 University of Rochester Rochester, New York, United States, 14642 United States, Oklahoma Oklahoma Medical Research Foundation Oklahoma City,, Oklahoma, United States, 73104 United States, Texas Baylor Institute of Immunology Research - Clinical Rheumatology Dallas, Texas, United States, 75204 Less <<
NCT01939366 Chronic Pain ... More >>Diabetic Neuropathies Diabetes Mellitus Less << Phase 2 Completed - -
NCT01973400 Diabetic Neuropathy ... More >> Cognitive Impairment Less << Phase 3 Completed - Malaysia ... More >> Seberang Jaya Hospital Seberang Jaya, Penang, Malaysia, 13700 Less <<
NCT03525171 Growth Hormone Deficiency Not Applicable Completed - Italy ... More >> Endocrinology - University of Palermo Palermo, Italy, 90127 Less <<
NCT01941719 Diabetes Mellitus ... More >> Diabetic Neuropathies Foot Complications Less << Not Applicable Suspended(Analysis of 99 subje... More >>cts showed no significant benefits of the novel diabetic foot education.) Less << - United States, Pennsylvania ... More >> Gait Study Center; Temple University School of Podiatric Medicine Philadelphia, Pennsylvania, United States, 19107 Less <<
NCT01983813 Diabetes Mellitus ... More >> Hypertension Coronary Artery Disease Atrial Fibrillation Stroke Less << Not Applicable Completed - United States, Iowa ... More >> Akron Mercy Medical Clinic Akron, Iowa, United States, 51001-0200 Iowa Specialty Hospitals - Belmond Clinic Belmond, Iowa, United States, 50421 Employee Health Clinic, Mercy Cedar Rapids Cedar Rapids, Iowa, United States, 52403 Iowa Speciality Hospitals - Clarion Clinic Clarion, Iowa, United States, 50525 Great River Medical Group Davenport, Iowa, United States, 52897 Des Moines University Family Medicine Clinic Des Moines, Iowa, United States, 50312 Grinnell Regional Family Practice Grinnell, Iowa, United States, 50112-1833 Knoxville Hospital Clinic Knoxville, Iowa, United States, 50138 Newton Clinic, P.C. Newton, Iowa, United States, 50208-3137 UI Health Care-River Crossing Riverside, Iowa, United States, 52327 Siouxland Community Health Center Sioux City, Iowa, United States, 511105 Burlington Area Family Practice Center West Burlington, Iowa, United States, 52655-1645 Less <<
NCT01989754 Diabetes Mellitus, Type 2 ... More >> Albuminuria Less << Phase 4 Completed - -
NCT01989988 Diabetes Mellitus Type 2 in Ob... More >>ese Less << Not Applicable Unknown December 2015 Taiwan ... More >> Min-Sheng General Hospital Taoyuan City, Taiwan, 330 Less <<
NCT01955694 Heart Failure Phase 2 Completed - Japan ... More >> Seto, Aichi, Japan, 489-8642 Toyota, Aichi, Japan, 471-8513 Funabashi, Chiba, Japan, 273-8588 Kamogawa, Chiba, Japan, 296-0041 Kamogawa, Chiba, Japan, 296-8602 Matsuyama, Ehime, Japan, 790-0067 Chikushino, Fukuoka, Japan, 818-8516 Amagasaki, Hyogo, Japan, 660-8550 Kobe, Hyogo, Japan, 650-0047 Kobe, Hyogo, Japan, 654-0155 Higashiibaraki, Ibaraki, Japan, 311-3193 Hiratsuka, Kanagawa, Japan, 254-8502 Kawasaki, Kanagawa, Japan, 211-8533 Yokohama, Kanagawa, Japan, 245-8575 Uji, Kyoto, Japan, 611-0041 Sendai, Miyagi, Japan, 983-8520 Naha, Okinawa, Japan, 900-0005 Naha, Okinawa, Japan, 902-8511 Urasoe, Okinawa, Japan, 901-2132 Sayama, Saitama, Japan, 350-1305 Sayama, Saitama, Japan, 350-1323 Kusatsu, Shiga, Japan, 525-8585 Shinjuku-ku, Tokyo, Japan, 162-8655 Shinjuku-ku, Tokyo, Japan, 162-8666 Kofu, Yamanashi, Japan, 400-8506 Fukuoka, Japan, 810-0001 Kagoshima, Japan, 892-0853 Kyoto, Japan, 607-8062 Okayama, Japan, 700-8607 Osaka, Japan, 558-8558 Shizuoka, Japan, 420-8630 Less <<
NCT02019446 Diabetes Mellitus, Type 2 ... More >> Onychomycosis Less << Not Applicable Not yet recruiting December 2021 Canada, British Columbia ... More >> Diamond Centre Not yet recruiting Vancouver, British Columbia, Canada, V5Z 1M9 Contact: Thomas G Elliott, MBBS    (604) 875-5900    info@bcdiabetes.ca    Principal Investigator: Thomas G Elliott, MBBS Less <<
NCT01970566 Obesity Diabe... More >>tes Mellitus Less << Not Applicable Withdrawn(The project was not ... More >>announced to the field and it was not funded.) Less << November 2017 United States, Illinois ... More >> Captain James A. Lovell Federal Health Care Center, North Chicago, IL North Chicago, Illinois, United States, 60064 Less <<
NCT01989754 - Completed - -
NCT02009527 Coronary Artery Disease ... More >> Type 2 Diabetes Mellitus Less << Phase 1 Completed - Sweden ... More >> Karolinska Institutet Stockholm, Sweden, 17176 Less <<
NCT02021604 Congenital Hyperinsulinism ... More >> Insulinoma Less << Phase 1 Recruiting June 2028 United States, Texas ... More >> Cook Children's Medical Center Recruiting Fort Worth, Texas, United States, 76104 Principal Investigator: Paul Thornton, MD Less <<
NCT02015988 Acute Coronary Syndrome ... More >> Diabetes Mellitus, Type 2 Hypertriglyceridemia Less << Phase 4 Unknown May 2017 Ukraine ... More >> State Institution "Dnipropetrovsk Medical Academy of Health Ministry of Ukraine" Dnipropetrovsk, Ukraine Less <<
NCT01991093 - Completed - Greece ... More >> Laboratory of Haematology & Blood Bank Unit, "Attiko" University General Hospital Medical School, National & Kapodistrian University of Athens, Athens, Greece, 12462, 2nd Cardiology Department, University of Athens, Attikon Hospital, Haidari, Athens, Greece, 12462 Attikon University Hospital Athens, Haidari, Greece Less <<
NCT03580967 Type2 Diabetes ... More >> Major Depressive Disorder Less << Phase 4 Not yet recruiting August 1, 2023 United States, Illinois ... More >> Loyola University Medical Center Not yet recruiting Maywood, Illinois, United States, 60153 Contact: Todd Doyle, PhD    708-216-4303    todddoyle1@lumc.edu Less <<
NCT02020850 - Unknown December 2014 Canada, British Columbia ... More >> Vancouver General Hospital (VGH) - Gordon and Leslie Diamond Health Care Centre Recruiting Vancouver, British Columbia, Canada, V5Z 1M9 Contact: York N Hsiang, MB FRCSC    604 876 5882    York.Hsiang@vch.ca    Contact: Whitney Quong    604 809 7293    wquong@alumni.ubc.ca    Principal Investigator: York N Hsiang, MB FRCSC Less <<
NCT03594240 Plasma Homocysteine ... More >> HbA1c Level Less << Phase 3 Completed - Egypt ... More >> Nancy Elbarbary Cairo, Egypt, 11361 Less <<
NCT02021890 Diabetes Obes... More >>ity Less << Not Applicable Completed - Italy ... More >> Unit of Endocrinology and Diabetology, General Hospital Gavardo, Brescia, Italy, 25085 Unit of Metabolic Diseases and Clinical Dietetics, "Alma Mater Studiorum" University Bologna, Italy, 40138 Less <<
NCT02035566 Heart Failure ... More >> Pulmonary Disease, Chronic Obstructive Hypertension Diabetes Mellitus Less << Not Applicable Completed - United States, Maryland ... More >> Chesapeake-Potomac Home Health Agency Hughesville, Maryland, United States, 20637 Garrett County Health Department Home Health Agency Oakland, Maryland, United States, 21550 Less <<
NCT02041832 Arterial Hypertension ... More >> Diabetes Mellitus Less << Not Applicable Completed - Denmark ... More >> Haderslev Hospital Haderslev, Denmark, 6100 Less <<
NCT03602378 - Enrolling by invitation May 2, 2019 Croatia ... More >> Ivana Kolcic Split, Croatia, 23000 Less <<
NCT02031081 Gastroparesis ... More >> Diabetes Mellitus Less << Phase 2 Phase 3 Completed - Canada, Alberta ... More >> University of Calgary Calgary, Alberta, Canada, T2N 4Z6 Less <<
NCT02050399 Coronary Artery Disease ... More >> Diabetes Mellitus, Type 2 Less << Not Applicable Completed - Brazil ... More >> Universidade Federal de São Carlos São Carlos, São Paulo, Brazil, 13565-905 Less <<
NCT02059005 Drug Use Alco... More >>hol Use Congestive Heart Failure Pneumonia Acute Myocardial Infarction Diabetes Mellitus Chronic Obstructive Pulmonary Disease End-Stage Renal Disease Less << Not Applicable Completed - United States, Pennsylvania ... More >> Temple University Hospital Philadelphia, Pennsylvania, United States, 19140 Less <<
NCT02059005 - Completed - -
NCT02060357 Coronary Artery Disease ... More >> Diabetes Less << Not Applicable Completed - United Kingdom ... More >> London Chest Hospital, Barts Health NHS Trust London, United Kingdom, E2 9JX Less <<
NCT02062034 Non-proliferative Diabetic Ret... More >>inopathy Diabetes Mellitus Type 2 Less << Phase 2 Completed - Mexico ... More >> Cardiovascular Research Unit, University of Guadalajara Guadalajara, Jalisco, Mexico, 44340 Less <<
NCT02063321 - Unknown December 2015 -
NCT02077218 Cancer Survivor ... More >> Diabetes Mellitus Hypertension Less << Not Applicable Completed - United States, California ... More >> City of Hope Medical Center Duarte, California, United States, 91010 Less <<
NCT02058641 Atherosclerosis Phase 1 Completed - United Kingdom ... More >> GSK Investigational Site Cambridge, United Kingdom, CB2 0GG Less <<
NCT02102958 Diabetes Visu... More >>al Impairment Less << Not Applicable Completed - United States, Ohio ... More >> Case Western Reserve University Cleveland, Ohio, United States, 44106 Less <<
NCT02070926 - Completed - Korea, Republic of ... More >> Seoul St. Mary's Hospital Seoul, Korea, Republic of, 137-701 Less <<
NCT02114554 - Unknown January 2015 Taiwan ... More >> National Taiwan University Hospital Recruiting Taipei, Taiwan, 100 Contact: Han-Chung Hsiue, MD    886-23123456 ext 66064    hanchunghsiue@gmail.com    Principal Investigator: Pei-Lin Lee, MD, PhD          Sub-Investigator: Ni-Chung Lee, MD, PhD Less <<
NCT02054650 Chronic Low Back Pain ... More >> Type 2 Diabetes Mellitus Less << Not Applicable Terminated(Scheduling and recr... More >>uitment difficulties) Less << - United States, Texas ... More >> University of North Texas Health Science Center Fort Worth, Texas, United States, 76107 Less <<
NCT02220036 Diabetes Not Applicable Unknown October 2014 Iran, Islamic Republic of ... More >> Isfahan University of Medical Sciences Not yet recruiting Isfahan, Iran, Islamic Republic of Contact: Ahmad Esmaeizadeh, Professor    3117922776 ext 0098    esmaillzadeh@hlth.mui.ac.ir    Principal Investigator: Ahmad Esmaeilzadeh, professor Less <<
NCT01099865 - Completed - Korea, Republic of ... More >> Korea University Guro Hospital Dept. of Endocrinology Seoul, Korea, Republic of Less <<
NCT01101269 Type 2 Diabetes Not Applicable Terminated(Slow Recruitment) - United States, Virginia ... More >> University of Virginia Health System Charlottesville, Virginia, United States, 22908 Less <<
NCT01130727 Diabetes Mellitus ... More >> Diabetic Nephropathy Arterial Hypertension Less << Not Applicable Completed - Brazil ... More >> University Hospital Campinas, Sao Paulo, Brazil, 13084-971 Less <<
NCT01113216 - Recruiting April 2020 United States, Illinois ... More >> Children's Memorial Hospital Not yet recruiting Chicago, Illinois, United States Contact: Susanna McColley, MD       smccolley@northwestern.edu    United States, Maryland Johns Hopkins Medicine Recruiting Baltimore, Maryland, United States, 21287 Contact: Scott M Blackman, MD, PhD    410-955-6463    sblackman@jhmi.edu    Contact: Karen S Raraigh, MS    410-502-7124    kraraigh@jhmi.edu    United States, Minnesota University of Minnesota Not yet recruiting Minneapolis, Minnesota, United States Contact: Antoinette Moran, MD       moran001@tc.uminn.edu Less <<
NCT01117831 - Completed - -
NCT01136512 - Completed - United States, New York ... More >> Staten Island University Hospital Staten Island, New York, United States, 10305 Less <<
NCT01107132 - Unknown - Israel ... More >> Soroka University Medical Center Not yet recruiting Beer-Sheva, Israel Contact: Hadar Shalev, M.D       shalev@bgu.ac.il    Principal Investigator: Hadar Shalev, M.D Less <<
NCT01145599 - Completed - Portugal ... More >> Centre for Clinical Trials- AIBILI - Association for Innovation and Biomedical Research on Light and Image Coimbra, Portugal, 3030-548 Less <<
NCT02290184 Insulin Resistance, ... More >> Metabolic Syndrome Type 2 Diabetes Less << Not Applicable Unknown October 2016 United States, California ... More >> San Francisco / Daly City Communities San Francisco, California, United States, 94115 Less <<
NCT02111967 - Completed - Switzerland ... More >> Pharmaceutical Care Research Group Basel, Switzerland, 4056 Less <<
NCT02321904 - Active, not recruiting December 2018 Canada, Alberta ... More >> Alberta Children's Hospital Calgary, Alberta, Canada, T2M 1V5 Less <<
NCT01171976 Diabetic Macular Edema Phase 3 Completed - -
NCT01146314 Pediatric Obesity ... More >> Type 2 Diabetes Metabolic Syndrome Less << Not Applicable Completed - United States, Florida ... More >> Nemours Children's Clinic Jacksonville, Florida, United States, 32207 Less <<
NCT01172977 - Completed - Germany ... More >> Evangelisches Krankenhaus Bielefeld, Germany, 33167 Less <<
NCT01173939 Hypercholesterolemia ... More >> Type 2 Diabetes Hypertension Less << Not Applicable Terminated(With recommendation... More >> from IDMC, Steering Committee terminated this trial due to ethical concerns raised by J-ART study.) Less << - -
NCT01192659 - Completed - -
NCT01190904 - Completed - United States, New Jersey ... More >> Hudson Heart Group Guttenberg, New Jersey, United States, 07093 United States, New York Elmhurst Hospital Elmhurst, New York, United States, 11373 Winthorp University Hospital Mineola, New York, United States, 11501 Icahn School of Medicine at Mount Sinai New York, New York, United States, 10029 Stony Brook University Hospital Stony Brook, New York, United States, 11794 Less <<
NCT01171976 - Completed - -
NCT01201785 - Completed - -
NCT02917772 Carcinoma, Renal Cell ... More >> Clear-cell Metastatic Renal Cell Carcinoma Less << Phase 2 Recruiting July 2021 -
NCT02347709 - Unknown December 2017 United States, New York ... More >> Winthrop University Hospital Recruiting Mineola, New York, United States, 11501 Contact: Julie DiGregorio, CCRP    516-663-9614    jdigregorio@winthrop.org    Principal Investigator: Mark Stecker, MD, PhD          Sub-Investigator: Harold Brem, MD          Sub-Investigator: Scott Gorenstein, MD          Sub-Investigator: Julie DiGregorio, CCRP Less <<
NCT01201785 Type 2 Diabetes Mellitus ... More >> Coronary Artery Disease Less << Phase 4 Completed - United States, Florida ... More >> University of Florida Jacksonville, Florida, United States, 32209 Less <<
NCT01208948 Diabetes Mellitus ... More >> Macular Edema Less << Phase 3 Completed - Germany ... More >> Department of Ophthalmology Munich, Germany, 80336 Less <<
NCT01206582 - Completed - -
NCT01179555 Diabetic Retinopathy ... More >> Diabetes Mellitus, Type 2 Glaucoma Less << Not Applicable Completed - United States, Pennsylvania ... More >> Thomas Jefferson University Philadelphia, Pennsylvania, United States, 19107 Wills Eye Health System Philadelphia, Pennsylvania, United States, 19107 Temple University Philadelphia, Pennsylvania, United States, 19140 Less <<
NCT01213212 Diabetes Mellitus Phase 2 Completed - Italy ... More >> Clinical Research Center for Rare Diseases Ranica, Bergamo, Italy, 24020 Less <<
NCT01230034 Hypertension ... More >>Type 2 Diabetes Mellitus Microalbuminuria Less << Phase 3 Unknown July 2011 Italy ... More >> University of Pavia Recruiting Pavia, Italy, 27100 Contact: Giuseppe Derosa, MD    +39 0382 526217    giuseppe.derosa@unipv.it    Sub-Investigator: Giuseppe Derosa, MD Less <<
NCT01250340 Type 2 Diabetes Mellitus Phase 4 Unknown December 2012 Italy ... More >> Sapienza Università di Roma Recruiting Rome, Italy, 00161 Contact: Francesco Violi, Full Prof    +39-06-4461933    francesco.violi@uniroma1.it    Contact: Stefania Basili, Ass Prof    +39-06-49974678    stefania.basili@uniroma1.it    Principal Investigator: Francesco Violi, full Prof Less <<
NCT01206582 Gastroparesis ... More >> Diabetes Mellitus Less << Phase 2 Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55901 Less <<
NCT01254552 Type 2 Diabetes Mellitus ... More >> Coronary Atherosclerosis Less << Phase 4 Active, not recruiting April 2018 Korea, Republic of ... More >> AMC Seoul, Korea, Republic of Less <<
NCT01238484 Ankle Equinus ... More >> Ankle Contracture Diabetes Mellitus Less << Not Applicable Terminated(Centers could not m... More >>eet enrollment goals) Less << - United States, Georgia ... More >> Atlanta Foot and Leg Clinic Jonesboro, Georgia, United States, 30236 United States, Texas Lopez Ankle and Foot Fort Worth, Texas, United States, 76164 Less <<
NCT01279161 - Completed - Poland ... More >> Department of Pediatrics, Endocrinology and Diabetology, Medical University Wrocław, Dolnośląskie, Poland, 50-376 Department of Pediatrics, Medical University Warsaw, Mazowieckie, Poland, 01-184 Department of Pediatrics, Endocrinology, Diabetology with Cardiology Division, Medical University Bialystok, Podlaskie, Poland, 15-089 Department of Pediatrics, Hematology, Oncology and Endocrinology, Medical University Gdańsk, Pomorskie, Poland, 80-211 Department of Pediatrics, Oncology, Hematology and Diabetology, Medical University Łódź, Łódzkie, Poland, 91-738 Department of Pediatrics, Endocrinology and Diabetology, Medical University Katowice, Śląskie, Poland, 40-752 Less <<
NCT01235260 - Completed - -
NCT01264263 - Completed - Korea, Republic of ... More >> Research Site Anyang, Korea, Republic of Research Site Koyang, Korea, Republic of Research Site Seoul, Korea, Republic of Less <<
NCT01286090 Gastroparesis ... More >> Diabetes Mellitus Less << Phase 4 Terminated(Sponsor request) - -
NCT01293461 Type 1 Diabetes ... More >> Diabetes Mellitus Peripheral Diabetic Neuropathy Less << Phase 1 Phase 2 Completed - United States, California ... More >> Escondido, California, United States Tustin, California, United States Walnut Creek, California, United States United States, Colorado Aurora, Colorado, United States United States, Montana Butte, Montana, United States United States, Texas San Antonio, Texas, United States United States, Washington Olympia, Washington, United States Renton, Washington, United States Less <<
NCT01281098 High Risk Proliferative Diabet... More >>ic Retinopathy Diabetes Mellitus Type I Diabetes Mellitus Type II Less << Phase 2 Completed - Portugal ... More >> Center for Clinical Trials - Aibili Coimbra, Portugal, 3000-548 Less <<
NCT01295073 Macular Edema Following Catara... More >>ct Surgery Less << Phase 2 Withdrawn(appropriate study me... More >>dication supply could not be identified) Less << - Canada, British Columbia ... More >> Univeristy of British Columbia/Vancouver Coastal Health Authority - Eye Care Center Vancouver, British Columbia, Canada Less <<
NCT01299246 Diabetic Foot ... More >> Type 2 Diabetes Mellitus With Established Diabetic Nephropathy Less << Phase 1 Phase 2 Unknown July 2013 Taiwan ... More >> Graduate Institute of Nursing, Chang Gung Institute of Technology, Chiayi Campus Chiayi, Taiwan, 61363 Less <<
NCT01281228 Diabetes Mellitus ... More >> Diabetes Mellitus, Type 2 Obesity Less << Not Applicable Completed - Netherlands ... More >> VU University Medical Center Amsterdam, De Boelelaan 1117, Netherlands, 1007MB Less <<
NCT01331681 Diabetes Mellitus ... More >> Macular Edema Less << Phase 3 Completed - -
NCT01323348 Diabetes Diab... More >>etic Retinopathy Less << Phase 3 Completed - -
NCT01279928 - Completed - Australia, New South Wales ... More >> John Hunter Children's Hospital New Lambton, New South Wales, Australia, 2305 Less <<
NCT01334203 Angina Pectoris ... More >> Coronary Artery Disease Type 2 Diabetes Mellitus Less << Phase 4 Withdrawn December 2012 -
NCT01320345 Type 1 Diabetes Mellitus ... More >> Retinopathy Diabetic Nephropathy Less << Phase 3 Unknown September 2014 United States, Oklahoma ... More >> Oklahoma University Health Sciences Center Not yet recruiting Oklahoma City, Oklahoma, United States, 73104 Contact: Alicia Jenkins, Professor       alicia-jenkins@ouhsc.edu    Principal Investigator: Alicia Jenkins, Professor          Principal Investigator: Timothy Lyons, Dr          Australia, New South Wales NHMRC Clinical Trials Centre Not yet recruiting Camperdown, New South Wales, Australia, 2050 Contact: Anthony Keech, Professor       tony@ctc.usyd.edu.au    Principal Investigator: Anthony Keech, Professor          Royal Prince Alfred Hospital Not yet recruiting Camperdown, New South Wales, Australia, 2050 Contact: Stephen Twigg, Professor       stephen.twigg@sydney.edu.au    Principal Investigator: Stephen Twigg, Professor          Westmead Children's Hospital Not yet recruiting Westmead, New South Wales, Australia, 2145 Contact: Kim Donaghue, Professor       kimd@chw.edu.au    Principal Investigator: Kim Donaghue, Professor          Australia, Victoria Royal Melbourne Hospital Not yet recruiting Melbourne, Victoria, Australia, 3050 Contact: Peter Colman, Professor       peter.colman@mh.org.au    Principal Investigator: Peter Colman, Professor          St Vincents Hospital Melbourne, Victoria, Australia, 3065 Less <<
NCT01370837 Diabetes Mellitus ... More >> Polyneuropathies Arthropathy, Neurogenic Less << Not Applicable Completed - Netherlands ... More >> Maastricht University Medical Center Maastricht, Limburg, Netherlands, 6202 AZ Less <<
NCT01370837 - Completed - -
NCT01316484 - Completed - United States, Kansas ... More >> University of Kansas Medical Center Kansas City, Kansas, United States, 66160 United States, North Carolina Wake Forest University Health Sciences Winston-Salem, North Carolina, United States, 27517 United States, Pennsylvania Temple University Health Sciences Center Philadelphia, Pennsylvania, United States, 19140 United States, Texas Texas Tech University Health Sciences Center El Paso, Texas, United States, 79905 Less <<
NCT01331681 - Completed - -
NCT01371955 - Completed - France ... More >> University Hospital of Grenoble Grenoble, France, 38043 Less <<
NCT01354262 Diabetes Mellitus ... More >> Vitamin D Deficiency Less << Phase 2 Completed - United States, Michigan ... More >> Genesys East Flint Campus Clinic Flint, Michigan, United States, 48503 Less <<
NCT01394055 Diabetes Mellitus Type 1 and 2... More >> Diabetes Mellitus Complications Gastroparesis Gastrointestinal Motility Disorder Less << Phase 1 Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT02582736 - Completed - Canada, Ontario ... More >> Women's College Hospital, Women's College Research Institute Toronto, Ontario, Canada, M5G 1N8 Less <<
NCT01383304 - Unknown January 2017 Denmark ... More >> Department of Clinical Biochemistry, Aarhus University Hospital, Skejby Aarhus N, Denmark, 8200 Less <<
NCT01404078 Ischemic Heart Disease ... More >> Ischemic Stroke Peripheral Vascular Disease Type 2 Diabetes Mellitus Less << Not Applicable Completed - -
NCT01422057 - Unknown January 2016 Germany ... More >> Department of Cardiology Recruiting Tübingen, Germany, 72076 Contact: Christine Zürn, MD    +49 7071 29 83153    christine.zuern@med.uni-tuebingen.de    Principal Investigator: Axel Bauer, MD Less <<
NCT01393873 - Terminated(Investigator has mo... More >>ved to other state.) Less << - United States, New York ... More >> NYU SOM New York, New York, United States, 10016 Less <<
NCT01404078 - Completed - -
NCT02700048 Hypoglycemia Unawareness ... More >> Type 1 Diabetes Less << Phase 1 Phase 2 Active, not recruiting December 2019 United States, Minnesota ... More >> Clinical and Translational Science Institute, University of Minnesota Minneapolis, Minnesota, United States, 55446 Less <<
NCT01440257 Diabetic Nephropathy ... More >> Type 2 Diabetes Mellitus Less << Phase 2 Completed - Netherlands ... More >> Centre for Human Drug Research Leiden, Netherlands Less <<
NCT01425359 Angina Pectoris ... More >> Coronary Artery Disease Type 2 Diabetes Mellitus Less << Phase 4 Completed - -
NCT02699983 Cancer Survivor ... More >> Invasive Breast Carcinoma Stage IA Breast Cancer Stage IB Breast Cancer Stage IIA Breast Cancer Stage IIB Breast Cancer Stage IIIA Breast Cancer Stage IIIB Breast Cancer Stage IIIC Breast Cancer Less << Not Applicable Recruiting May 2019 United States, New Jersey ... More >> Rutgers Cancer Institute of New Jersey Recruiting New Brunswick, New Jersey, United States, 08903 Contact: Jeanne Ferrante    732-743-3222       Principal Investigator: Jeanne Ferrante Less <<
NCT01448174 Renal Failure Chronic Requirin... More >>g Hemodialysis Metabolic Syndrome Diabetes Mellitus Type 2 Hyperlipidemia Less << Phase 4 Completed - Poland ... More >> BBraun Avitum Dialysis Center Nowy Tomyśl, Wielkopolska, Poland, 64-300 Less <<
NCT01446705 - Completed - -
NCT02747680 Type 1 Diabetes ... More >> Healthy Hypoglycemia Unawareness Less << Not Applicable Recruiting December 2018 United States, Minnesota ... More >> University of Minnesota Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Anjali Kumar, PA-C    612-624-0470    kumar045@umn.edu    Principal Investigator: Elizabeth Seaquist, MD          Sub-Investigator: Silvia Mangia, PhD Less <<
NCT01446705 - Completed - United States, Indiana ... More >> Richard L. Roudebush VA Medical Center, Indianapolis, IN Indianapolis, Indiana, United States, 46202-2884 Less <<
NCT01452815 Gastroparesis ... More >> Diabetes Mellitus, Type 1 Diabetes Mellitus, Type 2 Less << Phase 2 Completed - -
NCT01471275 Type 2 Diabetes Mellitus ;Obes... More >>ity,High Triglycerides；TCM Less << Not Applicable Unknown December 2013 China, Beijing ... More >> Guang'anmen Hospital of China Academy ofChinese Medical Sciences Recruiting Beijing, Beijing, China Contact: Zhou Qiang, doctor    15101016416    15101016416@126.com    Principal Investigator: Tong Xianlin, professor          Sub-Investigator: Lian Fengmei, professor          Sub-Investigator: Zhou Qiang, doctor          China, Hebei Baoding Hospital of TCM Recruiting Baoding, Hebei, China Contact: Li Liping       lilipingm@163.com    Principal Investigator: Li Liping, professor          China, Jilin Affiliated Hospital of Changchun University of TCM Recruiting Changchun, Jilin, China Contact: Piao Chunli, professor       piaochunli981027@yahoo.com.cn    Principal Investigator: Piao Chunli, professor          Sub-Investigator: Wang Yanyan          China, Qinghai Qinghai Provence Hospital of TCM Recruiting Xining, Qinghai, China Contact: Pu Weirong       puweirong123@163.com    Principal Investigator: Ba Zhuoma, professor          Sub-Investigator: Pu Weirong          China, Tianjin Tianjin Dagang Hospital Recruiting Dagang, Tianjin, China Contact: Jin Chuan       58023442@qq.com    Principal Investigator: Guo Hailong          Sub-Investigator: Jin Chuan          Tianjin University of Traditional Chinese Medicine, First Affiliated Hospital Recruiting Tianjin, Tianjin, China Contact: Wu Shentao, professor    13752262891    wushentao@yahoo.com.cn    Principal Investigator: Wu Shentao, professor          Sub-Investigator: Wang Bin, doctor          China, Yichang Yichang City Yiling Hospital Recruiting Yichang, Yichang, China Contact: Yang Xingzhong       clcy0401@163.com    Principal Investigator: Yang Xingzhong          China, Zhejiang Hangzhou Hospital of TCM Recruiting Hangzhou, Zhejiang, China Contact: Hong Yuzhi, professor       hyzhcy@yahoo.cn    Principal Investigator: Hong Yuzhi, professor          Sub-Investigator: Wei Yan Less <<
NCT01425359 - Completed - -
NCT02763423 Ketoacidosis, Diabetic Phase 2 Recruiting December 2019 China, Jiangsu ... More >> The affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School Recruiting Nanjing, Jiangsu, China, 210008 Contact: Dalong Zhu, MD.PhD.    86-25-83106666 ext 61430    zhudalong@nju.edu.cn    Contact: Jing Lu, PhD.    86-25-83106666 ext 61431    qiusnow16@hotmail.com Less <<
NCT01468519 Diabetes Mellitus, Type 2 ... More >> Erectile Dysfunction Less << Phase 4 Completed - India ... More >> Jothydev's Diabetes & Research Center Thiruvananthapuram, Kerala, India, 695032 Less <<
NCT01477476 Type I Diabetes Phase 2 Terminated(funding loss and on... More >>ly one subject enrolled) Less << - United States, Colorado ... More >> Childrens Hospital Colorado Aurora, Colorado, United States, 80045 University of Colorado, Anschutz Medical Campus Aurora, Colorado, United States, 80045 Less <<
NCT01474473 Foot Ulcer Di... More >>abetes Mellitus Diabetic Neuropathy Less << Not Applicable Completed - France ... More >> Pitié-Salpêtrière Hospital Paris, France, 75013 Less <<
NCT02766803 PCOS, Insulin Resistance Phase 4 Unknown June 2018 Poland ... More >> Division of Infertility and Reproductive Endocrinology, Department of Gynecology and Obsterics Recruiting Poznan, Poland, 60-184 Contact: Beata Banaszewska, Md Ph D    +48618419412    bbeata48@gmail.com    Contact: Robert Z Spaczynski, Md PhD Prof    +48618419412    rspaczynski@yahoo.com    Principal Investigator: Leszek A Pawelczyk, MD PhD Prof          Sub-Investigator: Antoni J Duleba, MD Prof Less <<
NCT01480297 - Completed - -
NCT01480297 Peripheral Neuropathy ... More >> Type 1 Diabetes Less << Phase 2 Completed - United States, Michigan ... More >> University of Michigan Ann Arbor, Michigan, United States, 48109 Less <<
NCT01518205 Foot Ulcers A... More >>rteriosclerosis Obliterans Diabetes Mellitus Less << Not Applicable Completed - Italy ... More >> universita Verona Verona, Italy, 37100 Less <<
NCT01515228 Coronary Artery Disease Phase 4 Completed - Korea, Republic of ... More >> Soon Chun Hyang University Hospital Cheonan Cheonan, Korea, Republic of Daegu Catholic University Medical Center Daegu, Korea, Republic of Keimyung University Dongsan Medical Center Daegu, Korea, Republic of Chungnam National University Hospital Daejeon, Korea, Republic of The Catholic University of Korea, Daejeon ST. Mary's Hospital Daejeon, Korea, Republic of Gangneung Asan Hospital Gangneung, Korea, Republic of Inje University Pusan Paik Hospital Pusan, Korea, Republic of Asan Medical Center Seoul, Korea, Republic of Ulsan University Hospital Ulsan, Korea, Republic of Less <<
NCT01528059 Gastric Cancer ... More >> Type 2 Diabetes Less << Phase 2 Phase 3 Unknown March 2013 China, Fujian ... More >> DongFang Hospital Recruiting Fuzhou, Fujian, China, 350025 Contact: Yu Wang, M.D    13805019453    flyfishwang@hotmail.com    Contact: ZhongDong Zhou, M.D    13705038043    fzptwk@21cn.com    Principal Investigator: Yu Wang, M.D Less <<
NCT01511393 - Enrolling by invitation December 2035 United States, West Virginia ... More >> United BioSource Corporation Morgantown, West Virginia, United States, 26505-8065 Less <<
NCT01531114 ST-Elevation Myocardial Infarc... More >>tion Less << Phase 3 Completed - Italy ... More >> Dept.of Cardiovascular Sciences,Policlinico Umberto I Rome, Italy, 00161 Less <<
NCT01534299 - Recruiting March 2022 Germany ... More >> Universitätsklinikum des Saarlandes Recruiting Homburg, Saarlandes, Germany, D-66421 Contact: Michael Böhm, MD    (+49) 6841-1623372    michael.boehm@uniklinikum-saarland.de    Contact: Felix Mahfoud, MD    +49 6841 16 21346    felix.mahfoud@uniklinikum-saarland.de    Principal Investigator: Michael Böhm, MD Less <<
NCT01521910 Type 1 Diabetes Mellitus With ... More >>Diabetic Nephropathy Less << Not Applicable Completed - Denmark ... More >> Steno Diabetes Center Gentofte, Denmark, 2820 Less <<
NCT01545401 Type 2 Diabetes Mellitus ... More >> Hypertension (Without Type 2 Diabetes Mellitus) Less << Early Phase 1 Completed - Malaysia ... More >> Universiti Teknologi MARA Batu Caves, Selangor, Malaysia, 68100 Less <<
NCT02914886 Type 1 Diabetes ... More >> Lipoatrophy Less << Phase 4 Enrolling by invitation October 2019 -
NCT01533142 - Unknown - Norway ... More >> Helse-Fonna Recruiting Haugesund, Norway, 5528 Contact: Bjorn Gunnar Nedrebo, MD, PhD    +4792226845    bned@helse-fonna.no    Contact: Per Espen Hovde-Hansen, MD    +475273200       Principal Investigator: Bjorn Gunnar Nedrebo, MD, Phd Less <<
NCT01571297 Diabetes Mellitus ... More >> Diabetes Mellitus Complications Gastroparesis Less << Phase 2 Completed - -
NCT01512030 - Completed - Austria ... More >> Dep. of Pediatrics, Academic Teaching Hospital, Landeskrankenhaus Feldkirch Feldkirch, Austria, 6900 Less <<
NCT01586481 Diabetes Mellitus ... More >> Diabetic Neuropathic Foot Ulcer Less << Phase 3 Completed - France ... More >> Groupe hospitalier Pitié-Salpêtrière Paris, France, 75013 Less <<
NCT01597843 Hypertension ... More >>Hyperlipidemia Coronary Artery Disease Diabetes Mellitus Less << Not Applicable Completed - United States, Wisconsin ... More >> Clement J. Zablocki VA Medical Center, Milwaukee, WI Milwaukee, Wisconsin, United States, 53295-1000 Less <<
NCT02928250 Type 1 Diabetes ... More >> Oxidative Stress Carnosine Diabetic Nephropathy Less << Not Applicable Completed - -
NCT01599442 - Terminated(recrution number wa... More >>s not reached) Less << - Germany ... More >> Krankenhaus Dresden-Friedrichstadt Dresden, Sachse, Germany, 01076 Less <<
NCT01600690 Type 2 Diabetes Mellitus ... More >> Atherosclerosis Dyslipidemia Less << Phase 4 Completed - Italy ... More >> University Hospital Diabetes Outpatient Clinic Padova, Italy, 35100 Less <<
NCT01606930 Chronic Disease ... More >> Hypertension Hyperlipidemia Diabetes Mellitus Osteoarthritis COPD Cardiovascular Disease Less << Not Applicable Completed - United States, Maryland ... More >> Walter Reed National Medical Military Center (WRNMMC) Bethesda, Maryland, United States, 20889 Less <<
NCT01597843 - Completed - -
NCT01607190 - Completed - India ... More >> LV Prasad Eye Institute Hyderabad, Andhra Pradesh, India, 500 034 Portugal AIBILI- Association for Biomedical Research and Inovation on Light and Image. Coimbra, Portugal, 3000-548 Less <<
NCT01606475 - - - United States, Minnesota ... More >> University of Minnesota Minneapolis, Minnesota, United States, 55455 Contact: Jayne Pederson    612-624-8402    peder059@umn.edu    Principal Investigator: Bernhard J Hering, M.D.          Sub-Investigator: Melena Bellin, M.D. Less <<
NCT01608932 Multiple Chronic Diseases Amon... More >>g Diabetes Mellitus, Chronic Obstructive Pulmonary Diseases and Heart Failure Less << Not Applicable Completed - Italy ... More >> Local Health Authority of Pieve di Soligo Pieve di Soligo, Treviso, Italy Local Health Authority of Mirano Mirano, Venezia, Italy Local Heath Authority of Thiene Thiene, Vicenza, Italy Local Heath Authority of Padova Padova, Italy Local Health Authority of Treviso Treviso, Italy Local Heath Authority Veneziana Venezia, Italy Local Heath Authority of Verona Verona, Italy Less <<
NCT01617031 - Completed - France ... More >> Department of Cardiology-Lariboisiere Hospital-Assistance Publique-Hôpitaux de Paris Paris, France, 75010 Less <<
NCT01604213 Type 2 Diabetes Mellitus ... More >> Ischemic Heart Disease Less << Phase 4 Completed - Israel ... More >> Sheba Medical Center, Cardiac Rehabilitation Institute Tel Hashomer, Israel, 52621 Less <<
NCT01629199 Diabetic Foot Ulcer Patients W... More >>ith Uncontrolled Diabetes Mellitus Less << Phase 3 Completed - Korea, Republic of ... More >> College of Medicine, Yonsei University Seoul, Korea, Republic of Less <<
NCT01608425 Diabetes Mellitus ... More >> Foot Ulcers Less << Phase 2 Unknown November 2013 Denmark ... More >> South-west Hospital Recruiting Esbjerg, Region of Southern Denmark, Denmark, 6700 Lillebaelt Hospital Recruiting Kolding, Region of Southern Denmark, Denmark, 6000 Odense University Hospital Recruiting Odense, Region of Southern Denmark, Denmark, 5000 Hospital South Jutland Recruiting Soenderborg, Region of Southern Denmark, Denmark, 6400 Svendborg Hospital Recruiting Svendborg, Region of Southern Denmark, Denmark, 5700 Hospital Lillebaelt Recruiting Vejle, Region of Southern Denmark, Denmark, 7100 Less <<
NCT01547897 Type 2 Diabetes Mellitus ... More >> Albuminuria Less << Phase 2 Completed - Czech Republic ... More >> Praha, Czech Republic Germany Aschaffenburg, Germany Dortmund, Germany Düsseldorf, Germany Hannover, Germany Kronberg, Germany Mainz, Germany Mannheim, Germany Offenbach, Germany Schwabenheim, Germany Witten, Germany Hungary Balatonfüred, Hungary Budapest, Hungary Gyula, Hungary Miskolc, Hungary Pecs, Hungary Szeged, Hungary Poland Bialystok, Poland Grodzisk Mazowiecki, Poland Katowice, Poland Warszawa, Poland Romania Arad, Romania Bucharest, Romania Timisoara, Romania Less <<
NCT01629862 - Completed - -
NCT01629862 Sleep Apnea, Obstructive ... More >> Diabetes Mellitus Less << Phase 2 Completed - United States, Massachusetts ... More >> Brigham & Women's Hospital Boston, Massachusetts, United States, 02115 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Less <<
NCT01627340 Hepatitis B Phase 4 Completed - -
NCT01637935 - Completed - -
NCT01637935 - Completed - -
NCT01643967 Diabetes Mellitus Phase 3 Unknown January 2013 Brazil ... More >> Associação Hospitalar Beneficente São Vicente de Paulo Recruiting Passo Fundo, Rio Grande do Sul, Brazil, 99010-080 Contact: Renato T Santos, Investigator    5554-3312-2099    renatotadeus@gmail.com    Contact: Keyla L Deucher, Coordinator    5554- 3316-4000    pesquisaclinica.hsvp@gmail.com    Principal Investigator: Renato T Santos, Investigator Less <<
NCT01635361 Asthma Pulmon... More >>ary Disease, Chronic Obstructive Diabetes Mellitus, Type 2 Hypertension Blood Coagulation Less << Not Applicable Completed - United Kingdom ... More >> Nottinghamshire County PCT/ County Health Partnerships Nottingham, Notts, United Kingdom Doncaster PCT Doncaster, South Yorkshire, United Kingdom Cambden, Barnet, Islington PCTs London, United Kingdom Nottingham City PCT/Nottingham City Care Nottingham, United Kingdom Less <<
NCT01646047 Diabetes Mellitus - Type 1 ... More >> Diabetes Mellitus - Type 2 Non-proliferative Diabetic Retinopathy Less << Not Applicable Completed - United States, Washington ... More >> Chous Eye Care Associates Tacoma, Washington, United States, 98466 Less <<
NCT01643031 Diabetes Mellitus ... More >> Coronary Disease Less << Phase 4 Unknown October 2014 Israel ... More >> Rabin Medical Center Not yet recruiting Petah-Tikva, Israel, 49100 Contact: Hagar Medan          Principal Investigator: Eli I Lev, MD Less <<
NCT01627340 - Completed - -
NCT02256111 Non-metastatic, Hormone na?ve ... More >>Prostate Cancer Less << Phase 2 Completed - United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10017 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 Less <<
NCT03113994 Spinal Cord Injuries ... More >> Osteoporosis Metabolic Syndrome Less << Phase 2 Recruiting December 2020 United States, Florida ... More >> University Of Miami Miller School of Medicine Not yet recruiting Miami, Florida, United States, 33136 Contact: Luisa Betancourt, MD, MS    305-243-6320    lbetancourt@med.miami.edu    Principal Investigator: Mark S Nash, Ph.D., FACSM          Canada, Ontario University Health Network - Toronto Rehab Lyndhurst Centre Recruiting Toronto, Ontario, Canada, M4G 3V9 Contact: Masae Miyatani, PhD    416-597-3422 ext 6304    masae.miyatani@uhn.ca    Contact: Lindsie Blencowe, MSc    416-597-3422 ext 6301    lindsie.blencowe@uhn.ca    Principal Investigator: Cathy Craven, BA, MD, MSc, FRCPC, CCD Less <<
NCT01697228 Type 1 Diabetes ... More >> Vitamin D Deficiency/Insufficiency Less << Not Applicable Completed - United States, California ... More >> Children's Hospital Los Angeles Los Angeles, California, United States, 90027 Less <<
NCT00693537 Type 2 Diabetes Mellitus ... More >> Coronary Artery Disease Less << Phase 4 Completed - Austria ... More >> University Institute of Sports Medicine, Prevention and Rehabilitation Salzburg, Austria, 5020 Less <<
NCT00689546 - Unknown - India ... More >> All India Institute Of Medical Sciences Recruiting New Delhi, Delhi, India, 110029 Contact: Subrat Acharya, DM    9868397200    subratacharya@yahoo.co.in    Contact: Kumar K Singh, MD    9868404908    kumarkirti73@yahoo.co.in    Sub-Investigator: Kumar K Singh, MD Less <<
NCT00678704 Erectile Dysfunction ... More >> Diabetes Mellitus Less << Phase 3 Completed - -
NCT00698698 - Unknown June 2011 Pakistan ... More >> Dow University of Health Sciences Karachi, Sindh, Pakistan, 75500 Less <<
NCT00695474 - Completed - -
NCT01707979 - Completed - Denmark ... More >> Steno Diabetes Center Gentofte, Denmark, 2820 Less <<
NCT00704652 - Terminated(Patient recruitment... More >> was not sufficient to achieve the needed patient numbers.) Less << - Austria ... More >> Departmen of Ophthalmology, Medical Unversity of Vienna Vienna, Austria, 1090 Less <<
NCT00705861 Erectile Dysfunction Phase 3 Completed - Korea, Republic of ... More >> SK Chemicals Co., Ltd Seoul, Korea, Republic of Less <<
NCT03121196 - Not yet recruiting May 2018 France ... More >> CHU Clermont-Ferrand Not yet recruiting Clermont-Ferrand, France, 63003 Contact: Patrick LACARIN    04 73 75 11 95    placarin@chu-clermontferrand.fr    Principal Investigator: Françoise VENDITELLI Less <<
NCT01731080 - Unknown July 2013 France ... More >> University Hospital Recruiting Angers, Pays de la Loire, France, 49933 Contact: Ludovic MARTIN, MD, PhD    33(2)41.35.34.19    lumartin@chu-angers.fr    Contact: Georges LEFTHERIOTIS, MD, PhD    33(2)41.35.44.56    geleftheriotis@chu-angers.fr    Principal Investigator: Yannick LE CORRE, MD          Sub-Investigator: Ludovic MARTIN, MD, PhD          Sub-Investigator: Georges LEFTHERIOTIS, MD, PhD          Sub-Investigator: Pierre ABRAHAM, MD, PhD          Sub-Investigator: Serge WILLOTEAUX, MD, PhD          Sub-Investigator: Jean-Francois SUBRA, MD, PhD          Sub-Investigator: Pierre-Henri DUCLUZEAU, MD Less <<
NCT00718614 Diabetes Mellitus, Type 1 ... More >> Diabetic Retinopathy Less << Not Applicable Terminated - Austria ... More >> Department of Clinical Pharmacology Vienna, Austria, 1090 Less <<
NCT00728156 Type 2 Diabetes Mellitus ... More >> Coronary Artery Disease Less << Phase 4 Completed - United Kingdom ... More >> Newcastle Diabetes Centre, Newcastle General Hospital Newcastle upon Tyne, Tyne and Wear, United Kingdom, NE4 6BE Freeman Hospital Newcastle upon Tyne, Tyne and Wear, United Kingdom, NE77DN Less <<
NCT00732407 Diabetes Mellitus ... More >> Atherosclerosis Less << Not Applicable Unknown - -
NCT00717483 - Completed - United States, Texas ... More >> Baylor College of Medicine Houston, Texas, United States, 77030 Texas Childrens Hospital Houston, Texas, United States, 77030 Less <<
NCT00736632 Vitamin D Deficiency ... More >> Insulin Resistance Type 2 Diabetes Mellitus Cardiovascular Disease Hypertension Less << Not Applicable Active, not recruiting December 2018 United States, Missouri ... More >> Washington Universiy Saint Louis, Missouri, United States, 63110 Less <<
NCT00739323 - Completed - United States, Massachusetts ... More >> Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Less <<
NCT00729456 Foot Ulceration in Diabetes Not Applicable Completed - United Kingdom ... More >> Derbyshire Royal Infirmary Derbyshire, United Kingdom, DE1 2QY Nottingham City Hospital Nottingham, United Kingdom, NG5 1PB Queens Medical Centre Nottingham, United Kingdom, NG7 2UH Less <<
NCT03221127 - Active, not recruiting December 31, 2052 -
NCT00766298 Type 2 Diabetes Mellitus Not Applicable Completed - United States, Pennsylvania ... More >> University of Pittsburgh Pittsburgh, Pennsylvania, United States, 15213 Less <<
NCT01800851 Chronic Renal Failure ... More >> Kidney Transplantation Weight Gain Insulin Resistance Diabetes Less << Not Applicable Completed - France ... More >> CHU Clermont-Ferrand Clermont-Ferrand, France, 63003 Less <<
NCT00752440 Diabetes Mellitus ... More >> Diabetic Autonomic Neuropathy Less << Phase 4 Unknown July 2009 Brazil ... More >> Institudo de Cardiologia do Rio Grande do Sul Recruiting Porto Alegre, RGS, Brazil Contact: Beatriz D Schann, MD, ScD    555132303600 ext 3757    beatrizschann@gmail.com Less <<
NCT01819883 - Completed - -
NCT01812291 Major Depressive Disorder ... More >> Minor Depressive Disorder Sub-Threshold Depression Diabetes Mellitus Less << Not Applicable Completed - Germany ... More >> Forschungsinstitut der Diabetes Akademie Mergentheim e. V. Bad Mergentheim, Baden-Wuerttemberg, Germany, D-97980 Less <<
NCT01828931 Type 2 Diabetes Mellitus ... More >> Schizophrenia Schizoaffective Disorder Schizophreniform Disorder Bipolar I Disorder Substance-induced Psychosis Psychotic Disorders Major Depressive Disorder Less << Not Applicable Completed - Canada, Ontario ... More >> Centre for Addiction and Mental Health Toronto, Ontario, Canada, M6J 1H4 Less <<
NCT01793168 - Recruiting December 2100 United States, South Dakota ... More >> Sanford Health Recruiting Sioux Falls, South Dakota, United States, 57104 Contact: CoRDS Team    877-658-9192    cords@sanfordhealth.org    Principal Investigator: Jill Weimer, PhD          Australia Online Patient Enrollment System Recruiting Sydney, Australia Contact: CoRDS Team    1-877-6589192    cords@sanfordhealth.org Less <<
NCT00792662 Diabetes Mellitus ... More >> Alzheimer's Disease Apathy Dementia Less << Phase 4 Withdrawn(No Subjects enrolled... More >>) Less << - United States, Nebraska ... More >> Veterans Affairs Medical Center Omaha, Nebraska, United States, 68105 University of Nebraska Medical Center Omaha, Nebraska, United States, 68198 Less <<
NCT00807976 - Completed - Netherlands ... More >> Diabetes centre, Isala Clinics Zwolle, Netherlands, 8000 GM Less <<
NCT03354676 - Completed - -
NCT01819883 - Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT00797186 Type 2 Diabetes ... More >> Microvascular Dysfunction Less << Not Applicable Unknown December 2011 United States, Virginia ... More >> University of Virginia Recruiting Charlottesville, Virginia, United States, 22902 Principal Investigator: Angela M Taylor, MD, MS          Sub-Investigator: Christopher Kramer, MD          Sub-Investigator: Amy West, MD          Sub-Investigator: Michael Ragosta, MD          Sub-Investigator: Anne Hedelt, MD          Sub-Investigator: Cherie Chaney, RN          Sub-Investigator: Joseph Aloi, MD          Sub-Investigator: Anthony McCall, MD          Sub-Investigator: Ellen Keeley, MD, MS          Sub-Investigator: Coleen McNamara, MD          Sub-Investigator: Amy Tucker, MD          Sub-Investigator: Lewis Lipson, MD          Sub-Investigator: Lawrence Gimple, MD Less <<
NCT00816010 Type 2 Diabetes Mellitus ... More >> Acute Coronary Syndrome Less << Not Applicable Terminated(Due to lack of manp... More >>ower at the various study sites) Less << - Hong Kong ... More >> 5 public hospitals in Hong Kong Hong Kong, Hong Kong Less <<
NCT03366337 IgA Nephropathy ... More >> CKD Associated With Type 1 Diabetes Focal Segmental Glomerulosclerosis Autosomal Dominant Polycystic Kidney Less << Phase 2 Recruiting August 2019 -
NCT00815178 Diabetes Complications ... More >> Inspiratory Muscle Weakness Less << Not Applicable Completed - Brazil ... More >> Hospital de Clínicas de Porto Alegre Porto Alegre, Rio Grande do Sul, Brazil, 90035-903 Less <<
NCT00818779 - Completed - -
NCT00824395 - Unknown November 2010 United States, California ... More >> UC Irvine General Clinical Research Center Recruiting Irvine, California, United States, 92697 Contact: Julia Platt, MS    949-824-9232    jplatt@uci.edu Less <<
NCT03364387 - Completed - Turkey ... More >> Emin Alioğlu Izmir, Turkey Less <<
NCT00845897 Diabetes Mellitus ... More >> Peripheral Neuropathy Plantar Ulcers Less << Not Applicable Completed - United States, Missouri ... More >> Washington University St. Louis, Missouri, United States, 63108 Less <<
NCT00845858 - Completed - -
NCT00818779 Coronary Artery Disease ... More >> Type 2 Diabetes Mellitus Less << Phase 4 Completed - United States, Texas ... More >> Texas Tech University Health Sciences Center Lubbock, Texas, United States, 79430 Less <<
NCT00849316 - Withdrawn(Due to company decis... More >>ion to focus resources on the finalisation of three ongoing studies in the region) Less << November 2009 -
NCT00845897 - Completed - -
NCT00845858 Gastroparesis ... More >> Diabetic Gastroparesis Diabetes Diabetes Mellitus Delayed Gastric Emptying Less << Phase 2 Completed - -
NCT00854984 Depression Di... More >>abetes Mellitus Type 2 Coronary Heart Disease Less << Not Applicable Unknown December 2009 United Kingdom ... More >> Faculty of Health and Social Care, Garthdee Campus, Robert Gordon University Recruiting Aberdeen, United Kingdom, AB10 7QG Community Health Sciences, GP Section, University of Edinburgh Recruiting Edinburgh, United Kingdom, EH8 9DX Less <<
NCT00863967 - Unknown October 2015 -
NCT01863147 Newly Diagnosed Type 2 Diabete... More >>s Coronary Artery Disease Less << Phase 4 Completed - China, Hubei ... More >> Guangda Xiang Wuhan, Hubei, China, 430070 Wuhan General Hospital Wuhan, Hubei, China, 430070 Less <<
NCT00879710 Type 1 Diabetes Mellitus ... More >> Type 2 Diabetes Mellitus Hypercholesterolemia Less << Not Applicable Completed - United States, Wisconsin ... More >> Medical College of Wisconsin /Froedtert Hospital Milwaukee, Wisconsin, United States, 53226 Less <<
NCT02971475 Pancreatitis Not Applicable Recruiting July 2019 China, Shanghai ... More >> Changhai Hospital Recruiting Shanghai, Shanghai, China, 200433 Contact: Yang-Yang Qian, MD          China Shanghai Changhai Hospital Recruiting Shanghai, China Contact: Zhao-shen Li       zhaoshen-li@hotmail.com    Contact: Zhuan Liao       liaozhuan@smmu.edu.cn    Sub-Investigator: Liang-hao Hu          Sub-Investigator: Yang-yang Qian Less <<
NCT01897688 Type 1 Diabetes ... More >> Severe Hypoglycemic Unawareness Less << Phase 3 Active, not recruiting March 2027 United States, Illinois ... More >> Northwestern University Chicago, Illinois, United States, 60611 Less <<
NCT01935466 - Recruiting July 2021 India ... More >> Deptt of Endocrinology Recruiting Chandigarh, India, 160012 Contact: Ashu Rastogi, MD, DM    919781001046    ashuendo@gmail.com    Principal Investigator: Ashu Rastogi, MD, DM Less <<
NCT00883259 Obesity Polyc... More >>ystic Ovary Syndrome Gestational Diabetes Less << Phase 4 Unknown - Italy ... More >> Pugliese Hospital Catanzaro, Catanzaro, CZ, Italy, 88100 "Pugliese" Hospital Not yet recruiting Catanzaro, Italy, 88100 Contact: Ingrid Tomaino, MD    +39-0961-883234    angela.falbo@libero.it    University of Catanzaro, Italy Catanzaro, Italy, 88100 Less <<
NCT03459638 - Recruiting March 13, 2020 Netherlands ... More >> Academic Centre for Dentistry Amsterdam Recruiting Amsterdam, Noord-Holland, Netherlands, 1081 LA Contact: Wijnand Teeuw, Dr.    +31205980322    w.teeuw@acta.nl Less <<
NCT03495999 - Terminated(The study interest ... More >>was reached) Less << - Taiwan ... More >> Tri-service General Hospital, songshan branch Taipei, Songshan Dist., Taiwan, 105 Less <<
NCT00886392 - Completed - Mexico ... More >> Hospital Juarez de Mexico Mexico, Distrito Federal, Mexico, 07760 Less <<
NCT03483584 - Not yet recruiting January 2021 Hong Kong ... More >> Prince of Wales Hospital Sha Tin, Hong Kong Less <<
NCT00891124 - Completed - Korea, Republic of ... More >> Research Site Busan, Korea, Republic of Research Site Cheiju, Korea, Republic of Research SIte Daegu, Korea, Republic of Research Site Gwangju, Korea, Republic of Research Site Hongsung, Korea, Republic of Research Site Seoul, Korea, Republic of Research Site Sungman, Korea, Republic of Less <<
NCT00907608 Diabetes Mellitus ... More >> Chronic Kidney Disease Anemia Less << Not Applicable Terminated(Due to difficulty i... More >>n patient recruitment) Less << - China ... More >> Prince of Wales Hospital Hong Kong, China Less <<
NCT00879710 - Completed - -
NCT00932048 Type 2 Diabetes ... More >> Atherosclerosis Less << Not Applicable Withdrawn March 2012 Korea, Republic of ... More >> Tae Nyun Kim Seoul, Korea, Republic of, 152-050 Less <<
NCT00549744 Asthma Phase 2 Completed - New Zealand ... More >> GSK Investigational Site Wellington, New Zealand, 6035 South Africa GSK Investigational Site George, Eastern Cape, South Africa, 6529 GSK Investigational Site Bloemfontein, South Africa, 9301 Less <<
NCT00889486 Gastroparesis ... More >> Diabetes Mellitus Less << Phase 2 Completed - -
NCT00933881 - Completed - United States, Delaware ... More >> Christiana Care Health Services Newark, Delaware, United States, 19713 Less <<
NCT00933101 - Completed - United States, Missouri ... More >> Children's Mercy Hospitals and Clinics Kansas City, Missouri, United States, 64108 Less <<
NCT01978405 Acute Kidney Injury ... More >> The Changes of Plasma Creatinine The Changes of Plasma Free Radicals The Changes of Endothelium-dependent Arterial Dilation Less << Phase 4 Unknown June 2014 China, Hubei ... More >> Wuhan General Hospital Recruiting Wuhan, Hubei, China, 430070 Contact: Xiang Guangda, MD    +8602768878410 Less <<
NCT00947635 Immunosuppression ... More >> Hyperlipidemias Diabetes Mellitus, Type 1 Less << Phase 1 Phase 2 Completed - Canada, Alberta ... More >> University of Alberta Edmonton, Alberta, Canada, T6G 2P5 Less <<
NCT03600675 - Recruiting May 8, 2020 United States, Pennsylvania ... More >> Drexel University Nutrition Sciences Research Lab Recruiting Philadelphia, Pennsylvania, United States, 19102 Contact: Deeptha Sukumar, PhD    267-359-5854    deeptha.sukumar@drexel.edu Less <<
NCT01967186 Type 1 Diabetes ... More >> End Stage Renal Disease Less << Not Applicable Unknown July 2016 -
NCT01254266 Morbid Obesity Not Applicable Unknown September 2014 Israel ... More >> Rabin Medical Center Recruiting Petah Tikva, Israel Contact: silvana Fennig, MD    +97239253761    silvanaf@clalit.org.il    Principal Investigator: Silvana Fennig, M.D. Less <<
NCT00937079 - Completed - Switzerland ... More >> University Hospital Basel, Institute of Nuclear Medicine Basel, Basel-Stadt, Switzerland, CH-4031 Less <<
NCT00960765 - Completed - United States, New York ... More >> Sisters of Charity Hospital Buffalo, New York, United States, 14214 Synergy Bariatrics Williamsville, New York, United States, 14221 Less <<
NCT00979225 Hypertension ... More >>Diabetes Mellitus Stroke Myocardial Ischemia Heart Failure Asthma Less << Not Applicable Completed - United States, North Carolina ... More >> Duke University Medical Center Durham, North Carolina, United States, 27705 Less <<
NCT00965315 - - - -
NCT00957957 - Completed - -
NCT03669692 Prostatic Hyperplasia, Benign ... More >> Metabolic Syndrome Less << Not Applicable Recruiting January 1, 2023 Spain ... More >> Jose Luis Ponce Diaz-Reixa Recruiting A Coruña, Spain, 15006 Contact: Jose L Ponce, MD    +34981178057    Jose.Luis.Ponce.DIaz-Reixa@sergas.es    Principal Investigator: Jose L Ponce, MD Less <<
NCT00982358 Hypertension ... More >>Type 2 Diabetes Mellitus Coronary Artery Disease Less << Phase 4 Completed - Germany ... More >> University of Ulm, Department of Internal Medicine II Ulm, Baden-Wuerttemberg, Germany, 89081 Charité University Medicine Berlin, Center for Cardiovascular Research, Outpatient Clinic Berlin, Germany, 10115 Less <<
NCT03607201 - Completed - Indonesia ... More >> Cengkareng General Hospital Jakarta, DKI Jakarta, Indonesia Less <<
NCT00997763 Coronary Artery Disease Phase 4 Completed - Korea, Republic of ... More >> Soonchunhyang University Bucheon Hospital Bucheon, Korea, Republic of Busan Saint Mary's Hospital Busan, Korea, Republic of Soonchunhyang University Cheonan Hospital Cheonan, Korea, Republic of Cheongju Saint Mary's Hospital Cheongju, Korea, Republic of Kangwon University Hospital Chuncheon, Korea, Republic of Chungnam National University Hospital Daejeon, Korea, Republic of Daejeon St Mary's Hospital Catholic University Daejeon, Korea, Republic of Asan Medical Center GangNeung, Korea, Republic of Chonbuk National University Hospital Jeonju, Korea, Republic of Kyungsang University Hospital Jinju, Korea, Republic of Inje University Pusan Paik Hospital Pusan, Korea, Republic of Pusan Natioanal University Hospital Pusan, Korea, Republic of Hallym University Sacred Heart Hospital PyeongChon, Korea, Republic of Asan Medical Center Seoul, Korea, Republic of Hallym University Sacred Heart Hospital Seoul, Korea, Republic of Korea Veterans Hospital Seoul, Korea, Republic of Soonchunhyang University Seoul Hospital Seoul, Korea, Republic of Ulsan University Hospital Ulsan, Korea, Republic of Less <<
NCT02339649 Severe Sepsis With Septic Shoc... More >>k Severe Sepsis Without Septic Shock Less << Not Applicable Recruiting October 2019 Germany ... More >> Department of Anesthesiology, University Hospital Bonn Recruiting Bonn, North Rhine-Westphalia (NRW), Germany, 53105 DZNE Center for Clinical Research Not yet recruiting Bonn, Northrhine-Westphalia, Germany, 53117 Less <<
NCT00979719 Pain Osteoart... More >>hritis Rheumatoid Arthritis Heart Diseases Diabetes Mellitus, Type 2 Behavior Motivation Less << Not Applicable Completed - Germany ... More >> Freie Universitaet Berlin Berlin, Germany, 14195 Less <<
NCT01019486 Coronary Artery Disease ... More >> Type 1 Diabetes Mellitus Less << Phase 4 Completed - United States, Colorado ... More >> Barbara Davis Center for Childhood Diabetes Aurora, Colorado, United States, 80045 University of Colorado Denver Aurora, Colorado, United States, 80045 University of Colorado Hospital Aurora, Colorado, United States, 80045 University Hospital, the University of Colorado Health Sciences Center Denver, Colorado, United States, 80262 Less <<
NCT00991575 - Unknown May 2010 Norway ... More >> Oslo University hospital, Aker Oslo, Norway, 0514 Less <<
NCT01014949 Coronary Microvascular Dysfunc... More >>tion Metabolic Syndrome Diabetes Less << Not Applicable Completed - Italy ... More >> Interventional Cardiology Unit, Misericordia Hospital Grosseto, Italy, 58100 Less <<
NCT00989976 Sleep Diabete... More >>s Less << Not Applicable Completed - United States, Illinois ... More >> The University of Chicago Chicago, Illinois, United States, 60637 Less <<
NCT01023919 Coronary Artery Disease ... More >> Diabetes Mellitus Less << Phase 4 Unknown June 2011 China, Heilong jiang ... More >> The second Affiliated Hospital of Harbin Medical University Recruiting Harbin, Heilong jiang, China, 150081 Contact: Bo Yu, MD,PhD    86-0451-86605180    yubodr@163.com    Principal Investigator: Bo Yu, MD, PhD Less <<
NCT01019486 - Completed - -
NCT01029639 Hypoglycemia Phase 2 Phase 3 Withdrawn(Administrative) - United States, Florida ... More >> Florida Atlantic University Center for Complex Systems and Brain Sciences Boca Raton, Florida, United States, 33431 Less <<
NCT01029392 - Completed - -
NCT01705951 Smoking Cardi... More >>ovascular Disease Risk Less << Not Applicable Unknown December 2013 United States, California ... More >> University of California, Los Angeles Recruiting Los Angeles, California, United States, 90095 Less <<
NCT01032395 H1N1 Influenza Virus ... More >> Chronic Pulmonary Disease Chronic Heart Disease Diabetes Mellitus Less << Phase 3 Completed - Brazil ... More >> Centro de Estudos de Pneumologia da Faculdade de Medicina do ABC Santo André, SP, Brazil Instituto de Ensino e Pesquisa em Geriatria e Gerontologia São Paulo, SP, Brazil Less <<
NCT01021930 Coronary Heart Disease ... More >> Diabetes Mellitus Less << Phase 4 Unknown June 2011 China, Heilong jiang ... More >> The second Affiliated Hospital of Harbin Medical University Recruiting Harbin, Heilong jiang, China, 150081 Contact: Bo Yu, MD, PhD    86-0451-86605180    yubodr@163.com    Principal Investigator: Bo Yu, MD.PhD Less <<
NCT01029392 Type 1 Diabetes Mellitus Phase 3 Completed - United States, Michigan ... More >> WilliamBH Royal Oak, Michigan, United States, 48073 Less <<
NCT01041599 - Completed - Turkey ... More >> Istanbul Univesity Istanbul Medical Faculty Department of Internal Medicine Istanbul, Turkey, 34390 Less <<
NCT01042769 Diabetes Mellitus Type 2 Phase 3 Completed - -
NCT01038050 Type 2 Diabetes Mellitus ... More >> Coronary Artery Disease Less << Phase 4 Unknown December 2010 Taiwan ... More >> Taipei Veterans General Hospital Taipei, Taiwan, 11217 Less <<
NCT01047865 - Recruiting May 2019 United States, Florida ... More >> University of Miami Miller School of Medicine Transplant Clinic Recruiting Miami, Florida, United States, 33136 Principal Investigator: George Burke, M.D. Less <<
NCT01051830 Diabetes Mellitus ... More >> Hip Fracture Less << Not Applicable Completed - Taiwan ... More >> Chang Gung Memorial Hospital, Taiwan Taipei, Taoyuan, Taiwan Less <<
NCT02162550 Type 2 Diabetes Phase 4 Active, not recruiting September 2019 United States, Arizona ... More >> Phoenix VA Health Care System Phoenix, Arizona, United States, 85012 Less <<
NCT01062763 Arterial Hypertension ... More >> Hypertension, Resistant to Conventional Therapy Diabetes Mellitus Less << Phase 3 Completed - -
NCT01062763 - Completed - -
NCT01053078 Type 1 Diabetes ... More >> Hypoglycemia Unawareness Less << Phase 1 Phase 2 Completed - United States, Minnesota ... More >> University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT01066130 Diabetes Mellitus ... More >> Arthritis, Rheumatoid Coping Skills Less << Not Applicable Completed - Sweden ... More >> Center for Family and Community Medicine Huddinge, Sweden, 14183 Karolinska University Hospital Solna Stockholm, Sweden, 17176 Less <<
NCT01065909 - Completed - France ... More >> Sanofi-Aventis Administrative Office Paris, France Less <<
NCT01064583 Peripheral Artery Disease ... More >> Diabetes Mellitus Less << Phase 1 Phase 2 Completed - Germany ... More >> Heinrich Heine University Düsseldorf, NRW, Germany, 40225 Less <<
NCT01086111 - Completed - Belgium ... More >> University Hospitals Leuven, gasthuisberg Leuven, Belgium, 3000 Less <<
NCT01079325 Diabetes Mellitus, Type 1 ... More >> Diabetes Mellitus, Type 2 Diabetic Polyneuropathy Less << Phase 2 Completed - -
NCT01053078 - Completed - -
NCT01071967 Heart Failure ... More >> Coronary Disease Diabetes Mellitus Asthma Hypertension Hypercholesterolemia Less << Not Applicable Unknown December 2016 United States, Pennsylvania ... More >> Health Quality Partners Doylestown, Pennsylvania, United States, 18902 Less <<
NCT00287651 Diabetes Mellitus, With Compli... More >>cations Less << Phase 2 Phase 3 Terminated(Administrative) - United States, Florida ... More >> Florida Atlantic University Center for Complex Systems and Brain Sciences Boca Raton, Florida, United States, 33431 Less <<
NCT00296374 Diabetes Mellitus Phase 2 Completed - -
NCT00309192 Diabetes Mellitus ... More >> Macular Edema Less << Phase 3 Unknown - Spain ... More >> INGO - Instituto Galego de Oftalmoloxia Not yet recruiting Santiago de Compostela, La Coruña, Spain Principal Investigator: Francisco Gómez Ulla de Irazabal, MD, PhD          Clínica Universitaria de Navarra Not yet recruiting Pamplona, Navarra, Spain Principal Investigator: Alfredo García Layana, MD, PhD          Instituto Oftalmológico de Alicante Not yet recruiting Alicante, Spain Principal Investigator: José María Ruiz Moreno, MD, PhD          Hospital de la Vall D´Hebrón Not yet recruiting Barcelona, Spain Principal Investigator: José García Arumí, MD, PhD          Hospital Clínico Universitario San Carlos Not yet recruiting Madrid, Spain Principal Investigator: Juan Donate López, MD, PhD          Hospital General Universitario Reina Sofía Not yet recruiting Murcia, Spain Principal Investigator: Inmaculada Selles, MD, PhD          IOBA - Instituto Universitario de Oftalmobiología Aplicada Recruiting Valladolid, Spain, 47005 Contact: José Carlos Pastor Jimeno, MD, PhD    34 9834761    pastor@ioba.med.uva.es    Contact: Francisco Blázquez Araúzo, MD    34 983 423238    blazquez@ioba.med.uva.es    Principal Investigator: José Carlos Pastor Jimeno, MD, PhD          Sub-Investigator: María Isabel López Gálvez, MD, PhD          Sub-Investigator: Miguel Ángel De la Fuente, MD          Sub-Investigator: Enrique Rodríguez de la Rua, MD, PhD Less <<
NCT00286572 - Completed - Switzerland ... More >> University Hospital Basel, CH, Switzerland, 4000 Less <<
NCT00295555 Diabetes Mellitus ... More >> Essential Hypertension Renal Failure Less << Phase 4 Completed - Japan ... More >> Yokohama City University Center Hospital Yokohama, Japan, 232-0024 Less <<
NCT02371343 Fetal Macrosomia ... More >> Congenital Abnormality Other Respiratory Problems After Birth Less << Not Applicable Unknown September 2016 Turkey ... More >> Sami Ulus CH Ankara, Turkey, 06120 Less <<
NCT00311298 Tuberculosis ... More >>HIV Diabetes Less << Phase 3 Completed - Tanzania ... More >> Mwanza Medical Centre, NIMR Mwanza, Tanzania Less <<
NCT00308386 Diabetes Mellitus ... More >> Hypertension Hyperlipidemia Less << Phase 3 Unknown August 2010 United States, Pennsylvania ... More >> Penn State College of Medicine Hershey, Pennsylvania, United States, 17033 Reading Hospital Reading, Pennsylvania, United States, 19612 Less <<
NCT00324350 - Completed - -
NCT00325611 Cerebrovascular Accident ... More >> Cancer Coronary Arteriosclerosis Heart Failure, Congestive Diabetes Mellitus Acquired Immunodeficiency Syndrome Failure to Thrive Pulmonary Disease, Chronic Obstructive Dementia Kidney Failure, Chronic Pneumonia Liver Failure Renal Failure Respiratory Failure Stroke Less << Not Applicable Completed - United States, Colorado ... More >> Kaiser Permanente of Colorado Aurora, Colorado, United States, 80014 Less <<
NCT00327054 Hypercholesterolemia ... More >> Hypertension Diabetes Mellitus Metabolic Syndrome X Less << Phase 1 Phase 2 Completed - Pakistan ... More >> Aga Khan University Karachi, Sindh, Pakistan, 74800 Less <<
NCT00328536 Atherosclerosis ... More >> Type 2 Diabetes Mellitus Less << Phase 4 Completed - Germany ... More >> Heart- and Diabetes Centre NRW, Diabetes Clinic Bad Oeynhausen, NRW, Germany, 32545 Less <<
NCT00316667 - Completed - Denmark ... More >> Research Centre for Prevention and Health Copenhagen, Glostrup, Denmark, DK-2600 Less <<
NCT00296374 - Completed - -
NCT00332826 Diabetes Mellitus, Type 1 ... More >> Diabetes Mellitus, Type 2 Asthma Less << Phase 3 Terminated(Non-safety related ... More >>business decision to combine special population protocols) Less << - -
NCT00335101 Coronary Artery Disease (CAD) ... More >> Renal Impairment Diabetes Mellitus Less << Phase 4 Terminated - United States, New Jersey ... More >> GE Healthcare Princeton, New Jersey, United States, 08540 Germany GE Healthcare Munich, Germany, 80807 Less <<
NCT00328848 Heart Failure, Congestive ... More >> Coronary Arteriosclerosis Atrial Fibrillation Cerebrovascular Accident Pulmonary Disease, Chronic Obstructive Diabetes Mellitus Hypertension Osteoarthritis Osteoporosis Less << Not Applicable Completed - -
NCT00337298 Type 1 Diabetes ... More >> Diabetic Retinopathy Eye Diseases Diabetes Complications Less << Not Applicable Completed - Denmark ... More >> Aarhus university hospital Aarhus, Denmark, 8000 Less <<
NCT00344903 - Completed - United States, Texas ... More >> UT Southwestern Medical Center Dallas, Texas, United States, 75390-9047 Less <<
NCT00324350 Atherosclerosis ... More >> Cardiovascular Diseases Hypercholesterolemia Hypertension Diabetes Mellitus Coronary Disease Less << Phase 3 Completed - United States, Minnesota ... More >> Berman Center for Outcomes & Clinical Research Minneapolis, Minnesota, United States, 55404 United States, North Carolina Wake Forest University Winston-Salem, North Carolina, United States, 27106 United States, Ohio Case Western Reserve University Cleveland, Ohio, United States, 44106 United States, Tennessee Veterans Affairs Memphis, Tennessee, United States, 38104 Canada, Ontario Population Health Research Institute Hamilton, Ontario, Canada Less <<
NCT00354237 Type 2 Diabetes Mellitus ... More >> Coronary Artery Disease Less << Not Applicable Completed - France ... More >> Centre hospitalier du pays d'Aix Aix en Provence, France, 13616 Clinique Rhône Durance Avignon, France, 84082 Hôpital J Minjoz Besancon, France, 25000 CMC Bligny Briis Sous Forges, France, 91640 centre de réadaptation cardiaque "Château le moine" Cenon, France, 33150 CHU du Bocage Dijon, France, 21079 Centre IRIS Marcy l'Etoile, France, 69280 Centre Hospitalier de MONTBARD Montbard, France, 21506 Hopital BROUSSAIS, APHP Paris, France, 75014 Hôpital du haut Lévêque Pessac, France, 33604 Rééducation cardiovasculaire CRF Kerpape Ploemeur, France, 56275 Hôpital jeanne d'arc Toul, France, 54201 Less <<
NCT00355537 Diabetes Mellitus ... More >> Peripheral Vascular Disease Less << Phase 4 Completed - United Kingdom ... More >> Barnsley Hospital NHS Foundation Trust Barnsley, South Yorkshire, United Kingdom, S75 2 EP Less <<
NCT00336349 Diabetes Mellitus ... More >> Neuropathic Pain Less << Not Applicable Completed - Taiwan ... More >> Chaur-Jong Hu Taipei, Taiwan, 106 Less <<
NCT00368095 - Unknown August 2016 Thailand ... More >> Rajavithi Hospital Recruiting Bangkok, Thailand Less <<
NCT00353561 Diabetes Mellitus ... More >> Vulvovaginal Candidiasis Less << Phase 3 Completed - India ... More >> Dr Ravinder Goswami Delhi, India, 29 Less <<
NCT00362960 Type 2 Diabetes Mellitus ... More >> Diabetic Nephropathy Proteinuria Renal Disease Less << Phase 3 Completed - Czech Republic ... More >> Frydlant v Cechach, Czech Republic Liberec, Czech Republic Prague, Czech Republic Estonia Tartu, Estonia Germany Augsburg, Germany Greifenstein-Beilstein, Germany Hannover, Germany Netherlands Zwijndrecht, Netherlands Poland Grodzisk Mazowiecki, Poland Krakow, Poland Plock, Poland Poznan, Poland Pruszkow, Poland Torun, Poland Warsaw, Poland Watlack, Poland Wolomin, Poland Wroclaw, Poland Slovakia Banska Bystrica, Slovakia Kosice, Slovakia Lucenec, Slovakia Martin, Slovakia Nitra, Slovakia Nove Zamky, Slovakia Sahy, Slovakia Spain Barcelona, Spain Madrid, Spain Less <<
NCT02502071 - Completed - -
NCT02520921 Diabetes Mellitus ... More >> Acute Coronary Syndrome Coronary Artery Disease Less << Phase 4 Recruiting February 2020 France ... More >> Department of Cardiology - Lariboisiere Hospital Recruiting Paris, France, 75010 Contact: Patrick HENRY, MD, PhD    (33) 1 49 95 82 24    patrick.henry@lrb.aphp.fr    Contact: Jean Guillaume DILLINGER, MD    (33) 1 49 95 85 74    jean-guillaume.dillinger@lrb.aphp.fr Less <<
NCT02502071 Type 1 Diabetes ... More >> Diabetic Nephropathy Diabetic Kidney Disease Less << Phase 4 Completed - United States, Colorado ... More >> Barbara Davis Center for Diabetes Aurora, Colorado, United States, 80045 Less <<
NCT00351676 Heart Failure, Congestive ... More >> Pulmonary Disease, Chronic Obstructive Pneumonia Diabetes Mellitus, Type 2 Coronary Arteriosclerosis Less << Phase 4 Completed - Canada, Alberta ... More >> Royal Alexandra Hospital Edmonton, Alberta, Canada, T5H 3V9 University of Alberta Hospital Edmonton, Alberta, Canada, T6G 2B7 Grey Nuns Community Hospital Edmonton, Alberta, Canada, T6L 5X8 Less <<
NCT00382564 - Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00374426 Major Depression ... More >> Diabetes Less << Phase 4 Completed - United States, Missouri ... More >> Washington University School of Medicine St. Louis, Missouri, United States, 63110 Less <<
NCT00406458 Diabetes Mellitus, Type 1 ... More >> Diabetes Mellitus, Type 2 Diabetic Polyneuropathy Less << Phase 2 Completed - United States, California ... More >> Coordinated Clinical Research La Jolla, California, United States, 92037 Advanced Medical Research, LLC Lakewood, California, United States, 90712 SF Clinical Research Center San Francisco, California, United States, 94109 Diablo Clinical Research Walnut Creek, California, United States, 94598 United States, Florida Bradenton Research Center Bradenton, Florida, United States, 34205 University of Miami, Diabetes Research Institute Miami, Florida, United States, 33136 Neurology Clinical Research Sunrise, Florida, United States, 33351 United States, Kansas University of Kansas Medical Center Kansas City, Kansas, United States, 66160 United States, Nebraska Creighton Diabetes Center Omaha, Nebraska, United States, 68131 United States, New York Upstate Clinical Research Albany, New York, United States, 12205 Peripheral Neuropathy Center, Weill Medical College of Cornell University New York, New York, United States, 10022 United States, Pennsylvania Altoona Center for Clinical Research Duncansville, Pennsylvania, United States, 16635 United States, Texas Nerve and Muscle Center of Texas Houston, Texas, United States, 77030 DGD Research San Antonio, Texas, United States, 78229 Mexico Instituto Mexicano de Investigación Clinica Mexico City, Col. Roma, Mexico, 06700 Less <<
NCT00406991 Diabetes Diab... More >>etic Retinopathy Less << Phase 2 Completed - United States, Massachusetts ... More >> Schepens Eye Research Institute Boston, Massachusetts, United States, 02114 Less <<
NCT00381992 - Completed - United States, North Carolina ... More >> Wake Forest University Health Sciences Winston-Salem, North Carolina, United States, 27157 Less <<
NCT00368953 Coronary Arteriosclerosis Phase 4 Completed - Germany ... More >> University of Leipzig Heart Center Leipzig, Germany, 04289 Less <<
NCT00417716 Diabetes Mellitus Type 2 ... More >> Diabetic Macular Edema Less << Phase 3 Unknown - Mexico ... More >> Asociación para Evitar la Ceguera en México Mexico city, Distrito Federal, Mexico, 04030 Less <<
NCT00412126 Diabetes Mellitus ... More >> Coronary Restenosis Less << Not Applicable Completed - Canada, Ontario ... More >> McMaster University/Hamilton Health Sciences Hamilton, Ontario, Canada, L8L 2X2 Less <<
NCT02596776 Obese Normal ... More >>Body Weight Prediabetes Metabolic Syndrome Less << Early Phase 1 Recruiting December 2019 United States, Kentucky ... More >> University of Kentucky Medical Center Center for Clinical and Translational Science Recruiting Lexington, Kentucky, United States, 40536 Contact: Brianna Harfmann, PhD    859-218-1362    harfmanndb@uky.edu Less <<
NCT00419835 Macroalbuminuric Diabetic Neph... More >>ropathy Less << Phase 4 Completed - Brazil ... More >> Nephrology Department, Sao Paulo University Medical School Sao Paulo, Brazil, 05403-010 Less <<
NCT00423488 Hypercholesterolemia ... More >> Diabetes Mellitus, Type 2 Coronary Disease Less << Phase 3 Completed - -
NCT00412230 - Completed - Italy ... More >> University Hospital Messina, Italy, 98121 Less <<
NCT00428961 - Completed - United States, Missouri ... More >> Saint Luke's Hospital Mid America Heart Institute Kansas City, Missouri, United States, 64111 Less <<
NCT00423488 - Completed - -
NCT00431717 - Completed - Korea, Republic of ... More >> Seoul National University Bundang hospital Sungnam-si, Kyungki-do, Korea, Republic of Less <<
NCT00431977 Coronary Atherosclerosis ... More >> Diabetes Mellitus Less << Not Applicable Completed - Korea, Republic of ... More >> Seoul National University Bundang hospital Sungnam-si, Kyungki-do, Korea, Republic of Less <<
NCT00442325 Coronary Arteriosclerosis ... More >> Diabetes Mellitus, Type 2 Cerebrovascular Accident Dyslipidemia Peripheral Vascular Disease Less << Phase 4 Completed - Greece ... More >> Pfizer Investigational Site Ioannina, Greece Pfizer Investigational Site Kallithea, Athens, Greece Pfizer Investigational Site Pireaus, Greece Pfizer Investigational Site Thessaloniki, Greece Hungary Pfizer Investigational Site Budapest, Hungary Pfizer Investigational Site Gyula, Hungary Pfizer Investigational Site Kecskemet, Hungary Pfizer Investigational Site Nyíregyháza, Hungary Pfizer Investigational Site Szekszárd, Hungary Ireland Pfizer Investigational Site Tullamore, Co. Offlay, Ireland Pfizer Investigational Site Tallaght, Dublin, Ireland Pfizer Investigational Site Gorey, Wexford, Ireland Pfizer Investigational Site Cork, Ireland Pfizer Investigational Site Dublin 8, Ireland Pfizer Investigational Site Dublin, Ireland Pfizer Investigational Site Galway, Ireland Poland Pfizer Investigational Site Czestochowa, Poland Pfizer Investigational Site Poznan, Poland Pfizer Investigational Site Warszawa, Poland Pfizer Investigational Site Wroclaw, Poland Pfizer Investigational Site Zabrze, Poland Portugal Pfizer Investigational Site Aveiro, Portugal Pfizer Investigational Site Lisboa, Portugal Pfizer Investigational Site Porto, Portugal Pfizer Investigational Site Vila Franca de Xira, Portugal Russian Federation Pfizer Investigational Site Moscow, Russian Federation Slovakia Pfizer Investigational Site Bratislava, Slovakia Pfizer Investigational Site Kosice, Slovakia Switzerland Pfizer Investigational Site Bern, Switzerland Pfizer Investigational Site Genève, Switzerland Pfizer Investigational Site Mendrisio, Switzerland Pfizer Investigational Site Zürich, Switzerland Less <<
NCT00433823 Coronary Heart Disease ... More >> Diabetes Mellitus Non-Coronary Atherosclerotic Disease Hypercholesterolemia Less << Phase 4 Unknown - Turkey ... More >> Bolu Izzet Baysal School of Medicine Recruiting Bolu, Turkey, 14280 Contact: Mustafa Kanat, MD    +905385448782    mustafa.kanat@gmail.com Less <<
NCT00428532 Diabetes Mellitus ... More >> Atherosclerosis Less << Not Applicable Unknown August 2007 Israel ... More >> HaEmek MC Recruiting Afula, Israel Contact: Wasseem Rock, MD    0547-866896    wasseem_rock@yahoo.com    Principal Investigator: Wasseem Rock, MD Less <<
NCT00442845 Coronary Arteriosclerosis ... More >> Diabetes Mellitus, Type 2 Cerebrovascular Accident Dyslipidemia Peripheral Vascular Disease Less << Phase 4 Completed - -
NCT00448344 Chronic Disease ... More >> Neoplasm Cardiovascular Disease Pulmonary Disease, Chronic Obstructive Diabetes Mellitus Hypertension Less << Not Applicable Completed - United States, North Carolina ... More >> Durham VA Medical Center, Durham, NC Durham, North Carolina, United States, 27705 Less <<
NCT00446277 - Suspended(The present study wa... More >>s joining 2005-41-4933 into one study) Less << June 2007 Denmark ... More >> Department of Ophthalmology, Frederiksberg University Hospital Frederiksberg, Copenhagen, Denmark, 2000 Less <<
NCT00432029 Diabetes Mellitus, Type 1 ... More >> Hypertension Hypercholesterolemia Regional Blood Flow Less << Not Applicable Completed - Austria ... More >> Department of Clinical Pharmacology, Medical University of Vienna Vienna, Austria, 1090 Less <<
NCT00457470 Diabetes Mellitus ... More >> Diabetic Retinopathy Less << Phase 2 Withdrawn(Cancelled before fir... More >>st patient enrolled) Less << - -
NCT00458081 Obesity Micro... More >>albuminuria Diabetes Mellitus, Type 2 Dyslipidemia Less << Phase 3 Terminated(Company decision ha... More >>s been taken in light of recent demands by certain national health authorities) Less << - Spain ... More >> Sanofi-Aventis Administrative Office Barcelona, Spain Less <<
NCT00461630 Cardiovascular Disease ... More >> Peripheral Arterial Disease Diabetes Mellitus Coronary Heart Disease Less << Phase 3 Completed - United Kingdom ... More >> Clinical Trial Service Unit, University of Oxford Oxford, United Kingdom, OX3 7LF Less <<
NCT00462631 Coronary Stenosis ... More >> Diabetes Mellitus Less << Phase 2 Phase 3 Completed - Malaysia ... More >> Cardiology Department, Institut Jantung Negara Kuala Lumpur, Malaysia, 50400 Less <<
NCT00462436 Coronary Artery Disease ... More >> Type II Diabetes Mellitus Less << Phase 2 Completed - Canada, Ontario ... More >> St. Michael's Hospital Toronto, Ontario, Canada, M5B 1W8 Less <<
NCT00448344 - Completed - -
NCT00473330 Diabetes Mellitus ... More >> Macular Edema Less << Phase 3 Completed - -
NCT00464061 Sleep Initiation and Maintenan... More >>ce Disorders Less << Phase 3 Terminated(Sponsor's decision ... More >>due to absence of demonstration of efficacy of volinanserin in primary insomnia with predominant sleep maintenance problems) Less << - -
NCT00461630 - Completed - -
NCT00476931 Diabetes Mellitus, Type 1 ... More >> Diabetes Mellitus, Type 2 Diabetic Polyneuropathy Less << Phase 2 Completed - United States, California ... More >> Coordinated Clinical Research La Jolla, California, United States, 92037 Advanced Medical Research, LLC Lakewood, California, United States, 90712 Torrance Clinical Research Lomita, California, United States, 90707 SF Clinical Research Center San Francisco, California, United States, 94109 Diablo Clinical Research Walnut Creek, California, United States, 94598 United States, Florida Bradenton Research Center Bradenton, Florida, United States, 34205 Neurology Clinical Research Sunrise, Florida, United States, 33351 Laszlo J. Mate', M.D. West Palm Beach, Florida, United States, 33407 United States, Kansas University of Kansas Medical Center Kansas City, Kansas, United States, 66160 United States, Nebraska Creighton Diabetes Center Omaha, Nebraska, United States, 68131 United States, Nevada Advanced Biomedical Research of America Las Vegas, Nevada, United States, 89123 United States, New York Upstate Clinical Research Albany, New York, United States, 12205 Peripheral Neuropathy Center, Weill Medical College of Cornell University New York, New York, United States, 10022 Neurological Institute Columbia University College of Physicians and Surgeons New York, New York, United States, 10032 United States, Pennsylvania Altoona Center for Clinical Research Duncansville, Pennsylvania, United States, 16635 United States, Texas Nerve and Muscle Center of Texas Houston, Texas, United States, 77030 Diabetes Center of the Southwest Midland, Texas, United States, 79705 DGD Research San Antonio, Texas, United States, 78229 United States, Washington Rainier Clinical Research Center Renton, Washington, United States, 98057 Mexico Instituto Mexicano de Investigación Clinica Mexico City, Col. Roma, Mexico, 06700 Less <<
NCT00482183 Coronary Artery Disease ... More >> Type 2 Diabetes Mellitus Less << Phase 2 Phase 3 Completed - -
NCT00488930 - Terminated(Terminated due to a... More >> lack of recruitment and decision by the PI not to continue.) Less << - United States, California ... More >> UCSD Medical Center San Diego, California, United States, 92103 Less <<
NCT01464320 Type 2 Diabetics, Chronic Kidn... More >>ey Disease, Protein in Urine Less << Phase 1 Completed - United States, Florida ... More >> Site Reference ID/Investigator# 63442 Miami, Florida, United States, 33136 Less <<
NCT00473382 - Completed - -
NCT00473330 - Completed - -
NCT00473382 Diabetes Mellitus ... More >> Macular Edema Less << Phase 3 Completed - -
NCT02766062 Postoperative Complications Not Applicable Completed - -
NCT01463969 - Completed - Turkey ... More >> Gulhane School of Medicine Dep. of Endocrine and Metabolism Ankara, Turkey, 06018 Gulhane School of Medicine Dep. of Endocrinology and Metabolism Ankara, Turkey, 06018 Gulhane School of Medicine Ankara, Turkey, 06018 Less <<
NCT00486629 Obesity Gesta... More >>tional Diabetes Type 2 Diabetes Less << Phase 2 Recruiting July 2020 Canada, Manitoba ... More >> University of Manitoba Recruiting Winnipeg, Manitoba, Canada, R3E 3P4 Contact: Garry Shen, MD PhD    204-789-3816    gshen@ms.umanitoba.ca Less <<
NCT01467193 - Completed - Switzerland ... More >> Department of Endocrinology, Diabetes and Clinical Nutrition, University Hospital Bern Berne, Switzerland, 3010 Less <<
NCT00490672 Hypertension ... More >>Diabetes Mellitus Hyperlipidemia Less << Phase 4 Completed - -
NCT00491543 Diabetes Coro... More >>nary Artery Disease Less << Phase 2 Completed - United States, Illinois ... More >> Radiant Research Chicago, Illinois, United States, 60610 United States, Ohio Radiant Research Cincinnati, Ohio, United States, 45249 Less <<
NCT00495885 Sleep Initiation and Maintenan... More >>ce Disorders Less << Phase 3 Completed - United States, New Jersey ... More >> Sanofi-Aventis Administrative Office Bridgewater, New Jersey, United States, 08807 Brazil Sanofi-Aventis Administrative Office Sao Paulo, Brazil Canada Sanofi-Aventis Administrative Office Laval, Canada Colombia Sanofi-Aventis Administrative Office Santafe de Bogota, Colombia Czech Republic Sanofi-Aventis Administrative Office Praha, Czech Republic Finland Sanofi-Aventis Administrative Office Helsinki, Finland France Sanofi-Aventis Administrative Office Paris, France Greece Sanofi-Aventis Administrative Office Athens, Greece Italy Sanofi-Aventis Administrative Office Milan, Italy Malaysia Sanofi-Aventis Administrative Office Kuala Lumpur, Malaysia Netherlands Sanofi-Aventis Administrative Office Gouda, Netherlands Russian Federation Sanofi-Aventis Administrative Office Moscow, Russian Federation South Africa Sanofi-Aventis Administrative Office Midrand, South Africa Switzerland Sanofi-Aventis Administrative Office Geneva, Switzerland Taiwan Sanofi-Aventis Administrative Office Taipei, Taiwan Turkey Sanofi-Aventis Administrative Office Istanbul, Turkey Less <<
NCT00513630 Type 2 Diabetes ... More >> Coronary Artery Disease Less << Phase 4 Completed - China ... More >> Shanghai Jiao Tong University School of Medicine Shanghai, China, 200025 Less <<
NCT02850562 Obesity Sarco... More >>penia Metabolic Syndrome X Less << Not Applicable Completed - -
NCT01472432 - Completed - -
NCT00536796 - Completed - Austria ... More >> Research Site Rohrbach, Upper Austria, Austria Less <<
NCT00536965 - Completed - Austria ... More >> Research Site Vienna, Austria Less <<
NCT01472432 Chronic Foot Ulcers Phase 4 Completed - Italy ... More >> Second university of Naples Naples, Italy, I-80100 Less <<
NCT00547872 Coronary Artery Disease ... More >> Diabetes Mellitus Less << Phase 3 Completed - Italy ... More >> Nuovo Ospedale Civile Sant'Agostino Estense Modena, MO, Italy, 41100 Less <<
NCT00550069 - Unknown January 2009 Israel ... More >> Sheba Medical Center Not yet recruiting Tel Hashomer, Israel, 52621 Principal Investigator: Iris Morag, MD Less <<
NCT01527747 Type 2 Diabetes ... More >> Hypertriglyceridemia Less << Phase 4 Enrolling by invitation December 2020 United States, Oregon ... More >> Oregon Health & Science University Portland, Oregon, United States, 97239 Less <<
NCT00550095 Microalbuminuria ... More >> Proteinuria Less << Phase 4 Completed - Egypt ... More >> Novartis Investigative Site , Cairo, Egypt Less <<
NCT00552903 Diabetes Mellitus, Type 2 ... More >> Heart Failure Coronary Disease Less << Phase 3 Unknown May 2010 Finland ... More >> Päijät-Hämeen Sosiaali - ja Terveysyhtymä Lahti, Finland, 15850 Less <<
NCT00561171 Hypertension ... More >>Type II Diabetes Mellitus Less << Phase 2 Completed - Ireland ... More >> Dr. John Barton Ballinasloe, Co Galway, Ireland Less <<
NCT00523042 Diabetes Diab... More >>etes Mellitus, Type 1 Diabetes Mellitus, Type 2 Asthma Less << Phase 3 Terminated(See termination rea... More >>son in detailed description) Less << - -
NCT00562952 Diabetes Mellitus ... More >> Heart Failure Coronary Artery Disease Less << Phase 2 Phase 3 Completed - Austria ... More >> General Hospital of Vienna Department of Endocrinology Vienna, Austria, 1090 Medical University of Vienna Vienna, Austria, 1090 Less <<
NCT00568854 - Terminated(Additional funding ... More >>was not secured) Less << - -
NCT00557518 Diabetes Mellitus, Type 1 ... More >> Diabetic Nephropathy Less << Phase 2 Terminated(Study has been term... More >>inated early due to financial constraints.) Less << November 2009 Australia, New South Wales ... More >> Royal Prince Alfred Hospital Camperdown, New South Wales, Australia, 2050 Australia, Victoria International Diabetes Institute Caulfield, Victoria, Australia, 3162 Dept. of Clinical and Biomedical Science Myers House Geelong, Victoria, Australia, 3220 Austin Health Heidelburg, Victoria, Australia, 3084 The Alfred Hospital Melbourne, Victoria, Australia, 3004 Denmark Steno Diabetes Center Gentofte, Denmark, DK-2820 Less <<
NCT00599040 Diabetes Hype... More >>rtension Insulin Resistance Less << Phase 4 Completed - United States, Alabama ... More >> University of Alabama at Birmingham Nutrition Sciences Department Birmingham, Alabama, United States, 35294 Less <<
NCT00600236 Diabetes Mellitus Type 2 ... More >> Proliferative Diabetic Retinopathy Less << Phase 3 Completed - Mexico ... More >> Asociación para Evitar la Ceguera en México, Hospital "Luis Sanchez Bulnes" Mexico City, Mexico DF, Mexico, 04030 Less <<
NCT00603499 Diabetes Mellitus ... More >> High Blood Pressure Hypomagnesemia Less << Phase 4 Completed - Mexico ... More >> Biomedical Research Unit Durango, Mexico, 34067 Less <<
NCT00611988 Peripheral Arterial Disease ... More >> Diabetes Mellitus Less << Phase 2 Completed - United States, Kansas ... More >> KU School of Medicine - Wichita Wichita, Kansas, United States, 67214 Less <<
NCT00605280 Macular Edema Associated With ... More >>Diabetes Mellitus Less << Phase 2 Phase 3 Completed - -
NCT01536236 Diabetic Polyneuropathy Not Applicable Withdrawn October 2014 United States, Missouri ... More >> Midwest Neurosurgery Associates Kansas City, Missouri, United States, 64132 Less <<
NCT00634608 Allergic Rhinitis ... More >> Asthma Back Pain Benign Prostatic Hypertrophy Bursitis Depression Anxiety Diabetes Mellitus Esophageal Reflux HIV Infections Hyperlipidemia Hypertension Insomnia Irritable Bowel Syndrome Obesity Osteoporosis (Senile) Shoulder Pain Sinusitis Symptomatic Menopause Urinary Incontinence Urinary Tract Infection Vaginitis Less << Not Applicable Completed - United States, Missouri ... More >> University of Missouri, Department of Internal Medicine Columbia, Missouri, United States, 65211 Less <<
NCT00642174 Diabetes Mellitus ... More >> Coronary Artery Disease Less << Phase 2 Completed - United States, Florida ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Jacksonville, Florida, United States, 32209 United States, Massachusetts For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Worcester, Massachusetts, United States, 01655 United States, New York For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. New York, New York, United States, 10029 United States, Oklahoma For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Oklahoma City, Oklahoma, United States, 73104 Less <<
NCT00645268 Erectile Dysfunction ... More >> Diabetes Mellitus, Type 2 Less << Phase 4 Completed - -
NCT00566189 Diabetes Mellitus, Type 2 ... More >> Insulin Resistance Obesity Less << Phase 2 Phase 3 Completed - Brazil ... More >> LIMED (Laboratory of Investigation of Metabolism and Diabetes)/GASTROCENTRO/Univeristy of Campinas (UNICAMP) Campinas, SP, Brazil Less <<
NCT00605280 - Completed - -
NCT00642616 - Terminated(Terminated upon rec... More >>ommendation of the Data Safety Monitoring Board (DSMB)) Less << - -
NCT00651196 - Completed - United States, Nebraska ... More >> Creighton University Omaha, Nebraska, United States, 68131 Less <<
NCT00642174 - Completed - -
NCT00568854 Tuberculosis ... More >>Diabetes Mellitus Less << Not Applicable Terminated(Additional funding ... More >>was not secured) Less << - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT00642616 Type 1 Diabetes Mellitus ... More >> Type 2 Diabetes Mellitus Moderate Chronic Obstructive Pulmonary Disease Asthma Less << Phase 3 Terminated(Terminated upon rec... More >>ommendation of the Data Safety Monitoring Board (DSMB)) Less << - United States, California ... More >> Mission Hills, California, United States, 91345 San Diego, California, United States, 92117 United States, Florida Palm Harbor, Florida, United States, 34684 United States, Michigan Flint, Michigan, United States, 48504 United States, North Carolina Morehead City, North Carolina, United States, 28557 United States, Oregon Medford, Oregon, United States, 97504 United States, South Carolina Greenville, South Carolina, United States, 29615 Spartanburg, South Carolina, United States, 29302 United States, Texas Dallas, Texas, United States, 75225 Dallas, Texas, United States, 75231 United States, Washington Federal Way, Washington, United States, 98003 Tacoma, Washington, United States, 98405 Russian Federation Yaroslavl, RUS, Russian Federation, 150002 Kemerovo, RU, Russian Federation, 650066 Moscow, RU, Russian Federation, 105120 St Petersburg, RU, Russian Federation, 198013 St. Petersburg, RU, Russian Federation, 191015 St. Petersburg, RU, Russian Federation, 191119 St. Petersburg, RU, Russian Federation, 194354 Ukraine Kiev, UA, Ukraine, 04114 Kyiv, UA, Ukraine, 01021 Less <<
NCT01681290 Diabetic Peripheral Neuropathy Phase 2 Completed - -
NCT00665145 Diabetes Mellitus, Type 1 ... More >> Diabetes Mellitus, Type 2 Diabetic Polyneuropathy Less << Phase 2 Completed - United States, California ... More >> La Jolla,, California, United States, 92037 Walnut Creek, California, United States, 94598 United States, Texas Houston, Texas, United States, 77030 San Antonio, Texas, United States, 78229 Less <<
NCT00666172 Atherosclerosis ... More >> Diabetes Mellitus Obesity Dyslipidemia Hypertension Less << Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00673621 Asthma Diabet... More >>es Mellitus Less << Phase 1 Completed - United Kingdom ... More >> Medicines Evaluation Unit (MEU) Manchester, England, United Kingdom, M23 9QZ ICON Development Solutions Manchester, United Kingdom, M15 6SH Less <<
NCT00655330 Type 2 Diabetes Mellitus ... More >> Nephropathy Less << Not Applicable Unknown May 2017 China, Guangdong ... More >> Guangdong General Hospital Guangzhou, Guangdong, China, 510080 Less <<
NCT02633462 Polycystic Ovary Syndrome ... More >> Periodontitis Insulin Resistance Less << Phase 2 Unknown October 2016 -
NCT03714282 Stroke Not Applicable Recruiting December 31, 2020 United States, Illinois ... More >> Shirley Ryan AbilityLab Recruiting Chicago, Illinois, United States, 60611 Contact: Lori McGee Koch    312-238-2091    lmkoch@ricres.org    Contact: Kristen Hohl    312-238-2640       Principal Investigator: Arun Jayaraman, PT,PhD Less <<
NCT00598013 Kidney Transplantation ... More >> Insulin Resistance Atherosclerosis Less << Not Applicable Completed - Korea, Republic of ... More >> Yonsei University College of Medicine Seoul, Korea, Republic of, 120-752 Less <<
NCT01589224 - Completed - Korea, Republic of ... More >> korea University Guro Hospital Seoul, Korea, Republic of Less <<
NCT00065793 - Completed - -
NCT01724749 - Unknown December 2016 Denmark ... More >> Department of Cardiology, Odense University Hospital Recruiting Odense, Region Syddanmark, Denmark, 5000 Contact: Axel Diederichsen, MD       Axel.Diederichsen@ouh.regionsyddanmark.dk    Department of Nuclear Medicine, Odense University Hospital Recruiting Odense, Region Syddanmark, Denmark, 5000 Contact: Poul F Høilund-Carlsen, MD, DMSc       pfhc@ouh.regionsyddanmark.dk    Principal Investigator: Björn A Blomberg, MD, MSc          Sub-Investigator: Anders Thomassen, MD          Sub-Investigator: Malene Hildebrandt, MD, PhD          Sub-Investigator: Søren Hess, MD Less <<
NCT02424539 Rhinitis, Allergic, Perennial ... More >>and Seasonal Less << Phase 4 Completed - China, Fujian ... More >> GSK Investigational Site Xiamen, Fujian, China, 361003 China, Guangdong GSK Investigational Site Shenzhen, Guangdong, China, 518038 China, Hunan GSK Investigational Site Changsha, Hunan, China, 410005 GSK Investigational Site Changsha, Hunan, China, 410011 China, Jiangsu GSK Investigational Site Nanjing, Jiangsu, China, 210029 China, Shanxi GSK Investigational Site Taiyuan, Shanxi, China, 030016 China, Zhejiang GSK Investigational Site Wenzhou, Zhejiang, China, 323027 China GSK Investigational Site Beijing, China, 100034 GSK Investigational Site Beijing, China GSK Investigational Site Changsha, China GSK Investigational Site Chongqing, China, 400014 GSK Investigational Site Fuzhou, China, 350025 GSK Investigational Site Hangzhou, China, 310052 GSK Investigational Site Shanghai, China, 200040 GSK Investigational Site Shanghai, China, 200092 GSK Investigational Site Shanghai, China, 200127 Less <<
NCT00072904 Cystic Fibrosis ... More >> Diabetes Mellitus Less << Phase 3 Completed - United States, California ... More >> Stanford University Palo Alto, California, United States, 94304 United States, Massachusetts Baystate Medical Center Springfield, Massachusetts, United States, 01199 United States, Minnesota University of Minnesota Medical Center Minneapolis, Minnesota, United States, 55455 United States, Pennsylvania Children's Hospital of Pittsburgh Pittsburgh, Pennsylvania, United States, 15213-2583 United States, Tennessee Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232-2650 United States, Utah University of Utah Salt Lake City, Utah, United States, 84132-4701 Canada, Ontario St. Michael's Hospital Toronto, Ontario, Canada, M5B 1W8 Less <<
NCT01684813 Diabetes Mellitus Type II ... More >> Acute Coronary Syndrome Less << Phase 4 Completed - Spain ... More >> Hospital Universitario Virgen del Rocío Seville, Spain, 41013 Less <<
NCT00607646 Type 1 Diabetes Early Phase 1 Completed - United States, Maryland ... More >> University of Maryland, Baltimore Baltimore, Maryland, United States, 21201 Less <<
NCT00073034 Diabetes Mellitus ... More >> Diabetic Neuropathy, Painful Less << Phase 2 Terminated - -
NCT02807974 Hypertension Phase 3 Completed - Japan ... More >> Sanuki-shi, Kagawa, Japan Less <<
NCT00575783 - Completed - United States, Connecticut ... More >> Yale University School of Medicine New Haven, Connecticut, United States, 06520 Less <<
NCT00078052 - Completed - -
NCT00738660 Diabetic Nephropathy Phase 3 Completed - India ... More >> Post Graduate Institute of Medical Education and Research Chandigarh, India, 1600012 Less <<
NCT01758770 - Completed - China, Beijing ... More >> Beijing ji shui tan hospitla Beijing, Beijing, China, 100035 Less <<
NCT01022619 - Unknown - Israel ... More >> Meir Hospital Not yet recruiting Kfar-Saba, Israel, 44281 Contact: Tal Biron Shental, MD          Sub-Investigator: Tal Biron-Shental, MD          Asaf Harofeh Medical Center Not yet recruiting Zerifin, Israel, 70300 Contact: Arnon Elizur, MD          Sub-Investigator: Arnon Elizur, MD Less <<
NCT01887119 Abdominal Obesity Metabolic Sy... More >>ndrome Insulin Resistance Hypertension Less << Phase 4 Terminated(Failure to recruit ... More >>sufficient participants) Less << - Netherlands ... More >> Maastricht University Maastricht, Limburg, Netherlands, 6229 ER Less <<
NCT02799264 Infection, Human Immunodeficie... More >>ncy Virus Less << Phase 1 Completed - United States, Kansas ... More >> GSK Investigational Site Overland Park, Kansas, United States, 66211 Less <<
NCT01087411 Cardiovascular Risk Factors ... More >> Metabolic Risk Factors Sedentary Lifestyle Overweight Less << Not Applicable Terminated(2010 represented co... More >>mplications recruiting. The team suffered from sick-leave.) Less << December 2012 Sweden ... More >> Karolinska Institutet, Dept. of Clinical Science, Intervention and Technology (CLINTEC), Division of Pediatrics. Huddinge, Södermanland, Sweden, 14186 Less <<
NCT03472846 Postmenopausal Osteoporosis ... More >> Diabetes Type 2 Less << Phase 4 Recruiting December 31, 2020 Austria ... More >> Medical University Vienna; St. Vincent Hospital Recruiting Vienna, Austria, 1060 Contact: Christian Muschitz, M.D.    +43159988 ext 2119    christian.muschitz@bhs.at    Contact: Zora Messner, M.D.    +43159988 ext 6145    zora.messner@bhs.at    Principal Investigator: Roland Kocijan, M.D.          Sub-Investigator: Zora Messner, M.D.          Sub-Investigator: Christian Muschitz, M.D.          Sub-Investigator: Heinrich Resch, M.D.          Sub-Investigator: Judith Haschka, M.D. Less <<
NCT01875341 Type 2 Diabetes ... More >> Diabetic Nephropathy Hypertension Sleep Apnea Less << Phase 3 Completed - Canada, Ontario ... More >> The Ottawa Hospital Ottawa, Ontario, Canada, K1H 7W9 Less <<
NCT00005130 - Completed - -
NCT00005133 - Completed - -
NCT00005116 Depression Di... More >>abetes Mellitus, Insulin-Dependent Less << Not Applicable Completed - United States, Pennsylvania ... More >> WPIC Pittsburgh, Pennsylvania, United States, 15213 Less <<
NCT00005135 - Completed - -
NCT00005140 - Completed - -
NCT00005124 - Completed - -
NCT00005168 - Completed - -
NCT00005205 - Completed - -
NCT00005134 - Completed - -
NCT00005347 - Completed - -
NCT00005184 - Completed - -
NCT00005365 - Completed - -
NCT00005419 - Completed - -
NCT00005441 - Completed - -
NCT00005266 - Completed - -
NCT00005474 - Completed - -
NCT00005462 - Completed - -
NCT00005374 - Completed - -
NCT00005489 - Completed - -
NCT00005754 - Completed - -
NCT00005152 - Active, not recruiting May 2019 -
NCT03520556 - Active, not recruiting June 2019 Canada ... More >> Institute of Nutrition and Functional Foods (INAF) Quebec, Canada, G1V 0A6 Less <<
NCT00005479 - Completed - United States, New York ... More >> Columbia University New York, New York, United States, 10032 Less <<
NCT00006426 Diabetes Mellitus ... More >> Foot Ulcer Peripheral Neuropathy Less << Phase 1 Completed - United States, Missouri ... More >> Barnes-Jewish Hospital, Orthopedic Surgery St. Louis, Missouri, United States, 63110 Less <<
NCT00172614 - Unknown - Taiwan ... More >> National Taiwan University Hospital Recruiting Taipei, Taiwan Contact: Jaw-Shiun Tsai, MD Less <<
NCT00005487 - Unknown - -
NCT00006305 Coronary Disease ... More >> Cardiovascular Diseases Heart Diseases Insulin Resistance Diabetes Mellitus Diabetes Mellitus, Non-Insulin-Dependent Less << Phase 3 Completed - -
NCT01106118 - Completed - Egypt ... More >> Many Locations, Egypt Israel Many Locations, Israel Kazakhstan Many Locations, Kazakhstan Korea, Republic of Many Locations, Korea, Republic of Kyrgyzstan Many Locations, Kyrgyzstan Lebanon Many Locations, Lebanon Russian Federation Many Locations, Russian Federation Saudi Arabia Many Locations, Saudi Arabia Singapore Many Locations, Singapore Ukraine Many Locations, Ukraine Less <<
NCT02878798 Cryptogenic Sensory Peripheral... More >> Neuropathy in Metabolic Syndrome Less << Phase 2 Recruiting December 2021 United States, Alabama ... More >> University of Alabama Birmingham Recruiting Birmingham, Alabama, United States, 35233 Contact: Melanie Benge    205-975-0445    melaniebenge@uabmc.edu    Principal Investigator: Eroboghene Ubogu, MD          United States, Colorado University of Colorado Denver Recruiting Aurora, Colorado, United States, 80045 Contact: Brianna Blume    303-724-6386    brianna.blume@ucdenver.edu    Principal Investigator: Dianna Quan, MD          United States, Florida University of Miami Recruiting Miami, Florida, United States, 33136 Contact: Wendy Levy    305-243-6725    wel20@med.miami.edu    Principal Investigator: Mario Saporta, MD, PhD          United States, Illinois Northwestern University Recruiting Chicago, Illinois, United States, 60611 Contact: Tina Ward    312-503-2128    tina.ward@northwestern.edu    Principal Investigator: Daniela Menichella, MD, PhD          United States, Kansas University of Kansas Medical Center Recruiting Kansas City, Kansas, United States, 66160 Contact: Chad Parks    913-945-9938    cparks@kumc.edu    Principal Investigator: Mamatha Pasnoor, MD          United States, Massachusetts Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: Peter James    617-643-4218    pfjames@partners.org    Principal Investigator: Reza Seyedsadjadi, MD          United States, Missouri Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: Mengesha Teshome    314-747-8420    teshomem@wustl.edu    Principal Investigator: Glenn Lopate, MD          United States, New York Columbia University Medical Center Recruiting New York, New York, United States, 10032 Contact: Arruem Kim    212-305-6036    ak3905@cumc.columbia.edu    Principal Investigator: Thomas Brannagan, MD          University of Rochester Medical Center Recruiting Rochester, New York, United States, 14642 Contact: Janet Sowden    585-275-1267    janet_sowden@urmc.rochester.edu    Principal Investigator: David Herrmann, MBBCh, MD          United States, Ohio Ohio State University Recruiting Columbus, Ohio, United States, 43221 Contact: Amy Bartlett    614-366-9050    amy.bartlett@osumc.edu    Principal Investigator: Amro Stino, MD          United States, Tennessee Vanderbilt University Medical Center Recruiting Nashville, Tennessee, United States, 37232 Contact: Kelly Lowen    615-936-0209    kelly.lowen@vumc.org    Principal Investigator: Amanda Peltier, MD          United States, Texas UT Southwestern Medical Center Not yet recruiting Dallas, Texas, United States, 75390 Contact: Mariam Andersen    214-648-6329    mariam.andersen@utsouthwestern.edu    Principal Investigator: Lauren Phillips, MD          United States, Virginia Eastern Virginia Medical Center Recruiting Norfolk, Virginia, United States, 23510 Contact: Carolina Caselllini    757-446-7976    casellcm@evms.edu    Principal Investigator: Aaron Vinik, MD,PhD          Virginia Commonwealth University Not yet recruiting Richmond, Virginia, United States, 23298 Contact: Gordon Smith, MD    804-828-9556    gordon.smith@vcuhealth.org    Contact: Brittney A Holmberg    804-658-6439    brittney.holmberg@vcuhealth.org    Principal Investigator: Gordon Smith, MD Less <<
NCT00006305 - Completed - -
NCT00252720 Type 1 Diabetes Phase 3 Completed - -
NCT01209000 - Recruiting June 30, 2019 -
NCT02898142 Hypertriglyceridemia ... More >> Metabolic Syndrome Less << Not Applicable Completed - France ... More >> Pitié Salpetriere Hospital Paris, France, 75013 Less <<
NCT00252733 Type 1 Diabetes Phase 3 Completed - Australia ... More >> Research Site Herston, Australia Research Site Perth, Australia Denmark Research Site Odense, Denmark Less <<
NCT00252733 - Completed - -
NCT00010751 Coronary Disease ... More >> Diabetes Mellitus, Non-Insulin-Dependent Less << Phase 2 Completed - United States, Michigan ... More >> Taubman Center Ann Arbor, Michigan, United States, 48109-0344 Less <<
NCT00011206 - Completed - -
NCT00252720 - Completed - -
NCT00007800 Diabetes Mellitus, Type 2 ... More >> Obesity Less << Phase 2 Completed - United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35205 Less <<
NCT02961088 - Unknown August 2018 -
NCT03713333 Cardiovascular Diseases ... More >> Hypertension Heart Failure Atrial Fibrillation Metabolic Syndrome Genetic Disease Less << Not Applicable Not yet recruiting October 20, 2019 -
NCT02026323 Polycystic Ovary Syndrome ... More >> Insulin Resistance Less << Not Applicable Unknown May 2015 China, Guangdong ... More >> The first affiliated hospital of Guangzhou Medical University Guangzhou, Guangdong, China, 510120 Less <<
NCT00289237 CHD AMI ... More >> CVD Type 2 Diabetes COLD Less << Not Applicable Completed - Denmark ... More >> Research Centre for Prevention and Health Glostrup, Denmark, 2600 Less <<
NCT00284960 - Completed - United States, Pennsylvania ... More >> Hershey Med Center Hershey, Pennsylvania, United States, 17033 Less <<
NCT00324675 Type 2 Diabetes ... More >> Overt Diabetic Nephropathy Less << Not Applicable Completed - Germany ... More >> University hospital Dresden Dresden, Germany, 01307 Less <<
NCT00324675 - Completed - -
NCT01253733 Cystic Fibrosis ... More >> Inflammatory Bowel Disease Type 1 Diabetes Chronic Disease Management Less << Not Applicable Completed - United States, California ... More >> University of California, San Diego La Jolla, California, United States, 92093 Less <<
NCT01258322 Peritoneal Dialysis ... More >> Pioglitazone Hypertriglyceridemia Insulin Resistance Inflammation Less << Not Applicable Completed - -
NCT03142503 Arthritis, Psoriatic ... More >> Metabolic Syndrome Less << Not Applicable Completed - -
NCT00029848 Obesity Diabe... More >>tes Mellitus, Non-Insulin-Dependent Obesity in Diabetes Less << Phase 3 Completed - -
NCT00017953 Diabetes Myoc... More >>ardial Infarction Stroke Kidney Diseases Bone Diseases Dyslipidemia Less << Not Applicable Active, not recruiting January 2020 United States, Alabama ... More >> The University of Alabama at Birmingham Birmingham, Alabama, United States, 35205 United States, Arizona Southwestern American Indian Center Phoenix, Arizona, United States, 85014 United States, California University of Southern California Los Angeles, California, United States, 90022 United States, Colorado University of Colorado Health Sciences Center Aurora, Colorado, United States, 80045-0808 United States, Louisiana Louisiana State University Baton Rouge, Louisiana, United States, 70808 United States, Maryland Johns Hopkins Pro-Health Baltimore, Maryland, United States, 21207 United States, Massachusetts Diabetes Center Boston, Massachusetts, United States, 02114 Joslin Diabetes Center Boston, Massachusetts, United States, 02114 United States, Minnesota University of Minnesota Minneapolis, Minnesota, United States, 55415-1226 United States, New Mexico Northern Navajo Medical Center Shiprock, New Mexico, United States, 87420 United States, New York Columbia University New York, New York, United States, 10019 United States, Pennsylvania University of Pennsylvania Medical Center Philadelphia, Pennsylvania, United States, 19104 University of Pittsburgh Pittsburgh, Pennsylvania, United States, 15213 United States, Rhode Island The Miriam Hospital Providence, Rhode Island, United States, 02906 United States, Tennessee The University of Tennessee, Memphis Memphis, Tennessee, United States, 38105 United States, Texas Baylor College of Medicine Houston, Texas, United States, 77030 University of Texas Health Sciences Center San Antonio, Texas, United States, 78229 United States, Washington University of Washington Seattle, Washington, United States, 98108 Less <<
NCT03182569 Diabetic Ketoacidosis Not Applicable Completed - Argentina ... More >> Hospital General de Niños Pedro de Elizalde Buenos Aires, Constitucion, Argentina, C1270AAN Less <<
NCT03206164 Obesity Hyper... More >>tension Hypercholesterolemia Hyperglycemia Less << Not Applicable Active, not recruiting June 30, 2018 United States, Illinois ... More >> UIC Chicago, Illinois, United States, 60608 Less <<
NCT00027287 Diabetes Mellitus ... More >> Macular Edema Less << Phase 1 Completed - United States, Maryland ... More >> National Eye Institute (NEI) Bethesda, Maryland, United States, 20892 Less <<
NCT00031213 - Completed - -
NCT00031239 - Completed - -
NCT00031200 - Completed - -
NCT03271866 Schizophrenia Not Applicable Recruiting March 1, 2019 China, Hunan ... More >> The Second Xiangya Hospital of Central South University Recruiting Changsha, Hunan, China, 410011 Contact: Tiannan Shao, M.D., Ph.D.    +86 13341318057    shaostndoc@163.com    Contact: Renrong Wu, M.D., Ph.D.       wurenrong2013@163.com    Principal Investigator: Dongyu Kang, M.D. Less <<
NCT00031226 - Completed - -
NCT00035750 - Completed - -
NCT01302327 Diabetes Mellitus Associated W... More >>ith Genetic Syndrome Wolfram Syndrome Less << Not Applicable Unknown - -
NCT03604315 Breast Carcinoma ... More >> Fallopian Tube Carcinoma Ovarian Carcinoma Primary Peritoneal Carcinoma Recurrent Fallopian Tube Carcinoma Recurrent Ovarian Carcinoma Recurrent Primary Peritoneal Carcinoma Solid Neoplasm Less << Phase 1 Not yet recruiting August 31, 2020 United States, Texas ... More >> M D Anderson Cancer Center Not yet recruiting Houston, Texas, United States, 77030 Contact: Lilie L. Lin    713-563-2300       Principal Investigator: Lilie L. Lin Less <<
NCT00035711 - Completed - -
NCT00412906 Healthy Type ... More >>2 Diabetes Endotoxemia Less << Not Applicable Completed - Denmark ... More >> Centre of Inflammaiton and Metabolism, Rigshospitalet Copenhagen, Denmark, 2100 Less <<
NCT03297749 - Active, not recruiting December 31, 2020 Italy ... More >> University of Catania Catania, Italy United Kingdom UCL London, United Kingdom, EN54LU Less <<
NCT00041405 - Completed - -
NCT03667469 Obesity Not Applicable Recruiting September 30, 2020 Kazakhstan ... More >> National Scientific Center for Oncology and Transplantation Recruiting Astana, Kazakhstan, 010000 Contact: Oral B Ospanov, Prof.    +77015287734    bariatric.kz@gmail.com    Contact: Alma A Syzdykova, PhD    +77014202882    alma.syzdykova@umc.org.kz Less <<
NCT00041444 - Completed - -
NCT01353807 Preterm Delivery ... More >> Atopy Metabolic Syndrome Less << Not Applicable Completed - Denmark ... More >> Aarhus University Hospital Aarhus, Denmark, DK-8000 Less <<
NCT00419484 - Completed - Japan ... More >> Dokkyo Medical University, Koshigaya Hospital Koshigaya, Saitama, Japan, 343-8555 Less <<
NCT03381469 Low Birth Weight Baby ... More >> Metabolic Syndrome Pregnancy Complications Adverse Pregnancy Outcomes Periodontitis Premature Birth Less << Not Applicable Recruiting December 1, 2018 Saudi Arabia ... More >> Riyadh Colleges of Dentistry and Pharmacy Recruiting Riyadh, Saudi Arabia, 11681 Riyadh Colleges of Dentistry and Pharmacy Recruiting Riyadh, Saudi Arabia, 11681 Contact: Hezakiah Mosadomi, PhD    00966112931177 ext 132    prof.mosadomi@riyadh.edu.sa Less <<
NCT00413348 Type 2 Diabetes ... More >> Healthy Endotoxemia Less << Not Applicable Unknown - Denmark ... More >> Center of Inflammation and metabolism 7641 and Intensive Care Unit 4131, Rigshospitalet Recruiting Copenhagen, Denmark, DK-2100 Principal Investigator: Anne Sofie Andreasen, MD Less <<
NCT00044746 Diabetes Mellitus ... More >> Diabetic Foot Less << Phase 4 Completed - -
NCT00044408 Diabetic Neuropathies ... More >> Diabetes Mellitus, Insulin-Dependent Diabetes Mellitus, Non-Insulin-Dependent Less << Phase 3 Completed - -
NCT00044395 Diabetic Neuropathies ... More >> Diabetes Mellitus, Insulin-Dependent Diabetes Mellitus, Non-Insulin-Dependent Less << Phase 3 Completed - -
NCT01412216 Endothelial Dysfunction ... More >> Insulin Resistance Metabolic Syndrome Peripheral Arterial Disease Less << Phase 2 Terminated(Funding Depleted.) - United States, California ... More >> University of California San Francisco San Francisco, California, United States Less <<
NCT02419898 - Recruiting December 31, 2018 United Kingdom ... More >> The Nuffield Department of Obstetrics and Gynaecology Recruiting Oxford, United Kingdom, OX39DU Contact: Ingrid Granne    01865 740887    ingrid.granne@obs-gyn.ox.ac.uk    Contact: Sian Harrison    01865 289358    sian.harrison@phc.ox.ac.uk Less <<
NCT03414957 - Completed - -
NCT03441620 Hyper-LDL-cholesterolemia ... More >> Metabolic Syndrome Less << Not Applicable Recruiting December 31, 2019 United States, Nevada ... More >> University of Nevada at Las Vegas Recruiting Las Vegas, Nevada, United States, 89154 Contact: Arpita Basu, PhD          United States, Oklahoma University of Oklahoma Health Sciences Center, OCTSI Recruiting Oklahoma City, Oklahoma, United States, 73104 Contact: Hal Scofield, MD Less <<
NCT02430987 - Completed - Brazil ... More >> Rua Maria José Pomar, 322 Apartamento 172 C São Paulo, Brazil, 02436070 Less <<
NCT03445741 Metabolic Syndrome Not Applicable Completed - -
NCT00413465 Healthy Type ... More >>2 Diabetes Endotoxemia Less << Not Applicable Unknown - Denmark ... More >> Intensiv Care Unit, Rigshospitalet, Recruiting Copenhagen, Denmark, 2100 Principal Investigator: Anne Sofie Andreasen, MD Less <<
NCT00457938 Insulin Resistance ... More >> Hypertriglyceridemia Diabetes Hepatic Steatosis Less << Not Applicable Completed - United States, Texas ... More >> UT Southwestern Medical Center Dallas, Texas, United States, 75390 Less <<
NCT00390845 Pain, Neuropathic Phase 2 Completed - Australia, New South Wales ... More >> GSK Investigational Site Broadmeadow, New South Wales, Australia, 2292 GSK Investigational Site Randwick, New South Wales, Australia, 2031 Germany GSK Investigational Site Wuerzburg, Bayern, Germany, 97080 GSK Investigational Site Hannover, Niedersachsen, Germany, 30625 GSK Investigational Site Bochum, Nordrhein-Westfalen, Germany, 44789 GSK Investigational Site Koeln, Nordrhein-Westfalen, Germany, 50937 Russian Federation GSK Investigational Site Moscow, Russian Federation, 117292 United Kingdom GSK Investigational Site Cambridge, Cambridgeshire, United Kingdom, CB2 0QQ GSK Investigational Site Glasgow, Lanarkshire, United Kingdom, G12 0YN GSK Investigational Site Solihull, West Midlands, United Kingdom, B91 2JL GSK Investigational Site Liverpool, United Kingdom, L9 7LJ GSK Investigational Site London, United Kingdom, W12 0NN GSK Investigational Site London, United Kingdom, WC1X 8LD Less <<
NCT00049907 - Completed - -
NCT00001395 - Completed - United States, Maryland ... More >> National Eye Institute (NEI) Bethesda, Maryland, United States, 20892 Less <<
NCT00460135 Childhood Obesity ... More >> Body Composition Resistance Training Insulin Resistance Less << Not Applicable Completed - Canada, Quebec ... More >> Montreal Children's Hospital Montreal, Quebec, Canada, H3H 1P3 Less <<
NCT00491322 - Completed - -
NCT00495235 - Completed - United States, Texas ... More >> Baylor College of Medicine/Clinics Houston, Texas, United States, 77030 Ben Taub Hospital Houston, Texas, United States, 77030 Gynecologic Oncology of Houston Houston, Texas, United States, 77030 Lyndon B. Johnson General Hospital Houston, Texas, United States, 77030 St. Luke's Episcopal Hospital Houston, Texas, United States, 77030 The Methodist Hospital Houston, Texas, United States, 77030 The Woman's Hospital of Texas Houston, Texas, United States, 77030 UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00491322 Vitamin D Deficiency Not Applicable Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT00053534 - Completed - -
NCT00497978 Insulin Resistance ... More >> Elderly Patient Oxidative Stress Less << Not Applicable Completed - Netherlands ... More >> Medical Center Alkmaar Alkmaar, Noord-Holland, Netherlands, 1800 AM Less <<
NCT00504712 Hypogonadism ... More >>Peripheral Vascular Disease Type 2 Diabetes Less << Phase 4 Unknown February 2008 United Kingdom ... More >> Barnsley Hospital NHS Foundation Trust Recruiting Barnsley, South Yorkshire, United Kingdom, S75 2EP Contact: Roger D Stanworth    01226 777947    roger.stanworth@nhs.net Less <<
NCT01534910 Metabolic Syndrome Phase 4 Completed - United States, California ... More >> Los Angeles Biomedical Research Institute Torrance, California, United States, 90502 Less <<
NCT01534910 - Completed - -
NCT03622320 - Recruiting June 30, 2019 Egypt ... More >> Cairo university hospitals, dermatology outpatient clinic Recruiting Cairo, Egypt Contact: Rania Mogawer, MSc    01113363019 ext 002    raniamogawer88@gmail.com    Contact: Sarah Ismail, MD    01224247232 ext 002    sarah.ibrahim@kasralainy.edu.eg Less <<
NCT00055042 Macular Edema ... More >> Diabetes Mellitus Less << Phase 1 Completed - United States, Maryland ... More >> National Eye Institute (NEI) Bethesda, Maryland, United States, 20892 Less <<
NCT03648138 Obesity Weigh... More >>t Gain Diabetes Type 2 Less << Not Applicable Not yet recruiting January 31, 2019 -
NCT02577536 - Recruiting September 30, 2021 United States, Maryland ... More >> National Institute of Child Health and Human Development Recruiting Bethesda, Maryland, United States, 20892 Contact: Caroline C Signore, MD    301-496-5577    signorec@mail.nih.gov    Contact: Stephanie Wilson Archer, MA    301-496-0430    archerst@mail.nih.gov    Sub-Investigator: Sujata Bardhan, PhD          Sub-Investigator: Lisa Kaeser, JD          Sub-Investigator: Melissa Parisi, MD PhD          Sub-Investigator: Debbie Jae, MS          Sub-Investigator: Vanessa Rangel Miller, MS CGC MBA          Sub-Investigator: Jud Rhode          Sub-Investigator: Albert Carrasco          Sub-Investigator: Scott Clarke          Sub-Investigator: Jan Laibe Less <<
NCT00082316 Herpes Zoster ... More >> Neuralgia Pain HIV Infections Peripheral Nervous System Diseases Diabetic Neuropathies Diabetes Mellitus Polyneuropathies Less << Phase 2 Completed - United States, Alabama ... More >> NeurogesX Investigational Site Huntsville, Alabama, United States, 35801 NeurogesX Investigational Site Mobile, Alabama, United States, 36608 United States, Arizona NeurogesX Investigational Site Phoenix, Arizona, United States, 85023 United States, California NeurogesX Investigational Site Fountain Valley, California, United States, 92708 NeurogesX Investigational Site Los Gatos, California, United States, 95032 United States, Colorado NeurogesX Investigational Site Denver, Colorado, United States, 80209 United States, Florida NeurogesX Investigational Site Clearwater, Florida, United States, 33765 NeurogesX Investigational Site New Port Richey, Florida, United States, 34652 NeurogesX Investigational Site North Miami, Florida, United States, 33161 NeurogesX Investigational Site Plantation, Florida, United States, 33324 United States, Iowa NeurogesX Investigational Site West Des Moines, Iowa, United States, 50265 United States, Massachusetts NeurogesX Investigational Site Wellesley Hills, Massachusetts, United States, 02481-2106 United States, Missouri NeurogesX Investigational Site Saint Louis, Missouri, United States, 63108 United States, New Jersey NeurogesX Investigational Site Greensboro, New Jersey, United States, 27408 United States, Pennsylvania NeurogesX Investigational Site Duncansville, Pennsylvania, United States, 16635 United States, Texas NeurogesX Investigational Site San Antonio, Texas, United States, 78229 United States, Utah NeurogesX Investigational Site Salt Lake City, Utah, United States, 84106 Less <<
NCT03642600 PCOS Obesity ... More >> Metabolic Syndrome Less << Phase 4 Not yet recruiting December 30, 2019 -
NCT00084110 - Terminated - United States, Texas ... More >> Jose A. Loera Galveston, Texas, United States, 77555-0460 Less <<
NCT00086450 Cardiovascular Diseases ... More >> Coronary Disease Diabetes Mellitus Heart Diseases Less << Phase 3 Unknown December 2018 United States, New York ... More >> Icahn School of Medicine at Mount Sinai New York, New York, United States, 10029 Less <<
NCT00089557 Herpes Zoster ... More >> Neuralgia Pain HIV Infections Peripheral Nervous System Diseases Diabetic Neuropathies Diabetes Mellitus Polyneuropathies Less << Phase 2 Terminated - -
NCT00780650 Type 1 Diabetes Early Phase 1 Completed - United States, Maryland ... More >> Univerisity of Maryland, Baltimore Baltimore, Maryland, United States, 21201 Less <<
NCT00818142 - Completed - United States, Minnesota ... More >> Park Nicollet Eating Disorder Institute Minneapolis, Minnesota, United States, 55416 Less <<
NCT01897363 - Completed - United States, Florida ... More >> University of Florida Gainesville, Florida, United States, 32610 Less <<
NCT00086450 - Unknown - -
NCT00840307 - Completed - United States, Texas ... More >> University of Texas Southwestern Dallas, Texas, United States, 75390 Less <<
NCT01923350 Weight Reduction Not Applicable Completed - United States, Maryland ... More >> Social & Scientific Systems Inc. Silver Spring, Maryland, United States, 20910 Less <<
NCT03534037 Hyperuricemia ... More >> Metabolic Syndrome Left Ventricular Diastolic Dysfunction Less << Phase 4 Active, not recruiting March 2020 Taiwan ... More >> Tri-service General Hospital, songshan branch Taipei, Songshan Dist., Taiwan, 105 Less <<
NCT01928355 - Unknown - -
NCT02289365 Radiodermatitis Phase 2 Unknown December 2016 Taiwan ... More >> Departmant of Radiotherapy, Kaohsiung Medical University Chung-Ho Memorial Hospital Kaohsiung, Taiwan, 80756 Department of Radiation Oncology, China Medical University Hospital Taichung, Taiwan Department of Oncology, Taipei Verterans General Hospital Taipei, Taiwan, 11217 Less <<
NCT01787591 Non-alcoholic Fatty Liver ... More >> Metabolic Syndrome Less << Not Applicable Completed - United States, Ohio ... More >> Ohio State University Columbus, Ohio, United States, 43210 Less <<
NCT01753921 - Recruiting July 2020 United States, California ... More >> Stanford University Recruiting Stanford, California, United States, 94305 Contact: Tandy Aye, MD    650-723-5791    taye@stanford.edu Less <<
NCT01806142 Metabolic Syndrome X Not Applicable Completed - Canada ... More >> Institute of Nutrition and Functional Foods (INAF) Quebec, Canada, G1V 0A6 Less <<
NCT00840307 - Completed - -
NCT02641925 Metabolic Syndrome ... More >> Gastric Cancer Less << Not Applicable Recruiting August 2020 Korea, Republic of ... More >> Chonnam National University Hwasun Hospital Recruiting Hwasun, Jeollanam-do, Korea, Republic of, 519-809 Contact: Young Kyu Park, MD, PhD          Sub-Investigator: Seong Yeop Ryu, MD, PhD          Sub-Investigator: Jeong Oh, MD, PhD          Sub-Investigator: Mi Ran Jung, MD, PhD          Dong-A University Hospital Recruiting Busan, Korea, Republic of, 602-715 Contact: Min Chan Kim, MD, PhD          Principal Investigator: Min Chan Kim, MD, PhD          Keimyung University Dongsan Medical Center Recruiting Daegu, Korea, Republic of, 700-712 Contact: Seung Wan Ryu, MD, PhD    82-53-250-7322    gsman@dsmc.or.kr    Contact: In Gyu Kwon, MD    82-53-250-7322    surgeon@dsmc.or.kr    Principal Investigator: Seung Wan Ryu, MD, PhD          Sub-Investigator: In Gyu Kwon, MD          Sub-Investigator: Young Gil Son, MD, PhD Less <<
NCT02649348 Stomach Neoplasms ... More >> Metabolic Syndrome X Less << Not Applicable Unknown December 2016 China, Shandong ... More >> the Affiliated Hospital of Qingdao University Recruiting Qingdao, Shandong, China, 266001 Contact: Yanbing Y Zhou, MD.    053282911324    zhouyanbing999999@163.com    Contact: Xuelong Jiao, MD.    053282911324    jiaoxuelong@163.com Less <<
NCT02626741 Abdominal Obesity-Metabolic Sy... More >>ndrome Less << Phase 3 Unknown April 2016 Thailand ... More >> Faculty of Medicine Siriraj Hospital, Mahidol University Recruiting Bangkok, Thailand, 10700 Contact: Kusuma Chaiyasoot, MD    +66819304743    kusuma.chs@mahidol.ac.th    Principal Investigator: Kusuma Chaiyasoot, MD Less <<
NCT01818505 - Unknown - Taiwan ... More >> National Taiwan University Hospital Yun-Lin Branch Recruiting Dou-Liou City, Yun-Lin County, Taiwan, 640 Contact: Yu-Minn Kuo, MD    8655323911 ext 5826    543goole@gmail.com Less <<
NCT00100204 - Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT02668601 - Completed - -
NCT02672592 Hypogonadism ... More >>Metabolic Syndrome X Obesity Less << Phase 3 Completed - Switzerland ... More >> University Department of Medicine, Kantonsspital Aarau Aarau, Switzerland, 5001 University Hospital Basel Basel, Switzerland, 4031 Less <<
NCT00408824 - Unknown - Japan ... More >> Department of Bio-information Analysis, Research Institute of Environmental Medicine, Nagoya University Recruiting Nagoya, Aichi, Japan, 464-8601 Contact: Kenji Yasui, MD, PhD    +81-52-788-6211    kenji@riem.nagoya-u.ac.jp    Principal Investigator: Kenji Yasui, MD, PhD Less <<
NCT02717832 Obesity Insul... More >>in Resistance Less << Not Applicable Recruiting March 2023 United States, Michigan ... More >> University of Michigan Recruiting Ann Arbor, Michigan, United States, 48109 Less <<
NCT01196273 - Completed - Germany ... More >> University Hospital of Bochum, Department of Dermatology Bochum, Germany, 44791 HIV Outpatient Department Dortmund, Germany, 44137 University Hospital, Department of Dermatology and Venerology Essen, Germany, 45122 University Hospital, West German Heart Center Essen Essen, Germany, 45122 Clinical Coordinating Center Leipzig Leipzig, Germany, 04107 Less <<
NCT02747277 - Recruiting May 2026 United States, Colorado ... More >> University of Colorado Recruiting Aurora, Colorado, United States, 80045 Contact: Roberta Pelanda, PhD    303-724-8666    Roberta.Pelanda@ucdenver.edu Less <<
NCT01787591 - Completed - -
NCT00491400 Diabetes Mellitus ... More >> Metabolic Syndrome Less << Not Applicable Terminated(Insufficient enroll... More >>ment) Less << - United States, Massachusetts ... More >> Boston Medical Center Boston, Massachusetts, United States, 02118 Less <<
NCT02730611 - Active, not recruiting April 2019 France ... More >> AP-HP, Antoine Béclère Hospital Clamart, France, 92141 Less <<
NCT02817542 - Completed - Italy ... More >> Cardarelli Hospital Naples, Italy, 80100 Less <<
NCT00491400 - Terminated(Insufficient enroll... More >>ment) Less << - -
NCT02796534 - Recruiting September 2019 France ... More >> University Hospital Grenoble Recruiting Grenoble, Isère, France, 38000 Contact: Marie PEETERS    +33476769265    MPeeters@chu-grenoble.fr Less <<
NCT00496730 Hypercholesterolemia Phase 3 Completed - -
NCT00496730 - Completed - -
NCT02858843 Cystic Fibrosis ... More >> Diabetes Less << Not Applicable Terminated(We were unable to e... More >>nroll eligible subjects for the study.) Less << - -
NCT00506428 Aging Sleep D... More >>eprivation Metabolic Syndrome Less << Not Applicable Unknown June 2011 United States, Massachusetts ... More >> Brigham & Women's Hospital Recruiting Boston, Massachusetts, United States, 02115 Contact: Tomoko Okada    617-732-7991    sleepstudy@partners.org    Contact: Sean W Cain, PhD    617-732-5174    swcain@rics.bwh.harvard.edu    Principal Investigator: Charles A Czeisler, PhD, MD          Sub-Investigator: Jeanne F Duffy, PhD          Sub-Investigator: Sean W Cain, PhD          Sub-Investigator: Orfeu M Buxton, PhD          Sub-Investigator: Mirjam Munch, PhD          Sub-Investigator: Daniel Aeschbach, PhD          Sub-Investigator: Elizabeth B Klerman, MD, PhD Less <<
NCT03200639 Breast Cancer Female ... More >> Gynecologic Cancer Menopause Physical Activity Less << Not Applicable Completed - -
NCT02886208 Pediatric Obesity ... More >> Prediabetic State Less << Not Applicable Completed - -
NCT02917434 Obesity Psori... More >>atic Arthritis Metabolic Syndrome Psoriasis Cardiovascular Disease Less << Not Applicable Enrolling by invitation December 2019 Sweden ... More >> Department of Rheumatology at the Hospital of Alingsås Alingsås, Sweden, 441 33 Department of Rheumatology at the Hospital of Borås Borås, Sweden, 501 82 Department of Obesity and Internal Medicine at Sahlgrenska University Hospital Gothenburg, Sweden, SE-41345 Department of Rheumatology at Sahlgrenska University Hospital Gothenburg, Sweden, SE-41345 Less <<
NCT02950181 Stroke Diabet... More >>ic Ketoacidosis Increased Intracranial Pressures Altered Mental Status Less << Not Applicable Recruiting January 2023 United States, Arkansas ... More >> Arkansas Children's Hospital Recruiting Little Rock, Arkansas, United States, 72202 Contact: Lee J Crawley, MS    501-364-3481    LCrawley@uams.edu    Principal Investigator: Thomas J Abramo, MD          Sub-Investigator: Matt Jaeger, MD          Sub-Investigator: Elizabeth Storm, MD Less <<
NCT00517062 Growth Hormone Deficiency Early Phase 1 Completed - United States, Oregon ... More >> Oregon Health and Science University Portland, Oregon, United States, 97239 Less <<
NCT00543595 Diabetes Mellitus, Type 2 ... More >> Metabolic Syndrome Less << Phase 2 Completed - -
NCT02970877 Obesity, Morbid ... More >> Insulin Resistance Less << Phase 2 Recruiting September 2021 Canada, Ontario ... More >> University Health Network Recruiting Toronto, Ontario, Canada, M5G 2C4 Contact: Katherine JP Schwenger, RD, PhD    416-340-4413    kschweng@uhnresearch.ca    Contact: Johane P Allard, MD    416-340-5159    johane.allard@uhn.on.ca    Principal Investigator: Johane P Allard, MD Less <<
NCT02950324 Cancer Not Applicable Not yet recruiting November 2022 United Kingdom ... More >> Royal Surrey County Hospital NHS Foundation Trust Not yet recruiting Guildford, United Kingdom, GU2 7XX Contact: Sophie Allen, MBBCh    07733 258752    sophieallen@doctors.org.uk    Contact: Javed Sultan       jav4144@gmail.com Less <<
NCT01365793 Cerebral Edema ... More >> Diabetic Ketoacidosis Less << Phase 3 Completed - United States, California ... More >> University of California, Davis Sacramento, California, United States, 95817 United States, Colorado Children's Hospital Colorado Aurora, Colorado, United States, 80045 United States, Delaware Alfred I. duPont Hospital for Children Wilmington, Delaware, United States, 19803 United States, District of Columbia Children's National Medical Center Washington, District of Columbia, United States, 20010 United States, Illinois Ann & Robert Lurie Children's Hospital of Chicago Chicago, Illinois, United States, 60614 United States, Massachusetts Children's Hospital Boston Boston, Massachusetts, United States, 02115 United States, Missouri Washington University & St. Louis Children's Hospital Saint Louis, Missouri, United States, 63110 United States, New York Columbia University New York, New York, United States, 10032 United States, Ohio Nationwide Children's Hospital Columbus, Ohio, United States, 43205 United States, Pennsylvania The Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 United States, Rhode Island Hasbro Children's Hospital/Rhode Island Hospital Providence, Rhode Island, United States, 02903 United States, Texas Texas Children's Hospital Houston, Texas, United States, 77030 United States, Utah University of Utah Salt Lake City, Utah, United States, 84158 Less <<
NCT03018561 Metabolic Syndrome ... More >> Coronary Artery Disease Heart Failure Less << Not Applicable Completed - -
NCT02984540 Mild Cognitive Impairment ... More >> Insulin Resistance Less << Not Applicable Active, not recruiting June 2019 United States, North Carolina ... More >> Wake Forest Baptist Health Winston-Salem, North Carolina, United States, 27157 Less <<
NCT01365793 - Completed - -
NCT03035149 Obesity Metab... More >>olic Syndrome Less << Not Applicable Completed - Canada, Ontario ... More >> The Ottawa Hospital Ottawa, Ontario, Canada, K1H 8L6 Less <<
NCT00573950 Diabetes Mellitus, Type 2 ... More >> Metabolic Syndrome X Less << Phase 4 Unknown December 2008 Korea, Republic of ... More >> Korea Univerisity Anam Hospital Recruiting Seoul, Korea, Republic of, 136-705 Contact: Dong Kim    +82-2-920-6566    ctcan@kumc.or.kr Less <<
NCT02117661 Metabolic Syndrome Phase 2 Active, not recruiting May 2019 Canada, Ontario ... More >> Queen's University, Cardiovascular Imaging Network at Queen's (CINQ), Kingston General Hospital Kingston, Ontario, Canada, K7L 3N6 Robarts Institute, Stroke Prevention & Atherosclerosis Research Centre (SPARC) London, Ontario, Canada, N6G 2V2 Less <<
NCT02066012 - Unknown October 2014 France ... More >> CHU de Clermont-Ferrand Recruiting Clermont-Ferrand, France, 63003 Contact: Patrick LACARIN    04 73 75 11 95    placarin@chu-celrmontferrand.fr Less <<
NCT00422396 Hypertriglyceridemia With the ... More >>Metabolic Syndrome Less << Not Applicable Completed - United States, Illinois ... More >> Northwestern University preventive Cardiology Center Chicago, Illinois, United States, 60611 Less <<
NCT03042416 Congenital Hyperinsulinism ... More >> Neuroblastoma Neuroendocrine Tumors Parkinson Disease Brain Glioma Less << Phase 3 Recruiting December 31, 2022 Canada, Alberta ... More >> University of Alberta Hospital Recruiting Edmonton, Alberta, Canada, T6G2B7 Contact: Jonathan Abele, MD    7804076907    jabele@ualberta.ca Less <<
NCT03102697 - Recruiting December 31, 2018 Brazil ... More >> School of Medice of ABC Recruiting Santo Andre, Sao Paolo, Brazil Contact: Thiago Souza, PhD    +55-11-97524-6754    tsouzahc@gmail.com    Contact: Eduardo Grecco, MD    +55-11-98162-0911    dreduardogrecco@gmail.com Less <<
NCT02774668 Metabolic Syndrome Not Applicable Withdrawn - United States, Missouri ... More >> University of Missouri Columbia, Missouri, United States, 65212 Less <<
NCT02172092 Diabetes Not Applicable Recruiting December 2019 Sweden ... More >> Vrinnevi Hospital Recruiting Norrköping, Östergötland, Sweden, 60379 Contact: Robert Svensson, MD    +46101040000    robert.svensson@lio.se    Contact: Fredrik Schiöler, MD    +46101040000    fredrik.schioler@lio.se    Principal Investigator: Robert Svensson, MD          Sub-Investigator: Fredikr Schiöler, MD Less <<
NCT00636766 Carotid Atherosclerosis ... More >> Stroke Type 2 Diabetes Metabolic Syndrome Less << Not Applicable Completed - Greece ... More >> General Hospital of Thessaloniki "Hippokratio" Thessaloniki, Greece Less <<
NCT00646815 Growth Hormone Deficiency Not Applicable Completed - Denmark ... More >> Medical department M (Endocrinology and Diabetes), Aarhus University Hospital, Aarhus Sygehus, Denmark. Aarhus, Denmark, 8000 Medical Department M, Aarhus University Hospital Aarhus, Denmark, 8000 Less <<
NCT00656032 End Stage Renal Disease Phase 2 Completed - United States, Tennessee ... More >> Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232 Less <<
NCT02178592 Infection, Human Immunodeficie... More >>ncy Virus Less << Phase 3 Active, not recruiting December 31, 2019 -
NCT03212391 Abdominal Obesity ... More >> Metabolic Syndrome Disability Physical Sarcopenic Obesity Hypertension Overweight and Obesity Cardiovascular Risk Factor Less << Not Applicable Recruiting July 20, 2018 Italy ... More >> AOUI Verona Recruiting Verona, Italy, 37126 Contact: Andrea P Rossi, MD, PhD    00390458122537    andrea.rossi@hotmail.it Less <<
NCT01422421 Type 2 Diabetes ... More >> Coronary Artery Disease Hypertension Dyslipidemia Less << Phase 4 Recruiting December 2029 Japan ... More >> University Hospital, University of the Ryukyus Recruiting Nishihara, Okinawa, Japan, 903-0215 Contact: Shinichiro Ueda, MD, PhD    81-98-895-1195    blessyou@med.u-ryukyu.ac.jp    Contact: Uru Nezu, MD, PhD    81-98-895-1195    amadeus@med.u-ryukyu.ac.jp    Principal Investigator: Shinichiro Ueda, MD, PhD          Saga University Hospital Recruiting Saga, Japan, 849-8501 Contact: Koichi Node, MD, PhD          Principal Investigator: Koichi Node, MD, PhD Less <<
NCT03215836 Asthma Obesit... More >>y Metabolic Syndrome Less << Not Applicable Recruiting December 31, 2019 United States, Colorado ... More >> University of Colorado Recruiting Aurora, Colorado, United States, 80045 Contact: Karen Wasil, RN, BSN    303-724-0761    karen.wasil@ucdenver.edu    Contact: Vong Smith, BA    3037240325 ext Smith    vongphone.smith@ucdenver.edu Less <<
NCT02252406 Stable Angina ... More >> Metabolic Syndrome Less << Phase 4 Recruiting November 2018 United States, Florida ... More >> University of Florida Recruiting Jacksonville, Florida, United States, 32209 Contact: Gladys Velarde    904-244-3095    gladys.velarde@jax.ufl.edu    Principal Investigator: Gladys Velarde, MD Less <<
NCT03222167 Chronic Hepatitis C Genotype 1... More >>B Metabolic Syndrome Fibrosis, Liver Cirrhoses, Liver Less << Phase 3 Not yet recruiting August 2019 Kazakhstan ... More >> National Research Institute of Cardiology and Internal Medicine Not yet recruiting Almaty, Kazakhstan, 050000 Contact: Alexandre V. Nersesov, MD, Prof.    +7 701 799 82 12    alexander.nersesov@gmail.com    Contact: Almagul Jumabayeva, MD, PhD    +7 701 512 23 26    almusa010@mail.ru Less <<
NCT02258126 Non-alcoholic Fatty Liver Dise... More >>ase Obesity Metabolic Syndrome Less << Not Applicable Completed - Spain ... More >> Pediatric Endocrinology Unit of the University Hospital of Araba (HUA) Vitoria-Gasteiz, Araba, Spain, 01009 Less <<
NCT03248921 - Recruiting November 2025 Canada, New Brunswick ... More >> Saint John Regional Hospital Recruiting Saint John, New Brunswick, Canada, E2L 4L2 Contact: Ansar Hassan, MD, PhD    506-648-6102    ahassan@dal.ca    Principal Investigator: Ansar Hassan, MD, PhD Less <<
NCT02937441 - Unknown June 2017 Turkey ... More >> Cukurova University Recruiting Adana, Turkey Less <<
NCT02128802 Severe Obesity ... More >> Renal Failure Less << Not Applicable Recruiting April 2019 United States, Tennessee ... More >> Vanderbilt University Medical Center Recruiting Nashville, Tennessee, United States, 37232 Principal Investigator: Seth Karp, MD Less <<
NCT03240419 Childhood Obesity ... More >> Maternal Obesity During Childbirth Insulin Resistance Inflammation Less << Not Applicable Recruiting December 2018 United States, Arkansas ... More >> Arkansas Children's Nutrition Center Recruiting Little Rock, Arkansas, United States, 72202 Contact: Eva C Diaz Fuentes, MD    501-364-3056    ecdiazfuentes@uams.edu    Contact: Aline Andres, MD    501-364-3301    AndresAline@uams.edu Less <<
NCT02281162 - Completed - United States, Nebraska ... More >> Alegent Creighton Clinic - Psychiatric Associates (Dodge Street) Omaha, Nebraska, United States, 68132 Less <<
NCT02285218 - Unknown March 2015 Korea, Republic of ... More >> Severance hospital Recruiting Seoul, Korea, Republic of, 120-752 Contact: Bong Soo Cha, MD    +82-2-2228-1932    bscha@yuhs.ac Less <<
NCT03167996 Cardiovascular Risk Factor ... More >> Insulin Resistance PreDiabetes Diabetes Coronary Artery Disease Hypertension Prehypertension Dyslipidemias Less << Not Applicable Active, not recruiting June 1, 2018 United States, California ... More >> Stanford University Stanford, California, United States, 94305 Less <<
NCT03318679 - Not yet recruiting December 25, 2020 -
NCT03306771 - Not yet recruiting July 2020 -
NCT02353767 - Completed - -
NCT00786721 - Completed - United States, California ... More >> Beckman Laser Institute Medical clinic Irvine, California, United States, 92612 Less <<
NCT02358928 NAFLD Fatty L... More >>iver Obesity Metabolic Syndrome Less << Not Applicable Unknown December 2016 United States, Texas ... More >> UTexasSouthwestern/Childrens Medical Center Recruiting Dallas, Texas, United States, 75234 Contact: Jennifer Panganiban, MD    818-448-2111    jennifer.panganiban@UTSouthwestern.edu    Contact: Charina Ramirez, MD    2144568000    Charina.Ramirez@UTSouthwestern.edu Less <<
NCT00728286 - Completed - United Kingdom ... More >> Royal Victoria Hospital, Newcastle upon Tyne Hospitals NHS Trust Newcastle upon Tyne, Tyne and Wear, United Kingdom, NE1 4LP Less <<
NCT03422900 Hyperglycaemia (Non Diabetic) ... More >> Enteral Feeding Intolerance Stroke Less << Not Applicable Recruiting December 15, 2020 Spain ... More >> Clinic Universitary Hospital Recruiting Valladolid, Spain, 47003 Contact: Juan J López-Gómez, Prof. Dr.    983420000 ext 86158    jjlopez161282@hotmail.com    Contact: Daniel A De Luis-Román, Prof. Dr.    983420000 ext 86660    dadluis@yahoo.es    Principal Investigator: Daniel A De Luis-Román, Prof. Dr.          Principal Investigator: Juan J López-Gómez, Prof. Dr.          Principal Investigator: Javier F Arenillas-Lara, Prof. Dr.          Sub-Investigator: Esther Delgado-García, Dra.          Sub-Investigator: Emilia Gómez-Hoyos, Dra.          Sub-Investigator: Ana Ortolá-Buigues, Dra.          Sub-Investigator: Beatriz Torres-Torres, Dra.          Sub-Investigator: Ana Calleja-Sanz, Dra.          Sub-Investigator: Elisa Cortijo-García, Dra.          Sub-Investigator: Mercedes De Lera, Dra.          Sub-Investigator: Ángeles Castro-Lozano, Dipl.          Sub-Investigator: Silvia Rodríguez-Gómez, Dipl.          Sub-Investigator: Lourdes De Marcos-White, Dipl.          Sub-Investigator: Beatriz Gómez-Vicente, Dipl.          Sub-Investigator: Pedro L Muñoz-Rubio, Dipl          Sub-Investigator: Javier Reyes-Muñoz, Dipl          Sub-Investigator: Rosa Alcaide-Flores, Dipl          Sub-Investigator: Ana Martín, Dipl Less <<
NCT01636349 Type 2 Diabetes ... More >> Hypertension Obesity Metabolic Syndrome Less << Not Applicable Completed - Denmark ... More >> University of Copenhagen Copenhagen, Denmark, 2200 Less <<
NCT03404180 Peripheral Vascular Diseases ... More >> Hyperglycaemia (Diabetic) Hypertension Coronary Artery Disease Pulmonary Disease, Chronic Obstructive Less << Not Applicable Recruiting May 2020 United States, Florida ... More >> University of Florida Recruiting Gainesville, Florida, United States, 32611 Less <<
NCT01665482 Inflammation ... More >>Insulin Sensitivity Less << Not Applicable Completed - Malaysia ... More >> Malaysia Palm Oil Board (MPOB) Kajang, Selangor, Malaysia, 43000 Less <<
NCT01667068 - Completed - Germany ... More >> University Hospital of Bochum, Department of Dermatology Bochum, Germany, 44791 HIV Outpatient Department Dortmund, Germany, 44137 Health Center Duisburg, Germany, 47249 University Hospital, Department of Dermatology and Venerology Essen, Germany, 45147 University Hospital, West German Heart Center Essen Essen, Germany, 45147 Clinical Coordinating Center Leipzig Leipzig, Germany, 04107 Less <<
NCT01624727 Coronary Heart Disease ... More >> Metabolic Syndrome Less << Not Applicable Completed - United States, Massachusetts ... More >> Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 South Shore Medical Group Milton, Massachusetts, United States, 02186 Less <<
NCT01647776 - Recruiting March 2019 United States, Ohio ... More >> University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center Recruiting Cleveland, Ohio, United States, 44106 Contact: Li Li, MD    216-368-5437    li.li@uhhospitals.org Less <<
NCT03458533 - Recruiting December 31, 2019 Italy ... More >> Andrea M Isidori Recruiting Rome, Italy, 00161 Contact: Andrea M Isidori, MD, PhD    00390649970540    andrea.isidori@uniroma1.it    Principal Investigator: Andrea M Isidori, MD, PhD          Sub-Investigator: Giulia Puliani, MD Less <<
NCT03489109 Human Immunodeficiency Virus ... More >> Metabolic Syndrome Less << Phase 1 Recruiting January 31, 2022 United States, Maryland ... More >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)    800-411-1222 ext TTY8664111010    prpl@cc.nih.gov Less <<
NCT03527446 Obesity Obesi... More >>ty; Endocrine Insulin Sensitivity Exercise Less << Not Applicable Recruiting August 2019 Canada, New Brunswick ... More >> University of New Brunswick - Kinesiology Recruiting Fredericton, New Brunswick, Canada, E3B 5A3 Contact: Martin Sénéchal, PhD    506-451-6889    msenech@unb.ca Less <<
NCT01638988 Polycystic Ovary Syndrome ... More >> Insulin Resistance Less << Phase 3 Withdrawn(Previous studies hav... More >>e been done regarding same condition) Less << December 2015 Canada, Quebec ... More >> Clinique Ovo Montréal, Quebec, Canada, H4P 2S4 Less <<
NCT03548103 Obesity Metab... More >>olic Syndrome Less << Not Applicable Recruiting March 31, 2019 Taiwan ... More >> Taipei City Hospital and Psychiatric Center Recruiting Taipei, Taiwan, 110 Contact: Shih-Ku Lin, MD    886979307713    sklin@tpech.gov.tw    Contact: Yen-Lung Chiu, Master    88627263141 ext 1224    yann.tpech@gmail.com Less <<
NCT03558685 Obesity Diet ... More >>Modification Less << Not Applicable Active, not recruiting July 2018 -
NCT02500147 Polycystic Ovary Syndrome ... More >> Non-Alcoholic Fatty Liver Disease Metabolic Syndrome Less << Phase 4 Recruiting June 2020 United States, New York ... More >> Columbia University Medical Center Recruiting New York, New York, United States, 10032 Contact: Hailey Roumimper, AB    212-305-1518    hr2388@cumc.columbia.edu    Contact: Aviva B Sopher, MD, MS, MS    212-305-9362    ahs32@cumc.columbia.edu    Principal Investigator: Aviva B Sopher, MD, MS, MS          Sub-Investigator: Sharon E Oberfield, MD          Sub-Investigator: Ilene Fennoy, MD, MPH          Sub-Investigator: Abeer Hassoun, MD          Sub-Investigator: Camila Pereira-Eshraghi, MD Less <<
NCT03553381 - Completed - Italy ... More >> Ospedale "L. Sacco" - ASST Fatebenefratelli Sacco Milano, Italy, 20157 ASST Centro Specialistico Ortopedico Traumatologico Gaetano Pini-CTO Milan, Italy, 20126 Less <<
NCT03665961 - Completed - Singapore ... More >> Changi General Hospital Singapore, Singapore, 529889 Less <<
NCT03696810 NPDR - Non Proliferative Diabe... More >>tic Retinopathy Less << Not Applicable Recruiting October 17, 2020 Portugal ... More >> AIBILI- Association for Biomedical Research and Inovation on Light and Image. Recruiting Coimbra, Portugal, 3000-548 Contact: Maria L Ribeiro, PhD    00351239480124    lr@aibili.pt    Contact: Liliana C Soares, BSc    00351239480151    lcarvalho@aibili.pt    Principal Investigator: Maria L Ribeiro, PhD Less <<
NCT03570840 - Completed - United States, South Carolina ... More >> MUSC Charleston, South Carolina, United States, 29425 Less <<
NCT03710447 Overweight and Obesity ... More >> Metabolic Syndrome Less << Not Applicable Recruiting October 30, 2021 Germany ... More >> Department of Medicine 1, Hector Center for Nutrition, Exercise and Sports, Friedrich-Alexander-University Erlangen-Nuremberg Recruiting Erlangen, Germany, 91052 Contact: Dejan Reljic, Dr.    +49 9131 8545218    dejan.reljic@uk-erlangen.de    Contact: Yurdaguel Zopf, Prof.    +49 9131 8545218    yurdaguel.zopf@uk-erlangen.de Less <<
NCT03708913 Craniopharyngioma ... More >> Hypothalamic Obesity Metabolic Syndrome Less << Phase 1 Withdrawn(no participants have... More >> been able to qualify for study) Less << April 2020 -
NCT03663062 - Recruiting July 1, 2019 United Kingdom ... More >> South Tyneside NHS Foundation Trust Recruiting South Shields, Tyne And Wear, United Kingdom, NE34 0PL Contact: Colin Rees       colin.rees@stft.nhs.uk    County Durham and Darlington NHS Foundation Trust Not yet recruiting Darlington, United Kingdom, DL3 6HX Contact: John Silcock       johnsilcock@nhs.net    Kettering General Hospitals NHS Foundation Trust Not yet recruiting Kettering, United Kingdom, NN16 8UZ Contact: Ajay Verma       ajay.verma@nhs.net    The Leeds Teaching Hospitals NHS Trust Not yet recruiting Leeds, United Kingdom, LS1 3EX Contact: Mark Hull       M.A.Hull@leeds.ac.uk    South Tees Hospitals NHS Foundation Trust Not yet recruiting Middlesbrough, United Kingdom, TS4 3BW Contact: John Greenaway       John.Greenaway@stees.nhs.uk    Northumbria Healthcare NHS Foundation Trust Not yet recruiting Newcastle Upon Tyne, United Kingdom, NE12 8EW Contact: Tom Lee, MD       Tom.Lee@northumbria-healthcare.nhs.uk    Newcastle Upon Tyne NHS Foundation Trust Not yet recruiting Newcastle Upon Tyne, United Kingdom, NE7 7DN Contact: Stuart McPherson       Stuart.McPherson@nuth.nhs.uk    North Tees and Hartlepool NHS Foundation Trust Not yet recruiting Stockton-on-Tees, United Kingdom, TS19 8PE Contact: Matt Rutter       Matt.Rutter@nth.nhs.uk    CIty Hospitals Sunderland NHS Foundation Trust Not yet recruiting Sunderland, United Kingdom, SR4 7TP Contact: Colin Rees       colin.rees@stft.nhs.uk Less <<
NCT03733132 Insulin Resistance ... More >> Obesity Obesity, Abdominal Less << Phase 2 Not yet recruiting May 31, 2020 United States, Minnesota ... More >> Mayo Clinic in Rochester Rochester, Minnesota, United States, 55905 Less <<
NCT02653495 Immune Deficiency ... More >> Metabolic Syndrome Less << Not Applicable Terminated(Target accrual not ... More >>met) Less << - United States, New York ... More >> Rockefeller University New York, New York, United States, 10065 Less <<
NCT03717909 Wolfram Syndrome Phase 2 Not yet recruiting January 31, 2022 -
NCT03758209 Colorectal Cancer ... More >> Insulin Resistance Less << Not Applicable Recruiting November 1, 2019 Hungary ... More >> Department of Surgery, St. Borbala Hospital Recruiting Tatabánya, Hungary, 2800 Contact: Balazs Banky, PhD    +3620 8231642    bankybalazs@gmail.com    Contact: Lóránd Lakatos, MD    +36305755326    lakatoslorandl@gmail.com    Principal Investigator: András Fülöp, PhD Less <<
NCT02653495 - Terminated(Target accrual not ... More >>met) Less << - -
NCT03719677 Breast Cancer Not Applicable Not yet recruiting December 30, 2019 United States, Michigan ... More >> Barbara Ann Karmanos Cancer Institute Not yet recruiting Detroit, Michigan, United States, 48201 Contact: Jamil Gharib       jamil.gharib@wayne.edu    Sub-Investigator: Wassim Tarraf          Sub-Investigator: Terrance Albrecht, Ph.D. Less <<
NCT00000462 Angina Pectoris ... More >> Cardiovascular Diseases Coronary Disease Diabetes Mellitus Heart Diseases Myocardial Ischemia Less << Phase 3 Completed - -
NCT03749200 Childhood Obesity ... More >> Metabolic Syndrome Body Composition Less << Not Applicable Active, not recruiting December 31, 2019 Spain ... More >> Faculty of Medicine, C/ Sant Llorenç 21 Reus, Tarragona, Spain, 43201 Iispv- Hospital Sant Joan de Reus Reus, Tarragona, Spain, E43204 IDIAP Jordi Gol Reus, Tarragona, Spain Hospital de Tarragona Joan XXIII Tarragona, Spain, 43005 Less <<
NCT00000153 Diabetic Retinopathy ... More >> Retinal Neovascularization Diabetes Mellitus Less << Phase 3 Completed - -
NCT00000159 Diabetic Retinopathy ... More >> Diabetes Mellitus Less << Phase 3 Completed - -
NCT00000542 Cardiovascular Diseases ... More >> Coronary Disease Diabetes Mellitus Heart Diseases Hypercholesterolemia Hypertension Myocardial Infarction Myocardial Ischemia Heart Failure Less << Phase 3 Completed - -
NCT00000466 Bone Diseases ... More >> Cardiovascular Diseases Coronary Disease Diabetes Mellitus Heart Diseases Hypercholesterolemia Hypertension Myocardial Ischemia Osteoporosis Thrombosis Postmenopause Less << Phase 3 Completed - -
NCT00001203 - Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00001276 - Recruiting - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)    800-411-1222 ext TTY8664111010    prpl@cc.nih.gov Less <<
NCT00001985 - Completed - United States, Maryland ... More >> National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Bethesda, Maryland, United States, 20892 Less <<
NCT00000620 Atherosclerosis ... More >> Cardiovascular Diseases Hypercholesterolemia Hypertension Diabetes Mellitus, Type 2 Diabetes Mellitus Coronary Disease Less << Phase 3 Completed - United States, Minnesota ... More >> Minneapolis Medical Research Foundation Minneapolis, Minnesota, United States, 55404 United States, New York Columbia University New York, New York, United States, 10027 United States, North Carolina Wake Forest University Winston-Salem, North Carolina, United States, 27106 United States, Ohio Case Western Reserve University Cleveland, Ohio, United States, 44106 United States, Tennessee Veterans Affairs Memphis, Tennessee, United States, 38104 United States, Washington University of Washington Seattle, Washington, United States, 98195 Canada, Ontario McMaster University Hamilton, Ontario, Canada Less <<
NCT00940966 Elevated Triglycerides ... More >> Systolic Hypertension Insulin Resistance Abdominal Obesity Less << Not Applicable Completed - United States, West Virginia ... More >> Wvu Department of Pediatrics Charleston, West Virginia, United States, 25302 Less <<
NCT02001376 Abdominal Obesity Metabolic Sy... More >>ndrome Subjects With Poor Fitness Status. Less << Not Applicable Unknown December 2014 Taiwan ... More >> Physical Therapy Center, National Taiwan University Hospital Recruiting Taipei, Taiwan Contact: Jau-Yih Tsauo, PhD, PT    +886-2-33668130    jytsauo@ntu.edu.tw    Contact: Chia-Te Lin, M.S. PT    +886-2-23123456 ext 66515    chiatelin@ntuh.gov.tw Less <<
NCT00000620 - Completed - -
NCT00001368 Carotid Atherosclerosis ... More >> Cerebrovascular Accident Diabetes Mellitus Hypercholesterolemia Hypertension Less << Phase 1 Completed - United States, Maryland ... More >> National Institute of Neurological Disorders and Stroke (NINDS) Bethesda, Maryland, United States, 20892 Less <<
NCT00949169 - Completed - Korea, Republic of ... More >> Eulji University Hospital Seoul, Korea, Republic of, 139-711 Less <<
NCT01979068 - Completed - Korea, Republic of ... More >> Korea University Guro Hospital Seoul, Korea, Republic of Less <<
NCT00945711 - Completed - United States, Minnesota ... More >> International Diabetes Center Minneapolis, Minnesota, United States, 55416 Less <<
NCT00105755 Diabetes Mellitus ... More >> Ulcer Diabetic Polyneuropathy Less << Not Applicable Completed - United States, Georgia ... More >> Southern Arizona VA Health Care System, Tucson, AZ Tucson, Georgia, United States, 85723 Less <<
NCT00948311 - Completed - United States, Minnesota ... More >> International Diabetes Center Minneapolis, Minnesota, United States, 55416 Less <<
NCT00108485 Diabetes Mellitus, Type 2 ... More >> Kidney Failure, Chronic Hyperlipidemia Less << Phase 3 Terminated(Unable to recruit s... More >>ufficient study subjects) Less << - United States, Florida ... More >> Univesity of Miami/Diabetes Research Institute Miami, Florida, United States, 33136 Less <<
NCT03344718 - Completed - Taiwan ... More >> Department of Family Medicine, National Cheng Kung Univ Hosp Tainan, Taiwan Less <<
NCT02078635 Cardiovascular Diseases ... More >> Hypercholesterolemia Diabetes Metabolic Syndrome Obesity Less << Not Applicable Withdrawn(Study was amalgamate... More >>d with another study to include exercise as another intervention.) Less << - Canada, British Columbia ... More >> Healthy Heart Lipid Clinic, St. Paul's Hospital Vancouver, British Columbia, Canada, V6Z 1Y6 Canada, Manitoba Richardson Center for Functional Foods and Nutraceuticals and the St. Boniface Hospital Cardiovascular Center, University of Manitoba Winnipeg, Manitoba, Canada, R3T 6C5 Canada, Ontario Risk Factor Modification Centre, St. Michael's Hospital Toronto, Ontario, Canada, M5C 2T2 Canada, Quebec Institute of Nutraceuticals and Functional Foods and the Quebec Heart and Lung Institute, Laval University Quebec City, Quebec, Canada, G1V 4G2 Less <<
NCT00106457 - Completed - -
NCT02114476 Diabetes Mellitus ... More >> Metabolic Syndrome Less << Not Applicable Active, not recruiting June 2022 Thailand ... More >> Faculty of Medicine Siriraj Hospital, Mahidol University Bangkok, Thailand, 10700 Less <<
NCT00885261 - Completed - Israel ... More >> Pain Medicine Unit Tel Aviv, Israel Less <<
NCT00108485 - Terminated(Unable to recruit s... More >>ufficient study subjects) Less << - -
NCT01541566 - Completed - Italy ... More >> Fondazione Maugeri Lumezzane, Brescia, Italy, 25066 Ospedale San Felice a Cancello San Felice a Cancello, Caserta, Italy, 81027 Ospedale di Broni Broni, Pavia, Italy, 27043 Policlinico Universitario Bari, Italy, 70124 Spedali Civili Brescia, Italy, 25123 Istituto Auxologico Italiano Milano, Italy, 20149 Policlinico Universitario Padova, Italy, 35128 Fondazione Maugeri Pavia, Italy, 27100 Ospedale Santa Chiara Pisa, Italy, 56100 Ospedale Fatebenefratelli Roma, Italy, 00186 Casa di Cura Tortorella Salerno, Italy, 84122 Ospedale di Circolo Varese, Italy, 21100 Less <<
NCT02109380 Disuse Atrophy Not Applicable Completed - Netherlands ... More >> Maastricht University Medical Centre Maastricht, Netherlands Less <<
NCT01555632 Recurrent Prostate Cancer ... More >> Stage I Prostate Cancer Stage IIA Prostate Cancer Stage IIB Prostate Cancer Stage III Prostate Cancer Stage IV Prostate Cancer Less << Not Applicable Withdrawn(Other more favorable... More >> treatments are now available.) Less << - -
NCT01561664 Obesity Insul... More >>in Resistance Less << Not Applicable Completed - France ... More >> Montpellier University Hospital Montpellier, France, 34295 Less <<
NCT01560676 Obesity Type ... More >>2 Diabetes Less << Phase 2 Phase 3 Completed - United States, Connecticut ... More >> Yale New Haven, Connecticut, United States Less <<
NCT01538082 - Unknown March 2013 Spain ... More >> Catalan Health Institute. ABS Reus-4 Recruiting Reus, Tarragona, Spain, 43202 Contact: Yolanda Ortega       yortega.tarte.ics@gencat.cat    Principal Investigator: Yolanda Ortega, MD Less <<
NCT01584960 Prostate Cancer ... More >> Insulin Sensitivity Body Composition, Beneficial Less << Not Applicable Completed - Denmark ... More >> Centre of Inflammation and Metabolism, Rigshospitalet Copenhagen, Denmark, 2100 Less <<
NCT00946868 - Completed - Brazil ... More >> Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo Sao Paulo, SP, Brazil, 05403 000 Less <<
NCT00110448 Coronary Disease ... More >> Arteriosclerosis Diabetes Mellitus, Type 2 Less << Phase 4 Completed - Japan ... More >> First Department of Internal Medicine, Nara Medical University Kashihara, Nara, Japan, 634-8522 Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University Kumamoto, Japan, 860-8556 Less <<
NCT01566188 Essential Hypertension ... More >> Metabolic Syndrome Less << Not Applicable Completed - France ... More >> Mahes Hospital Fleury-Mérogis, France, 91700 George Pompidou European Hospital Paris, France, 75000 Rouen University Hospital Rouen, France, 76031 Rangueil University Hospital Toulouse, France, 31059 Less <<
NCT01593397 Obesity Phase 1 Completed - United States, California ... More >> Stanford University School of Medicine, Department of Anesthesia Stanford, California, United States, 94305 Less <<
NCT01610648 - Completed - United States, Massachusetts ... More >> Sleep Center, Tufts Medical Center Boston, Massachusetts, United States, 02111 Less <<
NCT02910154 Angina Pectoris ... More >> Coronary Microvascular Disease Less << Not Applicable Recruiting December 2018 Denmark ... More >> Bispebjerg Hospital, Dept. of Cardiology Y builing 67, 1.floor, Bispebjerg Bakke 23 Recruiting Copenhagen, Denmark, 2400 Contact: Eva Prescott, MD, DMSc    +45 4026 2134    Eva.Irene.Bossano.Prescott@regionh.dk    Contact: Kira Bové, MD    +45 4035 5627    kira.bang.bove.01@regionh.dk    Frederiksberg Hospital, Dept. of Cardiology, Building 16, Y3, Nordre Fasanvej 57 Not yet recruiting Frederiksberg, Denmark, 2000 Contact: Eva Prescott, MD, DMSc    +45 4026 2134    Eva.Irene.Bossano.Prescott@regionh.dk    Contact: Kira Bové, MD    +45 4035 5627    kira.bang.bove.01@regionh.dk Less <<
NCT01635010 Obstructive Sleep Apnea Phase 4 Completed - Brazil ... More >> Associação Fundo de Incentivo à Pesquisa São Paulo, Brazil, 04020-060 Less <<
NCT01642355 Coronary Artery Disease ... More >> Peripheral Arterial Disease Hyperlipidemia Hypertension Diabetes Prediabetes Obesity Less << Not Applicable Completed - United States, New York ... More >> New York University Langone Medical Center New York, New York, United States, 10016 Less <<
NCT01676480 Prostate Cancer Not Applicable Completed - Denmark ... More >> Centre of Inflammation and Metabolism, Rigshospitalet Copenhagen, Denmark, 2100 Less <<
NCT01664845 Chronic Hepatitis c ... More >> Insulin Resistance Less << Phase 2 Phase 3 Unknown August 2014 Taiwan ... More >> Kaohsiung Veterans General Hospital Recruiting Kaohsiung, Taiwan, 813 Contact: Wei-Lun Tsai, MD    886-7-3422121 ext 2075    tsaiwl@yahoo.com.tw    Principal Investigator: Wei-Lun Tsai, MD Less <<
NCT01588795 Diabetic Nephropathy ... More >> Persistent Proteinuria With Type II Diabetes Less << Phase 4 Completed - France ... More >> CIC Hopital europeen george pompidou Paris, France, 75015 Less <<
NCT02149173 Estrogen Receptor Positive ... More >> Recurrent Breast Carcinoma Stage IV Breast Cancer AJCC v6 and v7 Less << Not Applicable Active, not recruiting September 15, 2021 United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT00982670 - Completed - Taiwan ... More >> Far Eastern Memorial Hospital Pan-Chiao, Taipei, Taiwan Less <<
NCT01722474 Healthy Diabe... More >>tes Type 2 Obesity Coronary Artery Disease Peripheral Arterial Disease Less << Not Applicable Terminated(Minor device modifi... More >>cations required, move revised device to clinical site in USA.) Less << - Canada, Manitoba ... More >> St. Boniface General Hospital - Asper Clinical Research Institute Winnipeg, Manitoba, Canada, R2H 2A6 Less <<
NCT01750333 - Unknown March 2013 Italy ... More >> University of Bari Medical School - Dept Biomedical Sciences and Human Oncology Bari, Italy, 70124 Less <<
NCT01753245 - Unknown June 2014 Spain ... More >> Department of Dermatology. Reina Sofia University Hospital. Cordoba, Spain, 14004 Less <<
NCT01682785 - Unknown - -
NCT01770223 Hepatitis C Phase 4 Withdrawn December 2015 -
NCT01775176 Polycystic Ovary Syndrome Phase 3 Completed - United States, Louisiana ... More >> Pennington Biomedical Research Center Baton Rouge, Louisiana, United States, 70808 Less <<
NCT01254019 Muscular Dystrophies Phase 3 Completed - -
NCT01123278 Hypogonadism ... More >>Metabolic Syndrome Obesity Erectile Dysfunction Less << Phase 4 Completed - Italy ... More >> Dipartimento di Fisiopatologia Medica - Policlinico Umberto I Rome, Italy, 00161 Policlinico Umberto I Hospital - Sapienza University Rome, Italy, 00161 Less <<
NCT01794429 Obesity Metab... More >>olic Syndrome X Drug-induced Obesity Schizophrenia Less << Phase 3 Completed - Denmark ... More >> Cnsr/Cins Glostrup, Denmark, 2600 Less <<
NCT01766362 Diabetes Type 1 or 2 With Diab... More >>etic Retinopathy. Less << Phase 3 Unknown - France ... More >> CHU Dijon Recruiting Dijon, France, 21000 Contact: Catherine CREUZOT-GARCHER    3 80 29 51 73    catherine.creuzot-garcher@chu-dijon.fr    Principal Investigator: Catherine CREUZOT-GARCHER          Sub-Investigator: Alain BRON          CHU de la Croix Rousse Recruiting Lyon, France, 69004 Contact: Laurent KODJIKIAN    4 26 10 93 21 ext +33       Principal Investigator: Laurent KODJIKIAN          Sub-Investigator: Zohra Nacera BOUSSAID          Hôpital Lariboisière Recruiting Paris, France, 75475 Contact: Pascale MASSIN    1 49 95 85 44 ext +33       Principal Investigator: Pascale MASSIN          Sub-Investigator: Ali ERGINAY          Sub-Investigator: Zeynep VICTOR          Sub-Investigator: Sébastien BRUNEAU          Sub-Investigator: Bénédicte DUPAS          Sub-Investigator: Julien PEROL Less <<
NCT01785134 - Completed - -
NCT00974311 Castration-Resistant Prostate ... More >>Cancer Less << Phase 3 Completed - -
NCT00974311 - Completed - -
NCT01785134 Obesity Type ... More >>2 Diabetes Insulin Sensitivity Less << Not Applicable Completed - Sweden ... More >> Södertälje Hospital Södertälje, Stockholm, Sweden, 15286 Ersta Hospital Stockholm, Sweden, 11691 Karolinska University Hospital Huddinge Stockholm, Sweden, 14186 Danderyds Hospital Stockholm, Sweden, 18288 Less <<
NCT01581801 Obesity With Complications ... More >> Morbid Obesity Reactive Hypoglycemia Bariatric Surgery Less << Not Applicable Completed - Italy ... More >> Catholic University School of Medicine Rome, Italy, 00168 Less <<
NCT00541554 Hyperprolactinemia ... More >> Weight Gain Dyslipidemia Less << Phase 4 Unknown February 2009 -
NCT01872182 Abdominal Obesity Metabolic Sy... More >>ndrome Less << Phase 3 Terminated - Korea, Republic of ... More >> 5 Institutions Seoul, Korea, Republic of Less <<
NCT01882114 - Recruiting December 2020 Italy ... More >> Umberto I Policlinico di Roma, Sapienza Università di Roma Recruiting Rome, Italy, 00155 Contact: Pasquale Pignatelli, MD    +390649970893    pasquale.pignatelli@uniroma1.it    Contact: Daniele Pastori, MD    +390649970893    daniele.pastori@uniroma1.it    Principal Investigator: Pasquale Pignatelli, MD          Principal Investigator: Daniele Pastori, MD Less <<
NCT01844349 - Completed - Morocco ... More >> Faculty of Sciences, Ibn Tofaïl University Kenitra, Rabat-Salé, Morocco, 14000 Tunisia National Institute of Nutrition and Food Technology (INNTA) Tunis, Great Tunis, Tunisia, 1007 Less <<
NCT01902654 - Unknown - Spain ... More >> Hospital Parc Tauli Sabadell Recruiting Sabadell, Barcelona, Spain, 08208 Contact: Joan Calvet, Dr    0034937231010 ext 24065    joan.calvet.fontova@gmail.com    Contact: Orellana Cristobal, Dr    0034937231010 ext 24065    corellana@tauli.cat    Principal Investigator: Joan Calvet, Dr          Sub-Investigator: Cristobal Orellana, Dr          Sub-Investigator: Maria Garcia-Manrique, Dra Less <<
NCT00629707 Diabetic Ketoacidosis Not Applicable Completed - United States, California ... More >> University of California, Davis Medical Center, 2315 Stockton Blvd Sacramento, California, United States, 95817 Less <<
NCT02734238 Caloric Restriction ... More >> Exercise Less << Phase 4 Completed - United States, Louisiana ... More >> Pennington Biomedical Research Center Baton Rouge, Louisiana, United States, 70808 Less <<
NCT01252810 - Completed - -
NCT00629707 - Completed - -
NCT01252810 Chronic Renal Insufficiency ... More >> Diabete Mellitus Congestive Heart Failure Less << Phase 2 Completed - United States, New Jersey ... More >> GE Healthcare Princeton, New Jersey, United States, 08540 Less <<
NCT01265160 - Unknown June 2011 China ... More >> Beijing Chinese Medicine Hospital Recruiting Beijing, China Contact: Bai Chang, PHD    13611089962       Beijing Ji Shui Tan Hospital Recruiting Beijing, China Contact: Xia Wang    13681007636       Beijing Medical University,DONGZHIMEN Hospital Recruiting Beijing, China Contact: Hongfang Liu, PHD    0086-010-84013243    lhfdoctor@sohu.com    Civil Aviation General Hospital Recruiting Beijing, China Contact: Yu Zhao, PHD    13522424090 Less <<
NCT00665444 Bipolar Disorder ... More >> Metabolic Syndrome Less << Not Applicable Terminated(The study was termi... More >>nated by the sponser due to low study enrollment.) Less << - United States, Pennsylvania ... More >> University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States, 15213 Less <<
NCT01946659 Obstructive Sleep Apnea Not Applicable Completed - United States, New York ... More >> New York University New York, New York, United States, 10016 Less <<
NCT01288638 Polycystic Ovary Syndrome ... More >> Metabolic Syndrome Less << Not Applicable Completed - Canada, Saskatchewan ... More >> University of Saskatchewan Saskatoon, Saskatchewan, Canada, S7N5C9 Less <<
NCT01996696 Prostatic Neoplasm Phase 2 Recruiting September 2021 Canada, Alberta ... More >> Cross Cancer Institute Recruiting Edmonton, Alberta, Canada, T6G 1Z2 Contact: Nawaid Usmani, MD    780-432-8518    Nawaid.usmani@albertahealthservices.ca    Canada, Manitoba Prairie Mountain Health - Western Manitoba Cancer Centre Not yet recruiting Brandon, Manitoba, Canada, R7A2B3 Contact: Joelle Dumontier    204-578-2108    jdumontier@pmh-mb.ca    Contact: William Hunter, MD    204-578-2208    whunter@cancercare.mb.ca    Principal Investigator: William Hunter, MD          CancerCare Manitoba Recruiting Winnipeg, Manitoba, Canada, R3E 0V9 Contact: Julian Kim, MD    204-787-4760    jkim7@cancercare.mb.ca Less <<
NCT00665444 - Terminated(The study was termi... More >>nated by the sponser due to low study enrollment.) Less << - -
NCT02015910 Type II Diabetes Phase 4 Terminated(Terminated by the s... More >>ponsor due to slow enrollment) Less << - United States, District of Col... More >>umbia Medstar Georgetown University Hospital Washington, District of Columbia, United States, 20007 Less <<
NCT00704912 Polycystic Ovary Syndrome Phase 2 Completed - United States, Pennsylvania ... More >> Penn State College of Medicine, Penn State Milton S. Hershey Medical Center Hershey, Pennsylvania, United States, 17033 University of Pennsylvania, Department of Obstetrics and Gynecology Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT02031913 - Recruiting December 2019 Korea, Republic of ... More >> Seoul Metropolitan Government Seoul National University Recruiting Seoul, Korea, Republic of, 156-707 Contact: Won Kim, M.D, PhD    8228702233    drwon1@snu.ac.kr    Contact: Saekyung Joo, M.D    821089619285    joo.sammy@gmail.com    Principal Investigator: Won Kim, M.D, PhD Less <<
NCT02023515 - Completed - -
NCT00704912 - Completed - -
NCT02015910 - Terminated(Terminated by the s... More >>ponsor due to slow enrollment) Less << - -
NCT02068781 Abdominal Obesity ... More >> Metabolic Syndrome Sodium-sensitivity Insulin Resistance Hypertension Less << Not Applicable Completed - Netherlands ... More >> Maastricht University Maastricht, Limburg, Netherlands, 6229 ER Less <<
NCT02054390 - Completed - Turkey ... More >> Ankara University School Of Medicine, Department of Cardiology Ankara, Turkey, 06230 Less <<
NCT02023515 Metabolic Syndrome Not Applicable Completed - United States, Kentucky ... More >> University of Kentucky Lexington, Kentucky, United States, 40506 Less <<
NCT02102646 Prostate Cancer ... More >> Metabolic Syndrome Hypogonadism Fatty Liver Less << Phase 4 Completed - Denmark ... More >> Herlev Hospital Herlev, Denmark, 2730 Less <<
NCT00743327 - Terminated(No Participants com... More >>pleted study) Less << - United States, Maryland ... More >> NIA Clinical Research Unit located at Harbor Hospital Baltimore, Maryland, United States, 21225 Less <<
NCT00732173 Endometrial Cancer Not Applicable Completed - United States, Ohio ... More >> Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5065 Less <<
NCT01417871 - Completed - Germany ... More >> University Magdeburg Magdeburg, Germany, 39120 Less <<
NCT02174783 Liver Transplantation ... More >> Metabolic Syndrome X Obesity Less << Not Applicable Terminated - United States, Ohio ... More >> Cleveland Clinic Cleveland, Ohio, United States, 44195 Less <<
NCT01837134 Overweight Ob... More >>esity Metabolic Syndrome Less << Not Applicable Completed - Germany ... More >> West-German Centre of Diabetes and Health Düsseldorf, Germany, 40591 Less <<
NCT00823277 - Completed - Denmark ... More >> The Children's Obesity Clinic, Paediatric Department, University Hospital Holbaek, Region Zealand, University of Copenhagen Holbaek, Denmark, 4300 Less <<
NCT00825266 Hypertension, Pulmonary Phase 2 Terminated(difficulty in findi... More >>ng eligible subjects) Less << - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT02137421 Metabolic Syndrome ... More >> Coronary Artery Disease Less << Not Applicable Completed - Iran, Islamic Republic of ... More >> Islamic Republic of Iran Tehran, Iran, Islamic Republic of Less <<
NCT02192684 Insulin Sensitivity ... More >> Obstructive Sleep Apnea Less << Not Applicable Completed - -
NCT02192684 - Completed - -
NCT01906957 Metabolic Syndrome ... More >> Coronary Heart Disease Chronic Heart Failure Less << Not Applicable Unknown October 2018 Canada, Quebec ... More >> Cardiovascular Prevention and Rehabilitation Centre, Montreal Heart Institute Recruiting Montreal, Quebec, Canada, H1T 1N6 Contact: Julie Lalongé    +1-514-374-1480 ext 259    julie.lalonge@icm-mhi.org    Principal Investigator: Mathieu Gayda, Ph.D          Cardiovascular Prevention and Rehabilitation Centre (EPIC), Montreal Heart Institute Not yet recruiting Montreal, Quebec, Canada, H1T1N6 Contact: Julie Lalongé, RT    514-374-1480 ext 259    julie.lalonge@icm-mhi.org    Principal Investigator: Mathieu Gayda, Ph.D Less <<
NCT02208141 - Recruiting - Germany ... More >> Center for Pediatric Research Leipzig (CPL) Recruiting Leipzig, Sachsen, Germany, 04103 Contact: Antje Körner, Prof. Dr.    0049/(0)341-9726854    Antje.Koerner@medizin.uni-leipzig.de    Contact: Julian Schwartze    0049/(0)341-9726537    JulianTristan.Schwartze@medizin.uni-leipzig.de Less <<
NCT02214056 - Completed - France ... More >> Cabinet Médical - 47 rue de la République Besseges, France, 30160 Centre de Santé Médical Besseges, France, 30160 Centre médical des Olivettes Ganges, France, 34190 Cabinet Médical - 5 rue Abbé Masson La Grand Combe, France, 30110 Cabinet Médical - 154 Place de la Poste Lasalle, France, 30460 Cabinet Médical - Les Glycines Lasalle, France, 30460 Cabinet Médical - Pont de Grammal Molières-sur-Cèze, France, 30410 Cabinet Médical - 9 rue Racine Nîmes, France, 30000 Cabinet Médical - 15 rue du Lac Quissac, France, 30260 Cabinet Médical - 7 bis avenue Rhin Danube Sauve, France, 30610 Cabinet Médical - 36 place de l'Esplanade St Ambroix, France, 30500 Centre Médical La Cantonnade St Florent sur Auzonnet, France, 30960 Cabinét Médical - 9 rue Villeneuve St Jean du Gard, France, 30270 Less <<
NCT00825266 - Terminated(difficulty in findi... More >>ng eligible subjects) Less << - -
NCT02226510 Left Ventricular Hypertrophy ... More >> Insulin Resistance Coronary Artery Disease Less << Phase 4 Completed - United Kingdom ... More >> Ninewells Hospital & Medical School Dundee, Angus, United Kingdom, DD1 9SY Less <<
NCT02216201 - Withdrawn(Sponsor terminated s... More >>tudy) Less << - United States, California ... More >> University of Southern California's Childhood Obesity Research Center (CORC) Los Angeles, California, United States, 90033 Less <<
NCT00835120 - Completed - -
NCT02241603 Obesity Phase 2 Recruiting December 31, 2019 United States, Missouri ... More >> St. Louis VA Medical Center John Cochran Division, St. Louis, MO Recruiting Saint Louis, Missouri, United States, 63106 Contact: Julia P Dunn, MD       julia.dunn@va.gov    Principal Investigator: Julia P Dunn, MD Less <<
NCT02266264 Hyperglycemia Phase 4 Completed - Thailand ... More >> Department of Medicine, Faculty of Medicine, Srinakharinwirot University Ongkharak, Nakhon nayok, Thailand, 26120 Less <<
NCT00835120 Metabolic Syndrome ... More >> Bipolar Depression Insulin Resistance Less << Phase 4 Completed - United States, Ohio ... More >> University Hospitals Cleveland Medical Center Cleveland, Ohio, United States, 44106 Less <<
NCT01510665 Gestational Diabetes ... More >> Obesity Less << Not Applicable Completed - United States, California ... More >> 200 Medical Plaza UCLA Ob/Gyn Clinic Westwood, California, United States, 90095 West Medical UCLA Ob/Gyn Clinic Westwood, California, United States, 90095 Less <<
NCT02271568 - Unknown December 2017 Korea, Republic of ... More >> Hanyang University Seoul Hospital Seongdong-gu, Seoul, Korea, Republic of, 133-792 Less <<
NCT00865683 Overweight and Obesity ... More >> Insulin Resistance Diabetes, Gestational Hypertension in Pregnancy Pre-Eclampsia Less << Phase 1 Unknown July 2011 United States, Ohio ... More >> General Clinical Research Center Recruiting Cincinnati, Ohio, United States, 45229-3039 Contact: Margaret Andrews, MD, MS, RD    513-558-7042    margaret.andrews@uc.edu    Contact: Anu Gundamaraju, BS    513-558-7041    gundamaa@email.uc.edu    Principal Investigator: Debra A. Krummel, PhD, RD Less <<
NCT00157924 Hypercholesterolemia Phase 4 Completed - -
NCT03610334 Healthy Volunteers Phase 1 Recruiting July 2019 France ... More >> Centre d'Investigation Clinique - Centre de Pharmacologie Clinique et d'Evaluations Thérapeutiques (CIC-CPCET) Recruiting Marseille, France, 13385 Contact: Christine Audebert, MD    491384641 ext +33    christine.audebert@ap-hm.fr    Contact: Laurence Attolini, PhD    491388003 ext +33    laurence.attolini@ap-hm.fr    Principal Investigator: Christine Audebert, MD          Sub-Investigator: Marie-Noelle Lefebvre, MD          Sub-Investigator: Frank Rouby, MD Less <<
NCT02295202 Sleep Apnea M... More >>etabolic Syndrome Less << Phase 4 Unknown December 2017 Brazil ... More >> Luciano Drager Recruiting Sao Paulo, Brazil Contact: Luciano F Drager, MD, PhD       luciano.drager@incor.usp.br Less <<
NCT00243984 Metabolic Syndrome X ... More >> Diabetes Mellitus, Type 2 Less << Phase 3 Suspended(Study was discontinu... More >>ed because of high drop out rate.) Less << November 2007 United States, Ohio ... More >> Akron General Medical Center Akron, Ohio, United States, 44307 Mercy Medical Center Canton, Ohio, United States, 44708 Aultman Hospital Canton, Ohio, United States, 44710 Forum Health/Northside Medical Center Youngstown, Ohio, United States, 44501 St. Elizabeth Health Center Youngstown, Ohio, United States, 44501 Less <<
NCT02320760 Low Physical Activity Level ... More >> Central Obesity Metabolic Syndrome Less << Not Applicable Completed - -
NCT00228176 Carotid Artery Plaque ... More >> Arteriosclerosis Obesity Metabolic Syndrome X Less << Phase 3 Terminated(Company decision ta... More >>ken in light of demands by certain national health authorities) Less << - United States, New Jersey ... More >> Sanofi-Aventis Administrative Office Bridgewater, New Jersey, United States, 08807 Canada Sanofi-Aventis Administrative Office Laval, Canada France Sanofi-Aventis Administrative Office Paris, France Netherlands Sanofi-Aventis Administrative Office Gouda, Netherlands Spain Sanofi-Aventis Administrative Office Barcelona, Spain United Kingdom Sanofi-Aventis Administrative Office Guildford Surrey, United Kingdom Less <<
NCT02326259 - Recruiting March 2018 United States, Pennsylvania ... More >> Temple University Recruiting Philadelphia, Pennsylvania, United States, 19140 Contact: Martin Schardt, BS    215-707-3185    tuf57654@temple.edu    Contact: William J Foster, MD, PhD    215-707-3185    william.foster@temple.edu Less <<
NCT02322073 - Active, not recruiting December 2019 Sweden ... More >> Sahglrenska University Hospital Gothenburg, Sweden, S41345 Less <<
NCT00225355 Angina Pectoris ... More >> Metabolic Syndrome X Less << Phase 4 Terminated November 2006 United Kingdom ... More >> Cardiology Department, Glasgow Royal Infirmary Glasgow, United Kingdom, G4 0SF Less <<
NCT02105428 Polycystic Ovarian Syndrome (P... More >>COS) Insulin Resistance Overweight Obese Less << Not Applicable Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT01605422 - Unknown December 2015 Canada, Ontario ... More >> The Toronto 3D (Diet, Digestive tract and Disease) Knowledge Synthesis and Clinical Trials Unit, Clinical Nutrition and Risk Factor Modification Centre, St. Micheal's Hospital Toronto, Ontario, Canada, M5C 2T2 Less <<
NCT02356653 Leukemia Inbo... More >>rn Errors of Metabolism Bone Marrow Failure Syndromes Immunodeficiencies Immunodysregulation Polyendocrinopathy Enteropathy X-linked Syndrome Less << Early Phase 1 Recruiting January 2020 United States, Pennsylvania ... More >> Children's Hospital of Philadelphia Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Margie Tartaglione, RN    215-590-4029    tartaglione@email.chop.edu    Contact: Patricia Hankins, RN    215-590-5168    hankinsp@email.chop.edu    Principal Investigator: Nancy J Bunin, MD          Sub-Investigator: Stephan A Grupp, MD, PhD Less <<
NCT01625442 Metabolic Syndrome ... More >> Hypercholesterolemia Hypertriglyceridemia Hyperglycemia Less << Phase 4 Completed - Iran, Islamic Republic of ... More >> Birjand University of medical sciences Birjand, South khorasan, Iran, Islamic Republic of, 9714815395 Less <<
NCT01608620 - Unknown September 2016 Canada, Ontario ... More >> The Toronto 3D (Diet, Digestive tract and Disease) Knowledge Synthesis and Clinical Trials Unit, Clinical Nutrition and Risk Factor Modification Centre, St. Michael's Hospital Toronto, Ontario, Canada, M5C 2T2 Less <<
NCT01594710 - Completed - Korea, Republic of ... More >> Korea University Guro Hospital Seoul, Korea, Republic of Less <<
NCT01634048 Overweight Ob... More >>ese Metabolic Syndrome Non Alcoholic Fatty Liver Disease Less << Not Applicable Completed - United Kingdom ... More >> Imperial College London London, United Kingdom, W12 0NN Less <<
NCT01631838 Metabolic Syndrome ... More >> Platelet Aggregation, Spontaneous Less << Not Applicable Completed - Malaysia ... More >> Malaysia Palm Oil Board Kajang, Selangor, Malaysia, 43000 Less <<
NCT01608607 - Unknown October 2015 Canada, Ontario ... More >> The Toronto 3D (Diet, Digestive tract and Disease) Knowledge Synthesis and Clinical Trials Unit, Clinical Nutrition and Risk Factor Modification Centre, St. Micheal's Hospital Toronto, Ontario, Canada, M5C 2T2 Less <<
NCT01046435 Periodontal Disease ... More >> Cardiovascular Disease Type 2 Diabetes Obesity Metabolic Syndrome Less << Not Applicable Completed - Chile ... More >> Dra Eloisa Díaz Health Center, Metropolitan Northen Health Service Santiago, Chile Less <<
NCT02496780 Cystic Fibrosis Phase 2 Phase 3 Recruiting July 2020 United States, Minnesota ... More >> University of Minnesota Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Antoinette Moran, MD          Children's Hospitals and Clinics of Minnesota Recruiting Saint Paul, Minnesota, United States Contact: Laura Gandrud, MD Less <<
NCT00298428 Coronary Artery Disease ... More >> Atherosclerosis Diabetes Mellitus Metabolic Syndrome X Less << Not Applicable Completed - France ... More >> Département de Cardiologie, Hôpital Bichat, Assistance Publique-Hôpitaux de Paris Paris, France, 75018 Service d'Hématologie et d'Immunologie Biologiques, Hôpital Bichat, Assistance Publique-Hôpitaux de Paris Paris, France, 75018 Less <<
NCT01077479 Metabolic Syndrome ... More >> Hypercholesterolemia Less << Phase 2 Completed - Australia, New South Wales ... More >> Westmead Hospital Sydney, New South Wales, Australia, 2145 Less <<
NCT01701557 Diabetes Not Applicable Completed - United States, Colorado ... More >> the Childrens Hospital Colorado Aurora, Colorado, United States, 80045 Less <<
NCT02466217 - Recruiting July 2021 France ... More >> Rhumatologie - Hôpital Saint-Antoine Recruiting Paris, France, 75012 Contact: Francis BERENBAUM, MD, PhD    33 1 49 28 25 20    francis.berenbaum@aphp.fr    Contact: Jérémie SELLAM, MD, PhD    33 1 49 28 25 20    jeremie.sellam@aphp.fr    CIC Paris-Est, Hôpital PITIE SALPETRIERE Recruiting Paris, France, 75013 Contact: Christian FUNCK- BRENTANO, MD, PhD    0033 1 42 17 85 31    christian.funck-brentano@psl.aphp.fr    Contact: Roberta LORENZON, MD    0033 1 42 17 85 33    roberta.lorenzon@upmc.fr Less <<
NCT00362440 - Completed - -
NCT00362440 HIV Lipodystrophy Phase 2 Completed - United States, Massachusetts ... More >> Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Less <<
NCT01641393 Exocrine Pancreatic Insufficie... More >>ncy: Cystic Fibrosis Less << Phase 3 Completed - -
NCT02126696 - Completed - Lesotho ... More >> Seboche Hospital Butha-Buthe, Lesotho, 400 Paray Hospital Thaba-Tseka, Lesotho Less <<
NCT01738256 Metabolic Syndrome Risk Factor... More >>s Overweight Psychological Stress Less << Not Applicable Completed - Finland ... More >> Institute of Biomedicine, University of Helsinki Helsinki, Finland, 00290 Department of Psychology and Department of Health Sciences, University of Jyvaskyla Jyvaskyla, Finland, 40014 Institute of Public Health and Clinical Nutrition, University of Eastern Finland (UEF) Kuopio, Finland, 80101 Less <<
NCT00118560 Diabetes Mellitus, Type 2 ... More >> Intermittent Claudication Less << Not Applicable Completed - United States, California ... More >> VA Greater Los Angeles Healthcare System, West LA West Los Angeles, California, United States, 90073 Less <<
NCT00116792 Coronary Artery Disease ... More >> Diabetes Mellitus Less << Phase 2 Phase 3 Unknown - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT02560376 Insulinoma Ne... More >>sidioblastosis Less << Early Phase 1 Unknown December 2016 China, Beijing ... More >> Peking Union Medical College Hospital Recruiting Beijing, Beijing, China, 100730 Contact: Fang Li, MD    +86 10 69155502    lifang@pumch.cn    Contact: Yaping Luo, MD    +86 10 69157033    luoyaping@live.com    Principal Investigator: Fang Li, MD          Principal Investigator: Shawn Chen, PHD Less <<
NCT00116545 Atherosclerosis ... More >> Diabetes Mellitus Less << Phase 2 Phase 3 Completed - United States, California ... More >> Atherosclerosis Research Unit, Division of Cardiovascular Medicine, Department of Medicine Los Angeles, California, United States, 90033 Less <<
NCT00119535 Diabetes Mellitus ... More >> Diabetic Retinopathy Less << Not Applicable Completed - United States, California ... More >> VA Greater Los Angeles Healthcare System, West Los Angeles, CA West Los Angeles, California, United States, 90073 United States, Michigan VA Ann Arbor Healthcare System, Ann Arbor, MI Ann Arbor, Michigan, United States, 48105 United States, Ohio Louis Stokes VA Medical Center, Cleveland, OH Cleveland, Ohio, United States, 44106 Less <<
NCT00118976 Diabetes Mellitus, Type I ... More >> Diabetic Nephropathy Less << Not Applicable Completed - Denmark ... More >> Steno Diabetes Center Gentofte, Denmark, 2820 Less <<
NCT01050465 Acne Vulgaris ... More >> Allergic Rhinitis Anxiety Asthma Back Pain Prostatic Hyperplasia Bursitis Chronic Obstructive Pulmonary Disease Cough Coronary Artery Disease Depression Diabetes Mellitus Diarrhea Gastroesophageal Reflux Fibromyalgia Headache HIV Infections Hypothyroidism Hyperlipidemia Hypertension Influenza Sleep Initiation and Maintenance Disorders Irritable Bowel Syndrome Migraine Disorders Obesity Obstructive Sleep Apnea Osteoarthritis Senile Osteoporosis Shoulder Pain Sinusitis Smoking Cessation Tobacco Use Cessation Menopause Urinary Incontinence Urinary Tract Infection Vaginitis Vertigo Less << Not Applicable Completed - -
NCT00134264 Coronary Disease ... More >> Diabetes Mellitus Less << Phase 3 Terminated - -
NCT00120341 Diabetes Mellitus ... More >> Diabetic Neuropathy Less << Phase 4 Completed - United States, Texas ... More >> Scott and White Santa Fe Center Temple,, Texas, United States, 76504 Less <<
NCT00134329 - Completed - Belgium ... More >> University Hospital Ghent Ghent, Belgium, 9000 Less <<
NCT00141453 Diabetic Nephropathy ... More >> Type 2 Diabetes Mellitus Proteinuria Less << Phase 3 Completed - China ... More >> Hong Kong, China Japan Tokyo, Japan Less <<
NCT00141453 - Completed - -
NCT00636142 Obesity Insul... More >>in Resistance Metabolic Syndrome Less << Phase 4 Completed - Austria ... More >> Department of Internal Medicine, Medical University of Graz Graz, Austria, 8036 Less <<
NCT00645775 Metabolic Syndrome ... More >> Obesity Dyslipidemia Less << Not Applicable Completed - Cameroon ... More >> Laboratory of Nutrition & Nutritional Biochemistry Yaounde, Centre, Cameroon, BP812 Less <<
NCT00136773 Albuminuria Phase 4 Completed - -
NCT00655902 Metabolic Syndrome ... More >> Abdominal Obesity Heart Disease Type 2 Diabetes Less << Not Applicable Completed - Denmark ... More >> Department of Human Nutrition, University of Copenhagen Frederiksberg, Copenhagen, Denmark, 1958 Less <<
NCT00664495 Obesity Not Applicable Completed - Canada, Ontario ... More >> Queen's University Kingston, Ontario, Canada, K7L 3N6 Less <<
NCT00477477 Childhood Obesity ... More >> Dyslipidemia Insulin Resistance Hypertension Less << Not Applicable Terminated(Inadequate enrollme... More >>nt and lack of funds.) Less << - United States, Massachusetts ... More >> Children's Hospital Boston Boston, Massachusetts, United States, 02115 Less <<
NCT00608465 - Terminated(Lack of enrollment) - -
NCT00665353 - Completed - -
NCT00666848 Metabolic Syndrome ... More >> Hypertension Less << Phase 4 Completed - United States, Tennessee ... More >> Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232 Less <<
NCT00671515 Depressive Disorder, Major ... More >> Metabolic Syndrome X Less << Phase 2 Completed - United States, Ohio ... More >> University Hospitals Cleveland Medical Center - Mood Disorders Program Cleveland, Ohio, United States, 44106 Less <<
NCT00671515 - Completed - -
NCT00665353 HIV-1 and Hepatitis C Co-Infec... More >>tion Less << Phase 2 Completed - United States, California ... More >> Ucsf Aids Crs (801) San Francisco, California, United States, 94110 United States, Illinois Northwestern University CRS (2701) Chicago, Illinois, United States, 60611 United States, New Jersey New Jersey Medical School-Adult Clinical Research Ctr. CRS (31477) Newark, New Jersey, United States, 07103 United States, New York Cornell CRS (7804) New York, New York, United States, 10011 NY Univ. HIV/AIDS CRS (401) New York, New York, United States, 10016 AIDS Care CRS (1108) Rochester, New York, United States, 14642 United States, Ohio Metro Health CRS (2503) Cleveland, Ohio, United States, 44109 United States, Virginia Virginia Commonwealth Univ. Medical Ctr. CRS (31475) Richmond, Virginia, United States, 23219 Less <<
NCT00186537 Insulin Resistance ... More >> Hypertriglyceridemia Less << Not Applicable Completed - United States, California ... More >> Stanford University Medical Center Stanford, California, United States, 94305 Less <<
NCT00694616 Obstructive Sleep Apnea ... More >> Metabolic Syndrome Less << Not Applicable Completed - India ... More >> All India Institute of Medical Sciences New Delhi, India, 110608 Less <<
NCT00666848 - Completed - -
NCT00194428 Obesity Metab... More >>olic Syndrome X Hyperlipidemia Hypertension Less << Phase 1 Phase 2 Completed - United States, Pennsylvania ... More >> Temple University Philadelphia, Pennsylvania, United States, 19140 Less <<
NCT00608465 Metabolic Syndrome X Phase 4 Terminated(Lack of enrollment) - United States, Tennessee ... More >> Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232 Less <<
NCT00189085 Metabolic Syndrome Phase 4 Completed - Netherlands ... More >> Department of Vascular Medicine UMC Utrecht Utrecht, Netherlands, 3584 CX Less <<
NCT00186537 - Completed - -
NCT00705224 - Completed - -
NCT00240305 Metabolic Syndrome ... More >> Dyslipidemia Less << Phase 3 Completed - Australia, Western Australia ... More >> Research Site Perth, Western Australia, Australia Less <<
NCT00707603 - Completed - Australia, New South Wales ... More >> Garvan Institute Of Medical Research Sydney, New South Wales, Australia, 2010 Storr Liver Unit Sydney, New South Wales, Australia, 2145 Less <<
NCT00705224 - Completed - -
NCT00526383 Major Depressive Disorder Not Applicable Completed - France ... More >> Assistance Publique hopital Bicêtre Paris, France, 75013 Less <<
NCT00738140 Prostate Cancer Phase 2 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT00512070 Schizophrenia ... More >> Schizoaffective Disorder Bipolar Disorder Obesity Metabolic Syndrome Less << Not Applicable Active, not recruiting December 2021 United States, Washington ... More >> VA Puget Sound Health Care System Tacoma, Washington, United States, 98493 Less <<
NCT00271921 - Completed - United States, New York ... More >> St. Luke's Roosevelt Hosptial Center New York, New York, United States, 10025 New York State Psychiatric Institute/Columbia University New York, New York, United States, 10032 Less <<
NCT00272311 Cardiovascular Diseases ... More >> Metabolic Syndrome X Atherosclerosis Less << Phase 4 Completed - United States, Maryland ... More >> HeartDrug Research, LLC Towson, Maryland, United States, 21204 Less <<
NCT00739479 Metabolic Syndrome ... More >> Overweight Less << Not Applicable Completed - United States, California ... More >> UC Davis CCRC Sacramento, California, United States, 95616 Less <<
NCT00283374 - Terminated - United States, California ... More >> Irvine, California, United States, 92697-1050 Orange, California, United States, 92868 United States, Georgia Atlanta, Georgia, United States, 30322 United States, Indiana Indianapolis, Indiana, United States, 46278 United States, Massachusetts Boston, Massachusetts, United States, 02111 United States, Minnesota Minneapolis, Minnesota, United States, 55455 United States, Ohio Cleveland, Ohio, United States, 44195 United States, Pennsylvania Pittsburgh, Pennsylvania, United States, 15213 Pittsburgh, Pennsylvania, United States, 15240 United States, Texas Dallas, Texas, United States, 75390-9156 Italy Aosta, Italy, 11100 Pisa, Italy, 56127 Roma, Italy, 00168 Sweden Gothenburg, Sweden, 413 45 Stockholm, Sweden, 116 91 Stockholm, Sweden, 141 86 Stockholm, Sweden, 182- 88 Less <<
NCT00782366 - Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT00763802 - Completed - Portugal ... More >> AIBILI Coimbra, Portugal, 3000-548 Less <<
NCT00804882 - Withdrawn(Principal investigat... More >>or is leaving the institution to obtain further training.) Less << - United States, Texas ... More >> Texas Tech University Health Sciences Center Lubbock, Texas, United States, 79430 Less <<
NCT00794963 - Terminated(Difficulty recruiti... More >>ng) Less << - -
NCT00272311 - Completed - -
NCT00855374 - Completed - United States, Tennessee ... More >> Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232 Less <<
NCT00794963 Metabolic Syndrome Not Applicable Terminated(Difficulty recruiti... More >>ng) Less << - United States, New York ... More >> Zucker Hillside Hospital Glen Oaks, New York, United States, 11004 Less <<
NCT00660998 Erectile Dysfunction Phase 4 Completed - -
NCT00826774 Obesity Hyper... More >>cholesterolemia Metabolic Syndrome Hypertension Diabetes Less << Phase 3 Completed - -
NCT00858221 - Completed - United States, Pennsylvania ... More >> Geisinger Health System Danville, Pennsylvania, United States, 17822 Less <<
NCT00288366 Schizophrenia ... More >> Schizoaffective Disorder Bipolar Disorder Less << Not Applicable Completed - United States, Tennessee ... More >> Psychiatric Hospital at Vanderbilt Nashville, Tennessee, United States, 37212 Less <<
NCT00871234 - Completed - -
NCT00871845 Obesity Insul... More >>in Resistance Metabolic Syndrome Hepatitis C Less << Not Applicable Terminated(Protocol expired an... More >>d not renewed) Less << - United States, Pennsylvania ... More >> Center for Liver Diseases, UPMC. Pittsburgh, Pennsylvania, United States, 15213 Less <<
NCT00857298 HIV (Human Immunodeficiency Vi... More >>rus) Metabolic Syndrome HIV Infections Less << Not Applicable Completed - United States, Missouri ... More >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Less <<
NCT00362908 Metabolic Syndrome X ... More >> Dyslipidemias Less << Not Applicable Completed - United States, Washington ... More >> Northwest Lipid Research Clinic Seattle, Washington, United States, 98104 Less <<
NCT00891267 Metabolic Syndrome ... More >> Hypertension Less << Phase 3 Completed - Germany ... More >> Erlangen, Germany Less <<
NCT00871234 Endothelial Function ... More >> Lipids Insulin Resistance Inflammation HIV Infections Less << Phase 1 Completed - United States, Indiana ... More >> Infectious Diseases Research Center Indianapolis, Indiana, United States, 46202 Less <<
NCT00927290 Chronic Hepatitis C ... More >> Insulin Resistance Less << Phase 3 Terminated(Suspension of use o... More >>f medicine containing Pioglitazone by French regulatory agency) Less << - France ... More >> Hôpital Pitié Salpêtrière, Service d'hépatogastroentérologie Paris, France, 75013 Less <<
NCT00920842 - Completed - United States, Washington ... More >> Clinical Research Center - Seattle Children's Hospital Seattle, Washington, United States, 98105 Less <<
NCT00871845 - Terminated(Protocol expired an... More >>d not renewed) Less << - -
NCT00942643 Obstructive Sleep Apnea ... More >> Insulin Resistance Endothelial Function Oxidative Stress Less << Not Applicable Terminated(Poor patient recrui... More >>tment) Less << - Hong Kong ... More >> Queen Mary Hospital Pokfulam, Hong Kong Less <<
NCT00930592 - Completed - United States, Massachusetts ... More >> Tufts Medical Center, Department of Dermatology Boston, Massachusetts, United States, 02111 Less <<
NCT00920738 - Completed - United States, Minnesota ... More >> University of Minnesota Children's Hospital - Fairview Minneapolis, Minnesota, United States, 55455 Less <<
NCT00409773 Hypercholesterolemia ... More >> Metabolic Syndrome Less << Phase 3 Completed - -
NCT00405015 Ischemia-Reperfusion Injury ... More >> The Metabolic Syndrome Less << Phase 2 Completed - Netherlands ... More >> Clinical research Center Nijmegen Nijmegen, Netherlands, 6500 HB Less <<
NCT00928473 Weight Loss O... More >>besity Metabolic Syndrome NAFLD, Non-alcoholic Fatty Liver Disease Cardiovascular Diseases Less << Not Applicable Recruiting December 2018 Denmark ... More >> The Children's Obesity Clinic, Paediatric department, University Hospital Holbæk, Region Zealand Recruiting Holbæk, Denmark, 4300 Contact: Jens-Christian Holm, Ph.d, MD       jhom@regionsjaelland.dk Less <<
NCT01007955 - Completed - United States, Massachusetts ... More >> UMass Memorial Medical Center Worcester, Massachusetts, United States, 01655 Less <<
NCT00994812 Polycystic Ovary Syndrome ... More >> Miscarriage Infertility Toxemia Gestational Diabetes Less << Phase 3 Completed - Finland ... More >> University Hospital Of Helsinki Helsinki, Finland University Hospital of Kuopio Kuopio, Finland University Hopsital of Oulu Oulu, Finland, 90029 University Hospital of Tampere Tampere, Finland University Hospital of Turku Turku, Finland Less <<
NCT00957294 - Completed - Denmark ... More >> Research Unit, Dep. Q of Affective Disorders, Aarhus University Hospital, Risskov Aarhus, Risskov, Denmark, 8240 Less <<
NCT01040546 Metabolic Syndrome ... More >> Obesity Less << Not Applicable Completed - Taiwan ... More >> Department of Famility Medicine,China Medical University Hospital Taichung, Taiwan Less <<
NCT01029561 Metabolic Syndrome ... More >> Insulin Resistance Adipokines Cytokines Less << Not Applicable Unknown January 2012 Spain ... More >> Hospital Universitari de Bellvitge Hospitalet de Llobregat, Barcelona, Spain, 08907 Less <<
NCT00468533 Schizophrenia, Tardive Dyskine... More >>sia, Metabolic Syndrome Less << Phase 4 Unknown July 2007 Taiwan ... More >> Yu-Li Hospital, DOH Recruiting Hualien, Taiwan, 981 Contact: Hsien-Jane Chiu, MD, MPH, PhD    03-8886141 ext 2220    ylh.ebmc@gmail.com    Principal Investigator: Tsuo-Hung Lan, MD, PhD Less <<
NCT01068080 - Completed - Japan ... More >> Toujinkai Hospital Kyoto, Japan, 612-8026 Less <<
NCT00409773 - Completed - -
NCT01008878 Obesity Metab... More >>olic Syndrome Less << Not Applicable Completed - Canada, Quebec ... More >> Centre de Recherche Clinique (CRC), Centre Hospitalier Universitaire de Sherbrooke Sherbrooke, Quebec, Canada, J1H 5N4 Less <<
NCT01083771 - Completed - -
NCT01083771 Prostate Cancer Not Applicable Completed - United States, Rhode Island ... More >> Miriam Hospital Providence, Rhode Island, United States, 02906 Less <<
NCT01045499 Morbid Obesity ... More >> Obstructive Sleep Apnea Syndrome Metabolic Syndrome Insulin Resistance Nonalcoholic Fatty Liver Disease Less << Not Applicable Completed - United States, New York ... More >> Morgan Stanley Children's Hospital of NY Presbyterian New York, New York, United States, 10032 Less <<
NCT01093417 Human Immunodeficiency Virus (... More >>HIV) Vitamin D Deficiency HIV Infections Less << Phase 2 Completed - United States, Ohio ... More >> University Hospitals of Cleveland Case Medical Center Cleveland, Ohio, United States, 44106 Less <<
NCT00005314 - Completed - -
NCT01044680 Overweight Me... More >>tabolic Syndrome X Less << Phase 2 Phase 3 Completed - China ... More >> Tongji University Medical College Shanghai, China Less <<
NCT00518960 Metabolic Syndrome ... More >> Hyperlipidemia Less << Not Applicable Unknown September 2007 United States, Minnesota ... More >> MAPS Applied Research Center (MARC) Edina, Minnesota, United States, 55435 Less <<
NCT00912210 Bone and Body Composition ... More >> Obesity Metabolic Syndrome Physical Function Quality of Life Less << Phase 1 Completed - United States, Illinois ... More >> University of Illinois at Urbana-Champaign Urbana, Illinois, United States, 61801 Less <<
NCT01093417 - Completed - -
NCT00099567 - Completed - United States, Pennsylvania ... More >> Pittsburgh, Pennsylvania, United States United States, Tennessee Memphis, Tennessee, United States Less <<
NCT01104220 - Active, not recruiting September 2020 United States, Missouri ... More >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Less <<
NCT01138423 Hypertension ... More >>Abdominal Obesity Metabolic Syndrome Less << Phase 4 Completed - Netherlands ... More >> UMC Utrecht Utrecht, Netherlands, 3508 GA Less <<
NCT00553007 Periodontal Disease ... More >> Metabolic Syndrome Less << Not Applicable Unknown October 2009 Japan ... More >> Aichi Gakuin University Recruiting Nagoya, Aichi, Japan, 464-8651 Less <<
NCT00523835 - Completed - Denmark ... More >> Medical department M, Endocrinology and Diabetes, and Medical Research Laboratories, Clinical Institute, Aarhus University Hospital Aarhus, Denmark, 8000 Less <<
NCT01158417 Type 2 Diabetes ... More >> Obesity Insulin Resistance Less << Phase 2 Phase 3 Unknown August 2014 United States, New York ... More >> 115 Flint Road Buffalo, New York, United States, 14221 Less <<
NCT01205347 Myocardial Infarction Phase 4 Completed - Brazil ... More >> Hospital de Base do Distrito Federal Brasilia, DF, Brazil, 70000.000 Less <<
NCT01200225 - Completed - France ... More >> Neuilly-sur-seine, France, 92521 Less <<
NCT01183442 Coronary Artery Disease ... More >> Postprandial Hyperglycemia Vitamin D Deficiency Less << Phase 3 Terminated(unable to recruit) - Austria ... More >> Dept. of Internal Medicine, Medical University of Graz Graz, Austria, 8036 Less <<
NCT01227213 - Completed - Netherlands ... More >> Radboud University Nijmegen Medical Centre Nijmegen, Netherlands, 6500HB Less <<
NCT01173705 - Terminated - United States, Tennessee ... More >> Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232 Less <<
NCT01184170 Obesity Metab... More >>olic Syndrome Less << Not Applicable Completed - United States, Missouri ... More >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Less <<
NCT00115232 - Completed - United States, Massachusetts ... More >> Children's Hospital Boston Boston, Massachusetts, United States, 02115 Less <<
NCT01046968 Obesity Hyper... More >>lipidemia Hyperglycemia Less << Phase 1 Phase 2 Completed - Cameroon ... More >> Laboratory of Nutrition and Nutritional Biochemistry Yaounde, Centre, Cameroon, 8418 Less <<
NCT01235663 Reduce the Risk of Obesity Dur... More >>ing Infancy Reduce the Risk of Insulin Resistance Less << Not Applicable Completed - Denmark ... More >> Department of Neonatology, Hvidovre University Hospital Hvidovre, Denmark, 2650 Less <<
NCT00659321 Metabolic Syndrome ... More >> Dyslipidaemia Less << Phase 3 Completed - Germany ... More >> GWT-TUD GmbH, Centre for Clinical Studies Dresden, Germany, 01307 Less <<
NCT00640276 Hypercholesterolemia ... More >> Metabolic Syndrome Less << Phase 4 Completed - Korea, Republic of ... More >> Seoul National University Bundang Hospital Bundang-gu, Gyeonggi-do, Korea, Republic of, 463-707 Hanyang Univ. Guri Hospital Guri-si, Gyeonggi-do, Korea, Republic of, 471-701 Less <<
NCT01080989 Flavivirus Infection ... More >> Alphavirus Infections Malaria Parasitic Disease Leptospirosis Hypertension Metabolic Syndromes Less << Not Applicable Completed - Taiwan ... More >> Kaoshing Medical University Chung-Ho Memorial Hospital Kaoshiung, Taiwan Less <<
NCT00703690 Metabolic X Syndrome Dyslipide... More >>mia Less << Phase 2 Terminated - -
NCT01261221 - Completed - Taiwan ... More >> Kaohsiung Medical University Chung-Ho Memorial Hospital Kaohsiung, Taiwan, 807 Less <<
NCT01316081 Metabolic Syndrome Not Applicable Completed - Switzerland ... More >> Swiss Federal Institute of Technology , Laboratory of Human Nutrition Zürich, Switzerland, 8092 Less <<
NCT01119404 - Unknown December 2014 Finland ... More >> Finnish Red Cross Blood Transfusion Service Completed Helsinki, Finland, 00310 Linnan Klinikka Completed Hämeenlinna, Finland, 13100 Mehiläinen Hämeenlinna Completed Hämeenlinna, Finland, 13100 Central Hospital of Kanta-Häme Recruiting Hämeenlinna, Finland, 13530 Contact: Ari K Palomäki, MD PhD    +35836294540    ari.palomaki@khshp.fi    Contact: Kalevi Oksanen, MD PhD    +35836292369    kalevi.oksanen@khshp.fi    Sub-Investigator: Hanna P Pohjantähti-Maaroos, MD          Sub-Investigator: Sari Husgafvel, MSc          Sub-Investigator: Päivi Kankkunen, MSc          Principal Investigator: Ari K Palomäki, MD PhD          Principal Investigator: Kalevi Oksanen, MD PhD Less <<
NCT01332526 - Unknown - -
NCT00686816 Obesity Phase 2 Completed - Russian Federation ... More >> Vasily Isakov, MD Moscow, Russian Federation, 109240 Less <<
NCT00738400 - Completed - -
NCT00738400 Erectile Dysfunction ... More >> Metabolic Syndrome Less << Phase 4 Completed - Germany ... More >> Cham, Bayern, Germany, 93413 Regensburg, Bayern, Germany, 93055 Frankfurt, Hessen, Germany, 60385 Marburg, Hessen, Germany, 35039 Stuhr, Niedersachsen, Germany, 28816 Bonn, Nordrhein-Westfalen, Germany, 53119 Grevenbroich, Nordrhein-Westfalen, Germany, 41515 Leverkusen, Nordrhein-Westfalen, Germany, 51373 Mülheim, Nordrhein-Westfalen, Germany, 45468 Wuppertal, Nordrhein-Westfalen, Germany, 42103 Dierdorf, Rheinland-Pfalz, Germany, 56269 Koblenz, Rheinland-Pfalz, Germany, 56068 Trier, Rheinland-Pfalz, Germany, 54290 Homburg, Saarland, Germany, 66424 Dresden, Sachsen, Germany, 01307 Leipzig, Sachsen, Germany, 04109 Berlin, Germany, 12107 Berlin, Germany, 14197 Hamburg, Germany, 20354 Less <<
NCT01300104 Prostate Cancer Not Applicable Completed - Denmark ... More >> Aarhus University, Institute of Sport Science Aarhus, Denmark, 8000 Counseling Center, Danish Cancer Society Aarhus, Denmark, 8000 Aarhus University Hospital Skejby Aarhus, Denmark, 8200 Danish Cancer Society Copenhagen, Denmark, 2100 Less <<
NCT01392027 Pancreatic Cancer ... More >> Chronic Pancreatitis Type II Diabetes Pancreatic Cysts Healthy Control Less << Not Applicable Completed - United States, Michigan ... More >> Univerisity of Michigan Ann Arbor, Michigan, United States, 48109 Less <<
NCT01412645 Obesity Infla... More >>mmation Insulin Sensitivity Osteoporosis Less << Not Applicable Completed - Denmark ... More >> Clinical Institute, Aarhus University Aarhus, Denmark, 8000 Less <<
NCT01344811 Obesity Metab... More >>olic Syndrome Less << Not Applicable Completed - Korea, Republic of ... More >> Seoul National University Hospital Seoul, Korea, Republic of Yonsei University Health System Seoul, Korea, Republic of Less <<
NCT01413542 Hypertension ... More >>Diabetes Type 2 Less << Not Applicable Completed - United States, Tennessee ... More >> Vanderbilt University- General Clinic Research Center Nashville, Tennessee, United States, 37232 Less <<
NCT01333839 Coronary Artery Disease Not Applicable Completed - Belgium ... More >> Jessa Hospital Hasselt, Belgium, 3500 Less <<
NCT01362777 Sleep Apnea, Obstructive ... More >> Metabolic Syndrome Less << Phase 3 Completed - France ... More >> Clinique du souffle "La Solane" Osseja, France, 66340 Less <<
NCT01447745 - Unknown March 2017 Canada, Quebec ... More >> Institut universitaire de cardiologie et de pneumologie de Québec Recruiting Québec, Quebec, Canada, G1V 4G5 Principal Investigator: DESPRÉS Jean-Pierre, PhD          Sub-Investigator: DAGENAIS Gilles, MD          Sub-Investigator: LAMARCHE Benoît, PhD          Sub-Investigator: LAROSE Eric, DVM, MD          Sub-Investigator: MATHIEU Patrick, MD          Sub-Investigator: PIBAROT Philippe, DVM, PhD          Sub-Investigator: POIRIER Paul, MD, PhD          Sub-Investigator: RHÉAUME Caroline, MD, PhD Less <<
NCT01441323 Obesity Type ... More >>2 Diabetes Cardiovascular Risk Cancer Less << Not Applicable Completed - United States, California ... More >> Veronica Atkins Lifestyle Intervention Laboratory Los Angeles, California, United States, 90033 Less <<
NCT01463449 - Completed - Denmark ... More >> Department of Endocrinology, Aarhus University Hospital Aarhus, C, Denmark, 8000 Department of Endocrinology, Aarhus University Hospital Aarhus, Denmark, 8000 Less <<
NCT01482286 Polycystic Ovary Syndrome Phase 3 Completed - United States, Louisiana ... More >> Pennington Biomedical Research Center Baton Rouge, Louisiana, United States, 70808 Less <<
NCT01413542 - Completed - -
NCT01428791 Depressive Symptoms ... More >> Metabolic Syndrome X Overweight Obesity Hypertension Hyperglycemia Dyslipidemias Less << Not Applicable Unknown December 2015 United States, Illinois ... More >> Cook County Health and Hospital System Chicago, Illinois, United States, 60612 Mercy Hospital and Health System Chicago, Illinois, United States, 60616 Less <<
NCT01502826 - Unknown December 2013 Italy ... More >> Regional Center for Pediatric Diabetes, Section of Clinical Nutrition & Metabolism, Department of Science of Life & Reproduction, University of Verona Active, not recruiting Verona, Italy, 37134 Less <<
NCT00318734 - Completed - United States, North Carolina ... More >> University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States, 27599-7461 Less <<
NCT00149435 - Completed - -
NCT00864461 - Completed - Mexico ... More >> School of Medicine, University of Guanajuato Leon, Guanajuato, Mexico, 37320 Less <<
NCT00155454 Diabetes Mellitus ... More >> Diabetic Retinopathy Vitreous Hemorrhage Less << Not Applicable Completed - Taiwan ... More >> National Taiwan University Hospital Taipei, Taiwan Less <<
NCT00162357 Diabetes Mellitus, Type 2 ... More >> Coronary Restenosis Less << Phase 4 Completed - United States, Connecticut ... More >> Local Institution Hartford, Connecticut, United States Local Institution Waterbury, Connecticut, United States United States, Michigan Local Institution Grand Rapids, Michigan, United States United States, New York Local Institution Roslyn, New York, United States United States, Vermont Local Institution Burlington, Vermont, United States United States, Virginia Local Institution Roanoke, Virginia, United States United States, Wisconsin Local Institution Wausau, Wisconsin, United States Puerto Rico Local Institution San Juan, Puerto Rico Less <<
NCT00160056 Diabetes Hypo... More >>glycemia Unawareness Less << Not Applicable Completed - Netherlands ... More >> Radboud University Nijmegen Medical Centre Nijmegen, Gelderland, Netherlands, 6500HB Less <<
NCT00144937 Peripheral Arterial Disease ... More >> Hypercholesterolemia Hypertension Diabetes Mellitus Smoking Less << Phase 4 Unknown - Spain ... More >> Hospital de Sabadell Sabadell, Barcelona, Spain, 08208 Less <<
NCT00163683 Type 2 Diabetes ... More >> Coronary Heart Disease Less << Not Applicable Completed - Australia, Victoria ... More >> Alfred Hospital Melbourne, Victoria, Australia, 3181 Less <<
NCT00166036 Diabetes Mellitus ... More >> Metabolic Syndrome X Hypercholesterolemia Less << Phase 2 Completed - United States, Georgia ... More >> Emory University Hospital Atlanta, Georgia, United States, 30322 Less <<
NCT00155922 - Unknown - Taiwan ... More >> National Taiwan University Hospital Recruiting Taipei, Taiwan, 10012 Contact: Wei-Shiung Yang, MD, PhD    886-2-23123456 ext 7258    wsyang@ha.mc.ntu.edu.tw Less <<
NCT00172757 - Unknown - Taiwan ... More >> Department of Surgery, National Taiwan University Hospital, No.7, Chung-Shan South Road, Taipei, TAIWAN, R.O.C. Recruiting Taipei, Taiwan, 100 Contact: Jin-Tung Liang, M.D., Ph.D.    886-2-23562068    jintung@ha.mc.ntu.edu.tw Less <<
NCT00171119 Hypertension ... More >>Diabetic Nephropathy Less << Phase 4 Terminated - Switzerland ... More >> Novartis Pharmaceuticals Basel, Switzerland Less <<
NCT00166036 - Completed - -
NCT00194909 Diabetic Neuropathy Phase 4 Completed - United States, New York ... More >> Peripheral Neuropathy Center - Weill Cornell Medical College New York, New York, United States, 10022 Less <<
NCT00194259 - Unknown June 2014 United States, New York ... More >> St. Luke's Roosevelt Hospital New York, New York, United States, 10025 United States, Pennsylvania University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 University of Pittsburgh Pittsburgh, Pennsylvania, United States, 15213 United States, Rhode Island Brown University Providence, Rhode Island, United States, 02903 Less <<
NCT02359214 Cardiovascular Disease ... More >> Diabetes Bone Disease Less << Not Applicable Active, not recruiting December 2017 United Kingdom ... More >> University of Chester Chester, United Kingdom, CH1 4BJ Less <<
NCT00184821 - Completed - Netherlands ... More >> Clinical Research Centre Nijmegen; Radboud University Nijmegen Medical Centre Nijmegen, Gelderland, Netherlands, 6500 HB Less <<
NCT02690987 Obesity Smoki... More >>ng Cessation Alcoholism Less << Early Phase 1 Recruiting October 2018 United Kingdom ... More >> Centre for Neuropsychopharmacology, Division of Brain Sciences, Imperial College London, Hammersmith Hospital Recruiting London, United Kingdom, W12 0NN Contact: Yong Yong Ling, MD    020 7594 8586    ghadd@imperial.ac.uk    Contact: Liam Nestor, PhD    020 7594 6648    ghadd@imperial.ac.uk Less <<
NCT01067950 Type 1 Diabetes Phase 3 Unknown - United States, Minnesota ... More >> University of Minnesota Not yet recruiting Minneapolis, Minnesota, United States, 55455 Contact: David ER SUTHERLAND          Brazil Albert Einstein Jewish Hospital Not yet recruiting Sao Paulo, Brazil Contact: Marcelo PEROSA          Czech Republic Diabetes Center - Institute for Clinical and Experimental Medicine Not yet recruiting Praha, Czech Republic Contact: Frantisek SAUDEK          France Hôpital Edouard-Herriot - Hospices Civils de Lyon Recruiting Lyon, France Contact: Charles THIVOLET          Centre Hospitalier et Universitaire de Nantes Recruiting Nantes, France Contact: Diego CANTAROVICH, MD, PhD          Italy Istituto Scientifico Ospedale San Raffaele Not yet recruiting Milano, Italy Contact: Antonio SECCHI          Azienda Ospedaliero-Universitaria Pisana Not yet recruiting Pisa, Italy Contact: Ugo BOGGI Less <<
NCT03764605 ADPKD Phase 3 Not yet recruiting January 30, 2022 Italy ... More >> AOUC "Policlinico" Bari, Italy, 70124 AOUConsorziale Policlinico Di Bari Not yet recruiting Bari, Italy, 70124 Contact: Loreto Gesualdo    +390805594040    trialnefrobari@gmail.com    Contact: Giovanni Piscopo    +393299664404    giopiscopo@gmail.com Less <<
NCT00844857 - Completed - -
NCT01974570 Prehypertension Phase 2 Completed - United States, Illinois ... More >> Biofortis Inc. Addison, Illinois, United States, 60101 Canada, Ontario Dr. William O'Mahony Medicine Professional Corporation Corunna, Ontario, Canada, N0N 1G0 Dr. Steven V. Zizzo Medicine Professional Corporation Hamilton, Ontario, Canada, L8J 0B6 Milestone Research London, Ontario, Canada, N5W 6A2 Schacter Medicine Professional Corporation London, Ontario, Canada, N5Y 5K7 KGK Synergize Inc. London, Ontario, Canada, N6A 5R8 Dr. Dorli Herman London, Ontario, Canada, N6J 0A8 SKDS Research Inc. Newmarket, Ontario, Canada, L3Y 5G8 Glencar Medical Inc. Sarnia, Ontario, Canada, N7T 4X3 Dr. Anil Gupta Medicine Professional Corporation Toronto, Ontario, Canada, M9V 4B4 Devonshire Clinical Research Woodstock, Ontario, Canada, N4S 5P5 Czech Republic A-Pharma, s.r.o Praha, Czech Republic Germany Analyze and Realize GmBH Professional Group Berlin, Germany Less <<
NCT02007512 Breast Cancer Phase 2 Active, not recruiting March 29, 2019 -
NCT00844857 Bipolar Depression Phase 4 Completed - United States, California ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. San Diego, California, United States, 92123 Russian Federation For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lipetsk, Russian Federation, 399313 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Moscow, Russian Federation, 123367 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Saratov, Russian Federation, 410060 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Stavropol, Russian Federation, 355038 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tver, Russian Federation, 170005 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Yaroslavl, Russian Federation, 150003 Less <<
NCT02007512 - Active, not recruiting - -
NCT03355079 Cancer-related Malnutrition Phase 4 Recruiting July 2020 France ... More >> Hôpital Cochin Recruiting Paris, France, 75014 Less <<
NCT02650193 - Completed - -
NCT01344031 Estrogen Receptor Positive ... More >> Invasive Breast Carcinoma Recurrent Breast Carcinoma Stage IV Breast Cancer AJCC v6 and v7 Less << Phase 1 Completed - United States, Missouri ... More >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Less <<
NCT01689233 Alzheimer's Disease Phase 3 Completed - -
NCT02650193 Non-metastatic Breast Cancer Phase 2 Completed - Hungary ... More >> CRU Hungary Kft.,CRU Early Phase Unit, Miskolci Semmelweis Kórház és Egyetemi Oktató Kórház Miskolc, BAZ Megye, Hungary, 3529 Debreceni Egyetem Klinikai Központ, ÁOK, Onkológiai Klinika Debrecen, Hajdú-bihar Megye, Hungary, 4032 Országos Onkológiai Intézet Budapest, Hungary, 1122 Spain Hospital Universitario Arnau de Vilanova Lleida, Cataluna, Spain, 25198 Hospital Universitario de Fuenlabrada, Servicio de oncologia Fuenlanbrada, Madrid, Spain, 28942 START Madrid - CIOCC, Unidad de fases 1 planta 3, Hospital Universitario HM Sanchinarro Madrid, Spain, 28050 Hospital Arnau de Vilanova. planta 6, unidad de Oncología Valencia, Spain, 46015 Less <<
NCT02757625 ICU Sedation Phase 3 Completed - Japan ... More >> Asahikawa Medical University Hospital Asahikawa, Hokkaido, Japan, 078-8510 Hyogo Prefectural Kobe Children's Hospital Kobe, Hyogo, Japan, 650-0047 Shikoku Medical Center for Children and Adults Zentsuji, Kagawa, Japan, 765-8507 Osaka Women's and Children's Hospital Izumi, Osaka, Japan, 594-1101 Osaka Medical College Hospital Takatsuki, Osaka, Japan, 569-8686 Jichi Medical University Hospital Shimotsuke, Tochigi, Japan, 329-0498 Juntendo University Hospital Bunkyo-ku, Tokyo, Japan, 113-8431 Tokyo Metropolitan Children's Medical Center Fuchu, Tokyo, Japan, 183-8561 University Hospital, Kyoto Prefectural University of Medicine Kyoto, Japan, 602-8566 Okayama University Hospital Okayama, Japan, 700-8558 Osaka City General Hospital Osaka, Japan, 534-0021 Shizuoka Children's Hospital Shizuoka, Japan, 420-8660 Less <<
NCT00662506 Adult Giant Cell Glioblastoma ... More >> Adult Glioblastoma Adult Gliosarcoma Less << Phase 1 Phase 2 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States, 02114 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 Less <<
NCT02612090 Hypercholesterolemia ... More >> Glycemic Response Less << Not Applicable Active, not recruiting May 4, 2019 United States, Illinois ... More >> Clinical Nutrition Research Center Chicago, Illinois, United States, 60616 Less <<
NCT00963807 Recurrent Non-Small Cell Lung ... More >>Carcinoma Stage IB Non-Small Cell Lung Carcinoma Stage IIA Non-Small Cell Lung Carcinoma Stage IIB Non-Small Cell Lung Carcinoma Stage IIIA Non-Small Cell Lung Cancer Stage IV Non-Small Cell Lung Cancer Less << Phase 2 Completed - United States, Maryland ... More >> Johns Hopkins University/Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States, 21287 United States, Ohio Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43210 Less <<
NCT02607423 Stage IIIA Non-Small Cell Lung... More >> Cancer Less << Phase 2 Withdrawn(The study failed to ... More >>meet its accrual targets.) Less << - United States, Pennsylvania ... More >> ECOG-ACRIN Cancer Research Group Philadelphia, Pennsylvania, United States, 19103 Less <<
NCT02757625 - Completed - -
NCT01507428 Stage III Non-Small Cell Lung ... More >>Cancer AJCC v7 Stage IIIA Non-Small Cell Lung Cancer AJCC v7 Stage IIIB Lung Non-Small Cell Cancer AJCC v7 Less << Phase 2 Active, not recruiting - -
NCT03432741 Breast Adenocarcinoma ... More >> Recurrent Breast Carcinoma Recurrent Hodgkin Lymphoma Recurrent Mycosis Fungoides Recurrent Non-Hodgkin Lymphoma Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma Refractory Hodgkin Lymphoma Refractory Mycosis Fungoides Refractory Nodal Marginal Zone Lymphoma Refractory Non-Hodgkin Lymphoma Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma Stage IV Breast Cancer AJCC v6 and v7 Less << Phase 1 Recruiting May 1, 2019 United States, Minnesota ... More >> Mayo Clinic Recruiting Rochester, Minnesota, United States, 55905 Contact: Clinical Trials Referral Office    855-776-0015       Principal Investigator: Grzegorz S. Nowakowski Less <<
NCT02885857 Chronic Kidney Disease Phase 4 Unknown December 2016 China, Beijing ... More >> National Clinical Research Center for Kidney Disease, State Key Laboratory of Kidney Disease, Department of Nephrology, Chinese PLA General Hospital Recruiting Beijing, Beijing, China, 100853 Contact: jie wu, doctor       wujie301@163.com    Principal Investigator: xiangmei chen, doctor          Guang'anmen Hospital, China Academy of Chinese Medical Sciences Recruiting Beijing, Beijing, China China, Chongqing Daping Hospital,Research Institute of Surgery Third Military Medical University Recruiting Chongqing, Chongqing, China China, Fujian Fuzhou General Hospital Nanjing Military Command Recruiting Fuzhou, Fujian, China 174th hospital of the People's Liberation Army Recruiting Xiamen, Fujian, China China, Hebei Beidaihe Sanatorium of Beijing Military Mrca Recruiting Qinhuangdao, Hebei, China China, Heilongjiang Heilongjiang University of Chinese Medicine Recruiting Harbin, Heilongjiang, China China, Henan Henan Provincial People'S Hospital Recruiting Zhengzhou, Henan, China China, Shandong Shandong Province Hospital Recruiting Jinan, Shandong, China China, Shanghai Changhai Hospital of Shanghai Recruiting Shanghai, Shanghai, China LONGHUA Hospital Shanghai University of TCM Recruiting Shanghai, Shanghai, China China, Shanxi First Hospital of Shanxi Medical University Recruiting Taiyuan, Shanxi, China China, Tianjin First Teaching Hospital of Tianjin University of TCM Recruiting Tianjin, Tianjin, China Less <<
NCT02065687 Endometrial Adenocarcinoma ... More >> Endometrial Clear Cell Adenocarcinoma Endometrial Serous Adenocarcinoma Endometrial Undifferentiated Carcinoma Recurrent Uterine Corpus Carcinoma Stage III Uterine Corpus Cancer AJCC v7 Stage IIIA Uterine Corpus Cancer AJCC v7 Stage IIIB Uterine Corpus Cancer AJCC v7 Stage IIIC Uterine Corpus Cancer AJCC v7 Stage IV Uterine Corpus Cancer AJCC v7 Stage IVA Uterine Corpus Cancer AJCC v7 Stage IVB Uterine Corpus Cancer AJCC v7 Less << Phase 2 Phase 3 Active, not recruiting - -
NCT03226249 Classical Hodgkin Lymphoma ... More >> Lymphocyte-Depleted Classical Hodgkin Lymphoma Lymphocyte-Rich Classical Hodgkin Lymphoma Mixed Cellularity Classical Hodgkin Lymphoma Nodular Sclerosis Classical Hodgkin Lymphoma Less << Phase 2 Recruiting September 2020 United States, California ... More >> Stanford Cancer Institute Recruiting Stanford, California, United States, 94305 Contact: Ranjana Advani, M.D.    650-725-6456       Principal Investigator: Ranjana Advani, M.D.          United States, Georgia Winship Cancer Institute of Emory University Recruiting Atlanta, Georgia, United States, 30322 Contact: Pamela Allen, M.D.    404-718-1900       Principal Investigator: Pamela Allen, M.D.          United States, Illinois Northwestern University Recruiting Chicago, Illinois, United States, 60611 Contact: Jane N. Winter, M.D.    312-695-4538    j-winter@northwestern.edu    Principal Investigator: Jane N. Winter, M.D.          Sub-Investigator: Pamela Allen, M.D.          Sub-Investigator: Leo Gordon, M.D.          Sub-Investigator: Barbara Pro, M.D.          Sub-Investigator: Jason Kaplan, M.D.          Sub-Investigator: Shuo Ma, M.D., Ph.D          Sub-Investigator: Reem Karmali, M.D.          United States, New Jersey Rutgers Cancer Institute Recruiting New Brunswick, New Jersey, United States, 08903 Contact: Andrew Evens, DO, MSc, FACP    732-235-8515       Principal Investigator: Andrew Evens, DO, MSc, FACP Less <<
NCT02773238 Stage IIB Non-Small Cell Lung ... More >>Carcinoma AJCC v7 Stage IIIA Non-Small Cell Lung Cancer AJCC v7 Stage IIIB Non-Small Cell Lung Cancer AJCC v7 Less << Phase 2 Recruiting - United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Jing Zeng    206-598-4100    jzeng13@uw.edu    Principal Investigator: Jing Zeng          Sub-Investigator: Shilpen Patel          Sub-Investigator: Ramesh Rengan          Sub-Investigator: Stephen R. Bowen          ProCure Proton Therapy Center-Seattle Recruiting Seattle, Washington, United States, 98133 Contact: Jing Zeng    206-598-4100    jzeng13@uw.edu    Principal Investigator: Jing Zeng          Sub-Investigator: Shilpen Patel          Sub-Investigator: Ramesh Rengan          Sub-Investigator: Stephen R. Bowen Less <<
NCT01889238 Advanced, Androgen Receptor Po... More >>sitive Triple Negative Breast Cancer Less << Phase 2 Active, not recruiting June 30, 2019 -
NCT00963807 - Completed - -
NCT00797108 Pneumonia, Bacterial Phase 2 Completed - United States, California ... More >> eStudySite, Inc. Chula Vista, California, United States, 91911 Sharp Chula Vista Medical Center Chula Vista, California, United States, 91911 eStudySite, Inc. Oceanside, California, United States, 92056 Tri-City Medical Center Oceanside, California, United States, 92056 United States, Illinois Medical Arts Associates, Ltd Moline, Illinois, United States, 61265 Trinity Medical Center Rock Island, Illinois, United States, 61201 United States, Minnesota Infectious Disease Minneapolis Limited Minneapolis, Minnesota, United States, 55422 United States, Ohio Summa Health System Akron, Ohio, United States, 44304 Summa Health System Akron, Ohio, United States, 44309 Summa Health System Akron, Ohio, United States, 44310 United States, Utah Utah Valley Pulmonary Clinic Provo, Utah, United States, 84604 Utah Valley Regional Medical Center Provo, Utah, United States, 84604 Australia, Queensland Infection Management Services, Building 17, Level 1 Brisbane, Queensland, Australia, 4102 Canada, Ontario Hamilton Health Sciences - General Site Hamilton, Ontario, Canada, L8L 2X2 Hamilton Health Sciences- McMaster Site Hamilton, Ontario, Canada, L8N 3Z5 Hamilton Health Sciences - Henderson Site Hamilton, Ontario, Canada, L8V 1C3 Korea, Republic of Asan Medical Center, Division of Infectious Diseases Seoul, Korea, Republic of, 138-736 Poland Oddzial Chorob Wewnetrznych i Gastroenterologii Bialystok, Poland, 15-003 Oddzial Chorob Pluc Brzesko, Poland, 32-800 Kliniczny Oddzial Gruzlicy i Chorob Pluc Krakow, Poland, 30-901 Oddzial Kliniczny Pulmonologii i Alergologii Lodz, Poland, 90-153 Oddzial Pulmonologiczny III Poznan, Poland, 60-569 Oddzial Pulmonologiczny Proszowice, Poland, 32-100 II Oddzial Chorob Wewnetrznych Warszawa, Poland, 03-401 Less <<
NCT01628107 Chronic Renal Failure Requirin... More >>g Hemodialysis Less << Phase 3 Completed - -
NCT01889238 - Active, not recruiting - -
NCT01628120 Chronic Renal Failure Requirin... More >>g Hemodialysis Less << Phase 3 Completed - -
NCT01628107 - Completed - -
NCT01006122 Excessive Daytime Sleepiness ... More >> Narcolepsy Less << Phase 2 Completed - United States, Arizona ... More >> Pfizer Investigational Site Phoenix, Arizona, United States, 85006 Pfizer Investigational Site Phoenix, Arizona, United States, 85051 Pfizer Investigational Site Tucson, Arizona, United States, 85712 United States, California Pfizer Investigational Site Los Angeles, California, United States, 90048 Pfizer Investigational Site Orange, California, United States, 92868 United States, Florida Pfizer Investigational Site Brandon, Florida, United States, 33511 Pfizer Investigational Site St. Petersburg, Florida, United States, 33707 United States, Georgia Pfizer Investigational Site Atlanta, Georgia, United States, 30342 Pfizer Investigational Site Macon, Georgia, United States, 31201 United States, Illinois Pfizer Investigational Site Vernon Hills, Illinois, United States, 60061 United States, Kentucky Pfizer Investigational Site Crestview Hills, Kentucky, United States, 41017 Pfizer Investigational Site Louisville, Kentucky, United States, 40217 United States, Mississippi Pfizer Investigational Site Hattiesburg, Mississippi, United States, 39401 Pfizer Investigational Site Hattiesburg, Mississippi, United States, 39402 United States, North Carolina Pfizer Investigational Site Durham, North Carolina, United States, 27710 United States, Ohio Pfizer Investigational Site Dublin, Ohio, United States, 43017 United States, Pennsylvania Pfizer Investigational Site Philadelphia, Pennsylvania, United States, 19114 Pfizer Investigational Site Philadelphia, Pennsylvania, United States, 19139 United States, South Carolina Pfizer Investigational Site Columbia, South Carolina, United States, 29201 United States, Texas Pfizer Investigational Site Austin, Texas, United States, 78731 Pfizer Investigational Site Houston, Texas, United States, 77063 Less <<
NCT03269617 Gastrointestinal Disorder, Fun... More >>ctional Less << Not Applicable Completed - -
NCT01628120 - Completed - -
NCT00797108 - Completed - -
NCT02606097 Gastrointestinal Stromal Tumou... More >>r (GIST) Less << Phase 2 Unknown - Taiwan ... More >> Chang Gung Memorial Hospital Recruiting Taoyuan, Taiwan, 333 Contact: Chun-Nan Yeh, MD    886-3-3281200 ext 3219    yehchunnan@gmail.com Less <<
NCT03340298 Cardiovascular Risk Factor Not Applicable Completed - -
NCT01006122 - Completed - -
NCT00565812 Osteoarthritis Phase 2 Completed - -
NCT02366637 - Terminated(Study terminated on... More >> 7 April 2015 for business reasons. No safety and/or efficacy concerns contributed to the termination of the study) Less << - -
NCT00942968 - Completed - -
NCT02052986 Dyslipidemia Phase 2 Unknown - United States, New York ... More >> The NYHQ Cardiac Health Center Not yet recruiting Fresh Meadows, New York, United States, 11365 Contact: Brian Marino, DO    814-404-4169    brm9071@nyp.org    Sub-Investigator: Todd Kerwin, MD          Sub-Investigator: Barbara Pistone, RD Less <<
NCT02418650 Healthy Phase 1 Completed - United Kingdom ... More >> Quotient Clinical Nottingham, United Kingdom, NG11 6JS Less <<
NCT02366637 Pulmonary Disease, Chronic Obs... More >>tructive Less << Phase 2 Terminated(Study terminated on... More >> 7 April 2015 for business reasons. No safety and/or efficacy concerns contributed to the termination of the study) Less << - United Kingdom ... More >> Medicines Evaluation Unit Ltd Wythenshawe, Manchester, United Kingdom, M23 9QZ Nottingham University Hospital NHS Trust Nottingham, Nottinghamshire, United Kingdom, NG5 1PB University Hospitals Birmingham NHS Foundation Trust Birmingham, United Kingdom, B15 2WB Heart of England NHS Foundation Trust Birmingham, United Kingdom, B9 5SS Respiratory Medicine, Bradford Institute of Health Research Bradford, United Kingdom, BD9 6RJ Less <<
NCT02269891 Menopausal Symptoms Phase 2 Completed - Canada, Ontario ... More >> KGK Synergize Inc. London, Ontario, Canada, N6A 5R8 Manna Research - Toronto Toronto, Ontario, Canada, M9W 4L6 Canada, Quebec Manna Research - Quebec Levis, Quebec, Canada, G6W 0M5 Manna Research - Montreal Pointe Claire, Quebec, Canada, H9R 4S3 Less <<
NCT03704064 Obesity Not Applicable Recruiting November 2022 United States, Pennsylvania ... More >> The University of Pennsylvania Center for Weight and Eating Disorders Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Caroline Bach    215-746-7191    caroline.bach@pennmedicine.upenn.edu    Contact: Rebecca L Pearl, PhD    215-746-5129    rpearl@pennmedicine.upenn.edu    Principal Investigator: Rebecca L Pearl, PhD Less <<
NCT00425061 Asthma Phase 2 Completed - -
NCT00942968 Cancer Phase 4 Completed - -
NCT00565812 - Completed - -
NCT02334943 Immune Deficiency ... More >> HIV-related Gut Disease - Cause Unknown Activation of Latent Virus Other Diagnoses, Comorbidities, and Complications Less << Not Applicable Completed - France ... More >> University hospital Montpellier Montpellier, France, 34295 Less <<
NCT00425061 - Completed - -
NCT00107718 Melanoma Phase 2 Completed - United States, California ... More >> GSK Investigational Site Los Angeles, California, United States, 90089 GSK Investigational Site San Francisco, California, United States, 94115 GSK Investigational Site Santa Monica, California, United States, 90404-2104 United States, Connecticut GSK Investigational Site New Haven, Connecticut, United States, 06520 United States, Florida GSK Investigational Site Jacksonville, Florida, United States, 32209 GSK Investigational Site Miami Beach, Florida, United States, 33140 United States, Illinois GSK Investigational Site Chicago, Illinois, United States, 60637 United States, Indiana GSK Investigational Site Indianapolis, Indiana, United States, 46202 United States, Maryland GSK Investigational Site Lutherville-Timonium, Maryland, United States, 21093 United States, New York GSK Investigational Site New York, New York, United States, 10016 United States, Ohio GSK Investigational Site Toledo, Ohio, United States, 43614-5809 United States, Pennsylvania GSK Investigational Site Pittsburgh, Pennsylvania, United States, 15213-2584 Australia, New South Wales GSK Investigational Site Waratah, New South Wales, Australia, 2298 GSK Investigational Site Westmead, New South Wales, Australia, 2145 Australia, Queensland GSK Investigational Site Douglas, Queensland, Australia, 4814 GSK Investigational Site South Brisbane, Queensland, Australia, 4101 GSK Investigational Site Woolloongabba, Queensland, Australia, 4102 Australia, Tasmania GSK Investigational Site Hobart, Tasmania, Australia, 7000 Australia, Victoria GSK Investigational Site East Melbourne, Victoria, Australia, 3002 Australia, Western Australia GSK Investigational Site Nedlands, Western Australia, Australia, 6009 Less <<
NCT00570063 - Terminated - -
NCT00431236 Nausea and Vomiting, Chemother... More >>apy-Induced Less << Phase 3 Completed - -
NCT00005654 Hyperinsulinism ... More >> Polycystic Ovary Syndrome Less << Not Applicable Completed - -
NCT00570063 Schizophrenia Phase 2 Terminated - United States, California ... More >> California Clinical Trials Medical Group, Inc. Glendale, California, United States, 91206 Glendale Adventist Medical Center Glendale, California, United States, 91206 Telecare-Cresta Loma Lemon Grove, California, United States, 91945 California Clinical Trials Medical Group Paramount, California, United States, 90723 LaPaz Geropsychiatric Center Paramount, California, United States, 90723 California Clinical Trials Medical Group San Diego, California, United States, 92123 United States, Connecticut Connecticut Mental Health Center-Yale University, Clinical Neuroscience Research Unit New Haven, Connecticut, United States, 06519 United States, New Jersey CRI Worldwide, LLC Willingboro, New Jersey, United States, 08046 United States, Oklahoma St. Anthony Hospital Oklahoma City, Oklahoma, United States, 73101 IPS Research Company Oklahoma City, Oklahoma, United States, 73103 Less <<
NCT01860196 Adult Cerebral Palsy Phase 4 Completed - -
NCT00025753 HIV Infections ... More >> Insulin Resistance Less << Not Applicable Completed - United States, Missouri ... More >> Washington University School of Medicine St. Louis, Missouri, United States, 63110 Less <<
NCT00005104 Polycystic Ovary Syndrome ... More >> Hyperinsulinism Less << Not Applicable Completed - United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35294-3300 United States, Louisiana Louisiana State University School of Medicine Shreveport, Louisiana, United States, 71130-3932 United States, Missouri Washington University - St. Louis St. Louis, Missouri, United States, 63110 United States, Virginia University of Virginia Charlottesville, Virginia, United States, 22908 Medical College of Virginia School of Medicine Richmond, Virginia, United States, 23298-0230 Italy University Alma Mater Bologna, Italy, 40100 Less <<
NCT00029250 HIV Infections ... More >> Hypercholesterolemia Hypertriglyceridemia Hyperglycemia Less << Phase 2 Withdrawn - United States, Washington ... More >> Bastyr University Center for Natural Health Seattle, Washington, United States, 98103 University of Washington Harborview Medical Center Seattle, Washington, United States, 98104 Less <<
NCT00005194 - Completed - -
NCT00049881 - Completed - -
NCT00005669 - Completed - -
NCT00091949 Stroke Myocar... More >>dial Infarction Diabetes Less << Phase 3 Completed - -
NCT00083798 - Completed - -
NCT00005669 Hyperinsulinemia ... More >> Obesity Less << Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00108459 Obesity Type ... More >>2 Diabetes Hyperlipidemia Less << Phase 3 Completed - United States, Pennsylvania ... More >> VA Medical Center Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT02655315 Parkinson Disease Phase 2 Recruiting February 2021 Austria ... More >> Medizinische Universitat Innsbruck Recruiting Innsbruck, Austria Principal Investigator: Werner Poewe, MD, PhD          Czechia Univerzita Karlova V Praze Recruiting Prague, Czechia Principal Investigator: Evzen Ruzicka, MD,PhD          Charles University Recruiting Praha, Czechia Principal Investigator: Evzen Ruzicka, MD          France CHU Pellegrin Recruiting Bordeaux, France Principal Investigator: Wassilios Meissner, MD,PhD          Hôpital Wertheimer Recruiting Bron, France Principal Investigator: Stéphane Thobois, MD,PhD          Hôpital Montpied Recruiting Clermont-Ferrand, France Principal Investigator: Frank Durif, MD,PhD          Hôpital Salengro, CHRU Recruiting Lille, France CHU la TIMONE Recruiting Marseille, France Principal Investigator: Alexandre Eusebio, MD, PhD          AP-HP, Hôpital Pitié-Salpêtrière Recruiting Paris, France Principal Investigator: Jean-Christophe Corvol, MD, PhD          CHU de Strasbourg, Hôpital de Hautepierre Recruiting Strasbourg, France Principal Investigator: Christine Tranchant, MD,PhD          Chu Purpan Recruiting Toulouse, France Principal Investigator: Olivier Rascol, MD,PhD          Germany University Hospital, Saarland University Not yet recruiting Homburg, Germany Principal Investigator: Stefanie Behnke, MD          Christian-albrechts universität zu kiel Recruiting Kiel, Germany Principal Investigator: Daniela Berg, MD,PhD          Klinik und Poliklinik für Neurologie der Universitätsmedizin Rostock Recruiting Rostock, Germany Principal Investigator: Uwe Walter, MD,PhD          Netherlands Acadamic central center, Amsterdam Recruiting Amsterdam, Netherlands Principal Investigator: Rob De Bie, MD          Radboud university medical center Recruiting Nijmegen, Netherlands Principal Investigator: Bart Post, MD          Portugal Centro Hospitalar e universitario de Coimbra Not yet recruiting Coimbra, Portugal Principal Investigator: Cristina Januario, MD          Centro Hospitalar do Alto Ave Recruiting Guimarães, Portugal Principal Investigator: Miguel Gago, MD          Centro Hospitalar Lisboa Norte Not yet recruiting Lisbon, Portugal Principal Investigator: Joaquim Ferreira, MD          Spain Hospital Clinic Universitari de Barcelona Recruiting Barcelona, Spain Principal Investigator: Eduard Tolosa, MD,PhD          Hospital de Bellvitge Not yet recruiting Barcelona, Spain Principal Investigator: Matilde Calopa, MD,Phd          Hospital de la Santa Creu i Sant Pau Recruiting Barcelona, Spain Principal Investigator: Jaime Kulisevsky, MD,PhD          United Kingdom Cambridge University Hospital Not yet recruiting Cambridge, United Kingdom Principal Investigator: Paul Worth, MD          University of Glasgow Terminated Glasgow, United Kingdom Newcastle University Not yet recruiting Newcastle, United Kingdom Principal Investigator: David Burn, MD,PhD Less <<
NCT00062374 - Completed - -
NCT00141076 Obesity Not Applicable Completed - United States, Massachusetts ... More >> Brigham & Women's Hospital Boston, Massachusetts, United States Less <<
NCT00163904 Heart Failure Phase 1 Unknown - Australia, Victoria ... More >> Alfred Hospital Recruiting Melbourne, Victoria, Australia, 3004 Contact: Fiona J Adams, BSc. Grad Dip Diet    +613 9276 3063 ext 3063    f.adams@alfred.org.au    Contact: Rachel M Stoney, BSc. MDiet, PhD    +613 9276 3063 ext 3063    r.stoney@alfred.org.au    Principal Investigator: Fiona J Adams, BSc. Grad Dip Diet Less <<
NCT00062374 Gastric Adenocarcinoma ... More >> Stage II Gastric Cancer Stage III Gastric Cancer Stage IV Gastric Cancer Less << Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00188240 Hepatitis C H... More >>epatitis B Less << Not Applicable Unknown - Canada, Ontario ... More >> Liver Clinic, Toronto Western Hospital, UHN. Recruiting Toronto, Ontario, Canada, M5T 2S8 Contact: E.J.L. (Jenny) Heathcote, MD    416-603-5914       Principal Investigator: E.J.L (Jenny) Heathcote, M.D. Less <<
NCT00200018 Severe to Morbid Obesity and T... More >>ype 2 Diabetes Less << Not Applicable Completed - United States, California ... More >> La Jolla, California, United States United States, Minnesota Eagan, Minnesota, United States Less <<
NCT00124826 Acute Stroke ... More >>Hyperglycemia Less << Phase 2 Completed - United Kingdom ... More >> Institute of Neurological Sciences Glasgow, United Kingdom, G51 4TF Less <<
NCT00229268 - Completed - United States, New York ... More >> Rockefeller University Hospital New York, New York, United States, 10021 Less <<
NCT00241150 Hypertension ... More >>Metabolic Syndrome Less << Phase 4 Completed - -
NCT00177892 Obstructive Sleep Apnea ... More >> Metabolic Syndrome X Less << Not Applicable Unknown August 2008 United States, Pennsylvania ... More >> University of Pittsburgh School of Medicine Recruiting Pittsburgh, Pennsylvania, United States, 15261 Contact: Marcie Conrad, BS    412-383-1628    conradm@dom.pitt.edu    Contact: Jason Rosol    412-383-1593    rosolj@dom.pitt.edu    Principal Investigator: Mark H Sanders, MD          Sub-Investigator: Jigme Sethi, MD          Sub-Investigator: Rachel Givelber, MD          Sub-Investigator: Augustine MK Choi, MD          Sub-Investigator: Naftali Kaminski, MD          Sub-Investigator: Valerian Kagan, PhD          Sub-Investigator: Yingze Zhang, PhD Less <<
NCT00246402 Insulin Resistance ... More >> Cardiovascular Diseases Heart Diseases HIV Infections Hypertriglyceridemia Hyperlipidemia Less << Not Applicable Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT00246376 - Completed - -
NCT00091949 - Completed - -
NCT00279851 - Unknown - United States, Missouri ... More >> Children's Mercy Hospitals and Clinics Recruiting Kansas City, Missouri, United States, 64108 Less <<
NCT00264589 Type 2 Diabetes ... More >> Obesity Less << Phase 4 Completed - France ... More >> Service d'Explorations et de Médecine Vasculaire University Hospital Center Nimes, France, 30029 Less <<
NCT00246376 Cardiovascular Diseases ... More >> Heart Diseases HIV Infections Hyperlipidemia Hypertriglyceridemia Insulin Resistance Atherosclerosis Less << Not Applicable Completed - United States, Texas ... More >> Baylor College of Medicine Houston, Texas, United States, 77098 Less <<
NCT00292994 Metabolic Syndrome ... More >> Insulin Resistance Obesity Less << Not Applicable Unknown - United States, South Dakota ... More >> Yankton Medical Clinic Yankton, South Dakota, United States, 57078 Less <<
NCT00293852 Heart Failure, Congestive ... More >> Metabolic Syndrome X Less << Not Applicable Unknown - United States, Texas ... More >> Ben Taub General Hospital Recruiting Houston, Texas, United States, 77030 Less <<
NCT00264251 HIV Infections ... More >> Insulin Resistance Obesity Less << Not Applicable Completed - United States, New York ... More >> St. Luke's-Roosevelt Hospital Center New York, New York, United States, 10025 Less <<
NCT00004311 Acanthosis Nigricans ... More >> Polycystic Ovary Syndrome Less << Phase 2 Completed - -
NCT00285285 Dehydration S... More >>eizure Gastroenteritis Hyperglycemia Less << Not Applicable Completed - -
NCT00351871 Chronic Hepatitis C Phase 4 Completed - -
NCT00370617 Chronic Hepatitis C ... More >> Insulin Resistance Less << Phase 4 Unknown - Italy ... More >> Division of Gastroenterology, University of Torino, Ospedale San Giovanni Battista Recruiting Torino, Italy, 10126 Contact: Mario Rizzetto, MD    +39-011-6336397    mrizzetto@molinette.piemonte.it    Contact: Elisabetta Bugianesi, MD    +39-011-6336397    ebugianesi@yahoo.it    Sub-Investigator: Elisabetta Bugianesi, MD Less <<
NCT00185094 Hypertension ... More >>Insulin Resistance Metabolic Syndrome Less << Phase 4 Completed - United States, Alabama ... More >> Birmingham, Alabama, United States United States, California San Diego, California, United States United States, Florida Miami, Florida, United States United States, Indiana Indianapolis, Indiana, United States United States, Maryland Baltimore, Maryland, United States United States, Massachusetts Boston, Massachusetts, United States United States, Minnesota Rochester, Minnesota, United States United States, Pennsylvania Philadelphia, Pennsylvania, United States United States, Texas Dallas, Texas, United States San Antonio, Texas, United States Less <<
NCT00394745 Hypertension ... More >>Metabolic Syndrome Less << Phase 3 Completed - Germany ... More >> Investigative Centers, Germany Switzerland Novartis Basel, Switzerland Less <<
NCT00327418 Major Coronary Event ... More >> Cerebrovascular Accident Coronary Artery Bypass Graft Angina, Unstable Revascularization Less << Phase 4 Completed - -
NCT00401336 Iron Overload ... More >> Metabolic Syndrome X Hepatitis B Hepatitis C Alcohol Abuse Less << Not Applicable Completed - France ... More >> CHU Angers Angers, France, 49033 Hôpital Beaujon Clichy, France, 92118 Hôpital Huriez Lille, France, 59037 Hôpital Edouard Herriot Lyon, France, 69003 Hôpital de la Timone Marseille, France, 13385 Hôpital Saint Eloi Montpellier, France, 34000 Hôpital Tenon Paris, France, 75970 Hôpital de Pontchaillou Rennes, France, 35033 Hôpital du Brabois Vandoeuvre les Nancy, France, 54511 Spain Hopital Donostia-San Sebastian San Sebastian, Spain Less <<
NCT00362778 Diabetes Hype... More >>rglycemia Acute Myocardial Infarction Less << Phase 4 Completed - -
NCT00437333 Polycystic Ovary Syndrome Phase 4 Completed - Italy ... More >> "Pugliese" Hospital Catanzaro, Italy, 88100 Less <<
NCT00392717 Obesity Dysli... More >>pidemia Insulin Resistance Less << Phase 3 Completed - Australia, Western Australia ... More >> Royal Perth Hospital Perth, Western Australia, Australia, 6000 Less <<
NCT00431587 - Unknown - Israel ... More >> Hadassah Medical Organization, Recruiting Jerusalem, Israel Contact: Arik Tzukert, DMD    00 972 2 6776095    arik@hadassah.org.il    Contact: Hadas Lemberg, PhD    00 972 2 6777572 Less <<
NCT00304941 - Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT02010489 Obesity Not Applicable Active, not recruiting December 2018 Canada, Manitoba ... More >> Centre for Metabolic and Bariatric Surgery, Victoria General Hospital Winnipeg, Manitoba, Canada, R3T 2E8 Less <<
NCT00438061 Obesity Dysli... More >>pidemia Insulin Resistance Less << Phase 3 Completed - Australia, Western Australia ... More >> Royal Perth Hospital Perth, Western Australia, Australia, 6000 Less <<
NCT00455624 - Completed - United States, Massachusetts ... More >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Massachusetts General Hospital Boston, Massachusetts, United States, 02215 Less <<
NCT00456144 - Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02215 Less <<
NCT00517777 Sleep Apnea Syndrome ... More >> Metabolic Syndrome Cardiac Remodelling Continuous Positive Airway Pressure Ventilation Less << Phase 4 Unknown August 2010 Italy ... More >> University of Insubria-Department of Clinical Medicine Recruiting Varese, Italy, 21100 Contact: anna maria grandi, MD    +39+332 278594    amgrandi@libero.it    Sub-Investigator: andrea maria maresca, MD          Sub-Investigator: fausto colombo, MD          Sub-Investigator: francesco solbiati, MD          Sub-Investigator: emanuela laurita, MD Less <<
NCT00455403 Metabolic Syndrome X ... More >> Overweight Hypertension Dyslipidemias Prediabetic State Less << Not Applicable Active, not recruiting December 2019 United States, Missouri ... More >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Less <<
NCT00486993 - Completed - Paraguay ... More >> Hospital Central Instituto de Prevision Social Asuncion, Dep. Central, Paraguay, 1749 Less <<
NCT00518635 Polycystic Ovary Syndrome Not Applicable Withdrawn October 2011 United States, Oregon ... More >> Oregon Health and Science University Portland, Oregon, United States, 97239 Less <<
NCT00383604 - Completed - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT00527774 - Completed - Taiwan ... More >> Hemodialysis Center, St. Martin De Porres Hospital Chiayi City, Taiwan, 60076 Less <<
NCT00552292 - Unknown May 2017 Russian Federation ... More >> Almazov Federal Center of Heart, Blood and Endocrinology Recruiting St.Petersburg, Russian Federation, 194156 Contact: Oxana P Rotari, MD    7-812-7025556    rotariox@mail.ru    Principal Investigator: Oxana Rotari, MD Less <<
NCT00390637 Obesity Metab... More >>olic Syndrome Type 2 Diabetes Cardiovascular Disease Less << Phase 4 Completed - Denmark ... More >> Arne V. Astrup Copenhagen, Denmark Less <<
NCT00553787 Obesity Type ... More >>2 Diabetes Less << Phase 3 Completed - United States, Alabama ... More >> Research Site Birmingham, Alabama, United States, 35294 United States, Connecticut Research Site Ridgefield, Connecticut, United States, 06877 United States, New York Research Site New York, New York, United States, 10025 United States, North Carolina Research Site Durham, North Carolina, United States, 27710 United States, Ohio Research Site Toledo, Ohio, United States, 43623 United States, Texas Research Site Austin, Texas, United States, 78731 Less <<
NCT00546442 Chronic Hepatitis C Phase 4 Completed - Spain ... More >> Hospital Germans Trias i Pujol Badalona, Barcelona, Spain, 08916 Hospital Parc Taulí Sabadell, Barcelona, Spain, 08208 Hospital de Donostia San Sebastian, Guipuzcoa, Spain, 20014 Fundación Hospital de Alcorcón Alcorcón, Madrid, Spain, 28922 Hospital del Mar Barcelona, Spain, 08003 Hospital General de Ciudad Real Ciudad Real, Spain, 13005 Hospital Reina Sofía Córdoba, Spain, 14004 Hospital Clínico Universitario San Cecilio Granada, Spain, 18003 Hospital Virgen de las Nieves Granada, Spain, 18004 Hospital de Leon Leon, Spain, 24071 Hospital de la Princesa Madrid, Spain, 28006 Hospital Gregorio Marañón Madrid, Spain, 28007 Hospital Carlos III Madrid, Spain, 28029 Hospital Puerta de Hierro Madrid, Spain, 28035 Hospital La Paz Madrid, Spain, 28046 Hospital Universitario Virgen de la Victoria Málaga, Spain, 29010 Hospital Virgen Macarena Sevilla, Spain, 41009 Hospital Universitario de Valme Sevilla, Spain, 41014 Hospital General Universitario Valencia, Spain, 46014 Less <<
NCT00569504 - Unknown September 2009 Korea, Republic of ... More >> Seoul National Hospital Recruiting Seoul, Korea, Republic of, 139-757 Contact: Shi Hyun Kang, M.D.    82-2-2204-0326    drshe@hanmail.net Less <<
NCT00553787 - Completed - -
NCT00196235 - Completed - Germany ... More >> Deutsches Herzzentrum Muenchen Munich, Germany, 80636 1. Medizinische Klinik, Klinikum rechts der Isar Munich, Germany, 81675 Less <<
NCT00485121 Metabolic Syndrome ... More >> Obesity Coronary Artery Disease Less << Not Applicable Completed - Canada, Ontario ... More >> Partners Research Brampton, Ontario, Canada, L6V 1B4 Less <<
NCT00201110 Cardiovascular Diseases ... More >> Heart Diseases Diabetes Mellitus, Type 2 Coronary Disease Less << Not Applicable Completed - United States, Maryland ... More >> Johns Hopkins School of Medicine/General Clinical Research Center Baltimore, Maryland, United States, 21205 Less <<
NCT00202618 Hypertension ... More >>Diabetes Mellitus Albuminuria Less << Phase 4 Unknown - Japan ... More >> Shiga University of Medical Science Recruiting Otsu, Shiga, Japan, 520-2192 Contact: Atsunori Kashiwagi, Professor    81-77-548-2221    kasiwagi@belle.shiga-med.ac.jp    Contact: Hiroshi Maegawa, A. Professor    81-77-548-2222    maegawa@belle.shiga-med.ac.jp    Principal Investigator: Hiroshi Maegawa          Principal Investigator: Yasuo Kida          Principal Investigator: Shu Yamada          Principal Investigator: Masataka Nishimura          Principal Investigator: Tetsuro Arimura          Principal Investigator: Noriko Takahara          Principal Investigator: Katsuya Egawa          Principal Investigator: Masanori Iwanishi          Principal Investigator: Toshiki Fujita          Principal Investigator: Aya Kadota Less <<
NCT00212004 Diabetes Mellitus ... More >> Myocardial Infarction Less << Phase 4 Terminated(Limited budget to c... More >>ontinue this study) Less << - Japan ... More >> National Cardiovascular Center Suita, Osaka, Japan, 565-8565 Less <<
NCT00422630 Metabolic Syndrome X ... More >> Obesity Insulin Resistance Hypertension Diabetes Less << Not Applicable Completed - United States, New York ... More >> Rockefeller University Hospital New York, New York, United States, 10021 Less <<
NCT00201227 Asthma Cardio... More >>vascular Diseases Atherosclerosis Diabetes Mellitus Heart Diseases Hypertension Lung Diseases Less << Not Applicable Completed - -
NCT00214825 Diabetes Mellitus ... More >> Endothelial Dysfunction Albuminuria Less << Not Applicable Completed - United States, Massachusetts ... More >> Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Less <<
NCT00531999 HIV Infections Phase 1 Completed - United Kingdom ... More >> St Stephens Centre, Chelsea & Westminster Hospital London, United Kingdom Less <<
NCT00227383 Diabetes Mellitus ... More >> Gastroparesis Less << Phase 3 Unknown - Taiwan ... More >> China Medical University Hospital Not yet recruiting Taichung, Taiwan, 404 Contact: Chung-Pang Wang, MD    886-4-22052121 ext 1431       Principal Investigator: Chung-Pang Wang Less <<
NCT00202670 - Terminated(Positive Predictive... More >> value not related to follow up duration.) Less << - France ... More >> Pitie Salpetriere Paris, France, 75013 Service de diabétologie - Pitié Salpêtrière Paris, France, 75013 Less <<
NCT00225342 Angina Pectoris ... More >> Diabetes Mellitus, Type 2 Less << Phase 4 Withdrawn - United Kingdom ... More >> Cardiology Department, Glasgow Royal Infirmary Glasgow, United Kingdom, G4 0SF Less <<
NCT00225628 Diabetes Mellitus ... More >> Coronary Artery Disease Osteoporosis Hypertension Hyperlipidemia Less << Not Applicable Completed - United States, Massachusetts ... More >> Brigham and Women's Hospital Boston, Massachusetts, United States, 02472 Less <<
NCT00208221 Hypertension ... More >>Type 2 Diabetes Albuminuria Less << Phase 3 Terminated(Not enough recruitm... More >>ent) Less << - Canada, Quebec ... More >> Institut de Recherches Cliniques de Montreal Montreal, Quebec, Canada, J4X 1J3 Less <<
NCT00226902 Kidney Failure, Chronic ... More >> Diabetes Mellitus, Type 1 Diabetes Mellitus, Type 2 Less << Not Applicable Completed - Australia, Victoria ... More >> The Royal Melbourne Hospital Melbourne, Victoria, Australia, 3050 Less <<
NCT03775096 REM Sleep Behavior Disorder ... More >> Pre-motor Parkinson Disease Symptomatic Parkinson Disease Less << Phase 2 Not yet recruiting December 2019 -
NCT00228891 Diabetes Mellitus, With Compli... More >>cations Less << Phase 2 Phase 3 Terminated(Administrative) - United States, Florida ... More >> Florida Atlantic University Center for Complex Systems and Brain Sciences Boca Raton, Florida, United States, 33431 Less <<
NCT00707239 - Terminated(See termination rea... More >>son in detailed description.) Less << - -
NCT02444442 Hypertension Not Applicable Recruiting April 2020 Australia, Victoria ... More >> Baker IDI Heart & Diabetes Institute Recruiting Melbourne, Victoria, Australia, 3004 Less <<
NCT01723007 Hypercholesterolemia ... More >> Overweight Less << Not Applicable Completed - Brazil ... More >> Department of Public Health-DSC-FM School of Medicine, Federal University of Amazon-UFAM Manaus-AM, Amazon, Brazil, 69000000 Department of Public Health-DSC, School of Medicine-FM, University of Aamazon-UFAM Manaus, Amazon, Brazil, 69000000 Less <<
NCT00707239 Pneumonia, Bacterial Phase 2 Terminated(See termination rea... More >>son in detailed description.) Less << - -
NCT02298439 - Recruiting January 2020 Canada, Ontario ... More >> Toronto General Hospital Recruiting Toronto, Ontario, Canada, M5G 1Z5 Contact: Johane P Allard, MD, FRCPC    416-340-5159    johane.allard@uhn.on.ca    Contact: Anastasia Teterina, PhD    416-340-4104    anastasia.teterina@uhnresearch.ca    Principal Investigator: Johane Allard, MD,FRCPC Less <<
NCT03747107 - Recruiting March 30, 2020 United Kingdom ... More >> NHS Tayside Recruiting Dundee, Scotland, United Kingdom, DD2 4BF Contact: Tobias Dreischulte, PhD    ++44(0)7540736211    t.dreischulte@dundee.ac.uk Less <<
NCT01659671 Obstructive Sleep Apnea Syndro... More >>me Less << Not Applicable Completed - Sweden ... More >> ORL dep, Karolinska University Hospital Stockholm, Sweden, 141 86 Less <<
NCT01997034 - Completed - Denmark ... More >> University of Copenhagen, Department of Biomedical Sciences Copenhagen, Denmark, 2200 Less <<
NCT02148471 - Completed - Canada, Ontario ... More >> Toronto General Hospital Toronto, Ontario, Canada, M5G 1Z5 Less <<
NCT03145220 Systemic Inflammatory Response... More >> Syndrome Coronary Artery Bypass Grafting Less << Phase 2 Active, not recruiting October 2018 Netherlands ... More >> Intensive care, research unit, Radboud University Medical Centre Nijmegen, Gelderland, Netherlands, 6525 GA Less <<
NCT02458521 Traumatic Brain Injury ... More >> Post-Traumatic Stress Disorder Less << Not Applicable Recruiting May 2019 United States, Maryland ... More >> National Intrepid Center of Excellence, Walter Reed National Military Medical Center Recruiting Bethesda, Maryland, United States, 20889 Contact: Ariana C Gover-Chamlou, BA    301-319-8148    ariana.gover-chamlou.ctr@mail.mil    Contact: Nancy de Almeida, RN    3014001234    nancy.k.dealmeida.ctr@mail.mil Less <<
NCT03448081 Pruritus Psor... More >>iasis Less << Phase 2 Active, not recruiting October 2018 United States, Alabama ... More >> Sienna 018 Anniston, Alabama, United States, 36207 Sienna 009 Mobile, Alabama, United States, 36608 United States, California Sienna 019 Fountain Valley, California, United States, 92708 Sienna 007 Los Angeles, California, United States, 90045 Site 016 Sherman Oaks, California, United States, 91403 United States, Florida Site 013 Coral Gables, Florida, United States, 33143 Site 015 Sanford, Florida, United States, 32771 United States, Indiana Site 012 Indianapolis, Indiana, United States, 46256 United States, Michigan Sienna 011 Warren, Michigan, United States, 48088 United States, New Jersey Sienna 005 Berlin, New Jersey, United States, 08009 United States, New York Sienna 020 Rochester, New York, United States, 14623 United States, North Carolina Site 014 Raleigh, North Carolina, United States, 27612 United States, Oklahoma Sienna 002 Oklahoma City, Oklahoma, United States, 73118 United States, Texas Sienna 017 Austin, Texas, United States, 78745 Sienna 010 Houston, Texas, United States, 77004 Sienna 021 Pflugerville, Texas, United States, 78660 Sienna 001 San Antonio, Texas, United States, 78213 Canada, British Columbia Sienna 006 Surrey, British Columbia, Canada, V3R 6A7 Canada, Ontario Sienna 008 Peterborough, Ontario, Canada, K9J 5K2 Canada, Quebec Sienna 003 Montreal, Quebec, Canada, H2K 4L5 Less <<
NCT02727699 Dementia, Alzheimer Type Phase 2 Active, not recruiting July 2019 United States, Arizona ... More >> Tucson Neuroscience Research, LLC Tucson, Arizona, United States, 85710 United States, California National Research Institute Los Angeles, California, United States, 90057 PCND Neuroscience Research Institute Poway, California, United States, 92064 Pacific Research Network, Inc. San Diego, California, United States, 92103 United States, Florida Research Alliance Inc. Clearwater, Florida, United States, 33756 The Neurology Research Group, LLC Miami, Florida, United States, 33186 Compass Research LLC Orlando, Florida, United States, 32806 IMIC, Inc. Palmetto Bay, Florida, United States, 33157 United States, Georgia Atlanta Center for Medical Research Atlanta, Georgia, United States, 30331 NeuroStudies.Net, LLC Decatur, Georgia, United States, 30033 United States, New Jersey The NeuroCognitive Institute Mount Arlington, New Jersey, United States, 07856 United States, New York Richmond Behavioral Associates Staten Island, New York, United States, 10312 United States, North Carolina PMG Research of Rocky Mount, LLC Rocky Mount, North Carolina, United States, 27804 United States, Pennsylvania The Clinical Trial Center Jenkintown, Pennsylvania, United States, 19046 Australia, New South Wales St Vincent's Hospital Sydney Darlinghurst, New South Wales, Australia, 2010 KaRa Institute of Neurological Diseases Macquarie Park, New South Wales, Australia, 2113 Central Coast Neurosciences Research Tumbi Umbi, New South Wales, Australia, 2261 Australia, Victoria Medical & Cognitive Research Unit, Heidelberg Repatriation Hospital - Austin Health Heidelberg West, Victoria, Australia, 3081 Australia, Western Australia Australian Alzheimer's Research Foundation Nedlands, Western Australia, Australia, 6009 United Kingdom The Research Institute for the Care of Older People Bath, Combe Park, United Kingdom, BA1 3NG Manchester Mental Health & Social Care Trust - Dementia Research Office - Park House North Manchester General Hospital Manchester, Lancashire, United Kingdom, M8 5RB West London Mental Health Trust Isleworth, London, United Kingdom, TW7 6FY St Pancras Clinical Research Kings Cross, London, United Kingdom, WC1X 8QD Institute of Clinical Sciences, Queen's University Belfast Belfast, Northern Ireland, United Kingdom, BT9 7AB Centre for Clinical Brain Sciences, Centre for Dementia Prevention, The University of Edinburgh Edinburgh, United Kingdom, EH8 9YL Less <<
NCT02471573 Infertility Not Applicable Completed - Vietnam ... More >> My Duc Hospital, IVFMD Ho Chi Minh City, Ho Chi Minh, Vietnam Less <<
NCT01226563 Acute Myocardial Infarction ... More >> Congestive Heart Failure ST-Elevation Myocardial Infarction Less << Not Applicable Completed - -
NCT01997060 Obesity Overw... More >>eight Less << Not Applicable Completed - Denmark ... More >> University of Copenhagen, Department of Biomedical Sciences Copenhagen, Denmark, 2200 Less <<
NCT01736098 Physical Activity Not Applicable Completed - United States, South Carolina ... More >> Public Health Research Center, University of South Carolina Columbia, South Carolina, United States, 29201 Less <<
NCT02905929 Sedentary Lifestyle Not Applicable Recruiting March 2020 United States, California ... More >> South Bay Latino Research Center Recruiting Chula Vista, California, United States, 91910 Contact: Nicole Villa, MPH    619-205-1931    nvilla@mail.sdsu.edu    UCSD Recruiting San Diego, California, United States, 92093 Contact: Katie Crist, MPH    858-534-9306    kcrist@ucsd.edu Less <<
NCT03022240 Cognitive Change ... More >> Behavior Less << Phase 4 Recruiting September 2018 Canada, Alberta ... More >> University of Calgary Recruiting Calgary, Alberta, Canada, T2N 1N4 Contact: Tiffany Rice, PhD, MD    403-955-5768    Tiffany.Rice@ahs.ca    Contact: Jillian Vinall, PhD    403-955-5768    jillian.vinall@ahs.ca    Principal Investigator: Tiffany Rice, PhD, MD          Sub-Investigator: Jillian Vinall, PhD          Sub-Investigator: Adam Spencer, MD          Sub-Investigator: Nivez Rasic, MD          Sub-Investigator: Andrew Walker, PhD          Sub-Investigator: Melanie Noel, PhD          Sub-Investigator: Frank MacMaster, PhD          Sub-Investigator: Naweed Syed, PhD Less <<
NCT02191462 Pharmacokinetics Phase 1 Completed - Canada, Ontario ... More >> KGK Synergize Inc. London, Ontario, Canada, N6A 5R8 Less <<
NCT01677325 NAFLD( Non-alcoholic Fatty Liv... More >>er Disease ) Less << Phase 1 Completed - -
NCT03547791 Twin Pregnancy, Antepartum Con... More >>dition or Complication Less << Phase 2 Phase 3 Recruiting December 31, 2022 Korea, Republic of ... More >> Seoul National University Hospital Recruiting Seoul, Korea, Republic of, 03080 Contact: Seung Mi Lee    +82-2-2072-4857    smleemd@hanmail.net Less <<
NCT00359177 Vomiting Phase 1 Completed - United States, Florida ... More >> GSK Investigational Site Gainesville, Florida, United States, 32608 GSK Investigational Site Orlando, Florida, United States, 32809 Less <<
NCT01707849 Hepatitis C Recurrence After L... More >>iver Transplant Less << Phase 3 Completed - Spain ... More >> Department of HPB Surgery and Transplant, Hospital Vall d´Hebron Barcelona, Spain, 08035 Less <<
NCT03052192 - Recruiting December 2019 Denmark ... More >> Amager & Hvidovre Hospital Recruiting Hvidovre, Region Hovedstaden, Denmark, 2650 Contact: Aino L Andersen, Msc    24616108    Aino.leegaard.andersen@regionh.dk Less <<
NCT02890836 - Recruiting February 2021 Denmark ... More >> Center for Pregnant Women with Diabetes Recruiting Copenhagen, Kbh Ø, Denmark, 2100 Contact: Elisabeth Mathiesen, DMSc       em@rh.dk    Contact: Marianne Vestgaard, MD       marianne.jenlev.vestgaard@regionh.dk Less <<
NCT02210806 Asthma Phase 2 Completed - United States, California ... More >> Amphastar Site 0001 San Jose, California, United States, 95117 United States, Oregon Amphastar Site 0025 Medford, Oregon, United States, 97504 United States, Texas Amphastar Site 0030 New Braunfels, Texas, United States, 78130 Amphastar Site 0032 San Antonio, Texas, United States, 78229 Less <<
NCT03284463 Acute Stroke Phase 4 Recruiting September 30, 2021 China, Guangdong ... More >> Huadu District People's Hospital of Guangzhou Not yet recruiting Guangzhou, Guangdong, China, 510515 Contact: Xiangmin Liu, M.D.          Nanfang Hospital of Southern Medical University Recruiting Guangzhou, Guangdong, China Contact: Kaibin Huang       hkb@smu.edu.cn    Principal Investigator: Suyue Pan, M.D., Ph.D.          Heyuan People's Hospital Recruiting Heyuan, Guangdong, China Contact: Yunqiang Huang, M.D.    +8613750225240    13750225240@126.com    Maoming People's Hospital Recruiting Maoming, Guangdong, China Contact: Hao Li, M.D.       185416656@qq.com    Principal Investigator: Zhi Yan, M.D.          Maoming Traditional Chinese Medical Hospital Recruiting Maoming, Guangdong, China Contact: Dongrun Yan, M.D.       1792191@qq.com    Principal Investigator: Wenguo Huang, M.D.          China, Hainan Hainan Provincial Hospital of Traditional Chinese Medicine Recruiting Haikou, Hainan, China, 570100 Contact: Guangfeng Zhao, M.D.    +8613700410380    408195770@qq.com    Principal Investigator: Guohu Weng, M.D.          China, Jiangsu The First Affiliated Hospital of Wenzhou Medical University Recruiting Wenzhou, Jiangsu, China, 325000 Contact: Saijun Zhou, M.D.    +8613857746659    2498093074@qq.com    Principal Investigator: Xu Zhang, M.D. Less <<
NCT02317536 Muscle Function Phase 2 Completed - Canada, Ontario ... More >> KGK Synergize Inc. London, Ontario, Canada, N6A 5R8 Less <<
NCT03398005 Hypertriglyceridemia Phase 3 Recruiting August 2019 -
NCT02108613 Prostate Cancer Not Applicable Unknown March 2017 Canada, British Columbia ... More >> BC Cancer Agency Not yet recruiting Victoria, British Columbia, Canada, V*R 6V5 Principal Investigator: Jennifer Goulart, MD Less <<
NCT01389596 Epilepsy, Partial Seizures Phase 3 Completed - -
NCT03240783 Acute Sciatica Phase 2 Recruiting October 2018 Australia, New South Wales ... More >> St George Hospital Recruiting Kogarah, New South Wales, Australia, 2217 Contact: Marissa ND Lassere, MBBS PhD    +61 2 91132139    m.lassere@unsw.edu.au    Contact: Sue Baker, BSc    +61 2 91132705    sue.baker@health.nsw.gov.au    Principal Investigator: Marissa N Lassere, MBBS PhD          Sub-Investigator: Peter Smerdely, MBBS PhD          Sub-Investigator: Grant Pickard, MBChB FRACP          Sub-Investigator: Derek Glenn, MBBS FRANZCR          Sub-Investigator: Carl Bryant, MBBS FRANZCR          Sub-Investigator: Jeanette Thom, BSc PhD          Sub-Investigator: Kent Johnson, MA MD Less <<
NCT03361501 Hypertriglyceridemia Phase 3 Recruiting August 2019 -
NCT03596099 Prehypertension Not Applicable Recruiting February 2019 United States, Georgia ... More >> Primary Care Research Group Recruiting Atlanta, Georgia, United States, 30312 Contact: Kelsey Gates       primarycareresearch@outlook.com    United States, Texas Endothelix Research Site c/o Bellaire Cardiology Associates Recruiting Bellaire, Texas, United States, 77401 Contact: Peggy Cosner    979-236-4606    Peggy.cosner@endothelix.com    Contact: Yasamin Naghavi    +1 713-410-9115    Yasamin.naghavi@endothelix.com    Sub-Investigator: Parth Shah, MD Less <<
NCT01732003 Skeletal Muscle Energy Metabol... More >>ism Less << Not Applicable Unknown February 2013 Canada, Ontario ... More >> University of Guelph Recruiting Guelph, Ontario, Canada, N1G 2W1 Less <<
NCT01435382 - Completed - -
NCT01389596 - Completed - -
NCT01435382 Hypercholesterolemia ... More >> Dyslipidemias Hyperlipidemias Lipid Metabolism Disorders Metabolic Diseases Less << Phase 1 Completed - United States, California ... More >> Profil Institute for Clinical Research, Inc. Chula Vista, California, United States, 91911 United States, Florida Elite Research Institute Miami, Florida, United States, 33169 United States, Kansas Vince and Associates Clinical Research Overland Park, Kansas, United States, 66212 United States, Maryland PAREXEL International - Baltimore Early Phase Clinical Unit Baltimore, Maryland, United States, 21225 United States, Michigan Jasper Clinic, Inc. Kalamazoo, Michigan, United States, 49007 United States, Minnesota Prism Research Saint Paul, Minnesota, United States, 55114 United States, Ohio Medpace Clinical Pharmacology Unit Cincinnati, Ohio, United States, 45212 Less <<
NCT03405701 PCOS IVF ... More >> IVM Less << Not Applicable Recruiting June 30, 2020 Vietnam ... More >> Mỹ Đức Hospital Recruiting Ho Chi Minh City, Tan Binh, Vietnam Contact: Vu NA Ho, MD    +84935843336    bsvu.hna@myduchospital.vn    Contact: Lan N Vuong, MD, PhD    +843008889    drlan@yahoo.com.vn Less <<
NCT02050984 - Recruiting December 2018 China, Chongqing ... More >> The Third Military Medical University Recruiting Chongqing, Chongqing, China, 400042 Contact: Hongbo He, MD.    86-23-68757880    cqhehongbo@gmail.com    Principal Investigator: Zhiming Zhu, MD.,PhD. Less <<
NCT03368235 Rheumatoid Arthritis Phase 2 Recruiting August 4, 2019 Denmark ... More >> Research Site Withdrawn Frederiksberg, Denmark, 2000 Netherlands Research Site Recruiting Amsterdam, Netherlands, 1056 AB Research Site Not yet recruiting Enschede, Netherlands, 7512 KZ Research Site Recruiting Maastricht, Netherlands, 6229 HX Research Site Withdrawn Roosendaal, Netherlands, 4707 CH Research Site Recruiting Utrecht, Netherlands, 3584 CX Sweden Research Site Recruiting Göteborg, Sweden, 413 45 Research Site Recruiting Lund, Sweden, 221 85 Research Site Recruiting Uppsala, Sweden, 751 85 Less <<
NCT01712074 Alzheimer's Disease Phase 2 Terminated(The study was termi... More >>nated October 23, 2015 as pre-specified, interim analysis futility criteria were met. The termination was not due to safety concerns.) Less << - -
NCT02367742 NAFLD Not Applicable Completed - -
NCT03198728 Hypogonadism, Male Phase 3 Recruiting April 30, 2019 -
NCT01473420 Chronic Renal Failure ... More >> Chronic Kidney Disease Less << Phase 3 Completed - -
NCT01712074 - Terminated(The study was termi... More >>nated October 23, 2015 as pre-specified, interim analysis futility criteria were met. The termination was not due to safety concerns.) Less << - -
NCT02972333 EGFR-TKI Resistant Mutation ... More >> Nonsmall Cell Lung Cancer AZD9291 Brain Metastases Less << Phase 3 Not yet recruiting December 2019 -
NCT01473420 - Completed - -
NCT02726555 Dyslipidemia ... More >>Atherosclerosis Less << Phase 3 Recruiting May 2019 China, Zhejiang ... More >> The Second Hispital of Wenzhou Medical University Recruiting Wenzhou, Zhejiang, China, 325000 Contact: Kangting Ji, MD    +8613676403180    jikt@wzmc.edu.cn Less <<
NCT03039205 Platelet Aggregation ... More >> Adenosine Coronary Artery Disease Kidney Dysfunction Antiplatelet Therapy Less << Phase 2 Recruiting December 15, 2018 Brazil ... More >> Instituto do Coração (InCor) - Hospital das Clínicas da FMUSP Recruiting Sao Paulo, Brazil Contact: André Franci, M.D.    55 11 2661-5850 Less <<
NCT01473407 - Completed - -
NCT01473407 Chronic Kidney Disease ... More >> Chronic Renal Failure Less << Phase 3 Completed - -
NCT02130557 - Active, not recruiting - -
NCT02130557 Leukemia, Myelogenous, Chronic... More >>, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive Less << Phase 3 Active, not recruiting April 4, 2020 -
NCT02536846 Healthy Phase 4 Recruiting October 2021 United States, Massachusetts ... More >> McLean Hospital Recruiting Belmont, Massachusetts, United States, 02478 Sub-Investigator: Virginie-Anne Chouinard, MD          Principal Investigator: Dost Ongur, MD, PhD Less <<
NCT02441244 HIV-1 Infection Phase 2 Terminated(Recruitment potenti... More >>al impaired by shift in clinical care whereby practically all HIV patients receive standard treatment as soon as possible after HIV diagnosis) Less << - Canada, Ontario ... More >> Maple Leaf Medical Clinic Toronto, Ontario, Canada, M5G 1K2 Toronto General Hospital, UHN Toronto, Ontario, Canada, M5G 2N2 Less <<
NCT02627378 MERS-CoV Infection ... More >> Refractory Hypoxemia Less << Phase 1 Completed - Saudi Arabia ... More >> Dammam University KFHU Al-Khobar, EP, Saudi Arabia, 31952 Less <<
NCT02487342 Appetite Regulation Not Applicable Completed - -
NCT00531752 Attention Deficit Hyperactivit... More >>y Disorder Less << Phase 2 Completed - United States, California ... More >> Bay Area Research Institute Lafayette, California, United States, 94549 Pharmacology Research Institute Los Alamitos, California, United States, 90720 Pharmacology Research Institute Newport Beach, California, United States, 92660 United States, Illinois The University of Illinois at Chicago, Institute for Juvenile Research Chicago, Illinois, United States, 60608 United States, Massachusetts Massachusetts General Hospital, ADHD Program Cambridge, Massachusetts, United States, 02138 United States, New York New York University School of Medicine New York, New York, United States, 10010 United States, Virginia NeuroScience, Inc Herndon, Virginia, United States, 20170 Less <<
NCT00418561 Metachromatic Leukodystrophy (... More >>MLD) Less << Phase 1 Completed - Denmark ... More >> Rigshospitalet Hvidovre, Denmark, DK-2650 Less <<
NCT00531752 - Completed - -
NCT02072824 Partial Onset Seizures Phase 3 Completed - -
NCT00418561 - Completed - -
NCT00356863 - Completed - -
NCT00356863 Coronary Artery Disease Not Applicable Completed - Israel ... More >> Sheba Medical Center, the Gertner institute for epidemiology and health service research Ramat Gan, Israel, 52621 Less <<
NCT02428998 Healthy Diabe... More >>tes Hypertension Hyperlipidemia Less << Not Applicable Completed - Korea, Republic of ... More >> Catholic Universtiy of Korea. Seoul St Mary's Hospital Seoul, Korea, Republic of, 137-701 Less <<
NCT02072824 - Completed - -
NCT01943006 Thrombophlebitis ... More >> Phlebitis Less << Phase 3 Completed - Thailand ... More >> Siriraj Hospital Bangkok, Thailand, 107000 Chulalongkorn Hospital Bangkok, Thailand Rajvithi Hospital Bangkok, Thailand Bamrasnaradua Infectious Diseases Institute Nonthaburi, Thailand Less <<
NCT00744497 - Completed - -
NCT00231673 Diabetic Neuropathies ... More >> Diabetes Mellitus, Type 2 Polyneuropathies Less << Phase 2 Completed - -
NCT00744497 Prostatic Neoplasms Phase 3 Completed - -
NCT00241904 Cardiovascular Diseases ... More >> Heart Diseases Coronary Disease Diabetes Mellitus Atherosclerosis Cerebral Arteriosclerosis Hypertension Less << Phase 4 Completed - United States, Maryland ... More >> Johns Hopkins University Baltimore, Maryland, United States, 21205 Less <<
NCT03527498 Hypoxic-Ischemic Encephalopath... More >>y Periventricular Leukomalacia Intraventricular Hemorrhage Bilirubin Encephalopathy Kernicterus Hypoglycemia, Neonatal Cerebral Infarction Less << Not Applicable Not yet recruiting December 31, 2020 China, Shanghai ... More >> Children Hospital of Fudan University Shanghai, Shanghai, China, 201102 Less <<
NCT00241904 - Completed - -
NCT00263393 Myocardial Infarction ... More >> Angina Pectoris Cerebrovascular Accidents Diabetes Mellitus Less << Phase 4 Completed - India ... More >> Byrraju Foundation Primary Healthcare Centres in rural West Godavari and East Godavari Dstricts Bhimavaram, Andhra Pradesh, India Less <<
NCT03542240 Obesity High ... More >>Blood Pressure High Cholesterol Type2 Diabetes Heart Diseases Less << Not Applicable Recruiting December 1, 2019 United States, Virginia ... More >> Virginia Commonwealth University Recruiting Richmond, Virginia, United States, 23298 Less <<
NCT00241085 PROTEINURIA H... More >>ypertension Type 2 Diabetes Less << Phase 4 Completed - -
NCT00263419 Albuminuria D... More >>iabetes Mellitus, Type 2 Diabetes Complications Less << Not Applicable Unknown June 2012 Germany ... More >> Department of Medicine, University of Heidelberg Heidelberg, Germany, 69120 Less <<
NCT00263939 Diabetes Mellitus ... More >> Congestive Heart Failure Arthritis COPD Depression Less << Not Applicable Completed - United States, California ... More >> UC Davis Medical Center Sacramento, California, United States, 95817 Less <<
NCT02278562 ESRD Phase 2 Completed - United States, Tennessee ... More >> Tennessee Valley Healthcare System Nashville Campus, Nashville, TN Nashville, Tennessee, United States, 37212-2637 Less <<
NCT03534466 Hypoxic-Ischemic Encephalopath... More >>y Periventricular Leukomalacia Intraventricular Hemorrhage Neonatal Bilirubin Encephalopathy Kernicterus Hypoglycemia, Neonatal Cerebral Infarction Less << Not Applicable Not yet recruiting December 31, 2020 China, Shanghai ... More >> Children Hospital of Fudan University Shanghai, Shanghai, China, 201102 Less <<
NCT00273104 Obstructive Sleep Apnea ... More >> Diabetes Mellitus Hypertension Less << Not Applicable Completed - Norway ... More >> Hospital in Vestfold Tonsberg, Norway, 3117 Less <<
NCT02276144 - Recruiting November 2019 Korea, Republic of ... More >> Seoul Women's Hospital Recruiting Incheon, Korea, Republic of, 402859 Contact: Ja Nam Koo, M.D    010-8355-2180       Seoul National University Hospital Recruiting Seoul, Korea, Republic of, 110744 Contact: Joong Shin Park, MD PhD          Contact: Sun Min Kim, MD          Seoul Metropolitan Goverment Seoul National University Boramae Medical Center Recruiting Seoul, Korea, Republic of, 156707 Contact: Seung Mi Lee, M.D, Ph.D. Less <<
NCT00276367 - Withdrawn(is involved in NIH s... More >>tudy) Less << - -
NCT02278562 - Completed - -
NCT00264394 Coronary Heart Disease ... More >> Dyslipidemia Diabetes Mellitus, Non-Insulin-Dependent HIV Infection Less << Phase 4 Completed - Switzerland ... More >> Departement Innere Medizin Kantonsspital St. Gallen St. Gallen, Canton St. Gall, Switzerland, CH-9007 Ospedale Civico Lugano Lugano, Canton Ticino, Switzerland, CH-6903 Abteilung für Infektionskrankheiten & Spitalhygiene, Universitätsspital Zürich Zurich, Canton Zurich, Switzerland, CH-8091 University Hospital Basel Basel, Kanton Basel Stadt, Switzerland, CH-4031 Division Maladies Infectieuses, Hopital Universitaire Vaudois (CHUV) Lausanne, Vaud, Switzerland, CH-1011 Klinik und Poliklinik für Infektiologie, Inselspital Berne, Switzerland, CH-3010 Division des Maladies Infectieuses, Hopital Universitaire Geneve Geneva, Switzerland, CH-1211 Less <<
NCT01143948 Type 2 Diabetes ... More >> Liver Cirrhosis Less << Phase 4 Unknown May 2011 Egypt ... More >> Internal medicine hospital ,Cairo University Active, not recruiting Cairo, Egypt, 11956 Less <<
NCT00278980 Diabetes Mellitus, Type 1 ... More >> Diabetic Polyneuropathy Less << Phase 2 Completed - Sweden ... More >> Karolinska University Hospital Solna Stockholm, Sweden, SE-171 76 Less <<
NCT01143480 - Enrolling by invitation - United States, North Carolina ... More >> NIEHS Clinical Research Unit (CRU) Research Triangle Park, North Carolina, United States Less <<
NCT03652987 - Not yet recruiting September 2023 -
NCT02718378 Prostatic Neoplasms Phase 1 Completed - Netherlands ... More >> QPS Netherlands BV Groningen, Netherlands, 9713 AG Less <<
NCT04821882 Bladder Pain Syndrome|Intersti... More >>tial Cystitis Less << COMPLETED 2020-10-11 National Defense of Medical Ce... More >>nter, Tri-Service General Hospital, Taipei city, 114, Taiwan Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

5.55mL

1.11mL

0.56mL

27.75mL

5.55mL

2.78mL

55.51mL

11.10mL

5.55mL
Dissolving Methods
The prepared working fluid is recommended to be prepared now and used up as soon as possible in a short period of time. The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1

References

[1]Jin Jiaojiao, et al. D-glucose, D-galactose, and D-lactose non-enzyme quantitative and qualitative analysis method based on Cu foam electrode. Food Chem. 2015 May 15;175:485-93.

[2]Rossini AA, et al. Beta cell protection to alloxan necrosis by anomers of D-glucose. Science. 1974;183(4123):424.

[3]Kim M, et al. D-glucose releases 5-hydroxytryptamine from human BON cells as a model of enterochromaffin cells. Gastroenterology. 2001 Dec;121(6):1400-6.

 

Historical Records

Categories

Chemistry
Organic Building Blocks
Alcohols
Pentahydroxyhexanal
Cell Biology
Cell Culture
Additive and Auxiliary Reagent
Pharmaceutical Research
Drug Analysis
Drug Standard

Tags: 50-99-7 synthesis path| 50-99-7 SDS| 50-99-7 COA| 50-99-7 purity| 50-99-7 application| 50-99-7 NMR| 50-99-7 COA| 50-99-7 structure